id|nct_id|result_group_id|ctgov_group_code|period|reason|count
5382326|NCT04608500|18504848|P2|Overall Study|Other|2
5382327|NCT04608500|18504849|P1|Overall Study|Other|6
5382328|NCT04608500|18504848|P2|Overall Study|Protocol Violation|0
5382329|NCT04608500|18504849|P1|Overall Study|Protocol Violation|1
5382330|NCT04608500|18504848|P2|Overall Study|Participant request|7
5382331|NCT04608500|18504849|P1|Overall Study|Participant request|11
5382332|NCT04608500|18504848|P2|Overall Study|Lost to Follow-up|9
5382333|NCT04608500|18504849|P1|Overall Study|Lost to Follow-up|15
5382334|NCT04608500|18504848|P2|Overall Study|Adverse Event|0
5382335|NCT04608500|18504849|P1|Overall Study|Adverse Event|2
5382336|NCT04574999|18504874|P2|Overall Study|Previous planned surgery|0
5382337|NCT04574999|18504875|P1|Overall Study|Previous planned surgery|1
5382338|NCT04574999|18504874|P2|Overall Study|Personal problems|0
5382339|NCT04574999|18504875|P1|Overall Study|Personal problems|1
5382340|NCT04574999|18504874|P2|Overall Study|Lost to Follow-up|0
5382341|NCT04574999|18504875|P1|Overall Study|Lost to Follow-up|1
5382342|NCT04574999|18504874|P2|Overall Study|Withdrawal by Subject|2
5382343|NCT04574999|18504875|P1|Overall Study|Withdrawal by Subject|2
5382344|NCT04574999|18504874|P2|Overall Study|Protocol Violation|0
5382345|NCT04574999|18504875|P1|Overall Study|Protocol Violation|1
5382346|NCT04574999|18504874|P2|Overall Study|Lack of Efficacy|3
5382347|NCT04574999|18504875|P1|Overall Study|Lack of Efficacy|2
5382348|NCT04574999|18504874|P2|Overall Study|Adverse Event|0
5382349|NCT04574999|18504875|P1|Overall Study|Adverse Event|1
5382350|NCT04542694|18504931|P2|Overall Study|Protocol Violation|0
5382351|NCT04542694|18504932|P1|Overall Study|Protocol Violation|1
5382352|NCT04542694|18504931|P2|Overall Study|Adverse Event|0
5382353|NCT04542694|18504932|P1|Overall Study|Adverse Event|1
5382354|NCT04542694|18504931|P2|Overall Study|The need for prohibited therapy|0
5382355|NCT04542694|18504932|P1|Overall Study|The need for prohibited therapy|2
5382356|NCT04534491|18504972|P1|Overall Study|Non-verifiable users|58
5382357|NCT04534491|18504972|P1|Overall Study|Non-users|70
5382358|NCT04534491|18504972|P1|Overall Study|Not completed end-of-study interview|24
5382359|NCT04532164|18505067|P1|Overall Study|Withdrawal by Subject|14
5382360|NCT04532164|18505067|P1|Overall Study|Found to be Ineligible|3
5382361|NCT04532164|18505067|P1|Overall Study|Lost to Follow-up|1
5382362|NCT04532164|18505067|P1|Overall Study|Protocol Violation|5
5382363|NCT04532164|18505067|P1|Overall Study|Adverse Event|1
5382364|NCT04531813|18505078|P1|Overall Study|Withdrawal by Subject|1
5382365|NCT04531813|18505078|P1|Overall Study|Protocol Violation|1
5382366|NCT04531540|18505082|P1|Overall Study|Found to be Ineligible|1
5382367|NCT04531540|18505082|P1|Overall Study|Withdrawal by Subject|4
5382368|NCT04531540|18505082|P1|Overall Study|Protocol Violation|3
5382369|NCT04531540|18505082|P1|Overall Study|Adverse Event|1
5382370|NCT04531527|18505089|P1|Overall Study|Found to be Ineligible|3
5382371|NCT04523831|18505096|P2|Overall Study|Adverse Event|0
5382372|NCT04523831|18505097|P1|Overall Study|Adverse Event|2
5382373|NCT04523831|18505096|P2|Overall Study|Death|3
5382374|NCT04523831|18505097|P1|Overall Study|Death|0
5382375|NCT04523831|18505096|P2|Overall Study|Lost to Follow-up|17
5382376|NCT04523831|18505097|P1|Overall Study|Lost to Follow-up|15
5382377|NCT04512482|18505111|P2|Second Intervention (1 Day)|Protocol Violation|1
5382378|NCT04512482|18505112|P1|Second Intervention (1 Day)|Protocol Violation|2
5382379|NCT04502979|18505120|P2|Overall Study|Withdrawal by Subject|1
5382380|NCT04502979|18505121|P1|Overall Study|Withdrawal by Subject|2
5382381|NCT04502979|18505120|P2|Overall Study|Lost to Follow-up|3
5382382|NCT04502979|18505121|P1|Overall Study|Lost to Follow-up|1
5382383|NCT04491994|18505150|P2|Overall Study|Lost to Follow-up|3
5382384|NCT04491994|18505151|P1|Overall Study|Lost to Follow-up|4
5382385|NCT04491994|18505150|P2|Overall Study|Protocol Violation|2
5382386|NCT04491994|18505151|P1|Overall Study|Protocol Violation|11
5382387|NCT04491994|18505150|P2|Overall Study|developed fever > 3 days|1
5382388|NCT04491994|18505151|P1|Overall Study|developed fever > 3 days|4
5382389|NCT04491994|18505150|P2|Overall Study|Withdrawal by Subject|5
5382390|NCT04491994|18505151|P1|Overall Study|Withdrawal by Subject|10
5382391|NCT04483011|18505187|P2|Washout (7 Days)|Withdrawal by Subject|1
5382392|NCT04483011|18505188|P1|Washout (7 Days)|Withdrawal by Subject|0
5382393|NCT04474405|18505222|P6|Overall Study|Other|0
5382394|NCT04474405|18505223|P5|Overall Study|Other|3
5382395|NCT04474405|18505224|P4|Overall Study|Other|0
5382396|NCT04474405|18505225|P3|Overall Study|Other|0
5382397|NCT04474405|18505226|P2|Overall Study|Other|0
5382398|NCT04474405|18505227|P1|Overall Study|Other|0
5382399|NCT04474405|18505222|P6|Overall Study|Withdrawal by Subject|0
5382400|NCT04474405|18505223|P5|Overall Study|Withdrawal by Subject|1
5382401|NCT04474405|18505224|P4|Overall Study|Withdrawal by Subject|0
5382402|NCT04474405|18505225|P3|Overall Study|Withdrawal by Subject|1
5382403|NCT04474405|18505226|P2|Overall Study|Withdrawal by Subject|0
5382404|NCT04474405|18505227|P1|Overall Study|Withdrawal by Subject|0
5382405|NCT04468347|18505254|P4|Overall Study|Protocol Violation|0
5382406|NCT04468347|18505255|P3|Overall Study|Protocol Violation|0
5382407|NCT04468347|18505256|P2|Overall Study|Protocol Violation|0
5382408|NCT04468347|18505257|P1|Overall Study|Protocol Violation|1
5382409|NCT04468347|18505254|P4|Overall Study|Physician Decision|0
5382410|NCT04468347|18505255|P3|Overall Study|Physician Decision|2
5382411|NCT04468347|18505256|P2|Overall Study|Physician Decision|0
5382412|NCT04468347|18505257|P1|Overall Study|Physician Decision|1
5382413|NCT04468347|18505254|P4|Overall Study|Lost to Follow-up|1
5382414|NCT04468347|18505255|P3|Overall Study|Lost to Follow-up|1
5382415|NCT04468347|18505256|P2|Overall Study|Lost to Follow-up|0
5382416|NCT04468347|18505257|P1|Overall Study|Lost to Follow-up|0
5382417|NCT04468347|18505254|P4|Overall Study|Withdrawal by Subject|3
5382418|NCT04468347|18505255|P3|Overall Study|Withdrawal by Subject|3
5382419|NCT04468347|18505256|P2|Overall Study|Withdrawal by Subject|1
5382420|NCT04468347|18505257|P1|Overall Study|Withdrawal by Subject|0
5382421|NCT04435808|18505359|P2|Overall Study|Study stopped by DSMB|1
5382422|NCT04435808|18505360|P1|Overall Study|Study stopped by DSMB|0
5382423|NCT04425863|18505369|P3|Overall Study|Death|1
5382424|NCT04425863|18505370|P2|Overall Study|Death|0
5382425|NCT04425863|18505371|P1|Overall Study|Death|0
5382426|NCT04422561|18505404|P2|Overall Study|Lost to Follow-up|11
5382427|NCT04422561|18505405|P1|Overall Study|Lost to Follow-up|25
5382428|NCT04406194|18505446|P2|Period 1|Withdrawal by Subject|1
5382429|NCT04406194|18505447|P1|Period 1|Withdrawal by Subject|0
5382430|NCT04400682|18505491|P2|Period 1|Withdrawal by Subject|4
5382431|NCT04400682|18505492|P1|Period 1|Withdrawal by Subject|1
5382432|NCT04399161|18505507|P3|Overall Study|Protocol Violation|0
5382433|NCT04399161|18505508|P2|Overall Study|Protocol Violation|2
5382434|NCT04399161|18505509|P1|Overall Study|Protocol Violation|1
5382435|NCT04399161|18505507|P3|Overall Study|Withdrawal by Subject|2
5382436|NCT04399161|18505508|P2|Overall Study|Withdrawal by Subject|0
5382437|NCT04399161|18505509|P1|Overall Study|Withdrawal by Subject|1
5382438|NCT04393493|18505530|P2|First 4 Days of Intervention|Early improvement|7
5382439|NCT04393493|18505531|P1|First 4 Days of Intervention|Early improvement|5
5382440|NCT04376060|18505621|P1|Overall Study|Physician Decision|1
5382441|NCT04359771|18505684|P2|Overall Study|Lack of Efficacy|2
5382442|NCT04359771|18505685|P1|Overall Study|Lack of Efficacy|2
5382443|NCT04355663|18505700|P3|Overall Study|Withdrawal by Subject|3
5382444|NCT04355663|18505701|P2|Overall Study|Withdrawal by Subject|8
5382445|NCT04355663|18505702|P1|Overall Study|Withdrawal by Subject|0
5382446|NCT04355663|18505700|P3|Overall Study|Adverse Event|1
5382447|NCT04355663|18505701|P2|Overall Study|Adverse Event|0
5382448|NCT04355663|18505702|P1|Overall Study|Adverse Event|0
5382449|NCT04355663|18505700|P3|Overall Study|Physician Decision|0
5382450|NCT04355663|18505701|P2|Overall Study|Physician Decision|7
5382451|NCT04355663|18505702|P1|Overall Study|Physician Decision|2
5382452|NCT04350788|18505745|P2|Overall Study|Protocol Violation|0
5382453|NCT04350788|18505746|P1|Overall Study|Protocol Violation|4
5382454|NCT04350788|18505745|P2|Overall Study|Withdrawal by Subject|4
5382455|NCT04350788|18505746|P1|Overall Study|Withdrawal by Subject|2
5382456|NCT04350788|18505745|P2|Overall Study|Lost to Follow-up|2
5382457|NCT04350788|18505746|P1|Overall Study|Lost to Follow-up|6
5382458|NCT04348851|18505802|P4|Post-Test 2|Stroke survivor death|1
5382459|NCT04348851|18505803|P3|Post-Test 2|Stroke survivor death|0
5382460|NCT04348851|18505804|P2|Post-Test 2|Stroke survivor death|1
5382461|NCT04348851|18505805|P1|Post-Test 2|Stroke survivor death|0
5382462|NCT04348851|18505802|P4|Post-Test 1|Lost to Follow-up|0
5382463|NCT04348851|18505803|P3|Post-Test 1|Lost to Follow-up|0
5382464|NCT04348851|18505804|P2|Post-Test 1|Lost to Follow-up|1
5382465|NCT04348851|18505805|P1|Post-Test 1|Lost to Follow-up|0
5382466|NCT04348851|18505802|P4|Post-Test 1|Withdrawal by Subject|0
5382467|NCT04348851|18505803|P3|Post-Test 1|Withdrawal by Subject|0
5382468|NCT04348851|18505804|P2|Post-Test 1|Withdrawal by Subject|1
5382469|NCT04348851|18505805|P1|Post-Test 1|Withdrawal by Subject|0
5382470|NCT04343261|18505912|P1|Overall Study|received inadequate amount of antibodies|7
5382471|NCT04343261|18505912|P1|Overall Study|Adverse Event|1
5382472|NCT04339296|18505953|P2|Overall Study|Discontinued intervention|3
5382473|NCT04339296|18505954|P1|Overall Study|Discontinued intervention|5
5382474|NCT04339296|18505953|P2|Overall Study|Lost to Follow-up|4
5382475|NCT04339296|18505954|P1|Overall Study|Lost to Follow-up|0
5382476|NCT04339296|18505953|P2|Overall Study|Withdrew after completion of baseline|1
5382477|NCT04339296|18505954|P1|Overall Study|Withdrew after completion of baseline|2
5382478|NCT04339296|18505953|P2|Overall Study|Refuse to participate after allocation|1
5382479|NCT04339296|18505954|P1|Overall Study|Refuse to participate after allocation|1
5382480|NCT04336475|18505964|P2|Overall Study|Lost to Follow-up|2
5382481|NCT04336475|18505965|P1|Overall Study|Lost to Follow-up|0
5382482|NCT04336475|18505964|P2|Overall Study|upper respiratory infection|0
5382483|NCT04336475|18505965|P1|Overall Study|upper respiratory infection|1
5382484|NCT04336475|18505964|P2|Overall Study|pain|0
5382485|NCT04336475|18505965|P1|Overall Study|pain|1
5382486|NCT04329923|18505977|P6|Overall Study|positive SARS-COV2 PCR at baseline|2
5382487|NCT04329923|18505978|P5|Overall Study|positive SARS-COV2 PCR at baseline|0
5382488|NCT04329923|18505979|P4|Overall Study|positive SARS-COV2 PCR at baseline|0
5382489|NCT04329923|18505980|P3|Overall Study|positive SARS-COV2 PCR at baseline|0
5382490|NCT04329923|18505981|P2|Overall Study|positive SARS-COV2 PCR at baseline|0
5382491|NCT04329923|18505982|P1|Overall Study|positive SARS-COV2 PCR at baseline|0
5382492|NCT04329923|18505977|P6|Overall Study|early termination of study|2
5382493|NCT04329923|18505978|P5|Overall Study|early termination of study|1
5382494|NCT04329923|18505979|P4|Overall Study|early termination of study|0
5382495|NCT04329923|18505980|P3|Overall Study|early termination of study|0
5382496|NCT04329923|18505981|P2|Overall Study|early termination of study|0
5382497|NCT04329923|18505982|P1|Overall Study|early termination of study|0
5382498|NCT04329923|18505977|P6|Overall Study|Withdrawal by Subject|1
5382499|NCT04329923|18505978|P5|Overall Study|Withdrawal by Subject|1
5382500|NCT04329923|18505979|P4|Overall Study|Withdrawal by Subject|1
5382501|NCT04329923|18505980|P3|Overall Study|Withdrawal by Subject|1
5544941|NCT01288430|19164750|P2|Part 2|Other|0
5382502|NCT04329923|18505981|P2|Overall Study|Withdrawal by Subject|4
5382503|NCT04329923|18505982|P1|Overall Study|Withdrawal by Subject|1
5382504|NCT04322526|18506079|P2|Washout (1 Week)|Lost to Follow-up|2
5382505|NCT04322526|18506080|P1|Washout (1 Week)|Lost to Follow-up|1
5382506|NCT04322526|18506079|P2|First Intervention (1 Day)|Withdrawal by Subject|1
5382507|NCT04322526|18506080|P1|First Intervention (1 Day)|Withdrawal by Subject|1
5382508|NCT04318535|18506097|P3|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
5382509|NCT04318535|18506098|P2|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1
5382510|NCT04318535|18506099|P1|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
5382511|NCT04308239|18506173|P2|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
5382512|NCT04308239|18506174|P1|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
5382513|NCT04308239|18506173|P2|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
5382514|NCT04308239|18506174|P1|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
5382515|NCT04308239|18506173|P2|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
5382516|NCT04308239|18506174|P1|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
5382517|NCT04308239|18506173|P2|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
5382518|NCT04308239|18506174|P1|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
5382519|NCT04295356|18506217|P2|Overall Study|Protocol Violation|1
5382520|NCT04295356|18506218|P1|Overall Study|Protocol Violation|0
5382521|NCT04295356|18506217|P2|Overall Study|Lost to Follow-up|3
5382522|NCT04295356|18506218|P1|Overall Study|Lost to Follow-up|0
5382523|NCT04295356|18506217|P2|Overall Study|Physician Decision|0
5382524|NCT04295356|18506218|P1|Overall Study|Physician Decision|1
5382525|NCT04292899|18506246|P4|Overall Study|Protocol Violation|1
5382526|NCT04292899|18506247|P3|Overall Study|Protocol Violation|0
5382527|NCT04292899|18506248|P2|Overall Study|Protocol Violation|0
5382528|NCT04292899|18506249|P1|Overall Study|Protocol Violation|0
5382529|NCT04292899|18506246|P4|Overall Study|Non-compliance With Study Drug|1
5382530|NCT04292899|18506247|P3|Overall Study|Non-compliance With Study Drug|0
5382531|NCT04292899|18506248|P2|Overall Study|Non-compliance With Study Drug|0
5382532|NCT04292899|18506249|P1|Overall Study|Non-compliance With Study Drug|0
5382533|NCT04292899|18506246|P4|Overall Study|Investigator's Discretion|3
5382534|NCT04292899|18506247|P3|Overall Study|Investigator's Discretion|0
5382535|NCT04292899|18506248|P2|Overall Study|Investigator's Discretion|0
5382536|NCT04292899|18506249|P1|Overall Study|Investigator's Discretion|0
5382537|NCT04292899|18506246|P4|Overall Study|Adverse Event|2
5382538|NCT04292899|18506247|P3|Overall Study|Adverse Event|2
5382539|NCT04292899|18506248|P2|Overall Study|Adverse Event|1
5382540|NCT04292899|18506249|P1|Overall Study|Adverse Event|2
5382541|NCT04292899|18506246|P4|Overall Study|Withdrew consent|32
5382542|NCT04292899|18506247|P3|Overall Study|Withdrew consent|11
5382543|NCT04292899|18506248|P2|Overall Study|Withdrew consent|0
5382544|NCT04292899|18506249|P1|Overall Study|Withdrew consent|1
5382545|NCT04292899|18506246|P4|Overall Study|Lost to Follow-up|235
5382546|NCT04292899|18506247|P3|Overall Study|Lost to Follow-up|22
5382547|NCT04292899|18506248|P2|Overall Study|Lost to Follow-up|4
5382548|NCT04292899|18506249|P1|Overall Study|Lost to Follow-up|8
5382549|NCT04292899|18506246|P4|Overall Study|Death|371
5382550|NCT04292899|18506247|P3|Overall Study|Death|188
5382551|NCT04292899|18506248|P2|Overall Study|Death|28
5382552|NCT04292899|18506249|P1|Overall Study|Death|21
5382553|NCT04292171|18506265|P2|Overall Study|Delivered prior to procedure|1
5382554|NCT04292171|18506266|P1|Overall Study|Delivered prior to procedure|0
5382555|NCT04292171|18506265|P2|Overall Study|Pharmacy error|0
5382556|NCT04292171|18506266|P1|Overall Study|Pharmacy error|2
5382557|NCT04287517|18506301|P2|Overall Study|Withdrawal by Subject|1
5382558|NCT04287517|18506302|P1|Overall Study|Withdrawal by Subject|1
5382559|NCT04280705|18506336|P2|Overall Study|Transferred to another hospital|1
5382560|NCT04280705|18506337|P1|Overall Study|Transferred to another hospital|1
5382561|NCT04280705|18506336|P2|Overall Study|Adverse Event|4
5382562|NCT04280705|18506337|P1|Overall Study|Adverse Event|0
5382563|NCT04280705|18506336|P2|Overall Study|Withdrawal by Subject|9
5382564|NCT04280705|18506337|P1|Overall Study|Withdrawal by Subject|7
5382565|NCT04280705|18506336|P2|Overall Study|Physician Decision|0
5382566|NCT04280705|18506337|P1|Overall Study|Physician Decision|1
5382567|NCT04280705|18506336|P2|Overall Study|Enrolled but not treated|10
5382568|NCT04280705|18506337|P1|Overall Study|Enrolled but not treated|4
5382569|NCT04272775|18506435|P2|Overall Study|Progressive Disease|1
5382570|NCT04272775|18506436|P1|Overall Study|Progressive Disease|3
5382571|NCT04272775|18506435|P2|Overall Study|Adverse Event|2
5382572|NCT04272775|18506436|P1|Overall Study|Adverse Event|1
5382573|NCT04272775|18506435|P2|Overall Study|Withdrawal by Subject|2
5382574|NCT04272775|18506436|P1|Overall Study|Withdrawal by Subject|1
5382575|NCT04272775|18506435|P2|Overall Study|Symptomatic Deterioration|1
5382576|NCT04272775|18506436|P1|Overall Study|Symptomatic Deterioration|1
5382577|NCT04272775|18506435|P2|Overall Study|Protocol Violation|1
5382578|NCT04272775|18506436|P1|Overall Study|Protocol Violation|0
5382579|NCT04272775|18506435|P2|Overall Study|Study Terminated by Sponsor|0
5382580|NCT04272775|18506436|P1|Overall Study|Study Terminated by Sponsor|1
5382581|NCT04223232|18506646|P1|Overall Study|Withdrawal by Subject|1
5382582|NCT04222699|18506675|P1|Overall Study|Lost to Follow-up|2
5382583|NCT04214600|18506710|P2|Overall Study|Lost to Follow-up|14
5382584|NCT04214600|18506711|P1|Overall Study|Lost to Follow-up|9
5382585|NCT04195893|18506787|P2|Second Intervention|Withdrawal by Subject|0
5382586|NCT04195893|18506788|P1|Second Intervention|Withdrawal by Subject|1
5382587|NCT04194151|18506847|P6|Overall Study|Monitorization problem|0
5382588|NCT04194151|18506848|P5|Overall Study|Monitorization problem|0
5382589|NCT04194151|18506849|P4|Overall Study|Monitorization problem|0
5382590|NCT04194151|18506850|P3|Overall Study|Monitorization problem|0
5382591|NCT04194151|18506851|P2|Overall Study|Monitorization problem|1
5382592|NCT04194151|18506852|P1|Overall Study|Monitorization problem|0
5382593|NCT04194151|18506847|P6|Overall Study|Physician Decision|1
5382594|NCT04194151|18506848|P5|Overall Study|Physician Decision|0
5382595|NCT04194151|18506849|P4|Overall Study|Physician Decision|1
5382596|NCT04194151|18506850|P3|Overall Study|Physician Decision|1
5382597|NCT04194151|18506851|P2|Overall Study|Physician Decision|1
5382598|NCT04194151|18506852|P1|Overall Study|Physician Decision|1
5382599|NCT04186806|18506892|P2|Period 1: 7 Days|Adverse Event|0
5382600|NCT04186806|18506893|P1|Period 1: 7 Days|Adverse Event|1
5382601|NCT04179838|18507049|P2|Second Intervention (1 Day)|Protocol Violation|1
5382602|NCT04179838|18507050|P1|Second Intervention (1 Day)|Protocol Violation|0
5382603|NCT04179838|18507049|P2|First Intervention (1 Day)|Withdrawal by Subject|3
5382604|NCT04179838|18507050|P1|First Intervention (1 Day)|Withdrawal by Subject|0
5382605|NCT04178590|18507068|P1|Overall Study|Lost to Follow-up|1
5382606|NCT04178590|18507068|P1|Overall Study|Pregnancy|1
5382607|NCT04173741|18507178|P2|Overall Study|IVC measurement cannot be done|1
5382608|NCT04173741|18507179|P1|Overall Study|IVC measurement cannot be done|1
5382609|NCT04170686|18507200|P2|Randomization and Treatment|Lost to Follow-up|15
5382610|NCT04170686|18507201|P1|Randomization and Treatment|Lost to Follow-up|26
5382611|NCT04170686|18507200|P2|Screening|Physician Decision|13
5382612|NCT04170686|18507201|P1|Screening|Physician Decision|12
5382613|NCT04161079|18507268|P1|Clinical Investigation 2010-040|Adverse Event|1
5382614|NCT04149353|18507506|P1|Overall Study|Study terminated|1
5382615|NCT04142216|18507534|P2|Overall Study|Use of clove|1
5382616|NCT04142216|18507535|P1|Overall Study|Use of clove|0
5382617|NCT04142216|18507534|P2|Overall Study|Referral to another hemodialysis unit|2
5382618|NCT04142216|18507535|P1|Overall Study|Referral to another hemodialysis unit|3
5382619|NCT04142216|18507534|P2|Overall Study|Death|1
5382620|NCT04142216|18507535|P1|Overall Study|Death|3
5382621|NCT04142216|18507534|P2|Overall Study|Hospitalization|2
5382622|NCT04142216|18507535|P1|Overall Study|Hospitalization|0
5382623|NCT04140890|18507557|P2|Overall Study|Withdrawal by Subject|1
5382624|NCT04140890|18507558|P1|Overall Study|Withdrawal by Subject|0
5382625|NCT04138810|18507586|P2|Overall Study|Subject cancelled surgery|0
5382626|NCT04138810|18507587|P1|Overall Study|Subject cancelled surgery|1
5382627|NCT04138810|18507586|P2|Overall Study|Withdrawal by Subject|1
5382628|NCT04138810|18507587|P1|Overall Study|Withdrawal by Subject|0
5382629|NCT04128293|18507667|P4|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5382630|NCT04128293|18507668|P3|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5382631|NCT04128293|18507669|P2|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5382632|NCT04128293|18507670|P1|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
5382633|NCT04123665|18507870|P2|Overall Study|Lost to Follow-up|0
5382634|NCT04123665|18507871|P1|Overall Study|Lost to Follow-up|1
5382635|NCT04123665|18507870|P2|Overall Study|Withdrawal by Subject|0
5382636|NCT04123665|18507871|P1|Overall Study|Withdrawal by Subject|7
5382637|NCT04122534|18507893|P1|Overall Study|Lost to Follow-up|4
5382638|NCT04109222|18507980|P3|Overall Study|Adverse Event|0
5382639|NCT04109222|18507981|P2|Overall Study|Adverse Event|0
5382640|NCT04109222|18507982|P1|Overall Study|Adverse Event|1
5382641|NCT04106817|18507993|P3|Overall Study|Lost to Follow-up|0
5382642|NCT04106817|18507994|P2|Overall Study|Lost to Follow-up|0
5382643|NCT04106817|18507995|P1|Overall Study|Lost to Follow-up|1
5382644|NCT04098809|18508011|P2|Overall Study|Physician Decision|1
5382645|NCT04098809|18508012|P1|Overall Study|Physician Decision|2
5382646|NCT04098809|18508011|P2|Overall Study|Withdrawal by Subject|3
5382647|NCT04098809|18508012|P1|Overall Study|Withdrawal by Subject|1
5382648|NCT04095286|18508038|P6|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5382649|NCT04095286|18508039|P5|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
5382650|NCT04095286|18508040|P4|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5382651|NCT04095286|18508041|P3|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5382652|NCT04095286|18508042|P2|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5382653|NCT04095286|18508043|P1|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
5382654|NCT04095286|18508038|P6|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382655|NCT04095286|18508039|P5|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382656|NCT04095286|18508040|P4|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382657|NCT04095286|18508041|P3|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
5382658|NCT04095286|18508042|P2|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382659|NCT04095286|18508043|P1|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382660|NCT04095286|18508038|P6|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5382661|NCT04095286|18508039|P5|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5382662|NCT04095286|18508040|P4|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5382663|NCT04095286|18508041|P3|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
5382664|NCT04095286|18508042|P2|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5382665|NCT04095286|18508043|P1|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
5382666|NCT04095286|18508038|P6|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5544942|NCT01288430|19164751|P1|Part 2|Other|0
5382667|NCT04095286|18508039|P5|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5382668|NCT04095286|18508040|P4|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5382669|NCT04095286|18508041|P3|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5382670|NCT04095286|18508042|P2|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
5382671|NCT04095286|18508043|P1|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
5382672|NCT04095286|18508038|P6|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382673|NCT04095286|18508039|P5|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382674|NCT04095286|18508040|P4|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382675|NCT04095286|18508041|P3|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382676|NCT04095286|18508042|P2|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
5382677|NCT04095286|18508043|P1|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
5382678|NCT04091659|18508086|P2|Overall Study|Lost to Follow-up|1
5382679|NCT04091659|18508087|P1|Overall Study|Lost to Follow-up|0
5382680|NCT04091659|18508086|P2|Overall Study|Protocol Violation|0
5382681|NCT04091659|18508087|P1|Overall Study|Protocol Violation|3
5382682|NCT04090164|18508097|P2|Overall Study|incomplete data on file|0
5382683|NCT04090164|18508098|P1|Overall Study|incomplete data on file|245
5382684|NCT04086641|18508107|P2|Foot 1 (Two Week Utilization)|COVID-19|2
5382685|NCT04086641|18508108|P1|Foot 1 (Two Week Utilization)|COVID-19|1
5382686|NCT04080297|18508208|P2|Overall Study|concurrent illness|0
5382687|NCT04080297|18508209|P1|Overall Study|concurrent illness|1
5382688|NCT04080297|18508208|P2|Overall Study|Adverse Event|3
5382689|NCT04080297|18508209|P1|Overall Study|Adverse Event|1
5382690|NCT04079790|18508231|P4|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
5382691|NCT04079790|18508232|P3|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
5382692|NCT04079790|18508233|P2|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
5382693|NCT04079790|18508234|P1|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
5382694|NCT04079790|18508231|P4|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
5382695|NCT04079790|18508232|P3|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
5382696|NCT04079790|18508233|P2|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
5382697|NCT04079790|18508234|P1|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
5382698|NCT04079790|18508231|P4|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
5382699|NCT04079790|18508232|P3|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
5382700|NCT04079790|18508233|P2|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
5382701|NCT04079790|18508234|P1|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
5382702|NCT04079114|18508378|P1|Overall Study|Study prematuely terminated.|166
5382703|NCT04069715|18508439|P2|Overall Study|Withdrawal by Subject|3
5382704|NCT04069715|18508440|P1|Overall Study|Withdrawal by Subject|3
5382705|NCT04069715|18508439|P2|Overall Study|Physician Decision|1
5382706|NCT04069715|18508440|P1|Overall Study|Physician Decision|1
5382707|NCT04069715|18508439|P2|Overall Study|Lost to Follow-up|1
5382708|NCT04069715|18508440|P1|Overall Study|Lost to Follow-up|1
5382709|NCT04067401|18508494|P2|Overall Study|no data provided|0
5382710|NCT04067401|18508495|P1|Overall Study|no data provided|1
5382711|NCT04067401|18508494|P2|Overall Study|Withdrawal by Subject|0
5382712|NCT04067401|18508495|P1|Overall Study|Withdrawal by Subject|7
5382713|NCT04067141|18508515|P2|Second Intervention|Adverse Event|2
5382714|NCT04067141|18508516|P1|Second Intervention|Adverse Event|0
5382715|NCT04067141|18508515|P2|First Intervention|Withdrawal by Subject|1
5382716|NCT04067141|18508516|P1|First Intervention|Withdrawal by Subject|0
5382717|NCT04065074|18508566|P1|Overall Study|Protocol Non-Compliance after injection|1
5382718|NCT04065074|18508566|P1|Overall Study|Adverse Event|1
5382719|NCT04054011|18508603|P1|Overall Study|COVID|3
5382720|NCT04053465|18508611|P2|Overall Study|Withdrawal by Subject|4
5382721|NCT04053465|18508612|P1|Overall Study|Withdrawal by Subject|4
5382722|NCT04053023|18508641|P2|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
5382723|NCT04053023|18508642|P1|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
5382724|NCT04050722|18508834|P2|Overall Study|Withdrawal by Subject|0
5382725|NCT04050722|18508835|P1|Overall Study|Withdrawal by Subject|1
5382726|NCT04050618|18508853|P2|Second Intervention|Withdrawal by Subject|0
5382727|NCT04050618|18508854|P1|Second Intervention|Withdrawal by Subject|1
5382728|NCT04050618|18508853|P2|First Intervention|Withdrawal by Subject|0
5382729|NCT04050618|18508854|P1|First Intervention|Withdrawal by Subject|2
5382730|NCT04049578|18509022|P1|Overall Study|Physician Decision|1
5382731|NCT04049552|18509032|P1|Overall Study|Lost to Follow-up|1
5382732|NCT04048681|18509040|P5|Overall Study|family emergency|0
5382733|NCT04048681|18509041|P4|Overall Study|family emergency|1
5382734|NCT04048681|18509042|P3|Overall Study|family emergency|0
5382735|NCT04048681|18509043|P2|Overall Study|family emergency|0
5382736|NCT04048681|18509044|P1|Overall Study|family emergency|0
5382737|NCT04043416|18509360|P2|Washout|Change in health condition|1
5382738|NCT04043416|18509361|P1|Washout|Change in health condition|0
5382739|NCT04037748|18509477|P2|Treatment Period 2|Protocol Violation|0
5382740|NCT04037748|18509478|P1|Treatment Period 2|Protocol Violation|2
5382741|NCT04037748|18509477|P2|Treatment Period 2|Adverse Event|1
5382742|NCT04037748|18509478|P1|Treatment Period 2|Adverse Event|0
5382743|NCT04037748|18509477|P2|Treatment Period 1|Protocol Violation|5
5382744|NCT04037748|18509478|P1|Treatment Period 1|Protocol Violation|4
5382745|NCT04037748|18509477|P2|Treatment Period 1|Adverse Event|1
5382746|NCT04037748|18509478|P1|Treatment Period 1|Adverse Event|1
5382747|NCT04037748|18509477|P2|Treatment Period 1|Withdrawal by Subject|0
5382748|NCT04037748|18509478|P1|Treatment Period 1|Withdrawal by Subject|3
5382749|NCT04035577|18509496|P1|Overall Study|Withdrawal by Subject|1
5382750|NCT04035577|18509496|P1|Overall Study|Lost to Follow-up|1
5382751|NCT04035564|18509516|P2|Overall Study|Guardian declined consent|2
5382752|NCT04035564|18509517|P1|Overall Study|Guardian declined consent|1
5382753|NCT04035564|18509516|P2|Overall Study|No laboratory available|2
5382754|NCT04035564|18509517|P1|Overall Study|No laboratory available|2
5382755|NCT04035564|18509516|P2|Overall Study|Protocol Violation|2
5382756|NCT04035564|18509517|P1|Overall Study|Protocol Violation|1
5382757|NCT04032652|18509548|P2|Overall Study|The study was terminated and the PI has|1
5382758|NCT04032652|18509549|P1|Overall Study|The study was terminated and the PI has|1
5382759|NCT04032613|18509559|P2|Overall Study|Did not complete post-program assessment|2
5382760|NCT04032613|18509560|P1|Overall Study|Did not complete post-program assessment|5
5382761|NCT04017611|18509832|P1|Overall Study|Withdrawn prior to completion|1
5382762|NCT04015232|18509931|P2|Overall Study|Medical Grounds|3
5382763|NCT04015232|18509932|P1|Overall Study|Medical Grounds|3
5382764|NCT04015232|18509931|P2|Overall Study|Protocol Violation|0
5382765|NCT04015232|18509932|P1|Overall Study|Protocol Violation|1
5382766|NCT04015232|18509931|P2|Overall Study|Withdrawal by Subject|4
5382767|NCT04015232|18509932|P1|Overall Study|Withdrawal by Subject|7
5382768|NCT04014062|18510004|P2|Period I: Dosing|Withdrawal by Subject|1
5382769|NCT04014062|18510005|P1|Period I: Dosing|Withdrawal by Subject|3
5382770|NCT04014062|18510004|P2|Period I: Dosing|Medical Grounds|5
5382771|NCT04014062|18510005|P1|Period I: Dosing|Medical Grounds|4
5382772|NCT04007159|18510106|P1|Challenge Phase|missed study visits|3
5382773|NCT04007159|18510106|P1|Induction Phase|Adverse Event|2
5382774|NCT04007159|18510106|P1|Induction Phase|Withdrawal by Subject|4
5382775|NCT04007159|18510106|P1|Induction Phase|(missed study visits)|16
5382776|NCT04007107|18510121|P4|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
5382777|NCT04007107|18510122|P3|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
5382778|NCT04007107|18510123|P2|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
5382779|NCT04007107|18510124|P1|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
5382780|NCT04006366|18510152|P1|Overall Study|Withdrawal by Subject|1
5382781|NCT04005885|18510158|P2|Second Intervention|Withdrawal by Subject|2
5382782|NCT04005885|18510159|P1|Second Intervention|Withdrawal by Subject|0
5382783|NCT04005885|18510158|P2|First Intervention|Withdrawal by Subject|1
5382784|NCT04005885|18510159|P1|First Intervention|Withdrawal by Subject|1
5382785|NCT04002960|18510218|P1|Overall Study|Withdrawn prior to Completion|2
5382786|NCT04002648|18510235|P2|Overall Study|Lost to Follow-up|0
5382787|NCT04002648|18510236|P1|Overall Study|Lost to Follow-up|2
5382788|NCT04000815|18510247|P3|Overall Study|Hypertension occured on follow up|2
5382789|NCT04000815|18510248|P2|Overall Study|Hypertension occured on follow up|0
5382790|NCT04000815|18510249|P1|Overall Study|Hypertension occured on follow up|0
5382791|NCT04000815|18510247|P3|Overall Study|Right ovarian cyst occured|0
5382792|NCT04000815|18510248|P2|Overall Study|Right ovarian cyst occured|0
5382793|NCT04000815|18510249|P1|Overall Study|Right ovarian cyst occured|1
5382794|NCT04000815|18510247|P3|Overall Study|Withdrawal by Subject|2
5382795|NCT04000815|18510248|P2|Overall Study|Withdrawal by Subject|3
5382796|NCT04000815|18510249|P1|Overall Study|Withdrawal by Subject|4
5382797|NCT04000815|18510247|P3|Overall Study|Lost to Follow-up|3
5382798|NCT04000815|18510248|P2|Overall Study|Lost to Follow-up|2
5382799|NCT04000815|18510249|P1|Overall Study|Lost to Follow-up|9
5382800|NCT03997825|18510269|P1|Overall Study|Refused participation|1
5382801|NCT03997825|18510269|P1|Overall Study|Withdrawal by Subject|3
5382802|NCT03997825|18510269|P1|Overall Study|Lost to Follow-up|10
5382803|NCT03997825|18510269|P1|Overall Study|Death|3
5382804|NCT03993392|18510303|P1|Overall Study|Did not meet Day 1 check-in criteria|1
5382805|NCT03993392|18510303|P1|Overall Study|Lost to Follow-up|2
5382806|NCT03993392|18510303|P1|Overall Study|Withdrawal by Subject|3
5382807|NCT03988907|18510451|P2|Overall Study|Unable to complete visit|1
5382808|NCT03988907|18510452|P1|Overall Study|Unable to complete visit|0
5382809|NCT03988088|18510508|P4|Open-Label Addendum|Lost to Follow-up|0
5382810|NCT03988088|18510509|P3|Open-Label Addendum|Lost to Follow-up|1
5382811|NCT03988088|18510510|P2|Open-Label Addendum|Lost to Follow-up|0
5382812|NCT03988088|18510511|P1|Open-Label Addendum|Lost to Follow-up|0
5382813|NCT03988088|18510508|P4|Single-Dose Pharmacokinetic Study|Adverse Event|0
5382814|NCT03988088|18510509|P3|Single-Dose Pharmacokinetic Study|Adverse Event|0
5382815|NCT03988088|18510510|P2|Single-Dose Pharmacokinetic Study|Adverse Event|1
5382816|NCT03988088|18510511|P1|Single-Dose Pharmacokinetic Study|Adverse Event|0
5382817|NCT03984825|18510594|P1|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
5382818|NCT03984825|18510594|P1|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
5382819|NCT03984825|18510594|P1|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
5382820|NCT03983317|18510708|P1|Overall Study|Physician Decision|5
5382821|NCT03982433|18510715|P1|Overall Study|Lost to Follow-up|1
5382822|NCT03977727|18510793|P2|Second Treatment|Lost to Follow-up|3
5382823|NCT03977727|18510794|P1|Second Treatment|Lost to Follow-up|0
5382824|NCT03976466|18510840|P2|Overall Study|Lost to Follow-up|3
5382825|NCT03976466|18510841|P1|Overall Study|Lost to Follow-up|1
5382826|NCT03972137|18511190|P1|Overall Study|Withdrawal by Subject|4
5382827|NCT03972137|18511190|P1|Overall Study|Lost to Follow-up|2
5382828|NCT03970824|18511215|P3|Overall Study|Adverse Event|0
5382829|NCT03970824|18511216|P2|Overall Study|Adverse Event|0
5382830|NCT03970824|18511217|P1|Overall Study|Adverse Event|1
5382831|NCT03970824|18511215|P3|Overall Study|Lost to Follow-up|1
5382832|NCT03970824|18511216|P2|Overall Study|Lost to Follow-up|2
5382833|NCT03970824|18511217|P1|Overall Study|Lost to Follow-up|0
5382834|NCT03970824|18511215|P3|Overall Study|Withdrawal by Subject|3
5382835|NCT03970824|18511216|P2|Overall Study|Withdrawal by Subject|1
5382836|NCT03970824|18511217|P1|Overall Study|Withdrawal by Subject|1
5382837|NCT03970395|18511239|P2|Overall Study|Lost to Follow-up|8
5382838|NCT03970395|18511240|P1|Overall Study|Lost to Follow-up|4
5382839|NCT03970395|18511239|P2|Overall Study|Withdrawal by Subject|4
5382840|NCT03970395|18511240|P1|Overall Study|Withdrawal by Subject|3
5382841|NCT03966365|18511258|P2|Overall Study|Protocol Violation|0
5382842|NCT03966365|18511259|P1|Overall Study|Protocol Violation|1
5382843|NCT03965403|18511394|P1|Overall Study|Subject not meeting eligibility criteria|1
5382844|NCT03965052|18511407|P2|Overall Study|Protocol Violation|0
5382845|NCT03965052|18511408|P1|Overall Study|Protocol Violation|1
5382846|NCT03962790|18511504|P2|Period 1|Withdrawal by Subject|0
5382847|NCT03962790|18511505|P1|Period 1|Withdrawal by Subject|1
5382848|NCT03962790|18511504|P2|Period 1|No Longer Meets Eligibility Criteria|0
5382849|NCT03962790|18511505|P1|Period 1|No Longer Meets Eligibility Criteria|1
5382850|NCT03962790|18511504|P2|Period 1|Failed to meet all eligibility criteria|1
5382851|NCT03962790|18511505|P1|Period 1|Failed to meet all eligibility criteria|1
5382852|NCT03962790|18511504|P2|Period 1|Adverse Event|1
5382853|NCT03962790|18511505|P1|Period 1|Adverse Event|0
5382854|NCT03961308|18511540|P2|Overall Study|Adverse Event|1
5382855|NCT03961308|18511541|P1|Overall Study|Adverse Event|0
5382856|NCT03961308|18511540|P2|Overall Study|Lost to Follow-up|1
5382857|NCT03961308|18511541|P1|Overall Study|Lost to Follow-up|0
5382858|NCT03961308|18511540|P2|Overall Study|Other|0
5382859|NCT03961308|18511541|P1|Overall Study|Other|1
5382860|NCT03961308|18511540|P2|Overall Study|Withdrawal by Subject|0
5382861|NCT03961308|18511541|P1|Overall Study|Withdrawal by Subject|1
5382862|NCT03953820|18511734|P3|Two-Sequence, Two-Way Crossover|Physician Decision|0
5382863|NCT03953820|18511735|P2|Two-Sequence, Two-Way Crossover|Physician Decision|0
5382864|NCT03953820|18511736|P1|Two-Sequence, Two-Way Crossover|Physician Decision|1
5382865|NCT03953820|18511734|P3|Two-Sequence, Two-Way Crossover|Adverse Event|0
5382866|NCT03953820|18511735|P2|Two-Sequence, Two-Way Crossover|Adverse Event|0
5382867|NCT03953820|18511736|P1|Two-Sequence, Two-Way Crossover|Adverse Event|1
5382868|NCT03953183|18511752|P2|Overall Study|Withdrawal by Subject|1
5382869|NCT03953183|18511753|P1|Overall Study|Withdrawal by Subject|0
5382870|NCT03953183|18511752|P2|Overall Study|Physician Decision|1
5382871|NCT03953183|18511753|P1|Overall Study|Physician Decision|0
5382872|NCT03950674|18511828|P2|Overall Study|Ongoing in Study|8
5382873|NCT03950674|18511829|P1|Overall Study|Ongoing in Study|22
5382874|NCT03950674|18511828|P2|Overall Study|Death|7
5382875|NCT03950674|18511829|P1|Overall Study|Death|3
5382876|NCT03948581|18511863|P2|Overall Study|Lost to Follow-up|1
5382877|NCT03948581|18511864|P1|Overall Study|Lost to Follow-up|0
5382878|NCT03946124|18511874|P1|Overall Study|Withdrawal by Subject|19
5382879|NCT03943095|18511880|P2|Overall Study|Withdrawal by Subject|0
5382880|NCT03943095|18511881|P1|Overall Study|Withdrawal by Subject|1
5382881|NCT03943095|18511880|P2|Overall Study|Incorrectly dispensed wrong box kit|1
5382882|NCT03943095|18511881|P1|Overall Study|Incorrectly dispensed wrong box kit|0
5382883|NCT03937479|18511930|P5|Overall Study|Physician Decision|1
5382884|NCT03937479|18511931|P4|Overall Study|Physician Decision|0
5382885|NCT03937479|18511932|P3|Overall Study|Physician Decision|1
5382886|NCT03937479|18511933|P2|Overall Study|Physician Decision|0
5382887|NCT03937479|18511934|P1|Overall Study|Physician Decision|0
5382888|NCT03937479|18511930|P5|Overall Study|Lost to Follow-up|0
5382889|NCT03937479|18511931|P4|Overall Study|Lost to Follow-up|1
5382890|NCT03937479|18511932|P3|Overall Study|Lost to Follow-up|0
5382891|NCT03937479|18511933|P2|Overall Study|Lost to Follow-up|1
5382892|NCT03937479|18511934|P1|Overall Study|Lost to Follow-up|0
5382893|NCT03937479|18511930|P5|Overall Study|Protocol Violation|2
5382894|NCT03937479|18511931|P4|Overall Study|Protocol Violation|3
5382895|NCT03937479|18511932|P3|Overall Study|Protocol Violation|4
5382896|NCT03937479|18511933|P2|Overall Study|Protocol Violation|6
5382897|NCT03937479|18511934|P1|Overall Study|Protocol Violation|5
5382898|NCT03937479|18511930|P5|Overall Study|Withdrawal by Subject|1
5382899|NCT03937479|18511931|P4|Overall Study|Withdrawal by Subject|2
5382900|NCT03937479|18511932|P3|Overall Study|Withdrawal by Subject|2
5382901|NCT03937479|18511933|P2|Overall Study|Withdrawal by Subject|5
5382902|NCT03937479|18511934|P1|Overall Study|Withdrawal by Subject|3
5382903|NCT03937479|18511930|P5|Overall Study|Adverse Event|1
5382904|NCT03937479|18511931|P4|Overall Study|Adverse Event|0
5382905|NCT03937479|18511932|P3|Overall Study|Adverse Event|0
5382906|NCT03937479|18511933|P2|Overall Study|Adverse Event|3
5382907|NCT03937479|18511934|P1|Overall Study|Adverse Event|2
5382908|NCT03936244|18512037|P2|Overall Study|Physician Decision|3
5382909|NCT03936244|18512038|P1|Overall Study|Physician Decision|7
5382910|NCT03936244|18512037|P2|Overall Study|Lost to Follow-up|1
5382911|NCT03936244|18512038|P1|Overall Study|Lost to Follow-up|5
5382912|NCT03933462|18512374|P2|Overall Study|Adverse Event|0
5382913|NCT03933462|18512375|P1|Overall Study|Adverse Event|2
5382914|NCT03933449|18512399|P2|Overall Study|Ongoing in Study|6
5382915|NCT03933449|18512400|P1|Overall Study|Ongoing in Study|20
5382916|NCT03933449|18512399|P2|Overall Study|Death|51
5382917|NCT03933449|18512400|P1|Overall Study|Death|36
5382918|NCT03933449|18512399|P2|Overall Study|Adverse Event|4
5382919|NCT03933449|18512400|P1|Overall Study|Adverse Event|6
5382920|NCT03927950|18512476|P1|Overall Study|Adverse Event|9
5382921|NCT03923933|18512509|P2|Overall Study|Withdrawal by Subject|1
5382922|NCT03923933|18512510|P1|Overall Study|Withdrawal by Subject|0
5382923|NCT03923933|18512509|P2|Overall Study|Lost to Follow-up|0
5382924|NCT03923933|18512510|P1|Overall Study|Lost to Follow-up|1
5382925|NCT03923530|18512528|P1|Overall Study|screen failure|3
5382926|NCT03923530|18512528|P1|Overall Study|Withdrawal by Subject|1
5382927|NCT03921723|18512538|P1|Period 3 (4 Days)|Withdrawal by Subject|1
5382928|NCT03921723|18512538|P1|Period 2 (4 Days)|Withdrawal by Subject|3
5382929|NCT03918239|18512608|P2|Overall Study|positive urine drug screening results|1
5382930|NCT03918239|18512609|P1|Overall Study|positive urine drug screening results|4
5382931|NCT03918239|18512608|P2|Overall Study|Withdrawal by Subject|3
5382932|NCT03918239|18512609|P1|Overall Study|Withdrawal by Subject|3
5382933|NCT03918239|18512608|P2|Overall Study|Pregnancy|2
5382934|NCT03918239|18512609|P1|Overall Study|Pregnancy|0
5382935|NCT03918239|18512608|P2|Overall Study|Lost to Follow-up|1
5382936|NCT03918239|18512609|P1|Overall Study|Lost to Follow-up|3
5382937|NCT03914950|18512633|P1|Overall Study|Physician Decision|54
5382938|NCT03914417|18512643|P1|Overall Study|Withdrawal by Subject|2
5382939|NCT03913377|18512650|P3|Period 1|No Longer Meets Eligibility Criteria|1
5382940|NCT03913377|18512651|P2|Period 1|No Longer Meets Eligibility Criteria|0
5382941|NCT03913377|18512652|P1|Period 1|No Longer Meets Eligibility Criteria|0
5382942|NCT03913377|18512650|P3|Period 1|Test Article no longer available|0
5382943|NCT03913377|18512651|P2|Period 1|Test Article no longer available|1
5382944|NCT03913377|18512652|P1|Period 1|Test Article no longer available|0
5382945|NCT03911960|18512669|P2|Overall Study|Lost to Follow-up|3
5382946|NCT03911960|18512670|P1|Overall Study|Lost to Follow-up|5
5382947|NCT03909295|18512718|P1|Overall Study|Study terminated by sponsor|50
5382948|NCT03909295|18512718|P1|Overall Study|Adverse Event|2
5382949|NCT03905642|18512873|P1|Overall Study|Completed study but not 24 of 28 days|2
5382950|NCT03905642|18512873|P1|Overall Study|Lack of Efficacy|1
5382951|NCT03905642|18512873|P1|Overall Study|Adverse Event|1
5382952|NCT03905642|18512873|P1|Overall Study|Pregnancy|1
5382953|NCT03905642|18512873|P1|Overall Study|Withdrawal by Subject|3
5382954|NCT03904420|18512884|P2|Overall Study|Study terminated|2
5382955|NCT03904420|18512885|P1|Overall Study|Study terminated|2
5382956|NCT03902613|18512891|P1|Overall Study|Physician Decision|1
5382957|NCT03902392|18512897|P2|Overall Study|Lost to Follow-up|7
5382958|NCT03902392|18512898|P1|Overall Study|Lost to Follow-up|7
5382959|NCT03899064|18512964|P1|Overall Study|Other|2
5382960|NCT03899064|18512964|P1|Overall Study|Withdrawal by Subject|2
5382961|NCT03899064|18512964|P1|Overall Study|Protocol Violation|2
5382962|NCT03899064|18512964|P1|Overall Study|Lost to Follow-up|1
5382963|NCT03897179|18512979|P1|Overall Study|Withdrawal by Subject|1
5382964|NCT03892564|18513205|P1|Overall Study|Withdrawal by Subject|2
5382965|NCT03891641|18513213|P2|Overall Study|Study Stoppage Due to COVID-19|2
5382966|NCT03891641|18513214|P1|Overall Study|Study Stoppage Due to COVID-19|2
5382967|NCT03888482|18513275|P2|Second Wear (8 -1/+2 Days)|Other|0
5382968|NCT03888482|18513276|P1|Second Wear (8 -1/+2 Days)|Other|1
5382969|NCT03888482|18513275|P2|Second Wear (8 -1/+2 Days)|Adverse Event|1
5382970|NCT03888482|18513276|P1|Second Wear (8 -1/+2 Days)|Adverse Event|0
5382971|NCT03888391|18513295|P1|Overall Study|Lost to Follow-up|15
5382972|NCT03887442|18513313|P2|Overall Study|Adverse Event|0
5382973|NCT03887442|18513314|P1|Overall Study|Adverse Event|1
5382974|NCT03885726|18513376|P1|Overall Study|Early discharge from hospital|3
5382975|NCT03885726|18513376|P1|Overall Study|Staffing issues/lost interest|1
5382976|NCT03883386|18513442|P2|First Assignment|Withdrawal by Subject|1
5382977|NCT03883386|18513443|P1|First Assignment|Withdrawal by Subject|1
5382978|NCT03883386|18513442|P2|First Assignment|Lost to Follow-up|0
5382979|NCT03883386|18513443|P1|First Assignment|Lost to Follow-up|1
5382980|NCT03882801|18513453|P2|Period 2|Non-compliance with study drug|1
5382981|NCT03882801|18513454|P1|Period 2|Non-compliance with study drug|0
5382982|NCT03882801|18513453|P2|Washout Period|Physician Decision|1
5382983|NCT03882801|18513454|P1|Washout Period|Physician Decision|0
5382984|NCT03882801|18513453|P2|Period 1|Never treated with study drug|0
5382985|NCT03882801|18513454|P1|Period 1|Never treated with study drug|1
5382986|NCT03882801|18513453|P2|Period 1|Non-compliance with study drug|1
5382987|NCT03882801|18513454|P1|Period 1|Non-compliance with study drug|1
5382988|NCT03882801|18513453|P2|Period 1|Adverse Event|1
5382989|NCT03882801|18513454|P1|Period 1|Adverse Event|0
5382990|NCT03882424|18513469|P3|Overall Study|schedule conflict|0
5382991|NCT03882424|18513470|P2|Overall Study|schedule conflict|0
5382992|NCT03882424|18513471|P1|Overall Study|schedule conflict|1
5382993|NCT03882424|18513469|P3|Overall Study|Lost to Follow-up|0
5382994|NCT03882424|18513470|P2|Overall Study|Lost to Follow-up|0
5382995|NCT03882424|18513471|P1|Overall Study|Lost to Follow-up|3
5382996|NCT03882047|18513494|P3|Overall Study|Did Not Meet Eligibility|1
5382997|NCT03882047|18513495|P2|Overall Study|Did Not Meet Eligibility|0
5382998|NCT03882047|18513496|P1|Overall Study|Did Not Meet Eligibility|0
5382999|NCT03882047|18513494|P3|Overall Study|Noncompliance With Protocol|0
5383000|NCT03882047|18513495|P2|Overall Study|Noncompliance With Protocol|0
5383001|NCT03882047|18513496|P1|Overall Study|Noncompliance With Protocol|2
5383002|NCT03882047|18513494|P3|Overall Study|Did Not Wish to Continue|1
5383003|NCT03882047|18513495|P2|Overall Study|Did Not Wish to Continue|4
5383004|NCT03882047|18513496|P1|Overall Study|Did Not Wish to Continue|1
5383005|NCT03882047|18513494|P3|Overall Study|Lost to Follow-up|0
5383006|NCT03882047|18513495|P2|Overall Study|Lost to Follow-up|1
5383007|NCT03882047|18513496|P1|Overall Study|Lost to Follow-up|0
5383008|NCT03882047|18513494|P3|Overall Study|Treatment Failure|12
5383009|NCT03882047|18513495|P2|Overall Study|Treatment Failure|3
5383010|NCT03882047|18513496|P1|Overall Study|Treatment Failure|3
5383011|NCT03882047|18513494|P3|Overall Study|Adverse Event|2
5383012|NCT03882047|18513495|P2|Overall Study|Adverse Event|2
5383013|NCT03882047|18513496|P1|Overall Study|Adverse Event|0
5383014|NCT03879772|18513552|P5|Overall Study|Did Not Meet Entry Requirements|0
5383015|NCT03879772|18513553|P4|Overall Study|Did Not Meet Entry Requirements|0
5383016|NCT03879772|18513554|P3|Overall Study|Did Not Meet Entry Requirements|1
5383017|NCT03879772|18513555|P2|Overall Study|Did Not Meet Entry Requirements|0
5383018|NCT03879772|18513556|P1|Overall Study|Did Not Meet Entry Requirements|1
5383019|NCT03879772|18513552|P5|Overall Study|Protocol Violation|2
5383020|NCT03879772|18513553|P4|Overall Study|Protocol Violation|1
5383021|NCT03879772|18513554|P3|Overall Study|Protocol Violation|3
5383022|NCT03879772|18513555|P2|Overall Study|Protocol Violation|0
5383023|NCT03879772|18513556|P1|Overall Study|Protocol Violation|0
5383024|NCT03879772|18513552|P5|Overall Study|Withdrawal by Subject|1
5383025|NCT03879772|18513553|P4|Overall Study|Withdrawal by Subject|1
5383026|NCT03879772|18513554|P3|Overall Study|Withdrawal by Subject|3
5383027|NCT03879772|18513555|P2|Overall Study|Withdrawal by Subject|1
5383028|NCT03879772|18513556|P1|Overall Study|Withdrawal by Subject|0
5383029|NCT03879772|18513552|P5|Overall Study|Lost to Follow-up|1
5383030|NCT03879772|18513553|P4|Overall Study|Lost to Follow-up|0
5383031|NCT03879772|18513554|P3|Overall Study|Lost to Follow-up|0
5383032|NCT03879772|18513555|P2|Overall Study|Lost to Follow-up|0
5383033|NCT03879772|18513556|P1|Overall Study|Lost to Follow-up|0
5383034|NCT03879772|18513552|P5|Overall Study|Treatment Failure|1
5383035|NCT03879772|18513553|P4|Overall Study|Treatment Failure|2
5383036|NCT03879772|18513554|P3|Overall Study|Treatment Failure|0
5383037|NCT03879772|18513555|P2|Overall Study|Treatment Failure|0
5383038|NCT03879772|18513556|P1|Overall Study|Treatment Failure|1
5383039|NCT03879772|18513552|P5|Overall Study|Adverse Event|3
5383040|NCT03879772|18513553|P4|Overall Study|Adverse Event|4
5383041|NCT03879772|18513554|P3|Overall Study|Adverse Event|3
5383042|NCT03879772|18513555|P2|Overall Study|Adverse Event|2
5383043|NCT03879772|18513556|P1|Overall Study|Adverse Event|2
5383044|NCT03878758|18513593|P1|Overall Study|Improper consent documentation|1
5383045|NCT03878758|18513593|P1|Overall Study|Protocol defined|2
5383046|NCT03878758|18513593|P1|Overall Study|Withdrawal by Subject|1
5383047|NCT03876743|18513634|P4|Overall Study|Lost to Follow-up|7
5383048|NCT03876743|18513635|P3|Overall Study|Lost to Follow-up|4
5383049|NCT03876743|18513636|P2|Overall Study|Lost to Follow-up|4
5383050|NCT03876743|18513637|P1|Overall Study|Lost to Follow-up|6
5383051|NCT03870997|18513732|P6|Overall Study|Did not complete mid-study/final survey|10531
5383052|NCT03870997|18513733|P5|Overall Study|Did not complete mid-study/final survey|10588
5383053|NCT03870997|18513734|P4|Overall Study|Did not complete mid-study/final survey|10947
5383054|NCT03870997|18513735|P3|Overall Study|Did not complete mid-study/final survey|10978
5383055|NCT03870997|18513736|P2|Overall Study|Did not complete mid-study/final survey|10431
5383056|NCT03870997|18513737|P1|Overall Study|Did not complete mid-study/final survey|10544
5383057|NCT03870555|18513804|P3|Period 3 (2 Days)|Adverse Event|0
5383058|NCT03870555|18513805|P2|Period 3 (2 Days)|Adverse Event|0
5383059|NCT03870555|18513806|P1|Period 3 (2 Days)|Adverse Event|1
5383060|NCT03868631|18513892|P2|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
5383061|NCT03868631|18513893|P1|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
5383062|NCT03868631|18513892|P2|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
5383063|NCT03868631|18513893|P1|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
5383064|NCT03868631|18513892|P2|Week 6 to Week 12 (Study Completion)|Adverse Event|0
5383065|NCT03868631|18513893|P1|Week 6 to Week 12 (Study Completion)|Adverse Event|2
5383066|NCT03868631|18513892|P2|Baseline to Week 6|Withdrawal by Subject|0
5383067|NCT03868631|18513893|P1|Baseline to Week 6|Withdrawal by Subject|3
5383068|NCT03868631|18513892|P2|Baseline to Week 6|Protocol Violation|1
5383069|NCT03868631|18513893|P1|Baseline to Week 6|Protocol Violation|1
5383070|NCT03868631|18513892|P2|Baseline to Week 6|Adverse Event|3
5383071|NCT03868631|18513893|P1|Baseline to Week 6|Adverse Event|0
5383072|NCT03864653|18513981|P1|Overall Study|Withdrawal by Subject|1
5383073|NCT03861559|18514021|P2|Overall Study|Did not meet eligibility requirements|0
5383074|NCT03861559|18514022|P1|Overall Study|Did not meet eligibility requirements|1
5383075|NCT03861559|18514021|P2|Overall Study|Noncompliance|1
5383076|NCT03861559|18514022|P1|Overall Study|Noncompliance|1
5383077|NCT03861559|18514021|P2|Overall Study|Treatment failure|2
5383078|NCT03861559|18514022|P1|Overall Study|Treatment failure|0
5383079|NCT03861559|18514021|P2|Overall Study|Adverse Event|2
5383080|NCT03861559|18514022|P1|Overall Study|Adverse Event|0
5383081|NCT03855228|18514205|P4|Overall Study|Did Not Meet Entry Requirements|1
5383082|NCT03855228|18514206|P3|Overall Study|Did Not Meet Entry Requirements|1
5383083|NCT03855228|18514207|P2|Overall Study|Did Not Meet Entry Requirements|2
5383084|NCT03855228|18514208|P1|Overall Study|Did Not Meet Entry Requirements|0
5383085|NCT03855228|18514205|P4|Overall Study|Protocol Violation|1
5383086|NCT03855228|18514206|P3|Overall Study|Protocol Violation|2
5383087|NCT03855228|18514207|P2|Overall Study|Protocol Violation|1
5383088|NCT03855228|18514208|P1|Overall Study|Protocol Violation|0
5383089|NCT03855228|18514205|P4|Overall Study|Lost to Follow-up|1
5383090|NCT03855228|18514206|P3|Overall Study|Lost to Follow-up|0
5383091|NCT03855228|18514207|P2|Overall Study|Lost to Follow-up|0
5383092|NCT03855228|18514208|P1|Overall Study|Lost to Follow-up|0
5383093|NCT03855228|18514205|P4|Overall Study|Treatment Failure|8
5383094|NCT03855228|18514206|P3|Overall Study|Treatment Failure|1
5383095|NCT03855228|18514207|P2|Overall Study|Treatment Failure|2
5383096|NCT03855228|18514208|P1|Overall Study|Treatment Failure|1
5383097|NCT03855228|18514205|P4|Overall Study|Adverse Event|8
5383098|NCT03855228|18514206|P3|Overall Study|Adverse Event|4
5383099|NCT03855228|18514207|P2|Overall Study|Adverse Event|4
5383100|NCT03855228|18514208|P1|Overall Study|Adverse Event|2
5383101|NCT03855189|18514257|P3|Overall Study|Did Not Return|0
5383102|NCT03855189|18514258|P2|Overall Study|Did Not Return|3
5383103|NCT03855189|18514259|P1|Overall Study|Did Not Return|4
5383104|NCT03855189|18514257|P3|Overall Study|Noncompliance with Protocol|0
5383105|NCT03855189|18514258|P2|Overall Study|Noncompliance with Protocol|1
5383106|NCT03855189|18514259|P1|Overall Study|Noncompliance with Protocol|0
5383107|NCT03855189|18514257|P3|Overall Study|Treatment Failure|2
5383108|NCT03855189|18514258|P2|Overall Study|Treatment Failure|1
5383109|NCT03855189|18514259|P1|Overall Study|Treatment Failure|1
5383110|NCT03855189|18514257|P3|Overall Study|Adverse Event|4
5383111|NCT03855189|18514258|P2|Overall Study|Adverse Event|2
5383112|NCT03855189|18514259|P1|Overall Study|Adverse Event|5
5383113|NCT03851016|18514377|P2|First Intervention (3 Weeks)|Withdrawal by Subject|2
5383114|NCT03851016|18514378|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
5383115|NCT03850496|18514391|P3|Overall Study|Lost to Follow-up|4
5383116|NCT03850496|18514392|P2|Overall Study|Lost to Follow-up|1
5383117|NCT03850496|18514393|P1|Overall Study|Lost to Follow-up|0
5383118|NCT03850496|18514391|P3|Overall Study|Withdrawal by Subject|0
5383119|NCT03850496|18514392|P2|Overall Study|Withdrawal by Subject|0
5383120|NCT03850496|18514393|P1|Overall Study|Withdrawal by Subject|1
5383121|NCT03850444|18514415|P2|Overall Study|Ongoing in Study|59
5383122|NCT03850444|18514416|P1|Overall Study|Ongoing in Study|78
5383123|NCT03850444|18514415|P2|Overall Study|Withdrawal by Subject|1
5383124|NCT03850444|18514416|P1|Overall Study|Withdrawal by Subject|0
5383125|NCT03850444|18514415|P2|Overall Study|Lost to Follow-up|1
5383126|NCT03850444|18514416|P1|Overall Study|Lost to Follow-up|0
5383127|NCT03850444|18514415|P2|Overall Study|Death|64
5383128|NCT03850444|18514416|P1|Overall Study|Death|38
5383129|NCT03850444|18514415|P2|Overall Study|Adverse Event|9
5383130|NCT03850444|18514416|P1|Overall Study|Adverse Event|12
5383131|NCT03850093|18514445|P3|Overall Study|Withdrawal by Subject|2
5383132|NCT03850093|18514446|P2|Overall Study|Withdrawal by Subject|0
5383133|NCT03850093|18514447|P1|Overall Study|Withdrawal by Subject|1
5383134|NCT03849300|18514509|P4|Overall Study|scheduling/transportation conflict|2
5383135|NCT03849300|18514510|P3|Overall Study|scheduling/transportation conflict|3
5383136|NCT03849300|18514511|P2|Overall Study|scheduling/transportation conflict|4
5383137|NCT03849300|18514512|P1|Overall Study|scheduling/transportation conflict|4
5383138|NCT03849300|18514509|P4|Overall Study|move out to different area|4
5383139|NCT03849300|18514510|P3|Overall Study|move out to different area|1
5383140|NCT03849300|18514511|P2|Overall Study|move out to different area|3
5383141|NCT03849300|18514512|P1|Overall Study|move out to different area|1
5383142|NCT03848416|18514614|P3|Overall Study|Death|1
5383143|NCT03848416|18514615|P2|Overall Study|Death|0
5383144|NCT03848416|18514616|P1|Overall Study|Death|0
5383145|NCT03848416|18514614|P3|Overall Study|Withdrawal by Subject|0
5383146|NCT03848416|18514615|P2|Overall Study|Withdrawal by Subject|0
5383147|NCT03848416|18514616|P1|Overall Study|Withdrawal by Subject|1
5383148|NCT03848403|18514630|P3|Period 2 (Day 8)|Sponsor Decision|5
5383149|NCT03848403|18514631|P2|Period 2 (Day 8)|Sponsor Decision|6
5383150|NCT03848403|18514632|P1|Period 2 (Day 8)|Sponsor Decision|8
5383151|NCT03848403|18514630|P3|Period 2 (Day 8)|Physician Decision|0
5383152|NCT03848403|18514631|P2|Period 2 (Day 8)|Physician Decision|1
5383153|NCT03848403|18514632|P1|Period 2 (Day 8)|Physician Decision|0
5383154|NCT03848403|18514630|P3|Period 2 (Day 8)|Adverse Event|2
5383155|NCT03848403|18514631|P2|Period 2 (Day 8)|Adverse Event|2
5383156|NCT03848403|18514632|P1|Period 2 (Day 8)|Adverse Event|1
5383157|NCT03847987|18514717|P2|Overall Study|Adverse Event|0
5383158|NCT03847987|18514718|P1|Overall Study|Adverse Event|2
5383159|NCT03847987|18514717|P2|Overall Study|Lost to Follow-up|0
5383160|NCT03847987|18514718|P1|Overall Study|Lost to Follow-up|1
5383161|NCT03847610|18514741|P1|Overall Study|Withdrawal by Subject|1
5383162|NCT03844945|18514765|P4|Overall Study|Lack of Efficacy|1
5383163|NCT03844945|18514766|P3|Overall Study|Lack of Efficacy|0
5383164|NCT03844945|18514767|P2|Overall Study|Lack of Efficacy|0
5383165|NCT03844945|18514768|P1|Overall Study|Lack of Efficacy|0
5383166|NCT03844945|18514765|P4|Overall Study|Withdrawal by Subject|0
5383167|NCT03844945|18514766|P3|Overall Study|Withdrawal by Subject|1
5383168|NCT03844945|18514767|P2|Overall Study|Withdrawal by Subject|0
5383169|NCT03844945|18514768|P1|Overall Study|Withdrawal by Subject|0
5383170|NCT03844945|18514765|P4|Overall Study|Adverse Event|0
5383171|NCT03844945|18514766|P3|Overall Study|Adverse Event|4
5383172|NCT03844945|18514767|P2|Overall Study|Adverse Event|1
5383173|NCT03844945|18514768|P1|Overall Study|Adverse Event|1
5383174|NCT03841331|18514800|P2|Overall Study|Lost to Follow-up|1
5383175|NCT03841331|18514801|P1|Overall Study|Lost to Follow-up|5
5383176|NCT03841331|18514800|P2|Overall Study|Withdrawal by Subject|9
5383177|NCT03841331|18514801|P1|Overall Study|Withdrawal by Subject|4
5383178|NCT03840135|18514842|P2|Overall Study|Withdrawal by Subject|0
5383179|NCT03840135|18514843|P1|Overall Study|Withdrawal by Subject|1
5383180|NCT03840135|18514842|P2|Overall Study|Protocol Violation|1
5383181|NCT03840135|18514843|P1|Overall Study|Protocol Violation|6
5383182|NCT03837028|18514873|P4|Overall Study|Withdrawal by Subject|7
5383183|NCT03837028|18514874|P3|Overall Study|Withdrawal by Subject|11
5383184|NCT03837028|18514875|P2|Overall Study|Withdrawal by Subject|11
5383185|NCT03837028|18514876|P1|Overall Study|Withdrawal by Subject|12
5383186|NCT03837028|18514873|P4|Overall Study|Lost to Follow-up|0
5383187|NCT03837028|18514874|P3|Overall Study|Lost to Follow-up|2
5383188|NCT03837028|18514875|P2|Overall Study|Lost to Follow-up|0
5383189|NCT03837028|18514876|P1|Overall Study|Lost to Follow-up|4
5383190|NCT03836729|18514929|P1|Treatment Period 2 (Up to Day 7)|Adverse Event|1
5383191|NCT03836664|18515043|P2|Overall Study|Didn't complete forms and lost drug|3
5383192|NCT03836664|18515044|P1|Overall Study|Didn't complete forms and lost drug|3
5383193|NCT03835221|18515085|P1|Methafilcon A|Withdrawal by Subject|1
5383194|NCT03832387|18515167|P2|Overall Study|EXCLUSION CRITERIA|1
5383195|NCT03832387|18515168|P1|Overall Study|EXCLUSION CRITERIA|3
5383196|NCT03832387|18515167|P2|Overall Study|Protocol Violation|6
5383197|NCT03832387|18515168|P1|Overall Study|Protocol Violation|2
5383198|NCT03832322|18515198|P2|Overall Study|Failed cecal intubation in 2nd exam|1
5383199|NCT03832322|18515199|P1|Overall Study|Failed cecal intubation in 2nd exam|3
5383200|NCT03831282|18515235|P1|Overall Study|Could not place sensor|1
5383201|NCT03828617|18515275|P4|Overall Study|Withdrawal by Subject|0
5383202|NCT03828617|18515276|P3|Overall Study|Withdrawal by Subject|2
5383203|NCT03828617|18515277|P2|Overall Study|Withdrawal by Subject|0
5383204|NCT03828617|18515278|P1|Overall Study|Withdrawal by Subject|2
5383205|NCT03828617|18515275|P4|Overall Study|Protocol Violation|0
5383206|NCT03828617|18515276|P3|Overall Study|Protocol Violation|0
5383207|NCT03828617|18515277|P2|Overall Study|Protocol Violation|2
5383208|NCT03828617|18515278|P1|Overall Study|Protocol Violation|0
5383209|NCT03828617|18515275|P4|Overall Study|No longer met eligibility criteria|3
5383210|NCT03828617|18515276|P3|Overall Study|No longer met eligibility criteria|1
5383211|NCT03828617|18515277|P2|Overall Study|No longer met eligibility criteria|1
5383212|NCT03828617|18515278|P1|Overall Study|No longer met eligibility criteria|0
5383213|NCT03828617|18515275|P4|Overall Study|Lost to Follow-up|7
5383214|NCT03828617|18515276|P3|Overall Study|Lost to Follow-up|23
5383215|NCT03828617|18515277|P2|Overall Study|Lost to Follow-up|12
5383216|NCT03828617|18515278|P1|Overall Study|Lost to Follow-up|22
5383217|NCT03827473|18515315|P2|Overall Study|Withdrawal by Subject|0
5383218|NCT03827473|18515316|P1|Overall Study|Withdrawal by Subject|1
5383219|NCT03826914|18515332|P2|Overall Study|Withdrawal by Subject|1
5383220|NCT03826914|18515333|P1|Overall Study|Withdrawal by Subject|1
5383221|NCT03825042|18515356|P2|Overall Study|Withdrawal by Subject|0
5383222|NCT03825042|18515357|P1|Overall Study|Withdrawal by Subject|1
5383223|NCT03825042|18515356|P2|Overall Study|Adverse Event|0
5383224|NCT03825042|18515357|P1|Overall Study|Adverse Event|1
5383225|NCT03824912|18515370|P3|Overall Study|Participation in another study|0
5383226|NCT03824912|18515371|P2|Overall Study|Participation in another study|1
5383227|NCT03824912|18515372|P1|Overall Study|Participation in another study|0
5383228|NCT03824912|18515370|P3|Overall Study|Withdrawal by Subject|1
5383229|NCT03824912|18515371|P2|Overall Study|Withdrawal by Subject|2
5383230|NCT03824912|18515372|P1|Overall Study|Withdrawal by Subject|3
5383231|NCT03824912|18515370|P3|Overall Study|Protocol Violation|1
5383232|NCT03824912|18515371|P2|Overall Study|Protocol Violation|4
5383233|NCT03824912|18515372|P1|Overall Study|Protocol Violation|1
5383234|NCT03824912|18515370|P3|Overall Study|Non-Compliance with Study Drug|1
5383235|NCT03824912|18515371|P2|Overall Study|Non-Compliance with Study Drug|0
5383236|NCT03824912|18515372|P1|Overall Study|Non-Compliance with Study Drug|0
5383237|NCT03824912|18515370|P3|Overall Study|Negative Baseline Culture Result|57
5383238|NCT03824912|18515371|P2|Overall Study|Negative Baseline Culture Result|112
5383239|NCT03824912|18515372|P1|Overall Study|Negative Baseline Culture Result|118
5383240|NCT03824912|18515370|P3|Overall Study|Lost to Follow-up|8
5383241|NCT03824912|18515371|P2|Overall Study|Lost to Follow-up|15
5383242|NCT03824912|18515372|P1|Overall Study|Lost to Follow-up|18
5383243|NCT03824236|18515395|P3|Overall Study|Lost to Follow-up|1
5383244|NCT03824236|18515396|P2|Overall Study|Lost to Follow-up|0
5383245|NCT03824236|18515397|P1|Overall Study|Lost to Follow-up|0
5383246|NCT03822884|18515455|P6|Overall Study|Withdrawal by Subject|0
5383247|NCT03822884|18515456|P5|Overall Study|Withdrawal by Subject|1
5383248|NCT03822884|18515457|P4|Overall Study|Withdrawal by Subject|0
5383249|NCT03822884|18515458|P3|Overall Study|Withdrawal by Subject|0
5383250|NCT03822884|18515459|P2|Overall Study|Withdrawal by Subject|0
5383251|NCT03822884|18515460|P1|Overall Study|Withdrawal by Subject|0
5383252|NCT03822182|18515492|P3|Overall Study|Protocol Violation|1
5383253|NCT03822182|18515493|P2|Overall Study|Protocol Violation|1
5383254|NCT03822182|18515494|P1|Overall Study|Protocol Violation|0
5383255|NCT03817879|18515649|P2|Overall Study|Withdrawal by Subject|1
5383256|NCT03817879|18515650|P1|Overall Study|Withdrawal by Subject|0
5383257|NCT03817879|18515649|P2|Overall Study|Drop out|12
5383258|NCT03817879|18515650|P1|Overall Study|Drop out|5
5383259|NCT03816761|18515686|P6|Second Treatment Period (7 Days)|Unclassified|0
5383260|NCT03816761|18515687|P5|Second Treatment Period (7 Days)|Unclassified|0
5383261|NCT03816761|18515688|P4|Second Treatment Period (7 Days)|Unclassified|1
5383262|NCT03816761|18515689|P3|Second Treatment Period (7 Days)|Unclassified|0
5383263|NCT03816761|18515690|P2|Second Treatment Period (7 Days)|Unclassified|0
5383264|NCT03816761|18515691|P1|Second Treatment Period (7 Days)|Unclassified|0
5383265|NCT03816761|18515686|P6|First Treatment Period (7 Days)|Withdrawal by Subject|1
5383266|NCT03816761|18515687|P5|First Treatment Period (7 Days)|Withdrawal by Subject|0
5383267|NCT03816761|18515688|P4|First Treatment Period (7 Days)|Withdrawal by Subject|0
5383268|NCT03816761|18515689|P3|First Treatment Period (7 Days)|Withdrawal by Subject|0
5383269|NCT03816761|18515690|P2|First Treatment Period (7 Days)|Withdrawal by Subject|0
5383270|NCT03816761|18515691|P1|First Treatment Period (7 Days)|Withdrawal by Subject|0
5383271|NCT03812510|18515994|P1|Overall Study|Adverse Event|5
5383272|NCT03812510|18515994|P1|Overall Study|Did Not Start Study Medication|55
5383273|NCT03812510|18515994|P1|Overall Study|Study Terminated by Sponsor|9
5383274|NCT03812510|18515994|P1|Overall Study|Physician Decision|2
5383275|NCT03812510|18515994|P1|Overall Study|Withdrawal by Subject|42
5383276|NCT03812510|18515994|P1|Overall Study|Lost to Follow-up|39
5383277|NCT03811093|18516041|P2|Overall Study|Unable to measure body fat percentage|0
5383278|NCT03811093|18516042|P1|Overall Study|Unable to measure body fat percentage|2
5383279|NCT03811093|18516041|P2|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
5383280|NCT03811093|18516042|P1|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
5383281|NCT03810235|18516054|P2|Overall Study|Withdrawal by Subject|0
5383282|NCT03810235|18516055|P1|Overall Study|Withdrawal by Subject|2
5383283|NCT03810014|18516087|P4|Overall Study|Pregnancy|2
5383284|NCT03810014|18516088|P3|Overall Study|Pregnancy|0
5383285|NCT03810014|18516089|P2|Overall Study|Pregnancy|2
5383286|NCT03810014|18516090|P1|Overall Study|Pregnancy|2
5383287|NCT03809611|18516147|P2|Overall Study|Withdrawal by Subject|1
5383288|NCT03809611|18516148|P1|Overall Study|Withdrawal by Subject|1
5383289|NCT03809104|18516180|P1|Overall Study|Withdrawal by Subject|3
5383290|NCT03808688|18516191|P2|Overall Study|Medication Non-Compliance|1
5383291|NCT03808688|18516192|P1|Overall Study|Medication Non-Compliance|0
5383292|NCT03808688|18516191|P2|Overall Study|Visit Out of Window|1
5383293|NCT03808688|18516192|P1|Overall Study|Visit Out of Window|0
5383294|NCT03808688|18516191|P2|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
5383295|NCT03808688|18516192|P1|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
5383296|NCT03808688|18516191|P2|Overall Study|IOP Too High|1
5383297|NCT03808688|18516192|P1|Overall Study|IOP Too High|1
5383298|NCT03808688|18516191|P2|Overall Study|Intolerance to Conjunctival Hyperemia|0
5383299|NCT03808688|18516192|P1|Overall Study|Intolerance to Conjunctival Hyperemia|1
5383300|NCT03808688|18516191|P2|Overall Study|Withdrawal by Subject|0
5383301|NCT03808688|18516192|P1|Overall Study|Withdrawal by Subject|1
5383302|NCT03808688|18516191|P2|Overall Study|Lost to Follow-up|2
5383303|NCT03808688|18516192|P1|Overall Study|Lost to Follow-up|0
5383304|NCT03808688|18516191|P2|Overall Study|Lack of Efficacy|0
5383305|NCT03808688|18516192|P1|Overall Study|Lack of Efficacy|2
5383306|NCT03808688|18516191|P2|Overall Study|Adverse Event|17
5383307|NCT03808688|18516192|P1|Overall Study|Adverse Event|13
5383308|NCT03808298|18516237|P1|Overall Study|Positive Urine Drug Screen at Check-in|3
5383309|NCT03808298|18516237|P1|Overall Study|Withdrawal by Subject|1
5383310|NCT03808298|18516237|P1|Overall Study|Physician Decision|1
5383311|NCT03808298|18516237|P1|Overall Study|Adverse Event|3
5383312|NCT03807739|18516314|P4|Overall Study|Withdrawal by Subject|0
5383313|NCT03807739|18516315|P3|Overall Study|Withdrawal by Subject|0
5383314|NCT03807739|18516316|P2|Overall Study|Withdrawal by Subject|0
5383315|NCT03807739|18516317|P1|Overall Study|Withdrawal by Subject|1
5383316|NCT03807739|18516314|P4|Overall Study|Adverse Event|0
5383317|NCT03807739|18516315|P3|Overall Study|Adverse Event|0
5383318|NCT03807739|18516316|P2|Overall Study|Adverse Event|0
5383319|NCT03807739|18516317|P1|Overall Study|Adverse Event|1
5383320|NCT03807700|18516333|P2|Overall Study|Withdrawal by Subject|1
5383321|NCT03807700|18516334|P1|Overall Study|Withdrawal by Subject|2
5383322|NCT03805971|18516450|P1|Overall Study|Protocol Violation|2
5383323|NCT03805971|18516450|P1|Overall Study|Withdrawal by Subject|1
5383324|NCT03804918|18516472|P1|Overall Study|Participant did not use the app|1
5383325|NCT03804710|18516479|P2|Overall Study|Other|1
5383326|NCT03804710|18516480|P1|Overall Study|Other|0
5383327|NCT03804710|18516479|P2|Overall Study|Withdrawal by Subject|1
5383328|NCT03804710|18516480|P1|Overall Study|Withdrawal by Subject|2
5383329|NCT03804710|18516479|P2|Overall Study|Adverse Event|3
5383330|NCT03804710|18516480|P1|Overall Study|Adverse Event|0
5383331|NCT03802565|18516574|P5|Overall Study|Elevated Enzymes|2
5383332|NCT03802565|18516575|P4|Overall Study|Elevated Enzymes|0
5383333|NCT03802565|18516576|P3|Overall Study|Elevated Enzymes|0
5383334|NCT03802565|18516577|P2|Overall Study|Elevated Enzymes|0
5383335|NCT03802565|18516578|P1|Overall Study|Elevated Enzymes|0
5383336|NCT03802565|18516574|P5|Overall Study|Subjects Related to Each Other|1
5383337|NCT03802565|18516575|P4|Overall Study|Subjects Related to Each Other|2
5383338|NCT03802565|18516576|P3|Overall Study|Subjects Related to Each Other|0
5383339|NCT03802565|18516577|P2|Overall Study|Subjects Related to Each Other|0
5383340|NCT03802565|18516578|P1|Overall Study|Subjects Related to Each Other|1
5383341|NCT03802565|18516574|P5|Overall Study|Lost to Follow-up|0
5383342|NCT03802565|18516575|P4|Overall Study|Lost to Follow-up|0
5383343|NCT03802565|18516576|P3|Overall Study|Lost to Follow-up|1
5383344|NCT03802565|18516577|P2|Overall Study|Lost to Follow-up|0
5383345|NCT03802565|18516578|P1|Overall Study|Lost to Follow-up|0
5383346|NCT03802565|18516574|P5|Overall Study|Protocol Violation|1
5383347|NCT03802565|18516575|P4|Overall Study|Protocol Violation|5
5383348|NCT03802565|18516576|P3|Overall Study|Protocol Violation|4
5383349|NCT03802565|18516577|P2|Overall Study|Protocol Violation|1
5383350|NCT03802565|18516578|P1|Overall Study|Protocol Violation|2
5383351|NCT03802565|18516574|P5|Overall Study|Withdrawal by Subject|1
5383352|NCT03802565|18516575|P4|Overall Study|Withdrawal by Subject|0
5383353|NCT03802565|18516576|P3|Overall Study|Withdrawal by Subject|2
5383354|NCT03802565|18516577|P2|Overall Study|Withdrawal by Subject|2
5383355|NCT03802565|18516578|P1|Overall Study|Withdrawal by Subject|2
5383356|NCT03802565|18516574|P5|Overall Study|Adverse Event|1
5383357|NCT03802565|18516575|P4|Overall Study|Adverse Event|1
5383358|NCT03802565|18516576|P3|Overall Study|Adverse Event|2
5383359|NCT03802565|18516577|P2|Overall Study|Adverse Event|1
5383360|NCT03802565|18516578|P1|Overall Study|Adverse Event|0
5383361|NCT03801148|18516610|P4|Follow-Up (12 Days)|Lost to Follow-up|0
5383362|NCT03801148|18516611|P3|Follow-Up (12 Days)|Lost to Follow-up|1
5383363|NCT03801148|18516612|P2|Follow-Up (12 Days)|Lost to Follow-up|1
5383364|NCT03801148|18516613|P1|Follow-Up (12 Days)|Lost to Follow-up|0
5383365|NCT03801148|18516610|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5383366|NCT03801148|18516611|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5383367|NCT03801148|18516612|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5383368|NCT03801148|18516613|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5383369|NCT03801148|18516610|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|1
5383370|NCT03801148|18516611|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5383371|NCT03801148|18516612|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5383372|NCT03801148|18516613|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5383373|NCT03801148|18516610|P4|Period 1 (2 Days)|Adverse Event|0
5383374|NCT03801148|18516611|P3|Period 1 (2 Days)|Adverse Event|0
5383375|NCT03801148|18516612|P2|Period 1 (2 Days)|Adverse Event|1
5383376|NCT03801148|18516613|P1|Period 1 (2 Days)|Adverse Event|1
5383377|NCT03799211|18516727|P2|Overall Study|Withdrawal by Subject|0
5383378|NCT03799211|18516728|P1|Overall Study|Withdrawal by Subject|2
5383379|NCT03799211|18516727|P2|Overall Study|Lost to Follow-up|13
5383380|NCT03799211|18516728|P1|Overall Study|Lost to Follow-up|2
5383381|NCT03793556|18516862|P2|Overall Study|Lost to Follow-up|1
5383382|NCT03793556|18516863|P1|Overall Study|Lost to Follow-up|1
5383383|NCT03793556|18516862|P2|Overall Study|Withdrawal by Subject|1
5383384|NCT03793556|18516863|P1|Overall Study|Withdrawal by Subject|12
5383385|NCT03793010|18516907|P2|Overall Study|Did not meet eligibility criteria|0
5383386|NCT03793010|18516908|P1|Overall Study|Did not meet eligibility criteria|1
5383387|NCT03793010|18516907|P2|Overall Study|Withdrew to pursue other treatment|0
5383388|NCT03793010|18516908|P1|Overall Study|Withdrew to pursue other treatment|1
5383389|NCT03793010|18516907|P2|Overall Study|Patient couldn't sit still for injection|0
5383390|NCT03793010|18516908|P1|Overall Study|Patient couldn't sit still for injection|1
5383391|NCT03793010|18516907|P2|Overall Study|Lost to Follow-up|2
5383392|NCT03793010|18516908|P1|Overall Study|Lost to Follow-up|1
5383393|NCT03793010|18516907|P2|Overall Study|Withdrawn by Investigator or Sponsor|18
5383394|NCT03793010|18516908|P1|Overall Study|Withdrawn by Investigator or Sponsor|19
5383395|NCT03793010|18516907|P2|Overall Study|Withdrawal by Subject|7
5383396|NCT03793010|18516908|P1|Overall Study|Withdrawal by Subject|5
5383397|NCT03792672|18516918|P6|Treatment Period 4 (2 Days)|Other|0
5383398|NCT03792672|18516919|P5|Treatment Period 4 (2 Days)|Other|0
5383399|NCT03792672|18516920|P4|Treatment Period 4 (2 Days)|Other|0
5383400|NCT03792672|18516921|P3|Treatment Period 4 (2 Days)|Other|0
5383401|NCT03792672|18516922|P2|Treatment Period 4 (2 Days)|Other|0
5383402|NCT03792672|18516923|P1|Treatment Period 4 (2 Days)|Other|1
5383403|NCT03792672|18516918|P6|Washout Period 3 (10 Days)|Physician Decision|0
5383404|NCT03792672|18516919|P5|Washout Period 3 (10 Days)|Physician Decision|0
5383405|NCT03792672|18516920|P4|Washout Period 3 (10 Days)|Physician Decision|0
5383406|NCT03792672|18516921|P3|Washout Period 3 (10 Days)|Physician Decision|1
5383407|NCT03792672|18516922|P2|Washout Period 3 (10 Days)|Physician Decision|0
5383408|NCT03792672|18516923|P1|Washout Period 3 (10 Days)|Physician Decision|0
5383409|NCT03792672|18516918|P6|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5383410|NCT03792672|18516919|P5|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5383411|NCT03792672|18516920|P4|Washout Period 3 (10 Days)|Withdrawal by Subject|2
5383412|NCT03792672|18516921|P3|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5383413|NCT03792672|18516922|P2|Washout Period 3 (10 Days)|Withdrawal by Subject|0
5383414|NCT03792672|18516923|P1|Washout Period 3 (10 Days)|Withdrawal by Subject|1
5383415|NCT03790917|18516950|P1|Overall Study|Death|1
5383416|NCT03787212|18517087|P2|Period 1|Study Termination|2
5383417|NCT03787212|18517088|P1|Period 1|Study Termination|2
5383418|NCT03786718|18517108|P1|Overall Study|diagnosis changed from type 2 to type 1|1
5383419|NCT03786718|18517108|P1|Overall Study|Did not use the intervention|2
5383420|NCT03786718|18517108|P1|Overall Study|Withdrawal by Subject|1
5383421|NCT03786718|18517108|P1|Overall Study|Lost to Follow-up|3
5383422|NCT03785548|18517125|P2|Overall Study|no Postop queries|0
5383423|NCT03785548|18517126|P1|Overall Study|no Postop queries|1
5383424|NCT03785548|18517125|P2|Overall Study|age > 80|0
5383425|NCT03785548|18517126|P1|Overall Study|age > 80|1
5383426|NCT03783780|18517175|P1|Overall Study|Withdrawn prior to completion|1
5383427|NCT03782571|18517189|P4|Period 3|Adverse Event|0
5383428|NCT03782571|18517190|P3|Period 3|Adverse Event|0
5383429|NCT03782571|18517191|P2|Period 3|Adverse Event|0
5383430|NCT03782571|18517192|P1|Period 3|Adverse Event|1
5383431|NCT03782571|18517189|P4|Period 3|Subject Unable to Attend V5|0
5383432|NCT03782571|18517190|P3|Period 3|Subject Unable to Attend V5|0
5383433|NCT03782571|18517191|P2|Period 3|Subject Unable to Attend V5|0
5383434|NCT03782571|18517192|P1|Period 3|Subject Unable to Attend V5|1
5383435|NCT03782571|18517189|P4|Period 1|Withdrawal by Subject|0
5383436|NCT03782571|18517190|P3|Period 1|Withdrawal by Subject|0
5383437|NCT03782571|18517191|P2|Period 1|Withdrawal by Subject|0
5383438|NCT03782571|18517192|P1|Period 1|Withdrawal by Subject|1
5383439|NCT03781375|18517290|P2|Open-label Phase|Other|2
5383440|NCT03781375|18517291|P1|Open-label Phase|Other|2
5383441|NCT03781375|18517290|P2|Open-label Phase|Suboptimal Clinical Response|0
5383442|NCT03781375|18517291|P1|Open-label Phase|Suboptimal Clinical Response|1
5383443|NCT03781375|18517290|P2|Open-label Phase|Protocol Issues|1
5383444|NCT03781375|18517291|P1|Open-label Phase|Protocol Issues|0
5383445|NCT03781375|18517290|P2|Double-blind Phase|Other|3
5383446|NCT03781375|18517291|P1|Double-blind Phase|Other|1
5383447|NCT03781375|18517290|P2|Double-blind Phase|Lack of Response|2
5383448|NCT03781375|18517291|P1|Double-blind Phase|Lack of Response|6
5383449|NCT03781375|18517290|P2|Double-blind Phase|Adverse Event|1
5383450|NCT03781375|18517291|P1|Double-blind Phase|Adverse Event|0
5383451|NCT03780959|18517305|P3|Part 2|Response Status|6
5383452|NCT03780959|18517306|P2|Part 2|Response Status|18
5383453|NCT03780959|18517307|P1|Part 2|Response Status|0
5383454|NCT03780959|18517305|P3|Part 2|Withdrawal by Parent/Guardian|0
5383455|NCT03780959|18517306|P2|Part 2|Withdrawal by Parent/Guardian|1
5383456|NCT03780959|18517307|P1|Part 2|Withdrawal by Parent/Guardian|0
5383457|NCT03780959|18517305|P3|Part 1|Response Status|0
5383458|NCT03780959|18517306|P2|Part 1|Response Status|0
5383459|NCT03780959|18517307|P1|Part 1|Response Status|2
5383460|NCT03780959|18517305|P3|Part 1|Withdrawal by Parent/Guardian|0
5383461|NCT03780959|18517306|P2|Part 1|Withdrawal by Parent/Guardian|0
5383462|NCT03780959|18517307|P1|Part 1|Withdrawal by Parent/Guardian|1
5383463|NCT03780959|18517305|P3|Part 1|Withdrawal by Subject|0
5383464|NCT03780959|18517306|P2|Part 1|Withdrawal by Subject|0
5383465|NCT03780959|18517307|P1|Part 1|Withdrawal by Subject|1
5383466|NCT03780959|18517305|P3|Part 1|Adverse Event|0
5383467|NCT03780959|18517306|P2|Part 1|Adverse Event|0
5383468|NCT03780959|18517307|P1|Part 1|Adverse Event|1
5383469|NCT03780400|18517319|P1|Overall Study|Withdrawal by Subject|2
5383470|NCT03780400|18517319|P1|Overall Study|Lost to Follow-up|5
5383471|NCT03779503|18517382|P2|First Intervention|Withdrawal by Subject|0
5383472|NCT03779503|18517383|P1|First Intervention|Withdrawal by Subject|1
5383473|NCT03779503|18517382|P2|First Intervention|Adverse Event|1
5383474|NCT03779503|18517383|P1|First Intervention|Adverse Event|0
5383475|NCT03776175|18517422|P4|Follow-Up Period (35 Days)|Lost to Follow-up|2
5383476|NCT03776175|18517423|P3|Follow-Up Period (35 Days)|Lost to Follow-up|0
5383477|NCT03776175|18517424|P2|Follow-Up Period (35 Days)|Lost to Follow-up|0
5383478|NCT03776175|18517425|P1|Follow-Up Period (35 Days)|Lost to Follow-up|0
5383479|NCT03776175|18517422|P4|Treatment Period (42 Days)|Unable to attend study visits|0
5383480|NCT03776175|18517423|P3|Treatment Period (42 Days)|Unable to attend study visits|0
5383481|NCT03776175|18517424|P2|Treatment Period (42 Days)|Unable to attend study visits|2
5383482|NCT03776175|18517425|P1|Treatment Period (42 Days)|Unable to attend study visits|0
5383483|NCT03776175|18517422|P4|Treatment Period (42 Days)|Withdrawal by Subject|0
5383484|NCT03776175|18517423|P3|Treatment Period (42 Days)|Withdrawal by Subject|3
5383485|NCT03776175|18517424|P2|Treatment Period (42 Days)|Withdrawal by Subject|2
5383486|NCT03776175|18517425|P1|Treatment Period (42 Days)|Withdrawal by Subject|1
5383487|NCT03776175|18517422|P4|Treatment Period (42 Days)|Participants screened at other site|0
5383488|NCT03776175|18517423|P3|Treatment Period (42 Days)|Participants screened at other site|0
5383489|NCT03776175|18517424|P2|Treatment Period (42 Days)|Participants screened at other site|2
5383490|NCT03776175|18517425|P1|Treatment Period (42 Days)|Participants screened at other site|0
5383491|NCT03776175|18517422|P4|Treatment Period (42 Days)|Lost to Follow-up|2
5383492|NCT03776175|18517423|P3|Treatment Period (42 Days)|Lost to Follow-up|0
5383493|NCT03776175|18517424|P2|Treatment Period (42 Days)|Lost to Follow-up|0
5383494|NCT03776175|18517425|P1|Treatment Period (42 Days)|Lost to Follow-up|0
5383495|NCT03776175|18517422|P4|Treatment Period (42 Days)|Adverse Event|0
5383496|NCT03776175|18517423|P3|Treatment Period (42 Days)|Adverse Event|1
5383497|NCT03776175|18517424|P2|Treatment Period (42 Days)|Adverse Event|1
5383498|NCT03776175|18517425|P1|Treatment Period (42 Days)|Adverse Event|0
5383499|NCT03774576|18517472|P1|Period 2|Adverse Event|1
5383500|NCT03773133|18517485|P1|Overall Study|Screen Failure|8
5383501|NCT03772522|18517492|P2|Post-intervention Follow-up|Lost to Follow-up|0
5383502|NCT03772522|18517493|P1|Post-intervention Follow-up|Lost to Follow-up|1
5383503|NCT03772522|18517492|P2|Intervention|Withdrawal by Subject|0
5383504|NCT03772522|18517493|P1|Intervention|Withdrawal by Subject|1
5383505|NCT03772522|18517492|P2|Pre-intervention|Withdrawal by Subject|4
5383506|NCT03772522|18517493|P1|Pre-intervention|Withdrawal by Subject|3
5383507|NCT03772327|18517516|P2|Overall Study|Withdrawal by Subject|3
5383508|NCT03772327|18517517|P1|Overall Study|Withdrawal by Subject|2
5383509|NCT03772327|18517516|P2|Overall Study|Lost to Follow-up|4
5383510|NCT03772327|18517517|P1|Overall Study|Lost to Follow-up|3
5383511|NCT03767894|18517563|P1|Overall Study|Withdrawal by Subject|1
5383512|NCT03766646|18517585|P2|Overall Study|Protocol Violation|3
5383513|NCT03766646|18517586|P1|Overall Study|Protocol Violation|0
5383514|NCT03766646|18517585|P2|Overall Study|Withdrawal by Subject|0
5383515|NCT03766646|18517586|P1|Overall Study|Withdrawal by Subject|1
5383516|NCT03765164|18517666|P2|Pre-intervention|Withdrawal by Subject|6
5383517|NCT03765164|18517667|P1|Pre-intervention|Withdrawal by Subject|5
5383518|NCT03765138|18517677|P1|Overall Study|Lost to Follow-up|1
5383519|NCT03764813|18517687|P4|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
5383520|NCT03764813|18517688|P3|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
5383521|NCT03764813|18517689|P2|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
5383522|NCT03764813|18517690|P1|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
5383523|NCT03762668|18517811|P2|Period 1, First Week of Wear|Withdrawal by Subject|1
5383524|NCT03762668|18517812|P1|Period 1, First Week of Wear|Withdrawal by Subject|0
5383525|NCT03760510|18517858|P2|Overall Study|Not ventilated for 24 hours|97
5383526|NCT03760510|18517859|P1|Overall Study|Not ventilated for 24 hours|105
5383527|NCT03760250|18517871|P1|Overall Study|Physician Decision|1
5383528|NCT03760250|18517871|P1|Overall Study|Withdrawal by Subject|1
5383529|NCT03760146|18517882|P6|Overall Study|Withdrawal by Subject|0
5383530|NCT03760146|18517883|P5|Overall Study|Withdrawal by Subject|1
5383531|NCT03760146|18517884|P4|Overall Study|Withdrawal by Subject|0
5383532|NCT03760146|18517885|P3|Overall Study|Withdrawal by Subject|1
5383533|NCT03760146|18517886|P2|Overall Study|Withdrawal by Subject|20
5383534|NCT03760146|18517887|P1|Overall Study|Withdrawal by Subject|19
5383535|NCT03760146|18517882|P6|Overall Study|Protocol Violation|0
5383536|NCT03760146|18517883|P5|Overall Study|Protocol Violation|1
5383537|NCT03760146|18517884|P4|Overall Study|Protocol Violation|0
5383538|NCT03760146|18517885|P3|Overall Study|Protocol Violation|1
5383539|NCT03760146|18517886|P2|Overall Study|Protocol Violation|13
5383540|NCT03760146|18517887|P1|Overall Study|Protocol Violation|21
5383541|NCT03760146|18517882|P6|Overall Study|No longer met eligibility criteria|0
5383542|NCT03760146|18517883|P5|Overall Study|No longer met eligibility criteria|1
5383543|NCT03760146|18517884|P4|Overall Study|No longer met eligibility criteria|0
5383544|NCT03760146|18517885|P3|Overall Study|No longer met eligibility criteria|0
5383545|NCT03760146|18517886|P2|Overall Study|No longer met eligibility criteria|9
5383546|NCT03760146|18517887|P1|Overall Study|No longer met eligibility criteria|3
5383547|NCT03760146|18517882|P6|Overall Study|Lost to Follow-up|8
5383548|NCT03760146|18517883|P5|Overall Study|Lost to Follow-up|14
5383549|NCT03760146|18517884|P4|Overall Study|Lost to Follow-up|2
5383550|NCT03760146|18517885|P3|Overall Study|Lost to Follow-up|9
5383551|NCT03760146|18517886|P2|Overall Study|Lost to Follow-up|28
5383552|NCT03760146|18517887|P1|Overall Study|Lost to Follow-up|41
5383553|NCT03760146|18517882|P6|Overall Study|Death|0
5383554|NCT03760146|18517883|P5|Overall Study|Death|0
5383555|NCT03760146|18517884|P4|Overall Study|Death|0
5383556|NCT03760146|18517885|P3|Overall Study|Death|0
5383557|NCT03760146|18517886|P2|Overall Study|Death|0
5383558|NCT03760146|18517887|P1|Overall Study|Death|1
5383559|NCT03760146|18517882|P6|Overall Study|Adverse Event|0
5383560|NCT03760146|18517883|P5|Overall Study|Adverse Event|0
5383561|NCT03760146|18517884|P4|Overall Study|Adverse Event|0
5383562|NCT03760146|18517885|P3|Overall Study|Adverse Event|0
5383563|NCT03760146|18517886|P2|Overall Study|Adverse Event|8
5383564|NCT03760146|18517887|P1|Overall Study|Adverse Event|11
5383565|NCT03759600|18517951|P1|Overall Study|Progressive Disease|3
5383566|NCT03759600|18517951|P1|Overall Study|Adverse Event|1
5383567|NCT03759600|18517951|P1|Overall Study|Ongoing at Data Cut-off|16
5383568|NCT03759587|18517965|P1|Overall Study|Ongoing|19
5383569|NCT03759340|18517978|P1|Overall Study|Study Terminated by Sponsor|38
5383570|NCT03759340|18517978|P1|Overall Study|Withdrawal by Subject|15
5383571|NCT03759340|18517978|P1|Overall Study|Lost to Follow-up|1
5383572|NCT03759340|18517978|P1|Overall Study|Adverse Event|2
5383573|NCT03757988|18517998|P1|Overall Study|Withdrawal by Subject|1
5383574|NCT03757234|18518021|P5|Overall Study|Other|0
5383575|NCT03757234|18518022|P4|Overall Study|Other|0
5383576|NCT03757234|18518023|P3|Overall Study|Other|0
5383577|NCT03757234|18518024|P2|Overall Study|Other|1
5383578|NCT03757234|18518025|P1|Overall Study|Other|1
5383579|NCT03757234|18518021|P5|Overall Study|Withdrawal by Subject|2
5383580|NCT03757234|18518022|P4|Overall Study|Withdrawal by Subject|1
5383581|NCT03757234|18518023|P3|Overall Study|Withdrawal by Subject|0
5383582|NCT03757234|18518024|P2|Overall Study|Withdrawal by Subject|1
5383583|NCT03757234|18518025|P1|Overall Study|Withdrawal by Subject|1
5383584|NCT03757234|18518021|P5|Overall Study|Lost to Follow-up|1
5383585|NCT03757234|18518022|P4|Overall Study|Lost to Follow-up|0
5383586|NCT03757234|18518023|P3|Overall Study|Lost to Follow-up|0
5383587|NCT03757234|18518024|P2|Overall Study|Lost to Follow-up|0
5383588|NCT03757234|18518025|P1|Overall Study|Lost to Follow-up|1
5383589|NCT03757234|18518021|P5|Overall Study|Adverse Event|1
5383590|NCT03757234|18518022|P4|Overall Study|Adverse Event|0
5383591|NCT03757234|18518023|P3|Overall Study|Adverse Event|0
5383592|NCT03757234|18518024|P2|Overall Study|Adverse Event|0
5383593|NCT03757234|18518025|P1|Overall Study|Adverse Event|0
5383594|NCT03755882|18518092|P2|Period 1|Unsatisfactory Lens Fitting Test Article|0
5383595|NCT03755882|18518093|P1|Period 1|Unsatisfactory Lens Fitting Test Article|3
5383596|NCT03755882|18518092|P2|Period 1|Protocol Violation|0
5383597|NCT03755882|18518093|P1|Period 1|Protocol Violation|1
5383598|NCT03752528|18518163|P1|Part B|Study terminated by sponsor|3
5383599|NCT03752528|18518163|P1|Part B|Protocol Violation|1
5383600|NCT03752528|18518163|P1|Part A|Protocol Violation|1
5383601|NCT03752528|18518163|P1|Part A|Lost to Follow-up|1
5383602|NCT03752151|18518182|P1|Overall Study|Protocol Violation|1
5383603|NCT03752151|18518182|P1|Overall Study|Withdrawal by Subject|1
5383604|NCT03751280|18518190|P2|Overall Study|Withdrawal by Subject|2
5383605|NCT03751280|18518191|P1|Overall Study|Withdrawal by Subject|5
5383606|NCT03751280|18518190|P2|Overall Study|Protocol Violation|2
5383607|NCT03751280|18518191|P1|Overall Study|Protocol Violation|0
5383608|NCT03751280|18518190|P2|Overall Study|Physician Decision|2
5383609|NCT03751280|18518191|P1|Overall Study|Physician Decision|0
5383610|NCT03751280|18518190|P2|Overall Study|Lost to Follow-up|5
5383611|NCT03751280|18518191|P1|Overall Study|Lost to Follow-up|3
5383612|NCT03751280|18518190|P2|Overall Study|Adverse Event|1
5383613|NCT03751280|18518191|P1|Overall Study|Adverse Event|0
5383614|NCT03751020|18518227|P3|Overall Study|Lost to Follow-up|10
5383615|NCT03751020|18518228|P2|Overall Study|Lost to Follow-up|4
5383616|NCT03751020|18518229|P1|Overall Study|Lost to Follow-up|7
5383617|NCT03751020|18518227|P3|Overall Study|Withdrawal by Subject|0
5383618|NCT03751020|18518228|P2|Overall Study|Withdrawal by Subject|0
5383619|NCT03751020|18518229|P1|Overall Study|Withdrawal by Subject|2
5383620|NCT03746405|18518455|P2|Overall Study|technical difficulties|2
5383621|NCT03746405|18518456|P1|Overall Study|technical difficulties|0
5383622|NCT03746405|18518455|P2|Overall Study|Withdrawal by Subject|0
5383623|NCT03746405|18518456|P1|Overall Study|Withdrawal by Subject|3
5383624|NCT03745937|18518466|P4|Overall Study|Not-specifed|1
5383625|NCT03745937|18518467|P3|Overall Study|Not-specifed|0
5383626|NCT03745937|18518468|P2|Overall Study|Not-specifed|1
5383627|NCT03745937|18518469|P1|Overall Study|Not-specifed|0
5383628|NCT03745937|18518466|P4|Overall Study|Withdrawal by Subject|1
5383629|NCT03745937|18518467|P3|Overall Study|Withdrawal by Subject|0
5383630|NCT03745937|18518468|P2|Overall Study|Withdrawal by Subject|0
5383631|NCT03745937|18518469|P1|Overall Study|Withdrawal by Subject|0
5383632|NCT03745222|18518583|P3|Overall Study|Withdrawal by Subject|0
5383633|NCT03745222|18518584|P2|Overall Study|Withdrawal by Subject|1
5383634|NCT03745222|18518585|P1|Overall Study|Withdrawal by Subject|0
5383635|NCT03742271|18518680|P1|Overall Study|Protocol Violation|1
5383636|NCT03742271|18518680|P1|Overall Study|Failed Insertion & removal|3
5383637|NCT03742271|18518680|P1|Overall Study|Lost to Follow-up|4
5383638|NCT03742271|18518680|P1|Overall Study|Withdrawal by Subject|3
5383639|NCT03742271|18518680|P1|Overall Study|Unsatisfactory Visual Response|1
5383640|NCT03741062|18518730|P2|Overall Study|Protocol Violation|0
5383641|NCT03741062|18518731|P1|Overall Study|Protocol Violation|1
5383642|NCT03739866|18518774|P8|Overall Study|Enrolled but not treated|0
5383643|NCT03739866|18518775|P7|Overall Study|Enrolled but not treated|0
5383644|NCT03739866|18518776|P6|Overall Study|Enrolled but not treated|0
5383645|NCT03739866|18518777|P5|Overall Study|Enrolled but not treated|1
5383646|NCT03739866|18518778|P4|Overall Study|Enrolled but not treated|0
5383647|NCT03739866|18518779|P3|Overall Study|Enrolled but not treated|1
5383648|NCT03739866|18518780|P2|Overall Study|Enrolled but not treated|0
5383649|NCT03739866|18518781|P1|Overall Study|Enrolled but not treated|0
5383650|NCT03739866|18518774|P8|Overall Study|Lost to Follow-up|0
5383651|NCT03739866|18518775|P7|Overall Study|Lost to Follow-up|0
5383652|NCT03739866|18518776|P6|Overall Study|Lost to Follow-up|0
5383653|NCT03739866|18518777|P5|Overall Study|Lost to Follow-up|0
5383654|NCT03739866|18518778|P4|Overall Study|Lost to Follow-up|1
5383655|NCT03739866|18518779|P3|Overall Study|Lost to Follow-up|0
5383656|NCT03739866|18518780|P2|Overall Study|Lost to Follow-up|0
5383657|NCT03739866|18518781|P1|Overall Study|Lost to Follow-up|0
5383658|NCT03739528|18518850|P2|Overall Study|Treatment discontinued + study completed|3
5383659|NCT03739528|18518851|P1|Overall Study|Treatment discontinued + study completed|1
5383660|NCT03739528|18518850|P2|Overall Study|Treatment and study discontinued|2
5383661|NCT03739528|18518851|P1|Overall Study|Treatment and study discontinued|6
5383662|NCT03739528|18518850|P2|Overall Study|Not treated|12
5383663|NCT03739528|18518851|P1|Overall Study|Not treated|8
5383664|NCT03739242|18518883|P2|Overall Study|Protocol Violation|1
5383665|NCT03739242|18518884|P1|Overall Study|Protocol Violation|0
5383666|NCT03739242|18518883|P2|Overall Study|Withdrawal by Subject|1
5383667|NCT03739242|18518884|P1|Overall Study|Withdrawal by Subject|1
5383668|NCT03738865|18518922|P2|Overall Study|Physician Decision|1
5383669|NCT03738865|18518923|P1|Overall Study|Physician Decision|0
5383670|NCT03738865|18518922|P2|Overall Study|Adverse Event|0
5383671|NCT03738865|18518923|P1|Overall Study|Adverse Event|2
5383672|NCT03738865|18518922|P2|Overall Study|Withdrawal by Subject|3
5383673|NCT03738865|18518923|P1|Overall Study|Withdrawal by Subject|3
5383674|NCT03738475|18518939|P2|Overall Study|Participant Non-Compliance|0
5383675|NCT03738475|18518940|P1|Overall Study|Participant Non-Compliance|1
5383676|NCT03736031|18518986|P2|Overall Study|Withdrawal by Subject|0
5383677|NCT03736031|18518987|P1|Overall Study|Withdrawal by Subject|9
5383678|NCT03736031|18518986|P2|Overall Study|Lost to Follow-up|2
5383679|NCT03736031|18518987|P1|Overall Study|Lost to Follow-up|21
5383680|NCT03736031|18518986|P2|Overall Study|Death|4
5383681|NCT03736031|18518987|P1|Overall Study|Death|2
5383682|NCT03733899|18519011|P6|Period 3|Withdrawal by Subject|0
5383683|NCT03733899|18519012|P5|Period 3|Withdrawal by Subject|0
5383684|NCT03733899|18519013|P4|Period 3|Withdrawal by Subject|0
5383685|NCT03733899|18519014|P3|Period 3|Withdrawal by Subject|0
5383686|NCT03733899|18519015|P2|Period 3|Withdrawal by Subject|0
5383687|NCT03733899|18519016|P1|Period 3|Withdrawal by Subject|1
5383688|NCT03733899|18519011|P6|Period 2|Unscuccessful Treatment|0
5383689|NCT03733899|18519012|P5|Period 2|Unscuccessful Treatment|0
5383690|NCT03733899|18519013|P4|Period 2|Unscuccessful Treatment|0
5383691|NCT03733899|18519014|P3|Period 2|Unscuccessful Treatment|0
5383692|NCT03733899|18519015|P2|Period 2|Unscuccessful Treatment|1
5383693|NCT03733899|18519016|P1|Period 2|Unscuccessful Treatment|0
5383694|NCT03733899|18519011|P6|Period 1|Protocol Violation|1
5383695|NCT03733899|18519012|P5|Period 1|Protocol Violation|0
5383696|NCT03733899|18519013|P4|Period 1|Protocol Violation|0
5383697|NCT03733899|18519014|P3|Period 1|Protocol Violation|0
5383698|NCT03733899|18519015|P2|Period 1|Protocol Violation|0
5383699|NCT03733899|18519016|P1|Period 1|Protocol Violation|0
5383700|NCT03733470|18519044|P2|Overall Study|PI Decision|1
5383701|NCT03733470|18519045|P1|Overall Study|PI Decision|1
5383702|NCT03733301|18519054|P3|Overall Study|Withdrawal by Subject|1
5383703|NCT03733301|18519055|P2|Overall Study|Withdrawal by Subject|5
5383704|NCT03733301|18519056|P1|Overall Study|Withdrawal by Subject|3
5383705|NCT03733301|18519054|P3|Overall Study|Adverse Event|3
5383706|NCT03733301|18519055|P2|Overall Study|Adverse Event|1
5383707|NCT03733301|18519056|P1|Overall Study|Adverse Event|0
5383708|NCT03733301|18519054|P3|Overall Study|Lack of Efficacy|0
5383709|NCT03733301|18519055|P2|Overall Study|Lack of Efficacy|3
5383710|NCT03733301|18519056|P1|Overall Study|Lack of Efficacy|2
5383711|NCT03733301|18519054|P3|Overall Study|Non-compliance|0
5383712|NCT03733301|18519055|P2|Overall Study|Non-compliance|0
5383713|NCT03733301|18519056|P1|Overall Study|Non-compliance|1
5383714|NCT03733301|18519054|P3|Overall Study|Screen Fail|0
5383715|NCT03733301|18519055|P2|Overall Study|Screen Fail|0
5383716|NCT03733301|18519056|P1|Overall Study|Screen Fail|1
5383717|NCT03730103|18519147|P2|Overall Study|Did not meet inclusion criteria|5
5383718|NCT03730103|18519148|P1|Overall Study|Did not meet inclusion criteria|0
5383719|NCT03728140|18519196|P2|Overall Study|Abnormal embryo transfer operation|7
5383720|NCT03728140|18519197|P1|Overall Study|Abnormal embryo transfer operation|10
5383721|NCT03726996|18519250|P1|Overall Study|Study early termination|2
5383722|NCT03726996|18519250|P1|Overall Study|Parent's decision|2
5383723|NCT03725982|18519269|P2|First Intervention|Physician Decision|1
5383724|NCT03725982|18519270|P1|First Intervention|Physician Decision|1
5383725|NCT03725982|18519269|P2|First Intervention|Withdrawal by Subject|1
5383726|NCT03725982|18519270|P1|First Intervention|Withdrawal by Subject|0
5383727|NCT03725085|18519303|P1|Overall Study|Lost to Follow-up|2
5383728|NCT03724981|18519311|P2|First Device|Protocol Violation|1
5383729|NCT03724981|18519312|P1|First Device|Protocol Violation|1
5383730|NCT03722784|18519458|P2|Overall Study|Protocol Violation|1
5383731|NCT03722784|18519459|P1|Overall Study|Protocol Violation|0
5383732|NCT03722784|18519458|P2|Overall Study|Physician Decision|1
5383733|NCT03722784|18519459|P1|Overall Study|Physician Decision|1
5383734|NCT03722784|18519458|P2|Overall Study|Withdrawal by Subject|0
5383735|NCT03722784|18519459|P1|Overall Study|Withdrawal by Subject|1
5383736|NCT03722446|18519503|P2|Overall Study|Protocol Violation|2
5383737|NCT03722446|18519504|P1|Overall Study|Protocol Violation|15
5383738|NCT03722264|18519520|P1|Overall Study|Physician Decision|3
5383739|NCT03722030|18519532|P2|Overall Study|Withdrawal by Subject|0
5383740|NCT03722030|18519533|P1|Overall Study|Withdrawal by Subject|1
5383741|NCT03720847|18519603|P2|Washout|Physician Decision|2
5383742|NCT03720847|18519604|P1|Washout|Physician Decision|1
5383743|NCT03718143|18519656|P3|Overall Study|Withdrawal of Informed Consent|1
5383744|NCT03718143|18519657|P2|Overall Study|Withdrawal of Informed Consent|2
5383745|NCT03718143|18519658|P1|Overall Study|Withdrawal of Informed Consent|1
5383746|NCT03718143|18519656|P3|Overall Study|Progression of Disease|0
5383747|NCT03718143|18519657|P2|Overall Study|Progression of Disease|0
5383748|NCT03718143|18519658|P1|Overall Study|Progression of Disease|1
5383749|NCT03718143|18519656|P3|Overall Study|Death|0
5383750|NCT03718143|18519657|P2|Overall Study|Death|0
5383751|NCT03718143|18519658|P1|Overall Study|Death|1
5383752|NCT03718000|18519674|P2|Overall Study|Pregnancy|1
5383753|NCT03718000|18519675|P1|Overall Study|Pregnancy|0
5383754|NCT03718000|18519674|P2|Overall Study|Relocation|4
5383755|NCT03718000|18519675|P1|Overall Study|Relocation|2
5383756|NCT03717064|18519697|P1|Period 2|Adverse Event|1
5383757|NCT03716050|18519729|P8|Overall Study|Protocol Violation|2
5383758|NCT03716050|18519730|P7|Overall Study|Protocol Violation|0
5383759|NCT03716050|18519731|P6|Overall Study|Protocol Violation|0
5383760|NCT03716050|18519732|P5|Overall Study|Protocol Violation|0
5383761|NCT03716050|18519733|P4|Overall Study|Protocol Violation|1
5383762|NCT03716050|18519734|P3|Overall Study|Protocol Violation|0
5383763|NCT03716050|18519735|P2|Overall Study|Protocol Violation|0
5383764|NCT03716050|18519736|P1|Overall Study|Protocol Violation|0
5383765|NCT03716050|18519729|P8|Overall Study|Physician Decision|0
5383766|NCT03716050|18519730|P7|Overall Study|Physician Decision|0
5383767|NCT03716050|18519731|P6|Overall Study|Physician Decision|0
5383768|NCT03716050|18519732|P5|Overall Study|Physician Decision|0
5383769|NCT03716050|18519733|P4|Overall Study|Physician Decision|1
5383770|NCT03716050|18519734|P3|Overall Study|Physician Decision|0
5383771|NCT03716050|18519735|P2|Overall Study|Physician Decision|0
5383772|NCT03716050|18519736|P1|Overall Study|Physician Decision|0
5383773|NCT03716050|18519729|P8|Overall Study|Lost to Follow-up|0
5383774|NCT03716050|18519730|P7|Overall Study|Lost to Follow-up|0
5383775|NCT03716050|18519731|P6|Overall Study|Lost to Follow-up|0
5383776|NCT03716050|18519732|P5|Overall Study|Lost to Follow-up|0
5383777|NCT03716050|18519733|P4|Overall Study|Lost to Follow-up|0
5383778|NCT03716050|18519734|P3|Overall Study|Lost to Follow-up|1
5383779|NCT03716050|18519735|P2|Overall Study|Lost to Follow-up|0
5383780|NCT03716050|18519736|P1|Overall Study|Lost to Follow-up|0
5383781|NCT03716024|18519790|P2|Overall Study|Missing Reason|1
5383782|NCT03716024|18519791|P1|Overall Study|Missing Reason|0
5383783|NCT03716024|18519790|P2|Overall Study|Withdrawal by Subject|1
5383784|NCT03716024|18519791|P1|Overall Study|Withdrawal by Subject|0
5383785|NCT03716024|18519790|P2|Overall Study|Lost to Follow-up|6
5383786|NCT03716024|18519791|P1|Overall Study|Lost to Follow-up|2
5383787|NCT03716024|18519790|P2|Overall Study|Treatment Failure|0
5383788|NCT03716024|18519791|P1|Overall Study|Treatment Failure|1
5383789|NCT03716024|18519790|P2|Overall Study|Adverse Event|2
5383790|NCT03716024|18519791|P1|Overall Study|Adverse Event|1
5383791|NCT03716024|18519790|P2|Overall Study|Randomized, not Treated|8
5383792|NCT03716024|18519791|P1|Overall Study|Randomized, not Treated|7
5383793|NCT03715530|18519825|P3|Overall Study|Lost to Follow-up|2
5383794|NCT03715530|18519826|P2|Overall Study|Lost to Follow-up|1
5383795|NCT03715530|18519827|P1|Overall Study|Lost to Follow-up|3
5383796|NCT03714672|18519887|P4|Overall Study|Lost to Follow-up|0
5383797|NCT03714672|18519888|P3|Overall Study|Lost to Follow-up|0
5383798|NCT03714672|18519889|P2|Overall Study|Lost to Follow-up|1
5383799|NCT03714672|18519890|P1|Overall Study|Lost to Follow-up|1
5383800|NCT03714672|18519887|P4|Overall Study|Other Reason|1
5383801|NCT03714672|18519888|P3|Overall Study|Other Reason|1
5383802|NCT03714672|18519889|P2|Overall Study|Other Reason|2
5383803|NCT03714672|18519890|P1|Overall Study|Other Reason|1
5383804|NCT03714672|18519887|P4|Overall Study|Physician Decision|0
5383805|NCT03714672|18519888|P3|Overall Study|Physician Decision|0
5383806|NCT03714672|18519889|P2|Overall Study|Physician Decision|1
5383807|NCT03714672|18519890|P1|Overall Study|Physician Decision|0
5383808|NCT03714672|18519887|P4|Overall Study|Adverse Event|0
5383809|NCT03714672|18519888|P3|Overall Study|Adverse Event|3
5383810|NCT03714672|18519889|P2|Overall Study|Adverse Event|0
5383811|NCT03714672|18519890|P1|Overall Study|Adverse Event|0
5383812|NCT03712917|18519944|P3|Overall Study|Lost to Follow-up|5
5383813|NCT03712917|18519945|P2|Overall Study|Lost to Follow-up|4
5383814|NCT03712917|18519946|P1|Overall Study|Lost to Follow-up|9
5383815|NCT03712917|18519944|P3|Overall Study|Adverse Event|3
5383816|NCT03712917|18519945|P2|Overall Study|Adverse Event|4
5383817|NCT03712917|18519946|P1|Overall Study|Adverse Event|0
5383818|NCT03712917|18519944|P3|Overall Study|Pregnancy|1
5383819|NCT03712917|18519945|P2|Overall Study|Pregnancy|0
5383820|NCT03712917|18519946|P1|Overall Study|Pregnancy|0
5383821|NCT03710083|18519974|P1|Overall Study|Unsuccessful Procedure|1
5383822|NCT03710083|18519974|P1|Overall Study|Withdrawal by Subject|2
5383823|NCT03709823|18519987|P6|Overall Study|Other, Not Specified|0
5383824|NCT03709823|18519988|P5|Overall Study|Other, Not Specified|0
5383825|NCT03709823|18519989|P4|Overall Study|Other, Not Specified|1
5383826|NCT03709823|18519990|P3|Overall Study|Other, Not Specified|0
5383827|NCT03709823|18519991|P2|Overall Study|Other, Not Specified|0
5383828|NCT03709823|18519992|P1|Overall Study|Other, Not Specified|0
5383829|NCT03709823|18519987|P6|Overall Study|Withdrawal by Subject|0
5383830|NCT03709823|18519988|P5|Overall Study|Withdrawal by Subject|0
5383831|NCT03709823|18519989|P4|Overall Study|Withdrawal by Subject|0
5383832|NCT03709823|18519990|P3|Overall Study|Withdrawal by Subject|0
5383833|NCT03709823|18519991|P2|Overall Study|Withdrawal by Subject|3
5383834|NCT03709823|18519992|P1|Overall Study|Withdrawal by Subject|1
5383835|NCT03709823|18519987|P6|Overall Study|Lost to Follow-up|0
5383836|NCT03709823|18519988|P5|Overall Study|Lost to Follow-up|1
5383837|NCT03709823|18519989|P4|Overall Study|Lost to Follow-up|1
5383838|NCT03709823|18519990|P3|Overall Study|Lost to Follow-up|2
5383839|NCT03709823|18519991|P2|Overall Study|Lost to Follow-up|2
5383840|NCT03709823|18519992|P1|Overall Study|Lost to Follow-up|2
5383841|NCT03709823|18519987|P6|Overall Study|Adverse Event|0
5383842|NCT03709823|18519988|P5|Overall Study|Adverse Event|0
5383843|NCT03709823|18519989|P4|Overall Study|Adverse Event|0
5383844|NCT03709823|18519990|P3|Overall Study|Adverse Event|1
5383845|NCT03709823|18519991|P2|Overall Study|Adverse Event|0
5383846|NCT03709823|18519992|P1|Overall Study|Adverse Event|0
5383847|NCT03709654|18520029|P2|Overall Study|Adverse Event|0
5383848|NCT03709654|18520030|P1|Overall Study|Adverse Event|1
5383849|NCT03709654|18520029|P2|Overall Study|Withdrawal by Subject|1
5383850|NCT03709654|18520030|P1|Overall Study|Withdrawal by Subject|1
5383851|NCT03709654|18520029|P2|Overall Study|Lost to Follow-up|1
5383852|NCT03709654|18520030|P1|Overall Study|Lost to Follow-up|1
5383853|NCT03709576|18520067|P1|Overall Study|progression prior to enrollment|1
5383854|NCT03708744|18520090|P4|Overall Study|Withdrawal by Subject|0
5383855|NCT03708744|18520091|P3|Overall Study|Withdrawal by Subject|1
5383856|NCT03708744|18520092|P2|Overall Study|Withdrawal by Subject|0
5383857|NCT03708744|18520093|P1|Overall Study|Withdrawal by Subject|0
5383858|NCT03708211|18520127|P2|Overall Study|Other|0
5383859|NCT03708211|18520128|P1|Overall Study|Other|2
5383860|NCT03708211|18520127|P2|Overall Study|Withdrawal by Subject|1
5383861|NCT03708211|18520128|P1|Overall Study|Withdrawal by Subject|0
5383862|NCT03708211|18520127|P2|Overall Study|Progressive Disease|7
5383863|NCT03708211|18520128|P1|Overall Study|Progressive Disease|10
5383864|NCT03707912|18520160|P2|Overall Study|Violation of inclusion criteria|0
5383865|NCT03707912|18520161|P1|Overall Study|Violation of inclusion criteria|1
5383866|NCT03707821|18520181|P2|Overall Study|Unsatisfactory Lens Fitting|0
5383867|NCT03707821|18520182|P1|Overall Study|Unsatisfactory Lens Fitting|1
5383868|NCT03707821|18520181|P2|Overall Study|Unsatisfactory Visual Response|0
5383869|NCT03707821|18520182|P1|Overall Study|Unsatisfactory Visual Response|1
5383870|NCT03707821|18520181|P2|Overall Study|Protocol Violation|1
5383871|NCT03707821|18520182|P1|Overall Study|Protocol Violation|0
5383872|NCT03707587|18520202|P2|Overall Study|Death|1
5383873|NCT03707587|18520203|P1|Overall Study|Death|0
5383874|NCT03707522|18520219|P4|Overall Study|Lost to Follow-up|36
5383875|NCT03707522|18520220|P3|Overall Study|Lost to Follow-up|41
5383876|NCT03707522|18520221|P2|Overall Study|Lost to Follow-up|27
5383877|NCT03707522|18520222|P1|Overall Study|Lost to Follow-up|24
5383878|NCT03705793|18520311|P2|Overall Study|Withdrawal by Subject|1
5383879|NCT03705793|18520312|P1|Overall Study|Withdrawal by Subject|2
5383880|NCT03705793|18520311|P2|Overall Study|Lost to Follow-up|4
5383881|NCT03705793|18520312|P1|Overall Study|Lost to Follow-up|3
5383882|NCT03705494|18520324|P2|Overall Study|Withdrawal by Subject|2
5383883|NCT03705494|18520325|P1|Overall Study|Withdrawal by Subject|5
5383884|NCT03705494|18520324|P2|Overall Study|Lost to Follow-up|1
5383885|NCT03705494|18520325|P1|Overall Study|Lost to Follow-up|2
5383886|NCT03704194|18520411|P2|Overall Study|Withdrawal by Subject|1
5383887|NCT03704194|18520412|P1|Overall Study|Withdrawal by Subject|0
5383888|NCT03703466|18520440|P3|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
5383889|NCT03703466|18520441|P2|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
5383890|NCT03703466|18520442|P1|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
5383891|NCT03703466|18520440|P3|Overall Study|Withdrawal by Subject|0
5383892|NCT03703466|18520441|P2|Overall Study|Withdrawal by Subject|3
5383893|NCT03703466|18520442|P1|Overall Study|Withdrawal by Subject|0
5383894|NCT03703466|18520440|P3|Overall Study|Protocol Violation|0
5383895|NCT03703466|18520441|P2|Overall Study|Protocol Violation|0
5383896|NCT03703466|18520442|P1|Overall Study|Protocol Violation|1
5383897|NCT03703466|18520440|P3|Overall Study|Death|0
5383898|NCT03703466|18520441|P2|Overall Study|Death|1
5383899|NCT03703466|18520442|P1|Overall Study|Death|2
5383900|NCT03702166|18520479|P1|Overall Study|Withdrawal by Subject|1
5383901|NCT03702166|18520479|P1|Overall Study|Lost to Follow-up|1
5383902|NCT03700671|18520505|P2|Overall Study|Lack of Efficacy|2
5383903|NCT03700671|18520506|P1|Overall Study|Lack of Efficacy|1
5383904|NCT03700385|18520518|P1|Overall Study|Lost to Follow-up|1
5383905|NCT03698591|18520525|P2|Overall Study|Could not establish TMS dosage|1
5383906|NCT03698591|18520526|P1|Overall Study|Could not establish TMS dosage|0
5383907|NCT03698591|18520525|P2|Overall Study|Equipment Error|0
5383908|NCT03698591|18520526|P1|Overall Study|Equipment Error|1
5383909|NCT03698591|18520525|P2|Overall Study|Ineligible for financial compensation|0
5383910|NCT03698591|18520526|P1|Overall Study|Ineligible for financial compensation|1
5383911|NCT03698591|18520525|P2|Overall Study|Failed health screen|1
5383912|NCT03698591|18520526|P1|Overall Study|Failed health screen|0
5383913|NCT03698591|18520525|P2|Overall Study|Failed drug screen|1
5383914|NCT03698591|18520526|P1|Overall Study|Failed drug screen|1
5383915|NCT03698591|18520525|P2|Overall Study|Withdrawal by Subject|2
5383916|NCT03698591|18520526|P1|Overall Study|Withdrawal by Subject|2
5383917|NCT03698331|18520540|P2|Overall Study|Non-compliance with study drug|0
5383918|NCT03698331|18520541|P1|Overall Study|Non-compliance with study drug|1
5383919|NCT03698331|18520540|P2|Overall Study|Lost to Follow-up|2
5383920|NCT03698331|18520541|P1|Overall Study|Lost to Follow-up|0
5383921|NCT03698331|18520540|P2|Overall Study|Withdrawal by Subject|1
5383922|NCT03698331|18520541|P1|Overall Study|Withdrawal by Subject|1
5383923|NCT03698331|18520540|P2|Overall Study|Adverse Event|3
5383924|NCT03698331|18520541|P1|Overall Study|Adverse Event|2
5383925|NCT03698279|18520563|P6|Overall Study|Lost to Follow-up|0
5383926|NCT03698279|18520564|P5|Overall Study|Lost to Follow-up|0
5383927|NCT03698279|18520565|P4|Overall Study|Lost to Follow-up|5
5383928|NCT03698279|18520566|P3|Overall Study|Lost to Follow-up|4
5383929|NCT03698279|18520567|P2|Overall Study|Lost to Follow-up|1
5383930|NCT03698279|18520568|P1|Overall Study|Lost to Follow-up|3
5383931|NCT03698279|18520563|P6|Overall Study|Withdrawal by Subject|0
5383932|NCT03698279|18520564|P5|Overall Study|Withdrawal by Subject|0
5383933|NCT03698279|18520565|P4|Overall Study|Withdrawal by Subject|0
5383934|NCT03698279|18520566|P3|Overall Study|Withdrawal by Subject|1
5383935|NCT03698279|18520567|P2|Overall Study|Withdrawal by Subject|0
5383936|NCT03698279|18520568|P1|Overall Study|Withdrawal by Subject|0
5383937|NCT03698279|18520563|P6|Overall Study|Protocol deviation|0
5383938|NCT03698279|18520564|P5|Overall Study|Protocol deviation|0
5383939|NCT03698279|18520565|P4|Overall Study|Protocol deviation|0
5383940|NCT03698279|18520566|P3|Overall Study|Protocol deviation|1
5383941|NCT03698279|18520567|P2|Overall Study|Protocol deviation|0
5383942|NCT03698279|18520568|P1|Overall Study|Protocol deviation|1
5383943|NCT03698279|18520563|P6|Overall Study|Withdrawal by parent/guardian|0
5383944|NCT03698279|18520564|P5|Overall Study|Withdrawal by parent/guardian|0
5383945|NCT03698279|18520565|P4|Overall Study|Withdrawal by parent/guardian|1
5383946|NCT03698279|18520566|P3|Overall Study|Withdrawal by parent/guardian|1
5383947|NCT03698279|18520567|P2|Overall Study|Withdrawal by parent/guardian|1
5383948|NCT03698279|18520568|P1|Overall Study|Withdrawal by parent/guardian|1
5383949|NCT03697993|18520664|P2|Overall Study|Initial Urine Culture Negative|1
5383950|NCT03697993|18520665|P1|Overall Study|Initial Urine Culture Negative|0
5383951|NCT03697993|18520664|P2|Overall Study|Physician Decision|0
5383952|NCT03697993|18520665|P1|Overall Study|Physician Decision|4
5383953|NCT03697993|18520664|P2|Overall Study|Lost to Follow-up|0
5383954|NCT03697993|18520665|P1|Overall Study|Lost to Follow-up|3
5383955|NCT03697993|18520664|P2|Overall Study|Enrolled but Treatment not Administered|1
5383956|NCT03697993|18520665|P1|Overall Study|Enrolled but Treatment not Administered|2
5384111|NCT03684044|18521942|P2|Overall Study|Lost to Follow-up|2
5383957|NCT03697993|18520664|P2|Overall Study|Became Ineligible after Enrollment|3
5383958|NCT03697993|18520665|P1|Overall Study|Became Ineligible after Enrollment|1
5383959|NCT03697252|18520691|P2|Overall Study|Other|1
5383960|NCT03697252|18520692|P1|Overall Study|Other|0
5383961|NCT03697252|18520691|P2|Overall Study|Physician Decision|1
5383962|NCT03697252|18520692|P1|Overall Study|Physician Decision|1
5383963|NCT03697252|18520691|P2|Overall Study|Lost to Follow-up|1
5383964|NCT03697252|18520692|P1|Overall Study|Lost to Follow-up|0
5383965|NCT03697252|18520691|P2|Overall Study|Withdrawal by Subject|14
5383966|NCT03697252|18520692|P1|Overall Study|Withdrawal by Subject|14
5383967|NCT03697252|18520691|P2|Overall Study|Adverse Event|2
5383968|NCT03697252|18520692|P1|Overall Study|Adverse Event|3
5383969|NCT03695094|18520773|P2|Overall Study|Withdrawal by Subject|0
5383970|NCT03695094|18520774|P1|Overall Study|Withdrawal by Subject|1
5383971|NCT03695094|18520773|P2|Overall Study|Adverse Event|1
5383972|NCT03695094|18520774|P1|Overall Study|Adverse Event|1
5383973|NCT03694925|18520810|P3|Overall Study|Inadequate laboratory testing|0
5383974|NCT03694925|18520811|P2|Overall Study|Inadequate laboratory testing|3
5383975|NCT03694925|18520812|P1|Overall Study|Inadequate laboratory testing|0
5383976|NCT03694821|18520828|P3|Overall Study|Study terminated|4
5383977|NCT03694821|18520829|P2|Overall Study|Study terminated|8
5383978|NCT03694821|18520830|P1|Overall Study|Study terminated|4
5383979|NCT03693989|18520861|P2|Overall Study|Protocol Violation|4
5383980|NCT03693989|18520862|P1|Overall Study|Protocol Violation|3
5383981|NCT03693950|18520886|P2|Overall Study|Withdrawal by Subject|0
5383982|NCT03693950|18520887|P1|Overall Study|Withdrawal by Subject|1
5383983|NCT03693625|18520911|P2|Overall Study|Withdrawal by Subject|1
5383984|NCT03693625|18520912|P1|Overall Study|Withdrawal by Subject|1
5383985|NCT03693625|18520911|P2|Overall Study|Study Terminated By Sponsor|7
5383986|NCT03693625|18520912|P1|Overall Study|Study Terminated By Sponsor|20
5383987|NCT03693625|18520911|P2|Overall Study|Adverse Event|0
5383988|NCT03693625|18520912|P1|Overall Study|Adverse Event|2
5383989|NCT03692676|18520924|P4|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3
5383990|NCT03692676|18520925|P3|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
5383991|NCT03692676|18520926|P2|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
5383992|NCT03692676|18520927|P1|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
5383993|NCT03692676|18520924|P4|Overall Study|Other|277
5383994|NCT03692676|18520925|P3|Overall Study|Other|758
5383995|NCT03692676|18520926|P2|Overall Study|Other|805
5383996|NCT03692676|18520927|P1|Overall Study|Other|0
5383997|NCT03692676|18520924|P4|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223
5383998|NCT03692676|18520925|P3|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
5383999|NCT03692676|18520926|P2|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
5384000|NCT03692676|18520927|P1|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
5384001|NCT03692676|18520924|P4|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198
5384002|NCT03692676|18520925|P3|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965
5384003|NCT03692676|18520926|P2|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
5384004|NCT03692676|18520927|P1|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
5384005|NCT03692676|18520924|P4|Overall Study|exclude patients with prior use of same substances and device|0
5384006|NCT03692676|18520925|P3|Overall Study|exclude patients with prior use of same substances and device|3700
5384007|NCT03692676|18520926|P2|Overall Study|exclude patients with prior use of same substances and device|0
5384008|NCT03692676|18520927|P1|Overall Study|exclude patients with prior use of same substances and device|0
5384009|NCT03692676|18520924|P4|Overall Study|exclude patients with multiple FDC prescriptions on index date|4
5384010|NCT03692676|18520925|P3|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147
5384011|NCT03692676|18520926|P2|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
5384012|NCT03692676|18520927|P1|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
5384013|NCT03692676|18520924|P4|Overall Study|exclude patients with prior recorded COPD diagnosis|173
5384014|NCT03692676|18520925|P3|Overall Study|exclude patients with prior recorded COPD diagnosis|1515
5384015|NCT03692676|18520926|P2|Overall Study|exclude patients with prior recorded COPD diagnosis|218
5384016|NCT03692676|18520927|P1|Overall Study|exclude patients with prior recorded COPD diagnosis|275
5384017|NCT03692676|18520924|P4|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684
5384018|NCT03692676|18520925|P3|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419
5384019|NCT03692676|18520926|P2|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759
5384020|NCT03692676|18520927|P1|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208
5384021|NCT03692676|18520924|P4|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273
5384022|NCT03692676|18520925|P3|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723
5384023|NCT03692676|18520926|P2|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717
5384024|NCT03692676|18520927|P1|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149
5384025|NCT03692676|18520924|P4|Overall Study|exclude patients less than 18 years of age on index date|193
5384026|NCT03692676|18520925|P3|Overall Study|exclude patients less than 18 years of age on index date|836
5384027|NCT03692676|18520926|P2|Overall Study|exclude patients less than 18 years of age on index date|613
5384028|NCT03692676|18520927|P1|Overall Study|exclude patients less than 18 years of age on index date|8
5384029|NCT03692676|18520924|P4|Overall Study|exclude patients without prior recorded asthma diagnosis|558
5384030|NCT03692676|18520925|P3|Overall Study|exclude patients without prior recorded asthma diagnosis|6281
5384031|NCT03692676|18520926|P2|Overall Study|exclude patients without prior recorded asthma diagnosis|563
5384032|NCT03692676|18520927|P1|Overall Study|exclude patients without prior recorded asthma diagnosis|881
5384033|NCT03692676|18520924|P4|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
5384034|NCT03692676|18520925|P3|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
5384035|NCT03692676|18520926|P2|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037
5384036|NCT03692676|18520927|P1|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480
5384037|NCT03692676|18520924|P4|Overall Study|exclude patients with prior use|0
5384038|NCT03692676|18520925|P3|Overall Study|exclude patients with prior use|0
5384039|NCT03692676|18520926|P2|Overall Study|exclude patients with prior use|24726
5384040|NCT03692676|18520927|P1|Overall Study|exclude patients with prior use|4424
5384041|NCT03691948|18520943|P2|Overall Study|Lost to Follow-up|3
5384042|NCT03691948|18520944|P1|Overall Study|Lost to Follow-up|1
5384043|NCT03691831|18521031|P2|Overall Study|Investigator Decision|2
5384044|NCT03691831|18521032|P1|Overall Study|Investigator Decision|2
5384045|NCT03691831|18521031|P2|Overall Study|Withdrawal by Subject|17
5384046|NCT03691831|18521032|P1|Overall Study|Withdrawal by Subject|9
5384047|NCT03691831|18521031|P2|Overall Study|Lost to Follow-up|12
5384048|NCT03691831|18521032|P1|Overall Study|Lost to Follow-up|16
5384049|NCT03689452|18521057|P2|Overall Study|Lost to Follow-up|1
5384050|NCT03689452|18521058|P1|Overall Study|Lost to Follow-up|1
5384051|NCT03688880|18521076|P2|Overall Study|Other|16
5384052|NCT03688880|18521077|P1|Overall Study|Other|10
5384053|NCT03688880|18521076|P2|Overall Study|Device deficiencies|2
5384054|NCT03688880|18521077|P1|Overall Study|Device deficiencies|0
5384055|NCT03688880|18521076|P2|Overall Study|Adverse Event|2
5384056|NCT03688880|18521077|P1|Overall Study|Adverse Event|0
5384057|NCT03688880|18521076|P2|Overall Study|Lost to Follow-up|7
5384058|NCT03688880|18521077|P1|Overall Study|Lost to Follow-up|4
5384059|NCT03688880|18521076|P2|Overall Study|Use of non-permitted concurrent therapy|2
5384060|NCT03688880|18521077|P1|Overall Study|Use of non-permitted concurrent therapy|0
5384061|NCT03688880|18521076|P2|Overall Study|Withdrawal by Subject|2
5384062|NCT03688880|18521077|P1|Overall Study|Withdrawal by Subject|0
5384063|NCT03688620|18521104|P3|Overall Study|Withdrawal by Subject|6
5384064|NCT03688620|18521105|P2|Overall Study|Withdrawal by Subject|0
5384065|NCT03688620|18521106|P1|Overall Study|Withdrawal by Subject|0
5384066|NCT03688620|18521104|P3|Overall Study|Lost to Follow-up|1
5384067|NCT03688620|18521105|P2|Overall Study|Lost to Follow-up|0
5384068|NCT03688620|18521106|P1|Overall Study|Lost to Follow-up|16
5384069|NCT03688620|18521104|P3|Overall Study|Unwilling to attend the scheduled visit|0
5384070|NCT03688620|18521105|P2|Overall Study|Unwilling to attend the scheduled visit|1
5384071|NCT03688620|18521106|P1|Overall Study|Unwilling to attend the scheduled visit|0
5384072|NCT03688620|18521104|P3|Overall Study|Other|1
5384073|NCT03688620|18521105|P2|Overall Study|Other|0
5384074|NCT03688620|18521106|P1|Overall Study|Other|0
5384075|NCT03687970|18521589|P2|Overall Study|visit scheduling conflicts|0
5384076|NCT03687970|18521590|P1|Overall Study|visit scheduling conflicts|2
5384077|NCT03687736|18521600|P1|Overall Study|Withdrawal by Subject|3
5384078|NCT03687736|18521600|P1|Overall Study|Lost to Follow-up|7
5384079|NCT03687372|18521746|P2|Overall Study|Investigator Decision|1
5384080|NCT03687372|18521747|P1|Overall Study|Investigator Decision|1
5384081|NCT03687372|18521746|P2|Overall Study|Withdrawal by Subject|17
5384082|NCT03687372|18521747|P1|Overall Study|Withdrawal by Subject|4
5384083|NCT03687372|18521746|P2|Overall Study|Lost to Follow-up|21
5384084|NCT03687372|18521747|P1|Overall Study|Lost to Follow-up|12
5384085|NCT03686176|18521764|P3|Overall Study|VR Malfunction|0
5384086|NCT03686176|18521765|P2|Overall Study|VR Malfunction|0
5384087|NCT03686176|18521766|P1|Overall Study|VR Malfunction|1
5384088|NCT03686176|18521764|P3|Overall Study|Procedure cancelled|0
5384089|NCT03686176|18521765|P2|Overall Study|Procedure cancelled|0
5384090|NCT03686176|18521766|P1|Overall Study|Procedure cancelled|1
5384091|NCT03686033|18521805|P6|Treatment Period 2 (1 Day)|Adverse Event|0
5384092|NCT03686033|18521806|P5|Treatment Period 2 (1 Day)|Adverse Event|1
5384093|NCT03686033|18521807|P4|Treatment Period 2 (1 Day)|Adverse Event|0
5384094|NCT03686033|18521808|P3|Treatment Period 2 (1 Day)|Adverse Event|0
5384095|NCT03686033|18521809|P2|Treatment Period 2 (1 Day)|Adverse Event|0
5384096|NCT03686033|18521810|P1|Treatment Period 2 (1 Day)|Adverse Event|0
5384097|NCT03685643|18521886|P2|Overall Study|Lost to Follow-up|22
5384098|NCT03685643|18521887|P1|Overall Study|Lost to Follow-up|14
5384099|NCT03684928|18521912|P2|Second Intervention|Soft Tissue Injury|0
5384100|NCT03684928|18521913|P1|Second Intervention|Soft Tissue Injury|1
5384101|NCT03684928|18521912|P2|First Intervention|Withdrawal by Subject|2
5384102|NCT03684928|18521913|P1|First Intervention|Withdrawal by Subject|0
5384103|NCT03684928|18521912|P2|First Intervention|Lost to Follow-up|1
5384104|NCT03684928|18521913|P1|First Intervention|Lost to Follow-up|0
5384105|NCT03684044|18521942|P2|Overall Study|Withdrawal by Subject|9
5384106|NCT03684044|18521943|P1|Overall Study|Withdrawal by Subject|11
5384107|NCT03684044|18521942|P2|Overall Study|Physician Decision|0
5384108|NCT03684044|18521943|P1|Overall Study|Physician Decision|1
5384109|NCT03684044|18521942|P2|Overall Study|Patient Not Available|2
5384110|NCT03684044|18521943|P1|Overall Study|Patient Not Available|0
5384112|NCT03684044|18521943|P1|Overall Study|Lost to Follow-up|3
5384113|NCT03684044|18521942|P2|Overall Study|Death|7
5384114|NCT03684044|18521943|P1|Overall Study|Death|4
5384115|NCT03684044|18521942|P2|Overall Study|Adverse Event|0
5384116|NCT03684044|18521943|P1|Overall Study|Adverse Event|3
5384117|NCT03683758|18522011|P2|Overall Study|Adverse Event|0
5384118|NCT03683758|18522012|P1|Overall Study|Adverse Event|1
5384119|NCT03683758|18522011|P2|Overall Study|Illness preventing participation|0
5384120|NCT03683758|18522012|P1|Overall Study|Illness preventing participation|1
5384121|NCT03683758|18522011|P2|Overall Study|Non-study commitment conflict|3
5384122|NCT03683758|18522012|P1|Overall Study|Non-study commitment conflict|1
5384123|NCT03681951|18522049|P8|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5384124|NCT03681951|18522050|P7|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5384125|NCT03681951|18522051|P6|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5384126|NCT03681951|18522052|P5|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5384127|NCT03681951|18522053|P4|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5384128|NCT03681951|18522054|P3|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5384129|NCT03681951|18522055|P2|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
5384130|NCT03681951|18522056|P1|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
5384131|NCT03681951|18522049|P8|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5384132|NCT03681951|18522050|P7|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5384133|NCT03681951|18522051|P6|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5384134|NCT03681951|18522052|P5|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5384135|NCT03681951|18522053|P4|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5384136|NCT03681951|18522054|P3|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5384137|NCT03681951|18522055|P2|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
5384138|NCT03681951|18522056|P1|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
5384139|NCT03681951|18522049|P8|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5384140|NCT03681951|18522050|P7|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5384141|NCT03681951|18522051|P6|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5384142|NCT03681951|18522052|P5|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5384143|NCT03681951|18522053|P4|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5384144|NCT03681951|18522054|P3|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5384145|NCT03681951|18522055|P2|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
5384146|NCT03681951|18522056|P1|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
5384147|NCT03681119|18522258|P2|Overall Study|Sickness|0
5384148|NCT03681119|18522259|P1|Overall Study|Sickness|2
5384149|NCT03681119|18522258|P2|Overall Study|No specific reason|0
5384150|NCT03681119|18522259|P1|Overall Study|No specific reason|4
5384151|NCT03679741|18522330|P2|Period 2|Withdrawal by Subject|1
5384152|NCT03679741|18522331|P1|Period 2|Withdrawal by Subject|1
5384153|NCT03679741|18522330|P2|Period 2|Adverse Event|1
5384154|NCT03679741|18522331|P1|Period 2|Adverse Event|2
5384155|NCT03679741|18522330|P2|Period 1|Withdrawal by Subject|1
5384156|NCT03679741|18522331|P1|Period 1|Withdrawal by Subject|0
5384157|NCT03679741|18522330|P2|Period 1|Adverse Event|1
5384158|NCT03679741|18522331|P1|Period 1|Adverse Event|1
5384159|NCT03679741|18522330|P2|Period 1|Lost to Follow-up|1
5384160|NCT03679741|18522331|P1|Period 1|Lost to Follow-up|0
5384161|NCT03679741|18522330|P2|Period 1|No longer meet eligibility criteria|0
5384162|NCT03679741|18522331|P1|Period 1|No longer meet eligibility criteria|1
5384163|NCT03678870|18522374|P2|Overall Study|Lost to Follow-up|2
5384164|NCT03678870|18522375|P1|Overall Study|Lost to Follow-up|3
5384165|NCT03678870|18522374|P2|Overall Study|prescribed non- protocol medications|6
5384166|NCT03678870|18522375|P1|Overall Study|prescribed non- protocol medications|10
5384167|NCT03677401|18522395|P2|Overall Study|Reason Unspecified|0
5384168|NCT03677401|18522396|P1|Overall Study|Reason Unspecified|1
5384169|NCT03677401|18522395|P2|Overall Study|Sponsor decision|1
5384170|NCT03677401|18522396|P1|Overall Study|Sponsor decision|0
5384171|NCT03677401|18522395|P2|Overall Study|Withdrawal by Subject|2
5384172|NCT03677401|18522396|P1|Overall Study|Withdrawal by Subject|2
5384173|NCT03677401|18522395|P2|Overall Study|Lack of Efficacy|1
5384174|NCT03677401|18522396|P1|Overall Study|Lack of Efficacy|3
5384175|NCT03677401|18522395|P2|Overall Study|Adverse Event|14
5384176|NCT03677401|18522396|P1|Overall Study|Adverse Event|4
5384177|NCT03677375|18522420|P1|Overall Study|Physician Decision|1
5384178|NCT03677375|18522420|P1|Overall Study|Adverse Event|3
5384179|NCT03677375|18522420|P1|Overall Study|Incomplete procedure|8
5384180|NCT03675776|18522474|P3|Double Blind Treatment Period|Lack of Efficacy|0
5384181|NCT03675776|18522475|P2|Double Blind Treatment Period|Lack of Efficacy|0
5384182|NCT03675776|18522476|P1|Double Blind Treatment Period|Lack of Efficacy|1
5384183|NCT03675776|18522474|P3|Double Blind Treatment Period|Study Terminated by Sponsor|8
5384184|NCT03675776|18522475|P2|Double Blind Treatment Period|Study Terminated by Sponsor|6
5384185|NCT03675776|18522476|P1|Double Blind Treatment Period|Study Terminated by Sponsor|5
5384186|NCT03674177|18522542|P4|Overall Study|Lost to Follow-up|2
5384187|NCT03674177|18522543|P3|Overall Study|Lost to Follow-up|0
5384188|NCT03674177|18522544|P2|Overall Study|Lost to Follow-up|1
5384189|NCT03674177|18522545|P1|Overall Study|Lost to Follow-up|2
5384190|NCT03673670|18522617|P6|Treatment Period 3 (3 Days)|Adverse Event|0
5384191|NCT03673670|18522618|P5|Treatment Period 3 (3 Days)|Adverse Event|1
5384192|NCT03673670|18522619|P4|Treatment Period 3 (3 Days)|Adverse Event|0
5384193|NCT03673670|18522620|P3|Treatment Period 3 (3 Days)|Adverse Event|0
5384194|NCT03673670|18522621|P2|Treatment Period 3 (3 Days)|Adverse Event|0
5384195|NCT03673670|18522622|P1|Treatment Period 3 (3 Days)|Adverse Event|0
5384196|NCT03673670|18522617|P6|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5384197|NCT03673670|18522618|P5|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
5384198|NCT03673670|18522619|P4|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5384199|NCT03673670|18522620|P3|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5384200|NCT03673670|18522621|P2|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5384201|NCT03673670|18522622|P1|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
5384202|NCT03673670|18522617|P6|Treatment Period 2 (3 Days)|Adverse Event|0
5384203|NCT03673670|18522618|P5|Treatment Period 2 (3 Days)|Adverse Event|1
5384204|NCT03673670|18522619|P4|Treatment Period 2 (3 Days)|Adverse Event|0
5384205|NCT03673670|18522620|P3|Treatment Period 2 (3 Days)|Adverse Event|1
5384206|NCT03673670|18522621|P2|Treatment Period 2 (3 Days)|Adverse Event|0
5384207|NCT03673670|18522622|P1|Treatment Period 2 (3 Days)|Adverse Event|0
5384208|NCT03673670|18522617|P6|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
5384209|NCT03673670|18522618|P5|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5384210|NCT03673670|18522619|P4|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5384211|NCT03673670|18522620|P3|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5384212|NCT03673670|18522621|P2|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5384213|NCT03673670|18522622|P1|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
5384214|NCT03673670|18522617|P6|Treatment Period 1 (3 Days)|Adverse Event|1
5384215|NCT03673670|18522618|P5|Treatment Period 1 (3 Days)|Adverse Event|0
5384216|NCT03673670|18522619|P4|Treatment Period 1 (3 Days)|Adverse Event|0
5384217|NCT03673670|18522620|P3|Treatment Period 1 (3 Days)|Adverse Event|0
5384218|NCT03673670|18522621|P2|Treatment Period 1 (3 Days)|Adverse Event|0
5384219|NCT03673670|18522622|P1|Treatment Period 1 (3 Days)|Adverse Event|0
5384220|NCT03673670|18522617|P6|Treatment Period 1 (3 Days)|Physician Decision|0
5384221|NCT03673670|18522618|P5|Treatment Period 1 (3 Days)|Physician Decision|0
5384222|NCT03673670|18522619|P4|Treatment Period 1 (3 Days)|Physician Decision|0
5384223|NCT03673670|18522620|P3|Treatment Period 1 (3 Days)|Physician Decision|1
5384224|NCT03673670|18522621|P2|Treatment Period 1 (3 Days)|Physician Decision|0
5384225|NCT03673670|18522622|P1|Treatment Period 1 (3 Days)|Physician Decision|0
5384226|NCT03673670|18522617|P6|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5384227|NCT03673670|18522618|P5|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5384228|NCT03673670|18522619|P4|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5384229|NCT03673670|18522620|P3|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5384230|NCT03673670|18522621|P2|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
5384231|NCT03673670|18522622|P1|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
5384232|NCT03670537|18522669|P1|Overall Study|Protocol Violation|1
5384233|NCT03669081|18522675|P2|Overall Study|Data could not be validated|1
5384234|NCT03669081|18522676|P1|Overall Study|Data could not be validated|1
5384235|NCT03668600|18522692|P1|Overall Study|Adverse Event|1
5384236|NCT03668600|18522692|P1|Overall Study|Lack of Efficacy|7
5384237|NCT03668600|18522692|P1|Overall Study|Withdrawal by Subject|56
5384238|NCT03668600|18522692|P1|Overall Study|Lost to Follow-up|7
5384239|NCT03668600|18522692|P1|Overall Study|Pregnancy|1
5384240|NCT03668600|18522692|P1|Overall Study|Protocol Violation|1
5384241|NCT03668600|18522692|P1|Overall Study|Study Terminated by the Sponsor|157
5384242|NCT03663582|18522743|P1|Overall Study|Physician Decision|1
5384243|NCT03663569|18522775|P1|Overall Study|Serious adverse event|1
5384244|NCT03663569|18522775|P1|Overall Study|Not meet inclusion / exclusion criterion|3
5384245|NCT03663569|18522775|P1|Overall Study|Not come to second visit|3
5384246|NCT03663569|18522775|P1|Overall Study|Adverse Event|4
5384247|NCT03663569|18522775|P1|Overall Study|Patient's request|11
5384248|NCT03663569|18522775|P1|Overall Study|Withdrawal of consent|5
5384249|NCT03663569|18522775|P1|Overall Study|Lost to Follow-up|18
5384250|NCT03663569|18522775|P1|Overall Study|Deceased patient|6
5384251|NCT03663569|18522775|P1|Overall Study|Never taken Spiolto® Respimat®|1
5384252|NCT03663569|18522775|P1|Overall Study|Discontinuation of study|11
5384253|NCT03663179|18522788|P2|Overall Study|Revealed exclusionary condition|0
5384254|NCT03663179|18522789|P1|Overall Study|Revealed exclusionary condition|1
5384255|NCT03663179|18522788|P2|Overall Study|Lost to Follow-up|1
5384256|NCT03663179|18522789|P1|Overall Study|Lost to Follow-up|1
5384257|NCT03663179|18522788|P2|Overall Study|Withdrawal by Subject|0
5384258|NCT03663179|18522789|P1|Overall Study|Withdrawal by Subject|2
5384259|NCT03662334|18522836|P2|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
5384260|NCT03662334|18522837|P1|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
5384261|NCT03658889|18523128|P2|Overall Study|Protocol Violation|0
5384262|NCT03658889|18523129|P1|Overall Study|Protocol Violation|2
5384263|NCT03658876|18523160|P2|Overall Study|Transplantation/other operation|5
5384264|NCT03658876|18523161|P1|Overall Study|Transplantation/other operation|1
5384265|NCT03658876|18523160|P2|Overall Study|Intercurrent illness|4
5384266|NCT03658876|18523161|P1|Overall Study|Intercurrent illness|6
5384267|NCT03658876|18523160|P2|Overall Study|Death|1
5384268|NCT03658876|18523161|P1|Overall Study|Death|0
5384269|NCT03658876|18523160|P2|Overall Study|Withdrawal by Subject|0
5384270|NCT03658876|18523161|P1|Overall Study|Withdrawal by Subject|2
5384271|NCT03658876|18523160|P2|Overall Study|Protocol Violation|2
5384272|NCT03658876|18523161|P1|Overall Study|Protocol Violation|3
5384273|NCT03658811|18523167|P1|Overall Study|Lost to Follow-up|3
5384274|NCT03657095|18523211|P2|Overall Study|Study Terminated by Sponsor|49
5384275|NCT03657095|18523212|P1|Overall Study|Study Terminated by Sponsor|58
5384276|NCT03657095|18523211|P2|Overall Study|Adverse Event|3
5384277|NCT03657095|18523212|P1|Overall Study|Adverse Event|0
5384278|NCT03657095|18523211|P2|Overall Study|Withdrawal by Subject|1
5384279|NCT03657095|18523212|P1|Overall Study|Withdrawal by Subject|1
5384280|NCT03655951|18523228|P2|Overall Study|Withdrawal by Subject|1
5384281|NCT03655951|18523229|P1|Overall Study|Withdrawal by Subject|0
5384282|NCT03655951|18523228|P2|Overall Study|Lost to Follow-up|20
5384283|NCT03655951|18523229|P1|Overall Study|Lost to Follow-up|39
5384284|NCT03655106|18523418|P2|Overall Study|Protocol Violation|0
5384285|NCT03655106|18523419|P1|Overall Study|Protocol Violation|3
5384286|NCT03655106|18523418|P2|Overall Study|Duplicate Enrollment|1
5384287|NCT03655106|18523419|P1|Overall Study|Duplicate Enrollment|1
5384288|NCT03655106|18523418|P2|Overall Study|Lost to Follow-up|1
5384289|NCT03655106|18523419|P1|Overall Study|Lost to Follow-up|2
5384290|NCT03655106|18523418|P2|Overall Study|Withdrawal by Subject|2
5384291|NCT03655106|18523419|P1|Overall Study|Withdrawal by Subject|3
5384292|NCT03654560|18523431|P2|Overall Study|Lost to Follow-up|0
5384293|NCT03654560|18523432|P1|Overall Study|Lost to Follow-up|1
5384294|NCT03654560|18523431|P2|Overall Study|Death|1
5384295|NCT03654560|18523432|P1|Overall Study|Death|3
5384296|NCT03653429|18523473|P2|Overall Study|Physician Decision|10
5384297|NCT03653429|18523474|P1|Overall Study|Physician Decision|4
5384298|NCT03653416|18523488|P2|Overall Study|Protocol Violation|1
5384299|NCT03653416|18523489|P1|Overall Study|Protocol Violation|6
5384300|NCT03650400|18523539|P2|Overall Study|Study terminated by sponsor|5
5384301|NCT03650400|18523540|P1|Overall Study|Study terminated by sponsor|0
5384302|NCT03649412|18523607|P2|Part B, Washout Period 5 (7 Days)|Adverse Event|1
5384303|NCT03649412|18523608|P1|Part B, Washout Period 5 (7 Days)|Adverse Event|0
5384304|NCT03649412|18523607|P2|Part B, Washout Period 1 (7 Days)|Adverse Event|1
5384305|NCT03649412|18523608|P1|Part B, Washout Period 1 (7 Days)|Adverse Event|0
5384306|NCT03649412|18523607|P2|Part A, Washout Period 5 (7 Days)|Adverse Event|0
5384307|NCT03649412|18523608|P1|Part A, Washout Period 5 (7 Days)|Adverse Event|1
5384308|NCT03649412|18523607|P2|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
5384309|NCT03649412|18523608|P1|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
5384310|NCT03649412|18523607|P2|Part A, Washout Period 4 (7 Days)|Adverse Event|0
5384311|NCT03649412|18523608|P1|Part A, Washout Period 4 (7 Days)|Adverse Event|1
5384312|NCT03649412|18523607|P2|Part A, Washout Period 1 (7 Days)|Physician Decision|0
5384313|NCT03649412|18523608|P1|Part A, Washout Period 1 (7 Days)|Physician Decision|1
5384314|NCT03648983|18523766|P1|Overall Study|Study was terminated due to PI departure|95
5384315|NCT03647709|18523776|P1|Overall Study|Withdrawal by Subject|3
5384316|NCT03647709|18523776|P1|Overall Study|Physician Decision|6
5384317|NCT03647709|18523776|P1|Overall Study|Lost to Follow-up|5
5384318|NCT03646656|18523809|P2|Overall Study|Withdrawal by Subject|0
5384319|NCT03646656|18523810|P1|Overall Study|Withdrawal by Subject|2
5384320|NCT03646656|18523809|P2|Overall Study|Lost to Follow-up|0
5384321|NCT03646656|18523810|P1|Overall Study|Lost to Follow-up|1
5384322|NCT03645434|18523840|P6|Period 1|COPD exacerbation|0
5384323|NCT03645434|18523841|P5|Period 1|COPD exacerbation|1
5384324|NCT03645434|18523842|P4|Period 1|COPD exacerbation|0
5384325|NCT03645434|18523843|P3|Period 1|COPD exacerbation|0
5384326|NCT03645434|18523844|P2|Period 1|COPD exacerbation|0
5384327|NCT03645434|18523845|P1|Period 1|COPD exacerbation|0
5384328|NCT03645434|18523840|P6|Period 1|Adverse Event|0
5384329|NCT03645434|18523841|P5|Period 1|Adverse Event|0
5384330|NCT03645434|18523842|P4|Period 1|Adverse Event|1
5384331|NCT03645434|18523843|P3|Period 1|Adverse Event|0
5384332|NCT03645434|18523844|P2|Period 1|Adverse Event|0
5384333|NCT03645434|18523845|P1|Period 1|Adverse Event|0
5384334|NCT03645421|18523896|P4|Overall Study|Study specific withdrawal criteria|0
5384335|NCT03645421|18523897|P3|Overall Study|Study specific withdrawal criteria|1
5384336|NCT03645421|18523898|P2|Overall Study|Study specific withdrawal criteria|0
5384337|NCT03645421|18523899|P1|Overall Study|Study specific withdrawal criteria|0
5384338|NCT03645421|18523896|P4|Overall Study|Withdrawal by patient|3
5384339|NCT03645421|18523897|P3|Overall Study|Withdrawal by patient|0
5384340|NCT03645421|18523898|P2|Overall Study|Withdrawal by patient|0
5384341|NCT03645421|18523899|P1|Overall Study|Withdrawal by patient|0
5384342|NCT03645421|18523896|P4|Overall Study|Adverse Event|1
5384343|NCT03645421|18523897|P3|Overall Study|Adverse Event|4
5384344|NCT03645421|18523898|P2|Overall Study|Adverse Event|0
5384345|NCT03645421|18523899|P1|Overall Study|Adverse Event|0
5384346|NCT03643575|18524008|P6|Washout: 7 Days|Non compliance check in|0
5384347|NCT03643575|18524009|P5|Washout: 7 Days|Non compliance check in|0
5384348|NCT03643575|18524010|P4|Washout: 7 Days|Non compliance check in|0
5384349|NCT03643575|18524011|P3|Washout: 7 Days|Non compliance check in|0
5384350|NCT03643575|18524012|P2|Washout: 7 Days|Non compliance check in|1
5384351|NCT03643575|18524013|P1|Washout: 7 Days|Non compliance check in|0
5384352|NCT03643575|18524008|P6|Washout: 7 Days|Adverse Event|0
5384353|NCT03643575|18524009|P5|Washout: 7 Days|Adverse Event|0
5384354|NCT03643575|18524010|P4|Washout: 7 Days|Adverse Event|0
5384355|NCT03643575|18524011|P3|Washout: 7 Days|Adverse Event|0
5384356|NCT03643575|18524012|P2|Washout: 7 Days|Adverse Event|0
5384357|NCT03643575|18524013|P1|Washout: 7 Days|Adverse Event|1
5384358|NCT03643575|18524008|P6|Washout: 7 Days|Withdrew consent due to illness|0
5384359|NCT03643575|18524009|P5|Washout: 7 Days|Withdrew consent due to illness|0
5384360|NCT03643575|18524010|P4|Washout: 7 Days|Withdrew consent due to illness|1
5384361|NCT03643575|18524011|P3|Washout: 7 Days|Withdrew consent due to illness|0
5384362|NCT03643575|18524012|P2|Washout: 7 Days|Withdrew consent due to illness|0
5384363|NCT03643575|18524013|P1|Washout: 7 Days|Withdrew consent due to illness|0
5384364|NCT03643432|18524071|P2|Overall Study|Lost to Follow-up|0
5384365|NCT03643432|18524072|P1|Overall Study|Lost to Follow-up|1
5384366|NCT03643159|18524096|P1|Overall Study|Withdrawal by Subject|1
5384367|NCT03643159|18524096|P1|Overall Study|Adverse Event|1
5384368|NCT03642873|18524103|P6|Third Intervention (1 Day)|Screen failure|0
5384369|NCT03642873|18524104|P5|Third Intervention (1 Day)|Screen failure|1
5384370|NCT03642873|18524105|P4|Third Intervention (1 Day)|Screen failure|0
5384371|NCT03642873|18524106|P3|Third Intervention (1 Day)|Screen failure|0
5384372|NCT03642873|18524107|P2|Third Intervention (1 Day)|Screen failure|0
5384373|NCT03642873|18524108|P1|Third Intervention (1 Day)|Screen failure|0
5384374|NCT03642262|18524159|P2|Period 1|Adverse Event|1
5384375|NCT03642262|18524160|P1|Period 1|Adverse Event|0
5384376|NCT03642262|18524159|P2|Period 1|Withdrawal by Subject|1
5384377|NCT03642262|18524160|P1|Period 1|Withdrawal by Subject|1
5384378|NCT03641508|18524181|P2|First Injection|Lost to Follow-up|0
5384379|NCT03641508|18524182|P1|First Injection|Lost to Follow-up|2
5384380|NCT03640559|18524209|P2|Overall Study|Withdrawal by Subject|0
5384381|NCT03640559|18524210|P1|Overall Study|Withdrawal by Subject|1
5384382|NCT03640559|18524209|P2|Overall Study|Physician Decision|1
5384383|NCT03640559|18524210|P1|Overall Study|Physician Decision|1
5384384|NCT03640507|18524219|P3|Overall Study|Withdrawal by Subject|1
5384385|NCT03640507|18524220|P2|Overall Study|Withdrawal by Subject|0
5384386|NCT03640507|18524221|P1|Overall Study|Withdrawal by Subject|0
5384387|NCT03640052|18524241|P5|Overall Study|Lost to Follow-up|0
5384388|NCT03640052|18524242|P4|Overall Study|Lost to Follow-up|0
5384389|NCT03640052|18524243|P3|Overall Study|Lost to Follow-up|0
5384390|NCT03640052|18524244|P2|Overall Study|Lost to Follow-up|1
5384391|NCT03640052|18524245|P1|Overall Study|Lost to Follow-up|0
5384392|NCT03639675|18524262|P1|Overall Study|Withdrawal by Subject|1
5384393|NCT03638635|18524284|P2|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
5384394|NCT03638635|18524285|P1|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
5384395|NCT03638635|18524284|P2|Initial Hospitalization|Withdrawal by study personnel|1
5384396|NCT03638635|18524285|P1|Initial Hospitalization|Withdrawal by study personnel|0
5384397|NCT03638635|18524284|P2|Initial Hospitalization|Study terminated prematurely|1
5384398|NCT03638635|18524285|P1|Initial Hospitalization|Study terminated prematurely|0
5384399|NCT03636893|18524374|P2|Overall Study|Adverse Event|1
5384400|NCT03636893|18524375|P1|Overall Study|Adverse Event|1
5384401|NCT03636893|18524374|P2|Overall Study|Early surgery (for acute bleeding)|0
5384402|NCT03636893|18524375|P1|Overall Study|Early surgery (for acute bleeding)|3
5384403|NCT03636893|18524374|P2|Overall Study|Refusal to surgery|3
5384404|NCT03636893|18524375|P1|Overall Study|Refusal to surgery|4
5384405|NCT03636893|18524374|P2|Overall Study|Withdrawal by Subject|2
5384406|NCT03636893|18524375|P1|Overall Study|Withdrawal by Subject|1
5384407|NCT03636893|18524374|P2|Overall Study|Protocol Violation|3
5384408|NCT03636893|18524375|P1|Overall Study|Protocol Violation|0
5384409|NCT03636893|18524374|P2|Overall Study|Death|1
5384410|NCT03636893|18524375|P1|Overall Study|Death|0
5384411|NCT03635957|18524392|P1|Pegloticase + IMM Period|Lack of Efficacy|3
5384412|NCT03635957|18524392|P1|Run-In Period|Lost to Follow-up|1
5384413|NCT03635424|18524403|P1|Overall Study|Device not implanted|1
5384414|NCT03635424|18524403|P1|Overall Study|Death|1
5384415|NCT03635424|18524403|P1|Overall Study|Adverse Event|1
5384416|NCT03634579|18524424|P1|Overall Study|study termination|9
5384417|NCT03634085|18524522|P2|Overall Study|Withdrawal by Subject|2
5384418|NCT03634085|18524523|P1|Overall Study|Withdrawal by Subject|0
5384419|NCT03634085|18524522|P2|Overall Study|Adverse Event|0
5384420|NCT03634085|18524523|P1|Overall Study|Adverse Event|1
5384421|NCT03633825|18524538|P2|Follow up|Lost to Follow-up|450
5384422|NCT03633825|18524539|P1|Follow up|Lost to Follow-up|478
5384423|NCT03633825|18524538|P2|Enrollment|Post not classified as crisis|13757
5384424|NCT03633825|18524539|P1|Enrollment|Post not classified as crisis|13967
5384425|NCT03633825|18524538|P2|Enrollment|Did not post on network|5080
5384426|NCT03633825|18524539|P1|Enrollment|Did not post on network|5066
5384427|NCT03631732|18524724|P2|Overall Study|Lost to Follow-up|1
5384428|NCT03631732|18524725|P1|Overall Study|Lost to Follow-up|5
5384429|NCT03631732|18524724|P2|Overall Study|Withdrew consent|4
5384430|NCT03631732|18524725|P1|Overall Study|Withdrew consent|3
5384431|NCT03631732|18524724|P2|Overall Study|Investigator's Discretion|0
5384432|NCT03631732|18524725|P1|Overall Study|Investigator's Discretion|1
5384433|NCT03631732|18524724|P2|Overall Study|Lack of Efficacy|0
5384434|NCT03631732|18524725|P1|Overall Study|Lack of Efficacy|1
5384435|NCT03631732|18524724|P2|Overall Study|Death|0
5384436|NCT03631732|18524725|P1|Overall Study|Death|1
5384437|NCT03631732|18524724|P2|Overall Study|Adverse Event|0
5384438|NCT03631732|18524725|P1|Overall Study|Adverse Event|3
5384439|NCT03631732|18524724|P2|Overall Study|Still in Study|148
5384440|NCT03631732|18524725|P1|Overall Study|Still in Study|285
5384441|NCT03631732|18524724|P2|Overall Study|Randomized and Never Treated|0
5384442|NCT03631732|18524725|P1|Overall Study|Randomized and Never Treated|1
5384443|NCT03630016|18524811|P1|Overall Study|Poor Sensor Placement|1
5384444|NCT03629886|18524817|P2|Overall Study|Refused vaccination step of the study|44
5384445|NCT03629886|18524818|P1|Overall Study|Refused vaccination step of the study|0
5384446|NCT03629886|18524817|P2|Overall Study|Didn't meet inclusion/exclusion criteria|28
5384447|NCT03629886|18524818|P1|Overall Study|Didn't meet inclusion/exclusion criteria|0
5384448|NCT03629886|18524817|P2|Overall Study|Study vaccine not administrated|3
5384449|NCT03629886|18524818|P1|Overall Study|Study vaccine not administrated|0
5384450|NCT03629886|18524817|P2|Overall Study|Consent withdrawal, not due to an AE|50
5384451|NCT03629886|18524818|P1|Overall Study|Consent withdrawal, not due to an AE|0
5384452|NCT03629886|18524817|P2|Overall Study|Migrated / moved from the study area|55
5384453|NCT03629886|18524818|P1|Overall Study|Migrated / moved from the study area|0
5384454|NCT03629184|18524837|P2|Overall Study|Physician Decision|0
5384455|NCT03629184|18524838|P1|Overall Study|Physician Decision|1
5384456|NCT03629184|18524837|P2|Overall Study|Withdrawal by Subject|1
5384457|NCT03629184|18524838|P1|Overall Study|Withdrawal by Subject|2
5384458|NCT03629054|18524888|P2|Period 2 (4 Days)|Not treated|1
5384459|NCT03629054|18524889|P1|Period 2 (4 Days)|Not treated|0
5384460|NCT03629041|18524913|P4|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
5384461|NCT03629041|18524914|P3|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
5384462|NCT03629041|18524915|P2|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
5384463|NCT03629041|18524916|P1|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
5384464|NCT03629028|18524944|P2|Overall Study|intolerance to examination|0
5384465|NCT03629028|18524945|P1|Overall Study|intolerance to examination|2
5384466|NCT03629028|18524944|P2|Overall Study|Pregnancy|2
5384467|NCT03629028|18524945|P1|Overall Study|Pregnancy|4
5384468|NCT03629028|18524944|P2|Overall Study|Lost to Follow-up|23
5384469|NCT03629028|18524945|P1|Overall Study|Lost to Follow-up|26
5384470|NCT03628599|18524976|P2|Overall Study|Adverse Event|1
5384471|NCT03628599|18524977|P1|Overall Study|Adverse Event|0
5384472|NCT03628417|18525007|P2|Overall Study|Death|1
5384473|NCT03628417|18525008|P1|Overall Study|Death|1
5384474|NCT03627832|18525020|P2|Overall Study|Withdrawal by Subject|1
5384475|NCT03627832|18525021|P1|Overall Study|Withdrawal by Subject|10
5384476|NCT03627494|18525055|P12|Part C Washout 1 (7 Days)|Adverse Event|1
5384477|NCT03627494|18525056|P11|Part C Washout 1 (7 Days)|Adverse Event|1
5384478|NCT03627494|18525057|P10|Part C Washout 1 (7 Days)|Adverse Event|0
5384479|NCT03627494|18525058|P9|Part C Washout 1 (7 Days)|Adverse Event|0
5384480|NCT03627494|18525059|P8|Part C Washout 1 (7 Days)|Adverse Event|0
5384481|NCT03627494|18525060|P7|Part C Washout 1 (7 Days)|Adverse Event|0
5384482|NCT03627494|18525061|P6|Part C Washout 1 (7 Days)|Adverse Event|0
5384483|NCT03627494|18525062|P5|Part C Washout 1 (7 Days)|Adverse Event|0
5384484|NCT03627494|18525063|P4|Part C Washout 1 (7 Days)|Adverse Event|0
5384485|NCT03627494|18525064|P3|Part C Washout 1 (7 Days)|Adverse Event|0
5384486|NCT03627494|18525065|P2|Part C Washout 1 (7 Days)|Adverse Event|0
5384487|NCT03627494|18525066|P1|Part C Washout 1 (7 Days)|Adverse Event|0
5384488|NCT03627494|18525055|P12|Part B (Maximum of 34 Days)|Adverse Event|0
5384489|NCT03627494|18525056|P11|Part B (Maximum of 34 Days)|Adverse Event|0
5384490|NCT03627494|18525057|P10|Part B (Maximum of 34 Days)|Adverse Event|0
5384491|NCT03627494|18525058|P9|Part B (Maximum of 34 Days)|Adverse Event|2
5384492|NCT03627494|18525059|P8|Part B (Maximum of 34 Days)|Adverse Event|0
5384493|NCT03627494|18525060|P7|Part B (Maximum of 34 Days)|Adverse Event|0
5384494|NCT03627494|18525061|P6|Part B (Maximum of 34 Days)|Adverse Event|0
5384495|NCT03627494|18525062|P5|Part B (Maximum of 34 Days)|Adverse Event|0
5384496|NCT03627494|18525063|P4|Part B (Maximum of 34 Days)|Adverse Event|0
5384497|NCT03627494|18525064|P3|Part B (Maximum of 34 Days)|Adverse Event|0
5384498|NCT03627494|18525065|P2|Part B (Maximum of 34 Days)|Adverse Event|0
5384499|NCT03627494|18525066|P1|Part B (Maximum of 34 Days)|Adverse Event|0
5384500|NCT03627494|18525055|P12|Part A Washout 2 (7 Days)|Adverse Event|0
5384501|NCT03627494|18525056|P11|Part A Washout 2 (7 Days)|Adverse Event|0
5384502|NCT03627494|18525057|P10|Part A Washout 2 (7 Days)|Adverse Event|0
5384503|NCT03627494|18525058|P9|Part A Washout 2 (7 Days)|Adverse Event|0
5384504|NCT03627494|18525059|P8|Part A Washout 2 (7 Days)|Adverse Event|0
5384505|NCT03627494|18525060|P7|Part A Washout 2 (7 Days)|Adverse Event|0
5384506|NCT03627494|18525061|P6|Part A Washout 2 (7 Days)|Adverse Event|0
5384507|NCT03627494|18525062|P5|Part A Washout 2 (7 Days)|Adverse Event|0
5384508|NCT03627494|18525063|P4|Part A Washout 2 (7 Days)|Adverse Event|0
5384509|NCT03627494|18525064|P3|Part A Washout 2 (7 Days)|Adverse Event|1
5384510|NCT03627494|18525065|P2|Part A Washout 2 (7 Days)|Adverse Event|0
5384511|NCT03627494|18525066|P1|Part A Washout 2 (7 Days)|Adverse Event|1
5384512|NCT03627195|18525280|P6|Overall Study|OTHER (LACK OF EFFICACY)|0
5384513|NCT03627195|18525281|P5|Overall Study|OTHER (LACK OF EFFICACY)|0
5384514|NCT03627195|18525282|P4|Overall Study|OTHER (LACK OF EFFICACY)|0
5384515|NCT03627195|18525283|P3|Overall Study|OTHER (LACK OF EFFICACY)|0
5384516|NCT03627195|18525284|P2|Overall Study|OTHER (LACK OF EFFICACY)|0
5384517|NCT03627195|18525285|P1|Overall Study|OTHER (LACK OF EFFICACY)|1
5384518|NCT03624946|18525356|P2|Overall Study|Lost to Follow-up|1
5384519|NCT03624946|18525357|P1|Overall Study|Lost to Follow-up|0
5384520|NCT03624504|18525411|P1|Overall Study|Unsuccessful Implant|1
5384521|NCT03622112|18525463|P7|Overall Study|Reason not specified|1
5384522|NCT03622112|18525464|P6|Overall Study|Reason not specified|2
5384523|NCT03622112|18525465|P5|Overall Study|Reason not specified|1
5384524|NCT03622112|18525466|P4|Overall Study|Reason not specified|1
5384525|NCT03622112|18525467|P3|Overall Study|Reason not specified|0
5384526|NCT03622112|18525468|P2|Overall Study|Reason not specified|1
5384527|NCT03622112|18525469|P1|Overall Study|Reason not specified|0
5384528|NCT03622112|18525463|P7|Overall Study|Adverse Event|2
5384529|NCT03622112|18525464|P6|Overall Study|Adverse Event|20
5384530|NCT03622112|18525465|P5|Overall Study|Adverse Event|4
5384531|NCT03622112|18525466|P4|Overall Study|Adverse Event|11
5384532|NCT03622112|18525467|P3|Overall Study|Adverse Event|4
5384533|NCT03622112|18525468|P2|Overall Study|Adverse Event|8
5384534|NCT03622112|18525469|P1|Overall Study|Adverse Event|6
5384535|NCT03622112|18525463|P7|Overall Study|Protocol Violation|0
5384536|NCT03622112|18525464|P6|Overall Study|Protocol Violation|0
5384537|NCT03622112|18525465|P5|Overall Study|Protocol Violation|0
5384538|NCT03622112|18525466|P4|Overall Study|Protocol Violation|1
5384539|NCT03622112|18525467|P3|Overall Study|Protocol Violation|1
5384540|NCT03622112|18525468|P2|Overall Study|Protocol Violation|0
5384541|NCT03622112|18525469|P1|Overall Study|Protocol Violation|2
5384542|NCT03622112|18525463|P7|Overall Study|Study-specific withdrawal criteria|4
5384543|NCT03622112|18525464|P6|Overall Study|Study-specific withdrawal criteria|18
5384544|NCT03622112|18525465|P5|Overall Study|Study-specific withdrawal criteria|4
5384545|NCT03622112|18525466|P4|Overall Study|Study-specific withdrawal criteria|6
5384546|NCT03622112|18525467|P3|Overall Study|Study-specific withdrawal criteria|7
5384547|NCT03622112|18525468|P2|Overall Study|Study-specific withdrawal criteria|8
5384548|NCT03622112|18525469|P1|Overall Study|Study-specific withdrawal criteria|10
5384549|NCT03622112|18525463|P7|Overall Study|Lost to Follow-up|0
5384550|NCT03622112|18525464|P6|Overall Study|Lost to Follow-up|0
5384551|NCT03622112|18525465|P5|Overall Study|Lost to Follow-up|0
5384552|NCT03622112|18525466|P4|Overall Study|Lost to Follow-up|0
5384553|NCT03622112|18525467|P3|Overall Study|Lost to Follow-up|0
5384554|NCT03622112|18525468|P2|Overall Study|Lost to Follow-up|1
5384555|NCT03622112|18525469|P1|Overall Study|Lost to Follow-up|1
5384556|NCT03622112|18525463|P7|Overall Study|Death|0
5384557|NCT03622112|18525464|P6|Overall Study|Death|0
5384558|NCT03622112|18525465|P5|Overall Study|Death|0
5384559|NCT03622112|18525466|P4|Overall Study|Death|1
5384560|NCT03622112|18525467|P3|Overall Study|Death|0
5384561|NCT03622112|18525468|P2|Overall Study|Death|0
5384562|NCT03622112|18525469|P1|Overall Study|Death|0
5384563|NCT03622112|18525463|P7|Overall Study|Withdrawal by Subject|2
5384564|NCT03622112|18525464|P6|Overall Study|Withdrawal by Subject|2
5384565|NCT03622112|18525465|P5|Overall Study|Withdrawal by Subject|1
5384566|NCT03622112|18525466|P4|Overall Study|Withdrawal by Subject|2
5384567|NCT03622112|18525467|P3|Overall Study|Withdrawal by Subject|4
5384568|NCT03622112|18525468|P2|Overall Study|Withdrawal by Subject|2
5384569|NCT03622112|18525469|P1|Overall Study|Withdrawal by Subject|6
5384570|NCT03620708|18525698|P3|Overall Study|Withdrawal by Subject|1
5384571|NCT03620708|18525699|P2|Overall Study|Withdrawal by Subject|0
5384572|NCT03620708|18525700|P1|Overall Study|Withdrawal by Subject|0
5384573|NCT03620708|18525698|P3|Overall Study|Lost to Follow-up|2
5384574|NCT03620708|18525699|P2|Overall Study|Lost to Follow-up|1
5384575|NCT03620708|18525700|P1|Overall Study|Lost to Follow-up|1
5384576|NCT03618628|18525781|P1|Overall Study|Lost to Follow-up|1
5384577|NCT03618628|18525781|P1|Overall Study|Death|1
5384578|NCT03617861|18525811|P4|Second Intervention (1 Day)|Adverse Event|0
5384579|NCT03617861|18525812|P3|Second Intervention (1 Day)|Adverse Event|1
5384580|NCT03617861|18525813|P2|Second Intervention (1 Day)|Adverse Event|0
5384581|NCT03617861|18525814|P1|Second Intervention (1 Day)|Adverse Event|0
5384582|NCT03617588|18525846|P2|Overall Study|Withdrawal by Subject|0
5384583|NCT03617588|18525847|P1|Overall Study|Withdrawal by Subject|1
5384584|NCT03616977|18525908|P2|Period 3|Adverse Event|1
5384585|NCT03616977|18525909|P1|Period 3|Adverse Event|1
5384586|NCT03616977|18525908|P2|Period 1|Physician Decision|1
5384587|NCT03616977|18525909|P1|Period 1|Physician Decision|0
5384588|NCT03616600|18525919|P2|Overall Study|Withdrawal by Subject|0
5384589|NCT03616600|18525920|P1|Overall Study|Withdrawal by Subject|1
5384590|NCT03616106|18525954|P2|Overall Study|Lost to Follow-up|0
5384591|NCT03616106|18525955|P1|Overall Study|Lost to Follow-up|7
5384592|NCT03616106|18525954|P2|Overall Study|Withdrawal by Subject|1
5384593|NCT03616106|18525955|P1|Overall Study|Withdrawal by Subject|1
5384594|NCT03616106|18525954|P2|Overall Study|Removed by PI|0
5384595|NCT03616106|18525955|P1|Overall Study|Removed by PI|6
5384596|NCT03615482|18526075|P2|Overall Study|Withdrawal by Subject|7
5384597|NCT03615482|18526076|P1|Overall Study|Withdrawal by Subject|7
5384598|NCT03615482|18526075|P2|Overall Study|Physician Decision|3
5384599|NCT03615482|18526076|P1|Overall Study|Physician Decision|2
5384600|NCT03615482|18526075|P2|Overall Study|Lost to Follow-up|7
5384601|NCT03615482|18526076|P1|Overall Study|Lost to Follow-up|7
5384602|NCT03615482|18526075|P2|Overall Study|Death|0
5384603|NCT03615482|18526076|P1|Overall Study|Death|1
5384604|NCT03614975|18526178|P2|Overall Study|Specimens not in lab batch shipment|1
5384605|NCT03614975|18526179|P1|Overall Study|Specimens not in lab batch shipment|1
5384606|NCT03614975|18526178|P2|Overall Study|Withdrawal by Subject|2
5384607|NCT03614975|18526179|P1|Overall Study|Withdrawal by Subject|2
5384608|NCT03614975|18526178|P2|Overall Study|Physician Decision|5
5384609|NCT03614975|18526179|P1|Overall Study|Physician Decision|7
5384610|NCT03614156|18526192|P4|Safety Follow-Up Period|Lost to Follow-up|1
5384611|NCT03614156|18526193|P3|Safety Follow-Up Period|Lost to Follow-up|0
5384612|NCT03614156|18526194|P2|Safety Follow-Up Period|Lost to Follow-up|0
5384613|NCT03614156|18526195|P1|Safety Follow-Up Period|Lost to Follow-up|1
5384614|NCT03614156|18526192|P4|Safety Follow-Up Period|Withdrawal by Subject|0
5384615|NCT03614156|18526193|P3|Safety Follow-Up Period|Withdrawal by Subject|1
5384616|NCT03614156|18526194|P2|Safety Follow-Up Period|Withdrawal by Subject|0
5384617|NCT03614156|18526195|P1|Safety Follow-Up Period|Withdrawal by Subject|0
5384618|NCT03614156|18526192|P4|Safety Follow-Up Period|Miscellaneous Reasons|0
5384619|NCT03614156|18526193|P3|Safety Follow-Up Period|Miscellaneous Reasons|0
5384620|NCT03614156|18526194|P2|Safety Follow-Up Period|Miscellaneous Reasons|0
5384621|NCT03614156|18526195|P1|Safety Follow-Up Period|Miscellaneous Reasons|2
5384622|NCT03614156|18526192|P4|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
5384623|NCT03614156|18526193|P3|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
5384624|NCT03614156|18526194|P2|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
5384625|NCT03614156|18526195|P1|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
5384626|NCT03614156|18526192|P4|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
5384627|NCT03614156|18526193|P3|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
5384628|NCT03614156|18526194|P2|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
5384629|NCT03614156|18526195|P1|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
5384630|NCT03614156|18526192|P4|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
5384631|NCT03614156|18526193|P3|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
5384632|NCT03614156|18526194|P2|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
5384633|NCT03614156|18526195|P1|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
5384634|NCT03614156|18526192|P4|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
5384635|NCT03614156|18526193|P3|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
5384636|NCT03614156|18526194|P2|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
5384637|NCT03614156|18526195|P1|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
5384638|NCT03614156|18526192|P4|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
5384639|NCT03614156|18526193|P3|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
5384640|NCT03614156|18526194|P2|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
5384641|NCT03614156|18526195|P1|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
5384642|NCT03614156|18526192|P4|Double-Blind Treatment Period (DBTP)|Adverse Event|1
5384643|NCT03614156|18526193|P3|Double-Blind Treatment Period (DBTP)|Adverse Event|0
5384644|NCT03614156|18526194|P2|Double-Blind Treatment Period (DBTP)|Adverse Event|2
5384645|NCT03614156|18526195|P1|Double-Blind Treatment Period (DBTP)|Adverse Event|0
5384646|NCT03614156|18526192|P4|Open-Label Treatment Period|Study terminated by sponsor|0
5384647|NCT03614156|18526193|P3|Open-Label Treatment Period|Study terminated by sponsor|0
5384648|NCT03614156|18526194|P2|Open-Label Treatment Period|Study terminated by sponsor|0
5384649|NCT03614156|18526195|P1|Open-Label Treatment Period|Study terminated by sponsor|74
5384650|NCT03614156|18526192|P4|Open-Label Treatment Period|Non-compliance with study drug|0
5384651|NCT03614156|18526193|P3|Open-Label Treatment Period|Non-compliance with study drug|0
5384652|NCT03614156|18526194|P2|Open-Label Treatment Period|Non-compliance with study drug|0
5384653|NCT03614156|18526195|P1|Open-Label Treatment Period|Non-compliance with study drug|1
5384654|NCT03614156|18526192|P4|Open-Label Treatment Period|Protocol Violation|0
5384655|NCT03614156|18526193|P3|Open-Label Treatment Period|Protocol Violation|0
5384656|NCT03614156|18526194|P2|Open-Label Treatment Period|Protocol Violation|0
5384657|NCT03614156|18526195|P1|Open-Label Treatment Period|Protocol Violation|2
5384658|NCT03614156|18526192|P4|Open-Label Treatment Period|Lost to Follow-up|0
5384659|NCT03614156|18526193|P3|Open-Label Treatment Period|Lost to Follow-up|0
5384660|NCT03614156|18526194|P2|Open-Label Treatment Period|Lost to Follow-up|0
5384661|NCT03614156|18526195|P1|Open-Label Treatment Period|Lost to Follow-up|10
5384662|NCT03614156|18526192|P4|Open-Label Treatment Period|Withdrawal by Subject|0
5384663|NCT03614156|18526193|P3|Open-Label Treatment Period|Withdrawal by Subject|0
5384664|NCT03614156|18526194|P2|Open-Label Treatment Period|Withdrawal by Subject|0
5384665|NCT03614156|18526195|P1|Open-Label Treatment Period|Withdrawal by Subject|36
5384666|NCT03614156|18526192|P4|Open-Label Treatment Period|Lack of Efficacy|0
5384667|NCT03614156|18526193|P3|Open-Label Treatment Period|Lack of Efficacy|0
5384668|NCT03614156|18526194|P2|Open-Label Treatment Period|Lack of Efficacy|0
5384669|NCT03614156|18526195|P1|Open-Label Treatment Period|Lack of Efficacy|18
5384670|NCT03614156|18526192|P4|Open-Label Treatment Period|Adverse Event|0
5384671|NCT03614156|18526193|P3|Open-Label Treatment Period|Adverse Event|0
5384672|NCT03614156|18526194|P2|Open-Label Treatment Period|Adverse Event|0
5384673|NCT03614156|18526195|P1|Open-Label Treatment Period|Adverse Event|7
5384674|NCT03614156|18526192|P4|Open-Label Treatment Period|Protocol-specified withdrawal met|0
5384675|NCT03614156|18526193|P3|Open-Label Treatment Period|Protocol-specified withdrawal met|0
5384676|NCT03614156|18526194|P2|Open-Label Treatment Period|Protocol-specified withdrawal met|0
5384677|NCT03614156|18526195|P1|Open-Label Treatment Period|Protocol-specified withdrawal met|6
5384678|NCT03614078|18526207|P3|Overall Study|Dizziness and Rash|0
5384679|NCT03614078|18526208|P2|Overall Study|Dizziness and Rash|1
5384680|NCT03614078|18526209|P1|Overall Study|Dizziness and Rash|0
5384681|NCT03614078|18526207|P3|Overall Study|Adverse Event|0
5384682|NCT03614078|18526208|P2|Overall Study|Adverse Event|2
5384683|NCT03614078|18526209|P1|Overall Study|Adverse Event|0
5384684|NCT03614078|18526207|P3|Overall Study|Exacerbation of Psoriasis|0
5384685|NCT03614078|18526208|P2|Overall Study|Exacerbation of Psoriasis|1
5384686|NCT03614078|18526209|P1|Overall Study|Exacerbation of Psoriasis|0
5384687|NCT03614078|18526207|P3|Overall Study|Patient Did Not Meet Eligibility|0
5384688|NCT03614078|18526208|P2|Overall Study|Patient Did Not Meet Eligibility|0
5384689|NCT03614078|18526209|P1|Overall Study|Patient Did Not Meet Eligibility|1
5384690|NCT03614078|18526207|P3|Overall Study|High Neutrophils|2
5384691|NCT03614078|18526208|P2|Overall Study|High Neutrophils|0
5384692|NCT03614078|18526209|P1|Overall Study|High Neutrophils|0
5384693|NCT03614078|18526207|P3|Overall Study|Participant Did Not Return for Visit|0
5384694|NCT03614078|18526208|P2|Overall Study|Participant Did Not Return for Visit|1
5384695|NCT03614078|18526209|P1|Overall Study|Participant Did Not Return for Visit|0
5384696|NCT03614078|18526207|P3|Overall Study|Withdrawal by Subject|3
5384697|NCT03614078|18526208|P2|Overall Study|Withdrawal by Subject|2
5384698|NCT03614078|18526209|P1|Overall Study|Withdrawal by Subject|2
5384699|NCT03613649|18526238|P12|Fourth Treatment|Physician Decision|0
5384700|NCT03613649|18526239|P11|Fourth Treatment|Physician Decision|0
5384701|NCT03613649|18526240|P10|Fourth Treatment|Physician Decision|0
5384702|NCT03613649|18526241|P9|Fourth Treatment|Physician Decision|0
5384703|NCT03613649|18526242|P8|Fourth Treatment|Physician Decision|0
5384704|NCT03613649|18526243|P7|Fourth Treatment|Physician Decision|1
5384705|NCT03613649|18526244|P6|Fourth Treatment|Physician Decision|0
5384706|NCT03613649|18526245|P5|Fourth Treatment|Physician Decision|0
5384707|NCT03613649|18526246|P4|Fourth Treatment|Physician Decision|0
5384708|NCT03613649|18526247|P3|Fourth Treatment|Physician Decision|0
5384709|NCT03613649|18526248|P2|Fourth Treatment|Physician Decision|0
5384710|NCT03613649|18526249|P1|Fourth Treatment|Physician Decision|0
5384711|NCT03613649|18526238|P12|Fourth Treatment|Protocol Violation|0
5384712|NCT03613649|18526239|P11|Fourth Treatment|Protocol Violation|0
5384713|NCT03613649|18526240|P10|Fourth Treatment|Protocol Violation|0
5384714|NCT03613649|18526241|P9|Fourth Treatment|Protocol Violation|0
5384715|NCT03613649|18526242|P8|Fourth Treatment|Protocol Violation|0
5384716|NCT03613649|18526243|P7|Fourth Treatment|Protocol Violation|0
5384717|NCT03613649|18526244|P6|Fourth Treatment|Protocol Violation|0
5384718|NCT03613649|18526245|P5|Fourth Treatment|Protocol Violation|1
5384719|NCT03613649|18526246|P4|Fourth Treatment|Protocol Violation|0
5384720|NCT03613649|18526247|P3|Fourth Treatment|Protocol Violation|0
5384721|NCT03613649|18526248|P2|Fourth Treatment|Protocol Violation|0
5384722|NCT03613649|18526249|P1|Fourth Treatment|Protocol Violation|1
5384723|NCT03613649|18526238|P12|Third Treatment|Protocol Violation|1
5384724|NCT03613649|18526239|P11|Third Treatment|Protocol Violation|0
5384725|NCT03613649|18526240|P10|Third Treatment|Protocol Violation|0
5384726|NCT03613649|18526241|P9|Third Treatment|Protocol Violation|0
5384727|NCT03613649|18526242|P8|Third Treatment|Protocol Violation|0
5384728|NCT03613649|18526243|P7|Third Treatment|Protocol Violation|1
5384729|NCT03613649|18526244|P6|Third Treatment|Protocol Violation|0
5384730|NCT03613649|18526245|P5|Third Treatment|Protocol Violation|0
5384731|NCT03613649|18526246|P4|Third Treatment|Protocol Violation|0
5384732|NCT03613649|18526247|P3|Third Treatment|Protocol Violation|0
5384733|NCT03613649|18526248|P2|Third Treatment|Protocol Violation|0
5384734|NCT03613649|18526249|P1|Third Treatment|Protocol Violation|0
5384735|NCT03613649|18526238|P12|Third Treatment|Lost to Follow-up|1
5384736|NCT03613649|18526239|P11|Third Treatment|Lost to Follow-up|0
5384737|NCT03613649|18526240|P10|Third Treatment|Lost to Follow-up|0
5384738|NCT03613649|18526241|P9|Third Treatment|Lost to Follow-up|0
5384739|NCT03613649|18526242|P8|Third Treatment|Lost to Follow-up|0
5384740|NCT03613649|18526243|P7|Third Treatment|Lost to Follow-up|0
5384741|NCT03613649|18526244|P6|Third Treatment|Lost to Follow-up|0
5384742|NCT03613649|18526245|P5|Third Treatment|Lost to Follow-up|1
5384743|NCT03613649|18526246|P4|Third Treatment|Lost to Follow-up|0
5384744|NCT03613649|18526247|P3|Third Treatment|Lost to Follow-up|0
5384745|NCT03613649|18526248|P2|Third Treatment|Lost to Follow-up|0
5384746|NCT03613649|18526249|P1|Third Treatment|Lost to Follow-up|0
5384747|NCT03613649|18526238|P12|Second Treatment|Withdrawal by Subject|0
5384748|NCT03613649|18526239|P11|Second Treatment|Withdrawal by Subject|0
5384749|NCT03613649|18526240|P10|Second Treatment|Withdrawal by Subject|0
5384750|NCT03613649|18526241|P9|Second Treatment|Withdrawal by Subject|0
5384751|NCT03613649|18526242|P8|Second Treatment|Withdrawal by Subject|0
5384752|NCT03613649|18526243|P7|Second Treatment|Withdrawal by Subject|0
5384753|NCT03613649|18526244|P6|Second Treatment|Withdrawal by Subject|0
5384754|NCT03613649|18526245|P5|Second Treatment|Withdrawal by Subject|1
5384755|NCT03613649|18526246|P4|Second Treatment|Withdrawal by Subject|0
5384756|NCT03613649|18526247|P3|Second Treatment|Withdrawal by Subject|0
5384757|NCT03613649|18526248|P2|Second Treatment|Withdrawal by Subject|0
5384758|NCT03613649|18526249|P1|Second Treatment|Withdrawal by Subject|0
5384759|NCT03613649|18526238|P12|Second Treatment|Lost to Follow-up|0
5384760|NCT03613649|18526239|P11|Second Treatment|Lost to Follow-up|0
5384761|NCT03613649|18526240|P10|Second Treatment|Lost to Follow-up|0
5384762|NCT03613649|18526241|P9|Second Treatment|Lost to Follow-up|0
5384763|NCT03613649|18526242|P8|Second Treatment|Lost to Follow-up|0
5384764|NCT03613649|18526243|P7|Second Treatment|Lost to Follow-up|0
5384765|NCT03613649|18526244|P6|Second Treatment|Lost to Follow-up|0
5384766|NCT03613649|18526245|P5|Second Treatment|Lost to Follow-up|0
5384767|NCT03613649|18526246|P4|Second Treatment|Lost to Follow-up|0
5384768|NCT03613649|18526247|P3|Second Treatment|Lost to Follow-up|1
5384769|NCT03613649|18526248|P2|Second Treatment|Lost to Follow-up|0
5384770|NCT03613649|18526249|P1|Second Treatment|Lost to Follow-up|0
5384771|NCT03613129|18526394|P5|Pre-treatment Assessment|Withdrawal by Subject|0
5384772|NCT03613129|18526395|P4|Pre-treatment Assessment|Withdrawal by Subject|0
5384773|NCT03613129|18526396|P3|Pre-treatment Assessment|Withdrawal by Subject|0
5384774|NCT03613129|18526397|P2|Pre-treatment Assessment|Withdrawal by Subject|0
5384775|NCT03613129|18526398|P1|Pre-treatment Assessment|Withdrawal by Subject|1
5384776|NCT03613129|18526394|P5|Pre-treatment Assessment|Protocol Violation|0
5384777|NCT03613129|18526395|P4|Pre-treatment Assessment|Protocol Violation|0
5384778|NCT03613129|18526396|P3|Pre-treatment Assessment|Protocol Violation|0
5384779|NCT03613129|18526397|P2|Pre-treatment Assessment|Protocol Violation|0
5384780|NCT03613129|18526398|P1|Pre-treatment Assessment|Protocol Violation|2
5384781|NCT03612856|18526423|P3|Pre-dose Period|Withdrawal by Subject|0
5384782|NCT03612856|18526424|P2|Pre-dose Period|Withdrawal by Subject|1
5384783|NCT03612856|18526425|P1|Pre-dose Period|Withdrawal by Subject|0
5384784|NCT03612856|18526423|P3|Pre-dose Period|Physician Decision|1
5384785|NCT03612856|18526424|P2|Pre-dose Period|Physician Decision|1
5384786|NCT03612856|18526425|P1|Pre-dose Period|Physician Decision|0
5384787|NCT03610269|18526625|P1|Overall Study|Screen fail|4
5384788|NCT03610269|18526625|P1|Overall Study|Unable to draw blood|1
5384789|NCT03610269|18526625|P1|Overall Study|Protocol Violation|1
5384790|NCT03610269|18526625|P1|Overall Study|Physician Decision|10
5384791|NCT03609619|18526631|P2|Overall Study|Lost to Follow-up|1
5384792|NCT03609619|18526632|P1|Overall Study|Lost to Follow-up|1
5384793|NCT03609619|18526631|P2|Overall Study|Withdrawal by Subject|3
5384794|NCT03609619|18526632|P1|Overall Study|Withdrawal by Subject|2
5384795|NCT03609619|18526631|P2|Overall Study|Protocol Violation|0
5384796|NCT03609619|18526632|P1|Overall Study|Protocol Violation|5
5384797|NCT03609619|18526631|P2|Overall Study|Lack of Efficacy|2
5384798|NCT03609619|18526632|P1|Overall Study|Lack of Efficacy|1
5384799|NCT03609619|18526631|P2|Overall Study|Adverse Event|0
5384800|NCT03609619|18526632|P1|Overall Study|Adverse Event|1
5384801|NCT03607682|18526713|P1|Overall Study|Disease progression|1
5384802|NCT03607682|18526713|P1|Overall Study|Withdrawal by Subject|1
5384803|NCT03607487|18526729|P4|Overall Study|Withdrawal by Subject|1
5384804|NCT03607487|18526730|P3|Overall Study|Withdrawal by Subject|0
5384805|NCT03607487|18526731|P2|Overall Study|Withdrawal by Subject|0
5384806|NCT03607487|18526732|P1|Overall Study|Withdrawal by Subject|2
5384807|NCT03606460|18526783|P2|Overall Study|Lost to Follow-up|8
5384808|NCT03606460|18526784|P1|Overall Study|Lost to Follow-up|1
5384809|NCT03605693|18526804|P2|Overall Study|Physician Decision|0
5384810|NCT03605693|18526805|P1|Overall Study|Physician Decision|1
5384811|NCT03605693|18526804|P2|Overall Study|Lost to Follow-up|0
5384812|NCT03605693|18526805|P1|Overall Study|Lost to Follow-up|4
5384813|NCT03605303|18526819|P2|Period 1|Study Terminated|1
5384814|NCT03605303|18526820|P1|Period 1|Study Terminated|2
5384815|NCT03604497|18526828|P1|Overall Study|Protocol Violation|52
5384816|NCT03604341|18526838|P2|Overall Study|Protocol Violation|1
5384817|NCT03604341|18526839|P1|Overall Study|Protocol Violation|0
5384818|NCT03604341|18526838|P2|Overall Study|Adverse Event|0
5384819|NCT03604341|18526839|P1|Overall Study|Adverse Event|1
5384820|NCT03604341|18526838|P2|Overall Study|Withdrawal by Subject|1
5384821|NCT03604341|18526839|P1|Overall Study|Withdrawal by Subject|1
5384822|NCT03603652|18526849|P1|Overall Study|Death|2
5384823|NCT03603028|18526935|P1|Overall Study|Withdrawal by Subject|1
5384824|NCT03602053|18526943|P3|Overall Study|Other|0
5384825|NCT03602053|18526944|P2|Overall Study|Other|0
5384826|NCT03602053|18526945|P1|Overall Study|Other|1
5384827|NCT03602053|18526943|P3|Overall Study|migration|0
5384828|NCT03602053|18526944|P2|Overall Study|migration|3
5384829|NCT03602053|18526945|P1|Overall Study|migration|2
5384830|NCT03602053|18526943|P3|Overall Study|Physician Decision|0
5384831|NCT03602053|18526944|P2|Overall Study|Physician Decision|0
5384832|NCT03602053|18526945|P1|Overall Study|Physician Decision|1
5384833|NCT03602053|18526943|P3|Overall Study|Protocol Violation|4
5384834|NCT03602053|18526944|P2|Overall Study|Protocol Violation|0
5384835|NCT03602053|18526945|P1|Overall Study|Protocol Violation|3
5384836|NCT03602053|18526943|P3|Overall Study|Lost to Follow-up|0
5384837|NCT03602053|18526944|P2|Overall Study|Lost to Follow-up|6
5384838|NCT03602053|18526945|P1|Overall Study|Lost to Follow-up|5
5384839|NCT03602053|18526943|P3|Overall Study|Withdrawal by Subject|7
5384840|NCT03602053|18526944|P2|Overall Study|Withdrawal by Subject|9
5384841|NCT03602053|18526945|P1|Overall Study|Withdrawal by Subject|7
5384842|NCT03601715|18526991|P3|Second Intervention|Lost to Follow-up|0
5384843|NCT03601715|18526992|P2|Second Intervention|Lost to Follow-up|1
5384844|NCT03601715|18526993|P1|Second Intervention|Lost to Follow-up|1
5384845|NCT03599349|18527026|P1|Overall Study|Lost to Follow-up|1
5384846|NCT03599193|18527040|P2|Overall Study|Lost to Follow-up|1
5384847|NCT03599193|18527041|P1|Overall Study|Lost to Follow-up|0
5384848|NCT03599193|18527040|P2|Overall Study|Protocol Violation|0
5384849|NCT03599193|18527041|P1|Overall Study|Protocol Violation|1
5384850|NCT03599193|18527040|P2|Overall Study|Withdrawal by Subject|0
5384851|NCT03599193|18527041|P1|Overall Study|Withdrawal by Subject|1
5384852|NCT03599193|18527040|P2|Overall Study|Adverse Event|2
5384853|NCT03599193|18527041|P1|Overall Study|Adverse Event|0
5384854|NCT03598140|18527055|P2|Overall Study|enrolled but didn't start|0
5384855|NCT03598140|18527056|P1|Overall Study|enrolled but didn't start|1
5384856|NCT03597022|18527075|P3|Overall Study|Serious adverse event|0
5384857|NCT03597022|18527076|P2|Overall Study|Serious adverse event|1
5384858|NCT03597022|18527077|P1|Overall Study|Serious adverse event|1
5384859|NCT03597022|18527075|P3|Overall Study|Premature termination of the study|8
5384860|NCT03597022|18527076|P2|Overall Study|Premature termination of the study|7
5384861|NCT03597022|18527077|P1|Overall Study|Premature termination of the study|7
5384862|NCT03594227|18527113|P4|Overall Study|Programmatic Analysis Non-completer|1
5384863|NCT03594227|18527114|P3|Overall Study|Programmatic Analysis Non-completer|1
5384864|NCT03594227|18527115|P2|Overall Study|Programmatic Analysis Non-completer|0
5384865|NCT03594227|18527116|P1|Overall Study|Programmatic Analysis Non-completer|1
5384866|NCT03594227|18527113|P4|Overall Study|Sponsor Decision|1
5384867|NCT03594227|18527114|P3|Overall Study|Sponsor Decision|0
5384868|NCT03594227|18527115|P2|Overall Study|Sponsor Decision|0
5384869|NCT03594227|18527116|P1|Overall Study|Sponsor Decision|0
5384870|NCT03594227|18527113|P4|Overall Study|Pregnancy|0
5384871|NCT03594227|18527114|P3|Overall Study|Pregnancy|0
5384872|NCT03594227|18527115|P2|Overall Study|Pregnancy|1
5384873|NCT03594227|18527116|P1|Overall Study|Pregnancy|0
5384874|NCT03594227|18527113|P4|Overall Study|Withdrawal by Subject|1
5384875|NCT03594227|18527114|P3|Overall Study|Withdrawal by Subject|1
5384876|NCT03594227|18527115|P2|Overall Study|Withdrawal by Subject|1
5384877|NCT03594227|18527116|P1|Overall Study|Withdrawal by Subject|1
5384878|NCT03594227|18527113|P4|Overall Study|Lost to Follow-up|0
5384879|NCT03594227|18527114|P3|Overall Study|Lost to Follow-up|1
5384880|NCT03594227|18527115|P2|Overall Study|Lost to Follow-up|1
5384881|NCT03594227|18527116|P1|Overall Study|Lost to Follow-up|1
5384882|NCT03594227|18527113|P4|Overall Study|Adverse Event|2
5384883|NCT03594227|18527114|P3|Overall Study|Adverse Event|0
5384884|NCT03594227|18527115|P2|Overall Study|Adverse Event|1
5384885|NCT03594227|18527116|P1|Overall Study|Adverse Event|2
5384886|NCT03592186|18527295|P2|Overall Study|Lost to Follow-up|11
5384887|NCT03592186|18527296|P1|Overall Study|Lost to Follow-up|16
5384888|NCT03592186|18527295|P2|Overall Study|Withdrawal by Subject|0
5384889|NCT03592186|18527296|P1|Overall Study|Withdrawal by Subject|1
5384890|NCT03591406|18527344|P2|Overall Study|Withdrawal by Subject|5
5384891|NCT03591406|18527345|P1|Overall Study|Withdrawal by Subject|0
5384892|NCT03591406|18527344|P2|Overall Study|Protocol Violation|1
5384893|NCT03591406|18527345|P1|Overall Study|Protocol Violation|2
5384894|NCT03591406|18527344|P2|Overall Study|Adverse Event|3
5384895|NCT03591406|18527345|P1|Overall Study|Adverse Event|5
5384896|NCT03590743|18527391|P2|Overall Study|Withdrawal by Subject|1
5384897|NCT03590743|18527392|P1|Overall Study|Withdrawal by Subject|0
5384898|NCT03590613|18527404|P4|Period 2, 4 Days|Physician Decision|1
5384899|NCT03590613|18527405|P3|Period 2, 4 Days|Physician Decision|0
5384900|NCT03590613|18527406|P2|Period 2, 4 Days|Physician Decision|0
5384901|NCT03590613|18527407|P1|Period 2, 4 Days|Physician Decision|0
5384902|NCT03588741|18527536|P1|Overall Study|Withdrawal by Subject|1
5384903|NCT03588572|18527543|P2|Visitation 3|Withdrawal by Subject|0
5384904|NCT03588572|18527544|P1|Visitation 3|Withdrawal by Subject|1
5384905|NCT03588572|18527543|P2|Visitation 3|Physician Decision|1
5384906|NCT03588572|18527544|P1|Visitation 3|Physician Decision|1
5384907|NCT03588572|18527543|P2|Visitation 3|Lost to Follow-up|1
5384908|NCT03588572|18527544|P1|Visitation 3|Lost to Follow-up|1
5384909|NCT03588572|18527543|P2|Visitation 2|Withdrawal by Subject|0
5384910|NCT03588572|18527544|P1|Visitation 2|Withdrawal by Subject|1
5384911|NCT03588572|18527543|P2|Visitation 2|Lack of Efficacy|1
5384912|NCT03588572|18527544|P1|Visitation 2|Lack of Efficacy|0
5384913|NCT03588572|18527543|P2|Visitation 2|Lost to Follow-up|1
5384914|NCT03588572|18527544|P1|Visitation 2|Lost to Follow-up|1
5384915|NCT03588572|18527543|P2|Visitation 1|Lack of Efficacy|1
5384916|NCT03588572|18527544|P1|Visitation 1|Lack of Efficacy|1
5384917|NCT03587974|18527562|P2|Overall Study|Withdrawal by Subject|1
5384918|NCT03587974|18527563|P1|Overall Study|Withdrawal by Subject|2
5384919|NCT03587974|18527562|P2|Overall Study|caregiver demented, care recipient died|3
5384920|NCT03587974|18527563|P1|Overall Study|caregiver demented, care recipient died|3
5384921|NCT03586830|18527679|P4|Overall Study|Withdrawal by Subject|1
5384922|NCT03586830|18527680|P3|Overall Study|Withdrawal by Subject|3
5384923|NCT03586830|18527681|P2|Overall Study|Withdrawal by Subject|0
5384924|NCT03586830|18527682|P1|Overall Study|Withdrawal by Subject|1
5384925|NCT03586830|18527679|P4|Overall Study|Lost to Follow-up|1
5384926|NCT03586830|18527680|P3|Overall Study|Lost to Follow-up|2
5384927|NCT03586830|18527681|P2|Overall Study|Lost to Follow-up|2
5384928|NCT03586830|18527682|P1|Overall Study|Lost to Follow-up|0
5384929|NCT03586830|18527679|P4|Overall Study|Site terminated by Sponsor|3
5384930|NCT03586830|18527680|P3|Overall Study|Site terminated by Sponsor|3
5384931|NCT03586830|18527681|P2|Overall Study|Site terminated by Sponsor|4
5384932|NCT03586830|18527682|P1|Overall Study|Site terminated by Sponsor|1
5384933|NCT03586726|18527704|P1|Overall Study|Withdrawal by Subject|1
5384934|NCT03586648|18527721|P2|Period 2|Adverse Event|0
5384935|NCT03586648|18527722|P1|Period 2|Adverse Event|1
5384936|NCT03586648|18527721|P2|Period 1|Physician Decision|1
5384937|NCT03586648|18527722|P1|Period 1|Physician Decision|0
5384938|NCT03586648|18527721|P2|Period 1|Study related symptoms or complaints|1
5384939|NCT03586648|18527722|P1|Period 1|Study related symptoms or complaints|2
5384940|NCT03586648|18527721|P2|Period 1|Adverse Event|0
5384941|NCT03586648|18527722|P1|Period 1|Adverse Event|1
5384942|NCT03586648|18527721|P2|Period 1|Lost to Follow-up|1
5384943|NCT03586648|18527722|P1|Period 1|Lost to Follow-up|1
5384944|NCT03586648|18527721|P2|Period 1|Withdrawal by Subject|1
5384945|NCT03586648|18527722|P1|Period 1|Withdrawal by Subject|0
5384946|NCT03585959|18527735|P1|Overall Study|Unsuccessful Procedure|2
5384947|NCT03585959|18527735|P1|Overall Study|Physician Decision|1
5384948|NCT03585504|18527786|P2|Overall Study|Lost to Follow-up|29
5384949|NCT03585504|18527787|P1|Overall Study|Lost to Follow-up|26
5384950|NCT03585296|18527797|P1|Overall Study|Withdrawal by Subject|2
5384951|NCT03585296|18527797|P1|Overall Study|Lost to Follow-up|2
5384952|NCT03585296|18527797|P1|Overall Study|Adverse Event|1
5384953|NCT03583450|18527803|P2|Overall Study|hardware malfunction (battery depletion)|0
5384954|NCT03583450|18527804|P1|Overall Study|hardware malfunction (battery depletion)|1
5384955|NCT03583385|18527826|P2|Treatment Period 2|Adverse Event|0
5384956|NCT03583385|18527827|P1|Treatment Period 2|Adverse Event|1
5384957|NCT03583385|18527826|P2|Treatment Period 1|Withdrawal by Subject|1
5384958|NCT03583385|18527827|P1|Treatment Period 1|Withdrawal by Subject|1
5384959|NCT03582943|18527845|P2|Analyzed|Protocol Violation|1
5384960|NCT03582943|18527846|P1|Analyzed|Protocol Violation|4
5384961|NCT03582943|18527845|P2|Intervention and Follow up|Withdrawal by Subject|2
5384962|NCT03582943|18527846|P1|Intervention and Follow up|Withdrawal by Subject|4
5384963|NCT03582943|18527845|P2|Allocated to Groups|Withdrawal by Subject|1
5384964|NCT03582943|18527846|P1|Allocated to Groups|Withdrawal by Subject|1
5384965|NCT03582813|18527854|P2|Overall Study|Withdrawal by Subject|0
5384966|NCT03582813|18527855|P1|Overall Study|Withdrawal by Subject|1
5384967|NCT03582813|18527854|P2|Overall Study|Lost to Follow-up|21
5384968|NCT03582813|18527855|P1|Overall Study|Lost to Follow-up|18
5384969|NCT03582215|18527922|P8|Overall Study|Adverse Event|2
5384970|NCT03582215|18527923|P7|Overall Study|Adverse Event|2
5384971|NCT03582215|18527924|P6|Overall Study|Adverse Event|0
5384972|NCT03582215|18527925|P5|Overall Study|Adverse Event|0
5384973|NCT03582215|18527926|P4|Overall Study|Adverse Event|0
5384974|NCT03582215|18527927|P3|Overall Study|Adverse Event|0
5384975|NCT03582215|18527928|P2|Overall Study|Adverse Event|0
5384976|NCT03582215|18527929|P1|Overall Study|Adverse Event|1
5384977|NCT03581825|18527970|P2|Period 2|Unsatisfactory Vision to Test|1
5384978|NCT03581825|18527971|P1|Period 2|Unsatisfactory Vision to Test|0
5384979|NCT03581825|18527970|P2|Period 1|Lens Discomfort|0
5384980|NCT03581825|18527971|P1|Period 1|Lens Discomfort|1
5384981|NCT03580382|18528007|P2|Overall Study|Early Termination of Study|3
5384982|NCT03580382|18528008|P1|Overall Study|Early Termination of Study|0
5384983|NCT03579940|18528026|P11|Period 2|Withdrawal by Subject|0
5384984|NCT03579940|18528027|P10|Period 2|Withdrawal by Subject|0
5384985|NCT03579940|18528028|P9|Period 2|Withdrawal by Subject|0
5384986|NCT03579940|18528029|P8|Period 2|Withdrawal by Subject|0
5384987|NCT03579940|18528030|P7|Period 2|Withdrawal by Subject|0
5384988|NCT03579940|18528031|P6|Period 2|Withdrawal by Subject|0
5384989|NCT03579940|18528032|P5|Period 2|Withdrawal by Subject|0
5384990|NCT03579940|18528033|P4|Period 2|Withdrawal by Subject|0
5384991|NCT03579940|18528034|P3|Period 2|Withdrawal by Subject|1
5384992|NCT03579940|18528035|P2|Period 2|Withdrawal by Subject|0
5384993|NCT03579940|18528036|P1|Period 2|Withdrawal by Subject|0
5384994|NCT03579719|18528076|P1|Overall Study|Protocol deviation, pre-existent disease|1
5384995|NCT03578146|18528133|P6|Overall Study|Lost to Follow-up|1
5384996|NCT03578146|18528134|P5|Overall Study|Lost to Follow-up|0
5384997|NCT03578146|18528135|P4|Overall Study|Lost to Follow-up|0
5384998|NCT03578146|18528136|P3|Overall Study|Lost to Follow-up|1
5384999|NCT03578146|18528137|P2|Overall Study|Lost to Follow-up|1
5385000|NCT03578146|18528138|P1|Overall Study|Lost to Follow-up|0
5385001|NCT03578146|18528133|P6|Overall Study|Did Not Receive Treatment|2
5385002|NCT03578146|18528134|P5|Overall Study|Did Not Receive Treatment|0
5385003|NCT03578146|18528135|P4|Overall Study|Did Not Receive Treatment|0
5385004|NCT03578146|18528136|P3|Overall Study|Did Not Receive Treatment|0
5385005|NCT03578146|18528137|P2|Overall Study|Did Not Receive Treatment|0
5385006|NCT03578146|18528138|P1|Overall Study|Did Not Receive Treatment|1
5385007|NCT03575871|18528279|P3|Overall Study|Other than specified|0
5385008|NCT03575871|18528280|P2|Overall Study|Other than specified|2
5385009|NCT03575871|18528281|P1|Overall Study|Other than specified|2
5385010|NCT03575871|18528279|P3|Overall Study|Withdrawal by Subject|9
5385011|NCT03575871|18528280|P2|Overall Study|Withdrawal by Subject|1
5385012|NCT03575871|18528281|P1|Overall Study|Withdrawal by Subject|6
5385013|NCT03575871|18528279|P3|Overall Study|Protocol Deviation|1
5385014|NCT03575871|18528280|P2|Overall Study|Protocol Deviation|1
5385015|NCT03575871|18528281|P1|Overall Study|Protocol Deviation|1
5385016|NCT03575871|18528279|P3|Overall Study|Lost to Follow-up|1
5385017|NCT03575871|18528280|P2|Overall Study|Lost to Follow-up|1
5385018|NCT03575871|18528281|P1|Overall Study|Lost to Follow-up|1
5385019|NCT03575871|18528279|P3|Overall Study|Lack of Efficacy|7
5385020|NCT03575871|18528280|P2|Overall Study|Lack of Efficacy|4
5385021|NCT03575871|18528281|P1|Overall Study|Lack of Efficacy|5
5385022|NCT03575871|18528279|P3|Overall Study|Death|0
5385023|NCT03575871|18528280|P2|Overall Study|Death|0
5385024|NCT03575871|18528281|P1|Overall Study|Death|1
5385025|NCT03575871|18528279|P3|Overall Study|Adverse Event|8
5385026|NCT03575871|18528280|P2|Overall Study|Adverse Event|5
5385027|NCT03575871|18528281|P1|Overall Study|Adverse Event|5
5385028|NCT03575806|18528345|P2|Overall Study|Protocol Violation|2
5385029|NCT03575806|18528346|P1|Overall Study|Protocol Violation|0
5385030|NCT03575806|18528345|P2|Overall Study|Withdrawal by Subject|2
5385031|NCT03575806|18528346|P1|Overall Study|Withdrawal by Subject|0
5385032|NCT03575702|18528356|P2|Overall Study|Patient non compliance|0
5385033|NCT03575702|18528357|P1|Overall Study|Patient non compliance|4
5385034|NCT03575702|18528356|P2|Overall Study|Protocol Violation|1
5385035|NCT03575702|18528357|P1|Overall Study|Protocol Violation|0
5385036|NCT03575702|18528356|P2|Overall Study|Lost to Follow-up|2
5385037|NCT03575702|18528357|P1|Overall Study|Lost to Follow-up|1
5385038|NCT03575702|18528356|P2|Overall Study|Withdrawal by Subject|1
5385039|NCT03575702|18528357|P1|Overall Study|Withdrawal by Subject|1
5385040|NCT03573908|18528413|P5|Randomized Withdrawal Period|Other, Not Specified|0
5385041|NCT03573908|18528414|P4|Randomized Withdrawal Period|Other, Not Specified|2
5385042|NCT03573908|18528415|P3|Randomized Withdrawal Period|Other, Not Specified|4
5385043|NCT03573908|18528416|P2|Randomized Withdrawal Period|Other, Not Specified|0
5385044|NCT03573908|18528417|P1|Randomized Withdrawal Period|Other, Not Specified|0
5385045|NCT03573908|18528413|P5|Randomized Withdrawal Period|Lost to Follow-up|0
5385046|NCT03573908|18528414|P4|Randomized Withdrawal Period|Lost to Follow-up|0
5385047|NCT03573908|18528415|P3|Randomized Withdrawal Period|Lost to Follow-up|1
5385048|NCT03573908|18528416|P2|Randomized Withdrawal Period|Lost to Follow-up|0
5385049|NCT03573908|18528417|P1|Randomized Withdrawal Period|Lost to Follow-up|0
5385050|NCT03573908|18528413|P5|Randomized Withdrawal Period|Withdrawal by Subject|2
5385051|NCT03573908|18528414|P4|Randomized Withdrawal Period|Withdrawal by Subject|0
5385052|NCT03573908|18528415|P3|Randomized Withdrawal Period|Withdrawal by Subject|0
5385053|NCT03573908|18528416|P2|Randomized Withdrawal Period|Withdrawal by Subject|0
5385054|NCT03573908|18528417|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
5385055|NCT03573908|18528413|P5|Randomized Withdrawal Period|Adverse Event|0
5385056|NCT03573908|18528414|P4|Randomized Withdrawal Period|Adverse Event|0
5385057|NCT03573908|18528415|P3|Randomized Withdrawal Period|Adverse Event|3
5385058|NCT03573908|18528416|P2|Randomized Withdrawal Period|Adverse Event|0
5385059|NCT03573908|18528417|P1|Randomized Withdrawal Period|Adverse Event|0
5385060|NCT03573908|18528413|P5|Treatment Period|Other, Not Specified|0
5385061|NCT03573908|18528414|P4|Treatment Period|Other, Not Specified|0
5385062|NCT03573908|18528415|P3|Treatment Period|Other, Not Specified|0
5385063|NCT03573908|18528416|P2|Treatment Period|Other, Not Specified|6
5385064|NCT03573908|18528417|P1|Treatment Period|Other, Not Specified|4
5385065|NCT03573908|18528413|P5|Treatment Period|Pregnancy|0
5385066|NCT03573908|18528414|P4|Treatment Period|Pregnancy|0
5385067|NCT03573908|18528415|P3|Treatment Period|Pregnancy|0
5385068|NCT03573908|18528416|P2|Treatment Period|Pregnancy|0
5385069|NCT03573908|18528417|P1|Treatment Period|Pregnancy|1
5385070|NCT03573908|18528413|P5|Treatment Period|Lost to Follow-up|0
5385071|NCT03573908|18528414|P4|Treatment Period|Lost to Follow-up|0
5385072|NCT03573908|18528415|P3|Treatment Period|Lost to Follow-up|0
5385073|NCT03573908|18528416|P2|Treatment Period|Lost to Follow-up|6
5385074|NCT03573908|18528417|P1|Treatment Period|Lost to Follow-up|7
5385075|NCT03573908|18528413|P5|Treatment Period|Withdrawal by Subject|0
5385076|NCT03573908|18528414|P4|Treatment Period|Withdrawal by Subject|0
5385077|NCT03573908|18528415|P3|Treatment Period|Withdrawal by Subject|0
5385078|NCT03573908|18528416|P2|Treatment Period|Withdrawal by Subject|5
5385079|NCT03573908|18528417|P1|Treatment Period|Withdrawal by Subject|7
5385080|NCT03573908|18528413|P5|Treatment Period|Protocol Violation|0
5385081|NCT03573908|18528414|P4|Treatment Period|Protocol Violation|0
5385082|NCT03573908|18528415|P3|Treatment Period|Protocol Violation|0
5385083|NCT03573908|18528416|P2|Treatment Period|Protocol Violation|0
5385084|NCT03573908|18528417|P1|Treatment Period|Protocol Violation|1
5385085|NCT03573908|18528413|P5|Treatment Period|Adverse Event|0
5385086|NCT03573908|18528414|P4|Treatment Period|Adverse Event|0
5385087|NCT03573908|18528415|P3|Treatment Period|Adverse Event|0
5385088|NCT03573908|18528416|P2|Treatment Period|Adverse Event|9
5385089|NCT03573908|18528417|P1|Treatment Period|Adverse Event|4
5385090|NCT03573830|18528434|P2|Overall Study|Lost to Follow-up|0
5385091|NCT03573830|18528435|P1|Overall Study|Lost to Follow-up|4
5385092|NCT03573830|18528434|P2|Overall Study|Dropped without completing treatment|7
5385093|NCT03573830|18528435|P1|Overall Study|Dropped without completing treatment|0
5385094|NCT03573817|18528458|P2|Overall Study|Withdrawal by Subject|1
5385095|NCT03573817|18528459|P1|Overall Study|Withdrawal by Subject|1
5385096|NCT03573817|18528458|P2|Overall Study|Protocol Violation|1
5385097|NCT03573817|18528459|P1|Overall Study|Protocol Violation|0
5385098|NCT03573817|18528458|P2|Overall Study|Adverse Event|2
5385099|NCT03573817|18528459|P1|Overall Study|Adverse Event|0
5385100|NCT03573505|18528487|P2|Overall Study|Death|4
5385101|NCT03573505|18528488|P1|Overall Study|Death|0
5385102|NCT03573505|18528487|P2|Overall Study|Reason not specified|1
5385103|NCT03573505|18528488|P1|Overall Study|Reason not specified|0
5385104|NCT03573505|18528487|P2|Overall Study|Study terminated by sponsor|45
5385105|NCT03573505|18528488|P1|Overall Study|Study terminated by sponsor|50
5385106|NCT03573505|18528487|P2|Overall Study|Site Terminated by Sponsor|1
5385107|NCT03573505|18528488|P1|Overall Study|Site Terminated by Sponsor|1
5385108|NCT03573505|18528487|P2|Overall Study|Disease progression|1
5385109|NCT03573505|18528488|P1|Overall Study|Disease progression|0
5385110|NCT03573505|18528487|P2|Overall Study|Consent withdrawn|1
5385111|NCT03573505|18528488|P1|Overall Study|Consent withdrawn|0
5385112|NCT03573505|18528487|P2|Overall Study|Adverse Event|1
5385113|NCT03573505|18528488|P1|Overall Study|Adverse Event|1
5385114|NCT03573323|18528533|P2|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
5385115|NCT03573323|18528534|P1|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
5385116|NCT03573323|18528533|P2|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
5385117|NCT03573323|18528534|P1|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
5385118|NCT03573323|18528533|P2|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
5385119|NCT03573323|18528534|P1|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
5385120|NCT03573323|18528533|P2|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
5385121|NCT03573323|18528534|P1|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
5385122|NCT03573323|18528533|P2|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
5385123|NCT03573323|18528534|P1|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
5385124|NCT03573323|18528533|P2|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
5385125|NCT03573323|18528534|P1|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
5385126|NCT03573323|18528533|P2|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
5385127|NCT03573323|18528534|P1|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
5385128|NCT03573323|18528533|P2|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
5385129|NCT03573323|18528534|P1|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
5385130|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
5385131|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
5385132|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
5385133|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
5385134|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
5385135|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
5385136|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
5385137|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
5385138|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
5385139|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
5385140|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
5385141|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
5385142|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
5385143|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
5385144|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
5385145|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
5385146|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
5385147|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
5385148|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
5385149|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
5385150|NCT03573323|18528533|P2|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
5385151|NCT03573323|18528534|P1|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
5385152|NCT03572218|18528682|P2|Overall Study|No longer interested|2
5385153|NCT03572218|18528683|P1|Overall Study|No longer interested|1
5385154|NCT03572218|18528682|P2|Overall Study|No longer available for study visits|1
5385155|NCT03572218|18528683|P1|Overall Study|No longer available for study visits|2
5385156|NCT03572218|18528682|P2|Overall Study|Lost to Follow-up|2
5385157|NCT03572218|18528683|P1|Overall Study|Lost to Follow-up|3
5385158|NCT03571256|18528954|P3|Overall Study|Protocol Violation|1
5385159|NCT03571256|18528955|P2|Overall Study|Protocol Violation|1
5385160|NCT03571256|18528956|P1|Overall Study|Protocol Violation|0
5385161|NCT03571256|18528954|P3|Overall Study|Other than specified|1
5385162|NCT03571256|18528955|P2|Overall Study|Other than specified|1
5385163|NCT03571256|18528956|P1|Overall Study|Other than specified|0
5385164|NCT03571256|18528954|P3|Overall Study|Withdrawal by Subject|1
5385165|NCT03571256|18528955|P2|Overall Study|Withdrawal by Subject|1
5385166|NCT03571256|18528956|P1|Overall Study|Withdrawal by Subject|3
5385167|NCT03571256|18528954|P3|Overall Study|Adverse Event|1
5385168|NCT03571256|18528955|P2|Overall Study|Adverse Event|0
5385169|NCT03571256|18528956|P1|Overall Study|Adverse Event|3
5385170|NCT03570554|18529044|P4|Overall Study|Adverse Event|1
5385171|NCT03570554|18529045|P3|Overall Study|Adverse Event|0
5385172|NCT03570554|18529046|P2|Overall Study|Adverse Event|0
5385173|NCT03570554|18529047|P1|Overall Study|Adverse Event|0
5385174|NCT03570554|18529044|P4|Overall Study|Non-compliance with study drug|0
5385175|NCT03570554|18529045|P3|Overall Study|Non-compliance with study drug|1
5385176|NCT03570554|18529046|P2|Overall Study|Non-compliance with study drug|0
5385177|NCT03570554|18529047|P1|Overall Study|Non-compliance with study drug|0
5385178|NCT03569371|18529161|P1|Overall Study|Adverse Event|1
5385179|NCT03569371|18529161|P1|Overall Study|Lost to Follow-up|1
5385180|NCT03569371|18529161|P1|Overall Study|Lack of Efficacy|1
5385181|NCT03569202|18529182|P2|Part 3|Other|1
5385182|NCT03569202|18529183|P1|Part 3|Other|1
5385183|NCT03569202|18529182|P2|Part 3|Physician Decision|0
5385184|NCT03569202|18529183|P1|Part 3|Physician Decision|1
5385185|NCT03568942|18529232|P1|Overall Study|Lost to Follow-up|1
5385186|NCT03568942|18529232|P1|Overall Study|Family emergency|1
5385187|NCT03568500|18529270|P3|Overall Study|Participant Noncompliance|0
5385188|NCT03568500|18529271|P2|Overall Study|Participant Noncompliance|1
5385189|NCT03568500|18529272|P1|Overall Study|Participant Noncompliance|1
5385190|NCT03568500|18529270|P3|Overall Study|Technical Problems|0
5385191|NCT03568500|18529271|P2|Overall Study|Technical Problems|1
5385192|NCT03568500|18529272|P1|Overall Study|Technical Problems|2
5385193|NCT03568500|18529270|P3|Overall Study|Withdrawal by Subject|0
5385194|NCT03568500|18529271|P2|Overall Study|Withdrawal by Subject|2
5385195|NCT03568500|18529272|P1|Overall Study|Withdrawal by Subject|4
5385196|NCT03568500|18529270|P3|Overall Study|Physician Decision|0
5385197|NCT03568500|18529271|P2|Overall Study|Physician Decision|0
5385198|NCT03568500|18529272|P1|Overall Study|Physician Decision|1
5385199|NCT03568500|18529270|P3|Overall Study|Adverse Event|2
5385200|NCT03568500|18529271|P2|Overall Study|Adverse Event|1
5385201|NCT03568500|18529272|P1|Overall Study|Adverse Event|1
5385202|NCT03568500|18529270|P3|Overall Study|Lost to Follow-up|2
5385203|NCT03568500|18529271|P2|Overall Study|Lost to Follow-up|1
5385204|NCT03568500|18529272|P1|Overall Study|Lost to Follow-up|1
5385205|NCT03566979|18529299|P4|Overall Study|Adverse Event|0
5385206|NCT03566979|18529300|P3|Overall Study|Adverse Event|0
5385207|NCT03566979|18529301|P2|Overall Study|Adverse Event|0
5385208|NCT03566979|18529302|P1|Overall Study|Adverse Event|1
5385209|NCT03566979|18529299|P4|Overall Study|Lost to Follow-up|5
5385210|NCT03566979|18529300|P3|Overall Study|Lost to Follow-up|9
5385211|NCT03566979|18529301|P2|Overall Study|Lost to Follow-up|7
5385212|NCT03566979|18529302|P1|Overall Study|Lost to Follow-up|2
5385213|NCT03566979|18529299|P4|Overall Study|Withdrawal by Subject|1
5385214|NCT03566979|18529300|P3|Overall Study|Withdrawal by Subject|1
5385215|NCT03566979|18529301|P2|Overall Study|Withdrawal by Subject|0
5385216|NCT03566979|18529302|P1|Overall Study|Withdrawal by Subject|2
5385217|NCT03566810|18529318|P4|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
5385218|NCT03566810|18529319|P3|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
5385219|NCT03566810|18529320|P2|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
5385220|NCT03566810|18529321|P1|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
5385221|NCT03566680|18529383|P1|Overall Study|Withdrawal by Subject|3
5385222|NCT03566680|18529383|P1|Overall Study|Lost to Follow-up|13
5385223|NCT03566680|18529383|P1|Overall Study|Pregnancy|1
5385224|NCT03565887|18529394|P2|Overall Study|Withdrawal by Subject|2
5385225|NCT03565887|18529395|P1|Overall Study|Withdrawal by Subject|0
5385226|NCT03565887|18529394|P2|Overall Study|Adverse Event|0
5385227|NCT03565887|18529395|P1|Overall Study|Adverse Event|1
5385228|NCT03565315|18529474|P4|Overall Study|IND Sponsor/PI Voluntary Study Pause|1
5385229|NCT03565315|18529475|P3|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
5385230|NCT03565315|18529476|P2|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
5385231|NCT03565315|18529477|P1|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
5385232|NCT03565211|18529514|P1|Overall Study|Personal issues|1
5385233|NCT03565211|18529514|P1|Overall Study|Adverse Event|44
5385234|NCT03565211|18529514|P1|Overall Study|Lost to Follow-up|1
5385235|NCT03565211|18529514|P1|Overall Study|Withdrawal by Subject|2
5385236|NCT03563716|18529588|P2|Overall Study|Still on Study|50
5385237|NCT03563716|18529589|P1|Overall Study|Still on Study|45
5385238|NCT03563716|18529588|P2|Overall Study|Withdrawal by Subject|3
5385239|NCT03563716|18529589|P1|Overall Study|Withdrawal by Subject|3
5385240|NCT03563716|18529588|P2|Overall Study|Death|14
5385241|NCT03563716|18529589|P1|Overall Study|Death|20
5385242|NCT03562481|18529821|P2|First Intervention|Lost to Follow-up|0
5385243|NCT03562481|18529822|P1|First Intervention|Lost to Follow-up|1
5385244|NCT03562117|18529847|P3|Part 1, Up to 3 Days|Adverse Event|0
5385245|NCT03562117|18529848|P2|Part 1, Up to 3 Days|Adverse Event|0
5385246|NCT03562117|18529849|P1|Part 1, Up to 3 Days|Adverse Event|1
5385247|NCT03560986|18529937|P2|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
5385248|NCT03560986|18529938|P1|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
5385249|NCT03560986|18529937|P2|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
5385250|NCT03560986|18529938|P1|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
5385251|NCT03560986|18529937|P2|Treatment Period B/Follow-up Period 2|Adverse Event|0
5385252|NCT03560986|18529938|P1|Treatment Period B/Follow-up Period 2|Adverse Event|1
5385253|NCT03560986|18529937|P2|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
5385254|NCT03560986|18529938|P1|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
5385255|NCT03560986|18529937|P2|Treatment Period A/Follow-up Period 1|Protocol Violation|1
5385256|NCT03560986|18529938|P1|Treatment Period A/Follow-up Period 1|Protocol Violation|0
5385257|NCT03560986|18529937|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
5385258|NCT03560986|18529938|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
5385259|NCT03560986|18529937|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
5385260|NCT03560986|18529938|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
5385261|NCT03560739|18529964|P4|Overall Study|Adverse Event|0
5385262|NCT03560739|18529965|P3|Overall Study|Adverse Event|0
5385263|NCT03560739|18529966|P2|Overall Study|Adverse Event|1
5385264|NCT03560739|18529967|P1|Overall Study|Adverse Event|0
5385265|NCT03560518|18529996|P3|Double Blind Treatment Period|Adverse Event|1
5385266|NCT03560518|18529997|P2|Double Blind Treatment Period|Adverse Event|3
5385267|NCT03560518|18529998|P1|Double Blind Treatment Period|Adverse Event|0
5385268|NCT03560518|18529996|P3|Double Blind Treatment Period|Lack of Efficacy|1
5385269|NCT03560518|18529997|P2|Double Blind Treatment Period|Lack of Efficacy|1
5385270|NCT03560518|18529998|P1|Double Blind Treatment Period|Lack of Efficacy|2
5385271|NCT03560518|18529996|P3|Double Blind Treatment Period|Withdrawal by Subject|5
5385272|NCT03560518|18529997|P2|Double Blind Treatment Period|Withdrawal by Subject|6
5385273|NCT03560518|18529998|P1|Double Blind Treatment Period|Withdrawal by Subject|10
5385274|NCT03560518|18529996|P3|Double Blind Treatment Period|Lost to Follow-up|6
5385275|NCT03560518|18529997|P2|Double Blind Treatment Period|Lost to Follow-up|6
5385276|NCT03560518|18529998|P1|Double Blind Treatment Period|Lost to Follow-up|5
5385277|NCT03560518|18529996|P3|Double Blind Treatment Period|Pregnancy|0
5385278|NCT03560518|18529997|P2|Double Blind Treatment Period|Pregnancy|2
5385279|NCT03560518|18529998|P1|Double Blind Treatment Period|Pregnancy|0
5385280|NCT03560518|18529996|P3|Double Blind Treatment Period|Protocol Violation|0
5385281|NCT03560518|18529997|P2|Double Blind Treatment Period|Protocol Violation|2
5385282|NCT03560518|18529998|P1|Double Blind Treatment Period|Protocol Violation|1
5385283|NCT03560518|18529996|P3|Double Blind Treatment Period|Study Terminated by the Sponsor|10
5385284|NCT03560518|18529997|P2|Double Blind Treatment Period|Study Terminated by the Sponsor|9
5385285|NCT03560518|18529998|P1|Double Blind Treatment Period|Study Terminated by the Sponsor|6
5385286|NCT03560518|18529996|P3|Double Blind Treatment Period|Miscellaneous Reasons|0
5385287|NCT03560518|18529997|P2|Double Blind Treatment Period|Miscellaneous Reasons|0
5385288|NCT03560518|18529998|P1|Double Blind Treatment Period|Miscellaneous Reasons|1
5385289|NCT03560245|18530011|P2|Overall Study|Other|1
5385290|NCT03560245|18530012|P1|Overall Study|Other|0
5385291|NCT03560245|18530011|P2|Overall Study|Physician Decision|1
5385292|NCT03560245|18530012|P1|Overall Study|Physician Decision|0
5385293|NCT03560245|18530011|P2|Overall Study|Lost to Follow-up|1
5385294|NCT03560245|18530012|P1|Overall Study|Lost to Follow-up|0
5385295|NCT03560245|18530011|P2|Overall Study|Death|1
5385296|NCT03560245|18530012|P1|Overall Study|Death|0
5385297|NCT03560245|18530011|P2|Overall Study|Protocol Violation|0
5385298|NCT03560245|18530012|P1|Overall Study|Protocol Violation|1
5385299|NCT03560245|18530011|P2|Overall Study|Adverse Event|1
5385300|NCT03560245|18530012|P1|Overall Study|Adverse Event|1
5385301|NCT03560245|18530011|P2|Overall Study|Withdrawal by Subject|2
5385302|NCT03560245|18530012|P1|Overall Study|Withdrawal by Subject|3
5385303|NCT03559257|18530066|P2|Open-label Treatment Period|Physician Decision|1
5385304|NCT03559257|18530067|P1|Open-label Treatment Period|Physician Decision|0
5385305|NCT03559257|18530066|P2|Open-label Treatment Period|Lost to Follow-up|0
5385306|NCT03559257|18530067|P1|Open-label Treatment Period|Lost to Follow-up|1
5385307|NCT03559257|18530066|P2|Open-label Treatment Period|Protocol Violation|0
5385308|NCT03559257|18530067|P1|Open-label Treatment Period|Protocol Violation|2
5385309|NCT03559257|18530066|P2|Open-label Treatment Period|Withdrawal by Subject|0
5385310|NCT03559257|18530067|P1|Open-label Treatment Period|Withdrawal by Subject|3
5385311|NCT03559257|18530066|P2|Open-label Treatment Period|Lack of Efficacy|2
5385312|NCT03559257|18530067|P1|Open-label Treatment Period|Lack of Efficacy|3
5385313|NCT03559257|18530066|P2|Open-label Treatment Period|Adverse Event|4
5385314|NCT03559257|18530067|P1|Open-label Treatment Period|Adverse Event|1
5385315|NCT03559257|18530066|P2|Double Blind Treatment Period|Screen Failure|1
5385316|NCT03559257|18530067|P1|Double Blind Treatment Period|Screen Failure|0
5385317|NCT03559257|18530066|P2|Double Blind Treatment Period|Adverse Event|1
5385318|NCT03559257|18530067|P1|Double Blind Treatment Period|Adverse Event|0
5385319|NCT03559257|18530066|P2|Double Blind Treatment Period|Lack of Efficacy|1
5385320|NCT03559257|18530067|P1|Double Blind Treatment Period|Lack of Efficacy|1
5385321|NCT03559257|18530066|P2|Double Blind Treatment Period|Protocol Violation|4
5385322|NCT03559257|18530067|P1|Double Blind Treatment Period|Protocol Violation|1
5385323|NCT03559257|18530066|P2|Double Blind Treatment Period|Withdrawal by Subject|1
5385324|NCT03559257|18530067|P1|Double Blind Treatment Period|Withdrawal by Subject|2
5385325|NCT03559062|18530137|P3|Overall Study|Other|0
5385326|NCT03559062|18530138|P2|Overall Study|Other|1
5385327|NCT03559062|18530139|P1|Overall Study|Other|0
5385328|NCT03558997|18530154|P4|Overall Study|Lost to Follow-up|0
5385329|NCT03558997|18530155|P3|Overall Study|Lost to Follow-up|1
5385330|NCT03558997|18530156|P2|Overall Study|Lost to Follow-up|0
5385331|NCT03558997|18530157|P1|Overall Study|Lost to Follow-up|0
5385332|NCT03558997|18530154|P4|Overall Study|Withdrawal by Subject|1
5385333|NCT03558997|18530155|P3|Overall Study|Withdrawal by Subject|1
5385334|NCT03558997|18530156|P2|Overall Study|Withdrawal by Subject|0
5385335|NCT03558997|18530157|P1|Overall Study|Withdrawal by Subject|1
5385336|NCT03558997|18530154|P4|Overall Study|Physician Decision|0
5385337|NCT03558997|18530155|P3|Overall Study|Physician Decision|1
5385338|NCT03558997|18530156|P2|Overall Study|Physician Decision|0
5385339|NCT03558997|18530157|P1|Overall Study|Physician Decision|0
5385340|NCT03558997|18530154|P4|Overall Study|Adverse Event|1
5385341|NCT03558997|18530155|P3|Overall Study|Adverse Event|5
5385342|NCT03558997|18530156|P2|Overall Study|Adverse Event|2
5385343|NCT03558997|18530157|P1|Overall Study|Adverse Event|0
5385344|NCT03558672|18530189|P1|Overall Study|Study Early Termination|10
5385345|NCT03558555|18530201|P2|Overall Study|Lost to Follow-up|1
5385346|NCT03558555|18530202|P1|Overall Study|Lost to Follow-up|2
5385347|NCT03558516|18530220|P2|Overall Study|Protocol Violation|2
5385348|NCT03558516|18530221|P1|Overall Study|Protocol Violation|2
5385349|NCT03557931|18530261|P3|Overall Study|Miscellaneous|3
5385350|NCT03557931|18530262|P2|Overall Study|Miscellaneous|5
5385351|NCT03557931|18530263|P1|Overall Study|Miscellaneous|8
5385352|NCT03557931|18530261|P3|Overall Study|Withdrawal by Subject|7
5385353|NCT03557931|18530262|P2|Overall Study|Withdrawal by Subject|0
5385354|NCT03557931|18530263|P1|Overall Study|Withdrawal by Subject|14
5385355|NCT03557931|18530261|P3|Overall Study|Protocol Violation|1
5385356|NCT03557931|18530262|P2|Overall Study|Protocol Violation|4
5385357|NCT03557931|18530263|P1|Overall Study|Protocol Violation|1
5385358|NCT03557931|18530261|P3|Overall Study|Lost to Follow-up|1
5385359|NCT03557931|18530262|P2|Overall Study|Lost to Follow-up|4
5385360|NCT03557931|18530263|P1|Overall Study|Lost to Follow-up|4
5385361|NCT03557931|18530261|P3|Overall Study|Adverse Event|1
5385362|NCT03557931|18530262|P2|Overall Study|Adverse Event|6
5385363|NCT03557931|18530263|P1|Overall Study|Adverse Event|4
5385364|NCT03557801|18530294|P3|Overall Study|Lost to Follow-up|0
5385365|NCT03557801|18530295|P2|Overall Study|Lost to Follow-up|1
5385366|NCT03557801|18530296|P1|Overall Study|Lost to Follow-up|0
5385367|NCT03557801|18530294|P3|Overall Study|Withdrawal by Subject|3
5385368|NCT03557801|18530295|P2|Overall Study|Withdrawal by Subject|0
5385369|NCT03557801|18530296|P1|Overall Study|Withdrawal by Subject|1
5385370|NCT03557801|18530294|P3|Overall Study|Protocol Violation|0
5385371|NCT03557801|18530295|P2|Overall Study|Protocol Violation|0
5385372|NCT03557801|18530296|P1|Overall Study|Protocol Violation|1
5385373|NCT03557775|18530313|P3|Overall Study|Physician Decision|0
5385374|NCT03557775|18530314|P2|Overall Study|Physician Decision|1
5385375|NCT03557775|18530315|P1|Overall Study|Physician Decision|0
5385376|NCT03557775|18530313|P3|Overall Study|Withdrawal by Subject|4
5385377|NCT03557775|18530314|P2|Overall Study|Withdrawal by Subject|2
5385378|NCT03557775|18530315|P1|Overall Study|Withdrawal by Subject|1
5385379|NCT03555890|18530446|P4|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5385380|NCT03555890|18530447|P3|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5385381|NCT03555890|18530448|P2|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5385382|NCT03555890|18530449|P1|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5385383|NCT03555565|18530583|P1|Overall Study|Protocol Deviation|13
5385384|NCT03555565|18530583|P1|Overall Study|Case Report Forms Uncollected|2
5385385|NCT03555435|18530593|P3|Overall Study|Lost to Follow-up|8
5385386|NCT03555435|18530594|P2|Overall Study|Lost to Follow-up|19
5385387|NCT03555435|18530595|P1|Overall Study|Lost to Follow-up|17
5385388|NCT03555305|18530606|P2|Period 1|Adverse Event|1
5385389|NCT03555305|18530607|P1|Period 1|Adverse Event|0
5385390|NCT03555305|18530606|P2|Period 1|Physician Decision|1
5385391|NCT03555305|18530607|P1|Period 1|Physician Decision|0
5385392|NCT03554629|18530689|P1|Overall Study|Inadequate data|6
5385393|NCT03554005|18530723|P6|Overall Study|Other|1
5385394|NCT03554005|18530724|P5|Overall Study|Other|0
5385395|NCT03554005|18530725|P4|Overall Study|Other|0
5385396|NCT03554005|18530726|P3|Overall Study|Other|0
5385397|NCT03554005|18530727|P2|Overall Study|Other|0
5385398|NCT03554005|18530728|P1|Overall Study|Other|0
5385399|NCT03554005|18530723|P6|Overall Study|Physician Decision|0
5385400|NCT03554005|18530724|P5|Overall Study|Physician Decision|1
5385401|NCT03554005|18530725|P4|Overall Study|Physician Decision|0
5385402|NCT03554005|18530726|P3|Overall Study|Physician Decision|0
5385403|NCT03554005|18530727|P2|Overall Study|Physician Decision|0
5385404|NCT03554005|18530728|P1|Overall Study|Physician Decision|0
5385405|NCT03554005|18530723|P6|Overall Study|Adverse Event|3
5385406|NCT03554005|18530724|P5|Overall Study|Adverse Event|0
5385407|NCT03554005|18530725|P4|Overall Study|Adverse Event|0
5385408|NCT03554005|18530726|P3|Overall Study|Adverse Event|0
5385409|NCT03554005|18530727|P2|Overall Study|Adverse Event|0
5385410|NCT03554005|18530728|P1|Overall Study|Adverse Event|0
5385411|NCT03554005|18530723|P6|Overall Study|Disease Progression|6
5385412|NCT03554005|18530724|P5|Overall Study|Disease Progression|5
5385413|NCT03554005|18530725|P4|Overall Study|Disease Progression|1
5385414|NCT03554005|18530726|P3|Overall Study|Disease Progression|1
5385415|NCT03554005|18530727|P2|Overall Study|Disease Progression|1
5385416|NCT03554005|18530728|P1|Overall Study|Disease Progression|1
5385417|NCT03554005|18530723|P6|Overall Study|Not in participant's best interest|1
5385418|NCT03554005|18530724|P5|Overall Study|Not in participant's best interest|0
5385419|NCT03554005|18530725|P4|Overall Study|Not in participant's best interest|0
5385420|NCT03554005|18530726|P3|Overall Study|Not in participant's best interest|0
5385421|NCT03554005|18530727|P2|Overall Study|Not in participant's best interest|0
5385422|NCT03554005|18530728|P1|Overall Study|Not in participant's best interest|0
5385423|NCT03553758|18530754|P1|Overall Study|Lost to Follow-up|1
5385424|NCT03552549|18530762|P2|Overall Study|Administrative|14
5385425|NCT03552549|18530763|P1|Overall Study|Administrative|0
5385426|NCT03552549|18530762|P2|Overall Study|Did not meet eligibility criteria|0
5385427|NCT03552549|18530763|P1|Overall Study|Did not meet eligibility criteria|1
5385428|NCT03552549|18530762|P2|Overall Study|Did not complete study treatment|3
5385429|NCT03552549|18530763|P1|Overall Study|Did not complete study treatment|2
5385430|NCT03552549|18530762|P2|Overall Study|Not in participant's best interest|1
5385431|NCT03552549|18530763|P1|Overall Study|Not in participant's best interest|2
5385432|NCT03552549|18530762|P2|Overall Study|Unknown (no reason provided)|2
5385433|NCT03552549|18530763|P1|Overall Study|Unknown (no reason provided)|4
5385434|NCT03552549|18530762|P2|Overall Study|Withdrawal by Subject|7
5385435|NCT03552549|18530763|P1|Overall Study|Withdrawal by Subject|7
5385436|NCT03552549|18530762|P2|Overall Study|Adverse event in first 12 months|8
5385437|NCT03552549|18530763|P1|Overall Study|Adverse event in first 12 months|12
5385438|NCT03552549|18530762|P2|Overall Study|Disease progression|17
5385439|NCT03552549|18530763|P1|Overall Study|Disease progression|25
5385440|NCT03552523|18530801|P2|Overall Study|Withdrawal by Subject|1
5385441|NCT03552523|18530802|P1|Overall Study|Withdrawal by Subject|1
5385442|NCT03551743|18530828|P4|Overall Study|Withdrawal by Subject|0
5385443|NCT03551743|18530829|P3|Overall Study|Withdrawal by Subject|0
5385444|NCT03551743|18530830|P2|Overall Study|Withdrawal by Subject|0
5385445|NCT03551743|18530831|P1|Overall Study|Withdrawal by Subject|1
5385446|NCT03551743|18530828|P4|Overall Study|Adverse Event|0
5385447|NCT03551743|18530829|P3|Overall Study|Adverse Event|0
5385448|NCT03551743|18530830|P2|Overall Study|Adverse Event|0
5385449|NCT03551743|18530831|P1|Overall Study|Adverse Event|1
5385450|NCT03551730|18530877|P4|Overall Study|Adverse Event|0
5385451|NCT03551730|18530878|P3|Overall Study|Adverse Event|0
5385452|NCT03551730|18530879|P2|Overall Study|Adverse Event|0
5385453|NCT03551730|18530880|P1|Overall Study|Adverse Event|1
5385454|NCT03550378|18531002|P2|Overall Study|Death|1
5385455|NCT03550378|18531003|P1|Overall Study|Death|0
5385456|NCT03549429|18531066|P2|Overall Study|Protocol Violation|3
5385457|NCT03549429|18531067|P1|Overall Study|Protocol Violation|5
5385458|NCT03549338|18531080|P3|Overall Study|Clinical Progression|0
5385459|NCT03549338|18531081|P2|Overall Study|Clinical Progression|1
5385460|NCT03549338|18531082|P1|Overall Study|Clinical Progression|0
5385461|NCT03549338|18531080|P3|Overall Study|Progressive Disease|0
5385462|NCT03549338|18531081|P2|Overall Study|Progressive Disease|0
5385463|NCT03549338|18531082|P1|Overall Study|Progressive Disease|1
5385464|NCT03549130|18531109|P2|Overall Study|Lost to Follow-up|1
5385465|NCT03549130|18531110|P1|Overall Study|Lost to Follow-up|0
5385466|NCT03549130|18531109|P2|Overall Study|Adverse Event|1
5385467|NCT03549130|18531110|P1|Overall Study|Adverse Event|0
5385468|NCT03549117|18531128|P2|Overall Study|Withdrawal by Subject|0
5385469|NCT03549117|18531129|P1|Overall Study|Withdrawal by Subject|1
5385470|NCT03548337|18531157|P2|Toddler Dose|Withdrawal by parent/guardian|1
5385471|NCT03548337|18531158|P1|Toddler Dose|Withdrawal by parent/guardian|1
5385472|NCT03548337|18531157|P2|Infant Series|Randomized but Not Vaccinated|0
5385473|NCT03548337|18531158|P1|Infant Series|Randomized but Not Vaccinated|1
5385474|NCT03548337|18531157|P2|Infant Series|Adverse Event|2
5385475|NCT03548337|18531158|P1|Infant Series|Adverse Event|0
5385476|NCT03548337|18531157|P2|Infant Series|Lost to Follow-up|1
5385477|NCT03548337|18531158|P1|Infant Series|Lost to Follow-up|2
5385478|NCT03548337|18531157|P2|Infant Series|No Longer Met Eligibility Criteria|0
5385479|NCT03548337|18531158|P1|Infant Series|No Longer Met Eligibility Criteria|1
5385480|NCT03548337|18531157|P2|Infant Series|Withdrawal by Parent/Guardian|8
5385481|NCT03548337|18531158|P1|Infant Series|Withdrawal by Parent/Guardian|8
5385482|NCT03547635|18531209|P3|Overall Study|Withdrawal by Subject|0
5385483|NCT03547635|18531210|P2|Overall Study|Withdrawal by Subject|0
5385484|NCT03547635|18531211|P1|Overall Study|Withdrawal by Subject|1
5385485|NCT03547635|18531209|P3|Overall Study|Errant Randomization before Treatment|0
5385486|NCT03547635|18531210|P2|Overall Study|Errant Randomization before Treatment|1
5385487|NCT03547635|18531211|P1|Overall Study|Errant Randomization before Treatment|0
5385488|NCT03547635|18531209|P3|Overall Study|Withdrawal by Sponsor|1
5385489|NCT03547635|18531210|P2|Overall Study|Withdrawal by Sponsor|0
5385490|NCT03547635|18531211|P1|Overall Study|Withdrawal by Sponsor|0
5385491|NCT03547635|18531209|P3|Overall Study|Withdrawal By PI|0
5385492|NCT03547635|18531210|P2|Overall Study|Withdrawal By PI|1
5385493|NCT03547635|18531211|P1|Overall Study|Withdrawal By PI|0
5385494|NCT03547635|18531209|P3|Overall Study|Withdrawal by Subject|0
5385495|NCT03547635|18531210|P2|Overall Study|Withdrawal by Subject|0
5385496|NCT03547635|18531211|P1|Overall Study|Withdrawal by Subject|1
5385497|NCT03547635|18531209|P3|Overall Study|Lost to Follow-up|4
5385498|NCT03547635|18531210|P2|Overall Study|Lost to Follow-up|3
5385499|NCT03547635|18531211|P1|Overall Study|Lost to Follow-up|1
5385500|NCT03547635|18531209|P3|Overall Study|Adverse Event|3
5385501|NCT03547635|18531210|P2|Overall Study|Adverse Event|2
5385502|NCT03547635|18531211|P1|Overall Study|Adverse Event|5
5385503|NCT03547583|18531222|P3|Overall Study|Other|3
5385504|NCT03547583|18531223|P2|Overall Study|Other|2
5385505|NCT03547583|18531224|P1|Overall Study|Other|2
5385506|NCT03547583|18531222|P3|Overall Study|Withdrawal by Subject|10
5385507|NCT03547583|18531223|P2|Overall Study|Withdrawal by Subject|19
5385508|NCT03547583|18531224|P1|Overall Study|Withdrawal by Subject|12
5385509|NCT03547583|18531222|P3|Overall Study|Protocol Violation|1
5385510|NCT03547583|18531223|P2|Overall Study|Protocol Violation|1
5385511|NCT03547583|18531224|P1|Overall Study|Protocol Violation|2
5385512|NCT03547583|18531222|P3|Overall Study|Physician Decision|3
5385513|NCT03547583|18531223|P2|Overall Study|Physician Decision|0
5385514|NCT03547583|18531224|P1|Overall Study|Physician Decision|1
5385515|NCT03547583|18531222|P3|Overall Study|Non-compliance with study drug|1
5385516|NCT03547583|18531223|P2|Overall Study|Non-compliance with study drug|0
5385517|NCT03547583|18531224|P1|Overall Study|Non-compliance with study drug|0
5385518|NCT03547583|18531222|P3|Overall Study|Lost to Follow-up|0
5385519|NCT03547583|18531223|P2|Overall Study|Lost to Follow-up|0
5385520|NCT03547583|18531224|P1|Overall Study|Lost to Follow-up|1
5385521|NCT03547583|18531222|P3|Overall Study|Death|4
5385522|NCT03547583|18531223|P2|Overall Study|Death|7
5385523|NCT03547583|18531224|P1|Overall Study|Death|11
5385524|NCT03547583|18531222|P3|Overall Study|Adverse Event|10
5385525|NCT03547583|18531223|P2|Overall Study|Adverse Event|11
5385526|NCT03547583|18531224|P1|Overall Study|Adverse Event|16
5385527|NCT03547531|18531240|P2|Overall Study|having family occasion|2
5385528|NCT03547531|18531241|P1|Overall Study|having family occasion|0
5385529|NCT03547531|18531240|P2|Overall Study|not coming in data collection : sick|2
5385530|NCT03547531|18531241|P1|Overall Study|not coming in data collection : sick|2
5385531|NCT03547154|18531255|P2|Overall Study|Continued treatment beyond 12 mo.|50
5385532|NCT03547154|18531256|P1|Overall Study|Continued treatment beyond 12 mo.|58
5385533|NCT03547154|18531255|P2|Overall Study|Not Selected|1
5385534|NCT03547154|18531256|P1|Overall Study|Not Selected|0
5385535|NCT03547154|18531255|P2|Overall Study|Withdrawal by Subject|6
5385536|NCT03547154|18531256|P1|Overall Study|Withdrawal by Subject|10
5385537|NCT03547154|18531255|P2|Overall Study|Insufficient Therapeutic Response|10
5385538|NCT03547154|18531256|P1|Overall Study|Insufficient Therapeutic Response|13
5385539|NCT03547154|18531255|P2|Overall Study|Physician Decision|3
5385540|NCT03547154|18531256|P1|Overall Study|Physician Decision|4
5385541|NCT03547154|18531255|P2|Overall Study|Protocol Violation|1
5385542|NCT03547154|18531256|P1|Overall Study|Protocol Violation|6
5385543|NCT03547154|18531255|P2|Overall Study|Adverse Event|31
5385544|NCT03547154|18531256|P1|Overall Study|Adverse Event|26
5385545|NCT03547154|18531255|P2|Overall Study|Disease Progression/Recurrence|14
5385546|NCT03547154|18531256|P1|Overall Study|Disease Progression/Recurrence|6
5385547|NCT03546842|18531268|P1|Overall Study|Withdrawal by Subject|2
5385548|NCT03546842|18531268|P1|Overall Study|Protocol Violation|1
5385549|NCT03546816|18531279|P2|Overall Study|Lost to Follow-up|2
5385550|NCT03546816|18531280|P1|Overall Study|Lost to Follow-up|3
5385551|NCT03546816|18531279|P2|Overall Study|Withdrawal by Subject|10
5385552|NCT03546816|18531280|P1|Overall Study|Withdrawal by Subject|8
5385553|NCT03546816|18531279|P2|Overall Study|Physician Decision|0
5385554|NCT03546816|18531280|P1|Overall Study|Physician Decision|2
5385555|NCT03546816|18531279|P2|Overall Study|Pregnancy|0
5385556|NCT03546816|18531280|P1|Overall Study|Pregnancy|1
5385557|NCT03546816|18531279|P2|Overall Study|Lack of Efficacy|4
5385558|NCT03546816|18531280|P1|Overall Study|Lack of Efficacy|2
5385559|NCT03546816|18531279|P2|Overall Study|Adverse Event|3
5385560|NCT03546816|18531280|P1|Overall Study|Adverse Event|5
5385561|NCT03546621|18531308|P4|Overall Study|Progressive disease|1
5385562|NCT03546621|18531309|P3|Overall Study|Progressive disease|0
5385563|NCT03546621|18531310|P2|Overall Study|Progressive disease|0
5385564|NCT03546621|18531311|P1|Overall Study|Progressive disease|0
5385565|NCT03546621|18531308|P4|Overall Study|Adverse Event|1
5385566|NCT03546621|18531309|P3|Overall Study|Adverse Event|0
5385567|NCT03546621|18531310|P2|Overall Study|Adverse Event|1
5385568|NCT03546621|18531311|P1|Overall Study|Adverse Event|0
5385569|NCT03546621|18531308|P4|Overall Study|Lost to Follow-up|0
5385570|NCT03546621|18531309|P3|Overall Study|Lost to Follow-up|0
5385571|NCT03546621|18531310|P2|Overall Study|Lost to Follow-up|1
5385572|NCT03546621|18531311|P1|Overall Study|Lost to Follow-up|0
5385573|NCT03546621|18531308|P4|Overall Study|Withdrawal by Subject|1
5385574|NCT03546621|18531309|P3|Overall Study|Withdrawal by Subject|2
5385575|NCT03546621|18531310|P2|Overall Study|Withdrawal by Subject|1
5385576|NCT03546621|18531311|P1|Overall Study|Withdrawal by Subject|0
5385577|NCT03545984|18531401|P2|Overall Study|CSF cases not present during rotation|9
5385578|NCT03545984|18531402|P1|Overall Study|CSF cases not present during rotation|11
5385579|NCT03543137|18531566|P2|Study Period 2: Up to Day 8|Adverse Event|1
5385580|NCT03543137|18531567|P1|Study Period 2: Up to Day 8|Adverse Event|0
5385581|NCT03543137|18531566|P2|Study Period 2: Up to Day 8|Protocol Violation|0
5385582|NCT03543137|18531567|P1|Study Period 2: Up to Day 8|Protocol Violation|1
5385583|NCT03543137|18531566|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
5385584|NCT03543137|18531567|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
5385585|NCT03541044|18531668|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
5385586|NCT03541044|18531669|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
5385587|NCT03541044|18531668|P2|Study Period 2: Up to Day 8|Protocol Violation|0
5385588|NCT03541044|18531669|P1|Study Period 2: Up to Day 8|Protocol Violation|1
5385589|NCT03540160|18531689|P1|Overall Study|Sponsor decision|191
5385590|NCT03540160|18531689|P1|Overall Study|Lost to Follow-up|18
5385591|NCT03540160|18531689|P1|Overall Study|Study Closure|10
5385592|NCT03540160|18531689|P1|Overall Study|COVID-19|2
5385593|NCT03540160|18531689|P1|Overall Study|Withdrawal by Subject|68
5385594|NCT03540160|18531689|P1|Overall Study|Adverse Event|20
5385595|NCT03540160|18531689|P1|Overall Study|Pregnancy|1
5385596|NCT03540160|18531689|P1|Overall Study|Lack of Efficacy|60
5385597|NCT03540160|18531689|P1|Overall Study|Physician Decision|8
5385598|NCT03540160|18531689|P1|Overall Study|Protocol Violation|1
5385599|NCT03540030|18531695|P2|Overall Study|never had surgery after signing consent|1
5385600|NCT03540030|18531696|P1|Overall Study|never had surgery after signing consent|9
5385601|NCT03540030|18531695|P2|Overall Study|screen fail|1
5385602|NCT03540030|18531696|P1|Overall Study|screen fail|7
5385603|NCT03540030|18531695|P2|Overall Study|Withdrawal by Subject|1
5385604|NCT03540030|18531696|P1|Overall Study|Withdrawal by Subject|2
5385605|NCT03539549|18531732|P1|Overall Study|Reason not Specified|1
5385606|NCT03539549|18531732|P1|Overall Study|Progressive Disease|1
5385607|NCT03539549|18531732|P1|Overall Study|Death|2
5385608|NCT03539549|18531732|P1|Overall Study|Lost to Follow-up|1
5385609|NCT03539549|18531732|P1|Overall Study|Adverse Event|12
5385610|NCT03539484|18531747|P7|Overall Study|Study Terminated by Sponsor|1
5385611|NCT03539484|18531748|P6|Overall Study|Study Terminated by Sponsor|2
5385612|NCT03539484|18531749|P5|Overall Study|Study Terminated by Sponsor|2
5385613|NCT03539484|18531750|P4|Overall Study|Study Terminated by Sponsor|1
5385614|NCT03539484|18531751|P3|Overall Study|Study Terminated by Sponsor|1
5385615|NCT03539484|18531752|P2|Overall Study|Study Terminated by Sponsor|0
5385616|NCT03539484|18531753|P1|Overall Study|Study Terminated by Sponsor|0
5385617|NCT03539484|18531747|P7|Overall Study|Withdrawal by Subject|1
5385618|NCT03539484|18531748|P6|Overall Study|Withdrawal by Subject|0
5385619|NCT03539484|18531749|P5|Overall Study|Withdrawal by Subject|2
5385620|NCT03539484|18531750|P4|Overall Study|Withdrawal by Subject|0
5385621|NCT03539484|18531751|P3|Overall Study|Withdrawal by Subject|0
5385622|NCT03539484|18531752|P2|Overall Study|Withdrawal by Subject|0
5385623|NCT03539484|18531753|P1|Overall Study|Withdrawal by Subject|0
5385624|NCT03539484|18531747|P7|Overall Study|Lost to Follow-up|0
5385625|NCT03539484|18531748|P6|Overall Study|Lost to Follow-up|0
5385626|NCT03539484|18531749|P5|Overall Study|Lost to Follow-up|1
5385627|NCT03539484|18531750|P4|Overall Study|Lost to Follow-up|0
5385628|NCT03539484|18531751|P3|Overall Study|Lost to Follow-up|0
5385629|NCT03539484|18531752|P2|Overall Study|Lost to Follow-up|1
5385630|NCT03539484|18531753|P1|Overall Study|Lost to Follow-up|0
5385631|NCT03539484|18531747|P7|Overall Study|Death|0
5385632|NCT03539484|18531748|P6|Overall Study|Death|3
5385633|NCT03539484|18531749|P5|Overall Study|Death|8
5385634|NCT03539484|18531750|P4|Overall Study|Death|2
5385635|NCT03539484|18531751|P3|Overall Study|Death|0
5385636|NCT03539484|18531752|P2|Overall Study|Death|0
5385637|NCT03539484|18531753|P1|Overall Study|Death|1
5385638|NCT03538743|18531938|P9|Overall Study|Withdrawal by Subject|0
5385639|NCT03538743|18531939|P8|Overall Study|Withdrawal by Subject|0
5385640|NCT03538743|18531940|P7|Overall Study|Withdrawal by Subject|0
5385641|NCT03538743|18531941|P6|Overall Study|Withdrawal by Subject|0
5385642|NCT03538743|18531942|P5|Overall Study|Withdrawal by Subject|0
5385643|NCT03538743|18531943|P4|Overall Study|Withdrawal by Subject|1
5385644|NCT03538743|18531944|P3|Overall Study|Withdrawal by Subject|0
5385645|NCT03538743|18531945|P2|Overall Study|Withdrawal by Subject|0
5385646|NCT03538743|18531946|P1|Overall Study|Withdrawal by Subject|0
5385647|NCT03538743|18531938|P9|Overall Study|Non-Treatment-Related Reasons|3
5385648|NCT03538743|18531939|P8|Overall Study|Non-Treatment-Related Reasons|0
5385649|NCT03538743|18531940|P7|Overall Study|Non-Treatment-Related Reasons|0
5385650|NCT03538743|18531941|P6|Overall Study|Non-Treatment-Related Reasons|0
5385651|NCT03538743|18531942|P5|Overall Study|Non-Treatment-Related Reasons|0
5385652|NCT03538743|18531943|P4|Overall Study|Non-Treatment-Related Reasons|0
5385653|NCT03538743|18531944|P3|Overall Study|Non-Treatment-Related Reasons|0
5385654|NCT03538743|18531945|P2|Overall Study|Non-Treatment-Related Reasons|0
5385655|NCT03538743|18531946|P1|Overall Study|Non-Treatment-Related Reasons|0
5385656|NCT03538743|18531938|P9|Overall Study|Adverse Event|0
5385657|NCT03538743|18531939|P8|Overall Study|Adverse Event|0
5385658|NCT03538743|18531940|P7|Overall Study|Adverse Event|0
5385659|NCT03538743|18531941|P6|Overall Study|Adverse Event|0
5385660|NCT03538743|18531942|P5|Overall Study|Adverse Event|0
5385661|NCT03538743|18531943|P4|Overall Study|Adverse Event|1
5385662|NCT03538743|18531944|P3|Overall Study|Adverse Event|1
5385663|NCT03538743|18531945|P2|Overall Study|Adverse Event|0
5385664|NCT03538743|18531946|P1|Overall Study|Adverse Event|0
5385665|NCT03536949|18532226|P2|Overall Study|Non-compliance|1
5385666|NCT03536949|18532227|P1|Overall Study|Non-compliance|2
5385667|NCT03536949|18532226|P2|Overall Study|Withdrawal by Subject|0
5385668|NCT03536949|18532227|P1|Overall Study|Withdrawal by Subject|6
5385669|NCT03536949|18532226|P2|Overall Study|Lost to Follow-up|1
5385670|NCT03536949|18532227|P1|Overall Study|Lost to Follow-up|2
5385671|NCT03536949|18532226|P2|Overall Study|Adverse Event|0
5385672|NCT03536949|18532227|P1|Overall Study|Adverse Event|4
5385673|NCT03536663|18532290|P1|Endexo|Protocol Violation|1
5385674|NCT03535974|18532308|P3|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
5385675|NCT03535974|18532309|P2|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
5385676|NCT03535974|18532310|P1|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
5385677|NCT03535974|18532308|P3|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
5385678|NCT03535974|18532309|P2|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
5385679|NCT03535974|18532310|P1|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
5385680|NCT03535844|18532320|P2|Overall Study|Withdrawal by Subject|1
5385681|NCT03535844|18532321|P1|Overall Study|Withdrawal by Subject|0
5385682|NCT03532048|18532609|P2|Overall Study|Withdrawal by Subject|0
5385683|NCT03532048|18532610|P1|Overall Study|Withdrawal by Subject|7
5385684|NCT03532048|18532609|P2|Overall Study|Lost to Follow-up|17
5385685|NCT03532048|18532610|P1|Overall Study|Lost to Follow-up|12
5385686|NCT03531905|18532627|P3|Overall Study|Could not speak with the participant|0
5385687|NCT03531905|18532628|P2|Overall Study|Could not speak with the participant|0
5385688|NCT03531905|18532629|P1|Overall Study|Could not speak with the participant|1
5385689|NCT03531905|18532627|P3|Overall Study|Participant was out of town|0
5385690|NCT03531905|18532628|P2|Overall Study|Participant was out of town|0
5385691|NCT03531905|18532629|P1|Overall Study|Participant was out of town|1
5385692|NCT03531905|18532627|P3|Overall Study|Lost to Follow-up|1
5385693|NCT03531905|18532628|P2|Overall Study|Lost to Follow-up|2
5385694|NCT03531905|18532629|P1|Overall Study|Lost to Follow-up|2
5385695|NCT03531905|18532627|P3|Overall Study|Withdrawal by Subject|2
5385696|NCT03531905|18532628|P2|Overall Study|Withdrawal by Subject|3
5385697|NCT03531905|18532629|P1|Overall Study|Withdrawal by Subject|3
5385698|NCT03530345|18532823|P2|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
5385699|NCT03530345|18532824|P1|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
5385700|NCT03530345|18532823|P2|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
5385701|NCT03530345|18532824|P1|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
5385702|NCT03530345|18532823|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
5385703|NCT03530345|18532824|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
5385704|NCT03530345|18532823|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
5385705|NCT03530345|18532824|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
5385706|NCT03529942|18532857|P1|Overall Study|Personal reasons|1
5385707|NCT03529942|18532857|P1|Overall Study|Needle inserted but no drug administered|1
5385708|NCT03529942|18532857|P1|Overall Study|Lost to Follow-up|7
5385709|NCT03529942|18532857|P1|Overall Study|Physician Decision|1
5385710|NCT03529942|18532857|P1|Overall Study|Withdrawal by Subject|13
5385711|NCT03528369|18532884|P3|Overall Study|Adverse Event|0
5385712|NCT03528369|18532885|P2|Overall Study|Adverse Event|1
5385713|NCT03528369|18532886|P1|Overall Study|Adverse Event|0
5385714|NCT03528369|18532884|P3|Overall Study|Lost to Follow-up|0
5385715|NCT03528369|18532885|P2|Overall Study|Lost to Follow-up|0
5385716|NCT03528369|18532886|P1|Overall Study|Lost to Follow-up|1
5385717|NCT03528369|18532884|P3|Overall Study|Withdrawal by Subject|0
5385718|NCT03528369|18532885|P2|Overall Study|Withdrawal by Subject|0
5385719|NCT03528369|18532886|P1|Overall Study|Withdrawal by Subject|2
5385720|NCT03528174|18532915|P1|Overall Study|sensors dislodged|1
5385721|NCT03528174|18532915|P1|Overall Study|Adverse Event|1
5385722|NCT03527966|18532935|P2|Overall Study|Lost to Follow-up|0
5385723|NCT03527966|18532936|P1|Overall Study|Lost to Follow-up|3
5385724|NCT03527173|18532950|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
5385725|NCT03527173|18532951|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
5385726|NCT03527173|18532950|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
5385727|NCT03527173|18532951|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
5385728|NCT03527173|18532950|P2|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
5385729|NCT03527173|18532951|P1|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
5385730|NCT03527173|18532950|P2|Overall Study|Lost to Follow-up|2
5385731|NCT03527173|18532951|P1|Overall Study|Lost to Follow-up|4
5385732|NCT03525678|18533011|P3|Overall Study|Death|4
5385733|NCT03525678|18533012|P2|Overall Study|Death|31
5385734|NCT03525678|18533013|P1|Overall Study|Death|32
5385735|NCT03525678|18533011|P3|Overall Study|Lost to Follow-up|0
5385736|NCT03525678|18533012|P2|Overall Study|Lost to Follow-up|0
5385737|NCT03525678|18533013|P1|Overall Study|Lost to Follow-up|1
5385738|NCT03525678|18533011|P3|Overall Study|Physician Decision|0
5385739|NCT03525678|18533012|P2|Overall Study|Physician Decision|2
5385740|NCT03525678|18533013|P1|Overall Study|Physician Decision|1
5385741|NCT03525678|18533011|P3|Overall Study|Withdrawal by Subject|0
5385742|NCT03525678|18533012|P2|Overall Study|Withdrawal by Subject|1
5385743|NCT03525678|18533013|P1|Overall Study|Withdrawal by Subject|3
5385744|NCT03525678|18533011|P3|Overall Study|Ongoing at the time of interim analysis|21
5385745|NCT03525678|18533012|P2|Overall Study|Ongoing at the time of interim analysis|65
5385746|NCT03525678|18533013|P1|Overall Study|Ongoing at the time of interim analysis|60
5385747|NCT03525444|18533215|P2|Overall Study|Other|1
5385748|NCT03525444|18533216|P1|Overall Study|Other|0
5385749|NCT03525444|18533215|P2|Overall Study|Withdrawal of consent (not due to AE)|1
5385750|NCT03525444|18533216|P1|Overall Study|Withdrawal of consent (not due to AE)|0
5385751|NCT03525444|18533215|P2|Overall Study|Adverse Event|1
5385752|NCT03525444|18533216|P1|Overall Study|Adverse Event|0
5385753|NCT03525119|18533259|P3|Overall Study|Randomized but not Vaccinated|2
5385754|NCT03525119|18533260|P2|Overall Study|Randomized but not Vaccinated|0
5385755|NCT03525119|18533261|P1|Overall Study|Randomized but not Vaccinated|1
5385756|NCT03525119|18533259|P3|Overall Study|Reason not Specified|2
5385757|NCT03525119|18533260|P2|Overall Study|Reason not Specified|1
5385758|NCT03525119|18533261|P1|Overall Study|Reason not Specified|2
5385759|NCT03525119|18533259|P3|Overall Study|Withdrawal by Subject|2
5385760|NCT03525119|18533260|P2|Overall Study|Withdrawal by Subject|4
5385761|NCT03525119|18533261|P1|Overall Study|Withdrawal by Subject|5
5385762|NCT03525119|18533259|P3|Overall Study|Lost to Follow-up|37
5385763|NCT03525119|18533260|P2|Overall Study|Lost to Follow-up|33
5385764|NCT03525119|18533261|P1|Overall Study|Lost to Follow-up|32
5385765|NCT03525119|18533259|P3|Overall Study|Adverse Event|0
5385766|NCT03525119|18533260|P2|Overall Study|Adverse Event|1
5385767|NCT03525119|18533261|P1|Overall Study|Adverse Event|0
5385768|NCT03524157|18533296|P3|Overall Study|cytology not readable|1
5385769|NCT03524157|18533297|P2|Overall Study|cytology not readable|0
5385770|NCT03524157|18533298|P1|Overall Study|cytology not readable|0
5385771|NCT03522675|18533352|P1|Overall Study|Non-reactive to histamine|1
5385772|NCT03522675|18533352|P1|Overall Study|Screen fail|1
5385773|NCT03522506|18533370|P4|Washout Period 2 (7 Days)|Withdrawal by Subject|1
5385774|NCT03522506|18533371|P3|Washout Period 2 (7 Days)|Withdrawal by Subject|0
5385775|NCT03522506|18533372|P2|Washout Period 2 (7 Days)|Withdrawal by Subject|0
5385776|NCT03522506|18533373|P1|Washout Period 2 (7 Days)|Withdrawal by Subject|0
5385777|NCT03522506|18533370|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5385778|NCT03522506|18533371|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5385779|NCT03522506|18533372|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5385780|NCT03522506|18533373|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5385781|NCT03521817|18533451|P2|Overall Study|Protocol Violation|1
5385782|NCT03521817|18533452|P1|Overall Study|Protocol Violation|0
5385783|NCT03521791|18533460|P2|Overall Study|Protocol Violation|17
5385784|NCT03521791|18533461|P1|Overall Study|Protocol Violation|7
5385785|NCT03521141|18533488|P3|Overall Study|Death|1
5385786|NCT03521141|18533489|P2|Overall Study|Death|0
5385787|NCT03521141|18533490|P1|Overall Study|Death|1
5385788|NCT03520959|18533557|P2|Overall Study|Study terminated by Sponsor|1
5385789|NCT03520959|18533558|P1|Overall Study|Study terminated by Sponsor|0
5385790|NCT03519932|18533605|P2|First Intervention|Adverse Event|3
5385791|NCT03519932|18533606|P1|First Intervention|Adverse Event|1
5385792|NCT03519919|18533632|P1|Overall Study|Screen Failure|1
5385793|NCT03519919|18533632|P1|Overall Study|Lack of Efficacy|1
5385794|NCT03519919|18533632|P1|Overall Study|Withdrawal by Subject|1
5385795|NCT03519867|18533684|P10|Overall Study|Reason not provided|0
5385796|NCT03519867|18533685|P9|Overall Study|Reason not provided|1
5385797|NCT03519867|18533686|P8|Overall Study|Reason not provided|1
5385798|NCT03519867|18533687|P7|Overall Study|Reason not provided|0
5385799|NCT03519867|18533688|P6|Overall Study|Reason not provided|1
5385800|NCT03519867|18533689|P5|Overall Study|Reason not provided|0
5385801|NCT03519867|18533690|P4|Overall Study|Reason not provided|1
5385802|NCT03519867|18533691|P3|Overall Study|Reason not provided|1
5385803|NCT03519867|18533692|P2|Overall Study|Reason not provided|1
5385804|NCT03519867|18533693|P1|Overall Study|Reason not provided|1
5385805|NCT03519867|18533684|P10|Overall Study|Admin. of other reversal agent|0
5385806|NCT03519867|18533685|P9|Overall Study|Admin. of other reversal agent|0
5385807|NCT03519867|18533686|P8|Overall Study|Admin. of other reversal agent|0
5385808|NCT03519867|18533687|P7|Overall Study|Admin. of other reversal agent|0
5385809|NCT03519867|18533688|P6|Overall Study|Admin. of other reversal agent|1
5385810|NCT03519867|18533689|P5|Overall Study|Admin. of other reversal agent|0
5385811|NCT03519867|18533690|P4|Overall Study|Admin. of other reversal agent|0
5385812|NCT03519867|18533691|P3|Overall Study|Admin. of other reversal agent|0
5385813|NCT03519867|18533692|P2|Overall Study|Admin. of other reversal agent|1
5385814|NCT03519867|18533693|P1|Overall Study|Admin. of other reversal agent|1
5385815|NCT03519867|18533684|P10|Overall Study|Admin. of relaxant other than Zemuron®|0
5385816|NCT03519867|18533685|P9|Overall Study|Admin. of relaxant other than Zemuron®|0
5385817|NCT03519867|18533686|P8|Overall Study|Admin. of relaxant other than Zemuron®|0
5385818|NCT03519867|18533687|P7|Overall Study|Admin. of relaxant other than Zemuron®|1
5385819|NCT03519867|18533688|P6|Overall Study|Admin. of relaxant other than Zemuron®|0
5385820|NCT03519867|18533689|P5|Overall Study|Admin. of relaxant other than Zemuron®|0
5385821|NCT03519867|18533690|P4|Overall Study|Admin. of relaxant other than Zemuron®|0
5385822|NCT03519867|18533691|P3|Overall Study|Admin. of relaxant other than Zemuron®|0
5385823|NCT03519867|18533692|P2|Overall Study|Admin. of relaxant other than Zemuron®|0
5385824|NCT03519867|18533693|P1|Overall Study|Admin. of relaxant other than Zemuron®|0
5385825|NCT03519867|18533684|P10|Overall Study|Protocol Violation|0
5385826|NCT03519867|18533685|P9|Overall Study|Protocol Violation|0
5385827|NCT03519867|18533686|P8|Overall Study|Protocol Violation|0
5385828|NCT03519867|18533687|P7|Overall Study|Protocol Violation|0
5385829|NCT03519867|18533688|P6|Overall Study|Protocol Violation|1
5385830|NCT03519867|18533689|P5|Overall Study|Protocol Violation|0
5385831|NCT03519867|18533690|P4|Overall Study|Protocol Violation|0
5385832|NCT03519867|18533691|P3|Overall Study|Protocol Violation|0
5385833|NCT03519867|18533692|P2|Overall Study|Protocol Violation|0
5385834|NCT03519867|18533693|P1|Overall Study|Protocol Violation|0
5385835|NCT03519867|18533684|P10|Overall Study|Adverse Event|0
5385836|NCT03519867|18533685|P9|Overall Study|Adverse Event|0
5385837|NCT03519867|18533686|P8|Overall Study|Adverse Event|0
5385838|NCT03519867|18533687|P7|Overall Study|Adverse Event|0
5385839|NCT03519867|18533688|P6|Overall Study|Adverse Event|0
5385840|NCT03519867|18533689|P5|Overall Study|Adverse Event|0
5385841|NCT03519867|18533690|P4|Overall Study|Adverse Event|0
5385842|NCT03519867|18533691|P3|Overall Study|Adverse Event|0
5385843|NCT03519867|18533692|P2|Overall Study|Adverse Event|1
5385844|NCT03519867|18533693|P1|Overall Study|Adverse Event|1
5385845|NCT03519854|18533743|P18|Overall Study|Technical Error|0
5385846|NCT03519854|18533744|P17|Overall Study|Technical Error|0
5385847|NCT03519854|18533745|P16|Overall Study|Technical Error|0
5385848|NCT03519854|18533746|P15|Overall Study|Technical Error|0
5385849|NCT03519854|18533747|P14|Overall Study|Technical Error|0
5385850|NCT03519854|18533748|P13|Overall Study|Technical Error|0
5385851|NCT03519854|18533749|P12|Overall Study|Technical Error|0
5385852|NCT03519854|18533750|P11|Overall Study|Technical Error|0
5385853|NCT03519854|18533751|P10|Overall Study|Technical Error|0
5385854|NCT03519854|18533752|P9|Overall Study|Technical Error|0
5385855|NCT03519854|18533753|P8|Overall Study|Technical Error|0
5385856|NCT03519854|18533754|P7|Overall Study|Technical Error|0
5385857|NCT03519854|18533755|P6|Overall Study|Technical Error|0
5385858|NCT03519854|18533756|P5|Overall Study|Technical Error|0
5385859|NCT03519854|18533757|P4|Overall Study|Technical Error|0
5385860|NCT03519854|18533758|P3|Overall Study|Technical Error|1
5385861|NCT03519854|18533759|P2|Overall Study|Technical Error|0
5385862|NCT03519854|18533760|P1|Overall Study|Technical Error|0
5385863|NCT03519516|18533926|P2|Overall Study|Adverse Event|1
5385864|NCT03519516|18533927|P1|Overall Study|Adverse Event|0
5385865|NCT03519204|18534001|P2|Overall Study|Other Miscellaneous Reasons|0
5385866|NCT03519204|18534002|P1|Overall Study|Other Miscellaneous Reasons|1
5385867|NCT03519204|18534001|P2|Overall Study|Withdrawal by Subject|7
5385868|NCT03519204|18534002|P1|Overall Study|Withdrawal by Subject|9
5385869|NCT03519204|18534001|P2|Overall Study|Lost to Follow-up|8
5385870|NCT03519204|18534002|P1|Overall Study|Lost to Follow-up|3
5385871|NCT03519087|18534021|P5|Laboratory Testing|Protocol Violation|0
5385872|NCT03519087|18534022|P4|Laboratory Testing|Protocol Violation|1
5385873|NCT03519087|18534023|P3|Laboratory Testing|Protocol Violation|0
5385874|NCT03519087|18534024|P2|Laboratory Testing|Protocol Violation|0
5385875|NCT03519087|18534025|P1|Laboratory Testing|Protocol Violation|0
5385876|NCT03519087|18534021|P5|Laboratory Testing|Lost to Follow-up|6
5385877|NCT03519087|18534022|P4|Laboratory Testing|Lost to Follow-up|3
5385878|NCT03519087|18534023|P3|Laboratory Testing|Lost to Follow-up|2
5385879|NCT03519087|18534024|P2|Laboratory Testing|Lost to Follow-up|0
5385880|NCT03519087|18534025|P1|Laboratory Testing|Lost to Follow-up|0
5385881|NCT03519087|18534021|P5|Re-randomization for Treatment|Not appropriate|0
5385882|NCT03519087|18534022|P4|Re-randomization for Treatment|Not appropriate|0
5385883|NCT03519087|18534023|P3|Re-randomization for Treatment|Not appropriate|0
5385884|NCT03519087|18534024|P2|Re-randomization for Treatment|Not appropriate|3
5385885|NCT03519087|18534025|P1|Re-randomization for Treatment|Not appropriate|2
5385886|NCT03519087|18534021|P5|Re-randomization for Treatment|Withdrawal by Subject|0
5385887|NCT03519087|18534022|P4|Re-randomization for Treatment|Withdrawal by Subject|0
5385888|NCT03519087|18534023|P3|Re-randomization for Treatment|Withdrawal by Subject|0
5385889|NCT03519087|18534024|P2|Re-randomization for Treatment|Withdrawal by Subject|29
5385890|NCT03519087|18534025|P1|Re-randomization for Treatment|Withdrawal by Subject|25
5385891|NCT03519087|18534021|P5|Clinic Evaluation|Protocol Violation|0
5385892|NCT03519087|18534022|P4|Clinic Evaluation|Protocol Violation|0
5385893|NCT03519087|18534023|P3|Clinic Evaluation|Protocol Violation|0
5385894|NCT03519087|18534024|P2|Clinic Evaluation|Protocol Violation|0
5385895|NCT03519087|18534025|P1|Clinic Evaluation|Protocol Violation|1
5385896|NCT03519087|18534021|P5|Clinic Evaluation|Physician Decision|0
5385897|NCT03519087|18534022|P4|Clinic Evaluation|Physician Decision|0
5385898|NCT03519087|18534023|P3|Clinic Evaluation|Physician Decision|0
5385899|NCT03519087|18534024|P2|Clinic Evaluation|Physician Decision|18
5385900|NCT03519087|18534025|P1|Clinic Evaluation|Physician Decision|15
5385901|NCT03518840|18534061|P1|Overall Study|Lost to Follow-up|6
5385902|NCT03518125|18534074|P6|Overall Study|Missed Day 394 Visit|0
5385903|NCT03518125|18534075|P5|Overall Study|Missed Day 394 Visit|0
5385904|NCT03518125|18534076|P4|Overall Study|Missed Day 394 Visit|0
5385905|NCT03518125|18534077|P3|Overall Study|Missed Day 394 Visit|0
5385906|NCT03518125|18534078|P2|Overall Study|Missed Day 394 Visit|0
5385907|NCT03518125|18534079|P1|Overall Study|Missed Day 394 Visit|1
5385908|NCT03518125|18534074|P6|Overall Study|Withdrawal by Subject|3
5385909|NCT03518125|18534075|P5|Overall Study|Withdrawal by Subject|1
5385910|NCT03518125|18534076|P4|Overall Study|Withdrawal by Subject|1
5385911|NCT03518125|18534077|P3|Overall Study|Withdrawal by Subject|0
5385912|NCT03518125|18534078|P2|Overall Study|Withdrawal by Subject|1
5385913|NCT03518125|18534079|P1|Overall Study|Withdrawal by Subject|1
5385914|NCT03518125|18534074|P6|Overall Study|Physician Decision|0
5385915|NCT03518125|18534075|P5|Overall Study|Physician Decision|0
5385916|NCT03518125|18534076|P4|Overall Study|Physician Decision|0
5385917|NCT03518125|18534077|P3|Overall Study|Physician Decision|0
5385918|NCT03518125|18534078|P2|Overall Study|Physician Decision|1
5385919|NCT03518125|18534079|P1|Overall Study|Physician Decision|0
5385920|NCT03518125|18534074|P6|Overall Study|Lost to Follow-up|5
5385921|NCT03518125|18534075|P5|Overall Study|Lost to Follow-up|3
5385922|NCT03518125|18534076|P4|Overall Study|Lost to Follow-up|0
5385923|NCT03518125|18534077|P3|Overall Study|Lost to Follow-up|0
5385924|NCT03518125|18534078|P2|Overall Study|Lost to Follow-up|2
5385925|NCT03518125|18534079|P1|Overall Study|Lost to Follow-up|0
5385926|NCT03518008|18534177|P2|Period 2, Second Week of Wear|Family emergency|1
5385927|NCT03518008|18534178|P1|Period 2, Second Week of Wear|Family emergency|0
5385928|NCT03515941|18534203|P2|Overall Study|Adverse Event|0
5385929|NCT03515941|18534204|P1|Overall Study|Adverse Event|1
5385930|NCT03513588|18534272|P3|Overall Study|Death|1
5385931|NCT03513588|18534273|P2|Overall Study|Death|0
5385932|NCT03513588|18534274|P1|Overall Study|Death|0
5385933|NCT03513588|18534272|P3|Overall Study|Study dosing paused by sponsor|0
5385934|NCT03513588|18534273|P2|Overall Study|Study dosing paused by sponsor|1
5385935|NCT03513588|18534274|P1|Overall Study|Study dosing paused by sponsor|1
5385936|NCT03513588|18534272|P3|Overall Study|Lost to Follow-up|1
5385937|NCT03513588|18534273|P2|Overall Study|Lost to Follow-up|1
5385938|NCT03513588|18534274|P1|Overall Study|Lost to Follow-up|0
5385939|NCT03512028|18534349|P2|Overall Study|Protocol Violation|0
5385940|NCT03512028|18534350|P1|Overall Study|Protocol Violation|2
5385941|NCT03512028|18534349|P2|Overall Study|Withdrawal by Subject|0
5385942|NCT03512028|18534350|P1|Overall Study|Withdrawal by Subject|2
5385943|NCT03511326|18534369|P1|Overall Study|Withdrawal by Subject|1
5385944|NCT03511105|18534376|P2|Overall Study|Withdrew consent|0
5385945|NCT03511105|18534377|P1|Overall Study|Withdrew consent|1
5385946|NCT03511105|18534376|P2|Overall Study|Adverse Event|0
5385947|NCT03511105|18534377|P1|Overall Study|Adverse Event|1
5385948|NCT03510715|18534433|P2|Overall Study|Adverse Event|0
5385949|NCT03510715|18534434|P1|Overall Study|Adverse Event|1
5385950|NCT03510273|18534452|P1|Overall Study|Moved away from study area|4
5385951|NCT03510273|18534452|P1|Overall Study|Care outside study, ineligible to cont.|3
5385952|NCT03510273|18534452|P1|Overall Study|Withdrawal by Subject|2
5385953|NCT03509948|18534475|P2|Overall Study|Protocol Violation|1
5385954|NCT03509948|18534476|P1|Overall Study|Protocol Violation|0
5385955|NCT03509675|18534544|P2|Second Intervention )7 Days)|Lost Rinse B|0
5385956|NCT03509675|18534545|P1|Second Intervention )7 Days)|Lost Rinse B|1
5385957|NCT03509675|18534544|P2|Second Intervention )7 Days)|Withdrawal by Subject|0
5385958|NCT03509675|18534545|P1|Second Intervention )7 Days)|Withdrawal by Subject|1
5385959|NCT03509675|18534544|P2|First Intervention (7 Days)|Lack of Efficacy|1
5385960|NCT03509675|18534545|P1|First Intervention (7 Days)|Lack of Efficacy|2
5385961|NCT03509675|18534544|P2|First Intervention (7 Days)|Lost to Follow-up|3
5385962|NCT03509675|18534545|P1|First Intervention (7 Days)|Lost to Follow-up|3
5385963|NCT03509350|18534553|P2|Overall Study|Withdrawal by Subject|2
5385964|NCT03509350|18534554|P1|Overall Study|Withdrawal by Subject|0
5385965|NCT03509207|18534560|P1|Overall Study|Death|2
5385966|NCT03508843|18534565|P1|Overall Study|technical difficulties|2
5385967|NCT03508843|18534565|P1|Overall Study|Withdrawal by Subject|1
5385968|NCT03508050|18534632|P2|Overall Study|Sustained desaturation|1
5385969|NCT03508050|18534633|P1|Overall Study|Sustained desaturation|0
5385970|NCT03508050|18534632|P2|Overall Study|Negative biopsy, surgery cancelled|1
5385971|NCT03508050|18534633|P1|Overall Study|Negative biopsy, surgery cancelled|3
5385972|NCT03508050|18534632|P2|Overall Study|Mucus plug|0
5385973|NCT03508050|18534633|P1|Overall Study|Mucus plug|1
5385974|NCT03508050|18534632|P2|Overall Study|Pleural adhesions|0
5385975|NCT03508050|18534633|P1|Overall Study|Pleural adhesions|1
5385976|NCT03506425|18534709|P3|Overall Study|Withdrawal by Subject|1
5385977|NCT03506425|18534710|P2|Overall Study|Withdrawal by Subject|0
5385978|NCT03506425|18534711|P1|Overall Study|Withdrawal by Subject|0
5385979|NCT03506425|18534709|P3|Overall Study|Death|0
5385980|NCT03506425|18534710|P2|Overall Study|Death|0
5385981|NCT03506425|18534711|P1|Overall Study|Death|1
5385982|NCT03506425|18534709|P3|Overall Study|Adverse Event|0
5385983|NCT03506425|18534710|P2|Overall Study|Adverse Event|3
5385984|NCT03506425|18534711|P1|Overall Study|Adverse Event|1
5385985|NCT03505593|18534746|P1|Overall Study|Obstruction by Endotracheal tube|1
5385986|NCT03505593|18534746|P1|Overall Study|Unable to pass through esophagus|1
5385987|NCT03505593|18534746|P1|Overall Study|Anatomical abnormality|1
5385988|NCT03505593|18534746|P1|Overall Study|Died before procedure|1
5385989|NCT03505593|18534746|P1|Overall Study|Withdrawal by Subject|1
5385990|NCT03504189|18534843|P1|Overall Study|Device Failure|2
5385991|NCT03504189|18534843|P1|Overall Study|Screening Failure|1
5385992|NCT03504189|18534843|P1|Overall Study|Withdrawal by Subject|1
5385993|NCT03503188|18534869|P2|Overall Study|Non eligible in the sub study|1
5385994|NCT03503188|18534870|P1|Overall Study|Non eligible in the sub study|0
5385995|NCT03502681|18534905|P2|Overall Study|Disease Progression|1
5385996|NCT03502681|18534906|P1|Overall Study|Disease Progression|2
5385997|NCT03502681|18534905|P2|Overall Study|Adverse Event|1
5385998|NCT03502681|18534906|P1|Overall Study|Adverse Event|1
5385999|NCT03502070|18534925|P1|Overall Study|Screen Failure|1
5386000|NCT03502070|18534925|P1|Overall Study|Withdrawal by Subject|1
5386001|NCT03501277|18534946|P4|Intervention Period 3 (4 Days)|Adverse Event|1
5386002|NCT03501277|18534947|P3|Intervention Period 3 (4 Days)|Adverse Event|0
5386003|NCT03501277|18534948|P2|Intervention Period 3 (4 Days)|Adverse Event|0
5386004|NCT03501277|18534949|P1|Intervention Period 3 (4 Days)|Adverse Event|0
5386005|NCT03501277|18534946|P4|Intervention Period 2 (4 Days)|Adverse Event|1
5386006|NCT03501277|18534947|P3|Intervention Period 2 (4 Days)|Adverse Event|0
5386007|NCT03501277|18534948|P2|Intervention Period 2 (4 Days)|Adverse Event|0
5386008|NCT03501277|18534949|P1|Intervention Period 2 (4 Days)|Adverse Event|0
5386009|NCT03501277|18534946|P4|Intervention Period 1 (4 Days)|Adverse Event|1
5386010|NCT03501277|18534947|P3|Intervention Period 1 (4 Days)|Adverse Event|0
5386011|NCT03501277|18534948|P2|Intervention Period 1 (4 Days)|Adverse Event|0
5386012|NCT03501277|18534949|P1|Intervention Period 1 (4 Days)|Adverse Event|0
5386013|NCT03501277|18534946|P4|Intervention Period 1 (4 Days)|Other|0
5386014|NCT03501277|18534947|P3|Intervention Period 1 (4 Days)|Other|1
5386015|NCT03501277|18534948|P2|Intervention Period 1 (4 Days)|Other|0
5386016|NCT03501277|18534949|P1|Intervention Period 1 (4 Days)|Other|0
5386017|NCT03500679|18535076|P2|Overall Study|Withdrawal by Subject|0
5386018|NCT03500679|18535077|P1|Overall Study|Withdrawal by Subject|3
5386019|NCT03500679|18535076|P2|Overall Study|Lost to Follow-up|3
5386020|NCT03500679|18535077|P1|Overall Study|Lost to Follow-up|6
5386021|NCT03500224|18535168|P1|Overall Study|Withdrawal by Subject|2
5386022|NCT03500211|18535207|P2|Overall Study|Withdrawal by Subject|1
5386023|NCT03500211|18535208|P1|Overall Study|Withdrawal by Subject|1
5386024|NCT03500198|18535224|P2|Overall Study|Lost to Follow-up|1
5386025|NCT03500198|18535225|P1|Overall Study|Lost to Follow-up|0
5386026|NCT03500159|18535241|P2|Overall Study|Study Terminated|1
5386027|NCT03500159|18535242|P1|Overall Study|Study Terminated|2
5386028|NCT03499067|18535248|P2|First Intervention|Withdrawal by Subject|6
5386029|NCT03499067|18535249|P1|First Intervention|Withdrawal by Subject|3
5386030|NCT03499067|18535248|P2|First Intervention|Physician Decision|1
5386031|NCT03499067|18535249|P1|First Intervention|Physician Decision|2
5386032|NCT03498560|18535289|P1|Overall Study|Death|1
5386033|NCT03498560|18535289|P1|Overall Study|Lost to Follow-up|4
5386034|NCT03498560|18535289|P1|Overall Study|Withdrawal by Subject|14
5386035|NCT03498560|18535289|P1|Overall Study|Found Ineligible|2
5386036|NCT03498287|18535306|P2|Overall Study|Adverse Event|1
5386037|NCT03498287|18535307|P1|Overall Study|Adverse Event|0
5386038|NCT03498287|18535306|P2|Overall Study|Protocol Violation|4
5386039|NCT03498287|18535307|P1|Overall Study|Protocol Violation|0
5386040|NCT03498287|18535306|P2|Overall Study|Withdrawal by Subject|0
5386041|NCT03498287|18535307|P1|Overall Study|Withdrawal by Subject|3
5386042|NCT03497130|18535432|P2|Overall Study|Lost to Follow-up|1
5386043|NCT03497130|18535433|P1|Overall Study|Lost to Follow-up|1
5386044|NCT03497039|18535445|P2|Overall Study|Protocol Violation|1
5386045|NCT03497039|18535446|P1|Overall Study|Protocol Violation|0
5386046|NCT03497039|18535445|P2|Overall Study|Withdrawal by Subject|0
5386047|NCT03497039|18535446|P1|Overall Study|Withdrawal by Subject|1
5386048|NCT03495817|18535580|P1|26 Week Extension|Lost to Follow-up|2
5386049|NCT03495817|18535580|P1|26 Week Open Label|Lost to Follow-up|1
5386050|NCT03495817|18535580|P1|26 Week Open Label|Withdrawal by Subject|4
5386051|NCT03495817|18535580|P1|26 Week Open Label|Adverse Event|3
5386052|NCT03495102|18535598|P3|Overall Study|Participant was in Rehabilitation|0
5386053|NCT03495102|18535599|P2|Overall Study|Participant was in Rehabilitation|0
5386054|NCT03495102|18535600|P1|Overall Study|Participant was in Rehabilitation|1
5386055|NCT03495102|18535598|P3|Overall Study|Relocated to Another Country|0
5386056|NCT03495102|18535599|P2|Overall Study|Relocated to Another Country|1
5386057|NCT03495102|18535600|P1|Overall Study|Relocated to Another Country|0
5386058|NCT03495102|18535598|P3|Overall Study|Primary Care Physician Recommendation|0
5386059|NCT03495102|18535599|P2|Overall Study|Primary Care Physician Recommendation|1
5386060|NCT03495102|18535600|P1|Overall Study|Primary Care Physician Recommendation|0
5386061|NCT03495102|18535598|P3|Overall Study|Participant Duplicated at Another Site|1
5386062|NCT03495102|18535599|P2|Overall Study|Participant Duplicated at Another Site|0
5386063|NCT03495102|18535600|P1|Overall Study|Participant Duplicated at Another Site|0
5386064|NCT03495102|18535598|P3|Overall Study|Non-compliance|0
5386065|NCT03495102|18535599|P2|Overall Study|Non-compliance|0
5386066|NCT03495102|18535600|P1|Overall Study|Non-compliance|1
5386067|NCT03495102|18535598|P3|Overall Study|Site Closure|2
5386068|NCT03495102|18535599|P2|Overall Study|Site Closure|1
5386069|NCT03495102|18535600|P1|Overall Study|Site Closure|3
5386070|NCT03495102|18535598|P3|Overall Study|Protocol Violation|0
5386071|NCT03495102|18535599|P2|Overall Study|Protocol Violation|1
5386072|NCT03495102|18535600|P1|Overall Study|Protocol Violation|1
5386073|NCT03495102|18535598|P3|Overall Study|Withdrawal by Subject|18
5386074|NCT03495102|18535599|P2|Overall Study|Withdrawal by Subject|36
5386075|NCT03495102|18535600|P1|Overall Study|Withdrawal by Subject|25
5386076|NCT03495102|18535598|P3|Overall Study|Physician Decision|2
5386077|NCT03495102|18535599|P2|Overall Study|Physician Decision|0
5386078|NCT03495102|18535600|P1|Overall Study|Physician Decision|2
5386079|NCT03495102|18535598|P3|Overall Study|Lost to Follow-up|17
5386080|NCT03495102|18535599|P2|Overall Study|Lost to Follow-up|16
5386081|NCT03495102|18535600|P1|Overall Study|Lost to Follow-up|15
5386082|NCT03495102|18535598|P3|Overall Study|Death|4
5386083|NCT03495102|18535599|P2|Overall Study|Death|4
5386084|NCT03495102|18535600|P1|Overall Study|Death|3
5386085|NCT03495102|18535598|P3|Overall Study|Adverse Event|10
5386086|NCT03495102|18535599|P2|Overall Study|Adverse Event|7
5386087|NCT03495102|18535600|P1|Overall Study|Adverse Event|5
5386088|NCT03494985|18535630|P4|Overall Study|Other (Not specified)|0
5386089|NCT03494985|18535631|P3|Overall Study|Other (Not specified)|1
5386090|NCT03494985|18535632|P2|Overall Study|Other (Not specified)|1
5386091|NCT03494985|18535633|P1|Overall Study|Other (Not specified)|0
5386092|NCT03494985|18535630|P4|Overall Study|Other (Withdrawal of consent)|5
5386093|NCT03494985|18535631|P3|Overall Study|Other (Withdrawal of consent)|2
5386094|NCT03494985|18535632|P2|Overall Study|Other (Withdrawal of consent)|3
5386095|NCT03494985|18535633|P1|Overall Study|Other (Withdrawal of consent)|2
5386096|NCT03494985|18535630|P4|Overall Study|Adverse Event|0
5386097|NCT03494985|18535631|P3|Overall Study|Adverse Event|3
5386098|NCT03494985|18535632|P2|Overall Study|Adverse Event|2
5386099|NCT03494985|18535633|P1|Overall Study|Adverse Event|3
5386100|NCT03493854|18535669|P2|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
5386101|NCT03493854|18535670|P1|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
5386102|NCT03493854|18535669|P2|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
5386103|NCT03493854|18535670|P1|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
5386104|NCT03493854|18535669|P2|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
5386105|NCT03493854|18535670|P1|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
5386106|NCT03493854|18535669|P2|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
5386107|NCT03493854|18535670|P1|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
5386108|NCT03493854|18535669|P2|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
5386109|NCT03493854|18535670|P1|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
5386110|NCT03493854|18535669|P2|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
5386111|NCT03493854|18535670|P1|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
5386112|NCT03493854|18535669|P2|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
5386113|NCT03493854|18535670|P1|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
5386114|NCT03493854|18535669|P2|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
5386115|NCT03493854|18535670|P1|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
5386116|NCT03493854|18535669|P2|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
5386117|NCT03493854|18535670|P1|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
5386118|NCT03493854|18535669|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
5386119|NCT03493854|18535670|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
5386120|NCT03493854|18535669|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
5386121|NCT03493854|18535670|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
5386122|NCT03493854|18535669|P2|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
5386123|NCT03493854|18535670|P1|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
5386124|NCT03493854|18535669|P2|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
5386125|NCT03493854|18535670|P1|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
5386126|NCT03493854|18535669|P2|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
5386127|NCT03493854|18535670|P1|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
5386128|NCT03493854|18535669|P2|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
5386129|NCT03493854|18535670|P1|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
5386130|NCT03493854|18535669|P2|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
5386131|NCT03493854|18535670|P1|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
5386132|NCT03493698|18535716|P1|Treatment Period C|Withdrawal by Subject|1
5386133|NCT03493698|18535716|P1|Treatment Period C|Adverse Event|1
5386134|NCT03493542|18535741|P2|Overall Study|Withdrawal by Subject|6
5386135|NCT03493542|18535742|P1|Overall Study|Withdrawal by Subject|2
5386136|NCT03493542|18535741|P2|Overall Study|Withdrawal by parent or guardian|0
5386137|NCT03493542|18535742|P1|Overall Study|Withdrawal by parent or guardian|3
5386138|NCT03493542|18535741|P2|Overall Study|Ongoing|3
5386139|NCT03493542|18535742|P1|Overall Study|Ongoing|2
5386140|NCT03493386|18535766|P4|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5386141|NCT03493386|18535767|P3|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5386142|NCT03493386|18535768|P2|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5386143|NCT03493386|18535769|P1|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5386144|NCT03492554|18535889|P2|Overall Study|Protocol Violation|14
5386145|NCT03492554|18535890|P1|Overall Study|Protocol Violation|0
5386146|NCT03492398|18535911|P9|Overall Study|Withdrawal by Subject|0
5386147|NCT03492398|18535912|P8|Overall Study|Withdrawal by Subject|1
5386148|NCT03492398|18535913|P7|Overall Study|Withdrawal by Subject|0
5386149|NCT03492398|18535914|P6|Overall Study|Withdrawal by Subject|0
5386150|NCT03492398|18535915|P5|Overall Study|Withdrawal by Subject|0
5386151|NCT03492398|18535916|P4|Overall Study|Withdrawal by Subject|0
5386152|NCT03492398|18535917|P3|Overall Study|Withdrawal by Subject|0
5386153|NCT03492398|18535918|P2|Overall Study|Withdrawal by Subject|0
5386154|NCT03492398|18535919|P1|Overall Study|Withdrawal by Subject|0
5386155|NCT03492398|18535911|P9|Overall Study|Protocol Violation|0
5386156|NCT03492398|18535912|P8|Overall Study|Protocol Violation|0
5386157|NCT03492398|18535913|P7|Overall Study|Protocol Violation|1
5386158|NCT03492398|18535914|P6|Overall Study|Protocol Violation|0
5386159|NCT03492398|18535915|P5|Overall Study|Protocol Violation|0
5386160|NCT03492398|18535916|P4|Overall Study|Protocol Violation|0
5386161|NCT03492398|18535917|P3|Overall Study|Protocol Violation|0
5386162|NCT03492398|18535918|P2|Overall Study|Protocol Violation|0
5386163|NCT03492398|18535919|P1|Overall Study|Protocol Violation|0
5386164|NCT03491553|18536039|P6|Overall Study|Withdrew Consent|0
5386165|NCT03491553|18536040|P5|Overall Study|Withdrew Consent|0
5386166|NCT03491553|18536041|P4|Overall Study|Withdrew Consent|0
5386167|NCT03491553|18536042|P3|Overall Study|Withdrew Consent|0
5386168|NCT03491553|18536043|P2|Overall Study|Withdrew Consent|1
5386169|NCT03491553|18536044|P1|Overall Study|Withdrew Consent|1
5386170|NCT03491553|18536039|P6|Overall Study|Adverse Event|0
5386171|NCT03491553|18536040|P5|Overall Study|Adverse Event|0
5386172|NCT03491553|18536041|P4|Overall Study|Adverse Event|1
5386173|NCT03491553|18536042|P3|Overall Study|Adverse Event|0
5386174|NCT03491553|18536043|P2|Overall Study|Adverse Event|0
5386175|NCT03491553|18536044|P1|Overall Study|Adverse Event|0
5386176|NCT03491150|18536159|P2|Overall Study|Withdrawal by Subject|2
5386177|NCT03491150|18536160|P1|Overall Study|Withdrawal by Subject|1
5386178|NCT03491150|18536159|P2|Overall Study|Other|1
5386179|NCT03491150|18536160|P1|Overall Study|Other|0
5386180|NCT03491150|18536159|P2|Overall Study|Study Terminated by Sponsor|70
5386181|NCT03491150|18536160|P1|Overall Study|Study Terminated by Sponsor|74
5386182|NCT03491150|18536159|P2|Overall Study|Adverse Event|0
5386183|NCT03491150|18536160|P1|Overall Study|Adverse Event|1
5386184|NCT03490032|18536199|P3|Overall Study|family issue (child custody)|0
5386185|NCT03490032|18536200|P2|Overall Study|family issue (child custody)|0
5386186|NCT03490032|18536201|P1|Overall Study|family issue (child custody)|1
5386187|NCT03489863|18536241|P2|Overall Study|Withdrawal by Subject|1
5386188|NCT03489863|18536242|P1|Overall Study|Withdrawal by Subject|0
5386189|NCT03489720|18536250|P2|Overall Study|Withdrawal by Subject|0
5386190|NCT03489720|18536251|P1|Overall Study|Withdrawal by Subject|2
5386191|NCT03489551|18536276|P1|Overall Study|Withdrawal by Subject|2
5386192|NCT03489304|18536280|P1|Overall Study|Lost to Follow-up|4
5386193|NCT03488927|18536289|P3|Overall Study|Withdrawal by Subject|217
5386194|NCT03488927|18536290|P2|Overall Study|Withdrawal by Subject|118
5386195|NCT03488927|18536291|P1|Overall Study|Withdrawal by Subject|44
5386196|NCT03488108|18536304|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
5386197|NCT03488108|18536305|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
5386198|NCT03488108|18536304|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
5386199|NCT03488108|18536305|P1|First Intervention (12 Weeks)|Withdrawal by Subject|0
5386200|NCT03486392|18536574|P5|Overall Study|Death|1
5386201|NCT03486392|18536575|P4|Overall Study|Death|0
5386202|NCT03486392|18536576|P3|Overall Study|Death|0
5386203|NCT03486392|18536577|P2|Overall Study|Death|0
5386204|NCT03486392|18536578|P1|Overall Study|Death|0
5386205|NCT03486392|18536574|P5|Overall Study|Withdrawal by Subject|1
5386206|NCT03486392|18536575|P4|Overall Study|Withdrawal by Subject|4
5386207|NCT03486392|18536576|P3|Overall Study|Withdrawal by Subject|6
5386208|NCT03486392|18536577|P2|Overall Study|Withdrawal by Subject|0
5386209|NCT03486392|18536578|P1|Overall Study|Withdrawal by Subject|3
5386210|NCT03486392|18536574|P5|Overall Study|Lost to Follow-up|2
5386211|NCT03486392|18536575|P4|Overall Study|Lost to Follow-up|5
5386212|NCT03486392|18536576|P3|Overall Study|Lost to Follow-up|8
5386213|NCT03486392|18536577|P2|Overall Study|Lost to Follow-up|0
5386214|NCT03486392|18536578|P1|Overall Study|Lost to Follow-up|0
5386215|NCT03483623|18536627|P1|Overall Study|43 complete sets achieved|1
5386216|NCT03482882|18536676|P1|Overall Study|Not further specified|1
5386217|NCT03482882|18536676|P1|Overall Study|Protocol Violation|2
5386218|NCT03482882|18536676|P1|Overall Study|Lost to Follow-up|1
5386219|NCT03482882|18536676|P1|Overall Study|Adverse Event|3
5386220|NCT03482453|18536737|P12|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386221|NCT03482453|18536738|P11|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
5386222|NCT03482453|18536739|P10|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386223|NCT03482453|18536740|P9|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386224|NCT03482453|18536741|P8|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386225|NCT03482453|18536742|P7|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386226|NCT03482453|18536743|P6|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386227|NCT03482453|18536744|P5|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386228|NCT03482453|18536745|P4|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386229|NCT03482453|18536746|P3|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386230|NCT03482453|18536747|P2|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386231|NCT03482453|18536748|P1|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
5386232|NCT03482011|18536867|P8|Follow-up Period (12 Weeks)|Lost to Follow-up|1
5386233|NCT03482011|18536868|P7|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5386234|NCT03482011|18536869|P6|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5386235|NCT03482011|18536870|P5|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5386236|NCT03482011|18536871|P4|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5386237|NCT03482011|18536872|P3|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5386238|NCT03482011|18536873|P2|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5386239|NCT03482011|18536874|P1|Follow-up Period (12 Weeks)|Lost to Follow-up|0
5386240|NCT03482011|18536867|P8|Follow-up Period (12 Weeks)|Physician Decision|1
5386241|NCT03482011|18536868|P7|Follow-up Period (12 Weeks)|Physician Decision|0
5386242|NCT03482011|18536869|P6|Follow-up Period (12 Weeks)|Physician Decision|0
5386243|NCT03482011|18536870|P5|Follow-up Period (12 Weeks)|Physician Decision|0
5386244|NCT03482011|18536871|P4|Follow-up Period (12 Weeks)|Physician Decision|0
5386245|NCT03482011|18536872|P3|Follow-up Period (12 Weeks)|Physician Decision|0
5386246|NCT03482011|18536873|P2|Follow-up Period (12 Weeks)|Physician Decision|0
5386247|NCT03482011|18536874|P1|Follow-up Period (12 Weeks)|Physician Decision|0
5386248|NCT03482011|18536867|P8|Follow-up Period (12 Weeks)|Lack of Efficacy|6
5386249|NCT03482011|18536868|P7|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5386250|NCT03482011|18536869|P6|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5386251|NCT03482011|18536870|P5|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5386252|NCT03482011|18536871|P4|Follow-up Period (12 Weeks)|Lack of Efficacy|3
5386253|NCT03482011|18536872|P3|Follow-up Period (12 Weeks)|Lack of Efficacy|1
5386254|NCT03482011|18536873|P2|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5386255|NCT03482011|18536874|P1|Follow-up Period (12 Weeks)|Lack of Efficacy|0
5386256|NCT03482011|18536867|P8|Follow-up Period (12 Weeks)|Adverse Event|4
5386257|NCT03482011|18536868|P7|Follow-up Period (12 Weeks)|Adverse Event|1
5386258|NCT03482011|18536869|P6|Follow-up Period (12 Weeks)|Adverse Event|0
5386259|NCT03482011|18536870|P5|Follow-up Period (12 Weeks)|Adverse Event|0
5386260|NCT03482011|18536871|P4|Follow-up Period (12 Weeks)|Adverse Event|0
5386261|NCT03482011|18536872|P3|Follow-up Period (12 Weeks)|Adverse Event|0
5386262|NCT03482011|18536873|P2|Follow-up Period (12 Weeks)|Adverse Event|0
5386263|NCT03482011|18536874|P1|Follow-up Period (12 Weeks)|Adverse Event|0
5386264|NCT03482011|18536867|P8|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
5386265|NCT03482011|18536868|P7|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
5386266|NCT03482011|18536869|P6|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
5386267|NCT03482011|18536870|P5|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5386268|NCT03482011|18536871|P4|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
5386269|NCT03482011|18536872|P3|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5386270|NCT03482011|18536873|P2|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5386271|NCT03482011|18536874|P1|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
5386272|NCT03482011|18536867|P8|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
5386273|NCT03482011|18536868|P7|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
5386274|NCT03482011|18536869|P6|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
5386275|NCT03482011|18536870|P5|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
5386276|NCT03482011|18536871|P4|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
5386277|NCT03482011|18536872|P3|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
5386278|NCT03482011|18536873|P2|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
5386279|NCT03482011|18536874|P1|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
5386280|NCT03482011|18536867|P8|Maintenance Period (36 Weeks)|Physician Decision|1
5386281|NCT03482011|18536868|P7|Maintenance Period (36 Weeks)|Physician Decision|1
5386282|NCT03482011|18536869|P6|Maintenance Period (36 Weeks)|Physician Decision|1
5386283|NCT03482011|18536870|P5|Maintenance Period (36 Weeks)|Physician Decision|0
5386284|NCT03482011|18536871|P4|Maintenance Period (36 Weeks)|Physician Decision|1
5386285|NCT03482011|18536872|P3|Maintenance Period (36 Weeks)|Physician Decision|0
5386286|NCT03482011|18536873|P2|Maintenance Period (36 Weeks)|Physician Decision|0
5386287|NCT03482011|18536874|P1|Maintenance Period (36 Weeks)|Physician Decision|0
5386288|NCT03482011|18536867|P8|Maintenance Period (36 Weeks)|Lost to Follow-up|1
5386289|NCT03482011|18536868|P7|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5386290|NCT03482011|18536869|P6|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5386291|NCT03482011|18536870|P5|Maintenance Period (36 Weeks)|Lost to Follow-up|2
5386292|NCT03482011|18536871|P4|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5386293|NCT03482011|18536872|P3|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5386294|NCT03482011|18536873|P2|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5386295|NCT03482011|18536874|P1|Maintenance Period (36 Weeks)|Lost to Follow-up|0
5386296|NCT03482011|18536867|P8|Maintenance Period (36 Weeks)|Lack of Efficacy|9
5386297|NCT03482011|18536868|P7|Maintenance Period (36 Weeks)|Lack of Efficacy|0
5386298|NCT03482011|18536869|P6|Maintenance Period (36 Weeks)|Lack of Efficacy|1
5386299|NCT03482011|18536870|P5|Maintenance Period (36 Weeks)|Lack of Efficacy|1
5386300|NCT03482011|18536871|P4|Maintenance Period (36 Weeks)|Lack of Efficacy|2
5386301|NCT03482011|18536872|P3|Maintenance Period (36 Weeks)|Lack of Efficacy|1
5386302|NCT03482011|18536873|P2|Maintenance Period (36 Weeks)|Lack of Efficacy|0
5386303|NCT03482011|18536874|P1|Maintenance Period (36 Weeks)|Lack of Efficacy|0
5386304|NCT03482011|18536867|P8|Maintenance Period (36 Weeks)|Adverse Event|4
5386305|NCT03482011|18536868|P7|Maintenance Period (36 Weeks)|Adverse Event|1
5386306|NCT03482011|18536869|P6|Maintenance Period (36 Weeks)|Adverse Event|1
5386307|NCT03482011|18536870|P5|Maintenance Period (36 Weeks)|Adverse Event|0
5386308|NCT03482011|18536871|P4|Maintenance Period (36 Weeks)|Adverse Event|0
5386309|NCT03482011|18536872|P3|Maintenance Period (36 Weeks)|Adverse Event|0
5386310|NCT03482011|18536873|P2|Maintenance Period (36 Weeks)|Adverse Event|0
5386311|NCT03482011|18536874|P1|Maintenance Period (36 Weeks)|Adverse Event|0
5386312|NCT03482011|18536867|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
5386313|NCT03482011|18536868|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
5386314|NCT03482011|18536869|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
5386315|NCT03482011|18536870|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
5386316|NCT03482011|18536871|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
5386317|NCT03482011|18536872|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
5386318|NCT03482011|18536873|P2|Induction Period (16 Weeks)|Withdrawal by Subject|5
5386319|NCT03482011|18536874|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
5386320|NCT03482011|18536867|P8|Induction Period (16 Weeks)|Screen Failure|0
5386321|NCT03482011|18536868|P7|Induction Period (16 Weeks)|Screen Failure|0
5386322|NCT03482011|18536869|P6|Induction Period (16 Weeks)|Screen Failure|0
5386323|NCT03482011|18536870|P5|Induction Period (16 Weeks)|Screen Failure|0
5386324|NCT03482011|18536871|P4|Induction Period (16 Weeks)|Screen Failure|0
5386325|NCT03482011|18536872|P3|Induction Period (16 Weeks)|Screen Failure|0
5386326|NCT03482011|18536873|P2|Induction Period (16 Weeks)|Screen Failure|1
5386327|NCT03482011|18536874|P1|Induction Period (16 Weeks)|Screen Failure|0
5386328|NCT03482011|18536867|P8|Induction Period (16 Weeks)|Lost to Follow-up|0
5386329|NCT03482011|18536868|P7|Induction Period (16 Weeks)|Lost to Follow-up|0
5386330|NCT03482011|18536869|P6|Induction Period (16 Weeks)|Lost to Follow-up|0
5386331|NCT03482011|18536870|P5|Induction Period (16 Weeks)|Lost to Follow-up|0
5386332|NCT03482011|18536871|P4|Induction Period (16 Weeks)|Lost to Follow-up|0
5386333|NCT03482011|18536872|P3|Induction Period (16 Weeks)|Lost to Follow-up|0
5386334|NCT03482011|18536873|P2|Induction Period (16 Weeks)|Lost to Follow-up|1
5386335|NCT03482011|18536874|P1|Induction Period (16 Weeks)|Lost to Follow-up|0
5386336|NCT03482011|18536867|P8|Induction Period (16 Weeks)|Lack of Efficacy|0
5386337|NCT03482011|18536868|P7|Induction Period (16 Weeks)|Lack of Efficacy|0
5386338|NCT03482011|18536869|P6|Induction Period (16 Weeks)|Lack of Efficacy|0
5386339|NCT03482011|18536870|P5|Induction Period (16 Weeks)|Lack of Efficacy|0
5386340|NCT03482011|18536871|P4|Induction Period (16 Weeks)|Lack of Efficacy|0
5386341|NCT03482011|18536872|P3|Induction Period (16 Weeks)|Lack of Efficacy|0
5386342|NCT03482011|18536873|P2|Induction Period (16 Weeks)|Lack of Efficacy|1
5386343|NCT03482011|18536874|P1|Induction Period (16 Weeks)|Lack of Efficacy|3
5386344|NCT03482011|18536867|P8|Induction Period (16 Weeks)|Adverse Event|0
5386345|NCT03482011|18536868|P7|Induction Period (16 Weeks)|Adverse Event|0
5386346|NCT03482011|18536869|P6|Induction Period (16 Weeks)|Adverse Event|0
5386347|NCT03482011|18536870|P5|Induction Period (16 Weeks)|Adverse Event|0
5386348|NCT03482011|18536871|P4|Induction Period (16 Weeks)|Adverse Event|0
5386349|NCT03482011|18536872|P3|Induction Period (16 Weeks)|Adverse Event|0
5386350|NCT03482011|18536873|P2|Induction Period (16 Weeks)|Adverse Event|3
5386351|NCT03482011|18536874|P1|Induction Period (16 Weeks)|Adverse Event|1
5386352|NCT03481816|18536933|P2|Dose Expansion|Physician Decision|5
5386353|NCT03481816|18536934|P1|Dose Expansion|Physician Decision|0
5386354|NCT03481816|18536933|P2|Dose Expansion|Withdrawal by Subject|2
5386355|NCT03481816|18536934|P1|Dose Expansion|Withdrawal by Subject|0
5386356|NCT03481816|18536933|P2|Dose Expansion|Off treatment due to progressive disease|5
5386357|NCT03481816|18536934|P1|Dose Expansion|Off treatment due to progressive disease|0
5386358|NCT03481816|18536933|P2|Starting Dose|Refused further vaccines after 1 dose|0
5386359|NCT03481816|18536934|P1|Starting Dose|Refused further vaccines after 1 dose|1
5386360|NCT03481309|18536961|P6|Washout (at Least 3 Days)|Withdrawal by Subject|0
5386361|NCT03481309|18536962|P5|Washout (at Least 3 Days)|Withdrawal by Subject|0
5386362|NCT03481309|18536963|P4|Washout (at Least 3 Days)|Withdrawal by Subject|0
5386363|NCT03481309|18536964|P3|Washout (at Least 3 Days)|Withdrawal by Subject|0
5386364|NCT03481309|18536965|P2|Washout (at Least 3 Days)|Withdrawal by Subject|0
5386365|NCT03481309|18536966|P1|Washout (at Least 3 Days)|Withdrawal by Subject|1
5386366|NCT03480841|18537008|P1|Overall Study|Lost to Follow-up|2
5386367|NCT03480802|18537019|P2|Overall Study|Relocated|1
5386368|NCT03480802|18537020|P1|Overall Study|Relocated|0
5386369|NCT03480802|18537019|P2|Overall Study|Withdrawal by Subject|1
5386370|NCT03480802|18537020|P1|Overall Study|Withdrawal by Subject|2
5386371|NCT03480802|18537019|P2|Overall Study|Lost to Follow-up|1
5386372|NCT03480802|18537020|P1|Overall Study|Lost to Follow-up|5
5386373|NCT03480750|18537052|P6|Overall Study|The interruption in Trientine shippment|1
5386374|NCT03480750|18537053|P5|Overall Study|The interruption in Trientine shippment|0
5386375|NCT03480750|18537054|P4|Overall Study|The interruption in Trientine shippment|0
5386376|NCT03480750|18537055|P3|Overall Study|The interruption in Trientine shippment|0
5386377|NCT03480750|18537056|P2|Overall Study|The interruption in Trientine shippment|0
5386378|NCT03480750|18537057|P1|Overall Study|The interruption in Trientine shippment|0
5386379|NCT03480750|18537052|P6|Overall Study|Withdrawal by Subject|0
5386380|NCT03480750|18537053|P5|Overall Study|Withdrawal by Subject|0
5386381|NCT03480750|18537054|P4|Overall Study|Withdrawal by Subject|0
5386382|NCT03480750|18537055|P3|Overall Study|Withdrawal by Subject|0
5386383|NCT03480750|18537056|P2|Overall Study|Withdrawal by Subject|1
5386384|NCT03480750|18537057|P1|Overall Study|Withdrawal by Subject|0
5386385|NCT03480425|18537081|P1|Overall Study|Force transducer technical failure|1
5386386|NCT03480152|18537087|P3|Phase I|Signed consent. Died before treatment.|0
5386387|NCT03480152|18537088|P2|Phase I|Signed consent. Died before treatment.|0
5386388|NCT03480152|18537089|P1|Phase I|Signed consent. Died before treatment.|1
5386389|NCT03480009|18537119|P4|Overall Study|Lost to Follow-up|0
5386390|NCT03480009|18537120|P3|Overall Study|Lost to Follow-up|4
5386391|NCT03480009|18537121|P2|Overall Study|Lost to Follow-up|5
5386392|NCT03480009|18537122|P1|Overall Study|Lost to Follow-up|4
5386393|NCT03479216|18537157|P2|Overall Study|Physician Decision|3
5386394|NCT03479216|18537158|P1|Overall Study|Physician Decision|2
5386395|NCT03479216|18537157|P2|Overall Study|Withdrawal by Subject|2
5386396|NCT03479216|18537158|P1|Overall Study|Withdrawal by Subject|3
5386397|NCT03478956|18537178|P2|Overall Study|Ongoing in the Study|11
5386398|NCT03478956|18537179|P1|Overall Study|Ongoing in the Study|11
5386399|NCT03478956|18537178|P2|Overall Study|Withdrawal by Subject|1
5386400|NCT03478956|18537179|P1|Overall Study|Withdrawal by Subject|0
5386401|NCT03478956|18537178|P2|Overall Study|Adverse Event|0
5386402|NCT03478956|18537179|P1|Overall Study|Adverse Event|1
5386403|NCT03478891|18537208|P3|Overall Study|Lost to Follow-up|1
5386404|NCT03478891|18537209|P2|Overall Study|Lost to Follow-up|0
5386405|NCT03478891|18537210|P1|Overall Study|Lost to Follow-up|1
5386406|NCT03478891|18537208|P3|Overall Study|Moved from area|1
5386407|NCT03478891|18537209|P2|Overall Study|Moved from area|0
5386408|NCT03478891|18537210|P1|Overall Study|Moved from area|0
5386409|NCT03478891|18537208|P3|Overall Study|Enrolled, but product never administered|1
5386410|NCT03478891|18537209|P2|Overall Study|Enrolled, but product never administered|0
5386411|NCT03478891|18537210|P1|Overall Study|Enrolled, but product never administered|0
5386412|NCT03478696|18537261|P2|Overall Study|Withdrawal by Subject|4
5386413|NCT03478696|18537262|P1|Overall Study|Withdrawal by Subject|9
5386414|NCT03478696|18537261|P2|Overall Study|Physician Decision|3
5386415|NCT03478696|18537262|P1|Overall Study|Physician Decision|6
5386416|NCT03478696|18537261|P2|Overall Study|Lost to Follow-up|0
5386417|NCT03478696|18537262|P1|Overall Study|Lost to Follow-up|1
5386418|NCT03478696|18537261|P2|Overall Study|Adverse Event|5
5386419|NCT03478696|18537262|P1|Overall Study|Adverse Event|1
5386420|NCT03478683|18537276|P2|Overall Study|Withdrawal by Subject|7
5386421|NCT03478683|18537277|P1|Overall Study|Withdrawal by Subject|7
5386422|NCT03478683|18537276|P2|Overall Study|Physician Decision|3
5386423|NCT03478683|18537277|P1|Overall Study|Physician Decision|1
5386424|NCT03478683|18537276|P2|Overall Study|Lost to Follow-up|5
5386425|NCT03478683|18537277|P1|Overall Study|Lost to Follow-up|0
5386426|NCT03478683|18537276|P2|Overall Study|Adverse Event|3
5386427|NCT03478683|18537277|P1|Overall Study|Adverse Event|5
5386428|NCT03478657|18537291|P2|Overall Study|Withdrawal by Subject|1
5386429|NCT03478657|18537292|P1|Overall Study|Withdrawal by Subject|0
5386430|NCT03478644|18537307|P2|Phase 2|Lost to Follow-up|0
5386431|NCT03478644|18537308|P1|Phase 2|Lost to Follow-up|1
5386432|NCT03478644|18537307|P2|Phase 2|Withdrawal by Subject|1
5386433|NCT03478644|18537308|P1|Phase 2|Withdrawal by Subject|2
5386434|NCT03478371|18537320|P1|Overall Study|Lost to Follow-up|4
5386435|NCT03478371|18537320|P1|Overall Study|non-compliance|1
5386436|NCT03477903|18537342|P1|Overall Study|Study Terminated by Sponsor|1
5386437|NCT03476239|18537418|P1|Overall Study|Did not receive study drug|1
5386438|NCT03476239|18537418|P1|Overall Study|Data Not Available|15
5386439|NCT03476239|18537418|P1|Overall Study|Lost to Follow-up|2
5386440|NCT03476239|18537418|P1|Overall Study|Death|39
5386441|NCT03476239|18537418|P1|Overall Study|Withdrawal by Subject|6
5386442|NCT03476239|18537418|P1|Overall Study|Continuing study|43
5386443|NCT03475875|18537468|P2|Period 2|Protocol Violation|1
5386444|NCT03475875|18537469|P1|Period 2|Protocol Violation|0
5386445|NCT03475875|18537468|P2|Period 2|Adverse Event|0
5386446|NCT03475875|18537469|P1|Period 2|Adverse Event|3
5386447|NCT03475875|18537468|P2|Period 1|Adverse Event|1
5386448|NCT03475875|18537469|P1|Period 1|Adverse Event|2
5386449|NCT03475875|18537468|P2|Period 1|Lost to Follow-up|0
5386450|NCT03475875|18537469|P1|Period 1|Lost to Follow-up|1
5386451|NCT03474081|18537507|P2|Overall Study|Investigator site closed|0
5386452|NCT03474081|18537508|P1|Overall Study|Investigator site closed|1
5386453|NCT03474081|18537507|P2|Overall Study|Withdrawal by Subject|7
5386454|NCT03474081|18537508|P1|Overall Study|Withdrawal by Subject|5
5386455|NCT03474081|18537507|P2|Overall Study|Physician Decision|2
5386456|NCT03474081|18537508|P1|Overall Study|Physician Decision|3
5386457|NCT03474081|18537507|P2|Overall Study|Lost to Follow-up|1
5386458|NCT03474081|18537508|P1|Overall Study|Lost to Follow-up|2
5386459|NCT03474081|18537507|P2|Overall Study|Adverse Event|3
5386460|NCT03474081|18537508|P1|Overall Study|Adverse Event|6
5386461|NCT03473808|18537549|P1|Overall Study|Withdrawal by Subject|1
5386462|NCT03473236|18537581|P10|Overall Study|Withdrawal by Subject|0
5386463|NCT03473236|18537582|P9|Overall Study|Withdrawal by Subject|1
5386464|NCT03473236|18537583|P8|Overall Study|Withdrawal by Subject|0
5386465|NCT03473236|18537584|P7|Overall Study|Withdrawal by Subject|0
5386466|NCT03473236|18537585|P6|Overall Study|Withdrawal by Subject|1
5386467|NCT03473236|18537586|P5|Overall Study|Withdrawal by Subject|0
5386468|NCT03473236|18537587|P4|Overall Study|Withdrawal by Subject|0
5386469|NCT03473236|18537588|P3|Overall Study|Withdrawal by Subject|0
5386470|NCT03473236|18537589|P2|Overall Study|Withdrawal by Subject|0
5386471|NCT03473236|18537590|P1|Overall Study|Withdrawal by Subject|0
5386472|NCT03473197|18537757|P1|Overall Study|Withdrawal by Subject|5
5386473|NCT03473197|18537757|P1|Overall Study|Lost to Follow-up|1
5386474|NCT03473197|18537757|P1|Overall Study|Adverse Event|4
5386475|NCT03472547|18537769|P1|Overall Study|Withdrawal by Subject|30
5386476|NCT03472534|18537773|P1|Overall Study|Adverse Event|2
5386477|NCT03472534|18537773|P1|Overall Study|Withdrawal by Subject|9
5386478|NCT03472014|18537786|P1|Overall Study|Lost to Follow-up|4
5386479|NCT03471871|18537808|P5|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5386480|NCT03471871|18537809|P4|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
5386481|NCT03471871|18537810|P3|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5386482|NCT03471871|18537811|P2|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5386483|NCT03471871|18537812|P1|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
5386484|NCT03471871|18537808|P5|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
5386485|NCT03471871|18537809|P4|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5386486|NCT03471871|18537810|P3|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5386487|NCT03471871|18537811|P2|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5386488|NCT03471871|18537812|P1|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
5386489|NCT03471871|18537808|P5|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
5386490|NCT03471871|18537809|P4|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5386491|NCT03471871|18537810|P3|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5386492|NCT03471871|18537811|P2|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5386493|NCT03471871|18537812|P1|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
5386494|NCT03471871|18537808|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
5386495|NCT03471871|18537809|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
5386496|NCT03471871|18537810|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
5386497|NCT03471871|18537811|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
5386498|NCT03471871|18537812|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
5386499|NCT03471871|18537808|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5386500|NCT03471871|18537809|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5386501|NCT03471871|18537810|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
5386502|NCT03471871|18537811|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5386503|NCT03471871|18537812|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
5386504|NCT03469349|18537926|P2|Overall Study|Adverse Event|4
5386505|NCT03469349|18537927|P1|Overall Study|Adverse Event|2
5386506|NCT03469349|18537926|P2|Overall Study|Lost to Follow-up|2
5386507|NCT03469349|18537927|P1|Overall Study|Lost to Follow-up|2
5386508|NCT03469349|18537926|P2|Overall Study|Progressive Disease|1
5386509|NCT03469349|18537927|P1|Overall Study|Progressive Disease|0
5386510|NCT03469349|18537926|P2|Overall Study|Withdrawal by Subject|3
5386511|NCT03469349|18537927|P1|Overall Study|Withdrawal by Subject|1
5386512|NCT03469336|18537943|P1|Overall Study|Adverse Event|1
5386513|NCT03469258|18537966|P1|Overall Study|Upon surgery, did not meet criteria|4
5386514|NCT03468855|18537995|P1|Overall Study|Inclusion/Exclusion Enrollment Violator|1
5386515|NCT03468855|18537995|P1|Overall Study|Withdrawal by Subject|3
5386516|NCT03468855|18537995|P1|Overall Study|Lost to Follow-up|5
5386517|NCT03468855|18537995|P1|Overall Study|Adverse Event|2
5386518|NCT03468543|18538049|P1|Overall Study|Protocol stopping rules met|3
5386519|NCT03467971|18538068|P2|Treatment Period 2|Withdrawal by Subject|1
5386520|NCT03467971|18538069|P1|Treatment Period 2|Withdrawal by Subject|0
5386521|NCT03467945|18538093|P4|Treatment Period 3|Withdrawal by Subject|1
5386522|NCT03467945|18538094|P3|Treatment Period 3|Withdrawal by Subject|2
5386523|NCT03467945|18538095|P2|Treatment Period 3|Withdrawal by Subject|0
5386524|NCT03467945|18538096|P1|Treatment Period 3|Withdrawal by Subject|1
5386525|NCT03467945|18538093|P4|Treatment Period 2|Withdrawal by Subject|0
5386526|NCT03467945|18538094|P3|Treatment Period 2|Withdrawal by Subject|0
5386527|NCT03467945|18538095|P2|Treatment Period 2|Withdrawal by Subject|1
5386528|NCT03467945|18538096|P1|Treatment Period 2|Withdrawal by Subject|0
5386529|NCT03467763|18538148|P1|Overall Study|Protocol Violation|2
5386530|NCT03467763|18538148|P1|Overall Study|Lost to Follow-up|1
5386531|NCT03467425|18538178|P2|Overall Study|Withdrawal by Subject|17
5386532|NCT03467425|18538179|P1|Overall Study|Withdrawal by Subject|15
5386533|NCT03467425|18538178|P2|Overall Study|Physician Decision|1
5386534|NCT03467425|18538179|P1|Overall Study|Physician Decision|2
5386535|NCT03467425|18538178|P2|Overall Study|Lost to Follow-up|25
5386536|NCT03467425|18538179|P1|Overall Study|Lost to Follow-up|18
5386537|NCT03467425|18538178|P2|Overall Study|Protocol Violation|1
5386538|NCT03467425|18538179|P1|Overall Study|Protocol Violation|0
5386539|NCT03467425|18538178|P2|Overall Study|Lack of Efficacy|1
5386540|NCT03467425|18538179|P1|Overall Study|Lack of Efficacy|3
5386541|NCT03467425|18538178|P2|Overall Study|Adverse Event|9
5386542|NCT03467425|18538179|P1|Overall Study|Adverse Event|9
5386543|NCT03466658|18538246|P1|Overall Study|Withdrawal by Subject|3
5386544|NCT03466099|18538255|P3|Overall Study|Worsening disease|1
5386545|NCT03466099|18538256|P2|Overall Study|Worsening disease|0
5386546|NCT03466099|18538257|P1|Overall Study|Worsening disease|0
5386547|NCT03466099|18538255|P3|Overall Study|Subject compliance|0
5386548|NCT03466099|18538256|P2|Overall Study|Subject compliance|0
5386549|NCT03466099|18538257|P1|Overall Study|Subject compliance|2
5386550|NCT03466099|18538255|P3|Overall Study|Rescued without meeting criteria|1
5386551|NCT03466099|18538256|P2|Overall Study|Rescued without meeting criteria|1
5386552|NCT03466099|18538257|P1|Overall Study|Rescued without meeting criteria|4
5386553|NCT03466099|18538255|P3|Overall Study|Use of rescue medication|13
5386554|NCT03466099|18538256|P2|Overall Study|Use of rescue medication|9
5386555|NCT03466099|18538257|P1|Overall Study|Use of rescue medication|8
5386556|NCT03466099|18538255|P3|Overall Study|Withdrawal by Subject|1
5386557|NCT03466099|18538256|P2|Overall Study|Withdrawal by Subject|3
5386558|NCT03466099|18538257|P1|Overall Study|Withdrawal by Subject|2
5386559|NCT03466099|18538255|P3|Overall Study|Adverse Event|1
5386560|NCT03466099|18538256|P2|Overall Study|Adverse Event|1
5386561|NCT03466099|18538257|P1|Overall Study|Adverse Event|1
5386562|NCT03466086|18538271|P2|Period 1|Withdrawal by Subject|0
5386563|NCT03466086|18538272|P1|Period 1|Withdrawal by Subject|1
5386564|NCT03466086|18538271|P2|Period 1|Sponsor decision due to study timeline|0
5386565|NCT03466086|18538272|P1|Period 1|Sponsor decision due to study timeline|1
5386566|NCT03466073|18538286|P6|Overall Study|Death|1
5386567|NCT03466073|18538287|P5|Overall Study|Death|0
5386568|NCT03466073|18538288|P4|Overall Study|Death|0
5386569|NCT03466073|18538289|P3|Overall Study|Death|0
5386570|NCT03466073|18538290|P2|Overall Study|Death|0
5386571|NCT03466073|18538291|P1|Overall Study|Death|1
5386572|NCT03466060|18538324|P6|Period 2|Lens Handling Difficulties|0
5386573|NCT03466060|18538325|P5|Period 2|Lens Handling Difficulties|0
5386574|NCT03466060|18538326|P4|Period 2|Lens Handling Difficulties|0
5386575|NCT03466060|18538327|P3|Period 2|Lens Handling Difficulties|1
5386576|NCT03466060|18538328|P2|Period 2|Lens Handling Difficulties|0
5386577|NCT03466060|18538329|P1|Period 2|Lens Handling Difficulties|0
5386578|NCT03466060|18538324|P6|Period 1|Grade 2 Conjunctivitis|0
5386579|NCT03466060|18538325|P5|Period 1|Grade 2 Conjunctivitis|0
5386580|NCT03466060|18538326|P4|Period 1|Grade 2 Conjunctivitis|0
5386581|NCT03466060|18538327|P3|Period 1|Grade 2 Conjunctivitis|1
5386582|NCT03466060|18538328|P2|Period 1|Grade 2 Conjunctivitis|0
5386583|NCT03466060|18538329|P1|Period 1|Grade 2 Conjunctivitis|0
5386584|NCT03466060|18538324|P6|Period 1|Lost to Follow-up|0
5386585|NCT03466060|18538325|P5|Period 1|Lost to Follow-up|0
5386586|NCT03466060|18538326|P4|Period 1|Lost to Follow-up|1
5386587|NCT03466060|18538327|P3|Period 1|Lost to Follow-up|0
5386588|NCT03466060|18538328|P2|Period 1|Lost to Follow-up|0
5386589|NCT03466060|18538329|P1|Period 1|Lost to Follow-up|0
5386590|NCT03466060|18538324|P6|Period 1|Withdrawal by Subject|0
5386591|NCT03466060|18538325|P5|Period 1|Withdrawal by Subject|0
5386592|NCT03466060|18538326|P4|Period 1|Withdrawal by Subject|0
5386593|NCT03466060|18538327|P3|Period 1|Withdrawal by Subject|2
5386594|NCT03466060|18538328|P2|Period 1|Withdrawal by Subject|0
5386595|NCT03466060|18538329|P1|Period 1|Withdrawal by Subject|0
5386596|NCT03466060|18538324|P6|Period 1|Test Lens Damage|0
5386597|NCT03466060|18538325|P5|Period 1|Test Lens Damage|0
5386598|NCT03466060|18538326|P4|Period 1|Test Lens Damage|0
5386599|NCT03466060|18538327|P3|Period 1|Test Lens Damage|0
5386600|NCT03466060|18538328|P2|Period 1|Test Lens Damage|2
5386601|NCT03466060|18538329|P1|Period 1|Test Lens Damage|0
5386602|NCT03465904|18538371|P2|Overall Study|Ineligible for mITT analysis|47
5386603|NCT03465904|18538372|P1|Overall Study|Ineligible for mITT analysis|62
5386604|NCT03465904|18538371|P2|Overall Study|Protocol Violation|5
5386605|NCT03465904|18538372|P1|Overall Study|Protocol Violation|8
5386606|NCT03465904|18538371|P2|Overall Study|Lost to Follow-up|9
5386607|NCT03465904|18538372|P1|Overall Study|Lost to Follow-up|10
5386608|NCT03465904|18538371|P2|Overall Study|Withdrawal by Subject|5
5386609|NCT03465904|18538372|P1|Overall Study|Withdrawal by Subject|9
5386610|NCT03465878|18538392|P4|Period 1-Part B First Intervention Day 1|Physician Decision|1
5386611|NCT03465878|18538393|P3|Period 1-Part B First Intervention Day 1|Physician Decision|0
5386612|NCT03465878|18538394|P2|Period 1-Part B First Intervention Day 1|Physician Decision|0
5386613|NCT03465878|18538395|P1|Period 1-Part B First Intervention Day 1|Physician Decision|0
5386614|NCT03465878|18538392|P4|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
5386615|NCT03465878|18538393|P3|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
5386616|NCT03465878|18538394|P2|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
5386617|NCT03465878|18538395|P1|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
5386618|NCT03465878|18538392|P4|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
5386619|NCT03465878|18538393|P3|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
5386620|NCT03465878|18538394|P2|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
5386621|NCT03465878|18538395|P1|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
5386622|NCT03465709|18538442|P1|Overall Study|Withdrawal by Subject|3
5386623|NCT03465709|18538442|P1|Overall Study|Study/Site Terminated by Sponsor|14
5386624|NCT03465436|18538454|P4|Period 4|Protocol Violation|0
5386625|NCT03465436|18538455|P3|Period 4|Protocol Violation|1
5386626|NCT03465436|18538456|P2|Period 4|Protocol Violation|0
5386627|NCT03465436|18538457|P1|Period 4|Protocol Violation|0
5386628|NCT03465436|18538454|P4|Period 3|Protocol Violation|0
5386629|NCT03465436|18538455|P3|Period 3|Protocol Violation|0
5386630|NCT03465436|18538456|P2|Period 3|Protocol Violation|1
5386631|NCT03465436|18538457|P1|Period 3|Protocol Violation|1
5386632|NCT03465436|18538454|P4|Period 2|Protocol Violation|0
5386633|NCT03465436|18538455|P3|Period 2|Protocol Violation|0
5386634|NCT03465436|18538456|P2|Period 2|Protocol Violation|1
5386635|NCT03465436|18538457|P1|Period 2|Protocol Violation|0
5386636|NCT03465436|18538454|P4|Period 1|Protocol Violation|0
5386637|NCT03465436|18538455|P3|Period 1|Protocol Violation|1
5386638|NCT03465436|18538456|P2|Period 1|Protocol Violation|0
5386639|NCT03465436|18538457|P1|Period 1|Protocol Violation|0
5386640|NCT03464383|18538494|P3|Overall Study|Withdrawal by Subject|0
5386641|NCT03464383|18538495|P2|Overall Study|Withdrawal by Subject|1
5386642|NCT03464383|18538496|P1|Overall Study|Withdrawal by Subject|0
5386643|NCT03464383|18538494|P3|Overall Study|Lost to Follow-up|0
5386644|NCT03464383|18538495|P2|Overall Study|Lost to Follow-up|0
5386645|NCT03464383|18538496|P1|Overall Study|Lost to Follow-up|1
5386646|NCT03463031|18538553|P2|Overall Study|Use of prohibited medication by subject|0
5386647|NCT03463031|18538554|P1|Overall Study|Use of prohibited medication by subject|1
5386648|NCT03463031|18538553|P2|Overall Study|Adverse Event|1
5386649|NCT03463031|18538554|P1|Overall Study|Adverse Event|4
5386650|NCT03463031|18538553|P2|Overall Study|Lost to Follow-up|1
5386651|NCT03463031|18538554|P1|Overall Study|Lost to Follow-up|1
5386652|NCT03463031|18538553|P2|Overall Study|Investigator/Sponsor Decision|1
5386653|NCT03463031|18538554|P1|Overall Study|Investigator/Sponsor Decision|0
5386654|NCT03463031|18538553|P2|Overall Study|Withdrawal by Subject|2
5386655|NCT03463031|18538554|P1|Overall Study|Withdrawal by Subject|4
5386656|NCT03461757|18538604|P2|Overall Study|Other Reasons|4
5386657|NCT03461757|18538605|P1|Overall Study|Other Reasons|1
5386658|NCT03461757|18538604|P2|Overall Study|Withdrawal by Subject|7
5386659|NCT03461757|18538605|P1|Overall Study|Withdrawal by Subject|7
5386660|NCT03461757|18538604|P2|Overall Study|Protocol Violation|1
5386661|NCT03461757|18538605|P1|Overall Study|Protocol Violation|1
5386662|NCT03461757|18538604|P2|Overall Study|Pregnancy|0
5386663|NCT03461757|18538605|P1|Overall Study|Pregnancy|2
5386664|NCT03461757|18538604|P2|Overall Study|Non-compliance with study treatment|1
5386665|NCT03461757|18538605|P1|Overall Study|Non-compliance with study treatment|0
5386666|NCT03461757|18538604|P2|Overall Study|Not Experienced Moderate/Severe Migraine|25
5386667|NCT03461757|18538605|P1|Overall Study|Not Experienced Moderate/Severe Migraine|28
5386668|NCT03461757|18538604|P2|Overall Study|Lost to Follow-up|7
5386669|NCT03461757|18538605|P1|Overall Study|Lost to Follow-up|13
5386670|NCT03461757|18538604|P2|Overall Study|Adverse Event|0
5386671|NCT03461757|18538605|P1|Overall Study|Adverse Event|1
5386672|NCT03459196|18538779|P1|Overall Study|Subject didn't receive study catheter|2
5386673|NCT03458702|18538823|P2|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
5386674|NCT03458702|18538824|P1|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
5386675|NCT03458702|18538823|P2|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
5386676|NCT03458702|18538824|P1|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
5386677|NCT03457727|18538853|P4|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
5386678|NCT03457727|18538854|P3|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
5386679|NCT03457727|18538855|P2|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
5386680|NCT03457727|18538856|P1|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
5386681|NCT03457636|18539053|P1|Overall Study|Lost to Follow-up|2
5386682|NCT03456960|18539066|P6|Period 2 (1 Day)|Adverse Event|0
5386683|NCT03456960|18539067|P5|Period 2 (1 Day)|Adverse Event|0
5386684|NCT03456960|18539068|P4|Period 2 (1 Day)|Adverse Event|1
5386685|NCT03456960|18539069|P3|Period 2 (1 Day)|Adverse Event|0
5386686|NCT03456960|18539070|P2|Period 2 (1 Day)|Adverse Event|0
5386687|NCT03456960|18539071|P1|Period 2 (1 Day)|Adverse Event|1
5386688|NCT03456960|18539066|P6|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5386689|NCT03456960|18539067|P5|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5386690|NCT03456960|18539068|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
5386691|NCT03456960|18539069|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
5386692|NCT03456960|18539070|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5386693|NCT03456960|18539071|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5386694|NCT03456856|18539163|P1|Overall Study|Withdrawal by Subject|1
5386695|NCT03456856|18539163|P1|Overall Study|Lost to Follow-up|2
5386696|NCT03456700|18539167|P1|Overall Study|Withdrawal by Subject|1
5386697|NCT03455543|18539199|P3|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
5386698|NCT03455543|18539200|P2|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
5386699|NCT03455543|18539201|P1|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
5386700|NCT03455543|18539199|P3|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
5386701|NCT03455543|18539200|P2|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
5386702|NCT03455543|18539201|P1|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
5386703|NCT03455543|18539199|P3|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
5386704|NCT03455543|18539200|P2|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
5386705|NCT03455543|18539201|P1|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
5386706|NCT03455543|18539199|P3|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
5386707|NCT03455543|18539200|P2|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
5386708|NCT03455543|18539201|P1|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
5386709|NCT03455543|18539199|P3|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
5386710|NCT03455543|18539200|P2|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
5386711|NCT03455543|18539201|P1|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
5386712|NCT03455543|18539199|P3|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
5386713|NCT03455543|18539200|P2|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
5386714|NCT03455543|18539201|P1|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
5386715|NCT03455543|18539199|P3|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
5386716|NCT03455543|18539200|P2|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
5386717|NCT03455543|18539201|P1|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
5386718|NCT03455543|18539199|P3|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
5386719|NCT03455543|18539200|P2|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
5386720|NCT03455543|18539201|P1|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
5386721|NCT03455543|18539199|P3|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
5386722|NCT03455543|18539200|P2|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
5386723|NCT03455543|18539201|P1|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
5386724|NCT03453151|18539390|P1|Overall Study|Physician Decision|3
5386725|NCT03453151|18539390|P1|Overall Study|Withdrawal by Subject|1
5386726|NCT03452943|18539627|P2|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
5386727|NCT03452943|18539628|P1|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
5386728|NCT03452943|18539627|P2|Maintenance Period (5 Weeks)|Adverse Event|0
5386729|NCT03452943|18539628|P1|Maintenance Period (5 Weeks)|Adverse Event|1
5386730|NCT03452943|18539627|P2|Titration Period (7 Weeks)|Lost to Follow-up|0
5386731|NCT03452943|18539628|P1|Titration Period (7 Weeks)|Lost to Follow-up|1
5386732|NCT03452943|18539627|P2|Titration Period (7 Weeks)|Withdrawal by Subject|2
5386733|NCT03452943|18539628|P1|Titration Period (7 Weeks)|Withdrawal by Subject|3
5386734|NCT03452943|18539627|P2|Titration Period (7 Weeks)|Protocol Violation|1
5386735|NCT03452943|18539628|P1|Titration Period (7 Weeks)|Protocol Violation|0
5386736|NCT03452943|18539627|P2|Titration Period (7 Weeks)|Adverse Event|1
5386737|NCT03452943|18539628|P1|Titration Period (7 Weeks)|Adverse Event|1
5386738|NCT03451721|18539680|P1|Overall Study|Death|1
5386739|NCT03450070|18539720|P1|Overall Study|Withdrawal by Subject|8
5386740|NCT03449979|18539728|P4|Overall Study|Technical difficulty|1
5386741|NCT03449979|18539729|P3|Overall Study|Technical difficulty|0
5386742|NCT03449979|18539730|P2|Overall Study|Technical difficulty|0
5386743|NCT03449979|18539731|P1|Overall Study|Technical difficulty|0
5386744|NCT03449758|18539741|P1|Overall Study|Other unspecified reason|3
5386745|NCT03449758|18539741|P1|Overall Study|Consent withdrawal|1
5386746|NCT03449758|18539741|P1|Overall Study|Adverse Event|9
5386747|NCT03449758|18539741|P1|Overall Study|Treatment inefficacy|5
5386748|NCT03449758|18539741|P1|Overall Study|Major protocol deviation|1
5386749|NCT03449446|18539781|P7|Overall Study|Death|0
5386750|NCT03449446|18539782|P6|Overall Study|Death|0
5386751|NCT03449446|18539783|P5|Overall Study|Death|1
5386752|NCT03449446|18539784|P4|Overall Study|Death|0
5386753|NCT03449446|18539785|P3|Overall Study|Death|0
5386754|NCT03449446|18539786|P2|Overall Study|Death|0
5386755|NCT03449446|18539787|P1|Overall Study|Death|0
5386756|NCT03449446|18539781|P7|Overall Study|Protocol Violation|0
5386757|NCT03449446|18539782|P6|Overall Study|Protocol Violation|1
5386758|NCT03449446|18539783|P5|Overall Study|Protocol Violation|1
5386759|NCT03449446|18539784|P4|Overall Study|Protocol Violation|0
5386760|NCT03449446|18539785|P3|Overall Study|Protocol Violation|0
5386761|NCT03449446|18539786|P2|Overall Study|Protocol Violation|0
5386762|NCT03449446|18539787|P1|Overall Study|Protocol Violation|0
5386763|NCT03449446|18539781|P7|Overall Study|Non Compliance with Study Drug|0
5386764|NCT03449446|18539782|P6|Overall Study|Non Compliance with Study Drug|0
5386765|NCT03449446|18539783|P5|Overall Study|Non Compliance with Study Drug|0
5386766|NCT03449446|18539784|P4|Overall Study|Non Compliance with Study Drug|0
5386767|NCT03449446|18539785|P3|Overall Study|Non Compliance with Study Drug|0
5386768|NCT03449446|18539786|P2|Overall Study|Non Compliance with Study Drug|0
5386769|NCT03449446|18539787|P1|Overall Study|Non Compliance with Study Drug|1
5386770|NCT03449446|18539781|P7|Overall Study|Investigator's Discretion|0
5386771|NCT03449446|18539782|P6|Overall Study|Investigator's Discretion|0
5386772|NCT03449446|18539783|P5|Overall Study|Investigator's Discretion|0
5386773|NCT03449446|18539784|P4|Overall Study|Investigator's Discretion|2
5386774|NCT03449446|18539785|P3|Overall Study|Investigator's Discretion|1
5386775|NCT03449446|18539786|P2|Overall Study|Investigator's Discretion|1
5386776|NCT03449446|18539787|P1|Overall Study|Investigator's Discretion|0
5386777|NCT03449446|18539781|P7|Overall Study|Lost to Follow-up|0
5386778|NCT03449446|18539782|P6|Overall Study|Lost to Follow-up|0
5386779|NCT03449446|18539783|P5|Overall Study|Lost to Follow-up|3
5386780|NCT03449446|18539784|P4|Overall Study|Lost to Follow-up|1
5386781|NCT03449446|18539785|P3|Overall Study|Lost to Follow-up|2
5386782|NCT03449446|18539786|P2|Overall Study|Lost to Follow-up|0
5386783|NCT03449446|18539787|P1|Overall Study|Lost to Follow-up|0
5386784|NCT03449446|18539781|P7|Overall Study|Adverse Event|0
5386785|NCT03449446|18539782|P6|Overall Study|Adverse Event|2
5386786|NCT03449446|18539783|P5|Overall Study|Adverse Event|0
5386787|NCT03449446|18539784|P4|Overall Study|Adverse Event|0
5386788|NCT03449446|18539785|P3|Overall Study|Adverse Event|1
5386789|NCT03449446|18539786|P2|Overall Study|Adverse Event|2
5386790|NCT03449446|18539787|P1|Overall Study|Adverse Event|1
5386791|NCT03449446|18539781|P7|Overall Study|Withdrew Consent|1
5386792|NCT03449446|18539782|P6|Overall Study|Withdrew Consent|4
5386793|NCT03449446|18539783|P5|Overall Study|Withdrew Consent|4
5386794|NCT03449446|18539784|P4|Overall Study|Withdrew Consent|4
5386795|NCT03449446|18539785|P3|Overall Study|Withdrew Consent|1
5386796|NCT03449446|18539786|P2|Overall Study|Withdrew Consent|3
5386797|NCT03449446|18539787|P1|Overall Study|Withdrew Consent|1
5386798|NCT03449446|18539781|P7|Overall Study|Unknown Reason|0
5386799|NCT03449446|18539782|P6|Overall Study|Unknown Reason|2
5386800|NCT03449446|18539783|P5|Overall Study|Unknown Reason|2
5386801|NCT03449446|18539784|P4|Overall Study|Unknown Reason|1
5386802|NCT03449446|18539785|P3|Overall Study|Unknown Reason|1
5386803|NCT03449446|18539786|P2|Overall Study|Unknown Reason|1
5386804|NCT03449446|18539787|P1|Overall Study|Unknown Reason|33
5386805|NCT03449446|18539781|P7|Overall Study|Randomized but Never Treated|0
5386806|NCT03449446|18539782|P6|Overall Study|Randomized but Never Treated|0
5386807|NCT03449446|18539783|P5|Overall Study|Randomized but Never Treated|1
5386808|NCT03449446|18539784|P4|Overall Study|Randomized but Never Treated|1
5386809|NCT03449446|18539785|P3|Overall Study|Randomized but Never Treated|1
5386810|NCT03449446|18539786|P2|Overall Study|Randomized but Never Treated|0
5386811|NCT03449446|18539787|P1|Overall Study|Randomized but Never Treated|0
5386812|NCT03448536|18539858|P2|Overall Study|Physician Decision|0
5386813|NCT03448536|18539859|P1|Overall Study|Physician Decision|1
5386814|NCT03448536|18539858|P2|Overall Study|Other|0
5386815|NCT03448536|18539859|P1|Overall Study|Other|3
5386816|NCT03448536|18539858|P2|Overall Study|Inadequate pain reporter|0
5386817|NCT03448536|18539859|P1|Overall Study|Inadequate pain reporter|1
5386818|NCT03448536|18539858|P2|Overall Study|Lost to Follow-up|2
5386819|NCT03448536|18539859|P1|Overall Study|Lost to Follow-up|3
5386820|NCT03448536|18539858|P2|Overall Study|Withdrawal by Subject|2
5386821|NCT03448536|18539859|P1|Overall Study|Withdrawal by Subject|1
5386822|NCT03448536|18539858|P2|Overall Study|Pregnancy|0
5386823|NCT03448536|18539859|P1|Overall Study|Pregnancy|1
5386824|NCT03448536|18539858|P2|Overall Study|Protocol Violation|0
5386825|NCT03448536|18539859|P1|Overall Study|Protocol Violation|2
5386826|NCT03448419|18539885|P2|Overall Study|Withdrawn by Sponsor|1
5386827|NCT03448419|18539886|P1|Overall Study|Withdrawn by Sponsor|0
5386828|NCT03448419|18539885|P2|Overall Study|Patient did not attend all visits|2
5386829|NCT03448419|18539886|P1|Overall Study|Patient did not attend all visits|0
5386830|NCT03448419|18539885|P2|Overall Study|Not treated|1
5386831|NCT03448419|18539886|P1|Overall Study|Not treated|0
5386832|NCT03448419|18539885|P2|Overall Study|Withdrawal by Subject|1
5386833|NCT03448419|18539886|P1|Overall Study|Withdrawal by Subject|3
5386834|NCT03448419|18539885|P2|Overall Study|Lost to Follow-up|2
5386835|NCT03448419|18539886|P1|Overall Study|Lost to Follow-up|0
5386836|NCT03448419|18539885|P2|Overall Study|Adverse Event|9
5386837|NCT03448419|18539886|P1|Overall Study|Adverse Event|10
5386838|NCT03448406|18539912|P2|Overall Study|Adverse Event|9
5386839|NCT03448406|18539913|P1|Overall Study|Adverse Event|8
5386840|NCT03448406|18539912|P2|Overall Study|Protocol Violation|0
5386841|NCT03448406|18539913|P1|Overall Study|Protocol Violation|1
5386842|NCT03448406|18539912|P2|Overall Study|Withdrawal by Subject|2
5386843|NCT03448406|18539913|P1|Overall Study|Withdrawal by Subject|1
5386844|NCT03448406|18539912|P2|Overall Study|Noncompliance of scheduled visits|2
5386845|NCT03448406|18539913|P1|Overall Study|Noncompliance of scheduled visits|1
5386846|NCT03448224|18539939|P2|Overall Study|Provided same answer to every question|0
5386847|NCT03448224|18539940|P1|Overall Study|Provided same answer to every question|1
5386848|NCT03447821|18539957|P3|Overall Study|Lost to Follow-up|1
5386849|NCT03447821|18539958|P2|Overall Study|Lost to Follow-up|0
5386850|NCT03447821|18539959|P1|Overall Study|Lost to Follow-up|0
5386851|NCT03447821|18539957|P3|Overall Study|Withdrawal by Subject|0
5386852|NCT03447821|18539958|P2|Overall Study|Withdrawal by Subject|1
5386853|NCT03447821|18539959|P1|Overall Study|Withdrawal by Subject|1
5386854|NCT03447730|18539985|P3|Overall Study|Adverse Event|0
5386855|NCT03447730|18539986|P2|Overall Study|Adverse Event|2
5386856|NCT03447730|18539987|P1|Overall Study|Adverse Event|0
5386857|NCT03447353|18540014|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
5386858|NCT03447353|18540014|P1|Overall Study|Scheduling Conflicts|3
5386859|NCT03447353|18540014|P1|Overall Study|Lost to Follow-up|4
5386860|NCT03447353|18540014|P1|Overall Study|Failure at Screening Visit|2
5386861|NCT03447249|18540030|P2|Overall Study|Other|0
5386862|NCT03447249|18540031|P1|Overall Study|Other|3
5386863|NCT03447249|18540030|P2|Overall Study|Withdrawal of consent (not due to AE)|0
5386864|NCT03447249|18540031|P1|Overall Study|Withdrawal of consent (not due to AE)|1
5386865|NCT03447249|18540030|P2|Overall Study|Adverse Event|0
5386866|NCT03447249|18540031|P1|Overall Study|Adverse Event|1
5386867|NCT03446781|18540103|P2|Overall Study|Protocol Violation|3
5386868|NCT03446781|18540104|P1|Overall Study|Protocol Violation|0
5386869|NCT03446781|18540103|P2|Overall Study|Adverse Event|2
5386870|NCT03446781|18540104|P1|Overall Study|Adverse Event|8
5386871|NCT03446781|18540103|P2|Overall Study|Withdrawal by Subject|7
5386872|NCT03446781|18540104|P1|Overall Study|Withdrawal by Subject|9
5386873|NCT03446781|18540103|P2|Overall Study|Lost to Follow-up|5
5386874|NCT03446781|18540104|P1|Overall Study|Lost to Follow-up|11
5386875|NCT03446573|18540162|P2|Overall Study|Ongoing at the time of interim analysis|343
5386876|NCT03446573|18540163|P1|Overall Study|Ongoing at the time of interim analysis|342
5386877|NCT03446573|18540162|P2|Overall Study|Adverse Event|2
5386878|NCT03446573|18540163|P1|Overall Study|Adverse Event|13
5386879|NCT03446573|18540162|P2|Overall Study|Lack of Efficacy|3
5386880|NCT03446573|18540163|P1|Overall Study|Lack of Efficacy|0
5386881|NCT03446573|18540162|P2|Overall Study|Protocol Violation|2
5386882|NCT03446573|18540163|P1|Overall Study|Protocol Violation|3
5386883|NCT03446573|18540162|P2|Overall Study|Lost to Follow-up|5
5386884|NCT03446573|18540163|P1|Overall Study|Lost to Follow-up|3
5386885|NCT03446573|18540162|P2|Overall Study|Physician Decision|1
5386886|NCT03446573|18540163|P1|Overall Study|Physician Decision|1
5386887|NCT03446573|18540162|P2|Overall Study|Withdrawal by Subject|16
5386888|NCT03446573|18540163|P1|Overall Study|Withdrawal by Subject|7
5386889|NCT03444766|18540283|P1|Overall Study|Disease Progression|49
5386890|NCT03444766|18540283|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
5386891|NCT03444766|18540283|P1|Overall Study|Death|2
5386892|NCT03444766|18540283|P1|Overall Study|Lost to Follow-up|2
5386893|NCT03444766|18540283|P1|Overall Study|Participant Withdrew Consent|5
5386894|NCT03444766|18540283|P1|Overall Study|Other Reasons|2
5386895|NCT03444584|18540292|P2|Overall Study|Other|1
5386896|NCT03444584|18540293|P1|Overall Study|Other|0
5386897|NCT03444584|18540292|P2|Overall Study|Withdrawal by Subject|1
5386898|NCT03444584|18540293|P1|Overall Study|Withdrawal by Subject|0
5386899|NCT03443713|18540363|P3|First at Home Period (9-14 Days)|Withdrawal by Subject|1
5386900|NCT03443713|18540364|P2|First at Home Period (9-14 Days)|Withdrawal by Subject|0
5386901|NCT03443713|18540365|P1|First at Home Period (9-14 Days)|Withdrawal by Subject|0
5386902|NCT03443427|18540396|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
5386903|NCT03443427|18540397|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
5386904|NCT03443427|18540396|P2|Overall Study|Adverse Event|3
5386905|NCT03443427|18540397|P1|Overall Study|Adverse Event|2
5386906|NCT03443414|18540434|P5|Overall Study|Reason not specified|1
5386907|NCT03443414|18540435|P4|Overall Study|Reason not specified|0
5386908|NCT03443414|18540436|P3|Overall Study|Reason not specified|0
5386909|NCT03443414|18540437|P2|Overall Study|Reason not specified|0
5386910|NCT03443414|18540438|P1|Overall Study|Reason not specified|2
5386911|NCT03443414|18540434|P5|Overall Study|Death|0
5386912|NCT03443414|18540435|P4|Overall Study|Death|1
5386913|NCT03443414|18540436|P3|Overall Study|Death|0
5386914|NCT03443414|18540437|P2|Overall Study|Death|1
5386915|NCT03443414|18540438|P1|Overall Study|Death|0
5386916|NCT03443414|18540434|P5|Overall Study|Withdrawal by Subject|1
5386917|NCT03443414|18540435|P4|Overall Study|Withdrawal by Subject|2
5386918|NCT03443414|18540436|P3|Overall Study|Withdrawal by Subject|2
5386919|NCT03443414|18540437|P2|Overall Study|Withdrawal by Subject|2
5386920|NCT03443414|18540438|P1|Overall Study|Withdrawal by Subject|3
5386921|NCT03443414|18540434|P5|Overall Study|Adverse Event|3
5386922|NCT03443414|18540435|P4|Overall Study|Adverse Event|2
5386923|NCT03443414|18540436|P3|Overall Study|Adverse Event|4
5386924|NCT03443414|18540437|P2|Overall Study|Adverse Event|0
5386925|NCT03443414|18540438|P1|Overall Study|Adverse Event|6
5386926|NCT03442829|18540549|P2|Overall Study|Illness unrelated to study|1
5386927|NCT03442829|18540550|P1|Overall Study|Illness unrelated to study|1
5386928|NCT03442829|18540549|P2|Overall Study|Scheduling clash|1
5386929|NCT03442829|18540550|P1|Overall Study|Scheduling clash|3
5386930|NCT03442595|18540609|P2|Overall Study|Lost to Follow-up|0
5386931|NCT03442595|18540610|P1|Overall Study|Lost to Follow-up|94
5386932|NCT03441984|18540642|P12|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386933|NCT03441984|18540643|P11|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386934|NCT03441984|18540644|P10|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386935|NCT03441984|18540645|P9|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386936|NCT03441984|18540646|P8|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386937|NCT03441984|18540647|P7|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386938|NCT03441984|18540648|P6|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386939|NCT03441984|18540649|P5|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386940|NCT03441984|18540650|P4|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386941|NCT03441984|18540651|P3|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
5386942|NCT03441984|18540652|P2|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386943|NCT03441984|18540653|P1|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
5386944|NCT03441789|18541014|P2|Overall Study|Lost to Follow-up|1
5386945|NCT03441789|18541015|P1|Overall Study|Lost to Follow-up|0
5386946|NCT03441789|18541014|P2|Overall Study|Protocol Violation|1
5386947|NCT03441789|18541015|P1|Overall Study|Protocol Violation|0
5386948|NCT03441789|18541014|P2|Overall Study|Adverse Event|1
5386949|NCT03441789|18541015|P1|Overall Study|Adverse Event|0
5386950|NCT03441789|18541014|P2|Overall Study|Withdrawal by Subject|1
5386951|NCT03441789|18541015|P1|Overall Study|Withdrawal by Subject|1
5386952|NCT03440918|18541236|P2|Overall Study|Protocol Violation|16
5386953|NCT03440918|18541237|P1|Overall Study|Protocol Violation|0
5386954|NCT03439124|18541335|P2|Overall Study|Other reasons|0
5386955|NCT03439124|18541336|P1|Overall Study|Other reasons|1
5386956|NCT03439124|18541335|P2|Overall Study|Lost to Follow-up|0
5386957|NCT03439124|18541336|P1|Overall Study|Lost to Follow-up|1
5386958|NCT03439124|18541335|P2|Overall Study|Adverse Event|0
5386959|NCT03439124|18541336|P1|Overall Study|Adverse Event|2
5386960|NCT03439072|18541350|P2|Overall Study|Physician Decision|1
5386961|NCT03439072|18541351|P1|Overall Study|Physician Decision|0
5386962|NCT03439072|18541350|P2|Overall Study|Withdrawal by Subject|3
5386963|NCT03439072|18541351|P1|Overall Study|Withdrawal by Subject|2
5386964|NCT03438539|18541402|P6|Overall Study|Lost to Follow-up|8
5386965|NCT03438539|18541403|P5|Overall Study|Lost to Follow-up|3
5386966|NCT03438539|18541404|P4|Overall Study|Lost to Follow-up|9
5386967|NCT03438539|18541405|P3|Overall Study|Lost to Follow-up|10
5386968|NCT03438539|18541406|P2|Overall Study|Lost to Follow-up|4
5386969|NCT03438539|18541407|P1|Overall Study|Lost to Follow-up|8
5386970|NCT03438383|18541435|P2|Overall Study|Protocol Violation|3
5386971|NCT03438383|18541436|P1|Overall Study|Protocol Violation|9
5386972|NCT03437733|18541467|P2|Overall Study|Eligibility criteria not met|3
5386973|NCT03437733|18541468|P1|Overall Study|Eligibility criteria not met|0
5386974|NCT03437447|18541523|P3|Treatment Period 1|Withdrawal by Subject|1
5386975|NCT03437447|18541524|P2|Treatment Period 1|Withdrawal by Subject|0
5386976|NCT03437447|18541525|P1|Treatment Period 1|Withdrawal by Subject|0
5386977|NCT03436732|18541580|P2|Overall Study|Death|1
5386978|NCT03436732|18541581|P1|Overall Study|Death|0
5386979|NCT03436732|18541580|P2|Overall Study|Adverse Event|0
5386980|NCT03436732|18541581|P1|Overall Study|Adverse Event|2
5386981|NCT03436732|18541580|P2|Overall Study|Off study after cycle 1|0
5386982|NCT03436732|18541581|P1|Overall Study|Off study after cycle 1|1
5386983|NCT03436732|18541580|P2|Overall Study|Not treated-enrolled in different study|0
5386984|NCT03436732|18541581|P1|Overall Study|Not treated-enrolled in different study|1
5386985|NCT03436420|18541594|P1|Overall Study|Lack of Efficacy|3
5386986|NCT03435497|18541747|P2|Overall Study|Wrong survey administered|2
5386987|NCT03435497|18541748|P1|Overall Study|Wrong survey administered|0
5386988|NCT03435497|18541747|P2|Overall Study|Withdrawal by Subject|4
5386989|NCT03435497|18541748|P1|Overall Study|Withdrawal by Subject|0
5386990|NCT03435497|18541747|P2|Overall Study|Death|0
5386991|NCT03435497|18541748|P1|Overall Study|Death|1
5386992|NCT03435497|18541747|P2|Overall Study|Lost to Follow-up|0
5386993|NCT03435497|18541748|P1|Overall Study|Lost to Follow-up|1
5386994|NCT03434977|18541775|P2|Washout Period (at Least 6 Days)|Adverse Event|1
5386995|NCT03434977|18541776|P1|Washout Period (at Least 6 Days)|Adverse Event|0
5386996|NCT03434249|18541843|P2|Overall Study|Difficulties in completing daily diary|1
5386997|NCT03434249|18541844|P1|Overall Study|Difficulties in completing daily diary|2
5386998|NCT03434249|18541843|P2|Overall Study|Non-compliance of family|1
5386999|NCT03434249|18541844|P1|Overall Study|Non-compliance of family|2
5387000|NCT03434249|18541843|P2|Overall Study|Lost to Follow-up|1
5387001|NCT03434249|18541844|P1|Overall Study|Lost to Follow-up|0
5387002|NCT03434249|18541843|P2|Overall Study|Adverse Event|0
5387003|NCT03434249|18541844|P1|Overall Study|Adverse Event|1
5387004|NCT03434119|18541878|P2|Overall Study|Other than specified|5
5387005|NCT03434119|18541879|P1|Overall Study|Other than specified|7
5387006|NCT03434119|18541878|P2|Overall Study|Withdrawal by Subject|5
5387007|NCT03434119|18541879|P1|Overall Study|Withdrawal by Subject|7
5387008|NCT03434119|18541878|P2|Overall Study|Study Terminated by Sponsor|102
5387009|NCT03434119|18541879|P1|Overall Study|Study Terminated by Sponsor|91
5387010|NCT03434119|18541878|P2|Overall Study|Poor Compliance to Protocol|1
5387011|NCT03434119|18541879|P1|Overall Study|Poor Compliance to Protocol|0
5387012|NCT03434119|18541878|P2|Overall Study|Adverse Event|0
5387013|NCT03434119|18541879|P1|Overall Study|Adverse Event|1
5387014|NCT03434119|18541878|P2|Overall Study|Randomized but not treated|0
5387015|NCT03434119|18541879|P1|Overall Study|Randomized but not treated|1
5387016|NCT03433703|18541913|P1|Overall Study|Study terminated by Sponsor|2
5387017|NCT03433677|18541922|P2|Period 2|Withdrawal by Subject|1
5387018|NCT03433677|18541923|P1|Period 2|Withdrawal by Subject|1
5387019|NCT03433677|18541922|P2|Period 1|Protocol Violation|0
5387020|NCT03433677|18541923|P1|Period 1|Protocol Violation|1
5387021|NCT03432533|18541943|P2|Overall Study|Withdrawal by Subject|9
5387022|NCT03432533|18541944|P1|Overall Study|Withdrawal by Subject|14
5387023|NCT03432533|18541943|P2|Overall Study|Lost to Follow-up|2
5387024|NCT03432533|18541944|P1|Overall Study|Lost to Follow-up|1
5387025|NCT03432390|18541960|P2|Apnea Period|Protocol Violation|2
5387026|NCT03432390|18541961|P1|Apnea Period|Protocol Violation|2
5387027|NCT03431441|18541971|P1|Overall Study|Dispensed Incorrect Replacement Lens|1
5387028|NCT03431441|18541971|P1|Overall Study|Adverse Event|2
5387029|NCT03431441|18541971|P1|Overall Study|Withdrawal by Subject|2
5387030|NCT03430986|18542006|P2|24-week Post-Control Period|Withdrawal by Participant|1
5387031|NCT03430986|18542007|P1|24-week Post-Control Period|Withdrawal by Participant|0
5387032|NCT03430986|18542006|P2|24-week Post-Control Period|Lost to Follow-up|1
5387033|NCT03430986|18542007|P1|24-week Post-Control Period|Lost to Follow-up|1
5387034|NCT03430986|18542006|P2|24-week Control Period|Protocol Deviation|2
5387035|NCT03430986|18542007|P1|24-week Control Period|Protocol Deviation|0
5387036|NCT03430986|18542006|P2|24-week Control Period|Withdrawal by Participant|0
5387037|NCT03430986|18542007|P1|24-week Control Period|Withdrawal by Participant|5
5387038|NCT03430986|18542006|P2|24-week Control Period|Lost to Follow-up|2
5387039|NCT03430986|18542007|P1|24-week Control Period|Lost to Follow-up|2
5387040|NCT03430986|18542006|P2|24-week Control Period|Adverse Event|0
5387041|NCT03430986|18542007|P1|24-week Control Period|Adverse Event|1
5387042|NCT03430856|18542024|P3|Overall Study|Voluntary withdrawal of consent|1
5387043|NCT03430856|18542025|P2|Overall Study|Voluntary withdrawal of consent|1
5387044|NCT03430856|18542026|P1|Overall Study|Voluntary withdrawal of consent|1
5387045|NCT03430856|18542024|P3|Overall Study|Rescue criteria|0
5387046|NCT03430856|18542025|P2|Overall Study|Rescue criteria|1
5387047|NCT03430856|18542026|P1|Overall Study|Rescue criteria|1
5387048|NCT03430856|18542024|P3|Overall Study|Adverse Event|0
5387049|NCT03430856|18542025|P2|Overall Study|Adverse Event|1
5387050|NCT03430856|18542026|P1|Overall Study|Adverse Event|0
5387051|NCT03430245|18542064|P1|Overall Study|Lost to Follow-up|1
5387052|NCT03430245|18542064|P1|Overall Study|Withdrawal by Subject|6
5387053|NCT03429556|18542111|P4|Overall Study|Lost to Follow-up|0
5387054|NCT03429556|18542112|P3|Overall Study|Lost to Follow-up|0
5387055|NCT03429556|18542113|P2|Overall Study|Lost to Follow-up|1
5387056|NCT03429556|18542114|P1|Overall Study|Lost to Follow-up|0
5387057|NCT03428997|18542165|P1|Overall Study|Lost to Follow-up|4
5387058|NCT03428997|18542165|P1|Overall Study|Withdrawal by Subject|3
5387059|NCT03428997|18542165|P1|Overall Study|Sponsor decision.|1
5387060|NCT03428750|18542173|P2|Overall Study|Administrative|1
5387061|NCT03428750|18542174|P1|Overall Study|Administrative|0
5387062|NCT03428750|18542173|P2|Overall Study|Protocol Violation|0
5387063|NCT03428750|18542174|P1|Overall Study|Protocol Violation|1
5387064|NCT03428750|18542173|P2|Overall Study|Adverse Event|1
5387065|NCT03428750|18542174|P1|Overall Study|Adverse Event|9
5387066|NCT03428750|18542173|P2|Overall Study|Lost to Follow-up|9
5387067|NCT03428750|18542174|P1|Overall Study|Lost to Follow-up|3
5387068|NCT03428750|18542173|P2|Overall Study|Withdrawal by Subject|10
5387069|NCT03428750|18542174|P1|Overall Study|Withdrawal by Subject|11
5387070|NCT03428152|18542223|P2|Overall Study|Lack of Efficacy|4
5387071|NCT03428152|18542224|P1|Overall Study|Lack of Efficacy|0
5387072|NCT03428152|18542223|P2|Overall Study|Protocol Violation|5
5387073|NCT03428152|18542224|P1|Overall Study|Protocol Violation|3
5387074|NCT03428152|18542223|P2|Overall Study|Physician Decision|2
5387075|NCT03428152|18542224|P1|Overall Study|Physician Decision|4
5387076|NCT03427892|18542245|P1|Overall Study|Lost to Follow-up|2
5387077|NCT03427073|18542269|P8|Overall Study|Physician Decision|1
5387078|NCT03427073|18542270|P7|Overall Study|Physician Decision|1
5387079|NCT03427073|18542271|P6|Overall Study|Physician Decision|0
5387080|NCT03427073|18542272|P5|Overall Study|Physician Decision|0
5387081|NCT03427073|18542273|P4|Overall Study|Physician Decision|0
5387082|NCT03427073|18542274|P3|Overall Study|Physician Decision|0
5387083|NCT03427073|18542275|P2|Overall Study|Physician Decision|0
5387084|NCT03427073|18542276|P1|Overall Study|Physician Decision|0
5387085|NCT03427073|18542269|P8|Overall Study|Disease Progression|3
5387086|NCT03427073|18542270|P7|Overall Study|Disease Progression|2
5387087|NCT03427073|18542271|P6|Overall Study|Disease Progression|4
5387088|NCT03427073|18542272|P5|Overall Study|Disease Progression|3
5387089|NCT03427073|18542273|P4|Overall Study|Disease Progression|3
5387090|NCT03427073|18542274|P3|Overall Study|Disease Progression|1
5387091|NCT03427073|18542275|P2|Overall Study|Disease Progression|1
5387092|NCT03427073|18542276|P1|Overall Study|Disease Progression|1
5387093|NCT03426995|18542345|P19|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387094|NCT03426995|18542346|P18|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387095|NCT03426995|18542347|P17|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387096|NCT03426995|18542348|P16|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3
5387097|NCT03426995|18542349|P15|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1
5387098|NCT03426995|18542350|P14|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387099|NCT03426995|18542351|P13|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387100|NCT03426995|18542352|P12|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387101|NCT03426995|18542353|P11|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387102|NCT03426995|18542354|P10|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387103|NCT03426995|18542355|P9|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387104|NCT03426995|18542356|P8|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387105|NCT03426995|18542357|P7|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387106|NCT03426995|18542358|P6|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387107|NCT03426995|18542359|P5|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387108|NCT03426995|18542360|P4|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387109|NCT03426995|18542361|P3|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387110|NCT03426995|18542362|P2|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387111|NCT03426995|18542363|P1|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
5387112|NCT03426995|18542345|P19|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387113|NCT03426995|18542346|P18|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387114|NCT03426995|18542347|P17|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387115|NCT03426995|18542348|P16|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9
5387116|NCT03426995|18542349|P15|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8
5387117|NCT03426995|18542350|P14|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387118|NCT03426995|18542351|P13|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387119|NCT03426995|18542352|P12|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387120|NCT03426995|18542353|P11|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387121|NCT03426995|18542354|P10|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387122|NCT03426995|18542355|P9|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387123|NCT03426995|18542356|P8|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387124|NCT03426995|18542357|P7|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387125|NCT03426995|18542358|P6|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387126|NCT03426995|18542359|P5|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387127|NCT03426995|18542360|P4|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387128|NCT03426995|18542361|P3|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387129|NCT03426995|18542362|P2|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387130|NCT03426995|18542363|P1|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
5387131|NCT03426995|18542345|P19|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387132|NCT03426995|18542346|P18|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387133|NCT03426995|18542347|P17|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387134|NCT03426995|18542348|P16|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387135|NCT03426995|18542349|P15|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387136|NCT03426995|18542350|P14|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387137|NCT03426995|18542351|P13|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387138|NCT03426995|18542352|P12|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387139|NCT03426995|18542353|P11|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387140|NCT03426995|18542354|P10|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387141|NCT03426995|18542355|P9|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387142|NCT03426995|18542356|P8|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1
5387143|NCT03426995|18542357|P7|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387144|NCT03426995|18542358|P6|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387145|NCT03426995|18542359|P5|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387146|NCT03426995|18542360|P4|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387147|NCT03426995|18542361|P3|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387148|NCT03426995|18542362|P2|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387149|NCT03426995|18542363|P1|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
5387150|NCT03426995|18542345|P19|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387151|NCT03426995|18542346|P18|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387152|NCT03426995|18542347|P17|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387153|NCT03426995|18542348|P16|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387154|NCT03426995|18542349|P15|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387155|NCT03426995|18542350|P14|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387156|NCT03426995|18542351|P13|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387157|NCT03426995|18542352|P12|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387158|NCT03426995|18542353|P11|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1
5387159|NCT03426995|18542354|P10|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387160|NCT03426995|18542355|P9|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387161|NCT03426995|18542356|P8|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387162|NCT03426995|18542357|P7|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387163|NCT03426995|18542358|P6|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387164|NCT03426995|18542359|P5|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387165|NCT03426995|18542360|P4|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387166|NCT03426995|18542361|P3|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387167|NCT03426995|18542362|P2|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387168|NCT03426995|18542363|P1|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
5387169|NCT03426995|18542345|P19|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387170|NCT03426995|18542346|P18|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387171|NCT03426995|18542347|P17|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387172|NCT03426995|18542348|P16|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387173|NCT03426995|18542349|P15|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387174|NCT03426995|18542350|P14|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387175|NCT03426995|18542351|P13|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387176|NCT03426995|18542352|P12|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387177|NCT03426995|18542353|P11|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387178|NCT03426995|18542354|P10|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387179|NCT03426995|18542355|P9|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387180|NCT03426995|18542356|P8|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387181|NCT03426995|18542357|P7|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387182|NCT03426995|18542358|P6|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
5387183|NCT03426995|18542359|P5|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
5387184|NCT03426995|18542360|P4|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387185|NCT03426995|18542361|P3|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387186|NCT03426995|18542362|P2|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387187|NCT03426995|18542363|P1|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
5387188|NCT03426995|18542345|P19|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387189|NCT03426995|18542346|P18|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387190|NCT03426995|18542347|P17|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387191|NCT03426995|18542348|P16|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387192|NCT03426995|18542349|P15|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387193|NCT03426995|18542350|P14|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387194|NCT03426995|18542351|P13|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387195|NCT03426995|18542352|P12|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387196|NCT03426995|18542353|P11|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387197|NCT03426995|18542354|P10|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387198|NCT03426995|18542355|P9|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387199|NCT03426995|18542356|P8|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387200|NCT03426995|18542357|P7|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387201|NCT03426995|18542358|P6|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1
5387202|NCT03426995|18542359|P5|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387203|NCT03426995|18542360|P4|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387204|NCT03426995|18542361|P3|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387205|NCT03426995|18542362|P2|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387206|NCT03426995|18542363|P1|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
5387207|NCT03426995|18542345|P19|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387208|NCT03426995|18542346|P18|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387209|NCT03426995|18542347|P17|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387210|NCT03426995|18542348|P16|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387211|NCT03426995|18542349|P15|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387212|NCT03426995|18542350|P14|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387213|NCT03426995|18542351|P13|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387214|NCT03426995|18542352|P12|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387215|NCT03426995|18542353|P11|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387216|NCT03426995|18542354|P10|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387217|NCT03426995|18542355|P9|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387218|NCT03426995|18542356|P8|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387219|NCT03426995|18542357|P7|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387220|NCT03426995|18542358|P6|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387221|NCT03426995|18542359|P5|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387222|NCT03426995|18542360|P4|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387223|NCT03426995|18542361|P3|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1
5387224|NCT03426995|18542362|P2|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387225|NCT03426995|18542363|P1|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
5387226|NCT03426787|18542710|P1|Overall Study|Unrelated to intervention death|1
5387227|NCT03426787|18542710|P1|Overall Study|Lost to Follow-up|7
5387228|NCT03426787|18542710|P1|Overall Study|Withdrawal by Subject|6
5387229|NCT03426631|18542720|P2|Overall Study|Lost to Follow-up|1
5387230|NCT03426631|18542721|P1|Overall Study|Lost to Follow-up|0
5387231|NCT03426436|18542733|P1|Overall Study|ECGs not saved|4
5387232|NCT03426436|18542733|P1|Overall Study|Consent issue|1
5387233|NCT03426436|18542733|P1|Overall Study|Withdrawal by Subject|2
5387234|NCT03426436|18542733|P1|Overall Study|Incorrect lead placement|12
5387235|NCT03426137|18542741|P3|Overall Study|Withdrawal by Subject|0
5387236|NCT03426137|18542742|P2|Overall Study|Withdrawal by Subject|0
5387237|NCT03426137|18542743|P1|Overall Study|Withdrawal by Subject|3
5387238|NCT03425396|18542756|P5|Overall Study|Other|1
5387239|NCT03425396|18542757|P4|Overall Study|Other|0
5387240|NCT03425396|18542758|P3|Overall Study|Other|1
5387241|NCT03425396|18542759|P2|Overall Study|Other|1
5387242|NCT03425396|18542760|P1|Overall Study|Other|0
5387243|NCT03425396|18542756|P5|Overall Study|Withdrawal by Subject|0
5387244|NCT03425396|18542757|P4|Overall Study|Withdrawal by Subject|1
5387245|NCT03425396|18542758|P3|Overall Study|Withdrawal by Subject|0
5387246|NCT03425396|18542759|P2|Overall Study|Withdrawal by Subject|1
5387247|NCT03425396|18542760|P1|Overall Study|Withdrawal by Subject|0
5387248|NCT03425396|18542756|P5|Overall Study|Lost to Follow-up|0
5387249|NCT03425396|18542757|P4|Overall Study|Lost to Follow-up|0
5387250|NCT03425396|18542758|P3|Overall Study|Lost to Follow-up|2
5387251|NCT03425396|18542759|P2|Overall Study|Lost to Follow-up|5
5387252|NCT03425396|18542760|P1|Overall Study|Lost to Follow-up|2
5387253|NCT03425253|18542842|P1|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5
5387254|NCT03425253|18542842|P1|Overall Study|Withdrew Consent|6
5387255|NCT03425253|18542842|P1|Overall Study|Lost to Follow-up|3
5387256|NCT03425253|18542842|P1|Overall Study|Adverse Event|2
5387257|NCT03424265|18542871|P2|Overall Study|Withdrawal by Subject|2
5387258|NCT03424265|18542872|P1|Overall Study|Withdrawal by Subject|0
5387259|NCT03424265|18542871|P2|Overall Study|screening failure|0
5387260|NCT03424265|18542872|P1|Overall Study|screening failure|1
5387261|NCT03424044|18542878|P9|Third Intervention (76 Hours)|Withdrawal by Subject|0
5387262|NCT03424044|18542879|P8|Third Intervention (76 Hours)|Withdrawal by Subject|0
5387263|NCT03424044|18542880|P7|Third Intervention (76 Hours)|Withdrawal by Subject|0
5387264|NCT03424044|18542881|P6|Third Intervention (76 Hours)|Withdrawal by Subject|0
5387265|NCT03424044|18542882|P5|Third Intervention (76 Hours)|Withdrawal by Subject|0
5387266|NCT03424044|18542883|P4|Third Intervention (76 Hours)|Withdrawal by Subject|1
5387267|NCT03424044|18542884|P3|Third Intervention (76 Hours)|Withdrawal by Subject|0
5387268|NCT03424044|18542885|P2|Third Intervention (76 Hours)|Withdrawal by Subject|0
5387269|NCT03424044|18542886|P1|Third Intervention (76 Hours)|Withdrawal by Subject|0
5387270|NCT03424044|18542878|P9|Third Intervention (76 Hours)|Adverse Event|0
5387271|NCT03424044|18542879|P8|Third Intervention (76 Hours)|Adverse Event|0
5387272|NCT03424044|18542880|P7|Third Intervention (76 Hours)|Adverse Event|1
5387273|NCT03424044|18542881|P6|Third Intervention (76 Hours)|Adverse Event|0
5387274|NCT03424044|18542882|P5|Third Intervention (76 Hours)|Adverse Event|0
5387275|NCT03424044|18542883|P4|Third Intervention (76 Hours)|Adverse Event|0
5387276|NCT03424044|18542884|P3|Third Intervention (76 Hours)|Adverse Event|0
5387277|NCT03424044|18542885|P2|Third Intervention (76 Hours)|Adverse Event|0
5387278|NCT03424044|18542886|P1|Third Intervention (76 Hours)|Adverse Event|1
5387279|NCT03424044|18542878|P9|First Intervention (76 Hours)|device issues|1
5387280|NCT03424044|18542879|P8|First Intervention (76 Hours)|device issues|1
5387281|NCT03424044|18542880|P7|First Intervention (76 Hours)|device issues|1
5387282|NCT03424044|18542881|P6|First Intervention (76 Hours)|device issues|0
5387283|NCT03424044|18542882|P5|First Intervention (76 Hours)|device issues|0
5387284|NCT03424044|18542883|P4|First Intervention (76 Hours)|device issues|0
5387285|NCT03424044|18542884|P3|First Intervention (76 Hours)|device issues|0
5387286|NCT03424044|18542885|P2|First Intervention (76 Hours)|device issues|0
5387287|NCT03424044|18542886|P1|First Intervention (76 Hours)|device issues|0
5387288|NCT03424044|18542878|P9|First Intervention (76 Hours)|Adverse Event|0
5387289|NCT03424044|18542879|P8|First Intervention (76 Hours)|Adverse Event|0
5387290|NCT03424044|18542880|P7|First Intervention (76 Hours)|Adverse Event|0
5387291|NCT03424044|18542881|P6|First Intervention (76 Hours)|Adverse Event|0
5387292|NCT03424044|18542882|P5|First Intervention (76 Hours)|Adverse Event|1
5387293|NCT03424044|18542883|P4|First Intervention (76 Hours)|Adverse Event|0
5387294|NCT03424044|18542884|P3|First Intervention (76 Hours)|Adverse Event|0
5387295|NCT03424044|18542885|P2|First Intervention (76 Hours)|Adverse Event|0
5387296|NCT03424044|18542886|P1|First Intervention (76 Hours)|Adverse Event|0
5387297|NCT03424044|18542878|P9|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5387298|NCT03424044|18542879|P8|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5387299|NCT03424044|18542880|P7|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5387300|NCT03424044|18542881|P6|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5387301|NCT03424044|18542882|P5|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5387302|NCT03424044|18542883|P4|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5387303|NCT03424044|18542884|P3|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
5387304|NCT03424044|18542885|P2|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5387305|NCT03424044|18542886|P1|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
5387306|NCT03423173|18542958|P4|Overall Study|Reason not Specified|1
5387307|NCT03423173|18542959|P3|Overall Study|Reason not Specified|3
5387308|NCT03423173|18542960|P2|Overall Study|Reason not Specified|5
5387309|NCT03423173|18542961|P1|Overall Study|Reason not Specified|2
5387310|NCT03423173|18542958|P4|Overall Study|Death|0
5387311|NCT03423173|18542959|P3|Overall Study|Death|0
5387312|NCT03423173|18542960|P2|Overall Study|Death|0
5387313|NCT03423173|18542961|P1|Overall Study|Death|1
5387314|NCT03423173|18542958|P4|Overall Study|Withdrawal of consent|5
5387315|NCT03423173|18542959|P3|Overall Study|Withdrawal of consent|4
5387316|NCT03423173|18542960|P2|Overall Study|Withdrawal of consent|10
5387317|NCT03423173|18542961|P1|Overall Study|Withdrawal of consent|4
5387318|NCT03423173|18542958|P4|Overall Study|Lost to Follow-up|22
5387319|NCT03423173|18542959|P3|Overall Study|Lost to Follow-up|17
5387320|NCT03423173|18542960|P2|Overall Study|Lost to Follow-up|19
5387321|NCT03423173|18542961|P1|Overall Study|Lost to Follow-up|10
5387322|NCT03423173|18542958|P4|Overall Study|Adverse Event|1
5387323|NCT03423173|18542959|P3|Overall Study|Adverse Event|1
5387324|NCT03423173|18542960|P2|Overall Study|Adverse Event|1
5387325|NCT03423173|18542961|P1|Overall Study|Adverse Event|1
5387326|NCT03423173|18542958|P4|Overall Study|Randomized but not vaccinated|1
5387327|NCT03423173|18542959|P3|Overall Study|Randomized but not vaccinated|2
5387328|NCT03423173|18542960|P2|Overall Study|Randomized but not vaccinated|0
5387329|NCT03423173|18542961|P1|Overall Study|Randomized but not vaccinated|1
5387330|NCT03421730|18543015|P12|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387331|NCT03421730|18543016|P11|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387332|NCT03421730|18543017|P10|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387333|NCT03421730|18543018|P9|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387334|NCT03421730|18543019|P8|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387335|NCT03421730|18543020|P7|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387336|NCT03421730|18543021|P6|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387337|NCT03421730|18543022|P5|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
5387338|NCT03421730|18543023|P4|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387339|NCT03421730|18543024|P3|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387340|NCT03421730|18543025|P2|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387341|NCT03421730|18543026|P1|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
5387342|NCT03421730|18543015|P12|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387343|NCT03421730|18543016|P11|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387344|NCT03421730|18543017|P10|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387345|NCT03421730|18543018|P9|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387346|NCT03421730|18543019|P8|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387347|NCT03421730|18543020|P7|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387348|NCT03421730|18543021|P6|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387349|NCT03421730|18543022|P5|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387350|NCT03421730|18543023|P4|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387351|NCT03421730|18543024|P3|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387352|NCT03421730|18543025|P2|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
5387353|NCT03421730|18543026|P1|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
5387354|NCT03421379|18543099|P2|Period 1|Did not receive treatment|2
5387355|NCT03421379|18543100|P1|Period 1|Did not receive treatment|1
5387356|NCT03421379|18543099|P2|Period 1|Physician Decision|1
5387357|NCT03421379|18543100|P1|Period 1|Physician Decision|1
5387358|NCT03421379|18543099|P2|Period 1|Withdrawal by Subject|1
5387359|NCT03421379|18543100|P1|Period 1|Withdrawal by Subject|0
5387360|NCT03420300|18543150|P1|Overall Study|Death|2
5387361|NCT03419962|18543159|P1|Overall Study|Missing completion data|31
5387362|NCT03419962|18543159|P1|Overall Study|Difficulty in inhaling the doses|1
5387363|NCT03419962|18543159|P1|Overall Study|Lost to Follow-up|3
5387364|NCT03419962|18543159|P1|Overall Study|Refusal of continuing with trial drug|1
5387365|NCT03419962|18543159|P1|Overall Study|Change to other medication|1
5387366|NCT03419598|18543190|P1|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2
5387367|NCT03418571|18543246|P2|Overall Study|Consent withdrawn by legal guardian|0
5387368|NCT03418571|18543247|P1|Overall Study|Consent withdrawn by legal guardian|1
5387369|NCT03418376|18543259|P4|Overall Study|Exacerbation|0
5387370|NCT03418376|18543260|P3|Overall Study|Exacerbation|0
5387371|NCT03418376|18543261|P2|Overall Study|Exacerbation|1
5387372|NCT03418376|18543262|P1|Overall Study|Exacerbation|0
5387373|NCT03418376|18543259|P4|Overall Study|Personal reasons|1
5387374|NCT03418376|18543260|P3|Overall Study|Personal reasons|2
5387375|NCT03418376|18543261|P2|Overall Study|Personal reasons|2
5387376|NCT03418376|18543262|P1|Overall Study|Personal reasons|0
5387377|NCT03418376|18543259|P4|Overall Study|Musculoskeletal injury|0
5387378|NCT03418376|18543260|P3|Overall Study|Musculoskeletal injury|1
5387379|NCT03418376|18543261|P2|Overall Study|Musculoskeletal injury|2
5387380|NCT03418376|18543262|P1|Overall Study|Musculoskeletal injury|1
5387381|NCT03418324|18543290|P2|Overall Study|Physician Decision|1
5387382|NCT03418324|18543291|P1|Overall Study|Physician Decision|1
5387383|NCT03418324|18543290|P2|Overall Study|Death|1
5387384|NCT03418324|18543291|P1|Overall Study|Death|0
5387385|NCT03417830|18543341|P2|Part A (up to 26 Days)|Study Closed/Terminated|0
5387386|NCT03417830|18543342|P1|Part A (up to 26 Days)|Study Closed/Terminated|1
5387387|NCT03417505|18543476|P2|First Lens Type (30 Days)|Lost to Follow-up|1
5387388|NCT03417505|18543477|P1|First Lens Type (30 Days)|Lost to Follow-up|1
5387389|NCT03417219|18543508|P2|Overall Study|Lost to Follow-up|3
5387390|NCT03417219|18543509|P1|Overall Study|Lost to Follow-up|0
5387391|NCT03417141|18543519|P1|Overall Study|Protocol Violation|3
5387392|NCT03417141|18543519|P1|Overall Study|Withdrawal by Subject|1
5387393|NCT03417024|18543526|P1|Overall Study|Physician Decision|2
5387394|NCT03417024|18543526|P1|Overall Study|Study Termination prior to follow-up|11
5387395|NCT03416127|18543551|P3|Overall Study|Withdrawal by Subject|1
5387396|NCT03416127|18543552|P2|Overall Study|Withdrawal by Subject|1
5387397|NCT03416127|18543553|P1|Overall Study|Withdrawal by Subject|0
5387398|NCT03415178|18543697|P2|Single Arm Period (up to Week 16)|Adverse Event|1
5387399|NCT03415178|18543698|P1|Single Arm Period (up to Week 16)|Adverse Event|0
5387400|NCT03415178|18543697|P2|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
5387401|NCT03415178|18543698|P1|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
5387402|NCT03415022|18543752|P2|Overall Study|Lost to Follow-up|0
5387403|NCT03415022|18543753|P1|Overall Study|Lost to Follow-up|2
5387404|NCT03415022|18543752|P2|Overall Study|COVID-19 Suspension|3
5387405|NCT03415022|18543753|P1|Overall Study|COVID-19 Suspension|2
5387406|NCT03415022|18543752|P2|Overall Study|Withdrawal by Subject|2
5387407|NCT03415022|18543753|P1|Overall Study|Withdrawal by Subject|1
5387408|NCT03414359|18543763|P2|Overall Study|Protocol Violation|1
5387409|NCT03414359|18543764|P1|Overall Study|Protocol Violation|0
5387410|NCT03414359|18543763|P2|Overall Study|Lack of Efficacy|1
5387411|NCT03414359|18543764|P1|Overall Study|Lack of Efficacy|1
5387412|NCT03414047|18543776|P4|Overall Study|Withdrawal by Subject|2
5387413|NCT03414047|18543777|P3|Overall Study|Withdrawal by Subject|0
5387414|NCT03414047|18543778|P2|Overall Study|Withdrawal by Subject|0
5387415|NCT03414047|18543779|P1|Overall Study|Withdrawal by Subject|1
5387416|NCT03414047|18543776|P4|Overall Study|Adverse Event|1
5387417|NCT03414047|18543777|P3|Overall Study|Adverse Event|0
5387418|NCT03414047|18543778|P2|Overall Study|Adverse Event|0
5387419|NCT03414047|18543779|P1|Overall Study|Adverse Event|0
5387420|NCT03412929|18543839|P1|Overall Study|Protocol Violation|3
5387421|NCT03412734|18543850|P2|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
5387422|NCT03412734|18543851|P1|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
5387423|NCT03412734|18543850|P2|Overall Study|Incorrect labeling of samples|0
5387424|NCT03412734|18543851|P1|Overall Study|Incorrect labeling of samples|2
5387425|NCT03412084|18543859|P2|Overall Study|Lost to Follow-up|1
5387426|NCT03412084|18543860|P1|Overall Study|Lost to Follow-up|1
5387427|NCT03412084|18543859|P2|Overall Study|Participant moved|0
5387428|NCT03412084|18543860|P1|Overall Study|Participant moved|1
5387429|NCT03412084|18543859|P2|Overall Study|Withdrawal by Subject|0
5387430|NCT03412084|18543860|P1|Overall Study|Withdrawal by Subject|2
5387431|NCT03412019|18543870|P2|Overall Study|Withdrawal by Subject|1
5387432|NCT03412019|18543871|P1|Overall Study|Withdrawal by Subject|1
5387433|NCT03409796|18543888|P2|Overall Study|Other|1
5387434|NCT03409796|18543889|P1|Overall Study|Other|0
5387435|NCT03409796|18543888|P2|Overall Study|Adverse Event|0
5387436|NCT03409796|18543889|P1|Overall Study|Adverse Event|2
5387437|NCT03409731|18543901|P1|Overall Study|Death|2
5387438|NCT03409731|18543901|P1|Overall Study|Withdrawal by Subject|1
5387439|NCT03408639|18543995|P2|Overall Study|Physician Decision|6
5387440|NCT03408639|18543996|P1|Overall Study|Physician Decision|3
5387441|NCT03408639|18543995|P2|Overall Study|Withdrawal by Subject|7
5387442|NCT03408639|18543996|P1|Overall Study|Withdrawal by Subject|2
5387443|NCT03408639|18543995|P2|Overall Study|Lost to Follow-up|4
5387444|NCT03408639|18543996|P1|Overall Study|Lost to Follow-up|1
5387445|NCT03408639|18543995|P2|Overall Study|Death|5
5387446|NCT03408639|18543996|P1|Overall Study|Death|5
5387447|NCT03408483|18544026|P2|Overall Study|Lost to Follow-up|0
5387448|NCT03408483|18544027|P1|Overall Study|Lost to Follow-up|3
5387449|NCT03408483|18544026|P2|Overall Study|Physician Decision|3
5387450|NCT03408483|18544027|P1|Overall Study|Physician Decision|3
5387451|NCT03407482|18544203|P1|Overall Study|Data Entry Error|1
5387452|NCT03407482|18544203|P1|Overall Study|Withdrawal by Subject|6
5387453|NCT03407482|18544203|P1|Overall Study|Study Terminated By Sponsor|106
5387454|NCT03407482|18544203|P1|Overall Study|Protocol Violation|1
5387455|NCT03407482|18544203|P1|Overall Study|Pregnancy|2
5387456|NCT03407482|18544203|P1|Overall Study|Non-Compliance With Study Drug|1
5387457|NCT03407482|18544203|P1|Overall Study|Lost to Follow-up|1
5387458|NCT03407482|18544203|P1|Overall Study|Disease Relapse|1
5387459|NCT03407482|18544203|P1|Overall Study|Adverse Event|12
5387460|NCT03407430|18544214|P2|Washout|Protocol Violation|0
5387461|NCT03407430|18544215|P1|Washout|Protocol Violation|1
5387462|NCT03407170|18544247|P1|Overall Study|Adverse Event|1
5387463|NCT03407118|18544260|P2|Period 2|Withdrawal by Subject|0
5387464|NCT03407118|18544261|P1|Period 2|Withdrawal by Subject|1
5387465|NCT03406260|18544338|P6|Period 1|Adverse Event|0
5387466|NCT03406260|18544339|P5|Period 1|Adverse Event|1
5387467|NCT03406260|18544340|P4|Period 1|Adverse Event|0
5387468|NCT03406260|18544341|P3|Period 1|Adverse Event|0
5387469|NCT03406260|18544342|P2|Period 1|Adverse Event|0
5387470|NCT03406260|18544343|P1|Period 1|Adverse Event|0
5387471|NCT03405935|18544355|P1|Overall Study|Lost to Follow-up|2
5387472|NCT03405935|18544355|P1|Overall Study|Withdrawal by Subject|1
5387473|NCT03405935|18544355|P1|Overall Study|Death|2
5387474|NCT03405935|18544355|P1|Overall Study|Adverse Event|3
5387475|NCT03405818|18544382|P1|Overall Study|Lost to Follow-up|4
5387476|NCT03405818|18544382|P1|Overall Study|Withdrawal by Subject|4
5387477|NCT03404843|18544436|P2|Overall Study|Study difficulties unrelated to Tx|1
5387478|NCT03404843|18544437|P1|Overall Study|Study difficulties unrelated to Tx|4
5387479|NCT03404206|18544466|P3|Overall Study|Lost to Follow-up|0
5387480|NCT03404206|18544467|P2|Overall Study|Lost to Follow-up|1
5387481|NCT03404206|18544468|P1|Overall Study|Lost to Follow-up|3
5387482|NCT03404206|18544466|P3|Overall Study|Withdrawal by Subject|0
5387483|NCT03404206|18544467|P2|Overall Study|Withdrawal by Subject|1
5387484|NCT03404206|18544468|P1|Overall Study|Withdrawal by Subject|1
5387485|NCT03403413|18544596|P1|Overall Study|Lack of Efficacy|2
5387486|NCT03403400|18544614|P3|Overall Study|Benign Paroxysmal Positional Vertigo|1
5387487|NCT03403400|18544615|P2|Overall Study|Benign Paroxysmal Positional Vertigo|0
5387488|NCT03403400|18544616|P1|Overall Study|Benign Paroxysmal Positional Vertigo|0
5387489|NCT03403400|18544614|P3|Overall Study|Hospitalization|0
5387490|NCT03403400|18544615|P2|Overall Study|Hospitalization|0
5387491|NCT03403400|18544616|P1|Overall Study|Hospitalization|1
5387492|NCT03403400|18544614|P3|Overall Study|Lost to Follow-up|1
5387493|NCT03403400|18544615|P2|Overall Study|Lost to Follow-up|0
5387494|NCT03403400|18544616|P1|Overall Study|Lost to Follow-up|1
5387495|NCT03403374|18544648|P1|Overall Study|Lost to Follow-up|1
5387496|NCT03403036|18544655|P1|Overall Study|Lack of Efficacy|5
5387497|NCT03402893|18544682|P1|Overall Study|Withdrawal by Subject|1
5387498|NCT03402750|18544693|P2|Overall Study|Lost to Follow-up|1
5387499|NCT03402750|18544694|P1|Overall Study|Lost to Follow-up|2
5387500|NCT03401450|18544759|P2|Overall Study|Cancelled surgery|2
5387501|NCT03401450|18544760|P1|Overall Study|Cancelled surgery|0
5387502|NCT03401450|18544759|P2|Overall Study|post surgery medication change|1
5387503|NCT03401450|18544760|P1|Overall Study|post surgery medication change|2
5387504|NCT03401450|18544759|P2|Overall Study|Did not complete medication diary|2
5387505|NCT03401450|18544760|P1|Overall Study|Did not complete medication diary|4
5387506|NCT03401450|18544759|P2|Overall Study|Anesthesia plan changed|2
5387507|NCT03401450|18544760|P1|Overall Study|Anesthesia plan changed|2
5387508|NCT03401450|18544759|P2|Overall Study|Lost to Follow-up|6
5387509|NCT03401450|18544760|P1|Overall Study|Lost to Follow-up|4
5387510|NCT03400787|18544795|P2|Overall Study|Unblinded before 3-month follow-upa-|6
5387511|NCT03400787|18544796|P1|Overall Study|Unblinded before 3-month follow-upa-|0
5387512|NCT03400787|18544795|P2|Overall Study|Protocol Violation|2
5387513|NCT03400787|18544796|P1|Overall Study|Protocol Violation|0
5387514|NCT03400787|18544795|P2|Overall Study|Death|0
5387515|NCT03400787|18544796|P1|Overall Study|Death|1
5387516|NCT03400787|18544795|P2|Overall Study|Lost to Follow-up|0
5387517|NCT03400787|18544796|P1|Overall Study|Lost to Follow-up|1
5387518|NCT03398356|18545059|P3|After 6 Weeks of Treatment|Physician Decision|0
5387519|NCT03398356|18545060|P2|After 6 Weeks of Treatment|Physician Decision|2
5387520|NCT03398356|18545061|P1|After 6 Weeks of Treatment|Physician Decision|0
5387521|NCT03398356|18545059|P3|Before Treatment|Physician Decision|11
5387522|NCT03398356|18545060|P2|Before Treatment|Physician Decision|0
5387523|NCT03398356|18545061|P1|Before Treatment|Physician Decision|0
5387524|NCT03398356|18545059|P3|Before Treatment|Withdrawal by Subject|0
5387525|NCT03398356|18545060|P2|Before Treatment|Withdrawal by Subject|5
5387526|NCT03398356|18545061|P1|Before Treatment|Withdrawal by Subject|0
5387527|NCT03398356|18545059|P3|Before Treatment|drug intolerance|0
5387528|NCT03398356|18545060|P2|Before Treatment|drug intolerance|1
5387529|NCT03398356|18545061|P1|Before Treatment|drug intolerance|2
5387530|NCT03398356|18545059|P3|Before Treatment|Lost to Follow-up|0
5387531|NCT03398356|18545060|P2|Before Treatment|Lost to Follow-up|2
5387532|NCT03398356|18545061|P1|Before Treatment|Lost to Follow-up|1
5387533|NCT03397771|18545166|P2|Overall Study|Adverse Event|1
5387534|NCT03397771|18545167|P1|Overall Study|Adverse Event|2
5387535|NCT03397771|18545166|P2|Overall Study|Protocol Violation|2
5387536|NCT03397771|18545167|P1|Overall Study|Protocol Violation|2
5387537|NCT03397771|18545166|P2|Overall Study|Withdrawal by Subject|3
5387538|NCT03397771|18545167|P1|Overall Study|Withdrawal by Subject|1
5387539|NCT03397771|18545166|P2|Overall Study|2 erroneously randomized, never treated|1
5387540|NCT03397771|18545167|P1|Overall Study|2 erroneously randomized, never treated|3
5387541|NCT03396913|18545227|P2|Overall Study|Lost to Follow-up|6
5387542|NCT03396913|18545228|P1|Overall Study|Lost to Follow-up|0
5387543|NCT03396835|18545238|P1|Overall Study|Did not meet criteria for data analysis|1
5387544|NCT03396835|18545238|P1|Overall Study|Withdrawn prior to completion|1
5387545|NCT03394508|18545273|P2|Overall Study|Lost to Follow-up|0
5387546|NCT03394508|18545274|P1|Overall Study|Lost to Follow-up|1
5387547|NCT03394508|18545273|P2|Overall Study|Protocol Violation|3
5387548|NCT03394508|18545274|P1|Overall Study|Protocol Violation|0
5387549|NCT03394391|18545300|P2|Overall Study|Lost to Follow-up|2
5387550|NCT03394391|18545301|P1|Overall Study|Lost to Follow-up|1
5387551|NCT03393806|18545319|P2|Overall Study|Physician Decision|0
5387552|NCT03393806|18545320|P1|Overall Study|Physician Decision|1
5387553|NCT03392194|18545446|P2|Overall Study|Conflicts with personal schedule|0
5387554|NCT03392194|18545447|P1|Overall Study|Conflicts with personal schedule|1
5387555|NCT03392194|18545446|P2|Overall Study|Withdrawal by Subject|2
5387556|NCT03392194|18545447|P1|Overall Study|Withdrawal by Subject|1
5387557|NCT03390426|18545482|P2|Overall Study|Protocol Violation|1
5387558|NCT03390426|18545483|P1|Overall Study|Protocol Violation|0
5387559|NCT03390166|18545503|P2|Overall Study|Move to work oversea|1
5387560|NCT03390166|18545504|P1|Overall Study|Move to work oversea|0
5387561|NCT03390166|18545503|P2|Overall Study|To drug therapy course|1
5387562|NCT03390166|18545504|P1|Overall Study|To drug therapy course|0
5387563|NCT03390166|18545503|P2|Overall Study|To militarycamp for conscript|0
5387564|NCT03390166|18545504|P1|Overall Study|To militarycamp for conscript|1
5387565|NCT03390166|18545503|P2|Overall Study|Move from study area|2
5387566|NCT03390166|18545504|P1|Overall Study|Move from study area|3
5387567|NCT03390166|18545503|P2|Overall Study|Physician Decision|1
5387568|NCT03390166|18545504|P1|Overall Study|Physician Decision|2
5387569|NCT03390166|18545503|P2|Overall Study|Lost to Follow-up|4
5387570|NCT03390166|18545504|P1|Overall Study|Lost to Follow-up|6
5387571|NCT03390166|18545503|P2|Overall Study|Death|1
5387572|NCT03390166|18545504|P1|Overall Study|Death|0
5387573|NCT03389308|18545558|P1|Overall Study|Sponsor Request|2
5387574|NCT03389308|18545558|P1|Overall Study|Adverse Event|2
5387575|NCT03389308|18545558|P1|Overall Study|Lost to Follow-up|3
5387576|NCT03389308|18545558|P1|Overall Study|Withdrawal by Subject|5
5387577|NCT03387683|18545583|P2|Overall Study|Did not receive treatment|0
5387578|NCT03387683|18545584|P1|Overall Study|Did not receive treatment|1
5387579|NCT03387683|18545583|P2|Overall Study|In receipt of disallowed medication|0
5387580|NCT03387683|18545584|P1|Overall Study|In receipt of disallowed medication|1
5387581|NCT03387462|18545592|P1|Overall Study|Lost to Follow-up|1
5387582|NCT03387059|18545622|P2|Overall Study|Study termination|4
5387583|NCT03387059|18545623|P1|Overall Study|Study termination|5
5387584|NCT03387046|18545637|P2|Overall Study|Adverse Event|1
5387585|NCT03387046|18545638|P1|Overall Study|Adverse Event|1
5387586|NCT03386994|18545665|P1|Overall Study|Death|16
5387587|NCT03386994|18545665|P1|Overall Study|Withdrawal by Subject|3
5387588|NCT03386994|18545665|P1|Overall Study|Lost to Follow-up|4
5387589|NCT03386994|18545665|P1|Overall Study|Adverse Event|14
5387590|NCT03386994|18545665|P1|Overall Study|Lung transplant|1
5387591|NCT03386474|18545725|P2|Overall Study|Adverse Event|1
5387592|NCT03386474|18545726|P1|Overall Study|Adverse Event|0
5387593|NCT03386474|18545725|P2|Overall Study|Death|0
5387594|NCT03386474|18545726|P1|Overall Study|Death|1
5387595|NCT03386448|18545748|P2|Overall Study|Adverse Event|2
5387596|NCT03386448|18545749|P1|Overall Study|Adverse Event|0
5387597|NCT03386435|18545757|P2|Overall Study|Protocol Violation|7
5387598|NCT03386435|18545758|P1|Overall Study|Protocol Violation|5
5387599|NCT03386032|18545773|P3|Overall Study|Lost to Follow-up|0
5387600|NCT03386032|18545774|P2|Overall Study|Lost to Follow-up|3
5387601|NCT03386032|18545775|P1|Overall Study|Lost to Follow-up|9
5387602|NCT03386032|18545773|P3|Overall Study|Withdrawal by Subject|0
5387603|NCT03386032|18545774|P2|Overall Study|Withdrawal by Subject|0
5387604|NCT03386032|18545775|P1|Overall Study|Withdrawal by Subject|1
5387605|NCT03386032|18545773|P3|Overall Study|Adverse Event|0
5387606|NCT03386032|18545774|P2|Overall Study|Adverse Event|2
5387607|NCT03386032|18545775|P1|Overall Study|Adverse Event|2
5387608|NCT03386032|18545773|P3|Overall Study|Lack of Efficacy|0
5387609|NCT03386032|18545774|P2|Overall Study|Lack of Efficacy|2
5387610|NCT03386032|18545775|P1|Overall Study|Lack of Efficacy|6
5387611|NCT03384316|18545810|P2|Overall Study|Screen failure|1
5387612|NCT03384316|18545811|P1|Overall Study|Screen failure|0
5387613|NCT03383887|18545850|P2|Overall Study|Lost to Follow-up|1
5387614|NCT03383887|18545851|P1|Overall Study|Lost to Follow-up|0
5387615|NCT03383783|18545859|P1|Overall Study|Withdrawal by Subject|2
5387616|NCT03383614|18545943|P4|Overall Study|Withdrawal by Subject|0
5387617|NCT03383614|18545944|P3|Overall Study|Withdrawal by Subject|0
5387618|NCT03383614|18545945|P2|Overall Study|Withdrawal by Subject|1
5387619|NCT03383614|18545946|P1|Overall Study|Withdrawal by Subject|0
5387620|NCT03382912|18546214|P2|Overall Study|Withdrawal by Subject|5
5387621|NCT03382912|18546215|P1|Overall Study|Withdrawal by Subject|0
5387622|NCT03382912|18546214|P2|Overall Study|Sponsor Decision|6
5387623|NCT03382912|18546215|P1|Overall Study|Sponsor Decision|6
5387624|NCT03382912|18546214|P2|Overall Study|Physician Decision|1
5387625|NCT03382912|18546215|P1|Overall Study|Physician Decision|0
5387626|NCT03382834|18546231|P2|Overall Study|Withdrawal by Subject|1
5387627|NCT03382834|18546232|P1|Overall Study|Withdrawal by Subject|0
5387628|NCT03382834|18546231|P2|Overall Study|Lost to Follow-up|0
5387629|NCT03382834|18546232|P1|Overall Study|Lost to Follow-up|1
5387630|NCT03382262|18546256|P4|Overall Study|Withdrawal by Subject|1
5387631|NCT03382262|18546257|P3|Overall Study|Withdrawal by Subject|0
5387632|NCT03382262|18546258|P2|Overall Study|Withdrawal by Subject|0
5387633|NCT03382262|18546259|P1|Overall Study|Withdrawal by Subject|0
5387634|NCT03382262|18546256|P4|Overall Study|Physician Decision|0
5387635|NCT03382262|18546257|P3|Overall Study|Physician Decision|1
5387636|NCT03382262|18546258|P2|Overall Study|Physician Decision|0
5387637|NCT03382262|18546259|P1|Overall Study|Physician Decision|0
5387638|NCT03381248|18546317|P2|Overall Study|Protocol Violation|1
5387639|NCT03381248|18546318|P1|Overall Study|Protocol Violation|2
5387640|NCT03381248|18546317|P2|Overall Study|Adverse Event|0
5387641|NCT03381248|18546318|P1|Overall Study|Adverse Event|2
5387642|NCT03381248|18546317|P2|Overall Study|Lack of Efficacy|0
5387643|NCT03381248|18546318|P1|Overall Study|Lack of Efficacy|1
5387644|NCT03381248|18546317|P2|Overall Study|Lost to Follow-up|2
5387645|NCT03381248|18546318|P1|Overall Study|Lost to Follow-up|3
5387646|NCT03381248|18546317|P2|Overall Study|Withdrawal by Subject|3
5387647|NCT03381248|18546318|P1|Overall Study|Withdrawal by Subject|5
5387648|NCT03380429|18546425|P5|Overall Study|Adverse Event|0
5387649|NCT03380429|18546426|P4|Overall Study|Adverse Event|2
5387650|NCT03380429|18546427|P3|Overall Study|Adverse Event|1
5387651|NCT03380429|18546428|P2|Overall Study|Adverse Event|1
5387652|NCT03380429|18546429|P1|Overall Study|Adverse Event|1
5387653|NCT03380429|18546425|P5|Overall Study|Lack of Efficacy|1
5387654|NCT03380429|18546426|P4|Overall Study|Lack of Efficacy|2
5387655|NCT03380429|18546427|P3|Overall Study|Lack of Efficacy|0
5387656|NCT03380429|18546428|P2|Overall Study|Lack of Efficacy|0
5387657|NCT03380429|18546429|P1|Overall Study|Lack of Efficacy|0
5387658|NCT03380429|18546425|P5|Overall Study|Protocol Violation|1
5387659|NCT03380429|18546426|P4|Overall Study|Protocol Violation|0
5387660|NCT03380429|18546427|P3|Overall Study|Protocol Violation|1
5387661|NCT03380429|18546428|P2|Overall Study|Protocol Violation|0
5387662|NCT03380429|18546429|P1|Overall Study|Protocol Violation|1
5387663|NCT03380429|18546425|P5|Overall Study|Lost to Follow-up|1
5387664|NCT03380429|18546426|P4|Overall Study|Lost to Follow-up|3
5387665|NCT03380429|18546427|P3|Overall Study|Lost to Follow-up|4
5387666|NCT03380429|18546428|P2|Overall Study|Lost to Follow-up|2
5387667|NCT03380429|18546429|P1|Overall Study|Lost to Follow-up|0
5387668|NCT03380429|18546425|P5|Overall Study|Withdrawal by Subject|1
5387669|NCT03380429|18546426|P4|Overall Study|Withdrawal by Subject|2
5387670|NCT03380429|18546427|P3|Overall Study|Withdrawal by Subject|5
5387671|NCT03380429|18546428|P2|Overall Study|Withdrawal by Subject|3
5387672|NCT03380429|18546429|P1|Overall Study|Withdrawal by Subject|3
5387673|NCT03380429|18546425|P5|Overall Study|Physician Decision|1
5387674|NCT03380429|18546426|P4|Overall Study|Physician Decision|1
5387675|NCT03380429|18546427|P3|Overall Study|Physician Decision|0
5387676|NCT03380429|18546428|P2|Overall Study|Physician Decision|1
5387677|NCT03380429|18546429|P1|Overall Study|Physician Decision|0
5387678|NCT03380390|18546482|P1|Overall Study|Adverse Event|3
5387679|NCT03379506|18546578|P4|Overall Study|Ongoing in study|11
5387680|NCT03379506|18546579|P3|Overall Study|Ongoing in study|0
5387681|NCT03379506|18546580|P2|Overall Study|Ongoing in study|9
5387682|NCT03379506|18546581|P1|Overall Study|Ongoing in study|0
5387683|NCT03379376|18546631|P1|Overall Study|Death|1
5387684|NCT03379376|18546631|P1|Overall Study|Overwhelmed, didn't want to continue|1
5387685|NCT03379376|18546631|P1|Overall Study|Did not wish to complete follow up|1
5387686|NCT03379376|18546631|P1|Overall Study|Lost to Follow-up|2
5387687|NCT03379233|18546641|P2|Overall Study|Technical issues with Concept 2 inhalers|6
5387688|NCT03379233|18546642|P1|Overall Study|Technical issues with Concept 2 inhalers|1
5387689|NCT03376516|18546714|P1|Overall Study|Consent withdrawn|1
5387690|NCT03376516|18546714|P1|Overall Study|Not treated|1
5387691|NCT03374995|18546795|P2|Overall Study|Withdrawal by Subject|1
5387692|NCT03374995|18546796|P1|Overall Study|Withdrawal by Subject|0
5387693|NCT03374488|18546810|P2|Overall Study|On-going at clinical cut off date|28
5387694|NCT03374488|18546811|P1|Overall Study|On-going at clinical cut off date|30
5387695|NCT03374488|18546810|P2|Overall Study|Withdrawal by Subject|1
5387696|NCT03374488|18546811|P1|Overall Study|Withdrawal by Subject|1
5387697|NCT03374488|18546810|P2|Overall Study|Death|8
5387698|NCT03374488|18546811|P1|Overall Study|Death|10
5387699|NCT03374189|18546823|P2|Overall Study|Lost to Follow-up|0
5387700|NCT03374189|18546824|P1|Overall Study|Lost to Follow-up|1
5387701|NCT03372603|18546937|P2|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
5387702|NCT03372603|18546938|P1|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
5387703|NCT03372603|18546937|P2|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
5387704|NCT03372603|18546938|P1|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
5387705|NCT03372551|18546980|P2|First Intervention (1 Week)|Withdrawal by Subject|0
5387706|NCT03372551|18546981|P1|First Intervention (1 Week)|Withdrawal by Subject|1
5387707|NCT03372369|18547011|P2|Intervention and Follow-Up Period|Withdrawal by Subject|3
5387708|NCT03372369|18547012|P1|Intervention and Follow-Up Period|Withdrawal by Subject|3
5387709|NCT03372369|18547011|P2|Qualification Period|Inconsistent Eligibility Results|9
5387710|NCT03372369|18547012|P1|Qualification Period|Inconsistent Eligibility Results|10
5387711|NCT03372369|18547011|P2|Qualification Period|Withdrawal by Subject|13
5387712|NCT03372369|18547012|P1|Qualification Period|Withdrawal by Subject|16
5387713|NCT03372083|18547024|P1|Overall Study|Withdrawal by Subject|1
5387714|NCT03372083|18547024|P1|Overall Study|Physician Decision|1
5387715|NCT03372083|18547024|P1|Overall Study|Adverse Event|3
5387716|NCT03371459|18547056|P2|Washout|Lost to Follow-up|1
5387717|NCT03371459|18547057|P1|Washout|Lost to Follow-up|0
5387718|NCT03371381|18547065|P1|Overall Study|Other|4
5387719|NCT03371381|18547065|P1|Overall Study|Study terminated by sponsor|3
5387720|NCT03371381|18547065|P1|Overall Study|Death|5
5387721|NCT03370770|18547077|P1|Overall Study|Death|5
5387722|NCT03370770|18547077|P1|Overall Study|Adverse Event|2
5387723|NCT03370770|18547077|P1|Overall Study|Progressive Disease|98
5387724|NCT03370770|18547077|P1|Overall Study|Patient was followed in another hospital center|1
5387725|NCT03370419|18547091|P1|Overall Study|Lost to Follow-up|16
5387726|NCT03370302|18547101|P6|Dose Expansion Phase|Progressive Disease|0
5387727|NCT03370302|18547102|P5|Dose Expansion Phase|Progressive Disease|0
5387728|NCT03370302|18547103|P4|Dose Expansion Phase|Progressive Disease|6
5387729|NCT03370302|18547104|P3|Dose Expansion Phase|Progressive Disease|0
5387730|NCT03370302|18547105|P2|Dose Expansion Phase|Progressive Disease|0
5387731|NCT03370302|18547106|P1|Dose Expansion Phase|Progressive Disease|0
5387732|NCT03370302|18547101|P6|Dose Escalation Phase|Progressive Disease|1
5387733|NCT03370302|18547102|P5|Dose Escalation Phase|Progressive Disease|3
5387734|NCT03370302|18547103|P4|Dose Escalation Phase|Progressive Disease|0
5387735|NCT03370302|18547104|P3|Dose Escalation Phase|Progressive Disease|2
5387736|NCT03370302|18547105|P2|Dose Escalation Phase|Progressive Disease|4
5387737|NCT03370302|18547106|P1|Dose Escalation Phase|Progressive Disease|2
5387738|NCT03370302|18547101|P6|Dose Escalation Phase|Adverse Event|0
5387739|NCT03370302|18547102|P5|Dose Escalation Phase|Adverse Event|0
5387740|NCT03370302|18547103|P4|Dose Escalation Phase|Adverse Event|0
5387741|NCT03370302|18547104|P3|Dose Escalation Phase|Adverse Event|2
5387742|NCT03370302|18547105|P2|Dose Escalation Phase|Adverse Event|0
5387743|NCT03370302|18547106|P1|Dose Escalation Phase|Adverse Event|1
5387744|NCT03370302|18547101|P6|Dose Escalation Phase|Withdrawal by Subject|2
5387745|NCT03370302|18547102|P5|Dose Escalation Phase|Withdrawal by Subject|0
5387746|NCT03370302|18547103|P4|Dose Escalation Phase|Withdrawal by Subject|0
5387747|NCT03370302|18547104|P3|Dose Escalation Phase|Withdrawal by Subject|2
5387748|NCT03370302|18547105|P2|Dose Escalation Phase|Withdrawal by Subject|1
5387749|NCT03370302|18547106|P1|Dose Escalation Phase|Withdrawal by Subject|0
5387750|NCT03370302|18547101|P6|Dose Escalation Phase|Other|0
5387751|NCT03370302|18547102|P5|Dose Escalation Phase|Other|0
5387752|NCT03370302|18547103|P4|Dose Escalation Phase|Other|0
5387753|NCT03370302|18547104|P3|Dose Escalation Phase|Other|1
5387754|NCT03370302|18547105|P2|Dose Escalation Phase|Other|1
5387755|NCT03370302|18547106|P1|Dose Escalation Phase|Other|0
5387756|NCT03370289|18547203|P1|Overall Study|Sample Size Sufficient|4
5387757|NCT03370289|18547203|P1|Overall Study|Screen Failure|1
5387758|NCT03369951|18547237|P1|Overall Study|Protocol Violation|1
5387759|NCT03369951|18547237|P1|Overall Study|Lost to Follow-up|1
5387760|NCT03369951|18547237|P1|Overall Study|Death|1
5387761|NCT03369951|18547237|P1|Overall Study|Withdrawal by Subject|3
5387762|NCT03369704|18547272|P2|Follow-up Epoch|Lost to Follow-up|0
5387763|NCT03369704|18547273|P1|Follow-up Epoch|Lost to Follow-up|1
5387764|NCT03369704|18547272|P2|Treatment Epoch|Adverse Event|0
5387765|NCT03369704|18547273|P1|Treatment Epoch|Adverse Event|2
5387766|NCT03369704|18547272|P2|Treatment Epoch|Lack of Efficacy|2
5387767|NCT03369704|18547273|P1|Treatment Epoch|Lack of Efficacy|0
5387768|NCT03369704|18547272|P2|Treatment Epoch|Lost to Follow-up|1
5387769|NCT03369704|18547273|P1|Treatment Epoch|Lost to Follow-up|0
5387770|NCT03369704|18547272|P2|Treatment Epoch|Protocol Violation|0
5387771|NCT03369704|18547273|P1|Treatment Epoch|Protocol Violation|1
5387772|NCT03369704|18547272|P2|Treatment Epoch|technical problems|0
5387773|NCT03369704|18547273|P1|Treatment Epoch|technical problems|1
5387774|NCT03369418|18547308|P2|Overall Study|Withdrawal by Subject|3
5387775|NCT03369418|18547309|P1|Overall Study|Withdrawal by Subject|3
5387776|NCT03368807|18547465|P1|Period 1 (Blinded CGM)|Lost to Follow-up|1
5387777|NCT03368807|18547465|P1|Period 1 (Blinded CGM)|Sponsor Decision|1
5387778|NCT03368807|18547465|P1|Period 1 (Blinded CGM)|Protocol Violation|1
5387779|NCT03368807|18547465|P1|Period 1 (Blinded CGM)|Withdrawal by Subject|3
5387780|NCT03368170|18547515|P2|Overall Study|Adverse Event|1
5387781|NCT03368170|18547516|P1|Overall Study|Adverse Event|2
5387782|NCT03365934|18547548|P1|Overall Study|Withdrawal by Subject|1
5387783|NCT03365934|18547548|P1|Overall Study|Adverse Event|1
5387784|NCT03365011|18547838|P2|Overall Study|Withdrawal by Subject|2
5387785|NCT03365011|18547839|P1|Overall Study|Withdrawal by Subject|1
5387786|NCT03364608|18547849|P1|Overall Study|Lost to Follow-up|2
5387787|NCT03364608|18547849|P1|Overall Study|Protocol Violation|2
5387788|NCT03364608|18547849|P1|Overall Study|Withdrawal by Subject|4
5387789|NCT03364335|18547876|P5|Overall Study|Lost to Follow-up|11
5387790|NCT03364335|18547877|P4|Overall Study|Lost to Follow-up|11
5387791|NCT03364335|18547878|P3|Overall Study|Lost to Follow-up|10
5387792|NCT03364335|18547879|P2|Overall Study|Lost to Follow-up|7
5387793|NCT03364335|18547880|P1|Overall Study|Lost to Follow-up|7
5387794|NCT03364335|18547876|P5|Overall Study|Adverse Event|0
5387795|NCT03364335|18547877|P4|Overall Study|Adverse Event|2
5387796|NCT03364335|18547878|P3|Overall Study|Adverse Event|1
5387797|NCT03364335|18547879|P2|Overall Study|Adverse Event|4
5387798|NCT03364335|18547880|P1|Overall Study|Adverse Event|3
5387799|NCT03364192|18547952|P1|Overall Study|Lost to Follow-up|1
5387800|NCT03364192|18547952|P1|Overall Study|Withdrawal by Subject|5
5387801|NCT03364192|18547952|P1|Overall Study|Ineligible|10
5387802|NCT03364023|18547959|P1|Overall Study|Death|14
5387803|NCT03364023|18547959|P1|Overall Study|Lost to Follow-up|3
5387804|NCT03363906|18547966|P2|Period 2 (Test or Reference)|Lost to Follow-up|0
5387805|NCT03363906|18547967|P1|Period 2 (Test or Reference)|Lost to Follow-up|1
5387806|NCT03363906|18547966|P2|Period 2 (Test or Reference)|Withdrawal by Subject|1
5387807|NCT03363906|18547967|P1|Period 2 (Test or Reference)|Withdrawal by Subject|1
5387808|NCT03363906|18547966|P2|Period 2 (Test or Reference)|Adverse Event|0
5387809|NCT03363906|18547967|P1|Period 2 (Test or Reference)|Adverse Event|2
5387810|NCT03363906|18547966|P2|Period 1 (Reference or Test)|Adverse Event|2
5387811|NCT03363906|18547967|P1|Period 1 (Reference or Test)|Adverse Event|1
5387812|NCT03363776|18547978|P3|Overall Study|Death|0
5387813|NCT03363776|18547979|P2|Overall Study|Death|0
5387814|NCT03363776|18547980|P1|Overall Study|Death|1
5387815|NCT03363776|18547978|P3|Overall Study|Study drug toxicity|1
5387816|NCT03363776|18547979|P2|Overall Study|Study drug toxicity|0
5387817|NCT03363776|18547980|P1|Overall Study|Study drug toxicity|0
5387818|NCT03363776|18547978|P3|Overall Study|Progressive disease|1
5387819|NCT03363776|18547979|P2|Overall Study|Progressive disease|3
5387820|NCT03363776|18547980|P1|Overall Study|Progressive disease|2
5387821|NCT03361865|18548134|P2|Overall Study|On-going at clinical cut off date|39
5387822|NCT03361865|18548135|P1|Overall Study|On-going at clinical cut off date|29
5387823|NCT03361865|18548134|P2|Overall Study|Physician Decision|0
5387824|NCT03361865|18548135|P1|Overall Study|Physician Decision|1
5387825|NCT03361865|18548134|P2|Overall Study|Death|10
5387826|NCT03361865|18548135|P1|Overall Study|Death|13
5387827|NCT03361605|18548145|P1|Overall Study|Analyzable data not available|3
5387828|NCT03361228|18548152|P2|Overall Study|Death|0
5387829|NCT03361228|18548153|P1|Overall Study|Death|3
5387830|NCT03361228|18548152|P2|Overall Study|Other|1
5387831|NCT03361228|18548153|P1|Overall Study|Other|1
5387832|NCT03361176|18548175|P2|Overall Study|Withdrawal by Subject|1
5387833|NCT03361176|18548176|P1|Overall Study|Withdrawal by Subject|0
5387834|NCT03361176|18548175|P2|Overall Study|Adverse Event|2
5387835|NCT03361176|18548176|P1|Overall Study|Adverse Event|0
5387836|NCT03361176|18548175|P2|Overall Study|Lost to Follow-up|2
5387837|NCT03361176|18548176|P1|Overall Study|Lost to Follow-up|1
5387838|NCT03360344|18548210|P3|Overall Study|Withdrawal by Subject|1
5387839|NCT03360344|18548211|P2|Overall Study|Withdrawal by Subject|1
5387840|NCT03360344|18548212|P1|Overall Study|Withdrawal by Subject|0
5387841|NCT03360071|18548275|P2|Overall Study|Lost to Follow-up|0
5387842|NCT03360071|18548276|P1|Overall Study|Lost to Follow-up|1
5387843|NCT03359850|18548290|P2|Extension Phase (Up to 18 Months)|Ongoing in the study|1
5387844|NCT03359850|18548291|P1|Extension Phase (Up to 18 Months)|Ongoing in the study|1
5387845|NCT03359850|18548290|P2|Extension Phase (Up to 18 Months)|Disease Progression|0
5387846|NCT03359850|18548291|P1|Extension Phase (Up to 18 Months)|Disease Progression|5
5387847|NCT03359850|18548290|P2|Extension Phase (Up to 18 Months)|Withdrawal by Subject|2
5387848|NCT03359850|18548291|P1|Extension Phase (Up to 18 Months)|Withdrawal by Subject|0
5387849|NCT03359850|18548290|P2|Extension Phase (Up to 18 Months)|Death|4
5387850|NCT03359850|18548291|P1|Extension Phase (Up to 18 Months)|Death|2
5387851|NCT03359850|18548290|P2|PK Phase (Up to Day 8)|Adverse Event|0
5387852|NCT03359850|18548291|P1|PK Phase (Up to Day 8)|Adverse Event|1
5387853|NCT03359850|18548290|P2|PK Phase (Up to Day 8)|Physician Decision|1
5387854|NCT03359850|18548291|P1|PK Phase (Up to Day 8)|Physician Decision|0
5387855|NCT03359473|18548374|P4|Overall Study|Protocol-defined stopping criteria|1
5387856|NCT03359473|18548375|P3|Overall Study|Protocol-defined stopping criteria|0
5387857|NCT03359473|18548376|P2|Overall Study|Protocol-defined stopping criteria|0
5387858|NCT03359473|18548377|P1|Overall Study|Protocol-defined stopping criteria|1
5387859|NCT03359473|18548374|P4|Overall Study|Withdrawal by Subject|0
5387860|NCT03359473|18548375|P3|Overall Study|Withdrawal by Subject|1
5387861|NCT03359473|18548376|P2|Overall Study|Withdrawal by Subject|2
5387862|NCT03359473|18548377|P1|Overall Study|Withdrawal by Subject|1
5387863|NCT03359473|18548374|P4|Overall Study|Physician Decision|1
5387864|NCT03359473|18548375|P3|Overall Study|Physician Decision|0
5387865|NCT03359473|18548376|P2|Overall Study|Physician Decision|1
5387866|NCT03359473|18548377|P1|Overall Study|Physician Decision|0
5387867|NCT03359473|18548374|P4|Overall Study|Lost to Follow-up|0
5387868|NCT03359473|18548375|P3|Overall Study|Lost to Follow-up|0
5387869|NCT03359473|18548376|P2|Overall Study|Lost to Follow-up|1
5387870|NCT03359473|18548377|P1|Overall Study|Lost to Follow-up|0
5387871|NCT03359473|18548374|P4|Overall Study|Adverse Event|3
5387872|NCT03359473|18548375|P3|Overall Study|Adverse Event|5
5387873|NCT03359473|18548376|P2|Overall Study|Adverse Event|2
5387874|NCT03359473|18548377|P1|Overall Study|Adverse Event|0
5387875|NCT03358472|18548601|P3|Overall Study|On-going at clinical cut off date|5
5387876|NCT03358472|18548602|P2|Overall Study|On-going at clinical cut off date|6
5387877|NCT03358472|18548603|P1|Overall Study|On-going at clinical cut off date|9
5387878|NCT03358472|18548601|P3|Overall Study|Withdrawal by Subject|1
5387879|NCT03358472|18548602|P2|Overall Study|Withdrawal by Subject|0
5387880|NCT03358472|18548603|P1|Overall Study|Withdrawal by Subject|0
5387881|NCT03358472|18548601|P3|Overall Study|Physician Decision|0
5387882|NCT03358472|18548602|P2|Overall Study|Physician Decision|1
5387883|NCT03358472|18548603|P1|Overall Study|Physician Decision|0
5387884|NCT03358472|18548601|P3|Overall Study|Death|10
5387885|NCT03358472|18548602|P2|Overall Study|Death|3
5387886|NCT03358472|18548603|P1|Overall Study|Death|6
5387887|NCT03358407|18548627|P10|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5387888|NCT03358407|18548628|P9|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5387960|NCT03358147|18548969|P1|Overall Study|Administrative reasons|0
5387889|NCT03358407|18548629|P8|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
5387890|NCT03358407|18548630|P7|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
5387891|NCT03358407|18548631|P6|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
5387892|NCT03358407|18548632|P5|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5387893|NCT03358407|18548633|P4|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5387894|NCT03358407|18548634|P3|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5387895|NCT03358407|18548635|P2|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5387896|NCT03358407|18548636|P1|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
5387897|NCT03358407|18548627|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5387898|NCT03358407|18548628|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5387899|NCT03358407|18548629|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5387900|NCT03358407|18548630|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
5387901|NCT03358407|18548631|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
5387902|NCT03358407|18548632|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5387903|NCT03358407|18548633|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5387904|NCT03358407|18548634|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5387905|NCT03358407|18548635|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5387906|NCT03358407|18548636|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
5387907|NCT03358407|18548627|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5387908|NCT03358407|18548628|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5387909|NCT03358407|18548629|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
5387910|NCT03358407|18548630|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5387911|NCT03358407|18548631|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
5387912|NCT03358407|18548632|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5387913|NCT03358407|18548633|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5387914|NCT03358407|18548634|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5387915|NCT03358407|18548635|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5387916|NCT03358407|18548636|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
5387917|NCT03358407|18548627|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5387918|NCT03358407|18548628|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5387919|NCT03358407|18548629|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
5387920|NCT03358407|18548630|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5387921|NCT03358407|18548631|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
5387922|NCT03358407|18548632|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5387923|NCT03358407|18548633|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5387924|NCT03358407|18548634|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5387925|NCT03358407|18548635|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5387926|NCT03358407|18548636|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
5387927|NCT03358407|18548627|P10|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5387928|NCT03358407|18548628|P9|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5387929|NCT03358407|18548629|P8|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5387930|NCT03358407|18548630|P7|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5387931|NCT03358407|18548631|P6|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5387932|NCT03358407|18548632|P5|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
5387933|NCT03358407|18548633|P4|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5387934|NCT03358407|18548634|P3|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5387935|NCT03358407|18548635|P2|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5387936|NCT03358407|18548636|P1|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
5387937|NCT03358407|18548627|P10|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5387938|NCT03358407|18548628|P9|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5387939|NCT03358407|18548629|P8|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5387940|NCT03358407|18548630|P7|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5387941|NCT03358407|18548631|P6|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5387942|NCT03358407|18548632|P5|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5387943|NCT03358407|18548633|P4|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5387944|NCT03358407|18548634|P3|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
5387945|NCT03358407|18548635|P2|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5387946|NCT03358407|18548636|P1|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
5387947|NCT03358329|18548913|P1|Overall Study|Withdrawal by Subject|2
5387948|NCT03358329|18548913|P1|Overall Study|Lost to Follow-up|2
5387949|NCT03358238|18548944|P2|Overall Study|Withdrawal by Subject|1
5387950|NCT03358238|18548945|P1|Overall Study|Withdrawal by Subject|0
5387951|NCT03358147|18548965|P5|Overall Study|Lack of Efficacy|0
5387952|NCT03358147|18548966|P4|Overall Study|Lack of Efficacy|0
5387953|NCT03358147|18548967|P3|Overall Study|Lack of Efficacy|1
5387954|NCT03358147|18548968|P2|Overall Study|Lack of Efficacy|1
5387955|NCT03358147|18548969|P1|Overall Study|Lack of Efficacy|0
5387956|NCT03358147|18548965|P5|Overall Study|Administrative reasons|0
5387957|NCT03358147|18548966|P4|Overall Study|Administrative reasons|3
5387958|NCT03358147|18548967|P3|Overall Study|Administrative reasons|0
5387959|NCT03358147|18548968|P2|Overall Study|Administrative reasons|1
5387961|NCT03358147|18548965|P5|Overall Study|Physician Decision|1
5387962|NCT03358147|18548966|P4|Overall Study|Physician Decision|6
5387963|NCT03358147|18548967|P3|Overall Study|Physician Decision|1
5387964|NCT03358147|18548968|P2|Overall Study|Physician Decision|0
5387965|NCT03358147|18548969|P1|Overall Study|Physician Decision|1
5387966|NCT03358147|18548965|P5|Overall Study|Protocol specified criteria|1
5387967|NCT03358147|18548966|P4|Overall Study|Protocol specified criteria|3
5387968|NCT03358147|18548967|P3|Overall Study|Protocol specified criteria|0
5387969|NCT03358147|18548968|P2|Overall Study|Protocol specified criteria|3
5387970|NCT03358147|18548969|P1|Overall Study|Protocol specified criteria|2
5387971|NCT03358147|18548965|P5|Overall Study|Major Protocol Deviation|1
5387972|NCT03358147|18548966|P4|Overall Study|Major Protocol Deviation|3
5387973|NCT03358147|18548967|P3|Overall Study|Major Protocol Deviation|2
5387974|NCT03358147|18548968|P2|Overall Study|Major Protocol Deviation|3
5387975|NCT03358147|18548969|P1|Overall Study|Major Protocol Deviation|11
5387976|NCT03358147|18548965|P5|Overall Study|Lost to Follow-up|4
5387977|NCT03358147|18548966|P4|Overall Study|Lost to Follow-up|6
5387978|NCT03358147|18548967|P3|Overall Study|Lost to Follow-up|7
5387979|NCT03358147|18548968|P2|Overall Study|Lost to Follow-up|3
5387980|NCT03358147|18548969|P1|Overall Study|Lost to Follow-up|4
5387981|NCT03358147|18548965|P5|Overall Study|Adverse Event|2
5387982|NCT03358147|18548966|P4|Overall Study|Adverse Event|5
5387983|NCT03358147|18548967|P3|Overall Study|Adverse Event|7
5387984|NCT03358147|18548968|P2|Overall Study|Adverse Event|9
5387985|NCT03358147|18548969|P1|Overall Study|Adverse Event|3
5387986|NCT03358147|18548965|P5|Overall Study|Withdrawal by Subject|5
5387987|NCT03358147|18548966|P4|Overall Study|Withdrawal by Subject|10
5387988|NCT03358147|18548967|P3|Overall Study|Withdrawal by Subject|16
5387989|NCT03358147|18548968|P2|Overall Study|Withdrawal by Subject|19
5387990|NCT03358147|18548969|P1|Overall Study|Withdrawal by Subject|13
5387991|NCT03357952|18549008|P2|Overall Study|Sponsor Decision|0
5387992|NCT03357952|18549009|P1|Overall Study|Sponsor Decision|9
5387993|NCT03357952|18549008|P2|Overall Study|Withdrawal by Subject|1
5387994|NCT03357952|18549009|P1|Overall Study|Withdrawal by Subject|0
5387995|NCT03357731|18549016|P6|Overall Study|Lost to Follow-up|0
5387996|NCT03357731|18549017|P5|Overall Study|Lost to Follow-up|0
5387997|NCT03357731|18549018|P4|Overall Study|Lost to Follow-up|1
5387998|NCT03357731|18549019|P3|Overall Study|Lost to Follow-up|0
5387999|NCT03357731|18549020|P2|Overall Study|Lost to Follow-up|0
5388000|NCT03357731|18549021|P1|Overall Study|Lost to Follow-up|0
5388001|NCT03357731|18549016|P6|Overall Study|Hypotension|0
5388002|NCT03357731|18549017|P5|Overall Study|Hypotension|0
5388003|NCT03357731|18549018|P4|Overall Study|Hypotension|1
5388004|NCT03357731|18549019|P3|Overall Study|Hypotension|1
5388005|NCT03357731|18549020|P2|Overall Study|Hypotension|0
5388006|NCT03357731|18549021|P1|Overall Study|Hypotension|0
5388007|NCT03357731|18549016|P6|Overall Study|Adverse Event|1
5388008|NCT03357731|18549017|P5|Overall Study|Adverse Event|0
5388009|NCT03357731|18549018|P4|Overall Study|Adverse Event|0
5388010|NCT03357731|18549019|P3|Overall Study|Adverse Event|0
5388011|NCT03357731|18549020|P2|Overall Study|Adverse Event|0
5388012|NCT03357731|18549021|P1|Overall Study|Adverse Event|0
5388013|NCT03357731|18549016|P6|Overall Study|Acute bradycardia and hypotension|0
5388014|NCT03357731|18549017|P5|Overall Study|Acute bradycardia and hypotension|0
5388015|NCT03357731|18549018|P4|Overall Study|Acute bradycardia and hypotension|1
5388016|NCT03357731|18549019|P3|Overall Study|Acute bradycardia and hypotension|0
5388017|NCT03357731|18549020|P2|Overall Study|Acute bradycardia and hypotension|0
5388018|NCT03357731|18549021|P1|Overall Study|Acute bradycardia and hypotension|0
5388019|NCT03357731|18549016|P6|Overall Study|Withdrew consent due to personal reasons|0
5388020|NCT03357731|18549017|P5|Overall Study|Withdrew consent due to personal reasons|1
5388021|NCT03357731|18549018|P4|Overall Study|Withdrew consent due to personal reasons|0
5388022|NCT03357731|18549019|P3|Overall Study|Withdrew consent due to personal reasons|0
5388023|NCT03357731|18549020|P2|Overall Study|Withdrew consent due to personal reasons|0
5388024|NCT03357731|18549021|P1|Overall Study|Withdrew consent due to personal reasons|0
5388025|NCT03357471|18549060|P2|Overall Study|Lost to Follow-up|0
5388026|NCT03357471|18549061|P1|Overall Study|Lost to Follow-up|1
5388027|NCT03357471|18549060|P2|Overall Study|Adverse Event|0
5388028|NCT03357471|18549061|P1|Overall Study|Adverse Event|1
5388029|NCT03357341|18549087|P2|Overall Study|Death|1
5388030|NCT03357341|18549088|P1|Overall Study|Death|0
5388031|NCT03357341|18549087|P2|Overall Study|Lost to Follow-up|5
5388032|NCT03357341|18549088|P1|Overall Study|Lost to Follow-up|4
5388033|NCT03357341|18549087|P2|Overall Study|Withdrawal by Subject|6
5388034|NCT03357341|18549088|P1|Overall Study|Withdrawal by Subject|3
5388035|NCT03356977|18549128|P1|Overall Study|Withdrawal by parent/guardian|2
5388036|NCT03356977|18549128|P1|Overall Study|Lost to Follow-up|3
5388037|NCT03354663|18549176|P1|Completed 30-day Visit|Missed Visit|1
5388038|NCT03354663|18549176|P1|Completed 30-day Visit|Withdrawal by Subject|1
5388039|NCT03354663|18549176|P1|Enrollment to Catheter Insertion|Adverse Event|1
5388040|NCT03354663|18549176|P1|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
5388041|NCT03354637|18549203|P3|Open Label Extension|Physician Decision|1
5388042|NCT03354637|18549204|P2|Open Label Extension|Physician Decision|0
5388043|NCT03354637|18549205|P1|Open Label Extension|Physician Decision|0
5388044|NCT03354637|18549203|P3|Open Label Extension|Lack of Efficacy|1
5388045|NCT03354637|18549204|P2|Open Label Extension|Lack of Efficacy|0
5388046|NCT03354637|18549205|P1|Open Label Extension|Lack of Efficacy|0
5388047|NCT03354637|18549203|P3|Open Label Extension|Subject Noncompliance|1
5388048|NCT03354637|18549204|P2|Open Label Extension|Subject Noncompliance|0
5388049|NCT03354637|18549205|P1|Open Label Extension|Subject Noncompliance|0
5388050|NCT03354637|18549203|P3|Open Label Extension|Study Terminated by Sponsor|17
5388051|NCT03354637|18549204|P2|Open Label Extension|Study Terminated by Sponsor|0
5388052|NCT03354637|18549205|P1|Open Label Extension|Study Terminated by Sponsor|0
5388053|NCT03354637|18549203|P3|Open Label Extension|Withdrawal by Subject|5
5388054|NCT03354637|18549204|P2|Open Label Extension|Withdrawal by Subject|0
5388055|NCT03354637|18549205|P1|Open Label Extension|Withdrawal by Subject|0
5388056|NCT03354637|18549203|P3|Open Label Extension|Lost to Follow-up|2
5388057|NCT03354637|18549204|P2|Open Label Extension|Lost to Follow-up|0
5388058|NCT03354637|18549205|P1|Open Label Extension|Lost to Follow-up|0
5388059|NCT03354637|18549203|P3|Open Label Extension|Adverse Event|1
5388060|NCT03354637|18549204|P2|Open Label Extension|Adverse Event|0
5388061|NCT03354637|18549205|P1|Open Label Extension|Adverse Event|0
5388062|NCT03354637|18549203|P3|Double-blind Period|Incomplete Efficacy Data Collection|0
5388063|NCT03354637|18549204|P2|Double-blind Period|Incomplete Efficacy Data Collection|1
5388064|NCT03354637|18549205|P1|Double-blind Period|Incomplete Efficacy Data Collection|1
5388065|NCT03354637|18549203|P3|Double-blind Period|Withdrawal by Subject|4
5388066|NCT03354637|18549204|P2|Double-blind Period|Withdrawal by Subject|6
5388067|NCT03354637|18549205|P1|Double-blind Period|Withdrawal by Subject|10
5388068|NCT03354637|18549203|P3|Double-blind Period|Lost to Follow-up|3
5388069|NCT03354637|18549204|P2|Double-blind Period|Lost to Follow-up|4
5388070|NCT03354637|18549205|P1|Double-blind Period|Lost to Follow-up|3
5388071|NCT03354637|18549203|P3|Double-blind Period|Adverse Event|0
5388072|NCT03354637|18549204|P2|Double-blind Period|Adverse Event|2
5388073|NCT03354637|18549205|P1|Double-blind Period|Adverse Event|1
5388074|NCT03354637|18549203|P3|Double-blind Period|Protocol Violation|0
5388075|NCT03354637|18549204|P2|Double-blind Period|Protocol Violation|0
5388076|NCT03354637|18549205|P1|Double-blind Period|Protocol Violation|2
5388077|NCT03354429|18549279|P2|Overall Study|Lost to Follow-up|0
5388078|NCT03354429|18549280|P1|Overall Study|Lost to Follow-up|1
5388079|NCT03354429|18549279|P2|Overall Study|Withdrawal by Subject|7
5388080|NCT03354429|18549280|P1|Overall Study|Withdrawal by Subject|8
5388081|NCT03353922|18549331|P6|Overall Study|Adverse Event|0
5388082|NCT03353922|18549332|P5|Overall Study|Adverse Event|0
5388083|NCT03353922|18549333|P4|Overall Study|Adverse Event|0
5388084|NCT03353922|18549334|P3|Overall Study|Adverse Event|0
5388085|NCT03353922|18549335|P2|Overall Study|Adverse Event|1
5388086|NCT03353922|18549336|P1|Overall Study|Adverse Event|0
5388087|NCT03353922|18549331|P6|Overall Study|Withdrawal by Subject|0
5388088|NCT03353922|18549332|P5|Overall Study|Withdrawal by Subject|0
5388089|NCT03353922|18549333|P4|Overall Study|Withdrawal by Subject|1
5388090|NCT03353922|18549334|P3|Overall Study|Withdrawal by Subject|1
5388091|NCT03353922|18549335|P2|Overall Study|Withdrawal by Subject|0
5388092|NCT03353922|18549336|P1|Overall Study|Withdrawal by Subject|1
5388093|NCT03352713|18549378|P1|Overall Study|Device incompatible/stolen|5
5388094|NCT03352713|18549378|P1|Overall Study|Completed 0 EMAs|8
5388095|NCT03352713|18549378|P1|Overall Study|Withdrawn by investigator|5
5388096|NCT03352713|18549378|P1|Overall Study|Lost to Follow-up|8
5388097|NCT03352453|18549399|P2|Overall Study|Adverse Event|9
5388098|NCT03352453|18549400|P1|Overall Study|Adverse Event|2
5388099|NCT03352453|18549399|P2|Overall Study|Lost to Follow-up|6
5388100|NCT03352453|18549400|P1|Overall Study|Lost to Follow-up|7
5388101|NCT03352453|18549399|P2|Overall Study|Protocol Deviation|0
5388102|NCT03352453|18549400|P1|Overall Study|Protocol Deviation|1
5388103|NCT03352453|18549399|P2|Overall Study|Study Terminated by Sponsor|1
5388104|NCT03352453|18549400|P1|Overall Study|Study Terminated by Sponsor|2
5388105|NCT03352453|18549399|P2|Overall Study|Withdrawal by Subject|14
5388106|NCT03352453|18549400|P1|Overall Study|Withdrawal by Subject|8
5388107|NCT03352453|18549399|P2|Overall Study|Lack of Efficacy|0
5388108|NCT03352453|18549400|P1|Overall Study|Lack of Efficacy|1
5388109|NCT03352453|18549399|P2|Overall Study|Miscellaneous Reasons|2
5388110|NCT03352453|18549400|P1|Overall Study|Miscellaneous Reasons|1
5388111|NCT03351738|18549422|P6|Overall Study|Withdrawal by Subject|0
5388112|NCT03351738|18549423|P5|Overall Study|Withdrawal by Subject|0
5388113|NCT03351738|18549424|P4|Overall Study|Withdrawal by Subject|1
5388114|NCT03351738|18549425|P3|Overall Study|Withdrawal by Subject|0
5388115|NCT03351738|18549426|P2|Overall Study|Withdrawal by Subject|1
5388116|NCT03351738|18549427|P1|Overall Study|Withdrawal by Subject|0
5388117|NCT03351335|18549579|P3|Overall Study|Failure to maintain inclusion/exclusion|4
5388118|NCT03351335|18549580|P2|Overall Study|Failure to maintain inclusion/exclusion|0
5388119|NCT03351335|18549581|P1|Overall Study|Failure to maintain inclusion/exclusion|0
5388120|NCT03351231|18549601|P1|Safety Follow-Up Period|Other reason|2
5388121|NCT03351231|18549601|P1|Safety Follow-Up Period|Participant withdrew consent|1
5388122|NCT03351231|18549601|P1|Combination Therapy Period|Adverse Event unrelated to study drug|1
5388123|NCT03351231|18549601|P1|Combination Therapy Period|Study drug toxicity|1
5388124|NCT03351231|18549601|P1|Combination Therapy Period|Disease progression|2
5388125|NCT03351231|18549601|P1|Combination Therapy Period|Administrative reason by the Sponsor|1
5388126|NCT03350984|18549636|P2|Overall Study|Physician Decision|0
5388127|NCT03350984|18549637|P1|Overall Study|Physician Decision|1
5388128|NCT03350984|18549636|P2|Overall Study|Protocol Violation|2
5388129|NCT03350984|18549637|P1|Overall Study|Protocol Violation|1
5388130|NCT03350984|18549636|P2|Overall Study|Lost to Follow-up|6
5388131|NCT03350984|18549637|P1|Overall Study|Lost to Follow-up|5
5388132|NCT03350984|18549636|P2|Overall Study|Death|0
5388133|NCT03350984|18549637|P1|Overall Study|Death|1
5388134|NCT03350503|18549715|P1|Overall Study|Subject Wishes|2
5388135|NCT03350503|18549715|P1|Overall Study|Hospital Transfer or Removal|2
5388136|NCT03350503|18549715|P1|Overall Study|Adverse Event|1
5388137|NCT03350256|18549719|P1|Overall Study|Lack of Efficacy|2
5388138|NCT03350256|18549719|P1|Overall Study|Lost to Follow-up|1
5388139|NCT03350256|18549719|P1|Overall Study|Subject moving out of state|1
5388140|NCT03350256|18549719|P1|Overall Study|Withdrawal by Subject|3
5388141|NCT03350256|18549719|P1|Overall Study|Did not proceed to permanent implant|3
5388142|NCT03350256|18549719|P1|Overall Study|Trial failure|12
5388143|NCT03350256|18549719|P1|Overall Study|Adverse Event|2
5388144|NCT03350256|18549719|P1|Overall Study|Denial by insurance|1
5388145|NCT03350256|18549719|P1|Overall Study|Non compliance|2
5388146|NCT03350256|18549719|P1|Overall Study|Protocol Violation|3
5388147|NCT03350256|18549719|P1|Overall Study|Recommended for other therapies|2
5388148|NCT03350256|18549719|P1|Overall Study|Inclusion/exclusion violation|4
5388149|NCT03349515|18549793|P2|Overall Study|Physician Decision|1
5388150|NCT03349515|18549794|P1|Overall Study|Physician Decision|3
5388151|NCT03349515|18549793|P2|Overall Study|Lack of Efficacy|0
5388152|NCT03349515|18549794|P1|Overall Study|Lack of Efficacy|2
5388153|NCT03349437|18549800|P3|Screening|Withdrawn|0
5388154|NCT03349437|18549801|P2|Screening|Withdrawn|0
5388155|NCT03349437|18549802|P1|Screening|Withdrawn|1
5388156|NCT03349437|18549800|P3|Screening|Screen Fail|0
5388157|NCT03349437|18549801|P2|Screening|Screen Fail|0
5388158|NCT03349437|18549802|P1|Screening|Screen Fail|4
5388159|NCT03349333|18549809|P1|Overall Study|Patients in treatment less than 24 month|8
5388160|NCT03349333|18549809|P1|Overall Study|3-week lapse between pralatrexate doses|1
5388161|NCT03349333|18549809|P1|Overall Study|Physician Decision|2
5388162|NCT03349333|18549809|P1|Overall Study|Conditions interfere with participation|2
5388163|NCT03349333|18549809|P1|Overall Study|Withdrawal by Subject|5
5388164|NCT03349333|18549809|P1|Overall Study|Other|6
5388165|NCT03349333|18549809|P1|Overall Study|Adverse Event|11
5388166|NCT03349333|18549809|P1|Overall Study|Progression of Disease|36
5388167|NCT03349099|18549832|P2|Overall Study|Stone migrated from the kidney|0
5388168|NCT03349099|18549833|P1|Overall Study|Stone migrated from the kidney|1
5388169|NCT03349099|18549832|P2|Overall Study|Physician Decision|4
5388170|NCT03349099|18549833|P1|Overall Study|Physician Decision|3
5388171|NCT03349060|18549846|P3|Overall Study|Other|0
5388172|NCT03349060|18549847|P2|Overall Study|Other|1
5388173|NCT03349060|18549848|P1|Overall Study|Other|2
5388174|NCT03349060|18549846|P3|Overall Study|Withdrawal By Parent/Guardian|0
5388175|NCT03349060|18549847|P2|Overall Study|Withdrawal By Parent/Guardian|1
5388176|NCT03349060|18549848|P1|Overall Study|Withdrawal By Parent/Guardian|0
5388177|NCT03349060|18549846|P3|Overall Study|Medication error,no linked adverse event|1
5388178|NCT03349060|18549847|P2|Overall Study|Medication error,no linked adverse event|0
5388179|NCT03349060|18549848|P1|Overall Study|Medication error,no linked adverse event|0
5388180|NCT03349060|18549846|P3|Overall Study|Withdrawal by Subject|4
5388181|NCT03349060|18549847|P2|Overall Study|Withdrawal by Subject|3
5388182|NCT03349060|18549848|P1|Overall Study|Withdrawal by Subject|5
5388183|NCT03349060|18549846|P3|Overall Study|Protocol Violation|1
5388184|NCT03349060|18549847|P2|Overall Study|Protocol Violation|2
5388185|NCT03349060|18549848|P1|Overall Study|Protocol Violation|2
5388186|NCT03349060|18549846|P3|Overall Study|Lost to Follow-up|1
5388187|NCT03349060|18549847|P2|Overall Study|Lost to Follow-up|1
5388188|NCT03349060|18549848|P1|Overall Study|Lost to Follow-up|2
5388189|NCT03349060|18549846|P3|Overall Study|Lack of Efficacy|2
5388190|NCT03349060|18549847|P2|Overall Study|Lack of Efficacy|0
5388191|NCT03349060|18549848|P1|Overall Study|Lack of Efficacy|1
5388192|NCT03349060|18549846|P3|Overall Study|Adverse Event|7
5388193|NCT03349060|18549847|P2|Overall Study|Adverse Event|9
5388194|NCT03349060|18549848|P1|Overall Study|Adverse Event|9
5388195|NCT03349034|18549989|P2|Overall Study|Other|1
5388196|NCT03349034|18549990|P1|Overall Study|Other|0
5388197|NCT03349034|18549989|P2|Overall Study|soft tissue flap used|0
5388198|NCT03349034|18549990|P1|Overall Study|soft tissue flap used|1
5388199|NCT03349034|18549989|P2|Overall Study|intubated for >48 hrs following surgery|1
5388200|NCT03349034|18549990|P1|Overall Study|intubated for >48 hrs following surgery|1
5388201|NCT03349034|18549989|P2|Overall Study|catheters dislodged during transport|0
5388202|NCT03349034|18549990|P1|Overall Study|catheters dislodged during transport|2
5388203|NCT03348904|18550011|P3|Overall Study|Administrative reason by the sponsor|0
5388204|NCT03348904|18550012|P2|Overall Study|Administrative reason by the sponsor|1
5388205|NCT03348904|18550013|P1|Overall Study|Administrative reason by the sponsor|0
5388206|NCT03346759|18550089|P2|Second Menstrual Cycle|Lost to Follow-up|0
5388207|NCT03346759|18550090|P1|Second Menstrual Cycle|Lost to Follow-up|1
5388208|NCT03346759|18550089|P2|First Menstrual Cycle|Withdrawal by Subject|0
5388209|NCT03346759|18550090|P1|First Menstrual Cycle|Withdrawal by Subject|1
5388210|NCT03346759|18550089|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
5388211|NCT03346759|18550090|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
5388212|NCT03346070|18550135|P5|Overall Study|Screen Failure|1
5388213|NCT03346070|18550136|P4|Overall Study|Screen Failure|1
5388214|NCT03346070|18550137|P3|Overall Study|Screen Failure|0
5388215|NCT03346070|18550138|P2|Overall Study|Screen Failure|0
5388216|NCT03346070|18550139|P1|Overall Study|Screen Failure|0
5388217|NCT03346070|18550135|P5|Overall Study|Study medication not received as planned|2
5388218|NCT03346070|18550136|P4|Overall Study|Study medication not received as planned|3
5388219|NCT03346070|18550137|P3|Overall Study|Study medication not received as planned|2
5388220|NCT03346070|18550138|P2|Overall Study|Study medication not received as planned|3
5388221|NCT03346070|18550139|P1|Overall Study|Study medication not received as planned|2
5388222|NCT03346070|18550135|P5|Overall Study|Withdrawal by Subject|0
5388223|NCT03346070|18550136|P4|Overall Study|Withdrawal by Subject|1
5388224|NCT03346070|18550137|P3|Overall Study|Withdrawal by Subject|0
5388225|NCT03346070|18550138|P2|Overall Study|Withdrawal by Subject|0
5388226|NCT03346070|18550139|P1|Overall Study|Withdrawal by Subject|1
5388227|NCT03346070|18550135|P5|Overall Study|Physician Decision|1
5388228|NCT03346070|18550136|P4|Overall Study|Physician Decision|1
5388229|NCT03346070|18550137|P3|Overall Study|Physician Decision|0
5388230|NCT03346070|18550138|P2|Overall Study|Physician Decision|0
5388231|NCT03346070|18550139|P1|Overall Study|Physician Decision|0
5388232|NCT03346070|18550135|P5|Overall Study|Lost to Follow-up|0
5388233|NCT03346070|18550136|P4|Overall Study|Lost to Follow-up|0
5388234|NCT03346070|18550137|P3|Overall Study|Lost to Follow-up|2
5388235|NCT03346070|18550138|P2|Overall Study|Lost to Follow-up|1
5388236|NCT03346070|18550139|P1|Overall Study|Lost to Follow-up|0
5388237|NCT03346070|18550135|P5|Overall Study|Death|1
5388238|NCT03346070|18550136|P4|Overall Study|Death|0
5388239|NCT03346070|18550137|P3|Overall Study|Death|0
5388240|NCT03346070|18550138|P2|Overall Study|Death|0
5388241|NCT03346070|18550139|P1|Overall Study|Death|0
5388242|NCT03346057|18550227|P4|Overall Study|Withdrawal by Subject|0
5388243|NCT03346057|18550228|P3|Overall Study|Withdrawal by Subject|0
5388244|NCT03346057|18550229|P2|Overall Study|Withdrawal by Subject|0
5388245|NCT03346057|18550230|P1|Overall Study|Withdrawal by Subject|1
5388246|NCT03346057|18550227|P4|Overall Study|Randomization Mistake - Not Treated|0
5388247|NCT03346057|18550228|P3|Overall Study|Randomization Mistake - Not Treated|0
5388248|NCT03346057|18550229|P2|Overall Study|Randomization Mistake - Not Treated|1
5388249|NCT03346057|18550230|P1|Overall Study|Randomization Mistake - Not Treated|1
5388250|NCT03346057|18550227|P4|Overall Study|Physician Decision|2
5388251|NCT03346057|18550228|P3|Overall Study|Physician Decision|0
5388252|NCT03346057|18550229|P2|Overall Study|Physician Decision|2
5388253|NCT03346057|18550230|P1|Overall Study|Physician Decision|3
5388254|NCT03346057|18550227|P4|Overall Study|Renal Insufficiency - Not Treated|0
5388255|NCT03346057|18550228|P3|Overall Study|Renal Insufficiency - Not Treated|0
5388256|NCT03346057|18550229|P2|Overall Study|Renal Insufficiency - Not Treated|0
5388257|NCT03346057|18550230|P1|Overall Study|Renal Insufficiency - Not Treated|1
5388258|NCT03346057|18550227|P4|Overall Study|Ineligible For Study - Not Treated|0
5388259|NCT03346057|18550228|P3|Overall Study|Ineligible For Study - Not Treated|0
5388260|NCT03346057|18550229|P2|Overall Study|Ineligible For Study - Not Treated|1
5388261|NCT03346057|18550230|P1|Overall Study|Ineligible For Study - Not Treated|0
5388262|NCT03346057|18550227|P4|Overall Study|Lost to Follow-up|0
5388263|NCT03346057|18550228|P3|Overall Study|Lost to Follow-up|1
5388264|NCT03346057|18550229|P2|Overall Study|Lost to Follow-up|2
5388265|NCT03346057|18550230|P1|Overall Study|Lost to Follow-up|0
5388266|NCT03346057|18550227|P4|Overall Study|Death|0
5388267|NCT03346057|18550228|P3|Overall Study|Death|0
5388268|NCT03346057|18550229|P2|Overall Study|Death|2
5388269|NCT03346057|18550230|P1|Overall Study|Death|1
5388270|NCT03345979|18550262|P2|Overall Study|Physician Decision|2
5388271|NCT03345979|18550263|P1|Overall Study|Physician Decision|0
5388272|NCT03345979|18550262|P2|Overall Study|Protocol Violation|3
5388273|NCT03345979|18550263|P1|Overall Study|Protocol Violation|1
5388274|NCT03345979|18550262|P2|Overall Study|Lack of Efficacy|2
5388275|NCT03345979|18550263|P1|Overall Study|Lack of Efficacy|4
5388276|NCT03345979|18550262|P2|Overall Study|Lost to Follow-up|9
5388277|NCT03345979|18550263|P1|Overall Study|Lost to Follow-up|8
5388278|NCT03345979|18550262|P2|Overall Study|Adverse Event|11
5388279|NCT03345979|18550263|P1|Overall Study|Adverse Event|10
5388280|NCT03345979|18550262|P2|Overall Study|Withdrawal by Subject|31
5388281|NCT03345979|18550263|P1|Overall Study|Withdrawal by Subject|20
5388282|NCT03345914|18550284|P3|Overall Study|Ongoing|1
5388283|NCT03345914|18550285|P2|Overall Study|Ongoing|0
5388284|NCT03345914|18550286|P1|Overall Study|Ongoing|0
5388285|NCT03345914|18550284|P3|Overall Study|Other|1
5388286|NCT03345914|18550285|P2|Overall Study|Other|1
5388287|NCT03345914|18550286|P1|Overall Study|Other|1
5388288|NCT03345914|18550284|P3|Overall Study|Withdrawal by Subject|2
5388289|NCT03345914|18550285|P2|Overall Study|Withdrawal by Subject|1
5388290|NCT03345914|18550286|P1|Overall Study|Withdrawal by Subject|5
5388291|NCT03345914|18550284|P3|Overall Study|Physician Decision|1
5388292|NCT03345914|18550285|P2|Overall Study|Physician Decision|1
5388293|NCT03345914|18550286|P1|Overall Study|Physician Decision|0
5388294|NCT03345914|18550284|P3|Overall Study|Transition to OLE during follow-up|39
5388295|NCT03345914|18550285|P2|Overall Study|Transition to OLE during follow-up|33
5388296|NCT03345914|18550286|P1|Overall Study|Transition to OLE during follow-up|37
5388297|NCT03345914|18550284|P3|Overall Study|Transition to another study at week 16|78
5388298|NCT03345914|18550285|P2|Overall Study|Transition to another study at week 16|86
5388299|NCT03345914|18550286|P1|Overall Study|Transition to another study at week 16|80
5388300|NCT03345901|18550357|P1|Overall Study|The study was terminated|18
5388301|NCT03345472|18550362|P1|3 Months to 12 Months|Death|1
5388302|NCT03345472|18550362|P1|3 Months to 12 Months|Adverse Event|1
5388303|NCT03345472|18550362|P1|3 Months to 12 Months|Withdrawal by Subject|1
5388304|NCT03345472|18550362|P1|3 Months to 12 Months|Lost to Follow-up|2
5388305|NCT03345472|18550362|P1|3 Months to 12 Months|Physician Decision|3
5388306|NCT03345472|18550362|P1|Implant to 3 Months|Adverse Event|1
5388307|NCT03345472|18550362|P1|Implant to 3 Months|Physician Decision|1
5388308|NCT03345472|18550362|P1|Implant to 3 Months|Withdrawal by Subject|2
5388309|NCT03345407|18550376|P7|Overall Study|Adverse Event|16
5388310|NCT03345407|18550377|P6|Overall Study|Adverse Event|5
5388311|NCT03345407|18550378|P5|Overall Study|Adverse Event|6
5388312|NCT03345407|18550379|P4|Overall Study|Adverse Event|4
5388313|NCT03345407|18550380|P3|Overall Study|Adverse Event|5
5388314|NCT03345407|18550381|P2|Overall Study|Adverse Event|0
5388315|NCT03345407|18550382|P1|Overall Study|Adverse Event|4
5388316|NCT03345407|18550376|P7|Overall Study|Lack of Efficacy|3
5388317|NCT03345407|18550377|P6|Overall Study|Lack of Efficacy|0
5388318|NCT03345407|18550378|P5|Overall Study|Lack of Efficacy|1
5388319|NCT03345407|18550379|P4|Overall Study|Lack of Efficacy|1
5388320|NCT03345407|18550380|P3|Overall Study|Lack of Efficacy|1
5388321|NCT03345407|18550381|P2|Overall Study|Lack of Efficacy|1
5388322|NCT03345407|18550382|P1|Overall Study|Lack of Efficacy|1
5388323|NCT03345407|18550376|P7|Overall Study|Protocol Violation|3
5388324|NCT03345407|18550377|P6|Overall Study|Protocol Violation|0
5388325|NCT03345407|18550378|P5|Overall Study|Protocol Violation|1
5388326|NCT03345407|18550379|P4|Overall Study|Protocol Violation|0
5388327|NCT03345407|18550380|P3|Overall Study|Protocol Violation|0
5388328|NCT03345407|18550381|P2|Overall Study|Protocol Violation|0
5388329|NCT03345407|18550382|P1|Overall Study|Protocol Violation|2
5388330|NCT03345407|18550376|P7|Overall Study|Protocol-defined stopping criteria|1
5388331|NCT03345407|18550377|P6|Overall Study|Protocol-defined stopping criteria|1
5388332|NCT03345407|18550378|P5|Overall Study|Protocol-defined stopping criteria|2
5388333|NCT03345407|18550379|P4|Overall Study|Protocol-defined stopping criteria|0
5388334|NCT03345407|18550380|P3|Overall Study|Protocol-defined stopping criteria|0
5388335|NCT03345407|18550381|P2|Overall Study|Protocol-defined stopping criteria|0
5388336|NCT03345407|18550382|P1|Overall Study|Protocol-defined stopping criteria|9
5388337|NCT03345407|18550376|P7|Overall Study|Lost to Follow-up|3
5388338|NCT03345407|18550377|P6|Overall Study|Lost to Follow-up|2
5388339|NCT03345407|18550378|P5|Overall Study|Lost to Follow-up|1
5388340|NCT03345407|18550379|P4|Overall Study|Lost to Follow-up|0
5388341|NCT03345407|18550380|P3|Overall Study|Lost to Follow-up|1
5388342|NCT03345407|18550381|P2|Overall Study|Lost to Follow-up|0
5388343|NCT03345407|18550382|P1|Overall Study|Lost to Follow-up|2
5388344|NCT03345407|18550376|P7|Overall Study|Physician Decision|3
5388345|NCT03345407|18550377|P6|Overall Study|Physician Decision|2
5388346|NCT03345407|18550378|P5|Overall Study|Physician Decision|1
5388347|NCT03345407|18550379|P4|Overall Study|Physician Decision|0
5388348|NCT03345407|18550380|P3|Overall Study|Physician Decision|0
5388349|NCT03345407|18550381|P2|Overall Study|Physician Decision|1
5388350|NCT03345407|18550382|P1|Overall Study|Physician Decision|3
5388351|NCT03345407|18550376|P7|Overall Study|Withdrawal by Subject|16
5388352|NCT03345407|18550377|P6|Overall Study|Withdrawal by Subject|6
5388353|NCT03345407|18550378|P5|Overall Study|Withdrawal by Subject|3
5388354|NCT03345407|18550379|P4|Overall Study|Withdrawal by Subject|6
5388355|NCT03345407|18550380|P3|Overall Study|Withdrawal by Subject|5
5388356|NCT03345407|18550381|P2|Overall Study|Withdrawal by Subject|1
5388357|NCT03345407|18550382|P1|Overall Study|Withdrawal by Subject|11
5388358|NCT03344640|18550611|P2|Follow-up Epoch|Withdrawal by Subject|2
5388359|NCT03344640|18550612|P1|Follow-up Epoch|Withdrawal by Subject|0
5388360|NCT03344640|18550611|P2|Overall Study|Withdrawal by Subject|2
5388361|NCT03344640|18550612|P1|Overall Study|Withdrawal by Subject|1
5388362|NCT03344640|18550611|P2|Overall Study|Physician Decision|1
5388363|NCT03344640|18550612|P1|Overall Study|Physician Decision|1
5388364|NCT03344640|18550611|P2|Overall Study|Adverse Event|0
5388365|NCT03344640|18550612|P1|Overall Study|Adverse Event|1
5388366|NCT03344562|18550641|P2|Overall Study|Withdrawal by Subject|0
5388367|NCT03344562|18550642|P1|Overall Study|Withdrawal by Subject|2
5388368|NCT03344172|18550662|P2|Overall Study|Received <1 dose of treatment|0
5388369|NCT03344172|18550663|P1|Overall Study|Received <1 dose of treatment|1
5388370|NCT03343639|18550681|P2|Overall Study|Protocol Violation|1
5388371|NCT03343639|18550682|P1|Overall Study|Protocol Violation|0
5388372|NCT03343639|18550681|P2|Overall Study|Lost to Follow-up|5
5388373|NCT03343639|18550682|P1|Overall Study|Lost to Follow-up|4
5388374|NCT03343639|18550681|P2|Overall Study|Withdrawal by Subject|6
5388375|NCT03343639|18550682|P1|Overall Study|Withdrawal by Subject|10
5388376|NCT03343067|18550710|P3|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
5388377|NCT03343067|18550711|P2|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
5388378|NCT03343067|18550712|P1|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
5388379|NCT03342898|18550840|P3|Overall Study|Reason not Specified|0
5388380|NCT03342898|18550841|P2|Overall Study|Reason not Specified|2
5388381|NCT03342898|18550842|P1|Overall Study|Reason not Specified|2
5388382|NCT03342898|18550840|P3|Overall Study|Death|1
5388383|NCT03342898|18550841|P2|Overall Study|Death|1
5388384|NCT03342898|18550842|P1|Overall Study|Death|0
5388385|NCT03342898|18550840|P3|Overall Study|Withdrawal of Consent|11
5388386|NCT03342898|18550841|P2|Overall Study|Withdrawal of Consent|9
5388387|NCT03342898|18550842|P1|Overall Study|Withdrawal of Consent|5
5388388|NCT03342898|18550840|P3|Overall Study|Lost to Follow-up|42
5388389|NCT03342898|18550841|P2|Overall Study|Lost to Follow-up|40
5388390|NCT03342898|18550842|P1|Overall Study|Lost to Follow-up|44
5388391|NCT03342898|18550840|P3|Overall Study|Adverse Event|0
5388392|NCT03342898|18550841|P2|Overall Study|Adverse Event|1
5388393|NCT03342898|18550842|P1|Overall Study|Adverse Event|3
5388394|NCT03342560|18550883|P1|Overall Study|Lost to Follow-up|2
5388395|NCT03342469|18550893|P4|Overall Study|Withdrawal by Subject|0
5388396|NCT03342469|18550894|P3|Overall Study|Withdrawal by Subject|0
5388397|NCT03342469|18550895|P2|Overall Study|Withdrawal by Subject|1
5388398|NCT03342469|18550896|P1|Overall Study|Withdrawal by Subject|0
5388399|NCT03341923|18550925|P2|Period 2, Second 14 Days of Wear|Adverse Event|1
5388400|NCT03341923|18550926|P1|Period 2, Second 14 Days of Wear|Adverse Event|0
5388401|NCT03341637|18550970|P2|Overall Study|Reason not Specified|1
5388402|NCT03341637|18550971|P1|Overall Study|Reason not Specified|1
5388403|NCT03341637|18550970|P2|Overall Study|Withdrawal by Subject|3
5388404|NCT03341637|18550971|P1|Overall Study|Withdrawal by Subject|3
5388405|NCT03341637|18550970|P2|Overall Study|Lost to Follow-up|0
5388406|NCT03341637|18550971|P1|Overall Study|Lost to Follow-up|1
5388407|NCT03341533|18550999|P2|Overall Study|Not eligible after randomization|1
5388408|NCT03341533|18551000|P1|Overall Study|Not eligible after randomization|2
5388409|NCT03341533|18550999|P2|Overall Study|Withdrawal by Subject|1
5388410|NCT03341533|18551000|P1|Overall Study|Withdrawal by Subject|1
5388411|NCT03341312|18551012|P4|Period 1|Withdrawal by Subject|0
5388412|NCT03341312|18551013|P3|Period 1|Withdrawal by Subject|0
5388413|NCT03341312|18551014|P2|Period 1|Withdrawal by Subject|1
5388414|NCT03341312|18551015|P1|Period 1|Withdrawal by Subject|0
5388415|NCT03341299|18551027|P4|Washout (A Minimum of 21 Hours)|Adverse Event|0
5388416|NCT03341299|18551028|P3|Washout (A Minimum of 21 Hours)|Adverse Event|1
5388417|NCT03341299|18551029|P2|Washout (A Minimum of 21 Hours)|Adverse Event|0
5388418|NCT03341299|18551030|P1|Washout (A Minimum of 21 Hours)|Adverse Event|0
5388419|NCT03340961|18551046|P4|Overall Study|Other|3
5388420|NCT03340961|18551047|P3|Overall Study|Other|1
5388421|NCT03340961|18551048|P2|Overall Study|Other|2
5388422|NCT03340961|18551049|P1|Overall Study|Other|0
5388423|NCT03340961|18551046|P4|Overall Study|Adverse Event|0
5388424|NCT03340961|18551047|P3|Overall Study|Adverse Event|0
5388425|NCT03340961|18551048|P2|Overall Study|Adverse Event|1
5388426|NCT03340961|18551049|P1|Overall Study|Adverse Event|1
5388427|NCT03340961|18551046|P4|Overall Study|Protocol Violation|0
5388428|NCT03340961|18551047|P3|Overall Study|Protocol Violation|1
5388429|NCT03340961|18551048|P2|Overall Study|Protocol Violation|0
5388430|NCT03340961|18551049|P1|Overall Study|Protocol Violation|1
5388431|NCT03340961|18551046|P4|Overall Study|Subject developed an exclusion criterion|0
5388432|NCT03340961|18551047|P3|Overall Study|Subject developed an exclusion criterion|0
5388433|NCT03340961|18551048|P2|Overall Study|Subject developed an exclusion criterion|1
5388434|NCT03340961|18551049|P1|Overall Study|Subject developed an exclusion criterion|0
5388435|NCT03340961|18551046|P4|Overall Study|rongful enrollment (I/E criteria not me|1
5388436|NCT03340961|18551047|P3|Overall Study|rongful enrollment (I/E criteria not me|0
5388437|NCT03340961|18551048|P2|Overall Study|rongful enrollment (I/E criteria not me|0
5388438|NCT03340961|18551049|P1|Overall Study|rongful enrollment (I/E criteria not me|0
5388439|NCT03340961|18551046|P4|Overall Study|Use of prohibited treatment|3
5388440|NCT03340961|18551047|P3|Overall Study|Use of prohibited treatment|2
5388441|NCT03340961|18551048|P2|Overall Study|Use of prohibited treatment|3
5388442|NCT03340961|18551049|P1|Overall Study|Use of prohibited treatment|0
5388443|NCT03340961|18551046|P4|Overall Study|Withdrawal by Subject|6
5388444|NCT03340961|18551047|P3|Overall Study|Withdrawal by Subject|3
5388445|NCT03340961|18551048|P2|Overall Study|Withdrawal by Subject|1
5388446|NCT03340961|18551049|P1|Overall Study|Withdrawal by Subject|3
5388447|NCT03340961|18551046|P4|Overall Study|Lost to Follow-up|1
5388448|NCT03340961|18551047|P3|Overall Study|Lost to Follow-up|0
5388449|NCT03340961|18551048|P2|Overall Study|Lost to Follow-up|1
5388450|NCT03340961|18551049|P1|Overall Study|Lost to Follow-up|0
5388451|NCT03340961|18551046|P4|Overall Study|Adverse Event|4
5388452|NCT03340961|18551047|P3|Overall Study|Adverse Event|2
5388453|NCT03340961|18551048|P2|Overall Study|Adverse Event|3
5388454|NCT03340961|18551049|P1|Overall Study|Adverse Event|1
5388455|NCT03339726|18551170|P3|Overall Study|Lost to Follow-up|0
5388456|NCT03339726|18551171|P2|Overall Study|Lost to Follow-up|1
5388457|NCT03339726|18551172|P1|Overall Study|Lost to Follow-up|0
5388458|NCT03339726|18551170|P3|Overall Study|Withdrawal by Subject|0
5388459|NCT03339726|18551171|P2|Overall Study|Withdrawal by Subject|0
5388460|NCT03339726|18551172|P1|Overall Study|Withdrawal by Subject|1
5388461|NCT03339583|18551230|P2|Follow-up (14 Days)|Physician Decision|3
5388462|NCT03339583|18551231|P1|Follow-up (14 Days)|Physician Decision|6
5388463|NCT03339583|18551230|P2|Second Intervention (14 Days)|Adverse Event|1
5388464|NCT03339583|18551231|P1|Second Intervention (14 Days)|Adverse Event|0
5388465|NCT03339583|18551230|P2|Second Intervention (14 Days)|unrelated acute exacerbation|1
5388466|NCT03339583|18551231|P1|Second Intervention (14 Days)|unrelated acute exacerbation|0
5388467|NCT03339583|18551230|P2|First Intervention (14 Days)|Adverse Event|0
5388468|NCT03339583|18551231|P1|First Intervention (14 Days)|Adverse Event|1
5388469|NCT03339453|18551269|P2|First Visit of Glucagon Treatment|Adverse Event|1
5388470|NCT03339453|18551270|P1|First Visit of Glucagon Treatment|Adverse Event|0
5388471|NCT03338816|18551334|P2|Open-Label Extension Period|Ongoing in Study|47
5388472|NCT03338816|18551335|P1|Open-Label Extension Period|Ongoing in Study|46
5388473|NCT03338816|18551334|P2|6-Month Double-blind Period|Adverse Event|1
5388474|NCT03338816|18551335|P1|6-Month Double-blind Period|Adverse Event|0
5388475|NCT03338673|18551372|P2|Overall Study|Lost to Follow-up|1
5388476|NCT03338673|18551373|P1|Overall Study|Lost to Follow-up|1
5388477|NCT03338400|18551408|P2|Overall Study|Lost to Follow-up|2
5388478|NCT03338400|18551409|P1|Overall Study|Lost to Follow-up|1
5388479|NCT03337490|18551445|P3|Overall Study|Lost to Follow-up|0
5388480|NCT03337490|18551446|P2|Overall Study|Lost to Follow-up|1
5388481|NCT03337490|18551447|P1|Overall Study|Lost to Follow-up|0
5388482|NCT03337490|18551445|P3|Overall Study|Physician Decision|0
5388483|NCT03337490|18551446|P2|Overall Study|Physician Decision|1
5388484|NCT03337490|18551447|P1|Overall Study|Physician Decision|0
5388485|NCT03337490|18551445|P3|Overall Study|Lack of Efficacy|35
5388486|NCT03337490|18551446|P2|Overall Study|Lack of Efficacy|12
5388487|NCT03337490|18551447|P1|Overall Study|Lack of Efficacy|10
5388488|NCT03337490|18551445|P3|Overall Study|Withdrawal by Subject|0
5388489|NCT03337490|18551446|P2|Overall Study|Withdrawal by Subject|0
5388490|NCT03337490|18551447|P1|Overall Study|Withdrawal by Subject|1
5388491|NCT03337477|18551460|P2|Overall Study|Lost to Follow-up|2
5388492|NCT03337477|18551461|P1|Overall Study|Lost to Follow-up|0
5388493|NCT03337477|18551460|P2|Overall Study|Death|1
5388494|NCT03337477|18551461|P1|Overall Study|Death|0
5388495|NCT03337477|18551460|P2|Overall Study|Withdrawal by Subject|1
5388496|NCT03337477|18551461|P1|Overall Study|Withdrawal by Subject|0
5388497|NCT03337477|18551460|P2|Overall Study|not categorized into the listed ones|9
5388498|NCT03337477|18551461|P1|Overall Study|not categorized into the listed ones|11
5388499|NCT03337308|18551485|P4|Overall Study|Protocol Violation|0
5388500|NCT03337308|18551486|P3|Overall Study|Protocol Violation|0
5388501|NCT03337308|18551487|P2|Overall Study|Protocol Violation|1
5388502|NCT03337308|18551488|P1|Overall Study|Protocol Violation|0
5388503|NCT03337308|18551485|P4|Overall Study|Withdrawal by Subject|1
5388504|NCT03337308|18551486|P3|Overall Study|Withdrawal by Subject|2
5388505|NCT03337308|18551487|P2|Overall Study|Withdrawal by Subject|1
5388506|NCT03337308|18551488|P1|Overall Study|Withdrawal by Subject|2
5388507|NCT03337308|18551485|P4|Overall Study|Lost to Follow-up|0
5388508|NCT03337308|18551486|P3|Overall Study|Lost to Follow-up|0
5388509|NCT03337308|18551487|P2|Overall Study|Lost to Follow-up|2
5388510|NCT03337308|18551488|P1|Overall Study|Lost to Follow-up|1
5388511|NCT03337308|18551485|P4|Overall Study|Adverse Event|1
5388512|NCT03337308|18551486|P3|Overall Study|Adverse Event|3
5388513|NCT03337308|18551487|P2|Overall Study|Adverse Event|3
5388514|NCT03337308|18551488|P1|Overall Study|Adverse Event|2
5388515|NCT03336502|18551555|P2|Overall Study|Adverse Event|5
5388516|NCT03336502|18551556|P1|Overall Study|Adverse Event|2
5388517|NCT03336502|18551555|P2|Overall Study|Death|2
5388518|NCT03336502|18551556|P1|Overall Study|Death|1
5388519|NCT03336502|18551555|P2|Overall Study|Prohibited Drugs|1
5388520|NCT03336502|18551556|P1|Overall Study|Prohibited Drugs|1
5388521|NCT03336502|18551555|P2|Overall Study|Physician Decision|1
5388522|NCT03336502|18551556|P1|Overall Study|Physician Decision|0
5388523|NCT03335566|18551592|P2|Overall Study|Other than specified above|2
5388524|NCT03335566|18551593|P1|Overall Study|Other than specified above|1
5388525|NCT03335566|18551592|P2|Overall Study|Protocol Violation|0
5388526|NCT03335566|18551593|P1|Overall Study|Protocol Violation|1
5388527|NCT03335566|18551592|P2|Overall Study|Technical Problems|0
5388528|NCT03335566|18551593|P1|Overall Study|Technical Problems|1
5388529|NCT03335566|18551592|P2|Overall Study|Lost to Follow-up|0
5388530|NCT03335566|18551593|P1|Overall Study|Lost to Follow-up|1
5388531|NCT03335566|18551592|P2|Overall Study|Adverse Event|1
5388532|NCT03335566|18551593|P1|Overall Study|Adverse Event|0
5388533|NCT03335150|18551675|P2|Overall Study|Adverse Event|1
5388534|NCT03335150|18551676|P1|Overall Study|Adverse Event|0
5388535|NCT03335150|18551675|P2|Overall Study|Withdrawal by Subject|4
5388536|NCT03335150|18551676|P1|Overall Study|Withdrawal by Subject|10
5388537|NCT03334747|18551747|P9|Follow-Up Phase|Subject/guardian decision|1
5388538|NCT03334747|18551748|P8|Follow-Up Phase|Subject/guardian decision|0
5388539|NCT03334747|18551749|P7|Follow-Up Phase|Subject/guardian decision|1
5388540|NCT03334747|18551750|P6|Follow-Up Phase|Subject/guardian decision|0
5388541|NCT03334747|18551751|P5|Follow-Up Phase|Subject/guardian decision|0
5388542|NCT03334747|18551752|P4|Follow-Up Phase|Subject/guardian decision|0
5388543|NCT03334747|18551753|P3|Follow-Up Phase|Subject/guardian decision|0
5388544|NCT03334747|18551754|P2|Follow-Up Phase|Subject/guardian decision|0
5388545|NCT03334747|18551755|P1|Follow-Up Phase|Subject/guardian decision|0
5388546|NCT03334747|18551747|P9|Treatment Phase|Subject/guardian decision|0
5388547|NCT03334747|18551748|P8|Treatment Phase|Subject/guardian decision|0
5388548|NCT03334747|18551749|P7|Treatment Phase|Subject/guardian decision|0
5388549|NCT03334747|18551750|P6|Treatment Phase|Subject/guardian decision|1
5388550|NCT03334747|18551751|P5|Treatment Phase|Subject/guardian decision|0
5388551|NCT03334747|18551752|P4|Treatment Phase|Subject/guardian decision|0
5388552|NCT03334747|18551753|P3|Treatment Phase|Subject/guardian decision|0
5388553|NCT03334747|18551754|P2|Treatment Phase|Subject/guardian decision|0
5388554|NCT03334747|18551755|P1|Treatment Phase|Subject/guardian decision|1
5388555|NCT03334747|18551747|P9|Treatment Phase|Technical problems|0
5388556|NCT03334747|18551748|P8|Treatment Phase|Technical problems|0
5388557|NCT03334747|18551749|P7|Treatment Phase|Technical problems|0
5388558|NCT03334747|18551750|P6|Treatment Phase|Technical problems|0
5388559|NCT03334747|18551751|P5|Treatment Phase|Technical problems|1
5388560|NCT03334747|18551752|P4|Treatment Phase|Technical problems|0
5388561|NCT03334747|18551753|P3|Treatment Phase|Technical problems|0
5388562|NCT03334747|18551754|P2|Treatment Phase|Technical problems|0
5388563|NCT03334747|18551755|P1|Treatment Phase|Technical problems|0
5388564|NCT03334721|18551945|P2|Overall Study|No longer met inclusion/exclusion criter|0
5388565|NCT03334721|18551946|P1|Overall Study|No longer met inclusion/exclusion criter|1
5388566|NCT03334721|18551945|P2|Overall Study|Withdrawal by Subject|0
5388567|NCT03334721|18551946|P1|Overall Study|Withdrawal by Subject|1
5388568|NCT03334630|18551954|P2|Overall Study|Subject unable to complete 12-month follow-up visit|1
5388569|NCT03334630|18551955|P1|Overall Study|Subject unable to complete 12-month follow-up visit|1
5388570|NCT03334630|18551954|P2|Overall Study|Subject not treated with study ablation due to technical difficulties|1
5388571|NCT03334630|18551955|P1|Overall Study|Subject not treated with study ablation due to technical difficulties|0
5388572|NCT03334630|18551954|P2|Overall Study|Enrollment closed|1
5388573|NCT03334630|18551955|P1|Overall Study|Enrollment closed|2
5388574|NCT03334630|18551954|P2|Overall Study|Physician Decision|1
5388575|NCT03334630|18551955|P1|Overall Study|Physician Decision|1
5388576|NCT03334630|18551954|P2|Overall Study|Adverse Event|1
5388577|NCT03334630|18551955|P1|Overall Study|Adverse Event|0
5388578|NCT03334630|18551954|P2|Overall Study|Lost to Follow-up|1
5388579|NCT03334630|18551955|P1|Overall Study|Lost to Follow-up|3
5388580|NCT03334630|18551954|P2|Overall Study|Withdrawal by Subject|7
5388581|NCT03334630|18551955|P1|Overall Study|Withdrawal by Subject|7
5388582|NCT03334448|18551997|P4|Washout|Protocol Violation|1
5388583|NCT03334448|18551998|P3|Washout|Protocol Violation|0
5388584|NCT03334448|18551999|P2|Washout|Protocol Violation|0
5388585|NCT03334448|18552000|P1|Washout|Protocol Violation|0
5388586|NCT03334448|18551997|P4|Washout|Personal Reason|0
5388587|NCT03334448|18551998|P3|Washout|Personal Reason|0
5388588|NCT03334448|18551999|P2|Washout|Personal Reason|1
5388589|NCT03334448|18552000|P1|Washout|Personal Reason|0
5388590|NCT03334422|18552012|P4|Overall Study|Pregnancy|0
5388591|NCT03334422|18552013|P3|Overall Study|Pregnancy|0
5388592|NCT03334422|18552014|P2|Overall Study|Pregnancy|1
5388593|NCT03334422|18552015|P1|Overall Study|Pregnancy|0
5388594|NCT03334422|18552012|P4|Overall Study|Inability to obtain laboratory samples|0
5388595|NCT03334422|18552013|P3|Overall Study|Inability to obtain laboratory samples|0
5388596|NCT03334422|18552014|P2|Overall Study|Inability to obtain laboratory samples|1
5388597|NCT03334422|18552015|P1|Overall Study|Inability to obtain laboratory samples|0
5388598|NCT03334422|18552012|P4|Overall Study|Lost to Follow-up|1
5388599|NCT03334422|18552013|P3|Overall Study|Lost to Follow-up|0
5388600|NCT03334422|18552014|P2|Overall Study|Lost to Follow-up|0
5388601|NCT03334422|18552015|P1|Overall Study|Lost to Follow-up|0
5388602|NCT03334422|18552012|P4|Overall Study|Withdrawal by Subject|0
5388603|NCT03334422|18552013|P3|Overall Study|Withdrawal by Subject|1
5388604|NCT03334422|18552014|P2|Overall Study|Withdrawal by Subject|3
5388605|NCT03334422|18552015|P1|Overall Study|Withdrawal by Subject|8
5388606|NCT03334422|18552012|P4|Overall Study|Lack of Efficacy|3
5388607|NCT03334422|18552013|P3|Overall Study|Lack of Efficacy|7
5388608|NCT03334422|18552014|P2|Overall Study|Lack of Efficacy|2
5388609|NCT03334422|18552015|P1|Overall Study|Lack of Efficacy|10
5388610|NCT03334422|18552012|P4|Overall Study|Adverse Event|2
5388611|NCT03334422|18552013|P3|Overall Study|Adverse Event|2
5388612|NCT03334422|18552014|P2|Overall Study|Adverse Event|3
5388613|NCT03334422|18552015|P1|Overall Study|Adverse Event|1
5388614|NCT03334396|18552122|P8|Overall Study|Started New Job|0
5388615|NCT03334396|18552123|P7|Overall Study|Started New Job|0
5388616|NCT03334396|18552124|P6|Overall Study|Started New Job|0
5388617|NCT03334396|18552125|P5|Overall Study|Started New Job|0
5388618|NCT03334396|18552126|P4|Overall Study|Started New Job|0
5388619|NCT03334396|18552127|P3|Overall Study|Started New Job|0
5388620|NCT03334396|18552128|P2|Overall Study|Started New Job|0
5388621|NCT03334396|18552129|P1|Overall Study|Started New Job|1
5388622|NCT03334396|18552122|P8|Overall Study|Ineligible|0
5388623|NCT03334396|18552123|P7|Overall Study|Ineligible|0
5388624|NCT03334396|18552124|P6|Overall Study|Ineligible|0
5388625|NCT03334396|18552125|P5|Overall Study|Ineligible|0
5388626|NCT03334396|18552126|P4|Overall Study|Ineligible|0
5388627|NCT03334396|18552127|P3|Overall Study|Ineligible|0
5388628|NCT03334396|18552128|P2|Overall Study|Ineligible|1
5388629|NCT03334396|18552129|P1|Overall Study|Ineligible|0
5388630|NCT03334396|18552122|P8|Overall Study|Pregnancy|0
5388631|NCT03334396|18552123|P7|Overall Study|Pregnancy|0
5388632|NCT03334396|18552124|P6|Overall Study|Pregnancy|0
5388633|NCT03334396|18552125|P5|Overall Study|Pregnancy|0
5388634|NCT03334396|18552126|P4|Overall Study|Pregnancy|0
5388635|NCT03334396|18552127|P3|Overall Study|Pregnancy|0
5388636|NCT03334396|18552128|P2|Overall Study|Pregnancy|1
5388637|NCT03334396|18552129|P1|Overall Study|Pregnancy|0
5388638|NCT03334396|18552122|P8|Overall Study|Withdrawal by Subject|0
5388639|NCT03334396|18552123|P7|Overall Study|Withdrawal by Subject|2
5388640|NCT03334396|18552124|P6|Overall Study|Withdrawal by Subject|1
5388641|NCT03334396|18552125|P5|Overall Study|Withdrawal by Subject|2
5388642|NCT03334396|18552126|P4|Overall Study|Withdrawal by Subject|2
5388643|NCT03334396|18552127|P3|Overall Study|Withdrawal by Subject|7
5388644|NCT03334396|18552128|P2|Overall Study|Withdrawal by Subject|5
5388645|NCT03334396|18552129|P1|Overall Study|Withdrawal by Subject|10
5388646|NCT03334396|18552122|P8|Overall Study|Physician Decision|0
5388647|NCT03334396|18552123|P7|Overall Study|Physician Decision|0
5388648|NCT03334396|18552124|P6|Overall Study|Physician Decision|0
5388649|NCT03334396|18552125|P5|Overall Study|Physician Decision|0
5388650|NCT03334396|18552126|P4|Overall Study|Physician Decision|0
5388651|NCT03334396|18552127|P3|Overall Study|Physician Decision|0
5388652|NCT03334396|18552128|P2|Overall Study|Physician Decision|0
5388653|NCT03334396|18552129|P1|Overall Study|Physician Decision|1
5388654|NCT03334396|18552122|P8|Overall Study|Lost to Follow-up|0
5388655|NCT03334396|18552123|P7|Overall Study|Lost to Follow-up|1
5388656|NCT03334396|18552124|P6|Overall Study|Lost to Follow-up|0
5388657|NCT03334396|18552125|P5|Overall Study|Lost to Follow-up|0
5388658|NCT03334396|18552126|P4|Overall Study|Lost to Follow-up|0
5388659|NCT03334396|18552127|P3|Overall Study|Lost to Follow-up|1
5388660|NCT03334396|18552128|P2|Overall Study|Lost to Follow-up|0
5388661|NCT03334396|18552129|P1|Overall Study|Lost to Follow-up|0
5388662|NCT03334396|18552122|P8|Overall Study|Lack of Efficacy|1
5388663|NCT03334396|18552123|P7|Overall Study|Lack of Efficacy|0
5388664|NCT03334396|18552124|P6|Overall Study|Lack of Efficacy|0
5388665|NCT03334396|18552125|P5|Overall Study|Lack of Efficacy|1
5388666|NCT03334396|18552126|P4|Overall Study|Lack of Efficacy|3
5388667|NCT03334396|18552127|P3|Overall Study|Lack of Efficacy|1
5388668|NCT03334396|18552128|P2|Overall Study|Lack of Efficacy|4
5388669|NCT03334396|18552129|P1|Overall Study|Lack of Efficacy|10
5388670|NCT03334396|18552122|P8|Overall Study|Adverse Event|0
5388671|NCT03334396|18552123|P7|Overall Study|Adverse Event|0
5388672|NCT03334396|18552124|P6|Overall Study|Adverse Event|0
5388673|NCT03334396|18552125|P5|Overall Study|Adverse Event|0
5388674|NCT03334396|18552126|P4|Overall Study|Adverse Event|0
5388675|NCT03334396|18552127|P3|Overall Study|Adverse Event|1
5388676|NCT03334396|18552128|P2|Overall Study|Adverse Event|0
5388677|NCT03334396|18552129|P1|Overall Study|Adverse Event|1
5388678|NCT03334214|18552234|P2|Overall Study|Other|0
5388679|NCT03334214|18552235|P1|Overall Study|Other|1
5388680|NCT03334214|18552234|P2|Overall Study|Withdrawal by Subject|1
5388681|NCT03334214|18552235|P1|Overall Study|Withdrawal by Subject|0
5388682|NCT03334214|18552234|P2|Overall Study|Adverse Event or Serious Adverse Event|1
5388683|NCT03334214|18552235|P1|Overall Study|Adverse Event or Serious Adverse Event|0
5388684|NCT03334175|18552261|P2|Overall Study|Lost to Follow-up|1
5388685|NCT03334175|18552262|P1|Overall Study|Lost to Follow-up|0
5388686|NCT03333876|18552284|P1|Mandibular Advancement|Product Damage|2
5388687|NCT03333876|18552284|P1|Mandibular Advancement|Adverse Event|2
5388688|NCT03333876|18552284|P1|Nasal Dilator|Bed Partner Lost to follow up|6
5388689|NCT03333876|18552284|P1|Screening Period|Screen Failure|4
5388690|NCT03332784|18552475|P20|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388691|NCT03332784|18552476|P19|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388692|NCT03332784|18552477|P18|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388693|NCT03332784|18552478|P17|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388694|NCT03332784|18552479|P16|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388695|NCT03332784|18552480|P15|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
5388696|NCT03332784|18552481|P14|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388697|NCT03332784|18552482|P13|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388698|NCT03332784|18552483|P12|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388699|NCT03332784|18552484|P11|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388700|NCT03332784|18552485|P10|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388701|NCT03332784|18552486|P9|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388702|NCT03332784|18552487|P8|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388703|NCT03332784|18552488|P7|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388704|NCT03332784|18552489|P6|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388705|NCT03332784|18552490|P5|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388706|NCT03332784|18552491|P4|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388707|NCT03332784|18552492|P3|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388708|NCT03332784|18552493|P2|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
5388709|NCT03332784|18552494|P1|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
5388710|NCT03332160|18552752|P2|Overall Study|Non-adherence to treatment|2
5388711|NCT03332160|18552753|P1|Overall Study|Non-adherence to treatment|0
5388712|NCT03332160|18552752|P2|Overall Study|Developed Exclusion Criteria|1
5388713|NCT03332160|18552753|P1|Overall Study|Developed Exclusion Criteria|0
5388714|NCT03332160|18552752|P2|Overall Study|Adverse Event|1
5388715|NCT03332160|18552753|P1|Overall Study|Adverse Event|0
5388716|NCT03332160|18552752|P2|Overall Study|Withdrawal by Subject|1
5388717|NCT03332160|18552753|P1|Overall Study|Withdrawal by Subject|1
5388718|NCT03331315|18552837|P2|Overall Study|Physician Decision|14
5388719|NCT03331315|18552838|P1|Overall Study|Physician Decision|18
5388720|NCT03331042|18552875|P4|Overall Study|Lost to Follow-up|1
5388721|NCT03331042|18552876|P3|Overall Study|Lost to Follow-up|0
5388722|NCT03331042|18552877|P2|Overall Study|Lost to Follow-up|0
5388723|NCT03331042|18552878|P1|Overall Study|Lost to Follow-up|0
5388724|NCT03331042|18552875|P4|Overall Study|Physician Decision|0
5388725|NCT03331042|18552876|P3|Overall Study|Physician Decision|1
5388726|NCT03331042|18552877|P2|Overall Study|Physician Decision|0
5388727|NCT03331042|18552878|P1|Overall Study|Physician Decision|0
5388728|NCT03331042|18552875|P4|Overall Study|Protocol Violation|0
5388729|NCT03331042|18552876|P3|Overall Study|Protocol Violation|0
5388730|NCT03331042|18552877|P2|Overall Study|Protocol Violation|0
5388731|NCT03331042|18552878|P1|Overall Study|Protocol Violation|1
5388732|NCT03330236|18552988|P2|Overall Study|Surgery aborted/converted to open|52
5388733|NCT03330236|18552989|P1|Overall Study|Surgery aborted/converted to open|60
5388734|NCT03330236|18552988|P2|Overall Study|Volatile anesthetics used|8
5388735|NCT03330236|18552989|P1|Overall Study|Volatile anesthetics used|11
5388736|NCT03330236|18552988|P2|Overall Study|SedLine malfunction/blinding|14
5388737|NCT03330236|18552989|P1|Overall Study|SedLine malfunction/blinding|19
5388738|NCT03330236|18552988|P2|Overall Study|Protocol Violation|3
5388739|NCT03330236|18552989|P1|Overall Study|Protocol Violation|4
5388740|NCT03330236|18552988|P2|Overall Study|Physician Decision|0
5388741|NCT03330236|18552989|P1|Overall Study|Physician Decision|2
5388742|NCT03330236|18552988|P2|Overall Study|Lost to Follow-up|2
5388743|NCT03330236|18552989|P1|Overall Study|Lost to Follow-up|0
5388744|NCT03330236|18552988|P2|Overall Study|Withdrawal by Subject|4
5388745|NCT03330236|18552989|P1|Overall Study|Withdrawal by Subject|2
5388746|NCT03330236|18552988|P2|Overall Study|Death|1
5388747|NCT03330236|18552989|P1|Overall Study|Death|2
5388748|NCT03329989|18553023|P1|Overall Study|Protocol Violation|1
5388749|NCT03329989|18553023|P1|Overall Study|Adverse Event|5
5388750|NCT03329989|18553023|P1|Overall Study|Lost to Follow-up|8
5388751|NCT03329989|18553023|P1|Overall Study|Withdrawal by Subject|9
5388752|NCT03329885|18553041|P9|Overall Study|Sponsor discontinued the study early|0
5388753|NCT03329885|18553042|P8|Overall Study|Sponsor discontinued the study early|1
5388754|NCT03329885|18553043|P7|Overall Study|Sponsor discontinued the study early|1
5388755|NCT03329885|18553044|P6|Overall Study|Sponsor discontinued the study early|0
5388756|NCT03329885|18553045|P5|Overall Study|Sponsor discontinued the study early|0
5388757|NCT03329885|18553046|P4|Overall Study|Sponsor discontinued the study early|0
5388758|NCT03329885|18553047|P3|Overall Study|Sponsor discontinued the study early|0
5388759|NCT03329885|18553048|P2|Overall Study|Sponsor discontinued the study early|0
5388760|NCT03329885|18553049|P1|Overall Study|Sponsor discontinued the study early|0
5388761|NCT03329690|18553218|P5|Overall Study|Did not receive treatment|0
5388762|NCT03329690|18553219|P4|Overall Study|Did not receive treatment|1
5388763|NCT03329690|18553220|P3|Overall Study|Did not receive treatment|0
5388764|NCT03329690|18553221|P2|Overall Study|Did not receive treatment|0
5388765|NCT03329690|18553222|P1|Overall Study|Did not receive treatment|1
5388766|NCT03329690|18553218|P5|Overall Study|Physician Decision|1
5388767|NCT03329690|18553219|P4|Overall Study|Physician Decision|0
5388768|NCT03329690|18553220|P3|Overall Study|Physician Decision|0
5388769|NCT03329690|18553221|P2|Overall Study|Physician Decision|0
5388770|NCT03329690|18553222|P1|Overall Study|Physician Decision|1
5388771|NCT03329690|18553218|P5|Overall Study|Withdrawal by Subject|0
5388772|NCT03329690|18553219|P4|Overall Study|Withdrawal by Subject|1
5388773|NCT03329690|18553220|P3|Overall Study|Withdrawal by Subject|0
5388774|NCT03329690|18553221|P2|Overall Study|Withdrawal by Subject|3
5388775|NCT03329690|18553222|P1|Overall Study|Withdrawal by Subject|2
5388776|NCT03329690|18553218|P5|Overall Study|Death|0
5388777|NCT03329690|18553219|P4|Overall Study|Death|1
5388778|NCT03329690|18553220|P3|Overall Study|Death|0
5388779|NCT03329690|18553221|P2|Overall Study|Death|0
5388780|NCT03329690|18553222|P1|Overall Study|Death|2
5388781|NCT03329690|18553218|P5|Overall Study|Adverse Event|2
5388782|NCT03329690|18553219|P4|Overall Study|Adverse Event|1
5388783|NCT03329690|18553220|P3|Overall Study|Adverse Event|0
5388784|NCT03329690|18553221|P2|Overall Study|Adverse Event|4
5388785|NCT03329690|18553222|P1|Overall Study|Adverse Event|19
5388786|NCT03329690|18553218|P5|Overall Study|Clinical progression|0
5388787|NCT03329690|18553219|P4|Overall Study|Clinical progression|1
5388788|NCT03329690|18553220|P3|Overall Study|Clinical progression|1
5388789|NCT03329690|18553221|P2|Overall Study|Clinical progression|4
5388790|NCT03329690|18553222|P1|Overall Study|Clinical progression|6
5388791|NCT03329690|18553218|P5|Overall Study|Progressive disease per RECIST|19
5388792|NCT03329690|18553219|P4|Overall Study|Progressive disease per RECIST|16
5388793|NCT03329690|18553220|P3|Overall Study|Progressive disease per RECIST|5
5388794|NCT03329690|18553221|P2|Overall Study|Progressive disease per RECIST|42
5388795|NCT03329690|18553222|P1|Overall Study|Progressive disease per RECIST|67
5388796|NCT03329573|18553304|P4|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
5388797|NCT03329573|18553305|P3|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
5388798|NCT03329573|18553306|P2|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
5388799|NCT03329573|18553307|P1|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
5388800|NCT03329573|18553304|P4|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
5388801|NCT03329573|18553305|P3|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
5388802|NCT03329573|18553306|P2|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
5388803|NCT03329573|18553307|P1|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
5388804|NCT03329573|18553304|P4|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
5388805|NCT03329573|18553305|P3|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
5388806|NCT03329573|18553306|P2|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
5388807|NCT03329573|18553307|P1|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
5388808|NCT03329573|18553304|P4|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
5388809|NCT03329573|18553305|P3|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
5388810|NCT03329573|18553306|P2|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
5388811|NCT03329573|18553307|P1|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
5388812|NCT03328897|18553391|P3|Follow-up Epoch|Patient/guardian decision|0
5388813|NCT03328897|18553392|P2|Follow-up Epoch|Patient/guardian decision|1
5388814|NCT03328897|18553393|P1|Follow-up Epoch|Patient/guardian decision|2
5388815|NCT03328897|18553391|P3|Follow-up Epoch|Pregnancy|0
5388816|NCT03328897|18553392|P2|Follow-up Epoch|Pregnancy|0
5388817|NCT03328897|18553393|P1|Follow-up Epoch|Pregnancy|1
5388818|NCT03328897|18553391|P3|Follow-up Epoch|Lost to Follow-up|0
5388819|NCT03328897|18553392|P2|Follow-up Epoch|Lost to Follow-up|1
5388820|NCT03328897|18553393|P1|Follow-up Epoch|Lost to Follow-up|0
5388821|NCT03328897|18553391|P3|Follow-up Epoch|Lack of Efficacy|1
5388822|NCT03328897|18553392|P2|Follow-up Epoch|Lack of Efficacy|1
5388823|NCT03328897|18553393|P1|Follow-up Epoch|Lack of Efficacy|1
5388824|NCT03328897|18553391|P3|Follow-up Epoch|Adverse Event|1
5388825|NCT03328897|18553392|P2|Follow-up Epoch|Adverse Event|0
5388826|NCT03328897|18553393|P1|Follow-up Epoch|Adverse Event|4
5388827|NCT03328897|18553391|P3|Randomized-treatment Epoch|Lack of Efficacy|0
5388828|NCT03328897|18553392|P2|Randomized-treatment Epoch|Lack of Efficacy|0
5388829|NCT03328897|18553393|P1|Randomized-treatment Epoch|Lack of Efficacy|1
5388830|NCT03328897|18553391|P3|Randomized-treatment Epoch|Patient/guardian decision|1
5388831|NCT03328897|18553392|P2|Randomized-treatment Epoch|Patient/guardian decision|3
5388832|NCT03328897|18553393|P1|Randomized-treatment Epoch|Patient/guardian decision|8
5388833|NCT03328897|18553391|P3|Randomized-treatment Epoch|Pregnancy|0
5388834|NCT03328897|18553392|P2|Randomized-treatment Epoch|Pregnancy|0
5388835|NCT03328897|18553393|P1|Randomized-treatment Epoch|Pregnancy|3
5388836|NCT03328897|18553391|P3|Randomized-treatment Epoch|Lost to Follow-up|0
5388837|NCT03328897|18553392|P2|Randomized-treatment Epoch|Lost to Follow-up|1
5388838|NCT03328897|18553393|P1|Randomized-treatment Epoch|Lost to Follow-up|0
5388839|NCT03328897|18553391|P3|Randomized-treatment Epoch|Adverse Event|1
5388840|NCT03328897|18553392|P2|Randomized-treatment Epoch|Adverse Event|1
5388841|NCT03328897|18553393|P1|Randomized-treatment Epoch|Adverse Event|4
5388842|NCT03328182|18553455|P1|Overall Study|No Product Evaluated|1
5388843|NCT03328182|18553455|P1|Overall Study|Protocol Violation|2
5388844|NCT03328182|18553455|P1|Overall Study|Withdrawal by Subject|1
5388845|NCT03327402|18553460|P1|Overall Study|Other (Visit Out-Of-Window)|1
5388846|NCT03327402|18553460|P1|Overall Study|Withdrawal by Subject|1
5388847|NCT03326869|18553774|P2|Overall Study|Study data has been lost to natural disa|1
5388848|NCT03326869|18553775|P1|Overall Study|Study data has been lost to natural disa|1
5388849|NCT03326518|18553791|P3|Overall Study|Lost to Follow-up|1
5388850|NCT03326518|18553792|P2|Overall Study|Lost to Follow-up|0
5388851|NCT03326518|18553793|P1|Overall Study|Lost to Follow-up|1
5388852|NCT03326518|18553791|P3|Overall Study|Withdrawal by Subject|0
5388853|NCT03326518|18553792|P2|Overall Study|Withdrawal by Subject|0
5388854|NCT03326518|18553793|P1|Overall Study|Withdrawal by Subject|1
5388855|NCT03326518|18553791|P3|Overall Study|Protocol Violation|0
5388856|NCT03326518|18553792|P2|Overall Study|Protocol Violation|0
5388857|NCT03326518|18553793|P1|Overall Study|Protocol Violation|1
5388858|NCT03326323|18553828|P1|Overall Study|Unable to receive ANH protocol|3
5388859|NCT03325894|18553835|P2|Overall Study|Other (Not received Treatment)|0
5388860|NCT03325894|18553836|P1|Overall Study|Other (Not received Treatment)|1
5388861|NCT03325894|18553835|P2|Overall Study|Study Terminated by Sponsor|43
5388862|NCT03325894|18553836|P1|Overall Study|Study Terminated by Sponsor|38
5388863|NCT03325894|18553835|P2|Overall Study|Lack of Efficacy|14
5388864|NCT03325894|18553836|P1|Overall Study|Lack of Efficacy|8
5388865|NCT03325894|18553835|P2|Overall Study|Lost to Follow-up|9
5388866|NCT03325894|18553836|P1|Overall Study|Lost to Follow-up|4
5388867|NCT03325894|18553835|P2|Overall Study|Withdrawal by Subject|6
5388868|NCT03325894|18553836|P1|Overall Study|Withdrawal by Subject|10
5388869|NCT03325894|18553835|P2|Overall Study|Protocol Violation|2
5388870|NCT03325894|18553836|P1|Overall Study|Protocol Violation|1
5388871|NCT03325894|18553835|P2|Overall Study|Adverse Event|3
5388872|NCT03325894|18553836|P1|Overall Study|Adverse Event|2
5388873|NCT03325881|18553904|P2|Overall Study|Not treated|0
5388874|NCT03325881|18553905|P1|Overall Study|Not treated|1
5388875|NCT03325881|18553904|P2|Overall Study|Lack of Efficacy|0
5388876|NCT03325881|18553905|P1|Overall Study|Lack of Efficacy|2
5388877|NCT03325881|18553904|P2|Overall Study|Withdrawal by Subject|2
5388878|NCT03325881|18553905|P1|Overall Study|Withdrawal by Subject|0
5388879|NCT03325881|18553904|P2|Overall Study|Protocol Violation|1
5388880|NCT03325881|18553905|P1|Overall Study|Protocol Violation|0
5388881|NCT03325673|18553933|P2|Overall Study|Adverse Event|0
5388882|NCT03325673|18553934|P1|Overall Study|Adverse Event|4
5388883|NCT03323736|18553966|P3|Overall Study|Iontophoresis fill/no iontophoresis|0
5388884|NCT03323736|18553967|P2|Overall Study|Iontophoresis fill/no iontophoresis|2
5388885|NCT03323736|18553968|P1|Overall Study|Iontophoresis fill/no iontophoresis|2
5388886|NCT03323736|18553966|P3|Overall Study|Withdrawal Before Treatment|1
5388887|NCT03323736|18553967|P2|Overall Study|Withdrawal Before Treatment|1
5388888|NCT03323736|18553968|P1|Overall Study|Withdrawal Before Treatment|3
5388889|NCT03323736|18553966|P3|Overall Study|Screen Failure|1
5388890|NCT03323736|18553967|P2|Overall Study|Screen Failure|9
5388891|NCT03323736|18553968|P1|Overall Study|Screen Failure|14
5388892|NCT03323164|18553995|P2|Overall Study|Poor quality imaging/scans|2
5388893|NCT03323164|18553996|P1|Overall Study|Poor quality imaging/scans|2
5388894|NCT03323086|18554022|P2|Overall Study|Lost to Follow-up|2
5388895|NCT03323086|18554023|P1|Overall Study|Lost to Follow-up|3
5388896|NCT03322566|18554051|P3|Overall Study|On-going at clinical cut off date|36
5388897|NCT03322566|18554052|P2|Overall Study|On-going at clinical cut off date|74
5388898|NCT03322566|18554053|P1|Overall Study|On-going at clinical cut off date|68
5388899|NCT03322566|18554051|P3|Overall Study|Withdrawal by Subject|5
5388900|NCT03322566|18554052|P2|Overall Study|Withdrawal by Subject|1
5388901|NCT03322566|18554053|P1|Overall Study|Withdrawal by Subject|3
5388902|NCT03322566|18554051|P3|Overall Study|Physician Decision|1
5388903|NCT03322566|18554052|P2|Overall Study|Physician Decision|0
5388904|NCT03322566|18554053|P1|Overall Study|Physician Decision|0
5388905|NCT03322566|18554051|P3|Overall Study|Death|13
5388906|NCT03322566|18554052|P2|Overall Study|Death|12
5388907|NCT03322566|18554053|P1|Overall Study|Death|20
5388908|NCT03322540|18554072|P2|Overall Study|Participants Ongoing|59
5388909|NCT03322540|18554073|P1|Overall Study|Participants Ongoing|63
5388910|NCT03322540|18554072|P2|Overall Study|Withdrawal by Subject|1
5388911|NCT03322540|18554073|P1|Overall Study|Withdrawal by Subject|2
5388912|NCT03322540|18554072|P2|Overall Study|Physician Decision|1
5388913|NCT03322540|18554073|P1|Overall Study|Physician Decision|0
5388914|NCT03322540|18554072|P2|Overall Study|Lost to Follow-up|1
5388915|NCT03322540|18554073|P1|Overall Study|Lost to Follow-up|0
5388916|NCT03322540|18554072|P2|Overall Study|Death|15
5388917|NCT03322540|18554073|P1|Overall Study|Death|12
5388918|NCT03322514|18554081|P2|Overall Study|Withdrawal by Subject|1
5388919|NCT03322514|18554082|P1|Overall Study|Withdrawal by Subject|1
5388920|NCT03322462|18554092|P1|Overall Study|Other|1
5388921|NCT03322462|18554092|P1|Overall Study|Technical difficulties|2
5388922|NCT03322423|18554101|P2|Period 2|Subject not eligible for Pytergiumectomy|1
5388923|NCT03322423|18554102|P1|Period 2|Subject not eligible for Pytergiumectomy|0
5388924|NCT03322423|18554101|P2|Period 2|Protocol Violation|0
5388925|NCT03322423|18554102|P1|Period 2|Protocol Violation|1
5388926|NCT03322423|18554101|P2|Period 2|Dispensed incorrect lens in left eye|1
5388927|NCT03322423|18554102|P1|Period 2|Dispensed incorrect lens in left eye|0
5388928|NCT03322423|18554101|P2|Period 1|Unsatisfactory Lens Fitting|0
5388929|NCT03322423|18554102|P1|Period 1|Unsatisfactory Lens Fitting|1
5388930|NCT03322423|18554101|P2|Period 1|Incorrect Lens Dispensed|0
5388931|NCT03322423|18554102|P1|Period 1|Incorrect Lens Dispensed|1
5388932|NCT03322423|18554101|P2|Period 1|Withdrawal by Subject|1
5388933|NCT03322423|18554102|P1|Period 1|Withdrawal by Subject|0
5388934|NCT03322423|18554101|P2|Period 1|Subject no longer eligible|1
5388935|NCT03322423|18554102|P1|Period 1|Subject no longer eligible|0
5388936|NCT03322293|18554115|P3|Overall Study|Lost to Follow-up|1
5388937|NCT03322293|18554116|P2|Overall Study|Lost to Follow-up|0
5388938|NCT03322293|18554117|P1|Overall Study|Lost to Follow-up|0
5388939|NCT03321721|18554140|P3|Overall Study|Lost to Follow-up|11
5388940|NCT03321721|18554141|P2|Overall Study|Lost to Follow-up|8
5388941|NCT03321721|18554142|P1|Overall Study|Lost to Follow-up|4
5388942|NCT03321396|18554159|P1|Overall Study|Physician Decision|1
5388943|NCT03320941|18554197|P5|Overall Study|subject/guardian decision|0
5388944|NCT03320941|18554198|P4|Overall Study|subject/guardian decision|1
5388945|NCT03320941|18554199|P3|Overall Study|subject/guardian decision|0
5388946|NCT03320941|18554200|P2|Overall Study|subject/guardian decision|0
5388947|NCT03320941|18554201|P1|Overall Study|subject/guardian decision|0
5388948|NCT03320824|18554304|P2|Overall Study|could not complete final visit|1
5388949|NCT03320824|18554305|P1|Overall Study|could not complete final visit|0
5388950|NCT03320824|18554304|P2|Overall Study|moved out of state|1
5388951|NCT03320824|18554305|P1|Overall Study|moved out of state|0
5388952|NCT03320824|18554304|P2|Overall Study|Lost to Follow-up|1
5388953|NCT03320824|18554305|P1|Overall Study|Lost to Follow-up|10
5388954|NCT03320824|18554304|P2|Overall Study|Withdrawal by Subject|1
5388955|NCT03320824|18554305|P1|Overall Study|Withdrawal by Subject|8
5388956|NCT03320564|18554321|P1|Overall Study|Protocol Violation|1
5388957|NCT03320369|18554325|P1|Overall Study|Withdrawal by Subject|2
5388958|NCT03320369|18554325|P1|Overall Study|Adverse Event|1
5388959|NCT03319719|18554346|P1|Overall Study|Lost to Follow-up|1
5388960|NCT03319212|18554379|P2|Overall Study|Physician Decision|0
5388961|NCT03319212|18554380|P1|Overall Study|Physician Decision|1
5388962|NCT03319212|18554379|P2|Overall Study|Lost to Follow-up|1
5388963|NCT03319212|18554380|P1|Overall Study|Lost to Follow-up|0
5388964|NCT03319212|18554379|P2|Overall Study|Withdrawal by Subject|1
5388965|NCT03319212|18554380|P1|Overall Study|Withdrawal by Subject|0
5388966|NCT03319212|18554379|P2|Overall Study|Adverse Event|2
5388967|NCT03319212|18554380|P1|Overall Study|Adverse Event|2
5388968|NCT03319212|18554379|P2|Overall Study|Discontinued as moving out of local area|1
5388969|NCT03319212|18554380|P1|Overall Study|Discontinued as moving out of local area|0
5388970|NCT03318861|18554462|P5|Overall Study|Enrolled But Did Not Initiate KITE-585|1
5388971|NCT03318861|18554463|P4|Overall Study|Enrolled But Did Not Initiate KITE-585|1
5388972|NCT03318861|18554464|P3|Overall Study|Enrolled But Did Not Initiate KITE-585|0
5388973|NCT03318861|18554465|P2|Overall Study|Enrolled But Did Not Initiate KITE-585|1
5388974|NCT03318861|18554466|P1|Overall Study|Enrolled But Did Not Initiate KITE-585|0
5388975|NCT03318861|18554462|P5|Overall Study|Still on Study|1
5388976|NCT03318861|18554463|P4|Overall Study|Still on Study|2
5388977|NCT03318861|18554464|P3|Overall Study|Still on Study|1
5388978|NCT03318861|18554465|P2|Overall Study|Still on Study|1
5388979|NCT03318861|18554466|P1|Overall Study|Still on Study|2
5388980|NCT03318861|18554462|P5|Overall Study|Death|1
5388981|NCT03318861|18554463|P4|Overall Study|Death|1
5388982|NCT03318861|18554464|P3|Overall Study|Death|2
5388983|NCT03318861|18554465|P2|Overall Study|Death|2
5388984|NCT03318861|18554466|P1|Overall Study|Death|1
5388985|NCT03318315|18554528|P3|Overall Study|Withdrawal by Subject|2
5388986|NCT03318315|18554529|P2|Overall Study|Withdrawal by Subject|0
5388987|NCT03318315|18554530|P1|Overall Study|Withdrawal by Subject|0
5388988|NCT03318315|18554528|P3|Overall Study|Protocol Violation|1
5388989|NCT03318315|18554529|P2|Overall Study|Protocol Violation|1
5388990|NCT03318315|18554530|P1|Overall Study|Protocol Violation|1
5388991|NCT03318315|18554528|P3|Overall Study|Lost to Follow-up|1
5388992|NCT03318315|18554529|P2|Overall Study|Lost to Follow-up|2
5388993|NCT03318315|18554530|P1|Overall Study|Lost to Follow-up|3
5388994|NCT03316911|18554644|P2|Overall Study|Lost to Follow-up|29
5388995|NCT03316911|18554645|P1|Overall Study|Lost to Follow-up|33
5388996|NCT03316131|18554690|P2|Treatment Period 2|Protocol deviation|0
5388997|NCT03316131|18554691|P1|Treatment Period 2|Protocol deviation|1
5388998|NCT03315689|18554757|P2|Open Label Extension = 52 Weeks|Lost to Follow-up|1
5388999|NCT03315689|18554758|P1|Open Label Extension = 52 Weeks|Lost to Follow-up|0
5389000|NCT03315689|18554757|P2|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
5389001|NCT03315689|18554758|P1|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
5389002|NCT03315689|18554757|P2|Double-blind Period = 28 Days|Withdrawal by Subject|0
5389003|NCT03315689|18554758|P1|Double-blind Period = 28 Days|Withdrawal by Subject|1
5389004|NCT03315286|18554852|P2|Overall Study|Protocol Violation|1
5389005|NCT03315286|18554853|P1|Overall Study|Protocol Violation|0
5389006|NCT03315286|18554852|P2|Overall Study|Withdrawal by Subject|0
5389007|NCT03315286|18554853|P1|Overall Study|Withdrawal by Subject|1
5389008|NCT03315286|18554852|P2|Overall Study|Lost to Follow-up|3
5389009|NCT03315286|18554853|P1|Overall Study|Lost to Follow-up|0
5389010|NCT03314857|18554894|P1|Overall Study|Physician Decision|1
5389011|NCT03314857|18554894|P1|Overall Study|Death|4
5389012|NCT03314662|18554928|P3|Overall Study|Death|0
5389013|NCT03314662|18554929|P2|Overall Study|Death|0
5389014|NCT03314662|18554930|P1|Overall Study|Death|2
5389015|NCT03314662|18554928|P3|Overall Study|Lost to Follow-up|4
5389016|NCT03314662|18554929|P2|Overall Study|Lost to Follow-up|4
5389017|NCT03314662|18554930|P1|Overall Study|Lost to Follow-up|5
5389018|NCT03314662|18554928|P3|Overall Study|Withdrawal by Subject|1
5389019|NCT03314662|18554929|P2|Overall Study|Withdrawal by Subject|1
5389020|NCT03314662|18554930|P1|Overall Study|Withdrawal by Subject|1
5389021|NCT03314519|18554975|P2|Overall Study|Protocol Violation|2
5389022|NCT03314519|18554976|P1|Overall Study|Protocol Violation|3
5389023|NCT03314233|18554986|P1|Overall Study|No longer eligible at time of delivery|1
5389024|NCT03313310|18554999|P2|Phase 3|Lost to Follow-up|1
5389025|NCT03313310|18555000|P1|Phase 3|Lost to Follow-up|0
5389026|NCT03313310|18554999|P2|Phase 2|Lost to Follow-up|0
5389027|NCT03313310|18555000|P1|Phase 2|Lost to Follow-up|4
5389028|NCT03313050|18555042|P4|Stage 2: 12 Months|Other|1
5389029|NCT03313050|18555043|P3|Stage 2: 12 Months|Other|0
5389030|NCT03313050|18555044|P2|Stage 2: 12 Months|Other|0
5389031|NCT03313050|18555045|P1|Stage 2: 12 Months|Other|0
5389032|NCT03313050|18555042|P4|Stage 2: 12 Months|Withdrawal by Subject|3
5389033|NCT03313050|18555043|P3|Stage 2: 12 Months|Withdrawal by Subject|0
5389034|NCT03313050|18555044|P2|Stage 2: 12 Months|Withdrawal by Subject|0
5389035|NCT03313050|18555045|P1|Stage 2: 12 Months|Withdrawal by Subject|0
5389036|NCT03313050|18555042|P4|Stage 2: 12 Months|Protocol deviation|7
5389037|NCT03313050|18555043|P3|Stage 2: 12 Months|Protocol deviation|7
5389038|NCT03313050|18555044|P2|Stage 2: 12 Months|Protocol deviation|0
5389039|NCT03313050|18555045|P1|Stage 2: 12 Months|Protocol deviation|0
5389040|NCT03313050|18555042|P4|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
5389041|NCT03313050|18555043|P3|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
5389042|NCT03313050|18555044|P2|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
5389043|NCT03313050|18555045|P1|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
5389044|NCT03313050|18555042|P4|Stage 2: 12 Months|Lost to Follow-up|5
5389045|NCT03313050|18555043|P3|Stage 2: 12 Months|Lost to Follow-up|1
5389046|NCT03313050|18555044|P2|Stage 2: 12 Months|Lost to Follow-up|0
5389047|NCT03313050|18555045|P1|Stage 2: 12 Months|Lost to Follow-up|0
5389048|NCT03313050|18555042|P4|Stage 2: 12 Months|Death|0
5389049|NCT03313050|18555043|P3|Stage 2: 12 Months|Death|3
5389050|NCT03313050|18555044|P2|Stage 2: 12 Months|Death|0
5389051|NCT03313050|18555045|P1|Stage 2: 12 Months|Death|0
5389052|NCT03313050|18555042|P4|Stage 2: 12 Months|Adverse Event|1
5389053|NCT03313050|18555043|P3|Stage 2: 12 Months|Adverse Event|0
5389054|NCT03313050|18555044|P2|Stage 2: 12 Months|Adverse Event|0
5389055|NCT03313050|18555045|P1|Stage 2: 12 Months|Adverse Event|0
5389056|NCT03313037|18555085|P2|Overall Study|Randomized but not treated|0
5389057|NCT03313037|18555086|P1|Overall Study|Randomized but not treated|1
5389058|NCT03313037|18555085|P2|Overall Study|Lost to Follow-up|8
5389059|NCT03313037|18555086|P1|Overall Study|Lost to Follow-up|9
5389060|NCT03313037|18555085|P2|Overall Study|No longer meets eligibility criteria|7
5389061|NCT03313037|18555086|P1|Overall Study|No longer meets eligibility criteria|1
5389062|NCT03313037|18555085|P2|Overall Study|Withdrawal by Subject|3
5389063|NCT03313037|18555086|P1|Overall Study|Withdrawal by Subject|4
5389064|NCT03313037|18555085|P2|Overall Study|Other|1
5389065|NCT03313037|18555086|P1|Overall Study|Other|1
5389066|NCT03313037|18555085|P2|Overall Study|Protocol Violation|1
5389067|NCT03313037|18555086|P1|Overall Study|Protocol Violation|4
5389068|NCT03312933|18555108|P1|Overall Study|Withdrawal by Subject|3
5389069|NCT03312933|18555108|P1|Overall Study|Lost to Follow-up|36
5389070|NCT03312933|18555108|P1|Overall Study|Protocol Violation|15
5389071|NCT03312543|18555114|P2|Regression (Week 12 to Week 24)|Death|1
5389072|NCT03312543|18555115|P1|Regression (Week 12 to Week 24)|Death|0
5389073|NCT03312543|18555114|P2|Regression (Week 12 to Week 24)|Protocol Violation|1
5389074|NCT03312543|18555115|P1|Regression (Week 12 to Week 24)|Protocol Violation|1
5389075|NCT03312543|18555114|P2|Treatment (Baseline to Week 12)|Protocol Violation|1
5389076|NCT03312543|18555115|P1|Treatment (Baseline to Week 12)|Protocol Violation|1
5389077|NCT03312543|18555114|P2|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
5389078|NCT03312543|18555115|P1|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
5389079|NCT03312543|18555114|P2|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
5389080|NCT03312543|18555115|P1|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
5389081|NCT03312543|18555114|P2|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
5389082|NCT03312543|18555115|P1|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
5389083|NCT03312231|18555211|P5|Overall Study|Study Vaccination not Received|0
5389084|NCT03312231|18555212|P4|Overall Study|Study Vaccination not Received|0
5389085|NCT03312231|18555213|P3|Overall Study|Study Vaccination not Received|1
5389086|NCT03312231|18555214|P2|Overall Study|Study Vaccination not Received|1
5389087|NCT03312231|18555215|P1|Overall Study|Study Vaccination not Received|1
5389088|NCT03312231|18555211|P5|Overall Study|Death|0
5389089|NCT03312231|18555212|P4|Overall Study|Death|0
5389090|NCT03312231|18555213|P3|Overall Study|Death|1
5389091|NCT03312231|18555214|P2|Overall Study|Death|1
5389092|NCT03312231|18555215|P1|Overall Study|Death|0
5389093|NCT03312231|18555211|P5|Overall Study|Withdrawal by Subject|0
5389094|NCT03312231|18555212|P4|Overall Study|Withdrawal by Subject|0
5389095|NCT03312231|18555213|P3|Overall Study|Withdrawal by Subject|1
5389096|NCT03312231|18555214|P2|Overall Study|Withdrawal by Subject|3
5389097|NCT03312231|18555215|P1|Overall Study|Withdrawal by Subject|0
5389098|NCT03312231|18555211|P5|Overall Study|Lost to Follow-up|1
5389099|NCT03312231|18555212|P4|Overall Study|Lost to Follow-up|3
5389100|NCT03312231|18555213|P3|Overall Study|Lost to Follow-up|1
5389101|NCT03312231|18555214|P2|Overall Study|Lost to Follow-up|6
5389102|NCT03312231|18555215|P1|Overall Study|Lost to Follow-up|2
5389103|NCT03312114|18555417|P1|Overall Study|All the five enrolled dropped out of the|5
5389104|NCT03311841|18555427|P5|14-day Wash-out|Non-Compliance With Study Drug|0
5389105|NCT03311841|18555428|P4|14-day Wash-out|Non-Compliance With Study Drug|1
5389106|NCT03311841|18555429|P3|14-day Wash-out|Non-Compliance With Study Drug|0
5389107|NCT03311841|18555430|P2|14-day Wash-out|Non-Compliance With Study Drug|0
5389108|NCT03311841|18555431|P1|14-day Wash-out|Non-Compliance With Study Drug|0
5389109|NCT03311841|18555427|P5|14-day Wash-out|Adverse Event|0
5389110|NCT03311841|18555428|P4|14-day Wash-out|Adverse Event|0
5389111|NCT03311841|18555429|P3|14-day Wash-out|Adverse Event|0
5389112|NCT03311841|18555430|P2|14-day Wash-out|Adverse Event|1
5389113|NCT03311841|18555431|P1|14-day Wash-out|Adverse Event|0
5389114|NCT03311659|18555532|P1|Overall Study|Protocol Violation|1
5389115|NCT03311646|18555547|P1|Overall Study|PI Withdrawal for Positive Drug Screen|4
5389116|NCT03311646|18555547|P1|Overall Study|Lost to Follow-up|5
5389117|NCT03311646|18555547|P1|Overall Study|Withdrawal by Subject|5
5389118|NCT03311646|18555547|P1|Overall Study|Physician Decision|1
5389119|NCT03311373|18555554|P1|Overall Study|Withdrawal by Subject|3
5389120|NCT03311373|18555554|P1|Overall Study|Physician Decision|1
5389121|NCT03311373|18555554|P1|Overall Study|Lost to Follow-up|1
5389122|NCT03311373|18555554|P1|Overall Study|Protocol Discontinuation Criteria|3
5389123|NCT03311373|18555554|P1|Overall Study|Adverse Event|1
5389124|NCT03311230|18555612|P4|Overall Study|Unrelated injury|0
5389125|NCT03311230|18555613|P3|Overall Study|Unrelated injury|0
5389126|NCT03311230|18555614|P2|Overall Study|Unrelated injury|1
5389127|NCT03311230|18555615|P1|Overall Study|Unrelated injury|0
5389128|NCT03311230|18555612|P4|Overall Study|Withdrawal by Subject|7
5389129|NCT03311230|18555613|P3|Overall Study|Withdrawal by Subject|2
5389130|NCT03311230|18555614|P2|Overall Study|Withdrawal by Subject|4
5389131|NCT03311230|18555615|P1|Overall Study|Withdrawal by Subject|1
5389132|NCT03310775|18555639|P2|Overall Study|aggravation of depression|1
5389133|NCT03310775|18555640|P1|Overall Study|aggravation of depression|0
5389134|NCT03310775|18555639|P2|Overall Study|Lost to Follow-up|3
5389135|NCT03310775|18555640|P1|Overall Study|Lost to Follow-up|2
5389136|NCT03310723|18555658|P2|Overall Study|Protocol Violation|2
5389137|NCT03310723|18555659|P1|Overall Study|Protocol Violation|0
5389138|NCT03310723|18555658|P2|Overall Study|Withdrawal by Subject|1
5389139|NCT03310723|18555659|P1|Overall Study|Withdrawal by Subject|0
5389140|NCT03310580|18555670|P3|Overall Study|Adverse Event|0
5389141|NCT03310580|18555671|P2|Overall Study|Adverse Event|1
5389142|NCT03310580|18555672|P1|Overall Study|Adverse Event|0
5389143|NCT03310411|18555705|P4|Period 1|Adverse Event|1
5389144|NCT03310411|18555706|P3|Period 1|Adverse Event|0
5389145|NCT03310411|18555707|P2|Period 1|Adverse Event|0
5389146|NCT03310411|18555708|P1|Period 1|Adverse Event|0
5389147|NCT03310268|18555729|P3|Overall Study|(Not specified)|0
5389148|NCT03310268|18555730|P2|Overall Study|(Not specified)|5
5389149|NCT03310268|18555731|P1|Overall Study|(Not specified)|1
5389150|NCT03310021|18555762|P20|Overall Study|Lost to Follow-up|0
5389151|NCT03310021|18555763|P19|Overall Study|Lost to Follow-up|0
5389152|NCT03310021|18555764|P18|Overall Study|Lost to Follow-up|0
5389153|NCT03310021|18555765|P17|Overall Study|Lost to Follow-up|0
5389154|NCT03310021|18555766|P16|Overall Study|Lost to Follow-up|0
5389155|NCT03310021|18555767|P15|Overall Study|Lost to Follow-up|0
5389156|NCT03310021|18555768|P14|Overall Study|Lost to Follow-up|0
5389157|NCT03310021|18555769|P13|Overall Study|Lost to Follow-up|0
5389158|NCT03310021|18555770|P12|Overall Study|Lost to Follow-up|0
5389159|NCT03310021|18555771|P11|Overall Study|Lost to Follow-up|1
5389160|NCT03310021|18555772|P10|Overall Study|Lost to Follow-up|0
5389161|NCT03310021|18555773|P9|Overall Study|Lost to Follow-up|0
5389162|NCT03310021|18555774|P8|Overall Study|Lost to Follow-up|0
5389163|NCT03310021|18555775|P7|Overall Study|Lost to Follow-up|0
5389164|NCT03310021|18555776|P6|Overall Study|Lost to Follow-up|0
5389165|NCT03310021|18555777|P5|Overall Study|Lost to Follow-up|0
5389166|NCT03310021|18555778|P4|Overall Study|Lost to Follow-up|0
5389167|NCT03310021|18555779|P3|Overall Study|Lost to Follow-up|0
5389168|NCT03310021|18555780|P2|Overall Study|Lost to Follow-up|0
5389169|NCT03310021|18555781|P1|Overall Study|Lost to Follow-up|0
5389170|NCT03310021|18555762|P20|Overall Study|Withdrawal by Subject|0
5389171|NCT03310021|18555763|P19|Overall Study|Withdrawal by Subject|0
5389172|NCT03310021|18555764|P18|Overall Study|Withdrawal by Subject|0
5389173|NCT03310021|18555765|P17|Overall Study|Withdrawal by Subject|0
5389174|NCT03310021|18555766|P16|Overall Study|Withdrawal by Subject|0
5389175|NCT03310021|18555767|P15|Overall Study|Withdrawal by Subject|0
5389176|NCT03310021|18555768|P14|Overall Study|Withdrawal by Subject|0
5389177|NCT03310021|18555769|P13|Overall Study|Withdrawal by Subject|0
5389178|NCT03310021|18555770|P12|Overall Study|Withdrawal by Subject|0
5389179|NCT03310021|18555771|P11|Overall Study|Withdrawal by Subject|0
5389180|NCT03310021|18555772|P10|Overall Study|Withdrawal by Subject|0
5389181|NCT03310021|18555773|P9|Overall Study|Withdrawal by Subject|0
5389182|NCT03310021|18555774|P8|Overall Study|Withdrawal by Subject|0
5389183|NCT03310021|18555775|P7|Overall Study|Withdrawal by Subject|1
5389184|NCT03310021|18555776|P6|Overall Study|Withdrawal by Subject|0
5389185|NCT03310021|18555777|P5|Overall Study|Withdrawal by Subject|0
5389186|NCT03310021|18555778|P4|Overall Study|Withdrawal by Subject|0
5389187|NCT03310021|18555779|P3|Overall Study|Withdrawal by Subject|0
5389188|NCT03310021|18555780|P2|Overall Study|Withdrawal by Subject|0
5389189|NCT03310021|18555781|P1|Overall Study|Withdrawal by Subject|0
5389190|NCT03309943|18555925|P2|Overall Study|Inappropriate behavior towards staff|1
5389191|NCT03309943|18555926|P1|Overall Study|Inappropriate behavior towards staff|0
5389192|NCT03309943|18555925|P2|Overall Study|Withdrawal by Subject|1
5389193|NCT03309943|18555926|P1|Overall Study|Withdrawal by Subject|0
5389194|NCT03309696|18555989|P4|Overall Study|Analysis of TEP data could not be completed|0
5389195|NCT03309696|18555990|P3|Overall Study|Analysis of TEP data could not be completed|0
5389196|NCT03309696|18555991|P2|Overall Study|Analysis of TEP data could not be completed|5
5389197|NCT03309696|18555992|P1|Overall Study|Analysis of TEP data could not be completed|0
5389198|NCT03309202|18556011|P4|Overall Study|Lost to Follow-up|0
5389199|NCT03309202|18556012|P3|Overall Study|Lost to Follow-up|0
5389200|NCT03309202|18556013|P2|Overall Study|Lost to Follow-up|0
5389201|NCT03309202|18556014|P1|Overall Study|Lost to Follow-up|1
5389202|NCT03308968|18556108|P3|Open-Label Period (12 Weeks)|Lack of Efficacy|0
5389203|NCT03308968|18556109|P2|Open-Label Period (12 Weeks)|Lack of Efficacy|2
5389204|NCT03308968|18556110|P1|Open-Label Period (12 Weeks)|Lack of Efficacy|1
5389205|NCT03308968|18556108|P3|Open-Label Period (12 Weeks)|Lost to Follow-up|1
5389206|NCT03308968|18556109|P2|Open-Label Period (12 Weeks)|Lost to Follow-up|1
5389207|NCT03308968|18556110|P1|Open-Label Period (12 Weeks)|Lost to Follow-up|0
5389208|NCT03308968|18556108|P3|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
5389209|NCT03308968|18556109|P2|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
5389210|NCT03308968|18556110|P1|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
5389211|NCT03308968|18556108|P3|Open-Label Period (12 Weeks)|Protocol Violation|1
5389212|NCT03308968|18556109|P2|Open-Label Period (12 Weeks)|Protocol Violation|1
5389213|NCT03308968|18556110|P1|Open-Label Period (12 Weeks)|Protocol Violation|0
5389214|NCT03308968|18556108|P3|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
5389215|NCT03308968|18556109|P2|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
5389216|NCT03308968|18556110|P1|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
5389217|NCT03308968|18556108|P3|Open-Label Period (12 Weeks)|Adverse Event|1
5389218|NCT03308968|18556109|P2|Open-Label Period (12 Weeks)|Adverse Event|1
5389219|NCT03308968|18556110|P1|Open-Label Period (12 Weeks)|Adverse Event|4
5389220|NCT03308968|18556108|P3|Open-Label Period (12 Weeks)|Other than specified|1
5389221|NCT03308968|18556109|P2|Open-Label Period (12 Weeks)|Other than specified|2
5389222|NCT03308968|18556110|P1|Open-Label Period (12 Weeks)|Other than specified|1
5389223|NCT03308968|18556108|P3|Double-Blind Period (12 Weeks)|Other than specified|2
5389224|NCT03308968|18556109|P2|Double-Blind Period (12 Weeks)|Other than specified|0
5389225|NCT03308968|18556110|P1|Double-Blind Period (12 Weeks)|Other than specified|1
5389226|NCT03308968|18556108|P3|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
5389227|NCT03308968|18556109|P2|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
5389228|NCT03308968|18556110|P1|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
5389229|NCT03308968|18556108|P3|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
5389230|NCT03308968|18556109|P2|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
5389231|NCT03308968|18556110|P1|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
5389232|NCT03308968|18556108|P3|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
5389233|NCT03308968|18556109|P2|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
5389234|NCT03308968|18556110|P1|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
5389235|NCT03308968|18556108|P3|Double-Blind Period (12 Weeks)|Protocol Violation|2
5389236|NCT03308968|18556109|P2|Double-Blind Period (12 Weeks)|Protocol Violation|0
5389237|NCT03308968|18556110|P1|Double-Blind Period (12 Weeks)|Protocol Violation|6
5389238|NCT03308968|18556108|P3|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
5389239|NCT03308968|18556109|P2|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
5389240|NCT03308968|18556110|P1|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
5389241|NCT03308968|18556108|P3|Double-Blind Period (12 Weeks)|Adverse Event|4
5389242|NCT03308968|18556109|P2|Double-Blind Period (12 Weeks)|Adverse Event|1
5389243|NCT03308968|18556110|P1|Double-Blind Period (12 Weeks)|Adverse Event|3
5389244|NCT03308825|18556188|P4|Overall Study|Protocol Violation|0
5389245|NCT03308825|18556189|P3|Overall Study|Protocol Violation|0
5389246|NCT03308825|18556190|P2|Overall Study|Protocol Violation|2
5389247|NCT03308825|18556191|P1|Overall Study|Protocol Violation|0
5389248|NCT03308825|18556188|P4|Overall Study|Lost to Follow-up|0
5389249|NCT03308825|18556189|P3|Overall Study|Lost to Follow-up|1
5389250|NCT03308825|18556190|P2|Overall Study|Lost to Follow-up|2
5389251|NCT03308825|18556191|P1|Overall Study|Lost to Follow-up|2
5389252|NCT03307252|18556279|P11|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
5389253|NCT03307252|18556280|P10|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389254|NCT03307252|18556281|P9|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389255|NCT03307252|18556282|P8|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389256|NCT03307252|18556283|P7|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389257|NCT03307252|18556284|P6|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389258|NCT03307252|18556285|P5|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389259|NCT03307252|18556286|P4|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389260|NCT03307252|18556287|P3|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389261|NCT03307252|18556288|P2|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389262|NCT03307252|18556289|P1|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
5389263|NCT03307252|18556279|P11|Part 2, Period 4|Other than listed|0
5389264|NCT03307252|18556280|P10|Part 2, Period 4|Other than listed|0
5389265|NCT03307252|18556281|P9|Part 2, Period 4|Other than listed|0
5389266|NCT03307252|18556282|P8|Part 2, Period 4|Other than listed|0
5389267|NCT03307252|18556283|P7|Part 2, Period 4|Other than listed|1
5389268|NCT03307252|18556284|P6|Part 2, Period 4|Other than listed|0
5389269|NCT03307252|18556285|P5|Part 2, Period 4|Other than listed|0
5389270|NCT03307252|18556286|P4|Part 2, Period 4|Other than listed|0
5389271|NCT03307252|18556287|P3|Part 2, Period 4|Other than listed|0
5389272|NCT03307252|18556288|P2|Part 2, Period 4|Other than listed|0
5389273|NCT03307252|18556289|P1|Part 2, Period 4|Other than listed|0
5389274|NCT03307252|18556279|P11|Part 2, Period 3|Other than listed|0
5389275|NCT03307252|18556280|P10|Part 2, Period 3|Other than listed|0
5389276|NCT03307252|18556281|P9|Part 2, Period 3|Other than listed|0
5389277|NCT03307252|18556282|P8|Part 2, Period 3|Other than listed|0
5389278|NCT03307252|18556283|P7|Part 2, Period 3|Other than listed|0
5389279|NCT03307252|18556284|P6|Part 2, Period 3|Other than listed|0
5389280|NCT03307252|18556285|P5|Part 2, Period 3|Other than listed|1
5389281|NCT03307252|18556286|P4|Part 2, Period 3|Other than listed|0
5389282|NCT03307252|18556287|P3|Part 2, Period 3|Other than listed|0
5389283|NCT03307252|18556288|P2|Part 2, Period 3|Other than listed|0
5389284|NCT03307252|18556289|P1|Part 2, Period 3|Other than listed|0
5389285|NCT03307252|18556279|P11|Part 2, Period 1|Treatment not received|0
5389286|NCT03307252|18556280|P10|Part 2, Period 1|Treatment not received|0
5389287|NCT03307252|18556281|P9|Part 2, Period 1|Treatment not received|0
5389288|NCT03307252|18556282|P8|Part 2, Period 1|Treatment not received|0
5389289|NCT03307252|18556283|P7|Part 2, Period 1|Treatment not received|0
5389290|NCT03307252|18556284|P6|Part 2, Period 1|Treatment not received|1
5389291|NCT03307252|18556285|P5|Part 2, Period 1|Treatment not received|0
5389292|NCT03307252|18556286|P4|Part 2, Period 1|Treatment not received|0
5389293|NCT03307252|18556287|P3|Part 2, Period 1|Treatment not received|0
5389294|NCT03307252|18556288|P2|Part 2, Period 1|Treatment not received|0
5389295|NCT03307252|18556289|P1|Part 2, Period 1|Treatment not received|0
5389296|NCT03307174|18556326|P2|Overall Study|Intrathecal catheter placement|1
5389297|NCT03307174|18556327|P1|Overall Study|Intrathecal catheter placement|0
5389298|NCT03307174|18556326|P2|Overall Study|Planned epidural removal|0
5389299|NCT03307174|18556327|P1|Overall Study|Planned epidural removal|1
5389300|NCT03307174|18556326|P2|Overall Study|Nonfunctional epidural|1
5389301|NCT03307174|18556327|P1|Overall Study|Nonfunctional epidural|1
5389302|NCT03307174|18556326|P2|Overall Study|Hypotension|0
5389303|NCT03307174|18556327|P1|Overall Study|Hypotension|6
5389304|NCT03307174|18556326|P2|Overall Study|Aborted Surgery|2
5389305|NCT03307174|18556327|P1|Overall Study|Aborted Surgery|1
5389306|NCT03307174|18556326|P2|Overall Study|Unplanned ICU Administrion|3
5389307|NCT03307174|18556327|P1|Overall Study|Unplanned ICU Administrion|5
5389308|NCT03306277|18556608|P1|Overall Study|Withdrawal by Subject|1
5389309|NCT03306277|18556608|P1|Overall Study|Adverse Event|1
5389310|NCT03306277|18556608|P1|Overall Study|Death|1
5389311|NCT03306043|18556619|P1|Overall Study|Withdrawal by Subject|2
5389312|NCT03306043|18556619|P1|Overall Study|Lost to Follow-up|1
5389313|NCT03306043|18556619|P1|Overall Study|Adverse Event|1
5389314|NCT03305770|18556645|P2|Overall Study|Subject moved|0
5389315|NCT03305770|18556646|P1|Overall Study|Subject moved|1
5389316|NCT03305770|18556645|P2|Overall Study|Physician Decision - prior to dispense|1
5389317|NCT03305770|18556646|P1|Overall Study|Physician Decision - prior to dispense|0
5389318|NCT03305731|18556654|P1|Overall Study|Protocol Violation|1
5389319|NCT03305575|18556665|P2|Overall Study|Physician Decision|0
5389320|NCT03305575|18556666|P1|Overall Study|Physician Decision|1
5389321|NCT03305419|18556686|P8|Part B (14 Days)|Physician Decision|0
5389322|NCT03305419|18556687|P7|Part B (14 Days)|Physician Decision|1
5389323|NCT03305419|18556688|P6|Part B (14 Days)|Physician Decision|8
5389324|NCT03305419|18556689|P5|Part B (14 Days)|Physician Decision|2
5389325|NCT03305419|18556690|P4|Part B (14 Days)|Physician Decision|0
5389326|NCT03305419|18556691|P3|Part B (14 Days)|Physician Decision|0
5389327|NCT03305419|18556692|P2|Part B (14 Days)|Physician Decision|0
5389328|NCT03305419|18556693|P1|Part B (14 Days)|Physician Decision|0
5389329|NCT03305419|18556686|P8|Part B (14 Days)|Adverse Event|0
5389330|NCT03305419|18556687|P7|Part B (14 Days)|Adverse Event|4
5389331|NCT03305419|18556688|P6|Part B (14 Days)|Adverse Event|2
5389332|NCT03305419|18556689|P5|Part B (14 Days)|Adverse Event|1
5389333|NCT03305419|18556690|P4|Part B (14 Days)|Adverse Event|0
5389334|NCT03305419|18556691|P3|Part B (14 Days)|Adverse Event|0
5389335|NCT03305419|18556692|P2|Part B (14 Days)|Adverse Event|0
5389336|NCT03305419|18556693|P1|Part B (14 Days)|Adverse Event|0
5389337|NCT03305419|18556686|P8|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5389338|NCT03305419|18556687|P7|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5389339|NCT03305419|18556688|P6|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5389340|NCT03305419|18556689|P5|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5389341|NCT03305419|18556690|P4|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5389342|NCT03305419|18556691|P3|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5389343|NCT03305419|18556692|P2|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
5389344|NCT03305419|18556693|P1|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
5389345|NCT03305419|18556686|P8|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5389346|NCT03305419|18556687|P7|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5389347|NCT03305419|18556688|P6|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5389348|NCT03305419|18556689|P5|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5389349|NCT03305419|18556690|P4|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5389350|NCT03305419|18556691|P3|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5389351|NCT03305419|18556692|P2|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
5389352|NCT03305419|18556693|P1|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
5389353|NCT03305419|18556686|P8|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5389354|NCT03305419|18556687|P7|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5389355|NCT03305419|18556688|P6|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5389356|NCT03305419|18556689|P5|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5389357|NCT03305419|18556690|P4|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5389358|NCT03305419|18556691|P3|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5389359|NCT03305419|18556692|P2|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
5389360|NCT03305419|18556693|P1|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
5389361|NCT03305055|18556834|P2|Overall Study|Adverse Event|1
5389362|NCT03305055|18556835|P1|Overall Study|Adverse Event|1
5389363|NCT03305055|18556834|P2|Overall Study|Withdrawal by Subject|1
5389364|NCT03305055|18556835|P1|Overall Study|Withdrawal by Subject|0
5389365|NCT03304873|18556853|P2|Overall Study|Lost to Follow-up|8
5389366|NCT03304873|18556854|P1|Overall Study|Lost to Follow-up|1
5389367|NCT03303521|18556960|P2|Overall Study|Adverse Event|0
5389368|NCT03303521|18556961|P1|Overall Study|Adverse Event|1
5389369|NCT03303521|18556960|P2|Overall Study|Non-comliance to study protocol|1
5389370|NCT03303521|18556961|P1|Overall Study|Non-comliance to study protocol|0
5389371|NCT03303521|18556960|P2|Overall Study|Transferred to non-study dialysis center|0
5389372|NCT03303521|18556961|P1|Overall Study|Transferred to non-study dialysis center|1
5389373|NCT03303521|18556960|P2|Overall Study|Investigational product discontinuation|1
5389374|NCT03303521|18556961|P1|Overall Study|Investigational product discontinuation|0
5389375|NCT03303521|18556960|P2|Overall Study|Kidney transplantation|1
5389376|NCT03303521|18556961|P1|Overall Study|Kidney transplantation|0
5389377|NCT03303521|18556960|P2|Overall Study|Death|0
5389378|NCT03303521|18556961|P1|Overall Study|Death|1
5389379|NCT03303521|18556960|P2|Overall Study|Withdrawal by Subject|0
5389380|NCT03303521|18556961|P1|Overall Study|Withdrawal by Subject|2
5389381|NCT03303417|18556971|P2|Overall Study|Withdrawal by Subject|1
5389382|NCT03303417|18556972|P1|Overall Study|Withdrawal by Subject|1
5389383|NCT03302975|18557013|P1|Overall Study|Lost to Follow-up|4
5389384|NCT03302936|18557021|P2|Overall Study|Protocol Violation|4
5389385|NCT03302936|18557022|P1|Overall Study|Protocol Violation|3
5389386|NCT03302559|18557071|P1|Overall Study|Withdrew Consent|3
5389387|NCT03302559|18557071|P1|Overall Study|Lost to Follow-up|1
5389388|NCT03302559|18557071|P1|Overall Study|Adverse Event|2
5389389|NCT03302247|18557089|P1|Overall Study|Death|1
5389390|NCT03302247|18557089|P1|Overall Study|the study has closed prematurely|2
5389391|NCT03301844|18557096|P2|Overall Study|suspected colon cancer|1
5389392|NCT03301844|18557097|P1|Overall Study|suspected colon cancer|1
5389393|NCT03301740|18557124|P2|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
5389394|NCT03301740|18557125|P1|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
5389395|NCT03301740|18557124|P2|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
5389396|NCT03301740|18557125|P1|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
5389397|NCT03301714|18557168|P3|Overall Study|Did not receive allocated intervention|3
5389398|NCT03301714|18557169|P2|Overall Study|Did not receive allocated intervention|2
5389399|NCT03301714|18557170|P1|Overall Study|Did not receive allocated intervention|0
5389400|NCT03301714|18557168|P3|Overall Study|Lost to Follow-up|4
5389401|NCT03301714|18557169|P2|Overall Study|Lost to Follow-up|4
5389402|NCT03301714|18557170|P1|Overall Study|Lost to Follow-up|10
5389403|NCT03301649|18557187|P3|Overall Study|Other than specified|0
5389404|NCT03301649|18557188|P2|Overall Study|Other than specified|3
5389405|NCT03301649|18557189|P1|Overall Study|Other than specified|5
5389406|NCT03301649|18557187|P3|Overall Study|Withdrawal by Subject|0
5389407|NCT03301649|18557188|P2|Overall Study|Withdrawal by Subject|4
5389408|NCT03301649|18557189|P1|Overall Study|Withdrawal by Subject|10
5389409|NCT03301649|18557187|P3|Overall Study|Protocol Violation|1
5389410|NCT03301649|18557188|P2|Overall Study|Protocol Violation|1
5389411|NCT03301649|18557189|P1|Overall Study|Protocol Violation|0
5389412|NCT03301649|18557187|P3|Overall Study|Lost to Follow-up|3
5389413|NCT03301649|18557188|P2|Overall Study|Lost to Follow-up|11
5389414|NCT03301649|18557189|P1|Overall Study|Lost to Follow-up|11
5389415|NCT03301649|18557187|P3|Overall Study|Need alternate therapy due to live lice|81
5389416|NCT03301649|18557188|P2|Overall Study|Need alternate therapy due to live lice|25
5389417|NCT03301649|18557189|P1|Overall Study|Need alternate therapy due to live lice|17
5389418|NCT03301155|18557272|P2|Overall Study|Сompliance with exclusion criteria|7
5389419|NCT03301155|18557273|P1|Overall Study|Сompliance with exclusion criteria|8
5389420|NCT03300570|18557308|P2|Overall Study|Inadequate bowel prep|0
5389421|NCT03300570|18557309|P1|Overall Study|Inadequate bowel prep|1
5389422|NCT03300570|18557308|P2|Overall Study|Withdrawal by Subject|0
5389423|NCT03300570|18557309|P1|Overall Study|Withdrawal by Subject|1
5389424|NCT03300570|18557308|P2|Overall Study|Adverse Event|1
5389425|NCT03300570|18557309|P1|Overall Study|Adverse Event|0
5389426|NCT03300024|18557332|P2|Overall Study|Physician Decision|6
5389427|NCT03300024|18557333|P1|Overall Study|Physician Decision|4
5389428|NCT03299686|18557387|P2|Follow-up Epoch|Subject/Guardian Decision|1
5389429|NCT03299686|18557388|P1|Follow-up Epoch|Subject/Guardian Decision|0
5389430|NCT03299686|18557387|P2|Treatment Epoch|Adverse Event|4
5389431|NCT03299686|18557388|P1|Treatment Epoch|Adverse Event|8
5389432|NCT03299686|18557387|P2|Treatment Epoch|Physician Decision|0
5389433|NCT03299686|18557388|P1|Treatment Epoch|Physician Decision|1
5389434|NCT03299686|18557387|P2|Treatment Epoch|Subject/Guardian Decision|0
5389435|NCT03299686|18557388|P1|Treatment Epoch|Subject/Guardian Decision|2
5389436|NCT03299101|18557404|P1|Overall Study|Not enough time to complete prehab|1
5389437|NCT03299101|18557404|P1|Overall Study|Surgery was changed|3
5389438|NCT03299101|18557404|P1|Overall Study|Withdrawal by Subject|5
5389439|NCT03299101|18557404|P1|Overall Study|Lost to Follow-up|1
5389440|NCT03299049|18557427|P2|Overall Study|Adverse Event|13
5389441|NCT03299049|18557428|P1|Overall Study|Adverse Event|12
5389442|NCT03299049|18557427|P2|Overall Study|Lack of Efficacy|3
5389443|NCT03299049|18557428|P1|Overall Study|Lack of Efficacy|9
5389444|NCT03299049|18557427|P2|Overall Study|Protocol Violation|1
5389445|NCT03299049|18557428|P1|Overall Study|Protocol Violation|1
5389446|NCT03299049|18557427|P2|Overall Study|Pregnancy|3
5389447|NCT03299049|18557428|P1|Overall Study|Pregnancy|1
5389448|NCT03299049|18557427|P2|Overall Study|Lost to Follow-up|0
5389449|NCT03299049|18557428|P1|Overall Study|Lost to Follow-up|2
5389450|NCT03299049|18557427|P2|Overall Study|Physician Decision|1
5389451|NCT03299049|18557428|P1|Overall Study|Physician Decision|5
5389452|NCT03299049|18557427|P2|Overall Study|Withdrawal by Subject|21
5389453|NCT03299049|18557428|P1|Overall Study|Withdrawal by Subject|6
5389454|NCT03299049|18557427|P2|Overall Study|On-going|481
5389455|NCT03299049|18557428|P1|Overall Study|On-going|486
5389456|NCT03298867|18557527|P2|Overall Study|Continued in the Follow-Up Period|1
5389457|NCT03298867|18557528|P1|Overall Study|Continued in the Follow-Up Period|0
5389458|NCT03298867|18557527|P2|Overall Study|Did not Continue in the Follow-Up Period|1
5389459|NCT03298867|18557528|P1|Overall Study|Did not Continue in the Follow-Up Period|2
5389460|NCT03298412|18557544|P1|Run-in Period|Decision by Sponsor|6
5389461|NCT03298412|18557544|P1|Run-in Period|Ineligibility Determined|1
5389462|NCT03298412|18557544|P1|Run-in Period|Disease Progression|1
5389463|NCT03298412|18557544|P1|Run-in Period|Other, Not Specified|1
5389464|NCT03297294|18557655|P5|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5389465|NCT03297294|18557656|P4|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
5389466|NCT03297294|18557657|P3|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5389467|NCT03297294|18557658|P2|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5389468|NCT03297294|18557659|P1|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
5389469|NCT03297294|18557655|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
5389470|NCT03297294|18557656|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
5389471|NCT03297294|18557657|P3|Double-Blind Treatment Period (DB)|Physician Decision|0
5389472|NCT03297294|18557658|P2|Double-Blind Treatment Period (DB)|Physician Decision|1
5389473|NCT03297294|18557659|P1|Double-Blind Treatment Period (DB)|Physician Decision|1
5389474|NCT03297294|18557655|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
5389475|NCT03297294|18557656|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
5389476|NCT03297294|18557657|P3|Double-Blind Treatment Period (DB)|Adverse Event|0
5389477|NCT03297294|18557658|P2|Double-Blind Treatment Period (DB)|Adverse Event|1
5389478|NCT03297294|18557659|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
5389479|NCT03297294|18557655|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5389480|NCT03297294|18557656|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5389481|NCT03297294|18557657|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5389482|NCT03297294|18557658|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
5389483|NCT03297294|18557659|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
5389484|NCT03297294|18557655|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5389485|NCT03297294|18557656|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5389486|NCT03297294|18557657|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5389487|NCT03297294|18557658|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
5389488|NCT03297294|18557659|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
5389489|NCT03297021|18557701|P3|Overall Study|Missing Post-Op Data|1
5389490|NCT03297021|18557702|P2|Overall Study|Missing Post-Op Data|2
5389491|NCT03297021|18557703|P1|Overall Study|Missing Post-Op Data|1
5389492|NCT03297021|18557701|P3|Overall Study|Incomplete/illegible data sheet|3
5389493|NCT03297021|18557702|P2|Overall Study|Incomplete/illegible data sheet|2
5389494|NCT03297021|18557703|P1|Overall Study|Incomplete/illegible data sheet|4
5389495|NCT03296566|18557767|P2|Overall Study|Withdrawal by Subject|3
5389496|NCT03296566|18557768|P1|Overall Study|Withdrawal by Subject|0
5389497|NCT03296566|18557767|P2|Overall Study|Lost to Follow-up|46
5389498|NCT03296566|18557768|P1|Overall Study|Lost to Follow-up|19
5389499|NCT03295201|18557865|P2|Overall Study|Hospital admission|1
5389500|NCT03295201|18557866|P1|Overall Study|Hospital admission|0
5389501|NCT03295201|18557865|P2|Overall Study|Lost to Follow-up|1
5389502|NCT03295201|18557866|P1|Overall Study|Lost to Follow-up|1
5389503|NCT03294681|18557918|P1|Overall Study|Withdrawal by Subject|1
5389504|NCT03294538|18557956|P3|Overall Study|Outside of Visit Window|1
5389505|NCT03294538|18557957|P2|Overall Study|Outside of Visit Window|4
5389506|NCT03294538|18557958|P1|Overall Study|Outside of Visit Window|4
5389507|NCT03294538|18557956|P3|Overall Study|Lost to Follow-up|0
5389508|NCT03294538|18557957|P2|Overall Study|Lost to Follow-up|0
5389509|NCT03294538|18557958|P1|Overall Study|Lost to Follow-up|1
5389510|NCT03294538|18557956|P3|Overall Study|Adverse Event|1
5389511|NCT03294538|18557957|P2|Overall Study|Adverse Event|1
5389512|NCT03294538|18557958|P1|Overall Study|Adverse Event|0
5389513|NCT03293654|18557976|P3|Overall Study|Lost to Follow-up|0
5389514|NCT03293654|18557977|P2|Overall Study|Lost to Follow-up|1
5389515|NCT03293654|18557978|P1|Overall Study|Lost to Follow-up|0
5389516|NCT03293485|18558016|P1|Overall Study|Withdrawal by Subject|2
5389517|NCT03293485|18558016|P1|Overall Study|Screen Failure|2
5389518|NCT03293485|18558016|P1|Overall Study|Death|1
5389519|NCT03293394|18558027|P2|Follow-up (6 Months)|Adverse Event|2
5389520|NCT03293394|18558028|P1|Follow-up (6 Months)|Adverse Event|4
5389521|NCT03292640|18558090|P2|Overall Study|Lost to Follow-up|24
5389522|NCT03292640|18558091|P1|Overall Study|Lost to Follow-up|24
5389523|NCT03292640|18558090|P2|Overall Study|Adverse Event|2
5389524|NCT03292640|18558091|P1|Overall Study|Adverse Event|20
5389525|NCT03292640|18558090|P2|Overall Study|Withdrawal by Subject|16
5389526|NCT03292640|18558091|P1|Overall Study|Withdrawal by Subject|17
5389527|NCT03292016|18558134|P6|Second Washout|Adverse Event|0
5389528|NCT03292016|18558135|P5|Second Washout|Adverse Event|0
5389529|NCT03292016|18558136|P4|Second Washout|Adverse Event|0
5389530|NCT03292016|18558137|P3|Second Washout|Adverse Event|0
5389531|NCT03292016|18558138|P2|Second Washout|Adverse Event|1
5389532|NCT03292016|18558139|P1|Second Washout|Adverse Event|0
5389533|NCT03291288|18558181|P2|Pexidartinib Only|Ongoing|13
5389534|NCT03291288|18558182|P1|Pexidartinib Only|Ongoing|0
5389535|NCT03291288|18558181|P2|Pexidartinib Only|Other|2
5389536|NCT03291288|18558182|P1|Pexidartinib Only|Other|0
5389537|NCT03291288|18558181|P2|Pexidartinib Only|Patient request|1
5389538|NCT03291288|18558182|P1|Pexidartinib Only|Patient request|0
5389539|NCT03291288|18558181|P2|Pexidartinib Only|Disease progression|8
5389540|NCT03291288|18558182|P1|Pexidartinib Only|Disease progression|0
5389541|NCT03291288|18558181|P2|Pexidartinib Only|Adverse Event|1
5389542|NCT03291288|18558182|P1|Pexidartinib Only|Adverse Event|0
5389543|NCT03291288|18558181|P2|Drug-drug Interaction Phase|Did not receive treatment|0
5389544|NCT03291288|18558182|P1|Drug-drug Interaction Phase|Did not receive treatment|2
5389545|NCT03291288|18558181|P2|Drug-drug Interaction Phase|Disease progression|0
5389546|NCT03291288|18558182|P1|Drug-drug Interaction Phase|Disease progression|2
5389547|NCT03291288|18558181|P2|Drug-drug Interaction Phase|Adverse Event|0
5389548|NCT03291288|18558182|P1|Drug-drug Interaction Phase|Adverse Event|3
5389549|NCT03290300|18558256|P1|Overall Study|Lost to Follow-up|3
5389550|NCT03289676|18558289|P2|Overall Study|Lost to Follow-up|1
5389551|NCT03289676|18558290|P1|Overall Study|Lost to Follow-up|0
5389552|NCT03289676|18558289|P2|Overall Study|Protocol Violation|0
5389553|NCT03289676|18558290|P1|Overall Study|Protocol Violation|2
5389554|NCT03289676|18558289|P2|Overall Study|Withdrawal by Subject|0
5389555|NCT03289676|18558290|P1|Overall Study|Withdrawal by Subject|2
5389556|NCT03289533|18558300|P1|Overall Study|Terminated from study by sponsor|10
5389557|NCT03289533|18558300|P1|Overall Study|Death|12
5389558|NCT03289208|18558361|P3|Overall Study|Adverse Event|0
5389559|NCT03289208|18558362|P2|Overall Study|Adverse Event|0
5389560|NCT03289208|18558363|P1|Overall Study|Adverse Event|1
5389561|NCT03288779|18558380|P1|Overall Study|Withdrawal by Subject|3
5389562|NCT03287869|18558387|P2|Overall Study|Reason not Specified|3
5389563|NCT03287869|18558388|P1|Overall Study|Reason not Specified|6
5389564|NCT03287869|18558387|P2|Overall Study|Physician Decision|5
5389565|NCT03287869|18558388|P1|Overall Study|Physician Decision|5
5389566|NCT03287869|18558387|P2|Overall Study|Early Closure of the Site|1
5389567|NCT03287869|18558388|P1|Overall Study|Early Closure of the Site|0
5389568|NCT03287869|18558387|P2|Overall Study|Withdrawal by Subject|43
5389569|NCT03287869|18558388|P1|Overall Study|Withdrawal by Subject|36
5389570|NCT03287869|18558387|P2|Overall Study|Protocol Deviation|1
5389571|NCT03287869|18558388|P1|Overall Study|Protocol Deviation|2
5389572|NCT03287869|18558387|P2|Overall Study|Progressive Disease|0
5389573|NCT03287869|18558388|P1|Overall Study|Progressive Disease|1
5389574|NCT03287869|18558387|P2|Overall Study|Non-Compliance With Study Drug|9
5389575|NCT03287869|18558388|P1|Overall Study|Non-Compliance With Study Drug|5
5389576|NCT03287869|18558387|P2|Overall Study|Lost to Follow-up|19
5389577|NCT03287869|18558388|P1|Overall Study|Lost to Follow-up|13
5389578|NCT03287869|18558387|P2|Overall Study|Lack of Efficacy|0
5389579|NCT03287869|18558388|P1|Overall Study|Lack of Efficacy|1
5389580|NCT03287869|18558387|P2|Overall Study|Adverse Event|12
5389581|NCT03287869|18558388|P1|Overall Study|Adverse Event|14
5389582|NCT03287804|18558409|P1|Overall Study|Progressive disease|8
5389583|NCT03287804|18558409|P1|Overall Study|Physician Decision|2
5389584|NCT03287804|18558409|P1|Overall Study|Death|1
5389585|NCT03287791|18558425|P3|Overall Study|Did not meet inclusion criteria|0
5389586|NCT03287791|18558426|P2|Overall Study|Did not meet inclusion criteria|0
5389587|NCT03287791|18558427|P1|Overall Study|Did not meet inclusion criteria|1
5389588|NCT03287791|18558425|P3|Overall Study|Non-compliance|0
5389589|NCT03287791|18558426|P2|Overall Study|Non-compliance|1
5389590|NCT03287791|18558427|P1|Overall Study|Non-compliance|0
5389591|NCT03287791|18558425|P3|Overall Study|Too much time between 2 visits|0
5389592|NCT03287791|18558426|P2|Overall Study|Too much time between 2 visits|1
5389593|NCT03287791|18558427|P1|Overall Study|Too much time between 2 visits|0
5389594|NCT03287791|18558425|P3|Overall Study|Participant was enrolled at 2 sites|1
5389595|NCT03287791|18558426|P2|Overall Study|Participant was enrolled at 2 sites|0
5389596|NCT03287791|18558427|P1|Overall Study|Participant was enrolled at 2 sites|1
5389597|NCT03287791|18558425|P3|Overall Study|Protocol Violation|1
5389598|NCT03287791|18558426|P2|Overall Study|Protocol Violation|2
5389599|NCT03287791|18558427|P1|Overall Study|Protocol Violation|7
5389600|NCT03287791|18558425|P3|Overall Study|Lost to Follow-up|11
5389601|NCT03287791|18558426|P2|Overall Study|Lost to Follow-up|14
5389602|NCT03287791|18558427|P1|Overall Study|Lost to Follow-up|8
5389603|NCT03287791|18558425|P3|Overall Study|Missed more than 6 consecutive doses|2
5389604|NCT03287791|18558426|P2|Overall Study|Missed more than 6 consecutive doses|2
5389605|NCT03287791|18558427|P1|Overall Study|Missed more than 6 consecutive doses|3
5389606|NCT03287791|18558425|P3|Overall Study|Withdrawal by Subject|17
5389607|NCT03287791|18558426|P2|Overall Study|Withdrawal by Subject|12
5389608|NCT03287791|18558427|P1|Overall Study|Withdrawal by Subject|12
5389609|NCT03287791|18558425|P3|Overall Study|Adverse Event|3
5389610|NCT03287791|18558426|P2|Overall Study|Adverse Event|4
5389611|NCT03287791|18558427|P1|Overall Study|Adverse Event|0
5389612|NCT03287791|18558425|P3|Overall Study|Insufficient Therapeutic Response|1
5389613|NCT03287791|18558426|P2|Overall Study|Insufficient Therapeutic Response|0
5389614|NCT03287791|18558427|P1|Overall Study|Insufficient Therapeutic Response|0
5389615|NCT03287622|18558440|P2|Overall Study|surgery related|2
5389616|NCT03287622|18558441|P1|Overall Study|surgery related|0
5389617|NCT03287622|18558440|P2|Overall Study|prolonged Length of stay|0
5389618|NCT03287622|18558441|P1|Overall Study|prolonged Length of stay|2
5389619|NCT03287622|18558440|P2|Overall Study|No prescripion after surgery|31
5389620|NCT03287622|18558441|P1|Overall Study|No prescripion after surgery|28
5389621|NCT03287622|18558440|P2|Overall Study|Lost to Follow-up|15
5389622|NCT03287622|18558441|P1|Overall Study|Lost to Follow-up|27
5389623|NCT03287622|18558440|P2|Overall Study|Withdrawal by Subject|0
5389624|NCT03287622|18558441|P1|Overall Study|Withdrawal by Subject|1
5389625|NCT03287089|18558463|P2|Overall Study|Withdrawal by Subject|2
5389626|NCT03287089|18558464|P1|Overall Study|Withdrawal by Subject|0
5389627|NCT03287089|18558463|P2|Overall Study|Physician Decision|2
5389628|NCT03287089|18558464|P1|Overall Study|Physician Decision|0
5389629|NCT03287089|18558463|P2|Overall Study|Lost to Follow-up|2
5389630|NCT03287089|18558464|P1|Overall Study|Lost to Follow-up|0
5389631|NCT03286751|18558499|P6|Washout Period 5|Adverse Event|0
5389632|NCT03286751|18558500|P5|Washout Period 5|Adverse Event|1
5389633|NCT03286751|18558501|P4|Washout Period 5|Adverse Event|0
5389634|NCT03286751|18558502|P3|Washout Period 5|Adverse Event|0
5389635|NCT03286751|18558503|P2|Washout Period 5|Adverse Event|0
5389636|NCT03286751|18558504|P1|Washout Period 5|Adverse Event|0
5389637|NCT03286751|18558499|P6|Washout Period 2|Personal Reasons|0
5389638|NCT03286751|18558500|P5|Washout Period 2|Personal Reasons|0
5389639|NCT03286751|18558501|P4|Washout Period 2|Personal Reasons|0
5389640|NCT03286751|18558502|P3|Washout Period 2|Personal Reasons|0
5389641|NCT03286751|18558503|P2|Washout Period 2|Personal Reasons|1
5389642|NCT03286751|18558504|P1|Washout Period 2|Personal Reasons|0
5389643|NCT03286751|18558499|P6|Washout Period 1|Withdrawal by Subject|0
5389644|NCT03286751|18558500|P5|Washout Period 1|Withdrawal by Subject|1
5389645|NCT03286751|18558501|P4|Washout Period 1|Withdrawal by Subject|0
5389646|NCT03286751|18558502|P3|Washout Period 1|Withdrawal by Subject|0
5389647|NCT03286751|18558503|P2|Washout Period 1|Withdrawal by Subject|0
5389648|NCT03286751|18558504|P1|Washout Period 1|Withdrawal by Subject|0
5389649|NCT03286400|18558524|P1|Overall Study|Scheduling difficulty|4
5389650|NCT03286400|18558524|P1|Overall Study|Physician Decision|1
5389651|NCT03286400|18558524|P1|Overall Study|Lost to Follow-up|10
5389652|NCT03286400|18558524|P1|Overall Study|Death|10
5389653|NCT03286218|18558553|P12|Treatment Phase Period 4|Withdrawal by Subject|1
5389654|NCT03286218|18558554|P11|Treatment Phase Period 4|Withdrawal by Subject|0
5389655|NCT03286218|18558555|P10|Treatment Phase Period 4|Withdrawal by Subject|0
5389656|NCT03286218|18558556|P9|Treatment Phase Period 4|Withdrawal by Subject|0
5389657|NCT03286218|18558557|P8|Treatment Phase Period 4|Withdrawal by Subject|0
5389658|NCT03286218|18558558|P7|Treatment Phase Period 4|Withdrawal by Subject|0
5389659|NCT03286218|18558559|P6|Treatment Phase Period 4|Withdrawal by Subject|0
5389660|NCT03286218|18558560|P5|Treatment Phase Period 4|Withdrawal by Subject|0
5389661|NCT03286218|18558561|P4|Treatment Phase Period 4|Withdrawal by Subject|0
5389662|NCT03286218|18558562|P3|Treatment Phase Period 4|Withdrawal by Subject|0
5389663|NCT03286218|18558563|P2|Treatment Phase Period 4|Withdrawal by Subject|0
5389664|NCT03286218|18558564|P1|Treatment Phase Period 4|Withdrawal by Subject|0
5389665|NCT03286218|18558553|P12|Treatment Phase Period 1|Withdrawal by Subject|1
5389666|NCT03286218|18558554|P11|Treatment Phase Period 1|Withdrawal by Subject|0
5389667|NCT03286218|18558555|P10|Treatment Phase Period 1|Withdrawal by Subject|0
5389668|NCT03286218|18558556|P9|Treatment Phase Period 1|Withdrawal by Subject|0
5389669|NCT03286218|18558557|P8|Treatment Phase Period 1|Withdrawal by Subject|0
5389670|NCT03286218|18558558|P7|Treatment Phase Period 1|Withdrawal by Subject|0
5389671|NCT03286218|18558559|P6|Treatment Phase Period 1|Withdrawal by Subject|1
5389672|NCT03286218|18558560|P5|Treatment Phase Period 1|Withdrawal by Subject|0
5389673|NCT03286218|18558561|P4|Treatment Phase Period 1|Withdrawal by Subject|1
5389674|NCT03286218|18558562|P3|Treatment Phase Period 1|Withdrawal by Subject|1
5389675|NCT03286218|18558563|P2|Treatment Phase Period 1|Withdrawal by Subject|0
5389676|NCT03286218|18558564|P1|Treatment Phase Period 1|Withdrawal by Subject|0
5389677|NCT03286218|18558553|P12|Qualification Phase Period 2|Withdrawal by Subject|0
5389678|NCT03286218|18558554|P11|Qualification Phase Period 2|Withdrawal by Subject|0
5389679|NCT03286218|18558555|P10|Qualification Phase Period 2|Withdrawal by Subject|0
5389680|NCT03286218|18558556|P9|Qualification Phase Period 2|Withdrawal by Subject|0
5389681|NCT03286218|18558557|P8|Qualification Phase Period 2|Withdrawal by Subject|0
5389682|NCT03286218|18558558|P7|Qualification Phase Period 2|Withdrawal by Subject|0
5389683|NCT03286218|18558559|P6|Qualification Phase Period 2|Withdrawal by Subject|0
5389684|NCT03286218|18558560|P5|Qualification Phase Period 2|Withdrawal by Subject|0
5389685|NCT03286218|18558561|P4|Qualification Phase Period 2|Withdrawal by Subject|0
5389686|NCT03286218|18558562|P3|Qualification Phase Period 2|Withdrawal by Subject|0
5389687|NCT03286218|18558563|P2|Qualification Phase Period 2|Withdrawal by Subject|2
5389688|NCT03286218|18558564|P1|Qualification Phase Period 2|Withdrawal by Subject|1
5389689|NCT03286218|18558553|P12|Qualification Phase Period 2|Protocol Violation|0
5389690|NCT03286218|18558554|P11|Qualification Phase Period 2|Protocol Violation|0
5389691|NCT03286218|18558555|P10|Qualification Phase Period 2|Protocol Violation|0
5389692|NCT03286218|18558556|P9|Qualification Phase Period 2|Protocol Violation|0
5389693|NCT03286218|18558557|P8|Qualification Phase Period 2|Protocol Violation|0
5389694|NCT03286218|18558558|P7|Qualification Phase Period 2|Protocol Violation|0
5389695|NCT03286218|18558559|P6|Qualification Phase Period 2|Protocol Violation|0
5389696|NCT03286218|18558560|P5|Qualification Phase Period 2|Protocol Violation|0
5389697|NCT03286218|18558561|P4|Qualification Phase Period 2|Protocol Violation|0
5389698|NCT03286218|18558562|P3|Qualification Phase Period 2|Protocol Violation|0
5389699|NCT03286218|18558563|P2|Qualification Phase Period 2|Protocol Violation|0
5389700|NCT03286218|18558564|P1|Qualification Phase Period 2|Protocol Violation|2
5389701|NCT03286218|18558553|P12|Qualification Phase Period 2|Lost to Follow-up|0
5389702|NCT03286218|18558554|P11|Qualification Phase Period 2|Lost to Follow-up|0
5389703|NCT03286218|18558555|P10|Qualification Phase Period 2|Lost to Follow-up|0
5389704|NCT03286218|18558556|P9|Qualification Phase Period 2|Lost to Follow-up|0
5389705|NCT03286218|18558557|P8|Qualification Phase Period 2|Lost to Follow-up|0
5389706|NCT03286218|18558558|P7|Qualification Phase Period 2|Lost to Follow-up|0
5389707|NCT03286218|18558559|P6|Qualification Phase Period 2|Lost to Follow-up|0
5389708|NCT03286218|18558560|P5|Qualification Phase Period 2|Lost to Follow-up|0
5389709|NCT03286218|18558561|P4|Qualification Phase Period 2|Lost to Follow-up|0
5389710|NCT03286218|18558562|P3|Qualification Phase Period 2|Lost to Follow-up|0
5389711|NCT03286218|18558563|P2|Qualification Phase Period 2|Lost to Follow-up|1
5389712|NCT03286218|18558564|P1|Qualification Phase Period 2|Lost to Follow-up|0
5389713|NCT03286218|18558553|P12|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389714|NCT03286218|18558554|P11|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389715|NCT03286218|18558555|P10|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389716|NCT03286218|18558556|P9|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389717|NCT03286218|18558557|P8|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389718|NCT03286218|18558558|P7|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389719|NCT03286218|18558559|P6|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389720|NCT03286218|18558560|P5|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389721|NCT03286218|18558561|P4|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389722|NCT03286218|18558562|P3|Qualification Phase Period 2|Failure to meet randomization criteria|0
5389723|NCT03286218|18558563|P2|Qualification Phase Period 2|Failure to meet randomization criteria|15
5389724|NCT03286218|18558564|P1|Qualification Phase Period 2|Failure to meet randomization criteria|14
5389725|NCT03286218|18558553|P12|Qualification Phase Period 2|Adverse Event|0
5389726|NCT03286218|18558554|P11|Qualification Phase Period 2|Adverse Event|0
5389727|NCT03286218|18558555|P10|Qualification Phase Period 2|Adverse Event|0
5389728|NCT03286218|18558556|P9|Qualification Phase Period 2|Adverse Event|0
5389729|NCT03286218|18558557|P8|Qualification Phase Period 2|Adverse Event|0
5389730|NCT03286218|18558558|P7|Qualification Phase Period 2|Adverse Event|0
5389731|NCT03286218|18558559|P6|Qualification Phase Period 2|Adverse Event|0
5389732|NCT03286218|18558560|P5|Qualification Phase Period 2|Adverse Event|0
5389733|NCT03286218|18558561|P4|Qualification Phase Period 2|Adverse Event|0
5389734|NCT03286218|18558562|P3|Qualification Phase Period 2|Adverse Event|0
5389735|NCT03286218|18558563|P2|Qualification Phase Period 2|Adverse Event|1
5389736|NCT03286218|18558564|P1|Qualification Phase Period 2|Adverse Event|0
5389737|NCT03286218|18558553|P12|Qualification Phase Period 1|Withdrawal by Subject|0
5389738|NCT03286218|18558554|P11|Qualification Phase Period 1|Withdrawal by Subject|0
5389739|NCT03286218|18558555|P10|Qualification Phase Period 1|Withdrawal by Subject|0
5389740|NCT03286218|18558556|P9|Qualification Phase Period 1|Withdrawal by Subject|0
5389741|NCT03286218|18558557|P8|Qualification Phase Period 1|Withdrawal by Subject|0
5389742|NCT03286218|18558558|P7|Qualification Phase Period 1|Withdrawal by Subject|0
5389743|NCT03286218|18558559|P6|Qualification Phase Period 1|Withdrawal by Subject|0
5389744|NCT03286218|18558560|P5|Qualification Phase Period 1|Withdrawal by Subject|0
5389745|NCT03286218|18558561|P4|Qualification Phase Period 1|Withdrawal by Subject|0
5389746|NCT03286218|18558562|P3|Qualification Phase Period 1|Withdrawal by Subject|0
5389747|NCT03286218|18558563|P2|Qualification Phase Period 1|Withdrawal by Subject|1
5389748|NCT03286218|18558564|P1|Qualification Phase Period 1|Withdrawal by Subject|0
5389749|NCT03286218|18558553|P12|Qualification Phase Period 1|Adverse Event|0
5389750|NCT03286218|18558554|P11|Qualification Phase Period 1|Adverse Event|0
5389751|NCT03286218|18558555|P10|Qualification Phase Period 1|Adverse Event|0
5389752|NCT03286218|18558556|P9|Qualification Phase Period 1|Adverse Event|0
5389753|NCT03286218|18558557|P8|Qualification Phase Period 1|Adverse Event|0
5389754|NCT03286218|18558558|P7|Qualification Phase Period 1|Adverse Event|0
5389755|NCT03286218|18558559|P6|Qualification Phase Period 1|Adverse Event|0
5389756|NCT03286218|18558560|P5|Qualification Phase Period 1|Adverse Event|0
5389757|NCT03286218|18558561|P4|Qualification Phase Period 1|Adverse Event|0
5389758|NCT03286218|18558562|P3|Qualification Phase Period 1|Adverse Event|0
5389759|NCT03286218|18558563|P2|Qualification Phase Period 1|Adverse Event|0
5389760|NCT03286218|18558564|P1|Qualification Phase Period 1|Adverse Event|1
5389761|NCT03285711|18558627|P4|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
5389762|NCT03285711|18558628|P3|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
5389763|NCT03285711|18558629|P2|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
5389764|NCT03285711|18558630|P1|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
5389765|NCT03285711|18558627|P4|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
5389766|NCT03285711|18558628|P3|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
5389767|NCT03285711|18558629|P2|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
5389768|NCT03285711|18558630|P1|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
5389769|NCT03285711|18558627|P4|Blinded Phase (Up to Week 16)|Protocol Violation|0
5389770|NCT03285711|18558628|P3|Blinded Phase (Up to Week 16)|Protocol Violation|0
5389771|NCT03285711|18558629|P2|Blinded Phase (Up to Week 16)|Protocol Violation|0
5389772|NCT03285711|18558630|P1|Blinded Phase (Up to Week 16)|Protocol Violation|1
5389773|NCT03285711|18558627|P4|Blinded Phase (Up to Week 16)|Adverse Event|0
5389774|NCT03285711|18558628|P3|Blinded Phase (Up to Week 16)|Adverse Event|0
5389775|NCT03285711|18558629|P2|Blinded Phase (Up to Week 16)|Adverse Event|1
5389776|NCT03285711|18558630|P1|Blinded Phase (Up to Week 16)|Adverse Event|2
5389777|NCT03285295|18558738|P5|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5389778|NCT03285295|18558739|P4|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5389779|NCT03285295|18558740|P3|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5389780|NCT03285295|18558741|P2|Alinity s Chagas Follow-Up|Lost to Follow-up|0
5389781|NCT03285295|18558742|P1|Alinity s Chagas Follow-Up|Lost to Follow-up|13
5389782|NCT03285295|18558738|P5|Alinity s Chagas|No Results Generated|0
5389783|NCT03285295|18558739|P4|Alinity s Chagas|No Results Generated|0
5389784|NCT03285295|18558740|P3|Alinity s Chagas|No Results Generated|0
5389785|NCT03285295|18558741|P2|Alinity s Chagas|No Results Generated|0
5389786|NCT03285295|18558742|P1|Alinity s Chagas|No Results Generated|105
5389787|NCT03285295|18558738|P5|Alinity s Chagas|No Results on Comparator Assay|0
5389788|NCT03285295|18558739|P4|Alinity s Chagas|No Results on Comparator Assay|0
5389789|NCT03285295|18558740|P3|Alinity s Chagas|No Results on Comparator Assay|0
5389790|NCT03285295|18558741|P2|Alinity s Chagas|No Results on Comparator Assay|0
5389791|NCT03285295|18558742|P1|Alinity s Chagas|No Results on Comparator Assay|38
5389792|NCT03285295|18558738|P5|Alinity s Chagas|Protocol Violation|0
5389793|NCT03285295|18558739|P4|Alinity s Chagas|Protocol Violation|0
5389794|NCT03285295|18558740|P3|Alinity s Chagas|Protocol Violation|0
5389795|NCT03285295|18558741|P2|Alinity s Chagas|Protocol Violation|0
5389796|NCT03285295|18558742|P1|Alinity s Chagas|Protocol Violation|76
5389797|NCT03285295|18558738|P5|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5389798|NCT03285295|18558739|P4|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5389799|NCT03285295|18558740|P3|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5389800|NCT03285295|18558741|P2|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
5389801|NCT03285295|18558742|P1|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
5389802|NCT03285295|18558738|P5|Alinity s Anti-HBc|No Results Generated|0
5389803|NCT03285295|18558739|P4|Alinity s Anti-HBc|No Results Generated|0
5389804|NCT03285295|18558740|P3|Alinity s Anti-HBc|No Results Generated|0
5389805|NCT03285295|18558741|P2|Alinity s Anti-HBc|No Results Generated|0
5389806|NCT03285295|18558742|P1|Alinity s Anti-HBc|No Results Generated|70
5389807|NCT03285295|18558738|P5|Alinity s Anti-HBc|No Results on Comparator Assay|0
5389808|NCT03285295|18558739|P4|Alinity s Anti-HBc|No Results on Comparator Assay|0
5389809|NCT03285295|18558740|P3|Alinity s Anti-HBc|No Results on Comparator Assay|0
5389810|NCT03285295|18558741|P2|Alinity s Anti-HBc|No Results on Comparator Assay|1
5389811|NCT03285295|18558742|P1|Alinity s Anti-HBc|No Results on Comparator Assay|13
5389812|NCT03285295|18558738|P5|Alinity s Anti-HBc|Protocol Violation|0
5389813|NCT03285295|18558739|P4|Alinity s Anti-HBc|Protocol Violation|0
5389814|NCT03285295|18558740|P3|Alinity s Anti-HBc|Protocol Violation|0
5389815|NCT03285295|18558741|P2|Alinity s Anti-HBc|Protocol Violation|0
5389816|NCT03285295|18558742|P1|Alinity s Anti-HBc|Protocol Violation|8
5389817|NCT03285295|18558738|P5|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5389818|NCT03285295|18558739|P4|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5389819|NCT03285295|18558740|P3|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5389820|NCT03285295|18558741|P2|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
5389821|NCT03285295|18558742|P1|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
5389822|NCT03285295|18558738|P5|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5389823|NCT03285295|18558739|P4|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5389824|NCT03285295|18558740|P3|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5389825|NCT03285295|18558741|P2|Alinity s HIV Ag/Ab Combo|No Results Generated|0
5389826|NCT03285295|18558742|P1|Alinity s HIV Ag/Ab Combo|No Results Generated|72
5389827|NCT03285295|18558738|P5|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5389828|NCT03285295|18558739|P4|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5389829|NCT03285295|18558740|P3|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5389830|NCT03285295|18558741|P2|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
5389831|NCT03285295|18558742|P1|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
5389832|NCT03285295|18558738|P5|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5389833|NCT03285295|18558739|P4|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5389834|NCT03285295|18558740|P3|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5389835|NCT03285295|18558741|P2|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
5389836|NCT03285295|18558742|P1|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
5389837|NCT03285295|18558738|P5|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5389838|NCT03285295|18558739|P4|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5389839|NCT03285295|18558740|P3|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5389840|NCT03285295|18558741|P2|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
5389841|NCT03285295|18558742|P1|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
5389842|NCT03285295|18558738|P5|Alinity s Anti-HCV|No Results Generated|0
5389843|NCT03285295|18558739|P4|Alinity s Anti-HCV|No Results Generated|0
5389844|NCT03285295|18558740|P3|Alinity s Anti-HCV|No Results Generated|0
5389845|NCT03285295|18558741|P2|Alinity s Anti-HCV|No Results Generated|0
5389846|NCT03285295|18558742|P1|Alinity s Anti-HCV|No Results Generated|71
5389847|NCT03285295|18558738|P5|Alinity s Anti-HCV|No Results on Comparator Assay|0
5389848|NCT03285295|18558739|P4|Alinity s Anti-HCV|No Results on Comparator Assay|0
5389849|NCT03285295|18558740|P3|Alinity s Anti-HCV|No Results on Comparator Assay|0
5389850|NCT03285295|18558741|P2|Alinity s Anti-HCV|No Results on Comparator Assay|0
5389851|NCT03285295|18558742|P1|Alinity s Anti-HCV|No Results on Comparator Assay|13
5389852|NCT03285295|18558738|P5|Alinity s Anti-HCV|Protocol Violation|0
5389853|NCT03285295|18558739|P4|Alinity s Anti-HCV|Protocol Violation|0
5389854|NCT03285295|18558740|P3|Alinity s Anti-HCV|Protocol Violation|0
5389855|NCT03285295|18558741|P2|Alinity s Anti-HCV|Protocol Violation|0
5389856|NCT03285295|18558742|P1|Alinity s Anti-HCV|Protocol Violation|12
5389857|NCT03285295|18558738|P5|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5389858|NCT03285295|18558739|P4|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5389859|NCT03285295|18558740|P3|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5389860|NCT03285295|18558741|P2|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
5389861|NCT03285295|18558742|P1|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
5389862|NCT03285295|18558738|P5|Alinity s HTLV I/II|No Results Generated|0
5389863|NCT03285295|18558739|P4|Alinity s HTLV I/II|No Results Generated|0
5389864|NCT03285295|18558740|P3|Alinity s HTLV I/II|No Results Generated|0
5389865|NCT03285295|18558741|P2|Alinity s HTLV I/II|No Results Generated|0
5389866|NCT03285295|18558742|P1|Alinity s HTLV I/II|No Results Generated|70
5389867|NCT03285295|18558738|P5|Alinity s HTLV I/II|No Result on Comparator Assay|0
5389868|NCT03285295|18558739|P4|Alinity s HTLV I/II|No Result on Comparator Assay|0
5389869|NCT03285295|18558740|P3|Alinity s HTLV I/II|No Result on Comparator Assay|0
5389870|NCT03285295|18558741|P2|Alinity s HTLV I/II|No Result on Comparator Assay|0
5389871|NCT03285295|18558742|P1|Alinity s HTLV I/II|No Result on Comparator Assay|15
5389872|NCT03285295|18558738|P5|Alinity s HTLV I/II|Protocol Violation|0
5389873|NCT03285295|18558739|P4|Alinity s HTLV I/II|Protocol Violation|0
5389874|NCT03285295|18558740|P3|Alinity s HTLV I/II|Protocol Violation|0
5389875|NCT03285295|18558741|P2|Alinity s HTLV I/II|Protocol Violation|0
5389876|NCT03285295|18558742|P1|Alinity s HTLV I/II|Protocol Violation|6
5389877|NCT03285295|18558738|P5|Alinity s HBsAg|No Results Generated|0
5389878|NCT03285295|18558739|P4|Alinity s HBsAg|No Results Generated|0
5389879|NCT03285295|18558740|P3|Alinity s HBsAg|No Results Generated|0
5389880|NCT03285295|18558741|P2|Alinity s HBsAg|No Results Generated|6
5389881|NCT03285295|18558742|P1|Alinity s HBsAg|No Results Generated|74
5389882|NCT03285295|18558738|P5|Alinity s HBsAg|No Result on Comparator Assay|0
5389883|NCT03285295|18558739|P4|Alinity s HBsAg|No Result on Comparator Assay|0
5389884|NCT03285295|18558740|P3|Alinity s HBsAg|No Result on Comparator Assay|0
5389885|NCT03285295|18558741|P2|Alinity s HBsAg|No Result on Comparator Assay|0
5389886|NCT03285295|18558742|P1|Alinity s HBsAg|No Result on Comparator Assay|17
5389887|NCT03285295|18558738|P5|Alinity s HBsAg|Protocol Violation|0
5389888|NCT03285295|18558739|P4|Alinity s HBsAg|Protocol Violation|0
5389889|NCT03285295|18558740|P3|Alinity s HBsAg|Protocol Violation|0
5389890|NCT03285295|18558741|P2|Alinity s HBsAg|Protocol Violation|0
5389891|NCT03285295|18558742|P1|Alinity s HBsAg|Protocol Violation|11
5389892|NCT03284229|18558776|P1|Overall Study|Lost to Follow-up|3
5389893|NCT03283709|18558810|P2|Overall Study|trial terminated|1
5389894|NCT03283709|18558811|P1|Overall Study|trial terminated|0
5389895|NCT03283696|18558843|P2|Overall Study|Withdrawal by Subject|0
5389896|NCT03283696|18558844|P1|Overall Study|Withdrawal by Subject|2
5389897|NCT03283696|18558843|P2|Overall Study|Physician Decision|6
5389898|NCT03283696|18558844|P1|Overall Study|Physician Decision|5
5389899|NCT03283319|18558889|P6|Overall Study|BARDA regulatory agency or IRB decision|0
5389900|NCT03283319|18558890|P5|Overall Study|BARDA regulatory agency or IRB decision|0
5389901|NCT03283319|18558891|P4|Overall Study|BARDA regulatory agency or IRB decision|1
5389902|NCT03283319|18558892|P3|Overall Study|BARDA regulatory agency or IRB decision|0
5389903|NCT03283319|18558893|P2|Overall Study|BARDA regulatory agency or IRB decision|0
5389904|NCT03283319|18558894|P1|Overall Study|BARDA regulatory agency or IRB decision|0
5389905|NCT03283319|18558889|P6|Overall Study|Withdrawal by Subject|1
5389906|NCT03283319|18558890|P5|Overall Study|Withdrawal by Subject|0
5389907|NCT03283319|18558891|P4|Overall Study|Withdrawal by Subject|1
5389908|NCT03283319|18558892|P3|Overall Study|Withdrawal by Subject|2
5389909|NCT03283319|18558893|P2|Overall Study|Withdrawal by Subject|2
5389910|NCT03283319|18558894|P1|Overall Study|Withdrawal by Subject|2
5389911|NCT03283319|18558889|P6|Overall Study|Lost to Follow-up|3
5389912|NCT03283319|18558890|P5|Overall Study|Lost to Follow-up|4
5389913|NCT03283319|18558891|P4|Overall Study|Lost to Follow-up|5
5389914|NCT03283319|18558892|P3|Overall Study|Lost to Follow-up|5
5389915|NCT03283319|18558893|P2|Overall Study|Lost to Follow-up|4
5389916|NCT03283319|18558894|P1|Overall Study|Lost to Follow-up|5
5389917|NCT03283098|18559036|P2|Overall Study|Withdrawal by Subject|1
5389918|NCT03283098|18559037|P1|Overall Study|Withdrawal by Subject|0
5389919|NCT03282240|18559157|P3|Overall Study|Withdrawal by Subject|1
5389920|NCT03282240|18559158|P2|Overall Study|Withdrawal by Subject|0
5389921|NCT03282240|18559159|P1|Overall Study|Withdrawal by Subject|1
5389922|NCT03282240|18559157|P3|Overall Study|Protocol Deviation|2
5389923|NCT03282240|18559158|P2|Overall Study|Protocol Deviation|1
5389924|NCT03282240|18559159|P1|Overall Study|Protocol Deviation|4
5389925|NCT03282240|18559157|P3|Overall Study|Lost to Follow-up|0
5389926|NCT03282240|18559158|P2|Overall Study|Lost to Follow-up|0
5389927|NCT03282240|18559159|P1|Overall Study|Lost to Follow-up|3
5389928|NCT03282240|18559157|P3|Overall Study|Adverse Event|0
5389929|NCT03282240|18559158|P2|Overall Study|Adverse Event|2
5389930|NCT03282240|18559159|P1|Overall Study|Adverse Event|2
5389931|NCT03282227|18559211|P1|Overall Study|Other|1
5389932|NCT03282227|18559211|P1|Overall Study|Pregnancy|2
5389933|NCT03282227|18559211|P1|Overall Study|Physician Decision|2
5389934|NCT03282227|18559211|P1|Overall Study|Sponsor decision|3
5389935|NCT03282227|18559211|P1|Overall Study|Lack of Efficacy|12
5389936|NCT03282227|18559211|P1|Overall Study|Withdrawal by Subject|20
5389937|NCT03282227|18559211|P1|Overall Study|Lost to Follow-up|21
5389938|NCT03282227|18559211|P1|Overall Study|Adverse Event|15
5389939|NCT03282227|18559211|P1|Overall Study|Non-compliance w/ protocol requirements|79
5389940|NCT03282227|18559211|P1|Overall Study|Exposure Goals Achieved|60
5389941|NCT03281668|18559245|P1|Overall Study|Lost to Follow-up|1
5389942|NCT03281668|18559245|P1|Overall Study|Withdrawal by Subject|4
5389943|NCT03281668|18559245|P1|Overall Study|scheduling conflict, family circumstance|2
5389944|NCT03281668|18559245|P1|Overall Study|Physician Decision|1
5389945|NCT03281577|18559273|P4|Overall Study|Withdrawal by Subject|0
5389946|NCT03281577|18559274|P3|Overall Study|Withdrawal by Subject|0
5389947|NCT03281577|18559275|P2|Overall Study|Withdrawal by Subject|0
5389948|NCT03281577|18559276|P1|Overall Study|Withdrawal by Subject|1
5389949|NCT03281577|18559273|P4|Overall Study|Adverse Event|1
5389950|NCT03281577|18559274|P3|Overall Study|Adverse Event|0
5389951|NCT03281577|18559275|P2|Overall Study|Adverse Event|0
5389952|NCT03281577|18559276|P1|Overall Study|Adverse Event|0
5389953|NCT03280615|18559331|P2|Overall Study|Withdrawal by Subject|2
5389954|NCT03280615|18559332|P1|Overall Study|Withdrawal by Subject|2
5389955|NCT03280615|18559331|P2|Overall Study|Adverse Event|1
5389956|NCT03280615|18559332|P1|Overall Study|Adverse Event|1
5389957|NCT03280615|18559331|P2|Overall Study|Lost to Follow-up|2
5389958|NCT03280615|18559332|P1|Overall Study|Lost to Follow-up|1
5389959|NCT03280550|18559344|P2|Overall Study|Physician Decision|1
5389960|NCT03280550|18559345|P1|Overall Study|Physician Decision|0
5389961|NCT03280550|18559344|P2|Overall Study|Withdrawal by Subject|2
5389962|NCT03280550|18559345|P1|Overall Study|Withdrawal by Subject|2
5389963|NCT03280537|18559397|P2|Overall Study|Withdrawal by Subject|4
5389964|NCT03280537|18559398|P1|Overall Study|Withdrawal by Subject|2
5389965|NCT03280381|18559450|P2|Overall Study|Physician Decision|2
5389966|NCT03280381|18559451|P1|Overall Study|Physician Decision|0
5389967|NCT03280108|18559461|P2|Overall Study|Lost to Follow-up|0
5389968|NCT03280108|18559462|P1|Overall Study|Lost to Follow-up|2
5389969|NCT03278106|18559544|P1|Overall Study|No protocol treatment|1
5389970|NCT03278028|18559960|P2|Overall Study|Pregnancy|1
5389971|NCT03278028|18559961|P1|Overall Study|Pregnancy|0
5389972|NCT03278028|18559960|P2|Overall Study|Withdrawal by Subject|1
5389973|NCT03278028|18559961|P1|Overall Study|Withdrawal by Subject|3
5389974|NCT03278028|18559960|P2|Overall Study|Lost to Follow-up|0
5389975|NCT03278028|18559961|P1|Overall Study|Lost to Follow-up|1
5389976|NCT03277846|18559969|P2|Overall Study|Inpatient stay too brief|11
5389977|NCT03277846|18559970|P1|Overall Study|Inpatient stay too brief|12
5389978|NCT03277105|18560027|P2|Overall Study|Ongoing|175
5389979|NCT03277105|18560028|P1|Overall Study|Ongoing|171
5389980|NCT03277105|18560027|P2|Overall Study|Other|3
5389981|NCT03277105|18560028|P1|Overall Study|Other|1
5389982|NCT03277105|18560027|P2|Overall Study|Withdrawal by Subject|9
5389983|NCT03277105|18560028|P1|Overall Study|Withdrawal by Subject|10
5389984|NCT03277105|18560027|P2|Overall Study|Lost to Follow-up|3
5389985|NCT03277105|18560028|P1|Overall Study|Lost to Follow-up|0
5389986|NCT03277105|18560027|P2|Overall Study|Death|73
5389987|NCT03277105|18560028|P1|Overall Study|Death|77
5389988|NCT03276936|18560060|P2|Overall Study|Not mentioned|3
5389989|NCT03276936|18560061|P1|Overall Study|Not mentioned|6
5389990|NCT03276936|18560060|P2|Overall Study|Withdrawal by Subject|20
5389991|NCT03276936|18560061|P1|Overall Study|Withdrawal by Subject|30
5389992|NCT03276936|18560060|P2|Overall Study|Lost to Follow-up|13
5389993|NCT03276936|18560061|P1|Overall Study|Lost to Follow-up|16
5389994|NCT03276936|18560060|P2|Overall Study|Adverse Event|2
5389995|NCT03276936|18560061|P1|Overall Study|Adverse Event|4
5389996|NCT03276078|18560099|P1|Overall Study|Adverse Event|1
5389997|NCT03276026|18560128|P2|Overall Study|Protocol Violation|0
5389998|NCT03276026|18560129|P1|Overall Study|Protocol Violation|1
5389999|NCT03274986|18560157|P2|Overall Study|Lost to Follow-up|1
5390000|NCT03274986|18560158|P1|Overall Study|Lost to Follow-up|0
5390001|NCT03274986|18560157|P2|Overall Study|Withdrawal by Subject|1
5390002|NCT03274986|18560158|P1|Overall Study|Withdrawal by Subject|0
5390003|NCT03274453|18560225|P4|Overall Study|Surgery Cancelled|0
5390004|NCT03274453|18560226|P3|Overall Study|Surgery Cancelled|0
5390005|NCT03274453|18560227|P2|Overall Study|Surgery Cancelled|1
5390006|NCT03274453|18560228|P1|Overall Study|Surgery Cancelled|0
5390007|NCT03274453|18560225|P4|Overall Study|Physician Decision|3
5390008|NCT03274453|18560226|P3|Overall Study|Physician Decision|0
5390009|NCT03274453|18560227|P2|Overall Study|Physician Decision|0
5390010|NCT03274453|18560228|P1|Overall Study|Physician Decision|2
5390011|NCT03274453|18560225|P4|Overall Study|Lost to Follow-up|1
5390012|NCT03274453|18560226|P3|Overall Study|Lost to Follow-up|4
5390013|NCT03274453|18560227|P2|Overall Study|Lost to Follow-up|5
5390014|NCT03274453|18560228|P1|Overall Study|Lost to Follow-up|2
5390015|NCT03274440|18560238|P6|Overall Study|Time commitment too great|0
5390016|NCT03274440|18560239|P5|Overall Study|Time commitment too great|0
5390017|NCT03274440|18560240|P4|Overall Study|Time commitment too great|1
5390018|NCT03274440|18560241|P3|Overall Study|Time commitment too great|0
5390019|NCT03274440|18560242|P2|Overall Study|Time commitment too great|0
5390020|NCT03274440|18560243|P1|Overall Study|Time commitment too great|1
5390021|NCT03274076|18560256|P4|24 Weeks Open Label|Withdrawal by Subject|1
5390022|NCT03274076|18560257|P3|24 Weeks Open Label|Withdrawal by Subject|0
5390023|NCT03274076|18560258|P2|24 Weeks Open Label|Withdrawal by Subject|0
5390024|NCT03274076|18560259|P1|24 Weeks Open Label|Withdrawal by Subject|0
5390025|NCT03274076|18560256|P4|24 Weeks Open Label|Adverse Event|0
5390026|NCT03274076|18560257|P3|24 Weeks Open Label|Adverse Event|2
5390027|NCT03274076|18560258|P2|24 Weeks Open Label|Adverse Event|0
5390028|NCT03274076|18560259|P1|24 Weeks Open Label|Adverse Event|0
5390029|NCT03274076|18560256|P4|24 Weeks Double Blind|Withdrawal by Subject|0
5390030|NCT03274076|18560257|P3|24 Weeks Double Blind|Withdrawal by Subject|0
5390031|NCT03274076|18560258|P2|24 Weeks Double Blind|Withdrawal by Subject|1
5390032|NCT03274076|18560259|P1|24 Weeks Double Blind|Withdrawal by Subject|0
5390033|NCT03273946|18560287|P1|Overall Study|Participant relative refused to use drug|1
5390034|NCT03273946|18560287|P1|Overall Study|Participant refused to use the drug|2
5390035|NCT03273946|18560287|P1|Overall Study|Unwillingness of the guardian|1
5390036|NCT03273946|18560287|P1|Overall Study|Withdrawal by Subject|5
5390037|NCT03273387|18560335|P2|Overall Study|Withdrawal by Subject|1
5390038|NCT03273387|18560336|P1|Overall Study|Withdrawal by Subject|1
5390039|NCT03273387|18560335|P2|Overall Study|Death|2
5390040|NCT03273387|18560336|P1|Overall Study|Death|2
5390041|NCT03273166|18560357|P1|Overall Study|Withdrawn prior to Completion|31
5390042|NCT03273153|18560364|P2|Overall Study|Other|1
5390043|NCT03273153|18560365|P1|Overall Study|Other|0
5390044|NCT03273153|18560364|P2|Overall Study|Symptomatic Deterioration|1
5390045|NCT03273153|18560365|P1|Overall Study|Symptomatic Deterioration|0
5390046|NCT03273153|18560364|P2|Overall Study|Withdrawal by Subject|13
5390047|NCT03273153|18560365|P1|Overall Study|Withdrawal by Subject|16
5390048|NCT03273153|18560364|P2|Overall Study|Protocol Violation|0
5390049|NCT03273153|18560365|P1|Overall Study|Protocol Violation|3
5390050|NCT03273153|18560364|P2|Overall Study|Lost to Follow-up|3
5390051|NCT03273153|18560365|P1|Overall Study|Lost to Follow-up|3
5390052|NCT03273153|18560364|P2|Overall Study|Death|45
5390053|NCT03273153|18560365|P1|Overall Study|Death|41
5390054|NCT03273153|18560364|P2|Overall Study|Remain on Study|159
5390055|NCT03273153|18560365|P1|Overall Study|Remain on Study|161
5390056|NCT03271307|18560431|P5|Overall Study|Lost to Follow-up|91
5390057|NCT03271307|18560432|P4|Overall Study|Lost to Follow-up|28
5390058|NCT03271307|18560433|P3|Overall Study|Lost to Follow-up|0
5390059|NCT03271307|18560434|P2|Overall Study|Lost to Follow-up|0
5390060|NCT03271307|18560435|P1|Overall Study|Lost to Follow-up|0
5390061|NCT03271021|18560491|P2|Overall Study|Miscellaneous|8
5390062|NCT03271021|18560492|P1|Overall Study|Miscellaneous|9
5390063|NCT03271021|18560491|P2|Overall Study|Abnormal Lab Results|0
5390064|NCT03271021|18560492|P1|Overall Study|Abnormal Lab Results|1
5390065|NCT03271021|18560491|P2|Overall Study|Protocol Violation|4
5390066|NCT03271021|18560492|P1|Overall Study|Protocol Violation|6
5390067|NCT03271021|18560491|P2|Overall Study|Lost to Follow-up|39
5390068|NCT03271021|18560492|P1|Overall Study|Lost to Follow-up|34
5390069|NCT03271021|18560491|P2|Overall Study|Withdrawal by Subject|53
5390070|NCT03271021|18560492|P1|Overall Study|Withdrawal by Subject|36
5390071|NCT03271021|18560491|P2|Overall Study|Adverse Event|2
5390072|NCT03271021|18560492|P1|Overall Study|Adverse Event|3
5390073|NCT03270657|18560510|P1|Overall Study|Withdrawal by Subject|1
5390074|NCT03270644|18560516|P1|Day 4 - 10 Propranolol Reference|Adverse Event|1
5390075|NCT03270644|18560516|P1|Day 1 Lasmiditan Reference|Physician Decision|1
5390076|NCT03270085|18560566|P2|Overall Study|Withdrawal by Subject|0
5390077|NCT03270085|18560567|P1|Overall Study|Withdrawal by Subject|1
5390078|NCT03269552|18560588|P1|Overall Study|Adverse Event|2
5390079|NCT03268941|18560599|P7|Part 2: Days 17 to 25|Withdrawal by Subject|1
5390080|NCT03268941|18560600|P6|Part 2: Days 17 to 25|Withdrawal by Subject|0
5390081|NCT03268941|18560601|P5|Part 2: Days 17 to 25|Withdrawal by Subject|0
5390082|NCT03268941|18560602|P4|Part 2: Days 17 to 25|Withdrawal by Subject|0
5390083|NCT03268941|18560603|P3|Part 2: Days 17 to 25|Withdrawal by Subject|0
5390084|NCT03268941|18560604|P2|Part 2: Days 17 to 25|Withdrawal by Subject|0
5390085|NCT03268941|18560605|P1|Part 2: Days 17 to 25|Withdrawal by Subject|0
5390086|NCT03268941|18560599|P7|Part 2: Days 17 to 25|Reason not specified|1
5390087|NCT03268941|18560600|P6|Part 2: Days 17 to 25|Reason not specified|0
5390088|NCT03268941|18560601|P5|Part 2: Days 17 to 25|Reason not specified|0
5390089|NCT03268941|18560602|P4|Part 2: Days 17 to 25|Reason not specified|0
5390090|NCT03268941|18560603|P3|Part 2: Days 17 to 25|Reason not specified|0
5390091|NCT03268941|18560604|P2|Part 2: Days 17 to 25|Reason not specified|0
5390092|NCT03268941|18560605|P1|Part 2: Days 17 to 25|Reason not specified|0
5390093|NCT03268941|18560599|P7|Part 1 (Days 1 to 9)|Protocol Deviation|0
5390094|NCT03268941|18560600|P6|Part 1 (Days 1 to 9)|Protocol Deviation|0
5390095|NCT03268941|18560601|P5|Part 1 (Days 1 to 9)|Protocol Deviation|0
5390096|NCT03268941|18560602|P4|Part 1 (Days 1 to 9)|Protocol Deviation|0
5390097|NCT03268941|18560603|P3|Part 1 (Days 1 to 9)|Protocol Deviation|0
5390098|NCT03268941|18560604|P2|Part 1 (Days 1 to 9)|Protocol Deviation|0
5390099|NCT03268941|18560605|P1|Part 1 (Days 1 to 9)|Protocol Deviation|1
5390100|NCT03268941|18560599|P7|Part 1 (Days 1 to 9)|Adverse Event|0
5390101|NCT03268941|18560600|P6|Part 1 (Days 1 to 9)|Adverse Event|0
5390102|NCT03268941|18560601|P5|Part 1 (Days 1 to 9)|Adverse Event|0
5390103|NCT03268941|18560602|P4|Part 1 (Days 1 to 9)|Adverse Event|1
5390104|NCT03268941|18560603|P3|Part 1 (Days 1 to 9)|Adverse Event|0
5390105|NCT03268941|18560604|P2|Part 1 (Days 1 to 9)|Adverse Event|0
5390106|NCT03268941|18560605|P1|Part 1 (Days 1 to 9)|Adverse Event|0
5390107|NCT03268941|18560599|P7|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5390108|NCT03268941|18560600|P6|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5390109|NCT03268941|18560601|P5|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5390110|NCT03268941|18560602|P4|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
5390111|NCT03268941|18560603|P3|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5390112|NCT03268941|18560604|P2|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5390113|NCT03268941|18560605|P1|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
5390114|NCT03268746|18560667|P1|Overall Study|Withdrawal by Subject|1
5390115|NCT03268590|18560689|P1|Overall Study|Previously unknown exclusion criteria|1
5390116|NCT03268005|18560724|P2|Overall Study|Withdrawal by Subject|11
5390117|NCT03268005|18560725|P1|Overall Study|Withdrawal by Subject|11
5390118|NCT03268005|18560724|P2|Overall Study|Lost to Follow-up|2
5390119|NCT03268005|18560725|P1|Overall Study|Lost to Follow-up|2
5390120|NCT03268005|18560724|P2|Overall Study|Death|1
5390121|NCT03268005|18560725|P1|Overall Study|Death|2
5390122|NCT03267940|18560839|P6|Expansion (Maximum Exposure: 421 Days)|Death|6
5390123|NCT03267940|18560840|P5|Expansion (Maximum Exposure: 421 Days)|Death|0
5390124|NCT03267940|18560841|P4|Expansion (Maximum Exposure: 421 Days)|Death|13
5390125|NCT03267940|18560842|P3|Expansion (Maximum Exposure: 421 Days)|Death|10
5390126|NCT03267940|18560843|P2|Expansion (Maximum Exposure: 421 Days)|Death|0
5390127|NCT03267940|18560844|P1|Expansion (Maximum Exposure: 421 Days)|Death|0
5390128|NCT03267940|18560839|P6|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
5390129|NCT03267940|18560840|P5|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
5390130|NCT03267940|18560841|P4|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
5390131|NCT03267940|18560842|P3|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
5390132|NCT03267940|18560843|P2|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
5390133|NCT03267940|18560844|P1|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
5390134|NCT03267940|18560839|P6|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
5390135|NCT03267940|18560840|P5|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
5390136|NCT03267940|18560841|P4|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
5390137|NCT03267940|18560842|P3|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
5390138|NCT03267940|18560843|P2|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
5390139|NCT03267940|18560844|P1|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
5390140|NCT03267940|18560839|P6|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
5390141|NCT03267940|18560840|P5|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
5390142|NCT03267940|18560841|P4|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
5390143|NCT03267940|18560842|P3|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
5390144|NCT03267940|18560843|P2|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
5390145|NCT03267940|18560844|P1|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
5390146|NCT03267940|18560839|P6|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5390147|NCT03267940|18560840|P5|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
5390148|NCT03267940|18560841|P4|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
5390149|NCT03267940|18560842|P3|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5390150|NCT03267940|18560843|P2|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5390151|NCT03267940|18560844|P1|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
5390152|NCT03267940|18560839|P6|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5390153|NCT03267940|18560840|P5|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5390154|NCT03267940|18560841|P4|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5390155|NCT03267940|18560842|P3|Run-in Portion (Max. Exposure: 508 Days)|Death|0
5390156|NCT03267940|18560843|P2|Run-in Portion (Max. Exposure: 508 Days)|Death|3
5390157|NCT03267940|18560844|P1|Run-in Portion (Max. Exposure: 508 Days)|Death|7
5390158|NCT03267940|18560839|P6|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5390159|NCT03267940|18560840|P5|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5390160|NCT03267940|18560841|P4|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5390161|NCT03267940|18560842|P3|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5390162|NCT03267940|18560843|P2|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
5390163|NCT03267940|18560844|P1|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
5390164|NCT03267940|18560839|P6|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5390165|NCT03267940|18560840|P5|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5390166|NCT03267940|18560841|P4|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5390167|NCT03267940|18560842|P3|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5390168|NCT03267940|18560843|P2|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
5390169|NCT03267940|18560844|P1|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
5390170|NCT03267940|18560839|P6|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5390171|NCT03267940|18560840|P5|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5390172|NCT03267940|18560841|P4|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5390173|NCT03267940|18560842|P3|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
5390174|NCT03267940|18560843|P2|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
5390175|NCT03267940|18560844|P1|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
5390176|NCT03267576|18560946|P2|Period 2: Day 44 to 71|Withdrawal by Subject|1
5390177|NCT03267576|18560947|P1|Period 2: Day 44 to 71|Withdrawal by Subject|1
5390178|NCT03267576|18560946|P2|Period 2: Day 44 to 71|Lost to Follow-up|1
5390179|NCT03267576|18560947|P1|Period 2: Day 44 to 71|Lost to Follow-up|0
5390180|NCT03267511|18560985|P4|Overall Study|Lost to Follow-up|1
5390181|NCT03267511|18560986|P3|Overall Study|Lost to Follow-up|0
5390182|NCT03267511|18560987|P2|Overall Study|Lost to Follow-up|0
5390183|NCT03267511|18560988|P1|Overall Study|Lost to Follow-up|0
5390184|NCT03267264|18561004|P4|Overall Study|Withdrawal by Subject|4
5390185|NCT03267264|18561005|P3|Overall Study|Withdrawal by Subject|2
5390186|NCT03267264|18561006|P2|Overall Study|Withdrawal by Subject|0
5390187|NCT03267264|18561007|P1|Overall Study|Withdrawal by Subject|1
5390188|NCT03267212|18561024|P2|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
5390189|NCT03267212|18561025|P1|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
5390190|NCT03267212|18561024|P2|First Intervention|Withdrawal by Subject|1
5390191|NCT03267212|18561025|P1|First Intervention|Withdrawal by Subject|1
5390192|NCT03267212|18561024|P2|First Intervention|Lost to Follow-up|2
5390193|NCT03267212|18561025|P1|First Intervention|Lost to Follow-up|0
5390194|NCT03266588|18561040|P3|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
5390195|NCT03266588|18561041|P2|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
5390196|NCT03266588|18561042|P1|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
5390197|NCT03266588|18561040|P3|Long-term Treatment Period|Other Reasons|0
5390198|NCT03266588|18561041|P2|Long-term Treatment Period|Other Reasons|0
5390199|NCT03266588|18561042|P1|Long-term Treatment Period|Other Reasons|5
5390200|NCT03266588|18561040|P3|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
5390201|NCT03266588|18561041|P2|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
5390202|NCT03266588|18561042|P1|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
5390203|NCT03266588|18561040|P3|Long-term Treatment Period|Withdrawal by Subject|16
5390204|NCT03266588|18561041|P2|Long-term Treatment Period|Withdrawal by Subject|63
5390205|NCT03266588|18561042|P1|Long-term Treatment Period|Withdrawal by Subject|100
5390206|NCT03266588|18561040|P3|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
5390207|NCT03266588|18561041|P2|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
5390208|NCT03266588|18561042|P1|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
5390209|NCT03266588|18561040|P3|Long-term Treatment Period|Protocol Deviation|4
5390210|NCT03266588|18561041|P2|Long-term Treatment Period|Protocol Deviation|10
5390211|NCT03266588|18561042|P1|Long-term Treatment Period|Protocol Deviation|17
5390212|NCT03266588|18561040|P3|Long-term Treatment Period|Pregnancy|0
5390213|NCT03266588|18561041|P2|Long-term Treatment Period|Pregnancy|5
5390214|NCT03266588|18561042|P1|Long-term Treatment Period|Pregnancy|11
5390215|NCT03266588|18561040|P3|Long-term Treatment Period|Non-Compliance|7
5390216|NCT03266588|18561041|P2|Long-term Treatment Period|Non-Compliance|57
5390217|NCT03266588|18561042|P1|Long-term Treatment Period|Non-Compliance|126
5390218|NCT03266588|18561040|P3|Long-term Treatment Period|Lost to Follow-up|8
5390219|NCT03266588|18561041|P2|Long-term Treatment Period|Lost to Follow-up|37
5390220|NCT03266588|18561042|P1|Long-term Treatment Period|Lost to Follow-up|39
5390221|NCT03266588|18561040|P3|Long-term Treatment Period|Lack of Efficacy|5
5390222|NCT03266588|18561041|P2|Long-term Treatment Period|Lack of Efficacy|31
5390223|NCT03266588|18561042|P1|Long-term Treatment Period|Lack of Efficacy|41
5390224|NCT03266588|18561040|P3|Long-term Treatment Period|Adverse Event|8
5390225|NCT03266588|18561041|P2|Long-term Treatment Period|Adverse Event|17
5390226|NCT03266588|18561042|P1|Long-term Treatment Period|Adverse Event|33
5390227|NCT03266588|18561040|P3|Observational Period|Other Reasons|1
5390228|NCT03266588|18561041|P2|Observational Period|Other Reasons|0
5390229|NCT03266588|18561042|P1|Observational Period|Other Reasons|3
5390230|NCT03266588|18561040|P3|Observational Period|Protocol Deviation|0
5390231|NCT03266588|18561041|P2|Observational Period|Protocol Deviation|0
5390232|NCT03266588|18561042|P1|Observational Period|Protocol Deviation|1
5390233|NCT03266588|18561040|P3|Observational Period|Eligibility Failure- Baseline Lab Values|0
5390234|NCT03266588|18561041|P2|Observational Period|Eligibility Failure- Baseline Lab Values|1
5390235|NCT03266588|18561042|P1|Observational Period|Eligibility Failure- Baseline Lab Values|3
5390236|NCT03266588|18561040|P3|Observational Period|Lost to Follow-up|4
5390237|NCT03266588|18561041|P2|Observational Period|Lost to Follow-up|12
5390238|NCT03266588|18561042|P1|Observational Period|Lost to Follow-up|8
5390239|NCT03266588|18561040|P3|Observational Period|Non-compliance|10
5390240|NCT03266588|18561041|P2|Observational Period|Non-compliance|12
5390241|NCT03266588|18561042|P1|Observational Period|Non-compliance|18
5390242|NCT03266588|18561040|P3|Observational Period|Withdrawal by Subject|13
5390243|NCT03266588|18561041|P2|Observational Period|Withdrawal by Subject|22
5390244|NCT03266588|18561042|P1|Observational Period|Withdrawal by Subject|44
5390245|NCT03266588|18561040|P3|Observational Period|Screen Failure: Eligibility Criteria|140
5390246|NCT03266588|18561041|P2|Observational Period|Screen Failure: Eligibility Criteria|228
5390247|NCT03266588|18561042|P1|Observational Period|Screen Failure: Eligibility Criteria|439
5390248|NCT03266172|18561073|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
5390249|NCT03266172|18561074|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5390250|NCT03266172|18561075|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5390251|NCT03266172|18561073|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
5390252|NCT03266172|18561074|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5390253|NCT03266172|18561075|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
5390254|NCT03266172|18561073|P3|Part B: Washout (7 Days)|Withdrawal by Subject|0
5390255|NCT03266172|18561074|P2|Part B: Washout (7 Days)|Withdrawal by Subject|2
5390256|NCT03266172|18561075|P1|Part B: Washout (7 Days)|Withdrawal by Subject|0
5390257|NCT03266172|18561073|P3|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
5390258|NCT03266172|18561074|P2|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
5390259|NCT03266172|18561075|P1|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
5390260|NCT03266172|18561073|P3|Part A: Washout Period (7 Days)|Adverse Event|0
5390261|NCT03266172|18561074|P2|Part A: Washout Period (7 Days)|Adverse Event|0
5390262|NCT03266172|18561075|P1|Part A: Washout Period (7 Days)|Adverse Event|1
5390263|NCT03266172|18561073|P3|Part A: Period 1(2 Days)|Withdrawal by Subject|0
5390264|NCT03266172|18561074|P2|Part A: Period 1(2 Days)|Withdrawal by Subject|0
5390265|NCT03266172|18561075|P1|Part A: Period 1(2 Days)|Withdrawal by Subject|1
5390266|NCT03266107|18561320|P1|12-Month Follow-up Visit|Lost to Follow-up|1
5390267|NCT03266107|18561320|P1|3-Month Follow-up Visit|Lost to Follow-up|1
5390268|NCT03266107|18561320|P1|Enrollment to Procedure|Study stopped prior to Procedure|2
5390269|NCT03266107|18561320|P1|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1
5390270|NCT03266094|18561332|P1|Overall Study|Withdrawal by Subject|1
5390271|NCT03266094|18561332|P1|Overall Study|Lost to Follow-up|1
5390272|NCT03265938|18561350|P1|Overall Study|friable mass|6
5390273|NCT03265938|18561350|P1|Overall Study|Physician Decision|1
5390274|NCT03265938|18561350|P1|Overall Study|Withdrawal by Subject|1
5390275|NCT03265600|18561363|P2|Overall Study|Partially completed 8 wk or 24 wk survey|5
5390276|NCT03265600|18561364|P1|Overall Study|Partially completed 8 wk or 24 wk survey|3
5390277|NCT03265600|18561363|P2|Overall Study|Withdrawal by Subject|2
5390278|NCT03265600|18561364|P1|Overall Study|Withdrawal by Subject|4
5390279|NCT03265600|18561363|P2|Overall Study|Lost to Follow-up|5
5390280|NCT03265600|18561364|P1|Overall Study|Lost to Follow-up|17
5390281|NCT03265132|18561390|P2|Overall Study|Withdrawal by Subject|1
5390282|NCT03265132|18561391|P1|Overall Study|Withdrawal by Subject|0
5390283|NCT03265132|18561390|P2|Overall Study|Progressive disease|2
5390284|NCT03265132|18561391|P1|Overall Study|Progressive disease|0
5390285|NCT03265132|18561390|P2|Overall Study|Lack of Efficacy|2
5390286|NCT03265132|18561391|P1|Overall Study|Lack of Efficacy|0
5390287|NCT03265132|18561390|P2|Overall Study|Adverse Event|1
5390288|NCT03265132|18561391|P1|Overall Study|Adverse Event|0
5390289|NCT03265119|18561489|P2|Overall Study|Lack of Compliance|0
5390290|NCT03265119|18561490|P1|Overall Study|Lack of Compliance|1
5390291|NCT03265119|18561489|P2|Overall Study|Lost to Follow-up|0
5390292|NCT03265119|18561490|P1|Overall Study|Lost to Follow-up|1
5390293|NCT03265119|18561489|P2|Overall Study|Withdrawal by Subject|4
5390294|NCT03265119|18561490|P1|Overall Study|Withdrawal by Subject|2
5390295|NCT03265119|18561489|P2|Overall Study|Protocol Violation|2
5390296|NCT03265119|18561490|P1|Overall Study|Protocol Violation|1
5390297|NCT03265119|18561489|P2|Overall Study|Lack of Efficacy|0
5390298|NCT03265119|18561490|P1|Overall Study|Lack of Efficacy|3
5390299|NCT03265119|18561489|P2|Overall Study|Adverse Event|1
5390300|NCT03265119|18561490|P1|Overall Study|Adverse Event|2
5390301|NCT03264456|18561498|P1|Overall Study|Lost to Follow-up|1
5390302|NCT03264456|18561498|P1|Overall Study|Withdrawal by Subject|3
5390303|NCT03263806|18561533|P2|Overall Study|Study Termination|6
5390304|NCT03263806|18561534|P1|Overall Study|Study Termination|5
5390305|NCT03263806|18561533|P2|Overall Study|Withdrawal by Subject|1
5390306|NCT03263806|18561534|P1|Overall Study|Withdrawal by Subject|0
5390307|NCT03263806|18561533|P2|Overall Study|Elevated Troponin (failed screen)|0
5390308|NCT03263806|18561534|P1|Overall Study|Elevated Troponin (failed screen)|1
5390309|NCT03263702|18561548|P2|Overall Study|Withdrawal by Subject|2
5390310|NCT03263702|18561549|P1|Overall Study|Withdrawal by Subject|1
5390311|NCT03263702|18561548|P2|Overall Study|Lost to Follow-up|2
5390312|NCT03263702|18561549|P1|Overall Study|Lost to Follow-up|2
5390313|NCT03262441|18561575|P1|Overall Study|Withdrawal by Subject|1
5390314|NCT03262233|18561587|P4|Overall Study|data collection artifact|0
5390315|NCT03262233|18561588|P3|Overall Study|data collection artifact|0
5390316|NCT03262233|18561589|P2|Overall Study|data collection artifact|1
5390317|NCT03262233|18561590|P1|Overall Study|data collection artifact|0
5390318|NCT03262233|18561587|P4|Overall Study|Protocol Violation|13
5390319|NCT03262233|18561588|P3|Overall Study|Protocol Violation|2
5390320|NCT03262233|18561589|P2|Overall Study|Protocol Violation|10
5390321|NCT03262233|18561590|P1|Overall Study|Protocol Violation|5
5390322|NCT03262233|18561587|P4|Overall Study|Declined due to shock|3
5390323|NCT03262233|18561588|P3|Overall Study|Declined due to shock|2
5390324|NCT03262233|18561589|P2|Overall Study|Declined due to shock|2
5390325|NCT03262233|18561590|P1|Overall Study|Declined due to shock|1
5390326|NCT03262233|18561587|P4|Overall Study|Withdrawal by Subject|13
5390327|NCT03262233|18561588|P3|Overall Study|Withdrawal by Subject|21
5390328|NCT03262233|18561589|P2|Overall Study|Withdrawal by Subject|8
5390329|NCT03262233|18561590|P1|Overall Study|Withdrawal by Subject|12
5390330|NCT03262012|18561616|P4|Overall Study|Protocol Discontinuation Criteria|0
5390331|NCT03262012|18561617|P3|Overall Study|Protocol Discontinuation Criteria|0
5390332|NCT03262012|18561618|P2|Overall Study|Protocol Discontinuation Criteria|1
5390333|NCT03262012|18561619|P1|Overall Study|Protocol Discontinuation Criteria|0
5390334|NCT03262012|18561616|P4|Overall Study|Lack of Efficacy|2
5390335|NCT03262012|18561617|P3|Overall Study|Lack of Efficacy|1
5390336|NCT03262012|18561618|P2|Overall Study|Lack of Efficacy|5
5390337|NCT03262012|18561619|P1|Overall Study|Lack of Efficacy|0
5390338|NCT03262012|18561616|P4|Overall Study|Physician Decision|0
5390339|NCT03262012|18561617|P3|Overall Study|Physician Decision|1
5390340|NCT03262012|18561618|P2|Overall Study|Physician Decision|5
5390341|NCT03262012|18561619|P1|Overall Study|Physician Decision|2
5390342|NCT03262012|18561616|P4|Overall Study|Adverse Event|6
5390343|NCT03262012|18561617|P3|Overall Study|Adverse Event|4
5390344|NCT03262012|18561618|P2|Overall Study|Adverse Event|12
5390345|NCT03262012|18561619|P1|Overall Study|Adverse Event|10
5390346|NCT03262012|18561616|P4|Overall Study|Withdrawal by Subject|7
5390347|NCT03262012|18561617|P3|Overall Study|Withdrawal by Subject|8
5390348|NCT03262012|18561618|P2|Overall Study|Withdrawal by Subject|13
5390349|NCT03262012|18561619|P1|Overall Study|Withdrawal by Subject|15
5390350|NCT03261531|18561642|P1|Overall Study|Withdrawal by Subject|4
5390351|NCT03261167|18561660|P2|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
5390352|NCT03261167|18561661|P1|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
5390353|NCT03261167|18561660|P2|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
5390354|NCT03261167|18561661|P1|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
5390355|NCT03261167|18561660|P2|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
5390356|NCT03261167|18561661|P1|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
5390357|NCT03261167|18561660|P2|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
5390358|NCT03261167|18561661|P1|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
5390359|NCT03261167|18561660|P2|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
5390360|NCT03261167|18561661|P1|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
5390361|NCT03260894|18561699|P2|Overall Study|On-going at clinical cut off date|31
5390362|NCT03260894|18561700|P1|Overall Study|On-going at clinical cut off date|36
5390363|NCT03260894|18561699|P2|Overall Study|Withdrawal by Subject|11
5390364|NCT03260894|18561700|P1|Overall Study|Withdrawal by Subject|4
5390365|NCT03260894|18561699|P2|Overall Study|Death|8
5390366|NCT03260894|18561700|P1|Overall Study|Death|6
5390367|NCT03260868|18561712|P2|Overall Study|Other than specified above|0
5390368|NCT03260868|18561713|P1|Overall Study|Other than specified above|1
5390369|NCT03260868|18561712|P2|Overall Study|Study Terminated By Sponsor|1
5390370|NCT03260868|18561713|P1|Overall Study|Study Terminated By Sponsor|2
5390371|NCT03260868|18561712|P2|Overall Study|Poor Compliance to Protocol|2
5390372|NCT03260868|18561713|P1|Overall Study|Poor Compliance to Protocol|0
5390373|NCT03260205|18561835|P5|Overall Study|Participant Who Did Not Received AnyDose|1
5390374|NCT03260205|18561836|P4|Overall Study|Participant Who Did Not Received AnyDose|3
5390375|NCT03260205|18561837|P3|Overall Study|Participant Who Did Not Received AnyDose|2
5390376|NCT03260205|18561838|P2|Overall Study|Participant Who Did Not Received AnyDose|1
5390377|NCT03260205|18561839|P1|Overall Study|Participant Who Did Not Received AnyDose|1
5390378|NCT03260205|18561835|P5|Overall Study|Other: Unspecified|1
5390379|NCT03260205|18561836|P4|Overall Study|Other: Unspecified|1
5390380|NCT03260205|18561837|P3|Overall Study|Other: Unspecified|3
5390381|NCT03260205|18561838|P2|Overall Study|Other: Unspecified|0
5390382|NCT03260205|18561839|P1|Overall Study|Other: Unspecified|0
5390383|NCT03260205|18561835|P5|Overall Study|Withdrawal by Participant or Parent/LAR|2
5390384|NCT03260205|18561836|P4|Overall Study|Withdrawal by Participant or Parent/LAR|0
5390385|NCT03260205|18561837|P3|Overall Study|Withdrawal by Participant or Parent/LAR|1
5390386|NCT03260205|18561838|P2|Overall Study|Withdrawal by Participant or Parent/LAR|5
5390387|NCT03260205|18561839|P1|Overall Study|Withdrawal by Participant or Parent/LAR|4
5390388|NCT03260205|18561835|P5|Overall Study|Protocol Violation|1
5390389|NCT03260205|18561836|P4|Overall Study|Protocol Violation|0
5390390|NCT03260205|18561837|P3|Overall Study|Protocol Violation|2
5390391|NCT03260205|18561838|P2|Overall Study|Protocol Violation|0
5390392|NCT03260205|18561839|P1|Overall Study|Protocol Violation|0
5390393|NCT03260205|18561835|P5|Overall Study|Lost to Follow-up|5
5390394|NCT03260205|18561836|P4|Overall Study|Lost to Follow-up|1
5390395|NCT03260205|18561837|P3|Overall Study|Lost to Follow-up|1
5390396|NCT03260205|18561838|P2|Overall Study|Lost to Follow-up|2
5390397|NCT03260205|18561839|P1|Overall Study|Lost to Follow-up|2
5390398|NCT03260205|18561835|P5|Overall Study|Adverse Event|4
5390399|NCT03260205|18561836|P4|Overall Study|Adverse Event|2
5390400|NCT03260205|18561837|P3|Overall Study|Adverse Event|2
5390401|NCT03260205|18561838|P2|Overall Study|Adverse Event|0
5390402|NCT03260205|18561839|P1|Overall Study|Adverse Event|2
5390403|NCT03259555|18561902|P2|Overall Study|Other|0
5390404|NCT03259555|18561903|P1|Overall Study|Other|1
5390405|NCT03259555|18561902|P2|Overall Study|Physician Decision|2
5390406|NCT03259555|18561903|P1|Overall Study|Physician Decision|1
5390407|NCT03259555|18561902|P2|Overall Study|Withdrawal by Subject|16
5390408|NCT03259555|18561903|P1|Overall Study|Withdrawal by Subject|19
5390409|NCT03259555|18561902|P2|Overall Study|Progressive Disease|2
5390410|NCT03259555|18561903|P1|Overall Study|Progressive Disease|0
5390411|NCT03259555|18561902|P2|Overall Study|Non-Compliance With Study Drug|0
5390412|NCT03259555|18561903|P1|Overall Study|Non-Compliance With Study Drug|1
5390413|NCT03259555|18561902|P2|Overall Study|Lost to Follow-up|2
5390414|NCT03259555|18561903|P1|Overall Study|Lost to Follow-up|0
5390415|NCT03259555|18561902|P2|Overall Study|Lack of Efficacy|4
5390416|NCT03259555|18561903|P1|Overall Study|Lack of Efficacy|6
5390417|NCT03259555|18561902|P2|Overall Study|Adverse Event|4
5390418|NCT03259555|18561903|P1|Overall Study|Adverse Event|6
5390419|NCT03259490|18561913|P2|Period 2|Protocol Violation|0
5390420|NCT03259490|18561914|P1|Period 2|Protocol Violation|1
5390421|NCT03259490|18561913|P2|Period 1|Withdrawal by Subject|1
5390422|NCT03259490|18561914|P1|Period 1|Withdrawal by Subject|0
5390423|NCT03259087|18561982|P5|Period 2 of Part 2|Adverse Event|1
5390424|NCT03259087|18561983|P4|Period 2 of Part 2|Adverse Event|0
5390425|NCT03259087|18561984|P3|Period 2 of Part 2|Adverse Event|0
5390426|NCT03259087|18561985|P2|Period 2 of Part 2|Adverse Event|0
5390427|NCT03259087|18561986|P1|Period 2 of Part 2|Adverse Event|0
5390428|NCT03259087|18561982|P5|Part 1 and Period 1 of Part 2|Adverse Event|1
5390429|NCT03259087|18561983|P4|Part 1 and Period 1 of Part 2|Adverse Event|0
5390430|NCT03259087|18561984|P3|Part 1 and Period 1 of Part 2|Adverse Event|0
5390431|NCT03259087|18561985|P2|Part 1 and Period 1 of Part 2|Adverse Event|0
5390432|NCT03259087|18561986|P1|Part 1 and Period 1 of Part 2|Adverse Event|0
5390433|NCT03258814|18562114|P3|Overall Study|Early Termination|10
5390434|NCT03258814|18562115|P2|Overall Study|Early Termination|3
5390435|NCT03258814|18562116|P1|Overall Study|Early Termination|4
5390436|NCT03258762|18562171|P2|Overall Study|Lost to Follow-up|1
5390437|NCT03258762|18562172|P1|Overall Study|Lost to Follow-up|0
5390438|NCT03258710|18562232|P1|Overall Study|Physician Decision|1
5390439|NCT03258710|18562232|P1|Overall Study|Protocol-defined stopping criteria|1
5390440|NCT03258710|18562232|P1|Overall Study|Adverse Event|1
5390441|NCT03257995|18562326|P6|Overall Study|Protocol deviation|2
5390442|NCT03257995|18562327|P5|Overall Study|Protocol deviation|0
5390443|NCT03257995|18562328|P4|Overall Study|Protocol deviation|0
5390444|NCT03257995|18562329|P3|Overall Study|Protocol deviation|0
5390445|NCT03257995|18562330|P2|Overall Study|Protocol deviation|0
5390446|NCT03257995|18562331|P1|Overall Study|Protocol deviation|0
5390447|NCT03257995|18562326|P6|Overall Study|Adverse Event|0
5390448|NCT03257995|18562327|P5|Overall Study|Adverse Event|0
5390449|NCT03257995|18562328|P4|Overall Study|Adverse Event|0
5390450|NCT03257995|18562329|P3|Overall Study|Adverse Event|0
5390451|NCT03257995|18562330|P2|Overall Study|Adverse Event|1
5390452|NCT03257995|18562331|P1|Overall Study|Adverse Event|0
5390453|NCT03257865|18562381|P2|Overall Study|Lost to Follow-up|4
5390454|NCT03257865|18562382|P1|Overall Study|Lost to Follow-up|4
5390455|NCT03257865|18562381|P2|Overall Study|Other|1
5390456|NCT03257865|18562382|P1|Overall Study|Other|0
5390457|NCT03257865|18562381|P2|Overall Study|Physician Decision|1
5390458|NCT03257865|18562382|P1|Overall Study|Physician Decision|3
5390459|NCT03257865|18562381|P2|Overall Study|Withdrawal by Subject|17
5390460|NCT03257865|18562382|P1|Overall Study|Withdrawal by Subject|23
5390461|NCT03257865|18562381|P2|Overall Study|Non-compliance with Study Drug|2
5390462|NCT03257865|18562382|P1|Overall Study|Non-compliance with Study Drug|0
5390463|NCT03257865|18562381|P2|Overall Study|Lack of Efficacy|2
5390464|NCT03257865|18562382|P1|Overall Study|Lack of Efficacy|1
5390465|NCT03257865|18562381|P2|Overall Study|Adverse Event|8
5390466|NCT03257865|18562382|P1|Overall Study|Adverse Event|4
5390467|NCT03257813|18562392|P2|Overall Study|Protocol Violation|3
5390468|NCT03257813|18562393|P1|Overall Study|Protocol Violation|6
5390469|NCT03257657|18562415|P2|Overall Study|Noted not eligible right after enrolled|1
5390470|NCT03257657|18562416|P1|Overall Study|Noted not eligible right after enrolled|0
5390471|NCT03257657|18562415|P2|Overall Study|Withdrawn|1
5390472|NCT03257657|18562416|P1|Overall Study|Withdrawn|0
5390473|NCT03257657|18562415|P2|Overall Study|Lost to Follow-up|3
5390474|NCT03257657|18562416|P1|Overall Study|Lost to Follow-up|0
5390475|NCT03257631|18562447|P4|Overall Study|Still on Study|4
5390476|NCT03257631|18562448|P3|Overall Study|Still on Study|4
5390477|NCT03257631|18562449|P2|Overall Study|Still on Study|2
5390478|NCT03257631|18562450|P1|Overall Study|Still on Study|3
5390479|NCT03257631|18562447|P4|Overall Study|Lost to Follow-up|0
5390480|NCT03257631|18562448|P3|Overall Study|Lost to Follow-up|1
5390481|NCT03257631|18562449|P2|Overall Study|Lost to Follow-up|0
5390482|NCT03257631|18562450|P1|Overall Study|Lost to Follow-up|0
5390483|NCT03257631|18562447|P4|Overall Study|Withdrawal by Parent/Guardian|1
5390484|NCT03257631|18562448|P3|Overall Study|Withdrawal by Parent/Guardian|4
5390485|NCT03257631|18562449|P2|Overall Study|Withdrawal by Parent/Guardian|2
5390486|NCT03257631|18562450|P1|Overall Study|Withdrawal by Parent/Guardian|0
5390487|NCT03257631|18562447|P4|Overall Study|Progressive Disease|0
5390488|NCT03257631|18562448|P3|Overall Study|Progressive Disease|1
5390489|NCT03257631|18562449|P2|Overall Study|Progressive Disease|0
5390490|NCT03257631|18562450|P1|Overall Study|Progressive Disease|0
5390491|NCT03257631|18562447|P4|Overall Study|Death|5
5390492|NCT03257631|18562448|P3|Overall Study|Death|13
5390493|NCT03257631|18562449|P2|Overall Study|Death|5
5390494|NCT03257631|18562450|P1|Overall Study|Death|8
5390495|NCT03257410|18562486|P2|Overall Study|Other|1
5390496|NCT03257410|18562487|P1|Overall Study|Other|0
5390497|NCT03257410|18562486|P2|Overall Study|Miscellaneous|2
5390498|NCT03257410|18562487|P1|Overall Study|Miscellaneous|2
5390499|NCT03257410|18562486|P2|Overall Study|Missing 3 consecutive study treatments|6
5390500|NCT03257410|18562487|P1|Overall Study|Missing 3 consecutive study treatments|5
5390501|NCT03257410|18562486|P2|Overall Study|Change to another dialysis center|2
5390502|NCT03257410|18562487|P1|Overall Study|Change to another dialysis center|2
5390503|NCT03257410|18562486|P2|Overall Study|Death|2
5390504|NCT03257410|18562487|P1|Overall Study|Death|3
5390505|NCT03257410|18562486|P2|Overall Study|Switch to peritoneal dialysis|0
5390506|NCT03257410|18562487|P1|Overall Study|Switch to peritoneal dialysis|1
5390507|NCT03257410|18562486|P2|Overall Study|Renal transplantation|0
5390508|NCT03257410|18562487|P1|Overall Study|Renal transplantation|2
5390509|NCT03257410|18562486|P2|Overall Study|Physician Decision|1
5390510|NCT03257410|18562487|P1|Overall Study|Physician Decision|1
5390511|NCT03257410|18562486|P2|Overall Study|Withdrawal by Subject|2
5390512|NCT03257410|18562487|P1|Overall Study|Withdrawal by Subject|1
5390513|NCT03257410|18562486|P2|Overall Study|Lost to Follow-up|0
5390514|NCT03257410|18562487|P1|Overall Study|Lost to Follow-up|1
5390515|NCT03257410|18562486|P2|Overall Study|Protocol Violation|2
5390516|NCT03257410|18562487|P1|Overall Study|Protocol Violation|1
5390517|NCT03257410|18562486|P2|Overall Study|Adverse Event|3
5390518|NCT03257410|18562487|P1|Overall Study|Adverse Event|2
5390519|NCT03257358|18562629|P2|Overall Study|No longer requires treatment|1
5390520|NCT03257358|18562630|P1|Overall Study|No longer requires treatment|0
5390521|NCT03257358|18562629|P2|Overall Study|New therapy for study indication|0
5390522|NCT03257358|18562630|P1|Overall Study|New therapy for study indication|1
5390523|NCT03257358|18562629|P2|Overall Study|Withdrawal of informed consent|5
5390524|NCT03257358|18562630|P1|Overall Study|Withdrawal of informed consent|9
5390525|NCT03257358|18562629|P2|Overall Study|Withdrawal by Subject|3
5390526|NCT03257358|18562630|P1|Overall Study|Withdrawal by Subject|8
5390527|NCT03257358|18562629|P2|Overall Study|Technical problems|1
5390528|NCT03257358|18562630|P1|Overall Study|Technical problems|4
5390529|NCT03257358|18562629|P2|Overall Study|Protocol Violation|3
5390530|NCT03257358|18562630|P1|Overall Study|Protocol Violation|5
5390531|NCT03257358|18562629|P2|Overall Study|Physician Decision|2
5390532|NCT03257358|18562630|P1|Overall Study|Physician Decision|2
5390533|NCT03257358|18562629|P2|Overall Study|Non-compliance with fingolimod treatment|2
5390534|NCT03257358|18562630|P1|Overall Study|Non-compliance with fingolimod treatment|4
5390535|NCT03257358|18562629|P2|Overall Study|Lost to Follow-up|4
5390536|NCT03257358|18562630|P1|Overall Study|Lost to Follow-up|12
5390537|NCT03257358|18562629|P2|Overall Study|Lack of Efficacy|1
5390538|NCT03257358|18562630|P1|Overall Study|Lack of Efficacy|1
5390539|NCT03257358|18562629|P2|Overall Study|Adverse Event|12
5390540|NCT03257358|18562630|P1|Overall Study|Adverse Event|25
5390541|NCT03256851|18562758|P2|Overall Study|Withdrawal by Subject|0
5390542|NCT03256851|18562759|P1|Overall Study|Withdrawal by Subject|1
5390543|NCT03256695|18562771|P1|Overall Study|Other than specified|3
5390544|NCT03256695|18562771|P1|Overall Study|Protocol Violation|5
5390545|NCT03256695|18562771|P1|Overall Study|Lack of Efficacy|3
5390546|NCT03256695|18562771|P1|Overall Study|Lost to Follow-up|3
5390547|NCT03256695|18562771|P1|Overall Study|Non-compliance with study drug|1
5390548|NCT03256695|18562771|P1|Overall Study|Withdrawal by Subject|14
5390549|NCT03256695|18562771|P1|Overall Study|Death|2
5390550|NCT03256695|18562771|P1|Overall Study|Adverse Event|8
5390551|NCT03256552|18562779|P1|Overall Study|Withdrawal by Subject|2
5390552|NCT03256552|18562779|P1|Overall Study|Adverse Event|1
5390553|NCT03256552|18562779|P1|Overall Study|Physician Decision|1
5390554|NCT03256552|18562779|P1|Overall Study|Protocol Violation|1
5390555|NCT03256526|18562804|P3|Overall Study|Lost to Follow-up|2
5390556|NCT03256526|18562805|P2|Overall Study|Lost to Follow-up|0
5390557|NCT03256526|18562806|P1|Overall Study|Lost to Follow-up|1
5390558|NCT03256526|18562804|P3|Overall Study|Adverse Event|1
5390559|NCT03256526|18562805|P2|Overall Study|Adverse Event|0
5390560|NCT03256526|18562806|P1|Overall Study|Adverse Event|1
5390561|NCT03255980|18562888|P4|Overall Study|Withdrawal by Subject|3
5390562|NCT03255980|18562889|P3|Overall Study|Withdrawal by Subject|0
5390563|NCT03255980|18562890|P2|Overall Study|Withdrawal by Subject|1
5390564|NCT03255980|18562891|P1|Overall Study|Withdrawal by Subject|0
5390565|NCT03255980|18562888|P4|Overall Study|Lost to Follow-up|3
5390566|NCT03255980|18562889|P3|Overall Study|Lost to Follow-up|0
5390567|NCT03255980|18562890|P2|Overall Study|Lost to Follow-up|1
5390568|NCT03255980|18562891|P1|Overall Study|Lost to Follow-up|1
5390569|NCT03255980|18562888|P4|Overall Study|Lack of compliance to study or assessmen|0
5390570|NCT03255980|18562889|P3|Overall Study|Lack of compliance to study or assessmen|0
5390571|NCT03255980|18562890|P2|Overall Study|Lack of compliance to study or assessmen|1
5390572|NCT03255980|18562891|P1|Overall Study|Lack of compliance to study or assessmen|0
5390573|NCT03255980|18562888|P4|Overall Study|Adverse Event|1
5390574|NCT03255980|18562889|P3|Overall Study|Adverse Event|0
5390575|NCT03255980|18562890|P2|Overall Study|Adverse Event|1
5390576|NCT03255980|18562891|P1|Overall Study|Adverse Event|1
5390577|NCT03255980|18562888|P4|Overall Study|Grade =>3 Skin Toxicity|5
5390578|NCT03255980|18562889|P3|Overall Study|Grade =>3 Skin Toxicity|6
5390579|NCT03255980|18562890|P2|Overall Study|Grade =>3 Skin Toxicity|4
5390580|NCT03255980|18562891|P1|Overall Study|Grade =>3 Skin Toxicity|1
5390581|NCT03255824|18562908|P2|Overall Study|Under-sedation|1
5390582|NCT03255824|18562909|P1|Overall Study|Under-sedation|2
5390583|NCT03255733|18562937|P1|Overall Study|Lost to Follow-up|4
5390584|NCT03255655|18562944|P2|Overall Study|Lost to Follow-up|4
5390585|NCT03255655|18562945|P1|Overall Study|Lost to Follow-up|7
5390586|NCT03255382|18562955|P2|Overall Study|Other|0
5390587|NCT03255382|18562956|P1|Overall Study|Other|6
5390588|NCT03255382|18562955|P2|Overall Study|Withdrawal by Subject|0
5390589|NCT03255382|18562956|P1|Overall Study|Withdrawal by Subject|2
5390590|NCT03255382|18562955|P2|Overall Study|Lost to Follow-up|0
5390591|NCT03255382|18562956|P1|Overall Study|Lost to Follow-up|2
5390592|NCT03255382|18562955|P2|Overall Study|Adverse Event|0
5390593|NCT03255382|18562956|P1|Overall Study|Adverse Event|3
5390594|NCT03255291|18563130|P6|Overall Study|Baseline data collection issues|0
5390595|NCT03255291|18563131|P5|Overall Study|Baseline data collection issues|2
5390596|NCT03255291|18563132|P4|Overall Study|Baseline data collection issues|0
5390597|NCT03255291|18563133|P3|Overall Study|Baseline data collection issues|0
5390598|NCT03255291|18563134|P2|Overall Study|Baseline data collection issues|0
5390599|NCT03255291|18563135|P1|Overall Study|Baseline data collection issues|3
5390600|NCT03255291|18563130|P6|Overall Study|Determined to be ineligible|10
5390601|NCT03255291|18563131|P5|Overall Study|Determined to be ineligible|5
5390602|NCT03255291|18563132|P4|Overall Study|Determined to be ineligible|6
5390603|NCT03255291|18563133|P3|Overall Study|Determined to be ineligible|6
5390604|NCT03255291|18563134|P2|Overall Study|Determined to be ineligible|12
5390605|NCT03255291|18563135|P1|Overall Study|Determined to be ineligible|10
5390606|NCT03255187|18563168|P2|Period From First to Second Follow-up|Withdrawal by Subject|1
5390607|NCT03255187|18563169|P1|Period From First to Second Follow-up|Withdrawal by Subject|0
5390608|NCT03255187|18563168|P2|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
5390609|NCT03255187|18563169|P1|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
5390610|NCT03254602|18563228|P1|Overall Study|Lost to Follow-up|4
5390611|NCT03254459|18563236|P2|Overall Study|Miscellaneous|1
5390612|NCT03254459|18563237|P1|Overall Study|Miscellaneous|0
5390613|NCT03254459|18563236|P2|Overall Study|Lost to Follow-up|1
5390614|NCT03254459|18563237|P1|Overall Study|Lost to Follow-up|0
5390615|NCT03254459|18563236|P2|Overall Study|Withdrawal by Subject Consent|1
5390616|NCT03254459|18563237|P1|Overall Study|Withdrawal by Subject Consent|3
5390617|NCT03254459|18563236|P2|Overall Study|Adverse Event|20
5390618|NCT03254459|18563237|P1|Overall Study|Adverse Event|7
5390619|NCT03254134|18563262|P2|Overall Study|Not eligible patients|3630
5390620|NCT03254134|18563263|P1|Overall Study|Not eligible patients|599
5390621|NCT03252015|18563302|P4|Overall Study|Adverse Event|1
5390622|NCT03252015|18563303|P3|Overall Study|Adverse Event|0
5390623|NCT03252015|18563304|P2|Overall Study|Adverse Event|0
5390624|NCT03252015|18563305|P1|Overall Study|Adverse Event|1
5390625|NCT03252015|18563302|P4|Overall Study|Withdrawal by Subject|0
5390626|NCT03252015|18563303|P3|Overall Study|Withdrawal by Subject|1
5390627|NCT03252015|18563304|P2|Overall Study|Withdrawal by Subject|1
5390628|NCT03252015|18563305|P1|Overall Study|Withdrawal by Subject|0
5390629|NCT03251963|18563343|P2|Overall Study|bled prior to Xa level|2
5390630|NCT03251963|18563344|P1|Overall Study|bled prior to Xa level|1
5390631|NCT03251963|18563343|P2|Overall Study|no peak Xa level drawn|0
5390632|NCT03251963|18563344|P1|Overall Study|no peak Xa level drawn|2
5390633|NCT03251963|18563343|P2|Overall Study|inappropriate Xa level timing|3
5390634|NCT03251963|18563344|P1|Overall Study|inappropriate Xa level timing|6
5390635|NCT03251482|18563363|P5|Overall Study|Withdrawal by Subject|0
5390636|NCT03251482|18563364|P4|Overall Study|Withdrawal by Subject|0
5390637|NCT03251482|18563365|P3|Overall Study|Withdrawal by Subject|0
5390638|NCT03251482|18563366|P2|Overall Study|Withdrawal by Subject|1
5390639|NCT03251482|18563367|P1|Overall Study|Withdrawal by Subject|0
5390640|NCT03250182|18563524|P1|Overall Study|Withdrawal by Subject|1
5390641|NCT03249935|18563548|P1|Overall Study|Protocol Violation|5
5390642|NCT03249935|18563548|P1|Overall Study|Negative for chlamydia at enrollment|4
5390643|NCT03249935|18563548|P1|Overall Study|Discharged from facility early|36
5390644|NCT03249909|18563557|P3|Overall Study|Lost to Follow-up|0
5390645|NCT03249909|18563558|P2|Overall Study|Lost to Follow-up|1
5390646|NCT03249909|18563559|P1|Overall Study|Lost to Follow-up|0
5390647|NCT03249909|18563557|P3|Overall Study|Adverse Event|0
5390648|NCT03249909|18563558|P2|Overall Study|Adverse Event|0
5390649|NCT03249909|18563559|P1|Overall Study|Adverse Event|3
5390650|NCT03249909|18563557|P3|Overall Study|Withdrawal by Subject|0
5390651|NCT03249909|18563558|P2|Overall Study|Withdrawal by Subject|0
5390652|NCT03249909|18563559|P1|Overall Study|Withdrawal by Subject|3
5390653|NCT03249454|18563603|P11|Overall Study|Withdrawal by Subject|1
5390654|NCT03249454|18563604|P10|Overall Study|Withdrawal by Subject|1
5390655|NCT03249454|18563605|P9|Overall Study|Withdrawal by Subject|0
5390656|NCT03249454|18563606|P8|Overall Study|Withdrawal by Subject|0
5390657|NCT03249454|18563607|P7|Overall Study|Withdrawal by Subject|0
5390658|NCT03249454|18563608|P6|Overall Study|Withdrawal by Subject|0
5390659|NCT03249454|18563609|P5|Overall Study|Withdrawal by Subject|0
5390660|NCT03249454|18563610|P4|Overall Study|Withdrawal by Subject|0
5390661|NCT03249454|18563611|P3|Overall Study|Withdrawal by Subject|0
5390662|NCT03249454|18563612|P2|Overall Study|Withdrawal by Subject|0
5390663|NCT03249454|18563613|P1|Overall Study|Withdrawal by Subject|0
5390664|NCT03248882|18563701|P5|Overall Study|Withdrawal by Subject|2
5390665|NCT03248882|18563702|P4|Overall Study|Withdrawal by Subject|4
5390666|NCT03248882|18563703|P3|Overall Study|Withdrawal by Subject|3
5390667|NCT03248882|18563704|P2|Overall Study|Withdrawal by Subject|2
5390668|NCT03248882|18563705|P1|Overall Study|Withdrawal by Subject|2
5390669|NCT03248882|18563701|P5|Overall Study|Protocol Violation|1
5390670|NCT03248882|18563702|P4|Overall Study|Protocol Violation|0
5390671|NCT03248882|18563703|P3|Overall Study|Protocol Violation|2
5390672|NCT03248882|18563704|P2|Overall Study|Protocol Violation|0
5390673|NCT03248882|18563705|P1|Overall Study|Protocol Violation|2
5390674|NCT03248882|18563701|P5|Overall Study|Lost to Follow-up|1
5390675|NCT03248882|18563702|P4|Overall Study|Lost to Follow-up|0
5390676|NCT03248882|18563703|P3|Overall Study|Lost to Follow-up|0
5390677|NCT03248882|18563704|P2|Overall Study|Lost to Follow-up|0
5390678|NCT03248882|18563705|P1|Overall Study|Lost to Follow-up|0
5390679|NCT03248882|18563701|P5|Overall Study|Adverse Event|9
5390680|NCT03248882|18563702|P4|Overall Study|Adverse Event|6
5390681|NCT03248882|18563703|P3|Overall Study|Adverse Event|2
5390682|NCT03248882|18563704|P2|Overall Study|Adverse Event|3
5390683|NCT03248882|18563705|P1|Overall Study|Adverse Event|3
5390684|NCT03248492|18563747|P5|Overall Study|Other|0
5390685|NCT03248492|18563748|P4|Overall Study|Other|4
5390686|NCT03248492|18563749|P3|Overall Study|Other|0
5390687|NCT03248492|18563750|P2|Overall Study|Other|1
5390688|NCT03248492|18563751|P1|Overall Study|Other|0
5390689|NCT03248492|18563747|P5|Overall Study|Death|0
5390690|NCT03248492|18563748|P4|Overall Study|Death|6
5390691|NCT03248492|18563749|P3|Overall Study|Death|0
5390692|NCT03248492|18563750|P2|Overall Study|Death|0
5390693|NCT03248492|18563751|P1|Overall Study|Death|1
5390694|NCT03248492|18563747|P5|Overall Study|Physician Decision|0
5390695|NCT03248492|18563748|P4|Overall Study|Physician Decision|2
5390696|NCT03248492|18563749|P3|Overall Study|Physician Decision|1
5390697|NCT03248492|18563750|P2|Overall Study|Physician Decision|0
5390698|NCT03248492|18563751|P1|Overall Study|Physician Decision|1
5390699|NCT03248492|18563747|P5|Overall Study|Withdrawal by Subject|1
5390700|NCT03248492|18563748|P4|Overall Study|Withdrawal by Subject|3
5390701|NCT03248492|18563749|P3|Overall Study|Withdrawal by Subject|0
5390702|NCT03248492|18563750|P2|Overall Study|Withdrawal by Subject|3
5390703|NCT03248492|18563751|P1|Overall Study|Withdrawal by Subject|3
5390704|NCT03248492|18563747|P5|Overall Study|Adverse Event|1
5390705|NCT03248492|18563748|P4|Overall Study|Adverse Event|8
5390706|NCT03248492|18563749|P3|Overall Study|Adverse Event|8
5390707|NCT03248492|18563750|P2|Overall Study|Adverse Event|6
5390708|NCT03248492|18563751|P1|Overall Study|Adverse Event|6
5390709|NCT03248492|18563747|P5|Overall Study|Progressive disease per RECIST v1.1|0
5390710|NCT03248492|18563748|P4|Overall Study|Progressive disease per RECIST v1.1|22
5390711|NCT03248492|18563749|P3|Overall Study|Progressive disease per RECIST v1.1|9
5390712|NCT03248492|18563750|P2|Overall Study|Progressive disease per RECIST v1.1|12
5390713|NCT03248492|18563751|P1|Overall Study|Progressive disease per RECIST v1.1|16
5390714|NCT03248492|18563747|P5|Overall Study|Ongoing|2
5390715|NCT03248492|18563748|P4|Overall Study|Ongoing|85
5390716|NCT03248492|18563749|P3|Overall Study|Ongoing|3
5390717|NCT03248492|18563750|P2|Overall Study|Ongoing|26
5390718|NCT03248492|18563751|P1|Overall Study|Ongoing|23
5390719|NCT03247816|18563817|P1|Overall Study|Missing Feraccru stop date|3
5390720|NCT03247816|18563817|P1|Overall Study|Lost to Follow-up|10
5390721|NCT03247816|18563817|P1|Overall Study|Lack of Efficacy|1
5390722|NCT03247816|18563817|P1|Overall Study|Physician Decision|3
5390723|NCT03247816|18563817|P1|Overall Study|Adverse Event|12
5390724|NCT03247673|18563873|P3|Overall Study|Lost to Follow-up|1
5390725|NCT03247673|18563874|P2|Overall Study|Lost to Follow-up|0
5390726|NCT03247673|18563875|P1|Overall Study|Lost to Follow-up|0
5390727|NCT03247673|18563873|P3|Overall Study|Withdrawal by Subject|3
5390728|NCT03247673|18563874|P2|Overall Study|Withdrawal by Subject|0
5390729|NCT03247673|18563875|P1|Overall Study|Withdrawal by Subject|1
5390730|NCT03246724|18563899|P4|Overall Study|Re-consented to participate|1
5390731|NCT03246724|18563900|P3|Overall Study|Re-consented to participate|0
5390732|NCT03246724|18563901|P2|Overall Study|Re-consented to participate|0
5390733|NCT03246724|18563902|P1|Overall Study|Re-consented to participate|0
5390734|NCT03246724|18563899|P4|Overall Study|Unable to obtain medication timely|1
5390735|NCT03246724|18563900|P3|Overall Study|Unable to obtain medication timely|2
5390736|NCT03246724|18563901|P2|Overall Study|Unable to obtain medication timely|2
5390737|NCT03246724|18563902|P1|Overall Study|Unable to obtain medication timely|0
5390738|NCT03246724|18563899|P4|Overall Study|Transferred to other arm|0
5390739|NCT03246724|18563900|P3|Overall Study|Transferred to other arm|1
5390740|NCT03246724|18563901|P2|Overall Study|Transferred to other arm|0
5390741|NCT03246724|18563902|P1|Overall Study|Transferred to other arm|0
5390742|NCT03246724|18563899|P4|Overall Study|Study completed before surgical date|1
5390743|NCT03246724|18563900|P3|Overall Study|Study completed before surgical date|8
5390744|NCT03246724|18563901|P2|Overall Study|Study completed before surgical date|1
5390745|NCT03246724|18563902|P1|Overall Study|Study completed before surgical date|2
5390746|NCT03246724|18563899|P4|Overall Study|Ineligible on day of surgery|3
5390747|NCT03246724|18563900|P3|Overall Study|Ineligible on day of surgery|0
5390748|NCT03246724|18563901|P2|Overall Study|Ineligible on day of surgery|2
5390749|NCT03246724|18563902|P1|Overall Study|Ineligible on day of surgery|7
5390750|NCT03246724|18563899|P4|Overall Study|Withdrawal by Subject|2
5390751|NCT03246724|18563900|P3|Overall Study|Withdrawal by Subject|4
5390752|NCT03246724|18563901|P2|Overall Study|Withdrawal by Subject|2
5390753|NCT03246724|18563902|P1|Overall Study|Withdrawal by Subject|5
5390754|NCT03246672|18563928|P1|Overall Study|Lost to Follow-up|2
5390755|NCT03246152|18563934|P1|Overall Study|Protocol Violation|1
5390756|NCT03246152|18563934|P1|Overall Study|Lost to Follow-up|2
5390757|NCT03246061|18563942|P2|Overall Study|Still in follow-up|21
5390758|NCT03246061|18563943|P1|Overall Study|Still in follow-up|15
5390759|NCT03245619|18563977|P17|Part A (Up to Day 22)|Physician Decision|0
5390760|NCT03245619|18563978|P16|Part A (Up to Day 22)|Physician Decision|0
5390761|NCT03245619|18563979|P15|Part A (Up to Day 22)|Physician Decision|0
5390762|NCT03245619|18563980|P14|Part A (Up to Day 22)|Physician Decision|0
5390763|NCT03245619|18563981|P13|Part A (Up to Day 22)|Physician Decision|0
5390764|NCT03245619|18563982|P12|Part A (Up to Day 22)|Physician Decision|0
5390765|NCT03245619|18563983|P11|Part A (Up to Day 22)|Physician Decision|0
5390766|NCT03245619|18563984|P10|Part A (Up to Day 22)|Physician Decision|0
5390767|NCT03245619|18563985|P9|Part A (Up to Day 22)|Physician Decision|0
5390768|NCT03245619|18563986|P8|Part A (Up to Day 22)|Physician Decision|0
5390769|NCT03245619|18563987|P7|Part A (Up to Day 22)|Physician Decision|0
5390770|NCT03245619|18563988|P6|Part A (Up to Day 22)|Physician Decision|0
5390771|NCT03245619|18563989|P5|Part A (Up to Day 22)|Physician Decision|0
5390772|NCT03245619|18563990|P4|Part A (Up to Day 22)|Physician Decision|0
5390773|NCT03245619|18563991|P3|Part A (Up to Day 22)|Physician Decision|6
5390774|NCT03245619|18563992|P2|Part A (Up to Day 22)|Physician Decision|6
5390775|NCT03245619|18563993|P1|Part A (Up to Day 22)|Physician Decision|4
5390776|NCT03245398|18564267|P2|Overall Study|Travelled to another island|0
5390777|NCT03245398|18564268|P1|Overall Study|Travelled to another island|1
5390778|NCT03244800|18564298|P4|Overall Study|Withdrew treatment|1
5390779|NCT03244800|18564299|P3|Overall Study|Withdrew treatment|0
5390780|NCT03244800|18564300|P2|Overall Study|Withdrew treatment|0
5390781|NCT03244800|18564301|P1|Overall Study|Withdrew treatment|0
5390782|NCT03244800|18564298|P4|Overall Study|Adverse Event|1
5390783|NCT03244800|18564299|P3|Overall Study|Adverse Event|0
5390784|NCT03244800|18564300|P2|Overall Study|Adverse Event|1
5390785|NCT03244800|18564301|P1|Overall Study|Adverse Event|0
5390786|NCT03244618|18564361|P2|Overall Study|Withdrawal by Subject|2
5390787|NCT03244618|18564362|P1|Overall Study|Withdrawal by Subject|0
5390788|NCT03244618|18564361|P2|Overall Study|Protocol Violation|3
5390789|NCT03244618|18564362|P1|Overall Study|Protocol Violation|4
5390790|NCT03244618|18564361|P2|Overall Study|Lost to Follow-up|4
5390791|NCT03244618|18564362|P1|Overall Study|Lost to Follow-up|3
5390792|NCT03243630|18564397|P1|Overall Study|Physician Decision|1
5390793|NCT03243630|18564397|P1|Overall Study|Protocol Violation|1
5390794|NCT03243305|18564405|P1|Overall Study|Early terminations|267
5390795|NCT03243305|18564405|P1|Overall Study|Study Terminated by Sponsor|1
5390796|NCT03243305|18564405|P1|Overall Study|Study method no longer primary method|12
5390797|NCT03243305|18564405|P1|Overall Study|Protocol Violation|22
5390798|NCT03243305|18564405|P1|Overall Study|Physician Decision|22
5390799|NCT03243305|18564405|P1|Overall Study|No sexually active|26
5390800|NCT03243305|18564405|P1|Overall Study|Adverse Event|23
5390801|NCT03243305|18564405|P1|Overall Study|Non-Compliance with Study Drug|38
5390802|NCT03243305|18564405|P1|Overall Study|Pregnancy|104
5390803|NCT03243305|18564405|P1|Overall Study|Withdrawal by Subject|170
5390804|NCT03243305|18564405|P1|Overall Study|Lost to Follow-up|250
5390805|NCT03243084|18564412|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
5390806|NCT03243084|18564413|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
5390807|NCT03242863|18564429|P6|Study Week 1|Withdrawal by Subject|0
5390808|NCT03242863|18564430|P5|Study Week 1|Withdrawal by Subject|3
5390809|NCT03242863|18564431|P4|Study Week 1|Withdrawal by Subject|0
5390810|NCT03242863|18564432|P3|Study Week 1|Withdrawal by Subject|0
5390811|NCT03242863|18564433|P2|Study Week 1|Withdrawal by Subject|1
5390812|NCT03242863|18564434|P1|Study Week 1|Withdrawal by Subject|0
5390813|NCT03242434|18564457|P2|Overall Study|Death|2
5390814|NCT03242434|18564458|P1|Overall Study|Death|0
5390815|NCT03241927|18564470|P2|Overall Study|study terminated|0
5390816|NCT03241927|18564471|P1|Overall Study|study terminated|1
5390817|NCT03241368|18564517|P1|Overall Study|Protocol Violation|1
5390818|NCT03241368|18564517|P1|Overall Study|Withdrawal by Subject|6
5390819|NCT03241368|18564517|P1|Overall Study|Physician Decision|6
5390820|NCT03241368|18564517|P1|Overall Study|Lost to Follow-up|1
5390821|NCT03241368|18564517|P1|Overall Study|MRE Stricture or Patency Capsule Failure|25
5390822|NCT03241342|18564527|P3|Overall Study|not reported|19
5390823|NCT03241342|18564528|P2|Overall Study|not reported|22
5390824|NCT03241342|18564529|P1|Overall Study|not reported|16
5390825|NCT03241342|18564527|P3|Overall Study|sponsor decision|2
5390826|NCT03241342|18564528|P2|Overall Study|sponsor decision|1
5390827|NCT03241342|18564529|P1|Overall Study|sponsor decision|0
5390828|NCT03241342|18564527|P3|Overall Study|noncompliance with study drug|1
5390829|NCT03241342|18564528|P2|Overall Study|noncompliance with study drug|1
5390830|NCT03241342|18564529|P1|Overall Study|noncompliance with study drug|2
5390831|NCT03241342|18564527|P3|Overall Study|Lack of Efficacy|1
5390832|NCT03241342|18564528|P2|Overall Study|Lack of Efficacy|0
5390833|NCT03241342|18564529|P1|Overall Study|Lack of Efficacy|0
5390834|NCT03241342|18564527|P3|Overall Study|Adverse Event|4
5390835|NCT03241342|18564528|P2|Overall Study|Adverse Event|8
5390836|NCT03241342|18564529|P1|Overall Study|Adverse Event|5
5390837|NCT03240575|18564541|P4|Overall Study|Other|0
5390838|NCT03240575|18564542|P3|Overall Study|Other|0
5390839|NCT03240575|18564543|P2|Overall Study|Other|1
5390840|NCT03240575|18564544|P1|Overall Study|Other|0
5390841|NCT03240575|18564541|P4|Overall Study|Withdrawal by Subject|1
5390842|NCT03240575|18564542|P3|Overall Study|Withdrawal by Subject|0
5390843|NCT03240575|18564543|P2|Overall Study|Withdrawal by Subject|11
5390844|NCT03240575|18564544|P1|Overall Study|Withdrawal by Subject|2
5390845|NCT03240575|18564541|P4|Overall Study|Adverse Event|1
5390846|NCT03240575|18564542|P3|Overall Study|Adverse Event|0
5390847|NCT03240575|18564543|P2|Overall Study|Adverse Event|2
5390848|NCT03240575|18564544|P1|Overall Study|Adverse Event|0
5390849|NCT03239873|18564566|P2|Overall Study|Protocol Violation|0
5390850|NCT03239873|18564567|P1|Overall Study|Protocol Violation|1
5390851|NCT03239873|18564566|P2|Overall Study|Contraindication to study medication|0
5390852|NCT03239873|18564567|P1|Overall Study|Contraindication to study medication|1
5390853|NCT03239873|18564566|P2|Overall Study|Withdrawal by Subject|0
5390854|NCT03239873|18564567|P1|Overall Study|Withdrawal by Subject|2
5390855|NCT03239873|18564566|P2|Overall Study|Withdrawal by Parent/Guardian|11
5390856|NCT03239873|18564567|P1|Overall Study|Withdrawal by Parent/Guardian|12
5390857|NCT03239873|18564566|P2|Overall Study|Physician Decision|0
5390858|NCT03239873|18564567|P1|Overall Study|Physician Decision|1
5390859|NCT03239873|18564566|P2|Overall Study|Lost to Follow-up|16
5390860|NCT03239873|18564567|P1|Overall Study|Lost to Follow-up|15
5390861|NCT03239483|18564759|P2|Overall Study|Withdrawal by Subject|0
5390862|NCT03239483|18564760|P1|Overall Study|Withdrawal by Subject|1
5390863|NCT03239483|18564759|P2|Overall Study|Lost to Follow-up|0
5390864|NCT03239483|18564760|P1|Overall Study|Lost to Follow-up|1
5390865|NCT03238924|18564781|P2|Overall Study|Withdrawal by Subject|2
5390866|NCT03238924|18564782|P1|Overall Study|Withdrawal by Subject|2
5390867|NCT03238911|18564794|P2|Overall Study|Lost to Follow-up|1
5390868|NCT03238911|18564795|P1|Overall Study|Lost to Follow-up|2
5390869|NCT03238911|18564794|P2|Overall Study|Withdrawal by Subject|2
5390870|NCT03238911|18564795|P1|Overall Study|Withdrawal by Subject|1
5390871|NCT03238781|18564838|P3|Overall Study|Decision by sponsor|0
5390872|NCT03238781|18564839|P2|Overall Study|Decision by sponsor|1
5390873|NCT03238781|18564840|P1|Overall Study|Decision by sponsor|0
5390874|NCT03238781|18564838|P3|Overall Study|Withdrawal by Subject|16
5390875|NCT03238781|18564839|P2|Overall Study|Withdrawal by Subject|14
5390876|NCT03238781|18564840|P1|Overall Study|Withdrawal by Subject|23
5390877|NCT03238781|18564838|P3|Overall Study|Lost to Follow-up|2
5390878|NCT03238781|18564839|P2|Overall Study|Lost to Follow-up|1
5390879|NCT03238781|18564840|P1|Overall Study|Lost to Follow-up|2
5390880|NCT03238781|18564838|P3|Overall Study|Adverse Event|2
5390881|NCT03238781|18564839|P2|Overall Study|Adverse Event|1
5390882|NCT03238781|18564840|P1|Overall Study|Adverse Event|1
5390883|NCT03238352|18564890|P3|Overall Study|Withdrawal by Subject|0
5390884|NCT03238352|18564891|P2|Overall Study|Withdrawal by Subject|1
5390885|NCT03238352|18564892|P1|Overall Study|Withdrawal by Subject|0
5390886|NCT03238352|18564890|P3|Overall Study|Lost to Follow-up|1
5390887|NCT03238352|18564891|P2|Overall Study|Lost to Follow-up|2
5390888|NCT03238352|18564892|P1|Overall Study|Lost to Follow-up|0
5390889|NCT03238001|18564903|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
5390890|NCT03238001|18564903|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
5390891|NCT03238001|18564903|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
5390892|NCT03238001|18564903|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
5390893|NCT03238001|18564903|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
5390894|NCT03238001|18564903|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
5390895|NCT03238001|18564903|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
5390896|NCT03238001|18564903|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
5390897|NCT03237845|18564934|P2|Overall Study|Other Reasons|0
5390898|NCT03237845|18564935|P1|Overall Study|Other Reasons|4
5390899|NCT03237845|18564934|P2|Overall Study|Withdrawal by Subject|3
5390900|NCT03237845|18564935|P1|Overall Study|Withdrawal by Subject|3
5390901|NCT03237845|18564934|P2|Overall Study|Technical Problems|1
5390902|NCT03237845|18564935|P1|Overall Study|Technical Problems|8
5390903|NCT03237845|18564934|P2|Overall Study|Protocol Deviation|1
5390904|NCT03237845|18564935|P1|Overall Study|Protocol Deviation|0
5390905|NCT03237845|18564934|P2|Overall Study|Pregnancy|0
5390906|NCT03237845|18564935|P1|Overall Study|Pregnancy|1
5390907|NCT03237845|18564934|P2|Overall Study|Physician Decision|2
5390908|NCT03237845|18564935|P1|Overall Study|Physician Decision|1
5390909|NCT03237845|18564934|P2|Overall Study|Non-Compliance With Study Treatment|1
5390910|NCT03237845|18564935|P1|Overall Study|Non-Compliance With Study Treatment|0
5390911|NCT03237845|18564934|P2|Overall Study|Not Experienced Moderate/Severe Migraine|31
5390912|NCT03237845|18564935|P1|Overall Study|Not Experienced Moderate/Severe Migraine|26
5390913|NCT03237845|18564934|P2|Overall Study|Lost to Follow-up|10
5390914|NCT03237845|18564935|P1|Overall Study|Lost to Follow-up|13
5390915|NCT03237845|18564934|P2|Overall Study|Adverse Event|1
5390916|NCT03237845|18564935|P1|Overall Study|Adverse Event|0
5390917|NCT03237065|18565065|P2|Overall Study|Unable to obtain venous access|1
5390918|NCT03237065|18565066|P1|Overall Study|Unable to obtain venous access|0
5390919|NCT03237065|18565065|P2|Overall Study|Lost to Follow-up|0
5390920|NCT03237065|18565066|P1|Overall Study|Lost to Follow-up|1
5390921|NCT03237065|18565065|P2|Overall Study|Withdrawal by Subject|0
5390922|NCT03237065|18565066|P1|Overall Study|Withdrawal by Subject|3
5390923|NCT03237065|18565065|P2|Overall Study|Protocol Violation|1
5390924|NCT03237065|18565066|P1|Overall Study|Protocol Violation|0
5390925|NCT03237065|18565065|P2|Overall Study|Adverse Event|2
5390926|NCT03237065|18565066|P1|Overall Study|Adverse Event|0
5390927|NCT03237013|18565109|P3|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
5390928|NCT03237013|18565110|P2|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
5390929|NCT03237013|18565111|P1|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
5390930|NCT03236311|18565160|P2|Overall Study|Adverse Event|1
5390931|NCT03236311|18565161|P1|Overall Study|Adverse Event|0
5390932|NCT03236311|18565160|P2|Overall Study|Study terminated by sponsor|2
5390933|NCT03236311|18565161|P1|Overall Study|Study terminated by sponsor|0
5390934|NCT03235726|18565205|P10|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5390935|NCT03235726|18565206|P9|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5390936|NCT03235726|18565207|P8|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5390937|NCT03235726|18565208|P7|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5390938|NCT03235726|18565209|P6|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5390939|NCT03235726|18565210|P5|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
5390940|NCT03235726|18565211|P4|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5390941|NCT03235726|18565212|P3|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5390942|NCT03235726|18565213|P2|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5390943|NCT03235726|18565214|P1|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
5390944|NCT03235726|18565205|P10|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5390945|NCT03235726|18565206|P9|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5390946|NCT03235726|18565207|P8|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5390947|NCT03235726|18565208|P7|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5390948|NCT03235726|18565209|P6|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5390949|NCT03235726|18565210|P5|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
5390950|NCT03235726|18565211|P4|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5390951|NCT03235726|18565212|P3|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5390952|NCT03235726|18565213|P2|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5390953|NCT03235726|18565214|P1|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
5390954|NCT03235479|18565368|P2|Overall Study|Other Reasons|5
5390955|NCT03235479|18565369|P1|Overall Study|Other Reasons|3
5390956|NCT03235479|18565368|P2|Overall Study|Withdrawal by Subject|2
5390957|NCT03235479|18565369|P1|Overall Study|Withdrawal by Subject|2
5390958|NCT03235479|18565368|P2|Overall Study|Technical Problems|2
5390959|NCT03235479|18565369|P1|Overall Study|Technical Problems|3
5390960|NCT03235479|18565368|P2|Overall Study|Protocol Deviation|3
5390961|NCT03235479|18565369|P1|Overall Study|Protocol Deviation|1
5390962|NCT03235479|18565368|P2|Overall Study|Pregnancy|0
5390963|NCT03235479|18565369|P1|Overall Study|Pregnancy|1
5390964|NCT03235479|18565368|P2|Overall Study|Not Experienced Moderate/Severe Migraine|17
5390965|NCT03235479|18565369|P1|Overall Study|Not Experienced Moderate/Severe Migraine|23
5390966|NCT03235479|18565368|P2|Overall Study|Lost to Follow-up|11
5390967|NCT03235479|18565369|P1|Overall Study|Lost to Follow-up|8
5390968|NCT03235349|18565406|P1|Overall Study|Other|1
5390969|NCT03235349|18565406|P1|Overall Study|Adverse Event|1
5390970|NCT03235284|18565416|P3|Overall Study|Adverse Event|1
5390971|NCT03235284|18565417|P2|Overall Study|Adverse Event|2
5390972|NCT03235284|18565418|P1|Overall Study|Adverse Event|1
5390973|NCT03235115|18565435|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
5390974|NCT03235115|18565436|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5390975|NCT03235115|18565437|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5390976|NCT03235115|18565438|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5390977|NCT03235115|18565439|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5390978|NCT03235115|18565440|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
5390979|NCT03235089|18565460|P2|Overall Study|Physician Decision|2
5390980|NCT03235089|18565461|P1|Overall Study|Physician Decision|2
5390981|NCT03235089|18565460|P2|Overall Study|Lost to Follow-up|1
5390982|NCT03235089|18565461|P1|Overall Study|Lost to Follow-up|1
5390983|NCT03235050|18565502|P5|Overall Study|Other reasons|2
5390984|NCT03235050|18565503|P4|Overall Study|Other reasons|1
5390985|NCT03235050|18565504|P3|Overall Study|Other reasons|0
5390986|NCT03235050|18565505|P2|Overall Study|Other reasons|1
5390987|NCT03235050|18565506|P1|Overall Study|Other reasons|0
5390988|NCT03235050|18565502|P5|Overall Study|Withdrawal by Subject|7
5390989|NCT03235050|18565503|P4|Overall Study|Withdrawal by Subject|5
5390990|NCT03235050|18565504|P3|Overall Study|Withdrawal by Subject|2
5390991|NCT03235050|18565505|P2|Overall Study|Withdrawal by Subject|2
5390992|NCT03235050|18565506|P1|Overall Study|Withdrawal by Subject|3
5390993|NCT03235050|18565502|P5|Overall Study|Lost to Follow-up|0
5390994|NCT03235050|18565503|P4|Overall Study|Lost to Follow-up|2
5390995|NCT03235050|18565504|P3|Overall Study|Lost to Follow-up|1
5390996|NCT03235050|18565505|P2|Overall Study|Lost to Follow-up|2
5390997|NCT03235050|18565506|P1|Overall Study|Lost to Follow-up|1
5390998|NCT03235050|18565502|P5|Overall Study|Death|1
5390999|NCT03235050|18565503|P4|Overall Study|Death|2
5391000|NCT03235050|18565504|P3|Overall Study|Death|0
5391001|NCT03235050|18565505|P2|Overall Study|Death|0
5391002|NCT03235050|18565506|P1|Overall Study|Death|0
5391003|NCT03235050|18565502|P5|Overall Study|Adverse Event|1
5391004|NCT03235050|18565503|P4|Overall Study|Adverse Event|4
5391005|NCT03235050|18565504|P3|Overall Study|Adverse Event|1
5391006|NCT03235050|18565505|P2|Overall Study|Adverse Event|0
5391007|NCT03235050|18565506|P1|Overall Study|Adverse Event|0
5391008|NCT03234465|18565567|P2|Overall Study|Other|8
5391009|NCT03234465|18565568|P1|Overall Study|Other|14
5391010|NCT03234465|18565567|P2|Overall Study|Non-compliance|0
5391011|NCT03234465|18565568|P1|Overall Study|Non-compliance|2
5391012|NCT03234465|18565567|P2|Overall Study|Symptomatic deterioration|1
5391013|NCT03234465|18565568|P1|Overall Study|Symptomatic deterioration|0
5391014|NCT03234465|18565567|P2|Overall Study|Withdrawal by Subject|27
5391015|NCT03234465|18565568|P1|Overall Study|Withdrawal by Subject|12
5391016|NCT03234465|18565567|P2|Overall Study|Lost to Follow-up|1
5391017|NCT03234465|18565568|P1|Overall Study|Lost to Follow-up|1
5391018|NCT03234465|18565567|P2|Overall Study|Death|1
5391019|NCT03234465|18565568|P1|Overall Study|Death|0
5391020|NCT03234465|18565567|P2|Overall Study|Adverse Event|2
5391021|NCT03234465|18565568|P1|Overall Study|Adverse Event|4
5391022|NCT03234036|18565598|P4|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
5391023|NCT03234036|18565599|P3|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
5391024|NCT03234036|18565600|P2|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
5391025|NCT03234036|18565601|P1|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
5391026|NCT03233529|18565772|P1|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
5391027|NCT03233529|18565772|P1|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
5391028|NCT03233438|18565816|P2|Overall Study|No recording of dalbavancin|1
5391029|NCT03233438|18565817|P1|Overall Study|No recording of dalbavancin|0
5391030|NCT03233438|18565816|P2|Overall Study|Withdrawal by Subject|1
5391031|NCT03233438|18565817|P1|Overall Study|Withdrawal by Subject|2
5391032|NCT03233438|18565816|P2|Overall Study|Lost to Follow-up|9
5391033|NCT03233438|18565817|P1|Overall Study|Lost to Follow-up|4
5391034|NCT03233308|18565883|P1|Overall Study|Protocol Violation|1
5391035|NCT03233308|18565883|P1|Overall Study|Adverse Event|1
5391036|NCT03233230|18565899|P4|Overall Study|Lost to Follow-up|0
5391037|NCT03233230|18565900|P3|Overall Study|Lost to Follow-up|0
5391038|NCT03233230|18565901|P2|Overall Study|Lost to Follow-up|3
5391039|NCT03233230|18565902|P1|Overall Study|Lost to Follow-up|0
5391040|NCT03233230|18565899|P4|Overall Study|Withdrawal by Subject|1
5391041|NCT03233230|18565900|P3|Overall Study|Withdrawal by Subject|0
5391042|NCT03233230|18565901|P2|Overall Study|Withdrawal by Subject|2
5391043|NCT03233230|18565902|P1|Overall Study|Withdrawal by Subject|2
5391044|NCT03233230|18565899|P4|Overall Study|Other|3
5391045|NCT03233230|18565900|P3|Overall Study|Other|5
5391046|NCT03233230|18565901|P2|Overall Study|Other|5
5391047|NCT03233230|18565902|P1|Overall Study|Other|5
5391048|NCT03233230|18565899|P4|Overall Study|Lack of Efficacy|0
5391049|NCT03233230|18565900|P3|Overall Study|Lack of Efficacy|0
5391050|NCT03233230|18565901|P2|Overall Study|Lack of Efficacy|0
5391051|NCT03233230|18565902|P1|Overall Study|Lack of Efficacy|1
5391052|NCT03233230|18565899|P4|Overall Study|Protocol Violation|1
5391053|NCT03233230|18565900|P3|Overall Study|Protocol Violation|1
5391054|NCT03233230|18565901|P2|Overall Study|Protocol Violation|2
5391055|NCT03233230|18565902|P1|Overall Study|Protocol Violation|1
5391056|NCT03233230|18565899|P4|Overall Study|Adverse Event|3
5391057|NCT03233230|18565900|P3|Overall Study|Adverse Event|6
5391058|NCT03233230|18565901|P2|Overall Study|Adverse Event|3
5391059|NCT03233230|18565902|P1|Overall Study|Adverse Event|6
5391060|NCT03233009|18566094|P1|Overall Study|Lost to Follow-up|1
5391061|NCT03232983|18566137|P4|Period 4|Withdrawal by Subject|0
5391062|NCT03232983|18566138|P3|Period 4|Withdrawal by Subject|0
5391063|NCT03232983|18566139|P2|Period 4|Withdrawal by Subject|0
5391064|NCT03232983|18566140|P1|Period 4|Withdrawal by Subject|1
5391065|NCT03232983|18566137|P4|Washout Period 2|Withdrawal by Subject|1
5391066|NCT03232983|18566138|P3|Washout Period 2|Withdrawal by Subject|0
5391067|NCT03232983|18566139|P2|Washout Period 2|Withdrawal by Subject|0
5391068|NCT03232983|18566140|P1|Washout Period 2|Withdrawal by Subject|0
5391069|NCT03232983|18566137|P4|Washout Period 2|Physician Decision|0
5391070|NCT03232983|18566138|P3|Washout Period 2|Physician Decision|1
5391071|NCT03232983|18566139|P2|Washout Period 2|Physician Decision|0
5391072|NCT03232983|18566140|P1|Washout Period 2|Physician Decision|0
5391073|NCT03232983|18566137|P4|Period 1|Physician Decision|0
5391074|NCT03232983|18566138|P3|Period 1|Physician Decision|1
5391075|NCT03232983|18566139|P2|Period 1|Physician Decision|0
5391076|NCT03232983|18566140|P1|Period 1|Physician Decision|0
5391077|NCT03232567|18566184|P4|Overall Study|Withdrawal by Subject|0
5391078|NCT03232567|18566185|P3|Overall Study|Withdrawal by Subject|0
5391079|NCT03232567|18566186|P2|Overall Study|Withdrawal by Subject|1
5391080|NCT03232567|18566187|P1|Overall Study|Withdrawal by Subject|0
5391081|NCT03232333|18566209|P1|Overall Study|Withdrawal by Subject|2
5391082|NCT03232333|18566209|P1|Overall Study|Lost to Follow-up|4
5391083|NCT03232333|18566209|P1|Overall Study|Infection or Osteomyelitis|9
5391084|NCT03231943|18566226|P13|Part 2|Withdrawal by Subject|0
5391085|NCT03231943|18566227|P12|Part 2|Withdrawal by Subject|1
5391086|NCT03231943|18566228|P11|Part 2|Withdrawal by Subject|0
5391087|NCT03231943|18566229|P10|Part 2|Withdrawal by Subject|0
5391088|NCT03231943|18566230|P9|Part 2|Withdrawal by Subject|0
5391089|NCT03231943|18566231|P8|Part 2|Withdrawal by Subject|0
5391090|NCT03231943|18566232|P7|Part 2|Withdrawal by Subject|0
5391091|NCT03231943|18566233|P6|Part 2|Withdrawal by Subject|0
5391092|NCT03231943|18566234|P5|Part 2|Withdrawal by Subject|0
5391093|NCT03231943|18566235|P4|Part 2|Withdrawal by Subject|0
5391094|NCT03231943|18566236|P3|Part 2|Withdrawal by Subject|0
5391095|NCT03231943|18566237|P2|Part 2|Withdrawal by Subject|0
5391096|NCT03231943|18566238|P1|Part 2|Withdrawal by Subject|0
5391097|NCT03231943|18566226|P13|Part 2|Adverse Event|0
5391098|NCT03231943|18566227|P12|Part 2|Adverse Event|0
5391099|NCT03231943|18566228|P11|Part 2|Adverse Event|1
5391100|NCT03231943|18566229|P10|Part 2|Adverse Event|0
5391101|NCT03231943|18566230|P9|Part 2|Adverse Event|0
5391102|NCT03231943|18566231|P8|Part 2|Adverse Event|0
5391103|NCT03231943|18566232|P7|Part 2|Adverse Event|0
5391104|NCT03231943|18566233|P6|Part 2|Adverse Event|0
5391105|NCT03231943|18566234|P5|Part 2|Adverse Event|0
5391106|NCT03231943|18566235|P4|Part 2|Adverse Event|0
5391107|NCT03231943|18566236|P3|Part 2|Adverse Event|0
5391108|NCT03231943|18566237|P2|Part 2|Adverse Event|0
5391109|NCT03231943|18566238|P1|Part 2|Adverse Event|0
5391110|NCT03231943|18566226|P13|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391111|NCT03231943|18566227|P12|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391112|NCT03231943|18566228|P11|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391113|NCT03231943|18566229|P10|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391114|NCT03231943|18566230|P9|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391115|NCT03231943|18566231|P8|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391116|NCT03231943|18566232|P7|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391117|NCT03231943|18566233|P6|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391118|NCT03231943|18566234|P5|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391119|NCT03231943|18566235|P4|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391120|NCT03231943|18566236|P3|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391121|NCT03231943|18566237|P2|Part 1, Period 3 (up to Day 45)|Adverse Event|0
5391122|NCT03231943|18566238|P1|Part 1, Period 3 (up to Day 45)|Adverse Event|1
5391123|NCT03231943|18566226|P13|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391124|NCT03231943|18566227|P12|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391125|NCT03231943|18566228|P11|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391126|NCT03231943|18566229|P10|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391127|NCT03231943|18566230|P9|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391128|NCT03231943|18566231|P8|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391129|NCT03231943|18566232|P7|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391130|NCT03231943|18566233|P6|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391131|NCT03231943|18566234|P5|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391132|NCT03231943|18566235|P4|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391133|NCT03231943|18566236|P3|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391134|NCT03231943|18566237|P2|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
5391135|NCT03231943|18566238|P1|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
5391136|NCT03231943|18566226|P13|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391137|NCT03231943|18566227|P12|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391138|NCT03231943|18566228|P11|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391139|NCT03231943|18566229|P10|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391140|NCT03231943|18566230|P9|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391141|NCT03231943|18566231|P8|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391142|NCT03231943|18566232|P7|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391143|NCT03231943|18566233|P6|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391144|NCT03231943|18566234|P5|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391145|NCT03231943|18566235|P4|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391146|NCT03231943|18566236|P3|Part 1, Period 2 (up to Day 30)|Adverse Event|1
5391147|NCT03231943|18566237|P2|Part 1, Period 2 (up to Day 30)|Adverse Event|1
5391148|NCT03231943|18566238|P1|Part 1, Period 2 (up to Day 30)|Adverse Event|0
5391149|NCT03231800|18566701|P2|Overall Study|reason not provided|0
5391150|NCT03231800|18566702|P1|Overall Study|reason not provided|2
5391151|NCT03231800|18566701|P2|Overall Study|Protocol Violation|1
5391152|NCT03231800|18566702|P1|Overall Study|Protocol Violation|1
5391153|NCT03231800|18566701|P2|Overall Study|Lost to Follow-up|2
5391154|NCT03231800|18566702|P1|Overall Study|Lost to Follow-up|0
5391155|NCT03231709|18566718|P2|Treatment Period 2|Pretreatment Event/Adverse Event|1
5391156|NCT03231709|18566719|P1|Treatment Period 2|Pretreatment Event/Adverse Event|0
5391157|NCT03231709|18566718|P2|Treatment Period 1|Reason not Specified|1
5391158|NCT03231709|18566719|P1|Treatment Period 1|Reason not Specified|0
5391159|NCT03231371|18566737|P1|Overall Study|chose or were ineligible to have MRI|12
5391160|NCT03231371|18566737|P1|Overall Study|Withdrawal by Subject|1
5391161|NCT03231228|18566750|P2|Overall Study|Physician Decision|0
5391162|NCT03231228|18566751|P1|Overall Study|Physician Decision|1
5391163|NCT03231228|18566750|P2|Overall Study|Lost to Follow-up|0
5391164|NCT03231228|18566751|P1|Overall Study|Lost to Follow-up|2
5391165|NCT03230864|18566762|P4|Double Blind Treatment (DBT) Period|Sponsor Decision|0
5391166|NCT03230864|18566763|P3|Double Blind Treatment (DBT) Period|Sponsor Decision|2
5391167|NCT03230864|18566764|P2|Double Blind Treatment (DBT) Period|Sponsor Decision|0
5391168|NCT03230864|18566765|P1|Double Blind Treatment (DBT) Period|Sponsor Decision|0
5391169|NCT03230864|18566762|P4|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
5391170|NCT03230864|18566763|P3|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
5391171|NCT03230864|18566764|P2|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
5391172|NCT03230864|18566765|P1|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
5391173|NCT03230864|18566762|P4|Double Blind Treatment (DBT) Period|Adverse Event|1
5391174|NCT03230864|18566763|P3|Double Blind Treatment (DBT) Period|Adverse Event|5
5391175|NCT03230864|18566764|P2|Double Blind Treatment (DBT) Period|Adverse Event|0
5391176|NCT03230864|18566765|P1|Double Blind Treatment (DBT) Period|Adverse Event|0
5391177|NCT03230864|18566762|P4|Prospective Confirmation (PC) Period|Study Personnel Decision|0
5391178|NCT03230864|18566763|P3|Prospective Confirmation (PC) Period|Study Personnel Decision|0
5391179|NCT03230864|18566764|P2|Prospective Confirmation (PC) Period|Study Personnel Decision|0
5391180|NCT03230864|18566765|P1|Prospective Confirmation (PC) Period|Study Personnel Decision|1
5391181|NCT03230864|18566762|P4|Prospective Confirmation (PC) Period|Sponsor Decision|0
5391182|NCT03230864|18566763|P3|Prospective Confirmation (PC) Period|Sponsor Decision|0
5391183|NCT03230864|18566764|P2|Prospective Confirmation (PC) Period|Sponsor Decision|9
5391184|NCT03230864|18566765|P1|Prospective Confirmation (PC) Period|Sponsor Decision|9
5391185|NCT03230864|18566762|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
5391186|NCT03230864|18566763|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
5391187|NCT03230864|18566764|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
5391188|NCT03230864|18566765|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
5391189|NCT03230864|18566762|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5391190|NCT03230864|18566763|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5391191|NCT03230864|18566764|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
5391192|NCT03230864|18566765|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
5391193|NCT03230864|18566762|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
5391194|NCT03230864|18566763|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
5391195|NCT03230864|18566764|P2|Prospective Confirmation (PC) Period|Protocol Violation|2
5391196|NCT03230864|18566765|P1|Prospective Confirmation (PC) Period|Protocol Violation|1
5391197|NCT03230864|18566762|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5391198|NCT03230864|18566763|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5391199|NCT03230864|18566764|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|2
5391200|NCT03230864|18566765|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5391201|NCT03230864|18566762|P4|Prospective Confirmation (PC) Period|Adverse Event|0
5391202|NCT03230864|18566763|P3|Prospective Confirmation (PC) Period|Adverse Event|0
5391203|NCT03230864|18566764|P2|Prospective Confirmation (PC) Period|Adverse Event|0
5391204|NCT03230864|18566765|P1|Prospective Confirmation (PC) Period|Adverse Event|3
5391205|NCT03229486|18566783|P2|Overall Study|Protocol Violation|1
5391206|NCT03229486|18566784|P1|Overall Study|Protocol Violation|0
5391207|NCT03229109|18566825|P4|Overall Study|Withdrawal by Subject|1
5391208|NCT03229109|18566826|P3|Overall Study|Withdrawal by Subject|0
5391209|NCT03229109|18566827|P2|Overall Study|Withdrawal by Subject|0
5391210|NCT03229109|18566828|P1|Overall Study|Withdrawal by Subject|0
5391211|NCT03228433|18566850|P6|Overall Study|Positive alcohol test|0
5391212|NCT03228433|18566851|P5|Overall Study|Positive alcohol test|0
5391213|NCT03228433|18566852|P4|Overall Study|Positive alcohol test|1
5391214|NCT03228433|18566853|P3|Overall Study|Positive alcohol test|0
5391215|NCT03228433|18566854|P2|Overall Study|Positive alcohol test|0
5391216|NCT03228433|18566855|P1|Overall Study|Positive alcohol test|0
5391217|NCT03228433|18566850|P6|Overall Study|Lost to Follow-up|0
5391218|NCT03228433|18566851|P5|Overall Study|Lost to Follow-up|0
5391219|NCT03228433|18566852|P4|Overall Study|Lost to Follow-up|0
5391220|NCT03228433|18566853|P3|Overall Study|Lost to Follow-up|0
5391221|NCT03228433|18566854|P2|Overall Study|Lost to Follow-up|0
5391222|NCT03228433|18566855|P1|Overall Study|Lost to Follow-up|1
5391223|NCT03228212|18566930|P2|Period 2|Lost to Follow-up|0
5391224|NCT03228212|18566931|P1|Period 2|Lost to Follow-up|1
5391225|NCT03228212|18566930|P2|Period 1|no longer meets eligibility criteria|1
5391226|NCT03228212|18566931|P1|Period 1|no longer meets eligibility criteria|0
5391227|NCT03228212|18566930|P2|Period 1|Adverse Event|0
5391228|NCT03228212|18566931|P1|Period 1|Adverse Event|1
5391229|NCT03227861|18566947|P1|Extension Period (Week 48 to Week 96)|Other|2
5391230|NCT03227861|18566947|P1|Extension Period (Week 48 to Week 96)|Adverse Event|1
5391231|NCT03227861|18566947|P1|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
5391316|NCT03224130|18567334|P2|Overall Study|consent issue|1
5391232|NCT03227861|18566947|P1|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
5391233|NCT03227861|18566947|P1|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
5391234|NCT03227861|18566947|P1|Main Study Period (Week 0 to Week 48)|Other|5
5391235|NCT03227861|18566947|P1|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
5391236|NCT03227861|18566947|P1|Main Study Period (Week 0 to Week 48)|Adverse Event|1
5391237|NCT03227861|18566947|P1|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
5391238|NCT03227861|18566947|P1|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
5391239|NCT03227692|18566979|P2|Overall Study|Adverse Event|2
5391240|NCT03227692|18566980|P1|Overall Study|Adverse Event|0
5391241|NCT03227692|18566979|P2|Overall Study|Lost to Follow-up|2
5391242|NCT03227692|18566980|P1|Overall Study|Lost to Follow-up|4
5391243|NCT03227692|18566979|P2|Overall Study|Protocol Violation|1
5391244|NCT03227692|18566980|P1|Overall Study|Protocol Violation|1
5391245|NCT03227445|18567008|P4|Period 2 (28 Days)|Withdrawal by Subject|1
5391246|NCT03227445|18567009|P3|Period 2 (28 Days)|Withdrawal by Subject|0
5391247|NCT03227445|18567010|P2|Period 2 (28 Days)|Withdrawal by Subject|1
5391248|NCT03227445|18567011|P1|Period 2 (28 Days)|Withdrawal by Subject|0
5391249|NCT03227445|18567008|P4|Period 2 (28 Days)|Protocol Violation|1
5391250|NCT03227445|18567009|P3|Period 2 (28 Days)|Protocol Violation|0
5391251|NCT03227445|18567010|P2|Period 2 (28 Days)|Protocol Violation|0
5391252|NCT03227445|18567011|P1|Period 2 (28 Days)|Protocol Violation|0
5391253|NCT03227445|18567008|P4|Period 2 (28 Days)|Adverse Event|1
5391254|NCT03227445|18567009|P3|Period 2 (28 Days)|Adverse Event|2
5391255|NCT03227445|18567010|P2|Period 2 (28 Days)|Adverse Event|0
5391256|NCT03227445|18567011|P1|Period 2 (28 Days)|Adverse Event|1
5391257|NCT03227445|18567008|P4|Period 1 (28 Days)|Withdrawal by Subject|1
5391258|NCT03227445|18567009|P3|Period 1 (28 Days)|Withdrawal by Subject|1
5391259|NCT03227445|18567010|P2|Period 1 (28 Days)|Withdrawal by Subject|0
5391260|NCT03227445|18567011|P1|Period 1 (28 Days)|Withdrawal by Subject|0
5391261|NCT03227445|18567008|P4|Period 1 (28 Days)|Protocol Violation|0
5391262|NCT03227445|18567009|P3|Period 1 (28 Days)|Protocol Violation|0
5391263|NCT03227445|18567010|P2|Period 1 (28 Days)|Protocol Violation|0
5391264|NCT03227445|18567011|P1|Period 1 (28 Days)|Protocol Violation|1
5391265|NCT03227445|18567008|P4|Period 1 (28 Days)|Adverse Event|1
5391266|NCT03227445|18567009|P3|Period 1 (28 Days)|Adverse Event|0
5391267|NCT03227445|18567010|P2|Period 1 (28 Days)|Adverse Event|2
5391268|NCT03227445|18567011|P1|Period 1 (28 Days)|Adverse Event|1
5391269|NCT03226769|18567037|P2|Overall Study|Withdrawal by Subject|1
5391270|NCT03226769|18567038|P1|Overall Study|Withdrawal by Subject|0
5391271|NCT03226392|18567052|P2|Overall Study|Subject/Guardian Decision|6
5391272|NCT03226392|18567053|P1|Overall Study|Subject/Guardian Decision|7
5391273|NCT03226392|18567052|P2|Overall Study|Technical Problems|2
5391274|NCT03226392|18567053|P1|Overall Study|Technical Problems|0
5391275|NCT03226392|18567052|P2|Overall Study|Adverse Event|0
5391276|NCT03226392|18567053|P1|Overall Study|Adverse Event|1
5391277|NCT03226392|18567052|P2|Overall Study|Lost to Follow-up|0
5391278|NCT03226392|18567053|P1|Overall Study|Lost to Follow-up|1
5391279|NCT03226392|18567052|P2|Overall Study|Physician Decision|0
5391280|NCT03226392|18567053|P1|Overall Study|Physician Decision|1
5391281|NCT03226392|18567052|P2|Overall Study|Protocol Deviation|0
5391282|NCT03226392|18567053|P1|Overall Study|Protocol Deviation|1
5391283|NCT03226353|18567094|P1|Overall Study|Screen Failure|5
5391284|NCT03226353|18567094|P1|Overall Study|Withdrawal by Subject|1
5391285|NCT03226275|18567118|P4|Treatment Period 1 (8 Days)|Protocol non-compliance|1
5391286|NCT03226275|18567119|P3|Treatment Period 1 (8 Days)|Protocol non-compliance|0
5391287|NCT03226275|18567120|P2|Treatment Period 1 (8 Days)|Protocol non-compliance|0
5391288|NCT03226275|18567121|P1|Treatment Period 1 (8 Days)|Protocol non-compliance|0
5391289|NCT03226275|18567118|P4|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
5391290|NCT03226275|18567119|P3|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
5391291|NCT03226275|18567120|P2|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
5391292|NCT03226275|18567121|P1|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
5391293|NCT03226249|18567167|P1|Survival Follow-up|Patients still in follow-up.|30
5391294|NCT03226249|18567167|P1|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
5391295|NCT03226249|18567167|P1|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
5391296|NCT03224598|18567237|P3|Overall Study|Other|0
5391297|NCT03224598|18567238|P2|Overall Study|Other|1
5391298|NCT03224598|18567239|P1|Overall Study|Other|0
5391299|NCT03224598|18567237|P3|Overall Study|Lost to Follow-up|0
5391300|NCT03224598|18567238|P2|Overall Study|Lost to Follow-up|2
5391301|NCT03224598|18567239|P1|Overall Study|Lost to Follow-up|0
5391302|NCT03224325|18567265|P7|Overall Study|Withdrawal by Subject|0
5391303|NCT03224325|18567266|P6|Overall Study|Withdrawal by Subject|0
5391304|NCT03224325|18567267|P5|Overall Study|Withdrawal by Subject|0
5391305|NCT03224325|18567268|P4|Overall Study|Withdrawal by Subject|1
5391306|NCT03224325|18567269|P3|Overall Study|Withdrawal by Subject|0
5391307|NCT03224325|18567270|P2|Overall Study|Withdrawal by Subject|0
5391308|NCT03224325|18567271|P1|Overall Study|Withdrawal by Subject|0
5391309|NCT03224325|18567265|P7|Overall Study|Adverse Event|1
5391310|NCT03224325|18567266|P6|Overall Study|Adverse Event|0
5391311|NCT03224325|18567267|P5|Overall Study|Adverse Event|0
5391312|NCT03224325|18567268|P4|Overall Study|Adverse Event|0
5391313|NCT03224325|18567269|P3|Overall Study|Adverse Event|0
5391314|NCT03224325|18567270|P2|Overall Study|Adverse Event|0
5391315|NCT03224325|18567271|P1|Overall Study|Adverse Event|1
5391317|NCT03224130|18567335|P1|Overall Study|consent issue|0
5391318|NCT03223909|18567356|P3|Overall Study|Protocol Violation|16
5391319|NCT03223909|18567357|P2|Overall Study|Protocol Violation|45
5391320|NCT03223909|18567358|P1|Overall Study|Protocol Violation|48
5391321|NCT03223662|18567387|P1|Overall Study|Study closure|1
5391322|NCT03223662|18567387|P1|Overall Study|Physician Decision|1
5391323|NCT03222583|18567491|P2|Overall Study|Other|3
5391324|NCT03222583|18567492|P1|Overall Study|Other|1
5391325|NCT03222583|18567491|P2|Overall Study|Lost to Follow-up|0
5391326|NCT03222583|18567492|P1|Overall Study|Lost to Follow-up|1
5391327|NCT03222583|18567491|P2|Overall Study|Withdrawal by Subject|3
5391328|NCT03222583|18567492|P1|Overall Study|Withdrawal by Subject|3
5391329|NCT03222141|18567542|P1|Overall Study|Lost to Follow-up|3
5391330|NCT03222141|18567542|P1|Overall Study|Death|15
5391331|NCT03220737|18567625|P7|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5391332|NCT03220737|18567626|P6|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5391333|NCT03220737|18567627|P5|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5391334|NCT03220737|18567628|P4|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5391335|NCT03220737|18567629|P3|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5391336|NCT03220737|18567630|P2|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
5391337|NCT03220737|18567631|P1|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
5391338|NCT03220737|18567625|P7|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5391339|NCT03220737|18567626|P6|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5391340|NCT03220737|18567627|P5|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5391341|NCT03220737|18567628|P4|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5391342|NCT03220737|18567629|P3|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5391343|NCT03220737|18567630|P2|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
5391344|NCT03220737|18567631|P1|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
5391345|NCT03220737|18567625|P7|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5391346|NCT03220737|18567626|P6|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5391347|NCT03220737|18567627|P5|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5391348|NCT03220737|18567628|P4|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5391349|NCT03220737|18567629|P3|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5391350|NCT03220737|18567630|P2|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
5391351|NCT03220737|18567631|P1|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
5391352|NCT03220737|18567625|P7|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5391353|NCT03220737|18567626|P6|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5391354|NCT03220737|18567627|P5|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
5391355|NCT03220737|18567628|P4|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5391356|NCT03220737|18567629|P3|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5391357|NCT03220737|18567630|P2|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5391358|NCT03220737|18567631|P1|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
5391359|NCT03220737|18567625|P7|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5391360|NCT03220737|18567626|P6|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5391361|NCT03220737|18567627|P5|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5391362|NCT03220737|18567628|P4|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5391363|NCT03220737|18567629|P3|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
5391364|NCT03220737|18567630|P2|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5391365|NCT03220737|18567631|P1|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
5391366|NCT03220737|18567625|P7|Main Study (Day 1 - 181)|Protocol Violation|1
5391367|NCT03220737|18567626|P6|Main Study (Day 1 - 181)|Protocol Violation|0
5391368|NCT03220737|18567627|P5|Main Study (Day 1 - 181)|Protocol Violation|3
5391369|NCT03220737|18567628|P4|Main Study (Day 1 - 181)|Protocol Violation|1
5391370|NCT03220737|18567629|P3|Main Study (Day 1 - 181)|Protocol Violation|1
5391371|NCT03220737|18567630|P2|Main Study (Day 1 - 181)|Protocol Violation|0
5391372|NCT03220737|18567631|P1|Main Study (Day 1 - 181)|Protocol Violation|0
5391373|NCT03220737|18567625|P7|Main Study (Day 1 - 181)|Lost to Follow-up|0
5391374|NCT03220737|18567626|P6|Main Study (Day 1 - 181)|Lost to Follow-up|1
5391375|NCT03220737|18567627|P5|Main Study (Day 1 - 181)|Lost to Follow-up|13
5391376|NCT03220737|18567628|P4|Main Study (Day 1 - 181)|Lost to Follow-up|1
5391377|NCT03220737|18567629|P3|Main Study (Day 1 - 181)|Lost to Follow-up|6
5391378|NCT03220737|18567630|P2|Main Study (Day 1 - 181)|Lost to Follow-up|1
5391379|NCT03220737|18567631|P1|Main Study (Day 1 - 181)|Lost to Follow-up|2
5391380|NCT03220737|18567625|P7|Main Study (Day 1 - 181)|Withdrawal by Subject|0
5391381|NCT03220737|18567626|P6|Main Study (Day 1 - 181)|Withdrawal by Subject|0
5391382|NCT03220737|18567627|P5|Main Study (Day 1 - 181)|Withdrawal by Subject|4
5391383|NCT03220737|18567628|P4|Main Study (Day 1 - 181)|Withdrawal by Subject|1
5391384|NCT03220737|18567629|P3|Main Study (Day 1 - 181)|Withdrawal by Subject|4
5391385|NCT03220737|18567630|P2|Main Study (Day 1 - 181)|Withdrawal by Subject|1
5391386|NCT03220737|18567631|P1|Main Study (Day 1 - 181)|Withdrawal by Subject|4
5391387|NCT03219723|18567771|P1|Overall Study|Protocol Deviation|4
5391388|NCT03219723|18567771|P1|Overall Study|Case Report Forms Uncollected|6
5391389|NCT03219216|18567814|P2|Overall Study|Lost to Follow-up|1
5391390|NCT03219216|18567815|P1|Overall Study|Lost to Follow-up|0
5391391|NCT03218397|18567861|P2|Overall Study|Randomized during laboratory off hours|1
5391392|NCT03218397|18567862|P1|Overall Study|Randomized during laboratory off hours|2
5391393|NCT03218397|18567861|P2|Overall Study|No gram-negative bacilli (GNB)|2
5391394|NCT03218397|18567862|P1|Overall Study|No gram-negative bacilli (GNB)|0
5391395|NCT03218397|18567861|P2|Overall Study|Inaccessible hospital records|5
5391396|NCT03218397|18567862|P1|Overall Study|Inaccessible hospital records|2
5391397|NCT03218397|18567861|P2|Overall Study|Mixed culture|2
5391398|NCT03218397|18567862|P1|Overall Study|Mixed culture|2
5391399|NCT03218397|18567861|P2|Overall Study|Comfort care and mixed culture|1
5391400|NCT03218397|18567862|P1|Overall Study|Comfort care and mixed culture|0
5391401|NCT03218397|18567861|P2|Overall Study|Comfort care and positive blood culture|0
5391402|NCT03218397|18567862|P1|Overall Study|Comfort care and positive blood culture|1
5391403|NCT03218397|18567861|P2|Overall Study|Comfort care|5
5391404|NCT03218397|18567862|P1|Overall Study|Comfort care|8
5391405|NCT03218397|18567861|P2|Overall Study|Prior positive blood culture|13
5391406|NCT03218397|18567862|P1|Overall Study|Prior positive blood culture|8
5391407|NCT03217968|18567894|P1|Overall Study|Protocol Violation|6
5391408|NCT03217968|18567894|P1|Overall Study|Lost to Follow-up|1
5391409|NCT03217968|18567894|P1|Overall Study|Withdrawal by Subject|4
5391410|NCT03217175|18567903|P2|Overall Study|Physician Decision|1
5391411|NCT03217175|18567904|P1|Overall Study|Physician Decision|4
5391412|NCT03216850|18567999|P1|Overall Study|Pre-analytical error|6
5391413|NCT03216746|18568007|P4|Overall Study|Lost to Follow-up|6
5391414|NCT03216746|18568008|P3|Overall Study|Lost to Follow-up|5
5391415|NCT03216746|18568009|P2|Overall Study|Lost to Follow-up|8
5391416|NCT03216746|18568010|P1|Overall Study|Lost to Follow-up|6
5391417|NCT03216265|18568051|P3|Overall Study|Withdrawal by Subject|1
5391418|NCT03216265|18568052|P2|Overall Study|Withdrawal by Subject|0
5391419|NCT03216265|18568053|P1|Overall Study|Withdrawal by Subject|0
5391420|NCT03216265|18568051|P3|Overall Study|Lost to Follow-up|0
5391421|NCT03216265|18568052|P2|Overall Study|Lost to Follow-up|1
5391422|NCT03216265|18568053|P1|Overall Study|Lost to Follow-up|0
5391423|NCT03216265|18568051|P3|Overall Study|Adverse Event|2
5391424|NCT03216265|18568052|P2|Overall Study|Adverse Event|0
5391425|NCT03216265|18568053|P1|Overall Study|Adverse Event|2
5391426|NCT03215758|18568144|P2|Overall Study|Subject/Guardian Decision|3
5391427|NCT03215758|18568145|P1|Overall Study|Subject/Guardian Decision|3
5391428|NCT03215758|18568144|P2|Overall Study|Adverse Event|2
5391429|NCT03215758|18568145|P1|Overall Study|Adverse Event|1
5391430|NCT03215758|18568144|P2|Overall Study|Death|1
5391431|NCT03215758|18568145|P1|Overall Study|Death|0
5391432|NCT03215758|18568144|P2|Overall Study|Physician Decision|1
5391433|NCT03215758|18568145|P1|Overall Study|Physician Decision|0
5391434|NCT03215758|18568144|P2|Overall Study|Protocol deviation|1
5391435|NCT03215758|18568145|P1|Overall Study|Protocol deviation|0
5391436|NCT03215758|18568144|P2|Overall Study|Technical Problems|0
5391437|NCT03215758|18568145|P1|Overall Study|Technical Problems|1
5391438|NCT03215706|18568159|P2|Treatment Period|Ongoing in the treatment period|43
5391439|NCT03215706|18568160|P1|Treatment Period|Ongoing in the treatment period|105
5391440|NCT03215706|18568159|P2|Treatment Period|Other Reasons|5
5391441|NCT03215706|18568160|P1|Treatment Period|Other Reasons|4
5391442|NCT03215706|18568159|P2|Treatment Period|Lost to Follow-up|1
5391443|NCT03215706|18568160|P1|Treatment Period|Lost to Follow-up|0
5391444|NCT03215706|18568159|P2|Treatment Period|Participant withdrew consent|4
5391445|NCT03215706|18568160|P1|Treatment Period|Participant withdrew consent|3
5391446|NCT03215706|18568159|P2|Treatment Period|Request to D/C treatment|6
5391447|NCT03215706|18568160|P1|Treatment Period|Request to D/C treatment|1
5391448|NCT03215706|18568159|P2|Treatment Period|Adverse event unrelated to study drug|23
5391449|NCT03215706|18568160|P1|Treatment Period|Adverse event unrelated to study drug|24
5391450|NCT03215706|18568159|P2|Treatment Period|Death|1
5391451|NCT03215706|18568160|P1|Treatment Period|Death|2
5391452|NCT03215706|18568159|P2|Treatment Period|Study Drug Toxicity|21
5391453|NCT03215706|18568160|P1|Treatment Period|Study Drug Toxicity|53
5391454|NCT03215706|18568159|P2|Treatment Period|Disease Progression|142
5391455|NCT03215706|18568160|P1|Treatment Period|Disease Progression|150
5391456|NCT03215706|18568159|P2|Randomization|other reasons|2
5391457|NCT03215706|18568160|P1|Randomization|other reasons|0
5391458|NCT03215706|18568159|P2|Randomization|no longer meets study criteria|4
5391459|NCT03215706|18568160|P1|Randomization|no longer meets study criteria|1
5391460|NCT03215706|18568159|P2|Randomization|participant withdrew consent|3
5391461|NCT03215706|18568160|P1|Randomization|participant withdrew consent|1
5391462|NCT03215706|18568159|P2|Randomization|Adverse Event unrelated to study drug|0
5391463|NCT03215706|18568160|P1|Randomization|Adverse Event unrelated to study drug|1
5391464|NCT03214952|18568180|P1|Overall Study|Case Report Forms Uncollected|13
5391465|NCT03214952|18568180|P1|Overall Study|Protocol Deviation|45
5391466|NCT03214588|18568195|P3|Overall Study|Reason Not Specified|0
5391467|NCT03214588|18568196|P2|Overall Study|Reason Not Specified|1
5391468|NCT03214588|18568197|P1|Overall Study|Reason Not Specified|0
5391469|NCT03214588|18568195|P3|Overall Study|Adverse Event|2
5391470|NCT03214588|18568196|P2|Overall Study|Adverse Event|0
5391471|NCT03214588|18568197|P1|Overall Study|Adverse Event|1
5391472|NCT03214406|18568264|P2|Overall Study|Lost to Follow-up|2
5391473|NCT03214406|18568265|P1|Overall Study|Lost to Follow-up|0
5391474|NCT03214406|18568264|P2|Overall Study|Withdrawal by Subject|0
5391475|NCT03214406|18568265|P1|Overall Study|Withdrawal by Subject|1
5391476|NCT03214406|18568264|P2|Overall Study|did not meet enrollment criteria|13
5391477|NCT03214406|18568265|P1|Overall Study|did not meet enrollment criteria|9
5391478|NCT03214380|18568279|P6|Treatment Period|Treatment Interruption|0
5391479|NCT03214380|18568280|P5|Treatment Period|Treatment Interruption|0
5391480|NCT03214380|18568281|P4|Treatment Period|Treatment Interruption|0
5391481|NCT03214380|18568282|P3|Treatment Period|Treatment Interruption|1
5391482|NCT03214380|18568283|P2|Treatment Period|Treatment Interruption|0
5391483|NCT03214380|18568284|P1|Treatment Period|Treatment Interruption|0
5391484|NCT03214380|18568279|P6|Treatment Period|Participant schedule|0
5391485|NCT03214380|18568280|P5|Treatment Period|Participant schedule|0
5391486|NCT03214380|18568281|P4|Treatment Period|Participant schedule|0
5391487|NCT03214380|18568282|P3|Treatment Period|Participant schedule|1
5391488|NCT03214380|18568283|P2|Treatment Period|Participant schedule|0
5391489|NCT03214380|18568284|P1|Treatment Period|Participant schedule|0
5391490|NCT03214380|18568279|P6|Treatment Period|Lost to Follow-up|0
5391491|NCT03214380|18568280|P5|Treatment Period|Lost to Follow-up|0
5391492|NCT03214380|18568281|P4|Treatment Period|Lost to Follow-up|0
5391493|NCT03214380|18568282|P3|Treatment Period|Lost to Follow-up|3
5391494|NCT03214380|18568283|P2|Treatment Period|Lost to Follow-up|6
5391495|NCT03214380|18568284|P1|Treatment Period|Lost to Follow-up|0
5391496|NCT03214380|18568279|P6|Treatment Period|Death|0
5391497|NCT03214380|18568280|P5|Treatment Period|Death|0
5391498|NCT03214380|18568281|P4|Treatment Period|Death|0
5391499|NCT03214380|18568282|P3|Treatment Period|Death|2
5391500|NCT03214380|18568283|P2|Treatment Period|Death|1
5391501|NCT03214380|18568284|P1|Treatment Period|Death|0
5391502|NCT03214380|18568279|P6|Treatment Period|Withdrawal by Subject|11
5391503|NCT03214380|18568280|P5|Treatment Period|Withdrawal by Subject|7
5391504|NCT03214380|18568281|P4|Treatment Period|Withdrawal by Subject|0
5391505|NCT03214380|18568282|P3|Treatment Period|Withdrawal by Subject|8
5391506|NCT03214380|18568283|P2|Treatment Period|Withdrawal by Subject|10
5391507|NCT03214380|18568284|P1|Treatment Period|Withdrawal by Subject|0
5391508|NCT03214380|18568279|P6|Treatment Period|Non-Compliance with Study Drug|0
5391509|NCT03214380|18568280|P5|Treatment Period|Non-Compliance with Study Drug|1
5391510|NCT03214380|18568281|P4|Treatment Period|Non-Compliance with Study Drug|0
5391511|NCT03214380|18568282|P3|Treatment Period|Non-Compliance with Study Drug|0
5391512|NCT03214380|18568283|P2|Treatment Period|Non-Compliance with Study Drug|0
5391513|NCT03214380|18568284|P1|Treatment Period|Non-Compliance with Study Drug|0
5391514|NCT03214380|18568279|P6|Treatment Period|Adverse Event|0
5391515|NCT03214380|18568280|P5|Treatment Period|Adverse Event|1
5391516|NCT03214380|18568281|P4|Treatment Period|Adverse Event|0
5391517|NCT03214380|18568282|P3|Treatment Period|Adverse Event|1
5391518|NCT03214380|18568283|P2|Treatment Period|Adverse Event|1
5391519|NCT03214380|18568284|P1|Treatment Period|Adverse Event|0
5391520|NCT03214380|18568279|P6|Lead-in|Participant Schedule|0
5391521|NCT03214380|18568280|P5|Lead-in|Participant Schedule|0
5391522|NCT03214380|18568281|P4|Lead-in|Participant Schedule|0
5391523|NCT03214380|18568282|P3|Lead-in|Participant Schedule|0
5391524|NCT03214380|18568283|P2|Lead-in|Participant Schedule|0
5391525|NCT03214380|18568284|P1|Lead-in|Participant Schedule|2
5391526|NCT03214380|18568279|P6|Lead-in|Non Compliance|0
5391527|NCT03214380|18568280|P5|Lead-in|Non Compliance|0
5391528|NCT03214380|18568281|P4|Lead-in|Non Compliance|0
5391529|NCT03214380|18568282|P3|Lead-in|Non Compliance|0
5391530|NCT03214380|18568283|P2|Lead-in|Non Compliance|0
5391531|NCT03214380|18568284|P1|Lead-in|Non Compliance|1
5391532|NCT03214380|18568279|P6|Lead-in|Natural Disaster|0
5391533|NCT03214380|18568280|P5|Lead-in|Natural Disaster|0
5391534|NCT03214380|18568281|P4|Lead-in|Natural Disaster|0
5391535|NCT03214380|18568282|P3|Lead-in|Natural Disaster|0
5391536|NCT03214380|18568283|P2|Lead-in|Natural Disaster|0
5391537|NCT03214380|18568284|P1|Lead-in|Natural Disaster|9
5391538|NCT03214380|18568279|P6|Lead-in|Family Emergency|0
5391539|NCT03214380|18568280|P5|Lead-in|Family Emergency|0
5391540|NCT03214380|18568281|P4|Lead-in|Family Emergency|0
5391541|NCT03214380|18568282|P3|Lead-in|Family Emergency|0
5391542|NCT03214380|18568283|P2|Lead-in|Family Emergency|0
5391543|NCT03214380|18568284|P1|Lead-in|Family Emergency|1
5391544|NCT03214380|18568279|P6|Lead-in|Withdrawal by Subject|0
5391545|NCT03214380|18568280|P5|Lead-in|Withdrawal by Subject|0
5391546|NCT03214380|18568281|P4|Lead-in|Withdrawal by Subject|14
5391547|NCT03214380|18568282|P3|Lead-in|Withdrawal by Subject|0
5391548|NCT03214380|18568283|P2|Lead-in|Withdrawal by Subject|0
5391549|NCT03214380|18568284|P1|Lead-in|Withdrawal by Subject|41
5391550|NCT03214380|18568279|P6|Lead-in|Protocol Deviation|0
5391551|NCT03214380|18568280|P5|Lead-in|Protocol Deviation|0
5391552|NCT03214380|18568281|P4|Lead-in|Protocol Deviation|3
5391553|NCT03214380|18568282|P3|Lead-in|Protocol Deviation|0
5391554|NCT03214380|18568283|P2|Lead-in|Protocol Deviation|0
5391555|NCT03214380|18568284|P1|Lead-in|Protocol Deviation|7
5391556|NCT03214380|18568279|P6|Lead-in|Physician Decision|0
5391557|NCT03214380|18568280|P5|Lead-in|Physician Decision|0
5391558|NCT03214380|18568281|P4|Lead-in|Physician Decision|0
5391559|NCT03214380|18568282|P3|Lead-in|Physician Decision|0
5391560|NCT03214380|18568283|P2|Lead-in|Physician Decision|0
5391561|NCT03214380|18568284|P1|Lead-in|Physician Decision|6
5391562|NCT03214380|18568279|P6|Lead-in|Eligibility Criteria|0
5391563|NCT03214380|18568280|P5|Lead-in|Eligibility Criteria|0
5391564|NCT03214380|18568281|P4|Lead-in|Eligibility Criteria|0
5391565|NCT03214380|18568282|P3|Lead-in|Eligibility Criteria|0
5391566|NCT03214380|18568283|P2|Lead-in|Eligibility Criteria|0
5391567|NCT03214380|18568284|P1|Lead-in|Eligibility Criteria|3
5391568|NCT03214380|18568279|P6|Lead-in|Lost to Follow-up|0
5391569|NCT03214380|18568280|P5|Lead-in|Lost to Follow-up|0
5391570|NCT03214380|18568281|P4|Lead-in|Lost to Follow-up|1
5391571|NCT03214380|18568282|P3|Lead-in|Lost to Follow-up|0
5391572|NCT03214380|18568283|P2|Lead-in|Lost to Follow-up|0
5391573|NCT03214380|18568284|P1|Lead-in|Lost to Follow-up|4
5391574|NCT03214380|18568279|P6|Lead-in|Adverse Event|0
5391575|NCT03214380|18568280|P5|Lead-in|Adverse Event|0
5391576|NCT03214380|18568281|P4|Lead-in|Adverse Event|1
5391577|NCT03214380|18568282|P3|Lead-in|Adverse Event|0
5391578|NCT03214380|18568283|P2|Lead-in|Adverse Event|0
5391579|NCT03214380|18568284|P1|Lead-in|Adverse Event|3
5391580|NCT03214367|18568320|P8|Treatment Period|Withdrawal by Subject|1
5391581|NCT03214367|18568321|P7|Treatment Period|Withdrawal by Subject|1
5391582|NCT03214367|18568322|P6|Treatment Period|Withdrawal by Subject|1
5391583|NCT03214367|18568323|P5|Treatment Period|Withdrawal by Subject|0
5391584|NCT03214367|18568324|P4|Treatment Period|Withdrawal by Subject|14
5391585|NCT03214367|18568325|P3|Treatment Period|Withdrawal by Subject|23
5391586|NCT03214367|18568326|P2|Treatment Period|Withdrawal by Subject|20
5391587|NCT03214367|18568327|P1|Treatment Period|Withdrawal by Subject|0
5391588|NCT03214367|18568320|P8|Treatment Period|Protocol Violation|0
5391589|NCT03214367|18568321|P7|Treatment Period|Protocol Violation|0
5391590|NCT03214367|18568322|P6|Treatment Period|Protocol Violation|0
5391591|NCT03214367|18568323|P5|Treatment Period|Protocol Violation|0
5391592|NCT03214367|18568324|P4|Treatment Period|Protocol Violation|0
5391593|NCT03214367|18568325|P3|Treatment Period|Protocol Violation|0
5391594|NCT03214367|18568326|P2|Treatment Period|Protocol Violation|3
5391595|NCT03214367|18568327|P1|Treatment Period|Protocol Violation|0
5391596|NCT03214367|18568320|P8|Treatment Period|Physician Decision|0
5391597|NCT03214367|18568321|P7|Treatment Period|Physician Decision|0
5391598|NCT03214367|18568322|P6|Treatment Period|Physician Decision|0
5391599|NCT03214367|18568323|P5|Treatment Period|Physician Decision|0
5391600|NCT03214367|18568324|P4|Treatment Period|Physician Decision|0
5391601|NCT03214367|18568325|P3|Treatment Period|Physician Decision|2
5391602|NCT03214367|18568326|P2|Treatment Period|Physician Decision|1
5391603|NCT03214367|18568327|P1|Treatment Period|Physician Decision|0
5391604|NCT03214367|18568320|P8|Treatment Period|Sponsor Decision|0
5391605|NCT03214367|18568321|P7|Treatment Period|Sponsor Decision|0
5391606|NCT03214367|18568322|P6|Treatment Period|Sponsor Decision|0
5391607|NCT03214367|18568323|P5|Treatment Period|Sponsor Decision|0
5391608|NCT03214367|18568324|P4|Treatment Period|Sponsor Decision|0
5391609|NCT03214367|18568325|P3|Treatment Period|Sponsor Decision|0
5391610|NCT03214367|18568326|P2|Treatment Period|Sponsor Decision|3
5391611|NCT03214367|18568327|P1|Treatment Period|Sponsor Decision|0
5391612|NCT03214367|18568320|P8|Treatment Period|Lost to Follow-up|0
5391613|NCT03214367|18568321|P7|Treatment Period|Lost to Follow-up|1
5391614|NCT03214367|18568322|P6|Treatment Period|Lost to Follow-up|2
5391615|NCT03214367|18568323|P5|Treatment Period|Lost to Follow-up|0
5391616|NCT03214367|18568324|P4|Treatment Period|Lost to Follow-up|2
5391617|NCT03214367|18568325|P3|Treatment Period|Lost to Follow-up|3
5391618|NCT03214367|18568326|P2|Treatment Period|Lost to Follow-up|5
5391619|NCT03214367|18568327|P1|Treatment Period|Lost to Follow-up|0
5391620|NCT03214367|18568320|P8|Treatment Period|Death|0
5391621|NCT03214367|18568321|P7|Treatment Period|Death|0
5391622|NCT03214367|18568322|P6|Treatment Period|Death|0
5391623|NCT03214367|18568323|P5|Treatment Period|Death|0
5391624|NCT03214367|18568324|P4|Treatment Period|Death|1
5391625|NCT03214367|18568325|P3|Treatment Period|Death|1
5391626|NCT03214367|18568326|P2|Treatment Period|Death|1
5391627|NCT03214367|18568327|P1|Treatment Period|Death|0
5391628|NCT03214367|18568320|P8|Treatment Period|Adverse Event|0
5391629|NCT03214367|18568321|P7|Treatment Period|Adverse Event|0
5391630|NCT03214367|18568322|P6|Treatment Period|Adverse Event|0
5391631|NCT03214367|18568323|P5|Treatment Period|Adverse Event|0
5391632|NCT03214367|18568324|P4|Treatment Period|Adverse Event|2
5391633|NCT03214367|18568325|P3|Treatment Period|Adverse Event|4
5391634|NCT03214367|18568326|P2|Treatment Period|Adverse Event|1
5391635|NCT03214367|18568327|P1|Treatment Period|Adverse Event|0
5391636|NCT03214367|18568320|P8|Lead-in Period|Treatment Interruption|0
5391637|NCT03214367|18568321|P7|Lead-in Period|Treatment Interruption|0
5391638|NCT03214367|18568322|P6|Lead-in Period|Treatment Interruption|0
5391639|NCT03214367|18568323|P5|Lead-in Period|Treatment Interruption|0
5391640|NCT03214367|18568324|P4|Lead-in Period|Treatment Interruption|0
5391641|NCT03214367|18568325|P3|Lead-in Period|Treatment Interruption|0
5391642|NCT03214367|18568326|P2|Lead-in Period|Treatment Interruption|0
5391643|NCT03214367|18568327|P1|Lead-in Period|Treatment Interruption|1
5391644|NCT03214367|18568320|P8|Lead-in Period|Protocol Violation|0
5391645|NCT03214367|18568321|P7|Lead-in Period|Protocol Violation|0
5391646|NCT03214367|18568322|P6|Lead-in Period|Protocol Violation|0
5391647|NCT03214367|18568323|P5|Lead-in Period|Protocol Violation|0
5391648|NCT03214367|18568324|P4|Lead-in Period|Protocol Violation|0
5391649|NCT03214367|18568325|P3|Lead-in Period|Protocol Violation|0
5391650|NCT03214367|18568326|P2|Lead-in Period|Protocol Violation|0
5391651|NCT03214367|18568327|P1|Lead-in Period|Protocol Violation|5
5391652|NCT03214367|18568320|P8|Lead-in Period|Physician Decision|0
5391653|NCT03214367|18568321|P7|Lead-in Period|Physician Decision|0
5391654|NCT03214367|18568322|P6|Lead-in Period|Physician Decision|0
5391655|NCT03214367|18568323|P5|Lead-in Period|Physician Decision|0
5391656|NCT03214367|18568324|P4|Lead-in Period|Physician Decision|0
5391657|NCT03214367|18568325|P3|Lead-in Period|Physician Decision|0
5391658|NCT03214367|18568326|P2|Lead-in Period|Physician Decision|0
5391659|NCT03214367|18568327|P1|Lead-in Period|Physician Decision|12
5391660|NCT03214367|18568320|P8|Lead-in Period|Sponsor Decision|0
5391661|NCT03214367|18568321|P7|Lead-in Period|Sponsor Decision|0
5391662|NCT03214367|18568322|P6|Lead-in Period|Sponsor Decision|0
5391663|NCT03214367|18568323|P5|Lead-in Period|Sponsor Decision|0
5391664|NCT03214367|18568324|P4|Lead-in Period|Sponsor Decision|0
5391665|NCT03214367|18568325|P3|Lead-in Period|Sponsor Decision|0
5391666|NCT03214367|18568326|P2|Lead-in Period|Sponsor Decision|0
5391667|NCT03214367|18568327|P1|Lead-in Period|Sponsor Decision|11
5391668|NCT03214367|18568320|P8|Lead-in Period|Lost to Follow-up|0
5391669|NCT03214367|18568321|P7|Lead-in Period|Lost to Follow-up|0
5391670|NCT03214367|18568322|P6|Lead-in Period|Lost to Follow-up|0
5391671|NCT03214367|18568323|P5|Lead-in Period|Lost to Follow-up|0
5391672|NCT03214367|18568324|P4|Lead-in Period|Lost to Follow-up|0
5391673|NCT03214367|18568325|P3|Lead-in Period|Lost to Follow-up|0
5391674|NCT03214367|18568326|P2|Lead-in Period|Lost to Follow-up|0
5391675|NCT03214367|18568327|P1|Lead-in Period|Lost to Follow-up|12
5391676|NCT03214367|18568320|P8|Lead-in Period|Adverse Event|0
5391677|NCT03214367|18568321|P7|Lead-in Period|Adverse Event|0
5391678|NCT03214367|18568322|P6|Lead-in Period|Adverse Event|0
5391679|NCT03214367|18568323|P5|Lead-in Period|Adverse Event|0
5391680|NCT03214367|18568324|P4|Lead-in Period|Adverse Event|0
5391681|NCT03214367|18568325|P3|Lead-in Period|Adverse Event|0
5391682|NCT03214367|18568326|P2|Lead-in Period|Adverse Event|0
5391683|NCT03214367|18568327|P1|Lead-in Period|Adverse Event|3
5391684|NCT03214367|18568320|P8|Lead-in Period|Withdrawal by Subject|0
5391685|NCT03214367|18568321|P7|Lead-in Period|Withdrawal by Subject|0
5391686|NCT03214367|18568322|P6|Lead-in Period|Withdrawal by Subject|0
5391687|NCT03214367|18568323|P5|Lead-in Period|Withdrawal by Subject|2
5391688|NCT03214367|18568324|P4|Lead-in Period|Withdrawal by Subject|0
5391689|NCT03214367|18568325|P3|Lead-in Period|Withdrawal by Subject|0
5391690|NCT03214367|18568326|P2|Lead-in Period|Withdrawal by Subject|0
5391691|NCT03214367|18568327|P1|Lead-in Period|Withdrawal by Subject|50
5391692|NCT03214224|18568372|P1|Overall Study|Practice controls or therapists|6
5391693|NCT03214224|18568372|P1|Overall Study|Withdrawal by Subject|2
5391694|NCT03214224|18568372|P1|Overall Study|Protocol Violation|1
5391695|NCT03214094|18568381|P1|Overall Study|Protocol Deviation|46
5391696|NCT03214094|18568381|P1|Overall Study|Case Report Forms Uncollected|14
5391697|NCT03214081|18568389|P1|Overall Study|Protocol Deviation|54
5391698|NCT03214081|18568389|P1|Overall Study|Case Report Forms Uncollected|9
5391699|NCT03213626|18568404|P1|Overall Study|Progressive Disease|6
5391700|NCT03213626|18568404|P1|Overall Study|Adverse Event|1
5391701|NCT03213509|18568414|P2|Overall Study|Did not consent for verbal autopsy|5
5391702|NCT03213509|18568415|P1|Overall Study|Did not consent for verbal autopsy|4
5391703|NCT03213366|18568445|P2|Overall Study|Lost to Follow-up|4
5391704|NCT03213366|18568446|P1|Overall Study|Lost to Follow-up|9
5391705|NCT03212690|18568472|P1|Overall Study|Protocol Violation|1
5391706|NCT03212521|18568520|P1|Overall Study|Other|1
5391707|NCT03212521|18568520|P1|Overall Study|Withdrawal by Subject|1
5391708|NCT03212521|18568520|P1|Overall Study|Lost to Follow-up|4
5391709|NCT03212521|18568520|P1|Overall Study|Adverse Event|1
5391710|NCT03212365|18568529|P2|Overall Study|developed acute renal failure|1
5391711|NCT03212365|18568530|P1|Overall Study|developed acute renal failure|0
5391712|NCT03212365|18568529|P2|Overall Study|Withdrawal by Subject|1
5391713|NCT03212365|18568530|P1|Overall Study|Withdrawal by Subject|0
5391714|NCT03212365|18568529|P2|Overall Study|Required epidural placement|0
5391715|NCT03212365|18568530|P1|Overall Study|Required epidural placement|1
5391716|NCT03212365|18568529|P2|Overall Study|Medication distribution error|0
5391717|NCT03212365|18568530|P1|Overall Study|Medication distribution error|1
5391718|NCT03212365|18568529|P2|Overall Study|Unexpected return to OR|1
5391719|NCT03212365|18568530|P1|Overall Study|Unexpected return to OR|1
5391720|NCT03212365|18568529|P2|Overall Study|Initiated heparin infusion on floor|1
5391721|NCT03212365|18568530|P1|Overall Study|Initiated heparin infusion on floor|1
5391722|NCT03212365|18568529|P2|Overall Study|Refused study medication|0
5391723|NCT03212365|18568530|P1|Overall Study|Refused study medication|3
5391724|NCT03212365|18568529|P2|Overall Study|Bled requiring enoxaparin cessation|2
5391725|NCT03212365|18568530|P1|Overall Study|Bled requiring enoxaparin cessation|4
5391726|NCT03212365|18568529|P2|Overall Study|Discharged prior to Xa level|8
5391727|NCT03212365|18568530|P1|Overall Study|Discharged prior to Xa level|12
5391728|NCT03212326|18568542|P1|Overall Study|Physician Decision|4
5391729|NCT03212261|18568547|P1|Overall Study|Too busy/ No time|5
5391730|NCT03212261|18568547|P1|Overall Study|Family Emergency|1
5391731|NCT03212261|18568547|P1|Overall Study|Lost to Follow-up|7
5391732|NCT03212261|18568547|P1|Overall Study|Tech Trouble- No first study visit|1
5391733|NCT03212261|18568547|P1|Overall Study|Became ineligible d/t tech|2
5391734|NCT03212144|18568555|P2|Second Sequence (4 Weeks)|Lost to Follow-up|1
5391735|NCT03212144|18568556|P1|Second Sequence (4 Weeks)|Lost to Follow-up|1
5391736|NCT03212144|18568555|P2|First Sequence (4 Weeks)|Lost to Follow-up|0
5391737|NCT03212144|18568556|P1|First Sequence (4 Weeks)|Lost to Follow-up|1
5391738|NCT03211858|18568564|P2|Overall Study|Other than specified above|21
5391739|NCT03211858|18568565|P1|Overall Study|Other than specified above|22
5391740|NCT03211858|18568564|P2|Overall Study|Non-serious Hypoglycemia|0
5391741|NCT03211858|18568565|P1|Overall Study|Non-serious Hypoglycemia|1
5391742|NCT03211858|18568564|P2|Overall Study|Poor compliance to protocol|2
5391743|NCT03211858|18568565|P1|Overall Study|Poor compliance to protocol|6
5391744|NCT03211858|18568564|P2|Overall Study|Lack of Efficacy|4
5391745|NCT03211858|18568565|P1|Overall Study|Lack of Efficacy|0
5391746|NCT03211858|18568564|P2|Overall Study|Adverse Event|6
5391747|NCT03211858|18568565|P1|Overall Study|Adverse Event|8
5391748|NCT03211156|18568617|P2|Overall Study|Adverse Event|0
5391749|NCT03211156|18568618|P1|Overall Study|Adverse Event|1
5391750|NCT03211156|18568617|P2|Overall Study|Lost to Follow-up|1
5391751|NCT03211156|18568618|P1|Overall Study|Lost to Follow-up|1
5391752|NCT03211156|18568617|P2|Overall Study|Withdrawal by Subject|2
5391753|NCT03211156|18568618|P1|Overall Study|Withdrawal by Subject|0
5391754|NCT03210961|18568649|P15|Overall Study|Other|0
5391755|NCT03210961|18568650|P14|Overall Study|Other|2
5391756|NCT03210961|18568651|P13|Overall Study|Other|2
5391757|NCT03210961|18568652|P12|Overall Study|Other|0
5391758|NCT03210961|18568653|P11|Overall Study|Other|1
5391759|NCT03210961|18568654|P10|Overall Study|Other|0
5391760|NCT03210961|18568655|P9|Overall Study|Other|0
5391761|NCT03210961|18568656|P8|Overall Study|Other|0
5391762|NCT03210961|18568657|P7|Overall Study|Other|1
5391763|NCT03210961|18568658|P6|Overall Study|Other|0
5391764|NCT03210961|18568659|P5|Overall Study|Other|0
5391765|NCT03210961|18568660|P4|Overall Study|Other|1
5391766|NCT03210961|18568661|P3|Overall Study|Other|0
5391767|NCT03210961|18568662|P2|Overall Study|Other|0
5391768|NCT03210961|18568663|P1|Overall Study|Other|0
5391769|NCT03210961|18568649|P15|Overall Study|No Longer Meets Eligibility Criteria|0
5391770|NCT03210961|18568650|P14|Overall Study|No Longer Meets Eligibility Criteria|1
5391771|NCT03210961|18568651|P13|Overall Study|No Longer Meets Eligibility Criteria|0
5391772|NCT03210961|18568652|P12|Overall Study|No Longer Meets Eligibility Criteria|0
5391773|NCT03210961|18568653|P11|Overall Study|No Longer Meets Eligibility Criteria|0
5391774|NCT03210961|18568654|P10|Overall Study|No Longer Meets Eligibility Criteria|0
5391775|NCT03210961|18568655|P9|Overall Study|No Longer Meets Eligibility Criteria|0
5391776|NCT03210961|18568656|P8|Overall Study|No Longer Meets Eligibility Criteria|0
5391777|NCT03210961|18568657|P7|Overall Study|No Longer Meets Eligibility Criteria|0
5391778|NCT03210961|18568658|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5391779|NCT03210961|18568659|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5391780|NCT03210961|18568660|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5391781|NCT03210961|18568661|P3|Overall Study|No Longer Meets Eligibility Criteria|0
5391782|NCT03210961|18568662|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5391783|NCT03210961|18568663|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5391784|NCT03210961|18568649|P15|Overall Study|Withdrawal by Subject|1
5391785|NCT03210961|18568650|P14|Overall Study|Withdrawal by Subject|0
5391786|NCT03210961|18568651|P13|Overall Study|Withdrawal by Subject|0
5391787|NCT03210961|18568652|P12|Overall Study|Withdrawal by Subject|0
5391788|NCT03210961|18568653|P11|Overall Study|Withdrawal by Subject|0
5391789|NCT03210961|18568654|P10|Overall Study|Withdrawal by Subject|0
5391790|NCT03210961|18568655|P9|Overall Study|Withdrawal by Subject|0
5391791|NCT03210961|18568656|P8|Overall Study|Withdrawal by Subject|0
5391792|NCT03210961|18568657|P7|Overall Study|Withdrawal by Subject|0
5391793|NCT03210961|18568658|P6|Overall Study|Withdrawal by Subject|0
5391794|NCT03210961|18568659|P5|Overall Study|Withdrawal by Subject|0
5391795|NCT03210961|18568660|P4|Overall Study|Withdrawal by Subject|0
5391796|NCT03210961|18568661|P3|Overall Study|Withdrawal by Subject|0
5391797|NCT03210961|18568662|P2|Overall Study|Withdrawal by Subject|0
5391798|NCT03210961|18568663|P1|Overall Study|Withdrawal by Subject|0
5391799|NCT03210961|18568649|P15|Overall Study|Lost to Follow-up|1
5391800|NCT03210961|18568650|P14|Overall Study|Lost to Follow-up|0
5391801|NCT03210961|18568651|P13|Overall Study|Lost to Follow-up|0
5391802|NCT03210961|18568652|P12|Overall Study|Lost to Follow-up|0
5391803|NCT03210961|18568653|P11|Overall Study|Lost to Follow-up|0
5391804|NCT03210961|18568654|P10|Overall Study|Lost to Follow-up|0
5391805|NCT03210961|18568655|P9|Overall Study|Lost to Follow-up|0
5391806|NCT03210961|18568656|P8|Overall Study|Lost to Follow-up|0
5391807|NCT03210961|18568657|P7|Overall Study|Lost to Follow-up|0
5391808|NCT03210961|18568658|P6|Overall Study|Lost to Follow-up|0
5391809|NCT03210961|18568659|P5|Overall Study|Lost to Follow-up|0
5391810|NCT03210961|18568660|P4|Overall Study|Lost to Follow-up|0
5391811|NCT03210961|18568661|P3|Overall Study|Lost to Follow-up|0
5391812|NCT03210961|18568662|P2|Overall Study|Lost to Follow-up|0
5391813|NCT03210961|18568663|P1|Overall Study|Lost to Follow-up|0
5391814|NCT03210961|18568649|P15|Overall Study|Adverse Event|0
5391815|NCT03210961|18568650|P14|Overall Study|Adverse Event|1
5391816|NCT03210961|18568651|P13|Overall Study|Adverse Event|0
5391817|NCT03210961|18568652|P12|Overall Study|Adverse Event|0
5391818|NCT03210961|18568653|P11|Overall Study|Adverse Event|0
5391819|NCT03210961|18568654|P10|Overall Study|Adverse Event|0
5391820|NCT03210961|18568655|P9|Overall Study|Adverse Event|0
5391821|NCT03210961|18568656|P8|Overall Study|Adverse Event|0
5391822|NCT03210961|18568657|P7|Overall Study|Adverse Event|0
5391823|NCT03210961|18568658|P6|Overall Study|Adverse Event|0
5391824|NCT03210961|18568659|P5|Overall Study|Adverse Event|0
5391825|NCT03210961|18568660|P4|Overall Study|Adverse Event|0
5391826|NCT03210961|18568661|P3|Overall Study|Adverse Event|0
5391827|NCT03210961|18568662|P2|Overall Study|Adverse Event|0
5391828|NCT03210961|18568663|P1|Overall Study|Adverse Event|0
5391829|NCT03210519|18569022|P2|Overall Study|Adverse Event|0
5391830|NCT03210519|18569023|P1|Overall Study|Adverse Event|2
5391831|NCT03210220|18569079|P2|Overall Study|Physician Decision|0
5391832|NCT03210220|18569080|P1|Overall Study|Physician Decision|1
5391833|NCT03209973|18569103|P1|Overall Study|Death|1
5391834|NCT03209973|18569103|P1|Overall Study|Patient withdrew consent|3
5391835|NCT03209570|18569109|P2|Overall Study|Withdrawal by Subject|3
5391836|NCT03209570|18569110|P1|Overall Study|Withdrawal by Subject|0
5391837|NCT03209570|18569109|P2|Overall Study|Protocol Violation|0
5391838|NCT03209570|18569110|P1|Overall Study|Protocol Violation|1
5391839|NCT03209570|18569109|P2|Overall Study|Incomplete Data|10
5391840|NCT03209570|18569110|P1|Overall Study|Incomplete Data|8
5391841|NCT03209570|18569109|P2|Overall Study|Death|0
5391842|NCT03209570|18569110|P1|Overall Study|Death|1
5391843|NCT03209518|18569120|P1|Overall Study|Protocol Deviation|1
5391844|NCT03209518|18569120|P1|Overall Study|Case Report Forms Uncollected|1
5391845|NCT03209492|18569125|P1|Overall Study|Case Report Forms Uncollected|5
5391846|NCT03208933|18569130|P1|Overall Study|Protocol Violation|1
5391847|NCT03208933|18569130|P1|Overall Study|Physician Decision|3
5391848|NCT03208933|18569130|P1|Overall Study|Lost to Follow-up|2
5391849|NCT03208933|18569130|P1|Overall Study|Adverse Event|1
5391850|NCT03208933|18569130|P1|Overall Study|Withdrawal by Subject|3
5391851|NCT03208933|18569130|P1|Overall Study|Death|3
5391852|NCT03208088|18569177|P10|Period 4|Unsatisfactory Test Article|0
5391853|NCT03208088|18569178|P9|Period 4|Unsatisfactory Test Article|0
5391854|NCT03208088|18569179|P8|Period 4|Unsatisfactory Test Article|0
5391855|NCT03208088|18569180|P7|Period 4|Unsatisfactory Test Article|0
5391856|NCT03208088|18569181|P6|Period 4|Unsatisfactory Test Article|0
5391857|NCT03208088|18569182|P5|Period 4|Unsatisfactory Test Article|0
5391858|NCT03208088|18569183|P4|Period 4|Unsatisfactory Test Article|1
5391859|NCT03208088|18569184|P3|Period 4|Unsatisfactory Test Article|0
5391860|NCT03208088|18569185|P2|Period 4|Unsatisfactory Test Article|0
5391861|NCT03208088|18569186|P1|Period 4|Unsatisfactory Test Article|0
5391862|NCT03208088|18569177|P10|Period 3|Unsatisfactory Test Article|0
5391863|NCT03208088|18569178|P9|Period 3|Unsatisfactory Test Article|0
5391864|NCT03208088|18569179|P8|Period 3|Unsatisfactory Test Article|0
5391865|NCT03208088|18569180|P7|Period 3|Unsatisfactory Test Article|0
5391866|NCT03208088|18569181|P6|Period 3|Unsatisfactory Test Article|0
5391867|NCT03208088|18569182|P5|Period 3|Unsatisfactory Test Article|0
5391868|NCT03208088|18569183|P4|Period 3|Unsatisfactory Test Article|1
5391869|NCT03208088|18569184|P3|Period 3|Unsatisfactory Test Article|0
5391870|NCT03208088|18569185|P2|Period 3|Unsatisfactory Test Article|0
5391871|NCT03208088|18569186|P1|Period 3|Unsatisfactory Test Article|0
5391872|NCT03208088|18569177|P10|Period 2|Withdrawal by Subject|0
5391873|NCT03208088|18569178|P9|Period 2|Withdrawal by Subject|1
5391874|NCT03208088|18569179|P8|Period 2|Withdrawal by Subject|0
5391875|NCT03208088|18569180|P7|Period 2|Withdrawal by Subject|0
5391876|NCT03208088|18569181|P6|Period 2|Withdrawal by Subject|0
5391877|NCT03208088|18569182|P5|Period 2|Withdrawal by Subject|0
5391878|NCT03208088|18569183|P4|Period 2|Withdrawal by Subject|0
5391879|NCT03208088|18569184|P3|Period 2|Withdrawal by Subject|0
5391880|NCT03208088|18569185|P2|Period 2|Withdrawal by Subject|0
5391881|NCT03208088|18569186|P1|Period 2|Withdrawal by Subject|0
5391882|NCT03207763|18569216|P2|Overall Study|Lost to Follow-up|0
5391883|NCT03207763|18569217|P1|Overall Study|Lost to Follow-up|1
5391884|NCT03207750|18569243|P2|Overall Study|OTHER, NOT SPECIFIED|4
5391885|NCT03207750|18569244|P1|Overall Study|OTHER, NOT SPECIFIED|5
5391886|NCT03207750|18569243|P2|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
5391887|NCT03207750|18569244|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
5391888|NCT03207750|18569243|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
5391889|NCT03207750|18569244|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
5391890|NCT03207750|18569243|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
5391891|NCT03207750|18569244|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
5391892|NCT03207750|18569243|P2|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
5391893|NCT03207750|18569244|P1|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
5391894|NCT03207750|18569243|P2|Overall Study|Protocol Violation|1
5391895|NCT03207750|18569244|P1|Overall Study|Protocol Violation|0
5391896|NCT03207750|18569243|P2|Overall Study|Lost to Follow-up|29
5391897|NCT03207750|18569244|P1|Overall Study|Lost to Follow-up|21
5391898|NCT03207750|18569243|P2|Overall Study|Adverse Event|2
5391899|NCT03207750|18569244|P1|Overall Study|Adverse Event|3
5391900|NCT03207243|18569324|P2|Overall Study|Protocol Violation|3
5391901|NCT03207243|18569325|P1|Overall Study|Protocol Violation|0
5391902|NCT03207243|18569324|P2|Overall Study|Protocol Specified Withdrawal Criteria|2
5391903|NCT03207243|18569325|P1|Overall Study|Protocol Specified Withdrawal Criteria|7
5391904|NCT03207243|18569324|P2|Overall Study|Lost to Follow-up|1
5391905|NCT03207243|18569325|P1|Overall Study|Lost to Follow-up|0
5391906|NCT03207243|18569324|P2|Overall Study|Physician Decision|1
5391907|NCT03207243|18569325|P1|Overall Study|Physician Decision|1
5391908|NCT03207243|18569324|P2|Overall Study|Withdrawal by Subject|4
5391909|NCT03207243|18569325|P1|Overall Study|Withdrawal by Subject|2
5391910|NCT03207243|18569324|P2|Overall Study|Loss of Asthma Control|31
5391911|NCT03207243|18569325|P1|Overall Study|Loss of Asthma Control|47
5391912|NCT03207243|18569324|P2|Overall Study|Adverse Event|2
5391913|NCT03207243|18569325|P1|Overall Study|Adverse Event|2
5391914|NCT03206970|18569436|P1|Overall Study|Lost to Follow-up|3
5391915|NCT03206970|18569436|P1|Overall Study|Withdrawal by Subject|9
5391916|NCT03206970|18569436|P1|Overall Study|Death|14
5391917|NCT03206918|18569440|P1|Overall Study|Withdrawal by Subject|2
5391918|NCT03206918|18569440|P1|Overall Study|Death|4
5391919|NCT03206788|18569446|P2|Overall Study|Physician Decision|1
5391920|NCT03206788|18569447|P1|Overall Study|Physician Decision|0
5391921|NCT03206788|18569446|P2|Overall Study|Adverse Event|1
5391922|NCT03206788|18569447|P1|Overall Study|Adverse Event|0
5391923|NCT03206788|18569446|P2|Overall Study|Withdrawal by Subject|1
5391924|NCT03206788|18569447|P1|Overall Study|Withdrawal by Subject|0
5391925|NCT03206216|18569485|P2|Overall Study|Withdrawal by Subject|1
5391926|NCT03206216|18569486|P1|Overall Study|Withdrawal by Subject|0
5391927|NCT03205488|18569497|P3|Overall Study|Protocol Violation|1
5391928|NCT03205488|18569498|P2|Overall Study|Protocol Violation|0
5391929|NCT03205488|18569499|P1|Overall Study|Protocol Violation|0
5391930|NCT03205488|18569497|P3|Overall Study|Adverse Event|4
5391931|NCT03205488|18569498|P2|Overall Study|Adverse Event|2
5391932|NCT03205488|18569499|P1|Overall Study|Adverse Event|1
5391933|NCT03205371|18569525|P12|Overall Study|Adverse Event|0
5391934|NCT03205371|18569526|P11|Overall Study|Adverse Event|0
5391935|NCT03205371|18569527|P10|Overall Study|Adverse Event|0
5391936|NCT03205371|18569528|P9|Overall Study|Adverse Event|0
5391937|NCT03205371|18569529|P8|Overall Study|Adverse Event|1
5391938|NCT03205371|18569530|P7|Overall Study|Adverse Event|0
5391939|NCT03205371|18569531|P6|Overall Study|Adverse Event|0
5391940|NCT03205371|18569532|P5|Overall Study|Adverse Event|0
5391941|NCT03205371|18569533|P4|Overall Study|Adverse Event|0
5391942|NCT03205371|18569534|P3|Overall Study|Adverse Event|0
5391943|NCT03205371|18569535|P2|Overall Study|Adverse Event|0
5391944|NCT03205371|18569536|P1|Overall Study|Adverse Event|0
5391945|NCT03205371|18569525|P12|Overall Study|Protocol Violation|0
5391946|NCT03205371|18569526|P11|Overall Study|Protocol Violation|0
5391947|NCT03205371|18569527|P10|Overall Study|Protocol Violation|0
5391948|NCT03205371|18569528|P9|Overall Study|Protocol Violation|0
5391949|NCT03205371|18569529|P8|Overall Study|Protocol Violation|0
5391950|NCT03205371|18569530|P7|Overall Study|Protocol Violation|1
5391951|NCT03205371|18569531|P6|Overall Study|Protocol Violation|0
5391952|NCT03205371|18569532|P5|Overall Study|Protocol Violation|0
5391953|NCT03205371|18569533|P4|Overall Study|Protocol Violation|0
5391954|NCT03205371|18569534|P3|Overall Study|Protocol Violation|0
5391955|NCT03205371|18569535|P2|Overall Study|Protocol Violation|0
5391956|NCT03205371|18569536|P1|Overall Study|Protocol Violation|0
5391957|NCT03205371|18569525|P12|Overall Study|Lost to Follow-up|0
5391958|NCT03205371|18569526|P11|Overall Study|Lost to Follow-up|0
5391959|NCT03205371|18569527|P10|Overall Study|Lost to Follow-up|0
5391960|NCT03205371|18569528|P9|Overall Study|Lost to Follow-up|3
5391961|NCT03205371|18569529|P8|Overall Study|Lost to Follow-up|2
5391962|NCT03205371|18569530|P7|Overall Study|Lost to Follow-up|5
5391963|NCT03205371|18569531|P6|Overall Study|Lost to Follow-up|0
5391964|NCT03205371|18569532|P5|Overall Study|Lost to Follow-up|0
5391965|NCT03205371|18569533|P4|Overall Study|Lost to Follow-up|0
5391966|NCT03205371|18569534|P3|Overall Study|Lost to Follow-up|0
5391967|NCT03205371|18569535|P2|Overall Study|Lost to Follow-up|0
5391968|NCT03205371|18569536|P1|Overall Study|Lost to Follow-up|0
5391969|NCT03205371|18569525|P12|Overall Study|Withdrawal by Subject|1
5391970|NCT03205371|18569526|P11|Overall Study|Withdrawal by Subject|0
5391971|NCT03205371|18569527|P10|Overall Study|Withdrawal by Subject|0
5391972|NCT03205371|18569528|P9|Overall Study|Withdrawal by Subject|2
5391973|NCT03205371|18569529|P8|Overall Study|Withdrawal by Subject|0
5391974|NCT03205371|18569530|P7|Overall Study|Withdrawal by Subject|4
5391975|NCT03205371|18569531|P6|Overall Study|Withdrawal by Subject|0
5391976|NCT03205371|18569532|P5|Overall Study|Withdrawal by Subject|0
5391977|NCT03205371|18569533|P4|Overall Study|Withdrawal by Subject|0
5391978|NCT03205371|18569534|P3|Overall Study|Withdrawal by Subject|0
5391979|NCT03205371|18569535|P2|Overall Study|Withdrawal by Subject|1
5391980|NCT03205371|18569536|P1|Overall Study|Withdrawal by Subject|4
5391981|NCT03205163|18569625|P2|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
5391982|NCT03205163|18569626|P1|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
5391983|NCT03204539|18569722|P2|Overall Study|Loss of funding|1
5391984|NCT03204539|18569723|P1|Overall Study|Loss of funding|0
5391985|NCT03204279|18569747|P2|Overall Study|Withdrawal by Subject|1
5391986|NCT03204279|18569748|P1|Overall Study|Withdrawal by Subject|0
5391987|NCT03203291|18569875|P1|Overall Study|Withdrawal by Subject|1
5391988|NCT03201900|18569923|P1|Extension Phase (Up to 124 Weeks)|Ongoing|41
5391989|NCT03201900|18569923|P1|Extension Phase (Up to 124 Weeks)|Withdrawal of consent|1
5391990|NCT03201900|18569923|P1|Extension Phase (Up to 124 Weeks)|Lost to Follow-up|1
5391991|NCT03201900|18569923|P1|Extension Phase (Up to 124 Weeks)|Inadequate therapeutic effect|1
5391992|NCT03201900|18569923|P1|Extension Phase (Up to 124 Weeks)|Pregnancy|1
5391993|NCT03201900|18569923|P1|Extension Phase (Up to 124 Weeks)|Subject choice|1
5391994|NCT03201900|18569923|P1|Treatment Phase (Up to 62 Weeks)|Not treated|2
5391995|NCT03201900|18569923|P1|Treatment Phase (Up to 62 Weeks)|Other than specified|11
5391996|NCT03201900|18569923|P1|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
5391997|NCT03201900|18569923|P1|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
5391998|NCT03201900|18569923|P1|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
5391999|NCT03201900|18569923|P1|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
5392000|NCT03201900|18569923|P1|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
5392001|NCT03201419|18569938|P9|Overall Study|Other|0
5392002|NCT03201419|18569939|P8|Overall Study|Other|0
5392003|NCT03201419|18569940|P7|Overall Study|Other|0
5392004|NCT03201419|18569941|P6|Overall Study|Other|0
5392005|NCT03201419|18569942|P5|Overall Study|Other|0
5392006|NCT03201419|18569943|P4|Overall Study|Other|0
5392007|NCT03201419|18569944|P3|Overall Study|Other|1
5392008|NCT03201419|18569945|P2|Overall Study|Other|0
5392009|NCT03201419|18569946|P1|Overall Study|Other|0
5392010|NCT03201419|18569938|P9|Overall Study|Withdrawal by Subject|2
5392011|NCT03201419|18569939|P8|Overall Study|Withdrawal by Subject|1
5392012|NCT03201419|18569940|P7|Overall Study|Withdrawal by Subject|0
5392013|NCT03201419|18569941|P6|Overall Study|Withdrawal by Subject|0
5392014|NCT03201419|18569942|P5|Overall Study|Withdrawal by Subject|0
5392015|NCT03201419|18569943|P4|Overall Study|Withdrawal by Subject|0
5392016|NCT03201419|18569944|P3|Overall Study|Withdrawal by Subject|1
5392017|NCT03201419|18569945|P2|Overall Study|Withdrawal by Subject|2
5392018|NCT03201419|18569946|P1|Overall Study|Withdrawal by Subject|4
5392019|NCT03201419|18569938|P9|Overall Study|Protocol Deviation|0
5392020|NCT03201419|18569939|P8|Overall Study|Protocol Deviation|0
5392021|NCT03201419|18569940|P7|Overall Study|Protocol Deviation|1
5392022|NCT03201419|18569941|P6|Overall Study|Protocol Deviation|0
5392023|NCT03201419|18569942|P5|Overall Study|Protocol Deviation|0
5392024|NCT03201419|18569943|P4|Overall Study|Protocol Deviation|0
5392025|NCT03201419|18569944|P3|Overall Study|Protocol Deviation|0
5392026|NCT03201419|18569945|P2|Overall Study|Protocol Deviation|0
5392027|NCT03201419|18569946|P1|Overall Study|Protocol Deviation|0
5392028|NCT03201419|18569938|P9|Overall Study|Lost to Follow-up|0
5392029|NCT03201419|18569939|P8|Overall Study|Lost to Follow-up|0
5392030|NCT03201419|18569940|P7|Overall Study|Lost to Follow-up|0
5392031|NCT03201419|18569941|P6|Overall Study|Lost to Follow-up|0
5392032|NCT03201419|18569942|P5|Overall Study|Lost to Follow-up|0
5392033|NCT03201419|18569943|P4|Overall Study|Lost to Follow-up|0
5392034|NCT03201419|18569944|P3|Overall Study|Lost to Follow-up|0
5392035|NCT03201419|18569945|P2|Overall Study|Lost to Follow-up|0
5392036|NCT03201419|18569946|P1|Overall Study|Lost to Follow-up|1
5392037|NCT03201419|18569938|P9|Overall Study|Adverse Event|0
5392038|NCT03201419|18569939|P8|Overall Study|Adverse Event|0
5392039|NCT03201419|18569940|P7|Overall Study|Adverse Event|5
5392040|NCT03201419|18569941|P6|Overall Study|Adverse Event|1
5392041|NCT03201419|18569942|P5|Overall Study|Adverse Event|1
5392042|NCT03201419|18569943|P4|Overall Study|Adverse Event|0
5392043|NCT03201419|18569944|P3|Overall Study|Adverse Event|0
5392044|NCT03201419|18569945|P2|Overall Study|Adverse Event|1
5392045|NCT03201419|18569946|P1|Overall Study|Adverse Event|3
5392046|NCT03200912|18570296|P3|Overall Study|Non-compliance with study drug|0
5392047|NCT03200912|18570297|P2|Overall Study|Non-compliance with study drug|1
5392048|NCT03200912|18570298|P1|Overall Study|Non-compliance with study drug|0
5392049|NCT03200912|18570296|P3|Overall Study|Withdrawal by Subject|4
5392050|NCT03200912|18570297|P2|Overall Study|Withdrawal by Subject|2
5392051|NCT03200912|18570298|P1|Overall Study|Withdrawal by Subject|1
5392052|NCT03200912|18570296|P3|Overall Study|Adverse Event|0
5392053|NCT03200912|18570297|P2|Overall Study|Adverse Event|0
5392054|NCT03200912|18570298|P1|Overall Study|Adverse Event|3
5392055|NCT03200860|18570308|P2|Overall Study|Withdrawal by Subject|0
5392056|NCT03200860|18570309|P1|Overall Study|Withdrawal by Subject|1
5392057|NCT03199911|18570352|P2|Overall Study|Did not proceed with surgery|1
5392058|NCT03199911|18570353|P1|Overall Study|Did not proceed with surgery|2
5392059|NCT03199911|18570352|P2|Overall Study|Lost to Follow-up|5
5392060|NCT03199911|18570353|P1|Overall Study|Lost to Follow-up|5
5392061|NCT03198767|18570404|P7|Overall Study|Protocol Violation|0
5392062|NCT03198767|18570405|P6|Overall Study|Protocol Violation|0
5392063|NCT03198767|18570406|P5|Overall Study|Protocol Violation|0
5392064|NCT03198767|18570407|P4|Overall Study|Protocol Violation|6
5392065|NCT03198767|18570408|P3|Overall Study|Protocol Violation|0
5392066|NCT03198767|18570409|P2|Overall Study|Protocol Violation|0
5392067|NCT03198767|18570410|P1|Overall Study|Protocol Violation|0
5392068|NCT03198754|18570451|P2|Overall Study|Ineligible|1
5392069|NCT03198754|18570452|P1|Overall Study|Ineligible|2
5392070|NCT03198754|18570451|P2|Overall Study|Lost to Follow-up|3
5392071|NCT03198754|18570452|P1|Overall Study|Lost to Follow-up|4
5392072|NCT03198754|18570451|P2|Overall Study|Withdrawal by Subject|4
5392073|NCT03198754|18570452|P1|Overall Study|Withdrawal by Subject|5
5392074|NCT03198520|18570490|P1|Overall Study|Study Ended|1
5392075|NCT03198520|18570490|P1|Overall Study|Withdrawal by Subject|1
5392076|NCT03198520|18570490|P1|Overall Study|Protocol Violation|2
5392077|NCT03198520|18570490|P1|Overall Study|Physician Decision|2
5392078|NCT03198507|18570513|P2|Overall Study|Withdrawal by Subject|0
5392079|NCT03198507|18570514|P1|Overall Study|Withdrawal by Subject|1
5392080|NCT03197883|18570640|P2|Overall Study|Other (Not Specified)|5
5392081|NCT03197883|18570641|P1|Overall Study|Other (Not Specified)|0
5392082|NCT03197883|18570640|P2|Overall Study|Protocol Violation|0
5392083|NCT03197883|18570641|P1|Overall Study|Protocol Violation|1
5392084|NCT03197883|18570640|P2|Overall Study|Lost to Follow-up|0
5392085|NCT03197883|18570641|P1|Overall Study|Lost to Follow-up|1
5392086|NCT03197883|18570640|P2|Overall Study|Adverse Event|1
5392087|NCT03197883|18570641|P1|Overall Study|Adverse Event|1
5392088|NCT03197558|18570671|P1|Overall Study|Tubes not placed|1
5392089|NCT03197376|18570679|P4|Immune Persistence Phase|Not vaccine related|1
5392090|NCT03197376|18570680|P3|Immune Persistence Phase|Not vaccine related|1
5392091|NCT03197376|18570681|P2|Immune Persistence Phase|Not vaccine related|0
5392092|NCT03197376|18570682|P1|Immune Persistence Phase|Not vaccine related|1
5392093|NCT03197376|18570679|P4|Immune Persistence Phase|Withdrawal by subject's parents|3
5392094|NCT03197376|18570680|P3|Immune Persistence Phase|Withdrawal by subject's parents|2
5392095|NCT03197376|18570681|P2|Immune Persistence Phase|Withdrawal by subject's parents|4
5392096|NCT03197376|18570682|P1|Immune Persistence Phase|Withdrawal by subject's parents|4
5392097|NCT03197376|18570679|P4|Immune Persistence Phase|Lost to Follow-up|1
5392098|NCT03197376|18570680|P3|Immune Persistence Phase|Lost to Follow-up|2
5392099|NCT03197376|18570681|P2|Immune Persistence Phase|Lost to Follow-up|0
5392100|NCT03197376|18570682|P1|Immune Persistence Phase|Lost to Follow-up|0
5392101|NCT03197376|18570679|P4|Primary and Booster Phase|Not vaccine related|6
5392102|NCT03197376|18570680|P3|Primary and Booster Phase|Not vaccine related|0
5392103|NCT03197376|18570681|P2|Primary and Booster Phase|Not vaccine related|2
5392104|NCT03197376|18570682|P1|Primary and Booster Phase|Not vaccine related|1
5392105|NCT03197376|18570679|P4|Primary and Booster Phase|Ineligibility criteria|2
5392106|NCT03197376|18570680|P3|Primary and Booster Phase|Ineligibility criteria|4
5392107|NCT03197376|18570681|P2|Primary and Booster Phase|Ineligibility criteria|1
5392108|NCT03197376|18570682|P1|Primary and Booster Phase|Ineligibility criteria|1
5392109|NCT03197376|18570679|P4|Primary and Booster Phase|Withdrawal by subject's parents|11
5392110|NCT03197376|18570680|P3|Primary and Booster Phase|Withdrawal by subject's parents|14
5392111|NCT03197376|18570681|P2|Primary and Booster Phase|Withdrawal by subject's parents|10
5392112|NCT03197376|18570682|P1|Primary and Booster Phase|Withdrawal by subject's parents|11
5392113|NCT03197376|18570679|P4|Primary and Booster Phase|Physician Decision|3
5392114|NCT03197376|18570680|P3|Primary and Booster Phase|Physician Decision|1
5392115|NCT03197376|18570681|P2|Primary and Booster Phase|Physician Decision|0
5392116|NCT03197376|18570682|P1|Primary and Booster Phase|Physician Decision|1
5392117|NCT03197376|18570679|P4|Primary and Booster Phase|Lost to Follow-up|0
5392118|NCT03197376|18570680|P3|Primary and Booster Phase|Lost to Follow-up|1
5392119|NCT03197376|18570681|P2|Primary and Booster Phase|Lost to Follow-up|0
5392120|NCT03197376|18570682|P1|Primary and Booster Phase|Lost to Follow-up|0
5392121|NCT03197376|18570679|P4|Primary and Booster Phase|Death|2
5392122|NCT03197376|18570680|P3|Primary and Booster Phase|Death|0
5392123|NCT03197376|18570681|P2|Primary and Booster Phase|Death|0
5392124|NCT03197376|18570682|P1|Primary and Booster Phase|Death|1
5392125|NCT03197376|18570679|P4|Primary and Booster Phase|Adverse Event|1
5392126|NCT03197376|18570680|P3|Primary and Booster Phase|Adverse Event|0
5392127|NCT03197376|18570681|P2|Primary and Booster Phase|Adverse Event|0
5392128|NCT03197376|18570682|P1|Primary and Booster Phase|Adverse Event|0
5392129|NCT03196635|18570756|P1|Overall Study|Withdrawal by Subject|1
5392130|NCT03196505|18570776|P2|Overall Study|Physician Decision|26
5392131|NCT03196505|18570777|P1|Overall Study|Physician Decision|26
5392132|NCT03196349|18570788|P3|Overall Study|Study Terminated early|11
5392133|NCT03196349|18570789|P2|Overall Study|Study Terminated early|9
5392134|NCT03196349|18570790|P1|Overall Study|Study Terminated early|15
5392135|NCT03196349|18570788|P3|Overall Study|No data entered|0
5392136|NCT03196349|18570789|P2|Overall Study|No data entered|4
5392137|NCT03196349|18570790|P1|Overall Study|No data entered|2
5392138|NCT03196349|18570788|P3|Overall Study|Did not receive study drug|2
5392139|NCT03196349|18570789|P2|Overall Study|Did not receive study drug|1
5392140|NCT03196349|18570790|P1|Overall Study|Did not receive study drug|0
5392141|NCT03196193|18570827|P2|Overall Study|Computed Tomography (CT) data missing|0
5392142|NCT03196193|18570828|P1|Overall Study|Computed Tomography (CT) data missing|2
5392143|NCT03196193|18570827|P2|Overall Study|Adverse Event|0
5392144|NCT03196193|18570828|P1|Overall Study|Adverse Event|1
5392145|NCT03194490|18570926|P2|Overall Study|participant developed specific neck pain|0
5392146|NCT03194490|18570927|P1|Overall Study|participant developed specific neck pain|1
5392147|NCT03194490|18570926|P2|Overall Study|Lost to Follow-up|3
5392148|NCT03194490|18570927|P1|Overall Study|Lost to Follow-up|1
5392149|NCT03194464|18570969|P1|Overall Study|data not usable|2
5392150|NCT03194217|18571060|P4|Overall Study|Other|0
5392151|NCT03194217|18571061|P3|Overall Study|Other|1
5392152|NCT03194217|18571062|P2|Overall Study|Other|1
5392153|NCT03194217|18571063|P1|Overall Study|Other|0
5392154|NCT03194217|18571060|P4|Overall Study|Failure to meet randomisation criteria|1
5392155|NCT03194217|18571061|P3|Overall Study|Failure to meet randomisation criteria|0
5392156|NCT03194217|18571062|P2|Overall Study|Failure to meet randomisation criteria|0
5392157|NCT03194217|18571063|P1|Overall Study|Failure to meet randomisation criteria|0
5392158|NCT03194217|18571060|P4|Overall Study|Adverse Event|3
5392159|NCT03194217|18571061|P3|Overall Study|Adverse Event|3
5392160|NCT03194217|18571062|P2|Overall Study|Adverse Event|2
5392161|NCT03194217|18571063|P1|Overall Study|Adverse Event|0
5392162|NCT03193047|18571104|P2|Overall Study|Participant Left State|0
5392163|NCT03193047|18571105|P1|Overall Study|Participant Left State|1
5392164|NCT03193047|18571104|P2|Overall Study|Physician Decision|0
5392165|NCT03193047|18571105|P1|Overall Study|Physician Decision|1
5392166|NCT03193021|18571125|P2|Overall Study|Lost to Follow-up|1
5392167|NCT03193021|18571126|P1|Overall Study|Lost to Follow-up|1
5392168|NCT03192904|18571151|P2|Overall Study|Lost to Follow-up|1
5392169|NCT03192904|18571152|P1|Overall Study|Lost to Follow-up|0
5392170|NCT03192904|18571151|P2|Overall Study|Physician Decision|1
5392171|NCT03192904|18571152|P1|Overall Study|Physician Decision|3
5392172|NCT03192488|18571208|P6|Third Intervention (d1)|Adverse Event|0
5392173|NCT03192488|18571209|P5|Third Intervention (d1)|Adverse Event|1
5392174|NCT03192488|18571210|P4|Third Intervention (d1)|Adverse Event|0
5392175|NCT03192488|18571211|P3|Third Intervention (d1)|Adverse Event|0
5392176|NCT03192488|18571212|P2|Third Intervention (d1)|Adverse Event|0
5392177|NCT03192488|18571213|P1|Third Intervention (d1)|Adverse Event|0
5392178|NCT03192488|18571208|P6|First Washout (>6d)|Withdrawal by Subject|1
5392179|NCT03192488|18571209|P5|First Washout (>6d)|Withdrawal by Subject|0
5392180|NCT03192488|18571210|P4|First Washout (>6d)|Withdrawal by Subject|0
5392181|NCT03192488|18571211|P3|First Washout (>6d)|Withdrawal by Subject|1
5392182|NCT03192488|18571212|P2|First Washout (>6d)|Withdrawal by Subject|0
5392183|NCT03192488|18571213|P1|First Washout (>6d)|Withdrawal by Subject|0
5392184|NCT03192475|18571229|P2|Overall Study|Lost to Follow-up|8
5392185|NCT03192475|18571230|P1|Overall Study|Lost to Follow-up|13
5392186|NCT03192475|18571229|P2|Overall Study|Death|1
5392187|NCT03192475|18571230|P1|Overall Study|Death|0
5392188|NCT03192306|18571266|P2|Overall Study|Protocol Violation|1
5392189|NCT03192306|18571267|P1|Overall Study|Protocol Violation|1
5392190|NCT03192306|18571266|P2|Overall Study|Lost to Follow-up|0
5392191|NCT03192306|18571267|P1|Overall Study|Lost to Follow-up|1
5392192|NCT03192306|18571266|P2|Overall Study|Withdrawal by Subject|1
5392193|NCT03192306|18571267|P1|Overall Study|Withdrawal by Subject|1
5392194|NCT03192306|18571266|P2|Overall Study|Did not treat cold sore during study|143
5392195|NCT03192306|18571267|P1|Overall Study|Did not treat cold sore during study|149
5392196|NCT03192137|18571287|P2|Overall Study|Other - Various Administrative Reasons|3
5392197|NCT03192137|18571288|P1|Overall Study|Other - Various Administrative Reasons|8
5392198|NCT03192137|18571287|P2|Overall Study|Surgery Cancelled|1
5392199|NCT03192137|18571288|P1|Overall Study|Surgery Cancelled|4
5392200|NCT03192137|18571287|P2|Overall Study|Protocol Violation|3
5392201|NCT03192137|18571288|P1|Overall Study|Protocol Violation|4
5392202|NCT03192137|18571287|P2|Overall Study|Withdrawal by Subject|3
5392203|NCT03192137|18571288|P1|Overall Study|Withdrawal by Subject|3
5392204|NCT03192137|18571287|P2|Overall Study|Lack of Efficacy|37
5392205|NCT03192137|18571288|P1|Overall Study|Lack of Efficacy|20
5392206|NCT03192137|18571287|P2|Overall Study|Physician Decision|0
5392207|NCT03192137|18571288|P1|Overall Study|Physician Decision|1
5392208|NCT03192137|18571287|P2|Overall Study|Adverse Event|11
5392209|NCT03192137|18571288|P1|Overall Study|Adverse Event|10
5392210|NCT03191552|18571299|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
5392211|NCT03191552|18571300|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
5392212|NCT03191552|18571301|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
5392213|NCT03191552|18571299|P3|Overall Study|Lost to Follow-up|0
5392214|NCT03191552|18571300|P2|Overall Study|Lost to Follow-up|0
5392215|NCT03191552|18571301|P1|Overall Study|Lost to Follow-up|1
5392216|NCT03191396|18571354|P2|Overall Study|Withdrawal by Subject|2
5392217|NCT03191396|18571355|P1|Overall Study|Withdrawal by Subject|3
5392218|NCT03191396|18571354|P2|Overall Study|Lost to Follow-up|3
5392219|NCT03191396|18571355|P1|Overall Study|Lost to Follow-up|0
5392220|NCT03190369|18571452|P2|Overall Study|Randomized but not treated|2
5392221|NCT03190369|18571453|P1|Overall Study|Randomized but not treated|0
5392222|NCT03190369|18571452|P2|Overall Study|Withdraw before treatment|5
5392223|NCT03190369|18571453|P1|Overall Study|Withdraw before treatment|1
5392224|NCT03190369|18571452|P2|Overall Study|Poor compliance to protocol|1
5392225|NCT03190369|18571453|P1|Overall Study|Poor compliance to protocol|0
5392226|NCT03189745|18571514|P2|Overall Study|Conflict in work schedule of participant|1
5392227|NCT03189745|18571515|P1|Overall Study|Conflict in work schedule of participant|1
5392228|NCT03188536|18571574|P1|Overall Study|Not participated/met inclusion criteria|1
5392229|NCT03188536|18571574|P1|Overall Study|No relapse/refractoriness(last 6 months)|5
5392230|NCT03188263|18571643|P2|Overall Study|Physician Decision|0
5392231|NCT03188263|18571644|P1|Overall Study|Physician Decision|1
5392232|NCT03188263|18571643|P2|Overall Study|Withdrawal by Subject|0
5392233|NCT03188263|18571644|P1|Overall Study|Withdrawal by Subject|3
5392234|NCT03188120|18571652|P1|Overall Study|No visit after the first visit|13
5392235|NCT03188120|18571652|P1|Overall Study|Other than specified|3
5392236|NCT03188120|18571652|P1|Overall Study|Lost to Follow-up|7
5392237|NCT03188120|18571652|P1|Overall Study|Improved|12
5392238|NCT03188120|18571652|P1|Overall Study|Insufficient Effectiveness|8
5392239|NCT03188120|18571652|P1|Overall Study|Adverse Event|4
5392240|NCT03188055|18571659|P6|Overall Study|Withdrawal by Subject|0
5392241|NCT03188055|18571660|P5|Overall Study|Withdrawal by Subject|0
5392242|NCT03188055|18571661|P4|Overall Study|Withdrawal by Subject|1
5392243|NCT03188055|18571662|P3|Overall Study|Withdrawal by Subject|0
5392244|NCT03188055|18571663|P2|Overall Study|Withdrawal by Subject|1
5392245|NCT03188055|18571664|P1|Overall Study|Withdrawal by Subject|0
5392246|NCT03188055|18571659|P6|Overall Study|Lost to Follow-up|0
5392247|NCT03188055|18571660|P5|Overall Study|Lost to Follow-up|0
5392248|NCT03188055|18571661|P4|Overall Study|Lost to Follow-up|11
5392249|NCT03188055|18571662|P3|Overall Study|Lost to Follow-up|0
5392250|NCT03188055|18571663|P2|Overall Study|Lost to Follow-up|18
5392251|NCT03188055|18571664|P1|Overall Study|Lost to Follow-up|0
5392252|NCT03188055|18571659|P6|Overall Study|Unavailable for training|0
5392253|NCT03188055|18571660|P5|Overall Study|Unavailable for training|0
5392254|NCT03188055|18571661|P4|Overall Study|Unavailable for training|0
5392255|NCT03188055|18571662|P3|Overall Study|Unavailable for training|19
5392256|NCT03188055|18571663|P2|Overall Study|Unavailable for training|0
5392257|NCT03188055|18571664|P1|Overall Study|Unavailable for training|0
5392258|NCT03187756|18571690|P1|Overall Study|Termination of study|4
5392259|NCT03187301|18571708|P7|Pre-Intervention|Withdrawal by Subject|0
5392260|NCT03187301|18571709|P6|Pre-Intervention|Withdrawal by Subject|0
5392261|NCT03187301|18571710|P5|Pre-Intervention|Withdrawal by Subject|0
5392262|NCT03187301|18571711|P4|Pre-Intervention|Withdrawal by Subject|0
5392263|NCT03187301|18571712|P3|Pre-Intervention|Withdrawal by Subject|0
5392264|NCT03187301|18571713|P2|Pre-Intervention|Withdrawal by Subject|0
5392265|NCT03187301|18571714|P1|Pre-Intervention|Withdrawal by Subject|1
5392266|NCT03187301|18571708|P7|Titration Period|Exclusion Criteria Met|1
5392267|NCT03187301|18571709|P6|Titration Period|Exclusion Criteria Met|0
5392268|NCT03187301|18571710|P5|Titration Period|Exclusion Criteria Met|0
5392269|NCT03187301|18571711|P4|Titration Period|Exclusion Criteria Met|0
5392270|NCT03187301|18571712|P3|Titration Period|Exclusion Criteria Met|0
5392271|NCT03187301|18571713|P2|Titration Period|Exclusion Criteria Met|0
5392272|NCT03187301|18571714|P1|Titration Period|Exclusion Criteria Met|0
5392273|NCT03187301|18571708|P7|Titration Period|Withdrawal by Subject|1
5392274|NCT03187301|18571709|P6|Titration Period|Withdrawal by Subject|0
5392275|NCT03187301|18571710|P5|Titration Period|Withdrawal by Subject|0
5392276|NCT03187301|18571711|P4|Titration Period|Withdrawal by Subject|0
5392277|NCT03187301|18571712|P3|Titration Period|Withdrawal by Subject|0
5392278|NCT03187301|18571713|P2|Titration Period|Withdrawal by Subject|0
5392279|NCT03187301|18571714|P1|Titration Period|Withdrawal by Subject|0
5392280|NCT03187301|18571708|P7|Titration Period|Adverse Event|5
5392281|NCT03187301|18571709|P6|Titration Period|Adverse Event|0
5392282|NCT03187301|18571710|P5|Titration Period|Adverse Event|0
5392283|NCT03187301|18571711|P4|Titration Period|Adverse Event|0
5392284|NCT03187301|18571712|P3|Titration Period|Adverse Event|0
5392285|NCT03187301|18571713|P2|Titration Period|Adverse Event|0
5392286|NCT03187301|18571714|P1|Titration Period|Adverse Event|0
5392287|NCT03187197|18571766|P3|Overall Study|NA in incl/excl criteria, not analyzed.|1
5392288|NCT03187197|18571767|P2|Overall Study|NA in incl/excl criteria, not analyzed.|45
5392289|NCT03187197|18571768|P1|Overall Study|NA in incl/excl criteria, not analyzed.|14
5392290|NCT03187197|18571766|P3|Overall Study|Status missing|3
5392291|NCT03187197|18571767|P2|Overall Study|Status missing|33
5392292|NCT03187197|18571768|P1|Overall Study|Status missing|2
5392293|NCT03187197|18571766|P3|Overall Study|Missing|3
5392294|NCT03187197|18571767|P2|Overall Study|Missing|32
5392295|NCT03187197|18571768|P1|Overall Study|Missing|1
5392296|NCT03187197|18571766|P3|Overall Study|Reason not listed|1
5392297|NCT03187197|18571767|P2|Overall Study|Reason not listed|54
5392298|NCT03187197|18571768|P1|Overall Study|Reason not listed|2
5392299|NCT03187197|18571766|P3|Overall Study|Administrative problem|0
5392300|NCT03187197|18571767|P2|Overall Study|Administrative problem|1
5392301|NCT03187197|18571768|P1|Overall Study|Administrative problem|1
5392302|NCT03187197|18571766|P3|Overall Study|Death|0
5392303|NCT03187197|18571767|P2|Overall Study|Death|11
5392304|NCT03187197|18571768|P1|Overall Study|Death|0
5392305|NCT03187197|18571766|P3|Overall Study|Adverse Event|0
5392306|NCT03187197|18571767|P2|Overall Study|Adverse Event|29
5392307|NCT03187197|18571768|P1|Overall Study|Adverse Event|6
5392308|NCT03187197|18571766|P3|Overall Study|Lost to Follow-up|7
5392309|NCT03187197|18571767|P2|Overall Study|Lost to Follow-up|60
5392310|NCT03187197|18571768|P1|Overall Study|Lost to Follow-up|1
5392311|NCT03187197|18571766|P3|Overall Study|Withdrawal by Subject|4
5392312|NCT03187197|18571767|P2|Overall Study|Withdrawal by Subject|63
5392313|NCT03187197|18571768|P1|Overall Study|Withdrawal by Subject|8
5392314|NCT03187197|18571766|P3|Overall Study|Stopped Pradaxa®/VKA|4
5392315|NCT03187197|18571767|P2|Overall Study|Stopped Pradaxa®/VKA|65
5392316|NCT03187197|18571768|P1|Overall Study|Stopped Pradaxa®/VKA|11
5392317|NCT03186781|18571806|P6|Overall Study|Withdrawal by Subject|0
5392318|NCT03186781|18571807|P5|Overall Study|Withdrawal by Subject|1
5392319|NCT03186781|18571808|P4|Overall Study|Withdrawal by Subject|0
5392320|NCT03186781|18571809|P3|Overall Study|Withdrawal by Subject|0
5392321|NCT03186781|18571810|P2|Overall Study|Withdrawal by Subject|0
5392322|NCT03186781|18571811|P1|Overall Study|Withdrawal by Subject|0
5392323|NCT03186781|18571806|P6|Overall Study|Moved from Area|0
5392324|NCT03186781|18571807|P5|Overall Study|Moved from Area|1
5392325|NCT03186781|18571808|P4|Overall Study|Moved from Area|0
5392326|NCT03186781|18571809|P3|Overall Study|Moved from Area|0
5392327|NCT03186781|18571810|P2|Overall Study|Moved from Area|0
5392328|NCT03186781|18571811|P1|Overall Study|Moved from Area|0
5392329|NCT03186781|18571806|P6|Overall Study|Lost to Follow-up|0
5392330|NCT03186781|18571807|P5|Overall Study|Lost to Follow-up|1
5392331|NCT03186781|18571808|P4|Overall Study|Lost to Follow-up|0
5392332|NCT03186781|18571809|P3|Overall Study|Lost to Follow-up|1
5392333|NCT03186781|18571810|P2|Overall Study|Lost to Follow-up|0
5392334|NCT03186781|18571811|P1|Overall Study|Lost to Follow-up|0
5392335|NCT03185481|18571908|P1|Overall Study|Study Terminated by Sponsor|4
5392336|NCT03185481|18571908|P1|Overall Study|Adverse Event|1
5392337|NCT03184987|18571979|P3|Overall Study|Adverse Event|1
5392338|NCT03184987|18571980|P2|Overall Study|Adverse Event|0
5392339|NCT03184987|18571981|P1|Overall Study|Adverse Event|1
5392340|NCT03184987|18571979|P3|Overall Study|Physician Decision|1
5392341|NCT03184987|18571980|P2|Overall Study|Physician Decision|0
5392342|NCT03184987|18571981|P1|Overall Study|Physician Decision|0
5392343|NCT03184987|18571979|P3|Overall Study|Withdrawal by Subject|2
5392344|NCT03184987|18571980|P2|Overall Study|Withdrawal by Subject|1
5392345|NCT03184987|18571981|P1|Overall Study|Withdrawal by Subject|0
5392346|NCT03184701|18572046|P1|Overall Study|Lost to Follow-up|5
5392347|NCT03184701|18572046|P1|Overall Study|Withdrawal by Subject|6
5392348|NCT03184701|18572046|P1|Overall Study|Physician Decision|3
5392349|NCT03184701|18572046|P1|Overall Study|Death|3
5392350|NCT03184519|18572050|P1|Overall Study|Physician Decision|21
5392351|NCT03184519|18572050|P1|Overall Study|Lost to Follow-up|6
5392352|NCT03184441|18572054|P1|Overall Study|Withdrawal by Subject|1
5392353|NCT03184077|18572080|P2|Overall Study|Lost to Follow-up|21
5392354|NCT03184077|18572081|P1|Overall Study|Lost to Follow-up|21
5392355|NCT03183518|18572100|P1|Overall Study|Other (Withdrawal of consent)|1
5392356|NCT03183518|18572100|P1|Overall Study|Other (Not specified)|2
5392357|NCT03183063|18572134|P3|Overall Study|Physician Decision|4
5392358|NCT03183063|18572135|P2|Overall Study|Physician Decision|4
5392359|NCT03183063|18572136|P1|Overall Study|Physician Decision|3
5392360|NCT03183063|18572134|P3|Overall Study|Withdrawal by Subject|0
5392361|NCT03183063|18572135|P2|Overall Study|Withdrawal by Subject|0
5392362|NCT03183063|18572136|P1|Overall Study|Withdrawal by Subject|2
5392363|NCT03182738|18572191|P2|Overall Study|Withdrawal by Subject|1
5392364|NCT03182738|18572192|P1|Overall Study|Withdrawal by Subject|0
5392365|NCT03182738|18572191|P2|Overall Study|Pregnancy|1
5392366|NCT03182738|18572192|P1|Overall Study|Pregnancy|0
5392367|NCT03182738|18572191|P2|Overall Study|Lost to Follow-up|3
5392368|NCT03182738|18572192|P1|Overall Study|Lost to Follow-up|9
5392369|NCT03181594|18572241|P1|Overall Study|Physician Decision|1
5392370|NCT03181594|18572241|P1|Overall Study|Lost to Follow-up|1
5392371|NCT03181503|18572249|P2|Overall Study|Lost to Follow-up|1
5392372|NCT03181503|18572250|P1|Overall Study|Lost to Follow-up|1
5392373|NCT03181503|18572249|P2|Overall Study|Withdrawal by Subject|0
5392374|NCT03181503|18572250|P1|Overall Study|Withdrawal by Subject|3
5392375|NCT03181503|18572249|P2|Overall Study|Protocol Violation|0
5392376|NCT03181503|18572250|P1|Overall Study|Protocol Violation|1
5392377|NCT03181503|18572249|P2|Overall Study|Adverse Event|2
5392378|NCT03181503|18572250|P1|Overall Study|Adverse Event|2
5392379|NCT03181451|18572289|P3|Overall Study|Withdrawal by Subject|0
5392380|NCT03181451|18572290|P2|Overall Study|Withdrawal by Subject|1
5392381|NCT03181451|18572291|P1|Overall Study|Withdrawal by Subject|0
5392382|NCT03181451|18572289|P3|Overall Study|Adverse Event|0
5392383|NCT03181451|18572290|P2|Overall Study|Adverse Event|1
5392384|NCT03181451|18572291|P1|Overall Study|Adverse Event|0
5392385|NCT03180801|18572478|P3|Overall Study|Lost to Follow-up|3
5392386|NCT03180801|18572479|P2|Overall Study|Lost to Follow-up|2
5392387|NCT03180801|18572480|P1|Overall Study|Lost to Follow-up|0
5392388|NCT03180801|18572478|P3|Overall Study|Withdrawal by Subject|1
5392389|NCT03180801|18572479|P2|Overall Study|Withdrawal by Subject|2
5392390|NCT03180801|18572480|P1|Overall Study|Withdrawal by Subject|2
5392391|NCT03180801|18572478|P3|Overall Study|Adverse Event|2
5392392|NCT03180801|18572479|P2|Overall Study|Adverse Event|0
5392393|NCT03180801|18572480|P1|Overall Study|Adverse Event|1
5392394|NCT03180801|18572478|P3|Overall Study|Inoculation Target Reached|3
5392395|NCT03180801|18572479|P2|Overall Study|Inoculation Target Reached|1
5392396|NCT03180801|18572480|P1|Overall Study|Inoculation Target Reached|1
5392397|NCT03180801|18572478|P3|Overall Study|Non-compliance|0
5392398|NCT03180801|18572479|P2|Overall Study|Non-compliance|4
5392399|NCT03180801|18572480|P1|Overall Study|Non-compliance|1
5392400|NCT03180801|18572478|P3|Overall Study|Physician Decision|1
5392401|NCT03180801|18572479|P2|Overall Study|Physician Decision|3
5392402|NCT03180801|18572480|P1|Overall Study|Physician Decision|3
5392403|NCT03180645|18572524|P3|Overall Study|Adverse Event|2
5392404|NCT03180645|18572525|P2|Overall Study|Adverse Event|1
5392405|NCT03180645|18572526|P1|Overall Study|Adverse Event|0
5392406|NCT03180619|18572568|P3|Overall Study|Investigator's discretion|1
5392407|NCT03180619|18572569|P2|Overall Study|Investigator's discretion|0
5392408|NCT03180619|18572570|P1|Overall Study|Investigator's discretion|1
5392409|NCT03180619|18572568|P3|Overall Study|Adverse Event|1
5392410|NCT03180619|18572569|P2|Overall Study|Adverse Event|0
5392411|NCT03180619|18572570|P1|Overall Study|Adverse Event|2
5392412|NCT03180619|18572568|P3|Overall Study|Still on Study|25
5392413|NCT03180619|18572569|P2|Overall Study|Still on Study|14
5392414|NCT03180619|18572570|P1|Overall Study|Still on Study|64
5392415|NCT03180619|18572568|P3|Overall Study|Death|0
5392416|NCT03180619|18572569|P2|Overall Study|Death|1
5392417|NCT03180619|18572570|P1|Overall Study|Death|1
5392418|NCT03180619|18572568|P3|Overall Study|Withdrew Consent|1
5392419|NCT03180619|18572569|P2|Overall Study|Withdrew Consent|0
5392420|NCT03180619|18572570|P1|Overall Study|Withdrew Consent|5
5392421|NCT03180138|18572773|P3|Overall Study|Found to be >24 mon after randomization|3
5392422|NCT03180138|18572774|P2|Overall Study|Found to be >24 mon after randomization|0
5392423|NCT03180138|18572775|P1|Overall Study|Found to be >24 mon after randomization|3
5392424|NCT03180138|18572773|P3|Overall Study|No prior immunization records|6
5392425|NCT03180138|18572774|P2|Overall Study|No prior immunization records|0
5392426|NCT03180138|18572775|P1|Overall Study|No prior immunization records|17
5392427|NCT03180138|18572773|P3|Overall Study|Mobile-phone could not be verified|15
5392428|NCT03180138|18572774|P2|Overall Study|Mobile-phone could not be verified|13
5392429|NCT03180138|18572775|P1|Overall Study|Mobile-phone could not be verified|2
5392430|NCT03179891|18572786|P2|First Intervention|Protocol Violation|1
5392431|NCT03179891|18572787|P1|First Intervention|Protocol Violation|0
5392432|NCT03179891|18572786|P2|First Intervention|Unspecified reason|0
5392433|NCT03179891|18572787|P1|First Intervention|Unspecified reason|1
5392434|NCT03179891|18572786|P2|First Intervention|Withdrawal by Subject|1
5392435|NCT03179891|18572787|P1|First Intervention|Withdrawal by Subject|1
5392436|NCT03179319|18572866|P2|Overall Study|Lost to Follow-up|0
5392437|NCT03179319|18572867|P1|Overall Study|Lost to Follow-up|6
5392438|NCT03178942|18572882|P2|Overall Study|Lost to Follow-up|2
5392439|NCT03178942|18572883|P1|Overall Study|Lost to Follow-up|1
5392440|NCT03178942|18572882|P2|Overall Study|Withdrawal by Subject|0
5392441|NCT03178942|18572883|P1|Overall Study|Withdrawal by Subject|2
5392442|NCT03178851|18572898|P3|Overall Study|Lost to Follow-up|0
5392443|NCT03178851|18572899|P2|Overall Study|Lost to Follow-up|1
5392444|NCT03178851|18572900|P1|Overall Study|Lost to Follow-up|2
5392445|NCT03178851|18572898|P3|Overall Study|Withdrawal by Subject|0
5392446|NCT03178851|18572899|P2|Overall Study|Withdrawal by Subject|0
5392447|NCT03178851|18572900|P1|Overall Study|Withdrawal by Subject|8
5392448|NCT03178851|18572898|P3|Overall Study|Death|10
5392449|NCT03178851|18572899|P2|Overall Study|Death|1
5392450|NCT03178851|18572900|P1|Overall Study|Death|35
5392451|NCT03178851|18572898|P3|Overall Study|Continuing on Study|42
5392452|NCT03178851|18572899|P2|Overall Study|Continuing on Study|9
5392453|NCT03178851|18572900|P1|Overall Study|Continuing on Study|47
5392454|NCT03178266|18572947|P2|Overall Study|Withdrawal by Subject|2
5392455|NCT03178266|18572948|P1|Overall Study|Withdrawal by Subject|0
5392456|NCT03178266|18572947|P2|Overall Study|Disont. Early|1
5392457|NCT03178266|18572948|P1|Overall Study|Disont. Early|0
5392458|NCT03178266|18572947|P2|Overall Study|Death|1
5392459|NCT03178266|18572948|P1|Overall Study|Death|0
5392460|NCT03178045|18572958|P2|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
5392461|NCT03178045|18572959|P1|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
5392462|NCT03178045|18572958|P2|Overall Study|Surgery Cancelled/Relocated|30
5392463|NCT03178045|18572959|P1|Overall Study|Surgery Cancelled/Relocated|34
5392464|NCT03178045|18572958|P2|Overall Study|Withdrawal by Subject|7
5392465|NCT03178045|18572959|P1|Overall Study|Withdrawal by Subject|5
5392466|NCT03176407|18573300|P1|Overall Study|EGD showed esophageal varices=excl. crit|1
5392467|NCT03176407|18573300|P1|Overall Study|human failure|1
5392468|NCT03176407|18573300|P1|Overall Study|Protocol Violation|1
5392469|NCT03176238|18573310|P2|Overall Study|Everolimus dose interrupt > 4 wks|0
5392470|NCT03176238|18573311|P1|Overall Study|Everolimus dose interrupt > 4 wks|9
5392471|NCT03176238|18573310|P2|Overall Study|Changes in the patient's condition|1
5392472|NCT03176238|18573311|P1|Overall Study|Changes in the patient's condition|2
5392473|NCT03176238|18573310|P2|Overall Study|Protocol Violation|0
5392474|NCT03176238|18573311|P1|Overall Study|Protocol Violation|1
5392475|NCT03176238|18573310|P2|Overall Study|Patient is switched to commercial drug|1
5392476|NCT03176238|18573311|P1|Overall Study|Patient is switched to commercial drug|16
5392477|NCT03176238|18573310|P2|Overall Study|Tx duration completed per EAP|1
5392478|NCT03176238|18573311|P1|Overall Study|Tx duration completed per EAP|0
5392479|NCT03176238|18573310|P2|Overall Study|Disease Progression|22
5392480|NCT03176238|18573311|P1|Overall Study|Disease Progression|133
5392481|NCT03176238|18573310|P2|Overall Study|Death|0
5392482|NCT03176238|18573311|P1|Overall Study|Death|3
5392483|NCT03176238|18573310|P2|Overall Study|Administrative problems|0
5392484|NCT03176238|18573311|P1|Overall Study|Administrative problems|1
5392485|NCT03176238|18573310|P2|Overall Study|Lost to Follow-up|0
5392486|NCT03176238|18573311|P1|Overall Study|Lost to Follow-up|3
5392487|NCT03176238|18573310|P2|Overall Study|Consent withdrawal|2
5392488|NCT03176238|18573311|P1|Overall Study|Consent withdrawal|14
5392489|NCT03176238|18573310|P2|Overall Study|Inter-current illness|1
5392490|NCT03176238|18573311|P1|Overall Study|Inter-current illness|0
5392491|NCT03176238|18573310|P2|Overall Study|Abnormal lab value(s)|0
5392492|NCT03176238|18573311|P1|Overall Study|Abnormal lab value(s)|2
5392493|NCT03176238|18573310|P2|Overall Study|Unacceptable AEs|8
5392494|NCT03176238|18573311|P1|Overall Study|Unacceptable AEs|15
5392495|NCT03175562|18573330|P1|Overall Study|Other (Not Specified)|5
5392496|NCT03175562|18573330|P1|Overall Study|Withdrawal by Subject|7
5392497|NCT03175562|18573330|P1|Overall Study|Lost to Follow-up|3
5392498|NCT03175562|18573330|P1|Overall Study|Adverse Event|1
5392499|NCT03175172|18573355|P1|Overall Study|Study Terminated by Sponsor|3
5392500|NCT03175172|18573355|P1|Overall Study|Lost to Follow-up|1
5392501|NCT03175172|18573355|P1|Overall Study|Withdrawal by Subject|3
5392502|NCT03175172|18573355|P1|Overall Study|Death|3
5392503|NCT03175120|18573365|P2|Overall Study|Other|3
5392504|NCT03175120|18573366|P1|Overall Study|Other|2
5392505|NCT03175120|18573365|P2|Overall Study|Withdrawal by Subject|5
5392506|NCT03175120|18573366|P1|Overall Study|Withdrawal by Subject|2
5392507|NCT03175120|18573365|P2|Overall Study|Lost to Follow-up|0
5392508|NCT03175120|18573366|P1|Overall Study|Lost to Follow-up|1
5392509|NCT03175120|18573365|P2|Overall Study|Protocol Violation|2
5392510|NCT03175120|18573366|P1|Overall Study|Protocol Violation|5
5392511|NCT03175120|18573365|P2|Overall Study|Adverse Event|2
5392512|NCT03175120|18573366|P1|Overall Study|Adverse Event|2
5392513|NCT03172702|18573550|P1|Overall Study|Other|2
5392514|NCT03172702|18573550|P1|Overall Study|Withdrawal by Subject|5
5392515|NCT03172702|18573550|P1|Overall Study|Study-specific Withdrawal Criteria|10
5392516|NCT03172702|18573550|P1|Overall Study|Death|2
5392517|NCT03172702|18573550|P1|Overall Study|Adverse Event|9
5392518|NCT03172494|18573578|P3|Overall Study|Non-compliance towards treatment|0
5392519|NCT03172494|18573579|P2|Overall Study|Non-compliance towards treatment|0
5392520|NCT03172494|18573580|P1|Overall Study|Non-compliance towards treatment|2
5392521|NCT03172494|18573578|P3|Overall Study|Severe hypoglycaemic episode|1
5392522|NCT03172494|18573579|P2|Overall Study|Severe hypoglycaemic episode|0
5392523|NCT03172494|18573580|P1|Overall Study|Severe hypoglycaemic episode|0
5392524|NCT03172494|18573578|P3|Overall Study|Withdrawal by Subject|8
5392525|NCT03172494|18573579|P2|Overall Study|Withdrawal by Subject|8
5392526|NCT03172494|18573580|P1|Overall Study|Withdrawal by Subject|10
5392527|NCT03172494|18573578|P3|Overall Study|Pregnancy|0
5392528|NCT03172494|18573579|P2|Overall Study|Pregnancy|1
5392529|NCT03172494|18573580|P1|Overall Study|Pregnancy|0
5392530|NCT03172494|18573578|P3|Overall Study|Lack of Efficacy|4
5392531|NCT03172494|18573579|P2|Overall Study|Lack of Efficacy|0
5392532|NCT03172494|18573580|P1|Overall Study|Lack of Efficacy|0
5392533|NCT03172494|18573578|P3|Overall Study|Protocol Violation|1
5392534|NCT03172494|18573579|P2|Overall Study|Protocol Violation|2
5392535|NCT03172494|18573580|P1|Overall Study|Protocol Violation|3
5392536|NCT03172494|18573578|P3|Overall Study|Adverse Event|15
5392537|NCT03172494|18573579|P2|Overall Study|Adverse Event|1
5392538|NCT03172494|18573580|P1|Overall Study|Adverse Event|5
5392539|NCT03172481|18573763|P2|Double-blind|Withdrawal by Subject|0
5392540|NCT03172481|18573764|P1|Double-blind|Withdrawal by Subject|1
5392541|NCT03172364|18573772|P2|Overall Study|Protocol Violation|0
5392542|NCT03172364|18573773|P1|Overall Study|Protocol Violation|1
5392543|NCT03172364|18573772|P2|Overall Study|Adverse Event|1
5392544|NCT03172364|18573773|P1|Overall Study|Adverse Event|1
5392545|NCT03172130|18573791|P2|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
5392546|NCT03172130|18573792|P1|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
5392547|NCT03171415|18573817|P5|Overall Study|Lost to Follow-up|2
5392548|NCT03171415|18573818|P4|Overall Study|Lost to Follow-up|0
5392549|NCT03171415|18573819|P3|Overall Study|Lost to Follow-up|0
5392550|NCT03171415|18573820|P2|Overall Study|Lost to Follow-up|0
5392551|NCT03171415|18573821|P1|Overall Study|Lost to Follow-up|0
5392552|NCT03170609|18573894|P7|Overall Study|Other|0
5392553|NCT03170609|18573895|P6|Overall Study|Other|1
5392554|NCT03170609|18573896|P5|Overall Study|Other|0
5392555|NCT03170609|18573897|P4|Overall Study|Other|0
5392556|NCT03170609|18573898|P3|Overall Study|Other|0
5392557|NCT03170609|18573899|P2|Overall Study|Other|0
5392558|NCT03170609|18573900|P1|Overall Study|Other|1
5392559|NCT03170609|18573894|P7|Overall Study|Lost to Follow-up|0
5392560|NCT03170609|18573895|P6|Overall Study|Lost to Follow-up|1
5392561|NCT03170609|18573896|P5|Overall Study|Lost to Follow-up|1
5392562|NCT03170609|18573897|P4|Overall Study|Lost to Follow-up|2
5392563|NCT03170609|18573898|P3|Overall Study|Lost to Follow-up|5
5392564|NCT03170609|18573899|P2|Overall Study|Lost to Follow-up|0
5392565|NCT03170609|18573900|P1|Overall Study|Lost to Follow-up|1
5392566|NCT03170609|18573894|P7|Overall Study|Withdrawal by Subject|1
5392567|NCT03170609|18573895|P6|Overall Study|Withdrawal by Subject|0
5392568|NCT03170609|18573896|P5|Overall Study|Withdrawal by Subject|0
5392569|NCT03170609|18573897|P4|Overall Study|Withdrawal by Subject|0
5392570|NCT03170609|18573898|P3|Overall Study|Withdrawal by Subject|0
5392571|NCT03170609|18573899|P2|Overall Study|Withdrawal by Subject|2
5392572|NCT03170609|18573900|P1|Overall Study|Withdrawal by Subject|1
5392573|NCT03170609|18573894|P7|Overall Study|Death|0
5392574|NCT03170609|18573895|P6|Overall Study|Death|0
5392575|NCT03170609|18573896|P5|Overall Study|Death|0
5392576|NCT03170609|18573897|P4|Overall Study|Death|0
5392577|NCT03170609|18573898|P3|Overall Study|Death|1
5392578|NCT03170609|18573899|P2|Overall Study|Death|0
5392579|NCT03170609|18573900|P1|Overall Study|Death|0
5392580|NCT03170544|18573970|P12|Part 1|Not treated|0
5392581|NCT03170544|18573971|P11|Part 1|Not treated|0
5392582|NCT03170544|18573972|P10|Part 1|Not treated|0
5392583|NCT03170544|18573973|P9|Part 1|Not treated|0
5392584|NCT03170544|18573974|P8|Part 1|Not treated|0
5392585|NCT03170544|18573975|P7|Part 1|Not treated|0
5392586|NCT03170544|18573976|P6|Part 1|Not treated|0
5392587|NCT03170544|18573977|P5|Part 1|Not treated|0
5392588|NCT03170544|18573978|P4|Part 1|Not treated|1
5392589|NCT03170544|18573979|P3|Part 1|Not treated|0
5392590|NCT03170544|18573980|P2|Part 1|Not treated|0
5392591|NCT03170544|18573981|P1|Part 1|Not treated|0
5392592|NCT03170544|18573970|P12|Part 1|Lost to Follow-up|0
5392593|NCT03170544|18573971|P11|Part 1|Lost to Follow-up|0
5392594|NCT03170544|18573972|P10|Part 1|Lost to Follow-up|0
5392595|NCT03170544|18573973|P9|Part 1|Lost to Follow-up|0
5392596|NCT03170544|18573974|P8|Part 1|Lost to Follow-up|0
5392597|NCT03170544|18573975|P7|Part 1|Lost to Follow-up|0
5392598|NCT03170544|18573976|P6|Part 1|Lost to Follow-up|0
5392599|NCT03170544|18573977|P5|Part 1|Lost to Follow-up|0
5392600|NCT03170544|18573978|P4|Part 1|Lost to Follow-up|0
5392601|NCT03170544|18573979|P3|Part 1|Lost to Follow-up|0
5392602|NCT03170544|18573980|P2|Part 1|Lost to Follow-up|0
5392603|NCT03170544|18573981|P1|Part 1|Lost to Follow-up|1
5392604|NCT03170271|18574145|P2|Overall Study|Randomized in error|0
5392605|NCT03170271|18574146|P1|Overall Study|Randomized in error|4
5392606|NCT03170271|18574145|P2|Overall Study|Other|2
5392607|NCT03170271|18574146|P1|Overall Study|Other|2
5392608|NCT03170271|18574145|P2|Overall Study|Withdrawal by Subject|5
5392609|NCT03170271|18574146|P1|Overall Study|Withdrawal by Subject|17
5392610|NCT03170271|18574145|P2|Overall Study|Protocol-specified withdrawal criterion|1
5392611|NCT03170271|18574146|P1|Overall Study|Protocol-specified withdrawal criterion|2
5392612|NCT03170271|18574145|P2|Overall Study|Physician Decision|0
5392613|NCT03170271|18574146|P1|Overall Study|Physician Decision|1
5392614|NCT03170271|18574145|P2|Overall Study|Lost to Follow-up|1
5392615|NCT03170271|18574146|P1|Overall Study|Lost to Follow-up|0
5392616|NCT03170271|18574145|P2|Overall Study|Adverse Event|2
5392617|NCT03170271|18574146|P1|Overall Study|Adverse Event|7
5392618|NCT03170232|18574174|P2|Overall Study|Withdrawal by Subject|1
5392619|NCT03170232|18574175|P1|Overall Study|Withdrawal by Subject|0
5392620|NCT03170232|18574174|P2|Overall Study|Lost to Follow-up|0
5392621|NCT03170232|18574175|P1|Overall Study|Lost to Follow-up|1
5392622|NCT03170232|18574174|P2|Overall Study|Study closed/terminated|23
5392623|NCT03170232|18574175|P1|Overall Study|Study closed/terminated|26
5392624|NCT03170232|18574174|P2|Overall Study|Lack of Efficacy|1
5392625|NCT03170232|18574175|P1|Overall Study|Lack of Efficacy|0
5392626|NCT03170232|18574174|P2|Overall Study|Protocol Violation|1
5392627|NCT03170232|18574175|P1|Overall Study|Protocol Violation|0
5392628|NCT03170232|18574174|P2|Overall Study|Adverse Event|1
5392629|NCT03170232|18574175|P1|Overall Study|Adverse Event|0
5392630|NCT03170193|18574253|P7|Overall Study|Lost to Follow-up|0
5392631|NCT03170193|18574254|P6|Overall Study|Lost to Follow-up|0
5392632|NCT03170193|18574255|P5|Overall Study|Lost to Follow-up|0
5392633|NCT03170193|18574256|P4|Overall Study|Lost to Follow-up|0
5392634|NCT03170193|18574257|P3|Overall Study|Lost to Follow-up|0
5392635|NCT03170193|18574258|P2|Overall Study|Lost to Follow-up|1
5392636|NCT03170193|18574259|P1|Overall Study|Lost to Follow-up|1
5392637|NCT03170193|18574253|P7|Overall Study|Withdrawal by Subject|0
5392638|NCT03170193|18574254|P6|Overall Study|Withdrawal by Subject|0
5392639|NCT03170193|18574255|P5|Overall Study|Withdrawal by Subject|0
5392640|NCT03170193|18574256|P4|Overall Study|Withdrawal by Subject|1
5392641|NCT03170193|18574257|P3|Overall Study|Withdrawal by Subject|0
5392642|NCT03170193|18574258|P2|Overall Study|Withdrawal by Subject|0
5392643|NCT03170193|18574259|P1|Overall Study|Withdrawal by Subject|0
5392644|NCT03170154|18574328|P1|Overall Study|Withdrawal by Subject|2
5392645|NCT03170154|18574328|P1|Overall Study|Death|2
5392646|NCT03170154|18574328|P1|Overall Study|Lost to Follow-up|4
5392647|NCT03169530|18574352|P2|Overall Study|Study ended by NIH|17
5392648|NCT03169530|18574353|P1|Overall Study|Study ended by NIH|15
5392649|NCT03169244|18574373|P2|Overall Study|Physician Decision|0
5392650|NCT03169244|18574374|P1|Overall Study|Physician Decision|1
5392651|NCT03169244|18574373|P2|Overall Study|Withdrawal by Subject|2
5392652|NCT03169244|18574374|P1|Overall Study|Withdrawal by Subject|2
5392653|NCT03169244|18574373|P2|Overall Study|Adverse Event|0
5392654|NCT03169244|18574374|P1|Overall Study|Adverse Event|1
5392655|NCT03169244|18574373|P2|Overall Study|Lost to Follow-up|2
5392656|NCT03169244|18574374|P1|Overall Study|Lost to Follow-up|1
5392657|NCT03169153|18574384|P2|Period 2, Second 30 Days of Wear|Could not attend visit|0
5392658|NCT03169153|18574385|P1|Period 2, Second 30 Days of Wear|Could not attend visit|1
5392659|NCT03169153|18574384|P2|Period 2, Second 30 Days of Wear|Adverse Event|2
5392660|NCT03169153|18574385|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
5392661|NCT03169153|18574384|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
5392662|NCT03169153|18574385|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
5392663|NCT03169153|18574384|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5392664|NCT03169153|18574385|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5392665|NCT03168919|18574396|P1|Overall Study|Withdrawal by Subject|2
5392666|NCT03168906|18574406|P2|Overall Study|Lack of Efficacy|6
5392667|NCT03168906|18574407|P1|Overall Study|Lack of Efficacy|6
5392668|NCT03168425|18574453|P2|Overall Study|unable to confirm post op opioids|3
5392669|NCT03168425|18574454|P1|Overall Study|unable to confirm post op opioids|2
5392670|NCT03168425|18574453|P2|Overall Study|Lost to Follow-up|8
5392671|NCT03168425|18574454|P1|Overall Study|Lost to Follow-up|5
5392672|NCT03167151|18574531|P3|Overall Study|No evidence of tumour at surgery|1
5392673|NCT03167151|18574532|P2|Overall Study|No evidence of tumour at surgery|1
5392674|NCT03167151|18574533|P1|Overall Study|No evidence of tumour at surgery|0
5392675|NCT03167151|18574531|P3|Overall Study|Withdrawal by Subject|0
5392676|NCT03167151|18574532|P2|Overall Study|Withdrawal by Subject|0
5392677|NCT03167151|18574533|P1|Overall Study|Withdrawal by Subject|1
5392678|NCT03166735|18574546|P5|Overall Study|Lost to Follow-up|1
5392679|NCT03166735|18574547|P4|Overall Study|Lost to Follow-up|0
5392680|NCT03166735|18574548|P3|Overall Study|Lost to Follow-up|1
5392681|NCT03166735|18574549|P2|Overall Study|Lost to Follow-up|2
5392682|NCT03166735|18574550|P1|Overall Study|Lost to Follow-up|0
5392683|NCT03166735|18574546|P5|Overall Study|Withdrawal by Subject|2
5392684|NCT03166735|18574547|P4|Overall Study|Withdrawal by Subject|1
5392685|NCT03166735|18574548|P3|Overall Study|Withdrawal by Subject|1
5392686|NCT03166735|18574549|P2|Overall Study|Withdrawal by Subject|0
5392687|NCT03166735|18574550|P1|Overall Study|Withdrawal by Subject|0
5392688|NCT03166735|18574546|P5|Overall Study|follow-up not completed as planned|1
5392689|NCT03166735|18574547|P4|Overall Study|follow-up not completed as planned|0
5392690|NCT03166735|18574548|P3|Overall Study|follow-up not completed as planned|1
5392691|NCT03166735|18574549|P2|Overall Study|follow-up not completed as planned|1
5392692|NCT03166735|18574550|P1|Overall Study|follow-up not completed as planned|0
5392693|NCT03166735|18574546|P5|Overall Study|Not Treated|0
5392694|NCT03166735|18574547|P4|Overall Study|Not Treated|0
5392695|NCT03166735|18574548|P3|Overall Study|Not Treated|0
5392696|NCT03166735|18574549|P2|Overall Study|Not Treated|0
5392697|NCT03166735|18574550|P1|Overall Study|Not Treated|1
5392698|NCT03166618|18574600|P2|Overall Study|Study was Terminated|1
5392699|NCT03166618|18574601|P1|Overall Study|Study was Terminated|0
5392700|NCT03166215|18574613|P3|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
5392701|NCT03166215|18574614|P2|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
5392702|NCT03166215|18574615|P1|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
5392703|NCT03166215|18574613|P3|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
5392704|NCT03166215|18574614|P2|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
5392705|NCT03166215|18574615|P1|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
5392706|NCT03166124|18574655|P4|Wash-out Period|Adverse Event|0
5392707|NCT03166124|18574656|P3|Wash-out Period|Adverse Event|1
5392708|NCT03166124|18574657|P2|Wash-out Period|Adverse Event|1
5392709|NCT03166124|18574658|P1|Wash-out Period|Adverse Event|0
5392710|NCT03166124|18574655|P4|Wash-out Period|Withdrawal by Subject|1
5392711|NCT03166124|18574656|P3|Wash-out Period|Withdrawal by Subject|0
5392712|NCT03166124|18574657|P2|Wash-out Period|Withdrawal by Subject|1
5392713|NCT03166124|18574658|P1|Wash-out Period|Withdrawal by Subject|0
5392714|NCT03166124|18574655|P4|Treatment Period 1|Adverse Event|0
5392715|NCT03166124|18574656|P3|Treatment Period 1|Adverse Event|1
5392716|NCT03166124|18574657|P2|Treatment Period 1|Adverse Event|0
5392717|NCT03166124|18574658|P1|Treatment Period 1|Adverse Event|0
5392718|NCT03165955|18574703|P1|Treatment|Progressive disease|3
5392719|NCT03165955|18574703|P1|Treatment|Adverse Event|1
5392720|NCT03165955|18574703|P1|Treatment|Death|1
5392721|NCT03165955|18574703|P1|Treatment|Withdrawal by Subject|3
5392722|NCT03165110|18574840|P1|Overall Study|Anroid phone software incompatibility|1
5392723|NCT03165045|18574862|P1|Visit 2|Available total CCQ score at vist 2 only|44
5392724|NCT03165045|18574862|P1|Visit 2|No available total CCQ score at all|29
5392725|NCT03165045|18574862|P1|Visit 2|Available CCQ score at visit 1 only|109
5392726|NCT03165045|18574862|P1|Visit 1|No visit 1|10
5392727|NCT03165045|18574862|P1|Visit 1|No treatment documented|10
5392728|NCT03165045|18574862|P1|Visit 1|No registration after visit 1|9
5392729|NCT03164551|18574882|P2|Overall Study|Other|2
5392730|NCT03164551|18574883|P1|Overall Study|Other|8
5392731|NCT03164551|18574882|P2|Overall Study|Cancellation of Fresh Embryo Transfer|14
5392732|NCT03164551|18574883|P1|Overall Study|Cancellation of Fresh Embryo Transfer|12
5392733|NCT03164551|18574882|P2|Overall Study|Participant was non-compliant|0
5392734|NCT03164551|18574883|P1|Overall Study|Participant was non-compliant|1
5392735|NCT03164551|18574882|P2|Overall Study|Imaging discontinued prior completion|0
5392736|NCT03164551|18574883|P1|Overall Study|Imaging discontinued prior completion|8
5392737|NCT03162796|18574994|P3|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
5392738|NCT03162796|18574995|P2|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
5392739|NCT03162796|18574996|P1|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
5392740|NCT03162796|18574994|P3|Active Treatment Period: Week 24 - 52|Adverse Event|0
5392741|NCT03162796|18574995|P2|Active Treatment Period: Week 24 - 52|Adverse Event|2
5392742|NCT03162796|18574996|P1|Active Treatment Period: Week 24 - 52|Adverse Event|3
5392743|NCT03162796|18574994|P3|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
5392744|NCT03162796|18574995|P2|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
5392745|NCT03162796|18574996|P1|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
5392746|NCT03162796|18574994|P3|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
5392747|NCT03162796|18574995|P2|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
5392748|NCT03162796|18574996|P1|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
5392749|NCT03162796|18574994|P3|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
5392750|NCT03162796|18574995|P2|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
5392751|NCT03162796|18574996|P1|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
5392752|NCT03162796|18574994|P3|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
5392753|NCT03162796|18574995|P2|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
5392754|NCT03162796|18574996|P1|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
5392755|NCT03162796|18574994|P3|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
5392756|NCT03162796|18574995|P2|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
5392757|NCT03162796|18574996|P1|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
5392758|NCT03162796|18574994|P3|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
5392759|NCT03162796|18574995|P2|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
5392760|NCT03162796|18574996|P1|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
5392761|NCT03162796|18574994|P3|Placebo Controlled Period: Week 0 - 24|Death|0
5392762|NCT03162796|18574995|P2|Placebo Controlled Period: Week 0 - 24|Death|0
5392763|NCT03162796|18574996|P1|Placebo Controlled Period: Week 0 - 24|Death|1
5392764|NCT03162796|18574994|P3|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
5392765|NCT03162796|18574995|P2|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
5392766|NCT03162796|18574996|P1|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
5392767|NCT03162796|18574994|P3|Placebo Controlled Period: Week 0 - 24|Other|1
5392768|NCT03162796|18574995|P2|Placebo Controlled Period: Week 0 - 24|Other|1
5392769|NCT03162796|18574996|P1|Placebo Controlled Period: Week 0 - 24|Other|0
5392770|NCT03162614|18575306|P6|Overall Study|Missed vaccination, exclusion criteria|0
5392771|NCT03162614|18575307|P5|Overall Study|Missed vaccination, exclusion criteria|3
5392772|NCT03162614|18575308|P4|Overall Study|Missed vaccination, exclusion criteria|4
5392773|NCT03162614|18575309|P3|Overall Study|Missed vaccination, exclusion criteria|2
5392774|NCT03162614|18575310|P2|Overall Study|Missed vaccination, exclusion criteria|2
5392775|NCT03162614|18575311|P1|Overall Study|Missed vaccination, exclusion criteria|2
5392776|NCT03162614|18575306|P6|Overall Study|Withdrawal by Subject|0
5392777|NCT03162614|18575307|P5|Overall Study|Withdrawal by Subject|0
5392778|NCT03162614|18575308|P4|Overall Study|Withdrawal by Subject|1
5392779|NCT03162614|18575309|P3|Overall Study|Withdrawal by Subject|1
5392780|NCT03162614|18575310|P2|Overall Study|Withdrawal by Subject|1
5392781|NCT03162614|18575311|P1|Overall Study|Withdrawal by Subject|2
5392782|NCT03162614|18575306|P6|Overall Study|Protocol Violation|0
5392783|NCT03162614|18575307|P5|Overall Study|Protocol Violation|0
5392784|NCT03162614|18575308|P4|Overall Study|Protocol Violation|1
5392785|NCT03162614|18575309|P3|Overall Study|Protocol Violation|0
5392786|NCT03162614|18575310|P2|Overall Study|Protocol Violation|1
5392787|NCT03162614|18575311|P1|Overall Study|Protocol Violation|0
5392788|NCT03162614|18575306|P6|Overall Study|Lost to Follow-up|0
5392789|NCT03162614|18575307|P5|Overall Study|Lost to Follow-up|2
5392790|NCT03162614|18575308|P4|Overall Study|Lost to Follow-up|1
5392791|NCT03162614|18575309|P3|Overall Study|Lost to Follow-up|1
5392792|NCT03162614|18575310|P2|Overall Study|Lost to Follow-up|1
5392793|NCT03162614|18575311|P1|Overall Study|Lost to Follow-up|2
5392794|NCT03162328|18575464|P3|Study Period|Withdrawal by Subject|1
5392795|NCT03162328|18575465|P2|Study Period|Withdrawal by Subject|0
5392796|NCT03162328|18575466|P1|Study Period|Withdrawal by Subject|0
5392797|NCT03162328|18575464|P3|Screening Period|Withdrawal by Subject|0
5392798|NCT03162328|18575465|P2|Screening Period|Withdrawal by Subject|0
5392799|NCT03162328|18575466|P1|Screening Period|Withdrawal by Subject|1
5392800|NCT03162328|18575464|P3|Screening Period|Did not meet inclusion/exclusion|0
5392801|NCT03162328|18575465|P2|Screening Period|Did not meet inclusion/exclusion|0
5392802|NCT03162328|18575466|P1|Screening Period|Did not meet inclusion/exclusion|21
5392803|NCT03162055|18575495|P2|Overall Study|Other|15
5392804|NCT03162055|18575496|P1|Overall Study|Other|8
5392805|NCT03162055|18575495|P2|Overall Study|Incorrect randomization|3
5392806|NCT03162055|18575496|P1|Overall Study|Incorrect randomization|4
5392807|NCT03162055|18575495|P2|Overall Study|Did not receive treatment|0
5392808|NCT03162055|18575496|P1|Overall Study|Did not receive treatment|2
5392809|NCT03162055|18575495|P2|Overall Study|Withdrawal by Subject|2
5392810|NCT03162055|18575496|P1|Overall Study|Withdrawal by Subject|17
5392811|NCT03162055|18575495|P2|Overall Study|Study-specific withdrawal criteria|14
5392812|NCT03162055|18575496|P1|Overall Study|Study-specific withdrawal criteria|22
5392813|NCT03162055|18575495|P2|Overall Study|Lost to Follow-up|1
5392814|NCT03162055|18575496|P1|Overall Study|Lost to Follow-up|0
5392815|NCT03162055|18575495|P2|Overall Study|Death|3
5392816|NCT03162055|18575496|P1|Overall Study|Death|3
5392817|NCT03162055|18575495|P2|Overall Study|Adverse Event|5
5392818|NCT03162055|18575496|P1|Overall Study|Adverse Event|6
5392819|NCT03161405|18575588|P1|Second Intervention Period (6 Days)|Positive urine drug screen|1
5392820|NCT03160898|18575608|P4|Overall Study|Other|2
5392821|NCT03160898|18575609|P3|Overall Study|Other|2
5392822|NCT03160898|18575610|P2|Overall Study|Other|0
5392823|NCT03160898|18575611|P1|Overall Study|Other|2
5392824|NCT03160898|18575608|P4|Overall Study|Withdrawal by Subject|1
5392825|NCT03160898|18575609|P3|Overall Study|Withdrawal by Subject|2
5392826|NCT03160898|18575610|P2|Overall Study|Withdrawal by Subject|3
5392827|NCT03160898|18575611|P1|Overall Study|Withdrawal by Subject|1
5392828|NCT03160898|18575608|P4|Overall Study|Sponsor Discretion|0
5392829|NCT03160898|18575609|P3|Overall Study|Sponsor Discretion|0
5392830|NCT03160898|18575610|P2|Overall Study|Sponsor Discretion|0
5392831|NCT03160898|18575611|P1|Overall Study|Sponsor Discretion|2
5392832|NCT03160898|18575608|P4|Overall Study|Protocol Violation|0
5392833|NCT03160898|18575609|P3|Overall Study|Protocol Violation|2
5392834|NCT03160898|18575610|P2|Overall Study|Protocol Violation|0
5392835|NCT03160898|18575611|P1|Overall Study|Protocol Violation|1
5392836|NCT03160898|18575608|P4|Overall Study|Progressive Disease|1
5392837|NCT03160898|18575609|P3|Overall Study|Progressive Disease|2
5392838|NCT03160898|18575610|P2|Overall Study|Progressive Disease|1
5392839|NCT03160898|18575611|P1|Overall Study|Progressive Disease|4
5392840|NCT03160898|18575608|P4|Overall Study|Physician Decision|1
5392841|NCT03160898|18575609|P3|Overall Study|Physician Decision|0
5392842|NCT03160898|18575610|P2|Overall Study|Physician Decision|0
5392843|NCT03160898|18575611|P1|Overall Study|Physician Decision|1
5392844|NCT03160898|18575608|P4|Overall Study|Lost to Follow-up|2
5392845|NCT03160898|18575609|P3|Overall Study|Lost to Follow-up|1
5392846|NCT03160898|18575610|P2|Overall Study|Lost to Follow-up|1
5392847|NCT03160898|18575611|P1|Overall Study|Lost to Follow-up|1
5392848|NCT03160898|18575608|P4|Overall Study|Difficulty Traveling to Clinic Visits|1
5392849|NCT03160898|18575609|P3|Overall Study|Difficulty Traveling to Clinic Visits|0
5392850|NCT03160898|18575610|P2|Overall Study|Difficulty Traveling to Clinic Visits|0
5392851|NCT03160898|18575611|P1|Overall Study|Difficulty Traveling to Clinic Visits|3
5392852|NCT03160898|18575608|P4|Overall Study|Death|1
5392853|NCT03160898|18575609|P3|Overall Study|Death|0
5392854|NCT03160898|18575610|P2|Overall Study|Death|0
5392855|NCT03160898|18575611|P1|Overall Study|Death|1
5392856|NCT03160898|18575608|P4|Overall Study|Adverse Event|10
5392857|NCT03160898|18575609|P3|Overall Study|Adverse Event|7
5392858|NCT03160898|18575610|P2|Overall Study|Adverse Event|8
5392859|NCT03160898|18575611|P1|Overall Study|Adverse Event|4
5392860|NCT03160885|18575634|P7|Maintenance Treatment Period|Completed Week 50|0
5392861|NCT03160885|18575635|P6|Maintenance Treatment Period|Completed Week 50|0
5392862|NCT03160885|18575636|P5|Maintenance Treatment Period|Completed Week 50|0
5392863|NCT03160885|18575637|P4|Maintenance Treatment Period|Completed Week 50|0
5392864|NCT03160885|18575638|P3|Maintenance Treatment Period|Completed Week 50|1
5392865|NCT03160885|18575639|P2|Maintenance Treatment Period|Completed Week 50|0
5392866|NCT03160885|18575640|P1|Maintenance Treatment Period|Completed Week 50|0
5392867|NCT03160885|18575634|P7|Maintenance Treatment Period|Transfer to open-label treatment|0
5392868|NCT03160885|18575635|P6|Maintenance Treatment Period|Transfer to open-label treatment|8
5392869|NCT03160885|18575636|P5|Maintenance Treatment Period|Transfer to open-label treatment|26
5392870|NCT03160885|18575637|P4|Maintenance Treatment Period|Transfer to open-label treatment|26
5392871|NCT03160885|18575638|P3|Maintenance Treatment Period|Transfer to open-label treatment|29
5392872|NCT03160885|18575639|P2|Maintenance Treatment Period|Transfer to open-label treatment|0
5392873|NCT03160885|18575640|P1|Maintenance Treatment Period|Transfer to open-label treatment|0
5392874|NCT03160885|18575634|P7|Maintenance Treatment Period|Discontinued IMP|0
5392875|NCT03160885|18575635|P6|Maintenance Treatment Period|Discontinued IMP|7
5392876|NCT03160885|18575636|P5|Maintenance Treatment Period|Discontinued IMP|5
5392877|NCT03160885|18575637|P4|Maintenance Treatment Period|Discontinued IMP|13
5392878|NCT03160885|18575638|P3|Maintenance Treatment Period|Discontinued IMP|9
5392879|NCT03160885|18575639|P2|Maintenance Treatment Period|Discontinued IMP|0
5392880|NCT03160885|18575640|P1|Maintenance Treatment Period|Discontinued IMP|0
5392881|NCT03160885|18575634|P7|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5392882|NCT03160885|18575635|P6|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5392883|NCT03160885|18575636|P5|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5392884|NCT03160885|18575637|P4|Maintenance Treatment Period|Not dosed - transfer to open-label|1
5392885|NCT03160885|18575638|P3|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5392886|NCT03160885|18575639|P2|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5392887|NCT03160885|18575640|P1|Maintenance Treatment Period|Not dosed - transfer to open-label|0
5392888|NCT03160885|18575634|P7|Open-label Treatment|Completed Week 50|4
5392889|NCT03160885|18575635|P6|Open-label Treatment|Completed Week 50|0
5392890|NCT03160885|18575636|P5|Open-label Treatment|Completed Week 50|0
5392891|NCT03160885|18575637|P4|Open-label Treatment|Completed Week 50|0
5392892|NCT03160885|18575638|P3|Open-label Treatment|Completed Week 50|0
5392893|NCT03160885|18575639|P2|Open-label Treatment|Completed Week 50|0
5392894|NCT03160885|18575640|P1|Open-label Treatment|Completed Week 50|0
5392895|NCT03160885|18575634|P7|Open-label Treatment|Discontinued IMP|131
5392896|NCT03160885|18575635|P6|Open-label Treatment|Discontinued IMP|0
5392897|NCT03160885|18575636|P5|Open-label Treatment|Discontinued IMP|0
5392898|NCT03160885|18575637|P4|Open-label Treatment|Discontinued IMP|0
5392899|NCT03160885|18575638|P3|Open-label Treatment|Discontinued IMP|0
5392900|NCT03160885|18575639|P2|Open-label Treatment|Discontinued IMP|0
5392901|NCT03160885|18575640|P1|Open-label Treatment|Discontinued IMP|0
5392902|NCT03160885|18575634|P7|Open-label Treatment|Not dosed|2
5392903|NCT03160885|18575635|P6|Open-label Treatment|Not dosed|0
5392904|NCT03160885|18575636|P5|Open-label Treatment|Not dosed|0
5392905|NCT03160885|18575637|P4|Open-label Treatment|Not dosed|0
5392906|NCT03160885|18575638|P3|Open-label Treatment|Not dosed|0
5392907|NCT03160885|18575639|P2|Open-label Treatment|Not dosed|0
5392908|NCT03160885|18575640|P1|Open-label Treatment|Not dosed|0
5392909|NCT03160885|18575634|P7|Initial Treatment Period|Discontinued IMP before Week 16|0
5392910|NCT03160885|18575635|P6|Initial Treatment Period|Discontinued IMP before Week 16|0
5392911|NCT03160885|18575636|P5|Initial Treatment Period|Discontinued IMP before Week 16|0
5392912|NCT03160885|18575637|P4|Initial Treatment Period|Discontinued IMP before Week 16|0
5392913|NCT03160885|18575638|P3|Initial Treatment Period|Discontinued IMP before Week 16|0
5392914|NCT03160885|18575639|P2|Initial Treatment Period|Discontinued IMP before Week 16|22
5392915|NCT03160885|18575640|P1|Initial Treatment Period|Discontinued IMP before Week 16|33
5392916|NCT03160885|18575634|P7|Initial Treatment Period|Not dosed|0
5392917|NCT03160885|18575635|P6|Initial Treatment Period|Not dosed|0
5392918|NCT03160885|18575636|P5|Initial Treatment Period|Not dosed|0
5392919|NCT03160885|18575637|P4|Initial Treatment Period|Not dosed|0
5392920|NCT03160885|18575638|P3|Initial Treatment Period|Not dosed|0
5392921|NCT03160885|18575639|P2|Initial Treatment Period|Not dosed|0
5392922|NCT03160885|18575640|P1|Initial Treatment Period|Not dosed|2
5392923|NCT03160716|18575686|P1|Overall Study|Lost to Follow-up|1
5392924|NCT03160703|18575697|P4|Overall Study|Withdrawal by Subject|1
5392925|NCT03160703|18575698|P3|Overall Study|Withdrawal by Subject|0
5392926|NCT03160703|18575699|P2|Overall Study|Withdrawal by Subject|0
5392927|NCT03160703|18575700|P1|Overall Study|Withdrawal by Subject|0
5392928|NCT03160573|18575714|P4|First Sequence (3 Weeks)|Withdrawal by Subject|2
5392929|NCT03160573|18575715|P3|First Sequence (3 Weeks)|Withdrawal by Subject|2
5392930|NCT03160573|18575716|P2|First Sequence (3 Weeks)|Withdrawal by Subject|3
5392931|NCT03160573|18575717|P1|First Sequence (3 Weeks)|Withdrawal by Subject|1
5392932|NCT03159611|18575795|P2|Overall Study|Inability to perform procedures|0
5392933|NCT03159611|18575796|P1|Overall Study|Inability to perform procedures|1
5392934|NCT03159611|18575795|P2|Overall Study|Non-compliance with protocol requirement|2
5392935|NCT03159611|18575796|P1|Overall Study|Non-compliance with protocol requirement|3
5392936|NCT03159611|18575795|P2|Overall Study|Withdrawal by Subject|1
5392937|NCT03159611|18575796|P1|Overall Study|Withdrawal by Subject|1
5392938|NCT03159611|18575795|P2|Overall Study|Adverse Event|0
5392939|NCT03159611|18575796|P1|Overall Study|Adverse Event|1
5392940|NCT03159611|18575795|P2|Overall Study|Protocol Violation|4
5392941|NCT03159611|18575796|P1|Overall Study|Protocol Violation|7
5392942|NCT03159611|18575795|P2|Overall Study|Did Not Meet Exclusion Criteria|3
5392943|NCT03159611|18575796|P1|Overall Study|Did Not Meet Exclusion Criteria|1
5392944|NCT03159611|18575795|P2|Overall Study|Did Not Meet Inclusion Criteria|5
5392945|NCT03159611|18575796|P1|Overall Study|Did Not Meet Inclusion Criteria|9
5392946|NCT03159468|18575816|P6|Overall Study|Withdrawal by Subject|0
5392947|NCT03159468|18575817|P5|Overall Study|Withdrawal by Subject|0
5392948|NCT03159468|18575818|P4|Overall Study|Withdrawal by Subject|0
5392949|NCT03159468|18575819|P3|Overall Study|Withdrawal by Subject|3
5392950|NCT03159468|18575820|P2|Overall Study|Withdrawal by Subject|0
5392951|NCT03159468|18575821|P1|Overall Study|Withdrawal by Subject|0
5392952|NCT03159091|18575870|P2|Overall Study|Patient has taken no dose of study drug|1
5392953|NCT03159091|18575871|P1|Overall Study|Patient has taken no dose of study drug|0
5392954|NCT03159091|18575870|P2|Overall Study|Incorrect inclusion ineligible patient|3
5392955|NCT03159091|18575871|P1|Overall Study|Incorrect inclusion ineligible patient|5
5392956|NCT03158688|18575887|P2|Overall Study|Lost to Follow-up|3
5392957|NCT03158688|18575888|P1|Overall Study|Lost to Follow-up|0
5392958|NCT03158688|18575887|P2|Overall Study|Decision by sponsor|3
5392959|NCT03158688|18575888|P1|Overall Study|Decision by sponsor|2
5392960|NCT03158688|18575887|P2|Overall Study|Withdrawal by Subject|14
5392961|NCT03158688|18575888|P1|Overall Study|Withdrawal by Subject|9
5392962|NCT03158688|18575887|P2|Overall Study|Death|59
5392963|NCT03158688|18575888|P1|Overall Study|Death|36
5392964|NCT03158688|18575887|P2|Overall Study|Continuing in study|233
5392965|NCT03158688|18575888|P1|Overall Study|Continuing in study|107
5392966|NCT03158311|18575921|P3|Overall Study|Randomized in error|1
5392967|NCT03158311|18575922|P2|Overall Study|Randomized in error|0
5392968|NCT03158311|18575923|P1|Overall Study|Randomized in error|0
5392969|NCT03158311|18575921|P3|Overall Study|Pregnancy|0
5392970|NCT03158311|18575922|P2|Overall Study|Pregnancy|2
5392971|NCT03158311|18575923|P1|Overall Study|Pregnancy|0
5392972|NCT03158311|18575921|P3|Overall Study|Sponsor decision|0
5392973|NCT03158311|18575922|P2|Overall Study|Sponsor decision|0
5392974|NCT03158311|18575923|P1|Overall Study|Sponsor decision|1
5392975|NCT03158311|18575921|P3|Overall Study|Lost to Follow-up|1
5392976|NCT03158311|18575922|P2|Overall Study|Lost to Follow-up|1
5392977|NCT03158311|18575923|P1|Overall Study|Lost to Follow-up|1
5392978|NCT03158311|18575921|P3|Overall Study|Physician Decision|7
5392979|NCT03158311|18575922|P2|Overall Study|Physician Decision|3
5392980|NCT03158311|18575923|P1|Overall Study|Physician Decision|2
5392981|NCT03158311|18575921|P3|Overall Study|Techinical Problems|5
5392982|NCT03158311|18575922|P2|Overall Study|Techinical Problems|1
5392983|NCT03158311|18575923|P1|Overall Study|Techinical Problems|3
5392984|NCT03158311|18575921|P3|Overall Study|Adverse Event|3
5392985|NCT03158311|18575922|P2|Overall Study|Adverse Event|3
5392986|NCT03158311|18575923|P1|Overall Study|Adverse Event|5
5392987|NCT03158311|18575921|P3|Overall Study|Subject/Guardian Decision|11
5392988|NCT03158311|18575922|P2|Overall Study|Subject/Guardian Decision|6
5392989|NCT03158311|18575923|P1|Overall Study|Subject/Guardian Decision|10
5392990|NCT03158285|18575955|P3|Active Treatment Period: Week 24 - 52|Other|0
5392991|NCT03158285|18575956|P2|Active Treatment Period: Week 24 - 52|Other|1
5392992|NCT03158285|18575957|P1|Active Treatment Period: Week 24 - 52|Other|1
5392993|NCT03158285|18575955|P3|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
5392994|NCT03158285|18575956|P2|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
5392995|NCT03158285|18575957|P1|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
5392996|NCT03158285|18575955|P3|Active Treatment Period: Week 24 - 52|Pregnancy|1
5392997|NCT03158285|18575956|P2|Active Treatment Period: Week 24 - 52|Pregnancy|0
5392998|NCT03158285|18575957|P1|Active Treatment Period: Week 24 - 52|Pregnancy|0
5392999|NCT03158285|18575955|P3|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
5393000|NCT03158285|18575956|P2|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
5393001|NCT03158285|18575957|P1|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
5393002|NCT03158285|18575955|P3|Active Treatment Period: Week 24 - 52|Adverse Event|1
5393003|NCT03158285|18575956|P2|Active Treatment Period: Week 24 - 52|Adverse Event|0
5393004|NCT03158285|18575957|P1|Active Treatment Period: Week 24 - 52|Adverse Event|3
5393005|NCT03158285|18575955|P3|Placebo-controlled Period: Week 0 - 24|Other|0
5393006|NCT03158285|18575956|P2|Placebo-controlled Period: Week 0 - 24|Other|1
5393007|NCT03158285|18575957|P1|Placebo-controlled Period: Week 0 - 24|Other|1
5393008|NCT03158285|18575955|P3|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
5393009|NCT03158285|18575956|P2|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
5393010|NCT03158285|18575957|P1|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
5393011|NCT03158285|18575955|P3|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
5393012|NCT03158285|18575956|P2|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
5393013|NCT03158285|18575957|P1|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
5393014|NCT03158285|18575955|P3|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
5393015|NCT03158285|18575956|P2|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
5393016|NCT03158285|18575957|P1|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
5393017|NCT03158285|18575955|P3|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
5393018|NCT03158285|18575956|P2|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
5393019|NCT03158285|18575957|P1|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
5393020|NCT03158272|18576173|P4|Overall Study|Adverse event unrelated to the drug|0
5393021|NCT03158272|18576174|P3|Overall Study|Adverse event unrelated to the drug|0
5393022|NCT03158272|18576175|P2|Overall Study|Adverse event unrelated to the drug|1
5393023|NCT03158272|18576176|P1|Overall Study|Adverse event unrelated to the drug|0
5393024|NCT03158272|18576173|P4|Overall Study|Other reasons|0
5393025|NCT03158272|18576174|P3|Overall Study|Other reasons|1
5393026|NCT03158272|18576175|P2|Overall Study|Other reasons|0
5393027|NCT03158272|18576176|P1|Overall Study|Other reasons|0
5393028|NCT03158272|18576173|P4|Overall Study|Death|0
5393029|NCT03158272|18576174|P3|Overall Study|Death|1
5393030|NCT03158272|18576175|P2|Overall Study|Death|0
5393031|NCT03158272|18576176|P1|Overall Study|Death|0
5393032|NCT03158272|18576173|P4|Overall Study|Disease progression|6
5393033|NCT03158272|18576174|P3|Overall Study|Disease progression|4
5393034|NCT03158272|18576175|P2|Overall Study|Disease progression|3
5393035|NCT03158272|18576176|P1|Overall Study|Disease progression|3
5393036|NCT03158220|18576246|P2|Overall Study|Physician Decision|0
5393037|NCT03158220|18576247|P1|Overall Study|Physician Decision|1
5393038|NCT03158220|18576246|P2|Overall Study|Lost to Follow-up|5
5393039|NCT03158220|18576247|P1|Overall Study|Lost to Follow-up|8
5393040|NCT03158220|18576246|P2|Overall Study|Status unknown|1
5393041|NCT03158220|18576247|P1|Overall Study|Status unknown|0
5393042|NCT03158220|18576246|P2|Overall Study|Withdrawal by Subject|9
5393043|NCT03158220|18576247|P1|Overall Study|Withdrawal by Subject|8
5393044|NCT03158220|18576246|P2|Overall Study|Screen Failure|1
5393045|NCT03158220|18576247|P1|Overall Study|Screen Failure|0
5393046|NCT03158012|18576284|P2|Overall Study|Withdrawal by Subject|1
5393047|NCT03158012|18576285|P1|Overall Study|Withdrawal by Subject|0
5393048|NCT03157583|18576291|P1|Overall Study|Other (did not meet study criteria)|1
5393049|NCT03157531|18576309|P1|Overall Study|Lost to Follow-up|4
5393050|NCT03157531|18576309|P1|Overall Study|Death|2
5393051|NCT03156543|18576330|P2|Overall Study|Withdrawal by Subject|0
5393052|NCT03156543|18576331|P1|Overall Study|Withdrawal by Subject|1
5393053|NCT03155269|18576341|P2|Overall Study|Lost to Follow-up|2
5393054|NCT03155269|18576342|P1|Overall Study|Lost to Follow-up|1
5393055|NCT03155269|18576341|P2|Overall Study|Withdrawal by Subject|5
5393056|NCT03155269|18576342|P1|Overall Study|Withdrawal by Subject|4
5393057|NCT03155178|18576388|P4|Overall Study|Did not meet treatment day baseline|7
5393058|NCT03155178|18576389|P3|Overall Study|Did not meet treatment day baseline|7
5393059|NCT03155178|18576390|P2|Overall Study|Did not meet treatment day baseline|7
5393060|NCT03155178|18576391|P1|Overall Study|Did not meet treatment day baseline|7
5393061|NCT03154086|18576435|P15|Part B (Up to 25 Days)|Adverse Event|0
5393062|NCT03154086|18576436|P14|Part B (Up to 25 Days)|Adverse Event|0
5393063|NCT03154086|18576437|P13|Part B (Up to 25 Days)|Adverse Event|0
5393064|NCT03154086|18576438|P12|Part B (Up to 25 Days)|Adverse Event|0
5393065|NCT03154086|18576439|P11|Part B (Up to 25 Days)|Adverse Event|1
5393066|NCT03154086|18576440|P10|Part B (Up to 25 Days)|Adverse Event|0
5393067|NCT03154086|18576441|P9|Part B (Up to 25 Days)|Adverse Event|0
5393068|NCT03154086|18576442|P8|Part B (Up to 25 Days)|Adverse Event|0
5393069|NCT03154086|18576443|P7|Part B (Up to 25 Days)|Adverse Event|0
5393070|NCT03154086|18576444|P6|Part B (Up to 25 Days)|Adverse Event|0
5393071|NCT03154086|18576445|P5|Part B (Up to 25 Days)|Adverse Event|0
5393072|NCT03154086|18576446|P4|Part B (Up to 25 Days)|Adverse Event|0
5393073|NCT03154086|18576447|P3|Part B (Up to 25 Days)|Adverse Event|0
5393074|NCT03154086|18576448|P2|Part B (Up to 25 Days)|Adverse Event|0
5393075|NCT03154086|18576449|P1|Part B (Up to 25 Days)|Adverse Event|0
5393076|NCT03154086|18576435|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393077|NCT03154086|18576436|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393078|NCT03154086|18576437|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393079|NCT03154086|18576438|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393080|NCT03154086|18576439|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393081|NCT03154086|18576440|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393082|NCT03154086|18576441|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393083|NCT03154086|18576442|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
5393084|NCT03154086|18576443|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393085|NCT03154086|18576444|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393086|NCT03154086|18576445|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393087|NCT03154086|18576446|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393088|NCT03154086|18576447|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393089|NCT03154086|18576448|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393090|NCT03154086|18576449|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
5393091|NCT03154086|18576435|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393092|NCT03154086|18576436|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393093|NCT03154086|18576437|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393094|NCT03154086|18576438|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393095|NCT03154086|18576439|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393096|NCT03154086|18576440|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393097|NCT03154086|18576441|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
5393098|NCT03154086|18576442|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393099|NCT03154086|18576443|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393100|NCT03154086|18576444|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393101|NCT03154086|18576445|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393102|NCT03154086|18576446|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393103|NCT03154086|18576447|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393104|NCT03154086|18576448|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393105|NCT03154086|18576449|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
5393106|NCT03154086|18576435|P15|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393107|NCT03154086|18576436|P14|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393108|NCT03154086|18576437|P13|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393109|NCT03154086|18576438|P12|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393110|NCT03154086|18576439|P11|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393111|NCT03154086|18576440|P10|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393112|NCT03154086|18576441|P9|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393113|NCT03154086|18576442|P8|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393114|NCT03154086|18576443|P7|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393115|NCT03154086|18576444|P6|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393116|NCT03154086|18576445|P5|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393117|NCT03154086|18576446|P4|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393118|NCT03154086|18576447|P3|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393119|NCT03154086|18576448|P2|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
5393120|NCT03154086|18576449|P1|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
5393121|NCT03154086|18576435|P15|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393122|NCT03154086|18576436|P14|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393123|NCT03154086|18576437|P13|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393124|NCT03154086|18576438|P12|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393125|NCT03154086|18576439|P11|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393126|NCT03154086|18576440|P10|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393127|NCT03154086|18576441|P9|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393128|NCT03154086|18576442|P8|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393129|NCT03154086|18576443|P7|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393130|NCT03154086|18576444|P6|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393131|NCT03154086|18576445|P5|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393132|NCT03154086|18576446|P4|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393133|NCT03154086|18576447|P3|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
5393134|NCT03154086|18576448|P2|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393135|NCT03154086|18576449|P1|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
5393136|NCT03154086|18576435|P15|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393137|NCT03154086|18576436|P14|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393138|NCT03154086|18576437|P13|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393139|NCT03154086|18576438|P12|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393140|NCT03154086|18576439|P11|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393141|NCT03154086|18576440|P10|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393142|NCT03154086|18576441|P9|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393143|NCT03154086|18576442|P8|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393144|NCT03154086|18576443|P7|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393145|NCT03154086|18576444|P6|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393146|NCT03154086|18576445|P5|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393147|NCT03154086|18576446|P4|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393148|NCT03154086|18576447|P3|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393149|NCT03154086|18576448|P2|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
5393150|NCT03154086|18576449|P1|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
5393151|NCT03154086|18576435|P15|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393152|NCT03154086|18576436|P14|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393153|NCT03154086|18576437|P13|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393154|NCT03154086|18576438|P12|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393155|NCT03154086|18576439|P11|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393156|NCT03154086|18576440|P10|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393157|NCT03154086|18576441|P9|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393158|NCT03154086|18576442|P8|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393159|NCT03154086|18576443|P7|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393160|NCT03154086|18576444|P6|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393161|NCT03154086|18576445|P5|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393162|NCT03154086|18576446|P4|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
5393163|NCT03154086|18576447|P3|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393164|NCT03154086|18576448|P2|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393165|NCT03154086|18576449|P1|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
5393166|NCT03154047|18576849|P1|Overall Study|Withdrawal by Subject|3
5393167|NCT03154047|18576849|P1|Overall Study|Study terminated by sponsor|76
5393168|NCT03154047|18576849|P1|Overall Study|Death|1
5393169|NCT03152552|18576896|P5|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
5393170|NCT03152552|18576897|P4|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
5393171|NCT03152552|18576898|P3|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
5393172|NCT03152552|18576899|P2|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
5393173|NCT03152552|18576900|P1|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
5393174|NCT03152552|18576896|P5|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5393175|NCT03152552|18576897|P4|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
5393176|NCT03152552|18576898|P3|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5393177|NCT03152552|18576899|P2|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5393178|NCT03152552|18576900|P1|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
5393179|NCT03152552|18576896|P5|Treatment Period 1 (12 Weeks)|Technical problems|0
5393180|NCT03152552|18576897|P4|Treatment Period 1 (12 Weeks)|Technical problems|0
5393181|NCT03152552|18576898|P3|Treatment Period 1 (12 Weeks)|Technical problems|1
5393182|NCT03152552|18576899|P2|Treatment Period 1 (12 Weeks)|Technical problems|0
5393183|NCT03152552|18576900|P1|Treatment Period 1 (12 Weeks)|Technical problems|0
5393184|NCT03152552|18576896|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5393185|NCT03152552|18576897|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5393186|NCT03152552|18576898|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5393187|NCT03152552|18576899|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5393188|NCT03152552|18576900|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5393189|NCT03152552|18576896|P5|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
5393190|NCT03152552|18576897|P4|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
5393191|NCT03152552|18576898|P3|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
5393192|NCT03152552|18576899|P2|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
5393193|NCT03152552|18576900|P1|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
5393194|NCT03152552|18576896|P5|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5393195|NCT03152552|18576897|P4|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5393196|NCT03152552|18576898|P3|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5393197|NCT03152552|18576899|P2|Treatment Period 1 (12 Weeks)|Protocol deviation|1
5393198|NCT03152552|18576900|P1|Treatment Period 1 (12 Weeks)|Protocol deviation|0
5393199|NCT03152552|18576896|P5|Treatment Period 1 (12 Weeks)|Death|1
5393200|NCT03152552|18576897|P4|Treatment Period 1 (12 Weeks)|Death|0
5393201|NCT03152552|18576898|P3|Treatment Period 1 (12 Weeks)|Death|0
5393202|NCT03152552|18576899|P2|Treatment Period 1 (12 Weeks)|Death|1
5393203|NCT03152552|18576900|P1|Treatment Period 1 (12 Weeks)|Death|0
5393204|NCT03152526|18577033|P2|Overall Study|Withdrawal by Subject|1
5393205|NCT03152526|18577034|P1|Overall Study|Withdrawal by Subject|0
5393206|NCT03152110|18577054|P1|Overall Study|Withdrawal by Subject|3
5393207|NCT03152019|18577069|P2|Overall Study|Adverse Event|1
5393208|NCT03152019|18577070|P1|Overall Study|Adverse Event|0
5393209|NCT03151551|18577078|P2|Post-Treatment Follow-Up Period|Physician Decision|1
5393210|NCT03151551|18577079|P1|Post-Treatment Follow-Up Period|Physician Decision|0
5393211|NCT03151551|18577078|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
5393212|NCT03151551|18577079|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
5393213|NCT03151551|18577078|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5393214|NCT03151551|18577079|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|4
5393215|NCT03151551|18577078|P2|Post-Treatment Follow-Up Period|Adverse Event|3
5393216|NCT03151551|18577079|P1|Post-Treatment Follow-Up Period|Adverse Event|1
5393217|NCT03151551|18577078|P2|Open-Label Treatment Period|Protocol Deviation|2
5393218|NCT03151551|18577079|P1|Open-Label Treatment Period|Protocol Deviation|1
5393219|NCT03151551|18577078|P2|Open-Label Treatment Period|Physician Decision|0
5393220|NCT03151551|18577079|P1|Open-Label Treatment Period|Physician Decision|3
5393221|NCT03151551|18577078|P2|Open-Label Treatment Period|Lack of Efficacy|1
5393222|NCT03151551|18577079|P1|Open-Label Treatment Period|Lack of Efficacy|1
5393223|NCT03151551|18577078|P2|Open-Label Treatment Period|Withdrawal by Subject|18
5393224|NCT03151551|18577079|P1|Open-Label Treatment Period|Withdrawal by Subject|12
5393225|NCT03151551|18577078|P2|Open-Label Treatment Period|Lost to Follow-up|1
5393226|NCT03151551|18577079|P1|Open-Label Treatment Period|Lost to Follow-up|1
5393227|NCT03151551|18577078|P2|Open-Label Treatment Period|Adverse Event|2
5393228|NCT03151551|18577079|P1|Open-Label Treatment Period|Adverse Event|0
5393229|NCT03151226|18577168|P1|Overall Study|not wear device correctly|1
5393230|NCT03151226|18577168|P1|Overall Study|Withdrawal by Subject|2
5393231|NCT03151148|18577174|P2|Overall Study|Withdrawal by Subject|0
5393232|NCT03151148|18577175|P1|Overall Study|Withdrawal by Subject|1
5393233|NCT03151148|18577174|P2|Overall Study|Lost to Follow-up|0
5393234|NCT03151148|18577175|P1|Overall Study|Lost to Follow-up|1
5393235|NCT03150719|18577229|P2|Overall Study|Other|0
5393236|NCT03150719|18577230|P1|Overall Study|Other|1
5393237|NCT03150719|18577229|P2|Overall Study|Death|1
5393238|NCT03150719|18577230|P1|Overall Study|Death|0
5393239|NCT03150719|18577229|P2|Overall Study|Adverse Event|1
5393240|NCT03150719|18577230|P1|Overall Study|Adverse Event|0
5393241|NCT03150485|18577246|P6|Overall Study|Unsatisfactory Lens Fitting|0
5393242|NCT03150485|18577247|P5|Overall Study|Unsatisfactory Lens Fitting|0
5393243|NCT03150485|18577248|P4|Overall Study|Unsatisfactory Lens Fitting|0
5393244|NCT03150485|18577249|P3|Overall Study|Unsatisfactory Lens Fitting|0
5393245|NCT03150485|18577250|P2|Overall Study|Unsatisfactory Lens Fitting|1
5393246|NCT03150485|18577251|P1|Overall Study|Unsatisfactory Lens Fitting|0
5393247|NCT03150082|18577428|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
5393248|NCT03150082|18577429|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
5393249|NCT03149848|18577535|P1|Period 2 (Day 15 to Day 28)|Adverse Event|2
5393250|NCT03149848|18577535|P1|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
5393251|NCT03149055|18577588|P1|Overall Study|Not treated|4
5393252|NCT03149042|18577593|P1|Overall Study|Invasive FFR Measurement cancelled|1
5393253|NCT03149042|18577593|P1|Overall Study|Poor CT Image Quality|1
5393254|NCT03149042|18577593|P1|Overall Study|Invasive FFR not performed|21
5393255|NCT03148756|18577607|P2|Overall Study|Study Terminated|1
5393256|NCT03148756|18577608|P1|Overall Study|Study Terminated|0
5393257|NCT03148691|18577641|P3|Overall Study|Withdrawal by Subject|0
5393258|NCT03148691|18577642|P2|Overall Study|Withdrawal by Subject|0
5393259|NCT03148691|18577643|P1|Overall Study|Withdrawal by Subject|1
5393260|NCT03148691|18577641|P3|Overall Study|Other|0
5393261|NCT03148691|18577642|P2|Overall Study|Other|0
5393262|NCT03148691|18577643|P1|Overall Study|Other|1
5393263|NCT03148691|18577641|P3|Overall Study|Lost to Follow-up|1
5393264|NCT03148691|18577642|P2|Overall Study|Lost to Follow-up|0
5393265|NCT03148691|18577643|P1|Overall Study|Lost to Follow-up|0
5393266|NCT03148691|18577641|P3|Overall Study|Protocol Violation|7
5393267|NCT03148691|18577642|P2|Overall Study|Protocol Violation|2
5393268|NCT03148691|18577643|P1|Overall Study|Protocol Violation|1
5393269|NCT03148067|18577706|P1|Overall Study|Death|1
5393270|NCT03148067|18577706|P1|Overall Study|Lost to Follow-up|3
5393271|NCT03147248|18577739|P6|Overall Study|Prolonged Dosing Interval|1
5393272|NCT03147248|18577740|P5|Overall Study|Prolonged Dosing Interval|1
5393273|NCT03147248|18577741|P4|Overall Study|Prolonged Dosing Interval|0
5393274|NCT03147248|18577742|P3|Overall Study|Prolonged Dosing Interval|0
5393275|NCT03147248|18577743|P2|Overall Study|Prolonged Dosing Interval|0
5393276|NCT03147248|18577744|P1|Overall Study|Prolonged Dosing Interval|0
5393277|NCT03147248|18577739|P6|Overall Study|Physician Decision|4
5393278|NCT03147248|18577740|P5|Overall Study|Physician Decision|2
5393279|NCT03147248|18577741|P4|Overall Study|Physician Decision|0
5393280|NCT03147248|18577742|P3|Overall Study|Physician Decision|0
5393281|NCT03147248|18577743|P2|Overall Study|Physician Decision|0
5393282|NCT03147248|18577744|P1|Overall Study|Physician Decision|0
5393283|NCT03147248|18577739|P6|Overall Study|Death|4
5393284|NCT03147248|18577740|P5|Overall Study|Death|0
5393285|NCT03147248|18577741|P4|Overall Study|Death|0
5393286|NCT03147248|18577742|P3|Overall Study|Death|0
5393287|NCT03147248|18577743|P2|Overall Study|Death|0
5393288|NCT03147248|18577744|P1|Overall Study|Death|0
5393289|NCT03147248|18577739|P6|Overall Study|Pregnancy|0
5393290|NCT03147248|18577740|P5|Overall Study|Pregnancy|1
5393291|NCT03147248|18577741|P4|Overall Study|Pregnancy|0
5393292|NCT03147248|18577742|P3|Overall Study|Pregnancy|0
5393293|NCT03147248|18577743|P2|Overall Study|Pregnancy|0
5393294|NCT03147248|18577744|P1|Overall Study|Pregnancy|0
5393295|NCT03147248|18577739|P6|Overall Study|Lost to Follow-up|0
5393296|NCT03147248|18577740|P5|Overall Study|Lost to Follow-up|2
5393297|NCT03147248|18577741|P4|Overall Study|Lost to Follow-up|0
5393298|NCT03147248|18577742|P3|Overall Study|Lost to Follow-up|0
5393299|NCT03147248|18577743|P2|Overall Study|Lost to Follow-up|0
5393300|NCT03147248|18577744|P1|Overall Study|Lost to Follow-up|0
5393301|NCT03147248|18577739|P6|Overall Study|Protocol Violation|0
5393302|NCT03147248|18577740|P5|Overall Study|Protocol Violation|2
5393303|NCT03147248|18577741|P4|Overall Study|Protocol Violation|0
5393304|NCT03147248|18577742|P3|Overall Study|Protocol Violation|0
5393305|NCT03147248|18577743|P2|Overall Study|Protocol Violation|0
5393306|NCT03147248|18577744|P1|Overall Study|Protocol Violation|0
5393307|NCT03147248|18577739|P6|Overall Study|Withdrawal by Subject|9
5393308|NCT03147248|18577740|P5|Overall Study|Withdrawal by Subject|12
5393309|NCT03147248|18577741|P4|Overall Study|Withdrawal by Subject|0
5393310|NCT03147248|18577742|P3|Overall Study|Withdrawal by Subject|0
5393311|NCT03147248|18577743|P2|Overall Study|Withdrawal by Subject|0
5393312|NCT03147248|18577744|P1|Overall Study|Withdrawal by Subject|0
5393313|NCT03147248|18577739|P6|Overall Study|Disease progression|2
5393314|NCT03147248|18577740|P5|Overall Study|Disease progression|0
5393315|NCT03147248|18577741|P4|Overall Study|Disease progression|0
5393316|NCT03147248|18577742|P3|Overall Study|Disease progression|0
5393317|NCT03147248|18577743|P2|Overall Study|Disease progression|0
5393318|NCT03147248|18577744|P1|Overall Study|Disease progression|1
5393319|NCT03147248|18577739|P6|Overall Study|Adverse Event|11
5393320|NCT03147248|18577740|P5|Overall Study|Adverse Event|6
5393321|NCT03147248|18577741|P4|Overall Study|Adverse Event|2
5393322|NCT03147248|18577742|P3|Overall Study|Adverse Event|2
5393323|NCT03147248|18577743|P2|Overall Study|Adverse Event|2
5393324|NCT03147248|18577744|P1|Overall Study|Adverse Event|0
5393325|NCT03146741|18577766|P1|Overall Study|Awaiting txp|2
5393326|NCT03146741|18577766|P1|Overall Study|Physician Decision|2
5393327|NCT03146741|18577766|P1|Overall Study|Listeted for MOT|2
5393328|NCT03146741|18577766|P1|Overall Study|Txp with non-HCV+ heart|4
5393329|NCT03146403|18577786|P2|Overall Study|Lost to Follow-up|0
5393330|NCT03146403|18577787|P1|Overall Study|Lost to Follow-up|2
5393331|NCT03146403|18577786|P2|Overall Study|Withdrawal by Subject|3
5393332|NCT03146403|18577787|P1|Overall Study|Withdrawal by Subject|0
5393333|NCT03145207|18577823|P1|Overall Study|baseline blood pressure high|1
5393334|NCT03145207|18577823|P1|Overall Study|volunteer started taking allergy shots|1
5393335|NCT03144180|18577868|P2|Overall Study|Scrub tech removed tube cap|1
5393336|NCT03144180|18577869|P1|Overall Study|Scrub tech removed tube cap|0
5393337|NCT03144180|18577868|P2|Overall Study|Provider forgot to use the Q-cup|1
5393338|NCT03144180|18577869|P1|Overall Study|Provider forgot to use the Q-cup|0
5393339|NCT03144180|18577868|P2|Overall Study|Provider forgot to fill out forms|3
5393340|NCT03144180|18577869|P1|Overall Study|Provider forgot to fill out forms|1
5393341|NCT03144180|18577868|P2|Overall Study|STAT Delivery|1
5393342|NCT03144180|18577869|P1|Overall Study|STAT Delivery|1
5393343|NCT03143855|18577881|P2|Overall Study|Participant experienced withdrawal|1
5393344|NCT03143855|18577882|P1|Overall Study|Participant experienced withdrawal|0
5393345|NCT03143855|18577881|P2|Overall Study|Protocol Violation|0
5393346|NCT03143855|18577882|P1|Overall Study|Protocol Violation|1
5393347|NCT03143855|18577881|P2|Overall Study|Withdrawal by Subject|3
5393348|NCT03143855|18577882|P1|Overall Study|Withdrawal by Subject|4
5393349|NCT03143166|18577913|P1|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
5393350|NCT03143101|18577932|P3|Overall Study|Lost to Follow-up|0
5393351|NCT03143101|18577933|P2|Overall Study|Lost to Follow-up|2
5393352|NCT03143101|18577934|P1|Overall Study|Lost to Follow-up|2
5393353|NCT03143101|18577932|P3|Overall Study|Withdrawal by Subject|0
5393354|NCT03143101|18577933|P2|Overall Study|Withdrawal by Subject|1
5393355|NCT03143101|18577934|P1|Overall Study|Withdrawal by Subject|0
5393356|NCT03142932|18577989|P2|Overall Study|Lost to Follow-up|11
5393357|NCT03142932|18577990|P1|Overall Study|Lost to Follow-up|2
5393358|NCT03142750|18578006|P2|Overall Study|Lost to Follow-up|1
5393359|NCT03142750|18578007|P1|Overall Study|Lost to Follow-up|4
5393360|NCT03142451|18578020|P2|Overall Study|Other|1
5393361|NCT03142451|18578021|P1|Overall Study|Other|1
5393362|NCT03142451|18578020|P2|Overall Study|Protocol Violation|1
5393363|NCT03142451|18578021|P1|Overall Study|Protocol Violation|3
5393364|NCT03142451|18578020|P2|Overall Study|Participant request|12
5393365|NCT03142451|18578021|P1|Overall Study|Participant request|24
5393366|NCT03142451|18578020|P2|Overall Study|Lost to Follow-up|8
5393367|NCT03142451|18578021|P1|Overall Study|Lost to Follow-up|25
5393368|NCT03142451|18578020|P2|Overall Study|Adverse Event|2
5393369|NCT03142451|18578021|P1|Overall Study|Adverse Event|5
5393370|NCT03141788|18578062|P1|Overall Study|Withdrawal by Subject|4
5393371|NCT03141788|18578062|P1|Overall Study|Protocol Violation|3
5393372|NCT03141788|18578062|P1|Overall Study|Lost to Follow-up|1
5393373|NCT03141307|18578143|P2|Follow-Up|Lost to Follow-up|54
5393374|NCT03141307|18578144|P1|Follow-Up|Lost to Follow-up|97
5393375|NCT03141307|18578143|P2|In-Hospital|Protocol Violation|0
5393376|NCT03141307|18578144|P1|In-Hospital|Protocol Violation|4
5393377|NCT03141307|18578143|P2|In-Hospital|Withdrawal by Subject|2
5393378|NCT03141307|18578144|P1|In-Hospital|Withdrawal by Subject|0
5393379|NCT03141151|18578162|P2|Overall Study|Withdrawal by Subject|2
5393380|NCT03141151|18578163|P1|Overall Study|Withdrawal by Subject|3
5393381|NCT03141151|18578162|P2|Overall Study|Lost to Follow-up|2
5393382|NCT03141151|18578163|P1|Overall Study|Lost to Follow-up|3
5393383|NCT03141086|18578181|P2|Overall Study|Adverse Event|2
5393384|NCT03141086|18578182|P1|Overall Study|Adverse Event|0
5393385|NCT03141086|18578181|P2|Overall Study|Protocol Violation|1
5393386|NCT03141086|18578182|P1|Overall Study|Protocol Violation|0
5393387|NCT03141086|18578181|P2|Overall Study|Withdrawal by Subject|1
5393388|NCT03141086|18578182|P1|Overall Study|Withdrawal by Subject|0
5393389|NCT03141086|18578181|P2|Overall Study|Study Terminated By Sponsor|1
5393390|NCT03141086|18578182|P1|Overall Study|Study Terminated By Sponsor|1
5393391|NCT03139604|18578222|P2|Overall Study|Continuing on Study|136
5393392|NCT03139604|18578223|P1|Overall Study|Continuing on Study|134
5393393|NCT03139604|18578222|P2|Overall Study|Death|64
5393394|NCT03139604|18578223|P1|Overall Study|Death|60
5393395|NCT03139604|18578222|P2|Overall Study|Lost to Follow-up|1
5393396|NCT03139604|18578223|P1|Overall Study|Lost to Follow-up|1
5393397|NCT03139604|18578222|P2|Overall Study|Physician Decision|2
5393398|NCT03139604|18578223|P1|Overall Study|Physician Decision|1
5393399|NCT03139604|18578222|P2|Overall Study|Withdrawal by Subject|15
5393400|NCT03139604|18578223|P1|Overall Study|Withdrawal by Subject|16
5393401|NCT03139604|18578222|P2|Overall Study|Other|2
5393402|NCT03139604|18578223|P1|Overall Study|Other|7
5393403|NCT03139552|18578272|P1|Overall Study|unable to attend tasting due to schedule|3
5393404|NCT03139448|18578315|P2|Overall Study|Physician Decision|2
5393405|NCT03139448|18578316|P1|Overall Study|Physician Decision|0
5393406|NCT03139448|18578315|P2|Overall Study|Screen fail|3
5393407|NCT03139448|18578316|P1|Overall Study|Screen fail|1
5393408|NCT03139448|18578315|P2|Overall Study|Withdrawal by Subject|6
5393409|NCT03139448|18578316|P1|Overall Study|Withdrawal by Subject|3
5393410|NCT03139448|18578315|P2|Overall Study|Location of procedure changed|8
5393411|NCT03139448|18578316|P1|Overall Study|Location of procedure changed|2
5393412|NCT03139448|18578315|P2|Overall Study|Lack of Efficacy|7
5393413|NCT03139448|18578316|P1|Overall Study|Lack of Efficacy|6
5393414|NCT03139279|18578340|P2|Overall Study|Withdrawal by Subject|2
5393415|NCT03139279|18578341|P1|Overall Study|Withdrawal by Subject|0
5393416|NCT03139279|18578340|P2|Overall Study|Protocol Violation|4
5393417|NCT03139279|18578341|P1|Overall Study|Protocol Violation|5
5393418|NCT03139279|18578340|P2|Overall Study|Physician Decision|0
5393419|NCT03139279|18578341|P1|Overall Study|Physician Decision|2
5393420|NCT03139240|18578359|P4|Overall Study|Lost to Follow-up|0
5393421|NCT03139240|18578360|P3|Overall Study|Lost to Follow-up|1
5393422|NCT03139240|18578361|P2|Overall Study|Lost to Follow-up|1
5393423|NCT03139240|18578362|P1|Overall Study|Lost to Follow-up|0
5393424|NCT03138967|18578394|P2|Overall Study|Physician Decision|3
5393425|NCT03138967|18578395|P1|Overall Study|Physician Decision|1
5393426|NCT03138967|18578394|P2|Overall Study|Death|1
5393427|NCT03138967|18578395|P1|Overall Study|Death|0
5393428|NCT03138655|18578446|P8|Overall Study|Reason not Specified|0
5393429|NCT03138655|18578447|P7|Overall Study|Reason not Specified|0
5393430|NCT03138655|18578448|P6|Overall Study|Reason not Specified|1
5393431|NCT03138655|18578449|P5|Overall Study|Reason not Specified|1
5393432|NCT03138655|18578450|P4|Overall Study|Reason not Specified|2
5393433|NCT03138655|18578451|P3|Overall Study|Reason not Specified|0
5393434|NCT03138655|18578452|P2|Overall Study|Reason not Specified|0
5393435|NCT03138655|18578453|P1|Overall Study|Reason not Specified|1
5393436|NCT03138655|18578446|P8|Overall Study|Withdrawal by Subject|0
5393437|NCT03138655|18578447|P7|Overall Study|Withdrawal by Subject|1
5393438|NCT03138655|18578448|P6|Overall Study|Withdrawal by Subject|0
5393439|NCT03138655|18578449|P5|Overall Study|Withdrawal by Subject|0
5393440|NCT03138655|18578450|P4|Overall Study|Withdrawal by Subject|0
5393441|NCT03138655|18578451|P3|Overall Study|Withdrawal by Subject|0
5393442|NCT03138655|18578452|P2|Overall Study|Withdrawal by Subject|1
5393443|NCT03138655|18578453|P1|Overall Study|Withdrawal by Subject|0
5393444|NCT03138655|18578446|P8|Overall Study|Adverse Event|2
5393445|NCT03138655|18578447|P7|Overall Study|Adverse Event|2
5393446|NCT03138655|18578448|P6|Overall Study|Adverse Event|4
5393447|NCT03138655|18578449|P5|Overall Study|Adverse Event|1
5393448|NCT03138655|18578450|P4|Overall Study|Adverse Event|1
5393449|NCT03138655|18578451|P3|Overall Study|Adverse Event|2
5393450|NCT03138655|18578452|P2|Overall Study|Adverse Event|1
5393451|NCT03138655|18578453|P1|Overall Study|Adverse Event|2
5393452|NCT03137784|18578574|P6|Overall Study|Non-compliance with study treatment|0
5393453|NCT03137784|18578575|P5|Overall Study|Non-compliance with study treatment|1
5393454|NCT03137784|18578576|P4|Overall Study|Non-compliance with study treatment|0
5393455|NCT03137784|18578577|P3|Overall Study|Non-compliance with study treatment|0
5393456|NCT03137784|18578578|P2|Overall Study|Non-compliance with study treatment|0
5393457|NCT03137784|18578579|P1|Overall Study|Non-compliance with study treatment|0
5393458|NCT03137784|18578574|P6|Overall Study|Subject/guardian decision|0
5393459|NCT03137784|18578575|P5|Overall Study|Subject/guardian decision|0
5393460|NCT03137784|18578576|P4|Overall Study|Subject/guardian decision|0
5393461|NCT03137784|18578577|P3|Overall Study|Subject/guardian decision|0
5393462|NCT03137784|18578578|P2|Overall Study|Subject/guardian decision|0
5393463|NCT03137784|18578579|P1|Overall Study|Subject/guardian decision|1
5393464|NCT03137784|18578574|P6|Overall Study|Adverse Event|0
5393465|NCT03137784|18578575|P5|Overall Study|Adverse Event|0
5393466|NCT03137784|18578576|P4|Overall Study|Adverse Event|0
5393467|NCT03137784|18578577|P3|Overall Study|Adverse Event|0
5393468|NCT03137784|18578578|P2|Overall Study|Adverse Event|1
5393469|NCT03137784|18578579|P1|Overall Study|Adverse Event|1
5393470|NCT03137173|18578635|P2|Overall Study|Other reasons|2
5393471|NCT03137173|18578636|P1|Overall Study|Other reasons|3
5393472|NCT03137173|18578635|P2|Overall Study|Lost to Follow-up|18
5393473|NCT03137173|18578636|P1|Overall Study|Lost to Follow-up|13
5393474|NCT03137173|18578635|P2|Overall Study|Physician Decision|0
5393475|NCT03137173|18578636|P1|Overall Study|Physician Decision|1
5393476|NCT03137173|18578635|P2|Overall Study|Death|3
5393477|NCT03137173|18578636|P1|Overall Study|Death|1
5393478|NCT03137173|18578635|P2|Overall Study|Withdrawal by Subject|13
5393479|NCT03137173|18578636|P1|Overall Study|Withdrawal by Subject|8
5393480|NCT03137069|18578652|P6|Overall Study|Data Entry Error|0
5393481|NCT03137069|18578653|P5|Overall Study|Data Entry Error|0
5393482|NCT03137069|18578654|P4|Overall Study|Data Entry Error|1
5393483|NCT03137069|18578655|P3|Overall Study|Data Entry Error|0
5393484|NCT03137069|18578656|P2|Overall Study|Data Entry Error|0
5393485|NCT03137069|18578657|P1|Overall Study|Data Entry Error|0
5393486|NCT03137069|18578652|P6|Overall Study|Study Terminated by Sponsor|0
5393487|NCT03137069|18578653|P5|Overall Study|Study Terminated by Sponsor|1
5393488|NCT03137069|18578654|P4|Overall Study|Study Terminated by Sponsor|0
5393489|NCT03137069|18578655|P3|Overall Study|Study Terminated by Sponsor|0
5393490|NCT03137069|18578656|P2|Overall Study|Study Terminated by Sponsor|0
5393491|NCT03137069|18578657|P1|Overall Study|Study Terminated by Sponsor|0
5393492|NCT03137069|18578652|P6|Overall Study|Physician Decision|0
5393493|NCT03137069|18578653|P5|Overall Study|Physician Decision|0
5393494|NCT03137069|18578654|P4|Overall Study|Physician Decision|1
5393495|NCT03137069|18578655|P3|Overall Study|Physician Decision|0
5393496|NCT03137069|18578656|P2|Overall Study|Physician Decision|0
5393497|NCT03137069|18578657|P1|Overall Study|Physician Decision|0
5393498|NCT03137069|18578652|P6|Overall Study|Protocol Violation|1
5393499|NCT03137069|18578653|P5|Overall Study|Protocol Violation|1
5393500|NCT03137069|18578654|P4|Overall Study|Protocol Violation|1
5393501|NCT03137069|18578655|P3|Overall Study|Protocol Violation|0
5393502|NCT03137069|18578656|P2|Overall Study|Protocol Violation|1
5393503|NCT03137069|18578657|P1|Overall Study|Protocol Violation|0
5393504|NCT03137069|18578652|P6|Overall Study|Adverse Event|1
5393505|NCT03137069|18578653|P5|Overall Study|Adverse Event|0
5393506|NCT03137069|18578654|P4|Overall Study|Adverse Event|1
5393507|NCT03137069|18578655|P3|Overall Study|Adverse Event|1
5393508|NCT03137069|18578656|P2|Overall Study|Adverse Event|3
5393509|NCT03137069|18578657|P1|Overall Study|Adverse Event|0
5393510|NCT03137069|18578652|P6|Overall Study|Withdrawal by Subject|0
5393511|NCT03137069|18578653|P5|Overall Study|Withdrawal by Subject|0
5393512|NCT03137069|18578654|P4|Overall Study|Withdrawal by Subject|2
5393513|NCT03137069|18578655|P3|Overall Study|Withdrawal by Subject|2
5393514|NCT03137069|18578656|P2|Overall Study|Withdrawal by Subject|2
5393515|NCT03137069|18578657|P1|Overall Study|Withdrawal by Subject|1
5393516|NCT03136861|18578700|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5393517|NCT03136861|18578701|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5393518|NCT03136861|18578702|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5393519|NCT03136861|18578703|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5393520|NCT03136861|18578704|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
5393521|NCT03136861|18578705|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5393522|NCT03136861|18578706|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
5393523|NCT03136861|18578700|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5393524|NCT03136861|18578701|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5393525|NCT03136861|18578702|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5393526|NCT03136861|18578703|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5393527|NCT03136861|18578704|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
5393528|NCT03136861|18578705|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5393529|NCT03136861|18578706|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
5393530|NCT03136861|18578700|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
5393531|NCT03136861|18578701|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5393532|NCT03136861|18578702|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
5393533|NCT03136861|18578703|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
5393534|NCT03136861|18578704|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5393535|NCT03136861|18578705|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5393536|NCT03136861|18578706|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
5393537|NCT03136861|18578700|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5393538|NCT03136861|18578701|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5393539|NCT03136861|18578702|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5393540|NCT03136861|18578703|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5393541|NCT03136861|18578704|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
5393542|NCT03136861|18578705|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
5393543|NCT03136861|18578706|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
5393544|NCT03136861|18578700|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5393545|NCT03136861|18578701|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5393546|NCT03136861|18578702|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5393547|NCT03136861|18578703|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5393548|NCT03136861|18578704|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5393549|NCT03136861|18578705|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
5393550|NCT03136861|18578706|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
5393551|NCT03136861|18578700|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5393552|NCT03136861|18578701|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5393553|NCT03136861|18578702|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5393554|NCT03136861|18578703|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5393555|NCT03136861|18578704|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
5393556|NCT03136861|18578705|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
5393557|NCT03136861|18578706|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
5393558|NCT03136861|18578700|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5393559|NCT03136861|18578701|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5393560|NCT03136861|18578702|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5393561|NCT03136861|18578703|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5393562|NCT03136861|18578704|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
5393563|NCT03136861|18578705|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
5393564|NCT03136861|18578706|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
5393565|NCT03136861|18578700|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5393566|NCT03136861|18578701|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5393567|NCT03136861|18578702|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5393568|NCT03136861|18578703|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5393569|NCT03136861|18578704|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
5393570|NCT03136861|18578705|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
5393571|NCT03136861|18578706|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
5393572|NCT03136484|18578721|P2|Overall Study|Death|0
5393573|NCT03136484|18578722|P1|Overall Study|Death|1
5393574|NCT03136484|18578721|P2|Overall Study|Lost to Follow-up|8
5393575|NCT03136484|18578722|P1|Overall Study|Lost to Follow-up|7
5393576|NCT03136484|18578721|P2|Overall Study|Withdrawal by Subject|14
5393577|NCT03136484|18578722|P1|Overall Study|Withdrawal by Subject|19
5393578|NCT03136380|18578850|P5|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5393579|NCT03136380|18578851|P4|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5393580|NCT03136380|18578852|P3|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5393581|NCT03136380|18578853|P2|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
5393582|NCT03136380|18578854|P1|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
5393583|NCT03136198|18579035|P2|Overall Study|Withdrawal by Subject|1
5393584|NCT03136198|18579036|P1|Overall Study|Withdrawal by Subject|0
5393585|NCT03136159|18579044|P2|Overall Study|never got dressing placed|0
5393586|NCT03136159|18579045|P1|Overall Study|never got dressing placed|1
5393587|NCT03136159|18579044|P2|Overall Study|additional dressing|0
5393588|NCT03136159|18579045|P1|Overall Study|additional dressing|1
5393589|NCT03136159|18579044|P2|Overall Study|vertical skin incision|0
5393590|NCT03136159|18579045|P1|Overall Study|vertical skin incision|1
5393591|NCT03136159|18579044|P2|Overall Study|chorioamnionitis|0
5393592|NCT03136159|18579045|P1|Overall Study|chorioamnionitis|2
5393593|NCT03136107|18579051|P1|Overall Study|Other (Not specified)|1
5393594|NCT03136068|18579061|P2|Overall Study|Protocol Violation|0
5393595|NCT03136068|18579062|P1|Overall Study|Protocol Violation|1
5393596|NCT03136068|18579061|P2|Overall Study|Lost to Follow-up|1
5393597|NCT03136068|18579062|P1|Overall Study|Lost to Follow-up|1
5393598|NCT03135899|18579084|P8|Overall Study|Withdrawal by Subject|0
5393599|NCT03135899|18579085|P7|Overall Study|Withdrawal by Subject|0
5393600|NCT03135899|18579086|P6|Overall Study|Withdrawal by Subject|2
5393601|NCT03135899|18579087|P5|Overall Study|Withdrawal by Subject|0
5393602|NCT03135899|18579088|P4|Overall Study|Withdrawal by Subject|0
5393603|NCT03135899|18579089|P3|Overall Study|Withdrawal by Subject|0
5393604|NCT03135899|18579090|P2|Overall Study|Withdrawal by Subject|0
5393605|NCT03135899|18579091|P1|Overall Study|Withdrawal by Subject|0
5393606|NCT03135899|18579084|P8|Overall Study|Failed spirometry,unable to repeat visit|0
5393607|NCT03135899|18579085|P7|Overall Study|Failed spirometry,unable to repeat visit|1
5393608|NCT03135899|18579086|P6|Overall Study|Failed spirometry,unable to repeat visit|0
5393609|NCT03135899|18579087|P5|Overall Study|Failed spirometry,unable to repeat visit|0
5393610|NCT03135899|18579088|P4|Overall Study|Failed spirometry,unable to repeat visit|0
5393611|NCT03135899|18579089|P3|Overall Study|Failed spirometry,unable to repeat visit|0
5393612|NCT03135899|18579090|P2|Overall Study|Failed spirometry,unable to repeat visit|0
5393613|NCT03135899|18579091|P1|Overall Study|Failed spirometry,unable to repeat visit|0
5393614|NCT03135548|18579124|P3|Overall Study|Other than listed|2
5393615|NCT03135548|18579125|P2|Overall Study|Other than listed|2
5393616|NCT03135548|18579126|P1|Overall Study|Other than listed|0
5393617|NCT03135548|18579124|P3|Overall Study|Withdrawal by Subject|1
5393618|NCT03135548|18579125|P2|Overall Study|Withdrawal by Subject|2
5393619|NCT03135548|18579126|P1|Overall Study|Withdrawal by Subject|2
5393620|NCT03135548|18579124|P3|Overall Study|Lost to Follow-up|0
5393621|NCT03135548|18579125|P2|Overall Study|Lost to Follow-up|0
5393622|NCT03135548|18579126|P1|Overall Study|Lost to Follow-up|3
5393623|NCT03135522|18579156|P2|Overall Study|Adverse Event|0
5393624|NCT03135522|18579157|P1|Overall Study|Adverse Event|1
5393625|NCT03135431|18579171|P2|Overall Study|Study Surgeon not available|0
5393626|NCT03135431|18579172|P1|Overall Study|Study Surgeon not available|2
5393627|NCT03135028|18579193|P1|Overall Study|Withdrew Consent|1
5393628|NCT03135028|18579193|P1|Overall Study|Study Terminated by Sponsor|2
5393629|NCT03135028|18579193|P1|Overall Study|Death|6
5393630|NCT03134911|18579339|P1|Overall Study|Not meeting inclusion/exclusion criteria|3
5393631|NCT03134911|18579339|P1|Overall Study|Screen failure|31
5393632|NCT03134599|18579401|P6|Week 3|Lost to Follow-up|1
5393633|NCT03134599|18579402|P5|Week 3|Lost to Follow-up|0
5393634|NCT03134599|18579403|P4|Week 3|Lost to Follow-up|1
5393635|NCT03134599|18579404|P3|Week 3|Lost to Follow-up|0
5393636|NCT03134599|18579405|P2|Week 3|Lost to Follow-up|0
5393637|NCT03134599|18579406|P1|Week 3|Lost to Follow-up|0
5393638|NCT03134599|18579401|P6|Week 2|Lost to Follow-up|0
5393639|NCT03134599|18579402|P5|Week 2|Lost to Follow-up|1
5393640|NCT03134599|18579403|P4|Week 2|Lost to Follow-up|1
5393641|NCT03134599|18579404|P3|Week 2|Lost to Follow-up|0
5393642|NCT03134599|18579405|P2|Week 2|Lost to Follow-up|0
5393643|NCT03134599|18579406|P1|Week 2|Lost to Follow-up|1
5393644|NCT03134599|18579401|P6|Week 1|Lost to Follow-up|0
5393645|NCT03134599|18579402|P5|Week 1|Lost to Follow-up|1
5393646|NCT03134599|18579403|P4|Week 1|Lost to Follow-up|0
5393647|NCT03134599|18579404|P3|Week 1|Lost to Follow-up|0
5393648|NCT03134599|18579405|P2|Week 1|Lost to Follow-up|0
5393649|NCT03134599|18579406|P1|Week 1|Lost to Follow-up|0
5393650|NCT03134222|18579446|P5|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5393651|NCT03134222|18579447|P4|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5393652|NCT03134222|18579448|P3|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5393653|NCT03134222|18579449|P2|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
5393654|NCT03134222|18579450|P1|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
5393655|NCT03134222|18579446|P5|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5393656|NCT03134222|18579447|P4|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
5393657|NCT03134222|18579448|P3|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5393658|NCT03134222|18579449|P2|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5393659|NCT03134222|18579450|P1|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
5393660|NCT03134222|18579446|P5|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5393661|NCT03134222|18579447|P4|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5393662|NCT03134222|18579448|P3|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5393663|NCT03134222|18579449|P2|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
5393664|NCT03134222|18579450|P1|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
5393665|NCT03134222|18579446|P5|Treatment Period (Week 12 to 48)|Withdrew Consent|1
5393666|NCT03134222|18579447|P4|Treatment Period (Week 12 to 48)|Withdrew Consent|0
5393667|NCT03134222|18579448|P3|Treatment Period (Week 12 to 48)|Withdrew Consent|0
5393668|NCT03134222|18579449|P2|Treatment Period (Week 12 to 48)|Withdrew Consent|2
5393669|NCT03134222|18579450|P1|Treatment Period (Week 12 to 48)|Withdrew Consent|0
5393670|NCT03134222|18579446|P5|Treatment Period (Up to Week 12)|Randomized but not treated|0
5393671|NCT03134222|18579447|P4|Treatment Period (Up to Week 12)|Randomized but not treated|0
5393672|NCT03134222|18579448|P3|Treatment Period (Up to Week 12)|Randomized but not treated|1
5393673|NCT03134222|18579449|P2|Treatment Period (Up to Week 12)|Randomized but not treated|1
5393674|NCT03134222|18579450|P1|Treatment Period (Up to Week 12)|Randomized but not treated|0
5393675|NCT03134222|18579446|P5|Treatment Period (Up to Week 12)|Withdrew Consent|0
5393676|NCT03134222|18579447|P4|Treatment Period (Up to Week 12)|Withdrew Consent|0
5393677|NCT03134222|18579448|P3|Treatment Period (Up to Week 12)|Withdrew Consent|0
5393678|NCT03134222|18579449|P2|Treatment Period (Up to Week 12)|Withdrew Consent|1
5393679|NCT03134222|18579450|P1|Treatment Period (Up to Week 12)|Withdrew Consent|0
5393680|NCT03134222|18579446|P5|Treatment Period (Up to Week 12)|Lost to Follow-up|0
5393681|NCT03134222|18579447|P4|Treatment Period (Up to Week 12)|Lost to Follow-up|0
5393682|NCT03134222|18579448|P3|Treatment Period (Up to Week 12)|Lost to Follow-up|1
5393683|NCT03134222|18579449|P2|Treatment Period (Up to Week 12)|Lost to Follow-up|1
5393684|NCT03134222|18579450|P1|Treatment Period (Up to Week 12)|Lost to Follow-up|1
5393685|NCT03134222|18579446|P5|Treatment Period (Up to Week 12)|Adverse Event|0
5393686|NCT03134222|18579447|P4|Treatment Period (Up to Week 12)|Adverse Event|0
5393687|NCT03134222|18579448|P3|Treatment Period (Up to Week 12)|Adverse Event|0
5393688|NCT03134222|18579449|P2|Treatment Period (Up to Week 12)|Adverse Event|1
5393689|NCT03134222|18579450|P1|Treatment Period (Up to Week 12)|Adverse Event|4
5393690|NCT03134183|18579472|P2|Overall Study|Withdrawal by Subject|1
5393691|NCT03134183|18579473|P1|Overall Study|Withdrawal by Subject|1
5393692|NCT03133767|18579524|P2|Overall Study|Protocol Violation|1
5393693|NCT03133767|18579525|P1|Overall Study|Protocol Violation|0
5393694|NCT03133767|18579524|P2|Overall Study|Lost to Follow-up|24
5393695|NCT03133767|18579525|P1|Overall Study|Lost to Follow-up|38
5393696|NCT03133481|18579541|P2|Overall Study|FC Catheter fell out post operative day1|4
5393697|NCT03133481|18579542|P1|Overall Study|FC Catheter fell out post operative day1|0
5393698|NCT03132753|18579572|P2|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
5393699|NCT03132753|18579573|P1|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
5393700|NCT03132753|18579572|P2|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
5393701|NCT03132753|18579573|P1|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
5393702|NCT03132220|18579718|P2|Overall Study|Withdrawal by Subject|4
5393703|NCT03132220|18579719|P1|Overall Study|Withdrawal by Subject|1
5393704|NCT03132220|18579718|P2|Overall Study|Lost to Follow-up|8
5393705|NCT03132220|18579719|P1|Overall Study|Lost to Follow-up|17
5393706|NCT03131999|18579747|P2|Overall Study|Withdrawal by Subject|1
5393707|NCT03131999|18579748|P1|Overall Study|Withdrawal by Subject|0
5393708|NCT03131895|18579760|P4|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
5393709|NCT03131895|18579761|P3|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
5393710|NCT03131895|18579762|P2|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
5393711|NCT03131895|18579763|P1|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
5393712|NCT03131895|18579760|P4|Intervention Period 2 (2 Days)|Lost to Follow-up|0
5393713|NCT03131895|18579761|P3|Intervention Period 2 (2 Days)|Lost to Follow-up|0
5393714|NCT03131895|18579762|P2|Intervention Period 2 (2 Days)|Lost to Follow-up|1
5393715|NCT03131895|18579763|P1|Intervention Period 2 (2 Days)|Lost to Follow-up|0
5393716|NCT03131895|18579760|P4|Washout Period (at Least 5 Days)|Other|0
5393717|NCT03131895|18579761|P3|Washout Period (at Least 5 Days)|Other|2
5393718|NCT03131895|18579762|P2|Washout Period (at Least 5 Days)|Other|0
5393719|NCT03131895|18579763|P1|Washout Period (at Least 5 Days)|Other|0
5393720|NCT03131895|18579760|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
5393721|NCT03131895|18579761|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5393722|NCT03131895|18579762|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
5393723|NCT03131895|18579763|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
5393724|NCT03131895|18579760|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|3
5393725|NCT03131895|18579761|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|2
5393726|NCT03131895|18579762|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|3
5393727|NCT03131895|18579763|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
5393728|NCT03131895|18579760|P4|Washout Period (at Least 5 Days)|Adverse Event|1
5393729|NCT03131895|18579761|P3|Washout Period (at Least 5 Days)|Adverse Event|0
5393730|NCT03131895|18579762|P2|Washout Period (at Least 5 Days)|Adverse Event|0
5393731|NCT03131895|18579763|P1|Washout Period (at Least 5 Days)|Adverse Event|1
5393732|NCT03131713|18579783|P2|Overall Study|Lost to Follow-up|0
5393733|NCT03131713|18579784|P1|Overall Study|Lost to Follow-up|5
5393734|NCT03131687|18579808|P6|Overall Study|Inadvertent Enrollment|0
5393735|NCT03131687|18579809|P5|Overall Study|Inadvertent Enrollment|0
5393736|NCT03131687|18579810|P4|Overall Study|Inadvertent Enrollment|1
5393737|NCT03131687|18579811|P3|Overall Study|Inadvertent Enrollment|0
5393738|NCT03131687|18579812|P2|Overall Study|Inadvertent Enrollment|0
5393739|NCT03131687|18579813|P1|Overall Study|Inadvertent Enrollment|0
5393740|NCT03131687|18579808|P6|Overall Study|Principle Investigator Decision|0
5393741|NCT03131687|18579809|P5|Overall Study|Principle Investigator Decision|0
5393742|NCT03131687|18579810|P4|Overall Study|Principle Investigator Decision|0
5393743|NCT03131687|18579811|P3|Overall Study|Principle Investigator Decision|0
5393744|NCT03131687|18579812|P2|Overall Study|Principle Investigator Decision|1
5393745|NCT03131687|18579813|P1|Overall Study|Principle Investigator Decision|0
5393746|NCT03131687|18579808|P6|Overall Study|Participant Started New Diabetic Drug|0
5393747|NCT03131687|18579809|P5|Overall Study|Participant Started New Diabetic Drug|0
5393748|NCT03131687|18579810|P4|Overall Study|Participant Started New Diabetic Drug|0
5393749|NCT03131687|18579811|P3|Overall Study|Participant Started New Diabetic Drug|0
5393750|NCT03131687|18579812|P2|Overall Study|Participant Started New Diabetic Drug|0
5393751|NCT03131687|18579813|P1|Overall Study|Participant Started New Diabetic Drug|1
5393752|NCT03131687|18579808|P6|Overall Study|Lost to Follow-up|2
5393753|NCT03131687|18579809|P5|Overall Study|Lost to Follow-up|4
5393754|NCT03131687|18579810|P4|Overall Study|Lost to Follow-up|1
5393755|NCT03131687|18579811|P3|Overall Study|Lost to Follow-up|0
5393756|NCT03131687|18579812|P2|Overall Study|Lost to Follow-up|4
5393757|NCT03131687|18579813|P1|Overall Study|Lost to Follow-up|1
5393758|NCT03131687|18579808|P6|Overall Study|Withdrawal by Subject|1
5393759|NCT03131687|18579809|P5|Overall Study|Withdrawal by Subject|2
5393760|NCT03131687|18579810|P4|Overall Study|Withdrawal by Subject|1
5393761|NCT03131687|18579811|P3|Overall Study|Withdrawal by Subject|3
5393762|NCT03131687|18579812|P2|Overall Study|Withdrawal by Subject|3
5393763|NCT03131687|18579813|P1|Overall Study|Withdrawal by Subject|3
5393764|NCT03131687|18579808|P6|Overall Study|Death|0
5393765|NCT03131687|18579809|P5|Overall Study|Death|0
5393766|NCT03131687|18579810|P4|Overall Study|Death|0
5393767|NCT03131687|18579811|P3|Overall Study|Death|0
5393768|NCT03131687|18579812|P2|Overall Study|Death|0
5393769|NCT03131687|18579813|P1|Overall Study|Death|1
5393770|NCT03131687|18579808|P6|Overall Study|Adverse Event|2
5393771|NCT03131687|18579809|P5|Overall Study|Adverse Event|2
5393772|NCT03131687|18579810|P4|Overall Study|Adverse Event|1
5393773|NCT03131687|18579811|P3|Overall Study|Adverse Event|0
5393774|NCT03131687|18579812|P2|Overall Study|Adverse Event|1
5393775|NCT03131687|18579813|P1|Overall Study|Adverse Event|0
5393776|NCT03131648|18579923|P8|Open-label (Short Term Extension)|Discontinued IMP|3
5393777|NCT03131648|18579924|P7|Open-label (Short Term Extension)|Discontinued IMP|0
5393778|NCT03131648|18579925|P6|Open-label (Short Term Extension)|Discontinued IMP|0
5393779|NCT03131648|18579926|P5|Open-label (Short Term Extension)|Discontinued IMP|0
5393780|NCT03131648|18579927|P4|Open-label (Short Term Extension)|Discontinued IMP|0
5393781|NCT03131648|18579928|P3|Open-label (Short Term Extension)|Discontinued IMP|0
5393782|NCT03131648|18579929|P2|Open-label (Short Term Extension)|Discontinued IMP|0
5393783|NCT03131648|18579930|P1|Open-label (Short Term Extension)|Discontinued IMP|0
5393784|NCT03131648|18579923|P8|Maintenance Treatment Period|Completed Week 50|0
5393785|NCT03131648|18579924|P7|Maintenance Treatment Period|Completed Week 50|0
5393786|NCT03131648|18579925|P6|Maintenance Treatment Period|Completed Week 50|0
5393787|NCT03131648|18579926|P5|Maintenance Treatment Period|Completed Week 50|1
5393788|NCT03131648|18579927|P4|Maintenance Treatment Period|Completed Week 50|0
5393789|NCT03131648|18579928|P3|Maintenance Treatment Period|Completed Week 50|0
5393790|NCT03131648|18579929|P2|Maintenance Treatment Period|Completed Week 50|0
5393791|NCT03131648|18579930|P1|Maintenance Treatment Period|Completed Week 50|0
5393792|NCT03131648|18579923|P8|Maintenance Treatment Period|Transfer to open-label treatment|0
5393793|NCT03131648|18579924|P7|Maintenance Treatment Period|Transfer to open-label treatment|0
5393794|NCT03131648|18579925|P6|Maintenance Treatment Period|Transfer to open-label treatment|10
5393795|NCT03131648|18579926|P5|Maintenance Treatment Period|Transfer to open-label treatment|9
5393796|NCT03131648|18579927|P4|Maintenance Treatment Period|Transfer to open-label treatment|18
5393797|NCT03131648|18579928|P3|Maintenance Treatment Period|Transfer to open-label treatment|21
5393798|NCT03131648|18579929|P2|Maintenance Treatment Period|Transfer to open-label treatment|0
5393799|NCT03131648|18579930|P1|Maintenance Treatment Period|Transfer to open-label treatment|0
5393800|NCT03131648|18579923|P8|Maintenance Treatment Period|Discontinued IMP|0
5393801|NCT03131648|18579924|P7|Maintenance Treatment Period|Discontinued IMP|0
5393802|NCT03131648|18579925|P6|Maintenance Treatment Period|Discontinued IMP|4
5393803|NCT03131648|18579926|P5|Maintenance Treatment Period|Discontinued IMP|4
5393804|NCT03131648|18579927|P4|Maintenance Treatment Period|Discontinued IMP|5
5393805|NCT03131648|18579928|P3|Maintenance Treatment Period|Discontinued IMP|3
5393806|NCT03131648|18579929|P2|Maintenance Treatment Period|Discontinued IMP|0
5393807|NCT03131648|18579930|P1|Maintenance Treatment Period|Discontinued IMP|0
5393808|NCT03131648|18579923|P8|Maintenance Treatment Period|Not dosed|0
5393809|NCT03131648|18579924|P7|Maintenance Treatment Period|Not dosed|0
5393810|NCT03131648|18579925|P6|Maintenance Treatment Period|Not dosed|0
5393811|NCT03131648|18579926|P5|Maintenance Treatment Period|Not dosed|1
5393812|NCT03131648|18579927|P4|Maintenance Treatment Period|Not dosed|2
5393813|NCT03131648|18579928|P3|Maintenance Treatment Period|Not dosed|3
5393814|NCT03131648|18579929|P2|Maintenance Treatment Period|Not dosed|0
5393815|NCT03131648|18579930|P1|Maintenance Treatment Period|Not dosed|0
5393816|NCT03131648|18579923|P8|Open-label Treatment|Completed Week 50|0
5393817|NCT03131648|18579924|P7|Open-label Treatment|Completed Week 50|6
5393818|NCT03131648|18579925|P6|Open-label Treatment|Completed Week 50|0
5393819|NCT03131648|18579926|P5|Open-label Treatment|Completed Week 50|0
5393820|NCT03131648|18579927|P4|Open-label Treatment|Completed Week 50|0
5393821|NCT03131648|18579928|P3|Open-label Treatment|Completed Week 50|0
5393822|NCT03131648|18579929|P2|Open-label Treatment|Completed Week 50|0
5393823|NCT03131648|18579930|P1|Open-label Treatment|Completed Week 50|0
5393824|NCT03131648|18579923|P8|Open-label Treatment|Discontinued IMP|0
5393825|NCT03131648|18579924|P7|Open-label Treatment|Discontinued IMP|112
5393826|NCT03131648|18579925|P6|Open-label Treatment|Discontinued IMP|0
5393827|NCT03131648|18579926|P5|Open-label Treatment|Discontinued IMP|0
5393828|NCT03131648|18579927|P4|Open-label Treatment|Discontinued IMP|0
5393829|NCT03131648|18579928|P3|Open-label Treatment|Discontinued IMP|0
5393830|NCT03131648|18579929|P2|Open-label Treatment|Discontinued IMP|0
5393831|NCT03131648|18579930|P1|Open-label Treatment|Discontinued IMP|0
5393832|NCT03131648|18579923|P8|Initial Treatment Period|Discontinued IMP before Week 16|0
5393833|NCT03131648|18579924|P7|Initial Treatment Period|Discontinued IMP before Week 16|0
5393834|NCT03131648|18579925|P6|Initial Treatment Period|Discontinued IMP before Week 16|0
5393835|NCT03131648|18579926|P5|Initial Treatment Period|Discontinued IMP before Week 16|0
5393836|NCT03131648|18579927|P4|Initial Treatment Period|Discontinued IMP before Week 16|0
5393837|NCT03131648|18579928|P3|Initial Treatment Period|Discontinued IMP before Week 16|0
5393838|NCT03131648|18579929|P2|Initial Treatment Period|Discontinued IMP before Week 16|18
5393839|NCT03131648|18579930|P1|Initial Treatment Period|Discontinued IMP before Week 16|51
5393840|NCT03131648|18579923|P8|Initial Treatment Period|Not dosed|0
5393841|NCT03131648|18579924|P7|Initial Treatment Period|Not dosed|0
5393842|NCT03131648|18579925|P6|Initial Treatment Period|Not dosed|0
5393843|NCT03131648|18579926|P5|Initial Treatment Period|Not dosed|0
5393844|NCT03131648|18579927|P4|Initial Treatment Period|Not dosed|0
5393845|NCT03131648|18579928|P3|Initial Treatment Period|Not dosed|0
5393846|NCT03131648|18579929|P2|Initial Treatment Period|Not dosed|2
5393847|NCT03131648|18579930|P1|Initial Treatment Period|Not dosed|2
5393848|NCT03131596|18579978|P2|Overall Study|Lost to Follow-up|0
5393849|NCT03131596|18579979|P1|Overall Study|Lost to Follow-up|3
5393850|NCT03131596|18579978|P2|Overall Study|Protocol Violation|3
5393851|NCT03131596|18579979|P1|Overall Study|Protocol Violation|3
5393852|NCT03131479|18579996|P5|Overall Study|Subject/Guardian Decision|0
5393853|NCT03131479|18579997|P4|Overall Study|Subject/Guardian Decision|1
5393854|NCT03131479|18579998|P3|Overall Study|Subject/Guardian Decision|0
5393855|NCT03131479|18579999|P2|Overall Study|Subject/Guardian Decision|0
5393856|NCT03131479|18580000|P1|Overall Study|Subject/Guardian Decision|0
5393857|NCT03131479|18579996|P5|Overall Study|Adverse Event|0
5393858|NCT03131479|18579997|P4|Overall Study|Adverse Event|1
5393859|NCT03131479|18579998|P3|Overall Study|Adverse Event|1
5393860|NCT03131479|18579999|P2|Overall Study|Adverse Event|0
5393861|NCT03131479|18580000|P1|Overall Study|Adverse Event|0
5393862|NCT03131219|18580059|P2|Initial Evaluation Period|Deemed ineligible post treatment|0
5393863|NCT03131219|18580060|P1|Initial Evaluation Period|Deemed ineligible post treatment|2
5393864|NCT03131219|18580059|P2|Initial Evaluation Period|Protocol Violation|0
5393865|NCT03131219|18580060|P1|Initial Evaluation Period|Protocol Violation|1
5393866|NCT03131219|18580059|P2|Initial Evaluation Period|Adverse Event|0
5393867|NCT03131219|18580060|P1|Initial Evaluation Period|Adverse Event|1
5393868|NCT03131167|18580120|P13|Overall Study|Other (Unspecified)|0
5393869|NCT03131167|18580121|P12|Overall Study|Other (Unspecified)|0
5393870|NCT03131167|18580122|P11|Overall Study|Other (Unspecified)|0
5393871|NCT03131167|18580123|P10|Overall Study|Other (Unspecified)|0
5393872|NCT03131167|18580124|P9|Overall Study|Other (Unspecified)|0
5393873|NCT03131167|18580125|P8|Overall Study|Other (Unspecified)|0
5393874|NCT03131167|18580126|P7|Overall Study|Other (Unspecified)|0
5393875|NCT03131167|18580127|P6|Overall Study|Other (Unspecified)|1
5393876|NCT03131167|18580128|P5|Overall Study|Other (Unspecified)|0
5393877|NCT03131167|18580129|P4|Overall Study|Other (Unspecified)|0
5393878|NCT03131167|18580130|P3|Overall Study|Other (Unspecified)|0
5393879|NCT03131167|18580131|P2|Overall Study|Other (Unspecified)|0
5393880|NCT03131167|18580132|P1|Overall Study|Other (Unspecified)|0
5393881|NCT03130257|18580192|P3|Overall Study|Withdrawal by Subject|2
5393882|NCT03130257|18580193|P2|Overall Study|Withdrawal by Subject|0
5393883|NCT03130257|18580194|P1|Overall Study|Withdrawal by Subject|1
5393884|NCT03128931|18580248|P1|Overall Study|Equipment Issues|3
5393885|NCT03128931|18580248|P1|Overall Study|Physician Decision|1
5393886|NCT03128892|18580252|P1|Overall Study|Physician Decision|1
5393887|NCT03128892|18580252|P1|Overall Study|Withdrawal by Subject|2
5393888|NCT03128723|18580258|P1|Overall Study|Withdrawal by Subject|2
5393889|NCT03128411|18580273|P1|Long Term Follow-up Phase|Ongoing|18
5393890|NCT03128411|18580273|P1|Long Term Follow-up Phase|Death|1
5393891|NCT03128411|18580273|P1|Treatment Phase|Ongoing|41
5393892|NCT03128411|18580273|P1|Treatment Phase|Physician Decision|1
5393893|NCT03128411|18580273|P1|Treatment Phase|Adverse Event|18
5393894|NCT03128307|18580316|P1|Overall Study|Withdrawal by Subject|5
5393895|NCT03128307|18580316|P1|Overall Study|Lost to Follow-up|29
5393896|NCT03128099|18580324|P3|Overall Study|Did not complete all the assessments|1
5393897|NCT03128099|18580325|P2|Overall Study|Did not complete all the assessments|0
5393898|NCT03128099|18580326|P1|Overall Study|Did not complete all the assessments|0
5393899|NCT03128099|18580324|P3|Overall Study|Became homeless and lost contact|0
5393900|NCT03128099|18580325|P2|Overall Study|Became homeless and lost contact|0
5393901|NCT03128099|18580326|P1|Overall Study|Became homeless and lost contact|1
5393902|NCT03128099|18580324|P3|Overall Study|Participant got a full time job.|0
5393903|NCT03128099|18580325|P2|Overall Study|Participant got a full time job.|0
5393904|NCT03128099|18580326|P1|Overall Study|Participant got a full time job.|1
5393905|NCT03128099|18580324|P3|Overall Study|High dose task was too long|0
5393906|NCT03128099|18580325|P2|Overall Study|High dose task was too long|4
5393907|NCT03128099|18580326|P1|Overall Study|High dose task was too long|0
5393908|NCT03127644|18580376|P3|Overall Study|Study-specific withdrawal criteria|2
5393909|NCT03127644|18580377|P2|Overall Study|Study-specific withdrawal criteria|0
5393910|NCT03127644|18580378|P1|Overall Study|Study-specific withdrawal criteria|0
5393911|NCT03127384|18580410|P1|Overall Study|Subject request|2
5393912|NCT03127384|18580410|P1|Overall Study|Lost to Follow-up|4
5393913|NCT03126539|18580446|P5|Overall Study|Lost to Follow-up|0
5393914|NCT03126539|18580447|P4|Overall Study|Lost to Follow-up|0
5393915|NCT03126539|18580448|P3|Overall Study|Lost to Follow-up|1
5393916|NCT03126539|18580449|P2|Overall Study|Lost to Follow-up|1
5393917|NCT03126539|18580450|P1|Overall Study|Lost to Follow-up|1
5393918|NCT03126344|18580479|P3|Overall Study|Lost to Follow-up|5
5393919|NCT03126344|18580480|P2|Overall Study|Lost to Follow-up|0
5393920|NCT03126344|18580481|P1|Overall Study|Lost to Follow-up|0
5393921|NCT03125941|18580497|P2|Overall Study|did not receive intervention|2
5393922|NCT03125941|18580498|P1|Overall Study|did not receive intervention|1
5393923|NCT03125915|18580534|P4|6 Month Follow-up|Lost to Follow-up|3
5393924|NCT03125915|18580535|P3|6 Month Follow-up|Lost to Follow-up|6
5393925|NCT03125915|18580536|P2|6 Month Follow-up|Lost to Follow-up|3
5393926|NCT03125915|18580537|P1|6 Month Follow-up|Lost to Follow-up|7
5393927|NCT03125915|18580534|P4|3 Month Follow-up|Lost to Follow-up|2
5393928|NCT03125915|18580535|P3|3 Month Follow-up|Lost to Follow-up|4
5393929|NCT03125915|18580536|P2|3 Month Follow-up|Lost to Follow-up|4
5393930|NCT03125915|18580537|P1|3 Month Follow-up|Lost to Follow-up|6
5393931|NCT03125915|18580534|P4|1 Month Follow up|Lost to Follow-up|3
5393932|NCT03125915|18580535|P3|1 Month Follow up|Lost to Follow-up|2
5393933|NCT03125915|18580536|P2|1 Month Follow up|Lost to Follow-up|3
5393934|NCT03125915|18580537|P1|1 Month Follow up|Lost to Follow-up|3
5393935|NCT03125395|18580555|P1|Overall Study|Commercial drug is available|5
5393936|NCT03125395|18580555|P1|Overall Study|Physician Decision|2
5393937|NCT03125395|18580555|P1|Overall Study|Withdrawal of consent (not due to AE)|1
5393938|NCT03125395|18580555|P1|Overall Study|Adverse Event|2
5393939|NCT03125200|18580581|P7|Overall Study|Consent Withdrawn by Subject|1
5393940|NCT03125200|18580582|P6|Overall Study|Consent Withdrawn by Subject|0
5393941|NCT03125200|18580583|P5|Overall Study|Consent Withdrawn by Subject|1
5393942|NCT03125200|18580584|P4|Overall Study|Consent Withdrawn by Subject|0
5393943|NCT03125200|18580585|P3|Overall Study|Consent Withdrawn by Subject|0
5393944|NCT03125200|18580586|P2|Overall Study|Consent Withdrawn by Subject|1
5393945|NCT03125200|18580587|P1|Overall Study|Consent Withdrawn by Subject|0
5393946|NCT03125200|18580581|P7|Overall Study|Toxicity|0
5393947|NCT03125200|18580582|P6|Overall Study|Toxicity|0
5393948|NCT03125200|18580583|P5|Overall Study|Toxicity|0
5393949|NCT03125200|18580584|P4|Overall Study|Toxicity|1
5393950|NCT03125200|18580585|P3|Overall Study|Toxicity|0
5393951|NCT03125200|18580586|P2|Overall Study|Toxicity|0
5393952|NCT03125200|18580587|P1|Overall Study|Toxicity|0
5393953|NCT03125200|18580581|P7|Overall Study|Lack of Efficacy|0
5393954|NCT03125200|18580582|P6|Overall Study|Lack of Efficacy|0
5393955|NCT03125200|18580583|P5|Overall Study|Lack of Efficacy|0
5393956|NCT03125200|18580584|P4|Overall Study|Lack of Efficacy|1
5393957|NCT03125200|18580585|P3|Overall Study|Lack of Efficacy|0
5393958|NCT03125200|18580586|P2|Overall Study|Lack of Efficacy|0
5393959|NCT03125200|18580587|P1|Overall Study|Lack of Efficacy|0
5393960|NCT03125200|18580581|P7|Overall Study|Progressive Disease|1
5393961|NCT03125200|18580582|P6|Overall Study|Progressive Disease|0
5393962|NCT03125200|18580583|P5|Overall Study|Progressive Disease|2
5393963|NCT03125200|18580584|P4|Overall Study|Progressive Disease|1
5393964|NCT03125200|18580585|P3|Overall Study|Progressive Disease|2
5393965|NCT03125200|18580586|P2|Overall Study|Progressive Disease|1
5393966|NCT03125200|18580587|P1|Overall Study|Progressive Disease|2
5393967|NCT03125200|18580581|P7|Overall Study|Clinical Progression|0
5393968|NCT03125200|18580582|P6|Overall Study|Clinical Progression|1
5393969|NCT03125200|18580583|P5|Overall Study|Clinical Progression|0
5393970|NCT03125200|18580584|P4|Overall Study|Clinical Progression|1
5393971|NCT03125200|18580585|P3|Overall Study|Clinical Progression|0
5393972|NCT03125200|18580586|P2|Overall Study|Clinical Progression|0
5393973|NCT03125200|18580587|P1|Overall Study|Clinical Progression|0
5393974|NCT03125200|18580581|P7|Overall Study|Study Termination|1
5393975|NCT03125200|18580582|P6|Overall Study|Study Termination|2
5393976|NCT03125200|18580583|P5|Overall Study|Study Termination|1
5393977|NCT03125200|18580584|P4|Overall Study|Study Termination|1
5393978|NCT03125200|18580585|P3|Overall Study|Study Termination|0
5393979|NCT03125200|18580586|P2|Overall Study|Study Termination|0
5393980|NCT03125200|18580587|P1|Overall Study|Study Termination|0
5393981|NCT03124784|18580827|P1|Overall Study|Computer/Equip Malfunction|1
5393982|NCT03124784|18580827|P1|Overall Study|Adverse Event|1
5393983|NCT03124563|18580849|P2|Overall Study|Withdrawal by Subject|1
5393984|NCT03124563|18580850|P1|Overall Study|Withdrawal by Subject|1
5393985|NCT03124563|18580849|P2|Overall Study|Lost to Follow-up|1
5393986|NCT03124563|18580850|P1|Overall Study|Lost to Follow-up|1
5393987|NCT03124537|18580875|P2|Overall Study|App Crash, Incomplete Data|8
5393988|NCT03124537|18580876|P1|Overall Study|App Crash, Incomplete Data|7
5393989|NCT03124537|18580875|P2|Overall Study|Lost to Follow-up|5
5393990|NCT03124537|18580876|P1|Overall Study|Lost to Follow-up|3
5393991|NCT03124407|18580900|P4|Overall Study|Adverse Event|0
5393992|NCT03124407|18580901|P3|Overall Study|Adverse Event|1
5393993|NCT03124407|18580902|P2|Overall Study|Adverse Event|0
5393994|NCT03124407|18580903|P1|Overall Study|Adverse Event|0
5393995|NCT03124407|18580900|P4|Overall Study|Lost to Follow-up|0
5393996|NCT03124407|18580901|P3|Overall Study|Lost to Follow-up|0
5393997|NCT03124407|18580902|P2|Overall Study|Lost to Follow-up|0
5393998|NCT03124407|18580903|P1|Overall Study|Lost to Follow-up|1
5393999|NCT03124381|18580923|P2|Overall Study|Non-Compliance with Study Treatment|0
5394000|NCT03124381|18580924|P1|Overall Study|Non-Compliance with Study Treatment|1
5394001|NCT03124381|18580923|P2|Overall Study|Adverse Event|1
5394002|NCT03124381|18580924|P1|Overall Study|Adverse Event|1
5394003|NCT03124381|18580923|P2|Overall Study|Protocol Violation|1
5394004|NCT03124381|18580924|P1|Overall Study|Protocol Violation|0
5394005|NCT03124381|18580923|P2|Overall Study|Withdrawal by Subject|3
5394006|NCT03124381|18580924|P1|Overall Study|Withdrawal by Subject|6
5394007|NCT03124381|18580923|P2|Overall Study|Lost to Follow-up|1
5394008|NCT03124381|18580924|P1|Overall Study|Lost to Follow-up|1
5394009|NCT03124199|18581031|P1|Overall Study|Lost to Follow-up|4
5394010|NCT03124108|18581040|P3|Overall Study|Adverse Event|0
5394011|NCT03124108|18581041|P2|Overall Study|Adverse Event|1
5394012|NCT03124108|18581042|P1|Overall Study|Adverse Event|0
5394013|NCT03123861|18581188|P2|Overall Study|Withdrawal by Subject|2
5394014|NCT03123861|18581189|P1|Overall Study|Withdrawal by Subject|2
5394015|NCT03123861|18581188|P2|Overall Study|Protocol Violation|1
5394016|NCT03123861|18581189|P1|Overall Study|Protocol Violation|1
5394017|NCT03123471|18581240|P2|Apremilast Extension Phase|Withdrawal by Subject|7
5394018|NCT03123471|18581241|P1|Apremilast Extension Phase|Withdrawal by Subject|3
5394019|NCT03123471|18581240|P2|Apremilast Extension Phase|Lack of Efficacy|8
5394020|NCT03123471|18581241|P1|Apremilast Extension Phase|Lack of Efficacy|2
5394021|NCT03123471|18581240|P2|Apremilast Extension Phase|Adverse Event|5
5394022|NCT03123471|18581241|P1|Apremilast Extension Phase|Adverse Event|1
5394023|NCT03123471|18581240|P2|Apremilast Extension Phase|Lost to Follow-up|5
5394024|NCT03123471|18581241|P1|Apremilast Extension Phase|Lost to Follow-up|2
5394025|NCT03123471|18581240|P2|Placebo-controlled Phase|Miscellaneous|1
5394026|NCT03123471|18581241|P1|Placebo-controlled Phase|Miscellaneous|0
5394027|NCT03123471|18581240|P2|Placebo-controlled Phase|Protocol Deviation|1
5394028|NCT03123471|18581241|P1|Placebo-controlled Phase|Protocol Deviation|2
5394029|NCT03123471|18581240|P2|Placebo-controlled Phase|Lost to Follow-up|3
5394030|NCT03123471|18581241|P1|Placebo-controlled Phase|Lost to Follow-up|1
5394031|NCT03123471|18581240|P2|Placebo-controlled Phase|Non-compliance with Study Drug|0
5394032|NCT03123471|18581241|P1|Placebo-controlled Phase|Non-compliance with Study Drug|3
5394033|NCT03123471|18581240|P2|Placebo-controlled Phase|Withdrawal by Subject|16
5394034|NCT03123471|18581241|P1|Placebo-controlled Phase|Withdrawal by Subject|6
5394035|NCT03123471|18581240|P2|Placebo-controlled Phase|Lack of Efficacy|4
5394036|NCT03123471|18581241|P1|Placebo-controlled Phase|Lack of Efficacy|3
5394037|NCT03123471|18581240|P2|Placebo-controlled Phase|Adverse Event|8
5394038|NCT03123471|18581241|P1|Placebo-controlled Phase|Adverse Event|3
5394039|NCT03123393|18581268|P2|Overall Study|Reason not Specified|13
5394040|NCT03123393|18581269|P1|Overall Study|Reason not Specified|13
5394041|NCT03123393|18581268|P2|Overall Study|Withdrawal by Subject|1
5394042|NCT03123393|18581269|P1|Overall Study|Withdrawal by Subject|2
5394043|NCT03123393|18581268|P2|Overall Study|Study Terminated by Sponsor|9
5394044|NCT03123393|18581269|P1|Overall Study|Study Terminated by Sponsor|6
5394045|NCT03123354|18581297|P1|Overall Study|Physician Decision|6
5394046|NCT03122886|18581322|P2|Overall Study|Withdrawal by Subject|2
5394047|NCT03122886|18581323|P1|Overall Study|Withdrawal by Subject|1
5394048|NCT03122548|18581345|P1|Overall Study|Study Terminated by Sponsor|2
5394049|NCT03122548|18581345|P1|Overall Study|Progression - subject went into hospice|1
5394050|NCT03122548|18581345|P1|Overall Study|Death|2
5394051|NCT03122457|18581353|P1|Overall Study|Withdrawal by Subject|6
5394052|NCT03122184|18581360|P2|Overall Study|Terminated due to cognitive problem|0
5394053|NCT03122184|18581361|P1|Overall Study|Terminated due to cognitive problem|1
5394054|NCT03122184|18581360|P2|Overall Study|Withdrawal by Subject|0
5394055|NCT03122184|18581361|P1|Overall Study|Withdrawal by Subject|3
5394056|NCT03122184|18581360|P2|Overall Study|Lost to Follow-up|6
5394057|NCT03122184|18581361|P1|Overall Study|Lost to Follow-up|4
5394058|NCT03122171|18581398|P1|Overall Study|Withdrawal by Subject|1
5394059|NCT03122145|18581407|P2|Overall Study|Concurrent respiratory disease|0
5394060|NCT03122145|18581408|P1|Overall Study|Concurrent respiratory disease|3
5394061|NCT03121950|18581418|P2|Overall Study|Withdrawal by Subject|2
5394062|NCT03121950|18581419|P1|Overall Study|Withdrawal by Subject|11
5394063|NCT03120676|18581520|P1|Overall Study|Not treated|1
5394064|NCT03120520|18581528|P4|Overall Study|Other|0
5394065|NCT03120520|18581529|P3|Overall Study|Other|0
5394066|NCT03120520|18581530|P2|Overall Study|Other|1
5394067|NCT03120520|18581531|P1|Overall Study|Other|0
5394068|NCT03120520|18581528|P4|Overall Study|Withdrawal by Subject|2
5394069|NCT03120520|18581529|P3|Overall Study|Withdrawal by Subject|3
5394070|NCT03120520|18581530|P2|Overall Study|Withdrawal by Subject|2
5394071|NCT03120520|18581531|P1|Overall Study|Withdrawal by Subject|3
5394072|NCT03120520|18581528|P4|Overall Study|Lost to Follow-up|1
5394073|NCT03120520|18581529|P3|Overall Study|Lost to Follow-up|1
5394074|NCT03120520|18581530|P2|Overall Study|Lost to Follow-up|1
5394075|NCT03120520|18581531|P1|Overall Study|Lost to Follow-up|1
5394076|NCT03120351|18581555|P2|Overall Study|Physician Decision|1
5394077|NCT03120351|18581556|P1|Overall Study|Physician Decision|1
5394078|NCT03120013|18581562|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
5394079|NCT03120013|18581563|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
5394080|NCT03119688|18581605|P1|Overall Study|Adverse Event|4
5394081|NCT03119662|18581638|P2|Overall Study|Withdrawal by Subject|1
5394082|NCT03119662|18581639|P1|Overall Study|Withdrawal by Subject|0
5394083|NCT03119610|18581709|P2|Overall Study|Lost to Follow-up|1
5394084|NCT03119610|18581710|P1|Overall Study|Lost to Follow-up|0
5394085|NCT03119610|18581709|P2|Overall Study|Adverse Event|0
5394086|NCT03119610|18581710|P1|Overall Study|Adverse Event|1
5394087|NCT03118947|18581788|P1|Overall Study|Lost to Follow-up|2
5394088|NCT03118947|18581788|P1|Overall Study|Change in patient's living situation|4
5394089|NCT03118947|18581788|P1|Overall Study|Withdrawal by caregiver|3
5394090|NCT03118947|18581788|P1|Overall Study|Withdrawal by Subject|3
5394091|NCT03118947|18581788|P1|Overall Study|Protocol Violation|2
5394092|NCT03118947|18581788|P1|Overall Study|Non-compliance with study drug|1
5394093|NCT03118947|18581788|P1|Overall Study|Lack of Efficacy|4
5394094|NCT03118947|18581788|P1|Overall Study|Death|3
5394095|NCT03118947|18581788|P1|Overall Study|Adverse Event|7
5394096|NCT03118934|18581795|P6|Overall Study|Discontinued prior to exposure|0
5394097|NCT03118934|18581796|P5|Overall Study|Discontinued prior to exposure|2
5394098|NCT03118934|18581797|P4|Overall Study|Discontinued prior to exposure|1
5394099|NCT03118934|18581798|P3|Overall Study|Discontinued prior to exposure|1
5394100|NCT03118934|18581799|P2|Overall Study|Discontinued prior to exposure|1
5394101|NCT03118934|18581800|P1|Overall Study|Discontinued prior to exposure|0
5394102|NCT03118934|18581795|P6|Overall Study|Physician Decision|1
5394103|NCT03118934|18581796|P5|Overall Study|Physician Decision|0
5394104|NCT03118934|18581797|P4|Overall Study|Physician Decision|0
5394105|NCT03118934|18581798|P3|Overall Study|Physician Decision|0
5394106|NCT03118934|18581799|P2|Overall Study|Physician Decision|0
5394107|NCT03118934|18581800|P1|Overall Study|Physician Decision|0
5394108|NCT03118934|18581795|P6|Overall Study|Adverse Event|1
5394109|NCT03118934|18581796|P5|Overall Study|Adverse Event|0
5394110|NCT03118934|18581797|P4|Overall Study|Adverse Event|0
5394111|NCT03118934|18581798|P3|Overall Study|Adverse Event|0
5394112|NCT03118934|18581799|P2|Overall Study|Adverse Event|0
5394113|NCT03118934|18581800|P1|Overall Study|Adverse Event|0
5394114|NCT03118765|18581824|P5|Overall Study|Sponsor Decision|1
5394115|NCT03118765|18581825|P4|Overall Study|Sponsor Decision|0
5394116|NCT03118765|18581826|P3|Overall Study|Sponsor Decision|1
5394117|NCT03118765|18581827|P2|Overall Study|Sponsor Decision|0
5394118|NCT03118765|18581828|P1|Overall Study|Sponsor Decision|1
5394119|NCT03118765|18581824|P5|Overall Study|Lost to Follow-up|0
5394120|NCT03118765|18581825|P4|Overall Study|Lost to Follow-up|0
5394121|NCT03118765|18581826|P3|Overall Study|Lost to Follow-up|1
5394122|NCT03118765|18581827|P2|Overall Study|Lost to Follow-up|0
5394123|NCT03118765|18581828|P1|Overall Study|Lost to Follow-up|1
5394124|NCT03118765|18581824|P5|Overall Study|COPD Exacerbation|0
5394125|NCT03118765|18581825|P4|Overall Study|COPD Exacerbation|1
5394126|NCT03118765|18581826|P3|Overall Study|COPD Exacerbation|0
5394127|NCT03118765|18581827|P2|Overall Study|COPD Exacerbation|0
5394128|NCT03118765|18581828|P1|Overall Study|COPD Exacerbation|1
5394129|NCT03118765|18581824|P5|Overall Study|Violation of Inclusion/ExclusionCriteria|0
5394130|NCT03118765|18581825|P4|Overall Study|Violation of Inclusion/ExclusionCriteria|0
5394131|NCT03118765|18581826|P3|Overall Study|Violation of Inclusion/ExclusionCriteria|1
5394132|NCT03118765|18581827|P2|Overall Study|Violation of Inclusion/ExclusionCriteria|1
5394133|NCT03118765|18581828|P1|Overall Study|Violation of Inclusion/ExclusionCriteria|0
5394134|NCT03118765|18581824|P5|Overall Study|Non compliance with Study Procedures|0
5394135|NCT03118765|18581825|P4|Overall Study|Non compliance with Study Procedures|1
5394136|NCT03118765|18581826|P3|Overall Study|Non compliance with Study Procedures|0
5394137|NCT03118765|18581827|P2|Overall Study|Non compliance with Study Procedures|0
5394138|NCT03118765|18581828|P1|Overall Study|Non compliance with Study Procedures|0
5394139|NCT03118765|18581824|P5|Overall Study|Adverse Event|1
5394140|NCT03118765|18581825|P4|Overall Study|Adverse Event|1
5394141|NCT03118765|18581826|P3|Overall Study|Adverse Event|1
5394142|NCT03118765|18581827|P2|Overall Study|Adverse Event|1
5394143|NCT03118765|18581828|P1|Overall Study|Adverse Event|1
5394144|NCT03118765|18581824|P5|Overall Study|Withdrawal by Subject|0
5394145|NCT03118765|18581825|P4|Overall Study|Withdrawal by Subject|0
5394146|NCT03118765|18581826|P3|Overall Study|Withdrawal by Subject|1
5394147|NCT03118765|18581827|P2|Overall Study|Withdrawal by Subject|0
5394148|NCT03118765|18581828|P1|Overall Study|Withdrawal by Subject|0
5394149|NCT03118739|18581924|P2|Overall Study|Lost to Follow-up|0
5394150|NCT03118739|18581925|P1|Overall Study|Lost to Follow-up|2
5394151|NCT03118739|18581924|P2|Overall Study|Withdrawal by Subject|3
5394152|NCT03118739|18581925|P1|Overall Study|Withdrawal by Subject|5
5394153|NCT03118739|18581924|P2|Overall Study|Physician Decision|1
5394154|NCT03118739|18581925|P1|Overall Study|Physician Decision|0
5394155|NCT03118297|18582038|P2|Overall Study|Lost to Follow-up|2
5394156|NCT03118297|18582039|P1|Overall Study|Lost to Follow-up|0
5394157|NCT03117361|18582091|P1|Overall Study|Treatment-related adverse event|1
5394158|NCT03117361|18582091|P1|Overall Study|On study treatment at the end of study|1
5394159|NCT03117361|18582091|P1|Overall Study|Physician Decision|2
5394160|NCT03117361|18582091|P1|Overall Study|Death|1
5394161|NCT03117361|18582091|P1|Overall Study|Progressive disease|5
5394162|NCT03116828|18582206|P2|Overall Study|OTHER|3
5394163|NCT03116828|18582207|P1|Overall Study|OTHER|3
5394164|NCT03116828|18582206|P2|Overall Study|Withdrawal by Subject|8
5394165|NCT03116828|18582207|P1|Overall Study|Withdrawal by Subject|4
5394166|NCT03116828|18582206|P2|Overall Study|Adverse Event|10
5394167|NCT03116828|18582207|P1|Overall Study|Adverse Event|1
5394168|NCT03116698|18582217|P4|Overall Study|Death|0
5394169|NCT03116698|18582218|P3|Overall Study|Death|2
5394170|NCT03116698|18582219|P2|Overall Study|Death|0
5394171|NCT03116698|18582220|P1|Overall Study|Death|0
5394172|NCT03116698|18582217|P4|Overall Study|Protocol Violation|0
5394173|NCT03116698|18582218|P3|Overall Study|Protocol Violation|0
5394174|NCT03116698|18582219|P2|Overall Study|Protocol Violation|0
5394175|NCT03116698|18582220|P1|Overall Study|Protocol Violation|1
5394176|NCT03116698|18582217|P4|Overall Study|Physician Decision|0
5394177|NCT03116698|18582218|P3|Overall Study|Physician Decision|0
5394178|NCT03116698|18582219|P2|Overall Study|Physician Decision|1
5394179|NCT03116698|18582220|P1|Overall Study|Physician Decision|1
5394180|NCT03116698|18582217|P4|Overall Study|Lost to Follow-up|0
5394181|NCT03116698|18582218|P3|Overall Study|Lost to Follow-up|0
5394182|NCT03116698|18582219|P2|Overall Study|Lost to Follow-up|0
5394183|NCT03116698|18582220|P1|Overall Study|Lost to Follow-up|2
5394184|NCT03116698|18582217|P4|Overall Study|Withdrawal by Subject|2
5394185|NCT03116698|18582218|P3|Overall Study|Withdrawal by Subject|5
5394186|NCT03116698|18582219|P2|Overall Study|Withdrawal by Subject|4
5394187|NCT03116698|18582220|P1|Overall Study|Withdrawal by Subject|1
5394188|NCT03116698|18582217|P4|Overall Study|Adverse Event|0
5394189|NCT03116698|18582218|P3|Overall Study|Adverse Event|1
5394190|NCT03116698|18582219|P2|Overall Study|Adverse Event|1
5394191|NCT03116698|18582220|P1|Overall Study|Adverse Event|1
5394192|NCT03115476|18582282|P3|LP0084-1369|Trial terminated by Sponsor|160
5394193|NCT03115476|18582283|P2|LP0084-1369|Trial terminated by Sponsor|210
5394194|NCT03115476|18582284|P1|LP0084-1369|Trial terminated by Sponsor|190
5394195|NCT03115476|18582282|P3|LP0084-1369|Death|2
5394196|NCT03115476|18582283|P2|LP0084-1369|Death|0
5394197|NCT03115476|18582284|P1|LP0084-1369|Death|1
5394198|NCT03114969|18582333|P9|Overall Study|Adverse Event|2
5394199|NCT03114969|18582334|P8|Overall Study|Adverse Event|0
5394200|NCT03114969|18582335|P7|Overall Study|Adverse Event|1
5394201|NCT03114969|18582336|P6|Overall Study|Adverse Event|1
5394202|NCT03114969|18582337|P5|Overall Study|Adverse Event|0
5394203|NCT03114969|18582338|P4|Overall Study|Adverse Event|0
5394204|NCT03114969|18582339|P3|Overall Study|Adverse Event|1
5394205|NCT03114969|18582340|P2|Overall Study|Adverse Event|0
5394206|NCT03114969|18582341|P1|Overall Study|Adverse Event|0
5394207|NCT03114969|18582333|P9|Overall Study|Lost to Follow-up|0
5394208|NCT03114969|18582334|P8|Overall Study|Lost to Follow-up|0
5394209|NCT03114969|18582335|P7|Overall Study|Lost to Follow-up|0
5394210|NCT03114969|18582336|P6|Overall Study|Lost to Follow-up|0
5394211|NCT03114969|18582337|P5|Overall Study|Lost to Follow-up|0
5394212|NCT03114969|18582338|P4|Overall Study|Lost to Follow-up|2
5394213|NCT03114969|18582339|P3|Overall Study|Lost to Follow-up|3
5394214|NCT03114969|18582340|P2|Overall Study|Lost to Follow-up|0
5394215|NCT03114969|18582341|P1|Overall Study|Lost to Follow-up|0
5394216|NCT03114657|18582442|P2|Overall Study|Withdrawal by Subject|22
5394217|NCT03114657|18582443|P1|Overall Study|Withdrawal by Subject|28
5394218|NCT03114657|18582442|P2|Overall Study|Symptomatic Deterioration|1
5394219|NCT03114657|18582443|P1|Overall Study|Symptomatic Deterioration|0
5394220|NCT03114657|18582442|P2|Overall Study|Study Terminated By Sponsor|374
5394221|NCT03114657|18582443|P1|Overall Study|Study Terminated By Sponsor|355
5394222|NCT03114657|18582442|P2|Overall Study|Physician Decision|2
5394223|NCT03114657|18582443|P1|Overall Study|Physician Decision|2
5394224|NCT03114657|18582442|P2|Overall Study|Multiple Reasons|2
5394225|NCT03114657|18582443|P1|Overall Study|Multiple Reasons|1
5394226|NCT03114657|18582442|P2|Overall Study|Death|0
5394227|NCT03114657|18582443|P1|Overall Study|Death|4
5394228|NCT03114657|18582442|P2|Overall Study|Adverse Event|6
5394229|NCT03114657|18582443|P1|Overall Study|Adverse Event|9
5394230|NCT03114488|18582488|P2|Time Period 2|Withdrawal by Subject|3
5394231|NCT03114488|18582489|P1|Time Period 2|Withdrawal by Subject|1
5394232|NCT03113916|18582501|P2|Overall Study|Lost to Follow-up|2
5394233|NCT03113916|18582502|P1|Overall Study|Lost to Follow-up|1
5394234|NCT03113916|18582501|P2|Overall Study|Pregnancy|3
5394235|NCT03113916|18582502|P1|Overall Study|Pregnancy|1
5394236|NCT03113916|18582501|P2|Overall Study|Withdrawal by Subject|7
5394237|NCT03113916|18582502|P1|Overall Study|Withdrawal by Subject|9
5394238|NCT03111108|18582599|P2|Overall Study|Withdrawal by Subject|0
5394239|NCT03111108|18582600|P1|Overall Study|Withdrawal by Subject|1
5394240|NCT03111108|18582599|P2|Overall Study|Death|1
5394241|NCT03111108|18582600|P1|Overall Study|Death|0
5394242|NCT03110900|18582618|P2|Overall Study|Sponsor withdrew|1
5394243|NCT03110900|18582619|P1|Overall Study|Sponsor withdrew|1
5394244|NCT03110770|18582630|P5|Overall Study|Illness/Injury unrelated to product|1
5394245|NCT03110770|18582631|P4|Overall Study|Illness/Injury unrelated to product|0
5394246|NCT03110770|18582632|P3|Overall Study|Illness/Injury unrelated to product|0
5394247|NCT03110770|18582633|P2|Overall Study|Illness/Injury unrelated to product|0
5394248|NCT03110770|18582634|P1|Overall Study|Illness/Injury unrelated to product|0
5394249|NCT03110770|18582630|P5|Overall Study|Moved from area|43
5394250|NCT03110770|18582631|P4|Overall Study|Moved from area|42
5394251|NCT03110770|18582632|P3|Overall Study|Moved from area|2
5394252|NCT03110770|18582633|P2|Overall Study|Moved from area|0
5394253|NCT03110770|18582634|P1|Overall Study|Moved from area|5
5394254|NCT03110770|18582630|P5|Overall Study|Withdrawal by Subject|24
5394255|NCT03110770|18582631|P4|Overall Study|Withdrawal by Subject|24
5394256|NCT03110770|18582632|P3|Overall Study|Withdrawal by Subject|0
5394257|NCT03110770|18582633|P2|Overall Study|Withdrawal by Subject|0
5394258|NCT03110770|18582634|P1|Overall Study|Withdrawal by Subject|0
5394259|NCT03110770|18582630|P5|Overall Study|Investigator Decision|3
5394260|NCT03110770|18582631|P4|Overall Study|Investigator Decision|5
5394261|NCT03110770|18582632|P3|Overall Study|Investigator Decision|0
5394262|NCT03110770|18582633|P2|Overall Study|Investigator Decision|0
5394263|NCT03110770|18582634|P1|Overall Study|Investigator Decision|0
5394264|NCT03110770|18582630|P5|Overall Study|Lost to Follow-up|45
5394265|NCT03110770|18582631|P4|Overall Study|Lost to Follow-up|53
5394266|NCT03110770|18582632|P3|Overall Study|Lost to Follow-up|0
5394267|NCT03110770|18582633|P2|Overall Study|Lost to Follow-up|0
5394268|NCT03110770|18582634|P1|Overall Study|Lost to Follow-up|0
5394269|NCT03110770|18582630|P5|Overall Study|Enrolled but did not receive product|7
5394270|NCT03110770|18582631|P4|Overall Study|Enrolled but did not receive product|8
5394271|NCT03110770|18582632|P3|Overall Study|Enrolled but did not receive product|0
5394272|NCT03110770|18582633|P2|Overall Study|Enrolled but did not receive product|0
5394273|NCT03110770|18582634|P1|Overall Study|Enrolled but did not receive product|0
5394274|NCT03110770|18582630|P5|Overall Study|Death|0
5394275|NCT03110770|18582631|P4|Overall Study|Death|1
5394276|NCT03110770|18582632|P3|Overall Study|Death|0
5394277|NCT03110770|18582633|P2|Overall Study|Death|0
5394278|NCT03110770|18582634|P1|Overall Study|Death|1
5394279|NCT03110380|18582738|P2|Overall Study|Lost to Follow-up|1
5394280|NCT03110380|18582739|P1|Overall Study|Lost to Follow-up|4
5394281|NCT03110380|18582738|P2|Overall Study|Withdrew Consent|16
5394282|NCT03110380|18582739|P1|Overall Study|Withdrew Consent|9
5394283|NCT03110380|18582738|P2|Overall Study|Protocol Violation|1
5394284|NCT03110380|18582739|P1|Overall Study|Protocol Violation|0
5394285|NCT03110380|18582738|P2|Overall Study|Non-Compliance with Study Drug|1
5394286|NCT03110380|18582739|P1|Overall Study|Non-Compliance with Study Drug|1
5394287|NCT03110380|18582738|P2|Overall Study|Investigator's Discretion|2
5394288|NCT03110380|18582739|P1|Overall Study|Investigator's Discretion|1
5394289|NCT03110380|18582738|P2|Overall Study|Death|1
5394290|NCT03110380|18582739|P1|Overall Study|Death|2
5394291|NCT03110380|18582738|P2|Overall Study|Adverse Event|3
5394292|NCT03110380|18582739|P1|Overall Study|Adverse Event|3
5394293|NCT03110380|18582738|P2|Overall Study|Still in Study|256
5394294|NCT03110380|18582739|P1|Overall Study|Still in Study|264
5394295|NCT03110380|18582738|P2|Overall Study|Randomized and Never Treated|2
5394296|NCT03110380|18582739|P1|Overall Study|Randomized and Never Treated|0
5394297|NCT03110185|18582751|P2|Overall Study|Patient Refusal|1
5394298|NCT03110185|18582752|P1|Overall Study|Patient Refusal|0
5394299|NCT03110185|18582751|P2|Overall Study|MRI Incompatible|0
5394300|NCT03110185|18582752|P1|Overall Study|MRI Incompatible|2
5394301|NCT03110185|18582751|P2|Overall Study|Protocol Violation|4
5394302|NCT03110185|18582752|P1|Overall Study|Protocol Violation|1
5394303|NCT03110185|18582751|P2|Overall Study|Conflict with care|12
5394304|NCT03110185|18582752|P1|Overall Study|Conflict with care|5
5394305|NCT03110185|18582751|P2|Overall Study|Time Constraints|6
5394306|NCT03110185|18582752|P1|Overall Study|Time Constraints|0
5394307|NCT03110185|18582751|P2|Overall Study|Withdrawal by Subject|7
5394308|NCT03110185|18582752|P1|Overall Study|Withdrawal by Subject|2
5394309|NCT03110185|18582751|P2|Overall Study|Death|1
5394310|NCT03110185|18582752|P1|Overall Study|Death|0
5394311|NCT03110159|18582762|P1|Overall Study|Study termination|1
5394312|NCT03110029|18582773|P2|Overall Study|Withdrawal by Subject|1
5394313|NCT03110029|18582774|P1|Overall Study|Withdrawal by Subject|1
5394314|NCT03109184|18582848|P2|Overall Study|Withdrawal by Subject|1
5394315|NCT03109184|18582849|P1|Overall Study|Withdrawal by Subject|1
5394316|NCT03109184|18582848|P2|Overall Study|Lost to Follow-up|6
5394317|NCT03109184|18582849|P1|Overall Study|Lost to Follow-up|6
5394318|NCT03108521|18583003|P2|Overall Study|Adverse Event|0
5394319|NCT03108521|18583004|P1|Overall Study|Adverse Event|3
5394320|NCT03108521|18583003|P2|Overall Study|Physician Decision|0
5394321|NCT03108521|18583004|P1|Overall Study|Physician Decision|4
5394322|NCT03108521|18583003|P2|Overall Study|Lack of Efficacy|0
5394323|NCT03108521|18583004|P1|Overall Study|Lack of Efficacy|2
5394324|NCT03108521|18583003|P2|Overall Study|Lost to Follow-up|0
5394325|NCT03108521|18583004|P1|Overall Study|Lost to Follow-up|3
5394326|NCT03108157|18583056|P2|Overall Study|Protocol Violation|4
5394327|NCT03108157|18583057|P1|Overall Study|Protocol Violation|15
5394328|NCT03108027|18583067|P6|Period 3|Adverse Event|0
5394329|NCT03108027|18583068|P5|Period 3|Adverse Event|0
5394330|NCT03108027|18583069|P4|Period 3|Adverse Event|0
5394331|NCT03108027|18583070|P3|Period 3|Adverse Event|0
5394332|NCT03108027|18583071|P2|Period 3|Adverse Event|1
5394333|NCT03108027|18583072|P1|Period 3|Adverse Event|0
5394334|NCT03108027|18583067|P6|Period 1|Subject/Guardian Decision|0
5394335|NCT03108027|18583068|P5|Period 1|Subject/Guardian Decision|0
5394336|NCT03108027|18583069|P4|Period 1|Subject/Guardian Decision|2
5394337|NCT03108027|18583070|P3|Period 1|Subject/Guardian Decision|0
5394338|NCT03108027|18583071|P2|Period 1|Subject/Guardian Decision|0
5394339|NCT03108027|18583072|P1|Period 1|Subject/Guardian Decision|0
5394340|NCT03107715|18583099|P2|Overall Study|infant stillborn|1
5394341|NCT03107715|18583100|P1|Overall Study|infant stillborn|0
5394342|NCT03107715|18583099|P2|Overall Study|did not deliver at the home hospital|6
5394343|NCT03107715|18583100|P1|Overall Study|did not deliver at the home hospital|4
5394344|NCT03107611|18583115|P3|Overall Study|Worsening signs/symptoms|2
5394345|NCT03107611|18583116|P2|Overall Study|Worsening signs/symptoms|1
5394346|NCT03107611|18583117|P1|Overall Study|Worsening signs/symptoms|2
5394347|NCT03107611|18583115|P3|Overall Study|Withdrawal by Subject|1
5394348|NCT03107611|18583116|P2|Overall Study|Withdrawal by Subject|0
5394349|NCT03107611|18583117|P1|Overall Study|Withdrawal by Subject|1
5394350|NCT03107611|18583115|P3|Overall Study|Protocol Violation|1
5394351|NCT03107611|18583116|P2|Overall Study|Protocol Violation|0
5394352|NCT03107611|18583117|P1|Overall Study|Protocol Violation|0
5394353|NCT03107611|18583115|P3|Overall Study|Lost to Follow-up|3
5394354|NCT03107611|18583116|P2|Overall Study|Lost to Follow-up|3
5394355|NCT03107611|18583117|P1|Overall Study|Lost to Follow-up|3
5394356|NCT03107611|18583115|P3|Overall Study|Adverse Event|2
5394357|NCT03107611|18583116|P2|Overall Study|Adverse Event|0
5394358|NCT03107611|18583117|P1|Overall Study|Adverse Event|1
5394359|NCT03107377|18583136|P2|Overall Study|Other reason not specified|15
5394360|NCT03107377|18583137|P1|Overall Study|Other reason not specified|16
5394361|NCT03107377|18583136|P2|Overall Study|Lost to Follow-up|34
5394362|NCT03107377|18583137|P1|Overall Study|Lost to Follow-up|37
5394363|NCT03107377|18583136|P2|Overall Study|Withdrawal by Subject|22
5394364|NCT03107377|18583137|P1|Overall Study|Withdrawal by Subject|16
5394365|NCT03107377|18583136|P2|Overall Study|Pregnancy|7
5394366|NCT03107377|18583137|P1|Overall Study|Pregnancy|7
5394367|NCT03107377|18583136|P2|Overall Study|Physician Decision|6
5394368|NCT03107377|18583137|P1|Overall Study|Physician Decision|3
5394369|NCT03107377|18583136|P2|Overall Study|Protocol Violation|12
5394370|NCT03107377|18583137|P1|Overall Study|Protocol Violation|9
5394371|NCT03107377|18583136|P2|Overall Study|Adverse Event|3
5394372|NCT03107377|18583137|P1|Overall Study|Adverse Event|3
5394373|NCT03107052|18583162|P3|Overall Study|Study terminated due to futility|23
5394374|NCT03107052|18583163|P2|Overall Study|Study terminated due to futility|31
5394375|NCT03107052|18583164|P1|Overall Study|Study terminated due to futility|67
5394376|NCT03107052|18583162|P3|Overall Study|Other than specified|0
5394377|NCT03107052|18583163|P2|Overall Study|Other than specified|2
5394378|NCT03107052|18583164|P1|Overall Study|Other than specified|4
5394379|NCT03107052|18583162|P3|Overall Study|Lack of Efficacy|4
5394380|NCT03107052|18583163|P2|Overall Study|Lack of Efficacy|7
5394381|NCT03107052|18583164|P1|Overall Study|Lack of Efficacy|23
5394382|NCT03107052|18583162|P3|Overall Study|Lost to Follow-up|1
5394383|NCT03107052|18583163|P2|Overall Study|Lost to Follow-up|0
5394384|NCT03107052|18583164|P1|Overall Study|Lost to Follow-up|4
5394385|NCT03107052|18583162|P3|Overall Study|Protocol Violation|3
5394386|NCT03107052|18583163|P2|Overall Study|Protocol Violation|0
5394387|NCT03107052|18583164|P1|Overall Study|Protocol Violation|6
5394388|NCT03107052|18583162|P3|Overall Study|Withdrawal by Subject|8
5394389|NCT03107052|18583163|P2|Overall Study|Withdrawal by Subject|5
5394390|NCT03107052|18583164|P1|Overall Study|Withdrawal by Subject|9
5394391|NCT03107052|18583162|P3|Overall Study|Adverse Event|2
5394392|NCT03107052|18583163|P2|Overall Study|Adverse Event|1
5394393|NCT03107052|18583164|P1|Overall Study|Adverse Event|6
5394394|NCT03107026|18583208|P3|Overall Study|Physician Decision|0
5394395|NCT03107026|18583209|P2|Overall Study|Physician Decision|1
5394396|NCT03107026|18583210|P1|Overall Study|Physician Decision|0
5394397|NCT03107026|18583208|P3|Overall Study|non-compliance with study drug|3
5394398|NCT03107026|18583209|P2|Overall Study|non-compliance with study drug|2
5394399|NCT03107026|18583210|P1|Overall Study|non-compliance with study drug|2
5394400|NCT03107026|18583208|P3|Overall Study|non compliance with study visits|0
5394401|NCT03107026|18583209|P2|Overall Study|non compliance with study visits|2
5394402|NCT03107026|18583210|P1|Overall Study|non compliance with study visits|1
5394403|NCT03107026|18583208|P3|Overall Study|Withdrawal by Subject|17
5394404|NCT03107026|18583209|P2|Overall Study|Withdrawal by Subject|5
5394405|NCT03107026|18583210|P1|Overall Study|Withdrawal by Subject|13
5394406|NCT03107026|18583208|P3|Overall Study|Pregnancy|0
5394407|NCT03107026|18583209|P2|Overall Study|Pregnancy|0
5394408|NCT03107026|18583210|P1|Overall Study|Pregnancy|1
5394409|NCT03107026|18583208|P3|Overall Study|Protocol Violation|0
5394410|NCT03107026|18583209|P2|Overall Study|Protocol Violation|2
5394411|NCT03107026|18583210|P1|Overall Study|Protocol Violation|1
5394412|NCT03107026|18583208|P3|Overall Study|Lost to Follow-up|13
5394413|NCT03107026|18583209|P2|Overall Study|Lost to Follow-up|12
5394414|NCT03107026|18583210|P1|Overall Study|Lost to Follow-up|12
5394415|NCT03107026|18583208|P3|Overall Study|Adverse Event|23
5394416|NCT03107026|18583209|P2|Overall Study|Adverse Event|14
5394417|NCT03107026|18583210|P1|Overall Study|Adverse Event|2
5394418|NCT03106753|18583277|P2|Overall Study|Withdrawal by Subject|1
5394419|NCT03106753|18583278|P1|Overall Study|Withdrawal by Subject|0
5394420|NCT03106077|18583344|P2|Overall Study|Screen Failure|0
5394421|NCT03106077|18583345|P1|Overall Study|Screen Failure|94
5394422|NCT03105362|18583389|P1|Overall Study|Lost to Follow-up|1
5394423|NCT03105362|18583389|P1|Overall Study|Withdrawal by Subject|1
5394424|NCT03105297|18583396|P1|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
5394425|NCT03105297|18583396|P1|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
5394426|NCT03105297|18583396|P1|Baseline Phase (Day 1)|Other|21
5394427|NCT03104816|18583440|P3|Overall Study|Protocol Violation|2
5394428|NCT03104816|18583441|P2|Overall Study|Protocol Violation|0
5394429|NCT03104816|18583442|P1|Overall Study|Protocol Violation|2
5394430|NCT03104816|18583440|P3|Overall Study|Lack of Efficacy|0
5394431|NCT03104816|18583441|P2|Overall Study|Lack of Efficacy|2
5394432|NCT03104816|18583442|P1|Overall Study|Lack of Efficacy|0
5394433|NCT03103919|18583550|P2|Overall Study|Adverse Event|2
5394434|NCT03103919|18583551|P1|Overall Study|Adverse Event|2
5394435|NCT03103906|18583587|P2|Overall Study|Other|0
5394436|NCT03103906|18583588|P1|Overall Study|Other|2
5394437|NCT03103906|18583587|P2|Overall Study|Adverse Event|3
5394438|NCT03103906|18583588|P1|Overall Study|Adverse Event|2
5394439|NCT03103763|18583611|P3|Overall Study|Withdrawal by Subject|2
5394440|NCT03103763|18583612|P2|Overall Study|Withdrawal by Subject|3
5394441|NCT03103763|18583613|P1|Overall Study|Withdrawal by Subject|0
5394442|NCT03103763|18583611|P3|Overall Study|Death|5
5394443|NCT03103763|18583612|P2|Overall Study|Death|5
5394444|NCT03103763|18583613|P1|Overall Study|Death|15
5394445|NCT03103503|18583642|P1|Overall Study|Study Closure|757
5394446|NCT03103503|18583642|P1|Overall Study|Lost to Follow-up|3
5394447|NCT03103503|18583642|P1|Overall Study|Plexa Lead or Pulse Generator Extraction|10
5394448|NCT03103503|18583642|P1|Overall Study|Withdrawal by Subject|10
5394449|NCT03103503|18583642|P1|Overall Study|Physician Decision|57
5394450|NCT03103503|18583642|P1|Overall Study|Death|64
5394451|NCT03103100|18583667|P3|Overall Study|Physician Decision|2
5394452|NCT03103100|18583668|P2|Overall Study|Physician Decision|0
5394453|NCT03103100|18583669|P1|Overall Study|Physician Decision|1
5394454|NCT03103100|18583667|P3|Overall Study|Adverse Event|0
5394455|NCT03103100|18583668|P2|Overall Study|Adverse Event|0
5394456|NCT03103100|18583669|P1|Overall Study|Adverse Event|1
5394457|NCT03102918|18583693|P2|Overall Study|Protocol Violation|0
5394458|NCT03102918|18583694|P1|Overall Study|Protocol Violation|1
5394459|NCT03102762|18583720|P2|Overall Study|Lost to Follow-up|0
5394460|NCT03102762|18583721|P1|Overall Study|Lost to Follow-up|1
5394461|NCT03102710|18583765|P3|Overall Study|Subject unable to attend final session|0
5394462|NCT03102710|18583766|P2|Overall Study|Subject unable to attend final session|1
5394463|NCT03102710|18583767|P1|Overall Study|Subject unable to attend final session|0
5394464|NCT03102710|18583765|P3|Overall Study|Nausea during MRI scan|0
5394465|NCT03102710|18583766|P2|Overall Study|Nausea during MRI scan|1
5394466|NCT03102710|18583767|P1|Overall Study|Nausea during MRI scan|0
5394467|NCT03102710|18583765|P3|Overall Study|Technical issues during final MRI scan|0
5394468|NCT03102710|18583766|P2|Overall Study|Technical issues during final MRI scan|1
5394469|NCT03102710|18583767|P1|Overall Study|Technical issues during final MRI scan|0
5394470|NCT03102710|18583765|P3|Overall Study|Dental metal affected MRI scan quality|0
5394471|NCT03102710|18583766|P2|Overall Study|Dental metal affected MRI scan quality|0
5394472|NCT03102710|18583767|P1|Overall Study|Dental metal affected MRI scan quality|1
5394473|NCT03102034|18583792|P2|Overall Study|Withdrawal by Subject|0
5394474|NCT03102034|18583793|P1|Overall Study|Withdrawal by Subject|1
5394475|NCT03101592|18583822|P3|Overall Study|participant files could not be located|118
5394476|NCT03101592|18583823|P2|Overall Study|participant files could not be located|170
5394477|NCT03101592|18583824|P1|Overall Study|participant files could not be located|111
5394478|NCT03101462|18583843|P2|Overall Study|Missed Visit 02 and/or Visit 03|1
5394479|NCT03101462|18583844|P1|Overall Study|Missed Visit 02 and/or Visit 03|1
5394480|NCT03101371|18583860|P2|Overall Study|Did not meet eligibility criteria|1
5394481|NCT03101371|18583861|P1|Overall Study|Did not meet eligibility criteria|2
5394482|NCT03101371|18583860|P2|Overall Study|Lost to Follow-up|4
5394483|NCT03101371|18583861|P1|Overall Study|Lost to Follow-up|1
5394484|NCT03101371|18583860|P2|Overall Study|Physician Decision|1
5394485|NCT03101371|18583861|P1|Overall Study|Physician Decision|0
5394486|NCT03101293|18583881|P2|Washout Period (at Least 7 Days)|Positive drug urine screen|0
5394487|NCT03101293|18583882|P1|Washout Period (at Least 7 Days)|Positive drug urine screen|1
5394488|NCT03101267|18583897|P3|Primary Study Period|Miscellaneous|0
5394489|NCT03101267|18583898|P2|Primary Study Period|Miscellaneous|0
5394490|NCT03101267|18583899|P1|Primary Study Period|Miscellaneous|2
5394491|NCT03101267|18583897|P3|Primary Study Period|Withdrawal by Subject|3
5394492|NCT03101267|18583898|P2|Primary Study Period|Withdrawal by Subject|2
5394493|NCT03101267|18583899|P1|Primary Study Period|Withdrawal by Subject|1
5394494|NCT03101150|18583954|P2|Overall Study|Miscarriage|6
5394495|NCT03101150|18583955|P1|Overall Study|Miscarriage|3
5394496|NCT03101150|18583954|P2|Overall Study|Lost to Follow-up|4
5394497|NCT03101150|18583955|P1|Overall Study|Lost to Follow-up|2
5394498|NCT03101020|18583990|P2|Overall Study|Withdrawal by Subject|2
5394499|NCT03101020|18583991|P1|Overall Study|Withdrawal by Subject|0
5394500|NCT03101020|18583990|P2|Overall Study|Ran over by a car|1
5394501|NCT03101020|18583991|P1|Overall Study|Ran over by a car|0
5394502|NCT03101020|18583990|P2|Overall Study|Lack of time to participate|0
5394503|NCT03101020|18583991|P1|Overall Study|Lack of time to participate|1
5394504|NCT03100942|18584026|P7|Placebo Arm Re-Randomized|Withdrew Consent|1
5394505|NCT03100942|18584027|P6|Placebo Arm Re-Randomized|Withdrew Consent|0
5394506|NCT03100942|18584028|P5|Placebo Arm Re-Randomized|Withdrew Consent|0
5394507|NCT03100942|18584029|P4|Placebo Arm Re-Randomized|Withdrew Consent|0
5394508|NCT03100942|18584030|P3|Placebo Arm Re-Randomized|Withdrew Consent|0
5394509|NCT03100942|18584031|P2|Placebo Arm Re-Randomized|Withdrew Consent|0
5394510|NCT03100942|18584032|P1|Placebo Arm Re-Randomized|Withdrew Consent|0
5394511|NCT03100942|18584026|P7|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5394512|NCT03100942|18584027|P6|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5394513|NCT03100942|18584028|P5|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5394514|NCT03100942|18584029|P4|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
5394515|NCT03100942|18584030|P3|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5394516|NCT03100942|18584031|P2|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
5394517|NCT03100942|18584032|P1|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
5394518|NCT03100942|18584026|P7|Randomized Treatment Period|Lost to Follow-up|0
5394519|NCT03100942|18584027|P6|Randomized Treatment Period|Lost to Follow-up|0
5394520|NCT03100942|18584028|P5|Randomized Treatment Period|Lost to Follow-up|0
5394521|NCT03100942|18584029|P4|Randomized Treatment Period|Lost to Follow-up|0
5394522|NCT03100942|18584030|P3|Randomized Treatment Period|Lost to Follow-up|1
5394523|NCT03100942|18584031|P2|Randomized Treatment Period|Lost to Follow-up|0
5394524|NCT03100942|18584032|P1|Randomized Treatment Period|Lost to Follow-up|0
5394525|NCT03100942|18584026|P7|Randomized Treatment Period|Protocol Violation|0
5394526|NCT03100942|18584027|P6|Randomized Treatment Period|Protocol Violation|0
5394527|NCT03100942|18584028|P5|Randomized Treatment Period|Protocol Violation|0
5394528|NCT03100942|18584029|P4|Randomized Treatment Period|Protocol Violation|1
5394529|NCT03100942|18584030|P3|Randomized Treatment Period|Protocol Violation|1
5394530|NCT03100942|18584031|P2|Randomized Treatment Period|Protocol Violation|1
5394531|NCT03100942|18584032|P1|Randomized Treatment Period|Protocol Violation|0
5394532|NCT03100942|18584026|P7|Randomized Treatment Period|Investigator's Discretion|0
5394533|NCT03100942|18584027|P6|Randomized Treatment Period|Investigator's Discretion|0
5394534|NCT03100942|18584028|P5|Randomized Treatment Period|Investigator's Discretion|0
5394535|NCT03100942|18584029|P4|Randomized Treatment Period|Investigator's Discretion|0
5394536|NCT03100942|18584030|P3|Randomized Treatment Period|Investigator's Discretion|0
5394537|NCT03100942|18584031|P2|Randomized Treatment Period|Investigator's Discretion|1
5394538|NCT03100942|18584032|P1|Randomized Treatment Period|Investigator's Discretion|2
5394539|NCT03100942|18584026|P7|Randomized Treatment Period|Adverse Event|0
5394540|NCT03100942|18584027|P6|Randomized Treatment Period|Adverse Event|0
5394541|NCT03100942|18584028|P5|Randomized Treatment Period|Adverse Event|0
5394542|NCT03100942|18584029|P4|Randomized Treatment Period|Adverse Event|0
5394543|NCT03100942|18584030|P3|Randomized Treatment Period|Adverse Event|1
5394544|NCT03100942|18584031|P2|Randomized Treatment Period|Adverse Event|2
5394545|NCT03100942|18584032|P1|Randomized Treatment Period|Adverse Event|5
5394546|NCT03100942|18584026|P7|Randomized Treatment Period|Withdrew Consent|0
5394547|NCT03100942|18584027|P6|Randomized Treatment Period|Withdrew Consent|0
5394548|NCT03100942|18584028|P5|Randomized Treatment Period|Withdrew Consent|0
5394549|NCT03100942|18584029|P4|Randomized Treatment Period|Withdrew Consent|3
5394550|NCT03100942|18584030|P3|Randomized Treatment Period|Withdrew Consent|3
5394551|NCT03100942|18584031|P2|Randomized Treatment Period|Withdrew Consent|5
5394552|NCT03100942|18584032|P1|Randomized Treatment Period|Withdrew Consent|4
5394553|NCT03100838|18584070|P4|Overall Study|Lost to Follow-up|0
5394554|NCT03100838|18584071|P3|Overall Study|Lost to Follow-up|1
5394555|NCT03100838|18584072|P2|Overall Study|Lost to Follow-up|0
5394556|NCT03100838|18584073|P1|Overall Study|Lost to Follow-up|0
5394557|NCT03100838|18584070|P4|Overall Study|Pregnancy|0
5394558|NCT03100838|18584071|P3|Overall Study|Pregnancy|0
5394559|NCT03100838|18584072|P2|Overall Study|Pregnancy|1
5394560|NCT03100838|18584073|P1|Overall Study|Pregnancy|0
5394561|NCT03100838|18584070|P4|Overall Study|Physician Decision|1
5394562|NCT03100838|18584071|P3|Overall Study|Physician Decision|1
5394563|NCT03100838|18584072|P2|Overall Study|Physician Decision|1
5394564|NCT03100838|18584073|P1|Overall Study|Physician Decision|1
5394565|NCT03100838|18584070|P4|Overall Study|Adverse Event|0
5394566|NCT03100838|18584071|P3|Overall Study|Adverse Event|0
5394567|NCT03100838|18584072|P2|Overall Study|Adverse Event|0
5394568|NCT03100838|18584073|P1|Overall Study|Adverse Event|1
5394569|NCT03100825|18584099|P1|Overall Study|Physician Decision|1
5394570|NCT03100825|18584099|P1|Overall Study|Participant/Guardian Decision|7
5394571|NCT03100344|18584126|P4|Overall Study|Lost to Follow-up|1
5394572|NCT03100344|18584127|P3|Overall Study|Lost to Follow-up|1
5394573|NCT03100344|18584128|P2|Overall Study|Lost to Follow-up|1
5394574|NCT03100344|18584129|P1|Overall Study|Lost to Follow-up|1
5394575|NCT03100344|18584126|P4|Overall Study|Withdrawal by Subject|8
5394576|NCT03100344|18584127|P3|Overall Study|Withdrawal by Subject|4
5394577|NCT03100344|18584128|P2|Overall Study|Withdrawal by Subject|7
5394578|NCT03100344|18584129|P1|Overall Study|Withdrawal by Subject|10
5394579|NCT03100344|18584126|P4|Overall Study|Protocol Violation|0
5394580|NCT03100344|18584127|P3|Overall Study|Protocol Violation|0
5394581|NCT03100344|18584128|P2|Overall Study|Protocol Violation|0
5394582|NCT03100344|18584129|P1|Overall Study|Protocol Violation|1
5394583|NCT03100344|18584126|P4|Overall Study|Lack of Efficacy|0
5394584|NCT03100344|18584127|P3|Overall Study|Lack of Efficacy|0
5394585|NCT03100344|18584128|P2|Overall Study|Lack of Efficacy|0
5394586|NCT03100344|18584129|P1|Overall Study|Lack of Efficacy|2
5394587|NCT03100344|18584126|P4|Overall Study|Adverse Event|3
5394588|NCT03100344|18584127|P3|Overall Study|Adverse Event|2
5394589|NCT03100344|18584128|P2|Overall Study|Adverse Event|3
5394590|NCT03100344|18584129|P1|Overall Study|Adverse Event|0
5394591|NCT03100058|18584232|P13|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394592|NCT03100058|18584233|P12|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394593|NCT03100058|18584234|P11|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394594|NCT03100058|18584235|P10|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
5394595|NCT03100058|18584236|P9|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394596|NCT03100058|18584237|P8|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394597|NCT03100058|18584238|P7|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394598|NCT03100058|18584239|P6|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394599|NCT03100058|18584240|P5|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394600|NCT03100058|18584241|P4|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394601|NCT03100058|18584242|P3|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394602|NCT03100058|18584243|P2|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394603|NCT03100058|18584244|P1|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
5394604|NCT03100058|18584232|P13|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
5394605|NCT03100058|18584233|P12|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394606|NCT03100058|18584234|P11|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394607|NCT03100058|18584235|P10|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394608|NCT03100058|18584236|P9|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394609|NCT03100058|18584237|P8|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394610|NCT03100058|18584238|P7|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394611|NCT03100058|18584239|P6|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394612|NCT03100058|18584240|P5|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394613|NCT03100058|18584241|P4|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394614|NCT03100058|18584242|P3|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394615|NCT03100058|18584243|P2|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394616|NCT03100058|18584244|P1|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
5394617|NCT03100058|18584232|P13|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394618|NCT03100058|18584233|P12|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394619|NCT03100058|18584234|P11|Epoch 4 (Last 24 Weeks of the Study)|Death|1
5394620|NCT03100058|18584235|P10|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394621|NCT03100058|18584236|P9|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394622|NCT03100058|18584237|P8|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394623|NCT03100058|18584238|P7|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394624|NCT03100058|18584239|P6|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394625|NCT03100058|18584240|P5|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394626|NCT03100058|18584241|P4|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394627|NCT03100058|18584242|P3|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394628|NCT03100058|18584243|P2|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394629|NCT03100058|18584244|P1|Epoch 4 (Last 24 Weeks of the Study)|Death|0
5394630|NCT03100058|18584232|P13|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
5394631|NCT03100058|18584233|P12|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394632|NCT03100058|18584234|P11|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
5394633|NCT03100058|18584235|P10|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
5394634|NCT03100058|18584236|P9|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394635|NCT03100058|18584237|P8|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394636|NCT03100058|18584238|P7|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394637|NCT03100058|18584239|P6|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394638|NCT03100058|18584240|P5|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394639|NCT03100058|18584241|P4|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394640|NCT03100058|18584242|P3|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394641|NCT03100058|18584243|P2|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394642|NCT03100058|18584244|P1|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
5394643|NCT03100058|18584232|P13|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394644|NCT03100058|18584233|P12|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
5394645|NCT03100058|18584234|P11|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
5394646|NCT03100058|18584235|P10|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394647|NCT03100058|18584236|P9|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394648|NCT03100058|18584237|P8|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394649|NCT03100058|18584238|P7|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394650|NCT03100058|18584239|P6|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394651|NCT03100058|18584240|P5|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394652|NCT03100058|18584241|P4|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394653|NCT03100058|18584242|P3|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394654|NCT03100058|18584243|P2|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394655|NCT03100058|18584244|P1|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
5394656|NCT03100058|18584232|P13|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
5394657|NCT03100058|18584233|P12|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
5394658|NCT03100058|18584234|P11|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
5394659|NCT03100058|18584235|P10|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394660|NCT03100058|18584236|P9|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394661|NCT03100058|18584237|P8|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394662|NCT03100058|18584238|P7|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394663|NCT03100058|18584239|P6|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394664|NCT03100058|18584240|P5|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394665|NCT03100058|18584241|P4|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394666|NCT03100058|18584242|P3|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394667|NCT03100058|18584243|P2|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394668|NCT03100058|18584244|P1|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
5394669|NCT03100058|18584232|P13|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394670|NCT03100058|18584233|P12|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394671|NCT03100058|18584234|P11|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394672|NCT03100058|18584235|P10|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394673|NCT03100058|18584236|P9|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394674|NCT03100058|18584237|P8|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394675|NCT03100058|18584238|P7|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
5394676|NCT03100058|18584239|P6|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394677|NCT03100058|18584240|P5|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394678|NCT03100058|18584241|P4|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394679|NCT03100058|18584242|P3|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394680|NCT03100058|18584243|P2|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394681|NCT03100058|18584244|P1|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
5394682|NCT03100058|18584232|P13|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394683|NCT03100058|18584233|P12|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394684|NCT03100058|18584234|P11|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394685|NCT03100058|18584235|P10|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394686|NCT03100058|18584236|P9|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394687|NCT03100058|18584237|P8|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394688|NCT03100058|18584238|P7|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394689|NCT03100058|18584239|P6|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394690|NCT03100058|18584240|P5|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394691|NCT03100058|18584241|P4|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394692|NCT03100058|18584242|P3|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394693|NCT03100058|18584243|P2|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
5394694|NCT03100058|18584244|P1|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
5394695|NCT03100058|18584232|P13|Epoch 3 (24 Weeks of Treatment)|Death|0
5394696|NCT03100058|18584233|P12|Epoch 3 (24 Weeks of Treatment)|Death|0
5394697|NCT03100058|18584234|P11|Epoch 3 (24 Weeks of Treatment)|Death|0
5394698|NCT03100058|18584235|P10|Epoch 3 (24 Weeks of Treatment)|Death|0
5394699|NCT03100058|18584236|P9|Epoch 3 (24 Weeks of Treatment)|Death|0
5394700|NCT03100058|18584237|P8|Epoch 3 (24 Weeks of Treatment)|Death|0
5394701|NCT03100058|18584238|P7|Epoch 3 (24 Weeks of Treatment)|Death|0
5394702|NCT03100058|18584239|P6|Epoch 3 (24 Weeks of Treatment)|Death|0
5394703|NCT03100058|18584240|P5|Epoch 3 (24 Weeks of Treatment)|Death|0
5394704|NCT03100058|18584241|P4|Epoch 3 (24 Weeks of Treatment)|Death|0
5394705|NCT03100058|18584242|P3|Epoch 3 (24 Weeks of Treatment)|Death|0
5394706|NCT03100058|18584243|P2|Epoch 3 (24 Weeks of Treatment)|Death|1
5394707|NCT03100058|18584244|P1|Epoch 3 (24 Weeks of Treatment)|Death|0
5394708|NCT03100058|18584232|P13|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394709|NCT03100058|18584233|P12|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394710|NCT03100058|18584234|P11|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394711|NCT03100058|18584235|P10|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394712|NCT03100058|18584236|P9|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394713|NCT03100058|18584237|P8|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394714|NCT03100058|18584238|P7|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
5394715|NCT03100058|18584239|P6|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394716|NCT03100058|18584240|P5|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394717|NCT03100058|18584241|P4|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
5394718|NCT03100058|18584242|P3|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394719|NCT03100058|18584243|P2|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394720|NCT03100058|18584244|P1|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
5394721|NCT03100058|18584232|P13|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394722|NCT03100058|18584233|P12|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394723|NCT03100058|18584234|P11|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394724|NCT03100058|18584235|P10|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394725|NCT03100058|18584236|P9|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394726|NCT03100058|18584237|P8|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
5394727|NCT03100058|18584238|P7|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394728|NCT03100058|18584239|P6|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394729|NCT03100058|18584240|P5|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394730|NCT03100058|18584241|P4|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
5394731|NCT03100058|18584242|P3|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394732|NCT03100058|18584243|P2|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394733|NCT03100058|18584244|P1|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
5394734|NCT03100058|18584232|P13|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5394735|NCT03100058|18584233|P12|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5394736|NCT03100058|18584234|P11|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5394737|NCT03100058|18584235|P10|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5394738|NCT03100058|18584236|P9|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5394739|NCT03100058|18584237|P8|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5394740|NCT03100058|18584238|P7|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5394741|NCT03100058|18584239|P6|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5394742|NCT03100058|18584240|P5|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5394743|NCT03100058|18584241|P4|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5394744|NCT03100058|18584242|P3|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5394745|NCT03100058|18584243|P2|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
5394746|NCT03100058|18584244|P1|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
5394747|NCT03100058|18584232|P13|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5394748|NCT03100058|18584233|P12|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5394749|NCT03100058|18584234|P11|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5394750|NCT03100058|18584235|P10|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5394751|NCT03100058|18584236|P9|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5394752|NCT03100058|18584237|P8|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5394753|NCT03100058|18584238|P7|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5394754|NCT03100058|18584239|P6|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5394755|NCT03100058|18584240|P5|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5394756|NCT03100058|18584241|P4|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5394757|NCT03100058|18584242|P3|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5394758|NCT03100058|18584243|P2|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
5394759|NCT03100058|18584244|P1|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
5394760|NCT03100058|18584232|P13|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5394761|NCT03100058|18584233|P12|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5394762|NCT03100058|18584234|P11|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5394763|NCT03100058|18584235|P10|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
5394764|NCT03100058|18584236|P9|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
5394765|NCT03100058|18584237|P8|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
5394766|NCT03100058|18584238|P7|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
5394767|NCT03100058|18584239|P6|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
5394768|NCT03100058|18584240|P5|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
5394769|NCT03100058|18584241|P4|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
5394770|NCT03100058|18584242|P3|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
5394771|NCT03100058|18584243|P2|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
5394772|NCT03100058|18584244|P1|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
5394773|NCT03100058|18584232|P13|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5394774|NCT03100058|18584233|P12|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5394775|NCT03100058|18584234|P11|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5394776|NCT03100058|18584235|P10|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5394777|NCT03100058|18584236|P9|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
5394778|NCT03100058|18584237|P8|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
5394779|NCT03100058|18584238|P7|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
5394780|NCT03100058|18584239|P6|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5394781|NCT03100058|18584240|P5|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
5394782|NCT03100058|18584241|P4|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
5394783|NCT03100058|18584242|P3|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
5394784|NCT03100058|18584243|P2|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5394785|NCT03100058|18584244|P1|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
5394786|NCT03099694|18584451|P2|Overall Study|Lost to Follow-up|5
5394787|NCT03099694|18584452|P1|Overall Study|Lost to Follow-up|9
5394788|NCT03099694|18584451|P2|Overall Study|Withdrawal by Subject|13
5394789|NCT03099694|18584452|P1|Overall Study|Withdrawal by Subject|11
5394790|NCT03099538|18584491|P1|Overall Study|Lack of Efficacy|3
5394791|NCT03099187|18584516|P2|Overall Study|Non-compliance with Protocol procedure|2
5394792|NCT03099187|18584517|P1|Overall Study|Non-compliance with Protocol procedure|1
5394793|NCT03099187|18584516|P2|Overall Study|Randomization error|2
5394794|NCT03099187|18584517|P1|Overall Study|Randomization error|0
5394795|NCT03099187|18584516|P2|Overall Study|Symptomatic deterioration|1
5394796|NCT03099187|18584517|P1|Overall Study|Symptomatic deterioration|0
5394797|NCT03099187|18584516|P2|Overall Study|Disease progression|1
5394798|NCT03099187|18584517|P1|Overall Study|Disease progression|0
5394799|NCT03099187|18584516|P2|Overall Study|Non-compliance with study drug|1
5394800|NCT03099187|18584517|P1|Overall Study|Non-compliance with study drug|0
5394801|NCT03099187|18584516|P2|Overall Study|Lung transplantation|3
5394802|NCT03099187|18584517|P1|Overall Study|Lung transplantation|1
5394803|NCT03099187|18584516|P2|Overall Study|Withdrawal by Subject|6
5394804|NCT03099187|18584517|P1|Overall Study|Withdrawal by Subject|11
5394805|NCT03099187|18584516|P2|Overall Study|Physician Decision|2
5394806|NCT03099187|18584517|P1|Overall Study|Physician Decision|2
5394807|NCT03099187|18584516|P2|Overall Study|Lack of Efficacy|0
5394808|NCT03099187|18584517|P1|Overall Study|Lack of Efficacy|1
5394809|NCT03099187|18584516|P2|Overall Study|Death|7
5394810|NCT03099187|18584517|P1|Overall Study|Death|4
5394811|NCT03099187|18584516|P2|Overall Study|Adverse Event|9
5394812|NCT03099187|18584517|P1|Overall Study|Adverse Event|23
5394813|NCT03099161|18584566|P3|Overall Study|Progressive Disease|1
5394814|NCT03099161|18584567|P2|Overall Study|Progressive Disease|4
5394815|NCT03099161|18584568|P1|Overall Study|Progressive Disease|1
5394816|NCT03099161|18584566|P3|Overall Study|Physician Decision|0
5394817|NCT03099161|18584567|P2|Overall Study|Physician Decision|0
5394818|NCT03099161|18584568|P1|Overall Study|Physician Decision|2
5394819|NCT03099161|18584566|P3|Overall Study|Adverse Event|2
5394820|NCT03099161|18584567|P2|Overall Study|Adverse Event|0
5394821|NCT03099161|18584568|P1|Overall Study|Adverse Event|0
5394822|NCT03099096|18584585|P1|Overall Study|Physician Decision|1
5394823|NCT03099096|18584585|P1|Overall Study|Adverse Event|1
5394824|NCT03098979|18584598|P6|Overall Study|Protocol Violation|1
5394825|NCT03098979|18584599|P5|Overall Study|Protocol Violation|0
5394826|NCT03098979|18584600|P4|Overall Study|Protocol Violation|0
5394827|NCT03098979|18584601|P3|Overall Study|Protocol Violation|0
5394828|NCT03098979|18584602|P2|Overall Study|Protocol Violation|0
5394829|NCT03098979|18584603|P1|Overall Study|Protocol Violation|0
5394830|NCT03098979|18584598|P6|Overall Study|Non-compliance|1
5394831|NCT03098979|18584599|P5|Overall Study|Non-compliance|0
5394832|NCT03098979|18584600|P4|Overall Study|Non-compliance|0
5394833|NCT03098979|18584601|P3|Overall Study|Non-compliance|0
5394834|NCT03098979|18584602|P2|Overall Study|Non-compliance|0
5394835|NCT03098979|18584603|P1|Overall Study|Non-compliance|0
5394836|NCT03098979|18584598|P6|Overall Study|Physician Decision|0
5394837|NCT03098979|18584599|P5|Overall Study|Physician Decision|0
5394838|NCT03098979|18584600|P4|Overall Study|Physician Decision|0
5394839|NCT03098979|18584601|P3|Overall Study|Physician Decision|0
5394840|NCT03098979|18584602|P2|Overall Study|Physician Decision|1
5394841|NCT03098979|18584603|P1|Overall Study|Physician Decision|2
5394842|NCT03098979|18584598|P6|Overall Study|Death|0
5394843|NCT03098979|18584599|P5|Overall Study|Death|1
5394844|NCT03098979|18584600|P4|Overall Study|Death|0
5394845|NCT03098979|18584601|P3|Overall Study|Death|2
5394846|NCT03098979|18584602|P2|Overall Study|Death|0
5394847|NCT03098979|18584603|P1|Overall Study|Death|1
5394848|NCT03098979|18584598|P6|Overall Study|Withdrawal by Subject|1
5394849|NCT03098979|18584599|P5|Overall Study|Withdrawal by Subject|2
5394850|NCT03098979|18584600|P4|Overall Study|Withdrawal by Subject|1
5394851|NCT03098979|18584601|P3|Overall Study|Withdrawal by Subject|1
5394852|NCT03098979|18584602|P2|Overall Study|Withdrawal by Subject|1
5394853|NCT03098979|18584603|P1|Overall Study|Withdrawal by Subject|2
5394854|NCT03098979|18584598|P6|Overall Study|Adverse Event|1
5394855|NCT03098979|18584599|P5|Overall Study|Adverse Event|6
5394856|NCT03098979|18584600|P4|Overall Study|Adverse Event|4
5394857|NCT03098979|18584601|P3|Overall Study|Adverse Event|1
5394858|NCT03098979|18584602|P2|Overall Study|Adverse Event|0
5394859|NCT03098979|18584603|P1|Overall Study|Adverse Event|1
5394860|NCT03098030|18584746|P4|Overall Study|Lost to Follow-up|1
5394861|NCT03098030|18584747|P3|Overall Study|Lost to Follow-up|2
5394862|NCT03098030|18584748|P2|Overall Study|Lost to Follow-up|0
5394863|NCT03098030|18584749|P1|Overall Study|Lost to Follow-up|0
5394864|NCT03098030|18584746|P4|Overall Study|Withdrawal by Subject|2
5394865|NCT03098030|18584747|P3|Overall Study|Withdrawal by Subject|8
5394866|NCT03098030|18584748|P2|Overall Study|Withdrawal by Subject|7
5394867|NCT03098030|18584749|P1|Overall Study|Withdrawal by Subject|0
5394868|NCT03098030|18584746|P4|Overall Study|Death|82
5394869|NCT03098030|18584747|P3|Overall Study|Death|156
5394870|NCT03098030|18584748|P2|Overall Study|Death|156
5394871|NCT03098030|18584749|P1|Overall Study|Death|10
5394872|NCT03097861|18584770|P3|Overall Study|Reason not provided|1
5394873|NCT03097861|18584771|P2|Overall Study|Reason not provided|1
5394874|NCT03097861|18584772|P1|Overall Study|Reason not provided|3
5394875|NCT03097861|18584770|P3|Overall Study|Withdrawal by Subject|3
5394876|NCT03097861|18584771|P2|Overall Study|Withdrawal by Subject|5
5394877|NCT03097861|18584772|P1|Overall Study|Withdrawal by Subject|1
5394878|NCT03097861|18584770|P3|Overall Study|Lost to Follow-up|1
5394879|NCT03097861|18584771|P2|Overall Study|Lost to Follow-up|7
5394880|NCT03097861|18584772|P1|Overall Study|Lost to Follow-up|0
5394881|NCT03097861|18584770|P3|Overall Study|Investigator Decision|0
5394882|NCT03097861|18584771|P2|Overall Study|Investigator Decision|1
5394883|NCT03097861|18584772|P1|Overall Study|Investigator Decision|0
5394884|NCT03097861|18584770|P3|Overall Study|Adverse Event|4
5394885|NCT03097861|18584771|P2|Overall Study|Adverse Event|8
5394886|NCT03097861|18584772|P1|Overall Study|Adverse Event|3
5394887|NCT03097614|18584789|P1|Overall Study|Adverse Event|3
5394888|NCT03097289|18584891|P1|Overall Study|Collected platelet product unusable|3
5394889|NCT03097289|18584891|P1|Overall Study|Equipment failure|2
5394890|NCT03097289|18584891|P1|Overall Study|Adverse Event|1
5394891|NCT03097133|18584900|P2|Overall Study|Adverse Event|0
5394892|NCT03097133|18584901|P1|Overall Study|Adverse Event|1
5394893|NCT03097133|18584900|P2|Overall Study|Other|2
5394894|NCT03097133|18584901|P1|Overall Study|Other|3
5394895|NCT03097133|18584900|P2|Overall Study|Discontinued DB, not entered FU Phase|25
5394896|NCT03097133|18584901|P1|Overall Study|Discontinued DB, not entered FU Phase|21
5394897|NCT03097133|18584900|P2|Overall Study|Withdrawal by Subject|5
5394898|NCT03097133|18584901|P1|Overall Study|Withdrawal by Subject|2
5394899|NCT03097133|18584900|P2|Overall Study|Lost to Follow-up|2
5394900|NCT03097133|18584901|P1|Overall Study|Lost to Follow-up|3
5394901|NCT03097029|18584951|P1|Overall Study|Withdrawal by Subject|1
5394902|NCT03096483|18584995|P1|Overall Study|Withdrawal by site|1
5394903|NCT03096314|18585024|P2|Screened Vitamin D Deficient|Lost to Follow-up|12
5394904|NCT03096314|18585025|P1|Screened Vitamin D Deficient|Lost to Follow-up|9
5394905|NCT03095651|18585087|P8|Overall Study|Withdrawal by Subject|0
5394906|NCT03095651|18585088|P7|Overall Study|Withdrawal by Subject|0
5394907|NCT03095651|18585089|P6|Overall Study|Withdrawal by Subject|1
5394908|NCT03095651|18585090|P5|Overall Study|Withdrawal by Subject|0
5394909|NCT03095651|18585091|P4|Overall Study|Withdrawal by Subject|0
5394910|NCT03095651|18585092|P3|Overall Study|Withdrawal by Subject|0
5394911|NCT03095651|18585093|P2|Overall Study|Withdrawal by Subject|0
5394912|NCT03095651|18585094|P1|Overall Study|Withdrawal by Subject|0
5394913|NCT03095651|18585087|P8|Overall Study|Lost to Follow-up|0
5394914|NCT03095651|18585088|P7|Overall Study|Lost to Follow-up|0
5394915|NCT03095651|18585089|P6|Overall Study|Lost to Follow-up|0
5394916|NCT03095651|18585090|P5|Overall Study|Lost to Follow-up|0
5394917|NCT03095651|18585091|P4|Overall Study|Lost to Follow-up|1
5394918|NCT03095651|18585092|P3|Overall Study|Lost to Follow-up|0
5394919|NCT03095651|18585093|P2|Overall Study|Lost to Follow-up|1
5394920|NCT03095651|18585094|P1|Overall Study|Lost to Follow-up|1
5394921|NCT03095599|18585373|P2|Overall Study|Withdrawal prior to vaccination|0
5394922|NCT03095599|18585374|P1|Overall Study|Withdrawal prior to vaccination|1
5394923|NCT03095599|18585373|P2|Overall Study|Lost to Follow-up|0
5394924|NCT03095599|18585374|P1|Overall Study|Lost to Follow-up|1
5394925|NCT03095599|18585373|P2|Overall Study|Withdrawal by Subject|0
5394926|NCT03095599|18585374|P1|Overall Study|Withdrawal by Subject|1
5394927|NCT03095521|18585410|P2|Overall Study|Lost to Follow-up|1
5394928|NCT03095521|18585411|P1|Overall Study|Lost to Follow-up|0
5394929|NCT03095521|18585410|P2|Overall Study|Withdrawal by Subject|1
5394930|NCT03095521|18585411|P1|Overall Study|Withdrawal by Subject|0
5394931|NCT03095508|18585429|P2|Overall Study|Adverse Event|1
5394932|NCT03095508|18585430|P1|Overall Study|Adverse Event|0
5394933|NCT03095027|18585478|P2|Period 2, Second Week of Wear|Adverse Event|0
5394934|NCT03095027|18585479|P1|Period 2, Second Week of Wear|Adverse Event|1
5394935|NCT03094195|18585515|P8|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5394936|NCT03094195|18585516|P7|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5394937|NCT03094195|18585517|P6|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5394938|NCT03094195|18585518|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5394939|NCT03094195|18585519|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5394940|NCT03094195|18585520|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
5394941|NCT03094195|18585521|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
5394942|NCT03094195|18585522|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
5394943|NCT03094195|18585515|P8|Double-Blind Treatment Period (DB)|Physician Decision|0
5394944|NCT03094195|18585516|P7|Double-Blind Treatment Period (DB)|Physician Decision|0
5394945|NCT03094195|18585517|P6|Double-Blind Treatment Period (DB)|Physician Decision|0
5394946|NCT03094195|18585518|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
5394947|NCT03094195|18585519|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
5394948|NCT03094195|18585520|P3|Double-Blind Treatment Period (DB)|Physician Decision|1
5394949|NCT03094195|18585521|P2|Double-Blind Treatment Period (DB)|Physician Decision|0
5394950|NCT03094195|18585522|P1|Double-Blind Treatment Period (DB)|Physician Decision|0
5394951|NCT03094195|18585515|P8|Double-Blind Treatment Period (DB)|Adverse Event|0
5394952|NCT03094195|18585516|P7|Double-Blind Treatment Period (DB)|Adverse Event|0
5394953|NCT03094195|18585517|P6|Double-Blind Treatment Period (DB)|Adverse Event|0
5394954|NCT03094195|18585518|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
5394955|NCT03094195|18585519|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
5394956|NCT03094195|18585520|P3|Double-Blind Treatment Period (DB)|Adverse Event|1
5394957|NCT03094195|18585521|P2|Double-Blind Treatment Period (DB)|Adverse Event|2
5394958|NCT03094195|18585522|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
5394959|NCT03094195|18585515|P8|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5394960|NCT03094195|18585516|P7|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5394961|NCT03094195|18585517|P6|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5394962|NCT03094195|18585518|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5394963|NCT03094195|18585519|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
5394964|NCT03094195|18585520|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
5394965|NCT03094195|18585521|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
5394966|NCT03094195|18585522|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
5394967|NCT03093415|18585580|P3|Enrollment to SVR12 Results|Lost to Follow-up|3
5394968|NCT03093415|18585581|P2|Enrollment to SVR12 Results|Lost to Follow-up|8
5394969|NCT03093415|18585582|P1|Enrollment to SVR12 Results|Lost to Follow-up|1
5394970|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
5394971|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
5394972|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
5394973|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
5394974|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
5394975|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
5394976|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
5394977|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
5394978|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
5394979|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
5394980|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
5394981|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
5394982|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
5394983|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
5394984|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
5394985|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
5394986|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
5394987|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
5394988|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
5394989|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
5394990|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
5394991|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
5394992|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
5394993|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
5394994|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
5394995|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
5394996|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
5394997|NCT03093415|18585580|P3|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
5394998|NCT03093415|18585581|P2|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
5394999|NCT03093415|18585582|P1|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
5395000|NCT03093350|18585605|P1|Overall Study|Signed consent, never began treartment|1
5395001|NCT03093350|18585605|P1|Overall Study|Death|1
5395002|NCT03093324|18585613|P2|Overall Study|Withdrawal by Subject|2
5395003|NCT03093324|18585614|P1|Overall Study|Withdrawal by Subject|2
5395004|NCT03093324|18585613|P2|Overall Study|Protocol Deviation|2
5395005|NCT03093324|18585614|P1|Overall Study|Protocol Deviation|2
5395006|NCT03093324|18585613|P2|Overall Study|Lost to Follow-up|0
5395007|NCT03093324|18585614|P1|Overall Study|Lost to Follow-up|1
5395008|NCT03093324|18585613|P2|Overall Study|Adverse Event|15
5395009|NCT03093324|18585614|P1|Overall Study|Adverse Event|4
5395010|NCT03093181|18585661|P3|Overall Study|Other (Protocol violation)|1
5395011|NCT03093181|18585662|P2|Overall Study|Other (Protocol violation)|0
5395012|NCT03093181|18585663|P1|Overall Study|Other (Protocol violation)|0
5395013|NCT03093181|18585661|P3|Overall Study|Adverse Event|0
5395014|NCT03093181|18585662|P2|Overall Study|Adverse Event|1
5395015|NCT03093181|18585663|P1|Overall Study|Adverse Event|0
5395016|NCT03093181|18585661|P3|Overall Study|Other (Not specified)|0
5395017|NCT03093181|18585662|P2|Overall Study|Other (Not specified)|0
5395018|NCT03093181|18585663|P1|Overall Study|Other (Not specified)|1
5395019|NCT03093181|18585661|P3|Overall Study|Withdrawal by Subject|2
5395020|NCT03093181|18585662|P2|Overall Study|Withdrawal by Subject|1
5395021|NCT03093181|18585663|P1|Overall Study|Withdrawal by Subject|2
5395022|NCT03092791|18585725|P8|Overall Study|Reason Not Specified|0
5395023|NCT03092791|18585726|P7|Overall Study|Reason Not Specified|0
5395024|NCT03092791|18585727|P6|Overall Study|Reason Not Specified|1
5395025|NCT03092791|18585728|P5|Overall Study|Reason Not Specified|1
5395026|NCT03092791|18585729|P4|Overall Study|Reason Not Specified|0
5395027|NCT03092791|18585730|P3|Overall Study|Reason Not Specified|0
5395028|NCT03092791|18585731|P2|Overall Study|Reason Not Specified|0
5395029|NCT03092791|18585732|P1|Overall Study|Reason Not Specified|0
5395030|NCT03092791|18585725|P8|Overall Study|Death|1
5395031|NCT03092791|18585726|P7|Overall Study|Death|0
5395032|NCT03092791|18585727|P6|Overall Study|Death|1
5395033|NCT03092791|18585728|P5|Overall Study|Death|0
5395034|NCT03092791|18585729|P4|Overall Study|Death|0
5395035|NCT03092791|18585730|P3|Overall Study|Death|0
5395036|NCT03092791|18585731|P2|Overall Study|Death|0
5395037|NCT03092791|18585732|P1|Overall Study|Death|0
5395038|NCT03092791|18585725|P8|Overall Study|Study Termination|55
5395039|NCT03092791|18585726|P7|Overall Study|Study Termination|53
5395040|NCT03092791|18585727|P6|Overall Study|Study Termination|46
5395041|NCT03092791|18585728|P5|Overall Study|Study Termination|55
5395042|NCT03092791|18585729|P4|Overall Study|Study Termination|0
5395043|NCT03092791|18585730|P3|Overall Study|Study Termination|0
5395044|NCT03092791|18585731|P2|Overall Study|Study Termination|0
5395045|NCT03092791|18585732|P1|Overall Study|Study Termination|0
5395046|NCT03092791|18585725|P8|Overall Study|Withdrawal of Consent|4
5395047|NCT03092791|18585726|P7|Overall Study|Withdrawal of Consent|6
5395048|NCT03092791|18585727|P6|Overall Study|Withdrawal of Consent|12
5395049|NCT03092791|18585728|P5|Overall Study|Withdrawal of Consent|4
5395050|NCT03092791|18585729|P4|Overall Study|Withdrawal of Consent|0
5395051|NCT03092791|18585730|P3|Overall Study|Withdrawal of Consent|0
5395052|NCT03092791|18585731|P2|Overall Study|Withdrawal of Consent|0
5395053|NCT03092791|18585732|P1|Overall Study|Withdrawal of Consent|0
5395054|NCT03092791|18585725|P8|Overall Study|Lost to Follow-up|0
5395055|NCT03092791|18585726|P7|Overall Study|Lost to Follow-up|1
5395056|NCT03092791|18585727|P6|Overall Study|Lost to Follow-up|0
5395057|NCT03092791|18585728|P5|Overall Study|Lost to Follow-up|0
5395058|NCT03092791|18585729|P4|Overall Study|Lost to Follow-up|0
5395059|NCT03092791|18585730|P3|Overall Study|Lost to Follow-up|0
5395060|NCT03092791|18585731|P2|Overall Study|Lost to Follow-up|0
5395061|NCT03092791|18585732|P1|Overall Study|Lost to Follow-up|0
5395062|NCT03092752|18585847|P1|Overall Study|<6 month history|245900
5395063|NCT03092752|18585847|P1|Overall Study|Average hospital visit interval >92 days|10779
5395064|NCT03092752|18585847|P1|Overall Study|Having no claim of study drugs|29282
5395065|NCT03092752|18585847|P1|Overall Study|At least one claim with T2DM|61299
5395066|NCT03092752|18585847|P1|Overall Study|Aged <40 years|14209
5395067|NCT03092726|18585912|P2|Overall Study|Withdrawal by Subject|3
5395068|NCT03092726|18585913|P1|Overall Study|Withdrawal by Subject|5
5395069|NCT03092726|18585912|P2|Overall Study|Lost to Follow-up|0
5395070|NCT03092726|18585913|P1|Overall Study|Lost to Follow-up|1
5395071|NCT03092726|18585912|P2|Overall Study|Lack of Efficacy|1
5395072|NCT03092726|18585913|P1|Overall Study|Lack of Efficacy|0
5395073|NCT03092726|18585912|P2|Overall Study|Adverse Event|10
5395074|NCT03092726|18585913|P1|Overall Study|Adverse Event|3
5395075|NCT03092479|18585939|P2|Overall Study|Withdrawal by Subject|0
5395076|NCT03092479|18585940|P1|Overall Study|Withdrawal by Subject|4
5395077|NCT03092479|18585939|P2|Overall Study|Lost to Follow-up|2
5395078|NCT03092479|18585940|P1|Overall Study|Lost to Follow-up|3
5395079|NCT03092375|18585962|P4|Overall Study|Lack of Efficacy|0
5395080|NCT03092375|18585963|P3|Overall Study|Lack of Efficacy|1
5395081|NCT03092375|18585964|P2|Overall Study|Lack of Efficacy|1
5395082|NCT03092375|18585965|P1|Overall Study|Lack of Efficacy|0
5395083|NCT03092219|18585993|P2|Overall Study|Protocol Violation|4
5395084|NCT03092219|18585994|P1|Overall Study|Protocol Violation|7
5395085|NCT03091920|18586038|P3|Overall Study|Adverse Event|0
5395086|NCT03091920|18586039|P2|Overall Study|Adverse Event|1
5395087|NCT03091920|18586040|P1|Overall Study|Adverse Event|0
5395088|NCT03091777|18586187|P3|Overall Study|Abnormal Laboratory Value|12
5395089|NCT03091777|18586188|P2|Overall Study|Abnormal Laboratory Value|11
5395090|NCT03091777|18586189|P1|Overall Study|Abnormal Laboratory Value|7
5395091|NCT03091777|18586187|P3|Overall Study|Physician Decision|1
5395092|NCT03091777|18586188|P2|Overall Study|Physician Decision|0
5395093|NCT03091777|18586189|P1|Overall Study|Physician Decision|1
5395094|NCT03091777|18586187|P3|Overall Study|Noncompliance with study drug|1
5395095|NCT03091777|18586188|P2|Overall Study|Noncompliance with study drug|3
5395096|NCT03091777|18586189|P1|Overall Study|Noncompliance with study drug|2
5395097|NCT03091777|18586187|P3|Overall Study|Lack of Efficacy|5
5395098|NCT03091777|18586188|P2|Overall Study|Lack of Efficacy|0
5395099|NCT03091777|18586189|P1|Overall Study|Lack of Efficacy|0
5395100|NCT03091777|18586187|P3|Overall Study|Lost to Follow-up|7
5395101|NCT03091777|18586188|P2|Overall Study|Lost to Follow-up|14
5395102|NCT03091777|18586189|P1|Overall Study|Lost to Follow-up|12
5395103|NCT03091777|18586187|P3|Overall Study|Protocol Violation|1
5395104|NCT03091777|18586188|P2|Overall Study|Protocol Violation|1
5395105|NCT03091777|18586189|P1|Overall Study|Protocol Violation|2
5395106|NCT03091777|18586187|P3|Overall Study|Withdrawal by Subject|6
5395107|NCT03091777|18586188|P2|Overall Study|Withdrawal by Subject|2
5395108|NCT03091777|18586189|P1|Overall Study|Withdrawal by Subject|4
5395109|NCT03091777|18586187|P3|Overall Study|Adverse Event|4
5395110|NCT03091777|18586188|P2|Overall Study|Adverse Event|1
5395111|NCT03091777|18586189|P1|Overall Study|Adverse Event|2
5395112|NCT03091777|18586187|P3|Overall Study|Pregnancy|0
5395113|NCT03091777|18586188|P2|Overall Study|Pregnancy|1
5395114|NCT03091777|18586189|P1|Overall Study|Pregnancy|2
5395115|NCT03091439|18586231|P2|Overall Study|Study Terminated by the Sponsor|0
5395116|NCT03091439|18586232|P1|Overall Study|Study Terminated by the Sponsor|1
5395117|NCT03091400|18586256|P2|Washout - 2 Weeks|Withdrawal by Subject|0
5395118|NCT03091400|18586257|P1|Washout - 2 Weeks|Withdrawal by Subject|1
5395119|NCT03091348|18586279|P2|Overall Study|Lost to Follow-up|1
5395120|NCT03091348|18586280|P1|Overall Study|Lost to Follow-up|2
5395121|NCT03091192|18586306|P2|Overall Study|Lost to Follow-up|0
5395122|NCT03091192|18586307|P1|Overall Study|Lost to Follow-up|1
5395123|NCT03091192|18586306|P2|Overall Study|Withdrawal by Subject|0
5395124|NCT03091192|18586307|P1|Overall Study|Withdrawal by Subject|2
5395125|NCT03091192|18586306|P2|Overall Study|Death|13
5395126|NCT03091192|18586307|P1|Overall Study|Death|9
5395127|NCT03091192|18586306|P2|Overall Study|Study terminated by sponsor|14
5395128|NCT03091192|18586307|P1|Overall Study|Study terminated by sponsor|21
5395129|NCT03090100|18586375|P2|Overall Study|Other|2
5395130|NCT03090100|18586376|P1|Overall Study|Other|2
5395131|NCT03090100|18586375|P2|Overall Study|Non-compliance|0
5395132|NCT03090100|18586376|P1|Overall Study|Non-compliance|2
5395133|NCT03090100|18586375|P2|Overall Study|Protocol Violation|6
5395134|NCT03090100|18586376|P1|Overall Study|Protocol Violation|2
5395135|NCT03090100|18586375|P2|Overall Study|Withdrawal by Subject|19
5395136|NCT03090100|18586376|P1|Overall Study|Withdrawal by Subject|7
5395137|NCT03090100|18586375|P2|Overall Study|Lost to Follow-up|2
5395138|NCT03090100|18586376|P1|Overall Study|Lost to Follow-up|2
5395139|NCT03090100|18586375|P2|Overall Study|Lack of Efficacy|7
5395140|NCT03090100|18586376|P1|Overall Study|Lack of Efficacy|2
5395141|NCT03090100|18586375|P2|Overall Study|Pregnancy|1
5395142|NCT03090100|18586376|P1|Overall Study|Pregnancy|1
5395143|NCT03090100|18586375|P2|Overall Study|Adverse Event|11
5395144|NCT03090100|18586376|P1|Overall Study|Adverse Event|9
5395145|NCT03089944|18586416|P1|Overall Study|Other|1
5395146|NCT03089944|18586416|P1|Overall Study|Adverse Event|1
5395147|NCT03089944|18586416|P1|Overall Study|Withdrew Consent|2
5395148|NCT03089944|18586416|P1|Overall Study|Lost to Follow-up|8
5395149|NCT03089853|18586463|P2|Overall Study|Lost to Follow-up|1
5395150|NCT03089853|18586464|P1|Overall Study|Lost to Follow-up|2
5395151|NCT03089580|18586486|P1|Overall Study|Lost to Follow-up|2
5395152|NCT03089216|18586497|P4|Overall Study|Adverse Event|1
5395153|NCT03089216|18586498|P3|Overall Study|Adverse Event|0
5395154|NCT03089216|18586499|P2|Overall Study|Adverse Event|0
5395155|NCT03089216|18586500|P1|Overall Study|Adverse Event|0
5395156|NCT03088917|18586514|P1|Overall Study|Moved outside study region|50
5395157|NCT03088917|18586514|P1|Overall Study|Severe comorbidity/short life expectancy|5
5395158|NCT03088917|18586514|P1|Overall Study|Contact not established|13
5395159|NCT03088917|18586514|P1|Overall Study|Refuse re-evaluation|13
5395160|NCT03088917|18586514|P1|Overall Study|In care/cured elsewhere|15
5395161|NCT03087643|18586584|P2|Overall Study|Death|2
5395162|NCT03087643|18586585|P1|Overall Study|Death|2
5395163|NCT03087643|18586584|P2|Overall Study|Withdrawal by Subject|4
5395164|NCT03087643|18586585|P1|Overall Study|Withdrawal by Subject|2
5395165|NCT03087513|18586612|P1|Second Intervention After 3 hr Washout|Equipment malfunction|2
5395166|NCT03086551|18586659|P2|Washout|Withdrawal by Subject|1
5395167|NCT03086551|18586660|P1|Washout|Withdrawal by Subject|2
5395168|NCT03086551|18586659|P2|Washout|Lost to Follow-up|2
5395169|NCT03086551|18586660|P1|Washout|Lost to Follow-up|1
5395170|NCT03086551|18586659|P2|First Intervention|Lost to Follow-up|1
5395171|NCT03086551|18586660|P1|First Intervention|Lost to Follow-up|0
5395172|NCT03086551|18586659|P2|First Intervention|Failure to meet inclusion criterion|0
5395173|NCT03086551|18586660|P1|First Intervention|Failure to meet inclusion criterion|1
5395174|NCT03086447|18586676|P2|Overall Study|Lens Discomfort|1
5395175|NCT03086447|18586677|P1|Overall Study|Lens Discomfort|2
5395176|NCT03086447|18586676|P2|Overall Study|Adverse Event|0
5395177|NCT03086447|18586677|P1|Overall Study|Adverse Event|3
5395178|NCT03086447|18586676|P2|Overall Study|Lost to Follow-up|1
5395179|NCT03086447|18586677|P1|Overall Study|Lost to Follow-up|0
5395180|NCT03086447|18586676|P2|Overall Study|Protocol Violation|4
5395181|NCT03086447|18586677|P1|Overall Study|Protocol Violation|2
5395182|NCT03086447|18586676|P2|Overall Study|Test Article No Longer Available|0
5395183|NCT03086447|18586677|P1|Overall Study|Test Article No Longer Available|1
5395184|NCT03086447|18586676|P2|Overall Study|Unsatisfactory Lens Fitting|1
5395185|NCT03086447|18586677|P1|Overall Study|Unsatisfactory Lens Fitting|0
5395186|NCT03086447|18586676|P2|Overall Study|Lens Damage|6
5395187|NCT03086447|18586677|P1|Overall Study|Lens Damage|1
5395188|NCT03086447|18586676|P2|Overall Study|Product quality complaint|1
5395189|NCT03086447|18586677|P1|Overall Study|Product quality complaint|0
5395190|NCT03086447|18586676|P2|Overall Study|Lost Lens|5
5395191|NCT03086447|18586677|P1|Overall Study|Lost Lens|2
5395192|NCT03086447|18586676|P2|Overall Study|No Longer Meets Eligibility Criteria|1
5395193|NCT03086447|18586677|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5395194|NCT03086343|18586735|P2|Overall Study|Missing|1
5395195|NCT03086343|18586736|P1|Overall Study|Missing|0
5395196|NCT03086343|18586735|P2|Overall Study|Other, not specified|4
5395197|NCT03086343|18586736|P1|Overall Study|Other, not specified|8
5395198|NCT03086343|18586735|P2|Overall Study|Lack of Efficacy|6
5395199|NCT03086343|18586736|P1|Overall Study|Lack of Efficacy|4
5395200|NCT03086343|18586735|P2|Overall Study|Lost to Follow-up|1
5395201|NCT03086343|18586736|P1|Overall Study|Lost to Follow-up|3
5395202|NCT03086343|18586735|P2|Overall Study|Withdrawal by Subject|6
5395203|NCT03086343|18586736|P1|Overall Study|Withdrawal by Subject|10
5395204|NCT03086343|18586735|P2|Overall Study|Adverse Event|7
5395205|NCT03086343|18586736|P1|Overall Study|Adverse Event|7
5395206|NCT03086330|18586748|P2|Overall Study|Lost to Follow-up|2
5395207|NCT03086330|18586749|P1|Overall Study|Lost to Follow-up|1
5395208|NCT03086330|18586748|P2|Overall Study|Withdrawal by Subject|2
5395209|NCT03086330|18586749|P1|Overall Study|Withdrawal by Subject|3
5395210|NCT03086135|18586946|P1|Overall Study|Lost to Follow-up|2
5395211|NCT03086135|18586946|P1|Overall Study|Adverse Event|1
5395212|NCT03086018|18586973|P1|Final Testing for End of Trial|Withdrawal by Subject|1
5395213|NCT03086018|18586973|P1|Final Testing for End of Trial|Adverse Event|1
5395214|NCT03085914|18586988|P7|Overall Study|Ongoing in Trial|3
5395215|NCT03085914|18586989|P6|Overall Study|Ongoing in Trial|3
5395216|NCT03085914|18586990|P5|Overall Study|Ongoing in Trial|4
5395217|NCT03085914|18586991|P4|Overall Study|Ongoing in Trial|3
5395218|NCT03085914|18586992|P3|Overall Study|Ongoing in Trial|5
5395219|NCT03085914|18586993|P2|Overall Study|Ongoing in Trial|0
5395220|NCT03085914|18586994|P1|Overall Study|Ongoing in Trial|1
5395221|NCT03085914|18586988|P7|Overall Study|Other Unspecified|4
5395222|NCT03085914|18586989|P6|Overall Study|Other Unspecified|2
5395223|NCT03085914|18586990|P5|Overall Study|Other Unspecified|2
5395224|NCT03085914|18586991|P4|Overall Study|Other Unspecified|3
5395225|NCT03085914|18586992|P3|Overall Study|Other Unspecified|1
5395226|NCT03085914|18586993|P2|Overall Study|Other Unspecified|2
5395227|NCT03085914|18586994|P1|Overall Study|Other Unspecified|2
5395228|NCT03085914|18586988|P7|Overall Study|Withdrawal by Subject|1
5395229|NCT03085914|18586989|P6|Overall Study|Withdrawal by Subject|0
5395230|NCT03085914|18586990|P5|Overall Study|Withdrawal by Subject|2
5395231|NCT03085914|18586991|P4|Overall Study|Withdrawal by Subject|2
5395232|NCT03085914|18586992|P3|Overall Study|Withdrawal by Subject|0
5395233|NCT03085914|18586993|P2|Overall Study|Withdrawal by Subject|1
5395234|NCT03085914|18586994|P1|Overall Study|Withdrawal by Subject|1
5395235|NCT03085914|18586988|P7|Overall Study|Lost to Follow-up|1
5395236|NCT03085914|18586989|P6|Overall Study|Lost to Follow-up|1
5395237|NCT03085914|18586990|P5|Overall Study|Lost to Follow-up|0
5395238|NCT03085914|18586991|P4|Overall Study|Lost to Follow-up|0
5395239|NCT03085914|18586992|P3|Overall Study|Lost to Follow-up|1
5395240|NCT03085914|18586993|P2|Overall Study|Lost to Follow-up|0
5395241|NCT03085914|18586994|P1|Overall Study|Lost to Follow-up|1
5395242|NCT03085914|18586988|P7|Overall Study|Death|2
5395243|NCT03085914|18586989|P6|Overall Study|Death|2
5395244|NCT03085914|18586990|P5|Overall Study|Death|5
5395245|NCT03085914|18586991|P4|Overall Study|Death|1
5395246|NCT03085914|18586992|P3|Overall Study|Death|4
5395247|NCT03085914|18586993|P2|Overall Study|Death|6
5395248|NCT03085914|18586994|P1|Overall Study|Death|4
5395249|NCT03085797|18587078|P2|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1
5395250|NCT03085797|18587079|P1|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0
5395251|NCT03085797|18587078|P2|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17
5395252|NCT03085797|18587079|P1|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16
5395253|NCT03085797|18587078|P2|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0
5395254|NCT03085797|18587079|P1|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1
5395255|NCT03085238|18587101|P1|Overall Study|Death|2
5395256|NCT03085238|18587101|P1|Overall Study|Adverse Event|2
5395257|NCT03085017|18587128|P2|Overall Study|Death|3
5395258|NCT03085017|18587129|P1|Overall Study|Death|0
5395259|NCT03084315|18587155|P2|Overall Study|Withdrawal by Subject|2
5395260|NCT03084315|18587156|P1|Overall Study|Withdrawal by Subject|2
5395261|NCT03084315|18587155|P2|Overall Study|Lost to Follow-up|7
5395262|NCT03084315|18587156|P1|Overall Study|Lost to Follow-up|8
5395263|NCT03083990|18587166|P2|Overall Study|Adverse Event|0
5395264|NCT03083990|18587167|P1|Overall Study|Adverse Event|1
5395265|NCT03083639|18587249|P2|Washout Period (at Least 6 Days)|Lost to Follow-up|0
5395266|NCT03083639|18587250|P1|Washout Period (at Least 6 Days)|Lost to Follow-up|1
5395267|NCT03083639|18587249|P2|Washout Period (at Least 6 Days)|Pregnancy|1
5395268|NCT03083639|18587250|P1|Washout Period (at Least 6 Days)|Pregnancy|0
5395269|NCT03083483|18587263|P3|Overall Study|technological issues|1
5395270|NCT03083483|18587264|P2|Overall Study|technological issues|0
5395271|NCT03083483|18587265|P1|Overall Study|technological issues|1
5395272|NCT03083483|18587263|P3|Overall Study|Lost to Follow-up|1
5395273|NCT03083483|18587264|P2|Overall Study|Lost to Follow-up|1
5395274|NCT03083483|18587265|P1|Overall Study|Lost to Follow-up|2
5395275|NCT03083483|18587263|P3|Overall Study|Adverse Event|1
5395276|NCT03083483|18587264|P2|Overall Study|Adverse Event|1
5395277|NCT03083483|18587265|P1|Overall Study|Adverse Event|1
5395278|NCT03083470|18587284|P5|Overall Study|Withdrawal by Subject|1
5395279|NCT03083470|18587285|P4|Overall Study|Withdrawal by Subject|0
5395280|NCT03083470|18587286|P3|Overall Study|Withdrawal by Subject|0
5395281|NCT03083470|18587287|P2|Overall Study|Withdrawal by Subject|0
5395282|NCT03083470|18587288|P1|Overall Study|Withdrawal by Subject|0
5395283|NCT03083470|18587284|P5|Overall Study|Lost to Follow-up|1
5395284|NCT03083470|18587285|P4|Overall Study|Lost to Follow-up|0
5395285|NCT03083470|18587286|P3|Overall Study|Lost to Follow-up|0
5395286|NCT03083470|18587287|P2|Overall Study|Lost to Follow-up|0
5395287|NCT03083470|18587288|P1|Overall Study|Lost to Follow-up|0
5395288|NCT03082599|18587336|P2|Overall Study|Lost to Follow-up|0
5395289|NCT03082599|18587337|P1|Overall Study|Lost to Follow-up|1
5395290|NCT03080961|18587409|P1|Overall Study|Withdrawal by Subject|3
5395291|NCT03080493|18587420|P2|Overall Study|Randomization error (parity group)|1
5395292|NCT03080493|18587421|P1|Overall Study|Randomization error (parity group)|0
5395293|NCT03080493|18587420|P2|Overall Study|Adverse Event|1
5395294|NCT03080493|18587421|P1|Overall Study|Adverse Event|0
5395295|NCT03080493|18587420|P2|Overall Study|Did not provide NRS pain results|0
5395296|NCT03080493|18587421|P1|Overall Study|Did not provide NRS pain results|1
5395297|NCT03080454|18587437|P1|Anodal FU (7 Days)|Lost to Follow-up|4
5395298|NCT03080454|18587437|P1|Anodal Doublestim (5 Days)|Adverse Event|1
5395299|NCT03080454|18587437|P1|Baseline|Adverse Event|2
5395300|NCT03078816|18587504|P1|Overall Study|Withdrawal by Subject|1
5395301|NCT03078582|18587554|P2|Overall Study|Adverse Event|8
5395302|NCT03078582|18587555|P1|Overall Study|Adverse Event|0
5395303|NCT03078556|18587575|P4|Washout Period 1 (7 Days)|Physician Decision|0
5395304|NCT03078556|18587576|P3|Washout Period 1 (7 Days)|Physician Decision|0
5395305|NCT03078556|18587577|P2|Washout Period 1 (7 Days)|Physician Decision|1
5395306|NCT03078556|18587578|P1|Washout Period 1 (7 Days)|Physician Decision|0
5395307|NCT03078556|18587575|P4|Washout Period 1 (7 Days)|Adverse Event|1
5395308|NCT03078556|18587576|P3|Washout Period 1 (7 Days)|Adverse Event|0
5395309|NCT03078556|18587577|P2|Washout Period 1 (7 Days)|Adverse Event|1
5395310|NCT03078556|18587578|P1|Washout Period 1 (7 Days)|Adverse Event|0
5395311|NCT03078556|18587575|P4|Washout Period 1 (7 Days)|Lost to Follow-up|0
5395312|NCT03078556|18587576|P3|Washout Period 1 (7 Days)|Lost to Follow-up|1
5395313|NCT03078556|18587577|P2|Washout Period 1 (7 Days)|Lost to Follow-up|0
5395314|NCT03078556|18587578|P1|Washout Period 1 (7 Days)|Lost to Follow-up|2
5395315|NCT03078556|18587575|P4|Treatment Period 1 (4 Days)|Adverse Event|0
5395316|NCT03078556|18587576|P3|Treatment Period 1 (4 Days)|Adverse Event|0
5395317|NCT03078556|18587577|P2|Treatment Period 1 (4 Days)|Adverse Event|1
5395318|NCT03078556|18587578|P1|Treatment Period 1 (4 Days)|Adverse Event|0
5395319|NCT03078478|18587722|P2|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
5395320|NCT03078478|18587723|P1|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
5395321|NCT03078478|18587722|P2|Maintencance Period 2 (36 Weeks)|Death|6
5395322|NCT03078478|18587723|P1|Maintencance Period 2 (36 Weeks)|Death|4
5395323|NCT03078478|18587722|P2|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
5395324|NCT03078478|18587723|P1|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
5395325|NCT03078478|18587722|P2|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
5395326|NCT03078478|18587723|P1|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
5395327|NCT03078478|18587722|P2|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
5395328|NCT03078478|18587723|P1|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
5395329|NCT03078478|18587722|P2|Maintenance Period 1 (36 Weeks)|Death|3
5395330|NCT03078478|18587723|P1|Maintenance Period 1 (36 Weeks)|Death|3
5395331|NCT03078478|18587722|P2|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
5395332|NCT03078478|18587723|P1|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
5395333|NCT03078478|18587722|P2|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
5395334|NCT03078478|18587723|P1|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
5395335|NCT03077919|18587809|P2|Overall Study|Lost to Follow-up|1
5395336|NCT03077919|18587810|P1|Overall Study|Lost to Follow-up|4
5395337|NCT03077724|18587870|P2|Overall Study|Withdrawal by Subject|1
5395338|NCT03077724|18587871|P1|Overall Study|Withdrawal by Subject|3
5395339|NCT03077724|18587870|P2|Overall Study|Lost to Follow-up|1
5395340|NCT03077724|18587871|P1|Overall Study|Lost to Follow-up|5
5395341|NCT03077711|18587883|P2|Overall Study|noncompliant taking medication|0
5395342|NCT03077711|18587884|P1|Overall Study|noncompliant taking medication|2
5395343|NCT03077711|18587883|P2|Overall Study|Lost to Follow-up|2
5395344|NCT03077711|18587884|P1|Overall Study|Lost to Follow-up|2
5395345|NCT03077659|18587903|P3|Overall Study|Withdrawal by Subject|1
5395346|NCT03077659|18587904|P2|Overall Study|Withdrawal by Subject|0
5395347|NCT03077659|18587905|P1|Overall Study|Withdrawal by Subject|0
5395348|NCT03077607|18587936|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
5395349|NCT03077607|18587937|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
5395350|NCT03077607|18587936|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
5395351|NCT03077607|18587937|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
5395352|NCT03077607|18587936|P2|Period 1 (15 Days)|Death|0
5395353|NCT03077607|18587937|P1|Period 1 (15 Days)|Death|1
5395354|NCT03077607|18587936|P2|Period 1 (15 Days)|Adverse Event|0
5395355|NCT03077607|18587937|P1|Period 1 (15 Days)|Adverse Event|1
5395356|NCT03077438|18588005|P2|Overall Study|Lost to Follow-up|3
5395357|NCT03077438|18588006|P1|Overall Study|Lost to Follow-up|6
5395358|NCT03077438|18588005|P2|Overall Study|Withdrawal by Subject|6
5395359|NCT03077438|18588006|P1|Overall Study|Withdrawal by Subject|3
5395360|NCT03077438|18588005|P2|Overall Study|Protocol Violation|5
5395361|NCT03077438|18588006|P1|Overall Study|Protocol Violation|3
5395362|NCT03076996|18588047|P1|Overall Study|Literacy precluded participation|1
5395363|NCT03076996|18588047|P1|Overall Study|Lost to Follow-up|3
5395364|NCT03076996|18588047|P1|Overall Study|Withdrawal by Subject|2
5395365|NCT03076970|18588073|P6|Period 3|Failure to meet I/E criteria|0
5395366|NCT03076970|18588074|P5|Period 3|Failure to meet I/E criteria|1
5395367|NCT03076970|18588075|P4|Period 3|Failure to meet I/E criteria|0
5395368|NCT03076970|18588076|P3|Period 3|Failure to meet I/E criteria|0
5395369|NCT03076970|18588077|P2|Period 3|Failure to meet I/E criteria|0
5395370|NCT03076970|18588078|P1|Period 3|Failure to meet I/E criteria|0
5395371|NCT03076970|18588073|P6|Period 3|Withdrawal by Subject|1
5395372|NCT03076970|18588074|P5|Period 3|Withdrawal by Subject|0
5395373|NCT03076970|18588075|P4|Period 3|Withdrawal by Subject|0
5395374|NCT03076970|18588076|P3|Period 3|Withdrawal by Subject|0
5395375|NCT03076970|18588077|P2|Period 3|Withdrawal by Subject|0
5395376|NCT03076970|18588078|P1|Period 3|Withdrawal by Subject|0
5395377|NCT03076970|18588073|P6|Washout Period 2|Adverse Event|0
5395378|NCT03076970|18588074|P5|Washout Period 2|Adverse Event|1
5395379|NCT03076970|18588075|P4|Washout Period 2|Adverse Event|0
5395380|NCT03076970|18588076|P3|Washout Period 2|Adverse Event|0
5395381|NCT03076970|18588077|P2|Washout Period 2|Adverse Event|0
5395382|NCT03076970|18588078|P1|Washout Period 2|Adverse Event|0
5395383|NCT03076515|18588130|P2|Overall Study|DMC decision based on interim analysis|29
5395384|NCT03076515|18588131|P1|Overall Study|DMC decision based on interim analysis|25
5395385|NCT03076190|18588150|P2|Overall Study|Excluded from Analysis (zero duration ev|7
5395386|NCT03076190|18588151|P1|Overall Study|Excluded from Analysis (zero duration ev|9
5395387|NCT03076190|18588150|P2|Overall Study|Lost to Follow-up|34
5395388|NCT03076190|18588151|P1|Overall Study|Lost to Follow-up|9
5395389|NCT03075904|18588164|P1|Overall Study|Need for Medication not Permitted|1
5395390|NCT03075904|18588164|P1|Overall Study|Physician Decision|3
5395391|NCT03075891|18588174|P2|Overall Study|Drug abuse relapse issue|1
5395392|NCT03075891|18588175|P1|Overall Study|Drug abuse relapse issue|0
5395393|NCT03075891|18588174|P2|Overall Study|Patient requiring study withdrawal|1
5395394|NCT03075891|18588175|P1|Overall Study|Patient requiring study withdrawal|0
5395395|NCT03075891|18588174|P2|Overall Study|Other visits not performed (no time)|0
5395396|NCT03075891|18588175|P1|Overall Study|Other visits not performed (no time)|1
5395397|NCT03075891|18588174|P2|Overall Study|Pregnancy|1
5395398|NCT03075891|18588175|P1|Overall Study|Pregnancy|3
5395399|NCT03075891|18588174|P2|Overall Study|Lost to Follow-up|0
5395400|NCT03075891|18588175|P1|Overall Study|Lost to Follow-up|1
5395401|NCT03075891|18588174|P2|Overall Study|Withdrawal by Subject|6
5395402|NCT03075891|18588175|P1|Overall Study|Withdrawal by Subject|3
5395403|NCT03075891|18588174|P2|Overall Study|Adverse Event|4
5395404|NCT03075891|18588175|P1|Overall Study|Adverse Event|1
5395405|NCT03075878|18588181|P1|Overall Study|Physician Decision|1
5395406|NCT03075839|18588189|P1|Overall Study|Lost to Follow-up|4
5395407|NCT03075644|18588197|P2|Overall Study|Withdrawal by Subject|1
5395408|NCT03075644|18588198|P1|Overall Study|Withdrawal by Subject|1
5395409|NCT03075527|18588268|P1|Overall Study|Ongoing treatment|2
5395410|NCT03075410|18588292|P9|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5395411|NCT03075410|18588293|P8|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5395412|NCT03075410|18588294|P7|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5395413|NCT03075410|18588295|P6|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5395414|NCT03075410|18588296|P5|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5395415|NCT03075410|18588297|P4|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5395416|NCT03075410|18588298|P3|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5395417|NCT03075410|18588299|P2|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
5395418|NCT03075410|18588300|P1|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
5395419|NCT03075410|18588292|P9|Part A-Period 2 (14 Days)|Personal reasons|0
5395420|NCT03075410|18588293|P8|Part A-Period 2 (14 Days)|Personal reasons|0
5395421|NCT03075410|18588294|P7|Part A-Period 2 (14 Days)|Personal reasons|0
5395422|NCT03075410|18588295|P6|Part A-Period 2 (14 Days)|Personal reasons|0
5395423|NCT03075410|18588296|P5|Part A-Period 2 (14 Days)|Personal reasons|0
5395424|NCT03075410|18588297|P4|Part A-Period 2 (14 Days)|Personal reasons|0
5395425|NCT03075410|18588298|P3|Part A-Period 2 (14 Days)|Personal reasons|1
5395426|NCT03075410|18588299|P2|Part A-Period 2 (14 Days)|Personal reasons|0
5395427|NCT03075410|18588300|P1|Part A-Period 2 (14 Days)|Personal reasons|1
5395428|NCT03075163|18588466|P2|Overall Study|not eligible for treatment limb|138
5395429|NCT03075163|18588467|P1|Overall Study|not eligible for treatment limb|138
5395430|NCT03074500|18588514|P3|Overall Study|Adverse Event|1
5395431|NCT03074500|18588515|P2|Overall Study|Adverse Event|0
5395432|NCT03074500|18588516|P1|Overall Study|Adverse Event|0
5395433|NCT03074500|18588514|P3|Overall Study|Lack of Efficacy|0
5395434|NCT03074500|18588515|P2|Overall Study|Lack of Efficacy|1
5395435|NCT03074500|18588516|P1|Overall Study|Lack of Efficacy|0
5395436|NCT03074500|18588514|P3|Overall Study|Lost to Follow-up|0
5395437|NCT03074500|18588515|P2|Overall Study|Lost to Follow-up|0
5395438|NCT03074500|18588516|P1|Overall Study|Lost to Follow-up|1
5395439|NCT03074331|18588553|P1|Overall Study|Withdrew Consent|1
5395440|NCT03074331|18588553|P1|Overall Study|Lost to Follow-up|5
5395441|NCT03074331|18588553|P1|Overall Study|Enrolled but Not Treated|1
5395442|NCT03074162|18588565|P6|Period 3|Withdrawal by Subject|0
5395443|NCT03074162|18588566|P5|Period 3|Withdrawal by Subject|1
5395444|NCT03074162|18588567|P4|Period 3|Withdrawal by Subject|0
5395445|NCT03074162|18588568|P3|Period 3|Withdrawal by Subject|0
5395446|NCT03074162|18588569|P2|Period 3|Withdrawal by Subject|0
5395447|NCT03074162|18588570|P1|Period 3|Withdrawal by Subject|1
5395448|NCT03074162|18588565|P6|Period 2 Including Washout 2|Withdrawal by Subject|1
5395449|NCT03074162|18588566|P5|Period 2 Including Washout 2|Withdrawal by Subject|0
5395450|NCT03074162|18588567|P4|Period 2 Including Washout 2|Withdrawal by Subject|0
5395451|NCT03074162|18588568|P3|Period 2 Including Washout 2|Withdrawal by Subject|1
5395452|NCT03074162|18588569|P2|Period 2 Including Washout 2|Withdrawal by Subject|0
5395453|NCT03074162|18588570|P1|Period 2 Including Washout 2|Withdrawal by Subject|0
5395454|NCT03074162|18588565|P6|Period 1 Including Washout 1|Withdrawal by Subject|0
5395455|NCT03074162|18588566|P5|Period 1 Including Washout 1|Withdrawal by Subject|0
5395456|NCT03074162|18588567|P4|Period 1 Including Washout 1|Withdrawal by Subject|0
5395457|NCT03074162|18588568|P3|Period 1 Including Washout 1|Withdrawal by Subject|1
5395458|NCT03074162|18588569|P2|Period 1 Including Washout 1|Withdrawal by Subject|0
5395459|NCT03074162|18588570|P1|Period 1 Including Washout 1|Withdrawal by Subject|0
5395460|NCT03073798|18588632|P1|Overall Study|Withdrawal by Subject|1
5395461|NCT03073798|18588632|P1|Overall Study|Adverse Event|1
5395462|NCT03073213|18588670|P3|Multiple Dose Period|Protocol Violation|1
5395463|NCT03073213|18588671|P2|Multiple Dose Period|Protocol Violation|0
5395464|NCT03073213|18588672|P1|Multiple Dose Period|Protocol Violation|0
5395465|NCT03073200|18588687|P3|Overall Study|Lack of Efficacy|0
5395466|NCT03073200|18588688|P2|Overall Study|Lack of Efficacy|0
5395467|NCT03073200|18588689|P1|Overall Study|Lack of Efficacy|1
5395468|NCT03073200|18588687|P3|Overall Study|Protocol Violation|0
5395469|NCT03073200|18588688|P2|Overall Study|Protocol Violation|0
5395470|NCT03073200|18588689|P1|Overall Study|Protocol Violation|2
5395471|NCT03073200|18588687|P3|Overall Study|Site closed by sponsor|1
5395472|NCT03073200|18588688|P2|Overall Study|Site closed by sponsor|0
5395473|NCT03073200|18588689|P1|Overall Study|Site closed by sponsor|0
5395474|NCT03073200|18588687|P3|Overall Study|Withdrawal by parent/guardian|1
5395475|NCT03073200|18588688|P2|Overall Study|Withdrawal by parent/guardian|1
5395476|NCT03073200|18588689|P1|Overall Study|Withdrawal by parent/guardian|0
5395477|NCT03073200|18588687|P3|Overall Study|Continuing treatment (Ongoing)|28
5395478|NCT03073200|18588688|P2|Overall Study|Continuing treatment (Ongoing)|106
5395479|NCT03073200|18588689|P1|Overall Study|Continuing treatment (Ongoing)|48
5395480|NCT03073200|18588687|P3|Overall Study|Withdrawal by Subject|0
5395481|NCT03073200|18588688|P2|Overall Study|Withdrawal by Subject|3
5395482|NCT03073200|18588689|P1|Overall Study|Withdrawal by Subject|3
5395483|NCT03073200|18588687|P3|Overall Study|Participant had Crohns disease|0
5395484|NCT03073200|18588688|P2|Overall Study|Participant had Crohns disease|1
5395485|NCT03073200|18588689|P1|Overall Study|Participant had Crohns disease|0
5395486|NCT03073200|18588687|P3|Overall Study|Lost to Follow-up|0
5395487|NCT03073200|18588688|P2|Overall Study|Lost to Follow-up|2
5395488|NCT03073200|18588689|P1|Overall Study|Lost to Follow-up|1
5395489|NCT03073200|18588687|P3|Overall Study|Adverse Event|0
5395490|NCT03073200|18588688|P2|Overall Study|Adverse Event|2
5395491|NCT03073200|18588689|P1|Overall Study|Adverse Event|0
5395492|NCT03073109|18588751|P2|Overall Study|Lost to Follow-up|1
5395493|NCT03073109|18588752|P1|Overall Study|Lost to Follow-up|8
5395494|NCT03073109|18588751|P2|Overall Study|Other|0
5395495|NCT03073109|18588752|P1|Overall Study|Other|2
5395496|NCT03073109|18588751|P2|Overall Study|Adverse Event|1
5395497|NCT03073109|18588752|P1|Overall Study|Adverse Event|0
5395498|NCT03072875|18588780|P1|Overall Study|Lost to Follow-up|1
5395499|NCT03072719|18588796|P2|Overall Study|Adverse Event|1
5395500|NCT03072719|18588797|P1|Overall Study|Adverse Event|1
5395501|NCT03071276|18588822|P1|Overall Study|Lack of Efficacy|14
5395502|NCT03071276|18588822|P1|Overall Study|Adverse Event|1
5395503|NCT03071263|18588830|P2|Overall Study|Participant moved to another city|1
5395504|NCT03071263|18588831|P1|Overall Study|Participant moved to another city|0
5395505|NCT03071263|18588830|P2|Overall Study|Physician Decision|0
5395506|NCT03071263|18588831|P1|Overall Study|Physician Decision|1
5395507|NCT03071263|18588830|P2|Overall Study|Withdrawal by Subject|3
5395508|NCT03071263|18588831|P1|Overall Study|Withdrawal by Subject|1
5395509|NCT03071263|18588830|P2|Overall Study|Adverse Event|3
5395510|NCT03071263|18588831|P1|Overall Study|Adverse Event|1
5395511|NCT03070964|18588855|P1|Overall Study|Adverse Event|1
5395512|NCT03070964|18588855|P1|Overall Study|Withdrawal by Subject|1
5395513|NCT03070964|18588855|P1|Overall Study|Physician Decision|1
5395514|NCT03070964|18588855|P1|Overall Study|Never treated|1
5395515|NCT03070964|18588855|P1|Overall Study|Treatment-unrelated adverse event|2
5395516|NCT03070964|18588855|P1|Overall Study|Progressive disease|8
5395517|NCT03070782|18588866|P6|Overall Study|Investigator Judgement|0
5395518|NCT03070782|18588867|P5|Overall Study|Investigator Judgement|0
5395519|NCT03070782|18588868|P4|Overall Study|Investigator Judgement|1
5395520|NCT03070782|18588869|P3|Overall Study|Investigator Judgement|0
5395521|NCT03070782|18588870|P2|Overall Study|Investigator Judgement|0
5395522|NCT03070782|18588871|P1|Overall Study|Investigator Judgement|0
5395523|NCT03070782|18588866|P6|Overall Study|Pregnancy|0
5395524|NCT03070782|18588867|P5|Overall Study|Pregnancy|0
5395525|NCT03070782|18588868|P4|Overall Study|Pregnancy|1
5395526|NCT03070782|18588869|P3|Overall Study|Pregnancy|0
5395527|NCT03070782|18588870|P2|Overall Study|Pregnancy|0
5395528|NCT03070782|18588871|P1|Overall Study|Pregnancy|0
5395529|NCT03070782|18588866|P6|Overall Study|Ineligibility|1
5395530|NCT03070782|18588867|P5|Overall Study|Ineligibility|0
5395531|NCT03070782|18588868|P4|Overall Study|Ineligibility|1
5395532|NCT03070782|18588869|P3|Overall Study|Ineligibility|0
5395533|NCT03070782|18588870|P2|Overall Study|Ineligibility|0
5395534|NCT03070782|18588871|P1|Overall Study|Ineligibility|0
5395535|NCT03070782|18588866|P6|Overall Study|Reason Not Specified|1
5395536|NCT03070782|18588867|P5|Overall Study|Reason Not Specified|2
5395537|NCT03070782|18588868|P4|Overall Study|Reason Not Specified|1
5395538|NCT03070782|18588869|P3|Overall Study|Reason Not Specified|0
5395539|NCT03070782|18588870|P2|Overall Study|Reason Not Specified|0
5395540|NCT03070782|18588871|P1|Overall Study|Reason Not Specified|2
5395541|NCT03070782|18588866|P6|Overall Study|Withdrawal by Subject|3
5395542|NCT03070782|18588867|P5|Overall Study|Withdrawal by Subject|4
5395543|NCT03070782|18588868|P4|Overall Study|Withdrawal by Subject|0
5395544|NCT03070782|18588869|P3|Overall Study|Withdrawal by Subject|1
5395545|NCT03070782|18588870|P2|Overall Study|Withdrawal by Subject|1
5395546|NCT03070782|18588871|P1|Overall Study|Withdrawal by Subject|2
5395547|NCT03070782|18588866|P6|Overall Study|Adverse Event|2
5395548|NCT03070782|18588867|P5|Overall Study|Adverse Event|6
5395549|NCT03070782|18588868|P4|Overall Study|Adverse Event|1
5395550|NCT03070782|18588869|P3|Overall Study|Adverse Event|3
5395551|NCT03070782|18588870|P2|Overall Study|Adverse Event|0
5395552|NCT03070782|18588871|P1|Overall Study|Adverse Event|3
5395553|NCT03070483|18589111|P1|Overall Study|Lost to Follow-up|2
5395554|NCT03070431|18589158|P1|Overall Study|Lost to Follow-up|2
5395555|NCT03070431|18589158|P1|Overall Study|Withdrawal by Subject|2
5395556|NCT03070171|18589180|P2|Treatment Period 4 + Washout|Withdrawal by Subject|1
5395557|NCT03070171|18589181|P1|Treatment Period 4 + Washout|Withdrawal by Subject|0
5395558|NCT03070171|18589180|P2|Treatment Period 2 + Washout|Other Adverse Event|1
5395559|NCT03070171|18589181|P1|Treatment Period 2 + Washout|Other Adverse Event|0
5395560|NCT03070002|18589197|P1|Follow up for 2 Years|Death|1
5395561|NCT03069989|18589205|P2|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
5395562|NCT03069989|18589206|P1|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
5395563|NCT03069482|18589313|P2|Overall Study|Physician Decision|0
5395564|NCT03069482|18589314|P1|Overall Study|Physician Decision|1
5395565|NCT03069482|18589313|P2|Overall Study|Lost to Follow-up|1
5395566|NCT03069482|18589314|P1|Overall Study|Lost to Follow-up|0
5395567|NCT03069365|18589424|P1|Overall Study|Adverse Event|1
5395568|NCT03069352|18589432|P2|Overall Study|Ongoing|40
5395569|NCT03069352|18589433|P1|Overall Study|Ongoing|12
5395570|NCT03069313|18589475|P1|Overall Study|Adverse Event|5
5395571|NCT03068767|18589513|P2|Overall Study|Protocol Violation|0
5395572|NCT03068767|18589514|P1|Overall Study|Protocol Violation|3
5395573|NCT03068767|18589513|P2|Overall Study|Lost to Follow-up|3
5395574|NCT03068767|18589514|P1|Overall Study|Lost to Follow-up|7
5395575|NCT03068754|18589524|P4|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
5395576|NCT03068754|18589525|P3|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
5395577|NCT03068754|18589526|P2|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
5395578|NCT03068754|18589527|P1|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
5395579|NCT03068754|18589524|P4|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
5395580|NCT03068754|18589525|P3|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
5395581|NCT03068754|18589526|P2|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
5395582|NCT03068754|18589527|P1|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
5395583|NCT03068754|18589524|P4|Open Label Extension Period (OLE)|Withdrawal by Subject|0
5395584|NCT03068754|18589525|P3|Open Label Extension Period (OLE)|Withdrawal by Subject|5
5395585|NCT03068754|18589526|P2|Open Label Extension Period (OLE)|Withdrawal by Subject|0
5395586|NCT03068754|18589527|P1|Open Label Extension Period (OLE)|Withdrawal by Subject|0
5395587|NCT03068754|18589524|P4|Open Label Extension Period (OLE)|Disease progression|1
5395588|NCT03068754|18589525|P3|Open Label Extension Period (OLE)|Disease progression|3
5395589|NCT03068754|18589526|P2|Open Label Extension Period (OLE)|Disease progression|0
5395590|NCT03068754|18589527|P1|Open Label Extension Period (OLE)|Disease progression|0
5395591|NCT03068754|18589524|P4|Open Label Extension Period (OLE)|Death|1
5395592|NCT03068754|18589525|P3|Open Label Extension Period (OLE)|Death|0
5395593|NCT03068754|18589526|P2|Open Label Extension Period (OLE)|Death|0
5395594|NCT03068754|18589527|P1|Open Label Extension Period (OLE)|Death|0
5395595|NCT03068754|18589524|P4|Open Label Extension Period (OLE)|Adverse Event|1
5395596|NCT03068754|18589525|P3|Open Label Extension Period (OLE)|Adverse Event|0
5395597|NCT03068754|18589526|P2|Open Label Extension Period (OLE)|Adverse Event|0
5395598|NCT03068754|18589527|P1|Open Label Extension Period (OLE)|Adverse Event|0
5395599|NCT03068754|18589524|P4|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
5395600|NCT03068754|18589525|P3|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
5395601|NCT03068754|18589526|P2|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
5395602|NCT03068754|18589527|P1|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
5395603|NCT03068754|18589524|P4|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
5395604|NCT03068754|18589525|P3|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
5395605|NCT03068754|18589526|P2|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
5395606|NCT03068754|18589527|P1|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
5395607|NCT03068754|18589524|P4|Randomized Treatment Period (RTP)|Discontinued by Physician|0
5395608|NCT03068754|18589525|P3|Randomized Treatment Period (RTP)|Discontinued by Physician|0
5395609|NCT03068754|18589526|P2|Randomized Treatment Period (RTP)|Discontinued by Physician|0
5395610|NCT03068754|18589527|P1|Randomized Treatment Period (RTP)|Discontinued by Physician|1
5395611|NCT03068754|18589524|P4|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
5395612|NCT03068754|18589525|P3|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
5395613|NCT03068754|18589526|P2|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
5395614|NCT03068754|18589527|P1|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
5395615|NCT03068754|18589524|P4|Randomized Treatment Period (RTP)|Lost to Follow-up|0
5395616|NCT03068754|18589525|P3|Randomized Treatment Period (RTP)|Lost to Follow-up|0
5395617|NCT03068754|18589526|P2|Randomized Treatment Period (RTP)|Lost to Follow-up|0
5395618|NCT03068754|18589527|P1|Randomized Treatment Period (RTP)|Lost to Follow-up|1
5395619|NCT03068754|18589524|P4|Randomized Treatment Period (RTP)|Disease progression|0
5395620|NCT03068754|18589525|P3|Randomized Treatment Period (RTP)|Disease progression|0
5395621|NCT03068754|18589526|P2|Randomized Treatment Period (RTP)|Disease progression|2
5395622|NCT03068754|18589527|P1|Randomized Treatment Period (RTP)|Disease progression|1
5395623|NCT03068754|18589524|P4|Randomized Treatment Period (RTP)|Death|0
5395624|NCT03068754|18589525|P3|Randomized Treatment Period (RTP)|Death|0
5395625|NCT03068754|18589526|P2|Randomized Treatment Period (RTP)|Death|2
5395626|NCT03068754|18589527|P1|Randomized Treatment Period (RTP)|Death|2
5395627|NCT03068754|18589524|P4|Randomized Treatment Period (RTP)|Adverse Event|0
5395628|NCT03068754|18589525|P3|Randomized Treatment Period (RTP)|Adverse Event|0
5395629|NCT03068754|18589526|P2|Randomized Treatment Period (RTP)|Adverse Event|3
5395630|NCT03068754|18589527|P1|Randomized Treatment Period (RTP)|Adverse Event|1
5395631|NCT03068468|18589562|P4|Open-Label Extension Period|Reason not Specified|4
5395632|NCT03068468|18589563|P3|Open-Label Extension Period|Reason not Specified|1
5395633|NCT03068468|18589564|P2|Open-Label Extension Period|Reason not Specified|0
5395634|NCT03068468|18589565|P1|Open-Label Extension Period|Reason not Specified|0
5395635|NCT03068468|18589562|P4|Open-Label Extension Period|Withdrawal by Parent/Guardian|4
5395636|NCT03068468|18589563|P3|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
5395637|NCT03068468|18589564|P2|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
5395638|NCT03068468|18589565|P1|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
5395639|NCT03068468|18589562|P4|Open-Label Extension Period|Withdrawal by Sponsor|228
5395640|NCT03068468|18589563|P3|Open-Label Extension Period|Withdrawal by Sponsor|115
5395641|NCT03068468|18589564|P2|Open-Label Extension Period|Withdrawal by Sponsor|0
5395642|NCT03068468|18589565|P1|Open-Label Extension Period|Withdrawal by Sponsor|0
5395643|NCT03068468|18589562|P4|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
5395644|NCT03068468|18589563|P3|Open-Label Extension Period|Failure to Meet Randomization Criteria|2
5395645|NCT03068468|18589564|P2|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
5395646|NCT03068468|18589565|P1|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
5395647|NCT03068468|18589562|P4|Open-Label Extension Period|Lost to Follow-up|0
5395648|NCT03068468|18589563|P3|Open-Label Extension Period|Lost to Follow-up|1
5395649|NCT03068468|18589564|P2|Open-Label Extension Period|Lost to Follow-up|0
5395650|NCT03068468|18589565|P1|Open-Label Extension Period|Lost to Follow-up|0
5395651|NCT03068468|18589562|P4|Open-Label Extension Period|Death|1
5395652|NCT03068468|18589563|P3|Open-Label Extension Period|Death|0
5395653|NCT03068468|18589564|P2|Open-Label Extension Period|Death|0
5395654|NCT03068468|18589565|P1|Open-Label Extension Period|Death|0
5395655|NCT03068468|18589562|P4|Open-Label Extension Period|Withdrawal by Subject|20
5395656|NCT03068468|18589563|P3|Open-Label Extension Period|Withdrawal by Subject|7
5395657|NCT03068468|18589564|P2|Open-Label Extension Period|Withdrawal by Subject|0
5395658|NCT03068468|18589565|P1|Open-Label Extension Period|Withdrawal by Subject|0
5395659|NCT03068468|18589562|P4|Open-Label Extension Period|Adverse Event|17
5395660|NCT03068468|18589563|P3|Open-Label Extension Period|Adverse Event|13
5395661|NCT03068468|18589564|P2|Open-Label Extension Period|Adverse Event|0
5395662|NCT03068468|18589565|P1|Open-Label Extension Period|Adverse Event|0
5395663|NCT03068468|18589562|P4|Open-Label Extension Period|Lack of Efficacy|2
5395664|NCT03068468|18589563|P3|Open-Label Extension Period|Lack of Efficacy|1
5395665|NCT03068468|18589564|P2|Open-Label Extension Period|Lack of Efficacy|0
5395666|NCT03068468|18589565|P1|Open-Label Extension Period|Lack of Efficacy|0
5395667|NCT03068468|18589562|P4|Placebo-Controlled Period|Death|0
5395668|NCT03068468|18589563|P3|Placebo-Controlled Period|Death|0
5395669|NCT03068468|18589564|P2|Placebo-Controlled Period|Death|1
5395670|NCT03068468|18589565|P1|Placebo-Controlled Period|Death|0
5395671|NCT03068468|18589562|P4|Placebo-Controlled Period|Reason Not Specified|0
5395672|NCT03068468|18589563|P3|Placebo-Controlled Period|Reason Not Specified|0
5395673|NCT03068468|18589564|P2|Placebo-Controlled Period|Reason Not Specified|6
5395674|NCT03068468|18589565|P1|Placebo-Controlled Period|Reason Not Specified|1
5395675|NCT03068468|18589562|P4|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
5395676|NCT03068468|18589563|P3|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
5395677|NCT03068468|18589564|P2|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2
5395678|NCT03068468|18589565|P1|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
5395679|NCT03068468|18589562|P4|Placebo-Controlled Period|Withdrawal by Subject|0
5395680|NCT03068468|18589563|P3|Placebo-Controlled Period|Withdrawal by Subject|0
5395681|NCT03068468|18589564|P2|Placebo-Controlled Period|Withdrawal by Subject|11
5395682|NCT03068468|18589565|P1|Placebo-Controlled Period|Withdrawal by Subject|3
5395683|NCT03068468|18589562|P4|Placebo-Controlled Period|Adverse Event|0
5395684|NCT03068468|18589563|P3|Placebo-Controlled Period|Adverse Event|0
5395685|NCT03068468|18589564|P2|Placebo-Controlled Period|Adverse Event|21
5395686|NCT03068468|18589565|P1|Placebo-Controlled Period|Adverse Event|16
5395687|NCT03068468|18589562|P4|Placebo-Controlled Period|Lack of Efficacy|0
5395688|NCT03068468|18589563|P3|Placebo-Controlled Period|Lack of Efficacy|0
5395689|NCT03068468|18589564|P2|Placebo-Controlled Period|Lack of Efficacy|1
5395690|NCT03068468|18589565|P1|Placebo-Controlled Period|Lack of Efficacy|0
5395691|NCT03068468|18589562|P4|Placebo-Controlled Period|Randomized but not Treated|0
5395692|NCT03068468|18589563|P3|Placebo-Controlled Period|Randomized but not Treated|0
5395693|NCT03068468|18589564|P2|Placebo-Controlled Period|Randomized but not Treated|3
5395694|NCT03068468|18589565|P1|Placebo-Controlled Period|Randomized but not Treated|1
5395695|NCT03067987|18589617|P2|Overall Study|Withdrawal by Subject|1
5395696|NCT03067987|18589618|P1|Overall Study|Withdrawal by Subject|2
5395697|NCT03067987|18589617|P2|Overall Study|Protocol Violation|2
5395698|NCT03067987|18589618|P1|Overall Study|Protocol Violation|1
5395699|NCT03067987|18589617|P2|Overall Study|Lost to Follow-up|10
5395700|NCT03067987|18589618|P1|Overall Study|Lost to Follow-up|7
5395701|NCT03067441|18589644|P2|Overall Study|Other|1
5395702|NCT03067441|18589645|P1|Overall Study|Other|1
5395703|NCT03067441|18589644|P2|Overall Study|Physician Decision|3
5395704|NCT03067441|18589645|P1|Overall Study|Physician Decision|1
5395705|NCT03067441|18589644|P2|Overall Study|Study Terminated by Sponsor or Investigator|0
5395706|NCT03067441|18589645|P1|Overall Study|Study Terminated by Sponsor or Investigator|1
5395707|NCT03067441|18589644|P2|Overall Study|Adverse Event|14
5395708|NCT03067441|18589645|P1|Overall Study|Adverse Event|7
5395709|NCT03067441|18589644|P2|Overall Study|Lost to Follow-up|5
5395710|NCT03067441|18589645|P1|Overall Study|Lost to Follow-up|7
5395711|NCT03067441|18589644|P2|Overall Study|Withdrawal by Subject|34
5395712|NCT03067441|18589645|P1|Overall Study|Withdrawal by Subject|16
5395713|NCT03066999|18589703|P2|Overall Study|abnormal urethraBladder neck contracture|2
5395714|NCT03066999|18589704|P1|Overall Study|abnormal urethraBladder neck contracture|0
5395715|NCT03066778|18589724|P2|Overall Study|Ongoing in Study|37
5395716|NCT03066778|18589725|P1|Overall Study|Ongoing in Study|57
5395717|NCT03066778|18589724|P2|Overall Study|Withdrawal by Subject|5
5395718|NCT03066778|18589725|P1|Overall Study|Withdrawal by Subject|4
5395719|NCT03066778|18589724|P2|Overall Study|Death|183
5395720|NCT03066778|18589725|P1|Overall Study|Death|167
5395721|NCT03066622|18589753|P2|Overall Study|Withdrawal by Subject|1
5395722|NCT03066622|18589754|P1|Overall Study|Withdrawal by Subject|2
5395723|NCT03066622|18589753|P2|Overall Study|Lost to Follow-up|25
5395724|NCT03066622|18589754|P1|Overall Study|Lost to Follow-up|24
5395725|NCT03066609|18589767|P4|OVERALL STUDY|discontinued follow up|0
5395726|NCT03066609|18589768|P3|OVERALL STUDY|discontinued follow up|0
5395727|NCT03066609|18589769|P2|OVERALL STUDY|discontinued follow up|2
5395728|NCT03066609|18589770|P1|OVERALL STUDY|discontinued follow up|0
5395729|NCT03066609|18589767|P4|OVERALL STUDY|Lack of Efficacy|1
5395730|NCT03066609|18589768|P3|OVERALL STUDY|Lack of Efficacy|1
5395731|NCT03066609|18589769|P2|OVERALL STUDY|Lack of Efficacy|1
5395732|NCT03066609|18589770|P1|OVERALL STUDY|Lack of Efficacy|2
5395733|NCT03066609|18589767|P4|OVERALL STUDY|Pregnancy|0
5395734|NCT03066609|18589768|P3|OVERALL STUDY|Pregnancy|1
5395735|NCT03066609|18589769|P2|OVERALL STUDY|Pregnancy|0
5395736|NCT03066609|18589770|P1|OVERALL STUDY|Pregnancy|1
5395737|NCT03066609|18589767|P4|OVERALL STUDY|Lost to Follow-up|1
5395738|NCT03066609|18589768|P3|OVERALL STUDY|Lost to Follow-up|1
5395739|NCT03066609|18589769|P2|OVERALL STUDY|Lost to Follow-up|1
5395740|NCT03066609|18589770|P1|OVERALL STUDY|Lost to Follow-up|1
5395741|NCT03066609|18589767|P4|OVERALL STUDY|Withdrawal by Subject|2
5395742|NCT03066609|18589768|P3|OVERALL STUDY|Withdrawal by Subject|1
5395743|NCT03066609|18589769|P2|OVERALL STUDY|Withdrawal by Subject|2
5395744|NCT03066609|18589770|P1|OVERALL STUDY|Withdrawal by Subject|4
5395745|NCT03066609|18589767|P4|OVERALL STUDY|Adverse Event|1
5395746|NCT03066609|18589768|P3|OVERALL STUDY|Adverse Event|0
5395747|NCT03066609|18589769|P2|OVERALL STUDY|Adverse Event|2
5395748|NCT03066609|18589770|P1|OVERALL STUDY|Adverse Event|2
5395749|NCT03066609|18589767|P4|MAINTENANCE|Lack of Efficacy|1
5395750|NCT03066609|18589768|P3|MAINTENANCE|Lack of Efficacy|0
5395751|NCT03066609|18589769|P2|MAINTENANCE|Lack of Efficacy|1
5395752|NCT03066609|18589770|P1|MAINTENANCE|Lack of Efficacy|2
5395753|NCT03066609|18589767|P4|MAINTENANCE|Pregnancy|0
5395754|NCT03066609|18589768|P3|MAINTENANCE|Pregnancy|0
5395755|NCT03066609|18589769|P2|MAINTENANCE|Pregnancy|0
5395756|NCT03066609|18589770|P1|MAINTENANCE|Pregnancy|1
5395757|NCT03066609|18589767|P4|MAINTENANCE|Lost to Follow-up|0
5395758|NCT03066609|18589768|P3|MAINTENANCE|Lost to Follow-up|1
5395759|NCT03066609|18589769|P2|MAINTENANCE|Lost to Follow-up|1
5395760|NCT03066609|18589770|P1|MAINTENANCE|Lost to Follow-up|0
5395761|NCT03066609|18589767|P4|MAINTENANCE|Withdrawal by Subject|1
5395762|NCT03066609|18589768|P3|MAINTENANCE|Withdrawal by Subject|1
5395763|NCT03066609|18589769|P2|MAINTENANCE|Withdrawal by Subject|2
5395764|NCT03066609|18589770|P1|MAINTENANCE|Withdrawal by Subject|4
5395765|NCT03066609|18589767|P4|MAINTENANCE|Adverse Event|1
5395766|NCT03066609|18589768|P3|MAINTENANCE|Adverse Event|0
5395767|NCT03066609|18589769|P2|MAINTENANCE|Adverse Event|0
5395768|NCT03066609|18589770|P1|MAINTENANCE|Adverse Event|0
5395769|NCT03066609|18589767|P4|INDUCTION|Adverse Event|0
5395770|NCT03066609|18589768|P3|INDUCTION|Adverse Event|0
5395771|NCT03066609|18589769|P2|INDUCTION|Adverse Event|2
5395772|NCT03066609|18589770|P1|INDUCTION|Adverse Event|2
5395773|NCT03066609|18589767|P4|INDUCTION|Lack of Efficacy|0
5395774|NCT03066609|18589768|P3|INDUCTION|Lack of Efficacy|1
5395775|NCT03066609|18589769|P2|INDUCTION|Lack of Efficacy|0
5395776|NCT03066609|18589770|P1|INDUCTION|Lack of Efficacy|0
5395777|NCT03066609|18589767|P4|INDUCTION|Pregnancy|0
5395778|NCT03066609|18589768|P3|INDUCTION|Pregnancy|1
5395779|NCT03066609|18589769|P2|INDUCTION|Pregnancy|0
5395780|NCT03066609|18589770|P1|INDUCTION|Pregnancy|0
5395781|NCT03066193|18589800|P1|Overall Study|Withdrawal by Subject|1
5395782|NCT03065933|18589813|P1|Overall Study|study terminated|5
5395783|NCT03065530|18589821|P4|Overall Study|Protocol Violation|1
5395784|NCT03065530|18589822|P3|Overall Study|Protocol Violation|1
5395785|NCT03065530|18589823|P2|Overall Study|Protocol Violation|0
5395786|NCT03065530|18589824|P1|Overall Study|Protocol Violation|1
5395787|NCT03065530|18589821|P4|Overall Study|Lack of Efficacy|1
5395788|NCT03065530|18589822|P3|Overall Study|Lack of Efficacy|0
5395789|NCT03065530|18589823|P2|Overall Study|Lack of Efficacy|1
5395790|NCT03065530|18589824|P1|Overall Study|Lack of Efficacy|1
5395791|NCT03065023|18589932|P5|Overall Study|Withdrawal by Subject|0
5395792|NCT03065023|18589933|P4|Overall Study|Withdrawal by Subject|1
5395793|NCT03065023|18589934|P3|Overall Study|Withdrawal by Subject|0
5395794|NCT03065023|18589935|P2|Overall Study|Withdrawal by Subject|0
5395795|NCT03065023|18589936|P1|Overall Study|Withdrawal by Subject|0
5395796|NCT03065023|18589932|P5|Overall Study|Participant Decision|0
5395797|NCT03065023|18589933|P4|Overall Study|Participant Decision|1
5395798|NCT03065023|18589934|P3|Overall Study|Participant Decision|0
5395799|NCT03065023|18589935|P2|Overall Study|Participant Decision|0
5395800|NCT03065023|18589936|P1|Overall Study|Participant Decision|0
5395801|NCT03065023|18589932|P5|Overall Study|Lost to Follow-up|0
5395802|NCT03065023|18589933|P4|Overall Study|Lost to Follow-up|0
5395803|NCT03065023|18589934|P3|Overall Study|Lost to Follow-up|0
5395804|NCT03065023|18589935|P2|Overall Study|Lost to Follow-up|1
5395805|NCT03065023|18589936|P1|Overall Study|Lost to Follow-up|0
5395806|NCT03065023|18589932|P5|Overall Study|Death|0
5395807|NCT03065023|18589933|P4|Overall Study|Death|1
5395808|NCT03065023|18589934|P3|Overall Study|Death|1
5395809|NCT03065023|18589935|P2|Overall Study|Death|0
5395810|NCT03065023|18589936|P1|Overall Study|Death|2
5395811|NCT03065023|18589932|P5|Overall Study|Progressive Disease|0
5395812|NCT03065023|18589933|P4|Overall Study|Progressive Disease|0
5395813|NCT03065023|18589934|P3|Overall Study|Progressive Disease|0
5395814|NCT03065023|18589935|P2|Overall Study|Progressive Disease|1
5395815|NCT03065023|18589936|P1|Overall Study|Progressive Disease|0
5395816|NCT03064841|18590002|P1|Overall Study|Screen failure|2
5395817|NCT03064841|18590002|P1|Overall Study|No glycated haemoglobinA1c measurement|11
5395818|NCT03064841|18590002|P1|Overall Study|Inclusion/exclusion criteria violation|4
5395819|NCT03064451|18590017|P1|Overall Study|Withdrew consent: 3-month FU visit|1
5395820|NCT03064451|18590017|P1|Overall Study|Exited prior to procedure|8
5395821|NCT03064451|18590017|P1|Overall Study|Mapping Failure|4
5395822|NCT03064451|18590017|P1|Overall Study|Lost to Follow-up|1
5395823|NCT03064126|18590035|P4|Overall Study|Protocol Violation|0
5395824|NCT03064126|18590036|P3|Overall Study|Protocol Violation|1
5395825|NCT03064126|18590037|P2|Overall Study|Protocol Violation|1
5395826|NCT03064126|18590038|P1|Overall Study|Protocol Violation|11
5395827|NCT03064126|18590035|P4|Overall Study|Subject moved|0
5395828|NCT03064126|18590036|P3|Overall Study|Subject moved|0
5395829|NCT03064126|18590037|P2|Overall Study|Subject moved|0
5395830|NCT03064126|18590038|P1|Overall Study|Subject moved|1
5395831|NCT03064126|18590035|P4|Overall Study|Withdrawal by Subject|0
5395832|NCT03064126|18590036|P3|Overall Study|Withdrawal by Subject|0
5395833|NCT03064126|18590037|P2|Overall Study|Withdrawal by Subject|4
5395834|NCT03064126|18590038|P1|Overall Study|Withdrawal by Subject|7
5395835|NCT03064126|18590035|P4|Overall Study|Investigator Discretion|0
5395836|NCT03064126|18590036|P3|Overall Study|Investigator Discretion|0
5395837|NCT03064126|18590037|P2|Overall Study|Investigator Discretion|0
5395838|NCT03064126|18590038|P1|Overall Study|Investigator Discretion|1
5395839|NCT03064126|18590035|P4|Overall Study|Death|1
5395840|NCT03064126|18590036|P3|Overall Study|Death|2
5395841|NCT03064126|18590037|P2|Overall Study|Death|2
5395842|NCT03064126|18590038|P1|Overall Study|Death|6
5395843|NCT03063086|18590180|P6|Overall Study|Physician Decision|0
5395844|NCT03063086|18590181|P5|Overall Study|Physician Decision|0
5395845|NCT03063086|18590182|P4|Overall Study|Physician Decision|1
5395846|NCT03063086|18590183|P3|Overall Study|Physician Decision|0
5395847|NCT03063086|18590184|P2|Overall Study|Physician Decision|0
5395848|NCT03063086|18590185|P1|Overall Study|Physician Decision|0
5395849|NCT03063086|18590180|P6|Overall Study|Non-compliance with study treatment|1
5395850|NCT03063086|18590181|P5|Overall Study|Non-compliance with study treatment|0
5395851|NCT03063086|18590182|P4|Overall Study|Non-compliance with study treatment|1
5395852|NCT03063086|18590183|P3|Overall Study|Non-compliance with study treatment|0
5395853|NCT03063086|18590184|P2|Overall Study|Non-compliance with study treatment|0
5395854|NCT03063086|18590185|P1|Overall Study|Non-compliance with study treatment|0
5395855|NCT03063086|18590180|P6|Overall Study|subject/guardian decision|0
5395856|NCT03063086|18590181|P5|Overall Study|subject/guardian decision|0
5395857|NCT03063086|18590182|P4|Overall Study|subject/guardian decision|0
5395858|NCT03063086|18590183|P3|Overall Study|subject/guardian decision|0
5395859|NCT03063086|18590184|P2|Overall Study|subject/guardian decision|0
5395860|NCT03063086|18590185|P1|Overall Study|subject/guardian decision|1
5395861|NCT03063086|18590180|P6|Overall Study|Adverse Event|0
5395862|NCT03063086|18590181|P5|Overall Study|Adverse Event|0
5395863|NCT03063086|18590182|P4|Overall Study|Adverse Event|1
5395864|NCT03063086|18590183|P3|Overall Study|Adverse Event|1
5395865|NCT03063086|18590184|P2|Overall Study|Adverse Event|1
5395866|NCT03063086|18590185|P1|Overall Study|Adverse Event|1
5395867|NCT03063086|18590180|P6|Overall Study|technical problems|0
5395868|NCT03063086|18590181|P5|Overall Study|technical problems|0
5395869|NCT03063086|18590182|P4|Overall Study|technical problems|0
5395870|NCT03063086|18590183|P3|Overall Study|technical problems|0
5395871|NCT03063086|18590184|P2|Overall Study|technical problems|0
5395872|NCT03063086|18590185|P1|Overall Study|technical problems|1
5395873|NCT03062891|18590231|P2|Overall Study|Lost to Follow-up|38
5395874|NCT03062891|18590232|P1|Overall Study|Lost to Follow-up|50
5395875|NCT03062891|18590231|P2|Overall Study|Withdrawal by Subject|0
5395876|NCT03062891|18590232|P1|Overall Study|Withdrawal by Subject|2
5395877|NCT03061331|18590342|P2|Washout Period (8 Weeks)|Adverse Event|1
5395878|NCT03061331|18590343|P1|Washout Period (8 Weeks)|Adverse Event|2
5395879|NCT03061214|18590373|P3|Overall Study|Death|0
5395880|NCT03061214|18590374|P2|Overall Study|Death|1
5395881|NCT03061214|18590375|P1|Overall Study|Death|1
5395882|NCT03061214|18590373|P3|Overall Study|Lost to Follow-up|1
5395883|NCT03061214|18590374|P2|Overall Study|Lost to Follow-up|1
5395884|NCT03061214|18590375|P1|Overall Study|Lost to Follow-up|3
5395885|NCT03061214|18590373|P3|Overall Study|Withdrawal by Subject|9
5395886|NCT03061214|18590374|P2|Overall Study|Withdrawal by Subject|26
5395887|NCT03061214|18590375|P1|Overall Study|Withdrawal by Subject|21
5395888|NCT03061188|18590601|P4|On Follow-up for 3 Years|Still in follow-up|3
5395889|NCT03061188|18590602|P3|On Follow-up for 3 Years|Still in follow-up|0
5395890|NCT03061188|18590603|P2|On Follow-up for 3 Years|Still in follow-up|0
5395891|NCT03061188|18590604|P1|On Follow-up for 3 Years|Still in follow-up|0
5395892|NCT03061188|18590601|P4|On Follow-up for 3 Years|Death|2
5395893|NCT03061188|18590602|P3|On Follow-up for 3 Years|Death|5
5395894|NCT03061188|18590603|P2|On Follow-up for 3 Years|Death|3
5395895|NCT03061188|18590604|P1|On Follow-up for 3 Years|Death|0
5395896|NCT03061188|18590601|P4|Went on to Cycle 2 and Beyond|Adverse Event|1
5395897|NCT03061188|18590602|P3|Went on to Cycle 2 and Beyond|Adverse Event|1
5395898|NCT03061188|18590603|P2|Went on to Cycle 2 and Beyond|Adverse Event|0
5395899|NCT03061188|18590604|P1|Went on to Cycle 2 and Beyond|Adverse Event|0
5395900|NCT03061175|18590626|P2|Followup 2 at 6 Months|Lost to Follow-up|7
5395901|NCT03061175|18590627|P1|Followup 2 at 6 Months|Lost to Follow-up|4
5395902|NCT03061175|18590626|P2|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
5395903|NCT03061175|18590627|P1|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
5395904|NCT03061175|18590626|P2|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
5395905|NCT03061175|18590627|P1|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
5395906|NCT03061175|18590626|P2|Baseline|Participant was deemed ineligible|0
5395907|NCT03061175|18590627|P1|Baseline|Participant was deemed ineligible|1
5395908|NCT03061097|18590651|P2|Overall Study|Withdrawal by Subject|3
5395909|NCT03061097|18590652|P1|Overall Study|Withdrawal by Subject|0
5395910|NCT03060551|18590673|P1|Overall Study|Adverse Event|1
5395911|NCT03060551|18590673|P1|Overall Study|Withdrawal by Subject|1
5395912|NCT03060512|18590694|P2|Overall Study|Non-compliance with study medication|2
5395913|NCT03060512|18590695|P1|Overall Study|Non-compliance with study medication|1
5395914|NCT03060512|18590694|P2|Overall Study|Withdrawal by Subject|0
5395915|NCT03060512|18590695|P1|Overall Study|Withdrawal by Subject|1
5395916|NCT03060512|18590694|P2|Overall Study|Lost to Follow-up|1
5395917|NCT03060512|18590695|P1|Overall Study|Lost to Follow-up|1
5395918|NCT03060512|18590694|P2|Overall Study|Adverse Event|6
5395919|NCT03060512|18590695|P1|Overall Study|Adverse Event|4
5395920|NCT03058991|18590732|P3|Overall Study|Withdrawal by Subject|0
5395921|NCT03058991|18590733|P2|Overall Study|Withdrawal by Subject|0
5395922|NCT03058991|18590734|P1|Overall Study|Withdrawal by Subject|1
5395923|NCT03058991|18590732|P3|Overall Study|Lost to Follow-up|12
5395924|NCT03058991|18590733|P2|Overall Study|Lost to Follow-up|12
5395925|NCT03058991|18590734|P1|Overall Study|Lost to Follow-up|17
5395926|NCT03058705|18590760|P1|Overall Study|Physician Decision|2
5395927|NCT03058705|18590760|P1|Overall Study|Withdrawal by Subject|2
5395928|NCT03058692|18590766|P2|Overall Study|Withdrawal by Subject|1
5395929|NCT03058692|18590767|P1|Overall Study|Withdrawal by Subject|1
5395930|NCT03058692|18590766|P2|Overall Study|Lost to Follow-up|1
5395931|NCT03058692|18590767|P1|Overall Study|Lost to Follow-up|2
5395932|NCT03057496|18590896|P1|Overall Study|Device failure|2
5395933|NCT03057496|18590896|P1|Overall Study|Did not use device during home trial|3
5395934|NCT03057496|18590896|P1|Overall Study|Lost to Follow-up|5
5395935|NCT03057496|18590896|P1|Overall Study|Withdrawal by Subject|8
5395936|NCT03056573|18590936|P2|Overall Study|Lost to Follow-up|1
5395937|NCT03056573|18590937|P1|Overall Study|Lost to Follow-up|1
5395938|NCT03056573|18590936|P2|Overall Study|Withdrawal by Subject|0
5395939|NCT03056573|18590937|P1|Overall Study|Withdrawal by Subject|2
5395940|NCT03056573|18590936|P2|Overall Study|Death|4
5395941|NCT03056573|18590937|P1|Overall Study|Death|2
5395942|NCT03056352|18590997|P1|Overall Study|Lost to Follow-up|1
5395943|NCT03056300|18591003|P1|Overall Study|Surgical reason per study protocol|3
5395944|NCT03056040|18591020|P2|Primary Evaluation Period|Pregnancy|1
5395945|NCT03056040|18591021|P1|Primary Evaluation Period|Pregnancy|0
5395946|NCT03056040|18591020|P2|Primary Evaluation Period|Lack of Efficacy|1
5395947|NCT03056040|18591021|P1|Primary Evaluation Period|Lack of Efficacy|0
5395948|NCT03056040|18591020|P2|Primary Evaluation Period|Withdrawal by Subject|1
5395949|NCT03056040|18591021|P1|Primary Evaluation Period|Withdrawal by Subject|1
5395950|NCT03055988|18591035|P2|Period 2|Other than listed|1
5395951|NCT03055988|18591036|P1|Period 2|Other than listed|1
5395952|NCT03055988|18591035|P2|Period 2|Adverse Event|1
5395953|NCT03055988|18591036|P1|Period 2|Adverse Event|0
5395954|NCT03055988|18591035|P2|Period 1|Withdrawal by Subject|4
5395955|NCT03055988|18591036|P1|Period 1|Withdrawal by Subject|0
5395956|NCT03055988|18591035|P2|Period 1|Lost to Follow-up|0
5395957|NCT03055988|18591036|P1|Period 1|Lost to Follow-up|1
5395958|NCT03055988|18591035|P2|Period 1|Adverse Event|1
5395959|NCT03055988|18591036|P1|Period 1|Adverse Event|0
5395960|NCT03055858|18591062|P1|Overall Study|Adverse Event|1
5395961|NCT03055858|18591062|P1|Overall Study|Death|5
5395962|NCT03055832|18591070|P2|Week 2|Withdrawal by Subject|0
5395963|NCT03055832|18591071|P1|Week 2|Withdrawal by Subject|1
5395964|NCT03055806|18591131|P4|Overall Study|Partner not willing to try intercourse|0
5395965|NCT03055806|18591132|P3|Overall Study|Partner not willing to try intercourse|0
5395966|NCT03055806|18591133|P2|Overall Study|Partner not willing to try intercourse|0
5395967|NCT03055806|18591134|P1|Overall Study|Partner not willing to try intercourse|1
5395968|NCT03055806|18591131|P4|Overall Study|Withdrawal of consent to continue study|6
5395969|NCT03055806|18591132|P3|Overall Study|Withdrawal of consent to continue study|4
5395970|NCT03055806|18591133|P2|Overall Study|Withdrawal of consent to continue study|3
5395971|NCT03055806|18591134|P1|Overall Study|Withdrawal of consent to continue study|2
5395972|NCT03055806|18591131|P4|Overall Study|Withdrawal of consent to continue drug|0
5395973|NCT03055806|18591132|P3|Overall Study|Withdrawal of consent to continue drug|2
5395974|NCT03055806|18591133|P2|Overall Study|Withdrawal of consent to continue drug|1
5395975|NCT03055806|18591134|P1|Overall Study|Withdrawal of consent to continue drug|1
5395976|NCT03055806|18591131|P4|Overall Study|Protocol Violation|0
5395977|NCT03055806|18591132|P3|Overall Study|Protocol Violation|0
5395978|NCT03055806|18591133|P2|Overall Study|Protocol Violation|0
5395979|NCT03055806|18591134|P1|Overall Study|Protocol Violation|1
5395980|NCT03055806|18591131|P4|Overall Study|Physician Decision|1
5395981|NCT03055806|18591132|P3|Overall Study|Physician Decision|0
5395982|NCT03055806|18591133|P2|Overall Study|Physician Decision|0
5395983|NCT03055806|18591134|P1|Overall Study|Physician Decision|1
5395984|NCT03055806|18591131|P4|Overall Study|Lost to Follow-up|7
5395985|NCT03055806|18591132|P3|Overall Study|Lost to Follow-up|6
5395986|NCT03055806|18591133|P2|Overall Study|Lost to Follow-up|3
5395987|NCT03055806|18591134|P1|Overall Study|Lost to Follow-up|0
5395988|NCT03055806|18591131|P4|Overall Study|Adverse Event|1
5395989|NCT03055806|18591132|P3|Overall Study|Adverse Event|1
5395990|NCT03055806|18591133|P2|Overall Study|Adverse Event|0
5395991|NCT03055806|18591134|P1|Overall Study|Adverse Event|0
5395992|NCT03055624|18591183|P1|Overall Study|Study closed|9
5395993|NCT03055494|18591194|P2|Overall Study|Non-compliance with study treatment|0
5395994|NCT03055494|18591195|P1|Overall Study|Non-compliance with study treatment|1
5395995|NCT03055494|18591194|P2|Overall Study|Adverse Event|1
5395996|NCT03055494|18591195|P1|Overall Study|Adverse Event|0
5395997|NCT03055494|18591194|P2|Overall Study|Withdrawal by Subject|0
5395998|NCT03055494|18591195|P1|Overall Study|Withdrawal by Subject|1
5395999|NCT03055494|18591194|P2|Overall Study|Physician Decision|0
5396000|NCT03055494|18591195|P1|Overall Study|Physician Decision|2
5396001|NCT03055494|18591194|P2|Overall Study|Lost to Follow-up|0
5396002|NCT03055494|18591195|P1|Overall Study|Lost to Follow-up|6
5396003|NCT03055338|18591226|P3|Overall Study|Withdrawal by Subject|7
5396004|NCT03055338|18591227|P2|Overall Study|Withdrawal by Subject|8
5396005|NCT03055338|18591228|P1|Overall Study|Withdrawal by Subject|9
5396006|NCT03055338|18591226|P3|Overall Study|Physician Decision|2
5396007|NCT03055338|18591227|P2|Overall Study|Physician Decision|0
5396008|NCT03055338|18591228|P1|Overall Study|Physician Decision|0
5396009|NCT03055338|18591226|P3|Overall Study|No Post-treatment Protocol Contact|0
5396010|NCT03055338|18591227|P2|Overall Study|No Post-treatment Protocol Contact|1
5396011|NCT03055338|18591228|P1|Overall Study|No Post-treatment Protocol Contact|0
5396012|NCT03055338|18591226|P3|Overall Study|Lost to Follow-up|3
5396013|NCT03055338|18591227|P2|Overall Study|Lost to Follow-up|2
5396014|NCT03055338|18591228|P1|Overall Study|Lost to Follow-up|9
5396015|NCT03055260|18591247|P2|Overall Study|Withdrawal by Subject|0
5396016|NCT03055260|18591248|P1|Overall Study|Withdrawal by Subject|1
5396017|NCT03055221|18591256|P1|Overall Study|Study terminated by Sponsor|3
5396018|NCT03055221|18591256|P1|Overall Study|Physician Decision|1
5396019|NCT03055221|18591256|P1|Overall Study|Death|6
5396020|NCT03055221|18591256|P1|Overall Study|Withdrawal by Subject|4
5396021|NCT03055221|18591256|P1|Overall Study|Adverse Event|2
5396022|NCT03055195|18591263|P2|Overall Study|Physician Decision|0
5396023|NCT03055195|18591264|P1|Overall Study|Physician Decision|1
5396024|NCT03055195|18591263|P2|Overall Study|Protocol Violation|1
5396025|NCT03055195|18591264|P1|Overall Study|Protocol Violation|2
5396026|NCT03055195|18591263|P2|Overall Study|Study Terminated by Sponsor|6
5396027|NCT03055195|18591264|P1|Overall Study|Study Terminated by Sponsor|2
5396028|NCT03055195|18591263|P2|Overall Study|Withdrawal by Subject|7
5396029|NCT03055195|18591264|P1|Overall Study|Withdrawal by Subject|6
5396030|NCT03055195|18591263|P2|Overall Study|Lack of Efficacy|0
5396031|NCT03055195|18591264|P1|Overall Study|Lack of Efficacy|1
5396032|NCT03054428|18591636|P3|Overall Study|Lost to Follow-up|1
5396033|NCT03054428|18591637|P2|Overall Study|Lost to Follow-up|0
5396034|NCT03054428|18591638|P1|Overall Study|Lost to Follow-up|0
5396035|NCT03054428|18591636|P3|Overall Study|Withdrawal by Subject|3
5396036|NCT03054428|18591637|P2|Overall Study|Withdrawal by Subject|2
5396037|NCT03054428|18591638|P1|Overall Study|Withdrawal by Subject|3
5396038|NCT03054428|18591636|P3|Overall Study|Transitioned to OLE study|73
5396039|NCT03054428|18591637|P2|Overall Study|Transitioned to OLE study|76
5396040|NCT03054428|18591638|P1|Overall Study|Transitioned to OLE study|76
5396041|NCT03054428|18591636|P3|Overall Study|Discont'd to enroll in OLE: not enrolled|0
5396042|NCT03054428|18591637|P2|Overall Study|Discont'd to enroll in OLE: not enrolled|0
5396043|NCT03054428|18591638|P1|Overall Study|Discont'd to enroll in OLE: not enrolled|1
5396044|NCT03054428|18591636|P3|Overall Study|Discontinued to enroll in OLE: enrolled|1
5396045|NCT03054428|18591637|P2|Overall Study|Discontinued to enroll in OLE: enrolled|0
5396046|NCT03054428|18591638|P1|Overall Study|Discontinued to enroll in OLE: enrolled|0
5396047|NCT03054428|18591636|P3|Overall Study|Lack of Efficacy|0
5396048|NCT03054428|18591637|P2|Overall Study|Lack of Efficacy|1
5396049|NCT03054428|18591638|P1|Overall Study|Lack of Efficacy|3
5396050|NCT03054428|18591636|P3|Overall Study|Physician Decision|1
5396051|NCT03054428|18591637|P2|Overall Study|Physician Decision|1
5396052|NCT03054428|18591638|P1|Overall Study|Physician Decision|0
5396053|NCT03054064|18591734|P1|Overall Study|Change in Status|1
5396054|NCT03054064|18591734|P1|Overall Study|High Blood Pressure|1
5396055|NCT03054064|18591734|P1|Overall Study|Bladder Issue|1
5396056|NCT03054064|18591734|P1|Overall Study|Investigator Decision|2
5396057|NCT03054064|18591734|P1|Overall Study|Lower Extremity Deep Vein Thrombosis|1
5396058|NCT03053518|18591779|P1|Overall Study|Ineligible|5
5396059|NCT03053518|18591779|P1|Overall Study|Lost to Follow-up|2
5396060|NCT03053518|18591779|P1|Overall Study|Withdrawal by Subject|3
5396061|NCT03053492|18591785|P2|Overall Study|Withdrawal by Subject|5
5396062|NCT03053492|18591786|P1|Overall Study|Withdrawal by Subject|7
5396063|NCT03053492|18591785|P2|Overall Study|Adverse Event|1
5396064|NCT03053492|18591786|P1|Overall Study|Adverse Event|1
5396065|NCT03053427|18591800|P2|Overall Study|Miscellaneous|1
5396066|NCT03053427|18591801|P1|Overall Study|Miscellaneous|0
5396067|NCT03053427|18591800|P2|Overall Study|Withdrawal by Subject|2
5396068|NCT03053427|18591801|P1|Overall Study|Withdrawal by Subject|3
5396069|NCT03053427|18591800|P2|Overall Study|Protocol Deviation|3
5396070|NCT03053427|18591801|P1|Overall Study|Protocol Deviation|3
5396071|NCT03053427|18591800|P2|Overall Study|Worsening of the target disease|1
5396072|NCT03053427|18591801|P1|Overall Study|Worsening of the target disease|0
5396073|NCT03053427|18591800|P2|Overall Study|Lost to Follow-up|2
5396074|NCT03053427|18591801|P1|Overall Study|Lost to Follow-up|2
5396075|NCT03053427|18591800|P2|Overall Study|Lack of Efficacy|3
5396076|NCT03053427|18591801|P1|Overall Study|Lack of Efficacy|1
5396077|NCT03053427|18591800|P2|Overall Study|Adverse Event|4
5396078|NCT03053427|18591801|P1|Overall Study|Adverse Event|4
5396079|NCT03053180|18591836|P1|Overall Study|Failure to Return|1
5396080|NCT03053063|18591848|P4|Open-Label Phase|Investigator's discretion|2
5396081|NCT03053063|18591849|P3|Open-Label Phase|Investigator's discretion|0
5396082|NCT03053063|18591850|P2|Open-Label Phase|Investigator's discretion|0
5396083|NCT03053063|18591851|P1|Open-Label Phase|Investigator's discretion|0
5396084|NCT03053063|18591848|P4|Open-Label Phase|Death|2
5396085|NCT03053063|18591849|P3|Open-Label Phase|Death|0
5396086|NCT03053063|18591850|P2|Open-Label Phase|Death|0
5396087|NCT03053063|18591851|P1|Open-Label Phase|Death|0
5396088|NCT03053063|18591848|P4|Open-Label Phase|Study Terminated by Sponsor|19
5396089|NCT03053063|18591849|P3|Open-Label Phase|Study Terminated by Sponsor|0
5396090|NCT03053063|18591850|P2|Open-Label Phase|Study Terminated by Sponsor|0
5396091|NCT03053063|18591851|P1|Open-Label Phase|Study Terminated by Sponsor|0
5396092|NCT03053063|18591848|P4|Randomized Phase|Entered the Open-Label Phase|0
5396093|NCT03053063|18591849|P3|Randomized Phase|Entered the Open-Label Phase|3
5396094|NCT03053063|18591850|P2|Randomized Phase|Entered the Open-Label Phase|11
5396095|NCT03053063|18591851|P1|Randomized Phase|Entered the Open-Label Phase|9
5396096|NCT03053063|18591848|P4|Randomized Phase|Randomized but Never Treated|0
5396097|NCT03053063|18591849|P3|Randomized Phase|Randomized but Never Treated|2
5396098|NCT03053063|18591850|P2|Randomized Phase|Randomized but Never Treated|3
5396099|NCT03053063|18591851|P1|Randomized Phase|Randomized but Never Treated|1
5396100|NCT03053063|18591848|P4|Randomized Phase|Adverse Event|0
5396101|NCT03053063|18591849|P3|Randomized Phase|Adverse Event|0
5396102|NCT03053063|18591850|P2|Randomized Phase|Adverse Event|1
5396103|NCT03053063|18591851|P1|Randomized Phase|Adverse Event|0
5396104|NCT03053063|18591848|P4|Randomized Phase|Lost to Follow-up|0
5396105|NCT03053063|18591849|P3|Randomized Phase|Lost to Follow-up|1
5396106|NCT03053063|18591850|P2|Randomized Phase|Lost to Follow-up|5
5396107|NCT03053063|18591851|P1|Randomized Phase|Lost to Follow-up|3
5396108|NCT03053063|18591848|P4|Randomized Phase|Investigator's Discretion|0
5396109|NCT03053063|18591849|P3|Randomized Phase|Investigator's Discretion|2
5396110|NCT03053063|18591850|P2|Randomized Phase|Investigator's Discretion|6
5396111|NCT03053063|18591851|P1|Randomized Phase|Investigator's Discretion|8
5396112|NCT03053063|18591848|P4|Randomized Phase|Withdrew consent|0
5396113|NCT03053063|18591849|P3|Randomized Phase|Withdrew consent|5
5396114|NCT03053063|18591850|P2|Randomized Phase|Withdrew consent|11
5396115|NCT03053063|18591851|P1|Randomized Phase|Withdrew consent|8
5396116|NCT03053063|18591848|P4|Randomized Phase|Study Terminated by Sponsor|0
5396117|NCT03053063|18591849|P3|Randomized Phase|Study Terminated by Sponsor|161
5396118|NCT03053063|18591850|P2|Randomized Phase|Study Terminated by Sponsor|317
5396119|NCT03053063|18591851|P1|Randomized Phase|Study Terminated by Sponsor|326
5396120|NCT03053050|18591881|P4|Open-label Phase|Investigator's Discretion|4
5396121|NCT03053050|18591882|P3|Open-label Phase|Investigator's Discretion|0
5396122|NCT03053050|18591883|P2|Open-label Phase|Investigator's Discretion|0
5396123|NCT03053050|18591884|P1|Open-label Phase|Investigator's Discretion|0
5396124|NCT03053050|18591881|P4|Open-label Phase|Withdrew Consent|6
5396125|NCT03053050|18591882|P3|Open-label Phase|Withdrew Consent|0
5396126|NCT03053050|18591883|P2|Open-label Phase|Withdrew Consent|0
5396127|NCT03053050|18591884|P1|Open-label Phase|Withdrew Consent|0
5396128|NCT03053050|18591881|P4|Open-label Phase|Study Terminated by Sponsor|89
5396129|NCT03053050|18591882|P3|Open-label Phase|Study Terminated by Sponsor|0
5396130|NCT03053050|18591883|P2|Open-label Phase|Study Terminated by Sponsor|0
5396131|NCT03053050|18591884|P1|Open-label Phase|Study Terminated by Sponsor|0
5396132|NCT03053050|18591881|P4|Randomized Phase|Entered the Open-Label Phase|0
5396133|NCT03053050|18591882|P3|Randomized Phase|Entered the Open-Label Phase|18
5396134|NCT03053050|18591883|P2|Randomized Phase|Entered the Open-Label Phase|45
5396135|NCT03053050|18591884|P1|Randomized Phase|Entered the Open-Label Phase|36
5396136|NCT03053050|18591881|P4|Randomized Phase|Randomized but Never Treated|0
5396137|NCT03053050|18591882|P3|Randomized Phase|Randomized but Never Treated|2
5396138|NCT03053050|18591883|P2|Randomized Phase|Randomized but Never Treated|2
5396139|NCT03053050|18591884|P1|Randomized Phase|Randomized but Never Treated|2
5396140|NCT03053050|18591881|P4|Randomized Phase|Adverse Event|0
5396141|NCT03053050|18591882|P3|Randomized Phase|Adverse Event|0
5396142|NCT03053050|18591883|P2|Randomized Phase|Adverse Event|1
5396143|NCT03053050|18591884|P1|Randomized Phase|Adverse Event|0
5396144|NCT03053050|18591881|P4|Randomized Phase|Lost to Follow-up|0
5396145|NCT03053050|18591882|P3|Randomized Phase|Lost to Follow-up|1
5396146|NCT03053050|18591883|P2|Randomized Phase|Lost to Follow-up|1
5396147|NCT03053050|18591884|P1|Randomized Phase|Lost to Follow-up|5
5396148|NCT03053050|18591881|P4|Randomized Phase|Investigator's Discretion|0
5396149|NCT03053050|18591882|P3|Randomized Phase|Investigator's Discretion|3
5396150|NCT03053050|18591883|P2|Randomized Phase|Investigator's Discretion|6
5396151|NCT03053050|18591884|P1|Randomized Phase|Investigator's Discretion|6
5396152|NCT03053050|18591881|P4|Randomized Phase|Withdrew Consent|0
5396153|NCT03053050|18591882|P3|Randomized Phase|Withdrew Consent|9
5396154|NCT03053050|18591883|P2|Randomized Phase|Withdrew Consent|8
5396155|NCT03053050|18591884|P1|Randomized Phase|Withdrew Consent|16
5396156|NCT03053050|18591881|P4|Randomized Phase|Study Terminated by Sponsor|0
5396157|NCT03053050|18591882|P3|Randomized Phase|Study Terminated by Sponsor|128
5396158|NCT03053050|18591883|P2|Randomized Phase|Study Terminated by Sponsor|260
5396159|NCT03053050|18591884|P1|Randomized Phase|Study Terminated by Sponsor|259
5396160|NCT03052764|18591928|P2|Double-Blind Treatment Period|Reason not Specified|1
5396161|NCT03052764|18591929|P1|Double-Blind Treatment Period|Reason not Specified|2
5396162|NCT03052764|18591928|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5396163|NCT03052764|18591929|P1|Double-Blind Treatment Period|Withdrawal by Subject|3
5396164|NCT03052764|18591928|P2|Double-Blind Treatment Period|Protocol Violation|1
5396165|NCT03052764|18591929|P1|Double-Blind Treatment Period|Protocol Violation|2
5396166|NCT03052764|18591928|P2|Double-Blind Treatment Period|Lack of Efficacy|0
5396167|NCT03052764|18591929|P1|Double-Blind Treatment Period|Lack of Efficacy|1
5396168|NCT03052764|18591928|P2|Double-Blind Treatment Period|Adverse Event|0
5396169|NCT03052764|18591929|P1|Double-Blind Treatment Period|Adverse Event|2
5396170|NCT03052725|18591949|P2|Overall Study|Study terminated by sponsor|144
5396171|NCT03052725|18591950|P1|Overall Study|Study terminated by sponsor|143
5396172|NCT03052725|18591949|P2|Overall Study|Site closure|1
5396173|NCT03052725|18591950|P1|Overall Study|Site closure|0
5396174|NCT03052725|18591949|P2|Overall Study|Pregnancy|1
5396175|NCT03052725|18591950|P1|Overall Study|Pregnancy|0
5396176|NCT03052725|18591949|P2|Overall Study|Withdrawal by Subject|4
5396177|NCT03052725|18591950|P1|Overall Study|Withdrawal by Subject|3
5396178|NCT03052725|18591949|P2|Overall Study|Adverse Event|0
5396179|NCT03052725|18591950|P1|Overall Study|Adverse Event|2
5396180|NCT03052517|18591997|P3|Overall Study|Technical Problems|0
5396181|NCT03052517|18591998|P2|Overall Study|Technical Problems|1
5396182|NCT03052517|18591999|P1|Overall Study|Technical Problems|0
5396183|NCT03052517|18591997|P3|Overall Study|Non-Compliance With Study Treatment|0
5396184|NCT03052517|18591998|P2|Overall Study|Non-Compliance With Study Treatment|2
5396185|NCT03052517|18591999|P1|Overall Study|Non-Compliance With Study Treatment|0
5396186|NCT03052517|18591997|P3|Overall Study|Pregnancy|1
5396187|NCT03052517|18591998|P2|Overall Study|Pregnancy|0
5396188|NCT03052517|18591999|P1|Overall Study|Pregnancy|1
5396189|NCT03052517|18591997|P3|Overall Study|Lost to Follow-up|0
5396190|NCT03052517|18591998|P2|Overall Study|Lost to Follow-up|4
5396191|NCT03052517|18591999|P1|Overall Study|Lost to Follow-up|2
5396192|NCT03052517|18591997|P3|Overall Study|Death|1
5396193|NCT03052517|18591998|P2|Overall Study|Death|0
5396194|NCT03052517|18591999|P1|Overall Study|Death|3
5396195|NCT03052517|18591997|P3|Overall Study|Physician Decision|1
5396196|NCT03052517|18591998|P2|Overall Study|Physician Decision|5
5396197|NCT03052517|18591999|P1|Overall Study|Physician Decision|4
5396198|NCT03052517|18591997|P3|Overall Study|Adverse Event|0
5396199|NCT03052517|18591998|P2|Overall Study|Adverse Event|5
5396200|NCT03052517|18591999|P1|Overall Study|Adverse Event|6
5396201|NCT03052517|18591997|P3|Overall Study|Lack of Efficacy|7
5396202|NCT03052517|18591998|P2|Overall Study|Lack of Efficacy|14
5396203|NCT03052517|18591999|P1|Overall Study|Lack of Efficacy|23
5396204|NCT03052517|18591997|P3|Overall Study|Subject/Guardian Decision|22
5396205|NCT03052517|18591998|P2|Overall Study|Subject/Guardian Decision|45
5396206|NCT03052517|18591999|P1|Overall Study|Subject/Guardian Decision|50
5396207|NCT03052517|18591997|P3|Overall Study|Study Terminated By Sponsor|296
5396208|NCT03052517|18591998|P2|Overall Study|Study Terminated By Sponsor|938
5396209|NCT03052517|18591999|P1|Overall Study|Study Terminated By Sponsor|928
5396210|NCT03052426|18592043|P3|Overall Study|Lost to Follow-up|1
5396211|NCT03052426|18592044|P2|Overall Study|Lost to Follow-up|0
5396212|NCT03052426|18592045|P1|Overall Study|Lost to Follow-up|2
5396213|NCT03052426|18592043|P3|Overall Study|Withdrawal by Subject|0
5396214|NCT03052426|18592044|P2|Overall Study|Withdrawal by Subject|1
5396215|NCT03052426|18592045|P1|Overall Study|Withdrawal by Subject|0
5396216|NCT03052322|18592060|P2|Overall Study|Adverse Event|13
5396217|NCT03052322|18592061|P1|Overall Study|Adverse Event|6
5396218|NCT03052322|18592060|P2|Overall Study|Lost to Follow-up|4
5396219|NCT03052322|18592061|P1|Overall Study|Lost to Follow-up|2
5396220|NCT03052322|18592060|P2|Overall Study|Protocol Violation|0
5396221|NCT03052322|18592061|P1|Overall Study|Protocol Violation|1
5396222|NCT03052322|18592060|P2|Overall Study|Lack of Efficacy|2
5396223|NCT03052322|18592061|P1|Overall Study|Lack of Efficacy|1
5396224|NCT03052322|18592060|P2|Overall Study|Death|2
5396225|NCT03052322|18592061|P1|Overall Study|Death|0
5396226|NCT03052322|18592060|P2|Overall Study|Withdrawal by Subject|9
5396227|NCT03052322|18592061|P1|Overall Study|Withdrawal by Subject|10
5396228|NCT03052322|18592060|P2|Overall Study|Other un-specified|2
5396229|NCT03052322|18592061|P1|Overall Study|Other un-specified|1
5396230|NCT03051607|18592144|P1|Overall Study|Adverse Event|66
5396231|NCT03051217|18592154|P7|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5396232|NCT03051217|18592155|P6|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
5396233|NCT03051217|18592156|P5|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5396234|NCT03051217|18592157|P4|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5396235|NCT03051217|18592158|P3|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5396236|NCT03051217|18592159|P2|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5396237|NCT03051217|18592160|P1|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
5396238|NCT03051217|18592154|P7|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5396239|NCT03051217|18592155|P6|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5396240|NCT03051217|18592156|P5|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
5396241|NCT03051217|18592157|P4|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5396242|NCT03051217|18592158|P3|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5396243|NCT03051217|18592159|P2|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5396244|NCT03051217|18592160|P1|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
5396245|NCT03051217|18592154|P7|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5396246|NCT03051217|18592155|P6|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5396247|NCT03051217|18592156|P5|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5396248|NCT03051217|18592157|P4|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
5396249|NCT03051217|18592158|P3|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5396250|NCT03051217|18592159|P2|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5396251|NCT03051217|18592160|P1|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
5396252|NCT03051217|18592154|P7|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5396253|NCT03051217|18592155|P6|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5396254|NCT03051217|18592156|P5|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5396255|NCT03051217|18592157|P4|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
5396256|NCT03051217|18592158|P3|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5396257|NCT03051217|18592159|P2|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5396258|NCT03051217|18592160|P1|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
5396259|NCT03051217|18592154|P7|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
5396260|NCT03051217|18592155|P6|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
5396261|NCT03051217|18592156|P5|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
5396262|NCT03051217|18592157|P4|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
5396263|NCT03051217|18592158|P3|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
5396264|NCT03051217|18592159|P2|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
5396265|NCT03051217|18592160|P1|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
5396266|NCT03051217|18592154|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5396267|NCT03051217|18592155|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5396268|NCT03051217|18592156|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5396269|NCT03051217|18592157|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5396270|NCT03051217|18592158|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5396271|NCT03051217|18592159|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5396272|NCT03051217|18592160|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5396273|NCT03051217|18592154|P7|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5396274|NCT03051217|18592155|P6|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5396275|NCT03051217|18592156|P5|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5396276|NCT03051217|18592157|P4|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5396277|NCT03051217|18592158|P3|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5396278|NCT03051217|18592159|P2|Initial Period (Week 0 to Week 16)|Protocol Violation|1
5396279|NCT03051217|18592160|P1|Initial Period (Week 0 to Week 16)|Protocol Violation|0
5396280|NCT03051217|18592154|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
5396281|NCT03051217|18592155|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
5396282|NCT03051217|18592156|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
5396283|NCT03051217|18592157|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
5396284|NCT03051217|18592158|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
5396285|NCT03051217|18592159|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
5396286|NCT03051217|18592160|P1|Initial Period (Week 0 to Week 16)|Adverse Event|2
5396287|NCT03051165|18592189|P1|Overall Study|Early termination of study|12
5396288|NCT03051165|18592189|P1|Overall Study|Withdrawal by Subject|1
5396289|NCT03051100|18592203|P2|Overall Study|Withdrawal by Subject|0
5396290|NCT03051100|18592204|P1|Overall Study|Withdrawal by Subject|1
5396291|NCT03050398|18592454|P1|Overall Study|Study terminated by sponsor|8
5396292|NCT03050372|18592459|P2|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
5396293|NCT03050372|18592460|P1|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
5396294|NCT03050372|18592459|P2|Adaptation Night (Night #1 PSG)|Adverse Event|0
5396295|NCT03050372|18592460|P1|Adaptation Night (Night #1 PSG)|Adverse Event|1
5396296|NCT03050359|18592483|P2|Overall Study|Reason Not Specified|0
5396297|NCT03050359|18592484|P1|Overall Study|Reason Not Specified|1
5396298|NCT03050359|18592483|P2|Overall Study|Pregnancy|0
5396299|NCT03050359|18592484|P1|Overall Study|Pregnancy|1
5396300|NCT03050359|18592483|P2|Overall Study|Voluntary Withdrawal|6
5396301|NCT03050359|18592484|P1|Overall Study|Voluntary Withdrawal|4
5396302|NCT03050359|18592483|P2|Overall Study|Lost to Follow-up|1
5396303|NCT03050359|18592484|P1|Overall Study|Lost to Follow-up|2
5396304|NCT03050359|18592483|P2|Overall Study|Significant Protocol Deviation|3
5396305|NCT03050359|18592484|P1|Overall Study|Significant Protocol Deviation|2
5396306|NCT03050359|18592483|P2|Overall Study|Pretreatment Event/Adverse Event|10
5396307|NCT03050359|18592484|P1|Overall Study|Pretreatment Event/Adverse Event|5
5396308|NCT03050359|18592483|P2|Overall Study|Randomized But Not Treated|0
5396309|NCT03050359|18592484|P1|Overall Study|Randomized But Not Treated|2
5396310|NCT03049852|18592580|P3|Overall Study|Lost to Follow-up|0
5396311|NCT03049852|18592581|P2|Overall Study|Lost to Follow-up|1
5396312|NCT03049852|18592582|P1|Overall Study|Lost to Follow-up|0
5396313|NCT03049748|18592594|P2|Overall Study|Moved out of state (relocation)|1
5396314|NCT03049748|18592595|P1|Overall Study|Moved out of state (relocation)|0
5396315|NCT03049748|18592594|P2|Overall Study|Protocol Violation|2
5396316|NCT03049748|18592595|P1|Overall Study|Protocol Violation|0
5396317|NCT03049748|18592594|P2|Overall Study|Withdrawal by Subject|3
5396318|NCT03049748|18592595|P1|Overall Study|Withdrawal by Subject|0
5396319|NCT03049748|18592594|P2|Overall Study|Death|0
5396320|NCT03049748|18592595|P1|Overall Study|Death|3
5396321|NCT03049748|18592594|P2|Overall Study|Lost to Follow-up|0
5396322|NCT03049748|18592595|P1|Overall Study|Lost to Follow-up|1
5396323|NCT03049488|18592636|P6|Overall Study|Withdrawal by Subject|0
5396324|NCT03049488|18592637|P5|Overall Study|Withdrawal by Subject|1
5396325|NCT03049488|18592638|P4|Overall Study|Withdrawal by Subject|1
5396326|NCT03049488|18592639|P3|Overall Study|Withdrawal by Subject|0
5396327|NCT03049488|18592640|P2|Overall Study|Withdrawal by Subject|0
5396328|NCT03049488|18592641|P1|Overall Study|Withdrawal by Subject|0
5396329|NCT03049488|18592636|P6|Overall Study|Physician Decision|0
5396330|NCT03049488|18592637|P5|Overall Study|Physician Decision|0
5396331|NCT03049488|18592638|P4|Overall Study|Physician Decision|0
5396332|NCT03049488|18592639|P3|Overall Study|Physician Decision|0
5396333|NCT03049488|18592640|P2|Overall Study|Physician Decision|1
5396334|NCT03049488|18592641|P1|Overall Study|Physician Decision|0
5396335|NCT03049488|18592636|P6|Overall Study|Moved from Area|0
5396336|NCT03049488|18592637|P5|Overall Study|Moved from Area|1
5396337|NCT03049488|18592638|P4|Overall Study|Moved from Area|1
5396338|NCT03049488|18592639|P3|Overall Study|Moved from Area|0
5396339|NCT03049488|18592640|P2|Overall Study|Moved from Area|0
5396340|NCT03049488|18592641|P1|Overall Study|Moved from Area|1
5396341|NCT03049488|18592636|P6|Overall Study|Lost to Follow-up|0
5396342|NCT03049488|18592637|P5|Overall Study|Lost to Follow-up|0
5396343|NCT03049488|18592638|P4|Overall Study|Lost to Follow-up|0
5396344|NCT03049488|18592639|P3|Overall Study|Lost to Follow-up|0
5396345|NCT03049488|18592640|P2|Overall Study|Lost to Follow-up|1
5396346|NCT03049488|18592641|P1|Overall Study|Lost to Follow-up|1
5396347|NCT03049280|18592724|P1|Overall Study|Physician Decision|1
5396348|NCT03048747|18592730|P1|Overall Study|Physician Decision|1
5396349|NCT03048747|18592730|P1|Overall Study|Participant Met Withdrawal Criteria|2
5396350|NCT03048747|18592730|P1|Overall Study|Adverse Event|2
5396351|NCT03048500|18592735|P1|Follow up for 3 Years|Death|12
5396352|NCT03048500|18592735|P1|Follow up for 3 Years|Currently in Follow-up|4
5396353|NCT03048500|18592735|P1|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
5396354|NCT03048500|18592735|P1|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
5396355|NCT03048500|18592735|P1|Reached 1st Response/Continued Treatment|Death|1
5396356|NCT03048500|18592735|P1|Reached 1st Response/Continued Treatment|Progressive Disease|4
5396357|NCT03048500|18592735|P1|2 Cycles of Treatment|Withdrawal by Subject|1
5396358|NCT03048058|18592758|P2|Overall Study|Withdrawal by Subject|4
5396359|NCT03048058|18592759|P1|Overall Study|Withdrawal by Subject|0
5396360|NCT03048058|18592758|P2|Overall Study|Lost to Follow-up|0
5396361|NCT03048058|18592759|P1|Overall Study|Lost to Follow-up|4
5396362|NCT03047720|18592785|P2|First Intervention (6weeks)|Participant data entry insufficient|0
5396363|NCT03047720|18592786|P1|First Intervention (6weeks)|Participant data entry insufficient|7
5396364|NCT03047551|18592800|P2|Overall Study|Ineligible|1
5396365|NCT03047551|18592801|P1|Overall Study|Ineligible|0
5396366|NCT03047551|18592800|P2|Overall Study|Probe malfunction|1
5396367|NCT03047551|18592801|P1|Overall Study|Probe malfunction|0
5396368|NCT03047551|18592800|P2|Overall Study|Withdrawal by Subject|1
5396369|NCT03047551|18592801|P1|Overall Study|Withdrawal by Subject|0
5396370|NCT03047551|18592800|P2|Overall Study|Physician Decision|0
5396371|NCT03047551|18592801|P1|Overall Study|Physician Decision|1
5396372|NCT03047551|18592800|P2|Overall Study|Did not receive TAS|0
5396373|NCT03047551|18592801|P1|Overall Study|Did not receive TAS|1
5396374|NCT03046446|18592878|P1|Overall Study|Non OA related knee surgery|1
5396375|NCT03046446|18592878|P1|Overall Study|Disease Progression (see caveats)|25
5396376|NCT03046446|18592878|P1|Overall Study|Withdrawn by Investigator/Sponsor|3
5396377|NCT03046446|18592878|P1|Overall Study|Withdrawal by Subject|14
5396378|NCT03046446|18592878|P1|Overall Study|Lost to Follow-up|3
5396379|NCT03046446|18592878|P1|Overall Study|Adverse Event|6
5396380|NCT03046446|18592878|P1|Overall Study|Lack of Efficacy|7
5396381|NCT03045887|18592941|P10|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5396382|NCT03045887|18592942|P9|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5396383|NCT03045887|18592943|P8|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5396384|NCT03045887|18592944|P7|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5396385|NCT03045887|18592945|P6|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5396386|NCT03045887|18592946|P5|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5396387|NCT03045887|18592947|P4|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
5396388|NCT03045887|18592948|P3|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5396389|NCT03045887|18592949|P2|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5396390|NCT03045887|18592950|P1|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
5396391|NCT03045887|18592941|P10|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5396392|NCT03045887|18592942|P9|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5396393|NCT03045887|18592943|P8|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5396394|NCT03045887|18592944|P7|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5396395|NCT03045887|18592945|P6|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5396396|NCT03045887|18592946|P5|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5396397|NCT03045887|18592947|P4|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
5396398|NCT03045887|18592948|P3|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
5396399|NCT03045887|18592949|P2|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5396400|NCT03045887|18592950|P1|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
5396401|NCT03045887|18592941|P10|Part A, Period 2 (1 Day)|Adverse Event|0
5396402|NCT03045887|18592942|P9|Part A, Period 2 (1 Day)|Adverse Event|0
5396403|NCT03045887|18592943|P8|Part A, Period 2 (1 Day)|Adverse Event|0
5396404|NCT03045887|18592944|P7|Part A, Period 2 (1 Day)|Adverse Event|0
5396405|NCT03045887|18592945|P6|Part A, Period 2 (1 Day)|Adverse Event|0
5396406|NCT03045887|18592946|P5|Part A, Period 2 (1 Day)|Adverse Event|0
5396407|NCT03045887|18592947|P4|Part A, Period 2 (1 Day)|Adverse Event|0
5396408|NCT03045887|18592948|P3|Part A, Period 2 (1 Day)|Adverse Event|0
5396409|NCT03045887|18592949|P2|Part A, Period 2 (1 Day)|Adverse Event|0
5396410|NCT03045887|18592950|P1|Part A, Period 2 (1 Day)|Adverse Event|1
5396411|NCT03045887|18592941|P10|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5396412|NCT03045887|18592942|P9|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5396413|NCT03045887|18592943|P8|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5396414|NCT03045887|18592944|P7|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5396415|NCT03045887|18592945|P6|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5396416|NCT03045887|18592946|P5|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5396417|NCT03045887|18592947|P4|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
5396418|NCT03045887|18592948|P3|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5396419|NCT03045887|18592949|P2|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5396420|NCT03045887|18592950|P1|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
5396421|NCT03045887|18592941|P10|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5396422|NCT03045887|18592942|P9|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5396423|NCT03045887|18592943|P8|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5396424|NCT03045887|18592944|P7|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5396425|NCT03045887|18592945|P6|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5396426|NCT03045887|18592946|P5|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5396427|NCT03045887|18592947|P4|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5396428|NCT03045887|18592948|P3|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5396429|NCT03045887|18592949|P2|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
5396430|NCT03045887|18592950|P1|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
5396431|NCT03045302|18593232|P1|Overall Study|Pre-treatment adverse event|1
5396432|NCT03045081|18593238|P2|Overall Study|Withdrawal by Subject|11
5396433|NCT03045081|18593239|P1|Overall Study|Withdrawal by Subject|6
5396434|NCT03044886|18593258|P3|Overall Study|Lost to Follow-up|12
5396435|NCT03044886|18593259|P2|Overall Study|Lost to Follow-up|10
5396436|NCT03044886|18593260|P1|Overall Study|Lost to Follow-up|15
5396437|NCT03044730|18593301|P1|On Follow-up for 2 Years|Death|17
5396438|NCT03044730|18593301|P1|On Follow-up for 2 Years|Lost to Follow-up|1
5396439|NCT03044730|18593301|P1|On Follow-up for 2 Years|Still in follow-up|7
5396440|NCT03044730|18593301|P1|Cycles 4 and Beyond|Adverse Event|1
5396441|NCT03044730|18593301|P1|Cycles 4 and Beyond|Progressive Disease|9
5396442|NCT03044730|18593301|P1|3 Cycles of Pembro + Capecitab|Adverse Event|1
5396443|NCT03044730|18593301|P1|3 Cycles of Pembro + Capecitab|Death|1
5396444|NCT03044730|18593301|P1|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
5396445|NCT03044730|18593301|P1|3 Cycles of Pembro + Capecitab|Progressive Disease|1
5396446|NCT03044574|18593321|P2|Overall Study|Lost to Follow-up|45
5396447|NCT03044574|18593322|P1|Overall Study|Lost to Follow-up|37
5396448|NCT03044431|18593348|P1|Overall Study|Lost to Follow-up|59
5396449|NCT03044353|18593361|P3|Overall Study|Adverse Event|0
5396450|NCT03044353|18593362|P2|Overall Study|Adverse Event|1
5396451|NCT03044353|18593363|P1|Overall Study|Adverse Event|0
5396452|NCT03044197|18593446|P2|Overall Study|Withdrawal by Subject|1
5396453|NCT03044197|18593447|P1|Overall Study|Withdrawal by Subject|3
5396454|NCT03044106|18593457|P2|Washout (1 Week)|Withdrawal by Subject|2
5396455|NCT03044106|18593458|P1|Washout (1 Week)|Withdrawal by Subject|0
5396456|NCT03043651|18593530|P1|Overall Study|Study Terminated by Sponsor|39
5396457|NCT03043651|18593530|P1|Overall Study|Withdrawal by Subject|4
5396458|NCT03043651|18593530|P1|Overall Study|Adverse Event|2
5396459|NCT03043651|18593530|P1|Overall Study|Progressive Disease|2
5396460|NCT03043651|18593530|P1|Overall Study|Death|1
5396461|NCT03043560|18593542|P2|Overall Study|Lost to Follow-up|1
5396462|NCT03043560|18593543|P1|Overall Study|Lost to Follow-up|0
5396463|NCT03043560|18593542|P2|Overall Study|Discontinued Intervention|2
5396464|NCT03043560|18593543|P1|Overall Study|Discontinued Intervention|1
5396465|NCT03043365|18593584|P2|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
5396466|NCT03043365|18593585|P1|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
5396467|NCT03043365|18593584|P2|Weeks 0 to Week 8|Lost to Follow-up|0
5396468|NCT03043365|18593585|P1|Weeks 0 to Week 8|Lost to Follow-up|2
5396469|NCT03043365|18593584|P2|Weeks 0 to Week 8|Adverse Event|3
5396470|NCT03043365|18593585|P1|Weeks 0 to Week 8|Adverse Event|1
5396471|NCT03042910|18593639|P1|Overall Study|Enrolled but not treated|1
5396472|NCT03042910|18593639|P1|Overall Study|Withdrawal by Subject|3
5396473|NCT03042910|18593639|P1|Overall Study|Disease Progression|2
5396474|NCT03042910|18593639|P1|Overall Study|Adverse Event|1
5396475|NCT03042559|18593683|P2|Overall Study|drop out|1
5396476|NCT03042559|18593684|P1|Overall Study|drop out|1
5396477|NCT03041792|18593819|P2|Overall Study|Randomized but not treated|1
5396478|NCT03041792|18593820|P1|Overall Study|Randomized but not treated|0
5396479|NCT03041792|18593819|P2|Overall Study|Death in the family|2
5396480|NCT03041792|18593820|P1|Overall Study|Death in the family|0
5396481|NCT03041792|18593819|P2|Overall Study|Adverse Event|0
5396482|NCT03041792|18593820|P1|Overall Study|Adverse Event|4
5396483|NCT03041181|18593893|P2|Overall Study|Disease Progression|2
5396484|NCT03041181|18593894|P1|Overall Study|Disease Progression|1
5396485|NCT03041116|18593910|P2|Open-label|Withdrawal by Subject|0
5396486|NCT03041116|18593911|P1|Open-label|Withdrawal by Subject|1
5396487|NCT03041116|18593910|P2|Open-label|Termination of the study by Sponsor|37
5396488|NCT03041116|18593911|P1|Open-label|Termination of the study by Sponsor|39
5396489|NCT03041116|18593910|P2|Open-label|Death|0
5396490|NCT03041116|18593911|P1|Open-label|Death|1
5396491|NCT03041116|18593910|P2|Double-blind|Withdrawal by Subject|4
5396492|NCT03041116|18593911|P1|Double-blind|Withdrawal by Subject|0
5396493|NCT03041116|18593910|P2|Double-blind|Death|2
5396494|NCT03041116|18593911|P1|Double-blind|Death|0
5396495|NCT03041090|18593927|P2|Overall Study|technical error|3
5396496|NCT03041090|18593928|P1|Overall Study|technical error|0
5396497|NCT03040713|18593938|P1|Overall Study|Positive amyloid scan|3
5396498|NCT03040687|18593946|P3|Overall Study|Withdrawal by Subject|0
5396499|NCT03040687|18593947|P2|Overall Study|Withdrawal by Subject|0
5396500|NCT03040687|18593948|P1|Overall Study|Withdrawal by Subject|1
5396501|NCT03040336|18594017|P2|Overall Study|Withdrawal by Subject|3
5396502|NCT03040336|18594018|P1|Overall Study|Withdrawal by Subject|2
5396503|NCT03040336|18594017|P2|Overall Study|Death|0
5396504|NCT03040336|18594018|P1|Overall Study|Death|1
5396505|NCT03039738|18594131|P2|Overall Study|Incomplete data sets|0
5396506|NCT03039738|18594132|P1|Overall Study|Incomplete data sets|54
5396507|NCT03039699|18594154|P2|Overall Study|Bacterial infection|28
5396508|NCT03039699|18594155|P1|Overall Study|Bacterial infection|12
5396509|NCT03039699|18594154|P2|Overall Study|Lack of data to assess study endpoint|3
5396510|NCT03039699|18594155|P1|Overall Study|Lack of data to assess study endpoint|5
5396511|NCT03039699|18594154|P2|Overall Study|Incorrect inclusion|4
5396512|NCT03039699|18594155|P1|Overall Study|Incorrect inclusion|5
5396513|NCT03039686|18594178|P3|Open Label Period|Withdrawal by Subject|1
5396514|NCT03039686|18594179|P2|Open Label Period|Withdrawal by Subject|3
5396515|NCT03039686|18594180|P1|Open Label Period|Withdrawal by Subject|0
5396516|NCT03039686|18594178|P3|Open Label Period|Subject Request to Discontinue Study Treatment|0
5396517|NCT03039686|18594179|P2|Open Label Period|Subject Request to Discontinue Study Treatment|1
5396518|NCT03039686|18594180|P1|Open Label Period|Subject Request to Discontinue Study Treatment|0
5396519|NCT03039686|18594178|P3|Open Label Period|Administrative Reason by Sponsor|41
5396520|NCT03039686|18594179|P2|Open Label Period|Administrative Reason by Sponsor|34
5396521|NCT03039686|18594180|P1|Open Label Period|Administrative Reason by Sponsor|0
5396522|NCT03039686|18594178|P3|Double-blind Period|Death|1
5396523|NCT03039686|18594179|P2|Double-blind Period|Death|0
5396524|NCT03039686|18594180|P1|Double-blind Period|Death|0
5396525|NCT03039686|18594178|P3|Double-blind Period|Withdrawal by Subject|1
5396526|NCT03039686|18594179|P2|Double-blind Period|Withdrawal by Subject|2
5396527|NCT03039686|18594180|P1|Double-blind Period|Withdrawal by Subject|2
5396528|NCT03039686|18594178|P3|Double-blind Period|Subject Request to Discontinue Study Treatment|0
5396529|NCT03039686|18594179|P2|Double-blind Period|Subject Request to Discontinue Study Treatment|2
5396530|NCT03039686|18594180|P1|Double-blind Period|Subject Request to Discontinue Study Treatment|1
5396531|NCT03039686|18594178|P3|Double-blind Period|Administrative Reason by Sponsor|21
5396532|NCT03039686|18594179|P2|Double-blind Period|Administrative Reason by Sponsor|25
5396533|NCT03039686|18594180|P1|Double-blind Period|Administrative Reason by Sponsor|24
5396534|NCT03039621|18594246|P2|Overall Study|Violation of non-inclusion criteria|2
5396535|NCT03039621|18594247|P1|Overall Study|Violation of non-inclusion criteria|1
5396536|NCT03039621|18594246|P2|Overall Study|Necessity to use drugs forbidden by pro|7
5396537|NCT03039621|18594247|P1|Overall Study|Necessity to use drugs forbidden by pro|4
5396538|NCT03039621|18594246|P2|Overall Study|Non-compliance with protocol requirement|5
5396539|NCT03039621|18594247|P1|Overall Study|Non-compliance with protocol requirement|4
5396540|NCT03039621|18594246|P2|Overall Study|Violation of inclusion criteria|2
5396541|NCT03039621|18594247|P1|Overall Study|Violation of inclusion criteria|3
5396542|NCT03039569|18594271|P2|Overall Study|Lost to Follow-up|4
5396543|NCT03039569|18594272|P1|Overall Study|Lost to Follow-up|5
5396544|NCT03039283|18594317|P1|Overall Study|Protocol Violation|2
5396545|NCT03039192|18594328|P2|Overall Study|Other|2
5396546|NCT03039192|18594329|P1|Overall Study|Other|3
5396547|NCT03039192|18594328|P2|Overall Study|Discontinued from treatment phase|12
5396548|NCT03039192|18594329|P1|Overall Study|Discontinued from treatment phase|19
5396549|NCT03039192|18594328|P2|Overall Study|Withdrawal by Subject|9
5396550|NCT03039192|18594329|P1|Overall Study|Withdrawal by Subject|6
5396551|NCT03039192|18594328|P2|Overall Study|Adverse event, non-fatal|2
5396552|NCT03039192|18594329|P1|Overall Study|Adverse event, non-fatal|0
5396553|NCT03039192|18594328|P2|Overall Study|Adverse event, serious fatal|1
5396554|NCT03039192|18594329|P1|Overall Study|Adverse event, serious fatal|0
5396555|NCT03039192|18594328|P2|Overall Study|Lost to Follow-up|4
5396556|NCT03039192|18594329|P1|Overall Study|Lost to Follow-up|4
5396557|NCT03038126|18594531|P2|Overall Study|Too Ill to Participate|2
5396558|NCT03038126|18594532|P1|Overall Study|Too Ill to Participate|1
5396559|NCT03038126|18594531|P2|Overall Study|Long Term Hospitalization|0
5396560|NCT03038126|18594532|P1|Overall Study|Long Term Hospitalization|2
5396561|NCT03038126|18594531|P2|Overall Study|Lost to Follow-up|1
5396562|NCT03038126|18594532|P1|Overall Study|Lost to Follow-up|0
5396563|NCT03038126|18594531|P2|Overall Study|Withdrawal by Subject|0
5396564|NCT03038126|18594532|P1|Overall Study|Withdrawal by Subject|5
5396565|NCT03038126|18594531|P2|Overall Study|Death|1
5396566|NCT03038126|18594532|P1|Overall Study|Death|1
5396567|NCT03038113|18594556|P14|Overall Study|Lost to Follow-up|0
5396568|NCT03038113|18594557|P13|Overall Study|Lost to Follow-up|0
5396569|NCT03038113|18594558|P12|Overall Study|Lost to Follow-up|0
5396570|NCT03038113|18594559|P11|Overall Study|Lost to Follow-up|0
5396571|NCT03038113|18594560|P10|Overall Study|Lost to Follow-up|0
5396572|NCT03038113|18594561|P9|Overall Study|Lost to Follow-up|0
5396573|NCT03038113|18594562|P8|Overall Study|Lost to Follow-up|0
5396574|NCT03038113|18594563|P7|Overall Study|Lost to Follow-up|1
5396575|NCT03038113|18594564|P6|Overall Study|Lost to Follow-up|0
5396576|NCT03038113|18594565|P5|Overall Study|Lost to Follow-up|0
5396577|NCT03038113|18594566|P4|Overall Study|Lost to Follow-up|0
5396578|NCT03038113|18594567|P3|Overall Study|Lost to Follow-up|0
5396579|NCT03038113|18594568|P2|Overall Study|Lost to Follow-up|0
5396580|NCT03038113|18594569|P1|Overall Study|Lost to Follow-up|0
5396581|NCT03038113|18594556|P14|Overall Study|Withdrawal by Subject|1
5396582|NCT03038113|18594557|P13|Overall Study|Withdrawal by Subject|0
5396583|NCT03038113|18594558|P12|Overall Study|Withdrawal by Subject|0
5396584|NCT03038113|18594559|P11|Overall Study|Withdrawal by Subject|0
5396585|NCT03038113|18594560|P10|Overall Study|Withdrawal by Subject|0
5396586|NCT03038113|18594561|P9|Overall Study|Withdrawal by Subject|0
5396587|NCT03038113|18594562|P8|Overall Study|Withdrawal by Subject|0
5396588|NCT03038113|18594563|P7|Overall Study|Withdrawal by Subject|0
5396589|NCT03038113|18594564|P6|Overall Study|Withdrawal by Subject|0
5396590|NCT03038113|18594565|P5|Overall Study|Withdrawal by Subject|0
5396591|NCT03038113|18594566|P4|Overall Study|Withdrawal by Subject|0
5396592|NCT03038113|18594567|P3|Overall Study|Withdrawal by Subject|1
5396593|NCT03038113|18594568|P2|Overall Study|Withdrawal by Subject|0
5396594|NCT03038113|18594569|P1|Overall Study|Withdrawal by Subject|0
5396595|NCT03037619|18594810|P2|Overall Study|Lost to Follow-up|1
5396596|NCT03037619|18594811|P1|Overall Study|Lost to Follow-up|0
5396597|NCT03037580|18594825|P2|Overall Study|Death|1
5396598|NCT03037580|18594826|P1|Overall Study|Death|0
5396599|NCT03037580|18594825|P2|Overall Study|Study Terminated by Sponsor|15
5396600|NCT03037580|18594826|P1|Overall Study|Study Terminated by Sponsor|12
5396601|NCT03037580|18594825|P2|Overall Study|Adverse Event|0
5396602|NCT03037580|18594826|P1|Overall Study|Adverse Event|1
5396603|NCT03037580|18594825|P2|Overall Study|Withdrawal by Subject|0
5396604|NCT03037580|18594826|P1|Overall Study|Withdrawal by Subject|3
5396605|NCT03037489|18594851|P2|Overall Study|Withdrawal by Subject|0
5396606|NCT03037489|18594852|P1|Overall Study|Withdrawal by Subject|3
5396607|NCT03037489|18594851|P2|Overall Study|Adverse Event|0
5396608|NCT03037489|18594852|P1|Overall Study|Adverse Event|4
5396609|NCT03037307|18594858|P6|Period 1|Did Not Meet Study Criteria|0
5396610|NCT03037307|18594859|P5|Period 1|Did Not Meet Study Criteria|0
5396611|NCT03037307|18594860|P4|Period 1|Did Not Meet Study Criteria|1
5396612|NCT03037307|18594861|P3|Period 1|Did Not Meet Study Criteria|0
5396613|NCT03037307|18594862|P2|Period 1|Did Not Meet Study Criteria|0
5396614|NCT03037307|18594863|P1|Period 1|Did Not Meet Study Criteria|0
5396615|NCT03036852|18594902|P1|Overall Study|Lost to Follow-up|1
5396616|NCT03036852|18594902|P1|Overall Study|Adverse Event|1
5396617|NCT03036852|18594902|P1|Overall Study|Lack of Efficacy|2
5396618|NCT03036852|18594902|P1|Overall Study|Death|2
5396619|NCT03036839|18594959|P3|Overall Study|Withdrew Consent|1
5396620|NCT03036839|18594960|P2|Overall Study|Withdrew Consent|0
5396621|NCT03036839|18594961|P1|Overall Study|Withdrew Consent|0
5396622|NCT03036839|18594959|P3|Overall Study|Death|3
5396623|NCT03036839|18594960|P2|Overall Study|Death|0
5396624|NCT03036839|18594961|P1|Overall Study|Death|3
5396625|NCT03036839|18594959|P3|Overall Study|Adverse Event|1
5396626|NCT03036839|18594960|P2|Overall Study|Adverse Event|0
5396627|NCT03036839|18594961|P1|Overall Study|Adverse Event|0
5396628|NCT03036124|18595220|P2|Overall Study|Withdrawal by Subject|4
5396629|NCT03036124|18595221|P1|Overall Study|Withdrawal by Subject|5
5396630|NCT03036124|18595220|P2|Overall Study|Lost to Follow-up|2
5396631|NCT03036124|18595221|P1|Overall Study|Lost to Follow-up|0
5396632|NCT03036072|18595239|P2|Overall Study|Physician Decision|1
5396633|NCT03036072|18595240|P1|Overall Study|Physician Decision|0
5396634|NCT03036072|18595239|P2|Overall Study|Withdrawal by Subject|1
5396635|NCT03036072|18595240|P1|Overall Study|Withdrawal by Subject|0
5396636|NCT03036072|18595239|P2|Overall Study|Death|1
5396637|NCT03036072|18595240|P1|Overall Study|Death|0
5396638|NCT03035942|18595260|P3|Overall Study|Adverse Event|5
5396639|NCT03035942|18595261|P2|Overall Study|Adverse Event|4
5396640|NCT03035942|18595262|P1|Overall Study|Adverse Event|8
5396641|NCT03035916|18595291|P3|Overall Study|Puncture failed|0
5396642|NCT03035916|18595292|P2|Overall Study|Puncture failed|2
5396643|NCT03035916|18595293|P1|Overall Study|Puncture failed|0
5396644|NCT03035864|18595342|P2|Follow-up Period|Other|2
5396645|NCT03035864|18595343|P1|Follow-up Period|Other|3
5396646|NCT03035864|18595342|P2|Follow-up Period|Physician Decision|0
5396647|NCT03035864|18595343|P1|Follow-up Period|Physician Decision|1
5396648|NCT03035864|18595342|P2|Follow-up Period|Lost to Follow-up|2
5396649|NCT03035864|18595343|P1|Follow-up Period|Lost to Follow-up|6
5396650|NCT03035864|18595342|P2|Follow-up Period|Adverse Event|0
5396651|NCT03035864|18595343|P1|Follow-up Period|Adverse Event|1
5396652|NCT03035864|18595342|P2|Treatment Period|Other|1
5396653|NCT03035864|18595343|P1|Treatment Period|Other|3
5396654|NCT03035864|18595342|P2|Treatment Period|Adverse Event|0
5396655|NCT03035864|18595343|P1|Treatment Period|Adverse Event|1
5396656|NCT03035032|18595417|P1|Overall Study|Physician Decision|5
5396657|NCT03035032|18595417|P1|Overall Study|Withdrawal by Subject|2
5396658|NCT03035032|18595417|P1|Overall Study|Protocol Violation|2
5396659|NCT03035032|18595417|P1|Overall Study|Progressive Disease|22
5396660|NCT03035032|18595417|P1|Overall Study|Lost to Follow-up|1
5396661|NCT03035032|18595417|P1|Overall Study|Death|9
5396662|NCT03035032|18595417|P1|Overall Study|Adverse Event|2
5396663|NCT03034967|18595438|P6|Overall Study|Adverse Event, Serious Fatal|1
5396664|NCT03034967|18595439|P5|Overall Study|Adverse Event, Serious Fatal|1
5396665|NCT03034967|18595440|P4|Overall Study|Adverse Event, Serious Fatal|2
5396666|NCT03034967|18595441|P3|Overall Study|Adverse Event, Serious Fatal|1
5396667|NCT03034967|18595442|P2|Overall Study|Adverse Event, Serious Fatal|1
5396668|NCT03034967|18595443|P1|Overall Study|Adverse Event, Serious Fatal|0
5396669|NCT03034967|18595438|P6|Overall Study|Adverse Event, non-fatal|8
5396670|NCT03034967|18595439|P5|Overall Study|Adverse Event, non-fatal|2
5396671|NCT03034967|18595440|P4|Overall Study|Adverse Event, non-fatal|0
5396672|NCT03034967|18595441|P3|Overall Study|Adverse Event, non-fatal|2
5396673|NCT03034967|18595442|P2|Overall Study|Adverse Event, non-fatal|1
5396674|NCT03034967|18595443|P1|Overall Study|Adverse Event, non-fatal|3
5396675|NCT03034967|18595438|P6|Overall Study|Lack of Efficacy|0
5396676|NCT03034967|18595439|P5|Overall Study|Lack of Efficacy|1
5396677|NCT03034967|18595440|P4|Overall Study|Lack of Efficacy|1
5396678|NCT03034967|18595441|P3|Overall Study|Lack of Efficacy|2
5396679|NCT03034967|18595442|P2|Overall Study|Lack of Efficacy|1
5396680|NCT03034967|18595443|P1|Overall Study|Lack of Efficacy|0
5396681|NCT03034967|18595438|P6|Overall Study|Protocol Violation|2
5396682|NCT03034967|18595439|P5|Overall Study|Protocol Violation|0
5396683|NCT03034967|18595440|P4|Overall Study|Protocol Violation|0
5396684|NCT03034967|18595441|P3|Overall Study|Protocol Violation|0
5396685|NCT03034967|18595442|P2|Overall Study|Protocol Violation|0
5396686|NCT03034967|18595443|P1|Overall Study|Protocol Violation|1
5396687|NCT03034967|18595438|P6|Overall Study|Liver function test abnormality|0
5396688|NCT03034967|18595439|P5|Overall Study|Liver function test abnormality|0
5396689|NCT03034967|18595440|P4|Overall Study|Liver function test abnormality|0
5396690|NCT03034967|18595441|P3|Overall Study|Liver function test abnormality|1
5396691|NCT03034967|18595442|P2|Overall Study|Liver function test abnormality|0
5396692|NCT03034967|18595443|P1|Overall Study|Liver function test abnormality|0
5396693|NCT03034967|18595438|P6|Overall Study|Lost to Follow-up|2
5396694|NCT03034967|18595439|P5|Overall Study|Lost to Follow-up|0
5396695|NCT03034967|18595440|P4|Overall Study|Lost to Follow-up|1
5396696|NCT03034967|18595441|P3|Overall Study|Lost to Follow-up|0
5396697|NCT03034967|18595442|P2|Overall Study|Lost to Follow-up|0
5396698|NCT03034967|18595443|P1|Overall Study|Lost to Follow-up|0
5396699|NCT03034967|18595438|P6|Overall Study|Physician Decision|0
5396700|NCT03034967|18595439|P5|Overall Study|Physician Decision|1
5396701|NCT03034967|18595440|P4|Overall Study|Physician Decision|1
5396702|NCT03034967|18595441|P3|Overall Study|Physician Decision|1
5396703|NCT03034967|18595442|P2|Overall Study|Physician Decision|0
5396704|NCT03034967|18595443|P1|Overall Study|Physician Decision|1
5396705|NCT03034967|18595438|P6|Overall Study|Withdrawal by Subject|2
5396706|NCT03034967|18595439|P5|Overall Study|Withdrawal by Subject|9
5396707|NCT03034967|18595440|P4|Overall Study|Withdrawal by Subject|6
5396708|NCT03034967|18595441|P3|Overall Study|Withdrawal by Subject|6
5396709|NCT03034967|18595442|P2|Overall Study|Withdrawal by Subject|2
5396710|NCT03034967|18595443|P1|Overall Study|Withdrawal by Subject|9
5396711|NCT03034954|18595641|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
5396712|NCT03034954|18595642|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
5396713|NCT03034915|18595709|P3|Overall Study|Physician Decision|2
5396714|NCT03034915|18595710|P2|Overall Study|Physician Decision|5
5396715|NCT03034915|18595711|P1|Overall Study|Physician Decision|1
5396716|NCT03034915|18595709|P3|Overall Study|Protocol-defined withdrawal criteria met|29
5396717|NCT03034915|18595710|P2|Overall Study|Protocol-defined withdrawal criteria met|26
5396718|NCT03034915|18595711|P1|Overall Study|Protocol-defined withdrawal criteria met|19
5396719|NCT03034915|18595709|P3|Overall Study|Site closed|4
5396720|NCT03034915|18595710|P2|Overall Study|Site closed|2
5396721|NCT03034915|18595711|P1|Overall Study|Site closed|2
5396722|NCT03034915|18595709|P3|Overall Study|Lack of Efficacy|18
5396723|NCT03034915|18595710|P2|Overall Study|Lack of Efficacy|16
5396724|NCT03034915|18595711|P1|Overall Study|Lack of Efficacy|8
5396725|NCT03034915|18595709|P3|Overall Study|Protocol Deviation|7
5396726|NCT03034915|18595710|P2|Overall Study|Protocol Deviation|14
5396727|NCT03034915|18595711|P1|Overall Study|Protocol Deviation|2
5396728|NCT03034915|18595709|P3|Overall Study|Withdrawal by Subject|41
5396729|NCT03034915|18595710|P2|Overall Study|Withdrawal by Subject|46
5396730|NCT03034915|18595711|P1|Overall Study|Withdrawal by Subject|29
5396731|NCT03034915|18595709|P3|Overall Study|Lost to Follow-up|3
5396732|NCT03034915|18595710|P2|Overall Study|Lost to Follow-up|13
5396733|NCT03034915|18595711|P1|Overall Study|Lost to Follow-up|5
5396734|NCT03034915|18595709|P3|Overall Study|Adverse Event|22
5396735|NCT03034915|18595710|P2|Overall Study|Adverse Event|32
5396736|NCT03034915|18595711|P1|Overall Study|Adverse Event|29
5396737|NCT03034772|18595751|P2|Overall Study|Withdrawal by Subject|1
5396738|NCT03034772|18595752|P1|Overall Study|Withdrawal by Subject|0
5396739|NCT03034772|18595751|P2|Overall Study|Adverse Event|1
5396740|NCT03034772|18595752|P1|Overall Study|Adverse Event|0
5396741|NCT03034577|18595768|P2|Overall Study|Lost to Follow-up|26
5396742|NCT03034577|18595769|P1|Overall Study|Lost to Follow-up|25
5396743|NCT03034577|18595768|P2|Overall Study|Withdrawal by Subject|9
5396744|NCT03034577|18595769|P1|Overall Study|Withdrawal by Subject|6
5396745|NCT03034460|18595787|P2|Overall Study|Personal Reasons|0
5396746|NCT03034460|18595788|P1|Overall Study|Personal Reasons|1
5396747|NCT03034460|18595787|P2|Overall Study|Withdrawal by Subject|2
5396748|NCT03034460|18595788|P1|Overall Study|Withdrawal by Subject|2
5396749|NCT03034460|18595787|P2|Overall Study|Adverse Event|1
5396750|NCT03034460|18595788|P1|Overall Study|Adverse Event|0
5396751|NCT03034057|18595830|P1|Overall Study|Medication error without associated AE|1
5396752|NCT03034057|18595830|P1|Overall Study|Adverse Event|22
5396753|NCT03034057|18595830|P1|Overall Study|Lost to Follow-up|19
5396754|NCT03034057|18595830|P1|Overall Study|Not defined|2
5396755|NCT03034057|18595830|P1|Overall Study|Protocol Violation|1
5396756|NCT03034057|18595830|P1|Overall Study|Withdrawal by Subject|10
5396757|NCT03034044|18595836|P1|Overall Study|Enrolled, but not received Xyntha|1
5396758|NCT03033745|18595859|P3|Overall Study|Withdrawal by Subject|0
5396759|NCT03033745|18595860|P2|Overall Study|Withdrawal by Subject|1
5396760|NCT03033745|18595861|P1|Overall Study|Withdrawal by Subject|0
5396761|NCT03033745|18595859|P3|Overall Study|Adverse Event|1
5396762|NCT03033745|18595860|P2|Overall Study|Adverse Event|0
5396763|NCT03033745|18595861|P1|Overall Study|Adverse Event|1
5396764|NCT03033745|18595859|P3|Overall Study|Protocol Violation|1
5396765|NCT03033745|18595860|P2|Overall Study|Protocol Violation|0
5396766|NCT03033745|18595861|P1|Overall Study|Protocol Violation|0
5396767|NCT03032523|18595957|P2|Overall Study|Physician Decision|0
5396768|NCT03032523|18595958|P1|Overall Study|Physician Decision|1
5396769|NCT03032523|18595957|P2|Overall Study|Withdrawal by Subject|2
5396770|NCT03032523|18595958|P1|Overall Study|Withdrawal by Subject|2
5396771|NCT03032510|18595970|P2|Overall Study|Physician Decision|0
5396772|NCT03032510|18595971|P1|Overall Study|Physician Decision|2
5396773|NCT03032510|18595970|P2|Overall Study|Subject noncompliance|2
5396774|NCT03032510|18595971|P1|Overall Study|Subject noncompliance|4
5396775|NCT03032510|18595970|P2|Overall Study|Withdrawal by Subject|7
5396776|NCT03032510|18595971|P1|Overall Study|Withdrawal by Subject|8
5396777|NCT03032510|18595970|P2|Overall Study|Lost to Follow-up|7
5396778|NCT03032510|18595971|P1|Overall Study|Lost to Follow-up|8
5396779|NCT03032510|18595970|P2|Overall Study|Adverse Event|2
5396780|NCT03032510|18595971|P1|Overall Study|Adverse Event|5
5396781|NCT03032380|18595992|P2|Overall Study|Other - Miscellaneous|1
5396782|NCT03032380|18595993|P1|Overall Study|Other - Miscellaneous|0
5396783|NCT03032380|18595992|P2|Overall Study|Death|34
5396784|NCT03032380|18595993|P1|Overall Study|Death|39
5396785|NCT03032380|18595992|P2|Overall Study|Recovery|1
5396786|NCT03032380|18595993|P1|Overall Study|Recovery|0
5396787|NCT03032380|18595992|P2|Overall Study|Withdrawal by Subject|3
5396788|NCT03032380|18595993|P1|Overall Study|Withdrawal by Subject|2
5396789|NCT03032380|18595992|P2|Overall Study|Lack of Efficacy|0
5396790|NCT03032380|18595993|P1|Overall Study|Lack of Efficacy|1
5396791|NCT03032380|18595992|P2|Overall Study|Adverse Event|1
5396792|NCT03032380|18595993|P1|Overall Study|Adverse Event|0
5396793|NCT03031899|18596040|P1|Overall Study|lesion disappeared after stopping habit|1
5396794|NCT03031899|18596040|P1|Overall Study|Protocol Violation|1
5396795|NCT03031678|18596057|P1|Overall Study|Study closed prior to completion|1
5396796|NCT03031496|18596066|P2|Period 1|Withdrawal by Subject|2
5396797|NCT03031496|18596067|P1|Period 1|Withdrawal by Subject|0
5396798|NCT03031496|18596066|P2|Period 1|Adverse Event|0
5396799|NCT03031496|18596067|P1|Period 1|Adverse Event|2
5396800|NCT03031431|18596103|P1|Overall Study|Infant removed by maternal request|1
5396801|NCT03030989|18596131|P2|Overall Study|No longer interested|3
5396802|NCT03030989|18596132|P1|Overall Study|No longer interested|5
5396803|NCT03030989|18596131|P2|Overall Study|Line Removed|2
5396804|NCT03030989|18596132|P1|Overall Study|Line Removed|0
5396805|NCT03030989|18596131|P2|Overall Study|Positive Blood Cultures|1
5396806|NCT03030989|18596132|P1|Overall Study|Positive Blood Cultures|2
5396807|NCT03030989|18596131|P2|Overall Study|Fatigue/Overwhelmed|5
5396808|NCT03030989|18596132|P1|Overall Study|Fatigue/Overwhelmed|1
5396809|NCT03030989|18596131|P2|Overall Study|Rash|1
5396810|NCT03030989|18596132|P1|Overall Study|Rash|2
5396811|NCT03030989|18596131|P2|Overall Study|Fever|2
5396812|NCT03030989|18596132|P1|Overall Study|Fever|2
5396813|NCT03030599|18596185|P3|Open-label Extension|Other Reason|0
5396814|NCT03030599|18596186|P2|Open-label Extension|Other Reason|0
5396815|NCT03030599|18596187|P1|Open-label Extension|Other Reason|1
5396816|NCT03030599|18596185|P3|Open-label Extension|Lack of Efficacy|0
5396817|NCT03030599|18596186|P2|Open-label Extension|Lack of Efficacy|0
5396818|NCT03030599|18596187|P1|Open-label Extension|Lack of Efficacy|1
5396819|NCT03030599|18596185|P3|Open-label Extension|Lost to Follow-up|0
5396820|NCT03030599|18596186|P2|Open-label Extension|Lost to Follow-up|0
5396821|NCT03030599|18596187|P1|Open-label Extension|Lost to Follow-up|2
5396822|NCT03030599|18596185|P3|Open-label Extension|Adverse Event|0
5396823|NCT03030599|18596186|P2|Open-label Extension|Adverse Event|0
5396824|NCT03030599|18596187|P1|Open-label Extension|Adverse Event|3
5396825|NCT03030599|18596185|P3|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
5396826|NCT03030599|18596186|P2|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
5396827|NCT03030599|18596187|P1|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
5396828|NCT03030599|18596185|P3|Double Blind Randomized Withdrawal|Randomized in error|2
5396829|NCT03030599|18596186|P2|Double Blind Randomized Withdrawal|Randomized in error|0
5396830|NCT03030599|18596187|P1|Double Blind Randomized Withdrawal|Randomized in error|0
5396831|NCT03030599|18596185|P3|Double Blind Randomized Withdrawal|Adverse Event|3
5396832|NCT03030599|18596186|P2|Double Blind Randomized Withdrawal|Adverse Event|0
5396833|NCT03030599|18596187|P1|Double Blind Randomized Withdrawal|Adverse Event|0
5396834|NCT03030599|18596185|P3|Double Blind Randomized Withdrawal|Lack of Efficacy|2
5396835|NCT03030599|18596186|P2|Double Blind Randomized Withdrawal|Lack of Efficacy|0
5396836|NCT03030599|18596187|P1|Double Blind Randomized Withdrawal|Lack of Efficacy|0
5396837|NCT03030599|18596185|P3|Stable Dose|Lost to Follow-up|0
5396838|NCT03030599|18596186|P2|Stable Dose|Lost to Follow-up|0
5396839|NCT03030599|18596187|P1|Stable Dose|Lost to Follow-up|1
5396840|NCT03030599|18596185|P3|Stable Dose|Adverse Event|0
5396841|NCT03030599|18596186|P2|Stable Dose|Adverse Event|0
5396842|NCT03030599|18596187|P1|Stable Dose|Adverse Event|1
5396843|NCT03030599|18596185|P3|Stable Dose|Protocol deviation|0
5396844|NCT03030599|18596186|P2|Stable Dose|Protocol deviation|0
5396845|NCT03030599|18596187|P1|Stable Dose|Protocol deviation|3
5396846|NCT03030599|18596185|P3|Open Label Treatment and Titration|Lost to Follow-up|0
5396847|NCT03030599|18596186|P2|Open Label Treatment and Titration|Lost to Follow-up|0
5396848|NCT03030599|18596187|P1|Open Label Treatment and Titration|Lost to Follow-up|3
5396849|NCT03030599|18596185|P3|Open Label Treatment and Titration|Sponsor decision|0
5396850|NCT03030599|18596186|P2|Open Label Treatment and Titration|Sponsor decision|0
5396851|NCT03030599|18596187|P1|Open Label Treatment and Titration|Sponsor decision|2
5396852|NCT03030599|18596185|P3|Open Label Treatment and Titration|Withdrawal by Subject|0
5396853|NCT03030599|18596186|P2|Open Label Treatment and Titration|Withdrawal by Subject|0
5396854|NCT03030599|18596187|P1|Open Label Treatment and Titration|Withdrawal by Subject|6
5396855|NCT03030599|18596185|P3|Open Label Treatment and Titration|Adverse Event|0
5396856|NCT03030599|18596186|P2|Open Label Treatment and Titration|Adverse Event|0
5396857|NCT03030599|18596187|P1|Open Label Treatment and Titration|Adverse Event|18
5396858|NCT03030599|18596185|P3|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
5396859|NCT03030599|18596186|P2|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
5396860|NCT03030599|18596187|P1|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
5396861|NCT03030599|18596185|P3|Open Label Treatment and Titration|Lack of Efficacy|0
5396862|NCT03030599|18596186|P2|Open Label Treatment and Titration|Lack of Efficacy|0
5396863|NCT03030599|18596187|P1|Open Label Treatment and Titration|Lack of Efficacy|1
5396864|NCT03030599|18596185|P3|Open Label Treatment and Titration|Physician Decision|0
5396865|NCT03030599|18596186|P2|Open Label Treatment and Titration|Physician Decision|0
5396866|NCT03030599|18596187|P1|Open Label Treatment and Titration|Physician Decision|3
5396867|NCT03030599|18596185|P3|Open Label Treatment and Titration|Other|0
5396868|NCT03030599|18596186|P2|Open Label Treatment and Titration|Other|0
5396869|NCT03030599|18596187|P1|Open Label Treatment and Titration|Other|1
5396870|NCT03030599|18596185|P3|Open Label Treatment and Titration|Protocol deviation|0
5396871|NCT03030599|18596186|P2|Open Label Treatment and Titration|Protocol deviation|0
5396872|NCT03030599|18596187|P1|Open Label Treatment and Titration|Protocol deviation|8
5396873|NCT03029832|18596220|P2|Overall Study|Study Terminated By Sponsor|1
5396874|NCT03029832|18596221|P1|Overall Study|Study Terminated By Sponsor|1
5396875|NCT03029832|18596220|P2|Overall Study|Death due to Disease Progression|0
5396876|NCT03029832|18596221|P1|Overall Study|Death due to Disease Progression|1
5396877|NCT03029832|18596220|P2|Overall Study|Safety Follow-Up Completed|0
5396878|NCT03029832|18596221|P1|Overall Study|Safety Follow-Up Completed|2
5396879|NCT03029819|18596251|P2|Overall Study|Removed due to disruptive behavior|1
5396880|NCT03029819|18596252|P1|Overall Study|Removed due to disruptive behavior|0
5396881|NCT03029819|18596251|P2|Overall Study|Lost to Follow-up|5
5396882|NCT03029819|18596252|P1|Overall Study|Lost to Follow-up|3
5396883|NCT03029780|18596266|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
5396884|NCT03029780|18596267|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
5396885|NCT03029780|18596266|P2|Overall Study|Study Drug Toxicity|5
5396886|NCT03029780|18596267|P1|Overall Study|Study Drug Toxicity|5
5396887|NCT03029780|18596266|P2|Overall Study|Disease Progression|3
5396888|NCT03029780|18596267|P1|Overall Study|Disease Progression|1
5396889|NCT03029650|18596290|P2|Washout (1 Week)|Physician Decision|1
5396890|NCT03029650|18596291|P1|Washout (1 Week)|Physician Decision|0
5396891|NCT03029650|18596290|P2|Washout (1 Week)|Withdrawal by Subject|1
5396892|NCT03029650|18596291|P1|Washout (1 Week)|Withdrawal by Subject|1
5396893|NCT03029624|18596306|P1|Overall Study|MRI need|2
5396894|NCT03029624|18596306|P1|Overall Study|Lack of Efficacy|1
5396895|NCT03029624|18596306|P1|Overall Study|Withdrawal by Subject|1
5396896|NCT03029624|18596306|P1|Overall Study|Adverse Event|1
5396897|NCT03029234|18596313|P1|Overall Study|Death|61
5396898|NCT03029234|18596313|P1|Overall Study|Withdrawal by Subject|5
5396899|NCT03029234|18596313|P1|Overall Study|Sponsor Decision|1
5396900|NCT03028870|18596436|P4|Overall Study|Administrative|4
5396901|NCT03028870|18596437|P3|Overall Study|Administrative|12
5396902|NCT03028870|18596438|P2|Overall Study|Administrative|5
5396903|NCT03028870|18596439|P1|Overall Study|Administrative|5
5396904|NCT03028870|18596436|P4|Overall Study|Lack of Efficacy|0
5396905|NCT03028870|18596437|P3|Overall Study|Lack of Efficacy|0
5396906|NCT03028870|18596438|P2|Overall Study|Lack of Efficacy|0
5396907|NCT03028870|18596439|P1|Overall Study|Lack of Efficacy|3
5396908|NCT03028870|18596436|P4|Overall Study|Lost to Follow-up|0
5396909|NCT03028870|18596437|P3|Overall Study|Lost to Follow-up|0
5396910|NCT03028870|18596438|P2|Overall Study|Lost to Follow-up|0
5396911|NCT03028870|18596439|P1|Overall Study|Lost to Follow-up|1
5396912|NCT03028870|18596436|P4|Overall Study|Withdrawal by Subject|2
5396913|NCT03028870|18596437|P3|Overall Study|Withdrawal by Subject|1
5396914|NCT03028870|18596438|P2|Overall Study|Withdrawal by Subject|1
5396915|NCT03028870|18596439|P1|Overall Study|Withdrawal by Subject|1
5396916|NCT03028870|18596436|P4|Overall Study|Adverse Event|3
5396917|NCT03028870|18596437|P3|Overall Study|Adverse Event|3
5396918|NCT03028870|18596438|P2|Overall Study|Adverse Event|4
5396919|NCT03028870|18596439|P1|Overall Study|Adverse Event|7
5396920|NCT03028142|18596644|P6|Overall Study|Withdrawal by Subject|0
5396921|NCT03028142|18596645|P5|Overall Study|Withdrawal by Subject|1
5396922|NCT03028142|18596646|P4|Overall Study|Withdrawal by Subject|0
5396923|NCT03028142|18596647|P3|Overall Study|Withdrawal by Subject|0
5396924|NCT03028142|18596648|P2|Overall Study|Withdrawal by Subject|0
5396925|NCT03028142|18596649|P1|Overall Study|Withdrawal by Subject|0
5396926|NCT03028142|18596644|P6|Overall Study|Adverse Event|1
5396927|NCT03028142|18596645|P5|Overall Study|Adverse Event|0
5396928|NCT03028142|18596646|P4|Overall Study|Adverse Event|0
5396929|NCT03028142|18596647|P3|Overall Study|Adverse Event|0
5396930|NCT03028142|18596648|P2|Overall Study|Adverse Event|1
5396931|NCT03028142|18596649|P1|Overall Study|Adverse Event|1
5396932|NCT03028129|18596668|P2|Overall Study|Withdrawal by Subject|45
5396933|NCT03028129|18596669|P1|Overall Study|Withdrawal by Subject|62
5396934|NCT03028129|18596668|P2|Overall Study|Protocol Violation|1
5396935|NCT03028129|18596669|P1|Overall Study|Protocol Violation|1
5396936|NCT03028129|18596668|P2|Overall Study|Physician Decision|1
5396937|NCT03028129|18596669|P1|Overall Study|Physician Decision|0
5396938|NCT03028129|18596668|P2|Overall Study|Lost to Follow-up|38
5396939|NCT03028129|18596669|P1|Overall Study|Lost to Follow-up|50
5396940|NCT03028129|18596668|P2|Overall Study|Adverse Event|2
5396941|NCT03028129|18596669|P1|Overall Study|Adverse Event|13
5396942|NCT03028012|18596689|P3|Overall Study|Lost to Follow-up|3
5396943|NCT03028012|18596690|P2|Overall Study|Lost to Follow-up|3
5396944|NCT03028012|18596691|P1|Overall Study|Lost to Follow-up|2
5396945|NCT03026530|18596784|P2|Overall Study|Protocol Violation|5
5396946|NCT03026530|18596785|P1|Overall Study|Protocol Violation|2
5396947|NCT03026530|18596784|P2|Overall Study|Lost to Follow-up|24
5396948|NCT03026530|18596785|P1|Overall Study|Lost to Follow-up|19
5396949|NCT03026283|18596793|P8|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5396950|NCT03026283|18596794|P7|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5396951|NCT03026283|18596795|P6|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
5396952|NCT03026283|18596796|P5|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
5396953|NCT03026283|18596797|P4|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5396954|NCT03026283|18596798|P3|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5396955|NCT03026283|18596799|P2|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5396956|NCT03026283|18596800|P1|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
5396957|NCT03026283|18596793|P8|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5396958|NCT03026283|18596794|P7|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5396959|NCT03026283|18596795|P6|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5396960|NCT03026283|18596796|P5|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5396961|NCT03026283|18596797|P4|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
5396962|NCT03026283|18596798|P3|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5396963|NCT03026283|18596799|P2|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5396964|NCT03026283|18596800|P1|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
5396965|NCT03026283|18596793|P8|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5396966|NCT03026283|18596794|P7|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5396967|NCT03026283|18596795|P6|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
5396968|NCT03026283|18596796|P5|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5396969|NCT03026283|18596797|P4|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
5396970|NCT03026283|18596798|P3|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5396971|NCT03026283|18596799|P2|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5396972|NCT03026283|18596800|P1|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
5396973|NCT03026283|18596793|P8|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5396974|NCT03026283|18596794|P7|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5396975|NCT03026283|18596795|P6|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
5396976|NCT03026283|18596796|P5|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
5396977|NCT03026283|18596797|P4|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
5396978|NCT03026283|18596798|P3|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5396979|NCT03026283|18596799|P2|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5396980|NCT03026283|18596800|P1|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
5396981|NCT03026283|18596793|P8|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5396982|NCT03026283|18596794|P7|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5396983|NCT03026283|18596795|P6|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5396984|NCT03026283|18596796|P5|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
5396985|NCT03026283|18596797|P4|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
5396986|NCT03026283|18596798|P3|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5396987|NCT03026283|18596799|P2|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5396988|NCT03026283|18596800|P1|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
5396989|NCT03026283|18596793|P8|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5396990|NCT03026283|18596794|P7|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5396991|NCT03026283|18596795|P6|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5396992|NCT03026283|18596796|P5|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5396993|NCT03026283|18596797|P4|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5396994|NCT03026283|18596798|P3|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
5396995|NCT03026283|18596799|P2|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5396996|NCT03026283|18596800|P1|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
5396997|NCT03026283|18596793|P8|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5396998|NCT03026283|18596794|P7|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5396999|NCT03026283|18596795|P6|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5397000|NCT03026283|18596796|P5|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5397001|NCT03026283|18596797|P4|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5397002|NCT03026283|18596798|P3|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5397003|NCT03026283|18596799|P2|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
5397004|NCT03026283|18596800|P1|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
5397005|NCT03026283|18596793|P8|CCTA Diagnosis|Withdrawal by Subject|0
5397006|NCT03026283|18596794|P7|CCTA Diagnosis|Withdrawal by Subject|0
5397007|NCT03026283|18596795|P6|CCTA Diagnosis|Withdrawal by Subject|0
5397008|NCT03026283|18596796|P5|CCTA Diagnosis|Withdrawal by Subject|0
5397009|NCT03026283|18596797|P4|CCTA Diagnosis|Withdrawal by Subject|0
5397010|NCT03026283|18596798|P3|CCTA Diagnosis|Withdrawal by Subject|0
5397011|NCT03026283|18596799|P2|CCTA Diagnosis|Withdrawal by Subject|0
5397012|NCT03026283|18596800|P1|CCTA Diagnosis|Withdrawal by Subject|5
5397013|NCT03026283|18596793|P8|CCTA Diagnosis|CCTA not performed as planned|0
5397014|NCT03026283|18596794|P7|CCTA Diagnosis|CCTA not performed as planned|0
5397015|NCT03026283|18596795|P6|CCTA Diagnosis|CCTA not performed as planned|0
5397016|NCT03026283|18596796|P5|CCTA Diagnosis|CCTA not performed as planned|0
5397017|NCT03026283|18596797|P4|CCTA Diagnosis|CCTA not performed as planned|0
5397018|NCT03026283|18596798|P3|CCTA Diagnosis|CCTA not performed as planned|0
5397019|NCT03026283|18596799|P2|CCTA Diagnosis|CCTA not performed as planned|0
5397020|NCT03026283|18596800|P1|CCTA Diagnosis|CCTA not performed as planned|9
5397021|NCT03026257|18596821|P6|Overall Study|Withdrawal by Subject|0
5397022|NCT03026257|18596822|P5|Overall Study|Withdrawal by Subject|0
5397023|NCT03026257|18596823|P4|Overall Study|Withdrawal by Subject|0
5397024|NCT03026257|18596824|P3|Overall Study|Withdrawal by Subject|0
5397025|NCT03026257|18596825|P2|Overall Study|Withdrawal by Subject|1
5397026|NCT03026257|18596826|P1|Overall Study|Withdrawal by Subject|1
5397027|NCT03026257|18596821|P6|Overall Study|Protocol Violation|0
5397028|NCT03026257|18596822|P5|Overall Study|Protocol Violation|1
5397029|NCT03026257|18596823|P4|Overall Study|Protocol Violation|1
5397030|NCT03026257|18596824|P3|Overall Study|Protocol Violation|0
5397031|NCT03026257|18596825|P2|Overall Study|Protocol Violation|0
5397032|NCT03026257|18596826|P1|Overall Study|Protocol Violation|1
5397033|NCT03026257|18596821|P6|Overall Study|Lost to Follow-up|0
5397034|NCT03026257|18596822|P5|Overall Study|Lost to Follow-up|0
5397035|NCT03026257|18596823|P4|Overall Study|Lost to Follow-up|0
5397036|NCT03026257|18596824|P3|Overall Study|Lost to Follow-up|0
5397037|NCT03026257|18596825|P2|Overall Study|Lost to Follow-up|0
5397038|NCT03026257|18596826|P1|Overall Study|Lost to Follow-up|1
5397039|NCT03026257|18596821|P6|Overall Study|Adverse Event|0
5397040|NCT03026257|18596822|P5|Overall Study|Adverse Event|0
5397041|NCT03026257|18596823|P4|Overall Study|Adverse Event|0
5397042|NCT03026257|18596824|P3|Overall Study|Adverse Event|0
5397043|NCT03026257|18596825|P2|Overall Study|Adverse Event|0
5397044|NCT03026257|18596826|P1|Overall Study|Adverse Event|3
5397045|NCT03026166|18596842|P2|Overall Study|Other|0
5397046|NCT03026166|18596843|P1|Overall Study|Other|1
5397047|NCT03026166|18596842|P2|Overall Study|Study Terminated by Sponsor|3
5397048|NCT03026166|18596843|P1|Overall Study|Study Terminated by Sponsor|3
5397049|NCT03026166|18596842|P2|Overall Study|Lost to Follow-up|0
5397050|NCT03026166|18596843|P1|Overall Study|Lost to Follow-up|1
5397051|NCT03026166|18596842|P2|Overall Study|Withdrawal by Subject|2
5397052|NCT03026166|18596843|P1|Overall Study|Withdrawal by Subject|1
5397053|NCT03026166|18596842|P2|Overall Study|Physician Decision|0
5397054|NCT03026166|18596843|P1|Overall Study|Physician Decision|2
5397055|NCT03026166|18596842|P2|Overall Study|Death|7
5397056|NCT03026166|18596843|P1|Overall Study|Death|22
5397057|NCT03026088|18596859|P1|Overall Study|Study termination|20
5397058|NCT03026075|18596883|P1|Overall Study|Physician Decision|1
5397059|NCT03025217|18596896|P1|Overall Study|Not eligible, poor English|2
5397060|NCT03025217|18596896|P1|Overall Study|Lost to Follow-up|1
5397061|NCT03025217|18596896|P1|Overall Study|Pregnancy|1
5397062|NCT03024970|18596901|P2|Second Intervention|Lost to Follow-up|0
5397063|NCT03024970|18596902|P1|Second Intervention|Lost to Follow-up|1
5397064|NCT03024970|18596901|P2|First Intervention|Adverse Event|0
5397065|NCT03024970|18596902|P1|First Intervention|Adverse Event|1
5397066|NCT03024606|18596980|P2|Overall Study|Withdrawal by Subject|10
5397067|NCT03024606|18596981|P1|Overall Study|Withdrawal by Subject|9
5397068|NCT03023878|18597009|P1|Long Term Follow-Up Period|Death|2
5397069|NCT03023878|18597009|P1|Treatment Period|Adverse Event|1
5397070|NCT03023878|18597009|P1|Treatment Period|Withdrawal by Subject|1
5397071|NCT03023878|18597009|P1|Treatment Period|Disease Progression|1
5397072|NCT03023878|18597009|P1|Between Run-In and Treatment Periods|Protocol-specified criteria|2
5397073|NCT03023878|18597009|P1|Pre-Study Run-In Period|Withdrawal by Subject|5
5397074|NCT03023878|18597009|P1|Pre-Study Run-In Period|Death|1
5397075|NCT03023878|18597009|P1|Pre-Study Run-In Period|Protocol-specified criteria|11
5397076|NCT03023423|18597071|P3|Overall Study|Ongoing|24
5397077|NCT03023423|18597072|P2|Overall Study|Ongoing|32
5397078|NCT03023423|18597073|P1|Overall Study|Ongoing|2
5397079|NCT03023423|18597071|P3|Overall Study|Other|2
5397080|NCT03023423|18597072|P2|Overall Study|Other|2
5397081|NCT03023423|18597073|P1|Overall Study|Other|0
5397082|NCT03023423|18597071|P3|Overall Study|Death|20
5397083|NCT03023423|18597072|P2|Overall Study|Death|12
5397084|NCT03023423|18597073|P1|Overall Study|Death|5
5397085|NCT03023137|18597110|P2|Overall Study|Lost the baby in a car accident|0
5397086|NCT03023137|18597111|P1|Overall Study|Lost the baby in a car accident|1
5397087|NCT03023137|18597110|P2|Overall Study|Protocol Violation|4
5397088|NCT03023137|18597111|P1|Overall Study|Protocol Violation|0
5397089|NCT03023137|18597110|P2|Overall Study|Lost to Follow-up|1
5397090|NCT03023137|18597111|P1|Overall Study|Lost to Follow-up|1
5397091|NCT03023137|18597110|P2|Overall Study|Multiple pregnancy|4
5397092|NCT03023137|18597111|P1|Overall Study|Multiple pregnancy|2
5397093|NCT03022981|18597140|P3|Overall Study|Withdrew Assent By Parent/Guardian|1
5397094|NCT03022981|18597141|P2|Overall Study|Withdrew Assent By Parent/Guardian|0
5397095|NCT03022981|18597142|P1|Overall Study|Withdrew Assent By Parent/Guardian|0
5397096|NCT03022981|18597140|P3|Overall Study|Non-Compliance With Study Drug|2
5397097|NCT03022981|18597141|P2|Overall Study|Non-Compliance With Study Drug|0
5397098|NCT03022981|18597142|P1|Overall Study|Non-Compliance With Study Drug|0
5397099|NCT03022981|18597140|P3|Overall Study|Lost to Follow-up|1
5397100|NCT03022981|18597141|P2|Overall Study|Lost to Follow-up|2
5397101|NCT03022981|18597142|P1|Overall Study|Lost to Follow-up|6
5397102|NCT03022981|18597140|P3|Overall Study|Investigator's Discretion|2
5397103|NCT03022981|18597141|P2|Overall Study|Investigator's Discretion|1
5397104|NCT03022981|18597142|P1|Overall Study|Investigator's Discretion|0
5397105|NCT03022981|18597140|P3|Overall Study|Adverse Event|0
5397106|NCT03022981|18597141|P2|Overall Study|Adverse Event|1
5397107|NCT03022981|18597142|P1|Overall Study|Adverse Event|0
5397108|NCT03022799|18597241|P13|Overall Study|Adverse Event|0
5397109|NCT03022799|18597242|P12|Overall Study|Adverse Event|0
5397110|NCT03022799|18597243|P11|Overall Study|Adverse Event|1
5397111|NCT03022799|18597244|P10|Overall Study|Adverse Event|1
5397112|NCT03022799|18597245|P9|Overall Study|Adverse Event|0
5397113|NCT03022799|18597246|P8|Overall Study|Adverse Event|0
5397114|NCT03022799|18597247|P7|Overall Study|Adverse Event|0
5397115|NCT03022799|18597248|P6|Overall Study|Adverse Event|0
5397116|NCT03022799|18597249|P5|Overall Study|Adverse Event|0
5397117|NCT03022799|18597250|P4|Overall Study|Adverse Event|0
5397118|NCT03022799|18597251|P3|Overall Study|Adverse Event|0
5397119|NCT03022799|18597252|P2|Overall Study|Adverse Event|0
5397120|NCT03022799|18597253|P1|Overall Study|Adverse Event|0
5397121|NCT03022630|18597450|P2|Overall Study|Withdrawal by Subject|5
5397122|NCT03022630|18597451|P1|Overall Study|Withdrawal by Subject|0
5397123|NCT03022630|18597450|P2|Overall Study|Death|7
5397124|NCT03022630|18597451|P1|Overall Study|Death|9
5397125|NCT03022422|18597568|P6|Overall Study|3 subjects consented but not vaccinated|0
5397126|NCT03022422|18597569|P5|Overall Study|3 subjects consented but not vaccinated|0
5397127|NCT03022422|18597570|P4|Overall Study|3 subjects consented but not vaccinated|0
5397128|NCT03022422|18597571|P3|Overall Study|3 subjects consented but not vaccinated|3
5397129|NCT03022422|18597572|P2|Overall Study|3 subjects consented but not vaccinated|0
5397130|NCT03022422|18597573|P1|Overall Study|3 subjects consented but not vaccinated|0
5397131|NCT03022370|18597628|P2|Overall Study|Lost to Follow-up|109
5397132|NCT03022370|18597629|P1|Overall Study|Lost to Follow-up|174
5397133|NCT03022370|18597628|P2|Overall Study|Death|12
5397134|NCT03022370|18597629|P1|Overall Study|Death|6
5397135|NCT03022084|18597705|P2|Overall Study|Lost to Follow-up|3
5397136|NCT03022084|18597706|P1|Overall Study|Lost to Follow-up|2
5397137|NCT03022045|18597714|P2|Overall Study|Withdrawal by Subject|1
5397138|NCT03022045|18597715|P1|Overall Study|Withdrawal by Subject|1
5397139|NCT03022045|18597714|P2|Overall Study|Adverse Event|1
5397140|NCT03022045|18597715|P1|Overall Study|Adverse Event|0
5397141|NCT03021668|18597744|P2|Overall Study|Physician Decision|1
5397142|NCT03021668|18597745|P1|Overall Study|Physician Decision|0
5397143|NCT03021642|18597757|P2|Washout Period (21 Days)|Adverse Event|1
5397144|NCT03021642|18597758|P1|Washout Period (21 Days)|Adverse Event|1
5397145|NCT03021564|18597798|P2|Overall Study|Lost to Follow-up|2
5397146|NCT03021564|18597799|P1|Overall Study|Lost to Follow-up|0
5397147|NCT03021564|18597798|P2|Overall Study|Death|466
5397148|NCT03021564|18597799|P1|Overall Study|Death|84
5397149|NCT03021304|18597843|P1|Overall Study|Lack of Efficacy|1
5397150|NCT03021265|18597848|P1|Overall Study|No visit since the first visit|4
5397151|NCT03021265|18597848|P1|Overall Study|No reason given|2
5397152|NCT03021265|18597848|P1|Overall Study|Lost to Follow-up|67
5397153|NCT03021265|18597848|P1|Overall Study|Improved|17
5397154|NCT03021265|18597848|P1|Overall Study|Lack of Efficacy|3
5397155|NCT03021265|18597848|P1|Overall Study|Adverse Event|29
5397156|NCT03021187|18597858|P4|Overall Study|Lost to Follow-up|4
5397157|NCT03021187|18597859|P3|Overall Study|Lost to Follow-up|1
5397158|NCT03021187|18597860|P2|Overall Study|Lost to Follow-up|3
5397159|NCT03021187|18597861|P1|Overall Study|Lost to Follow-up|10
5397160|NCT03021187|18597858|P4|Overall Study|Withdrawal by Subject|5
5397161|NCT03021187|18597859|P3|Overall Study|Withdrawal by Subject|2
5397162|NCT03021187|18597860|P2|Overall Study|Withdrawal by Subject|6
5397163|NCT03021187|18597861|P1|Overall Study|Withdrawal by Subject|0
5397164|NCT03021187|18597858|P4|Overall Study|Death|0
5397165|NCT03021187|18597859|P3|Overall Study|Death|3
5397166|NCT03021187|18597860|P2|Overall Study|Death|0
5397167|NCT03021187|18597861|P1|Overall Study|Death|0
5397168|NCT03021018|18598017|P3|Overall Study|Fall with subsequent nasal fracture|0
5397169|NCT03021018|18598018|P2|Overall Study|Fall with subsequent nasal fracture|0
5397170|NCT03021018|18598019|P1|Overall Study|Fall with subsequent nasal fracture|1
5397171|NCT03021018|18598017|P3|Overall Study|Adverse Event|0
5397172|NCT03021018|18598018|P2|Overall Study|Adverse Event|0
5397173|NCT03021018|18598019|P1|Overall Study|Adverse Event|1
5397174|NCT03021005|18598050|P2|Overall Study|Lost to Follow-up|26
5397175|NCT03021005|18598051|P1|Overall Study|Lost to Follow-up|39
5397176|NCT03020992|18598057|P1|Overall Study|Withdrawal by Subject|1
5397177|NCT03020992|18598057|P1|Overall Study|Adverse Event|5
5397178|NCT03020745|18598100|P10|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5397179|NCT03020745|18598101|P9|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
5397180|NCT03020745|18598102|P8|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5397181|NCT03020745|18598103|P7|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5397182|NCT03020745|18598104|P6|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5397183|NCT03020745|18598105|P5|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5397184|NCT03020745|18598106|P4|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5397185|NCT03020745|18598107|P3|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5397186|NCT03020745|18598108|P2|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5397187|NCT03020745|18598109|P1|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
5397188|NCT03020745|18598100|P10|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5397189|NCT03020745|18598101|P9|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
5397190|NCT03020745|18598102|P8|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5397191|NCT03020745|18598103|P7|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5397192|NCT03020745|18598104|P6|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
5397193|NCT03020745|18598105|P5|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5397194|NCT03020745|18598106|P4|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5397195|NCT03020745|18598107|P3|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5397196|NCT03020745|18598108|P2|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5397197|NCT03020745|18598109|P1|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
5397198|NCT03020745|18598100|P10|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5397199|NCT03020745|18598101|P9|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5397200|NCT03020745|18598102|P8|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
5397201|NCT03020745|18598103|P7|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5397202|NCT03020745|18598104|P6|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5397203|NCT03020745|18598105|P5|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5397204|NCT03020745|18598106|P4|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5397205|NCT03020745|18598107|P3|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5397206|NCT03020745|18598108|P2|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5397207|NCT03020745|18598109|P1|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
5397208|NCT03020745|18598100|P10|Part 2 (Up to 169 Days)|Adverse Event|0
5397209|NCT03020745|18598101|P9|Part 2 (Up to 169 Days)|Adverse Event|1
5397210|NCT03020745|18598102|P8|Part 2 (Up to 169 Days)|Adverse Event|0
5397211|NCT03020745|18598103|P7|Part 2 (Up to 169 Days)|Adverse Event|0
5397212|NCT03020745|18598104|P6|Part 2 (Up to 169 Days)|Adverse Event|0
5397213|NCT03020745|18598105|P5|Part 2 (Up to 169 Days)|Adverse Event|0
5397214|NCT03020745|18598106|P4|Part 2 (Up to 169 Days)|Adverse Event|0
5397215|NCT03020745|18598107|P3|Part 2 (Up to 169 Days)|Adverse Event|0
5397216|NCT03020745|18598108|P2|Part 2 (Up to 169 Days)|Adverse Event|0
5397217|NCT03020745|18598109|P1|Part 2 (Up to 169 Days)|Adverse Event|0
5397218|NCT03020576|18598470|P2|Overall Study|Withdrawal by Subject|2
5397219|NCT03020576|18598471|P1|Overall Study|Withdrawal by Subject|1
5397220|NCT03020160|18598545|P2|Overall Study|Continuing to receive emicizumab|41
5397221|NCT03020160|18598546|P1|Overall Study|Continuing to receive emicizumab|7
5397222|NCT03020069|18598605|P2|Overall Study|Lost to Follow-up|1
5397223|NCT03020069|18598606|P1|Overall Study|Lost to Follow-up|0
5397224|NCT03019627|18598652|P2|Overall Study|Other|2
5397225|NCT03019627|18598653|P1|Overall Study|Other|2
5397226|NCT03019627|18598652|P2|Overall Study|not compliance|2
5397227|NCT03019627|18598653|P1|Overall Study|not compliance|2
5397228|NCT03019627|18598652|P2|Overall Study|Lost to Follow-up|1
5397229|NCT03019627|18598653|P1|Overall Study|Lost to Follow-up|2
5397230|NCT03019627|18598652|P2|Overall Study|Unrelated to adverse event|3
5397231|NCT03019627|18598653|P1|Overall Study|Unrelated to adverse event|1
5397232|NCT03019627|18598652|P2|Overall Study|Adverse Event|0
5397233|NCT03019627|18598653|P1|Overall Study|Adverse Event|8
5397234|NCT03019549|18598669|P1|Period 2|Withdrawal by Subject|1
5397235|NCT03019549|18598669|P1|Period 2|Physician Decision|2
5397236|NCT03019549|18598669|P1|Period 2|Adverse Event|2
5397237|NCT03019549|18598669|P1|Washout|DId not meet genotype criteria|11
5397238|NCT03019458|18598682|P2|Overall Study|Death|1
5397239|NCT03019458|18598683|P1|Overall Study|Death|0
5397240|NCT03018938|18598697|P2|Overall Study|Not recorded|2
5397241|NCT03018938|18598698|P1|Overall Study|Not recorded|0
5397242|NCT03018938|18598697|P2|Overall Study|Screen failure-After randomization|2
5397243|NCT03018938|18598698|P1|Overall Study|Screen failure-After randomization|4
5397244|NCT03018938|18598697|P2|Overall Study|Sponsor Decision|1
5397245|NCT03018938|18598698|P1|Overall Study|Sponsor Decision|0
5397246|NCT03018938|18598697|P2|Overall Study|Physician Decision|2
5397247|NCT03018938|18598698|P1|Overall Study|Physician Decision|3
5397248|NCT03018938|18598697|P2|Overall Study|Withdrawal by Subject|45
5397249|NCT03018938|18598698|P1|Overall Study|Withdrawal by Subject|38
5397250|NCT03018938|18598697|P2|Overall Study|Lost to Follow-up|32
5397251|NCT03018938|18598698|P1|Overall Study|Lost to Follow-up|21
5397252|NCT03018938|18598697|P2|Overall Study|Death|1
5397253|NCT03018938|18598698|P1|Overall Study|Death|0
5397254|NCT03018691|18598737|P3|Overall Study|Withdrawal by parent/guardian|1
5397255|NCT03018691|18598738|P2|Overall Study|Withdrawal by parent/guardian|0
5397256|NCT03018691|18598739|P1|Overall Study|Withdrawal by parent/guardian|1
5397257|NCT03018691|18598737|P3|Overall Study|Withdrawal by Subject|1
5397258|NCT03018691|18598738|P2|Overall Study|Withdrawal by Subject|0
5397259|NCT03018691|18598739|P1|Overall Study|Withdrawal by Subject|0
5397260|NCT03018691|18598737|P3|Overall Study|Lack of Efficacy|1
5397261|NCT03018691|18598738|P2|Overall Study|Lack of Efficacy|0
5397262|NCT03018691|18598739|P1|Overall Study|Lack of Efficacy|0
5397263|NCT03018691|18598737|P3|Overall Study|Adverse Event|4
5397264|NCT03018691|18598738|P2|Overall Study|Adverse Event|1
5397265|NCT03018691|18598739|P1|Overall Study|Adverse Event|1
5397266|NCT03018340|18598775|P2|Overall Study|Not further specified|1
5397267|NCT03018340|18598776|P1|Overall Study|Not further specified|0
5397268|NCT03018340|18598775|P2|Overall Study|Protocol Violation|7
5397269|NCT03018340|18598776|P1|Overall Study|Protocol Violation|3
5397270|NCT03018340|18598775|P2|Overall Study|Lost to Follow-up|7
5397271|NCT03018340|18598776|P1|Overall Study|Lost to Follow-up|1
5397272|NCT03018340|18598775|P2|Overall Study|Non-compliance with study drug/procedure|4
5397273|NCT03018340|18598776|P1|Overall Study|Non-compliance with study drug/procedure|3
5397274|NCT03018340|18598775|P2|Overall Study|Lack of Efficacy|1
5397275|NCT03018340|18598776|P1|Overall Study|Lack of Efficacy|0
5397276|NCT03018340|18598775|P2|Overall Study|Withdrawal by Subject|8
5397277|NCT03018340|18598776|P1|Overall Study|Withdrawal by Subject|0
5397278|NCT03018340|18598775|P2|Overall Study|Adverse Event|2
5397279|NCT03018340|18598776|P1|Overall Study|Adverse Event|1
5397280|NCT03018106|18598835|P2|Overall Study|Lost to Follow-up|1
5397281|NCT03018106|18598836|P1|Overall Study|Lost to Follow-up|0
5397282|NCT03018028|18598849|P5|Overall Study|Withdrawal by Subject|0
5397283|NCT03018028|18598850|P4|Overall Study|Withdrawal by Subject|2
5397284|NCT03018028|18598851|P3|Overall Study|Withdrawal by Subject|1
5397285|NCT03018028|18598852|P2|Overall Study|Withdrawal by Subject|0
5397286|NCT03018028|18598853|P1|Overall Study|Withdrawal by Subject|3
5397287|NCT03017846|18599103|P1|Overall Study|Adverse Event|2
5397288|NCT03017846|18599103|P1|Overall Study|Lost to Follow-up|3
5397289|NCT03017612|18599111|P1|Overall Study|Adverse Event|2
5397290|NCT03017235|18599156|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
5397291|NCT03017235|18599157|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
5397292|NCT03017235|18599156|P2|Overall Study|Protocol Violation|1
5397293|NCT03017235|18599157|P1|Overall Study|Protocol Violation|2
5397294|NCT03017235|18599156|P2|Overall Study|Adverse Event|1
5397295|NCT03017235|18599157|P1|Overall Study|Adverse Event|0
5397296|NCT03017235|18599156|P2|Overall Study|Lost to Follow-up|7
5397297|NCT03017235|18599157|P1|Overall Study|Lost to Follow-up|2
5397298|NCT03017235|18599156|P2|Overall Study|Withdrawal by Subject|3
5397299|NCT03017235|18599157|P1|Overall Study|Withdrawal by Subject|4
5397300|NCT03016325|18599223|P5|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5397301|NCT03016325|18599224|P4|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5397302|NCT03016325|18599225|P3|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5397303|NCT03016325|18599226|P2|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
5397304|NCT03016325|18599227|P1|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
5397305|NCT03016325|18599223|P5|182-Day Follow-Up Period|Vital status collected via EMR|0
5397306|NCT03016325|18599224|P4|182-Day Follow-Up Period|Vital status collected via EMR|1
5397307|NCT03016325|18599225|P3|182-Day Follow-Up Period|Vital status collected via EMR|0
5397308|NCT03016325|18599226|P2|182-Day Follow-Up Period|Vital status collected via EMR|0
5397309|NCT03016325|18599227|P1|182-Day Follow-Up Period|Vital status collected via EMR|0
5397310|NCT03016325|18599223|P5|182-Day Follow-Up Period|Alive, per civil unit|1
5397311|NCT03016325|18599224|P4|182-Day Follow-Up Period|Alive, per civil unit|0
5397312|NCT03016325|18599225|P3|182-Day Follow-Up Period|Alive, per civil unit|0
5397313|NCT03016325|18599226|P2|182-Day Follow-Up Period|Alive, per civil unit|0
5397314|NCT03016325|18599227|P1|182-Day Follow-Up Period|Alive, per civil unit|0
5397315|NCT03016325|18599223|P5|182-Day Follow-Up Period|Alive, per Family doctor|1
5397316|NCT03016325|18599224|P4|182-Day Follow-Up Period|Alive, per Family doctor|0
5397317|NCT03016325|18599225|P3|182-Day Follow-Up Period|Alive, per Family doctor|0
5397318|NCT03016325|18599226|P2|182-Day Follow-Up Period|Alive, per Family doctor|0
5397319|NCT03016325|18599227|P1|182-Day Follow-Up Period|Alive, per Family doctor|0
5397320|NCT03016325|18599223|P5|182-Day Follow-Up Period|Participant withdrew consent|1
5397321|NCT03016325|18599224|P4|182-Day Follow-Up Period|Participant withdrew consent|0
5397322|NCT03016325|18599225|P3|182-Day Follow-Up Period|Participant withdrew consent|0
5397323|NCT03016325|18599226|P2|182-Day Follow-Up Period|Participant withdrew consent|0
5397324|NCT03016325|18599227|P1|182-Day Follow-Up Period|Participant withdrew consent|0
5397325|NCT03016325|18599223|P5|182-Day Follow-Up Period|Alive, per national insurance system|0
5397326|NCT03016325|18599224|P4|182-Day Follow-Up Period|Alive, per national insurance system|0
5397327|NCT03016325|18599225|P3|182-Day Follow-Up Period|Alive, per national insurance system|0
5397328|NCT03016325|18599226|P2|182-Day Follow-Up Period|Alive, per national insurance system|0
5397329|NCT03016325|18599227|P1|182-Day Follow-Up Period|Alive, per national insurance system|1
5397330|NCT03016325|18599223|P5|182-Day Follow-Up Period|Death|9
5397331|NCT03016325|18599224|P4|182-Day Follow-Up Period|Death|12
5397332|NCT03016325|18599225|P3|182-Day Follow-Up Period|Death|11
5397333|NCT03016325|18599226|P2|182-Day Follow-Up Period|Death|3
5397334|NCT03016325|18599227|P1|182-Day Follow-Up Period|Death|3
5397335|NCT03016325|18599223|P5|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5397336|NCT03016325|18599224|P4|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5397337|NCT03016325|18599225|P3|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5397338|NCT03016325|18599226|P2|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
5397339|NCT03016325|18599227|P1|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
5397340|NCT03016325|18599223|P5|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5397341|NCT03016325|18599224|P4|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5397342|NCT03016325|18599225|P3|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
5397343|NCT03016325|18599226|P2|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5397344|NCT03016325|18599227|P1|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
5397345|NCT03016325|18599223|P5|32-Day Follow-Up Period|Participant withdrew consent|2
5397346|NCT03016325|18599224|P4|32-Day Follow-Up Period|Participant withdrew consent|0
5397347|NCT03016325|18599225|P3|32-Day Follow-Up Period|Participant withdrew consent|0
5397348|NCT03016325|18599226|P2|32-Day Follow-Up Period|Participant withdrew consent|0
5397349|NCT03016325|18599227|P1|32-Day Follow-Up Period|Participant withdrew consent|0
5397350|NCT03016325|18599223|P5|32-Day Follow-Up Period|Participant refused to visit|2
5397351|NCT03016325|18599224|P4|32-Day Follow-Up Period|Participant refused to visit|0
5397352|NCT03016325|18599225|P3|32-Day Follow-Up Period|Participant refused to visit|2
5397353|NCT03016325|18599226|P2|32-Day Follow-Up Period|Participant refused to visit|1
5397354|NCT03016325|18599227|P1|32-Day Follow-Up Period|Participant refused to visit|0
5397355|NCT03016325|18599223|P5|32-Day Follow-Up Period|Poor/non-compliance|1
5397356|NCT03016325|18599224|P4|32-Day Follow-Up Period|Poor/non-compliance|1
5397357|NCT03016325|18599225|P3|32-Day Follow-Up Period|Poor/non-compliance|0
5397358|NCT03016325|18599226|P2|32-Day Follow-Up Period|Poor/non-compliance|0
5397359|NCT03016325|18599227|P1|32-Day Follow-Up Period|Poor/non-compliance|1
5397360|NCT03016325|18599223|P5|32-Day Follow-Up Period|Lost to Follow-up|0
5397361|NCT03016325|18599224|P4|32-Day Follow-Up Period|Lost to Follow-up|1
5397362|NCT03016325|18599225|P3|32-Day Follow-Up Period|Lost to Follow-up|1
5397363|NCT03016325|18599226|P2|32-Day Follow-Up Period|Lost to Follow-up|0
5397364|NCT03016325|18599227|P1|32-Day Follow-Up Period|Lost to Follow-up|1
5397365|NCT03016325|18599223|P5|32-Day Follow-Up Period|Death|3
5397366|NCT03016325|18599224|P4|32-Day Follow-Up Period|Death|6
5397367|NCT03016325|18599225|P3|32-Day Follow-Up Period|Death|5
5397368|NCT03016325|18599226|P2|32-Day Follow-Up Period|Death|0
5397369|NCT03016325|18599227|P1|32-Day Follow-Up Period|Death|2
5397370|NCT03016325|18599223|P5|Treatment Period|Participant refuses assessments|0
5397371|NCT03016325|18599224|P4|Treatment Period|Participant refuses assessments|0
5397372|NCT03016325|18599225|P3|Treatment Period|Participant refuses assessments|1
5397373|NCT03016325|18599226|P2|Treatment Period|Participant refuses assessments|0
5397374|NCT03016325|18599227|P1|Treatment Period|Participant refuses assessments|0
5397375|NCT03016325|18599223|P5|Treatment Period|Death|2
5397376|NCT03016325|18599224|P4|Treatment Period|Death|0
5397377|NCT03016325|18599225|P3|Treatment Period|Death|0
5397378|NCT03016325|18599226|P2|Treatment Period|Death|0
5397379|NCT03016325|18599227|P1|Treatment Period|Death|0
5397380|NCT03016325|18599223|P5|Treatment Period|Participant withdrew consent|0
5397381|NCT03016325|18599224|P4|Treatment Period|Participant withdrew consent|0
5397382|NCT03016325|18599225|P3|Treatment Period|Participant withdrew consent|0
5397383|NCT03016325|18599226|P2|Treatment Period|Participant withdrew consent|1
5397384|NCT03016325|18599227|P1|Treatment Period|Participant withdrew consent|0
5397385|NCT03016078|18599369|P1|Overall Study|Protocol Violation|1
5397386|NCT03016078|18599369|P1|Overall Study|Protocol Violation|1
5397387|NCT03015220|18599388|P4|Overall Study|Lost to Follow-up|0
5397388|NCT03015220|18599389|P3|Overall Study|Lost to Follow-up|1
5397389|NCT03015220|18599390|P2|Overall Study|Lost to Follow-up|0
5397390|NCT03015220|18599391|P1|Overall Study|Lost to Follow-up|0
5397391|NCT03015220|18599388|P4|Overall Study|Withdrawal by Subject|2
5397392|NCT03015220|18599389|P3|Overall Study|Withdrawal by Subject|2
5397393|NCT03015220|18599390|P2|Overall Study|Withdrawal by Subject|2
5397394|NCT03015220|18599391|P1|Overall Study|Withdrawal by Subject|3
5397395|NCT03015181|18599536|P7|Overall Study|Physician Decision|1
5397396|NCT03015181|18599537|P6|Overall Study|Physician Decision|0
5397397|NCT03015181|18599538|P5|Overall Study|Physician Decision|0
5397398|NCT03015181|18599539|P4|Overall Study|Physician Decision|0
5397399|NCT03015181|18599540|P3|Overall Study|Physician Decision|0
5397400|NCT03015181|18599541|P2|Overall Study|Physician Decision|0
5397401|NCT03015181|18599542|P1|Overall Study|Physician Decision|0
5397402|NCT03015181|18599536|P7|Overall Study|Withdrawal by Subject|0
5397403|NCT03015181|18599537|P6|Overall Study|Withdrawal by Subject|1
5397404|NCT03015181|18599538|P5|Overall Study|Withdrawal by Subject|0
5397405|NCT03015181|18599539|P4|Overall Study|Withdrawal by Subject|0
5397406|NCT03015181|18599540|P3|Overall Study|Withdrawal by Subject|0
5397407|NCT03015181|18599541|P2|Overall Study|Withdrawal by Subject|0
5397408|NCT03015181|18599542|P1|Overall Study|Withdrawal by Subject|0
5397409|NCT03015181|18599536|P7|Overall Study|Enrolled, but product never administered|0
5397410|NCT03015181|18599537|P6|Overall Study|Enrolled, but product never administered|0
5397411|NCT03015181|18599538|P5|Overall Study|Enrolled, but product never administered|0
5397412|NCT03015181|18599539|P4|Overall Study|Enrolled, but product never administered|0
5397413|NCT03015181|18599540|P3|Overall Study|Enrolled, but product never administered|0
5397414|NCT03015181|18599541|P2|Overall Study|Enrolled, but product never administered|0
5397415|NCT03015181|18599542|P1|Overall Study|Enrolled, but product never administered|1
5397416|NCT03014674|18599688|P3|Overall Study|Withdrawal by Subject|0
5397417|NCT03014674|18599689|P2|Overall Study|Withdrawal by Subject|0
5397418|NCT03014674|18599690|P1|Overall Study|Withdrawal by Subject|1
5397419|NCT03014479|18599765|P2|Overall Study|Unacceptable Inability of Site Visit|1
5397420|NCT03014479|18599766|P1|Overall Study|Unacceptable Inability of Site Visit|0
5397421|NCT03014479|18599765|P2|Overall Study|Voluntary Withdrawal|2
5397422|NCT03014479|18599766|P1|Overall Study|Voluntary Withdrawal|0
5397423|NCT03014479|18599765|P2|Overall Study|Adverse Event|1
5397424|NCT03014479|18599766|P1|Overall Study|Adverse Event|0
5397425|NCT03014453|18599812|P1|Overall Study|Refused to take part in|37
5397426|NCT03014453|18599812|P1|Overall Study|Excluded|19
5397427|NCT03014453|18599812|P1|Overall Study|Discontinued GER|3
5397428|NCT03014453|18599812|P1|Overall Study|Lost to Follow-up|12
5397429|NCT03014206|18599816|P1|Overall Study|Registration Violation|12
5397430|NCT03014180|18599820|P1|Overall Study|Protocol Violation|2
5397431|NCT03014011|18599829|P2|Washout|Withdrawal by Subject|0
5397432|NCT03014011|18599830|P1|Washout|Withdrawal by Subject|1
5397433|NCT03014011|18599829|P2|First Intervention|Withdrawal by Subject|0
5397434|NCT03014011|18599830|P1|First Intervention|Withdrawal by Subject|1
5397435|NCT03013985|18599838|P2|Overall Study|Withdrawal by Subject|17
5397436|NCT03013985|18599839|P1|Overall Study|Withdrawal by Subject|14
5397437|NCT03013985|18599838|P2|Overall Study|Protocol Violation|2
5397438|NCT03013985|18599839|P1|Overall Study|Protocol Violation|2
5397439|NCT03012841|18599871|P2|Overall Study|Insurance change|1
5397440|NCT03012841|18599872|P1|Overall Study|Insurance change|0
5397441|NCT03012841|18599871|P2|Overall Study|Study reached n=165 treated subject cap|5
5397442|NCT03012841|18599872|P1|Overall Study|Study reached n=165 treated subject cap|0
5397443|NCT03012841|18599871|P2|Overall Study|No ablation performed|2
5397444|NCT03012841|18599872|P1|Overall Study|No ablation performed|0
5397445|NCT03012841|18599871|P2|Overall Study|Physician Decision|2
5397446|NCT03012841|18599872|P1|Overall Study|Physician Decision|0
5397447|NCT03012841|18599871|P2|Overall Study|Seasonal winter travel|0
5397448|NCT03012841|18599872|P1|Overall Study|Seasonal winter travel|1
5397449|NCT03012841|18599871|P2|Overall Study|Subject relocation|0
5397450|NCT03012841|18599872|P1|Overall Study|Subject relocation|1
5397451|NCT03012841|18599871|P2|Overall Study|Unable to complete 12 month visit|0
5397452|NCT03012841|18599872|P1|Overall Study|Unable to complete 12 month visit|6
5397453|NCT03012841|18599871|P2|Overall Study|Withdrawal by Subject|0
5397454|NCT03012841|18599872|P1|Overall Study|Withdrawal by Subject|6
5397455|NCT03012841|18599871|P2|Overall Study|Lost to Follow-up|1
5397456|NCT03012841|18599872|P1|Overall Study|Lost to Follow-up|6
5397457|NCT03012841|18599871|P2|Overall Study|Protocol Violation|10
5397458|NCT03012841|18599872|P1|Overall Study|Protocol Violation|0
5397459|NCT03012828|18599886|P6|Overall Study|Delay to last visit would delay DBL|1
5397460|NCT03012828|18599887|P5|Overall Study|Delay to last visit would delay DBL|0
5397461|NCT03012828|18599888|P4|Overall Study|Delay to last visit would delay DBL|0
5397462|NCT03012828|18599889|P3|Overall Study|Delay to last visit would delay DBL|0
5397463|NCT03012828|18599890|P2|Overall Study|Delay to last visit would delay DBL|0
5397464|NCT03012828|18599891|P1|Overall Study|Delay to last visit would delay DBL|0
5397465|NCT03012828|18599886|P6|Overall Study|Non-compliance with protocol|0
5397466|NCT03012828|18599887|P5|Overall Study|Non-compliance with protocol|1
5397467|NCT03012828|18599888|P4|Overall Study|Non-compliance with protocol|0
5397468|NCT03012828|18599889|P3|Overall Study|Non-compliance with protocol|0
5397469|NCT03012828|18599890|P2|Overall Study|Non-compliance with protocol|0
5397470|NCT03012828|18599891|P1|Overall Study|Non-compliance with protocol|0
5397471|NCT03012828|18599886|P6|Overall Study|Withdrawal by Subject|1
5397472|NCT03012828|18599887|P5|Overall Study|Withdrawal by Subject|0
5397473|NCT03012828|18599888|P4|Overall Study|Withdrawal by Subject|0
5397474|NCT03012828|18599889|P3|Overall Study|Withdrawal by Subject|1
5397475|NCT03012828|18599890|P2|Overall Study|Withdrawal by Subject|0
5397476|NCT03012828|18599891|P1|Overall Study|Withdrawal by Subject|0
5397477|NCT03012828|18599886|P6|Overall Study|Lost to Follow-up|0
5397478|NCT03012828|18599887|P5|Overall Study|Lost to Follow-up|1
5397479|NCT03012828|18599888|P4|Overall Study|Lost to Follow-up|0
5397480|NCT03012828|18599889|P3|Overall Study|Lost to Follow-up|1
5397481|NCT03012828|18599890|P2|Overall Study|Lost to Follow-up|0
5397482|NCT03012828|18599891|P1|Overall Study|Lost to Follow-up|1
5397483|NCT03012334|18599934|P10|Period 4|Adverse Event|0
5397484|NCT03012334|18599935|P9|Period 4|Adverse Event|1
5397485|NCT03012334|18599936|P8|Period 4|Adverse Event|0
5397486|NCT03012334|18599937|P7|Period 4|Adverse Event|0
5397487|NCT03012334|18599938|P6|Period 4|Adverse Event|0
5397488|NCT03012334|18599939|P5|Period 4|Adverse Event|0
5397489|NCT03012334|18599940|P4|Period 4|Adverse Event|0
5397490|NCT03012334|18599941|P3|Period 4|Adverse Event|0
5397491|NCT03012334|18599942|P2|Period 4|Adverse Event|0
5397492|NCT03012334|18599943|P1|Period 4|Adverse Event|0
5397493|NCT03012334|18599934|P10|Period 4|Non-Compliance|0
5397494|NCT03012334|18599935|P9|Period 4|Non-Compliance|0
5397495|NCT03012334|18599936|P8|Period 4|Non-Compliance|0
5397496|NCT03012334|18599937|P7|Period 4|Non-Compliance|1
5397497|NCT03012334|18599938|P6|Period 4|Non-Compliance|0
5397498|NCT03012334|18599939|P5|Period 4|Non-Compliance|0
5397499|NCT03012334|18599940|P4|Period 4|Non-Compliance|0
5397500|NCT03012334|18599941|P3|Period 4|Non-Compliance|0
5397501|NCT03012334|18599942|P2|Period 4|Non-Compliance|0
5397502|NCT03012334|18599943|P1|Period 4|Non-Compliance|0
5397503|NCT03012334|18599934|P10|Period 2|Protocol Violation|0
5397504|NCT03012334|18599935|P9|Period 2|Protocol Violation|0
5397505|NCT03012334|18599936|P8|Period 2|Protocol Violation|1
5397506|NCT03012334|18599937|P7|Period 2|Protocol Violation|0
5397507|NCT03012334|18599938|P6|Period 2|Protocol Violation|0
5397508|NCT03012334|18599939|P5|Period 2|Protocol Violation|0
5397509|NCT03012334|18599940|P4|Period 2|Protocol Violation|0
5397510|NCT03012334|18599941|P3|Period 2|Protocol Violation|1
5397511|NCT03012334|18599942|P2|Period 2|Protocol Violation|0
5397512|NCT03012334|18599943|P1|Period 2|Protocol Violation|0
5397513|NCT03012334|18599934|P10|Period 2|Withdrawal by Subject|0
5397514|NCT03012334|18599935|P9|Period 2|Withdrawal by Subject|0
5397515|NCT03012334|18599936|P8|Period 2|Withdrawal by Subject|0
5397516|NCT03012334|18599937|P7|Period 2|Withdrawal by Subject|0
5397517|NCT03012334|18599938|P6|Period 2|Withdrawal by Subject|0
5397518|NCT03012334|18599939|P5|Period 2|Withdrawal by Subject|0
5397519|NCT03012334|18599940|P4|Period 2|Withdrawal by Subject|0
5397520|NCT03012334|18599941|P3|Period 2|Withdrawal by Subject|0
5397521|NCT03012334|18599942|P2|Period 2|Withdrawal by Subject|1
5397522|NCT03012334|18599943|P1|Period 2|Withdrawal by Subject|0
5397523|NCT03012334|18599934|P10|Period 1|Withdrawal by Subject|1
5397524|NCT03012334|18599935|P9|Period 1|Withdrawal by Subject|0
5397525|NCT03012334|18599936|P8|Period 1|Withdrawal by Subject|0
5397526|NCT03012334|18599937|P7|Period 1|Withdrawal by Subject|0
5397527|NCT03012334|18599938|P6|Period 1|Withdrawal by Subject|0
5397528|NCT03012334|18599939|P5|Period 1|Withdrawal by Subject|0
5397529|NCT03012334|18599940|P4|Period 1|Withdrawal by Subject|0
5397530|NCT03012334|18599941|P3|Period 1|Withdrawal by Subject|0
5397531|NCT03012334|18599942|P2|Period 1|Withdrawal by Subject|0
5397532|NCT03012334|18599943|P1|Period 1|Withdrawal by Subject|0
5397533|NCT03012061|18600013|P3|Overall Study|Adverse Event|0
5397534|NCT03012061|18600014|P2|Overall Study|Adverse Event|0
5397535|NCT03012061|18600015|P1|Overall Study|Adverse Event|2
5397536|NCT03012061|18600013|P3|Overall Study|Lack of Efficacy|0
5397537|NCT03012061|18600014|P2|Overall Study|Lack of Efficacy|1
5397538|NCT03012061|18600015|P1|Overall Study|Lack of Efficacy|0
5397539|NCT03012061|18600013|P3|Overall Study|Protocol Violation|2
5397540|NCT03012061|18600014|P2|Overall Study|Protocol Violation|0
5397541|NCT03012061|18600015|P1|Overall Study|Protocol Violation|0
5397542|NCT03012061|18600013|P3|Overall Study|Met Protocol Withdrawal Criterion|1
5397543|NCT03012061|18600014|P2|Overall Study|Met Protocol Withdrawal Criterion|0
5397544|NCT03012061|18600015|P1|Overall Study|Met Protocol Withdrawal Criterion|0
5397545|NCT03012061|18600013|P3|Overall Study|Study closed/ Terminated|1
5397546|NCT03012061|18600014|P2|Overall Study|Study closed/ Terminated|0
5397547|NCT03012061|18600015|P1|Overall Study|Study closed/ Terminated|0
5397548|NCT03012061|18600013|P3|Overall Study|Lost to Follow-up|0
5397549|NCT03012061|18600014|P2|Overall Study|Lost to Follow-up|1
5397550|NCT03012061|18600015|P1|Overall Study|Lost to Follow-up|2
5397551|NCT03012061|18600013|P3|Overall Study|Investigator Site Closed|0
5397552|NCT03012061|18600014|P2|Overall Study|Investigator Site Closed|2
5397553|NCT03012061|18600015|P1|Overall Study|Investigator Site Closed|1
5397554|NCT03012061|18600013|P3|Overall Study|Withdrawal by Subject|4
5397555|NCT03012061|18600014|P2|Overall Study|Withdrawal by Subject|5
5397556|NCT03012061|18600015|P1|Overall Study|Withdrawal by Subject|1
5397557|NCT03011840|18600040|P2|Overall Study|Not received PIL in post PIL phase|21
5397558|NCT03011840|18600041|P1|Overall Study|Not received PIL in post PIL phase|0
5397559|NCT03011099|18600051|P2|Overall Study|Withdrawal by Subject|2
5397560|NCT03011099|18600052|P1|Overall Study|Withdrawal by Subject|0
5397561|NCT03011034|18600078|P2|Overall Study|Adverse Event|0
5397562|NCT03011034|18600079|P1|Overall Study|Adverse Event|1
5397563|NCT03010501|18600141|P6|Study Week 3|Withdrawal by Subject|0
5397564|NCT03010501|18600142|P5|Study Week 3|Withdrawal by Subject|0
5397565|NCT03010501|18600143|P4|Study Week 3|Withdrawal by Subject|1
5397566|NCT03010501|18600144|P3|Study Week 3|Withdrawal by Subject|0
5397567|NCT03010501|18600145|P2|Study Week 3|Withdrawal by Subject|0
5397568|NCT03010501|18600146|P1|Study Week 3|Withdrawal by Subject|0
5397569|NCT03010501|18600141|P6|Study Week 1|Withdrawal by Subject|0
5397570|NCT03010501|18600142|P5|Study Week 1|Withdrawal by Subject|0
5397571|NCT03010501|18600143|P4|Study Week 1|Withdrawal by Subject|2
5397572|NCT03010501|18600144|P3|Study Week 1|Withdrawal by Subject|0
5397573|NCT03010501|18600145|P2|Study Week 1|Withdrawal by Subject|1
5397574|NCT03010501|18600146|P1|Study Week 1|Withdrawal by Subject|2
5397575|NCT03010423|18600160|P1|Overall Study|Study termination|8
5397576|NCT03010254|18600173|P2|Overall Study|Other|3
5397577|NCT03010254|18600174|P1|Overall Study|Other|2
5397578|NCT03010254|18600173|P2|Overall Study|Withdrawal by Subject|1
5397579|NCT03010254|18600174|P1|Overall Study|Withdrawal by Subject|1
5397580|NCT03010254|18600173|P2|Overall Study|Lost to Follow-up|0
5397581|NCT03010254|18600174|P1|Overall Study|Lost to Follow-up|4
5397582|NCT03010254|18600173|P2|Overall Study|Adverse Event|1
5397583|NCT03010254|18600174|P1|Overall Study|Adverse Event|0
5397584|NCT03007966|18600342|P2|Overall Study|Did not meeting inclusion/exclusion|0
5397585|NCT03007966|18600343|P1|Overall Study|Did not meeting inclusion/exclusion|1
5397586|NCT03007472|18600384|P1|Overall Study|Loss to Follow Up|1
5397587|NCT03007472|18600384|P1|Overall Study|Death|2
5397588|NCT03007472|18600384|P1|Overall Study|Did not have aidable contralateral thresholds at the time|2
5397589|NCT03006926|18600412|P2|Overall Study|Withdrawal by Subject|2
5397590|NCT03006926|18600413|P1|Overall Study|Withdrawal by Subject|0
5397591|NCT03006926|18600412|P2|Overall Study|Lost to Follow-up|1
5397592|NCT03006926|18600413|P1|Overall Study|Lost to Follow-up|0
5397593|NCT03006926|18600412|P2|Overall Study|Ongoing-on Treatment|36
5397594|NCT03006926|18600413|P1|Overall Study|Ongoing-on Treatment|0
5397595|NCT03006926|18600412|P2|Overall Study|Ongoing Survival Follow-up|26
5397596|NCT03006926|18600413|P1|Overall Study|Ongoing Survival Follow-up|0
5397597|NCT03006926|18600412|P2|Overall Study|Death|33
5397598|NCT03006926|18600413|P1|Overall Study|Death|0
5397599|NCT03006562|18600433|P2|Overall Study|Lost to Follow-up|1
5397600|NCT03006562|18600434|P1|Overall Study|Lost to Follow-up|0
5397601|NCT03006458|18600525|P2|First Intervention|Unsatisfied Vision|3
5397602|NCT03006458|18600526|P1|First Intervention|Unsatisfied Vision|0
5397603|NCT03006341|18600568|P4|Overall Study|Not linked in the EMR|10685
5397604|NCT03006341|18600569|P3|Overall Study|Not linked in the EMR|30993
5397605|NCT03006341|18600570|P2|Overall Study|Not linked in the EMR|67505
5397606|NCT03006341|18600571|P1|Overall Study|Not linked in the EMR|25069
5397607|NCT03005288|18600615|P2|Overall Study|Physician Decision|1
5397608|NCT03005288|18600616|P1|Overall Study|Physician Decision|0
5397609|NCT03005288|18600615|P2|Overall Study|Protocol deviation|1
5397610|NCT03005288|18600616|P1|Overall Study|Protocol deviation|0
5397611|NCT03005288|18600615|P2|Overall Study|Adverse Event|0
5397612|NCT03005288|18600616|P1|Overall Study|Adverse Event|5
5397613|NCT03005288|18600615|P2|Overall Study|Lost to Follow-up|1
5397614|NCT03005288|18600616|P1|Overall Study|Lost to Follow-up|0
5397615|NCT03005288|18600615|P2|Overall Study|Withdrawal by Subject|5
5397616|NCT03005288|18600616|P1|Overall Study|Withdrawal by Subject|7
5397617|NCT03005067|18600648|P2|Overall Study|Protocol Violation|1
5397618|NCT03005067|18600649|P1|Overall Study|Protocol Violation|0
5397619|NCT03005067|18600648|P2|Overall Study|Other (reason not specified)|1
5397620|NCT03005067|18600649|P1|Overall Study|Other (reason not specified)|3
5397621|NCT03005067|18600648|P2|Overall Study|Adverse Event|3
5397622|NCT03005067|18600649|P1|Overall Study|Adverse Event|4
5397623|NCT03005067|18600648|P2|Overall Study|Withdrawal by Subject|2
5397624|NCT03005067|18600649|P1|Overall Study|Withdrawal by Subject|3
5397625|NCT03004924|18600677|P3|Overall Study|HSV1 Positive|0
5397626|NCT03004924|18600678|P2|Overall Study|HSV1 Positive|0
5397627|NCT03004924|18600679|P1|Overall Study|HSV1 Positive|1
5397628|NCT03004924|18600677|P3|Overall Study|Missed Study Visit|2
5397629|NCT03004924|18600678|P2|Overall Study|Missed Study Visit|0
5397630|NCT03004924|18600679|P1|Overall Study|Missed Study Visit|0
5397631|NCT03004924|18600677|P3|Overall Study|Terminated by Sponsor|1
5397632|NCT03004924|18600678|P2|Overall Study|Terminated by Sponsor|0
5397633|NCT03004924|18600679|P1|Overall Study|Terminated by Sponsor|0
5397634|NCT03004924|18600677|P3|Overall Study|Pregnancy|0
5397635|NCT03004924|18600678|P2|Overall Study|Pregnancy|1
5397636|NCT03004924|18600679|P1|Overall Study|Pregnancy|0
5397637|NCT03004924|18600677|P3|Overall Study|Screen Failure|0
5397638|NCT03004924|18600678|P2|Overall Study|Screen Failure|0
5397639|NCT03004924|18600679|P1|Overall Study|Screen Failure|1
5397640|NCT03004924|18600677|P3|Overall Study|Withdrawal by parent/guardian|2
5397641|NCT03004924|18600678|P2|Overall Study|Withdrawal by parent/guardian|0
5397642|NCT03004924|18600679|P1|Overall Study|Withdrawal by parent/guardian|1
5397643|NCT03004924|18600677|P3|Overall Study|Physician Decision|1
5397644|NCT03004924|18600678|P2|Overall Study|Physician Decision|0
5397645|NCT03004924|18600679|P1|Overall Study|Physician Decision|1
5397646|NCT03004924|18600677|P3|Overall Study|Lack of Efficacy|2
5397647|NCT03004924|18600678|P2|Overall Study|Lack of Efficacy|4
5397648|NCT03004924|18600679|P1|Overall Study|Lack of Efficacy|2
5397649|NCT03004924|18600677|P3|Overall Study|Lost to Follow-up|4
5397650|NCT03004924|18600678|P2|Overall Study|Lost to Follow-up|1
5397651|NCT03004924|18600679|P1|Overall Study|Lost to Follow-up|6
5397652|NCT03004924|18600677|P3|Overall Study|Withdrawal by Subject|5
5397653|NCT03004924|18600678|P2|Overall Study|Withdrawal by Subject|3
5397654|NCT03004924|18600679|P1|Overall Study|Withdrawal by Subject|5
5397655|NCT03004924|18600677|P3|Overall Study|Protocol Violation|1
5397656|NCT03004924|18600678|P2|Overall Study|Protocol Violation|0
5397657|NCT03004924|18600679|P1|Overall Study|Protocol Violation|4
5397658|NCT03004924|18600677|P3|Overall Study|Adverse Event|10
5397659|NCT03004924|18600678|P2|Overall Study|Adverse Event|5
5397660|NCT03004924|18600679|P1|Overall Study|Adverse Event|6
5397661|NCT03004469|18600923|P3|Overall Study|Other unspecified reason|1
5397662|NCT03004469|18600924|P2|Overall Study|Other unspecified reason|4
5397663|NCT03004469|18600925|P1|Overall Study|Other unspecified reason|0
5397664|NCT03004469|18600923|P3|Overall Study|Withdrawal by Subject|10
5397665|NCT03004469|18600924|P2|Overall Study|Withdrawal by Subject|27
5397666|NCT03004469|18600925|P1|Overall Study|Withdrawal by Subject|29
5397667|NCT03004469|18600923|P3|Overall Study|Protocol Violation|1
5397668|NCT03004469|18600924|P2|Overall Study|Protocol Violation|0
5397669|NCT03004469|18600925|P1|Overall Study|Protocol Violation|0
5397670|NCT03004469|18600923|P3|Overall Study|Non-Compliance with Study Drug|0
5397671|NCT03004469|18600924|P2|Overall Study|Non-Compliance with Study Drug|0
5397672|NCT03004469|18600925|P1|Overall Study|Non-Compliance with Study Drug|2
5397673|NCT03004469|18600923|P3|Overall Study|Lost to Follow-up|6
5397674|NCT03004469|18600924|P2|Overall Study|Lost to Follow-up|14
5397675|NCT03004469|18600925|P1|Overall Study|Lost to Follow-up|23
5397676|NCT03004469|18600923|P3|Overall Study|Lack of Efficacy|1
5397677|NCT03004469|18600924|P2|Overall Study|Lack of Efficacy|0
5397678|NCT03004469|18600925|P1|Overall Study|Lack of Efficacy|1
5397679|NCT03004469|18600923|P3|Overall Study|Adverse Event|6
5397680|NCT03004469|18600924|P2|Overall Study|Adverse Event|4
5397681|NCT03004469|18600925|P1|Overall Study|Adverse Event|6
5397682|NCT03003520|18600968|P2|Follow-up|Withdrawal by Subject|0
5397683|NCT03003520|18600969|P1|Follow-up|Withdrawal by Subject|1
5397684|NCT03003520|18600968|P2|Follow-up|Ongoing|2
5397685|NCT03003520|18600969|P1|Follow-up|Ongoing|12
5397686|NCT03003520|18600968|P2|Follow-up|Death|1
5397687|NCT03003520|18600969|P1|Follow-up|Death|1
5397688|NCT03003520|18600968|P2|Consolidation|Withdrawal by Subject|0
5397689|NCT03003520|18600969|P1|Consolidation|Withdrawal by Subject|1
5397690|NCT03003520|18600968|P2|Consolidation|Progressive disease|1
5397691|NCT03003520|18600969|P1|Consolidation|Progressive disease|3
5397692|NCT03003520|18600968|P2|Consolidation|Adverse Event|0
5397693|NCT03003520|18600969|P1|Consolidation|Adverse Event|2
5397694|NCT03003520|18600968|P2|Consolidation|Ongoing|0
5397695|NCT03003520|18600969|P1|Consolidation|Ongoing|18
5397696|NCT03003520|18600968|P2|Induction|Progressive disease|0
5397697|NCT03003520|18600969|P1|Induction|Progressive disease|1
5397698|NCT03003520|18600968|P2|Induction|Withdrawal by Subject|0
5397699|NCT03003520|18600969|P1|Induction|Withdrawal by Subject|3
5397700|NCT03003520|18600968|P2|Induction|Physician Decision|0
5397701|NCT03003520|18600969|P1|Induction|Physician Decision|2
5397702|NCT03003520|18600968|P2|Induction|Palliative care|0
5397703|NCT03003520|18600969|P1|Induction|Palliative care|1
5397704|NCT03003520|18600968|P2|Induction|Death|0
5397705|NCT03003520|18600969|P1|Induction|Death|1
5397706|NCT03003520|18600968|P2|Induction|Adverse Event|0
5397707|NCT03003520|18600969|P1|Induction|Adverse Event|4
5397708|NCT03003520|18600968|P2|Induction|Ongoing|0
5397709|NCT03003520|18600969|P1|Induction|Ongoing|1
5397710|NCT03003494|18600987|P1|Overall Study|Evaluable PF10 questionnaire at visit1|28
5397711|NCT03003390|18600998|P2|Overall Study|Parent refused intervention|0
5397712|NCT03003390|18600999|P1|Overall Study|Parent refused intervention|2
5397713|NCT03003390|18600998|P2|Overall Study|Physician Decision|0
5397714|NCT03003390|18600999|P1|Overall Study|Physician Decision|2
5397715|NCT03003000|18601027|P3|Overall Study|Other than listed|1
5397716|NCT03003000|18601028|P2|Overall Study|Other than listed|1
5397717|NCT03003000|18601029|P1|Overall Study|Other than listed|1
5397718|NCT03003000|18601027|P3|Overall Study|Refused to continue medication|0
5397719|NCT03003000|18601028|P2|Overall Study|Refused to continue medication|0
5397720|NCT03003000|18601029|P1|Overall Study|Refused to continue medication|2
5397721|NCT03003000|18601027|P3|Overall Study|Non-compliant with protocol|1
5397722|NCT03003000|18601028|P2|Overall Study|Non-compliant with protocol|1
5397723|NCT03003000|18601029|P1|Overall Study|Non-compliant with protocol|0
5397724|NCT03003000|18601027|P3|Overall Study|Lack of Efficacy|0
5397725|NCT03003000|18601028|P2|Overall Study|Lack of Efficacy|0
5397726|NCT03003000|18601029|P1|Overall Study|Lack of Efficacy|1
5397727|NCT03003000|18601027|P3|Overall Study|Adverse Event|3
5397728|NCT03003000|18601028|P2|Overall Study|Adverse Event|2
5397729|NCT03003000|18601029|P1|Overall Study|Adverse Event|1
5397730|NCT03002818|18601131|P1|Overall Study|Decision of the investigator|1
5397731|NCT03002623|18601157|P2|Overall Study|Physician Decision|1
5397732|NCT03002623|18601158|P1|Overall Study|Physician Decision|1
5397733|NCT03002623|18601157|P2|Overall Study|Lost to Follow-up|0
5397734|NCT03002623|18601158|P1|Overall Study|Lost to Follow-up|1
5397735|NCT03002610|18601175|P3|Overall Study|Withdrawal by Subject|13
5397736|NCT03002610|18601176|P2|Overall Study|Withdrawal by Subject|25
5397737|NCT03002610|18601177|P1|Overall Study|Withdrawal by Subject|6
5397738|NCT03002311|18601201|P2|Overall Study|Physician Decision|1
5397739|NCT03002311|18601202|P1|Overall Study|Physician Decision|3
5397740|NCT03002311|18601201|P2|Overall Study|Referral provider called to schedule app|3
5397741|NCT03002311|18601202|P1|Overall Study|Referral provider called to schedule app|3
5397742|NCT03002311|18601201|P2|Overall Study|Lost to Follow-up|26
5397743|NCT03002311|18601202|P1|Overall Study|Lost to Follow-up|13
5397744|NCT03002194|18601210|P1|Overall Study|Withdrawal by Subject|2
5397745|NCT03002194|18601210|P1|Overall Study|Lack of Efficacy|1
5397746|NCT03002194|18601210|P1|Overall Study|Adverse Event|1
5397747|NCT03002194|18601210|P1|Overall Study|Lost to Follow-up|6
5397748|NCT03002077|18601216|P1|Overall Study|Protocol Violation|21
5397749|NCT03002077|18601216|P1|Overall Study|Pregnancy|4
5397750|NCT03002077|18601216|P1|Overall Study|Lost to Follow-up|21
5397751|NCT03002077|18601216|P1|Overall Study|Withdrawal by Subject|72
5397752|NCT03002077|18601216|P1|Overall Study|Lack of Efficacy|20
5397753|NCT03002077|18601216|P1|Overall Study|Adverse Event|23
5397754|NCT03002077|18601216|P1|Overall Study|Miscellaneous Reasons|10
5397755|NCT03002077|18601216|P1|Overall Study|Site Terminated by Sponsor|5
5397756|NCT03002077|18601216|P1|Overall Study|Study Terminated by Sponsor|257
5397757|NCT03002077|18601216|P1|Overall Study|Non-compliance w/Background ADT|1
5397758|NCT03002077|18601216|P1|Overall Study|Non-compliance with Study Drug|4
5397759|NCT03002038|18601224|P2|Overall Study|Immigration to another region|2
5397760|NCT03002038|18601225|P1|Overall Study|Immigration to another region|0
5397761|NCT03002038|18601224|P2|Overall Study|Withdrawal by Subject|4
5397762|NCT03002038|18601225|P1|Overall Study|Withdrawal by Subject|8
5397763|NCT03002038|18601224|P2|Overall Study|Adverse Event|1
5397764|NCT03002038|18601225|P1|Overall Study|Adverse Event|3
5397765|NCT03001557|18601281|P5|Overall Study|Randomized but not treated|0
5397766|NCT03001557|18601282|P4|Overall Study|Randomized but not treated|0
5397767|NCT03001557|18601283|P3|Overall Study|Randomized but not treated|1
5397768|NCT03001557|18601284|P2|Overall Study|Randomized but not treated|0
5397769|NCT03001557|18601285|P1|Overall Study|Randomized but not treated|0
5397770|NCT03001219|18601584|P2|Extension Period Analysis|Withdrawal by Subject|5
5397771|NCT03001219|18601585|P1|Extension Period Analysis|Withdrawal by Subject|4
5397772|NCT03001219|18601584|P2|Extension Period Analysis|Protocol Deviation|1
5397773|NCT03001219|18601585|P1|Extension Period Analysis|Protocol Deviation|0
5397774|NCT03001219|18601584|P2|Extension Period Analysis|Adverse Event|1
5397775|NCT03001219|18601585|P1|Extension Period Analysis|Adverse Event|1
5397776|NCT03001219|18601584|P2|Extension Period Analysis|Physician Decision|1
5397777|NCT03001219|18601585|P1|Extension Period Analysis|Physician Decision|0
5397778|NCT03001219|18601584|P2|Extension Period Analysis|Participant Non-Compliance|1
5397779|NCT03001219|18601585|P1|Extension Period Analysis|Participant Non-Compliance|0
5397780|NCT03001219|18601584|P2|Extension Period Analysis|Study Termination by Sponsor|36
5397781|NCT03001219|18601585|P1|Extension Period Analysis|Study Termination by Sponsor|0
5397782|NCT03001219|18601584|P2|Proof of Concept|Physician Decision|0
5397783|NCT03001219|18601585|P1|Proof of Concept|Physician Decision|1
5397784|NCT03001219|18601584|P2|Proof of Concept|Adverse Event|1
5397785|NCT03001219|18601585|P1|Proof of Concept|Adverse Event|1
5397786|NCT03001219|18601584|P2|Proof of Concept|Protocol Deviation|1
5397787|NCT03001219|18601585|P1|Proof of Concept|Protocol Deviation|0
5397788|NCT03001219|18601584|P2|Proof of Concept|Withdrawal by Subject|4
5397789|NCT03001219|18601585|P1|Proof of Concept|Withdrawal by Subject|0
5397790|NCT03001219|18601584|P2|Proof of Concept|Study Termination by Sponsor|1
5397791|NCT03001219|18601585|P1|Proof of Concept|Study Termination by Sponsor|0
5397792|NCT03001076|18601646|P2|Overall Study|Lost to Follow-up|2
5397793|NCT03001076|18601647|P1|Overall Study|Lost to Follow-up|0
5397794|NCT03001076|18601646|P2|Overall Study|Sponsor decision|0
5397795|NCT03001076|18601647|P1|Overall Study|Sponsor decision|1
5397796|NCT03001076|18601646|P2|Overall Study|Adverse Event|3
5397797|NCT03001076|18601647|P1|Overall Study|Adverse Event|3
5397798|NCT03001076|18601646|P2|Overall Study|Other|0
5397799|NCT03001076|18601647|P1|Overall Study|Other|1
5397800|NCT03001076|18601646|P2|Overall Study|Withdrawal by patient|0
5397801|NCT03001076|18601647|P1|Overall Study|Withdrawal by patient|2
5397802|NCT03001011|18601681|P2|Overall Study|Other than specified above|8
5397803|NCT03001011|18601682|P1|Overall Study|Other than specified above|3
5397804|NCT03001011|18601681|P2|Overall Study|Chronic kidney disease lead to dialysis|10
5397805|NCT03001011|18601682|P1|Overall Study|Chronic kidney disease lead to dialysis|15
5397806|NCT03001011|18601681|P2|Overall Study|Adverse Event|3
5397807|NCT03001011|18601682|P1|Overall Study|Adverse Event|9
5397808|NCT03000686|18601716|P4|Part 1, Period 1 (1 Day)|Adverse Event|0
5397809|NCT03000686|18601717|P3|Part 1, Period 1 (1 Day)|Adverse Event|0
5397810|NCT03000686|18601718|P2|Part 1, Period 1 (1 Day)|Adverse Event|1
5397811|NCT03000686|18601719|P1|Part 1, Period 1 (1 Day)|Adverse Event|0
5397812|NCT03000673|18601789|P4|Overall Study|Withdrawal by Subject|0
5397813|NCT03000673|18601790|P3|Overall Study|Withdrawal by Subject|0
5397814|NCT03000673|18601791|P2|Overall Study|Withdrawal by Subject|0
5397815|NCT03000673|18601792|P1|Overall Study|Withdrawal by Subject|1
5397816|NCT03000569|18601885|P2|Overall Study|Withdrawal by Subject|0
5397817|NCT03000569|18601886|P1|Overall Study|Withdrawal by Subject|1
5397818|NCT03000530|18602021|P3|Overall Study|Withdrawal by Subject|1
5397819|NCT03000530|18602022|P2|Overall Study|Withdrawal by Subject|2
5397820|NCT03000530|18602023|P1|Overall Study|Withdrawal by Subject|0
5397821|NCT03000530|18602021|P3|Overall Study|Lost to Follow-up|1
5397822|NCT03000530|18602022|P2|Overall Study|Lost to Follow-up|3
5397823|NCT03000530|18602023|P1|Overall Study|Lost to Follow-up|0
5397824|NCT03000530|18602021|P3|Overall Study|Adverse Event|2
5397825|NCT03000530|18602022|P2|Overall Study|Adverse Event|0
5397826|NCT03000530|18602023|P1|Overall Study|Adverse Event|0
5397827|NCT03000452|18602221|P1|Follow-Up Period|Withdrawal by Subject|3
5397828|NCT03000452|18602221|P1|Follow-Up Period|Death|3
5397829|NCT03000452|18602221|P1|Follow-Up Period|Study Terminated by Sponsor|1
5397830|NCT03000452|18602221|P1|Treatment Period|Miscellaneous|2
5397831|NCT03000452|18602221|P1|Treatment Period|Physician Decision|1
5397832|NCT03000452|18602221|P1|Treatment Period|Progressive Disease (PD)|14
5397833|NCT03000452|18602221|P1|Treatment Period|Death|1
5397834|NCT03000075|18602278|P7|Part B|Adverse Event|0
5397835|NCT03000075|18602279|P6|Part B|Adverse Event|0
5397836|NCT03000075|18602280|P5|Part B|Adverse Event|1
5397837|NCT03000075|18602281|P4|Part B|Adverse Event|0
5397838|NCT03000075|18602282|P3|Part B|Adverse Event|0
5397839|NCT03000075|18602283|P2|Part B|Adverse Event|0
5397840|NCT03000075|18602284|P1|Part B|Adverse Event|0
5397841|NCT03000075|18602278|P7|Part B|Not dosed due to AE|1
5397842|NCT03000075|18602279|P6|Part B|Not dosed due to AE|2
5397843|NCT03000075|18602280|P5|Part B|Not dosed due to AE|0
5397844|NCT03000075|18602281|P4|Part B|Not dosed due to AE|0
5397845|NCT03000075|18602282|P3|Part B|Not dosed due to AE|0
5397846|NCT03000075|18602283|P2|Part B|Not dosed due to AE|0
5397847|NCT03000075|18602284|P1|Part B|Not dosed due to AE|0
5397848|NCT03000075|18602278|P7|Part A|Adverse Event|0
5397849|NCT03000075|18602279|P6|Part A|Adverse Event|0
5397850|NCT03000075|18602280|P5|Part A|Adverse Event|0
5397851|NCT03000075|18602281|P4|Part A|Adverse Event|0
5397852|NCT03000075|18602282|P3|Part A|Adverse Event|0
5397853|NCT03000075|18602283|P2|Part A|Adverse Event|0
5397854|NCT03000075|18602284|P1|Part A|Adverse Event|4
5397855|NCT02999672|18602337|P2|Overall Study|Adverse Event|0
5397856|NCT02999672|18602338|P1|Overall Study|Adverse Event|4
5397857|NCT02999672|18602337|P2|Overall Study|Progressive Disease|5
5397858|NCT02999672|18602338|P1|Overall Study|Progressive Disease|9
5397859|NCT02999672|18602337|P2|Overall Study|Study Terminated by Sponsor|1
5397860|NCT02999672|18602338|P1|Overall Study|Study Terminated by Sponsor|0
5397861|NCT02999672|18602337|P2|Overall Study|Death|1
5397862|NCT02999672|18602338|P1|Overall Study|Death|0
5397863|NCT02999633|18602354|P1|Overall Study|Progressive disease|12
5397864|NCT02999633|18602354|P1|Overall Study|Adverse Event|2
5397865|NCT02999178|18602364|P2|Overall Study|Other reason not defined above|13
5397866|NCT02999178|18602365|P1|Overall Study|Other reason not defined above|7
5397867|NCT02999178|18602364|P2|Overall Study|Withdrawal by Subject|21
5397868|NCT02999178|18602365|P1|Overall Study|Withdrawal by Subject|21
5397869|NCT02999178|18602364|P2|Overall Study|Lost to Follow-up|2
5397870|NCT02999178|18602365|P1|Overall Study|Lost to Follow-up|0
5397871|NCT02999178|18602364|P2|Overall Study|Protocol Violation|2
5397872|NCT02999178|18602365|P1|Overall Study|Protocol Violation|1
5397873|NCT02999178|18602364|P2|Overall Study|Adverse Event|62
5397874|NCT02999178|18602365|P1|Overall Study|Adverse Event|85
5397875|NCT02999100|18602415|P6|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5397876|NCT02999100|18602416|P5|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5397877|NCT02999100|18602417|P4|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5397878|NCT02999100|18602418|P3|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
5397879|NCT02999100|18602419|P2|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5397880|NCT02999100|18602420|P1|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
5397881|NCT02999100|18602415|P6|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
5397882|NCT02999100|18602416|P5|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5397883|NCT02999100|18602417|P4|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5397884|NCT02999100|18602418|P3|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5397885|NCT02999100|18602419|P2|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5397886|NCT02999100|18602420|P1|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
5397887|NCT02999100|18602415|P6|Part 1 (up to 15 Days)|Adverse Event|0
5397888|NCT02999100|18602416|P5|Part 1 (up to 15 Days)|Adverse Event|0
5397889|NCT02999100|18602417|P4|Part 1 (up to 15 Days)|Adverse Event|0
5397890|NCT02999100|18602418|P3|Part 1 (up to 15 Days)|Adverse Event|0
5397891|NCT02999100|18602419|P2|Part 1 (up to 15 Days)|Adverse Event|1
5397892|NCT02999100|18602420|P1|Part 1 (up to 15 Days)|Adverse Event|0
5397893|NCT02998996|18602588|P6|Overall Study|Family reasons|0
5397894|NCT02998996|18602589|P5|Overall Study|Family reasons|1
5397895|NCT02998996|18602590|P4|Overall Study|Family reasons|0
5397896|NCT02998996|18602591|P3|Overall Study|Family reasons|0
5397897|NCT02998996|18602592|P2|Overall Study|Family reasons|0
5397898|NCT02998996|18602593|P1|Overall Study|Family reasons|0
5397899|NCT02998996|18602588|P6|Overall Study|Pregnancy|0
5397900|NCT02998996|18602589|P5|Overall Study|Pregnancy|0
5397901|NCT02998996|18602590|P4|Overall Study|Pregnancy|0
5397902|NCT02998996|18602591|P3|Overall Study|Pregnancy|0
5397903|NCT02998996|18602592|P2|Overall Study|Pregnancy|1
5397904|NCT02998996|18602593|P1|Overall Study|Pregnancy|0
5397905|NCT02998996|18602588|P6|Overall Study|Lost to Follow-up|0
5397906|NCT02998996|18602589|P5|Overall Study|Lost to Follow-up|0
5397907|NCT02998996|18602590|P4|Overall Study|Lost to Follow-up|0
5397908|NCT02998996|18602591|P3|Overall Study|Lost to Follow-up|1
5397909|NCT02998996|18602592|P2|Overall Study|Lost to Follow-up|0
5397910|NCT02998996|18602593|P1|Overall Study|Lost to Follow-up|0
5397911|NCT02998671|18602627|P5|Period 2|Lost to Follow-up|0
5397912|NCT02998671|18602628|P4|Period 2|Lost to Follow-up|1
5397913|NCT02998671|18602629|P3|Period 2|Lost to Follow-up|0
5397914|NCT02998671|18602630|P2|Period 2|Lost to Follow-up|0
5397915|NCT02998671|18602631|P1|Period 2|Lost to Follow-up|0
5397916|NCT02998671|18602627|P5|Period 2|Withdrawal by Subject|0
5397917|NCT02998671|18602628|P4|Period 2|Withdrawal by Subject|0
5397918|NCT02998671|18602629|P3|Period 2|Withdrawal by Subject|0
5397919|NCT02998671|18602630|P2|Period 2|Withdrawal by Subject|1
5397920|NCT02998671|18602631|P1|Period 2|Withdrawal by Subject|0
5397921|NCT02998671|18602627|P5|Period 2|Study Terminated By Sponsor|0
5397922|NCT02998671|18602628|P4|Period 2|Study Terminated By Sponsor|3
5397923|NCT02998671|18602629|P3|Period 2|Study Terminated By Sponsor|1
5397924|NCT02998671|18602630|P2|Period 2|Study Terminated By Sponsor|5
5397925|NCT02998671|18602631|P1|Period 2|Study Terminated By Sponsor|3
5397926|NCT02998671|18602627|P5|Period 2|Adverse Event|0
5397927|NCT02998671|18602628|P4|Period 2|Adverse Event|0
5397928|NCT02998671|18602629|P3|Period 2|Adverse Event|0
5397929|NCT02998671|18602630|P2|Period 2|Adverse Event|1
5397930|NCT02998671|18602631|P1|Period 2|Adverse Event|0
5397931|NCT02998671|18602627|P5|Period 1|Adverse Event|1
5397932|NCT02998671|18602628|P4|Period 1|Adverse Event|0
5397933|NCT02998671|18602629|P3|Period 1|Adverse Event|0
5397934|NCT02998671|18602630|P2|Period 1|Adverse Event|0
5397935|NCT02998671|18602631|P1|Period 1|Adverse Event|0
5397936|NCT02998671|18602627|P5|Period 1|Pregnancy|0
5397937|NCT02998671|18602628|P4|Period 1|Pregnancy|0
5397938|NCT02998671|18602629|P3|Period 1|Pregnancy|0
5397939|NCT02998671|18602630|P2|Period 1|Pregnancy|0
5397940|NCT02998671|18602631|P1|Period 1|Pregnancy|1
5397941|NCT02998671|18602627|P5|Period 1|Withdrawal by Subject|2
5397942|NCT02998671|18602628|P4|Period 1|Withdrawal by Subject|0
5397943|NCT02998671|18602629|P3|Period 1|Withdrawal by Subject|0
5397944|NCT02998671|18602630|P2|Period 1|Withdrawal by Subject|2
5397945|NCT02998671|18602631|P1|Period 1|Withdrawal by Subject|1
5397946|NCT02998671|18602627|P5|Period 1|Study Terminated By Sponsor|1
5397947|NCT02998671|18602628|P4|Period 1|Study Terminated By Sponsor|0
5397948|NCT02998671|18602629|P3|Period 1|Study Terminated By Sponsor|0
5397949|NCT02998671|18602630|P2|Period 1|Study Terminated By Sponsor|1
5397950|NCT02998671|18602631|P1|Period 1|Study Terminated By Sponsor|2
5397951|NCT02998554|18602676|P2|Overall Study|Lack of Efficacy|1
5397952|NCT02998554|18602677|P1|Overall Study|Lack of Efficacy|0
5397953|NCT02998554|18602676|P2|Overall Study|Lost to Follow-up|1
5397954|NCT02998554|18602677|P1|Overall Study|Lost to Follow-up|0
5397955|NCT02998554|18602676|P2|Overall Study|Withdrawal by Subject|6
5397956|NCT02998554|18602677|P1|Overall Study|Withdrawal by Subject|2
5397957|NCT02998554|18602676|P2|Overall Study|Protocol deviation|0
5397958|NCT02998554|18602677|P1|Overall Study|Protocol deviation|1
5397959|NCT02998554|18602676|P2|Overall Study|Adverse Event|3
5397960|NCT02998554|18602677|P1|Overall Study|Adverse Event|8
5397961|NCT02998541|18602708|P3|Overall Study|Withdrawal by Parent/Guardian|1
5397962|NCT02998541|18602709|P2|Overall Study|Withdrawal by Parent/Guardian|0
5397963|NCT02998541|18602710|P1|Overall Study|Withdrawal by Parent/Guardian|0
5397964|NCT02998541|18602708|P3|Overall Study|Physician Decision|3
5397965|NCT02998541|18602709|P2|Overall Study|Physician Decision|0
5397966|NCT02998541|18602710|P1|Overall Study|Physician Decision|0
5397967|NCT02998541|18602708|P3|Overall Study|Lost to Follow-up|1
5397968|NCT02998541|18602709|P2|Overall Study|Lost to Follow-up|3
5397969|NCT02998541|18602710|P1|Overall Study|Lost to Follow-up|0
5397970|NCT02998541|18602708|P3|Overall Study|Withdrawal by Subject|0
5397971|NCT02998541|18602709|P2|Overall Study|Withdrawal by Subject|1
5397972|NCT02998541|18602710|P1|Overall Study|Withdrawal by Subject|3
5397973|NCT02998541|18602708|P3|Overall Study|Protocol Violation|0
5397974|NCT02998541|18602709|P2|Overall Study|Protocol Violation|0
5397975|NCT02998541|18602710|P1|Overall Study|Protocol Violation|1
5397976|NCT02998541|18602708|P3|Overall Study|Adverse Event|1
5397977|NCT02998541|18602709|P2|Overall Study|Adverse Event|5
5397978|NCT02998541|18602710|P1|Overall Study|Adverse Event|4
5397979|NCT02998476|18602765|P2|Overall Study|Death|2
5397980|NCT02998476|18602766|P1|Overall Study|Death|32
5397981|NCT02998476|18602765|P2|Overall Study|Withdrawal by Subject|2
5397982|NCT02998476|18602766|P1|Overall Study|Withdrawal by Subject|1
5397983|NCT02998476|18602765|P2|Overall Study|Disease Progression|0
5397984|NCT02998476|18602766|P1|Overall Study|Disease Progression|1
5397985|NCT02998476|18602765|P2|Overall Study|Ongoing in study|1
5397986|NCT02998476|18602766|P1|Overall Study|Ongoing in study|21
5397987|NCT02998021|18602776|P2|Overall Study|unsafe home|1
5397988|NCT02998021|18602777|P1|Overall Study|unsafe home|0
5397989|NCT02998021|18602776|P2|Overall Study|Withdrawal by Subject|1
5397990|NCT02998021|18602777|P1|Overall Study|Withdrawal by Subject|3
5397991|NCT02997163|18602852|P4|Overall Study|Adverse Event|1
5397992|NCT02997163|18602853|P3|Overall Study|Adverse Event|0
5397993|NCT02997163|18602854|P2|Overall Study|Adverse Event|0
5397994|NCT02997163|18602855|P1|Overall Study|Adverse Event|1
5397995|NCT02996968|18602987|P2|Overall Study|Withdrawal by Subject|0
5397996|NCT02996968|18602988|P1|Overall Study|Withdrawal by Subject|1
5397997|NCT02996682|18602996|P2|Overall Study|Death|3
5397998|NCT02996682|18602997|P1|Overall Study|Death|0
5397999|NCT02996500|18603076|P6|Overall Study|Withdrawal by Subject|0
5398000|NCT02996500|18603077|P5|Overall Study|Withdrawal by Subject|2
5398001|NCT02996500|18603078|P4|Overall Study|Withdrawal by Subject|0
5398002|NCT02996500|18603079|P3|Overall Study|Withdrawal by Subject|3
5398003|NCT02996500|18603080|P2|Overall Study|Withdrawal by Subject|0
5398004|NCT02996500|18603081|P1|Overall Study|Withdrawal by Subject|3
5398005|NCT02996500|18603076|P6|Overall Study|Protocol Violation|0
5398006|NCT02996500|18603077|P5|Overall Study|Protocol Violation|0
5398007|NCT02996500|18603078|P4|Overall Study|Protocol Violation|1
5398008|NCT02996500|18603079|P3|Overall Study|Protocol Violation|0
5398009|NCT02996500|18603080|P2|Overall Study|Protocol Violation|0
5398010|NCT02996500|18603081|P1|Overall Study|Protocol Violation|0
5398011|NCT02996500|18603076|P6|Overall Study|Other|0
5398012|NCT02996500|18603077|P5|Overall Study|Other|0
5398013|NCT02996500|18603078|P4|Overall Study|Other|0
5398014|NCT02996500|18603079|P3|Overall Study|Other|2
5398015|NCT02996500|18603080|P2|Overall Study|Other|0
5398016|NCT02996500|18603081|P1|Overall Study|Other|2
5398017|NCT02996500|18603076|P6|Overall Study|Progressive Disease|0
5398018|NCT02996500|18603077|P5|Overall Study|Progressive Disease|0
5398019|NCT02996500|18603078|P4|Overall Study|Progressive Disease|0
5398020|NCT02996500|18603079|P3|Overall Study|Progressive Disease|0
5398021|NCT02996500|18603080|P2|Overall Study|Progressive Disease|0
5398022|NCT02996500|18603081|P1|Overall Study|Progressive Disease|1
5398023|NCT02996500|18603076|P6|Overall Study|Non-Compliance With Study Drug|1
5398024|NCT02996500|18603077|P5|Overall Study|Non-Compliance With Study Drug|0
5398025|NCT02996500|18603078|P4|Overall Study|Non-Compliance With Study Drug|0
5398026|NCT02996500|18603079|P3|Overall Study|Non-Compliance With Study Drug|0
5398027|NCT02996500|18603080|P2|Overall Study|Non-Compliance With Study Drug|0
5398028|NCT02996500|18603081|P1|Overall Study|Non-Compliance With Study Drug|0
5398029|NCT02996500|18603076|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5398030|NCT02996500|18603077|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5398031|NCT02996500|18603078|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5398032|NCT02996500|18603079|P3|Overall Study|No Longer Meets Eligibility Criteria|1
5398033|NCT02996500|18603080|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5398034|NCT02996500|18603081|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5398035|NCT02996500|18603076|P6|Overall Study|Lost to Follow-up|1
5398036|NCT02996500|18603077|P5|Overall Study|Lost to Follow-up|0
5398037|NCT02996500|18603078|P4|Overall Study|Lost to Follow-up|0
5398038|NCT02996500|18603079|P3|Overall Study|Lost to Follow-up|0
5398039|NCT02996500|18603080|P2|Overall Study|Lost to Follow-up|0
5398040|NCT02996500|18603081|P1|Overall Study|Lost to Follow-up|1
5398041|NCT02996500|18603076|P6|Overall Study|Lack of Efficacy|0
5398042|NCT02996500|18603077|P5|Overall Study|Lack of Efficacy|2
5398043|NCT02996500|18603078|P4|Overall Study|Lack of Efficacy|0
5398044|NCT02996500|18603079|P3|Overall Study|Lack of Efficacy|0
5398045|NCT02996500|18603080|P2|Overall Study|Lack of Efficacy|0
5398046|NCT02996500|18603081|P1|Overall Study|Lack of Efficacy|0
5398047|NCT02996500|18603076|P6|Overall Study|Adverse Event|2
5398048|NCT02996500|18603077|P5|Overall Study|Adverse Event|1
5398049|NCT02996500|18603078|P4|Overall Study|Adverse Event|3
5398050|NCT02996500|18603079|P3|Overall Study|Adverse Event|4
5398051|NCT02996500|18603080|P2|Overall Study|Adverse Event|1
5398052|NCT02996500|18603081|P1|Overall Study|Adverse Event|1
5398053|NCT02996474|18603264|P1|Overall Study|Physician Decision|5
5398054|NCT02996448|18603268|P1|Overall Study|Study terminated due to adverse effects|3
5398055|NCT02996097|18603274|P2|Overall Study|Lost to Follow-up|11
5398056|NCT02996097|18603275|P1|Overall Study|Lost to Follow-up|11
5398057|NCT02995980|18603282|P1|Overall Study|Lost to Follow-up|14
5398058|NCT02994940|18603335|P2|Overall Study|Did not receive study medications: red dye allergy|1
5398059|NCT02994940|18603336|P1|Overall Study|Did not receive study medications: red dye allergy|0
5398060|NCT02994940|18603335|P2|Overall Study|Did not receive study medications: vomited after ingestion|0
5398061|NCT02994940|18603336|P1|Overall Study|Did not receive study medications: vomited after ingestion|1
5398062|NCT02994940|18603335|P2|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0
5398063|NCT02994940|18603336|P1|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6
5398064|NCT02994108|18603374|P2|Phase 2 Assessment|Withdrawal by Subject|0
5398065|NCT02994108|18603375|P1|Phase 2 Assessment|Withdrawal by Subject|1
5398066|NCT02994108|18603374|P2|Phase 2 Assessment|Lost to Follow-up|7
5398067|NCT02994108|18603375|P1|Phase 2 Assessment|Lost to Follow-up|8
5398068|NCT02994108|18603374|P2|Phase 1 Assessment|Lost to Follow-up|3
5398069|NCT02994108|18603375|P1|Phase 1 Assessment|Lost to Follow-up|5
5398070|NCT02994108|18603374|P2|Intervention Messages|Withdrawal by Subject|0
5398071|NCT02994108|18603375|P1|Intervention Messages|Withdrawal by Subject|2
5398072|NCT02994056|18603407|P1|Overall Study|Withdrew Consent|1
5398073|NCT02994056|18603407|P1|Overall Study|Death|8
5398074|NCT02993926|18603441|P3|Enantone Treatment Phase|Reason Not Specified|0
5398075|NCT02993926|18603442|P2|Enantone Treatment Phase|Reason Not Specified|0
5398076|NCT02993926|18603443|P1|Enantone Treatment Phase|Reason Not Specified|4
5398077|NCT02993926|18603441|P3|Enantone Treatment Phase|Investigator Judgment|0
5398078|NCT02993926|18603442|P2|Enantone Treatment Phase|Investigator Judgment|0
5398079|NCT02993926|18603443|P1|Enantone Treatment Phase|Investigator Judgment|1
5398080|NCT02993926|18603441|P3|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
5398081|NCT02993926|18603442|P2|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
5398082|NCT02993926|18603443|P1|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
5398083|NCT02993926|18603441|P3|Enantone Treatment Phase|Adverse Event|0
5398084|NCT02993926|18603442|P2|Enantone Treatment Phase|Adverse Event|0
5398085|NCT02993926|18603443|P1|Enantone Treatment Phase|Adverse Event|1
5398086|NCT02993783|18603475|P2|Overall Study|Reason not Specified|9
5398087|NCT02993783|18603476|P1|Overall Study|Reason not Specified|6
5398088|NCT02993757|18603508|P2|Overall Study|Voluntary withdraw not due adverse event|8
5398089|NCT02993757|18603509|P1|Overall Study|Voluntary withdraw not due adverse event|8
5398090|NCT02993757|18603508|P2|Overall Study|Lost to Follow-up|0
5398091|NCT02993757|18603509|P1|Overall Study|Lost to Follow-up|1
5398092|NCT02993757|18603508|P2|Overall Study|Non compliance with the protocol|170
5398093|NCT02993757|18603509|P1|Overall Study|Non compliance with the protocol|155
5398094|NCT02993471|18603541|P1|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
5398095|NCT02993471|18603541|P1|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
5398096|NCT02993250|18603603|P2|Overall Study|Lost to Follow-up|1
5398097|NCT02993250|18603604|P1|Overall Study|Lost to Follow-up|0
5398098|NCT02992691|18603624|P1|Overall Study|Withdrawal by Subject|1
5398099|NCT02992691|18603624|P1|Overall Study|Adverse Event|2
5398100|NCT02992418|18603643|P2|Overall Study|Lost to Follow-up|22
5398101|NCT02992418|18603644|P1|Overall Study|Lost to Follow-up|27
5398102|NCT02992418|18603643|P2|Overall Study|Non-compliance with the protocol|308
5398103|NCT02992418|18603644|P1|Overall Study|Non-compliance with the protocol|308
5398104|NCT02992418|18603643|P2|Overall Study|Withdrawal by Subject|12
5398105|NCT02992418|18603644|P1|Overall Study|Withdrawal by Subject|11
5398106|NCT02992288|18603684|P6|Overall Study|Withdrawal by Subject|4
5398107|NCT02992288|18603685|P5|Overall Study|Withdrawal by Subject|3
5398108|NCT02992288|18603686|P4|Overall Study|Withdrawal by Subject|5
5398109|NCT02992288|18603687|P3|Overall Study|Withdrawal by Subject|1
5398110|NCT02992288|18603688|P2|Overall Study|Withdrawal by Subject|2
5398111|NCT02992288|18603689|P1|Overall Study|Withdrawal by Subject|4
5398112|NCT02992288|18603684|P6|Overall Study|Protocol Violation|1
5398113|NCT02992288|18603685|P5|Overall Study|Protocol Violation|0
5398114|NCT02992288|18603686|P4|Overall Study|Protocol Violation|0
5398115|NCT02992288|18603687|P3|Overall Study|Protocol Violation|0
5398116|NCT02992288|18603688|P2|Overall Study|Protocol Violation|0
5398117|NCT02992288|18603689|P1|Overall Study|Protocol Violation|0
5398118|NCT02992288|18603684|P6|Overall Study|Lost to Follow-up|0
5398119|NCT02992288|18603685|P5|Overall Study|Lost to Follow-up|0
5398120|NCT02992288|18603686|P4|Overall Study|Lost to Follow-up|1
5398121|NCT02992288|18603687|P3|Overall Study|Lost to Follow-up|0
5398122|NCT02992288|18603688|P2|Overall Study|Lost to Follow-up|0
5398123|NCT02992288|18603689|P1|Overall Study|Lost to Follow-up|0
5398124|NCT02992288|18603684|P6|Overall Study|Death|0
5398125|NCT02992288|18603685|P5|Overall Study|Death|2
5398126|NCT02992288|18603686|P4|Overall Study|Death|1
5398127|NCT02992288|18603687|P3|Overall Study|Death|2
5398128|NCT02992288|18603688|P2|Overall Study|Death|0
5398129|NCT02992288|18603689|P1|Overall Study|Death|2
5398130|NCT02992288|18603684|P6|Overall Study|Physician Decision|1
5398131|NCT02992288|18603685|P5|Overall Study|Physician Decision|0
5398132|NCT02992288|18603686|P4|Overall Study|Physician Decision|0
5398133|NCT02992288|18603687|P3|Overall Study|Physician Decision|1
5398134|NCT02992288|18603688|P2|Overall Study|Physician Decision|0
5398135|NCT02992288|18603689|P1|Overall Study|Physician Decision|3
5398136|NCT02992288|18603684|P6|Overall Study|Non-compliance with study drug|0
5398137|NCT02992288|18603685|P5|Overall Study|Non-compliance with study drug|1
5398138|NCT02992288|18603686|P4|Overall Study|Non-compliance with study drug|0
5398139|NCT02992288|18603687|P3|Overall Study|Non-compliance with study drug|1
5398140|NCT02992288|18603688|P2|Overall Study|Non-compliance with study drug|1
5398141|NCT02992288|18603689|P1|Overall Study|Non-compliance with study drug|0
5398142|NCT02992288|18603684|P6|Overall Study|Adverse Event|7
5398143|NCT02992288|18603685|P5|Overall Study|Adverse Event|2
5398144|NCT02992288|18603686|P4|Overall Study|Adverse Event|2
5398145|NCT02992288|18603687|P3|Overall Study|Adverse Event|2
5398146|NCT02992288|18603688|P2|Overall Study|Adverse Event|2
5398147|NCT02992288|18603689|P1|Overall Study|Adverse Event|8
5398148|NCT02992132|18603774|P3|Overall Study|Physician Decision|1
5398149|NCT02992132|18603775|P2|Overall Study|Physician Decision|0
5398150|NCT02992132|18603776|P1|Overall Study|Physician Decision|0
5398151|NCT02992132|18603774|P3|Overall Study|Withdrawal by Subject|1
5398152|NCT02992132|18603775|P2|Overall Study|Withdrawal by Subject|2
5398153|NCT02992132|18603776|P1|Overall Study|Withdrawal by Subject|0
5398154|NCT02992132|18603774|P3|Overall Study|Caregiver withdrew consent|2
5398155|NCT02992132|18603775|P2|Overall Study|Caregiver withdrew consent|3
5398156|NCT02992132|18603776|P1|Overall Study|Caregiver withdrew consent|2
5398157|NCT02992132|18603774|P3|Overall Study|Protocol Violation|0
5398158|NCT02992132|18603775|P2|Overall Study|Protocol Violation|2
5398159|NCT02992132|18603776|P1|Overall Study|Protocol Violation|2
5398160|NCT02992132|18603774|P3|Overall Study|Progressive disease|0
5398161|NCT02992132|18603775|P2|Overall Study|Progressive disease|0
5398162|NCT02992132|18603776|P1|Overall Study|Progressive disease|1
5398163|NCT02992132|18603774|P3|Overall Study|Non-compliance with study drug|0
5398164|NCT02992132|18603775|P2|Overall Study|Non-compliance with study drug|0
5398165|NCT02992132|18603776|P1|Overall Study|Non-compliance with study drug|2
5398166|NCT02992132|18603774|P3|Overall Study|Lack of Efficacy|0
5398167|NCT02992132|18603775|P2|Overall Study|Lack of Efficacy|0
5398168|NCT02992132|18603776|P1|Overall Study|Lack of Efficacy|2
5398169|NCT02992132|18603774|P3|Overall Study|Adverse Event|3
5398170|NCT02992132|18603775|P2|Overall Study|Adverse Event|1
5398171|NCT02992132|18603776|P1|Overall Study|Adverse Event|4
5398172|NCT02991859|18603889|P17|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398173|NCT02991859|18603890|P16|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398174|NCT02991859|18603891|P15|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398175|NCT02991859|18603892|P14|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398176|NCT02991859|18603893|P13|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398177|NCT02991859|18603894|P12|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398178|NCT02991859|18603895|P11|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398179|NCT02991859|18603896|P10|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398180|NCT02991859|18603897|P9|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
5398181|NCT02991859|18603898|P8|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398182|NCT02991859|18603899|P7|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398183|NCT02991859|18603900|P6|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398184|NCT02991859|18603901|P5|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398185|NCT02991859|18603902|P4|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398186|NCT02991859|18603903|P3|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398187|NCT02991859|18603904|P2|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398188|NCT02991859|18603905|P1|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
5398189|NCT02991859|18603889|P17|Wash Out, Up to Day 77|Lost to Follow-up|0
5398190|NCT02991859|18603890|P16|Wash Out, Up to Day 77|Lost to Follow-up|0
5398191|NCT02991859|18603891|P15|Wash Out, Up to Day 77|Lost to Follow-up|0
5398192|NCT02991859|18603892|P14|Wash Out, Up to Day 77|Lost to Follow-up|0
5398193|NCT02991859|18603893|P13|Wash Out, Up to Day 77|Lost to Follow-up|0
5398194|NCT02991859|18603894|P12|Wash Out, Up to Day 77|Lost to Follow-up|0
5398195|NCT02991859|18603895|P11|Wash Out, Up to Day 77|Lost to Follow-up|0
5398196|NCT02991859|18603896|P10|Wash Out, Up to Day 77|Lost to Follow-up|1
5398197|NCT02991859|18603897|P9|Wash Out, Up to Day 77|Lost to Follow-up|0
5398198|NCT02991859|18603898|P8|Wash Out, Up to Day 77|Lost to Follow-up|0
5398199|NCT02991859|18603899|P7|Wash Out, Up to Day 77|Lost to Follow-up|0
5398200|NCT02991859|18603900|P6|Wash Out, Up to Day 77|Lost to Follow-up|0
5398201|NCT02991859|18603901|P5|Wash Out, Up to Day 77|Lost to Follow-up|0
5398202|NCT02991859|18603902|P4|Wash Out, Up to Day 77|Lost to Follow-up|0
5398203|NCT02991859|18603903|P3|Wash Out, Up to Day 77|Lost to Follow-up|0
5398204|NCT02991859|18603904|P2|Wash Out, Up to Day 77|Lost to Follow-up|0
5398205|NCT02991859|18603905|P1|Wash Out, Up to Day 77|Lost to Follow-up|0
5398206|NCT02991859|18603889|P17|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398207|NCT02991859|18603890|P16|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398208|NCT02991859|18603891|P15|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398209|NCT02991859|18603892|P14|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398210|NCT02991859|18603893|P13|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398211|NCT02991859|18603894|P12|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398212|NCT02991859|18603895|P11|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398213|NCT02991859|18603896|P10|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398214|NCT02991859|18603897|P9|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398215|NCT02991859|18603898|P8|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398216|NCT02991859|18603899|P7|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398217|NCT02991859|18603900|P6|Wash Out, Up to Day 77|Withdrawal by Subject|1
5398218|NCT02991859|18603901|P5|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398219|NCT02991859|18603902|P4|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398220|NCT02991859|18603903|P3|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398221|NCT02991859|18603904|P2|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398222|NCT02991859|18603905|P1|Wash Out, Up to Day 77|Withdrawal by Subject|0
5398223|NCT02991859|18603889|P17|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398224|NCT02991859|18603890|P16|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398225|NCT02991859|18603891|P15|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398226|NCT02991859|18603892|P14|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
5398227|NCT02991859|18603893|P13|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
5398228|NCT02991859|18603894|P12|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398229|NCT02991859|18603895|P11|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398230|NCT02991859|18603896|P10|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398231|NCT02991859|18603897|P9|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398232|NCT02991859|18603898|P8|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398233|NCT02991859|18603899|P7|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398234|NCT02991859|18603900|P6|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398235|NCT02991859|18603901|P5|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398236|NCT02991859|18603902|P4|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398237|NCT02991859|18603903|P3|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398238|NCT02991859|18603904|P2|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398239|NCT02991859|18603905|P1|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
5398240|NCT02991859|18603889|P17|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398241|NCT02991859|18603890|P16|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398242|NCT02991859|18603891|P15|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398243|NCT02991859|18603892|P14|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398244|NCT02991859|18603893|P13|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398245|NCT02991859|18603894|P12|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398246|NCT02991859|18603895|P11|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398247|NCT02991859|18603896|P10|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398248|NCT02991859|18603897|P9|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398249|NCT02991859|18603898|P8|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398250|NCT02991859|18603899|P7|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398251|NCT02991859|18603900|P6|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398252|NCT02991859|18603901|P5|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
5398253|NCT02991859|18603902|P4|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398254|NCT02991859|18603903|P3|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398255|NCT02991859|18603904|P2|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
5398256|NCT02991859|18603905|P1|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
5398257|NCT02991430|18604200|P3|Post-treatment Observation Period|Study Termination|5
5398258|NCT02991430|18604201|P2|Post-treatment Observation Period|Study Termination|6
5398259|NCT02991430|18604202|P1|Post-treatment Observation Period|Study Termination|3
5398260|NCT02991430|18604200|P3|Treatment Period 2|Lost to Follow-up|1
5398261|NCT02991430|18604201|P2|Treatment Period 2|Lost to Follow-up|0
5398262|NCT02991430|18604202|P1|Treatment Period 2|Lost to Follow-up|0
5398263|NCT02991430|18604200|P3|Treatment Period 2|Study Termination|3
5398264|NCT02991430|18604201|P2|Treatment Period 2|Study Termination|3
5398265|NCT02991430|18604202|P1|Treatment Period 2|Study Termination|6
5398266|NCT02991430|18604200|P3|Treatment Period 1|Withdrawal by Subject|0
5398267|NCT02991430|18604201|P2|Treatment Period 1|Withdrawal by Subject|4
5398268|NCT02991430|18604202|P1|Treatment Period 1|Withdrawal by Subject|0
5398269|NCT02991430|18604200|P3|Treatment Period 1|Adverse Event|2
5398270|NCT02991430|18604201|P2|Treatment Period 1|Adverse Event|0
5398271|NCT02991430|18604202|P1|Treatment Period 1|Adverse Event|1
5398272|NCT02991118|18604239|P2|Overall Study|Lost to Follow-up|9
5398273|NCT02991118|18604240|P1|Overall Study|Lost to Follow-up|1
5398274|NCT02991118|18604239|P2|Overall Study|Could not attend study visits|1
5398275|NCT02991118|18604240|P1|Overall Study|Could not attend study visits|0
5398276|NCT02991118|18604239|P2|Overall Study|Withdrawal by Subject|7
5398277|NCT02991118|18604240|P1|Overall Study|Withdrawal by Subject|1
5398278|NCT02991118|18604239|P2|Overall Study|Adverse Event|2
5398279|NCT02991118|18604240|P1|Overall Study|Adverse Event|2
5398280|NCT02991118|18604239|P2|Overall Study|Moved out of the country|1
5398281|NCT02991118|18604240|P1|Overall Study|Moved out of the country|0
5398282|NCT02991118|18604239|P2|Overall Study|Physician Decision|1
5398283|NCT02991118|18604240|P1|Overall Study|Physician Decision|0
5398284|NCT02991118|18604239|P2|Overall Study|Protocol Violation|3
5398285|NCT02991118|18604240|P1|Overall Study|Protocol Violation|0
5398286|NCT02991118|18604239|P2|Overall Study|Death|8
5398287|NCT02991118|18604240|P1|Overall Study|Death|3
5398288|NCT02991040|18604284|P1|Overall Study|Lost to Follow-up|2
5398289|NCT02991040|18604284|P1|Overall Study|Withdrawal by Subject|2
5398290|NCT02990910|18604299|P2|Overall Study|Lack of Efficacy|10
5398291|NCT02990910|18604300|P1|Overall Study|Lack of Efficacy|6
5398292|NCT02990338|18604310|P2|Overall Study|Randomized but not treated|2
5398293|NCT02990338|18604311|P1|Overall Study|Randomized but not treated|4
5398294|NCT02990338|18604310|P2|Overall Study|Other|4
5398295|NCT02990338|18604311|P1|Overall Study|Other|1
5398296|NCT02990338|18604310|P2|Overall Study|Withdrawal by Subject|5
5398297|NCT02990338|18604311|P1|Overall Study|Withdrawal by Subject|6
5398298|NCT02990338|18604310|P2|Overall Study|Poor compliance to protocol|1
5398299|NCT02990338|18604311|P1|Overall Study|Poor compliance to protocol|0
5398300|NCT02990338|18604310|P2|Overall Study|Progressive disease|66
5398301|NCT02990338|18604311|P1|Overall Study|Progressive disease|88
5398302|NCT02990338|18604310|P2|Overall Study|Adverse Event|11
5398303|NCT02990338|18604311|P1|Overall Study|Adverse Event|19
5398304|NCT02990000|18604359|P2|Overall Study|Failed to provide data beyond baseline|34
5398305|NCT02990000|18604360|P1|Overall Study|Failed to provide data beyond baseline|36
5398306|NCT02989805|18604380|P2|Overall Study|invalid consent|4
5398307|NCT02989805|18604381|P1|Overall Study|invalid consent|6
5398308|NCT02989649|18604482|P1|Overall Study|Reason Not Specified|13
5398309|NCT02989649|18604482|P1|Overall Study|Lost For Observation During Study|3
5398310|NCT02989649|18604482|P1|Overall Study|Adverse Event/Adverse Drug Reaction|1
5398311|NCT02989649|18604482|P1|Overall Study|Patient/Investigator's Decision to Stop|403
5398312|NCT02989610|18604494|P1|Overall Study|Withdrawal/Other reasons|39
5398313|NCT02989389|18604524|P10|Period 1|Physician Decision|0
5398314|NCT02989389|18604525|P9|Period 1|Physician Decision|1
5398315|NCT02989389|18604526|P8|Period 1|Physician Decision|0
5398316|NCT02989389|18604527|P7|Period 1|Physician Decision|0
5398317|NCT02989389|18604528|P6|Period 1|Physician Decision|0
5398318|NCT02989389|18604529|P5|Period 1|Physician Decision|0
5398319|NCT02989389|18604530|P4|Period 1|Physician Decision|0
5398320|NCT02989389|18604531|P3|Period 1|Physician Decision|0
5398321|NCT02989389|18604532|P2|Period 1|Physician Decision|0
5398322|NCT02989389|18604533|P1|Period 1|Physician Decision|0
5398323|NCT02989389|18604524|P10|Period 1|Lost to Follow-up|0
5398324|NCT02989389|18604525|P9|Period 1|Lost to Follow-up|0
5398325|NCT02989389|18604526|P8|Period 1|Lost to Follow-up|0
5398326|NCT02989389|18604527|P7|Period 1|Lost to Follow-up|0
5398327|NCT02989389|18604528|P6|Period 1|Lost to Follow-up|0
5398328|NCT02989389|18604529|P5|Period 1|Lost to Follow-up|0
5398329|NCT02989389|18604530|P4|Period 1|Lost to Follow-up|0
5398330|NCT02989389|18604531|P3|Period 1|Lost to Follow-up|0
5398331|NCT02989389|18604532|P2|Period 1|Lost to Follow-up|1
5398332|NCT02989389|18604533|P1|Period 1|Lost to Follow-up|0
5398333|NCT02989168|18604599|P2|Overall Study|Sponsor stopped study.|0
5398334|NCT02989168|18604600|P1|Overall Study|Sponsor stopped study.|1
5398335|NCT02989168|18604599|P2|Overall Study|Adverse Event|2
5398336|NCT02989168|18604600|P1|Overall Study|Adverse Event|1
5398337|NCT02989168|18604599|P2|Overall Study|Physician Decision|1
5398338|NCT02989168|18604600|P1|Overall Study|Physician Decision|0
5398339|NCT02989168|18604599|P2|Overall Study|Withdrawal by Subject|0
5398340|NCT02989168|18604600|P1|Overall Study|Withdrawal by Subject|2
5398341|NCT02988622|18604646|P1|Overall Study|Lost to Follow-up|17
5398342|NCT02988219|18604681|P2|Overall Study|Withdrawal by Subject|2
5398343|NCT02988219|18604682|P1|Overall Study|Withdrawal by Subject|0
5398344|NCT02988219|18604681|P2|Overall Study|Lack of Efficacy|1
5398345|NCT02988219|18604682|P1|Overall Study|Lack of Efficacy|1
5398346|NCT02988115|18604701|P2|Overall Study|Lost to Follow-up|0
5398347|NCT02988115|18604702|P1|Overall Study|Lost to Follow-up|1
5398348|NCT02988115|18604701|P2|Overall Study|Withdrawn by Mistake|0
5398349|NCT02988115|18604702|P1|Overall Study|Withdrawn by Mistake|1
5398350|NCT02988115|18604701|P2|Overall Study|Withdrawal by Subject|1
5398351|NCT02988115|18604702|P1|Overall Study|Withdrawal by Subject|1
5398352|NCT02988115|18604701|P2|Overall Study|Sponsor Decision|2
5398353|NCT02988115|18604702|P1|Overall Study|Sponsor Decision|5
5398354|NCT02988115|18604701|P2|Overall Study|Adverse Event|1
5398355|NCT02988115|18604702|P1|Overall Study|Adverse Event|6
5398356|NCT02987972|18604728|P3|Overall Study|Withdrawal by Subject|21
5398357|NCT02987972|18604729|P2|Overall Study|Withdrawal by Subject|17
5398358|NCT02987972|18604730|P1|Overall Study|Withdrawal by Subject|22
5398359|NCT02987972|18604728|P3|Overall Study|Protocol Violation|5
5398360|NCT02987972|18604729|P2|Overall Study|Protocol Violation|1
5398361|NCT02987972|18604730|P1|Overall Study|Protocol Violation|2
5398362|NCT02987972|18604728|P3|Overall Study|Physician Decision|0
5398363|NCT02987972|18604729|P2|Overall Study|Physician Decision|6
5398364|NCT02987972|18604730|P1|Overall Study|Physician Decision|1
5398365|NCT02987972|18604728|P3|Overall Study|Lost to Follow-up|4
5398366|NCT02987972|18604729|P2|Overall Study|Lost to Follow-up|8
5398367|NCT02987972|18604730|P1|Overall Study|Lost to Follow-up|7
5398368|NCT02987972|18604728|P3|Overall Study|Lack of Efficacy|12
5398369|NCT02987972|18604729|P2|Overall Study|Lack of Efficacy|12
5398370|NCT02987972|18604730|P1|Overall Study|Lack of Efficacy|9
5398371|NCT02987972|18604728|P3|Overall Study|Death|0
5398372|NCT02987972|18604729|P2|Overall Study|Death|0
5398373|NCT02987972|18604730|P1|Overall Study|Death|1
5398374|NCT02987972|18604728|P3|Overall Study|Adverse Event|0
5398375|NCT02987972|18604729|P2|Overall Study|Adverse Event|1
5398376|NCT02987972|18604730|P1|Overall Study|Adverse Event|1
5398377|NCT02987660|18604768|P2|Overall Study|Study terminated by sponsor|10
5398378|NCT02987660|18604769|P1|Overall Study|Study terminated by sponsor|10
5398379|NCT02987543|18604793|P4|Overall Study|Investigator's decision|0
5398380|NCT02987543|18604794|P3|Overall Study|Investigator's decision|0
5398381|NCT02987543|18604795|P2|Overall Study|Investigator's decision|1
5398382|NCT02987543|18604796|P1|Overall Study|Investigator's decision|0
5398383|NCT02987543|18604793|P4|Overall Study|Disease Progression|1
5398384|NCT02987543|18604794|P3|Overall Study|Disease Progression|0
5398385|NCT02987543|18604795|P2|Overall Study|Disease Progression|0
5398386|NCT02987543|18604796|P1|Overall Study|Disease Progression|0
5398387|NCT02987543|18604793|P4|Overall Study|Withdrawal by Subject|7
5398388|NCT02987543|18604794|P3|Overall Study|Withdrawal by Subject|6
5398389|NCT02987543|18604795|P2|Overall Study|Withdrawal by Subject|6
5398390|NCT02987543|18604796|P1|Overall Study|Withdrawal by Subject|17
5398391|NCT02987543|18604793|P4|Overall Study|Screen failure|1
5398392|NCT02987543|18604794|P3|Overall Study|Screen failure|0
5398393|NCT02987543|18604795|P2|Overall Study|Screen failure|0
5398394|NCT02987543|18604796|P1|Overall Study|Screen failure|0
5398395|NCT02987543|18604793|P4|Overall Study|Death|21
5398396|NCT02987543|18604794|P3|Overall Study|Death|42
5398397|NCT02987543|18604795|P2|Overall Study|Death|36
5398398|NCT02987543|18604796|P1|Overall Study|Death|53
5398399|NCT02987543|18604793|P4|Overall Study|Ongoing study at data cut off|18
5398400|NCT02987543|18604794|P3|Overall Study|Ongoing study at data cut off|46
5398401|NCT02987543|18604795|P2|Overall Study|Ongoing study at data cut off|40
5398402|NCT02987543|18604796|P1|Overall Study|Ongoing study at data cut off|92
5398403|NCT02987205|18604826|P1|Overall Study|Withdrawal by Subject|3
5398404|NCT02987205|18604826|P1|Overall Study|Adverse Event|1
5398405|NCT02986854|18604860|P3|Overall Study|Lost to Follow-up|2
5398406|NCT02986854|18604861|P2|Overall Study|Lost to Follow-up|11
5398407|NCT02986854|18604862|P1|Overall Study|Lost to Follow-up|3
5398408|NCT02986854|18604860|P3|Overall Study|Withdrawal by Subject|1
5398409|NCT02986854|18604861|P2|Overall Study|Withdrawal by Subject|1
5398410|NCT02986854|18604862|P1|Overall Study|Withdrawal by Subject|0
5398411|NCT02986373|18604946|P1|Overall Study|Other|24
5398412|NCT02986373|18604946|P1|Overall Study|Withdrawal by Subject|10
5398413|NCT02986373|18604946|P1|Overall Study|Lost to Follow-up|1
5398414|NCT02986373|18604946|P1|Overall Study|Adverse Event|4
5398415|NCT02986139|18604988|P2|Overall Study|Lost to Follow-up|1
5398416|NCT02986139|18604989|P1|Overall Study|Lost to Follow-up|0
5398417|NCT02986139|18604988|P2|Overall Study|Withdrawal by Subject|1
5398418|NCT02986139|18604989|P1|Overall Study|Withdrawal by Subject|0
5398419|NCT02986139|18604988|P2|Overall Study|Sponsor Decision|2
5398420|NCT02986139|18604989|P1|Overall Study|Sponsor Decision|1
5398421|NCT02985996|18605006|P5|Overall Study|Protocol Violation|0
5398422|NCT02985996|18605007|P4|Overall Study|Protocol Violation|0
5398423|NCT02985996|18605008|P3|Overall Study|Protocol Violation|0
5398424|NCT02985996|18605009|P2|Overall Study|Protocol Violation|1
5398425|NCT02985996|18605010|P1|Overall Study|Protocol Violation|0
5398426|NCT02985996|18605006|P5|Overall Study|Withdrawal by Subject|0
5398427|NCT02985996|18605007|P4|Overall Study|Withdrawal by Subject|0
5398428|NCT02985996|18605008|P3|Overall Study|Withdrawal by Subject|1
5398429|NCT02985996|18605009|P2|Overall Study|Withdrawal by Subject|0
5398430|NCT02985996|18605010|P1|Overall Study|Withdrawal by Subject|0
5398431|NCT02985684|18605144|P1|6-Month Closure Success Evaluation|Device Removal|3
5398432|NCT02985684|18605144|P1|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
5398433|NCT02985684|18605144|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
5398434|NCT02985398|18605155|P1|Overall Study|Study Burden|9
5398435|NCT02985398|18605155|P1|Overall Study|Withdrawal by Subject|8
5398436|NCT02985398|18605155|P1|Overall Study|Lost to Follow-up|4
5398437|NCT02985398|18605155|P1|Overall Study|Adverse Event|1
5398438|NCT02984995|18605173|P2|Overall Study|Adverse Event|0
5398439|NCT02984995|18605174|P1|Overall Study|Adverse Event|1
5398440|NCT02984995|18605173|P2|Overall Study|Progressive disease|1
5398441|NCT02984995|18605174|P1|Overall Study|Progressive disease|11
5398442|NCT02984995|18605173|P2|Overall Study|Required stem cell transplant|2
5398443|NCT02984995|18605174|P1|Overall Study|Required stem cell transplant|13
5398444|NCT02984982|18605221|P2|Overall Study|Randomized but not treated|1
5398445|NCT02984982|18605222|P1|Overall Study|Randomized but not treated|0
5398446|NCT02984982|18605221|P2|Overall Study|Withdrawal by Subject|0
5398447|NCT02984982|18605222|P1|Overall Study|Withdrawal by Subject|2
5398448|NCT02984982|18605221|P2|Overall Study|Poor Compliance to Protocol|4
5398449|NCT02984982|18605222|P1|Overall Study|Poor Compliance to Protocol|4
5398450|NCT02984982|18605221|P2|Overall Study|Adverse Event|5
5398451|NCT02984982|18605222|P1|Overall Study|Adverse Event|2
5398452|NCT02984943|18605274|P1|Overall Study|Physician Decision|1
5398453|NCT02984943|18605274|P1|Overall Study|Withdrawal by Subject|3
5398454|NCT02984267|18605388|P2|Overall Study|Withdrawal by Subject|1
5398455|NCT02984267|18605389|P1|Overall Study|Withdrawal by Subject|0
5398456|NCT02984267|18605388|P2|Overall Study|Protocol Violation|0
5398457|NCT02984267|18605389|P1|Overall Study|Protocol Violation|1
5398458|NCT02983617|18605434|P2|Overall Study|Still on Study|28
5398459|NCT02983617|18605435|P1|Overall Study|Still on Study|6
5398460|NCT02983617|18605434|P2|Overall Study|Death|1
5398461|NCT02983617|18605435|P1|Overall Study|Death|0
5398462|NCT02983617|18605434|P2|Overall Study|Adverse Event|1
5398463|NCT02983617|18605435|P1|Overall Study|Adverse Event|0
5398464|NCT02983604|18605453|P4|Overall Study|Enrolled but not Treated|0
5398465|NCT02983604|18605454|P3|Overall Study|Enrolled but not Treated|1
5398466|NCT02983604|18605455|P2|Overall Study|Enrolled but not Treated|0
5398467|NCT02983604|18605456|P1|Overall Study|Enrolled but not Treated|0
5398468|NCT02983305|18605505|P2|Overall Study|incomplete data|0
5398469|NCT02983305|18605506|P1|Overall Study|incomplete data|2
5398470|NCT02983227|18605516|P2|Overall Study|Withdrawal by Subject|8
5398471|NCT02983227|18605517|P1|Overall Study|Withdrawal by Subject|19
5398472|NCT02983227|18605516|P2|Overall Study|Physician Decision|1
5398473|NCT02983227|18605517|P1|Overall Study|Physician Decision|3
5398474|NCT02983227|18605516|P2|Overall Study|Multiple Reasons|1
5398475|NCT02983227|18605517|P1|Overall Study|Multiple Reasons|2
5398476|NCT02983227|18605516|P2|Overall Study|Lost to Follow-up|0
5398477|NCT02983227|18605517|P1|Overall Study|Lost to Follow-up|3
5398478|NCT02983227|18605516|P2|Overall Study|Lack of Efficacy|1
5398479|NCT02983227|18605517|P1|Overall Study|Lack of Efficacy|8
5398480|NCT02983227|18605516|P2|Overall Study|Death|0
5398481|NCT02983227|18605517|P1|Overall Study|Death|3
5398482|NCT02983227|18605516|P2|Overall Study|Adverse Event|3
5398483|NCT02983227|18605517|P1|Overall Study|Adverse Event|21
5398484|NCT02982863|18605597|P5|Overall Study|Not eligible patients|492
5398485|NCT02982863|18605598|P4|Overall Study|Not eligible patients|1400
5398486|NCT02982863|18605599|P3|Overall Study|Not eligible patients|1852
5398487|NCT02982863|18605600|P2|Overall Study|Not eligible patients|4261
5398488|NCT02982863|18605601|P1|Overall Study|Not eligible patients|809
5398489|NCT02982720|18605658|P1|Overall Study|Death|1
5398490|NCT02982720|18605658|P1|Overall Study|Adverse Event|3
5398491|NCT02982239|18605668|P2|Overall Study|Lost to Follow-up|2
5398492|NCT02982239|18605669|P1|Overall Study|Lost to Follow-up|3
5398493|NCT02982187|18605685|P8|Overall Study|Withdrawal by Subject|0
5398494|NCT02982187|18605686|P7|Overall Study|Withdrawal by Subject|1
5398495|NCT02982187|18605687|P6|Overall Study|Withdrawal by Subject|0
5398496|NCT02982187|18605688|P5|Overall Study|Withdrawal by Subject|0
5398497|NCT02982187|18605689|P4|Overall Study|Withdrawal by Subject|0
5398498|NCT02982187|18605690|P3|Overall Study|Withdrawal by Subject|0
5398499|NCT02982187|18605691|P2|Overall Study|Withdrawal by Subject|0
5398500|NCT02982187|18605692|P1|Overall Study|Withdrawal by Subject|0
5398501|NCT02982018|18605742|P2|Overall Study|Withdrawal by Subject|1
5398502|NCT02982018|18605743|P1|Overall Study|Withdrawal by Subject|0
5398503|NCT02982018|18605742|P2|Overall Study|Lens Discomfort|0
5398504|NCT02982018|18605743|P1|Overall Study|Lens Discomfort|2
5398505|NCT02982018|18605742|P2|Overall Study|Adverse Event|1
5398506|NCT02982018|18605743|P1|Overall Study|Adverse Event|1
5398507|NCT02982018|18605742|P2|Overall Study|Protocol Violation|1
5398508|NCT02982018|18605743|P1|Overall Study|Protocol Violation|1
5398509|NCT02982018|18605742|P2|Overall Study|Incorrect Lens Dispensed|0
5398510|NCT02982018|18605743|P1|Overall Study|Incorrect Lens Dispensed|1
5398511|NCT02981602|18605762|P5|Overall Study|Adverse Event|0
5398512|NCT02981602|18605763|P4|Overall Study|Adverse Event|1
5398513|NCT02981602|18605764|P3|Overall Study|Adverse Event|0
5398514|NCT02981602|18605765|P2|Overall Study|Adverse Event|0
5398515|NCT02981602|18605766|P1|Overall Study|Adverse Event|0
5398516|NCT02981524|18605946|P1|Overall Study|Withdrawal by Subject|1
5398517|NCT02981524|18605946|P1|Overall Study|Treatment Related Toxicity|1
5398518|NCT02981524|18605946|P1|Overall Study|Death (unrelated)|1
5398519|NCT02981524|18605946|P1|Overall Study|Progressive Disease|14
5398520|NCT02981342|18605958|P4|Overall Study|Lost to Follow-up|0
5398521|NCT02981342|18605959|P3|Overall Study|Lost to Follow-up|0
5398522|NCT02981342|18605960|P2|Overall Study|Lost to Follow-up|1
5398523|NCT02981342|18605961|P1|Overall Study|Lost to Follow-up|0
5398524|NCT02981342|18605958|P4|Overall Study|Randomized, Never Treated|7
5398525|NCT02981342|18605959|P3|Overall Study|Randomized, Never Treated|0
5398526|NCT02981342|18605960|P2|Overall Study|Randomized, Never Treated|1
5398527|NCT02981342|18605961|P1|Overall Study|Randomized, Never Treated|0
5398528|NCT02981342|18605958|P4|Overall Study|Study closed by sponsor|1
5398529|NCT02981342|18605959|P3|Overall Study|Study closed by sponsor|1
5398530|NCT02981342|18605960|P2|Overall Study|Study closed by sponsor|0
5398531|NCT02981342|18605961|P1|Overall Study|Study closed by sponsor|0
5398532|NCT02981342|18605958|P4|Overall Study|Withdrawal by Subject|1
5398533|NCT02981342|18605959|P3|Overall Study|Withdrawal by Subject|3
5398534|NCT02981342|18605960|P2|Overall Study|Withdrawal by Subject|0
5398535|NCT02981342|18605961|P1|Overall Study|Withdrawal by Subject|0
5398536|NCT02981342|18605958|P4|Overall Study|Death|4
5398537|NCT02981342|18605959|P3|Overall Study|Death|9
5398538|NCT02981342|18605960|P2|Overall Study|Death|9
5398539|NCT02981342|18605961|P1|Overall Study|Death|0
5398540|NCT02981342|18605958|P4|Overall Study|Adverse Event|1
5398541|NCT02981342|18605959|P3|Overall Study|Adverse Event|0
5398542|NCT02981342|18605960|P2|Overall Study|Adverse Event|0
5398543|NCT02981342|18605961|P1|Overall Study|Adverse Event|0
5398544|NCT02980783|18606019|P1|Overall Study|Lost to Follow-up|1
5398545|NCT02980601|18606032|P2|Overall Study|Failed to sign consent|0
5398546|NCT02980601|18606033|P1|Overall Study|Failed to sign consent|2
5398547|NCT02980601|18606032|P2|Overall Study|Graft loss|0
5398548|NCT02980601|18606033|P1|Overall Study|Graft loss|1
5398549|NCT02980601|18606032|P2|Overall Study|Death|1
5398550|NCT02980601|18606033|P1|Overall Study|Death|0
5398551|NCT02980601|18606032|P2|Overall Study|Lost to Follow-up|2
5398552|NCT02980601|18606033|P1|Overall Study|Lost to Follow-up|2
5398553|NCT02980523|18606126|P5|Overall Study|Did not receive intervention|0
5398554|NCT02980523|18606127|P4|Overall Study|Did not receive intervention|1
5398555|NCT02980523|18606128|P3|Overall Study|Did not receive intervention|0
5398556|NCT02980523|18606129|P2|Overall Study|Did not receive intervention|0
5398557|NCT02980523|18606130|P1|Overall Study|Did not receive intervention|0
5398558|NCT02980523|18606126|P5|Overall Study|Lack of Efficacy|8
5398559|NCT02980523|18606127|P4|Overall Study|Lack of Efficacy|5
5398560|NCT02980523|18606128|P3|Overall Study|Lack of Efficacy|4
5398561|NCT02980523|18606129|P2|Overall Study|Lack of Efficacy|4
5398562|NCT02980523|18606130|P1|Overall Study|Lack of Efficacy|1
5398563|NCT02980523|18606126|P5|Overall Study|Excluded from analysis|1
5398564|NCT02980523|18606127|P4|Overall Study|Excluded from analysis|1
5398565|NCT02980523|18606128|P3|Overall Study|Excluded from analysis|1
5398566|NCT02980523|18606129|P2|Overall Study|Excluded from analysis|3
5398567|NCT02980523|18606130|P1|Overall Study|Excluded from analysis|1
5398568|NCT02980523|18606126|P5|Overall Study|Lost to Follow-up|1
5398569|NCT02980523|18606127|P4|Overall Study|Lost to Follow-up|2
5398570|NCT02980523|18606128|P3|Overall Study|Lost to Follow-up|1
5398571|NCT02980523|18606129|P2|Overall Study|Lost to Follow-up|4
5398572|NCT02980523|18606130|P1|Overall Study|Lost to Follow-up|1
5398573|NCT02980224|18606174|P2|Overall Study|Withdrawal by Subject|2
5398574|NCT02980224|18606175|P1|Overall Study|Withdrawal by Subject|0
5398575|NCT02980224|18606174|P2|Overall Study|Adverse Event|1
5398576|NCT02980224|18606175|P1|Overall Study|Adverse Event|4
5398577|NCT02980133|18606193|P4|Overall Study|Withdrawal by Subject|0
5398578|NCT02980133|18606194|P3|Overall Study|Withdrawal by Subject|1
5398579|NCT02980133|18606195|P2|Overall Study|Withdrawal by Subject|0
5398580|NCT02980133|18606196|P1|Overall Study|Withdrawal by Subject|0
5398581|NCT02980133|18606193|P4|Overall Study|Withdrawal by parent/guardian|1
5398582|NCT02980133|18606194|P3|Overall Study|Withdrawal by parent/guardian|3
5398583|NCT02980133|18606195|P2|Overall Study|Withdrawal by parent/guardian|3
5398584|NCT02980133|18606196|P1|Overall Study|Withdrawal by parent/guardian|6
5398585|NCT02980133|18606193|P4|Overall Study|Protocol Violation|0
5398586|NCT02980133|18606194|P3|Overall Study|Protocol Violation|0
5398587|NCT02980133|18606195|P2|Overall Study|Protocol Violation|1
5398588|NCT02980133|18606196|P1|Overall Study|Protocol Violation|0
5398589|NCT02980133|18606193|P4|Overall Study|Lost to Follow-up|3
5398590|NCT02980133|18606194|P3|Overall Study|Lost to Follow-up|1
5398591|NCT02980133|18606195|P2|Overall Study|Lost to Follow-up|0
5398592|NCT02980133|18606196|P1|Overall Study|Lost to Follow-up|0
5398593|NCT02980133|18606193|P4|Overall Study|Other than specified|2
5398594|NCT02980133|18606194|P3|Overall Study|Other than specified|2
5398595|NCT02980133|18606195|P2|Overall Study|Other than specified|1
5398596|NCT02980133|18606196|P1|Overall Study|Other than specified|1
5398597|NCT02980107|18606234|P2|Overall Study|Withdrawal by Subject|62
5398598|NCT02980107|18606235|P1|Overall Study|Withdrawal by Subject|51
5398599|NCT02980042|18606249|P2|Overall Study|Insurance issues/treatment plan changes|0
5398600|NCT02980042|18606250|P1|Overall Study|Insurance issues/treatment plan changes|2
5398601|NCT02980042|18606249|P2|Overall Study|Lost to Follow-up|0
5398602|NCT02980042|18606250|P1|Overall Study|Lost to Follow-up|5
5398603|NCT02979639|18606282|P1|Overall Study|Adverse Event|2
5398604|NCT02979639|18606282|P1|Overall Study|Withdrawal by Subject|3
5398605|NCT02979639|18606282|P1|Overall Study|Lost to Follow-up|8
5398606|NCT02979639|18606282|P1|Overall Study|Withdrawal based on medical judgement|1
5398607|NCT02979613|18606314|P2|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
5398608|NCT02979613|18606315|P1|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
5398609|NCT02979613|18606314|P2|Open-Label Extension (OLE) Phase|Death|1
5398610|NCT02979613|18606315|P1|Open-Label Extension (OLE) Phase|Death|0
5398611|NCT02979613|18606314|P2|Open-Label Extension (OLE) Phase|Adverse Event|0
5398612|NCT02979613|18606315|P1|Open-Label Extension (OLE) Phase|Adverse Event|1
5398613|NCT02979613|18606314|P2|Open-Label Extension (OLE) Phase|Withdrew Consent|4
5398614|NCT02979613|18606315|P1|Open-Label Extension (OLE) Phase|Withdrew Consent|2
5398615|NCT02979613|18606314|P2|Double-Blind Phase|Randomized but Never Treated|0
5398616|NCT02979613|18606315|P1|Double-Blind Phase|Randomized but Never Treated|2
5398617|NCT02979613|18606314|P2|Double-Blind Phase|Protocol Violation|1
5398618|NCT02979613|18606315|P1|Double-Blind Phase|Protocol Violation|1
5398619|NCT02979613|18606314|P2|Double-Blind Phase|Lost to Follow-up|1
5398620|NCT02979613|18606315|P1|Double-Blind Phase|Lost to Follow-up|1
5398621|NCT02979613|18606314|P2|Double-Blind Phase|Adverse Event|0
5398622|NCT02979613|18606315|P1|Double-Blind Phase|Adverse Event|2
5398623|NCT02979613|18606314|P2|Double-Blind Phase|Pregnancy|2
5398624|NCT02979613|18606315|P1|Double-Blind Phase|Pregnancy|2
5398625|NCT02979613|18606314|P2|Double-Blind Phase|Withdrew Consent|4
5398626|NCT02979613|18606315|P1|Double-Blind Phase|Withdrew Consent|2
5398627|NCT02979535|18606375|P2|Overall Study|Lost to Follow-up|1
5398628|NCT02979535|18606376|P1|Overall Study|Lost to Follow-up|6
5398629|NCT02979535|18606375|P2|Overall Study|Consent withdrawn by participant|18
5398630|NCT02979535|18606376|P1|Overall Study|Consent withdrawn by participant|11
5398631|NCT02979535|18606375|P2|Overall Study|Non compliance with the protocol|82
5398632|NCT02979535|18606376|P1|Overall Study|Non compliance with the protocol|78
5398633|NCT02979431|18606439|P4|Overall Study|Subject left country after Day14|0
5398634|NCT02979431|18606440|P3|Overall Study|Subject left country after Day14|0
5398635|NCT02979431|18606441|P2|Overall Study|Subject left country after Day14|0
5398636|NCT02979431|18606442|P1|Overall Study|Subject left country after Day14|1
5398637|NCT02979431|18606439|P4|Overall Study|Adverse Event|0
5398638|NCT02979431|18606440|P3|Overall Study|Adverse Event|1
5398639|NCT02979431|18606441|P2|Overall Study|Adverse Event|0
5398640|NCT02979431|18606442|P1|Overall Study|Adverse Event|0
5398641|NCT02979431|18606439|P4|Overall Study|Randomized but received no study drug|0
5398642|NCT02979431|18606440|P3|Overall Study|Randomized but received no study drug|0
5398643|NCT02979431|18606441|P2|Overall Study|Randomized but received no study drug|1
5398644|NCT02979431|18606442|P1|Overall Study|Randomized but received no study drug|1
5398645|NCT02979431|18606439|P4|Overall Study|Parent/guardian withdrew consent|1
5398646|NCT02979431|18606440|P3|Overall Study|Parent/guardian withdrew consent|1
5398647|NCT02979431|18606441|P2|Overall Study|Parent/guardian withdrew consent|1
5398648|NCT02979431|18606442|P1|Overall Study|Parent/guardian withdrew consent|2
5398649|NCT02979249|18606520|P1|Overall Study|Withdrawal by Subject|4
5398650|NCT02979249|18606520|P1|Overall Study|Lost to Follow-up|2
5398651|NCT02979197|18606528|P3|Overall Study|Subject unable to commit to study dates|0
5398652|NCT02979197|18606529|P2|Overall Study|Subject unable to commit to study dates|1
5398653|NCT02979197|18606530|P1|Overall Study|Subject unable to commit to study dates|0
5398654|NCT02979197|18606528|P3|Overall Study|Protocol Violation|0
5398655|NCT02979197|18606529|P2|Overall Study|Protocol Violation|1
5398656|NCT02979197|18606530|P1|Overall Study|Protocol Violation|0
5398657|NCT02979197|18606528|P3|Overall Study|Adverse Event|0
5398658|NCT02979197|18606529|P2|Overall Study|Adverse Event|2
5398659|NCT02979197|18606530|P1|Overall Study|Adverse Event|4
5398660|NCT02978833|18606573|P2|Overall Study|Study terminated|1
5398661|NCT02978833|18606574|P1|Overall Study|Study terminated|1
5398662|NCT02978417|18606603|P2|Overall Study|Lost to Follow-up|2
5398663|NCT02978417|18606604|P1|Overall Study|Lost to Follow-up|2
5398664|NCT02977572|18606659|P2|Overall Study|Exclusion criterion|2
5398665|NCT02977572|18606660|P1|Overall Study|Exclusion criterion|2
5398666|NCT02977507|18606682|P2|Overall Study|Lost to Follow-up|0
5398667|NCT02977507|18606683|P1|Overall Study|Lost to Follow-up|1
5398668|NCT02977507|18606682|P2|Overall Study|Protocol Deviation|0
5398669|NCT02977507|18606683|P1|Overall Study|Protocol Deviation|1
5398670|NCT02976519|18606713|P7|Treatment Period 2 (Part 2 Only)|Adverse Event|1
5398671|NCT02976519|18606714|P6|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5398672|NCT02976519|18606715|P5|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5398673|NCT02976519|18606716|P4|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5398674|NCT02976519|18606717|P3|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5398675|NCT02976519|18606718|P2|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5398676|NCT02976519|18606719|P1|Treatment Period 2 (Part 2 Only)|Adverse Event|0
5398677|NCT02976519|18606713|P7|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
5398678|NCT02976519|18606714|P6|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5398679|NCT02976519|18606715|P5|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5398680|NCT02976519|18606716|P4|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5398681|NCT02976519|18606717|P3|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5398682|NCT02976519|18606718|P2|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5398683|NCT02976519|18606719|P1|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
5398684|NCT02976519|18606713|P7|Wash-out Period (Part 2 Only)|Reason not listed|1
5398685|NCT02976519|18606714|P6|Wash-out Period (Part 2 Only)|Reason not listed|0
5398686|NCT02976519|18606715|P5|Wash-out Period (Part 2 Only)|Reason not listed|0
5398687|NCT02976519|18606716|P4|Wash-out Period (Part 2 Only)|Reason not listed|0
5398688|NCT02976519|18606717|P3|Wash-out Period (Part 2 Only)|Reason not listed|0
5398689|NCT02976519|18606718|P2|Wash-out Period (Part 2 Only)|Reason not listed|0
5398690|NCT02976519|18606719|P1|Wash-out Period (Part 2 Only)|Reason not listed|0
5398691|NCT02976519|18606713|P7|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5398692|NCT02976519|18606714|P6|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5398693|NCT02976519|18606715|P5|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5398694|NCT02976519|18606716|P4|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
5398695|NCT02976519|18606717|P3|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5398696|NCT02976519|18606718|P2|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5398697|NCT02976519|18606719|P1|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
5398698|NCT02976519|18606713|P7|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5398699|NCT02976519|18606714|P6|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5398700|NCT02976519|18606715|P5|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5398701|NCT02976519|18606716|P4|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5398702|NCT02976519|18606717|P3|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5398703|NCT02976519|18606718|P2|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
5398704|NCT02976519|18606719|P1|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
5398705|NCT02976103|18606750|P2|Overall Study|Lost to Follow-up|8
5398706|NCT02976103|18606751|P1|Overall Study|Lost to Follow-up|12
5398707|NCT02976103|18606750|P2|Overall Study|Withdrawal by Subject|0
5398708|NCT02976103|18606751|P1|Overall Study|Withdrawal by Subject|1
5398709|NCT02975973|18606806|P4|Overall Study|Adverse Event|0
5398710|NCT02975973|18606807|P3|Overall Study|Adverse Event|1
5398711|NCT02975973|18606808|P2|Overall Study|Adverse Event|1
5398712|NCT02975973|18606809|P1|Overall Study|Adverse Event|1
5398713|NCT02975700|18606872|P1|Overall Study|Failed screening criteria|2
5398714|NCT02975700|18606872|P1|Overall Study|Progressive disease|3
5398715|NCT02975700|18606872|P1|Overall Study|Adverse Event|1
5398716|NCT02975336|18606907|P4|Overall Study|Other|4
5398717|NCT02975336|18606908|P3|Overall Study|Other|6
5398718|NCT02975336|18606909|P2|Overall Study|Other|6
5398719|NCT02975336|18606910|P1|Overall Study|Other|5
5398720|NCT02975336|18606907|P4|Overall Study|Withdrawal by Subject|3
5398721|NCT02975336|18606908|P3|Overall Study|Withdrawal by Subject|1
5398722|NCT02975336|18606909|P2|Overall Study|Withdrawal by Subject|0
5398723|NCT02975336|18606910|P1|Overall Study|Withdrawal by Subject|1
5398724|NCT02975336|18606907|P4|Overall Study|Lack of Efficacy|3
5398725|NCT02975336|18606908|P3|Overall Study|Lack of Efficacy|2
5398726|NCT02975336|18606909|P2|Overall Study|Lack of Efficacy|4
5398727|NCT02975336|18606910|P1|Overall Study|Lack of Efficacy|4
5398728|NCT02975336|18606907|P4|Overall Study|Protocol Violation|1
5398729|NCT02975336|18606908|P3|Overall Study|Protocol Violation|3
5398730|NCT02975336|18606909|P2|Overall Study|Protocol Violation|1
5398731|NCT02975336|18606910|P1|Overall Study|Protocol Violation|4
5398732|NCT02975336|18606907|P4|Overall Study|Lost to Follow-up|4
5398733|NCT02975336|18606908|P3|Overall Study|Lost to Follow-up|2
5398734|NCT02975336|18606909|P2|Overall Study|Lost to Follow-up|1
5398735|NCT02975336|18606910|P1|Overall Study|Lost to Follow-up|2
5398736|NCT02975336|18606907|P4|Overall Study|Adverse Event|18
5398737|NCT02975336|18606908|P3|Overall Study|Adverse Event|13
5398738|NCT02975336|18606909|P2|Overall Study|Adverse Event|17
5398739|NCT02975336|18606910|P1|Overall Study|Adverse Event|16
5398740|NCT02975206|18607143|P3|Overall Study|Other (e.g., lost to follow up)|6
5398741|NCT02975206|18607144|P2|Overall Study|Other (e.g., lost to follow up)|6
5398742|NCT02975206|18607145|P1|Overall Study|Other (e.g., lost to follow up)|13
5398743|NCT02975206|18607143|P3|Overall Study|Withdrawal by Subject|11
5398744|NCT02975206|18607144|P2|Overall Study|Withdrawal by Subject|11
5398745|NCT02975206|18607145|P1|Overall Study|Withdrawal by Subject|14
5398746|NCT02974868|18607162|P4|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
5398747|NCT02974868|18607163|P3|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
5398748|NCT02974868|18607164|P2|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
5398749|NCT02974868|18607165|P1|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
5398750|NCT02974868|18607162|P4|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
5398751|NCT02974868|18607163|P3|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
5398752|NCT02974868|18607164|P2|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
5398753|NCT02974868|18607165|P1|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
5398754|NCT02974868|18607162|P4|Initial 24-Week Treatment Period (TP)|others|8
5398755|NCT02974868|18607163|P3|Initial 24-Week Treatment Period (TP)|others|1
5398756|NCT02974868|18607164|P2|Initial 24-Week Treatment Period (TP)|others|8
5398757|NCT02974868|18607165|P1|Initial 24-Week Treatment Period (TP)|others|3
5398758|NCT02974868|18607162|P4|Initial 24-Week Treatment Period (TP)|Adverse Event|4
5398759|NCT02974868|18607163|P3|Initial 24-Week Treatment Period (TP)|Adverse Event|2
5398760|NCT02974868|18607164|P2|Initial 24-Week Treatment Period (TP)|Adverse Event|1
5398761|NCT02974868|18607165|P1|Initial 24-Week Treatment Period (TP)|Adverse Event|1
5398762|NCT02974855|18607287|P4|Overall Study|Adverse Event|1
5398763|NCT02974855|18607288|P3|Overall Study|Adverse Event|0
5398764|NCT02974855|18607289|P2|Overall Study|Adverse Event|1
5398765|NCT02974855|18607290|P1|Overall Study|Adverse Event|0
5398766|NCT02974842|18607476|P1|Overall Study|Screen failures|4
5398767|NCT02974842|18607476|P1|Overall Study|Withdrawal by Subject|4
5398768|NCT02974634|18607495|P2|Overall Study|Death|11
5398769|NCT02974634|18607496|P1|Overall Study|Death|8
5398770|NCT02974634|18607495|P2|Overall Study|intervention technology related issues|0
5398771|NCT02974634|18607496|P1|Overall Study|intervention technology related issues|5
5398772|NCT02974634|18607495|P2|Overall Study|Noncompliance|7
5398773|NCT02974634|18607496|P1|Overall Study|Noncompliance|3
5398774|NCT02974634|18607495|P2|Overall Study|Advanced disease|3
5398775|NCT02974634|18607496|P1|Overall Study|Advanced disease|12
5398776|NCT02974543|18607506|P2|Overall Study|Withdrawal by Subject|0
5398777|NCT02974543|18607507|P1|Overall Study|Withdrawal by Subject|1
5398778|NCT02974153|18607541|P3|Overall Study|Other|7
5398779|NCT02974153|18607542|P2|Overall Study|Other|8
5398780|NCT02974153|18607543|P1|Overall Study|Other|14
5398781|NCT02974153|18607541|P3|Overall Study|Study Burden|3
5398782|NCT02974153|18607542|P2|Overall Study|Study Burden|7
5398783|NCT02974153|18607543|P1|Overall Study|Study Burden|8
5398784|NCT02974153|18607541|P3|Overall Study|Withdrawal by Subject|11
5398785|NCT02974153|18607542|P2|Overall Study|Withdrawal by Subject|16
5398786|NCT02974153|18607543|P1|Overall Study|Withdrawal by Subject|9
5398787|NCT02974153|18607541|P3|Overall Study|Physician Decision|1
5398788|NCT02974153|18607542|P2|Overall Study|Physician Decision|2
5398789|NCT02974153|18607543|P1|Overall Study|Physician Decision|0
5398790|NCT02974153|18607541|P3|Overall Study|Lost to Follow-up|17
5398791|NCT02974153|18607542|P2|Overall Study|Lost to Follow-up|10
5398792|NCT02974153|18607543|P1|Overall Study|Lost to Follow-up|9
5398793|NCT02974153|18607541|P3|Overall Study|Lack of Efficacy|10
5398794|NCT02974153|18607542|P2|Overall Study|Lack of Efficacy|5
5398795|NCT02974153|18607543|P1|Overall Study|Lack of Efficacy|6
5398796|NCT02974153|18607541|P3|Overall Study|Adverse Event|1
5398797|NCT02974153|18607542|P2|Overall Study|Adverse Event|0
5398798|NCT02974153|18607543|P1|Overall Study|Adverse Event|6
5398799|NCT02974140|18607629|P1|Overall Study|Study Terminated by Sponsor|36
5398800|NCT02974140|18607629|P1|Overall Study|Lost to Follow-up|1
5398801|NCT02974140|18607629|P1|Overall Study|Adverse Event|2
5398802|NCT02974114|18607645|P3|Overall Study|Other (Not specified)|2
5398803|NCT02974114|18607646|P2|Overall Study|Other (Not specified)|1
5398804|NCT02974114|18607647|P1|Overall Study|Other (Not specified)|0
5398805|NCT02974088|18607690|P2|Overall Study|Adverse Event|1
5398806|NCT02974088|18607691|P1|Overall Study|Adverse Event|0
5398807|NCT02974088|18607690|P2|Overall Study|Lost to Follow-up|2
5398808|NCT02974088|18607691|P1|Overall Study|Lost to Follow-up|0
5398809|NCT02973802|18607697|P1|Overall Study|Withdrawal by Subject|1
5398810|NCT02973802|18607697|P1|Overall Study|Lost to Follow-up|1
5398811|NCT02973477|18607724|P2|Second Intervention|Lost to Follow-up|0
5398812|NCT02973477|18607725|P1|Second Intervention|Lost to Follow-up|1
5398813|NCT02973477|18607724|P2|Washout|Withdrawal by Subject|0
5398814|NCT02973477|18607725|P1|Washout|Withdrawal by Subject|1
5398815|NCT02973477|18607724|P2|First Intervention|Lost to Follow-up|2
5398816|NCT02973477|18607725|P1|First Intervention|Lost to Follow-up|0
5398817|NCT02973100|18607763|P4|Overall Study|Failed to attend Safety followup period|0
5398818|NCT02973100|18607764|P3|Overall Study|Failed to attend Safety followup period|1
5398819|NCT02973100|18607765|P2|Overall Study|Failed to attend Safety followup period|0
5398820|NCT02973100|18607766|P1|Overall Study|Failed to attend Safety followup period|0
5398821|NCT02973100|18607763|P4|Overall Study|Notification of change in address|1
5398822|NCT02973100|18607764|P3|Overall Study|Notification of change in address|0
5398823|NCT02973100|18607765|P2|Overall Study|Notification of change in address|0
5398824|NCT02973100|18607766|P1|Overall Study|Notification of change in address|0
5398825|NCT02973100|18607763|P4|Overall Study|Withdrawal by Subject|4
5398826|NCT02973100|18607764|P3|Overall Study|Withdrawal by Subject|1
5398827|NCT02973100|18607765|P2|Overall Study|Withdrawal by Subject|5
5398828|NCT02973100|18607766|P1|Overall Study|Withdrawal by Subject|3
5398829|NCT02973100|18607763|P4|Overall Study|Lost to Follow-up|0
5398830|NCT02973100|18607764|P3|Overall Study|Lost to Follow-up|1
5398831|NCT02973100|18607765|P2|Overall Study|Lost to Follow-up|1
5398832|NCT02973100|18607766|P1|Overall Study|Lost to Follow-up|3
5398833|NCT02973100|18607763|P4|Overall Study|Adverse Event|2
5398834|NCT02973100|18607764|P3|Overall Study|Adverse Event|1
5398835|NCT02973100|18607765|P2|Overall Study|Adverse Event|2
5398836|NCT02973100|18607766|P1|Overall Study|Adverse Event|1
5398837|NCT02973048|18607804|P2|Overall Study|Withdrawal by Subject|3
5398838|NCT02973048|18607805|P1|Overall Study|Withdrawal by Subject|0
5398839|NCT02973048|18607804|P2|Overall Study|Epidural catheter insertion failure|0
5398840|NCT02973048|18607805|P1|Overall Study|Epidural catheter insertion failure|1
5398841|NCT02972658|18607857|P4|Overall Study|Sponsor Decision|119
5398842|NCT02972658|18607858|P3|Overall Study|Sponsor Decision|72
5398843|NCT02972658|18607859|P2|Overall Study|Sponsor Decision|127
5398844|NCT02972658|18607860|P1|Overall Study|Sponsor Decision|70
5398845|NCT02972658|18607857|P4|Overall Study|Withdrawal due to Caregiver Circumstance|0
5398846|NCT02972658|18607858|P3|Overall Study|Withdrawal due to Caregiver Circumstance|1
5398847|NCT02972658|18607859|P2|Overall Study|Withdrawal due to Caregiver Circumstance|1
5398848|NCT02972658|18607860|P1|Overall Study|Withdrawal due to Caregiver Circumstance|1
5398849|NCT02972658|18607857|P4|Overall Study|Withdrawal by Subject|6
5398850|NCT02972658|18607858|P3|Overall Study|Withdrawal by Subject|1
5398851|NCT02972658|18607859|P2|Overall Study|Withdrawal by Subject|4
5398852|NCT02972658|18607860|P1|Overall Study|Withdrawal by Subject|4
5398853|NCT02972658|18607857|P4|Overall Study|Progressive Disease|1
5398854|NCT02972658|18607858|P3|Overall Study|Progressive Disease|0
5398855|NCT02972658|18607859|P2|Overall Study|Progressive Disease|1
5398856|NCT02972658|18607860|P1|Overall Study|Progressive Disease|0
5398857|NCT02972658|18607857|P4|Overall Study|Lost to Follow-up|2
5398858|NCT02972658|18607858|P3|Overall Study|Lost to Follow-up|1
5398859|NCT02972658|18607859|P2|Overall Study|Lost to Follow-up|1
5398860|NCT02972658|18607860|P1|Overall Study|Lost to Follow-up|0
5398861|NCT02972658|18607857|P4|Overall Study|Death|1
5398862|NCT02972658|18607858|P3|Overall Study|Death|0
5398863|NCT02972658|18607859|P2|Overall Study|Death|0
5398864|NCT02972658|18607860|P1|Overall Study|Death|0
5398865|NCT02972658|18607857|P4|Overall Study|Other-determined by Investigator|0
5398866|NCT02972658|18607858|P3|Overall Study|Other-determined by Investigator|0
5398867|NCT02972658|18607859|P2|Overall Study|Other-determined by Investigator|1
5398868|NCT02972658|18607860|P1|Overall Study|Other-determined by Investigator|1
5398869|NCT02972658|18607857|P4|Overall Study|Adverse Event|2
5398870|NCT02972658|18607858|P3|Overall Study|Adverse Event|0
5398871|NCT02972658|18607859|P2|Overall Study|Adverse Event|3
5398872|NCT02972658|18607860|P1|Overall Study|Adverse Event|0
5398873|NCT02972632|18607890|P1|Overall Study|Voluntary Withdrawal|10
5398874|NCT02972632|18607890|P1|Overall Study|Lost to Follow-up|4
5398875|NCT02972632|18607890|P1|Overall Study|Pretreatment Event/Adverse Event|3
5398876|NCT02972515|18607920|P1|Overall Study|Lost to Follow-up|78
5398877|NCT02972502|18607929|P2|Overall Study|Withdrawal by Subject|1
5398878|NCT02972502|18607930|P1|Overall Study|Withdrawal by Subject|1
5398879|NCT02972502|18607929|P2|Overall Study|Lost to Follow-up|1
5398880|NCT02972502|18607930|P1|Overall Study|Lost to Follow-up|3
5398881|NCT02972359|18607940|P1|Overall Study|Missing|1
5398882|NCT02972359|18607940|P1|Overall Study|Other reasons|5
5398883|NCT02972359|18607940|P1|Overall Study|Lost to Follow-up|26
5398884|NCT02972359|18607940|P1|Overall Study|Protocol Violation|1
5398885|NCT02972359|18607940|P1|Overall Study|Withdrawal by Subject|30
5398886|NCT02972359|18607940|P1|Overall Study|Death|1
5398887|NCT02972359|18607940|P1|Overall Study|Adverse Event|4
5398888|NCT02972359|18607940|P1|Overall Study|Lack of Efficacy|1
5398889|NCT02972359|18607940|P1|Overall Study|Incl. criteria not met/Exclusion met|2
5398890|NCT02972242|18607953|P2|Overall Study|Withdrawal by Subject|0
5398891|NCT02972242|18607954|P1|Overall Study|Withdrawal by Subject|1
5398892|NCT02971670|18608011|P4|Overall Study|Withdrawal by Subject|2
5398893|NCT02971670|18608012|P3|Overall Study|Withdrawal by Subject|1
5398894|NCT02971670|18608013|P2|Overall Study|Withdrawal by Subject|1
5398895|NCT02971670|18608014|P1|Overall Study|Withdrawal by Subject|4
5398896|NCT02971605|18608053|P1|Overall Study|Withdrawal by Subject|1
5398897|NCT02971202|18608167|P3|Overall Study|screen fail after consent|1
5398898|NCT02971202|18608168|P2|Overall Study|screen fail after consent|0
5398899|NCT02971202|18608169|P1|Overall Study|screen fail after consent|1
5398900|NCT02971202|18608167|P3|Overall Study|Pregnancy|0
5398901|NCT02971202|18608168|P2|Overall Study|Pregnancy|0
5398902|NCT02971202|18608169|P1|Overall Study|Pregnancy|1
5398903|NCT02971163|18608185|P2|Overall Study|Lost to Follow-up|2
5398904|NCT02971163|18608186|P1|Overall Study|Lost to Follow-up|4
5398905|NCT02971007|18608209|P3|Overall Study|Patient discontinued study drug|0
5398906|NCT02971007|18608210|P2|Overall Study|Patient discontinued study drug|1
5398907|NCT02971007|18608211|P1|Overall Study|Patient discontinued study drug|0
5398908|NCT02971007|18608209|P3|Overall Study|Patient had yeast at Day 5 visit|0
5398909|NCT02971007|18608210|P2|Overall Study|Patient had yeast at Day 5 visit|0
5398910|NCT02971007|18608211|P1|Overall Study|Patient had yeast at Day 5 visit|1
5398911|NCT02971007|18608209|P3|Overall Study|Withdrawal by Subject|0
5398912|NCT02971007|18608210|P2|Overall Study|Withdrawal by Subject|1
5398913|NCT02971007|18608211|P1|Overall Study|Withdrawal by Subject|0
5398914|NCT02971007|18608209|P3|Overall Study|Lost to Follow-up|1
5398915|NCT02971007|18608210|P2|Overall Study|Lost to Follow-up|1
5398916|NCT02971007|18608211|P1|Overall Study|Lost to Follow-up|0
5398917|NCT02971007|18608209|P3|Overall Study|Adverse Event|0
5398918|NCT02971007|18608210|P2|Overall Study|Adverse Event|0
5398919|NCT02971007|18608211|P1|Overall Study|Adverse Event|1
5398920|NCT02970669|18608243|P2|Open-label Period|Physician Decision|0
5398921|NCT02970669|18608244|P1|Open-label Period|Physician Decision|1
5398922|NCT02970669|18608243|P2|Open-label Period|Adverse Event|0
5398923|NCT02970669|18608244|P1|Open-label Period|Adverse Event|1
5398924|NCT02970669|18608243|P2|Open-label Period|Withdrawal by Subject|2
5398925|NCT02970669|18608244|P1|Open-label Period|Withdrawal by Subject|2
5398926|NCT02970669|18608243|P2|Double-blind Period|Withdrawal by Subject|2
5398927|NCT02970669|18608244|P1|Double-blind Period|Withdrawal by Subject|2
5398928|NCT02970669|18608243|P2|Double-blind Period|Physician Decision|2
5398929|NCT02970669|18608244|P1|Double-blind Period|Physician Decision|0
5398930|NCT02970669|18608243|P2|Double-blind Period|Study terminated by sponsor|2
5398931|NCT02970669|18608244|P1|Double-blind Period|Study terminated by sponsor|1
5398932|NCT02970669|18608243|P2|Double-blind Period|Death|0
5398933|NCT02970669|18608244|P1|Double-blind Period|Death|1
5398934|NCT02970669|18608243|P2|Double-blind Period|Adverse Event|0
5398935|NCT02970669|18608244|P1|Double-blind Period|Adverse Event|4
5398936|NCT02970305|18608398|P2|Overall Study|Lost to Follow-up|2
5398937|NCT02970305|18608399|P1|Overall Study|Lost to Follow-up|1
5398938|NCT02970305|18608398|P2|Overall Study|Not further specified|2
5398939|NCT02970305|18608399|P1|Overall Study|Not further specified|1
5398940|NCT02970305|18608398|P2|Overall Study|Withdrawal by Subject|11
5398941|NCT02970305|18608399|P1|Overall Study|Withdrawal by Subject|12
5398942|NCT02970305|18608398|P2|Overall Study|Protocol Violation|2
5398943|NCT02970305|18608399|P1|Overall Study|Protocol Violation|2
5398944|NCT02970305|18608398|P2|Overall Study|Noncompliance with study drug|4
5398945|NCT02970305|18608399|P1|Overall Study|Noncompliance with study drug|2
5398946|NCT02970305|18608398|P2|Overall Study|Lack of Efficacy|1
5398947|NCT02970305|18608399|P1|Overall Study|Lack of Efficacy|1
5398948|NCT02970305|18608398|P2|Overall Study|Adverse Event|6
5398949|NCT02970305|18608399|P1|Overall Study|Adverse Event|10
5398950|NCT02970292|18608431|P2|Overall Study|Other|0
5398951|NCT02970292|18608432|P1|Overall Study|Other|1
5398952|NCT02970292|18608431|P2|Overall Study|Protocol Violation|0
5398953|NCT02970292|18608432|P1|Overall Study|Protocol Violation|2
5398954|NCT02970292|18608431|P2|Overall Study|Lost to Follow-up|0
5398955|NCT02970292|18608432|P1|Overall Study|Lost to Follow-up|1
5398956|NCT02970292|18608431|P2|Overall Study|Lack of Efficacy|0
5398957|NCT02970292|18608432|P1|Overall Study|Lack of Efficacy|1
5398958|NCT02970292|18608431|P2|Overall Study|Adverse Event|0
5398959|NCT02970292|18608432|P1|Overall Study|Adverse Event|5
5398960|NCT02970292|18608431|P2|Overall Study|Noncompliance with study drug|2
5398961|NCT02970292|18608432|P1|Overall Study|Noncompliance with study drug|2
5398962|NCT02970292|18608431|P2|Overall Study|Withdrawal by Subject|5
5398963|NCT02970292|18608432|P1|Overall Study|Withdrawal by Subject|11
5398964|NCT02970292|18608431|P2|Overall Study|Physician Decision|1
5398965|NCT02970292|18608432|P1|Overall Study|Physician Decision|1
5398966|NCT02969863|18608498|P6|Overall Study|Physician Decision|0
5398967|NCT02969863|18608499|P5|Overall Study|Physician Decision|0
5398968|NCT02969863|18608500|P4|Overall Study|Physician Decision|0
5398969|NCT02969863|18608501|P3|Overall Study|Physician Decision|0
5398970|NCT02969863|18608502|P2|Overall Study|Physician Decision|0
5398971|NCT02969863|18608503|P1|Overall Study|Physician Decision|1
5398972|NCT02969655|18608519|P2|Overall Study|Adverse Event|8
5398973|NCT02969655|18608520|P1|Overall Study|Adverse Event|10
5398974|NCT02969655|18608519|P2|Overall Study|Protocol-specified withdrawal criteria|2
5398975|NCT02969655|18608520|P1|Overall Study|Protocol-specified withdrawal criteria|4
5398976|NCT02969655|18608519|P2|Overall Study|Physician Decision|3
5398977|NCT02969655|18608520|P1|Overall Study|Physician Decision|4
5398978|NCT02969655|18608519|P2|Overall Study|Withdrawal by Subject|2
5398979|NCT02969655|18608520|P1|Overall Study|Withdrawal by Subject|3
5398980|NCT02969590|18608555|P3|Screening Period|Hormones not suppressed post Lupron|0
5398981|NCT02969590|18608556|P2|Screening Period|Hormones not suppressed post Lupron|0
5398982|NCT02969590|18608557|P1|Screening Period|Hormones not suppressed post Lupron|1
5398983|NCT02969525|18608580|P12|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398984|NCT02969525|18608581|P11|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
5398985|NCT02969525|18608582|P10|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398986|NCT02969525|18608583|P9|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398987|NCT02969525|18608584|P8|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398988|NCT02969525|18608585|P7|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398989|NCT02969525|18608586|P6|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398990|NCT02969525|18608587|P5|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398991|NCT02969525|18608588|P4|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398992|NCT02969525|18608589|P3|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398993|NCT02969525|18608590|P2|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398994|NCT02969525|18608591|P1|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
5398995|NCT02969525|18608580|P12|Dose-Blind Period|Non-cooperating patient|1
5398996|NCT02969525|18608581|P11|Dose-Blind Period|Non-cooperating patient|0
5398997|NCT02969525|18608582|P10|Dose-Blind Period|Non-cooperating patient|0
5398998|NCT02969525|18608583|P9|Dose-Blind Period|Non-cooperating patient|0
5398999|NCT02969525|18608584|P8|Dose-Blind Period|Non-cooperating patient|0
5399000|NCT02969525|18608585|P7|Dose-Blind Period|Non-cooperating patient|0
5399001|NCT02969525|18608586|P6|Dose-Blind Period|Non-cooperating patient|0
5399002|NCT02969525|18608587|P5|Dose-Blind Period|Non-cooperating patient|0
5399003|NCT02969525|18608588|P4|Dose-Blind Period|Non-cooperating patient|0
5399004|NCT02969525|18608589|P3|Dose-Blind Period|Non-cooperating patient|0
5399005|NCT02969525|18608590|P2|Dose-Blind Period|Non-cooperating patient|0
5399006|NCT02969525|18608591|P1|Dose-Blind Period|Non-cooperating patient|0
5399007|NCT02969525|18608580|P12|Dose-Blind Period|Withdrawal by Subject|0
5399008|NCT02969525|18608581|P11|Dose-Blind Period|Withdrawal by Subject|0
5399009|NCT02969525|18608582|P10|Dose-Blind Period|Withdrawal by Subject|2
5399010|NCT02969525|18608583|P9|Dose-Blind Period|Withdrawal by Subject|1
5399011|NCT02969525|18608584|P8|Dose-Blind Period|Withdrawal by Subject|0
5399012|NCT02969525|18608585|P7|Dose-Blind Period|Withdrawal by Subject|2
5399013|NCT02969525|18608586|P6|Dose-Blind Period|Withdrawal by Subject|0
5399014|NCT02969525|18608587|P5|Dose-Blind Period|Withdrawal by Subject|0
5399015|NCT02969525|18608588|P4|Dose-Blind Period|Withdrawal by Subject|0
5399016|NCT02969525|18608589|P3|Dose-Blind Period|Withdrawal by Subject|0
5399017|NCT02969525|18608590|P2|Dose-Blind Period|Withdrawal by Subject|0
5399018|NCT02969525|18608591|P1|Dose-Blind Period|Withdrawal by Subject|0
5399019|NCT02969525|18608580|P12|Dose-Blind Period|Adverse Event|1
5399020|NCT02969525|18608581|P11|Dose-Blind Period|Adverse Event|1
5399021|NCT02969525|18608582|P10|Dose-Blind Period|Adverse Event|1
5399022|NCT02969525|18608583|P9|Dose-Blind Period|Adverse Event|0
5399023|NCT02969525|18608584|P8|Dose-Blind Period|Adverse Event|0
5399024|NCT02969525|18608585|P7|Dose-Blind Period|Adverse Event|0
5399025|NCT02969525|18608586|P6|Dose-Blind Period|Adverse Event|0
5399026|NCT02969525|18608587|P5|Dose-Blind Period|Adverse Event|0
5399027|NCT02969525|18608588|P4|Dose-Blind Period|Adverse Event|0
5399028|NCT02969525|18608589|P3|Dose-Blind Period|Adverse Event|0
5399029|NCT02969525|18608590|P2|Dose-Blind Period|Adverse Event|0
5399030|NCT02969525|18608591|P1|Dose-Blind Period|Adverse Event|0
5399031|NCT02969525|18608580|P12|Double-Blind Period|Study medication discontinued prior Wk12|0
5399032|NCT02969525|18608581|P11|Double-Blind Period|Study medication discontinued prior Wk12|0
5399033|NCT02969525|18608582|P10|Double-Blind Period|Study medication discontinued prior Wk12|0
5399034|NCT02969525|18608583|P9|Double-Blind Period|Study medication discontinued prior Wk12|0
5399035|NCT02969525|18608584|P8|Double-Blind Period|Study medication discontinued prior Wk12|0
5399036|NCT02969525|18608585|P7|Double-Blind Period|Study medication discontinued prior Wk12|0
5399037|NCT02969525|18608586|P6|Double-Blind Period|Study medication discontinued prior Wk12|0
5399038|NCT02969525|18608587|P5|Double-Blind Period|Study medication discontinued prior Wk12|0
5399039|NCT02969525|18608588|P4|Double-Blind Period|Study medication discontinued prior Wk12|2
5399040|NCT02969525|18608589|P3|Double-Blind Period|Study medication discontinued prior Wk12|0
5399041|NCT02969525|18608590|P2|Double-Blind Period|Study medication discontinued prior Wk12|0
5399042|NCT02969525|18608591|P1|Double-Blind Period|Study medication discontinued prior Wk12|2
5399043|NCT02969525|18608580|P12|Double-Blind Period|LOW EGFR|0
5399044|NCT02969525|18608581|P11|Double-Blind Period|LOW EGFR|0
5399045|NCT02969525|18608582|P10|Double-Blind Period|LOW EGFR|0
5399046|NCT02969525|18608583|P9|Double-Blind Period|LOW EGFR|0
5399047|NCT02969525|18608584|P8|Double-Blind Period|LOW EGFR|0
5399048|NCT02969525|18608585|P7|Double-Blind Period|LOW EGFR|0
5399049|NCT02969525|18608586|P6|Double-Blind Period|LOW EGFR|0
5399050|NCT02969525|18608587|P5|Double-Blind Period|LOW EGFR|0
5399051|NCT02969525|18608588|P4|Double-Blind Period|LOW EGFR|1
5399052|NCT02969525|18608589|P3|Double-Blind Period|LOW EGFR|0
5399053|NCT02969525|18608590|P2|Double-Blind Period|LOW EGFR|0
5399054|NCT02969525|18608591|P1|Double-Blind Period|LOW EGFR|0
5399055|NCT02969525|18608580|P12|Double-Blind Period|Adverse Event|0
5399056|NCT02969525|18608581|P11|Double-Blind Period|Adverse Event|0
5399057|NCT02969525|18608582|P10|Double-Blind Period|Adverse Event|0
5399058|NCT02969525|18608583|P9|Double-Blind Period|Adverse Event|0
5399059|NCT02969525|18608584|P8|Double-Blind Period|Adverse Event|0
5399060|NCT02969525|18608585|P7|Double-Blind Period|Adverse Event|0
5399061|NCT02969525|18608586|P6|Double-Blind Period|Adverse Event|0
5399062|NCT02969525|18608587|P5|Double-Blind Period|Adverse Event|0
5399063|NCT02969525|18608588|P4|Double-Blind Period|Adverse Event|1
5399064|NCT02969525|18608589|P3|Double-Blind Period|Adverse Event|1
5399065|NCT02969525|18608590|P2|Double-Blind Period|Adverse Event|0
5399066|NCT02969525|18608591|P1|Double-Blind Period|Adverse Event|0
5399067|NCT02969408|18608742|P1|Overall Study|Other than specified|1
5399068|NCT02969408|18608742|P1|Overall Study|Protocol Violation|1
5399069|NCT02969408|18608742|P1|Overall Study|Lost to Follow-up|4
5399070|NCT02969408|18608742|P1|Overall Study|Withdrawal by Subject|8
5399071|NCT02969408|18608742|P1|Overall Study|Adverse Event|2
5399072|NCT02969356|18608750|P1|Overall Study|Personal reasons|5
5399073|NCT02969356|18608750|P1|Overall Study|Did not need to be reinjected|6
5399074|NCT02969356|18608750|P1|Overall Study|Lost to Follow-up|3
5399075|NCT02969356|18608750|P1|Overall Study|Consent withdrawn|2
5399076|NCT02969356|18608750|P1|Overall Study|Adverse Event|7
5399077|NCT02969187|18608793|P2|Overall Study|Physician Decision|13
5399078|NCT02969187|18608794|P1|Overall Study|Physician Decision|12
5399079|NCT02969044|18608806|P2|Overall Study|Adverse Event|0
5399080|NCT02969044|18608807|P1|Overall Study|Adverse Event|3
5399081|NCT02969044|18608806|P2|Overall Study|Withdrawal by Subject|6
5399082|NCT02969044|18608807|P1|Overall Study|Withdrawal by Subject|2
5399083|NCT02969018|18608866|P8|Overall Study|Withdrawal by Subject|3
5399084|NCT02969018|18608867|P7|Overall Study|Withdrawal by Subject|4
5399085|NCT02969018|18608868|P6|Overall Study|Withdrawal by Subject|4
5399086|NCT02969018|18608869|P5|Overall Study|Withdrawal by Subject|0
5399087|NCT02969018|18608870|P4|Overall Study|Withdrawal by Subject|1
5399088|NCT02969018|18608871|P3|Overall Study|Withdrawal by Subject|2
5399089|NCT02969018|18608872|P2|Overall Study|Withdrawal by Subject|1
5399090|NCT02969018|18608873|P1|Overall Study|Withdrawal by Subject|0
5399091|NCT02969018|18608866|P8|Overall Study|Protocol Violation|0
5399092|NCT02969018|18608867|P7|Overall Study|Protocol Violation|0
5399093|NCT02969018|18608868|P6|Overall Study|Protocol Violation|0
5399094|NCT02969018|18608869|P5|Overall Study|Protocol Violation|0
5399095|NCT02969018|18608870|P4|Overall Study|Protocol Violation|1
5399096|NCT02969018|18608871|P3|Overall Study|Protocol Violation|1
5399097|NCT02969018|18608872|P2|Overall Study|Protocol Violation|0
5399098|NCT02969018|18608873|P1|Overall Study|Protocol Violation|0
5399099|NCT02969018|18608866|P8|Overall Study|Pregnancy|0
5399100|NCT02969018|18608867|P7|Overall Study|Pregnancy|0
5399101|NCT02969018|18608868|P6|Overall Study|Pregnancy|1
5399102|NCT02969018|18608869|P5|Overall Study|Pregnancy|0
5399103|NCT02969018|18608870|P4|Overall Study|Pregnancy|0
5399104|NCT02969018|18608871|P3|Overall Study|Pregnancy|0
5399105|NCT02969018|18608872|P2|Overall Study|Pregnancy|0
5399106|NCT02969018|18608873|P1|Overall Study|Pregnancy|0
5399107|NCT02969018|18608866|P8|Overall Study|Other|2
5399108|NCT02969018|18608867|P7|Overall Study|Other|0
5399109|NCT02969018|18608868|P6|Overall Study|Other|0
5399110|NCT02969018|18608869|P5|Overall Study|Other|0
5399111|NCT02969018|18608870|P4|Overall Study|Other|1
5399112|NCT02969018|18608871|P3|Overall Study|Other|0
5399113|NCT02969018|18608872|P2|Overall Study|Other|0
5399114|NCT02969018|18608873|P1|Overall Study|Other|0
5399115|NCT02969018|18608866|P8|Overall Study|Non-Compliance With Study Drug|0
5399116|NCT02969018|18608867|P7|Overall Study|Non-Compliance With Study Drug|0
5399117|NCT02969018|18608868|P6|Overall Study|Non-Compliance With Study Drug|0
5399118|NCT02969018|18608869|P5|Overall Study|Non-Compliance With Study Drug|0
5399119|NCT02969018|18608870|P4|Overall Study|Non-Compliance With Study Drug|0
5399120|NCT02969018|18608871|P3|Overall Study|Non-Compliance With Study Drug|0
5399121|NCT02969018|18608872|P2|Overall Study|Non-Compliance With Study Drug|0
5399122|NCT02969018|18608873|P1|Overall Study|Non-Compliance With Study Drug|1
5399123|NCT02969018|18608866|P8|Overall Study|No Longer Meets Eligibility Criteria|0
5399124|NCT02969018|18608867|P7|Overall Study|No Longer Meets Eligibility Criteria|1
5399125|NCT02969018|18608868|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5399126|NCT02969018|18608869|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5399127|NCT02969018|18608870|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5399128|NCT02969018|18608871|P3|Overall Study|No Longer Meets Eligibility Criteria|0
5399129|NCT02969018|18608872|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5399130|NCT02969018|18608873|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5399131|NCT02969018|18608866|P8|Overall Study|Lost to Follow-up|1
5399132|NCT02969018|18608867|P7|Overall Study|Lost to Follow-up|0
5399133|NCT02969018|18608868|P6|Overall Study|Lost to Follow-up|1
5399134|NCT02969018|18608869|P5|Overall Study|Lost to Follow-up|1
5399135|NCT02969018|18608870|P4|Overall Study|Lost to Follow-up|0
5399136|NCT02969018|18608871|P3|Overall Study|Lost to Follow-up|2
5399137|NCT02969018|18608872|P2|Overall Study|Lost to Follow-up|2
5399138|NCT02969018|18608873|P1|Overall Study|Lost to Follow-up|1
5399139|NCT02969018|18608866|P8|Overall Study|Lack of Efficacy|1
5399140|NCT02969018|18608867|P7|Overall Study|Lack of Efficacy|1
5399141|NCT02969018|18608868|P6|Overall Study|Lack of Efficacy|1
5399142|NCT02969018|18608869|P5|Overall Study|Lack of Efficacy|1
5399143|NCT02969018|18608870|P4|Overall Study|Lack of Efficacy|0
5399144|NCT02969018|18608871|P3|Overall Study|Lack of Efficacy|0
5399145|NCT02969018|18608872|P2|Overall Study|Lack of Efficacy|1
5399146|NCT02969018|18608873|P1|Overall Study|Lack of Efficacy|0
5399147|NCT02969018|18608866|P8|Overall Study|Adverse Event|0
5399148|NCT02969018|18608867|P7|Overall Study|Adverse Event|2
5399149|NCT02969018|18608868|P6|Overall Study|Adverse Event|1
5399150|NCT02969018|18608869|P5|Overall Study|Adverse Event|0
5399151|NCT02969018|18608870|P4|Overall Study|Adverse Event|2
5399152|NCT02969018|18608871|P3|Overall Study|Adverse Event|1
5399153|NCT02969018|18608872|P2|Overall Study|Adverse Event|4
5399154|NCT02969018|18608873|P1|Overall Study|Adverse Event|2
5399155|NCT02968979|18609013|P1|Overall Study|Withdrawal by Subject|1
5399156|NCT02968979|18609013|P1|Overall Study|Protocol Violation|7
5399157|NCT02968576|18609138|P2|Overall Study|Pregnancy|1
5399158|NCT02968576|18609139|P1|Overall Study|Pregnancy|0
5399159|NCT02968563|18609146|P2|Overall Study|Still on Study|17
5399160|NCT02968563|18609147|P1|Overall Study|Still on Study|0
5399161|NCT02968563|18609146|P2|Overall Study|Death|1
5399162|NCT02968563|18609147|P1|Overall Study|Death|1
5399163|NCT02968563|18609146|P2|Overall Study|Adverse Event|5
5399164|NCT02968563|18609147|P1|Overall Study|Adverse Event|0
5399165|NCT02968433|18609161|P1|Overall Study|Withdrawal by Subject|1
5399166|NCT02968173|18609238|P1|Overall Study|Withdrawal by Subject|1
5399167|NCT02967679|18609275|P1|Overall Study|Adverse Event|1
5399168|NCT02967562|18609296|P2|Overall Study|High leak precluding analysis|1
5399169|NCT02967562|18609297|P1|Overall Study|High leak precluding analysis|1
5399170|NCT02967562|18609296|P2|Overall Study|Consent not obtained|0
5399171|NCT02967562|18609297|P1|Overall Study|Consent not obtained|1
5399172|NCT02967055|18609523|P1|Overall Study|Stopped due to drug cost|1
5399173|NCT02967055|18609523|P1|Overall Study|Stopped due to side effects|3
5399174|NCT02967055|18609523|P1|Overall Study|Lost to Follow-up|2
5399175|NCT02967055|18609523|P1|Overall Study|Screen fail|3
5399176|NCT02967055|18609523|P1|Overall Study|Excluded|40
5399177|NCT02966795|18609544|P2|Overall Study|Patient Left the Country|1
5399178|NCT02966795|18609545|P1|Overall Study|Patient Left the Country|0
5399179|NCT02966509|18609556|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
5399180|NCT02966509|18609557|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
5399181|NCT02966509|18609556|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
5399182|NCT02966509|18609557|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
5399183|NCT02966509|18609556|P2|6 Month Satisfaction Survey|Refused to Answer|11
5399184|NCT02966509|18609557|P1|6 Month Satisfaction Survey|Refused to Answer|8
5399185|NCT02966509|18609556|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
5399186|NCT02966509|18609557|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
5399187|NCT02966509|18609556|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
5399188|NCT02966509|18609557|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
5399189|NCT02966509|18609556|P2|6 Month Satisfaction Survey|Death|33
5399190|NCT02966509|18609557|P1|6 Month Satisfaction Survey|Death|36
5399191|NCT02966509|18609556|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
5399192|NCT02966509|18609557|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
5399193|NCT02966509|18609556|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
5399194|NCT02966509|18609557|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
5399195|NCT02966509|18609556|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
5399196|NCT02966509|18609557|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
5399197|NCT02966509|18609556|P2|6 Month Satisfaction Decision Survey|Death|25
5399198|NCT02966509|18609557|P1|6 Month Satisfaction Decision Survey|Death|22
5399199|NCT02966509|18609556|P2|Baseline Satisfaction Survey|Refused to Answer|2
5399200|NCT02966509|18609557|P1|Baseline Satisfaction Survey|Refused to Answer|1
5399201|NCT02966509|18609556|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
5399202|NCT02966509|18609557|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
5399203|NCT02966509|18609556|P2|Baseline Satisfaction Survey|Death|1
5399204|NCT02966509|18609557|P1|Baseline Satisfaction Survey|Death|0
5399205|NCT02966509|18609556|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
5399206|NCT02966509|18609557|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
5399207|NCT02966353|18609581|P1|Overall Study|Protocol deviation|2
5399208|NCT02966353|18609581|P1|Overall Study|Progressive disease|2
5399209|NCT02966353|18609581|P1|Overall Study|Physician Decision|3
5399210|NCT02966353|18609581|P1|Overall Study|Death|4
5399211|NCT02966353|18609581|P1|Overall Study|Adverse Event|4
5399212|NCT02966353|18609581|P1|Overall Study|Withdrawal by Subject|7
5399213|NCT02966340|18609590|P2|Overall Study|startle non-responder|1
5399214|NCT02966340|18609591|P1|Overall Study|startle non-responder|1
5399215|NCT02966340|18609590|P2|Overall Study|data acquisition error|0
5399216|NCT02966340|18609591|P1|Overall Study|data acquisition error|1
5399217|NCT02966340|18609590|P2|Overall Study|Withdrawal by Subject|0
5399218|NCT02966340|18609591|P1|Overall Study|Withdrawal by Subject|1
5399219|NCT02966340|18609590|P2|Overall Study|Lost to Follow-up|1
5399220|NCT02966340|18609591|P1|Overall Study|Lost to Follow-up|0
5399221|NCT02966340|18609590|P2|Overall Study|Adverse Event|1
5399222|NCT02966340|18609591|P1|Overall Study|Adverse Event|0
5399223|NCT02966223|18609634|P1|Overall Study|Lost to Follow-up|1
5399224|NCT02966223|18609634|P1|Overall Study|Withdrawal by Subject|11
5399225|NCT02966223|18609634|P1|Overall Study|Physician Decision|3
5399226|NCT02966015|18609642|P2|Inclusion Visit|did not answer questionnaire|3
5399227|NCT02966015|18609643|P1|Inclusion Visit|did not answer questionnaire|8
5399228|NCT02966002|18609649|P1|Overall Study|Lost to Follow-up|1
5399229|NCT02966002|18609649|P1|Overall Study|Adverse Event|1
5399230|NCT02966002|18609649|P1|Overall Study|Withdrawal by Subject|2
5399231|NCT02965846|18609664|P3|Overall Study|Participants not randomized|33
5399232|NCT02965846|18609665|P2|Overall Study|Participants not randomized|0
5399233|NCT02965846|18609666|P1|Overall Study|Participants not randomized|0
5399234|NCT02965846|18609664|P3|Overall Study|Study Terminated By Sponsor|0
5399235|NCT02965846|18609665|P2|Overall Study|Study Terminated By Sponsor|4
5399236|NCT02965846|18609666|P1|Overall Study|Study Terminated By Sponsor|4
5399237|NCT02965846|18609664|P3|Overall Study|Withdrawal by Subject|0
5399238|NCT02965846|18609665|P2|Overall Study|Withdrawal by Subject|1
5399239|NCT02965846|18609666|P1|Overall Study|Withdrawal by Subject|0
5399240|NCT02965846|18609664|P3|Overall Study|Lost to Follow-up|0
5399241|NCT02965846|18609665|P2|Overall Study|Lost to Follow-up|0
5399242|NCT02965846|18609666|P1|Overall Study|Lost to Follow-up|1
5399243|NCT02965833|18609674|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
5399244|NCT02965833|18609675|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
5399245|NCT02965833|18609674|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
5399246|NCT02965833|18609675|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
5399247|NCT02965833|18609674|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
5399248|NCT02965833|18609675|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
5399249|NCT02965833|18609674|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5399250|NCT02965833|18609675|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5399251|NCT02965833|18609674|P2|Period 1, First 30 Days of Wear|Adverse Event|1
5399252|NCT02965833|18609675|P1|Period 1, First 30 Days of Wear|Adverse Event|0
5399253|NCT02965820|18609681|P2|Period 2, Second 30 Days|Adverse Event|1
5399254|NCT02965820|18609682|P1|Period 2, Second 30 Days|Adverse Event|1
5399255|NCT02965599|18609721|P2|Overall Study|Protocol-defined stop criteria reached|0
5399256|NCT02965599|18609722|P1|Overall Study|Protocol-defined stop criteria reached|1
5399257|NCT02965456|18609801|P2|Overall Study|Participant ran out of study drug|1
5399258|NCT02965456|18609802|P1|Overall Study|Participant ran out of study drug|0
5399259|NCT02965456|18609801|P2|Overall Study|Protocol Violation|1
5399260|NCT02965456|18609802|P1|Overall Study|Protocol Violation|0
5399261|NCT02965456|18609801|P2|Overall Study|Pregnancy|0
5399262|NCT02965456|18609802|P1|Overall Study|Pregnancy|1
5399263|NCT02965456|18609801|P2|Overall Study|Physician Decision|1
5399264|NCT02965456|18609802|P1|Overall Study|Physician Decision|0
5399265|NCT02965456|18609801|P2|Overall Study|Lack of Efficacy|0
5399266|NCT02965456|18609802|P1|Overall Study|Lack of Efficacy|1
5399267|NCT02965456|18609801|P2|Overall Study|Worsening Condition|2
5399268|NCT02965456|18609802|P1|Overall Study|Worsening Condition|0
5399269|NCT02965456|18609801|P2|Overall Study|Noncompliance with Study Drug|1
5399270|NCT02965456|18609802|P1|Overall Study|Noncompliance with Study Drug|1
5399271|NCT02965456|18609801|P2|Overall Study|Adverse Event|0
5399272|NCT02965456|18609802|P1|Overall Study|Adverse Event|3
5399273|NCT02965456|18609801|P2|Overall Study|Withdrawal by Parent or Guardian|6
5399274|NCT02965456|18609802|P1|Overall Study|Withdrawal by Parent or Guardian|3
5399275|NCT02965456|18609801|P2|Overall Study|Subject Request|13
5399276|NCT02965456|18609802|P1|Overall Study|Subject Request|22
5399277|NCT02965456|18609801|P2|Overall Study|Lost to Follow-up|18
5399278|NCT02965456|18609802|P1|Overall Study|Lost to Follow-up|40
5399279|NCT02964338|18609893|P3|Overall Study|Did not meet criteria|0
5399280|NCT02964338|18609894|P2|Overall Study|Did not meet criteria|0
5399281|NCT02964338|18609895|P1|Overall Study|Did not meet criteria|1
5399282|NCT02964338|18609893|P3|Overall Study|Non-compliant with e-diary|0
5399283|NCT02964338|18609894|P2|Overall Study|Non-compliant with e-diary|1
5399284|NCT02964338|18609895|P1|Overall Study|Non-compliant with e-diary|0
5399285|NCT02964338|18609893|P3|Overall Study|Adverse Event|1
5399286|NCT02964338|18609894|P2|Overall Study|Adverse Event|1
5399287|NCT02964338|18609895|P1|Overall Study|Adverse Event|2
5399288|NCT02964338|18609893|P3|Overall Study|Withdrawal by Subject|1
5399289|NCT02964338|18609894|P2|Overall Study|Withdrawal by Subject|3
5399290|NCT02964338|18609895|P1|Overall Study|Withdrawal by Subject|1
5399291|NCT02964338|18609893|P3|Overall Study|Protocol Violation|0
5399292|NCT02964338|18609894|P2|Overall Study|Protocol Violation|1
5399293|NCT02964338|18609895|P1|Overall Study|Protocol Violation|0
5399294|NCT02964338|18609893|P3|Overall Study|Lost to Follow-up|3
5399295|NCT02964338|18609894|P2|Overall Study|Lost to Follow-up|0
5399296|NCT02964338|18609895|P1|Overall Study|Lost to Follow-up|1
5399297|NCT02964338|18609893|P3|Overall Study|Lack of Efficacy|0
5399298|NCT02964338|18609894|P2|Overall Study|Lack of Efficacy|3
5399299|NCT02964338|18609895|P1|Overall Study|Lack of Efficacy|0
5399300|NCT02964338|18609893|P3|Overall Study|Sponsor terminated study for futility|14
5399301|NCT02964338|18609894|P2|Overall Study|Sponsor terminated study for futility|15
5399302|NCT02964338|18609895|P1|Overall Study|Sponsor terminated study for futility|12
5399303|NCT02964312|18609939|P1|Overall Study|Death|1
5399304|NCT02964312|18609939|P1|Overall Study|Did not consent to long-term FU|14
5399305|NCT02964312|18609939|P1|Overall Study|Lack of Efficacy|10
5399306|NCT02964312|18609939|P1|Overall Study|Withdrawal by Subject|11
5399307|NCT02964312|18609939|P1|Overall Study|Lost to Follow-up|28
5399308|NCT02964247|18609950|P2|Overall Study|Withdrawal by Subject|2
5399309|NCT02964247|18609951|P1|Overall Study|Withdrawal by Subject|1
5399310|NCT02964247|18609950|P2|Overall Study|Lost to Follow-up|0
5399311|NCT02964247|18609951|P1|Overall Study|Lost to Follow-up|2
5399312|NCT02964234|18610009|P2|Overall Study|Lost to Follow-up|13
5399313|NCT02964234|18610010|P1|Overall Study|Lost to Follow-up|22
5399314|NCT02963935|18610039|P2|Overall Study|Unclassified|22
5399315|NCT02963935|18610040|P1|Overall Study|Unclassified|13
5399316|NCT02963935|18610039|P2|Overall Study|Lost to Follow-up|6
5399317|NCT02963935|18610040|P1|Overall Study|Lost to Follow-up|1
5399318|NCT02963935|18610039|P2|Overall Study|Lack of Efficacy|2
5399319|NCT02963935|18610040|P1|Overall Study|Lack of Efficacy|0
5399320|NCT02963935|18610039|P2|Overall Study|Protocol Violation|1
5399321|NCT02963935|18610040|P1|Overall Study|Protocol Violation|2
5399322|NCT02963935|18610039|P2|Overall Study|Adverse Event|6
5399323|NCT02963935|18610040|P1|Overall Study|Adverse Event|12
5399324|NCT02963922|18610148|P2|Overall Study|Other|14
5399325|NCT02963922|18610149|P1|Overall Study|Other|8
5399326|NCT02963922|18610148|P2|Overall Study|Lost to Follow-up|3
5399327|NCT02963922|18610149|P1|Overall Study|Lost to Follow-up|2
5399328|NCT02963922|18610148|P2|Overall Study|Lack of Efficacy|1
5399329|NCT02963922|18610149|P1|Overall Study|Lack of Efficacy|1
5399330|NCT02963922|18610148|P2|Overall Study|Protocol deviation|6
5399331|NCT02963922|18610149|P1|Overall Study|Protocol deviation|6
5399332|NCT02963922|18610148|P2|Overall Study|Adverse Event|6
5399333|NCT02963922|18610149|P1|Overall Study|Adverse Event|15
5399334|NCT02963701|18610247|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
5399335|NCT02963701|18610248|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
5399336|NCT02963506|18610308|P13|Dose-Blind Period|Meeting exclusion criteria 9|1
5399337|NCT02963506|18610309|P12|Dose-Blind Period|Meeting exclusion criteria 9|0
5399338|NCT02963506|18610310|P11|Dose-Blind Period|Meeting exclusion criteria 9|0
5399339|NCT02963506|18610311|P10|Dose-Blind Period|Meeting exclusion criteria 9|0
5399340|NCT02963506|18610312|P9|Dose-Blind Period|Meeting exclusion criteria 9|0
5399341|NCT02963506|18610313|P8|Dose-Blind Period|Meeting exclusion criteria 9|0
5399342|NCT02963506|18610314|P7|Dose-Blind Period|Meeting exclusion criteria 9|0
5399343|NCT02963506|18610315|P6|Dose-Blind Period|Meeting exclusion criteria 9|0
5399344|NCT02963506|18610316|P5|Dose-Blind Period|Meeting exclusion criteria 9|0
5399345|NCT02963506|18610317|P4|Dose-Blind Period|Meeting exclusion criteria 9|0
5399346|NCT02963506|18610318|P3|Dose-Blind Period|Meeting exclusion criteria 9|0
5399347|NCT02963506|18610319|P2|Dose-Blind Period|Meeting exclusion criteria 9|0
5399348|NCT02963506|18610320|P1|Dose-Blind Period|Meeting exclusion criteria 9|0
5399349|NCT02963506|18610308|P13|Dose-Blind Period|Sponsor decision|0
5399350|NCT02963506|18610309|P12|Dose-Blind Period|Sponsor decision|0
5399351|NCT02963506|18610310|P11|Dose-Blind Period|Sponsor decision|0
5399352|NCT02963506|18610311|P10|Dose-Blind Period|Sponsor decision|0
5399353|NCT02963506|18610312|P9|Dose-Blind Period|Sponsor decision|0
5399354|NCT02963506|18610313|P8|Dose-Blind Period|Sponsor decision|0
5399355|NCT02963506|18610314|P7|Dose-Blind Period|Sponsor decision|0
5399356|NCT02963506|18610315|P6|Dose-Blind Period|Sponsor decision|1
5399357|NCT02963506|18610316|P5|Dose-Blind Period|Sponsor decision|0
5399358|NCT02963506|18610317|P4|Dose-Blind Period|Sponsor decision|0
5399359|NCT02963506|18610318|P3|Dose-Blind Period|Sponsor decision|0
5399360|NCT02963506|18610319|P2|Dose-Blind Period|Sponsor decision|0
5399361|NCT02963506|18610320|P1|Dose-Blind Period|Sponsor decision|0
5399362|NCT02963506|18610308|P13|Dose-Blind Period|Withdrawal by Subject|0
5399363|NCT02963506|18610309|P12|Dose-Blind Period|Withdrawal by Subject|0
5399364|NCT02963506|18610310|P11|Dose-Blind Period|Withdrawal by Subject|0
5399365|NCT02963506|18610311|P10|Dose-Blind Period|Withdrawal by Subject|1
5399366|NCT02963506|18610312|P9|Dose-Blind Period|Withdrawal by Subject|0
5399367|NCT02963506|18610313|P8|Dose-Blind Period|Withdrawal by Subject|2
5399368|NCT02963506|18610314|P7|Dose-Blind Period|Withdrawal by Subject|2
5399369|NCT02963506|18610315|P6|Dose-Blind Period|Withdrawal by Subject|1
5399370|NCT02963506|18610316|P5|Dose-Blind Period|Withdrawal by Subject|0
5399371|NCT02963506|18610317|P4|Dose-Blind Period|Withdrawal by Subject|0
5399372|NCT02963506|18610318|P3|Dose-Blind Period|Withdrawal by Subject|0
5399373|NCT02963506|18610319|P2|Dose-Blind Period|Withdrawal by Subject|0
5399374|NCT02963506|18610320|P1|Dose-Blind Period|Withdrawal by Subject|0
5399375|NCT02963506|18610308|P13|Dose-Blind Period|Lost to Follow-up|0
5399376|NCT02963506|18610309|P12|Dose-Blind Period|Lost to Follow-up|1
5399377|NCT02963506|18610310|P11|Dose-Blind Period|Lost to Follow-up|0
5399378|NCT02963506|18610311|P10|Dose-Blind Period|Lost to Follow-up|0
5399379|NCT02963506|18610312|P9|Dose-Blind Period|Lost to Follow-up|1
5399380|NCT02963506|18610313|P8|Dose-Blind Period|Lost to Follow-up|0
5399381|NCT02963506|18610314|P7|Dose-Blind Period|Lost to Follow-up|0
5399382|NCT02963506|18610315|P6|Dose-Blind Period|Lost to Follow-up|1
5399383|NCT02963506|18610316|P5|Dose-Blind Period|Lost to Follow-up|0
5399384|NCT02963506|18610317|P4|Dose-Blind Period|Lost to Follow-up|0
5399385|NCT02963506|18610318|P3|Dose-Blind Period|Lost to Follow-up|0
5399386|NCT02963506|18610319|P2|Dose-Blind Period|Lost to Follow-up|0
5399387|NCT02963506|18610320|P1|Dose-Blind Period|Lost to Follow-up|0
5399388|NCT02963506|18610308|P13|Dose-Blind Period|Lack of Efficacy|0
5399389|NCT02963506|18610309|P12|Dose-Blind Period|Lack of Efficacy|0
5399390|NCT02963506|18610310|P11|Dose-Blind Period|Lack of Efficacy|0
5399391|NCT02963506|18610311|P10|Dose-Blind Period|Lack of Efficacy|1
5399392|NCT02963506|18610312|P9|Dose-Blind Period|Lack of Efficacy|0
5399393|NCT02963506|18610313|P8|Dose-Blind Period|Lack of Efficacy|1
5399394|NCT02963506|18610314|P7|Dose-Blind Period|Lack of Efficacy|0
5399395|NCT02963506|18610315|P6|Dose-Blind Period|Lack of Efficacy|0
5399396|NCT02963506|18610316|P5|Dose-Blind Period|Lack of Efficacy|0
5399397|NCT02963506|18610317|P4|Dose-Blind Period|Lack of Efficacy|0
5399398|NCT02963506|18610318|P3|Dose-Blind Period|Lack of Efficacy|0
5399399|NCT02963506|18610319|P2|Dose-Blind Period|Lack of Efficacy|0
5399400|NCT02963506|18610320|P1|Dose-Blind Period|Lack of Efficacy|0
5399401|NCT02963506|18610308|P13|Dose-Blind Period|Adverse Event|6
5399402|NCT02963506|18610309|P12|Dose-Blind Period|Adverse Event|1
5399403|NCT02963506|18610310|P11|Dose-Blind Period|Adverse Event|1
5399404|NCT02963506|18610311|P10|Dose-Blind Period|Adverse Event|2
5399405|NCT02963506|18610312|P9|Dose-Blind Period|Adverse Event|2
5399406|NCT02963506|18610313|P8|Dose-Blind Period|Adverse Event|2
5399407|NCT02963506|18610314|P7|Dose-Blind Period|Adverse Event|3
5399408|NCT02963506|18610315|P6|Dose-Blind Period|Adverse Event|1
5399409|NCT02963506|18610316|P5|Dose-Blind Period|Adverse Event|0
5399410|NCT02963506|18610317|P4|Dose-Blind Period|Adverse Event|0
5399411|NCT02963506|18610318|P3|Dose-Blind Period|Adverse Event|0
5399412|NCT02963506|18610319|P2|Dose-Blind Period|Adverse Event|0
5399413|NCT02963506|18610320|P1|Dose-Blind Period|Adverse Event|0
5399414|NCT02963506|18610308|P13|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399415|NCT02963506|18610309|P12|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399416|NCT02963506|18610310|P11|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399417|NCT02963506|18610311|P10|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399418|NCT02963506|18610312|P9|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399419|NCT02963506|18610313|P8|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399420|NCT02963506|18610314|P7|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399421|NCT02963506|18610315|P6|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399422|NCT02963506|18610316|P5|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399423|NCT02963506|18610317|P4|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399424|NCT02963506|18610318|P3|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399425|NCT02963506|18610319|P2|Double-Blind Period|Adverse event, non fatal after Wk12|1
5399426|NCT02963506|18610320|P1|Double-Blind Period|Adverse event, non fatal after Wk12|0
5399427|NCT02963506|18610308|P13|Double-Blind Period|No compliance|0
5399428|NCT02963506|18610309|P12|Double-Blind Period|No compliance|0
5399429|NCT02963506|18610310|P11|Double-Blind Period|No compliance|0
5399430|NCT02963506|18610311|P10|Double-Blind Period|No compliance|0
5399431|NCT02963506|18610312|P9|Double-Blind Period|No compliance|0
5399432|NCT02963506|18610313|P8|Double-Blind Period|No compliance|0
5399433|NCT02963506|18610314|P7|Double-Blind Period|No compliance|0
5399434|NCT02963506|18610315|P6|Double-Blind Period|No compliance|0
5399435|NCT02963506|18610316|P5|Double-Blind Period|No compliance|0
5399436|NCT02963506|18610317|P4|Double-Blind Period|No compliance|0
5399437|NCT02963506|18610318|P3|Double-Blind Period|No compliance|0
5399438|NCT02963506|18610319|P2|Double-Blind Period|No compliance|1
5399439|NCT02963506|18610320|P1|Double-Blind Period|No compliance|0
5399440|NCT02963506|18610308|P13|Double-Blind Period|Withdrawal by Subject|0
5399441|NCT02963506|18610309|P12|Double-Blind Period|Withdrawal by Subject|0
5399442|NCT02963506|18610310|P11|Double-Blind Period|Withdrawal by Subject|0
5399443|NCT02963506|18610311|P10|Double-Blind Period|Withdrawal by Subject|0
5399444|NCT02963506|18610312|P9|Double-Blind Period|Withdrawal by Subject|0
5399445|NCT02963506|18610313|P8|Double-Blind Period|Withdrawal by Subject|0
5399446|NCT02963506|18610314|P7|Double-Blind Period|Withdrawal by Subject|0
5399447|NCT02963506|18610315|P6|Double-Blind Period|Withdrawal by Subject|0
5399448|NCT02963506|18610316|P5|Double-Blind Period|Withdrawal by Subject|0
5399449|NCT02963506|18610317|P4|Double-Blind Period|Withdrawal by Subject|1
5399450|NCT02963506|18610318|P3|Double-Blind Period|Withdrawal by Subject|1
5399451|NCT02963506|18610319|P2|Double-Blind Period|Withdrawal by Subject|0
5399452|NCT02963506|18610320|P1|Double-Blind Period|Withdrawal by Subject|0
5399453|NCT02963506|18610308|P13|Double-Blind Period|Lost to Follow-up|0
5399454|NCT02963506|18610309|P12|Double-Blind Period|Lost to Follow-up|0
5399455|NCT02963506|18610310|P11|Double-Blind Period|Lost to Follow-up|0
5399456|NCT02963506|18610311|P10|Double-Blind Period|Lost to Follow-up|0
5399457|NCT02963506|18610312|P9|Double-Blind Period|Lost to Follow-up|0
5399458|NCT02963506|18610313|P8|Double-Blind Period|Lost to Follow-up|0
5399459|NCT02963506|18610314|P7|Double-Blind Period|Lost to Follow-up|0
5399460|NCT02963506|18610315|P6|Double-Blind Period|Lost to Follow-up|0
5399461|NCT02963506|18610316|P5|Double-Blind Period|Lost to Follow-up|0
5399462|NCT02963506|18610317|P4|Double-Blind Period|Lost to Follow-up|0
5399463|NCT02963506|18610318|P3|Double-Blind Period|Lost to Follow-up|0
5399464|NCT02963506|18610319|P2|Double-Blind Period|Lost to Follow-up|1
5399465|NCT02963506|18610320|P1|Double-Blind Period|Lost to Follow-up|0
5399466|NCT02963506|18610308|P13|Double-Blind Period|Death|0
5399467|NCT02963506|18610309|P12|Double-Blind Period|Death|0
5399468|NCT02963506|18610310|P11|Double-Blind Period|Death|0
5399469|NCT02963506|18610311|P10|Double-Blind Period|Death|0
5399470|NCT02963506|18610312|P9|Double-Blind Period|Death|0
5399471|NCT02963506|18610313|P8|Double-Blind Period|Death|0
5399472|NCT02963506|18610314|P7|Double-Blind Period|Death|0
5399473|NCT02963506|18610315|P6|Double-Blind Period|Death|0
5399474|NCT02963506|18610316|P5|Double-Blind Period|Death|0
5399475|NCT02963506|18610317|P4|Double-Blind Period|Death|1
5399476|NCT02963506|18610318|P3|Double-Blind Period|Death|0
5399477|NCT02963506|18610319|P2|Double-Blind Period|Death|0
5399478|NCT02963506|18610320|P1|Double-Blind Period|Death|0
5399479|NCT02963506|18610308|P13|Double-Blind Period|Adverse Event|0
5399480|NCT02963506|18610309|P12|Double-Blind Period|Adverse Event|0
5399481|NCT02963506|18610310|P11|Double-Blind Period|Adverse Event|0
5399482|NCT02963506|18610311|P10|Double-Blind Period|Adverse Event|0
5399483|NCT02963506|18610312|P9|Double-Blind Period|Adverse Event|0
5399484|NCT02963506|18610313|P8|Double-Blind Period|Adverse Event|0
5399485|NCT02963506|18610314|P7|Double-Blind Period|Adverse Event|0
5399486|NCT02963506|18610315|P6|Double-Blind Period|Adverse Event|0
5399487|NCT02963506|18610316|P5|Double-Blind Period|Adverse Event|0
5399488|NCT02963506|18610317|P4|Double-Blind Period|Adverse Event|0
5399489|NCT02963506|18610318|P3|Double-Blind Period|Adverse Event|1
5399490|NCT02963506|18610319|P2|Double-Blind Period|Adverse Event|0
5399491|NCT02963506|18610320|P1|Double-Blind Period|Adverse Event|0
5399492|NCT02963311|18610372|P1|Overall Study|Screen Failure|4
5399493|NCT02963311|18610372|P1|Overall Study|Withdrawal by Subject|1
5399494|NCT02962960|18610399|P3|Overall Study|Protocol Violation|0
5399495|NCT02962960|18610400|P2|Overall Study|Protocol Violation|0
5399496|NCT02962960|18610401|P1|Overall Study|Protocol Violation|1
5399497|NCT02962960|18610399|P3|Overall Study|Adverse Event|0
5399498|NCT02962960|18610400|P2|Overall Study|Adverse Event|1
5399499|NCT02962960|18610401|P1|Overall Study|Adverse Event|1
5399500|NCT02962960|18610399|P3|Overall Study|Withdrawal by Subject|0
5399501|NCT02962960|18610400|P2|Overall Study|Withdrawal by Subject|1
5399502|NCT02962960|18610401|P1|Overall Study|Withdrawal by Subject|1
5399503|NCT02962908|18610485|P4|Overall Study|Physician Decision|0
5399504|NCT02962908|18610486|P3|Overall Study|Physician Decision|0
5399505|NCT02962908|18610487|P2|Overall Study|Physician Decision|1
5399506|NCT02962908|18610488|P1|Overall Study|Physician Decision|0
5399507|NCT02962908|18610485|P4|Overall Study|Protocol Violation|0
5399508|NCT02962908|18610486|P3|Overall Study|Protocol Violation|0
5399509|NCT02962908|18610487|P2|Overall Study|Protocol Violation|1
5399510|NCT02962908|18610488|P1|Overall Study|Protocol Violation|0
5399511|NCT02962908|18610485|P4|Overall Study|Withdrawal by Subject|2
5399512|NCT02962908|18610486|P3|Overall Study|Withdrawal by Subject|0
5399513|NCT02962908|18610487|P2|Overall Study|Withdrawal by Subject|3
5399514|NCT02962908|18610488|P1|Overall Study|Withdrawal by Subject|0
5399515|NCT02962908|18610485|P4|Overall Study|Lost to Follow-up|1
5399516|NCT02962908|18610486|P3|Overall Study|Lost to Follow-up|0
5399517|NCT02962908|18610487|P2|Overall Study|Lost to Follow-up|3
5399518|NCT02962908|18610488|P1|Overall Study|Lost to Follow-up|0
5399519|NCT02962882|18610552|P1|Overall Study|Transfer from ICU|32
5399520|NCT02962882|18610552|P1|Overall Study|Withdrawal by Subject|2
5399521|NCT02962882|18610552|P1|Overall Study|Adverse Event|2
5399522|NCT02962648|18610588|P1|Overall Study|Subject had problems with transportation|2
5399523|NCT02962648|18610588|P1|Overall Study|Physician Decision|1
5399524|NCT02962648|18610588|P1|Overall Study|Lost to Follow-up|3
5399525|NCT02962648|18610588|P1|Overall Study|Withdrawal by Subject|3
5399526|NCT02962284|18610626|P2|Overall Study|Withdrawal by Subject|0
5399527|NCT02962284|18610627|P1|Overall Study|Withdrawal by Subject|1
5399528|NCT02962284|18610626|P2|Overall Study|Progressive disease|3
5399529|NCT02962284|18610627|P1|Overall Study|Progressive disease|2
5399530|NCT02962284|18610626|P2|Overall Study|Death|0
5399531|NCT02962284|18610627|P1|Overall Study|Death|2
5399532|NCT02961920|18610658|P2|Overall Study|did not achive stydy protocol schedule|1
5399533|NCT02961920|18610659|P1|Overall Study|did not achive stydy protocol schedule|1
5399534|NCT02961790|18610687|P4|Overall Study|without post baseline data|1
5399535|NCT02961790|18610688|P3|Overall Study|without post baseline data|4
5399536|NCT02961790|18610689|P2|Overall Study|without post baseline data|6
5399537|NCT02961790|18610690|P1|Overall Study|without post baseline data|7
5399538|NCT02961790|18610687|P4|Overall Study|without baseline data|0
5399539|NCT02961790|18610688|P3|Overall Study|without baseline data|1
5399540|NCT02961790|18610689|P2|Overall Study|without baseline data|0
5399541|NCT02961790|18610690|P1|Overall Study|without baseline data|4
5399542|NCT02961790|18610687|P4|Overall Study|Canceled|4
5399543|NCT02961790|18610688|P3|Overall Study|Canceled|1
5399544|NCT02961790|18610689|P2|Overall Study|Canceled|5
5399545|NCT02961790|18610690|P1|Overall Study|Canceled|4
5399546|NCT02961764|18610713|P2|Overall Study|Withdrawal by Subject|0
5399547|NCT02961764|18610714|P1|Overall Study|Withdrawal by Subject|2
5399548|NCT02961764|18610713|P2|Overall Study|Lost to Follow-up|24
5399549|NCT02961764|18610714|P1|Overall Study|Lost to Follow-up|35
5399550|NCT02961764|18610713|P2|Overall Study|Death|0
5399551|NCT02961764|18610714|P1|Overall Study|Death|2
5399552|NCT02961764|18610713|P2|Overall Study|Protocol Violation|1
5399553|NCT02961764|18610714|P1|Overall Study|Protocol Violation|0
5399554|NCT02961751|18610788|P1|Overall Study|Protocol Violation|1
5399555|NCT02961751|18610788|P1|Overall Study|Not Eligible at Enrollment|1
5399556|NCT02961751|18610788|P1|Overall Study|Physician Decision|2
5399557|NCT02961751|18610788|P1|Overall Study|Lost to Follow-up|11
5399558|NCT02961244|18610801|P2|Overall Study|İnadequate data|2
5399559|NCT02961244|18610802|P1|Overall Study|İnadequate data|0
5399560|NCT02961244|18610801|P2|Overall Study|Lost to Follow-up|2
5399561|NCT02961244|18610802|P1|Overall Study|Lost to Follow-up|0
5399562|NCT02961244|18610801|P2|Overall Study|Surgery plan change after study approval|2
5399563|NCT02961244|18610802|P1|Overall Study|Surgery plan change after study approval|0
5399564|NCT02961244|18610801|P2|Overall Study|Withdrawal by Subject|2
5399565|NCT02961244|18610802|P1|Overall Study|Withdrawal by Subject|1
5399566|NCT02961244|18610801|P2|Overall Study|Protocol Violation|1
5399567|NCT02961244|18610802|P1|Overall Study|Protocol Violation|0
5399568|NCT02961218|18610812|P2|Overall Study|Subject/Guardian Decision|1
5399569|NCT02961218|18610813|P1|Overall Study|Subject/Guardian Decision|3
5399570|NCT02961218|18610812|P2|Overall Study|Physician Decision|2
5399571|NCT02961218|18610813|P1|Overall Study|Physician Decision|0
5399572|NCT02961218|18610812|P2|Overall Study|Lost to Follow-up|2
5399573|NCT02961218|18610813|P1|Overall Study|Lost to Follow-up|0
5399574|NCT02960893|18610893|P2|Extension Phase (48-week)|Sponsors Decision|0
5399575|NCT02960893|18610894|P1|Extension Phase (48-week)|Sponsors Decision|1
5399576|NCT02960893|18610893|P2|Extension Phase (48-week)|Lost to Follow-up|1
5399577|NCT02960893|18610894|P1|Extension Phase (48-week)|Lost to Follow-up|1
5399578|NCT02960893|18610893|P2|Extension Phase (48-week)|Other Reason|1
5399579|NCT02960893|18610894|P1|Extension Phase (48-week)|Other Reason|2
5399580|NCT02960893|18610893|P2|Extension Phase (48-week)|Withdrawal by Subject|8
5399581|NCT02960893|18610894|P1|Extension Phase (48-week)|Withdrawal by Subject|8
5399582|NCT02960893|18610893|P2|Extension Phase (48-week)|Adverse Event|3
5399583|NCT02960893|18610894|P1|Extension Phase (48-week)|Adverse Event|2
5399584|NCT02960893|18610893|P2|Randomization Phase (8-week)|Reason Not Specified|1
5399585|NCT02960893|18610894|P1|Randomization Phase (8-week)|Reason Not Specified|0
5399586|NCT02960893|18610893|P2|Randomization Phase (8-week)|Withdrawal by Subject|1
5399587|NCT02960893|18610894|P1|Randomization Phase (8-week)|Withdrawal by Subject|2
5399588|NCT02960893|18610893|P2|Randomization Phase (8-week)|Adverse Event|0
5399589|NCT02960893|18610894|P1|Randomization Phase (8-week)|Adverse Event|5
5399590|NCT02960854|18610912|P2|Overall Study|Death|6
5399591|NCT02960854|18610913|P1|Overall Study|Death|4
5399592|NCT02960854|18610912|P2|Overall Study|Subject Withdrew Consent|1
5399593|NCT02960854|18610913|P1|Overall Study|Subject Withdrew Consent|0
5399594|NCT02960854|18610912|P2|Overall Study|Subject No Longer Meets Study Criteria|0
5399595|NCT02960854|18610913|P1|Overall Study|Subject No Longer Meets Study Criteria|1
5399596|NCT02960854|18610912|P2|Overall Study|Not Disclosed|2
5399597|NCT02960854|18610913|P1|Overall Study|Not Disclosed|2
5399598|NCT02960217|18610952|P2|Open-Label Extension Phase|Other, Not Specified|1
5399599|NCT02960217|18610953|P1|Open-Label Extension Phase|Other, Not Specified|0
5399600|NCT02960217|18610952|P2|Open-Label Extension Phase|Lack of Efficacy|1
5399601|NCT02960217|18610953|P1|Open-Label Extension Phase|Lack of Efficacy|1
5399602|NCT02960217|18610952|P2|Open-Label Extension Phase|Sponsor Decision|11
5399603|NCT02960217|18610953|P1|Open-Label Extension Phase|Sponsor Decision|18
5399604|NCT02960217|18610952|P2|Open-Label Extension Phase|Adverse Event|0
5399605|NCT02960217|18610953|P1|Open-Label Extension Phase|Adverse Event|1
5399606|NCT02960217|18610952|P2|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
5399607|NCT02960217|18610953|P1|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
5399608|NCT02960217|18610952|P2|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
5399609|NCT02960217|18610953|P1|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
5399610|NCT02960217|18610952|P2|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
5399611|NCT02960217|18610953|P1|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
5399612|NCT02960217|18610952|P2|Maintenance Phase: Treatment Period 2|Adverse Event|1
5399613|NCT02960217|18610953|P1|Maintenance Phase: Treatment Period 2|Adverse Event|0
5399614|NCT02960217|18610952|P2|Maintenance Phase: Treatment Period 1|Adverse Event|0
5399615|NCT02960217|18610953|P1|Maintenance Phase: Treatment Period 1|Adverse Event|1
5399616|NCT02959983|18611032|P2|Overall Study|Withdrawal by Subject|12
5399617|NCT02959983|18611033|P1|Overall Study|Withdrawal by Subject|7
5399618|NCT02959983|18611032|P2|Overall Study|Adverse Event|1
5399619|NCT02959983|18611033|P1|Overall Study|Adverse Event|5
5399620|NCT02959983|18611032|P2|Overall Study|Physician Decision|0
5399621|NCT02959983|18611033|P1|Overall Study|Physician Decision|1
5399622|NCT02959983|18611032|P2|Overall Study|Other|1
5399623|NCT02959983|18611033|P1|Overall Study|Other|1
5399624|NCT02959983|18611032|P2|Overall Study|Lost to Follow-up|9
5399625|NCT02959983|18611033|P1|Overall Study|Lost to Follow-up|12
5399626|NCT02959983|18611032|P2|Overall Study|Lack of Efficacy|1
5399627|NCT02959983|18611033|P1|Overall Study|Lack of Efficacy|0
5399628|NCT02959983|18611032|P2|Overall Study|Protocol Violation|1
5399629|NCT02959983|18611033|P1|Overall Study|Protocol Violation|0
5399630|NCT02959970|18611047|P2|Overall Study|Lost to Follow-up|5
5399631|NCT02959970|18611048|P1|Overall Study|Lost to Follow-up|1
5399632|NCT02959970|18611047|P2|Overall Study|Withdrawal by Subject|2
5399633|NCT02959970|18611048|P1|Overall Study|Withdrawal by Subject|0
5399634|NCT02959970|18611047|P2|Overall Study|Adverse Event|0
5399635|NCT02959970|18611048|P1|Overall Study|Adverse Event|1
5399636|NCT02959892|18611082|P2|Overall Study|Study termination|1
5399637|NCT02959892|18611083|P1|Overall Study|Study termination|0
5399638|NCT02959892|18611082|P2|Overall Study|PET tracer synthesis failure|0
5399639|NCT02959892|18611083|P1|Overall Study|PET tracer synthesis failure|1
5399640|NCT02959866|18611091|P1|Overall Study|Withdrawal by Subject|1
5399641|NCT02959814|18611180|P1|Overall Study|Excluded by FFR core-lab|24
5399642|NCT02959814|18611180|P1|Overall Study|In-procedure QFR not computed|6
5399643|NCT02959814|18611180|P1|Overall Study|FFR not measured|2
5399644|NCT02959814|18611180|P1|Overall Study|Protocol Violation|7
5399645|NCT02959814|18611180|P1|Overall Study|Excluded based on anatomical criteria|2
5399646|NCT02959814|18611180|P1|Overall Study|Excluded based on diagnostic angiography|16
5399647|NCT02959437|18611203|P4|Overall Study|Participants Ongoing in Study|0
5399648|NCT02959437|18611204|P3|Overall Study|Participants Ongoing in Study|0
5399649|NCT02959437|18611205|P2|Overall Study|Participants Ongoing in Study|0
5399650|NCT02959437|18611206|P1|Overall Study|Participants Ongoing in Study|7
5399651|NCT02959437|18611203|P4|Overall Study|Other Unspecified|0
5399652|NCT02959437|18611204|P3|Overall Study|Other Unspecified|0
5399653|NCT02959437|18611205|P2|Overall Study|Other Unspecified|0
5399654|NCT02959437|18611206|P1|Overall Study|Other Unspecified|2
5399655|NCT02959437|18611203|P4|Overall Study|Study Terminated by Sponsor|0
5399656|NCT02959437|18611204|P3|Overall Study|Study Terminated by Sponsor|0
5399657|NCT02959437|18611205|P2|Overall Study|Study Terminated by Sponsor|0
5399658|NCT02959437|18611206|P1|Overall Study|Study Terminated by Sponsor|2
5399659|NCT02959437|18611203|P4|Overall Study|Progressive Disease|0
5399660|NCT02959437|18611204|P3|Overall Study|Progressive Disease|0
5399661|NCT02959437|18611205|P2|Overall Study|Progressive Disease|1
5399662|NCT02959437|18611206|P1|Overall Study|Progressive Disease|8
5399663|NCT02959437|18611203|P4|Overall Study|Withdrawal by Subject|0
5399664|NCT02959437|18611204|P3|Overall Study|Withdrawal by Subject|0
5399665|NCT02959437|18611205|P2|Overall Study|Withdrawal by Subject|3
5399666|NCT02959437|18611206|P1|Overall Study|Withdrawal by Subject|10
5399667|NCT02959437|18611203|P4|Overall Study|Lost to Follow-up|0
5399668|NCT02959437|18611204|P3|Overall Study|Lost to Follow-up|0
5399669|NCT02959437|18611205|P2|Overall Study|Lost to Follow-up|1
5399670|NCT02959437|18611206|P1|Overall Study|Lost to Follow-up|2
5399671|NCT02959437|18611203|P4|Overall Study|Death|0
5399672|NCT02959437|18611204|P3|Overall Study|Death|0
5399673|NCT02959437|18611205|P2|Overall Study|Death|3
5399674|NCT02959437|18611206|P1|Overall Study|Death|31
5399675|NCT02959190|18611239|P4|Post Treatment Follow Up|Withdrawal by Subject|0
5399676|NCT02959190|18611240|P3|Post Treatment Follow Up|Withdrawal by Subject|1
5399677|NCT02959190|18611241|P2|Post Treatment Follow Up|Withdrawal by Subject|0
5399678|NCT02959190|18611242|P1|Post Treatment Follow Up|Withdrawal by Subject|2
5399679|NCT02959190|18611239|P4|Post Treatment Follow Up|Adverse Event|0
5399680|NCT02959190|18611240|P3|Post Treatment Follow Up|Adverse Event|0
5399681|NCT02959190|18611241|P2|Post Treatment Follow Up|Adverse Event|1
5399682|NCT02959190|18611242|P1|Post Treatment Follow Up|Adverse Event|1
5399683|NCT02959190|18611239|P4|Open Label|Protocol Violation|2
5399684|NCT02959190|18611240|P3|Open Label|Protocol Violation|0
5399685|NCT02959190|18611241|P2|Open Label|Protocol Violation|0
5399686|NCT02959190|18611242|P1|Open Label|Protocol Violation|0
5399687|NCT02959190|18611239|P4|Open Label|Physician Decision|0
5399688|NCT02959190|18611240|P3|Open Label|Physician Decision|1
5399689|NCT02959190|18611241|P2|Open Label|Physician Decision|0
5399690|NCT02959190|18611242|P1|Open Label|Physician Decision|0
5399691|NCT02959190|18611239|P4|Open Label|Withdrawal by Subject|0
5399692|NCT02959190|18611240|P3|Open Label|Withdrawal by Subject|0
5399693|NCT02959190|18611241|P2|Open Label|Withdrawal by Subject|8
5399694|NCT02959190|18611242|P1|Open Label|Withdrawal by Subject|2
5399695|NCT02959190|18611239|P4|Open Label|Pregnancy|0
5399696|NCT02959190|18611240|P3|Open Label|Pregnancy|0
5399697|NCT02959190|18611241|P2|Open Label|Pregnancy|1
5399698|NCT02959190|18611242|P1|Open Label|Pregnancy|0
5399699|NCT02959190|18611239|P4|Open Label|Adverse Event|4
5399700|NCT02959190|18611240|P3|Open Label|Adverse Event|3
5399701|NCT02959190|18611241|P2|Open Label|Adverse Event|7
5399702|NCT02959190|18611242|P1|Open Label|Adverse Event|5
5399703|NCT02959177|18611335|P3|Follow-up Post Treatment Phase|Withdrawal by Subject|2
5399704|NCT02959177|18611336|P2|Follow-up Post Treatment Phase|Withdrawal by Subject|0
5399705|NCT02959177|18611337|P1|Follow-up Post Treatment Phase|Withdrawal by Subject|0
5399706|NCT02959177|18611335|P3|Follow-up Post Treatment Phase|Adverse Event|0
5399707|NCT02959177|18611336|P2|Follow-up Post Treatment Phase|Adverse Event|1
5399708|NCT02959177|18611337|P1|Follow-up Post Treatment Phase|Adverse Event|0
5399709|NCT02959177|18611335|P3|Follow-up Post Treatment Phase|Lost to Follow-up|0
5399710|NCT02959177|18611336|P2|Follow-up Post Treatment Phase|Lost to Follow-up|0
5399711|NCT02959177|18611337|P1|Follow-up Post Treatment Phase|Lost to Follow-up|1
5399712|NCT02959177|18611335|P3|Double-Blind Treatment Phase|Withdrawal by Subject|5
5399713|NCT02959177|18611336|P2|Double-Blind Treatment Phase|Withdrawal by Subject|0
5399714|NCT02959177|18611337|P1|Double-Blind Treatment Phase|Withdrawal by Subject|5
5399715|NCT02959177|18611335|P3|Double-Blind Treatment Phase|Protocol Violation|0
5399716|NCT02959177|18611336|P2|Double-Blind Treatment Phase|Protocol Violation|1
5399717|NCT02959177|18611337|P1|Double-Blind Treatment Phase|Protocol Violation|0
5399718|NCT02959177|18611335|P3|Double-Blind Treatment Phase|Physician Decision|0
5399719|NCT02959177|18611336|P2|Double-Blind Treatment Phase|Physician Decision|0
5399720|NCT02959177|18611337|P1|Double-Blind Treatment Phase|Physician Decision|1
5399721|NCT02959177|18611335|P3|Double-Blind Treatment Phase|Adverse Event|0
5399722|NCT02959177|18611336|P2|Double-Blind Treatment Phase|Adverse Event|2
5399723|NCT02959177|18611337|P1|Double-Blind Treatment Phase|Adverse Event|5
5399724|NCT02959138|18611392|P3|Overall Study|Enrolled but Never Treated|0
5399725|NCT02959138|18611393|P2|Overall Study|Enrolled but Never Treated|1
5399726|NCT02959138|18611394|P1|Overall Study|Enrolled but Never Treated|0
5399727|NCT02958553|18611535|P1|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
5399728|NCT02958553|18611535|P1|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
5399729|NCT02958267|18611569|P2|Follow-up Visits|Additional treatment pursued|1
5399730|NCT02958267|18611570|P1|Follow-up Visits|Additional treatment pursued|2
5399731|NCT02958267|18611569|P2|Enrollment to Actual Treatment Complete|Physician Decision|0
5399732|NCT02958267|18611570|P1|Enrollment to Actual Treatment Complete|Physician Decision|1
5399733|NCT02958267|18611569|P2|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
5399734|NCT02958267|18611570|P1|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
5399735|NCT02957942|18611582|P2|Overall Study|Practicing experiment protocol|6
5399736|NCT02957942|18611583|P1|Overall Study|Practicing experiment protocol|0
5399737|NCT02957942|18611582|P2|Overall Study|Withdrawal by Subject|1
5399738|NCT02957942|18611583|P1|Overall Study|Withdrawal by Subject|0
5399739|NCT02957747|18611599|P2|Overall Study|Lost to Follow-up|5
5399740|NCT02957747|18611600|P1|Overall Study|Lost to Follow-up|10
5399741|NCT02957747|18611599|P2|Overall Study|Withdrawal by Subject|3
5399742|NCT02957747|18611600|P1|Overall Study|Withdrawal by Subject|0
5399743|NCT02957331|18611628|P2|Overall Study|Protocol Violation|0
5399744|NCT02957331|18611629|P1|Overall Study|Protocol Violation|1
5399745|NCT02956967|18611648|P1|Overall Study|Termination of Nivestim administration|29
5399746|NCT02956967|18611648|P1|Overall Study|Missing|1
5399747|NCT02956967|18611648|P1|Overall Study|Lost to Follow-up|5
5399748|NCT02956967|18611648|P1|Overall Study|Reason non-related to neutropenia|10
5399749|NCT02956967|18611648|P1|Overall Study|Adverse Event|3
5399750|NCT02956837|18611675|P4|Overall Study|Lost to Follow-up|0
5399751|NCT02956837|18611676|P3|Overall Study|Lost to Follow-up|2
5399752|NCT02956837|18611677|P2|Overall Study|Lost to Follow-up|1
5399753|NCT02956837|18611678|P1|Overall Study|Lost to Follow-up|0
5399754|NCT02956837|18611675|P4|Overall Study|Withdrawal by Subject|3
5399755|NCT02956837|18611676|P3|Overall Study|Withdrawal by Subject|0
5399756|NCT02956837|18611677|P2|Overall Study|Withdrawal by Subject|1
5399757|NCT02956837|18611678|P1|Overall Study|Withdrawal by Subject|0
5399758|NCT02956837|18611675|P4|Overall Study|Serious Adverse Events|0
5399759|NCT02956837|18611676|P3|Overall Study|Serious Adverse Events|0
5399760|NCT02956837|18611677|P2|Overall Study|Serious Adverse Events|1
5399761|NCT02956837|18611678|P1|Overall Study|Serious Adverse Events|0
5399762|NCT02956629|18611813|P6|Overall Study|Withdrawal by Subject|0
5399763|NCT02956629|18611814|P5|Overall Study|Withdrawal by Subject|0
5399764|NCT02956629|18611815|P4|Overall Study|Withdrawal by Subject|0
5399765|NCT02956629|18611816|P3|Overall Study|Withdrawal by Subject|0
5399766|NCT02956629|18611817|P2|Overall Study|Withdrawal by Subject|1
5399767|NCT02956629|18611818|P1|Overall Study|Withdrawal by Subject|3
5399768|NCT02956629|18611813|P6|Overall Study|Lost to Follow-up|1
5399769|NCT02956629|18611814|P5|Overall Study|Lost to Follow-up|0
5399770|NCT02956629|18611815|P4|Overall Study|Lost to Follow-up|1
5399771|NCT02956629|18611816|P3|Overall Study|Lost to Follow-up|3
5399772|NCT02956629|18611817|P2|Overall Study|Lost to Follow-up|5
5399773|NCT02956629|18611818|P1|Overall Study|Lost to Follow-up|2
5399774|NCT02956629|18611813|P6|Overall Study|Adverse Event|0
5399775|NCT02956629|18611814|P5|Overall Study|Adverse Event|0
5399776|NCT02956629|18611815|P4|Overall Study|Adverse Event|0
5399777|NCT02956629|18611816|P3|Overall Study|Adverse Event|1
5399778|NCT02956629|18611817|P2|Overall Study|Adverse Event|0
5399779|NCT02956629|18611818|P1|Overall Study|Adverse Event|0
5399780|NCT02956460|18611897|P2|Lens 1|Lost to Follow-up|0
5399781|NCT02956460|18611898|P1|Lens 1|Lost to Follow-up|1
5399782|NCT02956278|18611927|P3|Overall Study|Withdrawal by Subject|0
5399783|NCT02956278|18611928|P2|Overall Study|Withdrawal by Subject|2
5399784|NCT02956278|18611929|P1|Overall Study|Withdrawal by Subject|6
5399785|NCT02956057|18612013|P6|Overall Study|Lost to Follow-up|0
5399786|NCT02956057|18612014|P5|Overall Study|Lost to Follow-up|1
5399787|NCT02956057|18612015|P4|Overall Study|Lost to Follow-up|1
5399788|NCT02956057|18612016|P3|Overall Study|Lost to Follow-up|1
5399789|NCT02956057|18612017|P2|Overall Study|Lost to Follow-up|2
5399790|NCT02956057|18612018|P1|Overall Study|Lost to Follow-up|0
5399791|NCT02956057|18612013|P6|Overall Study|Discontinued intervention|17
5399792|NCT02956057|18612014|P5|Overall Study|Discontinued intervention|4
5399793|NCT02956057|18612015|P4|Overall Study|Discontinued intervention|14
5399794|NCT02956057|18612016|P3|Overall Study|Discontinued intervention|7
5399795|NCT02956057|18612017|P2|Overall Study|Discontinued intervention|10
5399796|NCT02956057|18612018|P1|Overall Study|Discontinued intervention|14
5399797|NCT02956005|18612038|P1|Overall Study|Physician Decision|12
5399798|NCT02956005|18612038|P1|Overall Study|Withdrawal by Subject|3
5399799|NCT02956005|18612038|P1|Overall Study|Not eligible|1
5399800|NCT02955797|18612047|P4|Overall Study|Lost to Follow-up|0
5399801|NCT02955797|18612048|P3|Overall Study|Lost to Follow-up|0
5399802|NCT02955797|18612049|P2|Overall Study|Lost to Follow-up|1
5399803|NCT02955797|18612050|P1|Overall Study|Lost to Follow-up|0
5399804|NCT02955797|18612047|P4|Overall Study|Withdrawal by Subject|1
5399805|NCT02955797|18612048|P3|Overall Study|Withdrawal by Subject|0
5399806|NCT02955797|18612049|P2|Overall Study|Withdrawal by Subject|2
5399807|NCT02955797|18612050|P1|Overall Study|Withdrawal by Subject|2
5399808|NCT02955797|18612047|P4|Overall Study|Protocol Violation|1
5399809|NCT02955797|18612048|P3|Overall Study|Protocol Violation|0
5399810|NCT02955797|18612049|P2|Overall Study|Protocol Violation|0
5399811|NCT02955797|18612050|P1|Overall Study|Protocol Violation|1
5399812|NCT02955212|18612068|P2|Overall Study|Other|2
5399813|NCT02955212|18612069|P1|Overall Study|Other|3
5399814|NCT02955212|18612068|P2|Overall Study|Lost to Follow-up|0
5399815|NCT02955212|18612069|P1|Overall Study|Lost to Follow-up|1
5399816|NCT02955212|18612068|P2|Overall Study|Withdrawal by Subject|3
5399817|NCT02955212|18612069|P1|Overall Study|Withdrawal by Subject|8
5399818|NCT02955212|18612068|P2|Overall Study|Adverse Event|7
5399819|NCT02955212|18612069|P1|Overall Study|Adverse Event|4
5399820|NCT02955186|18612095|P2|Overall Study|Protocol Violation|0
5399821|NCT02955186|18612096|P1|Overall Study|Protocol Violation|1
5399822|NCT02955186|18612095|P2|Overall Study|Withdrawal by Subject|2
5399823|NCT02955186|18612096|P1|Overall Study|Withdrawal by Subject|6
5399824|NCT02954952|18612118|P3|Overall Study|No data collected|0
5399825|NCT02954952|18612119|P2|Overall Study|No data collected|1
5399826|NCT02954952|18612120|P1|Overall Study|No data collected|0
5399827|NCT02954952|18612118|P3|Overall Study|Withdrawal by Subject|0
5399828|NCT02954952|18612119|P2|Overall Study|Withdrawal by Subject|0
5399829|NCT02954952|18612120|P1|Overall Study|Withdrawal by Subject|1
5399830|NCT02954887|18612128|P1|Overall Study|Other|1
5399831|NCT02954887|18612128|P1|Overall Study|Lack of Efficacy|3
5399832|NCT02954887|18612128|P1|Overall Study|Withdrawal by Subject|3
5399833|NCT02954848|18612157|P2|Overall Study|Withdrawal by Participant|1
5399834|NCT02954848|18612158|P1|Overall Study|Withdrawal by Participant|0
5399835|NCT02954848|18612157|P2|Overall Study|Adverse Event|3
5399836|NCT02954848|18612158|P1|Overall Study|Adverse Event|2
5399837|NCT02954848|18612157|P2|Overall Study|Randomized but Not Treated|1
5399838|NCT02954848|18612158|P1|Overall Study|Randomized but Not Treated|0
5399839|NCT02954653|18612218|P9|Overall Study|Treatment failure and consent withdrawal|0
5399840|NCT02954653|18612219|P8|Overall Study|Treatment failure and consent withdrawal|0
5399841|NCT02954653|18612220|P7|Overall Study|Treatment failure and consent withdrawal|0
5399842|NCT02954653|18612221|P6|Overall Study|Treatment failure and consent withdrawal|0
5399843|NCT02954653|18612222|P5|Overall Study|Treatment failure and consent withdrawal|0
5399844|NCT02954653|18612223|P4|Overall Study|Treatment failure and consent withdrawal|0
5399845|NCT02954653|18612224|P3|Overall Study|Treatment failure and consent withdrawal|0
5399846|NCT02954653|18612225|P2|Overall Study|Treatment failure and consent withdrawal|1
5399847|NCT02954653|18612226|P1|Overall Study|Treatment failure and consent withdrawal|0
5399848|NCT02954653|18612218|P9|Overall Study|Started another anti-cancer therapy|0
5399849|NCT02954653|18612219|P8|Overall Study|Started another anti-cancer therapy|0
5399850|NCT02954653|18612220|P7|Overall Study|Started another anti-cancer therapy|0
5399851|NCT02954653|18612221|P6|Overall Study|Started another anti-cancer therapy|0
5399852|NCT02954653|18612222|P5|Overall Study|Started another anti-cancer therapy|0
5399853|NCT02954653|18612223|P4|Overall Study|Started another anti-cancer therapy|0
5399854|NCT02954653|18612224|P3|Overall Study|Started another anti-cancer therapy|0
5399855|NCT02954653|18612225|P2|Overall Study|Started another anti-cancer therapy|1
5399856|NCT02954653|18612226|P1|Overall Study|Started another anti-cancer therapy|0
5399857|NCT02954653|18612218|P9|Overall Study|Randomized but did not receive treatment|0
5399858|NCT02954653|18612219|P8|Overall Study|Randomized but did not receive treatment|0
5399859|NCT02954653|18612220|P7|Overall Study|Randomized but did not receive treatment|0
5399860|NCT02954653|18612221|P6|Overall Study|Randomized but did not receive treatment|0
5399861|NCT02954653|18612222|P5|Overall Study|Randomized but did not receive treatment|0
5399862|NCT02954653|18612223|P4|Overall Study|Randomized but did not receive treatment|0
5399863|NCT02954653|18612224|P3|Overall Study|Randomized but did not receive treatment|0
5399864|NCT02954653|18612225|P2|Overall Study|Randomized but did not receive treatment|0
5399865|NCT02954653|18612226|P1|Overall Study|Randomized but did not receive treatment|1
5399866|NCT02954653|18612218|P9|Overall Study|Death|0
5399867|NCT02954653|18612219|P8|Overall Study|Death|0
5399868|NCT02954653|18612220|P7|Overall Study|Death|0
5399869|NCT02954653|18612221|P6|Overall Study|Death|0
5399870|NCT02954653|18612222|P5|Overall Study|Death|0
5399871|NCT02954653|18612223|P4|Overall Study|Death|0
5399872|NCT02954653|18612224|P3|Overall Study|Death|0
5399873|NCT02954653|18612225|P2|Overall Study|Death|1
5399874|NCT02954653|18612226|P1|Overall Study|Death|3
5399875|NCT02954601|18612345|P4|First Intervention (Five Days)|Withdrawal by Subject|0
5399876|NCT02954601|18612346|P3|First Intervention (Five Days)|Withdrawal by Subject|1
5399877|NCT02954601|18612347|P2|First Intervention (Five Days)|Withdrawal by Subject|0
5399878|NCT02954601|18612348|P1|First Intervention (Five Days)|Withdrawal by Subject|0
5399879|NCT02954575|18612370|P1|Overall Study|Adverse Event|1
5399880|NCT02954575|18612370|P1|Overall Study|Withdrawal by Subject|2
5399881|NCT02954354|18612390|P3|Overall Study|Miscellaneous|1
5399882|NCT02954354|18612391|P2|Overall Study|Miscellaneous|2
5399883|NCT02954354|18612392|P1|Overall Study|Miscellaneous|2
5399884|NCT02954354|18612390|P3|Overall Study|Lost to Follow-up|0
5399885|NCT02954354|18612391|P2|Overall Study|Lost to Follow-up|5
5399886|NCT02954354|18612392|P1|Overall Study|Lost to Follow-up|12
5399887|NCT02954354|18612390|P3|Overall Study|Withdrawal by Subject|11
5399888|NCT02954354|18612391|P2|Overall Study|Withdrawal by Subject|9
5399889|NCT02954354|18612392|P1|Overall Study|Withdrawal by Subject|17
5399890|NCT02954354|18612390|P3|Overall Study|Lack of Efficacy|0
5399891|NCT02954354|18612391|P2|Overall Study|Lack of Efficacy|2
5399892|NCT02954354|18612392|P1|Overall Study|Lack of Efficacy|0
5399893|NCT02954354|18612390|P3|Overall Study|Failure to Meet Eligibility Criteria|0
5399894|NCT02954354|18612391|P2|Overall Study|Failure to Meet Eligibility Criteria|0
5399895|NCT02954354|18612392|P1|Overall Study|Failure to Meet Eligibility Criteria|1
5399896|NCT02954354|18612390|P3|Overall Study|Adverse Event|4
5399897|NCT02954354|18612391|P2|Overall Study|Adverse Event|2
5399898|NCT02954354|18612392|P1|Overall Study|Adverse Event|2
5399899|NCT02954172|18612493|P2|Overall Study|non-measurable lesions at baseline|2
5399900|NCT02954172|18612494|P1|Overall Study|non-measurable lesions at baseline|1
5399901|NCT02954172|18612493|P2|Overall Study|allergic reaction|1
5399902|NCT02954172|18612494|P1|Overall Study|allergic reaction|2
5399903|NCT02954172|18612493|P2|Overall Study|Protocol Violation|0
5399904|NCT02954172|18612494|P1|Overall Study|Protocol Violation|3
5399905|NCT02954159|18612506|P2|Overall Study|Withdrawal by Subject|1
5399906|NCT02954159|18612507|P1|Overall Study|Withdrawal by Subject|0
5399907|NCT02954159|18612506|P2|Overall Study|Study ended prematurely due to low enrol|0
5399908|NCT02954159|18612507|P1|Overall Study|Study ended prematurely due to low enrol|1
5399909|NCT02953938|18612521|P2|Overall Study|Withdrawal by Subject|1
5399910|NCT02953938|18612522|P1|Overall Study|Withdrawal by Subject|1
5399911|NCT02953938|18612521|P2|Overall Study|Adverse Event|1
5399912|NCT02953938|18612522|P1|Overall Study|Adverse Event|0
5399913|NCT02953821|18612553|P2|Overall Study|Refused follow-up visit|1
5399914|NCT02953821|18612554|P1|Overall Study|Refused follow-up visit|2
5399915|NCT02953821|18612553|P2|Overall Study|No improvement|1
5399916|NCT02953821|18612554|P1|Overall Study|No improvement|0
5399917|NCT02953821|18612553|P2|Overall Study|Out of state for indeterminate time|1
5399918|NCT02953821|18612554|P1|Overall Study|Out of state for indeterminate time|0
5399919|NCT02953821|18612553|P2|Overall Study|Lack of Efficacy|0
5399920|NCT02953821|18612554|P1|Overall Study|Lack of Efficacy|1
5399921|NCT02953821|18612553|P2|Overall Study|Change of address|1
5399922|NCT02953821|18612554|P1|Overall Study|Change of address|0
5399923|NCT02953821|18612553|P2|Overall Study|Withdrawal by Subject|3
5399924|NCT02953821|18612554|P1|Overall Study|Withdrawal by Subject|3
5399925|NCT02953821|18612553|P2|Overall Study|Physician Decision|1
5399926|NCT02953821|18612554|P1|Overall Study|Physician Decision|1
5399927|NCT02953821|18612553|P2|Overall Study|Lost to Follow-up|0
5399928|NCT02953821|18612554|P1|Overall Study|Lost to Follow-up|2
5399929|NCT02953821|18612553|P2|Overall Study|Progressive Disease|1
5399930|NCT02953821|18612554|P1|Overall Study|Progressive Disease|5
5399931|NCT02953821|18612553|P2|Overall Study|Death|0
5399932|NCT02953821|18612554|P1|Overall Study|Death|1
5399933|NCT02953821|18612553|P2|Overall Study|Adverse Event|4
5399934|NCT02953821|18612554|P1|Overall Study|Adverse Event|0
5399935|NCT02953678|18612572|P1|Overall Study|Reason unspecified|2
5399936|NCT02953678|18612572|P1|Overall Study|Withdrawal by Subject|3
5399937|NCT02953678|18612572|P1|Overall Study|Relapse of Underlying Malignancy|2
5399938|NCT02953678|18612572|P1|Overall Study|Progressive Disease of GVHD|6
5399939|NCT02953678|18612572|P1|Overall Study|Physician Decision|20
5399940|NCT02953678|18612572|P1|Overall Study|Death|7
5399941|NCT02953678|18612572|P1|Overall Study|Adverse Event|20
5399942|NCT02953314|18612620|P2|Overall Study|Withdrawal of consent (not due to AE)|2
5399943|NCT02953314|18612621|P1|Overall Study|Withdrawal of consent (not due to AE)|0
5399944|NCT02953314|18612620|P2|Overall Study|Adverse Event|1
5399945|NCT02953314|18612621|P1|Overall Study|Adverse Event|0
5399946|NCT02952898|18612647|P3|Overall Study|Non-compliance with study drug|2
5399947|NCT02952898|18612648|P2|Overall Study|Non-compliance with study drug|1
5399948|NCT02952898|18612649|P1|Overall Study|Non-compliance with study drug|1
5399949|NCT02952898|18612647|P3|Overall Study|Lost to Follow-up|2
5399950|NCT02952898|18612648|P2|Overall Study|Lost to Follow-up|2
5399951|NCT02952898|18612649|P1|Overall Study|Lost to Follow-up|3
5399952|NCT02952898|18612647|P3|Overall Study|Adverse Event|3
5399953|NCT02952898|18612648|P2|Overall Study|Adverse Event|8
5399954|NCT02952898|18612649|P1|Overall Study|Adverse Event|8
5399955|NCT02952898|18612647|P3|Overall Study|Withdrawal by Subject|8
5399956|NCT02952898|18612648|P2|Overall Study|Withdrawal by Subject|8
5399957|NCT02952898|18612649|P1|Overall Study|Withdrawal by Subject|10
5399958|NCT02952820|18612773|P3|Active Treatment Period (6 Months)|Not treated|1
5399959|NCT02952820|18612774|P2|Active Treatment Period (6 Months)|Not treated|0
5399960|NCT02952820|18612775|P1|Active Treatment Period (6 Months)|Not treated|0
5399961|NCT02952820|18612773|P3|Active Treatment Period (6 Months)|Other than specified|2
5399962|NCT02952820|18612774|P2|Active Treatment Period (6 Months)|Other than specified|6
5399963|NCT02952820|18612775|P1|Active Treatment Period (6 Months)|Other than specified|0
5399964|NCT02952820|18612773|P3|Active Treatment Period (6 Months)|Withdrawal of consent|8
5399965|NCT02952820|18612774|P2|Active Treatment Period (6 Months)|Withdrawal of consent|6
5399966|NCT02952820|18612775|P1|Active Treatment Period (6 Months)|Withdrawal of consent|0
5399967|NCT02952820|18612773|P3|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
5399968|NCT02952820|18612774|P2|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
5399969|NCT02952820|18612775|P1|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
5399970|NCT02952820|18612773|P3|Active Treatment Period (6 Months)|Subject choice|7
5399971|NCT02952820|18612774|P2|Active Treatment Period (6 Months)|Subject choice|10
5399972|NCT02952820|18612775|P1|Active Treatment Period (6 Months)|Subject choice|0
5399973|NCT02952820|18612773|P3|Active Treatment Period (6 Months)|Lost to Follow-up|6
5399974|NCT02952820|18612774|P2|Active Treatment Period (6 Months)|Lost to Follow-up|4
5399975|NCT02952820|18612775|P1|Active Treatment Period (6 Months)|Lost to Follow-up|0
5399976|NCT02952820|18612773|P3|Active Treatment Period (6 Months)|Adverse Event|5
5399977|NCT02952820|18612774|P2|Active Treatment Period (6 Months)|Adverse Event|6
5399978|NCT02952820|18612775|P1|Active Treatment Period (6 Months)|Adverse Event|0
5399979|NCT02952820|18612773|P3|Placebo-Controlled Treatment (6 Months)|Not treated|4
5399980|NCT02952820|18612774|P2|Placebo-Controlled Treatment (6 Months)|Not treated|4
5399981|NCT02952820|18612775|P1|Placebo-Controlled Treatment (6 Months)|Not treated|4
5399982|NCT02952820|18612773|P3|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
5399983|NCT02952820|18612774|P2|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
5399984|NCT02952820|18612775|P1|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
5399985|NCT02952820|18612773|P3|Placebo-Controlled Treatment (6 Months)|Other than specified|13
5399986|NCT02952820|18612774|P2|Placebo-Controlled Treatment (6 Months)|Other than specified|14
5399987|NCT02952820|18612775|P1|Placebo-Controlled Treatment (6 Months)|Other than specified|0
5399988|NCT02952820|18612773|P3|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
5399989|NCT02952820|18612774|P2|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
5399990|NCT02952820|18612775|P1|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
5399991|NCT02952820|18612773|P3|Placebo-Controlled Treatment (6 Months)|Subject choice|17
5399992|NCT02952820|18612774|P2|Placebo-Controlled Treatment (6 Months)|Subject choice|12
5399993|NCT02952820|18612775|P1|Placebo-Controlled Treatment (6 Months)|Subject choice|15
5399994|NCT02952820|18612773|P3|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
5399995|NCT02952820|18612774|P2|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
5399996|NCT02952820|18612775|P1|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
5399997|NCT02952820|18612773|P3|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
5399998|NCT02952820|18612774|P2|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
5399999|NCT02952820|18612775|P1|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
5400000|NCT02952313|18612835|P1|Long-term Follow-up|Death|1
5400001|NCT02952313|18612835|P1|Long-term Follow-up|Physician Decision|1
5400002|NCT02952313|18612835|P1|Long-term Follow-up|Withdrawal by Subject|5
5400003|NCT02952313|18612835|P1|Long-term Follow-up|Lack of Efficacy|6
5400004|NCT02952313|18612835|P1|Long-term Follow-up|Did not reconsent for long-term FU|7
5400005|NCT02952313|18612835|P1|Long-term Follow-up|Lost to Follow-up|12
5400006|NCT02952313|18612835|P1|Primary Endpoint|Missed visit|1
5400007|NCT02952313|18612835|P1|Primary Endpoint|Lack of Efficacy|1
5400008|NCT02952313|18612835|P1|Primary Endpoint|Withdrawal by Subject|1
5400009|NCT02952313|18612835|P1|Primary Endpoint|Lost to Follow-up|4
5400010|NCT02952261|18612846|P2|Overall Study|Protocol Violation|0
5400011|NCT02952261|18612847|P1|Overall Study|Protocol Violation|1
5400012|NCT02952261|18612846|P2|Overall Study|Withdrawal by Subject|5
5400013|NCT02952261|18612847|P1|Overall Study|Withdrawal by Subject|4
5400014|NCT02951988|18612862|P4|Double-Blind Treatment Period|Miscellaneous Reasons|0
5400015|NCT02951988|18612863|P3|Double-Blind Treatment Period|Miscellaneous Reasons|1
5400016|NCT02951988|18612864|P2|Double-Blind Treatment Period|Miscellaneous Reasons|2
5400017|NCT02951988|18612865|P1|Double-Blind Treatment Period|Miscellaneous Reasons|0
5400018|NCT02951988|18612862|P4|Double-Blind Treatment Period|Adverse Event|6
5400019|NCT02951988|18612863|P3|Double-Blind Treatment Period|Adverse Event|3
5400020|NCT02951988|18612864|P2|Double-Blind Treatment Period|Adverse Event|8
5400021|NCT02951988|18612865|P1|Double-Blind Treatment Period|Adverse Event|0
5400022|NCT02951988|18612862|P4|Double-Blind Treatment Period|Withdrawal by Subject|28
5400023|NCT02951988|18612863|P3|Double-Blind Treatment Period|Withdrawal by Subject|22
5400024|NCT02951988|18612864|P2|Double-Blind Treatment Period|Withdrawal by Subject|23
5400025|NCT02951988|18612865|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5400026|NCT02951988|18612862|P4|Double-Blind Treatment Period|Lost to Follow-up|3
5400027|NCT02951988|18612863|P3|Double-Blind Treatment Period|Lost to Follow-up|12
5400028|NCT02951988|18612864|P2|Double-Blind Treatment Period|Lost to Follow-up|4
5400029|NCT02951988|18612865|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5400030|NCT02951988|18612862|P4|Double-Blind Treatment Period|Pregnancy|0
5400031|NCT02951988|18612863|P3|Double-Blind Treatment Period|Pregnancy|1
5400032|NCT02951988|18612864|P2|Double-Blind Treatment Period|Pregnancy|1
5400033|NCT02951988|18612865|P1|Double-Blind Treatment Period|Pregnancy|0
5400034|NCT02951988|18612862|P4|Double-Blind Treatment Period|Protocol Violation|8
5400035|NCT02951988|18612863|P3|Double-Blind Treatment Period|Protocol Violation|4
5400036|NCT02951988|18612864|P2|Double-Blind Treatment Period|Protocol Violation|4
5400037|NCT02951988|18612865|P1|Double-Blind Treatment Period|Protocol Violation|0
5400038|NCT02951988|18612862|P4|Double-Blind Treatment Period|Non-compliance with study drug|0
5400039|NCT02951988|18612863|P3|Double-Blind Treatment Period|Non-compliance with study drug|3
5400040|NCT02951988|18612864|P2|Double-Blind Treatment Period|Non-compliance with study drug|1
5400041|NCT02951988|18612865|P1|Double-Blind Treatment Period|Non-compliance with study drug|0
5400042|NCT02951988|18612862|P4|Double-Blind Treatment Period|Study terminated by sponsor|69
5400043|NCT02951988|18612863|P3|Double-Blind Treatment Period|Study terminated by sponsor|54
5400044|NCT02951988|18612864|P2|Double-Blind Treatment Period|Study terminated by sponsor|58
5400045|NCT02951988|18612865|P1|Double-Blind Treatment Period|Study terminated by sponsor|0
5400046|NCT02951988|18612862|P4|Double-Blind Treatment Period|Site terminated by sponsor|1
5400047|NCT02951988|18612863|P3|Double-Blind Treatment Period|Site terminated by sponsor|1
5400048|NCT02951988|18612864|P2|Double-Blind Treatment Period|Site terminated by sponsor|0
5400049|NCT02951988|18612865|P1|Double-Blind Treatment Period|Site terminated by sponsor|0
5400050|NCT02951988|18612862|P4|Open-Label Treatment Period|Adverse Event|0
5400051|NCT02951988|18612863|P3|Open-Label Treatment Period|Adverse Event|0
5400052|NCT02951988|18612864|P2|Open-Label Treatment Period|Adverse Event|0
5400053|NCT02951988|18612865|P1|Open-Label Treatment Period|Adverse Event|45
5400054|NCT02951988|18612862|P4|Open-Label Treatment Period|Lack of Efficacy|0
5400055|NCT02951988|18612863|P3|Open-Label Treatment Period|Lack of Efficacy|0
5400056|NCT02951988|18612864|P2|Open-Label Treatment Period|Lack of Efficacy|0
5400057|NCT02951988|18612865|P1|Open-Label Treatment Period|Lack of Efficacy|49
5400058|NCT02951988|18612862|P4|Open-Label Treatment Period|Withdrawal by Subject|0
5400059|NCT02951988|18612863|P3|Open-Label Treatment Period|Withdrawal by Subject|0
5400060|NCT02951988|18612864|P2|Open-Label Treatment Period|Withdrawal by Subject|0
5400061|NCT02951988|18612865|P1|Open-Label Treatment Period|Withdrawal by Subject|78
5400062|NCT02951988|18612862|P4|Open-Label Treatment Period|Lost to Follow-up|0
5400063|NCT02951988|18612863|P3|Open-Label Treatment Period|Lost to Follow-up|0
5400064|NCT02951988|18612864|P2|Open-Label Treatment Period|Lost to Follow-up|0
5400065|NCT02951988|18612865|P1|Open-Label Treatment Period|Lost to Follow-up|28
5400066|NCT02951988|18612862|P4|Open-Label Treatment Period|Pregnancy|0
5400067|NCT02951988|18612863|P3|Open-Label Treatment Period|Pregnancy|0
5400068|NCT02951988|18612864|P2|Open-Label Treatment Period|Pregnancy|0
5400069|NCT02951988|18612865|P1|Open-Label Treatment Period|Pregnancy|2
5400070|NCT02951988|18612862|P4|Open-Label Treatment Period|Protocol Violation|0
5400071|NCT02951988|18612863|P3|Open-Label Treatment Period|Protocol Violation|0
5400072|NCT02951988|18612864|P2|Open-Label Treatment Period|Protocol Violation|0
5400073|NCT02951988|18612865|P1|Open-Label Treatment Period|Protocol Violation|22
5400074|NCT02951988|18612862|P4|Open-Label Treatment Period|Non-compliance with study drug|0
5400075|NCT02951988|18612863|P3|Open-Label Treatment Period|Non-compliance with study drug|0
5400076|NCT02951988|18612864|P2|Open-Label Treatment Period|Non-compliance with study drug|0
5400077|NCT02951988|18612865|P1|Open-Label Treatment Period|Non-compliance with study drug|5
5400078|NCT02951988|18612862|P4|Open-Label Treatment Period|Non-compliance with background ADT|0
5400079|NCT02951988|18612863|P3|Open-Label Treatment Period|Non-compliance with background ADT|0
5400080|NCT02951988|18612864|P2|Open-Label Treatment Period|Non-compliance with background ADT|0
5400081|NCT02951988|18612865|P1|Open-Label Treatment Period|Non-compliance with background ADT|2
5400082|NCT02951988|18612862|P4|Open-Label Treatment Period|Study terminated by sponsor|0
5400083|NCT02951988|18612863|P3|Open-Label Treatment Period|Study terminated by sponsor|0
5400084|NCT02951988|18612864|P2|Open-Label Treatment Period|Study terminated by sponsor|0
5400085|NCT02951988|18612865|P1|Open-Label Treatment Period|Study terminated by sponsor|9
5400086|NCT02951988|18612862|P4|Open-Label Treatment Period|Miscellaneous Reasons|0
5400087|NCT02951988|18612863|P3|Open-Label Treatment Period|Miscellaneous Reasons|0
5400088|NCT02951988|18612864|P2|Open-Label Treatment Period|Miscellaneous Reasons|0
5400089|NCT02951988|18612865|P1|Open-Label Treatment Period|Miscellaneous Reasons|8
5400090|NCT02951819|18612898|P2|Overall Study|Ongoing|11
5400091|NCT02951819|18612899|P1|Overall Study|Ongoing|83
5400092|NCT02951819|18612898|P2|Overall Study|Other|0
5400093|NCT02951819|18612899|P1|Overall Study|Other|1
5400094|NCT02951819|18612898|P2|Overall Study|Progressive Disease|0
5400095|NCT02951819|18612899|P1|Overall Study|Progressive Disease|1
5400096|NCT02951819|18612898|P2|Overall Study|Withdrawal by Subject|0
5400097|NCT02951819|18612899|P1|Overall Study|Withdrawal by Subject|1
5400098|NCT02951819|18612898|P2|Overall Study|Death|3
5400099|NCT02951819|18612899|P1|Overall Study|Death|1
5400100|NCT02951780|18612930|P9|Period 2|Scheduling Conflicts|0
5400101|NCT02951780|18612931|P8|Period 2|Scheduling Conflicts|1
5400102|NCT02951780|18612932|P7|Period 2|Scheduling Conflicts|0
5400103|NCT02951780|18612933|P6|Period 2|Scheduling Conflicts|0
5400104|NCT02951780|18612934|P5|Period 2|Scheduling Conflicts|0
5400105|NCT02951780|18612935|P4|Period 2|Scheduling Conflicts|0
5400106|NCT02951780|18612936|P3|Period 2|Scheduling Conflicts|0
5400107|NCT02951780|18612937|P2|Period 2|Scheduling Conflicts|0
5400108|NCT02951780|18612938|P1|Period 2|Scheduling Conflicts|0
5400109|NCT02951780|18612930|P9|Period 1|Scheduling Conflicts|0
5400110|NCT02951780|18612931|P8|Period 1|Scheduling Conflicts|1
5400111|NCT02951780|18612932|P7|Period 1|Scheduling Conflicts|0
5400112|NCT02951780|18612933|P6|Period 1|Scheduling Conflicts|0
5400113|NCT02951780|18612934|P5|Period 1|Scheduling Conflicts|0
5400114|NCT02951780|18612935|P4|Period 1|Scheduling Conflicts|0
5400115|NCT02951780|18612936|P3|Period 1|Scheduling Conflicts|0
5400116|NCT02951780|18612937|P2|Period 1|Scheduling Conflicts|0
5400117|NCT02951780|18612938|P1|Period 1|Scheduling Conflicts|0
5400118|NCT02951780|18612930|P9|Period 1|Adverse Event|0
5400119|NCT02951780|18612931|P8|Period 1|Adverse Event|0
5400120|NCT02951780|18612932|P7|Period 1|Adverse Event|0
5400121|NCT02951780|18612933|P6|Period 1|Adverse Event|0
5400122|NCT02951780|18612934|P5|Period 1|Adverse Event|0
5400123|NCT02951780|18612935|P4|Period 1|Adverse Event|1
5400124|NCT02951780|18612936|P3|Period 1|Adverse Event|0
5400125|NCT02951780|18612937|P2|Period 1|Adverse Event|0
5400126|NCT02951780|18612938|P1|Period 1|Adverse Event|0
5400127|NCT02951767|18613003|P1|Overall Study|Lost to Follow-up|1
5400128|NCT02951767|18613003|P1|Overall Study|Death|59
5400129|NCT02951767|18613003|P1|Overall Study|Withdrawal by Subject|5
5400130|NCT02951767|18613003|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
5400131|NCT02951533|18613035|P3|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
5400132|NCT02951533|18613036|P2|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
5400133|NCT02951533|18613037|P1|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
5400134|NCT02951533|18613035|P3|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
5400135|NCT02951533|18613036|P2|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
5400136|NCT02951533|18613037|P1|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
5400137|NCT02951533|18613035|P3|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
5400138|NCT02951533|18613036|P2|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
5400139|NCT02951533|18613037|P1|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
5400140|NCT02951533|18613035|P3|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
5400141|NCT02951533|18613036|P2|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
5400142|NCT02951533|18613037|P1|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
5400143|NCT02951533|18613035|P3|Part IIb (Week 32 Through Week 56)|Adverse Event|0
5400144|NCT02951533|18613036|P2|Part IIb (Week 32 Through Week 56)|Adverse Event|2
5400145|NCT02951533|18613037|P1|Part IIb (Week 32 Through Week 56)|Adverse Event|0
5400146|NCT02951533|18613035|P3|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
5400147|NCT02951533|18613036|P2|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
5400148|NCT02951533|18613037|P1|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
5400149|NCT02951533|18613035|P3|Part IIa (Week 24 Through Week 32)|Adverse Event|0
5400150|NCT02951533|18613036|P2|Part IIa (Week 24 Through Week 32)|Adverse Event|1
5400151|NCT02951533|18613037|P1|Part IIa (Week 24 Through Week 32)|Adverse Event|0
5400152|NCT02951533|18613035|P3|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
5400153|NCT02951533|18613036|P2|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
5400154|NCT02951533|18613037|P1|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
5400155|NCT02951533|18613035|P3|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
5400156|NCT02951533|18613036|P2|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
5400157|NCT02951533|18613037|P1|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
5400158|NCT02951533|18613035|P3|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
5400159|NCT02951533|18613036|P2|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
5400160|NCT02951533|18613037|P1|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
5400161|NCT02951533|18613035|P3|Part I (Week 0 Through Week 24)|Adverse Event|0
5400162|NCT02951533|18613036|P2|Part I (Week 0 Through Week 24)|Adverse Event|16
5400163|NCT02951533|18613037|P1|Part I (Week 0 Through Week 24)|Adverse Event|0
5400164|NCT02951429|18613159|P2|Overall Study|Participant ongoing in the study|17
5400165|NCT02951429|18613160|P1|Overall Study|Participant ongoing in the study|23
5400166|NCT02951429|18613159|P2|Overall Study|Withdrawal by Subject|11
5400167|NCT02951429|18613160|P1|Overall Study|Withdrawal by Subject|7
5400168|NCT02951429|18613159|P2|Overall Study|Progressive Disease|1
5400169|NCT02951429|18613160|P1|Overall Study|Progressive Disease|1
5400170|NCT02951429|18613159|P2|Overall Study|Other|3
5400171|NCT02951429|18613160|P1|Overall Study|Other|1
5400172|NCT02951429|18613159|P2|Overall Study|Lung Transplantation|6
5400173|NCT02951429|18613160|P1|Overall Study|Lung Transplantation|9
5400174|NCT02951429|18613159|P2|Overall Study|Lost to Follow-up|1
5400175|NCT02951429|18613160|P1|Overall Study|Lost to Follow-up|0
5400176|NCT02951429|18613159|P2|Overall Study|Lack of Efficacy|1
5400177|NCT02951429|18613160|P1|Overall Study|Lack of Efficacy|0
5400178|NCT02951429|18613159|P2|Overall Study|Death|36
5400179|NCT02951429|18613160|P1|Overall Study|Death|28
5400180|NCT02951429|18613159|P2|Overall Study|Adverse Event|7
5400181|NCT02951429|18613160|P1|Overall Study|Adverse Event|3
5400182|NCT02951156|18613436|P3|Overall Study|Other|2
5400183|NCT02951156|18613437|P2|Overall Study|Other|1
5400184|NCT02951156|18613438|P1|Overall Study|Other|5
5400185|NCT02951156|18613436|P3|Overall Study|Study terminated by sponsor|1
5400186|NCT02951156|18613437|P2|Overall Study|Study terminated by sponsor|0
5400187|NCT02951156|18613438|P1|Overall Study|Study terminated by sponsor|0
5400188|NCT02951156|18613436|P3|Overall Study|Withdrawal by Subject|1
5400189|NCT02951156|18613437|P2|Overall Study|Withdrawal by Subject|0
5400190|NCT02951156|18613438|P1|Overall Study|Withdrawal by Subject|0
5400191|NCT02951156|18613436|P3|Overall Study|Progressive disease|1
5400192|NCT02951156|18613437|P2|Overall Study|Progressive disease|0
5400193|NCT02951156|18613438|P1|Overall Study|Progressive disease|1
5400194|NCT02951156|18613436|P3|Overall Study|Death|5
5400195|NCT02951156|18613437|P2|Overall Study|Death|8
5400196|NCT02951156|18613438|P1|Overall Study|Death|3
5400197|NCT02951052|18613498|P2|Overall Study|Ongoing|0
5400198|NCT02951052|18613499|P1|Overall Study|Ongoing|1
5400199|NCT02951052|18613498|P2|Overall Study|Lack of Efficacy|4
5400200|NCT02951052|18613499|P1|Overall Study|Lack of Efficacy|3
5400201|NCT02951052|18613498|P2|Overall Study|Protocol Violation|3
5400202|NCT02951052|18613499|P1|Overall Study|Protocol Violation|5
5400203|NCT02951052|18613498|P2|Overall Study|Protocol-specified withdrawal criterion|0
5400204|NCT02951052|18613499|P1|Overall Study|Protocol-specified withdrawal criterion|1
5400205|NCT02951052|18613498|P2|Overall Study|Lost to Follow-up|1
5400206|NCT02951052|18613499|P1|Overall Study|Lost to Follow-up|1
5400207|NCT02951052|18613498|P2|Overall Study|Physician Decision|0
5400208|NCT02951052|18613499|P1|Overall Study|Physician Decision|2
5400209|NCT02951052|18613498|P2|Overall Study|Withdrawal by Subject|5
5400210|NCT02951052|18613499|P1|Overall Study|Withdrawal by Subject|1
5400211|NCT02951052|18613498|P2|Overall Study|Adverse Event|5
5400212|NCT02951052|18613499|P1|Overall Study|Adverse Event|13
5400213|NCT02950831|18613667|P1|Overall Study|stimulation trail failure|5
5400214|NCT02950831|18613667|P1|Overall Study|Withdrawal by Subject|3
5400215|NCT02950831|18613667|P1|Overall Study|Lost to Follow-up|1
5400216|NCT02950545|18613709|P6|Session 3 (70 Minutes)|Withdrawal by Subject|1
5400217|NCT02950545|18613710|P5|Session 3 (70 Minutes)|Withdrawal by Subject|0
5400218|NCT02950545|18613711|P4|Session 3 (70 Minutes)|Withdrawal by Subject|0
5400219|NCT02950545|18613712|P3|Session 3 (70 Minutes)|Withdrawal by Subject|0
5400220|NCT02950545|18613713|P2|Session 3 (70 Minutes)|Withdrawal by Subject|0
5400221|NCT02950545|18613714|P1|Session 3 (70 Minutes)|Withdrawal by Subject|0
5400222|NCT02950545|18613709|P6|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5400223|NCT02950545|18613710|P5|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5400224|NCT02950545|18613711|P4|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5400225|NCT02950545|18613712|P3|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5400226|NCT02950545|18613713|P2|Washout 2 (5 Minutes)|Withdrawal by Subject|0
5400227|NCT02950545|18613714|P1|Washout 2 (5 Minutes)|Withdrawal by Subject|1
5400228|NCT02950545|18613709|P6|Session 2 (70 Minutes)|Withdrawal by Subject|0
5400229|NCT02950545|18613710|P5|Session 2 (70 Minutes)|Withdrawal by Subject|1
5400230|NCT02950545|18613711|P4|Session 2 (70 Minutes)|Withdrawal by Subject|0
5400231|NCT02950545|18613712|P3|Session 2 (70 Minutes)|Withdrawal by Subject|0
5400232|NCT02950545|18613713|P2|Session 2 (70 Minutes)|Withdrawal by Subject|0
5400233|NCT02950545|18613714|P1|Session 2 (70 Minutes)|Withdrawal by Subject|0
5400234|NCT02950545|18613709|P6|Washout 1 (5 Minutes)|Withdrawal by Subject|1
5400235|NCT02950545|18613710|P5|Washout 1 (5 Minutes)|Withdrawal by Subject|0
5400236|NCT02950545|18613711|P4|Washout 1 (5 Minutes)|Withdrawal by Subject|1
5400237|NCT02950545|18613712|P3|Washout 1 (5 Minutes)|Withdrawal by Subject|0
5400238|NCT02950545|18613713|P2|Washout 1 (5 Minutes)|Withdrawal by Subject|0
5400239|NCT02950545|18613714|P1|Washout 1 (5 Minutes)|Withdrawal by Subject|1
5400240|NCT02950545|18613709|P6|Session 1 (70 Minutes)|Withdrawal by Subject|1
5400241|NCT02950545|18613710|P5|Session 1 (70 Minutes)|Withdrawal by Subject|0
5400242|NCT02950545|18613711|P4|Session 1 (70 Minutes)|Withdrawal by Subject|0
5400243|NCT02950545|18613712|P3|Session 1 (70 Minutes)|Withdrawal by Subject|0
5400244|NCT02950545|18613713|P2|Session 1 (70 Minutes)|Withdrawal by Subject|0
5400245|NCT02950545|18613714|P1|Session 1 (70 Minutes)|Withdrawal by Subject|0
5400246|NCT02950480|18613723|P2|Overall Study|Withdrawal by Subject|0
5400247|NCT02950480|18613724|P1|Overall Study|Withdrawal by Subject|1
5400248|NCT02949947|18613757|P2|Overall Study|Insurance change|0
5400249|NCT02949947|18613758|P1|Overall Study|Insurance change|1
5400250|NCT02949947|18613757|P2|Overall Study|Non Compliance|1
5400251|NCT02949947|18613758|P1|Overall Study|Non Compliance|0
5400252|NCT02949908|18613791|P1|Overall Study|Study termination|2
5400253|NCT02949271|18613855|P2|Overall Study|Outside the window for cervical dilation|3
5400254|NCT02949271|18613856|P1|Overall Study|Outside the window for cervical dilation|2
5400255|NCT02949271|18613855|P2|Overall Study|Delivered prior to intervention|9
5400256|NCT02949271|18613856|P1|Overall Study|Delivered prior to intervention|7
5400257|NCT02949271|18613855|P2|Overall Study|Withdrawal by Subject|0
5400258|NCT02949271|18613856|P1|Overall Study|Withdrawal by Subject|1
5400259|NCT02949271|18613855|P2|Overall Study|Protocol Violation|3
5400260|NCT02949271|18613856|P1|Overall Study|Protocol Violation|6
5400261|NCT02949271|18613855|P2|Overall Study|Physician Decision|5
5400262|NCT02949271|18613856|P1|Overall Study|Physician Decision|5
5400263|NCT02949271|18613855|P2|Overall Study|Lost to Follow-up|6
5400264|NCT02949271|18613856|P1|Overall Study|Lost to Follow-up|3
5400265|NCT02949271|18613855|P2|Overall Study|Lack of Efficacy|4
5400266|NCT02949271|18613856|P1|Overall Study|Lack of Efficacy|5
5400267|NCT02949219|18613882|P1|Overall Study|Withdrawal by Subject|1
5400268|NCT02949128|18613896|P1|Extension Period|Withdrawal by Subject|1
5400269|NCT02949128|18613896|P1|Extension Period|Physician Decision|1
5400270|NCT02949128|18613896|P1|Initial Evaluation Period|Protocol Violation|1
5400271|NCT02949128|18613896|P1|Initial Evaluation Period|Physician Decision|1
5400272|NCT02949128|18613896|P1|Initial Evaluation Period|Death|2
5400273|NCT02949128|18613896|P1|Initial Evaluation Period|Adverse Event|3
5400274|NCT02949128|18613896|P1|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
5400275|NCT02949011|18613913|P3|Overall Study|Miscellaneous|6
5400276|NCT02949011|18613914|P2|Overall Study|Miscellaneous|4
5400277|NCT02949011|18613915|P1|Overall Study|Miscellaneous|2
5400278|NCT02949011|18613913|P3|Overall Study|Death|1
5400279|NCT02949011|18613914|P2|Overall Study|Death|0
5400280|NCT02949011|18613915|P1|Overall Study|Death|0
5400281|NCT02949011|18613913|P3|Overall Study|Lost to Follow-up|5
5400282|NCT02949011|18613914|P2|Overall Study|Lost to Follow-up|5
5400283|NCT02949011|18613915|P1|Overall Study|Lost to Follow-up|7
5400284|NCT02949011|18613913|P3|Overall Study|Withdrawal by Subject|21
5400285|NCT02949011|18613914|P2|Overall Study|Withdrawal by Subject|13
5400286|NCT02949011|18613915|P1|Overall Study|Withdrawal by Subject|13
5400287|NCT02949011|18613913|P3|Overall Study|Lack of Efficacy|0
5400288|NCT02949011|18613914|P2|Overall Study|Lack of Efficacy|2
5400289|NCT02949011|18613915|P1|Overall Study|Lack of Efficacy|0
5400290|NCT02949011|18613913|P3|Overall Study|Protocol Deviation|3
5400291|NCT02949011|18613914|P2|Overall Study|Protocol Deviation|3
5400292|NCT02949011|18613915|P1|Overall Study|Protocol Deviation|5
5400293|NCT02949011|18613913|P3|Overall Study|Failed Inclusion/Exclusion Criteria|3
5400294|NCT02949011|18613914|P2|Overall Study|Failed Inclusion/Exclusion Criteria|0
5400295|NCT02949011|18613915|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
5400296|NCT02949011|18613913|P3|Overall Study|Adverse Event|3
5400297|NCT02949011|18613914|P2|Overall Study|Adverse Event|7
5400298|NCT02949011|18613915|P1|Overall Study|Adverse Event|6
5400299|NCT02948634|18613985|P2|Overall Study|Lack of efficacy and study suspended|2
5400300|NCT02948634|18613986|P1|Overall Study|Lack of efficacy and study suspended|10
5400301|NCT02948582|18613996|P6|Washout Period 4|Adverse Event|0
5400302|NCT02948582|18613997|P5|Washout Period 4|Adverse Event|0
5400303|NCT02948582|18613998|P4|Washout Period 4|Adverse Event|0
5400304|NCT02948582|18613999|P3|Washout Period 4|Adverse Event|1
5400305|NCT02948582|18614000|P2|Washout Period 4|Adverse Event|0
5400306|NCT02948582|18614001|P1|Washout Period 4|Adverse Event|1
5400307|NCT02948582|18613996|P6|Washout Period 2|personal reasons|0
5400308|NCT02948582|18613997|P5|Washout Period 2|personal reasons|0
5400309|NCT02948582|18613998|P4|Washout Period 2|personal reasons|1
5400310|NCT02948582|18613999|P3|Washout Period 2|personal reasons|0
5400311|NCT02948582|18614000|P2|Washout Period 2|personal reasons|0
5400312|NCT02948582|18614001|P1|Washout Period 2|personal reasons|0
5400313|NCT02948582|18613996|P6|Washout Period 2|Adverse Event|0
5400314|NCT02948582|18613997|P5|Washout Period 2|Adverse Event|0
5400315|NCT02948582|18613998|P4|Washout Period 2|Adverse Event|0
5400316|NCT02948582|18613999|P3|Washout Period 2|Adverse Event|0
5400317|NCT02948582|18614000|P2|Washout Period 2|Adverse Event|1
5400318|NCT02948582|18614001|P1|Washout Period 2|Adverse Event|0
5400319|NCT02948582|18613996|P6|Washout Period 1|Protocol Violation|1
5400320|NCT02948582|18613997|P5|Washout Period 1|Protocol Violation|0
5400321|NCT02948582|18613998|P4|Washout Period 1|Protocol Violation|0
5400322|NCT02948582|18613999|P3|Washout Period 1|Protocol Violation|0
5400323|NCT02948582|18614000|P2|Washout Period 1|Protocol Violation|0
5400324|NCT02948582|18614001|P1|Washout Period 1|Protocol Violation|0
5400325|NCT02948582|18613996|P6|Washout Period 1|Adverse Event|0
5400326|NCT02948582|18613997|P5|Washout Period 1|Adverse Event|0
5400327|NCT02948582|18613998|P4|Washout Period 1|Adverse Event|0
5400328|NCT02948582|18613999|P3|Washout Period 1|Adverse Event|0
5400329|NCT02948582|18614000|P2|Washout Period 1|Adverse Event|2
5400330|NCT02948582|18614001|P1|Washout Period 1|Adverse Event|0
5400331|NCT02947100|18614123|P1|Overall Study|did not meet inclusion criteria|1
5400332|NCT02947100|18614123|P1|Overall Study|study terminated early|3
5400333|NCT02947022|18614131|P1|Overall Study|Study Stopped|1
5400334|NCT02946918|18614152|P2|Overall Study|Ran out of study medication|1
5400335|NCT02946918|18614153|P1|Overall Study|Ran out of study medication|0
5400336|NCT02946918|18614152|P2|Overall Study|Physician Decision|2
5400337|NCT02946918|18614153|P1|Overall Study|Physician Decision|0
5400338|NCT02946918|18614152|P2|Overall Study|Patient unblinded himself|0
5400339|NCT02946918|18614153|P1|Overall Study|Patient unblinded himself|1
5400340|NCT02946580|18614167|P2|Overall Study|Did not undergo posterior spinal fusion|1
5400341|NCT02946580|18614168|P1|Overall Study|Did not undergo posterior spinal fusion|0
5400342|NCT02946580|18614167|P2|Overall Study|Adverse Event|2
5400343|NCT02946580|18614168|P1|Overall Study|Adverse Event|0
5400344|NCT02946580|18614167|P2|Overall Study|Withdrawal by Subject|2
5400345|NCT02946580|18614168|P1|Overall Study|Withdrawal by Subject|1
5400346|NCT02946515|18614186|P2|Overall Study|Lost to Follow-up|1
5400347|NCT02946515|18614187|P1|Overall Study|Lost to Follow-up|2
5400348|NCT02946463|18614200|P2|Primary Evaluation Period|Withdrawal by Subject|1
5400349|NCT02946463|18614201|P1|Primary Evaluation Period|Withdrawal by Subject|0
5400350|NCT02946463|18614200|P2|Primary Evaluation Period|Physician Decision|1
5400351|NCT02946463|18614201|P1|Primary Evaluation Period|Physician Decision|0
5400352|NCT02946385|18614223|P6|Overall Study|Lost to Follow-up|1
5400353|NCT02946385|18614224|P5|Overall Study|Lost to Follow-up|2
5400354|NCT02946385|18614225|P4|Overall Study|Lost to Follow-up|0
5400355|NCT02946385|18614226|P3|Overall Study|Lost to Follow-up|3
5400356|NCT02946385|18614227|P2|Overall Study|Lost to Follow-up|0
5400357|NCT02946385|18614228|P1|Overall Study|Lost to Follow-up|0
5400358|NCT02945657|18614331|P1|Overall Study|Withdrawal by Parent/Guardian|3
5400359|NCT02945657|18614331|P1|Overall Study|Adverse Event|1
5400360|NCT02945410|18614354|P6|Washout 1 (14 Days)|Withdrawal by Subject|0
5400361|NCT02945410|18614355|P5|Washout 1 (14 Days)|Withdrawal by Subject|1
5400362|NCT02945410|18614356|P4|Washout 1 (14 Days)|Withdrawal by Subject|0
5400363|NCT02945410|18614357|P3|Washout 1 (14 Days)|Withdrawal by Subject|2
5400364|NCT02945410|18614358|P2|Washout 1 (14 Days)|Withdrawal by Subject|0
5400365|NCT02945410|18614359|P1|Washout 1 (14 Days)|Withdrawal by Subject|0
5400366|NCT02945410|18614354|P6|Intervention 1 (5 Days)|Adverse Event|1
5400367|NCT02945410|18614355|P5|Intervention 1 (5 Days)|Adverse Event|0
5400368|NCT02945410|18614356|P4|Intervention 1 (5 Days)|Adverse Event|0
5400369|NCT02945410|18614357|P3|Intervention 1 (5 Days)|Adverse Event|0
5400370|NCT02945410|18614358|P2|Intervention 1 (5 Days)|Adverse Event|0
5400371|NCT02945410|18614359|P1|Intervention 1 (5 Days)|Adverse Event|1
5400372|NCT02945410|18614354|P6|Intervention 1 (5 Days)|Withdrawal by Subject|0
5400373|NCT02945410|18614355|P5|Intervention 1 (5 Days)|Withdrawal by Subject|0
5400374|NCT02945410|18614356|P4|Intervention 1 (5 Days)|Withdrawal by Subject|0
5400375|NCT02945410|18614357|P3|Intervention 1 (5 Days)|Withdrawal by Subject|0
5400376|NCT02945410|18614358|P2|Intervention 1 (5 Days)|Withdrawal by Subject|3
5400377|NCT02945410|18614359|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
5400378|NCT02945254|18614390|P2|Overall Study|Withdrawal by Subject|0
5400379|NCT02945254|18614391|P1|Overall Study|Withdrawal by Subject|1
5400380|NCT02945254|18614390|P2|Overall Study|Lost to Follow-up|0
5400381|NCT02945254|18614391|P1|Overall Study|Lost to Follow-up|1
5400382|NCT02945046|18614407|P3|Overall Study|Other than specified|7
5400383|NCT02945046|18614408|P2|Overall Study|Other than specified|4
5400384|NCT02945046|18614409|P1|Overall Study|Other than specified|5
5400385|NCT02945046|18614407|P3|Overall Study|Lack of Efficacy|1
5400386|NCT02945046|18614408|P2|Overall Study|Lack of Efficacy|2
5400387|NCT02945046|18614409|P1|Overall Study|Lack of Efficacy|1
5400388|NCT02945046|18614407|P3|Overall Study|Lost to Follow-up|0
5400389|NCT02945046|18614408|P2|Overall Study|Lost to Follow-up|1
5400390|NCT02945046|18614409|P1|Overall Study|Lost to Follow-up|1
5400391|NCT02945046|18614407|P3|Overall Study|Protocol Violation|2
5400392|NCT02945046|18614408|P2|Overall Study|Protocol Violation|3
5400393|NCT02945046|18614409|P1|Overall Study|Protocol Violation|2
5400394|NCT02945046|18614407|P3|Overall Study|Withdrawal by Subject|3
5400395|NCT02945046|18614408|P2|Overall Study|Withdrawal by Subject|3
5400396|NCT02945046|18614409|P1|Overall Study|Withdrawal by Subject|3
5400397|NCT02945046|18614407|P3|Overall Study|Adverse Event|2
5400398|NCT02945046|18614408|P2|Overall Study|Adverse Event|0
5400399|NCT02945046|18614409|P1|Overall Study|Adverse Event|1
5400400|NCT02944968|18614462|P1|Overall Study|Subject didn't meet eligibility criteria|2
5400401|NCT02944968|18614462|P1|Overall Study|Subject excluded before study procedure|1
5400402|NCT02944656|18614469|P2|Overall Study|Lost to Follow-up|10
5400403|NCT02944656|18614470|P1|Overall Study|Lost to Follow-up|7
5400404|NCT02944656|18614469|P2|Overall Study|No longer eligible|0
5400405|NCT02944656|18614470|P1|Overall Study|No longer eligible|3
5400406|NCT02944513|18614506|P2|Overall Study|Withdrawal by Subject|1
5400407|NCT02944513|18614507|P1|Overall Study|Withdrawal by Subject|4
5400408|NCT02944448|18614532|P2|Overall Study|Abnormal laboratory values|0
5400409|NCT02944448|18614533|P1|Overall Study|Abnormal laboratory values|1
5400410|NCT02944448|18614532|P2|Overall Study|Noncompliant with dosing|0
5400411|NCT02944448|18614533|P1|Overall Study|Noncompliant with dosing|1
5400412|NCT02944448|18614532|P2|Overall Study|Sponsor did not supply drug in time|1
5400413|NCT02944448|18614533|P1|Overall Study|Sponsor did not supply drug in time|0
5400414|NCT02944448|18614532|P2|Overall Study|Withdrawal by Subject|4
5400415|NCT02944448|18614533|P1|Overall Study|Withdrawal by Subject|14
5400416|NCT02944448|18614532|P2|Overall Study|Protocol Violation|7
5400417|NCT02944448|18614533|P1|Overall Study|Protocol Violation|25
5400418|NCT02944448|18614532|P2|Overall Study|Lost to Follow-up|1
5400419|NCT02944448|18614533|P1|Overall Study|Lost to Follow-up|3
5400420|NCT02944448|18614532|P2|Overall Study|Lack of Efficacy|5
5400421|NCT02944448|18614533|P1|Overall Study|Lack of Efficacy|8
5400422|NCT02944448|18614532|P2|Overall Study|Adverse Event|6
5400423|NCT02944448|18614533|P1|Overall Study|Adverse Event|37
5400424|NCT02944383|18614560|P3|Overall Study|Withdrawal by Subject|0
5400425|NCT02944383|18614561|P2|Overall Study|Withdrawal by Subject|0
5400426|NCT02944383|18614562|P1|Overall Study|Withdrawal by Subject|1
5400427|NCT02944383|18614560|P3|Overall Study|Lost to Follow-up|1
5400428|NCT02944383|18614561|P2|Overall Study|Lost to Follow-up|0
5400429|NCT02944383|18614562|P1|Overall Study|Lost to Follow-up|0
5400430|NCT02943668|18614723|P1|Overall Study|Disease Progression|1
5400431|NCT02943577|18614734|P2|Overall Study|Pregnancy|0
5400432|NCT02943577|18614735|P1|Overall Study|Pregnancy|1
5400433|NCT02943577|18614734|P2|Overall Study|Withdrawal by Subject|1
5400434|NCT02943577|18614735|P1|Overall Study|Withdrawal by Subject|1
5400435|NCT02943577|18614734|P2|Overall Study|Lost to Follow-up|1
5400436|NCT02943577|18614735|P1|Overall Study|Lost to Follow-up|0
5400437|NCT02943577|18614734|P2|Overall Study|Adverse Event|2
5400438|NCT02943577|18614735|P1|Overall Study|Adverse Event|3
5400439|NCT02943577|18614734|P2|Overall Study|Protocol Violation|1
5400440|NCT02943577|18614735|P1|Overall Study|Protocol Violation|0
5400441|NCT02943564|18614750|P3|Overall Study|Lack of Efficacy|0
5400442|NCT02943564|18614751|P2|Overall Study|Lack of Efficacy|1
5400443|NCT02943564|18614752|P1|Overall Study|Lack of Efficacy|0
5400444|NCT02943564|18614750|P3|Overall Study|Adverse Event|1
5400445|NCT02943564|18614751|P2|Overall Study|Adverse Event|2
5400446|NCT02943564|18614752|P1|Overall Study|Adverse Event|1
5400447|NCT02943564|18614750|P3|Overall Study|Withdrawal by Subject|2
5400448|NCT02943564|18614751|P2|Overall Study|Withdrawal by Subject|5
5400449|NCT02943564|18614752|P1|Overall Study|Withdrawal by Subject|6
5400450|NCT02943564|18614750|P3|Overall Study|Lost to Follow-up|0
5400451|NCT02943564|18614751|P2|Overall Study|Lost to Follow-up|0
5400452|NCT02943564|18614752|P1|Overall Study|Lost to Follow-up|1
5400453|NCT02943564|18614750|P3|Overall Study|Protocol Violation|2
5400454|NCT02943564|18614751|P2|Overall Study|Protocol Violation|2
5400455|NCT02943564|18614752|P1|Overall Study|Protocol Violation|2
5400456|NCT02943564|18614750|P3|Overall Study|Pregnancy|1
5400457|NCT02943564|18614751|P2|Overall Study|Pregnancy|1
5400458|NCT02943564|18614752|P1|Overall Study|Pregnancy|0
5400459|NCT02943564|18614750|P3|Overall Study|Non-compliance with study drug|0
5400460|NCT02943564|18614751|P2|Overall Study|Non-compliance with study drug|1
5400461|NCT02943564|18614752|P1|Overall Study|Non-compliance with study drug|0
5400462|NCT02943564|18614750|P3|Overall Study|Site terminated by sponsor|0
5400463|NCT02943564|18614751|P2|Overall Study|Site terminated by sponsor|1
5400464|NCT02943564|18614752|P1|Overall Study|Site terminated by sponsor|0
5400465|NCT02943564|18614750|P3|Overall Study|Miscellaneous Reasons|3
5400466|NCT02943564|18614751|P2|Overall Study|Miscellaneous Reasons|0
5400467|NCT02943564|18614752|P1|Overall Study|Miscellaneous Reasons|0
5400468|NCT02943473|18614772|P1|Overall Study|Physician Decision|4
5400469|NCT02943473|18614772|P1|Overall Study|screen failure|1
5400470|NCT02943473|18614772|P1|Overall Study|enrolled but not dosed|1
5400471|NCT02943460|18614779|P3|Open Label Extension (OLE)|Still in Open Label Extension Phase|8
5400472|NCT02943460|18614780|P2|Open Label Extension (OLE)|Still in Open Label Extension Phase|14
5400473|NCT02943460|18614781|P1|Open Label Extension (OLE)|Still in Open Label Extension Phase|18
5400474|NCT02943460|18614779|P3|Open Label Extension (OLE)|Investigator's Discretion|0
5400475|NCT02943460|18614780|P2|Open Label Extension (OLE)|Investigator's Discretion|1
5400476|NCT02943460|18614781|P1|Open Label Extension (OLE)|Investigator's Discretion|0
5400477|NCT02943460|18614779|P3|Open Label Extension (OLE)|Withdrew Consent|0
5400478|NCT02943460|18614780|P2|Open Label Extension (OLE)|Withdrew Consent|1
5400479|NCT02943460|18614781|P1|Open Label Extension (OLE)|Withdrew Consent|1
5400480|NCT02943460|18614779|P3|Open Label Extension (OLE)|Adverse Event|1
5400481|NCT02943460|18614780|P2|Open Label Extension (OLE)|Adverse Event|2
5400482|NCT02943460|18614781|P1|Open Label Extension (OLE)|Adverse Event|0
5400483|NCT02943460|18614779|P3|Blinded Study|Withdrew Consent|0
5400484|NCT02943460|18614780|P2|Blinded Study|Withdrew Consent|1
5400485|NCT02943460|18614781|P1|Blinded Study|Withdrew Consent|0
5400486|NCT02943460|18614779|P3|Blinded Study|Adverse Event|0
5400487|NCT02943460|18614780|P2|Blinded Study|Adverse Event|0
5400488|NCT02943460|18614781|P1|Blinded Study|Adverse Event|3
5400489|NCT02943447|18614799|P3|Open-Label Extension Phase|Lost to Follow-up|0
5400490|NCT02943447|18614800|P2|Open-Label Extension Phase|Lost to Follow-up|1
5400491|NCT02943447|18614801|P1|Open-Label Extension Phase|Lost to Follow-up|0
5400492|NCT02943447|18614799|P3|Open-Label Extension Phase|Withdrew consent|1
5400493|NCT02943447|18614800|P2|Open-Label Extension Phase|Withdrew consent|1
5400494|NCT02943447|18614801|P1|Open-Label Extension Phase|Withdrew consent|1
5400495|NCT02943447|18614799|P3|Open-Label Extension Phase|Lack of Efficacy|0
5400496|NCT02943447|18614800|P2|Open-Label Extension Phase|Lack of Efficacy|4
5400497|NCT02943447|18614801|P1|Open-Label Extension Phase|Lack of Efficacy|3
5400498|NCT02943447|18614799|P3|Open-Label Extension Phase|Adverse Event|3
5400499|NCT02943447|18614800|P2|Open-Label Extension Phase|Adverse Event|7
5400500|NCT02943447|18614801|P1|Open-Label Extension Phase|Adverse Event|4
5400501|NCT02943447|18614799|P3|Open-Label Extension Phase|Study terminated by sponsor|6
5400502|NCT02943447|18614800|P2|Open-Label Extension Phase|Study terminated by sponsor|12
5400503|NCT02943447|18614801|P1|Open-Label Extension Phase|Study terminated by sponsor|10
5400504|NCT02943447|18614799|P3|Blinded Study Phase|Investigator's discretion|0
5400505|NCT02943447|18614800|P2|Blinded Study Phase|Investigator's discretion|0
5400506|NCT02943447|18614801|P1|Blinded Study Phase|Investigator's discretion|1
5400507|NCT02943447|18614799|P3|Blinded Study Phase|Adverse Event|0
5400508|NCT02943447|18614800|P2|Blinded Study Phase|Adverse Event|0
5400509|NCT02943447|18614801|P1|Blinded Study Phase|Adverse Event|3
5400510|NCT02943447|18614799|P3|Blinded Study Phase|Withdrew Consent|1
5400511|NCT02943447|18614800|P2|Blinded Study Phase|Withdrew Consent|2
5400512|NCT02943447|18614801|P1|Blinded Study Phase|Withdrew Consent|1
5400513|NCT02943096|18614870|P2|Overall Study|Lack of Efficacy|1
5400514|NCT02943096|18614871|P1|Overall Study|Lack of Efficacy|0
5400515|NCT02942771|18614890|P5|Overall Study|Withdrawal by Subject|2
5400516|NCT02942771|18614891|P4|Overall Study|Withdrawal by Subject|0
5400517|NCT02942771|18614892|P3|Overall Study|Withdrawal by Subject|0
5400518|NCT02942771|18614893|P2|Overall Study|Withdrawal by Subject|0
5400519|NCT02942771|18614894|P1|Overall Study|Withdrawal by Subject|1
5400520|NCT02942771|18614890|P5|Overall Study|Lost to Follow-up|0
5400521|NCT02942771|18614891|P4|Overall Study|Lost to Follow-up|0
5400522|NCT02942771|18614892|P3|Overall Study|Lost to Follow-up|0
5400523|NCT02942771|18614893|P2|Overall Study|Lost to Follow-up|0
5400524|NCT02942771|18614894|P1|Overall Study|Lost to Follow-up|1
5400525|NCT02942771|18614890|P5|Overall Study|Adverse Event|2
5400526|NCT02942771|18614891|P4|Overall Study|Adverse Event|0
5400527|NCT02942771|18614892|P3|Overall Study|Adverse Event|0
5400528|NCT02942771|18614893|P2|Overall Study|Adverse Event|0
5400529|NCT02942771|18614894|P1|Overall Study|Adverse Event|1
5400530|NCT02942576|18614947|P2|Overall Study|Other|8
5400531|NCT02942576|18614948|P1|Overall Study|Other|10
5400532|NCT02942576|18614947|P2|Overall Study|Physician Decision|4
5400533|NCT02942576|18614948|P1|Overall Study|Physician Decision|1
5400534|NCT02942576|18614947|P2|Overall Study|Withdrawal by Subject|5
5400535|NCT02942576|18614948|P1|Overall Study|Withdrawal by Subject|7
5400536|NCT02942576|18614947|P2|Overall Study|Adverse Event|6
5400537|NCT02942576|18614948|P1|Overall Study|Adverse Event|28
5400538|NCT02942485|18614962|P2|Overall Study|Lost to Follow-up|0
5400539|NCT02942485|18614963|P1|Overall Study|Lost to Follow-up|1
5400540|NCT02942407|18614975|P2|Overall Study|Death|13
5400541|NCT02942407|18614976|P1|Overall Study|Death|16
5400542|NCT02942407|18614975|P2|Overall Study|Withdrawal by Subject|9
5400543|NCT02942407|18614976|P1|Overall Study|Withdrawal by Subject|7
5400544|NCT02942407|18614975|P2|Overall Study|Lost to Follow-up|2
5400545|NCT02942407|18614976|P1|Overall Study|Lost to Follow-up|3
5400546|NCT02942017|18615038|P2|Overall Study|Randomized but not dosed|3
5400547|NCT02942017|18615039|P1|Overall Study|Randomized but not dosed|1
5400548|NCT02942017|18615038|P2|Overall Study|Lost to Follow-up|1
5400549|NCT02942017|18615039|P1|Overall Study|Lost to Follow-up|1
5400550|NCT02942017|18615038|P2|Overall Study|Withdrawal by Subject|1
5400551|NCT02942017|18615039|P1|Overall Study|Withdrawal by Subject|0
5400552|NCT02942017|18615038|P2|Overall Study|Adverse Event|1
5400553|NCT02942017|18615039|P1|Overall Study|Adverse Event|0
5400554|NCT02942004|18615070|P3|Overall Study|Randomized but not dosed|4
5400555|NCT02942004|18615071|P2|Overall Study|Randomized but not dosed|9
5400556|NCT02942004|18615072|P1|Overall Study|Randomized but not dosed|3
5400557|NCT02942004|18615070|P3|Overall Study|Lost to Follow-up|2
5400558|NCT02942004|18615071|P2|Overall Study|Lost to Follow-up|1
5400559|NCT02942004|18615072|P1|Overall Study|Lost to Follow-up|1
5400560|NCT02942004|18615070|P3|Overall Study|Withdrawal by Subject|3
5400561|NCT02942004|18615071|P2|Overall Study|Withdrawal by Subject|2
5400562|NCT02942004|18615072|P1|Overall Study|Withdrawal by Subject|0
5400563|NCT02940886|18615192|P2|Overall Study|Enrolment error|1
5400564|NCT02940886|18615193|P1|Overall Study|Enrolment error|0
5400565|NCT02940886|18615192|P2|Overall Study|No treatment|2
5400566|NCT02940886|18615193|P1|Overall Study|No treatment|7
5400567|NCT02940886|18615192|P2|Overall Study|Sponsor decision|1
5400568|NCT02940886|18615193|P1|Overall Study|Sponsor decision|0
5400569|NCT02940886|18615192|P2|Overall Study|Physician Decision|4
5400570|NCT02940886|18615193|P1|Overall Study|Physician Decision|9
5400571|NCT02940886|18615192|P2|Overall Study|Lost to Follow-up|21
5400572|NCT02940886|18615193|P1|Overall Study|Lost to Follow-up|49
5400573|NCT02940886|18615192|P2|Overall Study|Lack of Efficacy|0
5400574|NCT02940886|18615193|P1|Overall Study|Lack of Efficacy|1
5400575|NCT02940886|18615192|P2|Overall Study|Death|0
5400576|NCT02940886|18615193|P1|Overall Study|Death|1
5400577|NCT02940886|18615192|P2|Overall Study|Withdrawal by Subject|20
5400578|NCT02940886|18615193|P1|Overall Study|Withdrawal by Subject|28
5400579|NCT02940886|18615192|P2|Overall Study|Protocol Violation|2
5400580|NCT02940886|18615193|P1|Overall Study|Protocol Violation|0
5400581|NCT02940886|18615192|P2|Overall Study|Adverse Event|3
5400582|NCT02940886|18615193|P1|Overall Study|Adverse Event|7
5400583|NCT02940860|18615239|P2|Overall Study|Not treated|2
5400584|NCT02940860|18615240|P1|Overall Study|Not treated|2
5400585|NCT02940860|18615239|P2|Overall Study|Moved, poor venous access, transport|4
5400586|NCT02940860|18615240|P1|Overall Study|Moved, poor venous access, transport|6
5400587|NCT02940860|18615239|P2|Overall Study|Death|2
5400588|NCT02940860|18615240|P1|Overall Study|Death|3
5400589|NCT02940860|18615239|P2|Overall Study|Protocol Violation|2
5400590|NCT02940860|18615240|P1|Overall Study|Protocol Violation|0
5400591|NCT02940860|18615239|P2|Overall Study|Sponsor Decision|1
5400592|NCT02940860|18615240|P1|Overall Study|Sponsor Decision|0
5400593|NCT02940860|18615239|P2|Overall Study|Physician Decision|3
5400594|NCT02940860|18615240|P1|Overall Study|Physician Decision|5
5400595|NCT02940860|18615239|P2|Overall Study|Lost to Follow-up|7
5400596|NCT02940860|18615240|P1|Overall Study|Lost to Follow-up|13
5400597|NCT02940860|18615239|P2|Overall Study|Withdrawal by Subject|9
5400598|NCT02940860|18615240|P1|Overall Study|Withdrawal by Subject|19
5400599|NCT02940860|18615239|P2|Overall Study|Serious AE|3
5400600|NCT02940860|18615240|P1|Overall Study|Serious AE|7
5400601|NCT02940860|18615239|P2|Overall Study|Non-serious AE|2
5400602|NCT02940860|18615240|P1|Overall Study|Non-serious AE|1
5400603|NCT02940691|18615284|P1|Overall Study|Incarceration|1
5400604|NCT02940691|18615284|P1|Overall Study|Lost to Follow-up|5
5400605|NCT02940626|18615293|P2|Overall Study|Prohibited Concomitant Medication|1
5400606|NCT02940626|18615294|P1|Overall Study|Prohibited Concomitant Medication|0
5400607|NCT02940626|18615293|P2|Overall Study|Transfer to Hospice Care|0
5400608|NCT02940626|18615294|P1|Overall Study|Transfer to Hospice Care|1
5400609|NCT02940626|18615293|P2|Overall Study|Withdrawal by Subject|0
5400610|NCT02940626|18615294|P1|Overall Study|Withdrawal by Subject|1
5400611|NCT02940626|18615293|P2|Overall Study|Lost to Follow-up|2
5400612|NCT02940626|18615294|P1|Overall Study|Lost to Follow-up|5
5400613|NCT02940626|18615293|P2|Overall Study|Death|32
5400614|NCT02940626|18615294|P1|Overall Study|Death|40
5400615|NCT02940574|18615316|P2|1-year Follow-up|Lost to Follow-up|4
5400616|NCT02940574|18615317|P1|1-year Follow-up|Lost to Follow-up|3
5400617|NCT02940574|18615316|P2|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
5400618|NCT02940574|18615317|P1|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
5400619|NCT02940522|18615355|P2|Overall Study|Withdrawal by Subject|0
5400620|NCT02940522|18615356|P1|Overall Study|Withdrawal by Subject|1
5400621|NCT02940522|18615355|P2|Overall Study|Lost to Follow-up|2
5400622|NCT02940522|18615356|P1|Overall Study|Lost to Follow-up|1
5400623|NCT02939950|18615447|P2|Overall Study|Ineligible at Baseline|8
5400624|NCT02939950|18615448|P1|Overall Study|Ineligible at Baseline|2
5400625|NCT02939950|18615447|P2|Overall Study|Randomized, not dispensed|0
5400626|NCT02939950|18615448|P1|Overall Study|Randomized, not dispensed|1
5400627|NCT02939950|18615447|P2|Overall Study|Adverse Event|3
5400628|NCT02939950|18615448|P1|Overall Study|Adverse Event|7
5400629|NCT02939950|18615447|P2|Overall Study|Withdrawal by Subject|28
5400630|NCT02939950|18615448|P1|Overall Study|Withdrawal by Subject|12
5400631|NCT02939950|18615447|P2|Overall Study|Pregnancy|7
5400632|NCT02939950|18615448|P1|Overall Study|Pregnancy|6
5400633|NCT02939950|18615447|P2|Overall Study|Physician Decision|0
5400634|NCT02939950|18615448|P1|Overall Study|Physician Decision|2
5400635|NCT02939950|18615447|P2|Overall Study|Protocol Violation|3
5400636|NCT02939950|18615448|P1|Overall Study|Protocol Violation|6
5400637|NCT02939950|18615447|P2|Overall Study|Unacceptable lens movement|0
5400638|NCT02939950|18615448|P1|Overall Study|Unacceptable lens movement|2
5400639|NCT02939950|18615447|P2|Overall Study|Study related symptoms|8
5400640|NCT02939950|18615448|P1|Overall Study|Study related symptoms|8
5400641|NCT02939950|18615447|P2|Overall Study|Participant Relocated|3
5400642|NCT02939950|18615448|P1|Overall Study|Participant Relocated|5
5400643|NCT02939950|18615447|P2|Overall Study|Military orders|0
5400644|NCT02939950|18615448|P1|Overall Study|Military orders|1
5400645|NCT02939950|18615447|P2|Overall Study|Unacceptable distance lens visual acuity|1
5400646|NCT02939950|18615448|P1|Overall Study|Unacceptable distance lens visual acuity|1
5400647|NCT02939950|18615447|P2|Overall Study|Lack of motivation|2
5400648|NCT02939950|18615448|P1|Overall Study|Lack of motivation|0
5400649|NCT02939950|18615447|P2|Overall Study|Chalazion upper lid|1
5400650|NCT02939950|18615448|P1|Overall Study|Chalazion upper lid|0
5400651|NCT02939950|18615447|P2|Overall Study|Positive slit lamp findings|1
5400652|NCT02939950|18615448|P1|Overall Study|Positive slit lamp findings|0
5400653|NCT02939950|18615447|P2|Overall Study|Lost to Follow-up|16
5400654|NCT02939950|18615448|P1|Overall Study|Lost to Follow-up|13
5400655|NCT02939937|18615458|P2|Overall Study|Lost to Follow-up|3
5400656|NCT02939937|18615459|P1|Overall Study|Lost to Follow-up|1
5400657|NCT02939937|18615458|P2|Overall Study|Adverse Event|0
5400658|NCT02939937|18615459|P1|Overall Study|Adverse Event|5
5400659|NCT02939716|18615473|P6|Overall Study|scanner failure|1
5400660|NCT02939716|18615474|P5|Overall Study|scanner failure|1
5400661|NCT02939716|18615475|P4|Overall Study|scanner failure|1
5400662|NCT02939716|18615476|P3|Overall Study|scanner failure|0
5400663|NCT02939716|18615477|P2|Overall Study|scanner failure|0
5400664|NCT02939716|18615478|P1|Overall Study|scanner failure|0
5400665|NCT02939599|18615503|P2|Overall Study|Study Terminated By Sponsor|2
5400666|NCT02939599|18615504|P1|Overall Study|Study Terminated By Sponsor|2
5400667|NCT02939599|18615503|P2|Overall Study|Adverse Event|0
5400668|NCT02939599|18615504|P1|Overall Study|Adverse Event|1
5400669|NCT02939560|18615518|P1|Overall Study|Protocol Violation|1
5400670|NCT02939560|18615518|P1|Overall Study|Withdrawal by Subject|2
5400671|NCT02939131|18615576|P2|Overall Study|not willing to adhere to protocol|0
5400672|NCT02939131|18615577|P1|Overall Study|not willing to adhere to protocol|2
5400673|NCT02939131|18615576|P2|Overall Study|Other|1
5400674|NCT02939131|18615577|P1|Overall Study|Other|0
5400675|NCT02939131|18615576|P2|Overall Study|severe debilitation|0
5400676|NCT02939131|18615577|P1|Overall Study|severe debilitation|1
5400677|NCT02939131|18615576|P2|Overall Study|Lost to Follow-up|4
5400678|NCT02939131|18615577|P1|Overall Study|Lost to Follow-up|2
5400679|NCT02939131|18615576|P2|Overall Study|Unable to get to clinic|4
5400680|NCT02939131|18615577|P1|Overall Study|Unable to get to clinic|6
5400681|NCT02939079|18615595|P2|Overall Study|relapse during the study|1
5400682|NCT02939079|18615596|P1|Overall Study|relapse during the study|1
5400683|NCT02939079|18615595|P2|Overall Study|Withdrawal by Subject|1
5400684|NCT02939079|18615596|P1|Overall Study|Withdrawal by Subject|0
5400685|NCT02939079|18615595|P2|Overall Study|Protocol Violation|0
5400686|NCT02939079|18615596|P1|Overall Study|Protocol Violation|1
5400687|NCT02939079|18615595|P2|Overall Study|Lost to Follow-up|2
5400688|NCT02939079|18615596|P1|Overall Study|Lost to Follow-up|0
5400689|NCT02939079|18615595|P2|Overall Study|Adverse Event|1
5400690|NCT02939079|18615596|P1|Overall Study|Adverse Event|2
5400691|NCT02939014|18615626|P2|Overall Study|In Overall Survival Follow-up|4
5400692|NCT02939014|18615627|P1|Overall Study|In Overall Survival Follow-up|22
5400693|NCT02939014|18615626|P2|Overall Study|In Progression-Free Survival Follow-up|2
5400694|NCT02939014|18615627|P1|Overall Study|In Progression-Free Survival Follow-up|5
5400695|NCT02939014|18615626|P2|Overall Study|Death|3
5400696|NCT02939014|18615627|P1|Overall Study|Death|3
5400697|NCT02938585|18615671|P4|Overall Study|Withdrawal by Subject|5
5400698|NCT02938585|18615672|P3|Overall Study|Withdrawal by Subject|0
5400699|NCT02938585|18615673|P2|Overall Study|Withdrawal by Subject|0
5400700|NCT02938585|18615674|P1|Overall Study|Withdrawal by Subject|0
5400701|NCT02938585|18615671|P4|Overall Study|Withdrawal by parent or guardian|0
5400702|NCT02938585|18615672|P3|Overall Study|Withdrawal by parent or guardian|0
5400703|NCT02938585|18615673|P2|Overall Study|Withdrawal by parent or guardian|1
5400704|NCT02938585|18615674|P1|Overall Study|Withdrawal by parent or guardian|0
5400705|NCT02938520|18615838|P2|Overall Study|Adverse Event|4
5400706|NCT02938520|18615839|P1|Overall Study|Adverse Event|9
5400707|NCT02938520|18615838|P2|Overall Study|Lack of Efficacy|3
5400708|NCT02938520|18615839|P1|Overall Study|Lack of Efficacy|5
5400709|NCT02938520|18615838|P2|Overall Study|Protocol Violation|1
5400710|NCT02938520|18615839|P1|Overall Study|Protocol Violation|0
5400711|NCT02938520|18615838|P2|Overall Study|Withdrawal by Subject|7
5400712|NCT02938520|18615839|P1|Overall Study|Withdrawal by Subject|7
5400713|NCT02938520|18615838|P2|Overall Study|Lost to Follow-up|2
5400714|NCT02938520|18615839|P1|Overall Study|Lost to Follow-up|2
5400715|NCT02938520|18615838|P2|Overall Study|Physician Decision|5
5400716|NCT02938520|18615839|P1|Overall Study|Physician Decision|2
5400717|NCT02938520|18615838|P2|Overall Study|On-going at the time of analysis|261
5400718|NCT02938520|18615839|P1|Overall Study|On-going at the time of analysis|258
5400719|NCT02937870|18616061|P1|Overall Study|Protocol Deviation|2
5400720|NCT02937870|18616061|P1|Overall Study|Adverse Event|1
5400721|NCT02937740|18616092|P2|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
5400722|NCT02937740|18616093|P1|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
5400723|NCT02937740|18616092|P2|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
5400724|NCT02937740|18616093|P1|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
5400725|NCT02937740|18616092|P2|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
5400726|NCT02937740|18616093|P1|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
5400727|NCT02937740|18616092|P2|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
5400728|NCT02937740|18616093|P1|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
5400729|NCT02937740|18616092|P2|BID for 90 Days, 22 mg/Day|Adverse Event|10
5400730|NCT02937740|18616093|P1|BID for 90 Days, 22 mg/Day|Adverse Event|0
5400731|NCT02937740|18616092|P2|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
5400732|NCT02937740|18616093|P1|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
5400733|NCT02937701|18616109|P5|Week 22 to Week 50|Other|1
5400734|NCT02937701|18616110|P4|Week 22 to Week 50|Other|0
5400735|NCT02937701|18616111|P3|Week 22 to Week 50|Other|0
5400736|NCT02937701|18616112|P2|Week 22 to Week 50|Other|0
5400737|NCT02937701|18616113|P1|Week 22 to Week 50|Other|0
5400738|NCT02937701|18616109|P5|Week 22 to Week 50|Physician Decision|1
5400739|NCT02937701|18616110|P4|Week 22 to Week 50|Physician Decision|0
5400740|NCT02937701|18616111|P3|Week 22 to Week 50|Physician Decision|2
5400741|NCT02937701|18616112|P2|Week 22 to Week 50|Physician Decision|0
5400742|NCT02937701|18616113|P1|Week 22 to Week 50|Physician Decision|0
5400743|NCT02937701|18616109|P5|Week 22 to Week 50|Lost to Follow-up|1
5400744|NCT02937701|18616110|P4|Week 22 to Week 50|Lost to Follow-up|0
5400745|NCT02937701|18616111|P3|Week 22 to Week 50|Lost to Follow-up|2
5400746|NCT02937701|18616112|P2|Week 22 to Week 50|Lost to Follow-up|0
5400747|NCT02937701|18616113|P1|Week 22 to Week 50|Lost to Follow-up|0
5400748|NCT02937701|18616109|P5|Week 22 to Week 50|Withdrawal by Subject|1
5400749|NCT02937701|18616110|P4|Week 22 to Week 50|Withdrawal by Subject|2
5400750|NCT02937701|18616111|P3|Week 22 to Week 50|Withdrawal by Subject|8
5400751|NCT02937701|18616112|P2|Week 22 to Week 50|Withdrawal by Subject|0
5400752|NCT02937701|18616113|P1|Week 22 to Week 50|Withdrawal by Subject|0
5400753|NCT02937701|18616109|P5|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
5400754|NCT02937701|18616110|P4|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
5400755|NCT02937701|18616111|P3|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
5400756|NCT02937701|18616112|P2|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
5400757|NCT02937701|18616113|P1|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
5400758|NCT02937701|18616109|P5|Week 22 to Week 50|Adverse Event|3
5400759|NCT02937701|18616110|P4|Week 22 to Week 50|Adverse Event|3
5400760|NCT02937701|18616111|P3|Week 22 to Week 50|Adverse Event|10
5400761|NCT02937701|18616112|P2|Week 22 to Week 50|Adverse Event|0
5400762|NCT02937701|18616113|P1|Week 22 to Week 50|Adverse Event|0
5400763|NCT02937701|18616109|P5|Day 1 to Week 22|Other|0
5400764|NCT02937701|18616110|P4|Day 1 to Week 22|Other|0
5400765|NCT02937701|18616111|P3|Day 1 to Week 22|Other|0
5400766|NCT02937701|18616112|P2|Day 1 to Week 22|Other|0
5400767|NCT02937701|18616113|P1|Day 1 to Week 22|Other|1
5400768|NCT02937701|18616109|P5|Day 1 to Week 22|Physician Decision|0
5400769|NCT02937701|18616110|P4|Day 1 to Week 22|Physician Decision|0
5400770|NCT02937701|18616111|P3|Day 1 to Week 22|Physician Decision|0
5400771|NCT02937701|18616112|P2|Day 1 to Week 22|Physician Decision|0
5400772|NCT02937701|18616113|P1|Day 1 to Week 22|Physician Decision|2
5400773|NCT02937701|18616109|P5|Day 1 to Week 22|Lost to Follow-up|0
5400774|NCT02937701|18616110|P4|Day 1 to Week 22|Lost to Follow-up|0
5400775|NCT02937701|18616111|P3|Day 1 to Week 22|Lost to Follow-up|0
5400776|NCT02937701|18616112|P2|Day 1 to Week 22|Lost to Follow-up|1
5400777|NCT02937701|18616113|P1|Day 1 to Week 22|Lost to Follow-up|1
5400778|NCT02937701|18616109|P5|Day 1 to Week 22|Protocol Violation|0
5400779|NCT02937701|18616110|P4|Day 1 to Week 22|Protocol Violation|0
5400780|NCT02937701|18616111|P3|Day 1 to Week 22|Protocol Violation|0
5400781|NCT02937701|18616112|P2|Day 1 to Week 22|Protocol Violation|1
5400782|NCT02937701|18616113|P1|Day 1 to Week 22|Protocol Violation|1
5400783|NCT02937701|18616109|P5|Day 1 to Week 22|Death|0
5400784|NCT02937701|18616110|P4|Day 1 to Week 22|Death|0
5400785|NCT02937701|18616111|P3|Day 1 to Week 22|Death|0
5400786|NCT02937701|18616112|P2|Day 1 to Week 22|Death|1
5400787|NCT02937701|18616113|P1|Day 1 to Week 22|Death|1
5400788|NCT02937701|18616109|P5|Day 1 to Week 22|Withdrawal by Subject|0
5400789|NCT02937701|18616110|P4|Day 1 to Week 22|Withdrawal by Subject|0
5400790|NCT02937701|18616111|P3|Day 1 to Week 22|Withdrawal by Subject|0
5400791|NCT02937701|18616112|P2|Day 1 to Week 22|Withdrawal by Subject|6
5400792|NCT02937701|18616113|P1|Day 1 to Week 22|Withdrawal by Subject|6
5400793|NCT02937701|18616109|P5|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5400794|NCT02937701|18616110|P4|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5400795|NCT02937701|18616111|P3|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5400796|NCT02937701|18616112|P2|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
5400797|NCT02937701|18616113|P1|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
5400798|NCT02937701|18616109|P5|Day 1 to Week 22|Protocol Specified Criteria|0
5400799|NCT02937701|18616110|P4|Day 1 to Week 22|Protocol Specified Criteria|0
5400800|NCT02937701|18616111|P3|Day 1 to Week 22|Protocol Specified Criteria|0
5400801|NCT02937701|18616112|P2|Day 1 to Week 22|Protocol Specified Criteria|7
5400802|NCT02937701|18616113|P1|Day 1 to Week 22|Protocol Specified Criteria|7
5400803|NCT02937701|18616109|P5|Day 1 to Week 22|Adverse Event|0
5400804|NCT02937701|18616110|P4|Day 1 to Week 22|Adverse Event|0
5400805|NCT02937701|18616111|P3|Day 1 to Week 22|Adverse Event|0
5400806|NCT02937701|18616112|P2|Day 1 to Week 22|Adverse Event|14
5400807|NCT02937701|18616113|P1|Day 1 to Week 22|Adverse Event|11
5400808|NCT02937636|18616144|P2|Overall Study|Other (Not specified)|2
5400809|NCT02937636|18616145|P1|Overall Study|Other (Not specified)|3
5400810|NCT02937584|18616172|P2|Washout|Adverse Event|1
5400811|NCT02937584|18616173|P1|Washout|Adverse Event|0
5400812|NCT02937584|18616172|P2|Period 1|Adverse Event|2
5400813|NCT02937584|18616173|P1|Period 1|Adverse Event|1
5400814|NCT02936869|18616244|P2|Overall Study|Protocol Violation|0
5400815|NCT02936869|18616245|P1|Overall Study|Protocol Violation|1
5400816|NCT02936869|18616244|P2|Overall Study|Legal Case|1
5400817|NCT02936869|18616245|P1|Overall Study|Legal Case|0
5400818|NCT02936869|18616244|P2|Overall Study|Death|1
5400819|NCT02936869|18616245|P1|Overall Study|Death|0
5400820|NCT02936869|18616244|P2|Overall Study|Lost to Follow-up|3
5400821|NCT02936869|18616245|P1|Overall Study|Lost to Follow-up|1
5400822|NCT02936037|18616278|P2|Open Label Extension|Withdrawal by Subject|4
5400823|NCT02936037|18616279|P1|Open Label Extension|Withdrawal by Subject|0
5400824|NCT02936037|18616278|P2|Open Label Extension|Other|3
5400825|NCT02936037|18616279|P1|Open Label Extension|Other|0
5400826|NCT02936037|18616278|P2|Open Label Extension|Adverse Event|3
5400827|NCT02936037|18616279|P1|Open Label Extension|Adverse Event|0
5400828|NCT02936037|18616278|P2|Double-Blind Treatment Period|Lost to Follow-up|1
5400829|NCT02936037|18616279|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5400830|NCT02936037|18616278|P2|Double-Blind Treatment Period|Withdrawal by Subject|28
5400831|NCT02936037|18616279|P1|Double-Blind Treatment Period|Withdrawal by Subject|31
5400832|NCT02936037|18616278|P2|Double-Blind Treatment Period|Adverse Event|11
5400833|NCT02936037|18616279|P1|Double-Blind Treatment Period|Adverse Event|11
5400834|NCT02936037|18616278|P2|Double-Blind Treatment Period|Death|1
5400835|NCT02936037|18616279|P1|Double-Blind Treatment Period|Death|0
5400836|NCT02936037|18616278|P2|Double-Blind Treatment Period|Lack of Efficacy|12
5400837|NCT02936037|18616279|P1|Double-Blind Treatment Period|Lack of Efficacy|4
5400838|NCT02936037|18616278|P2|Double-Blind Treatment Period|Suicidal risk, etc.|8
5400839|NCT02936037|18616279|P1|Double-Blind Treatment Period|Suicidal risk, etc.|2
5400840|NCT02936037|18616278|P2|Double-Blind Treatment Period|Protocol Violation|4
5400841|NCT02936037|18616279|P1|Double-Blind Treatment Period|Protocol Violation|1
5400842|NCT02935894|18616285|P1|Overall Study|Subject dismissed|1
5400843|NCT02935842|18616300|P4|Testing and Therapy Period 3|Withdrawal by Subject|0
5400844|NCT02935842|18616301|P3|Testing and Therapy Period 3|Withdrawal by Subject|3
5400928|NCT02932462|18616931|P2|Overall Study|Withdrawal by Subject|4
5400845|NCT02935842|18616302|P2|Testing and Therapy Period 3|Withdrawal by Subject|0
5400846|NCT02935842|18616303|P1|Testing and Therapy Period 3|Withdrawal by Subject|0
5400847|NCT02935842|18616300|P4|Testing and Therapy Period 3|Lost to Follow-up|1
5400848|NCT02935842|18616301|P3|Testing and Therapy Period 3|Lost to Follow-up|0
5400849|NCT02935842|18616302|P2|Testing and Therapy Period 3|Lost to Follow-up|0
5400850|NCT02935842|18616303|P1|Testing and Therapy Period 3|Lost to Follow-up|0
5400851|NCT02935842|18616300|P4|Testing and Therapy Period 3|Accident prior to treatment|0
5400852|NCT02935842|18616301|P3|Testing and Therapy Period 3|Accident prior to treatment|0
5400853|NCT02935842|18616302|P2|Testing and Therapy Period 3|Accident prior to treatment|2
5400854|NCT02935842|18616303|P1|Testing and Therapy Period 3|Accident prior to treatment|2
5400855|NCT02935842|18616300|P4|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
5400856|NCT02935842|18616301|P3|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
5400857|NCT02935842|18616302|P2|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
5400858|NCT02935842|18616303|P1|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
5400859|NCT02935842|18616300|P4|Testing and Therapy Period 2|Withdrawal by Subject|0
5400860|NCT02935842|18616301|P3|Testing and Therapy Period 2|Withdrawal by Subject|0
5400861|NCT02935842|18616302|P2|Testing and Therapy Period 2|Withdrawal by Subject|0
5400862|NCT02935842|18616303|P1|Testing and Therapy Period 2|Withdrawal by Subject|2
5400863|NCT02935673|18616372|P3|Overall Study|Withdrawal by Subject|0
5400864|NCT02935673|18616373|P2|Overall Study|Withdrawal by Subject|2
5400865|NCT02935673|18616374|P1|Overall Study|Withdrawal by Subject|1
5400866|NCT02935673|18616372|P3|Overall Study|Adverse Event|0
5400867|NCT02935673|18616373|P2|Overall Study|Adverse Event|1
5400868|NCT02935673|18616374|P1|Overall Study|Adverse Event|0
5400869|NCT02935192|18616519|P2|Overall Study|Withdrawal by Subject|4
5400870|NCT02935192|18616520|P1|Overall Study|Withdrawal by Subject|8
5400871|NCT02934178|18616637|P2|Received Vaccination 3|Withdrawal by Subject|0
5400872|NCT02934178|18616638|P1|Received Vaccination 3|Withdrawal by Subject|1
5400873|NCT02934178|18616637|P2|Received Vaccination 2|Death|1
5400874|NCT02934178|18616638|P1|Received Vaccination 2|Death|0
5400875|NCT02933528|18616778|P1|Overall Study|Lost to Follow-up|2
5400876|NCT02933060|18616806|P2|Overall Study|Withdrawal by Subject|1
5400877|NCT02933060|18616807|P1|Overall Study|Withdrawal by Subject|0
5400878|NCT02932943|18616848|P2|Overall Study|Withdrawal by Subject|3
5400879|NCT02932943|18616849|P1|Overall Study|Withdrawal by Subject|3
5400880|NCT02932943|18616848|P2|Overall Study|Adverse Event|2
5400881|NCT02932943|18616849|P1|Overall Study|Adverse Event|2
5400882|NCT02932943|18616848|P2|Overall Study|Lost to Follow-up|2
5400883|NCT02932943|18616849|P1|Overall Study|Lost to Follow-up|0
5400884|NCT02932904|18616865|P4|Overall Study|Randomized But Not Treated|2
5400885|NCT02932904|18616866|P3|Overall Study|Randomized But Not Treated|0
5400886|NCT02932904|18616867|P2|Overall Study|Randomized But Not Treated|1
5400887|NCT02932904|18616868|P1|Overall Study|Randomized But Not Treated|1
5400888|NCT02932904|18616865|P4|Overall Study|Pretreatment Event/Adverse Event|3
5400889|NCT02932904|18616866|P3|Overall Study|Pretreatment Event/Adverse Event|1
5400890|NCT02932904|18616867|P2|Overall Study|Pretreatment Event/Adverse Event|5
5400891|NCT02932904|18616868|P1|Overall Study|Pretreatment Event/Adverse Event|3
5400892|NCT02932904|18616865|P4|Overall Study|Significant Protocol Deviation|1
5400893|NCT02932904|18616866|P3|Overall Study|Significant Protocol Deviation|6
5400894|NCT02932904|18616867|P2|Overall Study|Significant Protocol Deviation|3
5400895|NCT02932904|18616868|P1|Overall Study|Significant Protocol Deviation|2
5400896|NCT02932904|18616865|P4|Overall Study|Lost to Follow-up|0
5400897|NCT02932904|18616866|P3|Overall Study|Lost to Follow-up|6
5400898|NCT02932904|18616867|P2|Overall Study|Lost to Follow-up|3
5400899|NCT02932904|18616868|P1|Overall Study|Lost to Follow-up|5
5400900|NCT02932904|18616865|P4|Overall Study|Voluntary Withdrawal|2
5400901|NCT02932904|18616866|P3|Overall Study|Voluntary Withdrawal|4
5400902|NCT02932904|18616867|P2|Overall Study|Voluntary Withdrawal|1
5400903|NCT02932904|18616868|P1|Overall Study|Voluntary Withdrawal|2
5400904|NCT02932904|18616865|P4|Overall Study|Study Termination|0
5400905|NCT02932904|18616866|P3|Overall Study|Study Termination|0
5400906|NCT02932904|18616867|P2|Overall Study|Study Termination|1
5400907|NCT02932904|18616868|P1|Overall Study|Study Termination|0
5400908|NCT02932904|18616865|P4|Overall Study|Pregnancy|0
5400909|NCT02932904|18616866|P3|Overall Study|Pregnancy|1
5400910|NCT02932904|18616867|P2|Overall Study|Pregnancy|1
5400911|NCT02932904|18616868|P1|Overall Study|Pregnancy|0
5400912|NCT02932904|18616865|P4|Overall Study|Noncompliance with Study Drug|4
5400913|NCT02932904|18616866|P3|Overall Study|Noncompliance with Study Drug|3
5400914|NCT02932904|18616867|P2|Overall Study|Noncompliance with Study Drug|3
5400915|NCT02932904|18616868|P1|Overall Study|Noncompliance with Study Drug|2
5400916|NCT02932904|18616865|P4|Overall Study|Reason not Specified|2
5400917|NCT02932904|18616866|P3|Overall Study|Reason not Specified|2
5400918|NCT02932904|18616867|P2|Overall Study|Reason not Specified|0
5400919|NCT02932904|18616868|P1|Overall Study|Reason not Specified|1
5400920|NCT02932891|18616903|P1|Overall Study|HPA Suppress|2
5400921|NCT02932891|18616903|P1|Overall Study|Lost to Follow-up|2
5400922|NCT02932878|18616909|P2|Overall Study|Due to Lab Results|1
5400923|NCT02932878|18616910|P1|Overall Study|Due to Lab Results|2
5400924|NCT02932462|18616931|P2|Overall Study|Progressive Disease|0
5400925|NCT02932462|18616932|P1|Overall Study|Progressive Disease|1
5400926|NCT02932462|18616931|P2|Overall Study|Non-Compliance With Study Drug|1
5400927|NCT02932462|18616932|P1|Overall Study|Non-Compliance With Study Drug|0
5400929|NCT02932462|18616932|P1|Overall Study|Withdrawal by Subject|1
5400930|NCT02932462|18616931|P2|Overall Study|Protocol Violation|5
5400931|NCT02932462|18616932|P1|Overall Study|Protocol Violation|0
5400932|NCT02932462|18616931|P2|Overall Study|Lost to Follow-up|1
5400933|NCT02932462|18616932|P1|Overall Study|Lost to Follow-up|4
5400934|NCT02932462|18616931|P2|Overall Study|Adverse Event|2
5400935|NCT02932462|18616932|P1|Overall Study|Adverse Event|1
5400936|NCT02932306|18616944|P2|Overall Study|Withdrew due to burning,itching,stinging|0
5400937|NCT02932306|18616945|P1|Overall Study|Withdrew due to burning,itching,stinging|1
5400938|NCT02932306|18616944|P2|Overall Study|Worsening condition|0
5400939|NCT02932306|18616945|P1|Overall Study|Worsening condition|2
5400940|NCT02932306|18616944|P2|Overall Study|Lack of Efficacy|2
5400941|NCT02932306|18616945|P1|Overall Study|Lack of Efficacy|0
5400942|NCT02932306|18616944|P2|Overall Study|Withdrawal by Parent or Guardian|8
5400943|NCT02932306|18616945|P1|Overall Study|Withdrawal by Parent or Guardian|6
5400944|NCT02932306|18616944|P2|Overall Study|Lost to Follow-up|40
5400945|NCT02932306|18616945|P1|Overall Study|Lost to Follow-up|36
5400946|NCT02932306|18616944|P2|Overall Study|Noncompliance with Study Drug|1
5400947|NCT02932306|18616945|P1|Overall Study|Noncompliance with Study Drug|1
5400948|NCT02932306|18616944|P2|Overall Study|Protocol Violation|1
5400949|NCT02932306|18616945|P1|Overall Study|Protocol Violation|1
5400950|NCT02932306|18616944|P2|Overall Study|Pregnancy|0
5400951|NCT02932306|18616945|P1|Overall Study|Pregnancy|2
5400952|NCT02932306|18616944|P2|Overall Study|Adverse Event|0
5400953|NCT02932306|18616945|P1|Overall Study|Adverse Event|3
5400954|NCT02932306|18616944|P2|Overall Study|Withdrawal by Subject|25
5400955|NCT02932306|18616945|P1|Overall Study|Withdrawal by Subject|16
5400956|NCT02932267|18616959|P1|Overall Study|Pregnancy|1
5400957|NCT02932267|18616959|P1|Overall Study|Lost to Follow-up|4
5400958|NCT02932267|18616959|P1|Overall Study|Withdrawal by Subject|3
5400959|NCT02932228|18616965|P2|Overall Study|not eligible upon chart review|5
5400960|NCT02932228|18616966|P1|Overall Study|not eligible upon chart review|2
5400961|NCT02932228|18616965|P2|Overall Study|Death|23
5400962|NCT02932228|18616966|P1|Overall Study|Death|8
5400963|NCT02931838|18616991|P6|Overall Study|Adverse Event|1
5400964|NCT02931838|18616992|P5|Overall Study|Adverse Event|3
5400965|NCT02931838|18616993|P4|Overall Study|Adverse Event|1
5400966|NCT02931838|18616994|P3|Overall Study|Adverse Event|2
5400967|NCT02931838|18616995|P2|Overall Study|Adverse Event|1
5400968|NCT02931838|18616996|P1|Overall Study|Adverse Event|2
5400969|NCT02931838|18616991|P6|Overall Study|Withdrawal by Subject|0
5400970|NCT02931838|18616992|P5|Overall Study|Withdrawal by Subject|0
5400971|NCT02931838|18616993|P4|Overall Study|Withdrawal by Subject|1
5400972|NCT02931838|18616994|P3|Overall Study|Withdrawal by Subject|0
5400973|NCT02931838|18616995|P2|Overall Study|Withdrawal by Subject|2
5400974|NCT02931838|18616996|P1|Overall Study|Withdrawal by Subject|1
5400975|NCT02931838|18616991|P6|Overall Study|Subject request to discontinue treatment|0
5400976|NCT02931838|18616992|P5|Overall Study|Subject request to discontinue treatment|1
5400977|NCT02931838|18616993|P4|Overall Study|Subject request to discontinue treatment|0
5400978|NCT02931838|18616994|P3|Overall Study|Subject request to discontinue treatment|3
5400979|NCT02931838|18616995|P2|Overall Study|Subject request to discontinue treatment|3
5400980|NCT02931838|18616996|P1|Overall Study|Subject request to discontinue treatment|4
5400981|NCT02931838|18616991|P6|Overall Study|Lost to Follow-up|0
5400982|NCT02931838|18616992|P5|Overall Study|Lost to Follow-up|2
5400983|NCT02931838|18616993|P4|Overall Study|Lost to Follow-up|1
5400984|NCT02931838|18616994|P3|Overall Study|Lost to Follow-up|1
5400985|NCT02931838|18616995|P2|Overall Study|Lost to Follow-up|0
5400986|NCT02931838|18616996|P1|Overall Study|Lost to Follow-up|1
5400987|NCT02931838|18616991|P6|Overall Study|Lack of Efficacy|1
5400988|NCT02931838|18616992|P5|Overall Study|Lack of Efficacy|0
5400989|NCT02931838|18616993|P4|Overall Study|Lack of Efficacy|0
5400990|NCT02931838|18616994|P3|Overall Study|Lack of Efficacy|0
5400991|NCT02931838|18616995|P2|Overall Study|Lack of Efficacy|4
5400992|NCT02931838|18616996|P1|Overall Study|Lack of Efficacy|5
5400993|NCT02931838|18616991|P6|Overall Study|Poor/non-compliance|0
5400994|NCT02931838|18616992|P5|Overall Study|Poor/non-compliance|0
5400995|NCT02931838|18616993|P4|Overall Study|Poor/non-compliance|0
5400996|NCT02931838|18616994|P3|Overall Study|Poor/non-compliance|1
5400997|NCT02931838|18616995|P2|Overall Study|Poor/non-compliance|0
5400998|NCT02931838|18616996|P1|Overall Study|Poor/non-compliance|0
5400999|NCT02931838|18616991|P6|Overall Study|Reason not provided by investigator|0
5401000|NCT02931838|18616992|P5|Overall Study|Reason not provided by investigator|0
5401001|NCT02931838|18616993|P4|Overall Study|Reason not provided by investigator|0
5401002|NCT02931838|18616994|P3|Overall Study|Reason not provided by investigator|1
5401003|NCT02931838|18616995|P2|Overall Study|Reason not provided by investigator|0
5401004|NCT02931838|18616996|P1|Overall Study|Reason not provided by investigator|1
5401005|NCT02931396|18617047|P2|Overall Study|Withdrawal by Subject|0
5401006|NCT02931396|18617048|P1|Overall Study|Withdrawal by Subject|2
5401007|NCT02931396|18617047|P2|Overall Study|Lost to Follow-up|0
5401008|NCT02931396|18617048|P1|Overall Study|Lost to Follow-up|3
5401009|NCT02930837|18617094|P1|Overall Study|Withdrawal by Subject|1
5401010|NCT02930837|18617094|P1|Overall Study|Lost to Follow-up|5
5401011|NCT02930837|18617094|P1|Overall Study|Adverse Event|6
5401012|NCT02930226|18617390|P6|Overall Study|Technical Problems: Leak in plasma bag|0
5401013|NCT02930226|18617391|P5|Overall Study|Technical Problems: Leak in plasma bag|1
5401014|NCT02930226|18617392|P4|Overall Study|Technical Problems: Leak in plasma bag|0
5401015|NCT02930226|18617393|P3|Overall Study|Technical Problems: Leak in plasma bag|0
5401016|NCT02930226|18617394|P2|Overall Study|Technical Problems: Leak in plasma bag|0
5401017|NCT02930226|18617395|P1|Overall Study|Technical Problems: Leak in plasma bag|0
5401018|NCT02930018|18617449|P2|Overall Study|Withdrawal by Subject|2
5401019|NCT02930018|18617450|P1|Overall Study|Withdrawal by Subject|5
5401020|NCT02930018|18617449|P2|Overall Study|Lost to Follow-up|1
5401021|NCT02930018|18617450|P1|Overall Study|Lost to Follow-up|1
5401022|NCT02930005|18617474|P2|Overall Study|Lost to Follow-up|5
5401023|NCT02930005|18617475|P1|Overall Study|Lost to Follow-up|1
5401024|NCT02929498|18617515|P3|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
5401025|NCT02929498|18617516|P2|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
5401026|NCT02929498|18617517|P1|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
5401027|NCT02929498|18617515|P3|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
5401028|NCT02929498|18617516|P2|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
5401029|NCT02929498|18617517|P1|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
5401030|NCT02929407|18617611|P1|Overall Study|Adverse Event|1
5401031|NCT02928770|18617626|P1|Overall Study|Withdrawal by Subject|2
5401032|NCT02928224|18617666|P4|Overall Study|not listed|0
5401033|NCT02928224|18617667|P3|Overall Study|not listed|1
5401034|NCT02928224|18617668|P2|Overall Study|not listed|3
5401035|NCT02928224|18617669|P1|Overall Study|not listed|0
5401036|NCT02928224|18617666|P4|Overall Study|Physician Decision|2
5401037|NCT02928224|18617667|P3|Overall Study|Physician Decision|4
5401038|NCT02928224|18617668|P2|Overall Study|Physician Decision|2
5401039|NCT02928224|18617669|P1|Overall Study|Physician Decision|0
5401040|NCT02928224|18617666|P4|Overall Study|Patient Decision to Discontinue Drug|4
5401041|NCT02928224|18617667|P3|Overall Study|Patient Decision to Discontinue Drug|2
5401042|NCT02928224|18617668|P2|Overall Study|Patient Decision to Discontinue Drug|2
5401043|NCT02928224|18617669|P1|Overall Study|Patient Decision to Discontinue Drug|0
5401044|NCT02928224|18617666|P4|Overall Study|Dose Interruptions>28|4
5401045|NCT02928224|18617667|P3|Overall Study|Dose Interruptions>28|2
5401046|NCT02928224|18617668|P2|Overall Study|Dose Interruptions>28|2
5401047|NCT02928224|18617669|P1|Overall Study|Dose Interruptions>28|1
5401048|NCT02928224|18617666|P4|Overall Study|Withdrawal by Subject|9
5401049|NCT02928224|18617667|P3|Overall Study|Withdrawal by Subject|3
5401050|NCT02928224|18617668|P2|Overall Study|Withdrawal by Subject|4
5401051|NCT02928224|18617669|P1|Overall Study|Withdrawal by Subject|1
5401052|NCT02928224|18617666|P4|Overall Study|Death|11
5401053|NCT02928224|18617667|P3|Overall Study|Death|5
5401054|NCT02928224|18617668|P2|Overall Study|Death|7
5401055|NCT02928224|18617669|P1|Overall Study|Death|1
5401056|NCT02928224|18617666|P4|Overall Study|Changes in Patient's Condition|13
5401057|NCT02928224|18617667|P3|Overall Study|Changes in Patient's Condition|9
5401058|NCT02928224|18617668|P2|Overall Study|Changes in Patient's Condition|9
5401059|NCT02928224|18617669|P1|Overall Study|Changes in Patient's Condition|3
5401060|NCT02928224|18617666|P4|Overall Study|Adverse Event|10
5401061|NCT02928224|18617667|P3|Overall Study|Adverse Event|11
5401062|NCT02928224|18617668|P2|Overall Study|Adverse Event|11
5401063|NCT02928224|18617669|P1|Overall Study|Adverse Event|2
5401064|NCT02928224|18617666|P4|Overall Study|Progressive Disease|103
5401065|NCT02928224|18617667|P3|Overall Study|Progressive Disease|101
5401066|NCT02928224|18617668|P2|Overall Study|Progressive Disease|104
5401067|NCT02928224|18617669|P1|Overall Study|Progressive Disease|23
5401068|NCT02928224|18617666|P4|Overall Study|Treatment Ongoing|37
5401069|NCT02928224|18617667|P3|Overall Study|Treatment Ongoing|78
5401070|NCT02928224|18617668|P2|Overall Study|Treatment Ongoing|78
5401071|NCT02928224|18617669|P1|Overall Study|Treatment Ongoing|6
5401072|NCT02928224|18617666|P4|Overall Study|Randomized, Not Treated|28
5401073|NCT02928224|18617667|P3|Overall Study|Randomized, Not Treated|4
5401074|NCT02928224|18617668|P2|Overall Study|Randomized, Not Treated|2
5401075|NCT02928224|18617669|P1|Overall Study|Randomized, Not Treated|0
5401076|NCT02928029|18617773|P2|Overall Study|AE not related to clinical progression|1
5401077|NCT02928029|18617774|P1|Overall Study|AE not related to clinical progression|1
5401078|NCT02928029|18617773|P2|Overall Study|Clinical progression|2
5401079|NCT02928029|18617774|P1|Overall Study|Clinical progression|1
5401080|NCT02928029|18617773|P2|Overall Study|Radiological progression|0
5401081|NCT02928029|18617774|P1|Overall Study|Radiological progression|1
5401082|NCT02928029|18617773|P2|Overall Study|Withdrawal by Subject|1
5401083|NCT02928029|18617774|P1|Overall Study|Withdrawal by Subject|0
5401084|NCT02927938|18617788|P4|Overall Study|Early Study Termination|3
5401085|NCT02927938|18617789|P3|Overall Study|Early Study Termination|4
5401086|NCT02927938|18617790|P2|Overall Study|Early Study Termination|5
5401087|NCT02927938|18617791|P1|Overall Study|Early Study Termination|1
5401088|NCT02927938|18617788|P4|Overall Study|Death|4
5401089|NCT02927938|18617789|P3|Overall Study|Death|0
5401090|NCT02927938|18617790|P2|Overall Study|Death|1
5401091|NCT02927938|18617791|P1|Overall Study|Death|0
5401092|NCT02927834|18617802|P3|Overall Study|Lost to Follow-up|2
5401093|NCT02927834|18617803|P2|Overall Study|Lost to Follow-up|2
5401094|NCT02927834|18617804|P1|Overall Study|Lost to Follow-up|1
5401095|NCT02927795|18617818|P1|Overall Study|Not Treated|4
5401096|NCT02927795|18617818|P1|Overall Study|Non-evaluable PF10 quest. at visit 2|19
5401097|NCT02927431|18617874|P3|Overall Study|Withdrawal by Subject|1
5401098|NCT02927431|18617875|P2|Overall Study|Withdrawal by Subject|0
5401099|NCT02927431|18617876|P1|Overall Study|Withdrawal by Subject|0
5401100|NCT02927366|18617954|P2|Overall Study|Patient schedule|0
5401101|NCT02927366|18617955|P1|Overall Study|Patient schedule|1
5401102|NCT02927366|18617954|P2|Overall Study|Adverse Event|0
5401103|NCT02927366|18617955|P1|Overall Study|Adverse Event|1
5401104|NCT02927171|18618010|P2|Overall Study|Lost to Follow-up|1
5401105|NCT02927171|18618011|P1|Overall Study|Lost to Follow-up|0
5401106|NCT02926833|18618025|P4|Overall Study|Adverse Event|0
5401107|NCT02926833|18618026|P3|Overall Study|Adverse Event|1
5401108|NCT02926833|18618027|P2|Overall Study|Adverse Event|0
5401109|NCT02926833|18618028|P1|Overall Study|Adverse Event|0
5401110|NCT02926833|18618025|P4|Overall Study|Still on study|14
5401111|NCT02926833|18618026|P3|Overall Study|Still on study|5
5401112|NCT02926833|18618027|P2|Overall Study|Still on study|3
5401113|NCT02926833|18618028|P1|Overall Study|Still on study|2
5401114|NCT02926833|18618025|P4|Overall Study|Death|7
5401115|NCT02926833|18618026|P3|Overall Study|Death|1
5401116|NCT02926833|18618027|P2|Overall Study|Death|1
5401117|NCT02926833|18618028|P1|Overall Study|Death|1
5401118|NCT02926833|18618025|P4|Overall Study|Full Consent Withdrawal|2
5401119|NCT02926833|18618026|P3|Overall Study|Full Consent Withdrawal|0
5401120|NCT02926833|18618027|P2|Overall Study|Full Consent Withdrawal|0
5401121|NCT02926833|18618028|P1|Overall Study|Full Consent Withdrawal|0
5401122|NCT02926638|18618084|P2|Overall Study|Not protocol specified|0
5401123|NCT02926638|18618085|P1|Overall Study|Not protocol specified|1
5401124|NCT02926638|18618084|P2|Overall Study|Ineligible|0
5401125|NCT02926638|18618085|P1|Overall Study|Ineligible|1
5401126|NCT02926638|18618084|P2|Overall Study|Progression|5
5401127|NCT02926638|18618085|P1|Overall Study|Progression|2
5401128|NCT02926573|18618099|P2|Overall Study|Delirium|1
5401129|NCT02926573|18618100|P1|Overall Study|Delirium|0
5401130|NCT02926573|18618099|P2|Overall Study|Return to operating room|2
5401131|NCT02926573|18618100|P1|Overall Study|Return to operating room|0
5401132|NCT02926573|18618099|P2|Overall Study|Withdrawal by Subject|2
5401133|NCT02926573|18618100|P1|Overall Study|Withdrawal by Subject|0
5401134|NCT02926573|18618099|P2|Overall Study|Change to outpatient status|1
5401135|NCT02926573|18618100|P1|Overall Study|Change to outpatient status|5
5401136|NCT02926573|18618099|P2|Overall Study|Change in surgery plan|1
5401137|NCT02926573|18618100|P1|Overall Study|Change in surgery plan|3
5401138|NCT02926573|18618099|P2|Overall Study|Remain intubated|2
5401139|NCT02926573|18618100|P1|Overall Study|Remain intubated|2
5401140|NCT02926573|18618099|P2|Overall Study|Nausea|0
5401141|NCT02926573|18618100|P1|Overall Study|Nausea|1
5401142|NCT02926209|18618118|P2|Study Cohort|Poor Bowel Preparation|0
5401143|NCT02926209|18618119|P1|Study Cohort|Poor Bowel Preparation|1
5401144|NCT02925923|18618132|P2|Overall Study|blood samples hemolyzed|2
5401145|NCT02925923|18618133|P1|Overall Study|blood samples hemolyzed|0
5401146|NCT02925741|18618190|P2|Overall Study|Withdrawal by Subject|0
5401147|NCT02925741|18618191|P1|Overall Study|Withdrawal by Subject|11
5401148|NCT02925494|18618224|P4|Post-Treatment Follow-Up Period|Adverse Event|1
5401149|NCT02925494|18618225|P3|Post-Treatment Follow-Up Period|Adverse Event|0
5401150|NCT02925494|18618226|P2|Post-Treatment Follow-Up Period|Adverse Event|0
5401151|NCT02925494|18618227|P1|Post-Treatment Follow-Up Period|Adverse Event|0
5401152|NCT02925494|18618224|P4|Post-Treatment Follow-Up Period|Non-Compliance|2
5401153|NCT02925494|18618225|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
5401154|NCT02925494|18618226|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
5401155|NCT02925494|18618227|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
5401156|NCT02925494|18618224|P4|Post-Treatment Follow-Up Period|Pregnancy|2
5401157|NCT02925494|18618225|P3|Post-Treatment Follow-Up Period|Pregnancy|1
5401158|NCT02925494|18618226|P2|Post-Treatment Follow-Up Period|Pregnancy|0
5401159|NCT02925494|18618227|P1|Post-Treatment Follow-Up Period|Pregnancy|1
5401160|NCT02925494|18618224|P4|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
5401161|NCT02925494|18618225|P3|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
5401162|NCT02925494|18618226|P2|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
5401163|NCT02925494|18618227|P1|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
5401164|NCT02925494|18618224|P4|Post-Treatment Follow-Up Period|Other|6
5401165|NCT02925494|18618225|P3|Post-Treatment Follow-Up Period|Other|3
5401166|NCT02925494|18618226|P2|Post-Treatment Follow-Up Period|Other|4
5401167|NCT02925494|18618227|P1|Post-Treatment Follow-Up Period|Other|1
5401168|NCT02925494|18618224|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|10
5401169|NCT02925494|18618225|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|9
5401170|NCT02925494|18618226|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5401171|NCT02925494|18618227|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5401172|NCT02925494|18618224|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
5401173|NCT02925494|18618225|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
5401174|NCT02925494|18618226|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
5401175|NCT02925494|18618227|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
5401176|NCT02925403|18618255|P2|Overall Study|Lost to Follow-up|1
5401177|NCT02925403|18618256|P1|Overall Study|Lost to Follow-up|0
5401178|NCT02925312|18618270|P2|Overall Study|Adverse Event|0
5401179|NCT02925312|18618271|P1|Overall Study|Adverse Event|2
5401180|NCT02925312|18618270|P2|Overall Study|Lost to Follow-up|0
5401181|NCT02925312|18618271|P1|Overall Study|Lost to Follow-up|25
5401182|NCT02925117|18618287|P12|Period 2 (Weeks 16 - 88)|Other|0
5401183|NCT02925117|18618288|P11|Period 2 (Weeks 16 - 88)|Other|3
5401184|NCT02925117|18618289|P10|Period 2 (Weeks 16 - 88)|Other|4
5401185|NCT02925117|18618290|P9|Period 2 (Weeks 16 - 88)|Other|3
5401186|NCT02925117|18618291|P8|Period 2 (Weeks 16 - 88)|Other|1
5401187|NCT02925117|18618292|P7|Period 2 (Weeks 16 - 88)|Other|1
5401188|NCT02925117|18618293|P6|Period 2 (Weeks 16 - 88)|Other|1
5401189|NCT02925117|18618294|P5|Period 2 (Weeks 16 - 88)|Other|1
5401190|NCT02925117|18618295|P4|Period 2 (Weeks 16 - 88)|Other|0
5401191|NCT02925117|18618296|P3|Period 2 (Weeks 16 - 88)|Other|0
5401192|NCT02925117|18618297|P2|Period 2 (Weeks 16 - 88)|Other|0
5401193|NCT02925117|18618298|P1|Period 2 (Weeks 16 - 88)|Other|0
5401194|NCT02925117|18618287|P12|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5401195|NCT02925117|18618288|P11|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5401196|NCT02925117|18618289|P10|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5401197|NCT02925117|18618290|P9|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5401198|NCT02925117|18618291|P8|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5401199|NCT02925117|18618292|P7|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5401200|NCT02925117|18618293|P6|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
5401201|NCT02925117|18618294|P5|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
5401202|NCT02925117|18618295|P4|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5401203|NCT02925117|18618296|P3|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5401204|NCT02925117|18618297|P2|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5401205|NCT02925117|18618298|P1|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
5401206|NCT02925117|18618287|P12|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5401207|NCT02925117|18618288|P11|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5401208|NCT02925117|18618289|P10|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5401209|NCT02925117|18618290|P9|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
5401210|NCT02925117|18618291|P8|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
5401211|NCT02925117|18618292|P7|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
5401212|NCT02925117|18618293|P6|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
5401213|NCT02925117|18618294|P5|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5401214|NCT02925117|18618295|P4|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5401215|NCT02925117|18618296|P3|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5401216|NCT02925117|18618297|P2|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5401217|NCT02925117|18618298|P1|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
5401218|NCT02925117|18618287|P12|Period 2 (Weeks 16 - 88)|Adverse Event|2
5401219|NCT02925117|18618288|P11|Period 2 (Weeks 16 - 88)|Adverse Event|3
5401220|NCT02925117|18618289|P10|Period 2 (Weeks 16 - 88)|Adverse Event|0
5401221|NCT02925117|18618290|P9|Period 2 (Weeks 16 - 88)|Adverse Event|0
5401222|NCT02925117|18618291|P8|Period 2 (Weeks 16 - 88)|Adverse Event|0
5401223|NCT02925117|18618292|P7|Period 2 (Weeks 16 - 88)|Adverse Event|0
5401224|NCT02925117|18618293|P6|Period 2 (Weeks 16 - 88)|Adverse Event|1
5401225|NCT02925117|18618294|P5|Period 2 (Weeks 16 - 88)|Adverse Event|0
5401226|NCT02925117|18618295|P4|Period 2 (Weeks 16 - 88)|Adverse Event|0
5401227|NCT02925117|18618296|P3|Period 2 (Weeks 16 - 88)|Adverse Event|0
5401228|NCT02925117|18618297|P2|Period 2 (Weeks 16 - 88)|Adverse Event|0
5401229|NCT02925117|18618298|P1|Period 2 (Weeks 16 - 88)|Adverse Event|0
5401230|NCT02925117|18618287|P12|Period 1 (Weeks 0 - 16)|Other|0
5401231|NCT02925117|18618288|P11|Period 1 (Weeks 0 - 16)|Other|0
5401232|NCT02925117|18618289|P10|Period 1 (Weeks 0 - 16)|Other|0
5401233|NCT02925117|18618290|P9|Period 1 (Weeks 0 - 16)|Other|0
5401234|NCT02925117|18618291|P8|Period 1 (Weeks 0 - 16)|Other|0
5401235|NCT02925117|18618292|P7|Period 1 (Weeks 0 - 16)|Other|0
5401236|NCT02925117|18618293|P6|Period 1 (Weeks 0 - 16)|Other|0
5401237|NCT02925117|18618294|P5|Period 1 (Weeks 0 - 16)|Other|0
5401238|NCT02925117|18618295|P4|Period 1 (Weeks 0 - 16)|Other|1
5401239|NCT02925117|18618296|P3|Period 1 (Weeks 0 - 16)|Other|1
5401240|NCT02925117|18618297|P2|Period 1 (Weeks 0 - 16)|Other|4
5401241|NCT02925117|18618298|P1|Period 1 (Weeks 0 - 16)|Other|5
5401242|NCT02925117|18618287|P12|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401243|NCT02925117|18618288|P11|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401244|NCT02925117|18618289|P10|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401245|NCT02925117|18618290|P9|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401246|NCT02925117|18618291|P8|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401247|NCT02925117|18618292|P7|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401248|NCT02925117|18618293|P6|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401249|NCT02925117|18618294|P5|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401250|NCT02925117|18618295|P4|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401251|NCT02925117|18618296|P3|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
5401252|NCT02925117|18618297|P2|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
5401253|NCT02925117|18618298|P1|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
5401254|NCT02925117|18618287|P12|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5401255|NCT02925117|18618288|P11|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5401256|NCT02925117|18618289|P10|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5401257|NCT02925117|18618290|P9|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5401258|NCT02925117|18618291|P8|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5401259|NCT02925117|18618292|P7|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5401260|NCT02925117|18618293|P6|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5401261|NCT02925117|18618294|P5|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5401262|NCT02925117|18618295|P4|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
5401263|NCT02925117|18618296|P3|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
5401264|NCT02925117|18618297|P2|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
5401265|NCT02925117|18618298|P1|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
5401266|NCT02925117|18618287|P12|Period 1 (Weeks 0 - 16)|Adverse Event|0
5401267|NCT02925117|18618288|P11|Period 1 (Weeks 0 - 16)|Adverse Event|0
5401268|NCT02925117|18618289|P10|Period 1 (Weeks 0 - 16)|Adverse Event|0
5401269|NCT02925117|18618290|P9|Period 1 (Weeks 0 - 16)|Adverse Event|0
5401270|NCT02925117|18618291|P8|Period 1 (Weeks 0 - 16)|Adverse Event|0
5401271|NCT02925117|18618292|P7|Period 1 (Weeks 0 - 16)|Adverse Event|0
5401272|NCT02925117|18618293|P6|Period 1 (Weeks 0 - 16)|Adverse Event|0
5401273|NCT02925117|18618294|P5|Period 1 (Weeks 0 - 16)|Adverse Event|0
5401274|NCT02925117|18618295|P4|Period 1 (Weeks 0 - 16)|Adverse Event|2
5401275|NCT02925117|18618296|P3|Period 1 (Weeks 0 - 16)|Adverse Event|1
5401276|NCT02925117|18618297|P2|Period 1 (Weeks 0 - 16)|Adverse Event|3
5401277|NCT02925117|18618298|P1|Period 1 (Weeks 0 - 16)|Adverse Event|1
5401278|NCT02924883|18618409|P2|Overall Study|Ongoing in Study|115
5401279|NCT02924883|18618410|P1|Overall Study|Ongoing in Study|56
5401280|NCT02924883|18618409|P2|Overall Study|Death|13
5401281|NCT02924883|18618410|P1|Overall Study|Death|8
5401282|NCT02924883|18618409|P2|Overall Study|Protocol Violation|1
5401283|NCT02924883|18618410|P1|Overall Study|Protocol Violation|0
5401284|NCT02924883|18618409|P2|Overall Study|Withdrawal by Subject|4
5401285|NCT02924883|18618410|P1|Overall Study|Withdrawal by Subject|5
5401286|NCT02924688|18618435|P6|Overall Study|Withdrawal by Subject|14
5401287|NCT02924688|18618436|P5|Overall Study|Withdrawal by Subject|13
5401288|NCT02924688|18618437|P4|Overall Study|Withdrawal by Subject|12
5401289|NCT02924688|18618438|P3|Overall Study|Withdrawal by Subject|9
5401290|NCT02924688|18618439|P2|Overall Study|Withdrawal by Subject|13
5401291|NCT02924688|18618440|P1|Overall Study|Withdrawal by Subject|14
5401292|NCT02924688|18618435|P6|Overall Study|Physician Decision|1
5401293|NCT02924688|18618436|P5|Overall Study|Physician Decision|1
5401294|NCT02924688|18618437|P4|Overall Study|Physician Decision|1
5401295|NCT02924688|18618438|P3|Overall Study|Physician Decision|0
5401296|NCT02924688|18618439|P2|Overall Study|Physician Decision|1
5401297|NCT02924688|18618440|P1|Overall Study|Physician Decision|2
5401298|NCT02924688|18618435|P6|Overall Study|Lost to Follow-up|4
5401299|NCT02924688|18618436|P5|Overall Study|Lost to Follow-up|2
5401300|NCT02924688|18618437|P4|Overall Study|Lost to Follow-up|4
5401301|NCT02924688|18618438|P3|Overall Study|Lost to Follow-up|2
5401302|NCT02924688|18618439|P2|Overall Study|Lost to Follow-up|4
5401303|NCT02924688|18618440|P1|Overall Study|Lost to Follow-up|2
5401304|NCT02924688|18618435|P6|Overall Study|Protocol defined withdrawal criteria met|0
5401305|NCT02924688|18618436|P5|Overall Study|Protocol defined withdrawal criteria met|1
5401306|NCT02924688|18618437|P4|Overall Study|Protocol defined withdrawal criteria met|1
5401307|NCT02924688|18618438|P3|Overall Study|Protocol defined withdrawal criteria met|1
5401308|NCT02924688|18618439|P2|Overall Study|Protocol defined withdrawal criteria met|0
5401309|NCT02924688|18618440|P1|Overall Study|Protocol defined withdrawal criteria met|1
5401310|NCT02924688|18618435|P6|Overall Study|Protocol Violation|2
5401311|NCT02924688|18618436|P5|Overall Study|Protocol Violation|2
5401312|NCT02924688|18618437|P4|Overall Study|Protocol Violation|6
5401313|NCT02924688|18618438|P3|Overall Study|Protocol Violation|5
5401314|NCT02924688|18618439|P2|Overall Study|Protocol Violation|7
5401315|NCT02924688|18618440|P1|Overall Study|Protocol Violation|3
5401316|NCT02924688|18618435|P6|Overall Study|Lack of Efficacy|1
5401317|NCT02924688|18618436|P5|Overall Study|Lack of Efficacy|1
5401318|NCT02924688|18618437|P4|Overall Study|Lack of Efficacy|2
5401319|NCT02924688|18618438|P3|Overall Study|Lack of Efficacy|4
5401320|NCT02924688|18618439|P2|Overall Study|Lack of Efficacy|3
5401321|NCT02924688|18618440|P1|Overall Study|Lack of Efficacy|2
5401322|NCT02924688|18618435|P6|Overall Study|Adverse Event|2
5401323|NCT02924688|18618436|P5|Overall Study|Adverse Event|3
5401324|NCT02924688|18618437|P4|Overall Study|Adverse Event|2
5401325|NCT02924688|18618438|P3|Overall Study|Adverse Event|2
5401326|NCT02924688|18618439|P2|Overall Study|Adverse Event|3
5401327|NCT02924688|18618440|P1|Overall Study|Adverse Event|9
5401328|NCT02924428|18618510|P2|Overall Study|Pregnancy|1
5401329|NCT02924428|18618511|P1|Overall Study|Pregnancy|0
5401330|NCT02924428|18618510|P2|Overall Study|Lost to Follow-up|4
5401331|NCT02924428|18618511|P1|Overall Study|Lost to Follow-up|2
5401332|NCT02924428|18618510|P2|Overall Study|Physician Decision|0
5401333|NCT02924428|18618511|P1|Overall Study|Physician Decision|1
5401334|NCT02924428|18618510|P2|Overall Study|Adverse Event|0
5401335|NCT02924428|18618511|P1|Overall Study|Adverse Event|1
5401336|NCT02924051|18618546|P2|Overall Study|Withdrawal by Subject|9
5401337|NCT02924051|18618547|P1|Overall Study|Withdrawal by Subject|1
5401338|NCT02923921|18618559|P2|Overall Study|Unknown, Not Collected|6
5401339|NCT02923921|18618560|P1|Overall Study|Unknown, Not Collected|7
5401340|NCT02923921|18618559|P2|Overall Study|Withdrawal by Subject|13
5401341|NCT02923921|18618560|P1|Overall Study|Withdrawal by Subject|6
5401342|NCT02923921|18618559|P2|Overall Study|Lost to Follow-up|0
5401343|NCT02923921|18618560|P1|Overall Study|Lost to Follow-up|1
5401344|NCT02923921|18618559|P2|Overall Study|Sponsor Decision|38
5401345|NCT02923921|18618560|P1|Overall Study|Sponsor Decision|39
5401346|NCT02923830|18618593|P2|Overall Study|Physician Decision|15
5401347|NCT02923830|18618594|P1|Overall Study|Physician Decision|13
5401348|NCT02923427|18618614|P2|Overall Study|can not replace LMA|0
5401349|NCT02923427|18618615|P1|Overall Study|can not replace LMA|1
5401350|NCT02923427|18618614|P2|Overall Study|destaturation|0
5401351|NCT02923427|18618615|P1|Overall Study|destaturation|1
5401352|NCT02923427|18618614|P2|Overall Study|convert to laparatomy|2
5401353|NCT02923427|18618615|P1|Overall Study|convert to laparatomy|2
5401354|NCT02923349|18618642|P7|Overall Study|Death|0
5401355|NCT02923349|18618643|P6|Overall Study|Death|3
5401356|NCT02923349|18618644|P5|Overall Study|Death|2
5401357|NCT02923349|18618645|P4|Overall Study|Death|4
5401358|NCT02923349|18618646|P3|Overall Study|Death|2
5401359|NCT02923349|18618647|P2|Overall Study|Death|0
5401360|NCT02923349|18618648|P1|Overall Study|Death|1
5401361|NCT02923349|18618642|P7|Overall Study|Lost to Follow-up|0
5401362|NCT02923349|18618643|P6|Overall Study|Lost to Follow-up|1
5401363|NCT02923349|18618644|P5|Overall Study|Lost to Follow-up|1
5401364|NCT02923349|18618645|P4|Overall Study|Lost to Follow-up|0
5401365|NCT02923349|18618646|P3|Overall Study|Lost to Follow-up|3
5401366|NCT02923349|18618647|P2|Overall Study|Lost to Follow-up|0
5401367|NCT02923349|18618648|P1|Overall Study|Lost to Follow-up|0
5401368|NCT02923349|18618642|P7|Overall Study|Physician Decision|2
5401369|NCT02923349|18618643|P6|Overall Study|Physician Decision|0
5401370|NCT02923349|18618644|P5|Overall Study|Physician Decision|1
5401371|NCT02923349|18618645|P4|Overall Study|Physician Decision|1
5401372|NCT02923349|18618646|P3|Overall Study|Physician Decision|0
5401373|NCT02923349|18618647|P2|Overall Study|Physician Decision|0
5401374|NCT02923349|18618648|P1|Overall Study|Physician Decision|0
5401375|NCT02923349|18618642|P7|Overall Study|Withdrawal by Subject|0
5401376|NCT02923349|18618643|P6|Overall Study|Withdrawal by Subject|3
5401377|NCT02923349|18618644|P5|Overall Study|Withdrawal by Subject|12
5401378|NCT02923349|18618645|P4|Overall Study|Withdrawal by Subject|10
5401379|NCT02923349|18618646|P3|Overall Study|Withdrawal by Subject|8
5401380|NCT02923349|18618647|P2|Overall Study|Withdrawal by Subject|2
5401381|NCT02923349|18618648|P1|Overall Study|Withdrawal by Subject|2
5401382|NCT02923349|18618642|P7|Overall Study|Other|1
5401383|NCT02923349|18618643|P6|Overall Study|Other|0
5401384|NCT02923349|18618644|P5|Overall Study|Other|3
5401385|NCT02923349|18618645|P4|Overall Study|Other|1
5401386|NCT02923349|18618646|P3|Overall Study|Other|4
5401387|NCT02923349|18618647|P2|Overall Study|Other|2
5401388|NCT02923349|18618648|P1|Overall Study|Other|1
5401389|NCT02923245|18618733|P2|Overall Study|ultrasound order was cancelled|1
5401390|NCT02923245|18618734|P1|Overall Study|ultrasound order was cancelled|2
5401391|NCT02923115|18618757|P6|Overall Study|Randomized, but not dosed|0
5401392|NCT02923115|18618758|P5|Overall Study|Randomized, but not dosed|5
5401393|NCT02923115|18618759|P4|Overall Study|Randomized, but not dosed|1
5401394|NCT02923115|18618760|P3|Overall Study|Randomized, but not dosed|3
5401395|NCT02923115|18618761|P2|Overall Study|Randomized, but not dosed|0
5401396|NCT02923115|18618762|P1|Overall Study|Randomized, but not dosed|0
5401397|NCT02923115|18618757|P6|Overall Study|Withdrawal by Subject|0
5401398|NCT02923115|18618758|P5|Overall Study|Withdrawal by Subject|0
5401399|NCT02923115|18618759|P4|Overall Study|Withdrawal by Subject|0
5401400|NCT02923115|18618760|P3|Overall Study|Withdrawal by Subject|0
5401401|NCT02923115|18618761|P2|Overall Study|Withdrawal by Subject|1
5401402|NCT02923115|18618762|P1|Overall Study|Withdrawal by Subject|0
5401403|NCT02923115|18618757|P6|Overall Study|Lost to Follow-up|0
5401404|NCT02923115|18618758|P5|Overall Study|Lost to Follow-up|0
5401405|NCT02923115|18618759|P4|Overall Study|Lost to Follow-up|1
5401406|NCT02923115|18618760|P3|Overall Study|Lost to Follow-up|0
5401407|NCT02923115|18618761|P2|Overall Study|Lost to Follow-up|0
5401408|NCT02923115|18618762|P1|Overall Study|Lost to Follow-up|0
5401409|NCT02922153|18618944|P2|Overall Study|Physician Decision|1
5401410|NCT02922153|18618945|P1|Overall Study|Physician Decision|1
5401411|NCT02922153|18618944|P2|Overall Study|Lost to Follow-up|0
5401412|NCT02922153|18618945|P1|Overall Study|Lost to Follow-up|1
5401413|NCT02922153|18618944|P2|Overall Study|Death|1
5401414|NCT02922153|18618945|P1|Overall Study|Death|8
5401415|NCT02921750|18619004|P2|Overall Study|Serious Adverse Event|2
5401416|NCT02921750|18619005|P1|Overall Study|Serious Adverse Event|1
5401417|NCT02921750|18619004|P2|Overall Study|Wound healed|3
5401418|NCT02921750|18619005|P1|Overall Study|Wound healed|3
5401419|NCT02921750|18619004|P2|Overall Study|Lost to Follow-up|3
5401420|NCT02921750|18619005|P1|Overall Study|Lost to Follow-up|3
5401421|NCT02921750|18619004|P2|Overall Study|Withdrawal by Subject|1
5401422|NCT02921750|18619005|P1|Overall Study|Withdrawal by Subject|1
5401423|NCT02921750|18619004|P2|Overall Study|Adverse Event|2
5401424|NCT02921750|18619005|P1|Overall Study|Adverse Event|1
5401425|NCT02921425|18619036|P1|Overall Study|Protocol Violation|9
5401426|NCT02921087|18619108|P2|Overall Study|Withdrawal by Subject|1
5401427|NCT02921087|18619109|P1|Overall Study|Withdrawal by Subject|0
5401428|NCT02920983|18619138|P6|Dispense 3|Unacceptable Lens Fit|0
5401429|NCT02920983|18619139|P5|Dispense 3|Unacceptable Lens Fit|1
5401430|NCT02920983|18619140|P4|Dispense 3|Unacceptable Lens Fit|0
5401431|NCT02920983|18619141|P3|Dispense 3|Unacceptable Lens Fit|0
5401432|NCT02920983|18619142|P2|Dispense 3|Unacceptable Lens Fit|1
5401433|NCT02920983|18619143|P1|Dispense 3|Unacceptable Lens Fit|1
5401434|NCT02920983|18619138|P6|Dispense 2|Unscceptable lens fit|0
5401435|NCT02920983|18619139|P5|Dispense 2|Unscceptable lens fit|1
5401436|NCT02920983|18619140|P4|Dispense 2|Unscceptable lens fit|0
5401437|NCT02920983|18619141|P3|Dispense 2|Unscceptable lens fit|0
5401438|NCT02920983|18619142|P2|Dispense 2|Unscceptable lens fit|0
5401439|NCT02920983|18619143|P1|Dispense 2|Unscceptable lens fit|1
5401440|NCT02920983|18619138|P6|Dispense 1|Unacceptable Lens Fit|0
5401441|NCT02920983|18619139|P5|Dispense 1|Unacceptable Lens Fit|1
5401442|NCT02920983|18619140|P4|Dispense 1|Unacceptable Lens Fit|0
5401443|NCT02920983|18619141|P3|Dispense 1|Unacceptable Lens Fit|0
5401444|NCT02920983|18619142|P2|Dispense 1|Unacceptable Lens Fit|0
5401445|NCT02920983|18619143|P1|Dispense 1|Unacceptable Lens Fit|0
5401446|NCT02920970|18619172|P2|Second Intervention|Poor Lens Fit|0
5401447|NCT02920970|18619173|P1|Second Intervention|Poor Lens Fit|1
5401448|NCT02920970|18619172|P2|First Intervention|Adverse Event|1
5401449|NCT02920970|18619173|P1|First Intervention|Adverse Event|0
5401450|NCT02920970|18619172|P2|First Intervention|Protocol Violation|1
5401451|NCT02920970|18619173|P1|First Intervention|Protocol Violation|0
5401452|NCT02920957|18619199|P2|Second Intervention: 1 Month|Lost to Follow-up|1
5401453|NCT02920957|18619200|P1|Second Intervention: 1 Month|Lost to Follow-up|0
5401454|NCT02920957|18619199|P2|First Intervention : 1 Month|Adverse Event|0
5401455|NCT02920957|18619200|P1|First Intervention : 1 Month|Adverse Event|1
5401456|NCT02920957|18619199|P2|First Intervention : 1 Month|Lost to Follow-up|0
5401457|NCT02920957|18619200|P1|First Intervention : 1 Month|Lost to Follow-up|1
5401458|NCT02920957|18619199|P2|First Intervention : 1 Month|Withdrawal by Subject|0
5401459|NCT02920957|18619200|P1|First Intervention : 1 Month|Withdrawal by Subject|2
5401460|NCT02920450|18619289|P4|Overall Study|Withdrawal by Subject|0
5401461|NCT02920450|18619290|P3|Overall Study|Withdrawal by Subject|0
5401462|NCT02920450|18619291|P2|Overall Study|Withdrawal by Subject|0
5401463|NCT02920450|18619292|P1|Overall Study|Withdrawal by Subject|1
5401464|NCT02920450|18619289|P4|Overall Study|Death|0
5401465|NCT02920450|18619290|P3|Overall Study|Death|0
5401466|NCT02920450|18619291|P2|Overall Study|Death|0
5401467|NCT02920450|18619292|P1|Overall Study|Death|1
5401468|NCT02920242|18619303|P3|Overall Study|Did not meet inc./exc. criteria|0
5401469|NCT02920242|18619304|P2|Overall Study|Did not meet inc./exc. criteria|0
5401470|NCT02920242|18619305|P1|Overall Study|Did not meet inc./exc. criteria|1
5401471|NCT02920242|18619303|P3|Overall Study|Withdrawal by Subject|1
5401472|NCT02920242|18619304|P2|Overall Study|Withdrawal by Subject|0
5401473|NCT02920242|18619305|P1|Overall Study|Withdrawal by Subject|1
5401474|NCT02920177|18619333|P2|Overall Study|Lost to Follow-up|1
5401475|NCT02920177|18619334|P1|Overall Study|Lost to Follow-up|0
5401476|NCT02920177|18619333|P2|Overall Study|Physician Decision|0
5401477|NCT02920177|18619334|P1|Overall Study|Physician Decision|1
5401478|NCT02920177|18619333|P2|Overall Study|Withdrawal by Subject|1
5401479|NCT02920177|18619334|P1|Overall Study|Withdrawal by Subject|1
5401480|NCT02919995|18619354|P6|Overall Study|Adverse Event|1
5401481|NCT02919995|18619355|P5|Overall Study|Adverse Event|0
5401482|NCT02919995|18619356|P4|Overall Study|Adverse Event|0
5401483|NCT02919995|18619357|P3|Overall Study|Adverse Event|0
5401484|NCT02919995|18619358|P2|Overall Study|Adverse Event|0
5401485|NCT02919995|18619359|P1|Overall Study|Adverse Event|0
5401486|NCT02919761|18619422|P3|Part 2: Double-blind|Discontinued exclusion 16|2
5401487|NCT02919761|18619423|P2|Part 2: Double-blind|Discontinued exclusion 16|0
5401488|NCT02919761|18619424|P1|Part 2: Double-blind|Discontinued exclusion 16|0
5401489|NCT02919761|18619422|P3|Part 2: Double-blind|Did not meet LDA at Week 20|1
5401490|NCT02919761|18619423|P2|Part 2: Double-blind|Did not meet LDA at Week 20|0
5401491|NCT02919761|18619424|P1|Part 2: Double-blind|Did not meet LDA at Week 20|0
5401492|NCT02919761|18619422|P3|Part 2: Double-blind|Did not meet LDA at Week 16|1
5401493|NCT02919761|18619423|P2|Part 2: Double-blind|Did not meet LDA at Week 16|0
5401494|NCT02919761|18619424|P1|Part 2: Double-blind|Did not meet LDA at Week 16|0
5401495|NCT02919761|18619422|P3|Part 2: Double-blind|Worsening of disease activity|10
5401496|NCT02919761|18619423|P2|Part 2: Double-blind|Worsening of disease activity|4
5401497|NCT02919761|18619424|P1|Part 2: Double-blind|Worsening of disease activity|0
5401498|NCT02919761|18619422|P3|Part 2: Double-blind|Met withdrawal criteria|2
5401499|NCT02919761|18619423|P2|Part 2: Double-blind|Met withdrawal criteria|1
5401500|NCT02919761|18619424|P1|Part 2: Double-blind|Met withdrawal criteria|0
5401501|NCT02919761|18619422|P3|Part 2: Double-blind|Lost to Follow-up|3
5401502|NCT02919761|18619423|P2|Part 2: Double-blind|Lost to Follow-up|0
5401503|NCT02919761|18619424|P1|Part 2: Double-blind|Lost to Follow-up|0
5401504|NCT02919761|18619422|P3|Part 2: Double-blind|Adverse Event|0
5401505|NCT02919761|18619423|P2|Part 2: Double-blind|Adverse Event|1
5401506|NCT02919761|18619424|P1|Part 2: Double-blind|Adverse Event|0
5401507|NCT02919761|18619422|P3|Part 2: Double-blind|Withdrawal by Subject|2
5401508|NCT02919761|18619423|P2|Part 2: Double-blind|Withdrawal by Subject|0
5401509|NCT02919761|18619424|P1|Part 2: Double-blind|Withdrawal by Subject|0
5401510|NCT02919761|18619422|P3|Part 1: Open Label|Termination by Sponsor|0
5401511|NCT02919761|18619423|P2|Part 1: Open Label|Termination by Sponsor|0
5401512|NCT02919761|18619424|P1|Part 1: Open Label|Termination by Sponsor|1
5401513|NCT02919761|18619422|P3|Part 1: Open Label|did not meet inclusion criteria 8|0
5401514|NCT02919761|18619423|P2|Part 1: Open Label|did not meet inclusion criteria 8|0
5401515|NCT02919761|18619424|P1|Part 1: Open Label|did not meet inclusion criteria 8|1
5401516|NCT02919761|18619422|P3|Part 1: Open Label|Dose Greater Than 20mg/Week|0
5401517|NCT02919761|18619423|P2|Part 1: Open Label|Dose Greater Than 20mg/Week|0
5401518|NCT02919761|18619424|P1|Part 1: Open Label|Dose Greater Than 20mg/Week|1
5401519|NCT02919761|18619422|P3|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
5401520|NCT02919761|18619423|P2|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
5401521|NCT02919761|18619424|P1|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
5401522|NCT02919761|18619422|P3|Part 1: Open Label|Met withdrawal criteria|0
5401523|NCT02919761|18619423|P2|Part 1: Open Label|Met withdrawal criteria|0
5401524|NCT02919761|18619424|P1|Part 1: Open Label|Met withdrawal criteria|5
5401525|NCT02919761|18619422|P3|Part 1: Open Label|Lost to Follow-up|0
5401526|NCT02919761|18619423|P2|Part 1: Open Label|Lost to Follow-up|0
5401527|NCT02919761|18619424|P1|Part 1: Open Label|Lost to Follow-up|1
5401528|NCT02919761|18619422|P3|Part 1: Open Label|Adverse Event|0
5401529|NCT02919761|18619423|P2|Part 1: Open Label|Adverse Event|0
5401530|NCT02919761|18619424|P1|Part 1: Open Label|Adverse Event|1
5401531|NCT02919761|18619422|P3|Part 1: Open Label|Withdrawal by Subject|0
5401532|NCT02919761|18619423|P2|Part 1: Open Label|Withdrawal by Subject|0
5401533|NCT02919761|18619424|P1|Part 1: Open Label|Withdrawal by Subject|12
5401534|NCT02919696|18619452|P2|Overall Study|Never Treated|1
5401535|NCT02919696|18619453|P1|Overall Study|Never Treated|0
5401536|NCT02919696|18619452|P2|Overall Study|Sponsor Decision|1
5401537|NCT02919696|18619453|P1|Overall Study|Sponsor Decision|1
5401538|NCT02919696|18619452|P2|Overall Study|Withdrawal by Subject|1
5401539|NCT02919696|18619453|P1|Overall Study|Withdrawal by Subject|2
5401540|NCT02919696|18619452|P2|Overall Study|Adverse Event|2
5401541|NCT02919696|18619453|P1|Overall Study|Adverse Event|1
5401542|NCT02919683|18619475|P2|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
5401543|NCT02919683|18619476|P1|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
5401544|NCT02919683|18619475|P2|Post-Surgery Follow-Up|Death|2
5401545|NCT02919683|18619476|P1|Post-Surgery Follow-Up|Death|2
5401546|NCT02919618|18619489|P1|Overall Study|Death|1
5401547|NCT02919267|18619519|P4|Overall Study|Protocol Violation|4
5401548|NCT02919267|18619520|P3|Overall Study|Protocol Violation|3
5401549|NCT02919267|18619521|P2|Overall Study|Protocol Violation|3
5401550|NCT02919267|18619522|P1|Overall Study|Protocol Violation|0
5401551|NCT02918552|18619682|P2|Overall Study|Lost to Follow-up|1
5401552|NCT02918552|18619683|P1|Overall Study|Lost to Follow-up|0
5401553|NCT02918552|18619682|P2|Overall Study|Withdrawal by Subject|1
5401554|NCT02918552|18619683|P1|Overall Study|Withdrawal by Subject|0
5401555|NCT02918552|18619682|P2|Overall Study|Failed Pharmacokinetics|0
5401556|NCT02918552|18619683|P1|Overall Study|Failed Pharmacokinetics|1
5401557|NCT02918318|18619759|P5|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
5401558|NCT02918318|18619760|P4|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5401559|NCT02918318|18619761|P3|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5401560|NCT02918318|18619762|P2|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5401561|NCT02918318|18619763|P1|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
5401562|NCT02918318|18619759|P5|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
5401563|NCT02918318|18619760|P4|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5401564|NCT02918318|18619761|P3|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5401565|NCT02918318|18619762|P2|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5401566|NCT02918318|18619763|P1|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
5401567|NCT02918318|18619759|P5|Posttreatment Phase: Up to 24 Weeks|Other|0
5401568|NCT02918318|18619760|P4|Posttreatment Phase: Up to 24 Weeks|Other|1
5401569|NCT02918318|18619761|P3|Posttreatment Phase: Up to 24 Weeks|Other|1
5401570|NCT02918318|18619762|P2|Posttreatment Phase: Up to 24 Weeks|Other|3
5401571|NCT02918318|18619763|P1|Posttreatment Phase: Up to 24 Weeks|Other|0
5401572|NCT02918318|18619759|P5|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
5401573|NCT02918318|18619760|P4|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
5401574|NCT02918318|18619761|P3|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
5401575|NCT02918318|18619762|P2|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
5401576|NCT02918318|18619763|P1|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
5401577|NCT02918318|18619759|P5|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
5401578|NCT02918318|18619760|P4|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
5401579|NCT02918318|18619761|P3|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
5401580|NCT02918318|18619762|P2|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
5401581|NCT02918318|18619763|P1|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
5401582|NCT02918318|18619759|P5|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5401583|NCT02918318|18619760|P4|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
5401584|NCT02918318|18619761|P3|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5401585|NCT02918318|18619762|P2|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5401586|NCT02918318|18619763|P1|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
5401587|NCT02918318|18619759|P5|Double-blind Induction Phase: 4 Weeks|Other|0
5401588|NCT02918318|18619760|P4|Double-blind Induction Phase: 4 Weeks|Other|1
5401589|NCT02918318|18619761|P3|Double-blind Induction Phase: 4 Weeks|Other|0
5401590|NCT02918318|18619762|P2|Double-blind Induction Phase: 4 Weeks|Other|2
5401591|NCT02918318|18619763|P1|Double-blind Induction Phase: 4 Weeks|Other|0
5401592|NCT02918318|18619759|P5|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5401593|NCT02918318|18619760|P4|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
5401594|NCT02918318|18619761|P3|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5401595|NCT02918318|18619762|P2|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5401596|NCT02918318|18619763|P1|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
5401597|NCT02918318|18619759|P5|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
5401598|NCT02918318|18619760|P4|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
5401599|NCT02918318|18619761|P3|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
5401600|NCT02918318|18619762|P2|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
5401601|NCT02918318|18619763|P1|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
5401602|NCT02918318|18619759|P5|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5401603|NCT02918318|18619760|P4|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
5401604|NCT02918318|18619761|P3|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5401605|NCT02918318|18619762|P2|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5401606|NCT02918318|18619763|P1|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
5401607|NCT02918318|18619759|P5|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5401608|NCT02918318|18619760|P4|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
5401609|NCT02918318|18619761|P3|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5401610|NCT02918318|18619762|P2|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5401611|NCT02918318|18619763|P1|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
5401612|NCT02918318|18619759|P5|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
5401613|NCT02918318|18619760|P4|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
5401614|NCT02918318|18619761|P3|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
5401615|NCT02918318|18619762|P2|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
5401616|NCT02918318|18619763|P1|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
5401617|NCT02918279|18619824|P2|Overall Study|Other|1
5401618|NCT02918279|18619825|P1|Overall Study|Other|3
5401619|NCT02918279|18619824|P2|Overall Study|Withdrawal by parent/guardian|1
5401620|NCT02918279|18619825|P1|Overall Study|Withdrawal by parent/guardian|2
5401621|NCT02918279|18619824|P2|Overall Study|Withdrawal by Subject|15
5401622|NCT02918279|18619825|P1|Overall Study|Withdrawal by Subject|5
5401623|NCT02918279|18619824|P2|Overall Study|Lost to Follow-up|6
5401624|NCT02918279|18619825|P1|Overall Study|Lost to Follow-up|3
5401625|NCT02918266|18619961|P11|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5401626|NCT02918266|18619962|P10|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5401627|NCT02918266|18619963|P9|Part 2: Intervention Period 1 (2 Days)|Study termination|2
5401628|NCT02918266|18619964|P8|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5401629|NCT02918266|18619965|P7|Part 2: Intervention Period 1 (2 Days)|Study termination|2
5401630|NCT02918266|18619966|P6|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5401631|NCT02918266|18619967|P5|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5401632|NCT02918266|18619968|P4|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5401633|NCT02918266|18619969|P3|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5401634|NCT02918266|18619970|P2|Part 2: Intervention Period 1 (2 Days)|Study termination|1
5401635|NCT02918266|18619971|P1|Part 2: Intervention Period 1 (2 Days)|Study termination|0
5401636|NCT02918071|18620076|P1|Overall Study|Lost to Follow-up|1
5401637|NCT02918071|18620076|P1|Overall Study|Withdrawal by Subject|2
5401638|NCT02917941|18620086|P1|Survival Follow-up Period|Withdrawal by Subject|4
5401639|NCT02917941|18620086|P1|Survival Follow-up Period|Lost to Follow-up|1
5401640|NCT02917941|18620086|P1|Treatment Period|Reason not Specified|2
5401641|NCT02917941|18620086|P1|Treatment Period|Progressive Disease|11
5401642|NCT02917941|18620086|P1|Treatment Period|Adverse Event|11
5401643|NCT02917265|18620139|P2|Overall Study|Withdrawal by Subject|0
5401644|NCT02917265|18620140|P1|Overall Study|Withdrawal by Subject|1
5401645|NCT02917265|18620139|P2|Overall Study|Physician Decision|0
5401646|NCT02917265|18620140|P1|Overall Study|Physician Decision|1
5401647|NCT02916927|18620156|P2|Overall Study|Withdrawal before first time point|0
5401648|NCT02916927|18620157|P1|Overall Study|Withdrawal before first time point|1
5401649|NCT02916927|18620156|P2|Overall Study|At radiology for 45 & 60 min time points|1
5401650|NCT02916927|18620157|P1|Overall Study|At radiology for 45 & 60 min time points|0
5401651|NCT02916927|18620156|P2|Overall Study|Discharged prior to study drug receipt|2
5401652|NCT02916927|18620157|P1|Overall Study|Discharged prior to study drug receipt|0
5401653|NCT02916433|18620216|P2|Overall Study|Physician Decision|0
5401654|NCT02916433|18620217|P1|Overall Study|Physician Decision|1
5401655|NCT02916433|18620216|P2|Overall Study|Withdrawal by Subject|0
5401656|NCT02916433|18620217|P1|Overall Study|Withdrawal by Subject|1
5401657|NCT02915978|18620240|P3|Overall Study|Adverse Event|0
5401658|NCT02915978|18620241|P2|Overall Study|Adverse Event|1
5401659|NCT02915978|18620242|P1|Overall Study|Adverse Event|2
5401660|NCT02915874|18620294|P2|Overall Study|Started New Anxiety Medication|1
5401661|NCT02915874|18620295|P1|Overall Study|Started New Anxiety Medication|0
5401662|NCT02915874|18620294|P2|Overall Study|Withdrawal by Subject|1
5401663|NCT02915874|18620295|P1|Overall Study|Withdrawal by Subject|1
5401664|NCT02915874|18620294|P2|Overall Study|Lost to Follow-up|4
5401665|NCT02915874|18620295|P1|Overall Study|Lost to Follow-up|5
5401666|NCT02915835|18620315|P2|Overall Study|Withdrawal by Subject|1
5401667|NCT02915835|18620316|P1|Overall Study|Withdrawal by Subject|0
5401668|NCT02915835|18620315|P2|Overall Study|Physician Decision|0
5401669|NCT02915835|18620316|P1|Overall Study|Physician Decision|1
5401670|NCT02915783|18620440|P1|Overall Study|Ongoing: In Survival Follow Up|8
5401671|NCT02915783|18620440|P1|Overall Study|Ongoing: Receiving Treatment|6
5401672|NCT02915302|18620522|P2|Overall Study|Other|0
5401673|NCT02915302|18620523|P1|Overall Study|Other|1
5401674|NCT02915302|18620522|P2|Overall Study|Withdrawal by Subject|29
5401675|NCT02915302|18620523|P1|Overall Study|Withdrawal by Subject|22
5401676|NCT02915302|18620522|P2|Overall Study|Lost to Follow-up|22
5401677|NCT02915302|18620523|P1|Overall Study|Lost to Follow-up|19
5401678|NCT02915302|18620522|P2|Overall Study|Protocol Violation|27
5401679|NCT02915302|18620523|P1|Overall Study|Protocol Violation|20
5401680|NCT02915302|18620522|P2|Overall Study|Adverse Event|0
5401681|NCT02915302|18620523|P1|Overall Study|Adverse Event|3
5401682|NCT02915159|18620535|P2|Overall Study|Lack of Efficacy|3
5401683|NCT02915159|18620536|P1|Overall Study|Lack of Efficacy|0
5401684|NCT02915159|18620535|P2|Overall Study|Adverse Event|2
5401685|NCT02915159|18620536|P1|Overall Study|Adverse Event|2
5401686|NCT02915159|18620535|P2|Overall Study|Request to discontinue treatment|2
5401687|NCT02915159|18620536|P1|Overall Study|Request to discontinue treatment|1
5401688|NCT02915159|18620535|P2|Overall Study|Participant withdrew consent|1
5401689|NCT02915159|18620536|P1|Overall Study|Participant withdrew consent|5
5401690|NCT02915159|18620535|P2|Overall Study|poor/non-compliance|0
5401691|NCT02915159|18620536|P1|Overall Study|poor/non-compliance|1
5401692|NCT02915159|18620535|P2|Overall Study|Participant no longer meets criteria|0
5401693|NCT02915159|18620536|P1|Overall Study|Participant no longer meets criteria|2
5401694|NCT02915016|18620675|P8|Overall Study|Participant unable to adhere|1
5401695|NCT02915016|18620676|P7|Overall Study|Participant unable to adhere|0
5401696|NCT02915016|18620677|P6|Overall Study|Participant unable to adhere|0
5401697|NCT02915016|18620678|P5|Overall Study|Participant unable to adhere|0
5401698|NCT02915016|18620679|P4|Overall Study|Participant unable to adhere|0
5401699|NCT02915016|18620680|P3|Overall Study|Participant unable to adhere|0
5401700|NCT02915016|18620681|P2|Overall Study|Participant unable to adhere|0
5401701|NCT02915016|18620682|P1|Overall Study|Participant unable to adhere|0
5401702|NCT02915016|18620675|P8|Overall Study|HIV infection|0
5401703|NCT02915016|18620676|P7|Overall Study|HIV infection|0
5401704|NCT02915016|18620677|P6|Overall Study|HIV infection|0
5401705|NCT02915016|18620678|P5|Overall Study|HIV infection|1
5401706|NCT02915016|18620679|P4|Overall Study|HIV infection|0
5401707|NCT02915016|18620680|P3|Overall Study|HIV infection|1
5401708|NCT02915016|18620681|P2|Overall Study|HIV infection|1
5401709|NCT02915016|18620682|P1|Overall Study|HIV infection|1
5401710|NCT02915016|18620675|P8|Overall Study|Elected not to continue|0
5401711|NCT02915016|18620676|P7|Overall Study|Elected not to continue|1
5401712|NCT02915016|18620677|P6|Overall Study|Elected not to continue|0
5401713|NCT02915016|18620678|P5|Overall Study|Elected not to continue|0
5401714|NCT02915016|18620679|P4|Overall Study|Elected not to continue|1
5401715|NCT02915016|18620680|P3|Overall Study|Elected not to continue|0
5401716|NCT02915016|18620681|P2|Overall Study|Elected not to continue|0
5401717|NCT02915016|18620682|P1|Overall Study|Elected not to continue|0
5401718|NCT02915016|18620675|P8|Overall Study|Withdrawal by Subject|1
5401719|NCT02915016|18620676|P7|Overall Study|Withdrawal by Subject|1
5401720|NCT02915016|18620677|P6|Overall Study|Withdrawal by Subject|3
5401721|NCT02915016|18620678|P5|Overall Study|Withdrawal by Subject|1
5401722|NCT02915016|18620679|P4|Overall Study|Withdrawal by Subject|0
5401723|NCT02915016|18620680|P3|Overall Study|Withdrawal by Subject|1
5401724|NCT02915016|18620681|P2|Overall Study|Withdrawal by Subject|0
5401725|NCT02915016|18620682|P1|Overall Study|Withdrawal by Subject|2
5401726|NCT02915016|18620675|P8|Overall Study|Physician Decision|0
5401727|NCT02915016|18620676|P7|Overall Study|Physician Decision|2
5401728|NCT02915016|18620677|P6|Overall Study|Physician Decision|1
5401729|NCT02915016|18620678|P5|Overall Study|Physician Decision|0
5401730|NCT02915016|18620679|P4|Overall Study|Physician Decision|0
5401731|NCT02915016|18620680|P3|Overall Study|Physician Decision|1
5401732|NCT02915016|18620681|P2|Overall Study|Physician Decision|0
5401733|NCT02915016|18620682|P1|Overall Study|Physician Decision|0
5401734|NCT02915016|18620675|P8|Overall Study|Lost to Follow-up|2
5401735|NCT02915016|18620676|P7|Overall Study|Lost to Follow-up|8
5401736|NCT02915016|18620677|P6|Overall Study|Lost to Follow-up|2
5401737|NCT02915016|18620678|P5|Overall Study|Lost to Follow-up|5
5401738|NCT02915016|18620679|P4|Overall Study|Lost to Follow-up|3
5401739|NCT02915016|18620680|P3|Overall Study|Lost to Follow-up|5
5401740|NCT02915016|18620681|P2|Overall Study|Lost to Follow-up|2
5401741|NCT02915016|18620682|P1|Overall Study|Lost to Follow-up|4
5401742|NCT02914548|18620906|P3|Overall Study|>40% of body surface area|1
5401743|NCT02914548|18620907|P2|Overall Study|>40% of body surface area|1
5401744|NCT02914548|18620908|P1|Overall Study|>40% of body surface area|0
5401745|NCT02914548|18620906|P3|Overall Study|Withdrawal by Subject|4
5401746|NCT02914548|18620907|P2|Overall Study|Withdrawal by Subject|4
5401747|NCT02914548|18620908|P1|Overall Study|Withdrawal by Subject|3
5401748|NCT02914548|18620906|P3|Overall Study|Protocol Violation|0
5401749|NCT02914548|18620907|P2|Overall Study|Protocol Violation|0
5401750|NCT02914548|18620908|P1|Overall Study|Protocol Violation|1
5401751|NCT02914548|18620906|P3|Overall Study|Physician Decision|0
5401752|NCT02914548|18620907|P2|Overall Study|Physician Decision|2
5401753|NCT02914548|18620908|P1|Overall Study|Physician Decision|2
5401754|NCT02914548|18620906|P3|Overall Study|Adverse Event|15
5401755|NCT02914548|18620907|P2|Overall Study|Adverse Event|7
5401756|NCT02914548|18620908|P1|Overall Study|Adverse Event|15
5401757|NCT02914457|18620939|P1|Overall Study|Protocol Violation|1
5401758|NCT02914457|18620939|P1|Overall Study|ECG acquisition error due to sweating|1
5401759|NCT02914457|18620939|P1|Overall Study|Electrical instability of patient|1
5401760|NCT02914457|18620939|P1|Overall Study|No veins available for lead placement|1
5401761|NCT02914457|18620939|P1|Overall Study|Physician Decision|1
5401762|NCT02914457|18620939|P1|Overall Study|Withdrawal by Subject|1
5401763|NCT02914275|18620949|P2|Overall Study|Excluded due to invalid informed consent|0
5401764|NCT02914275|18620950|P1|Overall Study|Excluded due to invalid informed consent|3
5401765|NCT02914275|18620949|P2|Overall Study|Other|1
5401766|NCT02914275|18620950|P1|Overall Study|Other|4
5401767|NCT02914275|18620949|P2|Overall Study|Physician Decision|1
5401768|NCT02914275|18620950|P1|Overall Study|Physician Decision|3
5401769|NCT02914275|18620949|P2|Overall Study|Protocol Violation|1
5401770|NCT02914275|18620950|P1|Overall Study|Protocol Violation|1
5401771|NCT02914275|18620949|P2|Overall Study|Withdrawal by Subject|10
5401772|NCT02914275|18620950|P1|Overall Study|Withdrawal by Subject|26
5401773|NCT02914275|18620949|P2|Overall Study|Lost to Follow-up|29
5401774|NCT02914275|18620950|P1|Overall Study|Lost to Follow-up|84
5401775|NCT02914236|18620982|P1|Overall Study|Lost to Follow-up|1
5401776|NCT02914184|18621028|P4|Overall Study|Migrated/moved from the study area|1
5401777|NCT02914184|18621029|P3|Overall Study|Migrated/moved from the study area|2
5401778|NCT02914184|18621030|P2|Overall Study|Migrated/moved from the study area|1
5401779|NCT02914184|18621031|P1|Overall Study|Migrated/moved from the study area|2
5401780|NCT02914184|18621028|P4|Overall Study|Other|0
5401781|NCT02914184|18621029|P3|Overall Study|Other|0
5401782|NCT02914184|18621030|P2|Overall Study|Other|0
5401783|NCT02914184|18621031|P1|Overall Study|Other|1
5401784|NCT02914184|18621028|P4|Overall Study|Withdrawal by Subject|3
5401785|NCT02914184|18621029|P3|Overall Study|Withdrawal by Subject|7
5401786|NCT02914184|18621030|P2|Overall Study|Withdrawal by Subject|2
5401787|NCT02914184|18621031|P1|Overall Study|Withdrawal by Subject|4
5401788|NCT02914184|18621028|P4|Overall Study|Lost to Follow-up|7
5401789|NCT02914184|18621029|P3|Overall Study|Lost to Follow-up|8
5401790|NCT02914184|18621030|P2|Overall Study|Lost to Follow-up|10
5401791|NCT02914184|18621031|P1|Overall Study|Lost to Follow-up|7
5401792|NCT02913326|18621088|P2|Overall Study|Adverse Event|0
5401793|NCT02913326|18621089|P1|Overall Study|Adverse Event|1
5401794|NCT02913326|18621088|P2|Overall Study|Lost to Follow-up|1
5401795|NCT02913326|18621089|P1|Overall Study|Lost to Follow-up|0
5401796|NCT02913326|18621088|P2|Overall Study|Reason not listed|1
5401797|NCT02913326|18621089|P1|Overall Study|Reason not listed|0
5401798|NCT02913105|18621137|P3|Overall Study|Withdrawal by Subject|1
5401799|NCT02913105|18621138|P2|Overall Study|Withdrawal by Subject|3
5401800|NCT02913105|18621139|P1|Overall Study|Withdrawal by Subject|0
5401801|NCT02913105|18621137|P3|Overall Study|Physician Decision|0
5401802|NCT02913105|18621138|P2|Overall Study|Physician Decision|1
5401803|NCT02913105|18621139|P1|Overall Study|Physician Decision|1
5401804|NCT02913105|18621137|P3|Overall Study|Reason Not Specified|1
5401805|NCT02913105|18621138|P2|Overall Study|Reason Not Specified|1
5401806|NCT02913105|18621139|P1|Overall Study|Reason Not Specified|3
5401807|NCT02913105|18621137|P3|Overall Study|Non-Compliance With Study Drug|1
5401808|NCT02913105|18621138|P2|Overall Study|Non-Compliance With Study Drug|0
5401809|NCT02913105|18621139|P1|Overall Study|Non-Compliance With Study Drug|0
5401810|NCT02913105|18621137|P3|Overall Study|Adverse Event|4
5401811|NCT02913105|18621138|P2|Overall Study|Adverse Event|0
5401812|NCT02913105|18621139|P1|Overall Study|Adverse Event|11
5401813|NCT02912650|18621192|P4|Overall Study|Adverse Event|0
5401814|NCT02912650|18621193|P3|Overall Study|Adverse Event|1
5401815|NCT02912650|18621194|P2|Overall Study|Adverse Event|0
5401816|NCT02912650|18621195|P1|Overall Study|Adverse Event|0
5401817|NCT02912650|18621192|P4|Overall Study|Withdrawal by Subject|5
5401818|NCT02912650|18621193|P3|Overall Study|Withdrawal by Subject|1
5401819|NCT02912650|18621194|P2|Overall Study|Withdrawal by Subject|0
5401820|NCT02912650|18621195|P1|Overall Study|Withdrawal by Subject|1
5401821|NCT02912468|18621279|P2|Overall Study|Randomized and not treated|1
5401822|NCT02912468|18621280|P1|Overall Study|Randomized and not treated|0
5401823|NCT02912468|18621279|P2|Overall Study|Withdrawal by Subject|2
5401824|NCT02912468|18621280|P1|Overall Study|Withdrawal by Subject|6
5401825|NCT02912468|18621279|P2|Overall Study|Adverse Event|2
5401826|NCT02912468|18621280|P1|Overall Study|Adverse Event|3
5401827|NCT02912455|18621359|P2|Overall Study|Lost to Follow-up|1
5401828|NCT02912455|18621360|P1|Overall Study|Lost to Follow-up|2
5401829|NCT02912455|18621359|P2|Overall Study|Lack of Efficacy|1
5401830|NCT02912455|18621360|P1|Overall Study|Lack of Efficacy|0
5401831|NCT02912455|18621359|P2|Overall Study|Withdrawal by Subject|1
5401832|NCT02912455|18621360|P1|Overall Study|Withdrawal by Subject|0
5401833|NCT02911948|18621455|P2|Overall Study|Unclassified|3
5401834|NCT02911948|18621456|P1|Overall Study|Unclassified|0
5401835|NCT02911948|18621455|P2|Overall Study|Lack of Efficacy|1
5401836|NCT02911948|18621456|P1|Overall Study|Lack of Efficacy|0
5401837|NCT02911948|18621455|P2|Overall Study|Withdrawal by Subject|2
5401838|NCT02911948|18621456|P1|Overall Study|Withdrawal by Subject|0
5401839|NCT02911948|18621455|P2|Overall Study|Protocol Violation|1
5401840|NCT02911948|18621456|P1|Overall Study|Protocol Violation|0
5401841|NCT02911688|18621718|P2|Washout|Withdrawal by Subject|1
5401842|NCT02911688|18621719|P1|Washout|Withdrawal by Subject|0
5401843|NCT02911688|18621718|P2|Washout|Lost to Follow-up|1
5401844|NCT02911688|18621719|P1|Washout|Lost to Follow-up|1
5401845|NCT02911519|18621743|P2|Overall Study|Death|2
5401846|NCT02911519|18621744|P1|Overall Study|Death|0
5401847|NCT02911519|18621743|P2|Overall Study|Lost to Follow-up|2
5401848|NCT02911519|18621744|P1|Overall Study|Lost to Follow-up|2
5401849|NCT02910739|18621776|P4|Overall Study|Adverse Event|0
5401850|NCT02910739|18621777|P3|Overall Study|Adverse Event|0
5401851|NCT02910739|18621778|P2|Overall Study|Adverse Event|0
5401852|NCT02910739|18621779|P1|Overall Study|Adverse Event|1
5401853|NCT02910713|18621805|P1|Overall Study|Investigator Discretion|1
5401854|NCT02910713|18621805|P1|Overall Study|Enrollment cap|7
5401855|NCT02910713|18621805|P1|Overall Study|Received Neither Application|18
5401856|NCT02910713|18621805|P1|Overall Study|Received One Application|10
5401857|NCT02910713|18621805|P1|Overall Study|Subject Choice|4
5401858|NCT02910713|18621805|P1|Overall Study|Protocol Violation|2
5401859|NCT02910167|18621821|P1|Overall Study|Lost to Follow-up|18
5401860|NCT02910167|18621821|P1|Overall Study|Adverse Event|1
5401861|NCT02910089|18621846|P2|Overall Study|Lost insurance eligibility|16
5401862|NCT02910089|18621847|P1|Overall Study|Lost insurance eligibility|22
5401863|NCT02910011|18621859|P1|Overall Study|Physician Decision|2
5401864|NCT02909907|18621968|P2|Overall Study|Withdrawal by Subject|1
5401865|NCT02909907|18621969|P1|Overall Study|Withdrawal by Subject|0
5401866|NCT02909504|18622010|P1|Overall Study|Lost to Follow-up|1
5401867|NCT02909504|18622010|P1|Overall Study|Subject moved|1
5401868|NCT02909504|18622010|P1|Overall Study|Pregnancy|1
5401869|NCT02909504|18622010|P1|Overall Study|Withdrawal by Subject|4
5401870|NCT02909504|18622010|P1|Overall Study|Lack of Efficacy|3
5401871|NCT02909504|18622010|P1|Overall Study|Adverse Event|2
5401872|NCT02909153|18622047|P5|Overall Study|Withdrawal by Subject|0
5401873|NCT02909153|18622048|P4|Overall Study|Withdrawal by Subject|0
5401874|NCT02909153|18622049|P3|Overall Study|Withdrawal by Subject|0
5401875|NCT02909153|18622050|P2|Overall Study|Withdrawal by Subject|1
5401876|NCT02909153|18622051|P1|Overall Study|Withdrawal by Subject|0
5401877|NCT02909101|18622141|P2|Overall Study|Lost to Follow-up|1
5401878|NCT02909101|18622142|P1|Overall Study|Lost to Follow-up|1
5401879|NCT02908880|18622160|P1|Overall Study|Death|5
5401880|NCT02908880|18622160|P1|Overall Study|Withdrawal by Subject|17
5401881|NCT02908880|18622160|P1|Overall Study|Explantation of the device|1
5401882|NCT02908880|18622160|P1|Overall Study|Lost to Follow-up|4
5401883|NCT02908841|18622170|P2|Overall Study|Physician Decision|0
5401884|NCT02908841|18622171|P1|Overall Study|Physician Decision|4
5401885|NCT02908672|18622189|P2|Overall Study|Discontinued the study during run-in|0
5401886|NCT02908672|18622190|P1|Overall Study|Discontinued the study during run-in|3
5401887|NCT02908672|18622189|P2|Overall Study|Study is ongoing|141
5401888|NCT02908672|18622190|P1|Overall Study|Study is ongoing|124
5401889|NCT02908672|18622189|P2|Overall Study|Withdrawal by Subject|18
5401890|NCT02908672|18622190|P1|Overall Study|Withdrawal by Subject|13
5401891|NCT02908672|18622189|P2|Overall Study|Protocol Violation|1
5401892|NCT02908672|18622190|P1|Overall Study|Protocol Violation|1
5401893|NCT02908672|18622189|P2|Overall Study|Other|0
5401894|NCT02908672|18622190|P1|Overall Study|Other|2
5401895|NCT02908672|18622189|P2|Overall Study|Lost to Follow-up|3
5401896|NCT02908672|18622190|P1|Overall Study|Lost to Follow-up|3
5401897|NCT02908672|18622189|P2|Overall Study|Death|93
5401898|NCT02908672|18622190|P1|Overall Study|Death|112
5401899|NCT02908529|18622263|P2|Overall Study|Lost to Follow-up|2
5401900|NCT02908529|18622264|P1|Overall Study|Lost to Follow-up|0
5401901|NCT02908516|18622274|P2|Overall Study|Study Terminated|3
5401902|NCT02908516|18622275|P1|Overall Study|Study Terminated|3
5401903|NCT02908464|18622291|P2|Overall Study|Found ineligible after randomization|2
5401904|NCT02908464|18622292|P1|Overall Study|Found ineligible after randomization|0
5401905|NCT02908464|18622291|P2|Overall Study|Withdrawal by Subject|1
5401906|NCT02908464|18622292|P1|Overall Study|Withdrawal by Subject|2
5401907|NCT02908347|18622313|P2|Overall Study|Lost to Follow-up|0
5401908|NCT02908347|18622314|P1|Overall Study|Lost to Follow-up|1
5401909|NCT02908347|18622313|P2|Overall Study|Adverse Event|1
5401910|NCT02908347|18622314|P1|Overall Study|Adverse Event|0
5401911|NCT02908100|18622410|P3|Overall Study|Randomised in Error|0
5401912|NCT02908100|18622411|P2|Overall Study|Randomised in Error|0
5401913|NCT02908100|18622412|P1|Overall Study|Randomised in Error|1
5401914|NCT02908100|18622410|P3|Overall Study|Withdrawal by Subject|5
5401915|NCT02908100|18622411|P2|Overall Study|Withdrawal by Subject|7
5401916|NCT02908100|18622412|P1|Overall Study|Withdrawal by Subject|8
5401917|NCT02908100|18622410|P3|Overall Study|Pregnancy|0
5401918|NCT02908100|18622411|P2|Overall Study|Pregnancy|2
5401919|NCT02908100|18622412|P1|Overall Study|Pregnancy|1
5401920|NCT02908100|18622410|P3|Overall Study|Physician Decision|0
5401921|NCT02908100|18622411|P2|Overall Study|Physician Decision|1
5401922|NCT02908100|18622412|P1|Overall Study|Physician Decision|0
5401923|NCT02908100|18622410|P3|Overall Study|Non-Compliance With Contraceptive Method|0
5401924|NCT02908100|18622411|P2|Overall Study|Non-Compliance With Contraceptive Method|0
5401925|NCT02908100|18622412|P1|Overall Study|Non-Compliance With Contraceptive Method|1
5401926|NCT02908100|18622410|P3|Overall Study|Non-Compliance With Study Drug|2
5401927|NCT02908100|18622411|P2|Overall Study|Non-Compliance With Study Drug|1
5401928|NCT02908100|18622412|P1|Overall Study|Non-Compliance With Study Drug|1
5401929|NCT02908100|18622410|P3|Overall Study|Lost to Follow-up|2
5401930|NCT02908100|18622411|P2|Overall Study|Lost to Follow-up|1
5401931|NCT02908100|18622412|P1|Overall Study|Lost to Follow-up|0
5401932|NCT02908100|18622410|P3|Overall Study|Lack of Efficacy|3
5401933|NCT02908100|18622411|P2|Overall Study|Lack of Efficacy|3
5401934|NCT02908100|18622412|P1|Overall Study|Lack of Efficacy|2
5401935|NCT02908100|18622410|P3|Overall Study|Death|0
5401936|NCT02908100|18622411|P2|Overall Study|Death|0
5401937|NCT02908100|18622412|P1|Overall Study|Death|2
5401938|NCT02908100|18622410|P3|Overall Study|Adverse Event|9
5401939|NCT02908100|18622411|P2|Overall Study|Adverse Event|6
5401940|NCT02908100|18622412|P1|Overall Study|Adverse Event|7
5401941|NCT02907892|18622448|P2|Overall Study|Lost to Follow-up|40
5401942|NCT02907892|18622449|P1|Overall Study|Lost to Follow-up|27
5401943|NCT02907619|18622469|P3|Overall Study|Other|0
5401944|NCT02907619|18622470|P2|Overall Study|Other|1
5401945|NCT02907619|18622471|P1|Overall Study|Other|0
5401946|NCT02907619|18622469|P3|Overall Study|Withdrawal by Subject|0
5401947|NCT02907619|18622470|P2|Overall Study|Withdrawal by Subject|1
5401948|NCT02907619|18622471|P1|Overall Study|Withdrawal by Subject|1
5401949|NCT02907619|18622469|P3|Overall Study|Death|1
5401950|NCT02907619|18622470|P2|Overall Study|Death|0
5401951|NCT02907619|18622471|P1|Overall Study|Death|0
5401952|NCT02907619|18622469|P3|Overall Study|Study terminated by sponsor|19
5401953|NCT02907619|18622470|P2|Overall Study|Study terminated by sponsor|18
5401954|NCT02907619|18622471|P1|Overall Study|Study terminated by sponsor|18
5401955|NCT02907463|18622687|P1|Overall Study|Missing Exit Form|1
5401956|NCT02907463|18622687|P1|Overall Study|Device Explanted|1
5401957|NCT02907463|18622687|P1|Overall Study|Not Implanted with Study Device|2
5401958|NCT02907463|18622687|P1|Overall Study|MIS Approach was not used|2
5401959|NCT02907463|18622687|P1|Overall Study|Withdrawal by Subject|4
5401960|NCT02907463|18622687|P1|Overall Study|Death|10
5401961|NCT02907463|18622687|P1|Overall Study|Lost to Follow-up|17
5401962|NCT02907216|18622769|P2|Overall Study|Withdrawal by Subject|0
5401963|NCT02907216|18622770|P1|Overall Study|Withdrawal by Subject|1
5401964|NCT02907216|18622769|P2|Overall Study|No benefit to be obtained by continuing|1
5401965|NCT02907216|18622770|P1|Overall Study|No benefit to be obtained by continuing|0
5401966|NCT02906930|18622822|P4|Overall Study|Other|2
5401967|NCT02906930|18622823|P3|Overall Study|Other|1
5401968|NCT02906930|18622824|P2|Overall Study|Other|2
5401969|NCT02906930|18622825|P1|Overall Study|Other|1
5401970|NCT02906930|18622822|P4|Overall Study|Death|0
5401971|NCT02906930|18622823|P3|Overall Study|Death|1
5401972|NCT02906930|18622824|P2|Overall Study|Death|0
5401973|NCT02906930|18622825|P1|Overall Study|Death|0
5401974|NCT02906930|18622822|P4|Overall Study|Lost to Follow-up|2
5401975|NCT02906930|18622823|P3|Overall Study|Lost to Follow-up|5
5401976|NCT02906930|18622824|P2|Overall Study|Lost to Follow-up|7
5401977|NCT02906930|18622825|P1|Overall Study|Lost to Follow-up|5
5401978|NCT02906930|18622822|P4|Overall Study|Withdrawal by Subject|4
5401979|NCT02906930|18622823|P3|Overall Study|Withdrawal by Subject|5
5401980|NCT02906930|18622824|P2|Overall Study|Withdrawal by Subject|5
5401981|NCT02906930|18622825|P1|Overall Study|Withdrawal by Subject|0
5401982|NCT02906917|18623018|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
5401983|NCT02906917|18623019|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
5401984|NCT02906917|18623018|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
5401985|NCT02906917|18623019|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
5401986|NCT02906917|18623018|P2|Intensification Period (Week 26-38)|Adverse Event|2
5401987|NCT02906917|18623019|P1|Intensification Period (Week 26-38)|Adverse Event|0
5401988|NCT02906917|18623018|P2|Intensification Period (Week 26-38)|Unclassified|2
5401989|NCT02906917|18623019|P1|Intensification Period (Week 26-38)|Unclassified|3
5401990|NCT02906917|18623018|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
5401991|NCT02906917|18623019|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
5401992|NCT02906917|18623018|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
5401993|NCT02906917|18623019|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
5401994|NCT02906917|18623018|P2|Initiation Period (Week 0-26)|Adverse Event|0
5401995|NCT02906917|18623019|P1|Initiation Period (Week 0-26)|Adverse Event|1
5401996|NCT02906917|18623018|P2|Initiation Period (Week 0-26)|Unclassified|3
5401997|NCT02906917|18623019|P1|Initiation Period (Week 0-26)|Unclassified|1
5401998|NCT02906709|18623080|P2|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
5401999|NCT02906709|18623081|P1|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
5402000|NCT02906709|18623080|P2|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
5402001|NCT02906709|18623081|P1|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
5402002|NCT02906709|18623080|P2|Phase A (Week 0 to Week 16)|Death|1
5402003|NCT02906709|18623081|P1|Phase A (Week 0 to Week 16)|Death|0
5402004|NCT02906709|18623080|P2|Phase A (Week 0 to Week 16)|Adverse Event|2
5402005|NCT02906709|18623081|P1|Phase A (Week 0 to Week 16)|Adverse Event|1
5402006|NCT02906670|18623135|P10|Cohort 5P, QW|Radiological Progression|0
5402007|NCT02906670|18623136|P9|Cohort 5P, QW|Radiological Progression|0
5402008|NCT02906670|18623137|P8|Cohort 5P, QW|Radiological Progression|0
5402009|NCT02906670|18623138|P7|Cohort 5P, QW|Radiological Progression|0
5402010|NCT02906670|18623139|P6|Cohort 5P, QW|Radiological Progression|0
5402011|NCT02906670|18623140|P5|Cohort 5P, QW|Radiological Progression|3
5402012|NCT02906670|18623141|P4|Cohort 5P, QW|Radiological Progression|0
5402013|NCT02906670|18623142|P3|Cohort 5P, QW|Radiological Progression|0
5402014|NCT02906670|18623143|P2|Cohort 5P, QW|Radiological Progression|0
5402015|NCT02906670|18623144|P1|Cohort 5P, QW|Radiological Progression|0
5402016|NCT02906670|18623135|P10|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
5402017|NCT02906670|18623136|P9|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5402018|NCT02906670|18623137|P8|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5402019|NCT02906670|18623138|P7|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5402020|NCT02906670|18623139|P6|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5402021|NCT02906670|18623140|P5|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5402022|NCT02906670|18623141|P4|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5402023|NCT02906670|18623142|P3|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5402024|NCT02906670|18623143|P2|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5402025|NCT02906670|18623144|P1|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
5402026|NCT02906670|18623135|P10|Cohort 7P, Q2W|Physician Decision|1
5402027|NCT02906670|18623136|P9|Cohort 7P, Q2W|Physician Decision|0
5402028|NCT02906670|18623137|P8|Cohort 7P, Q2W|Physician Decision|0
5402029|NCT02906670|18623138|P7|Cohort 7P, Q2W|Physician Decision|0
5402030|NCT02906670|18623139|P6|Cohort 7P, Q2W|Physician Decision|0
5402031|NCT02906670|18623140|P5|Cohort 7P, Q2W|Physician Decision|0
5402032|NCT02906670|18623141|P4|Cohort 7P, Q2W|Physician Decision|0
5402033|NCT02906670|18623142|P3|Cohort 7P, Q2W|Physician Decision|0
5402034|NCT02906670|18623143|P2|Cohort 7P, Q2W|Physician Decision|0
5402035|NCT02906670|18623144|P1|Cohort 7P, Q2W|Physician Decision|0
5402036|NCT02906670|18623135|P10|Cohort 7P, Q2W|Adverse Event|1
5402037|NCT02906670|18623136|P9|Cohort 7P, Q2W|Adverse Event|0
5402038|NCT02906670|18623137|P8|Cohort 7P, Q2W|Adverse Event|0
5402039|NCT02906670|18623138|P7|Cohort 7P, Q2W|Adverse Event|0
5402040|NCT02906670|18623139|P6|Cohort 7P, Q2W|Adverse Event|0
5402041|NCT02906670|18623140|P5|Cohort 7P, Q2W|Adverse Event|0
5402042|NCT02906670|18623141|P4|Cohort 7P, Q2W|Adverse Event|0
5402043|NCT02906670|18623142|P3|Cohort 7P, Q2W|Adverse Event|0
5402044|NCT02906670|18623143|P2|Cohort 7P, Q2W|Adverse Event|0
5402045|NCT02906670|18623144|P1|Cohort 7P, Q2W|Adverse Event|0
5402046|NCT02906670|18623135|P10|Cohort 4P, QW|Radiological Progression|0
5402047|NCT02906670|18623136|P9|Cohort 4P, QW|Radiological Progression|0
5402048|NCT02906670|18623137|P8|Cohort 4P, QW|Radiological Progression|0
5402049|NCT02906670|18623138|P7|Cohort 4P, QW|Radiological Progression|0
5402050|NCT02906670|18623139|P6|Cohort 4P, QW|Radiological Progression|0
5402051|NCT02906670|18623140|P5|Cohort 4P, QW|Radiological Progression|0
5402052|NCT02906670|18623141|P4|Cohort 4P, QW|Radiological Progression|3
5402053|NCT02906670|18623142|P3|Cohort 4P, QW|Radiological Progression|0
5402054|NCT02906670|18623143|P2|Cohort 4P, QW|Radiological Progression|0
5402055|NCT02906670|18623144|P1|Cohort 4P, QW|Radiological Progression|0
5402056|NCT02906670|18623135|P10|Cohort 6P, Q2W|Clinical Progression|0
5402057|NCT02906670|18623136|P9|Cohort 6P, Q2W|Clinical Progression|3
5402058|NCT02906670|18623137|P8|Cohort 6P, Q2W|Clinical Progression|0
5402059|NCT02906670|18623138|P7|Cohort 6P, Q2W|Clinical Progression|0
5402060|NCT02906670|18623139|P6|Cohort 6P, Q2W|Clinical Progression|0
5402061|NCT02906670|18623140|P5|Cohort 6P, Q2W|Clinical Progression|0
5402062|NCT02906670|18623141|P4|Cohort 6P, Q2W|Clinical Progression|0
5402063|NCT02906670|18623142|P3|Cohort 6P, Q2W|Clinical Progression|0
5402064|NCT02906670|18623143|P2|Cohort 6P, Q2W|Clinical Progression|0
5402065|NCT02906670|18623144|P1|Cohort 6P, Q2W|Clinical Progression|0
5402066|NCT02906670|18623135|P10|Cohort 6P, Q2W|Radiological Progression|0
5402067|NCT02906670|18623136|P9|Cohort 6P, Q2W|Radiological Progression|1
5402068|NCT02906670|18623137|P8|Cohort 6P, Q2W|Radiological Progression|0
5402069|NCT02906670|18623138|P7|Cohort 6P, Q2W|Radiological Progression|0
5402070|NCT02906670|18623139|P6|Cohort 6P, Q2W|Radiological Progression|0
5402071|NCT02906670|18623140|P5|Cohort 6P, Q2W|Radiological Progression|0
5402072|NCT02906670|18623141|P4|Cohort 6P, Q2W|Radiological Progression|0
5402073|NCT02906670|18623142|P3|Cohort 6P, Q2W|Radiological Progression|0
5402074|NCT02906670|18623143|P2|Cohort 6P, Q2W|Radiological Progression|0
5402075|NCT02906670|18623144|P1|Cohort 6P, Q2W|Radiological Progression|0
5402076|NCT02906670|18623135|P10|Cohort 5P, Q2W|Adverse Event|0
5402077|NCT02906670|18623136|P9|Cohort 5P, Q2W|Adverse Event|0
5402078|NCT02906670|18623137|P8|Cohort 5P, Q2W|Adverse Event|1
5402079|NCT02906670|18623138|P7|Cohort 5P, Q2W|Adverse Event|0
5402080|NCT02906670|18623139|P6|Cohort 5P, Q2W|Adverse Event|0
5402081|NCT02906670|18623140|P5|Cohort 5P, Q2W|Adverse Event|0
5402082|NCT02906670|18623141|P4|Cohort 5P, Q2W|Adverse Event|0
5402083|NCT02906670|18623142|P3|Cohort 5P, Q2W|Adverse Event|0
5402084|NCT02906670|18623143|P2|Cohort 5P, Q2W|Adverse Event|0
5402085|NCT02906670|18623144|P1|Cohort 5P, Q2W|Adverse Event|0
5402086|NCT02906670|18623135|P10|Cohort 5P, Q2W|Radiological Progression|0
5402087|NCT02906670|18623136|P9|Cohort 5P, Q2W|Radiological Progression|0
5402088|NCT02906670|18623137|P8|Cohort 5P, Q2W|Radiological Progression|2
5402089|NCT02906670|18623138|P7|Cohort 5P, Q2W|Radiological Progression|0
5402090|NCT02906670|18623139|P6|Cohort 5P, Q2W|Radiological Progression|0
5402091|NCT02906670|18623140|P5|Cohort 5P, Q2W|Radiological Progression|0
5402092|NCT02906670|18623141|P4|Cohort 5P, Q2W|Radiological Progression|0
5402093|NCT02906670|18623142|P3|Cohort 5P, Q2W|Radiological Progression|0
5402094|NCT02906670|18623143|P2|Cohort 5P, Q2W|Radiological Progression|0
5402095|NCT02906670|18623144|P1|Cohort 5P, Q2W|Radiological Progression|0
5402096|NCT02906670|18623135|P10|Cohort 5, Q2W|Lack of Clinical Benefit|0
5402097|NCT02906670|18623136|P9|Cohort 5, Q2W|Lack of Clinical Benefit|0
5402098|NCT02906670|18623137|P8|Cohort 5, Q2W|Lack of Clinical Benefit|0
5402099|NCT02906670|18623138|P7|Cohort 5, Q2W|Lack of Clinical Benefit|1
5402100|NCT02906670|18623139|P6|Cohort 5, Q2W|Lack of Clinical Benefit|0
5402101|NCT02906670|18623140|P5|Cohort 5, Q2W|Lack of Clinical Benefit|0
5402102|NCT02906670|18623141|P4|Cohort 5, Q2W|Lack of Clinical Benefit|0
5402103|NCT02906670|18623142|P3|Cohort 5, Q2W|Lack of Clinical Benefit|0
5402104|NCT02906670|18623143|P2|Cohort 5, Q2W|Lack of Clinical Benefit|0
5402105|NCT02906670|18623144|P1|Cohort 5, Q2W|Lack of Clinical Benefit|0
5402106|NCT02906670|18623135|P10|Cohort 5, Q2W|Adverse Event|0
5402107|NCT02906670|18623136|P9|Cohort 5, Q2W|Adverse Event|0
5402108|NCT02906670|18623137|P8|Cohort 5, Q2W|Adverse Event|0
5402109|NCT02906670|18623138|P7|Cohort 5, Q2W|Adverse Event|1
5402110|NCT02906670|18623139|P6|Cohort 5, Q2W|Adverse Event|0
5402111|NCT02906670|18623140|P5|Cohort 5, Q2W|Adverse Event|0
5402112|NCT02906670|18623141|P4|Cohort 5, Q2W|Adverse Event|0
5402113|NCT02906670|18623142|P3|Cohort 5, Q2W|Adverse Event|0
5402114|NCT02906670|18623143|P2|Cohort 5, Q2W|Adverse Event|0
5402115|NCT02906670|18623144|P1|Cohort 5, Q2W|Adverse Event|0
5402116|NCT02906670|18623135|P10|Cohort 5, Q2W|Clinical Progression|0
5402117|NCT02906670|18623136|P9|Cohort 5, Q2W|Clinical Progression|0
5402118|NCT02906670|18623137|P8|Cohort 5, Q2W|Clinical Progression|0
5402119|NCT02906670|18623138|P7|Cohort 5, Q2W|Clinical Progression|1
5402120|NCT02906670|18623139|P6|Cohort 5, Q2W|Clinical Progression|0
5402121|NCT02906670|18623140|P5|Cohort 5, Q2W|Clinical Progression|0
5402122|NCT02906670|18623141|P4|Cohort 5, Q2W|Clinical Progression|0
5402123|NCT02906670|18623142|P3|Cohort 5, Q2W|Clinical Progression|0
5402124|NCT02906670|18623143|P2|Cohort 5, Q2W|Clinical Progression|0
5402125|NCT02906670|18623144|P1|Cohort 5, Q2W|Clinical Progression|0
5402126|NCT02906670|18623135|P10|Cohort 5, Q2W|Radiological Progression|0
5402127|NCT02906670|18623136|P9|Cohort 5, Q2W|Radiological Progression|0
5402128|NCT02906670|18623137|P8|Cohort 5, Q2W|Radiological Progression|0
5402129|NCT02906670|18623138|P7|Cohort 5, Q2W|Radiological Progression|4
5402130|NCT02906670|18623139|P6|Cohort 5, Q2W|Radiological Progression|0
5402131|NCT02906670|18623140|P5|Cohort 5, Q2W|Radiological Progression|0
5402132|NCT02906670|18623141|P4|Cohort 5, Q2W|Radiological Progression|0
5402133|NCT02906670|18623142|P3|Cohort 5, Q2W|Radiological Progression|0
5402134|NCT02906670|18623143|P2|Cohort 5, Q2W|Radiological Progression|0
5402135|NCT02906670|18623144|P1|Cohort 5, Q2W|Radiological Progression|0
5402136|NCT02906670|18623135|P10|Cohort 4, Q2W|Clinical Progression|0
5402137|NCT02906670|18623136|P9|Cohort 4, Q2W|Clinical Progression|0
5402138|NCT02906670|18623137|P8|Cohort 4, Q2W|Clinical Progression|0
5402139|NCT02906670|18623138|P7|Cohort 4, Q2W|Clinical Progression|0
5402140|NCT02906670|18623139|P6|Cohort 4, Q2W|Clinical Progression|2
5402141|NCT02906670|18623140|P5|Cohort 4, Q2W|Clinical Progression|0
5402142|NCT02906670|18623141|P4|Cohort 4, Q2W|Clinical Progression|0
5402143|NCT02906670|18623142|P3|Cohort 4, Q2W|Clinical Progression|0
5402144|NCT02906670|18623143|P2|Cohort 4, Q2W|Clinical Progression|0
5402145|NCT02906670|18623144|P1|Cohort 4, Q2W|Clinical Progression|0
5402146|NCT02906670|18623135|P10|Cohort 4, Q2W|Radiological Progression|0
5402147|NCT02906670|18623136|P9|Cohort 4, Q2W|Radiological Progression|0
5402148|NCT02906670|18623137|P8|Cohort 4, Q2W|Radiological Progression|0
5402149|NCT02906670|18623138|P7|Cohort 4, Q2W|Radiological Progression|0
5402150|NCT02906670|18623139|P6|Cohort 4, Q2W|Radiological Progression|1
5402151|NCT02906670|18623140|P5|Cohort 4, Q2W|Radiological Progression|0
5402152|NCT02906670|18623141|P4|Cohort 4, Q2W|Radiological Progression|0
5402153|NCT02906670|18623142|P3|Cohort 4, Q2W|Radiological Progression|0
5402154|NCT02906670|18623143|P2|Cohort 4, Q2W|Radiological Progression|0
5402155|NCT02906670|18623144|P1|Cohort 4, Q2W|Radiological Progression|0
5402156|NCT02906670|18623135|P10|Cohort 3, QW|Lack of Clinical Benefit|0
5402157|NCT02906670|18623136|P9|Cohort 3, QW|Lack of Clinical Benefit|0
5402158|NCT02906670|18623137|P8|Cohort 3, QW|Lack of Clinical Benefit|0
5402159|NCT02906670|18623138|P7|Cohort 3, QW|Lack of Clinical Benefit|0
5402160|NCT02906670|18623139|P6|Cohort 3, QW|Lack of Clinical Benefit|0
5402161|NCT02906670|18623140|P5|Cohort 3, QW|Lack of Clinical Benefit|0
5402162|NCT02906670|18623141|P4|Cohort 3, QW|Lack of Clinical Benefit|0
5402163|NCT02906670|18623142|P3|Cohort 3, QW|Lack of Clinical Benefit|2
5402164|NCT02906670|18623143|P2|Cohort 3, QW|Lack of Clinical Benefit|0
5402165|NCT02906670|18623144|P1|Cohort 3, QW|Lack of Clinical Benefit|0
5402166|NCT02906670|18623135|P10|Cohort 3, QW|Radiological Progression|0
5402167|NCT02906670|18623136|P9|Cohort 3, QW|Radiological Progression|0
5402168|NCT02906670|18623137|P8|Cohort 3, QW|Radiological Progression|0
5402169|NCT02906670|18623138|P7|Cohort 3, QW|Radiological Progression|0
5402170|NCT02906670|18623139|P6|Cohort 3, QW|Radiological Progression|0
5402171|NCT02906670|18623140|P5|Cohort 3, QW|Radiological Progression|0
5402172|NCT02906670|18623141|P4|Cohort 3, QW|Radiological Progression|0
5402173|NCT02906670|18623142|P3|Cohort 3, QW|Radiological Progression|2
5402174|NCT02906670|18623143|P2|Cohort 3, QW|Radiological Progression|0
5402175|NCT02906670|18623144|P1|Cohort 3, QW|Radiological Progression|0
5402176|NCT02906670|18623135|P10|Cohort 2, QW|Radiological Progression|0
5402177|NCT02906670|18623136|P9|Cohort 2, QW|Radiological Progression|0
5402178|NCT02906670|18623137|P8|Cohort 2, QW|Radiological Progression|0
5402179|NCT02906670|18623138|P7|Cohort 2, QW|Radiological Progression|0
5402180|NCT02906670|18623139|P6|Cohort 2, QW|Radiological Progression|0
5402181|NCT02906670|18623140|P5|Cohort 2, QW|Radiological Progression|0
5402182|NCT02906670|18623141|P4|Cohort 2, QW|Radiological Progression|0
5402183|NCT02906670|18623142|P3|Cohort 2, QW|Radiological Progression|0
5402184|NCT02906670|18623143|P2|Cohort 2, QW|Radiological Progression|1
5402185|NCT02906670|18623144|P1|Cohort 2, QW|Radiological Progression|0
5402186|NCT02906670|18623135|P10|Cohort 1, QW|Radiological Progression|0
5402187|NCT02906670|18623136|P9|Cohort 1, QW|Radiological Progression|0
5402188|NCT02906670|18623137|P8|Cohort 1, QW|Radiological Progression|0
5402189|NCT02906670|18623138|P7|Cohort 1, QW|Radiological Progression|0
5402190|NCT02906670|18623139|P6|Cohort 1, QW|Radiological Progression|0
5402191|NCT02906670|18623140|P5|Cohort 1, QW|Radiological Progression|0
5402192|NCT02906670|18623141|P4|Cohort 1, QW|Radiological Progression|0
5402193|NCT02906670|18623142|P3|Cohort 1, QW|Radiological Progression|0
5402194|NCT02906670|18623143|P2|Cohort 1, QW|Radiological Progression|0
5402195|NCT02906670|18623144|P1|Cohort 1, QW|Radiological Progression|1
5402196|NCT02906644|18623261|P2|Weeks 3 to 14|Lost to Follow-up|4
5402197|NCT02906644|18623262|P1|Weeks 3 to 14|Lost to Follow-up|3
5402198|NCT02906644|18623261|P2|Weeks 3 to 14|Withdrawal by Subject|7
5402199|NCT02906644|18623262|P1|Weeks 3 to 14|Withdrawal by Subject|13
5402200|NCT02906644|18623261|P2|First 2 Weeks|Physician Decision|1
5402201|NCT02906644|18623262|P1|First 2 Weeks|Physician Decision|1
5402202|NCT02906644|18623261|P2|First 2 Weeks|Withdrawal by Subject|2
5402203|NCT02906644|18623262|P1|First 2 Weeks|Withdrawal by Subject|0
5402204|NCT02906579|18623278|P1|Overall Study|Physician Decision|1
5402205|NCT02906579|18623278|P1|Overall Study|Adverse Event|1
5402206|NCT02906358|18623482|P2|Overall Study|Lost to Follow-up|15
5402207|NCT02906358|18623483|P1|Overall Study|Lost to Follow-up|12
5402208|NCT02906358|18623482|P2|Overall Study|Withdrawal by Subject|7
5402209|NCT02906358|18623483|P1|Overall Study|Withdrawal by Subject|10
5402210|NCT02905825|18623517|P1|Overall Study|Device Malfunction|1
5402211|NCT02905825|18623517|P1|Overall Study|Protocol Violation|11
5402212|NCT02905331|18623525|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
5402213|NCT02905331|18623526|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
5402214|NCT02905331|18623527|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
5402215|NCT02905331|18623525|P3|Active Treatment and Follow up (wk16-40)|Other|0
5402216|NCT02905331|18623526|P2|Active Treatment and Follow up (wk16-40)|Other|6
5402217|NCT02905331|18623527|P1|Active Treatment and Follow up (wk16-40)|Other|0
5402218|NCT02905331|18623525|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
5402219|NCT02905331|18623526|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
5402220|NCT02905331|18623527|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
5402221|NCT02905331|18623525|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
5402222|NCT02905331|18623526|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
5402223|NCT02905331|18623527|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
5402224|NCT02905331|18623525|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
5402225|NCT02905331|18623526|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
5402226|NCT02905331|18623527|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
5402227|NCT02905266|18623555|P2|Maintenance Phase Part 2|Maximum Clinical Benefit|2
5402228|NCT02905266|18623556|P1|Maintenance Phase Part 2|Maximum Clinical Benefit|0
5402229|NCT02905266|18623555|P2|Maintenance Phase Part 2|Study Drug Toxicity|4
5402230|NCT02905266|18623556|P1|Maintenance Phase Part 2|Study Drug Toxicity|3
5402231|NCT02905266|18623555|P2|Maintenance Phase Part 2|Disease Progression|2
5402232|NCT02905266|18623556|P1|Maintenance Phase Part 2|Disease Progression|9
5402233|NCT02905266|18623555|P2|Transition From Part 1 to Part 2|Adverse Event|1
5402234|NCT02905266|18623556|P1|Transition From Part 1 to Part 2|Adverse Event|1
5402235|NCT02905266|18623555|P2|Transition From Part 1 to Part 2|Participant withdrew consent|1
5402236|NCT02905266|18623556|P1|Transition From Part 1 to Part 2|Participant withdrew consent|0
5402237|NCT02905266|18623555|P2|Transition From Part 1 to Part 2|Death|1
5402238|NCT02905266|18623556|P1|Transition From Part 1 to Part 2|Death|0
5402239|NCT02905266|18623555|P2|Transition From Part 1 to Part 2|Study drug toxicity|4
5402240|NCT02905266|18623556|P1|Transition From Part 1 to Part 2|Study drug toxicity|0
5402241|NCT02905266|18623555|P2|Transition From Part 1 to Part 2|Disease progression|1
5402242|NCT02905266|18623556|P1|Transition From Part 1 to Part 2|Disease progression|2
5402243|NCT02905266|18623555|P2|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0
5402244|NCT02905266|18623556|P1|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1
5402245|NCT02905266|18623555|P2|Treatment Phase Part 1|Study Drug Toxicity|16
5402246|NCT02905266|18623556|P1|Treatment Phase Part 1|Study Drug Toxicity|22
5402247|NCT02905266|18623555|P2|Treatment Phase Part 1|Disease Progression|7
5402248|NCT02905266|18623556|P1|Treatment Phase Part 1|Disease Progression|6
5402249|NCT02905266|18623555|P2|Treatment Phase Part 1|Participant Withdrew Consent|0
5402250|NCT02905266|18623556|P1|Treatment Phase Part 1|Participant Withdrew Consent|1
5402251|NCT02905149|18623584|P2|Overall Study|Lost to Follow-up|0
5402252|NCT02905149|18623585|P1|Overall Study|Lost to Follow-up|2
5402253|NCT02905006|18623603|P6|Overall Study|Patient randomized by mistake|1
5402254|NCT02905006|18623604|P5|Overall Study|Patient randomized by mistake|0
5402255|NCT02905006|18623605|P4|Overall Study|Patient randomized by mistake|0
5402256|NCT02905006|18623606|P3|Overall Study|Patient randomized by mistake|0
5402257|NCT02905006|18623607|P2|Overall Study|Patient randomized by mistake|0
5402258|NCT02905006|18623608|P1|Overall Study|Patient randomized by mistake|0
5402259|NCT02905006|18623603|P6|Overall Study|Patient moved abroad|0
5402260|NCT02905006|18623604|P5|Overall Study|Patient moved abroad|0
5402261|NCT02905006|18623605|P4|Overall Study|Patient moved abroad|1
5402262|NCT02905006|18623606|P3|Overall Study|Patient moved abroad|0
5402263|NCT02905006|18623607|P2|Overall Study|Patient moved abroad|0
5402264|NCT02905006|18623608|P1|Overall Study|Patient moved abroad|0
5402265|NCT02905006|18623603|P6|Overall Study|Subject positive for Hep B|0
5402266|NCT02905006|18623604|P5|Overall Study|Subject positive for Hep B|0
5402267|NCT02905006|18623605|P4|Overall Study|Subject positive for Hep B|0
5402268|NCT02905006|18623606|P3|Overall Study|Subject positive for Hep B|1
5402269|NCT02905006|18623607|P2|Overall Study|Subject positive for Hep B|0
5402270|NCT02905006|18623608|P1|Overall Study|Subject positive for Hep B|0
5402271|NCT02905006|18623603|P6|Overall Study|Positive for Tuberculosis|0
5402272|NCT02905006|18623604|P5|Overall Study|Positive for Tuberculosis|0
5402273|NCT02905006|18623605|P4|Overall Study|Positive for Tuberculosis|0
5402274|NCT02905006|18623606|P3|Overall Study|Positive for Tuberculosis|0
5402275|NCT02905006|18623607|P2|Overall Study|Positive for Tuberculosis|1
5402276|NCT02905006|18623608|P1|Overall Study|Positive for Tuberculosis|0
5402277|NCT02905006|18623603|P6|Overall Study|Lab withdrawal criterion met|1
5402278|NCT02905006|18623604|P5|Overall Study|Lab withdrawal criterion met|2
5402279|NCT02905006|18623605|P4|Overall Study|Lab withdrawal criterion met|2
5402280|NCT02905006|18623606|P3|Overall Study|Lab withdrawal criterion met|2
5402281|NCT02905006|18623607|P2|Overall Study|Lab withdrawal criterion met|1
5402282|NCT02905006|18623608|P1|Overall Study|Lab withdrawal criterion met|0
5402283|NCT02905006|18623603|P6|Overall Study|Screening exclusion criteria met|0
5402284|NCT02905006|18623604|P5|Overall Study|Screening exclusion criteria met|0
5402285|NCT02905006|18623605|P4|Overall Study|Screening exclusion criteria met|0
5402286|NCT02905006|18623606|P3|Overall Study|Screening exclusion criteria met|0
5402287|NCT02905006|18623607|P2|Overall Study|Screening exclusion criteria met|0
5402288|NCT02905006|18623608|P1|Overall Study|Screening exclusion criteria met|1
5402289|NCT02905006|18623603|P6|Overall Study|Withdrawal by Subject|1
5402290|NCT02905006|18623604|P5|Overall Study|Withdrawal by Subject|0
5402291|NCT02905006|18623605|P4|Overall Study|Withdrawal by Subject|1
5402292|NCT02905006|18623606|P3|Overall Study|Withdrawal by Subject|1
5402293|NCT02905006|18623607|P2|Overall Study|Withdrawal by Subject|0
5402294|NCT02905006|18623608|P1|Overall Study|Withdrawal by Subject|0
5402295|NCT02905006|18623603|P6|Overall Study|Lost to Follow-up|0
5402296|NCT02905006|18623604|P5|Overall Study|Lost to Follow-up|1
5402297|NCT02905006|18623605|P4|Overall Study|Lost to Follow-up|1
5402298|NCT02905006|18623606|P3|Overall Study|Lost to Follow-up|0
5402299|NCT02905006|18623607|P2|Overall Study|Lost to Follow-up|0
5402300|NCT02905006|18623608|P1|Overall Study|Lost to Follow-up|0
5402301|NCT02905006|18623603|P6|Overall Study|Protocol Violation|0
5402302|NCT02905006|18623604|P5|Overall Study|Protocol Violation|0
5402303|NCT02905006|18623605|P4|Overall Study|Protocol Violation|0
5402304|NCT02905006|18623606|P3|Overall Study|Protocol Violation|0
5402305|NCT02905006|18623607|P2|Overall Study|Protocol Violation|0
5402306|NCT02905006|18623608|P1|Overall Study|Protocol Violation|2
5402307|NCT02905006|18623603|P6|Overall Study|Lack of Efficacy|0
5402308|NCT02905006|18623604|P5|Overall Study|Lack of Efficacy|0
5402309|NCT02905006|18623605|P4|Overall Study|Lack of Efficacy|0
5402310|NCT02905006|18623606|P3|Overall Study|Lack of Efficacy|0
5402311|NCT02905006|18623607|P2|Overall Study|Lack of Efficacy|0
5402312|NCT02905006|18623608|P1|Overall Study|Lack of Efficacy|1
5402313|NCT02905006|18623603|P6|Overall Study|Adverse Event|1
5402314|NCT02905006|18623604|P5|Overall Study|Adverse Event|0
5402315|NCT02905006|18623605|P4|Overall Study|Adverse Event|1
5402316|NCT02905006|18623606|P3|Overall Study|Adverse Event|1
5402317|NCT02905006|18623607|P2|Overall Study|Adverse Event|1
5402318|NCT02905006|18623608|P1|Overall Study|Adverse Event|1
5402319|NCT02904902|18623835|P1|Overall Study|Withdrawal by Subject|1
5402320|NCT02904265|18623848|P2|Overall Study|Physician Decision|2
5402321|NCT02904265|18623849|P1|Overall Study|Physician Decision|1
5402322|NCT02904096|18623857|P2|Overall Study|Sponsor instructed|0
5402323|NCT02904096|18623858|P1|Overall Study|Sponsor instructed|1
5402324|NCT02904096|18623857|P2|Overall Study|Non-compliant|1
5402325|NCT02904096|18623858|P1|Overall Study|Non-compliant|3
5402326|NCT02904096|18623857|P2|Overall Study|Lost to Follow-up|17
5402327|NCT02904096|18623858|P1|Overall Study|Lost to Follow-up|10
5402328|NCT02904096|18623857|P2|Overall Study|Withdrawal by Subject|3
5402329|NCT02904096|18623858|P1|Overall Study|Withdrawal by Subject|4
5402330|NCT02904096|18623857|P2|Overall Study|Adverse Event|0
5402331|NCT02904096|18623858|P1|Overall Study|Adverse Event|1
5402332|NCT02903966|18623894|P2|Part B (Day 44 to 112)|Withdrawal by Subject|1
5402333|NCT02903966|18623895|P1|Part B (Day 44 to 112)|Withdrawal by Subject|0
5402334|NCT02903966|18623894|P2|Part B (Day 44 to 112)|Lack of Efficacy|1
5402335|NCT02903966|18623895|P1|Part B (Day 44 to 112)|Lack of Efficacy|0
5402336|NCT02903966|18623894|P2|Part A (Day 1 to 43)|Adverse Event|0
5402337|NCT02903966|18623895|P1|Part A (Day 1 to 43)|Adverse Event|1
5402338|NCT02903420|18623977|P1|Overall Study|Death|3
5402339|NCT02903238|18624029|P1|Overall Study|Lost to Follow-up|4
5402340|NCT02903030|18624055|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
5402341|NCT02903030|18624056|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
5402342|NCT02902965|18624074|P1|Overall Study|Withdrawal by Subject|10
5402343|NCT02902809|18624092|P1|Overall Study|Discontinuation of asthma program|28
5402344|NCT02901054|18624184|P1|Overall Study|Withdrawal by Subject|3
5402345|NCT02901054|18624184|P1|Overall Study|Physician Decision|1
5402346|NCT02900378|18624199|P2|Randomization (Visit 2)|Withdrawal of Informed Consent|2
5402347|NCT02900378|18624200|P1|Randomization (Visit 2)|Withdrawal of Informed Consent|0
5402348|NCT02900378|18624199|P2|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
5402349|NCT02900378|18624200|P1|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
5402350|NCT02900378|18624199|P2|Randomization (Visit 2)|Protocol Deviation|7
5402351|NCT02900378|18624200|P1|Randomization (Visit 2)|Protocol Deviation|1
5402352|NCT02900378|18624199|P2|Randomization (Visit 2)|Non-compliance with Study Drug|1
5402353|NCT02900378|18624200|P1|Randomization (Visit 2)|Non-compliance with Study Drug|1
5402354|NCT02900378|18624199|P2|Randomization (Visit 2)|Lost to Follow-up|0
5402355|NCT02900378|18624200|P1|Randomization (Visit 2)|Lost to Follow-up|1
5402356|NCT02900378|18624199|P2|Randomization (Visit 2)|Death|4
5402357|NCT02900378|18624200|P1|Randomization (Visit 2)|Death|1
5402358|NCT02900378|18624199|P2|Randomization (Visit 2)|Adverse Event|11
5402359|NCT02900378|18624200|P1|Randomization (Visit 2)|Adverse Event|14
5402360|NCT02900170|18624244|P1|Overall Study|Lost to Follow-up|8
5402361|NCT02900092|18624248|P1|Overall Study|Adverse Event|1
5402362|NCT02899988|18624256|P11|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
5402363|NCT02899988|18624257|P10|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5402364|NCT02899988|18624258|P9|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
5402365|NCT02899988|18624259|P8|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
5402366|NCT02899988|18624260|P7|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
5402367|NCT02899988|18624261|P6|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5402368|NCT02899988|18624262|P5|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
5402369|NCT02899988|18624263|P4|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5402370|NCT02899988|18624264|P3|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5402371|NCT02899988|18624265|P2|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5402372|NCT02899988|18624266|P1|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
5402373|NCT02899988|18624256|P11|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5402374|NCT02899988|18624257|P10|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5402375|NCT02899988|18624258|P9|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5402376|NCT02899988|18624259|P8|Maintenance Period (88 Weeks)|Lost to Follow-up|1
5402377|NCT02899988|18624260|P7|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5402378|NCT02899988|18624261|P6|Maintenance Period (88 Weeks)|Lost to Follow-up|1
5402379|NCT02899988|18624262|P5|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5402380|NCT02899988|18624263|P4|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5402381|NCT02899988|18624264|P3|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5402382|NCT02899988|18624265|P2|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5402383|NCT02899988|18624266|P1|Maintenance Period (88 Weeks)|Lost to Follow-up|0
5402384|NCT02899988|18624256|P11|Maintenance Period (88 Weeks)|Adverse Event|1
5402385|NCT02899988|18624257|P10|Maintenance Period (88 Weeks)|Adverse Event|2
5402386|NCT02899988|18624258|P9|Maintenance Period (88 Weeks)|Adverse Event|2
5402387|NCT02899988|18624259|P8|Maintenance Period (88 Weeks)|Adverse Event|2
5402388|NCT02899988|18624260|P7|Maintenance Period (88 Weeks)|Adverse Event|1
5402389|NCT02899988|18624261|P6|Maintenance Period (88 Weeks)|Adverse Event|2
5402390|NCT02899988|18624262|P5|Maintenance Period (88 Weeks)|Adverse Event|1
5402391|NCT02899988|18624263|P4|Maintenance Period (88 Weeks)|Adverse Event|0
5402392|NCT02899988|18624264|P3|Maintenance Period (88 Weeks)|Adverse Event|0
5402393|NCT02899988|18624265|P2|Maintenance Period (88 Weeks)|Adverse Event|0
5402394|NCT02899988|18624266|P1|Maintenance Period (88 Weeks)|Adverse Event|0
5402395|NCT02899988|18624256|P11|Induction Period (16 Weeks)|Physician Decision|0
5402396|NCT02899988|18624257|P10|Induction Period (16 Weeks)|Physician Decision|0
5402397|NCT02899988|18624258|P9|Induction Period (16 Weeks)|Physician Decision|0
5402398|NCT02899988|18624259|P8|Induction Period (16 Weeks)|Physician Decision|0
5402399|NCT02899988|18624260|P7|Induction Period (16 Weeks)|Physician Decision|0
5402400|NCT02899988|18624261|P6|Induction Period (16 Weeks)|Physician Decision|0
5402401|NCT02899988|18624262|P5|Induction Period (16 Weeks)|Physician Decision|0
5402402|NCT02899988|18624263|P4|Induction Period (16 Weeks)|Physician Decision|0
5402403|NCT02899988|18624264|P3|Induction Period (16 Weeks)|Physician Decision|0
5402404|NCT02899988|18624265|P2|Induction Period (16 Weeks)|Physician Decision|1
5402405|NCT02899988|18624266|P1|Induction Period (16 Weeks)|Physician Decision|0
5402406|NCT02899988|18624256|P11|Induction Period (16 Weeks)|Adverse Event|0
5402407|NCT02899988|18624257|P10|Induction Period (16 Weeks)|Adverse Event|0
5402408|NCT02899988|18624258|P9|Induction Period (16 Weeks)|Adverse Event|0
5402409|NCT02899988|18624259|P8|Induction Period (16 Weeks)|Adverse Event|0
5402410|NCT02899988|18624260|P7|Induction Period (16 Weeks)|Adverse Event|0
5402411|NCT02899988|18624261|P6|Induction Period (16 Weeks)|Adverse Event|0
5402412|NCT02899988|18624262|P5|Induction Period (16 Weeks)|Adverse Event|0
5402413|NCT02899988|18624263|P4|Induction Period (16 Weeks)|Adverse Event|2
5402414|NCT02899988|18624264|P3|Induction Period (16 Weeks)|Adverse Event|0
5402415|NCT02899988|18624265|P2|Induction Period (16 Weeks)|Adverse Event|0
5402416|NCT02899988|18624266|P1|Induction Period (16 Weeks)|Adverse Event|0
5402417|NCT02899988|18624256|P11|Induction Period (16 Weeks)|Withdrawal by Subject|0
5402418|NCT02899988|18624257|P10|Induction Period (16 Weeks)|Withdrawal by Subject|0
5402419|NCT02899988|18624258|P9|Induction Period (16 Weeks)|Withdrawal by Subject|0
5402420|NCT02899988|18624259|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
5402421|NCT02899988|18624260|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
5402422|NCT02899988|18624261|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
5402423|NCT02899988|18624262|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
5402424|NCT02899988|18624263|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
5402425|NCT02899988|18624264|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
5402426|NCT02899988|18624265|P2|Induction Period (16 Weeks)|Withdrawal by Subject|1
5402427|NCT02899988|18624266|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
5402428|NCT02899962|18624325|P3|Maintenance Phase|Withdrawal by Subject|36
5402429|NCT02899962|18624326|P2|Maintenance Phase|Withdrawal by Subject|30
5402430|NCT02899962|18624327|P1|Maintenance Phase|Withdrawal by Subject|0
5402431|NCT02899962|18624325|P3|Maintenance Phase|Not clear/almost clear after rescue med|70
5402432|NCT02899962|18624326|P2|Maintenance Phase|Not clear/almost clear after rescue med|65
5402433|NCT02899962|18624327|P1|Maintenance Phase|Not clear/almost clear after rescue med|0
5402434|NCT02899962|18624325|P3|Maintenance Phase|Not achieve treatment success after Wk 4|2
5402435|NCT02899962|18624326|P2|Maintenance Phase|Not achieve treatment success after Wk 4|3
5402436|NCT02899962|18624327|P1|Maintenance Phase|Not achieve treatment success after Wk 4|0
5402437|NCT02899962|18624325|P3|Maintenance Phase|Other reasons|13
5402438|NCT02899962|18624326|P2|Maintenance Phase|Other reasons|9
5402439|NCT02899962|18624327|P1|Maintenance Phase|Other reasons|0
5402440|NCT02899962|18624325|P3|Maintenance Phase|Lost to Follow-up|14
5402441|NCT02899962|18624326|P2|Maintenance Phase|Lost to Follow-up|12
5402442|NCT02899962|18624327|P1|Maintenance Phase|Lost to Follow-up|0
5402443|NCT02899962|18624325|P3|Maintenance Phase|Lack of Efficacy|16
5402444|NCT02899962|18624326|P2|Maintenance Phase|Lack of Efficacy|20
5402445|NCT02899962|18624327|P1|Maintenance Phase|Lack of Efficacy|0
5402446|NCT02899962|18624325|P3|Maintenance Phase|Death|1
5402447|NCT02899962|18624326|P2|Maintenance Phase|Death|0
5402448|NCT02899962|18624327|P1|Maintenance Phase|Death|0
5402449|NCT02899962|18624325|P3|Maintenance Phase|Adverse Event|1
5402450|NCT02899962|18624326|P2|Maintenance Phase|Adverse Event|2
5402451|NCT02899962|18624327|P1|Maintenance Phase|Adverse Event|0
5402452|NCT02899962|18624325|P3|Open-label Phase|Withdrawal by Subject|0
5402453|NCT02899962|18624326|P2|Open-label Phase|Withdrawal by Subject|0
5402454|NCT02899962|18624327|P1|Open-label Phase|Withdrawal by Subject|7
5402455|NCT02899962|18624325|P3|Open-label Phase|Other reasons|0
5402456|NCT02899962|18624326|P2|Open-label Phase|Other reasons|0
5402457|NCT02899962|18624327|P1|Open-label Phase|Other reasons|9
5402458|NCT02899962|18624325|P3|Open-label Phase|Lost to Follow-up|0
5402459|NCT02899962|18624326|P2|Open-label Phase|Lost to Follow-up|0
5402460|NCT02899962|18624327|P1|Open-label Phase|Lost to Follow-up|9
5402461|NCT02899962|18624325|P3|Open-label Phase|Adverse Event|0
5402462|NCT02899962|18624326|P2|Open-label Phase|Adverse Event|0
5402463|NCT02899962|18624327|P1|Open-label Phase|Adverse Event|2
5402464|NCT02899377|18624377|P2|Overall Study|Adverse Event|0
5402465|NCT02899377|18624378|P1|Overall Study|Adverse Event|1
5402466|NCT02899338|18624411|P2|Overall Study|Withdrawal by Subject|0
5402467|NCT02899338|18624412|P1|Overall Study|Withdrawal by Subject|2
5402468|NCT02899338|18624411|P2|Overall Study|Adverse Event|2
5402469|NCT02899338|18624412|P1|Overall Study|Adverse Event|1
5402470|NCT02899156|18624426|P2|Overall Study|Physician Decision|1
5402471|NCT02899156|18624427|P1|Overall Study|Physician Decision|0
5402472|NCT02899156|18624426|P2|Overall Study|Death|0
5402473|NCT02899156|18624427|P1|Overall Study|Death|1
5402474|NCT02898662|18624469|P2|Overall Study|Other|1
5402475|NCT02898662|18624470|P1|Overall Study|Other|0
5402476|NCT02898662|18624469|P2|Overall Study|Subject decision|0
5402477|NCT02898662|18624470|P1|Overall Study|Subject decision|1
5402478|NCT02898662|18624469|P2|Overall Study|Randomized in error|1
5402479|NCT02898662|18624470|P1|Overall Study|Randomized in error|0
5402480|NCT02898662|18624469|P2|Overall Study|Technical issue|1
5402481|NCT02898662|18624470|P1|Overall Study|Technical issue|0
5402482|NCT02898662|18624469|P2|Overall Study|Withdrawal by Subject|1
5402483|NCT02898662|18624470|P1|Overall Study|Withdrawal by Subject|4
5402484|NCT02898662|18624469|P2|Overall Study|Loss of asthma control|24
5402485|NCT02898662|18624470|P1|Overall Study|Loss of asthma control|23
5402486|NCT02898662|18624469|P2|Overall Study|Adverse Event|0
5402487|NCT02898662|18624470|P1|Overall Study|Adverse Event|1
5402488|NCT02898597|18624494|P2|Overall Study|Death|1
5402489|NCT02898597|18624495|P1|Overall Study|Death|0
5402490|NCT02898597|18624494|P2|Overall Study|Lost to Follow-up|9
5402491|NCT02898597|18624495|P1|Overall Study|Lost to Follow-up|0
5402492|NCT02898597|18624494|P2|Overall Study|Protocol Violation|2
5402493|NCT02898597|18624495|P1|Overall Study|Protocol Violation|4
5402494|NCT02898454|18624504|P3|Overall Study|Did Not Met Eligibility Criteria|0
5402495|NCT02898454|18624505|P2|Overall Study|Did Not Met Eligibility Criteria|0
5402496|NCT02898454|18624506|P1|Overall Study|Did Not Met Eligibility Criteria|1
5402497|NCT02898454|18624504|P3|Overall Study|Lost to Follow-up|0
5402498|NCT02898454|18624505|P2|Overall Study|Lost to Follow-up|0
5402499|NCT02898454|18624506|P1|Overall Study|Lost to Follow-up|1
5402500|NCT02898454|18624504|P3|Overall Study|Withdrawal by Subject|3
5402501|NCT02898454|18624505|P2|Overall Study|Withdrawal by Subject|3
5402502|NCT02898454|18624506|P1|Overall Study|Withdrawal by Subject|6
5402503|NCT02898454|18624504|P3|Overall Study|Lack of Efficacy|0
5402504|NCT02898454|18624505|P2|Overall Study|Lack of Efficacy|1
5402505|NCT02898454|18624506|P1|Overall Study|Lack of Efficacy|4
5402506|NCT02898454|18624504|P3|Overall Study|Protocol Violation|1
5402507|NCT02898454|18624505|P2|Overall Study|Protocol Violation|0
5402508|NCT02898454|18624506|P1|Overall Study|Protocol Violation|1
5402509|NCT02898454|18624504|P3|Overall Study|Adverse Event|2
5402510|NCT02898454|18624505|P2|Overall Study|Adverse Event|1
5402511|NCT02898454|18624506|P1|Overall Study|Adverse Event|4
5402512|NCT02898116|18624619|P1|Overall Study|Progressive disease|1
5402513|NCT02898116|18624619|P1|Overall Study|Adverse Event|1
5402514|NCT02897349|18624627|P2|Overall Study|Other than listed above|1
5402515|NCT02897349|18624628|P1|Overall Study|Other than listed above|0
5402516|NCT02897349|18624627|P2|Overall Study|Adverse Event|3
5402517|NCT02897349|18624628|P1|Overall Study|Adverse Event|3
5402518|NCT02897349|18624627|P2|Overall Study|Lost to Follow-up|2
5402519|NCT02897349|18624628|P1|Overall Study|Lost to Follow-up|2
5402520|NCT02897115|18624670|P2|Overall Study|Early termination of study by sponsor|8
5402521|NCT02897115|18624671|P1|Overall Study|Early termination of study by sponsor|11
5402522|NCT02896855|18624748|P2|Overall Study|Withdrawal by Subject|1
5402523|NCT02896855|18624749|P1|Overall Study|Withdrawal by Subject|1
5402524|NCT02896855|18624748|P2|Overall Study|Lost to Follow-up|0
5402525|NCT02896855|18624749|P1|Overall Study|Lost to Follow-up|5
5402526|NCT02896855|18624748|P2|Overall Study|Death|12
5402527|NCT02896855|18624749|P1|Overall Study|Death|13
5402528|NCT02896855|18624748|P2|Overall Study|In Follow-Up|49
5402529|NCT02896855|18624749|P1|Overall Study|In Follow-Up|61
5402530|NCT02896855|18624748|P2|Overall Study|On Study Treatment|60
5402531|NCT02896855|18624749|P1|Overall Study|On Study Treatment|41
5402532|NCT02896569|18624832|P2|Overall Study|Withdrawal by Subject|0
5402533|NCT02896569|18624833|P1|Overall Study|Withdrawal by Subject|1
5402534|NCT02896569|18624832|P2|Overall Study|Adverse Event|1
5402535|NCT02896569|18624833|P1|Overall Study|Adverse Event|0
5402536|NCT02896569|18624832|P2|Overall Study|Physician Decision|3
5402537|NCT02896569|18624833|P1|Overall Study|Physician Decision|1
5402538|NCT02896569|18624832|P2|Overall Study|Lost to Follow-up|1
5402539|NCT02896569|18624833|P1|Overall Study|Lost to Follow-up|2
5402540|NCT02896400|18624867|P16|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
5402541|NCT02896400|18624868|P15|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
5402542|NCT02896400|18624869|P14|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5402543|NCT02896400|18624870|P13|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
5402544|NCT02896400|18624871|P12|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
5402545|NCT02896400|18624872|P11|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
5402546|NCT02896400|18624873|P10|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
5402547|NCT02896400|18624874|P9|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
5402548|NCT02896400|18624875|P8|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
5402549|NCT02896400|18624876|P7|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5402550|NCT02896400|18624877|P6|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5402551|NCT02896400|18624878|P5|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
5402552|NCT02896400|18624879|P4|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
5402553|NCT02896400|18624880|P3|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
5402554|NCT02896400|18624881|P2|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
5402555|NCT02896400|18624882|P1|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
5402556|NCT02896400|18624867|P16|Biochemical Verification at 3 Months|Lost to Follow-up|1
5402557|NCT02896400|18624868|P15|Biochemical Verification at 3 Months|Lost to Follow-up|3
5402558|NCT02896400|18624869|P14|Biochemical Verification at 3 Months|Lost to Follow-up|0
5402559|NCT02896400|18624870|P13|Biochemical Verification at 3 Months|Lost to Follow-up|1
5402560|NCT02896400|18624871|P12|Biochemical Verification at 3 Months|Lost to Follow-up|0
5402561|NCT02896400|18624872|P11|Biochemical Verification at 3 Months|Lost to Follow-up|0
5402562|NCT02896400|18624873|P10|Biochemical Verification at 3 Months|Lost to Follow-up|1
5402563|NCT02896400|18624874|P9|Biochemical Verification at 3 Months|Lost to Follow-up|1
5402564|NCT02896400|18624875|P8|Biochemical Verification at 3 Months|Lost to Follow-up|2
5402565|NCT02896400|18624876|P7|Biochemical Verification at 3 Months|Lost to Follow-up|3
5402566|NCT02896400|18624877|P6|Biochemical Verification at 3 Months|Lost to Follow-up|1
5402567|NCT02896400|18624878|P5|Biochemical Verification at 3 Months|Lost to Follow-up|0
5402568|NCT02896400|18624879|P4|Biochemical Verification at 3 Months|Lost to Follow-up|1
5402569|NCT02896400|18624880|P3|Biochemical Verification at 3 Months|Lost to Follow-up|1
5402570|NCT02896400|18624881|P2|Biochemical Verification at 3 Months|Lost to Follow-up|0
5402571|NCT02896400|18624882|P1|Biochemical Verification at 3 Months|Lost to Follow-up|1
5402572|NCT02896400|18624867|P16|3 Month Follow-up|Death|0
5402573|NCT02896400|18624868|P15|3 Month Follow-up|Death|1
5402574|NCT02896400|18624869|P14|3 Month Follow-up|Death|1
5402575|NCT02896400|18624870|P13|3 Month Follow-up|Death|0
5402576|NCT02896400|18624871|P12|3 Month Follow-up|Death|0
5402577|NCT02896400|18624872|P11|3 Month Follow-up|Death|0
5402578|NCT02896400|18624873|P10|3 Month Follow-up|Death|0
5402579|NCT02896400|18624874|P9|3 Month Follow-up|Death|0
5402580|NCT02896400|18624875|P8|3 Month Follow-up|Death|0
5402581|NCT02896400|18624876|P7|3 Month Follow-up|Death|0
5402582|NCT02896400|18624877|P6|3 Month Follow-up|Death|0
5402583|NCT02896400|18624878|P5|3 Month Follow-up|Death|0
5402584|NCT02896400|18624879|P4|3 Month Follow-up|Death|0
5402585|NCT02896400|18624880|P3|3 Month Follow-up|Death|0
5402586|NCT02896400|18624881|P2|3 Month Follow-up|Death|0
5402587|NCT02896400|18624882|P1|3 Month Follow-up|Death|0
5402588|NCT02896400|18624867|P16|3 Month Follow-up|Lost to Follow-up|2
5402589|NCT02896400|18624868|P15|3 Month Follow-up|Lost to Follow-up|3
5402590|NCT02896400|18624869|P14|3 Month Follow-up|Lost to Follow-up|5
5402591|NCT02896400|18624870|P13|3 Month Follow-up|Lost to Follow-up|3
5402592|NCT02896400|18624871|P12|3 Month Follow-up|Lost to Follow-up|6
5402593|NCT02896400|18624872|P11|3 Month Follow-up|Lost to Follow-up|6
5402594|NCT02896400|18624873|P10|3 Month Follow-up|Lost to Follow-up|5
5402595|NCT02896400|18624874|P9|3 Month Follow-up|Lost to Follow-up|6
5402596|NCT02896400|18624875|P8|3 Month Follow-up|Lost to Follow-up|3
5402597|NCT02896400|18624876|P7|3 Month Follow-up|Lost to Follow-up|4
5402598|NCT02896400|18624877|P6|3 Month Follow-up|Lost to Follow-up|6
5402599|NCT02896400|18624878|P5|3 Month Follow-up|Lost to Follow-up|12
5402600|NCT02896400|18624879|P4|3 Month Follow-up|Lost to Follow-up|11
5402601|NCT02896400|18624880|P3|3 Month Follow-up|Lost to Follow-up|6
5402602|NCT02896400|18624881|P2|3 Month Follow-up|Lost to Follow-up|3
5402603|NCT02896400|18624882|P1|3 Month Follow-up|Lost to Follow-up|6
5402604|NCT02896400|18624867|P16|1 Month Follow-up|Death|1
5402605|NCT02896400|18624868|P15|1 Month Follow-up|Death|0
5402606|NCT02896400|18624869|P14|1 Month Follow-up|Death|0
5402607|NCT02896400|18624870|P13|1 Month Follow-up|Death|0
5402608|NCT02896400|18624871|P12|1 Month Follow-up|Death|0
5402609|NCT02896400|18624872|P11|1 Month Follow-up|Death|0
5402610|NCT02896400|18624873|P10|1 Month Follow-up|Death|0
5402611|NCT02896400|18624874|P9|1 Month Follow-up|Death|0
5402612|NCT02896400|18624875|P8|1 Month Follow-up|Death|0
5402613|NCT02896400|18624876|P7|1 Month Follow-up|Death|0
5402614|NCT02896400|18624877|P6|1 Month Follow-up|Death|0
5402615|NCT02896400|18624878|P5|1 Month Follow-up|Death|0
5402616|NCT02896400|18624879|P4|1 Month Follow-up|Death|0
5402617|NCT02896400|18624880|P3|1 Month Follow-up|Death|0
5402618|NCT02896400|18624881|P2|1 Month Follow-up|Death|0
5402619|NCT02896400|18624882|P1|1 Month Follow-up|Death|0
5402620|NCT02896400|18624867|P16|1 Month Follow-up|Lost to Follow-up|2
5402621|NCT02896400|18624868|P15|1 Month Follow-up|Lost to Follow-up|1
5402622|NCT02896400|18624869|P14|1 Month Follow-up|Lost to Follow-up|4
5402623|NCT02896400|18624870|P13|1 Month Follow-up|Lost to Follow-up|3
5402624|NCT02896400|18624871|P12|1 Month Follow-up|Lost to Follow-up|5
5402625|NCT02896400|18624872|P11|1 Month Follow-up|Lost to Follow-up|5
5402626|NCT02896400|18624873|P10|1 Month Follow-up|Lost to Follow-up|7
5402627|NCT02896400|18624874|P9|1 Month Follow-up|Lost to Follow-up|4
5402628|NCT02896400|18624875|P8|1 Month Follow-up|Lost to Follow-up|6
5402629|NCT02896400|18624876|P7|1 Month Follow-up|Lost to Follow-up|5
5402630|NCT02896400|18624877|P6|1 Month Follow-up|Lost to Follow-up|6
5402631|NCT02896400|18624878|P5|1 Month Follow-up|Lost to Follow-up|9
5402632|NCT02896400|18624879|P4|1 Month Follow-up|Lost to Follow-up|8
5402633|NCT02896400|18624880|P3|1 Month Follow-up|Lost to Follow-up|5
5402634|NCT02896400|18624881|P2|1 Month Follow-up|Lost to Follow-up|7
5402635|NCT02896400|18624882|P1|1 Month Follow-up|Lost to Follow-up|7
5402636|NCT02896361|18624908|P3|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
5402637|NCT02896361|18624909|P2|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
5402638|NCT02896361|18624910|P1|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
5402639|NCT02896361|18624908|P3|Third Intervention (2 Weeks)|Protocol Violation|0
5402640|NCT02896361|18624909|P2|Third Intervention (2 Weeks)|Protocol Violation|0
5402641|NCT02896361|18624910|P1|Third Intervention (2 Weeks)|Protocol Violation|1
5402642|NCT02896296|18624928|P1|Overall Study|Relocation|1
5402643|NCT02896296|18624928|P1|Overall Study|Incarceration|1
5402644|NCT02896296|18624928|P1|Overall Study|Site closing|7
5402645|NCT02896296|18624928|P1|Overall Study|Withdrawal by Subject|10
5402646|NCT02896296|18624928|P1|Overall Study|Physician Decision|2
5402647|NCT02896296|18624928|P1|Overall Study|Pregnancy|1
5402648|NCT02896296|18624928|P1|Overall Study|Lost to Follow-up|19
5402649|NCT02896296|18624928|P1|Overall Study|Adverse Event|1
5402650|NCT02896127|18624936|P2|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1
5402651|NCT02896127|18624937|P1|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0
5402652|NCT02896127|18624936|P2|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0
5402653|NCT02896127|18624937|P1|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1
5402654|NCT02896127|18624936|P2|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0
5402655|NCT02896127|18624937|P1|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1
5402656|NCT02896127|18624936|P2|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1
5402657|NCT02896127|18624937|P1|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0
5402658|NCT02896127|18624936|P2|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3
5402659|NCT02896127|18624937|P1|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2
5402660|NCT02896127|18624936|P2|COMPLETED WEEK 52|Technical problems|0
5402661|NCT02896127|18624937|P1|COMPLETED WEEK 52|Technical problems|1
5402662|NCT02896127|18624936|P2|COMPLETED WEEK 52|Withdrawal by Subject|4
5402663|NCT02896127|18624937|P1|COMPLETED WEEK 52|Withdrawal by Subject|12
5402664|NCT02896127|18624936|P2|COMPLETED WEEK 52|Pregnancy|0
5402665|NCT02896127|18624937|P1|COMPLETED WEEK 52|Pregnancy|2
5402666|NCT02896127|18624936|P2|COMPLETED WEEK 52|Physician Decision|1
5402667|NCT02896127|18624937|P1|COMPLETED WEEK 52|Physician Decision|1
5402668|NCT02896127|18624936|P2|COMPLETED WEEK 52|Lost to Follow-up|1
5402669|NCT02896127|18624937|P1|COMPLETED WEEK 52|Lost to Follow-up|0
5402670|NCT02896127|18624936|P2|COMPLETED WEEK 52|Lack of Efficacy|3
5402671|NCT02896127|18624937|P1|COMPLETED WEEK 52|Lack of Efficacy|2
5402672|NCT02896127|18624936|P2|COMPLETED WEEK 52|Adverse Event|2
5402673|NCT02896127|18624937|P1|COMPLETED WEEK 52|Adverse Event|9
5402674|NCT02895347|18624959|P2|Overall Study|Withdrawal by Subject|1
5402675|NCT02895347|18624960|P1|Overall Study|Withdrawal by Subject|3
5402676|NCT02895295|18624972|P3|Overall Study|Survey Non-response|92
5402677|NCT02895295|18624973|P2|Overall Study|Survey Non-response|94
5402678|NCT02895295|18624974|P1|Overall Study|Survey Non-response|71
5402679|NCT02894840|18625008|P4|Overall Study|Lost to Follow-up|0
5402680|NCT02894840|18625009|P3|Overall Study|Lost to Follow-up|3
5402681|NCT02894840|18625010|P2|Overall Study|Lost to Follow-up|0
5402682|NCT02894840|18625011|P1|Overall Study|Lost to Follow-up|1
5402683|NCT02892734|18625283|P1|Follow up for 2 Years|Study closed early|1
5402684|NCT02892734|18625283|P1|Follow up for 2 Years|Death|2
5402685|NCT02892734|18625283|P1|Treatment on Study|Progressive Disease|2
5402686|NCT02892513|18625293|P2|Overall Study|Withdrawal by Subject|1
5402687|NCT02892513|18625294|P1|Overall Study|Withdrawal by Subject|0
5402688|NCT02892448|18625314|P3|Overall Study|Screening failure|1
5402689|NCT02892448|18625315|P2|Overall Study|Screening failure|2
5402690|NCT02892448|18625316|P1|Overall Study|Screening failure|2
5402691|NCT02892422|18625336|P1|Overall Study|Investigator decision|1
5402692|NCT02892422|18625336|P1|Overall Study|patient decision|7
5402693|NCT02892422|18625336|P1|Overall Study|patient legally incapable|1
5402694|NCT02892422|18625336|P1|Overall Study|non-compliance|10
5402695|NCT02892422|18625336|P1|Overall Study|moving elsewhere|4
5402696|NCT02892422|18625336|P1|Overall Study|exclusion criteria met|3
5402697|NCT02892422|18625336|P1|Overall Study|withdrawal of consent|13
5402698|NCT02892422|18625336|P1|Overall Study|sponsor information 16159A results|21
5402699|NCT02892422|18625336|P1|Overall Study|Lost to Follow-up|5
5402700|NCT02892422|18625336|P1|Overall Study|Withdrawal by Subject|56
5402701|NCT02892422|18625336|P1|Overall Study|Protocol Violation|4
5402702|NCT02892422|18625336|P1|Overall Study|Non-compliance with study drug|11
5402703|NCT02892422|18625336|P1|Overall Study|Lack of Efficacy|32
5402704|NCT02892422|18625336|P1|Overall Study|Adverse Event|38
5402705|NCT02892422|18625336|P1|Overall Study|Enrolled not treated|4
5402706|NCT02892409|18625342|P2|Overall Study|Withdrawal by Subject|1
5402707|NCT02892409|18625343|P1|Overall Study|Withdrawal by Subject|2
5402708|NCT02892409|18625342|P2|Overall Study|Adverse Event|0
5402709|NCT02892409|18625343|P1|Overall Study|Adverse Event|1
5402710|NCT02892344|18625365|P2|Overall Study|Technical problems|1
5402711|NCT02892344|18625366|P1|Overall Study|Technical problems|0
5402712|NCT02892344|18625365|P2|Overall Study|Subject/guardian decision|4
5402713|NCT02892344|18625366|P1|Overall Study|Subject/guardian decision|0
5402714|NCT02892344|18625365|P2|Overall Study|Physician Decision|2
5402715|NCT02892344|18625366|P1|Overall Study|Physician Decision|0
5402716|NCT02892344|18625365|P2|Overall Study|Non-compliance with study treatment|1
5402717|NCT02892344|18625366|P1|Overall Study|Non-compliance with study treatment|0
5402718|NCT02892344|18625365|P2|Overall Study|Lost to Follow-up|1
5402719|NCT02892344|18625366|P1|Overall Study|Lost to Follow-up|0
5402720|NCT02892344|18625365|P2|Overall Study|Adverse Event|8
5402721|NCT02892344|18625366|P1|Overall Study|Adverse Event|1
5402722|NCT02892344|18625365|P2|Overall Study|Protocol deviation|4
5402723|NCT02892344|18625366|P1|Overall Study|Protocol deviation|3
5402724|NCT02892019|18625415|P2|Overall Study|Adverse Event|1
5402725|NCT02892019|18625416|P1|Overall Study|Adverse Event|1
5402726|NCT02892019|18625415|P2|Overall Study|Withdrawal by Subject|1
5402727|NCT02892019|18625416|P1|Overall Study|Withdrawal by Subject|0
5402728|NCT02892019|18625415|P2|Overall Study|randomized but not treated|1
5402729|NCT02892019|18625416|P1|Overall Study|randomized but not treated|0
5402730|NCT02891408|18625461|P7|Overall Study|Lost to Follow-up|0
5402731|NCT02891408|18625462|P6|Overall Study|Lost to Follow-up|0
5402732|NCT02891408|18625463|P5|Overall Study|Lost to Follow-up|0
5402733|NCT02891408|18625464|P4|Overall Study|Lost to Follow-up|0
5402734|NCT02891408|18625465|P3|Overall Study|Lost to Follow-up|1
5402735|NCT02891408|18625466|P2|Overall Study|Lost to Follow-up|0
5402736|NCT02891408|18625467|P1|Overall Study|Lost to Follow-up|0
5402737|NCT02891200|18625580|P2|Overall Study|Withdrawal by Subject|4
5402738|NCT02891200|18625581|P1|Overall Study|Withdrawal by Subject|1
5402739|NCT02891200|18625580|P2|Overall Study|Death|9
5402740|NCT02891200|18625581|P1|Overall Study|Death|10
5402741|NCT02891200|18625580|P2|Overall Study|Lost to Follow-up|36
5402742|NCT02891200|18625581|P1|Overall Study|Lost to Follow-up|31
5402743|NCT02891174|18625609|P2|Second Intervention (24 Hours)|Protocol Violation|1
5402744|NCT02891174|18625610|P1|Second Intervention (24 Hours)|Protocol Violation|0
5402745|NCT02891174|18625609|P2|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
5402746|NCT02891174|18625610|P1|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
5402747|NCT02891174|18625609|P2|Second Intervention (24 Hours)|Discharged during second intervention|5
5402748|NCT02891174|18625610|P1|Second Intervention (24 Hours)|Discharged during second intervention|3
5402749|NCT02891174|18625609|P2|Second Intervention (24 Hours)|No blood pressure after cross-over|0
5402750|NCT02891174|18625610|P1|Second Intervention (24 Hours)|No blood pressure after cross-over|1
5402751|NCT02891174|18625609|P2|First Intervention (24 Hours)|Withdrew after receiving study drug|6
5402752|NCT02891174|18625610|P1|First Intervention (24 Hours)|Withdrew after receiving study drug|2
5402753|NCT02891174|18625609|P2|First Intervention (24 Hours)|Discharged prior to cross-over|2
5402754|NCT02891174|18625610|P1|First Intervention (24 Hours)|Discharged prior to cross-over|0
5402755|NCT02891174|18625609|P2|First Intervention (24 Hours)|Declined any study medication|5
5402756|NCT02891174|18625610|P1|First Intervention (24 Hours)|Declined any study medication|1
5402757|NCT02891070|18625624|P2|Overall Study|Death|0
5402758|NCT02891070|18625625|P1|Overall Study|Death|3
5402759|NCT02891070|18625624|P2|Overall Study|Withdrawal by Subject|2
5402760|NCT02891070|18625625|P1|Overall Study|Withdrawal by Subject|1
5402761|NCT02891070|18625624|P2|Overall Study|Protocol Violation|1
5402762|NCT02891070|18625625|P1|Overall Study|Protocol Violation|0
5402763|NCT02891070|18625624|P2|Overall Study|Other|0
5402764|NCT02891070|18625625|P1|Overall Study|Other|1
5402765|NCT02891070|18625624|P2|Overall Study|Lost to Follow-up|4
5402766|NCT02891070|18625625|P1|Overall Study|Lost to Follow-up|4
5402767|NCT02891070|18625624|P2|Overall Study|Physician Decision|1
5402768|NCT02891070|18625625|P1|Overall Study|Physician Decision|0
5402769|NCT02891070|18625624|P2|Overall Study|Adverse Event|0
5402770|NCT02891070|18625625|P1|Overall Study|Adverse Event|1
5402771|NCT02890992|18625651|P8|130 Weeks Open-Label Extension Period|Other than specified|0
5402772|NCT02890992|18625652|P7|130 Weeks Open-Label Extension Period|Other than specified|0
5402773|NCT02890992|18625653|P6|130 Weeks Open-Label Extension Period|Other than specified|0
5402774|NCT02890992|18625654|P5|130 Weeks Open-Label Extension Period|Other than specified|0
5402775|NCT02890992|18625655|P4|130 Weeks Open-Label Extension Period|Other than specified|0
5402776|NCT02890992|18625656|P3|130 Weeks Open-Label Extension Period|Other than specified|0
5402777|NCT02890992|18625657|P2|130 Weeks Open-Label Extension Period|Other than specified|2
5402778|NCT02890992|18625658|P1|130 Weeks Open-Label Extension Period|Other than specified|0
5402779|NCT02890992|18625651|P8|130 Weeks Open-Label Extension Period|Included but not treated|1
5402780|NCT02890992|18625652|P7|130 Weeks Open-Label Extension Period|Included but not treated|1
5402781|NCT02890992|18625653|P6|130 Weeks Open-Label Extension Period|Included but not treated|0
5402782|NCT02890992|18625654|P5|130 Weeks Open-Label Extension Period|Included but not treated|0
5402783|NCT02890992|18625655|P4|130 Weeks Open-Label Extension Period|Included but not treated|0
5402784|NCT02890992|18625656|P3|130 Weeks Open-Label Extension Period|Included but not treated|0
5402785|NCT02890992|18625657|P2|130 Weeks Open-Label Extension Period|Included but not treated|0
5402786|NCT02890992|18625658|P1|130 Weeks Open-Label Extension Period|Included but not treated|0
5402787|NCT02890992|18625651|P8|130 Weeks Open-Label Extension Period|Adverse Event|0
5402788|NCT02890992|18625652|P7|130 Weeks Open-Label Extension Period|Adverse Event|0
5402789|NCT02890992|18625653|P6|130 Weeks Open-Label Extension Period|Adverse Event|0
5402790|NCT02890992|18625654|P5|130 Weeks Open-Label Extension Period|Adverse Event|0
5402791|NCT02890992|18625655|P4|130 Weeks Open-Label Extension Period|Adverse Event|0
5402792|NCT02890992|18625656|P3|130 Weeks Open-Label Extension Period|Adverse Event|0
5402793|NCT02890992|18625657|P2|130 Weeks Open-Label Extension Period|Adverse Event|1
5402794|NCT02890992|18625658|P1|130 Weeks Open-Label Extension Period|Adverse Event|0
5402795|NCT02890355|18625855|P2|Overall Study|Not protocol specified|4
5402796|NCT02890355|18625856|P1|Overall Study|Not protocol specified|3
5402797|NCT02890355|18625855|P2|Overall Study|Progression/relapse|39
5402798|NCT02890355|18625856|P1|Overall Study|Progression/relapse|46
5402799|NCT02890355|18625855|P2|Overall Study|Refusal unrelated to adverse event|10
5402800|NCT02890355|18625856|P1|Overall Study|Refusal unrelated to adverse event|5
5402801|NCT02890355|18625855|P2|Overall Study|Adverse Event|5
5402802|NCT02890355|18625856|P1|Overall Study|Adverse Event|5
5402803|NCT02889900|18625876|P1|Overall Study|Not treated|2
5402804|NCT02889900|18625876|P1|Overall Study|Withdrawal by Subject|7
5402805|NCT02889900|18625876|P1|Overall Study|Other|5
5402806|NCT02889900|18625876|P1|Overall Study|Condition under investigation worsened|32
5402807|NCT02889900|18625876|P1|Overall Study|Adverse Event|11
5402808|NCT02889861|18625888|P1|Overall Study|Ongoing in Survival Follow-up|2
5402809|NCT02888756|18625921|P3|Analytical Treatment Interruption|Physician Decision|5
5402810|NCT02888756|18625922|P2|Analytical Treatment Interruption|Physician Decision|6
5402811|NCT02888756|18625923|P1|Analytical Treatment Interruption|Physician Decision|10
5402812|NCT02888171|18626063|P2|Overall Study|Adverse Event|1
5402813|NCT02888171|18626064|P1|Overall Study|Adverse Event|0
5402814|NCT02888171|18626063|P2|Overall Study|Withdrawal by Subject|2
5402815|NCT02888171|18626064|P1|Overall Study|Withdrawal by Subject|3
5402816|NCT02888171|18626063|P2|Overall Study|Lost to Follow-up|1
5402817|NCT02888171|18626064|P1|Overall Study|Lost to Follow-up|2
5402818|NCT02888080|18626093|P2|Overall Study|Adverse Event|1
5402819|NCT02888080|18626094|P1|Overall Study|Adverse Event|0
5402820|NCT02888080|18626093|P2|Overall Study|Lack of Efficacy|1
5402821|NCT02888080|18626094|P1|Overall Study|Lack of Efficacy|0
5402822|NCT02888080|18626093|P2|Overall Study|New Therapy for study indication|0
5402823|NCT02888080|18626094|P1|Overall Study|New Therapy for study indication|1
5402824|NCT02888080|18626093|P2|Overall Study|Subject / Guardian decision|3
5402825|NCT02888080|18626094|P1|Overall Study|Subject / Guardian decision|1
5402826|NCT02887989|18626120|P2|Overall Study|Death|0
5402827|NCT02887989|18626121|P1|Overall Study|Death|1
5402828|NCT02887989|18626120|P2|Overall Study|Withdrawal by Subject|11
5402829|NCT02887989|18626121|P1|Overall Study|Withdrawal by Subject|8
5402830|NCT02887521|18626133|P2|Overall Study|Withdrawal by Subject|3
5402831|NCT02887521|18626134|P1|Overall Study|Withdrawal by Subject|0
5402832|NCT02887183|18626197|P1|Overall Study|Withdrawal by Subject|35
5402833|NCT02887183|18626197|P1|Overall Study|Physician Decision|10
5402834|NCT02887183|18626197|P1|Overall Study|Lost to Follow-up|13
5402835|NCT02887183|18626197|P1|Overall Study|Technical Problems|2
5402836|NCT02887183|18626197|P1|Overall Study|Protocol Violation|6
5402837|NCT02887183|18626197|P1|Overall Study|Pregnancy|1
5402838|NCT02887183|18626197|P1|Overall Study|Death|30
5402839|NCT02887183|18626197|P1|Overall Study|Adverse Event|44
5402840|NCT02886715|18626224|P3|Overall Study|missing|2
5402841|NCT02886715|18626225|P2|Overall Study|missing|2
5402842|NCT02886715|18626226|P1|Overall Study|missing|7
5402843|NCT02886715|18626224|P3|Overall Study|Withdrawal by Subject|5
5402844|NCT02886715|18626225|P2|Overall Study|Withdrawal by Subject|18
5402845|NCT02886715|18626226|P1|Overall Study|Withdrawal by Subject|20
5402846|NCT02886715|18626224|P3|Overall Study|Protocol Violation|1
5402847|NCT02886715|18626225|P2|Overall Study|Protocol Violation|2
5402848|NCT02886715|18626226|P1|Overall Study|Protocol Violation|3
5402849|NCT02886715|18626224|P3|Overall Study|Pregnancy|1
5402850|NCT02886715|18626225|P2|Overall Study|Pregnancy|1
5402851|NCT02886715|18626226|P1|Overall Study|Pregnancy|1
5402852|NCT02886715|18626224|P3|Overall Study|Lost to Follow-up|10
5402853|NCT02886715|18626225|P2|Overall Study|Lost to Follow-up|26
5402854|NCT02886715|18626226|P1|Overall Study|Lost to Follow-up|29
5402855|NCT02886715|18626224|P3|Overall Study|Lack of Efficacy|1
5402856|NCT02886715|18626225|P2|Overall Study|Lack of Efficacy|2
5402857|NCT02886715|18626226|P1|Overall Study|Lack of Efficacy|0
5402858|NCT02886715|18626224|P3|Overall Study|Adverse Event|0
5402859|NCT02886715|18626225|P2|Overall Study|Adverse Event|2
5402860|NCT02886715|18626226|P1|Overall Study|Adverse Event|4
5402861|NCT02886715|18626224|P3|Overall Study|Non-Compliance With Study Drug|0
5402862|NCT02886715|18626225|P2|Overall Study|Non-Compliance With Study Drug|2
5402863|NCT02886715|18626226|P1|Overall Study|Non-Compliance With Study Drug|0
5402864|NCT02886702|18626243|P3|Overall Study|Administrative Reasons|1
5402865|NCT02886702|18626244|P2|Overall Study|Administrative Reasons|0
5402866|NCT02886702|18626245|P1|Overall Study|Administrative Reasons|0
5402867|NCT02886702|18626243|P3|Overall Study|Adverse Event|3
5402868|NCT02886702|18626244|P2|Overall Study|Adverse Event|9
5402869|NCT02886702|18626245|P1|Overall Study|Adverse Event|4
5402870|NCT02886702|18626243|P3|Overall Study|Lack of Efficacy|5
5402871|NCT02886702|18626244|P2|Overall Study|Lack of Efficacy|4
5402872|NCT02886702|18626245|P1|Overall Study|Lack of Efficacy|3
5402873|NCT02886702|18626243|P3|Overall Study|Lost to Follow-up|8
5402874|NCT02886702|18626244|P2|Overall Study|Lost to Follow-up|13
5402875|NCT02886702|18626245|P1|Overall Study|Lost to Follow-up|11
5402876|NCT02886702|18626243|P3|Overall Study|Non-Compliance With Study Drug|4
5402877|NCT02886702|18626244|P2|Overall Study|Non-Compliance With Study Drug|1
5402878|NCT02886702|18626245|P1|Overall Study|Non-Compliance With Study Drug|0
5402879|NCT02886702|18626243|P3|Overall Study|Protocol Violation|1
5402880|NCT02886702|18626244|P2|Overall Study|Protocol Violation|2
5402881|NCT02886702|18626245|P1|Overall Study|Protocol Violation|2
5402882|NCT02886702|18626243|P3|Overall Study|Significant Worsening of Condition|0
5402883|NCT02886702|18626244|P2|Overall Study|Significant Worsening of Condition|1
5402884|NCT02886702|18626245|P1|Overall Study|Significant Worsening of Condition|0
5402885|NCT02886702|18626243|P3|Overall Study|Withdrawal by Subject|22
5402886|NCT02886702|18626244|P2|Overall Study|Withdrawal by Subject|18
5402887|NCT02886702|18626245|P1|Overall Study|Withdrawal by Subject|24
5402888|NCT02886702|18626243|P3|Overall Study|Other|9
5402889|NCT02886702|18626244|P2|Overall Study|Other|3
5402890|NCT02886702|18626245|P1|Overall Study|Other|4
5402891|NCT02886624|18626259|P1|48-week Post Treatment Follow-up|Lost to Follow-up|1
5402892|NCT02886624|18626259|P1|12-week Post Treatment Follow-up|Death|1
5402893|NCT02886338|18626268|P1|Overall Study|Withdrawal by Subject|1
5402894|NCT02885181|18626457|P4|Overall Study|Withdrawal by Subject|1
5402895|NCT02885181|18626458|P3|Overall Study|Withdrawal by Subject|0
5402896|NCT02885181|18626459|P2|Overall Study|Withdrawal by Subject|0
5402897|NCT02885181|18626460|P1|Overall Study|Withdrawal by Subject|0
5402898|NCT02885181|18626457|P4|Overall Study|Adverse Event|1
5402899|NCT02885181|18626458|P3|Overall Study|Adverse Event|0
5402900|NCT02885181|18626459|P2|Overall Study|Adverse Event|0
5402901|NCT02885181|18626460|P1|Overall Study|Adverse Event|0
5402902|NCT02885181|18626457|P4|Overall Study|Investigator's Discretion|1
5402903|NCT02885181|18626458|P3|Overall Study|Investigator's Discretion|0
5402904|NCT02885181|18626459|P2|Overall Study|Investigator's Discretion|1
5402905|NCT02885181|18626460|P1|Overall Study|Investigator's Discretion|0
5402906|NCT02884089|18626572|P4|Follow-up Visit|Withdrawal by Subject|1
5402907|NCT02884089|18626573|P3|Follow-up Visit|Withdrawal by Subject|0
5402908|NCT02884089|18626574|P2|Follow-up Visit|Withdrawal by Subject|0
5402909|NCT02884089|18626575|P1|Follow-up Visit|Withdrawal by Subject|1
5402910|NCT02884089|18626572|P4|Period 4|Lost to Follow-up|0
5402911|NCT02884089|18626573|P3|Period 4|Lost to Follow-up|0
5402912|NCT02884089|18626574|P2|Period 4|Lost to Follow-up|0
5402913|NCT02884089|18626575|P1|Period 4|Lost to Follow-up|1
5402914|NCT02884089|18626572|P4|Period 4|Withdrawal by Subject|0
5402915|NCT02884089|18626573|P3|Period 4|Withdrawal by Subject|0
5402916|NCT02884089|18626574|P2|Period 4|Withdrawal by Subject|1
5402917|NCT02884089|18626575|P1|Period 4|Withdrawal by Subject|0
5402918|NCT02884089|18626572|P4|Washout Period 3|Lost to Follow-up|1
5402919|NCT02884089|18626573|P3|Washout Period 3|Lost to Follow-up|0
5402920|NCT02884089|18626574|P2|Washout Period 3|Lost to Follow-up|0
5402921|NCT02884089|18626575|P1|Washout Period 3|Lost to Follow-up|0
5402922|NCT02884089|18626572|P4|Washout Period 3|Withdrawal by Subject|0
5402923|NCT02884089|18626573|P3|Washout Period 3|Withdrawal by Subject|1
5402924|NCT02884089|18626574|P2|Washout Period 3|Withdrawal by Subject|0
5402925|NCT02884089|18626575|P1|Washout Period 3|Withdrawal by Subject|0
5402926|NCT02884089|18626572|P4|Period 3|Withdrawal by Subject|0
5402927|NCT02884089|18626573|P3|Period 3|Withdrawal by Subject|1
5402928|NCT02884089|18626574|P2|Period 3|Withdrawal by Subject|0
5402929|NCT02884089|18626575|P1|Period 3|Withdrawal by Subject|0
5402930|NCT02884089|18626572|P4|Period 2|Adverse Event|0
5402931|NCT02884089|18626573|P3|Period 2|Adverse Event|0
5402932|NCT02884089|18626574|P2|Period 2|Adverse Event|0
5402933|NCT02884089|18626575|P1|Period 2|Adverse Event|1
5402934|NCT02884089|18626572|P4|Washout Period 1|Withdrawal by Subject|0
5402935|NCT02884089|18626573|P3|Washout Period 1|Withdrawal by Subject|0
5402936|NCT02884089|18626574|P2|Washout Period 1|Withdrawal by Subject|1
5402937|NCT02884089|18626575|P1|Washout Period 1|Withdrawal by Subject|0
5402938|NCT02884089|18626572|P4|Washout Period 1|Lost to Follow-up|1
5402939|NCT02884089|18626573|P3|Washout Period 1|Lost to Follow-up|0
5402940|NCT02884089|18626574|P2|Washout Period 1|Lost to Follow-up|1
5402941|NCT02884089|18626575|P1|Washout Period 1|Lost to Follow-up|0
5402942|NCT02884089|18626572|P4|Period 1|Dosing error|0
5402943|NCT02884089|18626573|P3|Period 1|Dosing error|0
5402944|NCT02884089|18626574|P2|Period 1|Dosing error|2
5402945|NCT02884089|18626575|P1|Period 1|Dosing error|2
5402946|NCT02883452|18626595|P6|Overall Study|Other|1
5402947|NCT02883452|18626596|P5|Overall Study|Other|0
5402948|NCT02883452|18626597|P4|Overall Study|Other|0
5402949|NCT02883452|18626598|P3|Overall Study|Other|0
5402950|NCT02883452|18626599|P2|Overall Study|Other|0
5402951|NCT02883452|18626600|P1|Overall Study|Other|0
5402952|NCT02883452|18626595|P6|Overall Study|Death|0
5402953|NCT02883452|18626596|P5|Overall Study|Death|0
5402954|NCT02883452|18626597|P4|Overall Study|Death|0
5402955|NCT02883452|18626598|P3|Overall Study|Death|1
5402956|NCT02883452|18626599|P2|Overall Study|Death|0
5402957|NCT02883452|18626600|P1|Overall Study|Death|1
5402958|NCT02883452|18626595|P6|Overall Study|Physician Decision|1
5402959|NCT02883452|18626596|P5|Overall Study|Physician Decision|4
5402960|NCT02883452|18626597|P4|Overall Study|Physician Decision|0
5402961|NCT02883452|18626598|P3|Overall Study|Physician Decision|0
5402962|NCT02883452|18626599|P2|Overall Study|Physician Decision|0
5402963|NCT02883452|18626600|P1|Overall Study|Physician Decision|0
5402964|NCT02883452|18626595|P6|Overall Study|Adverse Event|3
5402965|NCT02883452|18626596|P5|Overall Study|Adverse Event|1
5402966|NCT02883452|18626597|P4|Overall Study|Adverse Event|1
5402967|NCT02883452|18626598|P3|Overall Study|Adverse Event|1
5402968|NCT02883452|18626599|P2|Overall Study|Adverse Event|1
5402969|NCT02883452|18626600|P1|Overall Study|Adverse Event|2
5402970|NCT02883452|18626595|P6|Overall Study|Disease progression|5
5402971|NCT02883452|18626596|P5|Overall Study|Disease progression|4
5402972|NCT02883452|18626597|P4|Overall Study|Disease progression|1
5402973|NCT02883452|18626598|P3|Overall Study|Disease progression|0
5402974|NCT02883452|18626599|P2|Overall Study|Disease progression|0
5402975|NCT02883452|18626600|P1|Overall Study|Disease progression|1
5402976|NCT02883452|18626595|P6|Overall Study|Withdrawal by Subject|5
5402977|NCT02883452|18626596|P5|Overall Study|Withdrawal by Subject|2
5402978|NCT02883452|18626597|P4|Overall Study|Withdrawal by Subject|0
5402979|NCT02883452|18626598|P3|Overall Study|Withdrawal by Subject|3
5402980|NCT02883452|18626599|P2|Overall Study|Withdrawal by Subject|1
5402981|NCT02883452|18626600|P1|Overall Study|Withdrawal by Subject|1
5402982|NCT02883244|18626628|P2|Overall Study|Lost to Follow-up|1
5402983|NCT02883244|18626629|P1|Overall Study|Lost to Follow-up|0
5402984|NCT02882854|18626647|P2|Overall Study|Physician Decision|1
5402985|NCT02882854|18626648|P1|Overall Study|Physician Decision|0
5402986|NCT02882854|18626647|P2|Overall Study|Lost to Follow-up|2
5402987|NCT02882854|18626648|P1|Overall Study|Lost to Follow-up|1
5402988|NCT02882152|18626691|P2|Overall Study|Lost to Follow-up|0
5402989|NCT02882152|18626692|P1|Overall Study|Lost to Follow-up|1
5402990|NCT02881957|18626702|P2|Overall Study|Protocol Violation|0
5402991|NCT02881957|18626703|P1|Overall Study|Protocol Violation|1
5402992|NCT02881957|18626702|P2|Overall Study|Withdrawal by Subject|1
5402993|NCT02881957|18626703|P1|Overall Study|Withdrawal by Subject|2
5402994|NCT02881957|18626702|P2|Overall Study|Discharged within 48 hours|1
5402995|NCT02881957|18626703|P1|Overall Study|Discharged within 48 hours|0
5402996|NCT02881957|18626702|P2|Overall Study|Concurrent trial enrollment|1
5402997|NCT02881957|18626703|P1|Overall Study|Concurrent trial enrollment|0
5402998|NCT02881957|18626702|P2|Overall Study|Comfort care|1
5402999|NCT02881957|18626703|P1|Overall Study|Comfort care|0
5403000|NCT02881567|18626789|P1|Overall Study|Reason not Specified|3
5403001|NCT02881567|18626789|P1|Overall Study|Study terminated by sponsor|9
5403002|NCT02881567|18626789|P1|Overall Study|Investigator decision|1
5403003|NCT02881567|18626789|P1|Overall Study|Consent withdrawn|1
5403004|NCT02881567|18626789|P1|Overall Study|Lost to Follow-up|3
5403005|NCT02881567|18626789|P1|Overall Study|Adverse Event|1
5403006|NCT02881047|18626805|P1|Overall Study|Withdrawal by Subject|1
5403007|NCT02881047|18626805|P1|Overall Study|Adverse Event|1
5403008|NCT02880865|18626857|P2|Overall Study|Physician Decision|1
5403009|NCT02880865|18626858|P1|Overall Study|Physician Decision|0
5403010|NCT02880865|18626857|P2|Overall Study|Withdrawal by Subject|2
5403011|NCT02880865|18626858|P1|Overall Study|Withdrawal by Subject|0
5403012|NCT02880865|18626857|P2|Overall Study|Adverse Event|0
5403013|NCT02880865|18626858|P1|Overall Study|Adverse Event|1
5403014|NCT02880761|18626941|P2|Overall Study|Lost to Follow-up|4
5403015|NCT02880761|18626942|P1|Overall Study|Lost to Follow-up|3
5403016|NCT02880761|18626941|P2|Overall Study|Protocol Violation|3
5403017|NCT02880761|18626942|P1|Overall Study|Protocol Violation|4
5403018|NCT02880761|18626941|P2|Overall Study|Withdrawal by Subject|6
5403019|NCT02880761|18626942|P1|Overall Study|Withdrawal by Subject|3
5403020|NCT02880761|18626941|P2|Overall Study|Death|8
5403021|NCT02880761|18626942|P1|Overall Study|Death|6
5403022|NCT02878590|18627170|P1|Overall Study|Withdrawal by Subject|2
5403023|NCT02878330|18627208|P2|Overall Study|Other|7
5403024|NCT02878330|18627209|P1|Overall Study|Other|4
5403025|NCT02878330|18627208|P2|Overall Study|Withdrawal by Subject|21
5403026|NCT02878330|18627209|P1|Overall Study|Withdrawal by Subject|11
5403027|NCT02878330|18627208|P2|Overall Study|Lost to Follow-up|26
5403028|NCT02878330|18627209|P1|Overall Study|Lost to Follow-up|11
5403029|NCT02878330|18627208|P2|Overall Study|Death|2
5403030|NCT02878330|18627209|P1|Overall Study|Death|3
5403031|NCT02878213|18627225|P1|Overall Study|Adverse Event|1
5403032|NCT02878213|18627225|P1|Overall Study|Withdrawal by Subject|2
5403033|NCT02877927|18627232|P2|Overall Study|Missed EOT/PTE Visit|6
5403034|NCT02877927|18627233|P1|Overall Study|Missed EOT/PTE Visit|5
5403035|NCT02877927|18627232|P2|Overall Study|Physician Decision|1
5403036|NCT02877927|18627233|P1|Overall Study|Physician Decision|0
5403037|NCT02877927|18627232|P2|Overall Study|Withdrawal by Subject|12
5403038|NCT02877927|18627233|P1|Overall Study|Withdrawal by Subject|11
5403039|NCT02877927|18627232|P2|Overall Study|Lost to Follow-up|38
5403040|NCT02877927|18627233|P1|Overall Study|Lost to Follow-up|37
5403041|NCT02877927|18627232|P2|Overall Study|Adverse Event|0
5403042|NCT02877927|18627233|P1|Overall Study|Adverse Event|1
5403043|NCT02877680|18627264|P2|Overall Study|Lost to Follow-up|1
5403044|NCT02877680|18627265|P1|Overall Study|Lost to Follow-up|1
5403045|NCT02877082|18627323|P1|Overall Study|Trial was closed early|5
5403046|NCT02877004|18627334|P3|Overall Study|Pregnancy|1
5403047|NCT02877004|18627335|P2|Overall Study|Pregnancy|0
5403048|NCT02877004|18627336|P1|Overall Study|Pregnancy|0
5403049|NCT02876601|18627420|P4|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
5403050|NCT02876601|18627421|P3|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
5403051|NCT02876601|18627422|P2|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
5403052|NCT02876601|18627423|P1|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
5403053|NCT02875977|18627521|P2|Overall Study|Lost to Follow-up|29
5403054|NCT02875977|18627522|P1|Overall Study|Lost to Follow-up|42
5403055|NCT02875834|18627540|P4|Randomized Treatment Phase|(Not collected)|9
5403056|NCT02875834|18627541|P3|Randomized Treatment Phase|(Not collected)|10
5403057|NCT02875834|18627542|P2|Randomized Treatment Phase|(Not collected)|9
5403058|NCT02875834|18627543|P1|Randomized Treatment Phase|(Not collected)|0
5403059|NCT02875834|18627540|P4|Randomized Treatment Phase|Protocol Violation|0
5403060|NCT02875834|18627541|P3|Randomized Treatment Phase|Protocol Violation|0
5403061|NCT02875834|18627542|P2|Randomized Treatment Phase|Protocol Violation|2
5403062|NCT02875834|18627543|P1|Randomized Treatment Phase|Protocol Violation|0
5403063|NCT02875834|18627540|P4|Randomized Treatment Phase|Withdrawal by Subject|0
5403064|NCT02875834|18627541|P3|Randomized Treatment Phase|Withdrawal by Subject|1
5403065|NCT02875834|18627542|P2|Randomized Treatment Phase|Withdrawal by Subject|3
5403066|NCT02875834|18627543|P1|Randomized Treatment Phase|Withdrawal by Subject|0
5403067|NCT02875834|18627540|P4|Open-label Phase|(Not collected)|0
5403068|NCT02875834|18627541|P3|Open-label Phase|(Not collected)|0
5403069|NCT02875834|18627542|P2|Open-label Phase|(Not collected)|0
5403070|NCT02875834|18627543|P1|Open-label Phase|(Not collected)|4
5403071|NCT02875834|18627540|P4|Open-label Phase|Withdrawal by Subject|0
5403072|NCT02875834|18627541|P3|Open-label Phase|Withdrawal by Subject|0
5403073|NCT02875834|18627542|P2|Open-label Phase|Withdrawal by Subject|0
5403074|NCT02875834|18627543|P1|Open-label Phase|Withdrawal by Subject|3
5403075|NCT02875613|18627601|P1|Overall Study|Withdrawal by Subject|1
5403076|NCT02875366|18627607|P2|Overall Study|Noncompliance|1
5403077|NCT02875366|18627608|P1|Overall Study|Noncompliance|0
5403078|NCT02875366|18627607|P2|Overall Study|Adverse Event|2
5403079|NCT02875366|18627608|P1|Overall Study|Adverse Event|0
5403080|NCT02875340|18627660|P1|Overall Study|Adverse Event|1
5403081|NCT02875340|18627660|P1|Overall Study|Physician Decision|3
5403082|NCT02875340|18627660|P1|Overall Study|Withdrawal by Subject|2
5403083|NCT02875340|18627660|P1|Overall Study|Death|2
5403084|NCT02875067|18627682|P1|Overall Study|Withdrawal by Termination of Study|5
5403085|NCT02875067|18627682|P1|Overall Study|Withdrawal by Subject|1
5403086|NCT02875028|18627697|P2|Washout Period|Withdrawal by Subject|1
5403087|NCT02875028|18627698|P1|Washout Period|Withdrawal by Subject|0
5403088|NCT02874924|18627729|P3|Overall Study|Withdrawal by Subject|0
5403089|NCT02874924|18627730|P2|Overall Study|Withdrawal by Subject|0
5403090|NCT02874924|18627731|P1|Overall Study|Withdrawal by Subject|1
5403091|NCT02874924|18627729|P3|Overall Study|Adverse Event|0
5403092|NCT02874924|18627730|P2|Overall Study|Adverse Event|0
5403093|NCT02874924|18627731|P1|Overall Study|Adverse Event|2
5403094|NCT02874794|18627764|P2|Overall Study|Death|1
5403095|NCT02874794|18627765|P1|Overall Study|Death|2
5403096|NCT02874794|18627764|P2|Overall Study|Withdrawal by Subject|8
5403097|NCT02874794|18627765|P1|Overall Study|Withdrawal by Subject|2
5403098|NCT02874794|18627764|P2|Overall Study|Physician Decision|2
5403099|NCT02874794|18627765|P1|Overall Study|Physician Decision|3
5403100|NCT02874742|18627797|P3|Overall Study|Ongoing|15
5403101|NCT02874742|18627798|P2|Overall Study|Ongoing|98
5403102|NCT02874742|18627799|P1|Overall Study|Ongoing|87
5403103|NCT02874742|18627797|P3|Overall Study|Other|0
5403104|NCT02874742|18627798|P2|Overall Study|Other|1
5403105|NCT02874742|18627799|P1|Overall Study|Other|3
5403106|NCT02874742|18627797|P3|Overall Study|Withdrawal by Subject|0
5403107|NCT02874742|18627798|P2|Overall Study|Withdrawal by Subject|4
5403108|NCT02874742|18627799|P1|Overall Study|Withdrawal by Subject|8
5403109|NCT02874742|18627797|P3|Overall Study|Lost to Follow-up|0
5403110|NCT02874742|18627798|P2|Overall Study|Lost to Follow-up|0
5403111|NCT02874742|18627799|P1|Overall Study|Lost to Follow-up|2
5403112|NCT02874742|18627797|P3|Overall Study|Death|1
5403113|NCT02874742|18627798|P2|Overall Study|Death|1
5403114|NCT02874742|18627799|P1|Overall Study|Death|3
5403115|NCT02874534|18627853|P2|Overall Study|Ongoing in study|1
5403116|NCT02874534|18627854|P1|Overall Study|Ongoing in study|1
5403117|NCT02874534|18627853|P2|Overall Study|Lost to Follow-up|2
5403118|NCT02874534|18627854|P1|Overall Study|Lost to Follow-up|2
5403119|NCT02874534|18627853|P2|Overall Study|Withdrawal by Subject|8
5403120|NCT02874534|18627854|P1|Overall Study|Withdrawal by Subject|5
5403121|NCT02873754|18627883|P1|Overall Study|Couldn't complete study procedures|1
5403122|NCT02873754|18627883|P1|Overall Study|Lost to Follow-up|5
5403123|NCT02873702|18627900|P4|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
5403124|NCT02873702|18627901|P3|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
5403125|NCT02873702|18627902|P2|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
5403126|NCT02873702|18627903|P1|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
5403127|NCT02873702|18627900|P4|Maintenance Period (up to Month 6)|Relapse of EE|1
5403128|NCT02873702|18627901|P3|Maintenance Period (up to Month 6)|Relapse of EE|4
5403129|NCT02873702|18627902|P2|Maintenance Period (up to Month 6)|Relapse of EE|0
5403130|NCT02873702|18627903|P1|Maintenance Period (up to Month 6)|Relapse of EE|0
5403131|NCT02873702|18627900|P4|Maintenance Period (up to Month 6)|Adverse Event|0
5403216|NCT02872311|18628312|P5|Overall Study|Death|0
5403132|NCT02873702|18627901|P3|Maintenance Period (up to Month 6)|Adverse Event|1
5403133|NCT02873702|18627902|P2|Maintenance Period (up to Month 6)|Adverse Event|0
5403134|NCT02873702|18627903|P1|Maintenance Period (up to Month 6)|Adverse Event|0
5403135|NCT02873702|18627900|P4|Healing Period (up to Week 8)|Withdrawal by Subject|0
5403136|NCT02873702|18627901|P3|Healing Period (up to Week 8)|Withdrawal by Subject|0
5403137|NCT02873702|18627902|P2|Healing Period (up to Week 8)|Withdrawal by Subject|1
5403138|NCT02873702|18627903|P1|Healing Period (up to Week 8)|Withdrawal by Subject|0
5403139|NCT02873702|18627900|P4|Healing Period (up to Week 8)|Adverse Event|0
5403140|NCT02873702|18627901|P3|Healing Period (up to Week 8)|Adverse Event|0
5403141|NCT02873702|18627902|P2|Healing Period (up to Week 8)|Adverse Event|0
5403142|NCT02873702|18627903|P1|Healing Period (up to Week 8)|Adverse Event|1
5403143|NCT02873689|18627915|P2|Overall Study|Randomized but not Treated|1
5403144|NCT02873689|18627916|P1|Overall Study|Randomized but not Treated|1
5403145|NCT02873689|18627915|P2|Overall Study|Adverse Event|2
5403146|NCT02873689|18627916|P1|Overall Study|Adverse Event|2
5403147|NCT02873689|18627915|P2|Overall Study|Protocol Violation|0
5403148|NCT02873689|18627916|P1|Overall Study|Protocol Violation|1
5403149|NCT02873689|18627915|P2|Overall Study|Withdrawal by Subject|2
5403150|NCT02873689|18627916|P1|Overall Study|Withdrawal by Subject|2
5403151|NCT02873689|18627915|P2|Overall Study|Lack of Efficacy|0
5403152|NCT02873689|18627916|P1|Overall Study|Lack of Efficacy|1
5403153|NCT02873429|18627957|P2|16 Weeks|Lost to Follow-up|0
5403154|NCT02873429|18627958|P1|16 Weeks|Lost to Follow-up|3
5403155|NCT02873429|18627957|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
5403156|NCT02873429|18627958|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
5403157|NCT02873429|18627957|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
5403158|NCT02873429|18627958|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
5403159|NCT02873377|18627970|P2|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
5403160|NCT02873377|18627971|P1|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
5403161|NCT02873377|18627970|P2|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
5403162|NCT02873377|18627971|P1|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
5403163|NCT02873221|18628229|P3|Safety Follow-up Period|Withdrawal of Consent|8
5403164|NCT02873221|18628230|P2|Safety Follow-up Period|Withdrawal of Consent|10
5403165|NCT02873221|18628231|P1|Safety Follow-up Period|Withdrawal of Consent|4
5403166|NCT02873221|18628229|P3|Safety Follow-up Period|Lost to Follow-up|5
5403167|NCT02873221|18628230|P2|Safety Follow-up Period|Lost to Follow-up|5
5403168|NCT02873221|18628231|P1|Safety Follow-up Period|Lost to Follow-up|3
5403169|NCT02873221|18628229|P3|Safety Follow-up Period|Protocol Violation|1
5403170|NCT02873221|18628230|P2|Safety Follow-up Period|Protocol Violation|0
5403171|NCT02873221|18628231|P1|Safety Follow-up Period|Protocol Violation|0
5403172|NCT02873221|18628229|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
5403173|NCT02873221|18628230|P2|Safety Follow-up Period|Other Miscellaneous Reasons|2
5403174|NCT02873221|18628231|P1|Safety Follow-up Period|Other Miscellaneous Reasons|0
5403175|NCT02873221|18628229|P3|Treatment Period|Lost to Follow-up|26
5403176|NCT02873221|18628230|P2|Treatment Period|Lost to Follow-up|30
5403177|NCT02873221|18628231|P1|Treatment Period|Lost to Follow-up|26
5403178|NCT02873221|18628229|P3|Treatment Period|Adverse Event|11
5403179|NCT02873221|18628230|P2|Treatment Period|Adverse Event|9
5403180|NCT02873221|18628231|P1|Treatment Period|Adverse Event|4
5403181|NCT02873221|18628229|P3|Treatment Period|Lack of Efficacy|12
5403182|NCT02873221|18628230|P2|Treatment Period|Lack of Efficacy|17
5403183|NCT02873221|18628231|P1|Treatment Period|Lack of Efficacy|0
5403184|NCT02873221|18628229|P3|Treatment Period|Withdrawal of Consent|41
5403185|NCT02873221|18628230|P2|Treatment Period|Withdrawal of Consent|51
5403186|NCT02873221|18628231|P1|Treatment Period|Withdrawal of Consent|52
5403187|NCT02873221|18628229|P3|Treatment Period|Lack of Qualifying Event|1
5403188|NCT02873221|18628230|P2|Treatment Period|Lack of Qualifying Event|3
5403189|NCT02873221|18628231|P1|Treatment Period|Lack of Qualifying Event|0
5403190|NCT02873221|18628229|P3|Treatment Period|Pregnancy|3
5403191|NCT02873221|18628230|P2|Treatment Period|Pregnancy|6
5403192|NCT02873221|18628231|P1|Treatment Period|Pregnancy|4
5403193|NCT02873221|18628229|P3|Treatment Period|Protocol Violation|8
5403194|NCT02873221|18628230|P2|Treatment Period|Protocol Violation|5
5403195|NCT02873221|18628231|P1|Treatment Period|Protocol Violation|2
5403196|NCT02873221|18628229|P3|Treatment Period|Non-Compliance with Study Drug|2
5403197|NCT02873221|18628230|P2|Treatment Period|Non-Compliance with Study Drug|3
5403198|NCT02873221|18628231|P1|Treatment Period|Non-Compliance with Study Drug|0
5403199|NCT02873221|18628229|P3|Treatment Period|Other Miscellaneous Reasons|1
5403200|NCT02873221|18628230|P2|Treatment Period|Other Miscellaneous Reasons|2
5403201|NCT02873221|18628231|P1|Treatment Period|Other Miscellaneous Reasons|0
5403202|NCT02873195|18628253|P2|Overall Study|Ineligible|0
5403203|NCT02873195|18628254|P1|Overall Study|Ineligible|5
5403204|NCT02872935|18628283|P2|Overall Study|Other|1
5403205|NCT02872935|18628284|P1|Overall Study|Other|0
5403206|NCT02872311|18628312|P5|Overall Study|Protocol Violation|0
5403207|NCT02872311|18628313|P4|Overall Study|Protocol Violation|0
5403208|NCT02872311|18628314|P3|Overall Study|Protocol Violation|1
5403209|NCT02872311|18628315|P2|Overall Study|Protocol Violation|2
5403210|NCT02872311|18628316|P1|Overall Study|Protocol Violation|0
5403211|NCT02872311|18628312|P5|Overall Study|Lost to Follow-up|0
5403212|NCT02872311|18628313|P4|Overall Study|Lost to Follow-up|0
5403213|NCT02872311|18628314|P3|Overall Study|Lost to Follow-up|0
5403214|NCT02872311|18628315|P2|Overall Study|Lost to Follow-up|0
5403215|NCT02872311|18628316|P1|Overall Study|Lost to Follow-up|2
5403217|NCT02872311|18628313|P4|Overall Study|Death|0
5403218|NCT02872311|18628314|P3|Overall Study|Death|0
5403219|NCT02872311|18628315|P2|Overall Study|Death|0
5403220|NCT02872311|18628316|P1|Overall Study|Death|2
5403221|NCT02872285|18628377|P2|Overall Study|Discontinued due to back surgery|0
5403222|NCT02872285|18628378|P1|Overall Study|Discontinued due to back surgery|1
5403223|NCT02872285|18628377|P2|Overall Study|Lost to Follow-up|2
5403224|NCT02872285|18628378|P1|Overall Study|Lost to Follow-up|2
5403225|NCT02872285|18628377|P2|Overall Study|Withdrawal by Subject|0
5403226|NCT02872285|18628378|P1|Overall Study|Withdrawal by Subject|2
5403227|NCT02872012|18628424|P5|Overall Study|Withdrawal by Subject|0
5403228|NCT02872012|18628425|P4|Overall Study|Withdrawal by Subject|0
5403229|NCT02872012|18628426|P3|Overall Study|Withdrawal by Subject|0
5403230|NCT02872012|18628427|P2|Overall Study|Withdrawal by Subject|0
5403231|NCT02872012|18628428|P1|Overall Study|Withdrawal by Subject|1
5403232|NCT02871739|18628446|P4|Overall Study|Lost to Follow-up|2
5403233|NCT02871739|18628447|P3|Overall Study|Lost to Follow-up|0
5403234|NCT02871739|18628448|P2|Overall Study|Lost to Follow-up|2
5403235|NCT02871739|18628449|P1|Overall Study|Lost to Follow-up|3
5403236|NCT02871635|18628461|P2|Overall Study|Secondary lack of efficacy|1
5403237|NCT02871635|18628462|P1|Overall Study|Secondary lack of efficacy|2
5403238|NCT02871635|18628461|P2|Overall Study|Adverse Event|4
5403239|NCT02871635|18628462|P1|Overall Study|Adverse Event|4
5403240|NCT02871635|18628461|P2|Overall Study|Withdrawal by Subject|4
5403241|NCT02871635|18628462|P1|Overall Study|Withdrawal by Subject|3
5403242|NCT02871635|18628461|P2|Overall Study|Physician Decision|1
5403243|NCT02871635|18628462|P1|Overall Study|Physician Decision|1
5403244|NCT02871635|18628461|P2|Overall Study|Pregnancy|2
5403245|NCT02871635|18628462|P1|Overall Study|Pregnancy|0
5403246|NCT02871635|18628461|P2|Overall Study|Lost to Follow-up|2
5403247|NCT02871635|18628462|P1|Overall Study|Lost to Follow-up|1
5403248|NCT02871635|18628461|P2|Overall Study|Protocol Violation|1
5403249|NCT02871635|18628462|P1|Overall Study|Protocol Violation|3
5403250|NCT02871635|18628461|P2|Overall Study|Primary lack of efficacy|4
5403251|NCT02871635|18628462|P1|Overall Study|Primary lack of efficacy|4
5403252|NCT02871375|18628552|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
5403253|NCT02871375|18628553|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
5403254|NCT02870933|18628599|P2|Overall Study|Withdrawal by Subject|1
5403255|NCT02870933|18628600|P1|Overall Study|Withdrawal by Subject|0
5403256|NCT02870933|18628599|P2|Overall Study|Death|1
5403257|NCT02870933|18628600|P1|Overall Study|Death|2
5403258|NCT02869893|18628673|P1|Overall Study|participant fear of MRI scanner|2
5403259|NCT02869893|18628673|P1|Overall Study|participant aversion to IV|5
5403260|NCT02869438|18628703|P2|Overall Study|Withdrawal by Subject|2
5403261|NCT02869438|18628704|P1|Overall Study|Withdrawal by Subject|1
5403262|NCT02869438|18628703|P2|Overall Study|Adverse Event|0
5403263|NCT02869438|18628704|P1|Overall Study|Adverse Event|1
5403264|NCT02869438|18628703|P2|Overall Study|Lost to Follow-up|0
5403265|NCT02869438|18628704|P1|Overall Study|Lost to Follow-up|1
5403266|NCT02868892|18628752|P1|Overall Study|Investigator left site and no follow-up|6
5403267|NCT02868554|18628761|P3|Overall Study|Lost to Follow-up|1
5403268|NCT02868554|18628762|P2|Overall Study|Lost to Follow-up|0
5403269|NCT02868554|18628763|P1|Overall Study|Lost to Follow-up|3
5403270|NCT02868281|18628788|P2|Overall Study|Long journey/moving away|1
5403271|NCT02868281|18628789|P1|Overall Study|Long journey/moving away|1
5403272|NCT02868281|18628788|P2|Overall Study|Inclusion/exclusion criteria violation|2
5403273|NCT02868281|18628789|P1|Overall Study|Inclusion/exclusion criteria violation|3
5403274|NCT02868281|18628788|P2|Overall Study|Had protocol-defined asthma exacerbation|8
5403275|NCT02868281|18628789|P1|Overall Study|Had protocol-defined asthma exacerbation|8
5403276|NCT02868281|18628788|P2|Overall Study|Physician Decision|0
5403277|NCT02868281|18628789|P1|Overall Study|Physician Decision|2
5403278|NCT02868281|18628788|P2|Overall Study|Withdrawal by Subject|15
5403279|NCT02868281|18628789|P1|Overall Study|Withdrawal by Subject|11
5403280|NCT02868281|18628788|P2|Overall Study|Lost to Follow-up|6
5403281|NCT02868281|18628789|P1|Overall Study|Lost to Follow-up|3
5403282|NCT02868281|18628788|P2|Overall Study|Protocol Violation|10
5403283|NCT02868281|18628789|P1|Overall Study|Protocol Violation|13
5403284|NCT02868281|18628788|P2|Overall Study|Adverse Event|2
5403285|NCT02868281|18628789|P1|Overall Study|Adverse Event|2
5403286|NCT02868216|18628823|P2|Overall Study|Withdrawal by Subject|5
5403287|NCT02868216|18628824|P1|Overall Study|Withdrawal by Subject|7
5403288|NCT02868216|18628823|P2|Overall Study|coronary artery bypass|0
5403289|NCT02868216|18628824|P1|Overall Study|coronary artery bypass|1
5403290|NCT02868216|18628823|P2|Overall Study|Death|1
5403291|NCT02868216|18628824|P1|Overall Study|Death|0
5403292|NCT02867995|18628832|P2|Overall Study|Lost to Follow-up|2
5403293|NCT02867995|18628833|P1|Overall Study|Lost to Follow-up|0
5403294|NCT02867995|18628832|P2|Overall Study|Withdrawal by Subject|1
5403295|NCT02867995|18628833|P1|Overall Study|Withdrawal by Subject|0
5403296|NCT02867709|18628852|P3|Safety Follow-up Period|Protocol Violation|1
5403297|NCT02867709|18628853|P2|Safety Follow-up Period|Protocol Violation|1
5403298|NCT02867709|18628854|P1|Safety Follow-up Period|Protocol Violation|0
5403299|NCT02867709|18628852|P3|Safety Follow-up Period|Pregnancy|0
5403300|NCT02867709|18628853|P2|Safety Follow-up Period|Pregnancy|1
5403301|NCT02867709|18628854|P1|Safety Follow-up Period|Pregnancy|0
5403302|NCT02867709|18628852|P3|Safety Follow-up Period|Lost to Follow-up|7
5403303|NCT02867709|18628853|P2|Safety Follow-up Period|Lost to Follow-up|5
5403304|NCT02867709|18628854|P1|Safety Follow-up Period|Lost to Follow-up|10
5403305|NCT02867709|18628852|P3|Safety Follow-up Period|Withdrawal of Consent|6
5403306|NCT02867709|18628853|P2|Safety Follow-up Period|Withdrawal of Consent|8
5403307|NCT02867709|18628854|P1|Safety Follow-up Period|Withdrawal of Consent|1
5403308|NCT02867709|18628852|P3|Treatment Period|Protocol Violation|3
5403309|NCT02867709|18628853|P2|Treatment Period|Protocol Violation|2
5403310|NCT02867709|18628854|P1|Treatment Period|Protocol Violation|3
5403311|NCT02867709|18628852|P3|Treatment Period|Lack of Qualifying Event|42
5403312|NCT02867709|18628853|P2|Treatment Period|Lack of Qualifying Event|55
5403313|NCT02867709|18628854|P1|Treatment Period|Lack of Qualifying Event|42
5403314|NCT02867709|18628852|P3|Treatment Period|Lost to Follow-up|20
5403315|NCT02867709|18628853|P2|Treatment Period|Lost to Follow-up|20
5403316|NCT02867709|18628854|P1|Treatment Period|Lost to Follow-up|17
5403317|NCT02867709|18628852|P3|Treatment Period|Withdrawal of Consent|8
5403318|NCT02867709|18628853|P2|Treatment Period|Withdrawal of Consent|9
5403319|NCT02867709|18628854|P1|Treatment Period|Withdrawal of Consent|7
5403320|NCT02867709|18628852|P3|Treatment Period|Adverse Event|2
5403321|NCT02867709|18628853|P2|Treatment Period|Adverse Event|1
5403322|NCT02867709|18628854|P1|Treatment Period|Adverse Event|1
5403323|NCT02866942|18628961|P1|Overall Study|Invalid consent|1
5403324|NCT02866695|18628966|P1|Overall Study|Lost to Follow-up|1
5403325|NCT02866695|18628966|P1|Overall Study|Adverse Event|1
5403326|NCT02866175|18628983|P2|Overall Study|Did not receive treatment|15
5403327|NCT02866175|18628984|P1|Overall Study|Did not receive treatment|5
5403328|NCT02866175|18628983|P2|Overall Study|Physician Decision|15
5403329|NCT02866175|18628984|P1|Overall Study|Physician Decision|3
5403330|NCT02866175|18628983|P2|Overall Study|Lack of Efficacy|1
5403331|NCT02866175|18628984|P1|Overall Study|Lack of Efficacy|0
5403332|NCT02866175|18628983|P2|Overall Study|Lost to Follow-up|0
5403333|NCT02866175|18628984|P1|Overall Study|Lost to Follow-up|2
5403334|NCT02866175|18628983|P2|Overall Study|Progressive disease|1
5403335|NCT02866175|18628984|P1|Overall Study|Progressive disease|1
5403336|NCT02866175|18628983|P2|Overall Study|Other|14
5403337|NCT02866175|18628984|P1|Overall Study|Other|7
5403338|NCT02866175|18628983|P2|Overall Study|Death|23
5403339|NCT02866175|18628984|P1|Overall Study|Death|30
5403340|NCT02866175|18628983|P2|Overall Study|Withdrawal by Subject|52
5403341|NCT02866175|18628984|P1|Overall Study|Withdrawal by Subject|31
5403342|NCT02866175|18628983|P2|Overall Study|Adverse Event|54
5403343|NCT02866175|18628984|P1|Overall Study|Adverse Event|56
5403344|NCT02865915|18629004|P2|Overall Study|Dosing group discontinued|5
5403345|NCT02865915|18629005|P1|Overall Study|Dosing group discontinued|0
5403346|NCT02865915|18629004|P2|Overall Study|Study terminated by sponsor|18
5403347|NCT02865915|18629005|P1|Overall Study|Study terminated by sponsor|23
5403348|NCT02865915|18629004|P2|Overall Study|Protocol Violation|1
5403349|NCT02865915|18629005|P1|Overall Study|Protocol Violation|0
5403350|NCT02865915|18629004|P2|Overall Study|Lost to Follow-up|1
5403351|NCT02865915|18629005|P1|Overall Study|Lost to Follow-up|0
5403352|NCT02865915|18629004|P2|Overall Study|Adverse Event|4
5403353|NCT02865915|18629005|P1|Overall Study|Adverse Event|0
5403354|NCT02865915|18629004|P2|Overall Study|Withdrawal by Subject|1
5403355|NCT02865915|18629005|P1|Overall Study|Withdrawal by Subject|1
5403356|NCT02865915|18629004|P2|Overall Study|Pregnancy|0
5403357|NCT02865915|18629005|P1|Overall Study|Pregnancy|1
5403358|NCT02865499|18629048|P1|Baseline|Withdrawal by Subject|1
5403359|NCT02865499|18629048|P1|Baseline|Adverse Event|1
5403360|NCT02865395|18629055|P3|Overall Study|Physician Decision|7
5403361|NCT02865395|18629056|P2|Overall Study|Physician Decision|10
5403362|NCT02865395|18629057|P1|Overall Study|Physician Decision|6
5403363|NCT02865083|18629083|P2|Overall Study|Early Termination|1
5403364|NCT02865083|18629084|P1|Overall Study|Early Termination|3
5403365|NCT02864394|18629145|P2|Overall Study|Ongoing In Study|53
5403366|NCT02864394|18629146|P1|Overall Study|Ongoing In Study|77
5403367|NCT02864394|18629145|P2|Overall Study|Withdrawal by Subject|9
5403368|NCT02864394|18629146|P1|Overall Study|Withdrawal by Subject|1
5403369|NCT02864394|18629145|P2|Overall Study|Death|150
5403370|NCT02864394|18629146|P1|Overall Study|Death|135
5403371|NCT02864381|18629172|P2|Overall Study|Protocol Violation|1
5403372|NCT02864381|18629173|P1|Overall Study|Protocol Violation|0
5403373|NCT02864381|18629172|P2|Overall Study|Investigator's Discretion|0
5403374|NCT02864381|18629173|P1|Overall Study|Investigator's Discretion|1
5403375|NCT02864381|18629172|P2|Overall Study|Lost to Follow-up|1
5403376|NCT02864381|18629173|P1|Overall Study|Lost to Follow-up|1
5403377|NCT02864381|18629172|P2|Overall Study|Reason Unknown|3
5403378|NCT02864381|18629173|P1|Overall Study|Reason Unknown|7
5403379|NCT02864381|18629172|P2|Overall Study|Withdrew Consent|6
5403380|NCT02864381|18629173|P1|Overall Study|Withdrew Consent|5
5403381|NCT02864381|18629172|P2|Overall Study|Death|61
5403382|NCT02864381|18629173|P1|Overall Study|Death|58
5403383|NCT02864342|18629191|P2|Overall Study|Adverse Event|0
5403384|NCT02864342|18629192|P1|Overall Study|Adverse Event|1
5403385|NCT02864342|18629191|P2|Overall Study|Lost Device|0
5403386|NCT02864342|18629192|P1|Overall Study|Lost Device|1
5403387|NCT02864342|18629191|P2|Overall Study|Lost to Follow-up|5
5403388|NCT02864342|18629192|P1|Overall Study|Lost to Follow-up|1
5403389|NCT02864342|18629191|P2|Overall Study|Did Not Start Treatment with Symbicort|1
5403390|NCT02864342|18629192|P1|Overall Study|Did Not Start Treatment with Symbicort|0
5403391|NCT02864342|18629191|P2|Overall Study|Death|1
5403392|NCT02864342|18629192|P1|Overall Study|Death|0
5403393|NCT02864342|18629191|P2|Overall Study|Device Technology Issue|7
5403394|NCT02864342|18629192|P1|Overall Study|Device Technology Issue|6
5403395|NCT02864342|18629191|P2|Overall Study|Withdrawal by Subject|2
5403396|NCT02864342|18629192|P1|Overall Study|Withdrawal by Subject|4
5403397|NCT02864342|18629191|P2|Overall Study|Eligibility Criteria Deviation|3
5403398|NCT02864342|18629192|P1|Overall Study|Eligibility Criteria Deviation|2
5403399|NCT02864316|18629209|P2|Overall Study|Adverse Event|1
5403400|NCT02864316|18629210|P1|Overall Study|Adverse Event|0
5403401|NCT02864316|18629209|P2|Overall Study|Progressive Disease|1
5403402|NCT02864316|18629210|P1|Overall Study|Progressive Disease|2
5403403|NCT02863575|18629248|P3|Overall Study|Adverse Event|0
5403404|NCT02863575|18629249|P2|Overall Study|Adverse Event|1
5403405|NCT02863575|18629250|P1|Overall Study|Adverse Event|0
5403406|NCT02863575|18629248|P3|Overall Study|Withdrawal by Subject|1
5403407|NCT02863575|18629249|P2|Overall Study|Withdrawal by Subject|1
5403408|NCT02863575|18629250|P1|Overall Study|Withdrawal by Subject|0
5403409|NCT02863575|18629248|P3|Overall Study|Participants Unable To Swallow Capsule|0
5403410|NCT02863575|18629249|P2|Overall Study|Participants Unable To Swallow Capsule|0
5403411|NCT02863575|18629250|P1|Overall Study|Participants Unable To Swallow Capsule|1
5403412|NCT02863419|18629302|P3|Overall Study|Died|1
5403413|NCT02863419|18629303|P2|Overall Study|Died|4
5403414|NCT02863419|18629304|P1|Overall Study|Died|3
5403415|NCT02863419|18629302|P3|Overall Study|Withdrawal by Subject|3
5403416|NCT02863419|18629303|P2|Overall Study|Withdrawal by Subject|5
5403417|NCT02863419|18629304|P1|Overall Study|Withdrawal by Subject|5
5403418|NCT02863419|18629302|P3|Overall Study|Lost to Follow-up|4
5403419|NCT02863419|18629303|P2|Overall Study|Lost to Follow-up|1
5403420|NCT02863419|18629304|P1|Overall Study|Lost to Follow-up|0
5403421|NCT02863328|18629421|P2|Overall Study|Died|1
5403422|NCT02863328|18629422|P1|Overall Study|Died|0
5403423|NCT02863328|18629421|P2|Overall Study|Withdrawal by Subject|12
5403424|NCT02863328|18629422|P1|Overall Study|Withdrawal by Subject|7
5403425|NCT02863328|18629421|P2|Overall Study|Lost to Follow-up|10
5403426|NCT02863328|18629422|P1|Overall Study|Lost to Follow-up|4
5403427|NCT02862730|18629579|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5403428|NCT02862730|18629580|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5403429|NCT02862730|18629581|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5403430|NCT02862730|18629582|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
5403431|NCT02862730|18629583|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5403432|NCT02862730|18629584|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5403433|NCT02862730|18629585|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
5403434|NCT02862730|18629579|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5403435|NCT02862730|18629580|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5403436|NCT02862730|18629581|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
5403437|NCT02862730|18629582|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5403438|NCT02862730|18629583|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
5403439|NCT02862730|18629584|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5403440|NCT02862730|18629585|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
5403441|NCT02862730|18629579|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
5403442|NCT02862730|18629580|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
5403443|NCT02862730|18629581|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
5403444|NCT02862730|18629582|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
5403445|NCT02862730|18629583|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
5403446|NCT02862730|18629584|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
5403447|NCT02862730|18629585|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
5403448|NCT02862730|18629579|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5403449|NCT02862730|18629580|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5403450|NCT02862730|18629581|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5403451|NCT02862730|18629582|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5403452|NCT02862730|18629583|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
5403453|NCT02862730|18629584|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5403454|NCT02862730|18629585|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
5403455|NCT02862600|18629640|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
5403456|NCT02862600|18629640|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
5403457|NCT02862600|18629640|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
5403458|NCT02862600|18629640|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
5403459|NCT02862574|18629650|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
5403460|NCT02862574|18629651|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
5403461|NCT02862574|18629652|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
5403462|NCT02862574|18629650|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
5403463|NCT02862574|18629651|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
5403464|NCT02862574|18629652|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
5403465|NCT02862574|18629650|P3|Double-Blind Treatment Period|Adverse Event|0
5403466|NCT02862574|18629651|P2|Double-Blind Treatment Period|Adverse Event|1
5403467|NCT02862574|18629652|P1|Double-Blind Treatment Period|Adverse Event|0
5403468|NCT02862548|18629672|P2|Open-Label Extension Phase|Still on Study|24
5403469|NCT02862548|18629673|P1|Open-Label Extension Phase|Still on Study|26
5403470|NCT02862548|18629672|P2|Open-Label Phase|Death|1
5403471|NCT02862548|18629673|P1|Open-Label Phase|Death|0
5403472|NCT02862535|18629701|P4|Overall Study|Enrolled, not Treated|1
5403473|NCT02862535|18629702|P3|Overall Study|Enrolled, not Treated|0
5403474|NCT02862535|18629703|P2|Overall Study|Enrolled, not Treated|0
5403475|NCT02862535|18629704|P1|Overall Study|Enrolled, not Treated|1
5403476|NCT02862535|18629701|P4|Overall Study|Study Terminated by Sponsor|5
5403477|NCT02862535|18629702|P3|Overall Study|Study Terminated by Sponsor|8
5403478|NCT02862535|18629703|P2|Overall Study|Study Terminated by Sponsor|3
5403479|NCT02862535|18629704|P1|Overall Study|Study Terminated by Sponsor|1
5403480|NCT02862535|18629701|P4|Overall Study|Death|5
5403481|NCT02862535|18629702|P3|Overall Study|Death|2
5403482|NCT02862535|18629703|P2|Overall Study|Death|3
5403483|NCT02862535|18629704|P1|Overall Study|Death|7
5403484|NCT02862106|18629732|P2|Overall Study|Subjects moved to other city|0
5403485|NCT02862106|18629733|P1|Overall Study|Subjects moved to other city|1
5403486|NCT02862106|18629732|P2|Overall Study|Withdrawal by Subject|0
5403487|NCT02862106|18629733|P1|Overall Study|Withdrawal by Subject|2
5403488|NCT02862106|18629732|P2|Overall Study|Lost to Follow-up|5
5403489|NCT02862106|18629733|P1|Overall Study|Lost to Follow-up|15
5403490|NCT02862106|18629732|P2|Overall Study|Protocol Violation|1
5403491|NCT02862106|18629733|P1|Overall Study|Protocol Violation|16
5403492|NCT02862106|18629732|P2|Overall Study|Adverse Event|0
5403493|NCT02862106|18629733|P1|Overall Study|Adverse Event|4
5403494|NCT02861807|18629818|P2|Overall Study|Withdrawal by Subject|8
5403495|NCT02861807|18629819|P1|Overall Study|Withdrawal by Subject|5
5403496|NCT02861807|18629818|P2|Overall Study|Lost to Follow-up|6
5403497|NCT02861807|18629819|P1|Overall Study|Lost to Follow-up|7
5403498|NCT02861664|18629835|P2|Overall Study|Withdrawal of Consent|1
5403499|NCT02861664|18629836|P1|Overall Study|Withdrawal of Consent|0
5403500|NCT02861534|18629848|P2|Overall Study|Withdrawal by Subject|18
5403501|NCT02861534|18629849|P1|Overall Study|Withdrawal by Subject|15
5403502|NCT02861534|18629848|P2|Overall Study|Site Terminated by Sponsor|3
5403503|NCT02861534|18629849|P1|Overall Study|Site Terminated by Sponsor|4
5403504|NCT02861534|18629848|P2|Overall Study|Lost to Follow-up|14
5403505|NCT02861534|18629849|P1|Overall Study|Lost to Follow-up|14
5403506|NCT02861534|18629848|P2|Overall Study|Death|552
5403507|NCT02861534|18629849|P1|Overall Study|Death|541
5403508|NCT02860169|18629937|P1|Part C|Other (Screening failure)|1
5403509|NCT02860169|18629937|P1|Part B|Withdrawal by Subject|1
5403510|NCT02860169|18629937|P1|Part B|Other (Screening failure)|10
5403511|NCT02860169|18629937|P1|Part A|Other (did not completed consent)|1
5403512|NCT02860169|18629937|P1|Part A|Other (Survey not completed)|3
5403513|NCT02860169|18629937|P1|Part A|Other (Screening failure)|6
5403514|NCT02860169|18629937|P1|Part A|Withdrawal by Subject|1
5403515|NCT02859454|18629966|P1|Overall Study|PI discretion/off study prior to trtmt|1
5403516|NCT02859246|18630022|P1|Overall Study|Withdrawal by Subject|1
5403517|NCT02859246|18630022|P1|Overall Study|Adverse Event|1
5403518|NCT02859246|18630022|P1|Overall Study|Screen fails|3
5403519|NCT02858726|18630031|P4|Overall Study|Noncompliance|0
5403520|NCT02858726|18630032|P3|Overall Study|Noncompliance|0
5403521|NCT02858726|18630033|P2|Overall Study|Noncompliance|1
5403522|NCT02858726|18630034|P1|Overall Study|Noncompliance|0
5403523|NCT02858726|18630031|P4|Overall Study|Withdrawal by Subject|0
5403524|NCT02858726|18630032|P3|Overall Study|Withdrawal by Subject|1
5403525|NCT02858726|18630033|P2|Overall Study|Withdrawal by Subject|2
5403526|NCT02858726|18630034|P1|Overall Study|Withdrawal by Subject|1
5403527|NCT02858726|18630031|P4|Overall Study|Study Terminated by Sponsor|1
5403528|NCT02858726|18630032|P3|Overall Study|Study Terminated by Sponsor|0
5403529|NCT02858726|18630033|P2|Overall Study|Study Terminated by Sponsor|0
5403530|NCT02858726|18630034|P1|Overall Study|Study Terminated by Sponsor|0
5403531|NCT02858726|18630031|P4|Overall Study|Protocol Violation|1
5403532|NCT02858726|18630032|P3|Overall Study|Protocol Violation|0
5403533|NCT02858726|18630033|P2|Overall Study|Protocol Violation|0
5403534|NCT02858726|18630034|P1|Overall Study|Protocol Violation|0
5403535|NCT02858726|18630031|P4|Overall Study|Physician Decision|0
5403536|NCT02858726|18630032|P3|Overall Study|Physician Decision|1
5403537|NCT02858726|18630033|P2|Overall Study|Physician Decision|0
5403538|NCT02858726|18630034|P1|Overall Study|Physician Decision|0
5403539|NCT02858726|18630031|P4|Overall Study|Adverse Event|1
5403540|NCT02858726|18630032|P3|Overall Study|Adverse Event|9
5403541|NCT02858726|18630033|P2|Overall Study|Adverse Event|4
5403542|NCT02858726|18630034|P1|Overall Study|Adverse Event|4
5403543|NCT02858492|18630065|P4|Overall Study|Protocol defined stopping criteria|1
5403544|NCT02858492|18630066|P3|Overall Study|Protocol defined stopping criteria|0
5403545|NCT02858492|18630067|P2|Overall Study|Protocol defined stopping criteria|0
5403546|NCT02858492|18630068|P1|Overall Study|Protocol defined stopping criteria|0
5403547|NCT02858492|18630065|P4|Overall Study|Lack of Efficacy|1
5403548|NCT02858492|18630066|P3|Overall Study|Lack of Efficacy|0
5403549|NCT02858492|18630067|P2|Overall Study|Lack of Efficacy|0
5403550|NCT02858492|18630068|P1|Overall Study|Lack of Efficacy|0
5403551|NCT02858492|18630065|P4|Overall Study|Adverse Event|3
5403552|NCT02858492|18630066|P3|Overall Study|Adverse Event|0
5403553|NCT02858492|18630067|P2|Overall Study|Adverse Event|0
5403554|NCT02858492|18630068|P1|Overall Study|Adverse Event|0
5403555|NCT02858492|18630065|P4|Overall Study|Withdrawal by Subject|1
5403556|NCT02858492|18630066|P3|Overall Study|Withdrawal by Subject|0
5403557|NCT02858492|18630067|P2|Overall Study|Withdrawal by Subject|1
5403558|NCT02858492|18630068|P1|Overall Study|Withdrawal by Subject|0
5403559|NCT02858440|18630244|P1|Overall Study|Migrated/moved from study area|4
5403560|NCT02858440|18630244|P1|Overall Study|Consent withdrawal|3
5403561|NCT02858440|18630244|P1|Overall Study|Protocol Violation|2
5403562|NCT02858440|18630244|P1|Overall Study|Lost to Follow-up|3
5403563|NCT02858401|18630277|P7|Overall Study|Lost to Follow-up|0
5403564|NCT02858401|18630278|P6|Overall Study|Lost to Follow-up|0
5403565|NCT02858401|18630279|P5|Overall Study|Lost to Follow-up|0
5403566|NCT02858401|18630280|P4|Overall Study|Lost to Follow-up|0
5403567|NCT02858401|18630281|P3|Overall Study|Lost to Follow-up|0
5403568|NCT02858401|18630282|P2|Overall Study|Lost to Follow-up|1
5403569|NCT02858401|18630283|P1|Overall Study|Lost to Follow-up|0
5403570|NCT02858401|18630277|P7|Overall Study|Withdrew Consent|0
5403571|NCT02858401|18630278|P6|Overall Study|Withdrew Consent|1
5403572|NCT02858401|18630279|P5|Overall Study|Withdrew Consent|0
5403573|NCT02858401|18630280|P4|Overall Study|Withdrew Consent|0
5403574|NCT02858401|18630281|P3|Overall Study|Withdrew Consent|0
5403575|NCT02858401|18630282|P2|Overall Study|Withdrew Consent|0
5403576|NCT02858401|18630283|P1|Overall Study|Withdrew Consent|0
5403577|NCT02858362|18630694|P3|Overall Study|Lost to Follow-up|0
5403578|NCT02858362|18630695|P2|Overall Study|Lost to Follow-up|0
5403579|NCT02858362|18630696|P1|Overall Study|Lost to Follow-up|1
5403580|NCT02858362|18630694|P3|Overall Study|Early Study Termination|3
5403581|NCT02858362|18630695|P2|Overall Study|Early Study Termination|0
5403582|NCT02858362|18630696|P1|Overall Study|Early Study Termination|0
5403583|NCT02858362|18630694|P3|Overall Study|Withdrawal by Subject|0
5403584|NCT02858362|18630695|P2|Overall Study|Withdrawal by Subject|0
5403585|NCT02858362|18630696|P1|Overall Study|Withdrawal by Subject|1
5403586|NCT02858362|18630694|P3|Overall Study|Protocol Violation|0
5403587|NCT02858362|18630695|P2|Overall Study|Protocol Violation|1
5403588|NCT02858362|18630696|P1|Overall Study|Protocol Violation|0
5403589|NCT02858180|18630737|P2|Overall Study|Lost to Follow-up|2
5403590|NCT02858180|18630738|P1|Overall Study|Lost to Follow-up|0
5403591|NCT02857816|18630759|P1|Overall Study|Lost to Follow-up|1
5403592|NCT02857816|18630759|P1|Overall Study|Withdrawal by Subject|4
5403593|NCT02857816|18630759|P1|Overall Study|Screen Failure|33
5403594|NCT02857426|18630767|P2|Follow-up|other reason|0
5403595|NCT02857426|18630768|P1|Follow-up|other reason|1
5403596|NCT02857426|18630767|P2|Follow-up|Participant withdrew consent|4
5403597|NCT02857426|18630768|P1|Follow-up|Participant withdrew consent|3
5403598|NCT02857426|18630767|P2|Follow-up|Death|2
5403599|NCT02857426|18630768|P1|Follow-up|Death|6
5403600|NCT02857426|18630767|P2|Treatment|Maximum clinical benefit|0
5403601|NCT02857426|18630768|P1|Treatment|Maximum clinical benefit|1
5403602|NCT02857426|18630767|P2|Treatment|Participant withdrew consent|1
5403603|NCT02857426|18630768|P1|Treatment|Participant withdrew consent|1
5403604|NCT02857426|18630767|P2|Treatment|Adverse event unrelated to study drug|2
5403605|NCT02857426|18630768|P1|Treatment|Adverse event unrelated to study drug|6
5403606|NCT02857426|18630767|P2|Treatment|Death|0
5403607|NCT02857426|18630768|P1|Treatment|Death|1
5403608|NCT02857426|18630767|P2|Treatment|Study drug toxicity|1
5403609|NCT02857426|18630768|P1|Treatment|Study drug toxicity|4
5403610|NCT02857426|18630767|P2|Treatment|Disease progression|13
5403611|NCT02857426|18630768|P1|Treatment|Disease progression|33
5403612|NCT02857283|18630784|P2|First Exposure|Withdrawal by Subject|0
5403613|NCT02857283|18630785|P1|First Exposure|Withdrawal by Subject|1
5403614|NCT02856880|18630819|P1|Overall Study|Withdrawal of consent|1
5403615|NCT02856555|18630863|P3|Overall Study|Randomized but Never Treated|0
5403616|NCT02856555|18630864|P2|Overall Study|Randomized but Never Treated|1
5403617|NCT02856555|18630865|P1|Overall Study|Randomized but Never Treated|0
5403618|NCT02856555|18630863|P3|Overall Study|Withdrawal by Subject|0
5403619|NCT02856555|18630864|P2|Overall Study|Withdrawal by Subject|0
5403620|NCT02856555|18630865|P1|Overall Study|Withdrawal by Subject|3
5403621|NCT02856555|18630863|P3|Overall Study|Lost to Follow-up|0
5403622|NCT02856555|18630864|P2|Overall Study|Lost to Follow-up|3
5403623|NCT02856555|18630865|P1|Overall Study|Lost to Follow-up|1
5403624|NCT02856555|18630863|P3|Overall Study|Adverse Event|0
5403625|NCT02856555|18630864|P2|Overall Study|Adverse Event|0
5403626|NCT02856555|18630865|P1|Overall Study|Adverse Event|1
5403627|NCT02856282|18630873|P1|Overall Study|Withdrawal by Subject|1
5403628|NCT02855541|18630905|P1|Overall Study|Withdrawal by Subject|2
5403629|NCT02855541|18630905|P1|Overall Study|Change in health status|2
5403630|NCT02855450|18630918|P2|Overall Study|Lost to Follow-up|0
5403631|NCT02855450|18630919|P1|Overall Study|Lost to Follow-up|4
5403632|NCT02855450|18630918|P2|Overall Study|Adverse Event|0
5403633|NCT02855450|18630919|P1|Overall Study|Adverse Event|1
5403634|NCT02855411|18630936|P1|Overall Study|Does not meet entrance criteria|14
5403635|NCT02855411|18630936|P1|Overall Study|Study terminated by sponsor|21
5403636|NCT02855359|18630958|P4|Overall Study|Study Termination by Sponsor|0
5403637|NCT02855359|18630959|P3|Overall Study|Study Termination by Sponsor|0
5403638|NCT02855359|18630960|P2|Overall Study|Study Termination by Sponsor|11
5403639|NCT02855359|18630961|P1|Overall Study|Study Termination by Sponsor|9
5403640|NCT02855359|18630958|P4|Overall Study|Death|0
5403641|NCT02855359|18630959|P3|Overall Study|Death|0
5403642|NCT02855359|18630960|P2|Overall Study|Death|2
5403643|NCT02855359|18630961|P1|Overall Study|Death|2
5403644|NCT02854800|18631007|P3|Overall Study|Withdrawal by Subject|3
5403645|NCT02854800|18631008|P2|Overall Study|Withdrawal by Subject|2
5403646|NCT02854800|18631009|P1|Overall Study|Withdrawal by Subject|4
5403647|NCT02854800|18631007|P3|Overall Study|Protocol Violation|3
5403648|NCT02854800|18631008|P2|Overall Study|Protocol Violation|11
5403649|NCT02854800|18631009|P1|Overall Study|Protocol Violation|16
5403650|NCT02854631|18631049|P2|Overall Study|Lost to Follow-up|2
5403651|NCT02854631|18631050|P1|Overall Study|Lost to Follow-up|4
5403652|NCT02854631|18631049|P2|Overall Study|Subjects Randomized but Never Treated|0
5403653|NCT02854631|18631050|P1|Overall Study|Subjects Randomized but Never Treated|2
5403654|NCT02854631|18631049|P2|Overall Study|Protocol Violation|1
5403655|NCT02854631|18631050|P1|Overall Study|Protocol Violation|0
5403656|NCT02854631|18631049|P2|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
5403657|NCT02854631|18631050|P1|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
5403658|NCT02854631|18631049|P2|Overall Study|Death|8
5403659|NCT02854631|18631050|P1|Overall Study|Death|12
5403660|NCT02854631|18631049|P2|Overall Study|Investigator's Discretion|0
5403661|NCT02854631|18631050|P1|Overall Study|Investigator's Discretion|2
5403662|NCT02854631|18631049|P2|Overall Study|Withdrew Consent|2
5403663|NCT02854631|18631050|P1|Overall Study|Withdrew Consent|3
5403664|NCT02854631|18631049|P2|Overall Study|Adverse Event|2
5403665|NCT02854631|18631050|P1|Overall Study|Adverse Event|1
5403666|NCT02854605|18631111|P3|Overall Study|Protocol Violation|1
5403667|NCT02854605|18631112|P2|Overall Study|Protocol Violation|0
5403668|NCT02854605|18631113|P1|Overall Study|Protocol Violation|0
5403669|NCT02854605|18631111|P3|Overall Study|Investigator's Discretion|0
5403670|NCT02854605|18631112|P2|Overall Study|Investigator's Discretion|0
5403671|NCT02854605|18631113|P1|Overall Study|Investigator's Discretion|1
5403672|NCT02854605|18631111|P3|Overall Study|Withdrew Consent|1
5403673|NCT02854605|18631112|P2|Overall Study|Withdrew Consent|0
5403674|NCT02854605|18631113|P1|Overall Study|Withdrew Consent|1
5403675|NCT02854605|18631111|P3|Overall Study|Lost to Follow-up|0
5403676|NCT02854605|18631112|P2|Overall Study|Lost to Follow-up|2
5403677|NCT02854605|18631113|P1|Overall Study|Lost to Follow-up|0
5403678|NCT02854605|18631111|P3|Overall Study|Adverse Event|2
5403679|NCT02854605|18631112|P2|Overall Study|Adverse Event|5
5403680|NCT02854605|18631113|P1|Overall Study|Adverse Event|1
5403681|NCT02854527|18631143|P10|Overall Study|Lost to Follow-up|0
5403682|NCT02854527|18631144|P9|Overall Study|Lost to Follow-up|0
5403683|NCT02854527|18631145|P8|Overall Study|Lost to Follow-up|0
5403684|NCT02854527|18631146|P7|Overall Study|Lost to Follow-up|0
5403685|NCT02854527|18631147|P6|Overall Study|Lost to Follow-up|0
5403686|NCT02854527|18631148|P5|Overall Study|Lost to Follow-up|0
5403687|NCT02854527|18631149|P4|Overall Study|Lost to Follow-up|1
5403688|NCT02854527|18631150|P3|Overall Study|Lost to Follow-up|0
5403689|NCT02854527|18631151|P2|Overall Study|Lost to Follow-up|0
5403690|NCT02854527|18631152|P1|Overall Study|Lost to Follow-up|0
5403691|NCT02854527|18631143|P10|Overall Study|Adverse Event|0
5403692|NCT02854527|18631144|P9|Overall Study|Adverse Event|0
5403693|NCT02854527|18631145|P8|Overall Study|Adverse Event|0
5403694|NCT02854527|18631146|P7|Overall Study|Adverse Event|0
5403695|NCT02854527|18631147|P6|Overall Study|Adverse Event|0
5403696|NCT02854527|18631148|P5|Overall Study|Adverse Event|1
5403697|NCT02854527|18631149|P4|Overall Study|Adverse Event|0
5403698|NCT02854527|18631150|P3|Overall Study|Adverse Event|0
5403699|NCT02854527|18631151|P2|Overall Study|Adverse Event|0
5403700|NCT02854527|18631152|P1|Overall Study|Adverse Event|0
5403701|NCT02853929|18631210|P2|Overall Study|Subjects enrolled but not vaccinated|4
5403702|NCT02853929|18631211|P1|Overall Study|Subjects enrolled but not vaccinated|7
5403703|NCT02853929|18631210|P2|Overall Study|Withdrawal by Subject|0
5403704|NCT02853929|18631211|P1|Overall Study|Withdrawal by Subject|1
5403705|NCT02853929|18631210|P2|Overall Study|Lost to Follow-up|0
5403706|NCT02853929|18631211|P1|Overall Study|Lost to Follow-up|3
5403707|NCT02853435|18631252|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5403708|NCT02853435|18631253|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
5403709|NCT02853435|18631254|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5403710|NCT02853435|18631255|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5403711|NCT02853435|18631256|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5403712|NCT02853435|18631257|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
5403713|NCT02853331|18631567|P2|Overall Study|Ongoing in study|325
5403714|NCT02853331|18631568|P1|Overall Study|Ongoing in study|368
5403715|NCT02853331|18631567|P2|Overall Study|Withdrawal by Subject|9
5403716|NCT02853331|18631568|P1|Overall Study|Withdrawal by Subject|5
5403717|NCT02853331|18631567|P2|Overall Study|Death|95
5403718|NCT02853331|18631568|P1|Overall Study|Death|59
5403719|NCT02853318|18631600|P1|Overall Study|Withdrawal by Subject|1
5403720|NCT02853123|18631608|P2|Washout Period|Adverse Event|0
5403721|NCT02853123|18631609|P1|Washout Period|Adverse Event|1
5403722|NCT02853123|18631608|P2|Washout Period|Worsening of COPD|3
5403723|NCT02853123|18631609|P1|Washout Period|Worsening of COPD|0
5403724|NCT02853123|18631608|P2|Treatment Period 1|Adverse Event|3
5403725|NCT02853123|18631609|P1|Treatment Period 1|Adverse Event|0
5403726|NCT02853032|18631632|P2|Overall Study|Requested to withdraw from all treatment|2
5403727|NCT02853032|18631633|P1|Overall Study|Requested to withdraw from all treatment|2
5403728|NCT02853032|18631632|P2|Overall Study|Withdrawal by Subject|1
5403729|NCT02853032|18631633|P1|Overall Study|Withdrawal by Subject|3
5403730|NCT02853032|18631632|P2|Overall Study|Adverse Event|0
5403731|NCT02853032|18631633|P1|Overall Study|Adverse Event|4
5403732|NCT02852434|18631709|P2|Overall Study|Unsuccessful Dilator Procedure|0
5403733|NCT02852434|18631710|P1|Overall Study|Unsuccessful Dilator Procedure|2
5403734|NCT02852434|18631709|P2|Overall Study|Withdrawal by Subject|1
5403735|NCT02852434|18631710|P1|Overall Study|Withdrawal by Subject|0
5403736|NCT02852265|18631726|P2|3-month Follow-up|Lost to Follow-up|1
5403737|NCT02852265|18631727|P1|3-month Follow-up|Lost to Follow-up|1
5403738|NCT02851069|18631760|P1|Overall Study|Other|3
5403739|NCT02851069|18631760|P1|Overall Study|Failure to Return|3
5403740|NCT02850978|18631782|P1|Overall Study|Reason not listed|88
5403741|NCT02850978|18631782|P1|Overall Study|Lost to Follow-up|121
5403742|NCT02850978|18631782|P1|Overall Study|Improvement in condition|34
5403743|NCT02850978|18631782|P1|Overall Study|Lack of Efficacy|40
5403744|NCT02850978|18631782|P1|Overall Study|Adverse Event|81
5403745|NCT02850978|18631782|P1|Overall Study|No visit since the first visit|35
5403746|NCT02850978|18631782|P1|Overall Study|Uncollectable CRF|27
5403747|NCT02850965|18631789|P2|Overall Study|Randomized but not treated|1
5403748|NCT02850965|18631790|P1|Overall Study|Randomized but not treated|0
5403749|NCT02850965|18631789|P2|Overall Study|Physician Decision|1
5403750|NCT02850965|18631790|P1|Overall Study|Physician Decision|0
5403751|NCT02850965|18631789|P2|Overall Study|Withdrawal by Subject|4
5403752|NCT02850965|18631790|P1|Overall Study|Withdrawal by Subject|3
5403753|NCT02850965|18631789|P2|Overall Study|Adverse Event|2
5403754|NCT02850965|18631790|P1|Overall Study|Adverse Event|3
5403755|NCT02850965|18631789|P2|Overall Study|Lack of Efficacy|8
5403756|NCT02850965|18631790|P1|Overall Study|Lack of Efficacy|4
5403757|NCT02850965|18631789|P2|Overall Study|Lost to Follow-up|3
5403758|NCT02850965|18631790|P1|Overall Study|Lost to Follow-up|5
5403759|NCT02850965|18631789|P2|Overall Study|Protocol Violation|2
5403760|NCT02850965|18631790|P1|Overall Study|Protocol Violation|0
5403761|NCT02850965|18631789|P2|Overall Study|Other than listed|4
5403762|NCT02850965|18631790|P1|Overall Study|Other than listed|3
5403763|NCT02850276|18631806|P1|Overall Study|Lost to Follow-up|2
5403764|NCT02850276|18631806|P1|Overall Study|Physician Decision|2
5403765|NCT02850276|18631806|P1|Overall Study|Withdrawal by Subject|14
5403766|NCT02850276|18631806|P1|Overall Study|screen failure|43
5403767|NCT02849990|18631833|P1|Overall Study|Withdrawal by Subject|1
5403768|NCT02849990|18631833|P1|Overall Study|Adverse Event|1
5403769|NCT02849704|18631858|P2|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
5403770|NCT02849704|18631859|P1|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
5403771|NCT02849704|18631858|P2|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
5403772|NCT02849704|18631859|P1|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
5403773|NCT02849704|18631858|P2|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
5403774|NCT02849704|18631859|P1|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
5403775|NCT02849678|18631874|P2|Overall Study|Protocol Violation|6
5403776|NCT02849678|18631875|P1|Overall Study|Protocol Violation|3
5403777|NCT02849626|18631895|P2|Extension Phase A (up to 29 Weeks)|Non-specified|0
5403778|NCT02849626|18631896|P1|Extension Phase A (up to 29 Weeks)|Non-specified|1
5403779|NCT02849626|18631895|P2|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
5403780|NCT02849626|18631896|P1|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
5403781|NCT02849626|18631895|P2|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
5403782|NCT02849626|18631896|P1|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
5403783|NCT02849626|18631895|P2|Extension Phase A (up to 29 Weeks)|Adverse Event|2
5403784|NCT02849626|18631896|P1|Extension Phase A (up to 29 Weeks)|Adverse Event|3
5403785|NCT02849626|18631895|P2|Core Phase (up to 23 Weeks)|Non-specified|0
5403786|NCT02849626|18631896|P1|Core Phase (up to 23 Weeks)|Non-specified|3
5403787|NCT02849626|18631895|P2|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
5403788|NCT02849626|18631896|P1|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
5403789|NCT02849626|18631895|P2|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
5403790|NCT02849626|18631896|P1|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
5403791|NCT02849626|18631895|P2|Core Phase (up to 23 Weeks)|Adverse Event|3
5403792|NCT02849626|18631896|P1|Core Phase (up to 23 Weeks)|Adverse Event|11
5403793|NCT02849509|18631959|P3|Overall Study|No inform. on termination of Pradaxa/VKA|1
5403794|NCT02849509|18631960|P2|Overall Study|No inform. on termination of Pradaxa/VKA|10
5403795|NCT02849509|18631961|P1|Overall Study|No inform. on termination of Pradaxa/VKA|6
5403796|NCT02849509|18631959|P3|Overall Study|Other, reason not specified|25
5403797|NCT02849509|18631960|P2|Overall Study|Other, reason not specified|29
5403798|NCT02849509|18631961|P1|Overall Study|Other, reason not specified|14
5403799|NCT02849509|18631959|P3|Overall Study|Lost to Follow-up|36
5403800|NCT02849509|18631960|P2|Overall Study|Lost to Follow-up|67
5403801|NCT02849509|18631961|P1|Overall Study|Lost to Follow-up|27
5403802|NCT02849509|18631959|P3|Overall Study|Withdrawal by Subject|12
5403803|NCT02849509|18631960|P2|Overall Study|Withdrawal by Subject|17
5403804|NCT02849509|18631961|P1|Overall Study|Withdrawal by Subject|6
5403805|NCT02849509|18631959|P3|Overall Study|Other adverse event|8
5403806|NCT02849509|18631960|P2|Overall Study|Other adverse event|41
5403807|NCT02849509|18631961|P1|Overall Study|Other adverse event|36
5403808|NCT02849509|18631959|P3|Overall Study|Worsening of other pre-existing disease|2
5403809|NCT02849509|18631960|P2|Overall Study|Worsening of other pre-existing disease|1
5403810|NCT02849509|18631961|P1|Overall Study|Worsening of other pre-existing disease|0
5403811|NCT02849509|18631959|P3|Overall Study|Worsening of disease under study|1
5403812|NCT02849509|18631960|P2|Overall Study|Worsening of disease under study|1
5403813|NCT02849509|18631961|P1|Overall Study|Worsening of disease under study|1
5403814|NCT02849080|18632168|P4|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
5403815|NCT02849080|18632169|P3|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
5403816|NCT02849080|18632170|P2|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
5403817|NCT02849080|18632171|P1|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
5403818|NCT02849080|18632168|P4|Extension Phase: 53 - 104 Weeks|Other|0
5403819|NCT02849080|18632169|P3|Extension Phase: 53 - 104 Weeks|Other|1
5403820|NCT02849080|18632170|P2|Extension Phase: 53 - 104 Weeks|Other|0
5403821|NCT02849080|18632171|P1|Extension Phase: 53 - 104 Weeks|Other|0
5403822|NCT02849080|18632168|P4|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
5403823|NCT02849080|18632169|P3|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
5403824|NCT02849080|18632170|P2|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
5403825|NCT02849080|18632171|P1|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
5403826|NCT02849080|18632168|P4|Main Phase: 0 - 52 Weeks|Death|0
5403827|NCT02849080|18632169|P3|Main Phase: 0 - 52 Weeks|Death|0
5403828|NCT02849080|18632170|P2|Main Phase: 0 - 52 Weeks|Death|2
5403829|NCT02849080|18632171|P1|Main Phase: 0 - 52 Weeks|Death|0
5403830|NCT02849080|18632168|P4|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
5403831|NCT02849080|18632169|P3|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
5403832|NCT02849080|18632170|P2|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
5403833|NCT02849080|18632171|P1|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
5403834|NCT02849080|18632168|P4|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
5403835|NCT02849080|18632169|P3|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
5403836|NCT02849080|18632170|P2|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
5403837|NCT02849080|18632171|P1|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
5403838|NCT02848729|18632298|P2|Overall Study|Emesis|11
5403839|NCT02848729|18632299|P1|Overall Study|Emesis|15
5403840|NCT02848729|18632298|P2|Overall Study|Withdrawal by Subject|0
5403841|NCT02848729|18632299|P1|Overall Study|Withdrawal by Subject|1
5403842|NCT02848664|18632316|P1|Overall Study|no assistance for device training|1
5403843|NCT02848664|18632316|P1|Overall Study|Adverse Event|1
5403844|NCT02848664|18632316|P1|Overall Study|Withdrawal by Subject|2
5403845|NCT02848651|18632324|P1|Overall Study|Withdrawal by Subject|14
5403846|NCT02848651|18632324|P1|Overall Study|Physician Decision|4
5403847|NCT02848651|18632324|P1|Overall Study|Symptomatic Deterioration|1
5403848|NCT02848651|18632324|P1|Overall Study|Non-Compliance|1
5403849|NCT02848651|18632324|P1|Overall Study|Lost to Follow-up|1
5403850|NCT02848651|18632324|P1|Overall Study|Death|85
5403851|NCT02848599|18632353|P2|Overall Study|Protocol Violation|9
5403852|NCT02848599|18632354|P1|Overall Study|Protocol Violation|7
5403853|NCT02848326|18632376|P6|Safety Follow-up Period|Lost to Follow-up|3
5403854|NCT02848326|18632377|P5|Safety Follow-up Period|Lost to Follow-up|1
5403855|NCT02848326|18632378|P4|Safety Follow-up Period|Lost to Follow-up|0
5403856|NCT02848326|18632379|P3|Safety Follow-up Period|Lost to Follow-up|2
5403857|NCT02848326|18632380|P2|Safety Follow-up Period|Lost to Follow-up|0
5403858|NCT02848326|18632381|P1|Safety Follow-up Period|Lost to Follow-up|4
5403859|NCT02848326|18632376|P6|Safety Follow-up Period|Withdrawal of Consent|2
5403860|NCT02848326|18632377|P5|Safety Follow-up Period|Withdrawal of Consent|0
5403861|NCT02848326|18632378|P4|Safety Follow-up Period|Withdrawal of Consent|0
5403862|NCT02848326|18632379|P3|Safety Follow-up Period|Withdrawal of Consent|1
5403863|NCT02848326|18632380|P2|Safety Follow-up Period|Withdrawal of Consent|1
5403864|NCT02848326|18632381|P1|Safety Follow-up Period|Withdrawal of Consent|0
5403865|NCT02848326|18632376|P6|Treatment Period|Non-compliance with Study Drug|0
5403866|NCT02848326|18632377|P5|Treatment Period|Non-compliance with Study Drug|0
5403867|NCT02848326|18632378|P4|Treatment Period|Non-compliance with Study Drug|1
5403868|NCT02848326|18632379|P3|Treatment Period|Non-compliance with Study Drug|0
5403869|NCT02848326|18632380|P2|Treatment Period|Non-compliance with Study Drug|0
5403870|NCT02848326|18632381|P1|Treatment Period|Non-compliance with Study Drug|4
5403871|NCT02848326|18632376|P6|Treatment Period|Protocol Violation|3
5403872|NCT02848326|18632377|P5|Treatment Period|Protocol Violation|3
5403873|NCT02848326|18632378|P4|Treatment Period|Protocol Violation|2
5403874|NCT02848326|18632379|P3|Treatment Period|Protocol Violation|4
5403875|NCT02848326|18632380|P2|Treatment Period|Protocol Violation|3
5403876|NCT02848326|18632381|P1|Treatment Period|Protocol Violation|4
5403877|NCT02848326|18632376|P6|Treatment Period|Pregnancy|1
5403878|NCT02848326|18632377|P5|Treatment Period|Pregnancy|0
5403879|NCT02848326|18632378|P4|Treatment Period|Pregnancy|1
5403880|NCT02848326|18632379|P3|Treatment Period|Pregnancy|1
5403881|NCT02848326|18632380|P2|Treatment Period|Pregnancy|0
5403882|NCT02848326|18632381|P1|Treatment Period|Pregnancy|0
5403883|NCT02848326|18632376|P6|Treatment Period|Lost to Follow-up|3
5403884|NCT02848326|18632377|P5|Treatment Period|Lost to Follow-up|2
5403885|NCT02848326|18632378|P4|Treatment Period|Lost to Follow-up|7
5403886|NCT02848326|18632379|P3|Treatment Period|Lost to Follow-up|11
5403887|NCT02848326|18632380|P2|Treatment Period|Lost to Follow-up|1
5403888|NCT02848326|18632381|P1|Treatment Period|Lost to Follow-up|5
5403889|NCT02848326|18632376|P6|Treatment Period|Withdrawal of Consent|6
5403890|NCT02848326|18632377|P5|Treatment Period|Withdrawal of Consent|9
5403891|NCT02848326|18632378|P4|Treatment Period|Withdrawal of Consent|6
5403892|NCT02848326|18632379|P3|Treatment Period|Withdrawal of Consent|9
5403893|NCT02848326|18632380|P2|Treatment Period|Withdrawal of Consent|6
5403894|NCT02848326|18632381|P1|Treatment Period|Withdrawal of Consent|20
5403895|NCT02848326|18632376|P6|Treatment Period|Adverse Event|7
5403896|NCT02848326|18632377|P5|Treatment Period|Adverse Event|5
5403897|NCT02848326|18632378|P4|Treatment Period|Adverse Event|6
5403898|NCT02848326|18632379|P3|Treatment Period|Adverse Event|11
5403899|NCT02848326|18632380|P2|Treatment Period|Adverse Event|4
5403900|NCT02848326|18632381|P1|Treatment Period|Adverse Event|5
5403901|NCT02848313|18632415|P2|Overall Study|Lost to follow up|0
5403902|NCT02848313|18632416|P1|Overall Study|Lost to follow up|1
5403903|NCT02848313|18632415|P2|Overall Study|Withdrawal by Subject|1
5403904|NCT02848313|18632416|P1|Overall Study|Withdrawal by Subject|1
5403905|NCT02848313|18632415|P2|Overall Study|Lack of Efficacy|1
5403906|NCT02848313|18632416|P1|Overall Study|Lack of Efficacy|0
5403907|NCT02848313|18632415|P2|Overall Study|Adverse Event|2
5403908|NCT02848313|18632416|P1|Overall Study|Adverse Event|1
5403909|NCT02847858|18632463|P2|Overall Study|Lost to Follow-up|269
5403910|NCT02847858|18632464|P1|Overall Study|Lost to Follow-up|401
5403911|NCT02847650|18632490|P2|Overall Study|Withdrawal by Subject|1
5403912|NCT02847650|18632491|P1|Overall Study|Withdrawal by Subject|1
5403913|NCT02847650|18632490|P2|Overall Study|Protocol Violation|1
5403914|NCT02847650|18632491|P1|Overall Study|Protocol Violation|0
5403915|NCT02847650|18632490|P2|Overall Study|Lost to Follow-up|0
5403916|NCT02847650|18632491|P1|Overall Study|Lost to Follow-up|1
5403917|NCT02847650|18632490|P2|Overall Study|Adverse Event|4
5403918|NCT02847650|18632491|P1|Overall Study|Adverse Event|2
5403919|NCT02847637|18632515|P4|Overall Study|First emicizumab dose delayed|0
5403920|NCT02847637|18632516|P3|Overall Study|First emicizumab dose delayed|0
5403921|NCT02847637|18632517|P2|Overall Study|First emicizumab dose delayed|0
5403922|NCT02847637|18632518|P1|Overall Study|First emicizumab dose delayed|1
5403923|NCT02847637|18632515|P4|Overall Study|Ongoing treatment with emicizumab|63
5403924|NCT02847637|18632516|P3|Overall Study|Ongoing treatment with emicizumab|34
5403925|NCT02847637|18632517|P2|Overall Study|Ongoing treatment with emicizumab|35
5403926|NCT02847637|18632518|P1|Overall Study|Ongoing treatment with emicizumab|16
5403927|NCT02847637|18632515|P4|Overall Study|Withdrew from treatment due to AE|0
5403928|NCT02847637|18632516|P3|Overall Study|Withdrew from treatment due to AE|1
5403929|NCT02847637|18632517|P2|Overall Study|Withdrew from treatment due to AE|0
5403930|NCT02847637|18632518|P1|Overall Study|Withdrew from treatment due to AE|0
5403931|NCT02847494|18632632|P2|Overall Study|Lost to Follow-up|5
5403932|NCT02847494|18632633|P1|Overall Study|Lost to Follow-up|8
5403933|NCT02847260|18632643|P1|Overall Study|Physician Decision|1
5403934|NCT02847260|18632643|P1|Overall Study|Clinical Deterioration|1
5403935|NCT02847260|18632643|P1|Overall Study|Withdrawal by Subject|2
5403936|NCT02847260|18632643|P1|Overall Study|Adverse Event|3
5403937|NCT02847182|18632657|P2|Overall Study|Withdrawal by Subject|1
5403938|NCT02847182|18632658|P1|Overall Study|Withdrawal by Subject|0
5403939|NCT02846779|18632782|P3|Overall Study|Less than 31 days of follow-up|52
5403940|NCT02846779|18632783|P2|Overall Study|Less than 31 days of follow-up|45
5403941|NCT02846779|18632784|P1|Overall Study|Less than 31 days of follow-up|56
5403942|NCT02846779|18632782|P3|Overall Study|Lost Enrollment|86
5403943|NCT02846779|18632783|P2|Overall Study|Lost Enrollment|82
5403944|NCT02846779|18632784|P1|Overall Study|Lost Enrollment|83
5403945|NCT02846558|18632840|P4|Overall Study|Lost to Follow-up|0
5403946|NCT02846558|18632841|P3|Overall Study|Lost to Follow-up|0
5403947|NCT02846558|18632842|P2|Overall Study|Lost to Follow-up|0
5403948|NCT02846558|18632843|P1|Overall Study|Lost to Follow-up|2
5403949|NCT02846558|18632840|P4|Overall Study|Withdrawal by Subject|2
5403950|NCT02846558|18632841|P3|Overall Study|Withdrawal by Subject|2
5403951|NCT02846558|18632842|P2|Overall Study|Withdrawal by Subject|4
5403952|NCT02846558|18632843|P1|Overall Study|Withdrawal by Subject|5
5403953|NCT02846558|18632840|P4|Overall Study|Adverse Event|0
5403954|NCT02846558|18632841|P3|Overall Study|Adverse Event|0
5403955|NCT02846558|18632842|P2|Overall Study|Adverse Event|0
5403956|NCT02846558|18632843|P1|Overall Study|Adverse Event|1
5403957|NCT02846415|18632881|P2|Overall Study|Withdrawal by Subject|1
5403958|NCT02846415|18632882|P1|Overall Study|Withdrawal by Subject|1
5403959|NCT02846415|18632881|P2|Overall Study|Lost to Follow-up|0
5403960|NCT02846415|18632882|P1|Overall Study|Lost to Follow-up|2
5403961|NCT02846324|18632896|P4|Overall Study|Withdrawal by Subject|0
5403962|NCT02846324|18632897|P3|Overall Study|Withdrawal by Subject|4
5403963|NCT02846324|18632898|P2|Overall Study|Withdrawal by Subject|0
5403964|NCT02846324|18632899|P1|Overall Study|Withdrawal by Subject|1
5403965|NCT02846324|18632896|P4|Overall Study|Other|0
5403966|NCT02846324|18632897|P3|Overall Study|Other|0
5403967|NCT02846324|18632898|P2|Overall Study|Other|0
5403968|NCT02846324|18632899|P1|Overall Study|Other|1
5403969|NCT02845375|18633016|P3|Overall Study|upper airway obstruction|1
5403970|NCT02845375|18633017|P2|Overall Study|upper airway obstruction|2
5403971|NCT02845375|18633018|P1|Overall Study|upper airway obstruction|1
5403972|NCT02845336|18633031|P2|Overall Study|Inability to get medication|0
5403973|NCT02845336|18633032|P1|Overall Study|Inability to get medication|2
5403974|NCT02845336|18633031|P2|Overall Study|Lost to Follow-up|1
5403975|NCT02845336|18633032|P1|Overall Study|Lost to Follow-up|3
5403976|NCT02844946|18633074|P2|Overall Study|Lost to Follow-up|0
5403977|NCT02844946|18633075|P1|Overall Study|Lost to Follow-up|7
5403978|NCT02844920|18633093|P1|Overall Study|Lost to Follow-up|2
5403979|NCT02844543|18633111|P1|Overall Study|Did not meet eligibility criteria|1
5403980|NCT02844543|18633111|P1|Overall Study|Withdrawal by Subject|4
5403981|NCT02843659|18633121|P3|Overall Study|Adverse Event|0
5403982|NCT02843659|18633122|P2|Overall Study|Adverse Event|1
5403983|NCT02843659|18633123|P1|Overall Study|Adverse Event|0
5403984|NCT02843659|18633121|P3|Overall Study|Administrative Reason by Sponsor|4
5403985|NCT02843659|18633122|P2|Overall Study|Administrative Reason by Sponsor|5
5403986|NCT02843659|18633123|P1|Overall Study|Administrative Reason by Sponsor|4
5403987|NCT02843659|18633121|P3|Overall Study|Subject Withdrew Consent|1
5403988|NCT02843659|18633122|P2|Overall Study|Subject Withdrew Consent|0
5403989|NCT02843659|18633123|P1|Overall Study|Subject Withdrew Consent|0
5403990|NCT02843178|18633201|P4|Overall Study|Withdrawal by Subject|1
5403991|NCT02843178|18633202|P3|Overall Study|Withdrawal by Subject|1
5403992|NCT02843178|18633203|P2|Overall Study|Withdrawal by Subject|0
5403993|NCT02843178|18633204|P1|Overall Study|Withdrawal by Subject|0
5403994|NCT02843178|18633201|P4|Overall Study|Lost to Follow-up|3
5403995|NCT02843178|18633202|P3|Overall Study|Lost to Follow-up|6
5403996|NCT02843178|18633203|P2|Overall Study|Lost to Follow-up|8
5403997|NCT02843178|18633204|P1|Overall Study|Lost to Follow-up|8
5403998|NCT02842866|18633244|P2|Overall Study|Withdrawal by Subject|0
5403999|NCT02842866|18633245|P1|Overall Study|Withdrawal by Subject|1
5404000|NCT02842866|18633244|P2|Overall Study|Lost to Follow-up|0
5404001|NCT02842866|18633245|P1|Overall Study|Lost to Follow-up|2
5404002|NCT02842866|18633244|P2|Overall Study|Protocol Violation|2
5404003|NCT02842866|18633245|P1|Overall Study|Protocol Violation|4
5404004|NCT02842866|18633244|P2|Overall Study|Serious Adverse Event|1
5404005|NCT02842866|18633245|P1|Overall Study|Serious Adverse Event|0
5404006|NCT02842853|18633257|P4|Overall Study|Lost to Follow-up|11
5404007|NCT02842853|18633258|P3|Overall Study|Lost to Follow-up|10
5404008|NCT02842853|18633259|P2|Overall Study|Lost to Follow-up|13
5404009|NCT02842853|18633260|P1|Overall Study|Lost to Follow-up|9
5404010|NCT02842853|18633257|P4|Overall Study|Withdrawal by Subject|8
5404011|NCT02842853|18633258|P3|Overall Study|Withdrawal by Subject|9
5404012|NCT02842853|18633259|P2|Overall Study|Withdrawal by Subject|13
5404013|NCT02842853|18633260|P1|Overall Study|Withdrawal by Subject|11
5404014|NCT02842853|18633257|P4|Overall Study|Subject met exclusion criteria|0
5404015|NCT02842853|18633258|P3|Overall Study|Subject met exclusion criteria|0
5404016|NCT02842853|18633259|P2|Overall Study|Subject met exclusion criteria|1
5404017|NCT02842853|18633260|P1|Overall Study|Subject met exclusion criteria|0
5404018|NCT02842853|18633257|P4|Overall Study|Non-compliance with the protocol|5
5404019|NCT02842853|18633258|P3|Overall Study|Non-compliance with the protocol|2
5404020|NCT02842853|18633259|P2|Overall Study|Non-compliance with the protocol|7
5404021|NCT02842853|18633260|P1|Overall Study|Non-compliance with the protocol|3
5404022|NCT02842736|18633280|P1|Overall Study|IUD: Mirena|1
5404023|NCT02842736|18633280|P1|Overall Study|Hysterectomy for uterine prolapse|1
5404024|NCT02842736|18633280|P1|Overall Study|Hysterectomy for fibroids|2
5404025|NCT02842736|18633280|P1|Overall Study|Pregnancy|3
5404026|NCT02842736|18633280|P1|Overall Study|Withdrawal by Subject|4
5404027|NCT02842736|18633280|P1|Overall Study|Intervention for menstrual bleeding|17
5404028|NCT02842736|18633280|P1|Overall Study|Lost to Follow-up|13
5404029|NCT02842151|18633323|P1|Overall Study|Subject moved too far away|1
5404030|NCT02842151|18633323|P1|Overall Study|Adverse Event|1
5404031|NCT02842086|18633331|P2|Overall Study|HIV-1 Infection|6
5404032|NCT02842086|18633332|P1|Overall Study|HIV-1 Infection|5
5404033|NCT02842086|18633331|P2|Overall Study|Lost to Follow-up|236
5404034|NCT02842086|18633332|P1|Overall Study|Lost to Follow-up|274
5404035|NCT02842086|18633331|P2|Overall Study|Withdrew Consent|194
5404036|NCT02842086|18633332|P1|Overall Study|Withdrew Consent|205
5404037|NCT02842086|18633331|P2|Overall Study|Protocol Violation|4
5404038|NCT02842086|18633332|P1|Overall Study|Protocol Violation|8
5404039|NCT02842086|18633331|P2|Overall Study|Non-Compliance with Study Drug|8
5404040|NCT02842086|18633332|P1|Overall Study|Non-Compliance with Study Drug|9
5404041|NCT02842086|18633331|P2|Overall Study|Investigator's Discretion|13
5404042|NCT02842086|18633332|P1|Overall Study|Investigator's Discretion|9
5404043|NCT02842086|18633331|P2|Overall Study|Death|3
5404044|NCT02842086|18633332|P1|Overall Study|Death|3
5404045|NCT02842086|18633331|P2|Overall Study|Adverse Event|20
5404046|NCT02842086|18633332|P1|Overall Study|Adverse Event|18
5404047|NCT02842086|18633331|P2|Overall Study|Still in Double-Blind Phase|3
5404048|NCT02842086|18633332|P1|Overall Study|Still in Double-Blind Phase|7
5404049|NCT02842086|18633331|P2|Overall Study|Randomized but Never Treated|6
5404050|NCT02842086|18633332|P1|Overall Study|Randomized but Never Treated|6
5404051|NCT02842073|18633368|P1|Overall Study|Withdrawal by Subject|1
5404052|NCT02841787|18633394|P3|Overall Study|Withdrawal by Subject|0
5404053|NCT02841787|18633395|P2|Overall Study|Withdrawal by Subject|4
5404054|NCT02841787|18633396|P1|Overall Study|Withdrawal by Subject|1
5404055|NCT02841787|18633394|P3|Overall Study|Symptoms dropped below threshold|0
5404056|NCT02841787|18633395|P2|Overall Study|Symptoms dropped below threshold|0
5404057|NCT02841787|18633396|P1|Overall Study|Symptoms dropped below threshold|1
5404058|NCT02841787|18633394|P3|Overall Study|Lost to Follow-up|0
5404059|NCT02841787|18633395|P2|Overall Study|Lost to Follow-up|0
5404060|NCT02841787|18633396|P1|Overall Study|Lost to Follow-up|1
5404061|NCT02841709|18633410|P5|5th Intervention|Adverse Event|2
5404062|NCT02841709|18633411|P4|5th Intervention|Adverse Event|0
5404063|NCT02841709|18633412|P3|5th Intervention|Adverse Event|0
5404064|NCT02841709|18633413|P2|5th Intervention|Adverse Event|0
5404065|NCT02841709|18633414|P1|5th Intervention|Adverse Event|2
5404066|NCT02840721|18633544|P1|Follow-Up|Withdrawal of Consent|2
5404067|NCT02840721|18633544|P1|Follow-Up|Withdrawal by Subject|4
5404068|NCT02840721|18633544|P1|Follow-Up|Lack of Efficacy|1
5404069|NCT02840721|18633544|P1|Treatment Period|Adverse Event|1
5404070|NCT02840461|18633566|P3|Overall Study|Worsening of Symptom & Kit Error|2
5404071|NCT02840461|18633567|P2|Overall Study|Worsening of Symptom & Kit Error|0
5404072|NCT02840461|18633568|P1|Overall Study|Worsening of Symptom & Kit Error|0
5404073|NCT02840461|18633566|P3|Overall Study|Withdrawal by Subject|2
5404074|NCT02840461|18633567|P2|Overall Study|Withdrawal by Subject|6
5404075|NCT02840461|18633568|P1|Overall Study|Withdrawal by Subject|10
5404076|NCT02840461|18633566|P3|Overall Study|Protocol Violation|1
5404077|NCT02840461|18633567|P2|Overall Study|Protocol Violation|3
5404078|NCT02840461|18633568|P1|Overall Study|Protocol Violation|2
5404079|NCT02840461|18633566|P3|Overall Study|Non-Comliance with Dosing Requirements|0
5404080|NCT02840461|18633567|P2|Overall Study|Non-Comliance with Dosing Requirements|1
5404081|NCT02840461|18633568|P1|Overall Study|Non-Comliance with Dosing Requirements|0
5404082|NCT02840461|18633566|P3|Overall Study|Lost to Follow-up|6
5404083|NCT02840461|18633567|P2|Overall Study|Lost to Follow-up|7
5404084|NCT02840461|18633568|P1|Overall Study|Lost to Follow-up|10
5404085|NCT02840461|18633566|P3|Overall Study|Adverse Event|3
5404086|NCT02840461|18633567|P2|Overall Study|Adverse Event|5
5404087|NCT02840461|18633568|P1|Overall Study|Adverse Event|1
5404088|NCT02840253|18633579|P1|Overall Study|Unsuccessful block|4
5404089|NCT02839876|18633664|P2|Overall Study|Protocol Violation|11
5404090|NCT02839876|18633665|P1|Overall Study|Protocol Violation|10
5404091|NCT02839798|18633727|P1|Overall Study|Withdrawal by Subject|2
5404092|NCT02839746|18633773|P1|Overall Study|Not met selection criteria|12
5404093|NCT02839681|18633787|P1|Overall Study|Death|2
5404094|NCT02839330|18633800|P4|Overall Study|Other reason, not specified|6
5404095|NCT02839330|18633801|P3|Overall Study|Other reason, not specified|3
5404096|NCT02839330|18633802|P2|Overall Study|Other reason, not specified|3
5404097|NCT02839330|18633803|P1|Overall Study|Other reason, not specified|4
5404098|NCT02839330|18633800|P4|Overall Study|Protocol Violation|3
5404099|NCT02839330|18633801|P3|Overall Study|Protocol Violation|2
5404100|NCT02839330|18633802|P2|Overall Study|Protocol Violation|2
5404101|NCT02839330|18633803|P1|Overall Study|Protocol Violation|1
5404102|NCT02839330|18633800|P4|Overall Study|Administrative Reason|1
5404103|NCT02839330|18633801|P3|Overall Study|Administrative Reason|0
5404104|NCT02839330|18633802|P2|Overall Study|Administrative Reason|0
5404105|NCT02839330|18633803|P1|Overall Study|Administrative Reason|0
5404106|NCT02839330|18633800|P4|Overall Study|Lost to Follow-up|25
5404107|NCT02839330|18633801|P3|Overall Study|Lost to Follow-up|29
5404108|NCT02839330|18633802|P2|Overall Study|Lost to Follow-up|27
5404109|NCT02839330|18633803|P1|Overall Study|Lost to Follow-up|22
5404110|NCT02839330|18633800|P4|Overall Study|Withdrawal by Subject|13
5404111|NCT02839330|18633801|P3|Overall Study|Withdrawal by Subject|11
5404112|NCT02839330|18633802|P2|Overall Study|Withdrawal by Subject|19
5404113|NCT02839330|18633803|P1|Overall Study|Withdrawal by Subject|27
5404114|NCT02839330|18633800|P4|Overall Study|Death|1
5404115|NCT02839330|18633801|P3|Overall Study|Death|1
5404116|NCT02839330|18633802|P2|Overall Study|Death|6
5404117|NCT02839330|18633803|P1|Overall Study|Death|4
5404118|NCT02839330|18633800|P4|Overall Study|Adverse Event|2
5404119|NCT02839330|18633801|P3|Overall Study|Adverse Event|2
5404120|NCT02839330|18633802|P2|Overall Study|Adverse Event|1
5404121|NCT02839330|18633803|P1|Overall Study|Adverse Event|0
5404122|NCT02839200|18633838|P6|Overall Study|Randomized in error|0
5404123|NCT02839200|18633839|P5|Overall Study|Randomized in error|0
5404124|NCT02839200|18633840|P4|Overall Study|Randomized in error|0
5404125|NCT02839200|18633841|P3|Overall Study|Randomized in error|0
5404126|NCT02839200|18633842|P2|Overall Study|Randomized in error|1
5404127|NCT02839200|18633843|P1|Overall Study|Randomized in error|0
5404128|NCT02839200|18633838|P6|Overall Study|Adverse Event|0
5404129|NCT02839200|18633839|P5|Overall Study|Adverse Event|1
5404130|NCT02839200|18633840|P4|Overall Study|Adverse Event|0
5404131|NCT02839200|18633841|P3|Overall Study|Adverse Event|0
5404132|NCT02839200|18633842|P2|Overall Study|Adverse Event|0
5404133|NCT02839200|18633843|P1|Overall Study|Adverse Event|0
5404134|NCT02839200|18633838|P6|Overall Study|Lost to Follow-up|0
5404135|NCT02839200|18633839|P5|Overall Study|Lost to Follow-up|1
5404136|NCT02839200|18633840|P4|Overall Study|Lost to Follow-up|0
5404137|NCT02839200|18633841|P3|Overall Study|Lost to Follow-up|0
5404138|NCT02839200|18633842|P2|Overall Study|Lost to Follow-up|0
5404139|NCT02839200|18633843|P1|Overall Study|Lost to Follow-up|2
5404140|NCT02839200|18633838|P6|Overall Study|Withdrawal by Subject|1
5404141|NCT02839200|18633839|P5|Overall Study|Withdrawal by Subject|0
5404142|NCT02839200|18633840|P4|Overall Study|Withdrawal by Subject|0
5404143|NCT02839200|18633841|P3|Overall Study|Withdrawal by Subject|1
5404144|NCT02839200|18633842|P2|Overall Study|Withdrawal by Subject|0
5404145|NCT02839200|18633843|P1|Overall Study|Withdrawal by Subject|2
5404146|NCT02838901|18633877|P2|Overall Study|Lost to Follow-up|1
5404147|NCT02838901|18633878|P1|Overall Study|Lost to Follow-up|1
5404148|NCT02838901|18633877|P2|Overall Study|Withdrawal by Subject|1
5404149|NCT02838901|18633878|P1|Overall Study|Withdrawal by Subject|1
5404150|NCT02838420|18633908|P2|Overall Study|Death|13
5404151|NCT02838420|18633909|P1|Overall Study|Death|8
5404152|NCT02838420|18633908|P2|Overall Study|Withdrawal by Subject|4
5404153|NCT02838420|18633909|P1|Overall Study|Withdrawal by Subject|3
5404154|NCT02838420|18633908|P2|Overall Study|Lost to Follow-up|0
5404155|NCT02838420|18633909|P1|Overall Study|Lost to Follow-up|1
5404156|NCT02838420|18633908|P2|Overall Study|Ongoing in Study|45
5404157|NCT02838420|18633909|P1|Overall Study|Ongoing in Study|113
5404158|NCT02838134|18633972|P2|Overall Study|logistic problems|1
5404159|NCT02838134|18633973|P1|Overall Study|logistic problems|1
5404160|NCT02838134|18633972|P2|Overall Study|Lost to Follow-up|2
5404161|NCT02838134|18633973|P1|Overall Study|Lost to Follow-up|1
5404162|NCT02838017|18634005|P2|Overall Study|Lost to Follow-up|11
5404163|NCT02838017|18634006|P1|Overall Study|Lost to Follow-up|14
5404164|NCT02837952|18634024|P2|Overall Study|Medication Error|0
5404165|NCT02837952|18634025|P1|Overall Study|Medication Error|1
5404166|NCT02837952|18634024|P2|Overall Study|Withdrawal by Subject|5
5404167|NCT02837952|18634025|P1|Overall Study|Withdrawal by Subject|4
5404168|NCT02837952|18634024|P2|Overall Study|Adverse Event|1
5404169|NCT02837952|18634025|P1|Overall Study|Adverse Event|0
5404170|NCT02837731|18634062|P2|Allocation|Known aortic abnormalities|1
5404171|NCT02837731|18634063|P1|Allocation|Known aortic abnormalities|0
5404172|NCT02837731|18634062|P2|Allocation|Did not meet sepsis criteria|2
5404173|NCT02837731|18634063|P1|Allocation|Did not meet sepsis criteria|1
5404174|NCT02837731|18634062|P2|Allocation|Moribund/Do not resuscitate|0
5404175|NCT02837731|18634063|P1|Allocation|Moribund/Do not resuscitate|2
5404176|NCT02837731|18634062|P2|Allocation|Protocol not implemented|0
5404177|NCT02837731|18634063|P1|Allocation|Protocol not implemented|7
5404178|NCT02837731|18634062|P2|Allocation|Device not available|0
5404179|NCT02837731|18634063|P1|Allocation|Device not available|1
5404180|NCT02837731|18634062|P2|Allocation|Withdrawal by Subject|0
5404181|NCT02837731|18634063|P1|Allocation|Withdrawal by Subject|2
5404182|NCT02837731|18634062|P2|Allocation|Diabetic Ketoacidosis/withdrew|0
5404183|NCT02837731|18634063|P1|Allocation|Diabetic Ketoacidosis/withdrew|1
5404184|NCT02837731|18634062|P2|Allocation|Immediate surgery/withdrew|0
5404185|NCT02837731|18634063|P1|Allocation|Immediate surgery/withdrew|2
5404186|NCT02837731|18634062|P2|Allocation|Admitted to General Floor|4
5404187|NCT02837731|18634063|P1|Allocation|Admitted to General Floor|3
5404188|NCT02837029|18634111|P3|2 Year Follow-up|Still in follow-up|0
5404189|NCT02837029|18634112|P2|2 Year Follow-up|Still in follow-up|1
5404190|NCT02837029|18634113|P1|2 Year Follow-up|Still in follow-up|0
5404191|NCT02837029|18634111|P3|2 Year Follow-up|Death|0
5404192|NCT02837029|18634112|P2|2 Year Follow-up|Death|6
5404193|NCT02837029|18634113|P1|2 Year Follow-up|Death|6
5404194|NCT02837029|18634111|P3|Cycle 2 and Beyond|Adverse Event|0
5404195|NCT02837029|18634112|P2|Cycle 2 and Beyond|Adverse Event|0
5404196|NCT02837029|18634113|P1|Cycle 2 and Beyond|Adverse Event|1
5404197|NCT02837029|18634111|P3|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
5404198|NCT02837029|18634112|P2|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
5404199|NCT02837029|18634113|P1|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
5404200|NCT02837029|18634111|P3|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
5404201|NCT02837029|18634112|P2|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
5404202|NCT02837029|18634113|P1|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
5404203|NCT02837029|18634111|P3|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
5404204|NCT02837029|18634112|P2|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
5404205|NCT02837029|18634113|P1|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
5404206|NCT02837029|18634111|P3|Screening|Failed to meet screening requirements.|0
5404207|NCT02837029|18634112|P2|Screening|Failed to meet screening requirements.|3
5404208|NCT02837029|18634113|P1|Screening|Failed to meet screening requirements.|7
5404209|NCT02836652|18634135|P2|Overall Study|Not on treatment regimen post-op day 15|3
5404210|NCT02836652|18634136|P1|Overall Study|Not on treatment regimen post-op day 15|3
5404211|NCT02836652|18634135|P2|Overall Study|Withdrawn|9
5404212|NCT02836652|18634136|P1|Overall Study|Withdrawn|9
5404213|NCT02836652|18634135|P2|Overall Study|Transplant/Explant|4
5404214|NCT02836652|18634136|P1|Overall Study|Transplant/Explant|3
5404215|NCT02836652|18634135|P2|Overall Study|Death|3
5404216|NCT02836652|18634136|P1|Overall Study|Death|3
5404217|NCT02836613|18634150|P2|Overall Study|Withdrawal by Subject|2
5404218|NCT02836613|18634151|P1|Overall Study|Withdrawal by Subject|0
5404219|NCT02836613|18634150|P2|Overall Study|Lost to Follow-up|1
5404220|NCT02836613|18634151|P1|Overall Study|Lost to Follow-up|0
5404221|NCT02836613|18634150|P2|Overall Study|Accidental drowning|0
5404222|NCT02836613|18634151|P1|Overall Study|Accidental drowning|1
5404223|NCT02836496|18634165|P2|Overall Study|Withdrawal by Subject|1
5404224|NCT02836496|18634166|P1|Overall Study|Withdrawal by Subject|0
5404225|NCT02836496|18634165|P2|Overall Study|Adverse Event|1
5404226|NCT02836496|18634166|P1|Overall Study|Adverse Event|2
5404227|NCT02836249|18634182|P2|Overall Study|Still on Study|55
5404228|NCT02836249|18634183|P1|Overall Study|Still on Study|121
5404229|NCT02836249|18634182|P2|Overall Study|Lost to Follow-up|1
5404230|NCT02836249|18634183|P1|Overall Study|Lost to Follow-up|0
5404231|NCT02836249|18634182|P2|Overall Study|Withdrew Consent|1
5404232|NCT02836249|18634183|P1|Overall Study|Withdrew Consent|0
5404233|NCT02836249|18634182|P2|Overall Study|Pregnancy|0
5404234|NCT02836249|18634183|P1|Overall Study|Pregnancy|2
5404235|NCT02836249|18634182|P2|Overall Study|Randomized but Never Treated|1
5404236|NCT02836249|18634183|P1|Overall Study|Randomized but Never Treated|0
5404237|NCT02836236|18634201|P2|Overall Study|Still on Study|49
5404238|NCT02836236|18634202|P1|Overall Study|Still on Study|101
5404239|NCT02836236|18634201|P2|Overall Study|Investigator's Discretion|0
5404240|NCT02836236|18634202|P1|Overall Study|Investigator's Discretion|1
5404241|NCT02836236|18634201|P2|Overall Study|Adverse Event|1
5404242|NCT02836236|18634202|P1|Overall Study|Adverse Event|0
5404243|NCT02836236|18634201|P2|Overall Study|Withdrew Consent|0
5404244|NCT02836236|18634202|P1|Overall Study|Withdrew Consent|2
5404245|NCT02836236|18634201|P2|Overall Study|Randomized but Never Treated|0
5404246|NCT02836236|18634202|P1|Overall Study|Randomized but Never Treated|1
5404247|NCT02835820|18634218|P2|Overall Study|Baseline Screen Failure|3
5404248|NCT02835820|18634219|P1|Overall Study|Baseline Screen Failure|0
5404249|NCT02835690|18634266|P3|Overall Study|Not Treated|0
5404250|NCT02835690|18634267|P2|Overall Study|Not Treated|2
5404251|NCT02835690|18634268|P1|Overall Study|Not Treated|0
5404252|NCT02835690|18634266|P3|Overall Study|Ongoing in Study (Follow-up)|9
5404253|NCT02835690|18634267|P2|Overall Study|Ongoing in Study (Follow-up)|7
5404254|NCT02835690|18634268|P1|Overall Study|Ongoing in Study (Follow-up)|10
5404255|NCT02835690|18634266|P3|Overall Study|Death|6
5404256|NCT02835690|18634267|P2|Overall Study|Death|6
5404257|NCT02835690|18634268|P1|Overall Study|Death|4
5404258|NCT02835495|18634331|P2|Overall Study|Declined in-person follow-up visit|2
5404259|NCT02835495|18634332|P1|Overall Study|Declined in-person follow-up visit|4
5404260|NCT02835495|18634331|P2|Overall Study|Cancer diagnosis prior intervention|0
5404261|NCT02835495|18634332|P1|Overall Study|Cancer diagnosis prior intervention|1
5404262|NCT02835339|18634358|P2|Overall Study|Did not receive allocated intervention|16
5404263|NCT02835339|18634359|P1|Overall Study|Did not receive allocated intervention|13
5404264|NCT02835092|18634381|P3|Overall Study|Lost to Follow-up|0
5404265|NCT02835092|18634382|P2|Overall Study|Lost to Follow-up|2
5404266|NCT02835092|18634383|P1|Overall Study|Lost to Follow-up|0
5404267|NCT02835092|18634381|P3|Overall Study|Withdrawal by Subject|3
5404268|NCT02835092|18634382|P2|Overall Study|Withdrawal by Subject|6
5404269|NCT02835092|18634383|P1|Overall Study|Withdrawal by Subject|3
5404270|NCT02834819|18634393|P2|Overall Study|Did not complete 7 day follow up call.|0
5404271|NCT02834819|18634394|P1|Overall Study|Did not complete 7 day follow up call.|5
5404272|NCT02834247|18634453|P4|Dose Expansion Phase|Withdrawal by Subject|1
5404273|NCT02834247|18634454|P3|Dose Expansion Phase|Withdrawal by Subject|0
5404274|NCT02834247|18634455|P2|Dose Expansion Phase|Withdrawal by Subject|0
5404275|NCT02834247|18634456|P1|Dose Expansion Phase|Withdrawal by Subject|0
5404276|NCT02834247|18634453|P4|Dose Expansion Phase|Lost to Follow-up|1
5404277|NCT02834247|18634454|P3|Dose Expansion Phase|Lost to Follow-up|0
5404278|NCT02834247|18634455|P2|Dose Expansion Phase|Lost to Follow-up|0
5404279|NCT02834247|18634456|P1|Dose Expansion Phase|Lost to Follow-up|0
5404280|NCT02834247|18634453|P4|Dose Expansion Phase|Death|8
5404281|NCT02834247|18634454|P3|Dose Expansion Phase|Death|0
5404282|NCT02834247|18634455|P2|Dose Expansion Phase|Death|0
5404283|NCT02834247|18634456|P1|Dose Expansion Phase|Death|0
5404284|NCT02834247|18634453|P4|Dose Expansion Phase|Study Terminated by Sponsor|7
5404285|NCT02834247|18634454|P3|Dose Expansion Phase|Study Terminated by Sponsor|0
5404286|NCT02834247|18634455|P2|Dose Expansion Phase|Study Terminated by Sponsor|0
5404287|NCT02834247|18634456|P1|Dose Expansion Phase|Study Terminated by Sponsor|0
5404288|NCT02834247|18634453|P4|Dose Escalation Phase|Withdrawal by Subject|0
5404289|NCT02834247|18634454|P3|Dose Escalation Phase|Withdrawal by Subject|0
5404290|NCT02834247|18634455|P2|Dose Escalation Phase|Withdrawal by Subject|2
5404291|NCT02834247|18634456|P1|Dose Escalation Phase|Withdrawal by Subject|2
5404292|NCT02834247|18634453|P4|Dose Escalation Phase|Lost to Follow-up|0
5404293|NCT02834247|18634454|P3|Dose Escalation Phase|Lost to Follow-up|0
5404294|NCT02834247|18634455|P2|Dose Escalation Phase|Lost to Follow-up|1
5404295|NCT02834247|18634456|P1|Dose Escalation Phase|Lost to Follow-up|0
5404296|NCT02834247|18634453|P4|Dose Escalation Phase|Death|0
5404297|NCT02834247|18634454|P3|Dose Escalation Phase|Death|5
5404298|NCT02834247|18634455|P2|Dose Escalation Phase|Death|6
5404299|NCT02834247|18634456|P1|Dose Escalation Phase|Death|5
5404300|NCT02834247|18634453|P4|Dose Escalation Phase|Study Terminated by Sponsor|0
5404301|NCT02834247|18634454|P3|Dose Escalation Phase|Study Terminated by Sponsor|0
5404302|NCT02834247|18634455|P2|Dose Escalation Phase|Study Terminated by Sponsor|2
5404303|NCT02834247|18634456|P1|Dose Escalation Phase|Study Terminated by Sponsor|1
5404304|NCT02833974|18634485|P2|Overall Study|Adverse Event|3
5404305|NCT02833974|18634486|P1|Overall Study|Adverse Event|0
5404306|NCT02833974|18634485|P2|Overall Study|Lost to Follow-up|0
5404307|NCT02833974|18634486|P1|Overall Study|Lost to Follow-up|1
5404308|NCT02833948|18634512|P2|Overall Study|scans could not be evaluated|2
5404309|NCT02833948|18634513|P1|Overall Study|scans could not be evaluated|5
5404310|NCT02833948|18634512|P2|Overall Study|were not scanned|13
5404311|NCT02833948|18634513|P1|Overall Study|were not scanned|8
5404312|NCT02833948|18634512|P2|Overall Study|Death|3
5404313|NCT02833948|18634513|P1|Overall Study|Death|2
5404314|NCT02833844|18634572|P2|Overall Study|Protocol Violation|4
5404315|NCT02833844|18634573|P1|Overall Study|Protocol Violation|0
5404316|NCT02833844|18634572|P2|Overall Study|Withdrawal by Subject|3
5404317|NCT02833844|18634573|P1|Overall Study|Withdrawal by Subject|2
5404318|NCT02833350|18634615|P7|Overall Study|Withdrawal by Subject|2
5404319|NCT02833350|18634616|P6|Overall Study|Withdrawal by Subject|0
5404320|NCT02833350|18634617|P5|Overall Study|Withdrawal by Subject|2
5404321|NCT02833350|18634618|P4|Overall Study|Withdrawal by Subject|0
5404322|NCT02833350|18634619|P3|Overall Study|Withdrawal by Subject|2
5404323|NCT02833350|18634620|P2|Overall Study|Withdrawal by Subject|3
5404324|NCT02833350|18634621|P1|Overall Study|Withdrawal by Subject|3
5404325|NCT02833350|18634615|P7|Overall Study|Lost to Follow-up|1
5404326|NCT02833350|18634616|P6|Overall Study|Lost to Follow-up|0
5404327|NCT02833350|18634617|P5|Overall Study|Lost to Follow-up|0
5404328|NCT02833350|18634618|P4|Overall Study|Lost to Follow-up|0
5404329|NCT02833350|18634619|P3|Overall Study|Lost to Follow-up|0
5404330|NCT02833350|18634620|P2|Overall Study|Lost to Follow-up|1
5404331|NCT02833350|18634621|P1|Overall Study|Lost to Follow-up|0
5404332|NCT02833350|18634615|P7|Overall Study|Lack of Efficacy|1
5404333|NCT02833350|18634616|P6|Overall Study|Lack of Efficacy|1
5404334|NCT02833350|18634617|P5|Overall Study|Lack of Efficacy|0
5404335|NCT02833350|18634618|P4|Overall Study|Lack of Efficacy|4
5404336|NCT02833350|18634619|P3|Overall Study|Lack of Efficacy|1
5404337|NCT02833350|18634620|P2|Overall Study|Lack of Efficacy|2
5404338|NCT02833350|18634621|P1|Overall Study|Lack of Efficacy|0
5404339|NCT02833350|18634615|P7|Overall Study|Death|0
5404340|NCT02833350|18634616|P6|Overall Study|Death|0
5404341|NCT02833350|18634617|P5|Overall Study|Death|0
5404342|NCT02833350|18634618|P4|Overall Study|Death|0
5404343|NCT02833350|18634619|P3|Overall Study|Death|1
5404344|NCT02833350|18634620|P2|Overall Study|Death|0
5404345|NCT02833350|18634621|P1|Overall Study|Death|0
5404346|NCT02833350|18634615|P7|Overall Study|Adverse Event|1
5404347|NCT02833350|18634616|P6|Overall Study|Adverse Event|0
5404348|NCT02833350|18634617|P5|Overall Study|Adverse Event|1
5404349|NCT02833350|18634618|P4|Overall Study|Adverse Event|4
5404350|NCT02833350|18634619|P3|Overall Study|Adverse Event|4
5404351|NCT02833350|18634620|P2|Overall Study|Adverse Event|3
5404352|NCT02833350|18634621|P1|Overall Study|Adverse Event|0
5404353|NCT02833077|18634828|P2|Overall Study|Protocol Deviation|1
5404354|NCT02833077|18634829|P1|Overall Study|Protocol Deviation|0
5404355|NCT02833077|18634828|P2|Overall Study|Personal Reasons|4
5404356|NCT02833077|18634829|P1|Overall Study|Personal Reasons|6
5404357|NCT02833077|18634828|P2|Overall Study|Lost to Follow-up|1
5404358|NCT02833077|18634829|P1|Overall Study|Lost to Follow-up|10
5404359|NCT02833077|18634828|P2|Overall Study|Adverse Event|2
5404360|NCT02833077|18634829|P1|Overall Study|Adverse Event|1
5404361|NCT02832375|18634852|P2|Overall Study|Withdrawal of Consent|0
5404362|NCT02832375|18634853|P1|Overall Study|Withdrawal of Consent|1
5404363|NCT02832375|18634852|P2|Overall Study|Lost to Follow-up|0
5404364|NCT02832375|18634853|P1|Overall Study|Lost to Follow-up|1
5404365|NCT02832167|18634871|P1|Treatment Period 2|Other reasons|3
5404366|NCT02832167|18634871|P1|Treatment Period 2|Participant withdrew consent|3
5404367|NCT02832167|18634871|P1|Treatment Period 2|Participant request to discontinue|2
5404368|NCT02832167|18634871|P1|Treatment Period 2|Study Drug Toxicity|5
5404369|NCT02832167|18634871|P1|Treatment Period 2|Maximum clinical benefit|1
5404370|NCT02832167|18634871|P1|Treatment Period 2|Adverse event unrelated to study drug|1
5404371|NCT02832167|18634871|P1|Treatment Period 2|Disease progression|68
5404372|NCT02832167|18634871|P1|Transition From Period 1 to Period 2|Lost to Follow-up|3
5404373|NCT02832167|18634871|P1|Transition From Period 1 to Period 2|Death|2
5404374|NCT02832167|18634871|P1|Transition From Period 1 to Period 2|Participant withdrew consent|1
5404375|NCT02832167|18634871|P1|Transition From Period 1 to Period 2|Other reasons|1
5404376|NCT02832167|18634871|P1|Treatment Period 1|Other reasons|6
5404377|NCT02832167|18634871|P1|Treatment Period 1|Participant withdrew consent|3
5404378|NCT02832167|18634871|P1|Treatment Period 1|No longer meet study criteria|1
5404379|NCT02832167|18634871|P1|Treatment Period 1|Participant request to discontinue|9
5404380|NCT02832167|18634871|P1|Treatment Period 1|Study Drug Toxicity|6
5404381|NCT02832167|18634871|P1|Treatment Period 1|Death|1
5404382|NCT02832167|18634871|P1|Treatment Period 1|Adverse event unrelated to study drug|11
5404383|NCT02832167|18634871|P1|Treatment Period 1|Disease progression|92
5404384|NCT02831855|18634912|P3|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
5404385|NCT02831855|18634913|P2|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
5404386|NCT02831855|18634914|P1|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
5404387|NCT02831855|18634912|P3|Double Blind Phase (24 Weeks)|Protocol Violation|2
5404388|NCT02831855|18634913|P2|Double Blind Phase (24 Weeks)|Protocol Violation|5
5404389|NCT02831855|18634914|P1|Double Blind Phase (24 Weeks)|Protocol Violation|0
5404390|NCT02831855|18634912|P3|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
5404391|NCT02831855|18634913|P2|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
5404392|NCT02831855|18634914|P1|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
5404393|NCT02831855|18634912|P3|Double Blind Phase (24 Weeks)|Other|5
5404394|NCT02831855|18634913|P2|Double Blind Phase (24 Weeks)|Other|2
5404395|NCT02831855|18634914|P1|Double Blind Phase (24 Weeks)|Other|0
5404396|NCT02831855|18634912|P3|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
5404397|NCT02831855|18634913|P2|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
5404398|NCT02831855|18634914|P1|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
5404399|NCT02831855|18634912|P3|Double Blind Phase (24 Weeks)|Screen Failure|0
5404400|NCT02831855|18634913|P2|Double Blind Phase (24 Weeks)|Screen Failure|1
5404401|NCT02831855|18634914|P1|Double Blind Phase (24 Weeks)|Screen Failure|0
5404402|NCT02831855|18634912|P3|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
5404403|NCT02831855|18634913|P2|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
5404404|NCT02831855|18634914|P1|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
5404405|NCT02831855|18634912|P3|Double Blind Phase (24 Weeks)|Death|2
5404406|NCT02831855|18634913|P2|Double Blind Phase (24 Weeks)|Death|0
5404407|NCT02831855|18634914|P1|Double Blind Phase (24 Weeks)|Death|0
5404408|NCT02831855|18634912|P3|Double Blind Phase (24 Weeks)|Adverse Event|6
5404409|NCT02831855|18634913|P2|Double Blind Phase (24 Weeks)|Adverse Event|6
5404410|NCT02831855|18634914|P1|Double Blind Phase (24 Weeks)|Adverse Event|0
5404411|NCT02831855|18634912|P3|Open Label Phase (24 Weeks)|Other|0
5404412|NCT02831855|18634913|P2|Open Label Phase (24 Weeks)|Other|0
5404413|NCT02831855|18634914|P1|Open Label Phase (24 Weeks)|Other|4
5404414|NCT02831855|18634912|P3|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
5404415|NCT02831855|18634913|P2|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
5404416|NCT02831855|18634914|P1|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
5404417|NCT02831855|18634912|P3|Open Label Phase (24 Weeks)|Protocol Violation|0
5404418|NCT02831855|18634913|P2|Open Label Phase (24 Weeks)|Protocol Violation|0
5404419|NCT02831855|18634914|P1|Open Label Phase (24 Weeks)|Protocol Violation|5
5404420|NCT02831855|18634912|P3|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
5404421|NCT02831855|18634913|P2|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
5404422|NCT02831855|18634914|P1|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
5404423|NCT02831855|18634912|P3|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
5404424|NCT02831855|18634913|P2|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
5404425|NCT02831855|18634914|P1|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
5404426|NCT02831855|18634912|P3|Open Label Phase (24 Weeks)|Lost to Follow-up|0
5404427|NCT02831855|18634913|P2|Open Label Phase (24 Weeks)|Lost to Follow-up|0
5404428|NCT02831855|18634914|P1|Open Label Phase (24 Weeks)|Lost to Follow-up|8
5404429|NCT02831855|18634912|P3|Open Label Phase (24 Weeks)|Adverse Event|0
5404430|NCT02831855|18634913|P2|Open Label Phase (24 Weeks)|Adverse Event|0
5404431|NCT02831855|18634914|P1|Open Label Phase (24 Weeks)|Adverse Event|39
5404432|NCT02831764|18634975|P2|Overall Study|Ongoing at the time of the analysis|335
5404433|NCT02831764|18634976|P1|Overall Study|Ongoing at the time of the analysis|330
5404434|NCT02831764|18634975|P2|Overall Study|Protocol Violation|2
5404435|NCT02831764|18634976|P1|Overall Study|Protocol Violation|5
5404436|NCT02831764|18634975|P2|Overall Study|Lack of Efficacy|2
5404437|NCT02831764|18634976|P1|Overall Study|Lack of Efficacy|2
5404438|NCT02831764|18634975|P2|Overall Study|Adverse Event|5
5404439|NCT02831764|18634976|P1|Overall Study|Adverse Event|8
5404440|NCT02831764|18634975|P2|Overall Study|Lost to Follow-up|5
5404441|NCT02831764|18634976|P1|Overall Study|Lost to Follow-up|6
5404442|NCT02831764|18634975|P2|Overall Study|Physician Decision|2
5404443|NCT02831764|18634976|P1|Overall Study|Physician Decision|2
5404444|NCT02831764|18634975|P2|Overall Study|Withdrawal by Subject|6
5404445|NCT02831764|18634976|P1|Overall Study|Withdrawal by Subject|7
5404446|NCT02831764|18634975|P2|Overall Study|Protocol specific withdrawal criteria|2
5404447|NCT02831764|18634976|P1|Overall Study|Protocol specific withdrawal criteria|0
5404448|NCT02831673|18635040|P2|Overall Study|Ongoing at Week 48 primary analysis.|330
5404449|NCT02831673|18635041|P1|Overall Study|Ongoing at Week 48 primary analysis.|320
5404450|NCT02831673|18635040|P2|Overall Study|Withdrawal by Subject|4
5404451|NCT02831673|18635041|P1|Overall Study|Withdrawal by Subject|6
5404452|NCT02831673|18635040|P2|Overall Study|Physician Decision|3
5404453|NCT02831673|18635041|P1|Overall Study|Physician Decision|6
5404454|NCT02831673|18635040|P2|Overall Study|Lost to Follow-up|6
5404455|NCT02831673|18635041|P1|Overall Study|Lost to Follow-up|9
5404456|NCT02831673|18635040|P2|Overall Study|Protocol Withdrawal Criterion Met|6
5404457|NCT02831673|18635041|P1|Overall Study|Protocol Withdrawal Criterion Met|1
5404458|NCT02831673|18635040|P2|Overall Study|Protocol Violation|4
5404459|NCT02831673|18635041|P1|Overall Study|Protocol Violation|5
5404460|NCT02831673|18635040|P2|Overall Study|Lack of Efficacy|1
5404461|NCT02831673|18635041|P1|Overall Study|Lack of Efficacy|3
5404462|NCT02831673|18635040|P2|Overall Study|Adverse Event|4
5404463|NCT02831673|18635041|P1|Overall Study|Adverse Event|6
5404464|NCT02831387|18635114|P2|Overall Study|Discontinued due to stock recovery|1
5404465|NCT02831387|18635115|P1|Overall Study|Discontinued due to stock recovery|0
5404466|NCT02831387|18635114|P2|Overall Study|Withdrawal by Subject|1
5404467|NCT02831387|18635115|P1|Overall Study|Withdrawal by Subject|1
5404468|NCT02831257|18635133|P1|Overall Study|Withdrawal by Subject|6
5404469|NCT02831257|18635133|P1|Overall Study|Physician Decision|1
5404470|NCT02831257|18635133|P1|Overall Study|Adverse Event|2
5404471|NCT02831257|18635133|P1|Overall Study|Lack of Efficacy|3
5404472|NCT02830893|18635147|P2|Overall Study|Discharged to SNF, no transportation.|1
5404473|NCT02830893|18635148|P1|Overall Study|Discharged to SNF, no transportation.|0
5404474|NCT02830893|18635147|P2|Overall Study|Lost to Follow-up|2
5404475|NCT02830893|18635148|P1|Overall Study|Lost to Follow-up|0
5404476|NCT02830893|18635147|P2|Overall Study|Relocation to out of the country|0
5404477|NCT02830893|18635148|P1|Overall Study|Relocation to out of the country|1
5404478|NCT02830880|18635160|P1|Overall Study|Physician Decision|1
5404479|NCT02830880|18635160|P1|Overall Study|Death|1
5404480|NCT02830880|18635160|P1|Overall Study|Adverse reaction to chemotherapy|1
5404481|NCT02830087|18635179|P6|Overall Study|No study staff to follow-up patients|3
5404482|NCT02830087|18635180|P5|Overall Study|No study staff to follow-up patients|3
5404483|NCT02830087|18635181|P4|Overall Study|No study staff to follow-up patients|3
5404484|NCT02830087|18635182|P3|Overall Study|No study staff to follow-up patients|4
5404485|NCT02830087|18635183|P2|Overall Study|No study staff to follow-up patients|4
5404486|NCT02830087|18635184|P1|Overall Study|No study staff to follow-up patients|4
5404487|NCT02829996|18635251|P5|Overall Study|Withdrawal by Subject|0
5404488|NCT02829996|18635252|P4|Overall Study|Withdrawal by Subject|0
5404489|NCT02829996|18635253|P3|Overall Study|Withdrawal by Subject|0
5404490|NCT02829996|18635254|P2|Overall Study|Withdrawal by Subject|0
5404491|NCT02829996|18635255|P1|Overall Study|Withdrawal by Subject|1
5404492|NCT02829944|18635280|P2|Overall Study|Staff unavailable|1
5404493|NCT02829944|18635281|P1|Overall Study|Staff unavailable|0
5404494|NCT02829944|18635280|P2|Overall Study|Catheter broke|1
5404495|NCT02829944|18635281|P1|Overall Study|Catheter broke|0
5404496|NCT02829944|18635280|P2|Overall Study|Catheter Displacement|0
5404497|NCT02829944|18635281|P1|Overall Study|Catheter Displacement|1
5404498|NCT02829944|18635280|P2|Overall Study|Withdrawal by Subject|1
5404499|NCT02829944|18635281|P1|Overall Study|Withdrawal by Subject|2
5404500|NCT02829944|18635280|P2|Overall Study|Inadequate Neuraxial Block|1
5404501|NCT02829944|18635281|P1|Overall Study|Inadequate Neuraxial Block|1
5404502|NCT02829944|18635280|P2|Overall Study|Screen Failure|2
5404503|NCT02829944|18635281|P1|Overall Study|Screen Failure|2
5404504|NCT02829944|18635280|P2|Overall Study|Physician Decision|1
5404505|NCT02829944|18635281|P1|Overall Study|Physician Decision|0
5404506|NCT02829918|18635331|P1|Overall Study|Progression|1
5404507|NCT02829918|18635331|P1|Overall Study|Adverse Event|1
5404508|NCT02829918|18635331|P1|Overall Study|Withdrawal by Subject|4
5404509|NCT02829918|18635331|P1|Overall Study|Death|2
5404510|NCT02829775|18635336|P1|Overall Study|Disease remission|1
5404511|NCT02829775|18635336|P1|Overall Study|Withdrawal by Subject|3
5404512|NCT02829775|18635336|P1|Overall Study|Death|1
5404513|NCT02829138|18635418|P2|Overall Study|Withdrawal by Subject|0
5404514|NCT02829138|18635419|P1|Overall Study|Withdrawal by Subject|1
5404515|NCT02828982|18635442|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
5404516|NCT02828982|18635443|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
5404517|NCT02828644|18635465|P2|Overall Study|Lost to Follow-up|22
5404518|NCT02828644|18635466|P1|Overall Study|Lost to Follow-up|23
5404519|NCT02828436|18635473|P2|Period 2|Lost to Follow-up|0
5404520|NCT02828436|18635474|P1|Period 2|Lost to Follow-up|1
5404521|NCT02828436|18635473|P2|Period 2|Did Not Meet Inclusion Criteria|0
5404522|NCT02828436|18635474|P1|Period 2|Did Not Meet Inclusion Criteria|3
5404523|NCT02828436|18635473|P2|Period 2|Withdrawal by Subject|0
5404524|NCT02828436|18635474|P1|Period 2|Withdrawal by Subject|4
5404525|NCT02828436|18635473|P2|Period 1|Lost to Follow-up|1
5404526|NCT02828436|18635474|P1|Period 1|Lost to Follow-up|0
5404527|NCT02828436|18635473|P2|Period 1|Did Not Meet Inclusion Criteria|3
5404528|NCT02828436|18635474|P1|Period 1|Did Not Meet Inclusion Criteria|0
5404529|NCT02828241|18635482|P2|Overall Study|Protocol Violation|0
5404530|NCT02828241|18635483|P1|Overall Study|Protocol Violation|1
5404531|NCT02828241|18635482|P2|Overall Study|Adverse Event|2
5404532|NCT02828241|18635483|P1|Overall Study|Adverse Event|7
5404533|NCT02828124|18635510|P4|Overall Study|Subject Withdrew Consent|1
5404534|NCT02828124|18635511|P3|Overall Study|Subject Withdrew Consent|0
5404535|NCT02828124|18635512|P2|Overall Study|Subject Withdrew Consent|0
5404536|NCT02828124|18635513|P1|Overall Study|Subject Withdrew Consent|0
5404537|NCT02828124|18635510|P4|Overall Study|AE Unrelated to Study Drug|1
5404538|NCT02828124|18635511|P3|Overall Study|AE Unrelated to Study Drug|0
5404539|NCT02828124|18635512|P2|Overall Study|AE Unrelated to Study Drug|0
5404540|NCT02828124|18635513|P1|Overall Study|AE Unrelated to Study Drug|0
5404541|NCT02828124|18635510|P4|Overall Study|Disease Progression|4
5404542|NCT02828124|18635511|P3|Overall Study|Disease Progression|1
5404543|NCT02828124|18635512|P2|Overall Study|Disease Progression|2
5404544|NCT02828124|18635513|P1|Overall Study|Disease Progression|1
5404545|NCT02828111|18635628|P5|Overall Study|Lost to Follow-up|1
5404546|NCT02828111|18635629|P4|Overall Study|Lost to Follow-up|1
5404547|NCT02828111|18635630|P3|Overall Study|Lost to Follow-up|0
5404548|NCT02828111|18635631|P2|Overall Study|Lost to Follow-up|0
5404549|NCT02828111|18635632|P1|Overall Study|Lost to Follow-up|0
5404550|NCT02828111|18635628|P5|Overall Study|Withdrawal by Subject|0
5404551|NCT02828111|18635629|P4|Overall Study|Withdrawal by Subject|0
5404552|NCT02828111|18635630|P3|Overall Study|Withdrawal by Subject|2
5404553|NCT02828111|18635631|P2|Overall Study|Withdrawal by Subject|0
5404554|NCT02828111|18635632|P1|Overall Study|Withdrawal by Subject|0
5404555|NCT02828020|18635693|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
5404556|NCT02828020|18635694|P2|Safety Follow-up Period|Other Miscellaneous Reasons|0
5404557|NCT02828020|18635695|P1|Safety Follow-up Period|Other Miscellaneous Reasons|1
5404558|NCT02828020|18635693|P3|Safety Follow-up Period|Protocol Violation|1
5404559|NCT02828020|18635694|P2|Safety Follow-up Period|Protocol Violation|2
5404560|NCT02828020|18635695|P1|Safety Follow-up Period|Protocol Violation|0
5404561|NCT02828020|18635693|P3|Safety Follow-up Period|Lost to Follow-up|11
5404562|NCT02828020|18635694|P2|Safety Follow-up Period|Lost to Follow-up|8
5404563|NCT02828020|18635695|P1|Safety Follow-up Period|Lost to Follow-up|9
5404564|NCT02828020|18635693|P3|Safety Follow-up Period|Withdrawal of Consent|7
5404565|NCT02828020|18635694|P2|Safety Follow-up Period|Withdrawal of Consent|8
5404566|NCT02828020|18635695|P1|Safety Follow-up Period|Withdrawal of Consent|10
5404567|NCT02828020|18635693|P3|Treatment Period|Other Miscellaneous Reasons|0
5404568|NCT02828020|18635694|P2|Treatment Period|Other Miscellaneous Reasons|1
5404569|NCT02828020|18635695|P1|Treatment Period|Other Miscellaneous Reasons|0
5404570|NCT02828020|18635693|P3|Treatment Period|Protocol Violation|7
5404571|NCT02828020|18635694|P2|Treatment Period|Protocol Violation|4
5404572|NCT02828020|18635695|P1|Treatment Period|Protocol Violation|2
5404573|NCT02828020|18635693|P3|Treatment Period|Pregnancy|0
5404574|NCT02828020|18635694|P2|Treatment Period|Pregnancy|2
5404575|NCT02828020|18635695|P1|Treatment Period|Pregnancy|0
5404576|NCT02828020|18635693|P3|Treatment Period|Lack of Qualifying Event|43
5404577|NCT02828020|18635694|P2|Treatment Period|Lack of Qualifying Event|53
5404578|NCT02828020|18635695|P1|Treatment Period|Lack of Qualifying Event|44
5404579|NCT02828020|18635693|P3|Treatment Period|Lost to Follow-up|18
5404580|NCT02828020|18635694|P2|Treatment Period|Lost to Follow-up|24
5404581|NCT02828020|18635695|P1|Treatment Period|Lost to Follow-up|21
5404582|NCT02828020|18635693|P3|Treatment Period|Withdrawal of Consent|9
5404583|NCT02828020|18635694|P2|Treatment Period|Withdrawal of Consent|14
5404584|NCT02828020|18635695|P1|Treatment Period|Withdrawal of Consent|10
5404585|NCT02828020|18635693|P3|Treatment Period|Adverse Event|1
5404586|NCT02828020|18635694|P2|Treatment Period|Adverse Event|1
5404587|NCT02828020|18635695|P1|Treatment Period|Adverse Event|3
5404588|NCT02827708|18635726|P2|Overall Study|Death|2
5404589|NCT02827708|18635727|P1|Overall Study|Death|1
5404590|NCT02827708|18635726|P2|Overall Study|Withdrawal by Subject|2
5404591|NCT02827708|18635727|P1|Overall Study|Withdrawal by Subject|1
5404592|NCT02827708|18635726|P2|Overall Study|Lost to Follow-up|1
5404593|NCT02827708|18635727|P1|Overall Study|Lost to Follow-up|3
5404594|NCT02827500|18635806|P2|Overall Study|Other|1
5404595|NCT02827500|18635807|P1|Overall Study|Other|5
5404596|NCT02827500|18635806|P2|Overall Study|Missing primary endpoint data|1
5404597|NCT02827500|18635807|P1|Overall Study|Missing primary endpoint data|3
5404598|NCT02827500|18635806|P2|Overall Study|Withdrawal by Subject|1
5404599|NCT02827500|18635807|P1|Overall Study|Withdrawal by Subject|3
5404600|NCT02827500|18635806|P2|Overall Study|Lost to Follow-up|1
5404601|NCT02827500|18635807|P1|Overall Study|Lost to Follow-up|1
5404602|NCT02827500|18635806|P2|Overall Study|Death|3
5404603|NCT02827500|18635807|P1|Overall Study|Death|7
5404604|NCT02826798|18635828|P5|Overall Study|Withdrawal by Subject|0
5404605|NCT02826798|18635829|P4|Overall Study|Withdrawal by Subject|1
5404606|NCT02826798|18635830|P3|Overall Study|Withdrawal by Subject|0
5404607|NCT02826798|18635831|P2|Overall Study|Withdrawal by Subject|1
5404608|NCT02826798|18635832|P1|Overall Study|Withdrawal by Subject|0
5404609|NCT02826603|18635894|P2|Overall Study|New therapy for study indication|1
5404610|NCT02826603|18635895|P1|Overall Study|New therapy for study indication|0
5404611|NCT02826603|18635894|P2|Overall Study|Death|0
5404612|NCT02826603|18635895|P1|Overall Study|Death|2
5404613|NCT02826603|18635894|P2|Overall Study|Withdrawal by Subject|19
5404614|NCT02826603|18635895|P1|Overall Study|Withdrawal by Subject|20
5404615|NCT02826603|18635894|P2|Overall Study|Protocol Violation|3
5404616|NCT02826603|18635895|P1|Overall Study|Protocol Violation|3
5404617|NCT02826603|18635894|P2|Overall Study|Pregnancy|2
5404618|NCT02826603|18635895|P1|Overall Study|Pregnancy|1
5404619|NCT02826603|18635894|P2|Overall Study|Physician Decision|7
5404620|NCT02826603|18635895|P1|Overall Study|Physician Decision|1
5404621|NCT02826603|18635894|P2|Overall Study|Noncompliance with treatment|2
5404622|NCT02826603|18635895|P1|Overall Study|Noncompliance with treatment|0
5404623|NCT02826603|18635894|P2|Overall Study|Lost to Follow-up|12
5404624|NCT02826603|18635895|P1|Overall Study|Lost to Follow-up|13
5404625|NCT02826603|18635894|P2|Overall Study|Lack of Efficacy|9
5404626|NCT02826603|18635895|P1|Overall Study|Lack of Efficacy|4
5404627|NCT02826603|18635894|P2|Overall Study|Adverse Event|9
5404628|NCT02826603|18635895|P1|Overall Study|Adverse Event|17
5404629|NCT02826421|18635935|P4|Overall Study|Reason not given|0
5404630|NCT02826421|18635936|P3|Overall Study|Reason not given|1
5404631|NCT02826421|18635937|P2|Overall Study|Reason not given|0
5404632|NCT02826421|18635938|P1|Overall Study|Reason not given|1
5404633|NCT02826421|18635935|P4|Overall Study|Withdrawal by Subject|1
5404634|NCT02826421|18635936|P3|Overall Study|Withdrawal by Subject|1
5404635|NCT02826421|18635937|P2|Overall Study|Withdrawal by Subject|3
5404636|NCT02826421|18635938|P1|Overall Study|Withdrawal by Subject|1
5404637|NCT02826421|18635935|P4|Overall Study|Adverse Event|1
5404638|NCT02826421|18635936|P3|Overall Study|Adverse Event|0
5404639|NCT02826421|18635937|P2|Overall Study|Adverse Event|0
5404640|NCT02826421|18635938|P1|Overall Study|Adverse Event|1
5404641|NCT02825992|18635950|P1|Overall Study|Procedure terminated|2
5404642|NCT02825992|18635950|P1|Overall Study|Lost to Follow-up|2
5404643|NCT02825992|18635950|P1|Overall Study|Withdrawal by Subject|4
5404644|NCT02825550|18635978|P1|Overall Study|Physician Decision|1
5404645|NCT02825251|18635986|P2|Overall Study|Unclassified|0
5404646|NCT02825251|18635987|P1|Overall Study|Unclassified|2
5404647|NCT02825251|18635986|P2|Overall Study|Withdrawal by Subject|4
5404648|NCT02825251|18635987|P1|Overall Study|Withdrawal by Subject|1
5404649|NCT02825251|18635986|P2|Overall Study|Lost to Follow-up|1
5404650|NCT02825251|18635987|P1|Overall Study|Lost to Follow-up|0
5404651|NCT02825251|18635986|P2|Overall Study|Adverse Event|1
5404652|NCT02825251|18635987|P1|Overall Study|Adverse Event|0
5404653|NCT02825043|18636178|P1|Overall Study|Lost to Follow-up|4
5404654|NCT02824562|18636200|P2|Overall Study|Death|1
5404655|NCT02824562|18636201|P1|Overall Study|Death|0
5404656|NCT02824562|18636200|P2|Overall Study|Lost to Follow-up|4
5404657|NCT02824562|18636201|P1|Overall Study|Lost to Follow-up|3
5404658|NCT02824432|18636210|P2|Overall Study|Major Protocol Deviation|0
5404659|NCT02824432|18636211|P1|Overall Study|Major Protocol Deviation|1
5404660|NCT02824224|18636287|P2|Overall Study|Did not show up for allocation visit|0
5404661|NCT02824224|18636288|P1|Overall Study|Did not show up for allocation visit|2
5404662|NCT02824224|18636287|P2|Overall Study|Discontinued, IUS expulsion|1
5404663|NCT02824224|18636288|P1|Overall Study|Discontinued, IUS expulsion|0
5404664|NCT02824198|18636308|P2|Overall Study|Withdrawal by Subject|0
5404665|NCT02824198|18636309|P1|Overall Study|Withdrawal by Subject|5
5404666|NCT02824198|18636308|P2|Overall Study|Lost to Follow-up|2
5404667|NCT02824198|18636309|P1|Overall Study|Lost to Follow-up|5
5404668|NCT02824198|18636308|P2|Overall Study|Non-compliance with the protocol|1
5404669|NCT02824198|18636309|P1|Overall Study|Non-compliance with the protocol|5
5404670|NCT02823964|18636339|P1|Overall Study|Withdrawal by Subject|1
5404671|NCT02823964|18636339|P1|Overall Study|Lack of Efficacy|1
5404672|NCT02823964|18636339|P1|Overall Study|Physician Decision|1
5404673|NCT02823964|18636339|P1|Overall Study|Adverse Event|2
5404674|NCT02823470|18636353|P2|Overall Study|Study terminated by sponsor|15
5404675|NCT02823470|18636354|P1|Overall Study|Study terminated by sponsor|8
5404676|NCT02823470|18636353|P2|Overall Study|Adverse Event|0
5404677|NCT02823470|18636354|P1|Overall Study|Adverse Event|1
5404678|NCT02822794|18636422|P2|Overall Study|Withdrew Consent|0
5404679|NCT02822794|18636423|P1|Overall Study|Withdrew Consent|1
5404680|NCT02822235|18636524|P2|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
5404681|NCT02822235|18636525|P1|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
5404682|NCT02822235|18636524|P2|Prospective Phase (Day 1 up to Month 12)|Death|0
5404683|NCT02822235|18636525|P1|Prospective Phase (Day 1 up to Month 12)|Death|1
5404684|NCT02822235|18636524|P2|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
5404685|NCT02822235|18636525|P1|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
5404686|NCT02822235|18636524|P2|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
5404687|NCT02822235|18636525|P1|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
5404688|NCT02822235|18636524|P2|Cross-sectional Phase (Day 1)|Reason Not Specified|0
5404689|NCT02822235|18636525|P1|Cross-sectional Phase (Day 1)|Reason Not Specified|2
5404690|NCT02822235|18636524|P2|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
5404691|NCT02822235|18636525|P1|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
5404692|NCT02822222|18636580|P2|Overall Study|Protocol requirement SBP<110 mmHg|0
5404693|NCT02822222|18636581|P1|Overall Study|Protocol requirement SBP<110 mmHg|1
5404694|NCT02821962|18636631|P2|Overall Study|Lost to Follow-up|0
5404695|NCT02821962|18636632|P1|Overall Study|Lost to Follow-up|2
5404696|NCT02821910|18636676|P6|Overall Study|Other than specified|0
5404697|NCT02821910|18636677|P5|Overall Study|Other than specified|0
5404698|NCT02821910|18636678|P4|Overall Study|Other than specified|0
5404699|NCT02821910|18636679|P3|Overall Study|Other than specified|1
5404700|NCT02821910|18636680|P2|Overall Study|Other than specified|0
5404701|NCT02821910|18636681|P1|Overall Study|Other than specified|1
5404702|NCT02821910|18636676|P6|Overall Study|Withdrawal by Subject|1
5404703|NCT02821910|18636677|P5|Overall Study|Withdrawal by Subject|0
5404704|NCT02821910|18636678|P4|Overall Study|Withdrawal by Subject|0
5404705|NCT02821910|18636679|P3|Overall Study|Withdrawal by Subject|1
5404706|NCT02821910|18636680|P2|Overall Study|Withdrawal by Subject|0
5404707|NCT02821910|18636681|P1|Overall Study|Withdrawal by Subject|0
5404708|NCT02821819|18636743|P1|Overall Study|Protocol Violation|1
5404709|NCT02821715|18636748|P6|Overall Study|Protocol Violation|0
5404710|NCT02821715|18636749|P5|Overall Study|Protocol Violation|0
5404711|NCT02821715|18636750|P4|Overall Study|Protocol Violation|0
5404712|NCT02821715|18636751|P3|Overall Study|Protocol Violation|0
5404713|NCT02821715|18636752|P2|Overall Study|Protocol Violation|0
5404714|NCT02821715|18636753|P1|Overall Study|Protocol Violation|1
5404715|NCT02821000|18636840|P1|Overall Study|Ongoing in Study|58
5404716|NCT02821000|18636840|P1|Overall Study|Withdrawal by Subject|1
5404717|NCT02821000|18636840|P1|Overall Study|Death|44
5404718|NCT02820844|18636878|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
5404719|NCT02820844|18636879|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5404720|NCT02820844|18636880|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5404721|NCT02820844|18636881|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5404722|NCT02820844|18636882|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5404723|NCT02820844|18636883|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5404724|NCT02820844|18636878|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5404725|NCT02820844|18636879|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
5404726|NCT02820844|18636880|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5404727|NCT02820844|18636881|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5404728|NCT02820844|18636882|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5404729|NCT02820844|18636883|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
5404730|NCT02820844|18636878|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5404731|NCT02820844|18636879|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5404732|NCT02820844|18636880|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
5404733|NCT02820844|18636881|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
5404734|NCT02820844|18636882|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5404735|NCT02820844|18636883|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
5404736|NCT02820844|18636878|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5404737|NCT02820844|18636879|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5404738|NCT02820844|18636880|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5404739|NCT02820844|18636881|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
5404740|NCT02820844|18636882|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5404741|NCT02820844|18636883|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
5404742|NCT02820844|18636878|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5404743|NCT02820844|18636879|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5404744|NCT02820844|18636880|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
5404745|NCT02820844|18636881|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
5404746|NCT02820844|18636882|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5404747|NCT02820844|18636883|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
5404748|NCT02820844|18636878|P6|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5404749|NCT02820844|18636879|P5|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5404750|NCT02820844|18636880|P4|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5404751|NCT02820844|18636881|P3|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5404752|NCT02820844|18636882|P2|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
5404753|NCT02820844|18636883|P1|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
5404754|NCT02820844|18636878|P6|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5404755|NCT02820844|18636879|P5|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5404756|NCT02820844|18636880|P4|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5404757|NCT02820844|18636881|P3|Double-blinded (Up to 48 Weeks)|Adverse Event|0
5404758|NCT02820844|18636882|P2|Double-blinded (Up to 48 Weeks)|Adverse Event|1
5404759|NCT02820844|18636883|P1|Double-blinded (Up to 48 Weeks)|Adverse Event|2
5404760|NCT02820844|18636878|P6|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5404761|NCT02820844|18636879|P5|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5404762|NCT02820844|18636880|P4|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5404763|NCT02820844|18636881|P3|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5404764|NCT02820844|18636882|P2|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
5404765|NCT02820844|18636883|P1|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
5404766|NCT02820844|18636878|P6|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5404767|NCT02820844|18636879|P5|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5404768|NCT02820844|18636880|P4|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5404769|NCT02820844|18636881|P3|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
5404770|NCT02820844|18636882|P2|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
5404771|NCT02820844|18636883|P1|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
5404772|NCT02820844|18636878|P6|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5404773|NCT02820844|18636879|P5|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5404774|NCT02820844|18636880|P4|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5404775|NCT02820844|18636881|P3|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
5404776|NCT02820844|18636882|P2|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
5404777|NCT02820844|18636883|P1|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
5404778|NCT02820597|18637097|P1|Overall Study|Lost to Follow-up|12
5404779|NCT02820038|18637148|P4|Overall Study|Withdrawal by Subject|13
5404780|NCT02820038|18637149|P3|Overall Study|Withdrawal by Subject|3
5404781|NCT02820038|18637150|P2|Overall Study|Withdrawal by Subject|14
5404782|NCT02820038|18637151|P1|Overall Study|Withdrawal by Subject|3
5404783|NCT02820038|18637148|P4|Overall Study|Lost to Follow-up|9
5404784|NCT02820038|18637149|P3|Overall Study|Lost to Follow-up|2
5404785|NCT02820038|18637150|P2|Overall Study|Lost to Follow-up|11
5404786|NCT02820038|18637151|P1|Overall Study|Lost to Follow-up|7
5404787|NCT02819804|18637278|P1|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
5404788|NCT02819726|18637285|P4|Part B (All Participants)|Protocol non-compliance|0
5404789|NCT02819726|18637286|P3|Part B (All Participants)|Protocol non-compliance|1
5404790|NCT02819726|18637287|P2|Part B (All Participants)|Protocol non-compliance|0
5404791|NCT02819726|18637288|P1|Part B (All Participants)|Protocol non-compliance|0
5404792|NCT02819726|18637285|P4|Part B (All Participants)|Withdrawal by Subject|0
5404793|NCT02819726|18637286|P3|Part B (All Participants)|Withdrawal by Subject|1
5404794|NCT02819726|18637287|P2|Part B (All Participants)|Withdrawal by Subject|1
5404795|NCT02819726|18637288|P1|Part B (All Participants)|Withdrawal by Subject|2
5404796|NCT02819726|18637285|P4|Part B (All Participants)|Lost to Follow-up|2
5404797|NCT02819726|18637286|P3|Part B (All Participants)|Lost to Follow-up|2
5404798|NCT02819726|18637287|P2|Part B (All Participants)|Lost to Follow-up|1
5404799|NCT02819726|18637288|P1|Part B (All Participants)|Lost to Follow-up|1
5404800|NCT02819726|18637285|P4|Part A (All Participants)|Protocol non-compliance|0
5404801|NCT02819726|18637286|P3|Part A (All Participants)|Protocol non-compliance|5
5404802|NCT02819726|18637287|P2|Part A (All Participants)|Protocol non-compliance|4
5404803|NCT02819726|18637288|P1|Part A (All Participants)|Protocol non-compliance|3
5404804|NCT02819726|18637285|P4|Part A (All Participants)|Withdrawal by Subject|0
5404805|NCT02819726|18637286|P3|Part A (All Participants)|Withdrawal by Subject|6
5404806|NCT02819726|18637287|P2|Part A (All Participants)|Withdrawal by Subject|5
5404807|NCT02819726|18637288|P1|Part A (All Participants)|Withdrawal by Subject|3
5404808|NCT02819726|18637285|P4|Part A (All Participants)|Lost to Follow-up|0
5404809|NCT02819726|18637286|P3|Part A (All Participants)|Lost to Follow-up|0
5404810|NCT02819726|18637287|P2|Part A (All Participants)|Lost to Follow-up|1
5404811|NCT02819726|18637288|P1|Part A (All Participants)|Lost to Follow-up|0
5404812|NCT02819310|18637415|P1|Overall Study|Protocol Violation|30
5404813|NCT02819310|18637415|P1|Overall Study|Physician Decision|8
5404814|NCT02819310|18637415|P1|Overall Study|Lack of Efficacy|5
5404815|NCT02819310|18637415|P1|Overall Study|Adverse Event|13
5404816|NCT02819310|18637415|P1|Overall Study|Lost to Follow-up|16
5404817|NCT02819310|18637415|P1|Overall Study|Withdrawal by Subject|37
5404818|NCT02819297|18637421|P2|Overall Study|Protocol Violation|2
5404819|NCT02819297|18637422|P1|Overall Study|Protocol Violation|1
5404820|NCT02819297|18637421|P2|Overall Study|Lack of Efficacy|8
5404821|NCT02819297|18637422|P1|Overall Study|Lack of Efficacy|5
5404822|NCT02819297|18637421|P2|Overall Study|Physician Decision|5
5404823|NCT02819297|18637422|P1|Overall Study|Physician Decision|5
5404824|NCT02819297|18637421|P2|Overall Study|Adverse Event|10
5404825|NCT02819297|18637422|P1|Overall Study|Adverse Event|12
5404826|NCT02819297|18637421|P2|Overall Study|Lost to Follow-up|14
5404827|NCT02819297|18637422|P1|Overall Study|Lost to Follow-up|12
5404828|NCT02819297|18637421|P2|Overall Study|Withdrawal by Subject|13
5404829|NCT02819297|18637422|P1|Overall Study|Withdrawal by Subject|25
5404830|NCT02818998|18637496|P3|Overall Study|Physician Decision|0
5404831|NCT02818998|18637497|P2|Overall Study|Physician Decision|0
5404832|NCT02818998|18637498|P1|Overall Study|Physician Decision|1
5404833|NCT02818998|18637496|P3|Overall Study|Withdrawal by Subject|6
5404834|NCT02818998|18637497|P2|Overall Study|Withdrawal by Subject|6
5404835|NCT02818998|18637498|P1|Overall Study|Withdrawal by Subject|7
5404836|NCT02818998|18637496|P3|Overall Study|Death|8
5404837|NCT02818998|18637497|P2|Overall Study|Death|6
5404838|NCT02818998|18637498|P1|Overall Study|Death|3
5404839|NCT02818998|18637496|P3|Overall Study|Withdrawal by sponsor|1
5404840|NCT02818998|18637497|P2|Overall Study|Withdrawal by sponsor|1
5404841|NCT02818998|18637498|P1|Overall Study|Withdrawal by sponsor|0
5404842|NCT02818998|18637496|P3|Overall Study|Lost to Follow-up|2
5404843|NCT02818998|18637497|P2|Overall Study|Lost to Follow-up|1
5404844|NCT02818998|18637498|P1|Overall Study|Lost to Follow-up|4
5404845|NCT02818998|18637496|P3|Overall Study|Adverse Event|1
5404846|NCT02818998|18637497|P2|Overall Study|Adverse Event|2
5404847|NCT02818998|18637498|P1|Overall Study|Adverse Event|3
5404848|NCT02818920|18637531|P1|Overall Study|Refused Further Treatment|1
5404849|NCT02818920|18637531|P1|Overall Study|Developed Other Disease|1
5404850|NCT02818920|18637531|P1|Overall Study|Adverse Event|3
5404851|NCT02818920|18637531|P1|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
5404852|NCT02818920|18637531|P1|Overall Study|Progressed After Neoadjuvant Therapy|1
5404853|NCT02818920|18637531|P1|Overall Study|Unresectable|4
5404854|NCT02818777|18637535|P1|Overall Study|Adverse Event|3
5404855|NCT02818036|18637602|P2|Overall Study|Withdrawal by Subject|0
5404856|NCT02818036|18637603|P1|Overall Study|Withdrawal by Subject|1
5404857|NCT02818036|18637602|P2|Overall Study|head did not fit in fMRI scanner headres|0
5404858|NCT02818036|18637603|P1|Overall Study|head did not fit in fMRI scanner headres|1
5404859|NCT02817841|18637611|P1|Overall Study|Protocol Violation|94
5404860|NCT02817841|18637611|P1|Overall Study|Other reasons|53
5404861|NCT02817841|18637611|P1|Overall Study|Pregnancy wish|17
5404862|NCT02817841|18637611|P1|Overall Study|Pregnancy|32
5404863|NCT02817841|18637611|P1|Overall Study|Adverse event related to bleeding|51
5404864|NCT02817841|18637611|P1|Overall Study|Adverse event not related to bleeding|131
5404865|NCT02817841|18637611|P1|Overall Study|Withdrawal by Subject|183
5404866|NCT02817841|18637611|P1|Overall Study|Lost to Follow-up|287
5404867|NCT02817828|18637638|P1|Overall Study|Other|26
5404868|NCT02817828|18637638|P1|Overall Study|Withdrawal by Subject|78
5404869|NCT02817828|18637638|P1|Overall Study|Pregnancy wish|15
5404870|NCT02817828|18637638|P1|Overall Study|Pregnancy|7
5404871|NCT02817828|18637638|P1|Overall Study|Protocol Violation|11
5404872|NCT02817828|18637638|P1|Overall Study|Adverse event related to bleeding|53
5404873|NCT02817828|18637638|P1|Overall Study|Adverse event not related to bleeding|104
5404874|NCT02817828|18637638|P1|Overall Study|Lost to Follow-up|41
5404875|NCT02817594|18637673|P1|Overall Study|Did Not Receive Treatment|1
5404876|NCT02817594|18637673|P1|Overall Study|Other|1
5404877|NCT02817594|18637673|P1|Overall Study|Withdrawal by Subject|1
5404878|NCT02817555|18637694|P2|Overall Study|changed to Peritoneal Dialysis|1
5404879|NCT02817555|18637695|P1|Overall Study|changed to Peritoneal Dialysis|0
5404880|NCT02817555|18637694|P2|Overall Study|transplant|1
5404881|NCT02817555|18637695|P1|Overall Study|transplant|1
5404882|NCT02817555|18637694|P2|Overall Study|moved away|0
5404883|NCT02817555|18637695|P1|Overall Study|moved away|1
5404884|NCT02817555|18637694|P2|Overall Study|Death|3
5404885|NCT02817555|18637695|P1|Overall Study|Death|1
5404886|NCT02817516|18637715|P4|Overall Study|Other|0
5404887|NCT02817516|18637716|P3|Overall Study|Other|1
5404888|NCT02817516|18637717|P2|Overall Study|Other|0
5404889|NCT02817516|18637718|P1|Overall Study|Other|0
5404890|NCT02817087|18637755|P2|Overall Study|Withdrawal by Subject|0
5404891|NCT02817087|18637756|P1|Overall Study|Withdrawal by Subject|2
5404892|NCT02816398|18637827|P1|Overall Study|Lost to Follow-up|1
5404893|NCT02816398|18637827|P1|Overall Study|Lack of Efficacy|8
5404894|NCT02816398|18637827|P1|Overall Study|Death|5
5404895|NCT02816138|18637885|P1|Overall Study|Adverse Event|1
5404896|NCT02815735|18637931|P2|Second Intervention (4 Weeks)|Protocol Violation|0
5404897|NCT02815735|18637932|P1|Second Intervention (4 Weeks)|Protocol Violation|1
5404898|NCT02815735|18637931|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
5404899|NCT02815735|18637932|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
5404900|NCT02815735|18637931|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
5404901|NCT02815735|18637932|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
5404902|NCT02815735|18637931|P2|First Intervention (4 Weeks)|Discomfort|0
5404903|NCT02815735|18637932|P1|First Intervention (4 Weeks)|Discomfort|1
5404904|NCT02815670|18637986|P1|Overall Study|Prematurely discontinued of the trial|1
5404905|NCT02815397|18638018|P1|Overall Study|Physician Decision|2
5404906|NCT02815293|18638028|P3|Overall Study|Adverse Event|0
5404907|NCT02815293|18638029|P2|Overall Study|Adverse Event|1
5404908|NCT02815293|18638030|P1|Overall Study|Adverse Event|0
5404909|NCT02815293|18638028|P3|Overall Study|Participants not randomized|18
5404910|NCT02815293|18638029|P2|Overall Study|Participants not randomized|0
5404911|NCT02815293|18638030|P1|Overall Study|Participants not randomized|0
5404912|NCT02815293|18638028|P3|Overall Study|Study termination by sponsor|0
5404913|NCT02815293|18638029|P2|Overall Study|Study termination by sponsor|7
5404914|NCT02815293|18638030|P1|Overall Study|Study termination by sponsor|10
5404915|NCT02815280|18638040|P2|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
5404916|NCT02815280|18638041|P1|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
5404917|NCT02815280|18638040|P2|Open-Label Phase|Administrative|12
5404918|NCT02815280|18638041|P1|Open-Label Phase|Administrative|26
5404919|NCT02815280|18638040|P2|Open-Label Phase|Protocol Violation|0
5404920|NCT02815280|18638041|P1|Open-Label Phase|Protocol Violation|3
5404921|NCT02815280|18638040|P2|Open-Label Phase|Withdrawal by Subject|18
5404922|NCT02815280|18638041|P1|Open-Label Phase|Withdrawal by Subject|33
5404923|NCT02815280|18638040|P2|Open-Label Phase|Lost to Follow-up|9
5404924|NCT02815280|18638041|P1|Open-Label Phase|Lost to Follow-up|18
5404925|NCT02815280|18638040|P2|Open-Label Phase|Adverse Event|3
5404926|NCT02815280|18638041|P1|Open-Label Phase|Adverse Event|2
5404927|NCT02815280|18638040|P2|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
5404928|NCT02815280|18638041|P1|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
5404929|NCT02815280|18638040|P2|Double-Blind Phase|Protocol Violation|2
5404930|NCT02815280|18638041|P1|Double-Blind Phase|Protocol Violation|2
5404931|NCT02815280|18638040|P2|Double-Blind Phase|Withdrawal by Subject|11
5404932|NCT02815280|18638041|P1|Double-Blind Phase|Withdrawal by Subject|20
5404933|NCT02815280|18638040|P2|Double-Blind Phase|Lost to Follow-up|9
5404934|NCT02815280|18638041|P1|Double-Blind Phase|Lost to Follow-up|10
5404935|NCT02815280|18638040|P2|Double-Blind Phase|Adverse Event|1
5404936|NCT02815280|18638041|P1|Double-Blind Phase|Adverse Event|1
5404937|NCT02815267|18638061|P2|Open-Label Phase|Other|5
5404938|NCT02815267|18638062|P1|Open-Label Phase|Other|2
5404939|NCT02815267|18638061|P2|Open-Label Phase|Administrative|12
5404940|NCT02815267|18638062|P1|Open-Label Phase|Administrative|21
5404941|NCT02815267|18638061|P2|Open-Label Phase|Protocol Violation|1
5404942|NCT02815267|18638062|P1|Open-Label Phase|Protocol Violation|0
5404943|NCT02815267|18638061|P2|Open-Label Phase|Withdrawal by Subject|13
5404944|NCT02815267|18638062|P1|Open-Label Phase|Withdrawal by Subject|24
5404945|NCT02815267|18638061|P2|Open-Label Phase|Lost to Follow-up|9
5404946|NCT02815267|18638062|P1|Open-Label Phase|Lost to Follow-up|23
5404947|NCT02815267|18638061|P2|Open-Label Phase|Adverse Event|1
5404948|NCT02815267|18638062|P1|Open-Label Phase|Adverse Event|1
5404949|NCT02815267|18638061|P2|Double-Blind Phase|Received a disallowed medication|1
5404950|NCT02815267|18638062|P1|Double-Blind Phase|Received a disallowed medication|1
5404951|NCT02815267|18638061|P2|Double-Blind Phase|Site withdrawal|6
5404952|NCT02815267|18638062|P1|Double-Blind Phase|Site withdrawal|1
5404953|NCT02815267|18638061|P2|Double-Blind Phase|Protocol Violation|2
5404954|NCT02815267|18638062|P1|Double-Blind Phase|Protocol Violation|3
5404955|NCT02815267|18638061|P2|Double-Blind Phase|Withdrawal by Subject|10
5404956|NCT02815267|18638062|P1|Double-Blind Phase|Withdrawal by Subject|11
5404957|NCT02815267|18638061|P2|Double-Blind Phase|Lost to Follow-up|9
5404958|NCT02815267|18638062|P1|Double-Blind Phase|Lost to Follow-up|17
5404959|NCT02815267|18638061|P2|Double-Blind Phase|Adverse Event|3
5404960|NCT02815267|18638062|P1|Double-Blind Phase|Adverse Event|0
5404961|NCT02814643|18638202|P2|Overall Study|Withdrawal by Subject|2
5404962|NCT02814643|18638203|P1|Overall Study|Withdrawal by Subject|1
5404963|NCT02814643|18638202|P2|Overall Study|Lost to Follow-up|1
5404964|NCT02814643|18638203|P1|Overall Study|Lost to Follow-up|0
5404965|NCT02814565|18638227|P2|Overall Study|Subject decision, caused by AE Influenza|1
5404966|NCT02814565|18638228|P1|Overall Study|Subject decision, caused by AE Influenza|1
5404967|NCT02814565|18638227|P2|Overall Study|Lack of Efficacy|1
5404968|NCT02814565|18638228|P1|Overall Study|Lack of Efficacy|0
5404969|NCT02814175|18638298|P6|Part 2|Lack of Efficacy|3
5404970|NCT02814175|18638299|P5|Part 2|Lack of Efficacy|0
5404971|NCT02814175|18638300|P4|Part 2|Lack of Efficacy|0
5404972|NCT02814175|18638301|P3|Part 2|Lack of Efficacy|0
5404973|NCT02814175|18638302|P2|Part 2|Lack of Efficacy|0
5404974|NCT02814175|18638303|P1|Part 2|Lack of Efficacy|0
5404975|NCT02814175|18638298|P6|Part 2|Lost to Follow-up|0
5404976|NCT02814175|18638299|P5|Part 2|Lost to Follow-up|0
5404977|NCT02814175|18638300|P4|Part 2|Lost to Follow-up|1
5404978|NCT02814175|18638301|P3|Part 2|Lost to Follow-up|0
5404979|NCT02814175|18638302|P2|Part 2|Lost to Follow-up|0
5404980|NCT02814175|18638303|P1|Part 2|Lost to Follow-up|0
5404981|NCT02814175|18638298|P6|Part 2|Withdrawal Consent|1
5404982|NCT02814175|18638299|P5|Part 2|Withdrawal Consent|1
5404983|NCT02814175|18638300|P4|Part 2|Withdrawal Consent|2
5404984|NCT02814175|18638301|P3|Part 2|Withdrawal Consent|0
5404985|NCT02814175|18638302|P2|Part 2|Withdrawal Consent|0
5404986|NCT02814175|18638303|P1|Part 2|Withdrawal Consent|0
5404987|NCT02814175|18638298|P6|Part 2|Adverse Event|2
5404988|NCT02814175|18638299|P5|Part 2|Adverse Event|1
5404989|NCT02814175|18638300|P4|Part 2|Adverse Event|1
5404990|NCT02814175|18638301|P3|Part 2|Adverse Event|0
5404991|NCT02814175|18638302|P2|Part 2|Adverse Event|0
5404992|NCT02814175|18638303|P1|Part 2|Adverse Event|0
5404993|NCT02814175|18638298|P6|Part 1|Lack of Efficacy|0
5404994|NCT02814175|18638299|P5|Part 1|Lack of Efficacy|0
5404995|NCT02814175|18638300|P4|Part 1|Lack of Efficacy|0
5404996|NCT02814175|18638301|P3|Part 1|Lack of Efficacy|0
5404997|NCT02814175|18638302|P2|Part 1|Lack of Efficacy|2
5404998|NCT02814175|18638303|P1|Part 1|Lack of Efficacy|1
5404999|NCT02814175|18638298|P6|Part 1|Lost to Follow-up|0
5405000|NCT02814175|18638299|P5|Part 1|Lost to Follow-up|0
5405001|NCT02814175|18638300|P4|Part 1|Lost to Follow-up|0
5405002|NCT02814175|18638301|P3|Part 1|Lost to Follow-up|0
5405003|NCT02814175|18638302|P2|Part 1|Lost to Follow-up|0
5405004|NCT02814175|18638303|P1|Part 1|Lost to Follow-up|1
5405005|NCT02814175|18638298|P6|Part 1|Withdrawal Consent|0
5405006|NCT02814175|18638299|P5|Part 1|Withdrawal Consent|0
5405007|NCT02814175|18638300|P4|Part 1|Withdrawal Consent|0
5405008|NCT02814175|18638301|P3|Part 1|Withdrawal Consent|0
5405009|NCT02814175|18638302|P2|Part 1|Withdrawal Consent|1
5405010|NCT02814175|18638303|P1|Part 1|Withdrawal Consent|8
5405011|NCT02814175|18638298|P6|Part 1|Adverse Event|0
5405012|NCT02814175|18638299|P5|Part 1|Adverse Event|0
5405013|NCT02814175|18638300|P4|Part 1|Adverse Event|0
5405014|NCT02814175|18638301|P3|Part 1|Adverse Event|0
5405015|NCT02814175|18638302|P2|Part 1|Adverse Event|3
5405016|NCT02814175|18638303|P1|Part 1|Adverse Event|2
5405017|NCT02813694|18638341|P2|Overall Study|Patient hospitalized|0
5405018|NCT02813694|18638342|P1|Overall Study|Patient hospitalized|1
5405019|NCT02813694|18638341|P2|Overall Study|Randomized- did not receive study drug|0
5405020|NCT02813694|18638342|P1|Overall Study|Randomized- did not receive study drug|2
5405021|NCT02813694|18638341|P2|Overall Study|Death|3
5405022|NCT02813694|18638342|P1|Overall Study|Death|3
5405023|NCT02813694|18638341|P2|Overall Study|Lost to Follow-up|1
5405024|NCT02813694|18638342|P1|Overall Study|Lost to Follow-up|1
5405025|NCT02813694|18638341|P2|Overall Study|Withdrawal by Subject|9
5405026|NCT02813694|18638342|P1|Overall Study|Withdrawal by Subject|10
5405027|NCT02813694|18638341|P2|Overall Study|Physician Decision|1
5405028|NCT02813694|18638342|P1|Overall Study|Physician Decision|0
5405029|NCT02813681|18638355|P3|Overall Study|Lost to Follow-up|0
5405030|NCT02813681|18638356|P2|Overall Study|Lost to Follow-up|1
5405031|NCT02813681|18638357|P1|Overall Study|Lost to Follow-up|0
5405032|NCT02813681|18638355|P3|Overall Study|Physician Decision|0
5405033|NCT02813681|18638356|P2|Overall Study|Physician Decision|5
5405034|NCT02813681|18638357|P1|Overall Study|Physician Decision|5
5405035|NCT02813577|18638378|P1|Overall Study|Study terminated|4
5405036|NCT02812186|18638488|P2|Period 1|nonevaluable data sets|6
5405037|NCT02812186|18638489|P1|Period 1|nonevaluable data sets|6
5405038|NCT02812186|18638488|P2|Period 1|Post randomization screen failure|9
5405039|NCT02812186|18638489|P1|Period 1|Post randomization screen failure|5
5405040|NCT02811640|18638533|P1|Overall Study|Technology malfunction|2
5405041|NCT02811159|18638568|P1|Treatment Course 1|Lost to Follow-up|1
5405042|NCT02810457|18638607|P2|Overall Study|Physician Decision|1
5405043|NCT02810457|18638608|P1|Overall Study|Physician Decision|0
5405044|NCT02810457|18638607|P2|Overall Study|Miscalculated PD|0
5405045|NCT02810457|18638608|P1|Overall Study|Miscalculated PD|1
5405046|NCT02810457|18638607|P2|Overall Study|Patient ineligibility|0
5405047|NCT02810457|18638608|P1|Overall Study|Patient ineligibility|3
5405048|NCT02810457|18638607|P2|Overall Study|Investigator decision|2
5405049|NCT02810457|18638608|P1|Overall Study|Investigator decision|3
5405050|NCT02810457|18638607|P2|Overall Study|Clinical progression|16
5405051|NCT02810457|18638608|P1|Overall Study|Clinical progression|15
5405052|NCT02810457|18638607|P2|Overall Study|Ongoing at data cutoff and discontinued|2
5405053|NCT02810457|18638608|P1|Overall Study|Ongoing at data cutoff and discontinued|3
5405054|NCT02810457|18638607|P2|Overall Study|Death|28
5405055|NCT02810457|18638608|P1|Overall Study|Death|39
5405056|NCT02810457|18638607|P2|Overall Study|Patient lost to follow-up|2
5405057|NCT02810457|18638608|P1|Overall Study|Patient lost to follow-up|2
5405058|NCT02810457|18638607|P2|Overall Study|Patient decision|35
5405059|NCT02810457|18638608|P1|Overall Study|Patient decision|31
5405060|NCT02810457|18638607|P2|Overall Study|Adverse Event|43
5405061|NCT02810457|18638608|P1|Overall Study|Adverse Event|37
5405062|NCT02810457|18638607|P2|Overall Study|Objective PD assessed by RECIST v1.1|199
5405063|NCT02810457|18638608|P1|Overall Study|Objective PD assessed by RECIST v1.1|191
5405064|NCT02810457|18638607|P2|Overall Study|Randomised but no treatment received|1
5405065|NCT02810457|18638608|P1|Overall Study|Randomised but no treatment received|2
5405066|NCT02809976|18638637|P1|Overall Study|Withdrawal by Subject|1
5405067|NCT02809976|18638637|P1|Overall Study|Lost to Follow-up|1
5405068|NCT02809833|18638675|P1|Overall Study|Missing Information|52
5405069|NCT02809833|18638675|P1|Overall Study|Other|5
5405070|NCT02809833|18638675|P1|Overall Study|Adverse Event (AE)|24
5405071|NCT02809833|18638675|P1|Overall Study|Lost to Follow-up|35
5405072|NCT02809833|18638675|P1|Overall Study|Withdrawal by Subject|34
5405073|NCT02809833|18638675|P1|Overall Study|Noncompliance|1
5405074|NCT02809833|18638675|P1|Overall Study|Remission/Treatment No Longer Needed|3
5405075|NCT02809833|18638675|P1|Overall Study|Lack of Efficacy|89
5405076|NCT02809833|18638675|P1|Overall Study|Intolerance|54
5405077|NCT02809833|18638675|P1|Overall Study|Death|3
5405078|NCT02809118|18638807|P3|Overall Study|Withdrawal by Subject|1
5405079|NCT02809118|18638808|P2|Overall Study|Withdrawal by Subject|1
5405080|NCT02809118|18638809|P1|Overall Study|Withdrawal by Subject|0
5405081|NCT02809053|18638822|P2|Overall Study|Disease Progression|1
5405082|NCT02809053|18638823|P1|Overall Study|Disease Progression|2
5405083|NCT02809053|18638822|P2|Overall Study|Withdrawal by Subject|3
5405084|NCT02809053|18638823|P1|Overall Study|Withdrawal by Subject|2
5405085|NCT02809053|18638822|P2|Overall Study|Lost to Follow-up|1
5405086|NCT02809053|18638823|P1|Overall Study|Lost to Follow-up|3
5405087|NCT02809053|18638822|P2|Overall Study|Death|1
5405088|NCT02809053|18638823|P1|Overall Study|Death|0
5405089|NCT02808975|18638869|P2|Overall Study|Other, not specified|1
5405090|NCT02808975|18638870|P1|Overall Study|Other, not specified|5
5405091|NCT02808975|18638869|P2|Overall Study|Planned HS surgery performed prior Wk 13|0
5405092|NCT02808975|18638870|P1|Overall Study|Planned HS surgery performed prior Wk 13|1
5405093|NCT02808975|18638869|P2|Overall Study|Lost to Follow-up|6
5405094|NCT02808975|18638870|P1|Overall Study|Lost to Follow-up|4
5405095|NCT02808975|18638869|P2|Overall Study|Withdrew consent|8
5405096|NCT02808975|18638870|P1|Overall Study|Withdrew consent|9
5405097|NCT02808975|18638869|P2|Overall Study|Adverse Event|4
5405098|NCT02808975|18638870|P1|Overall Study|Adverse Event|3
5405099|NCT02808338|18638897|P1|Overnight In-lab Polysomonography|Reason not given|1
5405100|NCT02808338|18638897|P1|Overnight In-lab Polysomonography|Withdrawal by Subject|1
5405101|NCT02808338|18638897|P1|Screening|Screen Failure|10
5405102|NCT02808312|18638912|P4|Overall Study|Enrolled but Never Treated|1
5405103|NCT02808312|18638913|P3|Overall Study|Enrolled but Never Treated|0
5405104|NCT02808312|18638914|P2|Overall Study|Enrolled but Never Treated|0
5405105|NCT02808312|18638915|P1|Overall Study|Enrolled but Never Treated|0
5405106|NCT02807948|18639072|P2|Overall Study|Physician Decision|0
5405107|NCT02807948|18639073|P1|Overall Study|Physician Decision|1
5405108|NCT02807623|18639081|P3|Overall Study|incomplete blood draw|1
5405109|NCT02807623|18639082|P2|Overall Study|incomplete blood draw|2
5405110|NCT02807623|18639083|P1|Overall Study|incomplete blood draw|0
5405111|NCT02807623|18639081|P3|Overall Study|Drug intolerance|0
5405112|NCT02807623|18639082|P2|Overall Study|Drug intolerance|1
5405113|NCT02807623|18639083|P1|Overall Study|Drug intolerance|0
5405114|NCT02807623|18639081|P3|Overall Study|Lost to Follow-up|22
5405115|NCT02807623|18639082|P2|Overall Study|Lost to Follow-up|18
5405116|NCT02807623|18639083|P1|Overall Study|Lost to Follow-up|23
5405117|NCT02807402|18639110|P1|Overall Study|Other|2
5405118|NCT02807402|18639110|P1|Overall Study|Death|3
5405119|NCT02807402|18639110|P1|Overall Study|Failure to Return|1
5405120|NCT02807376|18639148|P2|Overall Study|Lost to Follow-up|1
5405121|NCT02807376|18639149|P1|Overall Study|Lost to Follow-up|0
5405122|NCT02807376|18639148|P2|Overall Study|Intra-operative exclusion criteria|0
5405123|NCT02807376|18639149|P1|Overall Study|Intra-operative exclusion criteria|3
5405124|NCT02807259|18639159|P2|Endline (3 Months)|migration, refusal, not available|87
5405125|NCT02807259|18639160|P1|Endline (3 Months)|migration, refusal, not available|35
5405126|NCT02807259|18639159|P2|Midline (3 Months)|migration, refusal, not available|34
5405127|NCT02807259|18639160|P1|Midline (3 Months)|migration, refusal, not available|30
5405128|NCT02807259|18639159|P2|Baseline (3 Months)|migration, refusal, not available|112
5405129|NCT02807259|18639160|P1|Baseline (3 Months)|migration, refusal, not available|77
5405130|NCT02806986|18639178|P1|Treatment Stage 2|Withdrawal by Subject|2
5405131|NCT02806986|18639178|P1|Treatment Stage 2|Adverse Event|3
5405132|NCT02806986|18639178|P1|Treatment Stage 1|Adverse Event|1
5405133|NCT02806973|18639198|P4|Period 3|Adverse Event|0
5405134|NCT02806973|18639199|P3|Period 3|Adverse Event|1
5405135|NCT02806973|18639200|P2|Period 3|Adverse Event|0
5405136|NCT02806973|18639201|P1|Period 3|Adverse Event|0
5405137|NCT02806973|18639198|P4|Period 3|Withdrawal by Subject|3
5405138|NCT02806973|18639199|P3|Period 3|Withdrawal by Subject|0
5405139|NCT02806973|18639200|P2|Period 3|Withdrawal by Subject|0
5405140|NCT02806973|18639201|P1|Period 3|Withdrawal by Subject|0
5405141|NCT02806973|18639198|P4|Period 1|Adverse Event|1
5405142|NCT02806973|18639199|P3|Period 1|Adverse Event|0
5405143|NCT02806973|18639200|P2|Period 1|Adverse Event|0
5405144|NCT02806973|18639201|P1|Period 1|Adverse Event|0
5405145|NCT02806973|18639198|P4|Period 1|Withdrawal by Subject|1
5405146|NCT02806973|18639199|P3|Period 1|Withdrawal by Subject|1
5405147|NCT02806973|18639200|P2|Period 1|Withdrawal by Subject|2
5405148|NCT02806973|18639201|P1|Period 1|Withdrawal by Subject|0
5405149|NCT02806960|18639235|P4|Period 1|Study Terminated (withdrawn by sponsor)|3
5405150|NCT02806960|18639236|P3|Period 1|Study Terminated (withdrawn by sponsor)|3
5405151|NCT02806960|18639237|P2|Period 1|Study Terminated (withdrawn by sponsor)|3
5405152|NCT02806960|18639238|P1|Period 1|Study Terminated (withdrawn by sponsor)|3
5405153|NCT02806947|18639274|P2|Overall Study|Withdrawal by Subject|1
5405154|NCT02806947|18639275|P1|Overall Study|Withdrawal by Subject|5
5405155|NCT02806726|18639357|P1|Overall Study|Lost to Follow-up|1
5405156|NCT02806713|18639366|P2|Overall Study|cancelled surgery|2
5405157|NCT02806713|18639367|P1|Overall Study|cancelled surgery|1
5405158|NCT02806713|18639366|P2|Overall Study|Urethral injury during procedure|0
5405159|NCT02806713|18639367|P1|Overall Study|Urethral injury during procedure|1
5405160|NCT02806505|18639386|P2|Overall Study|Insufficient therapeutic response|4
5405161|NCT02806505|18639387|P1|Overall Study|Insufficient therapeutic response|2
5405162|NCT02806505|18639386|P2|Overall Study|Failure to return|1
5405163|NCT02806505|18639387|P1|Overall Study|Failure to return|0
5405164|NCT02806505|18639386|P2|Overall Study|Did not cooperate/refused treatment|3
5405165|NCT02806505|18639387|P1|Overall Study|Did not cooperate/refused treatment|3
5405166|NCT02806505|18639386|P2|Overall Study|Death|0
5405167|NCT02806505|18639387|P1|Overall Study|Death|4
5405168|NCT02806505|18639386|P2|Overall Study|Adverse event/intercurrent illness|3
5405169|NCT02806505|18639387|P1|Overall Study|Adverse event/intercurrent illness|1
5405170|NCT02806414|18639397|P1|Overall Study|Lost to Follow-up|2
5405171|NCT02806232|18639411|P9|Overall Study|Withdrawal by Subject|0
5405172|NCT02806232|18639412|P8|Overall Study|Withdrawal by Subject|0
5405173|NCT02806232|18639413|P7|Overall Study|Withdrawal by Subject|0
5405174|NCT02806232|18639414|P6|Overall Study|Withdrawal by Subject|1
5405175|NCT02806232|18639415|P5|Overall Study|Withdrawal by Subject|2
5405176|NCT02806232|18639416|P4|Overall Study|Withdrawal by Subject|0
5405177|NCT02806232|18639417|P3|Overall Study|Withdrawal by Subject|0
5405178|NCT02806232|18639418|P2|Overall Study|Withdrawal by Subject|2
5405179|NCT02806232|18639419|P1|Overall Study|Withdrawal by Subject|0
5405180|NCT02806232|18639411|P9|Overall Study|Lost to Follow-up|0
5405181|NCT02806232|18639412|P8|Overall Study|Lost to Follow-up|0
5405182|NCT02806232|18639413|P7|Overall Study|Lost to Follow-up|0
5405183|NCT02806232|18639414|P6|Overall Study|Lost to Follow-up|1
5405184|NCT02806232|18639415|P5|Overall Study|Lost to Follow-up|0
5405185|NCT02806232|18639416|P4|Overall Study|Lost to Follow-up|0
5405186|NCT02806232|18639417|P3|Overall Study|Lost to Follow-up|1
5405187|NCT02806232|18639418|P2|Overall Study|Lost to Follow-up|2
5405188|NCT02806232|18639419|P1|Overall Study|Lost to Follow-up|1
5405189|NCT02806024|18639459|P2|Overall Study|DVT during antepartum admission|1
5405190|NCT02806024|18639460|P1|Overall Study|DVT during antepartum admission|0
5405191|NCT02806024|18639459|P2|Overall Study|Night Delivery|1
5405192|NCT02806024|18639460|P1|Overall Study|Night Delivery|1
5405193|NCT02805907|18639470|P2|Overall Study|Lost to Follow-up|3
5405194|NCT02805907|18639471|P1|Overall Study|Lost to Follow-up|3
5405195|NCT02805790|18639485|P2|Second Intervention (4 Weeks)|Physician Decision|1
5405196|NCT02805790|18639486|P1|Second Intervention (4 Weeks)|Physician Decision|0
5405197|NCT02804750|18639521|P2|Period 4|Adverse Event|5
5405198|NCT02804750|18639522|P1|Period 4|Adverse Event|0
5405199|NCT02804750|18639521|P2|Period 3|Adverse Event|2
5405200|NCT02804750|18639522|P1|Period 3|Adverse Event|0
5405201|NCT02804750|18639521|P2|Period 2|Adverse Event|0
5405202|NCT02804750|18639522|P1|Period 2|Adverse Event|1
5405203|NCT02804750|18639521|P2|Period 1|Withdrawal by Subject|1
5405204|NCT02804750|18639522|P1|Period 1|Withdrawal by Subject|0
5405205|NCT02804750|18639521|P2|Period 1|Adverse Event|2
5405206|NCT02804750|18639522|P1|Period 1|Adverse Event|0
5405207|NCT02804399|18639549|P2|Period 2|Adverse Event|1
5405208|NCT02804399|18639550|P1|Period 2|Adverse Event|0
5405209|NCT02803580|18639622|P1|Overall Study|Inclusion in clinical trial|1
5405210|NCT02803580|18639622|P1|Overall Study|Withdrawal by Subject|3
5405211|NCT02803580|18639622|P1|Overall Study|Lost to Follow-up|19
5405212|NCT02803580|18639622|P1|Overall Study|Death|13
5405213|NCT02803138|18639661|P1|Overall Study|Other, not specified|28
5405214|NCT02803138|18639661|P1|Overall Study|Death|1
5405215|NCT02803138|18639661|P1|Overall Study|Withdrawn consent|1
5405216|NCT02803138|18639661|P1|Overall Study|Insufficient virological response|2
5405217|NCT02803138|18639661|P1|Overall Study|Failure to return|38
5405218|NCT02802878|18639677|P2|Overall Study|Protocol Violation|0
5405219|NCT02802878|18639678|P1|Overall Study|Protocol Violation|1
5405220|NCT02802878|18639677|P2|Overall Study|Withdrawal by Subject|3
5405221|NCT02802878|18639678|P1|Overall Study|Withdrawal by Subject|3
5405222|NCT02802865|18639694|P2|Overall Study|Ineliegible due to tuberculosis|1
5405223|NCT02802865|18639695|P1|Overall Study|Ineliegible due to tuberculosis|0
5405224|NCT02802865|18639694|P2|Overall Study|Pregnancy|1
5405225|NCT02802865|18639695|P1|Overall Study|Pregnancy|1
5405226|NCT02802592|18639717|P1|Overall Study|Study terminated due to loss of funding|4
5405227|NCT02802345|18639894|P2|Overall Study|Other than listed|5
5405228|NCT02802345|18639895|P1|Overall Study|Other than listed|1
5405229|NCT02802345|18639894|P2|Overall Study|Protocol Violation|1
5405230|NCT02802345|18639895|P1|Overall Study|Protocol Violation|0
5405231|NCT02802345|18639894|P2|Overall Study|Withdrawal by Subject|3
5405232|NCT02802345|18639895|P1|Overall Study|Withdrawal by Subject|3
5405233|NCT02802345|18639894|P2|Overall Study|Adverse Event|20
5405234|NCT02802345|18639895|P1|Overall Study|Adverse Event|28
5405235|NCT02802345|18639894|P2|Overall Study|Not Treated|1
5405236|NCT02802345|18639895|P1|Overall Study|Not Treated|0
5405237|NCT02802319|18639911|P2|Overall Study|Lost to Follow-up|4
5405238|NCT02802319|18639912|P1|Overall Study|Lost to Follow-up|0
5405239|NCT02802319|18639911|P2|Overall Study|Physician Decision|1
5405240|NCT02802319|18639912|P1|Overall Study|Physician Decision|2
5405241|NCT02801877|18640075|P4|Overall Study|Never Started Treatment|0
5405242|NCT02801877|18640076|P3|Overall Study|Never Started Treatment|4
5405243|NCT02801877|18640077|P2|Overall Study|Never Started Treatment|0
5405244|NCT02801877|18640078|P1|Overall Study|Never Started Treatment|2
5405245|NCT02801877|18640075|P4|Overall Study|Lost to Follow-up|0
5405246|NCT02801877|18640076|P3|Overall Study|Lost to Follow-up|2
5405247|NCT02801877|18640077|P2|Overall Study|Lost to Follow-up|1
5405248|NCT02801877|18640078|P1|Overall Study|Lost to Follow-up|1
5405249|NCT02801669|18640098|P2|Overall Study|Other|6
5405250|NCT02801669|18640099|P1|Overall Study|Other|4
5405251|NCT02801669|18640098|P2|Overall Study|Withdrawal by Subject|77
5405252|NCT02801669|18640099|P1|Overall Study|Withdrawal by Subject|81
5405253|NCT02801669|18640098|P2|Overall Study|Death|69
5405254|NCT02801669|18640099|P1|Overall Study|Death|66
5405255|NCT02801617|18640126|P2|Overall Study|Protocol Violation|6
5405256|NCT02801617|18640127|P1|Overall Study|Protocol Violation|2
5405257|NCT02801578|18640145|P1|Overall Study|Adverse Event|2
5405258|NCT02801396|18640149|P6|Period 1|Withdrawal by Subject|0
5405259|NCT02801396|18640150|P5|Period 1|Withdrawal by Subject|1
5405260|NCT02801396|18640151|P4|Period 1|Withdrawal by Subject|0
5405261|NCT02801396|18640152|P3|Period 1|Withdrawal by Subject|0
5405262|NCT02801396|18640153|P2|Period 1|Withdrawal by Subject|0
5405263|NCT02801396|18640154|P1|Period 1|Withdrawal by Subject|0
5405264|NCT02800928|18640199|P2|Overall Study|Protocol Violation|1
5405265|NCT02800928|18640200|P1|Overall Study|Protocol Violation|1
5405266|NCT02800928|18640199|P2|Overall Study|Withdrawal by Subject|1
5405267|NCT02800928|18640200|P1|Overall Study|Withdrawal by Subject|1
5405268|NCT02800642|18640208|P1|Overall Study|Lost to Follow-up|1
5405269|NCT02800642|18640208|P1|Overall Study|Withdrawal by Subject|3
5405270|NCT02800642|18640208|P1|Overall Study|Adverse Event|6
5405271|NCT02800642|18640208|P1|Overall Study|Physician Decision|2
5405272|NCT02800642|18640208|P1|Overall Study|Other|10
5405273|NCT02800642|18640208|P1|Overall Study|Death|3
5405274|NCT02799784|18640252|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
5405275|NCT02799784|18640253|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
5405276|NCT02799784|18640252|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
5405277|NCT02799784|18640253|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
5405278|NCT02799784|18640252|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
5405279|NCT02799784|18640253|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
5405280|NCT02799784|18640252|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
5405281|NCT02799784|18640253|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
5405282|NCT02799784|18640252|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
5405283|NCT02799784|18640253|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
5405284|NCT02799784|18640252|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
5405285|NCT02799784|18640253|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
5405286|NCT02799472|18640261|P2|Overall Study|Lost to Follow-up|1
5405287|NCT02799472|18640262|P1|Overall Study|Lost to Follow-up|0
5405288|NCT02799472|18640261|P2|Overall Study|Lack of Efficacy|0
5405289|NCT02799472|18640262|P1|Overall Study|Lack of Efficacy|2
5405290|NCT02799472|18640261|P2|Overall Study|Withdrawal by Subject|4
5405291|NCT02799472|18640262|P1|Overall Study|Withdrawal by Subject|2
5405292|NCT02799381|18640322|P2|Overall Study|Participant did not take any study drug|0
5405293|NCT02799381|18640323|P1|Overall Study|Participant did not take any study drug|1
5405294|NCT02799381|18640322|P2|Overall Study|Adverse Event|1
5405295|NCT02799381|18640323|P1|Overall Study|Adverse Event|0
5405296|NCT02799381|18640322|P2|Overall Study|Withdrew consent|2
5405297|NCT02799381|18640323|P1|Overall Study|Withdrew consent|3
5405298|NCT02799082|18640343|P2|Overall Study|Protocol Violation|1
5405299|NCT02799082|18640344|P1|Overall Study|Protocol Violation|0
5405300|NCT02799082|18640343|P2|Overall Study|Refused second PDT or withdraw consent|3
5405301|NCT02799082|18640344|P1|Overall Study|Refused second PDT or withdraw consent|4
5405302|NCT02799069|18640381|P3|Overall Study|Protocol Violation|2
5405303|NCT02799069|18640382|P2|Overall Study|Protocol Violation|0
5405304|NCT02799069|18640383|P1|Overall Study|Protocol Violation|1
5405305|NCT02799069|18640381|P3|Overall Study|Withdrawal by Subject|3
5405306|NCT02799069|18640382|P2|Overall Study|Withdrawal by Subject|4
5405307|NCT02799069|18640383|P1|Overall Study|Withdrawal by Subject|4
5405308|NCT02799069|18640381|P3|Overall Study|Lost to Follow-up|0
5405309|NCT02799069|18640382|P2|Overall Study|Lost to Follow-up|1
5405310|NCT02799069|18640383|P1|Overall Study|Lost to Follow-up|1
5405311|NCT02799069|18640381|P3|Overall Study|Lack of Efficacy|0
5405312|NCT02799069|18640382|P2|Overall Study|Lack of Efficacy|0
5405313|NCT02799069|18640383|P1|Overall Study|Lack of Efficacy|2
5405314|NCT02799069|18640381|P3|Overall Study|Adverse Event|2
5405315|NCT02799069|18640382|P2|Overall Study|Adverse Event|2
5405316|NCT02799069|18640383|P1|Overall Study|Adverse Event|0
5405317|NCT02798861|18640721|P1|Overall Study|Withdrawal by Subject|1
5405318|NCT02798861|18640721|P1|Overall Study|Lost to Follow-up|22
5405319|NCT02798835|18640729|P3|Overall Study|Protocol Violation|3
5405320|NCT02798835|18640730|P2|Overall Study|Protocol Violation|0
5405321|NCT02798835|18640731|P1|Overall Study|Protocol Violation|0
5405322|NCT02798315|18640797|P1|Overall Study|Failure to return|1
5405323|NCT02797678|18640831|P4|Second Intervention (5 Nights)|study/device use non-compliance|0
5405324|NCT02797678|18640832|P3|Second Intervention (5 Nights)|study/device use non-compliance|1
5405325|NCT02797678|18640833|P2|Second Intervention (5 Nights)|study/device use non-compliance|0
5405326|NCT02797678|18640834|P1|Second Intervention (5 Nights)|study/device use non-compliance|0
5405327|NCT02797678|18640831|P4|First Intervention (5 Nights)|study/device use non-compliance|0
5405328|NCT02797678|18640832|P3|First Intervention (5 Nights)|study/device use non-compliance|0
5405329|NCT02797678|18640833|P2|First Intervention (5 Nights)|study/device use non-compliance|1
5405330|NCT02797678|18640834|P1|First Intervention (5 Nights)|study/device use non-compliance|0
5405331|NCT02797678|18640831|P4|Screening Phase|Meeting Inclusion/Exclusion criteria|0
5405332|NCT02797678|18640832|P3|Screening Phase|Meeting Inclusion/Exclusion criteria|0
5405333|NCT02797678|18640833|P2|Screening Phase|Meeting Inclusion/Exclusion criteria|0
5405334|NCT02797678|18640834|P1|Screening Phase|Meeting Inclusion/Exclusion criteria|25
5405335|NCT02797522|18640869|P11|Overall Study|Study Terminated by Sponsor|1
5405336|NCT02797522|18640870|P10|Overall Study|Study Terminated by Sponsor|4
5405337|NCT02797522|18640871|P9|Overall Study|Study Terminated by Sponsor|2
5405338|NCT02797522|18640872|P8|Overall Study|Study Terminated by Sponsor|4
5405339|NCT02797522|18640873|P7|Overall Study|Study Terminated by Sponsor|0
5405340|NCT02797522|18640874|P6|Overall Study|Study Terminated by Sponsor|0
5405341|NCT02797522|18640875|P5|Overall Study|Study Terminated by Sponsor|0
5405342|NCT02797522|18640876|P4|Overall Study|Study Terminated by Sponsor|0
5405343|NCT02797522|18640877|P3|Overall Study|Study Terminated by Sponsor|0
5405344|NCT02797522|18640878|P2|Overall Study|Study Terminated by Sponsor|0
5405345|NCT02797522|18640879|P1|Overall Study|Study Terminated by Sponsor|0
5405346|NCT02797132|18640985|P1|Part B (24 Weeks)|Adverse Event|3
5405347|NCT02797132|18640985|P1|Part A (15 Days)|Adverse Event|1
5405348|NCT02797080|18641037|P1|Overall Study|Withdrawal by Subject|1
5405349|NCT02797080|18641037|P1|Overall Study|Lost to Follow-up|1
5405350|NCT02796963|18641079|P4|Overall Study|Lost to Follow-up|72
5405351|NCT02796963|18641080|P3|Overall Study|Lost to Follow-up|69
5405352|NCT02796963|18641081|P2|Overall Study|Lost to Follow-up|76
5405353|NCT02796963|18641082|P1|Overall Study|Lost to Follow-up|89
5405354|NCT02796677|18641152|P4|Overall Study|Reason not mentioned|5
5405355|NCT02796677|18641153|P3|Overall Study|Reason not mentioned|0
5405356|NCT02796677|18641154|P2|Overall Study|Reason not mentioned|3
5405357|NCT02796677|18641155|P1|Overall Study|Reason not mentioned|2
5405358|NCT02796677|18641152|P4|Overall Study|Progressive disease|18
5405359|NCT02796677|18641153|P3|Overall Study|Progressive disease|13
5405360|NCT02796677|18641154|P2|Overall Study|Progressive disease|15
5405361|NCT02796677|18641155|P1|Overall Study|Progressive disease|6
5405362|NCT02796677|18641152|P4|Overall Study|Withdrawal by Subject|7
5405363|NCT02796677|18641153|P3|Overall Study|Withdrawal by Subject|6
5405364|NCT02796677|18641154|P2|Overall Study|Withdrawal by Subject|14
5405365|NCT02796677|18641155|P1|Overall Study|Withdrawal by Subject|4
5405366|NCT02796677|18641152|P4|Overall Study|Lack of Efficacy|20
5405367|NCT02796677|18641153|P3|Overall Study|Lack of Efficacy|14
5405368|NCT02796677|18641154|P2|Overall Study|Lack of Efficacy|9
5405369|NCT02796677|18641155|P1|Overall Study|Lack of Efficacy|7
5405370|NCT02796677|18641152|P4|Overall Study|Lost to Follow-up|2
5405371|NCT02796677|18641153|P3|Overall Study|Lost to Follow-up|2
5405372|NCT02796677|18641154|P2|Overall Study|Lost to Follow-up|5
5405373|NCT02796677|18641155|P1|Overall Study|Lost to Follow-up|1
5405374|NCT02796677|18641152|P4|Overall Study|Protocol Violation|8
5405375|NCT02796677|18641153|P3|Overall Study|Protocol Violation|4
5405376|NCT02796677|18641154|P2|Overall Study|Protocol Violation|5
5405377|NCT02796677|18641155|P1|Overall Study|Protocol Violation|7
5405378|NCT02796677|18641152|P4|Overall Study|Adverse Event|14
5405379|NCT02796677|18641153|P3|Overall Study|Adverse Event|14
5405380|NCT02796677|18641154|P2|Overall Study|Adverse Event|22
5405381|NCT02796677|18641155|P1|Overall Study|Adverse Event|11
5405382|NCT02796651|18641179|P1|Overall Study|Other|10
5405383|NCT02796651|18641179|P1|Overall Study|Lack of Efficacy|1
5405384|NCT02796651|18641179|P1|Overall Study|Protocol Violation|4
5405385|NCT02796651|18641179|P1|Overall Study|Withdrawal by Subject|4
5405386|NCT02796651|18641179|P1|Overall Study|Lost to Follow-up|1
5405387|NCT02796651|18641179|P1|Overall Study|Adverse Event|6
5405388|NCT02796560|18641210|P2|Overall Study|Withdrawal by Subject|2
5405389|NCT02796560|18641211|P1|Overall Study|Withdrawal by Subject|2
5405390|NCT02796560|18641210|P2|Overall Study|Adverse Event|0
5405391|NCT02796560|18641211|P1|Overall Study|Adverse Event|2
5405392|NCT02795832|18641286|P6|Overall Study|Adverse Event|3
5405393|NCT02795832|18641287|P5|Overall Study|Adverse Event|0
5405394|NCT02795832|18641288|P4|Overall Study|Adverse Event|0
5405395|NCT02795832|18641289|P3|Overall Study|Adverse Event|0
5405396|NCT02795832|18641290|P2|Overall Study|Adverse Event|0
5405397|NCT02795832|18641291|P1|Overall Study|Adverse Event|0
5405398|NCT02795767|18641369|P3|Overall Study|Lack of Efficacy|1
5405399|NCT02795767|18641370|P2|Overall Study|Lack of Efficacy|0
5405400|NCT02795767|18641371|P1|Overall Study|Lack of Efficacy|0
5405401|NCT02795767|18641369|P3|Overall Study|Ongoing Study Treatment|9
5405402|NCT02795767|18641370|P2|Overall Study|Ongoing Study Treatment|10
5405403|NCT02795767|18641371|P1|Overall Study|Ongoing Study Treatment|66
5405404|NCT02795767|18641369|P3|Overall Study|Received Commercial Emicizumab|0
5405405|NCT02795767|18641370|P2|Overall Study|Received Commercial Emicizumab|0
5405406|NCT02795767|18641371|P1|Overall Study|Received Commercial Emicizumab|2
5405407|NCT02794974|18641492|P2|Overall Study|Physician Decision|1
5405408|NCT02794974|18641493|P1|Overall Study|Physician Decision|0
5405409|NCT02794870|18641509|P2|Overall Study|Withdrawal by Subject|0
5405410|NCT02794870|18641510|P1|Overall Study|Withdrawal by Subject|2
5405411|NCT02794480|18641607|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
5405412|NCT02794480|18641608|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5405413|NCT02794480|18641609|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5405414|NCT02794480|18641610|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
5405415|NCT02794480|18641607|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5405416|NCT02794480|18641608|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5405417|NCT02794480|18641609|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
5405418|NCT02794480|18641610|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5405419|NCT02794480|18641607|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
5405420|NCT02794480|18641608|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
5405421|NCT02794480|18641609|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
5405422|NCT02794480|18641610|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
5405423|NCT02794480|18641607|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
5405424|NCT02794480|18641608|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
5405425|NCT02794480|18641609|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
5405426|NCT02794480|18641610|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
5405427|NCT02794480|18641607|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
5405428|NCT02794480|18641608|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
5405429|NCT02794480|18641609|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
5405430|NCT02794480|18641610|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
5405431|NCT02794246|18641653|P1|Overall Study|Physician Decision|4
5405432|NCT02794246|18641653|P1|Overall Study|Withdrawal by Subject|2
5405433|NCT02794103|18641665|P1|Overall Study|Loss to follow up due to high sedation|3
5405434|NCT02793947|18641676|P2|Overall Study|Physician Decision|5
5405435|NCT02793947|18641677|P1|Overall Study|Physician Decision|1
5405436|NCT02793947|18641676|P2|Overall Study|Death|0
5405437|NCT02793947|18641677|P1|Overall Study|Death|1
5405438|NCT02793232|18641781|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5405439|NCT02793232|18641782|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5405440|NCT02793232|18641783|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
5405441|NCT02793232|18641784|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5405442|NCT02793232|18641785|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
5405443|NCT02793232|18641786|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5405444|NCT02793232|18641787|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5405445|NCT02793232|18641788|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5405446|NCT02793232|18641789|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
5405447|NCT02793128|18642042|P1|Overall Study|Patient elected nephroureterectomy|1
5405448|NCT02793128|18642042|P1|Overall Study|Comorbid conditions and noncompliance|1
5405449|NCT02793128|18642042|P1|Overall Study|Physician Decision|1
5405450|NCT02793128|18642042|P1|Overall Study|Withdrawal by Subject|2
5405451|NCT02793128|18642042|P1|Overall Study|Death|4
5405452|NCT02792829|18642064|P8|Treatment Period 2|Use of proscribed medications|1
5405453|NCT02792829|18642065|P7|Treatment Period 2|Use of proscribed medications|0
5405454|NCT02792829|18642066|P6|Treatment Period 2|Use of proscribed medications|0
5405455|NCT02792829|18642067|P5|Treatment Period 2|Use of proscribed medications|0
5405456|NCT02792829|18642068|P4|Treatment Period 2|Use of proscribed medications|0
5405457|NCT02792829|18642069|P3|Treatment Period 2|Use of proscribed medications|0
5405458|NCT02792829|18642070|P2|Treatment Period 2|Use of proscribed medications|0
5405459|NCT02792829|18642071|P1|Treatment Period 2|Use of proscribed medications|0
5405460|NCT02792829|18642064|P8|Treatment Period 2|Adverse Event|1
5405461|NCT02792829|18642065|P7|Treatment Period 2|Adverse Event|1
5405462|NCT02792829|18642066|P6|Treatment Period 2|Adverse Event|0
5405463|NCT02792829|18642067|P5|Treatment Period 2|Adverse Event|1
5405464|NCT02792829|18642068|P4|Treatment Period 2|Adverse Event|0
5405465|NCT02792829|18642069|P3|Treatment Period 2|Adverse Event|0
5405466|NCT02792829|18642070|P2|Treatment Period 2|Adverse Event|0
5405467|NCT02792829|18642071|P1|Treatment Period 2|Adverse Event|0
5405468|NCT02792829|18642064|P8|Treatment Period 2|Non compliance with alcohol prohibition|0
5405469|NCT02792829|18642065|P7|Treatment Period 2|Non compliance with alcohol prohibition|0
5405470|NCT02792829|18642066|P6|Treatment Period 2|Non compliance with alcohol prohibition|0
5405471|NCT02792829|18642067|P5|Treatment Period 2|Non compliance with alcohol prohibition|0
5405472|NCT02792829|18642068|P4|Treatment Period 2|Non compliance with alcohol prohibition|0
5405473|NCT02792829|18642069|P3|Treatment Period 2|Non compliance with alcohol prohibition|0
5405474|NCT02792829|18642070|P2|Treatment Period 2|Non compliance with alcohol prohibition|1
5405475|NCT02792829|18642071|P1|Treatment Period 2|Non compliance with alcohol prohibition|0
5405476|NCT02792777|18642179|P2|Overall Study|Participant interviewed twice|0
5405477|NCT02792777|18642180|P1|Overall Study|Participant interviewed twice|1
5405478|NCT02792777|18642179|P2|Overall Study|Later determined to be ineligible|0
5405479|NCT02792777|18642180|P1|Overall Study|Later determined to be ineligible|2
5405480|NCT02792777|18642179|P2|Overall Study|Recording malfunction|0
5405481|NCT02792777|18642180|P1|Overall Study|Recording malfunction|2
5405482|NCT02792777|18642179|P2|Overall Study|Withdrawal by Subject|0
5405483|NCT02792777|18642180|P1|Overall Study|Withdrawal by Subject|2
5405484|NCT02792699|18642196|P3|Overall Study|Other|0
5405485|NCT02792699|18642197|P2|Overall Study|Other|0
5405486|NCT02792699|18642198|P1|Overall Study|Other|1
5405487|NCT02792699|18642196|P3|Overall Study|Dissatisfaction with Treatment Efficacy|1
5405488|NCT02792699|18642197|P2|Overall Study|Dissatisfaction with Treatment Efficacy|3
5405489|NCT02792699|18642198|P1|Overall Study|Dissatisfaction with Treatment Efficacy|1
5405490|NCT02792699|18642196|P3|Overall Study|Physician Decision|0
5405491|NCT02792699|18642197|P2|Overall Study|Physician Decision|0
5405492|NCT02792699|18642198|P1|Overall Study|Physician Decision|2
5405493|NCT02792699|18642196|P3|Overall Study|Lost to Follow-up|2
5405494|NCT02792699|18642197|P2|Overall Study|Lost to Follow-up|1
5405495|NCT02792699|18642198|P1|Overall Study|Lost to Follow-up|0
5405496|NCT02792699|18642196|P3|Overall Study|Withdrawal by Subject|3
5405497|NCT02792699|18642197|P2|Overall Study|Withdrawal by Subject|4
5405498|NCT02792699|18642198|P1|Overall Study|Withdrawal by Subject|4
5405499|NCT02792699|18642196|P3|Overall Study|Adverse Event|4
5405500|NCT02792699|18642197|P2|Overall Study|Adverse Event|2
5405501|NCT02792699|18642198|P1|Overall Study|Adverse Event|1
5405502|NCT02792517|18642279|P1|Overall Study|Lost to Follow-up|3
5405503|NCT02792517|18642279|P1|Overall Study|Decision by Sponsor|7
5405504|NCT02792517|18642279|P1|Overall Study|Withdrawal by Subject|10
5405505|NCT02792231|18642295|P2|Overall Study|Ongoing at interim data cutoff|1
5405506|NCT02792231|18642296|P1|Overall Study|Ongoing at interim data cutoff|1
5405507|NCT02792231|18642295|P2|Overall Study|Technical problems|1
5405508|NCT02792231|18642296|P1|Overall Study|Technical problems|0
5405509|NCT02792231|18642295|P2|Overall Study|Protocol deviation|0
5405510|NCT02792231|18642296|P1|Overall Study|Protocol deviation|2
5405511|NCT02792231|18642295|P2|Overall Study|Non-compliance with study treatment|1
5405597|NCT02790073|18642749|P1|Overall Study|Death|1
5405512|NCT02792231|18642296|P1|Overall Study|Non-compliance with study treatment|2
5405513|NCT02792231|18642295|P2|Overall Study|Pregnancy|3
5405514|NCT02792231|18642296|P1|Overall Study|Pregnancy|1
5405515|NCT02792231|18642295|P2|Overall Study|Lost to Follow-up|5
5405516|NCT02792231|18642296|P1|Overall Study|Lost to Follow-up|9
5405517|NCT02792231|18642295|P2|Overall Study|Lack of Efficacy|9
5405518|NCT02792231|18642296|P1|Overall Study|Lack of Efficacy|7
5405519|NCT02792231|18642295|P2|Overall Study|Physician Decision|11
5405520|NCT02792231|18642296|P1|Overall Study|Physician Decision|14
5405521|NCT02792231|18642295|P2|Overall Study|Adverse Event|13
5405522|NCT02792231|18642296|P1|Overall Study|Adverse Event|16
5405523|NCT02792231|18642295|P2|Overall Study|Patient/guardian decision|41
5405524|NCT02792231|18642296|P1|Overall Study|Patient/guardian decision|32
5405525|NCT02792218|18642318|P2|Overall Study|Ongoing at interim cutoff|5
5405526|NCT02792218|18642319|P1|Overall Study|Ongoing at interim cutoff|1
5405527|NCT02792218|18642318|P2|Overall Study|Pregnancy|0
5405528|NCT02792218|18642319|P1|Overall Study|Pregnancy|1
5405529|NCT02792218|18642318|P2|Overall Study|Non-compliance with study treatment|1
5405530|NCT02792218|18642319|P1|Overall Study|Non-compliance with study treatment|0
5405531|NCT02792218|18642318|P2|Overall Study|New therapy for study indication|1
5405532|NCT02792218|18642319|P1|Overall Study|New therapy for study indication|0
5405533|NCT02792218|18642318|P2|Overall Study|Protocol deviation|2
5405534|NCT02792218|18642319|P1|Overall Study|Protocol deviation|3
5405535|NCT02792218|18642318|P2|Overall Study|Physician Decision|4
5405536|NCT02792218|18642319|P1|Overall Study|Physician Decision|3
5405537|NCT02792218|18642318|P2|Overall Study|Lack of Efficacy|12
5405538|NCT02792218|18642319|P1|Overall Study|Lack of Efficacy|1
5405539|NCT02792218|18642318|P2|Overall Study|Lost to Follow-up|5
5405540|NCT02792218|18642319|P1|Overall Study|Lost to Follow-up|10
5405541|NCT02792218|18642318|P2|Overall Study|Adverse Event|14
5405542|NCT02792218|18642319|P1|Overall Study|Adverse Event|14
5405543|NCT02792218|18642318|P2|Overall Study|Patient/guardian decision|42
5405544|NCT02792218|18642319|P1|Overall Study|Patient/guardian decision|16
5405545|NCT02792062|18642345|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5405546|NCT02792062|18642346|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5405547|NCT02792062|18642347|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5405548|NCT02792062|18642348|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5405549|NCT02792062|18642349|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
5405550|NCT02792062|18642350|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
5405551|NCT02791763|18642432|P3|Overall Study|Adverse Event|7
5405552|NCT02791763|18642433|P2|Overall Study|Adverse Event|13
5405553|NCT02791763|18642434|P1|Overall Study|Adverse Event|12
5405554|NCT02791763|18642432|P3|Overall Study|Met hemoglobin stopping criteria|0
5405555|NCT02791763|18642433|P2|Overall Study|Met hemoglobin stopping criteria|0
5405556|NCT02791763|18642434|P1|Overall Study|Met hemoglobin stopping criteria|1
5405557|NCT02791763|18642432|P3|Overall Study|Participant had renal transplant|0
5405558|NCT02791763|18642433|P2|Overall Study|Participant had renal transplant|0
5405559|NCT02791763|18642434|P1|Overall Study|Participant had renal transplant|3
5405560|NCT02791763|18642432|P3|Overall Study|Cancer event|0
5405561|NCT02791763|18642433|P2|Overall Study|Cancer event|3
5405562|NCT02791763|18642434|P1|Overall Study|Cancer event|1
5405563|NCT02791763|18642432|P3|Overall Study|Needs maintenance/changes in dialysis|5
5405564|NCT02791763|18642433|P2|Overall Study|Needs maintenance/changes in dialysis|19
5405565|NCT02791763|18642434|P1|Overall Study|Needs maintenance/changes in dialysis|16
5405566|NCT02791763|18642432|P3|Overall Study|Physician Decision|0
5405567|NCT02791763|18642433|P2|Overall Study|Physician Decision|1
5405568|NCT02791763|18642434|P1|Overall Study|Physician Decision|0
5405569|NCT02791763|18642432|P3|Overall Study|Withdrawal by Subject|0
5405570|NCT02791763|18642433|P2|Overall Study|Withdrawal by Subject|1
5405571|NCT02791763|18642434|P1|Overall Study|Withdrawal by Subject|5
5405572|NCT02791763|18642432|P3|Overall Study|Protocol Violation|1
5405573|NCT02791763|18642433|P2|Overall Study|Protocol Violation|0
5405574|NCT02791763|18642434|P1|Overall Study|Protocol Violation|0
5405575|NCT02791659|18642553|P2|Overall Study|Protocol Violation|1
5405576|NCT02791659|18642554|P1|Overall Study|Protocol Violation|0
5405577|NCT02791516|18642562|P2|Overall Study|Withdrawal by Subject|1
5405578|NCT02791516|18642563|P1|Overall Study|Withdrawal by Subject|1
5405579|NCT02791490|18642575|P2|Overall Study|Withdrawal by Subject|6
5405580|NCT02791490|18642576|P1|Overall Study|Withdrawal by Subject|2
5405581|NCT02791490|18642575|P2|Overall Study|Lost to Follow-up|2
5405582|NCT02791490|18642576|P1|Overall Study|Lost to Follow-up|1
5405583|NCT02791438|18642596|P2|Treatment Period|Withdrawal by Parent/Guardian|0
5405584|NCT02791438|18642597|P1|Treatment Period|Withdrawal by Parent/Guardian|2
5405585|NCT02791438|18642596|P2|Treatment Period|Withdrawal by Subject|1
5405586|NCT02791438|18642597|P1|Treatment Period|Withdrawal by Subject|0
5405587|NCT02791438|18642596|P2|Treatment Period|Adverse Event|0
5405588|NCT02791438|18642597|P1|Treatment Period|Adverse Event|1
5405589|NCT02791269|18642638|P2|Overall Study|Lost to Follow-up|1
5405590|NCT02791269|18642639|P1|Overall Study|Lost to Follow-up|0
5405591|NCT02790606|18642717|P1|Overall Study|Withdrawal by Subject|1
5405592|NCT02790606|18642717|P1|Overall Study|Physician Decision|3
5405593|NCT02790606|18642717|P1|Overall Study|Lost to Follow-up|4
5405594|NCT02790606|18642717|P1|Overall Study|Death|27
5405595|NCT02790073|18642749|P1|Overall Study|Withdrawal by Subject|1
5405596|NCT02790073|18642749|P1|Overall Study|Withdrawal from HD|1
5405598|NCT02789176|18642772|P4|Overall Study|Lost to Follow-up|1
5405599|NCT02789176|18642773|P3|Overall Study|Lost to Follow-up|6
5405600|NCT02789176|18642774|P2|Overall Study|Lost to Follow-up|2
5405601|NCT02789176|18642775|P1|Overall Study|Lost to Follow-up|8
5405602|NCT02789176|18642772|P4|Overall Study|Withdrawal by Subject|0
5405603|NCT02789176|18642773|P3|Overall Study|Withdrawal by Subject|1
5405604|NCT02789176|18642774|P2|Overall Study|Withdrawal by Subject|0
5405605|NCT02789176|18642775|P1|Overall Study|Withdrawal by Subject|0
5405606|NCT02789176|18642772|P4|Overall Study|Death|0
5405607|NCT02789176|18642773|P3|Overall Study|Death|3
5405608|NCT02789176|18642774|P2|Overall Study|Death|0
5405609|NCT02789176|18642775|P1|Overall Study|Death|0
5405610|NCT02789111|18642799|P2|Overall Study|Withdrawal by Subject|4
5405611|NCT02789111|18642800|P1|Overall Study|Withdrawal by Subject|1
5405612|NCT02788747|18642811|P3|Overall Study|Adverse Event|0
5405613|NCT02788747|18642812|P2|Overall Study|Adverse Event|0
5405614|NCT02788747|18642813|P1|Overall Study|Adverse Event|1
5405615|NCT02788656|18642883|P2|Overall Study|Withdrawal by Subject|0
5405616|NCT02788656|18642884|P1|Overall Study|Withdrawal by Subject|1
5405617|NCT02788513|18642909|P5|Overall Study|Decision by the study team|1
5405618|NCT02788513|18642910|P4|Overall Study|Decision by the study team|0
5405619|NCT02788513|18642911|P3|Overall Study|Decision by the study team|0
5405620|NCT02788513|18642912|P2|Overall Study|Decision by the study team|0
5405621|NCT02788513|18642913|P1|Overall Study|Decision by the study team|0
5405622|NCT02788513|18642909|P5|Overall Study|Subject decided to stop taking treatment|0
5405623|NCT02788513|18642910|P4|Overall Study|Subject decided to stop taking treatment|0
5405624|NCT02788513|18642911|P3|Overall Study|Subject decided to stop taking treatment|1
5405625|NCT02788513|18642912|P2|Overall Study|Subject decided to stop taking treatment|0
5405626|NCT02788513|18642913|P1|Overall Study|Subject decided to stop taking treatment|0
5405627|NCT02788513|18642909|P5|Overall Study|Protocol Violation|0
5405628|NCT02788513|18642910|P4|Overall Study|Protocol Violation|1
5405629|NCT02788513|18642911|P3|Overall Study|Protocol Violation|1
5405630|NCT02788513|18642912|P2|Overall Study|Protocol Violation|0
5405631|NCT02788513|18642913|P1|Overall Study|Protocol Violation|0
5405632|NCT02788513|18642909|P5|Overall Study|Adverse Event|2
5405633|NCT02788513|18642910|P4|Overall Study|Adverse Event|2
5405634|NCT02788513|18642911|P3|Overall Study|Adverse Event|4
5405635|NCT02788513|18642912|P2|Overall Study|Adverse Event|8
5405636|NCT02788513|18642913|P1|Overall Study|Adverse Event|5
5405637|NCT02788513|18642909|P5|Overall Study|Lost to Follow-up|1
5405638|NCT02788513|18642910|P4|Overall Study|Lost to Follow-up|0
5405639|NCT02788513|18642911|P3|Overall Study|Lost to Follow-up|0
5405640|NCT02788513|18642912|P2|Overall Study|Lost to Follow-up|0
5405641|NCT02788513|18642913|P1|Overall Study|Lost to Follow-up|1
5405642|NCT02788513|18642909|P5|Overall Study|Withdrawal by Subject|1
5405643|NCT02788513|18642910|P4|Overall Study|Withdrawal by Subject|3
5405644|NCT02788513|18642911|P3|Overall Study|Withdrawal by Subject|2
5405645|NCT02788513|18642912|P2|Overall Study|Withdrawal by Subject|0
5405646|NCT02788513|18642913|P1|Overall Study|Withdrawal by Subject|3
5405647|NCT02788474|18642937|P2|Open Label Treatment Period|Non-compliance|0
5405648|NCT02788474|18642938|P1|Open Label Treatment Period|Non-compliance|1
5405649|NCT02788474|18642937|P2|Open Label Treatment Period|Patient's refusal|3
5405650|NCT02788474|18642938|P1|Open Label Treatment Period|Patient's refusal|1
5405651|NCT02788474|18642937|P2|Open Label Treatment Period|Other than reason specified|0
5405652|NCT02788474|18642938|P1|Open Label Treatment Period|Other than reason specified|1
5405653|NCT02788474|18642937|P2|Open Label Treatment Period|Adverse Event|9
5405654|NCT02788474|18642938|P1|Open Label Treatment Period|Adverse Event|29
5405655|NCT02788474|18642937|P2|Double Blind Treatment Period|Adverse Event|4
5405656|NCT02788474|18642938|P1|Double Blind Treatment Period|Adverse Event|6
5405657|NCT02788474|18642937|P2|Double Blind Treatment Period|Patient's refusal|0
5405658|NCT02788474|18642938|P1|Double Blind Treatment Period|Patient's refusal|3
5405659|NCT02788474|18642937|P2|Double Blind Treatment Period|Not treated|0
5405660|NCT02788474|18642938|P1|Double Blind Treatment Period|Not treated|1
5405661|NCT02788357|18642953|P2|Overall Study|Lost to Follow-up|0
5405662|NCT02788357|18642954|P1|Overall Study|Lost to Follow-up|3
5405663|NCT02788279|18642969|P3|Overall Study|Sponsor decision|11
5405664|NCT02788279|18642970|P2|Overall Study|Sponsor decision|29
5405665|NCT02788279|18642971|P1|Overall Study|Sponsor decision|18
5405666|NCT02788279|18642969|P3|Overall Study|Lost to Follow-up|2
5405667|NCT02788279|18642970|P2|Overall Study|Lost to Follow-up|3
5405668|NCT02788279|18642971|P1|Overall Study|Lost to Follow-up|0
5405669|NCT02788279|18642969|P3|Overall Study|Withdrawal by Subject|5
5405670|NCT02788279|18642970|P2|Overall Study|Withdrawal by Subject|15
5405671|NCT02788279|18642971|P1|Overall Study|Withdrawal by Subject|10
5405672|NCT02788279|18642969|P3|Overall Study|Death|72
5405673|NCT02788279|18642970|P2|Overall Study|Death|136
5405674|NCT02788279|18642971|P1|Overall Study|Death|62
5405675|NCT02788201|18643008|P6|Overall Study|Withdrawal by Subject|1
5405676|NCT02788201|18643009|P5|Overall Study|Withdrawal by Subject|0
5405677|NCT02788201|18643010|P4|Overall Study|Withdrawal by Subject|0
5405678|NCT02788201|18643011|P3|Overall Study|Withdrawal by Subject|0
5405679|NCT02788201|18643012|P2|Overall Study|Withdrawal by Subject|0
5405680|NCT02788201|18643013|P1|Overall Study|Withdrawal by Subject|0
5405681|NCT02788201|18643008|P6|Overall Study|Ineligible|1
5405682|NCT02788201|18643009|P5|Overall Study|Ineligible|0
5405683|NCT02788201|18643010|P4|Overall Study|Ineligible|0
5405684|NCT02788201|18643011|P3|Overall Study|Ineligible|0
5405685|NCT02788201|18643012|P2|Overall Study|Ineligible|0
5405686|NCT02788201|18643013|P1|Overall Study|Ineligible|0
5405687|NCT02788201|18643008|P6|Overall Study|Death|1
5405688|NCT02788201|18643009|P5|Overall Study|Death|0
5405689|NCT02788201|18643010|P4|Overall Study|Death|1
5405690|NCT02788201|18643011|P3|Overall Study|Death|1
5405691|NCT02788201|18643012|P2|Overall Study|Death|1
5405692|NCT02788201|18643013|P1|Overall Study|Death|1
5405693|NCT02788175|18643066|P1|Overall Study|Ineligible prior to study agent|6
5405694|NCT02788175|18643066|P1|Overall Study|Withdrawal by Subject|4
5405695|NCT02788175|18643066|P1|Overall Study|Protocol Violation|3
5405696|NCT02787863|18643088|P8|Overall Study|Withdrawal by Subject|0
5405697|NCT02787863|18643089|P7|Overall Study|Withdrawal by Subject|0
5405698|NCT02787863|18643090|P6|Overall Study|Withdrawal by Subject|0
5405699|NCT02787863|18643091|P5|Overall Study|Withdrawal by Subject|0
5405700|NCT02787863|18643092|P4|Overall Study|Withdrawal by Subject|0
5405701|NCT02787863|18643093|P3|Overall Study|Withdrawal by Subject|1
5405702|NCT02787863|18643094|P2|Overall Study|Withdrawal by Subject|1
5405703|NCT02787863|18643095|P1|Overall Study|Withdrawal by Subject|0
5405704|NCT02787863|18643088|P8|Overall Study|Death|0
5405705|NCT02787863|18643089|P7|Overall Study|Death|0
5405706|NCT02787863|18643090|P6|Overall Study|Death|0
5405707|NCT02787863|18643091|P5|Overall Study|Death|0
5405708|NCT02787863|18643092|P4|Overall Study|Death|0
5405709|NCT02787863|18643093|P3|Overall Study|Death|1
5405710|NCT02787863|18643094|P2|Overall Study|Death|0
5405711|NCT02787863|18643095|P1|Overall Study|Death|1
5405712|NCT02787551|18643193|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
5405713|NCT02787551|18643194|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
5405714|NCT02787551|18643193|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
5405715|NCT02787551|18643194|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
5405716|NCT02787551|18643193|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
5405717|NCT02787551|18643194|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
5405718|NCT02787551|18643193|P2|Core Period: 26 Weeks|Other than specified|1
5405719|NCT02787551|18643194|P1|Core Period: 26 Weeks|Other than specified|3
5405720|NCT02787551|18643193|P2|Core Period: 26 Weeks|Randomized but not treated|1
5405721|NCT02787551|18643194|P1|Core Period: 26 Weeks|Randomized but not treated|2
5405722|NCT02787551|18643193|P2|Core Period: 26 Weeks|Withdrawal by Subject|9
5405723|NCT02787551|18643194|P1|Core Period: 26 Weeks|Withdrawal by Subject|9
5405724|NCT02787551|18643193|P2|Core Period: 26 Weeks|Poor compliance to protocol|0
5405725|NCT02787551|18643194|P1|Core Period: 26 Weeks|Poor compliance to protocol|2
5405726|NCT02787551|18643193|P2|Core Period: 26 Weeks|Lack of Efficacy|0
5405727|NCT02787551|18643194|P1|Core Period: 26 Weeks|Lack of Efficacy|1
5405728|NCT02787551|18643193|P2|Core Period: 26 Weeks|Adverse Event|0
5405729|NCT02787551|18643194|P1|Core Period: 26 Weeks|Adverse Event|10
5405730|NCT02787304|18643230|P4|Overall Study|Study terminated by sponsor|32
5405731|NCT02787304|18643231|P3|Overall Study|Study terminated by sponsor|31
5405732|NCT02787304|18643232|P2|Overall Study|Study terminated by sponsor|31
5405733|NCT02787304|18643233|P1|Overall Study|Study terminated by sponsor|25
5405734|NCT02787304|18643230|P4|Overall Study|Physician Decision|0
5405735|NCT02787304|18643231|P3|Overall Study|Physician Decision|1
5405736|NCT02787304|18643232|P2|Overall Study|Physician Decision|0
5405737|NCT02787304|18643233|P1|Overall Study|Physician Decision|0
5405738|NCT02787304|18643230|P4|Overall Study|Noncompliance with study drug|0
5405739|NCT02787304|18643231|P3|Overall Study|Noncompliance with study drug|1
5405740|NCT02787304|18643232|P2|Overall Study|Noncompliance with study drug|0
5405741|NCT02787304|18643233|P1|Overall Study|Noncompliance with study drug|0
5405742|NCT02787304|18643230|P4|Overall Study|Lost to Follow-up|1
5405743|NCT02787304|18643231|P3|Overall Study|Lost to Follow-up|0
5405744|NCT02787304|18643232|P2|Overall Study|Lost to Follow-up|0
5405745|NCT02787304|18643233|P1|Overall Study|Lost to Follow-up|1
5405746|NCT02787304|18643230|P4|Overall Study|Withdrawal by Subject|0
5405747|NCT02787304|18643231|P3|Overall Study|Withdrawal by Subject|0
5405748|NCT02787304|18643232|P2|Overall Study|Withdrawal by Subject|4
5405749|NCT02787304|18643233|P1|Overall Study|Withdrawal by Subject|1
5405750|NCT02787304|18643230|P4|Overall Study|Adverse Event|1
5405751|NCT02787304|18643231|P3|Overall Study|Adverse Event|8
5405752|NCT02787304|18643232|P2|Overall Study|Adverse Event|3
5405753|NCT02787304|18643233|P1|Overall Study|Adverse Event|9
5405754|NCT02787083|18643287|P2|Overall Study|Withdrawal by Subject|2
5405755|NCT02787083|18643288|P1|Overall Study|Withdrawal by Subject|2
5405756|NCT02787083|18643287|P2|Overall Study|Adverse Event|0
5405757|NCT02787083|18643288|P1|Overall Study|Adverse Event|1
5405758|NCT02786953|18643313|P2|Overall Study|Physician Decision|1
5405759|NCT02786953|18643314|P1|Overall Study|Physician Decision|0
5405760|NCT02786953|18643313|P2|Overall Study|Withdrawal by Subject|0
5405761|NCT02786953|18643314|P1|Overall Study|Withdrawal by Subject|3
5405762|NCT02786927|18643336|P1|Overall Study|Protocol Violation|4
5405763|NCT02786927|18643336|P1|Overall Study|Adverse Event|1
5405764|NCT02786901|18643346|P3|Overall Study|Randomized in error|1
5405765|NCT02786901|18643347|P2|Overall Study|Randomized in error|0
5405766|NCT02786901|18643348|P1|Overall Study|Randomized in error|2
5405767|NCT02786901|18643346|P3|Overall Study|Disallowed medication|0
5405768|NCT02786901|18643347|P2|Overall Study|Disallowed medication|1
5405769|NCT02786901|18643348|P1|Overall Study|Disallowed medication|1
5405770|NCT02786901|18643346|P3|Overall Study|Subject Request/Lost to Follow up|5
5405771|NCT02786901|18643347|P2|Overall Study|Subject Request/Lost to Follow up|5
5405772|NCT02786901|18643348|P1|Overall Study|Subject Request/Lost to Follow up|1
5405773|NCT02786901|18643346|P3|Overall Study|Rescue Therapy Use|33
5405774|NCT02786901|18643347|P2|Overall Study|Rescue Therapy Use|49
5405775|NCT02786901|18643348|P1|Overall Study|Rescue Therapy Use|71
5405776|NCT02786901|18643346|P3|Overall Study|Physician Decision|0
5405777|NCT02786901|18643347|P2|Overall Study|Physician Decision|0
5405778|NCT02786901|18643348|P1|Overall Study|Physician Decision|1
5405779|NCT02786901|18643346|P3|Overall Study|Adverse Event|2
5405780|NCT02786901|18643347|P2|Overall Study|Adverse Event|1
5405781|NCT02786901|18643348|P1|Overall Study|Adverse Event|1
5405782|NCT02786836|18643377|P1|Overall Study|Device or Pharmacy Issues|3
5405783|NCT02786836|18643377|P1|Overall Study|Liver Transplantation|2
5405784|NCT02786836|18643377|P1|Overall Study|Withdrawal by Subject|3
5405785|NCT02786836|18643377|P1|Overall Study|Protocol Violation|3
5405786|NCT02786836|18643377|P1|Overall Study|Lack of Efficacy|2
5405787|NCT02786836|18643377|P1|Overall Study|Death|1
5405788|NCT02786537|18643409|P6|As Treated|Advised to stop tx after loss of meds|0
5405789|NCT02786537|18643410|P5|As Treated|Advised to stop tx after loss of meds|0
5405790|NCT02786537|18643411|P4|As Treated|Advised to stop tx after loss of meds|0
5405791|NCT02786537|18643412|P3|As Treated|Advised to stop tx after loss of meds|0
5405792|NCT02786537|18643413|P2|As Treated|Advised to stop tx after loss of meds|1
5405793|NCT02786537|18643414|P1|As Treated|Advised to stop tx after loss of meds|0
5405794|NCT02786537|18643409|P6|As Treated|Drugs stolen from patient|0
5405795|NCT02786537|18643410|P5|As Treated|Drugs stolen from patient|0
5405796|NCT02786537|18643411|P4|As Treated|Drugs stolen from patient|0
5405797|NCT02786537|18643412|P3|As Treated|Drugs stolen from patient|0
5405798|NCT02786537|18643413|P2|As Treated|Drugs stolen from patient|1
5405799|NCT02786537|18643414|P1|As Treated|Drugs stolen from patient|0
5405800|NCT02786537|18643409|P6|As Treated|Opiate dependency relapse|0
5405801|NCT02786537|18643410|P5|As Treated|Opiate dependency relapse|0
5405802|NCT02786537|18643411|P4|As Treated|Opiate dependency relapse|0
5405803|NCT02786537|18643412|P3|As Treated|Opiate dependency relapse|0
5405804|NCT02786537|18643413|P2|As Treated|Opiate dependency relapse|1
5405805|NCT02786537|18643414|P1|As Treated|Opiate dependency relapse|0
5405806|NCT02786537|18643409|P6|As Treated|Incarceration|0
5405807|NCT02786537|18643410|P5|As Treated|Incarceration|0
5405808|NCT02786537|18643411|P4|As Treated|Incarceration|0
5405809|NCT02786537|18643412|P3|As Treated|Incarceration|0
5405810|NCT02786537|18643413|P2|As Treated|Incarceration|1
5405811|NCT02786537|18643414|P1|As Treated|Incarceration|0
5405812|NCT02786537|18643409|P6|As Treated|Withdrawal by Subject|0
5405813|NCT02786537|18643410|P5|As Treated|Withdrawal by Subject|1
5405814|NCT02786537|18643411|P4|As Treated|Withdrawal by Subject|0
5405815|NCT02786537|18643412|P3|As Treated|Withdrawal by Subject|0
5405816|NCT02786537|18643413|P2|As Treated|Withdrawal by Subject|2
5405817|NCT02786537|18643414|P1|As Treated|Withdrawal by Subject|1
5405818|NCT02786537|18643409|P6|As Treated|Lost insurance|0
5405819|NCT02786537|18643410|P5|As Treated|Lost insurance|0
5405820|NCT02786537|18643411|P4|As Treated|Lost insurance|1
5405821|NCT02786537|18643412|P3|As Treated|Lost insurance|0
5405822|NCT02786537|18643413|P2|As Treated|Lost insurance|0
5405823|NCT02786537|18643414|P1|As Treated|Lost insurance|0
5405824|NCT02786537|18643409|P6|As Treated|Non-compliance with study drug|1
5405825|NCT02786537|18643410|P5|As Treated|Non-compliance with study drug|0
5405826|NCT02786537|18643411|P4|As Treated|Non-compliance with study drug|1
5405827|NCT02786537|18643412|P3|As Treated|Non-compliance with study drug|0
5405828|NCT02786537|18643413|P2|As Treated|Non-compliance with study drug|11
5405829|NCT02786537|18643414|P1|As Treated|Non-compliance with study drug|1
5405830|NCT02786537|18643409|P6|As Treated|Lost to Follow-up|4
5405831|NCT02786537|18643410|P5|As Treated|Lost to Follow-up|4
5405832|NCT02786537|18643411|P4|As Treated|Lost to Follow-up|25
5405833|NCT02786537|18643412|P3|As Treated|Lost to Follow-up|0
5405834|NCT02786537|18643413|P2|As Treated|Lost to Follow-up|32
5405835|NCT02786537|18643414|P1|As Treated|Lost to Follow-up|4
5405836|NCT02786537|18643409|P6|As Treated|Lack of Efficacy|0
5405837|NCT02786537|18643410|P5|As Treated|Lack of Efficacy|0
5405838|NCT02786537|18643411|P4|As Treated|Lack of Efficacy|1
5405839|NCT02786537|18643412|P3|As Treated|Lack of Efficacy|0
5405840|NCT02786537|18643413|P2|As Treated|Lack of Efficacy|0
5405841|NCT02786537|18643414|P1|As Treated|Lack of Efficacy|0
5405842|NCT02786537|18643409|P6|As Treated|Death|0
5405843|NCT02786537|18643410|P5|As Treated|Death|1
5405844|NCT02786537|18643411|P4|As Treated|Death|3
5405845|NCT02786537|18643412|P3|As Treated|Death|0
5405846|NCT02786537|18643413|P2|As Treated|Death|2
5405847|NCT02786537|18643414|P1|As Treated|Death|0
5405848|NCT02786537|18643409|P6|As Treated|Adverse Event|2
5405849|NCT02786537|18643410|P5|As Treated|Adverse Event|6
5405850|NCT02786537|18643411|P4|As Treated|Adverse Event|4
5405851|NCT02786537|18643412|P3|As Treated|Adverse Event|0
5405852|NCT02786537|18643413|P2|As Treated|Adverse Event|11
5405853|NCT02786537|18643414|P1|As Treated|Adverse Event|0
5405854|NCT02786537|18643409|P6|As Randomized|Subject lost insurance|0
5405855|NCT02786537|18643410|P5|As Randomized|Subject lost insurance|0
5405856|NCT02786537|18643411|P4|As Randomized|Subject lost insurance|1
5405857|NCT02786537|18643412|P3|As Randomized|Subject lost insurance|0
5405858|NCT02786537|18643413|P2|As Randomized|Subject lost insurance|0
5405859|NCT02786537|18643414|P1|As Randomized|Subject lost insurance|0
5405860|NCT02786537|18643409|P6|As Randomized|Advised to stop after lapse in dosing|0
5405861|NCT02786537|18643410|P5|As Randomized|Advised to stop after lapse in dosing|0
5405862|NCT02786537|18643411|P4|As Randomized|Advised to stop after lapse in dosing|0
5405863|NCT02786537|18643412|P3|As Randomized|Advised to stop after lapse in dosing|0
5405864|NCT02786537|18643413|P2|As Randomized|Advised to stop after lapse in dosing|1
5405865|NCT02786537|18643414|P1|As Randomized|Advised to stop after lapse in dosing|0
5405866|NCT02786537|18643409|P6|As Randomized|HCV drugs stolen from pt|0
5405867|NCT02786537|18643410|P5|As Randomized|HCV drugs stolen from pt|0
5405868|NCT02786537|18643411|P4|As Randomized|HCV drugs stolen from pt|0
5405869|NCT02786537|18643412|P3|As Randomized|HCV drugs stolen from pt|0
5405870|NCT02786537|18643413|P2|As Randomized|HCV drugs stolen from pt|1
5405871|NCT02786537|18643414|P1|As Randomized|HCV drugs stolen from pt|0
5405872|NCT02786537|18643409|P6|As Randomized|Opiate Dependency Relapse|0
5405873|NCT02786537|18643410|P5|As Randomized|Opiate Dependency Relapse|0
5405874|NCT02786537|18643411|P4|As Randomized|Opiate Dependency Relapse|0
5405875|NCT02786537|18643412|P3|As Randomized|Opiate Dependency Relapse|0
5405876|NCT02786537|18643413|P2|As Randomized|Opiate Dependency Relapse|1
5405877|NCT02786537|18643414|P1|As Randomized|Opiate Dependency Relapse|0
5405878|NCT02786537|18643409|P6|As Randomized|Incarceration|0
5405879|NCT02786537|18643410|P5|As Randomized|Incarceration|0
5405880|NCT02786537|18643411|P4|As Randomized|Incarceration|0
5405881|NCT02786537|18643412|P3|As Randomized|Incarceration|0
5405882|NCT02786537|18643413|P2|As Randomized|Incarceration|1
5405883|NCT02786537|18643414|P1|As Randomized|Incarceration|0
5405884|NCT02786537|18643409|P6|As Randomized|Lost to treatment follow-up|4
5405885|NCT02786537|18643410|P5|As Randomized|Lost to treatment follow-up|4
5405886|NCT02786537|18643411|P4|As Randomized|Lost to treatment follow-up|24
5405887|NCT02786537|18643412|P3|As Randomized|Lost to treatment follow-up|0
5405888|NCT02786537|18643413|P2|As Randomized|Lost to treatment follow-up|32
5405889|NCT02786537|18643414|P1|As Randomized|Lost to treatment follow-up|4
5405890|NCT02786537|18643409|P6|As Randomized|Non-compliance with study drug|1
5405891|NCT02786537|18643410|P5|As Randomized|Non-compliance with study drug|0
5405892|NCT02786537|18643411|P4|As Randomized|Non-compliance with study drug|1
5405893|NCT02786537|18643412|P3|As Randomized|Non-compliance with study drug|0
5405894|NCT02786537|18643413|P2|As Randomized|Non-compliance with study drug|11
5405895|NCT02786537|18643414|P1|As Randomized|Non-compliance with study drug|1
5405896|NCT02786537|18643409|P6|As Randomized|Death|0
5405897|NCT02786537|18643410|P5|As Randomized|Death|1
5405898|NCT02786537|18643411|P4|As Randomized|Death|3
5405899|NCT02786537|18643412|P3|As Randomized|Death|0
5405900|NCT02786537|18643413|P2|As Randomized|Death|2
5405901|NCT02786537|18643414|P1|As Randomized|Death|0
5405902|NCT02786537|18643409|P6|As Randomized|Withdrawal by Subject|0
5405903|NCT02786537|18643410|P5|As Randomized|Withdrawal by Subject|1
5405904|NCT02786537|18643411|P4|As Randomized|Withdrawal by Subject|1
5405905|NCT02786537|18643412|P3|As Randomized|Withdrawal by Subject|0
5405906|NCT02786537|18643413|P2|As Randomized|Withdrawal by Subject|2
5405907|NCT02786537|18643414|P1|As Randomized|Withdrawal by Subject|1
5405908|NCT02786537|18643409|P6|As Randomized|Lack of Efficacy|0
5405909|NCT02786537|18643410|P5|As Randomized|Lack of Efficacy|0
5405910|NCT02786537|18643411|P4|As Randomized|Lack of Efficacy|1
5405911|NCT02786537|18643412|P3|As Randomized|Lack of Efficacy|0
5405912|NCT02786537|18643413|P2|As Randomized|Lack of Efficacy|0
5405913|NCT02786537|18643414|P1|As Randomized|Lack of Efficacy|0
5405914|NCT02786537|18643409|P6|As Randomized|Adverse Event|2
5405915|NCT02786537|18643410|P5|As Randomized|Adverse Event|6
5405916|NCT02786537|18643411|P4|As Randomized|Adverse Event|4
5405917|NCT02786537|18643412|P3|As Randomized|Adverse Event|0
5405918|NCT02786537|18643413|P2|As Randomized|Adverse Event|11
5405919|NCT02786537|18643414|P1|As Randomized|Adverse Event|0
5405920|NCT02786004|18643471|P2|Overall Study|Withdrawal by Subject|1
5405921|NCT02786004|18643472|P1|Overall Study|Withdrawal by Subject|0
5405922|NCT02785913|18643480|P1|Overall Study|Not protocol specified|1
5405923|NCT02785913|18643480|P1|Overall Study|Progression|18
5405924|NCT02785913|18643480|P1|Overall Study|Death|2
5405925|NCT02785913|18643480|P1|Overall Study|Adverse Event|5
5405926|NCT02785900|18643491|P2|Overall Study|Physician Decision|2
5405927|NCT02785900|18643492|P1|Overall Study|Physician Decision|3
5405928|NCT02785900|18643491|P2|Overall Study|Withdrawal by Subject|8
5405929|NCT02785900|18643492|P1|Overall Study|Withdrawal by Subject|4
5405930|NCT02785900|18643491|P2|Overall Study|Death|32
5405931|NCT02785900|18643492|P1|Overall Study|Death|46
5405932|NCT02785900|18643491|P2|Overall Study|Study Termination by Sponsor|81
5405933|NCT02785900|18643492|P1|Overall Study|Study Termination by Sponsor|64
5405934|NCT02785770|18643516|P4|Intervention Period 3 (1 Day)|Adverse Event|1
5405935|NCT02785770|18643517|P3|Intervention Period 3 (1 Day)|Adverse Event|0
5405936|NCT02785770|18643518|P2|Intervention Period 3 (1 Day)|Adverse Event|0
5405937|NCT02785770|18643519|P1|Intervention Period 3 (1 Day)|Adverse Event|0
5405938|NCT02785770|18643516|P4|Intervention Period 2 (1 Day)|Family related obligations|0
5405939|NCT02785770|18643517|P3|Intervention Period 2 (1 Day)|Family related obligations|1
5405940|NCT02785770|18643518|P2|Intervention Period 2 (1 Day)|Family related obligations|0
5405941|NCT02785770|18643519|P1|Intervention Period 2 (1 Day)|Family related obligations|0
5405942|NCT02785770|18643516|P4|Intervention Period 2 (1 Day)|Adverse Event|0
5405943|NCT02785770|18643517|P3|Intervention Period 2 (1 Day)|Adverse Event|0
5405944|NCT02785770|18643518|P2|Intervention Period 2 (1 Day)|Adverse Event|1
5405945|NCT02785770|18643519|P1|Intervention Period 2 (1 Day)|Adverse Event|0
5405946|NCT02785588|18643586|P1|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
5405947|NCT02785588|18643586|P1|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
5405948|NCT02785458|18643602|P2|3 Months|Completed Evaluation at 1 Month|89
5405949|NCT02785458|18643603|P1|3 Months|Completed Evaluation at 1 Month|100
5405950|NCT02785458|18643602|P2|3 Months|Lost to Follow-up|21
5405951|NCT02785458|18643603|P1|3 Months|Lost to Follow-up|25
5405952|NCT02785458|18643602|P2|3 Months|Withdrawal by Subject|1
5405953|NCT02785458|18643603|P1|3 Months|Withdrawal by Subject|3
5405954|NCT02785458|18643602|P2|1 Month|Partial Interview|4
5405955|NCT02785458|18643603|P1|1 Month|Partial Interview|0
5405956|NCT02785458|18643602|P2|1 Month|Completed Evaluation by Baseline|39
5405957|NCT02785458|18643603|P1|1 Month|Completed Evaluation by Baseline|42
5405958|NCT02785458|18643602|P2|1 Month|Deemed Ineligible|0
5405959|NCT02785458|18643603|P1|1 Month|Deemed Ineligible|1
5405960|NCT02785458|18643602|P2|1 Month|Lost to Follow-up|31
5405961|NCT02785458|18643603|P1|1 Month|Lost to Follow-up|38
5405962|NCT02785458|18643602|P2|1 Month|Withdrawal by Subject|1
5405963|NCT02785458|18643603|P1|1 Month|Withdrawal by Subject|2
5405964|NCT02784834|18643790|P1|Overall Study|Lack of Efficacy|1
5405965|NCT02784704|18643796|P2|Overall Study|Subject Non Compliance|0
5405966|NCT02784704|18643797|P1|Overall Study|Subject Non Compliance|2
5405967|NCT02784704|18643796|P2|Overall Study|Withdrawal by Subject|3
5405968|NCT02784704|18643797|P1|Overall Study|Withdrawal by Subject|1
5405969|NCT02784704|18643796|P2|Overall Study|Lost to Follow-up|4
5405970|NCT02784704|18643797|P1|Overall Study|Lost to Follow-up|6
5405971|NCT02784704|18643796|P2|Overall Study|Adverse Event|2
5405972|NCT02784704|18643797|P1|Overall Study|Adverse Event|4
5405973|NCT02784106|18643918|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
5405974|NCT02784106|18643919|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
5405975|NCT02784106|18643920|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
5405976|NCT02784106|18643921|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
5405977|NCT02784106|18643918|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
5405978|NCT02784106|18643919|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
5405979|NCT02784106|18643920|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
5405980|NCT02784106|18643921|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
5405981|NCT02784106|18643918|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5405982|NCT02784106|18643919|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5405983|NCT02784106|18643920|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5405984|NCT02784106|18643921|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
5405985|NCT02784106|18643918|P4|Double-Blind Treatment Period (12 Weeks)|Other|0
5405986|NCT02784106|18643919|P3|Double-Blind Treatment Period (12 Weeks)|Other|0
5405987|NCT02784106|18643920|P2|Double-Blind Treatment Period (12 Weeks)|Other|0
5405988|NCT02784106|18643921|P1|Double-Blind Treatment Period (12 Weeks)|Other|2
5405989|NCT02784106|18643918|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5405990|NCT02784106|18643919|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5405991|NCT02784106|18643920|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
5405992|NCT02784106|18643921|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
5405993|NCT02784106|18643918|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
5405994|NCT02784106|18643919|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
5405995|NCT02784106|18643920|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
5405996|NCT02784106|18643921|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
5405997|NCT02783768|18644022|P2|Overall Study|Lost to Follow-up|0
5405998|NCT02783768|18644023|P1|Overall Study|Lost to Follow-up|1
5405999|NCT02783729|18644045|P4|Overall Study|Lost to Follow-up|0
5406000|NCT02783729|18644046|P3|Overall Study|Lost to Follow-up|1
5406001|NCT02783729|18644047|P2|Overall Study|Lost to Follow-up|1
5406002|NCT02783729|18644048|P1|Overall Study|Lost to Follow-up|2
5406003|NCT02783729|18644045|P4|Overall Study|Participant's choice|1
5406004|NCT02783729|18644046|P3|Overall Study|Participant's choice|2
5406005|NCT02783729|18644047|P2|Overall Study|Participant's choice|1
5406006|NCT02783729|18644048|P1|Overall Study|Participant's choice|2
5406007|NCT02783729|18644045|P4|Overall Study|Withdrawal by Subject|2
5406008|NCT02783729|18644046|P3|Overall Study|Withdrawal by Subject|1
5406009|NCT02783729|18644047|P2|Overall Study|Withdrawal by Subject|3
5406010|NCT02783729|18644048|P1|Overall Study|Withdrawal by Subject|2
5406011|NCT02783729|18644045|P4|Overall Study|Other|3
5406012|NCT02783729|18644046|P3|Overall Study|Other|2
5406013|NCT02783729|18644047|P2|Overall Study|Other|6
5406014|NCT02783729|18644048|P1|Overall Study|Other|1
5406015|NCT02783729|18644045|P4|Overall Study|Adverse Event|3
5406016|NCT02783729|18644046|P3|Overall Study|Adverse Event|2
5406017|NCT02783729|18644047|P2|Overall Study|Adverse Event|6
5406018|NCT02783729|18644048|P1|Overall Study|Adverse Event|2
5406019|NCT02783729|18644045|P4|Overall Study|Lack of Efficacy|0
5406020|NCT02783729|18644046|P3|Overall Study|Lack of Efficacy|0
5406021|NCT02783729|18644047|P2|Overall Study|Lack of Efficacy|0
5406022|NCT02783729|18644048|P1|Overall Study|Lack of Efficacy|1
5406023|NCT02783599|18644114|P1|Overall Study|Death|1
5406024|NCT02783599|18644114|P1|Overall Study|Physician Decision|2
5406025|NCT02783599|18644114|P1|Overall Study|Adverse Event|4
5406026|NCT02783599|18644114|P1|Overall Study|Surgical Resection|10
5406027|NCT02783599|18644114|P1|Overall Study|Progressive disease|23
5406028|NCT02783573|18644130|P3|Delayed-Start Period|Sponsor Decision|12
5406029|NCT02783573|18644131|P2|Delayed-Start Period|Sponsor Decision|17
5406030|NCT02783573|18644132|P1|Delayed-Start Period|Sponsor Decision|0
5406031|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Sponsor Decision|492
5406032|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Sponsor Decision|512
5406033|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Sponsor Decision|494
5406034|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
5406035|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
5406036|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
5406037|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
5406038|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
5406039|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
5406040|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Protocol Violation|0
5406041|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Protocol Violation|2
5406042|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Protocol Violation|1
5406043|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Physician Decision|3
5406044|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Physician Decision|1
5406045|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Physician Decision|3
5406046|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
5406047|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
5406048|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
5406049|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Non-Compliance|0
5406050|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Non-Compliance|1
5406051|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Non-Compliance|0
5406052|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Lost to Follow-up|1
5406053|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Lost to Follow-up|3
5406054|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Lost to Follow-up|3
5406055|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Lack of Efficacy|2
5406056|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Lack of Efficacy|0
5406057|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Lack of Efficacy|0
5406058|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Death|3
5406059|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Death|2
5406060|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Death|4
5406061|NCT02783573|18644130|P3|Placebo-Controlled Treatment Period|Adverse Event|13
5406062|NCT02783573|18644131|P2|Placebo-Controlled Treatment Period|Adverse Event|17
5406063|NCT02783573|18644132|P1|Placebo-Controlled Treatment Period|Adverse Event|13
5406064|NCT02783170|18644197|P2|Overall Study|Randomized but not Vaccinated|0
5406065|NCT02783170|18644198|P1|Overall Study|Randomized but not Vaccinated|1
5406066|NCT02783066|18644239|P1|Overall Study|Withdrawal by Subject|13
5406067|NCT02782923|18644270|P1|Overall Study|Lost to Follow-up|15
5406068|NCT02782676|18644276|P2|Overall Study|Lost to Follow-up|1
5406069|NCT02782676|18644277|P1|Overall Study|Lost to Follow-up|0
5406070|NCT02782377|18644305|P1|Overall Study|Physician Decision|5
5406071|NCT02782325|18644340|P3|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
5406072|NCT02782325|18644341|P2|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
5406073|NCT02782325|18644342|P1|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
5406074|NCT02782325|18644340|P3|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
5406075|NCT02782325|18644341|P2|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
5406076|NCT02782325|18644342|P1|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
5406077|NCT02782169|18644370|P2|Overall Study|Lost to Follow-up|2
5406078|NCT02782169|18644371|P1|Overall Study|Lost to Follow-up|1
5406079|NCT02781844|18644389|P8|Treatment Period 1|Adverse Event|0
5406080|NCT02781844|18644390|P7|Treatment Period 1|Adverse Event|0
5406081|NCT02781844|18644391|P6|Treatment Period 1|Adverse Event|1
5406082|NCT02781844|18644392|P5|Treatment Period 1|Adverse Event|0
5406083|NCT02781844|18644393|P4|Treatment Period 1|Adverse Event|0
5406084|NCT02781844|18644394|P3|Treatment Period 1|Adverse Event|0
5406085|NCT02781844|18644395|P2|Treatment Period 1|Adverse Event|0
5406086|NCT02781844|18644396|P1|Treatment Period 1|Adverse Event|0
5406087|NCT02781818|18644529|P3|Overall Study|Lost to Follow-up|1
5406088|NCT02781818|18644530|P2|Overall Study|Lost to Follow-up|2
5406089|NCT02781818|18644531|P1|Overall Study|Lost to Follow-up|4
5406090|NCT02781558|18644597|P2|Overall Study|Adverse Event|0
5406091|NCT02781558|18644598|P1|Overall Study|Adverse Event|1
5406092|NCT02781558|18644597|P2|Overall Study|Lost to Follow-up|2
5406093|NCT02781558|18644598|P1|Overall Study|Lost to Follow-up|2
5406094|NCT02781324|18644685|P2|Overall Study|Physician Decision|2
5406095|NCT02781324|18644686|P1|Overall Study|Physician Decision|1
5406096|NCT02781324|18644685|P2|Overall Study|Withdrawal by Subject|0
5406097|NCT02781324|18644686|P1|Overall Study|Withdrawal by Subject|1
5406098|NCT02781311|18644715|P3|Overall Study|Non-Compliance with Study Drug|0
5406099|NCT02781311|18644716|P2|Overall Study|Non-Compliance with Study Drug|0
5406100|NCT02781311|18644717|P1|Overall Study|Non-Compliance with Study Drug|2
5406101|NCT02781311|18644715|P3|Overall Study|Lost to Follow-up|1
5406102|NCT02781311|18644716|P2|Overall Study|Lost to Follow-up|8
5406103|NCT02781311|18644717|P1|Overall Study|Lost to Follow-up|11
5406104|NCT02781311|18644715|P3|Overall Study|Withdrawal of Consent|2
5406105|NCT02781311|18644716|P2|Overall Study|Withdrawal of Consent|12
5406106|NCT02781311|18644717|P1|Overall Study|Withdrawal of Consent|11
5406107|NCT02781311|18644715|P3|Overall Study|Adverse Event|1
5406108|NCT02781311|18644716|P2|Overall Study|Adverse Event|6
5406109|NCT02781311|18644717|P1|Overall Study|Adverse Event|2
5406110|NCT02780856|18644744|P1|Overall Study|Lost to Follow-up|1
5406111|NCT02780700|18644763|P1|Overall Study|Progressive disease|1
5406112|NCT02780687|18644773|P2|Overall Study|progressive disease|6
5406113|NCT02780687|18644774|P1|Overall Study|progressive disease|29
5406114|NCT02780687|18644773|P2|Overall Study|Switched to commercial program (in CTP)|0
5406115|NCT02780687|18644774|P1|Overall Study|Switched to commercial program (in CTP)|2
5406116|NCT02780687|18644773|P2|Overall Study|Withdrawal by Subject|1
5406117|NCT02780687|18644774|P1|Overall Study|Withdrawal by Subject|2
5406118|NCT02780687|18644773|P2|Overall Study|Adverse Event|1
5406119|NCT02780687|18644774|P1|Overall Study|Adverse Event|1
5406120|NCT02780388|18644846|P5|Overall Study|Withdrawal by Subject|0
5406121|NCT02780388|18644847|P4|Overall Study|Withdrawal by Subject|0
5406122|NCT02780388|18644848|P3|Overall Study|Withdrawal by Subject|0
5406123|NCT02780388|18644849|P2|Overall Study|Withdrawal by Subject|1
5406124|NCT02780388|18644850|P1|Overall Study|Withdrawal by Subject|1
5406125|NCT02780388|18644846|P5|Overall Study|Lost to Follow-up|0
5406126|NCT02780388|18644847|P4|Overall Study|Lost to Follow-up|0
5406127|NCT02780388|18644848|P3|Overall Study|Lost to Follow-up|0
5406128|NCT02780388|18644849|P2|Overall Study|Lost to Follow-up|1
5406129|NCT02780388|18644850|P1|Overall Study|Lost to Follow-up|0
5406130|NCT02780167|18644916|P5|Overall Study|Other|2
5406131|NCT02780167|18644917|P4|Overall Study|Other|1
5406132|NCT02780167|18644918|P3|Overall Study|Other|3
5406133|NCT02780167|18644919|P2|Overall Study|Other|0
5406134|NCT02780167|18644920|P1|Overall Study|Other|0
5406135|NCT02780167|18644916|P5|Overall Study|Withdrawal by Subject|4
5406136|NCT02780167|18644917|P4|Overall Study|Withdrawal by Subject|3
5406137|NCT02780167|18644918|P3|Overall Study|Withdrawal by Subject|4
5406138|NCT02780167|18644919|P2|Overall Study|Withdrawal by Subject|4
5406139|NCT02780167|18644920|P1|Overall Study|Withdrawal by Subject|6
5406140|NCT02780167|18644916|P5|Overall Study|Protocol Violation|2
5406141|NCT02780167|18644917|P4|Overall Study|Protocol Violation|1
5406142|NCT02780167|18644918|P3|Overall Study|Protocol Violation|1
5406143|NCT02780167|18644919|P2|Overall Study|Protocol Violation|5
5406144|NCT02780167|18644920|P1|Overall Study|Protocol Violation|5
5406145|NCT02780167|18644916|P5|Overall Study|No longer meets eligibility criteria|1
5406146|NCT02780167|18644917|P4|Overall Study|No longer meets eligibility criteria|1
5406147|NCT02780167|18644918|P3|Overall Study|No longer meets eligibility criteria|0
5406148|NCT02780167|18644919|P2|Overall Study|No longer meets eligibility criteria|0
5406149|NCT02780167|18644920|P1|Overall Study|No longer meets eligibility criteria|0
5406150|NCT02780167|18644916|P5|Overall Study|Does not meet entrance criteria|0
5406151|NCT02780167|18644917|P4|Overall Study|Does not meet entrance criteria|0
5406152|NCT02780167|18644918|P3|Overall Study|Does not meet entrance criteria|1
5406153|NCT02780167|18644919|P2|Overall Study|Does not meet entrance criteria|0
5406154|NCT02780167|18644920|P1|Overall Study|Does not meet entrance criteria|0
5406155|NCT02780167|18644916|P5|Overall Study|Lost to Follow-up|0
5406156|NCT02780167|18644917|P4|Overall Study|Lost to Follow-up|0
5406157|NCT02780167|18644918|P3|Overall Study|Lost to Follow-up|1
5406158|NCT02780167|18644919|P2|Overall Study|Lost to Follow-up|0
5406159|NCT02780167|18644920|P1|Overall Study|Lost to Follow-up|2
5406160|NCT02780167|18644916|P5|Overall Study|Lack of Efficacy|0
5406161|NCT02780167|18644917|P4|Overall Study|Lack of Efficacy|1
5406162|NCT02780167|18644918|P3|Overall Study|Lack of Efficacy|6
5406163|NCT02780167|18644919|P2|Overall Study|Lack of Efficacy|5
5406164|NCT02780167|18644920|P1|Overall Study|Lack of Efficacy|6
5406165|NCT02780167|18644916|P5|Overall Study|Adverse Event|8
5406166|NCT02780167|18644917|P4|Overall Study|Adverse Event|12
5406167|NCT02780167|18644918|P3|Overall Study|Adverse Event|8
5406168|NCT02780167|18644919|P2|Overall Study|Adverse Event|8
5406169|NCT02780167|18644920|P1|Overall Study|Adverse Event|9
5406170|NCT02780115|18645057|P5|Overall Study|Adverse Event|1
5406171|NCT02780115|18645058|P4|Overall Study|Adverse Event|1
5406172|NCT02780115|18645059|P3|Overall Study|Adverse Event|0
5406173|NCT02780115|18645060|P2|Overall Study|Adverse Event|0
5406174|NCT02780115|18645061|P1|Overall Study|Adverse Event|0
5406175|NCT02780115|18645057|P5|Overall Study|Withdrawal by Subject|0
5406176|NCT02780115|18645058|P4|Overall Study|Withdrawal by Subject|0
5406177|NCT02780115|18645059|P3|Overall Study|Withdrawal by Subject|1
5406178|NCT02780115|18645060|P2|Overall Study|Withdrawal by Subject|1
5406179|NCT02780115|18645061|P1|Overall Study|Withdrawal by Subject|0
5406180|NCT02779075|18645131|P2|Overall Study|IV lost during 2nd study|0
5406181|NCT02779075|18645132|P1|Overall Study|IV lost during 2nd study|1
5406182|NCT02779075|18645131|P2|Overall Study|Withdrawal by Subject|3
5406183|NCT02779075|18645132|P1|Overall Study|Withdrawal by Subject|1
5406184|NCT02778867|18645195|P4|Phase 2|Adverse Event|1
5406185|NCT02778867|18645196|P3|Phase 2|Adverse Event|0
5406186|NCT02778867|18645197|P2|Phase 2|Adverse Event|0
5406187|NCT02778867|18645198|P1|Phase 2|Adverse Event|0
5406188|NCT02778867|18645195|P4|Phase 2|Physician Decision|1
5406189|NCT02778867|18645196|P3|Phase 2|Physician Decision|0
5406190|NCT02778867|18645197|P2|Phase 2|Physician Decision|0
5406191|NCT02778867|18645198|P1|Phase 2|Physician Decision|0
5406192|NCT02778867|18645195|P4|Phase 2|Withdrawal by Subject|0
5406193|NCT02778867|18645196|P3|Phase 2|Withdrawal by Subject|1
5406194|NCT02778867|18645197|P2|Phase 2|Withdrawal by Subject|0
5406195|NCT02778867|18645198|P1|Phase 2|Withdrawal by Subject|0
5406196|NCT02778867|18645195|P4|Phase 1|Withdrawal by Subject|0
5406197|NCT02778867|18645196|P3|Phase 1|Withdrawal by Subject|0
5406198|NCT02778867|18645197|P2|Phase 1|Withdrawal by Subject|3
5406199|NCT02778867|18645198|P1|Phase 1|Withdrawal by Subject|2
5406200|NCT02778555|18645219|P3|Overall Study|Withdrawal by Subject|107
5406201|NCT02778555|18645220|P2|Overall Study|Withdrawal by Subject|32
5406202|NCT02778555|18645221|P1|Overall Study|Withdrawal by Subject|55
5406203|NCT02778204|18645233|P4|Overall Study|Eligibility Violation|1
5406204|NCT02778204|18645234|P3|Overall Study|Eligibility Violation|0
5406205|NCT02778204|18645235|P2|Overall Study|Eligibility Violation|0
5406206|NCT02778204|18645236|P1|Overall Study|Eligibility Violation|0
5406207|NCT02778204|18645233|P4|Overall Study|Protocol Violation|0
5406208|NCT02778204|18645234|P3|Overall Study|Protocol Violation|1
5406209|NCT02778204|18645235|P2|Overall Study|Protocol Violation|0
5406210|NCT02778204|18645236|P1|Overall Study|Protocol Violation|0
5406211|NCT02778204|18645233|P4|Overall Study|Lost to Follow-up|1
5406212|NCT02778204|18645234|P3|Overall Study|Lost to Follow-up|2
5406213|NCT02778204|18645235|P2|Overall Study|Lost to Follow-up|0
5406214|NCT02778204|18645236|P1|Overall Study|Lost to Follow-up|1
5406215|NCT02778204|18645233|P4|Overall Study|Withdrawal by Subject|2
5406216|NCT02778204|18645234|P3|Overall Study|Withdrawal by Subject|1
5406217|NCT02778204|18645235|P2|Overall Study|Withdrawal by Subject|0
5406218|NCT02778204|18645236|P1|Overall Study|Withdrawal by Subject|0
5406219|NCT02778204|18645233|P4|Overall Study|Adverse Event|0
5406220|NCT02778204|18645234|P3|Overall Study|Adverse Event|0
5406221|NCT02778204|18645235|P2|Overall Study|Adverse Event|0
5406222|NCT02778204|18645236|P1|Overall Study|Adverse Event|1
5406223|NCT02778100|18645328|P2|Period 1 (Common Cold)|Withdrawal by Subject|0
5406224|NCT02778100|18645329|P1|Period 1 (Common Cold)|Withdrawal by Subject|1
5406225|NCT02778074|18645360|P2|Overall Study|Lost to Follow-up|10
5406226|NCT02778074|18645361|P1|Overall Study|Lost to Follow-up|7
5406227|NCT02777918|18645393|P2|Overall Study|Withdrawal by Subject|1
5406228|NCT02777918|18645394|P1|Overall Study|Withdrawal by Subject|1
5406229|NCT02777918|18645393|P2|Overall Study|Too busy / stressed|1
5406230|NCT02777918|18645394|P1|Overall Study|Too busy / stressed|1
5406231|NCT02777918|18645393|P2|Overall Study|Medical reasons|2
5406232|NCT02777918|18645394|P1|Overall Study|Medical reasons|1
5406233|NCT02777827|18645412|P6|Washout Between Periods 3 and 4|Protocol Violation|0
5406234|NCT02777827|18645413|P5|Washout Between Periods 3 and 4|Protocol Violation|0
5406235|NCT02777827|18645414|P4|Washout Between Periods 3 and 4|Protocol Violation|0
5406236|NCT02777827|18645415|P3|Washout Between Periods 3 and 4|Protocol Violation|1
5406237|NCT02777827|18645416|P2|Washout Between Periods 3 and 4|Protocol Violation|0
5406238|NCT02777827|18645417|P1|Washout Between Periods 3 and 4|Protocol Violation|0
5406239|NCT02777242|18645620|P1|Overall Study|Withdrawal by Subject|1
5406240|NCT02777242|18645620|P1|Overall Study|Sponsor's request|1
5406241|NCT02777242|18645620|P1|Overall Study|Multiple|1
5406242|NCT02777242|18645620|P1|Overall Study|Lost to Follow-up|1
5406243|NCT02777242|18645620|P1|Overall Study|Other|2
5406244|NCT02777125|18645626|P2|Overall Study|Protocol Violation|12
5406245|NCT02777125|18645627|P1|Overall Study|Protocol Violation|8
5406246|NCT02777125|18645626|P2|Overall Study|Assent form violation|23
5406247|NCT02777125|18645627|P1|Overall Study|Assent form violation|21
5406248|NCT02777125|18645626|P2|Overall Study|Consent form violation|12
5406249|NCT02777125|18645627|P1|Overall Study|Consent form violation|14
5406250|NCT02777086|18645643|P2|Overall Study|Lost to Follow-up|99
5406251|NCT02777086|18645644|P1|Overall Study|Lost to Follow-up|96
5406252|NCT02776683|18645687|P2|Post-switch Period|Other than listed|15
5406253|NCT02776683|18645688|P1|Post-switch Period|Other than listed|0
5406254|NCT02776683|18645687|P2|Post-switch Period|Progressive disease|20
5406255|NCT02776683|18645688|P1|Post-switch Period|Progressive disease|0
5406256|NCT02776683|18645687|P2|Post-switch Period|Physician Decision|3
5406257|NCT02776683|18645688|P1|Post-switch Period|Physician Decision|0
5406258|NCT02776683|18645687|P2|Post-switch Period|Withdrawal by Subject|2
5406259|NCT02776683|18645688|P1|Post-switch Period|Withdrawal by Subject|0
5406260|NCT02776683|18645687|P2|Post-switch Period|Adverse Event|3
5406261|NCT02776683|18645688|P1|Post-switch Period|Adverse Event|0
5406262|NCT02776683|18645687|P2|Pre-switch Period|Other than listed|0
5406263|NCT02776683|18645688|P1|Pre-switch Period|Other than listed|3
5406264|NCT02776683|18645687|P2|Pre-switch Period|Progressive disease|0
5406265|NCT02776683|18645688|P1|Pre-switch Period|Progressive disease|39
5406266|NCT02776683|18645687|P2|Pre-switch Period|Physician Decision|0
5406267|NCT02776683|18645688|P1|Pre-switch Period|Physician Decision|7
5406268|NCT02776683|18645687|P2|Pre-switch Period|Withdrawal by Subject|0
5406269|NCT02776683|18645688|P1|Pre-switch Period|Withdrawal by Subject|9
5406270|NCT02776683|18645687|P2|Pre-switch Period|Adverse Event|0
5406271|NCT02776683|18645688|P1|Pre-switch Period|Adverse Event|21
5406272|NCT02776683|18645687|P2|Pre-switch Period|Protocol Violation|0
5406273|NCT02776683|18645688|P1|Pre-switch Period|Protocol Violation|1
5406274|NCT02776670|18645699|P2|Overall Study|Other - Reason not given|1
5406275|NCT02776670|18645700|P1|Overall Study|Other - Reason not given|0
5406276|NCT02776670|18645699|P2|Overall Study|Withdrawal by Subject|1
5406277|NCT02776670|18645700|P1|Overall Study|Withdrawal by Subject|0
5406278|NCT02776670|18645699|P2|Overall Study|Protocol Violation|2
5406279|NCT02776670|18645700|P1|Overall Study|Protocol Violation|0
5406280|NCT02776670|18645699|P2|Overall Study|Adverse Event|2
5406281|NCT02776670|18645700|P1|Overall Study|Adverse Event|0
5406282|NCT02776553|18645757|P2|Overall Study|Protocol Violation|1
5406283|NCT02776553|18645758|P1|Overall Study|Protocol Violation|0
5406284|NCT02776553|18645757|P2|Overall Study|had other surgery|0
5406285|NCT02776553|18645758|P1|Overall Study|had other surgery|1
5406286|NCT02776553|18645757|P2|Overall Study|got liver transplant|2
5406287|NCT02776553|18645758|P1|Overall Study|got liver transplant|1
5406288|NCT02776553|18645757|P2|Overall Study|Lost to Follow-up|0
5406289|NCT02776553|18645758|P1|Overall Study|Lost to Follow-up|1
5406290|NCT02776033|18645771|P3|Overall Study|Adverse Event|0
5406291|NCT02776033|18645772|P2|Overall Study|Adverse Event|2
5406292|NCT02776033|18645773|P1|Overall Study|Adverse Event|1
5406293|NCT02776033|18645771|P3|Overall Study|Lost to Follow-up|0
5406294|NCT02776033|18645772|P2|Overall Study|Lost to Follow-up|0
5406295|NCT02776033|18645773|P1|Overall Study|Lost to Follow-up|1
5406296|NCT02776033|18645771|P3|Overall Study|Physician Decision|0
5406297|NCT02776033|18645772|P2|Overall Study|Physician Decision|0
5406298|NCT02776033|18645773|P1|Overall Study|Physician Decision|2
5406299|NCT02776033|18645771|P3|Overall Study|Withdrawal by Subject|2
5406300|NCT02776033|18645772|P2|Overall Study|Withdrawal by Subject|0
5406301|NCT02776033|18645773|P1|Overall Study|Withdrawal by Subject|0
5406302|NCT02775916|18645838|P2|Overall Study|Subject/Guardian Decision|0
5406303|NCT02775916|18645839|P1|Overall Study|Subject/Guardian Decision|2
5406304|NCT02775916|18645838|P2|Overall Study|Adverse Event|0
5406305|NCT02775916|18645839|P1|Overall Study|Adverse Event|1
5406306|NCT02775903|18645861|P4|Overall Study|Other-Miscellaneous|5
5406307|NCT02775903|18645862|P3|Overall Study|Other-Miscellaneous|4
5406308|NCT02775903|18645863|P2|Overall Study|Other-Miscellaneous|3
5406309|NCT02775903|18645864|P1|Overall Study|Other-Miscellaneous|4
5406310|NCT02775903|18645861|P4|Overall Study|Lost to Follow-up|1
5406311|NCT02775903|18645862|P3|Overall Study|Lost to Follow-up|1
5406312|NCT02775903|18645863|P2|Overall Study|Lost to Follow-up|0
5406313|NCT02775903|18645864|P1|Overall Study|Lost to Follow-up|0
5406314|NCT02775903|18645861|P4|Overall Study|Adverse Event|1
5406315|NCT02775903|18645862|P3|Overall Study|Adverse Event|1
5406316|NCT02775903|18645863|P2|Overall Study|Adverse Event|0
5406317|NCT02775903|18645864|P1|Overall Study|Adverse Event|0
5406318|NCT02775903|18645861|P4|Overall Study|Withdrawal by Subject|4
5406319|NCT02775903|18645862|P3|Overall Study|Withdrawal by Subject|5
5406320|NCT02775903|18645863|P2|Overall Study|Withdrawal by Subject|5
5406321|NCT02775903|18645864|P1|Overall Study|Withdrawal by Subject|5
5406322|NCT02775903|18645861|P4|Overall Study|Death|35
5406323|NCT02775903|18645862|P3|Overall Study|Death|38
5406324|NCT02775903|18645863|P2|Overall Study|Death|18
5406325|NCT02775903|18645864|P1|Overall Study|Death|19
5406326|NCT02775903|18645861|P4|Overall Study|Ongoing|19
5406327|NCT02775903|18645862|P3|Overall Study|Ongoing|15
5406328|NCT02775903|18645863|P2|Overall Study|Ongoing|15
5406329|NCT02775903|18645864|P1|Overall Study|Ongoing|14
5406330|NCT02775864|18645916|P4|Overall Study|Medicaid eligibility discontinued|890
5406331|NCT02775864|18645917|P3|Overall Study|Medicaid eligibility discontinued|720
5406332|NCT02775864|18645918|P2|Overall Study|Medicaid eligibility discontinued|2019
5406333|NCT02775864|18645919|P1|Overall Study|Medicaid eligibility discontinued|1478
5406334|NCT02775864|18645916|P4|Overall Study|Data ended end of 2010|1194
5406335|NCT02775864|18645917|P3|Overall Study|Data ended end of 2010|1140
5406336|NCT02775864|18645918|P2|Overall Study|Data ended end of 2010|2880
5406337|NCT02775864|18645919|P1|Overall Study|Data ended end of 2010|1764
5406338|NCT02775435|18645952|P2|Overall Study|Not Treated|1
5406339|NCT02775435|18645953|P1|Overall Study|Not Treated|0
5406340|NCT02775435|18645952|P2|Overall Study|Ongoing in Study|72
5406341|NCT02775435|18645953|P1|Overall Study|Ongoing in Study|121
5406342|NCT02775435|18645952|P2|Overall Study|Clinical Progression|26
5406343|NCT02775435|18645953|P1|Overall Study|Clinical Progression|13
5406344|NCT02775435|18645952|P2|Overall Study|Progressive Disease|140
5406345|NCT02775435|18645953|P1|Overall Study|Progressive Disease|86
5406346|NCT02775435|18645952|P2|Overall Study|Withdrawal by Subject|9
5406347|NCT02775435|18645953|P1|Overall Study|Withdrawal by Subject|5
5406348|NCT02775435|18645952|P2|Overall Study|Physician Decision|6
5406349|NCT02775435|18645953|P1|Overall Study|Physician Decision|5
5406350|NCT02775435|18645952|P2|Overall Study|Lost to Follow-up|2
5406351|NCT02775435|18645953|P1|Overall Study|Lost to Follow-up|0
5406352|NCT02775435|18645952|P2|Overall Study|Adverse Event|25
5406353|NCT02775435|18645953|P1|Overall Study|Adverse Event|48
5406354|NCT02775344|18645971|P2|Overall Study|No ovarian cyst identified|2
5406355|NCT02775344|18645972|P1|Overall Study|No ovarian cyst identified|3
5406356|NCT02774681|18646105|P1|Follow-Up for 3 Years|Withdrawal by Subject|1
5406357|NCT02774681|18646105|P1|Follow-Up for 3 Years|Death|11
5406358|NCT02774681|18646105|P1|Treatment on Study|Progressive Disease|7
5406359|NCT02774278|18646169|P1|Overall Study|Protocol Violation|2
5406360|NCT02774278|18646169|P1|Overall Study|Withdrawal by Subject|3
5406361|NCT02774278|18646169|P1|Overall Study|Administrative reasons|6
5406362|NCT02774278|18646169|P1|Overall Study|Refused treatment/did not cooperate|9
5406363|NCT02774278|18646169|P1|Overall Study|Adverse event/intercurrent illness|16
5406364|NCT02774278|18646169|P1|Overall Study|Death|29
5406365|NCT02774278|18646169|P1|Overall Study|Lack of Efficacy|199
5406366|NCT02773537|18646344|P3|Overall Study|Lost to Follow-up|4
5406367|NCT02773537|18646345|P2|Overall Study|Lost to Follow-up|1
5406368|NCT02773537|18646346|P1|Overall Study|Lost to Follow-up|0
5406369|NCT02773446|18646381|P6|First Admission|Lost to Follow-up|0
5406370|NCT02773446|18646382|P5|First Admission|Lost to Follow-up|0
5406371|NCT02773446|18646383|P4|First Admission|Lost to Follow-up|0
5406372|NCT02773446|18646384|P3|First Admission|Lost to Follow-up|0
5406373|NCT02773446|18646385|P2|First Admission|Lost to Follow-up|0
5406374|NCT02773446|18646386|P1|First Admission|Lost to Follow-up|1
5406375|NCT02773446|18646381|P6|First Admission|Withdrawal by Subject|0
5406376|NCT02773446|18646382|P5|First Admission|Withdrawal by Subject|0
5406377|NCT02773446|18646383|P4|First Admission|Withdrawal by Subject|1
5406378|NCT02773446|18646384|P3|First Admission|Withdrawal by Subject|0
5406379|NCT02773446|18646385|P2|First Admission|Withdrawal by Subject|0
5406380|NCT02773446|18646386|P1|First Admission|Withdrawal by Subject|0
5406381|NCT02773368|18646427|P2|Overall Study|Missing|1
5406382|NCT02773368|18646428|P1|Overall Study|Missing|0
5406383|NCT02773368|18646427|P2|Overall Study|Unclassified|1
5406384|NCT02773368|18646428|P1|Overall Study|Unclassified|1
5406385|NCT02773368|18646427|P2|Overall Study|Withdrawal by Subject|1
5406386|NCT02773368|18646428|P1|Overall Study|Withdrawal by Subject|5
5406387|NCT02773368|18646427|P2|Overall Study|Lost to Follow-up|1
5406388|NCT02773368|18646428|P1|Overall Study|Lost to Follow-up|4
5406389|NCT02772809|18646498|P1|Overall Study|not completed some tasks|6
5406390|NCT02772757|18646510|P3|Overall Study|Physician Decision|3
5406391|NCT02772757|18646511|P2|Overall Study|Physician Decision|3
5406392|NCT02772757|18646512|P1|Overall Study|Physician Decision|0
5406393|NCT02772757|18646510|P3|Overall Study|Protocol Violation|1
5406394|NCT02772757|18646511|P2|Overall Study|Protocol Violation|0
5406395|NCT02772757|18646512|P1|Overall Study|Protocol Violation|0
5406396|NCT02772757|18646510|P3|Overall Study|Withdrawal by Subject|1
5406397|NCT02772757|18646511|P2|Overall Study|Withdrawal by Subject|0
5406398|NCT02772757|18646512|P1|Overall Study|Withdrawal by Subject|1
5406399|NCT02771522|18646595|P1|Overall Study|No white spot lesions|3
5406400|NCT02771522|18646595|P1|Overall Study|Withdrawal by Subject|2
5406401|NCT02771522|18646595|P1|Overall Study|Lost to Follow-up|3
5406402|NCT02771366|18646606|P2|Period 2 (Crossover)|Withdrawal by Subject|0
5406403|NCT02771366|18646607|P1|Period 2 (Crossover)|Withdrawal by Subject|2
5406404|NCT02771366|18646606|P2|Period 1|Withdrawal by Subject|2
5406405|NCT02771366|18646607|P1|Period 1|Withdrawal by Subject|0
5406406|NCT02771275|18646633|P1|Overall Study|On Study|11
5406407|NCT02771275|18646633|P1|Overall Study|Reoperation|2
5406408|NCT02771145|18646641|P1|Overall Study|Lost to Follow-up|1
5406409|NCT02771145|18646641|P1|Overall Study|Adverse Event|3
5406410|NCT02770612|18646775|P1|Overall Study|Met exclusion criteria (postop LOS>7d)|1
5406411|NCT02770547|18646781|P2|Overall Study|Adverse Event|1
5406412|NCT02770547|18646782|P1|Overall Study|Adverse Event|0
5406413|NCT02770547|18646781|P2|Overall Study|Patient non-compliant|0
5406414|NCT02770547|18646782|P1|Overall Study|Patient non-compliant|1
5406415|NCT02770248|18646855|P2|Overall Study|Randomized in error, prior to treatment|1
5406416|NCT02770248|18646856|P1|Overall Study|Randomized in error, prior to treatment|0
5406417|NCT02770248|18646855|P2|Overall Study|Adverse Event|1
5406418|NCT02770248|18646856|P1|Overall Study|Adverse Event|0
5406419|NCT02769858|18646874|P1|Overall Study|Withdrawal by Subject|2
5406420|NCT02769624|18646885|P2|Overall Study|Lost to Follow-up|1
5406421|NCT02769624|18646886|P1|Overall Study|Lost to Follow-up|0
5406422|NCT02769312|18646915|P2|Follow-up|Lost to Follow-up|1
5406423|NCT02769312|18646916|P1|Follow-up|Lost to Follow-up|1
5406424|NCT02769312|18646915|P2|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
5406425|NCT02769312|18646916|P1|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
5406426|NCT02769312|18646915|P2|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
5406427|NCT02769312|18646916|P1|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
5406428|NCT02769312|18646915|P2|Double-Blind (0-2 Weeks)|Adverse Event|0
5406429|NCT02769312|18646916|P1|Double-Blind (0-2 Weeks)|Adverse Event|1
5406430|NCT02769312|18646915|P2|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
5406431|NCT02769312|18646916|P1|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
5406432|NCT02769247|18646933|P4|Overall Study|Physician Decision|0
5406433|NCT02769247|18646934|P3|Overall Study|Physician Decision|0
5406434|NCT02769247|18646935|P2|Overall Study|Physician Decision|0
5406435|NCT02769247|18646936|P1|Overall Study|Physician Decision|1
5406436|NCT02769247|18646933|P4|Overall Study|Protocol Violation|0
5406437|NCT02769247|18646934|P3|Overall Study|Protocol Violation|1
5406438|NCT02769247|18646935|P2|Overall Study|Protocol Violation|0
5406439|NCT02769247|18646936|P1|Overall Study|Protocol Violation|0
5406440|NCT02769247|18646933|P4|Overall Study|Withdrawal by Subject|1
5406441|NCT02769247|18646934|P3|Overall Study|Withdrawal by Subject|0
5406442|NCT02769247|18646935|P2|Overall Study|Withdrawal by Subject|0
5406443|NCT02769247|18646936|P1|Overall Study|Withdrawal by Subject|1
5406444|NCT02769065|18647004|P30|Overall Study|Pre-treatment Event/Adverse Event|0
5406445|NCT02769065|18647005|P29|Overall Study|Pre-treatment Event/Adverse Event|0
5406446|NCT02769065|18647006|P28|Overall Study|Pre-treatment Event/Adverse Event|0
5406447|NCT02769065|18647007|P27|Overall Study|Pre-treatment Event/Adverse Event|0
5406448|NCT02769065|18647008|P26|Overall Study|Pre-treatment Event/Adverse Event|0
5406449|NCT02769065|18647009|P25|Overall Study|Pre-treatment Event/Adverse Event|0
5406450|NCT02769065|18647010|P24|Overall Study|Pre-treatment Event/Adverse Event|0
5406451|NCT02769065|18647011|P23|Overall Study|Pre-treatment Event/Adverse Event|0
5406452|NCT02769065|18647012|P22|Overall Study|Pre-treatment Event/Adverse Event|0
5406453|NCT02769065|18647013|P21|Overall Study|Pre-treatment Event/Adverse Event|0
5406454|NCT02769065|18647014|P20|Overall Study|Pre-treatment Event/Adverse Event|0
5406455|NCT02769065|18647015|P19|Overall Study|Pre-treatment Event/Adverse Event|0
5406456|NCT02769065|18647016|P18|Overall Study|Pre-treatment Event/Adverse Event|0
5406457|NCT02769065|18647017|P17|Overall Study|Pre-treatment Event/Adverse Event|0
5406458|NCT02769065|18647018|P16|Overall Study|Pre-treatment Event/Adverse Event|0
5406459|NCT02769065|18647019|P15|Overall Study|Pre-treatment Event/Adverse Event|0
5406460|NCT02769065|18647020|P14|Overall Study|Pre-treatment Event/Adverse Event|0
5406461|NCT02769065|18647021|P13|Overall Study|Pre-treatment Event/Adverse Event|0
5406462|NCT02769065|18647022|P12|Overall Study|Pre-treatment Event/Adverse Event|0
5406463|NCT02769065|18647023|P11|Overall Study|Pre-treatment Event/Adverse Event|1
5406464|NCT02769065|18647024|P10|Overall Study|Pre-treatment Event/Adverse Event|0
5406465|NCT02769065|18647025|P9|Overall Study|Pre-treatment Event/Adverse Event|0
5406466|NCT02769065|18647026|P8|Overall Study|Pre-treatment Event/Adverse Event|0
5406467|NCT02769065|18647027|P7|Overall Study|Pre-treatment Event/Adverse Event|0
5406468|NCT02769065|18647028|P6|Overall Study|Pre-treatment Event/Adverse Event|0
5406469|NCT02769065|18647029|P5|Overall Study|Pre-treatment Event/Adverse Event|0
5406470|NCT02769065|18647030|P4|Overall Study|Pre-treatment Event/Adverse Event|0
5406471|NCT02769065|18647031|P3|Overall Study|Pre-treatment Event/Adverse Event|0
5406472|NCT02769065|18647032|P2|Overall Study|Pre-treatment Event/Adverse Event|0
5406473|NCT02769065|18647033|P1|Overall Study|Pre-treatment Event/Adverse Event|0
5406474|NCT02769065|18647004|P30|Overall Study|Reason Not Specified|0
5406475|NCT02769065|18647005|P29|Overall Study|Reason Not Specified|0
5406476|NCT02769065|18647006|P28|Overall Study|Reason Not Specified|0
5406477|NCT02769065|18647007|P27|Overall Study|Reason Not Specified|0
5406478|NCT02769065|18647008|P26|Overall Study|Reason Not Specified|0
5406479|NCT02769065|18647009|P25|Overall Study|Reason Not Specified|0
5406480|NCT02769065|18647010|P24|Overall Study|Reason Not Specified|0
5406481|NCT02769065|18647011|P23|Overall Study|Reason Not Specified|0
5406482|NCT02769065|18647012|P22|Overall Study|Reason Not Specified|0
5406483|NCT02769065|18647013|P21|Overall Study|Reason Not Specified|0
5406484|NCT02769065|18647014|P20|Overall Study|Reason Not Specified|0
5406485|NCT02769065|18647015|P19|Overall Study|Reason Not Specified|0
5406486|NCT02769065|18647016|P18|Overall Study|Reason Not Specified|0
5406487|NCT02769065|18647017|P17|Overall Study|Reason Not Specified|0
5406488|NCT02769065|18647018|P16|Overall Study|Reason Not Specified|0
5406489|NCT02769065|18647019|P15|Overall Study|Reason Not Specified|0
5406490|NCT02769065|18647020|P14|Overall Study|Reason Not Specified|0
5406491|NCT02769065|18647021|P13|Overall Study|Reason Not Specified|0
5406492|NCT02769065|18647022|P12|Overall Study|Reason Not Specified|0
5406493|NCT02769065|18647023|P11|Overall Study|Reason Not Specified|0
5406494|NCT02769065|18647024|P10|Overall Study|Reason Not Specified|0
5406495|NCT02769065|18647025|P9|Overall Study|Reason Not Specified|0
5406496|NCT02769065|18647026|P8|Overall Study|Reason Not Specified|0
5406497|NCT02769065|18647027|P7|Overall Study|Reason Not Specified|1
5406498|NCT02769065|18647028|P6|Overall Study|Reason Not Specified|0
5406499|NCT02769065|18647029|P5|Overall Study|Reason Not Specified|0
5406500|NCT02769065|18647030|P4|Overall Study|Reason Not Specified|0
5406501|NCT02769065|18647031|P3|Overall Study|Reason Not Specified|0
5406502|NCT02769065|18647032|P2|Overall Study|Reason Not Specified|0
5406503|NCT02769065|18647033|P1|Overall Study|Reason Not Specified|0
5406504|NCT02769065|18647004|P30|Overall Study|Voluntary Withdrawal|0
5406505|NCT02769065|18647005|P29|Overall Study|Voluntary Withdrawal|0
5406506|NCT02769065|18647006|P28|Overall Study|Voluntary Withdrawal|0
5406507|NCT02769065|18647007|P27|Overall Study|Voluntary Withdrawal|0
5406508|NCT02769065|18647008|P26|Overall Study|Voluntary Withdrawal|0
5406509|NCT02769065|18647009|P25|Overall Study|Voluntary Withdrawal|0
5406510|NCT02769065|18647010|P24|Overall Study|Voluntary Withdrawal|0
5406511|NCT02769065|18647011|P23|Overall Study|Voluntary Withdrawal|0
5406512|NCT02769065|18647012|P22|Overall Study|Voluntary Withdrawal|0
5406513|NCT02769065|18647013|P21|Overall Study|Voluntary Withdrawal|0
5406514|NCT02769065|18647014|P20|Overall Study|Voluntary Withdrawal|0
5406515|NCT02769065|18647015|P19|Overall Study|Voluntary Withdrawal|0
5406516|NCT02769065|18647016|P18|Overall Study|Voluntary Withdrawal|0
5406517|NCT02769065|18647017|P17|Overall Study|Voluntary Withdrawal|0
5406518|NCT02769065|18647018|P16|Overall Study|Voluntary Withdrawal|0
5406519|NCT02769065|18647019|P15|Overall Study|Voluntary Withdrawal|0
5406520|NCT02769065|18647020|P14|Overall Study|Voluntary Withdrawal|0
5406521|NCT02769065|18647021|P13|Overall Study|Voluntary Withdrawal|0
5406522|NCT02769065|18647022|P12|Overall Study|Voluntary Withdrawal|0
5406523|NCT02769065|18647023|P11|Overall Study|Voluntary Withdrawal|0
5406524|NCT02769065|18647024|P10|Overall Study|Voluntary Withdrawal|0
5406525|NCT02769065|18647025|P9|Overall Study|Voluntary Withdrawal|0
5406526|NCT02769065|18647026|P8|Overall Study|Voluntary Withdrawal|0
5406527|NCT02769065|18647027|P7|Overall Study|Voluntary Withdrawal|0
5406528|NCT02769065|18647028|P6|Overall Study|Voluntary Withdrawal|0
5406529|NCT02769065|18647029|P5|Overall Study|Voluntary Withdrawal|0
5406530|NCT02769065|18647030|P4|Overall Study|Voluntary Withdrawal|0
5406531|NCT02769065|18647031|P3|Overall Study|Voluntary Withdrawal|0
5406532|NCT02769065|18647032|P2|Overall Study|Voluntary Withdrawal|0
5406533|NCT02769065|18647033|P1|Overall Study|Voluntary Withdrawal|1
5406534|NCT02768870|18647443|P1|Overall Study|On Study|19
5406535|NCT02768870|18647443|P1|Overall Study|Reoperation|4
5406536|NCT02768870|18647443|P1|Overall Study|Death|1
5406537|NCT02768870|18647443|P1|Overall Study|Not Implanted with Device|2
5406538|NCT02768298|18647487|P2|Overall Study|Withdrawal of informed consent|1
5406539|NCT02768298|18647488|P1|Overall Study|Withdrawal of informed consent|0
5406540|NCT02768298|18647487|P2|Overall Study|Subject/guardian decision|0
5406541|NCT02768298|18647488|P1|Overall Study|Subject/guardian decision|1
5406542|NCT02768298|18647487|P2|Overall Study|Non-compliance with study treatment|1
5406543|NCT02768298|18647488|P1|Overall Study|Non-compliance with study treatment|0
5406544|NCT02768298|18647487|P2|Overall Study|Death|1
5406545|NCT02768298|18647488|P1|Overall Study|Death|2
5406546|NCT02768298|18647487|P2|Overall Study|Adverse Event|4
5406547|NCT02768298|18647488|P1|Overall Study|Adverse Event|1
5406548|NCT02768194|18647502|P6|Period 3|Other (Reason not specified)|0
5406549|NCT02768194|18647503|P5|Period 3|Other (Reason not specified)|0
5406550|NCT02768194|18647504|P4|Period 3|Other (Reason not specified)|0
5406551|NCT02768194|18647505|P3|Period 3|Other (Reason not specified)|0
5406552|NCT02768194|18647506|P2|Period 3|Other (Reason not specified)|1
5406553|NCT02768194|18647507|P1|Period 3|Other (Reason not specified)|0
5406554|NCT02768194|18647502|P6|Period 2|Other (Reason not specified)|0
5406555|NCT02768194|18647503|P5|Period 2|Other (Reason not specified)|0
5406556|NCT02768194|18647504|P4|Period 2|Other (Reason not specified)|0
5406557|NCT02768194|18647505|P3|Period 2|Other (Reason not specified)|0
5406558|NCT02768194|18647506|P2|Period 2|Other (Reason not specified)|0
5406559|NCT02768194|18647507|P1|Period 2|Other (Reason not specified)|1
5406560|NCT02768194|18647502|P6|Period 1|Adverse Event|0
5406561|NCT02768194|18647503|P5|Period 1|Adverse Event|0
5406562|NCT02768194|18647504|P4|Period 1|Adverse Event|1
5406563|NCT02768194|18647505|P3|Period 1|Adverse Event|0
5406564|NCT02768194|18647506|P2|Period 1|Adverse Event|0
5406565|NCT02768194|18647507|P1|Period 1|Adverse Event|0
5406566|NCT02768103|18647529|P1|Overall Study|1 participant did not fit in the fMRI|1
5406567|NCT02767765|18647590|P1|Overall Study|Withdrawal by Subject|1
5406568|NCT02767765|18647590|P1|Overall Study|Non-Compliance|1
5406569|NCT02767765|18647590|P1|Overall Study|Investigator decision|1
5406570|NCT02767765|18647590|P1|Overall Study|Lost to Follow-up|2
5406571|NCT02767765|18647590|P1|Overall Study|Insufficient response|1
5406572|NCT02767765|18647590|P1|Overall Study|Death|1
5406573|NCT02767765|18647590|P1|Overall Study|Adverse Event|4
5406574|NCT02766777|18647716|P1|Overall Study|Withdrawal by Subject|4
5406575|NCT02766777|18647716|P1|Overall Study|Protocol Violation|1
5406576|NCT02766777|18647716|P1|Overall Study|Non-Compliance With Study Drug|1
5406577|NCT02766777|18647716|P1|Overall Study|Lost to Follow-up|16
5406578|NCT02766777|18647716|P1|Overall Study|Adverse Event|12
5406579|NCT02766608|18647741|P5|Overall Study|Administrative Reasons|0
5406580|NCT02766608|18647742|P4|Overall Study|Administrative Reasons|0
5406581|NCT02766608|18647743|P3|Overall Study|Administrative Reasons|1
5406582|NCT02766608|18647744|P2|Overall Study|Administrative Reasons|1
5406583|NCT02766608|18647745|P1|Overall Study|Administrative Reasons|3
5406584|NCT02766608|18647741|P5|Overall Study|Protocol Violation|1
5406585|NCT02766608|18647742|P4|Overall Study|Protocol Violation|0
5406586|NCT02766608|18647743|P3|Overall Study|Protocol Violation|4
5406587|NCT02766608|18647744|P2|Overall Study|Protocol Violation|4
5406588|NCT02766608|18647745|P1|Overall Study|Protocol Violation|0
5406589|NCT02766608|18647741|P5|Overall Study|Protocol disc criteria|0
5406590|NCT02766608|18647742|P4|Overall Study|Protocol disc criteria|0
5406591|NCT02766608|18647743|P3|Overall Study|Protocol disc criteria|4
5406592|NCT02766608|18647744|P2|Overall Study|Protocol disc criteria|3
5406593|NCT02766608|18647745|P1|Overall Study|Protocol disc criteria|3
5406594|NCT02766608|18647741|P5|Overall Study|Physician Decision|2
5406595|NCT02766608|18647742|P4|Overall Study|Physician Decision|1
5406596|NCT02766608|18647743|P3|Overall Study|Physician Decision|3
5406597|NCT02766608|18647744|P2|Overall Study|Physician Decision|2
5406598|NCT02766608|18647745|P1|Overall Study|Physician Decision|3
5406599|NCT02766608|18647741|P5|Overall Study|Lost to Follow-up|2
5406600|NCT02766608|18647742|P4|Overall Study|Lost to Follow-up|2
5406601|NCT02766608|18647743|P3|Overall Study|Lost to Follow-up|5
5406602|NCT02766608|18647744|P2|Overall Study|Lost to Follow-up|3
5406603|NCT02766608|18647745|P1|Overall Study|Lost to Follow-up|6
5406604|NCT02766608|18647741|P5|Overall Study|Lack of Efficacy|2
5406605|NCT02766608|18647742|P4|Overall Study|Lack of Efficacy|8
5406606|NCT02766608|18647743|P3|Overall Study|Lack of Efficacy|32
5406607|NCT02766608|18647744|P2|Overall Study|Lack of Efficacy|15
5406608|NCT02766608|18647745|P1|Overall Study|Lack of Efficacy|16
5406609|NCT02766608|18647741|P5|Overall Study|Withdrawal by Subject|10
5406610|NCT02766608|18647742|P4|Overall Study|Withdrawal by Subject|13
5406611|NCT02766608|18647743|P3|Overall Study|Withdrawal by Subject|24
5406612|NCT02766608|18647744|P2|Overall Study|Withdrawal by Subject|20
5406613|NCT02766608|18647745|P1|Overall Study|Withdrawal by Subject|21
5406614|NCT02766608|18647741|P5|Overall Study|Adverse Event|12
5406615|NCT02766608|18647742|P4|Overall Study|Adverse Event|13
5406616|NCT02766608|18647743|P3|Overall Study|Adverse Event|17
5406617|NCT02766608|18647744|P2|Overall Study|Adverse Event|22
5406618|NCT02766608|18647745|P1|Overall Study|Adverse Event|27
5406619|NCT02766400|18647837|P2|Overall Study|Withdrawal by Subject|0
5406620|NCT02766400|18647838|P1|Overall Study|Withdrawal by Subject|1
5406621|NCT02766400|18647837|P2|Overall Study|Death|2
5406622|NCT02766400|18647838|P1|Overall Study|Death|1
5406623|NCT02766283|18647853|P1|Overall Study|Lost to Follow-up|27
5406624|NCT02766088|18647886|P1|Overall Study|Death|1
5406625|NCT02766088|18647886|P1|Overall Study|Other|1
5406626|NCT02766088|18647886|P1|Overall Study|Lost to Follow-up|5
5406627|NCT02766088|18647886|P1|Overall Study|Migrated/moved from the study area|1
5406628|NCT02766088|18647886|P1|Overall Study|Sponsor study termination|498
5406629|NCT02766023|18647901|P2|Overall Study|Not Eligible at Enrollment|1
5406630|NCT02766023|18647902|P1|Overall Study|Not Eligible at Enrollment|0
5406631|NCT02766023|18647901|P2|Overall Study|Physician Decision|0
5406632|NCT02766023|18647902|P1|Overall Study|Physician Decision|1
5406633|NCT02766023|18647901|P2|Overall Study|Withdrawal by Subject|5
5406634|NCT02766023|18647902|P1|Overall Study|Withdrawal by Subject|4
5406635|NCT02766023|18647901|P2|Overall Study|Adverse Event|0
5406636|NCT02766023|18647902|P1|Overall Study|Adverse Event|1
5406637|NCT02766023|18647901|P2|Overall Study|Pregnancy|0
5406638|NCT02766023|18647902|P1|Overall Study|Pregnancy|1
5406639|NCT02766023|18647901|P2|Overall Study|Lost to Follow-up|11
5406640|NCT02766023|18647902|P1|Overall Study|Lost to Follow-up|23
5406641|NCT02765490|18647952|P2|Overall Study|Death|1
5406642|NCT02765490|18647953|P1|Overall Study|Death|0
5406643|NCT02765490|18647952|P2|Overall Study|Other|1
5406644|NCT02765490|18647953|P1|Overall Study|Other|0
5406645|NCT02765490|18647952|P2|Overall Study|Lost to Follow-up|1
5406646|NCT02765490|18647953|P1|Overall Study|Lost to Follow-up|1
5406647|NCT02765100|18647986|P2|Overall Study|Lost to Follow-up|1
5406648|NCT02765100|18647987|P1|Overall Study|Lost to Follow-up|0
5406649|NCT02765100|18647986|P2|Overall Study|subject found ineligible after baseline|1
5406650|NCT02765100|18647987|P1|Overall Study|subject found ineligible after baseline|1
5406651|NCT02764775|18648008|P1|Overall Study|Withdrawal by Subject|3
5406652|NCT02764775|18648008|P1|Overall Study|Lost to Follow-up|2
5406653|NCT02764775|18648008|P1|Overall Study|Death|1
5406654|NCT02764697|18648012|P1|Overall Study|Lack of Efficacy|3
5406655|NCT02764229|18648017|P1|Overall Study|Study Stopped by Sponsor|69
5406656|NCT02764229|18648017|P1|Overall Study|Lack of Efficacy|1
5406657|NCT02764229|18648017|P1|Overall Study|Lost to Follow-up|3
5406658|NCT02764229|18648017|P1|Overall Study|Physician Decision|5
5406659|NCT02764229|18648017|P1|Overall Study|Adverse Event|9
5406660|NCT02764229|18648017|P1|Overall Study|Withdrawal by Subject|15
5406661|NCT02764190|18648023|P2|Overall Study|Lost to Follow-up|13
5406662|NCT02764190|18648024|P1|Overall Study|Lost to Follow-up|17
5406663|NCT02764151|18648078|P4|Overall Study|Other|2
5406664|NCT02764151|18648079|P3|Overall Study|Other|0
5406665|NCT02764151|18648080|P2|Overall Study|Other|0
5406666|NCT02764151|18648081|P1|Overall Study|Other|0
5406667|NCT02764151|18648078|P4|Overall Study|Subject refused further follow-up|1
5406668|NCT02764151|18648079|P3|Overall Study|Subject refused further follow-up|0
5406669|NCT02764151|18648080|P2|Overall Study|Subject refused further follow-up|0
5406670|NCT02764151|18648081|P1|Overall Study|Subject refused further follow-up|0
5406671|NCT02763644|18648220|P2|Overall Study|Adverse Event|1
5406672|NCT02763644|18648221|P1|Overall Study|Adverse Event|1
5406673|NCT02763644|18648220|P2|Overall Study|Death|1
5406674|NCT02763644|18648221|P1|Overall Study|Death|1
5406675|NCT02763644|18648220|P2|Overall Study|Patient/guardian decision|0
5406676|NCT02763644|18648221|P1|Overall Study|Patient/guardian decision|1
5406677|NCT02763579|18648241|P2|Overall Study|On-going in study|60
5406678|NCT02763579|18648242|P1|Overall Study|On-going in study|77
5406679|NCT02763579|18648241|P2|Overall Study|Physician Decision|0
5406680|NCT02763579|18648242|P1|Overall Study|Physician Decision|2
5406681|NCT02763579|18648241|P2|Overall Study|Withdrawal by Subject|9
5406682|NCT02763579|18648242|P1|Overall Study|Withdrawal by Subject|18
5406683|NCT02763579|18648241|P2|Overall Study|Lost to Follow-up|1
5406684|NCT02763579|18648242|P1|Overall Study|Lost to Follow-up|3
5406685|NCT02763579|18648241|P2|Overall Study|Death|132
5406686|NCT02763579|18648242|P1|Overall Study|Death|101
5406687|NCT02763566|18648254|P4|Overall Study|Withdrawal by Subject|0
5406688|NCT02763566|18648255|P3|Overall Study|Withdrawal by Subject|0
5406689|NCT02763566|18648256|P2|Overall Study|Withdrawal by Subject|1
5406690|NCT02763566|18648257|P1|Overall Study|Withdrawal by Subject|3
5406691|NCT02763566|18648254|P4|Overall Study|On study treatment at study conclusion|13
5406692|NCT02763566|18648255|P3|Overall Study|On study treatment at study conclusion|54
5406693|NCT02763566|18648256|P2|Overall Study|On study treatment at study conclusion|34
5406694|NCT02763566|18648257|P1|Overall Study|On study treatment at study conclusion|114
5406695|NCT02763566|18648254|P4|Overall Study|Lost to Follow-up|1
5406696|NCT02763566|18648255|P3|Overall Study|Lost to Follow-up|0
5406697|NCT02763566|18648256|P2|Overall Study|Lost to Follow-up|4
5406698|NCT02763566|18648257|P1|Overall Study|Lost to Follow-up|1
5406699|NCT02763254|18648285|P1|Overall Study|Adverse Event|1
5406700|NCT02763215|18648290|P1|Overall Study|Lost to Follow-up|1
5406701|NCT02763215|18648290|P1|Overall Study|Death|1
5406702|NCT02763215|18648290|P1|Overall Study|Visit outside visit-window|1
5406703|NCT02763215|18648290|P1|Overall Study|Missed visit|1
5406704|NCT02763215|18648290|P1|Overall Study|Participants withdrew from study|3
5406705|NCT02763189|18648313|P2|Overall Study|Device failure|2
5406706|NCT02763189|18648314|P1|Overall Study|Device failure|0
5406707|NCT02763046|18648332|P3|Overall Study|Subject/guardian decision|4
5406708|NCT02763046|18648333|P2|Overall Study|Subject/guardian decision|0
5406709|NCT02763046|18648334|P1|Overall Study|Subject/guardian decision|2
5406710|NCT02763046|18648332|P3|Overall Study|Physician Decision|1
5406711|NCT02763046|18648333|P2|Overall Study|Physician Decision|0
5406712|NCT02763046|18648334|P1|Overall Study|Physician Decision|1
5406713|NCT02763046|18648332|P3|Overall Study|Lack of Efficacy|3
5406714|NCT02763046|18648333|P2|Overall Study|Lack of Efficacy|1
5406715|NCT02763046|18648334|P1|Overall Study|Lack of Efficacy|1
5406716|NCT02763046|18648332|P3|Overall Study|Adverse Event|0
5406717|NCT02763046|18648333|P2|Overall Study|Adverse Event|4
5406718|NCT02763046|18648334|P1|Overall Study|Adverse Event|5
5406719|NCT02762578|18648450|P2|Overall Study|Unclassified|0
5406720|NCT02762578|18648451|P1|Overall Study|Unclassified|6
5406721|NCT02762578|18648450|P2|Overall Study|Withdrawal by Subject|2
5406722|NCT02762578|18648451|P1|Overall Study|Withdrawal by Subject|4
5406723|NCT02762578|18648450|P2|Overall Study|Protocol Violation|2
5406724|NCT02762578|18648451|P1|Overall Study|Protocol Violation|4
5406725|NCT02762578|18648450|P2|Overall Study|Adverse Event|6
5406726|NCT02762578|18648451|P1|Overall Study|Adverse Event|1
5406727|NCT02762500|18648553|P2|Overall Study|Adverse Event|2
5406728|NCT02762500|18648554|P1|Overall Study|Adverse Event|0
5406729|NCT02762500|18648553|P2|Overall Study|Withdrawal by Subject|1
5406730|NCT02762500|18648554|P1|Overall Study|Withdrawal by Subject|1
5406731|NCT02762500|18648553|P2|Overall Study|Lack of Efficacy|0
5406732|NCT02762500|18648554|P1|Overall Study|Lack of Efficacy|1
5406733|NCT02762370|18648574|P2|Overall Study|Protocol Violation|0
5406734|NCT02762370|18648575|P1|Overall Study|Protocol Violation|1
5406735|NCT02762084|18648615|P3|Overall Study|Adverse Event|1
5406736|NCT02762084|18648616|P2|Overall Study|Adverse Event|0
5406737|NCT02762084|18648617|P1|Overall Study|Adverse Event|0
5406738|NCT02762084|18648615|P3|Overall Study|Withdrawal by Subject|0
5406739|NCT02762084|18648616|P2|Overall Study|Withdrawal by Subject|0
5406740|NCT02762084|18648617|P1|Overall Study|Withdrawal by Subject|1
5406741|NCT02761980|18648678|P4|Overall Study|Other|0
5406742|NCT02761980|18648679|P3|Overall Study|Other|1
5406743|NCT02761980|18648680|P2|Overall Study|Other|0
5406744|NCT02761980|18648681|P1|Overall Study|Other|0
5406745|NCT02761980|18648678|P4|Overall Study|Withdrawal by Subject|0
5406746|NCT02761980|18648679|P3|Overall Study|Withdrawal by Subject|0
5406747|NCT02761980|18648680|P2|Overall Study|Withdrawal by Subject|1
5406748|NCT02761980|18648681|P1|Overall Study|Withdrawal by Subject|0
5406749|NCT02761980|18648678|P4|Overall Study|Adverse Event|6
5406750|NCT02761980|18648679|P3|Overall Study|Adverse Event|5
5406751|NCT02761980|18648680|P2|Overall Study|Adverse Event|6
5406752|NCT02761980|18648681|P1|Overall Study|Adverse Event|4
5406753|NCT02761733|18648728|P4|Overall Study|Cognitive Impairment|0
5406754|NCT02761733|18648729|P3|Overall Study|Cognitive Impairment|1
5406755|NCT02761733|18648730|P2|Overall Study|Cognitive Impairment|0
5406756|NCT02761733|18648731|P1|Overall Study|Cognitive Impairment|5
5406757|NCT02761733|18648728|P4|Overall Study|Discharged from Study Site|11
5406758|NCT02761733|18648729|P3|Overall Study|Discharged from Study Site|25
5406759|NCT02761733|18648730|P2|Overall Study|Discharged from Study Site|9
5406760|NCT02761733|18648731|P1|Overall Study|Discharged from Study Site|10
5406761|NCT02761733|18648728|P4|Overall Study|Withdrawal by Subject|0
5406762|NCT02761733|18648729|P3|Overall Study|Withdrawal by Subject|0
5406763|NCT02761733|18648730|P2|Overall Study|Withdrawal by Subject|0
5406764|NCT02761733|18648731|P1|Overall Study|Withdrawal by Subject|2
5406765|NCT02761733|18648728|P4|Overall Study|Physician Decision|0
5406766|NCT02761733|18648729|P3|Overall Study|Physician Decision|0
5406767|NCT02761733|18648730|P2|Overall Study|Physician Decision|0
5406768|NCT02761733|18648731|P1|Overall Study|Physician Decision|4
5406769|NCT02761733|18648728|P4|Overall Study|Lost to Follow-up|3
5406770|NCT02761733|18648729|P3|Overall Study|Lost to Follow-up|0
5406771|NCT02761733|18648730|P2|Overall Study|Lost to Follow-up|7
5406772|NCT02761733|18648731|P1|Overall Study|Lost to Follow-up|6
5406773|NCT02761733|18648728|P4|Overall Study|Death|1
5406774|NCT02761733|18648729|P3|Overall Study|Death|1
5406775|NCT02761733|18648730|P2|Overall Study|Death|5
5406776|NCT02761733|18648731|P1|Overall Study|Death|3
5406777|NCT02761642|18648761|P1|Overall Study|Reason Unspecified|21
5406778|NCT02761642|18648761|P1|Overall Study|Physician Decision|1
5406779|NCT02761642|18648761|P1|Overall Study|Lack of Efficacy|20
5406780|NCT02761642|18648761|P1|Overall Study|Death|3
5406781|NCT02761642|18648761|P1|Overall Study|Non-compliant|7
5406782|NCT02761642|18648761|P1|Overall Study|Withdrawal by Subject|2
5406783|NCT02761642|18648761|P1|Overall Study|Adverse Event|13
5406784|NCT02761642|18648761|P1|Overall Study|Did not Receive Study Treatment|3
5406785|NCT02761629|18648774|P2|Overall Study|Randomized But Not Treated|4
5406786|NCT02761629|18648775|P1|Overall Study|Randomized But Not Treated|8
5406787|NCT02761629|18648774|P2|Overall Study|Lost to Follow-up|1
5406788|NCT02761629|18648775|P1|Overall Study|Lost to Follow-up|4
5406789|NCT02761629|18648774|P2|Overall Study|Other|2
5406790|NCT02761629|18648775|P1|Overall Study|Other|0
5406791|NCT02761629|18648774|P2|Overall Study|Withdrawal by Subject|3
5406792|NCT02761629|18648775|P1|Overall Study|Withdrawal by Subject|0
5406793|NCT02761629|18648774|P2|Overall Study|Protocol Violation|2
5406794|NCT02761629|18648775|P1|Overall Study|Protocol Violation|2
5406795|NCT02761629|18648774|P2|Overall Study|Did not Cooperate/Refused Treatment|4
5406796|NCT02761629|18648775|P1|Overall Study|Did not Cooperate/Refused Treatment|2
5406797|NCT02761629|18648774|P2|Overall Study|Failure to Return|4
5406798|NCT02761629|18648775|P1|Overall Study|Failure to Return|2
5406799|NCT02761629|18648774|P2|Overall Study|Insufficient Therapeutic Response|7
5406800|NCT02761629|18648775|P1|Overall Study|Insufficient Therapeutic Response|2
5406801|NCT02761629|18648774|P2|Overall Study|Adverse Event/Intercurrent Illness|5
5406802|NCT02761629|18648775|P1|Overall Study|Adverse Event/Intercurrent Illness|7
5406803|NCT02760927|18648822|P1|Overall Study|Tube Slippage from Device|1
5406804|NCT02760810|18648839|P1|Overall Study|Protocol Violation|1
5406805|NCT02760654|18648847|P2|Overall Study|Withdrawal by Subject|3
5406806|NCT02760654|18648848|P1|Overall Study|Withdrawal by Subject|4
5406807|NCT02760654|18648847|P2|Overall Study|Lost to Follow-up|3
5406808|NCT02760654|18648848|P1|Overall Study|Lost to Follow-up|3
5406809|NCT02760602|18648874|P2|Overall Study|Terminated by sponsor|13
5406810|NCT02760602|18648875|P1|Overall Study|Terminated by sponsor|12
5406811|NCT02760602|18648874|P2|Overall Study|Withdrawal by Subject|0
5406812|NCT02760602|18648875|P1|Overall Study|Withdrawal by Subject|1
5406813|NCT02760368|18648916|P3|Overall Study|Withdrawal by Sponsor|1
5406814|NCT02760368|18648917|P2|Overall Study|Withdrawal by Sponsor|0
5406815|NCT02760368|18648918|P1|Overall Study|Withdrawal by Sponsor|0
5406816|NCT02760368|18648916|P3|Overall Study|Death|0
5406817|NCT02760368|18648917|P2|Overall Study|Death|0
5406818|NCT02760368|18648918|P1|Overall Study|Death|1
5406819|NCT02760368|18648916|P3|Overall Study|Screen Failure|1
5406820|NCT02760368|18648917|P2|Overall Study|Screen Failure|0
5406821|NCT02760368|18648918|P1|Overall Study|Screen Failure|0
5406822|NCT02760368|18648916|P3|Overall Study|Withdrawal by Subject|9
5406823|NCT02760368|18648917|P2|Overall Study|Withdrawal by Subject|8
5406824|NCT02760368|18648918|P1|Overall Study|Withdrawal by Subject|12
5406825|NCT02760069|18649100|P3|Overall Study|Withdrawal by Subject|1
5406826|NCT02760069|18649101|P2|Overall Study|Withdrawal by Subject|1
5406827|NCT02760069|18649102|P1|Overall Study|Withdrawal by Subject|0
5406828|NCT02759939|18649128|P4|Overall Study|Lost to Follow-up|650
5406829|NCT02759939|18649129|P3|Overall Study|Lost to Follow-up|783
5406830|NCT02759939|18649130|P2|Overall Study|Lost to Follow-up|791
5406831|NCT02759939|18649131|P1|Overall Study|Lost to Follow-up|735
5406832|NCT02759939|18649128|P4|Overall Study|Ineligible for T2 and T3|391
5406833|NCT02759939|18649129|P3|Overall Study|Ineligible for T2 and T3|366
5406834|NCT02759939|18649130|P2|Overall Study|Ineligible for T2 and T3|179
5406835|NCT02759939|18649131|P1|Overall Study|Ineligible for T2 and T3|310
5406836|NCT02759939|18649128|P4|Overall Study|Missing data on first outcome assessed|2
5406837|NCT02759939|18649129|P3|Overall Study|Missing data on first outcome assessed|5
5406838|NCT02759939|18649130|P2|Overall Study|Missing data on first outcome assessed|2
5406839|NCT02759939|18649131|P1|Overall Study|Missing data on first outcome assessed|11
5406840|NCT02759692|18649141|P2|Period 2|Test article no longer available|1
5406841|NCT02759692|18649142|P1|Period 2|Test article no longer available|0
5406842|NCT02759692|18649141|P2|Period 2|Lost to Follow-up|0
5406843|NCT02759692|18649142|P1|Period 2|Lost to Follow-up|1
5406844|NCT02759692|18649141|P2|Period 1|Miss-Randomized|1
5406845|NCT02759692|18649142|P1|Period 1|Miss-Randomized|1
5406846|NCT02759692|18649141|P2|Period 1|No longer meets eligibility criteria.|0
5406847|NCT02759692|18649142|P1|Period 1|No longer meets eligibility criteria.|1
5406848|NCT02759692|18649141|P2|Period 1|Test article no longer available|1
5406849|NCT02759692|18649142|P1|Period 1|Test article no longer available|1
5406850|NCT02759562|18649160|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
5406851|NCT02759562|18649161|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
5406852|NCT02759562|18649160|P2|Open-Label Treatment Period|Withdrew Consent|0
5406853|NCT02759562|18649161|P1|Open-Label Treatment Period|Withdrew Consent|1
5406854|NCT02759471|18649174|P1|Overall Study|discomfort|2
5406855|NCT02759315|18649230|P5|Overall Study|Study terminated prior to completion|1
5406856|NCT02759315|18649231|P4|Overall Study|Study terminated prior to completion|0
5406857|NCT02759315|18649232|P3|Overall Study|Study terminated prior to completion|5
5406858|NCT02759315|18649233|P2|Overall Study|Study terminated prior to completion|0
5406859|NCT02759315|18649234|P1|Overall Study|Study terminated prior to completion|2
5406860|NCT02759315|18649230|P5|Overall Study|Protocol Violation|0
5406861|NCT02759315|18649231|P4|Overall Study|Protocol Violation|0
5406862|NCT02759315|18649232|P3|Overall Study|Protocol Violation|0
5406863|NCT02759315|18649233|P2|Overall Study|Protocol Violation|1
5406864|NCT02759315|18649234|P1|Overall Study|Protocol Violation|0
5406865|NCT02759315|18649230|P5|Overall Study|Lost to Follow-up|0
5406866|NCT02759315|18649231|P4|Overall Study|Lost to Follow-up|0
5406867|NCT02759315|18649232|P3|Overall Study|Lost to Follow-up|4
5406868|NCT02759315|18649233|P2|Overall Study|Lost to Follow-up|0
5406869|NCT02759315|18649234|P1|Overall Study|Lost to Follow-up|2
5406870|NCT02759315|18649230|P5|Overall Study|Death|0
5406871|NCT02759315|18649231|P4|Overall Study|Death|0
5406872|NCT02759315|18649232|P3|Overall Study|Death|1
5406873|NCT02759315|18649233|P2|Overall Study|Death|0
5406874|NCT02759315|18649234|P1|Overall Study|Death|0
5406875|NCT02759315|18649230|P5|Overall Study|Adverse Event|0
5406876|NCT02759315|18649231|P4|Overall Study|Adverse Event|1
5406877|NCT02759315|18649232|P3|Overall Study|Adverse Event|0
5406878|NCT02759315|18649233|P2|Overall Study|Adverse Event|0
5406879|NCT02759315|18649234|P1|Overall Study|Adverse Event|0
5406880|NCT02759016|18649337|P2|Overall Study|Other not defined above|1
5406881|NCT02759016|18649338|P1|Overall Study|Other not defined above|2
5406882|NCT02759016|18649337|P2|Overall Study|SD, PR-MRDpos or PR-L|2
5406883|NCT02759016|18649338|P1|Overall Study|SD, PR-MRDpos or PR-L|0
5406884|NCT02759016|18649337|P2|Overall Study|Progressive disease|0
5406885|NCT02759016|18649338|P1|Overall Study|Progressive disease|1
5406886|NCT02759016|18649337|P2|Overall Study|Not treated with BI 836826|0
5406887|NCT02759016|18649338|P1|Overall Study|Not treated with BI 836826|1
5406888|NCT02758613|18649367|P4|Treatment|Withdrawal by Subject|0
5406889|NCT02758613|18649368|P3|Treatment|Withdrawal by Subject|1
5406890|NCT02758613|18649369|P2|Treatment|Withdrawal by Subject|0
5406891|NCT02758613|18649370|P1|Treatment|Withdrawal by Subject|1
5406892|NCT02758613|18649367|P4|Treatment|Physician and Sponsor Decision|0
5406893|NCT02758613|18649368|P3|Treatment|Physician and Sponsor Decision|0
5406894|NCT02758613|18649369|P2|Treatment|Physician and Sponsor Decision|0
5406895|NCT02758613|18649370|P1|Treatment|Physician and Sponsor Decision|1
5406896|NCT02758301|18649388|P2|Overall Study|Protocol Violation|1
5406897|NCT02758301|18649389|P1|Overall Study|Protocol Violation|0
5406898|NCT02758301|18649388|P2|Overall Study|Lost to Follow-up|0
5406899|NCT02758301|18649389|P1|Overall Study|Lost to Follow-up|7
5406900|NCT02758301|18649388|P2|Overall Study|Withdrawal by Subject|6
5406901|NCT02758301|18649389|P1|Overall Study|Withdrawal by Subject|5
5406902|NCT02758301|18649388|P2|Overall Study|Physician Decision|1
5406903|NCT02758301|18649389|P1|Overall Study|Physician Decision|10
5406904|NCT02758301|18649388|P2|Overall Study|Death|0
5406905|NCT02758301|18649389|P1|Overall Study|Death|12
5406906|NCT02758171|18649408|P2|Wash-out|Other reason|0
5406907|NCT02758171|18649409|P1|Wash-out|Other reason|1
5406908|NCT02758171|18649408|P2|Wash-out|Withdrawal by Subject|0
5406909|NCT02758171|18649409|P1|Wash-out|Withdrawal by Subject|1
5406910|NCT02757963|18649463|P1|Overall Study|Withdrawal by Subject|34
5406911|NCT02757963|18649463|P1|Overall Study|Physician Decision|1
5406912|NCT02757963|18649463|P1|Overall Study|Lost to Follow-up|5
5406913|NCT02757963|18649463|P1|Overall Study|Reached Stopping Criteria|1054
5406914|NCT02757963|18649463|P1|Overall Study|Adverse Event|3
5406915|NCT02757768|18649503|P2|Overall Study|Miscellaneous|2
5406916|NCT02757768|18649504|P1|Overall Study|Miscellaneous|4
5406917|NCT02757768|18649503|P2|Overall Study|Withdrawal by Subject|9
5406918|NCT02757768|18649504|P1|Overall Study|Withdrawal by Subject|16
5406919|NCT02757768|18649503|P2|Overall Study|Protocol Deviation|9
5406920|NCT02757768|18649504|P1|Overall Study|Protocol Deviation|2
5406921|NCT02757768|18649503|P2|Overall Study|Lost to Follow-up|0
5406922|NCT02757768|18649504|P1|Overall Study|Lost to Follow-up|1
5406923|NCT02757768|18649503|P2|Overall Study|Lack of Efficacy|1
5406924|NCT02757768|18649504|P1|Overall Study|Lack of Efficacy|2
5406925|NCT02757768|18649503|P2|Overall Study|Adverse Event|3
5406926|NCT02757768|18649504|P1|Overall Study|Adverse Event|5
5406927|NCT02757768|18649503|P2|Overall Study|Randomized Never Received Study Drug|4
5406928|NCT02757768|18649504|P1|Overall Study|Randomized Never Received Study Drug|3
5406929|NCT02757625|18649554|P4|Overall Study|Adverse Event|0
5406930|NCT02757625|18649555|P3|Overall Study|Adverse Event|1
5406931|NCT02757625|18649556|P2|Overall Study|Adverse Event|0
5406932|NCT02757625|18649557|P1|Overall Study|Adverse Event|0
5406933|NCT02757625|18649554|P4|Overall Study|Investigator's discretion|0
5406934|NCT02757625|18649555|P3|Overall Study|Investigator's discretion|1
5406935|NCT02757625|18649556|P2|Overall Study|Investigator's discretion|0
5406936|NCT02757625|18649557|P1|Overall Study|Investigator's discretion|0
5406937|NCT02757521|18649716|P2|Overall Study|Adverse Event|0
5406938|NCT02757521|18649717|P1|Overall Study|Adverse Event|1
5406939|NCT02757430|18649723|P1|Overall Study|No procedure performed|2
5406940|NCT02757430|18649723|P1|Overall Study|No informed consent|1
5406941|NCT02757430|18649723|P1|Overall Study|Inclusion/Exclusion criteria not met|3
5406942|NCT02757430|18649723|P1|Overall Study|Physician Decision|6
5406943|NCT02757352|18649742|P10|Follow-Up Period|Withdrawal by Subject|2
5406944|NCT02757352|18649743|P9|Follow-Up Period|Withdrawal by Subject|6
5406945|NCT02757352|18649744|P8|Follow-Up Period|Withdrawal by Subject|1
5406946|NCT02757352|18649745|P7|Follow-Up Period|Withdrawal by Subject|0
5406947|NCT02757352|18649746|P6|Follow-Up Period|Withdrawal by Subject|0
5406948|NCT02757352|18649747|P5|Follow-Up Period|Withdrawal by Subject|0
5406949|NCT02757352|18649748|P4|Follow-Up Period|Withdrawal by Subject|0
5406950|NCT02757352|18649749|P3|Follow-Up Period|Withdrawal by Subject|0
5406951|NCT02757352|18649750|P2|Follow-Up Period|Withdrawal by Subject|0
5406952|NCT02757352|18649751|P1|Follow-Up Period|Withdrawal by Subject|0
5406953|NCT02757352|18649742|P10|Follow-Up Period|Lack of Efficacy|1
5406954|NCT02757352|18649743|P9|Follow-Up Period|Lack of Efficacy|1
5406955|NCT02757352|18649744|P8|Follow-Up Period|Lack of Efficacy|0
5406956|NCT02757352|18649745|P7|Follow-Up Period|Lack of Efficacy|0
5406957|NCT02757352|18649746|P6|Follow-Up Period|Lack of Efficacy|0
5406958|NCT02757352|18649747|P5|Follow-Up Period|Lack of Efficacy|0
5406959|NCT02757352|18649748|P4|Follow-Up Period|Lack of Efficacy|0
5406960|NCT02757352|18649749|P3|Follow-Up Period|Lack of Efficacy|0
5406961|NCT02757352|18649750|P2|Follow-Up Period|Lack of Efficacy|0
5406962|NCT02757352|18649751|P1|Follow-Up Period|Lack of Efficacy|0
5406963|NCT02757352|18649742|P10|Follow-Up Period|Lost to Follow-up|0
5406964|NCT02757352|18649743|P9|Follow-Up Period|Lost to Follow-up|1
5406965|NCT02757352|18649744|P8|Follow-Up Period|Lost to Follow-up|0
5406966|NCT02757352|18649745|P7|Follow-Up Period|Lost to Follow-up|0
5406967|NCT02757352|18649746|P6|Follow-Up Period|Lost to Follow-up|0
5406968|NCT02757352|18649747|P5|Follow-Up Period|Lost to Follow-up|0
5406969|NCT02757352|18649748|P4|Follow-Up Period|Lost to Follow-up|0
5406970|NCT02757352|18649749|P3|Follow-Up Period|Lost to Follow-up|0
5406971|NCT02757352|18649750|P2|Follow-Up Period|Lost to Follow-up|0
5406972|NCT02757352|18649751|P1|Follow-Up Period|Lost to Follow-up|0
5406973|NCT02757352|18649742|P10|Follow-Up Period|Adverse Event|0
5406974|NCT02757352|18649743|P9|Follow-Up Period|Adverse Event|2
5406975|NCT02757352|18649744|P8|Follow-Up Period|Adverse Event|0
5406976|NCT02757352|18649745|P7|Follow-Up Period|Adverse Event|1
5406977|NCT02757352|18649746|P6|Follow-Up Period|Adverse Event|0
5406978|NCT02757352|18649747|P5|Follow-Up Period|Adverse Event|0
5406979|NCT02757352|18649748|P4|Follow-Up Period|Adverse Event|0
5406980|NCT02757352|18649749|P3|Follow-Up Period|Adverse Event|0
5406981|NCT02757352|18649750|P2|Follow-Up Period|Adverse Event|0
5406982|NCT02757352|18649751|P1|Follow-Up Period|Adverse Event|0
5406983|NCT02757352|18649742|P10|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5406984|NCT02757352|18649743|P9|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5406985|NCT02757352|18649744|P8|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5406986|NCT02757352|18649745|P7|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5406987|NCT02757352|18649746|P6|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
5406988|NCT02757352|18649747|P5|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
5406989|NCT02757352|18649748|P4|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
5406990|NCT02757352|18649749|P3|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5406991|NCT02757352|18649750|P2|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5406992|NCT02757352|18649751|P1|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
5406993|NCT02757352|18649742|P10|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5406994|NCT02757352|18649743|P9|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5406995|NCT02757352|18649744|P8|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5406996|NCT02757352|18649745|P7|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5406997|NCT02757352|18649746|P6|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
5406998|NCT02757352|18649747|P5|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5406999|NCT02757352|18649748|P4|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5407000|NCT02757352|18649749|P3|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5407001|NCT02757352|18649750|P2|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5407002|NCT02757352|18649751|P1|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
5407003|NCT02757352|18649742|P10|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5407004|NCT02757352|18649743|P9|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5407005|NCT02757352|18649744|P8|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5407006|NCT02757352|18649745|P7|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5407007|NCT02757352|18649746|P6|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5407008|NCT02757352|18649747|P5|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
5407009|NCT02757352|18649748|P4|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5407010|NCT02757352|18649749|P3|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5407011|NCT02757352|18649750|P2|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5407012|NCT02757352|18649751|P1|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
5407013|NCT02757352|18649742|P10|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5407014|NCT02757352|18649743|P9|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5407015|NCT02757352|18649744|P8|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5407016|NCT02757352|18649745|P7|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5407017|NCT02757352|18649746|P6|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
5407018|NCT02757352|18649747|P5|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
5407019|NCT02757352|18649748|P4|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
5407020|NCT02757352|18649749|P3|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5407021|NCT02757352|18649750|P2|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5407022|NCT02757352|18649751|P1|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
5407023|NCT02757352|18649742|P10|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5407024|NCT02757352|18649743|P9|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5407025|NCT02757352|18649744|P8|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5407026|NCT02757352|18649745|P7|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5407027|NCT02757352|18649746|P6|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
5407028|NCT02757352|18649747|P5|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5407029|NCT02757352|18649748|P4|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
5407030|NCT02757352|18649749|P3|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5407031|NCT02757352|18649750|P2|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5407032|NCT02757352|18649751|P1|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
5407033|NCT02757352|18649742|P10|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5407034|NCT02757352|18649743|P9|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5407035|NCT02757352|18649744|P8|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5407036|NCT02757352|18649745|P7|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5407037|NCT02757352|18649746|P6|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5407038|NCT02757352|18649747|P5|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5407039|NCT02757352|18649748|P4|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
5407040|NCT02757352|18649749|P3|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
5407041|NCT02757352|18649750|P2|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
5407042|NCT02757352|18649751|P1|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
5407043|NCT02757352|18649742|P10|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5407044|NCT02757352|18649743|P9|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5407045|NCT02757352|18649744|P8|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5407046|NCT02757352|18649745|P7|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5407047|NCT02757352|18649746|P6|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5407048|NCT02757352|18649747|P5|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5407049|NCT02757352|18649748|P4|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
5407050|NCT02757352|18649749|P3|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
5407051|NCT02757352|18649750|P2|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
5407052|NCT02757352|18649751|P1|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
5407128|NCT02756611|18650132|P1|Overall Study|Death|39
5407053|NCT02757352|18649742|P10|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5407054|NCT02757352|18649743|P9|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5407055|NCT02757352|18649744|P8|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5407056|NCT02757352|18649745|P7|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5407057|NCT02757352|18649746|P6|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5407058|NCT02757352|18649747|P5|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5407059|NCT02757352|18649748|P4|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5407060|NCT02757352|18649749|P3|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5407061|NCT02757352|18649750|P2|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
5407062|NCT02757352|18649751|P1|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
5407063|NCT02757352|18649742|P10|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5407064|NCT02757352|18649743|P9|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5407065|NCT02757352|18649744|P8|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5407066|NCT02757352|18649745|P7|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5407067|NCT02757352|18649746|P6|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5407068|NCT02757352|18649747|P5|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5407069|NCT02757352|18649748|P4|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5407070|NCT02757352|18649749|P3|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5407071|NCT02757352|18649750|P2|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
5407072|NCT02757352|18649751|P1|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
5407073|NCT02757352|18649742|P10|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5407074|NCT02757352|18649743|P9|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5407075|NCT02757352|18649744|P8|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5407076|NCT02757352|18649745|P7|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5407077|NCT02757352|18649746|P6|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5407078|NCT02757352|18649747|P5|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5407079|NCT02757352|18649748|P4|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
5407080|NCT02757352|18649749|P3|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
5407081|NCT02757352|18649750|P2|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
5407082|NCT02757352|18649751|P1|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
5407083|NCT02757352|18649742|P10|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5407084|NCT02757352|18649743|P9|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5407085|NCT02757352|18649744|P8|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5407086|NCT02757352|18649745|P7|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5407087|NCT02757352|18649746|P6|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5407088|NCT02757352|18649747|P5|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5407089|NCT02757352|18649748|P4|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5407090|NCT02757352|18649749|P3|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
5407091|NCT02757352|18649750|P2|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5407092|NCT02757352|18649751|P1|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
5407093|NCT02757352|18649742|P10|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5407094|NCT02757352|18649743|P9|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5407095|NCT02757352|18649744|P8|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5407096|NCT02757352|18649745|P7|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5407097|NCT02757352|18649746|P6|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5407098|NCT02757352|18649747|P5|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5407099|NCT02757352|18649748|P4|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5407100|NCT02757352|18649749|P3|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
5407101|NCT02757352|18649750|P2|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
5407102|NCT02757352|18649751|P1|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
5407103|NCT02756832|18649974|P1|Overall Study|Protocol Deviation|10
5407104|NCT02756832|18649974|P1|Overall Study|Reason not Specified|9
5407105|NCT02756832|18649974|P1|Overall Study|Sponsor Decision/Regulatory Requirement|1
5407106|NCT02756832|18649974|P1|Overall Study|Insufficient Efficacy|2
5407107|NCT02756832|18649974|P1|Overall Study|Patient's Unwillingness|12
5407108|NCT02756832|18649974|P1|Overall Study|Lost for Observation|13
5407109|NCT02756832|18649974|P1|Overall Study|Lost for Observation after Baseline|6
5407110|NCT02756819|18649988|P1|Overall Study|Reason not Specified|9
5407111|NCT02756819|18649988|P1|Overall Study|Adverse Event|2
5407112|NCT02756819|18649988|P1|Overall Study|Insufficient efficacy|2
5407113|NCT02756819|18649988|P1|Overall Study|Patient's unwillingness|16
5407114|NCT02756819|18649988|P1|Overall Study|Lost for observation|23
5407115|NCT02756650|18650087|P1|Overall Study|Adverse Event|1
5407116|NCT02756650|18650087|P1|Overall Study|Physician Decision|1
5407117|NCT02756637|18650110|P2|Overall Study|Did not complete curative therapy|0
5407118|NCT02756637|18650111|P1|Overall Study|Did not complete curative therapy|33
5407119|NCT02756637|18650110|P2|Overall Study|No available NLR value|44
5407120|NCT02756637|18650111|P1|Overall Study|No available NLR value|44
5407121|NCT02756637|18650110|P2|Overall Study|Not eligible for initial SWOG study|10
5407122|NCT02756637|18650111|P1|Overall Study|Not eligible for initial SWOG study|10
5407123|NCT02756611|18650132|P1|Overall Study|Active on Study|205
5407124|NCT02756611|18650132|P1|Overall Study|Missing|2
5407125|NCT02756611|18650132|P1|Overall Study|Other|7
5407126|NCT02756611|18650132|P1|Overall Study|Lost to Follow-up|2
5407127|NCT02756611|18650132|P1|Overall Study|Withdrawal by Subject|1
5407129|NCT02756364|18650146|P3|Overall Study|Lost to Follow-up|1
5407130|NCT02756364|18650147|P2|Overall Study|Lost to Follow-up|1
5407131|NCT02756364|18650148|P1|Overall Study|Lost to Follow-up|0
5407132|NCT02756364|18650146|P3|Overall Study|Withdrawal by Patient|8
5407133|NCT02756364|18650147|P2|Overall Study|Withdrawal by Patient|1
5407134|NCT02756364|18650148|P1|Overall Study|Withdrawal by Patient|2
5407135|NCT02756364|18650146|P3|Overall Study|Death|18
5407136|NCT02756364|18650147|P2|Overall Study|Death|15
5407137|NCT02756364|18650148|P1|Overall Study|Death|20
5407138|NCT02756364|18650146|P3|Overall Study|Site Terminated by Sponsor|21
5407139|NCT02756364|18650147|P2|Overall Study|Site Terminated by Sponsor|30
5407140|NCT02756364|18650148|P1|Overall Study|Site Terminated by Sponsor|24
5407141|NCT02756338|18650182|P1|Overall Study|Device Replaced with Pacemaker|4
5407142|NCT02756338|18650182|P1|Overall Study|Withdrawn by Investigator|1
5407143|NCT02756182|18650191|P1|Overall Study|StudyTechnical Difficulties|4
5407144|NCT02756078|18650206|P2|Period 2|Withdrawal by Subject|1
5407145|NCT02756078|18650207|P1|Period 2|Withdrawal by Subject|3
5407146|NCT02756078|18650206|P2|Period 2|Unsatisfactory Lens Fitting|1
5407147|NCT02756078|18650207|P1|Period 2|Unsatisfactory Lens Fitting|0
5407148|NCT02756078|18650206|P2|Period 2|Adverse Event|5
5407149|NCT02756078|18650207|P1|Period 2|Adverse Event|3
5407150|NCT02756078|18650206|P2|Period 1|Lens Discomfort|2
5407151|NCT02756078|18650207|P1|Period 1|Lens Discomfort|2
5407152|NCT02756078|18650206|P2|Period 1|Withdrawal by Subject|6
5407153|NCT02756078|18650207|P1|Period 1|Withdrawal by Subject|6
5407154|NCT02756078|18650206|P2|Period 1|Adverse Event|10
5407155|NCT02756078|18650207|P1|Period 1|Adverse Event|1
5407156|NCT02756078|18650206|P2|Period 1|Protocol Violation|1
5407157|NCT02756078|18650207|P1|Period 1|Protocol Violation|0
5407158|NCT02756078|18650206|P2|Period 1|Lost to Follow-up|2
5407159|NCT02756078|18650207|P1|Period 1|Lost to Follow-up|0
5407160|NCT02756078|18650206|P2|Period 1|Unsatisfactory Lens Fitting|1
5407161|NCT02756078|18650207|P1|Period 1|Unsatisfactory Lens Fitting|0
5407162|NCT02756013|18650225|P1|Overall Study|Hypersensitivity|1
5407163|NCT02756013|18650225|P1|Overall Study|Adverse Event|1
5407164|NCT02755831|18650237|P2|Overall Study|Lost to Follow-up|3
5407165|NCT02755831|18650238|P1|Overall Study|Lost to Follow-up|3
5407166|NCT02755818|18650254|P4|Overall Study|withdrawal by PI|1
5407167|NCT02755818|18650255|P3|Overall Study|withdrawal by PI|1
5407168|NCT02755818|18650256|P2|Overall Study|withdrawal by PI|0
5407169|NCT02755818|18650257|P1|Overall Study|withdrawal by PI|0
5407170|NCT02755818|18650254|P4|Overall Study|Withdrawal by Subject|2
5407171|NCT02755818|18650255|P3|Overall Study|Withdrawal by Subject|0
5407172|NCT02755818|18650256|P2|Overall Study|Withdrawal by Subject|0
5407173|NCT02755818|18650257|P1|Overall Study|Withdrawal by Subject|0
5407174|NCT02755805|18650293|P2|Overall Study|Withdrawal by Subject|2
5407175|NCT02755805|18650294|P1|Overall Study|Withdrawal by Subject|0
5407176|NCT02755805|18650293|P2|Overall Study|Refused assessments|0
5407177|NCT02755805|18650294|P1|Overall Study|Refused assessments|1
5407178|NCT02755805|18650293|P2|Overall Study|Lost to Follow-up|2
5407179|NCT02755805|18650294|P1|Overall Study|Lost to Follow-up|1
5407180|NCT02755649|18650309|P3|Overall Study|Undecided|0
5407181|NCT02755649|18650310|P2|Overall Study|Undecided|0
5407182|NCT02755649|18650311|P1|Overall Study|Undecided|1
5407183|NCT02755649|18650309|P3|Overall Study|Withdrawal by Subject|0
5407184|NCT02755649|18650310|P2|Overall Study|Withdrawal by Subject|1
5407185|NCT02755649|18650311|P1|Overall Study|Withdrawal by Subject|0
5407186|NCT02755649|18650309|P3|Overall Study|Physician Decision|2
5407187|NCT02755649|18650310|P2|Overall Study|Physician Decision|0
5407188|NCT02755649|18650311|P1|Overall Study|Physician Decision|0
5407189|NCT02755649|18650309|P3|Overall Study|Did Not Complete Follow-up Visits|0
5407190|NCT02755649|18650310|P2|Overall Study|Did Not Complete Follow-up Visits|0
5407191|NCT02755649|18650311|P1|Overall Study|Did Not Complete Follow-up Visits|1
5407192|NCT02755649|18650309|P3|Overall Study|Transitioned into OLE study|100
5407193|NCT02755649|18650310|P2|Overall Study|Transitioned into OLE study|98
5407194|NCT02755649|18650311|P1|Overall Study|Transitioned into OLE study|99
5407195|NCT02755116|18650386|P2|Overall Study|surgery converted to open, pt admitted|1
5407196|NCT02755116|18650387|P1|Overall Study|surgery converted to open, pt admitted|3
5407197|NCT02755090|18650403|P2|Overall Study|equipment malfunction|0
5407198|NCT02755090|18650404|P1|Overall Study|equipment malfunction|1
5407199|NCT02754492|18650456|P4|Overall Study|Venous access issues not resulting in AE|4
5407200|NCT02754492|18650457|P3|Overall Study|Venous access issues not resulting in AE|0
5407201|NCT02754492|18650458|P2|Overall Study|Venous access issues not resulting in AE|0
5407202|NCT02754492|18650459|P1|Overall Study|Venous access issues not resulting in AE|0
5407203|NCT02754492|18650456|P4|Overall Study|Adverse Event|13
5407204|NCT02754492|18650457|P3|Overall Study|Adverse Event|0
5407205|NCT02754492|18650458|P2|Overall Study|Adverse Event|0
5407206|NCT02754492|18650459|P1|Overall Study|Adverse Event|0
5407207|NCT02754492|18650456|P4|Overall Study|Equipment malfuntion|5
5407208|NCT02754492|18650457|P3|Overall Study|Equipment malfuntion|2
5407209|NCT02754492|18650458|P2|Overall Study|Equipment malfuntion|0
5407210|NCT02754492|18650459|P1|Overall Study|Equipment malfuntion|0
5407211|NCT02754492|18650456|P4|Overall Study|Withdrawal by Subject|0
5407212|NCT02754492|18650457|P3|Overall Study|Withdrawal by Subject|0
5407213|NCT02754492|18650458|P2|Overall Study|Withdrawal by Subject|0
5407214|NCT02754492|18650459|P1|Overall Study|Withdrawal by Subject|2
5407215|NCT02754492|18650456|P4|Overall Study|Protocol Violation|1
5407216|NCT02754492|18650457|P3|Overall Study|Protocol Violation|0
5407217|NCT02754492|18650458|P2|Overall Study|Protocol Violation|2
5407218|NCT02754492|18650459|P1|Overall Study|Protocol Violation|2
5407219|NCT02754440|18650475|P4|Overall Study|Subject issues not resulting in AE|12
5407220|NCT02754440|18650476|P3|Overall Study|Subject issues not resulting in AE|0
5407221|NCT02754440|18650477|P2|Overall Study|Subject issues not resulting in AE|0
5407222|NCT02754440|18650478|P1|Overall Study|Subject issues not resulting in AE|0
5407223|NCT02754440|18650475|P4|Overall Study|Equipment failure|7
5407224|NCT02754440|18650476|P3|Overall Study|Equipment failure|5
5407225|NCT02754440|18650477|P2|Overall Study|Equipment failure|5
5407226|NCT02754440|18650478|P1|Overall Study|Equipment failure|0
5407227|NCT02754440|18650475|P4|Overall Study|Withdrawal by Subject|1
5407228|NCT02754440|18650476|P3|Overall Study|Withdrawal by Subject|0
5407229|NCT02754440|18650477|P2|Overall Study|Withdrawal by Subject|0
5407230|NCT02754440|18650478|P1|Overall Study|Withdrawal by Subject|0
5407231|NCT02754440|18650475|P4|Overall Study|Adverse Event|9
5407232|NCT02754440|18650476|P3|Overall Study|Adverse Event|0
5407233|NCT02754440|18650477|P2|Overall Study|Adverse Event|1
5407234|NCT02754440|18650478|P1|Overall Study|Adverse Event|3
5407235|NCT02754440|18650475|P4|Overall Study|Protocol Violation|6
5407236|NCT02754440|18650476|P3|Overall Study|Protocol Violation|2
5407237|NCT02754440|18650477|P2|Overall Study|Protocol Violation|2
5407238|NCT02754440|18650478|P1|Overall Study|Protocol Violation|3
5407239|NCT02753946|18650530|P2|Overall Study|Physician Decision|2
5407240|NCT02753946|18650531|P1|Overall Study|Physician Decision|0
5407241|NCT02753946|18650530|P2|Overall Study|Lack of Efficacy|0
5407242|NCT02753946|18650531|P1|Overall Study|Lack of Efficacy|1
5407243|NCT02753946|18650530|P2|Overall Study|Withdrawal by Subject|1
5407244|NCT02753946|18650531|P1|Overall Study|Withdrawal by Subject|6
5407245|NCT02753946|18650530|P2|Overall Study|Adverse Event|6
5407246|NCT02753946|18650531|P1|Overall Study|Adverse Event|7
5407247|NCT02753595|18650632|P2|Overall Study|Sponsor termination|2
5407248|NCT02753595|18650633|P1|Overall Study|Sponsor termination|2
5407249|NCT02753075|18650677|P3|Overall Study|Physician Decision|0
5407250|NCT02753075|18650678|P2|Overall Study|Physician Decision|1
5407251|NCT02753075|18650679|P1|Overall Study|Physician Decision|3
5407252|NCT02753075|18650677|P3|Overall Study|Withdrawal of Consent|3
5407253|NCT02753075|18650678|P2|Overall Study|Withdrawal of Consent|1
5407254|NCT02753075|18650679|P1|Overall Study|Withdrawal of Consent|1
5407255|NCT02753075|18650677|P3|Overall Study|Lost to Follow-up|0
5407256|NCT02753075|18650678|P2|Overall Study|Lost to Follow-up|0
5407257|NCT02753075|18650679|P1|Overall Study|Lost to Follow-up|2
5407258|NCT02753075|18650677|P3|Overall Study|Adverse Event|0
5407259|NCT02753075|18650678|P2|Overall Study|Adverse Event|1
5407260|NCT02753075|18650679|P1|Overall Study|Adverse Event|2
5407261|NCT02752958|18650704|P1|Overall Study|Other (Reason not specified)|2
5407262|NCT02752958|18650704|P1|Overall Study|Withdrawal by Subject|2
5407263|NCT02752958|18650704|P1|Overall Study|Protocol Violation|1
5407264|NCT02752958|18650704|P1|Overall Study|Lost to Follow-up|1
5407265|NCT02752958|18650704|P1|Overall Study|Adverse Event|3
5407266|NCT02752906|18650775|P2|Overall Study|Lost to Follow-up|2
5407267|NCT02752906|18650776|P1|Overall Study|Lost to Follow-up|3
5407268|NCT02752906|18650775|P2|Overall Study|Withdrawal by Subject|2
5407269|NCT02752906|18650776|P1|Overall Study|Withdrawal by Subject|2
5407270|NCT02752906|18650775|P2|Overall Study|Protocol Violation|1
5407271|NCT02752906|18650776|P1|Overall Study|Protocol Violation|2
5407272|NCT02752802|18650801|P2|Overall Study|Contrast Volume Not Collected|0
5407273|NCT02752802|18650802|P1|Overall Study|Contrast Volume Not Collected|1
5407274|NCT02752776|18650814|P3|Overall Study|Withdrawal by Subject|2
5407275|NCT02752776|18650815|P2|Overall Study|Withdrawal by Subject|4
5407276|NCT02752776|18650816|P1|Overall Study|Withdrawal by Subject|3
5407277|NCT02752776|18650814|P3|Overall Study|Death|1
5407278|NCT02752776|18650815|P2|Overall Study|Death|0
5407279|NCT02752776|18650816|P1|Overall Study|Death|0
5407280|NCT02752776|18650814|P3|Overall Study|Subject/guardian decision|4
5407281|NCT02752776|18650815|P2|Overall Study|Subject/guardian decision|6
5407282|NCT02752776|18650816|P1|Overall Study|Subject/guardian decision|8
5407283|NCT02752776|18650814|P3|Overall Study|Protocol Violation|6
5407284|NCT02752776|18650815|P2|Overall Study|Protocol Violation|13
5407285|NCT02752776|18650816|P1|Overall Study|Protocol Violation|10
5407286|NCT02752776|18650814|P3|Overall Study|Pregnancy|3
5407287|NCT02752776|18650815|P2|Overall Study|Pregnancy|6
5407288|NCT02752776|18650816|P1|Overall Study|Pregnancy|1
5407289|NCT02752776|18650814|P3|Overall Study|Physician Decision|2
5407290|NCT02752776|18650815|P2|Overall Study|Physician Decision|6
5407291|NCT02752776|18650816|P1|Overall Study|Physician Decision|2
5407292|NCT02752776|18650814|P3|Overall Study|Non-compliance with study treatment|1
5407293|NCT02752776|18650815|P2|Overall Study|Non-compliance with study treatment|0
5407294|NCT02752776|18650816|P1|Overall Study|Non-compliance with study treatment|0
5407295|NCT02752776|18650814|P3|Overall Study|Lost to Follow-up|4
5407296|NCT02752776|18650815|P2|Overall Study|Lost to Follow-up|12
5407297|NCT02752776|18650816|P1|Overall Study|Lost to Follow-up|11
5407298|NCT02752776|18650814|P3|Overall Study|Lack of Efficacy|14
5407299|NCT02752776|18650815|P2|Overall Study|Lack of Efficacy|6
5407300|NCT02752776|18650816|P1|Overall Study|Lack of Efficacy|2
5407301|NCT02752776|18650814|P3|Overall Study|Adverse Event|11
5407302|NCT02752776|18650815|P2|Overall Study|Adverse Event|23
5407303|NCT02752776|18650816|P1|Overall Study|Adverse Event|15
5407304|NCT02752633|18650862|P1|Overall Study|Withdrawal by Subject|1
5407305|NCT02752087|18650900|P2|Washout|Physician Decision|0
5407306|NCT02752087|18650901|P1|Washout|Physician Decision|1
5407307|NCT02752074|18650911|P2|Overall Study|Withdrawal by Subject|10
5407308|NCT02752074|18650912|P1|Overall Study|Withdrawal by Subject|9
5407309|NCT02752074|18650911|P2|Overall Study|Death|129
5407310|NCT02752074|18650912|P1|Overall Study|Death|146
5407311|NCT02752074|18650911|P2|Overall Study|Lost to Follow-up|4
5407312|NCT02752074|18650912|P1|Overall Study|Lost to Follow-up|1
5407313|NCT02752048|18650937|P3|Overall Study|Withdrawal by Subject|3
5407314|NCT02752048|18650938|P2|Overall Study|Withdrawal by Subject|0
5407315|NCT02752048|18650939|P1|Overall Study|Withdrawal by Subject|0
5407316|NCT02751983|18650958|P2|Three-Month Follow-Up Assessments|Lost to Follow-up|16
5407317|NCT02751983|18650959|P1|Three-Month Follow-Up Assessments|Lost to Follow-up|12
5407318|NCT02751983|18650958|P2|One-Month Follow-Up Assessments|Lost to Follow-up|12
5407319|NCT02751983|18650959|P1|One-Month Follow-Up Assessments|Lost to Follow-up|14
5407320|NCT02751983|18650958|P2|Post-Treatment Assessment|Lost to Follow-up|0
5407321|NCT02751983|18650959|P1|Post-Treatment Assessment|Lost to Follow-up|5
5407322|NCT02751983|18650958|P2|Treatment|Discharged prior to beginning ACT|0
5407323|NCT02751983|18650959|P1|Treatment|Discharged prior to beginning ACT|2
5407324|NCT02751983|18650958|P2|Treatment|Stopped ACT, but Remained in study|0
5407325|NCT02751983|18650959|P1|Treatment|Stopped ACT, but Remained in study|2
5407326|NCT02751931|18650980|P2|Overall Study|Other: Miscelleneous|8
5407327|NCT02751931|18650981|P1|Overall Study|Other: Miscelleneous|10
5407328|NCT02751931|18650980|P2|Overall Study|Adverse Event|0
5407329|NCT02751931|18650981|P1|Overall Study|Adverse Event|3
5407330|NCT02751580|18651069|P1|Overall Study|Death|2
5407331|NCT02751580|18651069|P1|Overall Study|Lost to Follow-up|4
5407332|NCT02751450|18651082|P2|Overall Study|Adverse Event|0
5407333|NCT02751450|18651083|P1|Overall Study|Adverse Event|1
5407334|NCT02751424|18651104|P9|Part 2|Adverse Event|0
5407335|NCT02751424|18651105|P8|Part 2|Adverse Event|5
5407336|NCT02751424|18651106|P7|Part 2|Adverse Event|0
5407337|NCT02751424|18651107|P6|Part 2|Adverse Event|0
5407338|NCT02751424|18651108|P5|Part 2|Adverse Event|0
5407339|NCT02751424|18651109|P4|Part 2|Adverse Event|0
5407340|NCT02751424|18651110|P3|Part 2|Adverse Event|0
5407341|NCT02751424|18651111|P2|Part 2|Adverse Event|0
5407342|NCT02751424|18651112|P1|Part 2|Adverse Event|0
5407343|NCT02751320|18651268|P1|Overall Study|Withdrawal by Subject|1
5407344|NCT02751320|18651268|P1|Overall Study|Adverse Event|2
5407345|NCT02750943|18651306|P2|Overall Study|Withdrawal by Subject|7
5407346|NCT02750943|18651307|P1|Overall Study|Withdrawal by Subject|5
5407347|NCT02750943|18651306|P2|Overall Study|Lost to Follow-up|2
5407348|NCT02750943|18651307|P1|Overall Study|Lost to Follow-up|1
5407349|NCT02750930|18651321|P1|Overall Study|Study closed/terminated|8
5407350|NCT02750813|18651333|P2|Period 1, First 14 Days of Wear|Reason not given|1
5407351|NCT02750813|18651334|P1|Period 1, First 14 Days of Wear|Reason not given|0
5407352|NCT02750813|18651333|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
5407353|NCT02750813|18651334|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
5407354|NCT02750800|18651349|P1|Overall Study|Other, not specified|3
5407355|NCT02750800|18651349|P1|Overall Study|Patient request|12
5407356|NCT02750800|18651349|P1|Overall Study|Investigator decision|53
5407357|NCT02750800|18651349|P1|Overall Study|Lost to Follow-up|12
5407358|NCT02750800|18651349|P1|Overall Study|Adverse Event|18
5407359|NCT02750761|18651454|P6|Overall Study|Lost to Follow-up|0
5407360|NCT02750761|18651455|P5|Overall Study|Lost to Follow-up|0
5407361|NCT02750761|18651456|P4|Overall Study|Lost to Follow-up|0
5407362|NCT02750761|18651457|P3|Overall Study|Lost to Follow-up|1
5407363|NCT02750761|18651458|P2|Overall Study|Lost to Follow-up|0
5407364|NCT02750761|18651459|P1|Overall Study|Lost to Follow-up|0
5407365|NCT02750709|18651555|P6|Treatment Period 1|Adverse Event|1
5407366|NCT02750709|18651556|P5|Treatment Period 1|Adverse Event|0
5407367|NCT02750709|18651557|P4|Treatment Period 1|Adverse Event|0
5407368|NCT02750709|18651558|P3|Treatment Period 1|Adverse Event|0
5407369|NCT02750709|18651559|P2|Treatment Period 1|Adverse Event|0
5407370|NCT02750709|18651560|P1|Treatment Period 1|Adverse Event|0
5407371|NCT02750618|18651586|P1|Overall Study|Withdrawal by Subject|1
5407372|NCT02750592|18651602|P1|Overall Study|Lack of Efficacy|2
5407373|NCT02750592|18651602|P1|Overall Study|Adverse Event|3
5407374|NCT02750501|18651621|P1|Overall Study|Non-compliant use of PERT|1
5407375|NCT02750501|18651621|P1|Overall Study|G-tube came out|1
5407376|NCT02750501|18651621|P1|Overall Study|Protocol Violation|1
5407377|NCT02750501|18651621|P1|Overall Study|Physician Decision|1
5407378|NCT02750501|18651621|P1|Overall Study|Adverse Event|4
5407379|NCT02750410|18651635|P2|Open-Label Extension Period|Withdrawal by Subject|2
5407380|NCT02750410|18651636|P1|Open-Label Extension Period|Withdrawal by Subject|1
5407381|NCT02750410|18651635|P2|Open-Label Extension Period|Protocol Violation|1
5407382|NCT02750410|18651636|P1|Open-Label Extension Period|Protocol Violation|0
5407383|NCT02750410|18651635|P2|Open-Label Extension Period|Adverse Event|3
5407384|NCT02750410|18651636|P1|Open-Label Extension Period|Adverse Event|5
5407385|NCT02750410|18651635|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5407386|NCT02750410|18651636|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5407387|NCT02750410|18651635|P2|Double-Blind Treatment Period|Adverse Event|2
5407388|NCT02750410|18651636|P1|Double-Blind Treatment Period|Adverse Event|2
5407389|NCT02750345|18651654|P6|Intervention 1|Adverse Event|0
5407390|NCT02750345|18651655|P5|Intervention 1|Adverse Event|1
5407391|NCT02750345|18651656|P4|Intervention 1|Adverse Event|0
5407392|NCT02750345|18651657|P3|Intervention 1|Adverse Event|0
5407393|NCT02750345|18651658|P2|Intervention 1|Adverse Event|0
5407394|NCT02750345|18651659|P1|Intervention 1|Adverse Event|0
5407395|NCT02750332|18651685|P2|Treatment Period 1|Withdrawal by Subject|1
5407396|NCT02750332|18651686|P1|Treatment Period 1|Withdrawal by Subject|0
5407397|NCT02750306|18651706|P2|Overall Study|Protocol Violation|0
5407398|NCT02750306|18651707|P1|Overall Study|Protocol Violation|1
5407399|NCT02750306|18651706|P2|Overall Study|Withdrawal by Subject|2
5407400|NCT02750306|18651707|P1|Overall Study|Withdrawal by Subject|5
5407401|NCT02749799|18651766|P1|Overall Study|Withdrawal by Subject|1
5407402|NCT02749799|18651766|P1|Overall Study|Protocol Violation|1
5407403|NCT02749799|18651766|P1|Overall Study|Lost to Follow-up|4
5407404|NCT02749799|18651766|P1|Overall Study|Adverse Event|2
5407405|NCT02749370|18651772|P1|Overall Study|Lost to Follow-up|3
5407406|NCT02749370|18651772|P1|Overall Study|Withdrawal by Subject|11
5407407|NCT02748863|18651822|P5|Treatment Period 2|Pregnancy|1
5407408|NCT02748863|18651823|P4|Treatment Period 2|Pregnancy|0
5407409|NCT02748863|18651824|P3|Treatment Period 2|Pregnancy|0
5407410|NCT02748863|18651825|P2|Treatment Period 2|Pregnancy|0
5407411|NCT02748863|18651826|P1|Treatment Period 2|Pregnancy|0
5407412|NCT02748863|18651822|P5|Treatment Period 2|Lack of Efficacy|0
5407413|NCT02748863|18651823|P4|Treatment Period 2|Lack of Efficacy|0
5407414|NCT02748863|18651824|P3|Treatment Period 2|Lack of Efficacy|0
5407415|NCT02748863|18651825|P2|Treatment Period 2|Lack of Efficacy|1
5407416|NCT02748863|18651826|P1|Treatment Period 2|Lack of Efficacy|0
5407417|NCT02748863|18651822|P5|Treatment Period 2|Adverse Event|0
5407418|NCT02748863|18651823|P4|Treatment Period 2|Adverse Event|2
5407419|NCT02748863|18651824|P3|Treatment Period 2|Adverse Event|0
5407420|NCT02748863|18651825|P2|Treatment Period 2|Adverse Event|2
5407421|NCT02748863|18651826|P1|Treatment Period 2|Adverse Event|3
5407422|NCT02748863|18651822|P5|Treatment Period 2|Lost to Follow-up|0
5407423|NCT02748863|18651823|P4|Treatment Period 2|Lost to Follow-up|0
5407424|NCT02748863|18651824|P3|Treatment Period 2|Lost to Follow-up|0
5407425|NCT02748863|18651825|P2|Treatment Period 2|Lost to Follow-up|0
5407426|NCT02748863|18651826|P1|Treatment Period 2|Lost to Follow-up|2
5407427|NCT02748863|18651822|P5|Treatment Period 1|Withdrawal by Subject|0
5407428|NCT02748863|18651823|P4|Treatment Period 1|Withdrawal by Subject|0
5407429|NCT02748863|18651824|P3|Treatment Period 1|Withdrawal by Subject|1
5407430|NCT02748863|18651825|P2|Treatment Period 1|Withdrawal by Subject|1
5407431|NCT02748863|18651826|P1|Treatment Period 1|Withdrawal by Subject|0
5407432|NCT02748863|18651822|P5|Treatment Period 1|Lack of Efficacy|0
5407433|NCT02748863|18651823|P4|Treatment Period 1|Lack of Efficacy|0
5407434|NCT02748863|18651824|P3|Treatment Period 1|Lack of Efficacy|1
5407435|NCT02748863|18651825|P2|Treatment Period 1|Lack of Efficacy|0
5407436|NCT02748863|18651826|P1|Treatment Period 1|Lack of Efficacy|0
5407437|NCT02748863|18651822|P5|Treatment Period 1|Adverse Event|0
5407438|NCT02748863|18651823|P4|Treatment Period 1|Adverse Event|0
5407439|NCT02748863|18651824|P3|Treatment Period 1|Adverse Event|0
5407440|NCT02748863|18651825|P2|Treatment Period 1|Adverse Event|1
5407441|NCT02748863|18651826|P1|Treatment Period 1|Adverse Event|0
5407442|NCT02748512|18651910|P2|Overall Study|Lost to Follow-up|1
5407443|NCT02748512|18651911|P1|Overall Study|Lost to Follow-up|1
5407444|NCT02748356|18651919|P1|Overall Study|Withdrawal by Subject|1
5407445|NCT02748317|18651924|P1|Overall Study|Death|1
5407446|NCT02748317|18651924|P1|Overall Study|Lost to Follow-up|8
5407447|NCT02748317|18651924|P1|Overall Study|Withdrawal by Subject|14
5407448|NCT02748213|18651931|P2|Overall Study|Other|29
5407449|NCT02748213|18651932|P1|Overall Study|Other|30
5407450|NCT02748213|18651931|P2|Overall Study|Failure to Return|0
5407451|NCT02748213|18651932|P1|Overall Study|Failure to Return|1
5407452|NCT02748213|18651931|P2|Overall Study|Refused Treatment*|6
5407453|NCT02748213|18651932|P1|Overall Study|Refused Treatment*|6
5407454|NCT02748213|18651931|P2|Overall Study|Protocol Violation|4
5407455|NCT02748213|18651932|P1|Overall Study|Protocol Violation|6
5407456|NCT02748213|18651931|P2|Overall Study|Violation of Selection Criteria|0
5407457|NCT02748213|18651932|P1|Overall Study|Violation of Selection Criteria|2
5407458|NCT02748213|18651931|P2|Overall Study|Insufficient Therapeutic Response|57
5407459|NCT02748213|18651932|P1|Overall Study|Insufficient Therapeutic Response|56
5407460|NCT02748213|18651931|P2|Overall Study|Death|3
5407461|NCT02748213|18651932|P1|Overall Study|Death|5
5407462|NCT02748213|18651931|P2|Overall Study|Adverse Event or Intercurrent Illness|11
5407463|NCT02748213|18651932|P1|Overall Study|Adverse Event or Intercurrent Illness|5
5407464|NCT02748213|18651931|P2|Overall Study|Abnormal Laboratory Test|0
5407465|NCT02748213|18651932|P1|Overall Study|Abnormal Laboratory Test|1
5407466|NCT02748213|18651931|P2|Overall Study|Withdrawal Prior to Treatment|2
5407467|NCT02748213|18651932|P1|Overall Study|Withdrawal Prior to Treatment|1
5407468|NCT02748057|18651961|P2|Overall Study|Withdrawal by Subject|0
5407469|NCT02748057|18651962|P1|Overall Study|Withdrawal by Subject|1
5407470|NCT02748057|18651961|P2|Overall Study|Participant Moved|0
5407471|NCT02748057|18651962|P1|Overall Study|Participant Moved|1
5407472|NCT02748057|18651961|P2|Overall Study|Protocol Violation|1
5407473|NCT02748057|18651962|P1|Overall Study|Protocol Violation|2
5407474|NCT02748057|18651961|P2|Overall Study|Physician Decision|1
5407475|NCT02748057|18651962|P1|Overall Study|Physician Decision|0
5407476|NCT02748057|18651961|P2|Overall Study|Adverse Event|0
5407477|NCT02748057|18651962|P1|Overall Study|Adverse Event|1
5407478|NCT02747108|18652040|P2|Overall Study|Protocol Violation|0
5407479|NCT02747108|18652041|P1|Overall Study|Protocol Violation|2
5407480|NCT02747108|18652040|P2|Overall Study|Withdrawal by Subject|0
5407481|NCT02747108|18652041|P1|Overall Study|Withdrawal by Subject|1
5407482|NCT02747108|18652040|P2|Overall Study|Death|2
5407483|NCT02747108|18652041|P1|Overall Study|Death|2
5407484|NCT02747043|18652083|P2|Overall Study|Disease progression|0
5407485|NCT02747043|18652084|P1|Overall Study|Disease progression|4
5407486|NCT02747043|18652083|P2|Overall Study|Protocol Violation|1
5407487|NCT02747043|18652084|P1|Overall Study|Protocol Violation|0
5407488|NCT02747043|18652083|P2|Overall Study|Physician Decision|1
5407489|NCT02747043|18652084|P1|Overall Study|Physician Decision|1
5407490|NCT02747043|18652083|P2|Overall Study|Withdrawal by Subject|1
5407491|NCT02747043|18652084|P1|Overall Study|Withdrawal by Subject|1
5407492|NCT02747043|18652083|P2|Overall Study|Adverse Event|1
5407493|NCT02747043|18652084|P1|Overall Study|Adverse Event|3
5407494|NCT02747043|18652083|P2|Overall Study|Other|1
5407495|NCT02747043|18652084|P1|Overall Study|Other|1
5407496|NCT02747004|18652113|P3|Overall Study|on study treatment/follow-up|41
5407497|NCT02747004|18652114|P2|Overall Study|on study treatment/follow-up|42
5407498|NCT02747004|18652115|P1|Overall Study|on study treatment/follow-up|48
5407499|NCT02747004|18652113|P3|Overall Study|Lost to Follow-up|2
5407500|NCT02747004|18652114|P2|Overall Study|Lost to Follow-up|2
5407501|NCT02747004|18652115|P1|Overall Study|Lost to Follow-up|1
5407502|NCT02747004|18652113|P3|Overall Study|Withdrawal by Subject|4
5407503|NCT02747004|18652114|P2|Overall Study|Withdrawal by Subject|5
5407504|NCT02747004|18652115|P1|Overall Study|Withdrawal by Subject|8
5407505|NCT02746705|18652174|P2|Overall Study|outlier scores deemed not valid|1
5407506|NCT02746705|18652175|P1|Overall Study|outlier scores deemed not valid|0
5407507|NCT02746705|18652174|P2|Overall Study|Lost to Follow-up|0
5407508|NCT02746705|18652175|P1|Overall Study|Lost to Follow-up|1
5407509|NCT02746705|18652174|P2|Overall Study|Physician Decision|1
5407510|NCT02746705|18652175|P1|Overall Study|Physician Decision|1
5407511|NCT02746679|18652189|P2|Overall Study|Lost to Follow-up|6
5407512|NCT02746679|18652190|P1|Overall Study|Lost to Follow-up|4
5407513|NCT02746627|18652223|P3|Overall Study|Withdrawal by Subject|1
5407514|NCT02746627|18652224|P2|Overall Study|Withdrawal by Subject|1
5407515|NCT02746627|18652225|P1|Overall Study|Withdrawal by Subject|1
5407516|NCT02746575|18652248|P1|Overall Study|Unknown history of CVA|1
5407517|NCT02746575|18652248|P1|Overall Study|PI unavailable|1
5407518|NCT02746575|18652248|P1|Overall Study|typ of surgery|1
5407519|NCT02746575|18652248|P1|Overall Study|type of surgery|1
5407520|NCT02746575|18652248|P1|Overall Study|put on beta-blocker|3
5407521|NCT02746575|18652248|P1|Overall Study|Study paused|8
5407522|NCT02746575|18652248|P1|Overall Study|Bradycardia/hypotension|9
5407523|NCT02746575|18652248|P1|Overall Study|Withdrawal by Subject|3
5407524|NCT02746575|18652248|P1|Overall Study|Received epidural|10
5407525|NCT02746575|18652248|P1|Overall Study|Surgery cancelled or time chaned|13
5407526|NCT02745535|18652311|P1|Overall Study|Lost to Follow-up|2
5407527|NCT02745535|18652311|P1|Overall Study|Adverse Event|3
5407528|NCT02745535|18652311|P1|Overall Study|Death|1
5407529|NCT02745392|18652323|P4|Overall Study|Lost to Follow-up|0
5407530|NCT02745392|18652324|P3|Overall Study|Lost to Follow-up|0
5407531|NCT02745392|18652325|P2|Overall Study|Lost to Follow-up|1
5407532|NCT02745392|18652326|P1|Overall Study|Lost to Follow-up|0
5407533|NCT02745145|18652359|P3|Overall Study|Study Termination|7
5407534|NCT02745145|18652360|P2|Overall Study|Study Termination|3
5407535|NCT02745145|18652361|P1|Overall Study|Study Termination|8
5407536|NCT02745145|18652359|P3|Overall Study|Withdrew consent|1
5407537|NCT02745145|18652360|P2|Overall Study|Withdrew consent|1
5407538|NCT02745145|18652361|P1|Overall Study|Withdrew consent|1
5407539|NCT02745145|18652359|P3|Overall Study|Progressive disease|1
5407540|NCT02745145|18652360|P2|Overall Study|Progressive disease|0
5407541|NCT02745145|18652361|P1|Overall Study|Progressive disease|0
5407542|NCT02745145|18652359|P3|Overall Study|Death|0
5407543|NCT02745145|18652360|P2|Overall Study|Death|1
5407544|NCT02745145|18652361|P1|Overall Study|Death|0
5407545|NCT02745145|18652359|P3|Overall Study|Adverse Event|0
5407546|NCT02745145|18652360|P2|Overall Study|Adverse Event|0
5407547|NCT02745145|18652361|P1|Overall Study|Adverse Event|1
5407548|NCT02745119|18652400|P4|Overall Study|Reason Not Specified|1
5407549|NCT02745119|18652401|P3|Overall Study|Reason Not Specified|0
5407550|NCT02745119|18652402|P2|Overall Study|Reason Not Specified|2
5407551|NCT02745119|18652403|P1|Overall Study|Reason Not Specified|0
5407552|NCT02745119|18652400|P4|Overall Study|Physician Decision|2
5407553|NCT02745119|18652401|P3|Overall Study|Physician Decision|2
5407554|NCT02745119|18652402|P2|Overall Study|Physician Decision|2
5407555|NCT02745119|18652403|P1|Overall Study|Physician Decision|0
5407556|NCT02745119|18652400|P4|Overall Study|Study Terminated by Sponsor|251
5407557|NCT02745119|18652401|P3|Overall Study|Study Terminated by Sponsor|135
5407558|NCT02745119|18652402|P2|Overall Study|Study Terminated by Sponsor|252
5407559|NCT02745119|18652403|P1|Overall Study|Study Terminated by Sponsor|134
5407560|NCT02745119|18652400|P4|Overall Study|Withdrawal by Subject|14
5407561|NCT02745119|18652401|P3|Overall Study|Withdrawal by Subject|8
5407562|NCT02745119|18652402|P2|Overall Study|Withdrawal by Subject|15
5407563|NCT02745119|18652403|P1|Overall Study|Withdrawal by Subject|7
5407564|NCT02745119|18652400|P4|Overall Study|Protocol Deviation|1
5407565|NCT02745119|18652401|P3|Overall Study|Protocol Deviation|0
5407566|NCT02745119|18652402|P2|Overall Study|Protocol Deviation|0
5407567|NCT02745119|18652403|P1|Overall Study|Protocol Deviation|0
5407568|NCT02745119|18652400|P4|Overall Study|Lost to Follow-up|1
5407569|NCT02745119|18652401|P3|Overall Study|Lost to Follow-up|0
5407570|NCT02745119|18652402|P2|Overall Study|Lost to Follow-up|0
5407571|NCT02745119|18652403|P1|Overall Study|Lost to Follow-up|0
5407572|NCT02745119|18652400|P4|Overall Study|Death|4
5407573|NCT02745119|18652401|P3|Overall Study|Death|0
5407574|NCT02745119|18652402|P2|Overall Study|Death|3
5407575|NCT02745119|18652403|P1|Overall Study|Death|3
5407576|NCT02745119|18652400|P4|Overall Study|Adverse Event|3
5407577|NCT02745119|18652401|P3|Overall Study|Adverse Event|1
5407578|NCT02745119|18652402|P2|Overall Study|Adverse Event|0
5407579|NCT02745119|18652403|P1|Overall Study|Adverse Event|1
5407580|NCT02744898|18652425|P1|Overall Study|Toxicity|1
5407581|NCT02744898|18652425|P1|Overall Study|Physician Decision|1
5407582|NCT02744898|18652425|P1|Overall Study|Progressive Disease|2
5407583|NCT02744755|18652439|P2|Study Period 2|Lack of Efficacy|2
5407584|NCT02744755|18652440|P1|Study Period 2|Lack of Efficacy|3
5407585|NCT02744755|18652439|P2|Study Period 2|Withdrawal by Subject|2
5407586|NCT02744755|18652440|P1|Study Period 2|Withdrawal by Subject|2
5407587|NCT02744755|18652439|P2|Study Period 2|Lost to Follow-up|2
5407588|NCT02744755|18652440|P1|Study Period 2|Lost to Follow-up|0
5407589|NCT02744755|18652439|P2|Study Period 2|not defined|2
5407590|NCT02744755|18652440|P1|Study Period 2|not defined|3
5407591|NCT02744755|18652439|P2|Study Period 2|Protocol Violation|0
5407592|NCT02744755|18652440|P1|Study Period 2|Protocol Violation|1
5407593|NCT02744755|18652439|P2|Study Period 2|Adverse Event|0
5407594|NCT02744755|18652440|P1|Study Period 2|Adverse Event|5
5407595|NCT02744755|18652439|P2|Study Period 1|Withdrawal by Subject|4
5407596|NCT02744755|18652440|P1|Study Period 1|Withdrawal by Subject|8
5407597|NCT02744755|18652439|P2|Study Period 1|Lack of Efficacy|0
5407598|NCT02744755|18652440|P1|Study Period 1|Lack of Efficacy|1
5407599|NCT02744755|18652439|P2|Study Period 1|Lost to Follow-up|1
5407600|NCT02744755|18652440|P1|Study Period 1|Lost to Follow-up|1
5407601|NCT02744755|18652439|P2|Study Period 1|Adverse Event|1
5407602|NCT02744755|18652440|P1|Study Period 1|Adverse Event|1
5407603|NCT02744755|18652439|P2|Study Period 1|Pregnancy|0
5407604|NCT02744755|18652440|P1|Study Period 1|Pregnancy|1
5407605|NCT02744755|18652439|P2|Study Period 1|not defined|1
5407606|NCT02744755|18652440|P1|Study Period 1|not defined|0
5407607|NCT02744755|18652439|P2|Study Period 1|Protocol Violation|1
5407608|NCT02744755|18652440|P1|Study Period 1|Protocol Violation|2
5407609|NCT02744391|18652500|P1|Overall Study|Withdrawal by Subject|3
5407610|NCT02744391|18652500|P1|Overall Study|Physician Decision|2
5407611|NCT02744391|18652500|P1|Overall Study|Lost to Follow-up|9
5407612|NCT02744066|18652541|P2|Overall Study|Discharged from NICU prior to completion|4
5407613|NCT02744066|18652542|P1|Overall Study|Discharged from NICU prior to completion|0
5407614|NCT02744066|18652541|P2|Overall Study|Withdrawal by parent|1
5407615|NCT02744066|18652542|P1|Overall Study|Withdrawal by parent|0
5407616|NCT02743962|18652552|P2|Overall Study|Atrophic vaginitis diagnosed|0
5407617|NCT02743962|18652553|P1|Overall Study|Atrophic vaginitis diagnosed|1
5407618|NCT02743949|18652575|P3|Overall Study|Voluntary Withdrawal|0
5407619|NCT02743949|18652576|P2|Overall Study|Voluntary Withdrawal|1
5407620|NCT02743949|18652577|P1|Overall Study|Voluntary Withdrawal|2
5407621|NCT02743949|18652575|P3|Overall Study|Significant Protocol Deviation|1
5407622|NCT02743949|18652576|P2|Overall Study|Significant Protocol Deviation|0
5407623|NCT02743949|18652577|P1|Overall Study|Significant Protocol Deviation|2
5407624|NCT02743949|18652575|P3|Overall Study|Adverse Event|2
5407625|NCT02743949|18652576|P2|Overall Study|Adverse Event|0
5407626|NCT02743949|18652577|P1|Overall Study|Adverse Event|0
5407627|NCT02743780|18652604|P5|Part 3 (7 Days)|Adverse Event|0
5407628|NCT02743780|18652605|P4|Part 3 (7 Days)|Adverse Event|0
5407629|NCT02743780|18652606|P3|Part 3 (7 Days)|Adverse Event|1
5407630|NCT02743780|18652607|P2|Part 3 (7 Days)|Adverse Event|0
5407631|NCT02743780|18652608|P1|Part 3 (7 Days)|Adverse Event|0
5407632|NCT02743520|18652662|P1|Overall Study|Withdrawal by Subject|1
5407633|NCT02743221|18652735|P2|Overall Study|Patient not eligible, not treated|1
5407634|NCT02743221|18652736|P1|Overall Study|Patient not eligible, not treated|0
5407635|NCT02743221|18652735|P2|Overall Study|Physician Decision|5
5407636|NCT02743221|18652736|P1|Overall Study|Physician Decision|2
5407637|NCT02743221|18652735|P2|Overall Study|non medical reason|2
5407638|NCT02743221|18652736|P1|Overall Study|non medical reason|8
5407639|NCT02743221|18652735|P2|Overall Study|Adverse Event|14
5407640|NCT02743221|18652736|P1|Overall Study|Adverse Event|17
5407641|NCT02743221|18652735|P2|Overall Study|Progressive disease|38
5407642|NCT02743221|18652736|P1|Overall Study|Progressive disease|29
5407643|NCT02743117|18652752|P2|Overall Study|Other|0
5407644|NCT02743117|18652753|P1|Overall Study|Other|1
5407645|NCT02743117|18652752|P2|Overall Study|Lost to Follow-up|1
5407646|NCT02743117|18652753|P1|Overall Study|Lost to Follow-up|0
5407647|NCT02742818|18652786|P2|Overall Study|Protocol Violation|1
5407648|NCT02742818|18652787|P1|Overall Study|Protocol Violation|0
5407649|NCT02742818|18652786|P2|Overall Study|Adverse Event|1
5407650|NCT02742818|18652787|P1|Overall Study|Adverse Event|0
5407651|NCT02742766|18652820|P19|Part 2 (Up to 22 Days)|Physician Decision|0
5407652|NCT02742766|18652821|P18|Part 2 (Up to 22 Days)|Physician Decision|0
5407653|NCT02742766|18652822|P17|Part 2 (Up to 22 Days)|Physician Decision|0
5407654|NCT02742766|18652823|P16|Part 2 (Up to 22 Days)|Physician Decision|1
5407655|NCT02742766|18652824|P15|Part 2 (Up to 22 Days)|Physician Decision|0
5407656|NCT02742766|18652825|P14|Part 2 (Up to 22 Days)|Physician Decision|5
5407657|NCT02742766|18652826|P13|Part 2 (Up to 22 Days)|Physician Decision|2
5407658|NCT02742766|18652827|P12|Part 2 (Up to 22 Days)|Physician Decision|0
5407659|NCT02742766|18652828|P11|Part 2 (Up to 22 Days)|Physician Decision|0
5407660|NCT02742766|18652829|P10|Part 2 (Up to 22 Days)|Physician Decision|0
5407661|NCT02742766|18652830|P9|Part 2 (Up to 22 Days)|Physician Decision|0
5407662|NCT02742766|18652831|P8|Part 2 (Up to 22 Days)|Physician Decision|0
5407663|NCT02742766|18652832|P7|Part 2 (Up to 22 Days)|Physician Decision|0
5407664|NCT02742766|18652833|P6|Part 2 (Up to 22 Days)|Physician Decision|0
5407665|NCT02742766|18652834|P5|Part 2 (Up to 22 Days)|Physician Decision|0
5407666|NCT02742766|18652835|P4|Part 2 (Up to 22 Days)|Physician Decision|0
5407667|NCT02742766|18652836|P3|Part 2 (Up to 22 Days)|Physician Decision|0
5407668|NCT02742766|18652837|P2|Part 2 (Up to 22 Days)|Physician Decision|0
5407669|NCT02742766|18652838|P1|Part 2 (Up to 22 Days)|Physician Decision|0
5407670|NCT02742766|18652820|P19|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407671|NCT02742766|18652821|P18|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407672|NCT02742766|18652822|P17|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407673|NCT02742766|18652823|P16|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407674|NCT02742766|18652824|P15|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407675|NCT02742766|18652825|P14|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
5407676|NCT02742766|18652826|P13|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407677|NCT02742766|18652827|P12|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407678|NCT02742766|18652828|P11|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407679|NCT02742766|18652829|P10|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407680|NCT02742766|18652830|P9|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407681|NCT02742766|18652831|P8|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407682|NCT02742766|18652832|P7|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407683|NCT02742766|18652833|P6|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407684|NCT02742766|18652834|P5|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407685|NCT02742766|18652835|P4|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407686|NCT02742766|18652836|P3|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407687|NCT02742766|18652837|P2|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407688|NCT02742766|18652838|P1|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
5407689|NCT02742649|18653098|P5|Open-Label Period|Lost to Follow-up|1
5407690|NCT02742649|18653099|P4|Open-Label Period|Lost to Follow-up|0
5407691|NCT02742649|18653100|P3|Open-Label Period|Lost to Follow-up|0
5407692|NCT02742649|18653101|P2|Open-Label Period|Lost to Follow-up|0
5407693|NCT02742649|18653102|P1|Open-Label Period|Lost to Follow-up|0
5407694|NCT02742649|18653098|P5|Double-Blind Treatment Period|Adverse Event|0
5407695|NCT02742649|18653099|P4|Double-Blind Treatment Period|Adverse Event|0
5407696|NCT02742649|18653100|P3|Double-Blind Treatment Period|Adverse Event|0
5407697|NCT02742649|18653101|P2|Double-Blind Treatment Period|Adverse Event|1
5407698|NCT02742649|18653102|P1|Double-Blind Treatment Period|Adverse Event|0
5407699|NCT02742649|18653098|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5407700|NCT02742649|18653099|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5407701|NCT02742649|18653100|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5407702|NCT02742649|18653101|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
5407703|NCT02742649|18653102|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
5407704|NCT02742519|18653141|P3|Part 2 Open Label Period (32 Weeks)|Other|1
5407705|NCT02742519|18653142|P2|Part 2 Open Label Period (32 Weeks)|Other|0
5407706|NCT02742519|18653143|P1|Part 2 Open Label Period (32 Weeks)|Other|0
5407707|NCT02742519|18653141|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
5407708|NCT02742519|18653142|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
5407709|NCT02742519|18653143|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
5407710|NCT02742519|18653141|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
5407711|NCT02742519|18653142|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
5407712|NCT02742519|18653143|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
5407713|NCT02742441|18653163|P2|Overall Study|Adverse Event|2
5407714|NCT02742441|18653164|P1|Overall Study|Adverse Event|0
5407715|NCT02742441|18653163|P2|Overall Study|Withdrawal by Subject|2
5407716|NCT02742441|18653164|P1|Overall Study|Withdrawal by Subject|2
5407717|NCT02742441|18653163|P2|Overall Study|Lost to Follow-up|4
5407718|NCT02742441|18653164|P1|Overall Study|Lost to Follow-up|4
5407719|NCT02742103|18653211|P2|Overall Study|Withdrawal by Subject|2
5407720|NCT02742103|18653212|P1|Overall Study|Withdrawal by Subject|5
5407721|NCT02742103|18653211|P2|Overall Study|Moved to another town|1
5407722|NCT02742103|18653212|P1|Overall Study|Moved to another town|0
5407723|NCT02742103|18653211|P2|Overall Study|Adverse Event|0
5407724|NCT02742103|18653212|P1|Overall Study|Adverse Event|1
5407725|NCT02742103|18653211|P2|Overall Study|Death|2
5407726|NCT02742103|18653212|P1|Overall Study|Death|2
5407727|NCT02742103|18653211|P2|Overall Study|Protocol Violation|0
5407728|NCT02742103|18653212|P1|Overall Study|Protocol Violation|1
5407729|NCT02741713|18653258|P2|Overall Study|Surgery type changed intra-operatively|1
5407730|NCT02741713|18653259|P1|Overall Study|Surgery type changed intra-operatively|2
5407731|NCT02741635|18653299|P1|Overall Study|Withdrawal by Subject|1
5407732|NCT02741596|18653307|P2|Overall Study|Subject withdrawn-to commercial product|63
5407733|NCT02741596|18653308|P1|Overall Study|Subject withdrawn-to commercial product|54
5407734|NCT02741596|18653307|P2|Overall Study|Subject withdrawn-Other|4
5407735|NCT02741596|18653308|P1|Overall Study|Subject withdrawn-Other|17
5407736|NCT02741596|18653307|P2|Overall Study|Other (Unspecified)|3
5407737|NCT02741596|18653308|P1|Overall Study|Other (Unspecified)|0
5407738|NCT02741596|18653307|P2|Overall Study|Pregnancy|1
5407739|NCT02741596|18653308|P1|Overall Study|Pregnancy|3
5407740|NCT02741596|18653307|P2|Overall Study|Physician Decision|1
5407741|NCT02741596|18653308|P1|Overall Study|Physician Decision|2
5407742|NCT02741596|18653307|P2|Overall Study|Lost to Follow-up|1
5407743|NCT02741596|18653308|P1|Overall Study|Lost to Follow-up|1
5407744|NCT02741596|18653307|P2|Overall Study|Adverse Event|5
5407745|NCT02741596|18653308|P1|Overall Study|Adverse Event|1
5407746|NCT02741518|18653326|P2|Overall Study|Withdrawal by Subject|1
5407747|NCT02741518|18653327|P1|Overall Study|Withdrawal by Subject|1
5407748|NCT02741310|18653337|P2|Overall Study|Sponsor Decision|2
5407749|NCT02741310|18653338|P1|Overall Study|Sponsor Decision|2
5407750|NCT02741271|18653383|P2|Overall Study|Withdrawal by Parent/Guardian|2
5407751|NCT02741271|18653384|P1|Overall Study|Withdrawal by Parent/Guardian|0
5407752|NCT02741271|18653383|P2|Overall Study|Lost to Follow-up|0
5407753|NCT02741271|18653384|P1|Overall Study|Lost to Follow-up|2
5407754|NCT02741245|18653417|P5|Overall Study|Withdrawal by Subject|0
5407755|NCT02741245|18653418|P4|Overall Study|Withdrawal by Subject|1
5407756|NCT02741245|18653419|P3|Overall Study|Withdrawal by Subject|0
5407757|NCT02741245|18653420|P2|Overall Study|Withdrawal by Subject|0
5407758|NCT02741245|18653421|P1|Overall Study|Withdrawal by Subject|0
5407759|NCT02741245|18653417|P5|Overall Study|Protocol Violation|0
5407760|NCT02741245|18653418|P4|Overall Study|Protocol Violation|1
5407761|NCT02741245|18653419|P3|Overall Study|Protocol Violation|0
5407762|NCT02741245|18653420|P2|Overall Study|Protocol Violation|1
5407763|NCT02741245|18653421|P1|Overall Study|Protocol Violation|0
5407764|NCT02741245|18653417|P5|Overall Study|Adverse Event|2
5407765|NCT02741245|18653418|P4|Overall Study|Adverse Event|2
5407766|NCT02741245|18653419|P3|Overall Study|Adverse Event|0
5407767|NCT02741245|18653420|P2|Overall Study|Adverse Event|0
5407768|NCT02741245|18653421|P1|Overall Study|Adverse Event|0
5407769|NCT02741076|18653527|P4|Overall Study|No additional information available|1
5407770|NCT02741076|18653528|P3|Overall Study|No additional information available|1
5407771|NCT02741076|18653529|P2|Overall Study|No additional information available|0
5407772|NCT02741076|18653530|P1|Overall Study|No additional information available|0
5407773|NCT02741076|18653527|P4|Overall Study|Sponsor Request|1
5407774|NCT02741076|18653528|P3|Overall Study|Sponsor Request|0
5407775|NCT02741076|18653529|P2|Overall Study|Sponsor Request|3
5407776|NCT02741076|18653530|P1|Overall Study|Sponsor Request|2
5407777|NCT02741076|18653527|P4|Overall Study|Withdrawal by Subject|0
5407778|NCT02741076|18653528|P3|Overall Study|Withdrawal by Subject|0
5407779|NCT02741076|18653529|P2|Overall Study|Withdrawal by Subject|1
5407780|NCT02741076|18653530|P1|Overall Study|Withdrawal by Subject|0
5407781|NCT02741076|18653527|P4|Overall Study|Lack of Efficacy|0
5407782|NCT02741076|18653528|P3|Overall Study|Lack of Efficacy|0
5407783|NCT02741076|18653529|P2|Overall Study|Lack of Efficacy|0
5407784|NCT02741076|18653530|P1|Overall Study|Lack of Efficacy|1
5407785|NCT02741076|18653527|P4|Overall Study|Adverse Event|0
5407786|NCT02741076|18653528|P3|Overall Study|Adverse Event|1
5407787|NCT02741076|18653529|P2|Overall Study|Adverse Event|1
5407788|NCT02741076|18653530|P1|Overall Study|Adverse Event|0
5407789|NCT02740049|18653655|P1|Overall Study|Isolated cells did not grow sufficiently|1
5407790|NCT02739997|18653661|P1|Overall Study|Withdrawal by Subject|1
5407791|NCT02739997|18653661|P1|Overall Study|Death|1
5407792|NCT02739984|18653675|P2|Overall Study|Lost to Follow-up|0
5407793|NCT02739984|18653676|P1|Overall Study|Lost to Follow-up|3
5407794|NCT02739984|18653675|P2|Overall Study|Death|1
5407795|NCT02739984|18653676|P1|Overall Study|Death|0
5407796|NCT02739984|18653675|P2|Overall Study|Withdrawal by Subject|1
5407797|NCT02739984|18653676|P1|Overall Study|Withdrawal by Subject|1
5407798|NCT02739984|18653675|P2|Overall Study|Sponsor Decision|0
5407799|NCT02739984|18653676|P1|Overall Study|Sponsor Decision|1
5407800|NCT02739828|18653724|P1|Overall Study|Lost to Follow-up|4
5407801|NCT02739828|18653724|P1|Overall Study|Adverse Event|1
5407802|NCT02739594|18653784|P2|Overall Study|Other|2
5407803|NCT02739594|18653785|P1|Overall Study|Other|6
5407804|NCT02739594|18653784|P2|Overall Study|Elevated Serum Creatinine|1
5407805|NCT02739594|18653785|P1|Overall Study|Elevated Serum Creatinine|0
5407806|NCT02739594|18653784|P2|Overall Study|Lost to Follow-up|1
5407807|NCT02739594|18653785|P1|Overall Study|Lost to Follow-up|0
5407808|NCT02739594|18653784|P2|Overall Study|Withdrawal by Subject|1
5407809|NCT02739594|18653785|P1|Overall Study|Withdrawal by Subject|1
5407810|NCT02739594|18653784|P2|Overall Study|Administrative Reasons|3
5407811|NCT02739594|18653785|P1|Overall Study|Administrative Reasons|1
5407812|NCT02739594|18653784|P2|Overall Study|Renal Insufficiency|6
5407813|NCT02739594|18653785|P1|Overall Study|Renal Insufficiency|4
5407814|NCT02739594|18653784|P2|Overall Study|Death|2
5407815|NCT02739594|18653785|P1|Overall Study|Death|4
5407816|NCT02739594|18653784|P2|Overall Study|Protocol Violation|6
5407817|NCT02739594|18653785|P1|Overall Study|Protocol Violation|5
5407818|NCT02739594|18653784|P2|Overall Study|Violation of Eligibility Criteria|2
5407819|NCT02739594|18653785|P1|Overall Study|Violation of Eligibility Criteria|1
5407820|NCT02739594|18653784|P2|Overall Study|Undesired Event|4
5407821|NCT02739594|18653785|P1|Overall Study|Undesired Event|3
5407822|NCT02739360|18653815|P1|Overall Study|Study terminated by Sponsor|2
5407823|NCT02739360|18653815|P1|Overall Study|Adverse Event|1
5407824|NCT02739321|18653821|P2|Overall Study|Withdrawal by Subject|2
5407825|NCT02739321|18653822|P1|Overall Study|Withdrawal by Subject|1
5407826|NCT02739321|18653821|P2|Overall Study|Lost to Follow-up|1
5407827|NCT02739321|18653822|P1|Overall Study|Lost to Follow-up|1
5407828|NCT02739321|18653821|P2|Overall Study|Lack of Efficacy|1
5407829|NCT02739321|18653822|P1|Overall Study|Lack of Efficacy|1
5407830|NCT02739269|18653868|P2|Overall Study|Withdrawal by Subject|2
5407831|NCT02739269|18653869|P1|Overall Study|Withdrawal by Subject|0
5407832|NCT02739269|18653868|P2|Overall Study|Cycle cancellation|2
5407833|NCT02739269|18653869|P1|Overall Study|Cycle cancellation|2
5407834|NCT02739269|18653868|P2|Overall Study|Protocol Violation|0
5407835|NCT02739269|18653869|P1|Overall Study|Protocol Violation|5
5407836|NCT02738879|18653896|P2|Overall Study|Withdrawal by Subject|7
5407837|NCT02738879|18653897|P1|Overall Study|Withdrawal by Subject|5
5407838|NCT02738879|18653896|P2|Overall Study|Site Discontinued Study Participation|0
5407839|NCT02738879|18653897|P1|Overall Study|Site Discontinued Study Participation|1
5407840|NCT02738879|18653896|P2|Overall Study|Screen Failure|2
5407841|NCT02738879|18653897|P1|Overall Study|Screen Failure|1
5407842|NCT02738879|18653896|P2|Overall Study|Pregnancy|1
5407843|NCT02738879|18653897|P1|Overall Study|Pregnancy|0
5407844|NCT02738879|18653896|P2|Overall Study|Physician Decision|4
5407845|NCT02738879|18653897|P1|Overall Study|Physician Decision|3
5407846|NCT02738879|18653896|P2|Overall Study|Protocol Violation|3
5407847|NCT02738879|18653897|P1|Overall Study|Protocol Violation|1
5407848|NCT02738879|18653896|P2|Overall Study|Lost to Follow-up|5
5407849|NCT02738879|18653897|P1|Overall Study|Lost to Follow-up|1
5407850|NCT02738879|18653896|P2|Overall Study|Death|2
5407851|NCT02738879|18653897|P1|Overall Study|Death|0
5407852|NCT02738879|18653896|P2|Overall Study|Adverse Event|1
5407853|NCT02738879|18653897|P1|Overall Study|Adverse Event|1
5407854|NCT02738801|18653949|P2|Overall Study|Withdrawal by Subject|1
5407855|NCT02738801|18653950|P1|Overall Study|Withdrawal by Subject|0
5407856|NCT02738801|18653949|P2|Overall Study|Adverse Event|1
5407857|NCT02738801|18653950|P1|Overall Study|Adverse Event|1
5407858|NCT02738580|18653966|P2|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
5407859|NCT02738580|18653967|P1|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
5407860|NCT02738580|18653966|P2|Overall Study|Withdrawal by Subject|1
5407861|NCT02738580|18653967|P1|Overall Study|Withdrawal by Subject|0
5407862|NCT02738580|18653966|P2|Overall Study|Lack of Efficacy|2
5407863|NCT02738580|18653967|P1|Overall Study|Lack of Efficacy|3
5407864|NCT02738580|18653966|P2|Overall Study|Adverse Event|0
5407865|NCT02738580|18653967|P1|Overall Study|Adverse Event|1
5407866|NCT02738333|18653978|P3|Overall Study|Lost to Follow-up|0
5407867|NCT02738333|18653979|P2|Overall Study|Lost to Follow-up|0
5407868|NCT02738333|18653980|P1|Overall Study|Lost to Follow-up|1
5407869|NCT02738333|18653978|P3|Overall Study|Death|0
5407870|NCT02738333|18653979|P2|Overall Study|Death|0
5407871|NCT02738333|18653980|P1|Overall Study|Death|1
5407872|NCT02738203|18654069|P2|Overall Study|Protocol Violation|1
5407873|NCT02738203|18654070|P1|Overall Study|Protocol Violation|0
5407874|NCT02738203|18654069|P2|Overall Study|Failed IUD Insertion|2
5407875|NCT02738203|18654070|P1|Overall Study|Failed IUD Insertion|2
5407876|NCT02738151|18654086|P2|Overall Study|Other than specified above|21
5407877|NCT02738151|18654087|P1|Overall Study|Other than specified above|11
5407878|NCT02738151|18654086|P2|Overall Study|Poor Compliance to Protocol|3
5407879|NCT02738151|18654087|P1|Overall Study|Poor Compliance to Protocol|4
5407880|NCT02738151|18654086|P2|Overall Study|Hypoglycemia|1
5407881|NCT02738151|18654087|P1|Overall Study|Hypoglycemia|0
5407882|NCT02738151|18654086|P2|Overall Study|Adverse Event|5
5407883|NCT02738151|18654087|P1|Overall Study|Adverse Event|4
5407884|NCT02738151|18654086|P2|Overall Study|Randomized but not treated|1
5407885|NCT02738151|18654087|P1|Overall Study|Randomized but not treated|4
5407886|NCT02738138|18654131|P2|Overall Study|Other - not further specified|0
5407887|NCT02738138|18654132|P1|Overall Study|Other - not further specified|1
5407888|NCT02738138|18654131|P2|Overall Study|Lost to Follow-up|0
5407889|NCT02738138|18654132|P1|Overall Study|Lost to Follow-up|2
5407890|NCT02738138|18654131|P2|Overall Study|Adverse Event|1
5407891|NCT02738138|18654132|P1|Overall Study|Adverse Event|0
5407892|NCT02738008|18654169|P3|Overall Study|Adverse Event|2
5407893|NCT02738008|18654170|P2|Overall Study|Adverse Event|1
5407894|NCT02738008|18654171|P1|Overall Study|Adverse Event|0
5407895|NCT02738008|18654169|P3|Overall Study|Study Terminated by Sponsor|3
5407896|NCT02738008|18654170|P2|Overall Study|Study Terminated by Sponsor|5
5407897|NCT02738008|18654171|P1|Overall Study|Study Terminated by Sponsor|1
5407898|NCT02737852|18654209|P1|Overall Study|Withdrawal by Subject|2
5407899|NCT02737722|18654218|P4|Overall Study|Physician Decision|0
5407900|NCT02737722|18654219|P3|Overall Study|Physician Decision|1
5407901|NCT02737722|18654220|P2|Overall Study|Physician Decision|0
5407902|NCT02737722|18654221|P1|Overall Study|Physician Decision|0
5407903|NCT02737618|18654272|P1|Overall Study|Withdrawal by Subject|9
5407904|NCT02737592|18654277|P1|Overall Study|Withdrawal by Subject|1
5407905|NCT02737358|18654298|P2|Overall Study|Lost to Follow-up|3
5407906|NCT02737358|18654299|P1|Overall Study|Lost to Follow-up|2
5407907|NCT02737358|18654298|P2|Overall Study|Withdrawal by Subject|12
5407908|NCT02737358|18654299|P1|Overall Study|Withdrawal by Subject|7
5407909|NCT02736890|18654406|P2|Crossover Next 12 Weeks|Withdrawal by Subject|0
5407910|NCT02736890|18654407|P1|Crossover Next 12 Weeks|Withdrawal by Subject|1
5407911|NCT02736890|18654406|P2|Crossover Next 12 Weeks|Lost to Follow-up|2
5407912|NCT02736890|18654407|P1|Crossover Next 12 Weeks|Lost to Follow-up|1
5407913|NCT02736825|18654429|P2|Overall Study|Early Termination|1
5407914|NCT02736825|18654430|P1|Overall Study|Early Termination|0
5407915|NCT02736825|18654429|P2|Overall Study|Lost to Follow-up|11
5407916|NCT02736825|18654430|P1|Overall Study|Lost to Follow-up|10
5407917|NCT02736721|18654470|P1|Overall Study|Other|5
5407918|NCT02736721|18654470|P1|Overall Study|Lost to Follow-up|3
5407919|NCT02736721|18654470|P1|Overall Study|Adverse Event|8
5407920|NCT02736578|18654481|P2|Overall Study|Adverse Event|0
5407921|NCT02736578|18654482|P1|Overall Study|Adverse Event|1
5407922|NCT02736188|18654500|P1|Overall Study|Other|6
5407923|NCT02736188|18654500|P1|Overall Study|Withdrawal by Subject|1
5407924|NCT02736188|18654500|P1|Overall Study|Adverse Event|1
5407925|NCT02736188|18654500|P1|Overall Study|Discontinuation of Study by Sponsor|134
5407926|NCT02735980|18654538|P3|Overall Study|Withdrawal by Subject|0
5407927|NCT02735980|18654539|P2|Overall Study|Withdrawal by Subject|2
5407928|NCT02735980|18654540|P1|Overall Study|Withdrawal by Subject|1
5407929|NCT02735980|18654538|P3|Overall Study|Screen failure|0
5407930|NCT02735980|18654539|P2|Overall Study|Screen failure|0
5407931|NCT02735980|18654540|P1|Overall Study|Screen failure|1
5407932|NCT02735980|18654538|P3|Overall Study|Physician Decision|0
5407933|NCT02735980|18654539|P2|Overall Study|Physician Decision|1
5407934|NCT02735980|18654540|P1|Overall Study|Physician Decision|3
5407935|NCT02735980|18654538|P3|Overall Study|Death|0
5407936|NCT02735980|18654539|P2|Overall Study|Death|4
5407937|NCT02735980|18654540|P1|Overall Study|Death|5
5407938|NCT02735980|18654538|P3|Overall Study|Adverse Event|1
5407939|NCT02735980|18654539|P2|Overall Study|Adverse Event|4
5407940|NCT02735980|18654540|P1|Overall Study|Adverse Event|0
5407941|NCT02735915|18654569|P1|Overall Study|Withdrawal by Subject|1
5407942|NCT02735915|18654569|P1|Overall Study|Withdrawal following SAE|2
5407943|NCT02735915|18654569|P1|Overall Study|Not vaccinated but subject ID assigned|8
5407944|NCT02735577|18654601|P1|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
5407945|NCT02735577|18654601|P1|Disulfiram Treatment|Lost to Follow-up|1
5407946|NCT02735421|18654618|P1|Overall Study|Pregnancy|1
5407947|NCT02735421|18654618|P1|Overall Study|Inadequate compliance to treatment|1
5407948|NCT02735421|18654618|P1|Overall Study|Lost to Follow-up|3
5407949|NCT02735421|18654618|P1|Overall Study|Withdrawal by Subject|6
5407950|NCT02735421|18654618|P1|Overall Study|Adverse Event|2
5407951|NCT02735200|18654648|P2|Overall Study|Withdrawal by Subject|0
5407952|NCT02735200|18654649|P1|Overall Study|Withdrawal by Subject|8
5407953|NCT02735200|18654648|P2|Overall Study|Lost to Follow-up|5
5407954|NCT02735200|18654649|P1|Overall Study|Lost to Follow-up|0
5407955|NCT02735096|18654692|P1|Overall Study|No symptoms in clinic/personal leave|1
5407956|NCT02735044|18654701|P2|Overall Study|Other, not specified above|11
5407957|NCT02735044|18654702|P1|Overall Study|Other, not specified above|5
5407958|NCT02735044|18654701|P2|Overall Study|Randomized and not treated|2
5407959|NCT02735044|18654702|P1|Overall Study|Randomized and not treated|0
5407960|NCT02735044|18654701|P2|Overall Study|Poor compliance to protocol|7
5407961|NCT02735044|18654702|P1|Overall Study|Poor compliance to protocol|7
5407962|NCT02735044|18654701|P2|Overall Study|Lack of Efficacy|0
5407963|NCT02735044|18654702|P1|Overall Study|Lack of Efficacy|1
5407964|NCT02735044|18654701|P2|Overall Study|Adverse Event|3
5407965|NCT02735044|18654702|P1|Overall Study|Adverse Event|3
5407966|NCT02734862|18654771|P3|Part B|Other|0
5407967|NCT02734862|18654772|P2|Part B|Other|1
5407968|NCT02734862|18654773|P1|Part B|Other|0
5407969|NCT02734862|18654771|P3|Part B|Withdrawal by Subject|0
5407970|NCT02734862|18654772|P2|Part B|Withdrawal by Subject|1
5407971|NCT02734862|18654773|P1|Part B|Withdrawal by Subject|3
5407972|NCT02734862|18654771|P3|Part B|Lost to Follow-up|0
5407973|NCT02734862|18654772|P2|Part B|Lost to Follow-up|2
5407974|NCT02734862|18654773|P1|Part B|Lost to Follow-up|2
5407975|NCT02734862|18654771|P3|Part B|Death|5
5407976|NCT02734862|18654772|P2|Part B|Death|3
5407977|NCT02734862|18654773|P1|Part B|Death|8
5407978|NCT02734862|18654771|P3|Part A|Other|3
5407979|NCT02734862|18654772|P2|Part A|Other|1
5407980|NCT02734862|18654773|P1|Part A|Other|1
5407981|NCT02734862|18654771|P3|Part A|Noncompliance|0
5407982|NCT02734862|18654772|P2|Part A|Noncompliance|1
5407983|NCT02734862|18654773|P1|Part A|Noncompliance|1
5407984|NCT02734862|18654771|P3|Part A|Adverse Event|1
5407985|NCT02734862|18654772|P2|Part A|Adverse Event|0
5407986|NCT02734862|18654773|P1|Part A|Adverse Event|2
5407987|NCT02734862|18654771|P3|Part A|Physician Decision|1
5407988|NCT02734862|18654772|P2|Part A|Physician Decision|0
5407989|NCT02734862|18654773|P1|Part A|Physician Decision|2
5407990|NCT02734862|18654771|P3|Part A|Withdrawal by Subject|2
5407991|NCT02734862|18654772|P2|Part A|Withdrawal by Subject|1
5407992|NCT02734862|18654773|P1|Part A|Withdrawal by Subject|1
5407993|NCT02734862|18654771|P3|Part A|Lost to Follow-up|1
5407994|NCT02734862|18654772|P2|Part A|Lost to Follow-up|1
5407995|NCT02734862|18654773|P1|Part A|Lost to Follow-up|2
5407996|NCT02734862|18654771|P3|Part A|Death|6
5407997|NCT02734862|18654772|P2|Part A|Death|4
5407998|NCT02734862|18654773|P1|Part A|Death|3
5407999|NCT02734810|18654814|P2|Overall Study|Lack of Efficacy|0
5408000|NCT02734810|18654815|P1|Overall Study|Lack of Efficacy|1
5408001|NCT02734810|18654814|P2|Overall Study|Adverse Event|0
5408002|NCT02734810|18654815|P1|Overall Study|Adverse Event|1
5408003|NCT02734693|18654824|P3|Overall Study|Withdrawal by Subject|0
5408004|NCT02734693|18654825|P2|Overall Study|Withdrawal by Subject|0
5408005|NCT02734693|18654826|P1|Overall Study|Withdrawal by Subject|1
5408006|NCT02734693|18654824|P3|Overall Study|Protocol Violation|0
5408007|NCT02734693|18654825|P2|Overall Study|Protocol Violation|0
5408008|NCT02734693|18654826|P1|Overall Study|Protocol Violation|1
5408009|NCT02734693|18654824|P3|Overall Study|Lost to Follow-up|0
5408010|NCT02734693|18654825|P2|Overall Study|Lost to Follow-up|0
5408011|NCT02734693|18654826|P1|Overall Study|Lost to Follow-up|2
5408012|NCT02734693|18654824|P3|Overall Study|Lack of Efficacy|0
5408013|NCT02734693|18654825|P2|Overall Study|Lack of Efficacy|0
5408014|NCT02734693|18654826|P1|Overall Study|Lack of Efficacy|1
5408015|NCT02734693|18654824|P3|Overall Study|Adverse Event|3
5408016|NCT02734693|18654825|P2|Overall Study|Adverse Event|3
5408017|NCT02734693|18654826|P1|Overall Study|Adverse Event|1
5408018|NCT02734433|18654867|P2|Overall Study|Withdrawal by Subject|2
5408019|NCT02734433|18654868|P1|Overall Study|Withdrawal by Subject|1
5408020|NCT02734433|18654867|P2|Overall Study|Clinical progression|1
5408021|NCT02734433|18654868|P1|Overall Study|Clinical progression|0
5408022|NCT02734433|18654867|P2|Overall Study|Disease progression|5
5408023|NCT02734433|18654868|P1|Overall Study|Disease progression|1
5408024|NCT02734212|18654944|P2|Overall Study|Lost to Follow-up|10
5408025|NCT02734212|18654945|P1|Overall Study|Lost to Follow-up|5
5408026|NCT02733991|18654966|P2|Overall Study|Withdrawal by Subject|5
5408027|NCT02733991|18654967|P1|Overall Study|Withdrawal by Subject|0
5408028|NCT02733991|18654966|P2|Overall Study|Adverse Event|0
5408029|NCT02733991|18654967|P1|Overall Study|Adverse Event|1
5408030|NCT02733367|18655007|P1|Overall Study|Withdrawal by Subject|6
5408031|NCT02733042|18655033|P19|Follow-up Period|Withdrawal by Subject|0
5408032|NCT02733042|18655034|P18|Follow-up Period|Withdrawal by Subject|0
5408033|NCT02733042|18655035|P17|Follow-up Period|Withdrawal by Subject|0
5408034|NCT02733042|18655036|P16|Follow-up Period|Withdrawal by Subject|1
5408035|NCT02733042|18655037|P15|Follow-up Period|Withdrawal by Subject|0
5408036|NCT02733042|18655038|P14|Follow-up Period|Withdrawal by Subject|0
5408037|NCT02733042|18655039|P13|Follow-up Period|Withdrawal by Subject|0
5408038|NCT02733042|18655040|P12|Follow-up Period|Withdrawal by Subject|0
5408039|NCT02733042|18655041|P11|Follow-up Period|Withdrawal by Subject|1
5408040|NCT02733042|18655042|P10|Follow-up Period|Withdrawal by Subject|0
5408041|NCT02733042|18655043|P9|Follow-up Period|Withdrawal by Subject|1
5408042|NCT02733042|18655044|P8|Follow-up Period|Withdrawal by Subject|0
5408043|NCT02733042|18655045|P7|Follow-up Period|Withdrawal by Subject|0
5408044|NCT02733042|18655046|P6|Follow-up Period|Withdrawal by Subject|0
5408045|NCT02733042|18655047|P5|Follow-up Period|Withdrawal by Subject|0
5408046|NCT02733042|18655048|P4|Follow-up Period|Withdrawal by Subject|0
5408047|NCT02733042|18655049|P3|Follow-up Period|Withdrawal by Subject|0
5408048|NCT02733042|18655050|P2|Follow-up Period|Withdrawal by Subject|0
5408049|NCT02733042|18655051|P1|Follow-up Period|Withdrawal by Subject|0
5408050|NCT02733042|18655033|P19|Follow-up Period|Other|0
5408051|NCT02733042|18655034|P18|Follow-up Period|Other|0
5408052|NCT02733042|18655035|P17|Follow-up Period|Other|0
5408053|NCT02733042|18655036|P16|Follow-up Period|Other|0
5408054|NCT02733042|18655037|P15|Follow-up Period|Other|0
5408055|NCT02733042|18655038|P14|Follow-up Period|Other|0
5408056|NCT02733042|18655039|P13|Follow-up Period|Other|0
5408057|NCT02733042|18655040|P12|Follow-up Period|Other|0
5408058|NCT02733042|18655041|P11|Follow-up Period|Other|0
5408059|NCT02733042|18655042|P10|Follow-up Period|Other|0
5408060|NCT02733042|18655043|P9|Follow-up Period|Other|0
5408061|NCT02733042|18655044|P8|Follow-up Period|Other|0
5408062|NCT02733042|18655045|P7|Follow-up Period|Other|0
5408063|NCT02733042|18655046|P6|Follow-up Period|Other|0
5408064|NCT02733042|18655047|P5|Follow-up Period|Other|0
5408065|NCT02733042|18655048|P4|Follow-up Period|Other|1
5408066|NCT02733042|18655049|P3|Follow-up Period|Other|0
5408067|NCT02733042|18655050|P2|Follow-up Period|Other|0
5408068|NCT02733042|18655051|P1|Follow-up Period|Other|0
5408069|NCT02733042|18655033|P19|Follow-up Period|Death|2
5408070|NCT02733042|18655034|P18|Follow-up Period|Death|1
5408071|NCT02733042|18655035|P17|Follow-up Period|Death|0
5408072|NCT02733042|18655036|P16|Follow-up Period|Death|4
5408073|NCT02733042|18655037|P15|Follow-up Period|Death|1
5408074|NCT02733042|18655038|P14|Follow-up Period|Death|1
5408075|NCT02733042|18655039|P13|Follow-up Period|Death|8
5408076|NCT02733042|18655040|P12|Follow-up Period|Death|0
5408077|NCT02733042|18655041|P11|Follow-up Period|Death|0
5408078|NCT02733042|18655042|P10|Follow-up Period|Death|0
5408079|NCT02733042|18655043|P9|Follow-up Period|Death|3
5408080|NCT02733042|18655044|P8|Follow-up Period|Death|3
5408081|NCT02733042|18655045|P7|Follow-up Period|Death|0
5408082|NCT02733042|18655046|P6|Follow-up Period|Death|2
5408083|NCT02733042|18655047|P5|Follow-up Period|Death|1
5408084|NCT02733042|18655048|P4|Follow-up Period|Death|0
5408085|NCT02733042|18655049|P3|Follow-up Period|Death|2
5408086|NCT02733042|18655050|P2|Follow-up Period|Death|1
5408087|NCT02733042|18655051|P1|Follow-up Period|Death|1
5408088|NCT02733042|18655033|P19|Follow-up Period|Ongoing on Follow-up|0
5408089|NCT02733042|18655034|P18|Follow-up Period|Ongoing on Follow-up|1
5408090|NCT02733042|18655035|P17|Follow-up Period|Ongoing on Follow-up|0
5408091|NCT02733042|18655036|P16|Follow-up Period|Ongoing on Follow-up|0
5408092|NCT02733042|18655037|P15|Follow-up Period|Ongoing on Follow-up|0
5408093|NCT02733042|18655038|P14|Follow-up Period|Ongoing on Follow-up|3
5408094|NCT02733042|18655039|P13|Follow-up Period|Ongoing on Follow-up|1
5408095|NCT02733042|18655040|P12|Follow-up Period|Ongoing on Follow-up|9
5408096|NCT02733042|18655041|P11|Follow-up Period|Ongoing on Follow-up|4
5408097|NCT02733042|18655042|P10|Follow-up Period|Ongoing on Follow-up|2
5408098|NCT02733042|18655043|P9|Follow-up Period|Ongoing on Follow-up|0
5408099|NCT02733042|18655044|P8|Follow-up Period|Ongoing on Follow-up|1
5408100|NCT02733042|18655045|P7|Follow-up Period|Ongoing on Follow-up|0
5408101|NCT02733042|18655046|P6|Follow-up Period|Ongoing on Follow-up|0
5408102|NCT02733042|18655047|P5|Follow-up Period|Ongoing on Follow-up|0
5408103|NCT02733042|18655048|P4|Follow-up Period|Ongoing on Follow-up|2
5408104|NCT02733042|18655049|P3|Follow-up Period|Ongoing on Follow-up|4
5408105|NCT02733042|18655050|P2|Follow-up Period|Ongoing on Follow-up|2
5408106|NCT02733042|18655051|P1|Follow-up Period|Ongoing on Follow-up|2
5408107|NCT02733042|18655033|P19|Treatment Period|Death|0
5408108|NCT02733042|18655034|P18|Treatment Period|Death|0
5408109|NCT02733042|18655035|P17|Treatment Period|Death|0
5408110|NCT02733042|18655036|P16|Treatment Period|Death|2
5408111|NCT02733042|18655037|P15|Treatment Period|Death|1
5408112|NCT02733042|18655038|P14|Treatment Period|Death|0
5408113|NCT02733042|18655039|P13|Treatment Period|Death|0
5408114|NCT02733042|18655040|P12|Treatment Period|Death|0
5408115|NCT02733042|18655041|P11|Treatment Period|Death|1
5408116|NCT02733042|18655042|P10|Treatment Period|Death|0
5408117|NCT02733042|18655043|P9|Treatment Period|Death|1
5408118|NCT02733042|18655044|P8|Treatment Period|Death|0
5408119|NCT02733042|18655045|P7|Treatment Period|Death|1
5408120|NCT02733042|18655046|P6|Treatment Period|Death|0
5408121|NCT02733042|18655047|P5|Treatment Period|Death|0
5408122|NCT02733042|18655048|P4|Treatment Period|Death|0
5408123|NCT02733042|18655049|P3|Treatment Period|Death|0
5408124|NCT02733042|18655050|P2|Treatment Period|Death|0
5408125|NCT02733042|18655051|P1|Treatment Period|Death|0
5408126|NCT02733042|18655033|P19|Treatment Period|Ongoing on Assigned Treatment|1
5408127|NCT02733042|18655034|P18|Treatment Period|Ongoing on Assigned Treatment|0
5408128|NCT02733042|18655035|P17|Treatment Period|Ongoing on Assigned Treatment|0
5408129|NCT02733042|18655036|P16|Treatment Period|Ongoing on Assigned Treatment|0
5408130|NCT02733042|18655037|P15|Treatment Period|Ongoing on Assigned Treatment|0
5408131|NCT02733042|18655038|P14|Treatment Period|Ongoing on Assigned Treatment|0
5408132|NCT02733042|18655039|P13|Treatment Period|Ongoing on Assigned Treatment|0
5408133|NCT02733042|18655040|P12|Treatment Period|Ongoing on Assigned Treatment|0
5408134|NCT02733042|18655041|P11|Treatment Period|Ongoing on Assigned Treatment|4
5408135|NCT02733042|18655042|P10|Treatment Period|Ongoing on Assigned Treatment|8
5408136|NCT02733042|18655043|P9|Treatment Period|Ongoing on Assigned Treatment|0
5408137|NCT02733042|18655044|P8|Treatment Period|Ongoing on Assigned Treatment|0
5408138|NCT02733042|18655045|P7|Treatment Period|Ongoing on Assigned Treatment|0
5408139|NCT02733042|18655046|P6|Treatment Period|Ongoing on Assigned Treatment|0
5408140|NCT02733042|18655047|P5|Treatment Period|Ongoing on Assigned Treatment|3
5408141|NCT02733042|18655048|P4|Treatment Period|Ongoing on Assigned Treatment|0
5408142|NCT02733042|18655049|P3|Treatment Period|Ongoing on Assigned Treatment|0
5408143|NCT02733042|18655050|P2|Treatment Period|Ongoing on Assigned Treatment|0
5408144|NCT02733042|18655051|P1|Treatment Period|Ongoing on Assigned Treatment|0
5408145|NCT02733042|18655033|P19|Treatment Period|Other|0
5408146|NCT02733042|18655034|P18|Treatment Period|Other|1
5408147|NCT02733042|18655035|P17|Treatment Period|Other|0
5408148|NCT02733042|18655036|P16|Treatment Period|Other|1
5408149|NCT02733042|18655037|P15|Treatment Period|Other|0
5408150|NCT02733042|18655038|P14|Treatment Period|Other|0
5408151|NCT02733042|18655039|P13|Treatment Period|Other|0
5408152|NCT02733042|18655040|P12|Treatment Period|Other|0
5408153|NCT02733042|18655041|P11|Treatment Period|Other|1
5408154|NCT02733042|18655042|P10|Treatment Period|Other|1
5408155|NCT02733042|18655043|P9|Treatment Period|Other|0
5408156|NCT02733042|18655044|P8|Treatment Period|Other|0
5408157|NCT02733042|18655045|P7|Treatment Period|Other|0
5408158|NCT02733042|18655046|P6|Treatment Period|Other|0
5408159|NCT02733042|18655047|P5|Treatment Period|Other|0
5408160|NCT02733042|18655048|P4|Treatment Period|Other|0
5408161|NCT02733042|18655049|P3|Treatment Period|Other|1
5408162|NCT02733042|18655050|P2|Treatment Period|Other|0
5408163|NCT02733042|18655051|P1|Treatment Period|Other|0
5408164|NCT02733042|18655033|P19|Treatment Period|Withdrawal by Subject|0
5408165|NCT02733042|18655034|P18|Treatment Period|Withdrawal by Subject|0
5408166|NCT02733042|18655035|P17|Treatment Period|Withdrawal by Subject|0
5408167|NCT02733042|18655036|P16|Treatment Period|Withdrawal by Subject|0
5408168|NCT02733042|18655037|P15|Treatment Period|Withdrawal by Subject|0
5408169|NCT02733042|18655038|P14|Treatment Period|Withdrawal by Subject|1
5408170|NCT02733042|18655039|P13|Treatment Period|Withdrawal by Subject|1
5408171|NCT02733042|18655040|P12|Treatment Period|Withdrawal by Subject|2
5408172|NCT02733042|18655041|P11|Treatment Period|Withdrawal by Subject|0
5408173|NCT02733042|18655042|P10|Treatment Period|Withdrawal by Subject|1
5408174|NCT02733042|18655043|P9|Treatment Period|Withdrawal by Subject|1
5408175|NCT02733042|18655044|P8|Treatment Period|Withdrawal by Subject|0
5408176|NCT02733042|18655045|P7|Treatment Period|Withdrawal by Subject|0
5408177|NCT02733042|18655046|P6|Treatment Period|Withdrawal by Subject|0
5408178|NCT02733042|18655047|P5|Treatment Period|Withdrawal by Subject|0
5408179|NCT02733042|18655048|P4|Treatment Period|Withdrawal by Subject|1
5408180|NCT02733042|18655049|P3|Treatment Period|Withdrawal by Subject|2
5408181|NCT02733042|18655050|P2|Treatment Period|Withdrawal by Subject|1
5408182|NCT02733042|18655051|P1|Treatment Period|Withdrawal by Subject|0
5408183|NCT02733042|18655033|P19|Treatment Period|Progressive Disease|4
5408184|NCT02733042|18655034|P18|Treatment Period|Progressive Disease|3
5408185|NCT02733042|18655035|P17|Treatment Period|Progressive Disease|2
5408186|NCT02733042|18655036|P16|Treatment Period|Progressive Disease|7
5408187|NCT02733042|18655037|P15|Treatment Period|Progressive Disease|4
5408188|NCT02733042|18655038|P14|Treatment Period|Progressive Disease|1
5408189|NCT02733042|18655039|P13|Treatment Period|Progressive Disease|8
5408190|NCT02733042|18655040|P12|Treatment Period|Progressive Disease|2
5408191|NCT02733042|18655041|P11|Treatment Period|Progressive Disease|2
5408192|NCT02733042|18655042|P10|Treatment Period|Progressive Disease|0
5408193|NCT02733042|18655043|P9|Treatment Period|Progressive Disease|3
5408194|NCT02733042|18655044|P8|Treatment Period|Progressive Disease|3
5408195|NCT02733042|18655045|P7|Treatment Period|Progressive Disease|0
5408196|NCT02733042|18655046|P6|Treatment Period|Progressive Disease|3
5408197|NCT02733042|18655047|P5|Treatment Period|Progressive Disease|1
5408198|NCT02733042|18655048|P4|Treatment Period|Progressive Disease|1
5408199|NCT02733042|18655049|P3|Treatment Period|Progressive Disease|3
5408200|NCT02733042|18655050|P2|Treatment Period|Progressive Disease|1
5408201|NCT02733042|18655051|P1|Treatment Period|Progressive Disease|2
5408202|NCT02733042|18655033|P19|Treatment Period|Adverse Event|0
5408203|NCT02733042|18655034|P18|Treatment Period|Adverse Event|1
5408204|NCT02733042|18655035|P17|Treatment Period|Adverse Event|0
5408205|NCT02733042|18655036|P16|Treatment Period|Adverse Event|0
5408206|NCT02733042|18655037|P15|Treatment Period|Adverse Event|0
5408207|NCT02733042|18655038|P14|Treatment Period|Adverse Event|2
5408208|NCT02733042|18655039|P13|Treatment Period|Adverse Event|0
5408209|NCT02733042|18655040|P12|Treatment Period|Adverse Event|2
5408210|NCT02733042|18655041|P11|Treatment Period|Adverse Event|2
5408211|NCT02733042|18655042|P10|Treatment Period|Adverse Event|0
5408212|NCT02733042|18655043|P9|Treatment Period|Adverse Event|0
5408213|NCT02733042|18655044|P8|Treatment Period|Adverse Event|0
5408214|NCT02733042|18655045|P7|Treatment Period|Adverse Event|0
5408215|NCT02733042|18655046|P6|Treatment Period|Adverse Event|0
5408216|NCT02733042|18655047|P5|Treatment Period|Adverse Event|0
5408217|NCT02733042|18655048|P4|Treatment Period|Adverse Event|1
5408218|NCT02733042|18655049|P3|Treatment Period|Adverse Event|1
5408219|NCT02733042|18655050|P2|Treatment Period|Adverse Event|0
5408220|NCT02733042|18655051|P1|Treatment Period|Adverse Event|1
5408221|NCT02732951|18655256|P2|Overall Study|Protocol Violation|1
5408222|NCT02732951|18655257|P1|Overall Study|Protocol Violation|0
5408223|NCT02732951|18655256|P2|Overall Study|Adverse Event|4
5408224|NCT02732951|18655257|P1|Overall Study|Adverse Event|4
5408225|NCT02732951|18655256|P2|Overall Study|Lost to Follow-up|1
5408226|NCT02732951|18655257|P1|Overall Study|Lost to Follow-up|0
5408227|NCT02732951|18655256|P2|Overall Study|Other than listed|0
5408228|NCT02732951|18655257|P1|Overall Study|Other than listed|1
5408229|NCT02732938|18655267|P3|Overall Study|Study terminated by sponsor|0
5408230|NCT02732938|18655268|P2|Overall Study|Study terminated by sponsor|6
5408231|NCT02732938|18655269|P1|Overall Study|Study terminated by sponsor|3
5408232|NCT02732938|18655267|P3|Overall Study|Refused further follow-up|0
5408233|NCT02732938|18655268|P2|Overall Study|Refused further follow-up|0
5408234|NCT02732938|18655269|P1|Overall Study|Refused further follow-up|1
5408235|NCT02732938|18655267|P3|Overall Study|Randomized but did not receive treatment|0
5408236|NCT02732938|18655268|P2|Overall Study|Randomized but did not receive treatment|1
5408237|NCT02732938|18655269|P1|Overall Study|Randomized but did not receive treatment|0
5408238|NCT02732938|18655267|P3|Overall Study|Death|0
5408239|NCT02732938|18655268|P2|Overall Study|Death|11
5408240|NCT02732938|18655269|P1|Overall Study|Death|0
5408241|NCT02732912|18655315|P2|Overall Study|No outcome; discharged or refused|9
5408242|NCT02732912|18655316|P1|Overall Study|No outcome; discharged or refused|6
5408243|NCT02732912|18655315|P2|Overall Study|Incomplete completion of questionnaire|3
5408244|NCT02732912|18655316|P1|Overall Study|Incomplete completion of questionnaire|2
5408245|NCT02732912|18655315|P2|Overall Study|Discharged before night|6
5408246|NCT02732912|18655316|P1|Overall Study|Discharged before night|2
5408247|NCT02732639|18655341|P1|Overall Study|Lost to Follow-up|1
5408248|NCT02732561|18655367|P2|Overall Study|Withdrawal by Subject|0
5408249|NCT02732561|18655368|P1|Overall Study|Withdrawal by Subject|1
5408250|NCT02732561|18655367|P2|Overall Study|Lost to Follow-up|1
5408251|NCT02732561|18655368|P1|Overall Study|Lost to Follow-up|1
5408252|NCT02732327|18655394|P2|Overall Study|Protocol Violation|1
5408253|NCT02732327|18655395|P1|Overall Study|Protocol Violation|0
5408254|NCT02732210|18655403|P2|Overall Study|Missing|8
5408255|NCT02732210|18655404|P1|Overall Study|Missing|0
5408256|NCT02732210|18655403|P2|Overall Study|Other|103
5408257|NCT02732210|18655404|P1|Overall Study|Other|35
5408258|NCT02732210|18655403|P2|Overall Study|Death|15
5408259|NCT02732210|18655404|P1|Overall Study|Death|4
5408260|NCT02732210|18655403|P2|Overall Study|Lost to Follow-up|57
5408261|NCT02732210|18655404|P1|Overall Study|Lost to Follow-up|5
5408262|NCT02732210|18655403|P2|Overall Study|Withdrawal by Subject|87
5408263|NCT02732210|18655404|P1|Overall Study|Withdrawal by Subject|28
5408264|NCT02732210|18655403|P2|Overall Study|Study Ended|13
5408265|NCT02732210|18655404|P1|Overall Study|Study Ended|13
5408266|NCT02732210|18655403|P2|Overall Study|Site Closed|11
5408267|NCT02732210|18655404|P1|Overall Study|Site Closed|0
5408268|NCT02731755|18655583|P2|First Intervention|Withdrawal by Subject|2
5408269|NCT02731755|18655584|P1|First Intervention|Withdrawal by Subject|0
5408270|NCT02731742|18655608|P4|Overall Study|Study Terminated by Sponsor|1
5408271|NCT02731742|18655609|P3|Overall Study|Study Terminated by Sponsor|1
5408272|NCT02731742|18655610|P2|Overall Study|Study Terminated by Sponsor|1
5408273|NCT02731742|18655611|P1|Overall Study|Study Terminated by Sponsor|2
5408274|NCT02731742|18655608|P4|Overall Study|Physician Decision|1
5408275|NCT02731742|18655609|P3|Overall Study|Physician Decision|0
5408276|NCT02731742|18655610|P2|Overall Study|Physician Decision|0
5408277|NCT02731742|18655611|P1|Overall Study|Physician Decision|0
5408278|NCT02731742|18655608|P4|Overall Study|Death|0
5408279|NCT02731742|18655609|P3|Overall Study|Death|5
5408280|NCT02731742|18655610|P2|Overall Study|Death|2
5408281|NCT02731742|18655611|P1|Overall Study|Death|1
5408282|NCT02731690|18655629|P1|Overall Study|Discontinuation of Study by Sponsor|26
5408283|NCT02731690|18655629|P1|Overall Study|Withdrawal by Subject|3
5408284|NCT02731690|18655629|P1|Overall Study|Adverse Event|1
5408285|NCT02731638|18655649|P2|Overall Study|Lost to Follow-up|9
5408286|NCT02731638|18655650|P1|Overall Study|Lost to Follow-up|6
5408287|NCT02731157|18655893|P1|First Rejuvenated RCE|Withdrawal by Subject|1
5408288|NCT02731131|18655911|P2|Overall Study|Refused Therapy|1
5408289|NCT02731131|18655912|P1|Overall Study|Refused Therapy|0
5408290|NCT02731131|18655911|P2|Overall Study|Psychiatric Disorder|1
5408291|NCT02731131|18655912|P1|Overall Study|Psychiatric Disorder|0
5408292|NCT02730871|18655962|P2|Overall Study|Adverse Event|0
5408293|NCT02730871|18655963|P1|Overall Study|Adverse Event|6
5408294|NCT02730819|18655977|P1|Overall Study|Lost to Follow-up|9
5408295|NCT02730728|18655986|P3|Overall Study|Lack of Efficacy|1
5408296|NCT02730728|18655987|P2|Overall Study|Lack of Efficacy|1
5408297|NCT02730728|18655988|P1|Overall Study|Lack of Efficacy|0
5408298|NCT02730728|18655986|P3|Overall Study|Withdrawal by Subject|0
5408299|NCT02730728|18655987|P2|Overall Study|Withdrawal by Subject|1
5408300|NCT02730728|18655988|P1|Overall Study|Withdrawal by Subject|0
5408301|NCT02730598|18656017|P2|Overall Study|Unrelated Injury affecting outcomes.|0
5408302|NCT02730598|18656018|P1|Overall Study|Unrelated Injury affecting outcomes.|1
5408303|NCT02730598|18656017|P2|Overall Study|Protocol Violation|1
5408304|NCT02730598|18656018|P1|Overall Study|Protocol Violation|0
5408305|NCT02730598|18656017|P2|Overall Study|Withdrawal by Subject|3
5408306|NCT02730598|18656018|P1|Overall Study|Withdrawal by Subject|3
5408307|NCT02730455|18656041|P3|Overall Study|Other|0
5408308|NCT02730455|18656042|P2|Overall Study|Other|2
5408309|NCT02730455|18656043|P1|Overall Study|Other|2
5408310|NCT02730455|18656041|P3|Overall Study|Other|2
5408311|NCT02730455|18656042|P2|Overall Study|Other|1
5408312|NCT02730455|18656043|P1|Overall Study|Other|1
5408313|NCT02730455|18656041|P3|Overall Study|Lost to Follow-up|4
5408314|NCT02730455|18656042|P2|Overall Study|Lost to Follow-up|1
5408315|NCT02730455|18656043|P1|Overall Study|Lost to Follow-up|3
5408316|NCT02730455|18656041|P3|Overall Study|Consent withdrawn|1
5408317|NCT02730455|18656042|P2|Overall Study|Consent withdrawn|4
5408318|NCT02730455|18656043|P1|Overall Study|Consent withdrawn|2
5408319|NCT02730455|18656041|P3|Overall Study|Death|4
5408320|NCT02730455|18656042|P2|Overall Study|Death|6
5408321|NCT02730455|18656043|P1|Overall Study|Death|5
5408322|NCT02730377|18656093|P2|Overall Study|Lost to Follow-up|21
5408323|NCT02730377|18656094|P1|Overall Study|Lost to Follow-up|25
5408324|NCT02730377|18656093|P2|Overall Study|Withdrawal by Subject|42
5408325|NCT02730377|18656094|P1|Overall Study|Withdrawal by Subject|45
5408326|NCT02730377|18656093|P2|Overall Study|Pregnancy|1
5408327|NCT02730377|18656094|P1|Overall Study|Pregnancy|0
5408328|NCT02730377|18656093|P2|Overall Study|Lack of Efficacy|13
5408329|NCT02730377|18656094|P1|Overall Study|Lack of Efficacy|4
5408330|NCT02730377|18656093|P2|Overall Study|Protocol Violation|30
5408331|NCT02730377|18656094|P1|Overall Study|Protocol Violation|23
5408332|NCT02730377|18656093|P2|Overall Study|Adverse Event|41
5408333|NCT02730377|18656094|P1|Overall Study|Adverse Event|79
5408334|NCT02730377|18656093|P2|Overall Study|Inadequate glycaemic control|473
5408335|NCT02730377|18656094|P1|Overall Study|Inadequate glycaemic control|368
5408336|NCT02730377|18656093|P2|Overall Study|Death|8
5408337|NCT02730377|18656094|P1|Overall Study|Death|1
5408338|NCT02730377|18656093|P2|Overall Study|Other|4
5408339|NCT02730377|18656094|P1|Overall Study|Other|5
5408340|NCT02730351|18656144|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
5408341|NCT02730351|18656145|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
5408342|NCT02730351|18656144|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
5408343|NCT02730351|18656145|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
5408344|NCT02730351|18656144|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
5408345|NCT02730351|18656145|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
5408346|NCT02730351|18656144|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
5408347|NCT02730351|18656145|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
5408348|NCT02730351|18656144|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
5408349|NCT02730351|18656145|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
5408350|NCT02730208|18656179|P2|Overall Study|Withdrawal of consent (not due to AE)|1
5408351|NCT02730208|18656180|P1|Overall Study|Withdrawal of consent (not due to AE)|0
5408352|NCT02730195|18656188|P1|Overall Study|Withdrawal by Subject|1
5408353|NCT02730169|18656198|P4|Overall Study|Other|1
5408354|NCT02730169|18656199|P3|Overall Study|Other|1
5408355|NCT02730169|18656200|P2|Overall Study|Other|0
5408356|NCT02730169|18656201|P1|Overall Study|Other|0
5408357|NCT02730169|18656198|P4|Overall Study|Lost to Follow-up|6
5408358|NCT02730169|18656199|P3|Overall Study|Lost to Follow-up|5
5408359|NCT02730169|18656200|P2|Overall Study|Lost to Follow-up|6
5408360|NCT02730169|18656201|P1|Overall Study|Lost to Follow-up|5
5408361|NCT02730169|18656198|P4|Overall Study|Withdrawal by Subject|8
5408362|NCT02730169|18656199|P3|Overall Study|Withdrawal by Subject|6
5408363|NCT02730169|18656200|P2|Overall Study|Withdrawal by Subject|11
5408364|NCT02730169|18656201|P1|Overall Study|Withdrawal by Subject|6
5408365|NCT02730169|18656198|P4|Overall Study|Adverse Event of Special Interest|0
5408366|NCT02730169|18656199|P3|Overall Study|Adverse Event of Special Interest|2
5408367|NCT02730169|18656200|P2|Overall Study|Adverse Event of Special Interest|1
5408368|NCT02730169|18656201|P1|Overall Study|Adverse Event of Special Interest|0
5408369|NCT02730169|18656198|P4|Overall Study|Adverse Event|0
5408370|NCT02730169|18656199|P3|Overall Study|Adverse Event|3
5408371|NCT02730169|18656200|P2|Overall Study|Adverse Event|3
5408372|NCT02730169|18656201|P1|Overall Study|Adverse Event|2
5408373|NCT02730169|18656198|P4|Overall Study|Protocol Violation|1
5408374|NCT02730169|18656199|P3|Overall Study|Protocol Violation|0
5408375|NCT02730169|18656200|P2|Overall Study|Protocol Violation|0
5408376|NCT02730169|18656201|P1|Overall Study|Protocol Violation|1
5408377|NCT02729909|18656269|P2|Overall Study|Voluntary Withdrawal|0
5408378|NCT02729909|18656270|P1|Overall Study|Voluntary Withdrawal|1
5408379|NCT02729909|18656269|P2|Overall Study|Significant Protocol Deviation|2
5408380|NCT02729909|18656270|P1|Overall Study|Significant Protocol Deviation|0
5408381|NCT02729909|18656269|P2|Overall Study|Lack of Efficacy|2
5408382|NCT02729909|18656270|P1|Overall Study|Lack of Efficacy|0
5408383|NCT02729909|18656269|P2|Overall Study|Lost to Follow-up|1
5408384|NCT02729909|18656270|P1|Overall Study|Lost to Follow-up|0
5408385|NCT02729896|18656289|P3|Overall Study|Withdrawal by Subject|3
5408386|NCT02729896|18656290|P2|Overall Study|Withdrawal by Subject|0
5408387|NCT02729896|18656291|P1|Overall Study|Withdrawal by Subject|1
5408388|NCT02729896|18656289|P3|Overall Study|Progressive Disease|0
5408389|NCT02729896|18656290|P2|Overall Study|Progressive Disease|1
5408390|NCT02729896|18656291|P1|Overall Study|Progressive Disease|0
5408391|NCT02729896|18656289|P3|Overall Study|Physician Decision|3
5408392|NCT02729896|18656290|P2|Overall Study|Physician Decision|2
5408393|NCT02729896|18656291|P1|Overall Study|Physician Decision|1
5408394|NCT02729896|18656289|P3|Overall Study|Other|0
5408395|NCT02729896|18656290|P2|Overall Study|Other|2
5408396|NCT02729896|18656291|P1|Overall Study|Other|0
5408397|NCT02729896|18656289|P3|Overall Study|Lost to Follow-up|3
5408398|NCT02729896|18656290|P2|Overall Study|Lost to Follow-up|2
5408399|NCT02729896|18656291|P1|Overall Study|Lost to Follow-up|0
5408400|NCT02729896|18656289|P3|Overall Study|Death|13
5408401|NCT02729896|18656290|P2|Overall Study|Death|2
5408402|NCT02729896|18656291|P1|Overall Study|Death|0
5408403|NCT02729831|18656336|P4|6 Month Follow-up|Death|1
5408404|NCT02729831|18656337|P3|6 Month Follow-up|Death|0
5408405|NCT02729831|18656338|P2|6 Month Follow-up|Death|3
5408406|NCT02729831|18656339|P1|6 Month Follow-up|Death|1
5408407|NCT02729831|18656336|P4|6 Month Follow-up|Lost to Follow-up|42
5408408|NCT02729831|18656337|P3|6 Month Follow-up|Lost to Follow-up|48
5408409|NCT02729831|18656338|P2|6 Month Follow-up|Lost to Follow-up|51
5408410|NCT02729831|18656339|P1|6 Month Follow-up|Lost to Follow-up|54
5408411|NCT02729831|18656336|P4|1 Week Post-visit|Lost to Follow-up|36
5408412|NCT02729831|18656337|P3|1 Week Post-visit|Lost to Follow-up|38
5408413|NCT02729831|18656338|P2|1 Week Post-visit|Lost to Follow-up|40
5408414|NCT02729831|18656339|P1|1 Week Post-visit|Lost to Follow-up|43
5408415|NCT02729831|18656336|P4|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
5408416|NCT02729831|18656337|P3|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
5408417|NCT02729831|18656338|P2|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
5408418|NCT02729831|18656339|P1|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
5408419|NCT02729753|18656367|P2|Overall Study|Device Malfunction. No units in stock.|1
5408420|NCT02729753|18656368|P1|Overall Study|Device Malfunction. No units in stock.|0
5408421|NCT02729545|18656382|P2|Overall Study|Withdrawal by Subject|3
5408422|NCT02729545|18656383|P1|Overall Study|Withdrawal by Subject|2
5408423|NCT02729545|18656382|P2|Overall Study|Lost to Follow-up|1
5408424|NCT02729545|18656383|P1|Overall Study|Lost to Follow-up|0
5408425|NCT02729545|18656382|P2|Overall Study|Pregnancy|1
5408426|NCT02729545|18656383|P1|Overall Study|Pregnancy|1
5408427|NCT02729194|18656405|P1|Overall Study|Withdrawal by Subject|3
5408428|NCT02729051|18656417|P2|Overall Study|Withdrawal by Subject|17
5408429|NCT02729051|18656418|P1|Overall Study|Withdrawal by Subject|6
5408430|NCT02729051|18656417|P2|Overall Study|Physician Decision|1
5408431|NCT02729051|18656418|P1|Overall Study|Physician Decision|1
5408432|NCT02729051|18656417|P2|Overall Study|Lost to Follow-up|2
5408433|NCT02729051|18656418|P1|Overall Study|Lost to Follow-up|1
5408434|NCT02729051|18656417|P2|Overall Study|Lack of Efficacy|1
5408435|NCT02729051|18656418|P1|Overall Study|Lack of Efficacy|1
5408436|NCT02729051|18656417|P2|Overall Study|Adverse Event|11
5408437|NCT02729051|18656418|P1|Overall Study|Adverse Event|21
5408438|NCT02729025|18656562|P2|Overall Study|Sponsor Decision|1
5408439|NCT02729025|18656563|P1|Overall Study|Sponsor Decision|0
5408440|NCT02728895|18656577|P2|Overall Study|Withdrawal by Subject|3
5408441|NCT02728895|18656578|P1|Overall Study|Withdrawal by Subject|0
5408442|NCT02728895|18656577|P2|Overall Study|Other|2
5408443|NCT02728895|18656578|P1|Overall Study|Other|1
5408444|NCT02728830|18656598|P1|Overall Study|Language Barrier|1
5408445|NCT02728830|18656598|P1|Overall Study|Contraindicated Illness|1
5408446|NCT02728830|18656598|P1|Overall Study|Exclusionary Lab Values|1
5408447|NCT02728830|18656598|P1|Overall Study|Lost to Follow-up|1
5408448|NCT02728830|18656598|P1|Overall Study|Withdrawal by Subject|2
5408449|NCT02728830|18656598|P1|Overall Study|Physician Decision|3
5408450|NCT02728830|18656598|P1|Overall Study|Exclusionary Pathology|6
5408451|NCT02728830|18656598|P1|Overall Study|Exclusionary Surgery|9
5408452|NCT02728206|18656613|P1|Overall Study|Death|1
5408453|NCT02728089|18656621|P1|Overall Study|Withdrawal by Subject|1
5408454|NCT02728089|18656621|P1|Overall Study|Physician Decision|2
5408455|NCT02727777|18656709|P3|Overall Study|Progressive disease|0
5408456|NCT02727777|18656710|P2|Overall Study|Progressive disease|0
5408457|NCT02727777|18656711|P1|Overall Study|Progressive disease|2
5408458|NCT02727777|18656709|P3|Overall Study|Screen Failure|0
5408459|NCT02727777|18656710|P2|Overall Study|Screen Failure|0
5408460|NCT02727777|18656711|P1|Overall Study|Screen Failure|2
5408461|NCT02727660|18656732|P3|Overall Study|Administrative Reasons|4
5408462|NCT02727660|18656733|P2|Overall Study|Administrative Reasons|3
5408463|NCT02727660|18656734|P1|Overall Study|Administrative Reasons|2
5408464|NCT02727660|18656732|P3|Overall Study|Protocol Specified Disc. Criteria|2
5408465|NCT02727660|18656733|P2|Overall Study|Protocol Specified Disc. Criteria|5
5408466|NCT02727660|18656734|P1|Overall Study|Protocol Specified Disc. Criteria|5
5408467|NCT02727660|18656732|P3|Overall Study|Protocol Violation|5
5408468|NCT02727660|18656733|P2|Overall Study|Protocol Violation|5
5408469|NCT02727660|18656734|P1|Overall Study|Protocol Violation|7
5408470|NCT02727660|18656732|P3|Overall Study|Lost to Follow-up|8
5408471|NCT02727660|18656733|P2|Overall Study|Lost to Follow-up|9
5408472|NCT02727660|18656734|P1|Overall Study|Lost to Follow-up|5
5408473|NCT02727660|18656732|P3|Overall Study|Physician Decision|14
5408474|NCT02727660|18656733|P2|Overall Study|Physician Decision|8
5408475|NCT02727660|18656734|P1|Overall Study|Physician Decision|3
5408476|NCT02727660|18656732|P3|Overall Study|Withdrawal by Subject|30
5408477|NCT02727660|18656733|P2|Overall Study|Withdrawal by Subject|25
5408478|NCT02727660|18656734|P1|Overall Study|Withdrawal by Subject|26
5408479|NCT02727660|18656732|P3|Overall Study|Adverse Event|32
5408480|NCT02727660|18656733|P2|Overall Study|Adverse Event|21
5408481|NCT02727660|18656734|P1|Overall Study|Adverse Event|28
5408482|NCT02727660|18656732|P3|Overall Study|Lack of Efficacy|70
5408483|NCT02727660|18656733|P2|Overall Study|Lack of Efficacy|40
5408484|NCT02727660|18656734|P1|Overall Study|Lack of Efficacy|40
5408485|NCT02727322|18656753|P2|Overall Study|Protocol Violation|0
5408486|NCT02727322|18656754|P1|Overall Study|Protocol Violation|1
5408487|NCT02727322|18656753|P2|Overall Study|Withdrawal by Subject|1
5408488|NCT02727322|18656754|P1|Overall Study|Withdrawal by Subject|1
5408489|NCT02726945|18656780|P3|Overall Study|Elected to have total knee replacement|0
5408490|NCT02726945|18656781|P2|Overall Study|Elected to have total knee replacement|1
5408491|NCT02726945|18656782|P1|Overall Study|Elected to have total knee replacement|0
5408492|NCT02726945|18656780|P3|Overall Study|Withdrawal by Subject|1
5408493|NCT02726945|18656781|P2|Overall Study|Withdrawal by Subject|0
5408494|NCT02726945|18656782|P1|Overall Study|Withdrawal by Subject|0
5408495|NCT02726399|18656916|P1|Overall Study|Progression of disease|4
5408496|NCT02726399|18656916|P1|Overall Study|Adverse Event|2
5408497|NCT02726399|18656916|P1|Overall Study|Participant Non-Compliance|1
5408498|NCT02726113|18656933|P2|Genomic Analysis|Insurance non-coverage for surgery|1
5408499|NCT02726113|18656934|P1|Genomic Analysis|Insurance non-coverage for surgery|1
5408500|NCT02726113|18656933|P2|Genomic Analysis|Withdrawal by Subject|1
5408501|NCT02726113|18656934|P1|Genomic Analysis|Withdrawal by Subject|2
5408502|NCT02726113|18656933|P2|Genomic Analysis|Protocol Violation|0
5408503|NCT02726113|18656934|P1|Genomic Analysis|Protocol Violation|1
5408504|NCT02726113|18656933|P2|Total Enrollment|Insurance non-coverage for surgery|1
5408505|NCT02726113|18656934|P1|Total Enrollment|Insurance non-coverage for surgery|1
5408506|NCT02726113|18656933|P2|Total Enrollment|Withdrawal by Subject|1
5408507|NCT02726113|18656934|P1|Total Enrollment|Withdrawal by Subject|2
5408508|NCT02726113|18656933|P2|Total Enrollment|Protocol Violation|0
5408509|NCT02726113|18656934|P1|Total Enrollment|Protocol Violation|1
5408510|NCT02726113|18656933|P2|Total Enrollment|Physician Decision|1
5408511|NCT02726113|18656934|P1|Total Enrollment|Physician Decision|0
5408512|NCT02726074|18656941|P1|Overall Study|Others|3
5408513|NCT02726074|18656941|P1|Overall Study|Lost to Follow-up|2
5408514|NCT02726074|18656941|P1|Overall Study|Protocol Violation|3
5408515|NCT02726074|18656941|P1|Overall Study|Adverse Event|14
5408516|NCT02726074|18656941|P1|Overall Study|Withdrawal by Subject|4
5408517|NCT02726022|18656953|P1|Overall Study|Treatment Failure and Poor Compliance|1
5408518|NCT02726022|18656953|P1|Overall Study|Poor Compliance|13
5408519|NCT02726022|18656953|P1|Overall Study|Treatment Failure|8
5408520|NCT02726022|18656953|P1|Overall Study|Adverse Event|14
5408521|NCT02725866|18656962|P1|Overall Study|Other, not specified|4
5408522|NCT02725866|18656962|P1|Overall Study|Insufficient virological response|1
5408523|NCT02725866|18656962|P1|Overall Study|Withdrew consent|3
5408524|NCT02725866|18656962|P1|Overall Study|Failure to return|6
5408525|NCT02725788|18656986|P2|Overall Study|Protocol Violation|1
5408526|NCT02725788|18656987|P1|Overall Study|Protocol Violation|0
5408527|NCT02725788|18656986|P2|Overall Study|Lost to Follow-up|1
5408528|NCT02725788|18656987|P1|Overall Study|Lost to Follow-up|1
5408529|NCT02725710|18656995|P2|Overall Study|Lost to Follow-up|0
5408530|NCT02725710|18656996|P1|Overall Study|Lost to Follow-up|1
5408531|NCT02725671|18657024|P1|Overall Study|Lost to Follow-up|1
5408532|NCT02725593|18657039|P2|Long Term Extension|Withdrawal by Subject|3
5408533|NCT02725593|18657040|P1|Long Term Extension|Withdrawal by Subject|1
5408534|NCT02725593|18657039|P2|Blinded Treatment Period|Lost to Follow-up|1
5408535|NCT02725593|18657040|P1|Blinded Treatment Period|Lost to Follow-up|1
5408536|NCT02725593|18657039|P2|Blinded Treatment Period|Withdrawal by Parent/Guardian|2
5408537|NCT02725593|18657040|P1|Blinded Treatment Period|Withdrawal by Parent/Guardian|0
5408538|NCT02725593|18657039|P2|Blinded Treatment Period|Withdrawal by Subject|3
5408539|NCT02725593|18657040|P1|Blinded Treatment Period|Withdrawal by Subject|4
5408540|NCT02725515|18657054|P2|Overall Study|Lack of Response|1
5408541|NCT02725515|18657055|P1|Overall Study|Lack of Response|0
5408542|NCT02725515|18657054|P2|Overall Study|Completed Study Under Original Protocol|1
5408543|NCT02725515|18657055|P1|Overall Study|Completed Study Under Original Protocol|0
5408544|NCT02725515|18657054|P2|Overall Study|No Documented Disease Improvement|1
5408545|NCT02725515|18657055|P1|Overall Study|No Documented Disease Improvement|0
5408546|NCT02725515|18657054|P2|Overall Study|Adverse Event|2
5408547|NCT02725515|18657055|P1|Overall Study|Adverse Event|7
5408548|NCT02725515|18657054|P2|Overall Study|Lost to Follow-up|1
5408549|NCT02725515|18657055|P1|Overall Study|Lost to Follow-up|1
5408550|NCT02725515|18657054|P2|Overall Study|Non-Compliance With Study Drug|3
5408551|NCT02725515|18657055|P1|Overall Study|Non-Compliance With Study Drug|0
5408552|NCT02725515|18657054|P2|Overall Study|Withdrawal by Subject|1
5408553|NCT02725515|18657055|P1|Overall Study|Withdrawal by Subject|2
5408554|NCT02725515|18657054|P2|Overall Study|Loss of Improvement per Protocol|25
5408555|NCT02725515|18657055|P1|Overall Study|Loss of Improvement per Protocol|14
5408556|NCT02725515|18657054|P2|Overall Study|Refused infusion (no study treatment)|0
5408557|NCT02725515|18657055|P1|Overall Study|Refused infusion (no study treatment)|1
5408558|NCT02725476|18657067|P2|Overall Study|Adverse Event|1
5408559|NCT02725476|18657068|P1|Overall Study|Adverse Event|1
5408560|NCT02725476|18657067|P2|Overall Study|Physician Decision|0
5408561|NCT02725476|18657068|P1|Overall Study|Physician Decision|2
5408562|NCT02725411|18657079|P3|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
5408563|NCT02725411|18657080|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
5408564|NCT02725411|18657081|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
5408565|NCT02725411|18657079|P3|Follow-up Period (24 Weeks)|Other|2
5408566|NCT02725411|18657080|P2|Follow-up Period (24 Weeks)|Other|4
5408567|NCT02725411|18657081|P1|Follow-up Period (24 Weeks)|Other|1
5408568|NCT02725411|18657079|P3|Follow-up Period (24 Weeks)|Lost to Follow-up|0
5408569|NCT02725411|18657080|P2|Follow-up Period (24 Weeks)|Lost to Follow-up|1
5408570|NCT02725411|18657081|P1|Follow-up Period (24 Weeks)|Lost to Follow-up|1
5408571|NCT02725411|18657079|P3|Follow-up Period (24 Weeks)|Lack of Efficacy|0
5408572|NCT02725411|18657080|P2|Follow-up Period (24 Weeks)|Lack of Efficacy|2
5408573|NCT02725411|18657081|P1|Follow-up Period (24 Weeks)|Lack of Efficacy|0
5408574|NCT02725411|18657079|P3|Follow-up Period (24 Weeks)|Adverse Event|0
5408575|NCT02725411|18657080|P2|Follow-up Period (24 Weeks)|Adverse Event|1
5408576|NCT02725411|18657081|P1|Follow-up Period (24 Weeks)|Adverse Event|1
5408577|NCT02725411|18657079|P3|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
5408578|NCT02725411|18657080|P2|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
5408579|NCT02725411|18657081|P1|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
5408580|NCT02725411|18657079|P3|Treatment Period (56 Weeks)|Withdrawal by Subject|4
5408581|NCT02725411|18657080|P2|Treatment Period (56 Weeks)|Withdrawal by Subject|1
5408582|NCT02725411|18657081|P1|Treatment Period (56 Weeks)|Withdrawal by Subject|0
5408583|NCT02725411|18657079|P3|Treatment Period (56 Weeks)|Other|5
5408584|NCT02725411|18657080|P2|Treatment Period (56 Weeks)|Other|4
5408585|NCT02725411|18657081|P1|Treatment Period (56 Weeks)|Other|1
5408586|NCT02725411|18657079|P3|Treatment Period (56 Weeks)|Lost to Follow-up|0
5408587|NCT02725411|18657080|P2|Treatment Period (56 Weeks)|Lost to Follow-up|1
5408588|NCT02725411|18657081|P1|Treatment Period (56 Weeks)|Lost to Follow-up|0
5408589|NCT02725411|18657079|P3|Treatment Period (56 Weeks)|Lack of Efficacy|1
5408590|NCT02725411|18657080|P2|Treatment Period (56 Weeks)|Lack of Efficacy|4
5408591|NCT02725411|18657081|P1|Treatment Period (56 Weeks)|Lack of Efficacy|1
5408592|NCT02725411|18657079|P3|Treatment Period (56 Weeks)|Adverse Event|4
5408593|NCT02725411|18657080|P2|Treatment Period (56 Weeks)|Adverse Event|5
5408594|NCT02725411|18657081|P1|Treatment Period (56 Weeks)|Adverse Event|3
5408595|NCT02725268|18657297|P4|Overall Study|Ongoing|0
5408596|NCT02725268|18657298|P3|Overall Study|Ongoing|0
5408597|NCT02725268|18657299|P2|Overall Study|Ongoing|3
5408598|NCT02725268|18657300|P1|Overall Study|Ongoing|3
5408599|NCT02725268|18657297|P4|Overall Study|Reason not Specified|0
5408600|NCT02725268|18657298|P3|Overall Study|Reason not Specified|0
5408601|NCT02725268|18657299|P2|Overall Study|Reason not Specified|1
5408602|NCT02725268|18657300|P1|Overall Study|Reason not Specified|1
5408603|NCT02725268|18657297|P4|Overall Study|Withdrawal by Subject|1
5408604|NCT02725268|18657298|P3|Overall Study|Withdrawal by Subject|8
5408605|NCT02725268|18657299|P2|Overall Study|Withdrawal by Subject|4
5408606|NCT02725268|18657300|P1|Overall Study|Withdrawal by Subject|8
5408607|NCT02725268|18657297|P4|Overall Study|Lost to Follow-up|0
5408608|NCT02725268|18657298|P3|Overall Study|Lost to Follow-up|0
5408609|NCT02725268|18657299|P2|Overall Study|Lost to Follow-up|3
5408610|NCT02725268|18657300|P1|Overall Study|Lost to Follow-up|2
5408611|NCT02725268|18657297|P4|Overall Study|Death|16
5408612|NCT02725268|18657298|P3|Overall Study|Death|29
5408613|NCT02725268|18657299|P2|Overall Study|Death|48
5408614|NCT02725268|18657300|P1|Overall Study|Death|45
5408615|NCT02725008|18657336|P2|Overall Study|Admitted to hospital|1
5408616|NCT02725008|18657337|P1|Overall Study|Admitted to hospital|0
5408617|NCT02725008|18657336|P2|Overall Study|Withdrawal by Subject|2
5408618|NCT02725008|18657337|P1|Overall Study|Withdrawal by Subject|2
5408619|NCT02725008|18657336|P2|Overall Study|Lost to Follow-up|9
5408620|NCT02725008|18657337|P1|Overall Study|Lost to Follow-up|7
5408621|NCT02724839|18657348|P3|Overall Study|Physician Decision|3
5408622|NCT02724839|18657349|P2|Overall Study|Physician Decision|0
5408623|NCT02724839|18657350|P1|Overall Study|Physician Decision|0
5408624|NCT02724839|18657348|P3|Overall Study|Lost to Follow-up|2
5408625|NCT02724839|18657349|P2|Overall Study|Lost to Follow-up|3
5408626|NCT02724839|18657350|P1|Overall Study|Lost to Follow-up|0
5408627|NCT02724839|18657348|P3|Overall Study|Withdrawal by Subject|0
5408628|NCT02724839|18657349|P2|Overall Study|Withdrawal by Subject|1
5408629|NCT02724839|18657350|P1|Overall Study|Withdrawal by Subject|1
5408630|NCT02724644|18657427|P2|Overall Study|Administrative|0
5408631|NCT02724644|18657428|P1|Overall Study|Administrative|1
5408632|NCT02724644|18657427|P2|Overall Study|Withdrawal by Subject|1
5408633|NCT02724644|18657428|P1|Overall Study|Withdrawal by Subject|7
5408634|NCT02724644|18657427|P2|Overall Study|Lost to Follow-up|2
5408635|NCT02724644|18657428|P1|Overall Study|Lost to Follow-up|6
5408636|NCT02724644|18657427|P2|Overall Study|Adverse Event|1
5408637|NCT02724644|18657428|P1|Overall Study|Adverse Event|7
5408638|NCT02724111|18657462|P2|Overall Study|Protocol Violation|5
5408639|NCT02724111|18657463|P1|Overall Study|Protocol Violation|2
5408640|NCT02723786|18657515|P1|Overall Study|Lost to Follow-up|1
5408641|NCT02723630|18657543|P6|Intervention Period 3|consumption of restricted item|0
5408642|NCT02723630|18657544|P5|Intervention Period 3|consumption of restricted item|0
5408643|NCT02723630|18657545|P4|Intervention Period 3|consumption of restricted item|0
5408644|NCT02723630|18657546|P3|Intervention Period 3|consumption of restricted item|0
5408645|NCT02723630|18657547|P2|Intervention Period 3|consumption of restricted item|1
5408646|NCT02723630|18657548|P1|Intervention Period 3|consumption of restricted item|0
5408647|NCT02723630|18657543|P6|Intervention Period 1|Adverse Event|0
5408648|NCT02723630|18657544|P5|Intervention Period 1|Adverse Event|0
5408649|NCT02723630|18657545|P4|Intervention Period 1|Adverse Event|0
5408650|NCT02723630|18657546|P3|Intervention Period 1|Adverse Event|0
5408651|NCT02723630|18657547|P2|Intervention Period 1|Adverse Event|0
5408652|NCT02723630|18657548|P1|Intervention Period 1|Adverse Event|1
5408653|NCT02723591|18657579|P2|Overall Study|Miscellaneous|6
5408654|NCT02723591|18657580|P1|Overall Study|Miscellaneous|5
5408655|NCT02723591|18657579|P2|Overall Study|Randomized but Never Received StudyDrug|12
5408656|NCT02723591|18657580|P1|Overall Study|Randomized but Never Received StudyDrug|12
5408657|NCT02723591|18657579|P2|Overall Study|Withdrawal by Subject|8
5408658|NCT02723591|18657580|P1|Overall Study|Withdrawal by Subject|4
5408659|NCT02723591|18657579|P2|Overall Study|Protocol Violation|23
5408660|NCT02723591|18657580|P1|Overall Study|Protocol Violation|20
5408661|NCT02723591|18657579|P2|Overall Study|Lost to Follow-up|7
5408662|NCT02723591|18657580|P1|Overall Study|Lost to Follow-up|1
5408663|NCT02723591|18657579|P2|Overall Study|Lack of Efficacy|3
5408664|NCT02723591|18657580|P1|Overall Study|Lack of Efficacy|4
5408665|NCT02723591|18657579|P2|Overall Study|Death|2
5408666|NCT02723591|18657580|P1|Overall Study|Death|2
5408667|NCT02723591|18657579|P2|Overall Study|Adverse Event|40
5408668|NCT02723591|18657580|P1|Overall Study|Adverse Event|48
5408669|NCT02723344|18657708|P2|Overall Study|Lost to Follow-up|4
5408670|NCT02723344|18657709|P1|Overall Study|Lost to Follow-up|0
5408671|NCT02723201|18657732|P3|Second Intervention Period|Adverse Event|0
5408672|NCT02723201|18657733|P2|Second Intervention Period|Adverse Event|0
5408673|NCT02723201|18657734|P1|Second Intervention Period|Adverse Event|1
5408674|NCT02723201|18657732|P3|Second Intervention Period|Protocol Violation|0
5408675|NCT02723201|18657733|P2|Second Intervention Period|Protocol Violation|0
5408676|NCT02723201|18657734|P1|Second Intervention Period|Protocol Violation|1
5408677|NCT02723188|18657793|P3|Overall Study|Withdrawal by Subject|0
5408678|NCT02723188|18657794|P2|Overall Study|Withdrawal by Subject|0
5408679|NCT02723188|18657795|P1|Overall Study|Withdrawal by Subject|1
5408680|NCT02723175|18657808|P2|Overall Study|Lost to 3 Month Follow Up|1
5408681|NCT02723175|18657809|P1|Overall Study|Lost to 3 Month Follow Up|1
5408682|NCT02723175|18657808|P2|Overall Study|Lost to 1 Month Follow Up|2
5408683|NCT02723175|18657809|P1|Overall Study|Lost to 1 Month Follow Up|3
5408684|NCT02723084|18657851|P2|Overall Study|Lost to Follow-up|0
5408685|NCT02723084|18657852|P1|Overall Study|Lost to Follow-up|3
5408686|NCT02723084|18657851|P2|Overall Study|Withdrawal by Subject|1
5408687|NCT02723084|18657852|P1|Overall Study|Withdrawal by Subject|1
5408688|NCT02722967|18657866|P3|Overall Study|Non-adherence of the patch to the skin|2
5408689|NCT02722967|18657867|P2|Overall Study|Non-adherence of the patch to the skin|0
5408690|NCT02722967|18657868|P1|Overall Study|Non-adherence of the patch to the skin|0
5408691|NCT02722967|18657866|P3|Overall Study|Physician Decision|0
5408692|NCT02722967|18657867|P2|Overall Study|Physician Decision|0
5408693|NCT02722967|18657868|P1|Overall Study|Physician Decision|1
5408694|NCT02722967|18657866|P3|Overall Study|Withdrawal by Subject|1
5408695|NCT02722967|18657867|P2|Overall Study|Withdrawal by Subject|0
5408696|NCT02722967|18657868|P1|Overall Study|Withdrawal by Subject|1
5408697|NCT02722967|18657866|P3|Overall Study|Non-compliance with patch wearing|1
5408698|NCT02722967|18657867|P2|Overall Study|Non-compliance with patch wearing|1
5408699|NCT02722967|18657868|P1|Overall Study|Non-compliance with patch wearing|2
5408700|NCT02722967|18657866|P3|Overall Study|Lost to Follow-up|0
5408701|NCT02722967|18657867|P2|Overall Study|Lost to Follow-up|1
5408702|NCT02722967|18657868|P1|Overall Study|Lost to Follow-up|0
5408703|NCT02722967|18657866|P3|Overall Study|Adverse Event|0
5408704|NCT02722967|18657867|P2|Overall Study|Adverse Event|0
5408705|NCT02722967|18657868|P1|Overall Study|Adverse Event|1
5408706|NCT02722928|18657878|P2|Overall Study|Required Intraoperative MRI|7
5408707|NCT02722928|18657879|P1|Overall Study|Required Intraoperative MRI|5
5408708|NCT02722928|18657878|P2|Overall Study|Standard CT was not as required per prot|13
5408709|NCT02722928|18657879|P1|Overall Study|Standard CT was not as required per prot|5
5408710|NCT02722304|18658009|P5|Overall Study|Other|1
5408711|NCT02722304|18658010|P4|Overall Study|Other|1
5408712|NCT02722304|18658011|P3|Overall Study|Other|0
5408713|NCT02722304|18658012|P2|Overall Study|Other|0
5408714|NCT02722304|18658013|P1|Overall Study|Other|0
5408715|NCT02722304|18658009|P5|Overall Study|Study Terminated by Sponsor|1
5408716|NCT02722304|18658010|P4|Overall Study|Study Terminated by Sponsor|1
5408717|NCT02722304|18658011|P3|Overall Study|Study Terminated by Sponsor|2
5408718|NCT02722304|18658012|P2|Overall Study|Study Terminated by Sponsor|0
5408719|NCT02722304|18658013|P1|Overall Study|Study Terminated by Sponsor|1
5408720|NCT02722278|18658065|P2|Overall Study|Site closure not study related|1
5408721|NCT02722278|18658066|P1|Overall Study|Site closure not study related|0
5408722|NCT02722278|18658065|P2|Overall Study|Subject declined after tx assignment|1
5408723|NCT02722278|18658066|P1|Overall Study|Subject declined after tx assignment|0
5408724|NCT02722278|18658065|P2|Overall Study|High PSA pre-study/ not eligible|1
5408725|NCT02722278|18658066|P1|Overall Study|High PSA pre-study/ not eligible|0
5408726|NCT02722278|18658065|P2|Overall Study|Protocol Violation|0
5408727|NCT02722278|18658066|P1|Overall Study|Protocol Violation|1
5408728|NCT02722278|18658065|P2|Overall Study|Lost to Follow-up|0
5408729|NCT02722278|18658066|P1|Overall Study|Lost to Follow-up|2
5408730|NCT02722278|18658065|P2|Overall Study|Adverse Event|1
5408731|NCT02722278|18658066|P1|Overall Study|Adverse Event|4
5408732|NCT02722278|18658065|P2|Overall Study|Withdrawal by Subject|3
5408733|NCT02722278|18658066|P1|Overall Study|Withdrawal by Subject|5
5408734|NCT02722148|18658090|P1|Overall Study|Non compliant with treatment regimen|3
5408735|NCT02722148|18658090|P1|Overall Study|Lost to Follow-up|2
5408736|NCT02722044|18658097|P1|Overall Study|Did Not Meet Criteria at Week 14|1
5408737|NCT02722044|18658097|P1|Overall Study|Withdrawal by Subject|1
5408738|NCT02722044|18658097|P1|Overall Study|Physician Decision|1
5408739|NCT02722044|18658097|P1|Overall Study|Adverse Event|2
5408740|NCT02721966|18658127|P5|Overall Study|Did not continue to period 2|5
5408741|NCT02721966|18658128|P4|Overall Study|Did not continue to period 2|0
5408742|NCT02721966|18658129|P3|Overall Study|Did not continue to period 2|0
5408743|NCT02721966|18658130|P2|Overall Study|Did not continue to period 2|12
5408744|NCT02721966|18658131|P1|Overall Study|Did not continue to period 2|5
5408745|NCT02721966|18658127|P5|Overall Study|Pregnancy|0
5408746|NCT02721966|18658128|P4|Overall Study|Pregnancy|0
5408747|NCT02721966|18658129|P3|Overall Study|Pregnancy|0
5408748|NCT02721966|18658130|P2|Overall Study|Pregnancy|0
5408749|NCT02721966|18658131|P1|Overall Study|Pregnancy|1
5408750|NCT02721966|18658127|P5|Overall Study|Physician Decision|0
5408751|NCT02721966|18658128|P4|Overall Study|Physician Decision|0
5408752|NCT02721966|18658129|P3|Overall Study|Physician Decision|0
5408753|NCT02721966|18658130|P2|Overall Study|Physician Decision|1
5408754|NCT02721966|18658131|P1|Overall Study|Physician Decision|1
5408755|NCT02721966|18658127|P5|Overall Study|Lost to Follow-up|0
5408756|NCT02721966|18658128|P4|Overall Study|Lost to Follow-up|0
5408757|NCT02721966|18658129|P3|Overall Study|Lost to Follow-up|3
5408758|NCT02721966|18658130|P2|Overall Study|Lost to Follow-up|0
5408759|NCT02721966|18658131|P1|Overall Study|Lost to Follow-up|0
5408760|NCT02721966|18658127|P5|Overall Study|Lack of Efficacy|0
5408761|NCT02721966|18658128|P4|Overall Study|Lack of Efficacy|0
5408762|NCT02721966|18658129|P3|Overall Study|Lack of Efficacy|0
5408763|NCT02721966|18658130|P2|Overall Study|Lack of Efficacy|4
5408764|NCT02721966|18658131|P1|Overall Study|Lack of Efficacy|7
5408765|NCT02721966|18658127|P5|Overall Study|Death|0
5408766|NCT02721966|18658128|P4|Overall Study|Death|0
5408767|NCT02721966|18658129|P3|Overall Study|Death|0
5408768|NCT02721966|18658130|P2|Overall Study|Death|0
5408769|NCT02721966|18658131|P1|Overall Study|Death|1
5408770|NCT02721966|18658127|P5|Overall Study|Adverse Event|0
5408771|NCT02721966|18658128|P4|Overall Study|Adverse Event|0
5408772|NCT02721966|18658129|P3|Overall Study|Adverse Event|3
5408773|NCT02721966|18658130|P2|Overall Study|Adverse Event|4
5408774|NCT02721966|18658131|P1|Overall Study|Adverse Event|4
5408775|NCT02721966|18658127|P5|Overall Study|Withdrawal by Subject|0
5408776|NCT02721966|18658128|P4|Overall Study|Withdrawal by Subject|7
5408777|NCT02721966|18658129|P3|Overall Study|Withdrawal by Subject|3
5408778|NCT02721966|18658130|P2|Overall Study|Withdrawal by Subject|2
5408779|NCT02721966|18658131|P1|Overall Study|Withdrawal by Subject|9
5408780|NCT02721966|18658127|P5|Overall Study|Protocol Violation|0
5408781|NCT02721966|18658128|P4|Overall Study|Protocol Violation|0
5408782|NCT02721966|18658129|P3|Overall Study|Protocol Violation|0
5408783|NCT02721966|18658130|P2|Overall Study|Protocol Violation|0
5408784|NCT02721966|18658131|P1|Overall Study|Protocol Violation|1
5408785|NCT02721875|18658171|P2|Overall Study|Progressive disease/relapse|0
5408786|NCT02721875|18658172|P1|Overall Study|Progressive disease/relapse|1
5408787|NCT02721147|18658223|P3|Overall Study|Lost to Follow-up|0
5408788|NCT02721147|18658224|P2|Overall Study|Lost to Follow-up|0
5408789|NCT02721147|18658225|P1|Overall Study|Lost to Follow-up|2
5408790|NCT02720757|18658269|P1|Overall Study|General exclusion|3
5408791|NCT02720757|18658269|P1|Overall Study|Missing|3
5408792|NCT02720757|18658269|P1|Overall Study|Patients wish to withdraw|2
5408793|NCT02720757|18658269|P1|Overall Study|Informed consent withdrawal|1
5408794|NCT02720757|18658269|P1|Overall Study|Loss of contact|4
5408795|NCT02720757|18658269|P1|Overall Study|Other reason|5
5408796|NCT02720536|18658283|P1|Overall Study|PR- unwilling to comply with procedures|1
5408797|NCT02720536|18658283|P1|Overall Study|PR - abnormal lab value(s)|1
5408798|NCT02720536|18658283|P1|Overall Study|PR - adverse event|1
5408799|NCT02720536|18658283|P1|Overall Study|PR - death|1
5408800|NCT02720536|18658283|P1|Overall Study|PR - unsatisfactory therapeutic effect|2
5408801|NCT02720536|18658283|P1|Overall Study|PR - pregnancy|2
5408802|NCT02720536|18658283|P1|Overall Study|Primary reason (PR) - subject withdrawal|11
5408803|NCT02720523|18658318|P7|Period 2: Long-term Extension Period|Other|3
5408804|NCT02720523|18658319|P6|Period 2: Long-term Extension Period|Other|0
5408805|NCT02720523|18658320|P5|Period 2: Long-term Extension Period|Other|2
5408806|NCT02720523|18658321|P4|Period 2: Long-term Extension Period|Other|0
5408807|NCT02720523|18658322|P3|Period 2: Long-term Extension Period|Other|0
5408808|NCT02720523|18658323|P2|Period 2: Long-term Extension Period|Other|0
5408809|NCT02720523|18658324|P1|Period 2: Long-term Extension Period|Other|0
5408810|NCT02720523|18658318|P7|Period 2: Long-term Extension Period|Withdrawal by Subject|1
5408811|NCT02720523|18658319|P6|Period 2: Long-term Extension Period|Withdrawal by Subject|1
5408812|NCT02720523|18658320|P5|Period 2: Long-term Extension Period|Withdrawal by Subject|2
5408813|NCT02720523|18658321|P4|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5408814|NCT02720523|18658322|P3|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5408815|NCT02720523|18658323|P2|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5408816|NCT02720523|18658324|P1|Period 2: Long-term Extension Period|Withdrawal by Subject|0
5408817|NCT02720523|18658318|P7|Period 2: Long-term Extension Period|Adverse Event|11
5408818|NCT02720523|18658319|P6|Period 2: Long-term Extension Period|Adverse Event|7
5408819|NCT02720523|18658320|P5|Period 2: Long-term Extension Period|Adverse Event|4
5408820|NCT02720523|18658321|P4|Period 2: Long-term Extension Period|Adverse Event|0
5408821|NCT02720523|18658322|P3|Period 2: Long-term Extension Period|Adverse Event|0
5408822|NCT02720523|18658323|P2|Period 2: Long-term Extension Period|Adverse Event|0
5408823|NCT02720523|18658324|P1|Period 2: Long-term Extension Period|Adverse Event|0
5408824|NCT02720523|18658318|P7|Period 2: Long-term Extension Period|Ongoing|45
5408825|NCT02720523|18658319|P6|Period 2: Long-term Extension Period|Ongoing|54
5408826|NCT02720523|18658320|P5|Period 2: Long-term Extension Period|Ongoing|57
5408827|NCT02720523|18658321|P4|Period 2: Long-term Extension Period|Ongoing|0
5408828|NCT02720523|18658322|P3|Period 2: Long-term Extension Period|Ongoing|0
5408829|NCT02720523|18658323|P2|Period 2: Long-term Extension Period|Ongoing|0
5408830|NCT02720523|18658324|P1|Period 2: Long-term Extension Period|Ongoing|0
5408831|NCT02720523|18658318|P7|Period 1: Placebo-controlled Period|Other|0
5408832|NCT02720523|18658319|P6|Period 1: Placebo-controlled Period|Other|0
5408833|NCT02720523|18658320|P5|Period 1: Placebo-controlled Period|Other|0
5408834|NCT02720523|18658321|P4|Period 1: Placebo-controlled Period|Other|1
5408835|NCT02720523|18658322|P3|Period 1: Placebo-controlled Period|Other|1
5408836|NCT02720523|18658323|P2|Period 1: Placebo-controlled Period|Other|0
5408837|NCT02720523|18658324|P1|Period 1: Placebo-controlled Period|Other|0
5408838|NCT02720523|18658318|P7|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5408839|NCT02720523|18658319|P6|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5408840|NCT02720523|18658320|P5|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5408841|NCT02720523|18658321|P4|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5408842|NCT02720523|18658322|P3|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5408843|NCT02720523|18658323|P2|Period 1: Placebo-controlled Period|Lack of Efficacy|0
5408844|NCT02720523|18658324|P1|Period 1: Placebo-controlled Period|Lack of Efficacy|1
5408845|NCT02720523|18658318|P7|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5408846|NCT02720523|18658319|P6|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5408847|NCT02720523|18658320|P5|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5408848|NCT02720523|18658321|P4|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5408849|NCT02720523|18658322|P3|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5408850|NCT02720523|18658323|P2|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
5408851|NCT02720523|18658324|P1|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
5408852|NCT02720523|18658318|P7|Period 1: Placebo-controlled Period|Adverse Event|0
5408853|NCT02720523|18658319|P6|Period 1: Placebo-controlled Period|Adverse Event|0
5408854|NCT02720523|18658320|P5|Period 1: Placebo-controlled Period|Adverse Event|0
5408855|NCT02720523|18658321|P4|Period 1: Placebo-controlled Period|Adverse Event|5
5408856|NCT02720523|18658322|P3|Period 1: Placebo-controlled Period|Adverse Event|1
5408857|NCT02720523|18658323|P2|Period 1: Placebo-controlled Period|Adverse Event|0
5408858|NCT02720523|18658324|P1|Period 1: Placebo-controlled Period|Adverse Event|0
5408859|NCT02720510|18658383|P2|Overall Study|Physician Decision|2
5408860|NCT02720510|18658384|P1|Overall Study|Physician Decision|1
5408861|NCT02720510|18658383|P2|Overall Study|Adverse Event|1
5408862|NCT02720510|18658384|P1|Overall Study|Adverse Event|0
5408863|NCT02720510|18658383|P2|Overall Study|Study Terminated by the sponsor|0
5408864|NCT02720510|18658384|P1|Overall Study|Study Terminated by the sponsor|2
5408865|NCT02720484|18658402|P1|Follow Up for 2 Years|Lost to Follow-up|2
5408866|NCT02720484|18658402|P1|Follow Up for 2 Years|Death|3
5408867|NCT02720484|18658402|P1|Follow Up for 2 Years|Withdrawal by Subject|1
5408868|NCT02720484|18658402|P1|Treatment on Study|Progressive Disease|4
5408869|NCT02720484|18658402|P1|Treatment on Study|Withdrawal by Subject|1
5408870|NCT02720484|18658402|P1|Treatment on Study|Adverse Event|1
5408871|NCT02720198|18658434|P2|Overall Study|Withdrawal by Subject|1
5408872|NCT02720198|18658435|P1|Overall Study|Withdrawal by Subject|0
5408873|NCT02720081|18658470|P2|Overall Study|Protocol Violation|1
5408874|NCT02720081|18658471|P1|Overall Study|Protocol Violation|4
5408875|NCT02720081|18658470|P2|Overall Study|Adverse Event|3
5408876|NCT02720081|18658471|P1|Overall Study|Adverse Event|0
5408877|NCT02720042|18658527|P1|Overall Study|unable due to non-study-related illness|3
5408878|NCT02720042|18658527|P1|Overall Study|Phasix Mesh explanted|1
5408879|NCT02720042|18658527|P1|Overall Study|Physician Decision|3
5408880|NCT02720042|18658527|P1|Overall Study|Withdrawal by Subject|1
5408881|NCT02720042|18658527|P1|Overall Study|Lost to Follow-up|4
5408882|NCT02720042|18658527|P1|Overall Study|Death|3
5408883|NCT02719743|18658568|P5|Overall Study|Lost to Follow-up|0
5408884|NCT02719743|18658569|P4|Overall Study|Lost to Follow-up|0
5408885|NCT02719743|18658570|P3|Overall Study|Lost to Follow-up|0
5408886|NCT02719743|18658571|P2|Overall Study|Lost to Follow-up|1
5408887|NCT02719743|18658572|P1|Overall Study|Lost to Follow-up|1
5408888|NCT02719743|18658568|P5|Overall Study|Migrated/moved from study area|2
5408889|NCT02719743|18658569|P4|Overall Study|Migrated/moved from study area|0
5408890|NCT02719743|18658570|P3|Overall Study|Migrated/moved from study area|0
5408891|NCT02719743|18658571|P2|Overall Study|Migrated/moved from study area|0
5408892|NCT02719743|18658572|P1|Overall Study|Migrated/moved from study area|0
5408893|NCT02719743|18658568|P5|Overall Study|Consent withdrawal|0
5408894|NCT02719743|18658569|P4|Overall Study|Consent withdrawal|1
5408895|NCT02719743|18658570|P3|Overall Study|Consent withdrawal|0
5408896|NCT02719743|18658571|P2|Overall Study|Consent withdrawal|2
5408897|NCT02719743|18658572|P1|Overall Study|Consent withdrawal|0
5408898|NCT02719522|18658713|P1|Overall Study|Lost to Follow-up|5
5408899|NCT02719522|18658713|P1|Overall Study|Death|2
5408900|NCT02719522|18658713|P1|Overall Study|Implant Failure|4
5408901|NCT02719353|18658755|P2|First Intervention|Physician Decision|1
5408902|NCT02719353|18658756|P1|First Intervention|Physician Decision|0
5408903|NCT02719171|18658795|P5|Overall Study|Other|0
5408904|NCT02719171|18658796|P4|Overall Study|Other|1
5408905|NCT02719171|18658797|P3|Overall Study|Other|0
5408906|NCT02719171|18658798|P2|Overall Study|Other|0
5408907|NCT02719171|18658799|P1|Overall Study|Other|0
5408908|NCT02719171|18658795|P5|Overall Study|Subject Withdrawal|0
5408909|NCT02719171|18658796|P4|Overall Study|Subject Withdrawal|1
5408910|NCT02719171|18658797|P3|Overall Study|Subject Withdrawal|2
5408911|NCT02719171|18658798|P2|Overall Study|Subject Withdrawal|2
5408912|NCT02719171|18658799|P1|Overall Study|Subject Withdrawal|0
5408913|NCT02719171|18658795|P5|Overall Study|Lost to Follow-up|0
5408914|NCT02719171|18658796|P4|Overall Study|Lost to Follow-up|0
5408915|NCT02719171|18658797|P3|Overall Study|Lost to Follow-up|1
5408916|NCT02719171|18658798|P2|Overall Study|Lost to Follow-up|0
5408917|NCT02719171|18658799|P1|Overall Study|Lost to Follow-up|0
5408918|NCT02719171|18658795|P5|Overall Study|Adverse Event|2
5408919|NCT02719171|18658796|P4|Overall Study|Adverse Event|0
5408920|NCT02719171|18658797|P3|Overall Study|Adverse Event|0
5408921|NCT02719171|18658798|P2|Overall Study|Adverse Event|2
5408922|NCT02719171|18658799|P1|Overall Study|Adverse Event|1
5408923|NCT02719028|18658916|P4|Overall Study|Protocol Violation|1
5408924|NCT02719028|18658917|P3|Overall Study|Protocol Violation|0
5408925|NCT02719028|18658918|P2|Overall Study|Protocol Violation|0
5408926|NCT02719028|18658919|P1|Overall Study|Protocol Violation|0
5408927|NCT02719028|18658916|P4|Overall Study|Use of prohibited medication|0
5408928|NCT02719028|18658917|P3|Overall Study|Use of prohibited medication|1
5408929|NCT02719028|18658918|P2|Overall Study|Use of prohibited medication|0
5408930|NCT02719028|18658919|P1|Overall Study|Use of prohibited medication|0
5408931|NCT02719028|18658916|P4|Overall Study|Physician Decision|1
5408932|NCT02719028|18658917|P3|Overall Study|Physician Decision|1
5408933|NCT02719028|18658918|P2|Overall Study|Physician Decision|1
5408934|NCT02719028|18658919|P1|Overall Study|Physician Decision|0
5408935|NCT02719028|18658916|P4|Overall Study|Adverse Event|8
5408936|NCT02719028|18658917|P3|Overall Study|Adverse Event|4
5408937|NCT02719028|18658918|P2|Overall Study|Adverse Event|1
5408938|NCT02719028|18658919|P1|Overall Study|Adverse Event|2
5408939|NCT02718898|18658952|P7|Post Treatment Follow-up Period|Withdrawal by Subject|3
5408940|NCT02718898|18658953|P6|Post Treatment Follow-up Period|Withdrawal by Subject|5
5408941|NCT02718898|18658954|P5|Post Treatment Follow-up Period|Withdrawal by Subject|0
5408942|NCT02718898|18658955|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
5408943|NCT02718898|18658956|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
5408944|NCT02718898|18658957|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
5408945|NCT02718898|18658958|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
5408946|NCT02718898|18658952|P7|Post Treatment Follow-up Period|Lost to Follow-up|1
5408947|NCT02718898|18658953|P6|Post Treatment Follow-up Period|Lost to Follow-up|5
5408948|NCT02718898|18658954|P5|Post Treatment Follow-up Period|Lost to Follow-up|1
5408949|NCT02718898|18658955|P4|Post Treatment Follow-up Period|Lost to Follow-up|0
5408950|NCT02718898|18658956|P3|Post Treatment Follow-up Period|Lost to Follow-up|0
5408951|NCT02718898|18658957|P2|Post Treatment Follow-up Period|Lost to Follow-up|0
5408952|NCT02718898|18658958|P1|Post Treatment Follow-up Period|Lost to Follow-up|0
5408953|NCT02718898|18658952|P7|Post Treatment Follow-up Period|Adverse Event|1
5408954|NCT02718898|18658953|P6|Post Treatment Follow-up Period|Adverse Event|1
5408955|NCT02718898|18658954|P5|Post Treatment Follow-up Period|Adverse Event|0
5408956|NCT02718898|18658955|P4|Post Treatment Follow-up Period|Adverse Event|0
5408957|NCT02718898|18658956|P3|Post Treatment Follow-up Period|Adverse Event|0
5408958|NCT02718898|18658957|P2|Post Treatment Follow-up Period|Adverse Event|0
5408959|NCT02718898|18658958|P1|Post Treatment Follow-up Period|Adverse Event|0
5408960|NCT02718898|18658952|P7|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5408961|NCT02718898|18658953|P6|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5408962|NCT02718898|18658954|P5|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5408963|NCT02718898|18658955|P4|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
5408964|NCT02718898|18658956|P3|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5408965|NCT02718898|18658957|P2|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5408966|NCT02718898|18658958|P1|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
5408967|NCT02718898|18658952|P7|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5408968|NCT02718898|18658953|P6|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5408969|NCT02718898|18658954|P5|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5408970|NCT02718898|18658955|P4|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
5408971|NCT02718898|18658956|P3|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5408972|NCT02718898|18658957|P2|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5408973|NCT02718898|18658958|P1|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
5408974|NCT02718898|18658952|P7|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5408975|NCT02718898|18658953|P6|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5408976|NCT02718898|18658954|P5|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5408977|NCT02718898|18658955|P4|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
5408978|NCT02718898|18658956|P3|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
5408979|NCT02718898|18658957|P2|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5408980|NCT02718898|18658958|P1|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
5408981|NCT02718898|18658952|P7|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5408982|NCT02718898|18658953|P6|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5408983|NCT02718898|18658954|P5|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5408984|NCT02718898|18658955|P4|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
5408985|NCT02718898|18658956|P3|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
5408986|NCT02718898|18658957|P2|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5408987|NCT02718898|18658958|P1|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
5408988|NCT02718898|18658952|P7|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5408989|NCT02718898|18658953|P6|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5408990|NCT02718898|18658954|P5|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5408991|NCT02718898|18658955|P4|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
5408992|NCT02718898|18658956|P3|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5408993|NCT02718898|18658957|P2|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5408994|NCT02718898|18658958|P1|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
5408995|NCT02718898|18658952|P7|Open Label Treatment Period (OLTP)|Adverse Event|0
5408996|NCT02718898|18658953|P6|Open Label Treatment Period (OLTP)|Adverse Event|0
5408997|NCT02718898|18658954|P5|Open Label Treatment Period (OLTP)|Adverse Event|0
5408998|NCT02718898|18658955|P4|Open Label Treatment Period (OLTP)|Adverse Event|1
5408999|NCT02718898|18658956|P3|Open Label Treatment Period (OLTP)|Adverse Event|1
5409000|NCT02718898|18658957|P2|Open Label Treatment Period (OLTP)|Adverse Event|0
5409001|NCT02718898|18658958|P1|Open Label Treatment Period (OLTP)|Adverse Event|0
5409002|NCT02718898|18658952|P7|Blinded Treatment Period|Lost to Follow-up|0
5409003|NCT02718898|18658953|P6|Blinded Treatment Period|Lost to Follow-up|0
5409004|NCT02718898|18658954|P5|Blinded Treatment Period|Lost to Follow-up|0
5409005|NCT02718898|18658955|P4|Blinded Treatment Period|Lost to Follow-up|0
5409006|NCT02718898|18658956|P3|Blinded Treatment Period|Lost to Follow-up|0
5409007|NCT02718898|18658957|P2|Blinded Treatment Period|Lost to Follow-up|0
5409008|NCT02718898|18658958|P1|Blinded Treatment Period|Lost to Follow-up|2
5409009|NCT02718898|18658952|P7|Blinded Treatment Period|Lack of Efficacy|0
5409010|NCT02718898|18658953|P6|Blinded Treatment Period|Lack of Efficacy|0
5409011|NCT02718898|18658954|P5|Blinded Treatment Period|Lack of Efficacy|0
5409012|NCT02718898|18658955|P4|Blinded Treatment Period|Lack of Efficacy|0
5409013|NCT02718898|18658956|P3|Blinded Treatment Period|Lack of Efficacy|0
5409014|NCT02718898|18658957|P2|Blinded Treatment Period|Lack of Efficacy|0
5409015|NCT02718898|18658958|P1|Blinded Treatment Period|Lack of Efficacy|1
5409016|NCT02718898|18658952|P7|Blinded Treatment Period|Physician Decision|0
5409017|NCT02718898|18658953|P6|Blinded Treatment Period|Physician Decision|0
5409018|NCT02718898|18658954|P5|Blinded Treatment Period|Physician Decision|0
5409019|NCT02718898|18658955|P4|Blinded Treatment Period|Physician Decision|0
5409020|NCT02718898|18658956|P3|Blinded Treatment Period|Physician Decision|0
5409021|NCT02718898|18658957|P2|Blinded Treatment Period|Physician Decision|0
5409022|NCT02718898|18658958|P1|Blinded Treatment Period|Physician Decision|1
5409023|NCT02718898|18658952|P7|Blinded Treatment Period|Adverse Event|0
5409024|NCT02718898|18658953|P6|Blinded Treatment Period|Adverse Event|0
5409025|NCT02718898|18658954|P5|Blinded Treatment Period|Adverse Event|0
5409026|NCT02718898|18658955|P4|Blinded Treatment Period|Adverse Event|0
5409027|NCT02718898|18658956|P3|Blinded Treatment Period|Adverse Event|0
5409028|NCT02718898|18658957|P2|Blinded Treatment Period|Adverse Event|1
5409029|NCT02718898|18658958|P1|Blinded Treatment Period|Adverse Event|5
5409030|NCT02718625|18658993|P2|Overall Study|Termination of Study by Sponsor|1
5409031|NCT02718625|18658994|P1|Overall Study|Termination of Study by Sponsor|0
5409032|NCT02718625|18658993|P2|Overall Study|Adverse Event|1
5409033|NCT02718625|18658994|P1|Overall Study|Adverse Event|0
5409034|NCT02718417|18659013|P3|Long-term Follow-up Phase|Other|0
5409035|NCT02718417|18659014|P2|Long-term Follow-up Phase|Other|2
5409036|NCT02718417|18659015|P1|Long-term Follow-up Phase|Other|0
5409037|NCT02718417|18659013|P3|Long-term Follow-up Phase|Withdrawal by Subject|9
5409038|NCT02718417|18659014|P2|Long-term Follow-up Phase|Withdrawal by Subject|9
5409039|NCT02718417|18659015|P1|Long-term Follow-up Phase|Withdrawal by Subject|6
5409040|NCT02718417|18659013|P3|Long-term Follow-up Phase|Study terminated by sponsor|112
5409041|NCT02718417|18659014|P2|Long-term Follow-up Phase|Study terminated by sponsor|80
5409042|NCT02718417|18659015|P1|Long-term Follow-up Phase|Study terminated by sponsor|105
5409043|NCT02718417|18659013|P3|Long-term Follow-up Phase|Lost to Follow-up|3
5409044|NCT02718417|18659014|P2|Long-term Follow-up Phase|Lost to Follow-up|4
5409045|NCT02718417|18659015|P1|Long-term Follow-up Phase|Lost to Follow-up|8
5409046|NCT02718417|18659013|P3|Long-term Follow-up Phase|Death leading to discontinuation|11
5409047|NCT02718417|18659014|P2|Long-term Follow-up Phase|Death leading to discontinuation|17
5409048|NCT02718417|18659015|P1|Long-term Follow-up Phase|Death leading to discontinuation|20
5409049|NCT02718417|18659013|P3|Follow-up Phase|Death leading to discontinuation|3
5409050|NCT02718417|18659014|P2|Follow-up Phase|Death leading to discontinuation|7
5409051|NCT02718417|18659015|P1|Follow-up Phase|Death leading to discontinuation|7
5409052|NCT02718417|18659013|P3|Follow-up Phase|Lost to Follow-up|0
5409053|NCT02718417|18659014|P2|Follow-up Phase|Lost to Follow-up|3
5409054|NCT02718417|18659015|P1|Follow-up Phase|Lost to Follow-up|2
5409055|NCT02718417|18659013|P3|Follow-up Phase|Study terminated by sponsor|6
5409056|NCT02718417|18659014|P2|Follow-up Phase|Study terminated by sponsor|138
5409057|NCT02718417|18659015|P1|Follow-up Phase|Study terminated by sponsor|100
5409058|NCT02718417|18659013|P3|Follow-up Phase|Withdrawal by Subject|5
5409059|NCT02718417|18659014|P2|Follow-up Phase|Withdrawal by Subject|17
5409060|NCT02718417|18659015|P1|Follow-up Phase|Withdrawal by Subject|19
5409061|NCT02718417|18659013|P3|Follow-up Phase|Other|4
5409062|NCT02718417|18659014|P2|Follow-up Phase|Other|6
5409063|NCT02718417|18659015|P1|Follow-up Phase|Other|4
5409064|NCT02718417|18659013|P3|Follow-up Phase|Adverse Event|1
5409065|NCT02718417|18659014|P2|Follow-up Phase|Adverse Event|1
5409066|NCT02718417|18659015|P1|Follow-up Phase|Adverse Event|3
5409067|NCT02718417|18659013|P3|Observation Phase (OP)|Other|7
5409068|NCT02718417|18659014|P2|Observation Phase (OP)|Other|0
5409069|NCT02718417|18659015|P1|Observation Phase (OP)|Other|0
5409070|NCT02718417|18659013|P3|Observation Phase (OP)|Global deterioration of health status|1
5409071|NCT02718417|18659014|P2|Observation Phase (OP)|Global deterioration of health status|0
5409072|NCT02718417|18659015|P1|Observation Phase (OP)|Global deterioration of health status|0
5409073|NCT02718417|18659013|P3|Observation Phase (OP)|Withdrawal by Subject|34
5409074|NCT02718417|18659014|P2|Observation Phase (OP)|Withdrawal by Subject|0
5409075|NCT02718417|18659015|P1|Observation Phase (OP)|Withdrawal by Subject|0
5409076|NCT02718417|18659013|P3|Observation Phase (OP)|Study terminated by sponsor|135
5409077|NCT02718417|18659014|P2|Observation Phase (OP)|Study terminated by sponsor|0
5409078|NCT02718417|18659015|P1|Observation Phase (OP)|Study terminated by sponsor|0
5409079|NCT02718417|18659013|P3|Observation Phase (OP)|Progressive disease|92
5409080|NCT02718417|18659014|P2|Observation Phase (OP)|Progressive disease|0
5409081|NCT02718417|18659015|P1|Observation Phase (OP)|Progressive disease|0
5409082|NCT02718417|18659013|P3|Observation Phase (OP)|Physician Decision|9
5409083|NCT02718417|18659014|P2|Observation Phase (OP)|Physician Decision|0
5409084|NCT02718417|18659015|P1|Observation Phase (OP)|Physician Decision|0
5409085|NCT02718417|18659013|P3|Observation Phase (OP)|Lost to Follow-up|1
5409086|NCT02718417|18659014|P2|Observation Phase (OP)|Lost to Follow-up|0
5409087|NCT02718417|18659015|P1|Observation Phase (OP)|Lost to Follow-up|0
5409088|NCT02718417|18659013|P3|Observation Phase (OP)|Death leading to discontinuation|2
5409089|NCT02718417|18659014|P2|Observation Phase (OP)|Death leading to discontinuation|0
5409090|NCT02718417|18659015|P1|Observation Phase (OP)|Death leading to discontinuation|0
5409091|NCT02718417|18659013|P3|Observation Phase (OP)|Adverse Event|1
5409092|NCT02718417|18659014|P2|Observation Phase (OP)|Adverse Event|0
5409093|NCT02718417|18659015|P1|Observation Phase (OP)|Adverse Event|0
5409094|NCT02718417|18659013|P3|Maintenance Phase (MP)|Study terminated by sponsor|0
5409095|NCT02718417|18659014|P2|Maintenance Phase (MP)|Study terminated by sponsor|140
5409096|NCT02718417|18659015|P1|Maintenance Phase (MP)|Study terminated by sponsor|114
5409097|NCT02718417|18659013|P3|Maintenance Phase (MP)|Withdrawal by Subject|0
5409098|NCT02718417|18659014|P2|Maintenance Phase (MP)|Withdrawal by Subject|20
5409099|NCT02718417|18659015|P1|Maintenance Phase (MP)|Withdrawal by Subject|17
5409100|NCT02718417|18659013|P3|Maintenance Phase (MP)|Other|0
5409101|NCT02718417|18659014|P2|Maintenance Phase (MP)|Other|1
5409102|NCT02718417|18659015|P1|Maintenance Phase (MP)|Other|2
5409103|NCT02718417|18659013|P3|Maintenance Phase (MP)|Progressive disease|0
5409104|NCT02718417|18659014|P2|Maintenance Phase (MP)|Progressive disease|88
5409105|NCT02718417|18659015|P1|Maintenance Phase (MP)|Progressive disease|100
5409106|NCT02718417|18659013|P3|Maintenance Phase (MP)|Physician's decision|0
5409107|NCT02718417|18659014|P2|Maintenance Phase (MP)|Physician's decision|7
5409108|NCT02718417|18659015|P1|Maintenance Phase (MP)|Physician's decision|6
5409109|NCT02718417|18659013|P3|Maintenance Phase (MP)|No longer met eligibility criteria|0
5409110|NCT02718417|18659014|P2|Maintenance Phase (MP)|No longer met eligibility criteria|1
5409111|NCT02718417|18659015|P1|Maintenance Phase (MP)|No longer met eligibility criteria|0
5409405|NCT02715726|18659822|P2|Overall Study|Randomized but not treated|2
5409112|NCT02718417|18659013|P3|Maintenance Phase (MP)|Global deterioration of health status|0
5409113|NCT02718417|18659014|P2|Maintenance Phase (MP)|Global deterioration of health status|3
5409114|NCT02718417|18659015|P1|Maintenance Phase (MP)|Global deterioration of health status|5
5409115|NCT02718417|18659013|P3|Maintenance Phase (MP)|Death leading to discontinuation|0
5409116|NCT02718417|18659014|P2|Maintenance Phase (MP)|Death leading to discontinuation|1
5409117|NCT02718417|18659015|P1|Maintenance Phase (MP)|Death leading to discontinuation|1
5409118|NCT02718417|18659013|P3|Maintenance Phase (MP)|Adverse Event|0
5409119|NCT02718417|18659014|P2|Maintenance Phase (MP)|Adverse Event|26
5409120|NCT02718417|18659015|P1|Maintenance Phase (MP)|Adverse Event|21
5409121|NCT02718417|18659013|P3|Chemotherapy Phase (CP)|Other|1
5409122|NCT02718417|18659014|P2|Chemotherapy Phase (CP)|Other|0
5409123|NCT02718417|18659015|P1|Chemotherapy Phase (CP)|Other|2
5409124|NCT02718417|18659013|P3|Chemotherapy Phase (CP)|Withdrawal by Subject|15
5409125|NCT02718417|18659014|P2|Chemotherapy Phase (CP)|Withdrawal by Subject|8
5409126|NCT02718417|18659015|P1|Chemotherapy Phase (CP)|Withdrawal by Subject|13
5409127|NCT02718417|18659013|P3|Chemotherapy Phase (CP)|Progressive disease|10
5409128|NCT02718417|18659014|P2|Chemotherapy Phase (CP)|Progressive disease|7
5409129|NCT02718417|18659015|P1|Chemotherapy Phase (CP)|Progressive disease|11
5409130|NCT02718417|18659013|P3|Chemotherapy Phase (CP)|Physician's decision|4
5409131|NCT02718417|18659014|P2|Chemotherapy Phase (CP)|Physician's decision|0
5409132|NCT02718417|18659015|P1|Chemotherapy Phase (CP)|Physician's decision|5
5409133|NCT02718417|18659013|P3|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
5409134|NCT02718417|18659014|P2|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
5409135|NCT02718417|18659015|P1|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
5409136|NCT02718417|18659013|P3|Chemotherapy Phase (CP)|Global deterioration of health status|1
5409137|NCT02718417|18659014|P2|Chemotherapy Phase (CP)|Global deterioration of health status|2
5409138|NCT02718417|18659015|P1|Chemotherapy Phase (CP)|Global deterioration of health status|3
5409139|NCT02718417|18659013|P3|Chemotherapy Phase (CP)|Death leading to discontinuation|1
5409140|NCT02718417|18659014|P2|Chemotherapy Phase (CP)|Death leading to discontinuation|4
5409141|NCT02718417|18659015|P1|Chemotherapy Phase (CP)|Death leading to discontinuation|5
5409142|NCT02718417|18659013|P3|Chemotherapy Phase (CP)|Adverse Event|13
5409143|NCT02718417|18659014|P2|Chemotherapy Phase (CP)|Adverse Event|14
5409144|NCT02718417|18659015|P1|Chemotherapy Phase (CP)|Adverse Event|9
5409145|NCT02718326|18659121|P3|Overall Study|Pregnancy|0
5409146|NCT02718326|18659122|P2|Overall Study|Pregnancy|0
5409147|NCT02718326|18659123|P1|Overall Study|Pregnancy|1
5409148|NCT02718326|18659121|P3|Overall Study|Protocol Deviation|0
5409149|NCT02718326|18659122|P2|Overall Study|Protocol Deviation|0
5409150|NCT02718326|18659123|P1|Overall Study|Protocol Deviation|1
5409151|NCT02718326|18659121|P3|Overall Study|Lost to Follow-up|14
5409152|NCT02718326|18659122|P2|Overall Study|Lost to Follow-up|5
5409153|NCT02718326|18659123|P1|Overall Study|Lost to Follow-up|18
5409154|NCT02718326|18659121|P3|Overall Study|Withdrawal by Subject|6
5409155|NCT02718326|18659122|P2|Overall Study|Withdrawal by Subject|9
5409156|NCT02718326|18659123|P1|Overall Study|Withdrawal by Subject|4
5409157|NCT02718326|18659121|P3|Overall Study|Death|2
5409158|NCT02718326|18659122|P2|Overall Study|Death|1
5409159|NCT02718326|18659123|P1|Overall Study|Death|8
5409160|NCT02718326|18659121|P3|Overall Study|Adverse Event|0
5409161|NCT02718326|18659122|P2|Overall Study|Adverse Event|9
5409162|NCT02718326|18659123|P1|Overall Study|Adverse Event|4
5409163|NCT02717754|18659244|P6|Overall Study|Incorrect Infusion Duration|20
5409164|NCT02717754|18659245|P5|Overall Study|Incorrect Infusion Duration|20
5409165|NCT02717754|18659246|P4|Overall Study|Incorrect Infusion Duration|10
5409166|NCT02717754|18659247|P3|Overall Study|Incorrect Infusion Duration|0
5409167|NCT02717754|18659248|P2|Overall Study|Incorrect Infusion Duration|0
5409168|NCT02717754|18659249|P1|Overall Study|Incorrect Infusion Duration|0
5409169|NCT02717494|18659280|P3|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
5409170|NCT02717494|18659281|P2|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
5409171|NCT02717494|18659282|P1|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
5409172|NCT02717494|18659280|P3|First Intervention (Step 1)|Death|1
5409173|NCT02717494|18659281|P2|First Intervention (Step 1)|Death|0
5409174|NCT02717494|18659282|P1|First Intervention (Step 1)|Death|0
5409175|NCT02717494|18659280|P3|First Intervention (Step 1)|Withdrawal by Subject|1
5409176|NCT02717494|18659281|P2|First Intervention (Step 1)|Withdrawal by Subject|0
5409177|NCT02717494|18659282|P1|First Intervention (Step 1)|Withdrawal by Subject|2
5409178|NCT02717494|18659280|P3|First Intervention (Step 1)|Lost to Follow-up|3
5409179|NCT02717494|18659281|P2|First Intervention (Step 1)|Lost to Follow-up|7
5409180|NCT02717494|18659282|P1|First Intervention (Step 1)|Lost to Follow-up|4
5409181|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Patient missed required visits|1
5409182|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Patient missed required visits|1
5409183|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Patient missed required visits|0
5409184|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Patient missed required visits|0
5409185|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Patient missed required visits|0
5409186|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5409187|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5409188|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Psychosocial issues|1
5409189|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5409406|NCT02715726|18659823|P1|Overall Study|Randomized but not treated|1
5409190|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Psychosocial issues|0
5409191|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
5409192|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5409193|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5409194|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5409195|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
5409196|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Change of residence|1
5409197|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Change of residence|1
5409198|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Change of residence|0
5409199|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Change of residence|0
5409200|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Change of residence|0
5409201|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Family circumstances|1
5409202|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Family circumstances|0
5409203|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Family circumstances|0
5409204|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Family circumstances|0
5409205|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Family circumstances|0
5409206|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Investigator decision|1
5409207|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Investigator decision|1
5409208|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Investigator decision|0
5409209|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Investigator decision|0
5409210|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Investigator decision|0
5409211|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Patient decision|2
5409212|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Patient decision|2
5409213|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Patient decision|0
5409214|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Patient decision|0
5409215|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Patient decision|0
5409216|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5409217|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5409218|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
5409219|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5409220|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
5409221|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
5409222|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
5409223|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
5409224|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
5409225|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
5409226|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
5409227|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
5409228|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
5409229|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
5409230|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
5409231|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Protocol Violation|1
5409232|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Protocol Violation|0
5409233|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Protocol Violation|1
5409234|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Protocol Violation|0
5409235|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Protocol Violation|0
5409236|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
5409237|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
5409238|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
5409239|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
5409240|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
5409241|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
5409242|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
5409243|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
5409244|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
5409245|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
5409246|NCT02717195|18659344|P5|Double-blind Treatment (DBT) Period|Adverse Event|8
5409247|NCT02717195|18659345|P4|Double-blind Treatment (DBT) Period|Adverse Event|11
5409248|NCT02717195|18659346|P3|Double-blind Treatment (DBT) Period|Adverse Event|10
5409249|NCT02717195|18659347|P2|Double-blind Treatment (DBT) Period|Adverse Event|0
5409250|NCT02717195|18659348|P1|Double-blind Treatment (DBT) Period|Adverse Event|0
5409251|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5409252|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5409253|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5409254|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
5409255|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
5409256|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5409257|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5409258|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5409259|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Patient fraud with payment|0
5409260|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Patient fraud with payment|1
5409261|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Sponsor requested|0
5409262|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Sponsor requested|0
5409263|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Sponsor requested|0
5409264|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Sponsor requested|1
5409265|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Sponsor requested|0
5409266|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Duplicate subject|0
5409267|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Duplicate subject|0
5409268|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Duplicate subject|0
5409269|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Duplicate subject|0
5409270|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Duplicate subject|1
5409271|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5409272|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5409273|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5409274|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
5409275|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
5409276|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5409277|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5409278|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5409279|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
5409280|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
5409281|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5409282|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5409283|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5409284|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
5409285|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
5409286|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Investigator decision|0
5409287|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Investigator decision|0
5409288|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Investigator decision|0
5409289|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Investigator decision|1
5409290|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Investigator decision|2
5409291|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5409292|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5409293|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5409294|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
5409295|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
5409296|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Change of place of residence|0
5409297|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Change of place of residence|0
5409298|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Change of place of residence|0
5409299|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Change of place of residence|0
5409300|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Change of place of residence|1
5409301|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5409302|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5409303|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5409304|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
5409305|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
5409306|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Patient decision|0
5409307|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Patient decision|0
5409308|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Patient decision|0
5409309|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Patient decision|2
5409310|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Patient decision|5
5409311|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Technical error|0
5409312|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Technical error|0
5409313|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Technical error|0
5409314|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Technical error|0
5409315|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Technical error|1
5409316|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5409317|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5409318|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5409319|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
5409320|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
5409321|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Enrolled but not treated|0
5409322|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Enrolled but not treated|0
5409323|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Enrolled but not treated|0
5409324|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Enrolled but not treated|3
5409325|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Enrolled but not treated|3
5409407|NCT02715726|18659822|P2|Overall Study|Other than specified above|15
5409326|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
5409327|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
5409328|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
5409329|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
5409330|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
5409331|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Lost to Follow-up|0
5409332|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Lost to Follow-up|0
5409333|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Lost to Follow-up|0
5409334|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Lost to Follow-up|4
5409335|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Lost to Follow-up|9
5409336|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5409337|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5409338|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
5409339|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
5409340|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
5409341|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Protocol Violation|0
5409342|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
5409343|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
5409344|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Protocol Violation|1
5409345|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Protocol Violation|3
5409346|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
5409347|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
5409348|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
5409349|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
5409350|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
5409351|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5409352|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5409353|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
5409354|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|1
5409355|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|2
5409356|NCT02717195|18659344|P5|Prospective Confirmation (PC) Period|Adverse Event|0
5409357|NCT02717195|18659345|P4|Prospective Confirmation (PC) Period|Adverse Event|0
5409358|NCT02717195|18659346|P3|Prospective Confirmation (PC) Period|Adverse Event|0
5409359|NCT02717195|18659347|P2|Prospective Confirmation (PC) Period|Adverse Event|7
5409360|NCT02717195|18659348|P1|Prospective Confirmation (PC) Period|Adverse Event|19
5409361|NCT02717130|18659379|P1|Overall Study|Study Closure|4
5409362|NCT02717130|18659379|P1|Overall Study|Physician Decision|1
5409363|NCT02717130|18659379|P1|Overall Study|Adverse Event|1
5409364|NCT02717130|18659379|P1|Overall Study|Withdrawal by Subject|1
5409365|NCT02716987|18659389|P6|Overall Study|Withdrawal by Subject|1
5409366|NCT02716987|18659390|P5|Overall Study|Withdrawal by Subject|1
5409367|NCT02716987|18659391|P4|Overall Study|Withdrawal by Subject|0
5409368|NCT02716987|18659392|P3|Overall Study|Withdrawal by Subject|0
5409369|NCT02716987|18659393|P2|Overall Study|Withdrawal by Subject|0
5409370|NCT02716987|18659394|P1|Overall Study|Withdrawal by Subject|0
5409371|NCT02716987|18659389|P6|Overall Study|Ligand synthesis failure|0
5409372|NCT02716987|18659390|P5|Overall Study|Ligand synthesis failure|0
5409373|NCT02716987|18659391|P4|Overall Study|Ligand synthesis failure|0
5409374|NCT02716987|18659392|P3|Overall Study|Ligand synthesis failure|1
5409375|NCT02716987|18659393|P2|Overall Study|Ligand synthesis failure|0
5409376|NCT02716987|18659394|P1|Overall Study|Ligand synthesis failure|0
5409377|NCT02716896|18659460|P2|Overall Study|Physician Decision|1
5409378|NCT02716896|18659461|P1|Overall Study|Physician Decision|0
5409379|NCT02716805|18659512|P4|Overall Study|Progressive disease|0
5409380|NCT02716805|18659513|P3|Overall Study|Progressive disease|0
5409381|NCT02716805|18659514|P2|Overall Study|Progressive disease|0
5409382|NCT02716805|18659515|P1|Overall Study|Progressive disease|2
5409383|NCT02716779|18659523|P3|Combination Therapy|Adverse Event|1
5409384|NCT02716779|18659524|P2|Combination Therapy|Adverse Event|2
5409385|NCT02716779|18659525|P1|Combination Therapy|Adverse Event|0
5409386|NCT02716779|18659523|P3|Monotherapy|Adverse Event|1
5409387|NCT02716779|18659524|P2|Monotherapy|Adverse Event|1
5409388|NCT02716779|18659525|P1|Monotherapy|Adverse Event|0
5409389|NCT02716584|18659625|P2|Overall Study|Lost to Follow-up|5
5409390|NCT02716584|18659626|P1|Overall Study|Lost to Follow-up|8
5409391|NCT02716298|18659682|P2|First Intervention (1 Month)|Lens discomfort|1
5409392|NCT02716298|18659683|P1|First Intervention (1 Month)|Lens discomfort|1
5409393|NCT02716194|18659701|P3|Period 1 - ADVATE|Withdrawal by Subject|0
5409394|NCT02716194|18659702|P2|Period 1 - ADVATE|Withdrawal by Subject|1
5409395|NCT02716194|18659703|P1|Period 1 - ADVATE|Withdrawal by Subject|1
5409396|NCT02715804|18659783|P2|Overall Study|Other than specified|3
5409397|NCT02715804|18659784|P1|Overall Study|Other than specified|2
5409398|NCT02715804|18659783|P2|Overall Study|Withdrawal by Subject|4
5409399|NCT02715804|18659784|P1|Overall Study|Withdrawal by Subject|5
5409400|NCT02715804|18659783|P2|Overall Study|Death|106
5409401|NCT02715804|18659784|P1|Overall Study|Death|222
5409402|NCT02715765|18659807|P3|Overall Study|Study Termination|0
5409403|NCT02715765|18659808|P2|Overall Study|Study Termination|0
5409404|NCT02715765|18659809|P1|Overall Study|Study Termination|3
5409408|NCT02715726|18659823|P1|Overall Study|Other than specified above|11
5409409|NCT02715726|18659822|P2|Overall Study|Participant moved|3
5409410|NCT02715726|18659823|P1|Overall Study|Participant moved|1
5409411|NCT02715726|18659822|P2|Overall Study|Death|1
5409412|NCT02715726|18659823|P1|Overall Study|Death|2
5409413|NCT02715726|18659822|P2|Overall Study|Protocol Violation|0
5409414|NCT02715726|18659823|P1|Overall Study|Protocol Violation|1
5409415|NCT02715726|18659822|P2|Overall Study|Adverse Event|6
5409416|NCT02715726|18659823|P1|Overall Study|Adverse Event|2
5409417|NCT02714868|18659903|P2|Overall Study|PI withdraw did not meet inclusion|0
5409418|NCT02714868|18659904|P1|Overall Study|PI withdraw did not meet inclusion|1
5409419|NCT02714868|18659903|P2|Overall Study|PI withdrawal safety risk self/others|0
5409420|NCT02714868|18659904|P1|Overall Study|PI withdrawal safety risk self/others|1
5409421|NCT02714868|18659903|P2|Overall Study|Withdrawal by Subject|0
5409422|NCT02714868|18659904|P1|Overall Study|Withdrawal by Subject|3
5409423|NCT02714595|18659922|P2|Overall Study|Other-Miscellaneous|1
5409424|NCT02714595|18659923|P1|Overall Study|Other-Miscellaneous|0
5409425|NCT02714595|18659922|P2|Overall Study|Death|9
5409426|NCT02714595|18659923|P1|Overall Study|Death|30
5409427|NCT02714595|18659922|P2|Overall Study|Lack of Efficacy|1
5409428|NCT02714595|18659923|P1|Overall Study|Lack of Efficacy|0
5409429|NCT02714595|18659922|P2|Overall Study|Withdrawal by Subject|2
5409430|NCT02714595|18659923|P1|Overall Study|Withdrawal by Subject|1
5409431|NCT02714595|18659922|P2|Overall Study|Lost to Follow-up|0
5409432|NCT02714595|18659923|P1|Overall Study|Lost to Follow-up|1
5409433|NCT02714426|18660180|P2|Overall Study|Withdrawal by Subject|2
5409434|NCT02714426|18660181|P1|Overall Study|Withdrawal by Subject|2
5409435|NCT02714218|18660242|P3|Overall Study|Stop treatment, but will do follow up|0
5409436|NCT02714218|18660243|P2|Overall Study|Stop treatment, but will do follow up|1
5409437|NCT02714218|18660244|P1|Overall Study|Stop treatment, but will do follow up|0
5409438|NCT02714218|18660242|P3|Overall Study|Complete Response|0
5409439|NCT02714218|18660243|P2|Overall Study|Complete Response|0
5409440|NCT02714218|18660244|P1|Overall Study|Complete Response|1
5409441|NCT02714218|18660242|P3|Overall Study|Dose Delayed > 6 weeks|0
5409442|NCT02714218|18660243|P2|Overall Study|Dose Delayed > 6 weeks|0
5409443|NCT02714218|18660244|P1|Overall Study|Dose Delayed > 6 weeks|1
5409444|NCT02714218|18660242|P3|Overall Study|Completed|0
5409445|NCT02714218|18660243|P2|Overall Study|Completed|0
5409446|NCT02714218|18660244|P1|Overall Study|Completed|2
5409447|NCT02714218|18660242|P3|Overall Study|Not Reported|0
5409448|NCT02714218|18660243|P2|Overall Study|Not Reported|5
5409449|NCT02714218|18660244|P1|Overall Study|Not Reported|9
5409450|NCT02714218|18660242|P3|Overall Study|Medical Decision|0
5409451|NCT02714218|18660243|P2|Overall Study|Medical Decision|1
5409452|NCT02714218|18660244|P1|Overall Study|Medical Decision|0
5409453|NCT02714218|18660242|P3|Overall Study|Maximum Clinical Benefit|0
5409454|NCT02714218|18660243|P2|Overall Study|Maximum Clinical Benefit|2
5409455|NCT02714218|18660244|P1|Overall Study|Maximum Clinical Benefit|2
5409456|NCT02714218|18660242|P3|Overall Study|Participant Withdrew Consent|0
5409457|NCT02714218|18660243|P2|Overall Study|Participant Withdrew Consent|3
5409458|NCT02714218|18660244|P1|Overall Study|Participant Withdrew Consent|2
5409459|NCT02714218|18660242|P3|Overall Study|Request to Discontinue Treatment|1
5409460|NCT02714218|18660243|P2|Overall Study|Request to Discontinue Treatment|5
5409461|NCT02714218|18660244|P1|Overall Study|Request to Discontinue Treatment|1
5409462|NCT02714218|18660242|P3|Overall Study|Study Drug Toxicity|4
5409463|NCT02714218|18660243|P2|Overall Study|Study Drug Toxicity|69
5409464|NCT02714218|18660244|P1|Overall Study|Study Drug Toxicity|46
5409465|NCT02714218|18660242|P3|Overall Study|Adverse Event Unrelated to Study Drug|0
5409466|NCT02714218|18660243|P2|Overall Study|Adverse Event Unrelated to Study Drug|6
5409467|NCT02714218|18660244|P1|Overall Study|Adverse Event Unrelated to Study Drug|10
5409468|NCT02714218|18660242|P3|Overall Study|Disease Progression|14
5409469|NCT02714218|18660243|P2|Overall Study|Disease Progression|51
5409470|NCT02714218|18660244|P1|Overall Study|Disease Progression|56
5409471|NCT02714062|18660294|P3|Overall Study|Protocol Violation|0
5409472|NCT02714062|18660295|P2|Overall Study|Protocol Violation|1
5409473|NCT02714062|18660296|P1|Overall Study|Protocol Violation|0
5409474|NCT02714062|18660294|P3|Overall Study|Withdrawal by Subject|1
5409475|NCT02714062|18660295|P2|Overall Study|Withdrawal by Subject|0
5409476|NCT02714062|18660296|P1|Overall Study|Withdrawal by Subject|1
5409477|NCT02714062|18660294|P3|Overall Study|Adverse Event|2
5409478|NCT02714062|18660295|P2|Overall Study|Adverse Event|0
5409479|NCT02714062|18660296|P1|Overall Study|Adverse Event|0
5409480|NCT02713867|18660342|P2|Treatment Period|Disease Progression|78
5409481|NCT02713867|18660343|P1|Treatment Period|Disease Progression|79
5409482|NCT02713867|18660342|P2|Treatment Period|Study Drug Toxicity|20
5409483|NCT02713867|18660343|P1|Treatment Period|Study Drug Toxicity|16
5409484|NCT02713867|18660342|P2|Treatment Period|Death|3
5409485|NCT02713867|18660343|P1|Treatment Period|Death|7
5409486|NCT02713867|18660342|P2|Treatment Period|AE unrelated to Study Drug|9
5409487|NCT02713867|18660343|P1|Treatment Period|AE unrelated to Study Drug|8
5409488|NCT02713867|18660342|P2|Treatment Period|Requested to Discontinue|7
5409489|NCT02713867|18660343|P1|Treatment Period|Requested to Discontinue|8
5409490|NCT02713867|18660342|P2|Treatment Period|Withdrew consent|6
5409491|NCT02713867|18660343|P1|Treatment Period|Withdrew consent|1
5409492|NCT02713867|18660342|P2|Treatment Period|Maximum Clinical Benefit|4
5409493|NCT02713867|18660343|P1|Treatment Period|Maximum Clinical Benefit|3
5409494|NCT02713867|18660342|P2|Treatment Period|Poor/Non Compliance|0
5409495|NCT02713867|18660343|P1|Treatment Period|Poor/Non Compliance|1
5409496|NCT02713867|18660342|P2|Treatment Period|No longer meets study criteria|1
5409497|NCT02713867|18660343|P1|Treatment Period|No longer meets study criteria|2
5409498|NCT02713867|18660342|P2|Treatment Period|Administrative reason by sponsor|4
5409499|NCT02713867|18660343|P1|Treatment Period|Administrative reason by sponsor|9
5409500|NCT02713867|18660342|P2|Treatment Period|Other Reasons|18
5409501|NCT02713867|18660343|P1|Treatment Period|Other Reasons|12
5409502|NCT02713867|18660342|P2|Treatment Period|Not Reported|0
5409503|NCT02713867|18660343|P1|Treatment Period|Not Reported|1
5409504|NCT02713867|18660342|P2|Randomization|Participant Withdrew consent|2
5409505|NCT02713867|18660343|P1|Randomization|Participant Withdrew consent|0
5409506|NCT02713867|18660342|P2|Randomization|Other Reason|1
5409507|NCT02713867|18660343|P1|Randomization|Other Reason|2
5409508|NCT02713828|18660381|P2|Overall Study|study terminated but patient allowed to|0
5409509|NCT02713828|18660382|P1|Overall Study|study terminated but patient allowed to|2
5409510|NCT02713828|18660381|P2|Overall Study|Withdrawal by Subject|0
5409511|NCT02713828|18660382|P1|Overall Study|Withdrawal by Subject|1
5409512|NCT02713828|18660381|P2|Overall Study|Death|0
5409513|NCT02713828|18660382|P1|Overall Study|Death|2
5409514|NCT02713789|18660394|P3|Overall Study|Lost to Follow-up|1
5409515|NCT02713789|18660395|P2|Overall Study|Lost to Follow-up|1
5409516|NCT02713789|18660396|P1|Overall Study|Lost to Follow-up|0
5409517|NCT02713594|18660459|P2|Overall Study|Lost to Follow-up|374
5409518|NCT02713594|18660460|P1|Overall Study|Lost to Follow-up|358
5409519|NCT02713594|18660459|P2|Overall Study|Withdrawal by Subject|22
5409520|NCT02713594|18660460|P1|Overall Study|Withdrawal by Subject|32
5409521|NCT02713542|18660472|P2|Overall Study|Withdrawal by Subject|1
5409522|NCT02713542|18660473|P1|Overall Study|Withdrawal by Subject|4
5409523|NCT02713542|18660472|P2|Overall Study|Use of prohibited medication|5
5409524|NCT02713542|18660473|P1|Overall Study|Use of prohibited medication|14
5409525|NCT02713529|18660486|P7|Overall Study|Death|3
5409526|NCT02713529|18660487|P6|Overall Study|Death|13
5409527|NCT02713529|18660488|P5|Overall Study|Death|3
5409528|NCT02713529|18660489|P4|Overall Study|Death|27
5409529|NCT02713529|18660490|P3|Overall Study|Death|26
5409530|NCT02713529|18660491|P2|Overall Study|Death|3
5409531|NCT02713529|18660492|P1|Overall Study|Death|3
5409532|NCT02713529|18660486|P7|Overall Study|Lost to Follow-up|0
5409533|NCT02713529|18660487|P6|Overall Study|Lost to Follow-up|0
5409534|NCT02713529|18660488|P5|Overall Study|Lost to Follow-up|0
5409535|NCT02713529|18660489|P4|Overall Study|Lost to Follow-up|0
5409536|NCT02713529|18660490|P3|Overall Study|Lost to Follow-up|1
5409537|NCT02713529|18660491|P2|Overall Study|Lost to Follow-up|0
5409538|NCT02713529|18660492|P1|Overall Study|Lost to Follow-up|1
5409539|NCT02713529|18660486|P7|Overall Study|Withdrawal by Subject|1
5409540|NCT02713529|18660487|P6|Overall Study|Withdrawal by Subject|1
5409541|NCT02713529|18660488|P5|Overall Study|Withdrawal by Subject|0
5409542|NCT02713529|18660489|P4|Overall Study|Withdrawal by Subject|2
5409543|NCT02713529|18660490|P3|Overall Study|Withdrawal by Subject|4
5409544|NCT02713529|18660491|P2|Overall Study|Withdrawal by Subject|1
5409545|NCT02713529|18660492|P1|Overall Study|Withdrawal by Subject|3
5409546|NCT02713490|18660574|P2|Overall Study|Met exclusion criteria|1
5409547|NCT02713490|18660575|P1|Overall Study|Met exclusion criteria|0
5409548|NCT02713490|18660574|P2|Overall Study|Did not receive study drug|0
5409549|NCT02713490|18660575|P1|Overall Study|Did not receive study drug|1
5409550|NCT02713490|18660574|P2|Overall Study|Withdrawal by Subject|1
5409551|NCT02713490|18660575|P1|Overall Study|Withdrawal by Subject|2
5409552|NCT02713243|18660602|P2|Overall Study|Protocol deviation|1
5409553|NCT02713243|18660603|P1|Overall Study|Protocol deviation|0
5409554|NCT02713243|18660602|P2|Overall Study|Administrative problems|1
5409555|NCT02713243|18660603|P1|Overall Study|Administrative problems|0
5409556|NCT02713243|18660602|P2|Overall Study|Abnormal laboratory value(s)#|0
5409557|NCT02713243|18660603|P1|Overall Study|Abnormal laboratory value(s)#|1
5409558|NCT02713204|18660639|P8|From Week 12 up to Week 36|Participant Re-located|0
5409559|NCT02713204|18660640|P7|From Week 12 up to Week 36|Participant Re-located|0
5409560|NCT02713204|18660641|P6|From Week 12 up to Week 36|Participant Re-located|0
5409561|NCT02713204|18660642|P5|From Week 12 up to Week 36|Participant Re-located|1
5409562|NCT02713204|18660643|P4|From Week 12 up to Week 36|Participant Re-located|0
5409563|NCT02713204|18660644|P3|From Week 12 up to Week 36|Participant Re-located|0
5409564|NCT02713204|18660645|P2|From Week 12 up to Week 36|Participant Re-located|0
5409565|NCT02713204|18660646|P1|From Week 12 up to Week 36|Participant Re-located|0
5409566|NCT02713204|18660639|P8|From Week 12 up to Week 36|Lost to Follow-up|0
5409567|NCT02713204|18660640|P7|From Week 12 up to Week 36|Lost to Follow-up|0
5409568|NCT02713204|18660641|P6|From Week 12 up to Week 36|Lost to Follow-up|0
5409569|NCT02713204|18660642|P5|From Week 12 up to Week 36|Lost to Follow-up|0
5409570|NCT02713204|18660643|P4|From Week 12 up to Week 36|Lost to Follow-up|2
5409571|NCT02713204|18660644|P3|From Week 12 up to Week 36|Lost to Follow-up|0
5409572|NCT02713204|18660645|P2|From Week 12 up to Week 36|Lost to Follow-up|0
5409573|NCT02713204|18660646|P1|From Week 12 up to Week 36|Lost to Follow-up|0
5409574|NCT02713204|18660639|P8|From Week 12 up to Week 36|Death|3
5409575|NCT02713204|18660640|P7|From Week 12 up to Week 36|Death|0
5409576|NCT02713204|18660641|P6|From Week 12 up to Week 36|Death|1
5409577|NCT02713204|18660642|P5|From Week 12 up to Week 36|Death|0
5409578|NCT02713204|18660643|P4|From Week 12 up to Week 36|Death|1
5409579|NCT02713204|18660644|P3|From Week 12 up to Week 36|Death|0
5409580|NCT02713204|18660645|P2|From Week 12 up to Week 36|Death|0
5409581|NCT02713204|18660646|P1|From Week 12 up to Week 36|Death|0
5409582|NCT02713204|18660639|P8|From Week 12 up to Week 36|Adverse Event|1
5409583|NCT02713204|18660640|P7|From Week 12 up to Week 36|Adverse Event|2
5409584|NCT02713204|18660641|P6|From Week 12 up to Week 36|Adverse Event|0
5409585|NCT02713204|18660642|P5|From Week 12 up to Week 36|Adverse Event|1
5409586|NCT02713204|18660643|P4|From Week 12 up to Week 36|Adverse Event|1
5409587|NCT02713204|18660644|P3|From Week 12 up to Week 36|Adverse Event|0
5409588|NCT02713204|18660645|P2|From Week 12 up to Week 36|Adverse Event|0
5409589|NCT02713204|18660646|P1|From Week 12 up to Week 36|Adverse Event|1
5409590|NCT02713204|18660639|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409591|NCT02713204|18660640|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409592|NCT02713204|18660641|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409593|NCT02713204|18660642|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409594|NCT02713204|18660643|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409595|NCT02713204|18660644|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409596|NCT02713204|18660645|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
5409597|NCT02713204|18660646|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409598|NCT02713204|18660639|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409599|NCT02713204|18660640|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409600|NCT02713204|18660641|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409601|NCT02713204|18660642|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409602|NCT02713204|18660643|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409603|NCT02713204|18660644|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
5409604|NCT02713204|18660645|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409605|NCT02713204|18660646|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409606|NCT02713204|18660639|P8|Baseline (Day 1) up to Week 12|Adverse Event|0
5409607|NCT02713204|18660640|P7|Baseline (Day 1) up to Week 12|Adverse Event|0
5409608|NCT02713204|18660641|P6|Baseline (Day 1) up to Week 12|Adverse Event|0
5409609|NCT02713204|18660642|P5|Baseline (Day 1) up to Week 12|Adverse Event|0
5409610|NCT02713204|18660643|P4|Baseline (Day 1) up to Week 12|Adverse Event|0
5409611|NCT02713204|18660644|P3|Baseline (Day 1) up to Week 12|Adverse Event|1
5409612|NCT02713204|18660645|P2|Baseline (Day 1) up to Week 12|Adverse Event|0
5409613|NCT02713204|18660646|P1|Baseline (Day 1) up to Week 12|Adverse Event|1
5409614|NCT02712996|18660727|P2|Second Intervention (Study Days 43-84)|Adverse Event|1
5409615|NCT02712996|18660728|P1|Second Intervention (Study Days 43-84)|Adverse Event|0
5409616|NCT02712983|18660787|P9|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5409617|NCT02712983|18660788|P8|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
5409618|NCT02712983|18660789|P7|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
5409619|NCT02712983|18660790|P6|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
5409620|NCT02712983|18660791|P5|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
5409621|NCT02712983|18660792|P4|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5409622|NCT02712983|18660793|P3|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5409623|NCT02712983|18660794|P2|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5409624|NCT02712983|18660795|P1|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
5409625|NCT02712983|18660787|P9|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5409626|NCT02712983|18660788|P8|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5409627|NCT02712983|18660789|P7|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5409628|NCT02712983|18660790|P6|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5409629|NCT02712983|18660791|P5|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5409630|NCT02712983|18660792|P4|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
5409631|NCT02712983|18660793|P3|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5409632|NCT02712983|18660794|P2|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5409633|NCT02712983|18660795|P1|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
5409634|NCT02712983|18660787|P9|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5409635|NCT02712983|18660788|P8|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
5409636|NCT02712983|18660789|P7|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
5409637|NCT02712983|18660790|P6|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5409638|NCT02712983|18660791|P5|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5409639|NCT02712983|18660792|P4|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5409640|NCT02712983|18660793|P3|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5409641|NCT02712983|18660794|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
5409642|NCT02712983|18660795|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5409643|NCT02712983|18660787|P9|Treatment Phase|Subject Decision|0
5409644|NCT02712983|18660788|P8|Treatment Phase|Subject Decision|2
5409645|NCT02712983|18660789|P7|Treatment Phase|Subject Decision|1
5409646|NCT02712983|18660790|P6|Treatment Phase|Subject Decision|0
5409647|NCT02712983|18660791|P5|Treatment Phase|Subject Decision|1
5409648|NCT02712983|18660792|P4|Treatment Phase|Subject Decision|2
5409649|NCT02712983|18660793|P3|Treatment Phase|Subject Decision|0
5409650|NCT02712983|18660794|P2|Treatment Phase|Subject Decision|0
5409651|NCT02712983|18660795|P1|Treatment Phase|Subject Decision|2
5409652|NCT02712983|18660787|P9|Treatment Phase|Physician Decision|1
5409653|NCT02712983|18660788|P8|Treatment Phase|Physician Decision|1
5409654|NCT02712983|18660789|P7|Treatment Phase|Physician Decision|0
5409655|NCT02712983|18660790|P6|Treatment Phase|Physician Decision|0
5409656|NCT02712983|18660791|P5|Treatment Phase|Physician Decision|0
5409657|NCT02712983|18660792|P4|Treatment Phase|Physician Decision|0
5409658|NCT02712983|18660793|P3|Treatment Phase|Physician Decision|0
5409659|NCT02712983|18660794|P2|Treatment Phase|Physician Decision|0
5409660|NCT02712983|18660795|P1|Treatment Phase|Physician Decision|0
5409661|NCT02712983|18660787|P9|Treatment Phase|Technical Problems|0
5409662|NCT02712983|18660788|P8|Treatment Phase|Technical Problems|0
5409663|NCT02712983|18660789|P7|Treatment Phase|Technical Problems|1
5409664|NCT02712983|18660790|P6|Treatment Phase|Technical Problems|0
5409665|NCT02712983|18660791|P5|Treatment Phase|Technical Problems|0
5409666|NCT02712983|18660792|P4|Treatment Phase|Technical Problems|0
5409667|NCT02712983|18660793|P3|Treatment Phase|Technical Problems|0
5409668|NCT02712983|18660794|P2|Treatment Phase|Technical Problems|0
5409669|NCT02712983|18660795|P1|Treatment Phase|Technical Problems|0
5409670|NCT02712983|18660787|P9|Treatment Phase|Protocol Deviation|0
5409671|NCT02712983|18660788|P8|Treatment Phase|Protocol Deviation|0
5409672|NCT02712983|18660789|P7|Treatment Phase|Protocol Deviation|1
5409673|NCT02712983|18660790|P6|Treatment Phase|Protocol Deviation|0
5409674|NCT02712983|18660791|P5|Treatment Phase|Protocol Deviation|0
5409675|NCT02712983|18660792|P4|Treatment Phase|Protocol Deviation|2
5409676|NCT02712983|18660793|P3|Treatment Phase|Protocol Deviation|0
5409677|NCT02712983|18660794|P2|Treatment Phase|Protocol Deviation|0
5409678|NCT02712983|18660795|P1|Treatment Phase|Protocol Deviation|0
5409679|NCT02712983|18660787|P9|Treatment Phase|Adverse Event|1
5409680|NCT02712983|18660788|P8|Treatment Phase|Adverse Event|6
5409681|NCT02712983|18660789|P7|Treatment Phase|Adverse Event|6
5409682|NCT02712983|18660790|P6|Treatment Phase|Adverse Event|0
5409683|NCT02712983|18660791|P5|Treatment Phase|Adverse Event|3
5409684|NCT02712983|18660792|P4|Treatment Phase|Adverse Event|4
5409685|NCT02712983|18660793|P3|Treatment Phase|Adverse Event|1
5409686|NCT02712983|18660794|P2|Treatment Phase|Adverse Event|1
5409687|NCT02712983|18660795|P1|Treatment Phase|Adverse Event|3
5409688|NCT02712788|18661027|P2|Overall Study|Protocol Violation|0
5409689|NCT02712788|18661028|P1|Overall Study|Protocol Violation|1
5409690|NCT02712788|18661027|P2|Overall Study|Physician Decision|0
5409691|NCT02712788|18661028|P1|Overall Study|Physician Decision|1
5409692|NCT02712554|18661038|P2|Part B: Treatment Phase|Other|1
5409693|NCT02712554|18661039|P1|Part B: Treatment Phase|Other|0
5409694|NCT02712554|18661038|P2|Part B: Treatment Phase|Withdrawal by Subject|1
5409695|NCT02712554|18661039|P1|Part B: Treatment Phase|Withdrawal by Subject|0
5409696|NCT02712554|18661038|P2|Part B: Treatment Phase|Adverse Event|1
5409697|NCT02712554|18661039|P1|Part B: Treatment Phase|Adverse Event|0
5409698|NCT02712554|18661038|P2|Part B: Qualification Phase|Adverse Event|1
5409699|NCT02712554|18661039|P1|Part B: Qualification Phase|Adverse Event|0
5409700|NCT02712554|18661038|P2|Part B: Qualification Phase|Withdrawal by Subject|3
5409701|NCT02712554|18661039|P1|Part B: Qualification Phase|Withdrawal by Subject|0
5409702|NCT02712554|18661038|P2|Part B: Qualification Phase|Sponsor Decision|4
5409703|NCT02712554|18661039|P1|Part B: Qualification Phase|Sponsor Decision|0
5409704|NCT02712554|18661038|P2|Part B: Qualification Phase|Drug Discrimination Failure|13
5409705|NCT02712554|18661039|P1|Part B: Qualification Phase|Drug Discrimination Failure|0
5409706|NCT02712333|18661184|P2|First Period|Withdrawal by Subject|2
5409707|NCT02712333|18661185|P1|First Period|Withdrawal by Subject|3
5409708|NCT02712320|18661203|P1|Overall Study|Treating with the prohibited medications|2
5409709|NCT02712320|18661203|P1|Overall Study|Transferred to another facility|1
5409710|NCT02712320|18661203|P1|Overall Study|Withdrawal by Subject|1
5409711|NCT02712320|18661203|P1|Overall Study|Lost to Follow-up|1
5409712|NCT02712008|18661246|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
5409713|NCT02712008|18661247|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
5409714|NCT02712008|18661248|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
5409715|NCT02712008|18661249|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
5409716|NCT02712008|18661250|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
5409717|NCT02712008|18661251|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
5409718|NCT02712008|18661252|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
5409719|NCT02712008|18661253|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
5409720|NCT02712008|18661246|P8|From Week 12 up to Week 36|Physician Decision|0
5409721|NCT02712008|18661247|P7|From Week 12 up to Week 36|Physician Decision|0
5409722|NCT02712008|18661248|P6|From Week 12 up to Week 36|Physician Decision|0
5409723|NCT02712008|18661249|P5|From Week 12 up to Week 36|Physician Decision|1
5409724|NCT02712008|18661250|P4|From Week 12 up to Week 36|Physician Decision|1
5409725|NCT02712008|18661251|P3|From Week 12 up to Week 36|Physician Decision|0
5409726|NCT02712008|18661252|P2|From Week 12 up to Week 36|Physician Decision|0
5409727|NCT02712008|18661253|P1|From Week 12 up to Week 36|Physician Decision|0
5409728|NCT02712008|18661246|P8|From Week 12 up to Week 36|Lost to Follow-up|0
5409729|NCT02712008|18661247|P7|From Week 12 up to Week 36|Lost to Follow-up|1
5409730|NCT02712008|18661248|P6|From Week 12 up to Week 36|Lost to Follow-up|0
5409731|NCT02712008|18661249|P5|From Week 12 up to Week 36|Lost to Follow-up|0
5409732|NCT02712008|18661250|P4|From Week 12 up to Week 36|Lost to Follow-up|1
5409733|NCT02712008|18661251|P3|From Week 12 up to Week 36|Lost to Follow-up|0
5409734|NCT02712008|18661252|P2|From Week 12 up to Week 36|Lost to Follow-up|0
5409735|NCT02712008|18661253|P1|From Week 12 up to Week 36|Lost to Follow-up|0
5409736|NCT02712008|18661246|P8|From Week 12 up to Week 36|Death|0
5409737|NCT02712008|18661247|P7|From Week 12 up to Week 36|Death|1
5409738|NCT02712008|18661248|P6|From Week 12 up to Week 36|Death|0
5409739|NCT02712008|18661249|P5|From Week 12 up to Week 36|Death|0
5409740|NCT02712008|18661250|P4|From Week 12 up to Week 36|Death|0
5409741|NCT02712008|18661251|P3|From Week 12 up to Week 36|Death|0
5409742|NCT02712008|18661252|P2|From Week 12 up to Week 36|Death|0
5409743|NCT02712008|18661253|P1|From Week 12 up to Week 36|Death|1
5409744|NCT02712008|18661246|P8|From Week 12 up to Week 36|Adverse Event|2
5409745|NCT02712008|18661247|P7|From Week 12 up to Week 36|Adverse Event|0
5409746|NCT02712008|18661248|P6|From Week 12 up to Week 36|Adverse Event|0
5409747|NCT02712008|18661249|P5|From Week 12 up to Week 36|Adverse Event|1
5409748|NCT02712008|18661250|P4|From Week 12 up to Week 36|Adverse Event|0
5409749|NCT02712008|18661251|P3|From Week 12 up to Week 36|Adverse Event|0
5409750|NCT02712008|18661252|P2|From Week 12 up to Week 36|Adverse Event|0
5409751|NCT02712008|18661253|P1|From Week 12 up to Week 36|Adverse Event|0
5409752|NCT02712008|18661246|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
5409753|NCT02712008|18661247|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
5409754|NCT02712008|18661248|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
5409755|NCT02712008|18661249|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
5409756|NCT02712008|18661250|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
5409757|NCT02712008|18661251|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
5409758|NCT02712008|18661252|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
5409759|NCT02712008|18661253|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
5409760|NCT02712008|18661246|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
5409761|NCT02712008|18661247|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
5409762|NCT02712008|18661248|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
5409763|NCT02712008|18661249|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
5409764|NCT02712008|18661250|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
5409765|NCT02712008|18661251|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
5409766|NCT02712008|18661252|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
5409767|NCT02712008|18661253|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
5409768|NCT02712008|18661246|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409769|NCT02712008|18661247|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409770|NCT02712008|18661248|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409771|NCT02712008|18661249|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409772|NCT02712008|18661250|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409773|NCT02712008|18661251|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
5409774|NCT02712008|18661252|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
5409775|NCT02712008|18661253|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
5409776|NCT02712008|18661246|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409777|NCT02712008|18661247|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409778|NCT02712008|18661248|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409779|NCT02712008|18661249|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409780|NCT02712008|18661250|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409781|NCT02712008|18661251|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
5409782|NCT02712008|18661252|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
5409783|NCT02712008|18661253|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
5409784|NCT02712008|18661246|P8|Baseline (Day 1) up to Week 12|Death|0
5409785|NCT02712008|18661247|P7|Baseline (Day 1) up to Week 12|Death|0
5409786|NCT02712008|18661248|P6|Baseline (Day 1) up to Week 12|Death|0
5409787|NCT02712008|18661249|P5|Baseline (Day 1) up to Week 12|Death|0
5409788|NCT02712008|18661250|P4|Baseline (Day 1) up to Week 12|Death|0
5409789|NCT02712008|18661251|P3|Baseline (Day 1) up to Week 12|Death|0
5409790|NCT02712008|18661252|P2|Baseline (Day 1) up to Week 12|Death|0
5409791|NCT02712008|18661253|P1|Baseline (Day 1) up to Week 12|Death|3
5409792|NCT02711995|18661285|P1|Washout (90 Days)|Conflicting medication|1
5409793|NCT02711800|18661324|P1|Overall Study|Withdrawal by Subject|1
5409794|NCT02711800|18661324|P1|Overall Study|Lost to Follow-up|1
5409795|NCT02711345|18661343|P10|Overall Study|Death|0
5409796|NCT02711345|18661344|P9|Overall Study|Death|0
5409797|NCT02711345|18661345|P8|Overall Study|Death|1
5409798|NCT02711345|18661346|P7|Overall Study|Death|0
5409799|NCT02711345|18661347|P6|Overall Study|Death|0
5409800|NCT02711345|18661348|P5|Overall Study|Death|0
5409801|NCT02711345|18661349|P4|Overall Study|Death|0
5409802|NCT02711345|18661350|P3|Overall Study|Death|0
5409803|NCT02711345|18661351|P2|Overall Study|Death|0
5409804|NCT02711345|18661352|P1|Overall Study|Death|1
5409805|NCT02711345|18661343|P10|Overall Study|Subject/guardian decision|4
5409806|NCT02711345|18661344|P9|Overall Study|Subject/guardian decision|0
5409807|NCT02711345|18661345|P8|Overall Study|Subject/guardian decision|1
5409808|NCT02711345|18661346|P7|Overall Study|Subject/guardian decision|3
5409809|NCT02711345|18661347|P6|Overall Study|Subject/guardian decision|2
5409810|NCT02711345|18661348|P5|Overall Study|Subject/guardian decision|0
5409811|NCT02711345|18661349|P4|Overall Study|Subject/guardian decision|0
5409812|NCT02711345|18661350|P3|Overall Study|Subject/guardian decision|0
5409813|NCT02711345|18661351|P2|Overall Study|Subject/guardian decision|0
5409814|NCT02711345|18661352|P1|Overall Study|Subject/guardian decision|0
5409815|NCT02711345|18661343|P10|Overall Study|Progressive disease|6
5409816|NCT02711345|18661344|P9|Overall Study|Progressive disease|5
5409817|NCT02711345|18661345|P8|Overall Study|Progressive disease|4
5409818|NCT02711345|18661346|P7|Overall Study|Progressive disease|8
5409819|NCT02711345|18661347|P6|Overall Study|Progressive disease|2
5409820|NCT02711345|18661348|P5|Overall Study|Progressive disease|7
5409821|NCT02711345|18661349|P4|Overall Study|Progressive disease|3
5409822|NCT02711345|18661350|P3|Overall Study|Progressive disease|5
5409823|NCT02711345|18661351|P2|Overall Study|Progressive disease|3
5409824|NCT02711345|18661352|P1|Overall Study|Progressive disease|1
5409825|NCT02711345|18661343|P10|Overall Study|Physician Decision|0
5409826|NCT02711345|18661344|P9|Overall Study|Physician Decision|1
5409827|NCT02711345|18661345|P8|Overall Study|Physician Decision|0
5409828|NCT02711345|18661346|P7|Overall Study|Physician Decision|0
5409829|NCT02711345|18661347|P6|Overall Study|Physician Decision|0
5409830|NCT02711345|18661348|P5|Overall Study|Physician Decision|0
5409831|NCT02711345|18661349|P4|Overall Study|Physician Decision|0
5409832|NCT02711345|18661350|P3|Overall Study|Physician Decision|1
5409833|NCT02711345|18661351|P2|Overall Study|Physician Decision|0
5409834|NCT02711345|18661352|P1|Overall Study|Physician Decision|0
5409835|NCT02711345|18661343|P10|Overall Study|Adverse Event|2
5409836|NCT02711345|18661344|P9|Overall Study|Adverse Event|0
5409837|NCT02711345|18661345|P8|Overall Study|Adverse Event|0
5409838|NCT02711345|18661346|P7|Overall Study|Adverse Event|1
5409839|NCT02711345|18661347|P6|Overall Study|Adverse Event|2
5409840|NCT02711345|18661348|P5|Overall Study|Adverse Event|1
5409841|NCT02711345|18661349|P4|Overall Study|Adverse Event|1
5409842|NCT02711345|18661350|P3|Overall Study|Adverse Event|0
5409843|NCT02711345|18661351|P2|Overall Study|Adverse Event|0
5409844|NCT02711345|18661352|P1|Overall Study|Adverse Event|0
5409845|NCT02711306|18661538|P2|Overall Study|Withdrawal by Subject|2
5409846|NCT02711306|18661539|P1|Overall Study|Withdrawal by Subject|2
5409847|NCT02710422|18661732|P2|Overall Study|Termination of study|9
5409848|NCT02710422|18661733|P1|Overall Study|Termination of study|9
5409849|NCT02710292|18661749|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
5409850|NCT02710292|18661750|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
5409851|NCT02710292|18661749|P2|Period 1, First 10 Days of Wear|Adverse Event|1
5409852|NCT02710292|18661750|P1|Period 1, First 10 Days of Wear|Adverse Event|0
5409853|NCT02710214|18661759|P2|Overall Study|Death|1
5409854|NCT02710214|18661760|P1|Overall Study|Death|0
5409855|NCT02710214|18661759|P2|Overall Study|Lack of Efficacy|1
5409856|NCT02710214|18661760|P1|Overall Study|Lack of Efficacy|0
5409857|NCT02710214|18661759|P2|Overall Study|Lost to Follow-up|0
5409858|NCT02710214|18661760|P1|Overall Study|Lost to Follow-up|1
5409859|NCT02710136|18661794|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
5409860|NCT02710136|18661795|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
5409861|NCT02710071|18661820|P2|Second Intervention (6 Weeks).|Withdrawal by Subject|2
5409862|NCT02710071|18661821|P1|Second Intervention (6 Weeks).|Withdrawal by Subject|1
5409863|NCT02710071|18661820|P2|First Intervention (6 Weeks).|Withdrawal by Subject|4
5409864|NCT02710071|18661821|P1|First Intervention (6 Weeks).|Withdrawal by Subject|3
5409865|NCT02710045|18661831|P3|Overall Study|Poor Attendance|0
5409866|NCT02710045|18661832|P2|Overall Study|Poor Attendance|1
5409867|NCT02710045|18661833|P1|Overall Study|Poor Attendance|0
5409868|NCT02710045|18661831|P3|Overall Study|Physician Decision|1
5409869|NCT02710045|18661832|P2|Overall Study|Physician Decision|0
5409870|NCT02710045|18661833|P1|Overall Study|Physician Decision|0
5409871|NCT02710045|18661831|P3|Overall Study|Lost to Follow-up|7
5409872|NCT02710045|18661832|P2|Overall Study|Lost to Follow-up|6
5409873|NCT02710045|18661833|P1|Overall Study|Lost to Follow-up|3
5409874|NCT02710045|18661831|P3|Overall Study|Protocol Violation|3
5409875|NCT02710045|18661832|P2|Overall Study|Protocol Violation|2
5409876|NCT02710045|18661833|P1|Overall Study|Protocol Violation|1
5409877|NCT02710045|18661831|P3|Overall Study|Withdrawal by Subject|2
5409878|NCT02710045|18661832|P2|Overall Study|Withdrawal by Subject|6
5409879|NCT02710045|18661833|P1|Overall Study|Withdrawal by Subject|6
5409880|NCT02710045|18661831|P3|Overall Study|Death|0
5409881|NCT02710045|18661832|P2|Overall Study|Death|2
5409882|NCT02710045|18661833|P1|Overall Study|Death|1
5409883|NCT02709889|18661867|P4|Overall Study|Other, Not Specified|6
5409884|NCT02709889|18661868|P3|Overall Study|Other, Not Specified|1
5409885|NCT02709889|18661869|P2|Overall Study|Other, Not Specified|1
5409886|NCT02709889|18661870|P1|Overall Study|Other, Not Specified|0
5409887|NCT02709889|18661867|P4|Overall Study|Study Terminated by Sponsor|17
5409888|NCT02709889|18661868|P3|Overall Study|Study Terminated by Sponsor|2
5409889|NCT02709889|18661869|P2|Overall Study|Study Terminated by Sponsor|6
5409890|NCT02709889|18661870|P1|Overall Study|Study Terminated by Sponsor|4
5409891|NCT02709889|18661867|P4|Overall Study|Lost to Follow-up|4
5409892|NCT02709889|18661868|P3|Overall Study|Lost to Follow-up|0
5409893|NCT02709889|18661869|P2|Overall Study|Lost to Follow-up|0
5409894|NCT02709889|18661870|P1|Overall Study|Lost to Follow-up|2
5409895|NCT02709889|18661867|P4|Overall Study|Physician Decision|5
5409896|NCT02709889|18661868|P3|Overall Study|Physician Decision|3
5409897|NCT02709889|18661869|P2|Overall Study|Physician Decision|2
5409898|NCT02709889|18661870|P1|Overall Study|Physician Decision|1
5409899|NCT02709889|18661867|P4|Overall Study|Death|44
5409900|NCT02709889|18661868|P3|Overall Study|Death|4
5409901|NCT02709889|18661869|P2|Overall Study|Death|38
5409902|NCT02709889|18661870|P1|Overall Study|Death|25
5409903|NCT02709889|18661867|P4|Overall Study|Withdrawal by Subject|12
5409904|NCT02709889|18661868|P3|Overall Study|Withdrawal by Subject|2
5409905|NCT02709889|18661869|P2|Overall Study|Withdrawal by Subject|10
5409906|NCT02709889|18661870|P1|Overall Study|Withdrawal by Subject|11
5409907|NCT02709785|18661951|P3|Overall Study|Withdrawal by Subject|1
5409908|NCT02709785|18661952|P2|Overall Study|Withdrawal by Subject|2
5409909|NCT02709785|18661953|P1|Overall Study|Withdrawal by Subject|1
5409910|NCT02709746|18661978|P5|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
5409911|NCT02709746|18661979|P4|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
5409912|NCT02709746|18661980|P3|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
5409913|NCT02709746|18661981|P2|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
5409914|NCT02709746|18661982|P1|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
5409915|NCT02709746|18661978|P5|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5409916|NCT02709746|18661979|P4|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5409917|NCT02709746|18661980|P3|Phase B (Double-blind Treatment Period)|enrolled not treated|1
5409918|NCT02709746|18661981|P2|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5409919|NCT02709746|18661982|P1|Phase B (Double-blind Treatment Period)|enrolled not treated|0
5409920|NCT02709746|18661978|P5|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
5409921|NCT02709746|18661979|P4|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
5409922|NCT02709746|18661980|P3|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
5409923|NCT02709746|18661981|P2|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
5409924|NCT02709746|18661982|P1|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
5409925|NCT02709746|18661978|P5|Phase B (Double-blind Treatment Period)|Adverse Event|2
5409926|NCT02709746|18661979|P4|Phase B (Double-blind Treatment Period)|Adverse Event|5
5409927|NCT02709746|18661980|P3|Phase B (Double-blind Treatment Period)|Adverse Event|8
5409928|NCT02709746|18661981|P2|Phase B (Double-blind Treatment Period)|Adverse Event|4
5409929|NCT02709746|18661982|P1|Phase B (Double-blind Treatment Period)|Adverse Event|0
5409930|NCT02709746|18661978|P5|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
5409931|NCT02709746|18661979|P4|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
5409932|NCT02709746|18661980|P3|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
5409933|NCT02709746|18661981|P2|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
5409934|NCT02709746|18661982|P1|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
5409935|NCT02709746|18661978|P5|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
5409936|NCT02709746|18661979|P4|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
5409937|NCT02709746|18661980|P3|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
5409938|NCT02709746|18661981|P2|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
5409939|NCT02709746|18661982|P1|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
5409940|NCT02709746|18661978|P5|Phase B (Double-blind Treatment Period)|Other|7
5409941|NCT02709746|18661979|P4|Phase B (Double-blind Treatment Period)|Other|6
5409942|NCT02709746|18661980|P3|Phase B (Double-blind Treatment Period)|Other|5
5409943|NCT02709746|18661981|P2|Phase B (Double-blind Treatment Period)|Other|6
5409944|NCT02709746|18661982|P1|Phase B (Double-blind Treatment Period)|Other|0
5409945|NCT02709746|18661978|P5|Phase B (Double-blind Treatment Period)|Protocol Violation|2
5409946|NCT02709746|18661979|P4|Phase B (Double-blind Treatment Period)|Protocol Violation|0
5409947|NCT02709746|18661980|P3|Phase B (Double-blind Treatment Period)|Protocol Violation|0
5409948|NCT02709746|18661981|P2|Phase B (Double-blind Treatment Period)|Protocol Violation|1
5409949|NCT02709746|18661982|P1|Phase B (Double-blind Treatment Period)|Protocol Violation|0
5409950|NCT02709746|18661978|P5|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5409951|NCT02709746|18661979|P4|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5409952|NCT02709746|18661980|P3|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5409953|NCT02709746|18661981|P2|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
5409954|NCT02709746|18661982|P1|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
5409955|NCT02709746|18661978|P5|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5409956|NCT02709746|18661979|P4|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5409957|NCT02709746|18661980|P3|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5409958|NCT02709746|18661981|P2|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
5409959|NCT02709746|18661982|P1|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
5409960|NCT02709746|18661978|P5|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5409961|NCT02709746|18661979|P4|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5409962|NCT02709746|18661980|P3|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5409963|NCT02709746|18661981|P2|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
5409964|NCT02709746|18661982|P1|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
5409965|NCT02709746|18661978|P5|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5409966|NCT02709746|18661979|P4|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5409967|NCT02709746|18661980|P3|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5409968|NCT02709746|18661981|P2|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
5409969|NCT02709746|18661982|P1|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
5409970|NCT02709746|18661978|P5|Phase A (Single-blind Treatment Period)|Adverse Event|0
5409971|NCT02709746|18661979|P4|Phase A (Single-blind Treatment Period)|Adverse Event|0
5409972|NCT02709746|18661980|P3|Phase A (Single-blind Treatment Period)|Adverse Event|0
5409973|NCT02709746|18661981|P2|Phase A (Single-blind Treatment Period)|Adverse Event|0
5409974|NCT02709746|18661982|P1|Phase A (Single-blind Treatment Period)|Adverse Event|2
5409975|NCT02709746|18661978|P5|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5409976|NCT02709746|18661979|P4|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5409977|NCT02709746|18661980|P3|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5409978|NCT02709746|18661981|P2|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
5409979|NCT02709746|18661982|P1|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
5409980|NCT02709746|18661978|P5|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5409981|NCT02709746|18661979|P4|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5409982|NCT02709746|18661980|P3|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5409983|NCT02709746|18661981|P2|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
5409984|NCT02709746|18661982|P1|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
5409985|NCT02709746|18661978|P5|Phase A (Single-blind Treatment Period)|Not sepcified|0
5409986|NCT02709746|18661979|P4|Phase A (Single-blind Treatment Period)|Not sepcified|0
5409987|NCT02709746|18661980|P3|Phase A (Single-blind Treatment Period)|Not sepcified|0
5409988|NCT02709746|18661981|P2|Phase A (Single-blind Treatment Period)|Not sepcified|0
5409989|NCT02709746|18661982|P1|Phase A (Single-blind Treatment Period)|Not sepcified|14
5409990|NCT02709746|18661978|P5|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5409991|NCT02709746|18661979|P4|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5409992|NCT02709746|18661980|P3|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5409993|NCT02709746|18661981|P2|Phase A (Single-blind Treatment Period)|Protocol Violation|0
5409994|NCT02709746|18661982|P1|Phase A (Single-blind Treatment Period)|Protocol Violation|4
5409995|NCT02709577|18662104|P4|Overall Study|Withdrawal by Subject|0
5409996|NCT02709577|18662105|P3|Overall Study|Withdrawal by Subject|2
5409997|NCT02709577|18662106|P2|Overall Study|Withdrawal by Subject|3
5409998|NCT02709577|18662107|P1|Overall Study|Withdrawal by Subject|2
5409999|NCT02709577|18662104|P4|Overall Study|procedural complication|0
5410000|NCT02709577|18662105|P3|Overall Study|procedural complication|0
5410001|NCT02709577|18662106|P2|Overall Study|procedural complication|1
5410002|NCT02709577|18662107|P1|Overall Study|procedural complication|0
5410003|NCT02709577|18662104|P4|Overall Study|non-accommodating anatomy|0
5410004|NCT02709577|18662105|P3|Overall Study|non-accommodating anatomy|0
5410005|NCT02709577|18662106|P2|Overall Study|non-accommodating anatomy|1
5410006|NCT02709577|18662107|P1|Overall Study|non-accommodating anatomy|0
5410007|NCT02709538|18662122|P3|Overall Study|Other|5
5410008|NCT02709538|18662123|P2|Overall Study|Other|7
5410009|NCT02709538|18662124|P1|Overall Study|Other|16
5410010|NCT02709538|18662122|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
5410011|NCT02709538|18662123|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
5410012|NCT02709538|18662124|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
5410013|NCT02709538|18662122|P3|Overall Study|Protocol deviation|4
5410014|NCT02709538|18662123|P2|Overall Study|Protocol deviation|4
5410015|NCT02709538|18662124|P1|Overall Study|Protocol deviation|10
5410016|NCT02709538|18662122|P3|Overall Study|Non-compliance with study drug|0
5410017|NCT02709538|18662123|P2|Overall Study|Non-compliance with study drug|0
5410018|NCT02709538|18662124|P1|Overall Study|Non-compliance with study drug|2
5410019|NCT02709538|18662122|P3|Overall Study|Non-compliance with study procedures|0
5410020|NCT02709538|18662123|P2|Overall Study|Non-compliance with study procedures|0
5410021|NCT02709538|18662124|P1|Overall Study|Non-compliance with study procedures|5
5410022|NCT02709538|18662122|P3|Overall Study|Withdrawal by Subject|4
5410023|NCT02709538|18662123|P2|Overall Study|Withdrawal by Subject|7
5410024|NCT02709538|18662124|P1|Overall Study|Withdrawal by Subject|40
5410025|NCT02709538|18662122|P3|Overall Study|Physician Decision|0
5410026|NCT02709538|18662123|P2|Overall Study|Physician Decision|0
5410027|NCT02709538|18662124|P1|Overall Study|Physician Decision|1
5410028|NCT02709538|18662122|P3|Overall Study|Lost to Follow-up|4
5410029|NCT02709538|18662123|P2|Overall Study|Lost to Follow-up|8
5410030|NCT02709538|18662124|P1|Overall Study|Lost to Follow-up|24
5410031|NCT02709538|18662122|P3|Overall Study|Lack of Efficacy|0
5410032|NCT02709538|18662123|P2|Overall Study|Lack of Efficacy|0
5410033|NCT02709538|18662124|P1|Overall Study|Lack of Efficacy|1
5410034|NCT02709538|18662122|P3|Overall Study|Adverse Event|3
5410035|NCT02709538|18662123|P2|Overall Study|Adverse Event|2
5410036|NCT02709538|18662124|P1|Overall Study|Adverse Event|13
5410037|NCT02709486|18662135|P3|Overall Study|Withdrawal by Subject|32
5410038|NCT02709486|18662136|P2|Overall Study|Withdrawal by Subject|22
5410039|NCT02709486|18662137|P1|Overall Study|Withdrawal by Subject|32
5410040|NCT02709486|18662135|P3|Overall Study|Other|3
5410041|NCT02709486|18662136|P2|Overall Study|Other|2
5410042|NCT02709486|18662137|P1|Overall Study|Other|0
5410043|NCT02709486|18662135|P3|Overall Study|Lost to Follow-up|2
5410044|NCT02709486|18662136|P2|Overall Study|Lost to Follow-up|2
5410045|NCT02709486|18662137|P1|Overall Study|Lost to Follow-up|3
5410046|NCT02709486|18662135|P3|Overall Study|Insufficient clinical response|3
5410047|NCT02709486|18662136|P2|Overall Study|Insufficient clinical response|3
5410048|NCT02709486|18662137|P1|Overall Study|Insufficient clinical response|7
5410049|NCT02709486|18662135|P3|Overall Study|Death|2
5410050|NCT02709486|18662136|P2|Overall Study|Death|0
5410051|NCT02709486|18662137|P1|Overall Study|Death|0
5410052|NCT02709486|18662135|P3|Overall Study|Adverse Event|3
5410053|NCT02709486|18662136|P2|Overall Study|Adverse Event|5
5410054|NCT02709486|18662137|P1|Overall Study|Adverse Event|2
5410055|NCT02709369|18662328|P1|Overall Study|Did not received intervention|2
5410056|NCT02709369|18662328|P1|Overall Study|Withdrawal by Subject|10
5410057|NCT02709369|18662328|P1|Overall Study|Lost to Follow-up|15
5410058|NCT02709330|18662362|P2|Overall Study|Withdrawal by Subject|0
5410059|NCT02709330|18662363|P1|Overall Study|Withdrawal by Subject|4
5410060|NCT02709330|18662362|P2|Overall Study|Physician Decision|0
5410061|NCT02709330|18662363|P1|Overall Study|Physician Decision|2
5410062|NCT02709330|18662362|P2|Overall Study|Lost to Follow-up|0
5410063|NCT02709330|18662363|P1|Overall Study|Lost to Follow-up|2
5410064|NCT02709330|18662362|P2|Overall Study|Death|0
5410065|NCT02709330|18662363|P1|Overall Study|Death|5
5410066|NCT02709096|18662377|P2|Overall Study|non-compliance|1
5410067|NCT02709096|18662378|P1|Overall Study|non-compliance|1
5410068|NCT02709083|18662384|P1|Overall Study|Original PI left institution|7
5410069|NCT02709005|18662397|P2|Overall Study|Withdrawal by Subject|0
5410070|NCT02709005|18662398|P1|Overall Study|Withdrawal by Subject|3
5410071|NCT02709005|18662397|P2|Overall Study|Lost to Follow-up|1
5410072|NCT02709005|18662398|P1|Overall Study|Lost to Follow-up|1
5410073|NCT02708966|18662428|P2|Overall Study|Lost to Follow-up|2
5410074|NCT02708966|18662429|P1|Overall Study|Lost to Follow-up|2
5410075|NCT02708524|18662512|P4|Overall Study|Subject lost study lens|0
5410076|NCT02708524|18662513|P3|Overall Study|Subject lost study lens|0
5410077|NCT02708524|18662514|P2|Overall Study|Subject lost study lens|0
5410078|NCT02708524|18662515|P1|Overall Study|Subject lost study lens|1
5410079|NCT02708524|18662512|P4|Overall Study|Did not wear lens at final visit|0
5410080|NCT02708524|18662513|P3|Overall Study|Did not wear lens at final visit|0
5410081|NCT02708524|18662514|P2|Overall Study|Did not wear lens at final visit|1
5410082|NCT02708524|18662515|P1|Overall Study|Did not wear lens at final visit|0
5410083|NCT02708524|18662512|P4|Overall Study|Dispensed incorrect study lens|0
5410084|NCT02708524|18662513|P3|Overall Study|Dispensed incorrect study lens|1
5410085|NCT02708524|18662514|P2|Overall Study|Dispensed incorrect study lens|1
5410086|NCT02708524|18662515|P1|Overall Study|Dispensed incorrect study lens|0
5410087|NCT02708524|18662512|P4|Overall Study|Withdrawal by Subject|0
5410088|NCT02708524|18662513|P3|Overall Study|Withdrawal by Subject|0
5410089|NCT02708524|18662514|P2|Overall Study|Withdrawal by Subject|1
5410090|NCT02708524|18662515|P1|Overall Study|Withdrawal by Subject|1
5410091|NCT02708524|18662512|P4|Overall Study|Protocol Violation|0
5410092|NCT02708524|18662513|P3|Overall Study|Protocol Violation|0
5410093|NCT02708524|18662514|P2|Overall Study|Protocol Violation|1
5410094|NCT02708524|18662515|P1|Overall Study|Protocol Violation|0
5410095|NCT02708524|18662512|P4|Overall Study|Lost to Follow-up|0
5410096|NCT02708524|18662513|P3|Overall Study|Lost to Follow-up|1
5410097|NCT02708524|18662514|P2|Overall Study|Lost to Follow-up|1
5410098|NCT02708524|18662515|P1|Overall Study|Lost to Follow-up|1
5410099|NCT02708524|18662512|P4|Overall Study|Lens Discomfort|0
5410100|NCT02708524|18662513|P3|Overall Study|Lens Discomfort|1
5410101|NCT02708524|18662514|P2|Overall Study|Lens Discomfort|0
5410102|NCT02708524|18662515|P1|Overall Study|Lens Discomfort|1
5410103|NCT02708524|18662512|P4|Overall Study|Adverse Event|0
5410104|NCT02708524|18662513|P3|Overall Study|Adverse Event|0
5410105|NCT02708524|18662514|P2|Overall Study|Adverse Event|1
5410106|NCT02708524|18662515|P1|Overall Study|Adverse Event|0
5410107|NCT02708498|18662569|P8|Overall Study|Unknown reason, missing data|0
5410108|NCT02708498|18662570|P7|Overall Study|Unknown reason, missing data|0
5410109|NCT02708498|18662571|P6|Overall Study|Unknown reason, missing data|132
5410110|NCT02708498|18662572|P5|Overall Study|Unknown reason, missing data|195
5410111|NCT02708498|18662573|P4|Overall Study|Unknown reason, missing data|51
5410112|NCT02708498|18662574|P3|Overall Study|Unknown reason, missing data|62
5410113|NCT02708498|18662575|P2|Overall Study|Unknown reason, missing data|0
5410114|NCT02708498|18662576|P1|Overall Study|Unknown reason, missing data|0
5410115|NCT02708498|18662569|P8|Overall Study|Death|0
5410116|NCT02708498|18662570|P7|Overall Study|Death|0
5410117|NCT02708498|18662571|P6|Overall Study|Death|0
5410118|NCT02708498|18662572|P5|Overall Study|Death|1
5410119|NCT02708498|18662573|P4|Overall Study|Death|0
5410120|NCT02708498|18662574|P3|Overall Study|Death|0
5410121|NCT02708498|18662575|P2|Overall Study|Death|19
5410122|NCT02708498|18662576|P1|Overall Study|Death|20
5410123|NCT02708485|18662604|P2|Overall Study|Withdrawal by Subject|2
5410124|NCT02708485|18662605|P1|Overall Study|Withdrawal by Subject|3
5410125|NCT02708355|18662625|P3|Overall Study|Adverse Event|0
5410126|NCT02708355|18662626|P2|Overall Study|Adverse Event|0
5410127|NCT02708355|18662627|P1|Overall Study|Adverse Event|1
5410128|NCT02708277|18662649|P2|Overall Study|Lost to Follow-up|4
5410129|NCT02708277|18662650|P1|Overall Study|Lost to Follow-up|7
5410130|NCT02708121|18662702|P2|Overall Study|Withdrawal by Subject|4
5410131|NCT02708121|18662703|P1|Overall Study|Withdrawal by Subject|0
5410132|NCT02708121|18662702|P2|Overall Study|Withdrawn by Study Team|1
5410133|NCT02708121|18662703|P1|Overall Study|Withdrawn by Study Team|1
5410134|NCT02708095|18662715|P3|Overall Study|Withdrawal by Subject|4
5410135|NCT02708095|18662716|P2|Overall Study|Withdrawal by Subject|3
5410136|NCT02708095|18662717|P1|Overall Study|Withdrawal by Subject|5
5410137|NCT02708095|18662715|P3|Overall Study|Protocol Violation|1
5410138|NCT02708095|18662716|P2|Overall Study|Protocol Violation|0
5410139|NCT02708095|18662717|P1|Overall Study|Protocol Violation|0
5410140|NCT02708095|18662715|P3|Overall Study|Physician Decision|2
5410141|NCT02708095|18662716|P2|Overall Study|Physician Decision|3
5410142|NCT02708095|18662717|P1|Overall Study|Physician Decision|2
5410143|NCT02708095|18662715|P3|Overall Study|Lost to Follow-up|0
5410144|NCT02708095|18662716|P2|Overall Study|Lost to Follow-up|0
5410145|NCT02708095|18662717|P1|Overall Study|Lost to Follow-up|2
5410146|NCT02708095|18662715|P3|Overall Study|Lack of Efficacy|0
5410147|NCT02708095|18662716|P2|Overall Study|Lack of Efficacy|3
5410148|NCT02708095|18662717|P1|Overall Study|Lack of Efficacy|9
5410149|NCT02708095|18662715|P3|Overall Study|Adverse Event|11
5410150|NCT02708095|18662716|P2|Overall Study|Adverse Event|10
5410151|NCT02708095|18662717|P1|Overall Study|Adverse Event|4
5410152|NCT02707991|18662740|P2|Overall Study|Became ineligible|1
5410153|NCT02707991|18662741|P1|Overall Study|Became ineligible|0
5410154|NCT02707991|18662740|P2|Overall Study|Protocol Violation|0
5410155|NCT02707991|18662741|P1|Overall Study|Protocol Violation|1
5410156|NCT02707965|18662758|P16|Overall Study|Protocol deviation|0
5410157|NCT02707965|18662759|P15|Overall Study|Protocol deviation|0
5410158|NCT02707965|18662760|P14|Overall Study|Protocol deviation|0
5410159|NCT02707965|18662761|P13|Overall Study|Protocol deviation|0
5410160|NCT02707965|18662762|P12|Overall Study|Protocol deviation|0
5410161|NCT02707965|18662763|P11|Overall Study|Protocol deviation|0
5410162|NCT02707965|18662764|P10|Overall Study|Protocol deviation|0
5410163|NCT02707965|18662765|P9|Overall Study|Protocol deviation|0
5410164|NCT02707965|18662766|P8|Overall Study|Protocol deviation|1
5410165|NCT02707965|18662767|P7|Overall Study|Protocol deviation|0
5410166|NCT02707965|18662768|P6|Overall Study|Protocol deviation|0
5410167|NCT02707965|18662769|P5|Overall Study|Protocol deviation|0
5410168|NCT02707965|18662770|P4|Overall Study|Protocol deviation|0
5410169|NCT02707965|18662771|P3|Overall Study|Protocol deviation|0
5410170|NCT02707965|18662772|P2|Overall Study|Protocol deviation|1
5410171|NCT02707965|18662773|P1|Overall Study|Protocol deviation|1
5410172|NCT02707965|18662758|P16|Overall Study|PI decisions|0
5410173|NCT02707965|18662759|P15|Overall Study|PI decisions|2
5410174|NCT02707965|18662760|P14|Overall Study|PI decisions|0
5410175|NCT02707965|18662761|P13|Overall Study|PI decisions|0
5410176|NCT02707965|18662762|P12|Overall Study|PI decisions|0
5410177|NCT02707965|18662763|P11|Overall Study|PI decisions|0
5410178|NCT02707965|18662764|P10|Overall Study|PI decisions|0
5410179|NCT02707965|18662765|P9|Overall Study|PI decisions|0
5410180|NCT02707965|18662766|P8|Overall Study|PI decisions|0
5410181|NCT02707965|18662767|P7|Overall Study|PI decisions|0
5410182|NCT02707965|18662768|P6|Overall Study|PI decisions|0
5410183|NCT02707965|18662769|P5|Overall Study|PI decisions|0
5410184|NCT02707965|18662770|P4|Overall Study|PI decisions|0
5410185|NCT02707965|18662771|P3|Overall Study|PI decisions|0
5410186|NCT02707965|18662772|P2|Overall Study|PI decisions|0
5410187|NCT02707965|18662773|P1|Overall Study|PI decisions|0
5410188|NCT02707965|18662758|P16|Overall Study|Withdrawal by Subject|0
5410189|NCT02707965|18662759|P15|Overall Study|Withdrawal by Subject|0
5410190|NCT02707965|18662760|P14|Overall Study|Withdrawal by Subject|0
5410191|NCT02707965|18662761|P13|Overall Study|Withdrawal by Subject|0
5410192|NCT02707965|18662762|P12|Overall Study|Withdrawal by Subject|0
5410193|NCT02707965|18662763|P11|Overall Study|Withdrawal by Subject|0
5410194|NCT02707965|18662764|P10|Overall Study|Withdrawal by Subject|0
5410195|NCT02707965|18662765|P9|Overall Study|Withdrawal by Subject|0
5410196|NCT02707965|18662766|P8|Overall Study|Withdrawal by Subject|2
5410197|NCT02707965|18662767|P7|Overall Study|Withdrawal by Subject|0
5410198|NCT02707965|18662768|P6|Overall Study|Withdrawal by Subject|0
5410199|NCT02707965|18662769|P5|Overall Study|Withdrawal by Subject|0
5410200|NCT02707965|18662770|P4|Overall Study|Withdrawal by Subject|0
5410201|NCT02707965|18662771|P3|Overall Study|Withdrawal by Subject|1
5410202|NCT02707965|18662772|P2|Overall Study|Withdrawal by Subject|0
5410203|NCT02707965|18662773|P1|Overall Study|Withdrawal by Subject|0
5410204|NCT02707952|18662825|P4|Overall Study|Withdrawal by Subject|0
5410205|NCT02707952|18662826|P3|Overall Study|Withdrawal by Subject|2
5410206|NCT02707952|18662827|P2|Overall Study|Withdrawal by Subject|1
5410207|NCT02707952|18662828|P1|Overall Study|Withdrawal by Subject|0
5410208|NCT02707952|18662825|P4|Overall Study|Lost to Follow-up|0
5410209|NCT02707952|18662826|P3|Overall Study|Lost to Follow-up|0
5410210|NCT02707952|18662827|P2|Overall Study|Lost to Follow-up|0
5410211|NCT02707952|18662828|P1|Overall Study|Lost to Follow-up|1
5410212|NCT02707952|18662825|P4|Overall Study|Adverse Event|0
5410213|NCT02707952|18662826|P3|Overall Study|Adverse Event|0
5410214|NCT02707952|18662827|P2|Overall Study|Adverse Event|0
5410215|NCT02707952|18662828|P1|Overall Study|Adverse Event|1
5410216|NCT02707640|18662849|P2|Overall Study|Sponsor Discretion|0
5410217|NCT02707640|18662850|P1|Overall Study|Sponsor Discretion|1
5410218|NCT02707640|18662849|P2|Overall Study|Participant's Personal Decision|2
5410219|NCT02707640|18662850|P1|Overall Study|Participant's Personal Decision|1
5410220|NCT02707640|18662849|P2|Overall Study|Withdrawal by Subject|1
5410221|NCT02707640|18662850|P1|Overall Study|Withdrawal by Subject|0
5410222|NCT02707640|18662849|P2|Overall Study|Physician Decision|0
5410223|NCT02707640|18662850|P1|Overall Study|Physician Decision|2
5410224|NCT02707640|18662849|P2|Overall Study|Death|2
5410225|NCT02707640|18662850|P1|Overall Study|Death|1
5410226|NCT02707640|18662849|P2|Overall Study|Adverse Event|2
5410227|NCT02707640|18662850|P1|Overall Study|Adverse Event|4
5410228|NCT02707601|18662870|P2|Overall Study|Participants Randomized but Not Treated|0
5410229|NCT02707601|18662871|P1|Overall Study|Participants Randomized but Not Treated|2
5410230|NCT02707601|18662870|P2|Overall Study|Lost to Follow-up|1
5410231|NCT02707601|18662871|P1|Overall Study|Lost to Follow-up|1
5410232|NCT02707601|18662870|P2|Overall Study|Withdrew Consent|1
5410233|NCT02707601|18662871|P1|Overall Study|Withdrew Consent|0
5410234|NCT02707601|18662870|P2|Overall Study|Investigator's Discretion|0
5410235|NCT02707601|18662871|P1|Overall Study|Investigator's Discretion|1
5410236|NCT02707601|18662870|P2|Overall Study|Lack of Efficacy|1
5410237|NCT02707601|18662871|P1|Overall Study|Lack of Efficacy|0
5410238|NCT02707601|18662870|P2|Overall Study|Death|1
5410239|NCT02707601|18662871|P1|Overall Study|Death|0
5410240|NCT02706951|18662960|P3|Overall Study|Other|0
5410241|NCT02706951|18662961|P2|Overall Study|Other|1
5410242|NCT02706951|18662962|P1|Overall Study|Other|2
5410243|NCT02706951|18662960|P3|Overall Study|Lost to Follow-up|1
5410244|NCT02706951|18662961|P2|Overall Study|Lost to Follow-up|4
5410245|NCT02706951|18662962|P1|Overall Study|Lost to Follow-up|0
5410246|NCT02706951|18662960|P3|Overall Study|Withdrawal by Subject|6
5410247|NCT02706951|18662961|P2|Overall Study|Withdrawal by Subject|6
5410248|NCT02706951|18662962|P1|Overall Study|Withdrawal by Subject|11
5410249|NCT02706951|18662960|P3|Overall Study|Adverse Event|3
5410250|NCT02706951|18662961|P2|Overall Study|Adverse Event|5
5410251|NCT02706951|18662962|P1|Overall Study|Adverse Event|1
5410252|NCT02706938|18662996|P2|Second Period, 6 Weeks|Withdrawal by Subject|3
5410253|NCT02706938|18662997|P1|Second Period, 6 Weeks|Withdrawal by Subject|0
5410254|NCT02706938|18662996|P2|Second Period, 6 Weeks|Adverse Event|7
5410255|NCT02706938|18662997|P1|Second Period, 6 Weeks|Adverse Event|0
5410256|NCT02706938|18662996|P2|First Period, 6 Weeks|Withdrawal by Subject|0
5410257|NCT02706938|18662997|P1|First Period, 6 Weeks|Withdrawal by Subject|1
5410258|NCT02706938|18662996|P2|First Period, 6 Weeks|Lost to Follow-up|2
5410259|NCT02706938|18662997|P1|First Period, 6 Weeks|Lost to Follow-up|2
5410260|NCT02706938|18662996|P2|First Period, 6 Weeks|Adverse Event|0
5410261|NCT02706938|18662997|P1|First Period, 6 Weeks|Adverse Event|8
5410262|NCT02706899|18663061|P2|Overall Study|Study Termination by Sponsor|6
5410263|NCT02706899|18663062|P1|Overall Study|Study Termination by Sponsor|4
5410264|NCT02706899|18663061|P2|Overall Study|Death|0
5410265|NCT02706899|18663062|P1|Overall Study|Death|8
5410266|NCT02706899|18663061|P2|Overall Study|Withdrawal by Subject|0
5410267|NCT02706899|18663062|P1|Overall Study|Withdrawal by Subject|1
5410268|NCT02706886|18663093|P9|Part A: SAD Period|Withdrawal by Subject|0
5410269|NCT02706886|18663094|P8|Part A: SAD Period|Withdrawal by Subject|0
5410270|NCT02706886|18663095|P7|Part A: SAD Period|Withdrawal by Subject|0
5410271|NCT02706886|18663096|P6|Part A: SAD Period|Withdrawal by Subject|0
5410272|NCT02706886|18663097|P5|Part A: SAD Period|Withdrawal by Subject|0
5410273|NCT02706886|18663098|P4|Part A: SAD Period|Withdrawal by Subject|2
5410274|NCT02706886|18663099|P3|Part A: SAD Period|Withdrawal by Subject|0
5410275|NCT02706886|18663100|P2|Part A: SAD Period|Withdrawal by Subject|0
5410276|NCT02706886|18663101|P1|Part A: SAD Period|Withdrawal by Subject|0
5410277|NCT02706873|18663218|P4|Overall Study|Ongoing|1
5410278|NCT02706873|18663219|P3|Overall Study|Ongoing|0
5410279|NCT02706873|18663220|P2|Overall Study|Ongoing|0
5410280|NCT02706873|18663221|P1|Overall Study|Ongoing|0
5410281|NCT02706873|18663218|P4|Overall Study|Not Dosed|1
5410282|NCT02706873|18663219|P3|Overall Study|Not Dosed|0
5410283|NCT02706873|18663220|P2|Overall Study|Not Dosed|0
5410284|NCT02706873|18663221|P1|Overall Study|Not Dosed|1
5410285|NCT02706873|18663218|P4|Overall Study|Other|3
5410286|NCT02706873|18663219|P3|Overall Study|Other|2
5410287|NCT02706873|18663220|P2|Overall Study|Other|1
5410288|NCT02706873|18663221|P1|Overall Study|Other|5
5410289|NCT02706873|18663218|P4|Overall Study|Lack of Efficacy|3
5410290|NCT02706873|18663219|P3|Overall Study|Lack of Efficacy|0
5410291|NCT02706873|18663220|P2|Overall Study|Lack of Efficacy|0
5410292|NCT02706873|18663221|P1|Overall Study|Lack of Efficacy|10
5410293|NCT02706873|18663218|P4|Overall Study|Lost to Follow-up|2
5410294|NCT02706873|18663219|P3|Overall Study|Lost to Follow-up|4
5410295|NCT02706873|18663220|P2|Overall Study|Lost to Follow-up|0
5410296|NCT02706873|18663221|P1|Overall Study|Lost to Follow-up|3
5410297|NCT02706873|18663218|P4|Overall Study|Withdrawal by Subject|11
5410298|NCT02706873|18663219|P3|Overall Study|Withdrawal by Subject|8
5410299|NCT02706873|18663220|P2|Overall Study|Withdrawal by Subject|0
5410300|NCT02706873|18663221|P1|Overall Study|Withdrawal by Subject|15
5410301|NCT02706873|18663218|P4|Overall Study|Adverse Event|12
5410302|NCT02706873|18663219|P3|Overall Study|Adverse Event|13
5410303|NCT02706873|18663220|P2|Overall Study|Adverse Event|3
5410304|NCT02706873|18663221|P1|Overall Study|Adverse Event|13
5410305|NCT02706847|18663321|P4|Week 12 to Week 24|Other|4
5410306|NCT02706847|18663322|P3|Week 12 to Week 24|Other|1
5410307|NCT02706847|18663323|P2|Week 12 to Week 24|Other|0
5410308|NCT02706847|18663324|P1|Week 12 to Week 24|Other|1
5410309|NCT02706847|18663321|P4|Week 12 to Week 24|Lost to Follow-up|1
5410310|NCT02706847|18663322|P3|Week 12 to Week 24|Lost to Follow-up|0
5410311|NCT02706847|18663323|P2|Week 12 to Week 24|Lost to Follow-up|0
5410312|NCT02706847|18663324|P1|Week 12 to Week 24|Lost to Follow-up|0
5410313|NCT02706847|18663321|P4|Week 12 to Week 24|Withdrawal by Subject|4
5410314|NCT02706847|18663322|P3|Week 12 to Week 24|Withdrawal by Subject|1
5410315|NCT02706847|18663323|P2|Week 12 to Week 24|Withdrawal by Subject|0
5410316|NCT02706847|18663324|P1|Week 12 to Week 24|Withdrawal by Subject|1
5410317|NCT02706847|18663321|P4|Week 12 to Week 24|Adverse Event|5
5410318|NCT02706847|18663322|P3|Week 12 to Week 24|Adverse Event|2
5410319|NCT02706847|18663323|P2|Week 12 to Week 24|Adverse Event|2
5410320|NCT02706847|18663324|P1|Week 12 to Week 24|Adverse Event|1
5410321|NCT02706847|18663321|P4|Day 1 to Week 12|Randomized in Error|0
5410322|NCT02706847|18663322|P3|Day 1 to Week 12|Randomized in Error|1
5410323|NCT02706847|18663323|P2|Day 1 to Week 12|Randomized in Error|0
5410324|NCT02706847|18663324|P1|Day 1 to Week 12|Randomized in Error|0
5410325|NCT02706847|18663321|P4|Day 1 to Week 12|Other|2
5410326|NCT02706847|18663322|P3|Day 1 to Week 12|Other|2
5410327|NCT02706847|18663323|P2|Day 1 to Week 12|Other|4
5410328|NCT02706847|18663324|P1|Day 1 to Week 12|Other|4
5410329|NCT02706847|18663321|P4|Day 1 to Week 12|Lost to Follow-up|0
5410330|NCT02706847|18663322|P3|Day 1 to Week 12|Lost to Follow-up|0
5410331|NCT02706847|18663323|P2|Day 1 to Week 12|Lost to Follow-up|1
5410332|NCT02706847|18663324|P1|Day 1 to Week 12|Lost to Follow-up|2
5410333|NCT02706847|18663321|P4|Day 1 to Week 12|Withdrawal by Subject|2
5410334|NCT02706847|18663322|P3|Day 1 to Week 12|Withdrawal by Subject|4
5410335|NCT02706847|18663323|P2|Day 1 to Week 12|Withdrawal by Subject|1
5410336|NCT02706847|18663324|P1|Day 1 to Week 12|Withdrawal by Subject|2
5410337|NCT02706847|18663321|P4|Day 1 to Week 12|Adverse Event|12
5410338|NCT02706847|18663322|P3|Day 1 to Week 12|Adverse Event|1
5410339|NCT02706847|18663323|P2|Day 1 to Week 12|Adverse Event|2
5410340|NCT02706847|18663324|P1|Day 1 to Week 12|Adverse Event|2
5410341|NCT02706834|18663366|P11|Overall Study|Other Reason Not Specified|0
5410342|NCT02706834|18663367|P10|Overall Study|Other Reason Not Specified|0
5410343|NCT02706834|18663368|P9|Overall Study|Other Reason Not Specified|0
5410344|NCT02706834|18663369|P8|Overall Study|Other Reason Not Specified|0
5410345|NCT02706834|18663370|P7|Overall Study|Other Reason Not Specified|0
5410346|NCT02706834|18663371|P6|Overall Study|Other Reason Not Specified|0
5410347|NCT02706834|18663372|P5|Overall Study|Other Reason Not Specified|1
5410348|NCT02706834|18663373|P4|Overall Study|Other Reason Not Specified|0
5410349|NCT02706834|18663374|P3|Overall Study|Other Reason Not Specified|0
5410350|NCT02706834|18663375|P2|Overall Study|Other Reason Not Specified|0
5410351|NCT02706834|18663376|P1|Overall Study|Other Reason Not Specified|1
5410352|NCT02706834|18663366|P11|Overall Study|Voluntary Withdrawal|0
5410353|NCT02706834|18663367|P10|Overall Study|Voluntary Withdrawal|1
5410354|NCT02706834|18663368|P9|Overall Study|Voluntary Withdrawal|0
5410355|NCT02706834|18663369|P8|Overall Study|Voluntary Withdrawal|0
5410356|NCT02706834|18663370|P7|Overall Study|Voluntary Withdrawal|0
5410357|NCT02706834|18663371|P6|Overall Study|Voluntary Withdrawal|0
5410358|NCT02706834|18663372|P5|Overall Study|Voluntary Withdrawal|0
5410359|NCT02706834|18663373|P4|Overall Study|Voluntary Withdrawal|0
5410360|NCT02706834|18663374|P3|Overall Study|Voluntary Withdrawal|0
5410361|NCT02706834|18663375|P2|Overall Study|Voluntary Withdrawal|0
5410362|NCT02706834|18663376|P1|Overall Study|Voluntary Withdrawal|1
5410363|NCT02706834|18663366|P11|Overall Study|Lost to Follow-up|0
5410364|NCT02706834|18663367|P10|Overall Study|Lost to Follow-up|0
5410365|NCT02706834|18663368|P9|Overall Study|Lost to Follow-up|0
5410366|NCT02706834|18663369|P8|Overall Study|Lost to Follow-up|0
5410367|NCT02706834|18663370|P7|Overall Study|Lost to Follow-up|0
5410368|NCT02706834|18663371|P6|Overall Study|Lost to Follow-up|0
5410369|NCT02706834|18663372|P5|Overall Study|Lost to Follow-up|0
5410370|NCT02706834|18663373|P4|Overall Study|Lost to Follow-up|0
5410371|NCT02706834|18663374|P3|Overall Study|Lost to Follow-up|1
5410372|NCT02706834|18663375|P2|Overall Study|Lost to Follow-up|0
5410373|NCT02706834|18663376|P1|Overall Study|Lost to Follow-up|0
5410374|NCT02706834|18663366|P11|Overall Study|Pretreatment Event/Adverse Event|1
5410375|NCT02706834|18663367|P10|Overall Study|Pretreatment Event/Adverse Event|0
5410376|NCT02706834|18663368|P9|Overall Study|Pretreatment Event/Adverse Event|0
5410377|NCT02706834|18663369|P8|Overall Study|Pretreatment Event/Adverse Event|0
5410378|NCT02706834|18663370|P7|Overall Study|Pretreatment Event/Adverse Event|0
5410379|NCT02706834|18663371|P6|Overall Study|Pretreatment Event/Adverse Event|0
5410380|NCT02706834|18663372|P5|Overall Study|Pretreatment Event/Adverse Event|0
5410381|NCT02706834|18663373|P4|Overall Study|Pretreatment Event/Adverse Event|0
5410382|NCT02706834|18663374|P3|Overall Study|Pretreatment Event/Adverse Event|0
5410383|NCT02706834|18663375|P2|Overall Study|Pretreatment Event/Adverse Event|1
5410384|NCT02706834|18663376|P1|Overall Study|Pretreatment Event/Adverse Event|0
5410385|NCT02706717|18663520|P2|Overall Study|Death|1
5410386|NCT02706717|18663521|P1|Overall Study|Death|0
5410387|NCT02706717|18663520|P2|Overall Study|Physician Decision|1
5410388|NCT02706717|18663521|P1|Overall Study|Physician Decision|0
5410389|NCT02706717|18663520|P2|Overall Study|Lost to Follow-up|1
5410390|NCT02706717|18663521|P1|Overall Study|Lost to Follow-up|0
5410391|NCT02706717|18663520|P2|Overall Study|Withdrawal by Subject|8
5410392|NCT02706717|18663521|P1|Overall Study|Withdrawal by Subject|1
5410393|NCT02706691|18663585|P1|Overall Study|Adverse Event|1
5410394|NCT02706483|18663592|P1|Overall Study|Subject moved|1
5410395|NCT02706483|18663592|P1|Overall Study|Site closure|4
5410396|NCT02706483|18663592|P1|Overall Study|Non-compliance with visits|6
5410397|NCT02706483|18663592|P1|Overall Study|Withdrawal by Subject|136
5410398|NCT02706483|18663592|P1|Overall Study|Protocol Violation|18
5410399|NCT02706483|18663592|P1|Overall Study|Pregnancy|6
5410400|NCT02706483|18663592|P1|Overall Study|Physician Decision|6
5410401|NCT02706483|18663592|P1|Overall Study|Non-compliance with study drug|15
5410402|NCT02706483|18663592|P1|Overall Study|Lost to Follow-up|101
5410403|NCT02706483|18663592|P1|Overall Study|Lack of Efficacy|39
5410404|NCT02706483|18663592|P1|Overall Study|Death|1
5410405|NCT02706483|18663592|P1|Overall Study|Adverse Event|97
5410406|NCT02706327|18663599|P3|Overall Study|Lost to Follow-up|2
5410407|NCT02706327|18663600|P2|Overall Study|Lost to Follow-up|1
5410408|NCT02706327|18663601|P1|Overall Study|Lost to Follow-up|1
5410409|NCT02705716|18663653|P2|Overall Study|Withdrawal of Consent|1
5410410|NCT02705716|18663654|P1|Overall Study|Withdrawal of Consent|1
5410411|NCT02705716|18663653|P2|Overall Study|Protocol Violation|0
5410412|NCT02705716|18663654|P1|Overall Study|Protocol Violation|3
5410413|NCT02705716|18663653|P2|Overall Study|Adverse Event|1
5410414|NCT02705716|18663654|P1|Overall Study|Adverse Event|0
5410415|NCT02705625|18663667|P3|Overall Study|Overdosing|1
5410416|NCT02705625|18663668|P2|Overall Study|Overdosing|0
5410417|NCT02705625|18663669|P1|Overall Study|Overdosing|0
5410418|NCT02705625|18663667|P3|Overall Study|Non-compliance|1
5410419|NCT02705625|18663668|P2|Overall Study|Non-compliance|1
5410420|NCT02705625|18663669|P1|Overall Study|Non-compliance|0
5410421|NCT02705625|18663667|P3|Overall Study|Lost to Follow-up|1
5410422|NCT02705625|18663668|P2|Overall Study|Lost to Follow-up|0
5410423|NCT02705625|18663669|P1|Overall Study|Lost to Follow-up|0
5410424|NCT02705625|18663667|P3|Overall Study|Withdrawal by Subject|5
5410425|NCT02705625|18663668|P2|Overall Study|Withdrawal by Subject|4
5410426|NCT02705625|18663669|P1|Overall Study|Withdrawal by Subject|1
5410427|NCT02705625|18663667|P3|Overall Study|Death|1
5410428|NCT02705625|18663668|P2|Overall Study|Death|0
5410429|NCT02705625|18663669|P1|Overall Study|Death|0
5410430|NCT02705625|18663667|P3|Overall Study|Adverse Event|2
5410431|NCT02705625|18663668|P2|Overall Study|Adverse Event|5
5410432|NCT02705625|18663669|P1|Overall Study|Adverse Event|6
5410433|NCT02705625|18663667|P3|Overall Study|Protocol Violation|0
5410434|NCT02705625|18663668|P2|Overall Study|Protocol Violation|0
5410435|NCT02705625|18663669|P1|Overall Study|Protocol Violation|1
5410436|NCT02705586|18663698|P1|Overall Study|Vacation/Planned Absence|1
5410437|NCT02705586|18663698|P1|Overall Study|Transportation Difficulties|5
5410438|NCT02705586|18663698|P1|Overall Study|Health Issues|2
5410439|NCT02705105|18663736|P2|Follow-Up|Discontinued per Amendment 3|2
5410440|NCT02705105|18663737|P1|Follow-Up|Discontinued per Amendment 3|0
5410441|NCT02705105|18663736|P2|Follow-Up|Study Terminated|26
5410442|NCT02705105|18663737|P1|Follow-Up|Study Terminated|0
5410443|NCT02705105|18663736|P2|Follow-Up|Withdrawal by Subject|14
5410444|NCT02705105|18663737|P1|Follow-Up|Withdrawal by Subject|1
5410445|NCT02705105|18663736|P2|Follow-Up|Death|68
5410446|NCT02705105|18663737|P1|Follow-Up|Death|3
5410447|NCT02705105|18663736|P2|Treatment|Ongoing w/ Treatment at time of data cut|2
5410448|NCT02705105|18663737|P1|Treatment|Ongoing w/ Treatment at time of data cut|0
5410449|NCT02705105|18663736|P2|Treatment|Physician Decision|3
5410450|NCT02705105|18663737|P1|Treatment|Physician Decision|0
5410451|NCT02705105|18663736|P2|Treatment|Clinical Disease Progression|32
5410452|NCT02705105|18663737|P1|Treatment|Clinical Disease Progression|0
5410453|NCT02705105|18663736|P2|Treatment|Adverse Event|17
5410454|NCT02705105|18663737|P1|Treatment|Adverse Event|0
5410455|NCT02705105|18663736|P2|Treatment|Withdrawal by Subject|5
5410456|NCT02705105|18663737|P1|Treatment|Withdrawal by Subject|3
5410457|NCT02705105|18663736|P2|Treatment|Objective Disease Progression|50
5410458|NCT02705105|18663737|P1|Treatment|Objective Disease Progression|1
5410459|NCT02704689|18663800|P1|Overall Study|Study device not implanted|2
5410460|NCT02704689|18663800|P1|Overall Study|Physician Decision|1
5410461|NCT02704143|18663817|P1|Overall Study|disease progression|10
5410462|NCT02704091|18663842|P2|Overall Study|Other|8
5410463|NCT02704091|18663843|P1|Overall Study|Other|2
5410464|NCT02704091|18663842|P2|Overall Study|Lost to Follow-up|5
5410465|NCT02704091|18663843|P1|Overall Study|Lost to Follow-up|13
5410466|NCT02704091|18663842|P2|Overall Study|Consent withdrawn|4
5410467|NCT02704091|18663843|P1|Overall Study|Consent withdrawn|4
5410468|NCT02704091|18663842|P2|Overall Study|Protocol Violation|3
5410469|NCT02704091|18663843|P1|Overall Study|Protocol Violation|5
5410470|NCT02704091|18663842|P2|Overall Study|Adverse Event|3
5410471|NCT02704091|18663843|P1|Overall Study|Adverse Event|4
5410472|NCT02703636|18663903|P1|Overall Study|Withdrawal by Subject|1
5410473|NCT02703636|18663903|P1|Overall Study|Study stopped by sponsor|1
5410474|NCT02703636|18663903|P1|Overall Study|Adverse Event|14
5410475|NCT02703532|18663918|P4|Overall Study|Lost to Follow-up|0
5410476|NCT02703532|18663919|P3|Overall Study|Lost to Follow-up|2
5410477|NCT02703532|18663920|P2|Overall Study|Lost to Follow-up|0
5410478|NCT02703532|18663921|P1|Overall Study|Lost to Follow-up|2
5410479|NCT02703532|18663918|P4|Overall Study|Withdrawal by Subject|1
5410480|NCT02703532|18663919|P3|Overall Study|Withdrawal by Subject|0
5410481|NCT02703532|18663920|P2|Overall Study|Withdrawal by Subject|1
5410482|NCT02703532|18663921|P1|Overall Study|Withdrawal by Subject|0
5410483|NCT02703454|18663983|P2|Overall Study|Study discontinuation|8
5410484|NCT02703454|18663984|P1|Overall Study|Study discontinuation|5
5410485|NCT02703454|18663983|P2|Overall Study|Lost to Follow-up|2
5410486|NCT02703454|18663984|P1|Overall Study|Lost to Follow-up|1
5410487|NCT02703454|18663983|P2|Overall Study|Withdrawal by Subject|3
5410488|NCT02703454|18663984|P1|Overall Study|Withdrawal by Subject|4
5410489|NCT02703454|18663983|P2|Overall Study|Not treated|3
5410490|NCT02703454|18663984|P1|Overall Study|Not treated|1
5410491|NCT02703337|18664019|P8|Period One (Part A)|Withdrawal by Subject|0
5410492|NCT02703337|18664020|P7|Period One (Part A)|Withdrawal by Subject|0
5410493|NCT02703337|18664021|P6|Period One (Part A)|Withdrawal by Subject|0
5410494|NCT02703337|18664022|P5|Period One (Part A)|Withdrawal by Subject|1
5410495|NCT02703337|18664023|P4|Period One (Part A)|Withdrawal by Subject|0
5410496|NCT02703337|18664024|P3|Period One (Part A)|Withdrawal by Subject|0
5410497|NCT02703337|18664025|P2|Period One (Part A)|Withdrawal by Subject|0
5410498|NCT02703337|18664026|P1|Period One (Part A)|Withdrawal by Subject|0
5410499|NCT02703324|18664046|P6|Period Two|Withdrawal by Subject|0
5410500|NCT02703324|18664047|P5|Period Two|Withdrawal by Subject|0
5410501|NCT02703324|18664048|P4|Period Two|Withdrawal by Subject|0
5410502|NCT02703324|18664049|P3|Period Two|Withdrawal by Subject|1
5410503|NCT02703324|18664050|P2|Period Two|Withdrawal by Subject|0
5410504|NCT02703324|18664051|P1|Period Two|Withdrawal by Subject|0
5410505|NCT02703311|18664060|P1|Overall Study|Withdrawal by Subject|3
5410506|NCT02703311|18664060|P1|Overall Study|Death|5
5410507|NCT02703259|18664078|P2|2 Weeks Postoperative Assessment|Lost to Follow-up|10
5410508|NCT02703259|18664079|P1|2 Weeks Postoperative Assessment|Lost to Follow-up|10
5410509|NCT02703259|18664078|P2|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
5410510|NCT02703259|18664079|P1|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
5410511|NCT02703259|18664078|P2|24 Hours Postoperative Assessment|Lost to Follow-up|4
5410512|NCT02703259|18664079|P1|24 Hours Postoperative Assessment|Lost to Follow-up|1
5410513|NCT02702609|18664127|P2|Overall Study|Physician Decision|0
5410514|NCT02702609|18664128|P1|Overall Study|Physician Decision|1
5410515|NCT02702609|18664127|P2|Overall Study|Lost to Follow-up|4
5410516|NCT02702609|18664128|P1|Overall Study|Lost to Follow-up|8
5410517|NCT02702401|18664146|P2|Overall Study|Ongoing in study|34
5410518|NCT02702401|18664147|P1|Overall Study|Ongoing in study|94
5410519|NCT02702401|18664146|P2|Overall Study|Withdrawal by Subject|0
5410520|NCT02702401|18664147|P1|Overall Study|Withdrawal by Subject|4
5410521|NCT02702401|18664146|P2|Overall Study|Death|101
5410522|NCT02702401|18664147|P1|Overall Study|Death|180
5410523|NCT02702193|18664169|P2|12 Month Follow up|Lost to Follow-up|18
5410524|NCT02702193|18664170|P1|12 Month Follow up|Lost to Follow-up|16
5410525|NCT02702193|18664169|P2|12 Month Follow up|Withdrawal by Subject|0
5410526|NCT02702193|18664170|P1|12 Month Follow up|Withdrawal by Subject|1
5410527|NCT02702193|18664169|P2|8 Month Follow up|Lost to Follow-up|18
5410528|NCT02702193|18664170|P1|8 Month Follow up|Lost to Follow-up|14
5410529|NCT02702193|18664169|P2|8 Month Follow up|Withdrawal by Subject|0
5410530|NCT02702193|18664170|P1|8 Month Follow up|Withdrawal by Subject|1
5410531|NCT02702193|18664169|P2|4 Month Follow up|Lost to Follow-up|18
5410532|NCT02702193|18664170|P1|4 Month Follow up|Lost to Follow-up|17
5410533|NCT02702193|18664169|P2|4 Month Follow up|Withdrawal by Subject|0
5410534|NCT02702193|18664170|P1|4 Month Follow up|Withdrawal by Subject|1
5410535|NCT02702193|18664169|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
5410536|NCT02702193|18664170|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
5410537|NCT02702011|18664198|P4|Overall Study|Withdrawal by Subject|0
5410538|NCT02702011|18664199|P3|Overall Study|Withdrawal by Subject|0
5410539|NCT02702011|18664200|P2|Overall Study|Withdrawal by Subject|1
5410540|NCT02702011|18664201|P1|Overall Study|Withdrawal by Subject|0
5410541|NCT02701985|18664213|P2|Overall Study|Adverse Event|5
5410542|NCT02701985|18664214|P1|Overall Study|Adverse Event|0
5410543|NCT02701985|18664213|P2|Overall Study|Death|0
5410544|NCT02701985|18664214|P1|Overall Study|Death|1
5410545|NCT02701985|18664213|P2|Overall Study|Lost to Follow-up|0
5410546|NCT02701985|18664214|P1|Overall Study|Lost to Follow-up|1
5410547|NCT02701985|18664213|P2|Overall Study|Withdrawal by Subject|1
5410548|NCT02701985|18664214|P1|Overall Study|Withdrawal by Subject|1
5410549|NCT02701764|18664257|P2|Overall Study|Lost to Follow-up|1
5410550|NCT02701764|18664258|P1|Overall Study|Lost to Follow-up|0
5410551|NCT02701634|18664317|P2|Overall Study|Randomized but not treated|0
5410552|NCT02701634|18664318|P1|Overall Study|Randomized but not treated|1
5410553|NCT02701634|18664317|P2|Overall Study|Withdrew Consent|7
5410554|NCT02701634|18664318|P1|Overall Study|Withdrew Consent|6
5410555|NCT02701634|18664317|P2|Overall Study|Study terminated by Sponsor|17
5410556|NCT02701634|18664318|P1|Overall Study|Study terminated by Sponsor|15
5410557|NCT02701634|18664317|P2|Overall Study|Investigator's Discretion|4
5410558|NCT02701634|18664318|P1|Overall Study|Investigator's Discretion|7
5410559|NCT02701634|18664317|P2|Overall Study|Death|0
5410560|NCT02701634|18664318|P1|Overall Study|Death|1
5410561|NCT02701634|18664317|P2|Overall Study|Adverse Event|3
5410562|NCT02701634|18664318|P1|Overall Study|Adverse Event|2
5410563|NCT02701361|18664388|P3|Overall Study|incarceration|1
5410564|NCT02701361|18664389|P2|Overall Study|incarceration|0
5410565|NCT02701361|18664390|P1|Overall Study|incarceration|0
5410566|NCT02701361|18664388|P3|Overall Study|timed out in rehab center|0
5410567|NCT02701361|18664389|P2|Overall Study|timed out in rehab center|1
5410568|NCT02701361|18664390|P1|Overall Study|timed out in rehab center|0
5410569|NCT02701361|18664388|P3|Overall Study|Withdrawal by Subject|0
5410570|NCT02701361|18664389|P2|Overall Study|Withdrawal by Subject|0
5410571|NCT02701361|18664390|P1|Overall Study|Withdrawal by Subject|4
5410572|NCT02701361|18664388|P3|Overall Study|Lost to Follow-up|1
5410573|NCT02701361|18664389|P2|Overall Study|Lost to Follow-up|2
5410574|NCT02701361|18664390|P1|Overall Study|Lost to Follow-up|5
5410575|NCT02701296|18664431|P2|Overall Study|Incomplete Data|2
5410576|NCT02701296|18664432|P1|Overall Study|Incomplete Data|0
5410577|NCT02700997|18664684|P1|Overall Study|No CT measurement - pelvic calcification|1
5410578|NCT02700997|18664684|P1|Overall Study|Did not undergo CT imaging|1
5410579|NCT02700984|18664690|P2|Overall Study|Reason not specified|2
5410580|NCT02700984|18664691|P1|Overall Study|Reason not specified|3
5410581|NCT02700984|18664690|P2|Overall Study|Withdrawal by Subject|9
5410582|NCT02700984|18664691|P1|Overall Study|Withdrawal by Subject|8
5410583|NCT02700984|18664690|P2|Overall Study|Physician Decision|1
5410584|NCT02700984|18664691|P1|Overall Study|Physician Decision|0
5410585|NCT02700984|18664690|P2|Overall Study|Lost to Follow-up|1
5410586|NCT02700984|18664691|P1|Overall Study|Lost to Follow-up|2
5410587|NCT02700984|18664690|P2|Overall Study|Death|1
5410588|NCT02700984|18664691|P1|Overall Study|Death|2
5410589|NCT02700919|18664743|P3|Overall Study|Other|1
5410590|NCT02700919|18664744|P2|Overall Study|Other|1
5410591|NCT02700919|18664745|P1|Overall Study|Other|2
5410592|NCT02700919|18664743|P3|Overall Study|Lost to Follow-up|0
5410593|NCT02700919|18664744|P2|Overall Study|Lost to Follow-up|0
5410594|NCT02700919|18664745|P1|Overall Study|Lost to Follow-up|2
5410595|NCT02700919|18664743|P3|Overall Study|Withdrawal by Subject|2
5410596|NCT02700919|18664744|P2|Overall Study|Withdrawal by Subject|8
5410597|NCT02700919|18664745|P1|Overall Study|Withdrawal by Subject|5
5410598|NCT02700919|18664743|P3|Overall Study|Adverse Event|1
5410599|NCT02700919|18664744|P2|Overall Study|Adverse Event|3
5410600|NCT02700919|18664745|P1|Overall Study|Adverse Event|1
5410601|NCT02700919|18664743|P3|Overall Study|Protocol Violation|0
5410602|NCT02700919|18664744|P2|Overall Study|Protocol Violation|0
5410603|NCT02700919|18664745|P1|Overall Study|Protocol Violation|1
5410604|NCT02700919|18664743|P3|Overall Study|Physician Decision|0
5410605|NCT02700919|18664744|P2|Overall Study|Physician Decision|0
5410606|NCT02700919|18664745|P1|Overall Study|Physician Decision|1
5410607|NCT02700815|18664807|P4|Overall Study|Withdrawal by Subject|0
5410608|NCT02700815|18664808|P3|Overall Study|Withdrawal by Subject|1
5410609|NCT02700815|18664809|P2|Overall Study|Withdrawal by Subject|0
5410610|NCT02700815|18664810|P1|Overall Study|Withdrawal by Subject|0
5410611|NCT02700815|18664807|P4|Overall Study|Refusal to continue medication|1
5410612|NCT02700815|18664808|P3|Overall Study|Refusal to continue medication|0
5410613|NCT02700815|18664809|P2|Overall Study|Refusal to continue medication|1
5410614|NCT02700815|18664810|P1|Overall Study|Refusal to continue medication|0
5410615|NCT02700815|18664807|P4|Overall Study|Lost to Follow-up|1
5410616|NCT02700815|18664808|P3|Overall Study|Lost to Follow-up|0
5410617|NCT02700815|18664809|P2|Overall Study|Lost to Follow-up|0
5410618|NCT02700815|18664810|P1|Overall Study|Lost to Follow-up|1
5410619|NCT02700815|18664807|P4|Overall Study|Lack of Efficacy|2
5410620|NCT02700815|18664808|P3|Overall Study|Lack of Efficacy|1
5410621|NCT02700815|18664809|P2|Overall Study|Lack of Efficacy|0
5410622|NCT02700815|18664810|P1|Overall Study|Lack of Efficacy|0
5410623|NCT02700815|18664807|P4|Overall Study|Adverse Event|3
5410624|NCT02700815|18664808|P3|Overall Study|Adverse Event|2
5410625|NCT02700815|18664809|P2|Overall Study|Adverse Event|6
5410626|NCT02700815|18664810|P1|Overall Study|Adverse Event|0
5410627|NCT02700412|18664848|P1|Overall Study|Withdrawal by Subject|2
5410628|NCT02700412|18664848|P1|Overall Study|Protocol Violation|5
5410629|NCT02700412|18664848|P1|Overall Study|Lack of Efficacy|19
5410630|NCT02700412|18664848|P1|Overall Study|Death|1
5410631|NCT02700412|18664848|P1|Overall Study|Adverse Event|6
5410632|NCT02699996|18664899|P2|Overall Study|Withdrawal by Subject|2
5410633|NCT02699996|18664900|P1|Overall Study|Withdrawal by Subject|5
5410634|NCT02699983|18664918|P2|Overall Study|Withdrawal by Subject|0
5410635|NCT02699983|18664919|P1|Overall Study|Withdrawal by Subject|1
5410636|NCT02699892|18664984|P1|Overall Study|Other|36
5410637|NCT02699866|18664989|P1|Overall Study|Adverse Event|3
5410638|NCT02699866|18664989|P1|Overall Study|Physician Decision|2
5410639|NCT02699866|18664989|P1|Overall Study|Withdrawal by Subject|3
5410640|NCT02699684|18664997|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
5410641|NCT02699684|18664998|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
5410642|NCT02699593|18665015|P2|Period 2|Torn Contact Lens|0
5410643|NCT02699593|18665016|P1|Period 2|Torn Contact Lens|1
5410644|NCT02699593|18665015|P2|Period 2|Lost Contact Lens|1
5410645|NCT02699593|18665016|P1|Period 2|Lost Contact Lens|0
5410646|NCT02699593|18665015|P2|Period 2|Adverse Event|1
5410647|NCT02699593|18665016|P1|Period 2|Adverse Event|1
5410648|NCT02699593|18665015|P2|Period 1|Adverse Event|1
5410649|NCT02699593|18665016|P1|Period 1|Adverse Event|1
5410650|NCT02699593|18665015|P2|Period 1|Withdrawal by Subject|1
5410651|NCT02699593|18665016|P1|Period 1|Withdrawal by Subject|0
5410652|NCT02699593|18665015|P2|Period 1|Protocol Violation|1
5410653|NCT02699593|18665016|P1|Period 1|Protocol Violation|0
5410654|NCT02699593|18665015|P2|Period 1|Torn Contact Len|3
5410655|NCT02699593|18665016|P1|Period 1|Torn Contact Len|4
5410656|NCT02699593|18665015|P2|Period 1|Unsatisfactory Visual Response|1
5410657|NCT02699593|18665016|P1|Period 1|Unsatisfactory Visual Response|0
5410658|NCT02699450|18665027|P3|Overall Study|Adverse Event|0
5410659|NCT02699450|18665028|P2|Overall Study|Adverse Event|0
5410660|NCT02699450|18665029|P1|Overall Study|Adverse Event|1
5410661|NCT02699450|18665027|P3|Overall Study|Withdrawal by Subject|2
5410662|NCT02699450|18665028|P2|Overall Study|Withdrawal by Subject|1
5410663|NCT02699450|18665029|P1|Overall Study|Withdrawal by Subject|3
5410664|NCT02699450|18665027|P3|Overall Study|Physician Decision|0
5410665|NCT02699450|18665028|P2|Overall Study|Physician Decision|0
5410666|NCT02699450|18665029|P1|Overall Study|Physician Decision|2
5410667|NCT02699450|18665027|P3|Overall Study|Lost to Follow-up|5
5410668|NCT02699450|18665028|P2|Overall Study|Lost to Follow-up|0
5410669|NCT02699450|18665029|P1|Overall Study|Lost to Follow-up|3
5410670|NCT02699450|18665027|P3|Overall Study|Protocol Violation|5
5410671|NCT02699450|18665028|P2|Overall Study|Protocol Violation|3
5410672|NCT02699450|18665029|P1|Overall Study|Protocol Violation|4
5410673|NCT02699450|18665027|P3|Overall Study|Met Criteria for Study Exit|1
5410674|NCT02699450|18665028|P2|Overall Study|Met Criteria for Study Exit|0
5410675|NCT02699450|18665029|P1|Overall Study|Met Criteria for Study Exit|0
5410676|NCT02699450|18665027|P3|Overall Study|Death|2
5410677|NCT02699450|18665028|P2|Overall Study|Death|1
5410678|NCT02699450|18665029|P1|Overall Study|Death|2
5410679|NCT02699125|18665164|P2|Second Intervention (6 Weeks).|Withdrawal by Subject|2
5410680|NCT02699125|18665165|P1|Second Intervention (6 Weeks).|Withdrawal by Subject|7
5410681|NCT02699125|18665164|P2|Placebo|Withdrawal by Subject|4
5410682|NCT02699125|18665165|P1|Placebo|Withdrawal by Subject|0
5410683|NCT02699125|18665164|P2|Placebo|Protocol Violation|0
5410684|NCT02699125|18665165|P1|Placebo|Protocol Violation|1
5410685|NCT02699125|18665164|P2|Placebo|Lost to Follow-up|0
5410686|NCT02699125|18665165|P1|Placebo|Lost to Follow-up|2
5410687|NCT02699099|18665179|P3|Overall Study|Withdrawal by Subject|2
5410688|NCT02699099|18665180|P2|Overall Study|Withdrawal by Subject|1
5410689|NCT02699099|18665181|P1|Overall Study|Withdrawal by Subject|6
5410690|NCT02699099|18665179|P3|Overall Study|Lost to Follow-up|0
5410691|NCT02699099|18665180|P2|Overall Study|Lost to Follow-up|1
5410692|NCT02699099|18665181|P1|Overall Study|Lost to Follow-up|0
5410693|NCT02699099|18665179|P3|Overall Study|Adverse Event|1
5410694|NCT02699099|18665180|P2|Overall Study|Adverse Event|0
5410695|NCT02699099|18665181|P1|Overall Study|Adverse Event|1
5410696|NCT02698865|18665257|P2|Overall Study|Lost to Follow-up|2
5410697|NCT02698865|18665258|P1|Overall Study|Lost to Follow-up|4
5410698|NCT02698865|18665257|P2|Overall Study|Physician Decision|4
5410699|NCT02698865|18665258|P1|Overall Study|Physician Decision|0
5410700|NCT02698865|18665257|P2|Overall Study|Withdrawal by Subject|16
5410701|NCT02698865|18665258|P1|Overall Study|Withdrawal by Subject|20
5410702|NCT02698865|18665257|P2|Overall Study|Other|11
5410703|NCT02698865|18665258|P1|Overall Study|Other|11
5410704|NCT02698475|18665296|P1|Overall Study|Protocol Violation|1
5410705|NCT02698475|18665296|P1|Overall Study|Withdrawal by Subject|3
5410706|NCT02698475|18665296|P1|Overall Study|Lack of Efficacy|1
5410707|NCT02698436|18665313|P2|Overall Study|Non-compliance with study regimen|0
5410708|NCT02698436|18665314|P1|Overall Study|Non-compliance with study regimen|1
5410709|NCT02698436|18665313|P2|Overall Study|Lost to Follow-up|4
5410710|NCT02698436|18665314|P1|Overall Study|Lost to Follow-up|2
5410711|NCT02698436|18665313|P2|Overall Study|Withdrawal by Subject|3
5410712|NCT02698436|18665314|P1|Overall Study|Withdrawal by Subject|3
5410713|NCT02698436|18665313|P2|Overall Study|Adverse Event|0
5410714|NCT02698436|18665314|P1|Overall Study|Adverse Event|1
5410715|NCT02698423|18665354|P2|Overall Study|Lost to Follow-up|24
5410716|NCT02698423|18665355|P1|Overall Study|Lost to Follow-up|19
5410717|NCT02698410|18665363|P1|Overall Study|Other|1
5410718|NCT02698410|18665363|P1|Overall Study|Withdrawal by Subject|1
5410719|NCT02698410|18665363|P1|Overall Study|Adverse Event|2
5410720|NCT02698371|18665382|P1|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
5410721|NCT02698371|18665382|P1|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
5410722|NCT02698371|18665382|P1|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
5410723|NCT02698371|18665382|P1|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
5410724|NCT02698371|18665382|P1|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
5410725|NCT02698371|18665382|P1|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
5410726|NCT02698371|18665382|P1|All Participants Flow|Lost to Follow-up|3
5410727|NCT02698241|18665504|P1|Overall Study|Death|2
5410728|NCT02698241|18665504|P1|Overall Study|geographic and licensing issue|1
5410729|NCT02698241|18665504|P1|Overall Study|Subject on inodrip not safe to continue|6
5410730|NCT02698241|18665504|P1|Overall Study|Lost to Follow-up|3
5410731|NCT02698241|18665504|P1|Overall Study|Subject underwent system modification|2
5410732|NCT02698241|18665504|P1|Overall Study|Physician Decision|2
5410733|NCT02698241|18665504|P1|Overall Study|Withdrawal by Subject|7
5410734|NCT02698241|18665504|P1|Overall Study|Screening not met|7
5410735|NCT02698241|18665504|P1|Overall Study|Inclusion/exclusion criteria not met|4
5410736|NCT02698189|18665511|P2|Overall Study|Still ongoing in the study|1
5410737|NCT02698189|18665512|P1|Overall Study|Still ongoing in the study|0
5410738|NCT02698189|18665511|P2|Overall Study|Progressive disease|5
5410739|NCT02698189|18665512|P1|Overall Study|Progressive disease|3
5410740|NCT02698176|18665542|P4|Overall Study|Clinical progression|0
5410741|NCT02698176|18665543|P3|Overall Study|Clinical progression|0
5410742|NCT02698176|18665544|P2|Overall Study|Clinical progression|0
5410743|NCT02698176|18665545|P1|Overall Study|Clinical progression|3
5410744|NCT02698176|18665542|P4|Overall Study|Adverse Event|0
5410745|NCT02698176|18665543|P3|Overall Study|Adverse Event|0
5410746|NCT02698176|18665544|P2|Overall Study|Adverse Event|0
5410747|NCT02698176|18665545|P1|Overall Study|Adverse Event|2
5410748|NCT02698176|18665542|P4|Overall Study|Progressive disease|0
5410749|NCT02698176|18665543|P3|Overall Study|Progressive disease|1
5410750|NCT02698176|18665544|P2|Overall Study|Progressive disease|3
5410751|NCT02698176|18665545|P1|Overall Study|Progressive disease|4
5410752|NCT02697773|18665602|P3|Overall Study|Randomized but not treated|0
5410753|NCT02697773|18665603|P2|Overall Study|Randomized but not treated|1
5410754|NCT02697773|18665604|P1|Overall Study|Randomized but not treated|1
5410755|NCT02697773|18665602|P3|Overall Study|Withdrawal by Subject|13
5410756|NCT02697773|18665603|P2|Overall Study|Withdrawal by Subject|13
5410757|NCT02697773|18665604|P1|Overall Study|Withdrawal by Subject|10
5410758|NCT02697773|18665602|P3|Overall Study|Protocol Violation|0
5410759|NCT02697773|18665603|P2|Overall Study|Protocol Violation|1
5410760|NCT02697773|18665604|P1|Overall Study|Protocol Violation|1
5410761|NCT02697773|18665602|P3|Overall Study|Other|10
5410762|NCT02697773|18665603|P2|Overall Study|Other|11
5410763|NCT02697773|18665604|P1|Overall Study|Other|15
5410764|NCT02697773|18665602|P3|Overall Study|Lost to Follow-up|7
5410765|NCT02697773|18665603|P2|Overall Study|Lost to Follow-up|5
5410766|NCT02697773|18665604|P1|Overall Study|Lost to Follow-up|5
5410767|NCT02697773|18665602|P3|Overall Study|Lack of Efficacy|6
5410768|NCT02697773|18665603|P2|Overall Study|Lack of Efficacy|6
5410769|NCT02697773|18665604|P1|Overall Study|Lack of Efficacy|4
5410770|NCT02697773|18665602|P3|Overall Study|Death|2
5410771|NCT02697773|18665603|P2|Overall Study|Death|0
5410772|NCT02697773|18665604|P1|Overall Study|Death|0
5410773|NCT02697773|18665602|P3|Overall Study|Adverse Event|2
5410774|NCT02697773|18665603|P2|Overall Study|Adverse Event|1
5410775|NCT02697773|18665604|P1|Overall Study|Adverse Event|2
5410776|NCT02697435|18665785|P2|Overall Study|Physician Decision|4
5410777|NCT02697435|18665786|P1|Overall Study|Physician Decision|0
5410778|NCT02697435|18665785|P2|Overall Study|Withdrawal by Subject|0
5410779|NCT02697435|18665786|P1|Overall Study|Withdrawal by Subject|1
5410780|NCT02696902|18665895|P3|Overall Study|Transferred to other hospital|0
5410781|NCT02696902|18665896|P2|Overall Study|Transferred to other hospital|0
5410782|NCT02696902|18665897|P1|Overall Study|Transferred to other hospital|1
5410783|NCT02696902|18665895|P3|Overall Study|Sponsor's decision|0
5410784|NCT02696902|18665896|P2|Overall Study|Sponsor's decision|0
5410785|NCT02696902|18665897|P1|Overall Study|Sponsor's decision|1
5410786|NCT02696902|18665895|P3|Overall Study|Principal investigator's decision|0
5410787|NCT02696902|18665896|P2|Overall Study|Principal investigator's decision|0
5410788|NCT02696902|18665897|P1|Overall Study|Principal investigator's decision|1
5410789|NCT02696902|18665895|P3|Overall Study|Participant not eligible (negative PCR)|1
5410790|NCT02696902|18665896|P2|Overall Study|Participant not eligible (negative PCR)|0
5410791|NCT02696902|18665897|P1|Overall Study|Participant not eligible (negative PCR)|0
5410792|NCT02696902|18665895|P3|Overall Study|Participant not fit post-randomization|1
5410793|NCT02696902|18665896|P2|Overall Study|Participant not fit post-randomization|0
5410794|NCT02696902|18665897|P1|Overall Study|Participant not fit post-randomization|0
5410795|NCT02696902|18665895|P3|Overall Study|Death|24
5410796|NCT02696902|18665896|P2|Overall Study|Death|3
5410797|NCT02696902|18665897|P1|Overall Study|Death|19
5410798|NCT02696902|18665895|P3|Overall Study|Withdrawal by Subject|1
5410799|NCT02696902|18665896|P2|Overall Study|Withdrawal by Subject|0
5410800|NCT02696902|18665897|P1|Overall Study|Withdrawal by Subject|0
5410801|NCT02696902|18665895|P3|Overall Study|Lost to Follow-up|1
5410802|NCT02696902|18665896|P2|Overall Study|Lost to Follow-up|1
5410803|NCT02696902|18665897|P1|Overall Study|Lost to Follow-up|0
5410804|NCT02696850|18665929|P2|Overall Study|Lost to Follow-up|5
5410805|NCT02696850|18665930|P1|Overall Study|Lost to Follow-up|8
5410806|NCT02696850|18665929|P2|Overall Study|Withdrawal by Subject|3
5410807|NCT02696850|18665930|P1|Overall Study|Withdrawal by Subject|3
5410808|NCT02696798|18665943|P3|Post-treatment Follow-up Period|No progressive improvement|0
5410809|NCT02696798|18665944|P2|Post-treatment Follow-up Period|No progressive improvement|1
5410810|NCT02696798|18665945|P1|Post-treatment Follow-up Period|No progressive improvement|0
5410811|NCT02696798|18665943|P3|Post-treatment Follow-up Period|Physician Decision|0
5410812|NCT02696798|18665944|P2|Post-treatment Follow-up Period|Physician Decision|2
5410813|NCT02696798|18665945|P1|Post-treatment Follow-up Period|Physician Decision|0
5410814|NCT02696798|18665943|P3|Post-treatment Follow-up Period|Withdrawal by Subject|12
5410815|NCT02696798|18665944|P2|Post-treatment Follow-up Period|Withdrawal by Subject|8
5410816|NCT02696798|18665945|P1|Post-treatment Follow-up Period|Withdrawal by Subject|2
5410817|NCT02696798|18665943|P3|Post-treatment Follow-up Period|Lack of Efficacy|0
5410818|NCT02696798|18665944|P2|Post-treatment Follow-up Period|Lack of Efficacy|2
5410819|NCT02696798|18665945|P1|Post-treatment Follow-up Period|Lack of Efficacy|1
5410820|NCT02696798|18665943|P3|Post-treatment Follow-up Period|Lost to Follow-up|1
5410821|NCT02696798|18665944|P2|Post-treatment Follow-up Period|Lost to Follow-up|1
5410822|NCT02696798|18665945|P1|Post-treatment Follow-up Period|Lost to Follow-up|0
5410823|NCT02696798|18665943|P3|Post-treatment Follow-up Period|Adverse Event|6
5410824|NCT02696798|18665944|P2|Post-treatment Follow-up Period|Adverse Event|12
5410825|NCT02696798|18665945|P1|Post-treatment Follow-up Period|Adverse Event|2
5410826|NCT02696798|18665943|P3|Extended Treatment Period|Withdrawal by Subject|3
5410827|NCT02696798|18665944|P2|Extended Treatment Period|Withdrawal by Subject|2
5410828|NCT02696798|18665945|P1|Extended Treatment Period|Withdrawal by Subject|3
5410829|NCT02696798|18665943|P3|Extended Treatment Period|Physician Decision|0
5410830|NCT02696798|18665944|P2|Extended Treatment Period|Physician Decision|1
5410831|NCT02696798|18665945|P1|Extended Treatment Period|Physician Decision|0
5410832|NCT02696798|18665943|P3|Extended Treatment Period|Lost to Follow-up|0
5410833|NCT02696798|18665944|P2|Extended Treatment Period|Lost to Follow-up|0
5410834|NCT02696798|18665945|P1|Extended Treatment Period|Lost to Follow-up|1
5410835|NCT02696798|18665943|P3|Extended Treatment Period|Lack of Efficacy|2
5410836|NCT02696798|18665944|P2|Extended Treatment Period|Lack of Efficacy|2
5410837|NCT02696798|18665945|P1|Extended Treatment Period|Lack of Efficacy|7
5410838|NCT02696798|18665943|P3|Extended Treatment Period|Adverse Event|5
5410839|NCT02696798|18665944|P2|Extended Treatment Period|Adverse Event|4
5410840|NCT02696798|18665945|P1|Extended Treatment Period|Adverse Event|1
5410841|NCT02696798|18665943|P3|Blinded Treatment Dosing Period|Withdrawal by Subject|4
5410842|NCT02696798|18665944|P2|Blinded Treatment Dosing Period|Withdrawal by Subject|3
5410843|NCT02696798|18665945|P1|Blinded Treatment Dosing Period|Withdrawal by Subject|7
5410844|NCT02696798|18665943|P3|Blinded Treatment Dosing Period|Physician Decision|0
5410845|NCT02696798|18665944|P2|Blinded Treatment Dosing Period|Physician Decision|1
5410846|NCT02696798|18665945|P1|Blinded Treatment Dosing Period|Physician Decision|0
5410847|NCT02696798|18665943|P3|Blinded Treatment Dosing Period|Lost to Follow-up|0
5410848|NCT02696798|18665944|P2|Blinded Treatment Dosing Period|Lost to Follow-up|1
5410849|NCT02696798|18665945|P1|Blinded Treatment Dosing Period|Lost to Follow-up|0
5410850|NCT02696798|18665943|P3|Blinded Treatment Dosing Period|Lack of Efficacy|1
5410851|NCT02696798|18665944|P2|Blinded Treatment Dosing Period|Lack of Efficacy|1
5410935|NCT02696031|18666278|P1|Week 52|Pregnancy|0
5410852|NCT02696798|18665945|P1|Blinded Treatment Dosing Period|Lack of Efficacy|2
5410853|NCT02696798|18665943|P3|Blinded Treatment Dosing Period|Death|1
5410854|NCT02696798|18665944|P2|Blinded Treatment Dosing Period|Death|0
5410855|NCT02696798|18665945|P1|Blinded Treatment Dosing Period|Death|0
5410856|NCT02696798|18665943|P3|Blinded Treatment Dosing Period|Adverse Event|2
5410857|NCT02696798|18665944|P2|Blinded Treatment Dosing Period|Adverse Event|9
5410858|NCT02696798|18665945|P1|Blinded Treatment Dosing Period|Adverse Event|2
5410859|NCT02696785|18666042|P4|Follow-up Period|Withdrawal by Subject|4
5410860|NCT02696785|18666043|P3|Follow-up Period|Withdrawal by Subject|5
5410861|NCT02696785|18666044|P2|Follow-up Period|Withdrawal by Subject|0
5410862|NCT02696785|18666045|P1|Follow-up Period|Withdrawal by Subject|1
5410863|NCT02696785|18666042|P4|Follow-up Period|Lack of Efficacy|1
5410864|NCT02696785|18666043|P3|Follow-up Period|Lack of Efficacy|0
5410865|NCT02696785|18666044|P2|Follow-up Period|Lack of Efficacy|0
5410866|NCT02696785|18666045|P1|Follow-up Period|Lack of Efficacy|0
5410867|NCT02696785|18666042|P4|Follow-up Period|Lost to Follow-up|1
5410868|NCT02696785|18666043|P3|Follow-up Period|Lost to Follow-up|0
5410869|NCT02696785|18666044|P2|Follow-up Period|Lost to Follow-up|0
5410870|NCT02696785|18666045|P1|Follow-up Period|Lost to Follow-up|0
5410871|NCT02696785|18666042|P4|Follow-up Period|Adverse Event|2
5410872|NCT02696785|18666043|P3|Follow-up Period|Adverse Event|8
5410873|NCT02696785|18666044|P2|Follow-up Period|Adverse Event|0
5410874|NCT02696785|18666045|P1|Follow-up Period|Adverse Event|0
5410875|NCT02696785|18666042|P4|Extended Treatment Period|Withdrawal by Subject|5
5410876|NCT02696785|18666043|P3|Extended Treatment Period|Withdrawal by Subject|3
5410877|NCT02696785|18666044|P2|Extended Treatment Period|Withdrawal by Subject|2
5410878|NCT02696785|18666045|P1|Extended Treatment Period|Withdrawal by Subject|1
5410879|NCT02696785|18666042|P4|Extended Treatment Period|Lack of Efficacy|0
5410880|NCT02696785|18666043|P3|Extended Treatment Period|Lack of Efficacy|0
5410881|NCT02696785|18666044|P2|Extended Treatment Period|Lack of Efficacy|1
5410882|NCT02696785|18666045|P1|Extended Treatment Period|Lack of Efficacy|0
5410883|NCT02696785|18666042|P4|Extended Treatment Period|Adverse Event|1
5410884|NCT02696785|18666043|P3|Extended Treatment Period|Adverse Event|2
5410885|NCT02696785|18666044|P2|Extended Treatment Period|Adverse Event|3
5410886|NCT02696785|18666045|P1|Extended Treatment Period|Adverse Event|2
5410887|NCT02696785|18666042|P4|Washout Period|Lack of Efficacy|0
5410888|NCT02696785|18666043|P3|Washout Period|Lack of Efficacy|0
5410889|NCT02696785|18666044|P2|Washout Period|Lack of Efficacy|1
5410890|NCT02696785|18666045|P1|Washout Period|Lack of Efficacy|0
5410891|NCT02696785|18666042|P4|Washout Period|Withdrawal by Subject|0
5410892|NCT02696785|18666043|P3|Washout Period|Withdrawal by Subject|0
5410893|NCT02696785|18666044|P2|Washout Period|Withdrawal by Subject|1
5410894|NCT02696785|18666045|P1|Washout Period|Withdrawal by Subject|0
5410895|NCT02696785|18666042|P4|Blinded Treatment Period|Screen Failure|0
5410896|NCT02696785|18666043|P3|Blinded Treatment Period|Screen Failure|0
5410897|NCT02696785|18666044|P2|Blinded Treatment Period|Screen Failure|0
5410898|NCT02696785|18666045|P1|Blinded Treatment Period|Screen Failure|1
5410899|NCT02696785|18666042|P4|Blinded Treatment Period|Lack of Efficacy|1
5410900|NCT02696785|18666043|P3|Blinded Treatment Period|Lack of Efficacy|0
5410901|NCT02696785|18666044|P2|Blinded Treatment Period|Lack of Efficacy|0
5410902|NCT02696785|18666045|P1|Blinded Treatment Period|Lack of Efficacy|0
5410903|NCT02696785|18666042|P4|Blinded Treatment Period|Withdrawal by Subject|2
5410904|NCT02696785|18666043|P3|Blinded Treatment Period|Withdrawal by Subject|1
5410905|NCT02696785|18666044|P2|Blinded Treatment Period|Withdrawal by Subject|1
5410906|NCT02696785|18666045|P1|Blinded Treatment Period|Withdrawal by Subject|0
5410907|NCT02696785|18666042|P4|Blinded Treatment Period|Adverse Event|0
5410908|NCT02696785|18666043|P3|Blinded Treatment Period|Adverse Event|3
5410909|NCT02696785|18666044|P2|Blinded Treatment Period|Adverse Event|1
5410910|NCT02696785|18666045|P1|Blinded Treatment Period|Adverse Event|0
5410911|NCT02696434|18666165|P2|Overall Study|Physician Decision|1
5410912|NCT02696434|18666166|P1|Overall Study|Physician Decision|0
5410913|NCT02696434|18666165|P2|Overall Study|Withdrawal by Subject|12
5410914|NCT02696434|18666166|P1|Overall Study|Withdrawal by Subject|14
5410915|NCT02696434|18666165|P2|Overall Study|Lost to Follow-up|4
5410916|NCT02696434|18666166|P1|Overall Study|Lost to Follow-up|5
5410917|NCT02696434|18666165|P2|Overall Study|Adverse Event|1
5410918|NCT02696434|18666166|P1|Overall Study|Adverse Event|3
5410919|NCT02696317|18666184|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
5410920|NCT02696317|18666185|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
5410921|NCT02696317|18666184|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
5410922|NCT02696317|18666185|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
5410923|NCT02696226|18666229|P4|Overall Study|Study terminated - lack of enrollment|0
5410924|NCT02696226|18666230|P3|Overall Study|Study terminated - lack of enrollment|2
5410925|NCT02696226|18666231|P2|Overall Study|Study terminated - lack of enrollment|0
5410926|NCT02696226|18666232|P1|Overall Study|Study terminated - lack of enrollment|1
5410927|NCT02696031|18666276|P3|Week 52|Withdrawal by Subject|9
5410928|NCT02696031|18666277|P2|Week 52|Withdrawal by Subject|3
5410929|NCT02696031|18666278|P1|Week 52|Withdrawal by Subject|12
5410930|NCT02696031|18666276|P3|Week 52|Protocol Violation|0
5410931|NCT02696031|18666277|P2|Week 52|Protocol Violation|0
5410932|NCT02696031|18666278|P1|Week 52|Protocol Violation|1
5410933|NCT02696031|18666276|P3|Week 52|Pregnancy|0
5410934|NCT02696031|18666277|P2|Week 52|Pregnancy|2
5410936|NCT02696031|18666276|P3|Week 52|Physician Decision|2
5410937|NCT02696031|18666277|P2|Week 52|Physician Decision|1
5410938|NCT02696031|18666278|P1|Week 52|Physician Decision|1
5410939|NCT02696031|18666276|P3|Week 52|Lost to Follow-up|1
5410940|NCT02696031|18666277|P2|Week 52|Lost to Follow-up|1
5410941|NCT02696031|18666278|P1|Week 52|Lost to Follow-up|1
5410942|NCT02696031|18666276|P3|Week 52|Lack of Efficacy|11
5410943|NCT02696031|18666277|P2|Week 52|Lack of Efficacy|7
5410944|NCT02696031|18666278|P1|Week 52|Lack of Efficacy|10
5410945|NCT02696031|18666276|P3|Week 52|Adverse Event|3
5410946|NCT02696031|18666277|P2|Week 52|Adverse Event|5
5410947|NCT02696031|18666278|P1|Week 52|Adverse Event|4
5410948|NCT02696031|18666276|P3|Week 24|Withdrawal by Subject|5
5410949|NCT02696031|18666277|P2|Week 24|Withdrawal by Subject|1
5410950|NCT02696031|18666278|P1|Week 24|Withdrawal by Subject|4
5410951|NCT02696031|18666276|P3|Week 24|Protocol Violation|0
5410952|NCT02696031|18666277|P2|Week 24|Protocol Violation|0
5410953|NCT02696031|18666278|P1|Week 24|Protocol Violation|1
5410954|NCT02696031|18666276|P3|Week 24|Physician Decision|1
5410955|NCT02696031|18666277|P2|Week 24|Physician Decision|0
5410956|NCT02696031|18666278|P1|Week 24|Physician Decision|1
5410957|NCT02696031|18666276|P3|Week 24|Lost to Follow-up|1
5410958|NCT02696031|18666277|P2|Week 24|Lost to Follow-up|1
5410959|NCT02696031|18666278|P1|Week 24|Lost to Follow-up|0
5410960|NCT02696031|18666276|P3|Week 24|Lack of Efficacy|2
5410961|NCT02696031|18666277|P2|Week 24|Lack of Efficacy|1
5410962|NCT02696031|18666278|P1|Week 24|Lack of Efficacy|2
5410963|NCT02696031|18666276|P3|Week 24|Adverse Event|2
5410964|NCT02696031|18666277|P2|Week 24|Adverse Event|4
5410965|NCT02696031|18666278|P1|Week 24|Adverse Event|2
5410966|NCT02695719|18666292|P2|Overall Study|Voluntary Withdrawal|0
5410967|NCT02695719|18666293|P1|Overall Study|Voluntary Withdrawal|1
5410968|NCT02695719|18666292|P2|Overall Study|Significant Protocol Deviation|1
5410969|NCT02695719|18666293|P1|Overall Study|Significant Protocol Deviation|0
5410970|NCT02695719|18666292|P2|Overall Study|Pretreatment Event/Adverse Event|9
5410971|NCT02695719|18666293|P1|Overall Study|Pretreatment Event/Adverse Event|2
5410972|NCT02695628|18666311|P1|Overall Study|Withdrawal by Subject|1
5410973|NCT02695537|18666317|P1|Overall Study|Protocol Violation|3
5410974|NCT02695537|18666317|P1|Overall Study|Withdrawal by Subject|4
5410975|NCT02695537|18666317|P1|Overall Study|Lack of Efficacy|28
5410976|NCT02695537|18666317|P1|Overall Study|Adverse Event|3
5410977|NCT02695524|18666327|P2|Overall Study|Death|1
5410978|NCT02695524|18666328|P1|Overall Study|Death|0
5410979|NCT02695524|18666327|P2|Overall Study|Lost to Follow-up|2
5410980|NCT02695524|18666328|P1|Overall Study|Lost to Follow-up|3
5410981|NCT02695420|18666357|P4|Overall Study|Death|0
5410982|NCT02695420|18666358|P3|Overall Study|Death|0
5410983|NCT02695420|18666359|P2|Overall Study|Death|1
5410984|NCT02695420|18666360|P1|Overall Study|Death|0
5410985|NCT02695329|18666382|P2|Overall Study|Poor X-ray quality for measurement|5
5410986|NCT02695329|18666383|P1|Overall Study|Poor X-ray quality for measurement|4
5410987|NCT02695329|18666382|P2|Overall Study|Adverse Event|0
5410988|NCT02695329|18666383|P1|Overall Study|Adverse Event|1
5410989|NCT02694978|18666403|P2|Overall Study|Other-Withdrew prior to dosing|8
5410990|NCT02694978|18666404|P1|Overall Study|Other-Withdrew prior to dosing|9
5410991|NCT02694978|18666403|P2|Overall Study|Other-Personal reasons|3
5410992|NCT02694978|18666404|P1|Overall Study|Other-Personal reasons|3
5410993|NCT02694978|18666403|P2|Overall Study|Other-Protocol noncompliant|1
5410994|NCT02694978|18666404|P1|Overall Study|Other-Protocol noncompliant|2
5410995|NCT02694978|18666403|P2|Overall Study|Other-Unable to be reached|1
5410996|NCT02694978|18666404|P1|Overall Study|Other-Unable to be reached|0
5410997|NCT02694978|18666403|P2|Overall Study|Other-Investigator's decision|0
5410998|NCT02694978|18666404|P1|Overall Study|Other-Investigator's decision|1
5410999|NCT02694978|18666403|P2|Overall Study|Other-Decision of Participant|1
5411000|NCT02694978|18666404|P1|Overall Study|Other-Decision of Participant|6
5411001|NCT02694978|18666403|P2|Overall Study|Death|1
5411002|NCT02694978|18666404|P1|Overall Study|Death|4
5411003|NCT02694978|18666403|P2|Overall Study|Lost to Follow-up|17
5411004|NCT02694978|18666404|P1|Overall Study|Lost to Follow-up|14
5411005|NCT02694978|18666403|P2|Overall Study|Withdrawal by Subject|19
5411006|NCT02694978|18666404|P1|Overall Study|Withdrawal by Subject|22
5411007|NCT02694978|18666403|P2|Overall Study|Adverse Event|9
5411008|NCT02694978|18666404|P1|Overall Study|Adverse Event|10
5411009|NCT02694757|18666425|P1|Overall Study|Lack of Efficacy|3
5411010|NCT02694744|18666431|P2|Overall Study|Taking potassium supplement: exclusion 6|1
5411011|NCT02694744|18666432|P1|Overall Study|Taking potassium supplement: exclusion 6|0
5411012|NCT02694744|18666431|P2|Overall Study|Lost to Follow-up|0
5411013|NCT02694744|18666432|P1|Overall Study|Lost to Follow-up|1
5411014|NCT02694744|18666431|P2|Overall Study|Physician Decision|2
5411015|NCT02694744|18666432|P1|Overall Study|Physician Decision|1
5411016|NCT02694744|18666431|P2|Overall Study|Withdrawal by Subject|1
5411017|NCT02694744|18666432|P1|Overall Study|Withdrawal by Subject|2
5411018|NCT02694744|18666431|P2|Overall Study|Adverse Event|1
5411019|NCT02694744|18666432|P1|Overall Study|Adverse Event|2
5411020|NCT02694718|18666440|P1|Overall Study|Withdrawal by Subject|1
5411021|NCT02694718|18666440|P1|Overall Study|Death|1
5411022|NCT02694562|18666458|P1|Overall Study|Physician Decision|1
5411023|NCT02694562|18666458|P1|Overall Study|Screen Failure|2
5411024|NCT02694562|18666458|P1|Overall Study|Lost to Follow-up|3
5411025|NCT02694562|18666458|P1|Overall Study|Protocol Violation|4
5411026|NCT02694562|18666458|P1|Overall Study|Death|8
5411027|NCT02694549|18666467|P1|Overall Study|screen failures|2
5411028|NCT02694536|18666473|P1|Overall Study|Other|22
5411029|NCT02694536|18666473|P1|Overall Study|Death|8
5411030|NCT02694536|18666473|P1|Overall Study|Withdrawal by Subject|8
5411031|NCT02694536|18666473|P1|Overall Study|Study Drug-Related Adverse Event|1
5411032|NCT02694536|18666473|P1|Overall Study|Lost to Follow-up|1
5411033|NCT02694536|18666473|P1|Overall Study|Progressive Disease|40
5411034|NCT02694523|18666484|P7|Part B|Other|1
5411035|NCT02694523|18666485|P6|Part B|Other|0
5411036|NCT02694523|18666486|P5|Part B|Other|0
5411037|NCT02694523|18666487|P4|Part B|Other|0
5411038|NCT02694523|18666488|P3|Part B|Other|1
5411039|NCT02694523|18666489|P2|Part B|Other|0
5411040|NCT02694523|18666490|P1|Part B|Other|0
5411041|NCT02694523|18666484|P7|Part B|Withdrawal by Subject|0
5411042|NCT02694523|18666485|P6|Part B|Withdrawal by Subject|3
5411043|NCT02694523|18666486|P5|Part B|Withdrawal by Subject|1
5411044|NCT02694523|18666487|P4|Part B|Withdrawal by Subject|0
5411045|NCT02694523|18666488|P3|Part B|Withdrawal by Subject|9
5411046|NCT02694523|18666489|P2|Part B|Withdrawal by Subject|0
5411047|NCT02694523|18666490|P1|Part B|Withdrawal by Subject|0
5411048|NCT02694523|18666484|P7|Part B|Lost to Follow-up|1
5411049|NCT02694523|18666485|P6|Part B|Lost to Follow-up|0
5411050|NCT02694523|18666486|P5|Part B|Lost to Follow-up|2
5411051|NCT02694523|18666487|P4|Part B|Lost to Follow-up|3
5411052|NCT02694523|18666488|P3|Part B|Lost to Follow-up|2
5411053|NCT02694523|18666489|P2|Part B|Lost to Follow-up|0
5411054|NCT02694523|18666490|P1|Part B|Lost to Follow-up|0
5411055|NCT02694523|18666484|P7|Part B|Protocol Violation|0
5411056|NCT02694523|18666485|P6|Part B|Protocol Violation|0
5411057|NCT02694523|18666486|P5|Part B|Protocol Violation|0
5411058|NCT02694523|18666487|P4|Part B|Protocol Violation|0
5411059|NCT02694523|18666488|P3|Part B|Protocol Violation|1
5411060|NCT02694523|18666489|P2|Part B|Protocol Violation|0
5411061|NCT02694523|18666490|P1|Part B|Protocol Violation|0
5411062|NCT02694523|18666484|P7|Part B|Adverse Event|0
5411063|NCT02694523|18666485|P6|Part B|Adverse Event|2
5411064|NCT02694523|18666486|P5|Part B|Adverse Event|1
5411065|NCT02694523|18666487|P4|Part B|Adverse Event|1
5411066|NCT02694523|18666488|P3|Part B|Adverse Event|7
5411067|NCT02694523|18666489|P2|Part B|Adverse Event|0
5411068|NCT02694523|18666490|P1|Part B|Adverse Event|0
5411069|NCT02694523|18666484|P7|Part A|Other|0
5411070|NCT02694523|18666485|P6|Part A|Other|0
5411071|NCT02694523|18666486|P5|Part A|Other|0
5411072|NCT02694523|18666487|P4|Part A|Other|0
5411073|NCT02694523|18666488|P3|Part A|Other|0
5411074|NCT02694523|18666489|P2|Part A|Other|1
5411075|NCT02694523|18666490|P1|Part A|Other|1
5411076|NCT02694523|18666484|P7|Part A|Withdrawal by Subject|0
5411077|NCT02694523|18666485|P6|Part A|Withdrawal by Subject|0
5411078|NCT02694523|18666486|P5|Part A|Withdrawal by Subject|0
5411079|NCT02694523|18666487|P4|Part A|Withdrawal by Subject|0
5411080|NCT02694523|18666488|P3|Part A|Withdrawal by Subject|0
5411081|NCT02694523|18666489|P2|Part A|Withdrawal by Subject|1
5411082|NCT02694523|18666490|P1|Part A|Withdrawal by Subject|3
5411083|NCT02694523|18666484|P7|Part A|Lost to Follow-up|0
5411084|NCT02694523|18666485|P6|Part A|Lost to Follow-up|0
5411085|NCT02694523|18666486|P5|Part A|Lost to Follow-up|0
5411086|NCT02694523|18666487|P4|Part A|Lost to Follow-up|0
5411087|NCT02694523|18666488|P3|Part A|Lost to Follow-up|0
5411088|NCT02694523|18666489|P2|Part A|Lost to Follow-up|2
5411089|NCT02694523|18666490|P1|Part A|Lost to Follow-up|1
5411090|NCT02694523|18666484|P7|Part A|Protocol Violation|0
5411091|NCT02694523|18666485|P6|Part A|Protocol Violation|0
5411092|NCT02694523|18666486|P5|Part A|Protocol Violation|0
5411093|NCT02694523|18666487|P4|Part A|Protocol Violation|0
5411094|NCT02694523|18666488|P3|Part A|Protocol Violation|0
5411095|NCT02694523|18666489|P2|Part A|Protocol Violation|0
5411096|NCT02694523|18666490|P1|Part A|Protocol Violation|1
5411097|NCT02694523|18666484|P7|Part A|Adverse Event|0
5411098|NCT02694523|18666485|P6|Part A|Adverse Event|0
5411099|NCT02694523|18666486|P5|Part A|Adverse Event|0
5411100|NCT02694523|18666487|P4|Part A|Adverse Event|0
5411101|NCT02694523|18666488|P3|Part A|Adverse Event|0
5411102|NCT02694523|18666489|P2|Part A|Adverse Event|3
5411103|NCT02694523|18666490|P1|Part A|Adverse Event|7
5411104|NCT02694328|18666520|P2|Overall Study|Abnormal Laboratory Value|3
5411105|NCT02694328|18666521|P1|Overall Study|Abnormal Laboratory Value|0
5411106|NCT02694328|18666520|P2|Overall Study|Protocol Violation|5
5411107|NCT02694328|18666521|P1|Overall Study|Protocol Violation|6
5411108|NCT02694328|18666520|P2|Overall Study|Pregnancy|1
5411109|NCT02694328|18666521|P1|Overall Study|Pregnancy|1
5411110|NCT02694328|18666520|P2|Overall Study|Lack of Efficacy|2
5411111|NCT02694328|18666521|P1|Overall Study|Lack of Efficacy|1
5411112|NCT02694328|18666520|P2|Overall Study|Incarceration|1
5411113|NCT02694328|18666521|P1|Overall Study|Incarceration|1
5411114|NCT02694328|18666520|P2|Overall Study|Noncompliant with study drug|8
5411115|NCT02694328|18666521|P1|Overall Study|Noncompliant with study drug|11
5411116|NCT02694328|18666520|P2|Overall Study|Lost to Follow-up|22
5411117|NCT02694328|18666521|P1|Overall Study|Lost to Follow-up|26
5411118|NCT02694328|18666520|P2|Overall Study|Withdrawal by Subject|23
5411119|NCT02694328|18666521|P1|Overall Study|Withdrawal by Subject|27
5411120|NCT02694328|18666520|P2|Overall Study|Adverse Event|33
5411121|NCT02694328|18666521|P1|Overall Study|Adverse Event|27
5411122|NCT02693834|18666543|P2|Week 2 Practice|Adverse Event|1
5411123|NCT02693834|18666544|P1|Week 2 Practice|Adverse Event|0
5411124|NCT02693834|18666543|P2|Baseline Measurement|Adverse Event|0
5411125|NCT02693834|18666544|P1|Baseline Measurement|Adverse Event|1
5411126|NCT02693834|18666543|P2|Baseline Measurement|Withdrawal by Subject|0
5411127|NCT02693834|18666544|P1|Baseline Measurement|Withdrawal by Subject|1
5411128|NCT02693743|18666554|P2|Overall Study|Physician Decision|0
5411129|NCT02693743|18666555|P1|Overall Study|Physician Decision|1
5411130|NCT02693691|18666586|P1|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
5411131|NCT02693691|18666586|P1|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
5411132|NCT02693691|18666586|P1|Extended Follow-Up (Until Last pt 12M)|Death|12
5411133|NCT02693691|18666586|P1|Primary Endpoint Analysis (First 12M)|Adverse Event|1
5411134|NCT02693691|18666586|P1|Primary Endpoint Analysis (First 12M)|Physician Decision|7
5411135|NCT02693691|18666586|P1|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
5411136|NCT02693691|18666586|P1|Primary Endpoint Analysis (First 12M)|Death|30
5411137|NCT02693418|18666598|P5|Overall Study|Menses during study period|0
5411138|NCT02693418|18666599|P4|Overall Study|Menses during study period|0
5411139|NCT02693418|18666600|P3|Overall Study|Menses during study period|2
5411140|NCT02693418|18666601|P2|Overall Study|Menses during study period|0
5411141|NCT02693418|18666602|P1|Overall Study|Menses during study period|0
5411142|NCT02693418|18666598|P5|Overall Study|Lost to Follow-up|0
5411143|NCT02693418|18666599|P4|Overall Study|Lost to Follow-up|0
5411144|NCT02693418|18666600|P3|Overall Study|Lost to Follow-up|0
5411145|NCT02693418|18666601|P2|Overall Study|Lost to Follow-up|2
5411146|NCT02693418|18666602|P1|Overall Study|Lost to Follow-up|1
5411147|NCT02693171|18666619|P1|Overall Study|Discontinuation of Study by Sponsor|8
5411148|NCT02693171|18666619|P1|Overall Study|Adverse Event|1
5411149|NCT02693106|18666651|P1|Overall Study|No time|3
5411150|NCT02693002|18666663|P2|Overall Study|Withdrawal by Subject|0
5411151|NCT02693002|18666664|P1|Overall Study|Withdrawal by Subject|1
5411152|NCT02692716|18666687|P2|Overall Study|Withdrawal by Subject|1
5411153|NCT02692716|18666688|P1|Overall Study|Withdrawal by Subject|3
5411154|NCT02692716|18666687|P2|Overall Study|Lost to Follow-up|5
5411155|NCT02692716|18666688|P1|Overall Study|Lost to Follow-up|2
5411156|NCT02692703|18666728|P1|Overall Study|Other|1
5411157|NCT02692703|18666728|P1|Overall Study|Lost to Follow-up|1
5411158|NCT02692560|18666736|P2|Overall Study|Withdrawal by Subject|6
5411159|NCT02692560|18666737|P1|Overall Study|Withdrawal by Subject|0
5411160|NCT02692482|18666777|P2|Overall Study|Withdrawal by Subject|2
5411161|NCT02692482|18666778|P1|Overall Study|Withdrawal by Subject|1
5411162|NCT02692482|18666777|P2|Overall Study|Death|2
5411163|NCT02692482|18666778|P1|Overall Study|Death|2
5411164|NCT02692417|18666792|P2|Overall Study|Adverse Event|0
5411165|NCT02692417|18666793|P1|Overall Study|Adverse Event|1
5411166|NCT02692417|18666792|P2|Overall Study|Withdrawal by Subject|1
5411167|NCT02692417|18666793|P1|Overall Study|Withdrawal by Subject|5
5411168|NCT02692235|18666805|P2|Overall Study|Adverse Event|2
5411169|NCT02692235|18666806|P1|Overall Study|Adverse Event|1
5411170|NCT02692235|18666805|P2|Overall Study|Withdrawal by Subject|1
5411171|NCT02692235|18666806|P1|Overall Study|Withdrawal by Subject|2
5411172|NCT02692040|18666837|P17|Overall Study|Adverse Event|0
5411173|NCT02692040|18666838|P16|Overall Study|Adverse Event|1
5411174|NCT02692040|18666839|P15|Overall Study|Adverse Event|1
5411175|NCT02692040|18666840|P14|Overall Study|Adverse Event|3
5411176|NCT02692040|18666841|P13|Overall Study|Adverse Event|0
5411177|NCT02692040|18666842|P12|Overall Study|Adverse Event|0
5411178|NCT02692040|18666843|P11|Overall Study|Adverse Event|0
5411179|NCT02692040|18666844|P10|Overall Study|Adverse Event|0
5411180|NCT02692040|18666845|P9|Overall Study|Adverse Event|0
5411181|NCT02692040|18666846|P8|Overall Study|Adverse Event|0
5411182|NCT02692040|18666847|P7|Overall Study|Adverse Event|0
5411183|NCT02692040|18666848|P6|Overall Study|Adverse Event|0
5411184|NCT02692040|18666849|P5|Overall Study|Adverse Event|0
5411185|NCT02692040|18666850|P4|Overall Study|Adverse Event|0
5411186|NCT02692040|18666851|P3|Overall Study|Adverse Event|0
5411187|NCT02692040|18666852|P2|Overall Study|Adverse Event|0
5411188|NCT02692040|18666853|P1|Overall Study|Adverse Event|0
5411189|NCT02692040|18666837|P17|Overall Study|Protocol Violation|0
5411190|NCT02692040|18666838|P16|Overall Study|Protocol Violation|0
5411191|NCT02692040|18666839|P15|Overall Study|Protocol Violation|0
5411192|NCT02692040|18666840|P14|Overall Study|Protocol Violation|0
5411193|NCT02692040|18666841|P13|Overall Study|Protocol Violation|1
5411194|NCT02692040|18666842|P12|Overall Study|Protocol Violation|0
5411195|NCT02692040|18666843|P11|Overall Study|Protocol Violation|0
5411196|NCT02692040|18666844|P10|Overall Study|Protocol Violation|0
5411197|NCT02692040|18666845|P9|Overall Study|Protocol Violation|0
5411198|NCT02692040|18666846|P8|Overall Study|Protocol Violation|0
5411199|NCT02692040|18666847|P7|Overall Study|Protocol Violation|0
5411200|NCT02692040|18666848|P6|Overall Study|Protocol Violation|0
5411201|NCT02692040|18666849|P5|Overall Study|Protocol Violation|0
5411202|NCT02692040|18666850|P4|Overall Study|Protocol Violation|0
5411203|NCT02692040|18666851|P3|Overall Study|Protocol Violation|0
5411204|NCT02692040|18666852|P2|Overall Study|Protocol Violation|0
5411205|NCT02692040|18666853|P1|Overall Study|Protocol Violation|0
5411206|NCT02691936|18666945|P2|Overall Study|Withdrawal by Subject|5
5411207|NCT02691936|18666946|P1|Overall Study|Withdrawal by Subject|2
5411208|NCT02691741|18666968|P2|Overall Study|Withdrawal by Subject|4
5411209|NCT02691741|18666969|P1|Overall Study|Withdrawal by Subject|0
5411210|NCT02691741|18666968|P2|Overall Study|Physician Decision|1
5411211|NCT02691741|18666969|P1|Overall Study|Physician Decision|0
5411212|NCT02691741|18666968|P2|Overall Study|Lost to Follow-up|0
5411213|NCT02691741|18666969|P1|Overall Study|Lost to Follow-up|1
5411214|NCT02691741|18666968|P2|Overall Study|Adverse Event|2
5411215|NCT02691741|18666969|P1|Overall Study|Adverse Event|0
5411216|NCT02691702|18667009|P11|Overall Study|Protocol Violation|0
5411217|NCT02691702|18667010|P10|Overall Study|Protocol Violation|2
5411218|NCT02691702|18667011|P9|Overall Study|Protocol Violation|0
5411219|NCT02691702|18667012|P8|Overall Study|Protocol Violation|0
5411220|NCT02691702|18667013|P7|Overall Study|Protocol Violation|0
5411221|NCT02691702|18667014|P6|Overall Study|Protocol Violation|0
5411222|NCT02691702|18667015|P5|Overall Study|Protocol Violation|0
5411223|NCT02691702|18667016|P4|Overall Study|Protocol Violation|0
5411224|NCT02691702|18667017|P3|Overall Study|Protocol Violation|0
5411225|NCT02691702|18667018|P2|Overall Study|Protocol Violation|0
5411226|NCT02691702|18667019|P1|Overall Study|Protocol Violation|0
5411227|NCT02691702|18667009|P11|Overall Study|Other|0
5411228|NCT02691702|18667010|P10|Overall Study|Other|0
5411229|NCT02691702|18667011|P9|Overall Study|Other|1
5411230|NCT02691702|18667012|P8|Overall Study|Other|0
5411231|NCT02691702|18667013|P7|Overall Study|Other|1
5411232|NCT02691702|18667014|P6|Overall Study|Other|0
5411233|NCT02691702|18667015|P5|Overall Study|Other|0
5411234|NCT02691702|18667016|P4|Overall Study|Other|0
5411235|NCT02691702|18667017|P3|Overall Study|Other|0
5411236|NCT02691702|18667018|P2|Overall Study|Other|0
5411237|NCT02691702|18667019|P1|Overall Study|Other|0
5411238|NCT02691702|18667009|P11|Overall Study|Withdrawal by Subject|0
5411239|NCT02691702|18667010|P10|Overall Study|Withdrawal by Subject|0
5411240|NCT02691702|18667011|P9|Overall Study|Withdrawal by Subject|0
5411241|NCT02691702|18667012|P8|Overall Study|Withdrawal by Subject|0
5411242|NCT02691702|18667013|P7|Overall Study|Withdrawal by Subject|2
5411243|NCT02691702|18667014|P6|Overall Study|Withdrawal by Subject|1
5411244|NCT02691702|18667015|P5|Overall Study|Withdrawal by Subject|0
5411245|NCT02691702|18667016|P4|Overall Study|Withdrawal by Subject|0
5411246|NCT02691702|18667017|P3|Overall Study|Withdrawal by Subject|0
5411247|NCT02691702|18667018|P2|Overall Study|Withdrawal by Subject|1
5411248|NCT02691702|18667019|P1|Overall Study|Withdrawal by Subject|1
5411249|NCT02691702|18667009|P11|Overall Study|Lost to Follow-up|1
5411250|NCT02691702|18667010|P10|Overall Study|Lost to Follow-up|0
5411251|NCT02691702|18667011|P9|Overall Study|Lost to Follow-up|0
5411252|NCT02691702|18667012|P8|Overall Study|Lost to Follow-up|0
5411253|NCT02691702|18667013|P7|Overall Study|Lost to Follow-up|0
5411254|NCT02691702|18667014|P6|Overall Study|Lost to Follow-up|2
5411255|NCT02691702|18667015|P5|Overall Study|Lost to Follow-up|0
5411256|NCT02691702|18667016|P4|Overall Study|Lost to Follow-up|0
5411257|NCT02691702|18667017|P3|Overall Study|Lost to Follow-up|1
5411258|NCT02691702|18667018|P2|Overall Study|Lost to Follow-up|0
5411259|NCT02691702|18667019|P1|Overall Study|Lost to Follow-up|0
5411260|NCT02691702|18667009|P11|Overall Study|Adverse Event|1
5411261|NCT02691702|18667010|P10|Overall Study|Adverse Event|0
5411262|NCT02691702|18667011|P9|Overall Study|Adverse Event|1
5411263|NCT02691702|18667012|P8|Overall Study|Adverse Event|0
5411264|NCT02691702|18667013|P7|Overall Study|Adverse Event|0
5411265|NCT02691702|18667014|P6|Overall Study|Adverse Event|0
5411266|NCT02691702|18667015|P5|Overall Study|Adverse Event|0
5411267|NCT02691702|18667016|P4|Overall Study|Adverse Event|0
5411268|NCT02691702|18667017|P3|Overall Study|Adverse Event|0
5411269|NCT02691702|18667018|P2|Overall Study|Adverse Event|0
5411270|NCT02691702|18667019|P1|Overall Study|Adverse Event|1
5411271|NCT02691572|18667305|P2|Overall Study|Protocol Violation|1
5411272|NCT02691572|18667306|P1|Overall Study|Protocol Violation|0
5411273|NCT02691572|18667305|P2|Overall Study|Withdrawal by Subject|0
5411274|NCT02691572|18667306|P1|Overall Study|Withdrawal by Subject|1
5411275|NCT02691507|18667314|P2|Overall Study|Missed Visit 3|1
5411276|NCT02691507|18667315|P1|Overall Study|Missed Visit 3|0
5411277|NCT02691494|18667448|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
5411278|NCT02691494|18667449|P2|Post-Treatment Follow-Up Period|Non-Compliance|1
5411279|NCT02691494|18667450|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
5411280|NCT02691494|18667448|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
5411281|NCT02691494|18667449|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
5411282|NCT02691494|18667450|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
5411283|NCT02691494|18667448|P3|Post-Treatment Follow-Up Period|Other|1
5411284|NCT02691494|18667449|P2|Post-Treatment Follow-Up Period|Other|1
5411285|NCT02691494|18667450|P1|Post-Treatment Follow-Up Period|Other|2
5411286|NCT02691494|18667448|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
5411287|NCT02691494|18667449|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5411288|NCT02691494|18667450|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5411289|NCT02691494|18667448|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
5411290|NCT02691494|18667449|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
5411291|NCT02691494|18667450|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
5411292|NCT02691468|18667478|P2|Overall Study|Failure to advance FOB|0
5411293|NCT02691468|18667479|P1|Overall Study|Failure to advance FOB|2
5411294|NCT02691468|18667478|P2|Overall Study|Lost to Follow-up|1
5411295|NCT02691468|18667479|P1|Overall Study|Lost to Follow-up|2
5411296|NCT02691468|18667478|P2|Overall Study|Bronchial blocker use|1
5411297|NCT02691468|18667479|P1|Overall Study|Bronchial blocker use|2
5411298|NCT02691013|18667540|P2|Overall Study|Withdrawal by Subject|0
5411299|NCT02691013|18667541|P1|Overall Study|Withdrawal by Subject|3
5411300|NCT02690974|18667555|P1|Overall Study|Protocol Deviation|1
5411301|NCT02690974|18667555|P1|Overall Study|Protocol-defined stopping criteria|1
5411302|NCT02690974|18667555|P1|Overall Study|Non-compliance with study treatment|1
5411303|NCT02690974|18667555|P1|Overall Study|Physician Decision|2
5411304|NCT02690974|18667555|P1|Overall Study|Withdrawal of Informed Consent|3
5411305|NCT02690974|18667555|P1|Overall Study|Lost to Follow-up|3
5411306|NCT02690974|18667555|P1|Overall Study|Subject/guardian decision|4
5411307|NCT02690974|18667555|P1|Overall Study|Death|9
5411308|NCT02690974|18667555|P1|Overall Study|Adverse Event|16
5411309|NCT02690727|18667596|P2|Overall Study|Adverse Event|2
5411310|NCT02690727|18667597|P1|Overall Study|Adverse Event|2
5411311|NCT02690701|18667609|P2|Treatment Period 2|Protocol Violation|1
5411312|NCT02690701|18667610|P1|Treatment Period 2|Protocol Violation|0
5411313|NCT02690701|18667609|P2|Treatment Period 2|Withdrawal by Subject|2
5411314|NCT02690701|18667610|P1|Treatment Period 2|Withdrawal by Subject|0
5411315|NCT02690701|18667609|P2|Treatment Period 2|Lost to Follow-up|2
5411316|NCT02690701|18667610|P1|Treatment Period 2|Lost to Follow-up|0
5411317|NCT02690701|18667609|P2|Treatment Period 2|Lack of Efficacy|0
5411318|NCT02690701|18667610|P1|Treatment Period 2|Lack of Efficacy|1
5411319|NCT02690701|18667609|P2|Treatment Period 2|Adverse Event|0
5411320|NCT02690701|18667610|P1|Treatment Period 2|Adverse Event|2
5411321|NCT02690701|18667609|P2|Treatment Period 1|Withdrawal by Subject|1
5411322|NCT02690701|18667610|P1|Treatment Period 1|Withdrawal by Subject|0
5411323|NCT02690701|18667609|P2|Treatment Period 1|Adverse Event|2
5411324|NCT02690701|18667610|P1|Treatment Period 1|Adverse Event|2
5411325|NCT02690207|18667675|P1|Overall Study|Other reasons for withdrawal|23
5411326|NCT02690207|18667675|P1|Overall Study|Suspected HZ Episode|1
5411327|NCT02690207|18667675|P1|Overall Study|Migrated/moved from study area|5
5411328|NCT02690207|18667675|P1|Overall Study|Non-serious Adverse Event|18
5411329|NCT02690207|18667675|P1|Overall Study|Serious adverse event|110
5411330|NCT02690207|18667675|P1|Overall Study|Protocol Violation|2
5411331|NCT02690207|18667675|P1|Overall Study|Withdrawal by Subject|46
5411332|NCT02690207|18667675|P1|Overall Study|Lost to Follow-up|48
5411333|NCT02690194|18667685|P3|Overall Study|Withdrawal by Subject|0
5411334|NCT02690194|18667686|P2|Overall Study|Withdrawal by Subject|4
5411335|NCT02690194|18667687|P1|Overall Study|Withdrawal by Subject|1
5411336|NCT02689804|18667894|P2|Overall Study|Withdrawal by Subject|0
5411337|NCT02689804|18667895|P1|Overall Study|Withdrawal by Subject|2
5411338|NCT02689492|18667921|P1|Overall Study|Other than listed|1
5411339|NCT02689492|18667921|P1|Overall Study|Withdrawal/ Physician's Decision|1
5411340|NCT02689492|18667921|P1|Overall Study|Withdrawal/Loss To Follow-Up|1
5411341|NCT02689492|18667921|P1|Overall Study|Physician Decision|2
5411342|NCT02689492|18667921|P1|Overall Study|Death|9
5411343|NCT02689492|18667921|P1|Overall Study|Withdrawal by Subject|11
5411344|NCT02689492|18667921|P1|Overall Study|Lost to Follow-up|61
5411345|NCT02689219|18667937|P2|Overall Study|Disease Progression|6
5411346|NCT02689219|18667938|P1|Overall Study|Disease Progression|10
5411347|NCT02689219|18667937|P2|Overall Study|Death|1
5411348|NCT02689219|18667938|P1|Overall Study|Death|1
5411349|NCT02689206|18667955|P5|Overall Study|Withdrawal by Subject|0
5411350|NCT02689206|18667956|P4|Overall Study|Withdrawal by Subject|0
5411351|NCT02689206|18667957|P3|Overall Study|Withdrawal by Subject|1
5411352|NCT02689206|18667958|P2|Overall Study|Withdrawal by Subject|0
5411353|NCT02689206|18667959|P1|Overall Study|Withdrawal by Subject|1
5411354|NCT02689206|18667955|P5|Overall Study|Physician Decision|0
5411355|NCT02689206|18667956|P4|Overall Study|Physician Decision|0
5411356|NCT02689206|18667957|P3|Overall Study|Physician Decision|0
5411357|NCT02689206|18667958|P2|Overall Study|Physician Decision|0
5411358|NCT02689206|18667959|P1|Overall Study|Physician Decision|1
5411359|NCT02689206|18667955|P5|Overall Study|Other: Reached stopping criteria|4
5411360|NCT02689206|18667956|P4|Overall Study|Other: Reached stopping criteria|3
5411361|NCT02689206|18667957|P3|Overall Study|Other: Reached stopping criteria|2
5411362|NCT02689206|18667958|P2|Overall Study|Other: Reached stopping criteria|1
5411363|NCT02689206|18667959|P1|Overall Study|Other: Reached stopping criteria|0
5411364|NCT02689206|18667955|P5|Overall Study|Protocol Violation|2
5411365|NCT02689206|18667956|P4|Overall Study|Protocol Violation|1
5411366|NCT02689206|18667957|P3|Overall Study|Protocol Violation|0
5411367|NCT02689206|18667958|P2|Overall Study|Protocol Violation|0
5411368|NCT02689206|18667959|P1|Overall Study|Protocol Violation|1
5411369|NCT02689206|18667955|P5|Overall Study|Adverse Event|2
5411370|NCT02689206|18667956|P4|Overall Study|Adverse Event|0
5411371|NCT02689206|18667957|P3|Overall Study|Adverse Event|1
5411372|NCT02689206|18667958|P2|Overall Study|Adverse Event|0
5411373|NCT02689206|18667959|P1|Overall Study|Adverse Event|0
5411374|NCT02688933|18668172|P2|Overall Study|Lost to Follow-up|5
5411375|NCT02688933|18668173|P1|Overall Study|Lost to Follow-up|1
5411376|NCT02688933|18668172|P2|Overall Study|Other than Specified|25
5411377|NCT02688933|18668173|P1|Overall Study|Other than Specified|14
5411378|NCT02688933|18668172|P2|Overall Study|Hypoglycemia|0
5411379|NCT02688933|18668173|P1|Overall Study|Hypoglycemia|2
5411380|NCT02688933|18668172|P2|Overall Study|Poor compliance to protocol|4
5411381|NCT02688933|18668173|P1|Overall Study|Poor compliance to protocol|7
5411382|NCT02688933|18668172|P2|Overall Study|Lack of Efficacy|2
5411383|NCT02688933|18668173|P1|Overall Study|Lack of Efficacy|2
5411384|NCT02688933|18668172|P2|Overall Study|Adverse Event|1
5411385|NCT02688933|18668173|P1|Overall Study|Adverse Event|3
5411386|NCT02688764|18668233|P2|Overall Study|Withdrawal by parent|0
5411387|NCT02688764|18668234|P1|Overall Study|Withdrawal by parent|3
5411388|NCT02688764|18668233|P2|Overall Study|Subject taken off dialysis|0
5411389|NCT02688764|18668234|P1|Overall Study|Subject taken off dialysis|1
5411390|NCT02688764|18668233|P2|Overall Study|Subject moving out|0
5411391|NCT02688764|18668234|P1|Overall Study|Subject moving out|2
5411392|NCT02688764|18668233|P2|Overall Study|Study drug taste/Withd. parent|0
5411393|NCT02688764|18668234|P1|Overall Study|Study drug taste/Withd. parent|1
5411394|NCT02688764|18668233|P2|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
5411395|NCT02688764|18668234|P1|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
5411396|NCT02688764|18668233|P2|Overall Study|Phosphorus level outside safe range|1
5411397|NCT02688764|18668234|P1|Overall Study|Phosphorus level outside safe range|0
5411398|NCT02688764|18668233|P2|Overall Study|Non-compl./Withd. subject|2
5411399|NCT02688764|18668234|P1|Overall Study|Non-compl./Withd. subject|0
5411400|NCT02688764|18668233|P2|Overall Study|Non-compl./Ph. decision/Withd. subject|1
5411401|NCT02688764|18668234|P1|Overall Study|Non-compl./Ph. decision/Withd. subject|1
5411402|NCT02688764|18668233|P2|Overall Study|Non-compl./Physician decision|0
5411403|NCT02688764|18668234|P1|Overall Study|Non-compl./Physician decision|2
5411404|NCT02688764|18668233|P2|Overall Study|Non-compliance with study drug|0
5411405|NCT02688764|18668234|P1|Overall Study|Non-compliance with study drug|4
5411406|NCT02688764|18668233|P2|Overall Study|Lack of efficacy/Physician decision|1
5411407|NCT02688764|18668234|P1|Overall Study|Lack of efficacy/Physician decision|0
5411408|NCT02688764|18668233|P2|Overall Study|Lack of Efficacy|2
5411409|NCT02688764|18668234|P1|Overall Study|Lack of Efficacy|3
5411410|NCT02688764|18668233|P2|Overall Study|Kidney transplant|4
5411411|NCT02688764|18668234|P1|Overall Study|Kidney transplant|10
5411412|NCT02688764|18668233|P2|Overall Study|AE/Withd. subject|0
5411413|NCT02688764|18668234|P1|Overall Study|AE/Withd. subject|1
5411414|NCT02688764|18668233|P2|Overall Study|AE/Withd. parent/Withd. subject|1
5411415|NCT02688764|18668234|P1|Overall Study|AE/Withd. parent/Withd. subject|1
5411416|NCT02688764|18668233|P2|Overall Study|AE/Withd. parent|0
5411417|NCT02688764|18668234|P1|Overall Study|AE/Withd. parent|3
5411418|NCT02688764|18668233|P2|Overall Study|AE/Physician decision|0
5411419|NCT02688764|18668234|P1|Overall Study|AE/Physician decision|1
5411420|NCT02688764|18668233|P2|Overall Study|AE/Other|1
5411421|NCT02688764|18668234|P1|Overall Study|AE/Other|0
5411422|NCT02688764|18668233|P2|Overall Study|AE/Non-compl./Withd. parent|1
5411423|NCT02688764|18668234|P1|Overall Study|AE/Non-compl./Withd. parent|0
5411424|NCT02688764|18668233|P2|Overall Study|AE/Non-compl.|0
5411425|NCT02688764|18668234|P1|Overall Study|AE/Non-compl.|1
5411426|NCT02688764|18668233|P2|Overall Study|AE/Lack of efficacy|0
5411427|NCT02688764|18668234|P1|Overall Study|AE/Lack of efficacy|1
5411428|NCT02688764|18668233|P2|Overall Study|AE/Kidney transplant|0
5411429|NCT02688764|18668234|P1|Overall Study|AE/Kidney transplant|1
5411430|NCT02688764|18668233|P2|Overall Study|Adverse Event|3
5411431|NCT02688764|18668234|P1|Overall Study|Adverse Event|3
5411432|NCT02688387|18668301|P22|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411433|NCT02688387|18668302|P21|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411434|NCT02688387|18668303|P20|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
5411435|NCT02688387|18668304|P19|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411436|NCT02688387|18668305|P18|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411437|NCT02688387|18668306|P17|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411438|NCT02688387|18668307|P16|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411439|NCT02688387|18668308|P15|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411440|NCT02688387|18668309|P14|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411441|NCT02688387|18668310|P13|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411442|NCT02688387|18668311|P12|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411443|NCT02688387|18668312|P11|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411444|NCT02688387|18668313|P10|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411445|NCT02688387|18668314|P9|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411446|NCT02688387|18668315|P8|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411447|NCT02688387|18668316|P7|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411448|NCT02688387|18668317|P6|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411449|NCT02688387|18668318|P5|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411450|NCT02688387|18668319|P4|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411451|NCT02688387|18668320|P3|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411452|NCT02688387|18668321|P2|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411453|NCT02688387|18668322|P1|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
5411454|NCT02688387|18668301|P22|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411455|NCT02688387|18668302|P21|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
5411456|NCT02688387|18668303|P20|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411457|NCT02688387|18668304|P19|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
5411458|NCT02688387|18668305|P18|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411459|NCT02688387|18668306|P17|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411460|NCT02688387|18668307|P16|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411461|NCT02688387|18668308|P15|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411462|NCT02688387|18668309|P14|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411463|NCT02688387|18668310|P13|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411464|NCT02688387|18668311|P12|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411465|NCT02688387|18668312|P11|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411466|NCT02688387|18668313|P10|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411467|NCT02688387|18668314|P9|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411468|NCT02688387|18668315|P8|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411469|NCT02688387|18668316|P7|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411470|NCT02688387|18668317|P6|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411471|NCT02688387|18668318|P5|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411472|NCT02688387|18668319|P4|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411473|NCT02688387|18668320|P3|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411474|NCT02688387|18668321|P2|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411475|NCT02688387|18668322|P1|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
5411476|NCT02688387|18668301|P22|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411477|NCT02688387|18668302|P21|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
5411478|NCT02688387|18668303|P20|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411479|NCT02688387|18668304|P19|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411480|NCT02688387|18668305|P18|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411481|NCT02688387|18668306|P17|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411482|NCT02688387|18668307|P16|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411483|NCT02688387|18668308|P15|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411484|NCT02688387|18668309|P14|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411485|NCT02688387|18668310|P13|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411486|NCT02688387|18668311|P12|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411487|NCT02688387|18668312|P11|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411488|NCT02688387|18668313|P10|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411489|NCT02688387|18668314|P9|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411490|NCT02688387|18668315|P8|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411491|NCT02688387|18668316|P7|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411492|NCT02688387|18668317|P6|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411493|NCT02688387|18668318|P5|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411494|NCT02688387|18668319|P4|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411495|NCT02688387|18668320|P3|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411496|NCT02688387|18668321|P2|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411497|NCT02688387|18668322|P1|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
5411498|NCT02688387|18668301|P22|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411499|NCT02688387|18668302|P21|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411500|NCT02688387|18668303|P20|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411501|NCT02688387|18668304|P19|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411502|NCT02688387|18668305|P18|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411503|NCT02688387|18668306|P17|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411504|NCT02688387|18668307|P16|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411505|NCT02688387|18668308|P15|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
5411506|NCT02688387|18668309|P14|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411507|NCT02688387|18668310|P13|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411508|NCT02688387|18668311|P12|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411509|NCT02688387|18668312|P11|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411510|NCT02688387|18668313|P10|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411511|NCT02688387|18668314|P9|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411512|NCT02688387|18668315|P8|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411513|NCT02688387|18668316|P7|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411514|NCT02688387|18668317|P6|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411515|NCT02688387|18668318|P5|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411516|NCT02688387|18668319|P4|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411517|NCT02688387|18668320|P3|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411518|NCT02688387|18668321|P2|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411519|NCT02688387|18668322|P1|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411520|NCT02688387|18668301|P22|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411521|NCT02688387|18668302|P21|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411522|NCT02688387|18668303|P20|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411523|NCT02688387|18668304|P19|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411524|NCT02688387|18668305|P18|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411525|NCT02688387|18668306|P17|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411526|NCT02688387|18668307|P16|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411527|NCT02688387|18668308|P15|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411528|NCT02688387|18668309|P14|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411529|NCT02688387|18668310|P13|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411530|NCT02688387|18668311|P12|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411531|NCT02688387|18668312|P11|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
5411532|NCT02688387|18668313|P10|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411533|NCT02688387|18668314|P9|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411534|NCT02688387|18668315|P8|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411535|NCT02688387|18668316|P7|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411536|NCT02688387|18668317|P6|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411537|NCT02688387|18668318|P5|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411538|NCT02688387|18668319|P4|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411539|NCT02688387|18668320|P3|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411540|NCT02688387|18668321|P2|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411541|NCT02688387|18668322|P1|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
5411542|NCT02688387|18668301|P22|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411543|NCT02688387|18668302|P21|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411544|NCT02688387|18668303|P20|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411545|NCT02688387|18668304|P19|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411546|NCT02688387|18668305|P18|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411547|NCT02688387|18668306|P17|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411548|NCT02688387|18668307|P16|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411549|NCT02688387|18668308|P15|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411550|NCT02688387|18668309|P14|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411551|NCT02688387|18668310|P13|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411552|NCT02688387|18668311|P12|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411553|NCT02688387|18668312|P11|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411554|NCT02688387|18668313|P10|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411555|NCT02688387|18668314|P9|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411556|NCT02688387|18668315|P8|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411557|NCT02688387|18668316|P7|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411558|NCT02688387|18668317|P6|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411559|NCT02688387|18668318|P5|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411560|NCT02688387|18668319|P4|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411561|NCT02688387|18668320|P3|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411562|NCT02688387|18668321|P2|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
5411563|NCT02688387|18668322|P1|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
5411564|NCT02688387|18668301|P22|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411565|NCT02688387|18668302|P21|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411566|NCT02688387|18668303|P20|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411567|NCT02688387|18668304|P19|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411568|NCT02688387|18668305|P18|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411569|NCT02688387|18668306|P17|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411570|NCT02688387|18668307|P16|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411571|NCT02688387|18668308|P15|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411572|NCT02688387|18668309|P14|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411573|NCT02688387|18668310|P13|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411574|NCT02688387|18668311|P12|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411575|NCT02688387|18668312|P11|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411576|NCT02688387|18668313|P10|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411577|NCT02688387|18668314|P9|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411578|NCT02688387|18668315|P8|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411579|NCT02688387|18668316|P7|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411580|NCT02688387|18668317|P6|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411581|NCT02688387|18668318|P5|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
5411582|NCT02688387|18668319|P4|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411583|NCT02688387|18668320|P3|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
5411584|NCT02688387|18668321|P2|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411585|NCT02688387|18668322|P1|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
5411586|NCT02688387|18668301|P22|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411587|NCT02688387|18668302|P21|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411588|NCT02688387|18668303|P20|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411589|NCT02688387|18668304|P19|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411590|NCT02688387|18668305|P18|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411591|NCT02688387|18668306|P17|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411592|NCT02688387|18668307|P16|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411593|NCT02688387|18668308|P15|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411594|NCT02688387|18668309|P14|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411595|NCT02688387|18668310|P13|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411596|NCT02688387|18668311|P12|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411597|NCT02688387|18668312|P11|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411598|NCT02688387|18668313|P10|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411599|NCT02688387|18668314|P9|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411600|NCT02688387|18668315|P8|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411601|NCT02688387|18668316|P7|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411602|NCT02688387|18668317|P6|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411603|NCT02688387|18668318|P5|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411604|NCT02688387|18668319|P4|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411605|NCT02688387|18668320|P3|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411606|NCT02688387|18668321|P2|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
5411607|NCT02688387|18668322|P1|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
5411608|NCT02688387|18668301|P22|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411609|NCT02688387|18668302|P21|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411610|NCT02688387|18668303|P20|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411611|NCT02688387|18668304|P19|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411612|NCT02688387|18668305|P18|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411613|NCT02688387|18668306|P17|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411614|NCT02688387|18668307|P16|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411615|NCT02688387|18668308|P15|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411616|NCT02688387|18668309|P14|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411617|NCT02688387|18668310|P13|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411618|NCT02688387|18668311|P12|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411619|NCT02688387|18668312|P11|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411620|NCT02688387|18668313|P10|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411621|NCT02688387|18668314|P9|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411622|NCT02688387|18668315|P8|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411623|NCT02688387|18668316|P7|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411624|NCT02688387|18668317|P6|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411625|NCT02688387|18668318|P5|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411626|NCT02688387|18668319|P4|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
5411627|NCT02688387|18668320|P3|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411628|NCT02688387|18668321|P2|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411629|NCT02688387|18668322|P1|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
5411630|NCT02688387|18668301|P22|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411631|NCT02688387|18668302|P21|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411632|NCT02688387|18668303|P20|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411633|NCT02688387|18668304|P19|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411634|NCT02688387|18668305|P18|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411635|NCT02688387|18668306|P17|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411636|NCT02688387|18668307|P16|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411637|NCT02688387|18668308|P15|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411638|NCT02688387|18668309|P14|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411639|NCT02688387|18668310|P13|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411640|NCT02688387|18668311|P12|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411641|NCT02688387|18668312|P11|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411642|NCT02688387|18668313|P10|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411643|NCT02688387|18668314|P9|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411644|NCT02688387|18668315|P8|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411645|NCT02688387|18668316|P7|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411646|NCT02688387|18668317|P6|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411647|NCT02688387|18668318|P5|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411648|NCT02688387|18668319|P4|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411649|NCT02688387|18668320|P3|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
5411650|NCT02688387|18668321|P2|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411651|NCT02688387|18668322|P1|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
5411652|NCT02688192|18668590|P2|Overall Study|Physician Decision|0
5411653|NCT02688192|18668591|P1|Overall Study|Physician Decision|1
5411654|NCT02688192|18668590|P2|Overall Study|Lost to Follow-up|5
5411655|NCT02688192|18668591|P1|Overall Study|Lost to Follow-up|11
5411656|NCT02688153|18668610|P2|Overall Study|Conversion to Commercial Valve|0
5411657|NCT02688153|18668611|P1|Overall Study|Conversion to Commercial Valve|3
5411658|NCT02688153|18668610|P2|Overall Study|Valve Explant|0
5411659|NCT02688153|18668611|P1|Overall Study|Valve Explant|1
5411660|NCT02688153|18668610|P2|Overall Study|Withdrawal by Subject|2
5411661|NCT02688153|18668611|P1|Overall Study|Withdrawal by Subject|4
5411662|NCT02688153|18668610|P2|Overall Study|Death|5
5411663|NCT02688153|18668611|P1|Overall Study|Death|7
5411664|NCT02687919|18668671|P2|Overall Study|Protocol Violation|0
5411665|NCT02687919|18668672|P1|Overall Study|Protocol Violation|2
5411666|NCT02687919|18668671|P2|Overall Study|Withdrawal by Subject|6
5411667|NCT02687919|18668672|P1|Overall Study|Withdrawal by Subject|6
5411668|NCT02687815|18668702|P2|Overall Study|Withdrawal by Subject|4
5411669|NCT02687815|18668703|P1|Overall Study|Withdrawal by Subject|2
5411670|NCT02687815|18668702|P2|Overall Study|Lost to Follow-up|4
5411671|NCT02687815|18668703|P1|Overall Study|Lost to Follow-up|2
5411672|NCT02687542|18668720|P5|Overall Study|Withdrawal by Subject|4
5411673|NCT02687542|18668721|P4|Overall Study|Withdrawal by Subject|2
5411674|NCT02687542|18668722|P3|Overall Study|Withdrawal by Subject|1
5411675|NCT02687542|18668723|P2|Overall Study|Withdrawal by Subject|1
5411676|NCT02687542|18668724|P1|Overall Study|Withdrawal by Subject|0
5411677|NCT02687542|18668720|P5|Overall Study|Adverse Event|9
5411678|NCT02687542|18668721|P4|Overall Study|Adverse Event|2
5411679|NCT02687542|18668722|P3|Overall Study|Adverse Event|3
5411680|NCT02687542|18668723|P2|Overall Study|Adverse Event|1
5411681|NCT02687542|18668724|P1|Overall Study|Adverse Event|3
5411682|NCT02687542|18668720|P5|Overall Study|Other|5
5411683|NCT02687542|18668721|P4|Overall Study|Other|6
5411684|NCT02687542|18668722|P3|Overall Study|Other|10
5411685|NCT02687542|18668723|P2|Overall Study|Other|9
5411686|NCT02687542|18668724|P1|Overall Study|Other|5
5411687|NCT02687542|18668720|P5|Overall Study|Protocol Violation|0
5411688|NCT02687542|18668721|P4|Overall Study|Protocol Violation|0
5411689|NCT02687542|18668722|P3|Overall Study|Protocol Violation|0
5411690|NCT02687542|18668723|P2|Overall Study|Protocol Violation|1
5411691|NCT02687542|18668724|P1|Overall Study|Protocol Violation|0
5411692|NCT02687542|18668720|P5|Overall Study|Lost to Follow-up|1
5411693|NCT02687542|18668721|P4|Overall Study|Lost to Follow-up|0
5411694|NCT02687542|18668722|P3|Overall Study|Lost to Follow-up|0
5411695|NCT02687542|18668723|P2|Overall Study|Lost to Follow-up|0
5411696|NCT02687542|18668724|P1|Overall Study|Lost to Follow-up|0
5411697|NCT02687542|18668720|P5|Overall Study|Medication error without associated AEs|1
5411698|NCT02687542|18668721|P4|Overall Study|Medication error without associated AEs|0
5411699|NCT02687542|18668722|P3|Overall Study|Medication error without associated AEs|0
5411700|NCT02687542|18668723|P2|Overall Study|Medication error without associated AEs|0
5411701|NCT02687542|18668724|P1|Overall Study|Medication error without associated AEs|0
5411702|NCT02687191|18668853|P6|Overall Study|Withdrawal by Subject|0
5411703|NCT02687191|18668854|P5|Overall Study|Withdrawal by Subject|0
5411704|NCT02687191|18668855|P4|Overall Study|Withdrawal by Subject|1
5411705|NCT02687191|18668856|P3|Overall Study|Withdrawal by Subject|0
5411706|NCT02687191|18668857|P2|Overall Study|Withdrawal by Subject|0
5411707|NCT02687191|18668858|P1|Overall Study|Withdrawal by Subject|0
5411708|NCT02687191|18668853|P6|Overall Study|Death|1
5411709|NCT02687191|18668854|P5|Overall Study|Death|1
5411710|NCT02687191|18668855|P4|Overall Study|Death|0
5411711|NCT02687191|18668856|P3|Overall Study|Death|1
5411712|NCT02687191|18668857|P2|Overall Study|Death|1
5411713|NCT02687191|18668858|P1|Overall Study|Death|0
5411714|NCT02686164|18669022|P1|Overall Study|Clinical progression|1
5411715|NCT02686164|18669022|P1|Overall Study|Withdrawal of consent|1
5411716|NCT02686164|18669022|P1|Overall Study|Adverse Event|1
5411717|NCT02686034|18669059|P2|Open Label Period 3|Lost to Follow-up|1
5411718|NCT02686034|18669060|P1|Open Label Period 3|Lost to Follow-up|0
5411719|NCT02686034|18669059|P2|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
5411720|NCT02686034|18669060|P1|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
5411721|NCT02686034|18669059|P2|Randomized Controlled Period 2|Adverse Event|2
5411722|NCT02686034|18669060|P1|Randomized Controlled Period 2|Adverse Event|0
5411723|NCT02686034|18669059|P2|Randomized Controlled Period 2|Withdrawal by Subject|0
5411724|NCT02686034|18669060|P1|Randomized Controlled Period 2|Withdrawal by Subject|3
5411725|NCT02686034|18669059|P2|Randomized Controlled Period 2|Lost to Follow-up|2
5411726|NCT02686034|18669060|P1|Randomized Controlled Period 2|Lost to Follow-up|1
5411727|NCT02686034|18669059|P2|Run-In Period 1|Lost to Follow-up|4
5411728|NCT02686034|18669060|P1|Run-In Period 1|Lost to Follow-up|4
5411729|NCT02686034|18669059|P2|Run-In Period 1|Withdrawal by Subject|3
5411730|NCT02686034|18669060|P1|Run-In Period 1|Withdrawal by Subject|4
5411731|NCT02686034|18669059|P2|Run-In Period 1|Eligibility|10
5411732|NCT02686034|18669060|P1|Run-In Period 1|Eligibility|12
5411733|NCT02685826|18669110|P3|Overall Study|Full Clinical Hold by FDA|20
5411734|NCT02685826|18669111|P2|Overall Study|Full Clinical Hold by FDA|9
5411735|NCT02685826|18669112|P1|Overall Study|Full Clinical Hold by FDA|19
5411736|NCT02685826|18669110|P3|Overall Study|Withdrawal by Subject|0
5411737|NCT02685826|18669111|P2|Overall Study|Withdrawal by Subject|0
5411738|NCT02685826|18669112|P1|Overall Study|Withdrawal by Subject|2
5411739|NCT02685826|18669110|P3|Overall Study|Progressive Disease|0
5411740|NCT02685826|18669111|P2|Overall Study|Progressive Disease|1
5411741|NCT02685826|18669112|P1|Overall Study|Progressive Disease|2
5411742|NCT02685826|18669110|P3|Overall Study|Adverse Event|1
5411743|NCT02685826|18669111|P2|Overall Study|Adverse Event|0
5411744|NCT02685826|18669112|P1|Overall Study|Adverse Event|2
5411745|NCT02685488|18669206|P2|Overall Study|Withdrawal by Subject|1
5411746|NCT02685488|18669207|P1|Overall Study|Withdrawal by Subject|0
5411747|NCT02685202|18669260|P1|Overall Study|Lost to Follow-up|9
5411748|NCT02685072|18669268|P2|1-Month Follow-Up|Withdrawal by Subject|0
5411749|NCT02685072|18669269|P1|1-Month Follow-Up|Withdrawal by Subject|1
5411750|NCT02685072|18669268|P2|Treatment Period|Withdrawal by Subject|3
5411751|NCT02685072|18669269|P1|Treatment Period|Withdrawal by Subject|1
5411752|NCT02685072|18669268|P2|Treatment Period|Lost to Follow-up|6
5411753|NCT02685072|18669269|P1|Treatment Period|Lost to Follow-up|12
5411754|NCT02685033|18669313|P2|Overall Study|Adverse Event|0
5411755|NCT02685033|18669314|P1|Overall Study|Adverse Event|1
5411756|NCT02685033|18669313|P2|Overall Study|Lost to Follow-up|1
5411757|NCT02685033|18669314|P1|Overall Study|Lost to Follow-up|2
5411758|NCT02685033|18669313|P2|Overall Study|Withdrawal of Consent|1
5411759|NCT02685033|18669314|P1|Overall Study|Withdrawal of Consent|0
5411760|NCT02684981|18669350|P3|Overall Study|Other|17
5411761|NCT02684981|18669351|P2|Overall Study|Other|49
5411762|NCT02684981|18669352|P1|Overall Study|Other|83
5411763|NCT02684981|18669350|P3|Overall Study|Permanently discontinued the treatment|110
5411764|NCT02684981|18669351|P2|Overall Study|Permanently discontinued the treatment|161
5411765|NCT02684981|18669352|P1|Overall Study|Permanently discontinued the treatment|157
5411766|NCT02684370|18669512|P6|Part B|Subject Withdrawal|2
5411767|NCT02684370|18669513|P5|Part B|Subject Withdrawal|1
5411768|NCT02684370|18669514|P4|Part B|Subject Withdrawal|1
5411769|NCT02684370|18669515|P3|Part B|Subject Withdrawal|0
5411770|NCT02684370|18669516|P2|Part B|Subject Withdrawal|0
5411771|NCT02684370|18669517|P1|Part B|Subject Withdrawal|0
5411772|NCT02684370|18669512|P6|Part B|Lost to Follow-up|5
5411773|NCT02684370|18669513|P5|Part B|Lost to Follow-up|2
5411774|NCT02684370|18669514|P4|Part B|Lost to Follow-up|1
5411775|NCT02684370|18669515|P3|Part B|Lost to Follow-up|0
5411776|NCT02684370|18669516|P2|Part B|Lost to Follow-up|0
5411777|NCT02684370|18669517|P1|Part B|Lost to Follow-up|0
5411778|NCT02684370|18669512|P6|Part B|Adverse Event|1
5411779|NCT02684370|18669513|P5|Part B|Adverse Event|2
5411780|NCT02684370|18669514|P4|Part B|Adverse Event|0
5411781|NCT02684370|18669515|P3|Part B|Adverse Event|0
5411782|NCT02684370|18669516|P2|Part B|Adverse Event|0
5411783|NCT02684370|18669517|P1|Part B|Adverse Event|0
5411784|NCT02684370|18669512|P6|Part A|Other|0
5411785|NCT02684370|18669513|P5|Part A|Other|0
5411786|NCT02684370|18669514|P4|Part A|Other|0
5411787|NCT02684370|18669515|P3|Part A|Other|1
5411788|NCT02684370|18669516|P2|Part A|Other|0
5411789|NCT02684370|18669517|P1|Part A|Other|0
5411790|NCT02684370|18669512|P6|Part A|Subject Withdrawal|0
5411791|NCT02684370|18669513|P5|Part A|Subject Withdrawal|0
5411792|NCT02684370|18669514|P4|Part A|Subject Withdrawal|0
5411793|NCT02684370|18669515|P3|Part A|Subject Withdrawal|3
5411794|NCT02684370|18669516|P2|Part A|Subject Withdrawal|0
5411795|NCT02684370|18669517|P1|Part A|Subject Withdrawal|1
5411796|NCT02684370|18669512|P6|Part A|Lost to Follow-up|0
5411797|NCT02684370|18669513|P5|Part A|Lost to Follow-up|0
5411798|NCT02684370|18669514|P4|Part A|Lost to Follow-up|0
5411799|NCT02684370|18669515|P3|Part A|Lost to Follow-up|0
5411800|NCT02684370|18669516|P2|Part A|Lost to Follow-up|1
5411801|NCT02684370|18669517|P1|Part A|Lost to Follow-up|1
5411802|NCT02684370|18669512|P6|Part A|Adverse Event|0
5411803|NCT02684370|18669513|P5|Part A|Adverse Event|0
5411804|NCT02684370|18669514|P4|Part A|Adverse Event|0
5411805|NCT02684370|18669515|P3|Part A|Adverse Event|1
5411806|NCT02684370|18669516|P2|Part A|Adverse Event|0
5411807|NCT02684370|18669517|P1|Part A|Adverse Event|2
5411808|NCT02684357|18669562|P6|Part B|Other|1
5411809|NCT02684357|18669563|P5|Part B|Other|0
5411810|NCT02684357|18669564|P4|Part B|Other|1
5411811|NCT02684357|18669565|P3|Part B|Other|0
5411812|NCT02684357|18669566|P2|Part B|Other|0
5411813|NCT02684357|18669567|P1|Part B|Other|0
5411814|NCT02684357|18669562|P6|Part B|Withdrawal by Subject|4
5411815|NCT02684357|18669563|P5|Part B|Withdrawal by Subject|2
5411816|NCT02684357|18669564|P4|Part B|Withdrawal by Subject|0
5411817|NCT02684357|18669565|P3|Part B|Withdrawal by Subject|0
5411818|NCT02684357|18669566|P2|Part B|Withdrawal by Subject|0
5411819|NCT02684357|18669567|P1|Part B|Withdrawal by Subject|0
5411820|NCT02684357|18669562|P6|Part B|Lost to Follow-up|7
5411821|NCT02684357|18669563|P5|Part B|Lost to Follow-up|1
5411822|NCT02684357|18669564|P4|Part B|Lost to Follow-up|1
5411823|NCT02684357|18669565|P3|Part B|Lost to Follow-up|0
5411824|NCT02684357|18669566|P2|Part B|Lost to Follow-up|0
5411825|NCT02684357|18669567|P1|Part B|Lost to Follow-up|0
5411826|NCT02684357|18669562|P6|Part B|Adverse Event (Other)|1
5411827|NCT02684357|18669563|P5|Part B|Adverse Event (Other)|1
5411828|NCT02684357|18669564|P4|Part B|Adverse Event (Other)|1
5411829|NCT02684357|18669565|P3|Part B|Adverse Event (Other)|0
5411830|NCT02684357|18669566|P2|Part B|Adverse Event (Other)|0
5411831|NCT02684357|18669567|P1|Part B|Adverse Event (Other)|0
5411832|NCT02684357|18669562|P6|Part A|Other|0
5411833|NCT02684357|18669563|P5|Part A|Other|0
5411834|NCT02684357|18669564|P4|Part A|Other|0
5411835|NCT02684357|18669565|P3|Part A|Other|0
5411836|NCT02684357|18669566|P2|Part A|Other|1
5411837|NCT02684357|18669567|P1|Part A|Other|0
5411838|NCT02684357|18669562|P6|Part A|Withdrawal by Subject|0
5411839|NCT02684357|18669563|P5|Part A|Withdrawal by Subject|0
5411840|NCT02684357|18669564|P4|Part A|Withdrawal by Subject|0
5411841|NCT02684357|18669565|P3|Part A|Withdrawal by Subject|0
5411842|NCT02684357|18669566|P2|Part A|Withdrawal by Subject|0
5411843|NCT02684357|18669567|P1|Part A|Withdrawal by Subject|3
5411844|NCT02684357|18669562|P6|Part A|Lost to Follow-up|0
5411845|NCT02684357|18669563|P5|Part A|Lost to Follow-up|0
5411846|NCT02684357|18669564|P4|Part A|Lost to Follow-up|0
5411847|NCT02684357|18669565|P3|Part A|Lost to Follow-up|2
5411848|NCT02684357|18669566|P2|Part A|Lost to Follow-up|2
5411849|NCT02684357|18669567|P1|Part A|Lost to Follow-up|0
5411850|NCT02684357|18669562|P6|Part A|Adverse Event (Worsening of Disease)|0
5411851|NCT02684357|18669563|P5|Part A|Adverse Event (Worsening of Disease)|0
5411852|NCT02684357|18669564|P4|Part A|Adverse Event (Worsening of Disease)|0
5411853|NCT02684357|18669565|P3|Part A|Adverse Event (Worsening of Disease)|0
5411854|NCT02684357|18669566|P2|Part A|Adverse Event (Worsening of Disease)|0
5411855|NCT02684357|18669567|P1|Part A|Adverse Event (Worsening of Disease)|1
5411856|NCT02684344|18669617|P2|Overall Study|Withdrawal by Subject|1
5411857|NCT02684344|18669618|P1|Overall Study|Withdrawal by Subject|0
5411858|NCT02684279|18669624|P1|Overall Study|Physician Decision|1
5411859|NCT02684279|18669624|P1|Overall Study|Site closures|7
5411860|NCT02684279|18669624|P1|Overall Study|family emergency|1
5411861|NCT02684279|18669624|P1|Overall Study|subject to have surgery|1
5411862|NCT02684279|18669624|P1|Overall Study|non compliance with study visits|2
5411863|NCT02684279|18669624|P1|Overall Study|non-compliance with study drug|9
5411864|NCT02684279|18669624|P1|Overall Study|Withdrawal by Subject|92
5411865|NCT02684279|18669624|P1|Overall Study|Pregnancy|8
5411866|NCT02684279|18669624|P1|Overall Study|Protocol Violation|6
5411867|NCT02684279|18669624|P1|Overall Study|Lost to Follow-up|61
5411868|NCT02684279|18669624|P1|Overall Study|Lack of Efficacy|4
5411869|NCT02684279|18669624|P1|Overall Study|Adverse Event|87
5411870|NCT02684097|18669676|P2|Overall Study|Lack of Efficacy|6
5411871|NCT02684097|18669677|P1|Overall Study|Lack of Efficacy|13
5411872|NCT02683876|18669725|P2|Overall Study|samples damaged during shipping|0
5411873|NCT02683876|18669726|P1|Overall Study|samples damaged during shipping|2
5411874|NCT02683785|18669736|P2|Overall Study|Adverse Event|2
5411875|NCT02683785|18669737|P1|Overall Study|Adverse Event|0
5411876|NCT02683785|18669736|P2|Overall Study|Lost to Follow-up|1
5411877|NCT02683785|18669737|P1|Overall Study|Lost to Follow-up|0
5411878|NCT02683785|18669736|P2|Overall Study|Withdrawal by Subject|1
5411879|NCT02683785|18669737|P1|Overall Study|Withdrawal by Subject|1
5411880|NCT02683746|18669794|P2|Overall Study|Physician Decision|1
5411881|NCT02683746|18669795|P1|Overall Study|Physician Decision|2
5411882|NCT02683746|18669794|P2|Overall Study|Withdrawal by Subject|5
5411883|NCT02683746|18669795|P1|Overall Study|Withdrawal by Subject|6
5411884|NCT02683746|18669794|P2|Overall Study|Lost to Follow-up|6
5411885|NCT02683746|18669795|P1|Overall Study|Lost to Follow-up|5
5411886|NCT02683746|18669794|P2|Overall Study|Adverse Event|2
5411887|NCT02683746|18669795|P1|Overall Study|Adverse Event|3
5411888|NCT02683668|18669838|P3|Period 2|Withdrawal by Subject|0
5411889|NCT02683668|18669839|P2|Period 2|Withdrawal by Subject|1
5411890|NCT02683668|18669840|P1|Period 2|Withdrawal by Subject|0
5411891|NCT02683525|18669906|P1|Overall Study|Disease Progression|6
5411892|NCT02683525|18669906|P1|Overall Study|Physician Decision|1
5411893|NCT02683525|18669906|P1|Overall Study|Lost to Follow-up|1
5411894|NCT02683109|18669961|P2|Overall Study|Adverse Event|0
5411895|NCT02683109|18669962|P1|Overall Study|Adverse Event|1
5411896|NCT02682823|18669983|P5|Overall Study|Adverse Event|0
5411897|NCT02682823|18669984|P4|Overall Study|Adverse Event|1
5411898|NCT02682823|18669985|P3|Overall Study|Adverse Event|0
5411899|NCT02682823|18669986|P2|Overall Study|Adverse Event|0
5411900|NCT02682823|18669987|P1|Overall Study|Adverse Event|0
5411901|NCT02682823|18669983|P5|Overall Study|Protocol Deviation|0
5411902|NCT02682823|18669984|P4|Overall Study|Protocol Deviation|0
5411903|NCT02682823|18669985|P3|Overall Study|Protocol Deviation|0
5411904|NCT02682823|18669986|P2|Overall Study|Protocol Deviation|1
5411905|NCT02682823|18669987|P1|Overall Study|Protocol Deviation|0
5411906|NCT02682823|18669983|P5|Overall Study|Withdrawal by Subject|1
5411907|NCT02682823|18669984|P4|Overall Study|Withdrawal by Subject|0
5411908|NCT02682823|18669985|P3|Overall Study|Withdrawal by Subject|1
5411909|NCT02682823|18669986|P2|Overall Study|Withdrawal by Subject|0
5411910|NCT02682823|18669987|P1|Overall Study|Withdrawal by Subject|0
5411911|NCT02682602|18670023|P2|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
5411912|NCT02682602|18670024|P1|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
5411913|NCT02682602|18670023|P2|Pre-operative Diseased & Normal Hips|Unusable images|0
5411914|NCT02682602|18670024|P1|Pre-operative Diseased & Normal Hips|Unusable images|1
5411915|NCT02682264|18670157|P2|Overall Study|Stopped test article application|1
5411916|NCT02682264|18670158|P1|Overall Study|Stopped test article application|0
5411917|NCT02682264|18670157|P2|Overall Study|Moved abroad and unable to continue|3
5411918|NCT02682264|18670158|P1|Overall Study|Moved abroad and unable to continue|0
5411919|NCT02682264|18670157|P2|Overall Study|Technical Problems|1
5411920|NCT02682264|18670158|P1|Overall Study|Technical Problems|0
5411921|NCT02682264|18670157|P2|Overall Study|Progressive Disease|0
5411922|NCT02682264|18670158|P1|Overall Study|Progressive Disease|1
5411923|NCT02682264|18670157|P2|Overall Study|Recovery|2
5411924|NCT02682264|18670158|P1|Overall Study|Recovery|1
5411925|NCT02682264|18670157|P2|Overall Study|Pregnancy|2
5411926|NCT02682264|18670158|P1|Overall Study|Pregnancy|1
5411927|NCT02682264|18670157|P2|Overall Study|Noncompliance with study drug|4
5411928|NCT02682264|18670158|P1|Overall Study|Noncompliance with study drug|1
5411929|NCT02682264|18670157|P2|Overall Study|Adverse Event|0
5411930|NCT02682264|18670158|P1|Overall Study|Adverse Event|9
5411931|NCT02682264|18670157|P2|Overall Study|Withdrawal by Parent|7
5411932|NCT02682264|18670158|P1|Overall Study|Withdrawal by Parent|6
5411933|NCT02682264|18670157|P2|Overall Study|Lack of Efficacy|16
5411934|NCT02682264|18670158|P1|Overall Study|Lack of Efficacy|14
5411935|NCT02682264|18670157|P2|Overall Study|Lost to Follow-up|41
5411936|NCT02682264|18670158|P1|Overall Study|Lost to Follow-up|49
5411937|NCT02682264|18670157|P2|Overall Study|Withdrawal by Subject|45
5411938|NCT02682264|18670158|P1|Overall Study|Withdrawal by Subject|56
5411939|NCT02681510|18670244|P1|Overall Study|Lost to Follow-up|9
5411940|NCT02681510|18670244|P1|Overall Study|Withdrawal by Subject|1
5411941|NCT02681094|18670274|P3|2 - Enrolled Participants Set|No treatment given|1
5411942|NCT02681094|18670275|P2|2 - Enrolled Participants Set|No treatment given|1
5411943|NCT02681094|18670276|P1|2 - Enrolled Participants Set|No treatment given|0
5411944|NCT02681094|18670274|P3|2 - Enrolled Participants Set|Other|7
5411945|NCT02681094|18670275|P2|2 - Enrolled Participants Set|Other|6
5411946|NCT02681094|18670276|P1|2 - Enrolled Participants Set|Other|6
5411947|NCT02681094|18670274|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
5411948|NCT02681094|18670275|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
5411949|NCT02681094|18670276|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
5411950|NCT02681094|18670274|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
5411951|NCT02681094|18670275|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
5411952|NCT02681094|18670276|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
5411953|NCT02681094|18670274|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
5411954|NCT02681094|18670275|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
5411955|NCT02681094|18670276|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
5411956|NCT02681094|18670274|P3|2 - Enrolled Participants Set|Adverse Event|1
5411957|NCT02681094|18670275|P2|2 - Enrolled Participants Set|Adverse Event|4
5411958|NCT02681094|18670276|P1|2 - Enrolled Participants Set|Adverse Event|10
5411959|NCT02681094|18670274|P3|2 - Enrolled Participants Set|Participant decision|9
5411960|NCT02681094|18670275|P2|2 - Enrolled Participants Set|Participant decision|10
5411961|NCT02681094|18670276|P1|2 - Enrolled Participants Set|Participant decision|7
5411962|NCT02681094|18670274|P3|1 -Modified Enrolled Participants Set|No treatment given|1
5411963|NCT02681094|18670275|P2|1 -Modified Enrolled Participants Set|No treatment given|1
5411964|NCT02681094|18670276|P1|1 -Modified Enrolled Participants Set|No treatment given|0
5411965|NCT02681094|18670274|P3|1 -Modified Enrolled Participants Set|Other|7
5411966|NCT02681094|18670275|P2|1 -Modified Enrolled Participants Set|Other|6
5411967|NCT02681094|18670276|P1|1 -Modified Enrolled Participants Set|Other|6
5411968|NCT02681094|18670274|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
5411969|NCT02681094|18670275|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
5411970|NCT02681094|18670276|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
5411971|NCT02681094|18670274|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
5411972|NCT02681094|18670275|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
5411973|NCT02681094|18670276|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
5411974|NCT02681094|18670274|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
5411975|NCT02681094|18670275|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
5411976|NCT02681094|18670276|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
5411977|NCT02681094|18670274|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
5411978|NCT02681094|18670275|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
5411979|NCT02681094|18670276|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
5411980|NCT02681094|18670274|P3|1 -Modified Enrolled Participants Set|Participant decision|9
5411981|NCT02681094|18670275|P2|1 -Modified Enrolled Participants Set|Participant decision|10
5411982|NCT02681094|18670276|P1|1 -Modified Enrolled Participants Set|Participant decision|7
5411983|NCT02680847|18670295|P3|Overall Study|Adverse Event|1
5411984|NCT02680847|18670296|P2|Overall Study|Adverse Event|0
5411985|NCT02680847|18670297|P1|Overall Study|Adverse Event|0
5411986|NCT02680847|18670295|P3|Overall Study|Lack of Efficacy|2
5411987|NCT02680847|18670296|P2|Overall Study|Lack of Efficacy|0
5411988|NCT02680847|18670297|P1|Overall Study|Lack of Efficacy|0
5411989|NCT02680847|18670295|P3|Overall Study|Unwilling to participate in study|0
5411990|NCT02680847|18670296|P2|Overall Study|Unwilling to participate in study|1
5411991|NCT02680847|18670297|P1|Overall Study|Unwilling to participate in study|1
5411992|NCT02680847|18670295|P3|Overall Study|No longer met eligibility criteria|0
5411993|NCT02680847|18670296|P2|Overall Study|No longer met eligibility criteria|2
5411994|NCT02680847|18670297|P1|Overall Study|No longer met eligibility criteria|2
5411995|NCT02680847|18670295|P3|Overall Study|Other|0
5411996|NCT02680847|18670296|P2|Overall Study|Other|0
5411997|NCT02680847|18670297|P1|Overall Study|Other|2
5411998|NCT02680834|18670334|P2|Overall Study|Lost to Follow-up|1
5411999|NCT02680834|18670335|P1|Overall Study|Lost to Follow-up|0
5412000|NCT02680834|18670334|P2|Overall Study|Withdrawal by Subject|0
5412001|NCT02680834|18670335|P1|Overall Study|Withdrawal by Subject|6
5412002|NCT02680834|18670334|P2|Overall Study|Physician Decision|2
5412003|NCT02680834|18670335|P1|Overall Study|Physician Decision|5
5412004|NCT02680756|18670347|P2|Overall Study|None of above or not recorded|2
5412005|NCT02680756|18670348|P1|Overall Study|None of above or not recorded|3
5412006|NCT02680756|18670347|P2|Overall Study|TSAT above 60% or a ferritin above 800 m|0
5412007|NCT02680756|18670348|P1|Overall Study|TSAT above 60% or a ferritin above 800 m|1
5412008|NCT02680756|18670347|P2|Overall Study|Protocol Violation|0
5412009|NCT02680756|18670348|P1|Overall Study|Protocol Violation|1
5412010|NCT02680756|18670347|P2|Overall Study|Death|0
5412011|NCT02680756|18670348|P1|Overall Study|Death|1
5412012|NCT02680756|18670347|P2|Overall Study|Blood transfusion for any reason|1
5412013|NCT02680756|18670348|P1|Overall Study|Blood transfusion for any reason|0
5412014|NCT02680756|18670347|P2|Overall Study|Hb ≤7.5 g/dL|2
5412015|NCT02680756|18670348|P1|Overall Study|Hb ≤7.5 g/dL|0
5412016|NCT02680756|18670347|P2|Overall Study|Physician Decision|1
5412017|NCT02680756|18670348|P1|Overall Study|Physician Decision|4
5412018|NCT02680756|18670347|P2|Overall Study|Withdrawal by Subject|5
5412019|NCT02680756|18670348|P1|Overall Study|Withdrawal by Subject|5
5412020|NCT02680756|18670347|P2|Overall Study|Lost to Follow-up|6
5412021|NCT02680756|18670348|P1|Overall Study|Lost to Follow-up|7
5412022|NCT02680756|18670347|P2|Overall Study|Adverse Event|2
5412023|NCT02680756|18670348|P1|Overall Study|Adverse Event|10
5412024|NCT02680665|18670396|P1|Overall Study|No visit after the first prescription|5
5412025|NCT02680639|18670402|P3|Screening Period|Screen Failure|0
5412026|NCT02680639|18670403|P2|Screening Period|Screen Failure|0
5412027|NCT02680639|18670404|P1|Screening Period|Screen Failure|7
5412028|NCT02680041|18670486|P1|Overall Study|Lost to Follow-up|2
5412029|NCT02680041|18670486|P1|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
5412030|NCT02680002|18670501|P6|Overall Study|Adverse Event|2
5412031|NCT02680002|18670502|P5|Overall Study|Adverse Event|1
5412032|NCT02680002|18670503|P4|Overall Study|Adverse Event|0
5412033|NCT02680002|18670504|P3|Overall Study|Adverse Event|0
5412034|NCT02680002|18670505|P2|Overall Study|Adverse Event|0
5412035|NCT02680002|18670506|P1|Overall Study|Adverse Event|0
5412036|NCT02680002|18670501|P6|Overall Study|Other|0
5412037|NCT02680002|18670502|P5|Overall Study|Other|1
5412038|NCT02680002|18670503|P4|Overall Study|Other|0
5412039|NCT02680002|18670504|P3|Overall Study|Other|0
5412040|NCT02680002|18670505|P2|Overall Study|Other|1
5412041|NCT02680002|18670506|P1|Overall Study|Other|0
5412042|NCT02680002|18670501|P6|Overall Study|Missed Visit 8 (Day 201)|0
5412043|NCT02680002|18670502|P5|Overall Study|Missed Visit 8 (Day 201)|5
5412044|NCT02680002|18670503|P4|Overall Study|Missed Visit 8 (Day 201)|1
5412045|NCT02680002|18670504|P3|Overall Study|Missed Visit 8 (Day 201)|3
5412046|NCT02680002|18670505|P2|Overall Study|Missed Visit 8 (Day 201)|1
5412047|NCT02680002|18670506|P1|Overall Study|Missed Visit 8 (Day 201)|2
5412048|NCT02680002|18670501|P6|Overall Study|Withdrawal by Subject|2
5412049|NCT02680002|18670502|P5|Overall Study|Withdrawal by Subject|2
5412050|NCT02680002|18670503|P4|Overall Study|Withdrawal by Subject|0
5412051|NCT02680002|18670504|P3|Overall Study|Withdrawal by Subject|1
5412052|NCT02680002|18670505|P2|Overall Study|Withdrawal by Subject|0
5412053|NCT02680002|18670506|P1|Overall Study|Withdrawal by Subject|0
5412054|NCT02680002|18670501|P6|Overall Study|Protocol Violation|2
5412055|NCT02680002|18670502|P5|Overall Study|Protocol Violation|1
5412056|NCT02680002|18670503|P4|Overall Study|Protocol Violation|0
5412057|NCT02680002|18670504|P3|Overall Study|Protocol Violation|1
5412058|NCT02680002|18670505|P2|Overall Study|Protocol Violation|0
5412059|NCT02680002|18670506|P1|Overall Study|Protocol Violation|1
5412060|NCT02680002|18670501|P6|Overall Study|Physician Decision|1
5412061|NCT02680002|18670502|P5|Overall Study|Physician Decision|1
5412062|NCT02680002|18670503|P4|Overall Study|Physician Decision|1
5412063|NCT02680002|18670504|P3|Overall Study|Physician Decision|1
5412064|NCT02680002|18670505|P2|Overall Study|Physician Decision|1
5412065|NCT02680002|18670506|P1|Overall Study|Physician Decision|5
5412066|NCT02680002|18670501|P6|Overall Study|Lost to Follow-up|2
5412067|NCT02680002|18670502|P5|Overall Study|Lost to Follow-up|0
5412068|NCT02680002|18670503|P4|Overall Study|Lost to Follow-up|2
5412069|NCT02680002|18670504|P3|Overall Study|Lost to Follow-up|4
5412070|NCT02680002|18670505|P2|Overall Study|Lost to Follow-up|1
5412071|NCT02680002|18670506|P1|Overall Study|Lost to Follow-up|5
5412072|NCT02679755|18670649|P2|Overall Study|Adverse events not related to study drug|2
5412073|NCT02679755|18670650|P1|Overall Study|Adverse events not related to study drug|1
5412074|NCT02679755|18670649|P2|Overall Study|Adverse Event|4
5412075|NCT02679755|18670650|P1|Overall Study|Adverse Event|1
5412076|NCT02679755|18670649|P2|Overall Study|Withdrawal by participant|3
5412077|NCT02679755|18670650|P1|Overall Study|Withdrawal by participant|6
5412078|NCT02679755|18670649|P2|Overall Study|Not defined|2
5412079|NCT02679755|18670650|P1|Overall Study|Not defined|0
5412080|NCT02679755|18670649|P2|Overall Study|Objective progression or relapse|83
5412081|NCT02679755|18670650|P1|Overall Study|Objective progression or relapse|24
5412082|NCT02679755|18670649|P2|Overall Study|Lost to Follow-up|0
5412083|NCT02679755|18670650|P1|Overall Study|Lost to Follow-up|1
5412084|NCT02679755|18670649|P2|Overall Study|Global deterioration of health status|8
5412085|NCT02679755|18670650|P1|Overall Study|Global deterioration of health status|1
5412086|NCT02679755|18670649|P2|Overall Study|Death|3
5412087|NCT02679755|18670650|P1|Overall Study|Death|0
5412088|NCT02679729|18670692|P9|Overall Study|Participant decision|0
5412089|NCT02679729|18670693|P8|Overall Study|Participant decision|0
5412090|NCT02679729|18670694|P7|Overall Study|Participant decision|1
5412091|NCT02679729|18670695|P6|Overall Study|Participant decision|0
5412092|NCT02679729|18670696|P5|Overall Study|Participant decision|0
5412093|NCT02679729|18670697|P4|Overall Study|Participant decision|0
5412094|NCT02679729|18670698|P3|Overall Study|Participant decision|0
5412095|NCT02679729|18670699|P2|Overall Study|Participant decision|1
5412096|NCT02679729|18670700|P1|Overall Study|Participant decision|0
5412097|NCT02679729|18670692|P9|Overall Study|Lost to Follow-up|0
5412098|NCT02679729|18670693|P8|Overall Study|Lost to Follow-up|0
5412099|NCT02679729|18670694|P7|Overall Study|Lost to Follow-up|0
5412100|NCT02679729|18670695|P6|Overall Study|Lost to Follow-up|0
5412101|NCT02679729|18670696|P5|Overall Study|Lost to Follow-up|1
5412102|NCT02679729|18670697|P4|Overall Study|Lost to Follow-up|0
5412103|NCT02679729|18670698|P3|Overall Study|Lost to Follow-up|0
5412104|NCT02679729|18670699|P2|Overall Study|Lost to Follow-up|1
5412105|NCT02679729|18670700|P1|Overall Study|Lost to Follow-up|0
5412106|NCT02679573|18670812|P2|Overall Study|Lost to Follow-up|3
5412107|NCT02679573|18670813|P1|Overall Study|Lost to Follow-up|0
5412108|NCT02679573|18670812|P2|Overall Study|Physician Decision|4
5412109|NCT02679573|18670813|P1|Overall Study|Physician Decision|2
5412110|NCT02679573|18670812|P2|Overall Study|Death|0
5412111|NCT02679573|18670813|P1|Overall Study|Death|2
5412112|NCT02679573|18670812|P2|Overall Study|Withdrawal by Subject|9
5412113|NCT02679573|18670813|P1|Overall Study|Withdrawal by Subject|2
5412114|NCT02679573|18670812|P2|Overall Study|Could not complete required study visits|2
5412115|NCT02679573|18670813|P1|Overall Study|Could not complete required study visits|6
5412116|NCT02679573|18670812|P2|Overall Study|Lack of Efficacy|15
5412117|NCT02679573|18670813|P1|Overall Study|Lack of Efficacy|12
5412118|NCT02679573|18670812|P2|Overall Study|Adverse Event|6
5412119|NCT02679573|18670813|P1|Overall Study|Adverse Event|13
5412120|NCT02679287|18670837|P2|Period 3|Work/Scheduling Conflict|1
5412121|NCT02679287|18670838|P1|Period 3|Work/Scheduling Conflict|0
5412122|NCT02679287|18670837|P2|Period 2|Disliked Mobile System|0
5412123|NCT02679287|18670838|P1|Period 2|Disliked Mobile System|2
5412124|NCT02679287|18670837|P2|Period 2|Work/Scheduling Conflict|0
5412125|NCT02679287|18670838|P1|Period 2|Work/Scheduling Conflict|1
5412126|NCT02679287|18670837|P2|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
5412127|NCT02679287|18670838|P1|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
5412128|NCT02679287|18670837|P2|Period 1: Randomization-Study Session 1|Disliked mobile system|1
5412129|NCT02679287|18670838|P1|Period 1: Randomization-Study Session 1|Disliked mobile system|0
5412130|NCT02679287|18670837|P2|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
5412131|NCT02679287|18670838|P1|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
5412132|NCT02679287|18670837|P2|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
5412133|NCT02679287|18670838|P1|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
5412134|NCT02679274|18670868|P2|Overall Study|Withdrawal by Subject|0
5412135|NCT02679274|18670869|P1|Overall Study|Withdrawal by Subject|1
5412136|NCT02679235|18670899|P1|Overall Study|Adverse Event|1
5412137|NCT02679235|18670899|P1|Overall Study|Withdrawal by Subject|3
5412138|NCT02679222|18670906|P1|Overall Study|No time for project|1
5412139|NCT02678923|18670936|P2|Overall Study|Did Not Return for Study Visits|0
5412140|NCT02678923|18670937|P1|Overall Study|Did Not Return for Study Visits|1
5412141|NCT02678923|18670936|P2|Overall Study|Lost to Follow-up|0
5412142|NCT02678923|18670937|P1|Overall Study|Lost to Follow-up|1
5412143|NCT02678923|18670936|P2|Overall Study|Withdrawal by Subject|2
5412144|NCT02678923|18670937|P1|Overall Study|Withdrawal by Subject|3
5412145|NCT02678923|18670936|P2|Overall Study|Protocol Deviation (Not Dosed)|3
5412146|NCT02678923|18670937|P1|Overall Study|Protocol Deviation (Not Dosed)|1
5412147|NCT02678676|18670953|P2|Overall Study|Unconfirmed for lost to follow-up|67
5412148|NCT02678676|18670954|P1|Overall Study|Unconfirmed for lost to follow-up|85
5412149|NCT02678676|18670953|P2|Overall Study|Lost to Follow-up|151
5412150|NCT02678676|18670954|P1|Overall Study|Lost to Follow-up|171
5412151|NCT02678676|18670953|P2|Overall Study|Withdrawal by Subject|5
5412152|NCT02678676|18670954|P1|Overall Study|Withdrawal by Subject|13
5412153|NCT02678676|18670953|P2|Overall Study|Death|649
5412154|NCT02678676|18670954|P1|Overall Study|Death|619
5412155|NCT02678416|18670985|P1|Part 2|Withdrawal by Subject|1
5412156|NCT02678416|18670985|P1|Part 2|Adverse Event|2
5412157|NCT02678416|18670985|P1|Part 1|Withdrawal by Subject|1
5412158|NCT02678390|18671005|P2|AE (1 Day)|Withdrawal by Subject|1
5412159|NCT02678390|18671006|P1|AE (1 Day)|Withdrawal by Subject|0
5412160|NCT02678286|18671022|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
5412161|NCT02678286|18671023|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
5412162|NCT02678286|18671022|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
5412163|NCT02678286|18671023|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
5412164|NCT02678286|18671022|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
5412165|NCT02678286|18671023|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
5412166|NCT02678286|18671022|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
5412167|NCT02678286|18671023|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
5412168|NCT02678286|18671022|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
5412169|NCT02678286|18671023|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
5412170|NCT02678000|18671075|P5|PART 2|Withdrawal by Subject|0
5412171|NCT02678000|18671076|P4|PART 2|Withdrawal by Subject|0
5412172|NCT02678000|18671077|P3|PART 2|Withdrawal by Subject|1
5412173|NCT02678000|18671078|P2|PART 2|Withdrawal by Subject|0
5412174|NCT02678000|18671079|P1|PART 2|Withdrawal by Subject|0
5412175|NCT02678000|18671075|P5|PART 2|Adverse Event|0
5412176|NCT02678000|18671076|P4|PART 2|Adverse Event|1
5412177|NCT02678000|18671077|P3|PART 2|Adverse Event|2
5412178|NCT02678000|18671078|P2|PART 2|Adverse Event|0
5412179|NCT02678000|18671079|P1|PART 2|Adverse Event|0
5412180|NCT02677896|18671117|P2|Overall Study|Did not receive study drug|2
5412181|NCT02677896|18671118|P1|Overall Study|Did not receive study drug|2
5412182|NCT02677896|18671117|P2|Overall Study|Miscellaneous|11
5412183|NCT02677896|18671118|P1|Overall Study|Miscellaneous|6
5412184|NCT02677896|18671117|P2|Overall Study|Withdrawal by patient:|30
5412185|NCT02677896|18671118|P1|Overall Study|Withdrawal by patient:|25
5412186|NCT02677896|18671117|P2|Overall Study|Protocol deviation|1
5412187|NCT02677896|18671118|P1|Overall Study|Protocol deviation|2
5412188|NCT02677896|18671117|P2|Overall Study|Progressive disease:|171
5412189|NCT02677896|18671118|P1|Overall Study|Progressive disease:|65
5412190|NCT02677896|18671117|P2|Overall Study|Lost to Follow-up|1
5412191|NCT02677896|18671118|P1|Overall Study|Lost to Follow-up|0
5412192|NCT02677896|18671117|P2|Overall Study|Death|7
5412193|NCT02677896|18671118|P1|Overall Study|Death|9
5412194|NCT02677896|18671117|P2|Overall Study|Adverse Event|21
5412195|NCT02677896|18671118|P1|Overall Study|Adverse Event|28
5412196|NCT02677844|18671146|P7|Period 3|Withdrawal by Subject|0
5412197|NCT02677844|18671147|P6|Period 3|Withdrawal by Subject|0
5412198|NCT02677844|18671148|P5|Period 3|Withdrawal by Subject|0
5412199|NCT02677844|18671149|P4|Period 3|Withdrawal by Subject|1
5412200|NCT02677844|18671150|P3|Period 3|Withdrawal by Subject|0
5412201|NCT02677844|18671151|P2|Period 3|Withdrawal by Subject|0
5412202|NCT02677844|18671152|P1|Period 3|Withdrawal by Subject|0
5412203|NCT02677714|18671232|P2|Overall Study|Withdrawal by Subject|0
5412204|NCT02677714|18671233|P1|Overall Study|Withdrawal by Subject|2
5412205|NCT02677220|18671304|P1|Overall Study|Adverse Event|1
5412206|NCT02677116|18671319|P9|Overall Study|Withdrawal by Subject|0
5412207|NCT02677116|18671320|P8|Overall Study|Withdrawal by Subject|0
5412208|NCT02677116|18671321|P7|Overall Study|Withdrawal by Subject|0
5412209|NCT02677116|18671322|P6|Overall Study|Withdrawal by Subject|0
5412210|NCT02677116|18671323|P5|Overall Study|Withdrawal by Subject|0
5412211|NCT02677116|18671324|P4|Overall Study|Withdrawal by Subject|0
5412212|NCT02677116|18671325|P3|Overall Study|Withdrawal by Subject|0
5412213|NCT02677116|18671326|P2|Overall Study|Withdrawal by Subject|0
5412214|NCT02677116|18671327|P1|Overall Study|Withdrawal by Subject|1
5412215|NCT02677116|18671319|P9|Overall Study|Withdrawal by parent or guardian|0
5412216|NCT02677116|18671320|P8|Overall Study|Withdrawal by parent or guardian|1
5412217|NCT02677116|18671321|P7|Overall Study|Withdrawal by parent or guardian|2
5412218|NCT02677116|18671322|P6|Overall Study|Withdrawal by parent or guardian|0
5412219|NCT02677116|18671323|P5|Overall Study|Withdrawal by parent or guardian|0
5412220|NCT02677116|18671324|P4|Overall Study|Withdrawal by parent or guardian|1
5412221|NCT02677116|18671325|P3|Overall Study|Withdrawal by parent or guardian|0
5412222|NCT02677116|18671326|P2|Overall Study|Withdrawal by parent or guardian|1
5412223|NCT02677116|18671327|P1|Overall Study|Withdrawal by parent or guardian|2
5412224|NCT02677116|18671319|P9|Overall Study|Physician Decision|2
5412225|NCT02677116|18671320|P8|Overall Study|Physician Decision|1
5412226|NCT02677116|18671321|P7|Overall Study|Physician Decision|1
5412227|NCT02677116|18671322|P6|Overall Study|Physician Decision|3
5412228|NCT02677116|18671323|P5|Overall Study|Physician Decision|1
5412229|NCT02677116|18671324|P4|Overall Study|Physician Decision|2
5412230|NCT02677116|18671325|P3|Overall Study|Physician Decision|3
5412231|NCT02677116|18671326|P2|Overall Study|Physician Decision|2
5412232|NCT02677116|18671327|P1|Overall Study|Physician Decision|0
5412233|NCT02677116|18671319|P9|Overall Study|Adverse Event|0
5412234|NCT02677116|18671320|P8|Overall Study|Adverse Event|0
5412235|NCT02677116|18671321|P7|Overall Study|Adverse Event|1
5412236|NCT02677116|18671322|P6|Overall Study|Adverse Event|1
5412237|NCT02677116|18671323|P5|Overall Study|Adverse Event|0
5412238|NCT02677116|18671324|P4|Overall Study|Adverse Event|0
5412239|NCT02677116|18671325|P3|Overall Study|Adverse Event|0
5412240|NCT02677116|18671326|P2|Overall Study|Adverse Event|1
5412241|NCT02677116|18671327|P1|Overall Study|Adverse Event|0
5412242|NCT02676895|18671400|P3|Overall Study|Withdrawal by Subject|1
5412243|NCT02676895|18671401|P2|Overall Study|Withdrawal by Subject|0
5412244|NCT02676895|18671402|P1|Overall Study|Withdrawal by Subject|0
5412245|NCT02676895|18671400|P3|Overall Study|Lost to Follow-up|1
5412246|NCT02676895|18671401|P2|Overall Study|Lost to Follow-up|0
5412247|NCT02676895|18671402|P1|Overall Study|Lost to Follow-up|0
5412248|NCT02676895|18671400|P3|Overall Study|Adverse Event|1
5412249|NCT02676895|18671401|P2|Overall Study|Adverse Event|3
5412250|NCT02676895|18671402|P1|Overall Study|Adverse Event|0
5412251|NCT02676895|18671400|P3|Overall Study|Protocol Violation|0
5412252|NCT02676895|18671401|P2|Overall Study|Protocol Violation|0
5412253|NCT02676895|18671402|P1|Overall Study|Protocol Violation|1
5412254|NCT02676895|18671400|P3|Overall Study|Administrative reason|0
5412255|NCT02676895|18671401|P2|Overall Study|Administrative reason|0
5412256|NCT02676895|18671402|P1|Overall Study|Administrative reason|1
5412257|NCT02676882|18671445|P2|Overall Study|Withdrawal by Subject|2
5412258|NCT02676882|18671446|P1|Overall Study|Withdrawal by Subject|1
5412259|NCT02676882|18671445|P2|Overall Study|Lost to Follow-up|0
5412260|NCT02676882|18671446|P1|Overall Study|Lost to Follow-up|1
5412261|NCT02676882|18671445|P2|Overall Study|Adverse Event|0
5412262|NCT02676882|18671446|P1|Overall Study|Adverse Event|1
5412263|NCT02676466|18671465|P8|Overall Study|Withdrawal by Subject|1
5412264|NCT02676466|18671466|P7|Overall Study|Withdrawal by Subject|1
5412265|NCT02676466|18671467|P6|Overall Study|Withdrawal by Subject|1
5412266|NCT02676466|18671468|P5|Overall Study|Withdrawal by Subject|3
5412267|NCT02676466|18671469|P4|Overall Study|Withdrawal by Subject|0
5412268|NCT02676466|18671470|P3|Overall Study|Withdrawal by Subject|1
5412269|NCT02676466|18671471|P2|Overall Study|Withdrawal by Subject|3
5412270|NCT02676466|18671472|P1|Overall Study|Withdrawal by Subject|4
5412271|NCT02676466|18671465|P8|Overall Study|Death|0
5412272|NCT02676466|18671466|P7|Overall Study|Death|0
5412273|NCT02676466|18671467|P6|Overall Study|Death|0
5412274|NCT02676466|18671468|P5|Overall Study|Death|0
5412275|NCT02676466|18671469|P4|Overall Study|Death|0
5412276|NCT02676466|18671470|P3|Overall Study|Death|1
5412277|NCT02676466|18671471|P2|Overall Study|Death|2
5412278|NCT02676466|18671472|P1|Overall Study|Death|0
5412279|NCT02675998|18671555|P4|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
5412280|NCT02675998|18671556|P3|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
5412281|NCT02675998|18671557|P2|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
5412282|NCT02675998|18671558|P1|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
5412283|NCT02675998|18671555|P4|4-Week Randomized Withdrawal Period|Physician Decision|0
5412284|NCT02675998|18671556|P3|4-Week Randomized Withdrawal Period|Physician Decision|0
5412285|NCT02675998|18671557|P2|4-Week Randomized Withdrawal Period|Physician Decision|0
5412286|NCT02675998|18671558|P1|4-Week Randomized Withdrawal Period|Physician Decision|1
5412287|NCT02675998|18671555|P4|4-Week Randomized Withdrawal Period|Protocol Violation|1
5412288|NCT02675998|18671556|P3|4-Week Randomized Withdrawal Period|Protocol Violation|0
5412289|NCT02675998|18671557|P2|4-Week Randomized Withdrawal Period|Protocol Violation|0
5412290|NCT02675998|18671558|P1|4-Week Randomized Withdrawal Period|Protocol Violation|0
5412291|NCT02675998|18671555|P4|4-Week Randomized Withdrawal Period|Adverse Event|3
5412292|NCT02675998|18671556|P3|4-Week Randomized Withdrawal Period|Adverse Event|1
5412293|NCT02675998|18671557|P2|4-Week Randomized Withdrawal Period|Adverse Event|0
5412294|NCT02675998|18671558|P1|4-Week Randomized Withdrawal Period|Adverse Event|0
5412295|NCT02675998|18671555|P4|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
5412296|NCT02675998|18671556|P3|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
5412297|NCT02675998|18671557|P2|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
5412298|NCT02675998|18671558|P1|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
5412299|NCT02675998|18671555|P4|8-Week Treatment Period|Other|0
5412300|NCT02675998|18671556|P3|8-Week Treatment Period|Other|2
5412301|NCT02675998|18671557|P2|8-Week Treatment Period|Other|1
5412302|NCT02675998|18671558|P1|8-Week Treatment Period|Other|3
5412303|NCT02675998|18671555|P4|8-Week Treatment Period|Protocol Violation|0
5412304|NCT02675998|18671556|P3|8-Week Treatment Period|Protocol Violation|1
5412305|NCT02675998|18671557|P2|8-Week Treatment Period|Protocol Violation|1
5412306|NCT02675998|18671558|P1|8-Week Treatment Period|Protocol Violation|1
5412307|NCT02675998|18671555|P4|8-Week Treatment Period|GI side Effects|0
5412308|NCT02675998|18671556|P3|8-Week Treatment Period|GI side Effects|2
5412309|NCT02675998|18671557|P2|8-Week Treatment Period|GI side Effects|4
5412310|NCT02675998|18671558|P1|8-Week Treatment Period|GI side Effects|1
5412311|NCT02675998|18671555|P4|8-Week Treatment Period|Physician Decision|0
5412312|NCT02675998|18671556|P3|8-Week Treatment Period|Physician Decision|2
5412313|NCT02675998|18671557|P2|8-Week Treatment Period|Physician Decision|0
5412314|NCT02675998|18671558|P1|8-Week Treatment Period|Physician Decision|1
5412315|NCT02675998|18671555|P4|8-Week Treatment Period|Lack of Efficacy|0
5412316|NCT02675998|18671556|P3|8-Week Treatment Period|Lack of Efficacy|3
5412317|NCT02675998|18671557|P2|8-Week Treatment Period|Lack of Efficacy|5
5412318|NCT02675998|18671558|P1|8-Week Treatment Period|Lack of Efficacy|2
5412319|NCT02675998|18671555|P4|8-Week Treatment Period|Withdrawal by Subject|0
5412320|NCT02675998|18671556|P3|8-Week Treatment Period|Withdrawal by Subject|3
5412321|NCT02675998|18671557|P2|8-Week Treatment Period|Withdrawal by Subject|3
5412322|NCT02675998|18671558|P1|8-Week Treatment Period|Withdrawal by Subject|3
5412323|NCT02675998|18671555|P4|8-Week Treatment Period|Adverse Event|0
5412324|NCT02675998|18671556|P3|8-Week Treatment Period|Adverse Event|6
5412325|NCT02675998|18671557|P2|8-Week Treatment Period|Adverse Event|5
5412326|NCT02675998|18671558|P1|8-Week Treatment Period|Adverse Event|6
5412327|NCT02675907|18671574|P2|Study Overall|Lost to Follow-up|2
5412328|NCT02675907|18671575|P1|Study Overall|Lost to Follow-up|0
5412329|NCT02675907|18671574|P2|Study Overall|Withdrawal by Subject|2
5412330|NCT02675907|18671575|P1|Study Overall|Withdrawal by Subject|2
5412331|NCT02675907|18671574|P2|Study Overall|Lack of Efficacy|0
5412332|NCT02675907|18671575|P1|Study Overall|Lack of Efficacy|1
5412333|NCT02675907|18671574|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
5412334|NCT02675907|18671575|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
5412335|NCT02675907|18671574|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
5412336|NCT02675907|18671575|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
5412337|NCT02675751|18671620|P1|Overall Study|Lost to Follow-up|16
5412338|NCT02675634|18671624|P6|Test Period 2|Adverse Event|1
5412339|NCT02675634|18671625|P5|Test Period 2|Adverse Event|0
5412340|NCT02675634|18671626|P4|Test Period 2|Adverse Event|0
5412341|NCT02675634|18671627|P3|Test Period 2|Adverse Event|0
5412342|NCT02675634|18671628|P2|Test Period 2|Adverse Event|0
5412343|NCT02675634|18671629|P1|Test Period 2|Adverse Event|0
5412344|NCT02675634|18671624|P6|Test Period 2|Lack of Efficacy|0
5412345|NCT02675634|18671625|P5|Test Period 2|Lack of Efficacy|0
5412346|NCT02675634|18671626|P4|Test Period 2|Lack of Efficacy|0
5412347|NCT02675634|18671627|P3|Test Period 2|Lack of Efficacy|0
5412348|NCT02675634|18671628|P2|Test Period 2|Lack of Efficacy|0
5412349|NCT02675634|18671629|P1|Test Period 2|Lack of Efficacy|1
5412350|NCT02675634|18671624|P6|Test Period 1|Device deficiency that did not lead to A|0
5412351|NCT02675634|18671625|P5|Test Period 1|Device deficiency that did not lead to A|0
5412352|NCT02675634|18671626|P4|Test Period 1|Device deficiency that did not lead to A|0
5412353|NCT02675634|18671627|P3|Test Period 1|Device deficiency that did not lead to A|1
5412354|NCT02675634|18671628|P2|Test Period 1|Device deficiency that did not lead to A|0
5412355|NCT02675634|18671629|P1|Test Period 1|Device deficiency that did not lead to A|0
5412356|NCT02675634|18671624|P6|Test Period 1|Adverse Event|0
5412357|NCT02675634|18671625|P5|Test Period 1|Adverse Event|0
5412358|NCT02675634|18671626|P4|Test Period 1|Adverse Event|1
5412359|NCT02675634|18671627|P3|Test Period 1|Adverse Event|0
5412360|NCT02675634|18671628|P2|Test Period 1|Adverse Event|1
5412361|NCT02675634|18671629|P1|Test Period 1|Adverse Event|0
5412362|NCT02675517|18671646|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
5412363|NCT02675517|18671646|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
5412364|NCT02675426|18671658|P3|Overall Study|Other|2
5412365|NCT02675426|18671659|P2|Overall Study|Other|1
5412366|NCT02675426|18671660|P1|Overall Study|Other|3
5412367|NCT02675426|18671658|P3|Overall Study|Lost to Follow-up|2
5412368|NCT02675426|18671659|P2|Overall Study|Lost to Follow-up|0
5412369|NCT02675426|18671660|P1|Overall Study|Lost to Follow-up|1
5412370|NCT02675426|18671658|P3|Overall Study|Withdrawal by Subject|5
5412371|NCT02675426|18671659|P2|Overall Study|Withdrawal by Subject|5
5412372|NCT02675426|18671660|P1|Overall Study|Withdrawal by Subject|3
5412373|NCT02675426|18671658|P3|Overall Study|Adverse Event|9
5412374|NCT02675426|18671659|P2|Overall Study|Adverse Event|2
5412375|NCT02675426|18671660|P1|Overall Study|Adverse Event|6
5412376|NCT02675231|18671704|P3|Overall Study|On study treatment/follow up|23
5412377|NCT02675231|18671705|P2|Overall Study|On study treatment/follow up|31
5412378|NCT02675231|18671706|P1|Overall Study|On study treatment/follow up|23
5412379|NCT02675231|18671704|P3|Overall Study|Lost to Follow-up|2
5412380|NCT02675231|18671705|P2|Overall Study|Lost to Follow-up|2
5412381|NCT02675231|18671706|P1|Overall Study|Lost to Follow-up|2
5412382|NCT02675231|18671704|P3|Overall Study|Withdrawal by Subject|1
5412383|NCT02675231|18671705|P2|Overall Study|Withdrawal by Subject|3
5412384|NCT02675231|18671706|P1|Overall Study|Withdrawal by Subject|1
5412385|NCT02675075|18671742|P2|Overall Study|Lost to Follow-up|0
5412386|NCT02675075|18671743|P1|Overall Study|Lost to Follow-up|3
5412387|NCT02674854|18671755|P3|Overall Study|Subject missed V6.2|0
5412388|NCT02674854|18671756|P2|Overall Study|Subject missed V6.2|0
5412389|NCT02674854|18671757|P1|Overall Study|Subject missed V6.2|1
5412390|NCT02674854|18671755|P3|Overall Study|Death|0
5412391|NCT02674854|18671756|P2|Overall Study|Death|1
5412392|NCT02674854|18671757|P1|Overall Study|Death|0
5412393|NCT02674854|18671755|P3|Overall Study|Protocol Violation|2
5412394|NCT02674854|18671756|P2|Overall Study|Protocol Violation|1
5412395|NCT02674854|18671757|P1|Overall Study|Protocol Violation|1
5412396|NCT02674854|18671755|P3|Overall Study|Disallowed Concurrent Medication|0
5412397|NCT02674854|18671756|P2|Overall Study|Disallowed Concurrent Medication|2
5412398|NCT02674854|18671757|P1|Overall Study|Disallowed Concurrent Medication|2
5412399|NCT02674854|18671755|P3|Overall Study|Lack of Efficacy|0
5412400|NCT02674854|18671756|P2|Overall Study|Lack of Efficacy|3
5412401|NCT02674854|18671757|P1|Overall Study|Lack of Efficacy|0
5412402|NCT02674854|18671755|P3|Overall Study|Lost to Follow-up|2
5412403|NCT02674854|18671756|P2|Overall Study|Lost to Follow-up|0
5412404|NCT02674854|18671757|P1|Overall Study|Lost to Follow-up|1
5412405|NCT02674854|18671755|P3|Overall Study|No-compliant subject|1
5412406|NCT02674854|18671756|P2|Overall Study|No-compliant subject|0
5412407|NCT02674854|18671757|P1|Overall Study|No-compliant subject|1
5412408|NCT02674854|18671755|P3|Overall Study|Withdrawal by Subject|4
5412409|NCT02674854|18671756|P2|Overall Study|Withdrawal by Subject|5
5412410|NCT02674854|18671757|P1|Overall Study|Withdrawal by Subject|1
5412411|NCT02674854|18671755|P3|Overall Study|Adverse Event|5
5412412|NCT02674854|18671756|P2|Overall Study|Adverse Event|15
5412413|NCT02674854|18671757|P1|Overall Study|Adverse Event|17
5412414|NCT02674685|18671765|P1|Overall Study|Protocol Violation|4
5412415|NCT02674633|18671806|P2|Overall Study|Withdrawal by Parent/Guardian|2
5412416|NCT02674633|18671807|P1|Overall Study|Withdrawal by Parent/Guardian|1
5412417|NCT02674633|18671806|P2|Overall Study|Physician Decision|0
5412418|NCT02674633|18671807|P1|Overall Study|Physician Decision|1
5412419|NCT02674633|18671806|P2|Overall Study|Lost to Follow-up|2
5412420|NCT02674633|18671807|P1|Overall Study|Lost to Follow-up|3
5412421|NCT02674568|18671827|P1|Overall Study|Other, Not Specified|20
5412422|NCT02674568|18671827|P1|Overall Study|Lost to Follow-up|9
5412423|NCT02674568|18671827|P1|Overall Study|Physician Decision|2
5412424|NCT02674568|18671827|P1|Overall Study|Death|303
5412425|NCT02674568|18671827|P1|Overall Study|Withdrawal by Subject|5
5412426|NCT02674477|18671852|P2|Overall Study|Protocol Violation|2
5412427|NCT02674477|18671853|P1|Overall Study|Protocol Violation|8
5412428|NCT02674386|18671877|P3|Overall Study|Enrolled but not evaluated|0
5412429|NCT02674386|18671878|P2|Overall Study|Enrolled but not evaluated|4
5412430|NCT02674386|18671879|P1|Overall Study|Enrolled but not evaluated|0
5412431|NCT02674386|18671877|P3|Overall Study|Other|0
5412432|NCT02674386|18671878|P2|Overall Study|Other|1
5412433|NCT02674386|18671879|P1|Overall Study|Other|0
5412434|NCT02674386|18671877|P3|Overall Study|Withdrawal by Subject|0
5412435|NCT02674386|18671878|P2|Overall Study|Withdrawal by Subject|4
5412436|NCT02674386|18671879|P1|Overall Study|Withdrawal by Subject|0
5412437|NCT02674386|18671877|P3|Overall Study|Lost to Follow-up|1
5412438|NCT02674386|18671878|P2|Overall Study|Lost to Follow-up|1
5412439|NCT02674386|18671879|P1|Overall Study|Lost to Follow-up|0
5412440|NCT02674334|18671934|P2|Overall Study|NIRS not recording|0
5412441|NCT02674334|18671935|P1|Overall Study|NIRS not recording|1
5412442|NCT02674334|18671934|P2|Overall Study|participant difficulty breathing|0
5412443|NCT02674334|18671935|P1|Overall Study|participant difficulty breathing|1
5412444|NCT02674334|18671934|P2|Overall Study|Lost to Follow-up|3
5412445|NCT02674334|18671935|P1|Overall Study|Lost to Follow-up|5
5412446|NCT02674204|18671945|P2|Overall Study|Adverse Event|0
5412447|NCT02674204|18671946|P1|Overall Study|Adverse Event|1
5412448|NCT02674061|18671982|P2|Overall Study|Ongoing in Study|20
5412449|NCT02674061|18671983|P1|Overall Study|Ongoing in Study|71
5412450|NCT02674061|18671982|P2|Overall Study|Withdrawal by Subject|2
5412451|NCT02674061|18671983|P1|Overall Study|Withdrawal by Subject|9
5412452|NCT02674061|18671982|P2|Overall Study|Lost to Follow-up|0
5412453|NCT02674061|18671983|P1|Overall Study|Lost to Follow-up|1
5412454|NCT02674061|18671982|P2|Overall Study|Death|69
5412455|NCT02674061|18671983|P1|Overall Study|Death|204
5412456|NCT02673684|18672207|P2|Overall Study|Study not completed d/t loss of funding|8
5412457|NCT02673684|18672208|P1|Overall Study|Study not completed d/t loss of funding|9
5412458|NCT02673619|18672224|P4|Overall Study|Lack of Efficacy|0
5412459|NCT02673619|18672225|P3|Overall Study|Lack of Efficacy|1
5412460|NCT02673619|18672226|P2|Overall Study|Lack of Efficacy|0
5412461|NCT02673619|18672227|P1|Overall Study|Lack of Efficacy|0
5412462|NCT02673619|18672224|P4|Overall Study|Adverse Event|0
5412463|NCT02673619|18672225|P3|Overall Study|Adverse Event|1
5412464|NCT02673619|18672226|P2|Overall Study|Adverse Event|0
5412465|NCT02673619|18672227|P1|Overall Study|Adverse Event|0
5412466|NCT02673619|18672224|P4|Overall Study|Withdrawal by Subject|0
5412467|NCT02673619|18672225|P3|Overall Study|Withdrawal by Subject|1
5412468|NCT02673619|18672226|P2|Overall Study|Withdrawal by Subject|1
5412469|NCT02673619|18672227|P1|Overall Study|Withdrawal by Subject|1
5412470|NCT02673619|18672224|P4|Overall Study|Lost to Follow-up|0
5412471|NCT02673619|18672225|P3|Overall Study|Lost to Follow-up|0
5412472|NCT02673619|18672226|P2|Overall Study|Lost to Follow-up|0
5412473|NCT02673619|18672227|P1|Overall Study|Lost to Follow-up|1
5412474|NCT02673515|18672338|P2|Overall Study|Lack of motivation|1
5412475|NCT02673515|18672339|P1|Overall Study|Lack of motivation|2
5412476|NCT02673489|18672355|P2|Follow Up Period|Unable to return for follow-up|1
5412477|NCT02673489|18672356|P1|Follow Up Period|Unable to return for follow-up|0
5412478|NCT02673489|18672355|P2|Follow Up Period|Unable to return for week 24 follow-up|1
5412479|NCT02673489|18672356|P1|Follow Up Period|Unable to return for week 24 follow-up|0
5412480|NCT02673489|18672355|P2|Treatment Period|Adverse Event|1
5412481|NCT02673489|18672356|P1|Treatment Period|Adverse Event|0
5412482|NCT02673489|18672355|P2|Treatment Period|Participant was incarcerated|1
5412483|NCT02673489|18672356|P1|Treatment Period|Participant was incarcerated|0
5412484|NCT02673489|18672355|P2|Treatment Period|Participant moved to another province|0
5412485|NCT02673489|18672356|P1|Treatment Period|Participant moved to another province|1
5412486|NCT02673489|18672355|P2|Treatment Period|Participant request to discontinue|1
5412487|NCT02673489|18672356|P1|Treatment Period|Participant request to discontinue|1
5412488|NCT02673489|18672355|P2|Treatment Period|Lost to Follow-up|0
5412489|NCT02673489|18672356|P1|Treatment Period|Lost to Follow-up|3
5412490|NCT02672852|18672421|P7|Part B|Other|2
5412491|NCT02672852|18672422|P6|Part B|Other|1
5412492|NCT02672852|18672423|P5|Part B|Other|4
5412493|NCT02672852|18672424|P4|Part B|Other|0
5412494|NCT02672852|18672425|P3|Part B|Other|0
5412495|NCT02672852|18672426|P2|Part B|Other|0
5412496|NCT02672852|18672427|P1|Part B|Other|0
5412497|NCT02672852|18672421|P7|Part B|Withdrawal by Subject|7
5412498|NCT02672852|18672422|P6|Part B|Withdrawal by Subject|0
5412499|NCT02672852|18672423|P5|Part B|Withdrawal by Subject|5
5412500|NCT02672852|18672424|P4|Part B|Withdrawal by Subject|0
5412501|NCT02672852|18672425|P3|Part B|Withdrawal by Subject|0
5412502|NCT02672852|18672426|P2|Part B|Withdrawal by Subject|0
5412503|NCT02672852|18672427|P1|Part B|Withdrawal by Subject|0
5412504|NCT02672852|18672421|P7|Part B|Lost to Follow-up|1
5412505|NCT02672852|18672422|P6|Part B|Lost to Follow-up|4
5412506|NCT02672852|18672423|P5|Part B|Lost to Follow-up|3
5412507|NCT02672852|18672424|P4|Part B|Lost to Follow-up|0
5412508|NCT02672852|18672425|P3|Part B|Lost to Follow-up|0
5412509|NCT02672852|18672426|P2|Part B|Lost to Follow-up|0
5412510|NCT02672852|18672427|P1|Part B|Lost to Follow-up|0
5412511|NCT02672852|18672421|P7|Part B|Other adverse event|1
5412512|NCT02672852|18672422|P6|Part B|Other adverse event|5
5412513|NCT02672852|18672423|P5|Part B|Other adverse event|3
5412514|NCT02672852|18672424|P4|Part B|Other adverse event|0
5412515|NCT02672852|18672425|P3|Part B|Other adverse event|0
5412516|NCT02672852|18672426|P2|Part B|Other adverse event|0
5412517|NCT02672852|18672427|P1|Part B|Other adverse event|0
5412518|NCT02672852|18672421|P7|Part B|Worsening pre-existing condition|0
5412519|NCT02672852|18672422|P6|Part B|Worsening pre-existing condition|1
5412520|NCT02672852|18672423|P5|Part B|Worsening pre-existing condition|0
5412521|NCT02672852|18672424|P4|Part B|Worsening pre-existing condition|0
5412522|NCT02672852|18672425|P3|Part B|Worsening pre-existing condition|0
5412523|NCT02672852|18672426|P2|Part B|Worsening pre-existing condition|0
5412524|NCT02672852|18672427|P1|Part B|Worsening pre-existing condition|0
5412525|NCT02672852|18672421|P7|Part B|Disease worsening|1
5412526|NCT02672852|18672422|P6|Part B|Disease worsening|0
5412527|NCT02672852|18672423|P5|Part B|Disease worsening|1
5412528|NCT02672852|18672424|P4|Part B|Disease worsening|0
5412529|NCT02672852|18672425|P3|Part B|Disease worsening|0
5412530|NCT02672852|18672426|P2|Part B|Disease worsening|0
5412531|NCT02672852|18672427|P1|Part B|Disease worsening|0
5412532|NCT02672852|18672421|P7|Part A2|Not entered in Part B|0
5412533|NCT02672852|18672422|P6|Part A2|Not entered in Part B|0
5412534|NCT02672852|18672423|P5|Part A2|Not entered in Part B|0
5412535|NCT02672852|18672424|P4|Part A2|Not entered in Part B|4
5412536|NCT02672852|18672425|P3|Part A2|Not entered in Part B|0
5412537|NCT02672852|18672426|P2|Part A2|Not entered in Part B|0
5412538|NCT02672852|18672427|P1|Part A2|Not entered in Part B|0
5412539|NCT02672852|18672421|P7|Part A2|Other|0
5412540|NCT02672852|18672422|P6|Part A2|Other|0
5412541|NCT02672852|18672423|P5|Part A2|Other|0
5412542|NCT02672852|18672424|P4|Part A2|Other|0
5412543|NCT02672852|18672425|P3|Part A2|Other|3
5412544|NCT02672852|18672426|P2|Part A2|Other|0
5412545|NCT02672852|18672427|P1|Part A2|Other|0
5412546|NCT02672852|18672421|P7|Part A2|Withdrawal by Subject|0
5412547|NCT02672852|18672422|P6|Part A2|Withdrawal by Subject|0
5412548|NCT02672852|18672423|P5|Part A2|Withdrawal by Subject|0
5412549|NCT02672852|18672424|P4|Part A2|Withdrawal by Subject|0
5412550|NCT02672852|18672425|P3|Part A2|Withdrawal by Subject|1
5412551|NCT02672852|18672426|P2|Part A2|Withdrawal by Subject|0
5412552|NCT02672852|18672427|P1|Part A2|Withdrawal by Subject|0
5412553|NCT02672852|18672421|P7|Part A2|Lost to Follow-up|0
5412554|NCT02672852|18672422|P6|Part A2|Lost to Follow-up|0
5412555|NCT02672852|18672423|P5|Part A2|Lost to Follow-up|0
5412556|NCT02672852|18672424|P4|Part A2|Lost to Follow-up|0
5412557|NCT02672852|18672425|P3|Part A2|Lost to Follow-up|2
5412558|NCT02672852|18672426|P2|Part A2|Lost to Follow-up|0
5412559|NCT02672852|18672427|P1|Part A2|Lost to Follow-up|0
5412560|NCT02672852|18672421|P7|Part A2|Adverse Event|0
5412561|NCT02672852|18672422|P6|Part A2|Adverse Event|0
5412562|NCT02672852|18672423|P5|Part A2|Adverse Event|0
5412563|NCT02672852|18672424|P4|Part A2|Adverse Event|0
5412564|NCT02672852|18672425|P3|Part A2|Adverse Event|3
5412565|NCT02672852|18672426|P2|Part A2|Adverse Event|0
5412566|NCT02672852|18672427|P1|Part A2|Adverse Event|0
5412567|NCT02672852|18672421|P7|Part A2|Disease worsening|0
5412568|NCT02672852|18672422|P6|Part A2|Disease worsening|0
5412569|NCT02672852|18672423|P5|Part A2|Disease worsening|0
5412570|NCT02672852|18672424|P4|Part A2|Disease worsening|0
5412571|NCT02672852|18672425|P3|Part A2|Disease worsening|1
5412572|NCT02672852|18672426|P2|Part A2|Disease worsening|0
5412573|NCT02672852|18672427|P1|Part A2|Disease worsening|0
5412574|NCT02672852|18672421|P7|Part A1|Withdrawal by Subject|0
5412575|NCT02672852|18672422|P6|Part A1|Withdrawal by Subject|0
5412576|NCT02672852|18672423|P5|Part A1|Withdrawal by Subject|0
5412577|NCT02672852|18672424|P4|Part A1|Withdrawal by Subject|0
5412578|NCT02672852|18672425|P3|Part A1|Withdrawal by Subject|0
5412579|NCT02672852|18672426|P2|Part A1|Withdrawal by Subject|1
5412580|NCT02672852|18672427|P1|Part A1|Withdrawal by Subject|1
5412581|NCT02672852|18672421|P7|Part A1|Lost to Follow-up|0
5412582|NCT02672852|18672422|P6|Part A1|Lost to Follow-up|0
5412583|NCT02672852|18672423|P5|Part A1|Lost to Follow-up|0
5412584|NCT02672852|18672424|P4|Part A1|Lost to Follow-up|0
5412585|NCT02672852|18672425|P3|Part A1|Lost to Follow-up|0
5412586|NCT02672852|18672426|P2|Part A1|Lost to Follow-up|2
5412587|NCT02672852|18672427|P1|Part A1|Lost to Follow-up|1
5412588|NCT02672852|18672421|P7|Part A1|Adverse Event|0
5412589|NCT02672852|18672422|P6|Part A1|Adverse Event|0
5412590|NCT02672852|18672423|P5|Part A1|Adverse Event|0
5412591|NCT02672852|18672424|P4|Part A1|Adverse Event|0
5412592|NCT02672852|18672425|P3|Part A1|Adverse Event|0
5412593|NCT02672852|18672426|P2|Part A1|Adverse Event|1
5412594|NCT02672852|18672427|P1|Part A1|Adverse Event|0
5412595|NCT02672852|18672421|P7|Part A1|Disease Worsening|0
5412596|NCT02672852|18672422|P6|Part A1|Disease Worsening|0
5412597|NCT02672852|18672423|P5|Part A1|Disease Worsening|0
5412598|NCT02672852|18672424|P4|Part A1|Disease Worsening|0
5412599|NCT02672852|18672425|P3|Part A1|Disease Worsening|0
5412600|NCT02672852|18672426|P2|Part A1|Disease Worsening|0
5412601|NCT02672852|18672427|P1|Part A1|Disease Worsening|1
5412602|NCT02672553|18672458|P2|Overall Study|Intraoperative screen failure|0
5412603|NCT02672553|18672459|P1|Overall Study|Intraoperative screen failure|2
5412604|NCT02672553|18672458|P2|Overall Study|Withdrawal by Subject|3
5412605|NCT02672553|18672459|P1|Overall Study|Withdrawal by Subject|3
5412606|NCT02672553|18672458|P2|Overall Study|Conversion to Commercial Valve|0
5412607|NCT02672553|18672459|P1|Overall Study|Conversion to Commercial Valve|3
5412608|NCT02672553|18672458|P2|Overall Study|Valve Explant|0
5412609|NCT02672553|18672459|P1|Overall Study|Valve Explant|1
5412610|NCT02672553|18672458|P2|Overall Study|Death|5
5412611|NCT02672553|18672459|P1|Overall Study|Death|3
5412612|NCT02672423|18672531|P10|Period 3|Physician Decision|0
5412613|NCT02672423|18672532|P9|Period 3|Physician Decision|0
5412614|NCT02672423|18672533|P8|Period 3|Physician Decision|0
5412615|NCT02672423|18672534|P7|Period 3|Physician Decision|0
5412616|NCT02672423|18672535|P6|Period 3|Physician Decision|1
5412617|NCT02672423|18672536|P5|Period 3|Physician Decision|0
5412618|NCT02672423|18672537|P4|Period 3|Physician Decision|0
5412619|NCT02672423|18672538|P3|Period 3|Physician Decision|0
5412620|NCT02672423|18672539|P2|Period 3|Physician Decision|0
5412621|NCT02672423|18672540|P1|Period 3|Physician Decision|0
5412622|NCT02672423|18672531|P10|Period 3|Withdrawal by Subject|0
5412623|NCT02672423|18672532|P9|Period 3|Withdrawal by Subject|0
5412624|NCT02672423|18672533|P8|Period 3|Withdrawal by Subject|1
5412625|NCT02672423|18672534|P7|Period 3|Withdrawal by Subject|0
5412626|NCT02672423|18672535|P6|Period 3|Withdrawal by Subject|0
5412627|NCT02672423|18672536|P5|Period 3|Withdrawal by Subject|0
5412628|NCT02672423|18672537|P4|Period 3|Withdrawal by Subject|0
5412629|NCT02672423|18672538|P3|Period 3|Withdrawal by Subject|0
5412630|NCT02672423|18672539|P2|Period 3|Withdrawal by Subject|0
5412631|NCT02672423|18672540|P1|Period 3|Withdrawal by Subject|0
5412632|NCT02672423|18672531|P10|Period 2|Withdrawal by Subject|0
5412633|NCT02672423|18672532|P9|Period 2|Withdrawal by Subject|0
5412634|NCT02672423|18672533|P8|Period 2|Withdrawal by Subject|0
5412635|NCT02672423|18672534|P7|Period 2|Withdrawal by Subject|0
5412636|NCT02672423|18672535|P6|Period 2|Withdrawal by Subject|0
5412637|NCT02672423|18672536|P5|Period 2|Withdrawal by Subject|0
5412638|NCT02672423|18672537|P4|Period 2|Withdrawal by Subject|0
5412639|NCT02672423|18672538|P3|Period 2|Withdrawal by Subject|1
5412640|NCT02672423|18672539|P2|Period 2|Withdrawal by Subject|0
5412641|NCT02672423|18672540|P1|Period 2|Withdrawal by Subject|0
5412642|NCT02672423|18672531|P10|Period 1|Adverse Event|0
5412643|NCT02672423|18672532|P9|Period 1|Adverse Event|0
5412644|NCT02672423|18672533|P8|Period 1|Adverse Event|0
5412645|NCT02672423|18672534|P7|Period 1|Adverse Event|0
5412646|NCT02672423|18672535|P6|Period 1|Adverse Event|0
5412647|NCT02672423|18672536|P5|Period 1|Adverse Event|1
5412648|NCT02672423|18672537|P4|Period 1|Adverse Event|0
5412649|NCT02672423|18672538|P3|Period 1|Adverse Event|0
5412650|NCT02672423|18672539|P2|Period 1|Adverse Event|0
5412651|NCT02672423|18672540|P1|Period 1|Adverse Event|0
5412652|NCT02671760|18672635|P3|Overall Study|Lost to Follow-up|0
5412653|NCT02671760|18672636|P2|Overall Study|Lost to Follow-up|1
5412654|NCT02671760|18672637|P1|Overall Study|Lost to Follow-up|0
5412655|NCT02671500|18672663|P1|Overall Study|Lost to Follow-up|2
5412656|NCT02671500|18672663|P1|Overall Study|Lack of Efficacy|12
5412657|NCT02671461|18672678|P3|Follow-up|Administrative Reason by Sponsor|0
5412658|NCT02671461|18672679|P2|Follow-up|Administrative Reason by Sponsor|1
5412659|NCT02671461|18672680|P1|Follow-up|Administrative Reason by Sponsor|0
5412660|NCT02671461|18672678|P3|Follow-up|Lost to Follow-up|1
5412661|NCT02671461|18672679|P2|Follow-up|Lost to Follow-up|0
5412662|NCT02671461|18672680|P1|Follow-up|Lost to Follow-up|0
5412663|NCT02671461|18672678|P3|Follow-up|Withdrawal by Subject|0
5412664|NCT02671461|18672679|P2|Follow-up|Withdrawal by Subject|0
5412665|NCT02671461|18672680|P1|Follow-up|Withdrawal by Subject|1
5412666|NCT02671461|18672678|P3|Treatment|Randomized, not treated|0
5412667|NCT02671461|18672679|P2|Treatment|Randomized, not treated|0
5412668|NCT02671461|18672680|P1|Treatment|Randomized, not treated|1
5412669|NCT02671461|18672678|P3|Treatment|Administrative Reason by Sponsor|4
5412670|NCT02671461|18672679|P2|Treatment|Administrative Reason by Sponsor|3
5412671|NCT02671461|18672680|P1|Treatment|Administrative Reason by Sponsor|1
5412672|NCT02671461|18672678|P3|Treatment|Adverse Event|1
5412673|NCT02671461|18672679|P2|Treatment|Adverse Event|0
5412674|NCT02671461|18672680|P1|Treatment|Adverse Event|0
5412675|NCT02671422|18672703|P1|Overall Study|Other not defined above|3
5412676|NCT02671422|18672703|P1|Overall Study|Not treated with Vargatef®|3
5412677|NCT02671422|18672703|P1|Overall Study|Adverse Event unrelated to Vargatef®|8
5412678|NCT02671422|18672703|P1|Overall Study|Sponsor decision|5
5412679|NCT02671422|18672703|P1|Overall Study|Worsening of Disease|4
5412680|NCT02671422|18672703|P1|Overall Study|Progressive Disease|156
5412681|NCT02671422|18672703|P1|Overall Study|Withdrawal by Subject|7
5412682|NCT02671422|18672703|P1|Overall Study|Lost to Follow-up|4
5412683|NCT02671422|18672703|P1|Overall Study|Lack of Efficacy|1
5412684|NCT02671422|18672703|P1|Overall Study|Adverse Event|68
5412685|NCT02671422|18672703|P1|Overall Study|Lost to Follow-up|1
5412686|NCT02671266|18672709|P2|Overall Study|Withdrawal by Subject|1
5412687|NCT02671266|18672710|P1|Overall Study|Withdrawal by Subject|1
5412688|NCT02670928|18672741|P2|Overall Study|Miss 3 classes in a row in first 12 wks|0
5412689|NCT02670928|18672742|P1|Overall Study|Miss 3 classes in a row in first 12 wks|2
5412690|NCT02670928|18672741|P2|Overall Study|Lost to Follow-up|0
5412691|NCT02670928|18672742|P1|Overall Study|Lost to Follow-up|1
5412692|NCT02670928|18672741|P2|Overall Study|Withdrawal by Subject|0
5412693|NCT02670928|18672742|P1|Overall Study|Withdrawal by Subject|4
5412694|NCT02670928|18672741|P2|Overall Study|Adverse Event|1
5412695|NCT02670928|18672742|P1|Overall Study|Adverse Event|3
5412696|NCT02670915|18672769|P3|Overall Study|Unclassified|0
5412697|NCT02670915|18672770|P2|Overall Study|Unclassified|3
5412698|NCT02670915|18672771|P1|Overall Study|Unclassified|0
5412699|NCT02670915|18672769|P3|Overall Study|Withdrawal by parent/guardian|1
5412700|NCT02670915|18672770|P2|Overall Study|Withdrawal by parent/guardian|4
5412701|NCT02670915|18672771|P1|Overall Study|Withdrawal by parent/guardian|4
5412702|NCT02670915|18672769|P3|Overall Study|Withdrawal by Subject|4
5412703|NCT02670915|18672770|P2|Overall Study|Withdrawal by Subject|1
5412704|NCT02670915|18672771|P1|Overall Study|Withdrawal by Subject|0
5412705|NCT02670551|18673055|P3|Overall Study|Did Not Receive Treatment|0
5412706|NCT02670551|18673056|P2|Overall Study|Did Not Receive Treatment|3
5412707|NCT02670551|18673057|P1|Overall Study|Did Not Receive Treatment|5
5412708|NCT02670551|18673055|P3|Overall Study|Other Miscellaneous Reasons|3
5412709|NCT02670551|18673056|P2|Overall Study|Other Miscellaneous Reasons|3
5412710|NCT02670551|18673057|P1|Overall Study|Other Miscellaneous Reasons|2
5412711|NCT02670551|18673055|P3|Overall Study|Noncompliance with study drug|2
5412712|NCT02670551|18673056|P2|Overall Study|Noncompliance with study drug|3
5412713|NCT02670551|18673057|P1|Overall Study|Noncompliance with study drug|3
5412714|NCT02670551|18673055|P3|Overall Study|Protocol Violation|0
5412715|NCT02670551|18673056|P2|Overall Study|Protocol Violation|0
5412716|NCT02670551|18673057|P1|Overall Study|Protocol Violation|1
5412717|NCT02670551|18673055|P3|Overall Study|Lost to Follow-up|6
5412718|NCT02670551|18673056|P2|Overall Study|Lost to Follow-up|7
5412719|NCT02670551|18673057|P1|Overall Study|Lost to Follow-up|5
5412720|NCT02670551|18673055|P3|Overall Study|Withdrawal of Consent|8
5412721|NCT02670551|18673056|P2|Overall Study|Withdrawal of Consent|3
5412722|NCT02670551|18673057|P1|Overall Study|Withdrawal of Consent|6
5412723|NCT02670551|18673055|P3|Overall Study|Lack of Efficacy|3
5412724|NCT02670551|18673056|P2|Overall Study|Lack of Efficacy|0
5412725|NCT02670551|18673057|P1|Overall Study|Lack of Efficacy|2
5412726|NCT02670551|18673055|P3|Overall Study|Adverse Event|9
5412727|NCT02670551|18673056|P2|Overall Study|Adverse Event|7
5412728|NCT02670551|18673057|P1|Overall Study|Adverse Event|4
5412729|NCT02670538|18673071|P3|Overall Study|Other Miscellaneous Reasons|2
5412730|NCT02670538|18673072|P2|Overall Study|Other Miscellaneous Reasons|1
5412731|NCT02670538|18673073|P1|Overall Study|Other Miscellaneous Reasons|0
5412732|NCT02670538|18673071|P3|Overall Study|Noncompliance with Study Drug|2
5412733|NCT02670538|18673072|P2|Overall Study|Noncompliance with Study Drug|3
5412734|NCT02670538|18673073|P1|Overall Study|Noncompliance with Study Drug|1
5412735|NCT02670538|18673071|P3|Overall Study|Protocol Violation|1
5412736|NCT02670538|18673072|P2|Overall Study|Protocol Violation|4
5412737|NCT02670538|18673073|P1|Overall Study|Protocol Violation|3
5412738|NCT02670538|18673071|P3|Overall Study|Lack of Efficacy|2
5412739|NCT02670538|18673072|P2|Overall Study|Lack of Efficacy|1
5412740|NCT02670538|18673073|P1|Overall Study|Lack of Efficacy|7
5412741|NCT02670538|18673071|P3|Overall Study|Adverse Event|11
5412742|NCT02670538|18673072|P2|Overall Study|Adverse Event|5
5412743|NCT02670538|18673073|P1|Overall Study|Adverse Event|5
5412744|NCT02670538|18673071|P3|Overall Study|Lost to Follow-up|7
5412745|NCT02670538|18673072|P2|Overall Study|Lost to Follow-up|12
5412746|NCT02670538|18673073|P1|Overall Study|Lost to Follow-up|8
5412747|NCT02670538|18673071|P3|Overall Study|Withdrawal of Consent|5
5412748|NCT02670538|18673072|P2|Overall Study|Withdrawal of Consent|6
5412749|NCT02670538|18673073|P1|Overall Study|Withdrawal of Consent|8
5412750|NCT02670473|18673084|P1|Overall Study|Withdrawal by Subject|1
5412751|NCT02670330|18673143|P2|Overall Study|Lost to Follow-up|2
5412752|NCT02670330|18673144|P1|Overall Study|Lost to Follow-up|3
5412753|NCT02670330|18673143|P2|Overall Study|Withdrawal by Subject|29
5412754|NCT02670330|18673144|P1|Overall Study|Withdrawal by Subject|34
5412755|NCT02670330|18673143|P2|Overall Study|Adverse Event|3
5412756|NCT02670330|18673144|P1|Overall Study|Adverse Event|1
5412757|NCT02670330|18673143|P2|Overall Study|Study Terminated By Sponsor|43
5412758|NCT02670330|18673144|P1|Overall Study|Study Terminated By Sponsor|36
5412759|NCT02670330|18673143|P2|Overall Study|Protocol Deviation|0
5412760|NCT02670330|18673144|P1|Overall Study|Protocol Deviation|1
5412761|NCT02670083|18673156|P2|Overall Study|Non-Compliance With Study Drug|0
5412762|NCT02670083|18673157|P1|Overall Study|Non-Compliance With Study Drug|1
5412763|NCT02670083|18673156|P2|Overall Study|Withdrawal by Subject|31
5412764|NCT02670083|18673157|P1|Overall Study|Withdrawal by Subject|32
5412765|NCT02670083|18673156|P2|Overall Study|Symptomatic Deterioration|2
5412766|NCT02670083|18673157|P1|Overall Study|Symptomatic Deterioration|0
5412767|NCT02670083|18673156|P2|Overall Study|Study Terminated By Sponsor|254
5412768|NCT02670083|18673157|P1|Overall Study|Study Terminated By Sponsor|257
5412769|NCT02670083|18673156|P2|Overall Study|Physician Decision|2
5412770|NCT02670083|18673157|P1|Overall Study|Physician Decision|0
5412771|NCT02670083|18673156|P2|Overall Study|Multiple Reasons|9
5412772|NCT02670083|18673157|P1|Overall Study|Multiple Reasons|9
5412773|NCT02670083|18673156|P2|Overall Study|Lost to Follow-up|2
5412774|NCT02670083|18673157|P1|Overall Study|Lost to Follow-up|2
5412775|NCT02670083|18673156|P2|Overall Study|Death|6
5412776|NCT02670083|18673157|P1|Overall Study|Death|4
5412777|NCT02670083|18673156|P2|Overall Study|Adverse Event|13
5412778|NCT02670083|18673157|P1|Overall Study|Adverse Event|16
5412779|NCT02669940|18673202|P2|Overall Study|Insufficient follow-up data|0
5412780|NCT02669940|18673203|P1|Overall Study|Insufficient follow-up data|1
5412781|NCT02669940|18673202|P2|Overall Study|Failure to return|3
5412782|NCT02669940|18673203|P1|Overall Study|Failure to return|0
5412783|NCT02669862|18673305|P3|Overall Study|Protocol Violation|1
5412784|NCT02669862|18673306|P2|Overall Study|Protocol Violation|0
5412785|NCT02669862|18673307|P1|Overall Study|Protocol Violation|0
5412786|NCT02669862|18673305|P3|Overall Study|moved|0
5412787|NCT02669862|18673306|P2|Overall Study|moved|1
5412788|NCT02669862|18673307|P1|Overall Study|moved|0
5412789|NCT02669862|18673305|P3|Overall Study|Withdrawal by Subject|3
5412790|NCT02669862|18673306|P2|Overall Study|Withdrawal by Subject|2
5412791|NCT02669862|18673307|P1|Overall Study|Withdrawal by Subject|2
5412792|NCT02669862|18673305|P3|Overall Study|Lost to Follow-up|1
5412793|NCT02669862|18673306|P2|Overall Study|Lost to Follow-up|2
5412794|NCT02669862|18673307|P1|Overall Study|Lost to Follow-up|0
5412795|NCT02669849|18673323|P3|Overall Study|Other|2
5412796|NCT02669849|18673324|P2|Overall Study|Other|0
5412797|NCT02669849|18673325|P1|Overall Study|Other|0
5412798|NCT02669849|18673323|P3|Overall Study|Study terminated by sponsor|14
5412799|NCT02669849|18673324|P2|Overall Study|Study terminated by sponsor|1
5412800|NCT02669849|18673325|P1|Overall Study|Study terminated by sponsor|16
5412801|NCT02669849|18673323|P3|Overall Study|Death|2
5412802|NCT02669849|18673324|P2|Overall Study|Death|1
5412803|NCT02669849|18673325|P1|Overall Study|Death|1
5412804|NCT02669849|18673323|P3|Overall Study|Lost to Follow-up|3
5412805|NCT02669849|18673324|P2|Overall Study|Lost to Follow-up|0
5412806|NCT02669849|18673325|P1|Overall Study|Lost to Follow-up|1
5412807|NCT02669849|18673323|P3|Overall Study|Withdrawal of Consent (not due to AE)|3
5412808|NCT02669849|18673324|P2|Overall Study|Withdrawal of Consent (not due to AE)|0
5412809|NCT02669849|18673325|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
5412810|NCT02669758|18673368|P1|Overall Study|Protocol Violation|1
5412811|NCT02669758|18673368|P1|Overall Study|Study noncompliance|1
5412812|NCT02669758|18673368|P1|Overall Study|Pregnancy|1
5412813|NCT02669758|18673368|P1|Overall Study|Lack of Efficacy|5
5412814|NCT02669758|18673368|P1|Overall Study|Non-Compliance with Study Drug|8
5412815|NCT02669758|18673368|P1|Overall Study|Adverse Event|16
5412816|NCT02669758|18673368|P1|Overall Study|Lost to Follow-up|19
5412817|NCT02669758|18673368|P1|Overall Study|Withdrawal by Subject|43
5412818|NCT02669667|18673379|P7|Overall Study|Lost to Follow-up|0
5412819|NCT02669667|18673380|P6|Overall Study|Lost to Follow-up|1
5412820|NCT02669667|18673381|P5|Overall Study|Lost to Follow-up|0
5412821|NCT02669667|18673382|P4|Overall Study|Lost to Follow-up|0
5412822|NCT02669667|18673383|P3|Overall Study|Lost to Follow-up|0
5412823|NCT02669667|18673384|P2|Overall Study|Lost to Follow-up|0
5412824|NCT02669667|18673385|P1|Overall Study|Lost to Follow-up|0
5412825|NCT02669433|18673488|P3|Overall Study|Death|1
5412826|NCT02669433|18673489|P2|Overall Study|Death|1
5412827|NCT02669433|18673490|P1|Overall Study|Death|0
5412828|NCT02669433|18673488|P3|Overall Study|Withdrawal by Caregiver|2
5412829|NCT02669433|18673489|P2|Overall Study|Withdrawal by Caregiver|0
5412830|NCT02669433|18673490|P1|Overall Study|Withdrawal by Caregiver|1
5412831|NCT02669433|18673488|P3|Overall Study|Withdrawal by Subject|0
5412832|NCT02669433|18673489|P2|Overall Study|Withdrawal by Subject|1
5412833|NCT02669433|18673490|P1|Overall Study|Withdrawal by Subject|5
5412834|NCT02669433|18673488|P3|Overall Study|Sponsor Termination|1
5412835|NCT02669433|18673489|P2|Overall Study|Sponsor Termination|0
5412836|NCT02669433|18673490|P1|Overall Study|Sponsor Termination|1
5412837|NCT02669433|18673488|P3|Overall Study|Adverse Event|10
5412838|NCT02669433|18673489|P2|Overall Study|Adverse Event|7
5412839|NCT02669433|18673490|P1|Overall Study|Adverse Event|6
5412840|NCT02669433|18673488|P3|Overall Study|Physician Decision|0
5412841|NCT02669433|18673489|P2|Overall Study|Physician Decision|1
5412842|NCT02669433|18673490|P1|Overall Study|Physician Decision|1
5412843|NCT02669433|18673488|P3|Overall Study|Disease Progression|0
5412844|NCT02669433|18673489|P2|Overall Study|Disease Progression|0
5412845|NCT02669433|18673490|P1|Overall Study|Disease Progression|1
5412846|NCT02669433|18673488|P3|Overall Study|Protocol Violation|1
5412847|NCT02669433|18673489|P2|Overall Study|Protocol Violation|4
5412848|NCT02669433|18673490|P1|Overall Study|Protocol Violation|0
5412849|NCT02669407|18673504|P1|Overall Study|Physician Decision|3
5412850|NCT02669264|18673533|P7|Overall Study|Miscellaneous|2
5412851|NCT02669264|18673534|P6|Overall Study|Miscellaneous|0
5412852|NCT02669264|18673535|P5|Overall Study|Miscellaneous|0
5412853|NCT02669264|18673536|P4|Overall Study|Miscellaneous|0
5412854|NCT02669264|18673537|P3|Overall Study|Miscellaneous|0
5412855|NCT02669264|18673538|P2|Overall Study|Miscellaneous|0
5412856|NCT02669264|18673539|P1|Overall Study|Miscellaneous|0
5412857|NCT02669264|18673533|P7|Overall Study|Lost to Follow-up|0
5412858|NCT02669264|18673534|P6|Overall Study|Lost to Follow-up|0
5412859|NCT02669264|18673535|P5|Overall Study|Lost to Follow-up|1
5412860|NCT02669264|18673536|P4|Overall Study|Lost to Follow-up|0
5412861|NCT02669264|18673537|P3|Overall Study|Lost to Follow-up|0
5412862|NCT02669264|18673538|P2|Overall Study|Lost to Follow-up|0
5412863|NCT02669264|18673539|P1|Overall Study|Lost to Follow-up|0
5412864|NCT02669264|18673533|P7|Overall Study|Withdrawal by Subject|0
5412865|NCT02669264|18673534|P6|Overall Study|Withdrawal by Subject|0
5412866|NCT02669264|18673535|P5|Overall Study|Withdrawal by Subject|1
5412867|NCT02669264|18673536|P4|Overall Study|Withdrawal by Subject|0
5412868|NCT02669264|18673537|P3|Overall Study|Withdrawal by Subject|0
5412869|NCT02669264|18673538|P2|Overall Study|Withdrawal by Subject|1
5412870|NCT02669264|18673539|P1|Overall Study|Withdrawal by Subject|0
5412871|NCT02669264|18673533|P7|Overall Study|Death|3
5412872|NCT02669264|18673534|P6|Overall Study|Death|6
5412873|NCT02669264|18673535|P5|Overall Study|Death|3
5412874|NCT02669264|18673536|P4|Overall Study|Death|3
5412875|NCT02669264|18673537|P3|Overall Study|Death|3
5412876|NCT02669264|18673538|P2|Overall Study|Death|5
5412877|NCT02669264|18673539|P1|Overall Study|Death|5
5412878|NCT02669095|18673685|P2|Overall Study|Visit 5 assessments not completed|1
5412879|NCT02669095|18673686|P1|Overall Study|Visit 5 assessments not completed|0
5412880|NCT02669095|18673685|P2|Overall Study|Torn Lens|1
5412881|NCT02669095|18673686|P1|Overall Study|Torn Lens|0
5412882|NCT02669095|18673685|P2|Overall Study|Unsatisfactory Lens Fitting|1
5412883|NCT02669095|18673686|P1|Overall Study|Unsatisfactory Lens Fitting|0
5412884|NCT02669095|18673685|P2|Overall Study|Adverse Event|0
5412885|NCT02669095|18673686|P1|Overall Study|Adverse Event|1
5412886|NCT02669082|18673694|P1|Overall Study|Adverse Event|1
5412887|NCT02669043|18673706|P1|Overall Study|Didn't meet I/E criteria|4
5412888|NCT02669017|18673719|P9|Overall Study|Miscellaneous|2
5412889|NCT02669017|18673720|P8|Overall Study|Miscellaneous|13
5412890|NCT02669017|18673721|P7|Overall Study|Miscellaneous|1
5412891|NCT02669017|18673722|P6|Overall Study|Miscellaneous|1
5412892|NCT02669017|18673723|P5|Overall Study|Miscellaneous|2
5412893|NCT02669017|18673724|P4|Overall Study|Miscellaneous|0
5412894|NCT02669017|18673725|P3|Overall Study|Miscellaneous|0
5412895|NCT02669017|18673726|P2|Overall Study|Miscellaneous|0
5412896|NCT02669017|18673727|P1|Overall Study|Miscellaneous|0
5412897|NCT02669017|18673719|P9|Overall Study|Lost to Follow-up|1
5412898|NCT02669017|18673720|P8|Overall Study|Lost to Follow-up|0
5412899|NCT02669017|18673721|P7|Overall Study|Lost to Follow-up|0
5412900|NCT02669017|18673722|P6|Overall Study|Lost to Follow-up|0
5412901|NCT02669017|18673723|P5|Overall Study|Lost to Follow-up|0
5412902|NCT02669017|18673724|P4|Overall Study|Lost to Follow-up|0
5412903|NCT02669017|18673725|P3|Overall Study|Lost to Follow-up|0
5412904|NCT02669017|18673726|P2|Overall Study|Lost to Follow-up|0
5412905|NCT02669017|18673727|P1|Overall Study|Lost to Follow-up|0
5412906|NCT02669017|18673719|P9|Overall Study|Withdrawal by Subject|2
5412907|NCT02669017|18673720|P8|Overall Study|Withdrawal by Subject|2
5412908|NCT02669017|18673721|P7|Overall Study|Withdrawal by Subject|0
5412909|NCT02669017|18673722|P6|Overall Study|Withdrawal by Subject|0
5412910|NCT02669017|18673723|P5|Overall Study|Withdrawal by Subject|2
5412911|NCT02669017|18673724|P4|Overall Study|Withdrawal by Subject|1
5412912|NCT02669017|18673725|P3|Overall Study|Withdrawal by Subject|0
5412913|NCT02669017|18673726|P2|Overall Study|Withdrawal by Subject|0
5412914|NCT02669017|18673727|P1|Overall Study|Withdrawal by Subject|0
5412915|NCT02669017|18673719|P9|Overall Study|Death|20
5412916|NCT02669017|18673720|P8|Overall Study|Death|47
5412917|NCT02669017|18673721|P7|Overall Study|Death|10
5412918|NCT02669017|18673722|P6|Overall Study|Death|18
5412919|NCT02669017|18673723|P5|Overall Study|Death|8
5412920|NCT02669017|18673724|P4|Overall Study|Death|3
5412921|NCT02669017|18673725|P3|Overall Study|Death|2
5412922|NCT02669017|18673726|P2|Overall Study|Death|2
5412923|NCT02669017|18673727|P1|Overall Study|Death|1
5412924|NCT02668822|18673872|P2|Overall Study|Study Terminated by Sponsor|9
5412925|NCT02668822|18673873|P1|Overall Study|Study Terminated by Sponsor|7
5412926|NCT02668822|18673872|P2|Overall Study|Protocol Violation|0
5412927|NCT02668822|18673873|P1|Overall Study|Protocol Violation|2
5412928|NCT02668783|18673895|P2|Overall Study|Withdrawal by Subject|0
5412929|NCT02668783|18673896|P1|Overall Study|Withdrawal by Subject|1
5412930|NCT02668783|18673895|P2|Overall Study|Subject moved|0
5412931|NCT02668783|18673896|P1|Overall Study|Subject moved|1
5412932|NCT02668783|18673895|P2|Overall Study|Study terminated by sponsor|10
5412933|NCT02668783|18673896|P1|Overall Study|Study terminated by sponsor|9
5412934|NCT02668783|18673895|P2|Overall Study|Protocol Violation|1
5412935|NCT02668783|18673896|P1|Overall Study|Protocol Violation|2
5412936|NCT02668783|18673895|P2|Overall Study|Pregnancy|1
5412937|NCT02668783|18673896|P1|Overall Study|Pregnancy|0
5412938|NCT02668640|18673916|P1|Overall Study|Other, not specified|1
5412939|NCT02668640|18673916|P1|Overall Study|Lost to Follow-up|13
5412940|NCT02668302|18673968|P2|Overall Study|Withdrawal by Subject|0
5412941|NCT02668302|18673969|P1|Overall Study|Withdrawal by Subject|1
5412942|NCT02667912|18674008|P2|Overall Study|Withdrawal by Subject|0
5412943|NCT02667912|18674009|P1|Overall Study|Withdrawal by Subject|1
5412944|NCT02667912|18674008|P2|Overall Study|Withdrawal by Subject|2
5412945|NCT02667912|18674009|P1|Overall Study|Withdrawal by Subject|1
5412946|NCT02667912|18674008|P2|Overall Study|Death|1
5412947|NCT02667912|18674009|P1|Overall Study|Death|3
5412948|NCT02667626|18674109|P2|Overall Study|Withdrawal by Subject|1
5412949|NCT02667626|18674110|P1|Overall Study|Withdrawal by Subject|0
5412950|NCT02667457|18674126|P2|Overall Study|Other Reason|2
5412951|NCT02667457|18674127|P1|Overall Study|Other Reason|0
5412952|NCT02667457|18674126|P2|Overall Study|Withdrawal by Subject|0
5412953|NCT02667457|18674127|P1|Overall Study|Withdrawal by Subject|1
5412954|NCT02667288|18674151|P1|Overall Study|Withdrawal by Subject|5
5412955|NCT02667288|18674151|P1|Overall Study|Lost to Follow-up|3
5412956|NCT02667288|18674151|P1|Overall Study|Protocol Violation|5
5412957|NCT02667275|18674158|P2|Overall Study|Discontinued early without completing|1
5412958|NCT02667275|18674159|P1|Overall Study|Discontinued early without completing|0
5412959|NCT02667275|18674158|P2|Overall Study|Withdrawal by Subject|5
5412960|NCT02667275|18674159|P1|Overall Study|Withdrawal by Subject|0
5412961|NCT02667275|18674158|P2|Overall Study|Lost to Follow-up|2
5412962|NCT02667275|18674159|P1|Overall Study|Lost to Follow-up|0
5412963|NCT02667275|18674158|P2|Overall Study|Protocol Violation|7
5412964|NCT02667275|18674159|P1|Overall Study|Protocol Violation|11
5412965|NCT02667236|18674169|P2|Overall Study|Withdrawal by Subject|0
5412966|NCT02667236|18674170|P1|Overall Study|Withdrawal by Subject|2
5412967|NCT02667236|18674169|P2|Overall Study|Adverse Event|1
5412968|NCT02667236|18674170|P1|Overall Study|Adverse Event|1
5412969|NCT02666664|18674292|P2|Overall Study|Lost to Follow-up|2
5412970|NCT02666664|18674293|P1|Overall Study|Lost to Follow-up|1
5412971|NCT02666664|18674292|P2|Overall Study|Sponsor decision|1
5412972|NCT02666664|18674293|P1|Overall Study|Sponsor decision|0
5412973|NCT02666664|18674292|P2|Overall Study|Withdrawal by participant|40
5412974|NCT02666664|18674293|P1|Overall Study|Withdrawal by participant|23
5412975|NCT02666664|18674292|P2|Overall Study|Adverse Event|37
5412976|NCT02666664|18674293|P1|Overall Study|Adverse Event|12
5412977|NCT02666664|18674292|P2|Overall Study|Other|1
5412978|NCT02666664|18674293|P1|Overall Study|Other|0
5412979|NCT02666664|18674292|P2|Overall Study|Protocol Violation|2
5412980|NCT02666664|18674293|P1|Overall Study|Protocol Violation|0
5412981|NCT02666664|18674292|P2|Overall Study|Physician Decision|1
5412982|NCT02666664|18674293|P1|Overall Study|Physician Decision|0
5412983|NCT02666430|18674376|P2|Period 3|Lost to Follow-up|0
5412984|NCT02666430|18674377|P1|Period 3|Lost to Follow-up|1
5412985|NCT02666430|18674376|P2|Period 2|Withdrawal by Subject|4
5412986|NCT02666430|18674377|P1|Period 2|Withdrawal by Subject|1
5412987|NCT02666430|18674376|P2|Period 1|Adverse Event|1
5412988|NCT02666430|18674377|P1|Period 1|Adverse Event|0
5412989|NCT02666430|18674376|P2|Period 1|Lost to Follow-up|0
5412990|NCT02666430|18674377|P1|Period 1|Lost to Follow-up|1
5412991|NCT02666222|18674512|P1|Overall Study|Death|2
5412992|NCT02665689|18674548|P2|Overall Study|Lost to Follow-up|1
5412993|NCT02665689|18674549|P1|Overall Study|Lost to Follow-up|0
5412994|NCT02665689|18674548|P2|Overall Study|Trial termination|1
5412995|NCT02665689|18674549|P1|Overall Study|Trial termination|1
5412996|NCT02665689|18674548|P2|Overall Study|Adverse Event|0
5412997|NCT02665689|18674549|P1|Overall Study|Adverse Event|1
5412998|NCT02665455|18674584|P1|Overall Study|Protocol Violation|1
5412999|NCT02665455|18674584|P1|Overall Study|Adverse Event|1
5413000|NCT02665455|18674584|P1|Overall Study|Lost to Follow-up|1
5413001|NCT02665455|18674584|P1|Overall Study|Withdrawal by Subject|6
5413002|NCT02665286|18674628|P3|Overall Study|Lost to Follow-up|1
5413003|NCT02665286|18674629|P2|Overall Study|Lost to Follow-up|2
5413004|NCT02665286|18674630|P1|Overall Study|Lost to Follow-up|3
5413005|NCT02664415|18674781|P2|Overall Study|Adverse Event|0
5413006|NCT02664415|18674782|P1|Overall Study|Adverse Event|1
5413007|NCT02664272|18674828|P1|Overall Study|Fluoroscopic images not made available|2
5413008|NCT02663882|18674864|P2|Overall Study|Lost to Follow-up|2
5413009|NCT02663882|18674865|P1|Overall Study|Lost to Follow-up|4
5413010|NCT02663817|18674877|P1|Overall Study|Screen failure|2
5413011|NCT02663687|18674897|P5|Overall Study|Other|0
5413012|NCT02663687|18674898|P4|Overall Study|Other|0
5413013|NCT02663687|18674899|P3|Overall Study|Other|1
5413014|NCT02663687|18674900|P2|Overall Study|Other|0
5413015|NCT02663687|18674901|P1|Overall Study|Other|1
5413016|NCT02663687|18674897|P5|Overall Study|Adverse Event|0
5413017|NCT02663687|18674898|P4|Overall Study|Adverse Event|0
5413018|NCT02663687|18674899|P3|Overall Study|Adverse Event|0
5413019|NCT02663687|18674900|P2|Overall Study|Adverse Event|0
5413020|NCT02663687|18674901|P1|Overall Study|Adverse Event|1
5413021|NCT02663674|18674955|P2|Overall Study|Other Event (Health Related)|1
5413022|NCT02663674|18674956|P1|Overall Study|Other Event (Health Related)|0
5413023|NCT02663674|18674955|P2|Overall Study|Physician Decision|1
5413024|NCT02663674|18674956|P1|Overall Study|Physician Decision|1
5413025|NCT02663674|18674955|P2|Overall Study|Withdrawal by Subject|4
5413026|NCT02663674|18674956|P1|Overall Study|Withdrawal by Subject|1
5413027|NCT02663674|18674955|P2|Overall Study|Lost to Follow-up|4
5413028|NCT02663674|18674956|P1|Overall Study|Lost to Follow-up|5
5413029|NCT02663453|18675220|P2|Overall Study|Withdrawal by Subject|0
5413030|NCT02663453|18675221|P1|Overall Study|Withdrawal by Subject|1
5413031|NCT02663453|18675220|P2|Overall Study|Death|4
5413032|NCT02663453|18675221|P1|Overall Study|Death|4
5413033|NCT02663128|18675266|P6|Period 2|Physician Decision|0
5413034|NCT02663128|18675267|P5|Period 2|Physician Decision|1
5413035|NCT02663128|18675268|P4|Period 2|Physician Decision|0
5413036|NCT02663128|18675269|P3|Period 2|Physician Decision|0
5413037|NCT02663128|18675270|P2|Period 2|Physician Decision|0
5413038|NCT02663128|18675271|P1|Period 2|Physician Decision|0
5413039|NCT02662764|18675285|P1|Overall Study|Patient discharged prior to 24 hrs|5
5413040|NCT02662764|18675285|P1|Overall Study|Patient changed treatment|1
5413041|NCT02662764|18675285|P1|Overall Study|Device failure|4
5413042|NCT02662764|18675285|P1|Overall Study|Withdrawal by Subject|5
5413043|NCT02662764|18675285|P1|Overall Study|Protocol Violation|1
5413044|NCT02662764|18675285|P1|Overall Study|Lack of Efficacy|8
5413045|NCT02662764|18675285|P1|Overall Study|Adverse Event|6
5413046|NCT02662569|18675353|P4|Overall Study|Lost to Follow-up|0
5413047|NCT02662569|18675354|P3|Overall Study|Lost to Follow-up|0
5413048|NCT02662569|18675355|P2|Overall Study|Lost to Follow-up|0
5413049|NCT02662569|18675356|P1|Overall Study|Lost to Follow-up|1
5413050|NCT02662569|18675353|P4|Overall Study|Withdrawal by Subject|4
5413051|NCT02662569|18675354|P3|Overall Study|Withdrawal by Subject|6
5413052|NCT02662569|18675355|P2|Overall Study|Withdrawal by Subject|1
5413053|NCT02662569|18675356|P1|Overall Study|Withdrawal by Subject|6
5413054|NCT02662556|18675454|P1|Overall Study|Lack of Efficacy|4
5413055|NCT02662556|18675454|P1|Overall Study|Adverse Event|4
5413056|NCT02661815|18675523|P4|Overall Study|Withdrawal by Subject|0
5413057|NCT02661815|18675524|P3|Overall Study|Withdrawal by Subject|0
5413058|NCT02661815|18675525|P2|Overall Study|Withdrawal by Subject|0
5413059|NCT02661815|18675526|P1|Overall Study|Withdrawal by Subject|1
5413060|NCT02661594|18675548|P4|Overall Study|Protocol Violation|0
5413061|NCT02661594|18675549|P3|Overall Study|Protocol Violation|1
5413062|NCT02661594|18675550|P2|Overall Study|Protocol Violation|0
5413063|NCT02661594|18675551|P1|Overall Study|Protocol Violation|1
5413064|NCT02661490|18675566|P5|Overall Study|Reason not Specified|1
5413065|NCT02661490|18675567|P4|Overall Study|Reason not Specified|0
5413066|NCT02661490|18675568|P3|Overall Study|Reason not Specified|0
5413067|NCT02661490|18675569|P2|Overall Study|Reason not Specified|0
5413068|NCT02661490|18675570|P1|Overall Study|Reason not Specified|0
5413069|NCT02661490|18675566|P5|Overall Study|Death|0
5413070|NCT02661490|18675567|P4|Overall Study|Death|1
5413071|NCT02661490|18675568|P3|Overall Study|Death|0
5413072|NCT02661490|18675569|P2|Overall Study|Death|1
5413073|NCT02661490|18675570|P1|Overall Study|Death|1
5413074|NCT02661490|18675566|P5|Overall Study|Withdrawal by Subject|0
5413075|NCT02661490|18675567|P4|Overall Study|Withdrawal by Subject|0
5413076|NCT02661490|18675568|P3|Overall Study|Withdrawal by Subject|2
5413077|NCT02661490|18675569|P2|Overall Study|Withdrawal by Subject|0
5413078|NCT02661490|18675570|P1|Overall Study|Withdrawal by Subject|2
5413079|NCT02661490|18675566|P5|Overall Study|Lost to Follow-up|2
5413080|NCT02661490|18675567|P4|Overall Study|Lost to Follow-up|0
5413081|NCT02661490|18675568|P3|Overall Study|Lost to Follow-up|0
5413082|NCT02661490|18675569|P2|Overall Study|Lost to Follow-up|1
5413083|NCT02661490|18675570|P1|Overall Study|Lost to Follow-up|0
5413084|NCT02661178|18675738|P15|Part 1|Protocol Violation|0
5413085|NCT02661178|18675739|P14|Part 1|Protocol Violation|0
5413086|NCT02661178|18675740|P13|Part 1|Protocol Violation|0
5413087|NCT02661178|18675741|P12|Part 1|Protocol Violation|0
5413088|NCT02661178|18675742|P11|Part 1|Protocol Violation|0
5413089|NCT02661178|18675743|P10|Part 1|Protocol Violation|0
5413090|NCT02661178|18675744|P9|Part 1|Protocol Violation|0
5413091|NCT02661178|18675745|P8|Part 1|Protocol Violation|0
5413092|NCT02661178|18675746|P7|Part 1|Protocol Violation|0
5413093|NCT02661178|18675747|P6|Part 1|Protocol Violation|0
5413094|NCT02661178|18675748|P5|Part 1|Protocol Violation|0
5413095|NCT02661178|18675749|P4|Part 1|Protocol Violation|0
5413096|NCT02661178|18675750|P3|Part 1|Protocol Violation|0
5413097|NCT02661178|18675751|P2|Part 1|Protocol Violation|0
5413098|NCT02661178|18675752|P1|Part 1|Protocol Violation|1
5413099|NCT02661061|18676110|P2|Overall Study|Withdrawal by Subject|1
5413100|NCT02661061|18676111|P1|Overall Study|Withdrawal by Subject|1
5413101|NCT02661061|18676110|P2|Overall Study|Lack of Efficacy|1
5413102|NCT02661061|18676111|P1|Overall Study|Lack of Efficacy|1
5413103|NCT02660983|18676121|P2|Open Label Extension Phase (24 Weeks)|Other|1
5413104|NCT02660983|18676122|P1|Open Label Extension Phase (24 Weeks)|Other|0
5413105|NCT02660983|18676121|P2|Open Label Extension Phase (24 Weeks)|Adverse Event|3
5413106|NCT02660983|18676122|P1|Open Label Extension Phase (24 Weeks)|Adverse Event|1
5413107|NCT02660983|18676121|P2|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
5413108|NCT02660983|18676122|P1|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
5413109|NCT02660983|18676121|P2|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
5413110|NCT02660983|18676122|P1|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
5413111|NCT02660983|18676121|P2|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
5413112|NCT02660983|18676122|P1|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
5413113|NCT02660983|18676121|P2|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
5413114|NCT02660983|18676122|P1|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
5413115|NCT02660983|18676121|P2|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
5413116|NCT02660983|18676122|P1|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
5413117|NCT02660827|18676173|P1|2-6 Years Old Age Group|Withdrawal by Subject|1
5413118|NCT02660580|18676207|P5|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
5413119|NCT02660580|18676208|P4|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
5413120|NCT02660580|18676209|P3|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
5413121|NCT02660580|18676210|P2|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
5413122|NCT02660580|18676211|P1|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
5413123|NCT02660580|18676207|P5|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
5413124|NCT02660580|18676208|P4|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
5413125|NCT02660580|18676209|P3|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
5413126|NCT02660580|18676210|P2|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
5413127|NCT02660580|18676211|P1|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
5413128|NCT02660580|18676207|P5|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
5413129|NCT02660580|18676208|P4|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
5413130|NCT02660580|18676209|P3|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
5413131|NCT02660580|18676210|P2|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
5413132|NCT02660580|18676211|P1|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
5413133|NCT02660580|18676207|P5|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
5413134|NCT02660580|18676208|P4|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
5413135|NCT02660580|18676209|P3|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
5413136|NCT02660580|18676210|P2|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
5413137|NCT02660580|18676211|P1|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
5413138|NCT02660580|18676207|P5|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
5413139|NCT02660580|18676208|P4|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
5413140|NCT02660580|18676209|P3|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
5413141|NCT02660580|18676210|P2|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
5413142|NCT02660580|18676211|P1|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
5413143|NCT02660580|18676207|P5|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
5413144|NCT02660580|18676208|P4|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
5413145|NCT02660580|18676209|P3|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
5413146|NCT02660580|18676210|P2|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
5413147|NCT02660580|18676211|P1|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
5413148|NCT02660580|18676207|P5|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
5413149|NCT02660580|18676208|P4|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
5413150|NCT02660580|18676209|P3|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
5413151|NCT02660580|18676210|P2|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
5413152|NCT02660580|18676211|P1|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
5413153|NCT02660580|18676207|P5|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
5413154|NCT02660580|18676208|P4|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
5413155|NCT02660580|18676209|P3|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
5413156|NCT02660580|18676210|P2|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
5413157|NCT02660580|18676211|P1|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
5413158|NCT02660580|18676207|P5|Core Treatment Period (Week 1 to 16)|Adverse Event|0
5413159|NCT02660580|18676208|P4|Core Treatment Period (Week 1 to 16)|Adverse Event|0
5413160|NCT02660580|18676209|P3|Core Treatment Period (Week 1 to 16)|Adverse Event|0
5413161|NCT02660580|18676210|P2|Core Treatment Period (Week 1 to 16)|Adverse Event|9
5413162|NCT02660580|18676211|P1|Core Treatment Period (Week 1 to 16)|Adverse Event|2
5413163|NCT02660580|18676207|P5|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5413164|NCT02660580|18676208|P4|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5413165|NCT02660580|18676209|P3|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5413166|NCT02660580|18676210|P2|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
5413167|NCT02660580|18676211|P1|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
5413168|NCT02660580|18676207|P5|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5413169|NCT02660580|18676208|P4|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5413170|NCT02660580|18676209|P3|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5413171|NCT02660580|18676210|P2|Core Treatment Period (Week 1 to 16)|Other un-specified|0
5413172|NCT02660580|18676211|P1|Core Treatment Period (Week 1 to 16)|Other un-specified|1
5413173|NCT02660580|18676207|P5|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
5413174|NCT02660580|18676208|P4|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
5413175|NCT02660580|18676209|P3|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
5413176|NCT02660580|18676210|P2|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
5413177|NCT02660580|18676211|P1|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
5413178|NCT02660580|18676207|P5|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
5413179|NCT02660580|18676208|P4|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
5413180|NCT02660580|18676209|P3|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
5413181|NCT02660580|18676210|P2|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
5413182|NCT02660580|18676211|P1|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
5413183|NCT02660242|18676326|P1|Glucagon Injection|Lost to Follow-up|1
5413184|NCT02660242|18676326|P1|Glucose Tabs|Lost to Follow-up|1
5413185|NCT02660229|18676382|P2|Overall Study|Withdrawal by Subject|1
5413186|NCT02660229|18676383|P1|Overall Study|Withdrawal by Subject|0
5413187|NCT02660229|18676382|P2|Overall Study|Adverse Event|0
5413188|NCT02660229|18676383|P1|Overall Study|Adverse Event|2
5413189|NCT02659631|18676424|P10|Overall Study|Death (treatment phase)|0
5413190|NCT02659631|18676425|P9|Overall Study|Death (treatment phase)|0
5413191|NCT02659631|18676426|P8|Overall Study|Death (treatment phase)|0
5413192|NCT02659631|18676427|P7|Overall Study|Death (treatment phase)|1
5413193|NCT02659631|18676428|P6|Overall Study|Death (treatment phase)|0
5413194|NCT02659631|18676429|P5|Overall Study|Death (treatment phase)|1
5413195|NCT02659631|18676430|P4|Overall Study|Death (treatment phase)|0
5413196|NCT02659631|18676431|P3|Overall Study|Death (treatment phase)|0
5413197|NCT02659631|18676432|P2|Overall Study|Death (treatment phase)|0
5413198|NCT02659631|18676433|P1|Overall Study|Death (treatment phase)|0
5413199|NCT02659631|18676424|P10|Overall Study|Death (follow-up phase)|0
5413200|NCT02659631|18676425|P9|Overall Study|Death (follow-up phase)|1
5413201|NCT02659631|18676426|P8|Overall Study|Death (follow-up phase)|3
5413202|NCT02659631|18676427|P7|Overall Study|Death (follow-up phase)|0
5413203|NCT02659631|18676428|P6|Overall Study|Death (follow-up phase)|2
5413204|NCT02659631|18676429|P5|Overall Study|Death (follow-up phase)|3
5413205|NCT02659631|18676430|P4|Overall Study|Death (follow-up phase)|1
5413206|NCT02659631|18676431|P3|Overall Study|Death (follow-up phase)|1
5413207|NCT02659631|18676432|P2|Overall Study|Death (follow-up phase)|2
5413208|NCT02659631|18676433|P1|Overall Study|Death (follow-up phase)|1
5413209|NCT02659631|18676424|P10|Overall Study|Participant refused further follow-up|0
5413210|NCT02659631|18676425|P9|Overall Study|Participant refused further follow-up|1
5413211|NCT02659631|18676426|P8|Overall Study|Participant refused further follow-up|0
5413212|NCT02659631|18676427|P7|Overall Study|Participant refused further follow-up|0
5413213|NCT02659631|18676428|P6|Overall Study|Participant refused further follow-up|0
5413214|NCT02659631|18676429|P5|Overall Study|Participant refused further follow-up|0
5413215|NCT02659631|18676430|P4|Overall Study|Participant refused further follow-up|1
5413216|NCT02659631|18676431|P3|Overall Study|Participant refused further follow-up|0
5413217|NCT02659631|18676432|P2|Overall Study|Participant refused further follow-up|0
5413218|NCT02659631|18676433|P1|Overall Study|Participant refused further follow-up|0
5413219|NCT02659631|18676424|P10|Overall Study|Withdrawal prior to treatment|0
5413220|NCT02659631|18676425|P9|Overall Study|Withdrawal prior to treatment|0
5413221|NCT02659631|18676426|P8|Overall Study|Withdrawal prior to treatment|0
5413222|NCT02659631|18676427|P7|Overall Study|Withdrawal prior to treatment|0
5413223|NCT02659631|18676428|P6|Overall Study|Withdrawal prior to treatment|0
5413224|NCT02659631|18676429|P5|Overall Study|Withdrawal prior to treatment|1
5413225|NCT02659631|18676430|P4|Overall Study|Withdrawal prior to treatment|0
5413226|NCT02659631|18676431|P3|Overall Study|Withdrawal prior to treatment|0
5413227|NCT02659631|18676432|P2|Overall Study|Withdrawal prior to treatment|0
5413228|NCT02659631|18676433|P1|Overall Study|Withdrawal prior to treatment|0
5413229|NCT02659631|18676424|P10|Overall Study|Lost to Follow-up|0
5413230|NCT02659631|18676425|P9|Overall Study|Lost to Follow-up|0
5413231|NCT02659631|18676426|P8|Overall Study|Lost to Follow-up|0
5413232|NCT02659631|18676427|P7|Overall Study|Lost to Follow-up|0
5413233|NCT02659631|18676428|P6|Overall Study|Lost to Follow-up|1
5413234|NCT02659631|18676429|P5|Overall Study|Lost to Follow-up|0
5413235|NCT02659631|18676430|P4|Overall Study|Lost to Follow-up|0
5413236|NCT02659631|18676431|P3|Overall Study|Lost to Follow-up|2
5413237|NCT02659631|18676432|P2|Overall Study|Lost to Follow-up|0
5413238|NCT02659631|18676433|P1|Overall Study|Lost to Follow-up|0
5413239|NCT02659540|18676567|P2|Overall Study|Progressive disease|6
5413240|NCT02659540|18676568|P1|Overall Study|Progressive disease|2
5413241|NCT02659540|18676567|P2|Overall Study|Death|0
5413242|NCT02659540|18676568|P1|Overall Study|Death|1
5413243|NCT02659540|18676567|P2|Overall Study|Adverse Event|2
5413244|NCT02659540|18676568|P1|Overall Study|Adverse Event|3
5413245|NCT02659098|18676599|P1|Overall Study|Withdrawal by Subject|7
5413246|NCT02658487|18676661|P1|Overall Study|Refractory AML|1
5413247|NCT02658487|18676661|P1|Overall Study|Treatment Failure, circulating blasts|1
5413248|NCT02658487|18676661|P1|Overall Study|Adverse Event|1
5413249|NCT02658487|18676661|P1|Overall Study|Alternative therapy|1
5413250|NCT02658487|18676661|P1|Overall Study|Disease progression|10
5413251|NCT02658487|18676661|P1|Overall Study|Death|2
5413252|NCT02658149|18676732|P2|Overall Study|Physician Decision|0
5413253|NCT02658149|18676733|P1|Overall Study|Physician Decision|1
5413254|NCT02658084|18676749|P2|Overall Study|Study Termination|0
5413255|NCT02658084|18676750|P1|Overall Study|Study Termination|1
5413256|NCT02658084|18676749|P2|Overall Study|Withdrawal by Subject|0
5413257|NCT02658084|18676750|P1|Overall Study|Withdrawal by Subject|1
5413258|NCT02658019|18676759|P1|Overall Study|Adverse Event|1
5413259|NCT02657889|18676812|P4|Overall Study|Ongoing in Study|19
5413260|NCT02657889|18676813|P3|Overall Study|Ongoing in Study|24
5413261|NCT02657889|18676814|P2|Overall Study|Ongoing in Study|5
5413262|NCT02657889|18676815|P1|Overall Study|Ongoing in Study|0
5413263|NCT02657889|18676812|P4|Overall Study|Withdrawal by Subject|0
5413264|NCT02657889|18676813|P3|Overall Study|Withdrawal by Subject|8
5413265|NCT02657889|18676814|P2|Overall Study|Withdrawal by Subject|0
5413266|NCT02657889|18676815|P1|Overall Study|Withdrawal by Subject|0
5413267|NCT02657889|18676812|P4|Overall Study|Lost to Follow-up|2
5413268|NCT02657889|18676813|P3|Overall Study|Lost to Follow-up|1
5413269|NCT02657889|18676814|P2|Overall Study|Lost to Follow-up|0
5413270|NCT02657889|18676815|P1|Overall Study|Lost to Follow-up|2
5413271|NCT02657889|18676812|P4|Overall Study|Death|34
5413272|NCT02657889|18676813|P3|Overall Study|Death|20
5413273|NCT02657889|18676814|P2|Overall Study|Death|2
5413274|NCT02657889|18676815|P1|Overall Study|Death|5
5413275|NCT02657434|18676856|P2|Overall Study|Protocol Violation|0
5413276|NCT02657434|18676857|P1|Overall Study|Protocol Violation|1
5413277|NCT02657434|18676856|P2|Overall Study|Withdrawal by Subject|16
5413278|NCT02657434|18676857|P1|Overall Study|Withdrawal by Subject|27
5413279|NCT02657434|18676856|P2|Overall Study|Randomization by Error|0
5413280|NCT02657434|18676857|P1|Overall Study|Randomization by Error|2
5413281|NCT02657434|18676856|P2|Overall Study|Lost to Follow-up|2
5413282|NCT02657434|18676857|P1|Overall Study|Lost to Follow-up|2
5413283|NCT02657434|18676856|P2|Overall Study|Death|183
5413284|NCT02657434|18676857|P1|Overall Study|Death|177
5413285|NCT02657434|18676856|P2|Overall Study|On-Going in Study|91
5413286|NCT02657434|18676857|P1|Overall Study|On-Going in Study|77
5413287|NCT02657408|18676887|P2|Overall Study|Adverse Event|7
5413288|NCT02657408|18676888|P1|Overall Study|Adverse Event|3
5413289|NCT02657369|18676912|P1|Overall Study|Study terminated by sponsor|7
5413290|NCT02657369|18676912|P1|Overall Study|Death|27
5413291|NCT02657031|18676943|P2|Overall Study|Adverse Event|2
5413292|NCT02657031|18676944|P1|Overall Study|Adverse Event|1
5413293|NCT02656693|18676976|P3|Overall Study|Bariatric surgery|2
5413294|NCT02656693|18676977|P2|Overall Study|Bariatric surgery|1
5413295|NCT02656693|18676978|P1|Overall Study|Bariatric surgery|0
5413296|NCT02656693|18676976|P3|Overall Study|Pregnancy|1
5413297|NCT02656693|18676977|P2|Overall Study|Pregnancy|1
5413298|NCT02656693|18676978|P1|Overall Study|Pregnancy|1
5413299|NCT02656329|18677103|P2|Overall Study|Other than specified above|6
5413300|NCT02656329|18677104|P1|Overall Study|Other than specified above|5
5413301|NCT02656329|18677103|P2|Overall Study|Study termination by Sponsor|142
5413302|NCT02656329|18677104|P1|Overall Study|Study termination by Sponsor|150
5413303|NCT02656329|18677103|P2|Overall Study|Withdrawal by Subject|6
5413304|NCT02656329|18677104|P1|Overall Study|Withdrawal by Subject|7
5413305|NCT02656329|18677103|P2|Overall Study|Lost to Follow-up|3
5413306|NCT02656329|18677104|P1|Overall Study|Lost to Follow-up|2
5413307|NCT02656290|18677127|P1|Overall Study|Subjects Remain On Study|26
5413308|NCT02656173|18677137|P2|Overall Study|Miscellaneous|0
5413309|NCT02656173|18677138|P1|Overall Study|Miscellaneous|2
5413310|NCT02656173|18677137|P2|Overall Study|Protocol Violation|1
5413311|NCT02656173|18677138|P1|Overall Study|Protocol Violation|0
5413312|NCT02656173|18677137|P2|Overall Study|Withdrawal by Subject|3
5413313|NCT02656173|18677138|P1|Overall Study|Withdrawal by Subject|1
5413314|NCT02656173|18677137|P2|Overall Study|Adverse Event|5
5413315|NCT02656173|18677138|P1|Overall Study|Adverse Event|7
5413316|NCT02656173|18677137|P2|Overall Study|Deviation from the Eligible Criteria|2
5413317|NCT02656173|18677138|P1|Overall Study|Deviation from the Eligible Criteria|3
5413318|NCT02655887|18677210|P1|Overall Study|Missed 12-month follow-up visit|4
5413319|NCT02655887|18677210|P1|Overall Study|Withdrawal by Subject|3
5413320|NCT02655887|18677210|P1|Overall Study|Death|4
5413321|NCT02655887|18677210|P1|Overall Study|Lost to Follow-up|3
5413322|NCT02655679|18677229|P5|Overall Study|Other Miscellaneous Reasons|0
5413323|NCT02655679|18677230|P4|Overall Study|Other Miscellaneous Reasons|0
5413324|NCT02655679|18677231|P3|Overall Study|Other Miscellaneous Reasons|0
5413325|NCT02655679|18677232|P2|Overall Study|Other Miscellaneous Reasons|0
5413326|NCT02655679|18677233|P1|Overall Study|Other Miscellaneous Reasons|1
5413327|NCT02655679|18677229|P5|Overall Study|Lost to Follow-up|0
5413328|NCT02655679|18677230|P4|Overall Study|Lost to Follow-up|1
5413329|NCT02655679|18677231|P3|Overall Study|Lost to Follow-up|1
5413330|NCT02655679|18677232|P2|Overall Study|Lost to Follow-up|1
5413331|NCT02655679|18677233|P1|Overall Study|Lost to Follow-up|0
5413332|NCT02655679|18677229|P5|Overall Study|Inability to Comply with the Protocol|0
5413333|NCT02655679|18677230|P4|Overall Study|Inability to Comply with the Protocol|0
5413334|NCT02655679|18677231|P3|Overall Study|Inability to Comply with the Protocol|0
5413335|NCT02655679|18677232|P2|Overall Study|Inability to Comply with the Protocol|0
5413336|NCT02655679|18677233|P1|Overall Study|Inability to Comply with the Protocol|1
5413337|NCT02655679|18677229|P5|Overall Study|Withdrawal by Subject|1
5413338|NCT02655679|18677230|P4|Overall Study|Withdrawal by Subject|3
5413339|NCT02655679|18677231|P3|Overall Study|Withdrawal by Subject|0
5413340|NCT02655679|18677232|P2|Overall Study|Withdrawal by Subject|1
5413341|NCT02655679|18677233|P1|Overall Study|Withdrawal by Subject|1
5413342|NCT02655679|18677229|P5|Overall Study|Adverse Event|0
5413343|NCT02655679|18677230|P4|Overall Study|Adverse Event|0
5413344|NCT02655679|18677231|P3|Overall Study|Adverse Event|0
5413345|NCT02655679|18677232|P2|Overall Study|Adverse Event|1
5413346|NCT02655679|18677233|P1|Overall Study|Adverse Event|0
5413347|NCT02655666|18677305|P1|Overall Study|Sponsor stopped this clinical research.|12
5413348|NCT02655419|18677359|P2|Overall Study|Other|1
5413349|NCT02655419|18677360|P1|Overall Study|Other|0
5413350|NCT02655419|18677359|P2|Overall Study|Withdrawal by Subject|1
5413351|NCT02655419|18677360|P1|Overall Study|Withdrawal by Subject|4
5413352|NCT02655419|18677359|P2|Overall Study|Enrolled but not treated|5
5413353|NCT02655419|18677360|P1|Overall Study|Enrolled but not treated|1
5413354|NCT02655237|18677480|P2|Overall Study|Randomized but Not Treated|0
5413355|NCT02655237|18677481|P1|Overall Study|Randomized but Not Treated|1
5413356|NCT02655237|18677480|P2|Overall Study|Reduction of Hemoglobin Concentration|0
5413357|NCT02655237|18677481|P1|Overall Study|Reduction of Hemoglobin Concentration|1
5413358|NCT02655237|18677480|P2|Overall Study|Recovery Leading to Surgery|1
5413359|NCT02655237|18677481|P1|Overall Study|Recovery Leading to Surgery|2
5413360|NCT02655237|18677480|P2|Overall Study|Lack of Efficacy|1
5413361|NCT02655237|18677481|P1|Overall Study|Lack of Efficacy|0
5413362|NCT02655237|18677480|P2|Overall Study|Withdrawal by Participant|2
5413363|NCT02655237|18677481|P1|Overall Study|Withdrawal by Participant|1
5413364|NCT02655237|18677480|P2|Overall Study|Protocol Deviation|0
5413365|NCT02655237|18677481|P1|Overall Study|Protocol Deviation|2
5413366|NCT02655237|18677480|P2|Overall Study|Adverse Event|7
5413367|NCT02655237|18677481|P1|Overall Study|Adverse Event|10
5413368|NCT02655224|18677521|P2|Overall Study|Adverse Event|1
5413369|NCT02655224|18677522|P1|Overall Study|Adverse Event|1
5413370|NCT02655016|18677554|P2|Overall Study|Withdrawal by Subject|36
5413371|NCT02655016|18677555|P1|Overall Study|Withdrawal by Subject|18
5413372|NCT02655016|18677554|P2|Overall Study|Lost to Follow-up|1
5413373|NCT02655016|18677555|P1|Overall Study|Lost to Follow-up|1
5413374|NCT02655016|18677554|P2|Overall Study|Death|48
5413375|NCT02655016|18677555|P1|Overall Study|Death|30
5413376|NCT02655016|18677554|P2|Overall Study|Site closed|1
5413377|NCT02655016|18677555|P1|Overall Study|Site closed|0
5413378|NCT02655016|18677554|P2|Overall Study|Disease progression|4
5413379|NCT02655016|18677555|P1|Overall Study|Disease progression|6
5413380|NCT02654977|18677587|P1|Overall Study|Lack of Efficacy|3
5413381|NCT02654977|18677587|P1|Overall Study|Withdrawal by Subject|1
5413382|NCT02654977|18677587|P1|Overall Study|Adverse Event|1
5413383|NCT02654977|18677587|P1|Overall Study|Lost to Follow-up|1
5413384|NCT02654977|18677587|P1|Overall Study|Death|1
5413385|NCT02654717|18677621|P2|Overall Study|Non-permitted medication|0
5413386|NCT02654717|18677622|P1|Overall Study|Non-permitted medication|3
5413387|NCT02654717|18677621|P2|Overall Study|Withdrawal by Subject|1
5413388|NCT02654717|18677622|P1|Overall Study|Withdrawal by Subject|0
5413389|NCT02654717|18677621|P2|Overall Study|Protocol Violation|2
5413390|NCT02654717|18677622|P1|Overall Study|Protocol Violation|1
5413391|NCT02654717|18677621|P2|Overall Study|Adverse Event|2
5413392|NCT02654717|18677622|P1|Overall Study|Adverse Event|2
5413393|NCT02654145|18677673|P1|Overall Study|Withdrawal by Subject|5
5413394|NCT02654145|18677673|P1|Overall Study|Protocol Violation|1
5413395|NCT02654145|18677673|P1|Overall Study|Lack of Efficacy|1
5413396|NCT02654132|18677682|P2|Overall Study|Never treated|2
5413397|NCT02654132|18677683|P1|Overall Study|Never treated|0
5413398|NCT02654132|18677682|P2|Overall Study|Clinical Progression (not protocol)|1
5413399|NCT02654132|18677683|P1|Overall Study|Clinical Progression (not protocol)|0
5413400|NCT02654132|18677682|P2|Overall Study|Inadequate response to therapy|0
5413401|NCT02654132|18677683|P1|Overall Study|Inadequate response to therapy|1
5413402|NCT02654132|18677682|P2|Overall Study|Subject Withdrew Consent|1
5413403|NCT02654132|18677683|P1|Overall Study|Subject Withdrew Consent|2
5413404|NCT02654132|18677682|P2|Overall Study|Not Reported|1
5413405|NCT02654132|18677683|P1|Overall Study|Not Reported|0
5413406|NCT02654132|18677682|P2|Overall Study|Subj Request to Discontinue Treatment|0
5413407|NCT02654132|18677683|P1|Overall Study|Subj Request to Discontinue Treatment|1
5413408|NCT02654132|18677682|P2|Overall Study|Maximum Clinical Benefit|2
5413409|NCT02654132|18677683|P1|Overall Study|Maximum Clinical Benefit|0
5413410|NCT02654132|18677682|P2|Overall Study|Study Drug Toxicity|2
5413411|NCT02654132|18677683|P1|Overall Study|Study Drug Toxicity|1
5413412|NCT02654132|18677682|P2|Overall Study|Switched to another tx|1
5413413|NCT02654132|18677683|P1|Overall Study|Switched to another tx|0
5413414|NCT02654132|18677682|P2|Overall Study|Adverse Event Unrelated to Study Drug|5
5413415|NCT02654132|18677683|P1|Overall Study|Adverse Event Unrelated to Study Drug|5
5413416|NCT02654132|18677682|P2|Overall Study|Disease Progression|31
5413417|NCT02654132|18677683|P1|Overall Study|Disease Progression|26
5413418|NCT02654054|18677694|P3|Post-Treatment Follow-Up Period|Non-Compliance|4
5413419|NCT02654054|18677695|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
5413420|NCT02654054|18677696|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
5413421|NCT02654054|18677694|P3|Post-Treatment Follow-Up Period|Other|4
5413422|NCT02654054|18677695|P2|Post-Treatment Follow-Up Period|Other|0
5413423|NCT02654054|18677696|P1|Post-Treatment Follow-Up Period|Other|1
5413424|NCT02654054|18677694|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
5413425|NCT02654054|18677695|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
5413426|NCT02654054|18677696|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
5413427|NCT02654054|18677694|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|13
5413428|NCT02654054|18677695|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5413429|NCT02654054|18677696|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5413430|NCT02654054|18677694|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
5413431|NCT02654054|18677695|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
5413432|NCT02654054|18677696|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
5413433|NCT02654002|18677731|P9|Overall Study|Withdrew Consent|0
5413434|NCT02654002|18677732|P8|Overall Study|Withdrew Consent|1
5413435|NCT02654002|18677733|P7|Overall Study|Withdrew Consent|0
5413436|NCT02654002|18677734|P6|Overall Study|Withdrew Consent|1
5413437|NCT02654002|18677735|P5|Overall Study|Withdrew Consent|0
5413438|NCT02654002|18677736|P4|Overall Study|Withdrew Consent|0
5413439|NCT02654002|18677737|P3|Overall Study|Withdrew Consent|0
5413440|NCT02654002|18677738|P2|Overall Study|Withdrew Consent|0
5413441|NCT02654002|18677739|P1|Overall Study|Withdrew Consent|0
5413442|NCT02654002|18677731|P9|Overall Study|Adverse Event|0
5413443|NCT02654002|18677732|P8|Overall Study|Adverse Event|0
5413444|NCT02654002|18677733|P7|Overall Study|Adverse Event|1
5413445|NCT02654002|18677734|P6|Overall Study|Adverse Event|0
5413446|NCT02654002|18677735|P5|Overall Study|Adverse Event|0
5413447|NCT02654002|18677736|P4|Overall Study|Adverse Event|0
5413448|NCT02654002|18677737|P3|Overall Study|Adverse Event|0
5413449|NCT02654002|18677738|P2|Overall Study|Adverse Event|0
5413450|NCT02654002|18677739|P1|Overall Study|Adverse Event|0
5413451|NCT02653625|18677913|P1|Overall Study|Suspected Drug Induced Liver Injury|1
5413452|NCT02653625|18677913|P1|Overall Study|Protocol Violation|1
5413453|NCT02653625|18677913|P1|Overall Study|Non-compliance with Study Drug|1
5413454|NCT02653625|18677913|P1|Overall Study|Adverse Event|1
5413455|NCT02653495|18677937|P2|Overall Study|Screening Failure|0
5413456|NCT02653495|18677938|P1|Overall Study|Screening Failure|10
5413457|NCT02653495|18677937|P2|Overall Study|Lost to Follow-up|0
5413458|NCT02653495|18677938|P1|Overall Study|Lost to Follow-up|2
5413459|NCT02653326|18677990|P2|Overall Study|Lost to Follow-up|7
5413460|NCT02653326|18677991|P1|Overall Study|Lost to Follow-up|10
5413461|NCT02653170|18678029|P3|Overall Study|Lost to Follow-up|10
5413462|NCT02653170|18678030|P2|Overall Study|Lost to Follow-up|4
5413463|NCT02653170|18678031|P1|Overall Study|Lost to Follow-up|12
5413464|NCT02653170|18678029|P3|Overall Study|withdrawn by study team|5
5413465|NCT02653170|18678030|P2|Overall Study|withdrawn by study team|4
5413466|NCT02653170|18678031|P1|Overall Study|withdrawn by study team|2
5413467|NCT02653170|18678029|P3|Overall Study|Withdrawal by Subject|3
5413468|NCT02653170|18678030|P2|Overall Study|Withdrawal by Subject|8
5413469|NCT02653170|18678031|P1|Overall Study|Withdrawal by Subject|3
5413470|NCT02652949|18678073|P1|12-Month Follow-up Secondary Endpoint|Death|4
5413471|NCT02652949|18678073|P1|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
5413472|NCT02652949|18678073|P1|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
5413473|NCT02652949|18678073|P1|6-Month Follow-up Secondary Endpoint|Death|5
5413474|NCT02652949|18678073|P1|30-Day Follow-up for Secondary Endpoint|Death|1
5413475|NCT02652949|18678073|P1|30-Day Follow-up for Primary Endpoint|Death|1
5413476|NCT02652767|18678108|P1|Overall Study|Withdrawal by Subject|1
5413477|NCT02652767|18678108|P1|Overall Study|Lost to Follow-up|1
5413478|NCT02652767|18678108|P1|Overall Study|Death|2
5413479|NCT02652624|18678136|P2|Extension Phase|Withdrew Consent|1
5413480|NCT02652624|18678137|P1|Extension Phase|Withdrew Consent|0
5413481|NCT02652624|18678136|P2|Extension Phase|Adverse Event|1
5413482|NCT02652624|18678137|P1|Extension Phase|Adverse Event|0
5413483|NCT02652624|18678136|P2|Extension Phase|Pregnancy|1
5413484|NCT02652624|18678137|P1|Extension Phase|Pregnancy|1
5413485|NCT02652624|18678136|P2|Extension Phase|Lost to Follow-up|1
5413486|NCT02652624|18678137|P1|Extension Phase|Lost to Follow-up|3
5413487|NCT02652624|18678136|P2|Randomized Phase|Lost to Follow-up|1
5413488|NCT02652624|18678137|P1|Randomized Phase|Lost to Follow-up|0
5413489|NCT02652624|18678136|P2|Randomized Phase|Death|1
5413490|NCT02652624|18678137|P1|Randomized Phase|Death|0
5413491|NCT02652624|18678136|P2|Randomized Phase|Investigator's Discretion|2
5413492|NCT02652624|18678137|P1|Randomized Phase|Investigator's Discretion|0
5413493|NCT02652624|18678136|P2|Randomized Phase|Pregnancy|1
5413494|NCT02652624|18678137|P1|Randomized Phase|Pregnancy|3
5413495|NCT02652260|18678225|P2|Overall Study|Withdrawal by Subject|1
5413496|NCT02652260|18678226|P1|Overall Study|Withdrawal by Subject|0
5413497|NCT02652260|18678225|P2|Overall Study|Pregnancy|1
5413498|NCT02652260|18678226|P1|Overall Study|Pregnancy|0
5413499|NCT02652156|18678285|P3|Overall Study|Physician Decision|0
5413500|NCT02652156|18678286|P2|Overall Study|Physician Decision|0
5413501|NCT02652156|18678287|P1|Overall Study|Physician Decision|1
5413502|NCT02651987|18678315|P2|Overall Study|Investigator Decision|1
5413503|NCT02651987|18678316|P1|Overall Study|Investigator Decision|1
5413504|NCT02651987|18678315|P2|Overall Study|Local PD|2
5413505|NCT02651987|18678316|P1|Overall Study|Local PD|0
5413506|NCT02651987|18678315|P2|Overall Study|Consent Withdrawn|0
5413507|NCT02651987|18678316|P1|Overall Study|Consent Withdrawn|2
5413508|NCT02651987|18678315|P2|Overall Study|Adverse Event|2
5413509|NCT02651987|18678316|P1|Overall Study|Adverse Event|2
5413510|NCT02651922|18678357|P1|Overall Study|due to exclusion criteria|2
5413511|NCT02651688|18678377|P3|Overall Study|Withdrawal by Subject|2
5413512|NCT02651688|18678378|P2|Overall Study|Withdrawal by Subject|0
5413513|NCT02651688|18678379|P1|Overall Study|Withdrawal by Subject|1
5413514|NCT02651688|18678377|P3|Overall Study|Lost to Follow-up|0
5413515|NCT02651688|18678378|P2|Overall Study|Lost to Follow-up|3
5413516|NCT02651688|18678379|P1|Overall Study|Lost to Follow-up|1
5413517|NCT02651688|18678377|P3|Overall Study|Principal Investigator (PI) decision|0
5413518|NCT02651688|18678378|P2|Overall Study|Principal Investigator (PI) decision|2
5413519|NCT02651688|18678379|P1|Overall Study|Principal Investigator (PI) decision|0
5413520|NCT02651688|18678377|P3|Overall Study|Non-compliance|1
5413521|NCT02651688|18678378|P2|Overall Study|Non-compliance|0
5413522|NCT02651688|18678379|P1|Overall Study|Non-compliance|0
5413523|NCT02651467|18678462|P3|Overall Study|Other (Not specified)|2
5413524|NCT02651467|18678463|P2|Overall Study|Other (Not specified)|0
5413525|NCT02651467|18678464|P1|Overall Study|Other (Not specified)|1
5413526|NCT02651467|18678462|P3|Overall Study|Withdrawal by Subject|2
5413527|NCT02651467|18678463|P2|Overall Study|Withdrawal by Subject|0
5413528|NCT02651467|18678464|P1|Overall Study|Withdrawal by Subject|0
5413529|NCT02651220|18678558|P3|Overall Study|Withdrawal by Parent/Guardian|1
5413530|NCT02651220|18678559|P2|Overall Study|Withdrawal by Parent/Guardian|1
5413531|NCT02651220|18678560|P1|Overall Study|Withdrawal by Parent/Guardian|0
5413532|NCT02651220|18678558|P3|Overall Study|Miscellaneous|2
5413533|NCT02651220|18678559|P2|Overall Study|Miscellaneous|1
5413534|NCT02651220|18678560|P1|Overall Study|Miscellaneous|4
5413535|NCT02651220|18678558|P3|Overall Study|Withdrawal by Subject|8
5413536|NCT02651220|18678559|P2|Overall Study|Withdrawal by Subject|6
5413537|NCT02651220|18678560|P1|Overall Study|Withdrawal by Subject|5
5413538|NCT02651220|18678558|P3|Overall Study|Protocol Violation|1
5413539|NCT02651220|18678559|P2|Overall Study|Protocol Violation|0
5413540|NCT02651220|18678560|P1|Overall Study|Protocol Violation|0
5413541|NCT02651220|18678558|P3|Overall Study|Pregnancy|1
5413542|NCT02651220|18678559|P2|Overall Study|Pregnancy|0
5413543|NCT02651220|18678560|P1|Overall Study|Pregnancy|1
5413544|NCT02651220|18678558|P3|Overall Study|Non-Compliance with Study Drug|1
5413545|NCT02651220|18678559|P2|Overall Study|Non-Compliance with Study Drug|0
5413546|NCT02651220|18678560|P1|Overall Study|Non-Compliance with Study Drug|4
5413547|NCT02651220|18678558|P3|Overall Study|Lost to Follow-up|14
5413548|NCT02651220|18678559|P2|Overall Study|Lost to Follow-up|14
5413549|NCT02651220|18678560|P1|Overall Study|Lost to Follow-up|8
5413550|NCT02651220|18678558|P3|Overall Study|Adverse Event|1
5413551|NCT02651220|18678559|P2|Overall Study|Adverse Event|5
5413552|NCT02651220|18678560|P1|Overall Study|Adverse Event|1
5413553|NCT02651194|18678574|P1|Overall Study|Other|2
5413554|NCT02651194|18678574|P1|Overall Study|Lost to Follow-up|3
5413555|NCT02651155|18678582|P2|Overall Study|Voluntary Withdrawal|0
5413556|NCT02651155|18678583|P1|Overall Study|Voluntary Withdrawal|5
5413557|NCT02651155|18678582|P2|Overall Study|Pretreatment Event/Adverse Event|2
5413558|NCT02651155|18678583|P1|Overall Study|Pretreatment Event/Adverse Event|1
5413559|NCT02650921|18678608|P1|Overall Study|Due to Medical Condition|1
5413560|NCT02650921|18678608|P1|Overall Study|Adverse Event|1
5413561|NCT02650921|18678608|P1|Overall Study|Lost to Follow-up|2
5413562|NCT02650921|18678608|P1|Overall Study|Withdrawal by Subject|4
5413563|NCT02650895|18678662|P6|Overall Study|Withdrawal by Subject|0
5413564|NCT02650895|18678663|P5|Overall Study|Withdrawal by Subject|0
5413565|NCT02650895|18678664|P4|Overall Study|Withdrawal by Subject|0
5413566|NCT02650895|18678665|P3|Overall Study|Withdrawal by Subject|0
5413567|NCT02650895|18678666|P2|Overall Study|Withdrawal by Subject|1
5413568|NCT02650895|18678667|P1|Overall Study|Withdrawal by Subject|0
5413569|NCT02650466|18678714|P1|Overall Study|Lost to Follow-up|1
5413570|NCT02650466|18678714|P1|Overall Study|Withdrawal by Subject|5
5413571|NCT02650466|18678714|P1|Overall Study|Physician Decision|1
5413572|NCT02650128|18678844|P1|Overall Study|Death|2
5413573|NCT02649946|18678853|P2|Overall Study|Missed 6-month follow-up visit|4
5413574|NCT02649946|18678854|P1|Overall Study|Missed 6-month follow-up visit|0
5413575|NCT02649946|18678853|P2|Overall Study|Erroneously enrolled|0
5413576|NCT02649946|18678854|P1|Overall Study|Erroneously enrolled|1
5413577|NCT02649946|18678853|P2|Overall Study|Lost to Follow-up|1
5413578|NCT02649946|18678854|P1|Overall Study|Lost to Follow-up|2
5413579|NCT02649946|18678853|P2|Overall Study|Physician Decision|0
5413580|NCT02649946|18678854|P1|Overall Study|Physician Decision|1
5413581|NCT02649946|18678853|P2|Overall Study|Death|9
5413582|NCT02649946|18678854|P1|Overall Study|Death|7
5413583|NCT02649946|18678853|P2|Overall Study|Withdrawal by Subject|1
5413584|NCT02649946|18678854|P1|Overall Study|Withdrawal by Subject|1
5413585|NCT02649894|18678883|P2|Overall Study|Other, not specified|0
5413586|NCT02649894|18678884|P1|Overall Study|Other, not specified|6
5413587|NCT02649894|18678883|P2|Overall Study|Death|7
5413588|NCT02649894|18678884|P1|Overall Study|Death|30
5413589|NCT02649894|18678883|P2|Overall Study|Lost to Follow-up|1
5413590|NCT02649894|18678884|P1|Overall Study|Lost to Follow-up|2
5413591|NCT02649894|18678883|P2|Overall Study|Withdrawal by Subject|2
5413592|NCT02649894|18678884|P1|Overall Study|Withdrawal by Subject|5
5413593|NCT02649894|18678883|P2|Overall Study|Physician Decision|1
5413594|NCT02649894|18678884|P1|Overall Study|Physician Decision|0
5413595|NCT02649894|18678883|P2|Overall Study|Adverse Event|0
5413596|NCT02649894|18678884|P1|Overall Study|Adverse Event|1
5413597|NCT02649634|18678912|P2|Overall Study|Lost to Follow-up|1
5413598|NCT02649634|18678913|P1|Overall Study|Lost to Follow-up|0
5413599|NCT02649634|18678912|P2|Overall Study|Withdrawal by Subject|5
5413600|NCT02649634|18678913|P1|Overall Study|Withdrawal by Subject|3
5413601|NCT02649218|18679075|P1|Overall Study|Withdrawal by Subject|2
5413602|NCT02649218|18679075|P1|Overall Study|Physician Decision|1
5413603|NCT02649218|18679075|P1|Overall Study|Protocol Violation|3
5413604|NCT02649218|18679075|P1|Overall Study|Pregnancy|3
5413605|NCT02649218|18679075|P1|Overall Study|Lack of Efficacy|8
5413606|NCT02649218|18679075|P1|Overall Study|Adverse Event|8
5413607|NCT02648698|18679173|P2|Overall Study|Protocol Violation|5
5413608|NCT02648698|18679174|P1|Overall Study|Protocol Violation|1
5413609|NCT02648438|18679231|P3|Overall Study|Withdrawal by Subject|0
5413610|NCT02648438|18679232|P2|Overall Study|Withdrawal by Subject|1
5413611|NCT02648438|18679233|P1|Overall Study|Withdrawal by Subject|1
5413612|NCT02648438|18679231|P3|Overall Study|Protocol Violation|0
5413613|NCT02648438|18679232|P2|Overall Study|Protocol Violation|0
5413614|NCT02648438|18679233|P1|Overall Study|Protocol Violation|2
5413615|NCT02648438|18679231|P3|Overall Study|Eligibility criteria not fulfilled|0
5413616|NCT02648438|18679232|P2|Overall Study|Eligibility criteria not fulfilled|2
5413617|NCT02648438|18679233|P1|Overall Study|Eligibility criteria not fulfilled|0
5413618|NCT02648217|18679279|P2|Overall Study|Unclassified|0
5413619|NCT02648217|18679280|P1|Overall Study|Unclassified|5
5413620|NCT02648217|18679279|P2|Overall Study|Withdrawal by Subject|3
5413621|NCT02648217|18679280|P1|Overall Study|Withdrawal by Subject|4
5413622|NCT02648217|18679279|P2|Overall Study|Lost to Follow-up|1
5413623|NCT02648217|18679280|P1|Overall Study|Lost to Follow-up|1
5413624|NCT02648217|18679279|P2|Overall Study|Adverse Event|1
5413625|NCT02648217|18679280|P1|Overall Study|Adverse Event|0
5413626|NCT02648204|18679302|P4|Overall Study|Adverse Event|0
5413627|NCT02648204|18679303|P3|Overall Study|Adverse Event|1
5413628|NCT02648204|18679304|P2|Overall Study|Adverse Event|0
5413629|NCT02648204|18679305|P1|Overall Study|Adverse Event|0
5413630|NCT02648204|18679302|P4|Overall Study|Death|2
5413631|NCT02648204|18679303|P3|Overall Study|Death|2
5413632|NCT02648204|18679304|P2|Overall Study|Death|1
5413633|NCT02648204|18679305|P1|Overall Study|Death|1
5413634|NCT02648204|18679302|P4|Overall Study|Missing follow-up information|2
5413635|NCT02648204|18679303|P3|Overall Study|Missing follow-up information|4
5413636|NCT02648204|18679304|P2|Overall Study|Missing follow-up information|4
5413637|NCT02648204|18679305|P1|Overall Study|Missing follow-up information|4
5413638|NCT02648204|18679302|P4|Overall Study|Lost to Follow-up|6
5413639|NCT02648204|18679303|P3|Overall Study|Lost to Follow-up|4
5413640|NCT02648204|18679304|P2|Overall Study|Lost to Follow-up|8
5413641|NCT02648204|18679305|P1|Overall Study|Lost to Follow-up|5
5413642|NCT02648204|18679302|P4|Overall Study|Withdrawal by Subject|6
5413643|NCT02648204|18679303|P3|Overall Study|Withdrawal by Subject|2
5413644|NCT02648204|18679304|P2|Overall Study|Withdrawal by Subject|8
5413645|NCT02648204|18679305|P1|Overall Study|Withdrawal by Subject|12
5413646|NCT02647944|18679443|P2|Overall Study|Adverse Event|0
5413647|NCT02647944|18679444|P1|Overall Study|Adverse Event|2
5413648|NCT02647944|18679443|P2|Overall Study|Withdrawal by Subject|3
5413649|NCT02647944|18679444|P1|Overall Study|Withdrawal by Subject|0
5413650|NCT02647905|18679468|P1|Overall Study|Withdrawal by Subject|2
5413651|NCT02647905|18679468|P1|Overall Study|Lost to Follow-up|1
5413652|NCT02647866|18679478|P5|Overall Study|Subject moved to different country|0
5413653|NCT02647866|18679479|P4|Overall Study|Subject moved to different country|0
5413654|NCT02647866|18679480|P3|Overall Study|Subject moved to different country|0
5413655|NCT02647866|18679481|P2|Overall Study|Subject moved to different country|0
5413656|NCT02647866|18679482|P1|Overall Study|Subject moved to different country|1
5413657|NCT02647866|18679478|P5|Overall Study|Death|0
5413658|NCT02647866|18679479|P4|Overall Study|Death|0
5413659|NCT02647866|18679480|P3|Overall Study|Death|0
5413660|NCT02647866|18679481|P2|Overall Study|Death|1
5413661|NCT02647866|18679482|P1|Overall Study|Death|0
5413662|NCT02647866|18679478|P5|Overall Study|Physician Decision|2
5413663|NCT02647866|18679479|P4|Overall Study|Physician Decision|0
5413664|NCT02647866|18679480|P3|Overall Study|Physician Decision|1
5413665|NCT02647866|18679481|P2|Overall Study|Physician Decision|1
5413666|NCT02647866|18679482|P1|Overall Study|Physician Decision|0
5413667|NCT02647866|18679478|P5|Overall Study|Withdrawal by Subject|4
5413668|NCT02647866|18679479|P4|Overall Study|Withdrawal by Subject|4
5413669|NCT02647866|18679480|P3|Overall Study|Withdrawal by Subject|2
5413670|NCT02647866|18679481|P2|Overall Study|Withdrawal by Subject|1
5413671|NCT02647866|18679482|P1|Overall Study|Withdrawal by Subject|1
5413672|NCT02647866|18679478|P5|Overall Study|Disease Worsening|1
5413673|NCT02647866|18679479|P4|Overall Study|Disease Worsening|0
5413674|NCT02647866|18679480|P3|Overall Study|Disease Worsening|0
5413675|NCT02647866|18679481|P2|Overall Study|Disease Worsening|1
5413676|NCT02647866|18679482|P1|Overall Study|Disease Worsening|3
5413677|NCT02647866|18679478|P5|Overall Study|Adverse Event|1
5413678|NCT02647866|18679479|P4|Overall Study|Adverse Event|2
5413679|NCT02647866|18679480|P3|Overall Study|Adverse Event|2
5413680|NCT02647866|18679481|P2|Overall Study|Adverse Event|0
5413681|NCT02647866|18679482|P1|Overall Study|Adverse Event|0
5413682|NCT02647788|18679559|P2|Overall Study|Felt nauseous with assigned medication|1
5413683|NCT02647788|18679560|P1|Overall Study|Felt nauseous with assigned medication|1
5413684|NCT02647788|18679559|P2|Overall Study|Felt itchy with assigned medication|0
5413685|NCT02647788|18679560|P1|Overall Study|Felt itchy with assigned medication|1
5413686|NCT02647788|18679559|P2|Overall Study|Withdrawal by Subject|0
5413687|NCT02647788|18679560|P1|Overall Study|Withdrawal by Subject|1
5413688|NCT02647788|18679559|P2|Overall Study|Did not want opiate|1
5413689|NCT02647788|18679560|P1|Overall Study|Did not want opiate|0
5413690|NCT02647788|18679559|P2|Overall Study|Lost to Follow-up|11
5413691|NCT02647788|18679560|P1|Overall Study|Lost to Follow-up|13
5413692|NCT02647658|18679572|P2|Overall Study|Consent refusal|24
5413693|NCT02647658|18679573|P1|Overall Study|Consent refusal|15
5413694|NCT02647645|18679601|P2|Overall Study|Lost to Follow-up|1
5413695|NCT02647645|18679602|P1|Overall Study|Lost to Follow-up|2
5413696|NCT02647320|18679624|P5|Overall Study|Disposition Missing Due to Fire at Site|4
5413697|NCT02647320|18679625|P4|Overall Study|Disposition Missing Due to Fire at Site|3
5413698|NCT02647320|18679626|P3|Overall Study|Disposition Missing Due to Fire at Site|4
5413699|NCT02647320|18679627|P2|Overall Study|Disposition Missing Due to Fire at Site|3
5413700|NCT02647320|18679628|P1|Overall Study|Disposition Missing Due to Fire at Site|2
5413701|NCT02647320|18679624|P5|Overall Study|Lack of Efficacy|0
5413702|NCT02647320|18679625|P4|Overall Study|Lack of Efficacy|1
5413703|NCT02647320|18679626|P3|Overall Study|Lack of Efficacy|0
5413704|NCT02647320|18679627|P2|Overall Study|Lack of Efficacy|0
5413705|NCT02647320|18679628|P1|Overall Study|Lack of Efficacy|0
5413706|NCT02647320|18679624|P5|Overall Study|Develop anemia|0
5413707|NCT02647320|18679625|P4|Overall Study|Develop anemia|0
5413708|NCT02647320|18679626|P3|Overall Study|Develop anemia|0
5413709|NCT02647320|18679627|P2|Overall Study|Develop anemia|0
5413710|NCT02647320|18679628|P1|Overall Study|Develop anemia|1
5413711|NCT02647320|18679624|P5|Overall Study|Lost to Follow-up|0
5413712|NCT02647320|18679625|P4|Overall Study|Lost to Follow-up|0
5413713|NCT02647320|18679626|P3|Overall Study|Lost to Follow-up|0
5413714|NCT02647320|18679627|P2|Overall Study|Lost to Follow-up|1
5413715|NCT02647320|18679628|P1|Overall Study|Lost to Follow-up|1
5413716|NCT02647320|18679624|P5|Overall Study|Reason not provided|2
5413717|NCT02647320|18679625|P4|Overall Study|Reason not provided|0
5413718|NCT02647320|18679626|P3|Overall Study|Reason not provided|1
5413719|NCT02647320|18679627|P2|Overall Study|Reason not provided|0
5413720|NCT02647320|18679628|P1|Overall Study|Reason not provided|0
5413721|NCT02647320|18679624|P5|Overall Study|Study terminated by sponsor|2
5413722|NCT02647320|18679625|P4|Overall Study|Study terminated by sponsor|1
5413723|NCT02647320|18679626|P3|Overall Study|Study terminated by sponsor|1
5413724|NCT02647320|18679627|P2|Overall Study|Study terminated by sponsor|1
5413725|NCT02647320|18679628|P1|Overall Study|Study terminated by sponsor|1
5413726|NCT02647320|18679624|P5|Overall Study|Persistent hyperglycemia|1
5413727|NCT02647320|18679625|P4|Overall Study|Persistent hyperglycemia|1
5413728|NCT02647320|18679626|P3|Overall Study|Persistent hyperglycemia|1
5413729|NCT02647320|18679627|P2|Overall Study|Persistent hyperglycemia|1
5413730|NCT02647320|18679628|P1|Overall Study|Persistent hyperglycemia|0
5413731|NCT02647320|18679624|P5|Overall Study|Withdrawal by Subject|7
5413732|NCT02647320|18679625|P4|Overall Study|Withdrawal by Subject|2
5413733|NCT02647320|18679626|P3|Overall Study|Withdrawal by Subject|2
5413734|NCT02647320|18679627|P2|Overall Study|Withdrawal by Subject|4
5413735|NCT02647320|18679628|P1|Overall Study|Withdrawal by Subject|7
5413736|NCT02647320|18679624|P5|Overall Study|Protocol Violation|0
5413737|NCT02647320|18679625|P4|Overall Study|Protocol Violation|0
5413738|NCT02647320|18679626|P3|Overall Study|Protocol Violation|3
5413739|NCT02647320|18679627|P2|Overall Study|Protocol Violation|0
5413740|NCT02647320|18679628|P1|Overall Study|Protocol Violation|0
5413741|NCT02647320|18679624|P5|Overall Study|Adverse Event|1
5413742|NCT02647320|18679625|P4|Overall Study|Adverse Event|2
5413743|NCT02647320|18679626|P3|Overall Study|Adverse Event|3
5413744|NCT02647320|18679627|P2|Overall Study|Adverse Event|1
5413745|NCT02647320|18679628|P1|Overall Study|Adverse Event|0
5413746|NCT02647281|18679719|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
5413747|NCT02647281|18679720|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5413748|NCT02647281|18679721|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5413749|NCT02647281|18679722|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5413750|NCT02647281|18679723|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5413751|NCT02647281|18679724|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5413752|NCT02647281|18679725|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5413753|NCT02647281|18679726|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5413754|NCT02647281|18679727|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
5413755|NCT02646891|18679915|P10|Overall Study|Death|0
5413756|NCT02646891|18679916|P9|Overall Study|Death|1
5413757|NCT02646891|18679917|P8|Overall Study|Death|1
5413758|NCT02646891|18679918|P7|Overall Study|Death|1
5413759|NCT02646891|18679919|P6|Overall Study|Death|0
5413760|NCT02646891|18679920|P5|Overall Study|Death|0
5413761|NCT02646891|18679921|P4|Overall Study|Death|0
5413762|NCT02646891|18679922|P3|Overall Study|Death|0
5413763|NCT02646891|18679923|P2|Overall Study|Death|0
5413764|NCT02646891|18679924|P1|Overall Study|Death|0
5413765|NCT02646891|18679915|P10|Overall Study|Withdrawal by Subject|3
5413766|NCT02646891|18679916|P9|Overall Study|Withdrawal by Subject|7
5413767|NCT02646891|18679917|P8|Overall Study|Withdrawal by Subject|9
5413768|NCT02646891|18679918|P7|Overall Study|Withdrawal by Subject|5
5413769|NCT02646891|18679919|P6|Overall Study|Withdrawal by Subject|0
5413770|NCT02646891|18679920|P5|Overall Study|Withdrawal by Subject|0
5413771|NCT02646891|18679921|P4|Overall Study|Withdrawal by Subject|0
5413772|NCT02646891|18679922|P3|Overall Study|Withdrawal by Subject|1
5413773|NCT02646891|18679923|P2|Overall Study|Withdrawal by Subject|0
5413774|NCT02646891|18679924|P1|Overall Study|Withdrawal by Subject|2
5413775|NCT02646891|18679915|P10|Overall Study|Protocol Violation|0
5413776|NCT02646891|18679916|P9|Overall Study|Protocol Violation|0
5413777|NCT02646891|18679917|P8|Overall Study|Protocol Violation|1
5413778|NCT02646891|18679918|P7|Overall Study|Protocol Violation|1
5413779|NCT02646891|18679919|P6|Overall Study|Protocol Violation|0
5413780|NCT02646891|18679920|P5|Overall Study|Protocol Violation|0
5413781|NCT02646891|18679921|P4|Overall Study|Protocol Violation|0
5413782|NCT02646891|18679922|P3|Overall Study|Protocol Violation|0
5413783|NCT02646891|18679923|P2|Overall Study|Protocol Violation|0
5413784|NCT02646891|18679924|P1|Overall Study|Protocol Violation|0
5413785|NCT02646891|18679915|P10|Overall Study|Lost to Follow-up|2
5413786|NCT02646891|18679916|P9|Overall Study|Lost to Follow-up|2
5413787|NCT02646891|18679917|P8|Overall Study|Lost to Follow-up|2
5413788|NCT02646891|18679918|P7|Overall Study|Lost to Follow-up|2
5413789|NCT02646891|18679919|P6|Overall Study|Lost to Follow-up|0
5413790|NCT02646891|18679920|P5|Overall Study|Lost to Follow-up|0
5413791|NCT02646891|18679921|P4|Overall Study|Lost to Follow-up|0
5413792|NCT02646891|18679922|P3|Overall Study|Lost to Follow-up|0
5413793|NCT02646891|18679923|P2|Overall Study|Lost to Follow-up|0
5413794|NCT02646891|18679924|P1|Overall Study|Lost to Follow-up|0
5413795|NCT02646891|18679915|P10|Overall Study|Adverse Event|0
5413796|NCT02646891|18679916|P9|Overall Study|Adverse Event|0
5413797|NCT02646891|18679917|P8|Overall Study|Adverse Event|0
5413798|NCT02646891|18679918|P7|Overall Study|Adverse Event|0
5413799|NCT02646891|18679919|P6|Overall Study|Adverse Event|0
5413800|NCT02646891|18679920|P5|Overall Study|Adverse Event|0
5413801|NCT02646891|18679921|P4|Overall Study|Adverse Event|0
5413802|NCT02646891|18679922|P3|Overall Study|Adverse Event|0
5413803|NCT02646891|18679923|P2|Overall Study|Adverse Event|1
5413804|NCT02646891|18679924|P1|Overall Study|Adverse Event|0
5413805|NCT02646566|18680098|P3|Overall Study|Treatment failure|0
5413806|NCT02646566|18680099|P2|Overall Study|Treatment failure|0
5413807|NCT02646566|18680100|P1|Overall Study|Treatment failure|1
5413808|NCT02646566|18680098|P3|Overall Study|Lost to Follow-up|5
5413809|NCT02646566|18680099|P2|Overall Study|Lost to Follow-up|4
5413810|NCT02646566|18680100|P1|Overall Study|Lost to Follow-up|5
5413811|NCT02646332|18680151|P2|Overall Study|Lost to Follow-up|3
5413812|NCT02646332|18680152|P1|Overall Study|Lost to Follow-up|0
5413813|NCT02646124|18680160|P2|Overall Study|Lost to Follow-up|2
5413814|NCT02646124|18680161|P1|Overall Study|Lost to Follow-up|0
5413815|NCT02645409|18680197|P2|Overall Study|Physician Decision|0
5413816|NCT02645409|18680198|P1|Overall Study|Physician Decision|1
5413817|NCT02645409|18680197|P2|Overall Study|Withdrawal by Subject|0
5413818|NCT02645409|18680198|P1|Overall Study|Withdrawal by Subject|3
5413819|NCT02644668|18680385|P3|Overall Study|Withdrawal by Subject|1
5413820|NCT02644668|18680386|P2|Overall Study|Withdrawal by Subject|0
5413821|NCT02644668|18680387|P1|Overall Study|Withdrawal by Subject|0
5413822|NCT02644668|18680385|P3|Overall Study|Protocol Violation|1
5413823|NCT02644668|18680386|P2|Overall Study|Protocol Violation|0
5413824|NCT02644668|18680387|P1|Overall Study|Protocol Violation|0
5413825|NCT02644668|18680385|P3|Overall Study|Adverse Event|1
5413826|NCT02644668|18680386|P2|Overall Study|Adverse Event|0
5413827|NCT02644668|18680387|P1|Overall Study|Adverse Event|2
5413828|NCT02644356|18680426|P1|Overall Study|Withdrawal by Subject|2
5413829|NCT02644343|18680436|P1|Overall Study|Withdrawal by Subject|1
5413830|NCT02644122|18680513|P1|Overall Study|Withdrawal by Subject|1
5413831|NCT02644109|18680523|P2|Overall Study|Adverse Event|4
5413832|NCT02644109|18680524|P1|Overall Study|Adverse Event|0
5413833|NCT02644096|18680532|P2|Overall Study|Withdrawal by Subject|25
5413834|NCT02644096|18680533|P1|Overall Study|Withdrawal by Subject|28
5413835|NCT02643693|18680585|P6|Overall Study|Protocol Adherence Issues|1
5413836|NCT02643693|18680586|P5|Overall Study|Protocol Adherence Issues|0
5413837|NCT02643693|18680587|P4|Overall Study|Protocol Adherence Issues|0
5413838|NCT02643693|18680588|P3|Overall Study|Protocol Adherence Issues|1
5413839|NCT02643693|18680589|P2|Overall Study|Protocol Adherence Issues|0
5413840|NCT02643693|18680590|P1|Overall Study|Protocol Adherence Issues|2
5413841|NCT02643693|18680585|P6|Overall Study|Withdrawal by Subject|0
5413842|NCT02643693|18680586|P5|Overall Study|Withdrawal by Subject|0
5413843|NCT02643693|18680587|P4|Overall Study|Withdrawal by Subject|0
5413844|NCT02643693|18680588|P3|Overall Study|Withdrawal by Subject|0
5413845|NCT02643693|18680589|P2|Overall Study|Withdrawal by Subject|1
5413846|NCT02643693|18680590|P1|Overall Study|Withdrawal by Subject|0
5413847|NCT02643693|18680585|P6|Overall Study|Physician Decision|0
5413848|NCT02643693|18680586|P5|Overall Study|Physician Decision|0
5413849|NCT02643693|18680587|P4|Overall Study|Physician Decision|0
5413850|NCT02643693|18680588|P3|Overall Study|Physician Decision|0
5413851|NCT02643693|18680589|P2|Overall Study|Physician Decision|1
5413852|NCT02643693|18680590|P1|Overall Study|Physician Decision|0
5413853|NCT02643628|18680603|P2|Overall Study|Relocated out of state|1
5413854|NCT02643628|18680604|P1|Overall Study|Relocated out of state|0
5413855|NCT02643628|18680603|P2|Overall Study|Withdrawal by Subject|1
5413856|NCT02643628|18680604|P1|Overall Study|Withdrawal by Subject|0
5413857|NCT02643628|18680603|P2|Overall Study|Lost to Follow-up|4
5413858|NCT02643628|18680604|P1|Overall Study|Lost to Follow-up|1
5413859|NCT02643472|18680635|P2|Overall Study|Lost to Follow-up|26
5413860|NCT02643472|18680636|P1|Overall Study|Lost to Follow-up|22
5413861|NCT02643472|18680635|P2|Overall Study|Protocol Violation|1
5413862|NCT02643472|18680636|P1|Overall Study|Protocol Violation|0
5413863|NCT02643472|18680635|P2|Overall Study|Withdrawal by Subject|2
5413864|NCT02643472|18680636|P1|Overall Study|Withdrawal by Subject|3
5413865|NCT02643472|18680635|P2|Overall Study|Death|5
5413866|NCT02643472|18680636|P1|Overall Study|Death|2
5413867|NCT02643394|18680662|P2|Overall Study|Protocol Violation|5
5413868|NCT02643394|18680663|P1|Overall Study|Protocol Violation|4
5413869|NCT02643355|18680673|P2|Overall Study|Protocol Violation|2
5413870|NCT02643355|18680674|P1|Overall Study|Protocol Violation|0
5413871|NCT02643355|18680673|P2|Overall Study|Withdrawal by Subject|3
5413872|NCT02643355|18680674|P1|Overall Study|Withdrawal by Subject|1
5413873|NCT02643251|18680688|P2|Overall Study|PI Decision to terminate patient|0
5413874|NCT02643251|18680689|P1|Overall Study|PI Decision to terminate patient|1
5413875|NCT02643251|18680688|P2|Overall Study|Protocol Violation|0
5413876|NCT02643251|18680689|P1|Overall Study|Protocol Violation|1
5413877|NCT02643251|18680688|P2|Overall Study|Lost to Follow-up|1
5413878|NCT02643251|18680689|P1|Overall Study|Lost to Follow-up|4
5413879|NCT02643251|18680688|P2|Overall Study|Withdrawal by Subject|0
5413880|NCT02643251|18680689|P1|Overall Study|Withdrawal by Subject|2
5413881|NCT02643251|18680688|P2|Overall Study|Adverse Event|1
5413882|NCT02643251|18680689|P1|Overall Study|Adverse Event|3
5413883|NCT02643082|18680721|P2|Period 1|Adverse Event|0
5413884|NCT02643082|18680722|P1|Period 1|Adverse Event|1
5413885|NCT02642965|18680862|P1|Overall Study|Physician Decision|9
5413886|NCT02642965|18680862|P1|Overall Study|Lack of Efficacy|4
5413887|NCT02642679|18680906|P1|Overall Study|Physician Decision|1
5413888|NCT02642679|18680906|P1|Overall Study|Physician Decision|1
5413889|NCT02642679|18680906|P1|Overall Study|Withdrawal by Subject|1
5413890|NCT02642653|18680914|P2|Overall Study|Adverse Event|0
5413891|NCT02642653|18680915|P1|Overall Study|Adverse Event|2
5413892|NCT02642614|18680956|P4|Overall Study|Withdrawal by Subject|0
5413893|NCT02642614|18680957|P3|Overall Study|Withdrawal by Subject|0
5413894|NCT02642614|18680958|P2|Overall Study|Withdrawal by Subject|1
5413895|NCT02642614|18680959|P1|Overall Study|Withdrawal by Subject|1
5413896|NCT02642614|18680956|P4|Overall Study|Lost to Follow-up|0
5413897|NCT02642614|18680957|P3|Overall Study|Lost to Follow-up|0
5413898|NCT02642614|18680958|P2|Overall Study|Lost to Follow-up|0
5413899|NCT02642614|18680959|P1|Overall Study|Lost to Follow-up|1
5413900|NCT02642614|18680956|P4|Overall Study|Adverse Event|2
5413901|NCT02642614|18680957|P3|Overall Study|Adverse Event|2
5413902|NCT02642614|18680958|P2|Overall Study|Adverse Event|1
5413903|NCT02642614|18680959|P1|Overall Study|Adverse Event|1
5413904|NCT02642432|18681026|P1|Overall Study|Other|3
5413905|NCT02642432|18681026|P1|Overall Study|Lost to Follow-up|2
5413906|NCT02642432|18681026|P1|Overall Study|Withdrew Consent|1
5413907|NCT02642432|18681026|P1|Overall Study|Adverse Event|2
5413908|NCT02642159|18681072|P2|Overall Study|Other than specified above|3
5413909|NCT02642159|18681073|P1|Overall Study|Other than specified above|10
5413910|NCT02642159|18681072|P2|Overall Study|Poor compliance to study protocol|0
5413911|NCT02642159|18681073|P1|Overall Study|Poor compliance to study protocol|1
5413912|NCT02642159|18681072|P2|Overall Study|Withdrawal by Subject|1
5413913|NCT02642159|18681073|P1|Overall Study|Withdrawal by Subject|9
5413914|NCT02642159|18681072|P2|Overall Study|Adverse Event|4
5413915|NCT02642159|18681073|P1|Overall Study|Adverse Event|10
5413916|NCT02642159|18681072|P2|Overall Study|Randomized but not treated|0
5413917|NCT02642159|18681073|P1|Overall Study|Randomized but not treated|1
5413918|NCT02641730|18681197|P5|Observational Period (Week 60 - Week 84)|Other|1
5413919|NCT02641730|18681198|P4|Observational Period (Week 60 - Week 84)|Other|0
5413920|NCT02641730|18681199|P3|Observational Period (Week 60 - Week 84)|Other|0
5413921|NCT02641730|18681200|P2|Observational Period (Week 60 - Week 84)|Other|0
5413922|NCT02641730|18681201|P1|Observational Period (Week 60 - Week 84)|Other|0
5413923|NCT02641730|18681197|P5|After Controlled Period (Week 16 - 52)|Other|1
5413924|NCT02641730|18681198|P4|After Controlled Period (Week 16 - 52)|Other|0
5413925|NCT02641730|18681199|P3|After Controlled Period (Week 16 - 52)|Other|1
5413926|NCT02641730|18681200|P2|After Controlled Period (Week 16 - 52)|Other|1
5413927|NCT02641730|18681201|P1|After Controlled Period (Week 16 - 52)|Other|0
5413928|NCT02641730|18681197|P5|After Controlled Period (Week 16 - 52)|Pregnancy|1
5413929|NCT02641730|18681198|P4|After Controlled Period (Week 16 - 52)|Pregnancy|1
5413930|NCT02641730|18681199|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
5413931|NCT02641730|18681200|P2|After Controlled Period (Week 16 - 52)|Pregnancy|0
5413932|NCT02641730|18681201|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
5413933|NCT02641730|18681197|P5|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
5413934|NCT02641730|18681198|P4|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
5413935|NCT02641730|18681199|P3|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
5413936|NCT02641730|18681200|P2|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
5413937|NCT02641730|18681201|P1|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
5413938|NCT02641730|18681197|P5|After Controlled Period (Week 16 - 52)|Adverse Event|4
5413939|NCT02641730|18681198|P4|After Controlled Period (Week 16 - 52)|Adverse Event|5
5413940|NCT02641730|18681199|P3|After Controlled Period (Week 16 - 52)|Adverse Event|1
5413941|NCT02641730|18681200|P2|After Controlled Period (Week 16 - 52)|Adverse Event|1
5413942|NCT02641730|18681201|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
5413943|NCT02641730|18681197|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
5413944|NCT02641730|18681198|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
5413945|NCT02641730|18681199|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
5413946|NCT02641730|18681200|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
5413947|NCT02641730|18681201|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
5413948|NCT02641587|18681305|P2|Ambulatory Period|Withdrawal by Subject|0
5413949|NCT02641587|18681306|P1|Ambulatory Period|Withdrawal by Subject|1
5413950|NCT02641587|18681305|P2|Confinement Period|Withdrawal by Subject|1
5413951|NCT02641587|18681306|P1|Confinement Period|Withdrawal by Subject|2
5413952|NCT02641587|18681305|P2|Confinement Period|Adverse Event|0
5413953|NCT02641587|18681306|P1|Confinement Period|Adverse Event|1
5413954|NCT02641392|18681427|P3|Overall Study|Death|1
5413955|NCT02641392|18681428|P2|Overall Study|Death|0
5413956|NCT02641392|18681429|P1|Overall Study|Death|0
5413957|NCT02641392|18681427|P3|Overall Study|Miscellaneous|3
5413958|NCT02641392|18681428|P2|Overall Study|Miscellaneous|0
5413959|NCT02641392|18681429|P1|Overall Study|Miscellaneous|0
5413960|NCT02641392|18681427|P3|Overall Study|Lack of Efficacy|101
5413961|NCT02641392|18681428|P2|Overall Study|Lack of Efficacy|0
5413962|NCT02641392|18681429|P1|Overall Study|Lack of Efficacy|0
5413963|NCT02641392|18681427|P3|Overall Study|Study Terminated by Sponsor|144
5413964|NCT02641392|18681428|P2|Overall Study|Study Terminated by Sponsor|12
5413965|NCT02641392|18681429|P1|Overall Study|Study Terminated by Sponsor|4
5413966|NCT02641392|18681427|P3|Overall Study|Adverse Event|25
5413967|NCT02641392|18681428|P2|Overall Study|Adverse Event|1
5413968|NCT02641392|18681429|P1|Overall Study|Adverse Event|0
5413969|NCT02641392|18681427|P3|Overall Study|Withdrawal by Subject|17
5413970|NCT02641392|18681428|P2|Overall Study|Withdrawal by Subject|0
5413971|NCT02641392|18681429|P1|Overall Study|Withdrawal by Subject|0
5413972|NCT02641392|18681427|P3|Overall Study|Lost to Follow-up|2
5413973|NCT02641392|18681428|P2|Overall Study|Lost to Follow-up|0
5413974|NCT02641392|18681429|P1|Overall Study|Lost to Follow-up|0
5413975|NCT02641379|18681448|P11|Overall Study|PCR positive|0
5413976|NCT02641379|18681449|P10|Overall Study|PCR positive|0
5413977|NCT02641379|18681450|P9|Overall Study|PCR positive|0
5413978|NCT02641379|18681451|P8|Overall Study|PCR positive|0
5413979|NCT02641379|18681452|P7|Overall Study|PCR positive|1
5413980|NCT02641379|18681453|P6|Overall Study|PCR positive|0
5413981|NCT02641379|18681454|P5|Overall Study|PCR positive|0
5413982|NCT02641379|18681455|P4|Overall Study|PCR positive|0
5413983|NCT02641379|18681456|P3|Overall Study|PCR positive|0
5413984|NCT02641379|18681457|P2|Overall Study|PCR positive|0
5413985|NCT02641379|18681458|P1|Overall Study|PCR positive|0
5413986|NCT02641379|18681448|P11|Overall Study|Missing PCR result at Week 8|0
5413987|NCT02641379|18681449|P10|Overall Study|Missing PCR result at Week 8|1
5413988|NCT02641379|18681450|P9|Overall Study|Missing PCR result at Week 8|0
5413989|NCT02641379|18681451|P8|Overall Study|Missing PCR result at Week 8|0
5413990|NCT02641379|18681452|P7|Overall Study|Missing PCR result at Week 8|0
5413991|NCT02641379|18681453|P6|Overall Study|Missing PCR result at Week 8|0
5413992|NCT02641379|18681454|P5|Overall Study|Missing PCR result at Week 8|0
5413993|NCT02641379|18681455|P4|Overall Study|Missing PCR result at Week 8|0
5413994|NCT02641379|18681456|P3|Overall Study|Missing PCR result at Week 8|0
5413995|NCT02641379|18681457|P2|Overall Study|Missing PCR result at Week 8|0
5413996|NCT02641379|18681458|P1|Overall Study|Missing PCR result at Week 8|0
5413997|NCT02641379|18681448|P11|Overall Study|Participant treated after Week 24|0
5413998|NCT02641379|18681449|P10|Overall Study|Participant treated after Week 24|0
5413999|NCT02641379|18681450|P9|Overall Study|Participant treated after Week 24|1
5414000|NCT02641379|18681451|P8|Overall Study|Participant treated after Week 24|0
5414001|NCT02641379|18681452|P7|Overall Study|Participant treated after Week 24|0
5414002|NCT02641379|18681453|P6|Overall Study|Participant treated after Week 24|0
5414003|NCT02641379|18681454|P5|Overall Study|Participant treated after Week 24|0
5414004|NCT02641379|18681455|P4|Overall Study|Participant treated after Week 24|0
5414005|NCT02641379|18681456|P3|Overall Study|Participant treated after Week 24|0
5414006|NCT02641379|18681457|P2|Overall Study|Participant treated after Week 24|0
5414007|NCT02641379|18681458|P1|Overall Study|Participant treated after Week 24|0
5414008|NCT02641379|18681448|P11|Overall Study|Participant's PCR high|0
5414009|NCT02641379|18681449|P10|Overall Study|Participant's PCR high|0
5414010|NCT02641379|18681450|P9|Overall Study|Participant's PCR high|0
5414011|NCT02641379|18681451|P8|Overall Study|Participant's PCR high|1
5414012|NCT02641379|18681452|P7|Overall Study|Participant's PCR high|0
5414013|NCT02641379|18681453|P6|Overall Study|Participant's PCR high|0
5414014|NCT02641379|18681454|P5|Overall Study|Participant's PCR high|0
5414015|NCT02641379|18681455|P4|Overall Study|Participant's PCR high|0
5414016|NCT02641379|18681456|P3|Overall Study|Participant's PCR high|0
5414017|NCT02641379|18681457|P2|Overall Study|Participant's PCR high|0
5414018|NCT02641379|18681458|P1|Overall Study|Participant's PCR high|0
5414019|NCT02641379|18681448|P11|Overall Study|Negative PCR result|0
5414020|NCT02641379|18681449|P10|Overall Study|Negative PCR result|1
5414021|NCT02641379|18681450|P9|Overall Study|Negative PCR result|0
5414022|NCT02641379|18681451|P8|Overall Study|Negative PCR result|0
5414023|NCT02641379|18681452|P7|Overall Study|Negative PCR result|0
5414024|NCT02641379|18681453|P6|Overall Study|Negative PCR result|0
5414025|NCT02641379|18681454|P5|Overall Study|Negative PCR result|0
5414026|NCT02641379|18681455|P4|Overall Study|Negative PCR result|0
5414027|NCT02641379|18681456|P3|Overall Study|Negative PCR result|0
5414028|NCT02641379|18681457|P2|Overall Study|Negative PCR result|0
5414029|NCT02641379|18681458|P1|Overall Study|Negative PCR result|0
5414030|NCT02641379|18681448|P11|Overall Study|No 2 Log drop at Week 12|1
5414031|NCT02641379|18681449|P10|Overall Study|No 2 Log drop at Week 12|0
5414032|NCT02641379|18681450|P9|Overall Study|No 2 Log drop at Week 12|0
5414033|NCT02641379|18681451|P8|Overall Study|No 2 Log drop at Week 12|0
5414034|NCT02641379|18681452|P7|Overall Study|No 2 Log drop at Week 12|0
5414035|NCT02641379|18681453|P6|Overall Study|No 2 Log drop at Week 12|0
5414036|NCT02641379|18681454|P5|Overall Study|No 2 Log drop at Week 12|0
5414037|NCT02641379|18681455|P4|Overall Study|No 2 Log drop at Week 12|0
5414038|NCT02641379|18681456|P3|Overall Study|No 2 Log drop at Week 12|0
5414039|NCT02641379|18681457|P2|Overall Study|No 2 Log drop at Week 12|0
5414040|NCT02641379|18681458|P1|Overall Study|No 2 Log drop at Week 12|0
5414041|NCT02641379|18681448|P11|Overall Study|Non-response Week 12|0
5414042|NCT02641379|18681449|P10|Overall Study|Non-response Week 12|0
5414043|NCT02641379|18681450|P9|Overall Study|Non-response Week 12|0
5414044|NCT02641379|18681451|P8|Overall Study|Non-response Week 12|1
5414045|NCT02641379|18681452|P7|Overall Study|Non-response Week 12|0
5414046|NCT02641379|18681453|P6|Overall Study|Non-response Week 12|0
5414047|NCT02641379|18681454|P5|Overall Study|Non-response Week 12|0
5414048|NCT02641379|18681455|P4|Overall Study|Non-response Week 12|0
5414049|NCT02641379|18681456|P3|Overall Study|Non-response Week 12|0
5414050|NCT02641379|18681457|P2|Overall Study|Non-response Week 12|0
5414051|NCT02641379|18681458|P1|Overall Study|Non-response Week 12|0
5414052|NCT02641379|18681448|P11|Overall Study|Participant showed weight reduction|0
5414053|NCT02641379|18681449|P10|Overall Study|Participant showed weight reduction|0
5414054|NCT02641379|18681450|P9|Overall Study|Participant showed weight reduction|0
5414055|NCT02641379|18681451|P8|Overall Study|Participant showed weight reduction|1
5414056|NCT02641379|18681452|P7|Overall Study|Participant showed weight reduction|0
5414057|NCT02641379|18681453|P6|Overall Study|Participant showed weight reduction|0
5414058|NCT02641379|18681454|P5|Overall Study|Participant showed weight reduction|0
5414059|NCT02641379|18681455|P4|Overall Study|Participant showed weight reduction|0
5414060|NCT02641379|18681456|P3|Overall Study|Participant showed weight reduction|0
5414061|NCT02641379|18681457|P2|Overall Study|Participant showed weight reduction|0
5414062|NCT02641379|18681458|P1|Overall Study|Participant showed weight reduction|0
5414063|NCT02641379|18681448|P11|Overall Study|Source data not found|0
5414064|NCT02641379|18681449|P10|Overall Study|Source data not found|0
5414065|NCT02641379|18681450|P9|Overall Study|Source data not found|0
5414066|NCT02641379|18681451|P8|Overall Study|Source data not found|0
5414067|NCT02641379|18681452|P7|Overall Study|Source data not found|0
5414068|NCT02641379|18681453|P6|Overall Study|Source data not found|1
5414069|NCT02641379|18681454|P5|Overall Study|Source data not found|0
5414070|NCT02641379|18681455|P4|Overall Study|Source data not found|0
5414071|NCT02641379|18681456|P3|Overall Study|Source data not found|0
5414072|NCT02641379|18681457|P2|Overall Study|Source data not found|0
5414073|NCT02641379|18681458|P1|Overall Study|Source data not found|0
5414074|NCT02641379|18681448|P11|Overall Study|Lost to Follow-up|0
5414075|NCT02641379|18681449|P10|Overall Study|Lost to Follow-up|0
5414076|NCT02641379|18681450|P9|Overall Study|Lost to Follow-up|1
5414077|NCT02641379|18681451|P8|Overall Study|Lost to Follow-up|0
5414078|NCT02641379|18681452|P7|Overall Study|Lost to Follow-up|0
5414079|NCT02641379|18681453|P6|Overall Study|Lost to Follow-up|0
5414080|NCT02641379|18681454|P5|Overall Study|Lost to Follow-up|0
5414081|NCT02641379|18681455|P4|Overall Study|Lost to Follow-up|0
5414082|NCT02641379|18681456|P3|Overall Study|Lost to Follow-up|0
5414083|NCT02641379|18681457|P2|Overall Study|Lost to Follow-up|0
5414084|NCT02641379|18681458|P1|Overall Study|Lost to Follow-up|0
5414085|NCT02641379|18681448|P11|Overall Study|Participation in sili rescue study|0
5414086|NCT02641379|18681449|P10|Overall Study|Participation in sili rescue study|0
5414087|NCT02641379|18681450|P9|Overall Study|Participation in sili rescue study|0
5414088|NCT02641379|18681451|P8|Overall Study|Participation in sili rescue study|0
5414089|NCT02641379|18681452|P7|Overall Study|Participation in sili rescue study|0
5414090|NCT02641379|18681453|P6|Overall Study|Participation in sili rescue study|1
5414091|NCT02641379|18681454|P5|Overall Study|Participation in sili rescue study|0
5414092|NCT02641379|18681455|P4|Overall Study|Participation in sili rescue study|0
5414093|NCT02641379|18681456|P3|Overall Study|Participation in sili rescue study|0
5414094|NCT02641379|18681457|P2|Overall Study|Participation in sili rescue study|0
5414095|NCT02641379|18681458|P1|Overall Study|Participation in sili rescue study|0
5414096|NCT02641379|18681448|P11|Overall Study|Protocol Violation|0
5414097|NCT02641379|18681449|P10|Overall Study|Protocol Violation|0
5414098|NCT02641379|18681450|P9|Overall Study|Protocol Violation|1
5414099|NCT02641379|18681451|P8|Overall Study|Protocol Violation|0
5414100|NCT02641379|18681452|P7|Overall Study|Protocol Violation|0
5414101|NCT02641379|18681453|P6|Overall Study|Protocol Violation|0
5414102|NCT02641379|18681454|P5|Overall Study|Protocol Violation|2
5414103|NCT02641379|18681455|P4|Overall Study|Protocol Violation|0
5414104|NCT02641379|18681456|P3|Overall Study|Protocol Violation|0
5414105|NCT02641379|18681457|P2|Overall Study|Protocol Violation|0
5414106|NCT02641379|18681458|P1|Overall Study|Protocol Violation|0
5414107|NCT02641379|18681448|P11|Overall Study|Blood could not be drawn|0
5414108|NCT02641379|18681449|P10|Overall Study|Blood could not be drawn|0
5414109|NCT02641379|18681450|P9|Overall Study|Blood could not be drawn|0
5414110|NCT02641379|18681451|P8|Overall Study|Blood could not be drawn|0
5414111|NCT02641379|18681452|P7|Overall Study|Blood could not be drawn|0
5414112|NCT02641379|18681453|P6|Overall Study|Blood could not be drawn|0
5414113|NCT02641379|18681454|P5|Overall Study|Blood could not be drawn|1
5414114|NCT02641379|18681455|P4|Overall Study|Blood could not be drawn|0
5414115|NCT02641379|18681456|P3|Overall Study|Blood could not be drawn|0
5414116|NCT02641379|18681457|P2|Overall Study|Blood could not be drawn|0
5414117|NCT02641379|18681458|P1|Overall Study|Blood could not be drawn|0
5414118|NCT02641379|18681448|P11|Overall Study|Baseline viral load unavailable|0
5414119|NCT02641379|18681449|P10|Overall Study|Baseline viral load unavailable|0
5414120|NCT02641379|18681450|P9|Overall Study|Baseline viral load unavailable|0
5414121|NCT02641379|18681451|P8|Overall Study|Baseline viral load unavailable|0
5414122|NCT02641379|18681452|P7|Overall Study|Baseline viral load unavailable|0
5414203|NCT02641379|18681456|P3|Overall Study|PCR positive at Week 68|0
5414123|NCT02641379|18681453|P6|Overall Study|Baseline viral load unavailable|0
5414124|NCT02641379|18681454|P5|Overall Study|Baseline viral load unavailable|0
5414125|NCT02641379|18681455|P4|Overall Study|Baseline viral load unavailable|1
5414126|NCT02641379|18681456|P3|Overall Study|Baseline viral load unavailable|0
5414127|NCT02641379|18681457|P2|Overall Study|Baseline viral load unavailable|0
5414128|NCT02641379|18681458|P1|Overall Study|Baseline viral load unavailable|0
5414129|NCT02641379|18681448|P11|Overall Study|Inclusion criteria not fulfilled|0
5414130|NCT02641379|18681449|P10|Overall Study|Inclusion criteria not fulfilled|0
5414131|NCT02641379|18681450|P9|Overall Study|Inclusion criteria not fulfilled|0
5414132|NCT02641379|18681451|P8|Overall Study|Inclusion criteria not fulfilled|0
5414133|NCT02641379|18681452|P7|Overall Study|Inclusion criteria not fulfilled|0
5414134|NCT02641379|18681453|P6|Overall Study|Inclusion criteria not fulfilled|0
5414135|NCT02641379|18681454|P5|Overall Study|Inclusion criteria not fulfilled|0
5414136|NCT02641379|18681455|P4|Overall Study|Inclusion criteria not fulfilled|1
5414137|NCT02641379|18681456|P3|Overall Study|Inclusion criteria not fulfilled|0
5414138|NCT02641379|18681457|P2|Overall Study|Inclusion criteria not fulfilled|0
5414139|NCT02641379|18681458|P1|Overall Study|Inclusion criteria not fulfilled|0
5414140|NCT02641379|18681448|P11|Overall Study|PCR sample for Week 4 not drawn|0
5414141|NCT02641379|18681449|P10|Overall Study|PCR sample for Week 4 not drawn|0
5414142|NCT02641379|18681450|P9|Overall Study|PCR sample for Week 4 not drawn|0
5414143|NCT02641379|18681451|P8|Overall Study|PCR sample for Week 4 not drawn|0
5414144|NCT02641379|18681452|P7|Overall Study|PCR sample for Week 4 not drawn|0
5414145|NCT02641379|18681453|P6|Overall Study|PCR sample for Week 4 not drawn|0
5414146|NCT02641379|18681454|P5|Overall Study|PCR sample for Week 4 not drawn|0
5414147|NCT02641379|18681455|P4|Overall Study|PCR sample for Week 4 not drawn|1
5414148|NCT02641379|18681456|P3|Overall Study|PCR sample for Week 4 not drawn|0
5414149|NCT02641379|18681457|P2|Overall Study|PCR sample for Week 4 not drawn|0
5414150|NCT02641379|18681458|P1|Overall Study|PCR sample for Week 4 not drawn|0
5414151|NCT02641379|18681448|P11|Overall Study|PCR positive at Week 28|0
5414152|NCT02641379|18681449|P10|Overall Study|PCR positive at Week 28|0
5414153|NCT02641379|18681450|P9|Overall Study|PCR positive at Week 28|0
5414154|NCT02641379|18681451|P8|Overall Study|PCR positive at Week 28|0
5414155|NCT02641379|18681452|P7|Overall Study|PCR positive at Week 28|0
5414156|NCT02641379|18681453|P6|Overall Study|PCR positive at Week 28|0
5414157|NCT02641379|18681454|P5|Overall Study|PCR positive at Week 28|0
5414158|NCT02641379|18681455|P4|Overall Study|PCR positive at Week 28|0
5414159|NCT02641379|18681456|P3|Overall Study|PCR positive at Week 28|1
5414160|NCT02641379|18681457|P2|Overall Study|PCR positive at Week 28|0
5414161|NCT02641379|18681458|P1|Overall Study|PCR positive at Week 28|0
5414162|NCT02641379|18681448|P11|Overall Study|No PCR at baseline|0
5414163|NCT02641379|18681449|P10|Overall Study|No PCR at baseline|0
5414164|NCT02641379|18681450|P9|Overall Study|No PCR at baseline|0
5414165|NCT02641379|18681451|P8|Overall Study|No PCR at baseline|0
5414166|NCT02641379|18681452|P7|Overall Study|No PCR at baseline|0
5414167|NCT02641379|18681453|P6|Overall Study|No PCR at baseline|0
5414168|NCT02641379|18681454|P5|Overall Study|No PCR at baseline|0
5414169|NCT02641379|18681455|P4|Overall Study|No PCR at baseline|0
5414170|NCT02641379|18681456|P3|Overall Study|No PCR at baseline|1
5414171|NCT02641379|18681457|P2|Overall Study|No PCR at baseline|0
5414172|NCT02641379|18681458|P1|Overall Study|No PCR at baseline|0
5414173|NCT02641379|18681448|P11|Overall Study|PCR not performed at Week 12|0
5414174|NCT02641379|18681449|P10|Overall Study|PCR not performed at Week 12|0
5414175|NCT02641379|18681450|P9|Overall Study|PCR not performed at Week 12|0
5414176|NCT02641379|18681451|P8|Overall Study|PCR not performed at Week 12|0
5414177|NCT02641379|18681452|P7|Overall Study|PCR not performed at Week 12|0
5414178|NCT02641379|18681453|P6|Overall Study|PCR not performed at Week 12|0
5414179|NCT02641379|18681454|P5|Overall Study|PCR not performed at Week 12|0
5414180|NCT02641379|18681455|P4|Overall Study|PCR not performed at Week 12|0
5414181|NCT02641379|18681456|P3|Overall Study|PCR not performed at Week 12|1
5414182|NCT02641379|18681457|P2|Overall Study|PCR not performed at Week 12|0
5414183|NCT02641379|18681458|P1|Overall Study|PCR not performed at Week 12|0
5414184|NCT02641379|18681448|P11|Overall Study|PCR positive at Week 48|0
5414185|NCT02641379|18681449|P10|Overall Study|PCR positive at Week 48|0
5414186|NCT02641379|18681450|P9|Overall Study|PCR positive at Week 48|0
5414187|NCT02641379|18681451|P8|Overall Study|PCR positive at Week 48|0
5414188|NCT02641379|18681452|P7|Overall Study|PCR positive at Week 48|0
5414189|NCT02641379|18681453|P6|Overall Study|PCR positive at Week 48|0
5414190|NCT02641379|18681454|P5|Overall Study|PCR positive at Week 48|0
5414191|NCT02641379|18681455|P4|Overall Study|PCR positive at Week 48|0
5414192|NCT02641379|18681456|P3|Overall Study|PCR positive at Week 48|0
5414193|NCT02641379|18681457|P2|Overall Study|PCR positive at Week 48|1
5414194|NCT02641379|18681458|P1|Overall Study|PCR positive at Week 48|0
5414195|NCT02641379|18681448|P11|Overall Study|PCR positive at Week 68|0
5414196|NCT02641379|18681449|P10|Overall Study|PCR positive at Week 68|0
5414197|NCT02641379|18681450|P9|Overall Study|PCR positive at Week 68|0
5414198|NCT02641379|18681451|P8|Overall Study|PCR positive at Week 68|0
5414199|NCT02641379|18681452|P7|Overall Study|PCR positive at Week 68|0
5414200|NCT02641379|18681453|P6|Overall Study|PCR positive at Week 68|0
5414201|NCT02641379|18681454|P5|Overall Study|PCR positive at Week 68|0
5414202|NCT02641379|18681455|P4|Overall Study|PCR positive at Week 68|0
5414204|NCT02641379|18681457|P2|Overall Study|PCR positive at Week 68|1
5414205|NCT02641379|18681458|P1|Overall Study|PCR positive at Week 68|0
5414206|NCT02641379|18681448|P11|Overall Study|Financial problems|0
5414207|NCT02641379|18681449|P10|Overall Study|Financial problems|0
5414208|NCT02641379|18681450|P9|Overall Study|Financial problems|0
5414209|NCT02641379|18681451|P8|Overall Study|Financial problems|0
5414210|NCT02641379|18681452|P7|Overall Study|Financial problems|0
5414211|NCT02641379|18681453|P6|Overall Study|Financial problems|0
5414212|NCT02641379|18681454|P5|Overall Study|Financial problems|0
5414213|NCT02641379|18681455|P4|Overall Study|Financial problems|0
5414214|NCT02641379|18681456|P3|Overall Study|Financial problems|0
5414215|NCT02641379|18681457|P2|Overall Study|Financial problems|1
5414216|NCT02641379|18681458|P1|Overall Study|Financial problems|0
5414217|NCT02641379|18681448|P11|Overall Study|Therapy stopped due to misunderstanding|0
5414218|NCT02641379|18681449|P10|Overall Study|Therapy stopped due to misunderstanding|0
5414219|NCT02641379|18681450|P9|Overall Study|Therapy stopped due to misunderstanding|0
5414220|NCT02641379|18681451|P8|Overall Study|Therapy stopped due to misunderstanding|0
5414221|NCT02641379|18681452|P7|Overall Study|Therapy stopped due to misunderstanding|0
5414222|NCT02641379|18681453|P6|Overall Study|Therapy stopped due to misunderstanding|0
5414223|NCT02641379|18681454|P5|Overall Study|Therapy stopped due to misunderstanding|0
5414224|NCT02641379|18681455|P4|Overall Study|Therapy stopped due to misunderstanding|0
5414225|NCT02641379|18681456|P3|Overall Study|Therapy stopped due to misunderstanding|0
5414226|NCT02641379|18681457|P2|Overall Study|Therapy stopped due to misunderstanding|0
5414227|NCT02641379|18681458|P1|Overall Study|Therapy stopped due to misunderstanding|1
5414228|NCT02641379|18681448|P11|Overall Study|Participant stopped study/treatment|0
5414229|NCT02641379|18681449|P10|Overall Study|Participant stopped study/treatment|0
5414230|NCT02641379|18681450|P9|Overall Study|Participant stopped study/treatment|1
5414231|NCT02641379|18681451|P8|Overall Study|Participant stopped study/treatment|0
5414232|NCT02641379|18681452|P7|Overall Study|Participant stopped study/treatment|2
5414233|NCT02641379|18681453|P6|Overall Study|Participant stopped study/treatment|1
5414234|NCT02641379|18681454|P5|Overall Study|Participant stopped study/treatment|0
5414235|NCT02641379|18681455|P4|Overall Study|Participant stopped study/treatment|0
5414236|NCT02641379|18681456|P3|Overall Study|Participant stopped study/treatment|1
5414237|NCT02641379|18681457|P2|Overall Study|Participant stopped study/treatment|3
5414238|NCT02641379|18681458|P1|Overall Study|Participant stopped study/treatment|1
5414239|NCT02641379|18681448|P11|Overall Study|Participant showed relapse|0
5414240|NCT02641379|18681449|P10|Overall Study|Participant showed relapse|0
5414241|NCT02641379|18681450|P9|Overall Study|Participant showed relapse|0
5414242|NCT02641379|18681451|P8|Overall Study|Participant showed relapse|0
5414243|NCT02641379|18681452|P7|Overall Study|Participant showed relapse|1
5414244|NCT02641379|18681453|P6|Overall Study|Participant showed relapse|0
5414245|NCT02641379|18681454|P5|Overall Study|Participant showed relapse|0
5414246|NCT02641379|18681455|P4|Overall Study|Participant showed relapse|0
5414247|NCT02641379|18681456|P3|Overall Study|Participant showed relapse|0
5414248|NCT02641379|18681457|P2|Overall Study|Participant showed relapse|0
5414249|NCT02641379|18681458|P1|Overall Study|Participant showed relapse|1
5414250|NCT02641379|18681448|P11|Overall Study|PCR positive at follow up 2|0
5414251|NCT02641379|18681449|P10|Overall Study|PCR positive at follow up 2|0
5414252|NCT02641379|18681450|P9|Overall Study|PCR positive at follow up 2|0
5414253|NCT02641379|18681451|P8|Overall Study|PCR positive at follow up 2|0
5414254|NCT02641379|18681452|P7|Overall Study|PCR positive at follow up 2|0
5414255|NCT02641379|18681453|P6|Overall Study|PCR positive at follow up 2|0
5414256|NCT02641379|18681454|P5|Overall Study|PCR positive at follow up 2|0
5414257|NCT02641379|18681455|P4|Overall Study|PCR positive at follow up 2|0
5414258|NCT02641379|18681456|P3|Overall Study|PCR positive at follow up 2|0
5414259|NCT02641379|18681457|P2|Overall Study|PCR positive at follow up 2|0
5414260|NCT02641379|18681458|P1|Overall Study|PCR positive at follow up 2|1
5414261|NCT02641379|18681448|P11|Overall Study|PCR positive at Week 24|0
5414262|NCT02641379|18681449|P10|Overall Study|PCR positive at Week 24|1
5414263|NCT02641379|18681450|P9|Overall Study|PCR positive at Week 24|0
5414264|NCT02641379|18681451|P8|Overall Study|PCR positive at Week 24|8
5414265|NCT02641379|18681452|P7|Overall Study|PCR positive at Week 24|3
5414266|NCT02641379|18681453|P6|Overall Study|PCR positive at Week 24|6
5414267|NCT02641379|18681454|P5|Overall Study|PCR positive at Week 24|0
5414268|NCT02641379|18681455|P4|Overall Study|PCR positive at Week 24|0
5414269|NCT02641379|18681456|P3|Overall Study|PCR positive at Week 24|62
5414270|NCT02641379|18681457|P2|Overall Study|PCR positive at Week 24|21
5414271|NCT02641379|18681458|P1|Overall Study|PCR positive at Week 24|15
5414272|NCT02641379|18681448|P11|Overall Study|Participant cannot be reached|1
5414273|NCT02641379|18681449|P10|Overall Study|Participant cannot be reached|2
5414274|NCT02641379|18681450|P9|Overall Study|Participant cannot be reached|0
5414275|NCT02641379|18681451|P8|Overall Study|Participant cannot be reached|1
5414276|NCT02641379|18681452|P7|Overall Study|Participant cannot be reached|0
5414277|NCT02641379|18681453|P6|Overall Study|Participant cannot be reached|1
5414278|NCT02641379|18681454|P5|Overall Study|Participant cannot be reached|2
5414279|NCT02641379|18681455|P4|Overall Study|Participant cannot be reached|8
5414280|NCT02641379|18681456|P3|Overall Study|Participant cannot be reached|0
5414281|NCT02641379|18681457|P2|Overall Study|Participant cannot be reached|4
5414282|NCT02641379|18681458|P1|Overall Study|Participant cannot be reached|4
5414283|NCT02641379|18681448|P11|Overall Study|Participant's compliance|1
5414284|NCT02641379|18681449|P10|Overall Study|Participant's compliance|1
5414285|NCT02641379|18681450|P9|Overall Study|Participant's compliance|1
5414286|NCT02641379|18681451|P8|Overall Study|Participant's compliance|0
5414287|NCT02641379|18681452|P7|Overall Study|Participant's compliance|0
5414288|NCT02641379|18681453|P6|Overall Study|Participant's compliance|2
5414289|NCT02641379|18681454|P5|Overall Study|Participant's compliance|0
5414290|NCT02641379|18681455|P4|Overall Study|Participant's compliance|1
5414291|NCT02641379|18681456|P3|Overall Study|Participant's compliance|0
5414292|NCT02641379|18681457|P2|Overall Study|Participant's compliance|1
5414293|NCT02641379|18681458|P1|Overall Study|Participant's compliance|0
5414294|NCT02641379|18681448|P11|Overall Study|Participant unable to attend study visit|0
5414295|NCT02641379|18681449|P10|Overall Study|Participant unable to attend study visit|2
5414296|NCT02641379|18681450|P9|Overall Study|Participant unable to attend study visit|0
5414297|NCT02641379|18681451|P8|Overall Study|Participant unable to attend study visit|1
5414298|NCT02641379|18681452|P7|Overall Study|Participant unable to attend study visit|1
5414299|NCT02641379|18681453|P6|Overall Study|Participant unable to attend study visit|1
5414300|NCT02641379|18681454|P5|Overall Study|Participant unable to attend study visit|5
5414301|NCT02641379|18681455|P4|Overall Study|Participant unable to attend study visit|2
5414302|NCT02641379|18681456|P3|Overall Study|Participant unable to attend study visit|1
5414303|NCT02641379|18681457|P2|Overall Study|Participant unable to attend study visit|10
5414304|NCT02641379|18681458|P1|Overall Study|Participant unable to attend study visit|4
5414305|NCT02641379|18681448|P11|Overall Study|Lack of Efficacy|0
5414306|NCT02641379|18681449|P10|Overall Study|Lack of Efficacy|0
5414307|NCT02641379|18681450|P9|Overall Study|Lack of Efficacy|0
5414308|NCT02641379|18681451|P8|Overall Study|Lack of Efficacy|5
5414309|NCT02641379|18681452|P7|Overall Study|Lack of Efficacy|0
5414310|NCT02641379|18681453|P6|Overall Study|Lack of Efficacy|2
5414311|NCT02641379|18681454|P5|Overall Study|Lack of Efficacy|0
5414312|NCT02641379|18681455|P4|Overall Study|Lack of Efficacy|0
5414313|NCT02641379|18681456|P3|Overall Study|Lack of Efficacy|2
5414314|NCT02641379|18681457|P2|Overall Study|Lack of Efficacy|0
5414315|NCT02641379|18681458|P1|Overall Study|Lack of Efficacy|0
5414316|NCT02641379|18681448|P11|Overall Study|Adverse Event|5
5414317|NCT02641379|18681449|P10|Overall Study|Adverse Event|1
5414318|NCT02641379|18681450|P9|Overall Study|Adverse Event|1
5414319|NCT02641379|18681451|P8|Overall Study|Adverse Event|0
5414320|NCT02641379|18681452|P7|Overall Study|Adverse Event|5
5414321|NCT02641379|18681453|P6|Overall Study|Adverse Event|1
5414322|NCT02641379|18681454|P5|Overall Study|Adverse Event|5
5414323|NCT02641379|18681455|P4|Overall Study|Adverse Event|2
5414324|NCT02641379|18681456|P3|Overall Study|Adverse Event|2
5414325|NCT02641379|18681457|P2|Overall Study|Adverse Event|8
5414326|NCT02641379|18681458|P1|Overall Study|Adverse Event|7
5414327|NCT02641379|18681448|P11|Overall Study|Withdrawal of informed consent|0
5414328|NCT02641379|18681449|P10|Overall Study|Withdrawal of informed consent|0
5414329|NCT02641379|18681450|P9|Overall Study|Withdrawal of informed consent|0
5414330|NCT02641379|18681451|P8|Overall Study|Withdrawal of informed consent|1
5414331|NCT02641379|18681452|P7|Overall Study|Withdrawal of informed consent|0
5414332|NCT02641379|18681453|P6|Overall Study|Withdrawal of informed consent|0
5414333|NCT02641379|18681454|P5|Overall Study|Withdrawal of informed consent|0
5414334|NCT02641379|18681455|P4|Overall Study|Withdrawal of informed consent|0
5414335|NCT02641379|18681456|P3|Overall Study|Withdrawal of informed consent|0
5414336|NCT02641379|18681457|P2|Overall Study|Withdrawal of informed consent|1
5414337|NCT02641379|18681458|P1|Overall Study|Withdrawal of informed consent|0
5414338|NCT02641379|18681448|P11|Overall Study|Exclusion criterion during screening|0
5414339|NCT02641379|18681449|P10|Overall Study|Exclusion criterion during screening|0
5414340|NCT02641379|18681450|P9|Overall Study|Exclusion criterion during screening|0
5414341|NCT02641379|18681451|P8|Overall Study|Exclusion criterion during screening|0
5414342|NCT02641379|18681452|P7|Overall Study|Exclusion criterion during screening|0
5414343|NCT02641379|18681453|P6|Overall Study|Exclusion criterion during screening|0
5414344|NCT02641379|18681454|P5|Overall Study|Exclusion criterion during screening|2
5414345|NCT02641379|18681455|P4|Overall Study|Exclusion criterion during screening|1
5414346|NCT02641379|18681456|P3|Overall Study|Exclusion criterion during screening|0
5414347|NCT02641379|18681457|P2|Overall Study|Exclusion criterion during screening|0
5414348|NCT02641379|18681458|P1|Overall Study|Exclusion criterion during screening|1
5414349|NCT02641080|18681534|P2|Overall Study|Lost to Follow-up|3
5414350|NCT02641080|18681535|P1|Overall Study|Lost to Follow-up|0
5414351|NCT02641080|18681534|P2|Overall Study|Rehab Center denied use of pumps|3
5414352|NCT02641080|18681535|P1|Overall Study|Rehab Center denied use of pumps|0
5414353|NCT02641080|18681534|P2|Overall Study|Withdrawal by Subject|1
5414354|NCT02641080|18681535|P1|Overall Study|Withdrawal by Subject|0
5414355|NCT02641080|18681534|P2|Overall Study|Physician Decision|0
5414356|NCT02641080|18681535|P1|Overall Study|Physician Decision|2
5414357|NCT02640755|18681591|P2|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
5414358|NCT02640755|18681592|P1|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
5414359|NCT02640755|18681591|P2|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
5414360|NCT02640755|18681592|P1|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
5414361|NCT02640755|18681591|P2|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
5414362|NCT02640755|18681592|P1|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
5414363|NCT02640677|18681646|P1|Overall Study|Withdrawal by Subject|1
5414364|NCT02640677|18681646|P1|Overall Study|Lost to Follow-up|1
5414365|NCT02640625|18681653|P1|Overall Study|Adverse Event|1
5414366|NCT02640612|18681662|P3|Overall Study|Lack of Efficacy|0
5414367|NCT02640612|18681663|P2|Overall Study|Lack of Efficacy|1
5414368|NCT02640612|18681664|P1|Overall Study|Lack of Efficacy|1
5414369|NCT02640612|18681662|P3|Overall Study|Protocol Violation|0
5414370|NCT02640612|18681663|P2|Overall Study|Protocol Violation|2
5414371|NCT02640612|18681664|P1|Overall Study|Protocol Violation|0
5414372|NCT02640612|18681662|P3|Overall Study|Lost to Follow-up|1
5414373|NCT02640612|18681663|P2|Overall Study|Lost to Follow-up|1
5414374|NCT02640612|18681664|P1|Overall Study|Lost to Follow-up|4
5414375|NCT02640612|18681662|P3|Overall Study|Withdrawal by Subject|3
5414376|NCT02640612|18681663|P2|Overall Study|Withdrawal by Subject|3
5414377|NCT02640612|18681664|P1|Overall Study|Withdrawal by Subject|10
5414378|NCT02640612|18681662|P3|Overall Study|Death|0
5414379|NCT02640612|18681663|P2|Overall Study|Death|0
5414380|NCT02640612|18681664|P1|Overall Study|Death|1
5414381|NCT02640612|18681662|P3|Overall Study|Adverse Event|2
5414382|NCT02640612|18681663|P2|Overall Study|Adverse Event|7
5414383|NCT02640612|18681664|P1|Overall Study|Adverse Event|6
5414384|NCT02640547|18681688|P1|Overall Study|Miscellaneous|3
5414385|NCT02640547|18681688|P1|Overall Study|Death|6
5414386|NCT02640547|18681688|P1|Overall Study|Withdrawal by Subject|1
5414387|NCT02640547|18681688|P1|Overall Study|Failure to Return|1
5414388|NCT02640482|18681765|P2|Overall Study|Lost to Follow-up|0
5414389|NCT02640482|18681766|P1|Overall Study|Lost to Follow-up|3
5414390|NCT02640404|18681778|P2|Overall Study|Withdrawal by Subject|0
5414391|NCT02640404|18681779|P1|Overall Study|Withdrawal by Subject|1
5414392|NCT02640404|18681778|P2|Overall Study|Protocol Violation|0
5414393|NCT02640404|18681779|P1|Overall Study|Protocol Violation|1
5414394|NCT02640235|18681789|P2|Overall Study|Other|2
5414395|NCT02640235|18681790|P1|Overall Study|Other|1
5414396|NCT02640235|18681789|P2|Overall Study|Death|3
5414397|NCT02640235|18681790|P1|Overall Study|Death|2
5414398|NCT02640235|18681789|P2|Overall Study|Lost to Follow-up|3
5414399|NCT02640235|18681790|P1|Overall Study|Lost to Follow-up|4
5414400|NCT02640235|18681789|P2|Overall Study|Withdrawal by Subject|6
5414401|NCT02640235|18681790|P1|Overall Study|Withdrawal by Subject|7
5414402|NCT02640157|18681813|P3|Overall Study|Randomized in error; did not receive Tx|0
5414403|NCT02640157|18681814|P2|Overall Study|Randomized in error; did not receive Tx|1
5414404|NCT02640157|18681815|P1|Overall Study|Randomized in error; did not receive Tx|0
5414405|NCT02640157|18681813|P3|Overall Study|Lost to Follow-up|7
5414406|NCT02640157|18681814|P2|Overall Study|Lost to Follow-up|2
5414407|NCT02640157|18681815|P1|Overall Study|Lost to Follow-up|9
5414408|NCT02640157|18681813|P3|Overall Study|Withdrew consent|2
5414409|NCT02640157|18681814|P2|Overall Study|Withdrew consent|0
5414410|NCT02640157|18681815|P1|Overall Study|Withdrew consent|2
5414411|NCT02640157|18681813|P3|Overall Study|Adverse Event|1
5414412|NCT02640157|18681814|P2|Overall Study|Adverse Event|2
5414413|NCT02640157|18681815|P1|Overall Study|Adverse Event|2
5414414|NCT02640053|18681834|P2|Overall Study|Chemo regimen changed after 1st Rx|1
5414415|NCT02640053|18681835|P1|Overall Study|Chemo regimen changed after 1st Rx|0
5414416|NCT02640053|18681834|P2|Overall Study|Alternative Therapy|1
5414417|NCT02640053|18681835|P1|Overall Study|Alternative Therapy|1
5414418|NCT02640053|18681834|P2|Overall Study|Adverse Event|1
5414419|NCT02640053|18681835|P1|Overall Study|Adverse Event|1
5414420|NCT02640053|18681834|P2|Overall Study|Withdrawal by Subject|1
5414421|NCT02640053|18681835|P1|Overall Study|Withdrawal by Subject|2
5414422|NCT02639559|18681942|P2|Overall Study|Issues with vascular acess|0
5414423|NCT02639559|18681943|P1|Overall Study|Issues with vascular acess|1
5414424|NCT02639559|18681942|P2|Overall Study|Mobilization failure|3
5414425|NCT02639559|18681943|P1|Overall Study|Mobilization failure|0
5414426|NCT02639390|18682023|P2|Overall Study|Subject unable to comply with treatment schedule.|2
5414427|NCT02639390|18682024|P1|Overall Study|Subject unable to comply with treatment schedule.|0
5414428|NCT02639338|18682398|P2|Overall Study|Randomized but Not Treated|1
5414429|NCT02639338|18682399|P1|Overall Study|Randomized but Not Treated|0
5414430|NCT02639338|18682398|P2|Overall Study|Death|0
5414431|NCT02639338|18682399|P1|Overall Study|Death|1
5414432|NCT02639338|18682398|P2|Overall Study|Withdrew Consent|2
5414433|NCT02639338|18682399|P1|Overall Study|Withdrew Consent|1
5414434|NCT02639338|18682398|P2|Overall Study|Lost to Follow-up|2
5414435|NCT02639338|18682399|P1|Overall Study|Lost to Follow-up|2
5414436|NCT02639247|18682444|P2|Overall Study|Protocol Violation|0
5414437|NCT02639247|18682445|P1|Overall Study|Protocol Violation|1
5414438|NCT02639247|18682444|P2|Overall Study|Withdrew Consent|1
5414439|NCT02639247|18682445|P1|Overall Study|Withdrew Consent|0
5414440|NCT02639247|18682444|P2|Overall Study|Death|0
5414441|NCT02639247|18682445|P1|Overall Study|Death|2
5414442|NCT02639247|18682444|P2|Overall Study|Lost to Follow-up|1
5414443|NCT02639247|18682445|P1|Overall Study|Lost to Follow-up|2
5414444|NCT02639182|18682463|P2|Overall Study|Participants Still on Study|24
5414445|NCT02639182|18682464|P1|Overall Study|Participants Still on Study|25
5414446|NCT02639182|18682463|P2|Overall Study|Withdrew consent|0
5414447|NCT02639182|18682464|P1|Overall Study|Withdrew consent|6
5414448|NCT02639182|18682463|P2|Overall Study|Lost to Follow-up|1
5414449|NCT02639182|18682464|P1|Overall Study|Lost to Follow-up|1
5414450|NCT02639182|18682463|P2|Overall Study|Death|41
5414451|NCT02639182|18682464|P1|Overall Study|Death|35
5414452|NCT02639052|18682497|P1|Overall Study|Lost to Follow-up|1
5414453|NCT02638948|18682534|P4|Overall Study|Other than specified above|1
5414454|NCT02638948|18682535|P3|Overall Study|Other than specified above|1
5414455|NCT02638948|18682536|P2|Overall Study|Other than specified above|1
5414456|NCT02638948|18682537|P1|Overall Study|Other than specified above|4
5414457|NCT02638948|18682534|P4|Overall Study|Participant no longer met study criteria|0
5414458|NCT02638948|18682535|P3|Overall Study|Participant no longer met study criteria|0
5414459|NCT02638948|18682536|P2|Overall Study|Participant no longer met study criteria|1
5414460|NCT02638948|18682537|P1|Overall Study|Participant no longer met study criteria|0
5414461|NCT02638948|18682534|P4|Overall Study|Poor/Non-Compliance|0
5414462|NCT02638948|18682535|P3|Overall Study|Poor/Non-Compliance|1
5414463|NCT02638948|18682536|P2|Overall Study|Poor/Non-Compliance|2
5414464|NCT02638948|18682537|P1|Overall Study|Poor/Non-Compliance|0
5414465|NCT02638948|18682534|P4|Overall Study|Lost to Follow-up|1
5414466|NCT02638948|18682535|P3|Overall Study|Lost to Follow-up|1
5414467|NCT02638948|18682536|P2|Overall Study|Lost to Follow-up|0
5414468|NCT02638948|18682537|P1|Overall Study|Lost to Follow-up|0
5414469|NCT02638948|18682534|P4|Overall Study|Lack of Efficacy|0
5414470|NCT02638948|18682535|P3|Overall Study|Lack of Efficacy|0
5414471|NCT02638948|18682536|P2|Overall Study|Lack of Efficacy|1
5414472|NCT02638948|18682537|P1|Overall Study|Lack of Efficacy|1
5414473|NCT02638948|18682534|P4|Overall Study|Adverse Event|1
5414474|NCT02638948|18682535|P3|Overall Study|Adverse Event|1
5414475|NCT02638948|18682536|P2|Overall Study|Adverse Event|0
5414476|NCT02638948|18682537|P1|Overall Study|Adverse Event|0
5414477|NCT02638948|18682534|P4|Overall Study|Administrative Reason by Sponsor|4
5414478|NCT02638948|18682535|P3|Overall Study|Administrative Reason by Sponsor|0
5414479|NCT02638948|18682536|P2|Overall Study|Administrative Reason by Sponsor|1
5414480|NCT02638948|18682537|P1|Overall Study|Administrative Reason by Sponsor|0
5414481|NCT02638948|18682534|P4|Overall Study|Withdrawal by Subject|1
5414482|NCT02638948|18682535|P3|Overall Study|Withdrawal by Subject|3
5414483|NCT02638948|18682536|P2|Overall Study|Withdrawal by Subject|5
5414484|NCT02638948|18682537|P1|Overall Study|Withdrawal by Subject|4
5414485|NCT02638623|18682624|P2|Overall Study|Not given intervention|0
5414486|NCT02638623|18682625|P1|Overall Study|Not given intervention|2
5414487|NCT02638623|18682624|P2|Overall Study|Surgery timing|6
5414488|NCT02638623|18682625|P1|Overall Study|Surgery timing|5
5414489|NCT02638493|18682655|P3|Overall Study|Inability to provide semen samples|0
5414490|NCT02638493|18682656|P2|Overall Study|Inability to provide semen samples|0
5414491|NCT02638493|18682657|P1|Overall Study|Inability to provide semen samples|2
5414492|NCT02638337|18682688|P2|Overall Study|Other - Miscellaneous|3
5414493|NCT02638337|18682689|P1|Overall Study|Other - Miscellaneous|4
5414494|NCT02638337|18682688|P2|Overall Study|Lost to Follow-up|7
5414495|NCT02638337|18682689|P1|Overall Study|Lost to Follow-up|7
5414496|NCT02638337|18682688|P2|Overall Study|Withdrawal by Subject|16
5414497|NCT02638337|18682689|P1|Overall Study|Withdrawal by Subject|13
5414498|NCT02638337|18682688|P2|Overall Study|Protocol Violation|0
5414499|NCT02638337|18682689|P1|Overall Study|Protocol Violation|3
5414500|NCT02638337|18682688|P2|Overall Study|Adverse Event|10
5414501|NCT02638337|18682689|P1|Overall Study|Adverse Event|6
5414502|NCT02638259|18682773|P2|Treatment Period 2|Withdrawal by Subject|7
5414503|NCT02638259|18682774|P1|Treatment Period 2|Withdrawal by Subject|1
5414504|NCT02638259|18682773|P2|Treatment Period 2|Adverse Event|4
5414505|NCT02638259|18682774|P1|Treatment Period 2|Adverse Event|5
5414506|NCT02638259|18682773|P2|Treatment Period 1|Withdrawn per sponsor decision|2
5414507|NCT02638259|18682774|P1|Treatment Period 1|Withdrawn per sponsor decision|0
5414508|NCT02638259|18682773|P2|Treatment Period 1|Withdrawal by Subject|6
5414509|NCT02638259|18682774|P1|Treatment Period 1|Withdrawal by Subject|4
5414510|NCT02638259|18682773|P2|Treatment Period 1|Protocol Violation|3
5414511|NCT02638259|18682774|P1|Treatment Period 1|Protocol Violation|0
5414512|NCT02638259|18682773|P2|Treatment Period 1|Lack of Efficacy|1
5414513|NCT02638259|18682774|P1|Treatment Period 1|Lack of Efficacy|0
5414514|NCT02638259|18682773|P2|Treatment Period 1|Death|1
5414515|NCT02638259|18682774|P1|Treatment Period 1|Death|0
5414516|NCT02638259|18682773|P2|Treatment Period 1|Adverse Event|5
5414517|NCT02638259|18682774|P1|Treatment Period 1|Adverse Event|1
5414518|NCT02638129|18682866|P2|Overall Study|Study terminated|30
5414519|NCT02638129|18682867|P1|Overall Study|Study terminated|28
5414520|NCT02638103|18682883|P4|Overall Study|Other than specified|4
5414521|NCT02638103|18682884|P3|Overall Study|Other than specified|2
5414522|NCT02638103|18682885|P2|Overall Study|Other than specified|4
5414523|NCT02638103|18682886|P1|Overall Study|Other than specified|5
5414524|NCT02638103|18682883|P4|Overall Study|Lack of Efficacy|22
5414525|NCT02638103|18682884|P3|Overall Study|Lack of Efficacy|12
5414526|NCT02638103|18682885|P2|Overall Study|Lack of Efficacy|10
5414527|NCT02638103|18682886|P1|Overall Study|Lack of Efficacy|14
5414528|NCT02638103|18682883|P4|Overall Study|Lost to Follow-up|37
5414529|NCT02638103|18682884|P3|Overall Study|Lost to Follow-up|20
5414530|NCT02638103|18682885|P2|Overall Study|Lost to Follow-up|33
5414531|NCT02638103|18682886|P1|Overall Study|Lost to Follow-up|26
5414532|NCT02638103|18682883|P4|Overall Study|Non-compliance to Study Procedures|1
5414533|NCT02638103|18682884|P3|Overall Study|Non-compliance to Study Procedures|1
5414534|NCT02638103|18682885|P2|Overall Study|Non-compliance to Study Procedures|1
5414535|NCT02638103|18682886|P1|Overall Study|Non-compliance to Study Procedures|2
5414536|NCT02638103|18682883|P4|Overall Study|Pregnancy|1
5414537|NCT02638103|18682884|P3|Overall Study|Pregnancy|0
5414538|NCT02638103|18682885|P2|Overall Study|Pregnancy|3
5414539|NCT02638103|18682886|P1|Overall Study|Pregnancy|2
5414540|NCT02638103|18682883|P4|Overall Study|Protocol Violation|4
5414541|NCT02638103|18682884|P3|Overall Study|Protocol Violation|1
5414542|NCT02638103|18682885|P2|Overall Study|Protocol Violation|2
5414543|NCT02638103|18682886|P1|Overall Study|Protocol Violation|1
5414544|NCT02638103|18682883|P4|Overall Study|Withdrawal by Subject|61
5414545|NCT02638103|18682884|P3|Overall Study|Withdrawal by Subject|30
5414546|NCT02638103|18682885|P2|Overall Study|Withdrawal by Subject|53
5414547|NCT02638103|18682886|P1|Overall Study|Withdrawal by Subject|43
5414548|NCT02638103|18682883|P4|Overall Study|Adverse Event|12
5414549|NCT02638103|18682884|P3|Overall Study|Adverse Event|19
5414550|NCT02638103|18682885|P2|Overall Study|Adverse Event|12
5414551|NCT02638103|18682886|P1|Overall Study|Adverse Event|13
5414552|NCT02638012|18682973|P1|Overall Study|Lost to Follow-up|1
5414553|NCT02637856|18683018|P2|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
5414554|NCT02637856|18683019|P1|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
5414555|NCT02637856|18683018|P2|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
5414556|NCT02637856|18683019|P1|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
5414557|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Site Closing|0
5414558|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Site Closing|6
5414559|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
5414560|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
5414561|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Incarceration|0
5414562|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Incarceration|1
5414563|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Failed Drug Test|0
5414564|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Failed Drug Test|1
5414565|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
5414566|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
5414567|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Protocol Deviation|0
5414568|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Protocol Deviation|2
5414569|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
5414570|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
5414571|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Pregnancy|0
5414572|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Pregnancy|7
5414573|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Physician Decision|0
5414574|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Physician Decision|2
5414575|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Lost to Follow-up|0
5414576|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Lost to Follow-up|5
5414577|NCT02637856|18683018|P2|Main Study (Baseline to Week 100)|Adverse Event|0
5414578|NCT02637856|18683019|P1|Main Study (Baseline to Week 100)|Adverse Event|9
5414579|NCT02637557|18683149|P4|Overall Study|Withdrawal by Subject|2
5414580|NCT02637557|18683150|P3|Overall Study|Withdrawal by Subject|4
5414581|NCT02637557|18683151|P2|Overall Study|Withdrawal by Subject|3
5414582|NCT02637557|18683152|P1|Overall Study|Withdrawal by Subject|1
5414583|NCT02637557|18683149|P4|Overall Study|Protocol Violation|1
5414584|NCT02637557|18683150|P3|Overall Study|Protocol Violation|2
5414585|NCT02637557|18683151|P2|Overall Study|Protocol Violation|0
5414586|NCT02637557|18683152|P1|Overall Study|Protocol Violation|2
5414587|NCT02637557|18683149|P4|Overall Study|Physician Decision|0
5414588|NCT02637557|18683150|P3|Overall Study|Physician Decision|0
5414589|NCT02637557|18683151|P2|Overall Study|Physician Decision|0
5414590|NCT02637557|18683152|P1|Overall Study|Physician Decision|1
5414591|NCT02637557|18683149|P4|Overall Study|Lost to Follow-up|1
5414592|NCT02637557|18683150|P3|Overall Study|Lost to Follow-up|0
5414593|NCT02637557|18683151|P2|Overall Study|Lost to Follow-up|1
5414594|NCT02637557|18683152|P1|Overall Study|Lost to Follow-up|1
5414595|NCT02637557|18683149|P4|Overall Study|Adverse Event|3
5414596|NCT02637557|18683150|P3|Overall Study|Adverse Event|3
5414597|NCT02637557|18683151|P2|Overall Study|Adverse Event|1
5414598|NCT02637557|18683152|P1|Overall Study|Adverse Event|3
5414599|NCT02637323|18683244|P2|Overall Study|Protocol Violation|1
5414600|NCT02637323|18683245|P1|Overall Study|Protocol Violation|0
5414601|NCT02637323|18683244|P2|Overall Study|Lost to Follow-up|0
5414602|NCT02637323|18683245|P1|Overall Study|Lost to Follow-up|2
5414603|NCT02637141|18683256|P3|Overall Study|Withdrawal by Subject|1
5414604|NCT02637141|18683257|P2|Overall Study|Withdrawal by Subject|1
5414605|NCT02637141|18683258|P1|Overall Study|Withdrawal by Subject|1
5414606|NCT02637141|18683256|P3|Overall Study|Adverse Event|0
5414607|NCT02637141|18683257|P2|Overall Study|Adverse Event|1
5414608|NCT02637141|18683258|P1|Overall Study|Adverse Event|1
5414609|NCT02637063|18683293|P3|Overall Study|Withdrawal by Subject|3
5414610|NCT02637063|18683294|P2|Overall Study|Withdrawal by Subject|2
5414611|NCT02637063|18683295|P1|Overall Study|Withdrawal by Subject|2
5414612|NCT02637063|18683293|P3|Overall Study|Lost to Follow-up|3
5414613|NCT02637063|18683294|P2|Overall Study|Lost to Follow-up|2
5414614|NCT02637063|18683295|P1|Overall Study|Lost to Follow-up|3
5414615|NCT02637037|18683323|P2|Overall Study|Adverse Event|0
5414616|NCT02637037|18683324|P1|Overall Study|Adverse Event|1
5414617|NCT02637037|18683323|P2|Overall Study|Withdrawal by Subject|1
5414618|NCT02637037|18683324|P1|Overall Study|Withdrawal by Subject|2
5414619|NCT02637037|18683323|P2|Overall Study|Positive drug screen at admission|0
5414620|NCT02637037|18683324|P1|Overall Study|Positive drug screen at admission|1
5414621|NCT02636907|18683390|P1|Extension Phase|Lack of Efficacy|1
5414622|NCT02636907|18683390|P1|Extension Phase|Lost to Follow-up|2
5414623|NCT02636907|18683390|P1|Extension Phase|Physician Decision|1
5414624|NCT02636907|18683390|P1|Extension Phase|Withdrawal by Subject|4
5414625|NCT02636907|18683390|P1|Extension Phase|Adverse Event|2
5414626|NCT02636907|18683390|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
5414627|NCT02636907|18683390|P1|Autoinjector Assessment Period|Adverse Event|2
5414628|NCT02636608|18683407|P1|Overall Study|Did Not Receive Treatment|1
5414629|NCT02636608|18683407|P1|Overall Study|Other|2
5414630|NCT02636608|18683407|P1|Overall Study|Death|3
5414631|NCT02636608|18683407|P1|Overall Study|Insufficient Virological Response|1
5414632|NCT02636608|18683407|P1|Overall Study|Failure to Return|4
5414633|NCT02636595|18683435|P1|Overall Study|Other|1
5414634|NCT02636595|18683435|P1|Overall Study|Lost to Follow-up|1
5414635|NCT02636361|18683441|P5|Period 4|Physician Decision|0
5414636|NCT02636361|18683442|P4|Period 4|Physician Decision|1
5414637|NCT02636361|18683443|P3|Period 4|Physician Decision|0
5414638|NCT02636361|18683444|P2|Period 4|Physician Decision|0
5414639|NCT02636361|18683445|P1|Period 4|Physician Decision|0
5414640|NCT02636283|18683464|P2|Overall Study|Trial Terminated Prematurely|3
5414641|NCT02636283|18683465|P1|Overall Study|Trial Terminated Prematurely|0
5414642|NCT02636283|18683464|P2|Overall Study|Adverse Event|0
5414643|NCT02636283|18683465|P1|Overall Study|Adverse Event|2
5414644|NCT02635984|18683493|P2|Overall Study|Study Arm Closed|0
5414645|NCT02635984|18683494|P1|Overall Study|Study Arm Closed|1
5414646|NCT02635984|18683493|P2|Overall Study|Lost to Follow-up|4
5414647|NCT02635984|18683494|P1|Overall Study|Lost to Follow-up|2
5414648|NCT02635646|18683526|P2|Overall Study|Pregnancy|1
5414649|NCT02635646|18683527|P1|Overall Study|Pregnancy|1
5414650|NCT02635646|18683526|P2|Overall Study|Lost to Follow-up|25
5414651|NCT02635646|18683527|P1|Overall Study|Lost to Follow-up|24
5414652|NCT02635347|18683563|P2|Overall Study|Failed screening|7
5414653|NCT02635347|18683564|P1|Overall Study|Failed screening|20
5414654|NCT02635204|18683595|P2|Overall Study|Lost to Follow-up|1
5414655|NCT02635204|18683596|P1|Overall Study|Lost to Follow-up|1
5414656|NCT02635204|18683595|P2|Overall Study|Adverse Event|0
5414657|NCT02635204|18683596|P1|Overall Study|Adverse Event|1
5414658|NCT02634983|18683606|P2|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
5414659|NCT02634983|18683607|P1|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
5414660|NCT02634801|18683666|P3|Follow-up Period|Adverse Event|0
5414661|NCT02634801|18683667|P2|Follow-up Period|Adverse Event|5
5414662|NCT02634801|18683668|P1|Follow-up Period|Adverse Event|1
5414663|NCT02634801|18683666|P3|Follow-up Period|Withdrawal by Subject|5
5414664|NCT02634801|18683667|P2|Follow-up Period|Withdrawal by Subject|2
5414665|NCT02634801|18683668|P1|Follow-up Period|Withdrawal by Subject|1
5414666|NCT02634801|18683666|P3|Follow-up Period|Physician Decision|1
5414667|NCT02634801|18683667|P2|Follow-up Period|Physician Decision|0
5414668|NCT02634801|18683668|P1|Follow-up Period|Physician Decision|0
5414669|NCT02634801|18683666|P3|Follow-up Period|Lost to Follow-up|2
5414670|NCT02634801|18683667|P2|Follow-up Period|Lost to Follow-up|1
5414671|NCT02634801|18683668|P1|Follow-up Period|Lost to Follow-up|3
5414672|NCT02634801|18683666|P3|Extension Period (Weeks 24 to 36)|Missing|0
5414673|NCT02634801|18683667|P2|Extension Period (Weeks 24 to 36)|Missing|0
5414674|NCT02634801|18683668|P1|Extension Period (Weeks 24 to 36)|Missing|1
5414675|NCT02634801|18683666|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
5414676|NCT02634801|18683667|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
5414677|NCT02634801|18683668|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
5414678|NCT02634801|18683666|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
5414679|NCT02634801|18683667|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
5414680|NCT02634801|18683668|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
5414681|NCT02634801|18683666|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
5414682|NCT02634801|18683667|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
5414683|NCT02634801|18683668|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
5414684|NCT02634801|18683666|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
5414685|NCT02634801|18683667|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
5414686|NCT02634801|18683668|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
5414687|NCT02634801|18683666|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
5414688|NCT02634801|18683667|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
5414689|NCT02634801|18683668|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
5414690|NCT02634801|18683666|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
5414691|NCT02634801|18683667|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
5414692|NCT02634801|18683668|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
5414693|NCT02634801|18683666|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
5414694|NCT02634801|18683667|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
5414695|NCT02634801|18683668|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
5414696|NCT02634801|18683666|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
5414697|NCT02634801|18683667|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
5414698|NCT02634801|18683668|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
5414699|NCT02634788|18683768|P4|Overall Study|Withdrawal by Subject|0
5414700|NCT02634788|18683769|P3|Overall Study|Withdrawal by Subject|1
5414701|NCT02634788|18683770|P2|Overall Study|Withdrawal by Subject|1
5414702|NCT02634788|18683771|P1|Overall Study|Withdrawal by Subject|0
5414703|NCT02634788|18683768|P4|Overall Study|Lost to Follow-up|0
5414704|NCT02634788|18683769|P3|Overall Study|Lost to Follow-up|0
5414705|NCT02634788|18683770|P2|Overall Study|Lost to Follow-up|1
5414706|NCT02634788|18683771|P1|Overall Study|Lost to Follow-up|0
5414707|NCT02634788|18683768|P4|Overall Study|Lack of Efficacy|4
5414708|NCT02634788|18683769|P3|Overall Study|Lack of Efficacy|1
5414709|NCT02634788|18683770|P2|Overall Study|Lack of Efficacy|0
5414710|NCT02634788|18683771|P1|Overall Study|Lack of Efficacy|4
5414711|NCT02634788|18683768|P4|Overall Study|Adverse Event|1
5414712|NCT02634788|18683769|P3|Overall Study|Adverse Event|3
5414713|NCT02634788|18683770|P2|Overall Study|Adverse Event|8
5414714|NCT02634788|18683771|P1|Overall Study|Adverse Event|0
5414715|NCT02634606|18683837|P1|Overall Study|unable to obtain the drug at start|13
5414716|NCT02634580|18683849|P4|Open-label Extension Period|Withdrawal by Subject|1
5414717|NCT02634580|18683850|P3|Open-label Extension Period|Withdrawal by Subject|0
5414718|NCT02634580|18683851|P2|Open-label Extension Period|Withdrawal by Subject|1
5414719|NCT02634580|18683852|P1|Open-label Extension Period|Withdrawal by Subject|0
5414720|NCT02634580|18683849|P4|Double-blind Treatment Period|Subject Request|1
5414721|NCT02634580|18683850|P3|Double-blind Treatment Period|Subject Request|1
5414722|NCT02634580|18683851|P2|Double-blind Treatment Period|Subject Request|0
5414723|NCT02634580|18683852|P1|Double-blind Treatment Period|Subject Request|1
5414724|NCT02634346|18683910|P3|Overall Study|Protocol Violation|0
5414725|NCT02634346|18683911|P2|Overall Study|Protocol Violation|1
5414726|NCT02634346|18683912|P1|Overall Study|Protocol Violation|0
5414727|NCT02634346|18683910|P3|Overall Study|Lost to Follow-up|0
5414728|NCT02634346|18683911|P2|Overall Study|Lost to Follow-up|0
5414729|NCT02634346|18683912|P1|Overall Study|Lost to Follow-up|1
5414730|NCT02634346|18683910|P3|Overall Study|Lack of Efficacy|8
5414731|NCT02634346|18683911|P2|Overall Study|Lack of Efficacy|2
5414732|NCT02634346|18683912|P1|Overall Study|Lack of Efficacy|1
5414733|NCT02634346|18683910|P3|Overall Study|Adverse Event|7
5414734|NCT02634346|18683911|P2|Overall Study|Adverse Event|2
5414735|NCT02634346|18683912|P1|Overall Study|Adverse Event|2
5414736|NCT02634346|18683910|P3|Overall Study|Withdrawal by Subject|8
5414737|NCT02634346|18683911|P2|Overall Study|Withdrawal by Subject|9
5414738|NCT02634346|18683912|P1|Overall Study|Withdrawal by Subject|8
5414739|NCT02634320|18683926|P1|Overall Study|Lack of Efficacy|2
5414740|NCT02634320|18683926|P1|Overall Study|Withdrawal by Subject|5
5414741|NCT02634320|18683926|P1|Overall Study|Protocol Violation|1
5414742|NCT02634320|18683926|P1|Overall Study|Out of window for study visits|1
5414743|NCT02634320|18683926|P1|Overall Study|Moved out of area|2
5414744|NCT02634320|18683926|P1|Overall Study|Lost to Follow-up|3
5414745|NCT02634320|18683926|P1|Overall Study|Adverse Event|2
5414746|NCT02634151|18683962|P2|Overall Study|Other|1
5414747|NCT02634151|18683963|P1|Overall Study|Other|0
5414748|NCT02634151|18683962|P2|Overall Study|Non-Compliance|1
5414749|NCT02634151|18683963|P1|Overall Study|Non-Compliance|0
5414750|NCT02634151|18683962|P2|Overall Study|Withdrawal by Subject|0
5414751|NCT02634151|18683963|P1|Overall Study|Withdrawal by Subject|1
5414752|NCT02633800|18684165|P2|Overall Study|Patient Request|1
5414753|NCT02633800|18684166|P1|Overall Study|Patient Request|1
5414754|NCT02633800|18684165|P2|Overall Study|Withdrawal by Subject|3
5414755|NCT02633800|18684166|P1|Overall Study|Withdrawal by Subject|0
5414756|NCT02633800|18684165|P2|Overall Study|Adverse event, non-fatal|2
5414757|NCT02633800|18684166|P1|Overall Study|Adverse event, non-fatal|7
5414758|NCT02633800|18684165|P2|Overall Study|Study terminated by sponsor|5
5414759|NCT02633800|18684166|P1|Overall Study|Study terminated by sponsor|6
5414760|NCT02633800|18684165|P2|Overall Study|Clinical progression|6
5414761|NCT02633800|18684166|P1|Overall Study|Clinical progression|3
5414762|NCT02633800|18684165|P2|Overall Study|Radiologic(al) progression|23
5414763|NCT02633800|18684166|P1|Overall Study|Radiologic(al) progression|23
5414764|NCT02633800|18684165|P2|Overall Study|Reason not provided|0
5414765|NCT02633800|18684166|P1|Overall Study|Reason not provided|1
5414766|NCT02633800|18684165|P2|Overall Study|Death|3
5414767|NCT02633800|18684166|P1|Overall Study|Death|3
5414768|NCT02633787|18684176|P1|Overall Study|Withdrawal by Subject|1
5414769|NCT02633501|18684197|P6|Overall Study|Lost to Follow-up|0
5414770|NCT02633501|18684198|P5|Overall Study|Lost to Follow-up|2
5414771|NCT02633501|18684199|P4|Overall Study|Lost to Follow-up|1
5414772|NCT02633501|18684200|P3|Overall Study|Lost to Follow-up|0
5414773|NCT02633501|18684201|P2|Overall Study|Lost to Follow-up|0
5414774|NCT02633501|18684202|P1|Overall Study|Lost to Follow-up|0
5414775|NCT02633501|18684197|P6|Overall Study|Various other reasons|11
5414776|NCT02633501|18684198|P5|Overall Study|Various other reasons|7
5414777|NCT02633501|18684199|P4|Overall Study|Various other reasons|1
5414778|NCT02633501|18684200|P3|Overall Study|Various other reasons|4
5414779|NCT02633501|18684201|P2|Overall Study|Various other reasons|2
5414780|NCT02633501|18684202|P1|Overall Study|Various other reasons|0
5414781|NCT02633501|18684197|P6|Overall Study|Withdrawal by Subject|3
5414782|NCT02633501|18684198|P5|Overall Study|Withdrawal by Subject|1
5414783|NCT02633501|18684199|P4|Overall Study|Withdrawal by Subject|2
5414784|NCT02633501|18684200|P3|Overall Study|Withdrawal by Subject|2
5414785|NCT02633501|18684201|P2|Overall Study|Withdrawal by Subject|1
5414786|NCT02633501|18684202|P1|Overall Study|Withdrawal by Subject|2
5414787|NCT02633501|18684197|P6|Overall Study|Adverse Event|1
5414788|NCT02633501|18684198|P5|Overall Study|Adverse Event|1
5414789|NCT02633501|18684199|P4|Overall Study|Adverse Event|0
5414790|NCT02633501|18684200|P3|Overall Study|Adverse Event|1
5414791|NCT02633501|18684201|P2|Overall Study|Adverse Event|0
5414792|NCT02633501|18684202|P1|Overall Study|Adverse Event|0
5414793|NCT02633215|18684264|P2|Overall Study|Lost to Follow-up|3
5414794|NCT02633215|18684265|P1|Overall Study|Lost to Follow-up|2
5414795|NCT02633020|18684277|P2|Overall Study|Adverse Event|0
5414796|NCT02633020|18684278|P1|Overall Study|Adverse Event|1
5414797|NCT02632838|18684302|P2|Overall Study|Lost to Follow-up|2
5414798|NCT02632838|18684303|P1|Overall Study|Lost to Follow-up|0
5414799|NCT02632838|18684302|P2|Overall Study|Withdrawal by Subject|0
5414800|NCT02632838|18684303|P1|Overall Study|Withdrawal by Subject|3
5414801|NCT02632786|18684340|P2|Overall Study|Withdrawal by Subject|0
5414802|NCT02632786|18684341|P1|Overall Study|Withdrawal by Subject|1
5414803|NCT02632786|18684340|P2|Overall Study|Physician Decision|4
5414804|NCT02632786|18684341|P1|Overall Study|Physician Decision|5
5414805|NCT02632786|18684340|P2|Overall Study|Death|2
5414806|NCT02632786|18684341|P1|Overall Study|Death|3
5414807|NCT02632786|18684340|P2|Overall Study|Adverse Event|1
5414808|NCT02632786|18684341|P1|Overall Study|Adverse Event|2
5414809|NCT02632747|18684361|P2|Wash-out Period|Adverse Event|0
5414810|NCT02632747|18684362|P1|Wash-out Period|Adverse Event|1
5414811|NCT02632110|18684562|P10|Overall Study|Withdrawal by Subject|1
5414812|NCT02632110|18684563|P9|Overall Study|Withdrawal by Subject|1
5414813|NCT02632110|18684564|P8|Overall Study|Withdrawal by Subject|3
5414814|NCT02632110|18684565|P7|Overall Study|Withdrawal by Subject|3
5414815|NCT02632110|18684566|P6|Overall Study|Withdrawal by Subject|1
5414816|NCT02632110|18684567|P5|Overall Study|Withdrawal by Subject|1
5414817|NCT02632110|18684568|P4|Overall Study|Withdrawal by Subject|0
5414818|NCT02632110|18684569|P3|Overall Study|Withdrawal by Subject|0
5414819|NCT02632110|18684570|P2|Overall Study|Withdrawal by Subject|1
5414820|NCT02632110|18684571|P1|Overall Study|Withdrawal by Subject|1
5414821|NCT02631876|18685061|P2|Overall Study|Other than specified|4
5414822|NCT02631876|18685062|P1|Overall Study|Other than specified|4
5414823|NCT02631876|18685061|P2|Overall Study|Withdrawal by Subject|9
5414824|NCT02631876|18685062|P1|Overall Study|Withdrawal by Subject|16
5414825|NCT02631876|18685061|P2|Overall Study|Lost to Follow-up|0
5414826|NCT02631876|18685062|P1|Overall Study|Lost to Follow-up|2
5414827|NCT02631876|18685061|P2|Overall Study|Investigator's discretion|0
5414828|NCT02631876|18685062|P1|Overall Study|Investigator's discretion|1
5414829|NCT02631876|18685061|P2|Overall Study|Death|50
5414830|NCT02631876|18685062|P1|Overall Study|Death|96
5414831|NCT02631746|18685138|P1|Overall Study|Lack of Efficacy|3
5414832|NCT02631577|18685157|P2|Overall Study|Withdrawal by Subject|1
5414833|NCT02631577|18685158|P1|Overall Study|Withdrawal by Subject|0
5414834|NCT02631577|18685157|P2|Overall Study|Death|3
5414835|NCT02631577|18685158|P1|Overall Study|Death|1
5414836|NCT02631551|18685176|P4|Overall Study|Other, specific reasons not collected|2
5414837|NCT02631551|18685177|P3|Overall Study|Other, specific reasons not collected|2
5414838|NCT02631551|18685178|P2|Overall Study|Other, specific reasons not collected|7
5414839|NCT02631551|18685179|P1|Overall Study|Other, specific reasons not collected|5
5414840|NCT02631551|18685176|P4|Overall Study|Non-compliance with study drug|0
5414841|NCT02631551|18685177|P3|Overall Study|Non-compliance with study drug|0
5414842|NCT02631551|18685178|P2|Overall Study|Non-compliance with study drug|0
5414843|NCT02631551|18685179|P1|Overall Study|Non-compliance with study drug|1
5414844|NCT02631551|18685176|P4|Overall Study|Non-compliance with study procedures|1
5414845|NCT02631551|18685177|P3|Overall Study|Non-compliance with study procedures|1
5414846|NCT02631551|18685178|P2|Overall Study|Non-compliance with study procedures|0
5414847|NCT02631551|18685179|P1|Overall Study|Non-compliance with study procedures|0
5414848|NCT02631551|18685176|P4|Overall Study|Protocol deviation|0
5414849|NCT02631551|18685177|P3|Overall Study|Protocol deviation|3
5414850|NCT02631551|18685178|P2|Overall Study|Protocol deviation|6
5414851|NCT02631551|18685179|P1|Overall Study|Protocol deviation|3
5414852|NCT02631551|18685176|P4|Overall Study|Withdrawal by Subject|5
5414853|NCT02631551|18685177|P3|Overall Study|Withdrawal by Subject|0
5414854|NCT02631551|18685178|P2|Overall Study|Withdrawal by Subject|2
5414855|NCT02631551|18685179|P1|Overall Study|Withdrawal by Subject|2
5414856|NCT02631551|18685176|P4|Overall Study|Lost to Follow-up|3
5414857|NCT02631551|18685177|P3|Overall Study|Lost to Follow-up|0
5414858|NCT02631551|18685178|P2|Overall Study|Lost to Follow-up|2
5414859|NCT02631551|18685179|P1|Overall Study|Lost to Follow-up|1
5414860|NCT02631551|18685176|P4|Overall Study|Lack of Efficacy|0
5414861|NCT02631551|18685177|P3|Overall Study|Lack of Efficacy|1
5414862|NCT02631551|18685178|P2|Overall Study|Lack of Efficacy|0
5414863|NCT02631551|18685179|P1|Overall Study|Lack of Efficacy|0
5414864|NCT02631551|18685176|P4|Overall Study|Adverse Event|0
5414865|NCT02631551|18685177|P3|Overall Study|Adverse Event|4
5414866|NCT02631551|18685178|P2|Overall Study|Adverse Event|2
5414867|NCT02631551|18685179|P1|Overall Study|Adverse Event|1
5414868|NCT02631070|18685200|P2|Overall Study|Miscellaneous|10
5414869|NCT02631070|18685201|P1|Overall Study|Miscellaneous|4
5414870|NCT02631070|18685200|P2|Overall Study|Progressive Disease|2
5414871|NCT02631070|18685201|P1|Overall Study|Progressive Disease|6
5414872|NCT02631070|18685200|P2|Overall Study|Protocol Violation|0
5414873|NCT02631070|18685201|P1|Overall Study|Protocol Violation|2
5414874|NCT02631070|18685200|P2|Overall Study|Withdrawal by Subject|10
5414875|NCT02631070|18685201|P1|Overall Study|Withdrawal by Subject|17
5414876|NCT02631070|18685200|P2|Overall Study|Lack of Efficacy|50
5414877|NCT02631070|18685201|P1|Overall Study|Lack of Efficacy|68
5414878|NCT02631070|18685200|P2|Overall Study|Adverse Event|4
5414879|NCT02631070|18685201|P1|Overall Study|Adverse Event|15
5414880|NCT02630966|18685295|P2|Overall Study|Lack of Efficacy|2
5414881|NCT02630966|18685296|P1|Overall Study|Lack of Efficacy|0
5414882|NCT02630966|18685295|P2|Overall Study|Voluntary Withdrawal|1
5414883|NCT02630966|18685296|P1|Overall Study|Voluntary Withdrawal|1
5414884|NCT02630966|18685295|P2|Overall Study|Significant Protocol Deviation|2
5414885|NCT02630966|18685296|P1|Overall Study|Significant Protocol Deviation|0
5414886|NCT02630966|18685295|P2|Overall Study|Adverse Event|3
5414887|NCT02630966|18685296|P1|Overall Study|Adverse Event|1
5414888|NCT02630706|18685324|P3|Overall Study|Withdrawal by Subject|7
5414889|NCT02630706|18685325|P2|Overall Study|Withdrawal by Subject|5
5414890|NCT02630706|18685326|P1|Overall Study|Withdrawal by Subject|4
5414891|NCT02630706|18685324|P3|Overall Study|Pregnancy|0
5414892|NCT02630706|18685325|P2|Overall Study|Pregnancy|1
5414893|NCT02630706|18685326|P1|Overall Study|Pregnancy|0
5414894|NCT02630706|18685324|P3|Overall Study|Physician Decision|0
5414895|NCT02630706|18685325|P2|Overall Study|Physician Decision|1
5414896|NCT02630706|18685326|P1|Overall Study|Physician Decision|1
5414897|NCT02630706|18685324|P3|Overall Study|Lost to Follow-up|2
5414898|NCT02630706|18685325|P2|Overall Study|Lost to Follow-up|1
5414899|NCT02630706|18685326|P1|Overall Study|Lost to Follow-up|0
5414900|NCT02630706|18685324|P3|Overall Study|Adverse Event|1
5414901|NCT02630706|18685325|P2|Overall Study|Adverse Event|1
5414902|NCT02630706|18685326|P1|Overall Study|Adverse Event|2
5414903|NCT02630693|18685435|P2|Overall Study|No receive treatment|1
5414904|NCT02630693|18685436|P1|Overall Study|No receive treatment|0
5414905|NCT02630563|18685448|P1|Overall Study|Administrative|1
5414906|NCT02630472|18685459|P2|Overall Study|Physician Decision|0
5414907|NCT02630472|18685460|P1|Overall Study|Physician Decision|10
5414908|NCT02630459|18685478|P8|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5414909|NCT02630459|18685479|P7|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5414910|NCT02630459|18685480|P6|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5414911|NCT02630459|18685481|P5|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
5414912|NCT02630459|18685482|P4|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5414913|NCT02630459|18685483|P3|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5414914|NCT02630459|18685484|P2|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5414915|NCT02630459|18685485|P1|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
5414916|NCT02630459|18685478|P8|Open-Label Treatment Phase (OLTP)|Subject Request|0
5414917|NCT02630459|18685479|P7|Open-Label Treatment Phase (OLTP)|Subject Request|0
5414918|NCT02630459|18685480|P6|Open-Label Treatment Phase (OLTP)|Subject Request|3
5414919|NCT02630459|18685481|P5|Open-Label Treatment Phase (OLTP)|Subject Request|24
5414920|NCT02630459|18685482|P4|Open-Label Treatment Phase (OLTP)|Subject Request|0
5414921|NCT02630459|18685483|P3|Open-Label Treatment Phase (OLTP)|Subject Request|0
5414922|NCT02630459|18685484|P2|Open-Label Treatment Phase (OLTP)|Subject Request|0
5414923|NCT02630459|18685485|P1|Open-Label Treatment Phase (OLTP)|Subject Request|0
5414924|NCT02630459|18685478|P8|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5414925|NCT02630459|18685479|P7|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5414926|NCT02630459|18685480|P6|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
5414927|NCT02630459|18685481|P5|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
5414928|NCT02630459|18685482|P4|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5414929|NCT02630459|18685483|P3|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5414930|NCT02630459|18685484|P2|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5414931|NCT02630459|18685485|P1|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
5414932|NCT02630459|18685478|P8|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5414933|NCT02630459|18685479|P7|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5414934|NCT02630459|18685480|P6|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5414935|NCT02630459|18685481|P5|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5414936|NCT02630459|18685482|P4|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5414937|NCT02630459|18685483|P3|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5414938|NCT02630459|18685484|P2|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
5414939|NCT02630459|18685485|P1|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
5414940|NCT02630459|18685478|P8|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5414941|NCT02630459|18685479|P7|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5414942|NCT02630459|18685480|P6|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5414943|NCT02630459|18685481|P5|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
5414944|NCT02630459|18685482|P4|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
5414945|NCT02630459|18685483|P3|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
5414946|NCT02630459|18685484|P2|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
5414947|NCT02630459|18685485|P1|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
5414948|NCT02630459|18685478|P8|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5414949|NCT02630459|18685479|P7|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5414950|NCT02630459|18685480|P6|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5414951|NCT02630459|18685481|P5|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5414952|NCT02630459|18685482|P4|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5414953|NCT02630459|18685483|P3|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
5414954|NCT02630459|18685484|P2|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5414955|NCT02630459|18685485|P1|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
5415042|NCT02628600|18686001|P1|Overall Study|Physician Decision|2
5414956|NCT02630459|18685478|P8|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5414957|NCT02630459|18685479|P7|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5414958|NCT02630459|18685480|P6|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5414959|NCT02630459|18685481|P5|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5414960|NCT02630459|18685482|P4|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
5414961|NCT02630459|18685483|P3|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5414962|NCT02630459|18685484|P2|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
5414963|NCT02630459|18685485|P1|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
5414964|NCT02630251|18685544|P4|Overall Study|Physician Decision|0
5414965|NCT02630251|18685545|P3|Overall Study|Physician Decision|1
5414966|NCT02630251|18685546|P2|Overall Study|Physician Decision|0
5414967|NCT02630251|18685547|P1|Overall Study|Physician Decision|0
5414968|NCT02630186|18685661|P1|Overall Study|Withdrawal by Subject|1
5414969|NCT02629965|18685677|P2|Period 2|Adverse Event|0
5414970|NCT02629965|18685678|P1|Period 2|Adverse Event|1
5414971|NCT02629965|18685677|P2|Period 1|Other than listed above|2
5414972|NCT02629965|18685678|P1|Period 1|Other than listed above|1
5414973|NCT02629965|18685677|P2|Period 1|Unexpected worsening of disease|0
5414974|NCT02629965|18685678|P1|Period 1|Unexpected worsening of disease|2
5414975|NCT02629965|18685677|P2|Period 1|Adverse Event|0
5414976|NCT02629965|18685678|P1|Period 1|Adverse Event|1
5414977|NCT02629861|18685717|P3|Overall Study|Pregnancy|0
5414978|NCT02629861|18685718|P2|Overall Study|Pregnancy|1
5414979|NCT02629861|18685719|P1|Overall Study|Pregnancy|2
5414980|NCT02629861|18685717|P3|Overall Study|Other|0
5414981|NCT02629861|18685718|P2|Overall Study|Other|1
5414982|NCT02629861|18685719|P1|Overall Study|Other|1
5414983|NCT02629861|18685717|P3|Overall Study|Lost to Follow-up|4
5414984|NCT02629861|18685718|P2|Overall Study|Lost to Follow-up|9
5414985|NCT02629861|18685719|P1|Overall Study|Lost to Follow-up|12
5414986|NCT02629861|18685717|P3|Overall Study|Protocol Violation|7
5414987|NCT02629861|18685718|P2|Overall Study|Protocol Violation|3
5414988|NCT02629861|18685719|P1|Overall Study|Protocol Violation|2
5414989|NCT02629861|18685717|P3|Overall Study|Withdrawal by Subject|13
5414990|NCT02629861|18685718|P2|Overall Study|Withdrawal by Subject|8
5414991|NCT02629861|18685719|P1|Overall Study|Withdrawal by Subject|5
5414992|NCT02629861|18685717|P3|Overall Study|Adverse Event|4
5414993|NCT02629861|18685718|P2|Overall Study|Adverse Event|5
5414994|NCT02629861|18685719|P1|Overall Study|Adverse Event|7
5414995|NCT02629822|18685766|P1|Extension Study|Extension Period is Ongoing|6
5414996|NCT02629822|18685766|P1|Base Study|Non-Compliance With Study Drug|1
5414997|NCT02629822|18685766|P1|Base Study|Lost to Follow-up|2
5414998|NCT02629159|18685808|P3|Overall Study|Other|8
5414999|NCT02629159|18685809|P2|Overall Study|Other|4
5415000|NCT02629159|18685810|P1|Overall Study|Other|6
5415001|NCT02629159|18685808|P3|Overall Study|Lack of Efficacy|1
5415002|NCT02629159|18685809|P2|Overall Study|Lack of Efficacy|0
5415003|NCT02629159|18685810|P1|Overall Study|Lack of Efficacy|4
5415004|NCT02629159|18685808|P3|Overall Study|Lost to Follow-up|5
5415005|NCT02629159|18685809|P2|Overall Study|Lost to Follow-up|4
5415006|NCT02629159|18685810|P1|Overall Study|Lost to Follow-up|7
5415007|NCT02629159|18685808|P3|Overall Study|Withdrawal by Subject|15
5415008|NCT02629159|18685809|P2|Overall Study|Withdrawal by Subject|11
5415009|NCT02629159|18685810|P1|Overall Study|Withdrawal by Subject|22
5415010|NCT02629159|18685808|P3|Overall Study|Adverse Event|22
5415011|NCT02629159|18685809|P2|Overall Study|Adverse Event|20
5415012|NCT02629159|18685810|P1|Overall Study|Adverse Event|17
5415013|NCT02629133|18685862|P2|Overall Study|Withdrawal by Subject|1
5415014|NCT02629133|18685863|P1|Overall Study|Withdrawal by Subject|1
5415015|NCT02629133|18685862|P2|Overall Study|Lost to Follow-up|1
5415016|NCT02629133|18685863|P1|Overall Study|Lost to Follow-up|3
5415017|NCT02628938|18685906|P3|Overall Study|Failure to comply with the instructions|3
5415018|NCT02628938|18685907|P2|Overall Study|Failure to comply with the instructions|0
5415019|NCT02628938|18685908|P1|Overall Study|Failure to comply with the instructions|3
5415020|NCT02628938|18685906|P3|Overall Study|Did not attend the follow up recall|1
5415021|NCT02628938|18685907|P2|Overall Study|Did not attend the follow up recall|2
5415022|NCT02628938|18685908|P1|Overall Study|Did not attend the follow up recall|2
5415023|NCT02628873|18685924|P2|Second Test (1 Hour)|Physician Decision|0
5415024|NCT02628873|18685925|P1|Second Test (1 Hour)|Physician Decision|1
5415025|NCT02628873|18685924|P2|Break (1 Hour)|Withdrawal by Subject|1
5415026|NCT02628873|18685925|P1|Break (1 Hour)|Withdrawal by Subject|0
5415027|NCT02628769|18685935|P2|Second Intervention|Physician Decision|1
5415028|NCT02628769|18685936|P1|Second Intervention|Physician Decision|0
5415029|NCT02628769|18685935|P2|Second Intervention|Adverse Event|0
5415030|NCT02628769|18685936|P1|Second Intervention|Adverse Event|2
5415031|NCT02628769|18685935|P2|First Intervention|Withdrawal by Subject|1
5415032|NCT02628769|18685936|P1|First Intervention|Withdrawal by Subject|0
5415033|NCT02628769|18685935|P2|First Intervention|Adverse Event|0
5415034|NCT02628769|18685936|P1|First Intervention|Adverse Event|1
5415035|NCT02628743|18685974|P1|Overall Study|Physician Decision|2
5415036|NCT02628743|18685974|P1|Overall Study|Study Terminated by Sponsor|76
5415037|NCT02628743|18685974|P1|Overall Study|Withdrawal by Subject|50
5415038|NCT02628743|18685974|P1|Overall Study|Other|3
5415039|NCT02628600|18686000|P2|Overall Study|Other not specified|0
5415040|NCT02628600|18686001|P1|Overall Study|Other not specified|1
5415041|NCT02628600|18686000|P2|Overall Study|Physician Decision|2
5415043|NCT02628600|18686000|P2|Overall Study|Lost to Follow-up|0
5415044|NCT02628600|18686001|P1|Overall Study|Lost to Follow-up|1
5415045|NCT02628600|18686000|P2|Overall Study|Withdrawal by Subject|8
5415046|NCT02628600|18686001|P1|Overall Study|Withdrawal by Subject|13
5415047|NCT02628600|18686000|P2|Overall Study|Lack of Efficacy|0
5415048|NCT02628600|18686001|P1|Overall Study|Lack of Efficacy|2
5415049|NCT02628600|18686000|P2|Overall Study|Protocol Violation|1
5415050|NCT02628600|18686001|P1|Overall Study|Protocol Violation|0
5415051|NCT02628600|18686000|P2|Overall Study|Adverse Event|20
5415052|NCT02628600|18686001|P1|Overall Study|Adverse Event|3
5415053|NCT02628600|18686000|P2|Overall Study|Death|1
5415054|NCT02628600|18686001|P1|Overall Study|Death|2
5415055|NCT02628418|18686015|P2|Overall Study|Lost to Follow-up|2
5415056|NCT02628418|18686016|P1|Overall Study|Lost to Follow-up|1
5415057|NCT02628028|18686126|P8|Long-term Extension (LTE) Period|Other|3
5415058|NCT02628028|18686127|P7|Long-term Extension (LTE) Period|Other|4
5415059|NCT02628028|18686128|P6|Long-term Extension (LTE) Period|Other|3
5415060|NCT02628028|18686129|P5|Long-term Extension (LTE) Period|Other|0
5415061|NCT02628028|18686130|P4|Long-term Extension (LTE) Period|Other|0
5415062|NCT02628028|18686131|P3|Long-term Extension (LTE) Period|Other|0
5415063|NCT02628028|18686132|P2|Long-term Extension (LTE) Period|Other|0
5415064|NCT02628028|18686133|P1|Long-term Extension (LTE) Period|Other|0
5415065|NCT02628028|18686126|P8|Long-term Extension (LTE) Period|Withdrawal by Subject|3
5415066|NCT02628028|18686127|P7|Long-term Extension (LTE) Period|Withdrawal by Subject|3
5415067|NCT02628028|18686128|P6|Long-term Extension (LTE) Period|Withdrawal by Subject|2
5415068|NCT02628028|18686129|P5|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5415069|NCT02628028|18686130|P4|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5415070|NCT02628028|18686131|P3|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5415071|NCT02628028|18686132|P2|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5415072|NCT02628028|18686133|P1|Long-term Extension (LTE) Period|Withdrawal by Subject|0
5415073|NCT02628028|18686126|P8|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
5415074|NCT02628028|18686127|P7|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
5415075|NCT02628028|18686128|P6|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
5415076|NCT02628028|18686129|P5|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5415077|NCT02628028|18686130|P4|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5415078|NCT02628028|18686131|P3|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5415079|NCT02628028|18686132|P2|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5415080|NCT02628028|18686133|P1|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
5415081|NCT02628028|18686126|P8|Long-term Extension (LTE) Period|Lack of Efficacy|1
5415082|NCT02628028|18686127|P7|Long-term Extension (LTE) Period|Lack of Efficacy|0
5415083|NCT02628028|18686128|P6|Long-term Extension (LTE) Period|Lack of Efficacy|2
5415084|NCT02628028|18686129|P5|Long-term Extension (LTE) Period|Lack of Efficacy|0
5415085|NCT02628028|18686130|P4|Long-term Extension (LTE) Period|Lack of Efficacy|0
5415086|NCT02628028|18686131|P3|Long-term Extension (LTE) Period|Lack of Efficacy|0
5415087|NCT02628028|18686132|P2|Long-term Extension (LTE) Period|Lack of Efficacy|0
5415088|NCT02628028|18686133|P1|Long-term Extension (LTE) Period|Lack of Efficacy|0
5415089|NCT02628028|18686126|P8|Long-term Extension (LTE) Period|Adverse Event|3
5415090|NCT02628028|18686127|P7|Long-term Extension (LTE) Period|Adverse Event|0
5415091|NCT02628028|18686128|P6|Long-term Extension (LTE) Period|Adverse Event|1
5415092|NCT02628028|18686129|P5|Long-term Extension (LTE) Period|Adverse Event|0
5415093|NCT02628028|18686130|P4|Long-term Extension (LTE) Period|Adverse Event|0
5415094|NCT02628028|18686131|P3|Long-term Extension (LTE) Period|Adverse Event|0
5415095|NCT02628028|18686132|P2|Long-term Extension (LTE) Period|Adverse Event|0
5415096|NCT02628028|18686133|P1|Long-term Extension (LTE) Period|Adverse Event|0
5415097|NCT02628028|18686126|P8|Dosing Period|Other|4
5415098|NCT02628028|18686127|P7|Dosing Period|Other|2
5415099|NCT02628028|18686128|P6|Dosing Period|Other|1
5415100|NCT02628028|18686129|P5|Dosing Period|Other|2
5415101|NCT02628028|18686130|P4|Dosing Period|Other|0
5415102|NCT02628028|18686131|P3|Dosing Period|Other|0
5415103|NCT02628028|18686132|P2|Dosing Period|Other|0
5415104|NCT02628028|18686133|P1|Dosing Period|Other|0
5415105|NCT02628028|18686126|P8|Dosing Period|Lost to Follow-up|0
5415106|NCT02628028|18686127|P7|Dosing Period|Lost to Follow-up|1
5415107|NCT02628028|18686128|P6|Dosing Period|Lost to Follow-up|0
5415108|NCT02628028|18686129|P5|Dosing Period|Lost to Follow-up|0
5415109|NCT02628028|18686130|P4|Dosing Period|Lost to Follow-up|0
5415110|NCT02628028|18686131|P3|Dosing Period|Lost to Follow-up|0
5415111|NCT02628028|18686132|P2|Dosing Period|Lost to Follow-up|0
5415112|NCT02628028|18686133|P1|Dosing Period|Lost to Follow-up|0
5415113|NCT02628028|18686126|P8|Dosing Period|Site Terminated by Sponsor|0
5415114|NCT02628028|18686127|P7|Dosing Period|Site Terminated by Sponsor|1
5415115|NCT02628028|18686128|P6|Dosing Period|Site Terminated by Sponsor|1
5415116|NCT02628028|18686129|P5|Dosing Period|Site Terminated by Sponsor|0
5415117|NCT02628028|18686130|P4|Dosing Period|Site Terminated by Sponsor|0
5415118|NCT02628028|18686131|P3|Dosing Period|Site Terminated by Sponsor|0
5415119|NCT02628028|18686132|P2|Dosing Period|Site Terminated by Sponsor|0
5415120|NCT02628028|18686133|P1|Dosing Period|Site Terminated by Sponsor|0
5415121|NCT02628028|18686126|P8|Dosing Period|Physician Decision|0
5415122|NCT02628028|18686127|P7|Dosing Period|Physician Decision|0
5415123|NCT02628028|18686128|P6|Dosing Period|Physician Decision|1
5415124|NCT02628028|18686129|P5|Dosing Period|Physician Decision|0
5415125|NCT02628028|18686130|P4|Dosing Period|Physician Decision|0
5415126|NCT02628028|18686131|P3|Dosing Period|Physician Decision|0
5415127|NCT02628028|18686132|P2|Dosing Period|Physician Decision|0
5415128|NCT02628028|18686133|P1|Dosing Period|Physician Decision|0
5415129|NCT02628028|18686126|P8|Dosing Period|Study Terminated by Sponsor|7
5415130|NCT02628028|18686127|P7|Dosing Period|Study Terminated by Sponsor|7
5415131|NCT02628028|18686128|P6|Dosing Period|Study Terminated by Sponsor|6
5415132|NCT02628028|18686129|P5|Dosing Period|Study Terminated by Sponsor|7
5415133|NCT02628028|18686130|P4|Dosing Period|Study Terminated by Sponsor|0
5415134|NCT02628028|18686131|P3|Dosing Period|Study Terminated by Sponsor|0
5415135|NCT02628028|18686132|P2|Dosing Period|Study Terminated by Sponsor|0
5415136|NCT02628028|18686133|P1|Dosing Period|Study Terminated by Sponsor|0
5415137|NCT02628028|18686126|P8|Dosing Period|Lack of Efficacy|0
5415138|NCT02628028|18686127|P7|Dosing Period|Lack of Efficacy|1
5415139|NCT02628028|18686128|P6|Dosing Period|Lack of Efficacy|0
5415140|NCT02628028|18686129|P5|Dosing Period|Lack of Efficacy|3
5415141|NCT02628028|18686130|P4|Dosing Period|Lack of Efficacy|0
5415142|NCT02628028|18686131|P3|Dosing Period|Lack of Efficacy|0
5415143|NCT02628028|18686132|P2|Dosing Period|Lack of Efficacy|0
5415144|NCT02628028|18686133|P1|Dosing Period|Lack of Efficacy|0
5415145|NCT02628028|18686126|P8|Dosing Period|Death|1
5415146|NCT02628028|18686127|P7|Dosing Period|Death|0
5415147|NCT02628028|18686128|P6|Dosing Period|Death|0
5415148|NCT02628028|18686129|P5|Dosing Period|Death|0
5415149|NCT02628028|18686130|P4|Dosing Period|Death|0
5415150|NCT02628028|18686131|P3|Dosing Period|Death|0
5415151|NCT02628028|18686132|P2|Dosing Period|Death|0
5415152|NCT02628028|18686133|P1|Dosing Period|Death|0
5415153|NCT02628028|18686126|P8|Dosing Period|Adverse Event|2
5415154|NCT02628028|18686127|P7|Dosing Period|Adverse Event|3
5415155|NCT02628028|18686128|P6|Dosing Period|Adverse Event|1
5415156|NCT02628028|18686129|P5|Dosing Period|Adverse Event|2
5415157|NCT02628028|18686130|P4|Dosing Period|Adverse Event|0
5415158|NCT02628028|18686131|P3|Dosing Period|Adverse Event|0
5415159|NCT02628028|18686132|P2|Dosing Period|Adverse Event|0
5415160|NCT02628028|18686133|P1|Dosing Period|Adverse Event|0
5415161|NCT02628028|18686126|P8|Dosing Period|Withdrawal by Subject|1
5415162|NCT02628028|18686127|P7|Dosing Period|Withdrawal by Subject|1
5415163|NCT02628028|18686128|P6|Dosing Period|Withdrawal by Subject|4
5415164|NCT02628028|18686129|P5|Dosing Period|Withdrawal by Subject|2
5415165|NCT02628028|18686130|P4|Dosing Period|Withdrawal by Subject|0
5415166|NCT02628028|18686131|P3|Dosing Period|Withdrawal by Subject|1
5415167|NCT02628028|18686132|P2|Dosing Period|Withdrawal by Subject|0
5415168|NCT02628028|18686133|P1|Dosing Period|Withdrawal by Subject|0
5415169|NCT02627144|18686218|P1|Overall Study|Other|17
5415170|NCT02627144|18686218|P1|Overall Study|Enrolled, not treated|6
5415171|NCT02627144|18686218|P1|Overall Study|Lost to Follow-up|8
5415172|NCT02627144|18686218|P1|Overall Study|Administrative reasons|65
5415173|NCT02627144|18686218|P1|Overall Study|Refusal of treatment / poor cooperation|38
5415174|NCT02627144|18686218|P1|Overall Study|Death from other cause|8
5415175|NCT02627144|18686218|P1|Overall Study|Death from cancer|20
5415176|NCT02627144|18686218|P1|Overall Study|Cancer progression|171
5415177|NCT02627144|18686218|P1|Overall Study|Serious adverse event|32
5415178|NCT02626819|18686259|P2|Overall Study|Diagnosed w/ catastrophic illness|1
5415179|NCT02626819|18686260|P1|Overall Study|Diagnosed w/ catastrophic illness|0
5415180|NCT02626819|18686259|P2|Overall Study|Withdrawal by Subject|0
5415181|NCT02626819|18686260|P1|Overall Study|Withdrawal by Subject|1
5415182|NCT02626819|18686259|P2|Overall Study|Lost to Follow-up|2
5415183|NCT02626819|18686260|P1|Overall Study|Lost to Follow-up|3
5415184|NCT02626780|18686280|P1|Overall Study|Withdrawal by Subject|3
5415185|NCT02626520|18686313|P2|Overall Study|Study terminated|1
5415186|NCT02626520|18686314|P1|Overall Study|Study terminated|0
5415187|NCT02626520|18686313|P2|Overall Study|Did not start protocol therapy|2
5415188|NCT02626520|18686314|P1|Overall Study|Did not start protocol therapy|0
5415189|NCT02626520|18686313|P2|Overall Study|Lack of Efficacy|2
5415190|NCT02626520|18686314|P1|Overall Study|Lack of Efficacy|0
5415191|NCT02626520|18686313|P2|Overall Study|Adverse Event|4
5415192|NCT02626520|18686314|P1|Overall Study|Adverse Event|0
5415193|NCT02626520|18686313|P2|Overall Study|Physician Decision|1
5415194|NCT02626520|18686314|P1|Overall Study|Physician Decision|1
5415195|NCT02626182|18686326|P2|Overall Study|Adverse Event|0
5415196|NCT02626182|18686327|P1|Overall Study|Adverse Event|2
5415197|NCT02626026|18686343|P6|Overall Study|Randomized but Never Treated|0
5415198|NCT02626026|18686344|P5|Overall Study|Randomized but Never Treated|1
5415199|NCT02626026|18686345|P4|Overall Study|Randomized but Never Treated|0
5415200|NCT02626026|18686346|P3|Overall Study|Randomized but Never Treated|0
5415201|NCT02626026|18686347|P2|Overall Study|Randomized but Never Treated|0
5415202|NCT02626026|18686348|P1|Overall Study|Randomized but Never Treated|0
5415203|NCT02626000|18686426|P1|Overall Study|Death|23
5415204|NCT02626000|18686426|P1|Overall Study|Continuing Study|13
5415205|NCT02625974|18686440|P2|Overall Study|Protocol Violation|1
5415206|NCT02625974|18686441|P1|Overall Study|Protocol Violation|0
5415207|NCT02625974|18686440|P2|Overall Study|non-compliance with study drug|2
5415208|NCT02625974|18686441|P1|Overall Study|non-compliance with study drug|0
5415209|NCT02625974|18686440|P2|Overall Study|positive parasitemia|0
5415210|NCT02625974|18686441|P1|Overall Study|positive parasitemia|1
5415211|NCT02625974|18686440|P2|Overall Study|Withdrawal by Subject|1
5415212|NCT02625974|18686441|P1|Overall Study|Withdrawal by Subject|3
5415213|NCT02625974|18686440|P2|Overall Study|Adverse Event|2
5415214|NCT02625974|18686441|P1|Overall Study|Adverse Event|12
5415215|NCT02625922|18686551|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
5415216|NCT02625922|18686552|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
5415217|NCT02625922|18686551|P2|Overall Study|Non-availability of IMP|1
5415218|NCT02625922|18686552|P1|Overall Study|Non-availability of IMP|1
5415219|NCT02625623|18686571|P2|Overall Study|Participants randomized but not treated|1
5415220|NCT02625623|18686572|P1|Overall Study|Participants randomized but not treated|9
5415221|NCT02625324|18686635|P1|12-Month Follow-up Secondary Endpoint|Death|4
5415222|NCT02625324|18686635|P1|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
5415223|NCT02625324|18686635|P1|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
5415224|NCT02625324|18686635|P1|6-Month Follow-up Subject Accountability|Death|5
5415225|NCT02625324|18686635|P1|30-Day Follow-up for Secondary Endpoint|Death|1
5415226|NCT02625324|18686635|P1|30-Day Follow-up for Primary Endpoint|Death|1
5415227|NCT02625259|18686660|P5|First Intervention (Day 1)|Withdrawal by Subject|0
5415228|NCT02625259|18686661|P4|First Intervention (Day 1)|Withdrawal by Subject|1
5415229|NCT02625259|18686662|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5415230|NCT02625259|18686663|P2|First Intervention (Day 1)|Withdrawal by Subject|0
5415231|NCT02625259|18686664|P1|First Intervention (Day 1)|Withdrawal by Subject|0
5415232|NCT02625259|18686660|P5|First Intervention (Day 1)|Adverse Event|0
5415233|NCT02625259|18686661|P4|First Intervention (Day 1)|Adverse Event|0
5415234|NCT02625259|18686662|P3|First Intervention (Day 1)|Adverse Event|0
5415235|NCT02625259|18686663|P2|First Intervention (Day 1)|Adverse Event|1
5415236|NCT02625259|18686664|P1|First Intervention (Day 1)|Adverse Event|2
5415237|NCT02625259|18686660|P5|First Intervention (Day 1)|Other|0
5415238|NCT02625259|18686661|P4|First Intervention (Day 1)|Other|0
5415239|NCT02625259|18686662|P3|First Intervention (Day 1)|Other|1
5415240|NCT02625259|18686663|P2|First Intervention (Day 1)|Other|0
5415241|NCT02625259|18686664|P1|First Intervention (Day 1)|Other|0
5415242|NCT02625233|18686701|P2|Overall Study|Adverse Event|0
5415243|NCT02625233|18686702|P1|Overall Study|Adverse Event|2
5415244|NCT02625220|18686710|P1|Overall Study|Study discontinued at site|2
5415245|NCT02625220|18686710|P1|Overall Study|Protocol Violation|1
5415246|NCT02625220|18686710|P1|Overall Study|Lost to Follow-up|2
5415247|NCT02625220|18686710|P1|Overall Study|Adverse Event|2
5415248|NCT02624986|18686838|P8|Overall Study|Withdrawal by Subject|1
5415249|NCT02624986|18686839|P7|Overall Study|Withdrawal by Subject|0
5415250|NCT02624986|18686840|P6|Overall Study|Withdrawal by Subject|0
5415251|NCT02624986|18686841|P5|Overall Study|Withdrawal by Subject|0
5415252|NCT02624986|18686842|P4|Overall Study|Withdrawal by Subject|0
5415253|NCT02624986|18686843|P3|Overall Study|Withdrawal by Subject|0
5415254|NCT02624986|18686844|P2|Overall Study|Withdrawal by Subject|0
5415255|NCT02624986|18686845|P1|Overall Study|Withdrawal by Subject|0
5415256|NCT02624986|18686838|P8|Overall Study|Protocol Violation|0
5415257|NCT02624986|18686839|P7|Overall Study|Protocol Violation|0
5415258|NCT02624986|18686840|P6|Overall Study|Protocol Violation|0
5415259|NCT02624986|18686841|P5|Overall Study|Protocol Violation|0
5415260|NCT02624986|18686842|P4|Overall Study|Protocol Violation|0
5415261|NCT02624986|18686843|P3|Overall Study|Protocol Violation|0
5415262|NCT02624986|18686844|P2|Overall Study|Protocol Violation|0
5415263|NCT02624986|18686845|P1|Overall Study|Protocol Violation|1
5415264|NCT02624986|18686838|P8|Overall Study|Progressive Disease|0
5415265|NCT02624986|18686839|P7|Overall Study|Progressive Disease|0
5415266|NCT02624986|18686840|P6|Overall Study|Progressive Disease|0
5415267|NCT02624986|18686841|P5|Overall Study|Progressive Disease|0
5415268|NCT02624986|18686842|P4|Overall Study|Progressive Disease|0
5415269|NCT02624986|18686843|P3|Overall Study|Progressive Disease|0
5415270|NCT02624986|18686844|P2|Overall Study|Progressive Disease|1
5415271|NCT02624986|18686845|P1|Overall Study|Progressive Disease|0
5415272|NCT02624986|18686838|P8|Overall Study|Study Terminated by Sponsor|3
5415273|NCT02624986|18686839|P7|Overall Study|Study Terminated by Sponsor|4
5415274|NCT02624986|18686840|P6|Overall Study|Study Terminated by Sponsor|2
5415275|NCT02624986|18686841|P5|Overall Study|Study Terminated by Sponsor|2
5415276|NCT02624986|18686842|P4|Overall Study|Study Terminated by Sponsor|1
5415277|NCT02624986|18686843|P3|Overall Study|Study Terminated by Sponsor|0
5415278|NCT02624986|18686844|P2|Overall Study|Study Terminated by Sponsor|1
5415279|NCT02624986|18686845|P1|Overall Study|Study Terminated by Sponsor|1
5415280|NCT02624986|18686838|P8|Overall Study|Death|1
5415281|NCT02624986|18686839|P7|Overall Study|Death|0
5415282|NCT02624986|18686840|P6|Overall Study|Death|0
5415283|NCT02624986|18686841|P5|Overall Study|Death|2
5415284|NCT02624986|18686842|P4|Overall Study|Death|2
5415285|NCT02624986|18686843|P3|Overall Study|Death|2
5415286|NCT02624986|18686844|P2|Overall Study|Death|1
5415287|NCT02624986|18686845|P1|Overall Study|Death|0
5415288|NCT02624791|18687035|P6|Overall Study|Withdrawal by Subject|0
5415289|NCT02624791|18687036|P5|Overall Study|Withdrawal by Subject|0
5415290|NCT02624791|18687037|P4|Overall Study|Withdrawal by Subject|0
5415291|NCT02624791|18687038|P3|Overall Study|Withdrawal by Subject|0
5415292|NCT02624791|18687039|P2|Overall Study|Withdrawal by Subject|0
5415293|NCT02624791|18687040|P1|Overall Study|Withdrawal by Subject|2
5415294|NCT02624713|18687047|P2|Overall Study|Lost to Follow-up|0
5415295|NCT02624713|18687048|P1|Overall Study|Lost to Follow-up|14
5415296|NCT02624687|18687072|P2|Overall Study|medical leave from work|1
5415297|NCT02624687|18687073|P1|Overall Study|medical leave from work|0
5415298|NCT02624687|18687072|P2|Overall Study|Withdrawal by Subject|1
5415299|NCT02624687|18687073|P1|Overall Study|Withdrawal by Subject|1
5415300|NCT02624492|18687104|P3|Overall Study|Progressive disease|3
5415301|NCT02624492|18687105|P2|Overall Study|Progressive disease|2
5415302|NCT02624492|18687106|P1|Overall Study|Progressive disease|0
5415303|NCT02624492|18687104|P3|Overall Study|Adverse Event|2
5415304|NCT02624492|18687105|P2|Overall Study|Adverse Event|2
5415305|NCT02624492|18687106|P1|Overall Study|Adverse Event|2
5415306|NCT02624284|18687141|P3|Overall Study|Adverse Event|1
5415307|NCT02624284|18687142|P2|Overall Study|Adverse Event|0
5415308|NCT02624284|18687143|P1|Overall Study|Adverse Event|0
5415309|NCT02624284|18687141|P3|Overall Study|Revealed exclusionary condition|0
5415310|NCT02624284|18687142|P2|Overall Study|Revealed exclusionary condition|2
5415311|NCT02624284|18687143|P1|Overall Study|Revealed exclusionary condition|2
5415312|NCT02624284|18687141|P3|Overall Study|Protocol Violation|7
5415313|NCT02624284|18687142|P2|Overall Study|Protocol Violation|10
5415314|NCT02624284|18687143|P1|Overall Study|Protocol Violation|9
5415315|NCT02624284|18687141|P3|Overall Study|Withdrawal by Subject|3
5415316|NCT02624284|18687142|P2|Overall Study|Withdrawal by Subject|6
5415317|NCT02624284|18687143|P1|Overall Study|Withdrawal by Subject|3
5415318|NCT02624050|18687162|P2|Overall Study|Protocol Violation|0
5415319|NCT02624050|18687163|P1|Overall Study|Protocol Violation|2
5415320|NCT02624050|18687162|P2|Overall Study|Physician Decision|0
5415321|NCT02624050|18687163|P1|Overall Study|Physician Decision|4
5415322|NCT02623959|18687191|P2|Overall Study|Progression|1
5415323|NCT02623959|18687192|P1|Overall Study|Progression|0
5415324|NCT02623829|18687225|P2|Overall Study|Lost to Follow-up|1
5415325|NCT02623829|18687226|P1|Overall Study|Lost to Follow-up|1
5415326|NCT02623725|18687285|P2|Overall Study|Withdrawal by Subject|1
5415327|NCT02623725|18687286|P1|Overall Study|Withdrawal by Subject|7
5415328|NCT02623725|18687285|P2|Overall Study|Serious adverse event|2
5415329|NCT02623725|18687286|P1|Overall Study|Serious adverse event|0
5415330|NCT02623725|18687285|P2|Overall Study|Non compliance with protocol|3
5415331|NCT02623725|18687286|P1|Overall Study|Non compliance with protocol|9
5415332|NCT02623361|18687320|P2|Overall Study|Withdrawal by Subject|1
5415333|NCT02623361|18687321|P1|Overall Study|Withdrawal by Subject|0
5415334|NCT02623361|18687320|P2|Overall Study|Protocol Violation|1
5415335|NCT02623361|18687321|P1|Overall Study|Protocol Violation|0
5415336|NCT02623335|18687360|P2|Overall Study|Protocol Violation|1
5415337|NCT02623335|18687361|P1|Overall Study|Protocol Violation|2
5415338|NCT02623335|18687360|P2|Overall Study|Withdrawal by Subject|5
5415339|NCT02623335|18687361|P1|Overall Study|Withdrawal by Subject|2
5415340|NCT02623335|18687360|P2|Overall Study|Lost to Follow-up|23
5415341|NCT02623335|18687361|P1|Overall Study|Lost to Follow-up|15
5415342|NCT02623335|18687360|P2|Overall Study|Death|7
5415343|NCT02623335|18687361|P1|Overall Study|Death|8
5415344|NCT02623322|18687388|P3|Overall Study|Lost to Follow-up|0
5415345|NCT02623322|18687389|P2|Overall Study|Lost to Follow-up|1
5415346|NCT02623322|18687390|P1|Overall Study|Lost to Follow-up|2
5415347|NCT02623218|18687428|P5|Overall Study|Lost to Follow-up|0
5415348|NCT02623218|18687429|P4|Overall Study|Lost to Follow-up|0
5415349|NCT02623218|18687430|P3|Overall Study|Lost to Follow-up|0
5415350|NCT02623218|18687431|P2|Overall Study|Lost to Follow-up|1
5415351|NCT02623218|18687432|P1|Overall Study|Lost to Follow-up|0
5415352|NCT02622828|18687454|P1|Overall Study|participant withdrew|3
5415353|NCT02622724|18687461|P2|Overall Study|Early termination of study|43
5415354|NCT02622724|18687462|P1|Overall Study|Early termination of study|38
5415355|NCT02622724|18687461|P2|Overall Study|Lost to Follow-UP, withdrawal of consent|7
5415356|NCT02622724|18687462|P1|Overall Study|Lost to Follow-UP, withdrawal of consent|4
5415357|NCT02622724|18687461|P2|Overall Study|Death|53
5415358|NCT02622724|18687462|P1|Overall Study|Death|51
5415359|NCT02622568|18687540|P2|Overall Study|Lost to Follow-up|5
5415360|NCT02622568|18687541|P1|Overall Study|Lost to Follow-up|5
5415361|NCT02622321|18687551|P4|Overall Study|Withdrawal by Subject|0
5415362|NCT02622321|18687552|P3|Overall Study|Withdrawal by Subject|0
5415363|NCT02622321|18687553|P2|Overall Study|Withdrawal by Subject|0
5415364|NCT02622321|18687554|P1|Overall Study|Withdrawal by Subject|1
5415365|NCT02622321|18687551|P4|Overall Study|Ongoing treatment with emicizumab|7
5415366|NCT02622321|18687552|P3|Overall Study|Ongoing treatment with emicizumab|49
5415367|NCT02622321|18687553|P2|Overall Study|Ongoing treatment with emicizumab|13
5415368|NCT02622321|18687554|P1|Overall Study|Ongoing treatment with emicizumab|31
5415369|NCT02622321|18687551|P4|Overall Study|Ongoing in safety follow-up|0
5415370|NCT02622321|18687552|P3|Overall Study|Ongoing in safety follow-up|0
5415371|NCT02622321|18687553|P2|Overall Study|Ongoing in safety follow-up|0
5415372|NCT02622321|18687554|P1|Overall Study|Ongoing in safety follow-up|3
5415373|NCT02622321|18687551|P4|Overall Study|Ongoing treatment with no emicizumab|0
5415374|NCT02622321|18687552|P3|Overall Study|Ongoing treatment with no emicizumab|0
5415375|NCT02622321|18687553|P2|Overall Study|Ongoing treatment with no emicizumab|5
5415376|NCT02622321|18687554|P1|Overall Study|Ongoing treatment with no emicizumab|0
5415377|NCT02622113|18687625|P2|Overall Study|Stopping Criteria|3
5415378|NCT02622113|18687626|P1|Overall Study|Stopping Criteria|1
5415379|NCT02622113|18687625|P2|Overall Study|Withdrawal by Subject|2
5415380|NCT02622113|18687626|P1|Overall Study|Withdrawal by Subject|0
5415381|NCT02622113|18687625|P2|Overall Study|Physician Decision|1
5415382|NCT02622113|18687626|P1|Overall Study|Physician Decision|0
5415383|NCT02622113|18687625|P2|Overall Study|Adverse Event|4
5415384|NCT02622113|18687626|P1|Overall Study|Adverse Event|4
5415385|NCT02622074|18687644|P6|Overall Study|Withdrawal by Subject|0
5415386|NCT02622074|18687645|P5|Overall Study|Withdrawal by Subject|0
5415387|NCT02622074|18687646|P4|Overall Study|Withdrawal by Subject|0
5415388|NCT02622074|18687647|P3|Overall Study|Withdrawal by Subject|0
5415389|NCT02622074|18687648|P2|Overall Study|Withdrawal by Subject|1
5415390|NCT02622074|18687649|P1|Overall Study|Withdrawal by Subject|0
5415391|NCT02622074|18687644|P6|Overall Study|Death|0
5415392|NCT02622074|18687645|P5|Overall Study|Death|1
5415393|NCT02622074|18687646|P4|Overall Study|Death|1
5415394|NCT02622074|18687647|P3|Overall Study|Death|0
5415395|NCT02622074|18687648|P2|Overall Study|Death|0
5415396|NCT02622074|18687649|P1|Overall Study|Death|4
5415397|NCT02621931|18687753|P3|Overall Study|Other|3
5415398|NCT02621931|18687754|P2|Overall Study|Other|1
5415399|NCT02621931|18687755|P1|Overall Study|Other|1
5415400|NCT02621931|18687753|P3|Overall Study|Lack of Efficacy|1
5415401|NCT02621931|18687754|P2|Overall Study|Lack of Efficacy|0
5415402|NCT02621931|18687755|P1|Overall Study|Lack of Efficacy|0
5415403|NCT02621931|18687753|P3|Overall Study|Lost to Follow-up|10
5415404|NCT02621931|18687754|P2|Overall Study|Lost to Follow-up|7
5415405|NCT02621931|18687755|P1|Overall Study|Lost to Follow-up|8
5415406|NCT02621931|18687753|P3|Overall Study|Noncompliance to study procedures|2
5415407|NCT02621931|18687754|P2|Overall Study|Noncompliance to study procedures|1
5415408|NCT02621931|18687755|P1|Overall Study|Noncompliance to study procedures|0
5415409|NCT02621931|18687753|P3|Overall Study|Pregnancy|0
5415410|NCT02621931|18687754|P2|Overall Study|Pregnancy|0
5415411|NCT02621931|18687755|P1|Overall Study|Pregnancy|2
5415412|NCT02621931|18687753|P3|Overall Study|Protocol Violation|2
5415413|NCT02621931|18687754|P2|Overall Study|Protocol Violation|2
5415414|NCT02621931|18687755|P1|Overall Study|Protocol Violation|2
5415415|NCT02621931|18687753|P3|Overall Study|Withdrawal by Subject|11
5415416|NCT02621931|18687754|P2|Overall Study|Withdrawal by Subject|10
5415417|NCT02621931|18687755|P1|Overall Study|Withdrawal by Subject|12
5415418|NCT02621931|18687753|P3|Overall Study|Adverse Event|7
5415419|NCT02621931|18687754|P2|Overall Study|Adverse Event|5
5415420|NCT02621931|18687755|P1|Overall Study|Adverse Event|8
5415421|NCT02621931|18687753|P3|Overall Study|Death|0
5415422|NCT02621931|18687754|P2|Overall Study|Death|1
5415423|NCT02621931|18687755|P1|Overall Study|Death|0
5415424|NCT02621606|18687837|P3|Overall Study|Withdrawal by Subject|0
5415425|NCT02621606|18687838|P2|Overall Study|Withdrawal by Subject|1
5415426|NCT02621606|18687839|P1|Overall Study|Withdrawal by Subject|0
5415427|NCT02621424|18687867|P2|Overall Study|Withdrawal by Subject|2
5415428|NCT02621424|18687868|P1|Overall Study|Withdrawal by Subject|1
5415429|NCT02621073|18687876|P2|Overall Study|Physician Decision|2
5415430|NCT02621073|18687877|P1|Overall Study|Physician Decision|3
5415431|NCT02621073|18687876|P2|Overall Study|Lost to Follow-up|1
5415432|NCT02621073|18687877|P1|Overall Study|Lost to Follow-up|0
5415433|NCT02621047|18687939|P3|Overall Study|Adverse Event|1
5415434|NCT02621047|18687940|P2|Overall Study|Adverse Event|0
5415435|NCT02621047|18687941|P1|Overall Study|Adverse Event|0
5415436|NCT02621034|18688057|P3|Overall Study|Lost to Follow-up|5
5415437|NCT02621034|18688058|P2|Overall Study|Lost to Follow-up|2
5415438|NCT02621034|18688059|P1|Overall Study|Lost to Follow-up|3
5415439|NCT02620787|18688093|P2|Overall Study|Eligibility Criteria Not Met|0
5415440|NCT02620787|18688094|P1|Overall Study|Eligibility Criteria Not Met|1
5415441|NCT02620787|18688093|P2|Overall Study|Adverse Event|0
5415442|NCT02620787|18688094|P1|Overall Study|Adverse Event|1
5415443|NCT02620384|18688136|P2|Overall Study|Drug shortage prevented 2nd dose|1
5415444|NCT02620384|18688137|P1|Overall Study|Drug shortage prevented 2nd dose|0
5415445|NCT02620384|18688136|P2|Overall Study|Discharged prior to 2nd dose|5
5415446|NCT02620384|18688137|P1|Overall Study|Discharged prior to 2nd dose|2
5415447|NCT02620384|18688136|P2|Overall Study|Adverse Event|1
5415448|NCT02620384|18688137|P1|Overall Study|Adverse Event|2
5415449|NCT02620020|18688169|P4|Overall Study|Death|0
5415450|NCT02620020|18688170|P3|Overall Study|Death|0
5415451|NCT02620020|18688171|P2|Overall Study|Death|1
5415452|NCT02620020|18688172|P1|Overall Study|Death|0
5415453|NCT02620020|18688169|P4|Overall Study|Withdrawal by Subject|12
5415454|NCT02620020|18688170|P3|Overall Study|Withdrawal by Subject|17
5415455|NCT02620020|18688171|P2|Overall Study|Withdrawal by Subject|16
5415456|NCT02620020|18688172|P1|Overall Study|Withdrawal by Subject|20
5415457|NCT02620020|18688169|P4|Overall Study|Protocol Violation|1
5415458|NCT02620020|18688170|P3|Overall Study|Protocol Violation|1
5415459|NCT02620020|18688171|P2|Overall Study|Protocol Violation|2
5415460|NCT02620020|18688172|P1|Overall Study|Protocol Violation|5
5415461|NCT02620020|18688169|P4|Overall Study|Physician Decision|4
5415462|NCT02620020|18688170|P3|Overall Study|Physician Decision|3
5415463|NCT02620020|18688171|P2|Overall Study|Physician Decision|4
5415464|NCT02620020|18688172|P1|Overall Study|Physician Decision|7
5415465|NCT02620020|18688169|P4|Overall Study|Lost to Follow-up|4
5415466|NCT02620020|18688170|P3|Overall Study|Lost to Follow-up|1
5415467|NCT02620020|18688171|P2|Overall Study|Lost to Follow-up|8
5415468|NCT02620020|18688172|P1|Overall Study|Lost to Follow-up|4
5415469|NCT02620020|18688169|P4|Overall Study|Adverse Event|5
5415470|NCT02620020|18688170|P3|Overall Study|Adverse Event|3
5415471|NCT02620020|18688171|P2|Overall Study|Adverse Event|4
5415472|NCT02620020|18688172|P1|Overall Study|Adverse Event|8
5415473|NCT02619812|18688198|P4|Overall Study|Withdrawal by Subject|2
5415474|NCT02619812|18688199|P3|Overall Study|Withdrawal by Subject|1
5415475|NCT02619812|18688200|P2|Overall Study|Withdrawal by Subject|0
5415476|NCT02619812|18688201|P1|Overall Study|Withdrawal by Subject|0
5415477|NCT02619617|18688234|P2|Period 2 SOM230 - 2nd Attack|Physician Decision|3
5415478|NCT02619617|18688235|P1|Period 2 SOM230 - 2nd Attack|Physician Decision|0
5415479|NCT02619617|18688234|P2|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
5415480|NCT02619617|18688235|P1|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
5415481|NCT02619175|18688331|P2|Overall Study|foot pain|0
5415482|NCT02619175|18688332|P1|Overall Study|foot pain|1
5415483|NCT02619175|18688331|P2|Overall Study|Withdrawal by Subject|0
5415484|NCT02619175|18688332|P1|Overall Study|Withdrawal by Subject|1
5415485|NCT02618928|18688346|P1|Overall Study|Treatment Never Started|7
5415486|NCT02618928|18688346|P1|Overall Study|Missing|6
5415487|NCT02618928|18688346|P1|Overall Study|Other|11
5415488|NCT02618928|18688346|P1|Overall Study|Death|3
5415489|NCT02618928|18688346|P1|Overall Study|Withdrawal by Subject|2
5415490|NCT02618928|18688346|P1|Overall Study|Insufficient Virological Response|1
5415491|NCT02618928|18688346|P1|Overall Study|Failure to Return|28
5415492|NCT02618759|18688441|P2|Overall Study|Other Reasons|4
5415493|NCT02618759|18688442|P1|Overall Study|Other Reasons|1
5415494|NCT02618759|18688441|P2|Overall Study|Withdrawal by Subject|0
5415495|NCT02618759|18688442|P1|Overall Study|Withdrawal by Subject|1
5415496|NCT02618759|18688441|P2|Overall Study|Lost to Follow-up|1
5415497|NCT02618759|18688442|P1|Overall Study|Lost to Follow-up|0
5415498|NCT02617628|18688630|P2|Overall Study|Withdr, Transfers-other prisons, dropout|61
5415499|NCT02617628|18688631|P1|Overall Study|Withdr, Transfers-other prisons, dropout|62
5415500|NCT02616900|18688639|P1|Overall Study|Incomplete data|6
5415501|NCT02616900|18688639|P1|Overall Study|Withdrawal by Subject|3
5415502|NCT02616900|18688639|P1|Overall Study|Protocol Violation|5
5415503|NCT02616900|18688639|P1|Overall Study|Lost to Follow-up|2
5415504|NCT02616900|18688639|P1|Overall Study|Lack of Efficacy|7
5415505|NCT02616783|18688647|P2|Overall Study|Withdrew Consent|1
5415506|NCT02616783|18688648|P1|Overall Study|Withdrew Consent|1
5415507|NCT02616783|18688647|P2|Overall Study|Protocol Violation|1
5415508|NCT02616783|18688648|P1|Overall Study|Protocol Violation|1
5415509|NCT02616783|18688647|P2|Overall Study|Non-Compliance with Study Drug|0
5415510|NCT02616783|18688648|P1|Overall Study|Non-Compliance with Study Drug|1
5415511|NCT02616783|18688647|P2|Overall Study|Death|0
5415512|NCT02616783|18688648|P1|Overall Study|Death|1
5415513|NCT02616783|18688647|P2|Overall Study|Adverse Event|0
5415514|NCT02616783|18688648|P1|Overall Study|Adverse Event|1
5415515|NCT02616783|18688647|P2|Overall Study|Randomized but Not Treated|0
5415516|NCT02616783|18688648|P1|Overall Study|Randomized but Not Treated|1
5415517|NCT02616614|18688671|P3|Overall Study|Other|1
5415518|NCT02616614|18688672|P2|Overall Study|Other|2
5415519|NCT02616614|18688673|P1|Overall Study|Other|1
5415520|NCT02616614|18688671|P3|Overall Study|Pregnancy|1
5415521|NCT02616614|18688672|P2|Overall Study|Pregnancy|0
5415522|NCT02616614|18688673|P1|Overall Study|Pregnancy|2
5415523|NCT02616614|18688671|P3|Overall Study|Lost to Follow-up|13
5415524|NCT02616614|18688672|P2|Overall Study|Lost to Follow-up|28
5415525|NCT02616614|18688673|P1|Overall Study|Lost to Follow-up|31
5415526|NCT02616614|18688671|P3|Overall Study|More than 3 applications missed|1
5415527|NCT02616614|18688672|P2|Overall Study|More than 3 applications missed|8
5415528|NCT02616614|18688673|P1|Overall Study|More than 3 applications missed|6
5415529|NCT02616614|18688671|P3|Overall Study|Prohibited Medication|5
5415530|NCT02616614|18688672|P2|Overall Study|Prohibited Medication|9
5415531|NCT02616614|18688673|P1|Overall Study|Prohibited Medication|12
5415532|NCT02616614|18688671|P3|Overall Study|Protocol Violation|1
5415533|NCT02616614|18688672|P2|Overall Study|Protocol Violation|3
5415534|NCT02616614|18688673|P1|Overall Study|Protocol Violation|0
5415535|NCT02616614|18688671|P3|Overall Study|Adverse Event|1
5415536|NCT02616614|18688672|P2|Overall Study|Adverse Event|4
5415537|NCT02616614|18688673|P1|Overall Study|Adverse Event|1
5415538|NCT02616614|18688671|P3|Overall Study|Physician Decision|0
5415539|NCT02616614|18688672|P2|Overall Study|Physician Decision|1
5415540|NCT02616614|18688673|P1|Overall Study|Physician Decision|2
5415541|NCT02616614|18688671|P3|Overall Study|Withdrawal by Subject|6
5415542|NCT02616614|18688672|P2|Overall Study|Withdrawal by Subject|5
5415543|NCT02616614|18688673|P1|Overall Study|Withdrawal by Subject|10
5415544|NCT02616601|18688690|P3|Overall Study|Non-Compliance with Test Article|1
5415545|NCT02616601|18688691|P2|Overall Study|Non-Compliance with Test Article|0
5415546|NCT02616601|18688692|P1|Overall Study|Non-Compliance with Test Article|1
5415547|NCT02616601|18688690|P3|Overall Study|Lost to Follow-up|1
5415548|NCT02616601|18688691|P2|Overall Study|Lost to Follow-up|0
5415549|NCT02616601|18688692|P1|Overall Study|Lost to Follow-up|1
5415550|NCT02616601|18688690|P3|Overall Study|Death|0
5415551|NCT02616601|18688691|P2|Overall Study|Death|0
5415552|NCT02616601|18688692|P1|Overall Study|Death|1
5415553|NCT02616601|18688690|P3|Overall Study|Adverse Event|2
5415554|NCT02616601|18688691|P2|Overall Study|Adverse Event|0
5415555|NCT02616601|18688692|P1|Overall Study|Adverse Event|2
5415556|NCT02616601|18688690|P3|Overall Study|Withdrawal by Subject|3
5415557|NCT02616601|18688691|P2|Overall Study|Withdrawal by Subject|4
5415558|NCT02616601|18688692|P1|Overall Study|Withdrawal by Subject|4
5415559|NCT02616380|18688719|P1|Overall Study|Other|2
5415560|NCT02616380|18688719|P1|Overall Study|Lost to Follow-up|1
5415561|NCT02616146|18688743|P2|Overall Study|Physician Decision|1
5415562|NCT02616146|18688744|P1|Overall Study|Physician Decision|2
5415563|NCT02616146|18688743|P2|Overall Study|Withdrawal by Subject|24
5415564|NCT02616146|18688744|P1|Overall Study|Withdrawal by Subject|30
5415565|NCT02616146|18688743|P2|Overall Study|Participant moved|3
5415566|NCT02616146|18688744|P1|Overall Study|Participant moved|4
5415567|NCT02616146|18688743|P2|Overall Study|Study terminated by sponsor|432
5415568|NCT02616146|18688744|P1|Overall Study|Study terminated by sponsor|1372
5415569|NCT02616146|18688743|P2|Overall Study|Protocol Violation|3
5415570|NCT02616146|18688744|P1|Overall Study|Protocol Violation|6
5415571|NCT02616146|18688743|P2|Overall Study|Pregnancy wish|0
5415572|NCT02616146|18688744|P1|Overall Study|Pregnancy wish|3
5415573|NCT02616146|18688743|P2|Overall Study|Pregnancy|2
5415574|NCT02616146|18688744|P1|Overall Study|Pregnancy|2
5415575|NCT02616146|18688743|P2|Overall Study|Non-compliance with study drug|2
5415576|NCT02616146|18688744|P1|Overall Study|Non-compliance with study drug|4
5415577|NCT02616146|18688743|P2|Overall Study|Non-compliance with study protocol|0
5415578|NCT02616146|18688744|P1|Overall Study|Non-compliance with study protocol|2
5415579|NCT02616146|18688743|P2|Overall Study|Lost to Follow-up|13
5415580|NCT02616146|18688744|P1|Overall Study|Lost to Follow-up|23
5415581|NCT02616146|18688743|P2|Overall Study|Adverse Event|24
5415582|NCT02616146|18688744|P1|Overall Study|Adverse Event|64
5415583|NCT02616029|18688760|P2|Overall Study|Enrolled and Never Treated|1
5415584|NCT02616029|18688761|P1|Overall Study|Enrolled and Never Treated|1
5415585|NCT02616029|18688760|P2|Overall Study|Withdrew Consent|0
5415586|NCT02616029|18688761|P1|Overall Study|Withdrew Consent|1
5415587|NCT02616029|18688760|P2|Overall Study|Protocol Violation|0
5415588|NCT02616029|18688761|P1|Overall Study|Protocol Violation|1
5415589|NCT02616029|18688760|P2|Overall Study|Death|1
5415590|NCT02616029|18688761|P1|Overall Study|Death|0
5415591|NCT02616029|18688760|P2|Overall Study|Adverse Event|0
5415592|NCT02616029|18688761|P1|Overall Study|Adverse Event|1
5415593|NCT02615990|18688832|P2|Overall Study|study terminated|1
5415594|NCT02615990|18688833|P1|Overall Study|study terminated|1
5415595|NCT02615509|18688930|P1|Overall Study|Withdrawal by Subject|8
5415596|NCT02615509|18688930|P1|Overall Study|Death|4
5415597|NCT02615509|18688930|P1|Overall Study|Lost to Follow-up|134
5415598|NCT02615470|18688940|P2|Overall Study|Lost to Follow-up|32
5415599|NCT02615470|18688941|P1|Overall Study|Lost to Follow-up|21
5415600|NCT02615249|18688951|P1|Overall Study|Withdrawal by Subject|1
5415601|NCT02615145|18688992|P4|Overall Study|Other, Not Specified|0
5415602|NCT02615145|18688993|P3|Overall Study|Other, Not Specified|0
5415603|NCT02615145|18688994|P2|Overall Study|Other, Not Specified|2
5415604|NCT02615145|18688995|P1|Overall Study|Other, Not Specified|5
5415605|NCT02615145|18688992|P4|Overall Study|Death|0
5415606|NCT02615145|18688993|P3|Overall Study|Death|0
5415607|NCT02615145|18688994|P2|Overall Study|Death|3
5415608|NCT02615145|18688995|P1|Overall Study|Death|2
5415609|NCT02615145|18688992|P4|Overall Study|Failure to Return|0
5415610|NCT02615145|18688993|P3|Overall Study|Failure to Return|7
5415611|NCT02615145|18688994|P2|Overall Study|Failure to Return|10
5415612|NCT02615145|18688995|P1|Overall Study|Failure to Return|20
5415613|NCT02615145|18688992|P4|Overall Study|Did Not Start Treatment|1
5415614|NCT02615145|18688993|P3|Overall Study|Did Not Start Treatment|1
5415615|NCT02615145|18688994|P2|Overall Study|Did Not Start Treatment|0
5415616|NCT02615145|18688995|P1|Overall Study|Did Not Start Treatment|0
5415617|NCT02614898|18689082|P2|Overall Study|Missing|1
5415618|NCT02614898|18689083|P1|Overall Study|Missing|0
5415619|NCT02614898|18689082|P2|Overall Study|Other-Additional Information Unavailable|11
5415620|NCT02614898|18689083|P1|Overall Study|Other-Additional Information Unavailable|0
5415621|NCT02614898|18689082|P2|Overall Study|Withdrawal by Parent/Guardian|1
5415622|NCT02614898|18689083|P1|Overall Study|Withdrawal by Parent/Guardian|1
5415623|NCT02614898|18689082|P2|Overall Study|Withdrawal by Subject|2
5415624|NCT02614898|18689083|P1|Overall Study|Withdrawal by Subject|0
5415625|NCT02614898|18689082|P2|Overall Study|Study Terminated by Sponsor|0
5415626|NCT02614898|18689083|P1|Overall Study|Study Terminated by Sponsor|3
5415627|NCT02614898|18689082|P2|Overall Study|Physician Decision|8
5415628|NCT02614898|18689083|P1|Overall Study|Physician Decision|1
5415629|NCT02614898|18689082|P2|Overall Study|Lost to Follow-up|2
5415630|NCT02614898|18689083|P1|Overall Study|Lost to Follow-up|0
5415631|NCT02614898|18689082|P2|Overall Study|Participated until study termination|26
5415632|NCT02614898|18689083|P1|Overall Study|Participated until study termination|10
5415633|NCT02614794|18689095|P2|Overall Study|Physician Decision|1
5415634|NCT02614794|18689096|P1|Overall Study|Physician Decision|0
5415635|NCT02614794|18689095|P2|Overall Study|Lost to Follow-up|0
5415636|NCT02614794|18689096|P1|Overall Study|Lost to Follow-up|2
5415637|NCT02614794|18689095|P2|Overall Study|Withdrawal by Subject|5
5415638|NCT02614794|18689096|P1|Overall Study|Withdrawal by Subject|16
5415639|NCT02614794|18689095|P2|Overall Study|Death|84
5415640|NCT02614794|18689096|P1|Overall Study|Death|126
5415641|NCT02614794|18689095|P2|Overall Study|In long term follow up|85
5415642|NCT02614794|18689096|P1|Overall Study|In long term follow up|148
5415643|NCT02614794|18689095|P2|Overall Study|On treatment|27
5415644|NCT02614794|18689096|P1|Overall Study|On treatment|118
5415645|NCT02614729|18689130|P2|Overall Study|Withdrawal by Subject|0
5415646|NCT02614729|18689131|P1|Overall Study|Withdrawal by Subject|1
5415647|NCT02614703|18689151|P2|Overall Study|Withdrawal by Subject|1
5415648|NCT02614703|18689152|P1|Overall Study|Withdrawal by Subject|7
5415649|NCT02614560|18689196|P2|Overall Study|Death|2
5415650|NCT02614560|18689197|P1|Overall Study|Death|6
5415651|NCT02614287|18689245|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|3
5415652|NCT02614287|18689246|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|6
5415653|NCT02614287|18689245|P2|Post Treatment Follow-up Phase|Lost to Follow-up|2
5415654|NCT02614287|18689246|P1|Post Treatment Follow-up Phase|Lost to Follow-up|2
5415655|NCT02614287|18689245|P2|Post Treatment Follow-up Phase|Adverse Event|0
5415656|NCT02614287|18689246|P1|Post Treatment Follow-up Phase|Adverse Event|1
5415657|NCT02614287|18689245|P2|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
5415658|NCT02614287|18689246|P1|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
5415659|NCT02614287|18689245|P2|Open Label (OL) Treatment Phase|Physician Decision|0
5415660|NCT02614287|18689246|P1|Open Label (OL) Treatment Phase|Physician Decision|1
5415661|NCT02614287|18689245|P2|Open Label (OL) Treatment Phase|Lost to Follow-up|4
5415662|NCT02614287|18689246|P1|Open Label (OL) Treatment Phase|Lost to Follow-up|7
5415663|NCT02614287|18689245|P2|Open Label (OL) Treatment Phase|Lack of Efficacy|5
5415664|NCT02614287|18689246|P1|Open Label (OL) Treatment Phase|Lack of Efficacy|13
5415665|NCT02614287|18689245|P2|Open Label (OL) Treatment Phase|Adverse Event|6
5415666|NCT02614287|18689246|P1|Open Label (OL) Treatment Phase|Adverse Event|7
5415667|NCT02614261|18689292|P3|Overall Study|Withdrawal by Subject|7
5415668|NCT02614261|18689293|P2|Overall Study|Withdrawal by Subject|4
5415669|NCT02614261|18689294|P1|Overall Study|Withdrawal by Subject|19
5415670|NCT02614261|18689292|P3|Overall Study|Protocol Violation|0
5415671|NCT02614261|18689293|P2|Overall Study|Protocol Violation|1
5415672|NCT02614261|18689294|P1|Overall Study|Protocol Violation|6
5415673|NCT02614261|18689292|P3|Overall Study|Pregnancy|0
5415674|NCT02614261|18689293|P2|Overall Study|Pregnancy|2
5415675|NCT02614261|18689294|P1|Overall Study|Pregnancy|2
5415676|NCT02614261|18689292|P3|Overall Study|Physician Decision|1
5415677|NCT02614261|18689293|P2|Overall Study|Physician Decision|1
5415678|NCT02614261|18689294|P1|Overall Study|Physician Decision|2
5415679|NCT02614261|18689292|P3|Overall Study|Lost to Follow-up|1
5415680|NCT02614261|18689293|P2|Overall Study|Lost to Follow-up|4
5415681|NCT02614261|18689294|P1|Overall Study|Lost to Follow-up|10
5415682|NCT02614261|18689292|P3|Overall Study|Lack of Efficacy|0
5415683|NCT02614261|18689293|P2|Overall Study|Lack of Efficacy|0
5415684|NCT02614261|18689294|P1|Overall Study|Lack of Efficacy|4
5415685|NCT02614261|18689292|P3|Overall Study|Adverse Event|2
5415686|NCT02614261|18689293|P2|Overall Study|Adverse Event|3
5415687|NCT02614261|18689294|P1|Overall Study|Adverse Event|6
5415688|NCT02614196|18689360|P6|Post Treatment Follow-up Phase|Withdrawal by Subject|0
5415689|NCT02614196|18689361|P5|Post Treatment Follow-up Phase|Withdrawal by Subject|0
5415690|NCT02614196|18689362|P4|Post Treatment Follow-up Phase|Withdrawal by Subject|1
5415691|NCT02614196|18689363|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
5415692|NCT02614196|18689364|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
5415693|NCT02614196|18689365|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|10
5415694|NCT02614196|18689360|P6|Post Treatment Follow-up Phase|Protocol Violation|0
5415695|NCT02614196|18689361|P5|Post Treatment Follow-up Phase|Protocol Violation|1
5415696|NCT02614196|18689362|P4|Post Treatment Follow-up Phase|Protocol Violation|0
5415697|NCT02614196|18689363|P3|Post Treatment Follow-up Phase|Protocol Violation|0
5415698|NCT02614196|18689364|P2|Post Treatment Follow-up Phase|Protocol Violation|1
5415699|NCT02614196|18689365|P1|Post Treatment Follow-up Phase|Protocol Violation|0
5415700|NCT02614196|18689360|P6|Post Treatment Follow-up Phase|Pregnancy|0
5415701|NCT02614196|18689361|P5|Post Treatment Follow-up Phase|Pregnancy|0
5415702|NCT02614196|18689362|P4|Post Treatment Follow-up Phase|Pregnancy|0
5415703|NCT02614196|18689363|P3|Post Treatment Follow-up Phase|Pregnancy|0
5415704|NCT02614196|18689364|P2|Post Treatment Follow-up Phase|Pregnancy|0
5415705|NCT02614196|18689365|P1|Post Treatment Follow-up Phase|Pregnancy|2
5415706|NCT02614196|18689360|P6|Post Treatment Follow-up Phase|Lost to Follow-up|0
5415707|NCT02614196|18689361|P5|Post Treatment Follow-up Phase|Lost to Follow-up|1
5415708|NCT02614196|18689362|P4|Post Treatment Follow-up Phase|Lost to Follow-up|0
5415709|NCT02614196|18689363|P3|Post Treatment Follow-up Phase|Lost to Follow-up|3
5415710|NCT02614196|18689364|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
5415711|NCT02614196|18689365|P1|Post Treatment Follow-up Phase|Lost to Follow-up|8
5415712|NCT02614196|18689360|P6|Double Blind Treatment Phase|Did not receive study drug|0
5415713|NCT02614196|18689361|P5|Double Blind Treatment Phase|Did not receive study drug|0
5415714|NCT02614196|18689362|P4|Double Blind Treatment Phase|Did not receive study drug|0
5415715|NCT02614196|18689363|P3|Double Blind Treatment Phase|Did not receive study drug|3
5415716|NCT02614196|18689364|P2|Double Blind Treatment Phase|Did not receive study drug|2
5415717|NCT02614196|18689365|P1|Double Blind Treatment Phase|Did not receive study drug|2
5415718|NCT02614196|18689360|P6|Double Blind Treatment Phase|Withdrawal by Subject|0
5415719|NCT02614196|18689361|P5|Double Blind Treatment Phase|Withdrawal by Subject|0
5415720|NCT02614196|18689362|P4|Double Blind Treatment Phase|Withdrawal by Subject|4
5415721|NCT02614196|18689363|P3|Double Blind Treatment Phase|Withdrawal by Subject|14
5415722|NCT02614196|18689364|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
5415723|NCT02614196|18689365|P1|Double Blind Treatment Phase|Withdrawal by Subject|39
5415724|NCT02614196|18689360|P6|Double Blind Treatment Phase|Terminated by sponsor|0
5415725|NCT02614196|18689361|P5|Double Blind Treatment Phase|Terminated by sponsor|0
5415726|NCT02614196|18689362|P4|Double Blind Treatment Phase|Terminated by sponsor|0
5415727|NCT02614196|18689363|P3|Double Blind Treatment Phase|Terminated by sponsor|0
5415728|NCT02614196|18689364|P2|Double Blind Treatment Phase|Terminated by sponsor|0
5415729|NCT02614196|18689365|P1|Double Blind Treatment Phase|Terminated by sponsor|1
5415730|NCT02614196|18689360|P6|Double Blind Treatment Phase|Protocol Violation|0
5415731|NCT02614196|18689361|P5|Double Blind Treatment Phase|Protocol Violation|1
5415732|NCT02614196|18689362|P4|Double Blind Treatment Phase|Protocol Violation|0
5415733|NCT02614196|18689363|P3|Double Blind Treatment Phase|Protocol Violation|1
5415734|NCT02614196|18689364|P2|Double Blind Treatment Phase|Protocol Violation|2
5415735|NCT02614196|18689365|P1|Double Blind Treatment Phase|Protocol Violation|5
5415736|NCT02614196|18689360|P6|Double Blind Treatment Phase|Pregnancy|0
5415737|NCT02614196|18689361|P5|Double Blind Treatment Phase|Pregnancy|0
5415738|NCT02614196|18689362|P4|Double Blind Treatment Phase|Pregnancy|0
5415739|NCT02614196|18689363|P3|Double Blind Treatment Phase|Pregnancy|0
5415740|NCT02614196|18689364|P2|Double Blind Treatment Phase|Pregnancy|2
5415741|NCT02614196|18689365|P1|Double Blind Treatment Phase|Pregnancy|1
5415742|NCT02614196|18689360|P6|Double Blind Treatment Phase|Physician Decision|0
5415743|NCT02614196|18689361|P5|Double Blind Treatment Phase|Physician Decision|0
5415744|NCT02614196|18689362|P4|Double Blind Treatment Phase|Physician Decision|0
5415745|NCT02614196|18689363|P3|Double Blind Treatment Phase|Physician Decision|2
5415746|NCT02614196|18689364|P2|Double Blind Treatment Phase|Physician Decision|0
5415747|NCT02614196|18689365|P1|Double Blind Treatment Phase|Physician Decision|4
5415748|NCT02614196|18689360|P6|Double Blind Treatment Phase|Lost to Follow-up|0
5415749|NCT02614196|18689361|P5|Double Blind Treatment Phase|Lost to Follow-up|0
5415750|NCT02614196|18689362|P4|Double Blind Treatment Phase|Lost to Follow-up|0
5415751|NCT02614196|18689363|P3|Double Blind Treatment Phase|Lost to Follow-up|1
5415752|NCT02614196|18689364|P2|Double Blind Treatment Phase|Lost to Follow-up|7
5415753|NCT02614196|18689365|P1|Double Blind Treatment Phase|Lost to Follow-up|10
5415754|NCT02614196|18689360|P6|Double Blind Treatment Phase|Lack of Efficacy|0
5415755|NCT02614196|18689361|P5|Double Blind Treatment Phase|Lack of Efficacy|0
5415756|NCT02614196|18689362|P4|Double Blind Treatment Phase|Lack of Efficacy|0
5415757|NCT02614196|18689363|P3|Double Blind Treatment Phase|Lack of Efficacy|1
5415758|NCT02614196|18689364|P2|Double Blind Treatment Phase|Lack of Efficacy|1
5415759|NCT02614196|18689365|P1|Double Blind Treatment Phase|Lack of Efficacy|6
5415760|NCT02614196|18689360|P6|Double Blind Treatment Phase|Adverse Event|0
5415761|NCT02614196|18689361|P5|Double Blind Treatment Phase|Adverse Event|0
5415762|NCT02614196|18689362|P4|Double Blind Treatment Phase|Adverse Event|0
5415763|NCT02614196|18689363|P3|Double Blind Treatment Phase|Adverse Event|9
5415764|NCT02614196|18689364|P2|Double Blind Treatment Phase|Adverse Event|5
5415765|NCT02614196|18689365|P1|Double Blind Treatment Phase|Adverse Event|8
5415766|NCT02614183|18689411|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
5415767|NCT02614183|18689412|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
5415768|NCT02614183|18689413|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
5415769|NCT02614183|18689411|P3|Post Treatment Follow-up Phase|Protocol Violation|0
5415770|NCT02614183|18689412|P2|Post Treatment Follow-up Phase|Protocol Violation|0
5415771|NCT02614183|18689413|P1|Post Treatment Follow-up Phase|Protocol Violation|1
5415772|NCT02614183|18689411|P3|Post Treatment Follow-up Phase|Physician Decision|2
5415773|NCT02614183|18689412|P2|Post Treatment Follow-up Phase|Physician Decision|1
5415774|NCT02614183|18689413|P1|Post Treatment Follow-up Phase|Physician Decision|5
5415775|NCT02614183|18689411|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
5415776|NCT02614183|18689412|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
5415777|NCT02614183|18689413|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
5415778|NCT02614183|18689411|P3|Double Blind Treatment Phase|Did not receive study drug|2
5415779|NCT02614183|18689412|P2|Double Blind Treatment Phase|Did not receive study drug|1
5415780|NCT02614183|18689413|P1|Double Blind Treatment Phase|Did not receive study drug|1
5415781|NCT02614183|18689411|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
5415782|NCT02614183|18689412|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
5415783|NCT02614183|18689413|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
5415784|NCT02614183|18689411|P3|Double Blind Treatment Phase|Protocol Violation|2
5415785|NCT02614183|18689412|P2|Double Blind Treatment Phase|Protocol Violation|2
5415786|NCT02614183|18689413|P1|Double Blind Treatment Phase|Protocol Violation|2
5415787|NCT02614183|18689411|P3|Double Blind Treatment Phase|Pregnancy|3
5415788|NCT02614183|18689412|P2|Double Blind Treatment Phase|Pregnancy|1
5415789|NCT02614183|18689413|P1|Double Blind Treatment Phase|Pregnancy|2
5415790|NCT02614183|18689411|P3|Double Blind Treatment Phase|Physician Decision|2
5415791|NCT02614183|18689412|P2|Double Blind Treatment Phase|Physician Decision|3
5415792|NCT02614183|18689413|P1|Double Blind Treatment Phase|Physician Decision|7
5415793|NCT02614183|18689411|P3|Double Blind Treatment Phase|Lost to Follow-up|5
5415794|NCT02614183|18689412|P2|Double Blind Treatment Phase|Lost to Follow-up|9
5415795|NCT02614183|18689413|P1|Double Blind Treatment Phase|Lost to Follow-up|18
5415796|NCT02614183|18689411|P3|Double Blind Treatment Phase|Lack of Efficacy|2
5415797|NCT02614183|18689412|P2|Double Blind Treatment Phase|Lack of Efficacy|1
5415798|NCT02614183|18689413|P1|Double Blind Treatment Phase|Lack of Efficacy|10
5415799|NCT02614183|18689411|P3|Double Blind Treatment Phase|Adverse Event|7
5415800|NCT02614183|18689412|P2|Double Blind Treatment Phase|Adverse Event|9
5415801|NCT02614183|18689413|P1|Double Blind Treatment Phase|Adverse Event|10
5415802|NCT02614131|18689457|P7|Overall Study|Adverse Event|1
5415803|NCT02614131|18689458|P6|Overall Study|Adverse Event|0
5415804|NCT02614131|18689459|P5|Overall Study|Adverse Event|0
5415805|NCT02614131|18689460|P4|Overall Study|Adverse Event|0
5415806|NCT02614131|18689461|P3|Overall Study|Adverse Event|0
5415807|NCT02614131|18689462|P2|Overall Study|Adverse Event|0
5415808|NCT02614131|18689463|P1|Overall Study|Adverse Event|0
5415809|NCT02614131|18689457|P7|Overall Study|Withdrawal by Subject|0
5415810|NCT02614131|18689458|P6|Overall Study|Withdrawal by Subject|0
5415811|NCT02614131|18689459|P5|Overall Study|Withdrawal by Subject|0
5415812|NCT02614131|18689460|P4|Overall Study|Withdrawal by Subject|0
5415813|NCT02614131|18689461|P3|Overall Study|Withdrawal by Subject|0
5415814|NCT02614131|18689462|P2|Overall Study|Withdrawal by Subject|0
5415815|NCT02614131|18689463|P1|Overall Study|Withdrawal by Subject|1
5415816|NCT02614079|18689494|P1|Overall Study|Withdrawal by Subject|1
5415817|NCT02613910|18689498|P1|Overall Study|Termination of study|1
5415818|NCT02613871|18689584|P1|Overall Study|Withdrew Consent|1
5415819|NCT02613871|18689584|P1|Overall Study|Death|2
5415820|NCT02613572|18689606|P3|Phase II: Double-Blind Rand Plac Control|Death|0
5415821|NCT02613572|18689607|P2|Phase II: Double-Blind Rand Plac Control|Death|1
5415822|NCT02613572|18689608|P1|Phase II: Double-Blind Rand Plac Control|Death|0
5415823|NCT02613572|18689606|P3|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
5415824|NCT02613572|18689607|P2|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
5415825|NCT02613572|18689608|P1|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
5415826|NCT02613507|18689630|P2|Overall Study|Randomized but not Treated|10
5415827|NCT02613507|18689631|P1|Overall Study|Randomized but not Treated|1
5415828|NCT02613507|18689630|P2|Overall Study|Subject no Longer Meets Study Criteria|0
5415829|NCT02613507|18689631|P1|Overall Study|Subject no Longer Meets Study Criteria|1
5415830|NCT02613507|18689630|P2|Overall Study|Brain Radiotherapy Activity Limited|0
5415831|NCT02613507|18689631|P1|Overall Study|Brain Radiotherapy Activity Limited|1
5415832|NCT02613507|18689630|P2|Overall Study|Maximum Clinical Benefit|10
5415833|NCT02613507|18689631|P1|Overall Study|Maximum Clinical Benefit|4
5415834|NCT02613507|18689630|P2|Overall Study|Lost to Follow-up|0
5415835|NCT02613507|18689631|P1|Overall Study|Lost to Follow-up|1
5415836|NCT02613507|18689630|P2|Overall Study|Participant Withdrew Consent|2
5415837|NCT02613507|18689631|P1|Overall Study|Participant Withdrew Consent|0
5415838|NCT02613507|18689630|P2|Overall Study|Request to Discontinue Study Treatment|17
5415839|NCT02613507|18689631|P1|Overall Study|Request to Discontinue Study Treatment|8
5415840|NCT02613507|18689630|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
5415841|NCT02613507|18689631|P1|Overall Study|Adverse Event Unrelated to Study Drug|17
5415842|NCT02613507|18689630|P2|Overall Study|Death|0
5415843|NCT02613507|18689631|P1|Overall Study|Death|3
5415844|NCT02613507|18689630|P2|Overall Study|Study Drug Toxicity|14
5415845|NCT02613507|18689631|P1|Overall Study|Study Drug Toxicity|15
5415846|NCT02613507|18689630|P2|Overall Study|Disease Progression|109
5415847|NCT02613507|18689631|P1|Overall Study|Disease Progression|237
5415848|NCT02613481|18689647|P1|Overall Study|Withdrawal by Subject|2
5415849|NCT02613481|18689647|P1|Overall Study|Lost to Follow-up|7
5415850|NCT02613403|18689658|P5|Overall Study|Withdrawal by Subject|0
5415851|NCT02613403|18689659|P4|Overall Study|Withdrawal by Subject|0
5415852|NCT02613403|18689660|P3|Overall Study|Withdrawal by Subject|0
5415853|NCT02613403|18689661|P2|Overall Study|Withdrawal by Subject|0
5415854|NCT02613403|18689662|P1|Overall Study|Withdrawal by Subject|2
5415855|NCT02613403|18689658|P5|Overall Study|Lost to Follow-up|0
5415856|NCT02613403|18689659|P4|Overall Study|Lost to Follow-up|0
5415857|NCT02613403|18689660|P3|Overall Study|Lost to Follow-up|0
5415858|NCT02613403|18689661|P2|Overall Study|Lost to Follow-up|1
5415859|NCT02613403|18689662|P1|Overall Study|Lost to Follow-up|0
5415860|NCT02613221|18689714|P1|Overall Study|Enrolled but Not Treated|1
5415861|NCT02613221|18689714|P1|Overall Study|Delayed Treatment|1
5415862|NCT02613221|18689714|P1|Overall Study|Voluntary Discontinuation|1
5415863|NCT02613221|18689714|P1|Overall Study|Adverse Event|2
5415864|NCT02613221|18689714|P1|Overall Study|Lack of efficacy (exacerbation)|50
5415865|NCT02613208|18689726|P1|Overall Study|Death|37
5415866|NCT02613208|18689726|P1|Overall Study|Lost to Follow-up|5
5415867|NCT02613208|18689726|P1|Overall Study|Physician Decision|2
5415868|NCT02613208|18689726|P1|Overall Study|Change of address|2
5415869|NCT02613208|18689726|P1|Overall Study|Withdrawal by Subject|1
5415870|NCT02613182|18689740|P1|Overall Study|Withdrawal by Subject|6
5415871|NCT02613182|18689740|P1|Overall Study|Study Terminated by Sponsor|21
5415872|NCT02613182|18689740|P1|Overall Study|Physician Decision|1
5415873|NCT02613182|18689740|P1|Overall Study|Death|6
5415874|NCT02612909|18689762|P5|Phase 3|Withdrawal by Subject|0
5415875|NCT02612909|18689763|P4|Phase 3|Withdrawal by Subject|1
5415876|NCT02612909|18689764|P3|Phase 3|Withdrawal by Subject|0
5415877|NCT02612909|18689765|P2|Phase 3|Withdrawal by Subject|0
5415878|NCT02612909|18689766|P1|Phase 3|Withdrawal by Subject|0
5415879|NCT02612909|18689762|P5|Phase 2|Pregnancy|0
5415880|NCT02612909|18689763|P4|Phase 2|Pregnancy|0
5415881|NCT02612909|18689764|P3|Phase 2|Pregnancy|1
5415882|NCT02612909|18689765|P2|Phase 2|Pregnancy|0
5415883|NCT02612909|18689766|P1|Phase 2|Pregnancy|0
5415884|NCT02612909|18689762|P5|Phase 2|Withdrawal by Subject|0
5415885|NCT02612909|18689763|P4|Phase 2|Withdrawal by Subject|0
5415886|NCT02612909|18689764|P3|Phase 2|Withdrawal by Subject|0
5415887|NCT02612909|18689765|P2|Phase 2|Withdrawal by Subject|5
5415888|NCT02612909|18689766|P1|Phase 2|Withdrawal by Subject|2
5415889|NCT02612779|18689849|P2|Overall Study|Subsequent therapy|0
5415890|NCT02612779|18689850|P1|Overall Study|Subsequent therapy|3
5415891|NCT02612779|18689849|P2|Overall Study|Principal Investigator decision|0
5415892|NCT02612779|18689850|P1|Overall Study|Principal Investigator decision|2
5415893|NCT02612779|18689849|P2|Overall Study|Maximum clinical benefit|1
5415894|NCT02612779|18689850|P1|Overall Study|Maximum clinical benefit|10
5415895|NCT02612779|18689849|P2|Overall Study|Lost to Follow-up|0
5415896|NCT02612779|18689850|P1|Overall Study|Lost to Follow-up|1
5415897|NCT02612779|18689849|P2|Overall Study|Participant withdrew consent|0
5415898|NCT02612779|18689850|P1|Overall Study|Participant withdrew consent|4
5415899|NCT02612779|18689849|P2|Overall Study|Adverse event unrelated to study drug|0
5415900|NCT02612779|18689850|P1|Overall Study|Adverse event unrelated to study drug|5
5415901|NCT02612779|18689849|P2|Overall Study|Death|0
5415902|NCT02612779|18689850|P1|Overall Study|Death|1
5415903|NCT02612779|18689849|P2|Overall Study|Study drug toxicity|0
5415904|NCT02612779|18689850|P1|Overall Study|Study drug toxicity|9
5415905|NCT02612779|18689849|P2|Overall Study|Disease progression|2
5415906|NCT02612779|18689850|P1|Overall Study|Disease progression|29
5415907|NCT02612779|18689849|P2|Overall Study|No longer meet study criteria|1
5415908|NCT02612779|18689850|P1|Overall Study|No longer meet study criteria|0
5415909|NCT02612779|18689849|P2|Overall Study|Administrative reason by sponsor|1
5415910|NCT02612779|18689850|P1|Overall Study|Administrative reason by sponsor|0
5415911|NCT02612727|18689862|P2|Overall Study|Direct hyperbilirubinemia|2
5415912|NCT02612727|18689863|P1|Overall Study|Direct hyperbilirubinemia|0
5415913|NCT02612727|18689862|P2|Overall Study|Needed treatment incompatible with PT|1
5415914|NCT02612727|18689863|P1|Overall Study|Needed treatment incompatible with PT|1
5415915|NCT02612727|18689862|P2|Overall Study|Parent request|1
5415916|NCT02612727|18689863|P1|Overall Study|Parent request|4
5415917|NCT02612623|18689922|P4|Overall Study|Adverse Event|0
5415918|NCT02612623|18689923|P3|Overall Study|Adverse Event|1
5415919|NCT02612623|18689924|P2|Overall Study|Adverse Event|0
5415920|NCT02612623|18689925|P1|Overall Study|Adverse Event|1
5415921|NCT02612623|18689922|P4|Overall Study|Withdrawal by Subject|0
5415922|NCT02612623|18689923|P3|Overall Study|Withdrawal by Subject|0
5415923|NCT02612623|18689924|P2|Overall Study|Withdrawal by Subject|1
5415924|NCT02612623|18689925|P1|Overall Study|Withdrawal by Subject|0
5415925|NCT02612610|18689939|P4|Overall Study|Cough Improvement|0
5415926|NCT02612610|18689940|P3|Overall Study|Cough Improvement|1
5415927|NCT02612610|18689941|P2|Overall Study|Cough Improvement|0
5415928|NCT02612610|18689942|P1|Overall Study|Cough Improvement|0
5415929|NCT02612610|18689939|P4|Overall Study|Noncompliance|0
5415930|NCT02612610|18689940|P3|Overall Study|Noncompliance|0
5415931|NCT02612610|18689941|P2|Overall Study|Noncompliance|0
5415932|NCT02612610|18689942|P1|Overall Study|Noncompliance|1
5415933|NCT02612610|18689939|P4|Overall Study|Physician Decision|0
5415934|NCT02612610|18689940|P3|Overall Study|Physician Decision|0
5415935|NCT02612610|18689941|P2|Overall Study|Physician Decision|1
5415936|NCT02612610|18689942|P1|Overall Study|Physician Decision|0
5415937|NCT02612610|18689939|P4|Overall Study|Lack of Efficacy|1
5415938|NCT02612610|18689940|P3|Overall Study|Lack of Efficacy|0
5415939|NCT02612610|18689941|P2|Overall Study|Lack of Efficacy|2
5415940|NCT02612610|18689942|P1|Overall Study|Lack of Efficacy|1
5415941|NCT02612610|18689939|P4|Overall Study|Protocol Violation|0
5415942|NCT02612610|18689940|P3|Overall Study|Protocol Violation|1
5415943|NCT02612610|18689941|P2|Overall Study|Protocol Violation|1
5415944|NCT02612610|18689942|P1|Overall Study|Protocol Violation|0
5415945|NCT02612610|18689939|P4|Overall Study|Lost to Follow-up|0
5415946|NCT02612610|18689940|P3|Overall Study|Lost to Follow-up|0
5415947|NCT02612610|18689941|P2|Overall Study|Lost to Follow-up|1
5415948|NCT02612610|18689942|P1|Overall Study|Lost to Follow-up|0
5415949|NCT02612610|18689939|P4|Overall Study|Adverse Event|10
5415950|NCT02612610|18689940|P3|Overall Study|Adverse Event|3
5415951|NCT02612610|18689941|P2|Overall Study|Adverse Event|2
5415952|NCT02612610|18689942|P1|Overall Study|Adverse Event|2
5415953|NCT02612610|18689939|P4|Overall Study|Withdrawal by Subject|2
5415954|NCT02612610|18689940|P3|Overall Study|Withdrawal by Subject|0
5415955|NCT02612610|18689941|P2|Overall Study|Withdrawal by Subject|1
5415956|NCT02612610|18689942|P1|Overall Study|Withdrawal by Subject|1
5415957|NCT02612428|18690186|P2|VTL-308E|Lost to Follow-up|0
5415958|NCT02612428|18690187|P1|VTL-308E|Lost to Follow-up|2
5415959|NCT02612428|18690186|P2|VTL-308E|Death|7
5415960|NCT02612428|18690187|P1|VTL-308E|Death|9
5415961|NCT02612428|18690186|P2|VTL-308|Withdrawal by Subject|1
5415962|NCT02612428|18690187|P1|VTL-308|Withdrawal by Subject|0
5415963|NCT02612428|18690186|P2|VTL-308|Death|16
5415964|NCT02612428|18690187|P1|VTL-308|Death|14
5415965|NCT02612285|18690197|P1|Overall Study|Withdrawal by Subject|1
5415966|NCT02612155|18690203|P2|Overall Study|Lost to Follow-up|2
5415967|NCT02612155|18690204|P1|Overall Study|Lost to Follow-up|2
5415968|NCT02612155|18690203|P2|Overall Study|Death|1
5415969|NCT02612155|18690204|P1|Overall Study|Death|1
5415970|NCT02612077|18690224|P1|Overall Study|Unknown reason|2
5415971|NCT02612077|18690224|P1|Overall Study|Disease Progression|3
5415972|NCT02612077|18690224|P1|Overall Study|Enrollment in a Clinical Trial|1
5415973|NCT02612077|18690224|P1|Overall Study|Moved or Changed Medical Team|23
5415974|NCT02612077|18690224|P1|Overall Study|Death|377
5415975|NCT02612077|18690224|P1|Overall Study|Lost to Follow-up|20
5415976|NCT02612077|18690224|P1|Overall Study|Protocol Violation|28
5415977|NCT02612077|18690224|P1|Overall Study|Withdrawal by Subject|9
5415978|NCT02612077|18690224|P1|Overall Study|Adverse Event|3
5415979|NCT02612064|18690236|P2|Overall Study|Other|2
5415980|NCT02612064|18690237|P1|Overall Study|Other|0
5415981|NCT02612064|18690236|P2|Overall Study|Withdrawal by Subject|1
5415982|NCT02612064|18690237|P1|Overall Study|Withdrawal by Subject|1
5415983|NCT02611882|18690250|P3|Overall Study|Did not complete prostatectomy per protocol stipulation|0
5415984|NCT02611882|18690251|P2|Overall Study|Did not complete prostatectomy per protocol stipulation|0
5415985|NCT02611882|18690252|P1|Overall Study|Did not complete prostatectomy per protocol stipulation|33
5415986|NCT02611830|18690270|P4|Maintenance Phase|Reason not specified|0
5415987|NCT02611830|18690271|P3|Maintenance Phase|Reason not specified|4
5415988|NCT02611830|18690272|P2|Maintenance Phase|Reason not specified|1
5415989|NCT02611830|18690273|P1|Maintenance Phase|Reason not specified|0
5415990|NCT02611830|18690270|P4|Maintenance Phase|Pregnancy|0
5415991|NCT02611830|18690271|P3|Maintenance Phase|Pregnancy|1
5415992|NCT02611830|18690272|P2|Maintenance Phase|Pregnancy|0
5415993|NCT02611830|18690273|P1|Maintenance Phase|Pregnancy|0
5415994|NCT02611830|18690270|P4|Maintenance Phase|Voluntary Withdrawal|5
5415995|NCT02611830|18690271|P3|Maintenance Phase|Voluntary Withdrawal|2
5415996|NCT02611830|18690272|P2|Maintenance Phase|Voluntary Withdrawal|1
5415997|NCT02611830|18690273|P1|Maintenance Phase|Voluntary Withdrawal|0
5415998|NCT02611830|18690270|P4|Maintenance Phase|Lost to Follow-up|1
5415999|NCT02611830|18690271|P3|Maintenance Phase|Lost to Follow-up|0
5416000|NCT02611830|18690272|P2|Maintenance Phase|Lost to Follow-up|0
5416001|NCT02611830|18690273|P1|Maintenance Phase|Lost to Follow-up|0
5416002|NCT02611830|18690270|P4|Maintenance Phase|Significant Protocol Deviation|1
5416003|NCT02611830|18690271|P3|Maintenance Phase|Significant Protocol Deviation|1
5416004|NCT02611830|18690272|P2|Maintenance Phase|Significant Protocol Deviation|0
5416005|NCT02611830|18690273|P1|Maintenance Phase|Significant Protocol Deviation|0
5416006|NCT02611830|18690270|P4|Maintenance Phase|Pretreatment Event/Adverse Event|2
5416007|NCT02611830|18690271|P3|Maintenance Phase|Pretreatment Event/Adverse Event|5
5416008|NCT02611830|18690272|P2|Maintenance Phase|Pretreatment Event/Adverse Event|5
5416009|NCT02611830|18690273|P1|Maintenance Phase|Pretreatment Event/Adverse Event|0
5416010|NCT02611830|18690270|P4|Maintenance Phase|Lack of Efficacy|6
5416011|NCT02611830|18690271|P3|Maintenance Phase|Lack of Efficacy|18
5416012|NCT02611830|18690272|P2|Maintenance Phase|Lack of Efficacy|29
5416013|NCT02611830|18690273|P1|Maintenance Phase|Lack of Efficacy|0
5416014|NCT02611830|18690270|P4|OL Induction Phase|Reason not specified|0
5416015|NCT02611830|18690271|P3|OL Induction Phase|Reason not specified|0
5416016|NCT02611830|18690272|P2|OL Induction Phase|Reason not specified|0
5416017|NCT02611830|18690273|P1|OL Induction Phase|Reason not specified|3
5416018|NCT02611830|18690270|P4|OL Induction Phase|Lack of Efficacy|0
5416019|NCT02611830|18690271|P3|OL Induction Phase|Lack of Efficacy|0
5416020|NCT02611830|18690272|P2|OL Induction Phase|Lack of Efficacy|0
5416021|NCT02611830|18690273|P1|OL Induction Phase|Lack of Efficacy|9
5416022|NCT02611830|18690270|P4|OL Induction Phase|Voluntary Withdrawal|0
5416023|NCT02611830|18690271|P3|OL Induction Phase|Voluntary Withdrawal|0
5416024|NCT02611830|18690272|P2|OL Induction Phase|Voluntary Withdrawal|0
5416025|NCT02611830|18690273|P1|OL Induction Phase|Voluntary Withdrawal|5
5416026|NCT02611830|18690270|P4|OL Induction Phase|Significant Protocol Deviation|0
5416027|NCT02611830|18690271|P3|OL Induction Phase|Significant Protocol Deviation|0
5416028|NCT02611830|18690272|P2|OL Induction Phase|Significant Protocol Deviation|0
5416029|NCT02611830|18690273|P1|OL Induction Phase|Significant Protocol Deviation|4
5416030|NCT02611830|18690270|P4|OL Induction Phase|Pretreatment Event/Adverse Event|0
5416031|NCT02611830|18690271|P3|OL Induction Phase|Pretreatment Event/Adverse Event|0
5416032|NCT02611830|18690272|P2|OL Induction Phase|Pretreatment Event/Adverse Event|0
5416033|NCT02611830|18690273|P1|OL Induction Phase|Pretreatment Event/Adverse Event|9
5416034|NCT02611817|18690297|P3|Double-blind Maintenance Phase|Lost to Follow-up|1
5416035|NCT02611817|18690298|P2|Double-blind Maintenance Phase|Lost to Follow-up|0
5416036|NCT02611817|18690299|P1|Double-blind Maintenance Phase|Lost to Follow-up|0
5416037|NCT02611817|18690297|P3|Double-blind Maintenance Phase|Withdrawal by Subject|14
5416038|NCT02611817|18690298|P2|Double-blind Maintenance Phase|Withdrawal by Subject|5
5416039|NCT02611817|18690299|P1|Double-blind Maintenance Phase|Withdrawal by Subject|0
5416040|NCT02611817|18690297|P3|Double-blind Maintenance Phase|Pregnancy|1
5416041|NCT02611817|18690298|P2|Double-blind Maintenance Phase|Pregnancy|0
5416042|NCT02611817|18690299|P1|Double-blind Maintenance Phase|Pregnancy|0
5416043|NCT02611817|18690297|P3|Double-blind Maintenance Phase|Lack of Efficacy|78
5416044|NCT02611817|18690298|P2|Double-blind Maintenance Phase|Lack of Efficacy|43
5416045|NCT02611817|18690299|P1|Double-blind Maintenance Phase|Lack of Efficacy|0
5416046|NCT02611817|18690297|P3|Double-blind Maintenance Phase|Reason not Specified|2
5416047|NCT02611817|18690298|P2|Double-blind Maintenance Phase|Reason not Specified|1
5416048|NCT02611817|18690299|P1|Double-blind Maintenance Phase|Reason not Specified|0
5416049|NCT02611817|18690297|P3|Double-blind Maintenance Phase|Randomized but not Treated|0
5416050|NCT02611817|18690298|P2|Double-blind Maintenance Phase|Randomized but not Treated|1
5416051|NCT02611817|18690299|P1|Double-blind Maintenance Phase|Randomized but not Treated|0
5416052|NCT02611817|18690297|P3|Double-blind Maintenance Phase|Adverse Event|11
5416053|NCT02611817|18690298|P2|Double-blind Maintenance Phase|Adverse Event|12
5416054|NCT02611817|18690299|P1|Double-blind Maintenance Phase|Adverse Event|0
5416055|NCT02611817|18690297|P3|Open-label Induction Phase|Adverse Event|0
5416056|NCT02611817|18690298|P2|Open-label Induction Phase|Adverse Event|0
5416057|NCT02611817|18690299|P1|Open-label Induction Phase|Adverse Event|16
5416058|NCT02611817|18690297|P3|Open-label Induction Phase|Protocol Violation|0
5416059|NCT02611817|18690298|P2|Open-label Induction Phase|Protocol Violation|0
5416060|NCT02611817|18690299|P1|Open-label Induction Phase|Protocol Violation|5
5416061|NCT02611817|18690297|P3|Open-label Induction Phase|Lost to Follow-up|0
5416062|NCT02611817|18690298|P2|Open-label Induction Phase|Lost to Follow-up|0
5416063|NCT02611817|18690299|P1|Open-label Induction Phase|Lost to Follow-up|2
5416064|NCT02611817|18690297|P3|Open-label Induction Phase|Withdrawal by Subject|0
5416065|NCT02611817|18690298|P2|Open-label Induction Phase|Withdrawal by Subject|0
5416066|NCT02611817|18690299|P1|Open-label Induction Phase|Withdrawal by Subject|9
5416067|NCT02611817|18690297|P3|Open-label Induction Phase|Pregnancy|0
5416068|NCT02611817|18690298|P2|Open-label Induction Phase|Pregnancy|0
5416069|NCT02611817|18690299|P1|Open-label Induction Phase|Pregnancy|1
5416070|NCT02611817|18690297|P3|Open-label Induction Phase|Lack of Efficacy|0
5416071|NCT02611817|18690298|P2|Open-label Induction Phase|Lack of Efficacy|0
5416072|NCT02611817|18690299|P1|Open-label Induction Phase|Lack of Efficacy|8
5416073|NCT02611817|18690297|P3|Open-label Induction Phase|Reason not Specified|0
5416074|NCT02611817|18690298|P2|Open-label Induction Phase|Reason not Specified|0
5416075|NCT02611817|18690299|P1|Open-label Induction Phase|Reason not Specified|9
5416076|NCT02611752|18690323|P2|Overall Study|Adverse Event|1
5416077|NCT02611752|18690324|P1|Overall Study|Adverse Event|0
5416078|NCT02611479|18690356|P1|Data Cleaning|No baseline function or pain metrics|2
5416079|NCT02611479|18690356|P1|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
5416080|NCT02611479|18690356|P1|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
5416081|NCT02611479|18690356|P1|Baseline Enrollment|Exited study|13
5416082|NCT02610842|18690488|P1|Overall Study|Lost to Follow-up|5
5416083|NCT02610816|18690497|P4|Phase 2|Pregnancy|1
5416084|NCT02610816|18690498|P3|Phase 2|Pregnancy|0
5416085|NCT02610816|18690499|P2|Phase 2|Pregnancy|0
5416086|NCT02610816|18690500|P1|Phase 2|Pregnancy|0
5416087|NCT02610816|18690497|P4|Phase 2|Physician Decision|2
5416088|NCT02610816|18690498|P3|Phase 2|Physician Decision|0
5416089|NCT02610816|18690499|P2|Phase 2|Physician Decision|0
5416090|NCT02610816|18690500|P1|Phase 2|Physician Decision|0
5416091|NCT02610816|18690497|P4|Phase 2|Lost to Follow-up|0
5416092|NCT02610816|18690498|P3|Phase 2|Lost to Follow-up|2
5416093|NCT02610816|18690499|P2|Phase 2|Lost to Follow-up|0
5416094|NCT02610816|18690500|P1|Phase 2|Lost to Follow-up|0
5416095|NCT02610816|18690497|P4|Phase 2|Withdrawal by Subject|3
5416096|NCT02610816|18690498|P3|Phase 2|Withdrawal by Subject|9
5416097|NCT02610816|18690499|P2|Phase 2|Withdrawal by Subject|0
5416098|NCT02610816|18690500|P1|Phase 2|Withdrawal by Subject|0
5416099|NCT02610816|18690497|P4|Phase 1|Physician Decision|0
5416100|NCT02610816|18690498|P3|Phase 1|Physician Decision|0
5416101|NCT02610816|18690499|P2|Phase 1|Physician Decision|1
5416102|NCT02610816|18690500|P1|Phase 1|Physician Decision|0
5416103|NCT02610816|18690497|P4|Phase 1|Lost to Follow-up|0
5416104|NCT02610816|18690498|P3|Phase 1|Lost to Follow-up|0
5416105|NCT02610816|18690499|P2|Phase 1|Lost to Follow-up|1
5416106|NCT02610816|18690500|P1|Phase 1|Lost to Follow-up|2
5416107|NCT02610816|18690497|P4|Phase 1|Withdrawal by Subject|0
5416108|NCT02610816|18690498|P3|Phase 1|Withdrawal by Subject|0
5416109|NCT02610816|18690499|P2|Phase 1|Withdrawal by Subject|6
5416110|NCT02610816|18690500|P1|Phase 1|Withdrawal by Subject|2
5416111|NCT02610777|18690523|P2|Overall Study|Ongoing on Treatment|7
5416112|NCT02610777|18690524|P1|Overall Study|Ongoing on Treatment|6
5416113|NCT02610777|18690523|P2|Overall Study|Other|1
5416114|NCT02610777|18690524|P1|Overall Study|Other|0
5416115|NCT02610777|18690523|P2|Overall Study|Withdrawal by Subject|2
5416116|NCT02610777|18690524|P1|Overall Study|Withdrawal by Subject|1
5416117|NCT02610777|18690523|P2|Overall Study|Ongoing in Follow-up|12
5416118|NCT02610777|18690524|P1|Overall Study|Ongoing in Follow-up|14
5416119|NCT02610725|18690530|P1|Overall Study|self-reported contraindication|9
5416120|NCT02610725|18690530|P1|Overall Study|Lost to Follow-up|197
5416121|NCT02610231|18690545|P1|Overall Study|Other|3
5416122|NCT02610231|18690545|P1|Overall Study|Non Compliance|2
5416123|NCT02610231|18690545|P1|Overall Study|Physician Decision|1
5416124|NCT02610231|18690545|P1|Overall Study|Surgery|2
5416125|NCT02610231|18690545|P1|Overall Study|Death|5
5416126|NCT02610231|18690545|P1|Overall Study|Adverse Event|20
5416127|NCT02610231|18690545|P1|Overall Study|Withdrawal by Subject|27
5416128|NCT02610192|18690552|P1|Overall Study|Physician Decision|1
5416129|NCT02610192|18690552|P1|Overall Study|Received other treatment|8
5416130|NCT02610140|18690567|P2|Long-term Follow-up|Ongoing but not completed|17
5416131|NCT02610140|18690568|P1|Long-term Follow-up|Ongoing but not completed|30
5416132|NCT02610140|18690567|P2|Long-term Follow-up|Lost to Follow-up|2
5416133|NCT02610140|18690568|P1|Long-term Follow-up|Lost to Follow-up|1
5416134|NCT02610140|18690567|P2|Long-term Follow-up|Withdrawal by Subject|3
5416135|NCT02610140|18690568|P1|Long-term Follow-up|Withdrawal by Subject|6
5416136|NCT02610140|18690567|P2|Long-term Follow-up|Death|44
5416137|NCT02610140|18690568|P1|Long-term Follow-up|Death|86
5416138|NCT02610140|18690567|P2|Active Follow-up|Ongoing but not completed|1
5416139|NCT02610140|18690568|P1|Active Follow-up|Ongoing but not completed|4
5416140|NCT02610140|18690567|P2|Active Follow-up|Deterioration of general conditions|0
5416141|NCT02610140|18690568|P1|Active Follow-up|Deterioration of general conditions|1
5416142|NCT02610140|18690567|P2|Active Follow-up|Progressive disease - clinical|2
5416143|NCT02610140|18690568|P1|Active Follow-up|Progressive disease - clinical|1
5416144|NCT02610140|18690567|P2|Active Follow-up|Withdrawal by Subject|0
5416145|NCT02610140|18690568|P1|Active Follow-up|Withdrawal by Subject|4
5416146|NCT02610140|18690567|P2|Active Follow-up|Death|1
5416147|NCT02610140|18690568|P1|Active Follow-up|Death|8
5416148|NCT02610140|18690567|P2|Active Follow-up|Progressive disease - radiological|22
5416149|NCT02610140|18690568|P1|Active Follow-up|Progressive disease - radiological|30
5416150|NCT02610140|18690567|P2|Safety Follow-up|Withdrawal by Subject|12
5416151|NCT02610140|18690568|P1|Safety Follow-up|Withdrawal by Subject|12
5416152|NCT02610140|18690567|P2|Safety Follow-up|Deterioration of general conditions|5
5416153|NCT02610140|18690568|P1|Safety Follow-up|Deterioration of general conditions|15
5416154|NCT02610140|18690567|P2|Safety Follow-up|Death|2
5416155|NCT02610140|18690568|P1|Safety Follow-up|Death|12
5416156|NCT02610140|18690567|P2|Safety Follow-up|No follow-up|3
5416157|NCT02610140|18690568|P1|Safety Follow-up|No follow-up|5
5416158|NCT02610140|18690567|P2|Safety Follow-up|Lost to Follow-up|0
5416159|NCT02610140|18690568|P1|Safety Follow-up|Lost to Follow-up|1
5416160|NCT02610140|18690567|P2|Safety Follow-up|Other|2
5416161|NCT02610140|18690568|P1|Safety Follow-up|Other|0
5416162|NCT02610140|18690567|P2|Randomization and Treatment Period|Not treated|10
5416163|NCT02610140|18690568|P1|Randomization and Treatment Period|Not treated|3
5416164|NCT02610140|18690567|P2|Randomization and Treatment Period|Ongoing but not completed|2
5416165|NCT02610140|18690568|P1|Randomization and Treatment Period|Ongoing but not completed|9
5416166|NCT02610140|18690567|P2|Randomization and Treatment Period|Progressive disease - clinical|5
5416167|NCT02610140|18690568|P1|Randomization and Treatment Period|Progressive disease - clinical|12
5416168|NCT02610140|18690567|P2|Randomization and Treatment Period|Adverse Event|13
5416169|NCT02610140|18690568|P1|Randomization and Treatment Period|Adverse Event|44
5416170|NCT02610140|18690567|P2|Randomization and Treatment Period|Withdrawal by Subject|12
5416171|NCT02610140|18690568|P1|Randomization and Treatment Period|Withdrawal by Subject|12
5416172|NCT02610140|18690567|P2|Randomization and Treatment Period|Death|1
5416173|NCT02610140|18690568|P1|Randomization and Treatment Period|Death|7
5416174|NCT02610140|18690567|P2|Randomization and Treatment Period|Lack of Efficacy|0
5416175|NCT02610140|18690568|P1|Randomization and Treatment Period|Lack of Efficacy|1
5416176|NCT02610140|18690567|P2|Randomization and Treatment Period|Physician Decision|1
5416177|NCT02610140|18690568|P1|Randomization and Treatment Period|Physician Decision|0
5416178|NCT02610140|18690567|P2|Randomization and Treatment Period|Protocol Violation|0
5416179|NCT02610140|18690568|P1|Randomization and Treatment Period|Protocol Violation|1
5416180|NCT02610140|18690567|P2|Randomization and Treatment Period|Progressive disease - radiological|23
5416181|NCT02610140|18690568|P1|Randomization and Treatment Period|Progressive disease - radiological|54
5416182|NCT02610140|18690567|P2|Randomization and Treatment Period|Radiological progression|15
5416183|NCT02610140|18690568|P1|Randomization and Treatment Period|Radiological progression|23
5416184|NCT02609984|18690600|P2|Overall Study|Disease Progression|0
5416185|NCT02609984|18690601|P1|Overall Study|Disease Progression|2
5416186|NCT02609984|18690600|P2|Overall Study|Withdrawal by Subject|1
5416187|NCT02609984|18690601|P1|Overall Study|Withdrawal by Subject|0
5416188|NCT02609984|18690600|P2|Overall Study|Lost to Follow-up|2
5416189|NCT02609984|18690601|P1|Overall Study|Lost to Follow-up|1
5416190|NCT02609984|18690600|P2|Overall Study|Participation Discontinued by Sponsor|10
5416191|NCT02609984|18690601|P1|Overall Study|Participation Discontinued by Sponsor|12
5416192|NCT02609984|18690600|P2|Overall Study|Death|26
5416193|NCT02609984|18690601|P1|Overall Study|Death|29
5416194|NCT02609672|18690643|P2|Overall Study|Lost to Follow-up|1
5416195|NCT02609672|18690644|P1|Overall Study|Lost to Follow-up|3
5416196|NCT02609659|18690678|P1|Overall Study|Other|1
5416197|NCT02609659|18690678|P1|Overall Study|Lost to Follow-up|6
5416198|NCT02609659|18690678|P1|Overall Study|Adverse Event|1
5416199|NCT02609633|18690688|P2|Overall Study|Reason not Specified|1
5416200|NCT02609633|18690689|P1|Overall Study|Reason not Specified|2
5416201|NCT02609633|18690688|P2|Overall Study|Non-Compliant with Study Procedures|0
5416202|NCT02609633|18690689|P1|Overall Study|Non-Compliant with Study Procedures|2
5416203|NCT02609633|18690688|P2|Overall Study|Protocol Deviation|0
5416204|NCT02609633|18690689|P1|Overall Study|Protocol Deviation|1
5416205|NCT02609633|18690688|P2|Overall Study|Consent Withdrawn|1
5416206|NCT02609633|18690689|P1|Overall Study|Consent Withdrawn|0
5416207|NCT02609607|18690716|P2|Overall Study|Lost to Follow-up|1
5416208|NCT02609607|18690717|P1|Overall Study|Lost to Follow-up|0
5416209|NCT02609399|18690741|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
5416210|NCT02609399|18690742|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
5416211|NCT02609399|18690741|P2|Influenza Season 2016-2017|Lost to Follow-up|5
5416212|NCT02609399|18690742|P1|Influenza Season 2016-2017|Lost to Follow-up|8
5416213|NCT02609399|18690741|P2|Influenza Season 2015-2016|Lost to Follow-up|2
5416214|NCT02609399|18690742|P1|Influenza Season 2015-2016|Lost to Follow-up|3
5416215|NCT02609178|18690772|P6|First Crown|Withdrawal by Subject|0
5416216|NCT02609178|18690773|P5|First Crown|Withdrawal by Subject|0
5416217|NCT02609178|18690774|P4|First Crown|Withdrawal by Subject|1
5416218|NCT02609178|18690775|P3|First Crown|Withdrawal by Subject|1
5416219|NCT02609178|18690776|P2|First Crown|Withdrawal by Subject|0
5416220|NCT02609178|18690777|P1|First Crown|Withdrawal by Subject|0
5416221|NCT02608892|18690839|P2|Overall Study|Lost to Follow-up|0
5416222|NCT02608892|18690840|P1|Overall Study|Lost to Follow-up|1
5416223|NCT02608879|18690852|P3|Overall Study|Did not meet continuation criteria|3
5416224|NCT02608879|18690853|P2|Overall Study|Did not meet continuation criteria|0
5416225|NCT02608879|18690854|P1|Overall Study|Did not meet continuation criteria|0
5416226|NCT02608879|18690852|P3|Overall Study|Lost to Follow-up|0
5416227|NCT02608879|18690853|P2|Overall Study|Lost to Follow-up|0
5416228|NCT02608879|18690854|P1|Overall Study|Lost to Follow-up|1
5416229|NCT02608684|18690873|P1|Overall Study|Withdrawal by Subject|1
5416230|NCT02608684|18690873|P1|Overall Study|Physician Decision|2
5416231|NCT02608476|18690908|P2|Overall Study|Progressive disease|0
5416232|NCT02608476|18690909|P1|Overall Study|Progressive disease|1
5416233|NCT02608476|18690908|P2|Overall Study|Pregnancy|1
5416234|NCT02608476|18690909|P1|Overall Study|Pregnancy|0
5416235|NCT02608476|18690908|P2|Overall Study|Physician Decision|0
5416236|NCT02608476|18690909|P1|Overall Study|Physician Decision|1
5416237|NCT02608476|18690908|P2|Overall Study|Other|1
5416238|NCT02608476|18690909|P1|Overall Study|Other|0
5416239|NCT02608476|18690908|P2|Overall Study|Lack of Efficacy|1
5416240|NCT02608476|18690909|P1|Overall Study|Lack of Efficacy|3
5416241|NCT02608476|18690908|P2|Overall Study|Noncompliance with treatment|5
5416242|NCT02608476|18690909|P1|Overall Study|Noncompliance with treatment|1
5416243|NCT02608476|18690908|P2|Overall Study|Withdrawal by Parent/Guardian|4
5416244|NCT02608476|18690909|P1|Overall Study|Withdrawal by Parent/Guardian|5
5416245|NCT02608476|18690908|P2|Overall Study|Adverse Event|8
5416246|NCT02608476|18690909|P1|Overall Study|Adverse Event|2
5416247|NCT02608476|18690908|P2|Overall Study|Lost to Follow-up|24
5416248|NCT02608476|18690909|P1|Overall Study|Lost to Follow-up|24
5416249|NCT02608476|18690908|P2|Overall Study|Withdrawal by Subject|37
5416250|NCT02608476|18690909|P1|Overall Study|Withdrawal by Subject|30
5416251|NCT02608450|18690939|P2|Overall Study|Multiple reasons|2
5416252|NCT02608450|18690940|P1|Overall Study|Multiple reasons|0
5416253|NCT02608450|18690939|P2|Overall Study|Progressive disease|0
5416254|NCT02608450|18690940|P1|Overall Study|Progressive disease|1
5416255|NCT02608450|18690939|P2|Overall Study|Pregnancy|1
5416256|NCT02608450|18690940|P1|Overall Study|Pregnancy|0
5416257|NCT02608450|18690939|P2|Overall Study|Physician Decision|1
5416258|NCT02608450|18690940|P1|Overall Study|Physician Decision|0
5416259|NCT02608450|18690939|P2|Overall Study|Noncompliance with study drug|2
5416260|NCT02608450|18690940|P1|Overall Study|Noncompliance with study drug|0
5416261|NCT02608450|18690939|P2|Overall Study|Lack of Efficacy|3
5416262|NCT02608450|18690940|P1|Overall Study|Lack of Efficacy|0
5416263|NCT02608450|18690939|P2|Overall Study|Withdrawal by parent|3
5416264|NCT02608450|18690940|P1|Overall Study|Withdrawal by parent|2
5416265|NCT02608450|18690939|P2|Overall Study|Adverse Event|6
5416266|NCT02608450|18690940|P1|Overall Study|Adverse Event|3
5416267|NCT02608450|18690939|P2|Overall Study|Withdrawal by Subject|15
5416268|NCT02608450|18690940|P1|Overall Study|Withdrawal by Subject|21
5416269|NCT02608450|18690939|P2|Overall Study|Lost to Follow-up|32
5416270|NCT02608450|18690940|P1|Overall Study|Lost to Follow-up|39
5416271|NCT02608099|18691002|P2|Overall Study|Ablation procedure not initiated|2
5416272|NCT02608099|18691003|P1|Overall Study|Ablation procedure not initiated|3
5416273|NCT02607956|18691041|P2|Overall Study|Lost to Follow-up|15
5416274|NCT02607956|18691042|P1|Overall Study|Lost to Follow-up|18
5416275|NCT02607956|18691041|P2|Overall Study|Withdrew Consent|16
5416276|NCT02607956|18691042|P1|Overall Study|Withdrew Consent|16
5416277|NCT02607956|18691041|P2|Overall Study|Protocol Violation|1
5416278|NCT02607956|18691042|P1|Overall Study|Protocol Violation|3
5416279|NCT02607956|18691041|P2|Overall Study|Non-Compliance with Study Drug|3
5416280|NCT02607956|18691042|P1|Overall Study|Non-Compliance with Study Drug|0
5416281|NCT02607956|18691041|P2|Overall Study|Investigator's Discretion|2
5416282|NCT02607956|18691042|P1|Overall Study|Investigator's Discretion|7
5416283|NCT02607956|18691041|P2|Overall Study|Death|4
5416284|NCT02607956|18691042|P1|Overall Study|Death|4
5416285|NCT02607956|18691041|P2|Overall Study|Adverse Event|3
5416286|NCT02607956|18691042|P1|Overall Study|Adverse Event|4
5416287|NCT02607956|18691041|P2|Overall Study|Still on Study|281
5416288|NCT02607956|18691042|P1|Overall Study|Still on Study|268
5416289|NCT02607956|18691041|P2|Overall Study|Randomized and Never Treated|5
5416290|NCT02607956|18691042|P1|Overall Study|Randomized and Never Treated|7
5416291|NCT02607930|18691072|P2|Overall Study|Lost to Follow-up|16
5416292|NCT02607930|18691073|P1|Overall Study|Lost to Follow-up|24
5416293|NCT02607930|18691072|P2|Overall Study|Withdrew Consent|15
5416294|NCT02607930|18691073|P1|Overall Study|Withdrew Consent|14
5416295|NCT02607930|18691072|P2|Overall Study|Protocol Violation|3
5416296|NCT02607930|18691073|P1|Overall Study|Protocol Violation|2
5416297|NCT02607930|18691072|P2|Overall Study|Non-Compliance with Study Drug|5
5416298|NCT02607930|18691073|P1|Overall Study|Non-Compliance with Study Drug|3
5416299|NCT02607930|18691072|P2|Overall Study|Investigator's Discretion|2
5416300|NCT02607930|18691073|P1|Overall Study|Investigator's Discretion|6
5416301|NCT02607930|18691072|P2|Overall Study|Death|1
5416302|NCT02607930|18691073|P1|Overall Study|Death|2
5416303|NCT02607930|18691072|P2|Overall Study|Adverse Event|4
5416304|NCT02607930|18691073|P1|Overall Study|Adverse Event|0
5416305|NCT02607930|18691072|P2|Overall Study|Still in Study|269
5416306|NCT02607930|18691073|P1|Overall Study|Still in Study|263
5416307|NCT02607930|18691072|P2|Overall Study|Randomized and Never Treated|0
5416308|NCT02607930|18691073|P1|Overall Study|Randomized and Never Treated|2
5416309|NCT02607865|18691117|P4|Overall Study|Unclassified|0
5416310|NCT02607865|18691118|P3|Overall Study|Unclassified|2
5416311|NCT02607865|18691119|P2|Overall Study|Unclassified|1
5416312|NCT02607865|18691120|P1|Overall Study|Unclassified|1
5416313|NCT02607865|18691117|P4|Overall Study|Death|3
5416314|NCT02607865|18691118|P3|Overall Study|Death|1
5416315|NCT02607865|18691119|P2|Overall Study|Death|4
5416316|NCT02607865|18691120|P1|Overall Study|Death|5
5416317|NCT02607865|18691117|P4|Overall Study|Withdrawal by Subject|8
5416318|NCT02607865|18691118|P3|Overall Study|Withdrawal by Subject|17
5416319|NCT02607865|18691119|P2|Overall Study|Withdrawal by Subject|18
5416320|NCT02607865|18691120|P1|Overall Study|Withdrawal by Subject|18
5416321|NCT02607865|18691117|P4|Overall Study|Lost to Follow-up|5
5416322|NCT02607865|18691118|P3|Overall Study|Lost to Follow-up|7
5416323|NCT02607865|18691119|P2|Overall Study|Lost to Follow-up|7
5416324|NCT02607865|18691120|P1|Overall Study|Lost to Follow-up|9
5416325|NCT02607800|18691294|P2|Overall Study|Randomized/Enrolled but Not Treated|1
5416326|NCT02607800|18691295|P1|Overall Study|Randomized/Enrolled but Not Treated|1
5416327|NCT02607800|18691294|P2|Overall Study|Withdrew Consent|0
5416328|NCT02607800|18691295|P1|Overall Study|Withdrew Consent|2
5416329|NCT02607800|18691294|P2|Overall Study|Lost to Follow-up|10
5416330|NCT02607800|18691295|P1|Overall Study|Lost to Follow-up|7
5416331|NCT02607735|18691313|P3|Deferred Treatment Substudy|Withdrew Consent|1
5416332|NCT02607735|18691314|P2|Deferred Treatment Substudy|Withdrew Consent|0
5416333|NCT02607735|18691315|P1|Deferred Treatment Substudy|Withdrew Consent|0
5416334|NCT02607735|18691313|P3|Deferred Treatment Substudy|Lost to Follow-up|4
5416335|NCT02607735|18691314|P2|Deferred Treatment Substudy|Lost to Follow-up|0
5416336|NCT02607735|18691315|P1|Deferred Treatment Substudy|Lost to Follow-up|0
5416337|NCT02607735|18691313|P3|Primary Study|Withdrew Consent|0
5416338|NCT02607735|18691314|P2|Primary Study|Withdrew Consent|0
5416339|NCT02607735|18691315|P1|Primary Study|Withdrew Consent|2
5416340|NCT02607735|18691313|P3|Primary Study|Lost to Follow-up|0
5416341|NCT02607735|18691314|P2|Primary Study|Lost to Follow-up|0
5416342|NCT02607735|18691315|P1|Primary Study|Lost to Follow-up|4
5416343|NCT02607735|18691313|P3|Primary Study|Randomized but Never Treated|0
5416344|NCT02607735|18691314|P2|Primary Study|Randomized but Never Treated|0
5416345|NCT02607735|18691315|P1|Primary Study|Randomized but Never Treated|1
5416346|NCT02607306|18691349|P3|Overall Study|Protocol Violation|1
5416347|NCT02607306|18691350|P2|Overall Study|Protocol Violation|2
5416348|NCT02607306|18691351|P1|Overall Study|Protocol Violation|4
5416349|NCT02607306|18691349|P3|Overall Study|Lack of Efficacy|1
5416350|NCT02607306|18691350|P2|Overall Study|Lack of Efficacy|1
5416351|NCT02607306|18691351|P1|Overall Study|Lack of Efficacy|0
5416352|NCT02607306|18691349|P3|Overall Study|Withdrawal by Subject|2
5416353|NCT02607306|18691350|P2|Overall Study|Withdrawal by Subject|10
5416354|NCT02607306|18691351|P1|Overall Study|Withdrawal by Subject|8
5416355|NCT02607306|18691349|P3|Overall Study|Unclassified|0
5416356|NCT02607306|18691350|P2|Overall Study|Unclassified|4
5416357|NCT02607306|18691351|P1|Overall Study|Unclassified|1
5416358|NCT02607306|18691349|P3|Overall Study|Adverse Event|6
5416359|NCT02607306|18691350|P2|Overall Study|Adverse Event|6
5416360|NCT02607306|18691351|P1|Overall Study|Adverse Event|8
5416361|NCT02607280|18691473|P2|Overall Study|Decrease in CrCl <15|1
5416362|NCT02607280|18691474|P1|Overall Study|Decrease in CrCl <15|0
5416363|NCT02607280|18691473|P2|Overall Study|Adverse Event|0
5416364|NCT02607280|18691474|P1|Overall Study|Adverse Event|4
5416365|NCT02607228|18691509|P7|Overall Study|Study Terminated by Sponsor|0
5416366|NCT02607228|18691510|P6|Overall Study|Study Terminated by Sponsor|0
5416367|NCT02607228|18691511|P5|Overall Study|Study Terminated by Sponsor|0
5416368|NCT02607228|18691512|P4|Overall Study|Study Terminated by Sponsor|1
5416369|NCT02607228|18691513|P3|Overall Study|Study Terminated by Sponsor|0
5416370|NCT02607228|18691514|P2|Overall Study|Study Terminated by Sponsor|0
5416371|NCT02607228|18691515|P1|Overall Study|Study Terminated by Sponsor|0
5416372|NCT02607228|18691509|P7|Overall Study|Withdrew Consent|0
5416373|NCT02607228|18691510|P6|Overall Study|Withdrew Consent|1
5416374|NCT02607228|18691511|P5|Overall Study|Withdrew Consent|0
5416375|NCT02607228|18691512|P4|Overall Study|Withdrew Consent|0
5416376|NCT02607228|18691513|P3|Overall Study|Withdrew Consent|0
5416377|NCT02607228|18691514|P2|Overall Study|Withdrew Consent|1
5416378|NCT02607228|18691515|P1|Overall Study|Withdrew Consent|0
5416379|NCT02607228|18691509|P7|Overall Study|Investigator's Discretion|0
5416380|NCT02607228|18691510|P6|Overall Study|Investigator's Discretion|1
5416381|NCT02607228|18691511|P5|Overall Study|Investigator's Discretion|0
5416382|NCT02607228|18691512|P4|Overall Study|Investigator's Discretion|0
5416383|NCT02607228|18691513|P3|Overall Study|Investigator's Discretion|1
5416384|NCT02607228|18691514|P2|Overall Study|Investigator's Discretion|0
5416385|NCT02607228|18691515|P1|Overall Study|Investigator's Discretion|0
5416386|NCT02607228|18691509|P7|Overall Study|Adverse Event|1
5416387|NCT02607228|18691510|P6|Overall Study|Adverse Event|1
5416388|NCT02607228|18691511|P5|Overall Study|Adverse Event|1
5416389|NCT02607228|18691512|P4|Overall Study|Adverse Event|0
5416390|NCT02607228|18691513|P3|Overall Study|Adverse Event|1
5416391|NCT02607228|18691514|P2|Overall Study|Adverse Event|0
5416392|NCT02607228|18691515|P1|Overall Study|Adverse Event|1
5416393|NCT02607228|18691509|P7|Overall Study|Progressive Disease|1
5416394|NCT02607228|18691510|P6|Overall Study|Progressive Disease|3
5416395|NCT02607228|18691511|P5|Overall Study|Progressive Disease|4
5416396|NCT02607228|18691512|P4|Overall Study|Progressive Disease|5
5416397|NCT02607228|18691513|P3|Overall Study|Progressive Disease|1
5416398|NCT02607228|18691514|P2|Overall Study|Progressive Disease|3
5416399|NCT02607228|18691515|P1|Overall Study|Progressive Disease|4
5416400|NCT02606877|18691618|P2|Overall Study|Other than listed above|0
5416401|NCT02606877|18691619|P1|Overall Study|Other than listed above|1
5416402|NCT02606877|18691618|P2|Overall Study|Non-compliance with protocol|1
5416403|NCT02606877|18691619|P1|Overall Study|Non-compliance with protocol|0
5416404|NCT02606877|18691618|P2|Overall Study|Adverse Event|0
5416405|NCT02606877|18691619|P1|Overall Study|Adverse Event|3
5416406|NCT02606643|18691658|P2|Overall Study|did not meet inclusion criteria|3
5416407|NCT02606643|18691659|P1|Overall Study|did not meet inclusion criteria|1
5416408|NCT02606279|18691717|P2|Overall Study|Lost to Follow-up|1
5416409|NCT02606279|18691718|P1|Overall Study|Lost to Follow-up|0
5416410|NCT02606253|18691733|P3|Overall Study|Physician Decision|0
5416411|NCT02606253|18691734|P2|Overall Study|Physician Decision|1
5416412|NCT02606253|18691735|P1|Overall Study|Physician Decision|1
5416413|NCT02606253|18691733|P3|Overall Study|Protocol Violation|0
5416414|NCT02606253|18691734|P2|Overall Study|Protocol Violation|1
5416415|NCT02606253|18691735|P1|Overall Study|Protocol Violation|2
5416416|NCT02606253|18691733|P3|Overall Study|Adverse Event|0
5416417|NCT02606253|18691734|P2|Overall Study|Adverse Event|0
5416418|NCT02606253|18691735|P1|Overall Study|Adverse Event|2
5416419|NCT02605954|18691837|P2|Overall Study|Randomized but not treated|1
5416420|NCT02605954|18691838|P1|Overall Study|Randomized but not treated|0
5416421|NCT02605954|18691837|P2|Overall Study|Lost to Follow-up|0
5416422|NCT02605954|18691838|P1|Overall Study|Lost to Follow-up|3
5416423|NCT02605954|18691837|P2|Overall Study|Withdrew Consent|2
5416424|NCT02605954|18691838|P1|Overall Study|Withdrew Consent|2
5416425|NCT02605954|18691837|P2|Overall Study|Non-Compliance with Study Drug|0
5416426|NCT02605954|18691838|P1|Overall Study|Non-Compliance with Study Drug|1
5416427|NCT02605954|18691837|P2|Overall Study|Investigator's Discretion|0
5416428|NCT02605954|18691838|P1|Overall Study|Investigator's Discretion|1
5416429|NCT02605954|18691837|P2|Overall Study|Adverse Event|1
5416430|NCT02605954|18691838|P1|Overall Study|Adverse Event|5
5416431|NCT02605928|18691855|P1|Overall Study|Lack of Efficacy|5
5416432|NCT02605928|18691855|P1|Overall Study|Model tuning phase|28
5416433|NCT02605837|18691898|P2|Overall Study|Physician Decision|1
5416434|NCT02605837|18691899|P1|Overall Study|Physician Decision|0
5416435|NCT02605837|18691898|P2|Overall Study|Withdrawal by Subject|8
5416436|NCT02605837|18691899|P1|Overall Study|Withdrawal by Subject|8
5416437|NCT02605837|18691898|P2|Overall Study|Non-Compliance with Study Drug|1
5416438|NCT02605837|18691899|P1|Overall Study|Non-Compliance with Study Drug|0
5416439|NCT02605837|18691898|P2|Overall Study|Adverse Event|1
5416440|NCT02605837|18691899|P1|Overall Study|Adverse Event|3
5416441|NCT02605824|18691938|P2|Overall Study|Physician Decision|0
5416442|NCT02605824|18691939|P1|Overall Study|Physician Decision|1
5416443|NCT02605642|18691949|P2|Overall Study|Lack of response|11
5416444|NCT02605642|18691950|P1|Overall Study|Lack of response|24
5416445|NCT02605642|18691949|P2|Overall Study|Withdrawal by Subject|2
5416446|NCT02605642|18691950|P1|Overall Study|Withdrawal by Subject|23
5416447|NCT02605642|18691949|P2|Overall Study|Adverse Event|2
5416448|NCT02605642|18691950|P1|Overall Study|Adverse Event|14
5416449|NCT02605642|18691949|P2|Overall Study|Lost to Follow-up|1
5416450|NCT02605642|18691950|P1|Overall Study|Lost to Follow-up|12
5416451|NCT02605642|18691949|P2|Overall Study|Physician Decision|0
5416452|NCT02605642|18691950|P1|Overall Study|Physician Decision|10
5416453|NCT02605642|18691949|P2|Overall Study|Participant non-compliance|4
5416454|NCT02605642|18691950|P1|Overall Study|Participant non-compliance|2
5416455|NCT02605642|18691949|P2|Overall Study|Other|1
5416456|NCT02605642|18691950|P1|Overall Study|Other|11
5416457|NCT02605447|18691992|P1|Overall Study|Not disclosed|1
5416458|NCT02605447|18691992|P1|Overall Study|Withdrawal by Subject|10
5416459|NCT02605447|18691992|P1|Overall Study|Lost to Follow-up|24
5416460|NCT02605447|18691992|P1|Overall Study|Physician Decision|1
5416461|NCT02605447|18691992|P1|Overall Study|Death|66
5416462|NCT02605174|18692103|P7|Overall Study|Randomization Failure|30
5416463|NCT02605174|18692104|P6|Overall Study|Randomization Failure|11
5416464|NCT02605174|18692105|P5|Overall Study|Randomization Failure|16
5416465|NCT02605174|18692106|P4|Overall Study|Randomization Failure|7
5416466|NCT02605174|18692107|P3|Overall Study|Randomization Failure|20
5416467|NCT02605174|18692108|P2|Overall Study|Randomization Failure|6
5416468|NCT02605174|18692109|P1|Overall Study|Randomization Failure|22
5416469|NCT02605174|18692103|P7|Overall Study|Physician Decision|3
5416470|NCT02605174|18692104|P6|Overall Study|Physician Decision|0
5416471|NCT02605174|18692105|P5|Overall Study|Physician Decision|0
5416472|NCT02605174|18692106|P4|Overall Study|Physician Decision|0
5416473|NCT02605174|18692107|P3|Overall Study|Physician Decision|0
5416474|NCT02605174|18692108|P2|Overall Study|Physician Decision|0
5416475|NCT02605174|18692109|P1|Overall Study|Physician Decision|2
5416476|NCT02605174|18692103|P7|Overall Study|Withdrawal by Subject|15
5416477|NCT02605174|18692104|P6|Overall Study|Withdrawal by Subject|4
5416478|NCT02605174|18692105|P5|Overall Study|Withdrawal by Subject|6
5416479|NCT02605174|18692106|P4|Overall Study|Withdrawal by Subject|11
5416480|NCT02605174|18692107|P3|Overall Study|Withdrawal by Subject|14
5416481|NCT02605174|18692108|P2|Overall Study|Withdrawal by Subject|6
5416482|NCT02605174|18692109|P1|Overall Study|Withdrawal by Subject|9
5416483|NCT02605174|18692103|P7|Overall Study|Pregnancy|0
5416484|NCT02605174|18692104|P6|Overall Study|Pregnancy|0
5416485|NCT02605174|18692105|P5|Overall Study|Pregnancy|0
5416486|NCT02605174|18692106|P4|Overall Study|Pregnancy|2
5416487|NCT02605174|18692107|P3|Overall Study|Pregnancy|0
5416488|NCT02605174|18692108|P2|Overall Study|Pregnancy|0
5416489|NCT02605174|18692109|P1|Overall Study|Pregnancy|1
5416490|NCT02605174|18692103|P7|Overall Study|Protocol Violation|12
5416491|NCT02605174|18692104|P6|Overall Study|Protocol Violation|7
5416492|NCT02605174|18692105|P5|Overall Study|Protocol Violation|7
5416493|NCT02605174|18692106|P4|Overall Study|Protocol Violation|6
5416494|NCT02605174|18692107|P3|Overall Study|Protocol Violation|14
5416495|NCT02605174|18692108|P2|Overall Study|Protocol Violation|4
5416496|NCT02605174|18692109|P1|Overall Study|Protocol Violation|10
5416497|NCT02605174|18692103|P7|Overall Study|Lost to Follow-up|29
5416498|NCT02605174|18692104|P6|Overall Study|Lost to Follow-up|10
5416499|NCT02605174|18692105|P5|Overall Study|Lost to Follow-up|20
5416500|NCT02605174|18692106|P4|Overall Study|Lost to Follow-up|10
5416501|NCT02605174|18692107|P3|Overall Study|Lost to Follow-up|27
5416502|NCT02605174|18692108|P2|Overall Study|Lost to Follow-up|7
5416503|NCT02605174|18692109|P1|Overall Study|Lost to Follow-up|20
5416504|NCT02605174|18692103|P7|Overall Study|Adverse Event|0
5416505|NCT02605174|18692104|P6|Overall Study|Adverse Event|0
5416506|NCT02605174|18692105|P5|Overall Study|Adverse Event|4
5416507|NCT02605174|18692106|P4|Overall Study|Adverse Event|0
5416508|NCT02605174|18692107|P3|Overall Study|Adverse Event|1
5416509|NCT02605174|18692108|P2|Overall Study|Adverse Event|0
5416510|NCT02605174|18692109|P1|Overall Study|Adverse Event|0
5416511|NCT02605122|18692171|P2|Overall Study|Lost to Follow-up|1
5416512|NCT02605122|18692172|P1|Overall Study|Lost to Follow-up|1
5416513|NCT02605122|18692171|P2|Overall Study|Withdrawal by Subject|1
5416514|NCT02605122|18692172|P1|Overall Study|Withdrawal by Subject|4
5416515|NCT02604589|18692195|P3|Overall Study|catheter dislodgement|1
5416516|NCT02604589|18692196|P2|Overall Study|catheter dislodgement|0
5416517|NCT02604589|18692197|P1|Overall Study|catheter dislodgement|0
5416518|NCT02604550|18692225|P2|Overall Study|Incomplete data using paper journal|19
5416519|NCT02604550|18692226|P1|Overall Study|Incomplete data using paper journal|18
5416520|NCT02604550|18692225|P2|Overall Study|Withdrawal by Subject|1
5416521|NCT02604550|18692226|P1|Overall Study|Withdrawal by Subject|0
5416522|NCT02604550|18692225|P2|Overall Study|Lost to Follow-up|6
5416523|NCT02604550|18692226|P1|Overall Study|Lost to Follow-up|7
5416524|NCT02604433|18692252|P2|Post Treatment Follow-up Period|Follow-up is ongoing|24
5416525|NCT02604433|18692253|P1|Post Treatment Follow-up Period|Follow-up is ongoing|42
5416526|NCT02604433|18692252|P2|Double-blind Treatment Period|Study is ongoing|74
5416527|NCT02604433|18692253|P1|Double-blind Treatment Period|Study is ongoing|156
5416528|NCT02604433|18692252|P2|Double-blind Treatment Period|D/C TRT: protocol violation|0
5416529|NCT02604433|18692253|P1|Double-blind Treatment Period|D/C TRT: protocol violation|1
5416530|NCT02604433|18692252|P2|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
5416531|NCT02604433|18692253|P1|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
5416532|NCT02604433|18692252|P2|Double-blind Treatment Period|D/C TRT: lack of efficacy|8
5416533|NCT02604433|18692253|P1|Double-blind Treatment Period|D/C TRT: lack of efficacy|2
5416534|NCT02604433|18692252|P2|Double-blind Treatment Period|D/C TRT: adverse event|1
5416535|NCT02604433|18692253|P1|Double-blind Treatment Period|D/C TRT: adverse event|10
5416536|NCT02604433|18692252|P2|Double-blind Treatment Period|D/C TRT: withdrawal by subject|12
5416537|NCT02604433|18692253|P1|Double-blind Treatment Period|D/C TRT: withdrawal by subject|26
5416538|NCT02604433|18692252|P2|Double-blind Treatment Period|Death|1
5416539|NCT02604433|18692253|P1|Double-blind Treatment Period|Death|1
5416540|NCT02604433|18692252|P2|Double-blind Treatment Period|Personal reasons or moved|1
5416541|NCT02604433|18692253|P1|Double-blind Treatment Period|Personal reasons or moved|2
5416542|NCT02604433|18692252|P2|Double-blind Treatment Period|Adverse Event|0
5416543|NCT02604433|18692253|P1|Double-blind Treatment Period|Adverse Event|4
5416544|NCT02604433|18692252|P2|Double-blind Treatment Period|Withdrawal by Subject|6
5416545|NCT02604433|18692253|P1|Double-blind Treatment Period|Withdrawal by Subject|13
5416546|NCT02604407|18692322|P3|Overall Study|Other|4
5416547|NCT02604407|18692323|P2|Overall Study|Other|1
5416548|NCT02604407|18692324|P1|Overall Study|Other|3
5416549|NCT02604407|18692322|P3|Overall Study|Lack of Efficacy|0
5416550|NCT02604407|18692323|P2|Overall Study|Lack of Efficacy|0
5416551|NCT02604407|18692324|P1|Overall Study|Lack of Efficacy|1
5416552|NCT02604407|18692322|P3|Overall Study|Lost to Follow-up|2
5416553|NCT02604407|18692323|P2|Overall Study|Lost to Follow-up|1
5416554|NCT02604407|18692324|P1|Overall Study|Lost to Follow-up|2
5416555|NCT02604407|18692322|P3|Overall Study|Withdrawal by Subject|5
5416556|NCT02604407|18692323|P2|Overall Study|Withdrawal by Subject|3
5416557|NCT02604407|18692324|P1|Overall Study|Withdrawal by Subject|3
5416558|NCT02604407|18692322|P3|Overall Study|Protocol Violation|0
5416559|NCT02604407|18692323|P2|Overall Study|Protocol Violation|0
5416560|NCT02604407|18692324|P1|Overall Study|Protocol Violation|2
5416561|NCT02604407|18692322|P3|Overall Study|Adverse Event|5
5416562|NCT02604407|18692323|P2|Overall Study|Adverse Event|7
5416563|NCT02604407|18692324|P1|Overall Study|Adverse Event|0
5416564|NCT02604342|18692337|P2|Overall Study|Physician Decision|0
5416565|NCT02604342|18692338|P1|Overall Study|Physician Decision|2
5416566|NCT02604342|18692337|P2|Overall Study|Lost to Follow-up|1
5416567|NCT02604342|18692338|P1|Overall Study|Lost to Follow-up|1
5416568|NCT02604342|18692337|P2|Overall Study|Study Termination by Sponsor|0
5416569|NCT02604342|18692338|P1|Overall Study|Study Termination by Sponsor|1
5416570|NCT02604342|18692337|P2|Overall Study|Other|0
5416571|NCT02604342|18692338|P1|Overall Study|Other|1
5416572|NCT02604342|18692337|P2|Overall Study|Withdrawal by Subject|6
5416573|NCT02604342|18692338|P1|Overall Study|Withdrawal by Subject|5
5416574|NCT02604342|18692337|P2|Overall Study|Progression of disease|0
5416575|NCT02604342|18692338|P1|Overall Study|Progression of disease|1
5416576|NCT02604342|18692337|P2|Overall Study|Death|16
5416577|NCT02604342|18692338|P1|Overall Study|Death|32
5416578|NCT02604264|18692390|P2|Intervention|Didn't use CVC for at least 21 days|242
5416579|NCT02604264|18692391|P1|Intervention|Didn't use CVC for at least 21 days|200
5416580|NCT02604212|18692401|P4|Overall Study|Withdrawal by Subject|0
5416581|NCT02604212|18692402|P3|Overall Study|Withdrawal by Subject|1
5416582|NCT02604212|18692403|P2|Overall Study|Withdrawal by Subject|0
5416583|NCT02604212|18692404|P1|Overall Study|Withdrawal by Subject|0
5416584|NCT02604212|18692401|P4|Overall Study|Study Terminated by Sponsor|3
5416585|NCT02604212|18692402|P3|Overall Study|Study Terminated by Sponsor|3
5416586|NCT02604212|18692403|P2|Overall Study|Study Terminated by Sponsor|1
5416587|NCT02604212|18692404|P1|Overall Study|Study Terminated by Sponsor|2
5416588|NCT02604199|18692472|P4|Overall Study|Withdrawal by Subject|0
5416589|NCT02604199|18692473|P3|Overall Study|Withdrawal by Subject|0
5416590|NCT02604199|18692474|P2|Overall Study|Withdrawal by Subject|1
5416591|NCT02604199|18692475|P1|Overall Study|Withdrawal by Subject|0
5416592|NCT02604199|18692472|P4|Overall Study|Study terminated by sponsor|2
5416593|NCT02604199|18692473|P3|Overall Study|Study terminated by sponsor|0
5416594|NCT02604199|18692474|P2|Overall Study|Study terminated by sponsor|2
5416595|NCT02604199|18692475|P1|Overall Study|Study terminated by sponsor|0
5416596|NCT02604199|18692472|P4|Overall Study|Pregnancy|1
5416597|NCT02604199|18692473|P3|Overall Study|Pregnancy|0
5416598|NCT02604199|18692474|P2|Overall Study|Pregnancy|0
5416599|NCT02604199|18692475|P1|Overall Study|Pregnancy|0
5416600|NCT02604160|18692544|P2|Overall Study|Physician Decision|1
5416601|NCT02604160|18692545|P1|Overall Study|Physician Decision|0
5416602|NCT02604160|18692544|P2|Overall Study|Protocol Violation|1
5416603|NCT02604160|18692545|P1|Overall Study|Protocol Violation|0
5416604|NCT02604017|18692559|P2|Overall Study|Other|0
5416605|NCT02604017|18692560|P1|Overall Study|Other|1
5416606|NCT02604017|18692559|P2|Overall Study|Lost to Follow-up|6
5416607|NCT02604017|18692560|P1|Overall Study|Lost to Follow-up|5
5416608|NCT02604017|18692559|P2|Overall Study|Withdrew Consent|2
5416609|NCT02604017|18692560|P1|Overall Study|Withdrew Consent|0
5416610|NCT02603952|18692589|P4|Overall Study|Received oseltamivir by error|1
5416611|NCT02603952|18692590|P3|Overall Study|Received oseltamivir by error|0
5416612|NCT02603952|18692591|P2|Overall Study|Received oseltamivir by error|0
5416613|NCT02603952|18692592|P1|Overall Study|Received oseltamivir by error|0
5416614|NCT02603952|18692589|P4|Overall Study|Withdrawal by Subject|0
5416615|NCT02603952|18692590|P3|Overall Study|Withdrawal by Subject|0
5416616|NCT02603952|18692591|P2|Overall Study|Withdrawal by Subject|0
5416617|NCT02603952|18692592|P1|Overall Study|Withdrawal by Subject|1
5416618|NCT02603887|18692640|P1|Overall Study|Disease progression|1
5416619|NCT02603887|18692640|P1|Overall Study|Adverse Event|4
5416620|NCT02603887|18692640|P1|Overall Study|FDA Guidance|1
5416621|NCT02603809|18692653|P6|Overall Study|Lack of Efficacy|1
5416622|NCT02603809|18692654|P5|Overall Study|Lack of Efficacy|0
5416623|NCT02603809|18692655|P4|Overall Study|Lack of Efficacy|0
5416624|NCT02603809|18692656|P3|Overall Study|Lack of Efficacy|0
5416625|NCT02603809|18692657|P2|Overall Study|Lack of Efficacy|1
5416626|NCT02603809|18692658|P1|Overall Study|Lack of Efficacy|0
5416627|NCT02603809|18692653|P6|Overall Study|Adverse Event|1
5416628|NCT02603809|18692654|P5|Overall Study|Adverse Event|1
5416629|NCT02603809|18692655|P4|Overall Study|Adverse Event|2
5416630|NCT02603809|18692656|P3|Overall Study|Adverse Event|2
5416631|NCT02603809|18692657|P2|Overall Study|Adverse Event|0
5416632|NCT02603809|18692658|P1|Overall Study|Adverse Event|3
5416633|NCT02603809|18692653|P6|Overall Study|Physician Decision|1
5416634|NCT02603809|18692654|P5|Overall Study|Physician Decision|2
5416635|NCT02603809|18692655|P4|Overall Study|Physician Decision|1
5416636|NCT02603809|18692656|P3|Overall Study|Physician Decision|0
5416637|NCT02603809|18692657|P2|Overall Study|Physician Decision|0
5416638|NCT02603809|18692658|P1|Overall Study|Physician Decision|0
5416639|NCT02603809|18692653|P6|Overall Study|Pre-specified discontinuation criteria|1
5416640|NCT02603809|18692654|P5|Overall Study|Pre-specified discontinuation criteria|3
5416641|NCT02603809|18692655|P4|Overall Study|Pre-specified discontinuation criteria|2
5416642|NCT02603809|18692656|P3|Overall Study|Pre-specified discontinuation criteria|2
5416643|NCT02603809|18692657|P2|Overall Study|Pre-specified discontinuation criteria|3
5416644|NCT02603809|18692658|P1|Overall Study|Pre-specified discontinuation criteria|3
5416645|NCT02603809|18692653|P6|Overall Study|Lost to Follow-up|2
5416646|NCT02603809|18692654|P5|Overall Study|Lost to Follow-up|2
5416647|NCT02603809|18692655|P4|Overall Study|Lost to Follow-up|4
5416648|NCT02603809|18692656|P3|Overall Study|Lost to Follow-up|1
5416649|NCT02603809|18692657|P2|Overall Study|Lost to Follow-up|3
5416650|NCT02603809|18692658|P1|Overall Study|Lost to Follow-up|2
5416651|NCT02603809|18692653|P6|Overall Study|Withdrawal by Subject|4
5416652|NCT02603809|18692654|P5|Overall Study|Withdrawal by Subject|3
5416653|NCT02603809|18692655|P4|Overall Study|Withdrawal by Subject|3
5416654|NCT02603809|18692656|P3|Overall Study|Withdrawal by Subject|2
5416655|NCT02603809|18692657|P2|Overall Study|Withdrawal by Subject|1
5416656|NCT02603809|18692658|P1|Overall Study|Withdrawal by Subject|4
5416657|NCT02603432|18692720|P2|Overall Study|Other|1
5416658|NCT02603432|18692721|P1|Overall Study|Other|0
5416659|NCT02603432|18692720|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5416660|NCT02603432|18692721|P1|Overall Study|No Longer Meets Eligibility Criteria|3
5416661|NCT02603432|18692720|P2|Overall Study|Withdrawal by Subject|17
5416662|NCT02603432|18692721|P1|Overall Study|Withdrawal by Subject|9
5416663|NCT02603432|18692720|P2|Overall Study|Progressive Disease|5
5416664|NCT02603432|18692721|P1|Overall Study|Progressive Disease|5
5416665|NCT02603432|18692720|P2|Overall Study|Lost to Follow-up|6
5416666|NCT02603432|18692721|P1|Overall Study|Lost to Follow-up|4
5416667|NCT02603432|18692720|P2|Overall Study|Death|177
5416668|NCT02603432|18692721|P1|Overall Study|Death|144
5416669|NCT02603432|18692720|P2|Overall Study|Adverse Event|0
5416670|NCT02603432|18692721|P1|Overall Study|Adverse Event|1
5416671|NCT02603432|18692720|P2|Overall Study|Ongoing|144
5416672|NCT02603432|18692721|P1|Overall Study|Ongoing|184
5416673|NCT02603419|18692775|P6|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
5416674|NCT02603419|18692776|P5|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5416675|NCT02603419|18692777|P4|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5416676|NCT02603419|18692778|P3|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5416677|NCT02603419|18692779|P2|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5416678|NCT02603419|18692780|P1|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
5416679|NCT02603419|18692775|P6|Expansion Phase:Maximum Exposure:48Weeks|Death|1
5416680|NCT02603419|18692776|P5|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5416681|NCT02603419|18692777|P4|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5416682|NCT02603419|18692778|P3|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5416683|NCT02603419|18692779|P2|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5416684|NCT02603419|18692780|P1|Expansion Phase:Maximum Exposure:48Weeks|Death|0
5416685|NCT02603419|18692775|P6|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
5416686|NCT02603419|18692776|P5|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5416687|NCT02603419|18692777|P4|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5416688|NCT02603419|18692778|P3|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5416689|NCT02603419|18692779|P2|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5416690|NCT02603419|18692780|P1|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
5416691|NCT02603419|18692775|P6|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5416692|NCT02603419|18692776|P5|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5416693|NCT02603419|18692777|P4|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
5416694|NCT02603419|18692778|P3|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5416695|NCT02603419|18692779|P2|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5416696|NCT02603419|18692780|P1|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
5416697|NCT02603419|18692775|P6|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
5416698|NCT02603419|18692776|P5|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
5416699|NCT02603419|18692777|P4|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
5416700|NCT02603419|18692778|P3|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
5416701|NCT02603419|18692779|P2|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
5416702|NCT02603419|18692780|P1|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
5416703|NCT02603419|18692775|P6|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5416704|NCT02603419|18692776|P5|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5416705|NCT02603419|18692777|P4|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5416706|NCT02603419|18692778|P3|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5416707|NCT02603419|18692779|P2|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
5416708|NCT02603419|18692780|P1|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
5416709|NCT02603419|18692775|P6|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5416710|NCT02603419|18692776|P5|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
5416711|NCT02603419|18692777|P4|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5416712|NCT02603419|18692778|P3|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5416713|NCT02603419|18692779|P2|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5416714|NCT02603419|18692780|P1|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
5416715|NCT02603419|18692775|P6|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
5416716|NCT02603419|18692776|P5|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
5416717|NCT02603419|18692777|P4|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
5416718|NCT02603419|18692778|P3|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
5416719|NCT02603419|18692779|P2|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
5416720|NCT02603419|18692780|P1|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
5416721|NCT02603419|18692775|P6|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
5416722|NCT02603419|18692776|P5|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
5416723|NCT02603419|18692777|P4|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
5416724|NCT02603419|18692778|P3|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
5416725|NCT02603419|18692779|P2|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
5416726|NCT02603419|18692780|P1|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
5416727|NCT02603419|18692775|P6|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5416728|NCT02603419|18692776|P5|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5416729|NCT02603419|18692777|P4|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5416730|NCT02603419|18692778|P3|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5416731|NCT02603419|18692779|P2|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
5416732|NCT02603419|18692780|P1|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
5416733|NCT02603393|18692967|P2|Overall Study|Sponsor decision|0
5416734|NCT02603393|18692968|P1|Overall Study|Sponsor decision|1
5416735|NCT02603393|18692967|P2|Overall Study|Non-compliance with study treatment|0
5416736|NCT02603393|18692968|P1|Overall Study|Non-compliance with study treatment|1
5416737|NCT02603393|18692967|P2|Overall Study|Lost to Follow-up|2
5416738|NCT02603393|18692968|P1|Overall Study|Lost to Follow-up|1
5416739|NCT02603393|18692967|P2|Overall Study|Protocol deviation|3
5416740|NCT02603393|18692968|P1|Overall Study|Protocol deviation|2
5416741|NCT02603393|18692967|P2|Overall Study|Physician Decision|3
5416742|NCT02603393|18692968|P1|Overall Study|Physician Decision|3
5416743|NCT02603393|18692967|P2|Overall Study|Death|4
5416744|NCT02603393|18692968|P1|Overall Study|Death|3
5416745|NCT02603393|18692967|P2|Overall Study|Lack of Efficacy|2
5416746|NCT02603393|18692968|P1|Overall Study|Lack of Efficacy|7
5416747|NCT02603393|18692967|P2|Overall Study|Technical problems|7
5416748|NCT02603393|18692968|P1|Overall Study|Technical problems|4
5416749|NCT02603393|18692967|P2|Overall Study|Adverse Event|15
5416750|NCT02603393|18692968|P1|Overall Study|Adverse Event|17
5416751|NCT02603393|18692967|P2|Overall Study|Patient/guardian decision|18
5416752|NCT02603393|18692968|P1|Overall Study|Patient/guardian decision|32
5416753|NCT02603172|18693007|P8|Part A (Approximately 16 Weeks)|Adverse Event|0
5416754|NCT02603172|18693008|P7|Part A (Approximately 16 Weeks)|Adverse Event|0
5416755|NCT02603172|18693009|P6|Part A (Approximately 16 Weeks)|Adverse Event|0
5416756|NCT02603172|18693010|P5|Part A (Approximately 16 Weeks)|Adverse Event|0
5416757|NCT02603172|18693011|P4|Part A (Approximately 16 Weeks)|Adverse Event|0
5416758|NCT02603172|18693012|P3|Part A (Approximately 16 Weeks)|Adverse Event|1
5416759|NCT02603172|18693013|P2|Part A (Approximately 16 Weeks)|Adverse Event|0
5416760|NCT02603172|18693014|P1|Part A (Approximately 16 Weeks)|Adverse Event|0
5416761|NCT02603120|18693142|P2|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
5416762|NCT02603120|18693143|P1|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
5416763|NCT02603120|18693142|P2|OL Extension B/F/TAF Treatment Phase|Death|1
5416764|NCT02603120|18693143|P1|OL Extension B/F/TAF Treatment Phase|Death|0
5416765|NCT02603120|18693142|P2|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
5416766|NCT02603120|18693143|P1|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
5416767|NCT02603120|18693142|P2|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
5416768|NCT02603120|18693143|P1|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
5416769|NCT02603120|18693142|P2|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
5416770|NCT02603120|18693143|P1|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
5416771|NCT02603120|18693142|P2|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
5416772|NCT02603120|18693143|P1|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
5416773|NCT02603120|18693142|P2|Double-Blind Treatment Phase|Did not receive study drug|2
5416774|NCT02603120|18693143|P1|Double-Blind Treatment Phase|Did not receive study drug|2
5416775|NCT02603120|18693142|P2|Double-Blind Treatment Phase|Non-compliance with study drug|0
5416776|NCT02603120|18693143|P1|Double-Blind Treatment Phase|Non-compliance with study drug|1
5416777|NCT02603120|18693142|P2|Double-Blind Treatment Phase|Pregnancy|1
5416778|NCT02603120|18693143|P1|Double-Blind Treatment Phase|Pregnancy|1
5416779|NCT02603120|18693142|P2|Double-Blind Treatment Phase|Investigator's discretion|0
5416780|NCT02603120|18693143|P1|Double-Blind Treatment Phase|Investigator's discretion|2
5416781|NCT02603120|18693142|P2|Double-Blind Treatment Phase|Death|0
5416782|NCT02603120|18693143|P1|Double-Blind Treatment Phase|Death|2
5416783|NCT02603120|18693142|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
5416784|NCT02603120|18693143|P1|Double-Blind Treatment Phase|Lost to Follow-up|4
5416785|NCT02603120|18693142|P2|Double-Blind Treatment Phase|Adverse Event|3
5416786|NCT02603120|18693143|P1|Double-Blind Treatment Phase|Adverse Event|3
5416787|NCT02603120|18693142|P2|Double-Blind Treatment Phase|Withdrew consent|8
5416788|NCT02603120|18693143|P1|Double-Blind Treatment Phase|Withdrew consent|4
5416789|NCT02603107|18693165|P2|Optional Extension Phase|Protocol Violation|0
5416790|NCT02603107|18693166|P1|Optional Extension Phase|Protocol Violation|1
5416791|NCT02603107|18693165|P2|Optional Extension Phase|Not treated in extension phase|1
5416792|NCT02603107|18693166|P1|Optional Extension Phase|Not treated in extension phase|0
5416793|NCT02603107|18693165|P2|Optional Extension Phase|Adverse Event|2
5416794|NCT02603107|18693166|P1|Optional Extension Phase|Adverse Event|0
5416795|NCT02603107|18693165|P2|Optional Extension Phase|Pregnancy|3
5416796|NCT02603107|18693166|P1|Optional Extension Phase|Pregnancy|0
5416797|NCT02603107|18693165|P2|Optional Extension Phase|Investigator's discretion|2
5416798|NCT02603107|18693166|P1|Optional Extension Phase|Investigator's discretion|2
5416799|NCT02603107|18693165|P2|Optional Extension Phase|Withdrew consent|2
5416800|NCT02603107|18693166|P1|Optional Extension Phase|Withdrew consent|3
5416801|NCT02603107|18693165|P2|Optional Extension Phase|Lost to Follow-up|3
5416802|NCT02603107|18693166|P1|Optional Extension Phase|Lost to Follow-up|3
5416803|NCT02603107|18693165|P2|Randomized Phase|Protocol Violation|0
5416804|NCT02603107|18693166|P1|Randomized Phase|Protocol Violation|1
5416805|NCT02603107|18693165|P2|Randomized Phase|Lack of Efficacy|0
5416806|NCT02603107|18693166|P1|Randomized Phase|Lack of Efficacy|1
5416807|NCT02603107|18693165|P2|Randomized Phase|Investigator's discretion|1
5416808|NCT02603107|18693166|P1|Randomized Phase|Investigator's discretion|0
5416809|NCT02603107|18693165|P2|Randomized Phase|Non-compliance with study drug|1
5416810|NCT02603107|18693166|P1|Randomized Phase|Non-compliance with study drug|1
5416811|NCT02603107|18693165|P2|Randomized Phase|Death|1
5416812|NCT02603107|18693166|P1|Randomized Phase|Death|1
5416813|NCT02603107|18693165|P2|Randomized Phase|Adverse Event|0
5416814|NCT02603107|18693166|P1|Randomized Phase|Adverse Event|2
5416815|NCT02603107|18693165|P2|Randomized Phase|Lost to Follow-up|3
5416816|NCT02603107|18693166|P1|Randomized Phase|Lost to Follow-up|1
5416817|NCT02603107|18693165|P2|Randomized Phase|Withdrew consent|15
5416818|NCT02603107|18693166|P1|Randomized Phase|Withdrew consent|8
5416819|NCT02602080|18693231|P3|Overall Study|Protocol Violation|3
5416820|NCT02602080|18693232|P2|Overall Study|Protocol Violation|1
5416821|NCT02602080|18693233|P1|Overall Study|Protocol Violation|6
5416822|NCT02601820|18693276|P1|1-Yr Post-Treatment (T5)|Missing T5 Record|88
5416823|NCT02601820|18693276|P1|12 Weeks Post-Treatment (T4)|Missing T4 record|3
5416824|NCT02601820|18693276|P1|Late On-Treatment (T3)|missing T3 Record|49
5416825|NCT02601820|18693276|P1|Early On-Treatment (T2)|Missing T2 Record|51
5416826|NCT02601625|18693305|P4|Overall Study|Lost to Follow-up|1
5416827|NCT02601625|18693306|P3|Overall Study|Lost to Follow-up|1
5416828|NCT02601625|18693307|P2|Overall Study|Lost to Follow-up|0
5416829|NCT02601625|18693308|P1|Overall Study|Lost to Follow-up|0
5416830|NCT02601573|18693361|P5|Overall Study|Withdrawal by Subject|0
5416831|NCT02601573|18693362|P4|Overall Study|Withdrawal by Subject|1
5416832|NCT02601573|18693363|P3|Overall Study|Withdrawal by Subject|0
5416833|NCT02601573|18693364|P2|Overall Study|Withdrawal by Subject|1
5416834|NCT02601573|18693365|P1|Overall Study|Withdrawal by Subject|0
5416835|NCT02601573|18693361|P5|Overall Study|Lost to Follow-up|2
5416836|NCT02601573|18693362|P4|Overall Study|Lost to Follow-up|0
5416837|NCT02601573|18693363|P3|Overall Study|Lost to Follow-up|1
5416838|NCT02601573|18693364|P2|Overall Study|Lost to Follow-up|3
5416839|NCT02601573|18693365|P1|Overall Study|Lost to Follow-up|0
5416840|NCT02601560|18693400|P8|Overall Study|Other|0
5416841|NCT02601560|18693401|P7|Overall Study|Other|1
5416842|NCT02601560|18693402|P6|Overall Study|Other|0
5416843|NCT02601560|18693403|P5|Overall Study|Other|0
5416844|NCT02601560|18693404|P4|Overall Study|Other|0
5416845|NCT02601560|18693405|P3|Overall Study|Other|0
5416846|NCT02601560|18693406|P2|Overall Study|Other|0
5416847|NCT02601560|18693407|P1|Overall Study|Other|0
5416848|NCT02601469|18693591|P2|Overall Study|Enrolled in Error|0
5416849|NCT02601469|18693592|P1|Overall Study|Enrolled in Error|1
5416850|NCT02601313|18693601|P3|Overall Study|Enrolled, did not initiate AC|0
5416851|NCT02601313|18693602|P2|Overall Study|Enrolled, did not initiate AC|0
5416852|NCT02601313|18693603|P1|Overall Study|Enrolled, did not initiate AC|4
5416853|NCT02601313|18693601|P3|Overall Study|Still on study|10
5416854|NCT02601313|18693602|P2|Overall Study|Still on study|52
5416855|NCT02601313|18693603|P1|Overall Study|Still on study|0
5416856|NCT02601313|18693601|P3|Overall Study|Enrolled, did not initiate KTE-X19|1
5416857|NCT02601313|18693602|P2|Overall Study|Enrolled, did not initiate KTE-X19|1
5416858|NCT02601313|18693603|P1|Overall Study|Enrolled, did not initiate KTE-X19|0
5416859|NCT02601313|18693601|P3|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
5416860|NCT02601313|18693602|P2|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
5416861|NCT02601313|18693603|P1|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
5416862|NCT02601313|18693601|P3|Overall Study|Death|4
5416863|NCT02601313|18693602|P2|Overall Study|Death|16
5416864|NCT02601313|18693603|P1|Overall Study|Death|2
5416865|NCT02601300|18693622|P1|Extension Phase|Lack of Efficacy|10
5416866|NCT02601300|18693622|P1|Extension Phase|Adverse Event|4
5416867|NCT02601300|18693622|P1|Extension Phase|Withdrawal by Subject|3
5416868|NCT02601300|18693622|P1|Induction Phase|Protocol Violation|1
5416869|NCT02601300|18693622|P1|Induction Phase|Lack of Efficacy|2
5416870|NCT02601209|18693642|P9|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5416871|NCT02601209|18693643|P8|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5416872|NCT02601209|18693644|P7|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
5416873|NCT02601209|18693645|P6|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
5416874|NCT02601209|18693646|P5|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
5416875|NCT02601209|18693647|P4|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5416876|NCT02601209|18693648|P3|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5416877|NCT02601209|18693649|P2|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5416878|NCT02601209|18693650|P1|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
5416879|NCT02601209|18693642|P9|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5416880|NCT02601209|18693643|P8|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5416881|NCT02601209|18693644|P7|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5416882|NCT02601209|18693645|P6|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5416883|NCT02601209|18693646|P5|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5416884|NCT02601209|18693647|P4|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
5416885|NCT02601209|18693648|P3|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
5416886|NCT02601209|18693649|P2|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
5416887|NCT02601209|18693650|P1|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
5416888|NCT02600923|18693697|P1|Overall Study|Not treated|1
5416889|NCT02600923|18693697|P1|Overall Study|Study terminated by Sponsor|53
5416890|NCT02600923|18693697|P1|Overall Study|Objective progression or relapse|50
5416891|NCT02600923|18693697|P1|Overall Study|Withdrawal by Subject|5
5416892|NCT02600923|18693697|P1|Overall Study|Lost to Follow-up|1
5416893|NCT02600923|18693697|P1|Overall Study|Insufficient clinical response|6
5416894|NCT02600923|18693697|P1|Overall Study|Global deterioration of health status|2
5416895|NCT02600923|18693697|P1|Overall Study|Adverse Event|3
5416896|NCT02600923|18693697|P1|Overall Study|Death|10
5416897|NCT02600871|18693707|P2|Overall Study|Lost to Follow-up|10
5416898|NCT02600871|18693708|P1|Overall Study|Lost to Follow-up|13
5416899|NCT02600845|18693718|P1|Overall Study|Consent Withdrawal|5
5416900|NCT02600845|18693718|P1|Overall Study|Non-compliance with Study Procedures|10
5416901|NCT02600845|18693718|P1|Overall Study|Reason Not Specified|3
5416902|NCT02600819|18693733|P2|GEN Phase|Lost to Follow-up|0
5416903|NCT02600819|18693734|P1|GEN Phase|Lost to Follow-up|2
5416904|NCT02600819|18693733|P2|GEN Phase|Withdrew Consent|0
5416905|NCT02600819|18693734|P1|GEN Phase|Withdrew Consent|5
5416906|NCT02600819|18693733|P2|GEN Phase|Non-Compliance with Study Drug|0
5416907|NCT02600819|18693734|P1|GEN Phase|Non-Compliance with Study Drug|1
5416908|NCT02600819|18693733|P2|GEN Phase|Investigator's Discretion|0
5416909|NCT02600819|18693734|P1|GEN Phase|Investigator's Discretion|4
5416910|NCT02600819|18693733|P2|GEN Phase|Death|0
5416911|NCT02600819|18693734|P1|GEN Phase|Death|2
5416912|NCT02600819|18693733|P2|GEN Phase|Adverse Event|0
5416913|NCT02600819|18693734|P1|GEN Phase|Adverse Event|2
5416914|NCT02600559|18693814|P1|Overall Study|Lost to Follow-up|20
5416915|NCT02600559|18693814|P1|Overall Study|Withdrawal by Subject|3
5416916|NCT02600351|18693855|P4|Overall Study|Randomized but Not Treated|3
5416917|NCT02600351|18693856|P3|Overall Study|Randomized but Not Treated|1
5416918|NCT02600351|18693857|P2|Overall Study|Randomized but Not Treated|0
5416919|NCT02600351|18693858|P1|Overall Study|Randomized but Not Treated|1
5416920|NCT02600351|18693855|P4|Overall Study|Lost to Follow-up|0
5416921|NCT02600351|18693856|P3|Overall Study|Lost to Follow-up|0
5416922|NCT02600351|18693857|P2|Overall Study|Lost to Follow-up|0
5416923|NCT02600351|18693858|P1|Overall Study|Lost to Follow-up|1
5416924|NCT02600351|18693855|P4|Overall Study|Lack of Efficacy|2
5416925|NCT02600351|18693856|P3|Overall Study|Lack of Efficacy|5
5416926|NCT02600351|18693857|P2|Overall Study|Lack of Efficacy|0
5416927|NCT02600351|18693858|P1|Overall Study|Lack of Efficacy|3
5416928|NCT02599961|18693893|P1|Overall Study|Other, Not Specified|3
5416929|NCT02599961|18693893|P1|Overall Study|Discontinuation of Study by Sponsor|9
5416930|NCT02599961|18693893|P1|Overall Study|Subject Non-Compliance|2
5416931|NCT02599961|18693893|P1|Overall Study|Withdrawal by Subject|1
5416932|NCT02599688|18693935|P1|Overall Study|Termination by Sponsor|2
5416933|NCT02599688|18693935|P1|Overall Study|Withdrawal by Subject|1
5416934|NCT02599688|18693935|P1|Overall Study|Lack of Efficacy|1
5416935|NCT02599129|18693971|P2|Overall Study|Withdrawal by Subject|1
5416936|NCT02599129|18693972|P1|Overall Study|Withdrawal by Subject|2
5416937|NCT02599129|18693971|P2|Overall Study|Lost to Follow-up|0
5416938|NCT02599129|18693972|P1|Overall Study|Lost to Follow-up|1
5416939|NCT02599129|18693971|P2|Overall Study|Lack of Efficacy|2
5416940|NCT02599129|18693972|P1|Overall Study|Lack of Efficacy|2
5416941|NCT02598934|18693988|P2|Overall Study|Protocol Violation|2
5416942|NCT02598934|18693989|P1|Overall Study|Protocol Violation|1
5416943|NCT02598934|18693988|P2|Overall Study|Administrative|1
5416944|NCT02598934|18693989|P1|Overall Study|Administrative|2
5416945|NCT02598934|18693988|P2|Overall Study|Withdrawal by Subject|3
5416946|NCT02598934|18693989|P1|Overall Study|Withdrawal by Subject|2
5416947|NCT02598934|18693988|P2|Overall Study|Failure to Return|3
5416948|NCT02598934|18693989|P1|Overall Study|Failure to Return|3
5416949|NCT02598934|18693988|P2|Overall Study|Adverse Event|13
5416950|NCT02598934|18693989|P1|Overall Study|Adverse Event|11
5416951|NCT02598622|18694001|P2|Overall Study|Physician Decision|0
5416952|NCT02598622|18694002|P1|Overall Study|Physician Decision|3
5416953|NCT02598622|18694001|P2|Overall Study|Withdrawal by Subject|0
5416954|NCT02598622|18694002|P1|Overall Study|Withdrawal by Subject|3
5416955|NCT02598297|18694031|P2|Overall Study|Followed for survival|0
5416956|NCT02598297|18694032|P1|Overall Study|Followed for survival|1
5416957|NCT02598297|18694031|P2|Overall Study|Subject/guardian decision|0
5416958|NCT02598297|18694032|P1|Overall Study|Subject/guardian decision|1
5416959|NCT02598297|18694031|P2|Overall Study|Physician Decision|0
5416960|NCT02598297|18694032|P1|Overall Study|Physician Decision|1
5416961|NCT02598297|18694031|P2|Overall Study|Adverse Event|1
5416962|NCT02598297|18694032|P1|Overall Study|Adverse Event|1
5416963|NCT02598297|18694031|P2|Overall Study|Study terminated by Sponsor|23
5416964|NCT02598297|18694032|P1|Overall Study|Study terminated by Sponsor|21
5416965|NCT02598193|18694058|P1|Overall Study|Does not want to take Nintedanib|1
5416966|NCT02598193|18694058|P1|Overall Study|Listed in active lung transplant list|1
5416967|NCT02598193|18694058|P1|Overall Study|Withdrawal by Subject|1
5416968|NCT02598193|18694058|P1|Overall Study|Adverse Event|13
5416969|NCT02598128|18694066|P4|Period A: Days -7 to -1|Adverse Event|0
5416970|NCT02598128|18694067|P3|Period A: Days -7 to -1|Adverse Event|0
5416971|NCT02598128|18694068|P2|Period A: Days -7 to -1|Adverse Event|0
5416972|NCT02598128|18694069|P1|Period A: Days -7 to -1|Adverse Event|1
5416973|NCT02598076|18694112|P2|Overall Study|Lost to Follow-up|3
5416974|NCT02598076|18694113|P1|Overall Study|Lost to Follow-up|2
5416975|NCT02597946|18694127|P1|Overall Study|Other than above|1
5416976|NCT02597946|18694127|P1|Overall Study|Progressive disease|16
5416977|NCT02597946|18694127|P1|Overall Study|Withdrawal by Subject|1
5416978|NCT02597933|18694138|P2|Overall Study|Other than stated above|14
5416979|NCT02597933|18694139|P1|Overall Study|Other than stated above|7
5416980|NCT02597933|18694138|P2|Overall Study|Not treated|2
5416981|NCT02597933|18694139|P1|Overall Study|Not treated|2
5416982|NCT02597933|18694138|P2|Overall Study|Adverse Event|28
5416983|NCT02597933|18694139|P1|Overall Study|Adverse Event|20
5416984|NCT02597933|18694138|P2|Overall Study|Protocol Violation|2
5416985|NCT02597933|18694139|P1|Overall Study|Protocol Violation|2
5416986|NCT02597933|18694138|P2|Overall Study|Withdrawal by Subject|5
5416987|NCT02597933|18694139|P1|Overall Study|Withdrawal by Subject|7
5416988|NCT02597920|18694170|P3|Overall Study|Other|0
5416989|NCT02597920|18694171|P2|Overall Study|Other|0
5416990|NCT02597920|18694172|P1|Overall Study|Other|1
5416991|NCT02597920|18694170|P3|Overall Study|Other than specified|5
5416992|NCT02597920|18694171|P2|Overall Study|Other than specified|31
5416993|NCT02597920|18694172|P1|Overall Study|Other than specified|10
5416994|NCT02597920|18694170|P3|Overall Study|Refuse to continue in the study|1
5416995|NCT02597920|18694171|P2|Overall Study|Refuse to continue in the study|13
5416996|NCT02597920|18694172|P1|Overall Study|Refuse to continue in the study|3
5416997|NCT02597920|18694170|P3|Overall Study|Lost to Follow-up|0
5416998|NCT02597920|18694171|P2|Overall Study|Lost to Follow-up|9
5416999|NCT02597920|18694172|P1|Overall Study|Lost to Follow-up|7
5417000|NCT02597920|18694170|P3|Overall Study|Other adverse event|0
5417001|NCT02597920|18694171|P2|Overall Study|Other adverse event|30
5417002|NCT02597920|18694172|P1|Overall Study|Other adverse event|20
5417003|NCT02597920|18694170|P3|Overall Study|Worsening of other pre-existing disease|0
5417004|NCT02597920|18694171|P2|Overall Study|Worsening of other pre-existing disease|1
5417005|NCT02597920|18694172|P1|Overall Study|Worsening of other pre-existing disease|0
5417006|NCT02597855|18694206|P2|Overall Study|Lost to Follow-up|1
5417007|NCT02597855|18694207|P1|Overall Study|Lost to Follow-up|2
5417008|NCT02597478|18694312|P2|Overall Study|Insufficient exertional dyspnea|1
5417009|NCT02597478|18694313|P1|Overall Study|Insufficient exertional dyspnea|0
5417010|NCT02597478|18694312|P2|Overall Study|Change of opioid dose|0
5417011|NCT02597478|18694313|P1|Overall Study|Change of opioid dose|1
5417012|NCT02597478|18694312|P2|Overall Study|Withdrawal by Subject|0
5417013|NCT02597478|18694313|P1|Overall Study|Withdrawal by Subject|2
5417014|NCT02597452|18694327|P1|Overall Study|testing incomplete|30
5417015|NCT02597062|18694439|P1|Overall Study|Ineligible|1
5417016|NCT02597049|18694448|P3|Overall Study|Noncompliant with Study Visits|0
5417017|NCT02597049|18694449|P2|Overall Study|Noncompliant with Study Visits|0
5417018|NCT02597049|18694450|P1|Overall Study|Noncompliant with Study Visits|1
5417019|NCT02597049|18694448|P3|Overall Study|Death|0
5417020|NCT02597049|18694449|P2|Overall Study|Death|0
5417021|NCT02597049|18694450|P1|Overall Study|Death|2
5417022|NCT02597049|18694448|P3|Overall Study|Adverse Event|0
5417023|NCT02597049|18694449|P2|Overall Study|Adverse Event|0
5417024|NCT02597049|18694450|P1|Overall Study|Adverse Event|2
5417025|NCT02597049|18694448|P3|Overall Study|Withdrawal by Subject|1
5417026|NCT02597049|18694449|P2|Overall Study|Withdrawal by Subject|2
5417027|NCT02597049|18694450|P1|Overall Study|Withdrawal by Subject|2
5417028|NCT02597049|18694448|P3|Overall Study|Lost to Follow-up|2
5417029|NCT02597049|18694449|P2|Overall Study|Lost to Follow-up|3
5417030|NCT02597049|18694450|P1|Overall Study|Lost to Follow-up|0
5417031|NCT02596971|18694491|P3|Overall Study|Death|0
5417032|NCT02596971|18694492|P2|Overall Study|Death|0
5417033|NCT02596971|18694493|P1|Overall Study|Death|2
5417034|NCT02596971|18694491|P3|Overall Study|In Follow-up|15
5417035|NCT02596971|18694492|P2|Overall Study|In Follow-up|0
5417036|NCT02596971|18694493|P1|Overall Study|In Follow-up|4
5417037|NCT02596971|18694491|P3|Overall Study|Ongoing|24
5417038|NCT02596971|18694492|P2|Overall Study|Ongoing|6
5417039|NCT02596971|18694493|P1|Overall Study|Ongoing|36
5417040|NCT02596971|18694491|P3|Overall Study|Withdrawal by Subject|2
5417041|NCT02596971|18694492|P2|Overall Study|Withdrawal by Subject|0
5417042|NCT02596971|18694493|P1|Overall Study|Withdrawal by Subject|0
5417043|NCT02596971|18694491|P3|Overall Study|Physician Decision|1
5417044|NCT02596971|18694492|P2|Overall Study|Physician Decision|0
5417045|NCT02596971|18694493|P1|Overall Study|Physician Decision|0
5417046|NCT02596971|18694491|P3|Overall Study|Disease Progression|0
5417047|NCT02596971|18694492|P2|Overall Study|Disease Progression|1
5417048|NCT02596971|18694493|P1|Overall Study|Disease Progression|0
5417049|NCT02596958|18694522|P1|Overall Study|Excluded Due to Second Line Treatment|9
5417050|NCT02596958|18694522|P1|Overall Study|Missing|32
5417051|NCT02596958|18694522|P1|Overall Study|Lost to Follow-up|33
5417052|NCT02596958|18694522|P1|Overall Study|Administrative Reasons/Other|231
5417053|NCT02596958|18694522|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
5417054|NCT02596958|18694522|P1|Overall Study|Death From Other Cause|33
5417055|NCT02596958|18694522|P1|Overall Study|Death From Cancer|112
5417056|NCT02596958|18694522|P1|Overall Study|Cancer Progression|441
5417057|NCT02596958|18694522|P1|Overall Study|Serious Adverse Drug Reactions|44
5417058|NCT02596945|18694534|P1|Overall Study|Missing|1
5417059|NCT02596945|18694534|P1|Overall Study|Withdrawal by Subject|1
5417060|NCT02596945|18694534|P1|Overall Study|Other Erythropoietin stimulating agent|4
5417061|NCT02596945|18694534|P1|Overall Study|Change to hemodialysis|15
5417062|NCT02596945|18694534|P1|Overall Study|Other|32
5417063|NCT02596945|18694534|P1|Overall Study|No documentation of study drug dosing|3
5417064|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Early Escape|70
5417065|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Early Escape|69
5417066|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Early Escape|76
5417067|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Early Escape|66
5417068|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
5417069|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
5417070|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
5417071|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
5417072|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Death|0
5417073|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Death|1
5417074|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Death|0
5417075|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Death|0
5417076|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
5417077|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
5417078|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
5417079|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
5417080|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
5417081|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
5417082|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
5417083|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
5417084|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
5417085|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
5417086|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
5417087|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
5417088|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
5417089|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
5417090|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
5417091|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
5417092|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
5417093|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
5417094|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
5417095|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
5417096|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
5417097|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
5417098|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
5417099|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
5417100|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
5417101|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
5417102|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
5417103|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
5417104|NCT02596893|18694555|P4|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
5417105|NCT02596893|18694556|P3|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
5417106|NCT02596893|18694557|P2|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
5417107|NCT02596893|18694558|P1|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
5417108|NCT02596854|18694617|P1|Overall Study|Withdrawn|8
5417109|NCT02596711|18694639|P3|Overall Study|Lost to Follow-up|3
5417110|NCT02596711|18694640|P2|Overall Study|Lost to Follow-up|2
5417111|NCT02596711|18694641|P1|Overall Study|Lost to Follow-up|1
5417112|NCT02596620|18694657|P2|Overall Study|Lost to Follow-up|1
5417113|NCT02596620|18694658|P1|Overall Study|Lost to Follow-up|1
5417114|NCT02596230|18694696|P5|Objective 2, One Year|Other|0
5417115|NCT02596230|18694697|P4|Objective 2, One Year|Other|0
5417116|NCT02596230|18694698|P3|Objective 2, One Year|Other|2
5417117|NCT02596230|18694699|P2|Objective 2, One Year|Other|3
5417118|NCT02596230|18694700|P1|Objective 2, One Year|Other|0
5417119|NCT02596230|18694696|P5|Objective 2, One Year|Death|30
5417120|NCT02596230|18694697|P4|Objective 2, One Year|Death|21
5417121|NCT02596230|18694698|P3|Objective 2, One Year|Death|41
5417122|NCT02596230|18694699|P2|Objective 2, One Year|Death|12
5417123|NCT02596230|18694700|P1|Objective 2, One Year|Death|0
5417124|NCT02596230|18694696|P5|Objective 2, One Year|Adverse drug reaction|0
5417125|NCT02596230|18694697|P4|Objective 2, One Year|Adverse drug reaction|0
5417126|NCT02596230|18694698|P3|Objective 2, One Year|Adverse drug reaction|0
5417127|NCT02596230|18694699|P2|Objective 2, One Year|Adverse drug reaction|1
5417128|NCT02596230|18694700|P1|Objective 2, One Year|Adverse drug reaction|0
5417129|NCT02596230|18694696|P5|Objective 2, One Year|Withdrawal by Subject|2
5417130|NCT02596230|18694697|P4|Objective 2, One Year|Withdrawal by Subject|5
5417131|NCT02596230|18694698|P3|Objective 2, One Year|Withdrawal by Subject|14
5417132|NCT02596230|18694699|P2|Objective 2, One Year|Withdrawal by Subject|11
5417133|NCT02596230|18694700|P1|Objective 2, One Year|Withdrawal by Subject|0
5417134|NCT02596230|18694696|P5|Objective 2, One Year|Lost to Follow-up|46
5417135|NCT02596230|18694697|P4|Objective 2, One Year|Lost to Follow-up|32
5417136|NCT02596230|18694698|P3|Objective 2, One Year|Lost to Follow-up|41
5417137|NCT02596230|18694699|P2|Objective 2, One Year|Lost to Follow-up|41
5417138|NCT02596230|18694700|P1|Objective 2, One Year|Lost to Follow-up|0
5417139|NCT02596230|18694696|P5|Screening Period for Objective 2|Participants not participating in obj 2|0
5417140|NCT02596230|18694697|P4|Screening Period for Objective 2|Participants not participating in obj 2|846
5417141|NCT02596230|18694698|P3|Screening Period for Objective 2|Participants not participating in obj 2|0
5417142|NCT02596230|18694699|P2|Screening Period for Objective 2|Participants not participating in obj 2|228
5417143|NCT02596230|18694700|P1|Screening Period for Objective 2|Participants not participating in obj 2|3714
5417144|NCT02596035|18694724|P3|Overall Study|Other Reasons|0
5417145|NCT02596035|18694725|P2|Overall Study|Other Reasons|4
5417146|NCT02596035|18694726|P1|Overall Study|Other Reasons|3
5417147|NCT02596035|18694724|P3|Overall Study|Poor/Non-Compliance|0
5417148|NCT02596035|18694725|P2|Overall Study|Poor/Non-Compliance|1
5417149|NCT02596035|18694726|P1|Overall Study|Poor/Non-Compliance|0
5417150|NCT02596035|18694724|P3|Overall Study|Withdrawal by Subject|0
5417151|NCT02596035|18694725|P2|Overall Study|Withdrawal by Subject|2
5417152|NCT02596035|18694726|P1|Overall Study|Withdrawal by Subject|4
5417153|NCT02596035|18694724|P3|Overall Study|Adverse Event|0
5417154|NCT02596035|18694725|P2|Overall Study|Adverse Event|2
5417155|NCT02596035|18694726|P1|Overall Study|Adverse Event|6
5417156|NCT02596035|18694724|P3|Overall Study|Study Drug Toxicity|0
5417157|NCT02596035|18694725|P2|Overall Study|Study Drug Toxicity|3
5417158|NCT02596035|18694726|P1|Overall Study|Study Drug Toxicity|11
5417159|NCT02596035|18694724|P3|Overall Study|Disease Progression|1
5417160|NCT02596035|18694725|P2|Overall Study|Disease Progression|32
5417161|NCT02596035|18694726|P1|Overall Study|Disease Progression|62
5417162|NCT02596009|18694762|P6|Overall Study|Administrative problems|0
5417163|NCT02596009|18694763|P5|Overall Study|Administrative problems|0
5417164|NCT02596009|18694764|P4|Overall Study|Administrative problems|0
5417165|NCT02596009|18694765|P3|Overall Study|Administrative problems|0
5417166|NCT02596009|18694766|P2|Overall Study|Administrative problems|1
5417167|NCT02596009|18694767|P1|Overall Study|Administrative problems|0
5417168|NCT02595970|18694784|P1|Overall Study|Lack of Efficacy|7
5417169|NCT02595970|18694784|P1|Overall Study|Adverse Event|5
5417170|NCT02595970|18694784|P1|Overall Study|Protocol Violation|4
5417171|NCT02595970|18694784|P1|Overall Study|Physician Decision|2
5417172|NCT02595970|18694784|P1|Overall Study|Withdrawal by Subject|2
5417173|NCT02595723|18694801|P3|First Washout (21 Days)|Lost to Follow-up|0
5417174|NCT02595723|18694802|P2|First Washout (21 Days)|Lost to Follow-up|0
5417175|NCT02595723|18694803|P1|First Washout (21 Days)|Lost to Follow-up|1
5417176|NCT02595723|18694801|P3|First Washout (21 Days)|Withdrawal by Subject|0
5417177|NCT02595723|18694802|P2|First Washout (21 Days)|Withdrawal by Subject|0
5417178|NCT02595723|18694803|P1|First Washout (21 Days)|Withdrawal by Subject|1
5417179|NCT02595528|18694860|P4|Overall Study|Lost to Follow-up|1
5417180|NCT02595528|18694861|P3|Overall Study|Lost to Follow-up|0
5417181|NCT02595528|18694862|P2|Overall Study|Lost to Follow-up|1
5417182|NCT02595528|18694863|P1|Overall Study|Lost to Follow-up|1
5417183|NCT02595528|18694860|P4|Overall Study|Withdrawal by Subject|3
5417184|NCT02595528|18694861|P3|Overall Study|Withdrawal by Subject|1
5417185|NCT02595528|18694862|P2|Overall Study|Withdrawal by Subject|2
5417186|NCT02595528|18694863|P1|Overall Study|Withdrawal by Subject|1
5417187|NCT02595502|18694873|P2|Period 3|Received Incorrect Treatment at period 3|1
5417188|NCT02595502|18694874|P1|Period 3|Received Incorrect Treatment at period 3|0
5417189|NCT02595502|18694873|P2|Period 3|Lost to Follow-up|0
5417190|NCT02595502|18694874|P1|Period 3|Lost to Follow-up|1
5417191|NCT02595502|18694873|P2|Period 3|Protocol Violation|1
5417192|NCT02595502|18694874|P1|Period 3|Protocol Violation|0
5417193|NCT02595502|18694873|P2|Period 2|Received incorrect lens at Period 1|1
5417194|NCT02595502|18694874|P1|Period 2|Received incorrect lens at Period 1|0
5417195|NCT02595502|18694873|P2|Period 2|Adverse Event|1
5417196|NCT02595502|18694874|P1|Period 2|Adverse Event|1
5417197|NCT02595502|18694873|P2|Period 1|Lost to Follow-up|1
5417198|NCT02595502|18694874|P1|Period 1|Lost to Follow-up|0
5417199|NCT02595502|18694873|P2|Period 1|Withdrawal by Subject|0
5417200|NCT02595502|18694874|P1|Period 1|Withdrawal by Subject|1
5417201|NCT02595502|18694873|P2|Period 1|Adverse Event|1
5417202|NCT02595502|18694874|P1|Period 1|Adverse Event|0
5417203|NCT02595450|18694880|P1|Overall Study|Enrolled, but not treated|8
5417204|NCT02595450|18694880|P1|Overall Study|Unspecified (only completed 1 cycle)|73
5417205|NCT02595437|18694886|P1|Triferic Via IV|Withdrawal by Subject|1
5417206|NCT02595372|18694904|P1|Overall Study|Disease Progression|1
5417207|NCT02595372|18694904|P1|Overall Study|Physician Decision|2
5417208|NCT02595372|18694904|P1|Overall Study|Adverse Event|6
5417209|NCT02595073|18694915|P2|Overall Study|Protocol Violation|0
5417210|NCT02595073|18694916|P1|Overall Study|Protocol Violation|2
5417211|NCT02595073|18694915|P2|Overall Study|Progressive Disease|1
5417212|NCT02595073|18694916|P1|Overall Study|Progressive Disease|0
5417213|NCT02595008|18694926|P2|Overall Study|Enrolled In Error|0
5417214|NCT02595008|18694927|P1|Overall Study|Enrolled In Error|1
5417215|NCT02594163|18694965|P2|Follow-up Period|Physician Decision|1
5417216|NCT02594163|18694966|P1|Follow-up Period|Physician Decision|0
5417217|NCT02594163|18694965|P2|Follow-up Period|Progressive Disease|0
5417218|NCT02594163|18694966|P1|Follow-up Period|Progressive Disease|2
5417219|NCT02594163|18694965|P2|Follow-up Period|Adverse Event|1
5417220|NCT02594163|18694966|P1|Follow-up Period|Adverse Event|0
5417221|NCT02594163|18694965|P2|Follow-up Period|Death|5
5417222|NCT02594163|18694966|P1|Follow-up Period|Death|2
5417223|NCT02594163|18694965|P2|Follow-up Period|Lost to Follow-up|0
5417224|NCT02594163|18694966|P1|Follow-up Period|Lost to Follow-up|1
5417225|NCT02594163|18694965|P2|Follow-up Period|Study Termination by Sponsor|4
5417226|NCT02594163|18694966|P1|Follow-up Period|Study Termination by Sponsor|6
5417227|NCT02594163|18694965|P2|Follow-up Period|Withdrawal by Subject|1
5417228|NCT02594163|18694966|P1|Follow-up Period|Withdrawal by Subject|0
5417229|NCT02594163|18694965|P2|Treatment Period|Other, Non-AE|0
5417230|NCT02594163|18694966|P1|Treatment Period|Other, Non-AE|1
5417231|NCT02594163|18694965|P2|Treatment Period|Study termination by sponsor|1
5417232|NCT02594163|18694966|P1|Treatment Period|Study termination by sponsor|2
5417233|NCT02594163|18694965|P2|Treatment Period|Physician Decision|3
5417234|NCT02594163|18694966|P1|Treatment Period|Physician Decision|1
5417235|NCT02594163|18694965|P2|Treatment Period|Adverse Event|5
5417236|NCT02594163|18694966|P1|Treatment Period|Adverse Event|1
5417237|NCT02594163|18694965|P2|Treatment Period|Progressive disease|3
5417238|NCT02594163|18694966|P1|Treatment Period|Progressive disease|2
5417239|NCT02594098|18694997|P2|Overall Study|Other|1
5417240|NCT02594098|18694998|P1|Overall Study|Other|0
5417241|NCT02594098|18694997|P2|Overall Study|Seek alternative treatment|1
5417242|NCT02594098|18694998|P1|Overall Study|Seek alternative treatment|2
5417243|NCT02594098|18694997|P2|Overall Study|Terminated participation|2
5417244|NCT02594098|18694998|P1|Overall Study|Terminated participation|6
5417245|NCT02594098|18694997|P2|Overall Study|Withdrawal by Subject|3
5417246|NCT02594098|18694998|P1|Overall Study|Withdrawal by Subject|1
5417247|NCT02594098|18694997|P2|Overall Study|Lack of Efficacy|6
5417248|NCT02594098|18694998|P1|Overall Study|Lack of Efficacy|17
5417249|NCT02593864|18695067|P1|Overall Study|Lost to Follow-up|3
5417250|NCT02593864|18695067|P1|Overall Study|Withdrawal by Subject|3
5417251|NCT02593825|18695074|P2|Intervention|Lost to Follow-up|12
5417252|NCT02593825|18695075|P1|Intervention|Lost to Follow-up|10
5417253|NCT02593773|18695087|P1|Overall Study|Death|1
5417254|NCT02593773|18695087|P1|Overall Study|Study Terminated by Sponsor|31
5417255|NCT02593773|18695087|P1|Overall Study|Voluntary Withdrawal|3
5417256|NCT02593305|18695119|P3|Post 1|Comparison only group. No intervention.|10
5417257|NCT02593305|18695120|P2|Post 1|Comparison only group. No intervention.|0
5417258|NCT02593305|18695121|P1|Post 1|Comparison only group. No intervention.|0
5417259|NCT02593149|18695136|P2|Intervention|Didn't use CVC for at least 21 day|115
5417260|NCT02593149|18695137|P1|Intervention|Didn't use CVC for at least 21 day|116
5417261|NCT02593149|18695136|P2|Run-In|Didn't use CVC for at least 21 days|38
5417262|NCT02593149|18695137|P1|Run-In|Didn't use CVC for at least 21 days|36
5417263|NCT02593097|18695145|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
5417264|NCT02593097|18695146|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
5417265|NCT02593097|18695145|P2|Second Intervention (12 Weeks)|Lack of Efficacy|0
5417266|NCT02593097|18695146|P1|Second Intervention (12 Weeks)|Lack of Efficacy|1
5417267|NCT02593097|18695145|P2|Second Intervention (12 Weeks)|Lost to Follow-up|1
5417268|NCT02593097|18695146|P1|Second Intervention (12 Weeks)|Lost to Follow-up|1
5417269|NCT02593097|18695145|P2|First Intervention (12 Weeks)|Withdrawal by Subject|2
5417270|NCT02593097|18695146|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
5417271|NCT02593097|18695145|P2|First Intervention (12 Weeks)|Lost to Follow-up|2
5417272|NCT02593097|18695146|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
5417273|NCT02592876|18695167|P2|Overall Study|Death|9
5417274|NCT02592876|18695168|P1|Overall Study|Death|6
5417275|NCT02592876|18695167|P2|Overall Study|Lost to Follow-up|1
5417276|NCT02592876|18695168|P1|Overall Study|Lost to Follow-up|0
5417277|NCT02592876|18695167|P2|Overall Study|Study Termination by Sponsor|27
5417278|NCT02592876|18695168|P1|Overall Study|Study Termination by Sponsor|32
5417279|NCT02592876|18695167|P2|Overall Study|Withdrawal by Subject|3
5417280|NCT02592876|18695168|P1|Overall Study|Withdrawal by Subject|3
5417281|NCT02592447|18695239|P2|Overall Study|Withdrawal by Subject|1
5417282|NCT02592447|18695240|P1|Overall Study|Withdrawal by Subject|0
5417283|NCT02592447|18695239|P2|Overall Study|Ineligible after randomization|0
5417284|NCT02592447|18695240|P1|Overall Study|Ineligible after randomization|1
5417285|NCT02592447|18695239|P2|Overall Study|Lost to Follow-up|0
5417286|NCT02592447|18695240|P1|Overall Study|Lost to Follow-up|1
5417287|NCT02592434|18695248|P3|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
5417288|NCT02592434|18695249|P2|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
5417289|NCT02592434|18695250|P1|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
5417290|NCT02592434|18695248|P3|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
5417291|NCT02592434|18695249|P2|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
5417292|NCT02592434|18695250|P1|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
5417293|NCT02592434|18695248|P3|Double Blind Phase (26 Weeks)|Protocol Deviation|1
5417294|NCT02592434|18695249|P2|Double Blind Phase (26 Weeks)|Protocol Deviation|0
5417295|NCT02592434|18695250|P1|Double Blind Phase (26 Weeks)|Protocol Deviation|0
5417296|NCT02592434|18695248|P3|Double Blind Phase (26 Weeks)|Other|0
5417297|NCT02592434|18695249|P2|Double Blind Phase (26 Weeks)|Other|1
5417298|NCT02592434|18695250|P1|Double Blind Phase (26 Weeks)|Other|0
5417299|NCT02592434|18695248|P3|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
5417300|NCT02592434|18695249|P2|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
5417301|NCT02592434|18695250|P1|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
5417302|NCT02592434|18695248|P3|Double Blind Phase (26 Weeks)|Adverse Event|2
5417303|NCT02592434|18695249|P2|Double Blind Phase (26 Weeks)|Adverse Event|2
5417304|NCT02592434|18695250|P1|Double Blind Phase (26 Weeks)|Adverse Event|0
5417305|NCT02592434|18695248|P3|Open-Label Phase (18 Weeks)|Protocol Deviation|0
5417306|NCT02592434|18695249|P2|Open-Label Phase (18 Weeks)|Protocol Deviation|0
5417307|NCT02592434|18695250|P1|Open-Label Phase (18 Weeks)|Protocol Deviation|4
5417308|NCT02592434|18695248|P3|Open-Label Phase (18 Weeks)|Other|0
5417309|NCT02592434|18695249|P2|Open-Label Phase (18 Weeks)|Other|0
5417310|NCT02592434|18695250|P1|Open-Label Phase (18 Weeks)|Other|3
5417311|NCT02592434|18695248|P3|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
5417312|NCT02592434|18695249|P2|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
5417313|NCT02592434|18695250|P1|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
5417314|NCT02592434|18695248|P3|Open-Label Phase (18 Weeks)|Adverse Event|0
5417315|NCT02592434|18695249|P2|Open-Label Phase (18 Weeks)|Adverse Event|0
5417316|NCT02592434|18695250|P1|Open-Label Phase (18 Weeks)|Adverse Event|12
5417317|NCT02592018|18695381|P1|Overall Study|Lost to Follow-up|1
5417318|NCT02592018|18695381|P1|Overall Study|Adverse Event|1
5417319|NCT02591290|18695428|P1|Overall Study|Withdrawal by Subject|2
5417320|NCT02591238|18695438|P4|Overall Study|personal circumstances|0
5417321|NCT02591238|18695439|P3|Overall Study|personal circumstances|0
5417322|NCT02591238|18695440|P2|Overall Study|personal circumstances|1
5417323|NCT02591238|18695441|P1|Overall Study|personal circumstances|0
5417324|NCT02591238|18695438|P4|Overall Study|personal circumstances|1
5417325|NCT02591238|18695439|P3|Overall Study|personal circumstances|0
5417326|NCT02591238|18695440|P2|Overall Study|personal circumstances|0
5417327|NCT02591238|18695441|P1|Overall Study|personal circumstances|0
5417328|NCT02591238|18695438|P4|Overall Study|influenza|1
5417329|NCT02591238|18695439|P3|Overall Study|influenza|0
5417330|NCT02591238|18695440|P2|Overall Study|influenza|0
5417331|NCT02591238|18695441|P1|Overall Study|influenza|0
5417332|NCT02591238|18695438|P4|Overall Study|Withdrawal by Subject|1
5417333|NCT02591238|18695439|P3|Overall Study|Withdrawal by Subject|0
5417334|NCT02591238|18695440|P2|Overall Study|Withdrawal by Subject|0
5417335|NCT02591238|18695441|P1|Overall Study|Withdrawal by Subject|0
5417336|NCT02591238|18695438|P4|Overall Study|Pregnancy|0
5417337|NCT02591238|18695439|P3|Overall Study|Pregnancy|0
5417338|NCT02591238|18695440|P2|Overall Study|Pregnancy|0
5417339|NCT02591238|18695441|P1|Overall Study|Pregnancy|1
5417340|NCT02590939|18695477|P2|Overall Study|Failed the nociceptive test|1
5417341|NCT02590939|18695478|P1|Overall Study|Failed the nociceptive test|2
5417342|NCT02590939|18695477|P2|Overall Study|Withdrawal by Subject|1
5417343|NCT02590939|18695478|P1|Overall Study|Withdrawal by Subject|3
5417344|NCT02590588|18695498|P1|Overall Study|Adverse Event|1
5417345|NCT02590562|18695506|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
5417346|NCT02590432|18695565|P9|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5417347|NCT02590432|18695566|P8|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
5417348|NCT02590432|18695567|P7|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5417349|NCT02590432|18695568|P6|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5417350|NCT02590432|18695569|P5|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5417351|NCT02590432|18695570|P4|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5417352|NCT02590432|18695571|P3|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5417353|NCT02590432|18695572|P2|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5417354|NCT02590432|18695573|P1|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
5417355|NCT02590432|18695565|P9|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5417356|NCT02590432|18695566|P8|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
5417357|NCT02590432|18695567|P7|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5417358|NCT02590432|18695568|P6|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5417359|NCT02590432|18695569|P5|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5417360|NCT02590432|18695570|P4|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5417361|NCT02590432|18695571|P3|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5417362|NCT02590432|18695572|P2|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5417363|NCT02590432|18695573|P1|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
5417364|NCT02590432|18695565|P9|Dose-reduced Open Label Treatment Period|Protocol Violation|1
5417365|NCT02590432|18695566|P8|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5417366|NCT02590432|18695567|P7|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5417367|NCT02590432|18695568|P6|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5417368|NCT02590432|18695569|P5|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5417369|NCT02590432|18695570|P4|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5417370|NCT02590432|18695571|P3|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5417371|NCT02590432|18695572|P2|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5417372|NCT02590432|18695573|P1|Dose-reduced Open Label Treatment Period|Protocol Violation|0
5417373|NCT02590432|18695565|P9|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
5417374|NCT02590432|18695566|P8|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5417375|NCT02590432|18695567|P7|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5417376|NCT02590432|18695568|P6|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5417377|NCT02590432|18695569|P5|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5417378|NCT02590432|18695570|P4|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5417379|NCT02590432|18695571|P3|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5417380|NCT02590432|18695572|P2|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5417381|NCT02590432|18695573|P1|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
5417382|NCT02590432|18695565|P9|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
5417383|NCT02590432|18695566|P8|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
5417384|NCT02590432|18695567|P7|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5417385|NCT02590432|18695568|P6|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5417386|NCT02590432|18695569|P5|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5417387|NCT02590432|18695570|P4|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5417388|NCT02590432|18695571|P3|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5417389|NCT02590432|18695572|P2|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5417390|NCT02590432|18695573|P1|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
5417391|NCT02590432|18695565|P9|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5417392|NCT02590432|18695566|P8|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
5417393|NCT02590432|18695567|P7|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5417394|NCT02590432|18695568|P6|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5417395|NCT02590432|18695569|P5|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5417396|NCT02590432|18695570|P4|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5417397|NCT02590432|18695571|P3|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5417398|NCT02590432|18695572|P2|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5417399|NCT02590432|18695573|P1|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
5417400|NCT02590432|18695565|P9|Dose-reduced Open Label Treatment Period|Adverse Event|15
5417401|NCT02590432|18695566|P8|Dose-reduced Open Label Treatment Period|Adverse Event|12
5417402|NCT02590432|18695567|P7|Dose-reduced Open Label Treatment Period|Adverse Event|0
5417403|NCT02590432|18695568|P6|Dose-reduced Open Label Treatment Period|Adverse Event|0
5417404|NCT02590432|18695569|P5|Dose-reduced Open Label Treatment Period|Adverse Event|0
5417405|NCT02590432|18695570|P4|Dose-reduced Open Label Treatment Period|Adverse Event|0
5417406|NCT02590432|18695571|P3|Dose-reduced Open Label Treatment Period|Adverse Event|0
5417407|NCT02590432|18695572|P2|Dose-reduced Open Label Treatment Period|Adverse Event|0
5417408|NCT02590432|18695573|P1|Dose-reduced Open Label Treatment Period|Adverse Event|0
5417409|NCT02590432|18695565|P9|Double-blind Treatment Period|Non-compliance with Study Drug|0
5417410|NCT02590432|18695566|P8|Double-blind Treatment Period|Non-compliance with Study Drug|0
5417411|NCT02590432|18695567|P7|Double-blind Treatment Period|Non-compliance with Study Drug|0
5417412|NCT02590432|18695568|P6|Double-blind Treatment Period|Non-compliance with Study Drug|1
5417413|NCT02590432|18695569|P5|Double-blind Treatment Period|Non-compliance with Study Drug|0
5417414|NCT02590432|18695570|P4|Double-blind Treatment Period|Non-compliance with Study Drug|0
5417415|NCT02590432|18695571|P3|Double-blind Treatment Period|Non-compliance with Study Drug|0
5417416|NCT02590432|18695572|P2|Double-blind Treatment Period|Non-compliance with Study Drug|0
5417417|NCT02590432|18695573|P1|Double-blind Treatment Period|Non-compliance with Study Drug|0
5417418|NCT02590432|18695565|P9|Double-blind Treatment Period|Lost to Follow-up|0
5417419|NCT02590432|18695566|P8|Double-blind Treatment Period|Lost to Follow-up|0
5417420|NCT02590432|18695567|P7|Double-blind Treatment Period|Lost to Follow-up|0
5417421|NCT02590432|18695568|P6|Double-blind Treatment Period|Lost to Follow-up|2
5417422|NCT02590432|18695569|P5|Double-blind Treatment Period|Lost to Follow-up|0
5417423|NCT02590432|18695570|P4|Double-blind Treatment Period|Lost to Follow-up|0
5417424|NCT02590432|18695571|P3|Double-blind Treatment Period|Lost to Follow-up|1
5417425|NCT02590432|18695572|P2|Double-blind Treatment Period|Lost to Follow-up|0
5417426|NCT02590432|18695573|P1|Double-blind Treatment Period|Lost to Follow-up|0
5417427|NCT02590432|18695565|P9|Double-blind Treatment Period|Withdrawal of Consent|0
5417428|NCT02590432|18695566|P8|Double-blind Treatment Period|Withdrawal of Consent|0
5417429|NCT02590432|18695567|P7|Double-blind Treatment Period|Withdrawal of Consent|1
5417430|NCT02590432|18695568|P6|Double-blind Treatment Period|Withdrawal of Consent|1
5417431|NCT02590432|18695569|P5|Double-blind Treatment Period|Withdrawal of Consent|3
5417432|NCT02590432|18695570|P4|Double-blind Treatment Period|Withdrawal of Consent|3
5417433|NCT02590432|18695571|P3|Double-blind Treatment Period|Withdrawal of Consent|1
5417434|NCT02590432|18695572|P2|Double-blind Treatment Period|Withdrawal of Consent|0
5417435|NCT02590432|18695573|P1|Double-blind Treatment Period|Withdrawal of Consent|0
5417436|NCT02590432|18695565|P9|Double-blind Treatment Period|Lack of Efficacy|0
5417437|NCT02590432|18695566|P8|Double-blind Treatment Period|Lack of Efficacy|0
5417438|NCT02590432|18695567|P7|Double-blind Treatment Period|Lack of Efficacy|0
5417439|NCT02590432|18695568|P6|Double-blind Treatment Period|Lack of Efficacy|0
5417440|NCT02590432|18695569|P5|Double-blind Treatment Period|Lack of Efficacy|0
5417441|NCT02590432|18695570|P4|Double-blind Treatment Period|Lack of Efficacy|0
5417442|NCT02590432|18695571|P3|Double-blind Treatment Period|Lack of Efficacy|1
5417443|NCT02590432|18695572|P2|Double-blind Treatment Period|Lack of Efficacy|0
5417444|NCT02590432|18695573|P1|Double-blind Treatment Period|Lack of Efficacy|0
5417445|NCT02590432|18695565|P9|Double-blind Treatment Period|Adverse Event|0
5417446|NCT02590432|18695566|P8|Double-blind Treatment Period|Adverse Event|0
5417447|NCT02590432|18695567|P7|Double-blind Treatment Period|Adverse Event|20
5417448|NCT02590432|18695568|P6|Double-blind Treatment Period|Adverse Event|22
5417449|NCT02590432|18695569|P5|Double-blind Treatment Period|Adverse Event|6
5417450|NCT02590432|18695570|P4|Double-blind Treatment Period|Adverse Event|12
5417451|NCT02590432|18695571|P3|Double-blind Treatment Period|Adverse Event|14
5417452|NCT02590432|18695572|P2|Double-blind Treatment Period|Adverse Event|0
5417453|NCT02590432|18695573|P1|Double-blind Treatment Period|Adverse Event|0
5417454|NCT02590432|18695565|P9|Open-label Treatment Period|Other Miscellaneous Reasons|0
5417455|NCT02590432|18695566|P8|Open-label Treatment Period|Other Miscellaneous Reasons|0
5417456|NCT02590432|18695567|P7|Open-label Treatment Period|Other Miscellaneous Reasons|0
5417457|NCT02590432|18695568|P6|Open-label Treatment Period|Other Miscellaneous Reasons|0
5417458|NCT02590432|18695569|P5|Open-label Treatment Period|Other Miscellaneous Reasons|0
5417459|NCT02590432|18695570|P4|Open-label Treatment Period|Other Miscellaneous Reasons|0
5417460|NCT02590432|18695571|P3|Open-label Treatment Period|Other Miscellaneous Reasons|0
5417461|NCT02590432|18695572|P2|Open-label Treatment Period|Other Miscellaneous Reasons|6
5417462|NCT02590432|18695573|P1|Open-label Treatment Period|Other Miscellaneous Reasons|10
5417463|NCT02590432|18695565|P9|Open-label Treatment Period|Non-compliance with Study Drug|0
5417464|NCT02590432|18695566|P8|Open-label Treatment Period|Non-compliance with Study Drug|0
5417465|NCT02590432|18695567|P7|Open-label Treatment Period|Non-compliance with Study Drug|0
5417466|NCT02590432|18695568|P6|Open-label Treatment Period|Non-compliance with Study Drug|0
5417467|NCT02590432|18695569|P5|Open-label Treatment Period|Non-compliance with Study Drug|0
5417468|NCT02590432|18695570|P4|Open-label Treatment Period|Non-compliance with Study Drug|0
5417469|NCT02590432|18695571|P3|Open-label Treatment Period|Non-compliance with Study Drug|0
5417470|NCT02590432|18695572|P2|Open-label Treatment Period|Non-compliance with Study Drug|1
5417471|NCT02590432|18695573|P1|Open-label Treatment Period|Non-compliance with Study Drug|7
5417472|NCT02590432|18695565|P9|Open-label Treatment Period|Protocol Violation|0
5417473|NCT02590432|18695566|P8|Open-label Treatment Period|Protocol Violation|0
5417474|NCT02590432|18695567|P7|Open-label Treatment Period|Protocol Violation|0
5417475|NCT02590432|18695568|P6|Open-label Treatment Period|Protocol Violation|0
5417476|NCT02590432|18695569|P5|Open-label Treatment Period|Protocol Violation|0
5417477|NCT02590432|18695570|P4|Open-label Treatment Period|Protocol Violation|0
5417478|NCT02590432|18695571|P3|Open-label Treatment Period|Protocol Violation|0
5417479|NCT02590432|18695572|P2|Open-label Treatment Period|Protocol Violation|4
5417480|NCT02590432|18695573|P1|Open-label Treatment Period|Protocol Violation|10
5417481|NCT02590432|18695565|P9|Open-label Treatment Period|Lost to Follow-up|0
5417482|NCT02590432|18695566|P8|Open-label Treatment Period|Lost to Follow-up|0
5417483|NCT02590432|18695567|P7|Open-label Treatment Period|Lost to Follow-up|0
5417484|NCT02590432|18695568|P6|Open-label Treatment Period|Lost to Follow-up|0
5417485|NCT02590432|18695569|P5|Open-label Treatment Period|Lost to Follow-up|0
5417486|NCT02590432|18695570|P4|Open-label Treatment Period|Lost to Follow-up|0
5417487|NCT02590432|18695571|P3|Open-label Treatment Period|Lost to Follow-up|0
5417488|NCT02590432|18695572|P2|Open-label Treatment Period|Lost to Follow-up|29
5417489|NCT02590432|18695573|P1|Open-label Treatment Period|Lost to Follow-up|51
5417490|NCT02590432|18695565|P9|Open-label Treatment Period|Withdrawal of Consent|0
5417491|NCT02590432|18695566|P8|Open-label Treatment Period|Withdrawal of Consent|0
5417492|NCT02590432|18695567|P7|Open-label Treatment Period|Withdrawal of Consent|0
5417493|NCT02590432|18695568|P6|Open-label Treatment Period|Withdrawal of Consent|0
5417494|NCT02590432|18695569|P5|Open-label Treatment Period|Withdrawal of Consent|0
5417495|NCT02590432|18695570|P4|Open-label Treatment Period|Withdrawal of Consent|0
5417496|NCT02590432|18695571|P3|Open-label Treatment Period|Withdrawal of Consent|0
5417497|NCT02590432|18695572|P2|Open-label Treatment Period|Withdrawal of Consent|28
5417498|NCT02590432|18695573|P1|Open-label Treatment Period|Withdrawal of Consent|43
5417499|NCT02590432|18695565|P9|Open-label Treatment Period|Lack of Efficacy|0
5417500|NCT02590432|18695566|P8|Open-label Treatment Period|Lack of Efficacy|0
5417501|NCT02590432|18695567|P7|Open-label Treatment Period|Lack of Efficacy|0
5417502|NCT02590432|18695568|P6|Open-label Treatment Period|Lack of Efficacy|0
5417503|NCT02590432|18695569|P5|Open-label Treatment Period|Lack of Efficacy|0
5417504|NCT02590432|18695570|P4|Open-label Treatment Period|Lack of Efficacy|0
5417505|NCT02590432|18695571|P3|Open-label Treatment Period|Lack of Efficacy|0
5417506|NCT02590432|18695572|P2|Open-label Treatment Period|Lack of Efficacy|5
5417507|NCT02590432|18695573|P1|Open-label Treatment Period|Lack of Efficacy|14
5417508|NCT02590432|18695565|P9|Open-label Treatment Period|Adverse Event|0
5417509|NCT02590432|18695566|P8|Open-label Treatment Period|Adverse Event|0
5417510|NCT02590432|18695567|P7|Open-label Treatment Period|Adverse Event|0
5417511|NCT02590432|18695568|P6|Open-label Treatment Period|Adverse Event|0
5417512|NCT02590432|18695569|P5|Open-label Treatment Period|Adverse Event|0
5417513|NCT02590432|18695570|P4|Open-label Treatment Period|Adverse Event|0
5417514|NCT02590432|18695571|P3|Open-label Treatment Period|Adverse Event|0
5417515|NCT02590432|18695572|P2|Open-label Treatment Period|Adverse Event|79
5417516|NCT02590432|18695573|P1|Open-label Treatment Period|Adverse Event|97
5417517|NCT02590406|18695609|P2|Overall Study|Saturometer malfunction|1
5417518|NCT02590406|18695610|P1|Overall Study|Saturometer malfunction|0
5417519|NCT02590406|18695609|P2|Overall Study|Adverse Event|0
5417520|NCT02590406|18695610|P1|Overall Study|Adverse Event|1
5417521|NCT02590354|18695624|P1|Phase 2 - Treatment Interruption|Lost to Follow-up|2
5417522|NCT02590354|18695624|P1|Phase 1|Lost to Follow-up|1
5417523|NCT02590354|18695624|P1|Phase 1|Subject does not want to participate|20
5417524|NCT02590354|18695624|P1|Phase 1|Detectable level of HIV DNA or caRNA|75
5417525|NCT02590354|18695624|P1|Phase 1|Confirmed neutrophil count <1200/µl|1
5417526|NCT02590354|18695624|P1|Phase 1|Active hepatitis B or C infection|1
5417527|NCT02590003|18695651|P2|Overall Study|Death|2
5417528|NCT02590003|18695652|P1|Overall Study|Death|1
5417529|NCT02589665|18695689|P10|Maintenance Extension Period|Non-responder|1
5417530|NCT02589665|18695690|P9|Maintenance Extension Period|Non-responder|0
5417531|NCT02589665|18695691|P8|Maintenance Extension Period|Non-responder|0
5417532|NCT02589665|18695692|P7|Maintenance Extension Period|Non-responder|0
5417533|NCT02589665|18695693|P6|Maintenance Extension Period|Non-responder|0
5417534|NCT02589665|18695694|P5|Maintenance Extension Period|Non-responder|0
5417535|NCT02589665|18695695|P4|Maintenance Extension Period|Non-responder|0
5417536|NCT02589665|18695696|P3|Maintenance Extension Period|Non-responder|0
5417537|NCT02589665|18695697|P2|Maintenance Extension Period|Non-responder|0
5417538|NCT02589665|18695698|P1|Maintenance Extension Period|Non-responder|0
5417539|NCT02589665|18695689|P10|Maintenance Extension Period|Adverse Event|2
5417540|NCT02589665|18695690|P9|Maintenance Extension Period|Adverse Event|0
5417541|NCT02589665|18695691|P8|Maintenance Extension Period|Adverse Event|0
5417542|NCT02589665|18695692|P7|Maintenance Extension Period|Adverse Event|0
5417543|NCT02589665|18695693|P6|Maintenance Extension Period|Adverse Event|0
5417544|NCT02589665|18695694|P5|Maintenance Extension Period|Adverse Event|0
5417545|NCT02589665|18695695|P4|Maintenance Extension Period|Adverse Event|0
5417546|NCT02589665|18695696|P3|Maintenance Extension Period|Adverse Event|0
5417547|NCT02589665|18695697|P2|Maintenance Extension Period|Adverse Event|0
5417548|NCT02589665|18695698|P1|Maintenance Extension Period|Adverse Event|0
5417549|NCT02589665|18695689|P10|Maintenance Extension Period|Lack of Efficacy|4
5417550|NCT02589665|18695690|P9|Maintenance Extension Period|Lack of Efficacy|0
5417551|NCT02589665|18695691|P8|Maintenance Extension Period|Lack of Efficacy|0
5417552|NCT02589665|18695692|P7|Maintenance Extension Period|Lack of Efficacy|0
5417553|NCT02589665|18695693|P6|Maintenance Extension Period|Lack of Efficacy|0
5417554|NCT02589665|18695694|P5|Maintenance Extension Period|Lack of Efficacy|0
5417555|NCT02589665|18695695|P4|Maintenance Extension Period|Lack of Efficacy|0
5417556|NCT02589665|18695696|P3|Maintenance Extension Period|Lack of Efficacy|0
5417557|NCT02589665|18695697|P2|Maintenance Extension Period|Lack of Efficacy|0
5417558|NCT02589665|18695698|P1|Maintenance Extension Period|Lack of Efficacy|0
5417559|NCT02589665|18695689|P10|Maintenance Extension Period|Withdrawal by Subject|4
5417560|NCT02589665|18695690|P9|Maintenance Extension Period|Withdrawal by Subject|0
5417561|NCT02589665|18695691|P8|Maintenance Extension Period|Withdrawal by Subject|0
5417562|NCT02589665|18695692|P7|Maintenance Extension Period|Withdrawal by Subject|0
5417563|NCT02589665|18695693|P6|Maintenance Extension Period|Withdrawal by Subject|0
5417564|NCT02589665|18695694|P5|Maintenance Extension Period|Withdrawal by Subject|0
5417565|NCT02589665|18695695|P4|Maintenance Extension Period|Withdrawal by Subject|0
5417566|NCT02589665|18695696|P3|Maintenance Extension Period|Withdrawal by Subject|0
5417567|NCT02589665|18695697|P2|Maintenance Extension Period|Withdrawal by Subject|0
5417568|NCT02589665|18695698|P1|Maintenance Extension Period|Withdrawal by Subject|0
5417569|NCT02589665|18695689|P10|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
5417570|NCT02589665|18695690|P9|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5417571|NCT02589665|18695691|P8|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5417572|NCT02589665|18695692|P7|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5417573|NCT02589665|18695693|P6|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5417574|NCT02589665|18695694|P5|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5417575|NCT02589665|18695695|P4|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5417576|NCT02589665|18695696|P3|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5417577|NCT02589665|18695697|P2|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5417578|NCT02589665|18695698|P1|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
5417579|NCT02589665|18695689|P10|Induction Extension Period|Reason Not Collected|0
5417580|NCT02589665|18695690|P9|Induction Extension Period|Reason Not Collected|1
5417581|NCT02589665|18695691|P8|Induction Extension Period|Reason Not Collected|0
5417582|NCT02589665|18695692|P7|Induction Extension Period|Reason Not Collected|0
5417583|NCT02589665|18695693|P6|Induction Extension Period|Reason Not Collected|0
5417584|NCT02589665|18695694|P5|Induction Extension Period|Reason Not Collected|0
5417585|NCT02589665|18695695|P4|Induction Extension Period|Reason Not Collected|0
5417586|NCT02589665|18695696|P3|Induction Extension Period|Reason Not Collected|0
5417587|NCT02589665|18695697|P2|Induction Extension Period|Reason Not Collected|0
5417588|NCT02589665|18695698|P1|Induction Extension Period|Reason Not Collected|0
5417589|NCT02589665|18695689|P10|Induction Extension Period|Physician Decision|0
5417590|NCT02589665|18695690|P9|Induction Extension Period|Physician Decision|1
5417591|NCT02589665|18695691|P8|Induction Extension Period|Physician Decision|0
5417592|NCT02589665|18695692|P7|Induction Extension Period|Physician Decision|0
5417593|NCT02589665|18695693|P6|Induction Extension Period|Physician Decision|0
5417594|NCT02589665|18695694|P5|Induction Extension Period|Physician Decision|0
5417595|NCT02589665|18695695|P4|Induction Extension Period|Physician Decision|0
5417596|NCT02589665|18695696|P3|Induction Extension Period|Physician Decision|0
5417597|NCT02589665|18695697|P2|Induction Extension Period|Physician Decision|0
5417598|NCT02589665|18695698|P1|Induction Extension Period|Physician Decision|0
5417599|NCT02589665|18695689|P10|Induction Extension Period|Withdrawal by Subject|0
5417600|NCT02589665|18695690|P9|Induction Extension Period|Withdrawal by Subject|3
5417601|NCT02589665|18695691|P8|Induction Extension Period|Withdrawal by Subject|2
5417602|NCT02589665|18695692|P7|Induction Extension Period|Withdrawal by Subject|0
5417603|NCT02589665|18695693|P6|Induction Extension Period|Withdrawal by Subject|0
5417604|NCT02589665|18695694|P5|Induction Extension Period|Withdrawal by Subject|0
5417605|NCT02589665|18695695|P4|Induction Extension Period|Withdrawal by Subject|0
5417606|NCT02589665|18695696|P3|Induction Extension Period|Withdrawal by Subject|0
5417607|NCT02589665|18695697|P2|Induction Extension Period|Withdrawal by Subject|0
5417608|NCT02589665|18695698|P1|Induction Extension Period|Withdrawal by Subject|0
5417609|NCT02589665|18695689|P10|Induction Extension Period|Lack of Efficacy|0
5417610|NCT02589665|18695690|P9|Induction Extension Period|Lack of Efficacy|3
5417611|NCT02589665|18695691|P8|Induction Extension Period|Lack of Efficacy|0
5417612|NCT02589665|18695692|P7|Induction Extension Period|Lack of Efficacy|0
5417613|NCT02589665|18695693|P6|Induction Extension Period|Lack of Efficacy|0
5417614|NCT02589665|18695694|P5|Induction Extension Period|Lack of Efficacy|0
5417615|NCT02589665|18695695|P4|Induction Extension Period|Lack of Efficacy|0
5417616|NCT02589665|18695696|P3|Induction Extension Period|Lack of Efficacy|0
5417617|NCT02589665|18695697|P2|Induction Extension Period|Lack of Efficacy|0
5417618|NCT02589665|18695698|P1|Induction Extension Period|Lack of Efficacy|0
5417619|NCT02589665|18695689|P10|Induction Extension Period|Adverse Event|0
5417620|NCT02589665|18695690|P9|Induction Extension Period|Adverse Event|4
5417621|NCT02589665|18695691|P8|Induction Extension Period|Adverse Event|0
5417622|NCT02589665|18695692|P7|Induction Extension Period|Adverse Event|0
5417623|NCT02589665|18695693|P6|Induction Extension Period|Adverse Event|0
5417624|NCT02589665|18695694|P5|Induction Extension Period|Adverse Event|0
5417625|NCT02589665|18695695|P4|Induction Extension Period|Adverse Event|0
5417626|NCT02589665|18695696|P3|Induction Extension Period|Adverse Event|0
5417627|NCT02589665|18695697|P2|Induction Extension Period|Adverse Event|0
5417628|NCT02589665|18695698|P1|Induction Extension Period|Adverse Event|0
5417629|NCT02589665|18695689|P10|Maintenance Period|Reason Not Collected|0
5417630|NCT02589665|18695690|P9|Maintenance Period|Reason Not Collected|0
5417631|NCT02589665|18695691|P8|Maintenance Period|Reason Not Collected|0
5417632|NCT02589665|18695692|P7|Maintenance Period|Reason Not Collected|1
5417633|NCT02589665|18695693|P6|Maintenance Period|Reason Not Collected|1
5417634|NCT02589665|18695694|P5|Maintenance Period|Reason Not Collected|0
5417635|NCT02589665|18695695|P4|Maintenance Period|Reason Not Collected|0
5417636|NCT02589665|18695696|P3|Maintenance Period|Reason Not Collected|0
5417637|NCT02589665|18695697|P2|Maintenance Period|Reason Not Collected|0
5417638|NCT02589665|18695698|P1|Maintenance Period|Reason Not Collected|0
5417639|NCT02589665|18695689|P10|Maintenance Period|Physician Decision|0
5417640|NCT02589665|18695690|P9|Maintenance Period|Physician Decision|0
5417641|NCT02589665|18695691|P8|Maintenance Period|Physician Decision|0
5417642|NCT02589665|18695692|P7|Maintenance Period|Physician Decision|0
5417643|NCT02589665|18695693|P6|Maintenance Period|Physician Decision|1
5417644|NCT02589665|18695694|P5|Maintenance Period|Physician Decision|0
5417645|NCT02589665|18695695|P4|Maintenance Period|Physician Decision|0
5417646|NCT02589665|18695696|P3|Maintenance Period|Physician Decision|0
5417647|NCT02589665|18695697|P2|Maintenance Period|Physician Decision|0
5417648|NCT02589665|18695698|P1|Maintenance Period|Physician Decision|0
5417649|NCT02589665|18695689|P10|Maintenance Period|Lost to Follow-up|0
5417650|NCT02589665|18695690|P9|Maintenance Period|Lost to Follow-up|0
5417651|NCT02589665|18695691|P8|Maintenance Period|Lost to Follow-up|0
5417652|NCT02589665|18695692|P7|Maintenance Period|Lost to Follow-up|0
5417653|NCT02589665|18695693|P6|Maintenance Period|Lost to Follow-up|1
5417654|NCT02589665|18695694|P5|Maintenance Period|Lost to Follow-up|0
5417655|NCT02589665|18695695|P4|Maintenance Period|Lost to Follow-up|0
5417656|NCT02589665|18695696|P3|Maintenance Period|Lost to Follow-up|0
5417657|NCT02589665|18695697|P2|Maintenance Period|Lost to Follow-up|0
5417658|NCT02589665|18695698|P1|Maintenance Period|Lost to Follow-up|0
5417659|NCT02589665|18695689|P10|Maintenance Period|Adverse Event|0
5417660|NCT02589665|18695690|P9|Maintenance Period|Adverse Event|0
5417661|NCT02589665|18695691|P8|Maintenance Period|Adverse Event|0
5417662|NCT02589665|18695692|P7|Maintenance Period|Adverse Event|2
5417663|NCT02589665|18695693|P6|Maintenance Period|Adverse Event|0
5417664|NCT02589665|18695694|P5|Maintenance Period|Adverse Event|0
5417665|NCT02589665|18695695|P4|Maintenance Period|Adverse Event|0
5417666|NCT02589665|18695696|P3|Maintenance Period|Adverse Event|0
5417667|NCT02589665|18695697|P2|Maintenance Period|Adverse Event|0
5417668|NCT02589665|18695698|P1|Maintenance Period|Adverse Event|0
5417669|NCT02589665|18695689|P10|Maintenance Period|Lack of Efficacy|0
5417670|NCT02589665|18695690|P9|Maintenance Period|Lack of Efficacy|0
5417671|NCT02589665|18695691|P8|Maintenance Period|Lack of Efficacy|0
5417672|NCT02589665|18695692|P7|Maintenance Period|Lack of Efficacy|0
5417673|NCT02589665|18695693|P6|Maintenance Period|Lack of Efficacy|1
5417674|NCT02589665|18695694|P5|Maintenance Period|Lack of Efficacy|2
5417675|NCT02589665|18695695|P4|Maintenance Period|Lack of Efficacy|0
5417676|NCT02589665|18695696|P3|Maintenance Period|Lack of Efficacy|0
5417677|NCT02589665|18695697|P2|Maintenance Period|Lack of Efficacy|0
5417678|NCT02589665|18695698|P1|Maintenance Period|Lack of Efficacy|0
5417679|NCT02589665|18695689|P10|Maintenance Period|Withdrawal by Subject|0
5417680|NCT02589665|18695690|P9|Maintenance Period|Withdrawal by Subject|0
5417681|NCT02589665|18695691|P8|Maintenance Period|Withdrawal by Subject|0
5417682|NCT02589665|18695692|P7|Maintenance Period|Withdrawal by Subject|4
5417683|NCT02589665|18695693|P6|Maintenance Period|Withdrawal by Subject|2
5417684|NCT02589665|18695694|P5|Maintenance Period|Withdrawal by Subject|4
5417685|NCT02589665|18695695|P4|Maintenance Period|Withdrawal by Subject|0
5417686|NCT02589665|18695696|P3|Maintenance Period|Withdrawal by Subject|0
5417687|NCT02589665|18695697|P2|Maintenance Period|Withdrawal by Subject|0
5417688|NCT02589665|18695698|P1|Maintenance Period|Withdrawal by Subject|0
5417689|NCT02589665|18695689|P10|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5417690|NCT02589665|18695690|P9|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5417691|NCT02589665|18695691|P8|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5417692|NCT02589665|18695692|P7|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
5417693|NCT02589665|18695693|P6|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
5417694|NCT02589665|18695694|P5|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
5417695|NCT02589665|18695695|P4|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5417696|NCT02589665|18695696|P3|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5417697|NCT02589665|18695697|P2|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5417698|NCT02589665|18695698|P1|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
5417699|NCT02589665|18695689|P10|Induction Period|Protocol Violation|0
5417700|NCT02589665|18695690|P9|Induction Period|Protocol Violation|0
5417701|NCT02589665|18695691|P8|Induction Period|Protocol Violation|0
5417702|NCT02589665|18695692|P7|Induction Period|Protocol Violation|0
5417703|NCT02589665|18695693|P6|Induction Period|Protocol Violation|0
5417704|NCT02589665|18695694|P5|Induction Period|Protocol Violation|0
5417705|NCT02589665|18695695|P4|Induction Period|Protocol Violation|0
5417706|NCT02589665|18695696|P3|Induction Period|Protocol Violation|0
5417707|NCT02589665|18695697|P2|Induction Period|Protocol Violation|1
5417708|NCT02589665|18695698|P1|Induction Period|Protocol Violation|0
5417709|NCT02589665|18695689|P10|Induction Period|Withdrawal by Subject|0
5417710|NCT02589665|18695690|P9|Induction Period|Withdrawal by Subject|0
5417711|NCT02589665|18695691|P8|Induction Period|Withdrawal by Subject|0
5417712|NCT02589665|18695692|P7|Induction Period|Withdrawal by Subject|0
5417713|NCT02589665|18695693|P6|Induction Period|Withdrawal by Subject|0
5417714|NCT02589665|18695694|P5|Induction Period|Withdrawal by Subject|0
5417715|NCT02589665|18695695|P4|Induction Period|Withdrawal by Subject|1
5417716|NCT02589665|18695696|P3|Induction Period|Withdrawal by Subject|0
5417717|NCT02589665|18695697|P2|Induction Period|Withdrawal by Subject|1
5417718|NCT02589665|18695698|P1|Induction Period|Withdrawal by Subject|0
5417719|NCT02589665|18695689|P10|Induction Period|Adverse Event|0
5417720|NCT02589665|18695690|P9|Induction Period|Adverse Event|0
5417721|NCT02589665|18695691|P8|Induction Period|Adverse Event|0
5417722|NCT02589665|18695692|P7|Induction Period|Adverse Event|0
5417723|NCT02589665|18695693|P6|Induction Period|Adverse Event|0
5417724|NCT02589665|18695694|P5|Induction Period|Adverse Event|0
5417725|NCT02589665|18695695|P4|Induction Period|Adverse Event|2
5417726|NCT02589665|18695696|P3|Induction Period|Adverse Event|2
5417727|NCT02589665|18695697|P2|Induction Period|Adverse Event|0
5417728|NCT02589665|18695698|P1|Induction Period|Adverse Event|3
5417729|NCT02589665|18695689|P10|Induction Period|Did not receive drug|0
5417730|NCT02589665|18695690|P9|Induction Period|Did not receive drug|0
5417731|NCT02589665|18695691|P8|Induction Period|Did not receive drug|0
5417732|NCT02589665|18695692|P7|Induction Period|Did not receive drug|0
5417733|NCT02589665|18695693|P6|Induction Period|Did not receive drug|0
5417734|NCT02589665|18695694|P5|Induction Period|Did not receive drug|0
5417735|NCT02589665|18695695|P4|Induction Period|Did not receive drug|1
5417736|NCT02589665|18695696|P3|Induction Period|Did not receive drug|0
5417737|NCT02589665|18695697|P2|Induction Period|Did not receive drug|0
5417738|NCT02589665|18695698|P1|Induction Period|Did not receive drug|0
5417739|NCT02589639|18695763|P3|Overall Study|Not Treated|0
5417740|NCT02589639|18695764|P2|Overall Study|Not Treated|3
5417741|NCT02589639|18695765|P1|Overall Study|Not Treated|0
5417742|NCT02589639|18695763|P3|Overall Study|Other reason than specified above|1
5417743|NCT02589639|18695764|P2|Overall Study|Other reason than specified above|2
5417744|NCT02589639|18695765|P1|Overall Study|Other reason than specified above|1
5417745|NCT02589639|18695763|P3|Overall Study|Adverse Event|3
5417746|NCT02589639|18695764|P2|Overall Study|Adverse Event|5
5417747|NCT02589639|18695765|P1|Overall Study|Adverse Event|4
5417748|NCT02589639|18695763|P3|Overall Study|Patient withdrawal, not due to AE|0
5417749|NCT02589639|18695764|P2|Overall Study|Patient withdrawal, not due to AE|0
5417750|NCT02589639|18695765|P1|Overall Study|Patient withdrawal, not due to AE|3
5417751|NCT02589639|18695763|P3|Overall Study|Protocol Violation|0
5417752|NCT02589639|18695764|P2|Overall Study|Protocol Violation|0
5417753|NCT02589639|18695765|P1|Overall Study|Protocol Violation|1
5417754|NCT02589639|18695763|P3|Overall Study|Lost to Follow-up|0
5417755|NCT02589639|18695764|P2|Overall Study|Lost to Follow-up|0
5417756|NCT02589639|18695765|P1|Overall Study|Lost to Follow-up|1
5417757|NCT02589626|18695778|P2|Overall Study|Adverse Event|1
5417758|NCT02589626|18695779|P1|Overall Study|Adverse Event|1
5417759|NCT02589626|18695778|P2|Overall Study|Withdrawal by Subject|1
5417760|NCT02589626|18695779|P1|Overall Study|Withdrawal by Subject|1
5417761|NCT02589626|18695778|P2|Overall Study|Other than the reason specified|0
5417762|NCT02589626|18695779|P1|Overall Study|Other than the reason specified|1
5417763|NCT02589405|18695787|P1|Overall Study|Withdrawal by Subject|1
5417764|NCT02589405|18695787|P1|Overall Study|Adverse Event|3
5417765|NCT02588339|18695940|P1|Overall Study|GVHD Progression prior to treatment|2
5417766|NCT02588339|18695940|P1|Overall Study|Withdrawal by Subject|1
5417767|NCT02588261|18695952|P2|Overall Study|Lost to Follow-up|0
5417768|NCT02588261|18695953|P1|Overall Study|Lost to Follow-up|1
5417769|NCT02588261|18695952|P2|Overall Study|Adverse Event|24
5417770|NCT02588261|18695953|P1|Overall Study|Adverse Event|29
5417771|NCT02588261|18695952|P2|Overall Study|Progressive Disease|82
5417772|NCT02588261|18695953|P1|Overall Study|Progressive Disease|61
5417773|NCT02588261|18695952|P2|Overall Study|Miscellaneous|4
5417774|NCT02588261|18695953|P1|Overall Study|Miscellaneous|5
5417775|NCT02588261|18695952|P2|Overall Study|Noncompliance with Study Drug|1
5417776|NCT02588261|18695953|P1|Overall Study|Noncompliance with Study Drug|0
5417777|NCT02588261|18695952|P2|Overall Study|Withdrawal by Subject|8
5417778|NCT02588261|18695953|P1|Overall Study|Withdrawal by Subject|12
5417779|NCT02588261|18695952|P2|Overall Study|Death|2
5417780|NCT02588261|18695953|P1|Overall Study|Death|1
5417781|NCT02588261|18695952|P2|Overall Study|Protocol Deviation|0
5417782|NCT02588261|18695953|P1|Overall Study|Protocol Deviation|1
5417783|NCT02588261|18695952|P2|Overall Study|Study Terminated by Sponsor|142
5417784|NCT02588261|18695953|P1|Overall Study|Study Terminated by Sponsor|157
5417785|NCT02588092|18695989|P10|Overall Study|Sponsor Decision|1
5417786|NCT02588092|18695990|P9|Overall Study|Sponsor Decision|1
5417787|NCT02588092|18695991|P8|Overall Study|Sponsor Decision|0
5417788|NCT02588092|18695992|P7|Overall Study|Sponsor Decision|0
5417789|NCT02588092|18695993|P6|Overall Study|Sponsor Decision|0
5417790|NCT02588092|18695994|P5|Overall Study|Sponsor Decision|0
5417791|NCT02588092|18695995|P4|Overall Study|Sponsor Decision|0
5417792|NCT02588092|18695996|P3|Overall Study|Sponsor Decision|0
5417793|NCT02588092|18695997|P2|Overall Study|Sponsor Decision|0
5417794|NCT02588092|18695998|P1|Overall Study|Sponsor Decision|0
5417795|NCT02588092|18695989|P10|Overall Study|Started Another Treatment|0
5417796|NCT02588092|18695990|P9|Overall Study|Started Another Treatment|0
5417797|NCT02588092|18695991|P8|Overall Study|Started Another Treatment|1
5417798|NCT02588092|18695992|P7|Overall Study|Started Another Treatment|0
5417799|NCT02588092|18695993|P6|Overall Study|Started Another Treatment|0
5417800|NCT02588092|18695994|P5|Overall Study|Started Another Treatment|1
5417801|NCT02588092|18695995|P4|Overall Study|Started Another Treatment|0
5417802|NCT02588092|18695996|P3|Overall Study|Started Another Treatment|0
5417803|NCT02588092|18695997|P2|Overall Study|Started Another Treatment|0
5417804|NCT02588092|18695998|P1|Overall Study|Started Another Treatment|0
5417805|NCT02588092|18695989|P10|Overall Study|Withdrawal by Subject|0
5417806|NCT02588092|18695990|P9|Overall Study|Withdrawal by Subject|0
5417807|NCT02588092|18695991|P8|Overall Study|Withdrawal by Subject|2
5417808|NCT02588092|18695992|P7|Overall Study|Withdrawal by Subject|1
5417809|NCT02588092|18695993|P6|Overall Study|Withdrawal by Subject|1
5417810|NCT02588092|18695994|P5|Overall Study|Withdrawal by Subject|0
5417811|NCT02588092|18695995|P4|Overall Study|Withdrawal by Subject|0
5417812|NCT02588092|18695996|P3|Overall Study|Withdrawal by Subject|0
5417813|NCT02588092|18695997|P2|Overall Study|Withdrawal by Subject|0
5417814|NCT02588092|18695998|P1|Overall Study|Withdrawal by Subject|0
5417815|NCT02588092|18695989|P10|Overall Study|Death|2
5417816|NCT02588092|18695990|P9|Overall Study|Death|5
5417817|NCT02588092|18695991|P8|Overall Study|Death|1
5417818|NCT02588092|18695992|P7|Overall Study|Death|2
5417819|NCT02588092|18695993|P6|Overall Study|Death|2
5417820|NCT02588092|18695994|P5|Overall Study|Death|2
5417821|NCT02588092|18695995|P4|Overall Study|Death|3
5417822|NCT02588092|18695996|P3|Overall Study|Death|3
5417823|NCT02588092|18695997|P2|Overall Study|Death|3
5417824|NCT02588092|18695998|P1|Overall Study|Death|4
5417825|NCT02587819|18696192|P1|Overall Study|Lost to Follow-up|1
5417826|NCT02587819|18696192|P1|Overall Study|Adverse Event|1
5417827|NCT02587520|18696228|P18|Overall Study|Lost to Follow-up|0
5417828|NCT02587520|18696229|P17|Overall Study|Lost to Follow-up|0
5417829|NCT02587520|18696230|P16|Overall Study|Lost to Follow-up|0
5417830|NCT02587520|18696231|P15|Overall Study|Lost to Follow-up|0
5417831|NCT02587520|18696232|P14|Overall Study|Lost to Follow-up|0
5417832|NCT02587520|18696233|P13|Overall Study|Lost to Follow-up|0
5417833|NCT02587520|18696234|P12|Overall Study|Lost to Follow-up|1
5417834|NCT02587520|18696235|P11|Overall Study|Lost to Follow-up|2
5417835|NCT02587520|18696236|P10|Overall Study|Lost to Follow-up|2
5417836|NCT02587520|18696237|P9|Overall Study|Lost to Follow-up|0
5417837|NCT02587520|18696238|P8|Overall Study|Lost to Follow-up|1
5417838|NCT02587520|18696239|P7|Overall Study|Lost to Follow-up|1
5417839|NCT02587520|18696240|P6|Overall Study|Lost to Follow-up|1
5417840|NCT02587520|18696241|P5|Overall Study|Lost to Follow-up|0
5417841|NCT02587520|18696242|P4|Overall Study|Lost to Follow-up|2
5417842|NCT02587520|18696243|P3|Overall Study|Lost to Follow-up|0
5417843|NCT02587520|18696244|P2|Overall Study|Lost to Follow-up|2
5417844|NCT02587520|18696245|P1|Overall Study|Lost to Follow-up|0
5417845|NCT02587520|18696228|P18|Overall Study|Withdrawal by Subject|0
5417846|NCT02587520|18696229|P17|Overall Study|Withdrawal by Subject|0
5417847|NCT02587520|18696230|P16|Overall Study|Withdrawal by Subject|0
5417848|NCT02587520|18696231|P15|Overall Study|Withdrawal by Subject|0
5417849|NCT02587520|18696232|P14|Overall Study|Withdrawal by Subject|1
5417850|NCT02587520|18696233|P13|Overall Study|Withdrawal by Subject|0
5417851|NCT02587520|18696234|P12|Overall Study|Withdrawal by Subject|0
5417852|NCT02587520|18696235|P11|Overall Study|Withdrawal by Subject|0
5417853|NCT02587520|18696236|P10|Overall Study|Withdrawal by Subject|0
5417854|NCT02587520|18696237|P9|Overall Study|Withdrawal by Subject|0
5417855|NCT02587520|18696238|P8|Overall Study|Withdrawal by Subject|0
5417856|NCT02587520|18696239|P7|Overall Study|Withdrawal by Subject|1
5417857|NCT02587520|18696240|P6|Overall Study|Withdrawal by Subject|1
5417858|NCT02587520|18696241|P5|Overall Study|Withdrawal by Subject|0
5417859|NCT02587520|18696242|P4|Overall Study|Withdrawal by Subject|1
5417860|NCT02587520|18696243|P3|Overall Study|Withdrawal by Subject|1
5417861|NCT02587520|18696244|P2|Overall Study|Withdrawal by Subject|0
5417862|NCT02587520|18696245|P1|Overall Study|Withdrawal by Subject|0
5417863|NCT02587520|18696228|P18|Overall Study|Adverse Event|0
5417864|NCT02587520|18696229|P17|Overall Study|Adverse Event|0
5417865|NCT02587520|18696230|P16|Overall Study|Adverse Event|0
5417866|NCT02587520|18696231|P15|Overall Study|Adverse Event|0
5417867|NCT02587520|18696232|P14|Overall Study|Adverse Event|0
5417868|NCT02587520|18696233|P13|Overall Study|Adverse Event|0
5417869|NCT02587520|18696234|P12|Overall Study|Adverse Event|1
5417870|NCT02587520|18696235|P11|Overall Study|Adverse Event|0
5417871|NCT02587520|18696236|P10|Overall Study|Adverse Event|0
5417872|NCT02587520|18696237|P9|Overall Study|Adverse Event|0
5417873|NCT02587520|18696238|P8|Overall Study|Adverse Event|0
5417874|NCT02587520|18696239|P7|Overall Study|Adverse Event|0
5417875|NCT02587520|18696240|P6|Overall Study|Adverse Event|0
5417876|NCT02587520|18696241|P5|Overall Study|Adverse Event|0
5417877|NCT02587520|18696242|P4|Overall Study|Adverse Event|0
5417878|NCT02587520|18696243|P3|Overall Study|Adverse Event|0
5417879|NCT02587520|18696244|P2|Overall Study|Adverse Event|0
5417880|NCT02587520|18696245|P1|Overall Study|Adverse Event|0
5417881|NCT02587520|18696228|P18|Overall Study|Protocol Violation|0
5417882|NCT02587520|18696229|P17|Overall Study|Protocol Violation|0
5417883|NCT02587520|18696230|P16|Overall Study|Protocol Violation|0
5417884|NCT02587520|18696231|P15|Overall Study|Protocol Violation|0
5417885|NCT02587520|18696232|P14|Overall Study|Protocol Violation|0
5417886|NCT02587520|18696233|P13|Overall Study|Protocol Violation|0
5417887|NCT02587520|18696234|P12|Overall Study|Protocol Violation|2
5417888|NCT02587520|18696235|P11|Overall Study|Protocol Violation|1
5417889|NCT02587520|18696236|P10|Overall Study|Protocol Violation|3
5417890|NCT02587520|18696237|P9|Overall Study|Protocol Violation|3
5417891|NCT02587520|18696238|P8|Overall Study|Protocol Violation|1
5417892|NCT02587520|18696239|P7|Overall Study|Protocol Violation|1
5417893|NCT02587520|18696240|P6|Overall Study|Protocol Violation|1
5417894|NCT02587520|18696241|P5|Overall Study|Protocol Violation|0
5417895|NCT02587520|18696242|P4|Overall Study|Protocol Violation|2
5417896|NCT02587520|18696243|P3|Overall Study|Protocol Violation|0
5417897|NCT02587520|18696244|P2|Overall Study|Protocol Violation|0
5417898|NCT02587520|18696245|P1|Overall Study|Protocol Violation|2
5417899|NCT02587234|18696285|P2|Overall Study|Lost to Follow-up|2
5417900|NCT02587234|18696286|P1|Overall Study|Lost to Follow-up|0
5417901|NCT02587234|18696285|P2|Overall Study|Withdrawal by Subject|1
5417902|NCT02587234|18696286|P1|Overall Study|Withdrawal by Subject|1
5417903|NCT02587221|18696298|P2|Overall Study|Other Reason or Unspecified|1
5417904|NCT02587221|18696299|P1|Overall Study|Other Reason or Unspecified|2
5417905|NCT02587221|18696298|P2|Overall Study|Protocol Violation|5
5417906|NCT02587221|18696299|P1|Overall Study|Protocol Violation|6
5417907|NCT02587221|18696298|P2|Overall Study|Lost to Follow-up|19
5417908|NCT02587221|18696299|P1|Overall Study|Lost to Follow-up|21
5417909|NCT02587221|18696298|P2|Overall Study|Withdrawal by Subject|61
5417910|NCT02587221|18696299|P1|Overall Study|Withdrawal by Subject|66
5417911|NCT02587221|18696298|P2|Overall Study|Death|34
5417912|NCT02587221|18696299|P1|Overall Study|Death|33
5417913|NCT02587221|18696298|P2|Overall Study|Adverse Event|3
5417914|NCT02587221|18696299|P1|Overall Study|Adverse Event|3
5417915|NCT02587143|18696345|P2|Overall Study|Adverse Event|0
5417916|NCT02587143|18696346|P1|Overall Study|Adverse Event|1
5417917|NCT02587065|18696363|P1|Overall Study|Reason not Specified|3
5417918|NCT02587065|18696363|P1|Overall Study|Discontinuation of Study Medication|2
5417919|NCT02587065|18696363|P1|Overall Study|Non-adherence to the Protocol|3
5417920|NCT02587065|18696363|P1|Overall Study|Withdrawal of Informed Consent (IC)|5
5417921|NCT02587065|18696363|P1|Overall Study|Adverse Event|14
5417922|NCT02586805|18696428|P4|Overall Study|Physician Decision|0
5417923|NCT02586805|18696429|P3|Overall Study|Physician Decision|0
5417924|NCT02586805|18696430|P2|Overall Study|Physician Decision|0
5417925|NCT02586805|18696431|P1|Overall Study|Physician Decision|1
5417926|NCT02586805|18696428|P4|Overall Study|Lost to Follow-up|0
5417927|NCT02586805|18696429|P3|Overall Study|Lost to Follow-up|1
5417928|NCT02586805|18696430|P2|Overall Study|Lost to Follow-up|0
5417929|NCT02586805|18696431|P1|Overall Study|Lost to Follow-up|0
5417930|NCT02586805|18696428|P4|Overall Study|Adverse Event|0
5417931|NCT02586805|18696429|P3|Overall Study|Adverse Event|1
5417932|NCT02586805|18696430|P2|Overall Study|Adverse Event|0
5417933|NCT02586805|18696431|P1|Overall Study|Adverse Event|2
5417934|NCT02586805|18696428|P4|Overall Study|Withdrawal by Subject|2
5417935|NCT02586805|18696429|P3|Overall Study|Withdrawal by Subject|1
5417936|NCT02586805|18696430|P2|Overall Study|Withdrawal by Subject|1
5417937|NCT02586805|18696431|P1|Overall Study|Withdrawal by Subject|3
5417938|NCT02586506|18696459|P1|Overall Study|Other Reason|2
5417939|NCT02586506|18696459|P1|Overall Study|Lost to Follow-up|1
5417940|NCT02586506|18696459|P1|Overall Study|Protocol Violation|6
5417941|NCT02586493|18696465|P1|Overall Study|Withdrawal by Subject|1
5417942|NCT02586493|18696465|P1|Overall Study|Lost to Follow-up|1
5417943|NCT02586493|18696465|P1|Overall Study|Protocol Violation|6
5417944|NCT02586493|18696465|P1|Overall Study|Adverse Event|4
5417945|NCT02586415|18696473|P2|Overall Study|Lost to Follow-up|2
5417946|NCT02586415|18696474|P1|Overall Study|Lost to Follow-up|1
5417947|NCT02586415|18696473|P2|Overall Study|Death|23
5417948|NCT02586415|18696474|P1|Overall Study|Death|13
5417949|NCT02586233|18696491|P7|Overall Study|Death|0
5417950|NCT02586233|18696492|P6|Overall Study|Death|0
5417951|NCT02586233|18696493|P5|Overall Study|Death|2
5417952|NCT02586233|18696494|P4|Overall Study|Death|0
5417953|NCT02586233|18696495|P3|Overall Study|Death|0
5417954|NCT02586233|18696496|P2|Overall Study|Death|1
5417955|NCT02586233|18696497|P1|Overall Study|Death|0
5417956|NCT02586233|18696491|P7|Overall Study|Randomized but did not receive treatment|2
5417957|NCT02586233|18696492|P6|Overall Study|Randomized but did not receive treatment|2
5417958|NCT02586233|18696493|P5|Overall Study|Randomized but did not receive treatment|0
5417959|NCT02586233|18696494|P4|Overall Study|Randomized but did not receive treatment|0
5417960|NCT02586233|18696495|P3|Overall Study|Randomized but did not receive treatment|0
5417961|NCT02586233|18696496|P2|Overall Study|Randomized but did not receive treatment|1
5417962|NCT02586233|18696497|P1|Overall Study|Randomized but did not receive treatment|0
5417963|NCT02586077|18696556|P1|Overall Study|Lost to Follow-up|3
5417964|NCT02586077|18696556|P1|Overall Study|Physician Decision|4
5417965|NCT02586077|18696556|P1|Overall Study|Withdrawal by Subject|1
5417966|NCT02586025|18696566|P2|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
5417967|NCT02586025|18696567|P1|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
5417968|NCT02586025|18696566|P2|Adjuvant Treatment|Recurrent Disease|4
5417969|NCT02586025|18696567|P1|Adjuvant Treatment|Recurrent Disease|1
5417970|NCT02586025|18696566|P2|Adjuvant Treatment|Physician Decision|1
5417971|NCT02586025|18696567|P1|Adjuvant Treatment|Physician Decision|0
5417972|NCT02586025|18696566|P2|Adjuvant Treatment|Withdrawal by Subject|3
5417973|NCT02586025|18696567|P1|Adjuvant Treatment|Withdrawal by Subject|5
5417974|NCT02586025|18696566|P2|Adjuvant Treatment|Remain in Adjuvant Treatment|61
5417975|NCT02586025|18696567|P1|Adjuvant Treatment|Remain in Adjuvant Treatment|133
5417976|NCT02586025|18696566|P2|Neoadjuvant Treatment|Progressive Disease|3
5417977|NCT02586025|18696567|P1|Neoadjuvant Treatment|Progressive Disease|2
5417978|NCT02586025|18696566|P2|Neoadjuvant Treatment|Physician Decision|1
5417979|NCT02586025|18696567|P1|Neoadjuvant Treatment|Physician Decision|2
5417980|NCT02586025|18696566|P2|Neoadjuvant Treatment|Withdrawal by Subject|3
5417981|NCT02586025|18696567|P1|Neoadjuvant Treatment|Withdrawal by Subject|4
5417982|NCT02586025|18696566|P2|Neoadjuvant Treatment|Adverse Event|0
5417983|NCT02586025|18696567|P1|Neoadjuvant Treatment|Adverse Event|1
5417984|NCT02586025|18696566|P2|Neoadjuvant Treatment|Death|0
5417985|NCT02586025|18696567|P1|Neoadjuvant Treatment|Death|1
5417986|NCT02586025|18696566|P2|Neoadjuvant Treatment|Did Not Receive Study Drug|0
5417987|NCT02586025|18696567|P1|Neoadjuvant Treatment|Did Not Receive Study Drug|1
5417988|NCT02586012|18696603|P6|Overall Study|study terminated|0
5417989|NCT02586012|18696604|P5|Overall Study|study terminated|1
5417990|NCT02586012|18696605|P4|Overall Study|study terminated|1
5417991|NCT02586012|18696606|P3|Overall Study|study terminated|1
5417992|NCT02586012|18696607|P2|Overall Study|study terminated|2
5417993|NCT02586012|18696608|P1|Overall Study|study terminated|0
5417994|NCT02586012|18696603|P6|Overall Study|Protocol Violation|1
5417995|NCT02586012|18696604|P5|Overall Study|Protocol Violation|0
5417996|NCT02586012|18696605|P4|Overall Study|Protocol Violation|0
5417997|NCT02586012|18696606|P3|Overall Study|Protocol Violation|0
5417998|NCT02586012|18696607|P2|Overall Study|Protocol Violation|0
5417999|NCT02586012|18696608|P1|Overall Study|Protocol Violation|0
5418000|NCT02586012|18696603|P6|Overall Study|Withdrawal by Subject|2
5418001|NCT02586012|18696604|P5|Overall Study|Withdrawal by Subject|0
5418002|NCT02586012|18696605|P4|Overall Study|Withdrawal by Subject|1
5418003|NCT02586012|18696606|P3|Overall Study|Withdrawal by Subject|0
5418004|NCT02586012|18696607|P2|Overall Study|Withdrawal by Subject|1
5418005|NCT02586012|18696608|P1|Overall Study|Withdrawal by Subject|1
5418006|NCT02585999|18696619|P1|Overall Study|Protocol Violation|1
5418007|NCT02585999|18696619|P1|Overall Study|Lost to Follow-up|1
5418008|NCT02585960|18696627|P3|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
5418009|NCT02585960|18696628|P2|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
5418010|NCT02585960|18696629|P1|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
5418011|NCT02585960|18696627|P3|Prophylactic Treatment Period|Major protocol deviation|0
5418012|NCT02585960|18696628|P2|Prophylactic Treatment Period|Major protocol deviation|4
5418013|NCT02585960|18696629|P1|Prophylactic Treatment Period|Major protocol deviation|0
5418014|NCT02585960|18696627|P3|PK/Safety Assessment Period|Screen Failure|1
5418015|NCT02585960|18696628|P2|PK/Safety Assessment Period|Screen Failure|0
5418016|NCT02585960|18696629|P1|PK/Safety Assessment Period|Screen Failure|0
5418017|NCT02585960|18696627|P3|PK/Safety Assessment Period|Withdrawn by sponsor|0
5418018|NCT02585960|18696628|P2|PK/Safety Assessment Period|Withdrawn by sponsor|1
5418019|NCT02585960|18696629|P1|PK/Safety Assessment Period|Withdrawn by sponsor|0
5418020|NCT02585960|18696627|P3|PK/Safety Assessment Period|Other|0
5418021|NCT02585960|18696628|P2|PK/Safety Assessment Period|Other|4
5418022|NCT02585960|18696629|P1|PK/Safety Assessment Period|Other|4
5418023|NCT02585960|18696627|P3|PK/Safety Assessment Period|Non-compliance to study procedures|0
5418024|NCT02585960|18696628|P2|PK/Safety Assessment Period|Non-compliance to study procedures|2
5418025|NCT02585960|18696629|P1|PK/Safety Assessment Period|Non-compliance to study procedures|0
5418026|NCT02585960|18696627|P3|PK/Safety Assessment Period|Withdrawal by Subject|5
5418027|NCT02585960|18696628|P2|PK/Safety Assessment Period|Withdrawal by Subject|2
5418028|NCT02585960|18696629|P1|PK/Safety Assessment Period|Withdrawal by Subject|1
5418029|NCT02585960|18696627|P3|PK/Safety Assessment Period|Physician Decision|0
5418030|NCT02585960|18696628|P2|PK/Safety Assessment Period|Physician Decision|1
5418031|NCT02585960|18696629|P1|PK/Safety Assessment Period|Physician Decision|0
5418032|NCT02585934|18696699|P2|Overall Study|Another Reason|5
5418033|NCT02585934|18696700|P1|Overall Study|Another Reason|10
5418034|NCT02585934|18696699|P2|Overall Study|Sponsor Termination|2
5418035|NCT02585934|18696700|P1|Overall Study|Sponsor Termination|1
5418036|NCT02585934|18696699|P2|Overall Study|Caregiver Withdrew Consent|7
5418037|NCT02585934|18696700|P1|Overall Study|Caregiver Withdrew Consent|7
5418038|NCT02585934|18696699|P2|Overall Study|Death|0
5418039|NCT02585934|18696700|P1|Overall Study|Death|2
5418040|NCT02585934|18696699|P2|Overall Study|Lack of Efficacy|1
5418041|NCT02585934|18696700|P1|Overall Study|Lack of Efficacy|2
5418042|NCT02585934|18696699|P2|Overall Study|Withdrawal by Subject|21
5418043|NCT02585934|18696700|P1|Overall Study|Withdrawal by Subject|7
5418044|NCT02585934|18696699|P2|Overall Study|Physician Decision|2
5418045|NCT02585934|18696700|P1|Overall Study|Physician Decision|3
5418046|NCT02585934|18696699|P2|Overall Study|Adverse Event|22
5418047|NCT02585934|18696700|P1|Overall Study|Adverse Event|21
5418048|NCT02585934|18696699|P2|Overall Study|Protocol Violation|11
5418049|NCT02585934|18696700|P1|Overall Study|Protocol Violation|14
5418050|NCT02585934|18696699|P2|Overall Study|Lost to Follow-up|2
5418051|NCT02585934|18696700|P1|Overall Study|Lost to Follow-up|2
5418052|NCT02585830|18696756|P1|Overall Study|Withdrawal by Subject|3
5418053|NCT02585778|18696765|P2|Overall Study|Other than specified above|2
5418054|NCT02585778|18696766|P1|Overall Study|Other than specified above|6
5418055|NCT02585778|18696765|P2|Overall Study|Randomized but not treated|2
5418056|NCT02585778|18696766|P1|Overall Study|Randomized but not treated|1
5418057|NCT02585778|18696765|P2|Overall Study|Death|1
5418058|NCT02585778|18696766|P1|Overall Study|Death|0
5418059|NCT02585778|18696765|P2|Overall Study|Poor compliance to study protocol|2
5418060|NCT02585778|18696766|P1|Overall Study|Poor compliance to study protocol|0
5418061|NCT02585778|18696765|P2|Overall Study|Participant did not wish to continue|4
5418062|NCT02585778|18696766|P1|Overall Study|Participant did not wish to continue|9
5418063|NCT02585778|18696765|P2|Overall Study|Adverse Event|4
5418064|NCT02585778|18696766|P1|Overall Study|Adverse Event|17
5418065|NCT02585713|18696882|P2|Overall Study|Other|1
5418066|NCT02585713|18696883|P1|Overall Study|Other|3
5418067|NCT02585713|18696882|P2|Overall Study|Withdrew prior to treatment|7
5418068|NCT02585713|18696883|P1|Overall Study|Withdrew prior to treatment|2
5418069|NCT02584959|18696946|P3|Period 2|Withdrawn from study|2
5418070|NCT02584959|18696947|P2|Period 2|Withdrawn from study|1
5418071|NCT02584959|18696948|P1|Period 2|Withdrawn from study|6
5418072|NCT02584959|18696946|P3|Period 1|Withdrawn from study|0
5418073|NCT02584959|18696947|P2|Period 1|Withdrawn from study|4
5418074|NCT02584959|18696948|P1|Period 1|Withdrawn from study|3
5418075|NCT02584855|18697076|P6|Post Treatment Follow-up Period|Protocol Violation|0
5418076|NCT02584855|18697077|P5|Post Treatment Follow-up Period|Protocol Violation|1
5418077|NCT02584855|18697078|P4|Post Treatment Follow-up Period|Protocol Violation|0
5418078|NCT02584855|18697079|P3|Post Treatment Follow-up Period|Protocol Violation|0
5418079|NCT02584855|18697080|P2|Post Treatment Follow-up Period|Protocol Violation|0
5418080|NCT02584855|18697081|P1|Post Treatment Follow-up Period|Protocol Violation|0
5418081|NCT02584855|18697076|P6|Post Treatment Follow-up Period|Withdrawal by Subject|0
5418082|NCT02584855|18697077|P5|Post Treatment Follow-up Period|Withdrawal by Subject|7
5418083|NCT02584855|18697078|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
5418084|NCT02584855|18697079|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
5418085|NCT02584855|18697080|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
5418086|NCT02584855|18697081|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
5418087|NCT02584855|18697076|P6|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5418088|NCT02584855|18697077|P5|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5418089|NCT02584855|18697078|P4|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5418090|NCT02584855|18697079|P3|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5418091|NCT02584855|18697080|P2|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
5418092|NCT02584855|18697081|P1|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
5418093|NCT02584855|18697076|P6|Double-Blind Withdrawal Period|Lack of Efficacy|0
5418094|NCT02584855|18697077|P5|Double-Blind Withdrawal Period|Lack of Efficacy|0
5418095|NCT02584855|18697078|P4|Double-Blind Withdrawal Period|Lack of Efficacy|0
5418096|NCT02584855|18697079|P3|Double-Blind Withdrawal Period|Lack of Efficacy|0
5418097|NCT02584855|18697080|P2|Double-Blind Withdrawal Period|Lack of Efficacy|10
5418098|NCT02584855|18697081|P1|Double-Blind Withdrawal Period|Lack of Efficacy|0
5418099|NCT02584855|18697076|P6|Double-Blind Withdrawal Period|Adverse Event|0
5418100|NCT02584855|18697077|P5|Double-Blind Withdrawal Period|Adverse Event|0
5418101|NCT02584855|18697078|P4|Double-Blind Withdrawal Period|Adverse Event|1
5418102|NCT02584855|18697079|P3|Double-Blind Withdrawal Period|Adverse Event|0
5418103|NCT02584855|18697080|P2|Double-Blind Withdrawal Period|Adverse Event|4
5418104|NCT02584855|18697081|P1|Double-Blind Withdrawal Period|Adverse Event|0
5418105|NCT02584855|18697076|P6|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5418106|NCT02584855|18697077|P5|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5418107|NCT02584855|18697078|P4|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5418108|NCT02584855|18697079|P3|Double-Blind Withdrawal Period|Withdrawal by Subject|2
5418109|NCT02584855|18697080|P2|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5418110|NCT02584855|18697081|P1|Double-Blind Withdrawal Period|Withdrawal by Subject|0
5418111|NCT02584855|18697076|P6|Open-Label Treatment Period|Sponsor Decision|0
5418112|NCT02584855|18697077|P5|Open-Label Treatment Period|Sponsor Decision|0
5418113|NCT02584855|18697078|P4|Open-Label Treatment Period|Sponsor Decision|0
5418114|NCT02584855|18697079|P3|Open-Label Treatment Period|Sponsor Decision|0
5418115|NCT02584855|18697080|P2|Open-Label Treatment Period|Sponsor Decision|0
5418116|NCT02584855|18697081|P1|Open-Label Treatment Period|Sponsor Decision|1
5418117|NCT02584855|18697076|P6|Open-Label Treatment Period|No PI Available|0
5418118|NCT02584855|18697077|P5|Open-Label Treatment Period|No PI Available|0
5418119|NCT02584855|18697078|P4|Open-Label Treatment Period|No PI Available|0
5418120|NCT02584855|18697079|P3|Open-Label Treatment Period|No PI Available|0
5418121|NCT02584855|18697080|P2|Open-Label Treatment Period|No PI Available|0
5418122|NCT02584855|18697081|P1|Open-Label Treatment Period|No PI Available|2
5418123|NCT02584855|18697076|P6|Open-Label Treatment Period|Protocol Violation|0
5418124|NCT02584855|18697077|P5|Open-Label Treatment Period|Protocol Violation|0
5418125|NCT02584855|18697078|P4|Open-Label Treatment Period|Protocol Violation|0
5418126|NCT02584855|18697079|P3|Open-Label Treatment Period|Protocol Violation|0
5418127|NCT02584855|18697080|P2|Open-Label Treatment Period|Protocol Violation|0
5418128|NCT02584855|18697081|P1|Open-Label Treatment Period|Protocol Violation|1
5418129|NCT02584855|18697076|P6|Open-Label Treatment Period|Lost to Follow-up|0
5418130|NCT02584855|18697077|P5|Open-Label Treatment Period|Lost to Follow-up|0
5418131|NCT02584855|18697078|P4|Open-Label Treatment Period|Lost to Follow-up|0
5418132|NCT02584855|18697079|P3|Open-Label Treatment Period|Lost to Follow-up|0
5418133|NCT02584855|18697080|P2|Open-Label Treatment Period|Lost to Follow-up|0
5418134|NCT02584855|18697081|P1|Open-Label Treatment Period|Lost to Follow-up|1
5418135|NCT02584855|18697076|P6|Open-Label Treatment Period|Death|0
5418136|NCT02584855|18697077|P5|Open-Label Treatment Period|Death|0
5418137|NCT02584855|18697078|P4|Open-Label Treatment Period|Death|0
5418138|NCT02584855|18697079|P3|Open-Label Treatment Period|Death|0
5418139|NCT02584855|18697080|P2|Open-Label Treatment Period|Death|0
5418140|NCT02584855|18697081|P1|Open-Label Treatment Period|Death|2
5418141|NCT02584855|18697076|P6|Open-Label Treatment Period|Adverse Event|0
5418142|NCT02584855|18697077|P5|Open-Label Treatment Period|Adverse Event|0
5418143|NCT02584855|18697078|P4|Open-Label Treatment Period|Adverse Event|0
5418144|NCT02584855|18697079|P3|Open-Label Treatment Period|Adverse Event|0
5418145|NCT02584855|18697080|P2|Open-Label Treatment Period|Adverse Event|0
5418146|NCT02584855|18697081|P1|Open-Label Treatment Period|Adverse Event|14
5418147|NCT02584855|18697076|P6|Open-Label Treatment Period|Withdrawal by Subject|0
5418148|NCT02584855|18697077|P5|Open-Label Treatment Period|Withdrawal by Subject|0
5418149|NCT02584855|18697078|P4|Open-Label Treatment Period|Withdrawal by Subject|0
5418150|NCT02584855|18697079|P3|Open-Label Treatment Period|Withdrawal by Subject|0
5418151|NCT02584855|18697080|P2|Open-Label Treatment Period|Withdrawal by Subject|0
5418152|NCT02584855|18697081|P1|Open-Label Treatment Period|Withdrawal by Subject|21
5418153|NCT02584855|18697076|P6|Open-Label Treatment Period|Lack of Efficacy|0
5418154|NCT02584855|18697077|P5|Open-Label Treatment Period|Lack of Efficacy|0
5418155|NCT02584855|18697078|P4|Open-Label Treatment Period|Lack of Efficacy|0
5418156|NCT02584855|18697079|P3|Open-Label Treatment Period|Lack of Efficacy|0
5418157|NCT02584855|18697080|P2|Open-Label Treatment Period|Lack of Efficacy|0
5418158|NCT02584855|18697081|P1|Open-Label Treatment Period|Lack of Efficacy|61
5418159|NCT02584660|18697213|P2|Overall Study|Other|1
5418160|NCT02584660|18697214|P1|Overall Study|Other|0
5418161|NCT02584660|18697213|P2|Overall Study|Withdrawal by Subject|2
5418162|NCT02584660|18697214|P1|Overall Study|Withdrawal by Subject|0
5418163|NCT02584660|18697213|P2|Overall Study|Protocol Violation|1
5418164|NCT02584660|18697214|P1|Overall Study|Protocol Violation|0
5418165|NCT02584660|18697213|P2|Overall Study|Lost to Follow-up|4
5418166|NCT02584660|18697214|P1|Overall Study|Lost to Follow-up|3
5418167|NCT02584660|18697213|P2|Overall Study|Adverse Event|0
5418168|NCT02584660|18697214|P1|Overall Study|Adverse Event|4
5418169|NCT02584504|18697233|P3|Open-label Treatment|Entered but not treated|1
5418170|NCT02584504|18697234|P2|Open-label Treatment|Entered but not treated|1
5418171|NCT02584504|18697235|P1|Open-label Treatment|Entered but not treated|0
5418172|NCT02584504|18697233|P3|Open-label Treatment|Physician Decision|0
5418173|NCT02584504|18697234|P2|Open-label Treatment|Physician Decision|1
5418174|NCT02584504|18697235|P1|Open-label Treatment|Physician Decision|0
5418175|NCT02584504|18697233|P3|Open-label Treatment|Adverse Event|3
5418176|NCT02584504|18697234|P2|Open-label Treatment|Adverse Event|2
5418177|NCT02584504|18697235|P1|Open-label Treatment|Adverse Event|2
5418178|NCT02584504|18697233|P3|Open-label Treatment|Participant withdrew consent|4
5418179|NCT02584504|18697234|P2|Open-label Treatment|Participant withdrew consent|0
5418180|NCT02584504|18697235|P1|Open-label Treatment|Participant withdrew consent|0
5418181|NCT02584504|18697233|P3|Double-blind Treatment|Family Matter|0
5418182|NCT02584504|18697234|P2|Double-blind Treatment|Family Matter|1
5418183|NCT02584504|18697235|P1|Double-blind Treatment|Family Matter|0
5418184|NCT02584504|18697233|P3|Double-blind Treatment|Adverse Event|0
5418185|NCT02584504|18697234|P2|Double-blind Treatment|Adverse Event|1
5418186|NCT02584504|18697235|P1|Double-blind Treatment|Adverse Event|0
5418187|NCT02584504|18697233|P3|Double-blind Treatment|Participant withdrew consent|1
5418188|NCT02584504|18697234|P2|Double-blind Treatment|Participant withdrew consent|0
5418189|NCT02584504|18697235|P1|Double-blind Treatment|Participant withdrew consent|0
5418190|NCT02584452|18697291|P2|Overall Study|Lost to Follow-up|1
5418191|NCT02584452|18697292|P1|Overall Study|Lost to Follow-up|1
5418192|NCT02584452|18697291|P2|Overall Study|Physician Decision|1
5418193|NCT02584452|18697292|P1|Overall Study|Physician Decision|1
5418194|NCT02584257|18697320|P9|Period 2|Adverse Event|0
5418195|NCT02584257|18697321|P8|Period 2|Adverse Event|0
5418196|NCT02584257|18697322|P7|Period 2|Adverse Event|0
5418197|NCT02584257|18697323|P6|Period 2|Adverse Event|0
5418198|NCT02584257|18697324|P5|Period 2|Adverse Event|0
5418199|NCT02584257|18697325|P4|Period 2|Adverse Event|0
5418200|NCT02584257|18697326|P3|Period 2|Adverse Event|0
5418201|NCT02584257|18697327|P2|Period 2|Adverse Event|1
5418202|NCT02584257|18697328|P1|Period 2|Adverse Event|0
5418203|NCT02584257|18697320|P9|Period 2|Physician Decision|0
5418204|NCT02584257|18697321|P8|Period 2|Physician Decision|0
5418205|NCT02584257|18697322|P7|Period 2|Physician Decision|0
5418206|NCT02584257|18697323|P6|Period 2|Physician Decision|0
5418207|NCT02584257|18697324|P5|Period 2|Physician Decision|0
5418208|NCT02584257|18697325|P4|Period 2|Physician Decision|0
5418209|NCT02584257|18697326|P3|Period 2|Physician Decision|0
5418210|NCT02584257|18697327|P2|Period 2|Physician Decision|0
5418211|NCT02584257|18697328|P1|Period 2|Physician Decision|1
5418212|NCT02584257|18697320|P9|Period 1|Withdrawal by Subject|0
5418213|NCT02584257|18697321|P8|Period 1|Withdrawal by Subject|0
5418214|NCT02584257|18697322|P7|Period 1|Withdrawal by Subject|1
5418215|NCT02584257|18697323|P6|Period 1|Withdrawal by Subject|0
5418216|NCT02584257|18697324|P5|Period 1|Withdrawal by Subject|0
5418217|NCT02584257|18697325|P4|Period 1|Withdrawal by Subject|0
5418218|NCT02584257|18697326|P3|Period 1|Withdrawal by Subject|0
5418219|NCT02584257|18697327|P2|Period 1|Withdrawal by Subject|0
5418220|NCT02584257|18697328|P1|Period 1|Withdrawal by Subject|0
5418221|NCT02583477|18697349|P2|Overall Study|Study terminated|2
5418222|NCT02583477|18697350|P1|Overall Study|Study terminated|2
5418223|NCT02583477|18697349|P2|Overall Study|Death|16
5418224|NCT02583477|18697350|P1|Overall Study|Death|1
5418225|NCT02583477|18697349|P2|Overall Study|Adverse Event|2
5418226|NCT02583477|18697350|P1|Overall Study|Adverse Event|0
5418227|NCT02583425|18697370|P1|Treatment Period|Adverse Event|1
5418228|NCT02583425|18697370|P1|Baseline|Did not meet continued criteria|5
5418229|NCT02583425|18697370|P1|Screening|Did not meet entry criteria|12
5418230|NCT02583399|18697375|P1|Overall Study|Wanted to use a restricted medication|3
5418231|NCT02583399|18697375|P1|Overall Study|Able to be discharged|3
5418232|NCT02583269|18697400|P5|Overall Study|Patient hospitalized prior to start|0
5418233|NCT02583269|18697401|P4|Overall Study|Patient hospitalized prior to start|0
5418234|NCT02583269|18697402|P3|Overall Study|Patient hospitalized prior to start|0
5418235|NCT02583269|18697403|P2|Overall Study|Patient hospitalized prior to start|0
5418236|NCT02583269|18697404|P1|Overall Study|Patient hospitalized prior to start|1
5418237|NCT02583256|18697433|P4|Overall Study|Administrative/Other|2
5418238|NCT02583256|18697434|P3|Overall Study|Administrative/Other|1
5418239|NCT02583256|18697435|P2|Overall Study|Administrative/Other|0
5418240|NCT02583256|18697436|P1|Overall Study|Administrative/Other|2
5418241|NCT02583256|18697433|P4|Overall Study|Lost to Follow-up|1
5418242|NCT02583256|18697434|P3|Overall Study|Lost to Follow-up|0
5418243|NCT02583256|18697435|P2|Overall Study|Lost to Follow-up|1
5418244|NCT02583256|18697436|P1|Overall Study|Lost to Follow-up|1
5418245|NCT02583256|18697433|P4|Overall Study|Withdrawal by Subject|0
5418246|NCT02583256|18697434|P3|Overall Study|Withdrawal by Subject|1
5418247|NCT02583256|18697435|P2|Overall Study|Withdrawal by Subject|1
5418248|NCT02583256|18697436|P1|Overall Study|Withdrawal by Subject|0
5418249|NCT02583048|18697533|P3|Overall Study|Failed to meet eligibility criterion|1
5418250|NCT02583048|18697534|P2|Overall Study|Failed to meet eligibility criterion|0
5418251|NCT02583048|18697535|P1|Overall Study|Failed to meet eligibility criterion|0
5418252|NCT02583048|18697533|P3|Overall Study|Withdrawal by Subject|0
5418253|NCT02583048|18697534|P2|Overall Study|Withdrawal by Subject|1
5418254|NCT02583048|18697535|P1|Overall Study|Withdrawal by Subject|0
5418255|NCT02582983|18697570|P1|Overall Study|Adverse Event|1
5418256|NCT02582983|18697570|P1|Overall Study|Withdrawal by Subject|2
5418257|NCT02582983|18697570|P1|Overall Study|Death|3
5418258|NCT02582814|18697633|P2|Overall Study|Adverse Event|4
5418259|NCT02582814|18697634|P1|Overall Study|Adverse Event|4
5418260|NCT02582814|18697633|P2|Overall Study|Withdrawal by Subject|3
5418261|NCT02582814|18697634|P1|Overall Study|Withdrawal by Subject|4
5418262|NCT02582814|18697633|P2|Overall Study|Study-specific withdrawal criteria|0
5418263|NCT02582814|18697634|P1|Overall Study|Study-specific withdrawal criteria|1
5418264|NCT02582749|18697674|P2|Overall Study|Withdrawal by Subject|1
5418265|NCT02582749|18697675|P1|Overall Study|Withdrawal by Subject|0
5418266|NCT02582749|18697674|P2|Overall Study|Study terminated by funder|10
5418267|NCT02582749|18697675|P1|Overall Study|Study terminated by funder|5
5418268|NCT02582684|18697705|P1|Overall Study|Found to be ineligible after enrollment|2
5418269|NCT02582684|18697705|P1|Overall Study|Subject withdrew consent|1
5418270|NCT02582684|18697705|P1|Overall Study|Subject not able to get to clinic|10
5418271|NCT02582684|18697705|P1|Overall Study|Unable to contact subject/parent|4
5418272|NCT02582671|18697724|P1|Overall Study|Other, not specified|1
5418273|NCT02582671|18697724|P1|Overall Study|Failure to return|1
5418274|NCT02582658|18697736|P1|Overall Study|Not further specified|11
5418275|NCT02582658|18697736|P1|Overall Study|Death|1
5418276|NCT02582658|18697736|P1|Overall Study|Withdrawn Consent|1
5418277|NCT02582658|18697736|P1|Overall Study|Insufficient Virological Response|2
5418278|NCT02582658|18697736|P1|Overall Study|Failure to Return|10
5418279|NCT02582632|18697754|P1|Overall Study|Other|1
5418280|NCT02582515|18697769|P2|Overall Study|Withdrawal by Subject|1
5418281|NCT02582515|18697770|P1|Overall Study|Withdrawal by Subject|0
5418282|NCT02582255|18697778|P2|Overall Study|Protocol Violation|3
5418283|NCT02582255|18697779|P1|Overall Study|Protocol Violation|0
5418284|NCT02582242|18697792|P2|Overall Study|Unclassified|1
5418285|NCT02582242|18697793|P1|Overall Study|Unclassified|2
5418286|NCT02582242|18697792|P2|Overall Study|Withdrawal by Subject|11
5418287|NCT02582242|18697793|P1|Overall Study|Withdrawal by Subject|11
5418288|NCT02582242|18697792|P2|Overall Study|Lost to Follow-up|1
5418289|NCT02582242|18697793|P1|Overall Study|Lost to Follow-up|0
5418290|NCT02582242|18697792|P2|Overall Study|Protocol Violation|1
5418291|NCT02582242|18697793|P1|Overall Study|Protocol Violation|3
5418292|NCT02582242|18697792|P2|Overall Study|Adverse Event|3
5418293|NCT02582242|18697793|P1|Overall Study|Adverse Event|4
5418294|NCT02581995|18697857|P1|Overall Study|Death|4
5418295|NCT02581995|18697857|P1|Overall Study|Physician Decision|1
5418296|NCT02581995|18697857|P1|Overall Study|Withdrawal by participant|12
5418297|NCT02581995|18697857|P1|Overall Study|Lost to Follow-up|5
5418298|NCT02581995|18697857|P1|Overall Study|Adverse Event|6
5418299|NCT02581995|18697857|P1|Overall Study|Unspecified other|3
5418300|NCT02581930|18697871|P1|Overall Study|patient declined further treatment|1
5418301|NCT02581930|18697871|P1|Overall Study|Withdrawal by Subject|1
5418302|NCT02581891|18697879|P2|Overall Study|Discontinued during followup|0
5418303|NCT02581891|18697880|P1|Overall Study|Discontinued during followup|1
5418304|NCT02581891|18697879|P2|Overall Study|Other Reasons|1
5418305|NCT02581891|18697880|P1|Overall Study|Other Reasons|3
5418306|NCT02581891|18697879|P2|Overall Study|Withdrawal by Subject|5
5418307|NCT02581891|18697880|P1|Overall Study|Withdrawal by Subject|4
5418308|NCT02581891|18697879|P2|Overall Study|Physician Decision|1
5418309|NCT02581891|18697880|P1|Overall Study|Physician Decision|0
5418310|NCT02581891|18697879|P2|Overall Study|Lost to Follow-up|2
5418311|NCT02581891|18697880|P1|Overall Study|Lost to Follow-up|1
5418312|NCT02581891|18697879|P2|Overall Study|Death|4
5418313|NCT02581891|18697880|P1|Overall Study|Death|3
5418314|NCT02581891|18697879|P2|Overall Study|Adverse Event|6
5418315|NCT02581891|18697880|P1|Overall Study|Adverse Event|4
5418316|NCT02581488|18697943|P2|Overall Study|Protocol Violation|4
5418317|NCT02581488|18697944|P1|Overall Study|Protocol Violation|0
5418318|NCT02581488|18697943|P2|Overall Study|Non-Compliance|0
5418319|NCT02581488|18697944|P1|Overall Study|Non-Compliance|1
5418320|NCT02581488|18697943|P2|Overall Study|Withdrawal by Subject|0
5418321|NCT02581488|18697944|P1|Overall Study|Withdrawal by Subject|1
5418322|NCT02581488|18697943|P2|Overall Study|Lost to Follow-up|0
5418323|NCT02581488|18697944|P1|Overall Study|Lost to Follow-up|1
5418324|NCT02581488|18697943|P2|Overall Study|Adverse Event|7
5418325|NCT02581488|18697944|P1|Overall Study|Adverse Event|6
5418326|NCT02581410|18697975|P2|End of Study Phase|Other-transfer of subject not completed|1
5418327|NCT02581410|18697976|P1|End of Study Phase|Other-transfer of subject not completed|0
5418328|NCT02581410|18697975|P2|End of Study Phase|Lost to Follow-up|2
5418329|NCT02581410|18697976|P1|End of Study Phase|Lost to Follow-up|0
5418330|NCT02581410|18697975|P2|End of Study Phase|Migrated/moved from study area|3
5418331|NCT02581410|18697976|P1|End of Study Phase|Migrated/moved from study area|0
5418332|NCT02581410|18697975|P2|End of Study Phase|Withdrawal by Subject|2
5418333|NCT02581410|18697976|P1|End of Study Phase|Withdrawal by Subject|1
5418334|NCT02581410|18697975|P2|End of Study Phase|Adverse Event|3
5418335|NCT02581410|18697976|P1|End of Study Phase|Adverse Event|4
5418336|NCT02581410|18697975|P2|Vaccination Phase|Migrated/moved from study area|1
5418337|NCT02581410|18697976|P1|Vaccination Phase|Migrated/moved from study area|0
5418338|NCT02581410|18697975|P2|Vaccination Phase|Withdrawal by Subject|1
5418339|NCT02581410|18697976|P1|Vaccination Phase|Withdrawal by Subject|0
5418340|NCT02581410|18697975|P2|Vaccination Phase|Adverse Event|1
5418341|NCT02581410|18697976|P1|Vaccination Phase|Adverse Event|2
5418342|NCT02581345|18698006|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
5418343|NCT02581345|18698007|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
5418344|NCT02581345|18698008|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
5418345|NCT02581345|18698009|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
5418346|NCT02581345|18698006|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
5418347|NCT02581345|18698007|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
5418348|NCT02581345|18698008|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
5418349|NCT02581345|18698009|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
5418350|NCT02581345|18698006|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
5418351|NCT02581345|18698007|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
5418352|NCT02581345|18698008|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
5418353|NCT02581345|18698009|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
5418354|NCT02581345|18698006|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
5418355|NCT02581345|18698007|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
5418356|NCT02581345|18698008|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
5418357|NCT02581345|18698009|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
5418358|NCT02581345|18698006|P4|Part 2: Week 17 to Week 47|Physician Decision|1
5418359|NCT02581345|18698007|P3|Part 2: Week 17 to Week 47|Physician Decision|2
5418360|NCT02581345|18698008|P2|Part 2: Week 17 to Week 47|Physician Decision|0
5418361|NCT02581345|18698009|P1|Part 2: Week 17 to Week 47|Physician Decision|3
5418362|NCT02581345|18698006|P4|Part 2: Week 17 to Week 47|Adverse Event|2
5418363|NCT02581345|18698007|P3|Part 2: Week 17 to Week 47|Adverse Event|2
5418364|NCT02581345|18698008|P2|Part 2: Week 17 to Week 47|Adverse Event|0
5418365|NCT02581345|18698009|P1|Part 2: Week 17 to Week 47|Adverse Event|5
5418366|NCT02581345|18698006|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
5418367|NCT02581345|18698007|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
5418368|NCT02581345|18698008|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
5418369|NCT02581345|18698009|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
5418370|NCT02581345|18698006|P4|Part 1: up to Week 16|Unspecified Reason|0
5418371|NCT02581345|18698007|P3|Part 1: up to Week 16|Unspecified Reason|0
5418372|NCT02581345|18698008|P2|Part 1: up to Week 16|Unspecified Reason|3
5418373|NCT02581345|18698009|P1|Part 1: up to Week 16|Unspecified Reason|3
5418374|NCT02581345|18698006|P4|Part 1: up to Week 16|Lost to Follow-up|0
5418375|NCT02581345|18698007|P3|Part 1: up to Week 16|Lost to Follow-up|0
5418376|NCT02581345|18698008|P2|Part 1: up to Week 16|Lost to Follow-up|0
5418377|NCT02581345|18698009|P1|Part 1: up to Week 16|Lost to Follow-up|2
5418378|NCT02581345|18698006|P4|Part 1: up to Week 16|Withdrawal by Subject|0
5418379|NCT02581345|18698007|P3|Part 1: up to Week 16|Withdrawal by Subject|0
5418380|NCT02581345|18698008|P2|Part 1: up to Week 16|Withdrawal by Subject|7
5418381|NCT02581345|18698009|P1|Part 1: up to Week 16|Withdrawal by Subject|4
5418382|NCT02581345|18698006|P4|Part 1: up to Week 16|Physician Decision|0
5418383|NCT02581345|18698007|P3|Part 1: up to Week 16|Physician Decision|0
5418384|NCT02581345|18698008|P2|Part 1: up to Week 16|Physician Decision|4
5418385|NCT02581345|18698009|P1|Part 1: up to Week 16|Physician Decision|2
5418386|NCT02581345|18698006|P4|Part 1: up to Week 16|Adverse Event|0
5418387|NCT02581345|18698007|P3|Part 1: up to Week 16|Adverse Event|0
5418388|NCT02581345|18698008|P2|Part 1: up to Week 16|Adverse Event|8
5418389|NCT02581345|18698009|P1|Part 1: up to Week 16|Adverse Event|3
5418390|NCT02581202|18698111|P1|Overall Study|Pregnancy|3
5418391|NCT02581202|18698111|P1|Overall Study|Lost to Follow-up|5
5418392|NCT02581202|18698111|P1|Overall Study|Withdrawal by Subject|4
5418393|NCT02581202|18698111|P1|Overall Study|Lack of Efficacy|2
5418394|NCT02581189|18698150|P1|Overall Study|Other, not specified|7
5418395|NCT02581189|18698150|P1|Overall Study|Insufficient virological response|2
5418396|NCT02581189|18698150|P1|Overall Study|Death|3
5418397|NCT02581189|18698150|P1|Overall Study|Withdrew consent|5
5418398|NCT02581189|18698150|P1|Overall Study|Failure to return|36
5418399|NCT02581163|18698164|P1|Overall Study|Other, not specified|9
5418400|NCT02581163|18698164|P1|Overall Study|Death|1
5418401|NCT02581163|18698164|P1|Overall Study|Withdrew consent|1
5418402|NCT02581163|18698164|P1|Overall Study|Insufficient virological response|3
5418403|NCT02581163|18698164|P1|Overall Study|Failure to return|15
5418404|NCT02580877|18698198|P2|Overall Study|Adverse Event|1
5418405|NCT02580877|18698199|P1|Overall Study|Adverse Event|0
5418406|NCT02580877|18698198|P2|Overall Study|Withdrawal by Subject|3
5418407|NCT02580877|18698199|P1|Overall Study|Withdrawal by Subject|1
5418408|NCT02580591|18698233|P4|Overall Study|Other than specified|2
5418409|NCT02580591|18698234|P3|Overall Study|Other than specified|5
5418410|NCT02580591|18698235|P2|Overall Study|Other than specified|2
5418411|NCT02580591|18698236|P1|Overall Study|Other than specified|3
5418412|NCT02580591|18698233|P4|Overall Study|Not treated|0
5418413|NCT02580591|18698234|P3|Overall Study|Not treated|0
5418414|NCT02580591|18698235|P2|Overall Study|Not treated|1
5418415|NCT02580591|18698236|P1|Overall Study|Not treated|1
5418416|NCT02580591|18698233|P4|Overall Study|Withdrawal by Subject|3
5418417|NCT02580591|18698234|P3|Overall Study|Withdrawal by Subject|2
5418418|NCT02580591|18698235|P2|Overall Study|Withdrawal by Subject|1
5418419|NCT02580591|18698236|P1|Overall Study|Withdrawal by Subject|6
5418420|NCT02580591|18698233|P4|Overall Study|Lost to Follow-up|1
5418421|NCT02580591|18698234|P3|Overall Study|Lost to Follow-up|3
5418422|NCT02580591|18698235|P2|Overall Study|Lost to Follow-up|3
5418423|NCT02580591|18698236|P1|Overall Study|Lost to Follow-up|5
5418424|NCT02580591|18698233|P4|Overall Study|Protocol Violation|1
5418425|NCT02580591|18698234|P3|Overall Study|Protocol Violation|1
5418426|NCT02580591|18698235|P2|Overall Study|Protocol Violation|2
5418427|NCT02580591|18698236|P1|Overall Study|Protocol Violation|3
5418428|NCT02580591|18698233|P4|Overall Study|Adverse Event|5
5418429|NCT02580591|18698234|P3|Overall Study|Adverse Event|2
5418430|NCT02580591|18698235|P2|Overall Study|Adverse Event|1
5418431|NCT02580591|18698236|P1|Overall Study|Adverse Event|0
5418432|NCT02580357|18698269|P3|Overall Study|Protocol Violation|0
5418433|NCT02580357|18698270|P2|Overall Study|Protocol Violation|0
5418434|NCT02580357|18698271|P1|Overall Study|Protocol Violation|1
5418435|NCT02580357|18698269|P3|Overall Study|Lost to Follow-up|0
5418436|NCT02580357|18698270|P2|Overall Study|Lost to Follow-up|0
5418437|NCT02580357|18698271|P1|Overall Study|Lost to Follow-up|2
5418438|NCT02580240|18698288|P2|Overall Study|Physician Decision|0
5418439|NCT02580240|18698289|P1|Overall Study|Physician Decision|2
5418440|NCT02580058|18698327|P3|Overall Study|Withdrawal by Subject|36
5418441|NCT02580058|18698328|P2|Overall Study|Withdrawal by Subject|26
5418442|NCT02580058|18698329|P1|Overall Study|Withdrawal by Subject|24
5418443|NCT02580058|18698327|P3|Overall Study|Ongoing|46
5418444|NCT02580058|18698328|P2|Overall Study|Ongoing|55
5418445|NCT02580058|18698329|P1|Overall Study|Ongoing|51
5418446|NCT02580058|18698327|P3|Overall Study|Lost to Follow-up|4
5418447|NCT02580058|18698328|P2|Overall Study|Lost to Follow-up|5
5418448|NCT02580058|18698329|P1|Overall Study|Lost to Follow-up|4
5418449|NCT02579928|18698396|P2|Overall Study|Withdrawal by Subject|0
5418450|NCT02579928|18698397|P1|Overall Study|Withdrawal by Subject|1
5418451|NCT02579863|18698437|P2|Overall Study|Withdrawal by Subject|19
5418452|NCT02579863|18698438|P1|Overall Study|Withdrawal by Subject|17
5418453|NCT02579863|18698437|P2|Overall Study|Study Terminated at Selected Sites|3
5418454|NCT02579863|18698438|P1|Overall Study|Study Terminated at Selected Sites|3
5418455|NCT02579863|18698437|P2|Overall Study|Screen Failure|2
5418456|NCT02579863|18698438|P1|Overall Study|Screen Failure|1
5418457|NCT02579863|18698437|P2|Overall Study|Physician Decision|2
5418458|NCT02579863|18698438|P1|Overall Study|Physician Decision|0
5418459|NCT02579863|18698437|P2|Overall Study|Lost to Follow-up|1
5418460|NCT02579863|18698438|P1|Overall Study|Lost to Follow-up|2
5418461|NCT02579863|18698437|P2|Overall Study|Death|3
5418462|NCT02579863|18698438|P1|Overall Study|Death|11
5418463|NCT02579863|18698437|P2|Overall Study|Adverse Event|12
5418464|NCT02579863|18698438|P1|Overall Study|Adverse Event|17
5418465|NCT02579863|18698437|P2|Overall Study|Ongoing in Trial|112
5418466|NCT02579863|18698438|P1|Overall Study|Ongoing in Trial|105
5418467|NCT02579772|18698465|P2|Overall Study|flu-like illness, orthopedic trauma|1
5418468|NCT02579772|18698466|P1|Overall Study|flu-like illness, orthopedic trauma|1
5418469|NCT02579772|18698465|P2|Overall Study|Usage of additional antioxidants|0
5418470|NCT02579772|18698466|P1|Overall Study|Usage of additional antioxidants|1
5418471|NCT02579772|18698465|P2|Overall Study|Withdrawal by Subject|1
5418472|NCT02579772|18698466|P1|Overall Study|Withdrawal by Subject|0
5418473|NCT02579759|18698487|P3|Overall Study|Lost to Follow-up|2
5418474|NCT02579759|18698488|P2|Overall Study|Lost to Follow-up|2
5418475|NCT02579759|18698489|P1|Overall Study|Lost to Follow-up|2
5418476|NCT02579759|18698487|P3|Overall Study|Withdrawal by Subject|5
5418477|NCT02579759|18698488|P2|Overall Study|Withdrawal by Subject|3
5418478|NCT02579759|18698489|P1|Overall Study|Withdrawal by Subject|3
5418479|NCT02579759|18698487|P3|Overall Study|Adverse Event|1
5418480|NCT02579759|18698488|P2|Overall Study|Adverse Event|3
5418481|NCT02579759|18698489|P1|Overall Study|Adverse Event|4
5418482|NCT02579759|18698487|P3|Overall Study|Inclusion/exclusion criteria|1
5418483|NCT02579759|18698488|P2|Overall Study|Inclusion/exclusion criteria|0
5418484|NCT02579759|18698489|P1|Overall Study|Inclusion/exclusion criteria|0
5418485|NCT02579759|18698487|P3|Overall Study|Pregnancy|0
5418486|NCT02579759|18698488|P2|Overall Study|Pregnancy|1
5418487|NCT02579759|18698489|P1|Overall Study|Pregnancy|0
5418488|NCT02579759|18698487|P3|Overall Study|Non compliance|0
5418489|NCT02579759|18698488|P2|Overall Study|Non compliance|1
5418490|NCT02579759|18698489|P1|Overall Study|Non compliance|0
5418491|NCT02579759|18698487|P3|Overall Study|Sponsor stopped Dose 2|0
5418492|NCT02579759|18698488|P2|Overall Study|Sponsor stopped Dose 2|41
5418493|NCT02579759|18698489|P1|Overall Study|Sponsor stopped Dose 2|0
5418494|NCT02579759|18698487|P3|Overall Study|BfArM hold|12
5418495|NCT02579759|18698488|P2|Overall Study|BfArM hold|12
5418496|NCT02579759|18698489|P1|Overall Study|BfArM hold|13
5418497|NCT02579759|18698487|P3|Overall Study|Other (Sponsor stopped Dose 2)|0
5418498|NCT02579759|18698488|P2|Overall Study|Other (Sponsor stopped Dose 2)|1
5418499|NCT02579759|18698489|P1|Overall Study|Other (Sponsor stopped Dose 2)|0
5418500|NCT02579759|18698487|P3|Overall Study|Protocol Violation|0
5418501|NCT02579759|18698488|P2|Overall Study|Protocol Violation|0
5418502|NCT02579759|18698489|P1|Overall Study|Protocol Violation|2
5418503|NCT02579629|18698536|P3|Overall Study|Screen Failure|2
5418504|NCT02579629|18698537|P2|Overall Study|Screen Failure|0
5418505|NCT02579629|18698538|P1|Overall Study|Screen Failure|2
5418506|NCT02579629|18698536|P3|Overall Study|Withdrawal by Subject|0
5418507|NCT02579629|18698537|P2|Overall Study|Withdrawal by Subject|1
5418508|NCT02579629|18698538|P1|Overall Study|Withdrawal by Subject|0
5418509|NCT02579616|18698585|P1|Overall Study|Participants did not receive treatment|3
5418510|NCT02579603|18698598|P2|Overall Study|Other than stated|0
5418511|NCT02579603|18698599|P1|Overall Study|Other than stated|1
5418512|NCT02579603|18698598|P2|Overall Study|Adverse Event|2
5418513|NCT02579603|18698599|P1|Overall Study|Adverse Event|2
5418514|NCT02579603|18698598|P2|Overall Study|Not treated|0
5418515|NCT02579603|18698599|P1|Overall Study|Not treated|1
5418516|NCT02579382|18698629|P4|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
5418517|NCT02579382|18698630|P3|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
5418518|NCT02579382|18698631|P2|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
5418519|NCT02579382|18698632|P1|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
5418520|NCT02579382|18698629|P4|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
5418521|NCT02579382|18698630|P3|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
5418522|NCT02579382|18698631|P2|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
5418523|NCT02579382|18698632|P1|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
5418524|NCT02579382|18698629|P4|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
5418525|NCT02579382|18698630|P3|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
5418526|NCT02579382|18698631|P2|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
5418527|NCT02579382|18698632|P1|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
5418528|NCT02579382|18698629|P4|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
5418529|NCT02579382|18698630|P3|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
5418530|NCT02579382|18698631|P2|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
5418531|NCT02579382|18698632|P1|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
5418532|NCT02579382|18698629|P4|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
5418533|NCT02579382|18698630|P3|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
5418534|NCT02579382|18698631|P2|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
5418535|NCT02579382|18698632|P1|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
5418536|NCT02579382|18698629|P4|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
5418537|NCT02579382|18698630|P3|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
5418538|NCT02579382|18698631|P2|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
5418539|NCT02579382|18698632|P1|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
5418540|NCT02579382|18698629|P4|Main Study Phase|Lack of Efficacy|1
5418541|NCT02579382|18698630|P3|Main Study Phase|Lack of Efficacy|0
5418542|NCT02579382|18698631|P2|Main Study Phase|Lack of Efficacy|0
5418543|NCT02579382|18698632|P1|Main Study Phase|Lack of Efficacy|0
5418544|NCT02579382|18698629|P4|Main Study Phase|Withdrew Consent|2
5418545|NCT02579382|18698630|P3|Main Study Phase|Withdrew Consent|0
5418546|NCT02579382|18698631|P2|Main Study Phase|Withdrew Consent|0
5418547|NCT02579382|18698632|P1|Main Study Phase|Withdrew Consent|0
5418548|NCT02579382|18698629|P4|Main Study Phase|Lost to Follow-up|0
5418549|NCT02579382|18698630|P3|Main Study Phase|Lost to Follow-up|2
5418550|NCT02579382|18698631|P2|Main Study Phase|Lost to Follow-up|0
5418551|NCT02579382|18698632|P1|Main Study Phase|Lost to Follow-up|0
5418552|NCT02578992|18698754|P2|Overall Study|equipment not available or malfunction|3
5418553|NCT02578992|18698755|P1|Overall Study|equipment not available or malfunction|3
5418554|NCT02578940|18698767|P1|Overall Study|Lost to Follow-up|1
5418555|NCT02578940|18698767|P1|Overall Study|Screening failure|5
5418556|NCT02578862|18698776|P2|Overall Study|Unplanned unilateral procedure|1
5418557|NCT02578862|18698777|P1|Overall Study|Unplanned unilateral procedure|0
5418558|NCT02578862|18698776|P2|Overall Study|Withdrawal by Subject|1
5418559|NCT02578862|18698777|P1|Overall Study|Withdrawal by Subject|0
5418560|NCT02578706|18698815|P3|Overall Study|Physician Decision|0
5418561|NCT02578706|18698816|P2|Overall Study|Physician Decision|1
5418562|NCT02578706|18698817|P1|Overall Study|Physician Decision|0
5418563|NCT02578706|18698815|P3|Overall Study|Lost to Follow-up|0
5418564|NCT02578706|18698816|P2|Overall Study|Lost to Follow-up|4
5418565|NCT02578706|18698817|P1|Overall Study|Lost to Follow-up|0
5418566|NCT02578706|18698815|P3|Overall Study|Withdrawal by Subject|0
5418567|NCT02578706|18698816|P2|Overall Study|Withdrawal by Subject|0
5418568|NCT02578706|18698817|P1|Overall Study|Withdrawal by Subject|1
5418569|NCT02578680|18698896|P2|Overall Study|Ongoing in Study|96
5418570|NCT02578680|18698897|P1|Overall Study|Ongoing in Study|276
5418571|NCT02578680|18698896|P2|Overall Study|Withdrawal by Subject|5
5418572|NCT02578680|18698897|P1|Overall Study|Withdrawal by Subject|8
5418573|NCT02578680|18698896|P2|Overall Study|Withdrawal by Parent/Guardian|0
5418574|NCT02578680|18698897|P1|Overall Study|Withdrawal by Parent/Guardian|1
5418575|NCT02578680|18698896|P2|Overall Study|Protocol Violation|1
5418576|NCT02578680|18698897|P1|Overall Study|Protocol Violation|1
5418577|NCT02578680|18698896|P2|Overall Study|Death|104
5418578|NCT02578680|18698897|P1|Overall Study|Death|124
5418579|NCT02578316|18698913|P1|Extension Phase|Progression of disease|6
5418580|NCT02578186|18698946|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
5418581|NCT02578186|18698947|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
5418582|NCT02578186|18698946|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
5418583|NCT02578186|18698947|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
5418584|NCT02577887|18699036|P1|Overall Study|Withdrawal by Subject|80
5418585|NCT02577887|18699036|P1|Overall Study|Protocol Violation|125
5418586|NCT02577887|18699036|P1|Overall Study|Death|93
5418587|NCT02577718|18699062|P1|Overall Study|Withdrawal by Subject|2
5418588|NCT02577718|18699062|P1|Overall Study|Death|6
5418589|NCT02577354|18699104|P2|Overall Study|Adverse Event|5
5418590|NCT02577354|18699105|P1|Overall Study|Adverse Event|4
5418591|NCT02577354|18699104|P2|Overall Study|Missed Visit|3
5418592|NCT02577354|18699105|P1|Overall Study|Missed Visit|4
5418593|NCT02577354|18699104|P2|Overall Study|Lost to Follow-up|1
5418594|NCT02577354|18699105|P1|Overall Study|Lost to Follow-up|3
5418595|NCT02577354|18699104|P2|Overall Study|Lack of Efficacy|4
5418596|NCT02577354|18699105|P1|Overall Study|Lack of Efficacy|4
5418597|NCT02577315|18699165|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5418598|NCT02577315|18699166|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5418599|NCT02577146|18699182|P1|Overall Study|Screen Failure|17
5418600|NCT02577146|18699182|P1|Overall Study|Physician Decision|3
5418601|NCT02577146|18699182|P1|Overall Study|Lost to Follow-up|8
5418602|NCT02577107|18699189|P2|Overall Study|Protocol deviation|1
5418603|NCT02577107|18699190|P1|Overall Study|Protocol deviation|0
5418604|NCT02577029|18699257|P8|Overall Study|Sponsor Termination of the Study|12
5418605|NCT02577029|18699258|P7|Overall Study|Sponsor Termination of the Study|12
5418606|NCT02577029|18699259|P6|Overall Study|Sponsor Termination of the Study|12
5418607|NCT02577029|18699260|P5|Overall Study|Sponsor Termination of the Study|10
5418608|NCT02577029|18699261|P4|Overall Study|Sponsor Termination of the Study|12
5418609|NCT02577029|18699262|P3|Overall Study|Sponsor Termination of the Study|5
5418610|NCT02577029|18699263|P2|Overall Study|Sponsor Termination of the Study|2
5418611|NCT02577029|18699264|P1|Overall Study|Sponsor Termination of the Study|9
5418612|NCT02577029|18699257|P8|Overall Study|Withdrawal by Subject|0
5418613|NCT02577029|18699258|P7|Overall Study|Withdrawal by Subject|0
5418614|NCT02577029|18699259|P6|Overall Study|Withdrawal by Subject|1
5418615|NCT02577029|18699260|P5|Overall Study|Withdrawal by Subject|0
5418616|NCT02577029|18699261|P4|Overall Study|Withdrawal by Subject|0
5418617|NCT02577029|18699262|P3|Overall Study|Withdrawal by Subject|0
5418618|NCT02577029|18699263|P2|Overall Study|Withdrawal by Subject|0
5418619|NCT02577029|18699264|P1|Overall Study|Withdrawal by Subject|0
5418620|NCT02577029|18699257|P8|Overall Study|Adverse Event|0
5418621|NCT02577029|18699258|P7|Overall Study|Adverse Event|0
5418622|NCT02577029|18699259|P6|Overall Study|Adverse Event|0
5418623|NCT02577029|18699260|P5|Overall Study|Adverse Event|1
5418624|NCT02577029|18699261|P4|Overall Study|Adverse Event|0
5418625|NCT02577029|18699262|P3|Overall Study|Adverse Event|2
5418626|NCT02577029|18699263|P2|Overall Study|Adverse Event|0
5418627|NCT02577029|18699264|P1|Overall Study|Adverse Event|1
5418628|NCT02577016|18699372|P2|Overall Study|Physician Decision|1
5418629|NCT02577016|18699373|P1|Overall Study|Physician Decision|0
5418630|NCT02577016|18699372|P2|Overall Study|Adverse Event|1
5418631|NCT02577016|18699373|P1|Overall Study|Adverse Event|2
5418632|NCT02577003|18699391|P2|Overall Study|Withdrawal by Subject|1
5418633|NCT02577003|18699392|P1|Overall Study|Withdrawal by Subject|0
5418634|NCT02577003|18699391|P2|Overall Study|Adverse Event|4
5418635|NCT02577003|18699392|P1|Overall Study|Adverse Event|2
5418636|NCT02576990|18699412|P2|Overall Study|Clinical Progression|4
5418637|NCT02576990|18699413|P1|Overall Study|Clinical Progression|13
5418638|NCT02576990|18699412|P2|Overall Study|Did not receive study treatment|1
5418639|NCT02576990|18699413|P1|Overall Study|Did not receive study treatment|3
5418640|NCT02576990|18699412|P2|Overall Study|Withdrawal by Subject|2
5418641|NCT02576990|18699413|P1|Overall Study|Withdrawal by Subject|0
5418642|NCT02576990|18699412|P2|Overall Study|Complete Response|0
5418643|NCT02576990|18699413|P1|Overall Study|Complete Response|1
5418644|NCT02576990|18699412|P2|Overall Study|Adverse Event|4
5418645|NCT02576990|18699413|P1|Overall Study|Adverse Event|6
5418646|NCT02576990|18699412|P2|Overall Study|Progressive Disease|12
5418647|NCT02576990|18699413|P1|Overall Study|Progressive Disease|17
5418648|NCT02576990|18699412|P2|Overall Study|Physician Decision|1
5418649|NCT02576990|18699413|P1|Overall Study|Physician Decision|3
5418650|NCT02576977|18699441|P2|Overall Study|Ongoing in trial|77
5418651|NCT02576977|18699442|P1|Overall Study|Ongoing in trial|53
5418652|NCT02576977|18699441|P2|Overall Study|Withdrawal by Subject|9
5418653|NCT02576977|18699442|P1|Overall Study|Withdrawal by Subject|9
5418654|NCT02576977|18699441|P2|Overall Study|Study Terminated at Selected Sites|2
5418655|NCT02576977|18699442|P1|Overall Study|Study Terminated at Selected Sites|3
5418656|NCT02576977|18699441|P2|Overall Study|Screen failure|0
5418657|NCT02576977|18699442|P1|Overall Study|Screen failure|1
5418658|NCT02576977|18699441|P2|Overall Study|Death|35
5418659|NCT02576977|18699442|P1|Overall Study|Death|47
5418660|NCT02576977|18699441|P2|Overall Study|Adverse Event|2
5418661|NCT02576977|18699442|P1|Overall Study|Adverse Event|13
5418662|NCT02576951|18699464|P4|Overall Study|Protocol Violation|1
5418663|NCT02576951|18699465|P3|Overall Study|Protocol Violation|0
5418664|NCT02576951|18699466|P2|Overall Study|Protocol Violation|0
5418665|NCT02576951|18699467|P1|Overall Study|Protocol Violation|0
5418666|NCT02576951|18699464|P4|Overall Study|Withdrawal by Subject|2
5418667|NCT02576951|18699465|P3|Overall Study|Withdrawal by Subject|0
5418668|NCT02576951|18699466|P2|Overall Study|Withdrawal by Subject|0
5418669|NCT02576951|18699467|P1|Overall Study|Withdrawal by Subject|1
5418670|NCT02576951|18699464|P4|Overall Study|Lost to Follow-up|2
5418671|NCT02576951|18699465|P3|Overall Study|Lost to Follow-up|2
5418672|NCT02576951|18699466|P2|Overall Study|Lost to Follow-up|0
5418673|NCT02576951|18699467|P1|Overall Study|Lost to Follow-up|0
5418674|NCT02576938|18699491|P3|Overall Study|Met Exclusion Criteria|0
5418675|NCT02576938|18699492|P2|Overall Study|Met Exclusion Criteria|1
5418676|NCT02576938|18699493|P1|Overall Study|Met Exclusion Criteria|0
5418677|NCT02576938|18699491|P3|Overall Study|Physician Decision|0
5418678|NCT02576938|18699492|P2|Overall Study|Physician Decision|1
5418679|NCT02576938|18699493|P1|Overall Study|Physician Decision|0
5418680|NCT02576938|18699491|P3|Overall Study|Lost to Follow-up|1
5418681|NCT02576938|18699492|P2|Overall Study|Lost to Follow-up|0
5418682|NCT02576938|18699493|P1|Overall Study|Lost to Follow-up|2
5418683|NCT02576938|18699491|P3|Overall Study|Lack of Efficacy|0
5418684|NCT02576938|18699492|P2|Overall Study|Lack of Efficacy|4
5418685|NCT02576938|18699493|P1|Overall Study|Lack of Efficacy|9
5418686|NCT02576938|18699491|P3|Overall Study|Withdrawal by Subject|4
5418687|NCT02576938|18699492|P2|Overall Study|Withdrawal by Subject|2
5418688|NCT02576938|18699493|P1|Overall Study|Withdrawal by Subject|3
5418689|NCT02576938|18699491|P3|Overall Study|Protocol Violation|1
5418690|NCT02576938|18699492|P2|Overall Study|Protocol Violation|1
5418691|NCT02576938|18699493|P1|Overall Study|Protocol Violation|1
5418692|NCT02576938|18699491|P3|Overall Study|Adverse Event|6
5418693|NCT02576938|18699492|P2|Overall Study|Adverse Event|3
5418694|NCT02576938|18699493|P1|Overall Study|Adverse Event|5
5418695|NCT02576678|18699539|P3|Overall Study|Miscellaneous|0
5418696|NCT02576678|18699540|P2|Overall Study|Miscellaneous|0
5418697|NCT02576678|18699541|P1|Overall Study|Miscellaneous|2
5418698|NCT02576678|18699539|P3|Overall Study|Lost to Follow-up|1
5418699|NCT02576678|18699540|P2|Overall Study|Lost to Follow-up|0
5418700|NCT02576678|18699541|P1|Overall Study|Lost to Follow-up|0
5418701|NCT02576678|18699539|P3|Overall Study|Withdrawal by Subject|2
5418702|NCT02576678|18699540|P2|Overall Study|Withdrawal by Subject|1
5418703|NCT02576678|18699541|P1|Overall Study|Withdrawal by Subject|3
5418704|NCT02576678|18699539|P3|Overall Study|Adverse Event|2
5418705|NCT02576678|18699540|P2|Overall Study|Adverse Event|0
5418706|NCT02576678|18699541|P1|Overall Study|Adverse Event|0
5418707|NCT02576652|18699573|P1|Overall Study|Withdrawal by Subject|2
5418708|NCT02576639|18699585|P5|Overall Study|Physician Decision|1
5418709|NCT02576639|18699586|P4|Overall Study|Physician Decision|0
5418710|NCT02576639|18699587|P3|Overall Study|Physician Decision|0
5418711|NCT02576639|18699588|P2|Overall Study|Physician Decision|0
5418712|NCT02576639|18699589|P1|Overall Study|Physician Decision|0
5418713|NCT02576639|18699585|P5|Overall Study|Adverse Event|2
5418714|NCT02576639|18699586|P4|Overall Study|Adverse Event|1
5418715|NCT02576639|18699587|P3|Overall Study|Adverse Event|1
5418716|NCT02576639|18699588|P2|Overall Study|Adverse Event|0
5418717|NCT02576639|18699589|P1|Overall Study|Adverse Event|1
5418718|NCT02576639|18699585|P5|Overall Study|Withdrawal by Subject|1
5418719|NCT02576639|18699586|P4|Overall Study|Withdrawal by Subject|0
5418720|NCT02576639|18699587|P3|Overall Study|Withdrawal by Subject|1
5418721|NCT02576639|18699588|P2|Overall Study|Withdrawal by Subject|2
5418722|NCT02576639|18699589|P1|Overall Study|Withdrawal by Subject|1
5418723|NCT02576587|18699648|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
5418724|NCT02576587|18699649|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
5418725|NCT02576587|18699648|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
5418726|NCT02576587|18699649|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
5418727|NCT02576587|18699648|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
5418728|NCT02576587|18699649|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
5418729|NCT02576587|18699648|P2|Baseline|Equipment failure|1
5418730|NCT02576587|18699649|P1|Baseline|Equipment failure|0
5418731|NCT02576535|18699667|P1|Overall Study|Withdrawal by Subject|2
5418732|NCT02576509|18699678|P2|Follow-up Period|Other reason|2
5418733|NCT02576509|18699679|P1|Follow-up Period|Other reason|1
5418734|NCT02576509|18699678|P2|Follow-up Period|Lost to Follow-up|1
5418735|NCT02576509|18699679|P1|Follow-up Period|Lost to Follow-up|0
5418736|NCT02576509|18699678|P2|Follow-up Period|Participant withdrew consent|14
5418737|NCT02576509|18699679|P1|Follow-up Period|Participant withdrew consent|7
5418738|NCT02576509|18699678|P2|Follow-up Period|Death|35
5418739|NCT02576509|18699679|P1|Follow-up Period|Death|41
5418740|NCT02576509|18699678|P2|Treatment Period|Other reason|7
5418741|NCT02576509|18699679|P1|Treatment Period|Other reason|2
5418742|NCT02576509|18699678|P2|Treatment Period|Participant no longer meets criteria|0
5418743|NCT02576509|18699679|P1|Treatment Period|Participant no longer meets criteria|1
5418744|NCT02576509|18699678|P2|Treatment Period|Poor/non-compliance|1
5418745|NCT02576509|18699679|P1|Treatment Period|Poor/non-compliance|0
5418746|NCT02576509|18699678|P2|Treatment Period|Maximum clinical benefit|0
5418747|NCT02576509|18699679|P1|Treatment Period|Maximum clinical benefit|1
5418748|NCT02576509|18699678|P2|Treatment Period|Lost to Follow-up|1
5418749|NCT02576509|18699679|P1|Treatment Period|Lost to Follow-up|0
5418750|NCT02576509|18699678|P2|Treatment Period|Participant withdrew consent|7
5418751|NCT02576509|18699679|P1|Treatment Period|Participant withdrew consent|2
5418752|NCT02576509|18699678|P2|Treatment Period|Participant request to stop treatment|17
5418753|NCT02576509|18699679|P1|Treatment Period|Participant request to stop treatment|8
5418754|NCT02576509|18699678|P2|Treatment Period|Adverse event unrelated to study drug|40
5418755|NCT02576509|18699679|P1|Treatment Period|Adverse event unrelated to study drug|37
5418756|NCT02576509|18699678|P2|Treatment Period|Death|1
5418757|NCT02576509|18699679|P1|Treatment Period|Death|1
5418758|NCT02576509|18699678|P2|Treatment Period|Study drug toxicity|41
5418759|NCT02576509|18699679|P1|Treatment Period|Study drug toxicity|32
5418760|NCT02576509|18699678|P2|Treatment Period|Disease progression|240
5418761|NCT02576509|18699679|P1|Treatment Period|Disease progression|245
5418762|NCT02576509|18699678|P2|Pre-Treatment Period|Participant no longer meets criteria|2
5418763|NCT02576509|18699679|P1|Pre-Treatment Period|Participant no longer meets criteria|3
5418764|NCT02576509|18699678|P2|Pre-Treatment Period|Participant withdrew consent|5
5418765|NCT02576509|18699679|P1|Pre-Treatment Period|Participant withdrew consent|1
5418766|NCT02576509|18699678|P2|Pre-Treatment Period|Participant request to stop therapy|2
5418767|NCT02576509|18699679|P1|Pre-Treatment Period|Participant request to stop therapy|0
5418768|NCT02576145|18699708|P2|Overall Study|Tetanus Titers Decreased|1
5418769|NCT02576145|18699709|P1|Overall Study|Tetanus Titers Decreased|0
5418770|NCT02576145|18699708|P2|Overall Study|Acute rejection|0
5418771|NCT02576145|18699709|P1|Overall Study|Acute rejection|1
5418772|NCT02576145|18699708|P2|Overall Study|Withdrawal by Subject|0
5418773|NCT02576145|18699709|P1|Overall Study|Withdrawal by Subject|1
5418774|NCT02576145|18699708|P2|Overall Study|Adverse Event|0
5418775|NCT02576145|18699709|P1|Overall Study|Adverse Event|1
5418776|NCT02576067|18699747|P2|Overall Study|Physician Decision|0
5418777|NCT02576067|18699748|P1|Overall Study|Physician Decision|4
5418778|NCT02576067|18699747|P2|Overall Study|screen failure/ re-enrolled|25
5418779|NCT02576067|18699748|P1|Overall Study|screen failure/ re-enrolled|0
5418780|NCT02576067|18699747|P2|Overall Study|not randomized, failed run-in|0
5418781|NCT02576067|18699748|P1|Overall Study|not randomized, failed run-in|7
5418782|NCT02576067|18699747|P2|Overall Study|study closure of main CIRT trial)|8
5418783|NCT02576067|18699748|P1|Overall Study|study closure of main CIRT trial)|0
5418784|NCT02576067|18699747|P2|Overall Study|Withdrawal by Subject|2
5418785|NCT02576067|18699748|P1|Overall Study|Withdrawal by Subject|11
5418786|NCT02576067|18699747|P2|Overall Study|Lost to Follow-up|0
5418787|NCT02576067|18699748|P1|Overall Study|Lost to Follow-up|11
5418788|NCT02576067|18699747|P2|Overall Study|Lack of Efficacy|0
5418789|NCT02576067|18699748|P1|Overall Study|Lack of Efficacy|1
5418790|NCT02576067|18699747|P2|Overall Study|Death|1
5418791|NCT02576067|18699748|P1|Overall Study|Death|0
5418792|NCT02576054|18699758|P1|Overall Study|Withdrawal by Subject|1
5418793|NCT02575950|18699779|P4|Overall Study|Lost to Follow-up|3
5418794|NCT02575950|18699780|P3|Overall Study|Lost to Follow-up|0
5418795|NCT02575950|18699781|P2|Overall Study|Lost to Follow-up|1
5418796|NCT02575950|18699782|P1|Overall Study|Lost to Follow-up|0
5418797|NCT02575950|18699779|P4|Overall Study|Withdrawal by Subject|2
5418798|NCT02575950|18699780|P3|Overall Study|Withdrawal by Subject|0
5418799|NCT02575950|18699781|P2|Overall Study|Withdrawal by Subject|0
5418800|NCT02575950|18699782|P1|Overall Study|Withdrawal by Subject|0
5418801|NCT02575911|18699811|P1|Overall Study|Lost to Follow-up|1
5418802|NCT02575833|18699831|P2|Overall Study|Lost to Follow-up|0
5418803|NCT02575833|18699832|P1|Overall Study|Lost to Follow-up|1
5418804|NCT02575833|18699831|P2|Overall Study|Withdrawal by Subject|1
5418805|NCT02575833|18699832|P1|Overall Study|Withdrawal by Subject|0
5418806|NCT02575807|18699847|P5|Overall Study|Withdrawal by Subject|2
5418807|NCT02575807|18699848|P4|Overall Study|Withdrawal by Subject|1
5418808|NCT02575807|18699849|P3|Overall Study|Withdrawal by Subject|1
5418809|NCT02575807|18699850|P2|Overall Study|Withdrawal by Subject|0
5418810|NCT02575807|18699851|P1|Overall Study|Withdrawal by Subject|0
5418811|NCT02575807|18699847|P5|Overall Study|Subject ineligible - medical implant|0
5418812|NCT02575807|18699848|P4|Overall Study|Subject ineligible - medical implant|1
5418813|NCT02575807|18699849|P3|Overall Study|Subject ineligible - medical implant|0
5418814|NCT02575807|18699850|P2|Overall Study|Subject ineligible - medical implant|0
5418815|NCT02575807|18699851|P1|Overall Study|Subject ineligible - medical implant|0
5418816|NCT02575807|18699847|P5|Overall Study|Terminated due to physician decision|0
5418817|NCT02575807|18699848|P4|Overall Study|Terminated due to physician decision|0
5418818|NCT02575807|18699849|P3|Overall Study|Terminated due to physician decision|1
5418819|NCT02575807|18699850|P2|Overall Study|Terminated due to physician decision|0
5418820|NCT02575807|18699851|P1|Overall Study|Terminated due to physician decision|0
5418821|NCT02575807|18699847|P5|Overall Study|Terminated due to FDA clinical hold|0
5418822|NCT02575807|18699848|P4|Overall Study|Terminated due to FDA clinical hold|0
5418823|NCT02575807|18699849|P3|Overall Study|Terminated due to FDA clinical hold|0
5418824|NCT02575807|18699850|P2|Overall Study|Terminated due to FDA clinical hold|0
5418825|NCT02575807|18699851|P1|Overall Study|Terminated due to FDA clinical hold|1
5418826|NCT02575807|18699847|P5|Overall Study|Study terminated by Sponsor|1
5418827|NCT02575807|18699848|P4|Overall Study|Study terminated by Sponsor|0
5418828|NCT02575807|18699849|P3|Overall Study|Study terminated by Sponsor|7
5418829|NCT02575807|18699850|P2|Overall Study|Study terminated by Sponsor|1
5418830|NCT02575807|18699851|P1|Overall Study|Study terminated by Sponsor|0
5418831|NCT02575807|18699847|P5|Overall Study|Death|1
5418832|NCT02575807|18699848|P4|Overall Study|Death|0
5418833|NCT02575807|18699849|P3|Overall Study|Death|7
5418834|NCT02575807|18699850|P2|Overall Study|Death|3
5418835|NCT02575807|18699851|P1|Overall Study|Death|8
5418836|NCT02575365|18699891|P1|Overall Study|Lost to Follow-up|4
5418837|NCT02575079|18699911|P2|Overall Study|Withdrawal by Subject|0
5418838|NCT02575079|18699912|P1|Overall Study|Withdrawal by Subject|3
5418839|NCT02575079|18699911|P2|Overall Study|Death|0
5418840|NCT02575079|18699912|P1|Overall Study|Death|3
5418841|NCT02574845|18699937|P6|Overall Study|Adverse Event|1
5418842|NCT02574845|18699938|P5|Overall Study|Adverse Event|0
5418843|NCT02574845|18699939|P4|Overall Study|Adverse Event|0
5418844|NCT02574845|18699940|P3|Overall Study|Adverse Event|0
5418845|NCT02574845|18699941|P2|Overall Study|Adverse Event|1
5418846|NCT02574845|18699942|P1|Overall Study|Adverse Event|0
5418847|NCT02574845|18699937|P6|Overall Study|Consent withdrawn further participation|0
5418848|NCT02574845|18699938|P5|Overall Study|Consent withdrawn further participation|1
5418849|NCT02574845|18699939|P4|Overall Study|Consent withdrawn further participation|0
5418850|NCT02574845|18699940|P3|Overall Study|Consent withdrawn further participation|0
5418851|NCT02574845|18699941|P2|Overall Study|Consent withdrawn further participation|0
5418852|NCT02574845|18699942|P1|Overall Study|Consent withdrawn further participation|0
5418853|NCT02574637|18699977|P10|Open-label (OL) Period|Study Terminated By Sponsor|0
5418854|NCT02574637|18699978|P9|Open-label (OL) Period|Study Terminated By Sponsor|1
5418855|NCT02574637|18699979|P8|Open-label (OL) Period|Study Terminated By Sponsor|1
5418856|NCT02574637|18699980|P7|Open-label (OL) Period|Study Terminated By Sponsor|2
5418857|NCT02574637|18699981|P6|Open-label (OL) Period|Study Terminated By Sponsor|1
5418858|NCT02574637|18699982|P5|Open-label (OL) Period|Study Terminated By Sponsor|0
5418859|NCT02574637|18699983|P4|Open-label (OL) Period|Study Terminated By Sponsor|0
5418860|NCT02574637|18699984|P3|Open-label (OL) Period|Study Terminated By Sponsor|0
5418861|NCT02574637|18699985|P2|Open-label (OL) Period|Study Terminated By Sponsor|0
5418862|NCT02574637|18699986|P1|Open-label (OL) Period|Study Terminated By Sponsor|0
5418863|NCT02574637|18699977|P10|Open-label (OL) Period|Withdrawal by Subject|1
5418864|NCT02574637|18699978|P9|Open-label (OL) Period|Withdrawal by Subject|0
5418865|NCT02574637|18699979|P8|Open-label (OL) Period|Withdrawal by Subject|0
5418866|NCT02574637|18699980|P7|Open-label (OL) Period|Withdrawal by Subject|0
5418867|NCT02574637|18699981|P6|Open-label (OL) Period|Withdrawal by Subject|1
5418868|NCT02574637|18699982|P5|Open-label (OL) Period|Withdrawal by Subject|0
5418869|NCT02574637|18699983|P4|Open-label (OL) Period|Withdrawal by Subject|0
5418870|NCT02574637|18699984|P3|Open-label (OL) Period|Withdrawal by Subject|0
5418871|NCT02574637|18699985|P2|Open-label (OL) Period|Withdrawal by Subject|0
5418872|NCT02574637|18699986|P1|Open-label (OL) Period|Withdrawal by Subject|0
5418873|NCT02574637|18699977|P10|Open-label (OL) Period|Adverse Event|0
5418874|NCT02574637|18699978|P9|Open-label (OL) Period|Adverse Event|1
5418875|NCT02574637|18699979|P8|Open-label (OL) Period|Adverse Event|0
5418876|NCT02574637|18699980|P7|Open-label (OL) Period|Adverse Event|0
5418877|NCT02574637|18699981|P6|Open-label (OL) Period|Adverse Event|0
5418878|NCT02574637|18699982|P5|Open-label (OL) Period|Adverse Event|0
5418879|NCT02574637|18699983|P4|Open-label (OL) Period|Adverse Event|0
5418880|NCT02574637|18699984|P3|Open-label (OL) Period|Adverse Event|0
5418881|NCT02574637|18699985|P2|Open-label (OL) Period|Adverse Event|0
5418882|NCT02574637|18699986|P1|Open-label (OL) Period|Adverse Event|0
5418883|NCT02574637|18699977|P10|Double-blind Period|Reason Not Specified|0
5418884|NCT02574637|18699978|P9|Double-blind Period|Reason Not Specified|0
5418885|NCT02574637|18699979|P8|Double-blind Period|Reason Not Specified|0
5418886|NCT02574637|18699980|P7|Double-blind Period|Reason Not Specified|0
5418887|NCT02574637|18699981|P6|Double-blind Period|Reason Not Specified|0
5418888|NCT02574637|18699982|P5|Double-blind Period|Reason Not Specified|0
5418889|NCT02574637|18699983|P4|Double-blind Period|Reason Not Specified|1
5418890|NCT02574637|18699984|P3|Double-blind Period|Reason Not Specified|0
5418891|NCT02574637|18699985|P2|Double-blind Period|Reason Not Specified|0
5418892|NCT02574637|18699986|P1|Double-blind Period|Reason Not Specified|0
5418893|NCT02574637|18699977|P10|Double-blind Period|Study Terminated By Sponsor|0
5418894|NCT02574637|18699978|P9|Double-blind Period|Study Terminated By Sponsor|0
5418895|NCT02574637|18699979|P8|Double-blind Period|Study Terminated By Sponsor|0
5418896|NCT02574637|18699980|P7|Double-blind Period|Study Terminated By Sponsor|0
5418897|NCT02574637|18699981|P6|Double-blind Period|Study Terminated By Sponsor|0
5418898|NCT02574637|18699982|P5|Double-blind Period|Study Terminated By Sponsor|2
5418899|NCT02574637|18699983|P4|Double-blind Period|Study Terminated By Sponsor|2
5418900|NCT02574637|18699984|P3|Double-blind Period|Study Terminated By Sponsor|5
5418901|NCT02574637|18699985|P2|Double-blind Period|Study Terminated By Sponsor|1
5418902|NCT02574637|18699986|P1|Double-blind Period|Study Terminated By Sponsor|1
5418903|NCT02574637|18699977|P10|Double-blind Period|Non-Compliance With Study Drug|0
5418904|NCT02574637|18699978|P9|Double-blind Period|Non-Compliance With Study Drug|0
5418905|NCT02574637|18699979|P8|Double-blind Period|Non-Compliance With Study Drug|0
5418906|NCT02574637|18699980|P7|Double-blind Period|Non-Compliance With Study Drug|0
5418907|NCT02574637|18699981|P6|Double-blind Period|Non-Compliance With Study Drug|0
5418908|NCT02574637|18699982|P5|Double-blind Period|Non-Compliance With Study Drug|0
5418909|NCT02574637|18699983|P4|Double-blind Period|Non-Compliance With Study Drug|1
5418910|NCT02574637|18699984|P3|Double-blind Period|Non-Compliance With Study Drug|0
5418911|NCT02574637|18699985|P2|Double-blind Period|Non-Compliance With Study Drug|0
5418912|NCT02574637|18699986|P1|Double-blind Period|Non-Compliance With Study Drug|0
5418913|NCT02574637|18699977|P10|Double-blind Period|Protocol Deviation|0
5418914|NCT02574637|18699978|P9|Double-blind Period|Protocol Deviation|0
5418915|NCT02574637|18699979|P8|Double-blind Period|Protocol Deviation|0
5418916|NCT02574637|18699980|P7|Double-blind Period|Protocol Deviation|0
5418917|NCT02574637|18699981|P6|Double-blind Period|Protocol Deviation|0
5418918|NCT02574637|18699982|P5|Double-blind Period|Protocol Deviation|0
5418919|NCT02574637|18699983|P4|Double-blind Period|Protocol Deviation|0
5418920|NCT02574637|18699984|P3|Double-blind Period|Protocol Deviation|0
5418921|NCT02574637|18699985|P2|Double-blind Period|Protocol Deviation|0
5418922|NCT02574637|18699986|P1|Double-blind Period|Protocol Deviation|1
5418923|NCT02574637|18699977|P10|Double-blind Period|Lack of Efficacy|0
5418924|NCT02574637|18699978|P9|Double-blind Period|Lack of Efficacy|0
5418925|NCT02574637|18699979|P8|Double-blind Period|Lack of Efficacy|0
5418926|NCT02574637|18699980|P7|Double-blind Period|Lack of Efficacy|0
5418927|NCT02574637|18699981|P6|Double-blind Period|Lack of Efficacy|0
5418928|NCT02574637|18699982|P5|Double-blind Period|Lack of Efficacy|0
5418929|NCT02574637|18699983|P4|Double-blind Period|Lack of Efficacy|0
5418930|NCT02574637|18699984|P3|Double-blind Period|Lack of Efficacy|2
5418931|NCT02574637|18699985|P2|Double-blind Period|Lack of Efficacy|0
5418932|NCT02574637|18699986|P1|Double-blind Period|Lack of Efficacy|0
5418933|NCT02574637|18699977|P10|Double-blind Period|Adverse Event|0
5418934|NCT02574637|18699978|P9|Double-blind Period|Adverse Event|0
5418935|NCT02574637|18699979|P8|Double-blind Period|Adverse Event|0
5418936|NCT02574637|18699980|P7|Double-blind Period|Adverse Event|0
5418937|NCT02574637|18699981|P6|Double-blind Period|Adverse Event|0
5418938|NCT02574637|18699982|P5|Double-blind Period|Adverse Event|0
5418939|NCT02574637|18699983|P4|Double-blind Period|Adverse Event|0
5418940|NCT02574637|18699984|P3|Double-blind Period|Adverse Event|0
5418941|NCT02574637|18699985|P2|Double-blind Period|Adverse Event|0
5418942|NCT02574637|18699986|P1|Double-blind Period|Adverse Event|1
5418943|NCT02574481|18700095|P4|Overall Study|Death|0
5418944|NCT02574481|18700096|P3|Overall Study|Death|0
5418945|NCT02574481|18700097|P2|Overall Study|Death|6
5418946|NCT02574481|18700098|P1|Overall Study|Death|6
5418947|NCT02574481|18700095|P4|Overall Study|Other|0
5418948|NCT02574481|18700096|P3|Overall Study|Other|0
5418949|NCT02574481|18700097|P2|Overall Study|Other|0
5418950|NCT02574481|18700098|P1|Overall Study|Other|1
5418951|NCT02574481|18700095|P4|Overall Study|Visit Missed|0
5418952|NCT02574481|18700096|P3|Overall Study|Visit Missed|2
5418953|NCT02574481|18700097|P2|Overall Study|Visit Missed|4
5418954|NCT02574481|18700098|P1|Overall Study|Visit Missed|12
5418955|NCT02574481|18700095|P4|Overall Study|Adverse Event|0
5418956|NCT02574481|18700096|P3|Overall Study|Adverse Event|0
5418957|NCT02574481|18700097|P2|Overall Study|Adverse Event|0
5418958|NCT02574481|18700098|P1|Overall Study|Adverse Event|2
5418959|NCT02574481|18700095|P4|Overall Study|Withdrawal by Subject|0
5418960|NCT02574481|18700096|P3|Overall Study|Withdrawal by Subject|1
5418961|NCT02574481|18700097|P2|Overall Study|Withdrawal by Subject|4
5418962|NCT02574481|18700098|P1|Overall Study|Withdrawal by Subject|6
5418963|NCT02574312|18700138|P2|3 Months Follow-up|Withdrawal by Subject|0
5418964|NCT02574312|18700139|P1|3 Months Follow-up|Withdrawal by Subject|1
5418965|NCT02574260|18700155|P1|Overall Study|Disease Progression|1
5418966|NCT02574247|18700164|P3|Overall Study|Did not meet inclusion criteria|5
5418967|NCT02574247|18700165|P2|Overall Study|Did not meet inclusion criteria|3
5418968|NCT02574247|18700166|P1|Overall Study|Did not meet inclusion criteria|4
5418969|NCT02574247|18700164|P3|Overall Study|Withdrawal by Subject|0
5418970|NCT02574247|18700165|P2|Overall Study|Withdrawal by Subject|0
5418971|NCT02574247|18700166|P1|Overall Study|Withdrawal by Subject|1
5418972|NCT02573948|18700178|P1|Longitudinal Cohort|Incarcerated|25
5418973|NCT02573948|18700178|P1|Longitudinal Cohort|Lost to Follow-up|22
5418974|NCT02573948|18700178|P1|Longitudinal Cohort|Death|9
5418975|NCT02573870|18700188|P2|Overall Study|Other: Fail to Meet Visit|2
5418976|NCT02573870|18700189|P1|Overall Study|Other: Fail to Meet Visit|0
5418977|NCT02573870|18700188|P2|Overall Study|Lost to Follow-up|1
5418978|NCT02573870|18700189|P1|Overall Study|Lost to Follow-up|0
5418979|NCT02573870|18700188|P2|Overall Study|Other: Reached defined stopping criteria|1
5418980|NCT02573870|18700189|P1|Overall Study|Other: Reached defined stopping criteria|0
5418981|NCT02573870|18700188|P2|Overall Study|Lack of Efficacy|1
5418982|NCT02573870|18700189|P1|Overall Study|Lack of Efficacy|0
5418983|NCT02573870|18700188|P2|Overall Study|Adverse Event|2
5418984|NCT02573870|18700189|P1|Overall Study|Adverse Event|0
5418985|NCT02573467|18700237|P4|Post-treatment Follow up Epoch|Technical problems|0
5418986|NCT02573467|18700238|P3|Post-treatment Follow up Epoch|Technical problems|1
5418987|NCT02573467|18700239|P2|Post-treatment Follow up Epoch|Technical problems|0
5418988|NCT02573467|18700240|P1|Post-treatment Follow up Epoch|Technical problems|0
5418989|NCT02573467|18700237|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
5418990|NCT02573467|18700238|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
5418991|NCT02573467|18700239|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
5418992|NCT02573467|18700240|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
5418993|NCT02573467|18700237|P4|Post-treatment Follow up Epoch|Death|1
5418994|NCT02573467|18700238|P3|Post-treatment Follow up Epoch|Death|0
5418995|NCT02573467|18700239|P2|Post-treatment Follow up Epoch|Death|1
5418996|NCT02573467|18700240|P1|Post-treatment Follow up Epoch|Death|1
5418997|NCT02573467|18700237|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
5418998|NCT02573467|18700238|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
5418999|NCT02573467|18700239|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
5419000|NCT02573467|18700240|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
5419001|NCT02573467|18700237|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
5419002|NCT02573467|18700238|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
5419003|NCT02573467|18700239|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
5419004|NCT02573467|18700240|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
5419005|NCT02573467|18700237|P4|Double-blind Treatment Epoch|Adverse Event|0
5419006|NCT02573467|18700238|P3|Double-blind Treatment Epoch|Adverse Event|1
5419007|NCT02573467|18700239|P2|Double-blind Treatment Epoch|Adverse Event|0
5419008|NCT02573467|18700240|P1|Double-blind Treatment Epoch|Adverse Event|1
5419009|NCT02573467|18700237|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
5419010|NCT02573467|18700238|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
5419011|NCT02573467|18700239|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
5419012|NCT02573467|18700240|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
5419013|NCT02573311|18700304|P2|Disposition for Part 2|Other than specified above|3
5419014|NCT02573311|18700305|P1|Disposition for Part 2|Other than specified above|13
5419015|NCT02573311|18700304|P2|Disposition for Part 2|Investigator decision|1
5419016|NCT02573311|18700305|P1|Disposition for Part 2|Investigator decision|0
5419017|NCT02573311|18700304|P2|Disposition for Part 2|Withdrawal by Subject|3
5419018|NCT02573311|18700305|P1|Disposition for Part 2|Withdrawal by Subject|60
5419019|NCT02573311|18700304|P2|Disposition for Part 2|Lost to Follow-up|7
5419020|NCT02573311|18700305|P1|Disposition for Part 2|Lost to Follow-up|76
5419021|NCT02573311|18700304|P2|Disposition for Part 2|Adverse Event|5
5419022|NCT02573311|18700305|P1|Disposition for Part 2|Adverse Event|36
5419023|NCT02573311|18700304|P2|Disposition for Part 2|Physician Decision|7
5419024|NCT02573311|18700305|P1|Disposition for Part 2|Physician Decision|25
5419025|NCT02573311|18700304|P2|Disposition for Part 1|Withdrawal by Subject|3
5419026|NCT02573311|18700305|P1|Disposition for Part 1|Withdrawal by Subject|7
5419027|NCT02573155|18700374|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
5419028|NCT02573155|18700375|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
5419029|NCT02573155|18700374|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
5419030|NCT02573155|18700375|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
5419031|NCT02573155|18700374|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
5419032|NCT02573155|18700375|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
5419033|NCT02573155|18700374|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
5419034|NCT02573155|18700375|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
5419035|NCT02573155|18700374|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
5419036|NCT02573155|18700375|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
5419037|NCT02573155|18700374|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
5419038|NCT02573155|18700375|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
5419039|NCT02573155|18700374|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
5419040|NCT02573155|18700375|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
5419041|NCT02573155|18700374|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
5419042|NCT02573155|18700375|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
5419043|NCT02573012|18700523|P2|Overall Study|Physician Decision|2
5419044|NCT02573012|18700524|P1|Overall Study|Physician Decision|1
5419045|NCT02573012|18700523|P2|Overall Study|Study Ended per Protocol|0
5419046|NCT02573012|18700524|P1|Overall Study|Study Ended per Protocol|1
5419047|NCT02573012|18700523|P2|Overall Study|Withdrawal by Subject|2
5419048|NCT02573012|18700524|P1|Overall Study|Withdrawal by Subject|2
5419049|NCT02573012|18700523|P2|Overall Study|Non-compliance|2
5419050|NCT02573012|18700524|P1|Overall Study|Non-compliance|1
5419051|NCT02573012|18700523|P2|Overall Study|Lack of Efficacy|4
5419052|NCT02573012|18700524|P1|Overall Study|Lack of Efficacy|5
5419053|NCT02573012|18700523|P2|Overall Study|Adverse Event|5
5419054|NCT02573012|18700524|P1|Overall Study|Adverse Event|5
5419055|NCT02572817|18700576|P2|Overall Study|Lost to Follow-up|3
5419056|NCT02572817|18700577|P1|Overall Study|Lost to Follow-up|3
5419057|NCT02572817|18700576|P2|Overall Study|Death|3
5419058|NCT02572817|18700577|P1|Overall Study|Death|6
5419059|NCT02572570|18700670|P1|Overall Study|Study Terminated|27
5419060|NCT02572401|18700700|P4|Overall Study|Death|1
5419061|NCT02572401|18700701|P3|Overall Study|Death|0
5419062|NCT02572401|18700702|P2|Overall Study|Death|0
5419063|NCT02572401|18700703|P1|Overall Study|Death|0
5419064|NCT02572401|18700700|P4|Overall Study|Lost to Follow-up|9
5419065|NCT02572401|18700701|P3|Overall Study|Lost to Follow-up|9
5419066|NCT02572401|18700702|P2|Overall Study|Lost to Follow-up|8
5419067|NCT02572401|18700703|P1|Overall Study|Lost to Follow-up|5
5419068|NCT02572388|18700733|P4|Overall Study|Withdrawal by Subject|2
5419069|NCT02572388|18700734|P3|Overall Study|Withdrawal by Subject|2
5419070|NCT02572388|18700735|P2|Overall Study|Withdrawal by Subject|1
5419071|NCT02572388|18700736|P1|Overall Study|Withdrawal by Subject|1
5419072|NCT02572167|18700761|P3|Overall Study|Did not meet inclusion criteria|1
5419073|NCT02572167|18700762|P2|Overall Study|Did not meet inclusion criteria|0
5419074|NCT02572167|18700763|P1|Overall Study|Did not meet inclusion criteria|0
5419075|NCT02572167|18700761|P3|Overall Study|Death|1
5419076|NCT02572167|18700762|P2|Overall Study|Death|3
5419077|NCT02572167|18700763|P1|Overall Study|Death|0
5419078|NCT02572167|18700761|P3|Overall Study|Lost to Follow-up|1
5419079|NCT02572167|18700762|P2|Overall Study|Lost to Follow-up|2
5419080|NCT02572167|18700763|P1|Overall Study|Lost to Follow-up|0
5419081|NCT02572167|18700761|P3|Overall Study|Withdrawal by Subject|1
5419082|NCT02572167|18700762|P2|Overall Study|Withdrawal by Subject|3
5419083|NCT02572167|18700763|P1|Overall Study|Withdrawal by Subject|0
5419084|NCT02572167|18700761|P3|Overall Study|In follow up|27
5419085|NCT02572167|18700762|P2|Overall Study|In follow up|48
5419086|NCT02572167|18700763|P1|Overall Study|In follow up|6
5419087|NCT02572076|18700777|P1|Overall Study|Protocol Violation|1
5419088|NCT02571972|18700781|P1|Overall Study|Withdrawal by Subject|2
5419089|NCT02571972|18700781|P1|Overall Study|Protocol Violation|2
5419090|NCT02571777|18700793|P5|Overall Study|Pregnancy|0
5419091|NCT02571777|18700794|P4|Overall Study|Pregnancy|2
5419092|NCT02571777|18700795|P3|Overall Study|Pregnancy|0
5419093|NCT02571777|18700796|P2|Overall Study|Pregnancy|0
5419094|NCT02571777|18700797|P1|Overall Study|Pregnancy|0
5419095|NCT02571777|18700793|P5|Overall Study|Physician Decision|4
5419096|NCT02571777|18700794|P4|Overall Study|Physician Decision|2
5419097|NCT02571777|18700795|P3|Overall Study|Physician Decision|5
5419098|NCT02571777|18700796|P2|Overall Study|Physician Decision|7
5419099|NCT02571777|18700797|P1|Overall Study|Physician Decision|1
5419100|NCT02571777|18700793|P5|Overall Study|Lost to Follow-up|1
5419101|NCT02571777|18700794|P4|Overall Study|Lost to Follow-up|0
5419102|NCT02571777|18700795|P3|Overall Study|Lost to Follow-up|2
5419103|NCT02571777|18700796|P2|Overall Study|Lost to Follow-up|1
5419104|NCT02571777|18700797|P1|Overall Study|Lost to Follow-up|1
5419105|NCT02571777|18700793|P5|Overall Study|Death|0
5419106|NCT02571777|18700794|P4|Overall Study|Death|0
5419107|NCT02571777|18700795|P3|Overall Study|Death|4
5419108|NCT02571777|18700796|P2|Overall Study|Death|1
5419109|NCT02571777|18700797|P1|Overall Study|Death|1
5419110|NCT02571777|18700793|P5|Overall Study|Protocol Deviation|4
5419111|NCT02571777|18700794|P4|Overall Study|Protocol Deviation|8
5419112|NCT02571777|18700795|P3|Overall Study|Protocol Deviation|4
5419113|NCT02571777|18700796|P2|Overall Study|Protocol Deviation|3
5419114|NCT02571777|18700797|P1|Overall Study|Protocol Deviation|2
5419115|NCT02571777|18700793|P5|Overall Study|Subject/guardian decision|27
5419116|NCT02571777|18700794|P4|Overall Study|Subject/guardian decision|25
5419117|NCT02571777|18700795|P3|Overall Study|Subject/guardian decision|26
5419118|NCT02571777|18700796|P2|Overall Study|Subject/guardian decision|26
5419119|NCT02571777|18700797|P1|Overall Study|Subject/guardian decision|34
5419120|NCT02571452|18700934|P2|Overall Study 6-Month Follow-up|Protocol Violation|0
5419121|NCT02571452|18700935|P1|Overall Study 6-Month Follow-up|Protocol Violation|1
5419122|NCT02571452|18700934|P2|Overall Study 6-Month Follow-up|Lost to Follow-up|0
5419123|NCT02571452|18700935|P1|Overall Study 6-Month Follow-up|Lost to Follow-up|4
5419124|NCT02571452|18700934|P2|Overall Study Treatment|Protocol Violation|1
5419125|NCT02571452|18700935|P1|Overall Study Treatment|Protocol Violation|0
5419126|NCT02571244|18700976|P2|Overall Study|Unable to reach out post discharge|0
5419127|NCT02571244|18700977|P1|Overall Study|Unable to reach out post discharge|3
5419128|NCT02571244|18700976|P2|Overall Study|Lost to Follow-up|1
5419129|NCT02571244|18700977|P1|Overall Study|Lost to Follow-up|0
5419130|NCT02571075|18701035|P2|Overall Study|Lost to Follow-up|24
5419131|NCT02571075|18701036|P1|Overall Study|Lost to Follow-up|20
5419132|NCT02571049|18701050|P2|Randomization|Adverse Event|1
5419133|NCT02571049|18701051|P1|Randomization|Adverse Event|0
5419134|NCT02571049|18701050|P2|Randomization|No migraine attack|1
5419135|NCT02571049|18701051|P1|Randomization|No migraine attack|0
5419136|NCT02571049|18701050|P2|Screening|Did not meet entry criteria|2
5419137|NCT02571049|18701051|P1|Screening|Did not meet entry criteria|2
5419138|NCT02570750|18701059|P2|Overall Study|Adverse Event|1
5419139|NCT02570750|18701060|P1|Overall Study|Adverse Event|2
5419140|NCT02570750|18701059|P2|Overall Study|Lost to Follow-up|2
5419141|NCT02570750|18701060|P1|Overall Study|Lost to Follow-up|2
5419142|NCT02570750|18701059|P2|Overall Study|Withdrawal by Subject|0
5419143|NCT02570750|18701060|P1|Overall Study|Withdrawal by Subject|5
5419144|NCT02570750|18701059|P2|Overall Study|Protocol deviation|2
5419145|NCT02570750|18701060|P1|Overall Study|Protocol deviation|4
5419146|NCT02570750|18701059|P2|Overall Study|Inclusion/exclusion criteria deviation|0
5419147|NCT02570750|18701060|P1|Overall Study|Inclusion/exclusion criteria deviation|1
5419148|NCT02570711|18701078|P2|Overall Study|Early Termination of Study by Sponsor|2
5419149|NCT02570711|18701079|P1|Overall Study|Early Termination of Study by Sponsor|0
5419150|NCT02570711|18701078|P2|Overall Study|Death|0
5419151|NCT02570711|18701079|P1|Overall Study|Death|1
5419152|NCT02570165|18701167|P7|Overall Study|Withdrawal Request by GSK|0
5419153|NCT02570165|18701168|P6|Overall Study|Withdrawal Request by GSK|0
5419154|NCT02570165|18701169|P5|Overall Study|Withdrawal Request by GSK|0
5419155|NCT02570165|18701170|P4|Overall Study|Withdrawal Request by GSK|0
5419156|NCT02570165|18701171|P3|Overall Study|Withdrawal Request by GSK|2
5419157|NCT02570165|18701172|P2|Overall Study|Withdrawal Request by GSK|0
5419158|NCT02570165|18701173|P1|Overall Study|Withdrawal Request by GSK|0
5419159|NCT02570165|18701167|P7|Overall Study|Par. did not Meet Continuation Criteria|0
5419160|NCT02570165|18701168|P6|Overall Study|Par. did not Meet Continuation Criteria|1
5419161|NCT02570165|18701169|P5|Overall Study|Par. did not Meet Continuation Criteria|0
5419162|NCT02570165|18701170|P4|Overall Study|Par. did not Meet Continuation Criteria|0
5419163|NCT02570165|18701171|P3|Overall Study|Par. did not Meet Continuation Criteria|0
5419164|NCT02570165|18701172|P2|Overall Study|Par. did not Meet Continuation Criteria|0
5419165|NCT02570165|18701173|P1|Overall Study|Par. did not Meet Continuation Criteria|0
5419166|NCT02570165|18701167|P7|Overall Study|Withdrawal by Subject|0
5419167|NCT02570165|18701168|P6|Overall Study|Withdrawal by Subject|0
5419168|NCT02570165|18701169|P5|Overall Study|Withdrawal by Subject|1
5419169|NCT02570165|18701170|P4|Overall Study|Withdrawal by Subject|2
5419170|NCT02570165|18701171|P3|Overall Study|Withdrawal by Subject|0
5419171|NCT02570165|18701172|P2|Overall Study|Withdrawal by Subject|0
5419172|NCT02570165|18701173|P1|Overall Study|Withdrawal by Subject|0
5419173|NCT02570165|18701167|P7|Overall Study|Physician Decision|0
5419174|NCT02570165|18701168|P6|Overall Study|Physician Decision|0
5419175|NCT02570165|18701169|P5|Overall Study|Physician Decision|0
5419176|NCT02570165|18701170|P4|Overall Study|Physician Decision|0
5419177|NCT02570165|18701171|P3|Overall Study|Physician Decision|0
5419178|NCT02570165|18701172|P2|Overall Study|Physician Decision|1
5419179|NCT02570165|18701173|P1|Overall Study|Physician Decision|0
5419180|NCT02570165|18701167|P7|Overall Study|Lost to Follow-up|0
5419181|NCT02570165|18701168|P6|Overall Study|Lost to Follow-up|0
5419182|NCT02570165|18701169|P5|Overall Study|Lost to Follow-up|0
5419183|NCT02570165|18701170|P4|Overall Study|Lost to Follow-up|1
5419184|NCT02570165|18701171|P3|Overall Study|Lost to Follow-up|1
5419185|NCT02570165|18701172|P2|Overall Study|Lost to Follow-up|0
5419186|NCT02570165|18701173|P1|Overall Study|Lost to Follow-up|0
5419187|NCT02570165|18701167|P7|Overall Study|Par. Reached Stopping Criteria|0
5419188|NCT02570165|18701168|P6|Overall Study|Par. Reached Stopping Criteria|1
5419189|NCT02570165|18701169|P5|Overall Study|Par. Reached Stopping Criteria|1
5419190|NCT02570165|18701170|P4|Overall Study|Par. Reached Stopping Criteria|2
5419191|NCT02570165|18701171|P3|Overall Study|Par. Reached Stopping Criteria|0
5419192|NCT02570165|18701172|P2|Overall Study|Par. Reached Stopping Criteria|1
5419193|NCT02570165|18701173|P1|Overall Study|Par. Reached Stopping Criteria|1
5419194|NCT02570165|18701167|P7|Overall Study|Lack of Efficacy|0
5419195|NCT02570165|18701168|P6|Overall Study|Lack of Efficacy|0
5419196|NCT02570165|18701169|P5|Overall Study|Lack of Efficacy|4
5419197|NCT02570165|18701170|P4|Overall Study|Lack of Efficacy|0
5419198|NCT02570165|18701171|P3|Overall Study|Lack of Efficacy|0
5419199|NCT02570165|18701172|P2|Overall Study|Lack of Efficacy|1
5419200|NCT02570165|18701173|P1|Overall Study|Lack of Efficacy|0
5419201|NCT02570165|18701167|P7|Overall Study|Adverse Event|0
5419202|NCT02570165|18701168|P6|Overall Study|Adverse Event|0
5419203|NCT02570165|18701169|P5|Overall Study|Adverse Event|0
5419204|NCT02570165|18701170|P4|Overall Study|Adverse Event|0
5419205|NCT02570165|18701171|P3|Overall Study|Adverse Event|2
5419206|NCT02570165|18701172|P2|Overall Study|Adverse Event|0
5419207|NCT02570165|18701173|P1|Overall Study|Adverse Event|1
5419208|NCT02570152|18701196|P1|Overall Study|Migrated/moved from study area|13
5419209|NCT02570152|18701196|P1|Overall Study|Protocol Violation|2
5419210|NCT02570126|18701227|P2|Overall Study|Withdrawal by Subject|7
5419211|NCT02570126|18701228|P1|Overall Study|Withdrawal by Subject|3
5419212|NCT02570126|18701227|P2|Overall Study|Protocol Violation|1
5419213|NCT02570126|18701228|P1|Overall Study|Protocol Violation|0
5419214|NCT02570126|18701227|P2|Overall Study|Violation Of Procedures GSK|1
5419215|NCT02570126|18701228|P1|Overall Study|Violation Of Procedures GSK|0
5419216|NCT02570126|18701227|P2|Overall Study|Unable To Arrange Visit 3|0
5419217|NCT02570126|18701228|P1|Overall Study|Unable To Arrange Visit 3|1
5419218|NCT02570126|18701227|P2|Overall Study|Lost to Follow-up|0
5419219|NCT02570126|18701228|P1|Overall Study|Lost to Follow-up|2
5419220|NCT02570074|18701254|P2|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
5419221|NCT02570074|18701255|P1|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
5419222|NCT02569996|18701324|P1|Overall Study|Unknown reason|1
5419223|NCT02569996|18701324|P1|Overall Study|Complete remission|7
5419224|NCT02569996|18701324|P1|Overall Study|Lost to Follow-up|5
5419225|NCT02569996|18701324|P1|Overall Study|Withdrawal by Subject|5
5419226|NCT02569996|18701324|P1|Overall Study|Non-compliance|9
5419227|NCT02569996|18701324|P1|Overall Study|New anti-lymphoma treatment|1
5419228|NCT02569996|18701324|P1|Overall Study|Progression of the disease|18
5419229|NCT02569996|18701324|P1|Overall Study|Physician Decision|3
5419230|NCT02569996|18701324|P1|Overall Study|Adverse Event|6
5419231|NCT02569957|18701336|P2|Overall Study|Withdrawal by Subject|1
5419232|NCT02569957|18701337|P1|Overall Study|Withdrawal by Subject|0
5419233|NCT02569853|18701369|P2|Overall Study|Physician Decision|1
5419234|NCT02569853|18701370|P1|Overall Study|Physician Decision|1
5419235|NCT02569853|18701369|P2|Overall Study|Did not experience migraine attack|7
5419236|NCT02569853|18701370|P1|Overall Study|Did not experience migraine attack|10
5419237|NCT02569853|18701369|P2|Overall Study|Protocol Violation|1
5419238|NCT02569853|18701370|P1|Overall Study|Protocol Violation|1
5419239|NCT02569853|18701369|P2|Overall Study|Lost to Follow-up|3
5419240|NCT02569853|18701370|P1|Overall Study|Lost to Follow-up|3
5419241|NCT02569853|18701369|P2|Overall Study|Withdrawal by Subject|2
5419242|NCT02569853|18701370|P1|Overall Study|Withdrawal by Subject|3
5419243|NCT02569853|18701369|P2|Overall Study|Adverse Event|0
5419244|NCT02569853|18701370|P1|Overall Study|Adverse Event|2
5419245|NCT02569710|18701388|P10|Overall Study|Withdrawal by Subject|0
5419246|NCT02569710|18701389|P9|Overall Study|Withdrawal by Subject|0
5419247|NCT02569710|18701390|P8|Overall Study|Withdrawal by Subject|0
5419248|NCT02569710|18701391|P7|Overall Study|Withdrawal by Subject|0
5419249|NCT02569710|18701392|P6|Overall Study|Withdrawal by Subject|1
5419250|NCT02569710|18701393|P5|Overall Study|Withdrawal by Subject|0
5419251|NCT02569710|18701394|P4|Overall Study|Withdrawal by Subject|0
5419252|NCT02569710|18701395|P3|Overall Study|Withdrawal by Subject|0
5419253|NCT02569710|18701396|P2|Overall Study|Withdrawal by Subject|0
5419254|NCT02569710|18701397|P1|Overall Study|Withdrawal by Subject|0
5419255|NCT02569710|18701388|P10|Overall Study|Virologic failure|0
5419256|NCT02569710|18701389|P9|Overall Study|Virologic failure|0
5419257|NCT02569710|18701390|P8|Overall Study|Virologic failure|0
5419258|NCT02569710|18701391|P7|Overall Study|Virologic failure|1
5419259|NCT02569710|18701392|P6|Overall Study|Virologic failure|0
5419260|NCT02569710|18701393|P5|Overall Study|Virologic failure|1
5419261|NCT02569710|18701394|P4|Overall Study|Virologic failure|0
5419262|NCT02569710|18701395|P3|Overall Study|Virologic failure|0
5419263|NCT02569710|18701396|P2|Overall Study|Virologic failure|0
5419264|NCT02569710|18701397|P1|Overall Study|Virologic failure|0
5419265|NCT02569710|18701388|P10|Overall Study|Lost to Follow-up|0
5419266|NCT02569710|18701389|P9|Overall Study|Lost to Follow-up|1
5419267|NCT02569710|18701390|P8|Overall Study|Lost to Follow-up|0
5419268|NCT02569710|18701391|P7|Overall Study|Lost to Follow-up|1
5419269|NCT02569710|18701392|P6|Overall Study|Lost to Follow-up|0
5419270|NCT02569710|18701393|P5|Overall Study|Lost to Follow-up|0
5419271|NCT02569710|18701394|P4|Overall Study|Lost to Follow-up|0
5419272|NCT02569710|18701395|P3|Overall Study|Lost to Follow-up|0
5419273|NCT02569710|18701396|P2|Overall Study|Lost to Follow-up|0
5419274|NCT02569710|18701397|P1|Overall Study|Lost to Follow-up|0
5419275|NCT02569710|18701388|P10|Overall Study|Adverse Event|0
5419276|NCT02569710|18701389|P9|Overall Study|Adverse Event|0
5419277|NCT02569710|18701390|P8|Overall Study|Adverse Event|0
5419278|NCT02569710|18701391|P7|Overall Study|Adverse Event|0
5419279|NCT02569710|18701392|P6|Overall Study|Adverse Event|0
5419280|NCT02569710|18701393|P5|Overall Study|Adverse Event|0
5419281|NCT02569710|18701394|P4|Overall Study|Adverse Event|0
5419282|NCT02569710|18701395|P3|Overall Study|Adverse Event|0
5419283|NCT02569710|18701396|P2|Overall Study|Adverse Event|0
5419284|NCT02569710|18701397|P1|Overall Study|Adverse Event|1
5419285|NCT02569437|18701737|P2|Overall Study|Lost to Follow-up|14
5419286|NCT02569437|18701738|P1|Overall Study|Lost to Follow-up|12
5419287|NCT02569398|18701768|P3|Overall Study|Other|13
5419288|NCT02569398|18701769|P2|Overall Study|Other|14
5419289|NCT02569398|18701770|P1|Overall Study|Other|12
5419290|NCT02569398|18701768|P3|Overall Study|Study terminated by sponsor|134
5419291|NCT02569398|18701769|P2|Overall Study|Study terminated by sponsor|131
5419292|NCT02569398|18701770|P1|Overall Study|Study terminated by sponsor|130
5419293|NCT02569398|18701768|P3|Overall Study|Withdrawal by Subject|30
5419294|NCT02569398|18701769|P2|Overall Study|Withdrawal by Subject|43
5419295|NCT02569398|18701770|P1|Overall Study|Withdrawal by Subject|43
5419296|NCT02569398|18701768|P3|Overall Study|Adverse Event|6
5419297|NCT02569398|18701769|P2|Overall Study|Adverse Event|1
5419298|NCT02569398|18701770|P1|Overall Study|Adverse Event|0
5419299|NCT02568683|18701845|P2|Overall Study|Study Terminated By Sponsor|2
5419300|NCT02568683|18701846|P1|Overall Study|Study Terminated By Sponsor|5
5419301|NCT02568683|18701845|P2|Overall Study|Withdrew Consent|0
5419302|NCT02568683|18701846|P1|Overall Study|Withdrew Consent|1
5419303|NCT02568683|18701845|P2|Overall Study|Death|2
5419304|NCT02568683|18701846|P1|Overall Study|Death|0
5419305|NCT02568475|18701875|P2|Overall Study|Transferred to another facility|0
5419306|NCT02568475|18701876|P1|Overall Study|Transferred to another facility|1
5419307|NCT02568475|18701875|P2|Overall Study|Short-term: Discharge location unknown|0
5419308|NCT02568475|18701876|P1|Overall Study|Short-term: Discharge location unknown|4
5419309|NCT02568475|18701875|P2|Overall Study|Discharged home|4
5419310|NCT02568475|18701876|P1|Overall Study|Discharged home|4
5419311|NCT02568475|18701875|P2|Overall Study|Withdrawal by Subject|0
5419312|NCT02568475|18701876|P1|Overall Study|Withdrawal by Subject|2
5419313|NCT02568475|18701875|P2|Overall Study|Lost to Follow-up|39
5419314|NCT02568475|18701876|P1|Overall Study|Lost to Follow-up|40
5419315|NCT02568397|18701890|P2|Period 2|Physician Decision|1
5419316|NCT02568397|18701891|P1|Period 2|Physician Decision|0
5419317|NCT02568397|18701890|P2|Period 2|Withdrawal by Subject|1
5419318|NCT02568397|18701891|P1|Period 2|Withdrawal by Subject|0
5419319|NCT02568384|18701915|P1|Overall Study|Mobile devices incompatible with App|2
5419320|NCT02568254|18701929|P6|Period 3|Unstatisfactory Lens fitting|0
5419321|NCT02568254|18701930|P5|Period 3|Unstatisfactory Lens fitting|1
5419322|NCT02568254|18701931|P4|Period 3|Unstatisfactory Lens fitting|0
5419323|NCT02568254|18701932|P3|Period 3|Unstatisfactory Lens fitting|0
5419324|NCT02568254|18701933|P2|Period 3|Unstatisfactory Lens fitting|0
5419325|NCT02568254|18701934|P1|Period 3|Unstatisfactory Lens fitting|0
5419326|NCT02568254|18701929|P6|Period 2|Adverse Event|0
5419327|NCT02568254|18701930|P5|Period 2|Adverse Event|0
5419328|NCT02568254|18701931|P4|Period 2|Adverse Event|0
5419329|NCT02568254|18701932|P3|Period 2|Adverse Event|1
5419330|NCT02568254|18701933|P2|Period 2|Adverse Event|0
5419331|NCT02568254|18701934|P1|Period 2|Adverse Event|0
5419332|NCT02568046|18701944|P2|Overall Study|Other Events|1
5419333|NCT02568046|18701945|P1|Overall Study|Other Events|0
5419334|NCT02568046|18701944|P2|Overall Study|Withdrawal by Subject|1
5419335|NCT02568046|18701945|P1|Overall Study|Withdrawal by Subject|2
5419336|NCT02568046|18701944|P2|Overall Study|Progressive Disease|0
5419337|NCT02568046|18701945|P1|Overall Study|Progressive Disease|1
5419338|NCT02568046|18701944|P2|Overall Study|Death|0
5419339|NCT02568046|18701945|P1|Overall Study|Death|2
5419340|NCT02568046|18701944|P2|Overall Study|Adverse Event|1
5419341|NCT02568046|18701945|P1|Overall Study|Adverse Event|0
5419342|NCT02567708|18702008|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
5419343|NCT02567708|18702009|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
5419344|NCT02567708|18702008|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
5419345|NCT02567708|18702009|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
5419346|NCT02567708|18702008|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
5419347|NCT02567708|18702009|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
5419348|NCT02567708|18702008|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
5419349|NCT02567708|18702009|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
5419350|NCT02567656|18702054|P6|Overall Study|Premature discontinuation due to PD|0
5419351|NCT02567656|18702055|P5|Overall Study|Premature discontinuation due to PD|0
5419352|NCT02567656|18702056|P4|Overall Study|Premature discontinuation due to PD|0
5419353|NCT02567656|18702057|P3|Overall Study|Premature discontinuation due to PD|2
5419354|NCT02567656|18702058|P2|Overall Study|Premature discontinuation due to PD|1
5419355|NCT02567656|18702059|P1|Overall Study|Premature discontinuation due to PD|1
5419356|NCT02567552|18702091|P2|Overall Study|Adverse Event|1
5419357|NCT02567552|18702092|P1|Overall Study|Adverse Event|0
5419358|NCT02567188|18702122|P1|Overall Study|Protocol Violation|5
5419359|NCT02567188|18702122|P1|Overall Study|Started Hemodialysis|2
5419360|NCT02567188|18702122|P1|Overall Study|Moved and Changed Clinic|1
5419361|NCT02567188|18702122|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
5419362|NCT02567188|18702122|P1|Overall Study|Withdrawal by Subject|1
5419363|NCT02567188|18702122|P1|Overall Study|Adverse Event|1
5419364|NCT02567188|18702122|P1|Overall Study|Lost to Follow-up|5
5419365|NCT02567188|18702122|P1|Overall Study|Terminated Mircera Treatment|9
5419366|NCT02567188|18702122|P1|Overall Study|Death|10
5419367|NCT02566889|18702153|P2|Overall Study|Other|2
5419368|NCT02566889|18702154|P1|Overall Study|Other|6
5419369|NCT02566889|18702153|P2|Overall Study|Adverse Event|2
5419370|NCT02566889|18702154|P1|Overall Study|Adverse Event|4
5419371|NCT02566889|18702153|P2|Overall Study|Withdrawal by Subject|1
5419372|NCT02566889|18702154|P1|Overall Study|Withdrawal by Subject|3
5419373|NCT02566785|18702172|P2|Overall Study|Worsening condition|1
5419374|NCT02566785|18702173|P1|Overall Study|Worsening condition|1
5419375|NCT02566785|18702172|P2|Overall Study|Lost to Follow-up|2
5419376|NCT02566785|18702173|P1|Overall Study|Lost to Follow-up|0
5419377|NCT02566759|18702200|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
5419378|NCT02566759|18702201|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419379|NCT02566759|18702202|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419380|NCT02566759|18702203|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419381|NCT02566759|18702204|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419382|NCT02566759|18702205|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419383|NCT02566759|18702206|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419384|NCT02566759|18702207|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419385|NCT02566759|18702208|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419386|NCT02566759|18702209|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419387|NCT02566759|18702210|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419388|NCT02566759|18702211|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419389|NCT02566759|18702212|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419390|NCT02566759|18702213|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419391|NCT02566759|18702214|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419392|NCT02566759|18702215|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419393|NCT02566759|18702216|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
5419394|NCT02566759|18702200|P17|All Parts|Other|0
5419395|NCT02566759|18702201|P16|All Parts|Other|0
5419396|NCT02566759|18702202|P15|All Parts|Other|0
5419397|NCT02566759|18702203|P14|All Parts|Other|2
5419398|NCT02566759|18702204|P13|All Parts|Other|0
5419399|NCT02566759|18702205|P12|All Parts|Other|0
5419400|NCT02566759|18702206|P11|All Parts|Other|0
5419401|NCT02566759|18702207|P10|All Parts|Other|0
5419402|NCT02566759|18702208|P9|All Parts|Other|0
5419403|NCT02566759|18702209|P8|All Parts|Other|0
5419404|NCT02566759|18702210|P7|All Parts|Other|0
5419405|NCT02566759|18702211|P6|All Parts|Other|0
5419406|NCT02566759|18702212|P5|All Parts|Other|0
5419407|NCT02566759|18702213|P4|All Parts|Other|0
5419408|NCT02566759|18702214|P3|All Parts|Other|0
5419409|NCT02566759|18702215|P2|All Parts|Other|0
5419410|NCT02566759|18702216|P1|All Parts|Other|0
5419411|NCT02566759|18702200|P17|All Parts|Adverse Event|0
5419412|NCT02566759|18702201|P16|All Parts|Adverse Event|0
5419413|NCT02566759|18702202|P15|All Parts|Adverse Event|0
5419414|NCT02566759|18702203|P14|All Parts|Adverse Event|3
5419415|NCT02566759|18702204|P13|All Parts|Adverse Event|1
5419416|NCT02566759|18702205|P12|All Parts|Adverse Event|0
5419417|NCT02566759|18702206|P11|All Parts|Adverse Event|0
5419418|NCT02566759|18702207|P10|All Parts|Adverse Event|0
5419419|NCT02566759|18702208|P9|All Parts|Adverse Event|0
5419420|NCT02566759|18702209|P8|All Parts|Adverse Event|0
5419421|NCT02566759|18702210|P7|All Parts|Adverse Event|0
5419422|NCT02566759|18702211|P6|All Parts|Adverse Event|0
5419423|NCT02566759|18702212|P5|All Parts|Adverse Event|0
5419424|NCT02566759|18702213|P4|All Parts|Adverse Event|0
5419425|NCT02566759|18702214|P3|All Parts|Adverse Event|0
5419426|NCT02566759|18702215|P2|All Parts|Adverse Event|0
5419427|NCT02566759|18702216|P1|All Parts|Adverse Event|0
5419428|NCT02566759|18702200|P17|All Parts|Withdrawal by Subject|0
5419429|NCT02566759|18702201|P16|All Parts|Withdrawal by Subject|0
5419430|NCT02566759|18702202|P15|All Parts|Withdrawal by Subject|0
5419431|NCT02566759|18702203|P14|All Parts|Withdrawal by Subject|0
5419432|NCT02566759|18702204|P13|All Parts|Withdrawal by Subject|0
5419433|NCT02566759|18702205|P12|All Parts|Withdrawal by Subject|0
5419434|NCT02566759|18702206|P11|All Parts|Withdrawal by Subject|0
5419435|NCT02566759|18702207|P10|All Parts|Withdrawal by Subject|0
5419436|NCT02566759|18702208|P9|All Parts|Withdrawal by Subject|0
5419437|NCT02566759|18702209|P8|All Parts|Withdrawal by Subject|0
5419438|NCT02566759|18702210|P7|All Parts|Withdrawal by Subject|0
5419439|NCT02566759|18702211|P6|All Parts|Withdrawal by Subject|0
5419440|NCT02566759|18702212|P5|All Parts|Withdrawal by Subject|0
5419441|NCT02566759|18702213|P4|All Parts|Withdrawal by Subject|0
5419442|NCT02566759|18702214|P3|All Parts|Withdrawal by Subject|0
5419443|NCT02566759|18702215|P2|All Parts|Withdrawal by Subject|1
5419444|NCT02566759|18702216|P1|All Parts|Withdrawal by Subject|0
5419445|NCT02566577|18702378|P2|Overall Study|Physical limitation|0
5419446|NCT02566577|18702379|P1|Overall Study|Physical limitation|1
5419447|NCT02566577|18702378|P2|Overall Study|Equipment failure|1
5419448|NCT02566577|18702379|P1|Overall Study|Equipment failure|1
5419449|NCT02566577|18702378|P2|Overall Study|Withdrawal by Subject|1
5419450|NCT02566577|18702379|P1|Overall Study|Withdrawal by Subject|1
5419451|NCT02566109|18702459|P1|Overall Study|Withdrawal by Subject|1
5419452|NCT02566031|18702523|P2|Overall Study|Lost to Follow-up|1
5419453|NCT02566031|18702524|P1|Overall Study|Lost to Follow-up|1
5419454|NCT02566031|18702523|P2|Overall Study|Adverse Event|1
5419455|NCT02566031|18702524|P1|Overall Study|Adverse Event|3
5419456|NCT02566031|18702523|P2|Overall Study|Protocol deviation|3
5419457|NCT02566031|18702524|P1|Overall Study|Protocol deviation|2
5419458|NCT02566031|18702523|P2|Overall Study|Patient/guardian decision|7
5419459|NCT02566031|18702524|P1|Overall Study|Patient/guardian decision|14
5419460|NCT02566005|18702541|P2|Overall Study|labor after randomization|4
5419461|NCT02566005|18702542|P1|Overall Study|labor after randomization|0
5419462|NCT02566005|18702541|P2|Overall Study|did not receive foley|1
5419463|NCT02566005|18702542|P1|Overall Study|did not receive foley|0
5419464|NCT02566005|18702541|P2|Overall Study|received foley|0
5419465|NCT02566005|18702542|P1|Overall Study|received foley|8
5419466|NCT02566005|18702541|P2|Overall Study|vaginal bleeding|1
5419467|NCT02566005|18702542|P1|Overall Study|vaginal bleeding|0
5419468|NCT02565914|18702570|P1|Overall Study|Enrolled, but did not receive study drug|2
5419469|NCT02565914|18702570|P1|Overall Study|Other|18
5419470|NCT02565914|18702570|P1|Overall Study|Commercial drug available|5
5419471|NCT02565914|18702570|P1|Overall Study|Parent study termination by sponsor|1
5419472|NCT02565914|18702570|P1|Overall Study|Physician Decision|6
5419473|NCT02565914|18702570|P1|Overall Study|Other noncompliance|6
5419474|NCT02565914|18702570|P1|Overall Study|Death (not treatment emergent)|1
5419475|NCT02565914|18702570|P1|Overall Study|Lost to Follow-up|12
5419476|NCT02565914|18702570|P1|Overall Study|Withdrawal of consent (not due to AE)|25
5419477|NCT02565914|18702570|P1|Overall Study|Adverse Event|17
5419478|NCT02565810|18702604|P1|Overall Study|Withdrawal by Subject|1
5419479|NCT02565784|18702613|P1|Second Treatment|Withdrawal by Subject|2
5419480|NCT02565784|18702613|P1|First Treatment|Withdrawal by Subject|1
5419481|NCT02565784|18702613|P1|First Treatment|Adverse Event|1
5419482|NCT02565706|18702625|P4|Overall Study|Lost to Follow-up|74
5419483|NCT02565706|18702626|P3|Overall Study|Lost to Follow-up|82
5419484|NCT02565706|18702627|P2|Overall Study|Lost to Follow-up|75
5419485|NCT02565706|18702628|P1|Overall Study|Lost to Follow-up|72
5419486|NCT02565706|18702625|P4|Overall Study|Withdrawal by Subject|11
5419487|NCT02565706|18702626|P3|Overall Study|Withdrawal by Subject|7
5419488|NCT02565706|18702627|P2|Overall Study|Withdrawal by Subject|7
5419489|NCT02565706|18702628|P1|Overall Study|Withdrawal by Subject|5
5419490|NCT02565615|18702734|P5|Overall Study|Untreated|567
5419491|NCT02565615|18702735|P4|Overall Study|Untreated|0
5419492|NCT02565615|18702736|P3|Overall Study|Untreated|0
5419493|NCT02565615|18702737|P2|Overall Study|Untreated|0
5419494|NCT02565615|18702738|P1|Overall Study|Untreated|0
5419495|NCT02565615|18702734|P5|Overall Study|Adverse Event|9
5419496|NCT02565615|18702735|P4|Overall Study|Adverse Event|0
5419497|NCT02565615|18702736|P3|Overall Study|Adverse Event|0
5419498|NCT02565615|18702737|P2|Overall Study|Adverse Event|1
5419499|NCT02565615|18702738|P1|Overall Study|Adverse Event|1
5419500|NCT02565615|18702734|P5|Overall Study|Reason not defined|62
5419501|NCT02565615|18702735|P4|Overall Study|Reason not defined|1
5419502|NCT02565615|18702736|P3|Overall Study|Reason not defined|0
5419503|NCT02565615|18702737|P2|Overall Study|Reason not defined|2
5419504|NCT02565615|18702738|P1|Overall Study|Reason not defined|0
5419505|NCT02565615|18702734|P5|Overall Study|Not meeting eligibility criteria|25
5419506|NCT02565615|18702735|P4|Overall Study|Not meeting eligibility criteria|0
5419507|NCT02565615|18702736|P3|Overall Study|Not meeting eligibility criteria|0
5419508|NCT02565615|18702737|P2|Overall Study|Not meeting eligibility criteria|7
5419509|NCT02565615|18702738|P1|Overall Study|Not meeting eligibility criteria|0
5419510|NCT02565615|18702734|P5|Overall Study|Lost to Follow-up|765
5419511|NCT02565615|18702735|P4|Overall Study|Lost to Follow-up|1
5419512|NCT02565615|18702736|P3|Overall Study|Lost to Follow-up|0
5419513|NCT02565615|18702737|P2|Overall Study|Lost to Follow-up|4
5419514|NCT02565615|18702738|P1|Overall Study|Lost to Follow-up|0
5419515|NCT02565615|18702734|P5|Overall Study|Not willing to participate in study|169
5419516|NCT02565615|18702735|P4|Overall Study|Not willing to participate in study|1
5419517|NCT02565615|18702736|P3|Overall Study|Not willing to participate in study|0
5419518|NCT02565615|18702737|P2|Overall Study|Not willing to participate in study|21
5419519|NCT02565615|18702738|P1|Overall Study|Not willing to participate in study|2
5419520|NCT02565615|18702734|P5|Overall Study|Death|4
5419521|NCT02565615|18702735|P4|Overall Study|Death|0
5419522|NCT02565615|18702736|P3|Overall Study|Death|0
5419523|NCT02565615|18702737|P2|Overall Study|Death|1
5419524|NCT02565615|18702738|P1|Overall Study|Death|0
5419525|NCT02565576|18702852|P2|Overall Study|Adverse Event|0
5419526|NCT02565576|18702853|P1|Overall Study|Adverse Event|1
5419527|NCT02565576|18702852|P2|Overall Study|Death|2
5419528|NCT02565576|18702853|P1|Overall Study|Death|0
5419529|NCT02565576|18702852|P2|Overall Study|Lost to Follow-up|0
5419530|NCT02565576|18702853|P1|Overall Study|Lost to Follow-up|1
5419531|NCT02565576|18702852|P2|Overall Study|subject / guardian decision|3
5419532|NCT02565576|18702853|P1|Overall Study|subject / guardian decision|1
5419533|NCT02565576|18702852|P2|Overall Study|abnormal lab value|0
5419534|NCT02565576|18702853|P1|Overall Study|abnormal lab value|2
5419535|NCT02565381|18702896|P3|Overall Study|Lost to Follow-up|1
5419536|NCT02565381|18702897|P2|Overall Study|Lost to Follow-up|0
5419537|NCT02565381|18702898|P1|Overall Study|Lost to Follow-up|1
5419538|NCT02565186|18702938|P2|Overall Study|Did Not Receive Study Drug|86
5419539|NCT02565186|18702939|P1|Overall Study|Did Not Receive Study Drug|55
5419540|NCT02565186|18702938|P2|Overall Study|Missing|0
5419541|NCT02565186|18702939|P1|Overall Study|Missing|1
5419542|NCT02565186|18702938|P2|Overall Study|Sponsor Request|9
5419543|NCT02565186|18702939|P1|Overall Study|Sponsor Request|5
5419544|NCT02565186|18702938|P2|Overall Study|Physician Decision|16
5419545|NCT02565186|18702939|P1|Overall Study|Physician Decision|18
5419546|NCT02565186|18702938|P2|Overall Study|Withdrawal by Subject|214
5419547|NCT02565186|18702939|P1|Overall Study|Withdrawal by Subject|229
5419548|NCT02565186|18702938|P2|Overall Study|Non-Compliance|55
5419549|NCT02565186|18702939|P1|Overall Study|Non-Compliance|57
5419550|NCT02565186|18702938|P2|Overall Study|Lost to Follow-up|93
5419551|NCT02565186|18702939|P1|Overall Study|Lost to Follow-up|102
5419552|NCT02565186|18702938|P2|Overall Study|Adverse Event|148
5419553|NCT02565186|18702939|P1|Overall Study|Adverse Event|113
5419554|NCT02565147|18702953|P2|Overall Study|Death|1
5419555|NCT02565147|18702954|P1|Overall Study|Death|1
5419556|NCT02565147|18702953|P2|Overall Study|Lost to Follow-up|1
5419557|NCT02565147|18702954|P1|Overall Study|Lost to Follow-up|0
5419558|NCT02565147|18702953|P2|Overall Study|Withdrawal by Subject|1
5419559|NCT02565147|18702954|P1|Overall Study|Withdrawal by Subject|5
5419560|NCT02565108|18702978|P2|Overall Study|Withdrew Consent|0
5419561|NCT02565108|18702979|P1|Overall Study|Withdrew Consent|1
5419562|NCT02565108|18702978|P2|Overall Study|Adverse Event|0
5419563|NCT02565108|18702979|P1|Overall Study|Adverse Event|1
5419564|NCT02564952|18702995|P1|Overall Study|Participant Met Withdrawal Criteria|1
5419565|NCT02564952|18702995|P1|Overall Study|Low Efficacy|1
5419566|NCT02564952|18702995|P1|Overall Study|Withdrawal by Subject|1
5419567|NCT02564952|18702995|P1|Overall Study|Participant Withdrawn by Investigator|1
5419568|NCT02564952|18702995|P1|Overall Study|Lost to Follow-up|1
5419569|NCT02564952|18702995|P1|Overall Study|Adverse Event|6
5419570|NCT02564887|18703040|P2|Overall Study|Lost to Follow-up|0
5419571|NCT02564887|18703041|P1|Overall Study|Lost to Follow-up|6
5419572|NCT02564718|18703059|P2|Overall Study|Withdrew from treatment|1
5419573|NCT02564718|18703060|P1|Overall Study|Withdrew from treatment|0
5419574|NCT02564263|18703148|P2|Overall Study|Ongoing in Study|25
5419575|NCT02564263|18703149|P1|Overall Study|Ongoing in Study|42
5419576|NCT02564263|18703148|P2|Overall Study|Withdrawal by Subject|18
5419577|NCT02564263|18703149|P1|Overall Study|Withdrawal by Subject|5
5419578|NCT02564263|18703148|P2|Overall Study|Death|242
5419579|NCT02564263|18703149|P1|Overall Study|Death|236
5419580|NCT02564263|18703148|P2|Overall Study|Adverse Event|29
5419581|NCT02564263|18703149|P1|Overall Study|Adverse Event|31
5419582|NCT02564211|18703171|P1|Overall Study|Adverse Event|4
5419583|NCT02564120|18703182|P1|Overall Study|Other medical condition|24
5419584|NCT02564120|18703182|P1|Overall Study|Withdrawal by Subject|204
5419585|NCT02564120|18703182|P1|Overall Study|Death|58
5419586|NCT02564120|18703182|P1|Overall Study|Did not return release forms|160
5419587|NCT02564055|18703230|P6|Overall Study|Withdrawal by Subject|10
5419588|NCT02564055|18703231|P5|Overall Study|Withdrawal by Subject|10
5419589|NCT02564055|18703232|P4|Overall Study|Withdrawal by Subject|3
5419590|NCT02564055|18703233|P3|Overall Study|Withdrawal by Subject|3
5419591|NCT02564055|18703234|P2|Overall Study|Withdrawal by Subject|4
5419592|NCT02564055|18703235|P1|Overall Study|Withdrawal by Subject|4
5419593|NCT02564055|18703230|P6|Overall Study|Physician Decision|0
5419594|NCT02564055|18703231|P5|Overall Study|Physician Decision|0
5419595|NCT02564055|18703232|P4|Overall Study|Physician Decision|0
5419596|NCT02564055|18703233|P3|Overall Study|Physician Decision|1
5419597|NCT02564055|18703234|P2|Overall Study|Physician Decision|0
5419598|NCT02564055|18703235|P1|Overall Study|Physician Decision|0
5419599|NCT02564055|18703230|P6|Overall Study|Lost to Follow-up|0
5419600|NCT02564055|18703231|P5|Overall Study|Lost to Follow-up|1
5419601|NCT02564055|18703232|P4|Overall Study|Lost to Follow-up|2
5419602|NCT02564055|18703233|P3|Overall Study|Lost to Follow-up|4
5419603|NCT02564055|18703234|P2|Overall Study|Lost to Follow-up|1
5419604|NCT02564055|18703235|P1|Overall Study|Lost to Follow-up|0
5419605|NCT02564055|18703230|P6|Overall Study|Reached stopping criteria|1
5419606|NCT02564055|18703231|P5|Overall Study|Reached stopping criteria|0
5419607|NCT02564055|18703232|P4|Overall Study|Reached stopping criteria|0
5419608|NCT02564055|18703233|P3|Overall Study|Reached stopping criteria|0
5419609|NCT02564055|18703234|P2|Overall Study|Reached stopping criteria|0
5419610|NCT02564055|18703235|P1|Overall Study|Reached stopping criteria|0
5419611|NCT02564055|18703230|P6|Overall Study|Protocol Violation|0
5419612|NCT02564055|18703231|P5|Overall Study|Protocol Violation|0
5419613|NCT02564055|18703232|P4|Overall Study|Protocol Violation|0
5419614|NCT02564055|18703233|P3|Overall Study|Protocol Violation|0
5419615|NCT02564055|18703234|P2|Overall Study|Protocol Violation|0
5419616|NCT02564055|18703235|P1|Overall Study|Protocol Violation|1
5419617|NCT02564055|18703230|P6|Overall Study|Adverse Event|1
5419618|NCT02564055|18703231|P5|Overall Study|Adverse Event|4
5419619|NCT02564055|18703232|P4|Overall Study|Adverse Event|1
5419620|NCT02564055|18703233|P3|Overall Study|Adverse Event|4
5419621|NCT02564055|18703234|P2|Overall Study|Adverse Event|0
5419622|NCT02564055|18703235|P1|Overall Study|Adverse Event|1
5419623|NCT02564042|18703489|P6|Overall Study|Withdrawal by Subject|12
5419624|NCT02564042|18703490|P5|Overall Study|Withdrawal by Subject|10
5419625|NCT02564042|18703491|P4|Overall Study|Withdrawal by Subject|2
5419626|NCT02564042|18703492|P3|Overall Study|Withdrawal by Subject|2
5419627|NCT02564042|18703493|P2|Overall Study|Withdrawal by Subject|3
5419628|NCT02564042|18703494|P1|Overall Study|Withdrawal by Subject|5
5419629|NCT02564042|18703489|P6|Overall Study|Physician Decision|0
5419630|NCT02564042|18703490|P5|Overall Study|Physician Decision|0
5419631|NCT02564042|18703491|P4|Overall Study|Physician Decision|1
5419632|NCT02564042|18703492|P3|Overall Study|Physician Decision|0
5419633|NCT02564042|18703493|P2|Overall Study|Physician Decision|0
5419634|NCT02564042|18703494|P1|Overall Study|Physician Decision|1
5419635|NCT02564042|18703489|P6|Overall Study|Lost to Follow-up|1
5419636|NCT02564042|18703490|P5|Overall Study|Lost to Follow-up|1
5419637|NCT02564042|18703491|P4|Overall Study|Lost to Follow-up|0
5419638|NCT02564042|18703492|P3|Overall Study|Lost to Follow-up|1
5419639|NCT02564042|18703493|P2|Overall Study|Lost to Follow-up|1
5419640|NCT02564042|18703494|P1|Overall Study|Lost to Follow-up|1
5419641|NCT02564042|18703489|P6|Overall Study|Adverse Event|1
5419642|NCT02564042|18703490|P5|Overall Study|Adverse Event|0
5419643|NCT02564042|18703491|P4|Overall Study|Adverse Event|0
5419644|NCT02564042|18703492|P3|Overall Study|Adverse Event|3
5419645|NCT02564042|18703493|P2|Overall Study|Adverse Event|4
5419646|NCT02564042|18703494|P1|Overall Study|Adverse Event|4
5419647|NCT02563899|18703789|P4|Overall Study|Withdrawal by Subject|0
5419648|NCT02563899|18703790|P3|Overall Study|Withdrawal by Subject|1
5419649|NCT02563899|18703791|P2|Overall Study|Withdrawal by Subject|0
5419650|NCT02563899|18703792|P1|Overall Study|Withdrawal by Subject|0
5419651|NCT02563899|18703789|P4|Overall Study|Protocol Violation|0
5419652|NCT02563899|18703790|P3|Overall Study|Protocol Violation|0
5419653|NCT02563899|18703791|P2|Overall Study|Protocol Violation|0
5419654|NCT02563899|18703792|P1|Overall Study|Protocol Violation|1
5419655|NCT02563548|18703868|P6|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5419656|NCT02563548|18703869|P5|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
5419657|NCT02563548|18703870|P4|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5419658|NCT02563548|18703871|P3|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5419659|NCT02563548|18703872|P2|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5419660|NCT02563548|18703873|P1|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
5419661|NCT02563548|18703868|P6|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
5419662|NCT02563548|18703869|P5|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5419663|NCT02563548|18703870|P4|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5419664|NCT02563548|18703871|P3|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5419665|NCT02563548|18703872|P2|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5419666|NCT02563548|18703873|P1|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
5419667|NCT02563548|18703868|P6|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
5419668|NCT02563548|18703869|P5|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5419669|NCT02563548|18703870|P4|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5419670|NCT02563548|18703871|P3|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5419671|NCT02563548|18703872|P2|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5419672|NCT02563548|18703873|P1|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
5419673|NCT02563548|18703868|P6|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
5419674|NCT02563548|18703869|P5|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5419675|NCT02563548|18703870|P4|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5419676|NCT02563548|18703871|P3|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5419677|NCT02563548|18703872|P2|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5419678|NCT02563548|18703873|P1|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
5419679|NCT02563548|18703868|P6|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
5419680|NCT02563548|18703869|P5|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
5419681|NCT02563548|18703870|P4|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5419682|NCT02563548|18703871|P3|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5419683|NCT02563548|18703872|P2|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5419684|NCT02563548|18703873|P1|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
5419685|NCT02563548|18703868|P6|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5419686|NCT02563548|18703869|P5|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
5419687|NCT02563548|18703870|P4|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5419688|NCT02563548|18703871|P3|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5419689|NCT02563548|18703872|P2|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5419690|NCT02563548|18703873|P1|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
5419691|NCT02563548|18703868|P6|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
5419692|NCT02563548|18703869|P5|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
5419693|NCT02563548|18703870|P4|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5419694|NCT02563548|18703871|P3|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5419695|NCT02563548|18703872|P2|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5419696|NCT02563548|18703873|P1|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
5419697|NCT02563548|18703868|P6|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
5419698|NCT02563548|18703869|P5|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
5419699|NCT02563548|18703870|P4|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5419700|NCT02563548|18703871|P3|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5419701|NCT02563548|18703872|P2|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5419702|NCT02563548|18703873|P1|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
5419703|NCT02563548|18703868|P6|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5419704|NCT02563548|18703869|P5|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5419705|NCT02563548|18703870|P4|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
5419706|NCT02563548|18703871|P3|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
5419707|NCT02563548|18703872|P2|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5419708|NCT02563548|18703873|P1|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
5419709|NCT02563548|18703868|P6|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5419710|NCT02563548|18703869|P5|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5419711|NCT02563548|18703870|P4|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5419712|NCT02563548|18703871|P3|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
5419713|NCT02563548|18703872|P2|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5419714|NCT02563548|18703873|P1|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
5419715|NCT02563548|18703868|P6|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
5419716|NCT02563548|18703869|P5|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
5419717|NCT02563548|18703870|P4|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
5419718|NCT02563548|18703871|P3|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
5419719|NCT02563548|18703872|P2|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
5419720|NCT02563548|18703873|P1|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
5419721|NCT02563548|18703868|P6|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5419722|NCT02563548|18703869|P5|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5419723|NCT02563548|18703870|P4|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
5419724|NCT02563548|18703871|P3|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5419725|NCT02563548|18703872|P2|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
5419726|NCT02563548|18703873|P1|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
5419727|NCT02563106|18703982|P2|Overall Study|Other reason - not specified|1
5419728|NCT02563106|18703983|P1|Overall Study|Other reason - not specified|2
5419729|NCT02563106|18703982|P2|Overall Study|Physician Decision|1
5419730|NCT02563106|18703983|P1|Overall Study|Physician Decision|3
5419731|NCT02563106|18703982|P2|Overall Study|Lost to Follow-up|2
5419732|NCT02563106|18703983|P1|Overall Study|Lost to Follow-up|3
5419733|NCT02563106|18703982|P2|Overall Study|Use of non-permitted concurrent therapy|2
5419734|NCT02563106|18703983|P1|Overall Study|Use of non-permitted concurrent therapy|1
5419735|NCT02563106|18703982|P2|Overall Study|Protocol Violation|0
5419736|NCT02563106|18703983|P1|Overall Study|Protocol Violation|1
5419737|NCT02563106|18703982|P2|Overall Study|Adverse Event|15
5419738|NCT02563106|18703983|P1|Overall Study|Adverse Event|17
5419739|NCT02563106|18703982|P2|Overall Study|Withdrawal by Subject|8
5419740|NCT02563106|18703983|P1|Overall Study|Withdrawal by Subject|7
5419741|NCT02563028|18704022|P1|Overall Study|Unable to elicit VEP post induction|1
5419742|NCT02563028|18704022|P1|Overall Study|Lack of equipment|1
5419743|NCT02562482|18704120|P2|Overall Study|Illness/Injury unrelated to product|1
5419744|NCT02562482|18704121|P1|Overall Study|Illness/Injury unrelated to product|0
5419745|NCT02562482|18704120|P2|Overall Study|Physician Decision|3
5419746|NCT02562482|18704121|P1|Overall Study|Physician Decision|1
5419747|NCT02562482|18704120|P2|Overall Study|Withdrawal by Subject|3
5419748|NCT02562482|18704121|P1|Overall Study|Withdrawal by Subject|5
5419749|NCT02562482|18704120|P2|Overall Study|Moved from area|3
5419750|NCT02562482|18704121|P1|Overall Study|Moved from area|2
5419751|NCT02562482|18704120|P2|Overall Study|Lost to Follow-up|6
5419752|NCT02562482|18704121|P1|Overall Study|Lost to Follow-up|9
5419753|NCT02562482|18704120|P2|Overall Study|Enrolled, but did not receive product|0
5419754|NCT02562482|18704121|P1|Overall Study|Enrolled, but did not receive product|4
5419755|NCT02561832|18704156|P2|Overall Study|Disease progression|3
5419756|NCT02561832|18704157|P1|Overall Study|Disease progression|3
5419757|NCT02561832|18704156|P2|Overall Study|Adverse Event|0
5419758|NCT02561832|18704157|P1|Overall Study|Adverse Event|3
5419759|NCT02561832|18704156|P2|Overall Study|Withdrawal by Subject|1
5419760|NCT02561832|18704157|P1|Overall Study|Withdrawal by Subject|1
5419761|NCT02561806|18704165|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
5419762|NCT02561806|18704166|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
5419763|NCT02561806|18704165|P2|Post-Treatment Follow-up|Lost to Follow-up|1
5419764|NCT02561806|18704166|P1|Post-Treatment Follow-up|Lost to Follow-up|1
5419765|NCT02561806|18704165|P2|Maintenance Period|Site staff became unblinded|1
5419766|NCT02561806|18704166|P1|Maintenance Period|Site staff became unblinded|0
5419767|NCT02561806|18704165|P2|Maintenance Period|Withdrawal by Subject|3
5419768|NCT02561806|18704166|P1|Maintenance Period|Withdrawal by Subject|5
5419769|NCT02561806|18704165|P2|Maintenance Period|Protocol Violation|0
5419770|NCT02561806|18704166|P1|Maintenance Period|Protocol Violation|1
5419771|NCT02561806|18704165|P2|Maintenance Period|Lost to Follow-up|2
5419772|NCT02561806|18704166|P1|Maintenance Period|Lost to Follow-up|2
5419773|NCT02561806|18704165|P2|Maintenance Period|Lack of Efficacy|1
5419774|NCT02561806|18704166|P1|Maintenance Period|Lack of Efficacy|3
5419775|NCT02561806|18704165|P2|Maintenance Period|Adverse Event|1
5419776|NCT02561806|18704166|P1|Maintenance Period|Adverse Event|2
5419777|NCT02561806|18704165|P2|Induction Period|Randomized but not treated|1
5419778|NCT02561806|18704166|P1|Induction Period|Randomized but not treated|0
5419779|NCT02561806|18704165|P2|Induction Period|Site staff became unblinded|0
5419780|NCT02561806|18704166|P1|Induction Period|Site staff became unblinded|1
5419781|NCT02561806|18704165|P2|Induction Period|Withdrawal by Subject|2
5419782|NCT02561806|18704166|P1|Induction Period|Withdrawal by Subject|0
5419783|NCT02561806|18704165|P2|Induction Period|Lack of Efficacy|0
5419784|NCT02561806|18704166|P1|Induction Period|Lack of Efficacy|1
5419785|NCT02561806|18704165|P2|Induction Period|Adverse Event|2
5419786|NCT02561806|18704166|P1|Induction Period|Adverse Event|0
5419787|NCT02561572|18704270|P2|Overall Study|Protocol Violation|1
5419788|NCT02561572|18704271|P1|Overall Study|Protocol Violation|0
5419789|NCT02561572|18704270|P2|Overall Study|Inadequate time before surgery|1
5419790|NCT02561572|18704271|P1|Overall Study|Inadequate time before surgery|2
5419791|NCT02561195|18704425|P6|Overall Study|Randomized but not treated|0
5419792|NCT02561195|18704426|P5|Overall Study|Randomized but not treated|0
5419793|NCT02561195|18704427|P4|Overall Study|Randomized but not treated|0
5419794|NCT02561195|18704428|P3|Overall Study|Randomized but not treated|0
5419795|NCT02561195|18704429|P2|Overall Study|Randomized but not treated|0
5419796|NCT02561195|18704430|P1|Overall Study|Randomized but not treated|1
5419797|NCT02561195|18704425|P6|Overall Study|Withdrawal by Subject|0
5419798|NCT02561195|18704426|P5|Overall Study|Withdrawal by Subject|6
5419799|NCT02561195|18704427|P4|Overall Study|Withdrawal by Subject|2
5419800|NCT02561195|18704428|P3|Overall Study|Withdrawal by Subject|4
5419801|NCT02561195|18704429|P2|Overall Study|Withdrawal by Subject|4
5419802|NCT02561195|18704430|P1|Overall Study|Withdrawal by Subject|3
5419803|NCT02561195|18704425|P6|Overall Study|Death|0
5419804|NCT02561195|18704426|P5|Overall Study|Death|0
5419805|NCT02561195|18704427|P4|Overall Study|Death|2
5419806|NCT02561195|18704428|P3|Overall Study|Death|0
5419807|NCT02561195|18704429|P2|Overall Study|Death|1
5419808|NCT02561195|18704430|P1|Overall Study|Death|2
5419809|NCT02561195|18704425|P6|Overall Study|Protocol Violation|2
5419810|NCT02561195|18704426|P5|Overall Study|Protocol Violation|5
5419811|NCT02561195|18704427|P4|Overall Study|Protocol Violation|2
5419812|NCT02561195|18704428|P3|Overall Study|Protocol Violation|1
5419813|NCT02561195|18704429|P2|Overall Study|Protocol Violation|0
5419814|NCT02561195|18704430|P1|Overall Study|Protocol Violation|1
5419815|NCT02561195|18704425|P6|Overall Study|Other|1
5419816|NCT02561195|18704426|P5|Overall Study|Other|5
5419817|NCT02561195|18704427|P4|Overall Study|Other|7
5419818|NCT02561195|18704428|P3|Overall Study|Other|1
5419819|NCT02561195|18704429|P2|Overall Study|Other|3
5419820|NCT02561195|18704430|P1|Overall Study|Other|7
5419821|NCT02561195|18704425|P6|Overall Study|No longer willing to participate|3
5419822|NCT02561195|18704426|P5|Overall Study|No longer willing to participate|1
5419823|NCT02561195|18704427|P4|Overall Study|No longer willing to participate|4
5419824|NCT02561195|18704428|P3|Overall Study|No longer willing to participate|0
5419825|NCT02561195|18704429|P2|Overall Study|No longer willing to participate|4
5419826|NCT02561195|18704430|P1|Overall Study|No longer willing to participate|2
5419827|NCT02561195|18704425|P6|Overall Study|No longer meets eligibility criteria|1
5419828|NCT02561195|18704426|P5|Overall Study|No longer meets eligibility criteria|4
5419829|NCT02561195|18704427|P4|Overall Study|No longer meets eligibility criteria|4
5419830|NCT02561195|18704428|P3|Overall Study|No longer meets eligibility criteria|0
5419831|NCT02561195|18704429|P2|Overall Study|No longer meets eligibility criteria|1
5419832|NCT02561195|18704430|P1|Overall Study|No longer meets eligibility criteria|0
5419833|NCT02561195|18704425|P6|Overall Study|Lost to Follow-up|3
5419834|NCT02561195|18704426|P5|Overall Study|Lost to Follow-up|3
5419835|NCT02561195|18704427|P4|Overall Study|Lost to Follow-up|2
5419836|NCT02561195|18704428|P3|Overall Study|Lost to Follow-up|0
5419837|NCT02561195|18704429|P2|Overall Study|Lost to Follow-up|4
5419838|NCT02561195|18704430|P1|Overall Study|Lost to Follow-up|3
5419839|NCT02561195|18704425|P6|Overall Study|Adverse Event|0
5419840|NCT02561195|18704426|P5|Overall Study|Adverse Event|4
5419841|NCT02561195|18704427|P4|Overall Study|Adverse Event|3
5419842|NCT02561195|18704428|P3|Overall Study|Adverse Event|0
5419843|NCT02561195|18704429|P2|Overall Study|Adverse Event|5
5419844|NCT02561195|18704430|P1|Overall Study|Adverse Event|4
5419845|NCT02561156|18704591|P13|Part 2|Adverse Event|0
5419846|NCT02561156|18704592|P12|Part 2|Adverse Event|1
5419847|NCT02561156|18704593|P11|Part 2|Adverse Event|0
5419848|NCT02561156|18704594|P10|Part 2|Adverse Event|0
5419849|NCT02561156|18704595|P9|Part 2|Adverse Event|0
5419850|NCT02561156|18704596|P8|Part 2|Adverse Event|0
5419851|NCT02561156|18704597|P7|Part 2|Adverse Event|0
5419852|NCT02561156|18704598|P6|Part 2|Adverse Event|0
5419853|NCT02561156|18704599|P5|Part 2|Adverse Event|0
5419854|NCT02561156|18704600|P4|Part 2|Adverse Event|0
5419855|NCT02561156|18704601|P3|Part 2|Adverse Event|0
5419856|NCT02561156|18704602|P2|Part 2|Adverse Event|0
5419857|NCT02561156|18704603|P1|Part 2|Adverse Event|0
5419858|NCT02561078|18704800|P2|Overall Study|Withdrawal by Subject|10
5419859|NCT02561078|18704801|P1|Overall Study|Withdrawal by Subject|13
5419860|NCT02561078|18704800|P2|Overall Study|Physician Decision|3
5419861|NCT02561078|18704801|P1|Overall Study|Physician Decision|2
5419862|NCT02561078|18704800|P2|Overall Study|Non-Compliance with Study Drug|3
5419863|NCT02561078|18704801|P1|Overall Study|Non-Compliance with Study Drug|6
5419864|NCT02561078|18704800|P2|Overall Study|Lost to Follow-up|6
5419865|NCT02561078|18704801|P1|Overall Study|Lost to Follow-up|2
5419866|NCT02561078|18704800|P2|Overall Study|Death|1
5419867|NCT02561078|18704801|P1|Overall Study|Death|2
5419868|NCT02561078|18704800|P2|Overall Study|Adverse Event|2
5419869|NCT02561078|18704801|P1|Overall Study|Adverse Event|5
5419870|NCT02560558|18704926|P2|Overall Study|Withdrawal by Subject|0
5419871|NCT02560558|18704927|P1|Overall Study|Withdrawal by Subject|3
5419872|NCT02560558|18704926|P2|Overall Study|Protocol Violation|0
5419873|NCT02560558|18704927|P1|Overall Study|Protocol Violation|3
5419874|NCT02560558|18704926|P2|Overall Study|Lost to Follow-up|4
5419875|NCT02560558|18704927|P1|Overall Study|Lost to Follow-up|0
5419876|NCT02560558|18704926|P2|Overall Study|Death|2
5419877|NCT02560558|18704927|P1|Overall Study|Death|0
5419878|NCT02560558|18704926|P2|Overall Study|Adverse Event|0
5419879|NCT02560558|18704927|P1|Overall Study|Adverse Event|1
5419880|NCT02560389|18704979|P3|Overall Study|Tested positive for illicit substance|0
5419881|NCT02560389|18704980|P2|Overall Study|Tested positive for illicit substance|1
5419882|NCT02560389|18704981|P1|Overall Study|Tested positive for illicit substance|0
5419883|NCT02560389|18704979|P3|Overall Study|Lost to Follow-up|2
5419884|NCT02560389|18704980|P2|Overall Study|Lost to Follow-up|2
5419885|NCT02560389|18704981|P1|Overall Study|Lost to Follow-up|1
5419886|NCT02560025|18705079|P1|Overall Study|Ineligible after consent/ registration|3
5419887|NCT02560012|18705088|P1|Overall Study|Study Terminated|2
5419888|NCT02559895|18705096|P4|Overall Study|Other|3
5419889|NCT02559895|18705097|P3|Overall Study|Other|3
5419890|NCT02559895|18705098|P2|Overall Study|Other|5
5419891|NCT02559895|18705099|P1|Overall Study|Other|1
5419892|NCT02559895|18705096|P4|Overall Study|Study Burden|22
5419893|NCT02559895|18705097|P3|Overall Study|Study Burden|12
5419894|NCT02559895|18705098|P2|Overall Study|Study Burden|16
5419895|NCT02559895|18705099|P1|Overall Study|Study Burden|10
5419896|NCT02559895|18705096|P4|Overall Study|Withdrawal by Subject|9
5419897|NCT02559895|18705097|P3|Overall Study|Withdrawal by Subject|20
5419898|NCT02559895|18705098|P2|Overall Study|Withdrawal by Subject|9
5419899|NCT02559895|18705099|P1|Overall Study|Withdrawal by Subject|16
5419900|NCT02559895|18705096|P4|Overall Study|Physician Decision|0
5419901|NCT02559895|18705097|P3|Overall Study|Physician Decision|3
5419902|NCT02559895|18705098|P2|Overall Study|Physician Decision|1
5419903|NCT02559895|18705099|P1|Overall Study|Physician Decision|1
5419904|NCT02559895|18705096|P4|Overall Study|Lost to Follow-up|17
5419905|NCT02559895|18705097|P3|Overall Study|Lost to Follow-up|12
5419906|NCT02559895|18705098|P2|Overall Study|Lost to Follow-up|16
5419907|NCT02559895|18705099|P1|Overall Study|Lost to Follow-up|22
5419908|NCT02559895|18705096|P4|Overall Study|Lack of Efficacy|8
5419909|NCT02559895|18705097|P3|Overall Study|Lack of Efficacy|2
5419910|NCT02559895|18705098|P2|Overall Study|Lack of Efficacy|3
5419911|NCT02559895|18705099|P1|Overall Study|Lack of Efficacy|2
5419912|NCT02559895|18705096|P4|Overall Study|Adverse Event|1
5419913|NCT02559895|18705097|P3|Overall Study|Adverse Event|2
5419914|NCT02559895|18705098|P2|Overall Study|Adverse Event|3
5419915|NCT02559895|18705099|P1|Overall Study|Adverse Event|3
5419916|NCT02559817|18705194|P5|Treatment Period|Protocol Violation|0
5419917|NCT02559817|18705195|P4|Treatment Period|Protocol Violation|1
5419918|NCT02559817|18705196|P3|Treatment Period|Protocol Violation|0
5419919|NCT02559817|18705197|P2|Treatment Period|Protocol Violation|0
5419920|NCT02559817|18705198|P1|Treatment Period|Protocol Violation|0
5419921|NCT02559817|18705194|P5|Treatment Period|Non-Compliance With Study Drug|0
5419922|NCT02559817|18705195|P4|Treatment Period|Non-Compliance With Study Drug|0
5419923|NCT02559817|18705196|P3|Treatment Period|Non-Compliance With Study Drug|1
5419924|NCT02559817|18705197|P2|Treatment Period|Non-Compliance With Study Drug|0
5419925|NCT02559817|18705198|P1|Treatment Period|Non-Compliance With Study Drug|0
5419926|NCT02559817|18705194|P5|Treatment Period|Lost to Follow-up|0
5419927|NCT02559817|18705195|P4|Treatment Period|Lost to Follow-up|1
5419928|NCT02559817|18705196|P3|Treatment Period|Lost to Follow-up|0
5419929|NCT02559817|18705197|P2|Treatment Period|Lost to Follow-up|1
5419930|NCT02559817|18705198|P1|Treatment Period|Lost to Follow-up|0
5419931|NCT02559817|18705194|P5|Treatment Period|Lack of Efficacy|0
5419932|NCT02559817|18705195|P4|Treatment Period|Lack of Efficacy|0
5419933|NCT02559817|18705196|P3|Treatment Period|Lack of Efficacy|0
5419934|NCT02559817|18705197|P2|Treatment Period|Lack of Efficacy|1
5419935|NCT02559817|18705198|P1|Treatment Period|Lack of Efficacy|0
5419936|NCT02559817|18705194|P5|Treatment Period|Adverse Event|0
5419937|NCT02559817|18705195|P4|Treatment Period|Adverse Event|0
5419938|NCT02559817|18705196|P3|Treatment Period|Adverse Event|1
5419939|NCT02559817|18705197|P2|Treatment Period|Adverse Event|0
5419940|NCT02559817|18705198|P1|Treatment Period|Adverse Event|1
5419941|NCT02559713|18705235|P1|Overall Study|Pretreatment Event/ Adverse Event|1
5419942|NCT02559687|18705245|P1|Overall Study|Ongoing Follow-Up|14
5419943|NCT02559687|18705245|P1|Overall Study|Withdrawal by Subject|4
5419944|NCT02559687|18705245|P1|Overall Study|Death|103
5419945|NCT02559622|18705258|P4|Overall Study|Patient/guardian decision|1
5419946|NCT02559622|18705259|P3|Overall Study|Patient/guardian decision|0
5419947|NCT02559622|18705260|P2|Overall Study|Patient/guardian decision|2
5419948|NCT02559622|18705261|P1|Overall Study|Patient/guardian decision|1
5419949|NCT02559622|18705258|P4|Overall Study|Adverse Event|2
5419950|NCT02559622|18705259|P3|Overall Study|Adverse Event|2
5419951|NCT02559622|18705260|P2|Overall Study|Adverse Event|2
5419952|NCT02559622|18705261|P1|Overall Study|Adverse Event|0
5419953|NCT02559622|18705258|P4|Overall Study|Progressive disease|0
5419954|NCT02559622|18705259|P3|Overall Study|Progressive disease|0
5419955|NCT02559622|18705260|P2|Overall Study|Progressive disease|1
5419956|NCT02559622|18705261|P1|Overall Study|Progressive disease|0
5419957|NCT02559570|18705345|P5|Overall Study|Other Miscellaneous Reasons|0
5419958|NCT02559570|18705346|P4|Overall Study|Other Miscellaneous Reasons|0
5419959|NCT02559570|18705347|P3|Overall Study|Other Miscellaneous Reasons|1
5419960|NCT02559570|18705348|P2|Overall Study|Other Miscellaneous Reasons|0
5419961|NCT02559570|18705349|P1|Overall Study|Other Miscellaneous Reasons|0
5419962|NCT02559570|18705345|P5|Overall Study|Protocol Violation|1
5419963|NCT02559570|18705346|P4|Overall Study|Protocol Violation|0
5419964|NCT02559570|18705347|P3|Overall Study|Protocol Violation|0
5419965|NCT02559570|18705348|P2|Overall Study|Protocol Violation|0
5419966|NCT02559570|18705349|P1|Overall Study|Protocol Violation|1
5419967|NCT02559570|18705345|P5|Overall Study|Lost to Follow-up|0
5419968|NCT02559570|18705346|P4|Overall Study|Lost to Follow-up|0
5419969|NCT02559570|18705347|P3|Overall Study|Lost to Follow-up|0
5419970|NCT02559570|18705348|P2|Overall Study|Lost to Follow-up|0
5419971|NCT02559570|18705349|P1|Overall Study|Lost to Follow-up|1
5419972|NCT02559570|18705345|P5|Overall Study|Withdrawal of Consent|1
5419973|NCT02559570|18705346|P4|Overall Study|Withdrawal of Consent|2
5419974|NCT02559570|18705347|P3|Overall Study|Withdrawal of Consent|1
5419975|NCT02559570|18705348|P2|Overall Study|Withdrawal of Consent|0
5419976|NCT02559570|18705349|P1|Overall Study|Withdrawal of Consent|0
5419977|NCT02559570|18705345|P5|Overall Study|Adverse Event|0
5419978|NCT02559570|18705346|P4|Overall Study|Adverse Event|1
5419979|NCT02559570|18705347|P3|Overall Study|Adverse Event|0
5419980|NCT02559570|18705348|P2|Overall Study|Adverse Event|2
5419981|NCT02559570|18705349|P1|Overall Study|Adverse Event|0
5419982|NCT02559414|18705387|P3|Overall Study|Other|1
5419983|NCT02559414|18705388|P2|Overall Study|Other|1
5419984|NCT02559414|18705389|P1|Overall Study|Other|0
5419985|NCT02559414|18705387|P3|Overall Study|Withdrawal by Subject|1
5419986|NCT02559414|18705388|P2|Overall Study|Withdrawal by Subject|0
5419987|NCT02559414|18705389|P1|Overall Study|Withdrawal by Subject|1
5419988|NCT02559414|18705387|P3|Overall Study|Lost to Follow-up|0
5419989|NCT02559414|18705388|P2|Overall Study|Lost to Follow-up|1
5419990|NCT02559414|18705389|P1|Overall Study|Lost to Follow-up|0
5419991|NCT02559310|18705429|P2|Overall Study|Randomized but not treated|2
5419992|NCT02559310|18705430|P1|Overall Study|Randomized but not treated|3
5419993|NCT02559310|18705429|P2|Overall Study|Sponsor Decision|1
5419994|NCT02559310|18705430|P1|Overall Study|Sponsor Decision|0
5419995|NCT02559310|18705429|P2|Overall Study|Withdrawal by Subject|9
5419996|NCT02559310|18705430|P1|Overall Study|Withdrawal by Subject|13
5419997|NCT02559310|18705429|P2|Overall Study|Physician Decision|1
5419998|NCT02559310|18705430|P1|Overall Study|Physician Decision|2
5419999|NCT02559310|18705429|P2|Overall Study|Lost to Follow-up|3
5420000|NCT02559310|18705430|P1|Overall Study|Lost to Follow-up|5
5420001|NCT02559310|18705429|P2|Overall Study|Death|3
5420002|NCT02559310|18705430|P1|Overall Study|Death|4
5420003|NCT02559206|18705448|P8|Overall Study|Other Not Specified|0
5420004|NCT02559206|18705449|P7|Overall Study|Other Not Specified|0
5420005|NCT02559206|18705450|P6|Overall Study|Other Not Specified|0
5420006|NCT02559206|18705451|P5|Overall Study|Other Not Specified|0
5420007|NCT02559206|18705452|P4|Overall Study|Other Not Specified|1
5420008|NCT02559206|18705453|P3|Overall Study|Other Not Specified|0
5420009|NCT02559206|18705454|P2|Overall Study|Other Not Specified|0
5420010|NCT02559206|18705455|P1|Overall Study|Other Not Specified|0
5420011|NCT02559206|18705448|P8|Overall Study|Lack of Efficacy|3
5420012|NCT02559206|18705449|P7|Overall Study|Lack of Efficacy|3
5420013|NCT02559206|18705450|P6|Overall Study|Lack of Efficacy|3
5420014|NCT02559206|18705451|P5|Overall Study|Lack of Efficacy|2
5420015|NCT02559206|18705452|P4|Overall Study|Lack of Efficacy|2
5420016|NCT02559206|18705453|P3|Overall Study|Lack of Efficacy|3
5420017|NCT02559206|18705454|P2|Overall Study|Lack of Efficacy|0
5420018|NCT02559206|18705455|P1|Overall Study|Lack of Efficacy|1
5420019|NCT02559206|18705448|P8|Overall Study|Lost to Follow-up|4
5420020|NCT02559206|18705449|P7|Overall Study|Lost to Follow-up|1
5420021|NCT02559206|18705450|P6|Overall Study|Lost to Follow-up|5
5420022|NCT02559206|18705451|P5|Overall Study|Lost to Follow-up|2
5420023|NCT02559206|18705452|P4|Overall Study|Lost to Follow-up|3
5420024|NCT02559206|18705453|P3|Overall Study|Lost to Follow-up|3
5420025|NCT02559206|18705454|P2|Overall Study|Lost to Follow-up|5
5420026|NCT02559206|18705455|P1|Overall Study|Lost to Follow-up|3
5420027|NCT02559206|18705448|P8|Overall Study|Withdrawal by Subject|2
5420028|NCT02559206|18705449|P7|Overall Study|Withdrawal by Subject|1
5420029|NCT02559206|18705450|P6|Overall Study|Withdrawal by Subject|4
5420030|NCT02559206|18705451|P5|Overall Study|Withdrawal by Subject|5
5420031|NCT02559206|18705452|P4|Overall Study|Withdrawal by Subject|3
5420032|NCT02559206|18705453|P3|Overall Study|Withdrawal by Subject|1
5420033|NCT02559206|18705454|P2|Overall Study|Withdrawal by Subject|3
5420034|NCT02559206|18705455|P1|Overall Study|Withdrawal by Subject|3
5420035|NCT02559206|18705448|P8|Overall Study|Protocol Violation|0
5420036|NCT02559206|18705449|P7|Overall Study|Protocol Violation|0
5420037|NCT02559206|18705450|P6|Overall Study|Protocol Violation|2
5420038|NCT02559206|18705451|P5|Overall Study|Protocol Violation|0
5420039|NCT02559206|18705452|P4|Overall Study|Protocol Violation|0
5420040|NCT02559206|18705453|P3|Overall Study|Protocol Violation|1
5420041|NCT02559206|18705454|P2|Overall Study|Protocol Violation|0
5420042|NCT02559206|18705455|P1|Overall Study|Protocol Violation|1
5420043|NCT02559206|18705448|P8|Overall Study|Adverse Event|0
5420044|NCT02559206|18705449|P7|Overall Study|Adverse Event|1
5420045|NCT02559206|18705450|P6|Overall Study|Adverse Event|0
5420046|NCT02559206|18705451|P5|Overall Study|Adverse Event|3
5420047|NCT02559206|18705452|P4|Overall Study|Adverse Event|5
5420048|NCT02559206|18705453|P3|Overall Study|Adverse Event|1
5420049|NCT02559206|18705454|P2|Overall Study|Adverse Event|4
5420050|NCT02559206|18705455|P1|Overall Study|Adverse Event|0
5420051|NCT02558894|18705497|P2|Overall Study|Closure of Part A|1
5420052|NCT02558894|18705498|P1|Overall Study|Closure of Part A|2
5420053|NCT02558894|18705497|P2|Overall Study|Withdrawal by Subject|1
5420054|NCT02558894|18705498|P1|Overall Study|Withdrawal by Subject|2
5420055|NCT02558894|18705497|P2|Overall Study|Death; any cause, entire study duration|31
5420056|NCT02558894|18705498|P1|Overall Study|Death; any cause, entire study duration|28
5420057|NCT02558790|18705559|P1|Overall Study|Screen Fail|3
5420058|NCT02558790|18705559|P1|Overall Study|Withdrawal by Subject|1
5420059|NCT02558790|18705559|P1|Overall Study|Physician Decision|1
5420060|NCT02558790|18705559|P1|Overall Study|Lost to Follow-up|2
5420061|NCT02558400|18705566|P3|Overall Study|Ineligible for the study|0
5420062|NCT02558400|18705567|P2|Overall Study|Ineligible for the study|2
5420063|NCT02558400|18705568|P1|Overall Study|Ineligible for the study|0
5420064|NCT02558400|18705566|P3|Overall Study|Death|0
5420065|NCT02558400|18705567|P2|Overall Study|Death|1
5420066|NCT02558400|18705568|P1|Overall Study|Death|0
5420067|NCT02558400|18705566|P3|Overall Study|Protocol Violation|8
5420068|NCT02558400|18705567|P2|Overall Study|Protocol Violation|3
5420069|NCT02558400|18705568|P1|Overall Study|Protocol Violation|6
5420070|NCT02558400|18705566|P3|Overall Study|Physician Decision|0
5420071|NCT02558400|18705567|P2|Overall Study|Physician Decision|2
5420072|NCT02558400|18705568|P1|Overall Study|Physician Decision|2
5420073|NCT02558400|18705566|P3|Overall Study|Disallowed Concurrent Medication|5
5420074|NCT02558400|18705567|P2|Overall Study|Disallowed Concurrent Medication|7
5420075|NCT02558400|18705568|P1|Overall Study|Disallowed Concurrent Medication|6
5420076|NCT02558400|18705566|P3|Overall Study|Lack of Efficacy|1
5420077|NCT02558400|18705567|P2|Overall Study|Lack of Efficacy|13
5420078|NCT02558400|18705568|P1|Overall Study|Lack of Efficacy|0
5420079|NCT02558400|18705566|P3|Overall Study|Lost to Follow-up|4
5420080|NCT02558400|18705567|P2|Overall Study|Lost to Follow-up|5
5420081|NCT02558400|18705568|P1|Overall Study|Lost to Follow-up|5
5420082|NCT02558400|18705566|P3|Overall Study|Non-Compliant|3
5420083|NCT02558400|18705567|P2|Overall Study|Non-Compliant|1
5420084|NCT02558400|18705568|P1|Overall Study|Non-Compliant|0
5420085|NCT02558400|18705566|P3|Overall Study|Withdrawal by Subject|8
5420086|NCT02558400|18705567|P2|Overall Study|Withdrawal by Subject|9
5420087|NCT02558400|18705568|P1|Overall Study|Withdrawal by Subject|13
5420088|NCT02558400|18705566|P3|Overall Study|Adverse Event|4
5420089|NCT02558400|18705567|P2|Overall Study|Adverse Event|53
5420090|NCT02558400|18705568|P1|Overall Study|Adverse Event|47
5420091|NCT02558231|18705592|P2|Overall Study|Ongoing|104
5420092|NCT02558231|18705593|P1|Overall Study|Ongoing|109
5420093|NCT02558231|18705592|P2|Overall Study|Sponsor Decision|1
5420094|NCT02558231|18705593|P1|Overall Study|Sponsor Decision|0
5420095|NCT02558231|18705592|P2|Overall Study|Physician Decision|5
5420096|NCT02558231|18705593|P1|Overall Study|Physician Decision|6
5420097|NCT02558231|18705592|P2|Overall Study|Withdrawal by Subject|3
5420098|NCT02558231|18705593|P1|Overall Study|Withdrawal by Subject|4
5420099|NCT02558231|18705592|P2|Overall Study|Lost to Follow-up|2
5420100|NCT02558231|18705593|P1|Overall Study|Lost to Follow-up|2
5420101|NCT02558231|18705592|P2|Overall Study|Death|9
5420102|NCT02558231|18705593|P1|Overall Study|Death|2
5420103|NCT02557646|18705684|P1|Overall Study|Other|14
5420104|NCT02557646|18705684|P1|Overall Study|Lost to Follow-up|17
5420105|NCT02557646|18705684|P1|Overall Study|Withdrawal by Subject|18
5420106|NCT02557646|18705684|P1|Overall Study|Lack of Efficacy|186
5420107|NCT02557646|18705684|P1|Overall Study|Death|1
5420108|NCT02557646|18705684|P1|Overall Study|Adverse Event|40
5420109|NCT02557516|18705711|P4|Overall Study|Sponsor decision|8
5420110|NCT02557516|18705712|P3|Overall Study|Sponsor decision|2
5420111|NCT02557516|18705713|P2|Overall Study|Sponsor decision|1
5420112|NCT02557516|18705714|P1|Overall Study|Sponsor decision|0
5420113|NCT02557516|18705711|P4|Overall Study|Physician Decision|0
5420114|NCT02557516|18705712|P3|Overall Study|Physician Decision|0
5420115|NCT02557516|18705713|P2|Overall Study|Physician Decision|2
5420116|NCT02557516|18705714|P1|Overall Study|Physician Decision|0
5420117|NCT02557516|18705711|P4|Overall Study|Disease progression|0
5420118|NCT02557516|18705712|P3|Overall Study|Disease progression|0
5420119|NCT02557516|18705713|P2|Overall Study|Disease progression|2
5420120|NCT02557516|18705714|P1|Overall Study|Disease progression|0
5420121|NCT02557516|18705711|P4|Overall Study|Adverse Event|1
5420122|NCT02557516|18705712|P3|Overall Study|Adverse Event|2
5420123|NCT02557516|18705713|P2|Overall Study|Adverse Event|0
5420124|NCT02557516|18705714|P1|Overall Study|Adverse Event|1
5420125|NCT02557399|18705735|P2|Overall Study|Withdrawal by Subject|1
5420126|NCT02557399|18705736|P1|Overall Study|Withdrawal by Subject|1
5420127|NCT02557399|18705735|P2|Overall Study|Protocol-defined stopping criteria|1
5420128|NCT02557399|18705736|P1|Overall Study|Protocol-defined stopping criteria|0
5420129|NCT02557399|18705735|P2|Overall Study|Protocol Violation|1
5420130|NCT02557399|18705736|P1|Overall Study|Protocol Violation|0
5420131|NCT02557399|18705735|P2|Overall Study|Adverse Event|5
5420132|NCT02557399|18705736|P1|Overall Study|Adverse Event|6
5420133|NCT02557100|18705771|P3|Cumulative Abatacept Period|Request to Discontinue|1
5420134|NCT02557100|18705772|P2|Cumulative Abatacept Period|Request to Discontinue|0
5420135|NCT02557100|18705773|P1|Cumulative Abatacept Period|Request to Discontinue|0
5420136|NCT02557100|18705771|P3|Cumulative Abatacept Period|Lost to Follow-up|2
5420137|NCT02557100|18705772|P2|Cumulative Abatacept Period|Lost to Follow-up|0
5420138|NCT02557100|18705773|P1|Cumulative Abatacept Period|Lost to Follow-up|0
5420139|NCT02557100|18705771|P3|Cumulative Abatacept Period|Other Reasons|1
5420140|NCT02557100|18705772|P2|Cumulative Abatacept Period|Other Reasons|0
5420141|NCT02557100|18705773|P1|Cumulative Abatacept Period|Other Reasons|0
5420142|NCT02557100|18705771|P3|Transition to Open Label|Entered Cumulative Abatacept Period|0
5420143|NCT02557100|18705772|P2|Transition to Open Label|Entered Cumulative Abatacept Period|36
5420144|NCT02557100|18705773|P1|Transition to Open Label|Entered Cumulative Abatacept Period|40
5420145|NCT02557100|18705771|P3|Single Blind Treatment Period|Adverse Event|0
5420146|NCT02557100|18705772|P2|Single Blind Treatment Period|Adverse Event|1
5420147|NCT02557100|18705773|P1|Single Blind Treatment Period|Adverse Event|0
5420148|NCT02557100|18705771|P3|Single Blind Treatment Period|Request to Discontinue|0
5420149|NCT02557100|18705772|P2|Single Blind Treatment Period|Request to Discontinue|1
5420150|NCT02557100|18705773|P1|Single Blind Treatment Period|Request to Discontinue|0
5420151|NCT02557100|18705771|P3|Single Blind Treatment Period|Death|0
5420152|NCT02557100|18705772|P2|Single Blind Treatment Period|Death|1
5420153|NCT02557100|18705773|P1|Single Blind Treatment Period|Death|0
5420154|NCT02557100|18705771|P3|Single Blind Treatment Period|Lost to Follow-up|0
5420155|NCT02557100|18705772|P2|Single Blind Treatment Period|Lost to Follow-up|1
5420156|NCT02557100|18705773|P1|Single Blind Treatment Period|Lost to Follow-up|0
5420157|NCT02556918|18705826|P2|Overall Study|Withdrawal by Subject|4
5420158|NCT02556918|18705827|P1|Overall Study|Withdrawal by Subject|4
5420159|NCT02556918|18705826|P2|Overall Study|Protocol Violation|6
5420160|NCT02556918|18705827|P1|Overall Study|Protocol Violation|5
5420161|NCT02556801|18705887|P4|Overall Study|Personal reasons patient|1
5420162|NCT02556801|18705888|P3|Overall Study|Personal reasons patient|0
5420163|NCT02556801|18705889|P2|Overall Study|Personal reasons patient|0
5420164|NCT02556801|18705890|P1|Overall Study|Personal reasons patient|0
5420165|NCT02556801|18705887|P4|Overall Study|Pregnancy|0
5420166|NCT02556801|18705888|P3|Overall Study|Pregnancy|0
5420167|NCT02556801|18705889|P2|Overall Study|Pregnancy|1
5420168|NCT02556801|18705890|P1|Overall Study|Pregnancy|0
5420169|NCT02556801|18705887|P4|Overall Study|Adverse Event|3
5420170|NCT02556801|18705888|P3|Overall Study|Adverse Event|0
5420171|NCT02556801|18705889|P2|Overall Study|Adverse Event|2
5420172|NCT02556801|18705890|P1|Overall Study|Adverse Event|0
5420173|NCT02556801|18705887|P4|Overall Study|Protocol Violation|1
5420174|NCT02556801|18705888|P3|Overall Study|Protocol Violation|1
5420175|NCT02556801|18705889|P2|Overall Study|Protocol Violation|3
5420176|NCT02556801|18705890|P1|Overall Study|Protocol Violation|0
5420177|NCT02556801|18705887|P4|Overall Study|Withdrawal by Subject|0
5420178|NCT02556801|18705888|P3|Overall Study|Withdrawal by Subject|1
5420179|NCT02556801|18705889|P2|Overall Study|Withdrawal by Subject|1
5420180|NCT02556801|18705890|P1|Overall Study|Withdrawal by Subject|1
5420181|NCT02556801|18705887|P4|Overall Study|Lost to Follow-up|0
5420182|NCT02556801|18705888|P3|Overall Study|Lost to Follow-up|2
5420183|NCT02556801|18705889|P2|Overall Study|Lost to Follow-up|0
5420184|NCT02556801|18705890|P1|Overall Study|Lost to Follow-up|1
5420185|NCT02556632|18705952|P3|Overall Study|Treatment or Change Delay|1
5420186|NCT02556632|18705953|P2|Overall Study|Treatment or Change Delay|0
5420187|NCT02556632|18705954|P1|Overall Study|Treatment or Change Delay|0
5420188|NCT02556632|18705952|P3|Overall Study|Disliked Study Procedures|1
5420189|NCT02556632|18705953|P2|Overall Study|Disliked Study Procedures|0
5420190|NCT02556632|18705954|P1|Overall Study|Disliked Study Procedures|0
5420191|NCT02556632|18705952|P3|Overall Study|Ineligible|0
5420192|NCT02556632|18705953|P2|Overall Study|Ineligible|1
5420193|NCT02556632|18705954|P1|Overall Study|Ineligible|0
5420194|NCT02556632|18705952|P3|Overall Study|Did Not Start RT|0
5420195|NCT02556632|18705953|P2|Overall Study|Did Not Start RT|1
5420196|NCT02556632|18705954|P1|Overall Study|Did Not Start RT|0
5420197|NCT02556632|18705952|P3|Overall Study|Possibly Related Adverse Event|1
5420198|NCT02556632|18705953|P2|Overall Study|Possibly Related Adverse Event|0
5420199|NCT02556632|18705954|P1|Overall Study|Possibly Related Adverse Event|0
5420200|NCT02556632|18705952|P3|Overall Study|Related Adverse Event|0
5420201|NCT02556632|18705953|P2|Overall Study|Related Adverse Event|1
5420202|NCT02556632|18705954|P1|Overall Study|Related Adverse Event|0
5420203|NCT02556632|18705952|P3|Overall Study|Unrelated Adverse Event|3
5420204|NCT02556632|18705953|P2|Overall Study|Unrelated Adverse Event|0
5420205|NCT02556632|18705954|P1|Overall Study|Unrelated Adverse Event|1
5420206|NCT02556632|18705952|P3|Overall Study|Withdrew (Unrelated Medical)|0
5420207|NCT02556632|18705953|P2|Overall Study|Withdrew (Unrelated Medical)|0
5420208|NCT02556632|18705954|P1|Overall Study|Withdrew (Unrelated Medical)|1
5420209|NCT02556632|18705952|P3|Overall Study|Changed Mind|0
5420210|NCT02556632|18705953|P2|Overall Study|Changed Mind|1
5420211|NCT02556632|18705954|P1|Overall Study|Changed Mind|0
5420212|NCT02556632|18705952|P3|Overall Study|Personal Issues|1
5420213|NCT02556632|18705953|P2|Overall Study|Personal Issues|1
5420214|NCT02556632|18705954|P1|Overall Study|Personal Issues|0
5420215|NCT02556632|18705952|P3|Overall Study|No Reason|1
5420216|NCT02556632|18705953|P2|Overall Study|No Reason|0
5420217|NCT02556632|18705954|P1|Overall Study|No Reason|1
5420218|NCT02556632|18705952|P3|Overall Study|Disliked Intervention|1
5420219|NCT02556632|18705953|P2|Overall Study|Disliked Intervention|1
5420220|NCT02556632|18705954|P1|Overall Study|Disliked Intervention|1
5420221|NCT02556632|18705952|P3|Overall Study|Lost to Follow-up|0
5420222|NCT02556632|18705953|P2|Overall Study|Lost to Follow-up|0
5420223|NCT02556632|18705954|P1|Overall Study|Lost to Follow-up|1
5420224|NCT02556307|18705994|P1|Overall Study|Enrolled but not treated|2
5420225|NCT02556307|18705994|P1|Overall Study|Change to triple therapy|4
5420226|NCT02556307|18705994|P1|Overall Study|Lost to Follow-up|36
5420227|NCT02556307|18705994|P1|Overall Study|Premature treatment interruption|11
5420228|NCT02556255|18706004|P1|Overall Study|Lost to Follow-up|4
5420229|NCT02556203|18706019|P2|Overall Study|Adverse Event|0
5420230|NCT02556203|18706020|P1|Overall Study|Adverse Event|1
5420231|NCT02556203|18706019|P2|Overall Study|Lost to Follow-up|5
5420232|NCT02556203|18706020|P1|Overall Study|Lost to Follow-up|5
5420233|NCT02556203|18706019|P2|Overall Study|Withdrawal by Subject|21
5420234|NCT02556203|18706020|P1|Overall Study|Withdrawal by Subject|21
5420235|NCT02556177|18706042|P2|Overall Study|Subjects did not complete all 4 visits|61
5420236|NCT02556177|18706043|P1|Overall Study|Subjects did not complete all 4 visits|283
5420237|NCT02556138|18706051|P1|Overall Study|Withdrawal by Subject|1
5420238|NCT02555878|18706087|P2|Overall Study|Other|17
5420239|NCT02555878|18706088|P1|Overall Study|Other|17
5420240|NCT02555878|18706087|P2|Overall Study|Physician Decision|13
5420241|NCT02555878|18706088|P1|Overall Study|Physician Decision|12
5420242|NCT02555878|18706087|P2|Overall Study|Protocol Violation|2
5420243|NCT02555878|18706088|P1|Overall Study|Protocol Violation|1
5420244|NCT02555878|18706087|P2|Overall Study|Death|59
5420245|NCT02555878|18706088|P1|Overall Study|Death|74
5420246|NCT02555878|18706087|P2|Overall Study|Adverse Event|8
5420247|NCT02555878|18706088|P1|Overall Study|Adverse Event|12
5420248|NCT02555878|18706087|P2|Overall Study|Withdrawal by Subject|48
5420249|NCT02555878|18706088|P1|Overall Study|Withdrawal by Subject|48
5420250|NCT02555878|18706087|P2|Overall Study|Lost to Follow-up|3
5420251|NCT02555878|18706088|P1|Overall Study|Lost to Follow-up|2
5420252|NCT02555722|18706120|P2|Month 2|Lost to Follow-up|0
5420253|NCT02555722|18706121|P1|Month 2|Lost to Follow-up|1
5420254|NCT02555722|18706120|P2|Month 2|Withdrawal by Subject|0
5420255|NCT02555722|18706121|P1|Month 2|Withdrawal by Subject|3
5420256|NCT02555722|18706120|P2|Month 1|Lens Discomfort|0
5420257|NCT02555722|18706121|P1|Month 1|Lens Discomfort|1
5420258|NCT02555722|18706120|P2|Week 2|Withdrawal by Subject|0
5420259|NCT02555722|18706121|P1|Week 2|Withdrawal by Subject|1
5420260|NCT02555722|18706120|P2|Week 2|Adverse Event|1
5420261|NCT02555722|18706121|P1|Week 2|Adverse Event|0
5420262|NCT02555683|18706306|P3|Overall Study|Death post Treatment/safety period|0
5420263|NCT02555683|18706307|P2|Overall Study|Death post Treatment/safety period|1
5420264|NCT02555683|18706308|P1|Overall Study|Death post Treatment/safety period|0
5420265|NCT02555683|18706306|P3|Overall Study|Subject/guardian decision|22
5420266|NCT02555683|18706307|P2|Overall Study|Subject/guardian decision|12
5420267|NCT02555683|18706308|P1|Overall Study|Subject/guardian decision|12
5420268|NCT02555683|18706306|P3|Overall Study|Adverse Event|1
5420269|NCT02555683|18706307|P2|Overall Study|Adverse Event|0
5420270|NCT02555683|18706308|P1|Overall Study|Adverse Event|1
5420271|NCT02555683|18706306|P3|Overall Study|Death|2
5420272|NCT02555683|18706307|P2|Overall Study|Death|1
5420273|NCT02555683|18706308|P1|Overall Study|Death|0
5420274|NCT02555683|18706306|P3|Overall Study|Lack of Efficacy|0
5420275|NCT02555683|18706307|P2|Overall Study|Lack of Efficacy|0
5420276|NCT02555683|18706308|P1|Overall Study|Lack of Efficacy|2
5420277|NCT02555683|18706306|P3|Overall Study|Protocol deviation|0
5420278|NCT02555683|18706307|P2|Overall Study|Protocol deviation|1
5420279|NCT02555683|18706308|P1|Overall Study|Protocol deviation|0
5420280|NCT02555683|18706306|P3|Overall Study|Technical Problems|0
5420281|NCT02555683|18706307|P2|Overall Study|Technical Problems|1
5420282|NCT02555683|18706308|P1|Overall Study|Technical Problems|1
5420283|NCT02555683|18706306|P3|Overall Study|Lost to Follow-up|2
5420284|NCT02555683|18706307|P2|Overall Study|Lost to Follow-up|1
5420285|NCT02555683|18706308|P1|Overall Study|Lost to Follow-up|2
5420286|NCT02555683|18706306|P3|Overall Study|Physician Decision|2
5420287|NCT02555683|18706307|P2|Overall Study|Physician Decision|0
5420288|NCT02555683|18706308|P1|Overall Study|Physician Decision|1
5420289|NCT02555657|18706339|P2|Overall Study|Status Not Recorded|31
5420290|NCT02555657|18706340|P1|Overall Study|Status Not Recorded|44
5420291|NCT02555657|18706339|P2|Overall Study|Withdrawal by Subject|32
5420292|NCT02555657|18706340|P1|Overall Study|Withdrawal by Subject|11
5420293|NCT02555657|18706339|P2|Overall Study|Death|247
5420294|NCT02555657|18706340|P1|Overall Study|Death|257
5420295|NCT02555618|18706387|P2|Overall Study|Sponsor's Circumstances|0
5420296|NCT02555618|18706388|P1|Overall Study|Sponsor's Circumstances|1
5420297|NCT02555371|18706430|P5|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5420298|NCT02555371|18706431|P4|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
5420299|NCT02555371|18706432|P3|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5420300|NCT02555371|18706433|P2|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5420301|NCT02555371|18706434|P1|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
5420302|NCT02555371|18706430|P5|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
5420303|NCT02555371|18706431|P4|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5420304|NCT02555371|18706432|P3|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5420305|NCT02555371|18706433|P2|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5420306|NCT02555371|18706434|P1|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
5420307|NCT02555371|18706430|P5|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
5420308|NCT02555371|18706431|P4|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5420309|NCT02555371|18706432|P3|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5420310|NCT02555371|18706433|P2|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5420311|NCT02555371|18706434|P1|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
5420312|NCT02555371|18706430|P5|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5420313|NCT02555371|18706431|P4|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
5420314|NCT02555371|18706432|P3|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5420315|NCT02555371|18706433|P2|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5420316|NCT02555371|18706434|P1|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
5420317|NCT02555371|18706430|P5|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5420318|NCT02555371|18706431|P4|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
5420319|NCT02555371|18706432|P3|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5420320|NCT02555371|18706433|P2|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5420321|NCT02555371|18706434|P1|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
5420322|NCT02555371|18706430|P5|Part C (DB Period: Up to 52W)|Adverse Event|0
5420323|NCT02555371|18706431|P4|Part C (DB Period: Up to 52W)|Adverse Event|0
5420324|NCT02555371|18706432|P3|Part C (DB Period: Up to 52W)|Adverse Event|1
5420325|NCT02555371|18706433|P2|Part C (DB Period: Up to 52W)|Adverse Event|2
5420326|NCT02555371|18706434|P1|Part C (DB Period: Up to 52W)|Adverse Event|0
5420327|NCT02555371|18706430|P5|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5420328|NCT02555371|18706431|P4|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5420329|NCT02555371|18706432|P3|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5420330|NCT02555371|18706433|P2|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
5420331|NCT02555371|18706434|P1|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
5420332|NCT02555371|18706430|P5|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
5420333|NCT02555371|18706431|P4|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
5420334|NCT02555371|18706432|P3|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
5420335|NCT02555371|18706433|P2|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
5420336|NCT02555371|18706434|P1|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
5420337|NCT02555371|18706430|P5|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
5420338|NCT02555371|18706431|P4|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
5420339|NCT02555371|18706432|P3|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
5420340|NCT02555371|18706433|P2|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
5420341|NCT02555371|18706434|P1|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
5420342|NCT02555371|18706430|P5|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5420343|NCT02555371|18706431|P4|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5420344|NCT02555371|18706432|P3|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5420345|NCT02555371|18706433|P2|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
5420346|NCT02555371|18706434|P1|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
5420347|NCT02555371|18706430|P5|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5420348|NCT02555371|18706431|P4|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5420349|NCT02555371|18706432|P3|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5420350|NCT02555371|18706433|P2|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
5420351|NCT02555371|18706434|P1|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
5420352|NCT02555371|18706430|P5|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5420353|NCT02555371|18706431|P4|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5420354|NCT02555371|18706432|P3|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5420355|NCT02555371|18706433|P2|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
5420356|NCT02555371|18706434|P1|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
5420357|NCT02555371|18706430|P5|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5420358|NCT02555371|18706431|P4|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5420359|NCT02555371|18706432|P3|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5420360|NCT02555371|18706433|P2|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
5420361|NCT02555371|18706434|P1|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
5420362|NCT02555371|18706430|P5|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5420363|NCT02555371|18706431|P4|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5420364|NCT02555371|18706432|P3|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5420365|NCT02555371|18706433|P2|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
5420366|NCT02555371|18706434|P1|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
5420367|NCT02555215|18706485|P1|Overall Study|Investigator Decision|2
5420368|NCT02555215|18706485|P1|Overall Study|Other|1
5420369|NCT02554981|18706517|P1|Overall Study|Other Miscellaneous Reasons|3
5420370|NCT02554981|18706517|P1|Overall Study|Administrative Reasons|1
5420371|NCT02554981|18706517|P1|Overall Study|Adverse Event|1
5420372|NCT02554929|18706543|P2|Overall Study|Withdrawal by Subject|8
5420373|NCT02554929|18706544|P1|Overall Study|Withdrawal by Subject|2
5420374|NCT02554929|18706543|P2|Overall Study|Lost to Follow-up|4
5420375|NCT02554929|18706544|P1|Overall Study|Lost to Follow-up|4
5420376|NCT02554890|18706562|P2|Open-label|Withdrawal by Subject|1
5420377|NCT02554890|18706563|P1|Open-label|Withdrawal by Subject|0
5420378|NCT02554890|18706562|P2|Open-label|Technical problems|1
5420379|NCT02554890|18706563|P1|Open-label|Technical problems|0
5420380|NCT02554890|18706562|P2|Open-label|Lost to Follow-up|7
5420381|NCT02554890|18706563|P1|Open-label|Lost to Follow-up|0
5420382|NCT02554890|18706562|P2|Open-label|Subject/Guardian decision|11
5420383|NCT02554890|18706563|P1|Open-label|Subject/Guardian decision|0
5420384|NCT02554890|18706562|P2|Open-label|Physician Decision|1
5420385|NCT02554890|18706563|P1|Open-label|Physician Decision|0
5420386|NCT02554890|18706562|P2|Open-label|Death|1
5420387|NCT02554890|18706563|P1|Open-label|Death|0
5420388|NCT02554890|18706562|P2|Open-label|Adverse Event|30
5420389|NCT02554890|18706563|P1|Open-label|Adverse Event|0
5420390|NCT02554890|18706562|P2|Double-blind|Noncompliance with study treatment|5
5420391|NCT02554890|18706563|P1|Double-blind|Noncompliance with study treatment|6
5420392|NCT02554890|18706562|P2|Double-blind|Withdrawal by Subject|6
5420393|NCT02554890|18706563|P1|Double-blind|Withdrawal by Subject|5
5420394|NCT02554890|18706562|P2|Double-blind|Technical problems|0
5420395|NCT02554890|18706563|P1|Double-blind|Technical problems|1
5420396|NCT02554890|18706562|P2|Double-blind|Lost to Follow-up|5
5420397|NCT02554890|18706563|P1|Double-blind|Lost to Follow-up|7
5420398|NCT02554890|18706562|P2|Double-blind|Subject/Guardian decision|16
5420399|NCT02554890|18706563|P1|Double-blind|Subject/Guardian decision|21
5420400|NCT02554890|18706562|P2|Double-blind|Physician Decision|3
5420401|NCT02554890|18706563|P1|Double-blind|Physician Decision|4
5420402|NCT02554890|18706562|P2|Double-blind|Protocol Violation|1
5420403|NCT02554890|18706563|P1|Double-blind|Protocol Violation|1
5420404|NCT02554890|18706562|P2|Double-blind|Death|4
5420405|NCT02554890|18706563|P1|Double-blind|Death|6
5420406|NCT02554890|18706562|P2|Double-blind|Adverse Event|51
5420407|NCT02554890|18706563|P1|Double-blind|Adverse Event|45
5420408|NCT02554877|18706591|P4|Overall Study|No longer willing to participate|0
5420409|NCT02554877|18706592|P3|Overall Study|No longer willing to participate|2
5420410|NCT02554877|18706593|P2|Overall Study|No longer willing to participate|2
5420411|NCT02554877|18706594|P1|Overall Study|No longer willing to participate|0
5420412|NCT02554877|18706591|P4|Overall Study|Insufficient clinical response|0
5420413|NCT02554877|18706592|P3|Overall Study|Insufficient clinical response|0
5420414|NCT02554877|18706593|P2|Overall Study|Insufficient clinical response|0
5420415|NCT02554877|18706594|P1|Overall Study|Insufficient clinical response|4
5420416|NCT02554877|18706591|P4|Overall Study|Other|3
5420417|NCT02554877|18706592|P3|Overall Study|Other|0
5420418|NCT02554877|18706593|P2|Overall Study|Other|3
5420419|NCT02554877|18706594|P1|Overall Study|Other|1
5420420|NCT02554877|18706591|P4|Overall Study|Protocol Violation|0
5420421|NCT02554877|18706592|P3|Overall Study|Protocol Violation|1
5420422|NCT02554877|18706593|P2|Overall Study|Protocol Violation|1
5420423|NCT02554877|18706594|P1|Overall Study|Protocol Violation|3
5420424|NCT02554877|18706591|P4|Overall Study|No longer met eligibility criteria|1
5420425|NCT02554877|18706592|P3|Overall Study|No longer met eligibility criteria|1
5420426|NCT02554877|18706593|P2|Overall Study|No longer met eligibility criteria|0
5420427|NCT02554877|18706594|P1|Overall Study|No longer met eligibility criteria|1
5420428|NCT02554877|18706591|P4|Overall Study|Did not meet entrance criteria|0
5420429|NCT02554877|18706592|P3|Overall Study|Did not meet entrance criteria|1
5420430|NCT02554877|18706593|P2|Overall Study|Did not meet entrance criteria|0
5420431|NCT02554877|18706594|P1|Overall Study|Did not meet entrance criteria|0
5420432|NCT02554877|18706591|P4|Overall Study|Lost to Follow-up|2
5420433|NCT02554877|18706592|P3|Overall Study|Lost to Follow-up|1
5420434|NCT02554877|18706593|P2|Overall Study|Lost to Follow-up|1
5420435|NCT02554877|18706594|P1|Overall Study|Lost to Follow-up|1
5420436|NCT02554877|18706591|P4|Overall Study|Adverse Event|1
5420437|NCT02554877|18706592|P3|Overall Study|Adverse Event|0
5420438|NCT02554877|18706593|P2|Overall Study|Adverse Event|0
5420439|NCT02554877|18706594|P1|Overall Study|Adverse Event|2
5420440|NCT02554786|18706682|P5|Overall Study|Pregnancy|1
5420441|NCT02554786|18706683|P4|Overall Study|Pregnancy|1
5420442|NCT02554786|18706684|P3|Overall Study|Pregnancy|0
5420443|NCT02554786|18706685|P2|Overall Study|Pregnancy|0
5420444|NCT02554786|18706686|P1|Overall Study|Pregnancy|0
5420445|NCT02554786|18706682|P5|Overall Study|Physician Decision|1
5420446|NCT02554786|18706683|P4|Overall Study|Physician Decision|1
5420447|NCT02554786|18706684|P3|Overall Study|Physician Decision|4
5420448|NCT02554786|18706685|P2|Overall Study|Physician Decision|1
5420449|NCT02554786|18706686|P1|Overall Study|Physician Decision|0
5420450|NCT02554786|18706682|P5|Overall Study|Non-compliance with study treatment|1
5420451|NCT02554786|18706683|P4|Overall Study|Non-compliance with study treatment|0
5420452|NCT02554786|18706684|P3|Overall Study|Non-compliance with study treatment|1
5420453|NCT02554786|18706685|P2|Overall Study|Non-compliance with study treatment|1
5420454|NCT02554786|18706686|P1|Overall Study|Non-compliance with study treatment|0
5420455|NCT02554786|18706682|P5|Overall Study|Death|0
5420456|NCT02554786|18706683|P4|Overall Study|Death|1
5420457|NCT02554786|18706684|P3|Overall Study|Death|0
5420458|NCT02554786|18706685|P2|Overall Study|Death|0
5420459|NCT02554786|18706686|P1|Overall Study|Death|0
5420460|NCT02554786|18706682|P5|Overall Study|Adverse Event|2
5420461|NCT02554786|18706683|P4|Overall Study|Adverse Event|0
5420462|NCT02554786|18706684|P3|Overall Study|Adverse Event|0
5420463|NCT02554786|18706685|P2|Overall Study|Adverse Event|0
5420464|NCT02554786|18706686|P1|Overall Study|Adverse Event|0
5420465|NCT02554786|18706682|P5|Overall Study|Technical problems|1
5420466|NCT02554786|18706683|P4|Overall Study|Technical problems|2
5420467|NCT02554786|18706684|P3|Overall Study|Technical problems|0
5420468|NCT02554786|18706685|P2|Overall Study|Technical problems|1
5420469|NCT02554786|18706686|P1|Overall Study|Technical problems|1
5420470|NCT02554786|18706682|P5|Overall Study|Protocol deviation|2
5420471|NCT02554786|18706683|P4|Overall Study|Protocol deviation|4
5420472|NCT02554786|18706684|P3|Overall Study|Protocol deviation|3
5420473|NCT02554786|18706685|P2|Overall Study|Protocol deviation|3
5420474|NCT02554786|18706686|P1|Overall Study|Protocol deviation|1
5420475|NCT02554786|18706682|P5|Overall Study|Lost to Follow-up|2
5420476|NCT02554786|18706683|P4|Overall Study|Lost to Follow-up|2
5420477|NCT02554786|18706684|P3|Overall Study|Lost to Follow-up|4
5420478|NCT02554786|18706685|P2|Overall Study|Lost to Follow-up|3
5420479|NCT02554786|18706686|P1|Overall Study|Lost to Follow-up|4
5420480|NCT02554786|18706682|P5|Overall Study|Subject/guardian decision|20
5420481|NCT02554786|18706683|P4|Overall Study|Subject/guardian decision|30
5420482|NCT02554786|18706684|P3|Overall Study|Subject/guardian decision|18
5420483|NCT02554786|18706685|P2|Overall Study|Subject/guardian decision|17
5420484|NCT02554786|18706686|P1|Overall Study|Subject/guardian decision|29
5420485|NCT02554682|18706848|P10|Overall Study|Physician Decision|0
5420486|NCT02554682|18706849|P9|Overall Study|Physician Decision|0
5420487|NCT02554682|18706850|P8|Overall Study|Physician Decision|0
5420488|NCT02554682|18706851|P7|Overall Study|Physician Decision|0
5420489|NCT02554682|18706852|P6|Overall Study|Physician Decision|0
5420490|NCT02554682|18706853|P5|Overall Study|Physician Decision|0
5420491|NCT02554682|18706854|P4|Overall Study|Physician Decision|0
5420492|NCT02554682|18706855|P3|Overall Study|Physician Decision|0
5420493|NCT02554682|18706856|P2|Overall Study|Physician Decision|2
5420494|NCT02554682|18706857|P1|Overall Study|Physician Decision|2
5420495|NCT02554682|18706848|P10|Overall Study|Withdrawal by Subject|0
5420496|NCT02554682|18706849|P9|Overall Study|Withdrawal by Subject|0
5420497|NCT02554682|18706850|P8|Overall Study|Withdrawal by Subject|0
5420498|NCT02554682|18706851|P7|Overall Study|Withdrawal by Subject|0
5420499|NCT02554682|18706852|P6|Overall Study|Withdrawal by Subject|0
5420500|NCT02554682|18706853|P5|Overall Study|Withdrawal by Subject|0
5420501|NCT02554682|18706854|P4|Overall Study|Withdrawal by Subject|0
5420502|NCT02554682|18706855|P3|Overall Study|Withdrawal by Subject|0
5420503|NCT02554682|18706856|P2|Overall Study|Withdrawal by Subject|1
5420504|NCT02554682|18706857|P1|Overall Study|Withdrawal by Subject|2
5420505|NCT02554682|18706848|P10|Overall Study|Lost to Follow-up|2
5420506|NCT02554682|18706849|P9|Overall Study|Lost to Follow-up|2
5420507|NCT02554682|18706850|P8|Overall Study|Lost to Follow-up|6
5420508|NCT02554682|18706851|P7|Overall Study|Lost to Follow-up|6
5420509|NCT02554682|18706852|P6|Overall Study|Lost to Follow-up|1
5420510|NCT02554682|18706853|P5|Overall Study|Lost to Follow-up|2
5420511|NCT02554682|18706854|P4|Overall Study|Lost to Follow-up|3
5420512|NCT02554682|18706855|P3|Overall Study|Lost to Follow-up|4
5420513|NCT02554682|18706856|P2|Overall Study|Lost to Follow-up|9
5420514|NCT02554682|18706857|P1|Overall Study|Lost to Follow-up|11
5420515|NCT02554656|18706906|P1|Overall Study|Protocol Violation|3
5420516|NCT02554279|18706951|P2|Overall Study|Other reason|6
5420517|NCT02554279|18706952|P1|Overall Study|Other reason|19
5420518|NCT02554279|18706951|P2|Overall Study|Protocol Violation|1
5420519|NCT02554279|18706952|P1|Overall Study|Protocol Violation|2
5420520|NCT02554279|18706951|P2|Overall Study|Withdrawal by Subject|4
5420521|NCT02554279|18706952|P1|Overall Study|Withdrawal by Subject|6
5420522|NCT02554279|18706951|P2|Overall Study|Lost to Follow-up|2
5420523|NCT02554279|18706952|P1|Overall Study|Lost to Follow-up|3
5420524|NCT02554279|18706951|P2|Overall Study|Adverse Event|5
5420525|NCT02554279|18706952|P1|Overall Study|Adverse Event|2
5420526|NCT02554019|18706987|P3|Overall Study|Adverse Event|0
5420527|NCT02554019|18706988|P2|Overall Study|Adverse Event|0
5420528|NCT02554019|18706989|P1|Overall Study|Adverse Event|1
5420529|NCT02554019|18706987|P3|Overall Study|Withdrawal by Subject|2
5420530|NCT02554019|18706988|P2|Overall Study|Withdrawal by Subject|0
5420531|NCT02554019|18706989|P1|Overall Study|Withdrawal by Subject|1
5420532|NCT02553928|18707011|P2|Overall Study|Administrative reason(s)|1
5420533|NCT02553928|18707012|P1|Overall Study|Administrative reason(s)|0
5420534|NCT02553928|18707011|P2|Overall Study|Lost to Follow-up|1
5420535|NCT02553928|18707012|P1|Overall Study|Lost to Follow-up|0
5420536|NCT02553928|18707011|P2|Overall Study|Adverse Event|1
5420537|NCT02553928|18707012|P1|Overall Study|Adverse Event|2
5420538|NCT02553772|18707066|P2|Overall Study|Other Miscellaneous Reasons|1
5420539|NCT02553772|18707067|P1|Overall Study|Other Miscellaneous Reasons|0
5420540|NCT02553772|18707066|P2|Overall Study|Lack of Efficacy|0
5420541|NCT02553772|18707067|P1|Overall Study|Lack of Efficacy|1
5420542|NCT02553772|18707066|P2|Overall Study|Withdrawal of Consent|1
5420543|NCT02553772|18707067|P1|Overall Study|Withdrawal of Consent|1
5420544|NCT02553772|18707066|P2|Overall Study|Lost to Follow-up|1
5420545|NCT02553772|18707067|P1|Overall Study|Lost to Follow-up|2
5420546|NCT02553772|18707066|P2|Overall Study|Adverse Event|3
5420547|NCT02553772|18707067|P1|Overall Study|Adverse Event|2
5420548|NCT02553629|18707112|P2|Overall Study|Logistic reasons|6
5420549|NCT02553629|18707113|P1|Overall Study|Logistic reasons|3
5420550|NCT02553538|18707129|P2|Overall Study|Died or Left Network|56
5420551|NCT02553538|18707130|P1|Overall Study|Died or Left Network|54
5420552|NCT02553538|18707129|P2|Overall Study|Could Not Reach by Telephone|0
5420553|NCT02553538|18707130|P1|Overall Study|Could Not Reach by Telephone|133
5420554|NCT02553499|18707164|P14|Overall Study|Withdrawal by Subject|0
5420555|NCT02553499|18707165|P13|Overall Study|Withdrawal by Subject|0
5420556|NCT02553499|18707166|P12|Overall Study|Withdrawal by Subject|0
5420557|NCT02553499|18707167|P11|Overall Study|Withdrawal by Subject|1
5420558|NCT02553499|18707168|P10|Overall Study|Withdrawal by Subject|0
5420559|NCT02553499|18707169|P9|Overall Study|Withdrawal by Subject|1
5420560|NCT02553499|18707170|P8|Overall Study|Withdrawal by Subject|1
5420561|NCT02553499|18707171|P7|Overall Study|Withdrawal by Subject|0
5420562|NCT02553499|18707172|P6|Overall Study|Withdrawal by Subject|0
5420563|NCT02553499|18707173|P5|Overall Study|Withdrawal by Subject|0
5420564|NCT02553499|18707174|P4|Overall Study|Withdrawal by Subject|0
5420565|NCT02553499|18707175|P3|Overall Study|Withdrawal by Subject|0
5420566|NCT02553499|18707176|P2|Overall Study|Withdrawal by Subject|0
5420567|NCT02553499|18707177|P1|Overall Study|Withdrawal by Subject|2
5420568|NCT02553499|18707164|P14|Overall Study|Study Terminated by Sponsor|0
5420569|NCT02553499|18707165|P13|Overall Study|Study Terminated by Sponsor|0
5420570|NCT02553499|18707166|P12|Overall Study|Study Terminated by Sponsor|0
5420571|NCT02553499|18707167|P11|Overall Study|Study Terminated by Sponsor|0
5420572|NCT02553499|18707168|P10|Overall Study|Study Terminated by Sponsor|0
5420573|NCT02553499|18707169|P9|Overall Study|Study Terminated by Sponsor|1
5420574|NCT02553499|18707170|P8|Overall Study|Study Terminated by Sponsor|0
5420575|NCT02553499|18707171|P7|Overall Study|Study Terminated by Sponsor|0
5420576|NCT02553499|18707172|P6|Overall Study|Study Terminated by Sponsor|0
5420577|NCT02553499|18707173|P5|Overall Study|Study Terminated by Sponsor|0
5420578|NCT02553499|18707174|P4|Overall Study|Study Terminated by Sponsor|0
5420579|NCT02553499|18707175|P3|Overall Study|Study Terminated by Sponsor|0
5420580|NCT02553499|18707176|P2|Overall Study|Study Terminated by Sponsor|0
5420581|NCT02553499|18707177|P1|Overall Study|Study Terminated by Sponsor|0
5420582|NCT02553499|18707164|P14|Overall Study|Progressive Disease|1
5420583|NCT02553499|18707165|P13|Overall Study|Progressive Disease|2
5420584|NCT02553499|18707166|P12|Overall Study|Progressive Disease|0
5420585|NCT02553499|18707167|P11|Overall Study|Progressive Disease|0
5420586|NCT02553499|18707168|P10|Overall Study|Progressive Disease|1
5420587|NCT02553499|18707169|P9|Overall Study|Progressive Disease|0
5420588|NCT02553499|18707170|P8|Overall Study|Progressive Disease|0
5420589|NCT02553499|18707171|P7|Overall Study|Progressive Disease|1
5420590|NCT02553499|18707172|P6|Overall Study|Progressive Disease|1
5420591|NCT02553499|18707173|P5|Overall Study|Progressive Disease|1
5420592|NCT02553499|18707174|P4|Overall Study|Progressive Disease|2
5420593|NCT02553499|18707175|P3|Overall Study|Progressive Disease|0
5420594|NCT02553499|18707176|P2|Overall Study|Progressive Disease|0
5420595|NCT02553499|18707177|P1|Overall Study|Progressive Disease|0
5420596|NCT02553499|18707164|P14|Overall Study|Physician Decision|0
5420597|NCT02553499|18707165|P13|Overall Study|Physician Decision|1
5420598|NCT02553499|18707166|P12|Overall Study|Physician Decision|3
5420599|NCT02553499|18707167|P11|Overall Study|Physician Decision|1
5420600|NCT02553499|18707168|P10|Overall Study|Physician Decision|2
5420601|NCT02553499|18707169|P9|Overall Study|Physician Decision|1
5420602|NCT02553499|18707170|P8|Overall Study|Physician Decision|1
5420603|NCT02553499|18707171|P7|Overall Study|Physician Decision|0
5420604|NCT02553499|18707172|P6|Overall Study|Physician Decision|0
5420605|NCT02553499|18707173|P5|Overall Study|Physician Decision|1
5420606|NCT02553499|18707174|P4|Overall Study|Physician Decision|0
5420607|NCT02553499|18707175|P3|Overall Study|Physician Decision|1
5420608|NCT02553499|18707176|P2|Overall Study|Physician Decision|1
5420609|NCT02553499|18707177|P1|Overall Study|Physician Decision|0
5420610|NCT02553499|18707164|P14|Overall Study|Lost to Follow-up|0
5420611|NCT02553499|18707165|P13|Overall Study|Lost to Follow-up|0
5420612|NCT02553499|18707166|P12|Overall Study|Lost to Follow-up|0
5420613|NCT02553499|18707167|P11|Overall Study|Lost to Follow-up|0
5420614|NCT02553499|18707168|P10|Overall Study|Lost to Follow-up|0
5420615|NCT02553499|18707169|P9|Overall Study|Lost to Follow-up|0
5420616|NCT02553499|18707170|P8|Overall Study|Lost to Follow-up|0
5420617|NCT02553499|18707171|P7|Overall Study|Lost to Follow-up|1
5420618|NCT02553499|18707172|P6|Overall Study|Lost to Follow-up|0
5420619|NCT02553499|18707173|P5|Overall Study|Lost to Follow-up|0
5420620|NCT02553499|18707174|P4|Overall Study|Lost to Follow-up|0
5420621|NCT02553499|18707175|P3|Overall Study|Lost to Follow-up|0
5420622|NCT02553499|18707176|P2|Overall Study|Lost to Follow-up|0
5420623|NCT02553499|18707177|P1|Overall Study|Lost to Follow-up|0
5420624|NCT02553499|18707164|P14|Overall Study|Death|0
5420625|NCT02553499|18707165|P13|Overall Study|Death|0
5420626|NCT02553499|18707166|P12|Overall Study|Death|0
5420627|NCT02553499|18707167|P11|Overall Study|Death|1
5420628|NCT02553499|18707168|P10|Overall Study|Death|0
5420629|NCT02553499|18707169|P9|Overall Study|Death|0
5420630|NCT02553499|18707170|P8|Overall Study|Death|0
5420631|NCT02553499|18707171|P7|Overall Study|Death|0
5420632|NCT02553499|18707172|P6|Overall Study|Death|2
5420633|NCT02553499|18707173|P5|Overall Study|Death|1
5420634|NCT02553499|18707174|P4|Overall Study|Death|0
5420635|NCT02553499|18707175|P3|Overall Study|Death|1
5420636|NCT02553499|18707176|P2|Overall Study|Death|1
5420637|NCT02553499|18707177|P1|Overall Study|Death|0
5420638|NCT02553499|18707164|P14|Overall Study|Adverse Event|1
5420639|NCT02553499|18707165|P13|Overall Study|Adverse Event|0
5420640|NCT02553499|18707166|P12|Overall Study|Adverse Event|0
5420641|NCT02553499|18707167|P11|Overall Study|Adverse Event|0
5420642|NCT02553499|18707168|P10|Overall Study|Adverse Event|0
5420643|NCT02553499|18707169|P9|Overall Study|Adverse Event|0
5420644|NCT02553499|18707170|P8|Overall Study|Adverse Event|1
5420645|NCT02553499|18707171|P7|Overall Study|Adverse Event|1
5420646|NCT02553499|18707172|P6|Overall Study|Adverse Event|0
5420647|NCT02553499|18707173|P5|Overall Study|Adverse Event|0
5420648|NCT02553499|18707174|P4|Overall Study|Adverse Event|0
5420649|NCT02553499|18707175|P3|Overall Study|Adverse Event|0
5420650|NCT02553499|18707176|P2|Overall Study|Adverse Event|0
5420651|NCT02553499|18707177|P1|Overall Study|Adverse Event|0
5420652|NCT02553421|18707279|P2|Overall Study|Improper Device Placement|0
5420653|NCT02553421|18707280|P1|Overall Study|Improper Device Placement|3
5420654|NCT02553421|18707279|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
5420655|NCT02553421|18707280|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
5420656|NCT02553421|18707279|P2|Overall Study|Lost to Follow-up|1
5420657|NCT02553421|18707280|P1|Overall Study|Lost to Follow-up|21
5420658|NCT02553330|18707335|P3|Overall Study|Lost to Follow-up|4
5420659|NCT02553330|18707336|P2|Overall Study|Lost to Follow-up|4
5420660|NCT02553330|18707337|P1|Overall Study|Lost to Follow-up|0
5420661|NCT02553330|18707335|P3|Overall Study|Adverse Event|0
5420662|NCT02553330|18707336|P2|Overall Study|Adverse Event|1
5420663|NCT02553330|18707337|P1|Overall Study|Adverse Event|0
5420664|NCT02553330|18707335|P3|Overall Study|Non compliance to study treatment|0
5420665|NCT02553330|18707336|P2|Overall Study|Non compliance to study treatment|1
5420666|NCT02553330|18707337|P1|Overall Study|Non compliance to study treatment|0
5420667|NCT02553330|18707335|P3|Overall Study|Other|0
5420668|NCT02553330|18707336|P2|Overall Study|Other|1
5420669|NCT02553330|18707337|P1|Overall Study|Other|0
5420670|NCT02553330|18707335|P3|Overall Study|Withdrawal by Subject|21
5420671|NCT02553330|18707336|P2|Overall Study|Withdrawal by Subject|19
5420672|NCT02553330|18707337|P1|Overall Study|Withdrawal by Subject|3
5420673|NCT02553330|18707335|P3|Overall Study|Study Terminated by Sponsor|12
5420674|NCT02553330|18707336|P2|Overall Study|Study Terminated by Sponsor|13
5420675|NCT02553330|18707337|P1|Overall Study|Study Terminated by Sponsor|2
5420676|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
5420677|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
5420678|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Protocol Violation|1
5420679|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Protocol Violation|0
5420680|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
5420681|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
5420682|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Lost to Follow-up|1
5420683|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Lost to Follow-up|0
5420684|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
5420685|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
5420686|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Adverse Event|5
5420687|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Adverse Event|6
5420688|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Death|3
5420689|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Death|1
5420690|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
5420691|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
5420692|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Physician Decision|4
5420693|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Physician Decision|2
5420694|NCT02553317|18707361|P2|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
5420695|NCT02553317|18707362|P1|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
5420696|NCT02552966|18707392|P1|Overall Study|Withdrawal by Subject|3
5420697|NCT02552966|18707392|P1|Overall Study|Lost to Follow-up|2
5420698|NCT02552732|18707418|P1|Overall Study|Withdrawal by Subject|6
5420699|NCT02552732|18707418|P1|Overall Study|Day 1 SpO2 > 96%|1
5420700|NCT02552732|18707418|P1|Overall Study|Physician Decision|1
5420701|NCT02552732|18707418|P1|Overall Study|Lost to Follow-up|2
5420702|NCT02552355|18707454|P4|Overall Study|Withdrawal by Subject|1
5420703|NCT02552355|18707455|P3|Overall Study|Withdrawal by Subject|0
5420704|NCT02552355|18707456|P2|Overall Study|Withdrawal by Subject|0
5420705|NCT02552355|18707457|P1|Overall Study|Withdrawal by Subject|0
5420706|NCT02552355|18707454|P4|Overall Study|Adverse Event|0
5420707|NCT02552355|18707455|P3|Overall Study|Adverse Event|2
5420708|NCT02552355|18707456|P2|Overall Study|Adverse Event|2
5420709|NCT02552355|18707457|P1|Overall Study|Adverse Event|0
5420710|NCT02552316|18707499|P1|Overall Study|Withdrawal due to non-compliance|1
5420711|NCT02552316|18707499|P1|Overall Study|Withdrawal by Subject|1
5420712|NCT02552303|18707551|P4|Follow-Up|ineligible|0
5420713|NCT02552303|18707552|P3|Follow-Up|ineligible|0
5420714|NCT02552303|18707553|P2|Follow-Up|ineligible|2
5420715|NCT02552303|18707554|P1|Follow-Up|ineligible|0
5420716|NCT02552303|18707551|P4|Follow-Up|Lost to Follow-up|0
5420717|NCT02552303|18707552|P3|Follow-Up|Lost to Follow-up|1
5420718|NCT02552303|18707553|P2|Follow-Up|Lost to Follow-up|0
5420719|NCT02552303|18707554|P1|Follow-Up|Lost to Follow-up|0
5420720|NCT02552303|18707551|P4|Allocation|ineligible|0
5420721|NCT02552303|18707552|P3|Allocation|ineligible|0
5420722|NCT02552303|18707553|P2|Allocation|ineligible|1
5420723|NCT02552303|18707554|P1|Allocation|ineligible|1
5420724|NCT02552303|18707551|P4|Allocation|Withdrawal by Subject|1
5420725|NCT02552303|18707552|P3|Allocation|Withdrawal by Subject|1
5420726|NCT02552303|18707553|P2|Allocation|Withdrawal by Subject|1
5420727|NCT02552303|18707554|P1|Allocation|Withdrawal by Subject|2
5420728|NCT02552238|18707568|P1|Overall Study|Adverse Event|2
5420729|NCT02552212|18707581|P2|Overall Study|Missing/Unspecified|0
5420730|NCT02552212|18707582|P1|Overall Study|Missing/Unspecified|1
5420731|NCT02552212|18707581|P2|Overall Study|Not eligible|1
5420732|NCT02552212|18707582|P1|Overall Study|Not eligible|0
5420733|NCT02552212|18707581|P2|Overall Study|As per suggestion|1
5420734|NCT02552212|18707582|P1|Overall Study|As per suggestion|0
5420735|NCT02552212|18707581|P2|Overall Study|Patient's decision|1
5420736|NCT02552212|18707582|P1|Overall Study|Patient's decision|0
5420737|NCT02552212|18707581|P2|Overall Study|Study non-compliance|1
5420738|NCT02552212|18707582|P1|Overall Study|Study non-compliance|1
5420739|NCT02552212|18707581|P2|Overall Study|Withdrawal by Subject|7
5420740|NCT02552212|18707582|P1|Overall Study|Withdrawal by Subject|3
5420741|NCT02552212|18707581|P2|Overall Study|Lost to Follow-up|0
5420742|NCT02552212|18707582|P1|Overall Study|Lost to Follow-up|1
5420743|NCT02552212|18707581|P2|Overall Study|Protocol Violation|1
5420744|NCT02552212|18707582|P1|Overall Study|Protocol Violation|1
5420745|NCT02552212|18707581|P2|Overall Study|Lack of Efficacy|2
5420746|NCT02552212|18707582|P1|Overall Study|Lack of Efficacy|2
5420747|NCT02552212|18707581|P2|Overall Study|Adverse Event|3
5420748|NCT02552212|18707582|P1|Overall Study|Adverse Event|6
5420749|NCT02552147|18707656|P2|Second Intervention (7 Days)|Protocol Violation|0
5420750|NCT02552147|18707657|P1|Second Intervention (7 Days)|Protocol Violation|2
5420751|NCT02552147|18707656|P2|First Intervention (7 Days)|Protocol Violation|0
5420752|NCT02552147|18707657|P1|First Intervention (7 Days)|Protocol Violation|1
5420753|NCT02552121|18707691|P8|Part 2: Cohort Expansion|Death|0
5420754|NCT02552121|18707692|P7|Part 2: Cohort Expansion|Death|0
5420755|NCT02552121|18707693|P6|Part 2: Cohort Expansion|Death|0
5420756|NCT02552121|18707694|P5|Part 2: Cohort Expansion|Death|0
5420757|NCT02552121|18707695|P4|Part 2: Cohort Expansion|Death|0
5420758|NCT02552121|18707696|P3|Part 2: Cohort Expansion|Death|1
5420759|NCT02552121|18707697|P2|Part 2: Cohort Expansion|Death|0
5420760|NCT02552121|18707698|P1|Part 2: Cohort Expansion|Death|0
5420761|NCT02552121|18707691|P8|Part 2: Cohort Expansion|Adverse Event|0
5420762|NCT02552121|18707692|P7|Part 2: Cohort Expansion|Adverse Event|0
5420763|NCT02552121|18707693|P6|Part 2: Cohort Expansion|Adverse Event|0
5420764|NCT02552121|18707694|P5|Part 2: Cohort Expansion|Adverse Event|0
5420765|NCT02552121|18707695|P4|Part 2: Cohort Expansion|Adverse Event|1
5420766|NCT02552121|18707696|P3|Part 2: Cohort Expansion|Adverse Event|6
5420767|NCT02552121|18707697|P2|Part 2: Cohort Expansion|Adverse Event|0
5420768|NCT02552121|18707698|P1|Part 2: Cohort Expansion|Adverse Event|0
5420769|NCT02552121|18707691|P8|Part 2: Cohort Expansion|Disease Progression|3
5420770|NCT02552121|18707692|P7|Part 2: Cohort Expansion|Disease Progression|0
5420771|NCT02552121|18707693|P6|Part 2: Cohort Expansion|Disease Progression|4
5420772|NCT02552121|18707694|P5|Part 2: Cohort Expansion|Disease Progression|1
5420773|NCT02552121|18707695|P4|Part 2: Cohort Expansion|Disease Progression|2
5420774|NCT02552121|18707696|P3|Part 2: Cohort Expansion|Disease Progression|3
5420775|NCT02552121|18707697|P2|Part 2: Cohort Expansion|Disease Progression|0
5420776|NCT02552121|18707698|P1|Part 2: Cohort Expansion|Disease Progression|0
5420777|NCT02552121|18707691|P8|Part 2: Cohort Expansion|Patient Choice|0
5420778|NCT02552121|18707692|P7|Part 2: Cohort Expansion|Patient Choice|1
5420779|NCT02552121|18707693|P6|Part 2: Cohort Expansion|Patient Choice|0
5420780|NCT02552121|18707694|P5|Part 2: Cohort Expansion|Patient Choice|0
5420781|NCT02552121|18707695|P4|Part 2: Cohort Expansion|Patient Choice|0
5420782|NCT02552121|18707696|P3|Part 2: Cohort Expansion|Patient Choice|1
5420783|NCT02552121|18707697|P2|Part 2: Cohort Expansion|Patient Choice|0
5420784|NCT02552121|18707698|P1|Part 2: Cohort Expansion|Patient Choice|0
5420785|NCT02552121|18707691|P8|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5420786|NCT02552121|18707692|P7|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5420787|NCT02552121|18707693|P6|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5420788|NCT02552121|18707694|P5|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5420789|NCT02552121|18707695|P4|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5420790|NCT02552121|18707696|P3|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5420791|NCT02552121|18707697|P2|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
5420792|NCT02552121|18707698|P1|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
5420793|NCT02552121|18707691|P8|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5420794|NCT02552121|18707692|P7|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5420795|NCT02552121|18707693|P6|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5420796|NCT02552121|18707694|P5|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5420797|NCT02552121|18707695|P4|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5420798|NCT02552121|18707696|P3|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5420799|NCT02552121|18707697|P2|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
5420800|NCT02552121|18707698|P1|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
5420801|NCT02552121|18707691|P8|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5420802|NCT02552121|18707692|P7|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5420803|NCT02552121|18707693|P6|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5420804|NCT02552121|18707694|P5|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5420805|NCT02552121|18707695|P4|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5420806|NCT02552121|18707696|P3|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5420807|NCT02552121|18707697|P2|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
5420808|NCT02552121|18707698|P1|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
5420809|NCT02552121|18707691|P8|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5420810|NCT02552121|18707692|P7|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5420811|NCT02552121|18707693|P6|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5420812|NCT02552121|18707694|P5|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5420813|NCT02552121|18707695|P4|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5420814|NCT02552121|18707696|P3|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5420815|NCT02552121|18707697|P2|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
5420816|NCT02552121|18707698|P1|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
5420817|NCT02552121|18707691|P8|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5420818|NCT02552121|18707692|P7|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5420819|NCT02552121|18707693|P6|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5420820|NCT02552121|18707694|P5|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5420821|NCT02552121|18707695|P4|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5420822|NCT02552121|18707696|P3|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5420823|NCT02552121|18707697|P2|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
5420824|NCT02552121|18707698|P1|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
5420825|NCT02552121|18707691|P8|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5420826|NCT02552121|18707692|P7|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5420827|NCT02552121|18707693|P6|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5420828|NCT02552121|18707694|P5|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5420829|NCT02552121|18707695|P4|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5420830|NCT02552121|18707696|P3|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5420831|NCT02552121|18707697|P2|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
5420832|NCT02552121|18707698|P1|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
5420833|NCT02551874|18707959|P2|Overall Study|Did not enter long-term study|25
5420834|NCT02551874|18707960|P1|Overall Study|Did not enter long-term study|18
5420835|NCT02551874|18707959|P2|Overall Study|Did not receive randomized treatment|7
5420836|NCT02551874|18707960|P1|Overall Study|Did not receive randomized treatment|0
5420837|NCT02551874|18707959|P2|Overall Study|Reason not reported|4
5420838|NCT02551874|18707960|P1|Overall Study|Reason not reported|10
5420839|NCT02551874|18707959|P2|Overall Study|Pregnancy|1
5420840|NCT02551874|18707960|P1|Overall Study|Pregnancy|0
5420841|NCT02551874|18707959|P2|Overall Study|Lost to Follow-up|2
5420842|NCT02551874|18707960|P1|Overall Study|Lost to Follow-up|0
5420843|NCT02551731|18708042|P1|Overall Study|Withdrawal by Subject|2
5420844|NCT02551692|18708062|P3|Overall Study|Withdrawal by Subject|1
5420845|NCT02551692|18708063|P2|Overall Study|Withdrawal by Subject|0
5420846|NCT02551692|18708064|P1|Overall Study|Withdrawal by Subject|1
5420847|NCT02551692|18708062|P3|Overall Study|Lost to Follow-up|4
5420848|NCT02551692|18708063|P2|Overall Study|Lost to Follow-up|1
5420849|NCT02551692|18708064|P1|Overall Study|Lost to Follow-up|0
5420850|NCT02551666|18708080|P2|Overall Study|Withdrawal by Subject|3
5420851|NCT02551666|18708081|P1|Overall Study|Withdrawal by Subject|1
5420852|NCT02551055|18708171|P8|Overall Study|Reason not specified|0
5420853|NCT02551055|18708172|P7|Overall Study|Reason not specified|1
5420854|NCT02551055|18708173|P6|Overall Study|Reason not specified|0
5420855|NCT02551055|18708174|P5|Overall Study|Reason not specified|1
5420856|NCT02551055|18708175|P4|Overall Study|Reason not specified|0
5420857|NCT02551055|18708176|P3|Overall Study|Reason not specified|0
5420858|NCT02551055|18708177|P2|Overall Study|Reason not specified|0
5420859|NCT02551055|18708178|P1|Overall Study|Reason not specified|0
5420860|NCT02551055|18708171|P8|Overall Study|Withdrawal by Subject|0
5420861|NCT02551055|18708172|P7|Overall Study|Withdrawal by Subject|0
5420862|NCT02551055|18708173|P6|Overall Study|Withdrawal by Subject|0
5420863|NCT02551055|18708174|P5|Overall Study|Withdrawal by Subject|2
5420864|NCT02551055|18708175|P4|Overall Study|Withdrawal by Subject|1
5420865|NCT02551055|18708176|P3|Overall Study|Withdrawal by Subject|0
5420866|NCT02551055|18708177|P2|Overall Study|Withdrawal by Subject|1
5420867|NCT02551055|18708178|P1|Overall Study|Withdrawal by Subject|1
5420868|NCT02551055|18708171|P8|Overall Study|Study Terminated by Sponsor|0
5420869|NCT02551055|18708172|P7|Overall Study|Study Terminated by Sponsor|0
5420870|NCT02551055|18708173|P6|Overall Study|Study Terminated by Sponsor|0
5420871|NCT02551055|18708174|P5|Overall Study|Study Terminated by Sponsor|2
5420872|NCT02551055|18708175|P4|Overall Study|Study Terminated by Sponsor|2
5420873|NCT02551055|18708176|P3|Overall Study|Study Terminated by Sponsor|0
5420874|NCT02551055|18708177|P2|Overall Study|Study Terminated by Sponsor|1
5420875|NCT02551055|18708178|P1|Overall Study|Study Terminated by Sponsor|1
5420876|NCT02551055|18708171|P8|Overall Study|Death|0
5420877|NCT02551055|18708172|P7|Overall Study|Death|2
5420878|NCT02551055|18708173|P6|Overall Study|Death|1
5420879|NCT02551055|18708174|P5|Overall Study|Death|2
5420880|NCT02551055|18708175|P4|Overall Study|Death|2
5420881|NCT02551055|18708176|P3|Overall Study|Death|2
5420882|NCT02551055|18708177|P2|Overall Study|Death|4
5420883|NCT02551055|18708178|P1|Overall Study|Death|2
5420884|NCT02550873|18708253|P3|Open Label Extension|Study ongoing|111
5420885|NCT02550873|18708254|P2|Open Label Extension|Study ongoing|0
5420886|NCT02550873|18708255|P1|Open Label Extension|Study ongoing|0
5420887|NCT02550873|18708253|P3|Randomized Double Blind|Disease progression|0
5420888|NCT02550873|18708254|P2|Randomized Double Blind|Disease progression|1
5420889|NCT02550873|18708255|P1|Randomized Double Blind|Disease progression|1
5420890|NCT02550873|18708253|P3|Randomized Double Blind|Adverse Event|0
5420891|NCT02550873|18708254|P2|Randomized Double Blind|Adverse Event|1
5420892|NCT02550873|18708255|P1|Randomized Double Blind|Adverse Event|3
5420893|NCT02550795|18708336|P3|Overall Study|Physician Decision|0
5420894|NCT02550795|18708337|P2|Overall Study|Physician Decision|1
5420895|NCT02550795|18708338|P1|Overall Study|Physician Decision|0
5420896|NCT02550652|18708354|P2|Overall Study|Ongoing in study|56
5420897|NCT02550652|18708355|P1|Overall Study|Ongoing in study|59
5420898|NCT02550652|18708354|P2|Overall Study|Withdrawal by Subject|4
5420899|NCT02550652|18708355|P1|Overall Study|Withdrawal by Subject|3
5420900|NCT02550652|18708354|P2|Overall Study|Lack of Efficacy|0
5420901|NCT02550652|18708355|P1|Overall Study|Lack of Efficacy|1
5420902|NCT02550652|18708354|P2|Overall Study|Death|2
5420903|NCT02550652|18708355|P1|Overall Study|Death|0
5420904|NCT02550288|18708402|P5|Overall Study|Withdrawal by Subject|0
5420905|NCT02550288|18708403|P4|Overall Study|Withdrawal by Subject|1
5420906|NCT02550288|18708404|P3|Overall Study|Withdrawal by Subject|0
5420907|NCT02550288|18708405|P2|Overall Study|Withdrawal by Subject|0
5420908|NCT02550288|18708406|P1|Overall Study|Withdrawal by Subject|0
5420909|NCT02550288|18708402|P5|Overall Study|Participant moved|0
5420910|NCT02550288|18708403|P4|Overall Study|Participant moved|1
5420911|NCT02550288|18708404|P3|Overall Study|Participant moved|0
5420912|NCT02550288|18708405|P2|Overall Study|Participant moved|0
5420913|NCT02550288|18708406|P1|Overall Study|Participant moved|0
5420914|NCT02550288|18708402|P5|Overall Study|Protocol Violation|3
5420915|NCT02550288|18708403|P4|Overall Study|Protocol Violation|0
5420916|NCT02550288|18708404|P3|Overall Study|Protocol Violation|1
5420917|NCT02550288|18708405|P2|Overall Study|Protocol Violation|2
5420918|NCT02550288|18708406|P1|Overall Study|Protocol Violation|2
5420919|NCT02550288|18708402|P5|Overall Study|Physician Decision|0
5420920|NCT02550288|18708403|P4|Overall Study|Physician Decision|1
5420921|NCT02550288|18708404|P3|Overall Study|Physician Decision|0
5420922|NCT02550288|18708405|P2|Overall Study|Physician Decision|0
5420923|NCT02550288|18708406|P1|Overall Study|Physician Decision|0
5420924|NCT02550288|18708402|P5|Overall Study|Adverse Event|0
5420925|NCT02550288|18708403|P4|Overall Study|Adverse Event|0
5420926|NCT02550288|18708404|P3|Overall Study|Adverse Event|0
5420927|NCT02550288|18708405|P2|Overall Study|Adverse Event|1
5420928|NCT02550288|18708406|P1|Overall Study|Adverse Event|0
5420929|NCT02550106|18708562|P1|Overall Study|Withdrawal by Subject|2
5420930|NCT02550106|18708562|P1|Overall Study|Protocol Violation|6
5420931|NCT02550106|18708562|P1|Overall Study|Lack of Efficacy|3
5420932|NCT02550106|18708562|P1|Overall Study|Adverse Event|1
5420933|NCT02549859|18708586|P1|Long-term 60 Hz DBS|Study Closed|1
5420934|NCT02549573|18708672|P2|Overall Study|Protocol Violation|1
5420935|NCT02549573|18708673|P1|Overall Study|Protocol Violation|0
5420936|NCT02549573|18708672|P2|Overall Study|Withdrawal by Subject|2
5420937|NCT02549573|18708673|P1|Overall Study|Withdrawal by Subject|0
5420938|NCT02549352|18708740|P2|12-month Follow-up|Other|3
5420939|NCT02549352|18708741|P1|12-month Follow-up|Other|1
5420940|NCT02549352|18708740|P2|12-month Follow-up|Protocol Violation|1
5420941|NCT02549352|18708741|P1|12-month Follow-up|Protocol Violation|0
5420942|NCT02549352|18708740|P2|12-month Follow-up|Death|1
5420943|NCT02549352|18708741|P1|12-month Follow-up|Death|0
5420944|NCT02549352|18708740|P2|12-month Follow-up|Lost to Follow-up|2
5420945|NCT02549352|18708741|P1|12-month Follow-up|Lost to Follow-up|3
5420946|NCT02549352|18708740|P2|12-month Follow-up|Withdrawal by Subject|5
5420947|NCT02549352|18708741|P1|12-month Follow-up|Withdrawal by Subject|4
5420948|NCT02549352|18708740|P2|3-day Treatment and 8-week Follow-up|Other|2
5420949|NCT02549352|18708741|P1|3-day Treatment and 8-week Follow-up|Other|0
5420950|NCT02549352|18708740|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
5420951|NCT02549352|18708741|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
5420952|NCT02549352|18708740|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
5420953|NCT02549352|18708741|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
5420954|NCT02549339|18708757|P2|12-month Follow-up|Other|3
5420955|NCT02549339|18708758|P1|12-month Follow-up|Other|0
5420956|NCT02549339|18708757|P2|12-month Follow-up|Lost to Follow-up|3
5420957|NCT02549339|18708758|P1|12-month Follow-up|Lost to Follow-up|1
5420958|NCT02549339|18708757|P2|12-month Follow-up|Withdrawal by Subject|3
5420959|NCT02549339|18708758|P1|12-month Follow-up|Withdrawal by Subject|8
5420960|NCT02549339|18708757|P2|12-month Follow-up|Lack of Efficacy|2
5420961|NCT02549339|18708758|P1|12-month Follow-up|Lack of Efficacy|0
5420962|NCT02549339|18708757|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
5420963|NCT02549339|18708758|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
5420964|NCT02549339|18708757|P2|3-day Treatment and 8-week Follow-up|Other|0
5420965|NCT02549339|18708758|P1|3-day Treatment and 8-week Follow-up|Other|1
5420966|NCT02549339|18708757|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
5420967|NCT02549339|18708758|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
5420968|NCT02549339|18708757|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
5420969|NCT02549339|18708758|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
5420970|NCT02549287|18708774|P2|Overall Study|Withdrawal by Subject|6
5420971|NCT02549287|18708775|P1|Overall Study|Withdrawal by Subject|15
5420972|NCT02549287|18708774|P2|Overall Study|Lost to Follow-up|26
5420973|NCT02549287|18708775|P1|Overall Study|Lost to Follow-up|65
5420974|NCT02549196|18708809|P4|Overall Study|Withdrawal by Subject|0
5420975|NCT02549196|18708810|P3|Overall Study|Withdrawal by Subject|1
5420976|NCT02549196|18708811|P2|Overall Study|Withdrawal by Subject|0
5420977|NCT02549196|18708812|P1|Overall Study|Withdrawal by Subject|1
5420978|NCT02549196|18708809|P4|Overall Study|Protocol Violation|1
5420979|NCT02549196|18708810|P3|Overall Study|Protocol Violation|0
5420980|NCT02549196|18708811|P2|Overall Study|Protocol Violation|0
5420981|NCT02549196|18708812|P1|Overall Study|Protocol Violation|0
5420982|NCT02549027|18708868|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5420983|NCT02549027|18708869|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
5420984|NCT02549027|18708870|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5420985|NCT02549027|18708871|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5420986|NCT02549027|18708872|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5420987|NCT02549027|18708873|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
5420988|NCT02549027|18708868|P6|Washout After Period 4|Withdrawal by Subject|0
5420989|NCT02549027|18708869|P5|Washout After Period 4|Withdrawal by Subject|0
5420990|NCT02549027|18708870|P4|Washout After Period 4|Withdrawal by Subject|1
5420991|NCT02549027|18708871|P3|Washout After Period 4|Withdrawal by Subject|1
5420992|NCT02549027|18708872|P2|Washout After Period 4|Withdrawal by Subject|1
5420993|NCT02549027|18708873|P1|Washout After Period 4|Withdrawal by Subject|0
5420994|NCT02548962|18709003|P2|Overall Study|Withdrawal by Subject|0
5420995|NCT02548962|18709004|P1|Overall Study|Withdrawal by Subject|1
5420996|NCT02548650|18709056|P2|Double Therapy|Withdrawal by Subject|1
5420997|NCT02548650|18709057|P1|Double Therapy|Withdrawal by Subject|0
5420998|NCT02548650|18709056|P2|Double Therapy|Adverse Event|1
5420999|NCT02548650|18709057|P1|Double Therapy|Adverse Event|1
5421000|NCT02548650|18709056|P2|Triple Therapy|Withdrawal by Subject|4
5421001|NCT02548650|18709057|P1|Triple Therapy|Withdrawal by Subject|0
5421002|NCT02548650|18709056|P2|Triple Therapy|Adverse Event|0
5421003|NCT02548650|18709057|P1|Triple Therapy|Adverse Event|1
5421004|NCT02548585|18709072|P7|Overall Study|Randomized but not treated|0
5421005|NCT02548585|18709073|P6|Overall Study|Randomized but not treated|1
5421006|NCT02548585|18709074|P5|Overall Study|Randomized but not treated|0
5421007|NCT02548585|18709075|P4|Overall Study|Randomized but not treated|0
5421008|NCT02548585|18709076|P3|Overall Study|Randomized but not treated|0
5421009|NCT02548585|18709077|P2|Overall Study|Randomized but not treated|0
5421010|NCT02548585|18709078|P1|Overall Study|Randomized but not treated|0
5421011|NCT02548585|18709072|P7|Overall Study|Other|1
5421012|NCT02548585|18709073|P6|Overall Study|Other|0
5421013|NCT02548585|18709074|P5|Overall Study|Other|3
5421014|NCT02548585|18709075|P4|Overall Study|Other|2
5421015|NCT02548585|18709076|P3|Overall Study|Other|0
5421016|NCT02548585|18709077|P2|Overall Study|Other|0
5421017|NCT02548585|18709078|P1|Overall Study|Other|1
5421018|NCT02548585|18709072|P7|Overall Study|Lost to Follow-up|0
5421019|NCT02548585|18709073|P6|Overall Study|Lost to Follow-up|0
5421020|NCT02548585|18709074|P5|Overall Study|Lost to Follow-up|0
5421021|NCT02548585|18709075|P4|Overall Study|Lost to Follow-up|0
5421022|NCT02548585|18709076|P3|Overall Study|Lost to Follow-up|0
5421023|NCT02548585|18709077|P2|Overall Study|Lost to Follow-up|0
5421024|NCT02548585|18709078|P1|Overall Study|Lost to Follow-up|1
5421025|NCT02548585|18709072|P7|Overall Study|Withdrawal by Subject|0
5421026|NCT02548585|18709073|P6|Overall Study|Withdrawal by Subject|1
5421027|NCT02548585|18709074|P5|Overall Study|Withdrawal by Subject|0
5421028|NCT02548585|18709075|P4|Overall Study|Withdrawal by Subject|0
5421029|NCT02548585|18709076|P3|Overall Study|Withdrawal by Subject|0
5421030|NCT02548585|18709077|P2|Overall Study|Withdrawal by Subject|0
5421031|NCT02548585|18709078|P1|Overall Study|Withdrawal by Subject|0
5421032|NCT02548455|18709296|P1|Overall Study|Visit not completed|173
5421033|NCT02548455|18709296|P1|Overall Study|Lost to Follow-up|14
5421034|NCT02548455|18709296|P1|Overall Study|Death|26
5421035|NCT02548455|18709296|P1|Overall Study|Withdrawal by Subject|27
5421036|NCT02548156|18709357|P6|Washout Period 1|Lost to Follow-up|0
5421037|NCT02548156|18709358|P5|Washout Period 1|Lost to Follow-up|1
5421038|NCT02548156|18709359|P4|Washout Period 1|Lost to Follow-up|0
5421039|NCT02548156|18709360|P3|Washout Period 1|Lost to Follow-up|0
5421040|NCT02548156|18709361|P2|Washout Period 1|Lost to Follow-up|0
5421041|NCT02548156|18709362|P1|Washout Period 1|Lost to Follow-up|0
5421042|NCT02548143|18709381|P2|Overall Study|Withdrawal by Subject|1
5421043|NCT02548143|18709382|P1|Overall Study|Withdrawal by Subject|0
5421044|NCT02548143|18709381|P2|Overall Study|Adverse Event|0
5421045|NCT02548143|18709382|P1|Overall Study|Adverse Event|1
5421046|NCT02548078|18709394|P2|Overall Study|Lost to Follow-up|3
5421047|NCT02548078|18709395|P1|Overall Study|Lost to Follow-up|1
5421048|NCT02548078|18709394|P2|Overall Study|Moved from study area|3
5421049|NCT02548078|18709395|P1|Overall Study|Moved from study area|3
5421050|NCT02548078|18709394|P2|Overall Study|Serious adverse event/Adverse event|0
5421051|NCT02548078|18709395|P1|Overall Study|Serious adverse event/Adverse event|1
5421052|NCT02547987|18709583|P1|Overall Study|Adverse Event|2
5421053|NCT02547987|18709583|P1|Overall Study|Withdrawal by Subject|1
5421054|NCT02547974|18709591|P4|Overall Study|Withdrawal by Subject|0
5421055|NCT02547974|18709592|P3|Overall Study|Withdrawal by Subject|0
5421056|NCT02547974|18709593|P2|Overall Study|Withdrawal by Subject|0
5421057|NCT02547974|18709594|P1|Overall Study|Withdrawal by Subject|1
5421058|NCT02547935|18709681|P3|Overall Study|Death|0
5421059|NCT02547935|18709682|P2|Overall Study|Death|1
5421060|NCT02547935|18709683|P1|Overall Study|Death|1
5421061|NCT02547935|18709681|P3|Overall Study|Lost to Follow-up|1
5421062|NCT02547935|18709682|P2|Overall Study|Lost to Follow-up|2
5421063|NCT02547935|18709683|P1|Overall Study|Lost to Follow-up|0
5421064|NCT02547935|18709681|P3|Overall Study|Physician Decision|0
5421065|NCT02547935|18709682|P2|Overall Study|Physician Decision|1
5421066|NCT02547935|18709683|P1|Overall Study|Physician Decision|0
5421067|NCT02547935|18709681|P3|Overall Study|Screen Failure|0
5421068|NCT02547935|18709682|P2|Overall Study|Screen Failure|0
5421069|NCT02547935|18709683|P1|Overall Study|Screen Failure|2
5421070|NCT02547935|18709681|P3|Overall Study|Withdrawal by Subject|4
5421071|NCT02547935|18709682|P2|Overall Study|Withdrawal by Subject|3
5421072|NCT02547935|18709683|P1|Overall Study|Withdrawal by Subject|2
5421073|NCT02547935|18709681|P3|Overall Study|Other|0
5421074|NCT02547935|18709682|P2|Overall Study|Other|1
5421075|NCT02547935|18709683|P1|Overall Study|Other|0
5421076|NCT02547766|18709721|P1|Overall Study|Withdrawal by Subject|1
5421077|NCT02547649|18709741|P3|Overall Study|Withdrawal by Subject|2
5421078|NCT02547649|18709742|P2|Overall Study|Withdrawal by Subject|4
5421079|NCT02547649|18709743|P1|Overall Study|Withdrawal by Subject|0
5421080|NCT02547649|18709741|P3|Overall Study|Not vaccinated|1
5421081|NCT02547649|18709742|P2|Overall Study|Not vaccinated|0
5421082|NCT02547649|18709743|P1|Overall Study|Not vaccinated|0
5421083|NCT02547649|18709741|P3|Overall Study|Lost to Follow-up|1
5421084|NCT02547649|18709742|P2|Overall Study|Lost to Follow-up|1
5421085|NCT02547649|18709743|P1|Overall Study|Lost to Follow-up|3
5421086|NCT02547454|18709808|P1|Overall Study|No data|11
5421087|NCT02547454|18709808|P1|Overall Study|Other|39
5421088|NCT02547454|18709808|P1|Overall Study|Lost to Follow-up|26
5421089|NCT02547454|18709808|P1|Overall Study|Death|38
5421090|NCT02547454|18709808|P1|Overall Study|Due to no further need to treat|4
5421091|NCT02547454|18709808|P1|Overall Study|Due to transplantation|1
5421092|NCT02547454|18709808|P1|Overall Study|Due to hemodialysis|53
5421093|NCT02547363|18709838|P2|12-month Follow-up|Other|0
5421094|NCT02547363|18709839|P1|12-month Follow-up|Other|1
5421095|NCT02547363|18709838|P2|12-month Follow-up|Lack of Efficacy|1
5421096|NCT02547363|18709839|P1|12-month Follow-up|Lack of Efficacy|1
5421097|NCT02547363|18709838|P2|12-month Follow-up|Lost to Follow-up|1
5421098|NCT02547363|18709839|P1|12-month Follow-up|Lost to Follow-up|4
5421099|NCT02547363|18709838|P2|12-month Follow-up|Withdrawal by Subject|3
5421100|NCT02547363|18709839|P1|12-month Follow-up|Withdrawal by Subject|4
5421101|NCT02547363|18709838|P2|3-day Treatment and 8-week Follow-up|Other|1
5421102|NCT02547363|18709839|P1|3-day Treatment and 8-week Follow-up|Other|1
5421103|NCT02547363|18709838|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
5421104|NCT02547363|18709839|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
5421105|NCT02547363|18709838|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
5421106|NCT02547363|18709839|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
5421107|NCT02547363|18709838|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
5421108|NCT02547363|18709839|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
5421109|NCT02547233|18709855|P2|12-month Follow-up|Other|1
5421110|NCT02547233|18709856|P1|12-month Follow-up|Other|0
5421111|NCT02547233|18709855|P2|12-month Follow-up|Protocol Violation|1
5421112|NCT02547233|18709856|P1|12-month Follow-up|Protocol Violation|0
5421113|NCT02547233|18709855|P2|12-month Follow-up|Lack of Efficacy|2
5421114|NCT02547233|18709856|P1|12-month Follow-up|Lack of Efficacy|1
5421115|NCT02547233|18709855|P2|12-month Follow-up|Lost to Follow-up|3
5421116|NCT02547233|18709856|P1|12-month Follow-up|Lost to Follow-up|3
5421117|NCT02547233|18709855|P2|12-month Follow-up|Withdrawal by Subject|10
5421118|NCT02547233|18709856|P1|12-month Follow-up|Withdrawal by Subject|10
5421119|NCT02547233|18709855|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
5421120|NCT02547233|18709856|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
5421121|NCT02547233|18709855|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
5421122|NCT02547233|18709856|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
5421123|NCT02547233|18709855|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
5421124|NCT02547233|18709856|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
5421125|NCT02547233|18709855|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
5421126|NCT02547233|18709856|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
5421127|NCT02547220|18709872|P2|Overall Study|Study terminated by sponsor|20
5421128|NCT02547220|18709873|P1|Overall Study|Study terminated by sponsor|18
5421129|NCT02547220|18709872|P2|Overall Study|Withdrawal by Subject|0
5421130|NCT02547220|18709873|P1|Overall Study|Withdrawal by Subject|1
5421131|NCT02547129|18709909|P2|Overall Study|Difficulty with ongoing infection|0
5421132|NCT02547129|18709910|P1|Overall Study|Difficulty with ongoing infection|1
5421133|NCT02547038|18709953|P2|Overall Study|Lost to Follow-up|2
5421134|NCT02547038|18709954|P1|Overall Study|Lost to Follow-up|3
5421135|NCT02546986|18709971|P2|Survival Follow-Up Phase|Lost to Follow-up|2
5421136|NCT02546986|18709972|P1|Survival Follow-Up Phase|Lost to Follow-up|2
5421137|NCT02546986|18709971|P2|Survival Follow-Up Phase|Alive|16
5421138|NCT02546986|18709972|P1|Survival Follow-Up Phase|Alive|13
5421139|NCT02546986|18709971|P2|Survival Follow-Up Phase|Death|12
5421140|NCT02546986|18709972|P1|Survival Follow-Up Phase|Death|18
5421141|NCT02546986|18709971|P2|Survival Follow-Up Phase|Missing Status|5
5421142|NCT02546986|18709972|P1|Survival Follow-Up Phase|Missing Status|3
5421143|NCT02546986|18709971|P2|Treatment Period|Miscellaneous|9
5421144|NCT02546986|18709972|P1|Treatment Period|Miscellaneous|7
5421145|NCT02546986|18709971|P2|Treatment Period|Study Terminated by Sponsor|1
5421146|NCT02546986|18709972|P1|Treatment Period|Study Terminated by Sponsor|0
5421147|NCT02546986|18709971|P2|Treatment Period|Non-compliance with Study Drug|1
5421148|NCT02546986|18709972|P1|Treatment Period|Non-compliance with Study Drug|0
5421149|NCT02546986|18709971|P2|Treatment Period|Withdrawal by Subject|1
5421150|NCT02546986|18709972|P1|Treatment Period|Withdrawal by Subject|1
5421151|NCT02546986|18709971|P2|Treatment Period|Protocol Violation|0
5421152|NCT02546986|18709972|P1|Treatment Period|Protocol Violation|1
5421153|NCT02546986|18709971|P2|Treatment Period|Physician Decision|2
5421154|NCT02546986|18709972|P1|Treatment Period|Physician Decision|1
5421155|NCT02546986|18709971|P2|Treatment Period|Death|4
5421156|NCT02546986|18709972|P1|Treatment Period|Death|3
5421157|NCT02546986|18709971|P2|Treatment Period|Symptomatic Deterioration|3
5421158|NCT02546986|18709972|P1|Treatment Period|Symptomatic Deterioration|4
5421159|NCT02546986|18709971|P2|Treatment Period|Adverse Event|6
5421160|NCT02546986|18709972|P1|Treatment Period|Adverse Event|14
5421161|NCT02546986|18709971|P2|Treatment Period|Progressive Disease|22
5421162|NCT02546986|18709972|P1|Treatment Period|Progressive Disease|20
5421163|NCT02546856|18709997|P2|6 Months Evaluation|reasons not due to titration|1
5421164|NCT02546856|18709998|P1|6 Months Evaluation|reasons not due to titration|0
5421165|NCT02546856|18709997|P2|6 Months Evaluation|Working or living abroad|4
5421166|NCT02546856|18709998|P1|6 Months Evaluation|Working or living abroad|6
5421167|NCT02546856|18709997|P2|6 Months Evaluation|Lost to Follow-up|1
5421168|NCT02546856|18709998|P1|6 Months Evaluation|Lost to Follow-up|1
5421169|NCT02546856|18709997|P2|6 Months Evaluation|Death|1
5421170|NCT02546856|18709998|P1|6 Months Evaluation|Death|1
5421171|NCT02546856|18709997|P2|4 Months Evaluation|HF Unit not active in summer|0
5421172|NCT02546856|18709998|P1|4 Months Evaluation|HF Unit not active in summer|1
5421173|NCT02546856|18709997|P2|4 Months Evaluation|reasons not due to titration|1
5421174|NCT02546856|18709998|P1|4 Months Evaluation|reasons not due to titration|4
5421175|NCT02546856|18709997|P2|4 Months Evaluation|Working or living abroad|1
5421176|NCT02546856|18709998|P1|4 Months Evaluation|Working or living abroad|5
5421177|NCT02546856|18709997|P2|4 Months Evaluation|Physician Decision|0
5421178|NCT02546856|18709998|P1|4 Months Evaluation|Physician Decision|3
5421179|NCT02546856|18709997|P2|4 Months Evaluation|Lost to Follow-up|3
5421180|NCT02546856|18709998|P1|4 Months Evaluation|Lost to Follow-up|3
5421181|NCT02546856|18709997|P2|4 Months Evaluation|Withdrawal by Subject|3
5421182|NCT02546856|18709998|P1|4 Months Evaluation|Withdrawal by Subject|2
5421183|NCT02546856|18709997|P2|4 Months Evaluation|Death|3
5421184|NCT02546856|18709998|P1|4 Months Evaluation|Death|2
5421185|NCT02546765|18710048|P4|Overall Study|Withdrawal by Subject|0
5421186|NCT02546765|18710049|P3|Overall Study|Withdrawal by Subject|0
5421187|NCT02546765|18710050|P2|Overall Study|Withdrawal by Subject|1
5421188|NCT02546765|18710051|P1|Overall Study|Withdrawal by Subject|0
5421189|NCT02546609|18710092|P3|Overall Study|travel or work schedule restriction|2
5421190|NCT02546609|18710093|P2|Overall Study|travel or work schedule restriction|0
5421191|NCT02546609|18710094|P1|Overall Study|travel or work schedule restriction|0
5421192|NCT02546609|18710092|P3|Overall Study|Lost to Follow-up|1
5421193|NCT02546609|18710093|P2|Overall Study|Lost to Follow-up|3
5421194|NCT02546609|18710094|P1|Overall Study|Lost to Follow-up|2
5421195|NCT02546609|18710092|P3|Overall Study|Protocol Violation|1
5421196|NCT02546609|18710093|P2|Overall Study|Protocol Violation|1
5421197|NCT02546609|18710094|P1|Overall Study|Protocol Violation|0
5421198|NCT02546609|18710092|P3|Overall Study|Adverse Event|1
5421199|NCT02546609|18710093|P2|Overall Study|Adverse Event|6
5421200|NCT02546609|18710094|P1|Overall Study|Adverse Event|0
5421201|NCT02546609|18710092|P3|Overall Study|Withdrawal by Subject|2
5421202|NCT02546609|18710093|P2|Overall Study|Withdrawal by Subject|1
5421203|NCT02546609|18710094|P1|Overall Study|Withdrawal by Subject|0
5421204|NCT02546544|18710174|P1|Overall Study|Withdrawal by Subject|1
5421205|NCT02546544|18710174|P1|Overall Study|Adverse Event|1
5421206|NCT02546544|18710174|P1|Overall Study|Disease Progression|14
5421207|NCT02546362|18710215|P1|12-week Treatment Period|Change in medication|1
5421208|NCT02546362|18710215|P1|12-week Treatment Period|Lost to Follow-up|2
5421209|NCT02546362|18710215|P1|12-week Treatment Period|Withdrawal by Subject|6
5421210|NCT02546362|18710215|P1|4-week Treatment Period|Change in medication|2
5421211|NCT02546362|18710215|P1|4-week Treatment Period|Lost to Follow-up|1
5421212|NCT02546323|18710236|P2|Overall Study|Met Withdrawal Criteria|14
5421213|NCT02546323|18710237|P1|Overall Study|Met Withdrawal Criteria|2
5421214|NCT02546323|18710236|P2|Overall Study|Non-compliance with Study Drug|2
5421215|NCT02546323|18710237|P1|Overall Study|Non-compliance with Study Drug|2
5421216|NCT02546323|18710236|P2|Overall Study|Lost to Follow-up|3
5421217|NCT02546323|18710237|P1|Overall Study|Lost to Follow-up|2
5421218|NCT02546323|18710236|P2|Overall Study|Patient Specific Reasons|2
5421219|NCT02546323|18710237|P1|Overall Study|Patient Specific Reasons|1
5421220|NCT02546323|18710236|P2|Overall Study|Adverse Event|11
5421221|NCT02546323|18710237|P1|Overall Study|Adverse Event|17
5421222|NCT02546323|18710236|P2|Overall Study|Eligibility Criteria not Fulfilled|1
5421223|NCT02546323|18710237|P1|Overall Study|Eligibility Criteria not Fulfilled|0
5421224|NCT02546323|18710236|P2|Overall Study|Withdrawal by Subject|33
5421225|NCT02546323|18710237|P1|Overall Study|Withdrawal by Subject|36
5421226|NCT02546193|18710257|P4|Overall Study|Not eligible at time of induction|0
5421227|NCT02546193|18710258|P3|Overall Study|Not eligible at time of induction|1
5421228|NCT02546193|18710259|P2|Overall Study|Not eligible at time of induction|6
5421229|NCT02546193|18710260|P1|Overall Study|Not eligible at time of induction|4
5421230|NCT02546193|18710257|P4|Overall Study|Withdrawal by Subject|0
5421231|NCT02546193|18710258|P3|Overall Study|Withdrawal by Subject|1
5421232|NCT02546193|18710259|P2|Overall Study|Withdrawal by Subject|0
5421233|NCT02546193|18710260|P1|Overall Study|Withdrawal by Subject|2
5421234|NCT02545933|18710297|P3|Overall Study|Protocol Violation|1
5421235|NCT02545933|18710298|P2|Overall Study|Protocol Violation|0
5421236|NCT02545933|18710299|P1|Overall Study|Protocol Violation|1
5421237|NCT02545933|18710297|P3|Overall Study|Withdrawal by Subject|3
5421238|NCT02545933|18710298|P2|Overall Study|Withdrawal by Subject|3
5421239|NCT02545933|18710299|P1|Overall Study|Withdrawal by Subject|2
5421240|NCT02545933|18710297|P3|Overall Study|Adverse Event|0
5421241|NCT02545933|18710298|P2|Overall Study|Adverse Event|0
5421242|NCT02545933|18710299|P1|Overall Study|Adverse Event|3
5421243|NCT02545868|18710310|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
5421244|NCT02545868|18710311|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
5421245|NCT02545868|18710312|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
5421246|NCT02545543|18710395|P2|Overall Study|Enrolment of subject at >1 study site|1
5421247|NCT02545543|18710396|P1|Overall Study|Enrolment of subject at >1 study site|1
5421248|NCT02545543|18710395|P2|Overall Study|Noncomplaince|0
5421249|NCT02545543|18710396|P1|Overall Study|Noncomplaince|1
5421250|NCT02545543|18710395|P2|Overall Study|Withdrawal by Subject|8
5421251|NCT02545543|18710396|P1|Overall Study|Withdrawal by Subject|9
5421252|NCT02545543|18710395|P2|Overall Study|Physician Decision|0
5421253|NCT02545543|18710396|P1|Overall Study|Physician Decision|3
5421254|NCT02545543|18710395|P2|Overall Study|Lost to Follow-up|25
5421255|NCT02545543|18710396|P1|Overall Study|Lost to Follow-up|67
5421256|NCT02545504|18710422|P2|Overall Study|Lost to Follow-up|2
5421257|NCT02545504|18710423|P1|Overall Study|Lost to Follow-up|2
5421258|NCT02545504|18710422|P2|Overall Study|Investigator's discretion|1
5421259|NCT02545504|18710423|P1|Overall Study|Investigator's discretion|3
5421260|NCT02545504|18710422|P2|Overall Study|Withdrew consent|11
5421261|NCT02545504|18710423|P1|Overall Study|Withdrew consent|9
5421262|NCT02545504|18710422|P2|Overall Study|Unknown reason|32
5421263|NCT02545504|18710423|P1|Overall Study|Unknown reason|30
5421264|NCT02545504|18710422|P2|Overall Study|Death|168
5421265|NCT02545504|18710423|P1|Overall Study|Death|174
5421266|NCT02545322|18710437|P1|Overall Study|Withdrawal by Subject|3
5421267|NCT02545270|18710445|P3|Overall Study|Videos being too similar to other|2
5421268|NCT02545270|18710446|P2|Overall Study|Videos being too similar to other|0
5421269|NCT02545270|18710447|P1|Overall Study|Videos being too similar to other|0
5421270|NCT02545270|18710445|P3|Overall Study|technical difficulties|0
5421271|NCT02545270|18710446|P2|Overall Study|technical difficulties|1
5421272|NCT02545270|18710447|P1|Overall Study|technical difficulties|0
5421273|NCT02545075|18710476|P2|Treatment|Completed treatment|12
5421274|NCT02545075|18710477|P1|Treatment|Completed treatment|40
5421275|NCT02545075|18710476|P2|Treatment|Participant drug toxicity|0
5421276|NCT02545075|18710477|P1|Treatment|Participant drug toxicity|1
5421277|NCT02545075|18710476|P2|Treatment|Death|0
5421278|NCT02545075|18710477|P1|Treatment|Death|1
5421279|NCT02545075|18710476|P2|Treatment|Adverse event not related to study drug|0
5421280|NCT02545075|18710477|P1|Treatment|Adverse event not related to study drug|1
5421281|NCT02545075|18710476|P2|Treatment|Withdrawal by Subject|0
5421282|NCT02545075|18710477|P1|Treatment|Withdrawal by Subject|1
5421283|NCT02545075|18710476|P2|Treatment|Participant dicontinued study treatment|9
5421284|NCT02545075|18710477|P1|Treatment|Participant dicontinued study treatment|7
5421285|NCT02545075|18710476|P2|Treatment|Disease progression|32
5421286|NCT02545075|18710477|P1|Treatment|Disease progression|71
5421287|NCT02545075|18710476|P2|Randomization|Withdrawal by Subject|6
5421288|NCT02545075|18710477|P1|Randomization|Withdrawal by Subject|0
5421289|NCT02545075|18710476|P2|Randomization|Lost to Follow-up|1
5421290|NCT02545075|18710477|P1|Randomization|Lost to Follow-up|0
5421291|NCT02544763|18710513|P3|Overall Study|Difficulties taking IMP|0
5421292|NCT02544763|18710514|P2|Overall Study|Difficulties taking IMP|0
5421293|NCT02544763|18710515|P1|Overall Study|Difficulties taking IMP|1
5421294|NCT02544763|18710513|P3|Overall Study|Physician Decision|0
5421295|NCT02544763|18710514|P2|Overall Study|Physician Decision|1
5421296|NCT02544763|18710515|P1|Overall Study|Physician Decision|0
5421297|NCT02544763|18710513|P3|Overall Study|Met withdrawal criteria|0
5421298|NCT02544763|18710514|P2|Overall Study|Met withdrawal criteria|2
5421299|NCT02544763|18710515|P1|Overall Study|Met withdrawal criteria|0
5421300|NCT02544763|18710513|P3|Overall Study|Withdrawn by parent/guardian|1
5421301|NCT02544763|18710514|P2|Overall Study|Withdrawn by parent/guardian|1
5421302|NCT02544763|18710515|P1|Overall Study|Withdrawn by parent/guardian|1
5421303|NCT02544763|18710513|P3|Overall Study|Adverse Event|0
5421304|NCT02544763|18710514|P2|Overall Study|Adverse Event|8
5421305|NCT02544763|18710515|P1|Overall Study|Adverse Event|8
5421306|NCT02544633|18710539|P4|Survival Follow-up Period|Study Terminated by Sponsor|3
5421307|NCT02544633|18710540|P3|Survival Follow-up Period|Study Terminated by Sponsor|2
5421308|NCT02544633|18710541|P2|Survival Follow-up Period|Study Terminated by Sponsor|4
5421309|NCT02544633|18710542|P1|Survival Follow-up Period|Study Terminated by Sponsor|12
5421310|NCT02544633|18710539|P4|Survival Follow-up Period|Withdrawal by Subject|0
5421311|NCT02544633|18710540|P3|Survival Follow-up Period|Withdrawal by Subject|1
5421312|NCT02544633|18710541|P2|Survival Follow-up Period|Withdrawal by Subject|0
5421313|NCT02544633|18710542|P1|Survival Follow-up Period|Withdrawal by Subject|4
5421314|NCT02544633|18710539|P4|Survival Follow-up Period|Lost to Follow-up|0
5421315|NCT02544633|18710540|P3|Survival Follow-up Period|Lost to Follow-up|1
5421316|NCT02544633|18710541|P2|Survival Follow-up Period|Lost to Follow-up|1
5421317|NCT02544633|18710542|P1|Survival Follow-up Period|Lost to Follow-up|0
5421318|NCT02544633|18710539|P4|Survival Follow-up Period|Death|9
5421319|NCT02544633|18710540|P3|Survival Follow-up Period|Death|3
5421320|NCT02544633|18710541|P2|Survival Follow-up Period|Death|14
5421321|NCT02544633|18710542|P1|Survival Follow-up Period|Death|12
5421322|NCT02544633|18710539|P4|Treatment Period|Clinical Disease Progression|1
5421323|NCT02544633|18710540|P3|Treatment Period|Clinical Disease Progression|0
5421324|NCT02544633|18710541|P2|Treatment Period|Clinical Disease Progression|0
5421325|NCT02544633|18710542|P1|Treatment Period|Clinical Disease Progression|0
5421326|NCT02544633|18710539|P4|Treatment Period|Non-compliance|0
5421327|NCT02544633|18710540|P3|Treatment Period|Non-compliance|1
5421328|NCT02544633|18710541|P2|Treatment Period|Non-compliance|0
5421329|NCT02544633|18710542|P1|Treatment Period|Non-compliance|0
5421330|NCT02544633|18710539|P4|Treatment Period|Death|0
5421331|NCT02544633|18710540|P3|Treatment Period|Death|1
5421332|NCT02544633|18710541|P2|Treatment Period|Death|0
5421333|NCT02544633|18710542|P1|Treatment Period|Death|0
5421334|NCT02544633|18710539|P4|Treatment Period|Lost to Follow-up|0
5421335|NCT02544633|18710540|P3|Treatment Period|Lost to Follow-up|0
5421336|NCT02544633|18710541|P2|Treatment Period|Lost to Follow-up|1
5421337|NCT02544633|18710542|P1|Treatment Period|Lost to Follow-up|0
5421338|NCT02544633|18710539|P4|Treatment Period|Withdrawal by Subject|0
5421339|NCT02544633|18710540|P3|Treatment Period|Withdrawal by Subject|0
5421340|NCT02544633|18710541|P2|Treatment Period|Withdrawal by Subject|0
5421341|NCT02544633|18710542|P1|Treatment Period|Withdrawal by Subject|1
5421342|NCT02544633|18710539|P4|Treatment Period|Global Deterioration of Health|1
5421343|NCT02544633|18710540|P3|Treatment Period|Global Deterioration of Health|0
5421344|NCT02544633|18710541|P2|Treatment Period|Global Deterioration of Health|3
5421345|NCT02544633|18710542|P1|Treatment Period|Global Deterioration of Health|3
5421346|NCT02544633|18710539|P4|Treatment Period|Lack of Efficacy|5
5421347|NCT02544633|18710540|P3|Treatment Period|Lack of Efficacy|5
5421348|NCT02544633|18710541|P2|Treatment Period|Lack of Efficacy|11
5421349|NCT02544633|18710542|P1|Treatment Period|Lack of Efficacy|17
5421350|NCT02544633|18710539|P4|Treatment Period|Adverse Event|5
5421351|NCT02544633|18710540|P3|Treatment Period|Adverse Event|0
5421352|NCT02544633|18710541|P2|Treatment Period|Adverse Event|4
5421353|NCT02544633|18710542|P1|Treatment Period|Adverse Event|7
5421354|NCT02544633|18710539|P4|Treatment Period|Patient Still on Treatment/Study|0
5421355|NCT02544633|18710540|P3|Treatment Period|Patient Still on Treatment/Study|1
5421356|NCT02544633|18710541|P2|Treatment Period|Patient Still on Treatment/Study|1
5421357|NCT02544633|18710542|P1|Treatment Period|Patient Still on Treatment/Study|0
5421358|NCT02544451|18710626|P3|Overall Study|Other|0
5421359|NCT02544451|18710627|P2|Overall Study|Other|4
5421360|NCT02544451|18710628|P1|Overall Study|Other|4
5421361|NCT02544451|18710626|P3|Overall Study|Physician Decision|0
5421362|NCT02544451|18710627|P2|Overall Study|Physician Decision|0
5421363|NCT02544451|18710628|P1|Overall Study|Physician Decision|4
5421364|NCT02544451|18710626|P3|Overall Study|Lost to Follow-up|0
5421365|NCT02544451|18710627|P2|Overall Study|Lost to Follow-up|0
5421366|NCT02544451|18710628|P1|Overall Study|Lost to Follow-up|2
5421367|NCT02544451|18710626|P3|Overall Study|Withdrawal of consent (not due to AE)|1
5421368|NCT02544451|18710627|P2|Overall Study|Withdrawal of consent (not due to AE)|2
5421369|NCT02544451|18710628|P1|Overall Study|Withdrawal of consent (not due to AE)|3
5421370|NCT02544451|18710626|P3|Overall Study|Adverse Event|0
5421371|NCT02544451|18710627|P2|Overall Study|Adverse Event|6
5421372|NCT02544451|18710628|P1|Overall Study|Adverse Event|1
5421373|NCT02544217|18710677|P6|Overall Study|Withdrawal by Subject|0
5421374|NCT02544217|18710678|P5|Overall Study|Withdrawal by Subject|0
5421375|NCT02544217|18710679|P4|Overall Study|Withdrawal by Subject|0
5421376|NCT02544217|18710680|P3|Overall Study|Withdrawal by Subject|0
5421377|NCT02544217|18710681|P2|Overall Study|Withdrawal by Subject|1
5421378|NCT02544217|18710682|P1|Overall Study|Withdrawal by Subject|1
5421379|NCT02544152|18711477|P2|Overall Study|Other|0
5421380|NCT02544152|18711478|P1|Overall Study|Other|1
5421381|NCT02544152|18711477|P2|Overall Study|Withdrawal by Subject|3
5421382|NCT02544152|18711478|P1|Overall Study|Withdrawal by Subject|0
5421383|NCT02544152|18711477|P2|Overall Study|Adverse Event|4
5421384|NCT02544152|18711478|P1|Overall Study|Adverse Event|0
5421385|NCT02544074|18711521|P21|Overall Study|Tablet error|0
5421386|NCT02544074|18711522|P20|Overall Study|Tablet error|0
5421387|NCT02544074|18711523|P19|Overall Study|Tablet error|0
5421388|NCT02544074|18711524|P18|Overall Study|Tablet error|0
5421389|NCT02544074|18711525|P17|Overall Study|Tablet error|0
5421390|NCT02544074|18711526|P16|Overall Study|Tablet error|0
5421391|NCT02544074|18711527|P15|Overall Study|Tablet error|0
5421392|NCT02544074|18711528|P14|Overall Study|Tablet error|0
5421393|NCT02544074|18711529|P13|Overall Study|Tablet error|0
5421394|NCT02544074|18711530|P12|Overall Study|Tablet error|0
5421395|NCT02544074|18711531|P11|Overall Study|Tablet error|0
5421396|NCT02544074|18711532|P10|Overall Study|Tablet error|1
5421397|NCT02544074|18711533|P9|Overall Study|Tablet error|0
5421398|NCT02544074|18711534|P8|Overall Study|Tablet error|0
5421399|NCT02544074|18711535|P7|Overall Study|Tablet error|0
5421400|NCT02544074|18711536|P6|Overall Study|Tablet error|1
5421401|NCT02544074|18711537|P5|Overall Study|Tablet error|0
5421402|NCT02544074|18711538|P4|Overall Study|Tablet error|0
5421403|NCT02544074|18711539|P3|Overall Study|Tablet error|0
5421404|NCT02544074|18711540|P2|Overall Study|Tablet error|0
5421405|NCT02544074|18711541|P1|Overall Study|Tablet error|0
5421406|NCT02544074|18711521|P21|Overall Study|Withdrawal by Subject|0
5421407|NCT02544074|18711522|P20|Overall Study|Withdrawal by Subject|0
5421408|NCT02544074|18711523|P19|Overall Study|Withdrawal by Subject|0
5421409|NCT02544074|18711524|P18|Overall Study|Withdrawal by Subject|0
5421410|NCT02544074|18711525|P17|Overall Study|Withdrawal by Subject|0
5421411|NCT02544074|18711526|P16|Overall Study|Withdrawal by Subject|0
5421412|NCT02544074|18711527|P15|Overall Study|Withdrawal by Subject|0
5421413|NCT02544074|18711528|P14|Overall Study|Withdrawal by Subject|0
5421414|NCT02544074|18711529|P13|Overall Study|Withdrawal by Subject|0
5421415|NCT02544074|18711530|P12|Overall Study|Withdrawal by Subject|0
5421416|NCT02544074|18711531|P11|Overall Study|Withdrawal by Subject|0
5421417|NCT02544074|18711532|P10|Overall Study|Withdrawal by Subject|0
5421418|NCT02544074|18711533|P9|Overall Study|Withdrawal by Subject|0
5421419|NCT02544074|18711534|P8|Overall Study|Withdrawal by Subject|0
5421420|NCT02544074|18711535|P7|Overall Study|Withdrawal by Subject|0
5421421|NCT02544074|18711536|P6|Overall Study|Withdrawal by Subject|0
5421422|NCT02544074|18711537|P5|Overall Study|Withdrawal by Subject|0
5421423|NCT02544074|18711538|P4|Overall Study|Withdrawal by Subject|0
5421424|NCT02544074|18711539|P3|Overall Study|Withdrawal by Subject|0
5421425|NCT02544074|18711540|P2|Overall Study|Withdrawal by Subject|1
5421426|NCT02544074|18711541|P1|Overall Study|Withdrawal by Subject|0
5421427|NCT02543918|18711577|P2|Overall Study|Adverse Event|1
5421428|NCT02543918|18711578|P1|Overall Study|Adverse Event|1
5421429|NCT02543918|18711577|P2|Overall Study|Withdrawal by Subject|1
5421430|NCT02543918|18711578|P1|Overall Study|Withdrawal by Subject|1
5421431|NCT02543918|18711577|P2|Overall Study|Lost to Follow-up|1
5421432|NCT02543918|18711578|P1|Overall Study|Lost to Follow-up|1
5421433|NCT02543918|18711577|P2|Overall Study|Never treated|1
5421434|NCT02543918|18711578|P1|Overall Study|Never treated|0
5421435|NCT02543892|18711592|P8|Had Immunology Data|Withdrawal by Subject|0
5421436|NCT02543892|18711593|P7|Had Immunology Data|Withdrawal by Subject|1
5421437|NCT02543892|18711594|P6|Had Immunology Data|Withdrawal by Subject|0
5421438|NCT02543892|18711595|P5|Had Immunology Data|Withdrawal by Subject|0
5421439|NCT02543892|18711596|P4|Had Immunology Data|Withdrawal by Subject|0
5421440|NCT02543892|18711597|P3|Had Immunology Data|Withdrawal by Subject|0
5421441|NCT02543892|18711598|P2|Had Immunology Data|Withdrawal by Subject|0
5421442|NCT02543892|18711599|P1|Had Immunology Data|Withdrawal by Subject|0
5421443|NCT02543892|18711592|P8|Received Vaccination 2|Adverse Event|0
5421444|NCT02543892|18711593|P7|Received Vaccination 2|Adverse Event|0
5421445|NCT02543892|18711594|P6|Received Vaccination 2|Adverse Event|0
5421446|NCT02543892|18711595|P5|Received Vaccination 2|Adverse Event|0
5421447|NCT02543892|18711596|P4|Received Vaccination 2|Adverse Event|0
5421448|NCT02543892|18711597|P3|Received Vaccination 2|Adverse Event|0
5421449|NCT02543892|18711598|P2|Received Vaccination 2|Adverse Event|1
5421450|NCT02543892|18711599|P1|Received Vaccination 2|Adverse Event|0
5421451|NCT02543892|18711592|P8|Received Vaccination 2|Physician Decision|0
5421452|NCT02543892|18711593|P7|Received Vaccination 2|Physician Decision|0
5421453|NCT02543892|18711594|P6|Received Vaccination 2|Physician Decision|1
5421454|NCT02543892|18711595|P5|Received Vaccination 2|Physician Decision|0
5421455|NCT02543892|18711596|P4|Received Vaccination 2|Physician Decision|0
5421456|NCT02543892|18711597|P3|Received Vaccination 2|Physician Decision|0
5421457|NCT02543892|18711598|P2|Received Vaccination 2|Physician Decision|0
5421458|NCT02543892|18711599|P1|Received Vaccination 2|Physician Decision|0
5421459|NCT02543892|18711592|P8|Received Vaccination 2|Withdrawal by Subject|1
5421460|NCT02543892|18711593|P7|Received Vaccination 2|Withdrawal by Subject|0
5421461|NCT02543892|18711594|P6|Received Vaccination 2|Withdrawal by Subject|0
5421462|NCT02543892|18711595|P5|Received Vaccination 2|Withdrawal by Subject|0
5421463|NCT02543892|18711596|P4|Received Vaccination 2|Withdrawal by Subject|0
5421464|NCT02543892|18711597|P3|Received Vaccination 2|Withdrawal by Subject|0
5421465|NCT02543892|18711598|P2|Received Vaccination 2|Withdrawal by Subject|0
5421466|NCT02543892|18711599|P1|Received Vaccination 2|Withdrawal by Subject|1
5421467|NCT02543801|18711666|P4|Overall Study|Protocol Violation|0
5421468|NCT02543801|18711667|P3|Overall Study|Protocol Violation|0
5421469|NCT02543801|18711668|P2|Overall Study|Protocol Violation|2
5421470|NCT02543801|18711669|P1|Overall Study|Protocol Violation|1
5421471|NCT02543658|18711689|P2|Overall Study|Lack of Efficacy|4
5421472|NCT02543658|18711690|P1|Overall Study|Lack of Efficacy|0
5421473|NCT02543528|18711727|P5|Extended Wear Period|Withdrawal by Subject|0
5421474|NCT02543528|18711728|P4|Extended Wear Period|Withdrawal by Subject|5
5421475|NCT02543528|18711729|P3|Extended Wear Period|Withdrawal by Subject|4
5421476|NCT02543528|18711730|P2|Extended Wear Period|Withdrawal by Subject|9
5421477|NCT02543528|18711731|P1|Extended Wear Period|Withdrawal by Subject|10
5421478|NCT02543528|18711727|P5|Extended Wear Period|Lost to Follow-up|0
5421479|NCT02543528|18711728|P4|Extended Wear Period|Lost to Follow-up|1
5421480|NCT02543528|18711729|P3|Extended Wear Period|Lost to Follow-up|2
5421481|NCT02543528|18711730|P2|Extended Wear Period|Lost to Follow-up|1
5421482|NCT02543528|18711731|P1|Extended Wear Period|Lost to Follow-up|0
5421483|NCT02543528|18711727|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
5421484|NCT02543528|18711728|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
5421485|NCT02543528|18711729|P3|Extended Wear Period|Unsatisfactory Lens Fitting|0
5421486|NCT02543528|18711730|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
5421487|NCT02543528|18711731|P1|Extended Wear Period|Unsatisfactory Lens Fitting|1
5421488|NCT02543528|18711727|P5|Extended Wear Period|Missed too many scheduled visits|0
5421489|NCT02543528|18711728|P4|Extended Wear Period|Missed too many scheduled visits|3
5421490|NCT02543528|18711729|P3|Extended Wear Period|Missed too many scheduled visits|1
5421491|NCT02543528|18711730|P2|Extended Wear Period|Missed too many scheduled visits|0
5421492|NCT02543528|18711731|P1|Extended Wear Period|Missed too many scheduled visits|0
5421493|NCT02543528|18711727|P5|Extended Wear Period|Adverse Event|0
5421494|NCT02543528|18711728|P4|Extended Wear Period|Adverse Event|3
5421495|NCT02543528|18711729|P3|Extended Wear Period|Adverse Event|16
5421496|NCT02543528|18711730|P2|Extended Wear Period|Adverse Event|11
5421497|NCT02543528|18711731|P1|Extended Wear Period|Adverse Event|17
5421498|NCT02543528|18711727|P5|Adaptation Period|Adverse Event|2
5421499|NCT02543528|18711728|P4|Adaptation Period|Adverse Event|0
5421500|NCT02543528|18711729|P3|Adaptation Period|Adverse Event|0
5421501|NCT02543528|18711730|P2|Adaptation Period|Adverse Event|0
5421502|NCT02543528|18711731|P1|Adaptation Period|Adverse Event|0
5421503|NCT02543528|18711727|P5|Adaptation Period|Lost to Follow-up|14
5421504|NCT02543528|18711728|P4|Adaptation Period|Lost to Follow-up|0
5421505|NCT02543528|18711729|P3|Adaptation Period|Lost to Follow-up|0
5421506|NCT02543528|18711730|P2|Adaptation Period|Lost to Follow-up|0
5421507|NCT02543528|18711731|P1|Adaptation Period|Lost to Follow-up|0
5421508|NCT02543528|18711727|P5|Adaptation Period|Lens Handling Difficultes|8
5421509|NCT02543528|18711728|P4|Adaptation Period|Lens Handling Difficultes|0
5421510|NCT02543528|18711729|P3|Adaptation Period|Lens Handling Difficultes|0
5421511|NCT02543528|18711730|P2|Adaptation Period|Lens Handling Difficultes|0
5421512|NCT02543528|18711731|P1|Adaptation Period|Lens Handling Difficultes|0
5421513|NCT02543528|18711727|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
5421514|NCT02543528|18711728|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
5421515|NCT02543528|18711729|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
5421516|NCT02543528|18711730|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
5421517|NCT02543528|18711731|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
5421518|NCT02543346|18711764|P4|Second Priming Visit|Adverse Event|0
5421519|NCT02543346|18711765|P3|Second Priming Visit|Adverse Event|0
5421520|NCT02543346|18711766|P2|Second Priming Visit|Adverse Event|0
5421521|NCT02543346|18711767|P1|Second Priming Visit|Adverse Event|1
5421522|NCT02543346|18711764|P4|Second Priming Visit|Withdrawal by Subject|2
5421523|NCT02543346|18711765|P3|Second Priming Visit|Withdrawal by Subject|2
5421524|NCT02543346|18711766|P2|Second Priming Visit|Withdrawal by Subject|2
5421525|NCT02543346|18711767|P1|Second Priming Visit|Withdrawal by Subject|0
5421526|NCT02543294|18711793|P1|Overall Study|Withdrawal by Subject|7
5421527|NCT02543294|18711793|P1|Overall Study|Physician Decision|2
5421528|NCT02543294|18711793|P1|Overall Study|Lost to Follow-up|3
5421529|NCT02542943|18711801|P3|Overall Study|Withdrawal by Subject|0
5421530|NCT02542943|18711802|P2|Overall Study|Withdrawal by Subject|1
5421531|NCT02542943|18711803|P1|Overall Study|Withdrawal by Subject|0
5421532|NCT02542943|18711801|P3|Overall Study|Lost to Follow-up|0
5421533|NCT02542943|18711802|P2|Overall Study|Lost to Follow-up|0
5421534|NCT02542943|18711803|P1|Overall Study|Lost to Follow-up|1
5421535|NCT02542865|18711830|P2|Overall Study|Withdrawal by Subject|0
5421536|NCT02542865|18711831|P1|Overall Study|Withdrawal by Subject|16
5421537|NCT02542865|18711830|P2|Overall Study|Identified as screen failure|0
5421538|NCT02542865|18711831|P1|Overall Study|Identified as screen failure|1
5421539|NCT02542631|18711894|P2|Overall Study|Used Prohibited Medication|1
5421540|NCT02542631|18711895|P1|Overall Study|Used Prohibited Medication|2
5421541|NCT02542631|18711894|P2|Overall Study|Other|1
5421542|NCT02542631|18711895|P1|Overall Study|Other|2
5421543|NCT02542631|18711894|P2|Overall Study|Death|2
5421544|NCT02542631|18711895|P1|Overall Study|Death|1
5421545|NCT02542631|18711894|P2|Overall Study|Lost to Follow-up|5
5421546|NCT02542631|18711895|P1|Overall Study|Lost to Follow-up|6
5421547|NCT02542631|18711894|P2|Overall Study|Physician Decision|4
5421548|NCT02542631|18711895|P1|Overall Study|Physician Decision|6
5421549|NCT02542631|18711894|P2|Overall Study|Protocol Violation|1
5421550|NCT02542631|18711895|P1|Overall Study|Protocol Violation|1
5421551|NCT02542631|18711894|P2|Overall Study|Withdrawal by Subject|16
5421552|NCT02542631|18711895|P1|Overall Study|Withdrawal by Subject|11
5421553|NCT02542631|18711894|P2|Overall Study|Sponsor Termination|0
5421554|NCT02542631|18711895|P1|Overall Study|Sponsor Termination|1
5421555|NCT02542631|18711894|P2|Overall Study|Adverse Event|1
5421556|NCT02542631|18711895|P1|Overall Study|Adverse Event|1
5421557|NCT02542605|18711917|P3|Part B: Randomization Phase|Withdrawal by Subject|1
5421558|NCT02542605|18711918|P2|Part B: Randomization Phase|Withdrawal by Subject|0
5421559|NCT02542605|18711919|P1|Part B: Randomization Phase|Withdrawal by Subject|0
5421560|NCT02542605|18711917|P3|Part B: Challenge Phase|Sponsor decision|0
5421561|NCT02542605|18711918|P2|Part B: Challenge Phase|Sponsor decision|0
5421562|NCT02542605|18711919|P1|Part B: Challenge Phase|Sponsor decision|1
5421563|NCT02542267|18712007|P1|Overall Study|Other|5
5421564|NCT02542267|18712007|P1|Overall Study|Surgical Bypass of All Study Devices|12
5421565|NCT02542267|18712007|P1|Overall Study|Death|12
5421566|NCT02542267|18712007|P1|Overall Study|Lost to Follow-up|4
5421567|NCT02542267|18712007|P1|Overall Study|Physician Decision|5
5421568|NCT02542267|18712007|P1|Overall Study|Withdrawal by Subject|8
5421569|NCT02542267|18712007|P1|Overall Study|Ongoing|31
5421570|NCT02542072|18712015|P2|Second Intervention (1 Month)|Lens discomfort|0
5421571|NCT02542072|18712016|P1|Second Intervention (1 Month)|Lens discomfort|1
5421572|NCT02542072|18712015|P2|Second Intervention (1 Month)|Lost to Follow-up|0
5421573|NCT02542072|18712016|P1|Second Intervention (1 Month)|Lost to Follow-up|1
5421574|NCT02542072|18712015|P2|First Intervention (1 Month)|Protocol Violation|0
5421575|NCT02542072|18712016|P1|First Intervention (1 Month)|Protocol Violation|1
5421576|NCT02542072|18712015|P2|First Intervention (1 Month)|Lens discomfort|2
5421577|NCT02542072|18712016|P1|First Intervention (1 Month)|Lens discomfort|1
5421578|NCT02542072|18712015|P2|First Intervention (1 Month)|Lost to Follow-up|0
5421579|NCT02542072|18712016|P1|First Intervention (1 Month)|Lost to Follow-up|2
5421580|NCT02542072|18712015|P2|First Intervention (1 Month)|Adverse Event|1
5421581|NCT02542072|18712016|P1|First Intervention (1 Month)|Adverse Event|1
5421582|NCT02541903|18712140|P1|Overall Study|Death|1
5421583|NCT02541669|18712171|P5|Double-Blinded Treatment Period|Withdrawal by Subject|1
5421584|NCT02541669|18712172|P4|Double-Blinded Treatment Period|Withdrawal by Subject|0
5421585|NCT02541669|18712173|P3|Double-Blinded Treatment Period|Withdrawal by Subject|1
5421586|NCT02541669|18712174|P2|Double-Blinded Treatment Period|Withdrawal by Subject|0
5421587|NCT02541669|18712175|P1|Double-Blinded Treatment Period|Withdrawal by Subject|0
5421588|NCT02541604|18712222|P12|Overall Study|Medical condition may jeopardize safety|0
5421589|NCT02541604|18712223|P11|Overall Study|Medical condition may jeopardize safety|0
5421590|NCT02541604|18712224|P10|Overall Study|Medical condition may jeopardize safety|0
5421591|NCT02541604|18712225|P9|Overall Study|Medical condition may jeopardize safety|0
5421592|NCT02541604|18712226|P8|Overall Study|Medical condition may jeopardize safety|1
5421593|NCT02541604|18712227|P7|Overall Study|Medical condition may jeopardize safety|0
5421594|NCT02541604|18712228|P6|Overall Study|Medical condition may jeopardize safety|0
5421595|NCT02541604|18712229|P5|Overall Study|Medical condition may jeopardize safety|0
5421596|NCT02541604|18712230|P4|Overall Study|Medical condition may jeopardize safety|0
5421597|NCT02541604|18712231|P3|Overall Study|Medical condition may jeopardize safety|0
5421598|NCT02541604|18712232|P2|Overall Study|Medical condition may jeopardize safety|0
5421599|NCT02541604|18712233|P1|Overall Study|Medical condition may jeopardize safety|0
5421600|NCT02541604|18712222|P12|Overall Study|Study Terminated by Sponsor|0
5421601|NCT02541604|18712223|P11|Overall Study|Study Terminated by Sponsor|0
5421602|NCT02541604|18712224|P10|Overall Study|Study Terminated by Sponsor|0
5421603|NCT02541604|18712225|P9|Overall Study|Study Terminated by Sponsor|0
5421604|NCT02541604|18712226|P8|Overall Study|Study Terminated by Sponsor|0
5421605|NCT02541604|18712227|P7|Overall Study|Study Terminated by Sponsor|0
5421606|NCT02541604|18712228|P6|Overall Study|Study Terminated by Sponsor|0
5421607|NCT02541604|18712229|P5|Overall Study|Study Terminated by Sponsor|0
5421608|NCT02541604|18712230|P4|Overall Study|Study Terminated by Sponsor|1
5421609|NCT02541604|18712231|P3|Overall Study|Study Terminated by Sponsor|2
5421610|NCT02541604|18712232|P2|Overall Study|Study Terminated by Sponsor|4
5421611|NCT02541604|18712233|P1|Overall Study|Study Terminated by Sponsor|1
5421612|NCT02541604|18712222|P12|Overall Study|Withdrawal by Subject|0
5421613|NCT02541604|18712223|P11|Overall Study|Withdrawal by Subject|0
5421614|NCT02541604|18712224|P10|Overall Study|Withdrawal by Subject|0
5421615|NCT02541604|18712225|P9|Overall Study|Withdrawal by Subject|1
5421616|NCT02541604|18712226|P8|Overall Study|Withdrawal by Subject|0
5421617|NCT02541604|18712227|P7|Overall Study|Withdrawal by Subject|0
5421618|NCT02541604|18712228|P6|Overall Study|Withdrawal by Subject|1
5421619|NCT02541604|18712229|P5|Overall Study|Withdrawal by Subject|1
5421620|NCT02541604|18712230|P4|Overall Study|Withdrawal by Subject|0
5421621|NCT02541604|18712231|P3|Overall Study|Withdrawal by Subject|1
5421622|NCT02541604|18712232|P2|Overall Study|Withdrawal by Subject|0
5421623|NCT02541604|18712233|P1|Overall Study|Withdrawal by Subject|2
5421624|NCT02541604|18712222|P12|Overall Study|Lost to Follow-up|0
5421625|NCT02541604|18712223|P11|Overall Study|Lost to Follow-up|0
5421626|NCT02541604|18712224|P10|Overall Study|Lost to Follow-up|0
5421627|NCT02541604|18712225|P9|Overall Study|Lost to Follow-up|0
5421628|NCT02541604|18712226|P8|Overall Study|Lost to Follow-up|0
5421629|NCT02541604|18712227|P7|Overall Study|Lost to Follow-up|1
5421630|NCT02541604|18712228|P6|Overall Study|Lost to Follow-up|1
5421631|NCT02541604|18712229|P5|Overall Study|Lost to Follow-up|0
5421632|NCT02541604|18712230|P4|Overall Study|Lost to Follow-up|0
5421633|NCT02541604|18712231|P3|Overall Study|Lost to Follow-up|1
5421634|NCT02541604|18712232|P2|Overall Study|Lost to Follow-up|0
5421635|NCT02541604|18712233|P1|Overall Study|Lost to Follow-up|2
5421636|NCT02541604|18712222|P12|Overall Study|Death|3
5421637|NCT02541604|18712223|P11|Overall Study|Death|2
5421638|NCT02541604|18712224|P10|Overall Study|Death|4
5421639|NCT02541604|18712225|P9|Overall Study|Death|3
5421640|NCT02541604|18712226|P8|Overall Study|Death|9
5421641|NCT02541604|18712227|P7|Overall Study|Death|9
5421642|NCT02541604|18712228|P6|Overall Study|Death|8
5421643|NCT02541604|18712229|P5|Overall Study|Death|9
5421644|NCT02541604|18712230|P4|Overall Study|Death|2
5421645|NCT02541604|18712231|P3|Overall Study|Death|7
5421646|NCT02541604|18712232|P2|Overall Study|Death|5
5421647|NCT02541604|18712233|P1|Overall Study|Death|6
5421648|NCT02540850|18712352|P3|Overall Study|Lost to Follow-up|34
5421649|NCT02540850|18712353|P2|Overall Study|Lost to Follow-up|66
5421650|NCT02540850|18712354|P1|Overall Study|Lost to Follow-up|69
5421651|NCT02540668|18712395|P2|Period 2 - LY3314814 and Warfarin|Physician Decision|1
5421652|NCT02540668|18712396|P1|Period 2 - LY3314814 and Warfarin|Physician Decision|0
5421653|NCT02540538|18712427|P3|Overall Study|Pregnancy|0
5421654|NCT02540538|18712428|P2|Overall Study|Pregnancy|1
5421655|NCT02540538|18712429|P1|Overall Study|Pregnancy|0
5421656|NCT02540356|18712497|P2|Overall Study|Terminated due to disease progression|0
5421657|NCT02540356|18712498|P1|Overall Study|Terminated due to disease progression|1
5421658|NCT02540291|18712533|P4|Overall Study|Other|0
5421659|NCT02540291|18712534|P3|Overall Study|Other|1
5421660|NCT02540291|18712535|P2|Overall Study|Other|0
5421661|NCT02540291|18712536|P1|Overall Study|Other|0
5421662|NCT02540291|18712533|P4|Overall Study|Study Terminated By Sponsor|0
5421663|NCT02540291|18712534|P3|Overall Study|Study Terminated By Sponsor|0
5421664|NCT02540291|18712535|P2|Overall Study|Study Terminated By Sponsor|0
5421665|NCT02540291|18712536|P1|Overall Study|Study Terminated By Sponsor|1
5421666|NCT02540291|18712533|P4|Overall Study|Withdrawal Of Consent|0
5421667|NCT02540291|18712534|P3|Overall Study|Withdrawal Of Consent|0
5421668|NCT02540291|18712535|P2|Overall Study|Withdrawal Of Consent|1
5421669|NCT02540291|18712536|P1|Overall Study|Withdrawal Of Consent|0
5421670|NCT02540291|18712533|P4|Overall Study|Lost to Follow-up|0
5421671|NCT02540291|18712534|P3|Overall Study|Lost to Follow-up|1
5421672|NCT02540291|18712535|P2|Overall Study|Lost to Follow-up|0
5421673|NCT02540291|18712536|P1|Overall Study|Lost to Follow-up|0
5421674|NCT02540291|18712533|P4|Overall Study|Death|7
5421675|NCT02540291|18712534|P3|Overall Study|Death|5
5421676|NCT02540291|18712535|P2|Overall Study|Death|7
5421677|NCT02540291|18712536|P1|Overall Study|Death|7
5421678|NCT02540265|18712571|P3|Overall Study|Lost to Follow-up|1
5421679|NCT02540265|18712572|P2|Overall Study|Lost to Follow-up|0
5421680|NCT02540265|18712573|P1|Overall Study|Lost to Follow-up|0
5421681|NCT02540213|18712628|P1|Overall Study|Enrolled but not treated|2
5421682|NCT02540213|18712628|P1|Overall Study|Consent withdrawn|7
5421683|NCT02540213|18712628|P1|Overall Study|Lack of Efficacy|6
5421684|NCT02540213|18712628|P1|Overall Study|Kidney transplant|3
5421685|NCT02540213|18712628|P1|Overall Study|Administrative reasons|3
5421686|NCT02540213|18712628|P1|Overall Study|Death/adverse event|18
5421687|NCT02540083|18712682|P1|Overall Study|Withdrawal by Subject|16
5421688|NCT02539797|18712723|P3|Overall Study|Lost to Follow-up|0
5421689|NCT02539797|18712724|P2|Overall Study|Lost to Follow-up|1
5421690|NCT02539797|18712725|P1|Overall Study|Lost to Follow-up|0
5421691|NCT02539368|18712777|P5|Overall Study|Missing|0
5421692|NCT02539368|18712778|P4|Overall Study|Missing|0
5421693|NCT02539368|18712779|P3|Overall Study|Missing|0
5421694|NCT02539368|18712780|P2|Overall Study|Missing|3
5421695|NCT02539368|18712781|P1|Overall Study|Missing|10
5421696|NCT02539368|18712777|P5|Overall Study|Other|3
5421697|NCT02539368|18712778|P4|Overall Study|Other|1
5421698|NCT02539368|18712779|P3|Overall Study|Other|24
5421699|NCT02539368|18712780|P2|Overall Study|Other|18
5421700|NCT02539368|18712781|P1|Overall Study|Other|145
5421701|NCT02539368|18712777|P5|Overall Study|Participant Non-compliant|0
5421702|NCT02539368|18712778|P4|Overall Study|Participant Non-compliant|1
5421703|NCT02539368|18712779|P3|Overall Study|Participant Non-compliant|1
5421704|NCT02539368|18712780|P2|Overall Study|Participant Non-compliant|2
5421705|NCT02539368|18712781|P1|Overall Study|Participant Non-compliant|13
5421706|NCT02539368|18712777|P5|Overall Study|Adverse Event|3
5421707|NCT02539368|18712778|P4|Overall Study|Adverse Event|0
5421708|NCT02539368|18712779|P3|Overall Study|Adverse Event|9
5421709|NCT02539368|18712780|P2|Overall Study|Adverse Event|5
5421710|NCT02539368|18712781|P1|Overall Study|Adverse Event|44
5421711|NCT02539368|18712777|P5|Overall Study|Lost to Follow-up|3
5421712|NCT02539368|18712778|P4|Overall Study|Lost to Follow-up|4
5421713|NCT02539368|18712779|P3|Overall Study|Lost to Follow-up|16
5421714|NCT02539368|18712780|P2|Overall Study|Lost to Follow-up|21
5421715|NCT02539368|18712781|P1|Overall Study|Lost to Follow-up|96
5421716|NCT02539368|18712777|P5|Overall Study|Physician Decision|2
5421717|NCT02539368|18712778|P4|Overall Study|Physician Decision|0
5421718|NCT02539368|18712779|P3|Overall Study|Physician Decision|7
5421719|NCT02539368|18712780|P2|Overall Study|Physician Decision|15
5421720|NCT02539368|18712781|P1|Overall Study|Physician Decision|49
5421721|NCT02539368|18712777|P5|Overall Study|Withdrawal by Subject|3
5421722|NCT02539368|18712778|P4|Overall Study|Withdrawal by Subject|1
5421723|NCT02539368|18712779|P3|Overall Study|Withdrawal by Subject|9
5421724|NCT02539368|18712780|P2|Overall Study|Withdrawal by Subject|35
5421725|NCT02539368|18712781|P1|Overall Study|Withdrawal by Subject|44
5421726|NCT02539368|18712777|P5|Overall Study|Death|0
5421727|NCT02539368|18712778|P4|Overall Study|Death|0
5421728|NCT02539368|18712779|P3|Overall Study|Death|1
5421729|NCT02539368|18712780|P2|Overall Study|Death|2
5421730|NCT02539368|18712781|P1|Overall Study|Death|4
5421731|NCT02539225|18712914|P2|Part B|Physician Decision|9
5421732|NCT02539225|18712915|P1|Part B|Physician Decision|0
5421733|NCT02539225|18712914|P2|Part B|Withdrawal by Subject|3
5421734|NCT02539225|18712915|P1|Part B|Withdrawal by Subject|0
5421735|NCT02539225|18712914|P2|Part B|Adverse Event|4
5421736|NCT02539225|18712915|P1|Part B|Adverse Event|4
5421737|NCT02539225|18712914|P2|Pre Treatment for Part B|Physician Decision|0
5421738|NCT02539225|18712915|P1|Pre Treatment for Part B|Physician Decision|2
5421739|NCT02539225|18712914|P2|Pre Treatment for Part B|Withdrawal by Subject|0
5421740|NCT02539225|18712915|P1|Pre Treatment for Part B|Withdrawal by Subject|1
5421741|NCT02539225|18712914|P2|Pre Treatment for Part B|Adverse Event|1
5421742|NCT02539225|18712915|P1|Pre Treatment for Part B|Adverse Event|1
5421743|NCT02539225|18712914|P2|Pre Treatment for Part B|Progressive disease|1
5421744|NCT02539225|18712915|P1|Pre Treatment for Part B|Progressive disease|1
5421745|NCT02539225|18712914|P2|Part A|Did Not Receive study Drug|1
5421746|NCT02539225|18712915|P1|Part A|Did Not Receive study Drug|1
5421747|NCT02539225|18712914|P2|Part A|Physician Decision|7
5421748|NCT02539225|18712915|P1|Part A|Physician Decision|4
5421749|NCT02539225|18712914|P2|Part A|Withdrawal by Subject|4
5421750|NCT02539225|18712915|P1|Part A|Withdrawal by Subject|2
5421751|NCT02539225|18712914|P2|Part A|Adverse Event|4
5421752|NCT02539225|18712915|P1|Part A|Adverse Event|13
5421753|NCT02539134|18712942|P6|Overall Study|Lost to Follow-up|0
5421754|NCT02539134|18712943|P5|Overall Study|Lost to Follow-up|0
5421755|NCT02539134|18712944|P4|Overall Study|Lost to Follow-up|0
5421756|NCT02539134|18712945|P3|Overall Study|Lost to Follow-up|0
5421757|NCT02539134|18712946|P2|Overall Study|Lost to Follow-up|0
5421758|NCT02539134|18712947|P1|Overall Study|Lost to Follow-up|1
5421759|NCT02538965|18713016|P1|Follow-Up Period|Withdrawal by Parent|4
5421760|NCT02538965|18713016|P1|Follow-Up Period|Other = Death due to disease progression|13
5421761|NCT02538965|18713016|P1|Treatment Period|Physician Decision|2
5421762|NCT02538965|18713016|P1|Treatment Period|Disease Progression|1
5421763|NCT02538965|18713016|P1|Treatment Period|Treatment Failure|9
5421764|NCT02538965|18713016|P1|Treatment Period|Withdrawal by Parent/Guardian|2
5421765|NCT02538965|18713016|P1|Treatment Period|Adverse Event|2
5421766|NCT02538965|18713016|P1|Treatment Period|Other = Death due to disease progression|1
5421767|NCT02538666|18713062|P3|Overall Study|Withdrew Consent|1
5421768|NCT02538666|18713063|P2|Overall Study|Withdrew Consent|1
5421769|NCT02538666|18713064|P1|Overall Study|Withdrew Consent|0
5421770|NCT02538666|18713062|P3|Overall Study|no longer meets study criteria|0
5421771|NCT02538666|18713063|P2|Overall Study|no longer meets study criteria|0
5421772|NCT02538666|18713064|P1|Overall Study|no longer meets study criteria|1
5421773|NCT02538666|18713062|P3|Overall Study|Disease progression|0
5421774|NCT02538666|18713063|P2|Overall Study|Disease progression|0
5421775|NCT02538666|18713064|P1|Overall Study|Disease progression|1
5421776|NCT02538614|18713083|P1|Overall Study|Progressive Disease|2
5421777|NCT02538471|18713123|P1|Overall Study|Progression of disease|2
5421778|NCT02538107|18713159|P1|Overall Study|Not recorded|7
5421779|NCT02538107|18713159|P1|Overall Study|Other|7
5421780|NCT02538107|18713159|P1|Overall Study|Surgery|1
5421781|NCT02538107|18713159|P1|Overall Study|Adverse Event|4
5421782|NCT02538107|18713159|P1|Overall Study|Administrative reason|5
5421783|NCT02538107|18713159|P1|Overall Study|Death|4
5421784|NCT02538107|18713159|P1|Overall Study|Withdrawal by Subject|17
5421785|NCT02538107|18713159|P1|Overall Study|No further treatment necessary|18
5421786|NCT02538107|18713159|P1|Overall Study|Administration of other ESA|11
5421787|NCT02538107|18713159|P1|Overall Study|Necessity of dialysis|20
5421788|NCT02538107|18713159|P1|Overall Study|Missing|5
5421789|NCT02538107|18713159|P1|Overall Study|Did not receive any Mircera dose|11
5421790|NCT02538094|18713179|P2|Washout (4 Weeks)|Withdrawal by Subject|1
5421791|NCT02538094|18713180|P1|Washout (4 Weeks)|Withdrawal by Subject|0
5421792|NCT02538094|18713179|P2|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
5421793|NCT02538094|18713180|P1|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
5421794|NCT02538029|18713210|P3|Overall Study|unable to complete cognitive assessments|1
5421795|NCT02538029|18713211|P2|Overall Study|unable to complete cognitive assessments|0
5421796|NCT02538029|18713212|P1|Overall Study|unable to complete cognitive assessments|1
5421797|NCT02537574|18713303|P3|Overall Study|Noncompliance with Protocol|1
5421798|NCT02537574|18713304|P2|Overall Study|Noncompliance with Protocol|0
5421799|NCT02537574|18713305|P1|Overall Study|Noncompliance with Protocol|0
5421800|NCT02537574|18713303|P3|Overall Study|Subject did not want last Vivitrol Injec|1
5421801|NCT02537574|18713304|P2|Overall Study|Subject did not want last Vivitrol Injec|0
5421802|NCT02537574|18713305|P1|Overall Study|Subject did not want last Vivitrol Injec|0
5421803|NCT02537574|18713303|P3|Overall Study|Transportation Issues|1
5421804|NCT02537574|18713304|P2|Overall Study|Transportation Issues|0
5421805|NCT02537574|18713305|P1|Overall Study|Transportation Issues|0
5421806|NCT02537574|18713303|P3|Overall Study|Failed Naloxone Challenge|0
5421807|NCT02537574|18713304|P2|Overall Study|Failed Naloxone Challenge|1
5421808|NCT02537574|18713305|P1|Overall Study|Failed Naloxone Challenge|0
5421809|NCT02537574|18713303|P3|Overall Study|Incarceration|0
5421810|NCT02537574|18713304|P2|Overall Study|Incarceration|1
5421811|NCT02537574|18713305|P1|Overall Study|Incarceration|0
5421812|NCT02537574|18713303|P3|Overall Study|Patient not Stable|0
5421813|NCT02537574|18713304|P2|Overall Study|Patient not Stable|1
5421814|NCT02537574|18713305|P1|Overall Study|Patient not Stable|0
5421815|NCT02537574|18713303|P3|Overall Study|Duplicate Patient|0
5421816|NCT02537574|18713304|P2|Overall Study|Duplicate Patient|0
5421817|NCT02537574|18713305|P1|Overall Study|Duplicate Patient|1
5421818|NCT02537574|18713303|P3|Overall Study|Lack of Efficacy|15
5421819|NCT02537574|18713304|P2|Overall Study|Lack of Efficacy|16
5421820|NCT02537574|18713305|P1|Overall Study|Lack of Efficacy|14
5421821|NCT02537574|18713303|P3|Overall Study|Withdrawal by Subject|29
5421822|NCT02537574|18713304|P2|Overall Study|Withdrawal by Subject|27
5421823|NCT02537574|18713305|P1|Overall Study|Withdrawal by Subject|37
5421824|NCT02537574|18713303|P3|Overall Study|Protocol Violation|3
5421825|NCT02537574|18713304|P2|Overall Study|Protocol Violation|2
5421826|NCT02537574|18713305|P1|Overall Study|Protocol Violation|4
5421827|NCT02537574|18713303|P3|Overall Study|Physician Decision|0
5421828|NCT02537574|18713304|P2|Overall Study|Physician Decision|0
5421829|NCT02537574|18713305|P1|Overall Study|Physician Decision|2
5421830|NCT02537574|18713303|P3|Overall Study|Noncompliance with study drug|1
5421831|NCT02537574|18713304|P2|Overall Study|Noncompliance with study drug|1
5421832|NCT02537574|18713305|P1|Overall Study|Noncompliance with study drug|0
5421833|NCT02537574|18713303|P3|Overall Study|Lost to Follow-up|55
5421834|NCT02537574|18713304|P2|Overall Study|Lost to Follow-up|51
5421835|NCT02537574|18713305|P1|Overall Study|Lost to Follow-up|40
5421836|NCT02537574|18713303|P3|Overall Study|Adverse Event|2
5421837|NCT02537574|18713304|P2|Overall Study|Adverse Event|3
5421838|NCT02537574|18713305|P1|Overall Study|Adverse Event|1
5421839|NCT02537522|18713331|P4|Phase II - Period 1 Bilateral|Adverse Event|1
5421840|NCT02537522|18713332|P3|Phase II - Period 1 Bilateral|Adverse Event|0
5421841|NCT02537522|18713333|P2|Phase II - Period 1 Bilateral|Adverse Event|0
5421842|NCT02537522|18713334|P1|Phase II - Period 1 Bilateral|Adverse Event|0
5421843|NCT02537522|18713331|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
5421844|NCT02537522|18713332|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
5421845|NCT02537522|18713333|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
5421846|NCT02537522|18713334|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
5421847|NCT02537522|18713331|P4|Phase I - Contralateral|incorrect randomization|0
5421848|NCT02537522|18713332|P3|Phase I - Contralateral|incorrect randomization|0
5421849|NCT02537522|18713333|P2|Phase I - Contralateral|incorrect randomization|1
5421850|NCT02537522|18713334|P1|Phase I - Contralateral|incorrect randomization|0
5421851|NCT02537522|18713331|P4|Phase I - Contralateral|Withdrawal by Subject|0
5421852|NCT02537522|18713332|P3|Phase I - Contralateral|Withdrawal by Subject|0
5421853|NCT02537522|18713333|P2|Phase I - Contralateral|Withdrawal by Subject|1
5421854|NCT02537522|18713334|P1|Phase I - Contralateral|Withdrawal by Subject|0
5421855|NCT02537522|18713331|P4|Phase I - Contralateral|Subject no longer eligible|0
5421856|NCT02537522|18713332|P3|Phase I - Contralateral|Subject no longer eligible|0
5421857|NCT02537522|18713333|P2|Phase I - Contralateral|Subject no longer eligible|7
5421858|NCT02537522|18713334|P1|Phase I - Contralateral|Subject no longer eligible|15
5421859|NCT02537431|18713351|P1|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
5421860|NCT02537015|18713380|P1|Overall Study|Other Miscellaneous Reasons|1
5421861|NCT02537015|18713380|P1|Overall Study|Withdrawal by Subject|2
5421862|NCT02537015|18713380|P1|Overall Study|Adverse Event|3
5421863|NCT02536976|18713386|P2|Overall Study|Physician Decision|1
5421864|NCT02536976|18713387|P1|Overall Study|Physician Decision|0
5421865|NCT02536963|18713397|P1|Overall Study|Withdrawal by Subject|18
5421866|NCT02536833|18713405|P4|Overall Study|Withdrawal by Subject|11
5421867|NCT02536833|18713406|P3|Overall Study|Withdrawal by Subject|5
5421868|NCT02536833|18713407|P2|Overall Study|Withdrawal by Subject|3
5421869|NCT02536833|18713408|P1|Overall Study|Withdrawal by Subject|4
5421870|NCT02536833|18713405|P4|Overall Study|Subject Non-Compliance|0
5421871|NCT02536833|18713406|P3|Overall Study|Subject Non-Compliance|1
5421872|NCT02536833|18713407|P2|Overall Study|Subject Non-Compliance|1
5421873|NCT02536833|18713408|P1|Overall Study|Subject Non-Compliance|0
5421874|NCT02536833|18713405|P4|Overall Study|Site Terminated by Sponsor|2
5421875|NCT02536833|18713406|P3|Overall Study|Site Terminated by Sponsor|2
5421876|NCT02536833|18713407|P2|Overall Study|Site Terminated by Sponsor|2
5421877|NCT02536833|18713408|P1|Overall Study|Site Terminated by Sponsor|2
5421878|NCT02536833|18713405|P4|Overall Study|Physician Decision|1
5421879|NCT02536833|18713406|P3|Overall Study|Physician Decision|0
5421880|NCT02536833|18713407|P2|Overall Study|Physician Decision|0
5421881|NCT02536833|18713408|P1|Overall Study|Physician Decision|0
5421882|NCT02536833|18713405|P4|Overall Study|Lost to Follow-up|2
5421883|NCT02536833|18713406|P3|Overall Study|Lost to Follow-up|2
5421884|NCT02536833|18713407|P2|Overall Study|Lost to Follow-up|1
5421885|NCT02536833|18713408|P1|Overall Study|Lost to Follow-up|2
5421886|NCT02536833|18713405|P4|Overall Study|Adverse Event|1
5421887|NCT02536833|18713406|P3|Overall Study|Adverse Event|4
5421888|NCT02536833|18713407|P2|Overall Study|Adverse Event|3
5421889|NCT02536833|18713408|P1|Overall Study|Adverse Event|1
5421890|NCT02536833|18713405|P4|Overall Study|Discontinued Before Treatment|2
5421891|NCT02536833|18713406|P3|Overall Study|Discontinued Before Treatment|1
5421892|NCT02536833|18713407|P2|Overall Study|Discontinued Before Treatment|0
5421893|NCT02536833|18713408|P1|Overall Study|Discontinued Before Treatment|0
5421894|NCT02536781|18713469|P2|Overall Study|Lost to Follow-up|0
5421895|NCT02536781|18713470|P1|Overall Study|Lost to Follow-up|2
5421896|NCT02536664|18713480|P2|Overall Study|Missing|20
5421897|NCT02536664|18713481|P1|Overall Study|Missing|53
5421898|NCT02536664|18713480|P2|Overall Study|Other|24
5421899|NCT02536664|18713481|P1|Overall Study|Other|18
5421900|NCT02536664|18713480|P2|Overall Study|Withdrawal by Subject|5
5421901|NCT02536664|18713481|P1|Overall Study|Withdrawal by Subject|8
5421902|NCT02536664|18713480|P2|Overall Study|Intolerability|6
5421903|NCT02536664|18713481|P1|Overall Study|Intolerability|8
5421904|NCT02536664|18713480|P2|Overall Study|Death due to other reason|2
5421905|NCT02536664|18713481|P1|Overall Study|Death due to other reason|3
5421906|NCT02536664|18713480|P2|Overall Study|Death due to lymphoma|1
5421907|NCT02536664|18713481|P1|Overall Study|Death due to lymphoma|2
5421908|NCT02536664|18713480|P2|Overall Study|Progression|18
5421909|NCT02536664|18713481|P1|Overall Study|Progression|13
5421910|NCT02536664|18713480|P2|Overall Study|Inadequate completion of documentation|4
5421911|NCT02536664|18713481|P1|Overall Study|Inadequate completion of documentation|2
5421912|NCT02536378|18713501|P2|Overall Study|Patient refused further follow up|2
5421913|NCT02536378|18713502|P1|Overall Study|Patient refused further follow up|6
5421914|NCT02536378|18713501|P2|Overall Study|Death|2
5421915|NCT02536378|18713502|P1|Overall Study|Death|1
5421916|NCT02536378|18713501|P2|Overall Study|Withdrawal by Subject|1
5421917|NCT02536378|18713502|P1|Overall Study|Withdrawal by Subject|0
5421918|NCT02536378|18713501|P2|Overall Study|Physician Decision|2
5421919|NCT02536378|18713502|P1|Overall Study|Physician Decision|0
5421920|NCT02536339|18713516|P1|Overall Study|Death|20
5421921|NCT02536339|18713516|P1|Overall Study|Withdrawal by Subject|3
5421922|NCT02536339|18713516|P1|Overall Study|Lost to Follow-up|2
5421923|NCT02536339|18713516|P1|Overall Study|Treatment Ongoing|2
5421924|NCT02536339|18713516|P1|Overall Study|In Survival Follow-Up|4
5421925|NCT02536313|18713542|P2|Overall Study|Lack of Efficacy|1
5421926|NCT02536313|18713543|P1|Overall Study|Lack of Efficacy|0
5421927|NCT02535741|18713612|P1|Overall Study|Missing data|6
5421928|NCT02535741|18713612|P1|Overall Study|Exclusion criteria: Bilateral implant|4
5421929|NCT02535741|18713612|P1|Overall Study|Lost to Follow-up|10
5421930|NCT02535741|18713612|P1|Overall Study|Withdrawal by Subject|9
5421931|NCT02535741|18713612|P1|Overall Study|Adverse Event|3
5421932|NCT02535715|18713620|P3|Overall Study|Withdrawal by Subject|1
5421933|NCT02535715|18713621|P2|Overall Study|Withdrawal by Subject|0
5421934|NCT02535715|18713622|P1|Overall Study|Withdrawal by Subject|0
5421935|NCT02535416|18713685|P9|Overall Study|Family bereavement overseas|0
5421936|NCT02535416|18713686|P8|Overall Study|Family bereavement overseas|0
5421937|NCT02535416|18713687|P7|Overall Study|Family bereavement overseas|0
5421938|NCT02535416|18713688|P6|Overall Study|Family bereavement overseas|0
5421939|NCT02535416|18713689|P5|Overall Study|Family bereavement overseas|0
5421940|NCT02535416|18713690|P4|Overall Study|Family bereavement overseas|0
5421941|NCT02535416|18713691|P3|Overall Study|Family bereavement overseas|0
5421942|NCT02535416|18713692|P2|Overall Study|Family bereavement overseas|0
5421943|NCT02535416|18713693|P1|Overall Study|Family bereavement overseas|1
5421944|NCT02535364|18713745|P1|12-Month Follow-up Period|Subject transferred to hospice|1
5421945|NCT02535364|18713745|P1|12-Month Follow-up Period|Subject received alternative therapy|2
5421946|NCT02535364|18713745|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
5421947|NCT02535364|18713745|P1|12-Month Follow-up Period|Death|5
5421948|NCT02535364|18713745|P1|12-Month Follow-up Period|Disease progression|22
5421949|NCT02535364|18713745|P1|Study Treatment|Study placed on clinical hold by FDA|1
5421950|NCT02535364|18713745|P1|Study Treatment|Death|1
5421951|NCT02535364|18713745|P1|Part B Screening|Change in diagnosis, no longer eligible|2
5421952|NCT02535364|18713745|P1|Part B Screening|Adverse Event|1
5421953|NCT02535364|18713745|P1|Part B Screening|Withdrawal by Subject|1
5421954|NCT02535364|18713745|P1|Part B Screening|Physician Decision|1
5421955|NCT02535364|18713745|P1|Part B Screening|Death|2
5421956|NCT02535364|18713745|P1|Part B Screening|Unable to manufacture JCAR015|3
5421957|NCT02535364|18713745|P1|Part B Screening|Study placed on clinical hold by FDA|7
5421958|NCT02535364|18713745|P1|Part A Screening Through Leukapheresis|Disease progression|1
5421959|NCT02535364|18713745|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
5421960|NCT02535364|18713745|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
5421961|NCT02535000|18713829|P2|Overall Study|Cancellation of surgery.|2
5421962|NCT02535000|18713830|P1|Overall Study|Cancellation of surgery.|1
5421963|NCT02534935|18713841|P3|Overall Study|Lost to Follow-up|1
5421964|NCT02534935|18713842|P2|Overall Study|Lost to Follow-up|1
5421965|NCT02534935|18713843|P1|Overall Study|Lost to Follow-up|0
5421966|NCT02534935|18713841|P3|Overall Study|Adverse Event|0
5421967|NCT02534935|18713842|P2|Overall Study|Adverse Event|2
5421968|NCT02534935|18713843|P1|Overall Study|Adverse Event|0
5421969|NCT02534935|18713841|P3|Overall Study|No longer meets the eligibility criteria|0
5421970|NCT02534935|18713842|P2|Overall Study|No longer meets the eligibility criteria|3
5421971|NCT02534935|18713843|P1|Overall Study|No longer meets the eligibility criteria|0
5421972|NCT02534935|18713841|P3|Overall Study|Withdrawal by Subject|3
5421973|NCT02534935|18713842|P2|Overall Study|Withdrawal by Subject|3
5421974|NCT02534935|18713843|P1|Overall Study|Withdrawal by Subject|0
5421975|NCT02534935|18713841|P3|Overall Study|No longer willing to participate|1
5421976|NCT02534935|18713842|P2|Overall Study|No longer willing to participate|1
5421977|NCT02534935|18713843|P1|Overall Study|No longer willing to participate|0
5421978|NCT02534896|18714004|P3|Overall Study|Insufficient therapeutic response|0
5421979|NCT02534896|18714005|P2|Overall Study|Insufficient therapeutic response|0
5421980|NCT02534896|18714006|P1|Overall Study|Insufficient therapeutic response|2
5421981|NCT02534896|18714004|P3|Overall Study|Adverse Event|1
5421982|NCT02534896|18714005|P2|Overall Study|Adverse Event|1
5421983|NCT02534896|18714006|P1|Overall Study|Adverse Event|2
5421984|NCT02534883|18714025|P2|Overall Study|Early Termination|3
5421985|NCT02534883|18714026|P1|Overall Study|Early Termination|8
5421986|NCT02534493|18714042|P1|Overall Study|Withdrawal by Subject|1
5421987|NCT02534493|18714042|P1|Overall Study|Lost to Follow-up|1
5421988|NCT02534350|18714053|P2|Overall Study|Withdrew Consent|0
5421989|NCT02534350|18714054|P1|Overall Study|Withdrew Consent|2
5421990|NCT02534350|18714053|P2|Overall Study|Protocol Violation|0
5421991|NCT02534350|18714054|P1|Overall Study|Protocol Violation|1
5421992|NCT02534350|18714053|P2|Overall Study|Randomized But Not Treated|0
5421993|NCT02534350|18714054|P1|Overall Study|Randomized But Not Treated|1
5421994|NCT02534324|18714068|P2|Overall Study|Adverse Event|0
5421995|NCT02534324|18714069|P1|Overall Study|Adverse Event|1
5421996|NCT02534324|18714068|P2|Overall Study|Lost to Follow-up|7
5421997|NCT02534324|18714069|P1|Overall Study|Lost to Follow-up|20
5421998|NCT02534324|18714068|P2|Overall Study|Protocol Violation|1
5421999|NCT02534324|18714069|P1|Overall Study|Protocol Violation|4
5422000|NCT02533999|18714134|P2|Overall Study|Randomized but intervention not received|1
5422001|NCT02533999|18714135|P1|Overall Study|Randomized but intervention not received|0
5422002|NCT02533999|18714134|P2|Overall Study|Adverse Event|1
5422003|NCT02533999|18714135|P1|Overall Study|Adverse Event|0
5422004|NCT02533999|18714134|P2|Overall Study|Protocol Violation|0
5422005|NCT02533999|18714135|P1|Overall Study|Protocol Violation|3
5422006|NCT02533999|18714134|P2|Overall Study|Lost to Follow-up|5
5422007|NCT02533999|18714135|P1|Overall Study|Lost to Follow-up|3
5422008|NCT02533570|18714186|P3|Overall Study|Adverse Event|1
5422009|NCT02533570|18714187|P2|Overall Study|Adverse Event|1
5422010|NCT02533570|18714188|P1|Overall Study|Adverse Event|0
5422011|NCT02533531|18714199|P1|Overall Study|Device did not turn on|1
5422012|NCT02533453|18714262|P1|Overall Study|Withdrawal by Subject|2
5422013|NCT02533453|18714262|P1|Overall Study|Protocol Violation|1
5422014|NCT02533453|18714262|P1|Overall Study|Adverse Event|6
5422015|NCT02533401|18714321|P1|Overall Study|Violation of Selection Criteria|1
5422016|NCT02533401|18714321|P1|Overall Study|Lost to Follow-up|1
5422017|NCT02533401|18714321|P1|Overall Study|Insufficient Response/Progressed Disease|1
5422018|NCT02533401|18714321|P1|Overall Study|Death|5
5422019|NCT02533401|18714321|P1|Overall Study|Adverse Event/Intercurrent Disease|3
5422020|NCT02533375|18714329|P1|Overall Study|Adverse Event|2
5422021|NCT02533375|18714329|P1|Overall Study|Lack of Efficacy|3
5422022|NCT02533258|18714361|P1|Overall Study|Lack of Efficacy|2
5422023|NCT02533258|18714361|P1|Overall Study|Progression of pleural effusion|1
5422024|NCT02533258|18714361|P1|Overall Study|Economic factor|1
5422025|NCT02533258|18714361|P1|Overall Study|Other|1
5422026|NCT02533258|18714361|P1|Overall Study|Death|2
5422027|NCT02533258|18714361|P1|Overall Study|Adverse Event|1
5422028|NCT02532972|18714502|P1|Overall Study|Withdrawal by Subject|1
5422029|NCT02532855|18714519|P2|Overall Study|Withdrawal by Subject|8
5422030|NCT02532855|18714520|P1|Overall Study|Withdrawal by Subject|4
5422031|NCT02532855|18714519|P2|Overall Study|Lost to Follow-up|3
5422032|NCT02532855|18714520|P1|Overall Study|Lost to Follow-up|4
5422033|NCT02532764|18714554|P10|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
5422034|NCT02532764|18714555|P9|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
5422035|NCT02532764|18714556|P8|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
5422036|NCT02532764|18714557|P7|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5422037|NCT02532764|18714558|P6|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5422038|NCT02532764|18714559|P5|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5422039|NCT02532764|18714560|P4|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5422040|NCT02532764|18714561|P3|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5422041|NCT02532764|18714562|P2|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5422042|NCT02532764|18714563|P1|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
5422043|NCT02532647|18714714|P3|Overall Study|Did not receive trial medication|1
5422044|NCT02532647|18714715|P2|Overall Study|Did not receive trial medication|0
5422045|NCT02532647|18714716|P1|Overall Study|Did not receive trial medication|1
5422046|NCT02532543|18714758|P4|Overall Study|Lost to Follow-up|0
5422047|NCT02532543|18714759|P3|Overall Study|Lost to Follow-up|1
5422048|NCT02532543|18714760|P2|Overall Study|Lost to Follow-up|0
5422049|NCT02532543|18714761|P1|Overall Study|Lost to Follow-up|0
5422050|NCT02532517|18714795|P1|Overall Study|Death|4
5422051|NCT02532517|18714795|P1|Overall Study|Withdrawal by Subject|4
5422052|NCT02532517|18714795|P1|Overall Study|Lost to Follow-up|4
5422053|NCT02532517|18714795|P1|Overall Study|Failed Angiographic eligibility|1
5422054|NCT02532517|18714795|P1|Overall Study|Did not complete 24-Month visit|4
5422055|NCT02532465|18714815|P2|Overall Study|Lack of Efficacy|1
5422056|NCT02532465|18714816|P1|Overall Study|Lack of Efficacy|0
5422057|NCT02532465|18714815|P2|Overall Study|Protocol Violation|0
5422058|NCT02532465|18714816|P1|Overall Study|Protocol Violation|1
5422059|NCT02532374|18714826|P1|Overall Study|Physician Decision|1
5422060|NCT02532374|18714826|P1|Overall Study|Withdrawal by Subject|1
5422061|NCT02532283|18714852|P2|Overall Study|Withdrawal by Subject|3
5422062|NCT02532283|18714853|P1|Overall Study|Withdrawal by Subject|8
5422063|NCT02532283|18714852|P2|Overall Study|Lost to Follow-up|1
5422064|NCT02532283|18714853|P1|Overall Study|Lost to Follow-up|0
5422065|NCT02532283|18714852|P2|Overall Study|Death|0
5422066|NCT02532283|18714853|P1|Overall Study|Death|1
5422067|NCT02532283|18714852|P2|Overall Study|Adverse Event|1
5422068|NCT02532283|18714853|P1|Overall Study|Adverse Event|0
5422069|NCT02532179|18714895|P1|Overall Study|Subject received depot steroid injection|1
5422070|NCT02532179|18714895|P1|Overall Study|Pregnancy|1
5422071|NCT02532179|18714895|P1|Overall Study|Lost to Follow-up|1
5422072|NCT02531802|18714965|P21|Received Vaccination 2|Withdrawal by Subject|0
5422073|NCT02531802|18714966|P20|Received Vaccination 2|Withdrawal by Subject|1
5422074|NCT02531802|18714967|P19|Received Vaccination 2|Withdrawal by Subject|1
5422075|NCT02531802|18714968|P18|Received Vaccination 2|Withdrawal by Subject|1
5422076|NCT02531802|18714969|P17|Received Vaccination 2|Withdrawal by Subject|0
5422077|NCT02531802|18714970|P16|Received Vaccination 2|Withdrawal by Subject|0
5422078|NCT02531802|18714971|P15|Received Vaccination 2|Withdrawal by Subject|1
5422079|NCT02531802|18714972|P14|Received Vaccination 2|Withdrawal by Subject|1
5422080|NCT02531802|18714973|P13|Received Vaccination 2|Withdrawal by Subject|1
5422081|NCT02531802|18714974|P12|Received Vaccination 2|Withdrawal by Subject|0
5422082|NCT02531802|18714975|P11|Received Vaccination 2|Withdrawal by Subject|1
5422083|NCT02531802|18714976|P10|Received Vaccination 2|Withdrawal by Subject|0
5422084|NCT02531802|18714977|P9|Received Vaccination 2|Withdrawal by Subject|0
5422085|NCT02531802|18714978|P8|Received Vaccination 2|Withdrawal by Subject|0
5422086|NCT02531802|18714979|P7|Received Vaccination 2|Withdrawal by Subject|0
5422087|NCT02531802|18714980|P6|Received Vaccination 2|Withdrawal by Subject|0
5422088|NCT02531802|18714981|P5|Received Vaccination 2|Withdrawal by Subject|0
5422089|NCT02531802|18714982|P4|Received Vaccination 2|Withdrawal by Subject|0
5422090|NCT02531802|18714983|P3|Received Vaccination 2|Withdrawal by Subject|0
5422091|NCT02531802|18714984|P2|Received Vaccination 2|Withdrawal by Subject|0
5422092|NCT02531802|18714985|P1|Received Vaccination 2|Withdrawal by Subject|0
5422093|NCT02531802|18714965|P21|Received Vaccination 2|Adverse Event|1
5422094|NCT02531802|18714966|P20|Received Vaccination 2|Adverse Event|0
5422095|NCT02531802|18714967|P19|Received Vaccination 2|Adverse Event|1
5422096|NCT02531802|18714968|P18|Received Vaccination 2|Adverse Event|2
5422097|NCT02531802|18714969|P17|Received Vaccination 2|Adverse Event|0
5422098|NCT02531802|18714970|P16|Received Vaccination 2|Adverse Event|0
5422099|NCT02531802|18714971|P15|Received Vaccination 2|Adverse Event|0
5422100|NCT02531802|18714972|P14|Received Vaccination 2|Adverse Event|0
5422101|NCT02531802|18714973|P13|Received Vaccination 2|Adverse Event|0
5422102|NCT02531802|18714974|P12|Received Vaccination 2|Adverse Event|0
5422103|NCT02531802|18714975|P11|Received Vaccination 2|Adverse Event|0
5422104|NCT02531802|18714976|P10|Received Vaccination 2|Adverse Event|0
5422105|NCT02531802|18714977|P9|Received Vaccination 2|Adverse Event|0
5422106|NCT02531802|18714978|P8|Received Vaccination 2|Adverse Event|0
5422107|NCT02531802|18714979|P7|Received Vaccination 2|Adverse Event|0
5422108|NCT02531802|18714980|P6|Received Vaccination 2|Adverse Event|2
5422109|NCT02531802|18714981|P5|Received Vaccination 2|Adverse Event|0
5422110|NCT02531802|18714982|P4|Received Vaccination 2|Adverse Event|0
5422111|NCT02531802|18714983|P3|Received Vaccination 2|Adverse Event|0
5422112|NCT02531802|18714984|P2|Received Vaccination 2|Adverse Event|0
5422113|NCT02531802|18714985|P1|Received Vaccination 2|Adverse Event|0
5422114|NCT02531802|18714965|P21|Received Vaccination 2|Physician Decision|0
5422115|NCT02531802|18714966|P20|Received Vaccination 2|Physician Decision|0
5422116|NCT02531802|18714967|P19|Received Vaccination 2|Physician Decision|0
5422117|NCT02531802|18714968|P18|Received Vaccination 2|Physician Decision|1
5422118|NCT02531802|18714969|P17|Received Vaccination 2|Physician Decision|0
5422119|NCT02531802|18714970|P16|Received Vaccination 2|Physician Decision|0
5422120|NCT02531802|18714971|P15|Received Vaccination 2|Physician Decision|0
5422121|NCT02531802|18714972|P14|Received Vaccination 2|Physician Decision|1
5422122|NCT02531802|18714973|P13|Received Vaccination 2|Physician Decision|0
5422123|NCT02531802|18714974|P12|Received Vaccination 2|Physician Decision|0
5422124|NCT02531802|18714975|P11|Received Vaccination 2|Physician Decision|0
5422125|NCT02531802|18714976|P10|Received Vaccination 2|Physician Decision|2
5422126|NCT02531802|18714977|P9|Received Vaccination 2|Physician Decision|0
5422127|NCT02531802|18714978|P8|Received Vaccination 2|Physician Decision|0
5422128|NCT02531802|18714979|P7|Received Vaccination 2|Physician Decision|0
5422129|NCT02531802|18714980|P6|Received Vaccination 2|Physician Decision|1
5422130|NCT02531802|18714981|P5|Received Vaccination 2|Physician Decision|0
5422131|NCT02531802|18714982|P4|Received Vaccination 2|Physician Decision|0
5422132|NCT02531802|18714983|P3|Received Vaccination 2|Physician Decision|0
5422133|NCT02531802|18714984|P2|Received Vaccination 2|Physician Decision|0
5422134|NCT02531802|18714985|P1|Received Vaccination 2|Physician Decision|0
5422135|NCT02531802|18714965|P21|Received Vaccination 2|Medication interfering with study taken|0
5422136|NCT02531802|18714966|P20|Received Vaccination 2|Medication interfering with study taken|0
5422137|NCT02531802|18714967|P19|Received Vaccination 2|Medication interfering with study taken|1
5422138|NCT02531802|18714968|P18|Received Vaccination 2|Medication interfering with study taken|0
5422139|NCT02531802|18714969|P17|Received Vaccination 2|Medication interfering with study taken|0
5422140|NCT02531802|18714970|P16|Received Vaccination 2|Medication interfering with study taken|0
5422141|NCT02531802|18714971|P15|Received Vaccination 2|Medication interfering with study taken|0
5422142|NCT02531802|18714972|P14|Received Vaccination 2|Medication interfering with study taken|0
5422143|NCT02531802|18714973|P13|Received Vaccination 2|Medication interfering with study taken|1
5422144|NCT02531802|18714974|P12|Received Vaccination 2|Medication interfering with study taken|0
5422145|NCT02531802|18714975|P11|Received Vaccination 2|Medication interfering with study taken|1
5422146|NCT02531802|18714976|P10|Received Vaccination 2|Medication interfering with study taken|1
5422147|NCT02531802|18714977|P9|Received Vaccination 2|Medication interfering with study taken|0
5422148|NCT02531802|18714978|P8|Received Vaccination 2|Medication interfering with study taken|0
5422149|NCT02531802|18714979|P7|Received Vaccination 2|Medication interfering with study taken|0
5422150|NCT02531802|18714980|P6|Received Vaccination 2|Medication interfering with study taken|0
5422151|NCT02531802|18714981|P5|Received Vaccination 2|Medication interfering with study taken|0
5422152|NCT02531802|18714982|P4|Received Vaccination 2|Medication interfering with study taken|0
5422153|NCT02531802|18714983|P3|Received Vaccination 2|Medication interfering with study taken|1
5422154|NCT02531802|18714984|P2|Received Vaccination 2|Medication interfering with study taken|0
5422155|NCT02531802|18714985|P1|Received Vaccination 2|Medication interfering with study taken|0
5422156|NCT02531698|18715417|P2|Overall Study|Lost to Follow-up|0
5422157|NCT02531698|18715418|P1|Overall Study|Lost to Follow-up|1
5422158|NCT02531698|18715417|P2|Overall Study|Protocol Violation|0
5422159|NCT02531698|18715418|P1|Overall Study|Protocol Violation|2
5422160|NCT02531698|18715417|P2|Overall Study|Withdrawal by Subject|1
5422161|NCT02531698|18715418|P1|Overall Study|Withdrawal by Subject|6
5422162|NCT02531698|18715417|P2|Overall Study|Adverse Event|1
5422163|NCT02531698|18715418|P1|Overall Study|Adverse Event|2
5422164|NCT02531646|18715665|P3|Overall Study|equip. image processing issue|0
5422165|NCT02531646|18715666|P2|Overall Study|equip. image processing issue|1
5422166|NCT02531646|18715667|P1|Overall Study|equip. image processing issue|5
5422167|NCT02531633|18715686|P10|Part B (104 Weeks)|Lost to Follow-up|0
5422168|NCT02531633|18715687|P9|Part B (104 Weeks)|Lost to Follow-up|0
5422169|NCT02531633|18715688|P8|Part B (104 Weeks)|Lost to Follow-up|1
5422170|NCT02531633|18715689|P7|Part B (104 Weeks)|Lost to Follow-up|0
5422171|NCT02531633|18715690|P6|Part B (104 Weeks)|Lost to Follow-up|0
5422172|NCT02531633|18715691|P5|Part B (104 Weeks)|Lost to Follow-up|0
5422173|NCT02531633|18715692|P4|Part B (104 Weeks)|Lost to Follow-up|0
5422174|NCT02531633|18715693|P3|Part B (104 Weeks)|Lost to Follow-up|0
5422175|NCT02531633|18715694|P2|Part B (104 Weeks)|Lost to Follow-up|0
5422176|NCT02531633|18715695|P1|Part B (104 Weeks)|Lost to Follow-up|0
5422177|NCT02531633|18715686|P10|Part B (104 Weeks)|Sponsor request|4
5422178|NCT02531633|18715687|P9|Part B (104 Weeks)|Sponsor request|5
5422179|NCT02531633|18715688|P8|Part B (104 Weeks)|Sponsor request|3
5422180|NCT02531633|18715689|P7|Part B (104 Weeks)|Sponsor request|5
5422181|NCT02531633|18715690|P6|Part B (104 Weeks)|Sponsor request|8
5422182|NCT02531633|18715691|P5|Part B (104 Weeks)|Sponsor request|0
5422183|NCT02531633|18715692|P4|Part B (104 Weeks)|Sponsor request|0
5422184|NCT02531633|18715693|P3|Part B (104 Weeks)|Sponsor request|0
5422185|NCT02531633|18715694|P2|Part B (104 Weeks)|Sponsor request|0
5422186|NCT02531633|18715695|P1|Part B (104 Weeks)|Sponsor request|0
5422187|NCT02531633|18715686|P10|Part A (52 Weeks)|Other|0
5422188|NCT02531633|18715687|P9|Part A (52 Weeks)|Other|0
5422189|NCT02531633|18715688|P8|Part A (52 Weeks)|Other|0
5422190|NCT02531633|18715689|P7|Part A (52 Weeks)|Other|0
5422191|NCT02531633|18715690|P6|Part A (52 Weeks)|Other|0
5422192|NCT02531633|18715691|P5|Part A (52 Weeks)|Other|0
5422193|NCT02531633|18715692|P4|Part A (52 Weeks)|Other|0
5422194|NCT02531633|18715693|P3|Part A (52 Weeks)|Other|0
5422195|NCT02531633|18715694|P2|Part A (52 Weeks)|Other|0
5422196|NCT02531633|18715695|P1|Part A (52 Weeks)|Other|2
5422197|NCT02531633|18715686|P10|Part A (52 Weeks)|Withdrawal by Subject|0
5422198|NCT02531633|18715687|P9|Part A (52 Weeks)|Withdrawal by Subject|0
5422199|NCT02531633|18715688|P8|Part A (52 Weeks)|Withdrawal by Subject|0
5422200|NCT02531633|18715689|P7|Part A (52 Weeks)|Withdrawal by Subject|0
5422201|NCT02531633|18715690|P6|Part A (52 Weeks)|Withdrawal by Subject|0
5422202|NCT02531633|18715691|P5|Part A (52 Weeks)|Withdrawal by Subject|3
5422203|NCT02531633|18715692|P4|Part A (52 Weeks)|Withdrawal by Subject|3
5422204|NCT02531633|18715693|P3|Part A (52 Weeks)|Withdrawal by Subject|1
5422205|NCT02531633|18715694|P2|Part A (52 Weeks)|Withdrawal by Subject|6
5422206|NCT02531633|18715695|P1|Part A (52 Weeks)|Withdrawal by Subject|6
5422207|NCT02531633|18715686|P10|Part A (52 Weeks)|Physician Decision|0
5422208|NCT02531633|18715687|P9|Part A (52 Weeks)|Physician Decision|0
5422209|NCT02531633|18715688|P8|Part A (52 Weeks)|Physician Decision|0
5422210|NCT02531633|18715689|P7|Part A (52 Weeks)|Physician Decision|0
5422211|NCT02531633|18715690|P6|Part A (52 Weeks)|Physician Decision|0
5422212|NCT02531633|18715691|P5|Part A (52 Weeks)|Physician Decision|0
5422213|NCT02531633|18715692|P4|Part A (52 Weeks)|Physician Decision|1
5422214|NCT02531633|18715693|P3|Part A (52 Weeks)|Physician Decision|3
5422215|NCT02531633|18715694|P2|Part A (52 Weeks)|Physician Decision|4
5422216|NCT02531633|18715695|P1|Part A (52 Weeks)|Physician Decision|1
5422217|NCT02531633|18715686|P10|Part A (52 Weeks)|Lost to Follow-up|0
5422218|NCT02531633|18715687|P9|Part A (52 Weeks)|Lost to Follow-up|0
5422219|NCT02531633|18715688|P8|Part A (52 Weeks)|Lost to Follow-up|0
5422220|NCT02531633|18715689|P7|Part A (52 Weeks)|Lost to Follow-up|0
5422221|NCT02531633|18715690|P6|Part A (52 Weeks)|Lost to Follow-up|0
5422222|NCT02531633|18715691|P5|Part A (52 Weeks)|Lost to Follow-up|1
5422223|NCT02531633|18715692|P4|Part A (52 Weeks)|Lost to Follow-up|0
5422224|NCT02531633|18715693|P3|Part A (52 Weeks)|Lost to Follow-up|0
5422225|NCT02531633|18715694|P2|Part A (52 Weeks)|Lost to Follow-up|0
5422226|NCT02531633|18715695|P1|Part A (52 Weeks)|Lost to Follow-up|0
5422227|NCT02531633|18715686|P10|Part A (52 Weeks)|Protocol Violation|0
5422228|NCT02531633|18715687|P9|Part A (52 Weeks)|Protocol Violation|0
5422229|NCT02531633|18715688|P8|Part A (52 Weeks)|Protocol Violation|0
5422230|NCT02531633|18715689|P7|Part A (52 Weeks)|Protocol Violation|0
5422231|NCT02531633|18715690|P6|Part A (52 Weeks)|Protocol Violation|0
5422232|NCT02531633|18715691|P5|Part A (52 Weeks)|Protocol Violation|0
5422233|NCT02531633|18715692|P4|Part A (52 Weeks)|Protocol Violation|0
5422234|NCT02531633|18715693|P3|Part A (52 Weeks)|Protocol Violation|0
5422235|NCT02531633|18715694|P2|Part A (52 Weeks)|Protocol Violation|0
5422236|NCT02531633|18715695|P1|Part A (52 Weeks)|Protocol Violation|1
5422237|NCT02531633|18715686|P10|Part A (52 Weeks)|Sponsor request|0
5422238|NCT02531633|18715687|P9|Part A (52 Weeks)|Sponsor request|0
5422239|NCT02531633|18715688|P8|Part A (52 Weeks)|Sponsor request|0
5422240|NCT02531633|18715689|P7|Part A (52 Weeks)|Sponsor request|0
5422241|NCT02531633|18715690|P6|Part A (52 Weeks)|Sponsor request|0
5422242|NCT02531633|18715691|P5|Part A (52 Weeks)|Sponsor request|19
5422243|NCT02531633|18715692|P4|Part A (52 Weeks)|Sponsor request|18
5422244|NCT02531633|18715693|P3|Part A (52 Weeks)|Sponsor request|18
5422245|NCT02531633|18715694|P2|Part A (52 Weeks)|Sponsor request|24
5422246|NCT02531633|18715695|P1|Part A (52 Weeks)|Sponsor request|24
5422247|NCT02531438|18716174|P2|Overall Study|Randomized with Exclusion Criteria|0
5422248|NCT02531438|18716175|P1|Overall Study|Randomized with Exclusion Criteria|1
5422249|NCT02531438|18716174|P2|Overall Study|Missed EOT/PTE Visit|2
5422250|NCT02531438|18716175|P1|Overall Study|Missed EOT/PTE Visit|5
5422251|NCT02531438|18716174|P2|Overall Study|Randomized, but Not Treated|0
5422252|NCT02531438|18716175|P1|Overall Study|Randomized, but Not Treated|4
5422253|NCT02531438|18716174|P2|Overall Study|Death|3
5422254|NCT02531438|18716175|P1|Overall Study|Death|6
5422255|NCT02531438|18716174|P2|Overall Study|Physician Decision|1
5422256|NCT02531438|18716175|P1|Overall Study|Physician Decision|0
5422257|NCT02531438|18716174|P2|Overall Study|Withdrawal by Subject|8
5422258|NCT02531438|18716175|P1|Overall Study|Withdrawal by Subject|7
5422259|NCT02531438|18716174|P2|Overall Study|Lost to Follow-up|3
5422260|NCT02531438|18716175|P1|Overall Study|Lost to Follow-up|0
5422261|NCT02531438|18716174|P2|Overall Study|Adverse Event|9
5422262|NCT02531438|18716175|P1|Overall Study|Adverse Event|7
5422263|NCT02531373|18716194|P9|Overall Study|Withdrawal by Subject|0
5422264|NCT02531373|18716195|P8|Overall Study|Withdrawal by Subject|0
5422265|NCT02531373|18716196|P7|Overall Study|Withdrawal by Subject|0
5422266|NCT02531373|18716197|P6|Overall Study|Withdrawal by Subject|0
5422267|NCT02531373|18716198|P5|Overall Study|Withdrawal by Subject|3
5422268|NCT02531373|18716199|P4|Overall Study|Withdrawal by Subject|0
5422269|NCT02531373|18716200|P3|Overall Study|Withdrawal by Subject|0
5422270|NCT02531373|18716201|P2|Overall Study|Withdrawal by Subject|0
5422271|NCT02531373|18716202|P1|Overall Study|Withdrawal by Subject|0
5422272|NCT02531373|18716194|P9|Overall Study|Withdrawal by Parent/Guardian|3
5422273|NCT02531373|18716195|P8|Overall Study|Withdrawal by Parent/Guardian|1
5422274|NCT02531373|18716196|P7|Overall Study|Withdrawal by Parent/Guardian|4
5422275|NCT02531373|18716197|P6|Overall Study|Withdrawal by Parent/Guardian|3
5422276|NCT02531373|18716198|P5|Overall Study|Withdrawal by Parent/Guardian|0
5422277|NCT02531373|18716199|P4|Overall Study|Withdrawal by Parent/Guardian|0
5422278|NCT02531373|18716200|P3|Overall Study|Withdrawal by Parent/Guardian|0
5422279|NCT02531373|18716201|P2|Overall Study|Withdrawal by Parent/Guardian|0
5422280|NCT02531373|18716202|P1|Overall Study|Withdrawal by Parent/Guardian|0
5422281|NCT02531373|18716194|P9|Overall Study|Protocol Violation|1
5422282|NCT02531373|18716195|P8|Overall Study|Protocol Violation|0
5422283|NCT02531373|18716196|P7|Overall Study|Protocol Violation|1
5422284|NCT02531373|18716197|P6|Overall Study|Protocol Violation|1
5422285|NCT02531373|18716198|P5|Overall Study|Protocol Violation|0
5422286|NCT02531373|18716199|P4|Overall Study|Protocol Violation|0
5422287|NCT02531373|18716200|P3|Overall Study|Protocol Violation|0
5422288|NCT02531373|18716201|P2|Overall Study|Protocol Violation|0
5422289|NCT02531373|18716202|P1|Overall Study|Protocol Violation|0
5422290|NCT02531373|18716194|P9|Overall Study|Physician Decision|0
5422291|NCT02531373|18716195|P8|Overall Study|Physician Decision|0
5422292|NCT02531373|18716196|P7|Overall Study|Physician Decision|0
5422293|NCT02531373|18716197|P6|Overall Study|Physician Decision|1
5422294|NCT02531373|18716198|P5|Overall Study|Physician Decision|2
5422295|NCT02531373|18716199|P4|Overall Study|Physician Decision|0
5422296|NCT02531373|18716200|P3|Overall Study|Physician Decision|0
5422297|NCT02531373|18716201|P2|Overall Study|Physician Decision|0
5422298|NCT02531373|18716202|P1|Overall Study|Physician Decision|0
5422299|NCT02531373|18716194|P9|Overall Study|Lost to Follow-up|0
5422300|NCT02531373|18716195|P8|Overall Study|Lost to Follow-up|0
5422301|NCT02531373|18716196|P7|Overall Study|Lost to Follow-up|2
5422302|NCT02531373|18716197|P6|Overall Study|Lost to Follow-up|2
5422303|NCT02531373|18716198|P5|Overall Study|Lost to Follow-up|0
5422304|NCT02531373|18716199|P4|Overall Study|Lost to Follow-up|0
5422305|NCT02531373|18716200|P3|Overall Study|Lost to Follow-up|0
5422306|NCT02531373|18716201|P2|Overall Study|Lost to Follow-up|0
5422307|NCT02531373|18716202|P1|Overall Study|Lost to Follow-up|0
5422308|NCT02531373|18716194|P9|Overall Study|Lack of Efficacy|5
5422309|NCT02531373|18716195|P8|Overall Study|Lack of Efficacy|8
5422310|NCT02531373|18716196|P7|Overall Study|Lack of Efficacy|4
5422311|NCT02531373|18716197|P6|Overall Study|Lack of Efficacy|2
5422312|NCT02531373|18716198|P5|Overall Study|Lack of Efficacy|3
5422313|NCT02531373|18716199|P4|Overall Study|Lack of Efficacy|0
5422314|NCT02531373|18716200|P3|Overall Study|Lack of Efficacy|0
5422315|NCT02531373|18716201|P2|Overall Study|Lack of Efficacy|0
5422316|NCT02531373|18716202|P1|Overall Study|Lack of Efficacy|0
5422317|NCT02531113|18716274|P1|Extension Period: Week 12 up to Week 160|Pregnancy|1
5422318|NCT02531113|18716274|P1|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
5422319|NCT02531113|18716274|P1|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
5422320|NCT02531113|18716274|P1|Extension Period: Week 12 up to Week 160|Adverse Event|5
5422321|NCT02531113|18716274|P1|Extension Period: Week 12 up to Week 160|Physician Decision|2
5422322|NCT02531113|18716274|P1|Induction Period: Week 0 to 12|Withdrawal by Subject|3
5422323|NCT02531113|18716274|P1|Induction Period: Week 0 to 12|Lack of Efficacy|4
5422324|NCT02531113|18716274|P1|Induction Period: Week 0 to 12|Adverse Event|4
5422325|NCT02531035|18716306|P2|Overall Study|Randomized, not treated|1
5422326|NCT02531035|18716307|P1|Overall Study|Randomized, not treated|2
5422327|NCT02531035|18716306|P2|Overall Study|Lost to Follow-up|10
5422328|NCT02531035|18716307|P1|Overall Study|Lost to Follow-up|8
5422329|NCT02531035|18716306|P2|Overall Study|Withdrawal by Subject|32
5422330|NCT02531035|18716307|P1|Overall Study|Withdrawal by Subject|42
5422331|NCT02531035|18716306|P2|Overall Study|Other|2
5422332|NCT02531035|18716307|P1|Overall Study|Other|3
5422333|NCT02531035|18716306|P2|Overall Study|Adverse Event|45
5422334|NCT02531035|18716307|P1|Overall Study|Adverse Event|16
5422335|NCT02531035|18716306|P2|Overall Study|Physician Decision|0
5422336|NCT02531035|18716307|P1|Overall Study|Physician Decision|1
5422337|NCT02531035|18716306|P2|Overall Study|Noncompliance with study drug|3
5422338|NCT02531035|18716307|P1|Overall Study|Noncompliance with study drug|8
5422339|NCT02531035|18716306|P2|Overall Study|Protocol Violation|1
5422340|NCT02531035|18716307|P1|Overall Study|Protocol Violation|1
5422341|NCT02531035|18716306|P2|Overall Study|Death|1
5422342|NCT02531035|18716307|P1|Overall Study|Death|0
5422343|NCT02530970|18716332|P1|Overall Study|Relocation|3
5422344|NCT02530970|18716332|P1|Overall Study|Change in Provider|5
5422345|NCT02530970|18716332|P1|Overall Study|Explant|2
5422346|NCT02530970|18716332|P1|Overall Study|Insurance|2
5422347|NCT02530970|18716332|P1|Overall Study|Hospitalization|1
5422348|NCT02530970|18716332|P1|Overall Study|Death|6
5422349|NCT02530970|18716332|P1|Overall Study|Withdrawal by Subject|14
5422350|NCT02530970|18716332|P1|Overall Study|Physician Decision|5
5422351|NCT02530970|18716332|P1|Overall Study|Lost to Follow-up|88
5422352|NCT02530970|18716332|P1|Overall Study|Adverse Event|8
5422353|NCT02530671|18716339|P2|Overall Study|Withdrawal by Subject|0
5422354|NCT02530671|18716340|P1|Overall Study|Withdrawal by Subject|1
5422355|NCT02530671|18716339|P2|Overall Study|Lost to Follow-up|0
5422356|NCT02530671|18716340|P1|Overall Study|Lost to Follow-up|2
5422357|NCT02530619|18716356|P1|Follow-up Period (6 Months)|Withdrawal by Subject|5
5422358|NCT02530619|18716356|P1|Follow-up Period (6 Months)|Lost to Follow-up|2
5422359|NCT02530619|18716356|P1|Follow-up Period (6 Months)|Death|4
5422360|NCT02530619|18716356|P1|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2
5422361|NCT02530619|18716356|P1|Continued Treatment Cycles 2 Through 6|Progressive Disease|4
5422362|NCT02530619|18716356|P1|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2
5422363|NCT02530619|18716356|P1|Continued Treatment Cycles 2 Through 6|Adverse Event|2
5422364|NCT02530619|18716356|P1|Registered for Study|Withdrawal by Subject|2
5422365|NCT02530385|18716432|P2|Overall Study|Withdrawal by Subject|1
5422366|NCT02530385|18716433|P1|Overall Study|Withdrawal by Subject|0
5422367|NCT02530242|18716485|P2|Overall Study|excluded due to asthma and oxcarbazepine|1
5422368|NCT02530242|18716486|P1|Overall Study|excluded due to asthma and oxcarbazepine|0
5422369|NCT02530125|18716505|P1|Followed for Survival for 2 Years|Early termination of study|3
5422370|NCT02530125|18716505|P1|Completed Treatment|Early termination of study|1
5422371|NCT02529995|18716519|P2|Part B|Discontinued Study|5
5422372|NCT02529995|18716520|P1|Part B|Discontinued Study|6
5422373|NCT02529995|18716519|P2|Part B|Ongoing Study at Data Cut-off|7
5422374|NCT02529995|18716520|P1|Part B|Ongoing Study at Data Cut-off|0
5422375|NCT02529995|18716519|P2|Part A|Discontinued Study|0
5422376|NCT02529995|18716520|P1|Part A|Discontinued Study|1
5422377|NCT02529995|18716519|P2|Part A|Ongoing Study at Data Cut-off|16
5422378|NCT02529995|18716520|P1|Part A|Ongoing Study at Data Cut-off|14
5422379|NCT02529553|18716563|P9|Overall Study|Withdrawal by Subject|0
5422380|NCT02529553|18716564|P8|Overall Study|Withdrawal by Subject|1
5422381|NCT02529553|18716565|P7|Overall Study|Withdrawal by Subject|0
5422382|NCT02529553|18716566|P6|Overall Study|Withdrawal by Subject|1
5422383|NCT02529553|18716567|P5|Overall Study|Withdrawal by Subject|0
5422384|NCT02529553|18716568|P4|Overall Study|Withdrawal by Subject|0
5422385|NCT02529553|18716569|P3|Overall Study|Withdrawal by Subject|0
5422386|NCT02529553|18716570|P2|Overall Study|Withdrawal by Subject|0
5422387|NCT02529553|18716571|P1|Overall Study|Withdrawal by Subject|0
5422388|NCT02529553|18716563|P9|Overall Study|Physician Decision|0
5422389|NCT02529553|18716564|P8|Overall Study|Physician Decision|0
5422390|NCT02529553|18716565|P7|Overall Study|Physician Decision|0
5422391|NCT02529553|18716566|P6|Overall Study|Physician Decision|0
5422392|NCT02529553|18716567|P5|Overall Study|Physician Decision|1
5422393|NCT02529553|18716568|P4|Overall Study|Physician Decision|0
5422394|NCT02529553|18716569|P3|Overall Study|Physician Decision|0
5422395|NCT02529553|18716570|P2|Overall Study|Physician Decision|1
5422396|NCT02529553|18716571|P1|Overall Study|Physician Decision|0
5422397|NCT02529553|18716563|P9|Overall Study|Progressive Disease|3
5422398|NCT02529553|18716564|P8|Overall Study|Progressive Disease|5
5422399|NCT02529553|18716565|P7|Overall Study|Progressive Disease|3
5422400|NCT02529553|18716566|P6|Overall Study|Progressive Disease|3
5422401|NCT02529553|18716567|P5|Overall Study|Progressive Disease|2
5422402|NCT02529553|18716568|P4|Overall Study|Progressive Disease|3
5422403|NCT02529553|18716569|P3|Overall Study|Progressive Disease|1
5422404|NCT02529553|18716570|P2|Overall Study|Progressive Disease|0
5422405|NCT02529553|18716571|P1|Overall Study|Progressive Disease|1
5422406|NCT02529488|18716610|P1|Overall Study|Death|3
5422407|NCT02529488|18716610|P1|Overall Study|Adverse Event|1
5422408|NCT02529137|18716618|P1|Overall Study|Discontinuation for different reasons|8
5422409|NCT02528643|18716655|P2|Overall Study|No End of Study Information Available|0
5422410|NCT02528643|18716656|P1|Overall Study|No End of Study Information Available|1
5422411|NCT02528643|18716655|P2|Overall Study|Miscellaneous|1
5422412|NCT02528643|18716656|P1|Overall Study|Miscellaneous|0
5422413|NCT02528643|18716655|P2|Overall Study|Withdrawal by Subject|7
5422414|NCT02528643|18716656|P1|Overall Study|Withdrawal by Subject|0
5422415|NCT02528643|18716655|P2|Overall Study|Lost to Follow-up|1
5422416|NCT02528643|18716656|P1|Overall Study|Lost to Follow-up|0
5422417|NCT02528643|18716655|P2|Overall Study|Death|76
5422418|NCT02528643|18716656|P1|Overall Study|Death|38
5422419|NCT02528331|18716698|P1|Overall Study|Withdrawal by Subject|2
5422420|NCT02528305|18716766|P1|Overall Study|Physician Decision|1
5422421|NCT02528305|18716766|P1|Overall Study|Adverse Event|1
5422422|NCT02528305|18716766|P1|Overall Study|Withdrawal by Subject|1
5422423|NCT02528253|18716813|P5|Overall Study|Withdrawn Due to Pregnancy|1
5422424|NCT02528253|18716814|P4|Overall Study|Withdrawn Due to Pregnancy|0
5422425|NCT02528253|18716815|P3|Overall Study|Withdrawn Due to Pregnancy|0
5422426|NCT02528253|18716816|P2|Overall Study|Withdrawn Due to Pregnancy|1
5422427|NCT02528253|18716817|P1|Overall Study|Withdrawn Due to Pregnancy|0
5422428|NCT02528253|18716813|P5|Overall Study|Protocol Violation|4
5422429|NCT02528253|18716814|P4|Overall Study|Protocol Violation|0
5422430|NCT02528253|18716815|P3|Overall Study|Protocol Violation|4
5422431|NCT02528253|18716816|P2|Overall Study|Protocol Violation|2
5422432|NCT02528253|18716817|P1|Overall Study|Protocol Violation|1
5422433|NCT02528253|18716813|P5|Overall Study|Withdrawal by Subject|73
5422434|NCT02528253|18716814|P4|Overall Study|Withdrawal by Subject|48
5422435|NCT02528253|18716815|P3|Overall Study|Withdrawal by Subject|29
5422436|NCT02528253|18716816|P2|Overall Study|Withdrawal by Subject|20
5422437|NCT02528253|18716817|P1|Overall Study|Withdrawal by Subject|25
5422438|NCT02528253|18716813|P5|Overall Study|Other|76
5422439|NCT02528253|18716814|P4|Overall Study|Other|52
5422440|NCT02528253|18716815|P3|Overall Study|Other|58
5422441|NCT02528253|18716816|P2|Overall Study|Other|22
5422442|NCT02528253|18716817|P1|Overall Study|Other|21
5422443|NCT02528253|18716813|P5|Overall Study|Lost to Follow-up|34
5422444|NCT02528253|18716814|P4|Overall Study|Lost to Follow-up|16
5422445|NCT02528253|18716815|P3|Overall Study|Lost to Follow-up|31
5422446|NCT02528253|18716816|P2|Overall Study|Lost to Follow-up|9
5422447|NCT02528253|18716817|P1|Overall Study|Lost to Follow-up|16
5422448|NCT02528253|18716813|P5|Overall Study|Insufficient clinical response|16
5422449|NCT02528253|18716814|P4|Overall Study|Insufficient clinical response|12
5422450|NCT02528253|18716815|P3|Overall Study|Insufficient clinical response|13
5422451|NCT02528253|18716816|P2|Overall Study|Insufficient clinical response|10
5422452|NCT02528253|18716817|P1|Overall Study|Insufficient clinical response|7
5422453|NCT02528253|18716813|P5|Overall Study|Death|1
5422454|NCT02528253|18716814|P4|Overall Study|Death|0
5422455|NCT02528253|18716815|P3|Overall Study|Death|1
5422456|NCT02528253|18716816|P2|Overall Study|Death|2
5422457|NCT02528253|18716817|P1|Overall Study|Death|2
5422458|NCT02528253|18716813|P5|Overall Study|Adverse Event|18
5422459|NCT02528253|18716814|P4|Overall Study|Adverse Event|8
5422460|NCT02528253|18716815|P3|Overall Study|Adverse Event|4
5422461|NCT02528253|18716816|P2|Overall Study|Adverse Event|4
5422462|NCT02528253|18716817|P1|Overall Study|Adverse Event|3
5422463|NCT02528214|18717110|P2|Overall Study|Other than specified above|1
5422464|NCT02528214|18717111|P1|Overall Study|Other than specified above|0
5422465|NCT02528214|18717110|P2|Overall Study|Adverse Event|1
5422466|NCT02528214|18717111|P1|Overall Study|Adverse Event|0
5422467|NCT02528214|18717110|P2|Overall Study|Protocol Violation|1
5422468|NCT02528214|18717111|P1|Overall Study|Protocol Violation|0
5422469|NCT02528188|18717146|P3|Overall Study|Randomized but not treated|12
5422470|NCT02528188|18717147|P2|Overall Study|Randomized but not treated|7
5422471|NCT02528188|18717148|P1|Overall Study|Randomized but not treated|6
5422472|NCT02528188|18717146|P3|Overall Study|Other|74
5422473|NCT02528188|18717147|P2|Overall Study|Other|91
5422474|NCT02528188|18717148|P1|Overall Study|Other|89
5422475|NCT02528188|18717146|P3|Overall Study|Death|0
5422476|NCT02528188|18717147|P2|Overall Study|Death|4
5422477|NCT02528188|18717148|P1|Overall Study|Death|4
5422478|NCT02528188|18717146|P3|Overall Study|Lost to Follow-up|31
5422479|NCT02528188|18717147|P2|Overall Study|Lost to Follow-up|21
5422480|NCT02528188|18717148|P1|Overall Study|Lost to Follow-up|25
5422481|NCT02528188|18717146|P3|Overall Study|Withdrawal by Subject|100
5422482|NCT02528188|18717147|P2|Overall Study|Withdrawal by Subject|104
5422483|NCT02528188|18717148|P1|Overall Study|Withdrawal by Subject|97
5422484|NCT02528188|18717146|P3|Overall Study|Lack of Efficacy|22
5422485|NCT02528188|18717147|P2|Overall Study|Lack of Efficacy|21
5422486|NCT02528188|18717148|P1|Overall Study|Lack of Efficacy|19
5422487|NCT02528188|18717146|P3|Overall Study|Protocol Violation|4
5422488|NCT02528188|18717147|P2|Overall Study|Protocol Violation|6
5422489|NCT02528188|18717148|P1|Overall Study|Protocol Violation|4
5422490|NCT02528188|18717146|P3|Overall Study|Adverse Event|8
5422491|NCT02528188|18717147|P2|Overall Study|Adverse Event|22
5422492|NCT02528188|18717148|P1|Overall Study|Adverse Event|23
5422493|NCT02527434|18717423|P3|Overall Study|Site closure|0
5422494|NCT02527434|18717424|P2|Overall Study|Site closure|0
5422495|NCT02527434|18717425|P1|Overall Study|Site closure|1
5422496|NCT02527434|18717423|P3|Overall Study|Reason Not Specified|0
5422497|NCT02527434|18717424|P2|Overall Study|Reason Not Specified|0
5422498|NCT02527434|18717425|P1|Overall Study|Reason Not Specified|1
5422499|NCT02527434|18717423|P3|Overall Study|Withdrawal by Subject|3
5422500|NCT02527434|18717424|P2|Overall Study|Withdrawal by Subject|3
5422501|NCT02527434|18717425|P1|Overall Study|Withdrawal by Subject|5
5422502|NCT02527434|18717423|P3|Overall Study|Death|17
5422503|NCT02527434|18717424|P2|Overall Study|Death|6
5422504|NCT02527434|18717425|P1|Overall Study|Death|19
5422505|NCT02527434|18717423|P3|Overall Study|Lost to Follow-up|0
5422506|NCT02527434|18717424|P2|Overall Study|Lost to Follow-up|2
5422507|NCT02527434|18717425|P1|Overall Study|Lost to Follow-up|2
5422508|NCT02527161|18717483|P1|Overall Study|Lost to Follow-up|6
5422509|NCT02527161|18717483|P1|Overall Study|Adverse Event|1
5422510|NCT02527161|18717483|P1|Overall Study|Physician Decision|1
5422511|NCT02527161|18717483|P1|Overall Study|Only Recruited to Part A|27
5422512|NCT02527161|18717483|P1|Overall Study|Consent violation|4
5422513|NCT02527161|18717483|P1|Overall Study|MRI contraindication|6
5422514|NCT02527161|18717483|P1|Overall Study|Delay in or unfit for surgery|16
5422515|NCT02527161|18717483|P1|Overall Study|Withdrawal by Subject|19
5422516|NCT02527161|18717483|P1|Overall Study|Failed MRI|52
5422517|NCT02527148|18717502|P2|Overall Study|Did not receive study intervention|0
5422518|NCT02527148|18717503|P1|Overall Study|Did not receive study intervention|1
5422519|NCT02526693|18717533|P2|Overall Study|Physician Decision|1
5422520|NCT02526693|18717534|P1|Overall Study|Physician Decision|3
5422521|NCT02526550|18717579|P1|Overall Study|Lost to Follow-up|1
5422522|NCT02526524|18717591|P6|Overall Study|Sponsor Decision|0
5422523|NCT02526524|18717592|P5|Overall Study|Sponsor Decision|0
5422524|NCT02526524|18717593|P4|Overall Study|Sponsor Decision|0
5422525|NCT02526524|18717594|P3|Overall Study|Sponsor Decision|0
5422526|NCT02526524|18717595|P2|Overall Study|Sponsor Decision|0
5422527|NCT02526524|18717596|P1|Overall Study|Sponsor Decision|1
5422528|NCT02526524|18717591|P6|Overall Study|Physician Decision|0
5422529|NCT02526524|18717592|P5|Overall Study|Physician Decision|1
5422530|NCT02526524|18717593|P4|Overall Study|Physician Decision|0
5422531|NCT02526524|18717594|P3|Overall Study|Physician Decision|0
5422532|NCT02526524|18717595|P2|Overall Study|Physician Decision|0
5422533|NCT02526524|18717596|P1|Overall Study|Physician Decision|0
5422534|NCT02526524|18717591|P6|Overall Study|Loss of Glucose Control|0
5422535|NCT02526524|18717592|P5|Overall Study|Loss of Glucose Control|2
5422536|NCT02526524|18717593|P4|Overall Study|Loss of Glucose Control|0
5422537|NCT02526524|18717594|P3|Overall Study|Loss of Glucose Control|3
5422538|NCT02526524|18717595|P2|Overall Study|Loss of Glucose Control|0
5422539|NCT02526524|18717596|P1|Overall Study|Loss of Glucose Control|0
5422540|NCT02526524|18717591|P6|Overall Study|Protocol Violation|3
5422541|NCT02526524|18717592|P5|Overall Study|Protocol Violation|4
5422542|NCT02526524|18717593|P4|Overall Study|Protocol Violation|3
5422543|NCT02526524|18717594|P3|Overall Study|Protocol Violation|5
5422544|NCT02526524|18717595|P2|Overall Study|Protocol Violation|1
5422545|NCT02526524|18717596|P1|Overall Study|Protocol Violation|3
5422546|NCT02526524|18717591|P6|Overall Study|Lost to Follow-up|5
5422547|NCT02526524|18717592|P5|Overall Study|Lost to Follow-up|2
5422548|NCT02526524|18717593|P4|Overall Study|Lost to Follow-up|1
5422549|NCT02526524|18717594|P3|Overall Study|Lost to Follow-up|8
5422550|NCT02526524|18717595|P2|Overall Study|Lost to Follow-up|3
5422551|NCT02526524|18717596|P1|Overall Study|Lost to Follow-up|2
5422552|NCT02526524|18717591|P6|Overall Study|Adverse Event|8
5422553|NCT02526524|18717592|P5|Overall Study|Adverse Event|6
5422554|NCT02526524|18717593|P4|Overall Study|Adverse Event|2
5422555|NCT02526524|18717594|P3|Overall Study|Adverse Event|4
5422556|NCT02526524|18717595|P2|Overall Study|Adverse Event|2
5422557|NCT02526524|18717596|P1|Overall Study|Adverse Event|3
5422558|NCT02526524|18717591|P6|Overall Study|Withdrawal by Subject|5
5422559|NCT02526524|18717592|P5|Overall Study|Withdrawal by Subject|9
5422560|NCT02526524|18717593|P4|Overall Study|Withdrawal by Subject|1
5422561|NCT02526524|18717594|P3|Overall Study|Withdrawal by Subject|6
5422562|NCT02526524|18717595|P2|Overall Study|Withdrawal by Subject|3
5422563|NCT02526524|18717596|P1|Overall Study|Withdrawal by Subject|3
5422564|NCT02526290|18717610|P1|Overall Study|Physician Decision|1
5422565|NCT02526290|18717610|P1|Overall Study|Withdrawal by Subject|4
5422566|NCT02526290|18717610|P1|Overall Study|Adverse Event|3
5422567|NCT02526212|18717644|P2|Overall Study|Death|1
5422568|NCT02526212|18717645|P1|Overall Study|Death|0
5422569|NCT02526212|18717644|P2|Overall Study|Lost to Follow-up|0
5422570|NCT02526212|18717645|P1|Overall Study|Lost to Follow-up|1
5422571|NCT02526212|18717644|P2|Overall Study|Incarceration|0
5422572|NCT02526212|18717645|P1|Overall Study|Incarceration|1
5422573|NCT02525874|18717659|P1|Overall Study|New lesions in Brain|1
5422574|NCT02525874|18717659|P1|Overall Study|Alternative Treatment for MS|2
5422575|NCT02525874|18717659|P1|Overall Study|Disease relapse|4
5422576|NCT02525874|18717659|P1|Overall Study|Disease progression, defined by protocol|2
5422577|NCT02525874|18717659|P1|Overall Study|Lost to Follow-up|7
5422578|NCT02525874|18717659|P1|Overall Study|Adverse Event|17
5422579|NCT02525874|18717659|P1|Overall Study|Non-compliance with study drug|3
5422580|NCT02525874|18717659|P1|Overall Study|Consent withdrawn|22
5422581|NCT02525874|18717659|P1|Overall Study|Investigator Decision|1
5422582|NCT02525874|18717659|P1|Overall Study|Other|1
5422583|NCT02525744|18717672|P4|Period 5|Physician Decision|0
5422584|NCT02525744|18717673|P3|Period 5|Physician Decision|0
5422585|NCT02525744|18717674|P2|Period 5|Physician Decision|0
5422586|NCT02525744|18717675|P1|Period 5|Physician Decision|1
5422587|NCT02525744|18717672|P4|Period 4|Withdrawal by Subject|0
5422588|NCT02525744|18717673|P3|Period 4|Withdrawal by Subject|0
5422589|NCT02525744|18717674|P2|Period 4|Withdrawal by Subject|0
5422590|NCT02525744|18717675|P1|Period 4|Withdrawal by Subject|1
5422591|NCT02525744|18717672|P4|Period 3|Adverse Event|0
5422592|NCT02525744|18717673|P3|Period 3|Adverse Event|0
5422593|NCT02525744|18717674|P2|Period 3|Adverse Event|1
5422594|NCT02525744|18717675|P1|Period 3|Adverse Event|0
5422595|NCT02525744|18717672|P4|Period 1|Physician Decision|0
5422596|NCT02525744|18717673|P3|Period 1|Physician Decision|1
5422597|NCT02525744|18717674|P2|Period 1|Physician Decision|0
5422598|NCT02525744|18717675|P1|Period 1|Physician Decision|0
5422599|NCT02525627|18717711|P2|Overall Study|Site terminated|10
5422600|NCT02525627|18717712|P1|Overall Study|Site terminated|11
5422601|NCT02525627|18717711|P2|Overall Study|Death|0
5422602|NCT02525627|18717712|P1|Overall Study|Death|1
5422603|NCT02525627|18717711|P2|Overall Study|Withdrawal by Subject|2
5422604|NCT02525627|18717712|P1|Overall Study|Withdrawal by Subject|1
5422605|NCT02525627|18717711|P2|Overall Study|Revision|1
5422606|NCT02525627|18717712|P1|Overall Study|Revision|1
5422607|NCT02525588|18717724|P2|Overall Study|Adverse Event|1
5422608|NCT02525588|18717725|P1|Overall Study|Adverse Event|0
5422609|NCT02525588|18717724|P2|Overall Study|Withdrawal by Subject|1
5422610|NCT02525588|18717725|P1|Overall Study|Withdrawal by Subject|1
5422611|NCT02525588|18717724|P2|Overall Study|Lost to Follow-up|0
5422612|NCT02525588|18717725|P1|Overall Study|Lost to Follow-up|2
5422613|NCT02525588|18717724|P2|Overall Study|Death|1
5422614|NCT02525588|18717725|P1|Overall Study|Death|3
5422615|NCT02525094|18717837|P2|Overall Study|Not Treated|1
5422616|NCT02525094|18717838|P1|Overall Study|Not Treated|1
5422617|NCT02525094|18717837|P2|Overall Study|Withdrawal by Subject|6
5422618|NCT02525094|18717838|P1|Overall Study|Withdrawal by Subject|5
5422619|NCT02525094|18717837|P2|Overall Study|Lost to Follow-up|1
5422620|NCT02525094|18717838|P1|Overall Study|Lost to Follow-up|2
5422621|NCT02524847|18717901|P1|Overall Study|Reason not Specified|1
5422622|NCT02524847|18717901|P1|Overall Study|Death|1
5422623|NCT02524847|18717901|P1|Overall Study|Condition no Longer Requires Treatment|4
5422624|NCT02524847|18717901|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
5422625|NCT02524847|18717901|P1|Overall Study|Adverse Event|4
5422626|NCT02524665|18717913|P1|Overall Study|Lost to Follow-up|1
5422627|NCT02524288|18717964|P1|Overall Study|Physician Decision|2
5422628|NCT02524288|18717964|P1|Overall Study|Pregnancy|22
5422629|NCT02524288|18717964|P1|Overall Study|Withdrawal by Subject|76
5422630|NCT02524288|18717964|P1|Overall Study|Subject Moved|32
5422631|NCT02524288|18717964|P1|Overall Study|Study Terminated By Sponsor|1417
5422632|NCT02524288|18717964|P1|Overall Study|Site Discontinued Study Participation|1
5422633|NCT02524288|18717964|P1|Overall Study|Screen Failure|2
5422634|NCT02524288|18717964|P1|Overall Study|Protocol Violation|6
5422635|NCT02524288|18717964|P1|Overall Study|Pregnancy Wish|6
5422636|NCT02524288|18717964|P1|Overall Study|Non-Compliance With Study Drug|14
5422637|NCT02524288|18717964|P1|Overall Study|Non-Compliance With Protocol|32
5422638|NCT02524288|18717964|P1|Overall Study|Lost to Follow-up|216
5422639|NCT02524288|18717964|P1|Overall Study|Adverse Event|115
5422640|NCT02524158|18717974|P2|6-month Assessment|Lost to Follow-up|20
5422641|NCT02524158|18717975|P1|6-month Assessment|Lost to Follow-up|21
5422642|NCT02524158|18717974|P2|6-month Assessment|Withdrawal by Subject|1
5422643|NCT02524158|18717975|P1|6-month Assessment|Withdrawal by Subject|1
5422644|NCT02524158|18717974|P2|12-weeks Assessment|Lost to Follow-up|12
5422645|NCT02524158|18717975|P1|12-weeks Assessment|Lost to Follow-up|18
5422646|NCT02524158|18717974|P2|12-weeks Assessment|Withdrawal by Subject|1
5422647|NCT02524158|18717975|P1|12-weeks Assessment|Withdrawal by Subject|1
5422648|NCT02524145|18718017|P3|Overall Study|Withdrawal by Subject|3
5422649|NCT02524145|18718018|P2|Overall Study|Withdrawal by Subject|2
5422650|NCT02524145|18718019|P1|Overall Study|Withdrawal by Subject|2
5422651|NCT02522884|18718116|P1|Overall Study|Missed 12-month Follow-up|9
5422652|NCT02522884|18718116|P1|Overall Study|Death|3
5422653|NCT02522884|18718116|P1|Overall Study|Withdrawal by Subject|6
5422654|NCT02522728|18718148|P2|Overall Study|Did not receive randomized study device|1
5422655|NCT02522728|18718149|P1|Overall Study|Did not receive randomized study device|0
5422656|NCT02522728|18718148|P2|Overall Study|Adverse Event|1
5422657|NCT02522728|18718149|P1|Overall Study|Adverse Event|2
5422658|NCT02522728|18718148|P2|Overall Study|Death|3
5422659|NCT02522728|18718149|P1|Overall Study|Death|4
5422660|NCT02522728|18718148|P2|Overall Study|Withdrawal by Subject|6
5422661|NCT02522728|18718149|P1|Overall Study|Withdrawal by Subject|6
5422662|NCT02522624|18718176|P2|Overall Study|Technical failure|0
5422663|NCT02522624|18718177|P1|Overall Study|Technical failure|1
5422664|NCT02522481|18718193|P1|Overall Study|Not dosed|1
5422665|NCT02522481|18718193|P1|Overall Study|discontinued|1
5422666|NCT02522403|18718223|P2|Overall Study|Withdrawal by Subject|4
5422667|NCT02522403|18718224|P1|Overall Study|Withdrawal by Subject|2
5422668|NCT02522403|18718223|P2|Overall Study|Lost to Follow-up|2
5422669|NCT02522403|18718224|P1|Overall Study|Lost to Follow-up|2
5422670|NCT02522377|18718236|P2|Overall Study|Remission Achieved|0
5422671|NCT02522377|18718237|P1|Overall Study|Remission Achieved|3
5422672|NCT02522377|18718236|P2|Overall Study|Withdrawal by Subject|0
5422673|NCT02522377|18718237|P1|Overall Study|Withdrawal by Subject|1
5422674|NCT02522325|18718253|P2|Overall Study|Adverse Event|1
5422675|NCT02522325|18718254|P1|Overall Study|Adverse Event|0
5422676|NCT02522299|18718262|P2|Overall Study|Withdrawal by Subject|0
5422677|NCT02522299|18718263|P1|Overall Study|Withdrawal by Subject|2
5422678|NCT02522299|18718262|P2|Overall Study|Physician Decision|1
5422679|NCT02522299|18718263|P1|Overall Study|Physician Decision|0
5422680|NCT02522299|18718262|P2|Overall Study|Adverse Event|0
5422681|NCT02522299|18718263|P1|Overall Study|Adverse Event|2
5422682|NCT02522286|18718346|P4|Overall Study|Withdrawal by Subject|3
5422683|NCT02522286|18718347|P3|Overall Study|Withdrawal by Subject|0
5422684|NCT02522286|18718348|P2|Overall Study|Withdrawal by Subject|0
5422685|NCT02522286|18718349|P1|Overall Study|Withdrawal by Subject|3
5422686|NCT02521948|18718385|P1|Overall Study|Did not attend one or both follow-ups|6
5422687|NCT02521948|18718385|P1|Overall Study|Lost to Follow-up|1
5422688|NCT02521948|18718385|P1|Overall Study|Death|4
5422689|NCT02521948|18718385|P1|Overall Study|Adverse Event|2
5422690|NCT02521792|18718394|P1|Overall Study|Study Terminated|6
5422691|NCT02521376|18718444|P4|Overall Study|Enrolled, But Not Treated|0
5422692|NCT02521376|18718445|P3|Overall Study|Enrolled, But Not Treated|0
5422693|NCT02521376|18718446|P2|Overall Study|Enrolled, But Not Treated|0
5422694|NCT02521376|18718447|P1|Overall Study|Enrolled, But Not Treated|1
5422695|NCT02520726|18718501|P2|Overall Study|Lost to Follow-up|2
5422696|NCT02520726|18718502|P1|Overall Study|Lost to Follow-up|3
5422697|NCT02520531|18718512|P2|Overall Study|Not study device|0
5422698|NCT02520531|18718513|P1|Overall Study|Not study device|1
5422699|NCT02520531|18718512|P2|Overall Study|Withdrawal by Subject|0
5422700|NCT02520531|18718513|P1|Overall Study|Withdrawal by Subject|1
5422701|NCT02520531|18718512|P2|Overall Study|Meet exclusion criterion|1
5422702|NCT02520531|18718513|P1|Overall Study|Meet exclusion criterion|0
5422703|NCT02520531|18718512|P2|Overall Study|Lost to Follow-up|1
5422704|NCT02520531|18718513|P1|Overall Study|Lost to Follow-up|1
5422705|NCT02520531|18718512|P2|Overall Study|Death|2
5422706|NCT02520531|18718513|P1|Overall Study|Death|1
5422707|NCT02520531|18718512|P2|Overall Study|Revision of study device components|2
5422708|NCT02520531|18718513|P1|Overall Study|Revision of study device components|2
5422709|NCT02520388|18718598|P2|Overall Study|Other (reason not defined)|4
5422710|NCT02520388|18718599|P1|Overall Study|Other (reason not defined)|4
5422711|NCT02520388|18718598|P2|Overall Study|Lost to Follow-up|2
5422712|NCT02520388|18718599|P1|Overall Study|Lost to Follow-up|3
5422713|NCT02520388|18718598|P2|Overall Study|Adverse Event|4
5422714|NCT02520388|18718599|P1|Overall Study|Adverse Event|1
5422715|NCT02520388|18718598|P2|Overall Study|Subject or parent/guardian request|6
5422716|NCT02520388|18718599|P1|Overall Study|Subject or parent/guardian request|0
5422717|NCT02520388|18718598|P2|Overall Study|Physician Decision|0
5422718|NCT02520388|18718599|P1|Overall Study|Physician Decision|1
5422719|NCT02520310|18718607|P1|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
5422720|NCT02520310|18718607|P1|AT 3 Year Clinical Follow-up|Death|2
5422721|NCT02520310|18718607|P1|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
5422722|NCT02520310|18718607|P1|At 6 Months Clinical Follow-up|Death|1
5422723|NCT02520284|18718788|P3|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
5422724|NCT02520284|18718789|P2|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
5422725|NCT02520284|18718790|P1|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
5422726|NCT02520284|18718788|P3|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
5422727|NCT02520284|18718789|P2|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
5422728|NCT02520284|18718790|P1|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
5422729|NCT02520284|18718788|P3|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
5422730|NCT02520284|18718789|P2|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
5422731|NCT02520284|18718790|P1|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
5422732|NCT02520284|18718788|P3|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
5422733|NCT02520284|18718789|P2|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
5422734|NCT02520284|18718790|P1|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
5422735|NCT02520284|18718788|P3|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
5422736|NCT02520284|18718789|P2|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
5422737|NCT02520284|18718790|P1|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
5422738|NCT02520284|18718788|P3|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
5422739|NCT02520284|18718789|P2|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
5422740|NCT02520284|18718790|P1|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
5422741|NCT02520284|18718788|P3|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
5422742|NCT02520284|18718789|P2|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
5422743|NCT02520284|18718790|P1|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
5422744|NCT02520284|18718788|P3|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
5422745|NCT02520284|18718789|P2|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
5422746|NCT02520284|18718790|P1|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
5422747|NCT02520284|18718788|P3|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
5422748|NCT02520284|18718789|P2|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
5422749|NCT02520284|18718790|P1|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
5422750|NCT02520284|18718788|P3|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
5422751|NCT02520284|18718789|P2|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
5422752|NCT02520284|18718790|P1|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
5422753|NCT02520284|18718788|P3|Blinded Induction Phase: Up to Week 8|Adverse Event|0
5422754|NCT02520284|18718789|P2|Blinded Induction Phase: Up to Week 8|Adverse Event|3
5422755|NCT02520284|18718790|P1|Blinded Induction Phase: Up to Week 8|Adverse Event|1
5422756|NCT02520089|18718824|P2|Overall Study|Lost to Follow-up|4
5422757|NCT02520089|18718825|P1|Overall Study|Lost to Follow-up|3
5422758|NCT02519855|18718835|P2|Overall Study|Lost to Follow-up|3
5422759|NCT02519855|18718836|P1|Overall Study|Lost to Follow-up|3
5422760|NCT02519855|18718835|P2|Overall Study|Adverse Event|1
5422761|NCT02519855|18718836|P1|Overall Study|Adverse Event|0
5422762|NCT02519842|18718854|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
5422763|NCT02519842|18718855|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
5422764|NCT02519842|18718856|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
5422765|NCT02519842|18718854|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
5422766|NCT02519842|18718855|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
5422767|NCT02519842|18718856|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
5422768|NCT02519842|18718854|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
5422769|NCT02519842|18718855|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
5422770|NCT02519842|18718856|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
5422771|NCT02519842|18718854|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
5422772|NCT02519842|18718855|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
5422773|NCT02519842|18718856|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
5422774|NCT02519842|18718854|P3|Optional Extension: Cycles 2-6|Death|1
5422775|NCT02519842|18718855|P2|Optional Extension: Cycles 2-6|Death|0
5422776|NCT02519842|18718856|P1|Optional Extension: Cycles 2-6|Death|0
5422777|NCT02519842|18718854|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
5422778|NCT02519842|18718855|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
5422779|NCT02519842|18718856|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
5422780|NCT02519842|18718854|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
5422781|NCT02519842|18718855|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
5422782|NCT02519842|18718856|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
5422783|NCT02519842|18718854|P3|Optional Extension: Cycles 2-6|Adverse Event|1
5422784|NCT02519842|18718855|P2|Optional Extension: Cycles 2-6|Adverse Event|0
5422785|NCT02519842|18718856|P1|Optional Extension: Cycles 2-6|Adverse Event|0
5422786|NCT02519842|18718854|P3|Optional Extension: Cycles 2-6|Physician Decision|5
5422787|NCT02519842|18718855|P2|Optional Extension: Cycles 2-6|Physician Decision|0
5422788|NCT02519842|18718856|P1|Optional Extension: Cycles 2-6|Physician Decision|0
5422789|NCT02519842|18718854|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
5422790|NCT02519842|18718855|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
5422791|NCT02519842|18718856|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
5422792|NCT02519842|18718854|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
5422793|NCT02519842|18718855|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
5422794|NCT02519842|18718856|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
5422795|NCT02519842|18718854|P3|Base Study: Cycle 1|Adverse Event|0
5422796|NCT02519842|18718855|P2|Base Study: Cycle 1|Adverse Event|0
5422797|NCT02519842|18718856|P1|Base Study: Cycle 1|Adverse Event|1
5422798|NCT02519842|18718854|P3|Base Study: Cycle 1|Screening Failure|0
5422799|NCT02519842|18718855|P2|Base Study: Cycle 1|Screening Failure|1
5422800|NCT02519842|18718856|P1|Base Study: Cycle 1|Screening Failure|1
5422801|NCT02519712|18718875|P1|Overall Study|Accruals are donors|2
5422802|NCT02519712|18718875|P1|Overall Study|Disease Progression|1
5422803|NCT02519712|18718875|P1|Overall Study|Disease Relapse|1
5422804|NCT02519595|18718904|P3|Overall Study|Protocol Violation|16
5422805|NCT02519595|18718905|P2|Overall Study|Protocol Violation|22
5422806|NCT02519595|18718906|P1|Overall Study|Protocol Violation|8
5422807|NCT02519504|18718931|P2|Overall Study|Did not participate in direct testing|86
5422808|NCT02519504|18718932|P1|Overall Study|Did not participate in direct testing|95
5422809|NCT02519504|18718931|P2|Overall Study|Ineligible for direct testing|12
5422810|NCT02519504|18718932|P1|Overall Study|Ineligible for direct testing|12
5422811|NCT02519504|18718931|P2|Overall Study|Protocol Violation|5
5422812|NCT02519504|18718932|P1|Overall Study|Protocol Violation|6
5422813|NCT02519231|18719031|P2|Overall Study|Withdrawal by Subject|1
5422814|NCT02519231|18719032|P1|Overall Study|Withdrawal by Subject|0
5422815|NCT02519231|18719031|P2|Overall Study|Lost to Follow-up|5
5422816|NCT02519231|18719032|P1|Overall Study|Lost to Follow-up|2
5422817|NCT02518971|18719148|P2|Overall Study|eligibility criteria no longer met|3
5422818|NCT02518971|18719149|P1|Overall Study|eligibility criteria no longer met|6
5422819|NCT02518971|18719148|P2|Overall Study|medication lost in mail|1
5422820|NCT02518971|18719149|P1|Overall Study|medication lost in mail|0
5422821|NCT02518971|18719148|P2|Overall Study|Side effects|0
5422822|NCT02518971|18719149|P1|Overall Study|Side effects|1
5422823|NCT02518971|18719148|P2|Overall Study|Withdrawal by Subject|5
5422824|NCT02518971|18719149|P1|Overall Study|Withdrawal by Subject|4
5422825|NCT02518971|18719148|P2|Overall Study|Protocol Violation|4
5422826|NCT02518971|18719149|P1|Overall Study|Protocol Violation|6
5422827|NCT02518971|18719148|P2|Overall Study|Physician Decision|6
5422828|NCT02518971|18719149|P1|Overall Study|Physician Decision|6
5422829|NCT02518971|18719148|P2|Overall Study|Lost to Follow-up|1
5422830|NCT02518971|18719149|P1|Overall Study|Lost to Follow-up|0
5422831|NCT02518919|18719169|P3|Overall Study|Protocol Violation|2
5422832|NCT02518919|18719170|P2|Overall Study|Protocol Violation|1
5422833|NCT02518919|18719171|P1|Overall Study|Protocol Violation|1
5422834|NCT02518685|18719201|P2|Overall Study|Lost to Follow-up|4
5422835|NCT02518685|18719202|P1|Overall Study|Lost to Follow-up|1
5422836|NCT02518685|18719201|P2|Overall Study|Physician Decision|0
5422837|NCT02518685|18719202|P1|Overall Study|Physician Decision|1
5422838|NCT02518685|18719201|P2|Overall Study|Pregnancy|0
5422839|NCT02518685|18719202|P1|Overall Study|Pregnancy|1
5422840|NCT02518685|18719201|P2|Overall Study|relocation, study fatigue|2
5422841|NCT02518685|18719202|P1|Overall Study|relocation, study fatigue|7
5422842|NCT02518685|18719201|P2|Overall Study|Withdrawal by Subject|3
5422843|NCT02518685|18719202|P1|Overall Study|Withdrawal by Subject|10
5422844|NCT02518685|18719201|P2|Overall Study|Adverse Event|1
5422845|NCT02518685|18719202|P1|Overall Study|Adverse Event|29
5422846|NCT02518620|18719211|P2|Overall Study|Relocation|1
5422847|NCT02518620|18719212|P1|Overall Study|Relocation|2
5422848|NCT02518620|18719211|P2|Overall Study|Pregnancy|0
5422849|NCT02518620|18719212|P1|Overall Study|Pregnancy|1
5422850|NCT02518620|18719211|P2|Overall Study|Pregnancy Wish|0
5422851|NCT02518620|18719212|P1|Overall Study|Pregnancy Wish|3
5422852|NCT02518620|18719211|P2|Overall Study|Death|0
5422853|NCT02518620|18719212|P1|Overall Study|Death|1
5422854|NCT02518620|18719211|P2|Overall Study|Withdrawal by Subject|9
5422855|NCT02518620|18719212|P1|Overall Study|Withdrawal by Subject|17
5422856|NCT02518620|18719211|P2|Overall Study|Lost to Follow-up|1
5422857|NCT02518620|18719212|P1|Overall Study|Lost to Follow-up|1
5422858|NCT02518620|18719211|P2|Overall Study|Sponsor's Decision|3
5422859|NCT02518620|18719212|P1|Overall Study|Sponsor's Decision|0
5422860|NCT02518620|18719211|P2|Overall Study|Physician Decision|1
5422861|NCT02518620|18719212|P1|Overall Study|Physician Decision|1
5422862|NCT02518620|18719211|P2|Overall Study|Non-Compliance with Study Drug|0
5422863|NCT02518620|18719212|P1|Overall Study|Non-Compliance with Study Drug|1
5422864|NCT02518620|18719211|P2|Overall Study|Lack of Efficacy|0
5422865|NCT02518620|18719212|P1|Overall Study|Lack of Efficacy|2
5422866|NCT02518620|18719211|P2|Overall Study|Adverse Event|11
5422867|NCT02518620|18719212|P1|Overall Study|Adverse Event|23
5422868|NCT02518490|18719235|P2|Overall Study|Withdrawal by Subject|1
5422869|NCT02518490|18719236|P1|Overall Study|Withdrawal by Subject|1
5422870|NCT02518464|18719254|P1|Overall Study|Adverse Event|2
5422871|NCT02518113|18719275|P4|Overall Study|Progressive Disease|0
5422872|NCT02518113|18719276|P3|Overall Study|Progressive Disease|3
5422873|NCT02518113|18719277|P2|Overall Study|Progressive Disease|2
5422874|NCT02518113|18719278|P1|Overall Study|Progressive Disease|1
5422875|NCT02518113|18719275|P4|Overall Study|Physician Decision|0
5422876|NCT02518113|18719276|P3|Overall Study|Physician Decision|0
5422877|NCT02518113|18719277|P2|Overall Study|Physician Decision|1
5422878|NCT02518113|18719278|P1|Overall Study|Physician Decision|0
5422879|NCT02518113|18719275|P4|Overall Study|Death|0
5422880|NCT02518113|18719276|P3|Overall Study|Death|0
5422881|NCT02518113|18719277|P2|Overall Study|Death|2
5422882|NCT02518113|18719278|P1|Overall Study|Death|1
5422883|NCT02518113|18719275|P4|Overall Study|Adverse Event|0
5422884|NCT02518113|18719276|P3|Overall Study|Adverse Event|1
5422885|NCT02518113|18719277|P2|Overall Study|Adverse Event|0
5422886|NCT02518113|18719278|P1|Overall Study|Adverse Event|1
5422887|NCT02518048|18719319|P1|Overall Study|Withdrawal by Subject|1
5422888|NCT02517905|18719347|P2|Overall Study|Screen failure|2
5422889|NCT02517905|18719348|P1|Overall Study|Screen failure|2
5422890|NCT02517905|18719347|P2|Overall Study|Withdrawal by Subject|0
5422891|NCT02517905|18719348|P1|Overall Study|Withdrawal by Subject|4
5422892|NCT02517905|18719347|P2|Overall Study|Lost to Follow-up|0
5422893|NCT02517905|18719348|P1|Overall Study|Lost to Follow-up|4
5422894|NCT02517866|18719364|P3|Overall Study|Reason not specified|0
5422895|NCT02517866|18719365|P2|Overall Study|Reason not specified|0
5422896|NCT02517866|18719366|P1|Overall Study|Reason not specified|2
5422897|NCT02517866|18719364|P3|Overall Study|Investigator Decision|0
5422898|NCT02517866|18719365|P2|Overall Study|Investigator Decision|1
5422899|NCT02517866|18719366|P1|Overall Study|Investigator Decision|2
5422900|NCT02517866|18719364|P3|Overall Study|Voluntary Withdrawal|0
5422901|NCT02517866|18719365|P2|Overall Study|Voluntary Withdrawal|2
5422902|NCT02517866|18719366|P1|Overall Study|Voluntary Withdrawal|2
5422903|NCT02517866|18719364|P3|Overall Study|Lost to Follow-up|0
5422904|NCT02517866|18719365|P2|Overall Study|Lost to Follow-up|0
5422905|NCT02517866|18719366|P1|Overall Study|Lost to Follow-up|1
5422906|NCT02517866|18719364|P3|Overall Study|Significant Protocol Deviation|0
5422907|NCT02517866|18719365|P2|Overall Study|Significant Protocol Deviation|1
5422908|NCT02517866|18719366|P1|Overall Study|Significant Protocol Deviation|4
5422909|NCT02517866|18719364|P3|Overall Study|Pretreatment Event/Adverse Event|0
5422910|NCT02517866|18719365|P2|Overall Study|Pretreatment Event/Adverse Event|2
5422911|NCT02517866|18719366|P1|Overall Study|Pretreatment Event/Adverse Event|9
5422912|NCT02517541|18719437|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
5422913|NCT02517541|18719437|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
5422914|NCT02517541|18719437|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
5422915|NCT02517541|18719437|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
5422916|NCT02517541|18719437|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
5422917|NCT02517541|18719437|P1|Baseline Period (Own Product)|Protocol Violation|1
5422918|NCT02517528|18719443|P1|Overall Study|Withdrawal by Subject|1
5422919|NCT02517515|18719453|P2|Overall Study|Other|0
5422920|NCT02517515|18719454|P1|Overall Study|Other|1
5422921|NCT02517515|18719453|P2|Overall Study|Lost to Follow-up|0
5422922|NCT02517515|18719454|P1|Overall Study|Lost to Follow-up|1
5422923|NCT02517515|18719453|P2|Overall Study|Withdrew Consent|1
5422924|NCT02517515|18719454|P1|Overall Study|Withdrew Consent|0
5422925|NCT02517515|18719453|P2|Overall Study|Adverse Event|1
5422926|NCT02517515|18719454|P1|Overall Study|Adverse Event|0
5422927|NCT02517463|18719471|P2|Overall Study|Lost to Follow-up|2
5422928|NCT02517463|18719472|P1|Overall Study|Lost to Follow-up|5
5422929|NCT02517268|18719484|P2|Overall Study|Withdrawal by Subject|0
5422930|NCT02517268|18719485|P1|Overall Study|Withdrawal by Subject|1
5422931|NCT02516982|18719537|P4|Overall Study|Did not install the app|47
5422932|NCT02516982|18719538|P3|Overall Study|Did not install the app|46
5422933|NCT02516982|18719539|P2|Overall Study|Did not install the app|0
5422934|NCT02516982|18719540|P1|Overall Study|Did not install the app|0
5422935|NCT02516982|18719537|P4|Overall Study|Protocol Violation|1
5422936|NCT02516982|18719538|P3|Overall Study|Protocol Violation|1
5422937|NCT02516982|18719539|P2|Overall Study|Protocol Violation|0
5422938|NCT02516982|18719540|P1|Overall Study|Protocol Violation|0
5422939|NCT02516982|18719537|P4|Overall Study|Withdrawal by Subject|2
5422940|NCT02516982|18719538|P3|Overall Study|Withdrawal by Subject|1
5422941|NCT02516982|18719539|P2|Overall Study|Withdrawal by Subject|0
5422942|NCT02516982|18719540|P1|Overall Study|Withdrawal by Subject|0
5422943|NCT02516982|18719537|P4|Overall Study|Called in to antenatal appointment|0
5422944|NCT02516982|18719538|P3|Overall Study|Called in to antenatal appointment|0
5422945|NCT02516982|18719539|P2|Overall Study|Called in to antenatal appointment|35
5422946|NCT02516982|18719540|P1|Overall Study|Called in to antenatal appointment|32
5422947|NCT02516605|18719567|P5|Overall Study|Withdrawal by Subject|0
5422948|NCT02516605|18719568|P4|Overall Study|Withdrawal by Subject|1
5422949|NCT02516605|18719569|P3|Overall Study|Withdrawal by Subject|0
5422950|NCT02516605|18719570|P2|Overall Study|Withdrawal by Subject|0
5422951|NCT02516605|18719571|P1|Overall Study|Withdrawal by Subject|0
5422952|NCT02516605|18719567|P5|Overall Study|Protocol Violation|1
5422953|NCT02516605|18719568|P4|Overall Study|Protocol Violation|0
5422954|NCT02516605|18719569|P3|Overall Study|Protocol Violation|0
5422955|NCT02516605|18719570|P2|Overall Study|Protocol Violation|0
5422956|NCT02516605|18719571|P1|Overall Study|Protocol Violation|0
5422957|NCT02516592|18719642|P2|Overall Study|Death|1
5422958|NCT02516592|18719643|P1|Overall Study|Death|1
5422959|NCT02516592|18719642|P2|Overall Study|Abnormal test procedure result|0
5422960|NCT02516592|18719643|P1|Overall Study|Abnormal test procedure result|1
5422961|NCT02516592|18719642|P2|Overall Study|Adverse Event|2
5422962|NCT02516592|18719643|P1|Overall Study|Adverse Event|1
5422963|NCT02516592|18719642|P2|Overall Study|Patient/guardian decision|1
5422964|NCT02516592|18719643|P1|Overall Study|Patient/guardian decision|2
5422965|NCT02516592|18719642|P2|Overall Study|Lost to Follow-up|3
5422966|NCT02516592|18719643|P1|Overall Study|Lost to Follow-up|2
5422967|NCT02516592|18719642|P2|Overall Study|Protocol deviation|4
5422968|NCT02516592|18719643|P1|Overall Study|Protocol deviation|4
5422969|NCT02516592|18719642|P2|Overall Study|Patient withdrew consent|2
5422970|NCT02516592|18719643|P1|Overall Study|Patient withdrew consent|5
5422971|NCT02516410|18719665|P2|Overall Study|Withdrawal by Subject|1
5422972|NCT02516410|18719666|P1|Overall Study|Withdrawal by Subject|0
5422973|NCT02516410|18719665|P2|Overall Study|Adverse Event|1
5422974|NCT02516410|18719666|P1|Overall Study|Adverse Event|0
5422975|NCT02516306|18719695|P2|Period 2: Day 8 - 91|Protocol Violation|2
5422976|NCT02516306|18719696|P1|Period 2: Day 8 - 91|Protocol Violation|1
5422977|NCT02516228|18719702|P1|Overall Study|Physician Decision|1
5422978|NCT02516228|18719702|P1|Overall Study|Withdrawal by Subject|1
5422979|NCT02516228|18719702|P1|Overall Study|Lost to Follow-up|1
5422980|NCT02516202|18719713|P3|Overall Study|Stopped Follow-up|1
5422981|NCT02516202|18719714|P2|Overall Study|Stopped Follow-up|0
5422982|NCT02516202|18719715|P1|Overall Study|Stopped Follow-up|0
5422983|NCT02516202|18719713|P3|Overall Study|Lost to Follow-up|1
5422984|NCT02516202|18719714|P2|Overall Study|Lost to Follow-up|1
5422985|NCT02516202|18719715|P1|Overall Study|Lost to Follow-up|1
5422986|NCT02516202|18719713|P3|Overall Study|Withdrawal by Subject|1
5422987|NCT02516202|18719714|P2|Overall Study|Withdrawal by Subject|0
5422988|NCT02516202|18719715|P1|Overall Study|Withdrawal by Subject|1
5422989|NCT02516163|18719741|P1|Overall Study|MRI contraindication exclusion|6
5422990|NCT02516163|18719741|P1|Overall Study|Data not recorded|2
5422991|NCT02516163|18719741|P1|Overall Study|Use of incorrect measurement technique|5
5422992|NCT02516163|18719741|P1|Overall Study|Unfit/delay in surgery|3
5422993|NCT02516163|18719741|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
5422994|NCT02516163|18719741|P1|Overall Study|Withdrawal by Subject|1
5422995|NCT02516098|18719755|P2|Period 2|Withdrawal by Subject|1
5422996|NCT02516098|18719756|P1|Period 2|Withdrawal by Subject|0
5422997|NCT02516098|18719755|P2|Washout After Period 1|Adverse Event|1
5422998|NCT02516098|18719756|P1|Washout After Period 1|Adverse Event|0
5422999|NCT02516098|18719755|P2|Period 1|Protocol Violation|0
5423000|NCT02516098|18719756|P1|Period 1|Protocol Violation|1
5423001|NCT02515994|18719784|P2|Overall Study|Withdrawal by Subject|0
5423002|NCT02515994|18719785|P1|Overall Study|Withdrawal by Subject|2
5423003|NCT02515994|18719784|P2|Overall Study|Adverse Event|1
5423004|NCT02515994|18719785|P1|Overall Study|Adverse Event|3
5423005|NCT02515994|18719784|P2|Overall Study|No Longer Meets Eligibility Criteria|1
5423006|NCT02515994|18719785|P1|Overall Study|No Longer Meets Eligibility Criteria|2
5423007|NCT02515994|18719784|P2|Overall Study|Protocol Violation|5
5423008|NCT02515994|18719785|P1|Overall Study|Protocol Violation|3
5423009|NCT02515942|18719800|P3|Overall Study|Withdrawal by Subject|2
5423010|NCT02515942|18719801|P2|Overall Study|Withdrawal by Subject|3
5423011|NCT02515942|18719802|P1|Overall Study|Withdrawal by Subject|0
5423012|NCT02515942|18719800|P3|Overall Study|Lost to Follow-up|0
5423013|NCT02515942|18719801|P2|Overall Study|Lost to Follow-up|0
5423014|NCT02515942|18719802|P1|Overall Study|Lost to Follow-up|2
5423015|NCT02515942|18719800|P3|Overall Study|Lack of Efficacy|1
5423016|NCT02515942|18719801|P2|Overall Study|Lack of Efficacy|0
5423017|NCT02515942|18719802|P1|Overall Study|Lack of Efficacy|0
5423018|NCT02515942|18719800|P3|Overall Study|Death|1
5423019|NCT02515942|18719801|P2|Overall Study|Death|0
5423020|NCT02515942|18719802|P1|Overall Study|Death|0
5423021|NCT02515942|18719800|P3|Overall Study|Adverse Event|0
5423022|NCT02515942|18719801|P2|Overall Study|Adverse Event|0
5423023|NCT02515942|18719802|P1|Overall Study|Adverse Event|5
5423024|NCT02515669|18719888|P4|228 Week Open-Label Phase|Missing|2
5423025|NCT02515669|18719889|P3|228 Week Open-Label Phase|Missing|2
5423026|NCT02515669|18719890|P2|228 Week Open-Label Phase|Missing|2
5423027|NCT02515669|18719891|P1|228 Week Open-Label Phase|Missing|0
5423028|NCT02515669|18719888|P4|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
5423029|NCT02515669|18719889|P3|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
5423030|NCT02515669|18719890|P2|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
5423031|NCT02515669|18719891|P1|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
5423032|NCT02515669|18719888|P4|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
5423033|NCT02515669|18719889|P3|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
5423034|NCT02515669|18719890|P2|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
5423035|NCT02515669|18719891|P1|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
5423036|NCT02515669|18719888|P4|228 Week Open-Label Phase|Lack of Efficacy|0
5423037|NCT02515669|18719889|P3|228 Week Open-Label Phase|Lack of Efficacy|1
5423038|NCT02515669|18719890|P2|228 Week Open-Label Phase|Lack of Efficacy|0
5423039|NCT02515669|18719891|P1|228 Week Open-Label Phase|Lack of Efficacy|0
5423040|NCT02515669|18719888|P4|228 Week Open-Label Phase|Other|4
5423041|NCT02515669|18719889|P3|228 Week Open-Label Phase|Other|1
5423042|NCT02515669|18719890|P2|228 Week Open-Label Phase|Other|0
5423043|NCT02515669|18719891|P1|228 Week Open-Label Phase|Other|0
5423044|NCT02515331|18719989|P3|Overall Study|Adverse Event|0
5423045|NCT02515331|18719990|P2|Overall Study|Adverse Event|0
5423046|NCT02515331|18719991|P1|Overall Study|Adverse Event|2
5423047|NCT02515331|18719989|P3|Overall Study|Protocol deviation|3
5423048|NCT02515331|18719990|P2|Overall Study|Protocol deviation|0
5423049|NCT02515331|18719991|P1|Overall Study|Protocol deviation|0
5423050|NCT02515331|18719989|P3|Overall Study|Withdrawal by Subject|1
5423051|NCT02515331|18719990|P2|Overall Study|Withdrawal by Subject|0
5423052|NCT02515331|18719991|P1|Overall Study|Withdrawal by Subject|0
5423053|NCT02515279|18720028|P1|Overall Study|Other|22
5423054|NCT02515279|18720028|P1|Overall Study|End-of-treatment visit not attended|17
5423055|NCT02515279|18720028|P1|Overall Study|Withdrawal by Subject|18
5423056|NCT02515279|18720028|P1|Overall Study|Lost to Follow-up|9
5423057|NCT02515279|18720028|P1|Overall Study|Lack of Efficacy|31
5423058|NCT02515279|18720028|P1|Overall Study|Adverse Event|7
5423059|NCT02515097|18720047|P2|Overall Study|Adverse Event|1
5423060|NCT02515097|18720048|P1|Overall Study|Adverse Event|2
5423061|NCT02515097|18720047|P2|Overall Study|Withdrawal by Subject|3
5423062|NCT02515097|18720048|P1|Overall Study|Withdrawal by Subject|1
5423063|NCT02515097|18720047|P2|Overall Study|Lost to Follow-up|2
5423064|NCT02515097|18720048|P1|Overall Study|Lost to Follow-up|4
5423065|NCT02515045|18720069|P3|Overall Study|Lost to Follow-up|1
5423066|NCT02515045|18720070|P2|Overall Study|Lost to Follow-up|1
5423067|NCT02515045|18720071|P1|Overall Study|Lost to Follow-up|0
5423068|NCT02515045|18720069|P3|Overall Study|Adverse Event|3
5423069|NCT02515045|18720070|P2|Overall Study|Adverse Event|3
5423070|NCT02515045|18720071|P1|Overall Study|Adverse Event|0
5423071|NCT02514824|18720108|P4|Overall Study|Dose-Limiting Toxicity|0
5423072|NCT02514824|18720109|P3|Overall Study|Dose-Limiting Toxicity|0
5423073|NCT02514824|18720110|P2|Overall Study|Dose-Limiting Toxicity|1
5423074|NCT02514824|18720111|P1|Overall Study|Dose-Limiting Toxicity|0
5423075|NCT02514824|18720108|P4|Overall Study|Withdrawal by Subject|0
5423076|NCT02514824|18720109|P3|Overall Study|Withdrawal by Subject|0
5423077|NCT02514824|18720110|P2|Overall Study|Withdrawal by Subject|0
5423078|NCT02514824|18720111|P1|Overall Study|Withdrawal by Subject|1
5423079|NCT02514772|18720122|P2|Overall Study|Withdrawal by Subject|1
5423080|NCT02514772|18720123|P1|Overall Study|Withdrawal by Subject|2
5423081|NCT02514772|18720122|P2|Overall Study|Death|1
5423082|NCT02514772|18720123|P1|Overall Study|Death|0
5423083|NCT02514772|18720122|P2|Overall Study|Adverse Event|0
5423084|NCT02514772|18720123|P1|Overall Study|Adverse Event|1
5423085|NCT02514746|18720137|P2|Overall Study|Other|1
5423086|NCT02514746|18720138|P1|Overall Study|Other|5
5423087|NCT02514746|18720137|P2|Overall Study|Withdrawal by Subject|10
5423088|NCT02514746|18720138|P1|Overall Study|Withdrawal by Subject|12
5423089|NCT02514746|18720137|P2|Overall Study|Physician Decision|2
5423090|NCT02514746|18720138|P1|Overall Study|Physician Decision|4
5423091|NCT02514746|18720137|P2|Overall Study|Chronically Ill|2
5423092|NCT02514746|18720138|P1|Overall Study|Chronically Ill|1
5423093|NCT02514577|18720175|P2|Overall Study|Adverse Event|1
5423094|NCT02514577|18720176|P1|Overall Study|Adverse Event|1
5423095|NCT02514577|18720175|P2|Overall Study|Withdrawal by Subject|6
5423096|NCT02514577|18720176|P1|Overall Study|Withdrawal by Subject|6
5423097|NCT02514577|18720175|P2|Overall Study|Protocol Violation|0
5423098|NCT02514577|18720176|P1|Overall Study|Protocol Violation|1
5423099|NCT02514577|18720175|P2|Overall Study|Lost to Follow-up|6
5423100|NCT02514577|18720176|P1|Overall Study|Lost to Follow-up|6
5423101|NCT02514551|18720186|P2|Overall Study|Participant Never Treated|2
5423102|NCT02514551|18720187|P1|Overall Study|Participant Never Treated|0
5423103|NCT02514551|18720186|P2|Overall Study|Lost to Follow-up|1
5423104|NCT02514551|18720187|P1|Overall Study|Lost to Follow-up|0
5423105|NCT02514473|18720204|P2|Overall Study|Other|1
5423106|NCT02514473|18720205|P1|Overall Study|Other|1
5423107|NCT02514473|18720204|P2|Overall Study|Lost to Follow-up|1
5423108|NCT02514473|18720205|P1|Overall Study|Lost to Follow-up|0
5423109|NCT02514473|18720204|P2|Overall Study|Withdrawal by Subject|1
5423110|NCT02514473|18720205|P1|Overall Study|Withdrawal by Subject|2
5423111|NCT02514473|18720204|P2|Overall Study|Adverse Event|2
5423112|NCT02514473|18720205|P1|Overall Study|Adverse Event|0
5423113|NCT02514174|18720246|P1|Overall Study|Treated off study with Afatinib.|1
5423114|NCT02514174|18720246|P1|Overall Study|Treatment change|1
5423115|NCT02514174|18720246|P1|Overall Study|Progressive disease|11
5423116|NCT02514174|18720246|P1|Overall Study|Study closed by sponsor|9
5423117|NCT02514174|18720246|P1|Overall Study|Adverse Event|2
5423118|NCT02514174|18720246|P1|Overall Study|Patient refused to continue medication|1
5423119|NCT02514122|18720257|P2|Overall Study|Withdrawal by Subject|0
5423120|NCT02514122|18720258|P1|Overall Study|Withdrawal by Subject|2
5423121|NCT02514083|18720266|P1|Overall Study|Adverse Event|1
5423122|NCT02513823|18720324|P1|Overall Study|Physician Decision|1
5423123|NCT02513823|18720324|P1|Overall Study|Lost to Follow-up|4
5423124|NCT02513771|18720331|P2|Overall Study|Not being able to get to clinic|0
5423125|NCT02513771|18720332|P1|Overall Study|Not being able to get to clinic|1
5423126|NCT02513771|18720331|P2|Overall Study|Lost to Follow-up|1
5423127|NCT02513771|18720332|P1|Overall Study|Lost to Follow-up|1
5423128|NCT02513745|18720370|P2|Overall Study|Criteria at time of surgery not met.|3
5423129|NCT02513745|18720371|P1|Overall Study|Criteria at time of surgery not met.|3
5423130|NCT02513550|18720625|P6|Post-Treatment Follow-up Period|Labor Reasons|0
5423131|NCT02513550|18720626|P5|Post-Treatment Follow-up Period|Labor Reasons|0
5423132|NCT02513550|18720627|P4|Post-Treatment Follow-up Period|Labor Reasons|0
5423133|NCT02513550|18720628|P3|Post-Treatment Follow-up Period|Labor Reasons|1
5423134|NCT02513550|18720629|P2|Post-Treatment Follow-up Period|Labor Reasons|0
5423135|NCT02513550|18720630|P1|Post-Treatment Follow-up Period|Labor Reasons|0
5423136|NCT02513550|18720625|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5423137|NCT02513550|18720626|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5423138|NCT02513550|18720627|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5423139|NCT02513550|18720628|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
5423140|NCT02513550|18720629|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5423141|NCT02513550|18720630|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
5423142|NCT02513550|18720625|P6|Post-Treatment Follow-up Period|Subject move out of town|0
5423143|NCT02513550|18720626|P5|Post-Treatment Follow-up Period|Subject move out of town|0
5423144|NCT02513550|18720627|P4|Post-Treatment Follow-up Period|Subject move out of town|0
5423145|NCT02513550|18720628|P3|Post-Treatment Follow-up Period|Subject move out of town|1
5423146|NCT02513550|18720629|P2|Post-Treatment Follow-up Period|Subject move out of town|0
5423147|NCT02513550|18720630|P1|Post-Treatment Follow-up Period|Subject move out of town|0
5423148|NCT02513550|18720625|P6|Post-Treatment Follow-up Period|Death|0
5423149|NCT02513550|18720626|P5|Post-Treatment Follow-up Period|Death|0
5423150|NCT02513550|18720627|P4|Post-Treatment Follow-up Period|Death|0
5423151|NCT02513550|18720628|P3|Post-Treatment Follow-up Period|Death|1
5423152|NCT02513550|18720629|P2|Post-Treatment Follow-up Period|Death|0
5423153|NCT02513550|18720630|P1|Post-Treatment Follow-up Period|Death|0
5423154|NCT02513550|18720625|P6|Post-Treatment Follow-up Period|Physician Decision|0
5423155|NCT02513550|18720626|P5|Post-Treatment Follow-up Period|Physician Decision|0
5423156|NCT02513550|18720627|P4|Post-Treatment Follow-up Period|Physician Decision|0
5423157|NCT02513550|18720628|P3|Post-Treatment Follow-up Period|Physician Decision|0
5423158|NCT02513550|18720629|P2|Post-Treatment Follow-up Period|Physician Decision|0
5423159|NCT02513550|18720630|P1|Post-Treatment Follow-up Period|Physician Decision|2
5423160|NCT02513550|18720625|P6|Post-Treatment Follow-up Period|Adverse Event|0
5423161|NCT02513550|18720626|P5|Post-Treatment Follow-up Period|Adverse Event|0
5423162|NCT02513550|18720627|P4|Post-Treatment Follow-up Period|Adverse Event|0
5423163|NCT02513550|18720628|P3|Post-Treatment Follow-up Period|Adverse Event|4
5423164|NCT02513550|18720629|P2|Post-Treatment Follow-up Period|Adverse Event|1
5423165|NCT02513550|18720630|P1|Post-Treatment Follow-up Period|Adverse Event|1
5423166|NCT02513550|18720625|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
5423167|NCT02513550|18720626|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
5423168|NCT02513550|18720627|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
5423169|NCT02513550|18720628|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
5423170|NCT02513550|18720629|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
5423171|NCT02513550|18720630|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
5423172|NCT02513550|18720625|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
5423173|NCT02513550|18720626|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
5423174|NCT02513550|18720627|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
5423175|NCT02513550|18720628|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
5423176|NCT02513550|18720629|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
5423177|NCT02513550|18720630|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
5423178|NCT02513550|18720625|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
5423179|NCT02513550|18720626|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
5423180|NCT02513550|18720627|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
5423181|NCT02513550|18720628|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
5423182|NCT02513550|18720629|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
5423183|NCT02513550|18720630|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
5423184|NCT02513550|18720625|P6|Double Blind Treatment Period|Death|0
5423185|NCT02513550|18720626|P5|Double Blind Treatment Period|Death|0
5423186|NCT02513550|18720627|P4|Double Blind Treatment Period|Death|0
5423187|NCT02513550|18720628|P3|Double Blind Treatment Period|Death|2
5423188|NCT02513550|18720629|P2|Double Blind Treatment Period|Death|0
5423189|NCT02513550|18720630|P1|Double Blind Treatment Period|Death|1
5423190|NCT02513550|18720625|P6|Double Blind Treatment Period|Due to personal business|0
5423191|NCT02513550|18720626|P5|Double Blind Treatment Period|Due to personal business|0
5423192|NCT02513550|18720627|P4|Double Blind Treatment Period|Due to personal business|0
5423193|NCT02513550|18720628|P3|Double Blind Treatment Period|Due to personal business|1
5423194|NCT02513550|18720629|P2|Double Blind Treatment Period|Due to personal business|0
5423195|NCT02513550|18720630|P1|Double Blind Treatment Period|Due to personal business|2
5423196|NCT02513550|18720625|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5423197|NCT02513550|18720626|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5423198|NCT02513550|18720627|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5423199|NCT02513550|18720628|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
5423200|NCT02513550|18720629|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5423201|NCT02513550|18720630|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
5423202|NCT02513550|18720625|P6|Double Blind Treatment Period|Site terminated by sponsor|0
5423203|NCT02513550|18720626|P5|Double Blind Treatment Period|Site terminated by sponsor|0
5423204|NCT02513550|18720627|P4|Double Blind Treatment Period|Site terminated by sponsor|0
5423205|NCT02513550|18720628|P3|Double Blind Treatment Period|Site terminated by sponsor|3
5423206|NCT02513550|18720629|P2|Double Blind Treatment Period|Site terminated by sponsor|1
5423207|NCT02513550|18720630|P1|Double Blind Treatment Period|Site terminated by sponsor|1
5423208|NCT02513550|18720625|P6|Double Blind Treatment Period|Physician Decision|0
5423209|NCT02513550|18720626|P5|Double Blind Treatment Period|Physician Decision|0
5423210|NCT02513550|18720627|P4|Double Blind Treatment Period|Physician Decision|0
5423211|NCT02513550|18720628|P3|Double Blind Treatment Period|Physician Decision|4
5423212|NCT02513550|18720629|P2|Double Blind Treatment Period|Physician Decision|0
5423213|NCT02513550|18720630|P1|Double Blind Treatment Period|Physician Decision|2
5423214|NCT02513550|18720625|P6|Double Blind Treatment Period|Protocol Violation|0
5423215|NCT02513550|18720626|P5|Double Blind Treatment Period|Protocol Violation|0
5423216|NCT02513550|18720627|P4|Double Blind Treatment Period|Protocol Violation|0
5423217|NCT02513550|18720628|P3|Double Blind Treatment Period|Protocol Violation|4
5423218|NCT02513550|18720629|P2|Double Blind Treatment Period|Protocol Violation|1
5423219|NCT02513550|18720630|P1|Double Blind Treatment Period|Protocol Violation|1
5423220|NCT02513550|18720625|P6|Double Blind Treatment Period|Lack of Efficacy|0
5423221|NCT02513550|18720626|P5|Double Blind Treatment Period|Lack of Efficacy|0
5423222|NCT02513550|18720627|P4|Double Blind Treatment Period|Lack of Efficacy|0
5423223|NCT02513550|18720628|P3|Double Blind Treatment Period|Lack of Efficacy|6
5423224|NCT02513550|18720629|P2|Double Blind Treatment Period|Lack of Efficacy|5
5423225|NCT02513550|18720630|P1|Double Blind Treatment Period|Lack of Efficacy|4
5423226|NCT02513550|18720625|P6|Double Blind Treatment Period|Lost to Follow-up|1
5423227|NCT02513550|18720626|P5|Double Blind Treatment Period|Lost to Follow-up|0
5423228|NCT02513550|18720627|P4|Double Blind Treatment Period|Lost to Follow-up|0
5423229|NCT02513550|18720628|P3|Double Blind Treatment Period|Lost to Follow-up|11
5423230|NCT02513550|18720629|P2|Double Blind Treatment Period|Lost to Follow-up|7
5423231|NCT02513550|18720630|P1|Double Blind Treatment Period|Lost to Follow-up|9
5423232|NCT02513550|18720625|P6|Double Blind Treatment Period|Adverse Event|0
5423233|NCT02513550|18720626|P5|Double Blind Treatment Period|Adverse Event|1
5423234|NCT02513550|18720627|P4|Double Blind Treatment Period|Adverse Event|0
5423235|NCT02513550|18720628|P3|Double Blind Treatment Period|Adverse Event|17
5423236|NCT02513550|18720629|P2|Double Blind Treatment Period|Adverse Event|13
5423237|NCT02513550|18720630|P1|Double Blind Treatment Period|Adverse Event|5
5423238|NCT02513550|18720625|P6|Double Blind Treatment Period|Withdrawal by Subject|0
5423239|NCT02513550|18720626|P5|Double Blind Treatment Period|Withdrawal by Subject|0
5423240|NCT02513550|18720627|P4|Double Blind Treatment Period|Withdrawal by Subject|0
5423241|NCT02513550|18720628|P3|Double Blind Treatment Period|Withdrawal by Subject|25
5423242|NCT02513550|18720629|P2|Double Blind Treatment Period|Withdrawal by Subject|11
5423243|NCT02513550|18720630|P1|Double Blind Treatment Period|Withdrawal by Subject|11
5423244|NCT02513472|18720724|P2|Overall Study|Other|3
5423245|NCT02513472|18720725|P1|Overall Study|Other|3
5423246|NCT02513472|18720724|P2|Overall Study|Treatment Completed as per Protocol|1
5423247|NCT02513472|18720725|P1|Overall Study|Treatment Completed as per Protocol|3
5423248|NCT02513472|18720724|P2|Overall Study|Subject Choice|6
5423249|NCT02513472|18720725|P1|Overall Study|Subject Choice|2
5423250|NCT02513472|18720724|P2|Overall Study|Withdrawal by Subject|4
5423251|NCT02513472|18720725|P1|Overall Study|Withdrawal by Subject|0
5423252|NCT02513472|18720724|P2|Overall Study|Adverse Event|11
5423253|NCT02513472|18720725|P1|Overall Study|Adverse Event|7
5423254|NCT02513472|18720724|P2|Overall Study|Clinical Disease Progression|12
5423255|NCT02513472|18720725|P1|Overall Study|Clinical Disease Progression|5
5423256|NCT02513472|18720724|P2|Overall Study|Radiological Disease Progression|56
5423257|NCT02513472|18720725|P1|Overall Study|Radiological Disease Progression|45
5423258|NCT02513459|18720760|P1|Overall Study|Surgery planned-- not done|1
5423259|NCT02513459|18720760|P1|Overall Study|Reproductive plans|1
5423260|NCT02513459|18720760|P1|Overall Study|Lack of response|1
5423261|NCT02513459|18720760|P1|Overall Study|Subject decision|2
5423262|NCT02513459|18720760|P1|Overall Study|Pregnancy|2
5423263|NCT02513459|18720760|P1|Overall Study|Loss of efficacy|2
5423264|NCT02513459|18720760|P1|Overall Study|Withdrew consent|5
5423265|NCT02513459|18720760|P1|Overall Study|Adverse Event|7
5423266|NCT02513160|18720828|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
5423267|NCT02513160|18720829|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
5423268|NCT02513160|18720830|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
5423269|NCT02513160|18720831|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
5423270|NCT02513160|18720828|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
5423271|NCT02513160|18720829|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
5423272|NCT02513160|18720830|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
5423273|NCT02513160|18720831|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
5423274|NCT02513160|18720828|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
5423275|NCT02513160|18720829|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
5423276|NCT02513160|18720830|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
5423277|NCT02513160|18720831|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
5423278|NCT02513160|18720828|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
5423279|NCT02513160|18720829|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
5423280|NCT02513160|18720830|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
5423281|NCT02513160|18720831|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
5423282|NCT02513160|18720828|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
5423283|NCT02513160|18720829|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
5423284|NCT02513160|18720830|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
5423285|NCT02513160|18720831|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
5423286|NCT02513160|18720828|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
5423287|NCT02513160|18720829|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
5423288|NCT02513160|18720830|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
5423289|NCT02513160|18720831|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
5423290|NCT02513160|18720828|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
5423291|NCT02513160|18720829|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
5423292|NCT02513160|18720830|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
5423293|NCT02513160|18720831|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
5423294|NCT02513160|18720828|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
5423295|NCT02513160|18720829|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
5423296|NCT02513160|18720830|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
5423297|NCT02513160|18720831|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
5423298|NCT02513160|18720828|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
5423299|NCT02513160|18720829|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
5423300|NCT02513160|18720830|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
5423301|NCT02513160|18720831|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
5423302|NCT02513160|18720828|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
5423303|NCT02513160|18720829|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
5423304|NCT02513160|18720830|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
5423305|NCT02513160|18720831|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
5423306|NCT02513160|18720828|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
5423307|NCT02513160|18720829|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
5423308|NCT02513160|18720830|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
5423309|NCT02513160|18720831|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
5423310|NCT02513160|18720828|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
5423311|NCT02513160|18720829|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
5423312|NCT02513160|18720830|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
5423313|NCT02513160|18720831|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
5423314|NCT02513095|18720889|P2|Overall Study|Stampede resulted in transfers out of ER|16
5423315|NCT02513095|18720890|P1|Overall Study|Stampede resulted in transfers out of ER|14
5423316|NCT02512861|18720941|P2|Overall Study|Withdrawal by Subject|1
5423317|NCT02512861|18720942|P1|Overall Study|Withdrawal by Subject|0
5423318|NCT02512861|18720941|P2|Overall Study|Physician Decision|1
5423319|NCT02512861|18720942|P1|Overall Study|Physician Decision|3
5423320|NCT02512861|18720941|P2|Overall Study|Protocol Violation|7
5423321|NCT02512861|18720942|P1|Overall Study|Protocol Violation|3
5423322|NCT02512302|18721220|P10|Period 4|Adverse Event|0
5423323|NCT02512302|18721221|P9|Period 4|Adverse Event|0
5423324|NCT02512302|18721222|P8|Period 4|Adverse Event|0
5423325|NCT02512302|18721223|P7|Period 4|Adverse Event|1
5423326|NCT02512302|18721224|P6|Period 4|Adverse Event|0
5423327|NCT02512302|18721225|P5|Period 4|Adverse Event|0
5423328|NCT02512302|18721226|P4|Period 4|Adverse Event|0
5423329|NCT02512302|18721227|P3|Period 4|Adverse Event|0
5423330|NCT02512302|18721228|P2|Period 4|Adverse Event|0
5423331|NCT02512302|18721229|P1|Period 4|Adverse Event|0
5423332|NCT02512302|18721220|P10|Period 3|Lost to Follow-up|0
5423333|NCT02512302|18721221|P9|Period 3|Lost to Follow-up|0
5423334|NCT02512302|18721222|P8|Period 3|Lost to Follow-up|0
5423335|NCT02512302|18721223|P7|Period 3|Lost to Follow-up|0
5423336|NCT02512302|18721224|P6|Period 3|Lost to Follow-up|0
5423337|NCT02512302|18721225|P5|Period 3|Lost to Follow-up|0
5423338|NCT02512302|18721226|P4|Period 3|Lost to Follow-up|0
5423339|NCT02512302|18721227|P3|Period 3|Lost to Follow-up|1
5423340|NCT02512302|18721228|P2|Period 3|Lost to Follow-up|0
5423341|NCT02512302|18721229|P1|Period 3|Lost to Follow-up|0
5423342|NCT02512302|18721220|P10|Period 2|Adverse Event|1
5423343|NCT02512302|18721221|P9|Period 2|Adverse Event|0
5423344|NCT02512302|18721222|P8|Period 2|Adverse Event|0
5423345|NCT02512302|18721223|P7|Period 2|Adverse Event|0
5423346|NCT02512302|18721224|P6|Period 2|Adverse Event|0
5423347|NCT02512302|18721225|P5|Period 2|Adverse Event|0
5423348|NCT02512302|18721226|P4|Period 2|Adverse Event|0
5423349|NCT02512302|18721227|P3|Period 2|Adverse Event|0
5423350|NCT02512302|18721228|P2|Period 2|Adverse Event|0
5423351|NCT02512302|18721229|P1|Period 2|Adverse Event|0
5423352|NCT02512302|18721220|P10|Period 1|Adverse Event|0
5423353|NCT02512302|18721221|P9|Period 1|Adverse Event|0
5423354|NCT02512302|18721222|P8|Period 1|Adverse Event|0
5423355|NCT02512302|18721223|P7|Period 1|Adverse Event|0
5423356|NCT02512302|18721224|P6|Period 1|Adverse Event|0
5423357|NCT02512302|18721225|P5|Period 1|Adverse Event|0
5423358|NCT02512302|18721226|P4|Period 1|Adverse Event|0
5423359|NCT02512302|18721227|P3|Period 1|Adverse Event|0
5423360|NCT02512302|18721228|P2|Period 1|Adverse Event|1
5423361|NCT02512302|18721229|P1|Period 1|Adverse Event|0
5423362|NCT02512068|18721345|P2|Overall Study|Reason Not Specified|5
5423363|NCT02512068|18721346|P1|Overall Study|Reason Not Specified|3
5423364|NCT02512068|18721345|P2|Overall Study|Lack of Efficacy|1
5423365|NCT02512068|18721346|P1|Overall Study|Lack of Efficacy|0
5423366|NCT02512068|18721345|P2|Overall Study|Voluntary Withdrawal|1
5423367|NCT02512068|18721346|P1|Overall Study|Voluntary Withdrawal|0
5423368|NCT02512068|18721345|P2|Overall Study|Major Protocol Deviation|0
5423369|NCT02512068|18721346|P1|Overall Study|Major Protocol Deviation|1
5423370|NCT02512068|18721345|P2|Overall Study|Pretreatment Event/Adverse Event|6
5423371|NCT02512068|18721346|P1|Overall Study|Pretreatment Event/Adverse Event|8
5423372|NCT02512042|18721372|P2|Overall Study|Other|11
5423373|NCT02512042|18721373|P1|Overall Study|Other|11
5423374|NCT02512042|18721372|P2|Overall Study|Lost to Follow-up|2
5423375|NCT02512042|18721373|P1|Overall Study|Lost to Follow-up|5
5423376|NCT02512042|18721372|P2|Overall Study|Non-compliance with study drug|2
5423377|NCT02512042|18721373|P1|Overall Study|Non-compliance with study drug|1
5423378|NCT02512042|18721372|P2|Overall Study|Withdrawal by Subject|6
5423379|NCT02512042|18721373|P1|Overall Study|Withdrawal by Subject|6
5423380|NCT02512042|18721372|P2|Overall Study|Adverse Event|4
5423381|NCT02512042|18721373|P1|Overall Study|Adverse Event|0
5423382|NCT02511782|18721382|P3|Overall Study|Withdrawal by Subject|0
5423383|NCT02511782|18721383|P2|Overall Study|Withdrawal by Subject|0
5423384|NCT02511782|18721384|P1|Overall Study|Withdrawal by Subject|1
5423385|NCT02511678|18721410|P1|Overall Study|Received Radiation Treatment|1
5423386|NCT02511678|18721410|P1|Overall Study|Protocol Violation|1
5423387|NCT02511678|18721410|P1|Overall Study|Biopsy was Negative|1
5423388|NCT02511678|18721410|P1|Overall Study|Required Radiofrequency Ablation|1
5423389|NCT02511678|18721410|P1|Overall Study|Oncologist Cancelled Study Cryoablation|1
5423390|NCT02511678|18721410|P1|Overall Study|Targeted Therapy to Index Tumor Required|5
5423391|NCT02511678|18721410|P1|Overall Study|Adverse Event|1
5423392|NCT02511678|18721410|P1|Overall Study|Death|19
5423393|NCT02511678|18721410|P1|Overall Study|Lost to Follow-up|4
5423394|NCT02511678|18721410|P1|Overall Study|Withdrawal by Subject|2
5423395|NCT02511431|18721492|P6|Treatment|Lost to Follow-up|1
5423396|NCT02511431|18721493|P5|Treatment|Lost to Follow-up|0
5423397|NCT02511431|18721494|P4|Treatment|Lost to Follow-up|0
5423398|NCT02511431|18721495|P3|Treatment|Lost to Follow-up|1
5423399|NCT02511431|18721496|P2|Treatment|Lost to Follow-up|0
5423400|NCT02511431|18721497|P1|Treatment|Lost to Follow-up|0
5423401|NCT02511184|18721524|P2|Overall Study|Withdrawal by Subject|1
5423402|NCT02511184|18721525|P1|Overall Study|Withdrawal by Subject|0
5423403|NCT02511184|18721524|P2|Overall Study|Study terminated by sponsor|5
5423404|NCT02511184|18721525|P1|Overall Study|Study terminated by sponsor|1
5423405|NCT02511184|18721524|P2|Overall Study|Lost to Follow-up|1
5423406|NCT02511184|18721525|P1|Overall Study|Lost to Follow-up|0
5423407|NCT02511184|18721524|P2|Overall Study|Death|0
5423408|NCT02511184|18721525|P1|Overall Study|Death|1
5423409|NCT02510820|18721575|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
5423410|NCT02510820|18721576|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5423411|NCT02510820|18721575|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
5423412|NCT02510820|18721576|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
5423413|NCT02510664|18721617|P3|Overall Study|Time Constraints|0
5423414|NCT02510664|18721618|P2|Overall Study|Time Constraints|1
5423415|NCT02510664|18721619|P1|Overall Study|Time Constraints|1
5423416|NCT02510664|18721617|P3|Overall Study|Provider Retired/No Time to Reschedule|0
5423417|NCT02510664|18721618|P2|Overall Study|Provider Retired/No Time to Reschedule|10
5423418|NCT02510664|18721619|P1|Overall Study|Provider Retired/No Time to Reschedule|10
5423419|NCT02510664|18721617|P3|Overall Study|Transferred Care|0
5423420|NCT02510664|18721618|P2|Overall Study|Transferred Care|9
5423421|NCT02510664|18721619|P1|Overall Study|Transferred Care|9
5423422|NCT02510014|18721661|P2|Treatment Period|Incarceration, pregnancy, misc|5
5423423|NCT02510014|18721662|P1|Treatment Period|Incarceration, pregnancy, misc|29
5423424|NCT02510014|18721661|P2|Treatment Period|Protocol Violation|4
5423425|NCT02510014|18721662|P1|Treatment Period|Protocol Violation|4
5423426|NCT02510014|18721661|P2|Treatment Period|Withdrawn by the investigator|1
5423427|NCT02510014|18721662|P1|Treatment Period|Withdrawn by the investigator|7
5423428|NCT02510014|18721661|P2|Treatment Period|Withdrawal by Subject|24
5423429|NCT02510014|18721662|P1|Treatment Period|Withdrawal by Subject|67
5423430|NCT02510014|18721661|P2|Treatment Period|Physician Decision|0
5423431|NCT02510014|18721662|P1|Treatment Period|Physician Decision|5
5423432|NCT02510014|18721661|P2|Treatment Period|Lost to Follow-up|19
5423433|NCT02510014|18721662|P1|Treatment Period|Lost to Follow-up|80
5423434|NCT02510014|18721661|P2|Treatment Period|Withdrawal symptoms|0
5423435|NCT02510014|18721662|P1|Treatment Period|Withdrawal symptoms|3
5423436|NCT02510014|18721661|P2|Treatment Period|Adverse Event|4
5423437|NCT02510014|18721662|P1|Treatment Period|Adverse Event|11
5423438|NCT02510014|18721661|P2|Run-In Period (Days -14 to Day -1)|Other|1
5423439|NCT02510014|18721662|P1|Run-In Period (Days -14 to Day -1)|Other|19
5423440|NCT02510014|18721661|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
5423441|NCT02510014|18721662|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
5423442|NCT02510014|18721661|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
5423443|NCT02510014|18721662|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
5423444|NCT02510014|18721661|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
5423445|NCT02510014|18721662|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
5423446|NCT02510014|18721661|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
5423447|NCT02510014|18721662|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
5423448|NCT02510014|18721661|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
5423449|NCT02510014|18721662|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
5423450|NCT02510014|18721661|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
5423451|NCT02510014|18721662|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
5423452|NCT02510014|18721661|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
5423453|NCT02510014|18721662|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
5423454|NCT02509156|18721757|P2|Randomized Phase|Withdrawal by Subject|1
5423455|NCT02509156|18721758|P1|Randomized Phase|Withdrawal by Subject|1
5423456|NCT02509156|18721757|P2|Randomized Phase|Death|0
5423457|NCT02509156|18721758|P1|Randomized Phase|Death|1
5423458|NCT02509117|18721828|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
5423459|NCT02509117|18721829|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5423460|NCT02509117|18721830|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5423461|NCT02509117|18721831|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5423462|NCT02509117|18721832|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5423463|NCT02509117|18721833|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5423464|NCT02509117|18721834|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5423465|NCT02509117|18721835|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5423466|NCT02509117|18721836|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5423467|NCT02509117|18721837|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
5423468|NCT02509117|18721828|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
5423469|NCT02509117|18721829|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5423470|NCT02509117|18721830|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5423471|NCT02509117|18721831|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5423472|NCT02509117|18721832|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5423473|NCT02509117|18721833|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5423474|NCT02509117|18721834|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5423475|NCT02509117|18721835|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5423476|NCT02509117|18721836|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5423477|NCT02509117|18721837|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
5423478|NCT02509117|18721828|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5423479|NCT02509117|18721829|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5423480|NCT02509117|18721830|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5423481|NCT02509117|18721831|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5423482|NCT02509117|18721832|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5423483|NCT02509117|18721833|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5423484|NCT02509117|18721834|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5423485|NCT02509117|18721835|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5423486|NCT02509117|18721836|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
5423487|NCT02509117|18721837|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
5423488|NCT02509078|18722048|P2|Overall Study|Protocol Violation|1
5423489|NCT02509078|18722049|P1|Overall Study|Protocol Violation|1
5423490|NCT02509026|18722192|P1|Retreatment Period (12 Weeks)|Enrolled but not treated|1
5423491|NCT02509026|18722192|P1|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
5423492|NCT02509026|18722192|P1|Retreatment Period (12 Weeks)|Lost to Follow-up|1
5423493|NCT02509026|18722192|P1|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
5423494|NCT02509026|18722192|P1|Withdrawal Period (40 Weeks)|Protocol Violation|2
5423495|NCT02509026|18722192|P1|Induction Period (24 Weeks)|Enrolled but not treated|1
5423496|NCT02509026|18722192|P1|Induction Period (24 Weeks)|Withdrawal by Subject|1
5423497|NCT02509026|18722192|P1|Induction Period (24 Weeks)|Protocol Violation|1
5423498|NCT02509026|18722192|P1|Induction Period (24 Weeks)|Other|2
5423499|NCT02509026|18722192|P1|Induction Period (24 Weeks)|Lost to Follow-up|1
5423500|NCT02509026|18722192|P1|Induction Period (24 Weeks)|Lack of Efficacy|6
5423501|NCT02509026|18722192|P1|Induction Period (24 Weeks)|Eligibility Criteria|5
5423502|NCT02509026|18722192|P1|Induction Period (24 Weeks)|Adverse Event|5
5423503|NCT02508935|18722389|P1|Overall Study|Trial terminated by sponsor|5
5423504|NCT02508935|18722389|P1|Overall Study|Physician Decision|1
5423505|NCT02508935|18722389|P1|Overall Study|Protocol Violation|1
5423506|NCT02508935|18722389|P1|Overall Study|Adverse Event|3
5423507|NCT02508935|18722389|P1|Overall Study|Emesis|3
5423508|NCT02508935|18722389|P1|Overall Study|Pain Score <4|1
5423509|NCT02508935|18722389|P1|Overall Study|Withdrawal by Caregiver|8
5423510|NCT02508935|18722389|P1|Overall Study|Withdrawal by Subject|1
5423511|NCT02508701|18722405|P4|Overall Study|Lost to Follow-up|3
5423512|NCT02508701|18722406|P3|Overall Study|Lost to Follow-up|5
5423513|NCT02508701|18722407|P2|Overall Study|Lost to Follow-up|5
5423514|NCT02508701|18722408|P1|Overall Study|Lost to Follow-up|9
5423515|NCT02508428|18722457|P2|Overall Study|Incomplete follow-up|15
5423516|NCT02508428|18722458|P1|Overall Study|Incomplete follow-up|17
5423517|NCT02508428|18722457|P2|Overall Study|Liner revised|19
5423518|NCT02508428|18722458|P1|Overall Study|Liner revised|3
5423519|NCT02508428|18722457|P2|Overall Study|Death|33
5423520|NCT02508428|18722458|P1|Overall Study|Death|32
5423521|NCT02508194|18722510|P2|Overall Study|Principal Investigator Decision|2
5423522|NCT02508194|18722511|P1|Overall Study|Principal Investigator Decision|1
5423523|NCT02508194|18722510|P2|Overall Study|Error in Randomization|3
5423524|NCT02508194|18722511|P1|Overall Study|Error in Randomization|1
5423525|NCT02508194|18722510|P2|Overall Study|Withdrawal by Subject|18
5423526|NCT02508194|18722511|P1|Overall Study|Withdrawal by Subject|20
5423527|NCT02508194|18722510|P2|Overall Study|Lost to Follow-up|18
5423528|NCT02508194|18722511|P1|Overall Study|Lost to Follow-up|25
5423529|NCT02508194|18722510|P2|Overall Study|Death|3
5423530|NCT02508194|18722511|P1|Overall Study|Death|5
5423531|NCT02508116|18722551|P2|Overall Study|Physician Decision|0
5423532|NCT02508116|18722552|P1|Overall Study|Physician Decision|2
5423533|NCT02508116|18722551|P2|Overall Study|Protocol Violation|2
5423534|NCT02508116|18722552|P1|Overall Study|Protocol Violation|1
5423535|NCT02508116|18722551|P2|Overall Study|Withdrawal by Subject|2
5423536|NCT02508116|18722552|P1|Overall Study|Withdrawal by Subject|3
5423537|NCT02508116|18722551|P2|Overall Study|Lost to Follow-up|3
5423538|NCT02508116|18722552|P1|Overall Study|Lost to Follow-up|2
5423539|NCT02507973|18722579|P1|Overall Study|Adverse Event|1
5423540|NCT02507752|18722585|P1|Overall Study|Participant didn't perform visit Week 24|1
5423541|NCT02507752|18722585|P1|Overall Study|Participant didn't perform visit Week 12|1
5423542|NCT02507752|18722585|P1|Overall Study|Infusion reaction at first infusion|1
5423543|NCT02507752|18722585|P1|Overall Study|Lost to Follow-up|7
5423544|NCT02507752|18722585|P1|Overall Study|Protocol Violation|6
5423545|NCT02507752|18722585|P1|Overall Study|Adverse Event|1
5423546|NCT02507375|18722629|P2|Overall Study|Adverse Event|1
5423547|NCT02507375|18722630|P1|Overall Study|Adverse Event|0
5423548|NCT02507375|18722629|P2|Overall Study|Refused treatment|1
5423549|NCT02507375|18722630|P1|Overall Study|Refused treatment|0
5423550|NCT02507375|18722629|P2|Overall Study|Death|1
5423551|NCT02507375|18722630|P1|Overall Study|Death|0
5423552|NCT02507375|18722629|P2|Overall Study|Progressive Disease|5
5423553|NCT02507375|18722630|P1|Overall Study|Progressive Disease|4
5423554|NCT02507349|18722649|P2|Overall Study|Lost to Follow-up|144
5423555|NCT02507349|18722650|P1|Overall Study|Lost to Follow-up|174
5423556|NCT02507349|18722649|P2|Overall Study|Withdrawal by Subject|1
5423557|NCT02507349|18722650|P1|Overall Study|Withdrawal by Subject|1
5423558|NCT02507349|18722649|P2|Overall Study|Death|16
5423559|NCT02507349|18722650|P1|Overall Study|Death|12
5423560|NCT02507219|18722674|P6|Overall Study|Withdrawal by Subject|0
5423561|NCT02507219|18722675|P5|Overall Study|Withdrawal by Subject|1
5423562|NCT02507219|18722676|P4|Overall Study|Withdrawal by Subject|0
5423563|NCT02507219|18722677|P3|Overall Study|Withdrawal by Subject|0
5423564|NCT02507219|18722678|P2|Overall Study|Withdrawal by Subject|0
5423565|NCT02507219|18722679|P1|Overall Study|Withdrawal by Subject|0
5423566|NCT02507219|18722674|P6|Overall Study|Physician Decision|0
5423567|NCT02507219|18722675|P5|Overall Study|Physician Decision|0
5423568|NCT02507219|18722676|P4|Overall Study|Physician Decision|0
5423569|NCT02507219|18722677|P3|Overall Study|Physician Decision|0
5423570|NCT02507219|18722678|P2|Overall Study|Physician Decision|0
5423571|NCT02507219|18722679|P1|Overall Study|Physician Decision|1
5423572|NCT02506881|18722715|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
5423573|NCT02506881|18722716|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
5423729|NCT02504892|18723272|P1|Overall Study|Adverse event-pneumonitis|2
5423574|NCT02506881|18722717|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
5423575|NCT02506881|18722718|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
5423576|NCT02506881|18722715|P4|First Intervention (Day 1)|Withdrawal by Subject|0
5423577|NCT02506881|18722716|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5423578|NCT02506881|18722717|P2|First Intervention (Day 1)|Withdrawal by Subject|0
5423579|NCT02506881|18722718|P1|First Intervention (Day 1)|Withdrawal by Subject|1
5423580|NCT02506881|18722715|P4|First Intervention (Day 1)|Protocol Violation|0
5423581|NCT02506881|18722716|P3|First Intervention (Day 1)|Protocol Violation|1
5423582|NCT02506881|18722717|P2|First Intervention (Day 1)|Protocol Violation|0
5423583|NCT02506881|18722718|P1|First Intervention (Day 1)|Protocol Violation|0
5423584|NCT02506816|18722791|P1|Overall Study|Adverse Event|3
5423585|NCT02506257|18722917|P4|Overall Study|Protocol Violation|0
5423586|NCT02506257|18722918|P3|Overall Study|Protocol Violation|1
5423587|NCT02506257|18722919|P2|Overall Study|Protocol Violation|0
5423588|NCT02506257|18722920|P1|Overall Study|Protocol Violation|0
5423589|NCT02506257|18722917|P4|Overall Study|Adverse Event|0
5423590|NCT02506257|18722918|P3|Overall Study|Adverse Event|3
5423591|NCT02506257|18722919|P2|Overall Study|Adverse Event|2
5423592|NCT02506257|18722920|P1|Overall Study|Adverse Event|0
5423593|NCT02506101|18722952|P2|Overall Study|No enrollment and staff unavailability|0
5423594|NCT02506101|18722953|P1|Overall Study|No enrollment and staff unavailability|1
5423595|NCT02506101|18722952|P2|Overall Study|Transportation issues|0
5423596|NCT02506101|18722953|P1|Overall Study|Transportation issues|1
5423597|NCT02506036|18722969|P2|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
5423598|NCT02506036|18722970|P1|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
5423599|NCT02506036|18722969|P2|First Intervention (4-6 Weeks)|Lost to Follow-up|1
5423600|NCT02506036|18722970|P1|First Intervention (4-6 Weeks)|Lost to Follow-up|0
5423601|NCT02506036|18722969|P2|First Intervention (4-6 Weeks)|Death|0
5423602|NCT02506036|18722970|P1|First Intervention (4-6 Weeks)|Death|1
5423603|NCT02505945|18722978|P2|Overall Study|Lost to Follow-up|1
5423604|NCT02505945|18722979|P1|Overall Study|Lost to Follow-up|6
5423605|NCT02505945|18722978|P2|Overall Study|Physician Decision|1
5423606|NCT02505945|18722979|P1|Overall Study|Physician Decision|2
5423607|NCT02505945|18722978|P2|Overall Study|Adverse Event|0
5423608|NCT02505945|18722979|P1|Overall Study|Adverse Event|1
5423609|NCT02505945|18722978|P2|Overall Study|Withdrawal by Subject|2
5423610|NCT02505945|18722979|P1|Overall Study|Withdrawal by Subject|13
5423611|NCT02505867|18723000|P2|Overall Study|Lack of Efficacy|6
5423612|NCT02505867|18723001|P1|Overall Study|Lack of Efficacy|6
5423613|NCT02505542|18723007|P4|Part B: Double-Blind Period|Subject did not complete all visits|0
5423614|NCT02505542|18723008|P3|Part B: Double-Blind Period|Subject did not complete all visits|0
5423615|NCT02505542|18723009|P2|Part B: Double-Blind Period|Subject did not complete all visits|1
5423616|NCT02505542|18723010|P1|Part B: Double-Blind Period|Subject did not complete all visits|0
5423617|NCT02505542|18723007|P4|Part B: Double-Blind Period|Miscalculation|0
5423618|NCT02505542|18723008|P3|Part B: Double-Blind Period|Miscalculation|0
5423619|NCT02505542|18723009|P2|Part B: Double-Blind Period|Miscalculation|1
5423620|NCT02505542|18723010|P1|Part B: Double-Blind Period|Miscalculation|0
5423621|NCT02505542|18723007|P4|Part B: Double-Blind Period|Lack of Efficacy|0
5423622|NCT02505542|18723008|P3|Part B: Double-Blind Period|Lack of Efficacy|0
5423623|NCT02505542|18723009|P2|Part B: Double-Blind Period|Lack of Efficacy|1
5423624|NCT02505542|18723010|P1|Part B: Double-Blind Period|Lack of Efficacy|0
5423625|NCT02505542|18723007|P4|Part B: Double-Blind Period|Patient was moved from the country|1
5423626|NCT02505542|18723008|P3|Part B: Double-Blind Period|Patient was moved from the country|0
5423627|NCT02505542|18723009|P2|Part B: Double-Blind Period|Patient was moved from the country|0
5423628|NCT02505542|18723010|P1|Part B: Double-Blind Period|Patient was moved from the country|0
5423629|NCT02505542|18723007|P4|Part B: Double-Blind Period|Week 94 missed|0
5423630|NCT02505542|18723008|P3|Part B: Double-Blind Period|Week 94 missed|1
5423631|NCT02505542|18723009|P2|Part B: Double-Blind Period|Week 94 missed|0
5423632|NCT02505542|18723010|P1|Part B: Double-Blind Period|Week 94 missed|0
5423633|NCT02505542|18723007|P4|Part B: Double-Blind Period|Planning pregnancy|0
5423634|NCT02505542|18723008|P3|Part B: Double-Blind Period|Planning pregnancy|0
5423635|NCT02505542|18723009|P2|Part B: Double-Blind Period|Planning pregnancy|1
5423636|NCT02505542|18723010|P1|Part B: Double-Blind Period|Planning pregnancy|0
5423637|NCT02505542|18723007|P4|Part B: Double-Blind Period|Withdrawal by Subject|2
5423638|NCT02505542|18723008|P3|Part B: Double-Blind Period|Withdrawal by Subject|7
5423639|NCT02505542|18723009|P2|Part B: Double-Blind Period|Withdrawal by Subject|8
5423640|NCT02505542|18723010|P1|Part B: Double-Blind Period|Withdrawal by Subject|0
5423641|NCT02505542|18723007|P4|Part B: Double-Blind Period|Lost to Follow-up|1
5423642|NCT02505542|18723008|P3|Part B: Double-Blind Period|Lost to Follow-up|0
5423643|NCT02505542|18723009|P2|Part B: Double-Blind Period|Lost to Follow-up|0
5423644|NCT02505542|18723010|P1|Part B: Double-Blind Period|Lost to Follow-up|0
5423645|NCT02505542|18723007|P4|Part B: Double-Blind Period|Adverse Event|3
5423646|NCT02505542|18723008|P3|Part B: Double-Blind Period|Adverse Event|1
5423647|NCT02505542|18723009|P2|Part B: Double-Blind Period|Adverse Event|0
5423648|NCT02505542|18723010|P1|Part B: Double-Blind Period|Adverse Event|0
5423649|NCT02505542|18723007|P4|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
5423650|NCT02505542|18723008|P3|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
5423651|NCT02505542|18723009|P2|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
5423652|NCT02505542|18723010|P1|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
5423653|NCT02505542|18723007|P4|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
5423654|NCT02505542|18723008|P3|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
5423655|NCT02505542|18723009|P2|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
5423656|NCT02505542|18723010|P1|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
5423657|NCT02505542|18723007|P4|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
5423658|NCT02505542|18723008|P3|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
5423659|NCT02505542|18723009|P2|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
5423660|NCT02505542|18723010|P1|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
5423661|NCT02505542|18723007|P4|Part A: Open-Label Period|Non-compliance|0
5423662|NCT02505542|18723008|P3|Part A: Open-Label Period|Non-compliance|0
5423663|NCT02505542|18723009|P2|Part A: Open-Label Period|Non-compliance|0
5423664|NCT02505542|18723010|P1|Part A: Open-Label Period|Non-compliance|1
5423665|NCT02505542|18723007|P4|Part A: Open-Label Period|Screening failure (detected too late)|0
5423666|NCT02505542|18723008|P3|Part A: Open-Label Period|Screening failure (detected too late)|0
5423667|NCT02505542|18723009|P2|Part A: Open-Label Period|Screening failure (detected too late)|0
5423668|NCT02505542|18723010|P1|Part A: Open-Label Period|Screening failure (detected too late)|1
5423669|NCT02505542|18723007|P4|Part A: Open-Label Period|Medical monitor decision|0
5423670|NCT02505542|18723008|P3|Part A: Open-Label Period|Medical monitor decision|0
5423671|NCT02505542|18723009|P2|Part A: Open-Label Period|Medical monitor decision|0
5423672|NCT02505542|18723010|P1|Part A: Open-Label Period|Medical monitor decision|1
5423673|NCT02505542|18723007|P4|Part A: Open-Label Period|Sponsor directive|0
5423674|NCT02505542|18723008|P3|Part A: Open-Label Period|Sponsor directive|0
5423675|NCT02505542|18723009|P2|Part A: Open-Label Period|Sponsor directive|0
5423676|NCT02505542|18723010|P1|Part A: Open-Label Period|Sponsor directive|1
5423677|NCT02505542|18723007|P4|Part A: Open-Label Period|Pregnancy|0
5423678|NCT02505542|18723008|P3|Part A: Open-Label Period|Pregnancy|0
5423679|NCT02505542|18723009|P2|Part A: Open-Label Period|Pregnancy|0
5423680|NCT02505542|18723010|P1|Part A: Open-Label Period|Pregnancy|2
5423681|NCT02505542|18723007|P4|Part A: Open-Label Period|Participant did not attend week 48 visit|0
5423682|NCT02505542|18723008|P3|Part A: Open-Label Period|Participant did not attend week 48 visit|0
5423683|NCT02505542|18723009|P2|Part A: Open-Label Period|Participant did not attend week 48 visit|0
5423684|NCT02505542|18723010|P1|Part A: Open-Label Period|Participant did not attend week 48 visit|1
5423685|NCT02505542|18723007|P4|Part A: Open-Label Period|New medical history available|0
5423686|NCT02505542|18723008|P3|Part A: Open-Label Period|New medical history available|0
5423687|NCT02505542|18723009|P2|Part A: Open-Label Period|New medical history available|0
5423688|NCT02505542|18723010|P1|Part A: Open-Label Period|New medical history available|1
5423689|NCT02505542|18723007|P4|Part A: Open-Label Period|Withdrawal by Subject|0
5423690|NCT02505542|18723008|P3|Part A: Open-Label Period|Withdrawal by Subject|0
5423691|NCT02505542|18723009|P2|Part A: Open-Label Period|Withdrawal by Subject|0
5423692|NCT02505542|18723010|P1|Part A: Open-Label Period|Withdrawal by Subject|27
5423693|NCT02505542|18723007|P4|Part A: Open-Label Period|Lost to Follow-up|0
5423694|NCT02505542|18723008|P3|Part A: Open-Label Period|Lost to Follow-up|0
5423695|NCT02505542|18723009|P2|Part A: Open-Label Period|Lost to Follow-up|0
5423696|NCT02505542|18723010|P1|Part A: Open-Label Period|Lost to Follow-up|5
5423697|NCT02505542|18723007|P4|Part A: Open-Label Period|Protocol Violation|0
5423698|NCT02505542|18723008|P3|Part A: Open-Label Period|Protocol Violation|0
5423699|NCT02505542|18723009|P2|Part A: Open-Label Period|Protocol Violation|0
5423700|NCT02505542|18723010|P1|Part A: Open-Label Period|Protocol Violation|1
5423701|NCT02505542|18723007|P4|Part A: Open-Label Period|Lack of Efficacy|0
5423702|NCT02505542|18723008|P3|Part A: Open-Label Period|Lack of Efficacy|0
5423703|NCT02505542|18723009|P2|Part A: Open-Label Period|Lack of Efficacy|0
5423704|NCT02505542|18723010|P1|Part A: Open-Label Period|Lack of Efficacy|5
5423705|NCT02505542|18723007|P4|Part A: Open-Label Period|Adverse Event|0
5423706|NCT02505542|18723008|P3|Part A: Open-Label Period|Adverse Event|0
5423707|NCT02505542|18723009|P2|Part A: Open-Label Period|Adverse Event|0
5423708|NCT02505542|18723010|P1|Part A: Open-Label Period|Adverse Event|31
5423709|NCT02505334|18723118|P2|Extension Treatment Period|Unclassified|0
5423710|NCT02505334|18723119|P1|Extension Treatment Period|Unclassified|3
5423711|NCT02505334|18723118|P2|Extension Treatment Period|Withdrawal by Subject|0
5423712|NCT02505334|18723119|P1|Extension Treatment Period|Withdrawal by Subject|6
5423713|NCT02505334|18723118|P2|Extension Treatment Period|Lack of Efficacy|0
5423714|NCT02505334|18723119|P1|Extension Treatment Period|Lack of Efficacy|4
5423715|NCT02505334|18723118|P2|Extension Treatment Period|Adverse Event|0
5423716|NCT02505334|18723119|P1|Extension Treatment Period|Adverse Event|5
5423717|NCT02505334|18723118|P2|Main Treatment Period|Unclassified|10
5423718|NCT02505334|18723119|P1|Main Treatment Period|Unclassified|4
5423719|NCT02505334|18723118|P2|Main Treatment Period|Withdrawal by Subject|8
5423720|NCT02505334|18723119|P1|Main Treatment Period|Withdrawal by Subject|1
5423721|NCT02505334|18723118|P2|Main Treatment Period|Protocol Violation|1
5423722|NCT02505334|18723119|P1|Main Treatment Period|Protocol Violation|0
5423723|NCT02505334|18723118|P2|Main Treatment Period|Lack of Efficacy|17
5423724|NCT02505334|18723119|P1|Main Treatment Period|Lack of Efficacy|7
5423725|NCT02505334|18723118|P2|Main Treatment Period|Adverse Event|3
5423726|NCT02505334|18723119|P1|Main Treatment Period|Adverse Event|3
5423727|NCT02505217|18723252|P2|Overall Study|Withdrawal by Subject|2
5423728|NCT02505217|18723253|P1|Overall Study|Withdrawal by Subject|1
5423730|NCT02504827|18723279|P1|Overall Study|Could not produce sputum|1
5423731|NCT02504671|18723318|P6|Overall Study|Protocol defined stopping criteria|3
5423732|NCT02504671|18723319|P5|Overall Study|Protocol defined stopping criteria|3
5423733|NCT02504671|18723320|P4|Overall Study|Protocol defined stopping criteria|5
5423734|NCT02504671|18723321|P3|Overall Study|Protocol defined stopping criteria|3
5423735|NCT02504671|18723322|P2|Overall Study|Protocol defined stopping criteria|4
5423736|NCT02504671|18723323|P1|Overall Study|Protocol defined stopping criteria|7
5423737|NCT02504671|18723318|P6|Overall Study|Lost to Follow-up|1
5423738|NCT02504671|18723319|P5|Overall Study|Lost to Follow-up|0
5423739|NCT02504671|18723320|P4|Overall Study|Lost to Follow-up|0
5423740|NCT02504671|18723321|P3|Overall Study|Lost to Follow-up|2
5423741|NCT02504671|18723322|P2|Overall Study|Lost to Follow-up|0
5423742|NCT02504671|18723323|P1|Overall Study|Lost to Follow-up|0
5423743|NCT02504671|18723318|P6|Overall Study|Protocol Violation|1
5423744|NCT02504671|18723319|P5|Overall Study|Protocol Violation|0
5423745|NCT02504671|18723320|P4|Overall Study|Protocol Violation|0
5423746|NCT02504671|18723321|P3|Overall Study|Protocol Violation|0
5423747|NCT02504671|18723322|P2|Overall Study|Protocol Violation|1
5423748|NCT02504671|18723323|P1|Overall Study|Protocol Violation|2
5423749|NCT02504671|18723318|P6|Overall Study|Adverse Event|2
5423750|NCT02504671|18723319|P5|Overall Study|Adverse Event|0
5423751|NCT02504671|18723320|P4|Overall Study|Adverse Event|1
5423752|NCT02504671|18723321|P3|Overall Study|Adverse Event|0
5423753|NCT02504671|18723322|P2|Overall Study|Adverse Event|1
5423754|NCT02504671|18723323|P1|Overall Study|Adverse Event|1
5423755|NCT02504671|18723318|P6|Overall Study|Lack of Efficacy|4
5423756|NCT02504671|18723319|P5|Overall Study|Lack of Efficacy|4
5423757|NCT02504671|18723320|P4|Overall Study|Lack of Efficacy|0
5423758|NCT02504671|18723321|P3|Overall Study|Lack of Efficacy|1
5423759|NCT02504671|18723322|P2|Overall Study|Lack of Efficacy|3
5423760|NCT02504671|18723323|P1|Overall Study|Lack of Efficacy|1
5423761|NCT02504671|18723318|P6|Overall Study|Withdrawal by Subject|3
5423762|NCT02504671|18723319|P5|Overall Study|Withdrawal by Subject|5
5423763|NCT02504671|18723320|P4|Overall Study|Withdrawal by Subject|4
5423764|NCT02504671|18723321|P3|Overall Study|Withdrawal by Subject|4
5423765|NCT02504671|18723322|P2|Overall Study|Withdrawal by Subject|5
5423766|NCT02504671|18723323|P1|Overall Study|Withdrawal by Subject|1
5423767|NCT02504541|18723495|P1|Overall Study|Multiple|5
5423768|NCT02504541|18723495|P1|Overall Study|Other|2
5423769|NCT02504541|18723495|P1|Overall Study|Termination by Sponsor|1
5423770|NCT02504541|18723495|P1|Overall Study|Protocol Violation|2
5423771|NCT02504541|18723495|P1|Overall Study|Met Stopping Criteria|1
5423772|NCT02504541|18723495|P1|Overall Study|Lost to Follow-up|1
5423773|NCT02504541|18723495|P1|Overall Study|Withdrawal by Subject|4
5423774|NCT02504541|18723495|P1|Overall Study|Adverse Event|4
5423775|NCT02504502|18723501|P2|Crossover to Enhanced Report|Lost to Follow-up|0
5423776|NCT02504502|18723502|P1|Crossover to Enhanced Report|Lost to Follow-up|5
5423777|NCT02504502|18723501|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
5423778|NCT02504502|18723502|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
5423779|NCT02504424|18723508|P1|Overall Study|Withdrawal by Subject|2
5423780|NCT02504320|18723517|P4|Treatment Period 3|Adverse Event|0
5423781|NCT02504320|18723518|P3|Treatment Period 3|Adverse Event|1
5423782|NCT02504320|18723519|P2|Treatment Period 3|Adverse Event|0
5423783|NCT02504320|18723520|P1|Treatment Period 3|Adverse Event|0
5423784|NCT02504320|18723517|P4|Treatment Period 3|Positive Drug Screen|1
5423785|NCT02504320|18723518|P3|Treatment Period 3|Positive Drug Screen|0
5423786|NCT02504320|18723519|P2|Treatment Period 3|Positive Drug Screen|0
5423787|NCT02504320|18723520|P1|Treatment Period 3|Positive Drug Screen|0
5423788|NCT02504320|18723517|P4|Treatment Period 2|Positive Drug Screen|0
5423789|NCT02504320|18723518|P3|Treatment Period 2|Positive Drug Screen|0
5423790|NCT02504320|18723519|P2|Treatment Period 2|Positive Drug Screen|1
5423791|NCT02504320|18723520|P1|Treatment Period 2|Positive Drug Screen|0
5423792|NCT02504320|18723517|P4|Treatment Period 1|Positive Drug Screen|0
5423793|NCT02504320|18723518|P3|Treatment Period 1|Positive Drug Screen|1
5423794|NCT02504320|18723519|P2|Treatment Period 1|Positive Drug Screen|0
5423795|NCT02504320|18723520|P1|Treatment Period 1|Positive Drug Screen|0
5423796|NCT02504294|18723540|P2|Overall Study|Lost to Follow-up|7
5423797|NCT02504294|18723541|P1|Overall Study|Lost to Follow-up|6
5423798|NCT02504294|18723540|P2|Overall Study|Physician Decision|2
5423799|NCT02504294|18723541|P1|Overall Study|Physician Decision|1
5423800|NCT02504294|18723540|P2|Overall Study|Protocol Violation|26
5423801|NCT02504294|18723541|P1|Overall Study|Protocol Violation|27
5423802|NCT02504294|18723540|P2|Overall Study|Withdrawal by Subject|1
5423803|NCT02504294|18723541|P1|Overall Study|Withdrawal by Subject|7
5423804|NCT02504294|18723540|P2|Overall Study|Adverse Event|12
5423805|NCT02504294|18723541|P1|Overall Study|Adverse Event|15
5423806|NCT02504268|18723551|P2|Overall Study|Not Disclosed|0
5423807|NCT02504268|18723552|P1|Overall Study|Not Disclosed|1
5423808|NCT02504268|18723551|P2|Overall Study|Poor/Non-Compliance|2
5423809|NCT02504268|18723552|P1|Overall Study|Poor/Non-Compliance|3
5423810|NCT02504268|18723551|P2|Overall Study|Lack of Efficacy|35
5423811|NCT02504268|18723552|P1|Overall Study|Lack of Efficacy|11
5423812|NCT02504268|18723551|P2|Overall Study|No Longer Meets Study Criteria|3
5423813|NCT02504268|18723552|P1|Overall Study|No Longer Meets Study Criteria|2
5423814|NCT02504268|18723551|P2|Overall Study|Subject Request to Discontinue|3
5423815|NCT02504268|18723552|P1|Overall Study|Subject Request to Discontinue|11
5423816|NCT02504268|18723551|P2|Overall Study|Death|1
5423817|NCT02504268|18723552|P1|Overall Study|Death|1
5423818|NCT02504268|18723551|P2|Overall Study|Lost to Follow-up|6
5423819|NCT02504268|18723552|P1|Overall Study|Lost to Follow-up|3
5423820|NCT02504268|18723551|P2|Overall Study|Pregnancy|0
5423821|NCT02504268|18723552|P1|Overall Study|Pregnancy|2
5423822|NCT02504268|18723551|P2|Overall Study|Withdrawal of Consent|10
5423823|NCT02504268|18723552|P1|Overall Study|Withdrawal of Consent|11
5423824|NCT02504268|18723551|P2|Overall Study|Adverse Event|8
5423825|NCT02504268|18723552|P1|Overall Study|Adverse Event|18
5423826|NCT02504216|18723568|P2|Overall Study|Withdrawal by Subject|12
5423827|NCT02504216|18723569|P1|Overall Study|Withdrawal by Subject|8
5423828|NCT02504216|18723568|P2|Overall Study|Lost to Follow-up|3
5423829|NCT02504216|18723569|P1|Overall Study|Lost to Follow-up|3
5423830|NCT02503865|18723616|P3|Overall Study|Refused treatment|2
5423831|NCT02503865|18723617|P2|Overall Study|Refused treatment|39
5423832|NCT02503865|18723618|P1|Overall Study|Refused treatment|4
5423833|NCT02503865|18723616|P3|Overall Study|Moved out of area|0
5423834|NCT02503865|18723617|P2|Overall Study|Moved out of area|8
5423835|NCT02503865|18723618|P1|Overall Study|Moved out of area|1
5423836|NCT02503787|18723663|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
5423837|NCT02503787|18723663|P1|Implant to 3 Month Endpoint|Adverse Event|2
5423838|NCT02503787|18723663|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
5423839|NCT02503787|18723663|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
5423840|NCT02503787|18723663|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
5423841|NCT02503787|18723663|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
5423842|NCT02503787|18723663|P1|Enrollment|Unable to be programmed|1
5423843|NCT02503787|18723663|P1|Enrollment|Inability to implant system|1
5423844|NCT02503787|18723663|P1|Enrollment|Protocol Violation|1
5423845|NCT02503787|18723663|P1|Enrollment|Adverse Event|1
5423846|NCT02503787|18723663|P1|Enrollment|Study closure|1
5423847|NCT02503787|18723663|P1|Enrollment|Lost to Follow-up|1
5423848|NCT02503787|18723663|P1|Enrollment|Insurance issue|2
5423849|NCT02503787|18723663|P1|Enrollment|Physician Decision|2
5423850|NCT02503787|18723663|P1|Enrollment|Inclusion/exclusion criteria not met|4
5423851|NCT02503787|18723663|P1|Enrollment|Withdrawal by Subject|6
5423852|NCT02503540|18723680|P1|Overall Study|Withdrawal by Subject|1
5423853|NCT02503540|18723680|P1|Overall Study|Death|2
5423854|NCT02503501|18723701|P2|Overall Study|Withdrawal by Subject|2
5423855|NCT02503501|18723702|P1|Overall Study|Withdrawal by Subject|0
5423856|NCT02503501|18723701|P2|Overall Study|Protocol Violation|1
5423857|NCT02503501|18723702|P1|Overall Study|Protocol Violation|0
5423858|NCT02503501|18723701|P2|Overall Study|Physician Decision|0
5423859|NCT02503501|18723702|P1|Overall Study|Physician Decision|1
5423860|NCT02503332|18723738|P4|Overall Study|Other|1
5423861|NCT02503332|18723739|P3|Overall Study|Other|1
5423862|NCT02503332|18723740|P2|Overall Study|Other|6
5423863|NCT02503332|18723741|P1|Overall Study|Other|5
5423864|NCT02503332|18723738|P4|Overall Study|Death|0
5423865|NCT02503332|18723739|P3|Overall Study|Death|2
5423866|NCT02503332|18723740|P2|Overall Study|Death|2
5423867|NCT02503332|18723741|P1|Overall Study|Death|0
5423868|NCT02503332|18723738|P4|Overall Study|Subject Request|1
5423869|NCT02503332|18723739|P3|Overall Study|Subject Request|2
5423870|NCT02503332|18723740|P2|Overall Study|Subject Request|5
5423871|NCT02503332|18723741|P1|Overall Study|Subject Request|6
5423872|NCT02503332|18723738|P4|Overall Study|Sponsor's Decision|1
5423873|NCT02503332|18723739|P3|Overall Study|Sponsor's Decision|0
5423874|NCT02503332|18723740|P2|Overall Study|Sponsor's Decision|0
5423875|NCT02503332|18723741|P1|Overall Study|Sponsor's Decision|1
5423876|NCT02503332|18723738|P4|Overall Study|Investigator's Decision|0
5423877|NCT02503332|18723739|P3|Overall Study|Investigator's Decision|0
5423878|NCT02503332|18723740|P2|Overall Study|Investigator's Decision|1
5423879|NCT02503332|18723741|P1|Overall Study|Investigator's Decision|5
5423880|NCT02503332|18723738|P4|Overall Study|Adverse Event|1
5423881|NCT02503332|18723739|P3|Overall Study|Adverse Event|3
5423882|NCT02503332|18723740|P2|Overall Study|Adverse Event|5
5423883|NCT02503332|18723741|P1|Overall Study|Adverse Event|17
5423884|NCT02503215|18723792|P1|Overall Study|Unable to use positive airway pressure|2
5423885|NCT02503215|18723792|P1|Overall Study|Unable to wear compression stockings|1
5423886|NCT02503202|18723803|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
5423887|NCT02503202|18723804|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
5423888|NCT02503202|18723805|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
5423889|NCT02503202|18723806|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
5423890|NCT02503202|18723807|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
5423891|NCT02503202|18723803|P5|Extension: Month 6 to 24|Physician Decision|0
5423892|NCT02503202|18723804|P4|Extension: Month 6 to 24|Physician Decision|3
5423893|NCT02503202|18723805|P3|Extension: Month 6 to 24|Physician Decision|1
5423894|NCT02503202|18723806|P2|Extension: Month 6 to 24|Physician Decision|0
5423895|NCT02503202|18723807|P1|Extension: Month 6 to 24|Physician Decision|1
5423896|NCT02503202|18723803|P5|Extension: Month 6 to 24|Lost to Follow-up|1
5423897|NCT02503202|18723804|P4|Extension: Month 6 to 24|Lost to Follow-up|10
5423898|NCT02503202|18723805|P3|Extension: Month 6 to 24|Lost to Follow-up|6
5423899|NCT02503202|18723806|P2|Extension: Month 6 to 24|Lost to Follow-up|8
5423900|NCT02503202|18723807|P1|Extension: Month 6 to 24|Lost to Follow-up|4
5423901|NCT02503202|18723803|P5|Extension: Month 6 to 24|Death|0
5423902|NCT02503202|18723804|P4|Extension: Month 6 to 24|Death|0
5423903|NCT02503202|18723805|P3|Extension: Month 6 to 24|Death|0
5423904|NCT02503202|18723806|P2|Extension: Month 6 to 24|Death|0
5423905|NCT02503202|18723807|P1|Extension: Month 6 to 24|Death|1
5423906|NCT02503202|18723803|P5|Extension: Month 6 to 24|Protocol Violation|0
5423907|NCT02503202|18723804|P4|Extension: Month 6 to 24|Protocol Violation|1
5423908|NCT02503202|18723805|P3|Extension: Month 6 to 24|Protocol Violation|0
5423909|NCT02503202|18723806|P2|Extension: Month 6 to 24|Protocol Violation|0
5423910|NCT02503202|18723807|P1|Extension: Month 6 to 24|Protocol Violation|0
5423911|NCT02503202|18723803|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
5423912|NCT02503202|18723804|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
5423913|NCT02503202|18723805|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
5423914|NCT02503202|18723806|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
5423915|NCT02503202|18723807|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
5423916|NCT02503202|18723803|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
5423917|NCT02503202|18723804|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
5423918|NCT02503202|18723805|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
5423919|NCT02503202|18723806|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
5423920|NCT02503202|18723807|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
5423921|NCT02503202|18723803|P5|Base Study: Up to Month 6|Physician Decision|1
5423922|NCT02503202|18723804|P4|Base Study: Up to Month 6|Physician Decision|0
5423923|NCT02503202|18723805|P3|Base Study: Up to Month 6|Physician Decision|0
5423924|NCT02503202|18723806|P2|Base Study: Up to Month 6|Physician Decision|0
5423925|NCT02503202|18723807|P1|Base Study: Up to Month 6|Physician Decision|0
5423926|NCT02503202|18723803|P5|Base Study: Up to Month 6|Lost to Follow-up|1
5423927|NCT02503202|18723804|P4|Base Study: Up to Month 6|Lost to Follow-up|5
5423928|NCT02503202|18723805|P3|Base Study: Up to Month 6|Lost to Follow-up|10
5423929|NCT02503202|18723806|P2|Base Study: Up to Month 6|Lost to Follow-up|8
5423930|NCT02503202|18723807|P1|Base Study: Up to Month 6|Lost to Follow-up|11
5423931|NCT02503202|18723803|P5|Base Study: Up to Month 6|Death|0
5423932|NCT02503202|18723804|P4|Base Study: Up to Month 6|Death|0
5423933|NCT02503202|18723805|P3|Base Study: Up to Month 6|Death|0
5423934|NCT02503202|18723806|P2|Base Study: Up to Month 6|Death|1
5423935|NCT02503202|18723807|P1|Base Study: Up to Month 6|Death|1
5423936|NCT02503085|18723849|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
5423937|NCT02503085|18723850|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
5423938|NCT02503085|18723851|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
5423939|NCT02503085|18723852|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
5423940|NCT02502864|18723891|P1|Overall Study|Withdrawal by Subject|1
5423941|NCT02502734|18723900|P2|Washout Period|Adverse Event|0
5423942|NCT02502734|18723901|P1|Washout Period|Adverse Event|1
5423943|NCT02502734|18723900|P2|Double-blind Treatment Period 1|Adverse Event|0
5423944|NCT02502734|18723901|P1|Double-blind Treatment Period 1|Adverse Event|1
5423945|NCT02502526|18723912|P3|Overall Study|Enrollment suspension|1
5423946|NCT02502526|18723913|P2|Overall Study|Enrollment suspension|1
5423947|NCT02502526|18723914|P1|Overall Study|Enrollment suspension|4
5423948|NCT02502526|18723912|P3|Overall Study|Disqualified due to cataract grading|1
5423949|NCT02502526|18723913|P2|Overall Study|Disqualified due to cataract grading|0
5423950|NCT02502526|18723914|P1|Overall Study|Disqualified due to cataract grading|0
5423951|NCT02502526|18723912|P3|Overall Study|Withdrawal by Subject|1
5423952|NCT02502526|18723913|P2|Overall Study|Withdrawal by Subject|1
5423953|NCT02502526|18723914|P1|Overall Study|Withdrawal by Subject|0
5423954|NCT02502526|18723912|P3|Overall Study|Lost to Follow-up|3
5423955|NCT02502526|18723913|P2|Overall Study|Lost to Follow-up|2
5423956|NCT02502526|18723914|P1|Overall Study|Lost to Follow-up|2
5423957|NCT02502149|18724011|P5|Intermediate|Discontinued prematurely|0
5423958|NCT02502149|18724012|P4|Intermediate|Discontinued prematurely|0
5423959|NCT02502149|18724013|P3|Intermediate|Discontinued prematurely|0
5423960|NCT02502149|18724014|P2|Intermediate|Discontinued prematurely|0
5423961|NCT02502149|18724015|P1|Intermediate|Discontinued prematurely|1
5423962|NCT02501928|18724150|P6|Overall Study|Withdrawal By Parent/Guardian|0
5423963|NCT02501928|18724151|P5|Overall Study|Withdrawal By Parent/Guardian|1
5423964|NCT02501928|18724152|P4|Overall Study|Withdrawal By Parent/Guardian|0
5423965|NCT02501928|18724153|P3|Overall Study|Withdrawal By Parent/Guardian|0
5423966|NCT02501928|18724154|P2|Overall Study|Withdrawal By Parent/Guardian|0
5423967|NCT02501928|18724155|P1|Overall Study|Withdrawal By Parent/Guardian|0
5423968|NCT02501629|18724381|P2|Overall Study|Subject did not return to site|1
5423969|NCT02501629|18724382|P1|Overall Study|Subject did not return to site|0
5423970|NCT02501629|18724381|P2|Overall Study|Withdrawal by Subject|5
5423971|NCT02501629|18724382|P1|Overall Study|Withdrawal by Subject|3
5423972|NCT02501629|18724381|P2|Overall Study|Early termination by sponsor|0
5423973|NCT02501629|18724382|P1|Overall Study|Early termination by sponsor|1
5423974|NCT02501629|18724381|P2|Overall Study|Withdrawn from study by sponsor|0
5423975|NCT02501629|18724382|P1|Overall Study|Withdrawn from study by sponsor|1
5423976|NCT02501629|18724381|P2|Overall Study|Death|1
5423977|NCT02501629|18724382|P1|Overall Study|Death|0
5423978|NCT02501473|18724428|P8|Overall Study|Reason not specified|0
5423979|NCT02501473|18724429|P7|Overall Study|Reason not specified|0
5423980|NCT02501473|18724430|P6|Overall Study|Reason not specified|0
5423981|NCT02501473|18724431|P5|Overall Study|Reason not specified|0
5423982|NCT02501473|18724432|P4|Overall Study|Reason not specified|1
5423983|NCT02501473|18724433|P3|Overall Study|Reason not specified|1
5423984|NCT02501473|18724434|P2|Overall Study|Reason not specified|0
5423985|NCT02501473|18724435|P1|Overall Study|Reason not specified|0
5423986|NCT02501473|18724428|P8|Overall Study|Lost to Follow-up|0
5423987|NCT02501473|18724429|P7|Overall Study|Lost to Follow-up|0
5423988|NCT02501473|18724430|P6|Overall Study|Lost to Follow-up|1
5423989|NCT02501473|18724431|P5|Overall Study|Lost to Follow-up|0
5423990|NCT02501473|18724432|P4|Overall Study|Lost to Follow-up|0
5423991|NCT02501473|18724433|P3|Overall Study|Lost to Follow-up|1
5423992|NCT02501473|18724434|P2|Overall Study|Lost to Follow-up|0
5423993|NCT02501473|18724435|P1|Overall Study|Lost to Follow-up|1
5423994|NCT02501473|18724428|P8|Overall Study|Death|0
5423995|NCT02501473|18724429|P7|Overall Study|Death|0
5423996|NCT02501473|18724430|P6|Overall Study|Death|1
5423997|NCT02501473|18724431|P5|Overall Study|Death|0
5423998|NCT02501473|18724432|P4|Overall Study|Death|1
5423999|NCT02501473|18724433|P3|Overall Study|Death|1
5424000|NCT02501473|18724434|P2|Overall Study|Death|0
5424001|NCT02501473|18724435|P1|Overall Study|Death|0
5424002|NCT02501473|18724428|P8|Overall Study|Withdrawal by Subject|0
5424003|NCT02501473|18724429|P7|Overall Study|Withdrawal by Subject|0
5424004|NCT02501473|18724430|P6|Overall Study|Withdrawal by Subject|2
5424005|NCT02501473|18724431|P5|Overall Study|Withdrawal by Subject|2
5424006|NCT02501473|18724432|P4|Overall Study|Withdrawal by Subject|3
5424007|NCT02501473|18724433|P3|Overall Study|Withdrawal by Subject|3
5424008|NCT02501473|18724434|P2|Overall Study|Withdrawal by Subject|0
5424009|NCT02501473|18724435|P1|Overall Study|Withdrawal by Subject|0
5424010|NCT02501473|18724428|P8|Overall Study|Study Terminated|0
5424011|NCT02501473|18724429|P7|Overall Study|Study Terminated|1
5424012|NCT02501473|18724430|P6|Overall Study|Study Terminated|10
5424013|NCT02501473|18724431|P5|Overall Study|Study Terminated|2
5424014|NCT02501473|18724432|P4|Overall Study|Study Terminated|9
5424015|NCT02501473|18724433|P3|Overall Study|Study Terminated|7
5424016|NCT02501473|18724434|P2|Overall Study|Study Terminated|3
5424017|NCT02501473|18724435|P1|Overall Study|Study Terminated|2
5424018|NCT02501161|18724530|P2|Overall Study|Other|0
5424019|NCT02501161|18724531|P1|Overall Study|Other|3
5424020|NCT02501161|18724530|P2|Overall Study|Withdrawal by Subject|15
5424021|NCT02501161|18724531|P1|Overall Study|Withdrawal by Subject|10
5424022|NCT02501161|18724530|P2|Overall Study|Lost to Follow-up|4
5424023|NCT02501161|18724531|P1|Overall Study|Lost to Follow-up|7
5424024|NCT02501161|18724530|P2|Overall Study|Adverse Event|6
5424025|NCT02501161|18724531|P1|Overall Study|Adverse Event|2
5424026|NCT02500979|18724655|P2|Period 2|Change in risk|0
5424027|NCT02500979|18724656|P1|Period 2|Change in risk|1
5424028|NCT02500979|18724655|P2|Period 1|Subject decision|0
5424029|NCT02500979|18724656|P1|Period 1|Subject decision|2
5424030|NCT02500979|18724655|P2|Period 1|Adverse Event|0
5424031|NCT02500979|18724656|P1|Period 1|Adverse Event|1
5424032|NCT02500979|18724655|P2|Period 1|Severe non-compliance to protocol|1
5424033|NCT02500979|18724656|P1|Period 1|Severe non-compliance to protocol|0
5424034|NCT02500979|18724655|P2|Period 1|Hyperglycemia|0
5424035|NCT02500979|18724656|P1|Period 1|Hyperglycemia|1
5424036|NCT02500901|18724690|P1|Overall Study|Disease ProgressionDD|2
5424037|NCT02500797|18724718|P8|Overall Study|Withdrawal by Subject|0
5424038|NCT02500797|18724719|P7|Overall Study|Withdrawal by Subject|0
5424039|NCT02500797|18724720|P6|Overall Study|Withdrawal by Subject|0
5424040|NCT02500797|18724721|P5|Overall Study|Withdrawal by Subject|0
5424041|NCT02500797|18724722|P4|Overall Study|Withdrawal by Subject|0
5424042|NCT02500797|18724723|P3|Overall Study|Withdrawal by Subject|0
5424043|NCT02500797|18724724|P2|Overall Study|Withdrawal by Subject|0
5424044|NCT02500797|18724725|P1|Overall Study|Withdrawal by Subject|1
5424045|NCT02500797|18724718|P8|Overall Study|Cancel (rapid disease progression)|0
5424046|NCT02500797|18724719|P7|Overall Study|Cancel (rapid disease progression)|0
5424047|NCT02500797|18724720|P6|Overall Study|Cancel (rapid disease progression)|1
5424048|NCT02500797|18724721|P5|Overall Study|Cancel (rapid disease progression)|1
5424049|NCT02500797|18724722|P4|Overall Study|Cancel (rapid disease progression)|0
5424050|NCT02500797|18724723|P3|Overall Study|Cancel (rapid disease progression)|0
5424051|NCT02500797|18724724|P2|Overall Study|Cancel (rapid disease progression)|0
5424052|NCT02500797|18724725|P1|Overall Study|Cancel (rapid disease progression)|0
5424053|NCT02500758|18724785|P2|Second Intervention (2 Minutes)|Protocol Violation|1
5424054|NCT02500758|18724786|P1|Second Intervention (2 Minutes)|Protocol Violation|1
5424055|NCT02500758|18724785|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
5424056|NCT02500758|18724786|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
5424057|NCT02500758|18724785|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
5424058|NCT02500758|18724786|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
5424059|NCT02500758|18724785|P2|Washout (1 Week)|Lost to Follow-up|2
5424060|NCT02500758|18724786|P1|Washout (1 Week)|Lost to Follow-up|2
5424061|NCT02500758|18724785|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
5424062|NCT02500758|18724786|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
5424063|NCT02500732|18724796|P2|Overall Study|Physician Decision|1
5424064|NCT02500732|18724797|P1|Overall Study|Physician Decision|0
5424065|NCT02500706|18724814|P3|Overall Study|Unclassified|1
5424066|NCT02500706|18724815|P2|Overall Study|Unclassified|0
5424067|NCT02500706|18724816|P1|Overall Study|Unclassified|0
5424068|NCT02500706|18724814|P3|Overall Study|Withdrawal by Subject|4
5424069|NCT02500706|18724815|P2|Overall Study|Withdrawal by Subject|6
5424070|NCT02500706|18724816|P1|Overall Study|Withdrawal by Subject|4
5424071|NCT02500706|18724814|P3|Overall Study|Lost to Follow-up|1
5424072|NCT02500706|18724815|P2|Overall Study|Lost to Follow-up|1
5424073|NCT02500706|18724816|P1|Overall Study|Lost to Follow-up|0
5424074|NCT02500706|18724814|P3|Overall Study|Adverse Event|1
5424075|NCT02500706|18724815|P2|Overall Study|Adverse Event|0
5424076|NCT02500706|18724816|P1|Overall Study|Adverse Event|0
5424077|NCT02500641|18724970|P2|Overall Study|Non compliance to study drug|1
5424078|NCT02500641|18724971|P1|Overall Study|Non compliance to study drug|0
5424079|NCT02500641|18724970|P2|Overall Study|Sponsor decision|0
5424080|NCT02500641|18724971|P1|Overall Study|Sponsor decision|1
5424081|NCT02500641|18724970|P2|Overall Study|Lost to Follow-up|0
5424082|NCT02500641|18724971|P1|Overall Study|Lost to Follow-up|1
5424083|NCT02500641|18724970|P2|Overall Study|Protocol Violation|2
5424084|NCT02500641|18724971|P1|Overall Study|Protocol Violation|1
5424085|NCT02500641|18724970|P2|Overall Study|Unable to follow study procedures|2
5424086|NCT02500641|18724971|P1|Overall Study|Unable to follow study procedures|3
5424087|NCT02500641|18724970|P2|Overall Study|Withdrawal by Subject|5
5424088|NCT02500641|18724971|P1|Overall Study|Withdrawal by Subject|4
5424089|NCT02500641|18724970|P2|Overall Study|Adverse Event|2
5424090|NCT02500641|18724971|P1|Overall Study|Adverse Event|0
5424091|NCT02500537|18724992|P2|Overall Study|Withdrawal by Subject|0
5424092|NCT02500537|18724993|P1|Overall Study|Withdrawal by Subject|1
5424093|NCT02500537|18724992|P2|Overall Study|Lost to Follow-up|1
5424094|NCT02500537|18724993|P1|Overall Study|Lost to Follow-up|0
5424095|NCT02500537|18724992|P2|Overall Study|Death|0
5424096|NCT02500537|18724993|P1|Overall Study|Death|2
5424097|NCT02500056|18725062|P2|Overall Study|Death|1
5424098|NCT02500056|18725063|P1|Overall Study|Death|3
5424099|NCT02500056|18725062|P2|Overall Study|Recurrence|0
5424100|NCT02500056|18725063|P1|Overall Study|Recurrence|1
5424101|NCT02500056|18725062|P2|Overall Study|Lost to Follow-up|7
5424102|NCT02500056|18725063|P1|Overall Study|Lost to Follow-up|3
5424103|NCT02499952|18725073|P1|Overall Study|Death|9
5424104|NCT02499952|18725073|P1|Overall Study|Lost to Follow-up|1
5424105|NCT02499900|18725082|P2|Extension Study Period|Other|2
5424106|NCT02499900|18725083|P1|Extension Study Period|Other|0
5424107|NCT02499900|18725082|P2|Extension Study Period|Lost to Follow-up|5
5424108|NCT02499900|18725083|P1|Extension Study Period|Lost to Follow-up|2
5424109|NCT02499900|18725082|P2|Extension Study Period|Pregnancy|2
5424110|NCT02499900|18725083|P1|Extension Study Period|Pregnancy|1
5424111|NCT02499900|18725082|P2|Extension Study Period|Physician Decision|5
5424112|NCT02499900|18725083|P1|Extension Study Period|Physician Decision|2
5424113|NCT02499900|18725082|P2|Extension Study Period|Withdrawal by Subject|2
5424114|NCT02499900|18725083|P1|Extension Study Period|Withdrawal by Subject|5
5424115|NCT02499900|18725082|P2|Extension Study Period|Adverse Event|4
5424116|NCT02499900|18725083|P1|Extension Study Period|Adverse Event|2
5424117|NCT02499900|18725082|P2|Completed Core, Continued Into Extension|Personal motivation|0
5424118|NCT02499900|18725083|P1|Completed Core, Continued Into Extension|Personal motivation|1
5424119|NCT02499900|18725082|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
5424120|NCT02499900|18725083|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
5424121|NCT02499900|18725082|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
5424122|NCT02499900|18725083|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
5424123|NCT02499900|18725082|P2|Completed Core, Continued Into Extension|Physician Decision|0
5424124|NCT02499900|18725083|P1|Completed Core, Continued Into Extension|Physician Decision|1
5424125|NCT02499900|18725082|P2|Core Study Period|Death|1
5424126|NCT02499900|18725083|P1|Core Study Period|Death|0
5424127|NCT02499900|18725082|P2|Core Study Period|Adverse Event|14
5424128|NCT02499900|18725083|P1|Core Study Period|Adverse Event|18
5424129|NCT02499900|18725082|P2|Core Study Period|Withdrawal by Subject|10
5424130|NCT02499900|18725083|P1|Core Study Period|Withdrawal by Subject|11
5424131|NCT02499900|18725082|P2|Core Study Period|Protocol Violation|0
5424132|NCT02499900|18725083|P1|Core Study Period|Protocol Violation|3
5424133|NCT02499900|18725082|P2|Core Study Period|Pregnancy|0
5424134|NCT02499900|18725083|P1|Core Study Period|Pregnancy|1
5424135|NCT02499900|18725082|P2|Core Study Period|Per sponsor request|1
5424136|NCT02499900|18725083|P1|Core Study Period|Per sponsor request|0
5424137|NCT02499900|18725082|P2|Core Study Period|Lost to Follow-up|2
5424138|NCT02499900|18725083|P1|Core Study Period|Lost to Follow-up|1
5424139|NCT02499900|18725082|P2|Core Study Period|Other|4
5424140|NCT02499900|18725083|P1|Core Study Period|Other|1
5424141|NCT02499783|18725114|P3|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
5424142|NCT02499783|18725115|P2|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
5424143|NCT02499783|18725116|P1|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
5424144|NCT02499783|18725114|P3|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
5424145|NCT02499783|18725115|P2|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
5424146|NCT02499783|18725116|P1|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
5424147|NCT02499783|18725114|P3|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
5424148|NCT02499783|18725115|P2|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
5424149|NCT02499783|18725116|P1|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
5424150|NCT02499783|18725114|P3|Open Label Period: Weeks 8 to 26|Adverse Event|16
5424151|NCT02499783|18725115|P2|Open Label Period: Weeks 8 to 26|Adverse Event|0
5424152|NCT02499783|18725116|P1|Open Label Period: Weeks 8 to 26|Adverse Event|0
5424153|NCT02499783|18725114|P3|DB Period: Weeks 0-8|Other|0
5424154|NCT02499783|18725115|P2|DB Period: Weeks 0-8|Other|1
5424155|NCT02499783|18725116|P1|DB Period: Weeks 0-8|Other|1
5424156|NCT02499783|18725114|P3|DB Period: Weeks 0-8|Withdrew Consent|0
5424157|NCT02499783|18725115|P2|DB Period: Weeks 0-8|Withdrew Consent|0
5424158|NCT02499783|18725116|P1|DB Period: Weeks 0-8|Withdrew Consent|1
5424159|NCT02499783|18725114|P3|DB Period: Weeks 0-8|Adverse Event|0
5424160|NCT02499783|18725115|P2|DB Period: Weeks 0-8|Adverse Event|6
5424161|NCT02499783|18725116|P1|DB Period: Weeks 0-8|Adverse Event|8
5424162|NCT02499783|18725114|P3|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
5424163|NCT02499783|18725115|P2|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
5424164|NCT02499783|18725116|P1|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
5424165|NCT02499783|18725114|P3|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
5424166|NCT02499783|18725115|P2|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
5424167|NCT02499783|18725116|P1|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
5424168|NCT02499783|18725114|P3|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
5424169|NCT02499783|18725115|P2|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
5424170|NCT02499783|18725116|P1|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
5424171|NCT02499770|18725165|P2|Overall Study|Randomized but not enrolled|1
5424172|NCT02499770|18725166|P1|Overall Study|Randomized but not enrolled|0
5424173|NCT02499770|18725165|P2|Overall Study|Withdrawn by PI for compassionate reason|1
5424174|NCT02499770|18725166|P1|Overall Study|Withdrawn by PI for compassionate reason|0
5424175|NCT02499770|18725165|P2|Overall Study|Subject declined further treatment|0
5424176|NCT02499770|18725166|P1|Overall Study|Subject declined further treatment|1
5424177|NCT02499770|18725165|P2|Overall Study|Lost to Follow-up|2
5424178|NCT02499770|18725166|P1|Overall Study|Lost to Follow-up|0
5424179|NCT02499770|18725165|P2|Overall Study|Withdrawal by Subject|7
5424180|NCT02499770|18725166|P1|Overall Study|Withdrawal by Subject|0
5424181|NCT02499770|18725165|P2|Overall Study|Study completion|10
5424182|NCT02499770|18725166|P1|Overall Study|Study completion|1
5424183|NCT02499770|18725165|P2|Overall Study|Death|56
5424184|NCT02499770|18725166|P1|Overall Study|Death|17
5424185|NCT02499575|18725286|P2|Overall Study|Protocol Violation|1
5424186|NCT02499575|18725287|P1|Overall Study|Protocol Violation|0
5424187|NCT02499406|18725297|P1|Overall Study|missed 3 treatment sessions|4
5424188|NCT02499263|18725318|P1|Overall Study|Pregnancy|1
5424189|NCT02499263|18725318|P1|Overall Study|Participant's decision|3
5424190|NCT02499263|18725318|P1|Overall Study|Adverse Events/Serious Adverse Events|11
5424191|NCT02499263|18725318|P1|Overall Study|investigator's judgment|12
5424192|NCT02499263|18725318|P1|Overall Study|Lack of Efficacy|22
5424193|NCT02499263|18725318|P1|Overall Study|Participant's withdrawal of consent|4
5424194|NCT02499263|18725318|P1|Overall Study|Lost to Follow-up|9
5424195|NCT02499172|18725355|P4|Overall Study|Lost to Follow-up|0
5424196|NCT02499172|18725356|P3|Overall Study|Lost to Follow-up|0
5424197|NCT02499172|18725357|P2|Overall Study|Lost to Follow-up|64
5424198|NCT02499172|18725358|P1|Overall Study|Lost to Follow-up|65
5424199|NCT02499172|18725355|P4|Overall Study|Financial reason|436
5424200|NCT02499172|18725356|P3|Overall Study|Financial reason|523
5424201|NCT02499172|18725357|P2|Overall Study|Financial reason|0
5424202|NCT02499172|18725358|P1|Overall Study|Financial reason|0
5424203|NCT02499159|18725370|P2|30-Day Follow-Up Phone Call|Other|0
5424204|NCT02499159|18725371|P1|30-Day Follow-Up Phone Call|Other|1
5424205|NCT02499159|18725370|P2|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
5424206|NCT02499159|18725371|P1|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
5424207|NCT02499159|18725370|P2|30-Day Follow-Up Phone Call|Lost to Follow-up|1
5424208|NCT02499159|18725371|P1|30-Day Follow-Up Phone Call|Lost to Follow-up|3
5424209|NCT02499159|18725370|P2|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
5424210|NCT02499159|18725371|P1|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
5424211|NCT02499159|18725370|P2|Randomization|Protocol Violation|1
5424212|NCT02499159|18725371|P1|Randomization|Protocol Violation|1
5424213|NCT02499146|18725395|P1|Overall Study|Began other treatment/therapy|13
5424214|NCT02499146|18725395|P1|Overall Study|Ongoing at date of cut-off|9
5424215|NCT02499146|18725395|P1|Overall Study|Other|2
5424216|NCT02499146|18725395|P1|Overall Study|Withdrawal by Subject|1
5424217|NCT02499146|18725395|P1|Overall Study|Lost to Follow-up|1
5424218|NCT02499120|18725435|P2|Overall Study|Ongoing on study|11
5424219|NCT02499120|18725436|P1|Overall Study|Ongoing on study|15
5424220|NCT02499120|18725435|P2|Overall Study|Other|0
5424221|NCT02499120|18725436|P1|Overall Study|Other|1
5424222|NCT02499120|18725435|P2|Overall Study|Withdrawal by Subject|5
5424223|NCT02499120|18725436|P1|Overall Study|Withdrawal by Subject|2
5424224|NCT02499120|18725435|P2|Overall Study|Participant refused further follow-up|0
5424225|NCT02499120|18725436|P1|Overall Study|Participant refused further follow-up|1
5424226|NCT02499120|18725435|P2|Overall Study|Lost to Follow-up|2
5424227|NCT02499120|18725436|P1|Overall Study|Lost to Follow-up|1
5424228|NCT02499120|18725435|P2|Overall Study|Death|42
5424229|NCT02499120|18725436|P1|Overall Study|Death|45
5424230|NCT02499029|18725467|P2|Overall Study|Death|0
5424231|NCT02499029|18725468|P1|Overall Study|Death|1
5424232|NCT02499029|18725467|P2|Overall Study|Physician Decision|1
5424233|NCT02499029|18725468|P1|Overall Study|Physician Decision|2
5424234|NCT02499029|18725467|P2|Overall Study|Lost to Follow-up|2
5424235|NCT02499029|18725468|P1|Overall Study|Lost to Follow-up|2
5424236|NCT02498821|18725495|P2|Overall Study|Screen failure|5
5424237|NCT02498821|18725496|P1|Overall Study|Screen failure|3
5424238|NCT02498678|18725540|P2|Overall Study|interference from the surgical team|2
5424239|NCT02498678|18725541|P1|Overall Study|interference from the surgical team|0
5424240|NCT02498652|18725557|P2|Overall Study|Protocol Violation|1
5424241|NCT02498652|18725558|P1|Overall Study|Protocol Violation|0
5424242|NCT02498418|18725701|P3|Overall Study|Participant taken prohibited medication|1
5424243|NCT02498418|18725702|P2|Overall Study|Participant taken prohibited medication|1
5424244|NCT02498418|18725703|P1|Overall Study|Participant taken prohibited medication|0
5424245|NCT02498418|18725701|P3|Overall Study|Lost to Follow-up|1
5424246|NCT02498418|18725702|P2|Overall Study|Lost to Follow-up|1
5424247|NCT02498418|18725703|P1|Overall Study|Lost to Follow-up|0
5424248|NCT02498418|18725701|P3|Overall Study|Withdrawal by Subject|3
5424249|NCT02498418|18725702|P2|Overall Study|Withdrawal by Subject|0
5424250|NCT02498418|18725703|P1|Overall Study|Withdrawal by Subject|2
5424251|NCT02498418|18725701|P3|Overall Study|Lack of Efficacy|1
5424252|NCT02498418|18725702|P2|Overall Study|Lack of Efficacy|0
5424253|NCT02498418|18725703|P1|Overall Study|Lack of Efficacy|0
5424254|NCT02498236|18725727|P8|Overall Study|Withdrawal by Subject|0
5424255|NCT02498236|18725728|P7|Overall Study|Withdrawal by Subject|0
5424256|NCT02498236|18725729|P6|Overall Study|Withdrawal by Subject|0
5424257|NCT02498236|18725730|P5|Overall Study|Withdrawal by Subject|1
5424258|NCT02498236|18725731|P4|Overall Study|Withdrawal by Subject|0
5424259|NCT02498236|18725732|P3|Overall Study|Withdrawal by Subject|0
5424260|NCT02498236|18725733|P2|Overall Study|Withdrawal by Subject|0
5424261|NCT02498236|18725734|P1|Overall Study|Withdrawal by Subject|0
5424262|NCT02498236|18725727|P8|Overall Study|Equipment failure|0
5424263|NCT02498236|18725728|P7|Overall Study|Equipment failure|1
5424264|NCT02498236|18725729|P6|Overall Study|Equipment failure|0
5424265|NCT02498236|18725730|P5|Overall Study|Equipment failure|0
5424266|NCT02498236|18725731|P4|Overall Study|Equipment failure|0
5424267|NCT02498236|18725732|P3|Overall Study|Equipment failure|0
5424268|NCT02498236|18725733|P2|Overall Study|Equipment failure|0
5424269|NCT02498236|18725734|P1|Overall Study|Equipment failure|0
5424270|NCT02498236|18725727|P8|Overall Study|Did not show for testing|1
5424271|NCT02498236|18725728|P7|Overall Study|Did not show for testing|0
5424272|NCT02498236|18725729|P6|Overall Study|Did not show for testing|0
5424273|NCT02498236|18725730|P5|Overall Study|Did not show for testing|0
5424274|NCT02498236|18725731|P4|Overall Study|Did not show for testing|0
5424275|NCT02498236|18725732|P3|Overall Study|Did not show for testing|0
5424276|NCT02498236|18725733|P2|Overall Study|Did not show for testing|0
5424277|NCT02498236|18725734|P1|Overall Study|Did not show for testing|1
5424278|NCT02498067|18725763|P1|Overall Study|Did not meet inclusion criteria|11
5424279|NCT02498067|18725763|P1|Overall Study|Lost to Follow-up|22
5424280|NCT02497976|18725784|P2|Overall Study|Moved out of area|1
5424281|NCT02497976|18725785|P1|Overall Study|Moved out of area|0
5424282|NCT02497976|18725784|P2|Overall Study|Withdrawal by Subject|0
5424283|NCT02497976|18725785|P1|Overall Study|Withdrawal by Subject|2
5424284|NCT02497781|18725880|P2|Overall Study|Lost to Follow-up|1
5424285|NCT02497781|18725881|P1|Overall Study|Lost to Follow-up|1
5424286|NCT02497781|18725880|P2|Overall Study|Randomised but not treated|1
5424287|NCT02497781|18725881|P1|Overall Study|Randomised but not treated|1
5424288|NCT02497781|18725880|P2|Overall Study|Lack of Efficacy|1
5424289|NCT02497781|18725881|P1|Overall Study|Lack of Efficacy|0
5424290|NCT02497781|18725880|P2|Overall Study|Withdrawal by Subject|0
5424291|NCT02497781|18725881|P1|Overall Study|Withdrawal by Subject|2
5424292|NCT02497755|18725944|P2|Overall Study|Protocol Violation|0
5424293|NCT02497755|18725945|P1|Overall Study|Protocol Violation|1
5424294|NCT02497612|18725962|P4|Overall Study|Not eligible|1
5424295|NCT02497612|18725963|P3|Overall Study|Not eligible|0
5424296|NCT02497612|18725964|P2|Overall Study|Not eligible|0
5424297|NCT02497612|18725965|P1|Overall Study|Not eligible|1
5424298|NCT02497612|18725962|P4|Overall Study|Other unspecified|0
5424299|NCT02497612|18725963|P3|Overall Study|Other unspecified|2
5424300|NCT02497612|18725964|P2|Overall Study|Other unspecified|1
5424301|NCT02497612|18725965|P1|Overall Study|Other unspecified|1
5424302|NCT02497612|18725962|P4|Overall Study|Lost to Follow-up|1
5424303|NCT02497612|18725963|P3|Overall Study|Lost to Follow-up|0
5424304|NCT02497612|18725964|P2|Overall Study|Lost to Follow-up|1
5424305|NCT02497612|18725965|P1|Overall Study|Lost to Follow-up|1
5424306|NCT02497612|18725962|P4|Overall Study|Adverse Event|1
5424307|NCT02497612|18725963|P3|Overall Study|Adverse Event|4
5424308|NCT02497612|18725964|P2|Overall Study|Adverse Event|1
5424309|NCT02497612|18725965|P1|Overall Study|Adverse Event|3
5424310|NCT02497612|18725962|P4|Overall Study|Investigator's judgement|2
5424311|NCT02497612|18725963|P3|Overall Study|Investigator's judgement|0
5424312|NCT02497612|18725964|P2|Overall Study|Investigator's judgement|0
5424313|NCT02497612|18725965|P1|Overall Study|Investigator's judgement|1
5424314|NCT02497612|18725962|P4|Overall Study|Participant's request|1
5424315|NCT02497612|18725963|P3|Overall Study|Participant's request|4
5424316|NCT02497612|18725964|P2|Overall Study|Participant's request|3
5424317|NCT02497612|18725965|P1|Overall Study|Participant's request|2
5424318|NCT02497612|18725962|P4|Overall Study|Met >=1 anti-malarial treatment criteria|41
5424319|NCT02497612|18725963|P3|Overall Study|Met >=1 anti-malarial treatment criteria|39
5424320|NCT02497612|18725964|P2|Overall Study|Met >=1 anti-malarial treatment criteria|51
5424321|NCT02497612|18725965|P1|Overall Study|Met >=1 anti-malarial treatment criteria|57
5424322|NCT02497469|18726093|P2|Overall Study|Reason not Specified|6
5424323|NCT02497469|18726094|P1|Overall Study|Reason not Specified|6
5424324|NCT02497469|18726093|P2|Overall Study|Lack of Efficacy|40
5424325|NCT02497469|18726094|P1|Overall Study|Lack of Efficacy|86
5424326|NCT02497469|18726093|P2|Overall Study|Pregnancy|1
5424327|NCT02497469|18726094|P1|Overall Study|Pregnancy|1
5424328|NCT02497469|18726093|P2|Overall Study|Voluntary Withdrawal|41
5424329|NCT02497469|18726094|P1|Overall Study|Voluntary Withdrawal|39
5424330|NCT02497469|18726093|P2|Overall Study|Lost to Follow-up|4
5424331|NCT02497469|18726094|P1|Overall Study|Lost to Follow-up|14
5424332|NCT02497469|18726093|P2|Overall Study|Significant Protocol Deviation|5
5424333|NCT02497469|18726094|P1|Overall Study|Significant Protocol Deviation|4
5424334|NCT02497469|18726093|P2|Overall Study|Leukopenia or Lymphopenia|0
5424335|NCT02497469|18726094|P1|Overall Study|Leukopenia or Lymphopenia|1
5424336|NCT02497469|18726093|P2|Overall Study|Pretreatment Event/Adverse Event|16
5424337|NCT02497469|18726094|P1|Overall Study|Pretreatment Event/Adverse Event|18
5424338|NCT02497469|18726093|P2|Overall Study|Randomized but not Treated|2
5424339|NCT02497469|18726094|P1|Overall Study|Randomized but not Treated|0
5424340|NCT02497391|18726104|P6|Period 3 (14 Days)|Withdrawal by Subject|0
5424341|NCT02497391|18726105|P5|Period 3 (14 Days)|Withdrawal by Subject|0
5424342|NCT02497391|18726106|P4|Period 3 (14 Days)|Withdrawal by Subject|0
5424343|NCT02497391|18726107|P3|Period 3 (14 Days)|Withdrawal by Subject|1
5424344|NCT02497391|18726108|P2|Period 3 (14 Days)|Withdrawal by Subject|0
5424345|NCT02497391|18726109|P1|Period 3 (14 Days)|Withdrawal by Subject|0
5424346|NCT02497391|18726104|P6|Period 3 (14 Days)|Sponsor Decision|0
5424347|NCT02497391|18726105|P5|Period 3 (14 Days)|Sponsor Decision|1
5424348|NCT02497391|18726106|P4|Period 3 (14 Days)|Sponsor Decision|0
5424349|NCT02497391|18726107|P3|Period 3 (14 Days)|Sponsor Decision|0
5424350|NCT02497391|18726108|P2|Period 3 (14 Days)|Sponsor Decision|0
5424351|NCT02497391|18726109|P1|Period 3 (14 Days)|Sponsor Decision|0
5424352|NCT02497391|18726104|P6|Period 3 (14 Days)|Adverse Event|0
5424353|NCT02497391|18726105|P5|Period 3 (14 Days)|Adverse Event|0
5424354|NCT02497391|18726106|P4|Period 3 (14 Days)|Adverse Event|0
5424355|NCT02497391|18726107|P3|Period 3 (14 Days)|Adverse Event|0
5424356|NCT02497391|18726108|P2|Period 3 (14 Days)|Adverse Event|1
5424357|NCT02497391|18726109|P1|Period 3 (14 Days)|Adverse Event|0
5424358|NCT02497391|18726104|P6|Period 2 (14 Days)|Sponsor Decision|3
5424359|NCT02497391|18726105|P5|Period 2 (14 Days)|Sponsor Decision|2
5424360|NCT02497391|18726106|P4|Period 2 (14 Days)|Sponsor Decision|3
5424361|NCT02497391|18726107|P3|Period 2 (14 Days)|Sponsor Decision|2
5424362|NCT02497391|18726108|P2|Period 2 (14 Days)|Sponsor Decision|1
5424363|NCT02497391|18726109|P1|Period 2 (14 Days)|Sponsor Decision|3
5424364|NCT02497391|18726104|P6|Period 2 (14 Days)|Withdrawal by Subject|0
5424365|NCT02497391|18726105|P5|Period 2 (14 Days)|Withdrawal by Subject|0
5424366|NCT02497391|18726106|P4|Period 2 (14 Days)|Withdrawal by Subject|0
5424367|NCT02497391|18726107|P3|Period 2 (14 Days)|Withdrawal by Subject|1
5424368|NCT02497391|18726108|P2|Period 2 (14 Days)|Withdrawal by Subject|0
5424369|NCT02497391|18726109|P1|Period 2 (14 Days)|Withdrawal by Subject|1
5424370|NCT02497287|18726120|P1|Follow-up Phase (4 Week)|Other|1
5424371|NCT02497287|18726120|P1|Follow-up Phase (4 Week)|Adverse Event|3
5424372|NCT02497287|18726120|P1|Follow-up Phase (4 Week)|Lost to Follow-up|5
5424373|NCT02497287|18726120|P1|Follow-up Phase (4 Week)|Withdrawal by Subject|10
5424374|NCT02497287|18726120|P1|Follow-up Phase (4 Week)|PI Decision|12
5424375|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
5424376|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Death|2
5424377|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Pregnancy|2
5424378|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
5424379|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
5424380|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
5424381|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Other|21
5424382|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
5424383|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Adverse Event|25
5424384|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
5424385|NCT02497287|18726120|P1|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
5424386|NCT02497287|18726120|P1|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
5424387|NCT02497287|18726120|P1|Induction Phase (4 Weeks)|Protocol Violation|1
5424388|NCT02497287|18726120|P1|Induction Phase (4 Weeks)|Lost to Follow-up|5
5424389|NCT02497287|18726120|P1|Induction Phase (4 Weeks)|Other|13
5424390|NCT02497287|18726120|P1|Induction Phase (4 Weeks)|Lack of Efficacy|21
5424391|NCT02497287|18726120|P1|Induction Phase (4 Weeks)|Withdrawal by Subject|22
5424392|NCT02497287|18726120|P1|Induction Phase (4 Weeks)|Adverse Event|52
5424393|NCT02497287|18726120|P1|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
5424394|NCT02497001|18726215|P4|Overall Study|Protocol Violation|1
5424395|NCT02497001|18726216|P3|Overall Study|Protocol Violation|3
5424396|NCT02497001|18726217|P2|Overall Study|Protocol Violation|1
5424397|NCT02497001|18726218|P1|Overall Study|Protocol Violation|3
5424398|NCT02497001|18726215|P4|Overall Study|Lack of Efficacy|6
5424399|NCT02497001|18726216|P3|Overall Study|Lack of Efficacy|6
5424400|NCT02497001|18726217|P2|Overall Study|Lack of Efficacy|16
5424401|NCT02497001|18726218|P1|Overall Study|Lack of Efficacy|10
5424402|NCT02497001|18726215|P4|Overall Study|Major Protocol Deviation|4
5424403|NCT02497001|18726216|P3|Overall Study|Major Protocol Deviation|4
5424404|NCT02497001|18726217|P2|Overall Study|Major Protocol Deviation|4
5424405|NCT02497001|18726218|P1|Overall Study|Major Protocol Deviation|3
5424406|NCT02497001|18726215|P4|Overall Study|subjects that were not treated|1
5424407|NCT02497001|18726216|P3|Overall Study|subjects that were not treated|2
5424408|NCT02497001|18726217|P2|Overall Study|subjects that were not treated|2
5424409|NCT02497001|18726218|P1|Overall Study|subjects that were not treated|1
5424410|NCT02497001|18726215|P4|Overall Study|Physician Decision|1
5424411|NCT02497001|18726216|P3|Overall Study|Physician Decision|5
5424412|NCT02497001|18726217|P2|Overall Study|Physician Decision|11
5424413|NCT02497001|18726218|P1|Overall Study|Physician Decision|5
5424414|NCT02497001|18726215|P4|Overall Study|Withdrawal by Subject|15
5424415|NCT02497001|18726216|P3|Overall Study|Withdrawal by Subject|19
5424416|NCT02497001|18726217|P2|Overall Study|Withdrawal by Subject|37
5424417|NCT02497001|18726218|P1|Overall Study|Withdrawal by Subject|14
5424418|NCT02497001|18726215|P4|Overall Study|Adverse Event|11
5424419|NCT02497001|18726216|P3|Overall Study|Adverse Event|11
5424420|NCT02497001|18726217|P2|Overall Study|Adverse Event|30
5424421|NCT02497001|18726218|P1|Overall Study|Adverse Event|28
5424422|NCT02497001|18726215|P4|Overall Study|Lost to Follow-up|2
5424423|NCT02497001|18726216|P3|Overall Study|Lost to Follow-up|0
5424424|NCT02497001|18726217|P2|Overall Study|Lost to Follow-up|2
5424425|NCT02497001|18726218|P1|Overall Study|Lost to Follow-up|10
5424426|NCT02496884|18726279|P4|Overall Study|Withdrawal by Subject|0
5424427|NCT02496884|18726280|P3|Overall Study|Withdrawal by Subject|0
5424428|NCT02496884|18726281|P2|Overall Study|Withdrawal by Subject|3
5424429|NCT02496884|18726282|P1|Overall Study|Withdrawal by Subject|0
5424430|NCT02496884|18726279|P4|Overall Study|Counted twice as enrolled|0
5424431|NCT02496884|18726280|P3|Overall Study|Counted twice as enrolled|0
5424432|NCT02496884|18726281|P2|Overall Study|Counted twice as enrolled|0
5424433|NCT02496884|18726282|P1|Overall Study|Counted twice as enrolled|2
5424434|NCT02496767|18726308|P8|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
5424435|NCT02496767|18726309|P7|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
5424436|NCT02496767|18726310|P6|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
5424437|NCT02496767|18726311|P5|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5424438|NCT02496767|18726312|P4|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5424439|NCT02496767|18726313|P3|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5424440|NCT02496767|18726314|P2|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5424441|NCT02496767|18726315|P1|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
5424442|NCT02496767|18726308|P8|Double-blind, Withdrawal Phase|Death|2
5424443|NCT02496767|18726309|P7|Double-blind, Withdrawal Phase|Death|1
5424444|NCT02496767|18726310|P6|Double-blind, Withdrawal Phase|Death|0
5424445|NCT02496767|18726311|P5|Double-blind, Withdrawal Phase|Death|0
5424446|NCT02496767|18726312|P4|Double-blind, Withdrawal Phase|Death|0
5424447|NCT02496767|18726313|P3|Double-blind, Withdrawal Phase|Death|0
5424448|NCT02496767|18726314|P2|Double-blind, Withdrawal Phase|Death|0
5424449|NCT02496767|18726315|P1|Double-blind, Withdrawal Phase|Death|0
5424450|NCT02496767|18726308|P8|Double-blind, Withdrawal Phase|Adverse Event|1
5424451|NCT02496767|18726309|P7|Double-blind, Withdrawal Phase|Adverse Event|2
5424452|NCT02496767|18726310|P6|Double-blind, Withdrawal Phase|Adverse Event|1
5424453|NCT02496767|18726311|P5|Double-blind, Withdrawal Phase|Adverse Event|0
5424454|NCT02496767|18726312|P4|Double-blind, Withdrawal Phase|Adverse Event|0
5424455|NCT02496767|18726313|P3|Double-blind, Withdrawal Phase|Adverse Event|0
5424456|NCT02496767|18726314|P2|Double-blind, Withdrawal Phase|Adverse Event|0
5424457|NCT02496767|18726315|P1|Double-blind, Withdrawal Phase|Adverse Event|0
5424458|NCT02496767|18726308|P8|Double-blind, Withdrawal Phase|Progressive disease|1
5424459|NCT02496767|18726309|P7|Double-blind, Withdrawal Phase|Progressive disease|0
5424460|NCT02496767|18726310|P6|Double-blind, Withdrawal Phase|Progressive disease|4
5424461|NCT02496767|18726311|P5|Double-blind, Withdrawal Phase|Progressive disease|0
5424462|NCT02496767|18726312|P4|Double-blind, Withdrawal Phase|Progressive disease|0
5424463|NCT02496767|18726313|P3|Double-blind, Withdrawal Phase|Progressive disease|0
5424464|NCT02496767|18726314|P2|Double-blind, Withdrawal Phase|Progressive disease|0
5424465|NCT02496767|18726315|P1|Double-blind, Withdrawal Phase|Progressive disease|0
5424466|NCT02496767|18726308|P8|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5424467|NCT02496767|18726309|P7|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5424468|NCT02496767|18726310|P6|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5424469|NCT02496767|18726311|P5|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5424470|NCT02496767|18726312|P4|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5424471|NCT02496767|18726313|P3|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5424472|NCT02496767|18726314|P2|Double-blind, Placebo-controlled Phase|Protocol Violation|1
5424473|NCT02496767|18726315|P1|Double-blind, Placebo-controlled Phase|Protocol Violation|0
5424474|NCT02496767|18726308|P8|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5424475|NCT02496767|18726309|P7|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5424476|NCT02496767|18726310|P6|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5424477|NCT02496767|18726311|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
5424478|NCT02496767|18726312|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
5424479|NCT02496767|18726313|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5424480|NCT02496767|18726314|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
5424481|NCT02496767|18726315|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5424482|NCT02496767|18726308|P8|Double-blind, Placebo-controlled Phase|Physician Decision|0
5424483|NCT02496767|18726309|P7|Double-blind, Placebo-controlled Phase|Physician Decision|0
5424484|NCT02496767|18726310|P6|Double-blind, Placebo-controlled Phase|Physician Decision|0
5424485|NCT02496767|18726311|P5|Double-blind, Placebo-controlled Phase|Physician Decision|0
5424486|NCT02496767|18726312|P4|Double-blind, Placebo-controlled Phase|Physician Decision|0
5424487|NCT02496767|18726313|P3|Double-blind, Placebo-controlled Phase|Physician Decision|1
5424488|NCT02496767|18726314|P2|Double-blind, Placebo-controlled Phase|Physician Decision|4
5424489|NCT02496767|18726315|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
5424490|NCT02496767|18726308|P8|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5424491|NCT02496767|18726309|P7|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5424492|NCT02496767|18726310|P6|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5424493|NCT02496767|18726311|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
5424494|NCT02496767|18726312|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
5424495|NCT02496767|18726313|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
5424496|NCT02496767|18726314|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
5424497|NCT02496767|18726315|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5424498|NCT02496767|18726308|P8|Double-blind, Placebo-controlled Phase|Various|0
5424499|NCT02496767|18726309|P7|Double-blind, Placebo-controlled Phase|Various|0
5424500|NCT02496767|18726310|P6|Double-blind, Placebo-controlled Phase|Various|0
5424501|NCT02496767|18726311|P5|Double-blind, Placebo-controlled Phase|Various|2
5424502|NCT02496767|18726312|P4|Double-blind, Placebo-controlled Phase|Various|5
5424503|NCT02496767|18726313|P3|Double-blind, Placebo-controlled Phase|Various|4
5424504|NCT02496767|18726314|P2|Double-blind, Placebo-controlled Phase|Various|9
5424505|NCT02496767|18726315|P1|Double-blind, Placebo-controlled Phase|Various|0
5424506|NCT02496767|18726308|P8|Double-blind, Placebo-controlled Phase|Death|0
5424507|NCT02496767|18726309|P7|Double-blind, Placebo-controlled Phase|Death|0
5424508|NCT02496767|18726310|P6|Double-blind, Placebo-controlled Phase|Death|0
5424509|NCT02496767|18726311|P5|Double-blind, Placebo-controlled Phase|Death|4
5424510|NCT02496767|18726312|P4|Double-blind, Placebo-controlled Phase|Death|2
5424511|NCT02496767|18726313|P3|Double-blind, Placebo-controlled Phase|Death|6
5424512|NCT02496767|18726314|P2|Double-blind, Placebo-controlled Phase|Death|10
5424513|NCT02496767|18726315|P1|Double-blind, Placebo-controlled Phase|Death|0
5424514|NCT02496767|18726308|P8|Double-blind, Placebo-controlled Phase|Progressive disease|0
5424515|NCT02496767|18726309|P7|Double-blind, Placebo-controlled Phase|Progressive disease|0
5424516|NCT02496767|18726310|P6|Double-blind, Placebo-controlled Phase|Progressive disease|0
5424517|NCT02496767|18726311|P5|Double-blind, Placebo-controlled Phase|Progressive disease|14
5424518|NCT02496767|18726312|P4|Double-blind, Placebo-controlled Phase|Progressive disease|8
5424519|NCT02496767|18726313|P3|Double-blind, Placebo-controlled Phase|Progressive disease|9
5424520|NCT02496767|18726314|P2|Double-blind, Placebo-controlled Phase|Progressive disease|13
5424521|NCT02496767|18726315|P1|Double-blind, Placebo-controlled Phase|Progressive disease|0
5424522|NCT02496767|18726308|P8|Double-blind, Placebo-controlled Phase|Adverse Event|0
5424523|NCT02496767|18726309|P7|Double-blind, Placebo-controlled Phase|Adverse Event|0
5424524|NCT02496767|18726310|P6|Double-blind, Placebo-controlled Phase|Adverse Event|0
5424525|NCT02496767|18726311|P5|Double-blind, Placebo-controlled Phase|Adverse Event|43
5424526|NCT02496767|18726312|P4|Double-blind, Placebo-controlled Phase|Adverse Event|43
5424527|NCT02496767|18726313|P3|Double-blind, Placebo-controlled Phase|Adverse Event|23
5424528|NCT02496767|18726314|P2|Double-blind, Placebo-controlled Phase|Adverse Event|13
5424529|NCT02496767|18726315|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
5424530|NCT02496767|18726308|P8|Open-label Lead-in Phase|Lost to Follow-up|0
5424531|NCT02496767|18726309|P7|Open-label Lead-in Phase|Lost to Follow-up|0
5424532|NCT02496767|18726310|P6|Open-label Lead-in Phase|Lost to Follow-up|0
5424533|NCT02496767|18726311|P5|Open-label Lead-in Phase|Lost to Follow-up|0
5424534|NCT02496767|18726312|P4|Open-label Lead-in Phase|Lost to Follow-up|0
5424535|NCT02496767|18726313|P3|Open-label Lead-in Phase|Lost to Follow-up|0
5424536|NCT02496767|18726314|P2|Open-label Lead-in Phase|Lost to Follow-up|0
5424537|NCT02496767|18726315|P1|Open-label Lead-in Phase|Lost to Follow-up|1
5424538|NCT02496767|18726308|P8|Open-label Lead-in Phase|Protocol Violation|0
5424539|NCT02496767|18726309|P7|Open-label Lead-in Phase|Protocol Violation|0
5424540|NCT02496767|18726310|P6|Open-label Lead-in Phase|Protocol Violation|0
5424541|NCT02496767|18726311|P5|Open-label Lead-in Phase|Protocol Violation|0
5424542|NCT02496767|18726312|P4|Open-label Lead-in Phase|Protocol Violation|0
5424543|NCT02496767|18726313|P3|Open-label Lead-in Phase|Protocol Violation|0
5424544|NCT02496767|18726314|P2|Open-label Lead-in Phase|Protocol Violation|0
5424545|NCT02496767|18726315|P1|Open-label Lead-in Phase|Protocol Violation|2
5424546|NCT02496767|18726308|P8|Open-label Lead-in Phase|Adverse Event|0
5424547|NCT02496767|18726309|P7|Open-label Lead-in Phase|Adverse Event|0
5424548|NCT02496767|18726310|P6|Open-label Lead-in Phase|Adverse Event|0
5424549|NCT02496767|18726311|P5|Open-label Lead-in Phase|Adverse Event|0
5424550|NCT02496767|18726312|P4|Open-label Lead-in Phase|Adverse Event|0
5424551|NCT02496767|18726313|P3|Open-label Lead-in Phase|Adverse Event|0
5424552|NCT02496767|18726314|P2|Open-label Lead-in Phase|Adverse Event|0
5424553|NCT02496767|18726315|P1|Open-label Lead-in Phase|Adverse Event|176
5424554|NCT02496702|18726355|P2|Overall Study|Only partially tested|2
5424555|NCT02496702|18726356|P1|Overall Study|Only partially tested|0
5424556|NCT02496702|18726355|P2|Overall Study|Lost to Follow-up|6
5424557|NCT02496702|18726356|P1|Overall Study|Lost to Follow-up|8
5424558|NCT02496533|18726378|P2|Overall Study|Late for radiologic testing|2
5424559|NCT02496533|18726379|P1|Overall Study|Late for radiologic testing|0
5424560|NCT02496533|18726378|P2|Overall Study|Patient did not complete all measures|4
5424561|NCT02496533|18726379|P1|Overall Study|Patient did not complete all measures|0
5424562|NCT02496533|18726378|P2|Overall Study|Lack of data on outcome|0
5424563|NCT02496533|18726379|P1|Overall Study|Lack of data on outcome|3
5424564|NCT02496221|18726391|P2|Treatment Period 2 - 4 Days|Physician Decision|0
5424565|NCT02496221|18726392|P1|Treatment Period 2 - 4 Days|Physician Decision|1
5424566|NCT02496221|18726391|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
5424567|NCT02496221|18726392|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
5424568|NCT02496221|18726391|P2|Treatment Period 2 - 4 Days|Adverse Event|1
5424569|NCT02496221|18726392|P1|Treatment Period 2 - 4 Days|Adverse Event|0
5424570|NCT02496091|18726426|P1|Overall Study|Eligibility criteria not fulfilled|2
5424571|NCT02496039|18726435|P1|Overall Study|Protocol Violation|1
5424572|NCT02496039|18726435|P1|Overall Study|Adverse Event|3
5424573|NCT02496000|18726450|P3|Overall Study|undetermined|0
5424574|NCT02496000|18726451|P2|Overall Study|undetermined|1
5424575|NCT02496000|18726452|P1|Overall Study|undetermined|0
5424576|NCT02496000|18726450|P3|Overall Study|Non-compliance or lack of cooperation|0
5424577|NCT02496000|18726451|P2|Overall Study|Non-compliance or lack of cooperation|2
5424578|NCT02496000|18726452|P1|Overall Study|Non-compliance or lack of cooperation|0
5424579|NCT02496000|18726450|P3|Overall Study|Protocol Violation|1
5424580|NCT02496000|18726451|P2|Overall Study|Protocol Violation|0
5424581|NCT02496000|18726452|P1|Overall Study|Protocol Violation|0
5424582|NCT02496000|18726450|P3|Overall Study|Lost to Follow-up|1
5424583|NCT02496000|18726451|P2|Overall Study|Lost to Follow-up|0
5424584|NCT02496000|18726452|P1|Overall Study|Lost to Follow-up|1
5424585|NCT02496000|18726450|P3|Overall Study|Withdrawal by Subject|0
5424586|NCT02496000|18726451|P2|Overall Study|Withdrawal by Subject|2
5424587|NCT02496000|18726452|P1|Overall Study|Withdrawal by Subject|1
5424588|NCT02495948|18726473|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
5424589|NCT02495948|18726474|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
5424590|NCT02495948|18726473|P2|Period 1, First 30 Days of Wear|Adverse Event|1
5424591|NCT02495948|18726474|P1|Period 1, First 30 Days of Wear|Adverse Event|0
5424592|NCT02495883|18726483|P2|Overall Study|Excessive head motion|0
5424593|NCT02495883|18726484|P1|Overall Study|Excessive head motion|1
5424594|NCT02495857|18726492|P3|Overall Study|Other|2
5424595|NCT02495857|18726493|P2|Overall Study|Other|3
5424596|NCT02495857|18726494|P1|Overall Study|Other|3
5424597|NCT02495857|18726492|P3|Overall Study|Lost to Follow-up|3
5424598|NCT02495857|18726493|P2|Overall Study|Lost to Follow-up|5
5424599|NCT02495857|18726494|P1|Overall Study|Lost to Follow-up|4
5424600|NCT02495857|18726492|P3|Overall Study|Protocol Violation|2
5424601|NCT02495857|18726493|P2|Overall Study|Protocol Violation|1
5424602|NCT02495857|18726494|P1|Overall Study|Protocol Violation|1
5424603|NCT02495857|18726492|P3|Overall Study|Physician Decision|0
5424604|NCT02495857|18726493|P2|Overall Study|Physician Decision|1
5424605|NCT02495857|18726494|P1|Overall Study|Physician Decision|0
5424606|NCT02495857|18726492|P3|Overall Study|Withdrawal by Subject|10
5424607|NCT02495857|18726493|P2|Overall Study|Withdrawal by Subject|6
5424608|NCT02495857|18726494|P1|Overall Study|Withdrawal by Subject|9
5424609|NCT02495857|18726492|P3|Overall Study|Adverse Event|1
5424610|NCT02495857|18726493|P2|Overall Study|Adverse Event|0
5424611|NCT02495857|18726494|P1|Overall Study|Adverse Event|5
5424612|NCT02495844|18726510|P2|Overall Study|Hepatitis Positivity|1
5424613|NCT02495844|18726511|P1|Overall Study|Hepatitis Positivity|0
5424614|NCT02495844|18726510|P2|Overall Study|AE, non-fatal|1
5424615|NCT02495844|18726511|P1|Overall Study|AE, non-fatal|0
5424616|NCT02495844|18726510|P2|Overall Study|Lack of Efficacy|2
5424617|NCT02495844|18726511|P1|Overall Study|Lack of Efficacy|1
5424618|NCT02495389|18726613|P1|Overall Study|Withdrawal by Subject|40
5424619|NCT02495233|18726651|P2|Overall Study|Miscellaneous|1
5424620|NCT02495233|18726652|P1|Overall Study|Miscellaneous|0
5424621|NCT02495168|18726681|P3|Overall Study|Lack of Efficacy|3
5424622|NCT02495168|18726682|P2|Overall Study|Lack of Efficacy|0
5424623|NCT02495168|18726683|P1|Overall Study|Lack of Efficacy|0
5424624|NCT02495168|18726681|P3|Overall Study|Adverse Event|3
5424625|NCT02495168|18726682|P2|Overall Study|Adverse Event|8
5424626|NCT02495168|18726683|P1|Overall Study|Adverse Event|4
5424627|NCT02495168|18726681|P3|Overall Study|Protocol Violation|1
5424628|NCT02495168|18726682|P2|Overall Study|Protocol Violation|10
5424629|NCT02495168|18726683|P1|Overall Study|Protocol Violation|0
5424630|NCT02495168|18726681|P3|Overall Study|Withdrawal by Subject|2
5424631|NCT02495168|18726682|P2|Overall Study|Withdrawal by Subject|4
5424632|NCT02495168|18726683|P1|Overall Study|Withdrawal by Subject|1
5424633|NCT02495168|18726681|P3|Overall Study|Lost to Follow-up|1
5424634|NCT02495168|18726682|P2|Overall Study|Lost to Follow-up|6
5424635|NCT02495168|18726683|P1|Overall Study|Lost to Follow-up|10
5424636|NCT02495168|18726681|P3|Overall Study|Physician Decision|0
5424637|NCT02495168|18726682|P2|Overall Study|Physician Decision|1
5424638|NCT02495168|18726683|P1|Overall Study|Physician Decision|1
5424639|NCT02495168|18726681|P3|Overall Study|Did not Complete Final Visit On Time|2
5424640|NCT02495168|18726682|P2|Overall Study|Did not Complete Final Visit On Time|3
5424641|NCT02495168|18726683|P1|Overall Study|Did not Complete Final Visit On Time|4
5424642|NCT02495168|18726681|P3|Overall Study|Other than Specified|5
5424643|NCT02495168|18726682|P2|Overall Study|Other than Specified|22
5424644|NCT02495168|18726683|P1|Overall Study|Other than Specified|18
5424645|NCT02495025|18726742|P2|Overall Study|Withdrawal by Subject|0
5424646|NCT02495025|18726743|P1|Overall Study|Withdrawal by Subject|5
5424647|NCT02495025|18726742|P2|Overall Study|Lost to Follow-up|14
5424648|NCT02495025|18726743|P1|Overall Study|Lost to Follow-up|21
5424649|NCT02494596|18726795|P3|Overall Study|Refused Treatment|0
5424650|NCT02494596|18726796|P2|Overall Study|Refused Treatment|1
5424651|NCT02494596|18726797|P1|Overall Study|Refused Treatment|0
5424652|NCT02494596|18726795|P3|Overall Study|Adverse Event|0
5424653|NCT02494596|18726796|P2|Overall Study|Adverse Event|1
5424654|NCT02494596|18726797|P1|Overall Study|Adverse Event|0
5424655|NCT02494596|18726795|P3|Overall Study|Insufficient Therapeutic Response|1
5424656|NCT02494596|18726796|P2|Overall Study|Insufficient Therapeutic Response|3
5424657|NCT02494596|18726797|P1|Overall Study|Insufficient Therapeutic Response|3
5424658|NCT02494583|18726825|P3|Overall Study|Ongoing in Study|34
5424659|NCT02494583|18726826|P2|Overall Study|Ongoing in Study|51
5424660|NCT02494583|18726827|P1|Overall Study|Ongoing in Study|56
5424661|NCT02494583|18726825|P3|Overall Study|Withdrawal by Subject|15
5424662|NCT02494583|18726826|P2|Overall Study|Withdrawal by Subject|15
5424663|NCT02494583|18726827|P1|Overall Study|Withdrawal by Subject|3
5424664|NCT02494583|18726825|P3|Overall Study|Protocol Violation|0
5424665|NCT02494583|18726826|P2|Overall Study|Protocol Violation|2
5424666|NCT02494583|18726827|P1|Overall Study|Protocol Violation|1
5424667|NCT02494583|18726825|P3|Overall Study|Lost to Follow-up|0
5424668|NCT02494583|18726826|P2|Overall Study|Lost to Follow-up|0
5424669|NCT02494583|18726827|P1|Overall Study|Lost to Follow-up|1
5424670|NCT02494583|18726825|P3|Overall Study|Death|201
5424671|NCT02494583|18726826|P2|Overall Study|Death|189
5424672|NCT02494583|18726827|P1|Overall Study|Death|195
5424673|NCT02494401|18726925|P2|Overall Study|Withdrawal by Subject|2
5424674|NCT02494401|18726926|P1|Overall Study|Withdrawal by Subject|3
5424675|NCT02494401|18726925|P2|Overall Study|Lost to Follow-up|25
5424676|NCT02494401|18726926|P1|Overall Study|Lost to Follow-up|22
5424677|NCT02494206|18726978|P1|Overall Study|Disease Progression|1
5424678|NCT02494206|18726978|P1|Overall Study|Adverse Event|1
5424679|NCT02493946|18727032|P3|Open Label Period|Site error|1
5424680|NCT02493946|18727033|P2|Open Label Period|Site error|0
5424681|NCT02493946|18727034|P1|Open Label Period|Site error|0
5424682|NCT02493946|18727032|P3|Open Label Period|Pregnancy|3
5424683|NCT02493946|18727033|P2|Open Label Period|Pregnancy|0
5424684|NCT02493946|18727034|P1|Open Label Period|Pregnancy|0
5424685|NCT02493946|18727032|P3|Open Label Period|Investigator decision, non-availability|1
5424686|NCT02493946|18727033|P2|Open Label Period|Investigator decision, non-availability|0
5424687|NCT02493946|18727034|P1|Open Label Period|Investigator decision, non-availability|0
5424688|NCT02493946|18727032|P3|Open Label Period|Investigator decision, non-compliance|2
5424689|NCT02493946|18727033|P2|Open Label Period|Investigator decision, non-compliance|0
5424690|NCT02493946|18727034|P1|Open Label Period|Investigator decision, non-compliance|0
5424691|NCT02493946|18727032|P3|Open Label Period|Lost to Follow-up|1
5424692|NCT02493946|18727033|P2|Open Label Period|Lost to Follow-up|0
5424693|NCT02493946|18727034|P1|Open Label Period|Lost to Follow-up|0
5424694|NCT02493946|18727032|P3|Open Label Period|Adverse Event|4
5424695|NCT02493946|18727033|P2|Open Label Period|Adverse Event|0
5424696|NCT02493946|18727034|P1|Open Label Period|Adverse Event|0
5424697|NCT02493946|18727032|P3|Open Label Period|Withdrawal by Subject|74
5424698|NCT02493946|18727033|P2|Open Label Period|Withdrawal by Subject|0
5424699|NCT02493946|18727034|P1|Open Label Period|Withdrawal by Subject|0
5424700|NCT02493946|18727032|P3|DB Period|Withdrawal by Subject|0
5424701|NCT02493946|18727033|P2|DB Period|Withdrawal by Subject|5
5424702|NCT02493946|18727034|P1|DB Period|Withdrawal by Subject|8
5424703|NCT02493868|18727067|P2|Follow-up Phase|Other|1
5424704|NCT02493868|18727068|P1|Follow-up Phase|Other|2
5424705|NCT02493868|18727067|P2|Follow-up Phase|Investigator Decision|1
5424706|NCT02493868|18727068|P1|Follow-up Phase|Investigator Decision|5
5424707|NCT02493868|18727067|P2|Follow-up Phase|Withdrawal by Subject|0
5424708|NCT02493868|18727068|P1|Follow-up Phase|Withdrawal by Subject|3
5424709|NCT02493868|18727067|P2|Follow-up Phase|Lost to Follow-up|0
5424710|NCT02493868|18727068|P1|Follow-up Phase|Lost to Follow-up|1
5424711|NCT02493868|18727067|P2|Maintenance Phase: DE+TE Participants|Other|9
5424712|NCT02493868|18727068|P1|Maintenance Phase: DE+TE Participants|Other|4
5424713|NCT02493868|18727067|P2|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
5424714|NCT02493868|18727068|P1|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
5424715|NCT02493868|18727067|P2|Maintenance Phase: DE+TE Participants|Pregnancy|0
5424716|NCT02493868|18727068|P1|Maintenance Phase: DE+TE Participants|Pregnancy|1
5424717|NCT02493868|18727067|P2|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
5424718|NCT02493868|18727068|P1|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
5424719|NCT02493868|18727067|P2|Maintenance Phase: DE+TE Participants|Protocol Violation|1
5424720|NCT02493868|18727068|P1|Maintenance Phase: DE+TE Participants|Protocol Violation|1
5424721|NCT02493868|18727067|P2|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
5424722|NCT02493868|18727068|P1|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
5424723|NCT02493868|18727067|P2|Maintenance Phase: DE+TE Participants|Adverse Event|4
5424724|NCT02493868|18727068|P1|Maintenance Phase: DE+TE Participants|Adverse Event|1
5424725|NCT02493868|18727067|P2|Optimization Phase: DE+TE Participants|Other|2
5424726|NCT02493868|18727068|P1|Optimization Phase: DE+TE Participants|Other|10
5424727|NCT02493868|18727067|P2|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
5424728|NCT02493868|18727068|P1|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
5424729|NCT02493868|18727067|P2|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
5424730|NCT02493868|18727068|P1|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
5424731|NCT02493868|18727067|P2|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
5424732|NCT02493868|18727068|P1|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
5424733|NCT02493868|18727067|P2|Optimization Phase: DE+TE Participants|Protocol Violation|1
5424734|NCT02493868|18727068|P1|Optimization Phase: DE+TE Participants|Protocol Violation|4
5424735|NCT02493868|18727067|P2|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
5424736|NCT02493868|18727068|P1|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
5424737|NCT02493868|18727067|P2|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
5424738|NCT02493868|18727068|P1|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
5424739|NCT02493868|18727067|P2|Optimization Phase: DE+TE Participants|Adverse Event|0
5424740|NCT02493868|18727068|P1|Optimization Phase: DE+TE Participants|Adverse Event|5
5424741|NCT02493868|18727067|P2|Induction Phase: DE Participants|Other|0
5424742|NCT02493868|18727068|P1|Induction Phase: DE Participants|Other|8
5424743|NCT02493868|18727067|P2|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
5424744|NCT02493868|18727068|P1|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
5424745|NCT02493868|18727067|P2|Induction Phase: DE Participants|Withdrawal by Subject|0
5424746|NCT02493868|18727068|P1|Induction Phase: DE Participants|Withdrawal by Subject|15
5424747|NCT02493868|18727067|P2|Induction Phase: DE Participants|Protocol Violation|0
5424748|NCT02493868|18727068|P1|Induction Phase: DE Participants|Protocol Violation|2
5424749|NCT02493868|18727067|P2|Induction Phase: DE Participants|Lack of Efficacy|0
5424750|NCT02493868|18727068|P1|Induction Phase: DE Participants|Lack of Efficacy|2
5424751|NCT02493868|18727067|P2|Induction Phase: DE Participants|Lost to Follow-up|0
5424752|NCT02493868|18727068|P1|Induction Phase: DE Participants|Lost to Follow-up|1
5424753|NCT02493868|18727067|P2|Induction Phase: DE Participants|Adverse Event|0
5424754|NCT02493868|18727068|P1|Induction Phase: DE Participants|Adverse Event|22
5424755|NCT02493855|18727117|P3|Overall Study|Withdrawal by Subject|0
5424756|NCT02493855|18727118|P2|Overall Study|Withdrawal by Subject|0
5424757|NCT02493855|18727119|P1|Overall Study|Withdrawal by Subject|1
5424758|NCT02493855|18727117|P3|Overall Study|Adverse Event|0
5424759|NCT02493855|18727118|P2|Overall Study|Adverse Event|1
5424760|NCT02493855|18727119|P1|Overall Study|Adverse Event|0
5424761|NCT02493855|18727117|P3|Overall Study|Non-compliance|0
5424762|NCT02493855|18727118|P2|Overall Study|Non-compliance|0
5424763|NCT02493855|18727119|P1|Overall Study|Non-compliance|1
5424764|NCT02493777|18727129|P2|Overall Study|Lost to Follow-up|1
5424765|NCT02493777|18727130|P1|Overall Study|Lost to Follow-up|0
5424766|NCT02493764|18727140|P2|Overall Study|Withdrawal by Subject|7
5424767|NCT02493764|18727141|P1|Overall Study|Withdrawal by Subject|11
5424768|NCT02493764|18727140|P2|Overall Study|Withdrawal parent/guardian|1
5424769|NCT02493764|18727141|P1|Overall Study|Withdrawal parent/guardian|0
5424770|NCT02493764|18727140|P2|Overall Study|Participant moved|5
5424771|NCT02493764|18727141|P1|Overall Study|Participant moved|17
5424772|NCT02493764|18727140|P2|Overall Study|Physician Decision|1
5424773|NCT02493764|18727141|P1|Overall Study|Physician Decision|1
5424774|NCT02493764|18727140|P2|Overall Study|Protocol Violation|7
5424775|NCT02493764|18727141|P1|Overall Study|Protocol Violation|6
5424776|NCT02493764|18727140|P2|Overall Study|Lost to Follow-up|1
5424777|NCT02493764|18727141|P1|Overall Study|Lost to Follow-up|2
5424778|NCT02493764|18727140|P2|Overall Study|Death|58
5424779|NCT02493764|18727141|P1|Overall Study|Death|44
5424780|NCT02493764|18727140|P2|Overall Study|Adverse Event|2
5424781|NCT02493764|18727141|P1|Overall Study|Adverse Event|2
5424782|NCT02493751|18727191|P2|Overall Study|Ongoing|23
5424783|NCT02493751|18727192|P1|Overall Study|Ongoing|11
5424784|NCT02493751|18727191|P2|Overall Study|Withdrawal by Subject|5
5424785|NCT02493751|18727192|P1|Overall Study|Withdrawal by Subject|2
5424786|NCT02493751|18727191|P2|Overall Study|Lost to Follow-up|1
5424787|NCT02493751|18727192|P1|Overall Study|Lost to Follow-up|0
5424788|NCT02493712|18727200|P3|Overall Study|Lack of Efficacy|3
5424789|NCT02493712|18727201|P2|Overall Study|Lack of Efficacy|5
5424790|NCT02493712|18727202|P1|Overall Study|Lack of Efficacy|0
5424791|NCT02493712|18727200|P3|Overall Study|Physician Decision|0
5424792|NCT02493712|18727201|P2|Overall Study|Physician Decision|1
5424793|NCT02493712|18727202|P1|Overall Study|Physician Decision|0
5424794|NCT02493712|18727200|P3|Overall Study|Lost to Follow-up|0
5424795|NCT02493712|18727201|P2|Overall Study|Lost to Follow-up|0
5424796|NCT02493712|18727202|P1|Overall Study|Lost to Follow-up|1
5424797|NCT02493712|18727200|P3|Overall Study|Protocol Violation|1
5424798|NCT02493712|18727201|P2|Overall Study|Protocol Violation|0
5424799|NCT02493712|18727202|P1|Overall Study|Protocol Violation|0
5424800|NCT02493712|18727200|P3|Overall Study|Withdrawal by Subject|2
5424801|NCT02493712|18727201|P2|Overall Study|Withdrawal by Subject|0
5424802|NCT02493712|18727202|P1|Overall Study|Withdrawal by Subject|1
5424803|NCT02493517|18727239|P2|Overall Study|Missed study visit|1
5424804|NCT02493517|18727240|P1|Overall Study|Missed study visit|0
5424805|NCT02493517|18727239|P2|Overall Study|Adverse Event|2
5424806|NCT02493517|18727240|P1|Overall Study|Adverse Event|0
5424807|NCT02493517|18727239|P2|Overall Study|Withdrawal by Subject|2
5424808|NCT02493517|18727240|P1|Overall Study|Withdrawal by Subject|1
5424809|NCT02493517|18727239|P2|Overall Study|Protocol Violation|2
5424810|NCT02493517|18727240|P1|Overall Study|Protocol Violation|1
5424811|NCT02493127|18727320|P2|Overall Study|Lost to Follow-up|1
5424812|NCT02493127|18727321|P1|Overall Study|Lost to Follow-up|1
5424813|NCT02493062|18727339|P1|Overall Study|Physician Decision|12
5424814|NCT02492997|18727362|P2|Overall Study|Lost to Follow-up|1
5424815|NCT02492997|18727363|P1|Overall Study|Lost to Follow-up|0
5424816|NCT02492997|18727362|P2|Overall Study|Gained Weight|0
5424817|NCT02492997|18727363|P1|Overall Study|Gained Weight|1
5424818|NCT02492997|18727362|P2|Overall Study|Withdrawal by Subject|0
5424819|NCT02492997|18727363|P1|Overall Study|Withdrawal by Subject|1
5424820|NCT02492984|18727373|P2|Overall Study|Withdrawal by Subject|0
5424821|NCT02492984|18727374|P1|Overall Study|Withdrawal by Subject|1
5424822|NCT02492984|18727373|P2|Overall Study|Protocol Violation|0
5424823|NCT02492984|18727374|P1|Overall Study|Protocol Violation|1
5424824|NCT02492984|18727373|P2|Overall Study|Adverse Event|0
5424825|NCT02492984|18727374|P1|Overall Study|Adverse Event|1
5424826|NCT02492958|18727398|P4|Overall Study|Adverse Event|0
5424827|NCT02492958|18727399|P3|Overall Study|Adverse Event|1
5424828|NCT02492958|18727400|P2|Overall Study|Adverse Event|0
5424829|NCT02492958|18727401|P1|Overall Study|Adverse Event|1
5424830|NCT02492958|18727398|P4|Overall Study|Withdrawal by Subject|0
5424831|NCT02492958|18727399|P3|Overall Study|Withdrawal by Subject|1
5424832|NCT02492958|18727400|P2|Overall Study|Withdrawal by Subject|0
5424833|NCT02492958|18727401|P1|Overall Study|Withdrawal by Subject|0
5424834|NCT02492880|18727487|P1|Overall Study|Protocol Violation|1
5424835|NCT02492880|18727487|P1|Overall Study|Lost to Follow-up|1
5424836|NCT02492841|18727494|P3|Overall Study|Lost to Follow-up|35
5424837|NCT02492841|18727495|P2|Overall Study|Lost to Follow-up|31
5424838|NCT02492841|18727496|P1|Overall Study|Lost to Follow-up|34
5424839|NCT02492763|18727515|P4|Overall Study|Study Terminated by Sponsor|10
5424840|NCT02492763|18727516|P3|Overall Study|Study Terminated by Sponsor|6
5424841|NCT02492763|18727517|P2|Overall Study|Study Terminated by Sponsor|10
5424842|NCT02492763|18727518|P1|Overall Study|Study Terminated by Sponsor|13
5424843|NCT02492763|18727515|P4|Overall Study|Screen Failure|1
5424844|NCT02492763|18727516|P3|Overall Study|Screen Failure|0
5424845|NCT02492763|18727517|P2|Overall Study|Screen Failure|0
5424846|NCT02492763|18727518|P1|Overall Study|Screen Failure|0
5424847|NCT02492763|18727515|P4|Overall Study|Non-Compliance With Study Drug|0
5424848|NCT02492763|18727516|P3|Overall Study|Non-Compliance With Study Drug|0
5424849|NCT02492763|18727517|P2|Overall Study|Non-Compliance With Study Drug|1
5424850|NCT02492763|18727518|P1|Overall Study|Non-Compliance With Study Drug|0
5424851|NCT02492763|18727515|P4|Overall Study|Lost to Follow-up|0
5424852|NCT02492763|18727516|P3|Overall Study|Lost to Follow-up|1
5424853|NCT02492763|18727517|P2|Overall Study|Lost to Follow-up|0
5424854|NCT02492763|18727518|P1|Overall Study|Lost to Follow-up|0
5424855|NCT02492763|18727515|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
5424856|NCT02492763|18727516|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
5424857|NCT02492763|18727517|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
5424858|NCT02492763|18727518|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
5424859|NCT02492763|18727515|P4|Overall Study|Death|0
5424860|NCT02492763|18727516|P3|Overall Study|Death|1
5424861|NCT02492763|18727517|P2|Overall Study|Death|0
5424862|NCT02492763|18727518|P1|Overall Study|Death|0
5424863|NCT02492763|18727515|P4|Overall Study|Adverse Event|2
5424864|NCT02492763|18727516|P3|Overall Study|Adverse Event|1
5424865|NCT02492763|18727517|P2|Overall Study|Adverse Event|1
5424866|NCT02492763|18727518|P1|Overall Study|Adverse Event|3
5424867|NCT02492763|18727515|P4|Overall Study|Withdrawal by Subject|0
5424868|NCT02492763|18727516|P3|Overall Study|Withdrawal by Subject|1
5424869|NCT02492763|18727517|P2|Overall Study|Withdrawal by Subject|2
5424870|NCT02492763|18727518|P1|Overall Study|Withdrawal by Subject|0
5424871|NCT02492165|18727623|P4|Overall Study|Withdrawal by Subject|0
5424872|NCT02492165|18727624|P3|Overall Study|Withdrawal by Subject|0
5424873|NCT02492165|18727625|P2|Overall Study|Withdrawal by Subject|1
5424874|NCT02492165|18727626|P1|Overall Study|Withdrawal by Subject|0
5424875|NCT02492100|18727648|P1|Overall Study|Death|1
5424876|NCT02491892|18727677|P2|Overall Study|Lost to Follow-up|0
5424877|NCT02491892|18727678|P1|Overall Study|Lost to Follow-up|1
5424878|NCT02491892|18727677|P2|Overall Study|Refused Treatment|0
5424879|NCT02491892|18727678|P1|Overall Study|Refused Treatment|1
5424880|NCT02491892|18727677|P2|Overall Study|Lack of Efficacy|36
5424881|NCT02491892|18727678|P1|Overall Study|Lack of Efficacy|37
5424882|NCT02491892|18727677|P2|Overall Study|Death|1
5424883|NCT02491892|18727678|P1|Overall Study|Death|1
5424884|NCT02491892|18727677|P2|Overall Study|Adverse Event|1
5424885|NCT02491892|18727678|P1|Overall Study|Adverse Event|1
5424886|NCT02491684|18727733|P2|Treatment Phase|Investigator and Sponsor decision|1
5424887|NCT02491684|18727734|P1|Treatment Phase|Investigator and Sponsor decision|0
5424888|NCT02491684|18727733|P2|Treatment Phase|Incorrect randomisation|0
5424889|NCT02491684|18727734|P1|Treatment Phase|Incorrect randomisation|1
5424890|NCT02491684|18727733|P2|Treatment Phase|Adverse Event|2
5424891|NCT02491684|18727734|P1|Treatment Phase|Adverse Event|2
5424892|NCT02491463|18727772|P4|Overall Study|Lost to Follow-up|0
5424893|NCT02491463|18727773|P3|Overall Study|Lost to Follow-up|3
5424894|NCT02491463|18727774|P2|Overall Study|Lost to Follow-up|3
5424895|NCT02491463|18727775|P1|Overall Study|Lost to Follow-up|0
5424896|NCT02491463|18727772|P4|Overall Study|Migrated/moved from study area|1
5424897|NCT02491463|18727773|P3|Overall Study|Migrated/moved from study area|1
5424898|NCT02491463|18727774|P2|Overall Study|Migrated/moved from study area|5
5424899|NCT02491463|18727775|P1|Overall Study|Migrated/moved from study area|1
5424900|NCT02491463|18727772|P4|Overall Study|Withdrawal by Subject|0
5424901|NCT02491463|18727773|P3|Overall Study|Withdrawal by Subject|0
5424902|NCT02491463|18727774|P2|Overall Study|Withdrawal by Subject|2
5424903|NCT02491463|18727775|P1|Overall Study|Withdrawal by Subject|1
5424904|NCT02491411|18727878|P1|Overall Study|Physician Decision|4
5424905|NCT02491073|18727909|P2|Overall Study|screen failure|0
5424906|NCT02491073|18727910|P1|Overall Study|screen failure|1
5424907|NCT02490475|18727962|P4|Period 2: Extension Phase|Adverse Event|0
5424908|NCT02490475|18727963|P3|Period 2: Extension Phase|Adverse Event|1
5424909|NCT02490475|18727964|P2|Period 2: Extension Phase|Adverse Event|0
5424910|NCT02490475|18727965|P1|Period 2: Extension Phase|Adverse Event|0
5424911|NCT02490475|18727962|P4|Period 2: Extension Phase|Refused Treatment|1
5424912|NCT02490475|18727963|P3|Period 2: Extension Phase|Refused Treatment|0
5424913|NCT02490475|18727964|P2|Period 2: Extension Phase|Refused Treatment|0
5424914|NCT02490475|18727965|P1|Period 2: Extension Phase|Refused Treatment|0
5424915|NCT02490475|18727962|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
5424916|NCT02490475|18727963|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
5424917|NCT02490475|18727964|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
5424918|NCT02490475|18727965|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
5424919|NCT02490475|18727962|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
5424920|NCT02490475|18727963|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
5424921|NCT02490475|18727964|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
5424922|NCT02490475|18727965|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
5424923|NCT02490475|18727962|P4|Period 1: First 6 Cycles|Refused Treatment|0
5424924|NCT02490475|18727963|P3|Period 1: First 6 Cycles|Refused Treatment|0
5424925|NCT02490475|18727964|P2|Period 1: First 6 Cycles|Refused Treatment|0
5424926|NCT02490475|18727965|P1|Period 1: First 6 Cycles|Refused Treatment|1
5424927|NCT02490475|18727962|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
5424928|NCT02490475|18727963|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
5424929|NCT02490475|18727964|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
5424930|NCT02490475|18727965|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
5424931|NCT02490475|18727962|P4|Period 1: First 6 Cycles|Adverse Event|1
5424932|NCT02490475|18727963|P3|Period 1: First 6 Cycles|Adverse Event|0
5424933|NCT02490475|18727964|P2|Period 1: First 6 Cycles|Adverse Event|1
5424934|NCT02490475|18727965|P1|Period 1: First 6 Cycles|Adverse Event|2
5424935|NCT02490371|18728043|P2|Overall Study|Lost to Follow-up|1
5424936|NCT02490371|18728044|P1|Overall Study|Lost to Follow-up|1
5424937|NCT02489981|18728071|P1|Overall Study|Other than listed|28
5424938|NCT02489981|18728071|P1|Overall Study|Lost to Follow-up|31
5424939|NCT02489981|18728071|P1|Overall Study|Improved|31
5424940|NCT02489981|18728071|P1|Overall Study|Insufficient effectiveness|16
5424941|NCT02489981|18728071|P1|Overall Study|Adverse Event|21
5424942|NCT02489968|18728078|P6|Double-blind Treatment Period|Other than specified above|0
5424943|NCT02489968|18728079|P5|Double-blind Treatment Period|Other than specified above|1
5424944|NCT02489968|18728080|P4|Double-blind Treatment Period|Other than specified above|0
5424945|NCT02489968|18728081|P3|Double-blind Treatment Period|Other than specified above|0
5424946|NCT02489968|18728082|P2|Double-blind Treatment Period|Other than specified above|0
5424947|NCT02489968|18728083|P1|Double-blind Treatment Period|Other than specified above|0
5424948|NCT02489968|18728078|P6|Double-blind Treatment Period|Withdrawal by Subject|2
5424949|NCT02489968|18728079|P5|Double-blind Treatment Period|Withdrawal by Subject|0
5424950|NCT02489968|18728080|P4|Double-blind Treatment Period|Withdrawal by Subject|2
5424951|NCT02489968|18728081|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5424952|NCT02489968|18728082|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5424953|NCT02489968|18728083|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5424954|NCT02489968|18728078|P6|Double-blind Treatment Period|Protocol Violation|1
5424955|NCT02489968|18728079|P5|Double-blind Treatment Period|Protocol Violation|1
5424956|NCT02489968|18728080|P4|Double-blind Treatment Period|Protocol Violation|0
5424957|NCT02489968|18728081|P3|Double-blind Treatment Period|Protocol Violation|0
5424958|NCT02489968|18728082|P2|Double-blind Treatment Period|Protocol Violation|0
5424959|NCT02489968|18728083|P1|Double-blind Treatment Period|Protocol Violation|0
5424960|NCT02489968|18728078|P6|Double-blind Treatment Period|Adverse Event|5
5424961|NCT02489968|18728079|P5|Double-blind Treatment Period|Adverse Event|4
5424962|NCT02489968|18728080|P4|Double-blind Treatment Period|Adverse Event|6
5424963|NCT02489968|18728081|P3|Double-blind Treatment Period|Adverse Event|2
5424964|NCT02489968|18728082|P2|Double-blind Treatment Period|Adverse Event|0
5424965|NCT02489968|18728083|P1|Double-blind Treatment Period|Adverse Event|0
5424966|NCT02489968|18728078|P6|Open-label Treatment Period|Other than specified above|0
5424967|NCT02489968|18728079|P5|Open-label Treatment Period|Other than specified above|0
5424968|NCT02489968|18728080|P4|Open-label Treatment Period|Other than specified above|0
5424969|NCT02489968|18728081|P3|Open-label Treatment Period|Other than specified above|0
5424970|NCT02489968|18728082|P2|Open-label Treatment Period|Other than specified above|189
5424971|NCT02489968|18728083|P1|Open-label Treatment Period|Other than specified above|204
5424972|NCT02489968|18728078|P6|Open-label Treatment Period|Withdrawal by Subject|0
5424973|NCT02489968|18728079|P5|Open-label Treatment Period|Withdrawal by Subject|0
5424974|NCT02489968|18728080|P4|Open-label Treatment Period|Withdrawal by Subject|0
5424975|NCT02489968|18728081|P3|Open-label Treatment Period|Withdrawal by Subject|0
5424976|NCT02489968|18728082|P2|Open-label Treatment Period|Withdrawal by Subject|7
5424977|NCT02489968|18728083|P1|Open-label Treatment Period|Withdrawal by Subject|4
5424978|NCT02489968|18728078|P6|Open-label Treatment Period|Lost to Follow-up|0
5424979|NCT02489968|18728079|P5|Open-label Treatment Period|Lost to Follow-up|0
5424980|NCT02489968|18728080|P4|Open-label Treatment Period|Lost to Follow-up|0
5424981|NCT02489968|18728081|P3|Open-label Treatment Period|Lost to Follow-up|0
5424982|NCT02489968|18728082|P2|Open-label Treatment Period|Lost to Follow-up|3
5424983|NCT02489968|18728083|P1|Open-label Treatment Period|Lost to Follow-up|0
5424984|NCT02489968|18728078|P6|Open-label Treatment Period|Protocol Violation|0
5424985|NCT02489968|18728079|P5|Open-label Treatment Period|Protocol Violation|0
5424986|NCT02489968|18728080|P4|Open-label Treatment Period|Protocol Violation|0
5424987|NCT02489968|18728081|P3|Open-label Treatment Period|Protocol Violation|0
5424988|NCT02489968|18728082|P2|Open-label Treatment Period|Protocol Violation|2
5424989|NCT02489968|18728083|P1|Open-label Treatment Period|Protocol Violation|2
5424990|NCT02489968|18728078|P6|Open-label Treatment Period|Adverse Event|0
5424991|NCT02489968|18728079|P5|Open-label Treatment Period|Adverse Event|0
5424992|NCT02489968|18728080|P4|Open-label Treatment Period|Adverse Event|0
5424993|NCT02489968|18728081|P3|Open-label Treatment Period|Adverse Event|0
5424994|NCT02489968|18728082|P2|Open-label Treatment Period|Adverse Event|7
5424995|NCT02489968|18728083|P1|Open-label Treatment Period|Adverse Event|14
5424996|NCT02489799|18728097|P2|Overall Study|Death|1
5424997|NCT02489799|18728098|P1|Overall Study|Death|0
5424998|NCT02489799|18728097|P2|Overall Study|Withdrawal by Subject|1
5424999|NCT02489799|18728098|P1|Overall Study|Withdrawal by Subject|1
5425000|NCT02489799|18728097|P2|Overall Study|Failure to Maintain Eligibility|6
5425001|NCT02489799|18728098|P1|Overall Study|Failure to Maintain Eligibility|4
5425002|NCT02489799|18728097|P2|Overall Study|Lost to Follow-up|1
5425003|NCT02489799|18728098|P1|Overall Study|Lost to Follow-up|4
5425004|NCT02489773|18728124|P2|Overall Study|Leave the country or the state|1
5425005|NCT02489773|18728125|P1|Overall Study|Leave the country or the state|1
5425006|NCT02489773|18728124|P2|Overall Study|Withdrawal by Subject|0
5425007|NCT02489773|18728125|P1|Overall Study|Withdrawal by Subject|1
5425008|NCT02489773|18728124|P2|Overall Study|Physician Decision|0
5425009|NCT02489773|18728125|P1|Overall Study|Physician Decision|1
5425010|NCT02489773|18728124|P2|Overall Study|Lost to Follow-up|1
5425011|NCT02489773|18728125|P1|Overall Study|Lost to Follow-up|4
5425012|NCT02489500|18728135|P2|Overall Study|Death|1
5425013|NCT02489500|18728136|P1|Overall Study|Death|1
5425014|NCT02489344|18728154|P1|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
5425015|NCT02489344|18728154|P1|LTS14116 (Extension Study): 31 Months|Adverse Event|1
5425016|NCT02489344|18728154|P1|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
5425017|NCT02489344|18728154|P1|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
5425018|NCT02489279|18728196|P2|Overall Study|Lost to Follow-up|10
5425019|NCT02489279|18728197|P1|Overall Study|Lost to Follow-up|12
5425020|NCT02488980|18728238|P3|Overall Study|Protocol Violation|2
5425021|NCT02488980|18728239|P2|Overall Study|Protocol Violation|2
5425022|NCT02488980|18728240|P1|Overall Study|Protocol Violation|2
5425023|NCT02488915|18728257|P1|Overall Study|Withdrawal by Subject|1
5425024|NCT02488915|18728257|P1|Overall Study|Lost to Follow-up|4
5425025|NCT02488915|18728257|P1|Overall Study|Death|21
5425026|NCT02488824|18728275|P2|Overall Study|Adverse Event|1
5425027|NCT02488824|18728276|P1|Overall Study|Adverse Event|1
5425028|NCT02488681|18728290|P1|Overall Study|Implant unsuccessful|7
5425029|NCT02488330|18728294|P1|Overall Study|Study Termination by Sponsor|4
5425030|NCT02488330|18728294|P1|Overall Study|Disease Progression|3
5425031|NCT02488330|18728294|P1|Overall Study|Death|2
5425032|NCT02488330|18728294|P1|Overall Study|Physician Decision|2
5425033|NCT02488330|18728294|P1|Overall Study|Adverse Event|1
5425034|NCT02488239|18728315|P1|Overall Study|Did not undergo implant procedure|1
5425035|NCT02488239|18728315|P1|Overall Study|Consent ineligible|1
5425036|NCT02488239|18728315|P1|Overall Study|Physician Decision|2
5425037|NCT02488239|18728315|P1|Overall Study|Withdrawal by Subject|3
5425038|NCT02488239|18728315|P1|Overall Study|Death|3
5425039|NCT02488005|18728332|P1|Overall Study|Lost to Follow-up|2
5425040|NCT02487979|18728342|P1|Overall Study|Progressive Disease|17
5425041|NCT02487979|18728342|P1|Overall Study|Withdrawal by Subject|2
5425042|NCT02487979|18728342|P1|Overall Study|Physician Decision|2
5425043|NCT02487810|18728354|P2|Overall Study|Withdrawal by Subject|0
5425044|NCT02487810|18728355|P1|Overall Study|Withdrawal by Subject|1
5425045|NCT02487771|18728387|P2|Overall Study|Withdrawal by Subject|5
5425046|NCT02487771|18728388|P1|Overall Study|Withdrawal by Subject|3
5425047|NCT02487771|18728387|P2|Overall Study|Moved out of area|6
5425048|NCT02487771|18728388|P1|Overall Study|Moved out of area|5
5425049|NCT02487771|18728387|P2|Overall Study|Lost to Follow-up|3
5425050|NCT02487771|18728388|P1|Overall Study|Lost to Follow-up|2
5425051|NCT02487498|18728554|P2|Period: Period 2|Physician Decision|0
5425052|NCT02487498|18728555|P1|Period: Period 2|Physician Decision|1
5425053|NCT02487498|18728554|P2|Period: Period 2|Death|1
5425054|NCT02487498|18728555|P1|Period: Period 2|Death|0
5425055|NCT02487498|18728554|P2|Period: Period 2|Lost to Follow-up|1
5425056|NCT02487498|18728555|P1|Period: Period 2|Lost to Follow-up|1
5425057|NCT02487498|18728554|P2|Period: Period 2|Subject/guardian decision|1
5425058|NCT02487498|18728555|P1|Period: Period 2|Subject/guardian decision|2
5425059|NCT02487498|18728554|P2|Period: Period 2|Adverse Event|2
5425060|NCT02487498|18728555|P1|Period: Period 2|Adverse Event|2
5425061|NCT02487498|18728554|P2|Period: Washout|Non-compliance with study treatment|1
5425062|NCT02487498|18728555|P1|Period: Washout|Non-compliance with study treatment|0
5425063|NCT02487498|18728554|P2|Period: Washout|Physician Decision|0
5425064|NCT02487498|18728555|P1|Period: Washout|Physician Decision|1
5425065|NCT02487498|18728554|P2|Period: Washout|Lack of Efficacy|1
5425066|NCT02487498|18728555|P1|Period: Washout|Lack of Efficacy|1
5425067|NCT02487498|18728554|P2|Period: Washout|Subject/guardian decision|5
5425068|NCT02487498|18728555|P1|Period: Washout|Subject/guardian decision|0
5425069|NCT02487498|18728554|P2|Period: Period 1|Protocol deviation|0
5425070|NCT02487498|18728555|P1|Period: Period 1|Protocol deviation|1
5425071|NCT02487498|18728554|P2|Period: Period 1|Physician Decision|1
5425072|NCT02487498|18728555|P1|Period: Period 1|Physician Decision|0
5425073|NCT02487498|18728554|P2|Period: Period 1|Lack of Efficacy|0
5425074|NCT02487498|18728555|P1|Period: Period 1|Lack of Efficacy|1
5425075|NCT02487498|18728554|P2|Period: Period 1|Lost to Follow-up|2
5425076|NCT02487498|18728555|P1|Period: Period 1|Lost to Follow-up|0
5425077|NCT02487498|18728554|P2|Period: Period 1|Subject/guardian decision|4
5425078|NCT02487498|18728555|P1|Period: Period 1|Subject/guardian decision|2
5425079|NCT02487498|18728554|P2|Period: Period 1|Adverse Event|4
5425080|NCT02487498|18728555|P1|Period: Period 1|Adverse Event|2
5425081|NCT02487472|18728599|P1|Overall Study|Other|2
5425082|NCT02487472|18728599|P1|Overall Study|Did not complete telephonic interviews|9
5425083|NCT02487446|18728615|P2|Period 2|Adverse Event|2
5425084|NCT02487446|18728616|P1|Period 2|Adverse Event|6
5425085|NCT02487446|18728615|P2|Period 2|Withdrawal by Subject|1
5425086|NCT02487446|18728616|P1|Period 2|Withdrawal by Subject|1
5425087|NCT02487446|18728615|P2|Period 2|Lost to Follow-up|1
5425088|NCT02487446|18728616|P1|Period 2|Lost to Follow-up|1
5425089|NCT02487446|18728615|P2|Period 2|Protocol deviation|1
5425090|NCT02487446|18728616|P1|Period 2|Protocol deviation|0
5425091|NCT02487446|18728615|P2|Washout|Adverse Event|2
5425092|NCT02487446|18728616|P1|Washout|Adverse Event|2
5425093|NCT02487446|18728615|P2|Washout|Withdrawal by Subject|4
5425094|NCT02487446|18728616|P1|Washout|Withdrawal by Subject|1
5425095|NCT02487446|18728615|P2|Washout|Lost to Follow-up|2
5425096|NCT02487446|18728616|P1|Washout|Lost to Follow-up|0
5425097|NCT02487446|18728615|P2|Period 1|Adverse Event|5
5425098|NCT02487446|18728616|P1|Period 1|Adverse Event|5
5425099|NCT02487446|18728615|P2|Period 1|Withdrawal by Subject|0
5425100|NCT02487446|18728616|P1|Period 1|Withdrawal by Subject|2
5425101|NCT02487446|18728615|P2|Period 1|Lost to Follow-up|0
5425102|NCT02487446|18728616|P1|Period 1|Lost to Follow-up|2
5425103|NCT02487446|18728615|P2|Period 1|Protocol deviation|2
5425104|NCT02487446|18728616|P1|Period 1|Protocol deviation|3
5425105|NCT02487446|18728615|P2|Period 1|Lack of Efficacy|0
5425106|NCT02487446|18728616|P1|Period 1|Lack of Efficacy|1
5425107|NCT02487446|18728615|P2|Period 1|Physician Decision|1
5425108|NCT02487446|18728616|P1|Period 1|Physician Decision|0
5425109|NCT02487199|18728696|P2|Overall Study|Withdrew Consent|1
5425110|NCT02487199|18728697|P1|Overall Study|Withdrew Consent|0
5425111|NCT02487030|18728722|P7|Overall Study|Death|0
5425112|NCT02487030|18728723|P6|Overall Study|Death|0
5425113|NCT02487030|18728724|P5|Overall Study|Death|1
5425114|NCT02487030|18728725|P4|Overall Study|Death|0
5425115|NCT02487030|18728726|P3|Overall Study|Death|0
5425116|NCT02487030|18728727|P2|Overall Study|Death|0
5425117|NCT02487030|18728728|P1|Overall Study|Death|0
5425118|NCT02487030|18728722|P7|Overall Study|Adverse Event|0
5425119|NCT02487030|18728723|P6|Overall Study|Adverse Event|0
5425120|NCT02487030|18728724|P5|Overall Study|Adverse Event|0
5425121|NCT02487030|18728725|P4|Overall Study|Adverse Event|1
5425122|NCT02487030|18728726|P3|Overall Study|Adverse Event|0
5425123|NCT02487030|18728727|P2|Overall Study|Adverse Event|0
5425124|NCT02487030|18728728|P1|Overall Study|Adverse Event|0
5425125|NCT02487030|18728722|P7|Overall Study|Lost to Follow-up|0
5425126|NCT02487030|18728723|P6|Overall Study|Lost to Follow-up|1
5425127|NCT02487030|18728724|P5|Overall Study|Lost to Follow-up|0
5425128|NCT02487030|18728725|P4|Overall Study|Lost to Follow-up|1
5425129|NCT02487030|18728726|P3|Overall Study|Lost to Follow-up|1
5425130|NCT02487030|18728727|P2|Overall Study|Lost to Follow-up|0
5425131|NCT02487030|18728728|P1|Overall Study|Lost to Follow-up|0
5425132|NCT02487030|18728722|P7|Overall Study|Lack of Efficacy|0
5425133|NCT02487030|18728723|P6|Overall Study|Lack of Efficacy|0
5425134|NCT02487030|18728724|P5|Overall Study|Lack of Efficacy|1
5425135|NCT02487030|18728725|P4|Overall Study|Lack of Efficacy|0
5425136|NCT02487030|18728726|P3|Overall Study|Lack of Efficacy|1
5425137|NCT02487030|18728727|P2|Overall Study|Lack of Efficacy|4
5425138|NCT02487030|18728728|P1|Overall Study|Lack of Efficacy|2
5425139|NCT02486952|18728759|P1|Overall Study|Other|2
5425140|NCT02486952|18728759|P1|Overall Study|Lost to Follow-up|26
5425141|NCT02486952|18728759|P1|Overall Study|Lack of Efficacy|3
5425142|NCT02486952|18728759|P1|Overall Study|Death|15
5425143|NCT02486952|18728759|P1|Overall Study|Adverse Event|1
5425144|NCT02486952|18728759|P1|Overall Study|Not Started Induction Therapy|3
5425145|NCT02486796|18728777|P2|Overall Study|Physician Decision|0
5425146|NCT02486796|18728778|P1|Overall Study|Physician Decision|1
5425147|NCT02486796|18728777|P2|Overall Study|Withdrawal by Subject|1
5425148|NCT02486796|18728778|P1|Overall Study|Withdrawal by Subject|1
5425149|NCT02486757|18728790|P1|Overall Study|Lost to Follow-up|1
5425150|NCT02486692|18728796|P2|Overall Study|did not login for randomization|7
5425151|NCT02486692|18728797|P1|Overall Study|did not login for randomization|4
5425152|NCT02486653|18728809|P2|Overall Study|surgery cancelled|1
5425153|NCT02486653|18728810|P1|Overall Study|surgery cancelled|4
5425154|NCT02486653|18728809|P2|Overall Study|Protocol Violation|0
5425155|NCT02486653|18728810|P1|Overall Study|Protocol Violation|1
5425156|NCT02486653|18728809|P2|Overall Study|Withdrawal by Subject|3
5425157|NCT02486653|18728810|P1|Overall Study|Withdrawal by Subject|1
5425158|NCT02486627|18728834|P2|Overall Study|Lost to Follow-up|3
5425159|NCT02486627|18728835|P1|Overall Study|Lost to Follow-up|1
5425160|NCT02486627|18728834|P2|Overall Study|Significant Participant Noncompliance|1
5425161|NCT02486627|18728835|P1|Overall Study|Significant Participant Noncompliance|1
5425162|NCT02486627|18728834|P2|Overall Study|Consent Withdrawn by Participant|3
5425163|NCT02486627|18728835|P1|Overall Study|Consent Withdrawn by Participant|4
5425164|NCT02486627|18728834|P2|Overall Study|Other Unspecified|2
5425165|NCT02486627|18728835|P1|Overall Study|Other Unspecified|0
5425166|NCT02486627|18728834|P2|Overall Study|Death|0
5425167|NCT02486627|18728835|P1|Overall Study|Death|1
5425168|NCT02486588|18728858|P6|Overall Study|Randomized in error- ineligible|746
5425169|NCT02486588|18728859|P5|Overall Study|Randomized in error- ineligible|746
5425170|NCT02486588|18728860|P4|Overall Study|Randomized in error- ineligible|738
5425171|NCT02486588|18728861|P3|Overall Study|Randomized in error- ineligible|755
5425172|NCT02486588|18728862|P2|Overall Study|Randomized in error- ineligible|750
5425173|NCT02486588|18728863|P1|Overall Study|Randomized in error- ineligible|738
5425174|NCT02486302|18728938|P1|Overall Study|Not treated|3
5425175|NCT02486302|18728938|P1|Overall Study|Excluded due to legal reasons|8
5425176|NCT02486302|18728938|P1|Overall Study|Documentation not completed|255
5425177|NCT02486302|18728938|P1|Overall Study|Discontinued prematurely|410
5425178|NCT02485925|18729035|P1|Overall Study|Lost to Follow-up|11
5425179|NCT02485925|18729035|P1|Overall Study|Death|1
5425180|NCT02485925|18729035|P1|Overall Study|Withdrawal by Subject|3
5425181|NCT02485717|18729067|P3|Overall Study|Did Not Meet Exclusion Criteria #12|0
5425182|NCT02485717|18729068|P2|Overall Study|Did Not Meet Exclusion Criteria #12|1
5425183|NCT02485717|18729069|P1|Overall Study|Did Not Meet Exclusion Criteria #12|0
5425184|NCT02485717|18729067|P3|Overall Study|Did Not Meet Exclusion Criteria #2|0
5425185|NCT02485717|18729068|P2|Overall Study|Did Not Meet Exclusion Criteria #2|1
5425186|NCT02485717|18729069|P1|Overall Study|Did Not Meet Exclusion Criteria #2|0
5425187|NCT02485717|18729067|P3|Overall Study|Withdrawal by Subject|1
5425188|NCT02485717|18729068|P2|Overall Study|Withdrawal by Subject|0
5425189|NCT02485717|18729069|P1|Overall Study|Withdrawal by Subject|0
5425190|NCT02485717|18729067|P3|Overall Study|Lost to Follow-up|0
5425191|NCT02485717|18729068|P2|Overall Study|Lost to Follow-up|0
5425192|NCT02485717|18729069|P1|Overall Study|Lost to Follow-up|6
5425193|NCT02485704|18729084|P2|Overall Study|Did Not Meet Inclusion Criteria #2|0
5425194|NCT02485704|18729085|P1|Overall Study|Did Not Meet Inclusion Criteria #2|1
5425195|NCT02485704|18729084|P2|Overall Study|Withdrawal by Subject|3
5425196|NCT02485704|18729085|P1|Overall Study|Withdrawal by Subject|0
5425197|NCT02485704|18729084|P2|Overall Study|Lost to Follow-up|5
5425198|NCT02485704|18729085|P1|Overall Study|Lost to Follow-up|4
5425199|NCT02485483|18729133|P2|Overall Study|Discontinued after baseline|0
5425200|NCT02485483|18729134|P1|Overall Study|Discontinued after baseline|39
5425201|NCT02485483|18729133|P2|Overall Study|Depression at baseline|0
5425202|NCT02485483|18729134|P1|Overall Study|Depression at baseline|15
5425203|NCT02485353|18729149|P1|Overall Study|Disease Progression|1
5425204|NCT02485353|18729149|P1|Overall Study|Death|1
5425205|NCT02485301|18729156|P2|Overall Study|Other|4
5425206|NCT02485301|18729157|P1|Overall Study|Other|3
5425207|NCT02485301|18729156|P2|Overall Study|Lost to Follow-up|17
5425208|NCT02485301|18729157|P1|Overall Study|Lost to Follow-up|17
5425209|NCT02485301|18729156|P2|Overall Study|Migrated/moved from study area|19
5425210|NCT02485301|18729157|P1|Overall Study|Migrated/moved from study area|10
5425211|NCT02485301|18729156|P2|Overall Study|Withdrawal by Subject|7
5425212|NCT02485301|18729157|P1|Overall Study|Withdrawal by Subject|6
5425213|NCT02485301|18729156|P2|Overall Study|Protocol Violation|1
5425214|NCT02485301|18729157|P1|Overall Study|Protocol Violation|0
5425215|NCT02485301|18729156|P2|Overall Study|Serious Adverse Events|1
5425216|NCT02485301|18729157|P1|Overall Study|Serious Adverse Events|2
5425217|NCT02485158|18729207|P1|Overall Study|expected drug side effect|1
5425218|NCT02485158|18729207|P1|Overall Study|Withdrawal by Subject|3
5425219|NCT02484911|18729296|P2|Overall Study|Protocol Violation|1
5425220|NCT02484911|18729297|P1|Overall Study|Protocol Violation|2
5425221|NCT02484911|18729296|P2|Overall Study|Withdrawal by Subject|1
5425222|NCT02484911|18729297|P1|Overall Study|Withdrawal by Subject|2
5425223|NCT02484729|18729387|P10|Overall Study|Failure of IntelliCap Error|1
5425224|NCT02484729|18729388|P9|Overall Study|Failure of IntelliCap Error|0
5425225|NCT02484729|18729389|P8|Overall Study|Failure of IntelliCap Error|0
5425226|NCT02484729|18729390|P7|Overall Study|Failure of IntelliCap Error|0
5425227|NCT02484729|18729391|P6|Overall Study|Failure of IntelliCap Error|0
5425228|NCT02484729|18729392|P5|Overall Study|Failure of IntelliCap Error|0
5425229|NCT02484729|18729393|P4|Overall Study|Failure of IntelliCap Error|0
5425230|NCT02484729|18729394|P3|Overall Study|Failure of IntelliCap Error|0
5425231|NCT02484729|18729395|P2|Overall Study|Failure of IntelliCap Error|0
5425232|NCT02484729|18729396|P1|Overall Study|Failure of IntelliCap Error|0
5425233|NCT02484690|18729597|P5|Overall Study|Lost to Follow-up|0
5425234|NCT02484690|18729598|P4|Overall Study|Lost to Follow-up|0
5425235|NCT02484690|18729599|P3|Overall Study|Lost to Follow-up|1
5425236|NCT02484690|18729600|P2|Overall Study|Lost to Follow-up|0
5425237|NCT02484690|18729601|P1|Overall Study|Lost to Follow-up|0
5425238|NCT02484690|18729597|P5|Overall Study|Physician Decision|0
5425239|NCT02484690|18729598|P4|Overall Study|Physician Decision|0
5425240|NCT02484690|18729599|P3|Overall Study|Physician Decision|1
5425241|NCT02484690|18729600|P2|Overall Study|Physician Decision|0
5425242|NCT02484690|18729601|P1|Overall Study|Physician Decision|2
5425243|NCT02484690|18729597|P5|Overall Study|Withdrawal by Subject|0
5425244|NCT02484690|18729598|P4|Overall Study|Withdrawal by Subject|2
5425245|NCT02484690|18729599|P3|Overall Study|Withdrawal by Subject|1
5425246|NCT02484690|18729600|P2|Overall Study|Withdrawal by Subject|3
5425247|NCT02484690|18729601|P1|Overall Study|Withdrawal by Subject|1
5425248|NCT02484690|18729597|P5|Overall Study|Death|1
5425249|NCT02484690|18729598|P4|Overall Study|Death|0
5425250|NCT02484690|18729599|P3|Overall Study|Death|0
5425251|NCT02484690|18729600|P2|Overall Study|Death|0
5425252|NCT02484690|18729601|P1|Overall Study|Death|0
5425253|NCT02484690|18729597|P5|Overall Study|Adverse Event|5
5425254|NCT02484690|18729598|P4|Overall Study|Adverse Event|0
5425255|NCT02484690|18729599|P3|Overall Study|Adverse Event|0
5425256|NCT02484690|18729600|P2|Overall Study|Adverse Event|3
5425257|NCT02484690|18729601|P1|Overall Study|Adverse Event|1
5425258|NCT02484651|18729745|P2|Overall Study|Time of the procedure less than 90 min.|2
5425259|NCT02484651|18729746|P1|Overall Study|Time of the procedure less than 90 min.|1
5425260|NCT02484651|18729745|P2|Overall Study|BIS monitoring failed.|1
5425261|NCT02484651|18729746|P1|Overall Study|BIS monitoring failed.|1
5425262|NCT02484651|18729745|P2|Overall Study|Patients' data files were corrupted.|1
5425263|NCT02484651|18729746|P1|Overall Study|Patients' data files were corrupted.|1
5425264|NCT02483975|18729780|P2|Overall Study|Physician Decision|0
5425265|NCT02483975|18729781|P1|Overall Study|Physician Decision|2
5425266|NCT02483975|18729780|P2|Overall Study|Lost to Follow-up|1
5425267|NCT02483975|18729781|P1|Overall Study|Lost to Follow-up|0
5425268|NCT02483975|18729780|P2|Overall Study|Adverse Event|1
5425269|NCT02483975|18729781|P1|Overall Study|Adverse Event|0
5425270|NCT02483611|18729819|P3|Overall Study|Protocol Violation|1
5425271|NCT02483611|18729820|P2|Overall Study|Protocol Violation|0
5425272|NCT02483611|18729821|P1|Overall Study|Protocol Violation|0
5425273|NCT02483585|18729918|P2|Open-label Treatment Phase|Lost to Follow-up|5
5425274|NCT02483585|18729919|P1|Open-label Treatment Phase|Lost to Follow-up|3
5425275|NCT02483585|18729918|P2|Open-label Treatment Phase|Withdrawal by Subject|14
5425276|NCT02483585|18729919|P1|Open-label Treatment Phase|Withdrawal by Subject|18
5425277|NCT02483585|18729918|P2|Open-label Treatment Phase|Decision by Sponsor|1
5425278|NCT02483585|18729919|P1|Open-label Treatment Phase|Decision by Sponsor|0
5425279|NCT02483585|18729918|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
5425280|NCT02483585|18729919|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
5425281|NCT02483585|18729918|P2|Double-blind Treatment Phase|Lost to Follow-up|2
5425282|NCT02483585|18729919|P1|Double-blind Treatment Phase|Lost to Follow-up|3
5425283|NCT02483585|18729918|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
5425284|NCT02483585|18729919|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
5425285|NCT02483585|18729918|P2|Double-blind Treatment Phase|Decision by Sponsor|1
5425286|NCT02483585|18729919|P1|Double-blind Treatment Phase|Decision by Sponsor|1
5425287|NCT02483572|18729941|P2|Overall Study|Physician Decision|1
5425288|NCT02483572|18729942|P1|Overall Study|Physician Decision|0
5425289|NCT02483572|18729941|P2|Overall Study|Lost to Follow-up|0
5425290|NCT02483572|18729942|P1|Overall Study|Lost to Follow-up|1
5425291|NCT02483572|18729941|P2|Overall Study|Withdrawal by Subject|0
5425292|NCT02483572|18729942|P1|Overall Study|Withdrawal by Subject|1
5425293|NCT02483533|18729956|P2|Overall Study|Lack of Efficacy|50
5425294|NCT02483533|18729957|P1|Overall Study|Lack of Efficacy|50
5425295|NCT02483520|18729967|P2|Overall Study|Moved to LTC|3
5425296|NCT02483520|18729968|P1|Overall Study|Moved to LTC|2
5425297|NCT02483520|18729967|P2|Overall Study|Hospitalized|3
5425298|NCT02483520|18729968|P1|Overall Study|Hospitalized|2
5425299|NCT02483520|18729967|P2|Overall Study|Withdrawal by Subject|14
5425300|NCT02483520|18729968|P1|Overall Study|Withdrawal by Subject|4
5425301|NCT02483520|18729967|P2|Overall Study|Lost to Follow-up|4
5425302|NCT02483520|18729968|P1|Overall Study|Lost to Follow-up|3
5425303|NCT02483416|18730008|P2|Overall Study|Treatment stop|0
5425304|NCT02483416|18730009|P1|Overall Study|Treatment stop|3
5425305|NCT02483416|18730008|P2|Overall Study|Other reason|1
5425306|NCT02483416|18730009|P1|Overall Study|Other reason|0
5425307|NCT02482935|18730073|P2|Period 1|Withdrawal by Subject|0
5425308|NCT02482935|18730074|P1|Period 1|Withdrawal by Subject|1
5425309|NCT02482805|18730102|P3|Overall Study|Lost to Follow-up|0
5425310|NCT02482805|18730103|P2|Overall Study|Lost to Follow-up|4
5425311|NCT02482805|18730104|P1|Overall Study|Lost to Follow-up|4
5425312|NCT02482571|18730223|P1|Overall Study|Withdrawal by Subject|4
5425313|NCT02482571|18730223|P1|Overall Study|Scanner or Respiract failure|3
5425314|NCT02482571|18730223|P1|Overall Study|Adverse Event|1
5425315|NCT02482428|18730235|P5|Overall Study|subject/guardian decision|2
5425316|NCT02482428|18730236|P4|Overall Study|subject/guardian decision|0
5425317|NCT02482428|18730237|P3|Overall Study|subject/guardian decision|0
5425318|NCT02482428|18730238|P2|Overall Study|subject/guardian decision|2
5425319|NCT02482428|18730239|P1|Overall Study|subject/guardian decision|4
5425320|NCT02482428|18730235|P5|Overall Study|protocol deviation|0
5425321|NCT02482428|18730236|P4|Overall Study|protocol deviation|0
5425322|NCT02482428|18730237|P3|Overall Study|protocol deviation|0
5425323|NCT02482428|18730238|P2|Overall Study|protocol deviation|1
5425324|NCT02482428|18730239|P1|Overall Study|protocol deviation|1
5425325|NCT02482428|18730235|P5|Overall Study|Physician Decision|1
5425326|NCT02482428|18730236|P4|Overall Study|Physician Decision|0
5425327|NCT02482428|18730237|P3|Overall Study|Physician Decision|0
5425328|NCT02482428|18730238|P2|Overall Study|Physician Decision|0
5425329|NCT02482428|18730239|P1|Overall Study|Physician Decision|0
5425330|NCT02482428|18730235|P5|Overall Study|Lost to Follow-up|4
5425331|NCT02482428|18730236|P4|Overall Study|Lost to Follow-up|2
5425332|NCT02482428|18730237|P3|Overall Study|Lost to Follow-up|1
5425333|NCT02482428|18730238|P2|Overall Study|Lost to Follow-up|9
5425334|NCT02482428|18730239|P1|Overall Study|Lost to Follow-up|4
5425335|NCT02482298|18730262|P3|Overall Study|Lost to Follow-up|0
5425336|NCT02482298|18730263|P2|Overall Study|Lost to Follow-up|1
5425337|NCT02482298|18730264|P1|Overall Study|Lost to Follow-up|0
5425338|NCT02482298|18730262|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
5425339|NCT02482298|18730263|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
5425340|NCT02482298|18730264|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
5425341|NCT02482298|18730262|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
5425342|NCT02482298|18730263|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
5425343|NCT02482298|18730264|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
5425344|NCT02482298|18730262|P3|Overall Study|Withdrawal by Subject|2
5425345|NCT02482298|18730263|P2|Overall Study|Withdrawal by Subject|1
5425346|NCT02482298|18730264|P1|Overall Study|Withdrawal by Subject|2
5425347|NCT02482233|18730286|P2|Overall Study|Lost to Follow-up|1
5425348|NCT02482233|18730287|P1|Overall Study|Lost to Follow-up|1
5425349|NCT02482129|18730323|P2|Overall Study|Criteria not met|0
5425350|NCT02482129|18730324|P1|Overall Study|Criteria not met|1
5425351|NCT02482129|18730323|P2|Overall Study|Withdrawal by Subject|0
5425352|NCT02482129|18730324|P1|Overall Study|Withdrawal by Subject|2
5425353|NCT02482129|18730323|P2|Overall Study|Adverse Event|0
5425354|NCT02482129|18730324|P1|Overall Study|Adverse Event|1
5425355|NCT02482129|18730323|P2|Overall Study|Criteria not met-prior to treatment|0
5425356|NCT02482129|18730324|P1|Overall Study|Criteria not met-prior to treatment|1
5425357|NCT02482129|18730323|P2|Overall Study|Unable to draw blood-prior to treatment|0
5425358|NCT02482129|18730324|P1|Overall Study|Unable to draw blood-prior to treatment|1
5425359|NCT02482129|18730323|P2|Overall Study|Withdrawal by subject-prior to treatment|1
5425360|NCT02482129|18730324|P1|Overall Study|Withdrawal by subject-prior to treatment|0
5425361|NCT02482129|18730323|P2|Overall Study|Adverse Event-prior to treatment|1
5425362|NCT02482129|18730324|P1|Overall Study|Adverse Event-prior to treatment|0
5425363|NCT02481947|18730364|P2|Overall Study|Protocol Violation|5
5425364|NCT02481947|18730365|P1|Overall Study|Protocol Violation|1
5425365|NCT02481947|18730364|P2|Overall Study|Physician Decision|5
5425366|NCT02481947|18730365|P1|Overall Study|Physician Decision|4
5425367|NCT02481947|18730364|P2|Overall Study|Adverse Event|11
5425368|NCT02481947|18730365|P1|Overall Study|Adverse Event|6
5425369|NCT02481947|18730364|P2|Overall Study|Lost to Follow-up|5
5425370|NCT02481947|18730365|P1|Overall Study|Lost to Follow-up|11
5425371|NCT02481947|18730364|P2|Overall Study|Withdrawal by Subject|10
5425372|NCT02481947|18730365|P1|Overall Study|Withdrawal by Subject|24
5425373|NCT02481934|18730371|P1|Overall Study|Death|2
5425374|NCT02481830|18730378|P2|Overall Study|Participant not eligible for trial|1
5425375|NCT02481830|18730379|P1|Overall Study|Participant not eligible for trial|0
5425376|NCT02481830|18730378|P2|Overall Study|Disease Progression|1
5425377|NCT02481830|18730379|P1|Overall Study|Disease Progression|1
5425378|NCT02481830|18730378|P2|Overall Study|Withdrawal by Subject|14
5425379|NCT02481830|18730379|P1|Overall Study|Withdrawal by Subject|0
5425380|NCT02481830|18730378|P2|Overall Study|No longer meets Study Criteria|4
5425381|NCT02481830|18730379|P1|Overall Study|No longer meets Study Criteria|1
5425382|NCT02481050|18730554|P1|Overall Study|Other|3
5425383|NCT02481050|18730554|P1|Overall Study|Withdrawal by Subject|7
5425384|NCT02481050|18730554|P1|Overall Study|Disease Progression|47
5425385|NCT02481050|18730554|P1|Overall Study|Adverse Event|1
5425386|NCT02480764|18730585|P3|Overall Study|Reason not Specified|0
5425387|NCT02480764|18730586|P2|Overall Study|Reason not Specified|1
5425388|NCT02480764|18730587|P1|Overall Study|Reason not Specified|0
5425389|NCT02480764|18730585|P3|Overall Study|Lack of Efficacy|3
5425390|NCT02480764|18730586|P2|Overall Study|Lack of Efficacy|3
5425391|NCT02480764|18730587|P1|Overall Study|Lack of Efficacy|0
5425392|NCT02480764|18730585|P3|Overall Study|Voluntary Withdrawal|10
5425393|NCT02480764|18730586|P2|Overall Study|Voluntary Withdrawal|5
5425394|NCT02480764|18730587|P1|Overall Study|Voluntary Withdrawal|6
5425395|NCT02480764|18730585|P3|Overall Study|Lost to Follow-up|2
5425396|NCT02480764|18730586|P2|Overall Study|Lost to Follow-up|1
5425397|NCT02480764|18730587|P1|Overall Study|Lost to Follow-up|0
5425398|NCT02480764|18730585|P3|Overall Study|Major Protocol Deviation|3
5425399|NCT02480764|18730586|P2|Overall Study|Major Protocol Deviation|4
5425400|NCT02480764|18730587|P1|Overall Study|Major Protocol Deviation|1
5425401|NCT02480764|18730585|P3|Overall Study|Pretreatment Event/Adverse Event|3
5425402|NCT02480764|18730586|P2|Overall Study|Pretreatment Event/Adverse Event|6
5425403|NCT02480764|18730587|P1|Overall Study|Pretreatment Event/Adverse Event|3
5425404|NCT02480712|18730613|P1|Overall Study|Lack of Efficacy|1
5425405|NCT02480712|18730613|P1|Overall Study|Death|1
5425406|NCT02480712|18730613|P1|Overall Study|Withdrew Consent|3
5425407|NCT02480712|18730613|P1|Overall Study|Lost to Follow-up|5
5425408|NCT02480712|18730613|P1|Overall Study|Enrolled but Never Treated|1
5425409|NCT02480621|18730632|P2|Follow Up|Lost to Follow-up|2
5425410|NCT02480621|18730633|P1|Follow Up|Lost to Follow-up|4
5425411|NCT02480621|18730632|P2|Randomization|Surgeon did not give intervention|1
5425412|NCT02480621|18730633|P1|Randomization|Surgeon did not give intervention|0
5425413|NCT02480621|18730632|P2|Randomization|Withdrawal by Subject|0
5425414|NCT02480621|18730633|P1|Randomization|Withdrawal by Subject|1
5425415|NCT02480153|18730710|P3|Period 3: Week 52 Dosing to Week 78|Death|0
5425416|NCT02480153|18730711|P2|Period 3: Week 52 Dosing to Week 78|Death|1
5425417|NCT02480153|18730712|P1|Period 3: Week 52 Dosing to Week 78|Death|0
5425418|NCT02480153|18730710|P3|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
5425419|NCT02480153|18730711|P2|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
5425420|NCT02480153|18730712|P1|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
5425421|NCT02480153|18730710|P3|Period 3: Week 52 Dosing to Week 78|Other|1
5425422|NCT02480153|18730711|P2|Period 3: Week 52 Dosing to Week 78|Other|0
5425423|NCT02480153|18730712|P1|Period 3: Week 52 Dosing to Week 78|Other|0
5425424|NCT02480153|18730710|P3|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
5425425|NCT02480153|18730711|P2|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
5425426|NCT02480153|18730712|P1|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
5425427|NCT02480153|18730710|P3|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
5425428|NCT02480153|18730711|P2|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
5425429|NCT02480153|18730712|P1|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
5425430|NCT02480153|18730710|P3|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
5425431|NCT02480153|18730711|P2|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
5425432|NCT02480153|18730712|P1|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
5425433|NCT02480153|18730710|P3|Period 2: Week 26 to Week 52 Pre-dose|Other|0
5425434|NCT02480153|18730711|P2|Period 2: Week 26 to Week 52 Pre-dose|Other|0
5425435|NCT02480153|18730712|P1|Period 2: Week 26 to Week 52 Pre-dose|Other|2
5425436|NCT02480153|18730710|P3|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
5425437|NCT02480153|18730711|P2|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
5425438|NCT02480153|18730712|P1|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
5425439|NCT02480153|18730710|P3|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
5425440|NCT02480153|18730711|P2|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
5425441|NCT02480153|18730712|P1|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
5425442|NCT02480153|18730710|P3|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
5425443|NCT02480153|18730711|P2|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
5425444|NCT02480153|18730712|P1|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
5425445|NCT02480153|18730710|P3|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
5425446|NCT02480153|18730711|P2|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
5425447|NCT02480153|18730712|P1|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
5425448|NCT02480153|18730710|P3|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
5425449|NCT02480153|18730711|P2|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
5425450|NCT02480153|18730712|P1|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
5425451|NCT02480153|18730710|P3|Period 1: First Dose to Week 26 Pre-dose|Death|0
5425452|NCT02480153|18730711|P2|Period 1: First Dose to Week 26 Pre-dose|Death|1
5425453|NCT02480153|18730712|P1|Period 1: First Dose to Week 26 Pre-dose|Death|0
5425454|NCT02480153|18730710|P3|Period 1: First Dose to Week 26 Pre-dose|Other|0
5425455|NCT02480153|18730711|P2|Period 1: First Dose to Week 26 Pre-dose|Other|1
5425456|NCT02480153|18730712|P1|Period 1: First Dose to Week 26 Pre-dose|Other|0
5425457|NCT02480153|18730710|P3|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
5425458|NCT02480153|18730711|P2|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
5425459|NCT02480153|18730712|P1|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
5425460|NCT02480153|18730710|P3|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
5425461|NCT02480153|18730711|P2|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
5425462|NCT02480153|18730712|P1|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
5425463|NCT02480153|18730710|P3|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
5425464|NCT02480153|18730711|P2|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
5425465|NCT02480153|18730712|P1|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
5425466|NCT02480153|18730710|P3|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
5425467|NCT02480153|18730711|P2|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
5425468|NCT02480153|18730712|P1|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
5425469|NCT02480114|18730889|P2|Overall Study|Not eligible|1
5425470|NCT02480114|18730890|P1|Overall Study|Not eligible|0
5425471|NCT02480114|18730889|P2|Overall Study|Improper completion of survey|1
5425472|NCT02480114|18730890|P1|Overall Study|Improper completion of survey|1
5425473|NCT02480114|18730889|P2|Overall Study|Disease progression|0
5425474|NCT02480114|18730890|P1|Overall Study|Disease progression|3
5425475|NCT02480114|18730889|P2|Overall Study|Withdrawal by Subject|4
5425476|NCT02480114|18730890|P1|Overall Study|Withdrawal by Subject|2
5425477|NCT02480114|18730889|P2|Overall Study|Not completing surveys|2
5425478|NCT02480114|18730890|P1|Overall Study|Not completing surveys|3
5425479|NCT02480010|18730902|P2|Overall Study|Refused Treatment|3
5425480|NCT02480010|18730903|P1|Overall Study|Refused Treatment|0
5425481|NCT02480010|18730902|P2|Overall Study|Insufficient therapeutic response|29
5425482|NCT02480010|18730903|P1|Overall Study|Insufficient therapeutic response|31
5425483|NCT02480010|18730902|P2|Overall Study|Death|0
5425484|NCT02480010|18730903|P1|Overall Study|Death|1
5425485|NCT02480010|18730902|P2|Overall Study|Adverse Event|1
5425486|NCT02480010|18730903|P1|Overall Study|Adverse Event|3
5425487|NCT02479880|18730949|P2|Overall Study|Pregnancy|1
5425488|NCT02479880|18730950|P1|Overall Study|Pregnancy|0
5425489|NCT02479880|18730949|P2|Overall Study|Study Terminated by Sponsor|12
5425490|NCT02479880|18730950|P1|Overall Study|Study Terminated by Sponsor|13
5425491|NCT02479802|18730956|P1|Overall Study|Adverse Event|1
5425492|NCT02479802|18730956|P1|Overall Study|Lost to Follow-up|1
5425493|NCT02479412|18730983|P9|Overall Study|Randomization to wrong PK sampling group|0
5425494|NCT02479412|18730984|P8|Overall Study|Randomization to wrong PK sampling group|0
5425495|NCT02479412|18730985|P7|Overall Study|Randomization to wrong PK sampling group|0
5425496|NCT02479412|18730986|P6|Overall Study|Randomization to wrong PK sampling group|0
5425497|NCT02479412|18730987|P5|Overall Study|Randomization to wrong PK sampling group|1
5425498|NCT02479412|18730988|P4|Overall Study|Randomization to wrong PK sampling group|0
5425499|NCT02479412|18730989|P3|Overall Study|Randomization to wrong PK sampling group|0
5425500|NCT02479412|18730990|P2|Overall Study|Randomization to wrong PK sampling group|0
5425501|NCT02479412|18730991|P1|Overall Study|Randomization to wrong PK sampling group|0
5425502|NCT02479412|18730983|P9|Overall Study|Study-specific withdrawal criteria|1
5425503|NCT02479412|18730984|P8|Overall Study|Study-specific withdrawal criteria|1
5425504|NCT02479412|18730985|P7|Overall Study|Study-specific withdrawal criteria|0
5425505|NCT02479412|18730986|P6|Overall Study|Study-specific withdrawal criteria|0
5425506|NCT02479412|18730987|P5|Overall Study|Study-specific withdrawal criteria|0
5425507|NCT02479412|18730988|P4|Overall Study|Study-specific withdrawal criteria|1
5425508|NCT02479412|18730989|P3|Overall Study|Study-specific withdrawal criteria|1
5425509|NCT02479412|18730990|P2|Overall Study|Study-specific withdrawal criteria|0
5425510|NCT02479412|18730991|P1|Overall Study|Study-specific withdrawal criteria|0
5425511|NCT02479412|18730983|P9|Overall Study|Adverse Event|0
5425512|NCT02479412|18730984|P8|Overall Study|Adverse Event|0
5425513|NCT02479412|18730985|P7|Overall Study|Adverse Event|0
5425514|NCT02479412|18730986|P6|Overall Study|Adverse Event|0
5425515|NCT02479412|18730987|P5|Overall Study|Adverse Event|0
5425516|NCT02479412|18730988|P4|Overall Study|Adverse Event|0
5425517|NCT02479412|18730989|P3|Overall Study|Adverse Event|1
5425518|NCT02479412|18730990|P2|Overall Study|Adverse Event|0
5425519|NCT02479412|18730991|P1|Overall Study|Adverse Event|0
5425520|NCT02479139|18731068|P6|Overall Study|Other Miscellaneous Reasons|0
5425521|NCT02479139|18731069|P5|Overall Study|Other Miscellaneous Reasons|1
5425522|NCT02479139|18731070|P4|Overall Study|Other Miscellaneous Reasons|1
5425523|NCT02479139|18731071|P3|Overall Study|Other Miscellaneous Reasons|1
5425524|NCT02479139|18731072|P2|Overall Study|Other Miscellaneous Reasons|0
5425525|NCT02479139|18731073|P1|Overall Study|Other Miscellaneous Reasons|1
5425526|NCT02479139|18731068|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
5425527|NCT02479139|18731069|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
5425528|NCT02479139|18731070|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
5425529|NCT02479139|18731071|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
5425530|NCT02479139|18731072|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
5425531|NCT02479139|18731073|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
5425532|NCT02479139|18731068|P6|Overall Study|Withdrew Consent|1
5425533|NCT02479139|18731069|P5|Overall Study|Withdrew Consent|1
5425534|NCT02479139|18731070|P4|Overall Study|Withdrew Consent|4
5425535|NCT02479139|18731071|P3|Overall Study|Withdrew Consent|1
5425536|NCT02479139|18731072|P2|Overall Study|Withdrew Consent|6
5425537|NCT02479139|18731073|P1|Overall Study|Withdrew Consent|5
5425538|NCT02479139|18731068|P6|Overall Study|Lost to Follow-up|5
5425539|NCT02479139|18731069|P5|Overall Study|Lost to Follow-up|3
5425540|NCT02479139|18731070|P4|Overall Study|Lost to Follow-up|2
5425541|NCT02479139|18731071|P3|Overall Study|Lost to Follow-up|4
5425542|NCT02479139|18731072|P2|Overall Study|Lost to Follow-up|4
5425543|NCT02479139|18731073|P1|Overall Study|Lost to Follow-up|2
5425544|NCT02478632|18731106|P2|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
5425545|NCT02478632|18731107|P1|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
5425546|NCT02478632|18731106|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
5425547|NCT02478632|18731107|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
5425548|NCT02478632|18731106|P2|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
5425549|NCT02478632|18731107|P1|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
5425550|NCT02478463|18731142|P1|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
5425551|NCT02478463|18731142|P1|Washout Period (Up to 42 Days)|Lost to Follow-up|1
5425552|NCT02478463|18731142|P1|Treatment Period 1 (Up to Day 29)|Physician Decision|1
5425553|NCT02478398|18731259|P2|Overall Study|Withdrawal By Participant|4
5425554|NCT02478398|18731260|P1|Overall Study|Withdrawal By Participant|10
5425555|NCT02478398|18731259|P2|Overall Study|Withdrawal By Parent/Guardian|6
5425556|NCT02478398|18731260|P1|Overall Study|Withdrawal By Parent/Guardian|9
5425557|NCT02478398|18731259|P2|Overall Study|Protocol Violation|1
5425558|NCT02478398|18731260|P1|Overall Study|Protocol Violation|3
5425559|NCT02478398|18731259|P2|Overall Study|Non-Compliance With Study Drug|1
5425560|NCT02478398|18731260|P1|Overall Study|Non-Compliance With Study Drug|5
5425561|NCT02478398|18731259|P2|Overall Study|Lost to Follow-up|4
5425562|NCT02478398|18731260|P1|Overall Study|Lost to Follow-up|5
5425563|NCT02478398|18731259|P2|Overall Study|Adverse Event|5
5425564|NCT02478398|18731260|P1|Overall Study|Adverse Event|20
5425565|NCT02478372|18731280|P2|Overall Study|Death|2
5425566|NCT02478372|18731281|P1|Overall Study|Death|0
5425567|NCT02478372|18731280|P2|Overall Study|Lost to Follow-up|4
5425568|NCT02478372|18731281|P1|Overall Study|Lost to Follow-up|1
5425569|NCT02478372|18731280|P2|Overall Study|Protocol Violation|8
5425570|NCT02478372|18731281|P1|Overall Study|Protocol Violation|12
5425571|NCT02478359|18731305|P2|Overall Study|Disenrolled from health plan|65
5425572|NCT02478359|18731306|P1|Overall Study|Disenrolled from health plan|106
5425573|NCT02478164|18731378|P1|Overall Study|Withdrawal by Subject|1
5425574|NCT02478164|18731378|P1|Overall Study|Adverse Event|1
5425575|NCT02478164|18731378|P1|Overall Study|Lack of Efficacy|13
5425576|NCT02477670|18731391|P7|Stage 2|Withdrawal by Subject|0
5425577|NCT02477670|18731392|P6|Stage 2|Withdrawal by Subject|0
5425578|NCT02477670|18731393|P5|Stage 2|Withdrawal by Subject|0
5425579|NCT02477670|18731394|P4|Stage 2|Withdrawal by Subject|1
5425580|NCT02477670|18731395|P3|Stage 2|Withdrawal by Subject|0
5425581|NCT02477670|18731396|P2|Stage 2|Withdrawal by Subject|0
5425582|NCT02477670|18731397|P1|Stage 2|Withdrawal by Subject|0
5425583|NCT02477670|18731391|P7|Stage 2|Antipsychotic Medication Changed|0
5425584|NCT02477670|18731392|P6|Stage 2|Antipsychotic Medication Changed|0
5425585|NCT02477670|18731393|P5|Stage 2|Antipsychotic Medication Changed|0
5425586|NCT02477670|18731394|P4|Stage 2|Antipsychotic Medication Changed|0
5425587|NCT02477670|18731395|P3|Stage 2|Antipsychotic Medication Changed|1
5425588|NCT02477670|18731396|P2|Stage 2|Antipsychotic Medication Changed|0
5425589|NCT02477670|18731397|P1|Stage 2|Antipsychotic Medication Changed|0
5425590|NCT02477670|18731391|P7|Stage 2|Adverse Event|0
5425591|NCT02477670|18731392|P6|Stage 2|Adverse Event|0
5425592|NCT02477670|18731393|P5|Stage 2|Adverse Event|0
5425593|NCT02477670|18731394|P4|Stage 2|Adverse Event|0
5425594|NCT02477670|18731395|P3|Stage 2|Adverse Event|1
5425595|NCT02477670|18731396|P2|Stage 2|Adverse Event|0
5425596|NCT02477670|18731397|P1|Stage 2|Adverse Event|0
5425597|NCT02477670|18731391|P7|Stage 1|Non-compliance with Study Drug|0
5425598|NCT02477670|18731392|P6|Stage 1|Non-compliance with Study Drug|0
5425599|NCT02477670|18731393|P5|Stage 1|Non-compliance with Study Drug|0
5425600|NCT02477670|18731394|P4|Stage 1|Non-compliance with Study Drug|0
5425601|NCT02477670|18731395|P3|Stage 1|Non-compliance with Study Drug|0
5425602|NCT02477670|18731396|P2|Stage 1|Non-compliance with Study Drug|2
5425603|NCT02477670|18731397|P1|Stage 1|Non-compliance with Study Drug|1
5425604|NCT02477670|18731391|P7|Stage 1|Withdrawal by Subject|0
5425605|NCT02477670|18731392|P6|Stage 1|Withdrawal by Subject|0
5425606|NCT02477670|18731393|P5|Stage 1|Withdrawal by Subject|0
5425607|NCT02477670|18731394|P4|Stage 1|Withdrawal by Subject|0
5425608|NCT02477670|18731395|P3|Stage 1|Withdrawal by Subject|0
5425609|NCT02477670|18731396|P2|Stage 1|Withdrawal by Subject|2
5425610|NCT02477670|18731397|P1|Stage 1|Withdrawal by Subject|1
5425611|NCT02477670|18731391|P7|Stage 1|Lost to Follow-up|0
5425612|NCT02477670|18731392|P6|Stage 1|Lost to Follow-up|0
5425613|NCT02477670|18731393|P5|Stage 1|Lost to Follow-up|0
5425614|NCT02477670|18731394|P4|Stage 1|Lost to Follow-up|0
5425615|NCT02477670|18731395|P3|Stage 1|Lost to Follow-up|0
5425616|NCT02477670|18731396|P2|Stage 1|Lost to Follow-up|2
5425617|NCT02477670|18731397|P1|Stage 1|Lost to Follow-up|0
5425618|NCT02477670|18731391|P7|Stage 1|Adverse Event|0
5425619|NCT02477670|18731392|P6|Stage 1|Adverse Event|0
5425620|NCT02477670|18731393|P5|Stage 1|Adverse Event|0
5425621|NCT02477670|18731394|P4|Stage 1|Adverse Event|0
5425622|NCT02477670|18731395|P3|Stage 1|Adverse Event|0
5425623|NCT02477670|18731396|P2|Stage 1|Adverse Event|7
5425624|NCT02477670|18731397|P1|Stage 1|Adverse Event|2
5425625|NCT02477618|18731613|P2|Overall Study|Left Study Site for Rehabilitation|1
5425626|NCT02477618|18731614|P1|Overall Study|Left Study Site for Rehabilitation|0
5425627|NCT02477618|18731613|P2|Overall Study|Transferred Away from Study Site|0
5425628|NCT02477618|18731614|P1|Overall Study|Transferred Away from Study Site|1
5425629|NCT02477618|18731613|P2|Overall Study|Adverse Event|1
5425630|NCT02477618|18731614|P1|Overall Study|Adverse Event|1
5425631|NCT02477618|18731613|P2|Overall Study|Died in Double-Blind Treatment Period|11
5425632|NCT02477618|18731614|P1|Overall Study|Died in Double-Blind Treatment Period|11
5425633|NCT02477618|18731613|P2|Overall Study|Completed Visits but Discontinued Drug|1
5425634|NCT02477618|18731614|P1|Overall Study|Completed Visits but Discontinued Drug|2
5425635|NCT02477605|18731638|P2|Overall Study|Administered gas during surgery|1
5425636|NCT02477605|18731639|P1|Overall Study|Administered gas during surgery|0
5425637|NCT02477605|18731638|P2|Overall Study|Withdrawal by Subject|1
5425638|NCT02477605|18731639|P1|Overall Study|Withdrawal by Subject|0
5425639|NCT02477605|18731638|P2|Overall Study|Lost to Follow-up|2
5425640|NCT02477605|18731639|P1|Overall Study|Lost to Follow-up|0
5425641|NCT02477605|18731638|P2|Overall Study|Discontinued prior to treatment|0
5425642|NCT02477605|18731639|P1|Overall Study|Discontinued prior to treatment|1
5425643|NCT02477553|18731655|P2|Overall Study|patient deceased|0
5425644|NCT02477553|18731656|P1|Overall Study|patient deceased|1
5425645|NCT02477553|18731655|P2|Overall Study|MD advised against screening|3
5425646|NCT02477553|18731656|P1|Overall Study|MD advised against screening|1
5425647|NCT02477553|18731655|P2|Overall Study|Elevated risk for CRC|2
5425648|NCT02477553|18731656|P1|Overall Study|Elevated risk for CRC|2
5425649|NCT02477553|18731655|P2|Overall Study|Technical issues with intervention|0
5425650|NCT02477553|18731656|P1|Overall Study|Technical issues with intervention|2
5425651|NCT02477553|18731655|P2|Overall Study|Workup consistent w/CRC|1
5425652|NCT02477553|18731656|P1|Overall Study|Workup consistent w/CRC|1
5425653|NCT02477553|18731655|P2|Overall Study|No MD visit|1
5425654|NCT02477553|18731656|P1|Overall Study|No MD visit|1
5425655|NCT02477553|18731655|P2|Overall Study|Screening up-to-date|13
5425656|NCT02477553|18731656|P1|Overall Study|Screening up-to-date|12
5425657|NCT02477527|18731676|P1|Overall Study|Screen Failure|3
5425658|NCT02477527|18731676|P1|Overall Study|Withdrawal by Subject|1
5425659|NCT02477527|18731676|P1|Overall Study|Lost to Follow-up|2
5425660|NCT02477332|18731711|P6|Overall Study|Withdrawal by Subject|0
5425661|NCT02477332|18731712|P5|Overall Study|Withdrawal by Subject|1
5425662|NCT02477332|18731713|P4|Overall Study|Withdrawal by Subject|2
5425663|NCT02477332|18731714|P3|Overall Study|Withdrawal by Subject|1
5425664|NCT02477332|18731715|P2|Overall Study|Withdrawal by Subject|3
5425665|NCT02477332|18731716|P1|Overall Study|Withdrawal by Subject|0
5425666|NCT02477332|18731711|P6|Overall Study|Physician Decision|1
5425667|NCT02477332|18731712|P5|Overall Study|Physician Decision|0
5425668|NCT02477332|18731713|P4|Overall Study|Physician Decision|3
5425669|NCT02477332|18731714|P3|Overall Study|Physician Decision|1
5425670|NCT02477332|18731715|P2|Overall Study|Physician Decision|0
5425671|NCT02477332|18731716|P1|Overall Study|Physician Decision|0
5425672|NCT02477332|18731711|P6|Overall Study|Lost to Follow-up|0
5425673|NCT02477332|18731712|P5|Overall Study|Lost to Follow-up|0
5425674|NCT02477332|18731713|P4|Overall Study|Lost to Follow-up|0
5425675|NCT02477332|18731714|P3|Overall Study|Lost to Follow-up|2
5425676|NCT02477332|18731715|P2|Overall Study|Lost to Follow-up|0
5425677|NCT02477332|18731716|P1|Overall Study|Lost to Follow-up|0
5425678|NCT02477332|18731711|P6|Overall Study|Technical problems|0
5425679|NCT02477332|18731712|P5|Overall Study|Technical problems|0
5425680|NCT02477332|18731713|P4|Overall Study|Technical problems|0
5425681|NCT02477332|18731714|P3|Overall Study|Technical problems|1
5425682|NCT02477332|18731715|P2|Overall Study|Technical problems|0
5425683|NCT02477332|18731716|P1|Overall Study|Technical problems|0
5425684|NCT02477332|18731711|P6|Overall Study|Protocol Violation|1
5425685|NCT02477332|18731712|P5|Overall Study|Protocol Violation|1
5425686|NCT02477332|18731713|P4|Overall Study|Protocol Violation|3
5425687|NCT02477332|18731714|P3|Overall Study|Protocol Violation|3
5425688|NCT02477332|18731715|P2|Overall Study|Protocol Violation|0
5425689|NCT02477332|18731716|P1|Overall Study|Protocol Violation|2
5425690|NCT02477332|18731711|P6|Overall Study|Pregnancy|0
5425691|NCT02477332|18731712|P5|Overall Study|Pregnancy|0
5425692|NCT02477332|18731713|P4|Overall Study|Pregnancy|1
5425693|NCT02477332|18731714|P3|Overall Study|Pregnancy|0
5425694|NCT02477332|18731715|P2|Overall Study|Pregnancy|0
5425695|NCT02477332|18731716|P1|Overall Study|Pregnancy|0
5425696|NCT02477332|18731711|P6|Overall Study|Non-compliance with study treatment|0
5425697|NCT02477332|18731712|P5|Overall Study|Non-compliance with study treatment|0
5425698|NCT02477332|18731713|P4|Overall Study|Non-compliance with study treatment|0
5425699|NCT02477332|18731714|P3|Overall Study|Non-compliance with study treatment|2
5425700|NCT02477332|18731715|P2|Overall Study|Non-compliance with study treatment|1
5425701|NCT02477332|18731716|P1|Overall Study|Non-compliance with study treatment|0
5425702|NCT02477332|18731711|P6|Overall Study|Lack of Efficacy|1
5425703|NCT02477332|18731712|P5|Overall Study|Lack of Efficacy|1
5425704|NCT02477332|18731713|P4|Overall Study|Lack of Efficacy|2
5425705|NCT02477332|18731714|P3|Overall Study|Lack of Efficacy|1
5425706|NCT02477332|18731715|P2|Overall Study|Lack of Efficacy|2
5425707|NCT02477332|18731716|P1|Overall Study|Lack of Efficacy|1
5425708|NCT02477332|18731711|P6|Overall Study|Adverse Event|2
5425709|NCT02477332|18731712|P5|Overall Study|Adverse Event|1
5425710|NCT02477332|18731713|P4|Overall Study|Adverse Event|2
5425711|NCT02477332|18731714|P3|Overall Study|Adverse Event|1
5425712|NCT02477332|18731715|P2|Overall Study|Adverse Event|1
5425713|NCT02477332|18731716|P1|Overall Study|Adverse Event|0
5425714|NCT02477215|18731808|P3|Fixed Dose Phase|Physician Decision|0
5425715|NCT02477215|18731809|P2|Fixed Dose Phase|Physician Decision|7
5425716|NCT02477215|18731810|P1|Fixed Dose Phase|Physician Decision|0
5425717|NCT02477215|18731808|P3|Dose Escalation Phase|Physician Decision|0
5425718|NCT02477215|18731809|P2|Dose Escalation Phase|Physician Decision|2
5425719|NCT02477215|18731810|P1|Dose Escalation Phase|Physician Decision|1
5425720|NCT02477020|18731826|P2|Overall Study|Lack of Efficacy|5
5425721|NCT02477020|18731827|P1|Overall Study|Lack of Efficacy|14
5425722|NCT02477020|18731826|P2|Overall Study|Reason not Specified|1
5425723|NCT02477020|18731827|P1|Overall Study|Reason not Specified|3
5425724|NCT02477020|18731826|P2|Overall Study|Voluntary Withdrawal|16
5425725|NCT02477020|18731827|P1|Overall Study|Voluntary Withdrawal|7
5425726|NCT02477020|18731826|P2|Overall Study|Pretreatment Event/Adverse Event|6
5425727|NCT02477020|18731827|P1|Overall Study|Pretreatment Event/Adverse Event|6
5425728|NCT02476994|18731857|P2|Overall Study|Based on feedback from FDA|0
5425729|NCT02476994|18731858|P1|Overall Study|Based on feedback from FDA|1
5425730|NCT02476916|18731886|P2|Extension Period|On Treatment|17
5425731|NCT02476916|18731887|P1|Extension Period|On Treatment|12
5425732|NCT02476916|18731886|P2|Extension Period|Prematurely Discontinued Treatment|1
5425733|NCT02476916|18731887|P1|Extension Period|Prematurely Discontinued Treatment|6
5425734|NCT02476916|18731886|P2|Core Period|Withdrawal by Subject|0
5425735|NCT02476916|18731887|P1|Core Period|Withdrawal by Subject|3
5425736|NCT02476916|18731886|P2|Core Period|Investigator decision|1
5425737|NCT02476916|18731887|P1|Core Period|Investigator decision|1
5425738|NCT02476916|18731886|P2|Core Period|Adverse Event|2
5425739|NCT02476916|18731887|P1|Core Period|Adverse Event|2
5425740|NCT02476617|18731972|P1|Overall Study|Lost to Follow-up|1
5425741|NCT02476617|18731972|P1|Overall Study|Adverse Event|1
5425742|NCT02476578|18731978|P2|Overall Study|Lost to Follow-up|13
5425743|NCT02476578|18731979|P1|Overall Study|Lost to Follow-up|6
5425744|NCT02476578|18731978|P2|Overall Study|Died before Email was sent (<9.11.2015)|43
5425745|NCT02476578|18731979|P1|Overall Study|Died before Email was sent (<9.11.2015)|35
5425746|NCT02476422|18732041|P2|Overall Study|Subject/guardian decision|1
5425747|NCT02476422|18732042|P1|Overall Study|Subject/guardian decision|0
5425748|NCT02476201|18732083|P1|Overall Study|Unsuccessful implant|1
5425749|NCT02476201|18732083|P1|Overall Study|Withdrawal by Subject|1
5425750|NCT02476201|18732083|P1|Overall Study|MPP programmed to OFF|2
5425751|NCT02476201|18732083|P1|Overall Study|Lost to Follow-up|2
5425752|NCT02476201|18732083|P1|Overall Study|Death|2
5425753|NCT02476201|18732083|P1|Overall Study|Adverse Event|4
5425754|NCT02476201|18732083|P1|Overall Study|Study echo not performed|5
5425755|NCT02476201|18732083|P1|Overall Study|Unable to program MPP|9
5425756|NCT02476175|18732091|P1|Overall Study|Adverse Event|2
5425757|NCT02476006|18732115|P1|Overall Study|Enrolled but not treated|4
5425758|NCT02476006|18732115|P1|Overall Study|Protocol Violation|1
5425759|NCT02476006|18732115|P1|Overall Study|Excluded from study|1
5425760|NCT02476006|18732115|P1|Overall Study|Switched to commercial drug|4
5425761|NCT02476006|18732115|P1|Overall Study|Study ended treatment not available|4
5425762|NCT02476006|18732115|P1|Overall Study|Physician Decision|5
5425763|NCT02476006|18732115|P1|Overall Study|Lost to Follow-up|5
5425764|NCT02476006|18732115|P1|Overall Study|Sponsor decision|6
5425765|NCT02476006|18732115|P1|Overall Study|Poor compliance to study protocol|3
5425766|NCT02476006|18732115|P1|Overall Study|Adverse Event|41
5425767|NCT02476006|18732115|P1|Overall Study|Participant did not wish to continue|39
5425768|NCT02476006|18732115|P1|Overall Study|Pregnancy|1
5425769|NCT02476006|18732115|P1|Overall Study|Lack of treatment efficacy|2
5425770|NCT02476006|18732115|P1|Overall Study|Death|4
5425771|NCT02475980|18732129|P1|Overall Study|Withdrawal by Subject|1
5425772|NCT02475980|18732129|P1|Overall Study|Lost to Follow-up|4
5425773|NCT02475733|18732155|P2|Overall Study|Physician Decision|0
5425774|NCT02475733|18732156|P1|Overall Study|Physician Decision|1
5425775|NCT02475733|18732155|P2|Overall Study|Withdrawal by Subject|0
5425776|NCT02475733|18732156|P1|Overall Study|Withdrawal by Subject|1
5425777|NCT02475655|18732213|P2|Overall Study|Lost to Follow-up|1
5425778|NCT02475655|18732214|P1|Overall Study|Lost to Follow-up|0
5425779|NCT02475629|18732366|P1|Overall Study|Subject non-compliance|1
5425780|NCT02475629|18732366|P1|Overall Study|Lost to Follow-up|1
5425781|NCT02475629|18732366|P1|Overall Study|Withdrawal by Subject|1
5425782|NCT02475629|18732366|P1|Overall Study|Physician Decision|1
5425783|NCT02475629|18732366|P1|Overall Study|Death|4
5425784|NCT02475629|18732366|P1|Overall Study|Adverse Event|1
5425785|NCT02475564|18732389|P2|Overall Study|Intense Menstrual bleeding|0
5425786|NCT02475564|18732390|P1|Overall Study|Intense Menstrual bleeding|1
5425787|NCT02475564|18732389|P2|Overall Study|Lost to Follow-up|1
5425788|NCT02475564|18732390|P1|Overall Study|Lost to Follow-up|2
5425789|NCT02475564|18732389|P2|Overall Study|Withdrawal by Subject|0
5425790|NCT02475564|18732390|P1|Overall Study|Withdrawal by Subject|1
5425791|NCT02475395|18732402|P2|Overall Study|Protocol Violation|3
5425792|NCT02475395|18732403|P1|Overall Study|Protocol Violation|30
5425793|NCT02475278|18732413|P1|Overall Study|Reason Not Specified|1
5425794|NCT02475278|18732413|P1|Overall Study|Lost to Follow-up|1
5425795|NCT02475265|18732424|P1|Overall Study|Withdrawal by Subject|2
5425796|NCT02475265|18732424|P1|Overall Study|Physician Decision|1
5425797|NCT02474589|18732475|P2|Overall Study|Inability to complete study procedures|1
5425798|NCT02474589|18732476|P1|Overall Study|Inability to complete study procedures|5
5425799|NCT02474589|18732475|P2|Overall Study|Withdrawal by Subject|0
5425800|NCT02474589|18732476|P1|Overall Study|Withdrawal by Subject|4
5425801|NCT02474589|18732475|P2|Overall Study|Protocol Violation|1
5425802|NCT02474589|18732476|P1|Overall Study|Protocol Violation|4
5425803|NCT02474589|18732475|P2|Overall Study|Lost to Follow-up|1
5425804|NCT02474589|18732476|P1|Overall Study|Lost to Follow-up|6
5425805|NCT02474589|18732475|P2|Overall Study|Adverse Event|2
5425806|NCT02474589|18732476|P1|Overall Study|Adverse Event|6
5425807|NCT02474082|18732535|P2|Overall Study|Protocol deviation|1
5425808|NCT02474082|18732536|P1|Overall Study|Protocol deviation|0
5425809|NCT02474082|18732535|P2|Overall Study|Non-compliance with study treatment|2
5425810|NCT02474082|18732536|P1|Overall Study|Non-compliance with study treatment|0
5425811|NCT02474082|18732535|P2|Overall Study|Participant/guardian decision|2
5425812|NCT02474082|18732536|P1|Overall Study|Participant/guardian decision|1
5425813|NCT02474082|18732535|P2|Overall Study|Dose tapering not achieved|4
5425814|NCT02474082|18732536|P1|Overall Study|Dose tapering not achieved|0
5425815|NCT02474082|18732535|P2|Overall Study|Lost to Follow-up|2
5425816|NCT02474082|18732536|P1|Overall Study|Lost to Follow-up|2
5425817|NCT02474082|18732535|P2|Overall Study|Withdrawal of informed consent|11
5425818|NCT02474082|18732536|P1|Overall Study|Withdrawal of informed consent|1
5425819|NCT02474082|18732535|P2|Overall Study|Adverse Event|32
5425820|NCT02474082|18732536|P1|Overall Study|Adverse Event|2
5425821|NCT02474069|18732570|P3|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
5425822|NCT02474069|18732571|P2|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
5425823|NCT02474069|18732572|P1|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
5425824|NCT02474069|18732570|P3|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
5425825|NCT02474069|18732571|P2|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
5425826|NCT02474069|18732572|P1|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
5425827|NCT02474069|18732570|P3|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
5425828|NCT02474069|18732571|P2|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
5425829|NCT02474069|18732572|P1|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
5425830|NCT02474069|18732570|P3|Comparative Dosing Phase (CDP)|Adverse Event|2
5425831|NCT02474069|18732571|P2|Comparative Dosing Phase (CDP)|Adverse Event|3
5425832|NCT02474069|18732572|P1|Comparative Dosing Phase (CDP)|Adverse Event|0
5425833|NCT02474069|18732570|P3|Selection Phase (SP)|Withdrawal of Informed Consent|0
5425834|NCT02474069|18732571|P2|Selection Phase (SP)|Withdrawal of Informed Consent|0
5425835|NCT02474069|18732572|P1|Selection Phase (SP)|Withdrawal of Informed Consent|3
5425836|NCT02474069|18732570|P3|Selection Phase (SP)|Withdrawal by Subject|0
5425837|NCT02474069|18732571|P2|Selection Phase (SP)|Withdrawal by Subject|0
5425838|NCT02474069|18732572|P1|Selection Phase (SP)|Withdrawal by Subject|3
5425839|NCT02474069|18732570|P3|Selection Phase (SP)|Technical Problem|0
5425840|NCT02474069|18732571|P2|Selection Phase (SP)|Technical Problem|0
5425841|NCT02474069|18732572|P1|Selection Phase (SP)|Technical Problem|1
5425842|NCT02474069|18732570|P3|Selection Phase (SP)|No longer requires treatment|0
5425843|NCT02474069|18732571|P2|Selection Phase (SP)|No longer requires treatment|0
5425844|NCT02474069|18732572|P1|Selection Phase (SP)|No longer requires treatment|1
5425845|NCT02474069|18732570|P3|Selection Phase (SP)|Protocol Violation|0
5425846|NCT02474069|18732571|P2|Selection Phase (SP)|Protocol Violation|0
5425847|NCT02474069|18732572|P1|Selection Phase (SP)|Protocol Violation|1
5425848|NCT02474069|18732570|P3|Selection Phase (SP)|Physician Decision|0
5425849|NCT02474069|18732571|P2|Selection Phase (SP)|Physician Decision|0
5425850|NCT02474069|18732572|P1|Selection Phase (SP)|Physician Decision|1
5425851|NCT02474069|18732570|P3|Selection Phase (SP)|Lost to Follow-up|0
5425852|NCT02474069|18732571|P2|Selection Phase (SP)|Lost to Follow-up|0
5425853|NCT02474069|18732572|P1|Selection Phase (SP)|Lost to Follow-up|4
5425854|NCT02474069|18732570|P3|Selection Phase (SP)|Lack of Efficacy|0
5425855|NCT02474069|18732571|P2|Selection Phase (SP)|Lack of Efficacy|0
5425856|NCT02474069|18732572|P1|Selection Phase (SP)|Lack of Efficacy|1
5425857|NCT02474069|18732570|P3|Selection Phase (SP)|Adverse Event|0
5425858|NCT02474069|18732571|P2|Selection Phase (SP)|Adverse Event|0
5425859|NCT02474069|18732572|P1|Selection Phase (SP)|Adverse Event|8
5425860|NCT02473965|18732605|P2|Overall Study|Physician Decision|2
5425861|NCT02473965|18732606|P1|Overall Study|Physician Decision|0
5425862|NCT02473965|18732605|P2|Overall Study|Withdrawal by Subject|3
5425863|NCT02473965|18732606|P1|Overall Study|Withdrawal by Subject|2
5425864|NCT02473965|18732605|P2|Overall Study|MG worsening|1
5425865|NCT02473965|18732606|P1|Overall Study|MG worsening|4
5425866|NCT02473965|18732605|P2|Overall Study|Adverse Event|4
5425867|NCT02473965|18732606|P1|Overall Study|Adverse Event|6
5425868|NCT02473952|18732618|P2|Overall Study|Withdrawal by Subject|6
5425869|NCT02473952|18732619|P1|Overall Study|Withdrawal by Subject|0
5425870|NCT02473952|18732618|P2|Overall Study|Adverse Event|2
5425871|NCT02473952|18732619|P1|Overall Study|Adverse Event|2
5425872|NCT02473913|18732627|P2|Overall Study|Lost to Follow-up|3
5425873|NCT02473913|18732628|P1|Overall Study|Lost to Follow-up|3
5425874|NCT02473640|18732680|P1|Treatment Period 1|Adverse Event|1
5425875|NCT02473523|18732689|P1|Overall Study|Lost to Follow-up|1
5425876|NCT02473523|18732689|P1|Overall Study|Death|1
5425877|NCT02473510|18732710|P2|Overall Study|Lost to Follow-up|2
5425878|NCT02473510|18732711|P1|Overall Study|Lost to Follow-up|1
5425879|NCT02473471|18732725|P1|Overall Study|Lost to Follow-up|1
5425880|NCT02473471|18732725|P1|Overall Study|poor oral hygiene|2
5425881|NCT02473445|18732756|P1|Overall Study|Sponsor Decision|20
5425882|NCT02473445|18732756|P1|Overall Study|Withdrawal by Subject|2
5425883|NCT02473367|18732762|P1|Period 4|Lost to Follow-up|1
5425884|NCT02473367|18732762|P1|Wait 1|Withdrawal by Subject|1
5425885|NCT02473289|18732782|P2|Overall Study|Other|0
5425886|NCT02473289|18732783|P1|Overall Study|Other|2
5425887|NCT02473289|18732782|P2|Overall Study|Treatment Unblinded + Adverse event|1
5425888|NCT02473289|18732783|P1|Overall Study|Treatment Unblinded + Adverse event|0
5425889|NCT02473289|18732782|P2|Overall Study|Withdrawal of consent|7
5425890|NCT02473289|18732783|P1|Overall Study|Withdrawal of consent|6
5425891|NCT02473289|18732782|P2|Overall Study|Protocol Violation|1
5425892|NCT02473289|18732783|P1|Overall Study|Protocol Violation|0
5425893|NCT02473289|18732782|P2|Overall Study|Lost to Follow-up|1
5425894|NCT02473289|18732783|P1|Overall Study|Lost to Follow-up|1
5425895|NCT02473289|18732782|P2|Overall Study|Adverse Event|3
5425896|NCT02473289|18732783|P1|Overall Study|Adverse Event|2
5425897|NCT02472977|18732808|P3|Overall Study|Subject request to discontinue treatment|0
5425898|NCT02472977|18732809|P2|Overall Study|Subject request to discontinue treatment|1
5425899|NCT02472977|18732810|P1|Overall Study|Subject request to discontinue treatment|0
5425900|NCT02472977|18732808|P3|Overall Study|Study drug toxicity|2
5425901|NCT02472977|18732809|P2|Overall Study|Study drug toxicity|0
5425902|NCT02472977|18732810|P1|Overall Study|Study drug toxicity|2
5425903|NCT02472977|18732808|P3|Overall Study|Withdrawal by Subject|0
5425904|NCT02472977|18732809|P2|Overall Study|Withdrawal by Subject|1
5425905|NCT02472977|18732810|P1|Overall Study|Withdrawal by Subject|0
5425906|NCT02472977|18732808|P3|Overall Study|Disease progression|6
5425907|NCT02472977|18732809|P2|Overall Study|Disease progression|25
5425908|NCT02472977|18732810|P1|Overall Study|Disease progression|4
5425909|NCT02472964|18732835|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
5425910|NCT02472964|18732836|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
5425911|NCT02472964|18732835|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
5425912|NCT02472964|18732836|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
5425913|NCT02472964|18732835|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
5425914|NCT02472964|18732836|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
5425915|NCT02472964|18732835|P2|Part 2 (Week 24-week 48)|Physician Decision|1
5425916|NCT02472964|18732836|P1|Part 2 (Week 24-week 48)|Physician Decision|1
5425917|NCT02472964|18732835|P2|Part 2 (Week 24-week 48)|Death|1
5425918|NCT02472964|18732836|P1|Part 2 (Week 24-week 48)|Death|0
5425919|NCT02472964|18732835|P2|Part 2 (Week 24-week 48)|Disease Progression|56
5425920|NCT02472964|18732836|P1|Part 2 (Week 24-week 48)|Disease Progression|52
5425921|NCT02472964|18732835|P2|Part 2 (Week 24-week 48)|Adverse Event|2
5425922|NCT02472964|18732836|P1|Part 2 (Week 24-week 48)|Adverse Event|4
5425923|NCT02472964|18732835|P2|Part 1 (up to Week 24)|Other|1
5425924|NCT02472964|18732836|P1|Part 1 (up to Week 24)|Other|2
5425925|NCT02472964|18732835|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
5425926|NCT02472964|18732836|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
5425927|NCT02472964|18732835|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
5425928|NCT02472964|18732836|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
5425929|NCT02472964|18732835|P2|Part 1 (up to Week 24)|Physician Decision|1
5425930|NCT02472964|18732836|P1|Part 1 (up to Week 24)|Physician Decision|3
5425931|NCT02472964|18732835|P2|Part 1 (up to Week 24)|Death|6
5425932|NCT02472964|18732836|P1|Part 1 (up to Week 24)|Death|3
5425933|NCT02472964|18732835|P2|Part 1 (up to Week 24)|disease progression|47
5425934|NCT02472964|18732836|P1|Part 1 (up to Week 24)|disease progression|58
5425935|NCT02472964|18732835|P2|Part 1 (up to Week 24)|Adverse Event|4
5425936|NCT02472964|18732836|P1|Part 1 (up to Week 24)|Adverse Event|2
5425937|NCT02472886|18732845|P3|Overall Study|Lack of Efficacy|1
5425938|NCT02472886|18732846|P2|Overall Study|Lack of Efficacy|2
5425939|NCT02472886|18732847|P1|Overall Study|Lack of Efficacy|0
5425940|NCT02472847|18732875|P2|Overall Study|Withdrawal by Subject|5
5425941|NCT02472847|18732876|P1|Overall Study|Withdrawal by Subject|1
5425942|NCT02472795|18732887|P5|Overall Study|Withdrawal by Subject|1
5425943|NCT02472795|18732888|P4|Overall Study|Withdrawal by Subject|0
5425944|NCT02472795|18732889|P3|Overall Study|Withdrawal by Subject|0
5425945|NCT02472795|18732890|P2|Overall Study|Withdrawal by Subject|0
5425946|NCT02472795|18732891|P1|Overall Study|Withdrawal by Subject|0
5425947|NCT02472795|18732887|P5|Overall Study|Adverse Event|2
5425948|NCT02472795|18732888|P4|Overall Study|Adverse Event|0
5425949|NCT02472795|18732889|P3|Overall Study|Adverse Event|0
5425950|NCT02472795|18732890|P2|Overall Study|Adverse Event|1
5425951|NCT02472795|18732891|P1|Overall Study|Adverse Event|0
5425952|NCT02472756|18732923|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
5425953|NCT02472756|18732923|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
5425954|NCT02472756|18732923|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
5425955|NCT02472756|18732923|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
5425956|NCT02472756|18732923|P1|Induction (Approximately 6 Months)|Adverse Event|1
5425957|NCT02472652|18732944|P1|Overall Study|Lost to Follow-up|1
5425958|NCT02472639|18732951|P2|Overall Study|Physician Decision|3
5425959|NCT02472639|18732952|P1|Overall Study|Physician Decision|4
5425960|NCT02472405|18733008|P1|Overall Study|Adverse Event|1
5425961|NCT02472405|18733008|P1|Overall Study|Lost to Follow-up|9
5425962|NCT02472366|18733016|P2|Overall Study|Lost to Follow-up|0
5425963|NCT02472366|18733017|P1|Overall Study|Lost to Follow-up|1
5425964|NCT02472353|18733033|P2|Overall Study|Study Termination|4
5425965|NCT02472353|18733034|P1|Overall Study|Study Termination|1
5425966|NCT02472353|18733033|P2|Overall Study|Withdrawal by Subject|1
5425967|NCT02472353|18733034|P1|Overall Study|Withdrawal by Subject|2
5425968|NCT02472353|18733033|P2|Overall Study|Lost to Follow-up|1
5425969|NCT02472353|18733034|P1|Overall Study|Lost to Follow-up|1
5425970|NCT02472145|18733071|P3|Overall Study|Other|43
5425971|NCT02472145|18733072|P2|Overall Study|Other|45
5425972|NCT02472145|18733073|P1|Overall Study|Other|0
5425973|NCT02472145|18733071|P3|Overall Study|Sponsor decision|2
5425974|NCT02472145|18733072|P2|Overall Study|Sponsor decision|3
5425975|NCT02472145|18733073|P1|Overall Study|Sponsor decision|0
5425976|NCT02472145|18733071|P3|Overall Study|Withdrawal by Subject|13
5425977|NCT02472145|18733072|P2|Overall Study|Withdrawal by Subject|9
5425978|NCT02472145|18733073|P1|Overall Study|Withdrawal by Subject|0
5425979|NCT02472145|18733071|P3|Overall Study|Lost to Follow-up|0
5425980|NCT02472145|18733072|P2|Overall Study|Lost to Follow-up|1
5425981|NCT02472145|18733073|P1|Overall Study|Lost to Follow-up|0
5425982|NCT02472145|18733071|P3|Overall Study|Death|99
5425983|NCT02472145|18733072|P2|Overall Study|Death|101
5425984|NCT02472145|18733073|P1|Overall Study|Death|10
5425985|NCT02471755|18733094|P2|Overall Study|Lost to Follow-up|1
5425986|NCT02471755|18733095|P1|Overall Study|Lost to Follow-up|0
5425987|NCT02471755|18733094|P2|Overall Study|Withdrawal by Subject|0
5425988|NCT02471755|18733095|P1|Overall Study|Withdrawal by Subject|1
5425989|NCT02471612|18733124|P1|Overall Study|Lost to Follow-up|2
5425990|NCT02471404|18733155|P3|Overall Study|Other reasons not specified|12
5425991|NCT02471404|18733156|P2|Overall Study|Other reasons not specified|7
5425992|NCT02471404|18733157|P1|Overall Study|Other reasons not specified|10
5425993|NCT02471404|18733155|P3|Overall Study|Withdrawal by Subject|5
5425994|NCT02471404|18733156|P2|Overall Study|Withdrawal by Subject|4
5425995|NCT02471404|18733157|P1|Overall Study|Withdrawal by Subject|8
5425996|NCT02471404|18733155|P3|Overall Study|Protocol Violation|0
5425997|NCT02471404|18733156|P2|Overall Study|Protocol Violation|0
5425998|NCT02471404|18733157|P1|Overall Study|Protocol Violation|1
5425999|NCT02471404|18733155|P3|Overall Study|Lost to Follow-up|3
5426000|NCT02471404|18733156|P2|Overall Study|Lost to Follow-up|1
5426001|NCT02471404|18733157|P1|Overall Study|Lost to Follow-up|1
5426002|NCT02471404|18733155|P3|Overall Study|Failure to Meet Randomization Criteria|1
5426003|NCT02471404|18733156|P2|Overall Study|Failure to Meet Randomization Criteria|0
5426004|NCT02471404|18733157|P1|Overall Study|Failure to Meet Randomization Criteria|2
5426005|NCT02471404|18733155|P3|Overall Study|Developed Study Withdrawal Criteria|2
5426006|NCT02471404|18733156|P2|Overall Study|Developed Study Withdrawal Criteria|1
5426007|NCT02471404|18733157|P1|Overall Study|Developed Study Withdrawal Criteria|4
5426008|NCT02471404|18733155|P3|Overall Study|Adverse Event|2
5426009|NCT02471404|18733156|P2|Overall Study|Adverse Event|1
5426010|NCT02471404|18733157|P1|Overall Study|Adverse Event|7
5426011|NCT02471183|18733189|P1|Extended Treatment Period|Lack of Efficacy|1
5426012|NCT02471183|18733189|P1|Main Treatment Period|Withdrawal by Subject|1
5426013|NCT02471183|18733189|P1|Main Treatment Period|Adverse Event|1
5426014|NCT02471014|18733206|P2|Overall Study|Lost to Follow-up|2
5426015|NCT02471014|18733207|P1|Overall Study|Lost to Follow-up|2
5426016|NCT02470806|18733233|P2|Overall Study|Lack of Efficacy|15
5426017|NCT02470806|18733234|P1|Overall Study|Lack of Efficacy|5
5426018|NCT02470806|18733233|P2|Overall Study|Withdrawal by Subject|10
5426019|NCT02470806|18733234|P1|Overall Study|Withdrawal by Subject|3
5426020|NCT02470806|18733233|P2|Overall Study|Physician Decision|3
5426021|NCT02470806|18733234|P1|Overall Study|Physician Decision|0
5426022|NCT02470806|18733233|P2|Overall Study|Protocol Violation|11
5426023|NCT02470806|18733234|P1|Overall Study|Protocol Violation|4
5426024|NCT02470806|18733233|P2|Overall Study|Adverse Event|2
5426025|NCT02470806|18733234|P1|Overall Study|Adverse Event|5
5426026|NCT02470806|18733233|P2|Overall Study|Lost to Follow-up|1
5426027|NCT02470806|18733234|P1|Overall Study|Lost to Follow-up|1
5426028|NCT02470585|18733287|P3|Overall Study|Other|6
5426029|NCT02470585|18733288|P2|Overall Study|Other|4
5426030|NCT02470585|18733289|P1|Overall Study|Other|4
5426031|NCT02470585|18733287|P3|Overall Study|Lost to Follow-up|4
5426032|NCT02470585|18733288|P2|Overall Study|Lost to Follow-up|5
5426033|NCT02470585|18733289|P1|Overall Study|Lost to Follow-up|2
5426034|NCT02470585|18733287|P3|Overall Study|Withdrawal by Subject|29
5426035|NCT02470585|18733288|P2|Overall Study|Withdrawal by Subject|21
5426036|NCT02470585|18733289|P1|Overall Study|Withdrawal by Subject|19
5426037|NCT02470585|18733287|P3|Overall Study|Death|86
5426038|NCT02470585|18733288|P2|Overall Study|Death|87
5426039|NCT02470585|18733289|P1|Overall Study|Death|82
5426040|NCT02470429|18733322|P2|Overall Study|Withdrawal by Subject|0
5426041|NCT02470429|18733323|P1|Overall Study|Withdrawal by Subject|1
5426042|NCT02470429|18733322|P2|Overall Study|Adverse Event|0
5426043|NCT02470429|18733323|P1|Overall Study|Adverse Event|1
5426044|NCT02470403|18733341|P5|Overall Study|Subject/guardian decision|0
5426045|NCT02470403|18733342|P4|Overall Study|Subject/guardian decision|4
5426046|NCT02470403|18733343|P3|Overall Study|Subject/guardian decision|0
5426047|NCT02470403|18733344|P2|Overall Study|Subject/guardian decision|0
5426048|NCT02470403|18733345|P1|Overall Study|Subject/guardian decision|1
5426049|NCT02470403|18733341|P5|Overall Study|Lost to Follow-up|0
5426050|NCT02470403|18733342|P4|Overall Study|Lost to Follow-up|0
5426051|NCT02470403|18733343|P3|Overall Study|Lost to Follow-up|0
5426052|NCT02470403|18733344|P2|Overall Study|Lost to Follow-up|1
5426053|NCT02470403|18733345|P1|Overall Study|Lost to Follow-up|0
5426054|NCT02470403|18733341|P5|Overall Study|Adverse Event|0
5426055|NCT02470403|18733342|P4|Overall Study|Adverse Event|0
5426056|NCT02470403|18733343|P3|Overall Study|Adverse Event|0
5426057|NCT02470403|18733344|P2|Overall Study|Adverse Event|0
5426058|NCT02470403|18733345|P1|Overall Study|Adverse Event|1
5426059|NCT02469961|18733425|P2|Overall Study|Physician Decision|1
5426060|NCT02469961|18733426|P1|Overall Study|Physician Decision|4
5426061|NCT02469896|18733440|P2|Overall Study|Withdrawal by Subject|0
5426062|NCT02469896|18733441|P1|Overall Study|Withdrawal by Subject|2
5426063|NCT02469623|18733511|P1|Overall Study|Death|3
5426064|NCT02469623|18733511|P1|Overall Study|Withdrawal by Subject|2
5426065|NCT02469623|18733511|P1|Overall Study|Lost to Follow-up|4
5426066|NCT02469623|18733511|P1|Overall Study|Not consented for long-term follow-up|4
5426067|NCT02469610|18733518|P2|Overall Study|exclusion criteria|1
5426068|NCT02469610|18733519|P1|Overall Study|exclusion criteria|2
5426069|NCT02469610|18733518|P2|Overall Study|Lost to Follow-up|0
5426070|NCT02469610|18733519|P1|Overall Study|Lost to Follow-up|1
5426071|NCT02469610|18733518|P2|Overall Study|Death|0
5426072|NCT02469610|18733519|P1|Overall Study|Death|1
5426073|NCT02469415|18733546|P1|Overall Study|Investigational agent placed on hold|2
5426074|NCT02469415|18733546|P1|Overall Study|Withdrawal by Subject|1
5426075|NCT02469298|18733554|P4|Overall Study|Withdrawal by Subject|1
5426076|NCT02469298|18733555|P3|Overall Study|Withdrawal by Subject|0
5426077|NCT02469298|18733556|P2|Overall Study|Withdrawal by Subject|0
5426078|NCT02469298|18733557|P1|Overall Study|Withdrawal by Subject|0
5426079|NCT02469298|18733554|P4|Overall Study|Physician Decision|1
5426080|NCT02469298|18733555|P3|Overall Study|Physician Decision|0
5426081|NCT02469298|18733556|P2|Overall Study|Physician Decision|0
5426082|NCT02469298|18733557|P1|Overall Study|Physician Decision|0
5426083|NCT02469298|18733554|P4|Overall Study|Lost to Follow-up|0
5426084|NCT02469298|18733555|P3|Overall Study|Lost to Follow-up|1
5426085|NCT02469298|18733556|P2|Overall Study|Lost to Follow-up|0
5426086|NCT02469298|18733557|P1|Overall Study|Lost to Follow-up|1
5426087|NCT02469298|18733554|P4|Overall Study|Protocol Violation|0
5426088|NCT02469298|18733555|P3|Overall Study|Protocol Violation|1
5426089|NCT02469298|18733556|P2|Overall Study|Protocol Violation|1
5426090|NCT02469298|18733557|P1|Overall Study|Protocol Violation|0
5426091|NCT02469246|18733697|P2|Double-Blind Phase|Lost to Follow-up|5
5426092|NCT02469246|18733698|P1|Double-Blind Phase|Lost to Follow-up|9
5426093|NCT02469246|18733697|P2|Double-Blind Phase|Withdrew Consent|25
5426094|NCT02469246|18733698|P1|Double-Blind Phase|Withdrew Consent|25
5426095|NCT02469246|18733697|P2|Double-Blind Phase|Protocol Violation|1
5426096|NCT02469246|18733698|P1|Double-Blind Phase|Protocol Violation|1
5426097|NCT02469246|18733697|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5426098|NCT02469246|18733698|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
5426099|NCT02469246|18733697|P2|Double-Blind Phase|Investigator's Discretion|8
5426100|NCT02469246|18733698|P1|Double-Blind Phase|Investigator's Discretion|8
5426101|NCT02469246|18733697|P2|Double-Blind Phase|Lack of Efficacy|1
5426102|NCT02469246|18733698|P1|Double-Blind Phase|Lack of Efficacy|2
5426103|NCT02469246|18733697|P2|Double-Blind Phase|Death|0
5426104|NCT02469246|18733698|P1|Double-Blind Phase|Death|2
5426105|NCT02469246|18733697|P2|Double-Blind Phase|Adverse Event|9
5426106|NCT02469246|18733698|P1|Double-Blind Phase|Adverse Event|12
5426107|NCT02469246|18733697|P2|Double-Blind Phase|Randomized and Never Treated|6
5426108|NCT02469246|18733698|P1|Double-Blind Phase|Randomized and Never Treated|5
5426109|NCT02469168|18733730|P2|Overall Study|Trial closed|0
5426110|NCT02469168|18733731|P1|Overall Study|Trial closed|1
5426111|NCT02469090|18733751|P3|Period 2: Maintenance Treatment Phase|Death|1
5426112|NCT02469090|18733752|P2|Period 2: Maintenance Treatment Phase|Death|0
5426113|NCT02469090|18733753|P1|Period 2: Maintenance Treatment Phase|Death|0
5426114|NCT02469090|18733751|P3|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
5426115|NCT02469090|18733752|P2|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
5426116|NCT02469090|18733753|P1|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
5426117|NCT02469090|18733751|P3|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
5426118|NCT02469090|18733752|P2|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
5426119|NCT02469090|18733753|P1|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
5426120|NCT02469090|18733751|P3|Period 2: Maintenance Treatment Phase|Adverse Event|15
5426121|NCT02469090|18733752|P2|Period 2: Maintenance Treatment Phase|Adverse Event|5
5426122|NCT02469090|18733753|P1|Period 2: Maintenance Treatment Phase|Adverse Event|0
5426123|NCT02469090|18733751|P3|Period 1: Dose Titration Phase|Lack of Efficacy|0
5426124|NCT02469090|18733752|P2|Period 1: Dose Titration Phase|Lack of Efficacy|0
5426125|NCT02469090|18733753|P1|Period 1: Dose Titration Phase|Lack of Efficacy|11
5426126|NCT02469090|18733751|P3|Period 1: Dose Titration Phase|Lost to Follow-up|0
5426127|NCT02469090|18733752|P2|Period 1: Dose Titration Phase|Lost to Follow-up|0
5426128|NCT02469090|18733753|P1|Period 1: Dose Titration Phase|Lost to Follow-up|1
5426129|NCT02469090|18733751|P3|Period 1: Dose Titration Phase|Withdrawal by Subject|0
5426130|NCT02469090|18733752|P2|Period 1: Dose Titration Phase|Withdrawal by Subject|0
5426131|NCT02469090|18733753|P1|Period 1: Dose Titration Phase|Withdrawal by Subject|8
5426132|NCT02469090|18733751|P3|Period 1: Dose Titration Phase|Adverse Event|0
5426133|NCT02469090|18733752|P2|Period 1: Dose Titration Phase|Adverse Event|0
5426134|NCT02469090|18733753|P1|Period 1: Dose Titration Phase|Adverse Event|12
5426135|NCT02469077|18733780|P2|Post Intervention /Followup|Withdrawal by Subject|1
5426136|NCT02469077|18733781|P1|Post Intervention /Followup|Withdrawal by Subject|2
5426137|NCT02469077|18733780|P2|Post Randomization/Intervention Period|Conflicting health issues|1
5426138|NCT02469077|18733781|P1|Post Randomization/Intervention Period|Conflicting health issues|0
5426139|NCT02469077|18733780|P2|Post Randomization/Intervention Period|Relocated|1
5426140|NCT02469077|18733781|P1|Post Randomization/Intervention Period|Relocated|1
5426141|NCT02469077|18733780|P2|Post Randomization/Intervention Period|Scheduling issues|2
5426142|NCT02469077|18733781|P1|Post Randomization/Intervention Period|Scheduling issues|3
5426143|NCT02469064|18733813|P2|Overall Study|Request not to receive intervention.|3
5426144|NCT02469064|18733814|P1|Overall Study|Request not to receive intervention.|1
5426145|NCT02469038|18733824|P2|Overall Study|Physician Decision|5
5426146|NCT02469038|18733825|P1|Overall Study|Physician Decision|4
5426147|NCT02468934|18733843|P1|Overall Study|Screen Failure|3
5426148|NCT02468934|18733843|P1|Overall Study|Withdrawal by Subject|4
5426149|NCT02468674|18733894|P9|Overall Study|Protocol Deviation|1
5426150|NCT02468674|18733895|P8|Overall Study|Protocol Deviation|1
5426151|NCT02468674|18733896|P7|Overall Study|Protocol Deviation|0
5426152|NCT02468674|18733897|P6|Overall Study|Protocol Deviation|0
5426153|NCT02468674|18733898|P5|Overall Study|Protocol Deviation|0
5426154|NCT02468674|18733899|P4|Overall Study|Protocol Deviation|0
5426155|NCT02468674|18733900|P3|Overall Study|Protocol Deviation|0
5426156|NCT02468674|18733901|P2|Overall Study|Protocol Deviation|0
5426157|NCT02468674|18733902|P1|Overall Study|Protocol Deviation|0
5426158|NCT02468674|18733894|P9|Overall Study|Patient/Guardian Decision|1
5426159|NCT02468674|18733895|P8|Overall Study|Patient/Guardian Decision|2
5426160|NCT02468674|18733896|P7|Overall Study|Patient/Guardian Decision|0
5426161|NCT02468674|18733897|P6|Overall Study|Patient/Guardian Decision|0
5426162|NCT02468674|18733898|P5|Overall Study|Patient/Guardian Decision|1
5426163|NCT02468674|18733899|P4|Overall Study|Patient/Guardian Decision|0
5426164|NCT02468674|18733900|P3|Overall Study|Patient/Guardian Decision|0
5426165|NCT02468674|18733901|P2|Overall Study|Patient/Guardian Decision|0
5426166|NCT02468674|18733902|P1|Overall Study|Patient/Guardian Decision|0
5426167|NCT02468674|18733894|P9|Overall Study|Physician Decision|0
5426168|NCT02468674|18733895|P8|Overall Study|Physician Decision|0
5426169|NCT02468674|18733896|P7|Overall Study|Physician Decision|1
5426170|NCT02468674|18733897|P6|Overall Study|Physician Decision|0
5426171|NCT02468674|18733898|P5|Overall Study|Physician Decision|0
5426172|NCT02468674|18733899|P4|Overall Study|Physician Decision|0
5426173|NCT02468674|18733900|P3|Overall Study|Physician Decision|0
5426174|NCT02468674|18733901|P2|Overall Study|Physician Decision|0
5426175|NCT02468674|18733902|P1|Overall Study|Physician Decision|0
5426176|NCT02468674|18733894|P9|Overall Study|Lost to Follow-up|1
5426177|NCT02468674|18733895|P8|Overall Study|Lost to Follow-up|1
5426178|NCT02468674|18733896|P7|Overall Study|Lost to Follow-up|0
5426179|NCT02468674|18733897|P6|Overall Study|Lost to Follow-up|0
5426180|NCT02468674|18733898|P5|Overall Study|Lost to Follow-up|0
5426181|NCT02468674|18733899|P4|Overall Study|Lost to Follow-up|0
5426182|NCT02468674|18733900|P3|Overall Study|Lost to Follow-up|0
5426183|NCT02468674|18733901|P2|Overall Study|Lost to Follow-up|0
5426184|NCT02468674|18733902|P1|Overall Study|Lost to Follow-up|1
5426185|NCT02468674|18733894|P9|Overall Study|Adverse Event|0
5426186|NCT02468674|18733895|P8|Overall Study|Adverse Event|0
5426187|NCT02468674|18733896|P7|Overall Study|Adverse Event|0
5426188|NCT02468674|18733897|P6|Overall Study|Adverse Event|1
5426189|NCT02468674|18733898|P5|Overall Study|Adverse Event|0
5426190|NCT02468674|18733899|P4|Overall Study|Adverse Event|1
5426191|NCT02468674|18733900|P3|Overall Study|Adverse Event|0
5426192|NCT02468674|18733901|P2|Overall Study|Adverse Event|0
5426193|NCT02468674|18733902|P1|Overall Study|Adverse Event|0
5426194|NCT02468648|18733958|P1|Overall Study|Death|1
5426195|NCT02468414|18734025|P2|Overall Study|Screen Failure|0
5426196|NCT02468414|18734026|P1|Overall Study|Screen Failure|1
5426197|NCT02468414|18734025|P2|Overall Study|Poor in-vitro secreting TARGTs|0
5426198|NCT02468414|18734026|P1|Overall Study|Poor in-vitro secreting TARGTs|1
5426199|NCT02468414|18734025|P2|Overall Study|Early Study Termination by Sponsor|0
5426200|NCT02468414|18734026|P1|Overall Study|Early Study Termination by Sponsor|1
5426201|NCT02468193|18734032|P1|Overall Study|Subject/ Guardian decision|2
5426202|NCT02468193|18734032|P1|Overall Study|Adverse Event|4
5426203|NCT02466659|18734354|P2|Overall Study|Lost to Follow-up|2
5426204|NCT02466659|18734355|P1|Overall Study|Lost to Follow-up|5
5426205|NCT02466555|18734409|P1|Overall Study|Lost to Follow-up|2
5426206|NCT02466516|18734421|P5|Overall Study|Lost to Follow-up|0
5426207|NCT02466516|18734422|P4|Overall Study|Lost to Follow-up|0
5426208|NCT02466516|18734423|P3|Overall Study|Lost to Follow-up|1
5426209|NCT02466516|18734424|P2|Overall Study|Lost to Follow-up|0
5426210|NCT02466516|18734425|P1|Overall Study|Lost to Follow-up|2
5426211|NCT02466516|18734421|P5|Overall Study|Withdrew Consent|0
5426212|NCT02466516|18734422|P4|Overall Study|Withdrew Consent|0
5426213|NCT02466516|18734423|P3|Overall Study|Withdrew Consent|0
5426214|NCT02466516|18734424|P2|Overall Study|Withdrew Consent|0
5426215|NCT02466516|18734425|P1|Overall Study|Withdrew Consent|1
5426216|NCT02466516|18734421|P5|Overall Study|Adverse Event|0
5426217|NCT02466516|18734422|P4|Overall Study|Adverse Event|0
5426218|NCT02466516|18734423|P3|Overall Study|Adverse Event|0
5426219|NCT02466516|18734424|P2|Overall Study|Adverse Event|1
5426220|NCT02466516|18734425|P1|Overall Study|Adverse Event|1
5426221|NCT02466425|18734444|P2|Overall Study|Withdrawal by Parent/Guardian|0
5426222|NCT02466425|18734445|P1|Overall Study|Withdrawal by Parent/Guardian|2
5426223|NCT02466425|18734444|P2|Overall Study|Other|3
5426224|NCT02466425|18734445|P1|Overall Study|Other|1
5426225|NCT02466425|18734444|P2|Overall Study|Withdrawal by Subject|1
5426226|NCT02466425|18734445|P1|Overall Study|Withdrawal by Subject|0
5426227|NCT02466425|18734444|P2|Overall Study|Protocol Violation|0
5426228|NCT02466425|18734445|P1|Overall Study|Protocol Violation|1
5426229|NCT02466425|18734444|P2|Overall Study|Lost to Follow-up|0
5426230|NCT02466425|18734445|P1|Overall Study|Lost to Follow-up|3
5426231|NCT02466425|18734444|P2|Overall Study|Lack of Efficacy|1
5426232|NCT02466425|18734445|P1|Overall Study|Lack of Efficacy|4
5426233|NCT02466425|18734444|P2|Overall Study|Adverse Event|11
5426234|NCT02466425|18734445|P1|Overall Study|Adverse Event|3
5426235|NCT02466399|18734467|P2|Overall Study|Early exit due to family emergency|0
5426236|NCT02466399|18734468|P1|Overall Study|Early exit due to family emergency|1
5426237|NCT02466399|18734467|P2|Overall Study|Adverse Event|0
5426238|NCT02466399|18734468|P1|Overall Study|Adverse Event|1
5426239|NCT02465931|18734492|P2|Overall Study|Withdrawal by Subject|0
5426240|NCT02465931|18734493|P1|Overall Study|Withdrawal by Subject|1
5426241|NCT02465931|18734492|P2|Overall Study|Protocol Violation|0
5426242|NCT02465931|18734493|P1|Overall Study|Protocol Violation|1
5426243|NCT02465931|18734492|P2|Overall Study|Lost to Follow-up|11
5426244|NCT02465931|18734493|P1|Overall Study|Lost to Follow-up|9
5426245|NCT02465866|18734499|P4|Period 3|Withdrawal by Subject|0
5426246|NCT02465866|18734500|P3|Period 3|Withdrawal by Subject|0
5426247|NCT02465866|18734501|P2|Period 3|Withdrawal by Subject|1
5426248|NCT02465866|18734502|P1|Period 3|Withdrawal by Subject|0
5426249|NCT02465528|18734592|P4|Overall Study|Physician Decision|0
5426250|NCT02465528|18734593|P3|Overall Study|Physician Decision|1
5426251|NCT02465528|18734594|P2|Overall Study|Physician Decision|0
5426252|NCT02465528|18734595|P1|Overall Study|Physician Decision|0
5426253|NCT02465528|18734592|P4|Overall Study|Adverse Event|1
5426254|NCT02465528|18734593|P3|Overall Study|Adverse Event|0
5426255|NCT02465528|18734594|P2|Overall Study|Adverse Event|0
5426256|NCT02465528|18734595|P1|Overall Study|Adverse Event|0
5426257|NCT02465528|18734592|P4|Overall Study|Withdrawal by Subject|0
5426258|NCT02465528|18734593|P3|Overall Study|Withdrawal by Subject|2
5426259|NCT02465528|18734594|P2|Overall Study|Withdrawal by Subject|0
5426260|NCT02465528|18734595|P1|Overall Study|Withdrawal by Subject|0
5426261|NCT02465528|18734592|P4|Overall Study|Study terminated by sponsor|0
5426262|NCT02465528|18734593|P3|Overall Study|Study terminated by sponsor|0
5426263|NCT02465528|18734594|P2|Overall Study|Study terminated by sponsor|2
5426264|NCT02465528|18734595|P1|Overall Study|Study terminated by sponsor|1
5426265|NCT02465528|18734592|P4|Overall Study|Progressive disease|4
5426266|NCT02465528|18734593|P3|Overall Study|Progressive disease|9
5426267|NCT02465528|18734594|P2|Overall Study|Progressive disease|2
5426268|NCT02465528|18734595|P1|Overall Study|Progressive disease|0
5426269|NCT02465515|18734628|P2|Overall Study|Lost to Follow-up|51
5426270|NCT02465515|18734629|P1|Overall Study|Lost to Follow-up|68
5426271|NCT02465515|18734628|P2|Overall Study|Physician Decision|12
5426272|NCT02465515|18734629|P1|Overall Study|Physician Decision|8
5426273|NCT02465515|18734628|P2|Overall Study|Withdrawal by Subject|43
5426274|NCT02465515|18734629|P1|Overall Study|Withdrawal by Subject|74
5426275|NCT02465515|18734628|P2|Overall Study|Investigator site closed|5
5426276|NCT02465515|18734629|P1|Overall Study|Investigator site closed|4
5426277|NCT02465489|18734675|P1|Overall Study|Adverse Event|5
5426278|NCT02465463|18734704|P2|Overall Study|Protocol Violation|0
5426279|NCT02465463|18734705|P1|Overall Study|Protocol Violation|1
5426280|NCT02465463|18734704|P2|Overall Study|Death|0
5426281|NCT02465463|18734705|P1|Overall Study|Death|1
5426282|NCT02465463|18734704|P2|Overall Study|Lost to Follow-up|1
5426283|NCT02465463|18734705|P1|Overall Study|Lost to Follow-up|2
5426284|NCT02465437|18734753|P4|Overall Study|Adverse Event|0
5426285|NCT02465437|18734754|P3|Overall Study|Adverse Event|0
5426286|NCT02465437|18734755|P2|Overall Study|Adverse Event|1
5426287|NCT02465437|18734756|P1|Overall Study|Adverse Event|0
5426288|NCT02465437|18734753|P4|Overall Study|Withdrawal by Subject|1
5426289|NCT02465437|18734754|P3|Overall Study|Withdrawal by Subject|0
5426290|NCT02465437|18734755|P2|Overall Study|Withdrawal by Subject|0
5426291|NCT02465437|18734756|P1|Overall Study|Withdrawal by Subject|1
5426292|NCT02465437|18734753|P4|Overall Study|Physician Decision|0
5426293|NCT02465437|18734754|P3|Overall Study|Physician Decision|1
5426294|NCT02465437|18734755|P2|Overall Study|Physician Decision|0
5426295|NCT02465437|18734756|P1|Overall Study|Physician Decision|0
5426296|NCT02465203|18734816|P3|Overall Study|Patient/guardian decision|1
5426297|NCT02465203|18734817|P2|Overall Study|Patient/guardian decision|1
5426298|NCT02465203|18734818|P1|Overall Study|Patient/guardian decision|1
5426299|NCT02465203|18734816|P3|Overall Study|New therapy for study indication|0
5426300|NCT02465203|18734817|P2|Overall Study|New therapy for study indication|0
5426301|NCT02465203|18734818|P1|Overall Study|New therapy for study indication|4
5426302|NCT02465203|18734816|P3|Overall Study|Study terminated by sponsor|11
5426303|NCT02465203|18734817|P2|Overall Study|Study terminated by sponsor|34
5426304|NCT02465203|18734818|P1|Overall Study|Study terminated by sponsor|50
5426305|NCT02465203|18734816|P3|Overall Study|Protocol Violation|1
5426306|NCT02465203|18734817|P2|Overall Study|Protocol Violation|1
5426307|NCT02465203|18734818|P1|Overall Study|Protocol Violation|1
5426308|NCT02464059|18734938|P1|Overall Study|Lost to Follow-up|6
5426309|NCT02463409|18734997|P1|Overall Study|Screen failure|1
5426310|NCT02463409|18734997|P1|Overall Study|Withdrawal by Subject|1
5426311|NCT02463331|18735005|P2|Overall Study|Physician Decision|0
5426312|NCT02463331|18735006|P1|Overall Study|Physician Decision|3
5426313|NCT02463331|18735005|P2|Overall Study|Lack of Efficacy|0
5426314|NCT02463331|18735006|P1|Overall Study|Lack of Efficacy|6
5426315|NCT02463331|18735005|P2|Overall Study|Pregnancy|3
5426316|NCT02463331|18735006|P1|Overall Study|Pregnancy|2
5426317|NCT02463331|18735005|P2|Overall Study|Lost to Follow-up|1
5426318|NCT02463331|18735006|P1|Overall Study|Lost to Follow-up|1
5426319|NCT02463331|18735005|P2|Overall Study|Adverse Event|2
5426320|NCT02463331|18735006|P1|Overall Study|Adverse Event|4
5426321|NCT02463097|18735022|P1|Overall Study|Withdrawal by Subject|1
5426322|NCT02463071|18735031|P3|Overall Study|Lost to Follow-up|1
5426323|NCT02463071|18735032|P2|Overall Study|Lost to Follow-up|0
5426324|NCT02463071|18735033|P1|Overall Study|Lost to Follow-up|0
5426325|NCT02463071|18735031|P3|Overall Study|Protocol Violation|0
5426326|NCT02463071|18735032|P2|Overall Study|Protocol Violation|2
5426327|NCT02463071|18735033|P1|Overall Study|Protocol Violation|0
5426328|NCT02463071|18735031|P3|Overall Study|Reason not specified|4
5426329|NCT02463071|18735032|P2|Overall Study|Reason not specified|9
5426330|NCT02463071|18735033|P1|Overall Study|Reason not specified|7
5426331|NCT02463071|18735031|P3|Overall Study|Eligibility criteria not fulfilled|0
5426332|NCT02463071|18735032|P2|Overall Study|Eligibility criteria not fulfilled|0
5426333|NCT02463071|18735033|P1|Overall Study|Eligibility criteria not fulfilled|1
5426334|NCT02463071|18735031|P3|Overall Study|Death|0
5426335|NCT02463071|18735032|P2|Overall Study|Death|0
5426336|NCT02463071|18735033|P1|Overall Study|Death|1
5426337|NCT02463071|18735031|P3|Overall Study|Adverse Event|1
5426338|NCT02463071|18735032|P2|Overall Study|Adverse Event|5
5426339|NCT02463071|18735033|P1|Overall Study|Adverse Event|3
5426340|NCT02463032|18735061|P2|Overall Study|Adverse Event|6
5426341|NCT02463032|18735062|P1|Overall Study|Adverse Event|2
5426342|NCT02463032|18735061|P2|Overall Study|Death|8
5426343|NCT02463032|18735062|P1|Overall Study|Death|8
5426344|NCT02463032|18735061|P2|Overall Study|Lack of Efficacy|50
5426345|NCT02463032|18735062|P1|Overall Study|Lack of Efficacy|61
5426346|NCT02462928|18735114|P3|Overall Study|Reason not Specified|5
5426347|NCT02462928|18735115|P2|Overall Study|Reason not Specified|6
5426348|NCT02462928|18735116|P1|Overall Study|Reason not Specified|4
5426349|NCT02462928|18735114|P3|Overall Study|Protocol Violation|0
5426350|NCT02462928|18735115|P2|Overall Study|Protocol Violation|1
5426351|NCT02462928|18735116|P1|Overall Study|Protocol Violation|0
5426352|NCT02462928|18735114|P3|Overall Study|Withdrawal by Patient|21
5426353|NCT02462928|18735115|P2|Overall Study|Withdrawal by Patient|21
5426354|NCT02462928|18735116|P1|Overall Study|Withdrawal by Patient|31
5426355|NCT02462928|18735114|P3|Overall Study|Lost to Follow-up|1
5426356|NCT02462928|18735115|P2|Overall Study|Lost to Follow-up|4
5426357|NCT02462928|18735116|P1|Overall Study|Lost to Follow-up|4
5426358|NCT02462928|18735114|P3|Overall Study|Lack of Efficacy|3
5426359|NCT02462928|18735115|P2|Overall Study|Lack of Efficacy|8
5426360|NCT02462928|18735116|P1|Overall Study|Lack of Efficacy|3
5426361|NCT02462928|18735114|P3|Overall Study|Adverse Event|25
5426362|NCT02462928|18735115|P2|Overall Study|Adverse Event|51
5426363|NCT02462928|18735116|P1|Overall Study|Adverse Event|47
5426364|NCT02462928|18735114|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|2
5426365|NCT02462928|18735115|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5426366|NCT02462928|18735116|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5426367|NCT02462876|18735136|P1|Overall Study|Ongoing|10
5426368|NCT02462876|18735136|P1|Overall Study|Other|6
5426369|NCT02462876|18735136|P1|Overall Study|Amputation Above the Metatarsals|1
5426370|NCT02462876|18735136|P1|Overall Study|Surgical Bypass|9
5426371|NCT02462876|18735136|P1|Overall Study|Lost to Follow-up|4
5426372|NCT02462876|18735136|P1|Overall Study|Death|3
5426373|NCT02462759|18735146|P3|Part 1: Double Blind|Death|0
5426374|NCT02462759|18735147|P2|Part 1: Double Blind|Death|0
5426375|NCT02462759|18735148|P1|Part 1: Double Blind|Death|1
5426376|NCT02462720|18735196|P2|Part 2|Protocol Violation|1
5426377|NCT02462720|18735197|P1|Part 2|Protocol Violation|0
5426378|NCT02462720|18735196|P2|Part 2|Withdrawal by Subject|0
5426379|NCT02462720|18735197|P1|Part 2|Withdrawal by Subject|1
5426380|NCT02462486|18735210|P3|Overall Study|Reason not Specified|3
5426381|NCT02462486|18735211|P2|Overall Study|Reason not Specified|4
5426382|NCT02462486|18735212|P1|Overall Study|Reason not Specified|3
5426383|NCT02462486|18735210|P3|Overall Study|Protocol Violation|1
5426384|NCT02462486|18735211|P2|Overall Study|Protocol Violation|1
5426385|NCT02462486|18735212|P1|Overall Study|Protocol Violation|3
5426386|NCT02462486|18735210|P3|Overall Study|Withdrawal by Subject|19
5426387|NCT02462486|18735211|P2|Overall Study|Withdrawal by Subject|22
5426388|NCT02462486|18735212|P1|Overall Study|Withdrawal by Subject|25
5426389|NCT02462486|18735210|P3|Overall Study|Lost to Follow-up|2
5426390|NCT02462486|18735211|P2|Overall Study|Lost to Follow-up|4
5426391|NCT02462486|18735212|P1|Overall Study|Lost to Follow-up|3
5426392|NCT02462486|18735210|P3|Overall Study|Lack of Efficacy|3
5426393|NCT02462486|18735211|P2|Overall Study|Lack of Efficacy|12
5426394|NCT02462486|18735212|P1|Overall Study|Lack of Efficacy|6
5426395|NCT02462486|18735210|P3|Overall Study|Adverse Event|21
5426396|NCT02462486|18735211|P2|Overall Study|Adverse Event|48
5426397|NCT02462486|18735212|P1|Overall Study|Adverse Event|53
5426398|NCT02462486|18735210|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|3
5426399|NCT02462486|18735211|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5426400|NCT02462486|18735212|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
5426401|NCT02462473|18735232|P1|Overall Study|Other|3
5426402|NCT02462473|18735232|P1|Overall Study|Death|1
5426403|NCT02462083|18735338|P1|Overall Study|Other than specified|45
5426404|NCT02462083|18735338|P1|Overall Study|Worsening condition|16
5426405|NCT02462083|18735338|P1|Overall Study|Adverse Event|33
5426406|NCT02462083|18735338|P1|Overall Study|Protocol Violation|6
5426407|NCT02462083|18735338|P1|Overall Study|Pregnancy|1
5426408|NCT02462083|18735338|P1|Overall Study|Lack of Efficacy|151
5426409|NCT02462083|18735338|P1|Overall Study|Lost to Follow-up|41
5426410|NCT02462083|18735338|P1|Overall Study|Withdrawal by Subject|87
5426411|NCT02462083|18735338|P1|Overall Study|Sponsor request|39
5426412|NCT02462057|18735358|P5|Overall Study|Joined HealthyFood Before Intervention|17
5426413|NCT02462057|18735359|P4|Overall Study|Joined HealthyFood Before Intervention|16
5426414|NCT02462057|18735360|P3|Overall Study|Joined HealthyFood Before Intervention|23
5426415|NCT02462057|18735361|P2|Overall Study|Joined HealthyFood Before Intervention|13
5426416|NCT02462057|18735362|P1|Overall Study|Joined HealthyFood Before Intervention|22
5426417|NCT02462057|18735358|P5|Overall Study|Left Vitality|33
5426418|NCT02462057|18735359|P4|Overall Study|Left Vitality|35
5426419|NCT02462057|18735360|P3|Overall Study|Left Vitality|23
5426420|NCT02462057|18735361|P2|Overall Study|Left Vitality|27
5426421|NCT02462057|18735362|P1|Overall Study|Left Vitality|32
5426422|NCT02461758|18735448|P4|Overall Study|Lost to Follow-up|0
5426423|NCT02461758|18735449|P3|Overall Study|Lost to Follow-up|1
5426424|NCT02461758|18735450|P2|Overall Study|Lost to Follow-up|1
5426425|NCT02461758|18735451|P1|Overall Study|Lost to Follow-up|0
5426426|NCT02461628|18735492|P2|Overall Study|Refused to complete survey|7
5426427|NCT02461628|18735493|P1|Overall Study|Refused to complete survey|4
5426428|NCT02461589|18735517|P10|Overall Study|Withdrawal from trial before exposure|1
5426429|NCT02461589|18735518|P9|Overall Study|Withdrawal from trial before exposure|0
5426430|NCT02461589|18735519|P8|Overall Study|Withdrawal from trial before exposure|0
5426431|NCT02461589|18735520|P7|Overall Study|Withdrawal from trial before exposure|0
5426432|NCT02461589|18735521|P6|Overall Study|Withdrawal from trial before exposure|0
5426433|NCT02461589|18735522|P5|Overall Study|Withdrawal from trial before exposure|0
5426434|NCT02461589|18735523|P4|Overall Study|Withdrawal from trial before exposure|0
5426435|NCT02461589|18735524|P3|Overall Study|Withdrawal from trial before exposure|0
5426436|NCT02461589|18735525|P2|Overall Study|Withdrawal from trial before exposure|0
5426437|NCT02461589|18735526|P1|Overall Study|Withdrawal from trial before exposure|0
5426438|NCT02461589|18735517|P10|Overall Study|Missing follow-up information|0
5426439|NCT02461589|18735518|P9|Overall Study|Missing follow-up information|0
5426440|NCT02461589|18735519|P8|Overall Study|Missing follow-up information|0
5426441|NCT02461589|18735520|P7|Overall Study|Missing follow-up information|1
5426442|NCT02461589|18735521|P6|Overall Study|Missing follow-up information|0
5426443|NCT02461589|18735522|P5|Overall Study|Missing follow-up information|0
5426444|NCT02461589|18735523|P4|Overall Study|Missing follow-up information|0
5426445|NCT02461589|18735524|P3|Overall Study|Missing follow-up information|0
5426446|NCT02461589|18735525|P2|Overall Study|Missing follow-up information|1
5426447|NCT02461589|18735526|P1|Overall Study|Missing follow-up information|1
5426448|NCT02461589|18735517|P10|Overall Study|Unclassified|2
5426449|NCT02461589|18735518|P9|Overall Study|Unclassified|0
5426450|NCT02461589|18735519|P8|Overall Study|Unclassified|0
5426451|NCT02461589|18735520|P7|Overall Study|Unclassified|1
5426452|NCT02461589|18735521|P6|Overall Study|Unclassified|0
5426453|NCT02461589|18735522|P5|Overall Study|Unclassified|0
5426454|NCT02461589|18735523|P4|Overall Study|Unclassified|0
5426455|NCT02461589|18735524|P3|Overall Study|Unclassified|0
5426456|NCT02461589|18735525|P2|Overall Study|Unclassified|0
5426457|NCT02461589|18735526|P1|Overall Study|Unclassified|0
5426458|NCT02461589|18735517|P10|Overall Study|Death|0
5426459|NCT02461589|18735518|P9|Overall Study|Death|0
5426460|NCT02461589|18735519|P8|Overall Study|Death|1
5426461|NCT02461589|18735520|P7|Overall Study|Death|0
5426462|NCT02461589|18735521|P6|Overall Study|Death|0
5426463|NCT02461589|18735522|P5|Overall Study|Death|0
5426464|NCT02461589|18735523|P4|Overall Study|Death|0
5426465|NCT02461589|18735524|P3|Overall Study|Death|0
5426466|NCT02461589|18735525|P2|Overall Study|Death|0
5426467|NCT02461589|18735526|P1|Overall Study|Death|0
5426468|NCT02461589|18735517|P10|Overall Study|Lost to Follow-up|1
5426469|NCT02461589|18735518|P9|Overall Study|Lost to Follow-up|3
5426470|NCT02461589|18735519|P8|Overall Study|Lost to Follow-up|1
5426471|NCT02461589|18735520|P7|Overall Study|Lost to Follow-up|3
5426472|NCT02461589|18735521|P6|Overall Study|Lost to Follow-up|1
5426473|NCT02461589|18735522|P5|Overall Study|Lost to Follow-up|1
5426474|NCT02461589|18735523|P4|Overall Study|Lost to Follow-up|3
5426475|NCT02461589|18735524|P3|Overall Study|Lost to Follow-up|2
5426476|NCT02461589|18735525|P2|Overall Study|Lost to Follow-up|0
5426477|NCT02461589|18735526|P1|Overall Study|Lost to Follow-up|0
5426478|NCT02461589|18735517|P10|Overall Study|Withdrawal by Subject|1
5426479|NCT02461589|18735518|P9|Overall Study|Withdrawal by Subject|3
5426480|NCT02461589|18735519|P8|Overall Study|Withdrawal by Subject|3
5426481|NCT02461589|18735520|P7|Overall Study|Withdrawal by Subject|1
5426482|NCT02461589|18735521|P6|Overall Study|Withdrawal by Subject|2
5426483|NCT02461589|18735522|P5|Overall Study|Withdrawal by Subject|1
5426484|NCT02461589|18735523|P4|Overall Study|Withdrawal by Subject|2
5426485|NCT02461589|18735524|P3|Overall Study|Withdrawal by Subject|3
5426486|NCT02461589|18735525|P2|Overall Study|Withdrawal by Subject|1
5426487|NCT02461589|18735526|P1|Overall Study|Withdrawal by Subject|5
5426488|NCT02461290|18735659|P1|Overall Study|Lost to Follow-up|3
5426489|NCT02461290|18735659|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
5426490|NCT02461160|18735679|P13|Overall Study|Lost to Follow-up|0
5426491|NCT02461160|18735680|P12|Overall Study|Lost to Follow-up|0
5426492|NCT02461160|18735681|P11|Overall Study|Lost to Follow-up|0
5426493|NCT02461160|18735682|P10|Overall Study|Lost to Follow-up|0
5426494|NCT02461160|18735683|P9|Overall Study|Lost to Follow-up|0
5426495|NCT02461160|18735684|P8|Overall Study|Lost to Follow-up|1
5426496|NCT02461160|18735685|P7|Overall Study|Lost to Follow-up|0
5426497|NCT02461160|18735686|P6|Overall Study|Lost to Follow-up|0
5426498|NCT02461160|18735687|P5|Overall Study|Lost to Follow-up|0
5426499|NCT02461160|18735688|P4|Overall Study|Lost to Follow-up|0
5426500|NCT02461160|18735689|P3|Overall Study|Lost to Follow-up|0
5426501|NCT02461160|18735690|P2|Overall Study|Lost to Follow-up|0
5426502|NCT02461160|18735691|P1|Overall Study|Lost to Follow-up|0
5426503|NCT02461134|18735902|P1|Overall Study|Adverse Event|1
5426504|NCT02460991|18735910|P2|Overall Study|Withdrawal by Subject|2
5426505|NCT02460991|18735911|P1|Overall Study|Withdrawal by Subject|0
5426506|NCT02460978|18735928|P3|Overall Study|Pregnancy|2
5426507|NCT02460978|18735929|P2|Overall Study|Pregnancy|0
5426508|NCT02460978|18735930|P1|Overall Study|Pregnancy|0
5426509|NCT02460978|18735928|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
5426510|NCT02460978|18735929|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
5426511|NCT02460978|18735930|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
5426512|NCT02460978|18735928|P3|Overall Study|Protocol Violation|1
5426513|NCT02460978|18735929|P2|Overall Study|Protocol Violation|1
5426514|NCT02460978|18735930|P1|Overall Study|Protocol Violation|1
5426515|NCT02460978|18735928|P3|Overall Study|Lost to Follow-up|1
5426516|NCT02460978|18735929|P2|Overall Study|Lost to Follow-up|3
5426517|NCT02460978|18735930|P1|Overall Study|Lost to Follow-up|2
5426518|NCT02460978|18735928|P3|Overall Study|Withdrawal by Subject|14
5426519|NCT02460978|18735929|P2|Overall Study|Withdrawal by Subject|5
5426520|NCT02460978|18735930|P1|Overall Study|Withdrawal by Subject|5
5426521|NCT02460978|18735928|P3|Overall Study|Adverse Event|11
5426522|NCT02460978|18735929|P2|Overall Study|Adverse Event|11
5426523|NCT02460978|18735930|P1|Overall Study|Adverse Event|17
5426524|NCT02460822|18735956|P1|Overall Study|Withdrawal by Subject|1
5426525|NCT02460679|18735965|P1|Overall Study|Withdrawal by Subject|4
5426526|NCT02460679|18735965|P1|Overall Study|Investigator Decision|1
5426527|NCT02460575|18735990|P2|Overall Study|Lost to Follow-up|0
5426528|NCT02460575|18735991|P1|Overall Study|Lost to Follow-up|1
5426529|NCT02460562|18736001|P2|Overall Study|Lost to Follow-up|16
5426530|NCT02460562|18736002|P1|Overall Study|Lost to Follow-up|15
5426531|NCT02460458|18736010|P1|Confirmation of Clinical Phase Data|Lost to Follow-up|9
5426532|NCT02460458|18736010|P1|First Prospective Phase|Lost to Follow-up|16
5426533|NCT02460458|18736010|P1|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14
5426534|NCT02460458|18736010|P1|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27
5426535|NCT02460458|18736010|P1|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47
5426536|NCT02460380|18736026|P2|Overall Study|Withdrawal by Subject|5
5426537|NCT02460380|18736027|P1|Overall Study|Withdrawal by Subject|10
5426538|NCT02460263|18736047|P1|Transition Period|Death|1
5426539|NCT02460263|18736047|P1|Transition Period|Withdrawal by Subject|1
5426540|NCT02460198|18736060|P2|Overall Study|Ongoing|30
5426541|NCT02460198|18736061|P1|Overall Study|Ongoing|25
5426542|NCT02460198|18736060|P2|Overall Study|Withdrawal by Subject|4
5426543|NCT02460198|18736061|P1|Overall Study|Withdrawal by Subject|2
5426544|NCT02460198|18736060|P2|Overall Study|Lost to Follow-up|1
5426545|NCT02460198|18736061|P1|Overall Study|Lost to Follow-up|1
5426546|NCT02460198|18736060|P2|Overall Study|Death|25
5426547|NCT02460198|18736061|P1|Overall Study|Death|32
5426548|NCT02460198|18736060|P2|Overall Study|Adverse Event|3
5426549|NCT02460198|18736061|P1|Overall Study|Adverse Event|1
5426550|NCT02460159|18736095|P2|Overall Study|Withdrawal by Subject|0
5426551|NCT02460159|18736096|P1|Overall Study|Withdrawal by Subject|2
5426552|NCT02460159|18736095|P2|Overall Study|Adverse Event|1
5426553|NCT02460159|18736096|P1|Overall Study|Adverse Event|4
5426554|NCT02459951|18736124|P1|Overall Study|Unable to meet holding requirement|1
5426555|NCT02459899|18736135|P4|Overall Study|Withdrawal by Subject|0
5426556|NCT02459899|18736136|P3|Overall Study|Withdrawal by Subject|0
5426557|NCT02459899|18736137|P2|Overall Study|Withdrawal by Subject|3
5426558|NCT02459899|18736138|P1|Overall Study|Withdrawal by Subject|1
5426559|NCT02459899|18736135|P4|Overall Study|Non-compliance with the treatment|1
5426560|NCT02459899|18736136|P3|Overall Study|Non-compliance with the treatment|0
5426561|NCT02459899|18736137|P2|Overall Study|Non-compliance with the treatment|0
5426562|NCT02459899|18736138|P1|Overall Study|Non-compliance with the treatment|0
5426563|NCT02459899|18736135|P4|Overall Study|Lost to Follow-up|1
5426564|NCT02459899|18736136|P3|Overall Study|Lost to Follow-up|0
5426565|NCT02459899|18736137|P2|Overall Study|Lost to Follow-up|2
5426566|NCT02459899|18736138|P1|Overall Study|Lost to Follow-up|1
5426567|NCT02459899|18736135|P4|Overall Study|Adverse Event|0
5426568|NCT02459899|18736136|P3|Overall Study|Adverse Event|0
5426569|NCT02459899|18736137|P2|Overall Study|Adverse Event|1
5426570|NCT02459899|18736138|P1|Overall Study|Adverse Event|1
5426571|NCT02459665|18736172|P4|Overall Study|Withdrawal by Subject|2
5426572|NCT02459665|18736173|P3|Overall Study|Withdrawal by Subject|1
5426573|NCT02459665|18736174|P2|Overall Study|Withdrawal by Subject|1
5426574|NCT02459665|18736175|P1|Overall Study|Withdrawal by Subject|0
5426575|NCT02459418|18736206|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
5426576|NCT02459418|18736207|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
5426577|NCT02459418|18736206|P2|Overall Study|Elevated Creatine Kinase|0
5426578|NCT02459418|18736207|P1|Overall Study|Elevated Creatine Kinase|1
5426579|NCT02459418|18736206|P2|Overall Study|Withdrawal by Subject|1
5426580|NCT02459418|18736207|P1|Overall Study|Withdrawal by Subject|1
5426581|NCT02459418|18736206|P2|Overall Study|Adverse Event|1
5426582|NCT02459418|18736207|P1|Overall Study|Adverse Event|0
5426583|NCT02459418|18736206|P2|Overall Study|Endometrial thickness of >5 mm|0
5426584|NCT02459418|18736207|P1|Overall Study|Endometrial thickness of >5 mm|1
5426585|NCT02459418|18736206|P2|Overall Study|Physician Decision|2
5426586|NCT02459418|18736207|P1|Overall Study|Physician Decision|0
5426587|NCT02459418|18736206|P2|Overall Study|Protocol Violation|2
5426588|NCT02459418|18736207|P1|Overall Study|Protocol Violation|0
5426589|NCT02459418|18736206|P2|Overall Study|Exclusion Criteria|0
5426590|NCT02459418|18736207|P1|Overall Study|Exclusion Criteria|4
5426591|NCT02459093|18736273|P2|Overall Study|Lost to Follow-up|7
5426592|NCT02459093|18736274|P1|Overall Study|Lost to Follow-up|6
5426593|NCT02459093|18736273|P2|Overall Study|Protocol Violation|11
5426594|NCT02459093|18736274|P1|Overall Study|Protocol Violation|6
5426595|NCT02458469|18736328|P6|Second Intervention (2 Weeks)|Withdrawal by Subject|1
5426596|NCT02458469|18736329|P5|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5426597|NCT02458469|18736330|P4|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5426598|NCT02458469|18736331|P3|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5426599|NCT02458469|18736332|P2|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5426600|NCT02458469|18736333|P1|Second Intervention (2 Weeks)|Withdrawal by Subject|0
5426601|NCT02458469|18736328|P6|First Intervention (2 Weeks)|Physician Decision|0
5426602|NCT02458469|18736329|P5|First Intervention (2 Weeks)|Physician Decision|0
5426603|NCT02458469|18736330|P4|First Intervention (2 Weeks)|Physician Decision|0
5426604|NCT02458469|18736331|P3|First Intervention (2 Weeks)|Physician Decision|0
5426605|NCT02458469|18736332|P2|First Intervention (2 Weeks)|Physician Decision|0
5426606|NCT02458469|18736333|P1|First Intervention (2 Weeks)|Physician Decision|1
5426607|NCT02458469|18736328|P6|First Intervention (2 Weeks)|Lost to Follow-up|0
5426608|NCT02458469|18736329|P5|First Intervention (2 Weeks)|Lost to Follow-up|0
5426609|NCT02458469|18736330|P4|First Intervention (2 Weeks)|Lost to Follow-up|0
5426610|NCT02458469|18736331|P3|First Intervention (2 Weeks)|Lost to Follow-up|1
5426611|NCT02458469|18736332|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
5426612|NCT02458469|18736333|P1|First Intervention (2 Weeks)|Lost to Follow-up|0
5426613|NCT02458287|18736379|P4|Overall Study|Relocated Out of State|1
5426614|NCT02458287|18736380|P3|Overall Study|Relocated Out of State|0
5426615|NCT02458287|18736381|P2|Overall Study|Relocated Out of State|0
5426616|NCT02458287|18736382|P1|Overall Study|Relocated Out of State|0
5426617|NCT02458287|18736379|P4|Overall Study|Withdrawal by Subject|1
5426618|NCT02458287|18736380|P3|Overall Study|Withdrawal by Subject|2
5426619|NCT02458287|18736381|P2|Overall Study|Withdrawal by Subject|2
5426620|NCT02458287|18736382|P1|Overall Study|Withdrawal by Subject|0
5426621|NCT02458287|18736379|P4|Overall Study|Protocol Violation|0
5426622|NCT02458287|18736380|P3|Overall Study|Protocol Violation|0
5426623|NCT02458287|18736381|P2|Overall Study|Protocol Violation|1
5426624|NCT02458287|18736382|P1|Overall Study|Protocol Violation|0
5426625|NCT02458287|18736379|P4|Overall Study|Lost to Follow-up|0
5426626|NCT02458287|18736380|P3|Overall Study|Lost to Follow-up|1
5426627|NCT02458287|18736381|P2|Overall Study|Lost to Follow-up|1
5426628|NCT02458287|18736382|P1|Overall Study|Lost to Follow-up|0
5426629|NCT02458287|18736379|P4|Overall Study|Adverse Event|1
5426630|NCT02458287|18736380|P3|Overall Study|Adverse Event|0
5426631|NCT02458287|18736381|P2|Overall Study|Adverse Event|0
5426632|NCT02458287|18736382|P1|Overall Study|Adverse Event|0
5426633|NCT02458092|18736440|P2|Overall Study|Withdrawal by Subject|0
5426634|NCT02458092|18736441|P1|Overall Study|Withdrawal by Subject|1
5426635|NCT02457910|18736459|P6|Overall Study|Death|0
5426636|NCT02457910|18736460|P5|Overall Study|Death|0
5426637|NCT02457910|18736461|P4|Overall Study|Death|0
5426638|NCT02457910|18736462|P3|Overall Study|Death|1
5426639|NCT02457910|18736463|P2|Overall Study|Death|0
5426640|NCT02457910|18736464|P1|Overall Study|Death|0
5426641|NCT02457910|18736459|P6|Overall Study|Other complicating illness|1
5426642|NCT02457910|18736460|P5|Overall Study|Other complicating illness|0
5426643|NCT02457910|18736461|P4|Overall Study|Other complicating illness|0
5426644|NCT02457910|18736462|P3|Overall Study|Other complicating illness|0
5426645|NCT02457910|18736463|P2|Overall Study|Other complicating illness|0
5426646|NCT02457910|18736464|P1|Overall Study|Other complicating illness|0
5426647|NCT02457910|18736459|P6|Overall Study|Disease progression|6
5426648|NCT02457910|18736460|P5|Overall Study|Disease progression|4
5426649|NCT02457910|18736461|P4|Overall Study|Disease progression|1
5426650|NCT02457910|18736462|P3|Overall Study|Disease progression|1
5426651|NCT02457910|18736463|P2|Overall Study|Disease progression|3
5426652|NCT02457910|18736464|P1|Overall Study|Disease progression|3
5426653|NCT02457910|18736459|P6|Overall Study|Adverse Event|3
5426654|NCT02457910|18736460|P5|Overall Study|Adverse Event|1
5426655|NCT02457910|18736461|P4|Overall Study|Adverse Event|1
5426656|NCT02457910|18736462|P3|Overall Study|Adverse Event|1
5426657|NCT02457910|18736463|P2|Overall Study|Adverse Event|2
5426658|NCT02457910|18736464|P1|Overall Study|Adverse Event|0
5426659|NCT02457910|18736459|P6|Overall Study|Withdrawal by Subject|1
5426660|NCT02457910|18736460|P5|Overall Study|Withdrawal by Subject|0
5426661|NCT02457910|18736461|P4|Overall Study|Withdrawal by Subject|0
5426662|NCT02457910|18736462|P3|Overall Study|Withdrawal by Subject|0
5426663|NCT02457910|18736463|P2|Overall Study|Withdrawal by Subject|0
5426664|NCT02457910|18736464|P1|Overall Study|Withdrawal by Subject|0
5426665|NCT02457819|18736488|P1|Overall Study|Adverse Event|33
5426666|NCT02457819|18736488|P1|Overall Study|Lack of Efficacy|19
5426667|NCT02457819|18736488|P1|Overall Study|Lost to Follow-up|10
5426668|NCT02457819|18736488|P1|Overall Study|non compliance with study drug|4
5426669|NCT02457819|18736488|P1|Overall Study|Protocol Violation|1
5426670|NCT02457819|18736488|P1|Overall Study|Withdrawal by Subject|24
5426671|NCT02457819|18736488|P1|Overall Study|reason not given|8
5426672|NCT02457793|18736500|P6|Overall Study|Physician Decision|3
5426673|NCT02457793|18736501|P5|Overall Study|Physician Decision|1
5426674|NCT02457793|18736502|P4|Overall Study|Physician Decision|1
5426675|NCT02457793|18736503|P3|Overall Study|Physician Decision|1
5426676|NCT02457793|18736504|P2|Overall Study|Physician Decision|0
5426677|NCT02457793|18736505|P1|Overall Study|Physician Decision|1
5426678|NCT02457793|18736500|P6|Overall Study|Adverse Event|0
5426679|NCT02457793|18736501|P5|Overall Study|Adverse Event|0
5426680|NCT02457793|18736502|P4|Overall Study|Adverse Event|1
5426681|NCT02457793|18736503|P3|Overall Study|Adverse Event|0
5426682|NCT02457793|18736504|P2|Overall Study|Adverse Event|0
5426683|NCT02457793|18736505|P1|Overall Study|Adverse Event|0
5426684|NCT02457793|18736500|P6|Overall Study|Withdrawal by Subject|2
5426685|NCT02457793|18736501|P5|Overall Study|Withdrawal by Subject|2
5426686|NCT02457793|18736502|P4|Overall Study|Withdrawal by Subject|2
5426687|NCT02457793|18736503|P3|Overall Study|Withdrawal by Subject|2
5426688|NCT02457793|18736504|P2|Overall Study|Withdrawal by Subject|4
5426689|NCT02457793|18736505|P1|Overall Study|Withdrawal by Subject|0
5426690|NCT02457793|18736500|P6|Overall Study|Reason not specified|1
5426691|NCT02457793|18736501|P5|Overall Study|Reason not specified|1
5426692|NCT02457793|18736502|P4|Overall Study|Reason not specified|1
5426693|NCT02457793|18736503|P3|Overall Study|Reason not specified|0
5426694|NCT02457793|18736504|P2|Overall Study|Reason not specified|0
5426695|NCT02457793|18736505|P1|Overall Study|Reason not specified|0
5426696|NCT02457637|18736649|P1|Clinic or Telephone Follow-up|Lost to Follow-up|71
5426697|NCT02457611|18736657|P1|Overall Study|Lost to Follow-up|3
5426698|NCT02457546|18736671|P2|Overall Study|Adverse Event|1
5426699|NCT02457546|18736672|P1|Overall Study|Adverse Event|0
5426700|NCT02457546|18736671|P2|Overall Study|Lost to Follow-up|1
5426701|NCT02457546|18736672|P1|Overall Study|Lost to Follow-up|4
5426702|NCT02457546|18736671|P2|Overall Study|Refused to complete study/procedures|1
5426703|NCT02457546|18736672|P1|Overall Study|Refused to complete study/procedures|1
5426704|NCT02457546|18736671|P2|Overall Study|Other reasons|1
5426705|NCT02457546|18736672|P1|Overall Study|Other reasons|4
5426706|NCT02457325|18736682|P2|First Intervention (1 Day)|Lost to Follow-up|2
5426707|NCT02457325|18736683|P1|First Intervention (1 Day)|Lost to Follow-up|2
5426708|NCT02457247|18736756|P4|Period 2|Voluntary Withdrawal|0
5426709|NCT02457247|18736757|P3|Period 2|Voluntary Withdrawal|0
5426710|NCT02457247|18736758|P2|Period 2|Voluntary Withdrawal|1
5426711|NCT02457247|18736759|P1|Period 2|Voluntary Withdrawal|1
5426712|NCT02457247|18736756|P4|Period 2|Lost to Follow-up|0
5426713|NCT02457247|18736757|P3|Period 2|Lost to Follow-up|0
5426714|NCT02457247|18736758|P2|Period 2|Lost to Follow-up|1
5426715|NCT02457247|18736759|P1|Period 2|Lost to Follow-up|0
5426716|NCT02457247|18736756|P4|Period 2|Significant Protocol Deviation|0
5426717|NCT02457247|18736757|P3|Period 2|Significant Protocol Deviation|0
5426718|NCT02457247|18736758|P2|Period 2|Significant Protocol Deviation|0
5426719|NCT02457247|18736759|P1|Period 2|Significant Protocol Deviation|1
5426720|NCT02457247|18736756|P4|Period 2|Pretreatment Event/Adverse Event|0
5426721|NCT02457247|18736757|P3|Period 2|Pretreatment Event/Adverse Event|0
5426722|NCT02457247|18736758|P2|Period 2|Pretreatment Event/Adverse Event|1
5426723|NCT02457247|18736759|P1|Period 2|Pretreatment Event/Adverse Event|0
5426724|NCT02457247|18736756|P4|Period 1|Voluntary Withdrawal|0
5426725|NCT02457247|18736757|P3|Period 1|Voluntary Withdrawal|0
5426726|NCT02457247|18736758|P2|Period 1|Voluntary Withdrawal|0
5426727|NCT02457247|18736759|P1|Period 1|Voluntary Withdrawal|1
5426728|NCT02457247|18736756|P4|Period 1|Significant Protocol Deviation|0
5426729|NCT02457247|18736757|P3|Period 1|Significant Protocol Deviation|0
5426730|NCT02457247|18736758|P2|Period 1|Significant Protocol Deviation|1
5426731|NCT02457247|18736759|P1|Period 1|Significant Protocol Deviation|1
5426732|NCT02457247|18736756|P4|Period 1|Pretreatment Event/Adverse Event|0
5426733|NCT02457247|18736757|P3|Period 1|Pretreatment Event/Adverse Event|0
5426734|NCT02457247|18736758|P2|Period 1|Pretreatment Event/Adverse Event|1
5426735|NCT02457247|18736759|P1|Period 1|Pretreatment Event/Adverse Event|0
5426736|NCT02457195|18736779|P1|Overall Study|Withdrawal by Subject|4
5426737|NCT02457195|18736779|P1|Overall Study|Protocol Violation|2
5426738|NCT02457195|18736779|P1|Overall Study|Adverse Event|3
5426739|NCT02457182|18736785|P2|Overall Study|Lost to Follow-up|0
5426740|NCT02457182|18736786|P1|Overall Study|Lost to Follow-up|1
5426741|NCT02457065|18736804|P2|Overall Study|Lost to Follow-up|11
5426742|NCT02457065|18736805|P1|Overall Study|Lost to Follow-up|9
5426743|NCT02456740|18736827|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
5426744|NCT02456740|18736828|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
5426745|NCT02456740|18736829|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
5426746|NCT02456740|18736830|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
5426747|NCT02456740|18736831|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
5426748|NCT02456740|18736832|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
5426749|NCT02456740|18736833|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5426750|NCT02456740|18736834|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5426751|NCT02456740|18736835|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5426752|NCT02456740|18736827|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
5426753|NCT02456740|18736828|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
5426754|NCT02456740|18736829|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
5426755|NCT02456740|18736830|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
5426756|NCT02456740|18736831|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
5426757|NCT02456740|18736832|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
5426758|NCT02456740|18736833|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
5426759|NCT02456740|18736834|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
5426760|NCT02456740|18736835|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
5426761|NCT02456740|18736827|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
5426762|NCT02456740|18736828|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
5426763|NCT02456740|18736829|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
5426764|NCT02456740|18736830|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
5426765|NCT02456740|18736831|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
5426766|NCT02456740|18736832|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
5426767|NCT02456740|18736833|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5426768|NCT02456740|18736834|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5426769|NCT02456740|18736835|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5426770|NCT02456740|18736827|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
5426771|NCT02456740|18736828|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5426772|NCT02456740|18736829|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5426773|NCT02456740|18736830|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5426774|NCT02456740|18736831|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
5426775|NCT02456740|18736832|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
5426776|NCT02456740|18736833|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5426777|NCT02456740|18736834|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5426778|NCT02456740|18736835|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
5426779|NCT02456740|18736827|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5426780|NCT02456740|18736828|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5426781|NCT02456740|18736829|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5426782|NCT02456740|18736830|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5426783|NCT02456740|18736831|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5426784|NCT02456740|18736832|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
5426785|NCT02456740|18736833|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
5426786|NCT02456740|18736834|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
5426787|NCT02456740|18736835|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
5426788|NCT02456740|18736827|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5426789|NCT02456740|18736828|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5426790|NCT02456740|18736829|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5426791|NCT02456740|18736830|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5426792|NCT02456740|18736831|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5426793|NCT02456740|18736832|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
5426794|NCT02456740|18736833|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
5426795|NCT02456740|18736834|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
5426796|NCT02456740|18736835|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
5426797|NCT02456740|18736827|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5426798|NCT02456740|18736828|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5426799|NCT02456740|18736829|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5426800|NCT02456740|18736830|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5426801|NCT02456740|18736831|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5426802|NCT02456740|18736832|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
5426803|NCT02456740|18736833|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
5426804|NCT02456740|18736834|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
5426805|NCT02456740|18736835|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
5426806|NCT02456727|18736859|P2|Overall Study|Never Initiated Treatment|30
5426807|NCT02456727|18736860|P1|Overall Study|Never Initiated Treatment|43
5426808|NCT02456727|18736859|P2|Overall Study|Withdrawal by Subject|10
5426809|NCT02456727|18736860|P1|Overall Study|Withdrawal by Subject|1
5426810|NCT02456727|18736859|P2|Overall Study|Death|1
5426811|NCT02456727|18736860|P1|Overall Study|Death|2
5426812|NCT02456727|18736859|P2|Overall Study|Lost to Follow-up|65
5426813|NCT02456727|18736860|P1|Overall Study|Lost to Follow-up|63
5426814|NCT02456662|18736942|P2|Overall Study|Lost to Follow-up|1
5426815|NCT02456662|18736943|P1|Overall Study|Lost to Follow-up|2
5426816|NCT02456636|18736952|P3|Overall Study|Lost to Follow-up|50
5426817|NCT02456636|18736953|P2|Overall Study|Lost to Follow-up|44
5426818|NCT02456636|18736954|P1|Overall Study|Lost to Follow-up|50
5426819|NCT02456636|18736952|P3|Overall Study|Withdrawal by Subject|16
5426820|NCT02456636|18736953|P2|Overall Study|Withdrawal by Subject|14
5426821|NCT02456636|18736954|P1|Overall Study|Withdrawal by Subject|13
5426822|NCT02456636|18736952|P3|Overall Study|Physician Decision|4
5426823|NCT02456636|18736953|P2|Overall Study|Physician Decision|5
5426824|NCT02456636|18736954|P1|Overall Study|Physician Decision|4
5426825|NCT02456636|18736952|P3|Overall Study|Pregnancy|5
5426826|NCT02456636|18736953|P2|Overall Study|Pregnancy|3
5426827|NCT02456636|18736954|P1|Overall Study|Pregnancy|1
5426828|NCT02456636|18736952|P3|Overall Study|Death|0
5426829|NCT02456636|18736953|P2|Overall Study|Death|3
5426830|NCT02456636|18736954|P1|Overall Study|Death|0
5426831|NCT02456103|18737004|P1|Overall Study|Withdrawal by Subject|24
5426832|NCT02456103|18737004|P1|Overall Study|Lost to Follow-up|1
5426833|NCT02456103|18737004|P1|Overall Study|Abnormal Laboratory Value|2
5426834|NCT02456103|18737004|P1|Overall Study|Adverse Event|5
5426835|NCT02456103|18737004|P1|Overall Study|Protocol Violation|1
5426836|NCT02456103|18737004|P1|Overall Study|Required prohibited medications|5
5426837|NCT02456103|18737004|P1|Overall Study|Physician Decision|1
5426838|NCT02456103|18737004|P1|Overall Study|Study Closure|207
5426839|NCT02455518|18737017|P4|Overall Study|Protocol Violation|3
5426840|NCT02455518|18737018|P3|Overall Study|Protocol Violation|1
5426841|NCT02455518|18737019|P2|Overall Study|Protocol Violation|1
5426842|NCT02455518|18737020|P1|Overall Study|Protocol Violation|0
5426843|NCT02455388|18737042|P3|Overall Study|Withdrawal by Subject|7
5426844|NCT02455388|18737043|P2|Overall Study|Withdrawal by Subject|0
5426845|NCT02455388|18737044|P1|Overall Study|Withdrawal by Subject|0
5426846|NCT02455388|18737042|P3|Overall Study|Protocol Violation|4
5426847|NCT02455388|18737043|P2|Overall Study|Protocol Violation|0
5426848|NCT02455388|18737044|P1|Overall Study|Protocol Violation|1
5426849|NCT02455336|18737055|P2|Overall Study|Non-responder to treatment|0
5426850|NCT02455336|18737056|P1|Overall Study|Non-responder to treatment|2
5426851|NCT02455336|18737055|P2|Overall Study|Adverse Event|0
5426852|NCT02455336|18737056|P1|Overall Study|Adverse Event|3
5426853|NCT02455336|18737055|P2|Overall Study|Withdrawal by Subject|2
5426854|NCT02455336|18737056|P1|Overall Study|Withdrawal by Subject|0
5426855|NCT02455076|18737071|P5|Outpatient|Lost to Follow-up|12
5426856|NCT02455076|18737072|P4|Outpatient|Lost to Follow-up|1
5426857|NCT02455076|18737073|P3|Outpatient|Lost to Follow-up|0
5426858|NCT02455076|18737074|P2|Outpatient|Lost to Follow-up|0
5426859|NCT02455076|18737075|P1|Outpatient|Lost to Follow-up|0
5426860|NCT02455076|18737071|P5|Outpatient|Adverse Event|0
5426861|NCT02455076|18737072|P4|Outpatient|Adverse Event|5
5426862|NCT02455076|18737073|P3|Outpatient|Adverse Event|0
5426863|NCT02455076|18737074|P2|Outpatient|Adverse Event|0
5426864|NCT02455076|18737075|P1|Outpatient|Adverse Event|0
5426865|NCT02455076|18737071|P5|Inpatient|Adverse Event|0
5426866|NCT02455076|18737072|P4|Inpatient|Adverse Event|0
5426867|NCT02455076|18737073|P3|Inpatient|Adverse Event|0
5426868|NCT02455076|18737074|P2|Inpatient|Adverse Event|0
5426869|NCT02455076|18737075|P1|Inpatient|Adverse Event|3
5426870|NCT02455076|18737071|P5|Inpatient|Discharged <24 h after admission|0
5426871|NCT02455076|18737072|P4|Inpatient|Discharged <24 h after admission|0
5426872|NCT02455076|18737073|P3|Inpatient|Discharged <24 h after admission|0
5426873|NCT02455076|18737074|P2|Inpatient|Discharged <24 h after admission|1
5426874|NCT02455076|18737075|P1|Inpatient|Discharged <24 h after admission|0
5426875|NCT02455076|18737071|P5|Inpatient|Withdrawal by Subject|0
5426876|NCT02455076|18737072|P4|Inpatient|Withdrawal by Subject|0
5426877|NCT02455076|18737073|P3|Inpatient|Withdrawal by Subject|0
5426878|NCT02455076|18737074|P2|Inpatient|Withdrawal by Subject|0
5426879|NCT02455076|18737075|P1|Inpatient|Withdrawal by Subject|1
5426880|NCT02455050|18737161|P4|Treatment Period 2|Lost to Follow-up|1
5426881|NCT02455050|18737162|P3|Treatment Period 2|Lost to Follow-up|2
5426882|NCT02455050|18737163|P2|Treatment Period 2|Lost to Follow-up|0
5426883|NCT02455050|18737164|P1|Treatment Period 2|Lost to Follow-up|1
5426884|NCT02455050|18737161|P4|Treatment Period 1|Lost to Follow-up|2
5426885|NCT02455050|18737162|P3|Treatment Period 1|Lost to Follow-up|1
5426886|NCT02455050|18737163|P2|Treatment Period 1|Lost to Follow-up|1
5426887|NCT02455050|18737164|P1|Treatment Period 1|Lost to Follow-up|1
5426888|NCT02454959|18737228|P1|Overall Study|Adverse Event|2
5426889|NCT02454959|18737228|P1|Overall Study|Withdrawal by Subject|3
5426890|NCT02454959|18737228|P1|Overall Study|Physician Decision|1
5426891|NCT02454959|18737228|P1|Overall Study|Protocol-Specified Criteria|3
5426892|NCT02454933|18737248|P2|Overall Study|Withdrawal by Subject|2
5426893|NCT02454933|18737249|P1|Overall Study|Withdrawal by Subject|0
5426894|NCT02454933|18737248|P2|Overall Study|Adverse Event|1
5426895|NCT02454933|18737249|P1|Overall Study|Adverse Event|1
5426896|NCT02454933|18737248|P2|Overall Study|Progressive disease|5
5426897|NCT02454933|18737249|P1|Overall Study|Progressive disease|7
5426898|NCT02454608|18737257|P3|Open Label Period|Withdrawal by Subject|8
5426899|NCT02454608|18737258|P2|Open Label Period|Withdrawal by Subject|0
5426900|NCT02454608|18737259|P1|Open Label Period|Withdrawal by Subject|0
5426901|NCT02454608|18737257|P3|Open Label Period|Lost to Follow-up|11
5426902|NCT02454608|18737258|P2|Open Label Period|Lost to Follow-up|0
5426903|NCT02454608|18737259|P1|Open Label Period|Lost to Follow-up|0
5426904|NCT02454608|18737257|P3|Double-Blind Period|Lack of Efficacy|0
5426905|NCT02454608|18737258|P2|Double-Blind Period|Lack of Efficacy|2
5426906|NCT02454608|18737259|P1|Double-Blind Period|Lack of Efficacy|0
5426907|NCT02454530|18737282|P2|Overall Study|Lost to Follow-up|4
5426908|NCT02454530|18737283|P1|Overall Study|Lost to Follow-up|4
5426909|NCT02454530|18737282|P2|Overall Study|Death|41
5426910|NCT02454530|18737283|P1|Overall Study|Death|2
5426911|NCT02454530|18737282|P2|Overall Study|Missing information|69
5426912|NCT02454530|18737283|P1|Overall Study|Missing information|56
5426913|NCT02454530|18737282|P2|Overall Study|Other|13
5426914|NCT02454530|18737283|P1|Overall Study|Other|8
5426915|NCT02454478|18737320|P1|Overall Study|Incomplete DLT Evaluation|1
5426916|NCT02454101|18737414|P2|Overall Study|Lost to Follow-up|4
5426917|NCT02454101|18737415|P1|Overall Study|Lost to Follow-up|3
5426918|NCT02454101|18737414|P2|Overall Study|Adverse Event|3
5426919|NCT02454101|18737415|P1|Overall Study|Adverse Event|2
5426920|NCT02453841|18737437|P1|Overall Study|Unable to obtain blood samples|2
5426921|NCT02453841|18737437|P1|Overall Study|Protocol Violation|1
5426922|NCT02453711|18737460|P9|Overall Study|Unclassified|0
5426923|NCT02453711|18737461|P8|Overall Study|Unclassified|0
5426924|NCT02453711|18737462|P7|Overall Study|Unclassified|0
5426925|NCT02453711|18737463|P6|Overall Study|Unclassified|0
5426926|NCT02453711|18737464|P5|Overall Study|Unclassified|0
5426927|NCT02453711|18737465|P4|Overall Study|Unclassified|0
5426928|NCT02453711|18737466|P3|Overall Study|Unclassified|1
5426929|NCT02453711|18737467|P2|Overall Study|Unclassified|0
5426930|NCT02453711|18737468|P1|Overall Study|Unclassified|1
5426931|NCT02453711|18737460|P9|Overall Study|Death|0
5426932|NCT02453711|18737461|P8|Overall Study|Death|0
5426933|NCT02453711|18737462|P7|Overall Study|Death|1
5426934|NCT02453711|18737463|P6|Overall Study|Death|0
5426935|NCT02453711|18737464|P5|Overall Study|Death|0
5426936|NCT02453711|18737465|P4|Overall Study|Death|0
5426937|NCT02453711|18737466|P3|Overall Study|Death|0
5426938|NCT02453711|18737467|P2|Overall Study|Death|0
5426939|NCT02453711|18737468|P1|Overall Study|Death|0
5426940|NCT02453711|18737460|P9|Overall Study|Lost to Follow-up|6
5426941|NCT02453711|18737461|P8|Overall Study|Lost to Follow-up|6
5426942|NCT02453711|18737462|P7|Overall Study|Lost to Follow-up|2
5426943|NCT02453711|18737463|P6|Overall Study|Lost to Follow-up|5
5426944|NCT02453711|18737464|P5|Overall Study|Lost to Follow-up|1
5426945|NCT02453711|18737465|P4|Overall Study|Lost to Follow-up|3
5426946|NCT02453711|18737466|P3|Overall Study|Lost to Follow-up|2
5426947|NCT02453711|18737467|P2|Overall Study|Lost to Follow-up|3
5426948|NCT02453711|18737468|P1|Overall Study|Lost to Follow-up|5
5426949|NCT02453711|18737460|P9|Overall Study|Withdrawal by Subject|7
5426950|NCT02453711|18737461|P8|Overall Study|Withdrawal by Subject|1
5426951|NCT02453711|18737462|P7|Overall Study|Withdrawal by Subject|0
5426952|NCT02453711|18737463|P6|Overall Study|Withdrawal by Subject|1
5426953|NCT02453711|18737464|P5|Overall Study|Withdrawal by Subject|1
5426954|NCT02453711|18737465|P4|Overall Study|Withdrawal by Subject|4
5426955|NCT02453711|18737466|P3|Overall Study|Withdrawal by Subject|6
5426956|NCT02453711|18737467|P2|Overall Study|Withdrawal by Subject|4
5426957|NCT02453711|18737468|P1|Overall Study|Withdrawal by Subject|5
5426958|NCT02453685|18737812|P2|Overall Study|Unclassified|2
5426959|NCT02453685|18737813|P1|Overall Study|Unclassified|4
5426960|NCT02453685|18737812|P2|Overall Study|Withdrawal by Subject|4
5426961|NCT02453685|18737813|P1|Overall Study|Withdrawal by Subject|8
5426962|NCT02453685|18737812|P2|Overall Study|Lost to Follow-up|1
5426963|NCT02453685|18737813|P1|Overall Study|Lost to Follow-up|0
5426964|NCT02453685|18737812|P2|Overall Study|Protocol Violation|4
5426965|NCT02453685|18737813|P1|Overall Study|Protocol Violation|7
5426966|NCT02453685|18737812|P2|Overall Study|Adverse Event|1
5426967|NCT02453685|18737813|P1|Overall Study|Adverse Event|0
5426968|NCT02453555|18737871|P6|Extension Period|Withdrawal by Subject|0
5426969|NCT02453555|18737872|P5|Extension Period|Withdrawal by Subject|0
5426970|NCT02453555|18737873|P4|Extension Period|Withdrawal by Subject|0
5426971|NCT02453555|18737874|P3|Extension Period|Withdrawal by Subject|1
5426972|NCT02453555|18737875|P2|Extension Period|Withdrawal by Subject|0
5426973|NCT02453555|18737876|P1|Extension Period|Withdrawal by Subject|0
5426974|NCT02453555|18737871|P6|Extension Period|Protocol Violation|0
5426975|NCT02453555|18737872|P5|Extension Period|Protocol Violation|0
5426976|NCT02453555|18737873|P4|Extension Period|Protocol Violation|0
5426977|NCT02453555|18737874|P3|Extension Period|Protocol Violation|1
5426978|NCT02453555|18737875|P2|Extension Period|Protocol Violation|0
5426979|NCT02453555|18737876|P1|Extension Period|Protocol Violation|0
5426980|NCT02453555|18737871|P6|Extension Period|Adverse Event|1
5426981|NCT02453555|18737872|P5|Extension Period|Adverse Event|1
5426982|NCT02453555|18737873|P4|Extension Period|Adverse Event|2
5426983|NCT02453555|18737874|P3|Extension Period|Adverse Event|1
5426984|NCT02453555|18737875|P2|Extension Period|Adverse Event|0
5426985|NCT02453555|18737876|P1|Extension Period|Adverse Event|0
5426986|NCT02453555|18737871|P6|24-week Double-blind Treatment Period|Other than specified above|0
5426987|NCT02453555|18737872|P5|24-week Double-blind Treatment Period|Other than specified above|0
5426988|NCT02453555|18737873|P4|24-week Double-blind Treatment Period|Other than specified above|0
5426989|NCT02453555|18737874|P3|24-week Double-blind Treatment Period|Other than specified above|0
5426990|NCT02453555|18737875|P2|24-week Double-blind Treatment Period|Other than specified above|3
5426991|NCT02453555|18737876|P1|24-week Double-blind Treatment Period|Other than specified above|0
5426992|NCT02453555|18737871|P6|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5426993|NCT02453555|18737872|P5|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5426994|NCT02453555|18737873|P4|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5426995|NCT02453555|18737874|P3|24-week Double-blind Treatment Period|Withdrawal by Subject|0
5426996|NCT02453555|18737875|P2|24-week Double-blind Treatment Period|Withdrawal by Subject|4
5426997|NCT02453555|18737876|P1|24-week Double-blind Treatment Period|Withdrawal by Subject|2
5426998|NCT02453555|18737871|P6|24-week Double-blind Treatment Period|Lost to Follow-up|0
5426999|NCT02453555|18737872|P5|24-week Double-blind Treatment Period|Lost to Follow-up|0
5427000|NCT02453555|18737873|P4|24-week Double-blind Treatment Period|Lost to Follow-up|0
5427001|NCT02453555|18737874|P3|24-week Double-blind Treatment Period|Lost to Follow-up|0
5427002|NCT02453555|18737875|P2|24-week Double-blind Treatment Period|Lost to Follow-up|0
5427003|NCT02453555|18737876|P1|24-week Double-blind Treatment Period|Lost to Follow-up|1
5427004|NCT02453555|18737871|P6|24-week Double-blind Treatment Period|Adverse Event|0
5427005|NCT02453555|18737872|P5|24-week Double-blind Treatment Period|Adverse Event|0
5427006|NCT02453555|18737873|P4|24-week Double-blind Treatment Period|Adverse Event|0
5427007|NCT02453555|18737874|P3|24-week Double-blind Treatment Period|Adverse Event|0
5427008|NCT02453555|18737875|P2|24-week Double-blind Treatment Period|Adverse Event|0
5427009|NCT02453555|18737876|P1|24-week Double-blind Treatment Period|Adverse Event|2
5427010|NCT02453386|18737892|P3|Overall Study|Other|1
5427011|NCT02453386|18737893|P2|Overall Study|Other|0
5427012|NCT02453386|18737894|P1|Overall Study|Other|1
5427013|NCT02453386|18737892|P3|Overall Study|Lost to Follow-up|1
5427014|NCT02453386|18737893|P2|Overall Study|Lost to Follow-up|0
5427015|NCT02453386|18737894|P1|Overall Study|Lost to Follow-up|0
5427016|NCT02453386|18737892|P3|Overall Study|Sponsor Terminated by Investigator|2
5427017|NCT02453386|18737893|P2|Overall Study|Sponsor Terminated by Investigator|1
5427018|NCT02453386|18737894|P1|Overall Study|Sponsor Terminated by Investigator|0
5427019|NCT02453386|18737892|P3|Overall Study|Subject Terminated by Sponsor|1
5427020|NCT02453386|18737893|P2|Overall Study|Subject Terminated by Sponsor|1
5427021|NCT02453386|18737894|P1|Overall Study|Subject Terminated by Sponsor|1
5427022|NCT02453386|18737892|P3|Overall Study|Sponsor Terminated Study|11
5427023|NCT02453386|18737893|P2|Overall Study|Sponsor Terminated Study|8
5427024|NCT02453386|18737894|P1|Overall Study|Sponsor Terminated Study|14
5427025|NCT02453386|18737892|P3|Overall Study|Withdrawal by Subject|9
5427026|NCT02453386|18737893|P2|Overall Study|Withdrawal by Subject|9
5427027|NCT02453386|18737894|P1|Overall Study|Withdrawal by Subject|10
5427028|NCT02453386|18737892|P3|Overall Study|Protocol Violation|1
5427029|NCT02453386|18737893|P2|Overall Study|Protocol Violation|0
5427030|NCT02453386|18737894|P1|Overall Study|Protocol Violation|1
5427031|NCT02453386|18737892|P3|Overall Study|Adverse Event|15
5427032|NCT02453386|18737893|P2|Overall Study|Adverse Event|30
5427033|NCT02453386|18737894|P1|Overall Study|Adverse Event|22
5427034|NCT02453321|18737958|P3|Overall Study|Deep Venous Thrombosis|0
5427035|NCT02453321|18737959|P2|Overall Study|Deep Venous Thrombosis|1
5427036|NCT02453321|18737960|P1|Overall Study|Deep Venous Thrombosis|0
5427037|NCT02453321|18737958|P3|Overall Study|Weakness|2
5427038|NCT02453321|18737959|P2|Overall Study|Weakness|1
5427039|NCT02453321|18737960|P1|Overall Study|Weakness|1
5427040|NCT02453282|18737980|P3|Overall Study|Other|1
5427041|NCT02453282|18737981|P2|Overall Study|Other|1
5427042|NCT02453282|18737982|P1|Overall Study|Other|1
5427043|NCT02453282|18737980|P3|Overall Study|Participants ongoing at data cut-off|62
5427044|NCT02453282|18737981|P2|Overall Study|Participants ongoing at data cut-off|84
5427045|NCT02453282|18737982|P1|Overall Study|Participants ongoing at data cut-off|85
5427046|NCT02453282|18737980|P3|Overall Study|Withdrawal by Subject|11
5427047|NCT02453282|18737981|P2|Overall Study|Withdrawal by Subject|10
5427048|NCT02453282|18737982|P1|Overall Study|Withdrawal by Subject|12
5427049|NCT02453282|18737980|P3|Overall Study|Lost to Follow-up|2
5427050|NCT02453282|18737981|P2|Overall Study|Lost to Follow-up|0
5427051|NCT02453282|18737982|P1|Overall Study|Lost to Follow-up|1
5427052|NCT02453282|18737980|P3|Overall Study|Death|296
5427053|NCT02453282|18737981|P2|Overall Study|Death|277
5427054|NCT02453282|18737982|P1|Overall Study|Death|275
5427055|NCT02453256|18738063|P2|Open Label Period|Withdrawal by Subject|1
5427056|NCT02453256|18738064|P1|Open Label Period|Withdrawal by Subject|5
5427057|NCT02453256|18738063|P2|Open Label Period|Other|2
5427058|NCT02453256|18738064|P1|Open Label Period|Other|0
5427059|NCT02453256|18738063|P2|Open Label Period|Lost to Follow-up|0
5427060|NCT02453256|18738064|P1|Open Label Period|Lost to Follow-up|1
5427061|NCT02453256|18738063|P2|Open Label Period|Death|1
5427062|NCT02453256|18738064|P1|Open Label Period|Death|0
5427063|NCT02453256|18738063|P2|Open Label Period|Adverse Event|3
5427064|NCT02453256|18738064|P1|Open Label Period|Adverse Event|1
5427065|NCT02453256|18738063|P2|Double Blind Period|Other|1
5427066|NCT02453256|18738064|P1|Double Blind Period|Other|0
5427067|NCT02453256|18738063|P2|Double Blind Period|Withdrawal by Subject|5
5427068|NCT02453256|18738064|P1|Double Blind Period|Withdrawal by Subject|9
5427069|NCT02453256|18738063|P2|Double Blind Period|Adverse Event|2
5427070|NCT02453256|18738064|P1|Double Blind Period|Adverse Event|3
5427071|NCT02453256|18738063|P2|Double Blind Period|Death|1
5427072|NCT02453256|18738064|P1|Double Blind Period|Death|1
5427073|NCT02453191|18738184|P1|Overall Study|Withdrawal by Subject|1
5427074|NCT02453048|18738201|P5|Overall Study|Lost to Follow-up|0
5427075|NCT02453048|18738202|P4|Overall Study|Lost to Follow-up|0
5427076|NCT02453048|18738203|P3|Overall Study|Lost to Follow-up|2
5427077|NCT02453048|18738204|P2|Overall Study|Lost to Follow-up|1
5427078|NCT02453048|18738205|P1|Overall Study|Lost to Follow-up|0
5427079|NCT02453048|18738201|P5|Overall Study|Only part of initial 6 mo. study|6
5427080|NCT02453048|18738202|P4|Overall Study|Only part of initial 6 mo. study|0
5427081|NCT02453048|18738203|P3|Overall Study|Only part of initial 6 mo. study|0
5427082|NCT02453048|18738204|P2|Overall Study|Only part of initial 6 mo. study|0
5427083|NCT02453048|18738205|P1|Overall Study|Only part of initial 6 mo. study|0
5427084|NCT02452892|18738265|P4|Follow-up|Subject left town on Day 42|0
5427085|NCT02452892|18738266|P3|Follow-up|Subject left town on Day 42|0
5427086|NCT02452892|18738267|P2|Follow-up|Subject left town on Day 42|0
5427087|NCT02452892|18738268|P1|Follow-up|Subject left town on Day 42|1
5427088|NCT02452892|18738265|P4|Follow-up|Withdrawal by Subject|1
5427089|NCT02452892|18738266|P3|Follow-up|Withdrawal by Subject|0
5427090|NCT02452892|18738267|P2|Follow-up|Withdrawal by Subject|0
5427091|NCT02452892|18738268|P1|Follow-up|Withdrawal by Subject|0
5427092|NCT02452892|18738265|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5427093|NCT02452892|18738266|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5427094|NCT02452892|18738267|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
5427095|NCT02452892|18738268|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
5427096|NCT02452892|18738265|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
5427097|NCT02452892|18738266|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5427098|NCT02452892|18738267|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5427099|NCT02452892|18738268|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
5427100|NCT02452892|18738265|P4|Week 1 Initial Randommization|Lost to Follow-up|0
5427101|NCT02452892|18738266|P3|Week 1 Initial Randommization|Lost to Follow-up|1
5427102|NCT02452892|18738267|P2|Week 1 Initial Randommization|Lost to Follow-up|0
5427103|NCT02452892|18738268|P1|Week 1 Initial Randommization|Lost to Follow-up|0
5427104|NCT02452892|18738265|P4|Week 1 Initial Randommization|Adverse Event|0
5427105|NCT02452892|18738266|P3|Week 1 Initial Randommization|Adverse Event|0
5427106|NCT02452892|18738267|P2|Week 1 Initial Randommization|Adverse Event|0
5427107|NCT02452892|18738268|P1|Week 1 Initial Randommization|Adverse Event|1
5427108|NCT02452554|18738303|P6|Overall Study|Never Received Treatment|0
5427109|NCT02452554|18738304|P5|Overall Study|Never Received Treatment|0
5427110|NCT02452554|18738305|P4|Overall Study|Never Received Treatment|0
5427111|NCT02452554|18738306|P3|Overall Study|Never Received Treatment|0
5427112|NCT02452554|18738307|P2|Overall Study|Never Received Treatment|0
5427113|NCT02452554|18738308|P1|Overall Study|Never Received Treatment|1
5427114|NCT02452554|18738303|P6|Overall Study|Ineligible|0
5427115|NCT02452554|18738304|P5|Overall Study|Ineligible|0
5427116|NCT02452554|18738305|P4|Overall Study|Ineligible|0
5427117|NCT02452554|18738306|P3|Overall Study|Ineligible|0
5427118|NCT02452554|18738307|P2|Overall Study|Ineligible|1
5427119|NCT02452554|18738308|P1|Overall Study|Ineligible|0
5427120|NCT02452554|18738303|P6|Overall Study|Withdrawal by Subject|1
5427121|NCT02452554|18738304|P5|Overall Study|Withdrawal by Subject|0
5427122|NCT02452554|18738305|P4|Overall Study|Withdrawal by Subject|0
5427123|NCT02452554|18738306|P3|Overall Study|Withdrawal by Subject|2
5427124|NCT02452554|18738307|P2|Overall Study|Withdrawal by Subject|0
5427125|NCT02452554|18738308|P1|Overall Study|Withdrawal by Subject|1
5427126|NCT02452554|18738303|P6|Overall Study|Physician Decision|0
5427127|NCT02452554|18738304|P5|Overall Study|Physician Decision|0
5427128|NCT02452554|18738305|P4|Overall Study|Physician Decision|0
5427129|NCT02452554|18738306|P3|Overall Study|Physician Decision|0
5427130|NCT02452554|18738307|P2|Overall Study|Physician Decision|1
5427131|NCT02452554|18738308|P1|Overall Study|Physician Decision|0
5427132|NCT02452554|18738303|P6|Overall Study|Lack of Efficacy|8
5427133|NCT02452554|18738304|P5|Overall Study|Lack of Efficacy|5
5427134|NCT02452554|18738305|P4|Overall Study|Lack of Efficacy|1
5427135|NCT02452554|18738306|P3|Overall Study|Lack of Efficacy|9
5427136|NCT02452554|18738307|P2|Overall Study|Lack of Efficacy|14
5427137|NCT02452554|18738308|P1|Overall Study|Lack of Efficacy|13
5427138|NCT02452554|18738303|P6|Overall Study|Death|0
5427139|NCT02452554|18738304|P5|Overall Study|Death|0
5427140|NCT02452554|18738305|P4|Overall Study|Death|0
5427141|NCT02452554|18738306|P3|Overall Study|Death|0
5427142|NCT02452554|18738307|P2|Overall Study|Death|1
5427143|NCT02452554|18738308|P1|Overall Study|Death|2
5427144|NCT02452463|18738361|P3|Overall Study|Withdrawal by Subject|0
5427145|NCT02452463|18738362|P2|Overall Study|Withdrawal by Subject|1
5427146|NCT02452463|18738363|P1|Overall Study|Withdrawal by Subject|0
5427147|NCT02452463|18738361|P3|Overall Study|Recommended by DSMB|0
5427148|NCT02452463|18738362|P2|Overall Study|Recommended by DSMB|1
5427149|NCT02452463|18738363|P1|Overall Study|Recommended by DSMB|0
5427150|NCT02452463|18738361|P3|Overall Study|Study Suspended|0
5427151|NCT02452463|18738362|P2|Overall Study|Study Suspended|0
5427152|NCT02452463|18738363|P1|Overall Study|Study Suspended|1
5427153|NCT02452463|18738361|P3|Overall Study|Death|0
5427154|NCT02452463|18738362|P2|Overall Study|Death|0
5427155|NCT02452463|18738363|P1|Overall Study|Death|1
5427156|NCT02452424|18738406|P11|Overall Study|Adverse Event|1
5427157|NCT02452424|18738407|P10|Overall Study|Adverse Event|0
5427158|NCT02452424|18738408|P9|Overall Study|Adverse Event|0
5427159|NCT02452424|18738409|P8|Overall Study|Adverse Event|0
5427160|NCT02452424|18738410|P7|Overall Study|Adverse Event|0
5427161|NCT02452424|18738411|P6|Overall Study|Adverse Event|0
5427162|NCT02452424|18738412|P5|Overall Study|Adverse Event|0
5427163|NCT02452424|18738413|P4|Overall Study|Adverse Event|0
5427164|NCT02452424|18738414|P3|Overall Study|Adverse Event|0
5427165|NCT02452424|18738415|P2|Overall Study|Adverse Event|0
5427166|NCT02452424|18738416|P1|Overall Study|Adverse Event|0
5427167|NCT02452424|18738406|P11|Overall Study|Progressive disease (per RECIST)|0
5427168|NCT02452424|18738407|P10|Overall Study|Progressive disease (per RECIST)|0
5427169|NCT02452424|18738408|P9|Overall Study|Progressive disease (per RECIST)|2
5427170|NCT02452424|18738409|P8|Overall Study|Progressive disease (per RECIST)|0
5427171|NCT02452424|18738410|P7|Overall Study|Progressive disease (per RECIST)|0
5427172|NCT02452424|18738411|P6|Overall Study|Progressive disease (per RECIST)|0
5427173|NCT02452424|18738412|P5|Overall Study|Progressive disease (per RECIST)|0
5427174|NCT02452424|18738413|P4|Overall Study|Progressive disease (per RECIST)|0
5427175|NCT02452424|18738414|P3|Overall Study|Progressive disease (per RECIST)|0
5427176|NCT02452424|18738415|P2|Overall Study|Progressive disease (per RECIST)|0
5427177|NCT02452424|18738416|P1|Overall Study|Progressive disease (per RECIST)|0
5427178|NCT02452424|18738406|P11|Overall Study|Other|1
5427179|NCT02452424|18738407|P10|Overall Study|Other|0
5427180|NCT02452424|18738408|P9|Overall Study|Other|0
5427181|NCT02452424|18738409|P8|Overall Study|Other|3
5427182|NCT02452424|18738410|P7|Overall Study|Other|4
5427183|NCT02452424|18738411|P6|Overall Study|Other|1
5427184|NCT02452424|18738412|P5|Overall Study|Other|0
5427185|NCT02452424|18738413|P4|Overall Study|Other|0
5427186|NCT02452424|18738414|P3|Overall Study|Other|1
5427187|NCT02452424|18738415|P2|Overall Study|Other|0
5427188|NCT02452424|18738416|P1|Overall Study|Other|0
5427189|NCT02452424|18738406|P11|Overall Study|Withdrawal by Subject|0
5427190|NCT02452424|18738407|P10|Overall Study|Withdrawal by Subject|1
5427191|NCT02452424|18738408|P9|Overall Study|Withdrawal by Subject|1
5427192|NCT02452424|18738409|P8|Overall Study|Withdrawal by Subject|0
5427193|NCT02452424|18738410|P7|Overall Study|Withdrawal by Subject|1
5427194|NCT02452424|18738411|P6|Overall Study|Withdrawal by Subject|0
5427195|NCT02452424|18738412|P5|Overall Study|Withdrawal by Subject|0
5427196|NCT02452424|18738413|P4|Overall Study|Withdrawal by Subject|2
5427197|NCT02452424|18738414|P3|Overall Study|Withdrawal by Subject|3
5427198|NCT02452424|18738415|P2|Overall Study|Withdrawal by Subject|0
5427199|NCT02452424|18738416|P1|Overall Study|Withdrawal by Subject|0
5427200|NCT02452424|18738406|P11|Overall Study|Lost to Follow-up|0
5427201|NCT02452424|18738407|P10|Overall Study|Lost to Follow-up|0
5427202|NCT02452424|18738408|P9|Overall Study|Lost to Follow-up|0
5427203|NCT02452424|18738409|P8|Overall Study|Lost to Follow-up|0
5427204|NCT02452424|18738410|P7|Overall Study|Lost to Follow-up|0
5427205|NCT02452424|18738411|P6|Overall Study|Lost to Follow-up|0
5427206|NCT02452424|18738412|P5|Overall Study|Lost to Follow-up|0
5427207|NCT02452424|18738413|P4|Overall Study|Lost to Follow-up|0
5427208|NCT02452424|18738414|P3|Overall Study|Lost to Follow-up|1
5427209|NCT02452424|18738415|P2|Overall Study|Lost to Follow-up|1
5427210|NCT02452424|18738416|P1|Overall Study|Lost to Follow-up|0
5427211|NCT02452424|18738406|P11|Overall Study|Death|0
5427212|NCT02452424|18738407|P10|Overall Study|Death|1
5427213|NCT02452424|18738408|P9|Overall Study|Death|3
5427214|NCT02452424|18738409|P8|Overall Study|Death|1
5427215|NCT02452424|18738410|P7|Overall Study|Death|5
5427216|NCT02452424|18738411|P6|Overall Study|Death|0
5427217|NCT02452424|18738412|P5|Overall Study|Death|2
5427218|NCT02452424|18738413|P4|Overall Study|Death|6
5427219|NCT02452424|18738414|P3|Overall Study|Death|2
5427220|NCT02452424|18738415|P2|Overall Study|Death|2
5427221|NCT02452424|18738416|P1|Overall Study|Death|2
5427222|NCT02452398|18738451|P1|Overall Study|Moved away|4
5427223|NCT02452398|18738451|P1|Overall Study|Withdrawal by Subject|6
5427224|NCT02452398|18738451|P1|Overall Study|Physician Decision|2
5427225|NCT02452398|18738451|P1|Overall Study|Lost to Follow-up|28
5427226|NCT02452398|18738451|P1|Overall Study|Adverse Event|1
5427227|NCT02452359|18738455|P1|Overall Study|Withdrawal by Subject|4
5427228|NCT02452359|18738455|P1|Overall Study|Pregnancy|1
5427229|NCT02452359|18738455|P1|Overall Study|Lost to Follow-up|15
5427230|NCT02452359|18738455|P1|Overall Study|Adverse Event|1
5427231|NCT02452320|18738467|P2|Overall Study|Adverse Event|1
5427232|NCT02452320|18738468|P1|Overall Study|Adverse Event|0
5427233|NCT02452190|18738480|P2|Overall Study|Death|1
5427234|NCT02452190|18738481|P1|Overall Study|Death|0
5427235|NCT02452190|18738480|P2|Overall Study|Participant traveled abroad|0
5427236|NCT02452190|18738481|P1|Overall Study|Participant traveled abroad|1
5427237|NCT02452190|18738480|P2|Overall Study|Noncompliance with study drug|0
5427238|NCT02452190|18738481|P1|Overall Study|Noncompliance with study drug|1
5427239|NCT02452190|18738480|P2|Overall Study|Withdrawal by Subject|11
5427240|NCT02452190|18738481|P1|Overall Study|Withdrawal by Subject|20
5427241|NCT02452190|18738480|P2|Overall Study|Adverse Event|5
5427242|NCT02452190|18738481|P1|Overall Study|Adverse Event|2
5427243|NCT02452190|18738480|P2|Overall Study|Lost to Follow-up|3
5427244|NCT02452190|18738481|P1|Overall Study|Lost to Follow-up|4
5427245|NCT02452190|18738480|P2|Overall Study|Lack of Efficacy|1
5427246|NCT02452190|18738481|P1|Overall Study|Lack of Efficacy|3
5427247|NCT02452190|18738480|P2|Overall Study|Investigator's Decision|0
5427248|NCT02452190|18738481|P1|Overall Study|Investigator's Decision|2
5427249|NCT02452190|18738480|P2|Overall Study|Pregnancy|0
5427250|NCT02452190|18738481|P1|Overall Study|Pregnancy|1
5427251|NCT02452190|18738480|P2|Overall Study|Withdrawal by Sponsor|3
5427252|NCT02452190|18738481|P1|Overall Study|Withdrawal by Sponsor|1
5427253|NCT02452047|18738519|P3|Overall Study|Withdrawal by Subject|0
5427254|NCT02452047|18738520|P2|Overall Study|Withdrawal by Subject|0
5427255|NCT02452047|18738521|P1|Overall Study|Withdrawal by Subject|1
5427256|NCT02452047|18738519|P3|Overall Study|Lost to Follow-up|0
5427257|NCT02452047|18738520|P2|Overall Study|Lost to Follow-up|1
5427258|NCT02452047|18738521|P1|Overall Study|Lost to Follow-up|1
5427259|NCT02452047|18738519|P3|Overall Study|Physician Decision|0
5427260|NCT02452047|18738520|P2|Overall Study|Physician Decision|0
5427261|NCT02452047|18738521|P1|Overall Study|Physician Decision|1
5427262|NCT02452047|18738519|P3|Overall Study|Death|1
5427263|NCT02452047|18738520|P2|Overall Study|Death|3
5427264|NCT02452047|18738521|P1|Overall Study|Death|1
5427265|NCT02452047|18738519|P3|Overall Study|Adverse Event|1
5427266|NCT02452047|18738520|P2|Overall Study|Adverse Event|1
5427267|NCT02452047|18738521|P1|Overall Study|Adverse Event|0
5427268|NCT02452034|18738586|P6|Overall Study|Withdrawn by Parent/Guardian|0
5427269|NCT02452034|18738587|P5|Overall Study|Withdrawn by Parent/Guardian|0
5427270|NCT02452034|18738588|P4|Overall Study|Withdrawn by Parent/Guardian|0
5427271|NCT02452034|18738589|P3|Overall Study|Withdrawn by Parent/Guardian|0
5427272|NCT02452034|18738590|P2|Overall Study|Withdrawn by Parent/Guardian|0
5427273|NCT02452034|18738591|P1|Overall Study|Withdrawn by Parent/Guardian|1
5427274|NCT02452034|18738586|P6|Overall Study|Screen Failure|0
5427275|NCT02452034|18738587|P5|Overall Study|Screen Failure|0
5427276|NCT02452034|18738588|P4|Overall Study|Screen Failure|1
5427277|NCT02452034|18738589|P3|Overall Study|Screen Failure|0
5427278|NCT02452034|18738590|P2|Overall Study|Screen Failure|0
5427279|NCT02452034|18738591|P1|Overall Study|Screen Failure|1
5427280|NCT02452034|18738586|P6|Overall Study|Protocol Violation|1
5427281|NCT02452034|18738587|P5|Overall Study|Protocol Violation|0
5427282|NCT02452034|18738588|P4|Overall Study|Protocol Violation|0
5427283|NCT02452034|18738589|P3|Overall Study|Protocol Violation|0
5427284|NCT02452034|18738590|P2|Overall Study|Protocol Violation|0
5427285|NCT02452034|18738591|P1|Overall Study|Protocol Violation|0
5427286|NCT02452034|18738586|P6|Overall Study|Physician Decision|0
5427287|NCT02452034|18738587|P5|Overall Study|Physician Decision|0
5427288|NCT02452034|18738588|P4|Overall Study|Physician Decision|0
5427289|NCT02452034|18738589|P3|Overall Study|Physician Decision|1
5427290|NCT02452034|18738590|P2|Overall Study|Physician Decision|1
5427291|NCT02452034|18738591|P1|Overall Study|Physician Decision|0
5427292|NCT02452034|18738586|P6|Overall Study|Death|1
5427293|NCT02452034|18738587|P5|Overall Study|Death|1
5427294|NCT02452034|18738588|P4|Overall Study|Death|0
5427295|NCT02452034|18738589|P3|Overall Study|Death|0
5427296|NCT02452034|18738590|P2|Overall Study|Death|0
5427297|NCT02452034|18738591|P1|Overall Study|Death|0
5427298|NCT02452034|18738586|P6|Overall Study|Adverse Event|1
5427299|NCT02452034|18738587|P5|Overall Study|Adverse Event|0
5427300|NCT02452034|18738588|P4|Overall Study|Adverse Event|0
5427301|NCT02452034|18738589|P3|Overall Study|Adverse Event|0
5427302|NCT02452034|18738590|P2|Overall Study|Adverse Event|0
5427303|NCT02452034|18738591|P1|Overall Study|Adverse Event|0
5427304|NCT02451943|18738664|P2|Overall Study|Lost to Follow-up|4
5427305|NCT02451943|18738665|P1|Overall Study|Lost to Follow-up|3
5427306|NCT02451943|18738664|P2|Overall Study|Withdrawal by Subject|16
5427307|NCT02451943|18738665|P1|Overall Study|Withdrawal by Subject|13
5427308|NCT02451943|18738664|P2|Overall Study|On Treatment|4
5427309|NCT02451943|18738665|P1|Overall Study|On Treatment|4
5427310|NCT02451930|18738694|P2|Overall Study|Other|1
5427311|NCT02451930|18738695|P1|Overall Study|Other|0
5427312|NCT02451930|18738694|P2|Overall Study|Withdrawal by Subject|1
5427313|NCT02451930|18738695|P1|Overall Study|Withdrawal by Subject|0
5427314|NCT02451930|18738694|P2|Overall Study|Sponsor Decision|10
5427315|NCT02451930|18738695|P1|Overall Study|Sponsor Decision|2
5427316|NCT02451930|18738694|P2|Overall Study|Lost to Follow-up|3
5427317|NCT02451930|18738695|P1|Overall Study|Lost to Follow-up|0
5427318|NCT02451930|18738694|P2|Overall Study|Death|15
5427319|NCT02451930|18738695|P1|Overall Study|Death|0
5427320|NCT02451917|18738718|P2|First Intervention (24 Weeks)|Adverse Event|2
5427321|NCT02451917|18738719|P1|First Intervention (24 Weeks)|Adverse Event|0
5427322|NCT02451917|18738718|P2|First Intervention (24 Weeks)|Death|1
5427323|NCT02451917|18738719|P1|First Intervention (24 Weeks)|Death|0
5427324|NCT02451917|18738718|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
5427325|NCT02451917|18738719|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
5427326|NCT02451670|18738761|P2|Overall Study|Did not have qualifying follow-up visit.|696
5427327|NCT02451670|18738762|P1|Overall Study|Did not have qualifying follow-up visit.|714
5427328|NCT02451358|18738872|P4|Overall Study|Protocol Violation|0
5427329|NCT02451358|18738873|P3|Overall Study|Protocol Violation|1
5427330|NCT02451358|18738874|P2|Overall Study|Protocol Violation|1
5427331|NCT02451358|18738875|P1|Overall Study|Protocol Violation|0
5427332|NCT02451358|18738872|P4|Overall Study|Withdrawal by Subject|0
5427333|NCT02451358|18738873|P3|Overall Study|Withdrawal by Subject|0
5427334|NCT02451358|18738874|P2|Overall Study|Withdrawal by Subject|1
5427335|NCT02451358|18738875|P1|Overall Study|Withdrawal by Subject|1
5427336|NCT02451137|18738963|P2|Overall Study|Other than specified above|3
5427337|NCT02451137|18738964|P1|Overall Study|Other than specified above|2
5427338|NCT02451137|18738963|P2|Overall Study|Withdrawal by Subject|63
5427339|NCT02451137|18738964|P1|Overall Study|Withdrawal by Subject|40
5427340|NCT02451137|18738963|P2|Overall Study|Sponsor decision|25
5427341|NCT02451137|18738964|P1|Overall Study|Sponsor decision|13
5427342|NCT02451137|18738963|P2|Overall Study|Physician Decision|5
5427343|NCT02451137|18738964|P1|Overall Study|Physician Decision|6
5427344|NCT02451137|18738963|P2|Overall Study|Lost to Follow-up|61
5427345|NCT02451137|18738964|P1|Overall Study|Lost to Follow-up|53
5427346|NCT02451137|18738963|P2|Overall Study|Investigator's decision|19
5427347|NCT02451137|18738964|P1|Overall Study|Investigator's decision|23
5427348|NCT02451137|18738963|P2|Overall Study|Hypoglycemia|1
5427349|NCT02451137|18738964|P1|Overall Study|Hypoglycemia|2
5427350|NCT02451137|18738963|P2|Overall Study|Participant decision:discontinue insulin|43
5427351|NCT02451137|18738964|P1|Overall Study|Participant decision:discontinue insulin|41
5427352|NCT02451137|18738963|P2|Overall Study|Lack of Efficacy|9
5427353|NCT02451137|18738964|P1|Overall Study|Lack of Efficacy|4
5427354|NCT02451137|18738963|P2|Overall Study|Adverse Event|42
5427355|NCT02451137|18738964|P1|Overall Study|Adverse Event|43
5427356|NCT02451137|18738963|P2|Overall Study|Randomized but not treated|27
5427357|NCT02451137|18738964|P1|Overall Study|Randomized but not treated|19
5427358|NCT02451124|18738994|P1|Overall Study|Withdrawal by Subject|1
5427359|NCT02451007|18739005|P1|Overall Study|Disease Progression|2
5427360|NCT02451007|18739005|P1|Overall Study|Adverse Event|1
5427361|NCT02451007|18739005|P1|Overall Study|Withdrawal by Subject|4
5427362|NCT02450903|18739012|P1|Overall Study|Subject/guardian decision|1
5427363|NCT02450903|18739012|P1|Overall Study|Switched to commercial drug|1
5427364|NCT02450903|18739012|P1|Overall Study|Progressive disease|15
5427365|NCT02450903|18739012|P1|Overall Study|Adverse Event|3
5427366|NCT02450578|18739056|P4|Overall Study|ECG abnormality so not treated|0
5427367|NCT02450578|18739057|P3|Overall Study|ECG abnormality so not treated|0
5427368|NCT02450578|18739058|P2|Overall Study|ECG abnormality so not treated|0
5427369|NCT02450578|18739059|P1|Overall Study|ECG abnormality so not treated|1
5427370|NCT02450552|18739106|P3|Overall Study|Physician Decision|1
5427371|NCT02450552|18739107|P2|Overall Study|Physician Decision|0
5427372|NCT02450552|18739108|P1|Overall Study|Physician Decision|1
5427373|NCT02450552|18739106|P3|Overall Study|Withdrawal by Subject|4
5427374|NCT02450552|18739107|P2|Overall Study|Withdrawal by Subject|0
5427375|NCT02450552|18739108|P1|Overall Study|Withdrawal by Subject|4
5427376|NCT02450539|18739151|P2|Overall Study|On study treatment/follow up|25
5427377|NCT02450539|18739152|P1|Overall Study|On study treatment/follow up|27
5427378|NCT02450539|18739151|P2|Overall Study|Lost to Follow-up|1
5427379|NCT02450539|18739152|P1|Overall Study|Lost to Follow-up|4
5427380|NCT02450539|18739151|P2|Overall Study|Withdrawal by Subject|7
5427381|NCT02450539|18739152|P1|Overall Study|Withdrawal by Subject|19
5427382|NCT02450526|18739176|P5|OL Period (Cycles 2-5)|Protocol Violation|7
5427383|NCT02450526|18739177|P4|OL Period (Cycles 2-5)|Protocol Violation|0
5427384|NCT02450526|18739178|P3|OL Period (Cycles 2-5)|Protocol Violation|0
5427385|NCT02450526|18739179|P2|OL Period (Cycles 2-5)|Protocol Violation|0
5427386|NCT02450526|18739180|P1|OL Period (Cycles 2-5)|Protocol Violation|0
5427387|NCT02450526|18739176|P5|OL Period (Cycles 2-5)|Lack of Efficacy|1
5427388|NCT02450526|18739177|P4|OL Period (Cycles 2-5)|Lack of Efficacy|0
5427389|NCT02450526|18739178|P3|OL Period (Cycles 2-5)|Lack of Efficacy|0
5427390|NCT02450526|18739179|P2|OL Period (Cycles 2-5)|Lack of Efficacy|0
5427391|NCT02450526|18739180|P1|OL Period (Cycles 2-5)|Lack of Efficacy|0
5427392|NCT02450526|18739176|P5|OL Period (Cycles 2-5)|Withdrawal by Subject|31
5427393|NCT02450526|18739177|P4|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5427394|NCT02450526|18739178|P3|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5427395|NCT02450526|18739179|P2|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5427396|NCT02450526|18739180|P1|OL Period (Cycles 2-5)|Withdrawal by Subject|0
5427397|NCT02450526|18739176|P5|OL Period (Cycles 2-5)|Adverse Event|2
5427398|NCT02450526|18739177|P4|OL Period (Cycles 2-5)|Adverse Event|0
5427399|NCT02450526|18739178|P3|OL Period (Cycles 2-5)|Adverse Event|0
5427400|NCT02450526|18739179|P2|OL Period (Cycles 2-5)|Adverse Event|0
5427401|NCT02450526|18739180|P1|OL Period (Cycles 2-5)|Adverse Event|0
5427402|NCT02450526|18739176|P5|DB Period (Cycle 1)|Protocol Violation|0
5427403|NCT02450526|18739177|P4|DB Period (Cycle 1)|Protocol Violation|1
5427404|NCT02450526|18739178|P3|DB Period (Cycle 1)|Protocol Violation|0
5427405|NCT02450526|18739179|P2|DB Period (Cycle 1)|Protocol Violation|0
5427406|NCT02450526|18739180|P1|DB Period (Cycle 1)|Protocol Violation|2
5427407|NCT02450526|18739176|P5|DB Period (Cycle 1)|Lost to Follow-up|0
5427408|NCT02450526|18739177|P4|DB Period (Cycle 1)|Lost to Follow-up|0
5427409|NCT02450526|18739178|P3|DB Period (Cycle 1)|Lost to Follow-up|0
5427410|NCT02450526|18739179|P2|DB Period (Cycle 1)|Lost to Follow-up|0
5427411|NCT02450526|18739180|P1|DB Period (Cycle 1)|Lost to Follow-up|1
5427412|NCT02450526|18739176|P5|DB Period (Cycle 1)|Withdrawal by Subject|0
5427413|NCT02450526|18739177|P4|DB Period (Cycle 1)|Withdrawal by Subject|1
5427414|NCT02450526|18739178|P3|DB Period (Cycle 1)|Withdrawal by Subject|8
5427415|NCT02450526|18739179|P2|DB Period (Cycle 1)|Withdrawal by Subject|3
5427416|NCT02450526|18739180|P1|DB Period (Cycle 1)|Withdrawal by Subject|28
5427417|NCT02450526|18739176|P5|DB Period (Cycle 1)|Adverse Event|0
5427418|NCT02450526|18739177|P4|DB Period (Cycle 1)|Adverse Event|0
5427419|NCT02450526|18739178|P3|DB Period (Cycle 1)|Adverse Event|2
5427420|NCT02450526|18739179|P2|DB Period (Cycle 1)|Adverse Event|0
5427421|NCT02450526|18739180|P1|DB Period (Cycle 1)|Adverse Event|0
5427422|NCT02450487|18739265|P1|Overall Study|Lost to Follow-up|3
5427423|NCT02450331|18739287|P2|Overall Study|On-Study Status: In Survival follow-up|38
5427424|NCT02450331|18739288|P1|Overall Study|On-Study Status: In Survival follow-up|45
5427425|NCT02450331|18739287|P2|Overall Study|On-Study Status: In Disease recurrence follow-up|208
5427426|NCT02450331|18739288|P1|Overall Study|On-Study Status: In Disease recurrence follow-up|179
5427427|NCT02450331|18739287|P2|Overall Study|Withdrawal by Subject|39
5427428|NCT02450331|18739288|P1|Overall Study|Withdrawal by Subject|50
5427429|NCT02450331|18739287|P2|Overall Study|Lost to Follow-up|7
5427430|NCT02450331|18739288|P1|Overall Study|Lost to Follow-up|9
5427431|NCT02450331|18739287|P2|Overall Study|Death|114
5427432|NCT02450331|18739288|P1|Overall Study|Death|120
5427433|NCT02449915|18739311|P2|Overall Study|Abnormal preop lab|1
5427434|NCT02449915|18739312|P1|Overall Study|Abnormal preop lab|0
5427435|NCT02449915|18739311|P2|Overall Study|Intraoperative surgical findings|1
5427436|NCT02449915|18739312|P1|Overall Study|Intraoperative surgical findings|1
5427437|NCT02449915|18739311|P2|Overall Study|Withdrawal by Subject|2
5427438|NCT02449915|18739312|P1|Overall Study|Withdrawal by Subject|0
5427439|NCT02449915|18739311|P2|Overall Study|Exclusion criteria - drug use|0
5427440|NCT02449915|18739312|P1|Overall Study|Exclusion criteria - drug use|1
5427441|NCT02449902|18739320|P2|Overall Study|Withdrawal by Subject|1
5427442|NCT02449902|18739321|P1|Overall Study|Withdrawal by Subject|0
5427443|NCT02449902|18739320|P2|Overall Study|Adverse Event|1
5427444|NCT02449902|18739321|P1|Overall Study|Adverse Event|0
5427445|NCT02449889|18739348|P3|Overall Study|Protocol Violation|1
5427446|NCT02449889|18739349|P2|Overall Study|Protocol Violation|4
5427447|NCT02449889|18739350|P1|Overall Study|Protocol Violation|0
5427448|NCT02449889|18739348|P3|Overall Study|Adverse Event|0
5427449|NCT02449889|18739349|P2|Overall Study|Adverse Event|2
5427450|NCT02449889|18739350|P1|Overall Study|Adverse Event|1
5427451|NCT02449044|18739484|P1|Overall Study|Sponsor Discontinued Trial|3
5427452|NCT02449044|18739484|P1|Overall Study|Physician Decision|9
5427453|NCT02449044|18739484|P1|Overall Study|Met Withdrawal Criteria|7
5427454|NCT02449044|18739484|P1|Overall Study|Adverse Event|30
5427455|NCT02449044|18739484|P1|Overall Study|Withdrawal by Subject|13
5427456|NCT02449044|18739484|P1|Overall Study|Lost to Follow-up|2
5427457|NCT02449018|18739505|P2|Overall Study|Patient decision|0
5427458|NCT02449018|18739506|P1|Overall Study|Patient decision|2
5427459|NCT02449018|18739505|P2|Overall Study|Protocol deviation|0
5427460|NCT02449018|18739506|P1|Overall Study|Protocol deviation|4
5427461|NCT02449018|18739505|P2|Overall Study|Adverse Event|1
5427462|NCT02449018|18739506|P1|Overall Study|Adverse Event|5
5427463|NCT02449018|18739505|P2|Overall Study|Administrative problems|0
5427464|NCT02449018|18739506|P1|Overall Study|Administrative problems|1
5427465|NCT02449018|18739505|P2|Overall Study|Abnormal laboratory value|1
5427466|NCT02449018|18739506|P1|Overall Study|Abnormal laboratory value|0
5427467|NCT02448875|18739553|P3|Overall Study|Withdrawal by Subject|0
5427468|NCT02448875|18739554|P2|Overall Study|Withdrawal by Subject|0
5427469|NCT02448875|18739555|P1|Overall Study|Withdrawal by Subject|1
5427470|NCT02448875|18739553|P3|Overall Study|Investigator Decision|1
5427471|NCT02448875|18739554|P2|Overall Study|Investigator Decision|0
5427472|NCT02448875|18739555|P1|Overall Study|Investigator Decision|3
5427473|NCT02448875|18739553|P3|Overall Study|Lost to Follow-up|0
5427474|NCT02448875|18739554|P2|Overall Study|Lost to Follow-up|0
5427475|NCT02448875|18739555|P1|Overall Study|Lost to Follow-up|1
5427476|NCT02448875|18739553|P3|Overall Study|Adverse Event|0
5427477|NCT02448875|18739554|P2|Overall Study|Adverse Event|1
5427478|NCT02448875|18739555|P1|Overall Study|Adverse Event|2
5427479|NCT02448810|18739603|P8|Overall Study|Other (unspecified)|0
5427480|NCT02448810|18739604|P7|Overall Study|Other (unspecified)|2
5427481|NCT02448810|18739605|P6|Overall Study|Other (unspecified)|0
5427482|NCT02448810|18739606|P5|Overall Study|Other (unspecified)|0
5427483|NCT02448810|18739607|P4|Overall Study|Other (unspecified)|0
5427484|NCT02448810|18739608|P3|Overall Study|Other (unspecified)|0
5427485|NCT02448810|18739609|P2|Overall Study|Other (unspecified)|0
5427486|NCT02448810|18739610|P1|Overall Study|Other (unspecified)|0
5427487|NCT02448810|18739603|P8|Overall Study|Lost to Follow-up|0
5427488|NCT02448810|18739604|P7|Overall Study|Lost to Follow-up|0
5427489|NCT02448810|18739605|P6|Overall Study|Lost to Follow-up|0
5427490|NCT02448810|18739606|P5|Overall Study|Lost to Follow-up|0
5427491|NCT02448810|18739607|P4|Overall Study|Lost to Follow-up|0
5427492|NCT02448810|18739608|P3|Overall Study|Lost to Follow-up|0
5427493|NCT02448810|18739609|P2|Overall Study|Lost to Follow-up|1
5427494|NCT02448810|18739610|P1|Overall Study|Lost to Follow-up|0
5427495|NCT02448810|18739603|P8|Overall Study|Other (Progressive disease)|5
5427496|NCT02448810|18739604|P7|Overall Study|Other (Progressive disease)|14
5427497|NCT02448810|18739605|P6|Overall Study|Other (Progressive disease)|9
5427498|NCT02448810|18739606|P5|Overall Study|Other (Progressive disease)|23
5427499|NCT02448810|18739607|P4|Overall Study|Other (Progressive disease)|3
5427500|NCT02448810|18739608|P3|Overall Study|Other (Progressive disease)|0
5427501|NCT02448810|18739609|P2|Overall Study|Other (Progressive disease)|2
5427502|NCT02448810|18739610|P1|Overall Study|Other (Progressive disease)|2
5427503|NCT02448810|18739603|P8|Overall Study|Death|0
5427504|NCT02448810|18739604|P7|Overall Study|Death|0
5427505|NCT02448810|18739605|P6|Overall Study|Death|0
5427506|NCT02448810|18739606|P5|Overall Study|Death|1
5427507|NCT02448810|18739607|P4|Overall Study|Death|0
5427508|NCT02448810|18739608|P3|Overall Study|Death|1
5427509|NCT02448810|18739609|P2|Overall Study|Death|0
5427510|NCT02448810|18739610|P1|Overall Study|Death|1
5427511|NCT02448810|18739603|P8|Overall Study|Other (study terminated by sponsor)|1
5427512|NCT02448810|18739604|P7|Overall Study|Other (study terminated by sponsor)|2
5427513|NCT02448810|18739605|P6|Overall Study|Other (study terminated by sponsor)|2
5427514|NCT02448810|18739606|P5|Overall Study|Other (study terminated by sponsor)|4
5427515|NCT02448810|18739607|P4|Overall Study|Other (study terminated by sponsor)|0
5427516|NCT02448810|18739608|P3|Overall Study|Other (study terminated by sponsor)|0
5427517|NCT02448810|18739609|P2|Overall Study|Other (study terminated by sponsor)|0
5427518|NCT02448810|18739610|P1|Overall Study|Other (study terminated by sponsor)|0
5427519|NCT02448810|18739603|P8|Overall Study|Withdrawal by Subject|2
5427520|NCT02448810|18739604|P7|Overall Study|Withdrawal by Subject|0
5427521|NCT02448810|18739605|P6|Overall Study|Withdrawal by Subject|5
5427522|NCT02448810|18739606|P5|Overall Study|Withdrawal by Subject|3
5427523|NCT02448810|18739607|P4|Overall Study|Withdrawal by Subject|0
5427524|NCT02448810|18739608|P3|Overall Study|Withdrawal by Subject|1
5427525|NCT02448810|18739609|P2|Overall Study|Withdrawal by Subject|0
5427526|NCT02448810|18739610|P1|Overall Study|Withdrawal by Subject|0
5427527|NCT02448810|18739603|P8|Overall Study|Adverse Event|0
5427528|NCT02448810|18739604|P7|Overall Study|Adverse Event|0
5427529|NCT02448810|18739605|P6|Overall Study|Adverse Event|0
5427530|NCT02448810|18739606|P5|Overall Study|Adverse Event|0
5427531|NCT02448810|18739607|P4|Overall Study|Adverse Event|0
5427532|NCT02448810|18739608|P3|Overall Study|Adverse Event|1
5427533|NCT02448810|18739609|P2|Overall Study|Adverse Event|0
5427534|NCT02448810|18739610|P1|Overall Study|Adverse Event|0
5427535|NCT02448719|18739687|P11|Overall Study|Withdrawal by Subject|0
5427536|NCT02448719|18739688|P10|Overall Study|Withdrawal by Subject|0
5427537|NCT02448719|18739689|P9|Overall Study|Withdrawal by Subject|0
5427538|NCT02448719|18739690|P8|Overall Study|Withdrawal by Subject|0
5427539|NCT02448719|18739691|P7|Overall Study|Withdrawal by Subject|0
5427540|NCT02448719|18739692|P6|Overall Study|Withdrawal by Subject|0
5427541|NCT02448719|18739693|P5|Overall Study|Withdrawal by Subject|1
5427542|NCT02448719|18739694|P4|Overall Study|Withdrawal by Subject|0
5427543|NCT02448719|18739695|P3|Overall Study|Withdrawal by Subject|0
5427544|NCT02448719|18739696|P2|Overall Study|Withdrawal by Subject|0
5427545|NCT02448719|18739697|P1|Overall Study|Withdrawal by Subject|0
5427546|NCT02448706|18739921|P2|Overall Study|Protocol Violation|1
5427547|NCT02448706|18739922|P1|Overall Study|Protocol Violation|1
5427548|NCT02448706|18739921|P2|Overall Study|Withdrawal by Subject|3
5427549|NCT02448706|18739922|P1|Overall Study|Withdrawal by Subject|4
5427550|NCT02448680|18739936|P2|Overall Study|Withdrawal by Subject|2
5427551|NCT02448680|18739937|P1|Overall Study|Withdrawal by Subject|0
5427552|NCT02448680|18739936|P2|Overall Study|Physician Decision|1
5427553|NCT02448680|18739937|P1|Overall Study|Physician Decision|1
5427554|NCT02448563|18740006|P2|Overall Study|Withdrawal by Subject|1
5427555|NCT02448563|18740007|P1|Overall Study|Withdrawal by Subject|0
5427556|NCT02448563|18740006|P2|Overall Study|Lost to Follow-up|10
5427557|NCT02448563|18740007|P1|Overall Study|Lost to Follow-up|16
5427558|NCT02448537|18740029|P3|Overall Study|Withdrawal by Subject|1
5427559|NCT02448537|18740030|P2|Overall Study|Withdrawal by Subject|1
5427560|NCT02448537|18740031|P1|Overall Study|Withdrawal by Subject|1
5427561|NCT02448043|18740145|P2|Overall Study|Protocol Violation|2
5427562|NCT02448043|18740146|P1|Overall Study|Protocol Violation|1
5427563|NCT02448043|18740145|P2|Overall Study|Withdrawal by Subject|2
5427564|NCT02448043|18740146|P1|Overall Study|Withdrawal by Subject|2
5427565|NCT02447952|18740164|P1|Overall Study|Withdrawal by Subject|4
5427566|NCT02447952|18740164|P1|Overall Study|Physician Decision|1
5427567|NCT02447952|18740164|P1|Overall Study|Adverse Event|2
5427568|NCT02447887|18740221|P1|Overall Study|Study was terminated|3
5427569|NCT02447848|18740234|P1|Overall Study|Withdrawal by Subject|4
5427570|NCT02447848|18740234|P1|Overall Study|Lack of Efficacy|4
5427571|NCT02447848|18740234|P1|Overall Study|Patient discharged|3
5427572|NCT02447497|18740248|P4|Overall Study|Did not meet treatment day baseline|2
5427573|NCT02447497|18740249|P3|Overall Study|Did not meet treatment day baseline|2
5427574|NCT02447497|18740250|P2|Overall Study|Did not meet treatment day baseline|6
5427575|NCT02447497|18740251|P1|Overall Study|Did not meet treatment day baseline|6
5427576|NCT02447458|18740275|P6|Overall Study|Other|0
5427577|NCT02447458|18740276|P5|Overall Study|Other|0
5427578|NCT02447458|18740277|P4|Overall Study|Other|0
5427579|NCT02447458|18740278|P3|Overall Study|Other|1
5427580|NCT02447458|18740279|P2|Overall Study|Other|0
5427581|NCT02447458|18740280|P1|Overall Study|Other|0
5427582|NCT02447432|18740378|P2|Epoch 001|Lost to Follow-up|3
5427583|NCT02447432|18740379|P1|Epoch 001|Lost to Follow-up|1
5427584|NCT02447432|18740378|P2|Epoch 001|Migrated/moved from study area|5
5427585|NCT02447432|18740379|P1|Epoch 001|Migrated/moved from study area|3
5427586|NCT02447432|18740378|P2|Epoch 001|Withdrawal by Subject|4
5427587|NCT02447432|18740379|P1|Epoch 001|Withdrawal by Subject|0
5427588|NCT02447432|18740378|P2|Epoch 001|Adverse Event|1
5427589|NCT02447432|18740379|P1|Epoch 001|Adverse Event|1
5427590|NCT02447328|18740411|P1|Overall Study|Withdrawal by Subject|1
5427591|NCT02447250|18740415|P1|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
5427592|NCT02447250|18740415|P1|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
5427593|NCT02447250|18740415|P1|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
5427594|NCT02447081|18740432|P1|Overall Study|unsuccessful implant procedure|10
5427595|NCT02447081|18740432|P1|Overall Study|Visit not completed|17
5427596|NCT02447081|18740432|P1|Overall Study|Lost to Follow-up|36
5427597|NCT02447081|18740432|P1|Overall Study|Death|161
5427598|NCT02447029|18740448|P2|Overall Study|Withdrawal by Subject|2
5427599|NCT02447029|18740449|P1|Overall Study|Withdrawal by Subject|3
5427600|NCT02447003|18740469|P2|Overall Study|Death|63
5427601|NCT02447003|18740470|P1|Overall Study|Death|154
5427602|NCT02447003|18740469|P2|Overall Study|Lost to Follow-up|0
5427603|NCT02447003|18740470|P1|Overall Study|Lost to Follow-up|5
5427604|NCT02447003|18740469|P2|Overall Study|Progressive Disease|0
5427605|NCT02447003|18740470|P1|Overall Study|Progressive Disease|1
5427606|NCT02447003|18740469|P2|Overall Study|Sponsor Decision|11
5427607|NCT02447003|18740470|P1|Overall Study|Sponsor Decision|6
5427608|NCT02447003|18740469|P2|Overall Study|Withdrawal by Subject|3
5427609|NCT02447003|18740470|P1|Overall Study|Withdrawal by Subject|4
5427610|NCT02447003|18740469|P2|Overall Study|Physician Decision|1
5427611|NCT02447003|18740470|P1|Overall Study|Physician Decision|0
5427612|NCT02447003|18740469|P2|Overall Study|Site discontinued|2
5427613|NCT02447003|18740470|P1|Overall Study|Site discontinued|0
5427614|NCT02447003|18740469|P2|Overall Study|Other|4
5427615|NCT02447003|18740470|P1|Overall Study|Other|0
5427616|NCT02446990|18740506|P2|Overall Study|Withdrawal by Subject|199
5427617|NCT02446990|18740507|P1|Overall Study|Withdrawal by Subject|231
5427618|NCT02446990|18740506|P2|Overall Study|Physician Decision|0
5427619|NCT02446990|18740507|P1|Overall Study|Physician Decision|1
5427620|NCT02446990|18740506|P2|Overall Study|Lost to Follow-up|1
5427621|NCT02446990|18740507|P1|Overall Study|Lost to Follow-up|3
5427622|NCT02446990|18740506|P2|Overall Study|Death|458
5427623|NCT02446990|18740507|P1|Overall Study|Death|485
5427624|NCT02446912|18740542|P3|Overall Study|Miscellaneous|4
5427625|NCT02446912|18740543|P2|Overall Study|Miscellaneous|2
5427626|NCT02446912|18740544|P1|Overall Study|Miscellaneous|2
5427627|NCT02446912|18740542|P3|Overall Study|Withdrawal by Subject|15
5427628|NCT02446912|18740543|P2|Overall Study|Withdrawal by Subject|15
5427629|NCT02446912|18740544|P1|Overall Study|Withdrawal by Subject|10
5427630|NCT02446912|18740542|P3|Overall Study|Severe non-compliance to protocol|1
5427631|NCT02446912|18740543|P2|Overall Study|Severe non-compliance to protocol|0
5427632|NCT02446912|18740544|P1|Overall Study|Severe non-compliance to protocol|1
5427633|NCT02446912|18740542|P3|Overall Study|Lost to Follow-up|2
5427634|NCT02446912|18740543|P2|Overall Study|Lost to Follow-up|0
5427635|NCT02446912|18740544|P1|Overall Study|Lost to Follow-up|0
5427636|NCT02446912|18740542|P3|Overall Study|Lack of Efficacy|7
5427637|NCT02446912|18740543|P2|Overall Study|Lack of Efficacy|4
5427638|NCT02446912|18740544|P1|Overall Study|Lack of Efficacy|1
5427639|NCT02446912|18740542|P3|Overall Study|Study-specific withdrawal criteria|0
5427640|NCT02446912|18740543|P2|Overall Study|Study-specific withdrawal criteria|0
5427641|NCT02446912|18740544|P1|Overall Study|Study-specific withdrawal criteria|1
5427642|NCT02446912|18740542|P3|Overall Study|Condition under investigation worsened|1
5427643|NCT02446912|18740543|P2|Overall Study|Condition under investigation worsened|1
5427644|NCT02446912|18740544|P1|Overall Study|Condition under investigation worsened|0
5427645|NCT02446912|18740542|P3|Overall Study|Adverse Event|5
5427646|NCT02446912|18740543|P2|Overall Study|Adverse Event|13
5427647|NCT02446912|18740544|P1|Overall Study|Adverse Event|3
5427648|NCT02446899|18740617|P2|Overall Study|Failure to Meet Randomization Criteria|2
5427649|NCT02446899|18740618|P1|Overall Study|Failure to Meet Randomization Criteria|0
5427650|NCT02446899|18740617|P2|Overall Study|Miscellaneous|4
5427651|NCT02446899|18740618|P1|Overall Study|Miscellaneous|5
5427652|NCT02446899|18740617|P2|Overall Study|Withdrawal by Subject|19
5427653|NCT02446899|18740618|P1|Overall Study|Withdrawal by Subject|11
5427654|NCT02446899|18740617|P2|Overall Study|Severe Non-Compliance to Protocol|1
5427655|NCT02446899|18740618|P1|Overall Study|Severe Non-Compliance to Protocol|0
5427656|NCT02446899|18740617|P2|Overall Study|Lost to Follow-up|3
5427657|NCT02446899|18740618|P1|Overall Study|Lost to Follow-up|1
5427658|NCT02446899|18740617|P2|Overall Study|Lack of Efficacy|8
5427659|NCT02446899|18740618|P1|Overall Study|Lack of Efficacy|2
5427660|NCT02446899|18740617|P2|Overall Study|Study Specific Withdrawal Criteria|0
5427661|NCT02446899|18740618|P1|Overall Study|Study Specific Withdrawal Criteria|1
5427662|NCT02446899|18740617|P2|Overall Study|Condition Under Investigation Worsened|4
5427663|NCT02446899|18740618|P1|Overall Study|Condition Under Investigation Worsened|1
5427664|NCT02446899|18740617|P2|Overall Study|Adverse Event|7
5427665|NCT02446899|18740618|P1|Overall Study|Adverse Event|4
5427666|NCT02446769|18740655|P3|Study Period|Randomized in Error|0
5427667|NCT02446769|18740656|P2|Study Period|Randomized in Error|2
5427668|NCT02446769|18740657|P1|Study Period|Randomized in Error|0
5427669|NCT02446769|18740655|P3|Screening Period|Screen Failure|0
5427670|NCT02446769|18740656|P2|Screening Period|Screen Failure|0
5427671|NCT02446769|18740657|P1|Screening Period|Screen Failure|11
5427672|NCT02446743|18740680|P2|Overall Study|Other|3
5427673|NCT02446743|18740681|P1|Overall Study|Other|2
5427674|NCT02446743|18740680|P2|Overall Study|Adverse Event|1
5427675|NCT02446743|18740681|P1|Overall Study|Adverse Event|1
5427676|NCT02446743|18740680|P2|Overall Study|Lost to Follow-up|0
5427677|NCT02446743|18740681|P1|Overall Study|Lost to Follow-up|1
5427678|NCT02446743|18740680|P2|Overall Study|Withdrawal by Subject|1
5427679|NCT02446743|18740681|P1|Overall Study|Withdrawal by Subject|1
5427680|NCT02446717|18740836|P5|Overall Study|Withdrew consent|0
5427681|NCT02446717|18740837|P4|Overall Study|Withdrew consent|1
5427682|NCT02446717|18740838|P3|Overall Study|Withdrew consent|0
5427683|NCT02446717|18740839|P2|Overall Study|Withdrew consent|0
5427684|NCT02446717|18740840|P1|Overall Study|Withdrew consent|0
5427685|NCT02446717|18740836|P5|Overall Study|Lost to Follow-up|1
5427686|NCT02446717|18740837|P4|Overall Study|Lost to Follow-up|0
5427687|NCT02446717|18740838|P3|Overall Study|Lost to Follow-up|1
5427688|NCT02446717|18740839|P2|Overall Study|Lost to Follow-up|1
5427689|NCT02446717|18740840|P1|Overall Study|Lost to Follow-up|0
5427690|NCT02446717|18740836|P5|Overall Study|Adverse Event|0
5427691|NCT02446717|18740837|P4|Overall Study|Adverse Event|0
5427692|NCT02446717|18740838|P3|Overall Study|Adverse Event|1
5427693|NCT02446717|18740839|P2|Overall Study|Adverse Event|0
5427694|NCT02446717|18740840|P1|Overall Study|Adverse Event|0
5427695|NCT02446691|18740867|P1|Overall Study|Protocol Violation|1
5427696|NCT02446691|18740867|P1|Overall Study|Lost to Follow-up|8
5427697|NCT02446691|18740867|P1|Overall Study|Withdrawal by Subject|2
5427698|NCT02446418|18740937|P2|Overall Study|Protocol defined stopping criteria reach|0
5427699|NCT02446418|18740938|P1|Overall Study|Protocol defined stopping criteria reach|1
5427700|NCT02446418|18740937|P2|Overall Study|Lack of Efficacy|0
5427701|NCT02446418|18740938|P1|Overall Study|Lack of Efficacy|2
5427702|NCT02446418|18740937|P2|Overall Study|Protocol Violation|2
5427703|NCT02446418|18740938|P1|Overall Study|Protocol Violation|1
5427704|NCT02446418|18740937|P2|Overall Study|Lost to Follow-up|2
5427705|NCT02446418|18740938|P1|Overall Study|Lost to Follow-up|2
5427706|NCT02446418|18740937|P2|Overall Study|Withdrawal by Subject|3
5427707|NCT02446418|18740938|P1|Overall Study|Withdrawal by Subject|3
5427708|NCT02446418|18740937|P2|Overall Study|Physician Decision|1
5427709|NCT02446418|18740938|P1|Overall Study|Physician Decision|5
5427710|NCT02446418|18740937|P2|Overall Study|Adverse Event|8
5427711|NCT02446418|18740938|P1|Overall Study|Adverse Event|4
5427712|NCT02446171|18741009|P4|Overall Study|Withdrawal by Subject|0
5427713|NCT02446171|18741010|P3|Overall Study|Withdrawal by Subject|2
5427714|NCT02446171|18741011|P2|Overall Study|Withdrawal by Subject|0
5427715|NCT02446171|18741012|P1|Overall Study|Withdrawal by Subject|0
5427716|NCT02446015|18741083|P2|Overall Study|Withdrawal by Subject|0
5427717|NCT02446015|18741084|P1|Overall Study|Withdrawal by Subject|1
5427718|NCT02446015|18741083|P2|Overall Study|Adverse Event|1
5427719|NCT02446015|18741084|P1|Overall Study|Adverse Event|0
5427720|NCT02445963|18741099|P4|Overall Study|Symptoms post-vaccination|0
5427721|NCT02445963|18741100|P3|Overall Study|Symptoms post-vaccination|1
5427722|NCT02445963|18741101|P2|Overall Study|Symptoms post-vaccination|0
5427723|NCT02445963|18741102|P1|Overall Study|Symptoms post-vaccination|0
5427724|NCT02445963|18741099|P4|Overall Study|Change in employment|0
5427725|NCT02445963|18741100|P3|Overall Study|Change in employment|0
5427726|NCT02445963|18741101|P2|Overall Study|Change in employment|0
5427727|NCT02445963|18741102|P1|Overall Study|Change in employment|1
5427728|NCT02445963|18741099|P4|Overall Study|Lost to Follow-up|0
5427729|NCT02445963|18741100|P3|Overall Study|Lost to Follow-up|0
5427730|NCT02445963|18741101|P2|Overall Study|Lost to Follow-up|0
5427731|NCT02445963|18741102|P1|Overall Study|Lost to Follow-up|1
5427732|NCT02445794|18741227|P4|Overall Study|Adverse Event|0
5427733|NCT02445794|18741228|P3|Overall Study|Adverse Event|2
5427734|NCT02445794|18741229|P2|Overall Study|Adverse Event|0
5427735|NCT02445794|18741230|P1|Overall Study|Adverse Event|0
5427736|NCT02445755|18741260|P1|Overall Study|Screen Failure|5
5427737|NCT02445755|18741260|P1|Overall Study|Protocol Violation|6
5427738|NCT02445755|18741260|P1|Overall Study|Withdrawal by Subject|2
5427739|NCT02445586|18741274|P1|Overall Study|Medical Condition|1
5427740|NCT02445586|18741274|P1|Overall Study|Protocol Violation|1
5427741|NCT02445586|18741274|P1|Overall Study|Disease Progression|10
5427742|NCT02445586|18741274|P1|Overall Study|Withdrawal by Subject|13
5427743|NCT02445586|18741274|P1|Overall Study|Death|14
5427744|NCT02445573|18741314|P2|Overall Study|Lost to Follow-up|1
5427745|NCT02445573|18741315|P1|Overall Study|Lost to Follow-up|0
5427746|NCT02445573|18741314|P2|Overall Study|Withdrawal by Subject|1
5427747|NCT02445573|18741315|P1|Overall Study|Withdrawal by Subject|1
5427748|NCT02444793|18741412|P4|Overall Study|Objective progression or relapse|3
5427749|NCT02444793|18741413|P3|Overall Study|Objective progression or relapse|2
5427750|NCT02444793|18741414|P2|Overall Study|Objective progression or relapse|1
5427751|NCT02444793|18741415|P1|Overall Study|Objective progression or relapse|9
5427752|NCT02444793|18741412|P4|Overall Study|Other|0
5427753|NCT02444793|18741413|P3|Overall Study|Other|2
5427754|NCT02444793|18741414|P2|Overall Study|Other|0
5427755|NCT02444793|18741415|P1|Overall Study|Other|0
5427756|NCT02444793|18741412|P4|Overall Study|Death|0
5427757|NCT02444793|18741413|P3|Overall Study|Death|0
5427758|NCT02444793|18741414|P2|Overall Study|Death|3
5427759|NCT02444793|18741415|P1|Overall Study|Death|0
5427760|NCT02444793|18741412|P4|Overall Study|Lost to Follow-up|0
5427761|NCT02444793|18741413|P3|Overall Study|Lost to Follow-up|0
5427762|NCT02444793|18741414|P2|Overall Study|Lost to Follow-up|2
5427763|NCT02444793|18741415|P1|Overall Study|Lost to Follow-up|2
5427764|NCT02444533|18741574|P2|Overall Study|Only gave post-procedure complications|2
5427765|NCT02444533|18741575|P1|Overall Study|Only gave post-procedure complications|2
5427766|NCT02444533|18741574|P2|Overall Study|Not able to complete forms|2
5427767|NCT02444533|18741575|P1|Overall Study|Not able to complete forms|0
5427768|NCT02444182|18741608|P2|Overall Study|Lost to Follow-up|4
5427769|NCT02444182|18741609|P1|Overall Study|Lost to Follow-up|0
5427770|NCT02444182|18741608|P2|Overall Study|non-compliance|1
5427771|NCT02444182|18741609|P1|Overall Study|non-compliance|2
5427772|NCT02443883|18741632|P4|Overall Study|Randomized, but never treated|0
5427773|NCT02443883|18741633|P3|Overall Study|Randomized, but never treated|0
5427774|NCT02443883|18741634|P2|Overall Study|Randomized, but never treated|0
5427775|NCT02443883|18741635|P1|Overall Study|Randomized, but never treated|1
5427776|NCT02443883|18741632|P4|Overall Study|Withdrawal by Subject|2
5427777|NCT02443883|18741633|P3|Overall Study|Withdrawal by Subject|0
5427778|NCT02443883|18741634|P2|Overall Study|Withdrawal by Subject|0
5427779|NCT02443883|18741635|P1|Overall Study|Withdrawal by Subject|1
5427780|NCT02443883|18741632|P4|Overall Study|Physician Decision|3
5427781|NCT02443883|18741633|P3|Overall Study|Physician Decision|0
5427782|NCT02443883|18741634|P2|Overall Study|Physician Decision|1
5427783|NCT02443883|18741635|P1|Overall Study|Physician Decision|1
5427784|NCT02443883|18741632|P4|Overall Study|Lost to Follow-up|0
5427785|NCT02443883|18741633|P3|Overall Study|Lost to Follow-up|1
5427786|NCT02443883|18741634|P2|Overall Study|Lost to Follow-up|2
5427787|NCT02443883|18741635|P1|Overall Study|Lost to Follow-up|3
5427788|NCT02443883|18741632|P4|Overall Study|Adverse Event|0
5427789|NCT02443883|18741633|P3|Overall Study|Adverse Event|0
5427790|NCT02443883|18741634|P2|Overall Study|Adverse Event|1
5427791|NCT02443883|18741635|P1|Overall Study|Adverse Event|0
5427792|NCT02443805|18741655|P2|Overall Study|Any other reason not above-mentioned|2
5427793|NCT02443805|18741656|P1|Overall Study|Any other reason not above-mentioned|3
5427794|NCT02443805|18741655|P2|Overall Study|Withdrawal by parent/guardian|5
5427795|NCT02443805|18741656|P1|Overall Study|Withdrawal by parent/guardian|3
5427796|NCT02443805|18741655|P2|Overall Study|Non-compliance with study drug|4
5427797|NCT02443805|18741656|P1|Overall Study|Non-compliance with study drug|6
5427798|NCT02443805|18741655|P2|Overall Study|Lack of Efficacy|1
5427799|NCT02443805|18741656|P1|Overall Study|Lack of Efficacy|1
5427800|NCT02443805|18741655|P2|Overall Study|Protocol Violation|4
5427801|NCT02443805|18741656|P1|Overall Study|Protocol Violation|2
5427802|NCT02443805|18741655|P2|Overall Study|Pregnancy|5
5427803|NCT02443805|18741656|P1|Overall Study|Pregnancy|6
5427804|NCT02443805|18741655|P2|Overall Study|Lost to Follow-up|14
5427805|NCT02443805|18741656|P1|Overall Study|Lost to Follow-up|19
5427806|NCT02443805|18741655|P2|Overall Study|Withdrawal by Subject|74
5427807|NCT02443805|18741656|P1|Overall Study|Withdrawal by Subject|73
5427808|NCT02443805|18741655|P2|Overall Study|Adverse Event|18
5427809|NCT02443805|18741656|P1|Overall Study|Adverse Event|100
5427810|NCT02443740|18741687|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427811|NCT02443740|18741688|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427812|NCT02443740|18741689|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427813|NCT02443740|18741690|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427814|NCT02443740|18741691|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427815|NCT02443740|18741692|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
5427816|NCT02443740|18741693|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427817|NCT02443740|18741694|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427818|NCT02443740|18741695|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427819|NCT02443740|18741696|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427820|NCT02443740|18741697|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
5427821|NCT02443740|18741687|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
5427822|NCT02443740|18741688|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
5427823|NCT02443740|18741689|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
5427824|NCT02443740|18741690|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
5427825|NCT02443740|18741691|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
5427826|NCT02443740|18741692|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
5427827|NCT02443740|18741693|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
5427828|NCT02443740|18741694|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
5427829|NCT02443740|18741695|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
5427830|NCT02443740|18741696|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
5427831|NCT02443740|18741697|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
5427832|NCT02443740|18741687|P11|Intervention Period 1 (3 Days)|Adverse Event|0
5427833|NCT02443740|18741688|P10|Intervention Period 1 (3 Days)|Adverse Event|0
5427834|NCT02443740|18741689|P9|Intervention Period 1 (3 Days)|Adverse Event|0
5427835|NCT02443740|18741690|P8|Intervention Period 1 (3 Days)|Adverse Event|0
5427836|NCT02443740|18741691|P7|Intervention Period 1 (3 Days)|Adverse Event|0
5427837|NCT02443740|18741692|P6|Intervention Period 1 (3 Days)|Adverse Event|1
5427838|NCT02443740|18741693|P5|Intervention Period 1 (3 Days)|Adverse Event|0
5427839|NCT02443740|18741694|P4|Intervention Period 1 (3 Days)|Adverse Event|0
5427840|NCT02443740|18741695|P3|Intervention Period 1 (3 Days)|Adverse Event|0
5427841|NCT02443740|18741696|P2|Intervention Period 1 (3 Days)|Adverse Event|0
5427842|NCT02443740|18741697|P1|Intervention Period 1 (3 Days)|Adverse Event|0
5427843|NCT02443688|18741879|P3|Overall Study|Sponsor Request|0
5427844|NCT02443688|18741880|P2|Overall Study|Sponsor Request|1
5427845|NCT02443688|18741881|P1|Overall Study|Sponsor Request|2
5427846|NCT02443688|18741879|P3|Overall Study|Non-compliance with study drug|4
5427847|NCT02443688|18741880|P2|Overall Study|Non-compliance with study drug|2
5427848|NCT02443688|18741881|P1|Overall Study|Non-compliance with study drug|1
5427849|NCT02443688|18741879|P3|Overall Study|Withdrawal by Subject|4
5427850|NCT02443688|18741880|P2|Overall Study|Withdrawal by Subject|3
5427851|NCT02443688|18741881|P1|Overall Study|Withdrawal by Subject|3
5427852|NCT02443688|18741879|P3|Overall Study|Pregnancy|1
5427853|NCT02443688|18741880|P2|Overall Study|Pregnancy|0
5427854|NCT02443688|18741881|P1|Overall Study|Pregnancy|0
5427855|NCT02443688|18741879|P3|Overall Study|Physician Decision|1
5427856|NCT02443688|18741880|P2|Overall Study|Physician Decision|0
5427857|NCT02443688|18741881|P1|Overall Study|Physician Decision|3
5427858|NCT02443688|18741879|P3|Overall Study|Lost to Follow-up|0
5427859|NCT02443688|18741880|P2|Overall Study|Lost to Follow-up|0
5427860|NCT02443688|18741881|P1|Overall Study|Lost to Follow-up|1
5427861|NCT02443688|18741879|P3|Overall Study|Adverse Event|2
5427862|NCT02443688|18741880|P2|Overall Study|Adverse Event|3
5427863|NCT02443688|18741881|P1|Overall Study|Adverse Event|2
5427864|NCT02443402|18741991|P2|Overall Study|Screen Failure|2
5427865|NCT02443402|18741992|P1|Overall Study|Screen Failure|1
5427866|NCT02443402|18741991|P2|Overall Study|Withdrawal by Subject|1
5427867|NCT02443402|18741992|P1|Overall Study|Withdrawal by Subject|3
5427868|NCT02443337|18742054|P2|Overall Study|Withdrawal by Subject|1
5427869|NCT02443337|18742055|P1|Overall Study|Withdrawal by Subject|2
5427870|NCT02443337|18742054|P2|Overall Study|Clinical Progressive Disease|0
5427871|NCT02443337|18742055|P1|Overall Study|Clinical Progressive Disease|3
5427872|NCT02443337|18742054|P2|Overall Study|Adverse Event|1
5427873|NCT02443337|18742055|P1|Overall Study|Adverse Event|0
5427874|NCT02443298|18742073|P2|Overall Study|Withdrawal by Subject|2
5427875|NCT02443298|18742074|P1|Overall Study|Withdrawal by Subject|1
5427876|NCT02443298|18742073|P2|Overall Study|Adverse Event|3
5427877|NCT02443298|18742074|P1|Overall Study|Adverse Event|3
5427878|NCT02443103|18742094|P1|Overall Study|Noncompliance|1
5427879|NCT02443103|18742094|P1|Overall Study|Adverse Event|2
5427880|NCT02442830|18742107|P2|Overall Study|Technical Failure|1
5427881|NCT02442830|18742108|P1|Overall Study|Technical Failure|0
5427882|NCT02442804|18742118|P2|Overall Study|Adverse Event|0
5427883|NCT02442804|18742119|P1|Overall Study|Adverse Event|1
5427884|NCT02442804|18742118|P2|Overall Study|Withdrawal by Subject|1
5427885|NCT02442804|18742119|P1|Overall Study|Withdrawal by Subject|0
5427886|NCT02442622|18742226|P2|Overall Study|Withdrawal by Subject|1
5427887|NCT02442622|18742227|P1|Overall Study|Withdrawal by Subject|3
5427888|NCT02442349|18742237|P1|Overall Study|On-going Study at Data Cut-off|149
5427889|NCT02442349|18742237|P1|Overall Study|Withdrawal by Subject|8
5427890|NCT02442349|18742237|P1|Overall Study|Death|14
5427891|NCT02442310|18742242|P1|Overall Study|Withdrawal by Subject|1
5427892|NCT02442310|18742242|P1|Overall Study|Adverse Event|2
5427893|NCT02442284|18742264|P1|Overall Study|Other|1
5427894|NCT02442284|18742264|P1|Overall Study|Lost to Follow-up|3
5427895|NCT02442284|18742264|P1|Overall Study|Withdrew Consent|2
5427896|NCT02442284|18742264|P1|Overall Study|Adverse Event|1
5427897|NCT02442271|18742271|P1|Overall Study|Other|1
5427898|NCT02442271|18742271|P1|Overall Study|Lost to Follow-up|1
5427899|NCT02442271|18742271|P1|Overall Study|Withdrew Consent|1
5427900|NCT02442271|18742271|P1|Overall Study|Adverse Event|1
5427901|NCT02442206|18742297|P2|Period 2|Adverse Event|0
5427902|NCT02442206|18742298|P1|Period 2|Adverse Event|1
5427903|NCT02442206|18742297|P2|Period 1|COPD exacerbation|1
5427904|NCT02442206|18742298|P1|Period 1|COPD exacerbation|0
5427905|NCT02442206|18742297|P2|Period 1|withdrew consent|1
5427906|NCT02442206|18742298|P1|Period 1|withdrew consent|0
5427907|NCT02442206|18742297|P2|Period 1|Adverse Event|1
5427908|NCT02442206|18742298|P1|Period 1|Adverse Event|1
5427909|NCT02441946|18742330|P3|Extension Period (8 Weeks)|Withdrawal by Subject|0
5427910|NCT02441946|18742331|P2|Extension Period (8 Weeks)|Withdrawal by Subject|0
5427911|NCT02441946|18742332|P1|Extension Period (8 Weeks)|Withdrawal by Subject|1
5427912|NCT02441946|18742330|P3|Extension Period (8 Weeks)|Adverse Event|0
5427913|NCT02441946|18742331|P2|Extension Period (8 Weeks)|Adverse Event|0
5427914|NCT02441946|18742332|P1|Extension Period (8 Weeks)|Adverse Event|1
5427915|NCT02441946|18742330|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
5427916|NCT02441946|18742331|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
5427917|NCT02441946|18742332|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
5427918|NCT02441946|18742330|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
5427919|NCT02441946|18742331|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
5427920|NCT02441946|18742332|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
5427921|NCT02441946|18742330|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
5427922|NCT02441946|18742331|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
5427923|NCT02441946|18742332|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
5427924|NCT02441946|18742330|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
5427925|NCT02441946|18742331|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
5427926|NCT02441946|18742332|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
5427927|NCT02441946|18742330|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
5427928|NCT02441946|18742331|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
5427929|NCT02441946|18742332|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
5427930|NCT02441946|18742330|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
5427931|NCT02441946|18742331|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
5427932|NCT02441946|18742332|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
5427933|NCT02441946|18742330|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
5427934|NCT02441946|18742331|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
5427935|NCT02441946|18742332|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
5427936|NCT02441946|18742330|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
5427937|NCT02441946|18742331|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
5427938|NCT02441946|18742332|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
5427939|NCT02441946|18742330|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
5427940|NCT02441946|18742331|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
5427941|NCT02441946|18742332|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
5427942|NCT02441517|18742353|P1|Overall Study|Study Terminated by Sponsor|1
5427943|NCT02441517|18742353|P1|Overall Study|Withdrawal by Subject|2
5427944|NCT02441517|18742353|P1|Overall Study|Lost to Follow-up|1
5427945|NCT02441309|18742366|P3|Overall Study|Withdrawal by Subject|1
5427946|NCT02441309|18742367|P2|Overall Study|Withdrawal by Subject|0
5427947|NCT02441309|18742368|P1|Overall Study|Withdrawal by Subject|1
5427948|NCT02441309|18742366|P3|Overall Study|Adverse Event|0
5427949|NCT02441309|18742367|P2|Overall Study|Adverse Event|1
5427950|NCT02441309|18742368|P1|Overall Study|Adverse Event|0
5427951|NCT02441309|18742366|P3|Overall Study|Disease progression|2
5427952|NCT02441309|18742367|P2|Overall Study|Disease progression|1
5427953|NCT02441309|18742368|P1|Overall Study|Disease progression|2
5427954|NCT02441283|18742397|P1|Overall Study|Other, not specified|32
5427955|NCT02441283|18742397|P1|Overall Study|Death|1
5427956|NCT02441283|18742397|P1|Overall Study|Lost to Follow-up|42
5427957|NCT02441283|18742397|P1|Overall Study|Withdrew consent|15
5427958|NCT02441218|18742410|P2|Overall Study|Lost to Follow-up|1
5427959|NCT02441218|18742411|P1|Overall Study|Lost to Follow-up|2
5427960|NCT02441218|18742410|P2|Overall Study|Withdrawal by Subject|58
5427961|NCT02441218|18742411|P1|Overall Study|Withdrawal by Subject|73
5427962|NCT02441218|18742410|P2|Overall Study|Death|553
5427963|NCT02441218|18742411|P1|Overall Study|Death|503
5427964|NCT02441179|18742437|P2|Overall Study|Withdrawal by Subject|1
5427965|NCT02441179|18742438|P1|Overall Study|Withdrawal by Subject|1
5427966|NCT02441114|18742456|P1|Washout2|Withdrawal by Subject|4
5427967|NCT02441036|18742471|P5|Overall Study|No tissue resected|0
5427968|NCT02441036|18742472|P4|Overall Study|No tissue resected|1
5427969|NCT02441036|18742473|P3|Overall Study|No tissue resected|0
5427970|NCT02441036|18742474|P2|Overall Study|No tissue resected|1
5427971|NCT02441036|18742475|P1|Overall Study|No tissue resected|0
5427972|NCT02440789|18742502|P1|Overall Study|Not willing to adhere to reqs|1
5427973|NCT02440789|18742502|P1|Overall Study|Withdrawal by Subject|3
5427974|NCT02440594|18742577|P8|Overall Study|Administratively w/drawn|1
5427975|NCT02440594|18742578|P7|Overall Study|Administratively w/drawn|2
5427976|NCT02440594|18742579|P6|Overall Study|Administratively w/drawn|0
5427977|NCT02440594|18742580|P5|Overall Study|Administratively w/drawn|0
5427978|NCT02440594|18742581|P4|Overall Study|Administratively w/drawn|0
5427979|NCT02440594|18742582|P3|Overall Study|Administratively w/drawn|0
5427980|NCT02440594|18742583|P2|Overall Study|Administratively w/drawn|2
5427981|NCT02440594|18742584|P1|Overall Study|Administratively w/drawn|3
5427982|NCT02440594|18742577|P8|Overall Study|Withdrawal by Subject|7
5427983|NCT02440594|18742578|P7|Overall Study|Withdrawal by Subject|7
5427984|NCT02440594|18742579|P6|Overall Study|Withdrawal by Subject|2
5427985|NCT02440594|18742580|P5|Overall Study|Withdrawal by Subject|2
5427986|NCT02440594|18742581|P4|Overall Study|Withdrawal by Subject|38
5427987|NCT02440594|18742582|P3|Overall Study|Withdrawal by Subject|59
5427988|NCT02440594|18742583|P2|Overall Study|Withdrawal by Subject|67
5427989|NCT02440594|18742584|P1|Overall Study|Withdrawal by Subject|81
5427990|NCT02440594|18742577|P8|Overall Study|Cognitive Impairment/Communication Issue|0
5427991|NCT02440594|18742578|P7|Overall Study|Cognitive Impairment/Communication Issue|0
5427992|NCT02440594|18742579|P6|Overall Study|Cognitive Impairment/Communication Issue|1
5427993|NCT02440594|18742580|P5|Overall Study|Cognitive Impairment/Communication Issue|2
5427994|NCT02440594|18742581|P4|Overall Study|Cognitive Impairment/Communication Issue|4
5427995|NCT02440594|18742582|P3|Overall Study|Cognitive Impairment/Communication Issue|4
5427996|NCT02440594|18742583|P2|Overall Study|Cognitive Impairment/Communication Issue|6
5427997|NCT02440594|18742584|P1|Overall Study|Cognitive Impairment/Communication Issue|14
5427998|NCT02440594|18742577|P8|Overall Study|Lost to Follow-up|48
5427999|NCT02440594|18742578|P7|Overall Study|Lost to Follow-up|28
5428000|NCT02440594|18742579|P6|Overall Study|Lost to Follow-up|4
5428001|NCT02440594|18742580|P5|Overall Study|Lost to Follow-up|5
5428002|NCT02440594|18742581|P4|Overall Study|Lost to Follow-up|47
5428003|NCT02440594|18742582|P3|Overall Study|Lost to Follow-up|54
5428004|NCT02440594|18742583|P2|Overall Study|Lost to Follow-up|33
5428005|NCT02440594|18742584|P1|Overall Study|Lost to Follow-up|34
5428006|NCT02439320|18742701|P3|Overall Study|Randomization Failure|34
5428007|NCT02439320|18742702|P2|Overall Study|Randomization Failure|46
5428008|NCT02439320|18742703|P1|Overall Study|Randomization Failure|35
5428009|NCT02439320|18742701|P3|Overall Study|Sponsor Request|1
5428010|NCT02439320|18742702|P2|Overall Study|Sponsor Request|2
5428011|NCT02439320|18742703|P1|Overall Study|Sponsor Request|0
5428012|NCT02439320|18742701|P3|Overall Study|Physician Decision|0
5428013|NCT02439320|18742702|P2|Overall Study|Physician Decision|1
5428014|NCT02439320|18742703|P1|Overall Study|Physician Decision|2
5428015|NCT02439320|18742701|P3|Overall Study|Withdrawal by Subject|14
5428016|NCT02439320|18742702|P2|Overall Study|Withdrawal by Subject|16
5428017|NCT02439320|18742703|P1|Overall Study|Withdrawal by Subject|12
5428018|NCT02439320|18742701|P3|Overall Study|Pregnancy|1
5428019|NCT02439320|18742702|P2|Overall Study|Pregnancy|1
5428020|NCT02439320|18742703|P1|Overall Study|Pregnancy|0
5428021|NCT02439320|18742701|P3|Overall Study|Noncompliance with Protocol|7
5428022|NCT02439320|18742702|P2|Overall Study|Noncompliance with Protocol|11
5428023|NCT02439320|18742703|P1|Overall Study|Noncompliance with Protocol|10
5428024|NCT02439320|18742701|P3|Overall Study|Death|0
5428025|NCT02439320|18742702|P2|Overall Study|Death|1
5428026|NCT02439320|18742703|P1|Overall Study|Death|0
5428027|NCT02439320|18742701|P3|Overall Study|Lost to Follow-up|42
5428028|NCT02439320|18742702|P2|Overall Study|Lost to Follow-up|34
5428029|NCT02439320|18742703|P1|Overall Study|Lost to Follow-up|37
5428030|NCT02439320|18742701|P3|Overall Study|Adverse Event|0
5428031|NCT02439320|18742702|P2|Overall Study|Adverse Event|2
5428032|NCT02439320|18742703|P1|Overall Study|Adverse Event|0
5428033|NCT02439138|18742783|P1|Overall Study|PI decision to terminate the study|2
5428034|NCT02439138|18742783|P1|Overall Study|Adverse Event|1
5428035|NCT02438826|18742796|P4|Post-Treatment Phase|Withdrawal by Subject|0
5428036|NCT02438826|18742797|P3|Post-Treatment Phase|Withdrawal by Subject|0
5428037|NCT02438826|18742798|P2|Post-Treatment Phase|Withdrawal by Subject|1
5428038|NCT02438826|18742799|P1|Post-Treatment Phase|Withdrawal by Subject|1
5428039|NCT02438826|18742796|P4|Post-Treatment Phase|Physician Decision|0
5428040|NCT02438826|18742797|P3|Post-Treatment Phase|Physician Decision|0
5428041|NCT02438826|18742798|P2|Post-Treatment Phase|Physician Decision|0
5428042|NCT02438826|18742799|P1|Post-Treatment Phase|Physician Decision|1
5428043|NCT02438826|18742796|P4|Post-Treatment Phase|Lack of Efficacy|0
5428044|NCT02438826|18742797|P3|Post-Treatment Phase|Lack of Efficacy|0
5428045|NCT02438826|18742798|P2|Post-Treatment Phase|Lack of Efficacy|0
5428046|NCT02438826|18742799|P1|Post-Treatment Phase|Lack of Efficacy|4
5428047|NCT02438826|18742796|P4|Post-Treatment Phase|Adverse Event|0
5428048|NCT02438826|18742797|P3|Post-Treatment Phase|Adverse Event|0
5428049|NCT02438826|18742798|P2|Post-Treatment Phase|Adverse Event|0
5428050|NCT02438826|18742799|P1|Post-Treatment Phase|Adverse Event|3
5428051|NCT02438826|18742796|P4|Open-Label Treatment Phase|Withdrawal by Subject|0
5428052|NCT02438826|18742797|P3|Open-Label Treatment Phase|Withdrawal by Subject|0
5428053|NCT02438826|18742798|P2|Open-Label Treatment Phase|Withdrawal by Subject|7
5428054|NCT02438826|18742799|P1|Open-Label Treatment Phase|Withdrawal by Subject|6
5428055|NCT02438826|18742796|P4|Open-Label Treatment Phase|Lost to Follow-up|0
5428056|NCT02438826|18742797|P3|Open-Label Treatment Phase|Lost to Follow-up|0
5428057|NCT02438826|18742798|P2|Open-Label Treatment Phase|Lost to Follow-up|2
5428058|NCT02438826|18742799|P1|Open-Label Treatment Phase|Lost to Follow-up|0
5428059|NCT02438826|18742796|P4|Open-Label Treatment Phase|Lack of Efficacy|0
5428060|NCT02438826|18742797|P3|Open-Label Treatment Phase|Lack of Efficacy|0
5428061|NCT02438826|18742798|P2|Open-Label Treatment Phase|Lack of Efficacy|18
5428062|NCT02438826|18742799|P1|Open-Label Treatment Phase|Lack of Efficacy|27
5428063|NCT02438826|18742796|P4|Open-Label Treatment Phase|Adverse Event|0
5428064|NCT02438826|18742797|P3|Open-Label Treatment Phase|Adverse Event|0
5428065|NCT02438826|18742798|P2|Open-Label Treatment Phase|Adverse Event|6
5428066|NCT02438826|18742799|P1|Open-Label Treatment Phase|Adverse Event|11
5428067|NCT02438826|18742796|P4|Double-Blind Treatment Phase|Screen Failure|0
5428068|NCT02438826|18742797|P3|Double-Blind Treatment Phase|Screen Failure|0
5428069|NCT02438826|18742798|P2|Double-Blind Treatment Phase|Screen Failure|0
5428070|NCT02438826|18742799|P1|Double-Blind Treatment Phase|Screen Failure|2
5428071|NCT02438826|18742796|P4|Double-Blind Treatment Phase|Protocol Violation|0
5428072|NCT02438826|18742797|P3|Double-Blind Treatment Phase|Protocol Violation|0
5428073|NCT02438826|18742798|P2|Double-Blind Treatment Phase|Protocol Violation|2
5428074|NCT02438826|18742799|P1|Double-Blind Treatment Phase|Protocol Violation|1
5428075|NCT02438826|18742796|P4|Double-Blind Treatment Phase|Withdrawal by Subject|0
5428076|NCT02438826|18742797|P3|Double-Blind Treatment Phase|Withdrawal by Subject|0
5428077|NCT02438826|18742798|P2|Double-Blind Treatment Phase|Withdrawal by Subject|1
5428078|NCT02438826|18742799|P1|Double-Blind Treatment Phase|Withdrawal by Subject|1
5428079|NCT02438826|18742796|P4|Double-Blind Treatment Phase|Lack of Efficacy|0
5428080|NCT02438826|18742797|P3|Double-Blind Treatment Phase|Lack of Efficacy|0
5428081|NCT02438826|18742798|P2|Double-Blind Treatment Phase|Lack of Efficacy|0
5428082|NCT02438826|18742799|P1|Double-Blind Treatment Phase|Lack of Efficacy|1
5428083|NCT02438826|18742796|P4|Double-Blind Treatment Phase|Adverse Event|0
5428084|NCT02438826|18742797|P3|Double-Blind Treatment Phase|Adverse Event|0
5428085|NCT02438826|18742798|P2|Double-Blind Treatment Phase|Adverse Event|1
5428086|NCT02438826|18742799|P1|Double-Blind Treatment Phase|Adverse Event|1
5428087|NCT02438813|18742833|P1|Overall Study|Patients Not Treated/No EOT Visit|249
5428088|NCT02438813|18742833|P1|Overall Study|Study Ended by Sponsor|80
5428089|NCT02438813|18742833|P1|Overall Study|Patient Lost to Follow-Up|137
5428090|NCT02438813|18742833|P1|Overall Study|Patient Decision|59
5428091|NCT02438787|18742885|P3|Overall Study|Site terminated by sponsor|1
5428092|NCT02438787|18742886|P2|Overall Study|Site terminated by sponsor|0
5428093|NCT02438787|18742887|P1|Overall Study|Site terminated by sponsor|0
5428094|NCT02438787|18742885|P3|Overall Study|Other|0
5428095|NCT02438787|18742886|P2|Overall Study|Other|1
5428096|NCT02438787|18742887|P1|Overall Study|Other|0
5428097|NCT02438787|18742885|P3|Overall Study|Study discontinued by sponsor|69
5428098|NCT02438787|18742886|P2|Overall Study|Study discontinued by sponsor|72
5428099|NCT02438787|18742887|P1|Overall Study|Study discontinued by sponsor|64
5428100|NCT02438787|18742885|P3|Overall Study|Withdrawal by Subject|10
5428101|NCT02438787|18742886|P2|Overall Study|Withdrawal by Subject|7
5428102|NCT02438787|18742887|P1|Overall Study|Withdrawal by Subject|15
5428103|NCT02438787|18742885|P3|Overall Study|Protocol Violation|1
5428104|NCT02438787|18742886|P2|Overall Study|Protocol Violation|0
5428105|NCT02438787|18742887|P1|Overall Study|Protocol Violation|0
5428106|NCT02438787|18742885|P3|Overall Study|Lost to Follow-up|0
5428107|NCT02438787|18742886|P2|Overall Study|Lost to Follow-up|1
5428108|NCT02438787|18742887|P1|Overall Study|Lost to Follow-up|0
5428109|NCT02438787|18742885|P3|Overall Study|Lack of Efficacy|0
5428110|NCT02438787|18742886|P2|Overall Study|Lack of Efficacy|2
5428111|NCT02438787|18742887|P1|Overall Study|Lack of Efficacy|1
5428112|NCT02438787|18742885|P3|Overall Study|Adverse Event|2
5428113|NCT02438787|18742886|P2|Overall Study|Adverse Event|0
5428114|NCT02438787|18742887|P1|Overall Study|Adverse Event|1
5428115|NCT02438384|18743020|P3|Overall Study|Lost to Follow-up|4
5428116|NCT02438384|18743021|P2|Overall Study|Lost to Follow-up|6
5428117|NCT02438384|18743022|P1|Overall Study|Lost to Follow-up|8
5428118|NCT02438280|18743041|P2|Overall Study|Physician Decision|0
5428119|NCT02438280|18743042|P1|Overall Study|Physician Decision|1
5428120|NCT02438137|18743052|P2|Overall Study|Physician Decision|1
5428121|NCT02438137|18743053|P1|Overall Study|Physician Decision|0
5428122|NCT02438137|18743052|P2|Overall Study|Withdrawal by Subject|3
5428123|NCT02438137|18743053|P1|Overall Study|Withdrawal by Subject|4
5428124|NCT02438137|18743052|P2|Overall Study|Adverse Event|0
5428125|NCT02438137|18743053|P1|Overall Study|Adverse Event|1
5428126|NCT02438137|18743052|P2|Overall Study|Lost to Follow-up|2
5428127|NCT02438137|18743053|P1|Overall Study|Lost to Follow-up|3
5428128|NCT02437903|18743061|P1|Overall Study|Lost to Follow-up|3
5428129|NCT02437903|18743061|P1|Overall Study|Withdrawal by Subject|1
5428130|NCT02437903|18743061|P1|Overall Study|Adverse Event|1
5428131|NCT02437890|18743074|P5|Overall Study|Death|0
5428132|NCT02437890|18743075|P4|Overall Study|Death|2
5428133|NCT02437890|18743076|P3|Overall Study|Death|0
5428134|NCT02437890|18743077|P2|Overall Study|Death|0
5428135|NCT02437890|18743078|P1|Overall Study|Death|0
5428136|NCT02437890|18743074|P5|Overall Study|Withdrawal by Subject|5
5428137|NCT02437890|18743075|P4|Overall Study|Withdrawal by Subject|5
5428138|NCT02437890|18743076|P3|Overall Study|Withdrawal by Subject|6
5428139|NCT02437890|18743077|P2|Overall Study|Withdrawal by Subject|2
5428140|NCT02437890|18743078|P1|Overall Study|Withdrawal by Subject|1
5428141|NCT02437890|18743074|P5|Overall Study|Adverse Event|7
5428142|NCT02437890|18743075|P4|Overall Study|Adverse Event|11
5428143|NCT02437890|18743076|P3|Overall Study|Adverse Event|5
5428144|NCT02437890|18743077|P2|Overall Study|Adverse Event|9
5428145|NCT02437890|18743078|P1|Overall Study|Adverse Event|4
5428146|NCT02437890|18743074|P5|Overall Study|Lack of Efficacy|1
5428147|NCT02437890|18743075|P4|Overall Study|Lack of Efficacy|3
5428148|NCT02437890|18743076|P3|Overall Study|Lack of Efficacy|0
5428149|NCT02437890|18743077|P2|Overall Study|Lack of Efficacy|3
5428150|NCT02437890|18743078|P1|Overall Study|Lack of Efficacy|1
5428151|NCT02437890|18743074|P5|Overall Study|Unable to attend visit(s)|0
5428152|NCT02437890|18743075|P4|Overall Study|Unable to attend visit(s)|0
5428153|NCT02437890|18743076|P3|Overall Study|Unable to attend visit(s)|0
5428154|NCT02437890|18743077|P2|Overall Study|Unable to attend visit(s)|0
5428155|NCT02437890|18743078|P1|Overall Study|Unable to attend visit(s)|1
5428156|NCT02437890|18743074|P5|Overall Study|Physician Decision|0
5428157|NCT02437890|18743075|P4|Overall Study|Physician Decision|1
5428158|NCT02437890|18743076|P3|Overall Study|Physician Decision|0
5428159|NCT02437890|18743077|P2|Overall Study|Physician Decision|0
5428160|NCT02437890|18743078|P1|Overall Study|Physician Decision|0
5428161|NCT02437890|18743074|P5|Overall Study|Sponsor's decision|2
5428162|NCT02437890|18743075|P4|Overall Study|Sponsor's decision|0
5428163|NCT02437890|18743076|P3|Overall Study|Sponsor's decision|4
5428164|NCT02437890|18743077|P2|Overall Study|Sponsor's decision|1
5428165|NCT02437890|18743078|P1|Overall Study|Sponsor's decision|1
5428166|NCT02437890|18743074|P5|Overall Study|Non-compliance to study drug|1
5428167|NCT02437890|18743075|P4|Overall Study|Non-compliance to study drug|0
5428168|NCT02437890|18743076|P3|Overall Study|Non-compliance to study drug|0
5428169|NCT02437890|18743077|P2|Overall Study|Non-compliance to study drug|1
5428170|NCT02437890|18743078|P1|Overall Study|Non-compliance to study drug|0
5428171|NCT02437864|18743291|P2|Overall Study|Protocol Violation|0
5428172|NCT02437864|18743292|P1|Overall Study|Protocol Violation|4
5428173|NCT02437513|18743313|P1|Overall Study|Withdrawal by Subject|2
5428174|NCT02437409|18743338|P1|Overall Study|Screening failure|12
5428175|NCT02437409|18743338|P1|Overall Study|Withdrawal by Subject|3
5428176|NCT02437318|18743431|P2|Overall Study|Untreated|1
5428177|NCT02437318|18743432|P1|Overall Study|Untreated|0
5428178|NCT02437318|18743431|P2|Overall Study|Protocol Violation|6
5428179|NCT02437318|18743432|P1|Overall Study|Protocol Violation|5
5428180|NCT02437318|18743431|P2|Overall Study|Death|4
5428181|NCT02437318|18743432|P1|Overall Study|Death|4
5428182|NCT02437318|18743431|P2|Overall Study|Adverse Event|3
5428183|NCT02437318|18743432|P1|Overall Study|Adverse Event|14
5428184|NCT02437318|18743431|P2|Overall Study|Physician Decision|10
5428185|NCT02437318|18743432|P1|Overall Study|Physician Decision|11
5428186|NCT02437318|18743431|P2|Overall Study|Subject/guardian decision|10
5428187|NCT02437318|18743432|P1|Overall Study|Subject/guardian decision|22
5428188|NCT02437318|18743431|P2|Overall Study|Progressive disease|208
5428189|NCT02437318|18743432|P1|Overall Study|Progressive disease|173
5428190|NCT02437305|18743440|P2|Overall Study|Lost to Follow-up|12
5428191|NCT02437305|18743441|P1|Overall Study|Lost to Follow-up|18
5428192|NCT02437188|18743468|P2|Overall Study|Adverse Event|1
5428193|NCT02437188|18743469|P1|Overall Study|Adverse Event|0
5428194|NCT02437188|18743468|P2|Overall Study|Randomized but did not receive surgery|8
5428195|NCT02437188|18743469|P1|Overall Study|Randomized but did not receive surgery|4
5428196|NCT02437162|18743486|P3|Overall Study|Other|1
5428197|NCT02437162|18743487|P2|Overall Study|Other|0
5428198|NCT02437162|18743488|P1|Overall Study|Other|0
5428199|NCT02437162|18743486|P3|Overall Study|Death|0
5428200|NCT02437162|18743487|P2|Overall Study|Death|1
5428201|NCT02437162|18743488|P1|Overall Study|Death|0
5428202|NCT02437162|18743486|P3|Overall Study|Lost to Follow-up|1
5428203|NCT02437162|18743487|P2|Overall Study|Lost to Follow-up|0
5428204|NCT02437162|18743488|P1|Overall Study|Lost to Follow-up|1
5428205|NCT02437162|18743486|P3|Overall Study|Adverse Event|0
5428206|NCT02437162|18743487|P2|Overall Study|Adverse Event|1
5428207|NCT02437162|18743488|P1|Overall Study|Adverse Event|0
5428208|NCT02437162|18743486|P3|Overall Study|Withdrawal by Subject|9
5428209|NCT02437162|18743487|P2|Overall Study|Withdrawal by Subject|7
5428210|NCT02437162|18743488|P1|Overall Study|Withdrawal by Subject|13
5428211|NCT02437162|18743486|P3|Overall Study|Study discontinued by Sponsor|97
5428212|NCT02437162|18743487|P2|Overall Study|Study discontinued by Sponsor|98
5428213|NCT02437162|18743488|P1|Overall Study|Study discontinued by Sponsor|93
5428214|NCT02437162|18743486|P3|Overall Study|Randomized but not treated|1
5428215|NCT02437162|18743487|P2|Overall Study|Randomized but not treated|0
5428216|NCT02437162|18743488|P1|Overall Study|Randomized but not treated|0
5428217|NCT02437162|18743486|P3|Overall Study|Protocol Violation|0
5428218|NCT02437162|18743487|P2|Overall Study|Protocol Violation|1
5428219|NCT02437162|18743488|P1|Overall Study|Protocol Violation|0
5428220|NCT02436915|18743608|P2|Overall Study|Withdrawal by Subject|1
5428221|NCT02436915|18743609|P1|Overall Study|Withdrawal by Subject|0
5428222|NCT02436889|18743631|P2|Overall Study|Does not like/could not tolerate medicat|1
5428223|NCT02436889|18743632|P1|Overall Study|Does not like/could not tolerate medicat|0
5428224|NCT02436889|18743631|P2|Overall Study|No improvement in symptoms|0
5428225|NCT02436889|18743632|P1|Overall Study|No improvement in symptoms|1
5428226|NCT02436811|18743651|P3|Overall Study|Lost to Follow-up|7
5428227|NCT02436811|18743652|P2|Overall Study|Lost to Follow-up|9
5428228|NCT02436811|18743653|P1|Overall Study|Lost to Follow-up|2
5428229|NCT02436759|18743663|P2|Overall Study|Withdrawal by Subject|1
5428230|NCT02436759|18743664|P1|Overall Study|Withdrawal by Subject|0
5428231|NCT02436759|18743663|P2|Overall Study|Protocol Violation|0
5428232|NCT02436759|18743664|P1|Overall Study|Protocol Violation|1
5428233|NCT02436759|18743663|P2|Overall Study|Adverse Event|0
5428234|NCT02436759|18743664|P1|Overall Study|Adverse Event|3
5428235|NCT02436681|18743672|P1|Overall Study|Death|2
5428236|NCT02436681|18743672|P1|Overall Study|Withdrawal by Subject|2
5428237|NCT02436681|18743672|P1|Overall Study|Lost to Follow-up|10
5428238|NCT02436577|18743712|P6|Overall Study|Protocol Deviation|0
5428239|NCT02436577|18743713|P5|Overall Study|Protocol Deviation|0
5428240|NCT02436577|18743714|P4|Overall Study|Protocol Deviation|0
5428241|NCT02436577|18743715|P3|Overall Study|Protocol Deviation|0
5428242|NCT02436577|18743716|P2|Overall Study|Protocol Deviation|1
5428243|NCT02436577|18743717|P1|Overall Study|Protocol Deviation|0
5428244|NCT02436356|18743773|P3|Overall Study|Withdrawal by Subject|0
5428245|NCT02436356|18743774|P2|Overall Study|Withdrawal by Subject|0
5428246|NCT02436356|18743775|P1|Overall Study|Withdrawal by Subject|1
5428247|NCT02436356|18743773|P3|Overall Study|Excluded due to other medical conditions|0
5428248|NCT02436356|18743774|P2|Overall Study|Excluded due to other medical conditions|0
5428249|NCT02436356|18743775|P1|Overall Study|Excluded due to other medical conditions|3
5428250|NCT02436356|18743773|P3|Overall Study|Surgical Approach (Dorsal not volar)|0
5428251|NCT02436356|18743774|P2|Overall Study|Surgical Approach (Dorsal not volar)|0
5428252|NCT02436356|18743775|P1|Overall Study|Surgical Approach (Dorsal not volar)|1
5428253|NCT02436356|18743773|P3|Overall Study|Lost to Follow-up|0
5428254|NCT02436356|18743774|P2|Overall Study|Lost to Follow-up|1
5428255|NCT02436356|18743775|P1|Overall Study|Lost to Follow-up|0
5428256|NCT02436356|18743773|P3|Overall Study|Excluded by MRI Screening|2
5428257|NCT02436356|18743774|P2|Overall Study|Excluded by MRI Screening|0
5428258|NCT02436356|18743775|P1|Overall Study|Excluded by MRI Screening|0
5428259|NCT02436330|18743806|P2|Cohort 6|Withdrawal by Subject|1
5428260|NCT02436330|18743807|P1|Cohort 6|Withdrawal by Subject|1
5428261|NCT02436330|18743806|P2|Cohort 6|Lost to Follow-up|0
5428262|NCT02436330|18743807|P1|Cohort 6|Lost to Follow-up|2
5428263|NCT02436330|18743806|P2|Cohort 5|Withdrawal by Subject|2
5428264|NCT02436330|18743807|P1|Cohort 5|Withdrawal by Subject|3
5428265|NCT02436330|18743806|P2|Cohort 5|Lost to Follow-up|2
5428266|NCT02436330|18743807|P1|Cohort 5|Lost to Follow-up|3
5428267|NCT02436330|18743806|P2|Cohort 4|Withdrawal by Subject|0
5428268|NCT02436330|18743807|P1|Cohort 4|Withdrawal by Subject|1
5428269|NCT02436330|18743806|P2|Cohort 4|Lost to Follow-up|0
5428270|NCT02436330|18743807|P1|Cohort 4|Lost to Follow-up|1
5428271|NCT02436330|18743806|P2|Cohort 3|Withdrawal by Subject|0
5428272|NCT02436330|18743807|P1|Cohort 3|Withdrawal by Subject|4
5428273|NCT02436330|18743806|P2|Cohort 3|Lost to Follow-up|0
5428274|NCT02436330|18743807|P1|Cohort 3|Lost to Follow-up|1
5428275|NCT02436330|18743806|P2|Cohort 2|Withdrawal by Subject|3
5428276|NCT02436330|18743807|P1|Cohort 2|Withdrawal by Subject|2
5428277|NCT02436330|18743806|P2|Cohort 2|Lost to Follow-up|0
5428278|NCT02436330|18743807|P1|Cohort 2|Lost to Follow-up|2
5428279|NCT02436330|18743806|P2|Cohort 1|Withdrawal by Subject|1
5428280|NCT02436330|18743807|P1|Cohort 1|Withdrawal by Subject|0
5428281|NCT02436330|18743806|P2|Cohort 1|Lost to Follow-up|2
5428282|NCT02436330|18743807|P1|Cohort 1|Lost to Follow-up|5
5428283|NCT02436304|18743852|P3|Overall Study|Randomized in error didn't meet I/E crit|1
5428284|NCT02436304|18743853|P2|Overall Study|Randomized in error didn't meet I/E crit|0
5428285|NCT02436304|18743854|P1|Overall Study|Randomized in error didn't meet I/E crit|0
5428286|NCT02436304|18743852|P3|Overall Study|Withdrawal by Subject|0
5428287|NCT02436304|18743853|P2|Overall Study|Withdrawal by Subject|1
5428288|NCT02436304|18743854|P1|Overall Study|Withdrawal by Subject|0
5428289|NCT02436304|18743852|P3|Overall Study|Lost to Follow-up|0
5428290|NCT02436304|18743853|P2|Overall Study|Lost to Follow-up|1
5428291|NCT02436304|18743854|P1|Overall Study|Lost to Follow-up|0
5428292|NCT02436239|18743873|P4|Down-Taper Period|Withdrawal by Subject|2
5428293|NCT02436239|18743874|P3|Down-Taper Period|Withdrawal by Subject|1
5428294|NCT02436239|18743875|P2|Down-Taper Period|Withdrawal by Subject|4
5428295|NCT02436239|18743876|P1|Down-Taper Period|Withdrawal by Subject|4
5428296|NCT02436239|18743873|P4|Open-Lable Treatment Period|Other Reason|0
5428297|NCT02436239|18743874|P3|Open-Lable Treatment Period|Other Reason|0
5428298|NCT02436239|18743875|P2|Open-Lable Treatment Period|Other Reason|1
5428299|NCT02436239|18743876|P1|Open-Lable Treatment Period|Other Reason|1
5428300|NCT02436239|18743873|P4|Open-Lable Treatment Period|Noncompliance with Study Drug|1
5428301|NCT02436239|18743874|P3|Open-Lable Treatment Period|Noncompliance with Study Drug|3
5428302|NCT02436239|18743875|P2|Open-Lable Treatment Period|Noncompliance with Study Drug|6
5428303|NCT02436239|18743876|P1|Open-Lable Treatment Period|Noncompliance with Study Drug|5
5428304|NCT02436239|18743873|P4|Open-Lable Treatment Period|Protocol Violation|0
5428305|NCT02436239|18743874|P3|Open-Lable Treatment Period|Protocol Violation|1
5428306|NCT02436239|18743875|P2|Open-Lable Treatment Period|Protocol Violation|1
5428307|NCT02436239|18743876|P1|Open-Lable Treatment Period|Protocol Violation|0
5428308|NCT02436239|18743873|P4|Open-Lable Treatment Period|Lost to Follow-up|1
5428309|NCT02436239|18743874|P3|Open-Lable Treatment Period|Lost to Follow-up|4
5428310|NCT02436239|18743875|P2|Open-Lable Treatment Period|Lost to Follow-up|2
5428311|NCT02436239|18743876|P1|Open-Lable Treatment Period|Lost to Follow-up|4
5428312|NCT02436239|18743873|P4|Open-Lable Treatment Period|Withdrawal by Subject|0
5428313|NCT02436239|18743874|P3|Open-Lable Treatment Period|Withdrawal by Subject|9
5428314|NCT02436239|18743875|P2|Open-Lable Treatment Period|Withdrawal by Subject|15
5428315|NCT02436239|18743876|P1|Open-Lable Treatment Period|Withdrawal by Subject|10
5428316|NCT02436239|18743873|P4|Open-Lable Treatment Period|Lack of Efficacy|1
5428317|NCT02436239|18743874|P3|Open-Lable Treatment Period|Lack of Efficacy|6
5428318|NCT02436239|18743875|P2|Open-Lable Treatment Period|Lack of Efficacy|6
5428319|NCT02436239|18743876|P1|Open-Lable Treatment Period|Lack of Efficacy|1
5428320|NCT02436239|18743873|P4|Open-Lable Treatment Period|Adverse Event|2
5428321|NCT02436239|18743874|P3|Open-Lable Treatment Period|Adverse Event|4
5428322|NCT02436239|18743875|P2|Open-Lable Treatment Period|Adverse Event|3
5428323|NCT02436239|18743876|P1|Open-Lable Treatment Period|Adverse Event|12
5428324|NCT02436200|18743898|P1|Overall Study|Significant outlier|1
5428325|NCT02436135|18743905|P2|Overall Study|Study Terminated By Sponsor|1
5428326|NCT02436135|18743906|P1|Overall Study|Study Terminated By Sponsor|0
5428327|NCT02436135|18743905|P2|Overall Study|Withdrawal by Participant|0
5428328|NCT02436135|18743906|P1|Overall Study|Withdrawal by Participant|1
5428329|NCT02436135|18743905|P2|Overall Study|Adverse Event|0
5428330|NCT02436135|18743906|P1|Overall Study|Adverse Event|1
5428331|NCT02436135|18743905|P2|Overall Study|Investigator Discretion|2
5428332|NCT02436135|18743906|P1|Overall Study|Investigator Discretion|1
5428333|NCT02436135|18743905|P2|Overall Study|Progressive Disease|1
5428334|NCT02436135|18743906|P1|Overall Study|Progressive Disease|3
5428335|NCT02436005|18743941|P2|Second Intervention|Adverse Event|1
5428336|NCT02436005|18743942|P1|Second Intervention|Adverse Event|0
5428337|NCT02435966|18744007|P3|Overall Study|Withdrawal by Subject|0
5428338|NCT02435966|18744008|P2|Overall Study|Withdrawal by Subject|1
5428339|NCT02435966|18744009|P1|Overall Study|Withdrawal by Subject|0
5428340|NCT02435914|18744021|P4|Overall Study|Other Miscellaneous Reason|0
5428341|NCT02435914|18744022|P3|Overall Study|Other Miscellaneous Reason|1
5428342|NCT02435914|18744023|P2|Overall Study|Other Miscellaneous Reason|0
5428343|NCT02435914|18744024|P1|Overall Study|Other Miscellaneous Reason|0
5428344|NCT02435914|18744021|P4|Overall Study|Withdrawal by Subject|0
5428345|NCT02435914|18744022|P3|Overall Study|Withdrawal by Subject|0
5428346|NCT02435914|18744023|P2|Overall Study|Withdrawal by Subject|1
5428347|NCT02435914|18744024|P1|Overall Study|Withdrawal by Subject|0
5428348|NCT02435914|18744021|P4|Overall Study|Ocular Adverse Event|0
5428349|NCT02435914|18744022|P3|Overall Study|Ocular Adverse Event|0
5428350|NCT02435914|18744023|P2|Overall Study|Ocular Adverse Event|0
5428351|NCT02435914|18744024|P1|Overall Study|Ocular Adverse Event|1
5428352|NCT02435836|18744052|P1|Overall Study|AE of Worsening Schizophrenia|96
5428353|NCT02435836|18744052|P1|Overall Study|Met Withdrawal Criteria|7
5428354|NCT02435836|18744052|P1|Overall Study|Protocol Violation|6
5428355|NCT02435836|18744052|P1|Overall Study|Noncompliance|27
5428356|NCT02435836|18744052|P1|Overall Study|Sponsor discontinued trial|167
5428357|NCT02435836|18744052|P1|Overall Study|Adverse Event|44
5428358|NCT02435836|18744052|P1|Overall Study|Insufficient Clinical Response|26
5428359|NCT02435836|18744052|P1|Overall Study|Withdrawal by Subject|236
5428360|NCT02435836|18744052|P1|Overall Study|Lack of Efficacy|1
5428361|NCT02435836|18744052|P1|Overall Study|Lost to Follow-up|21
5428362|NCT02435433|18744111|P5|Overall Study|Lost to Follow-up|0
5428363|NCT02435433|18744112|P4|Overall Study|Lost to Follow-up|0
5428364|NCT02435433|18744113|P3|Overall Study|Lost to Follow-up|0
5428365|NCT02435433|18744114|P2|Overall Study|Lost to Follow-up|2
5428366|NCT02435433|18744115|P1|Overall Study|Lost to Follow-up|2
5428367|NCT02435433|18744111|P5|Overall Study|Withdrawal by Subject|0
5428368|NCT02435433|18744112|P4|Overall Study|Withdrawal by Subject|0
5428369|NCT02435433|18744113|P3|Overall Study|Withdrawal by Subject|0
5428370|NCT02435433|18744114|P2|Overall Study|Withdrawal by Subject|3
5428371|NCT02435433|18744115|P1|Overall Study|Withdrawal by Subject|2
5428372|NCT02435433|18744111|P5|Overall Study|On Treatment|0
5428373|NCT02435433|18744112|P4|Overall Study|On Treatment|0
5428374|NCT02435433|18744113|P3|Overall Study|On Treatment|0
5428375|NCT02435433|18744114|P2|Overall Study|On Treatment|0
5428376|NCT02435433|18744115|P1|Overall Study|On Treatment|11
5428377|NCT02435277|18744141|P4|Overall Study|Withdrawal by Subject|0
5428378|NCT02435277|18744142|P3|Overall Study|Withdrawal by Subject|0
5428379|NCT02435277|18744143|P2|Overall Study|Withdrawal by Subject|0
5428380|NCT02435277|18744144|P1|Overall Study|Withdrawal by Subject|1
5428381|NCT02435277|18744141|P4|Overall Study|Adverse Event|0
5428382|NCT02435277|18744142|P3|Overall Study|Adverse Event|0
5428383|NCT02435277|18744143|P2|Overall Study|Adverse Event|1
5428384|NCT02435277|18744144|P1|Overall Study|Adverse Event|1
5428385|NCT02435147|18744158|P1|Overall Study|non-evaluable DXA scan|11
5428386|NCT02435069|18744163|P5|Effectiveness - Second Intervention|Lack of Efficacy|1
5428387|NCT02435069|18744164|P4|Effectiveness - Second Intervention|Lack of Efficacy|0
5428388|NCT02435069|18744165|P3|Effectiveness - Second Intervention|Lack of Efficacy|0
5428389|NCT02435069|18744166|P2|Effectiveness - Second Intervention|Lack of Efficacy|0
5428390|NCT02435069|18744167|P1|Effectiveness - Second Intervention|Lack of Efficacy|0
5428391|NCT02435069|18744163|P5|Dose Response - First Intervention|Adverse Event|0
5428392|NCT02435069|18744164|P4|Dose Response - First Intervention|Adverse Event|0
5428393|NCT02435069|18744165|P3|Dose Response - First Intervention|Adverse Event|1
5428394|NCT02435069|18744166|P2|Dose Response - First Intervention|Adverse Event|1
5428395|NCT02435069|18744167|P1|Dose Response - First Intervention|Adverse Event|0
5428396|NCT02434939|18744189|P2|Overall Study|Adverse Event|1
5428397|NCT02434939|18744190|P1|Overall Study|Adverse Event|0
5428398|NCT02434939|18744189|P2|Overall Study|Withdrawal by Subject|0
5428399|NCT02434939|18744190|P1|Overall Study|Withdrawal by Subject|3
5428400|NCT02434939|18744189|P2|Overall Study|Lack of Efficacy|48
5428401|NCT02434939|18744190|P1|Overall Study|Lack of Efficacy|34
5428402|NCT02434770|18744205|P3|Week 18 to Week|Received Non-study Polio Vaccine|3
5428403|NCT02434770|18744206|P2|Week 18 to Week|Received Non-study Polio Vaccine|6
5428404|NCT02434770|18744207|P1|Week 18 to Week|Received Non-study Polio Vaccine|6
5428405|NCT02434770|18744205|P3|Week 18 to Week|Withdrawal by Subject|2
5428406|NCT02434770|18744206|P2|Week 18 to Week|Withdrawal by Subject|0
5428407|NCT02434770|18744207|P1|Week 18 to Week|Withdrawal by Subject|0
5428408|NCT02434770|18744205|P3|Week 18 to Week|Lost to Follow-up|1
5428409|NCT02434770|18744206|P2|Week 18 to Week|Lost to Follow-up|2
5428410|NCT02434770|18744207|P1|Week 18 to Week|Lost to Follow-up|2
5428411|NCT02434770|18744205|P3|Week 1 to Week 18|Death|0
5428412|NCT02434770|18744206|P2|Week 1 to Week 18|Death|0
5428413|NCT02434770|18744207|P1|Week 1 to Week 18|Death|1
5428414|NCT02434770|18744205|P3|Week 1 to Week 18|Relocated Out of Study Area|1
5428415|NCT02434770|18744206|P2|Week 1 to Week 18|Relocated Out of Study Area|0
5428416|NCT02434770|18744207|P1|Week 1 to Week 18|Relocated Out of Study Area|0
5428417|NCT02434770|18744205|P3|Week 1 to Week 18|Received Non-study Polio Vaccine|9
5428418|NCT02434770|18744206|P2|Week 1 to Week 18|Received Non-study Polio Vaccine|10
5428419|NCT02434770|18744207|P1|Week 1 to Week 18|Received Non-study Polio Vaccine|8
5428420|NCT02434770|18744205|P3|Week 1 to Week 18|Withdrawal by Subject|5
5428421|NCT02434770|18744206|P2|Week 1 to Week 18|Withdrawal by Subject|12
5428422|NCT02434770|18744207|P1|Week 1 to Week 18|Withdrawal by Subject|6
5428423|NCT02434770|18744205|P3|Week 1 to Week 18|Lost to Follow-up|2
5428424|NCT02434770|18744206|P2|Week 1 to Week 18|Lost to Follow-up|0
5428425|NCT02434770|18744207|P1|Week 1 to Week 18|Lost to Follow-up|0
5428426|NCT02434471|18744357|P1|Overall Study|Physician Decision|9
5428427|NCT02434328|18744366|P2|Overall Study|Other|1
5428428|NCT02434328|18744367|P1|Overall Study|Other|4
5428429|NCT02434328|18744366|P2|Overall Study|Lost to Follow-up|6
5428430|NCT02434328|18744367|P1|Overall Study|Lost to Follow-up|1
5428431|NCT02434328|18744366|P2|Overall Study|Death|7
5428432|NCT02434328|18744367|P1|Overall Study|Death|4
5428433|NCT02434328|18744366|P2|Overall Study|Withdrawal by Subject|21
5428434|NCT02434328|18744367|P1|Overall Study|Withdrawal by Subject|12
5428435|NCT02434328|18744366|P2|Overall Study|Physician Decision|1
5428436|NCT02434328|18744367|P1|Overall Study|Physician Decision|0
5428437|NCT02434328|18744366|P2|Overall Study|Lack of Efficacy|2
5428438|NCT02434328|18744367|P1|Overall Study|Lack of Efficacy|0
5428439|NCT02434328|18744366|P2|Overall Study|Adverse Event|4
5428440|NCT02434328|18744367|P1|Overall Study|Adverse Event|9
5428441|NCT02433834|18744442|P1|Overall Study|Physician Decision|1
5428442|NCT02433834|18744442|P1|Overall Study|Adverse Event|6
5428443|NCT02433834|18744442|P1|Overall Study|Withdrawal by Subject|14
5428444|NCT02433834|18744442|P1|Overall Study|Lost to Follow-up|6
5428445|NCT02433834|18744442|P1|Overall Study|Protocol Violation|3
5428446|NCT02433834|18744442|P1|Overall Study|Protocol-specified criteria|7
5428447|NCT02433678|18744502|P2|Overall Study|Lost to Follow-up|2
5428448|NCT02433678|18744503|P1|Overall Study|Lost to Follow-up|1
5428449|NCT02433483|18744596|P1|Overall Study|Other antineoplastic therapy/HSCT|1
5428450|NCT02433483|18744596|P1|Overall Study|Unacceptable toxicity|1
5428451|NCT02433340|18744623|P4|Overall Study|Other|0
5428452|NCT02433340|18744624|P3|Overall Study|Other|0
5428453|NCT02433340|18744625|P2|Overall Study|Other|1
5428454|NCT02433340|18744626|P1|Overall Study|Other|0
5428455|NCT02433340|18744623|P4|Overall Study|Required Alternative/Prohibited Therapy|0
5428456|NCT02433340|18744624|P3|Overall Study|Required Alternative/Prohibited Therapy|0
5428457|NCT02433340|18744625|P2|Overall Study|Required Alternative/Prohibited Therapy|0
5428458|NCT02433340|18744626|P1|Overall Study|Required Alternative/Prohibited Therapy|1
5428459|NCT02433340|18744623|P4|Overall Study|Lost to Follow-up|0
5428460|NCT02433340|18744624|P3|Overall Study|Lost to Follow-up|0
5428461|NCT02433340|18744625|P2|Overall Study|Lost to Follow-up|1
5428462|NCT02433340|18744626|P1|Overall Study|Lost to Follow-up|0
5428463|NCT02433340|18744623|P4|Overall Study|Withdrawal by Subject|2
5428464|NCT02433340|18744624|P3|Overall Study|Withdrawal by Subject|1
5428465|NCT02433340|18744625|P2|Overall Study|Withdrawal by Subject|0
5428466|NCT02433340|18744626|P1|Overall Study|Withdrawal by Subject|1
5428467|NCT02433340|18744623|P4|Overall Study|Adverse Event|0
5428468|NCT02433340|18744624|P3|Overall Study|Adverse Event|1
5428469|NCT02433340|18744625|P2|Overall Study|Adverse Event|0
5428470|NCT02433340|18744626|P1|Overall Study|Adverse Event|0
5428471|NCT02433288|18745520|P2|Overall Study|Death|3
5428472|NCT02433288|18745521|P1|Overall Study|Death|0
5428473|NCT02433288|18745520|P2|Overall Study|Lost to Follow-up|14
5428474|NCT02433288|18745521|P1|Overall Study|Lost to Follow-up|2
5428475|NCT02433288|18745520|P2|Overall Study|Withdrawal by Subject|99
5428476|NCT02433288|18745521|P1|Overall Study|Withdrawal by Subject|101
5428477|NCT02433288|18745520|P2|Overall Study|Eligibility criteria not fullfilled|3
5428478|NCT02433288|18745521|P1|Overall Study|Eligibility criteria not fullfilled|7
5428479|NCT02433288|18745520|P2|Overall Study|Severe non-compliance to protocol|7
5428480|NCT02433288|18745521|P1|Overall Study|Severe non-compliance to protocol|13
5428481|NCT02433080|18745537|P2|Overall Study|Withdrawal by Subject|2
5428482|NCT02433080|18745538|P1|Overall Study|Withdrawal by Subject|0
5428483|NCT02433080|18745537|P2|Overall Study|Lost to Follow-up|2
5428484|NCT02433080|18745538|P1|Overall Study|Lost to Follow-up|1
5428485|NCT02432274|18745663|P8|Overall Study|Ongoing|7
5428486|NCT02432274|18745664|P7|Overall Study|Ongoing|0
5428487|NCT02432274|18745665|P6|Overall Study|Ongoing|0
5428488|NCT02432274|18745666|P5|Overall Study|Ongoing|3
5428489|NCT02432274|18745667|P4|Overall Study|Ongoing|1
5428490|NCT02432274|18745668|P3|Overall Study|Ongoing|1
5428491|NCT02432274|18745669|P2|Overall Study|Ongoing|0
5428492|NCT02432274|18745670|P1|Overall Study|Ongoing|0
5428493|NCT02432274|18745663|P8|Overall Study|Other than specified|1
5428494|NCT02432274|18745664|P7|Overall Study|Other than specified|0
5428495|NCT02432274|18745665|P6|Overall Study|Other than specified|1
5428496|NCT02432274|18745666|P5|Overall Study|Other than specified|0
5428497|NCT02432274|18745667|P4|Overall Study|Other than specified|0
5428498|NCT02432274|18745668|P3|Overall Study|Other than specified|0
5428499|NCT02432274|18745669|P2|Overall Study|Other than specified|1
5428500|NCT02432274|18745670|P1|Overall Study|Other than specified|0
5428501|NCT02432274|18745663|P8|Overall Study|Participant Choice|0
5428502|NCT02432274|18745664|P7|Overall Study|Participant Choice|1
5428503|NCT02432274|18745665|P6|Overall Study|Participant Choice|0
5428504|NCT02432274|18745666|P5|Overall Study|Participant Choice|0
5428505|NCT02432274|18745667|P4|Overall Study|Participant Choice|0
5428506|NCT02432274|18745668|P3|Overall Study|Participant Choice|1
5428507|NCT02432274|18745669|P2|Overall Study|Participant Choice|0
5428508|NCT02432274|18745670|P1|Overall Study|Participant Choice|0
5428509|NCT02432274|18745663|P8|Overall Study|Withdrawal by Subject|2
5428510|NCT02432274|18745664|P7|Overall Study|Withdrawal by Subject|1
5428511|NCT02432274|18745665|P6|Overall Study|Withdrawal by Subject|0
5428512|NCT02432274|18745666|P5|Overall Study|Withdrawal by Subject|2
5428513|NCT02432274|18745667|P4|Overall Study|Withdrawal by Subject|0
5428514|NCT02432274|18745668|P3|Overall Study|Withdrawal by Subject|0
5428515|NCT02432274|18745669|P2|Overall Study|Withdrawal by Subject|0
5428516|NCT02432274|18745670|P1|Overall Study|Withdrawal by Subject|0
5428517|NCT02432274|18745663|P8|Overall Study|Adverse Event|0
5428518|NCT02432274|18745664|P7|Overall Study|Adverse Event|2
5428519|NCT02432274|18745665|P6|Overall Study|Adverse Event|0
5428520|NCT02432274|18745666|P5|Overall Study|Adverse Event|1
5428521|NCT02432274|18745667|P4|Overall Study|Adverse Event|0
5428522|NCT02432274|18745668|P3|Overall Study|Adverse Event|1
5428523|NCT02432274|18745669|P2|Overall Study|Adverse Event|0
5428524|NCT02432274|18745670|P1|Overall Study|Adverse Event|0
5428525|NCT02432274|18745663|P8|Overall Study|Clinical Disease Progression|1
5428526|NCT02432274|18745664|P7|Overall Study|Clinical Disease Progression|0
5428527|NCT02432274|18745665|P6|Overall Study|Clinical Disease Progression|0
5428528|NCT02432274|18745666|P5|Overall Study|Clinical Disease Progression|1
5428529|NCT02432274|18745667|P4|Overall Study|Clinical Disease Progression|0
5428530|NCT02432274|18745668|P3|Overall Study|Clinical Disease Progression|1
5428531|NCT02432274|18745669|P2|Overall Study|Clinical Disease Progression|4
5428532|NCT02432274|18745670|P1|Overall Study|Clinical Disease Progression|0
5428533|NCT02432274|18745663|P8|Overall Study|Radiological Disease Progression|9
5428534|NCT02432274|18745664|P7|Overall Study|Radiological Disease Progression|11
5428535|NCT02432274|18745665|P6|Overall Study|Radiological Disease Progression|6
5428536|NCT02432274|18745666|P5|Overall Study|Radiological Disease Progression|24
5428537|NCT02432274|18745667|P4|Overall Study|Radiological Disease Progression|0
5428538|NCT02432274|18745668|P3|Overall Study|Radiological Disease Progression|7
5428539|NCT02432274|18745669|P2|Overall Study|Radiological Disease Progression|4
5428540|NCT02432274|18745670|P1|Overall Study|Radiological Disease Progression|3
5428541|NCT02432196|18745783|P1|Overall Study|On Study|20
5428542|NCT02432196|18745783|P1|Overall Study|Reoperation|3
5428543|NCT02432196|18745783|P1|Overall Study|Death|2
5428544|NCT02432196|18745783|P1|Overall Study|Not Implanted with Device|1
5428545|NCT02432144|18745791|P1|Overall Study|Participant Non-Compliance|1
5428546|NCT02432105|18745799|P3|Overall Study|Randomized in error|2
5428547|NCT02432105|18745800|P2|Overall Study|Randomized in error|0
5428548|NCT02432105|18745801|P1|Overall Study|Randomized in error|0
5428549|NCT02432105|18745799|P3|Overall Study|Culture positive for yeast|0
5428550|NCT02432105|18745800|P2|Overall Study|Culture positive for yeast|1
5428551|NCT02432105|18745801|P1|Overall Study|Culture positive for yeast|0
5428552|NCT02432105|18745799|P3|Overall Study|Withdrawal by Subject|1
5428553|NCT02432105|18745800|P2|Overall Study|Withdrawal by Subject|0
5428554|NCT02432105|18745801|P1|Overall Study|Withdrawal by Subject|1
5428555|NCT02432105|18745799|P3|Overall Study|Lost to Follow-up|0
5428556|NCT02432105|18745800|P2|Overall Study|Lost to Follow-up|1
5428557|NCT02432105|18745801|P1|Overall Study|Lost to Follow-up|1
5428558|NCT02432040|18745818|P2|Overall Study|Physician Decision|1
5428559|NCT02432040|18745819|P1|Overall Study|Physician Decision|1
5428560|NCT02432040|18745818|P2|Overall Study|Lost to Follow-up|5
5428561|NCT02432040|18745819|P1|Overall Study|Lost to Follow-up|4
5428562|NCT02432040|18745818|P2|Overall Study|Lack of Efficacy|0
5428563|NCT02432040|18745819|P1|Overall Study|Lack of Efficacy|3
5428564|NCT02431806|18745843|P4|Double-blind Treatment Period|Reason Not Specified|2
5428565|NCT02431806|18745844|P3|Double-blind Treatment Period|Reason Not Specified|5
5428566|NCT02431806|18745845|P2|Double-blind Treatment Period|Reason Not Specified|1
5428567|NCT02431806|18745846|P1|Double-blind Treatment Period|Reason Not Specified|0
5428568|NCT02431806|18745843|P4|Double-blind Treatment Period|Investigational Product Non-compliance|1
5428569|NCT02431806|18745844|P3|Double-blind Treatment Period|Investigational Product Non-compliance|3
5428570|NCT02431806|18745845|P2|Double-blind Treatment Period|Investigational Product Non-compliance|0
5428571|NCT02431806|18745846|P1|Double-blind Treatment Period|Investigational Product Non-compliance|1
5428572|NCT02431806|18745843|P4|Double-blind Treatment Period|Lost to Follow-up|8
5428573|NCT02431806|18745844|P3|Double-blind Treatment Period|Lost to Follow-up|5
5428574|NCT02431806|18745845|P2|Double-blind Treatment Period|Lost to Follow-up|4
5428575|NCT02431806|18745846|P1|Double-blind Treatment Period|Lost to Follow-up|7
5428576|NCT02431806|18745843|P4|Double-blind Treatment Period|Withdrawal of Consent|5
5428577|NCT02431806|18745844|P3|Double-blind Treatment Period|Withdrawal of Consent|5
5428578|NCT02431806|18745845|P2|Double-blind Treatment Period|Withdrawal of Consent|7
5428579|NCT02431806|18745846|P1|Double-blind Treatment Period|Withdrawal of Consent|10
5428580|NCT02431806|18745843|P4|Double-blind Treatment Period|Lack of Efficacy|2
5428581|NCT02431806|18745844|P3|Double-blind Treatment Period|Lack of Efficacy|2
5428582|NCT02431806|18745845|P2|Double-blind Treatment Period|Lack of Efficacy|0
5428583|NCT02431806|18745846|P1|Double-blind Treatment Period|Lack of Efficacy|2
5428584|NCT02431806|18745843|P4|Double-blind Treatment Period|Adverse Event|7
5428585|NCT02431806|18745844|P3|Double-blind Treatment Period|Adverse Event|11
5428586|NCT02431806|18745845|P2|Double-blind Treatment Period|Adverse Event|7
5428587|NCT02431806|18745846|P1|Double-blind Treatment Period|Adverse Event|4
5428588|NCT02431806|18745843|P4|Double-blind Treatment Period|Did not Receive Treatment|1
5428589|NCT02431806|18745844|P3|Double-blind Treatment Period|Did not Receive Treatment|1
5428590|NCT02431806|18745845|P2|Double-blind Treatment Period|Did not Receive Treatment|2
5428591|NCT02431806|18745846|P1|Double-blind Treatment Period|Did not Receive Treatment|1
5428592|NCT02431793|18745863|P3|Overall Study|Lost to Follow-up|104
5428593|NCT02431793|18745864|P2|Overall Study|Lost to Follow-up|122
5428594|NCT02431793|18745865|P1|Overall Study|Lost to Follow-up|101
5428595|NCT02431793|18745863|P3|Overall Study|Withdrawal by Subject|5
5428596|NCT02431793|18745864|P2|Overall Study|Withdrawal by Subject|5
5428597|NCT02431793|18745865|P1|Overall Study|Withdrawal by Subject|7
5428598|NCT02431793|18745863|P3|Overall Study|Ineligible doe to not filling Rx|8
5428599|NCT02431793|18745864|P2|Overall Study|Ineligible doe to not filling Rx|7
5428600|NCT02431793|18745865|P1|Overall Study|Ineligible doe to not filling Rx|11
5428601|NCT02431676|18745913|P3|Overall Study|no lab obtained|2
5428602|NCT02431676|18745914|P2|Overall Study|no lab obtained|1
5428603|NCT02431676|18745915|P1|Overall Study|no lab obtained|0
5428604|NCT02431559|18745991|P4|Overall Study|Physician Decision|1
5428605|NCT02431559|18745992|P3|Overall Study|Physician Decision|0
5428606|NCT02431559|18745993|P2|Overall Study|Physician Decision|0
5428607|NCT02431559|18745994|P1|Overall Study|Physician Decision|0
5428608|NCT02431559|18745991|P4|Overall Study|Withdrawal by Subject|4
5428609|NCT02431559|18745992|P3|Overall Study|Withdrawal by Subject|0
5428610|NCT02431559|18745993|P2|Overall Study|Withdrawal by Subject|1
5428611|NCT02431559|18745994|P1|Overall Study|Withdrawal by Subject|0
5428612|NCT02431559|18745991|P4|Overall Study|Progressive disease|22
5428613|NCT02431559|18745992|P3|Overall Study|Progressive disease|4
5428614|NCT02431559|18745993|P2|Overall Study|Progressive disease|1
5428615|NCT02431559|18745994|P1|Overall Study|Progressive disease|2
5428616|NCT02431559|18745991|P4|Overall Study|Adverse Event|4
5428617|NCT02431559|18745992|P3|Overall Study|Adverse Event|0
5428618|NCT02431559|18745993|P2|Overall Study|Adverse Event|1
5428619|NCT02431559|18745994|P1|Overall Study|Adverse Event|0
5428620|NCT02431533|18746018|P2|Overall Study|Developed Exclusionary criteria|0
5428621|NCT02431533|18746019|P1|Overall Study|Developed Exclusionary criteria|1
5428622|NCT02431533|18746018|P2|Overall Study|Withdrawal by Subject|3
5428623|NCT02431533|18746019|P1|Overall Study|Withdrawal by Subject|1
5428624|NCT02431468|18746085|P3|Overall Study|noncompliance, investigator termination,|2
5428625|NCT02431468|18746086|P2|Overall Study|noncompliance, investigator termination,|2
5428626|NCT02431468|18746087|P1|Overall Study|noncompliance, investigator termination,|2
5428627|NCT02431468|18746085|P3|Overall Study|Withdrawal by Subject|2
5428628|NCT02431468|18746086|P2|Overall Study|Withdrawal by Subject|12
5428629|NCT02431468|18746087|P1|Overall Study|Withdrawal by Subject|4
5428630|NCT02431468|18746085|P3|Overall Study|Adverse Event|5
5428631|NCT02431468|18746086|P2|Overall Study|Adverse Event|4
5428632|NCT02431468|18746087|P1|Overall Study|Adverse Event|2
5428633|NCT02431260|18746178|P14|Overall Study|Other Unspecified|0
5428634|NCT02431260|18746179|P13|Overall Study|Other Unspecified|1
5428635|NCT02431260|18746180|P12|Overall Study|Other Unspecified|1
5428636|NCT02431260|18746181|P11|Overall Study|Other Unspecified|0
5428637|NCT02431260|18746182|P10|Overall Study|Other Unspecified|0
5428638|NCT02431260|18746183|P9|Overall Study|Other Unspecified|0
5428639|NCT02431260|18746184|P8|Overall Study|Other Unspecified|0
5428640|NCT02431260|18746185|P7|Overall Study|Other Unspecified|0
5428641|NCT02431260|18746186|P6|Overall Study|Other Unspecified|0
5428642|NCT02431260|18746187|P5|Overall Study|Other Unspecified|0
5428643|NCT02431260|18746188|P4|Overall Study|Other Unspecified|0
5428644|NCT02431260|18746189|P3|Overall Study|Other Unspecified|0
5428645|NCT02431260|18746190|P2|Overall Study|Other Unspecified|0
5428646|NCT02431260|18746191|P1|Overall Study|Other Unspecified|0
5428647|NCT02431260|18746178|P14|Overall Study|Physician Decision|0
5428648|NCT02431260|18746179|P13|Overall Study|Physician Decision|0
5428649|NCT02431260|18746180|P12|Overall Study|Physician Decision|0
5428650|NCT02431260|18746181|P11|Overall Study|Physician Decision|0
5428651|NCT02431260|18746182|P10|Overall Study|Physician Decision|0
5428652|NCT02431260|18746183|P9|Overall Study|Physician Decision|0
5428653|NCT02431260|18746184|P8|Overall Study|Physician Decision|0
5428654|NCT02431260|18746185|P7|Overall Study|Physician Decision|0
5428655|NCT02431260|18746186|P6|Overall Study|Physician Decision|1
5428656|NCT02431260|18746187|P5|Overall Study|Physician Decision|0
5428657|NCT02431260|18746188|P4|Overall Study|Physician Decision|0
5428658|NCT02431260|18746189|P3|Overall Study|Physician Decision|0
5428659|NCT02431260|18746190|P2|Overall Study|Physician Decision|0
5428660|NCT02431260|18746191|P1|Overall Study|Physician Decision|0
5428661|NCT02431260|18746178|P14|Overall Study|Study Terminated by the Sponsor|0
5428662|NCT02431260|18746179|P13|Overall Study|Study Terminated by the Sponsor|4
5428663|NCT02431260|18746180|P12|Overall Study|Study Terminated by the Sponsor|0
5428664|NCT02431260|18746181|P11|Overall Study|Study Terminated by the Sponsor|1
5428665|NCT02431260|18746182|P10|Overall Study|Study Terminated by the Sponsor|1
5428666|NCT02431260|18746183|P9|Overall Study|Study Terminated by the Sponsor|1
5428667|NCT02431260|18746184|P8|Overall Study|Study Terminated by the Sponsor|2
5428668|NCT02431260|18746185|P7|Overall Study|Study Terminated by the Sponsor|1
5428669|NCT02431260|18746186|P6|Overall Study|Study Terminated by the Sponsor|0
5428670|NCT02431260|18746187|P5|Overall Study|Study Terminated by the Sponsor|1
5428671|NCT02431260|18746188|P4|Overall Study|Study Terminated by the Sponsor|1
5428672|NCT02431260|18746189|P3|Overall Study|Study Terminated by the Sponsor|2
5428673|NCT02431260|18746190|P2|Overall Study|Study Terminated by the Sponsor|0
5428674|NCT02431260|18746191|P1|Overall Study|Study Terminated by the Sponsor|0
5428675|NCT02431260|18746178|P14|Overall Study|Lost to Follow-up|0
5428676|NCT02431260|18746179|P13|Overall Study|Lost to Follow-up|0
5428677|NCT02431260|18746180|P12|Overall Study|Lost to Follow-up|0
5428678|NCT02431260|18746181|P11|Overall Study|Lost to Follow-up|0
5428679|NCT02431260|18746182|P10|Overall Study|Lost to Follow-up|0
5428680|NCT02431260|18746183|P9|Overall Study|Lost to Follow-up|0
5428681|NCT02431260|18746184|P8|Overall Study|Lost to Follow-up|0
5428682|NCT02431260|18746185|P7|Overall Study|Lost to Follow-up|0
5428683|NCT02431260|18746186|P6|Overall Study|Lost to Follow-up|1
5428684|NCT02431260|18746187|P5|Overall Study|Lost to Follow-up|0
5428685|NCT02431260|18746188|P4|Overall Study|Lost to Follow-up|0
5428686|NCT02431260|18746189|P3|Overall Study|Lost to Follow-up|0
5428687|NCT02431260|18746190|P2|Overall Study|Lost to Follow-up|0
5428688|NCT02431260|18746191|P1|Overall Study|Lost to Follow-up|0
5428689|NCT02431260|18746178|P14|Overall Study|Death|1
5428690|NCT02431260|18746179|P13|Overall Study|Death|5
5428691|NCT02431260|18746180|P12|Overall Study|Death|2
5428692|NCT02431260|18746181|P11|Overall Study|Death|3
5428693|NCT02431260|18746182|P10|Overall Study|Death|6
5428694|NCT02431260|18746183|P9|Overall Study|Death|6
5428695|NCT02431260|18746184|P8|Overall Study|Death|1
5428696|NCT02431260|18746185|P7|Overall Study|Death|3
5428697|NCT02431260|18746186|P6|Overall Study|Death|2
5428698|NCT02431260|18746187|P5|Overall Study|Death|2
5428699|NCT02431260|18746188|P4|Overall Study|Death|4
5428700|NCT02431260|18746189|P3|Overall Study|Death|3
5428701|NCT02431260|18746190|P2|Overall Study|Death|4
5428702|NCT02431260|18746191|P1|Overall Study|Death|4
5428703|NCT02431260|18746178|P14|Overall Study|Subject Decision|0
5428704|NCT02431260|18746179|P13|Overall Study|Subject Decision|0
5428705|NCT02431260|18746180|P12|Overall Study|Subject Decision|1
5428706|NCT02431260|18746181|P11|Overall Study|Subject Decision|0
5428707|NCT02431260|18746182|P10|Overall Study|Subject Decision|1
5428708|NCT02431260|18746183|P9|Overall Study|Subject Decision|1
5428709|NCT02431260|18746184|P8|Overall Study|Subject Decision|0
5428710|NCT02431260|18746185|P7|Overall Study|Subject Decision|0
5428711|NCT02431260|18746186|P6|Overall Study|Subject Decision|0
5428712|NCT02431260|18746187|P5|Overall Study|Subject Decision|0
5428713|NCT02431260|18746188|P4|Overall Study|Subject Decision|0
5428714|NCT02431260|18746189|P3|Overall Study|Subject Decision|1
5428715|NCT02431260|18746190|P2|Overall Study|Subject Decision|1
5428716|NCT02431260|18746191|P1|Overall Study|Subject Decision|0
5428717|NCT02431247|18746284|P2|Overall Study|Non-compliance with study drug|0
5428718|NCT02431247|18746285|P1|Overall Study|Non-compliance with study drug|1
5428719|NCT02431247|18746284|P2|Overall Study|Ongoing|336
5428720|NCT02431247|18746285|P1|Overall Study|Ongoing|339
5428721|NCT02431247|18746284|P2|Overall Study|Other|1
5428722|NCT02431247|18746285|P1|Overall Study|Other|2
5428723|NCT02431247|18746284|P2|Overall Study|Withdrawal by Subject|6
5428724|NCT02431247|18746285|P1|Overall Study|Withdrawal by Subject|4
5428725|NCT02431247|18746284|P2|Overall Study|Physician Decision|0
5428726|NCT02431247|18746285|P1|Overall Study|Physician Decision|3
5428727|NCT02431247|18746284|P2|Overall Study|Adverse Event|15
5428728|NCT02431247|18746285|P1|Overall Study|Adverse Event|8
5428729|NCT02431247|18746284|P2|Overall Study|Lost to Follow-up|5
5428730|NCT02431247|18746285|P1|Overall Study|Lost to Follow-up|5
5428731|NCT02430870|18746378|P8|Part 2|Other Reason Not Specified|1
5428732|NCT02430870|18746379|P7|Part 2|Other Reason Not Specified|0
5428733|NCT02430870|18746380|P6|Part 2|Other Reason Not Specified|0
5428734|NCT02430870|18746381|P5|Part 2|Other Reason Not Specified|0
5428735|NCT02430870|18746382|P4|Part 2|Other Reason Not Specified|0
5428736|NCT02430870|18746383|P3|Part 2|Other Reason Not Specified|0
5428737|NCT02430870|18746384|P2|Part 2|Other Reason Not Specified|0
5428738|NCT02430870|18746385|P1|Part 2|Other Reason Not Specified|0
5428739|NCT02430870|18746378|P8|Part 2|Voluntary Withdrawal|0
5428740|NCT02430870|18746379|P7|Part 2|Voluntary Withdrawal|1
5428741|NCT02430870|18746380|P6|Part 2|Voluntary Withdrawal|0
5428742|NCT02430870|18746381|P5|Part 2|Voluntary Withdrawal|0
5428743|NCT02430870|18746382|P4|Part 2|Voluntary Withdrawal|0
5428744|NCT02430870|18746383|P3|Part 2|Voluntary Withdrawal|0
5428745|NCT02430870|18746384|P2|Part 2|Voluntary Withdrawal|0
5428746|NCT02430870|18746385|P1|Part 2|Voluntary Withdrawal|0
5428747|NCT02430532|18746472|P2|Overall Study|Adverse Event|1
5428748|NCT02430532|18746473|P1|Overall Study|Adverse Event|0
5428749|NCT02430532|18746472|P2|Overall Study|Consent Withdrawn|2
5428750|NCT02430532|18746473|P1|Overall Study|Consent Withdrawn|0
5428751|NCT02430532|18746472|P2|Overall Study|Sponsor Decision to Stop Study Early|25
5428752|NCT02430532|18746473|P1|Overall Study|Sponsor Decision to Stop Study Early|30
5428753|NCT02430480|18746487|P1|Overall Study|Progressed on treatment|1
5428754|NCT02430480|18746487|P1|Overall Study|Anesthesia concerns|1
5428755|NCT02430480|18746487|P1|Overall Study|Death|1
5428756|NCT02430311|18746530|P2|Part B|Death|0
5428757|NCT02430311|18746531|P1|Part B|Death|1
5428758|NCT02430311|18746530|P2|Part B|Adverse Event|0
5428759|NCT02430311|18746531|P1|Part B|Adverse Event|1
5428760|NCT02430311|18746530|P2|Part B|Withdrawal by Subject|2
5428761|NCT02430311|18746531|P1|Part B|Withdrawal by Subject|2
5428762|NCT02430311|18746530|P2|Part B|Meet study-specific withdrawal criteria|6
5428763|NCT02430311|18746531|P1|Part B|Meet study-specific withdrawal criteria|6
5428764|NCT02430311|18746530|P2|Part A|Withdrawal by Subject|0
5428765|NCT02430311|18746531|P1|Part A|Withdrawal by Subject|1
5428766|NCT02430311|18746530|P2|Part A|Adverse Event|1
5428767|NCT02430311|18746531|P1|Part A|Adverse Event|0
5428768|NCT02429856|18746585|P2|Overall Study|Withdrawal by Subject|1
5428769|NCT02429856|18746586|P1|Overall Study|Withdrawal by Subject|1
5428770|NCT02429856|18746585|P2|Overall Study|Lost to Follow-up|5
5428771|NCT02429856|18746586|P1|Overall Study|Lost to Follow-up|6
5428772|NCT02429856|18746585|P2|Overall Study|Death|13
5428773|NCT02429856|18746586|P1|Overall Study|Death|12
5428774|NCT02429791|18746604|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
5428775|NCT02429791|18746605|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
5428776|NCT02429791|18746604|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
5428777|NCT02429791|18746605|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
5428778|NCT02429791|18746604|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
5428779|NCT02429791|18746605|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
5428780|NCT02429791|18746604|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
5428781|NCT02429791|18746605|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
5428782|NCT02429791|18746604|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
5428783|NCT02429791|18746605|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
5428784|NCT02429791|18746604|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
5428785|NCT02429791|18746605|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
5428786|NCT02429791|18746604|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
5428787|NCT02429791|18746605|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
5428788|NCT02429791|18746604|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|4
5428789|NCT02429791|18746605|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|1
5428790|NCT02429791|18746604|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
5428791|NCT02429791|18746605|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
5428792|NCT02429791|18746604|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
5428793|NCT02429791|18746605|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
5428794|NCT02429791|18746604|P2|Early Switch Phase (Up to Week 52)|Physician Decision|2
5428795|NCT02429791|18746605|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
5428796|NCT02429791|18746604|P2|Early Switch Phase (Up to Week 52)|Adverse Event|2
5428797|NCT02429791|18746605|P1|Early Switch Phase (Up to Week 52)|Adverse Event|6
5428798|NCT02429778|18746693|P2|Overall Study|Withdrawal by Subject|0
5428799|NCT02429778|18746694|P1|Overall Study|Withdrawal by Subject|5
5428800|NCT02429778|18746693|P2|Overall Study|Lost to Follow-up|0
5428801|NCT02429778|18746694|P1|Overall Study|Lost to Follow-up|2
5428802|NCT02429427|18746725|P2|Overall Study|Other|41
5428803|NCT02429427|18746726|P1|Overall Study|Other|62
5428804|NCT02429427|18746725|P2|Overall Study|Withdrawal by Subject|34
5428805|NCT02429427|18746726|P1|Overall Study|Withdrawal by Subject|64
5428806|NCT02429427|18746725|P2|Overall Study|Lost to Follow-up|6
5428807|NCT02429427|18746726|P1|Overall Study|Lost to Follow-up|15
5428808|NCT02429427|18746725|P2|Overall Study|Protocol Violation|6
5428809|NCT02429427|18746726|P1|Overall Study|Protocol Violation|10
5428810|NCT02429427|18746725|P2|Overall Study|Adverse Event|92
5428811|NCT02429427|18746726|P1|Overall Study|Adverse Event|220
5428812|NCT02429310|18746740|P2|Overall Study|Protocol Violation|1
5428813|NCT02429310|18746741|P1|Overall Study|Protocol Violation|1
5428814|NCT02429310|18746740|P2|Overall Study|Lost to Follow-up|2
5428815|NCT02429310|18746741|P1|Overall Study|Lost to Follow-up|1
5428816|NCT02429258|18746751|P2|Overall Study|Protocol Violation|1
5428817|NCT02429258|18746752|P1|Overall Study|Protocol Violation|0
5428818|NCT02429258|18746751|P2|Overall Study|Withdrawal by Subject|0
5428819|NCT02429258|18746752|P1|Overall Study|Withdrawal by Subject|2
5428820|NCT02428855|18746806|P1|Overall Study|Withdrawal by Subject|2
5428821|NCT02428699|18746813|P2|Washout Period 1|Screen Failure|2
5428822|NCT02428699|18746814|P1|Washout Period 1|Screen Failure|1
5428823|NCT02428608|18746842|P1|Overall Study|various|16
5428824|NCT02428608|18746842|P1|Overall Study|Death|1
5428825|NCT02428608|18746842|P1|Overall Study|moved away|10
5428826|NCT02428608|18746842|P1|Overall Study|scheduling conflicts|15
5428827|NCT02428608|18746842|P1|Overall Study|Withdrawal by Subject|2
5428828|NCT02428608|18746842|P1|Overall Study|Lost to Follow-up|37
5428829|NCT02428608|18746842|P1|Overall Study|Pregnancy|2
5428830|NCT02428413|18746874|P2|Overall Study|Nurse Refusal|0
5428831|NCT02428413|18746875|P1|Overall Study|Nurse Refusal|1
5428832|NCT02428413|18746874|P2|Overall Study|Missed Cases|2
5428833|NCT02428413|18746875|P1|Overall Study|Missed Cases|1
5428834|NCT02428413|18746874|P2|Overall Study|Case Cancelled|0
5428835|NCT02428413|18746875|P1|Overall Study|Case Cancelled|2
5428836|NCT02428413|18746874|P2|Overall Study|Protocol Violation|2
5428837|NCT02428413|18746875|P1|Overall Study|Protocol Violation|1
5428838|NCT02428413|18746874|P2|Overall Study|Device to measure WAG malfunctioned|5
5428839|NCT02428413|18746875|P1|Overall Study|Device to measure WAG malfunctioned|3
5428840|NCT02428296|18746910|P1|Overall Study|Withdrawal by Subject|2
5428841|NCT02428296|18746910|P1|Overall Study|Adverse Event|7
5428842|NCT02428231|18746922|P2|Overall Study|Adverse Event|0
5428843|NCT02428231|18746923|P1|Overall Study|Adverse Event|3
5428844|NCT02428231|18746922|P2|Overall Study|Required Symptomatic Therapy|1
5428845|NCT02428231|18746923|P1|Overall Study|Required Symptomatic Therapy|0
5428846|NCT02428231|18746922|P2|Overall Study|Other|16
5428847|NCT02428231|18746923|P1|Overall Study|Other|10
5428848|NCT02427984|18746955|P3|Overall Study|Lost to Follow-up|18
5428849|NCT02427984|18746956|P2|Overall Study|Lost to Follow-up|5
5428850|NCT02427984|18746957|P1|Overall Study|Lost to Follow-up|13
5428851|NCT02427958|18746971|P1|Overall Study|Lack of Efficacy|1
5428852|NCT02427958|18746971|P1|Overall Study|Withdrawal by Subject|14
5428853|NCT02427958|18746971|P1|Overall Study|Lost to Follow-up|6
5428854|NCT02427958|18746971|P1|Overall Study|Pretreatment Event (PTE) or AE|3
5428855|NCT02427646|18747064|P2|Overall Study|Bothersome hand weakness|4
5428856|NCT02427646|18747065|P1|Overall Study|Bothersome hand weakness|2
5428857|NCT02427646|18747064|P2|Overall Study|Protocol Violation|3
5428858|NCT02427646|18747065|P1|Overall Study|Protocol Violation|3
5428859|NCT02427646|18747064|P2|Overall Study|Physician Decision|4
5428860|NCT02427646|18747065|P1|Overall Study|Physician Decision|1
5428861|NCT02427646|18747064|P2|Overall Study|Lack of Efficacy|3
5428862|NCT02427646|18747065|P1|Overall Study|Lack of Efficacy|2
5428863|NCT02427607|18747073|P1|Overall Study|Withdrawal by Subject|1
5428864|NCT02427477|18747079|P2|Period 1|Adverse Event|0
5428865|NCT02427477|18747080|P1|Period 1|Adverse Event|1
5428866|NCT02427399|18747093|P5|Overall Study|Protocol Violation|15
5428867|NCT02427399|18747094|P4|Overall Study|Protocol Violation|18
5428868|NCT02427399|18747095|P3|Overall Study|Protocol Violation|12
5428869|NCT02427399|18747096|P2|Overall Study|Protocol Violation|16
5428870|NCT02427399|18747097|P1|Overall Study|Protocol Violation|14
5428871|NCT02427100|18747121|P2|Overall Study|Lost to Follow-up|2
5428872|NCT02427100|18747122|P1|Overall Study|Lost to Follow-up|0
5428873|NCT02426918|18747133|P3|Overall Study|Other|9
5428874|NCT02426918|18747134|P2|Overall Study|Other|11
5428875|NCT02426918|18747135|P1|Overall Study|Other|9
5428876|NCT02426918|18747133|P3|Overall Study|Withdrawal by Subject|4
5428877|NCT02426918|18747134|P2|Overall Study|Withdrawal by Subject|5
5428878|NCT02426918|18747135|P1|Overall Study|Withdrawal by Subject|5
5428879|NCT02426918|18747133|P3|Overall Study|Physician Decision|1
5428880|NCT02426918|18747134|P2|Overall Study|Physician Decision|1
5428881|NCT02426918|18747135|P1|Overall Study|Physician Decision|1
5428882|NCT02426918|18747133|P3|Overall Study|Adverse Event|0
5428883|NCT02426918|18747134|P2|Overall Study|Adverse Event|2
5428884|NCT02426918|18747135|P1|Overall Study|Adverse Event|2
5428885|NCT02426658|18747170|P1|Overall Study|Patient expired before treatment|2
5428886|NCT02426658|18747170|P1|Overall Study|Withdrawal by Subject|1
5428887|NCT02426580|18747177|P2|Overall Study|Allergic to egg white|0
5428888|NCT02426580|18747178|P1|Overall Study|Allergic to egg white|1
5428889|NCT02426580|18747177|P2|Overall Study|Kidney transplant|0
5428890|NCT02426580|18747178|P1|Overall Study|Kidney transplant|3
5428891|NCT02426580|18747177|P2|Overall Study|transfer to hemodialysis|5
5428892|NCT02426580|18747178|P1|Overall Study|transfer to hemodialysis|5
5428893|NCT02426580|18747177|P2|Overall Study|Lost to Follow-up|9
5428894|NCT02426580|18747178|P1|Overall Study|Lost to Follow-up|0
5428895|NCT02426580|18747177|P2|Overall Study|Death|2
5428896|NCT02426580|18747178|P1|Overall Study|Death|2
5428897|NCT02426541|18747186|P2|Overall Study|Protocol Violation|0
5428898|NCT02426541|18747187|P1|Overall Study|Protocol Violation|1
5428899|NCT02426138|18747199|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
5428900|NCT02426138|18747200|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
5428901|NCT02426125|18747240|P2|Overall Study|Withdrawal by Subject|16
5428902|NCT02426125|18747241|P1|Overall Study|Withdrawal by Subject|16
5428903|NCT02426125|18747240|P2|Overall Study|Protocol Violation|0
5428904|NCT02426125|18747241|P1|Overall Study|Protocol Violation|1
5428905|NCT02426125|18747240|P2|Overall Study|Lost to Follow-up|10
5428906|NCT02426125|18747241|P1|Overall Study|Lost to Follow-up|12
5428907|NCT02425826|18747272|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
5428908|NCT02425826|18747273|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
5428909|NCT02425826|18747274|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
5428910|NCT02425826|18747272|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
5428911|NCT02425826|18747273|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
5428912|NCT02425826|18747274|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
5428913|NCT02425826|18747272|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
5428914|NCT02425826|18747273|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
5428915|NCT02425826|18747274|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
5428916|NCT02425826|18747272|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
5428917|NCT02425826|18747273|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
5428918|NCT02425826|18747274|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
5428919|NCT02425826|18747272|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
5428920|NCT02425826|18747273|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
5428921|NCT02425826|18747274|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
5428922|NCT02425826|18747272|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
5428923|NCT02425826|18747273|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
5428924|NCT02425826|18747274|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
5428925|NCT02425826|18747272|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
5428926|NCT02425826|18747273|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
5428927|NCT02425826|18747274|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
5428928|NCT02425826|18747272|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
5428929|NCT02425826|18747273|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
5428930|NCT02425826|18747274|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
5428931|NCT02425826|18747272|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
5428932|NCT02425826|18747273|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
5428933|NCT02425826|18747274|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
5428934|NCT02425826|18747272|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
5428935|NCT02425826|18747273|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
5428936|NCT02425826|18747274|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
5428937|NCT02425111|18747328|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
5428938|NCT02425111|18747328|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
5428939|NCT02425111|18747328|P1|Part A: Treatment Period|Lost to Follow-up|2
5428940|NCT02425111|18747328|P1|Part A: Treatment Period|Voluntary Withdrawal|4
5428941|NCT02425111|18747328|P1|Part A: Treatment Period|Lack of Efficacy|15
5428942|NCT02425111|18747328|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
5428943|NCT02425098|18747349|P2|Overall Study|Reason not Specified|1
5428944|NCT02425098|18747350|P1|Overall Study|Reason not Specified|0
5428945|NCT02425098|18747349|P2|Overall Study|Pregnancy|0
5428946|NCT02425098|18747350|P1|Overall Study|Pregnancy|2
5428947|NCT02425098|18747349|P2|Overall Study|Withdrawal by Subject|8
5428948|NCT02425098|18747350|P1|Overall Study|Withdrawal by Subject|4
5428949|NCT02425098|18747349|P2|Overall Study|Lost to Follow-up|7
5428950|NCT02425098|18747350|P1|Overall Study|Lost to Follow-up|7
5428951|NCT02424734|18747502|P3|Overall Study|Treatment stopped to be discharged home|0
5428952|NCT02424734|18747503|P2|Overall Study|Treatment stopped to be discharged home|2
5428953|NCT02424734|18747504|P1|Overall Study|Treatment stopped to be discharged home|2
5428954|NCT02424630|18747523|P2|Overall Study|Open procedure|1
5428955|NCT02424630|18747524|P1|Overall Study|Open procedure|0
5428956|NCT02424630|18747523|P2|Overall Study|No rotator cuff tear|2
5428957|NCT02424630|18747524|P1|Overall Study|No rotator cuff tear|1
5428958|NCT02424591|18747534|P2|Overall Study|Protocol Violation|3
5428959|NCT02424591|18747535|P1|Overall Study|Protocol Violation|2
5428960|NCT02424578|18747547|P2|Overall Study|Withdrawal by Subject|1
5428961|NCT02424578|18747548|P1|Overall Study|Withdrawal by Subject|0
5428962|NCT02424565|18747554|P2|Period 1 (D0)|Protocol Violation|1
5428963|NCT02424565|18747555|P1|Period 1 (D0)|Protocol Violation|0
5428964|NCT02424539|18747564|P3|Overall Study|Other: Reached stopping criteria|6
5428965|NCT02424539|18747565|P2|Overall Study|Other: Reached stopping criteria|7
5428966|NCT02424539|18747566|P1|Overall Study|Other: Reached stopping criteria|11
5428967|NCT02424539|18747564|P3|Overall Study|Withdrawal by Subject|0
5428968|NCT02424539|18747565|P2|Overall Study|Withdrawal by Subject|1
5428969|NCT02424539|18747566|P1|Overall Study|Withdrawal by Subject|3
5428970|NCT02424539|18747564|P3|Overall Study|Physician Decision|1
5428971|NCT02424539|18747565|P2|Overall Study|Physician Decision|0
5428972|NCT02424539|18747566|P1|Overall Study|Physician Decision|0
5428973|NCT02424539|18747564|P3|Overall Study|Adverse Event|1
5428974|NCT02424539|18747565|P2|Overall Study|Adverse Event|0
5428975|NCT02424539|18747566|P1|Overall Study|Adverse Event|0
5428976|NCT02424383|18747649|P1|Overall Study|Ineligible for Major Protocol Deviation|39
5428977|NCT02424383|18747649|P1|Overall Study|Other|7
5428978|NCT02424383|18747649|P1|Overall Study|Lost to Follow-up|81
5428979|NCT02424383|18747649|P1|Overall Study|Investigator's decision|44
5428980|NCT02424383|18747649|P1|Overall Study|Sponsor's decision|3
5428981|NCT02424383|18747649|P1|Overall Study|Death|170
5428982|NCT02424383|18747649|P1|Overall Study|Withdrawal by Subject|32
5428983|NCT02424344|18747673|P2|Overall Study|Adverse Event|8
5428984|NCT02424344|18747674|P1|Overall Study|Adverse Event|4
5428985|NCT02424344|18747673|P2|Overall Study|Lost to Follow-up|0
5428986|NCT02424344|18747674|P1|Overall Study|Lost to Follow-up|1
5428987|NCT02424344|18747673|P2|Overall Study|Withdrawal by Subject|1
5428988|NCT02424344|18747674|P1|Overall Study|Withdrawal by Subject|2
5428989|NCT02424344|18747673|P2|Overall Study|Lack of Efficacy|1
5428990|NCT02424344|18747674|P1|Overall Study|Lack of Efficacy|0
5428991|NCT02424149|18747692|P2|Overall Study|Withdrawal by Subject|1
5428992|NCT02424149|18747693|P1|Overall Study|Withdrawal by Subject|0
5428993|NCT02424149|18747692|P2|Overall Study|surgery cancelled|0
5428994|NCT02424149|18747693|P1|Overall Study|surgery cancelled|2
5428995|NCT02424097|18747709|P2|Overall Study|Lost to Follow-up|2
5428996|NCT02424097|18747710|P1|Overall Study|Lost to Follow-up|1
5428997|NCT02423798|18747765|P1|Overall Study|Withdrawal by Subject|3
5428998|NCT02423291|18747831|P1|Overall Study|Adverse Event|1
5428999|NCT02423291|18747831|P1|Overall Study|Lack of Efficacy|14
5429000|NCT02423109|18747861|P2|Lens 1|Adverse Event|0
5429001|NCT02423109|18747862|P1|Lens 1|Adverse Event|1
5429002|NCT02422797|18747895|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
5429003|NCT02422797|18747896|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
5429004|NCT02422797|18747895|P2|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
5429005|NCT02422797|18747896|P1|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
5429006|NCT02422797|18747895|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
5429007|NCT02422797|18747896|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
5429008|NCT02422797|18747895|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
5429009|NCT02422797|18747896|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
5429010|NCT02422797|18747895|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
5429011|NCT02422797|18747896|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
5429012|NCT02422797|18747895|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
5429013|NCT02422797|18747896|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
5429014|NCT02422797|18747895|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
5429015|NCT02422797|18747896|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
5429016|NCT02422797|18747895|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
5429017|NCT02422797|18747896|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
5429018|NCT02422797|18747895|P2|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
5429019|NCT02422797|18747896|P1|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
5429020|NCT02422797|18747895|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|3
5429021|NCT02422797|18747896|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|0
5429022|NCT02422797|18747895|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
5429023|NCT02422797|18747896|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
5429024|NCT02422797|18747895|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
5429025|NCT02422797|18747896|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
5429026|NCT02422797|18747895|P2|Early Switch Phase (Up to Week 52)|Physician Decision|1
5429027|NCT02422797|18747896|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
5429028|NCT02422797|18747895|P2|Early Switch Phase (Up to Week 52)|Adverse Event|1
5429029|NCT02422797|18747896|P1|Early Switch Phase (Up to Week 52)|Adverse Event|11
5429030|NCT02422615|18747984|P2|Overall Study|Technical problems|1
5429031|NCT02422615|18747985|P1|Overall Study|Technical problems|0
5429032|NCT02422615|18747984|P2|Overall Study|Protocol Violation|1
5429033|NCT02422615|18747985|P1|Overall Study|Protocol Violation|1
5429034|NCT02422615|18747984|P2|Overall Study|Death|0
5429035|NCT02422615|18747985|P1|Overall Study|Death|2
5429036|NCT02422615|18747984|P2|Overall Study|Subject/guardian decision|5
5429037|NCT02422615|18747985|P1|Overall Study|Subject/guardian decision|21
5429038|NCT02422615|18747984|P2|Overall Study|Physician Decision|7
5429039|NCT02422615|18747985|P1|Overall Study|Physician Decision|22
5429040|NCT02422615|18747984|P2|Overall Study|Adverse Event|10
5429041|NCT02422615|18747985|P1|Overall Study|Adverse Event|41
5429042|NCT02422615|18747984|P2|Overall Study|Progressive disease|142
5429043|NCT02422615|18747985|P1|Overall Study|Progressive disease|193
5429044|NCT02422303|18748002|P2|Overall Study|Lost to Follow-up|1
5429045|NCT02422303|18748003|P1|Overall Study|Lost to Follow-up|1
5429046|NCT02422264|18748018|P2|Overall Study|Subject vaccinated outside of the study|1
5429047|NCT02422264|18748019|P1|Overall Study|Subject vaccinated outside of the study|0
5429048|NCT02422264|18748018|P2|Overall Study|Migrated/moved from study area|1
5429049|NCT02422264|18748019|P1|Overall Study|Migrated/moved from study area|3
5429050|NCT02422264|18748018|P2|Overall Study|Withdrawal by Subject|2
5429051|NCT02422264|18748019|P1|Overall Study|Withdrawal by Subject|1
5429052|NCT02422264|18748018|P2|Overall Study|Serious Adverse Event|0
5429053|NCT02422264|18748019|P1|Overall Study|Serious Adverse Event|1
5429054|NCT02422186|18748065|P2|Follow-up Phase (2 Weeks)|Other|0
5429055|NCT02422186|18748066|P1|Follow-up Phase (2 Weeks)|Other|3
5429056|NCT02422186|18748065|P2|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
5429057|NCT02422186|18748066|P1|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
5429058|NCT02422186|18748065|P2|Double-blind Induction Phase (4 Weeks)|Other|0
5429059|NCT02422186|18748066|P1|Double-blind Induction Phase (4 Weeks)|Other|1
5429060|NCT02422186|18748065|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
5429061|NCT02422186|18748066|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
5429062|NCT02422186|18748065|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
5429063|NCT02422186|18748066|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
5429064|NCT02422186|18748065|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
5429065|NCT02422186|18748066|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
5429066|NCT02422186|18748065|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
5429067|NCT02422186|18748066|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
5429068|NCT02422186|18748065|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
5429069|NCT02422186|18748066|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
5429070|NCT02421952|18748088|P1|Overall Study|Surgery cancelled|1
5429071|NCT02421952|18748088|P1|Overall Study|Subject uncooperative for baseline test|2
5429072|NCT02421952|18748088|P1|Overall Study|Failed seriation task|13
5429073|NCT02421952|18748088|P1|Overall Study|Diary Not Returned|93
5429074|NCT02421939|18748097|P2|Overall Study|Protocol deviation|1
5429075|NCT02421939|18748098|P1|Overall Study|Protocol deviation|1
5429076|NCT02421939|18748097|P2|Overall Study|Miscellaneous|5
5429077|NCT02421939|18748098|P1|Overall Study|Miscellaneous|4
5429078|NCT02421939|18748097|P2|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
5429079|NCT02421939|18748098|P1|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
5429080|NCT02421939|18748097|P2|Overall Study|Physician Decision|11
5429081|NCT02421939|18748098|P1|Overall Study|Physician Decision|11
5429082|NCT02421939|18748097|P2|Overall Study|Withdrawal by Subject|24
5429083|NCT02421939|18748098|P1|Overall Study|Withdrawal by Subject|5
5429084|NCT02421939|18748097|P2|Overall Study|Adverse Event|5
5429085|NCT02421939|18748098|P1|Overall Study|Adverse Event|28
5429086|NCT02421939|18748097|P2|Overall Study|Disease relapse|2
5429087|NCT02421939|18748098|P1|Overall Study|Disease relapse|33
5429088|NCT02421939|18748097|P2|Overall Study|Death|10
5429089|NCT02421939|18748098|P1|Overall Study|Death|36
5429090|NCT02421939|18748097|P2|Overall Study|Lack of Efficacy|31
5429091|NCT02421939|18748098|P1|Overall Study|Lack of Efficacy|21
5429092|NCT02421939|18748097|P2|Overall Study|Progressive disease|16
5429093|NCT02421939|18748098|P1|Overall Study|Progressive disease|70
5429094|NCT02421887|18748126|P2|Overall Study|Adverse Event|0
5429095|NCT02421887|18748127|P1|Overall Study|Adverse Event|2
5429096|NCT02421887|18748126|P2|Overall Study|Physician Decision|4
5429097|NCT02421887|18748127|P1|Overall Study|Physician Decision|2
5429098|NCT02421887|18748126|P2|Overall Study|Withdrawal by Subject|5
5429099|NCT02421887|18748127|P1|Overall Study|Withdrawal by Subject|8
5429100|NCT02421887|18748126|P2|Overall Study|Lost to Follow-up|0
5429101|NCT02421887|18748127|P1|Overall Study|Lost to Follow-up|5
5429102|NCT02421666|18748153|P2|12-month Follow-up|Withdrawal by Subject|11
5429103|NCT02421666|18748154|P1|12-month Follow-up|Withdrawal by Subject|6
5429104|NCT02421666|18748153|P2|12-month Follow-up|Lost to Follow-up|5
5429105|NCT02421666|18748154|P1|12-month Follow-up|Lost to Follow-up|5
5429106|NCT02421666|18748153|P2|6-month Follow-up|Withdrawal by Subject|6
5429107|NCT02421666|18748154|P1|6-month Follow-up|Withdrawal by Subject|5
5429108|NCT02421666|18748153|P2|6-month Follow-up|Lost to Follow-up|7
5429109|NCT02421666|18748154|P1|6-month Follow-up|Lost to Follow-up|8
5429110|NCT02421588|18748162|P2|Overall Study|Not treated|8
5429111|NCT02421588|18748163|P1|Overall Study|Not treated|2
5429112|NCT02421588|18748162|P2|Overall Study|Withdrawal by Subject|16
5429113|NCT02421588|18748163|P1|Overall Study|Withdrawal by Subject|14
5429114|NCT02421588|18748162|P2|Overall Study|Treatment-related AE|14
5429115|NCT02421588|18748163|P1|Overall Study|Treatment-related AE|10
5429116|NCT02421588|18748162|P2|Overall Study|Symptomatic deterioration|19
5429117|NCT02421588|18748163|P1|Overall Study|Symptomatic deterioration|13
5429118|NCT02421588|18748162|P2|Overall Study|Other reason not specified|1
5429119|NCT02421588|18748163|P1|Overall Study|Other reason not specified|3
5429120|NCT02421588|18748162|P2|Overall Study|Physician Decision|17
5429121|NCT02421588|18748163|P1|Overall Study|Physician Decision|8
5429122|NCT02421588|18748162|P2|Overall Study|Death|3
5429123|NCT02421588|18748163|P1|Overall Study|Death|11
5429124|NCT02421588|18748162|P2|Overall Study|Progressive disease|135
5429125|NCT02421588|18748163|P1|Overall Study|Progressive disease|152
5429126|NCT02421588|18748162|P2|Overall Study|Non-treatment-related AE|8
5429127|NCT02421588|18748163|P1|Overall Study|Non-treatment-related AE|8
5429128|NCT02421510|18748186|P3|Overall Study|Lost to Follow-up|0
5429129|NCT02421510|18748187|P2|Overall Study|Lost to Follow-up|1
5429130|NCT02421510|18748188|P1|Overall Study|Lost to Follow-up|1
5429131|NCT02421510|18748186|P3|Overall Study|Withdrawal by Subject|12
5429132|NCT02421510|18748187|P2|Overall Study|Withdrawal by Subject|18
5429133|NCT02421510|18748188|P1|Overall Study|Withdrawal by Subject|14
5429134|NCT02421510|18748186|P3|Overall Study|Pregnancy|0
5429135|NCT02421510|18748187|P2|Overall Study|Pregnancy|1
5429136|NCT02421510|18748188|P1|Overall Study|Pregnancy|1
5429137|NCT02421510|18748186|P3|Overall Study|Adverse Event|18
5429138|NCT02421510|18748187|P2|Overall Study|Adverse Event|10
5429139|NCT02421510|18748188|P1|Overall Study|Adverse Event|9
5429140|NCT02421510|18748186|P3|Overall Study|Physician Decision|3
5429141|NCT02421510|18748187|P2|Overall Study|Physician Decision|1
5429142|NCT02421510|18748188|P1|Overall Study|Physician Decision|1
5429143|NCT02421510|18748186|P3|Overall Study|Noncompliance with study drug|0
5429144|NCT02421510|18748187|P2|Overall Study|Noncompliance with study drug|0
5429145|NCT02421510|18748188|P1|Overall Study|Noncompliance with study drug|1
5429146|NCT02421510|18748186|P3|Overall Study|Death|0
5429147|NCT02421510|18748187|P2|Overall Study|Death|0
5429148|NCT02421510|18748188|P1|Overall Study|Death|1
5429149|NCT02421510|18748186|P3|Overall Study|Protocol Violation|0
5429150|NCT02421510|18748187|P2|Overall Study|Protocol Violation|2
5429151|NCT02421510|18748188|P1|Overall Study|Protocol Violation|1
5429152|NCT02421510|18748186|P3|Overall Study|Other|3
5429153|NCT02421510|18748187|P2|Overall Study|Other|2
5429154|NCT02421510|18748188|P1|Overall Study|Other|4
5429155|NCT02421419|18748220|P3|Overall Study|Physician Decision|1
5429156|NCT02421419|18748221|P2|Overall Study|Physician Decision|0
5429157|NCT02421419|18748222|P1|Overall Study|Physician Decision|0
5429158|NCT02421172|18748356|P5|Period 2|Patient/guardian decision|1
5429159|NCT02421172|18748357|P4|Period 2|Patient/guardian decision|2
5429160|NCT02421172|18748358|P3|Period 2|Patient/guardian decision|3
5429161|NCT02421172|18748359|P2|Period 2|Patient/guardian decision|0
5429162|NCT02421172|18748360|P1|Period 2|Patient/guardian decision|0
5429163|NCT02421172|18748356|P5|Period 2|Lost to Follow-up|0
5429164|NCT02421172|18748357|P4|Period 2|Lost to Follow-up|1
5429165|NCT02421172|18748358|P3|Period 2|Lost to Follow-up|0
5429166|NCT02421172|18748359|P2|Period 2|Lost to Follow-up|0
5429167|NCT02421172|18748360|P1|Period 2|Lost to Follow-up|0
5429168|NCT02421172|18748356|P5|Period 2|Adverse Event|0
5429169|NCT02421172|18748357|P4|Period 2|Adverse Event|0
5429170|NCT02421172|18748358|P3|Period 2|Adverse Event|4
5429171|NCT02421172|18748359|P2|Period 2|Adverse Event|0
5429172|NCT02421172|18748360|P1|Period 2|Adverse Event|0
5429173|NCT02421172|18748356|P5|Period 1|Patient/guardian decision|0
5429174|NCT02421172|18748357|P4|Period 1|Patient/guardian decision|0
5429175|NCT02421172|18748358|P3|Period 1|Patient/guardian decision|0
5429176|NCT02421172|18748359|P2|Period 1|Patient/guardian decision|1
5429177|NCT02421172|18748360|P1|Period 1|Patient/guardian decision|0
5429178|NCT02421172|18748356|P5|Period 1|Lost to Follow-up|0
5429179|NCT02421172|18748357|P4|Period 1|Lost to Follow-up|0
5429180|NCT02421172|18748358|P3|Period 1|Lost to Follow-up|0
5429181|NCT02421172|18748359|P2|Period 1|Lost to Follow-up|1
5429182|NCT02421172|18748360|P1|Period 1|Lost to Follow-up|3
5429183|NCT02421172|18748356|P5|Period 1|Adverse Event|0
5429184|NCT02421172|18748357|P4|Period 1|Adverse Event|0
5429185|NCT02421172|18748358|P3|Period 1|Adverse Event|0
5429186|NCT02421172|18748359|P2|Period 1|Adverse Event|0
5429187|NCT02421172|18748360|P1|Period 1|Adverse Event|1
5429188|NCT02421120|18748404|P1|Overall Study|Adverse Event|1
5429189|NCT02420821|18748488|P2|Overall Study|Death|116
5429190|NCT02420821|18748489|P1|Overall Study|Death|129
5429191|NCT02420821|18748488|P2|Overall Study|Withdrawal by Subject|17
5429192|NCT02420821|18748489|P1|Overall Study|Withdrawal by Subject|31
5429193|NCT02420821|18748488|P2|Overall Study|Physician Decision|2
5429194|NCT02420821|18748489|P1|Overall Study|Physician Decision|5
5429195|NCT02420821|18748488|P2|Overall Study|Non-compliance|2
5429196|NCT02420821|18748489|P1|Overall Study|Non-compliance|1
5429197|NCT02420821|18748488|P2|Overall Study|Lost to Follow-up|0
5429198|NCT02420821|18748489|P1|Overall Study|Lost to Follow-up|2
5429199|NCT02420691|18748557|P1|Overall Study|Withdrawal by Subject|3
5429200|NCT02420691|18748557|P1|Overall Study|Adverse Event|3
5429201|NCT02420379|18748567|P2|Overall Study|Transitioned to commercial drug|0
5429202|NCT02420379|18748568|P1|Overall Study|Transitioned to commercial drug|1
5429203|NCT02420379|18748567|P2|Overall Study|Unable to complete due to schooling|1
5429204|NCT02420379|18748568|P1|Overall Study|Unable to complete due to schooling|0
5429205|NCT02420379|18748567|P2|Overall Study|Withdrawal by Subject|3
5429206|NCT02420379|18748568|P1|Overall Study|Withdrawal by Subject|0
5429207|NCT02420353|18748586|P2|Overall Study|Withdrawal by Subject|1
5429208|NCT02420353|18748587|P1|Overall Study|Withdrawal by Subject|0
5429209|NCT02420327|18748679|P1|Overall Study|Protocol Violation|1
5429210|NCT02420327|18748679|P1|Overall Study|Lost to Follow-up|1
5429211|NCT02420327|18748679|P1|Overall Study|Withdrawal by Subject|6
5429212|NCT02420327|18748679|P1|Overall Study|Pregnancy|1
5429213|NCT02420327|18748679|P1|Overall Study|Adverse Event|7
5429214|NCT02420262|18748715|P2|Overall Study|Unclassified|1
5429215|NCT02420262|18748716|P1|Overall Study|Unclassified|0
5429216|NCT02420262|18748715|P2|Overall Study|Withdrawal by Subject|4
5429217|NCT02420262|18748716|P1|Overall Study|Withdrawal by Subject|1
5429218|NCT02420262|18748715|P2|Overall Study|Adverse Event|0
5429219|NCT02420262|18748716|P1|Overall Study|Adverse Event|1
5429220|NCT02420093|18748742|P2|Overall Study|Withdrawal by Subject|1
5429221|NCT02420093|18748743|P1|Overall Study|Withdrawal by Subject|1
5429222|NCT02419937|18748805|P2|Overall Study|Lost to Follow-up|0
5429223|NCT02419937|18748806|P1|Overall Study|Lost to Follow-up|1
5429224|NCT02419807|18748819|P1|Overall Study|Protocol Violation|5
5429225|NCT02419807|18748819|P1|Overall Study|Physician Decision|1
5429226|NCT02419807|18748819|P1|Overall Study|Withdrawal by Subject|4
5429227|NCT02419755|18748825|P2|Overall Study|Withdrawal by Subject|0
5429228|NCT02419755|18748826|P1|Overall Study|Withdrawal by Subject|1
5429229|NCT02419755|18748825|P2|Overall Study|Ineligible|0
5429230|NCT02419755|18748826|P1|Overall Study|Ineligible|1
5429231|NCT02419755|18748825|P2|Overall Study|Relapse|1
5429232|NCT02419755|18748826|P1|Overall Study|Relapse|0
5429233|NCT02419755|18748825|P2|Overall Study|Death|3
5429234|NCT02419755|18748826|P1|Overall Study|Death|1
5429235|NCT02419612|18748867|P2|Long-term Treatment Period|Withdrawal by Subject|2
5429236|NCT02419612|18748868|P1|Long-term Treatment Period|Withdrawal by Subject|8
5429237|NCT02419612|18748867|P2|Long-term Treatment Period|Subject Decision|4
5429238|NCT02419612|18748868|P1|Long-term Treatment Period|Subject Decision|2
5429239|NCT02419612|18748867|P2|Long-term Treatment Period|Other|4
5429240|NCT02419612|18748868|P1|Long-term Treatment Period|Other|4
5429241|NCT02419612|18748867|P2|Long-term Treatment Period|Adverse Event|5
5429242|NCT02419612|18748868|P1|Long-term Treatment Period|Adverse Event|0
5429243|NCT02419612|18748867|P2|Long-term Treatment Period|Death|1
5429244|NCT02419612|18748868|P1|Long-term Treatment Period|Death|0
5429245|NCT02419612|18748867|P2|Long-term Treatment Period|Lack of Efficacy|1
5429246|NCT02419612|18748868|P1|Long-term Treatment Period|Lack of Efficacy|1
5429247|NCT02419612|18748867|P2|Long-term Treatment Period|Lost to Follow-up|4
5429248|NCT02419612|18748868|P1|Long-term Treatment Period|Lost to Follow-up|6
5429249|NCT02419612|18748867|P2|Long-term Treatment Period|Non-compliance with Study Drug|1
5429250|NCT02419612|18748868|P1|Long-term Treatment Period|Non-compliance with Study Drug|1
5429251|NCT02419612|18748867|P2|Short-term Treatment Period|Subject moved out of state|1
5429252|NCT02419612|18748868|P1|Short-term Treatment Period|Subject moved out of state|0
5429253|NCT02419612|18748867|P2|Short-term Treatment Period|Worsening of liver function|1
5429254|NCT02419612|18748868|P1|Short-term Treatment Period|Worsening of liver function|0
5429255|NCT02419612|18748867|P2|Short-term Treatment Period|Non-compliance with Study Drug|2
5429256|NCT02419612|18748868|P1|Short-term Treatment Period|Non-compliance with Study Drug|0
5429257|NCT02419612|18748867|P2|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
5429258|NCT02419612|18748868|P1|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
5429259|NCT02419612|18748867|P2|Short-term Treatment Period|Withdrawal by Subject|9
5429260|NCT02419612|18748868|P1|Short-term Treatment Period|Withdrawal by Subject|9
5429261|NCT02419612|18748867|P2|Short-term Treatment Period|Lost to Follow-up|6
5429262|NCT02419612|18748868|P1|Short-term Treatment Period|Lost to Follow-up|6
5429263|NCT02419612|18748867|P2|Short-term Treatment Period|Death|2
5429264|NCT02419612|18748868|P1|Short-term Treatment Period|Death|0
5429265|NCT02419612|18748867|P2|Short-term Treatment Period|Adverse Event|1
5429266|NCT02419612|18748868|P1|Short-term Treatment Period|Adverse Event|1
5429267|NCT02419573|18748890|P2|Overall Study|Withdrawal by Subject|0
5429268|NCT02419573|18748891|P1|Overall Study|Withdrawal by Subject|1
5429269|NCT02419573|18748890|P2|Overall Study|Lost to Follow-up|0
5429270|NCT02419573|18748891|P1|Overall Study|Lost to Follow-up|3
5429271|NCT02419508|18748921|P2|Overall Study|Other - Reason not specified|1
5429272|NCT02419508|18748922|P1|Overall Study|Other - Reason not specified|0
5429273|NCT02419508|18748921|P2|Overall Study|Withdrawal by Subject|0
5429274|NCT02419508|18748922|P1|Overall Study|Withdrawal by Subject|1
5429275|NCT02419508|18748921|P2|Overall Study|Adverse Event|3
5429276|NCT02419508|18748922|P1|Overall Study|Adverse Event|9
5429277|NCT02419469|18748940|P1|Overall Study|Withdrawal by Subject|1
5429278|NCT02419313|18748944|P2|Second Intervention|Lost to Follow-up|0
5429279|NCT02419313|18748945|P1|Second Intervention|Lost to Follow-up|1
5429280|NCT02419313|18748944|P2|First Intervention|Lost to Follow-up|0
5429281|NCT02419313|18748945|P1|First Intervention|Lost to Follow-up|2
5429282|NCT02419001|18748957|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
5429283|NCT02419001|18748958|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
5429284|NCT02418910|18748968|P1|Overall Study|Withdrawal by Subject|4
5429285|NCT02418910|18748968|P1|Overall Study|Lost to Follow-up|3
5429286|NCT02418819|18748976|P4|Overall Study|No longer willing to participate|1
5429287|NCT02418819|18748977|P3|Overall Study|No longer willing to participate|2
5429288|NCT02418819|18748978|P2|Overall Study|No longer willing to participate|0
5429289|NCT02418819|18748979|P1|Overall Study|No longer willing to participate|0
5429290|NCT02418819|18748976|P4|Overall Study|No longer meets eligibility criteria|0
5429291|NCT02418819|18748977|P3|Overall Study|No longer meets eligibility criteria|1
5429292|NCT02418819|18748978|P2|Overall Study|No longer meets eligibility criteria|0
5429293|NCT02418819|18748979|P1|Overall Study|No longer meets eligibility criteria|0
5429294|NCT02418819|18748976|P4|Overall Study|Lost to Follow-up|0
5429295|NCT02418819|18748977|P3|Overall Study|Lost to Follow-up|0
5429296|NCT02418819|18748978|P2|Overall Study|Lost to Follow-up|0
5429297|NCT02418819|18748979|P1|Overall Study|Lost to Follow-up|1
5429298|NCT02418819|18748976|P4|Overall Study|Adverse Event|0
5429299|NCT02418819|18748977|P3|Overall Study|Adverse Event|1
5429300|NCT02418819|18748978|P2|Overall Study|Adverse Event|0
5429301|NCT02418819|18748979|P1|Overall Study|Adverse Event|0
5429302|NCT02418754|18749022|P5|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
5429303|NCT02418754|18749023|P4|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
5429304|NCT02418754|18749024|P3|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
5429305|NCT02418754|18749025|P2|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
5429306|NCT02418754|18749026|P1|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
5429307|NCT02418754|18749022|P5|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
5429308|NCT02418754|18749023|P4|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
5429309|NCT02418754|18749024|P3|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
5429310|NCT02418754|18749025|P2|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
5429311|NCT02418754|18749026|P1|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
5429312|NCT02418754|18749022|P5|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
5429313|NCT02418754|18749023|P4|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
5429314|NCT02418754|18749024|P3|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
5429315|NCT02418754|18749025|P2|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
5429316|NCT02418754|18749026|P1|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
5429317|NCT02418754|18749022|P5|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
5429318|NCT02418754|18749023|P4|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
5429319|NCT02418754|18749024|P3|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
5429320|NCT02418754|18749025|P2|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
5429321|NCT02418754|18749026|P1|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
5429322|NCT02418754|18749022|P5|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5429323|NCT02418754|18749023|P4|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5429324|NCT02418754|18749024|P3|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5429325|NCT02418754|18749025|P2|Period 2 (Day 1 to Week 52/End of Study)|Death|0
5429326|NCT02418754|18749026|P1|Period 2 (Day 1 to Week 52/End of Study)|Death|1
5429327|NCT02418754|18749022|P5|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
5429328|NCT02418754|18749023|P4|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
5429329|NCT02418754|18749024|P3|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
5429330|NCT02418754|18749025|P2|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
5429331|NCT02418754|18749026|P1|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
5429332|NCT02418754|18749022|P5|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5429333|NCT02418754|18749023|P4|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5429334|NCT02418754|18749024|P3|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
5429335|NCT02418754|18749025|P2|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5429336|NCT02418754|18749026|P1|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
5429337|NCT02418754|18749022|P5|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
5429338|NCT02418754|18749023|P4|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
5429339|NCT02418754|18749024|P3|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
5429340|NCT02418754|18749025|P2|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
5429341|NCT02418754|18749026|P1|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
5429342|NCT02418754|18749022|P5|Period 1 (Day 1 to Week 12)|Physician Decision|0
5429343|NCT02418754|18749023|P4|Period 1 (Day 1 to Week 12)|Physician Decision|0
5429344|NCT02418754|18749024|P3|Period 1 (Day 1 to Week 12)|Physician Decision|0
5429345|NCT02418754|18749025|P2|Period 1 (Day 1 to Week 12)|Physician Decision|0
5429346|NCT02418754|18749026|P1|Period 1 (Day 1 to Week 12)|Physician Decision|1
5429347|NCT02418754|18749022|P5|Period 1 (Day 1 to Week 12)|Death|0
5429348|NCT02418754|18749023|P4|Period 1 (Day 1 to Week 12)|Death|0
5429349|NCT02418754|18749024|P3|Period 1 (Day 1 to Week 12)|Death|0
5429350|NCT02418754|18749025|P2|Period 1 (Day 1 to Week 12)|Death|0
5429351|NCT02418754|18749026|P1|Period 1 (Day 1 to Week 12)|Death|1
5429352|NCT02418754|18749022|P5|Period 1 (Day 1 to Week 12)|Adverse Event|0
5429353|NCT02418754|18749023|P4|Period 1 (Day 1 to Week 12)|Adverse Event|0
5429354|NCT02418754|18749024|P3|Period 1 (Day 1 to Week 12)|Adverse Event|0
5429355|NCT02418754|18749025|P2|Period 1 (Day 1 to Week 12)|Adverse Event|2
5429356|NCT02418754|18749026|P1|Period 1 (Day 1 to Week 12)|Adverse Event|0
5429357|NCT02418585|18749075|P2|Follow-up Phase (24 Weeks)|Other|2
5429358|NCT02418585|18749076|P1|Follow-up Phase (24 Weeks)|Other|3
5429359|NCT02418585|18749075|P2|Follow-up Phase (24 Weeks)|Investigator Decision|17
5429360|NCT02418585|18749076|P1|Follow-up Phase (24 Weeks)|Investigator Decision|6
5429361|NCT02418585|18749075|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
5429362|NCT02418585|18749076|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
5429363|NCT02418585|18749075|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
5429364|NCT02418585|18749076|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
5429365|NCT02418585|18749075|P2|Double Blind (DB) Phase (4 Weeks)|Other|1
5429366|NCT02418585|18749076|P1|Double Blind (DB) Phase (4 Weeks)|Other|0
5429367|NCT02418585|18749075|P2|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
5429368|NCT02418585|18749076|P1|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
5429369|NCT02418585|18749075|P2|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
5429370|NCT02418585|18749076|P1|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
5429371|NCT02418585|18749075|P2|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
5429372|NCT02418585|18749076|P1|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
5429373|NCT02418585|18749075|P2|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
5429374|NCT02418585|18749076|P1|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
5429375|NCT02418585|18749075|P2|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
5429376|NCT02418585|18749076|P1|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
5429377|NCT02418468|18749132|P2|Overall Study|Withdrawal of informed consent|1
5429378|NCT02418468|18749133|P1|Overall Study|Withdrawal of informed consent|1
5429379|NCT02418468|18749132|P2|Overall Study|Adverse Event|0
5429380|NCT02418468|18749133|P1|Overall Study|Adverse Event|1
5429381|NCT02418455|18749139|P1|Continuation Period|Sponsor Decision|7
5429382|NCT02418455|18749139|P1|48-Week Treatment Period|Other- Not Specified|1
5429383|NCT02418182|18749182|P2|Overall Study|Lost to Follow-up|2
5429384|NCT02418182|18749183|P1|Overall Study|Lost to Follow-up|0
5429385|NCT02418182|18749182|P2|Overall Study|Unable to re-consent|15
5429386|NCT02418182|18749183|P1|Overall Study|Unable to re-consent|18
5429387|NCT02418156|18749195|P1|Overall Study|Subject refused to return|1
5429388|NCT02418156|18749195|P1|Overall Study|Withdrawal by Subject|1
5429389|NCT02418156|18749195|P1|Overall Study|Physician Decision|1
5429390|NCT02418156|18749195|P1|Overall Study|Death|2
5429391|NCT02418156|18749195|P1|Overall Study|Lost to Follow-up|12
5429392|NCT02418000|18749237|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
5429393|NCT02418000|18749238|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429394|NCT02418000|18749239|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429395|NCT02418000|18749240|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429396|NCT02418000|18749241|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429397|NCT02418000|18749237|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
5429398|NCT02418000|18749238|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5429399|NCT02418000|18749239|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5429400|NCT02418000|18749240|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5429401|NCT02418000|18749241|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
5429402|NCT02418000|18749237|P5|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429403|NCT02418000|18749238|P4|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
5429404|NCT02418000|18749239|P3|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429405|NCT02418000|18749240|P2|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429406|NCT02418000|18749241|P1|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429407|NCT02418000|18749237|P5|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429408|NCT02418000|18749238|P4|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429409|NCT02418000|18749239|P3|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
5429410|NCT02418000|18749240|P2|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429411|NCT02418000|18749241|P1|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
5429412|NCT02418000|18749237|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5429413|NCT02418000|18749238|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5429414|NCT02418000|18749239|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5429415|NCT02418000|18749240|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
5429416|NCT02418000|18749241|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
5429417|NCT02418000|18749237|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5429418|NCT02418000|18749238|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5429419|NCT02418000|18749239|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5429420|NCT02418000|18749240|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
5429421|NCT02418000|18749241|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
5429422|NCT02418000|18749237|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5429423|NCT02418000|18749238|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5429424|NCT02418000|18749239|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5429425|NCT02418000|18749240|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
5429426|NCT02418000|18749241|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
5429427|NCT02418000|18749237|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5429428|NCT02418000|18749238|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5429429|NCT02418000|18749239|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5429430|NCT02418000|18749240|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
5429431|NCT02418000|18749241|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
5429432|NCT02418000|18749237|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5429433|NCT02418000|18749238|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5429434|NCT02418000|18749239|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5429435|NCT02418000|18749240|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
5429436|NCT02418000|18749241|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
5429437|NCT02417961|18749359|P1|Overall Study|Withdrawal by Subject|2
5429438|NCT02417961|18749359|P1|Overall Study|Lost to Follow-up|1
5429439|NCT02417961|18749359|P1|Overall Study|Adverse Event|1
5429440|NCT02417935|18749371|P2|Treatment Period|Physician Decision|1
5429441|NCT02417935|18749372|P1|Treatment Period|Physician Decision|3
5429442|NCT02417935|18749371|P2|Treatment Period|Withdrawal by Subject|3
5429443|NCT02417935|18749372|P1|Treatment Period|Withdrawal by Subject|3
5429444|NCT02417935|18749371|P2|Treatment Period|Protocol Violation|1
5429445|NCT02417935|18749372|P1|Treatment Period|Protocol Violation|2
5429446|NCT02417935|18749371|P2|Treatment Period|Entry Criteria not met|1
5429447|NCT02417935|18749372|P1|Treatment Period|Entry Criteria not met|0
5429448|NCT02417935|18749371|P2|Treatment Period|Lost to Follow-up|0
5429449|NCT02417935|18749372|P1|Treatment Period|Lost to Follow-up|1
5429450|NCT02417935|18749371|P2|Treatment Period|Adverse Event|10
5429451|NCT02417935|18749372|P1|Treatment Period|Adverse Event|12
5429452|NCT02417753|18749430|P1|Overall Study|Death|1
5429453|NCT02417441|18749450|P2|Overall Study|Inconclusive due to missing data|19
5429454|NCT02417441|18749451|P1|Overall Study|Inconclusive due to missing data|52
5429455|NCT02417246|18749519|P2|Phase 2 1st Generic Administered|Physician Decision|0
5429456|NCT02417246|18749520|P1|Phase 2 1st Generic Administered|Physician Decision|1
5429457|NCT02417246|18749519|P2|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
5429458|NCT02417246|18749520|P1|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
5429459|NCT02417246|18749519|P2|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
5429460|NCT02417246|18749520|P1|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
5429461|NCT02417246|18749519|P2|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
5429462|NCT02417246|18749520|P1|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
5429463|NCT02417233|18749543|P3|Overall Study|Mentally unstable|0
5429464|NCT02417233|18749544|P2|Overall Study|Mentally unstable|1
5429465|NCT02417233|18749545|P1|Overall Study|Mentally unstable|0
5429466|NCT02417233|18749543|P3|Overall Study|Relocation out of study area|1
5429467|NCT02417233|18749544|P2|Overall Study|Relocation out of study area|0
5429468|NCT02417233|18749545|P1|Overall Study|Relocation out of study area|1
5429469|NCT02417233|18749543|P3|Overall Study|Withdrawal by Subject|8
5429470|NCT02417233|18749544|P2|Overall Study|Withdrawal by Subject|1
5429471|NCT02417233|18749545|P1|Overall Study|Withdrawal by Subject|2
5429472|NCT02417233|18749543|P3|Overall Study|Protocol Violation|2
5429473|NCT02417233|18749544|P2|Overall Study|Protocol Violation|0
5429474|NCT02417233|18749545|P1|Overall Study|Protocol Violation|2
5429475|NCT02417233|18749543|P3|Overall Study|Lost to Follow-up|34
5429476|NCT02417233|18749544|P2|Overall Study|Lost to Follow-up|39
5429477|NCT02417233|18749545|P1|Overall Study|Lost to Follow-up|27
5429478|NCT02417233|18749543|P3|Overall Study|Death|14
5429479|NCT02417233|18749544|P2|Overall Study|Death|10
5429480|NCT02417233|18749545|P1|Overall Study|Death|4
5429481|NCT02417064|18749582|P3|Follow-up Phase (24 Weeks)|Other|3
5429482|NCT02417064|18749583|P2|Follow-up Phase (24 Weeks)|Other|2
5429483|NCT02417064|18749584|P1|Follow-up Phase (24 Weeks)|Other|2
5429484|NCT02417064|18749582|P3|Follow-up Phase (24 Weeks)|PI Decision|44
5429485|NCT02417064|18749583|P2|Follow-up Phase (24 Weeks)|PI Decision|29
5429486|NCT02417064|18749584|P1|Follow-up Phase (24 Weeks)|PI Decision|34
5429487|NCT02417064|18749582|P3|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
5429488|NCT02417064|18749583|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
5429489|NCT02417064|18749584|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
5429490|NCT02417064|18749582|P3|Follow-up Phase (24 Weeks)|Protocol Violation|1
5429491|NCT02417064|18749583|P2|Follow-up Phase (24 Weeks)|Protocol Violation|0
5429492|NCT02417064|18749584|P1|Follow-up Phase (24 Weeks)|Protocol Violation|0
5429493|NCT02417064|18749582|P3|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
5429494|NCT02417064|18749583|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
5429495|NCT02417064|18749584|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
5429496|NCT02417064|18749582|P3|Double-blind Induction Phase (4 Weeks)|Other|2
5429497|NCT02417064|18749583|P2|Double-blind Induction Phase (4 Weeks)|Other|4
5429498|NCT02417064|18749584|P1|Double-blind Induction Phase (4 Weeks)|Other|1
5429499|NCT02417064|18749582|P3|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
5429500|NCT02417064|18749583|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
5429501|NCT02417064|18749584|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
5429502|NCT02417064|18749582|P3|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
5429503|NCT02417064|18749583|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
5429504|NCT02417064|18749584|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
5429505|NCT02417064|18749582|P3|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
5429506|NCT02417064|18749583|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
5429507|NCT02417064|18749584|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
5429508|NCT02417064|18749582|P3|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
5429509|NCT02417064|18749583|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
5429510|NCT02417064|18749584|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
5429511|NCT02417064|18749582|P3|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
5429512|NCT02417064|18749583|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
5429513|NCT02417064|18749584|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
5429514|NCT02416934|18749655|P2|Overall Study|re-operation|0
5429515|NCT02416934|18749656|P1|Overall Study|re-operation|1
5429516|NCT02416934|18749655|P2|Overall Study|surgery started late|1
5429517|NCT02416934|18749656|P1|Overall Study|surgery started late|0
5429518|NCT02416934|18749655|P2|Overall Study|Protocol Violation|1
5429519|NCT02416934|18749656|P1|Overall Study|Protocol Violation|0
5429520|NCT02416934|18749655|P2|Overall Study|recruited during continuing renewal proc|1
5429521|NCT02416934|18749656|P1|Overall Study|recruited during continuing renewal proc|0
5429522|NCT02416934|18749655|P2|Overall Study|Withdrawal by Subject|0
5429523|NCT02416934|18749656|P1|Overall Study|Withdrawal by Subject|1
5429524|NCT02416934|18749655|P2|Overall Study|Lost to Follow-up|2
5429525|NCT02416934|18749656|P1|Overall Study|Lost to Follow-up|0
5429526|NCT02416934|18749655|P2|Overall Study|given steroids|2
5429527|NCT02416934|18749656|P1|Overall Study|given steroids|1
5429528|NCT02416908|18749671|P4|Dose Escalation Phase|Withdrawal by Subject|0
5429529|NCT02416908|18749672|P3|Dose Escalation Phase|Withdrawal by Subject|1
5429530|NCT02416908|18749673|P2|Dose Escalation Phase|Withdrawal by Subject|0
5429531|NCT02416908|18749674|P1|Dose Escalation Phase|Withdrawal by Subject|0
5429532|NCT02416908|18749671|P4|Dose Escalation Phase|Adverse Event|0
5429533|NCT02416908|18749672|P3|Dose Escalation Phase|Adverse Event|3
5429534|NCT02416908|18749673|P2|Dose Escalation Phase|Adverse Event|0
5429535|NCT02416908|18749674|P1|Dose Escalation Phase|Adverse Event|0
5429536|NCT02416791|18749692|P3|6 Months|Lost to Follow-up|1
5429537|NCT02416791|18749693|P2|6 Months|Lost to Follow-up|0
5429538|NCT02416791|18749694|P1|6 Months|Lost to Follow-up|0
5429539|NCT02416180|18749792|P1|Overall Study|Withdrawal by Subject|1
5429540|NCT02415959|18749853|P5|Overall Study|Protocol Violation|0
5429541|NCT02415959|18749854|P4|Overall Study|Protocol Violation|1
5429542|NCT02415959|18749855|P3|Overall Study|Protocol Violation|0
5429543|NCT02415959|18749856|P2|Overall Study|Protocol Violation|0
5429544|NCT02415959|18749857|P1|Overall Study|Protocol Violation|0
5429545|NCT02415959|18749853|P5|Overall Study|Adverse Event|0
5429546|NCT02415959|18749854|P4|Overall Study|Adverse Event|0
5429547|NCT02415959|18749855|P3|Overall Study|Adverse Event|0
5429548|NCT02415959|18749856|P2|Overall Study|Adverse Event|1
5429549|NCT02415959|18749857|P1|Overall Study|Adverse Event|0
5429550|NCT02415595|18750303|P4|Overall Study|Other|0
5429551|NCT02415595|18750304|P3|Overall Study|Other|1
5429552|NCT02415595|18750305|P2|Overall Study|Other|1
5429553|NCT02415595|18750306|P1|Overall Study|Other|0
5429554|NCT02415595|18750303|P4|Overall Study|Withdrawal by Subject|3
5429555|NCT02415595|18750304|P3|Overall Study|Withdrawal by Subject|1
5429556|NCT02415595|18750305|P2|Overall Study|Withdrawal by Subject|0
5429557|NCT02415595|18750306|P1|Overall Study|Withdrawal by Subject|4
5429558|NCT02415595|18750303|P4|Overall Study|Reached stopping criteria|0
5429559|NCT02415595|18750304|P3|Overall Study|Reached stopping criteria|1
5429560|NCT02415595|18750305|P2|Overall Study|Reached stopping criteria|1
5429561|NCT02415595|18750306|P1|Overall Study|Reached stopping criteria|0
5429562|NCT02415595|18750303|P4|Overall Study|Poor/Non-compliance|0
5429563|NCT02415595|18750304|P3|Overall Study|Poor/Non-compliance|1
5429564|NCT02415595|18750305|P2|Overall Study|Poor/Non-compliance|0
5429565|NCT02415595|18750306|P1|Overall Study|Poor/Non-compliance|1
5429566|NCT02415595|18750303|P4|Overall Study|Lost to Follow-up|1
5429567|NCT02415595|18750304|P3|Overall Study|Lost to Follow-up|1
5429568|NCT02415595|18750305|P2|Overall Study|Lost to Follow-up|3
5429569|NCT02415595|18750306|P1|Overall Study|Lost to Follow-up|1
5429570|NCT02415595|18750303|P4|Overall Study|Lack of Efficacy|0
5429571|NCT02415595|18750304|P3|Overall Study|Lack of Efficacy|0
5429572|NCT02415595|18750305|P2|Overall Study|Lack of Efficacy|4
5429573|NCT02415595|18750306|P1|Overall Study|Lack of Efficacy|4
5429574|NCT02415595|18750303|P4|Overall Study|Adverse Event|10
5429575|NCT02415595|18750304|P3|Overall Study|Adverse Event|5
5429576|NCT02415595|18750305|P2|Overall Study|Adverse Event|3
5429577|NCT02415595|18750306|P1|Overall Study|Adverse Event|1
5429578|NCT02415595|18750303|P4|Overall Study|Administrative reason by sponsor|39
5429579|NCT02415595|18750304|P3|Overall Study|Administrative reason by sponsor|41
5429580|NCT02415595|18750305|P2|Overall Study|Administrative reason by sponsor|40
5429581|NCT02415595|18750306|P1|Overall Study|Administrative reason by sponsor|39
5429582|NCT02415400|18750448|P4|Overall Study|Site closure; participant won't transfer|1
5429583|NCT02415400|18750449|P3|Overall Study|Site closure; participant won't transfer|0
5429584|NCT02415400|18750450|P2|Overall Study|Site closure; participant won't transfer|0
5429585|NCT02415400|18750451|P1|Overall Study|Site closure; participant won't transfer|0
5429586|NCT02415400|18750448|P4|Overall Study|Investigator decision|1
5429587|NCT02415400|18750449|P3|Overall Study|Investigator decision|1
5429588|NCT02415400|18750450|P2|Overall Study|Investigator decision|0
5429589|NCT02415400|18750451|P1|Overall Study|Investigator decision|0
5429590|NCT02415400|18750448|P4|Overall Study|Participant in jail|0
5429591|NCT02415400|18750449|P3|Overall Study|Participant in jail|1
5429592|NCT02415400|18750450|P2|Overall Study|Participant in jail|0
5429593|NCT02415400|18750451|P1|Overall Study|Participant in jail|0
5429594|NCT02415400|18750448|P4|Overall Study|Poor treatment monitoring|0
5429595|NCT02415400|18750449|P3|Overall Study|Poor treatment monitoring|1
5429596|NCT02415400|18750450|P2|Overall Study|Poor treatment monitoring|0
5429597|NCT02415400|18750451|P1|Overall Study|Poor treatment monitoring|0
5429598|NCT02415400|18750448|P4|Overall Study|State regulations prevent participation|0
5429599|NCT02415400|18750449|P3|Overall Study|State regulations prevent participation|1
5429600|NCT02415400|18750450|P2|Overall Study|State regulations prevent participation|0
5429601|NCT02415400|18750451|P1|Overall Study|State regulations prevent participation|0
5429602|NCT02415400|18750448|P4|Overall Study|Coagulation values cannot be set|0
5429603|NCT02415400|18750449|P3|Overall Study|Coagulation values cannot be set|1
5429604|NCT02415400|18750450|P2|Overall Study|Coagulation values cannot be set|0
5429605|NCT02415400|18750451|P1|Overall Study|Coagulation values cannot be set|0
5429606|NCT02415400|18750448|P4|Overall Study|Stroke and stroke rehabilitation|0
5429607|NCT02415400|18750449|P3|Overall Study|Stroke and stroke rehabilitation|1
5429608|NCT02415400|18750450|P2|Overall Study|Stroke and stroke rehabilitation|0
5429609|NCT02415400|18750451|P1|Overall Study|Stroke and stroke rehabilitation|0
5429610|NCT02415400|18750448|P4|Overall Study|No study drug on site|0
5429611|NCT02415400|18750449|P3|Overall Study|No study drug on site|0
5429612|NCT02415400|18750450|P2|Overall Study|No study drug on site|1
5429613|NCT02415400|18750451|P1|Overall Study|No study drug on site|0
5429614|NCT02415400|18750448|P4|Overall Study|Randomized in error|0
5429615|NCT02415400|18750449|P3|Overall Study|Randomized in error|0
5429616|NCT02415400|18750450|P2|Overall Study|Randomized in error|0
5429617|NCT02415400|18750451|P1|Overall Study|Randomized in error|2
5429618|NCT02415400|18750448|P4|Overall Study|Participant wanted home visits|0
5429619|NCT02415400|18750449|P3|Overall Study|Participant wanted home visits|0
5429620|NCT02415400|18750450|P2|Overall Study|Participant wanted home visits|0
5429621|NCT02415400|18750451|P1|Overall Study|Participant wanted home visits|1
5429622|NCT02415400|18750448|P4|Overall Study|Participant doesn't answer phone|0
5429623|NCT02415400|18750449|P3|Overall Study|Participant doesn't answer phone|0
5429624|NCT02415400|18750450|P2|Overall Study|Participant doesn't answer phone|0
5429625|NCT02415400|18750451|P1|Overall Study|Participant doesn't answer phone|1
5429626|NCT02415400|18750448|P4|Overall Study|Participant no longer meets criteria|1
5429627|NCT02415400|18750449|P3|Overall Study|Participant no longer meets criteria|0
5429628|NCT02415400|18750450|P2|Overall Study|Participant no longer meets criteria|0
5429629|NCT02415400|18750451|P1|Overall Study|Participant no longer meets criteria|2
5429630|NCT02415400|18750448|P4|Overall Study|Poor/Non-Compliance|4
5429631|NCT02415400|18750449|P3|Overall Study|Poor/Non-Compliance|3
5429632|NCT02415400|18750450|P2|Overall Study|Poor/Non-Compliance|1
5429633|NCT02415400|18750451|P1|Overall Study|Poor/Non-Compliance|0
5429634|NCT02415400|18750448|P4|Overall Study|Lost to Follow-up|5
5429635|NCT02415400|18750449|P3|Overall Study|Lost to Follow-up|2
5429636|NCT02415400|18750450|P2|Overall Study|Lost to Follow-up|3
5429637|NCT02415400|18750451|P1|Overall Study|Lost to Follow-up|3
5429638|NCT02415400|18750448|P4|Overall Study|Death|42
5429639|NCT02415400|18750449|P3|Overall Study|Death|35
5429640|NCT02415400|18750450|P2|Overall Study|Death|41
5429641|NCT02415400|18750451|P1|Overall Study|Death|39
5429642|NCT02415400|18750448|P4|Overall Study|Participant withdrew consent|21
5429643|NCT02415400|18750449|P3|Overall Study|Participant withdrew consent|30
5429644|NCT02415400|18750450|P2|Overall Study|Participant withdrew consent|12
5429645|NCT02415400|18750451|P1|Overall Study|Participant withdrew consent|14
5429646|NCT02415400|18750448|P4|Overall Study|Participant request to stop therapy|6
5429647|NCT02415400|18750449|P3|Overall Study|Participant request to stop therapy|8
5429648|NCT02415400|18750450|P2|Overall Study|Participant request to stop therapy|3
5429649|NCT02415400|18750451|P1|Overall Study|Participant request to stop therapy|4
5429650|NCT02415400|18750448|P4|Overall Study|Adverse Event|2
5429651|NCT02415400|18750449|P3|Overall Study|Adverse Event|1
5429652|NCT02415400|18750450|P2|Overall Study|Adverse Event|1
5429653|NCT02415400|18750451|P1|Overall Study|Adverse Event|0
5429654|NCT02415127|18750519|P2|Overall Study|Adverse Event|0
5429655|NCT02415127|18750520|P1|Overall Study|Adverse Event|1
5429656|NCT02414958|18750537|P3|Overall Study|Other than specified|5
5429657|NCT02414958|18750538|P2|Overall Study|Other than specified|4
5429658|NCT02414958|18750539|P1|Overall Study|Other than specified|4
5429659|NCT02414958|18750537|P3|Overall Study|Withdrawal by Subject|5
5429660|NCT02414958|18750538|P2|Overall Study|Withdrawal by Subject|3
5429661|NCT02414958|18750539|P1|Overall Study|Withdrawal by Subject|5
5429662|NCT02414958|18750537|P3|Overall Study|Lost to Follow-up|0
5429663|NCT02414958|18750538|P2|Overall Study|Lost to Follow-up|4
5429664|NCT02414958|18750539|P1|Overall Study|Lost to Follow-up|7
5429665|NCT02414958|18750537|P3|Overall Study|Protocol Violation|1
5429666|NCT02414958|18750538|P2|Overall Study|Protocol Violation|3
5429667|NCT02414958|18750539|P1|Overall Study|Protocol Violation|10
5429668|NCT02414958|18750537|P3|Overall Study|Adverse Event|3
5429669|NCT02414958|18750538|P2|Overall Study|Adverse Event|6
5429670|NCT02414958|18750539|P1|Overall Study|Adverse Event|6
5429671|NCT02414854|18750572|P4|Overall Study|Other than specified above|37
5429672|NCT02414854|18750573|P3|Overall Study|Other than specified above|17
5429673|NCT02414854|18750574|P2|Overall Study|Other than specified above|37
5429674|NCT02414854|18750575|P1|Overall Study|Other than specified above|12
5429675|NCT02414854|18750572|P4|Overall Study|Poor compliance to protocol|2
5429676|NCT02414854|18750573|P3|Overall Study|Poor compliance to protocol|2
5429677|NCT02414854|18750574|P2|Overall Study|Poor compliance to protocol|1
5429678|NCT02414854|18750575|P1|Overall Study|Poor compliance to protocol|1
5429679|NCT02414854|18750572|P4|Overall Study|Adverse Event|12
5429680|NCT02414854|18750573|P3|Overall Study|Adverse Event|1
5429681|NCT02414854|18750574|P2|Overall Study|Adverse Event|7
5429682|NCT02414854|18750575|P1|Overall Study|Adverse Event|9
5429683|NCT02414841|18750739|P2|Overall Study|Randomized But Not Treated|4
5429684|NCT02414841|18750740|P1|Overall Study|Randomized But Not Treated|6
5429685|NCT02414841|18750739|P2|Overall Study|Received a Kidney Transplant|4
5429686|NCT02414841|18750740|P1|Overall Study|Received a Kidney Transplant|13
5429687|NCT02414841|18750739|P2|Overall Study|Death|14
5429688|NCT02414841|18750740|P1|Overall Study|Death|17
5429689|NCT02414841|18750739|P2|Overall Study|Lost to Follow-up|6
5429690|NCT02414841|18750740|P1|Overall Study|Lost to Follow-up|13
5429691|NCT02414841|18750739|P2|Overall Study|Withdrawal by Subject|5
5429692|NCT02414841|18750740|P1|Overall Study|Withdrawal by Subject|7
5429693|NCT02414828|18750752|P4|Overall Study|Lost to Follow-up|2
5429694|NCT02414828|18750753|P3|Overall Study|Lost to Follow-up|1
5429695|NCT02414828|18750754|P2|Overall Study|Lost to Follow-up|1
5429696|NCT02414828|18750755|P1|Overall Study|Lost to Follow-up|0
5429697|NCT02414152|18750848|P1|Overall Study|Lack of Efficacy|1
5429698|NCT02414152|18750848|P1|Overall Study|Withdrawal by Subject|1
5429699|NCT02413996|18750854|P2|Overall Study|not comfortable with the intervention|2
5429700|NCT02413996|18750855|P1|Overall Study|not comfortable with the intervention|9
5429701|NCT02413593|18750900|P1|Overall Study|Adverse Event|1
5429702|NCT02413593|18750900|P1|Overall Study|Lost to Follow-up|3
5429703|NCT02413489|18750919|P3|Overall Study|Study Terminated By Sponsor|1
5429704|NCT02413489|18750920|P2|Overall Study|Study Terminated By Sponsor|13
5429705|NCT02413489|18750921|P1|Overall Study|Study Terminated By Sponsor|2
5429706|NCT02413489|18750919|P3|Overall Study|Withdrawal by Subject|0
5429707|NCT02413489|18750920|P2|Overall Study|Withdrawal by Subject|0
5429708|NCT02413489|18750921|P1|Overall Study|Withdrawal by Subject|2
5429709|NCT02413489|18750919|P3|Overall Study|Death|4
5429710|NCT02413489|18750920|P2|Overall Study|Death|3
5429711|NCT02413489|18750921|P1|Overall Study|Death|11
5429712|NCT02413398|18750962|P2|Overall Study|Other Eligibility criteria|2
5429713|NCT02413398|18750963|P1|Overall Study|Other Eligibility criteria|1
5429714|NCT02413398|18750962|P2|Overall Study|Withdrawal by Subject|1
5429715|NCT02413398|18750963|P1|Overall Study|Withdrawal by Subject|1
5429716|NCT02413398|18750962|P2|Overall Study|Lost to Follow-up|4
5429717|NCT02413398|18750963|P1|Overall Study|Lost to Follow-up|2
5429718|NCT02413372|18750978|P3|Follow-up|Subject unable to return for visit|1
5429719|NCT02413372|18750979|P2|Follow-up|Subject unable to return for visit|0
5429720|NCT02413372|18750980|P1|Follow-up|Subject unable to return for visit|0
5429721|NCT02413372|18750978|P3|Follow-up|Subject Withdrew Consent|1
5429722|NCT02413372|18750979|P2|Follow-up|Subject Withdrew Consent|0
5429723|NCT02413372|18750980|P1|Follow-up|Subject Withdrew Consent|1
5429724|NCT02413372|18750978|P3|Follow-up|Lost to Follow-up|0
5429725|NCT02413372|18750979|P2|Follow-up|Lost to Follow-up|1
5429726|NCT02413372|18750980|P1|Follow-up|Lost to Follow-up|1
5429727|NCT02413372|18750978|P3|Treatment|Withdrawal by Subject|0
5429728|NCT02413372|18750979|P2|Treatment|Withdrawal by Subject|0
5429729|NCT02413372|18750980|P1|Treatment|Withdrawal by Subject|1
5429730|NCT02413372|18750978|P3|Treatment|Lost to Follow-up|1
5429731|NCT02413372|18750979|P2|Treatment|Lost to Follow-up|2
5429732|NCT02413372|18750980|P1|Treatment|Lost to Follow-up|0
5429733|NCT02413346|18751029|P2|Overall Study|Other Miscellaneous Reasons|3
5429734|NCT02413346|18751030|P1|Overall Study|Other Miscellaneous Reasons|4
5429735|NCT02413346|18751029|P2|Overall Study|Protocol Violation|0
5429736|NCT02413346|18751030|P1|Overall Study|Protocol Violation|2
5429737|NCT02413346|18751029|P2|Overall Study|Lost to Follow-up|21
5429738|NCT02413346|18751030|P1|Overall Study|Lost to Follow-up|17
5429739|NCT02413346|18751029|P2|Overall Study|Withdrawal by Subject|40
5429740|NCT02413346|18751030|P1|Overall Study|Withdrawal by Subject|30
5429741|NCT02413346|18751029|P2|Overall Study|Adverse Event|6
5429742|NCT02413346|18751030|P1|Overall Study|Adverse Event|6
5429743|NCT02413333|18751040|P2|Period 2|Protocol Deviation|0
5429744|NCT02413333|18751041|P1|Period 2|Protocol Deviation|1
5429745|NCT02413333|18751040|P2|Period 1|Reason Not Specified|1
5429746|NCT02413333|18751041|P1|Period 1|Reason Not Specified|0
5429747|NCT02413333|18751040|P2|Period 1|Adverse Event|0
5429748|NCT02413333|18751041|P1|Period 1|Adverse Event|1
5429749|NCT02413294|18751049|P1|Overall Study|Withdrawal by Subject|1
5429750|NCT02413255|18751084|P17|Overall Study|Voluntary Withdrawal|0
5429751|NCT02413255|18751085|P16|Overall Study|Voluntary Withdrawal|0
5429752|NCT02413255|18751086|P15|Overall Study|Voluntary Withdrawal|1
5429753|NCT02413255|18751087|P14|Overall Study|Voluntary Withdrawal|0
5429754|NCT02413255|18751088|P13|Overall Study|Voluntary Withdrawal|0
5429755|NCT02413255|18751089|P12|Overall Study|Voluntary Withdrawal|0
5429756|NCT02413255|18751090|P11|Overall Study|Voluntary Withdrawal|0
5429757|NCT02413255|18751091|P10|Overall Study|Voluntary Withdrawal|0
5429758|NCT02413255|18751092|P9|Overall Study|Voluntary Withdrawal|0
5429759|NCT02413255|18751093|P8|Overall Study|Voluntary Withdrawal|0
5429760|NCT02413255|18751094|P7|Overall Study|Voluntary Withdrawal|0
5429761|NCT02413255|18751095|P6|Overall Study|Voluntary Withdrawal|0
5429762|NCT02413255|18751096|P5|Overall Study|Voluntary Withdrawal|0
5429763|NCT02413255|18751097|P4|Overall Study|Voluntary Withdrawal|0
5429764|NCT02413255|18751098|P3|Overall Study|Voluntary Withdrawal|0
5429765|NCT02413255|18751099|P2|Overall Study|Voluntary Withdrawal|0
5429766|NCT02413255|18751100|P1|Overall Study|Voluntary Withdrawal|0
5429767|NCT02413229|18751456|P8|Overall Study|Progressive Disease|1
5429768|NCT02413229|18751457|P7|Overall Study|Progressive Disease|0
5429769|NCT02413229|18751458|P6|Overall Study|Progressive Disease|0
5429770|NCT02413229|18751459|P5|Overall Study|Progressive Disease|0
5429771|NCT02413229|18751460|P4|Overall Study|Progressive Disease|0
5429772|NCT02413229|18751461|P3|Overall Study|Progressive Disease|0
5429773|NCT02413229|18751462|P2|Overall Study|Progressive Disease|0
5429774|NCT02413229|18751463|P1|Overall Study|Progressive Disease|0
5429775|NCT02413229|18751456|P8|Overall Study|Withdrawal by Subject|2
5429776|NCT02413229|18751457|P7|Overall Study|Withdrawal by Subject|0
5429777|NCT02413229|18751458|P6|Overall Study|Withdrawal by Subject|0
5429778|NCT02413229|18751459|P5|Overall Study|Withdrawal by Subject|1
5429779|NCT02413229|18751460|P4|Overall Study|Withdrawal by Subject|0
5429780|NCT02413229|18751461|P3|Overall Study|Withdrawal by Subject|0
5429781|NCT02413229|18751462|P2|Overall Study|Withdrawal by Subject|1
5429782|NCT02413229|18751463|P1|Overall Study|Withdrawal by Subject|1
5429783|NCT02413229|18751456|P8|Overall Study|Lost to Follow-up|0
5429784|NCT02413229|18751457|P7|Overall Study|Lost to Follow-up|0
5429785|NCT02413229|18751458|P6|Overall Study|Lost to Follow-up|0
5429786|NCT02413229|18751459|P5|Overall Study|Lost to Follow-up|2
5429787|NCT02413229|18751460|P4|Overall Study|Lost to Follow-up|0
5429788|NCT02413229|18751461|P3|Overall Study|Lost to Follow-up|1
5429789|NCT02413229|18751462|P2|Overall Study|Lost to Follow-up|0
5429790|NCT02413229|18751463|P1|Overall Study|Lost to Follow-up|0
5429791|NCT02413229|18751456|P8|Overall Study|Adverse Event|1
5429792|NCT02413229|18751457|P7|Overall Study|Adverse Event|0
5429793|NCT02413229|18751458|P6|Overall Study|Adverse Event|0
5429794|NCT02413229|18751459|P5|Overall Study|Adverse Event|0
5429795|NCT02413229|18751460|P4|Overall Study|Adverse Event|1
5429796|NCT02413229|18751461|P3|Overall Study|Adverse Event|0
5429797|NCT02413229|18751462|P2|Overall Study|Adverse Event|0
5429798|NCT02413229|18751463|P1|Overall Study|Adverse Event|0
5429799|NCT02412878|18751602|P2|Overall Study|Lost to Follow-up|3
5429800|NCT02412878|18751603|P1|Overall Study|Lost to Follow-up|2
5429801|NCT02412878|18751602|P2|Overall Study|Withdrawal by Subject|10
5429802|NCT02412878|18751603|P1|Overall Study|Withdrawal by Subject|19
5429803|NCT02412852|18751621|P4|Overall Study|Physician Decision|1
5429804|NCT02412852|18751622|P3|Overall Study|Physician Decision|0
5429805|NCT02412852|18751623|P2|Overall Study|Physician Decision|0
5429806|NCT02412852|18751624|P1|Overall Study|Physician Decision|0
5429807|NCT02412852|18751621|P4|Overall Study|Withdrawal by Subject|0
5429808|NCT02412852|18751622|P3|Overall Study|Withdrawal by Subject|0
5429809|NCT02412852|18751623|P2|Overall Study|Withdrawal by Subject|1
5429810|NCT02412852|18751624|P1|Overall Study|Withdrawal by Subject|0
5429811|NCT02412761|18751650|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
5429812|NCT02412761|18751651|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
5429813|NCT02412761|18751652|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
5429814|NCT02412761|18751653|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
5429815|NCT02412761|18751654|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
5429816|NCT02412761|18751655|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
5429817|NCT02412722|18751669|P6|Overall Study|Reason not Specified|6
5429818|NCT02412722|18751670|P5|Overall Study|Reason not Specified|2
5429819|NCT02412722|18751671|P4|Overall Study|Reason not Specified|1
5429820|NCT02412722|18751672|P3|Overall Study|Reason not Specified|2
5429821|NCT02412722|18751673|P2|Overall Study|Reason not Specified|0
5429822|NCT02412722|18751674|P1|Overall Study|Reason not Specified|3
5429823|NCT02412722|18751669|P6|Overall Study|Received drug in run-in and discontinued|0
5429824|NCT02412722|18751670|P5|Overall Study|Received drug in run-in and discontinued|0
5429825|NCT02412722|18751671|P4|Overall Study|Received drug in run-in and discontinued|0
5429826|NCT02412722|18751672|P3|Overall Study|Received drug in run-in and discontinued|0
5429827|NCT02412722|18751673|P2|Overall Study|Received drug in run-in and discontinued|2
5429828|NCT02412722|18751674|P1|Overall Study|Received drug in run-in and discontinued|0
5429829|NCT02412722|18751669|P6|Overall Study|Lost to Follow-up|0
5429830|NCT02412722|18751670|P5|Overall Study|Lost to Follow-up|1
5429831|NCT02412722|18751671|P4|Overall Study|Lost to Follow-up|0
5429832|NCT02412722|18751672|P3|Overall Study|Lost to Follow-up|0
5429833|NCT02412722|18751673|P2|Overall Study|Lost to Follow-up|0
5429834|NCT02412722|18751674|P1|Overall Study|Lost to Follow-up|0
5429835|NCT02412722|18751669|P6|Overall Study|Withdrawal by Subject|1
5429836|NCT02412722|18751670|P5|Overall Study|Withdrawal by Subject|1
5429837|NCT02412722|18751671|P4|Overall Study|Withdrawal by Subject|2
5429838|NCT02412722|18751672|P3|Overall Study|Withdrawal by Subject|1
5429839|NCT02412722|18751673|P2|Overall Study|Withdrawal by Subject|0
5429840|NCT02412722|18751674|P1|Overall Study|Withdrawal by Subject|2
5429841|NCT02412722|18751669|P6|Overall Study|Progressive Disease|3
5429842|NCT02412722|18751670|P5|Overall Study|Progressive Disease|3
5429843|NCT02412722|18751671|P4|Overall Study|Progressive Disease|9
5429844|NCT02412722|18751672|P3|Overall Study|Progressive Disease|4
5429845|NCT02412722|18751673|P2|Overall Study|Progressive Disease|4
5429846|NCT02412722|18751674|P1|Overall Study|Progressive Disease|6
5429847|NCT02412722|18751669|P6|Overall Study|Adverse Event|3
5429848|NCT02412722|18751670|P5|Overall Study|Adverse Event|0
5429849|NCT02412722|18751671|P4|Overall Study|Adverse Event|3
5429850|NCT02412722|18751672|P3|Overall Study|Adverse Event|0
5429851|NCT02412722|18751673|P2|Overall Study|Adverse Event|2
5429852|NCT02412722|18751674|P1|Overall Study|Adverse Event|0
5429853|NCT02412657|18751745|P3|Overall Study|Protocol Violation|3
5429854|NCT02412657|18751746|P2|Overall Study|Protocol Violation|2
5429855|NCT02412657|18751747|P1|Overall Study|Protocol Violation|0
5429856|NCT02412657|18751745|P3|Overall Study|Lost to Follow-up|0
5429857|NCT02412657|18751746|P2|Overall Study|Lost to Follow-up|0
5429858|NCT02412657|18751747|P1|Overall Study|Lost to Follow-up|1
5429859|NCT02412488|18751791|P1|Overall Study|Reveal LINQ explant|1
5429860|NCT02412488|18751791|P1|Overall Study|No Reveal LINQ Insertion Attempt|1
5429861|NCT02412488|18751791|P1|Overall Study|Physician Decision|1
5429862|NCT02412488|18751791|P1|Overall Study|Withdrawal by Subject|5
5429863|NCT02412488|18751791|P1|Overall Study|Lost to Follow-up|10
5429864|NCT02412436|18751795|P1|Overall Study|Not Willing to Adhere to Requirements|1
5429865|NCT02412436|18751795|P1|Overall Study|Death|1
5429866|NCT02412436|18751795|P1|Overall Study|Unable to get to clinic|3
5429867|NCT02412436|18751795|P1|Overall Study|Lost to Follow-up|6
5429868|NCT02412436|18751795|P1|Overall Study|Protocol-mandated Discontinuation|7
5429869|NCT02412371|18751815|P6|Overall Study|Other|3
5429870|NCT02412371|18751816|P5|Overall Study|Other|1
5429871|NCT02412371|18751817|P4|Overall Study|Other|0
5429872|NCT02412371|18751818|P3|Overall Study|Other|0
5429873|NCT02412371|18751819|P2|Overall Study|Other|1
5429874|NCT02412371|18751820|P1|Overall Study|Other|2
5429875|NCT02412371|18751815|P6|Overall Study|Death|2
5429876|NCT02412371|18751816|P5|Overall Study|Death|5
5429877|NCT02412371|18751817|P4|Overall Study|Death|3
5429878|NCT02412371|18751818|P3|Overall Study|Death|1
5429879|NCT02412371|18751819|P2|Overall Study|Death|2
5429880|NCT02412371|18751820|P1|Overall Study|Death|4
5429881|NCT02412371|18751815|P6|Overall Study|Sponsor Discontinued Study|0
5429882|NCT02412371|18751816|P5|Overall Study|Sponsor Discontinued Study|5
5429883|NCT02412371|18751817|P4|Overall Study|Sponsor Discontinued Study|4
5429884|NCT02412371|18751818|P3|Overall Study|Sponsor Discontinued Study|6
5429885|NCT02412371|18751819|P2|Overall Study|Sponsor Discontinued Study|4
5429886|NCT02412371|18751820|P1|Overall Study|Sponsor Discontinued Study|1
5429887|NCT02412371|18751815|P6|Overall Study|Withdrawal by Subject|0
5429888|NCT02412371|18751816|P5|Overall Study|Withdrawal by Subject|1
5429889|NCT02412371|18751817|P4|Overall Study|Withdrawal by Subject|1
5429890|NCT02412371|18751818|P3|Overall Study|Withdrawal by Subject|0
5429891|NCT02412371|18751819|P2|Overall Study|Withdrawal by Subject|2
5429892|NCT02412371|18751820|P1|Overall Study|Withdrawal by Subject|0
5429893|NCT02412306|18751848|P5|Overall Study|Death|2
5429894|NCT02412306|18751849|P4|Overall Study|Death|0
5429895|NCT02412306|18751850|P3|Overall Study|Death|15
5429896|NCT02412306|18751851|P2|Overall Study|Death|7
5429897|NCT02412306|18751852|P1|Overall Study|Death|5
5429898|NCT02412306|18751848|P5|Overall Study|Withdrawal by Subject|0
5429899|NCT02412306|18751849|P4|Overall Study|Withdrawal by Subject|0
5429900|NCT02412306|18751850|P3|Overall Study|Withdrawal by Subject|1
5429901|NCT02412306|18751851|P2|Overall Study|Withdrawal by Subject|0
5429902|NCT02412306|18751852|P1|Overall Study|Withdrawal by Subject|0
5429903|NCT02412306|18751848|P5|Overall Study|Lost to Follow-up|0
5429904|NCT02412306|18751849|P4|Overall Study|Lost to Follow-up|0
5429905|NCT02412306|18751850|P3|Overall Study|Lost to Follow-up|0
5429906|NCT02412306|18751851|P2|Overall Study|Lost to Follow-up|1
5429907|NCT02412306|18751852|P1|Overall Study|Lost to Follow-up|0
5429908|NCT02412111|18751914|P3|Active Comparator Period (8 Weeks)|Other|2
5429909|NCT02412111|18751915|P2|Active Comparator Period (8 Weeks)|Other|0
5429910|NCT02412111|18751916|P1|Active Comparator Period (8 Weeks)|Other|0
5429911|NCT02412111|18751914|P3|Active Comparator Period (8 Weeks)|Other non-compliance|0
5429912|NCT02412111|18751915|P2|Active Comparator Period (8 Weeks)|Other non-compliance|1
5429913|NCT02412111|18751916|P1|Active Comparator Period (8 Weeks)|Other non-compliance|0
5429914|NCT02412111|18751914|P3|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
5429915|NCT02412111|18751915|P2|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
5429916|NCT02412111|18751916|P1|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
5429917|NCT02412111|18751914|P3|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
5429918|NCT02412111|18751915|P2|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
5429919|NCT02412111|18751916|P1|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
5429920|NCT02412111|18751914|P3|Active Comparator Period (8 Weeks)|Adverse Event|2
5429921|NCT02412111|18751915|P2|Active Comparator Period (8 Weeks)|Adverse Event|0
5429922|NCT02412111|18751916|P1|Active Comparator Period (8 Weeks)|Adverse Event|0
5429923|NCT02412111|18751914|P3|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
5429924|NCT02412111|18751915|P2|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
5429925|NCT02412111|18751916|P1|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
5429926|NCT02412111|18751914|P3|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
5429927|NCT02412111|18751915|P2|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
5429928|NCT02412111|18751916|P1|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
5429929|NCT02411747|18751999|P2|Overall Study|Protocol Violation|4
5429930|NCT02411747|18752000|P1|Overall Study|Protocol Violation|2
5429931|NCT02411747|18751999|P2|Overall Study|Withdrawal by Subject|0
5429932|NCT02411747|18752000|P1|Overall Study|Withdrawal by Subject|1
5429933|NCT02411591|18752016|P3|Overall Study|Physician Decision|1
5429934|NCT02411591|18752017|P2|Overall Study|Physician Decision|3
5429935|NCT02411591|18752018|P1|Overall Study|Physician Decision|0
5429936|NCT02411591|18752016|P3|Overall Study|Withdrawal by Subject|0
5429937|NCT02411591|18752017|P2|Overall Study|Withdrawal by Subject|3
5429938|NCT02411591|18752018|P1|Overall Study|Withdrawal by Subject|0
5429939|NCT02411591|18752016|P3|Overall Study|Adverse Event|2
5429940|NCT02411591|18752017|P2|Overall Study|Adverse Event|4
5429941|NCT02411591|18752018|P1|Overall Study|Adverse Event|0
5429942|NCT02411578|18752050|P2|Crossover Trial Phase|Pregnancy|1
5429943|NCT02411578|18752051|P1|Crossover Trial Phase|Pregnancy|0
5429944|NCT02411539|18752108|P2|Overall Study|Confounding medical condition|1
5429945|NCT02411539|18752109|P1|Overall Study|Confounding medical condition|0
5429946|NCT02411539|18752108|P2|Overall Study|Lost to Follow-up|0
5429947|NCT02411539|18752109|P1|Overall Study|Lost to Follow-up|2
5429948|NCT02411448|18752200|P3|Overall Study|Alive on study treatment|43
5429949|NCT02411448|18752201|P2|Overall Study|Alive on study treatment|64
5429950|NCT02411448|18752202|P1|Overall Study|Alive on study treatment|3
5429951|NCT02411448|18752200|P3|Overall Study|Did not receive study treatment|0
5429952|NCT02411448|18752201|P2|Overall Study|Did not receive study treatment|3
5429953|NCT02411448|18752202|P1|Overall Study|Did not receive study treatment|0
5429954|NCT02411448|18752200|P3|Overall Study|Other|0
5429955|NCT02411448|18752201|P2|Overall Study|Other|2
5429956|NCT02411448|18752202|P1|Overall Study|Other|0
5429957|NCT02411448|18752200|P3|Overall Study|Withdrawal by Subject|9
5429958|NCT02411448|18752201|P2|Overall Study|Withdrawal by Subject|14
5429959|NCT02411448|18752202|P1|Overall Study|Withdrawal by Subject|1
5429960|NCT02411396|18752231|P1|Overall Study|Death|10
5429961|NCT02411396|18752231|P1|Overall Study|Lost to Follow-up|31
5429962|NCT02411292|18752244|P1|Overall Study|Lost to Follow-up|3
5429963|NCT02411292|18752244|P1|Overall Study|Death|2
5429964|NCT02411292|18752244|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
5429965|NCT02411201|18752250|P1|Overall Study|Age group completed|2
5429966|NCT02411201|18752250|P1|Overall Study|Withdrawal by Subject|2
5429967|NCT02411201|18752250|P1|Overall Study|Adverse Event|2
5429968|NCT02411110|18752263|P2|Treatment Period 2|Personal Reasons|2
5429969|NCT02411110|18752264|P1|Treatment Period 2|Personal Reasons|0
5429970|NCT02411110|18752263|P2|Treatment Period 2|Lost to Follow-up|2
5429971|NCT02411110|18752264|P1|Treatment Period 2|Lost to Follow-up|0
5429972|NCT02411110|18752263|P2|Treatment Period 2|Adverse Event|0
5429973|NCT02411110|18752264|P1|Treatment Period 2|Adverse Event|1
5429974|NCT02411110|18752263|P2|Treatment Period 1|Other Miscellaneous Reasons|0
5429975|NCT02411110|18752264|P1|Treatment Period 1|Other Miscellaneous Reasons|2
5429976|NCT02411110|18752263|P2|Treatment Period 1|Personal Reasons|5
5429977|NCT02411110|18752264|P1|Treatment Period 1|Personal Reasons|2
5429978|NCT02411110|18752263|P2|Treatment Period 1|Lost to Follow-up|0
5429979|NCT02411110|18752264|P1|Treatment Period 1|Lost to Follow-up|1
5429980|NCT02411110|18752263|P2|Treatment Period 1|Adverse Event|2
5429981|NCT02411110|18752264|P1|Treatment Period 1|Adverse Event|4
5429982|NCT02411084|18752274|P2|Overall Study|Other reasons|5
5429983|NCT02411084|18752275|P1|Overall Study|Other reasons|0
5429984|NCT02411084|18752274|P2|Overall Study|Adverse Event|1
5429985|NCT02411084|18752275|P1|Overall Study|Adverse Event|2
5429986|NCT02411084|18752274|P2|Overall Study|Death|4
5429987|NCT02411084|18752275|P1|Overall Study|Death|5
5429988|NCT02411084|18752274|P2|Overall Study|Lack of Efficacy|3
5429989|NCT02411084|18752275|P1|Overall Study|Lack of Efficacy|6
5429990|NCT02410824|18752307|P2|First Intervention (One Week)|Headache|1
5429991|NCT02410824|18752308|P1|First Intervention (One Week)|Headache|0
5429992|NCT02410811|18752344|P4|Overall Study|Withdrawal by Subject|0
5429993|NCT02410811|18752345|P3|Overall Study|Withdrawal by Subject|1
5429994|NCT02410811|18752346|P2|Overall Study|Withdrawal by Subject|0
5429995|NCT02410811|18752347|P1|Overall Study|Withdrawal by Subject|0
5429996|NCT02410629|18752374|P2|Overall Study|Subject underwent heart surgery|1
5429997|NCT02410629|18752375|P1|Overall Study|Subject underwent heart surgery|0
5429998|NCT02410629|18752374|P2|Overall Study|Subject moved back to home country|1
5429999|NCT02410629|18752375|P1|Overall Study|Subject moved back to home country|0
5430000|NCT02410629|18752374|P2|Overall Study|Subject returned to work|0
5430001|NCT02410629|18752375|P1|Overall Study|Subject returned to work|1
5430002|NCT02410629|18752374|P2|Overall Study|Family cannot commit to the study|1
5430003|NCT02410629|18752375|P1|Overall Study|Family cannot commit to the study|2
5430004|NCT02410551|18752391|P1|Overall Study|FDA Clinical hold-patients taken off|2
5430005|NCT02410551|18752391|P1|Overall Study|Withdrawal by Subject|1
5430006|NCT02410551|18752391|P1|Overall Study|Adverse Event|1
5430007|NCT02410343|18752409|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
5430008|NCT02410343|18752410|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
5430009|NCT02410343|18752409|P2|Extension Period (12 Months)|Adverse Event|0
5430010|NCT02410343|18752410|P1|Extension Period (12 Months)|Adverse Event|1
5430011|NCT02410343|18752409|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
5430012|NCT02410343|18752410|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
5430013|NCT02410343|18752409|P2|Core Period (24 Weeks)|Adverse Event|0
5430014|NCT02410343|18752410|P1|Core Period (24 Weeks)|Adverse Event|1
5430015|NCT02410278|18752456|P3|Study Treatment Period|GSRS Threshold Not Met|0
5430016|NCT02410278|18752457|P2|Study Treatment Period|GSRS Threshold Not Met|1
5430017|NCT02410278|18752458|P1|Study Treatment Period|GSRS Threshold Not Met|0
5430018|NCT02410278|18752456|P3|Study Treatment Period|Other|0
5430019|NCT02410278|18752457|P2|Study Treatment Period|Other|3
5430020|NCT02410278|18752458|P1|Study Treatment Period|Other|0
5430021|NCT02410278|18752456|P3|Study Treatment Period|Withdrawal by Subject|0
5430022|NCT02410278|18752457|P2|Study Treatment Period|Withdrawal by Subject|1
5430023|NCT02410278|18752458|P1|Study Treatment Period|Withdrawal by Subject|0
5430024|NCT02410278|18752456|P3|Study Treatment Period|Physician Decision|1
5430025|NCT02410278|18752457|P2|Study Treatment Period|Physician Decision|0
5430026|NCT02410278|18752458|P1|Study Treatment Period|Physician Decision|0
5430027|NCT02410278|18752456|P3|Study Treatment Period|Adverse Event|3
5430028|NCT02410278|18752457|P2|Study Treatment Period|Adverse Event|6
5430029|NCT02410278|18752458|P1|Study Treatment Period|Adverse Event|0
5430030|NCT02410278|18752456|P3|Run-in Period|Pregnancy|0
5430031|NCT02410278|18752457|P2|Run-in Period|Pregnancy|0
5430032|NCT02410278|18752458|P1|Run-in Period|Pregnancy|1
5430033|NCT02410278|18752456|P3|Run-in Period|Withdrawal by Subject|0
5430034|NCT02410278|18752457|P2|Run-in Period|Withdrawal by Subject|0
5430035|NCT02410278|18752458|P1|Run-in Period|Withdrawal by Subject|1
5430036|NCT02410278|18752456|P3|Run-in Period|Lost to Follow-up|0
5430037|NCT02410278|18752457|P2|Run-in Period|Lost to Follow-up|0
5430038|NCT02410278|18752458|P1|Run-in Period|Lost to Follow-up|1
5430039|NCT02410278|18752456|P3|Run-in Period|GSRS Threshold Not Met|0
5430040|NCT02410278|18752457|P2|Run-in Period|GSRS Threshold Not Met|0
5430041|NCT02410278|18752458|P1|Run-in Period|GSRS Threshold Not Met|30
5430042|NCT02410278|18752456|P3|Run-in Period|Adverse Event|0
5430043|NCT02410278|18752457|P2|Run-in Period|Adverse Event|0
5430044|NCT02410278|18752458|P1|Run-in Period|Adverse Event|5
5430045|NCT02410252|18752483|P1|Overall Study|Physician Decision|2
5430046|NCT02410252|18752483|P1|Overall Study|Withdrawal by Subject|4
5430047|NCT02410200|18752496|P1|Overall Study|Adverse Event|2
5430048|NCT02409732|18752566|P1|Overall Study|Lost to Follow-up|2
5430049|NCT02409732|18752566|P1|Overall Study|Withdrawal by Subject|4
5430050|NCT02409719|18752576|P2|Overall Study|Lost to Follow-up|3
5430051|NCT02409719|18752577|P1|Overall Study|Lost to Follow-up|3
5430052|NCT02409667|18752587|P5|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5430053|NCT02409667|18752588|P4|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5430054|NCT02409667|18752589|P3|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
5430055|NCT02409667|18752590|P2|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5430056|NCT02409667|18752591|P1|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
5430057|NCT02409667|18752587|P5|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
5430058|NCT02409667|18752588|P4|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
5430059|NCT02409667|18752589|P3|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
5430060|NCT02409667|18752590|P2|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
5430061|NCT02409667|18752591|P1|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
5430062|NCT02409667|18752587|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
5430063|NCT02409667|18752588|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
5430064|NCT02409667|18752589|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
5430065|NCT02409667|18752590|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
5430066|NCT02409667|18752591|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
5430067|NCT02409667|18752587|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
5430068|NCT02409667|18752588|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
5430069|NCT02409667|18752589|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
5430070|NCT02409667|18752590|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
5430071|NCT02409667|18752591|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
5430072|NCT02409667|18752587|P5|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
5430073|NCT02409667|18752588|P4|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
5430074|NCT02409667|18752589|P3|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
5430075|NCT02409667|18752590|P2|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
5430076|NCT02409667|18752591|P1|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
5430077|NCT02409667|18752587|P5|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5430078|NCT02409667|18752588|P4|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
5430079|NCT02409667|18752589|P3|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5430080|NCT02409667|18752590|P2|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5430081|NCT02409667|18752591|P1|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
5430082|NCT02409667|18752587|P5|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
5430083|NCT02409667|18752588|P4|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
5430084|NCT02409667|18752589|P3|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
5430085|NCT02409667|18752590|P2|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
5430086|NCT02409667|18752591|P1|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
5430087|NCT02409667|18752587|P5|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5430088|NCT02409667|18752588|P4|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5430089|NCT02409667|18752589|P3|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5430090|NCT02409667|18752590|P2|Treatment Period 1, Baseline to Week 24|Adverse Event|0
5430091|NCT02409667|18752591|P1|Treatment Period 1, Baseline to Week 24|Adverse Event|25
5430092|NCT02409667|18752587|P5|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5430093|NCT02409667|18752588|P4|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5430094|NCT02409667|18752589|P3|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5430095|NCT02409667|18752590|P2|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
5430096|NCT02409667|18752591|P1|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
5430097|NCT02409667|18752587|P5|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5430098|NCT02409667|18752588|P4|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5430099|NCT02409667|18752589|P3|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5430100|NCT02409667|18752590|P2|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
5430101|NCT02409667|18752591|P1|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
5430102|NCT02409667|18752587|P5|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5430103|NCT02409667|18752588|P4|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5430104|NCT02409667|18752589|P3|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5430105|NCT02409667|18752590|P2|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
5430106|NCT02409667|18752591|P1|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
5430107|NCT02409667|18752587|P5|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5430108|NCT02409667|18752588|P4|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5430109|NCT02409667|18752589|P3|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5430110|NCT02409667|18752590|P2|Treatment Period 1, Baseline to Week 24|Physician Decision|0
5430111|NCT02409667|18752591|P1|Treatment Period 1, Baseline to Week 24|Physician Decision|4
5430112|NCT02409667|18752587|P5|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5430113|NCT02409667|18752588|P4|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5430114|NCT02409667|18752589|P3|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5430115|NCT02409667|18752590|P2|Treatment Period 1, Baseline to Week 24|Pregnancy|0
5430116|NCT02409667|18752591|P1|Treatment Period 1, Baseline to Week 24|Pregnancy|1
5430117|NCT02409667|18752587|P5|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5430118|NCT02409667|18752588|P4|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5430119|NCT02409667|18752589|P3|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5430120|NCT02409667|18752590|P2|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
5430121|NCT02409667|18752591|P1|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
5430122|NCT02409667|18752587|P5|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5430123|NCT02409667|18752588|P4|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5430124|NCT02409667|18752589|P3|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5430125|NCT02409667|18752590|P2|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
5430126|NCT02409667|18752591|P1|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
5430127|NCT02409667|18752587|P5|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5430128|NCT02409667|18752588|P4|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5430129|NCT02409667|18752589|P3|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5430130|NCT02409667|18752590|P2|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
5430131|NCT02409667|18752591|P1|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
5430132|NCT02409355|18752653|P2|Overall Study|Study terminated by Sponsor|3
5430133|NCT02409355|18752654|P1|Overall Study|Study terminated by Sponsor|2
5430134|NCT02409355|18752653|P2|Overall Study|Death|1
5430135|NCT02409355|18752654|P1|Overall Study|Death|1
5430136|NCT02409355|18752653|P2|Overall Study|Withdrawal by Subject|0
5430137|NCT02409355|18752654|P1|Overall Study|Withdrawal by Subject|1
5430138|NCT02408523|18752777|P2|Overall Study|Did not satisfy extension conditions|1
5430139|NCT02408523|18752778|P1|Overall Study|Did not satisfy extension conditions|0
5430140|NCT02408523|18752777|P2|Overall Study|Sponsor request|0
5430141|NCT02408523|18752778|P1|Overall Study|Sponsor request|1
5430142|NCT02408523|18752777|P2|Overall Study|Withdrawal by Subject|1
5430143|NCT02408523|18752778|P1|Overall Study|Withdrawal by Subject|3
5430144|NCT02408523|18752777|P2|Overall Study|Lost to Follow-up|3
5430145|NCT02408523|18752778|P1|Overall Study|Lost to Follow-up|2
5430146|NCT02408523|18752777|P2|Overall Study|Protocol Violation|2
5430147|NCT02408523|18752778|P1|Overall Study|Protocol Violation|1
5430148|NCT02408523|18752777|P2|Overall Study|Lack of Efficacy|1
5430149|NCT02408523|18752778|P1|Overall Study|Lack of Efficacy|0
5430150|NCT02408523|18752777|P2|Overall Study|Adverse Event|10
5430151|NCT02408523|18752778|P1|Overall Study|Adverse Event|4
5430152|NCT02408484|18752798|P1|Overall Study|Not treated during study period|1
5430153|NCT02408484|18752798|P1|Overall Study|Withdrawal by Subject|3
5430154|NCT02408068|18752901|P6|Treatment 3 (1.5 Days)|Adverse Event|0
5430155|NCT02408068|18752902|P5|Treatment 3 (1.5 Days)|Adverse Event|0
5430156|NCT02408068|18752903|P4|Treatment 3 (1.5 Days)|Adverse Event|0
5430157|NCT02408068|18752904|P3|Treatment 3 (1.5 Days)|Adverse Event|1
5430158|NCT02408068|18752905|P2|Treatment 3 (1.5 Days)|Adverse Event|0
5430159|NCT02408068|18752906|P1|Treatment 3 (1.5 Days)|Adverse Event|0
5430160|NCT02407704|18752978|P4|Overall Study|Withdrawal by Subject|0
5430161|NCT02407704|18752979|P3|Overall Study|Withdrawal by Subject|1
5430162|NCT02407704|18752980|P2|Overall Study|Withdrawal by Subject|0
5430163|NCT02407704|18752981|P1|Overall Study|Withdrawal by Subject|0
5430164|NCT02407704|18752978|P4|Overall Study|Protocol Violation|1
5430165|NCT02407704|18752979|P3|Overall Study|Protocol Violation|0
5430166|NCT02407704|18752980|P2|Overall Study|Protocol Violation|0
5430167|NCT02407704|18752981|P1|Overall Study|Protocol Violation|0
5430168|NCT02407704|18752978|P4|Overall Study|Lost to Follow-up|2
5430169|NCT02407704|18752979|P3|Overall Study|Lost to Follow-up|0
5430170|NCT02407704|18752980|P2|Overall Study|Lost to Follow-up|0
5430171|NCT02407704|18752981|P1|Overall Study|Lost to Follow-up|0
5430172|NCT02407249|18753024|P1|Overall Study|Not treated|13
5430173|NCT02407249|18753024|P1|Overall Study|Did not complete 12-month follow-up|13
5430174|NCT02407236|18753040|P8|Maintenance Study (44 Weeks)|Other|1
5430175|NCT02407236|18753041|P7|Maintenance Study (44 Weeks)|Other|2
5430176|NCT02407236|18753042|P6|Maintenance Study (44 Weeks)|Other|1
5430177|NCT02407236|18753043|P5|Maintenance Study (44 Weeks)|Other|1
5430178|NCT02407236|18753044|P4|Maintenance Study (44 Weeks)|Other|0
5430179|NCT02407236|18753045|P3|Maintenance Study (44 Weeks)|Other|0
5430180|NCT02407236|18753046|P2|Maintenance Study (44 Weeks)|Other|0
5430181|NCT02407236|18753047|P1|Maintenance Study (44 Weeks)|Other|0
5430182|NCT02407236|18753040|P8|Maintenance Study (44 Weeks)|Sponsor decision|0
5430183|NCT02407236|18753041|P7|Maintenance Study (44 Weeks)|Sponsor decision|0
5430184|NCT02407236|18753042|P6|Maintenance Study (44 Weeks)|Sponsor decision|1
5430185|NCT02407236|18753043|P5|Maintenance Study (44 Weeks)|Sponsor decision|0
5430186|NCT02407236|18753044|P4|Maintenance Study (44 Weeks)|Sponsor decision|1
5430187|NCT02407236|18753045|P3|Maintenance Study (44 Weeks)|Sponsor decision|0
5430188|NCT02407236|18753046|P2|Maintenance Study (44 Weeks)|Sponsor decision|0
5430189|NCT02407236|18753047|P1|Maintenance Study (44 Weeks)|Sponsor decision|0
5430190|NCT02407236|18753040|P8|Maintenance Study (44 Weeks)|Withdraw of consent|5
5430191|NCT02407236|18753041|P7|Maintenance Study (44 Weeks)|Withdraw of consent|7
5430192|NCT02407236|18753042|P6|Maintenance Study (44 Weeks)|Withdraw of consent|5
5430193|NCT02407236|18753043|P5|Maintenance Study (44 Weeks)|Withdraw of consent|10
5430194|NCT02407236|18753044|P4|Maintenance Study (44 Weeks)|Withdraw of consent|8
5430195|NCT02407236|18753045|P3|Maintenance Study (44 Weeks)|Withdraw of consent|0
5430196|NCT02407236|18753046|P2|Maintenance Study (44 Weeks)|Withdraw of consent|0
5430197|NCT02407236|18753047|P1|Maintenance Study (44 Weeks)|Withdraw of consent|0
5430198|NCT02407236|18753040|P8|Maintenance Study (44 Weeks)|Death|1
5430199|NCT02407236|18753041|P7|Maintenance Study (44 Weeks)|Death|0
5430200|NCT02407236|18753042|P6|Maintenance Study (44 Weeks)|Death|0
5430201|NCT02407236|18753043|P5|Maintenance Study (44 Weeks)|Death|0
5430202|NCT02407236|18753044|P4|Maintenance Study (44 Weeks)|Death|0
5430203|NCT02407236|18753045|P3|Maintenance Study (44 Weeks)|Death|0
5430204|NCT02407236|18753046|P2|Maintenance Study (44 Weeks)|Death|0
5430205|NCT02407236|18753047|P1|Maintenance Study (44 Weeks)|Death|0
5430206|NCT02407236|18753040|P8|Maintenance Study (44 Weeks)|Lost to Follow-up|1
5430207|NCT02407236|18753041|P7|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5430208|NCT02407236|18753042|P6|Maintenance Study (44 Weeks)|Lost to Follow-up|1
5430209|NCT02407236|18753043|P5|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5430210|NCT02407236|18753044|P4|Maintenance Study (44 Weeks)|Lost to Follow-up|1
5430211|NCT02407236|18753045|P3|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5430212|NCT02407236|18753046|P2|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5430213|NCT02407236|18753047|P1|Maintenance Study (44 Weeks)|Lost to Follow-up|0
5430214|NCT02407236|18753040|P8|Induction Study (8 Weeks)|Other|0
5430215|NCT02407236|18753041|P7|Induction Study (8 Weeks)|Other|0
5430216|NCT02407236|18753042|P6|Induction Study (8 Weeks)|Other|0
5430217|NCT02407236|18753043|P5|Induction Study (8 Weeks)|Other|0
5430218|NCT02407236|18753044|P4|Induction Study (8 Weeks)|Other|0
5430219|NCT02407236|18753045|P3|Induction Study (8 Weeks)|Other|5
5430220|NCT02407236|18753046|P2|Induction Study (8 Weeks)|Other|1
5430221|NCT02407236|18753047|P1|Induction Study (8 Weeks)|Other|2
5430222|NCT02407236|18753040|P8|Induction Study (8 Weeks)|Physician Decision|0
5430223|NCT02407236|18753041|P7|Induction Study (8 Weeks)|Physician Decision|0
5430224|NCT02407236|18753042|P6|Induction Study (8 Weeks)|Physician Decision|0
5430225|NCT02407236|18753043|P5|Induction Study (8 Weeks)|Physician Decision|0
5430226|NCT02407236|18753044|P4|Induction Study (8 Weeks)|Physician Decision|0
5430227|NCT02407236|18753045|P3|Induction Study (8 Weeks)|Physician Decision|0
5430228|NCT02407236|18753046|P2|Induction Study (8 Weeks)|Physician Decision|1
5430229|NCT02407236|18753047|P1|Induction Study (8 Weeks)|Physician Decision|1
5430230|NCT02407236|18753040|P8|Induction Study (8 Weeks)|Lost to Follow-up|0
5430231|NCT02407236|18753041|P7|Induction Study (8 Weeks)|Lost to Follow-up|0
5430232|NCT02407236|18753042|P6|Induction Study (8 Weeks)|Lost to Follow-up|0
5430233|NCT02407236|18753043|P5|Induction Study (8 Weeks)|Lost to Follow-up|0
5430234|NCT02407236|18753044|P4|Induction Study (8 Weeks)|Lost to Follow-up|0
5430235|NCT02407236|18753045|P3|Induction Study (8 Weeks)|Lost to Follow-up|1
5430236|NCT02407236|18753046|P2|Induction Study (8 Weeks)|Lost to Follow-up|0
5430237|NCT02407236|18753047|P1|Induction Study (8 Weeks)|Lost to Follow-up|0
5430238|NCT02407236|18753040|P8|Induction Study (8 Weeks)|Withdrawal by Subject|0
5430239|NCT02407236|18753041|P7|Induction Study (8 Weeks)|Withdrawal by Subject|0
5430240|NCT02407236|18753042|P6|Induction Study (8 Weeks)|Withdrawal by Subject|0
5430241|NCT02407236|18753043|P5|Induction Study (8 Weeks)|Withdrawal by Subject|0
5430242|NCT02407236|18753044|P4|Induction Study (8 Weeks)|Withdrawal by Subject|0
5430243|NCT02407236|18753045|P3|Induction Study (8 Weeks)|Withdrawal by Subject|7
5430244|NCT02407236|18753046|P2|Induction Study (8 Weeks)|Withdrawal by Subject|9
5430245|NCT02407236|18753047|P1|Induction Study (8 Weeks)|Withdrawal by Subject|17
5430246|NCT02407236|18753040|P8|Induction Study (8 Weeks)|Death|0
5430247|NCT02407236|18753041|P7|Induction Study (8 Weeks)|Death|0
5430248|NCT02407236|18753042|P6|Induction Study (8 Weeks)|Death|0
5430249|NCT02407236|18753043|P5|Induction Study (8 Weeks)|Death|0
5430250|NCT02407236|18753044|P4|Induction Study (8 Weeks)|Death|0
5430251|NCT02407236|18753045|P3|Induction Study (8 Weeks)|Death|1
5430252|NCT02407236|18753046|P2|Induction Study (8 Weeks)|Death|0
5430253|NCT02407236|18753047|P1|Induction Study (8 Weeks)|Death|0
5430254|NCT02407236|18753040|P8|Induction Study (8 Weeks)|Adverse Event|0
5430255|NCT02407236|18753041|P7|Induction Study (8 Weeks)|Adverse Event|0
5430256|NCT02407236|18753042|P6|Induction Study (8 Weeks)|Adverse Event|0
5430257|NCT02407236|18753043|P5|Induction Study (8 Weeks)|Adverse Event|0
5430258|NCT02407236|18753044|P4|Induction Study (8 Weeks)|Adverse Event|0
5430259|NCT02407236|18753045|P3|Induction Study (8 Weeks)|Adverse Event|1
5430260|NCT02407236|18753046|P2|Induction Study (8 Weeks)|Adverse Event|0
5430261|NCT02407236|18753047|P1|Induction Study (8 Weeks)|Adverse Event|3
5430262|NCT02407223|18753287|P3|Overall Study|Other|25
5430263|NCT02407223|18753288|P2|Overall Study|Other|27
5430264|NCT02407223|18753289|P1|Overall Study|Other|29
5430265|NCT02407223|18753287|P3|Overall Study|Subject Refused Further Study Treatment|0
5430266|NCT02407223|18753288|P2|Overall Study|Subject Refused Further Study Treatment|1
5430267|NCT02407223|18753289|P1|Overall Study|Subject Refused Further Study Treatment|0
5430268|NCT02407223|18753287|P3|Overall Study|Study Terminated by Sponsor|86
5430269|NCT02407223|18753288|P2|Overall Study|Study Terminated by Sponsor|80
5430270|NCT02407223|18753289|P1|Overall Study|Study Terminated by Sponsor|77
5430271|NCT02407223|18753287|P3|Overall Study|Withdrawal by Subject|4
5430272|NCT02407223|18753288|P2|Overall Study|Withdrawal by Subject|4
5430273|NCT02407223|18753289|P1|Overall Study|Withdrawal by Subject|2
5430274|NCT02407223|18753287|P3|Overall Study|Lost to Follow-up|2
5430275|NCT02407223|18753288|P2|Overall Study|Lost to Follow-up|0
5430276|NCT02407223|18753289|P1|Overall Study|Lost to Follow-up|1
5430277|NCT02407223|18753287|P3|Overall Study|Lack of Efficacy|4
5430278|NCT02407223|18753288|P2|Overall Study|Lack of Efficacy|6
5430279|NCT02407223|18753289|P1|Overall Study|Lack of Efficacy|6
5430280|NCT02407223|18753287|P3|Overall Study|Adverse Event|1
5430281|NCT02407223|18753288|P2|Overall Study|Adverse Event|0
5430282|NCT02407223|18753289|P1|Overall Study|Adverse Event|1
5430283|NCT02406677|18753441|P2|Overall Study|Withdrawal by Subject|0
5430284|NCT02406677|18753442|P1|Overall Study|Withdrawal by Subject|1
5430285|NCT02406677|18753441|P2|Overall Study|Discharged on prasugrel|587
5430286|NCT02406677|18753442|P1|Overall Study|Discharged on prasugrel|283
5430287|NCT02406677|18753441|P2|Overall Study|Discharged without P2Y12|3
5430288|NCT02406677|18753442|P1|Overall Study|Discharged without P2Y12|1
5430289|NCT02406677|18753441|P2|Overall Study|Death|8
5430290|NCT02406677|18753442|P1|Overall Study|Death|16
5430291|NCT02406612|18753456|P2|Overall Study|Guidewire Failure|1
5430292|NCT02406612|18753457|P1|Overall Study|Guidewire Failure|0
5430293|NCT02406612|18753456|P2|Overall Study|Intra-procedural Exclusion|3
5430294|NCT02406612|18753457|P1|Overall Study|Intra-procedural Exclusion|1
5430295|NCT02406612|18753456|P2|Overall Study|Screening Failure|0
5430296|NCT02406612|18753457|P1|Overall Study|Screening Failure|3
5430297|NCT02406586|18753472|P3|Overall Study|Withdrawal by Subject|0
5430298|NCT02406586|18753473|P2|Overall Study|Withdrawal by Subject|0
5430299|NCT02406586|18753474|P1|Overall Study|Withdrawal by Subject|1
5430300|NCT02406586|18753472|P3|Overall Study|Lost to Follow-up|2
5430301|NCT02406586|18753473|P2|Overall Study|Lost to Follow-up|4
5430302|NCT02406586|18753474|P1|Overall Study|Lost to Follow-up|0
5430303|NCT02406261|18753616|P2|Period 2|Withdrawal by Subject|1
5430304|NCT02406261|18753617|P1|Period 2|Withdrawal by Subject|0
5430305|NCT02406261|18753616|P2|Period 2|Protocol Violation|1
5430306|NCT02406261|18753617|P1|Period 2|Protocol Violation|0
5430307|NCT02406261|18753616|P2|Period 2|Physician Decision|1
5430308|NCT02406261|18753617|P1|Period 2|Physician Decision|0
5430309|NCT02406261|18753616|P2|Period 1|Adverse Event|0
5430310|NCT02406261|18753617|P1|Period 1|Adverse Event|1
5430311|NCT02406261|18753616|P2|Period 1|Lost to Follow-up|0
5430312|NCT02406261|18753617|P1|Period 1|Lost to Follow-up|2
5430313|NCT02406248|18753629|P1|Overall Study|Withdrawal by Subject|2
5430314|NCT02406248|18753629|P1|Overall Study|Death|7
5430315|NCT02406027|18753640|P7|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5430316|NCT02406027|18753641|P6|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5430317|NCT02406027|18753642|P5|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
5430318|NCT02406027|18753643|P4|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5430319|NCT02406027|18753644|P3|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5430320|NCT02406027|18753645|P2|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5430321|NCT02406027|18753646|P1|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
5430322|NCT02406027|18753640|P7|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5430323|NCT02406027|18753641|P6|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
5430324|NCT02406027|18753642|P5|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5430325|NCT02406027|18753643|P4|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5430326|NCT02406027|18753644|P3|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5430327|NCT02406027|18753645|P2|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5430328|NCT02406027|18753646|P1|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
5430329|NCT02406027|18753640|P7|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
5430330|NCT02406027|18753641|P6|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
5430331|NCT02406027|18753642|P5|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
5430332|NCT02406027|18753643|P4|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
5430333|NCT02406027|18753644|P3|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
5430334|NCT02406027|18753645|P2|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
5430335|NCT02406027|18753646|P1|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
5430336|NCT02406027|18753640|P7|Open-label Phase (Period 2)|Withdrawal by Subject|2
5430337|NCT02406027|18753641|P6|Open-label Phase (Period 2)|Withdrawal by Subject|0
5430338|NCT02406027|18753642|P5|Open-label Phase (Period 2)|Withdrawal by Subject|4
5430339|NCT02406027|18753643|P4|Open-label Phase (Period 2)|Withdrawal by Subject|2
5430340|NCT02406027|18753644|P3|Open-label Phase (Period 2)|Withdrawal by Subject|0
5430341|NCT02406027|18753645|P2|Open-label Phase (Period 2)|Withdrawal by Subject|0
5430342|NCT02406027|18753646|P1|Open-label Phase (Period 2)|Withdrawal by Subject|0
5430343|NCT02406027|18753640|P7|Open-label Phase (Period 2)|Physician Decision|1
5430344|NCT02406027|18753641|P6|Open-label Phase (Period 2)|Physician Decision|1
5430345|NCT02406027|18753642|P5|Open-label Phase (Period 2)|Physician Decision|0
5430346|NCT02406027|18753643|P4|Open-label Phase (Period 2)|Physician Decision|0
5430347|NCT02406027|18753644|P3|Open-label Phase (Period 2)|Physician Decision|0
5430348|NCT02406027|18753645|P2|Open-label Phase (Period 2)|Physician Decision|0
5430349|NCT02406027|18753646|P1|Open-label Phase (Period 2)|Physician Decision|0
5430350|NCT02406027|18753640|P7|Open-label Phase (Period 2)|Adverse Event|0
5430351|NCT02406027|18753641|P6|Open-label Phase (Period 2)|Adverse Event|0
5430352|NCT02406027|18753642|P5|Open-label Phase (Period 2)|Adverse Event|2
5430353|NCT02406027|18753643|P4|Open-label Phase (Period 2)|Adverse Event|2
5430354|NCT02406027|18753644|P3|Open-label Phase (Period 2)|Adverse Event|0
5430355|NCT02406027|18753645|P2|Open-label Phase (Period 2)|Adverse Event|0
5430356|NCT02406027|18753646|P1|Open-label Phase (Period 2)|Adverse Event|0
5430357|NCT02406027|18753640|P7|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5430358|NCT02406027|18753641|P6|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5430359|NCT02406027|18753642|P5|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5430360|NCT02406027|18753643|P4|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5430361|NCT02406027|18753644|P3|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
5430362|NCT02406027|18753645|P2|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
5430363|NCT02406027|18753646|P1|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
5430364|NCT02406027|18753640|P7|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5430365|NCT02406027|18753641|P6|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5430366|NCT02406027|18753642|P5|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5430367|NCT02406027|18753643|P4|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
5430368|NCT02406027|18753644|P3|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
5430369|NCT02406027|18753645|P2|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
5430370|NCT02406027|18753646|P1|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
5430371|NCT02406027|18753640|P7|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5430372|NCT02406027|18753641|P6|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5430373|NCT02406027|18753642|P5|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5430374|NCT02406027|18753643|P4|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5430375|NCT02406027|18753644|P3|Double-blind Treatment Phase (Period 1)|Physician Decision|1
5430376|NCT02406027|18753645|P2|Double-blind Treatment Phase (Period 1)|Physician Decision|0
5430377|NCT02406027|18753646|P1|Double-blind Treatment Phase (Period 1)|Physician Decision|3
5430378|NCT02406027|18753640|P7|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5430379|NCT02406027|18753641|P6|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5430380|NCT02406027|18753642|P5|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5430381|NCT02406027|18753643|P4|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5430382|NCT02406027|18753644|P3|Double-blind Treatment Phase (Period 1)|Adverse Event|1
5430383|NCT02406027|18753645|P2|Double-blind Treatment Phase (Period 1)|Adverse Event|2
5430384|NCT02406027|18753646|P1|Double-blind Treatment Phase (Period 1)|Adverse Event|0
5430385|NCT02405962|18753676|P2|Overall Study|A participant has moved to another place|1
5430386|NCT02405962|18753677|P1|Overall Study|A participant has moved to another place|0
5430387|NCT02405962|18753676|P2|Overall Study|Lost to Follow-up|4
5430388|NCT02405962|18753677|P1|Overall Study|Lost to Follow-up|1
5430389|NCT02405780|18753715|P4|Period II|Non-compliance with study procedures|4
5430390|NCT02405780|18753716|P3|Period II|Non-compliance with study procedures|7
5430391|NCT02405780|18753717|P2|Period II|Non-compliance with study procedures|2
5430392|NCT02405780|18753718|P1|Period II|Non-compliance with study procedures|5
5430393|NCT02405780|18753715|P4|Period II|Withdrawal by Subject|3
5430394|NCT02405780|18753716|P3|Period II|Withdrawal by Subject|0
5430395|NCT02405780|18753717|P2|Period II|Withdrawal by Subject|4
5430396|NCT02405780|18753718|P1|Period II|Withdrawal by Subject|7
5430397|NCT02405780|18753715|P4|Period II|Pregnancy|0
5430398|NCT02405780|18753716|P3|Period II|Pregnancy|1
5430399|NCT02405780|18753717|P2|Period II|Pregnancy|0
5430400|NCT02405780|18753718|P1|Period II|Pregnancy|0
5430401|NCT02405780|18753715|P4|Period II|Medical reason|0
5430402|NCT02405780|18753716|P3|Period II|Medical reason|0
5430403|NCT02405780|18753717|P2|Period II|Medical reason|1
5430404|NCT02405780|18753718|P1|Period II|Medical reason|0
5430405|NCT02405780|18753715|P4|Period II|Adverse Event|11
5430406|NCT02405780|18753716|P3|Period II|Adverse Event|4
5430407|NCT02405780|18753717|P2|Period II|Adverse Event|5
5430408|NCT02405780|18753718|P1|Period II|Adverse Event|3
5430409|NCT02405780|18753715|P4|Period I|Non-compliance with study procedures|11
5430410|NCT02405780|18753716|P3|Period I|Non-compliance with study procedures|8
5430411|NCT02405780|18753717|P2|Period I|Non-compliance with study procedures|6
5430412|NCT02405780|18753718|P1|Period I|Non-compliance with study procedures|8
5430413|NCT02405780|18753715|P4|Period I|Withdrawal by Subject|4
5430414|NCT02405780|18753716|P3|Period I|Withdrawal by Subject|3
5430415|NCT02405780|18753717|P2|Period I|Withdrawal by Subject|1
5430416|NCT02405780|18753718|P1|Period I|Withdrawal by Subject|9
5430417|NCT02405780|18753715|P4|Period I|Screening Failure|0
5430418|NCT02405780|18753716|P3|Period I|Screening Failure|1
5430419|NCT02405780|18753717|P2|Period I|Screening Failure|0
5430420|NCT02405780|18753718|P1|Period I|Screening Failure|1
5430421|NCT02405780|18753715|P4|Period I|Medical reasons|1
5430422|NCT02405780|18753716|P3|Period I|Medical reasons|0
5430423|NCT02405780|18753717|P2|Period I|Medical reasons|1
5430424|NCT02405780|18753718|P1|Period I|Medical reasons|1
5430425|NCT02405780|18753715|P4|Period I|Adverse Event|7
5430426|NCT02405780|18753716|P3|Period I|Adverse Event|3
5430427|NCT02405780|18753717|P2|Period I|Adverse Event|0
5430428|NCT02405780|18753718|P1|Period I|Adverse Event|8
5430429|NCT02405442|18753781|P4|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
5430430|NCT02405442|18753782|P3|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
5430431|NCT02405442|18753783|P2|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
5430432|NCT02405442|18753784|P1|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
5430433|NCT02405442|18753781|P4|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
5430434|NCT02405442|18753782|P3|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
5430435|NCT02405442|18753783|P2|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
5430436|NCT02405442|18753784|P1|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
5430437|NCT02405442|18753781|P4|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
5430438|NCT02405442|18753782|P3|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
5430439|NCT02405442|18753783|P2|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
5430440|NCT02405442|18753784|P1|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
5430441|NCT02405442|18753781|P4|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
5430442|NCT02405442|18753782|P3|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
5430443|NCT02405442|18753783|P2|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
5430444|NCT02405442|18753784|P1|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
5430445|NCT02405442|18753781|P4|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
5430446|NCT02405442|18753782|P3|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
5430447|NCT02405442|18753783|P2|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
5430448|NCT02405442|18753784|P1|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
5430449|NCT02405442|18753781|P4|Open-Label Phase (up to Week 52)|Withdrew Consent|1
5430450|NCT02405442|18753782|P3|Open-Label Phase (up to Week 52)|Withdrew Consent|1
5430451|NCT02405442|18753783|P2|Open-Label Phase (up to Week 52)|Withdrew Consent|2
5430452|NCT02405442|18753784|P1|Open-Label Phase (up to Week 52)|Withdrew Consent|1
5430453|NCT02405442|18753781|P4|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
5430454|NCT02405442|18753782|P3|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
5430455|NCT02405442|18753783|P2|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
5430456|NCT02405442|18753784|P1|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
5430457|NCT02405442|18753781|P4|Open-Label Phase (up to Week 52)|Adverse Event|6
5430458|NCT02405442|18753782|P3|Open-Label Phase (up to Week 52)|Adverse Event|2
5430459|NCT02405442|18753783|P2|Open-Label Phase (up to Week 52)|Adverse Event|1
5430460|NCT02405442|18753784|P1|Open-Label Phase (up to Week 52)|Adverse Event|6
5430461|NCT02405442|18753781|P4|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
5430462|NCT02405442|18753782|P3|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
5430463|NCT02405442|18753783|P2|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
5430464|NCT02405442|18753784|P1|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
5430465|NCT02405442|18753781|P4|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
5430466|NCT02405442|18753782|P3|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
5430467|NCT02405442|18753783|P2|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
5430468|NCT02405442|18753784|P1|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
5430469|NCT02405442|18753781|P4|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
5430470|NCT02405442|18753782|P3|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
5430471|NCT02405442|18753783|P2|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
5430472|NCT02405442|18753784|P1|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
5430473|NCT02405442|18753781|P4|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
5430474|NCT02405442|18753782|P3|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
5430475|NCT02405442|18753783|P2|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
5430476|NCT02405442|18753784|P1|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
5430477|NCT02405442|18753781|P4|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
5430478|NCT02405442|18753782|P3|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
5430479|NCT02405442|18753783|P2|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
5430480|NCT02405442|18753784|P1|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
5430481|NCT02405442|18753781|P4|Double-Blind Phase (up to Week 8)|Adverse Event|1
5430482|NCT02405442|18753782|P3|Double-Blind Phase (up to Week 8)|Adverse Event|4
5430483|NCT02405442|18753783|P2|Double-Blind Phase (up to Week 8)|Adverse Event|2
5430484|NCT02405442|18753784|P1|Double-Blind Phase (up to Week 8)|Adverse Event|0
5430485|NCT02405091|18753838|P3|Overall Study|Physician Decision|0
5430486|NCT02405091|18753839|P2|Overall Study|Physician Decision|2
5430487|NCT02405091|18753840|P1|Overall Study|Physician Decision|2
5430488|NCT02405091|18753838|P3|Overall Study|Lost to Follow-up|0
5430489|NCT02405091|18753839|P2|Overall Study|Lost to Follow-up|6
5430490|NCT02405091|18753840|P1|Overall Study|Lost to Follow-up|5
5430491|NCT02405091|18753838|P3|Overall Study|Death|0
5430492|NCT02405091|18753839|P2|Overall Study|Death|1
5430493|NCT02405091|18753840|P1|Overall Study|Death|0
5430494|NCT02405091|18753838|P3|Overall Study|Withdrawal by Subject|0
5430495|NCT02405091|18753839|P2|Overall Study|Withdrawal by Subject|8
5430496|NCT02405091|18753840|P1|Overall Study|Withdrawal by Subject|4
5430497|NCT02405091|18753838|P3|Overall Study|Noncompliance|2
5430498|NCT02405091|18753839|P2|Overall Study|Noncompliance|6
5430499|NCT02405091|18753840|P1|Overall Study|Noncompliance|1
5430500|NCT02405091|18753838|P3|Overall Study|Protocol Violation|0
5430501|NCT02405091|18753839|P2|Overall Study|Protocol Violation|0
5430502|NCT02405091|18753840|P1|Overall Study|Protocol Violation|1
5430503|NCT02405091|18753838|P3|Overall Study|Adverse Event|0
5430504|NCT02405091|18753839|P2|Overall Study|Adverse Event|10
5430505|NCT02405091|18753840|P1|Overall Study|Adverse Event|16
5430506|NCT02404649|18753876|P2|Overall Study|Adverse Event|2
5430507|NCT02404649|18753877|P1|Overall Study|Adverse Event|1
5430508|NCT02404545|18753896|P2|Overall Study|Sponsor Termination|6
5430509|NCT02404545|18753897|P1|Overall Study|Sponsor Termination|6
5430510|NCT02404493|18753916|P2|Overall Study|Adverse Event|1
5430511|NCT02404493|18753917|P1|Overall Study|Adverse Event|1
5430512|NCT02404389|18754162|P5|Overall Study|Subject/guardian decision|1
5430513|NCT02404389|18754163|P4|Overall Study|Subject/guardian decision|1
5430514|NCT02404389|18754164|P3|Overall Study|Subject/guardian decision|0
5430515|NCT02404389|18754165|P2|Overall Study|Subject/guardian decision|0
5430516|NCT02404389|18754166|P1|Overall Study|Subject/guardian decision|1
5430517|NCT02404389|18754162|P5|Overall Study|Adverse Event|2
5430518|NCT02404389|18754163|P4|Overall Study|Adverse Event|0
5430519|NCT02404389|18754164|P3|Overall Study|Adverse Event|1
5430520|NCT02404389|18754165|P2|Overall Study|Adverse Event|0
5430521|NCT02404389|18754166|P1|Overall Study|Adverse Event|1
5430522|NCT02404350|18754206|P4|Overall Study|Due to Technical problems|1
5430523|NCT02404350|18754207|P3|Overall Study|Due to Technical problems|0
5430524|NCT02404350|18754208|P2|Overall Study|Due to Technical problems|0
5430525|NCT02404350|18754209|P1|Overall Study|Due to Technical problems|0
5430526|NCT02404350|18754206|P4|Overall Study|Due to Non-compliance with treatment|1
5430527|NCT02404350|18754207|P3|Overall Study|Due to Non-compliance with treatment|0
5430528|NCT02404350|18754208|P2|Overall Study|Due to Non-compliance with treatment|0
5430529|NCT02404350|18754209|P1|Overall Study|Due to Non-compliance with treatment|0
5430530|NCT02404350|18754206|P4|Overall Study|Withdrawal by Subject|19
5430531|NCT02404350|18754207|P3|Overall Study|Withdrawal by Subject|3
5430532|NCT02404350|18754208|P2|Overall Study|Withdrawal by Subject|3
5430533|NCT02404350|18754209|P1|Overall Study|Withdrawal by Subject|7
5430534|NCT02404350|18754206|P4|Overall Study|Pregnancy|1
5430535|NCT02404350|18754207|P3|Overall Study|Pregnancy|0
5430536|NCT02404350|18754208|P2|Overall Study|Pregnancy|0
5430537|NCT02404350|18754209|P1|Overall Study|Pregnancy|0
5430538|NCT02404350|18754206|P4|Overall Study|Physician Decision|2
5430539|NCT02404350|18754207|P3|Overall Study|Physician Decision|0
5430540|NCT02404350|18754208|P2|Overall Study|Physician Decision|0
5430541|NCT02404350|18754209|P1|Overall Study|Physician Decision|1
5430542|NCT02404350|18754206|P4|Overall Study|Lost to Follow-up|1
5430543|NCT02404350|18754207|P3|Overall Study|Lost to Follow-up|0
5430544|NCT02404350|18754208|P2|Overall Study|Lost to Follow-up|0
5430545|NCT02404350|18754209|P1|Overall Study|Lost to Follow-up|2
5430546|NCT02404350|18754206|P4|Overall Study|Lack of Efficacy|3
5430547|NCT02404350|18754207|P3|Overall Study|Lack of Efficacy|0
5430548|NCT02404350|18754208|P2|Overall Study|Lack of Efficacy|1
5430549|NCT02404350|18754209|P1|Overall Study|Lack of Efficacy|3
5430550|NCT02404350|18754206|P4|Overall Study|Adverse Event|9
5430551|NCT02404350|18754207|P3|Overall Study|Adverse Event|3
5430552|NCT02404350|18754208|P2|Overall Study|Adverse Event|2
5430553|NCT02404350|18754209|P1|Overall Study|Adverse Event|2
5430554|NCT02404311|18754257|P5|Part A: Month 0-18|Participant unable to adhere|0
5430555|NCT02404311|18754258|P4|Part A: Month 0-18|Participant unable to adhere|0
5430556|NCT02404311|18754259|P3|Part A: Month 0-18|Participant unable to adhere|0
5430557|NCT02404311|18754260|P2|Part A: Month 0-18|Participant unable to adhere|0
5430558|NCT02404311|18754261|P1|Part A: Month 0-18|Participant unable to adhere|7
5430559|NCT02404311|18754257|P5|Part A: Month 0-18|HIV Infection|0
5430560|NCT02404311|18754258|P4|Part A: Month 0-18|HIV Infection|0
5430561|NCT02404311|18754259|P3|Part A: Month 0-18|HIV Infection|0
5430562|NCT02404311|18754260|P2|Part A: Month 0-18|HIV Infection|2
5430563|NCT02404311|18754261|P1|Part A: Month 0-18|HIV Infection|6
5430564|NCT02404311|18754257|P5|Part A: Month 0-18|Withdrawal by Subject|0
5430565|NCT02404311|18754258|P4|Part A: Month 0-18|Withdrawal by Subject|0
5430566|NCT02404311|18754259|P3|Part A: Month 0-18|Withdrawal by Subject|0
5430567|NCT02404311|18754260|P2|Part A: Month 0-18|Withdrawal by Subject|2
5430568|NCT02404311|18754261|P1|Part A: Month 0-18|Withdrawal by Subject|6
5430569|NCT02404311|18754257|P5|Part A: Month 0-18|Lost to Follow-up|0
5430570|NCT02404311|18754258|P4|Part A: Month 0-18|Lost to Follow-up|0
5430571|NCT02404311|18754259|P3|Part A: Month 0-18|Lost to Follow-up|0
5430572|NCT02404311|18754260|P2|Part A: Month 0-18|Lost to Follow-up|2
5430573|NCT02404311|18754261|P1|Part A: Month 0-18|Lost to Follow-up|4
5430574|NCT02404311|18754257|P5|Part A: Month 0-18|Physician Decision|0
5430575|NCT02404311|18754258|P4|Part A: Month 0-18|Physician Decision|0
5430576|NCT02404311|18754259|P3|Part A: Month 0-18|Physician Decision|0
5430577|NCT02404311|18754260|P2|Part A: Month 0-18|Physician Decision|0
5430578|NCT02404311|18754261|P1|Part A: Month 0-18|Physician Decision|1
5430579|NCT02404311|18754257|P5|Part A: Month 0-18|Death|0
5430580|NCT02404311|18754258|P4|Part A: Month 0-18|Death|0
5430581|NCT02404311|18754259|P3|Part A: Month 0-18|Death|0
5430582|NCT02404311|18754260|P2|Part A: Month 0-18|Death|0
5430583|NCT02404311|18754261|P1|Part A: Month 0-18|Death|2
5430584|NCT02404220|18754402|P4|Overall Study|Enrolled but Never Treated|0
5430585|NCT02404220|18754403|P3|Overall Study|Enrolled but Never Treated|0
5430586|NCT02404220|18754404|P2|Overall Study|Enrolled but Never Treated|2
5430587|NCT02404220|18754405|P1|Overall Study|Enrolled but Never Treated|0
5430588|NCT02404220|18754402|P4|Overall Study|Withdrawal by Subject|0
5430589|NCT02404220|18754403|P3|Overall Study|Withdrawal by Subject|0
5430590|NCT02404220|18754404|P2|Overall Study|Withdrawal by Subject|1
5430591|NCT02404220|18754405|P1|Overall Study|Withdrawal by Subject|0
5430592|NCT02404220|18754402|P4|Overall Study|Study Terminated by Sponsor|1
5430593|NCT02404220|18754403|P3|Overall Study|Study Terminated by Sponsor|2
5430594|NCT02404220|18754404|P2|Overall Study|Study Terminated by Sponsor|0
5430595|NCT02404220|18754405|P1|Overall Study|Study Terminated by Sponsor|0
5430596|NCT02404220|18754402|P4|Overall Study|Progressive Disease|1
5430597|NCT02404220|18754403|P3|Overall Study|Progressive Disease|1
5430598|NCT02404220|18754404|P2|Overall Study|Progressive Disease|0
5430599|NCT02404220|18754405|P1|Overall Study|Progressive Disease|0
5430600|NCT02404220|18754402|P4|Overall Study|Death|8
5430601|NCT02404220|18754403|P3|Overall Study|Death|3
5430602|NCT02404220|18754404|P2|Overall Study|Death|5
5430603|NCT02404220|18754405|P1|Overall Study|Death|5
5430604|NCT02404220|18754402|P4|Overall Study|Adverse Event|0
5430605|NCT02404220|18754403|P3|Overall Study|Adverse Event|1
5430606|NCT02404220|18754404|P2|Overall Study|Adverse Event|0
5430607|NCT02404220|18754405|P1|Overall Study|Adverse Event|0
5430608|NCT02404103|18754441|P2|Overall Study|Lost to Follow-up|3
5430609|NCT02404103|18754442|P1|Overall Study|Lost to Follow-up|3
5430610|NCT02404103|18754441|P2|Overall Study|Adverse Event|0
5430611|NCT02404103|18754442|P1|Overall Study|Adverse Event|1
5430612|NCT02404025|18754462|P1|Overall Study|Lack of Efficacy|3
5430613|NCT02404025|18754462|P1|Overall Study|Adverse Event|1
5430614|NCT02403817|18754544|P2|Overall Study|Withdrawal by Subject|0
5430615|NCT02403817|18754545|P1|Overall Study|Withdrawal by Subject|5
5430616|NCT02403674|18754576|P2|Overall Study|Protocol Violation|2
5430617|NCT02403674|18754577|P1|Overall Study|Protocol Violation|4
5430618|NCT02403674|18754576|P2|Overall Study|Pregnancy|1
5430619|NCT02403674|18754577|P1|Overall Study|Pregnancy|1
5430620|NCT02403674|18754576|P2|Overall Study|Not treated with study drug|2
5430621|NCT02403674|18754577|P1|Overall Study|Not treated with study drug|4
5430622|NCT02403674|18754576|P2|Overall Study|Physician Decision|2
5430623|NCT02403674|18754577|P1|Overall Study|Physician Decision|2
5430624|NCT02403674|18754576|P2|Overall Study|Withdrawal by Subject|11
5430625|NCT02403674|18754577|P1|Overall Study|Withdrawal by Subject|8
5430626|NCT02403674|18754576|P2|Overall Study|Noncompliance with study drug|2
5430627|NCT02403674|18754577|P1|Overall Study|Noncompliance with study drug|1
5430628|NCT02403674|18754576|P2|Overall Study|Lost to Follow-up|7
5430629|NCT02403674|18754577|P1|Overall Study|Lost to Follow-up|6
5430630|NCT02403674|18754576|P2|Overall Study|Lack of Efficacy|10
5430631|NCT02403674|18754577|P1|Overall Study|Lack of Efficacy|18
5430632|NCT02403674|18754576|P2|Overall Study|Death|3
5430633|NCT02403674|18754577|P1|Overall Study|Death|1
5430634|NCT02403674|18754576|P2|Overall Study|Adverse Event|23
5430635|NCT02403674|18754577|P1|Overall Study|Adverse Event|10
5430636|NCT02403635|18754616|P1|Overall Study|Not eligible|9
5430637|NCT02403271|18754693|P2|Period 2|Other varied reasons|10
5430638|NCT02403271|18754694|P1|Period 2|Other varied reasons|0
5430639|NCT02403271|18754693|P2|Period 2|Study Terminated by Sponsor|14
5430640|NCT02403271|18754694|P1|Period 2|Study Terminated by Sponsor|0
5430641|NCT02403271|18754693|P2|Period 2|Lost to Follow-up|2
5430642|NCT02403271|18754694|P1|Period 2|Lost to Follow-up|0
5430643|NCT02403271|18754693|P2|Period 2|Death|84
5430644|NCT02403271|18754694|P1|Period 2|Death|0
5430645|NCT02403271|18754693|P2|Period 2|Withdrawal by Subject|14
5430646|NCT02403271|18754694|P1|Period 2|Withdrawal by Subject|0
5430647|NCT02403271|18754693|P2|Period 1|Other varied reasons|0
5430648|NCT02403271|18754694|P1|Period 1|Other varied reasons|1
5430649|NCT02403206|18754708|P2|Overall Study|Reason not given|4
5430650|NCT02403206|18754709|P1|Overall Study|Reason not given|2
5430651|NCT02403206|18754708|P2|Overall Study|Withdrawal by Subject|3
5430652|NCT02403206|18754709|P1|Overall Study|Withdrawal by Subject|3
5430653|NCT02403206|18754708|P2|Overall Study|Physician Decision|0
5430654|NCT02403206|18754709|P1|Overall Study|Physician Decision|2
5430655|NCT02403206|18754708|P2|Overall Study|Lost to Follow-up|3
5430656|NCT02403206|18754709|P1|Overall Study|Lost to Follow-up|4
5430657|NCT02403180|18754720|P2|Period 2 (5 Days)|Withdrawal by Subject|1
5430658|NCT02403180|18754721|P1|Period 2 (5 Days)|Withdrawal by Subject|0
5430659|NCT02403180|18754720|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
5430660|NCT02403180|18754721|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
5430661|NCT02402933|18754750|P1|Overall Study|Discontinued; Site Termination|10
5430662|NCT02402933|18754750|P1|Overall Study|Withdrawal by Subject|4
5430663|NCT02402907|18754759|P2|Overall Study|Lost to follow up after C-Section|23
5430664|NCT02402907|18754760|P1|Overall Study|Lost to follow up after C-Section|10
5430665|NCT02402907|18754759|P2|Overall Study|Delivered outside of Sinai|1
5430666|NCT02402907|18754760|P1|Overall Study|Delivered outside of Sinai|1
5430667|NCT02402907|18754759|P2|Overall Study|Delivered vaginally|3
5430668|NCT02402907|18754760|P1|Overall Study|Delivered vaginally|9
5430669|NCT02402322|18754815|P3|Follow-up|Withdrawal by Subject|24
5430670|NCT02402322|18754816|P2|Follow-up|Withdrawal by Subject|3
5430671|NCT02402322|18754817|P1|Follow-up|Withdrawal by Subject|6
5430672|NCT02402322|18754815|P3|Pretreatment|Withdrawal by Subject|1
5430673|NCT02402322|18754816|P2|Pretreatment|Withdrawal by Subject|1
5430674|NCT02402322|18754817|P1|Pretreatment|Withdrawal by Subject|3
5430675|NCT02402218|18754867|P3|Overall Study|Withdrawal by Subject|1
5430676|NCT02402218|18754868|P2|Overall Study|Withdrawal by Subject|1
5430677|NCT02402218|18754869|P1|Overall Study|Withdrawal by Subject|1
5430678|NCT02402218|18754867|P3|Overall Study|Adverse Event|1
5430679|NCT02402218|18754868|P2|Overall Study|Adverse Event|2
5430680|NCT02402218|18754869|P1|Overall Study|Adverse Event|0
5430681|NCT02402218|18754867|P3|Overall Study|Reinfection|1
5430682|NCT02402218|18754868|P2|Overall Study|Reinfection|0
5430683|NCT02402218|18754869|P1|Overall Study|Reinfection|0
5430684|NCT02402218|18754867|P3|Overall Study|Death|0
5430685|NCT02402218|18754868|P2|Overall Study|Death|0
5430686|NCT02402218|18754869|P1|Overall Study|Death|1
5430687|NCT02402218|18754867|P3|Overall Study|Lack of Efficacy|1
5430688|NCT02402218|18754868|P2|Overall Study|Lack of Efficacy|1
5430689|NCT02402218|18754869|P1|Overall Study|Lack of Efficacy|0
5430690|NCT02402218|18754867|P3|Overall Study|Did not pickup study medication|13
5430691|NCT02402218|18754868|P2|Overall Study|Did not pickup study medication|9
5430692|NCT02402218|18754869|P1|Overall Study|Did not pickup study medication|12
5430693|NCT02402166|18754892|P1|Overall Study|Lost to Follow-up|1
5430694|NCT02402166|18754892|P1|Overall Study|Withdrawal by Subject|2
5430695|NCT02402166|18754892|P1|Overall Study|Adverse Event|2
5430696|NCT02401867|18754959|P1|Analysis|Cervical assay could not be conducted|9
5430697|NCT02401867|18754959|P1|Specimen Collection|Didn't receive 1 or more tests|10
5430698|NCT02401672|18754966|P2|Overall Study|Withdrawal by Subject|3
5430699|NCT02401672|18754967|P1|Overall Study|Withdrawal by Subject|1
5430700|NCT02401529|18755009|P2|Overall Study|Protocol Violation|0
5430701|NCT02401529|18755010|P1|Overall Study|Protocol Violation|5
5430702|NCT02401529|18755009|P2|Overall Study|Physician Decision|6
5430703|NCT02401529|18755010|P1|Overall Study|Physician Decision|2
5430704|NCT02401529|18755009|P2|Overall Study|Lost to Follow-up|1
5430705|NCT02401529|18755010|P1|Overall Study|Lost to Follow-up|2
5430706|NCT02401412|18755077|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
5430707|NCT02401412|18755078|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
5430708|NCT02401412|18755077|P2|Overall Study|Subject withdrawal prior to intervention|1
5430709|NCT02401412|18755078|P1|Overall Study|Subject withdrawal prior to intervention|0
5430710|NCT02401412|18755077|P2|Overall Study|Withdrawal by Subject|4
5430711|NCT02401412|18755078|P1|Overall Study|Withdrawal by Subject|4
5430712|NCT02401412|18755077|P2|Overall Study|Discontinued Intervention|21
5430713|NCT02401412|18755078|P1|Overall Study|Discontinued Intervention|15
5430714|NCT02401412|18755077|P2|Overall Study|Lost to Follow-up|0
5430715|NCT02401412|18755078|P1|Overall Study|Lost to Follow-up|1
5430716|NCT02401256|18755086|P1|Overall Study|Withdrawal by Subject|12
5430717|NCT02401256|18755086|P1|Overall Study|Adverse Event|5
5430718|NCT02401230|18755095|P3|Overall Study|Lost to Follow-up|3
5430719|NCT02401230|18755096|P2|Overall Study|Lost to Follow-up|3
5430720|NCT02401230|18755097|P1|Overall Study|Lost to Follow-up|1
5430721|NCT02401230|18755095|P3|Overall Study|Withdrawal by Subject|1
5430722|NCT02401230|18755096|P2|Overall Study|Withdrawal by Subject|1
5430723|NCT02401230|18755097|P1|Overall Study|Withdrawal by Subject|2
5430724|NCT02401230|18755095|P3|Overall Study|Adverse Event|0
5430725|NCT02401230|18755096|P2|Overall Study|Adverse Event|2
5430726|NCT02401230|18755097|P1|Overall Study|Adverse Event|3
5430727|NCT02400905|18755176|P1|Overall Study|Subject refused visit|1
5430728|NCT02400905|18755176|P1|Overall Study|Death|3
5430729|NCT02400905|18755176|P1|Overall Study|Withdrawal by Subject|5
5430730|NCT02400905|18755176|P1|Overall Study|Lost to Follow-up|6
5430731|NCT02400905|18755176|P1|Overall Study|Ongoing Follow-up|256
5430732|NCT02400749|18755186|P2|Week 17 - 32|Adverse Event|1
5430733|NCT02400749|18755187|P1|Week 17 - 32|Adverse Event|2
5430734|NCT02400749|18755186|P2|Week 17 - 32|Withdrawal by Subject|2
5430735|NCT02400749|18755187|P1|Week 17 - 32|Withdrawal by Subject|3
5430736|NCT02400749|18755186|P2|Week 0 -16|Protocol Violation|0
5430737|NCT02400749|18755187|P1|Week 0 -16|Protocol Violation|1
5430738|NCT02400749|18755186|P2|Week 0 -16|Lost to Follow-up|0
5430739|NCT02400749|18755187|P1|Week 0 -16|Lost to Follow-up|2
5430740|NCT02400749|18755186|P2|Week 0 -16|Adverse Event|1
5430741|NCT02400749|18755187|P1|Week 0 -16|Adverse Event|3
5430742|NCT02400749|18755186|P2|Week 0 -16|Withdrawal by Subject|5
5430743|NCT02400749|18755187|P1|Week 0 -16|Withdrawal by Subject|5
5430744|NCT02400580|18755214|P2|Overall Study|Adverse Event|0
5430745|NCT02400580|18755215|P1|Overall Study|Adverse Event|1
5430746|NCT02400580|18755214|P2|Overall Study|Withdrawal by Subject|1
5430747|NCT02400580|18755215|P1|Overall Study|Withdrawal by Subject|1
5430748|NCT02400346|18755248|P1|Overall Study|Lost to Follow-up|1
5430749|NCT02400346|18755248|P1|Overall Study|Administrative or other reason(s)|2
5430750|NCT02400346|18755248|P1|Overall Study|Withdrawal by Subject|7
5430751|NCT02400346|18755248|P1|Overall Study|Non-compliance with IMP|1
5430752|NCT02400346|18755248|P1|Overall Study|Lack of Efficacy|9
5430753|NCT02400346|18755248|P1|Overall Study|Adverse Event|24
5430754|NCT02400333|18755256|P4|Overall Study|Protocol Violation|1
5430755|NCT02400333|18755257|P3|Overall Study|Protocol Violation|2
5430756|NCT02400333|18755258|P2|Overall Study|Protocol Violation|0
5430757|NCT02400333|18755259|P1|Overall Study|Protocol Violation|1
5430758|NCT02400333|18755256|P4|Overall Study|Withdrawal by Subject|1
5430759|NCT02400333|18755257|P3|Overall Study|Withdrawal by Subject|0
5430760|NCT02400333|18755258|P2|Overall Study|Withdrawal by Subject|1
5430761|NCT02400333|18755259|P1|Overall Study|Withdrawal by Subject|0
5430762|NCT02400307|18755319|P2|Overall Study|Enrolled and Never Dosed|0
5430763|NCT02400307|18755320|P1|Overall Study|Enrolled and Never Dosed|1
5430764|NCT02399254|18755374|P1|Overall Study|Physician Decision|2
5430765|NCT02399163|18755381|P1|Overall Study|Withdrawal by Participant|5
5430766|NCT02399163|18755381|P1|Overall Study|Protocol Deviation|2
5430767|NCT02399163|18755381|P1|Overall Study|Adverse Event|2
5430768|NCT02398227|18755451|P2|Overall Study|Removed from treatment and dropped out|0
5430769|NCT02398227|18755452|P1|Overall Study|Removed from treatment and dropped out|1
5430770|NCT02398227|18755451|P2|Overall Study|Withdrawal by Subject|6
5430771|NCT02398227|18755452|P1|Overall Study|Withdrawal by Subject|5
5430772|NCT02398227|18755451|P2|Overall Study|Lost to Follow-up|12
5430773|NCT02398227|18755452|P1|Overall Study|Lost to Follow-up|21
5430774|NCT02398188|18755462|P2|Overall Study|Withdrawal by Subject|16
5430775|NCT02398188|18755463|P1|Overall Study|Withdrawal by Subject|7
5430776|NCT02398188|18755462|P2|Overall Study|Pregnancy|0
5430777|NCT02398188|18755463|P1|Overall Study|Pregnancy|1
5430778|NCT02398188|18755462|P2|Overall Study|Sponsor Decision|1
5430779|NCT02398188|18755463|P1|Overall Study|Sponsor Decision|2
5430780|NCT02398188|18755462|P2|Overall Study|Protocol Violation|10
5430781|NCT02398188|18755463|P1|Overall Study|Protocol Violation|6
5430782|NCT02398188|18755462|P2|Overall Study|Non-compliance|4
5430783|NCT02398188|18755463|P1|Overall Study|Non-compliance|4
5430784|NCT02398188|18755462|P2|Overall Study|Lost to Follow-up|0
5430785|NCT02398188|18755463|P1|Overall Study|Lost to Follow-up|5
5430786|NCT02398188|18755462|P2|Overall Study|Adverse Event|3
5430787|NCT02398188|18755463|P1|Overall Study|Adverse Event|2
5430788|NCT02397915|18755481|P4|Period 1|Physician Decision|0
5430789|NCT02397915|18755482|P3|Period 1|Physician Decision|0
5430790|NCT02397915|18755483|P2|Period 1|Physician Decision|0
5430791|NCT02397915|18755484|P1|Period 1|Physician Decision|1
5430792|NCT02397915|18755481|P4|Period 1|Protocol Violation|0
5430793|NCT02397915|18755482|P3|Period 1|Protocol Violation|0
5430794|NCT02397915|18755483|P2|Period 1|Protocol Violation|1
5430795|NCT02397915|18755484|P1|Period 1|Protocol Violation|0
5430796|NCT02397837|18755536|P2|Overall Study|Physician Decision|1
5430797|NCT02397837|18755537|P1|Overall Study|Physician Decision|1
5430798|NCT02397837|18755536|P2|Overall Study|Withdrawal by Subject|5
5430799|NCT02397837|18755537|P1|Overall Study|Withdrawal by Subject|6
5430800|NCT02397694|18755632|P2|Open Label Extension Phase|Lost to Follow-up|0
5430801|NCT02397694|18755633|P1|Open Label Extension Phase|Lost to Follow-up|4
5430802|NCT02397694|18755632|P2|Open Label Extension Phase|Withdrew Consent|1
5430803|NCT02397694|18755633|P1|Open Label Extension Phase|Withdrew Consent|3
5430804|NCT02397694|18755632|P2|Open Label Extension Phase|Protocol Violation|0
5430805|NCT02397694|18755633|P1|Open Label Extension Phase|Protocol Violation|1
5430806|NCT02397694|18755632|P2|Double-Blinded Phase|Lost to Follow-up|1
5430807|NCT02397694|18755633|P1|Double-Blinded Phase|Lost to Follow-up|1
5430808|NCT02397694|18755632|P2|Double-Blinded Phase|Withdrawal by Subject|0
5430809|NCT02397694|18755633|P1|Double-Blinded Phase|Withdrawal by Subject|1
5430810|NCT02397694|18755632|P2|Double-Blinded Phase|Non-compliance with study drug|2
5430811|NCT02397694|18755633|P1|Double-Blinded Phase|Non-compliance with study drug|0
5430812|NCT02397694|18755632|P2|Double-Blinded Phase|Adverse Event|0
5430813|NCT02397694|18755633|P1|Double-Blinded Phase|Adverse Event|1
5430814|NCT02397655|18755671|P1|Overall Study|data not completed|1301
5430815|NCT02397473|18755682|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
5430816|NCT02397473|18755683|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|0
5430817|NCT02397473|18755682|P2|Post Treatment Follow-up Phase|Protocol Violation|0
5430818|NCT02397473|18755683|P1|Post Treatment Follow-up Phase|Protocol Violation|1
5430819|NCT02397473|18755682|P2|Post Treatment Follow-up Phase|Lost to Follow-up|0
5430820|NCT02397473|18755683|P1|Post Treatment Follow-up Phase|Lost to Follow-up|1
5430821|NCT02397473|18755682|P2|Post Treatment Follow-up Phase|Lack of Efficacy|1
5430822|NCT02397473|18755683|P1|Post Treatment Follow-up Phase|Lack of Efficacy|1
5430823|NCT02397473|18755682|P2|Treatment Phase|Protocol Violation(did not receive drug)|3
5430824|NCT02397473|18755683|P1|Treatment Phase|Protocol Violation(did not receive drug)|0
5430825|NCT02397473|18755682|P2|Treatment Phase|Withdrawal by Subject|1
5430826|NCT02397473|18755683|P1|Treatment Phase|Withdrawal by Subject|2
5430827|NCT02397473|18755682|P2|Treatment Phase|Lost to Follow-up|0
5430828|NCT02397473|18755683|P1|Treatment Phase|Lost to Follow-up|1
5430829|NCT02397473|18755682|P2|Treatment Phase|Lack of Efficacy|1
5430830|NCT02397473|18755683|P1|Treatment Phase|Lack of Efficacy|8
5430831|NCT02397473|18755682|P2|Treatment Phase|Adverse Event|2
5430832|NCT02397473|18755683|P1|Treatment Phase|Adverse Event|1
5430833|NCT02397447|18755713|P2|Overall Study|Lost to Follow-up|2
5430834|NCT02397447|18755714|P1|Overall Study|Lost to Follow-up|2
5430835|NCT02397408|18755760|P1|Overall Study|Surgery not completed within protocol timeframe|2
5430836|NCT02397408|18755760|P1|Overall Study|Physician Decision|4
5430837|NCT02397096|18755809|P2|Study Extensions|Ongoing|202
5430838|NCT02397096|18755810|P1|Study Extensions|Ongoing|399
5430839|NCT02397096|18755809|P2|Week 24 to Week 48|Lost to Follow-up|0
5430840|NCT02397096|18755810|P1|Week 24 to Week 48|Lost to Follow-up|2
5430841|NCT02397096|18755809|P2|Week 24 to Week 48|Withdrawal by Subject|2
5430842|NCT02397096|18755810|P1|Week 24 to Week 48|Withdrawal by Subject|5
5430843|NCT02397096|18755809|P2|Week 24 to Week 48|Physician Decision|1
5430844|NCT02397096|18755810|P1|Week 24 to Week 48|Physician Decision|2
5430845|NCT02397096|18755809|P2|Week 24 to Week 48|Non-Compliance With Study Drug|1
5430846|NCT02397096|18755810|P1|Week 24 to Week 48|Non-Compliance With Study Drug|0
5430847|NCT02397096|18755809|P2|Week 24 to Week 48|Lack of Efficacy|1
5430848|NCT02397096|18755810|P1|Week 24 to Week 48|Lack of Efficacy|5
5430849|NCT02397096|18755809|P2|Week 24 to Week 48|Adverse Event|2
5430850|NCT02397096|18755810|P1|Week 24 to Week 48|Adverse Event|6
5430851|NCT02397096|18755809|P2|Day 1 to Week 24|Withdrawal by Subject|1
5430852|NCT02397096|18755810|P1|Day 1 to Week 24|Withdrawal by Subject|6
5430853|NCT02397096|18755809|P2|Day 1 to Week 24|Protocol Violation|4
5430854|NCT02397096|18755810|P1|Day 1 to Week 24|Protocol Violation|1
5430855|NCT02397096|18755809|P2|Day 1 to Week 24|Physician Decision|3
5430856|NCT02397096|18755810|P1|Day 1 to Week 24|Physician Decision|2
5430857|NCT02397096|18755809|P2|Day 1 to Week 24|Lost to Follow-up|4
5430858|NCT02397096|18755810|P1|Day 1 to Week 24|Lost to Follow-up|3
5430859|NCT02397096|18755809|P2|Day 1 to Week 24|Lack of Efficacy|1
5430860|NCT02397096|18755810|P1|Day 1 to Week 24|Lack of Efficacy|0
5430861|NCT02397096|18755809|P2|Day 1 to Week 24|Death|0
5430862|NCT02397096|18755810|P1|Day 1 to Week 24|Death|1
5430863|NCT02397096|18755809|P2|Day 1 to Week 24|Adverse Event|1
5430864|NCT02397096|18755810|P1|Day 1 to Week 24|Adverse Event|7
5430865|NCT02396953|18755843|P3|Overall Study|Personal Reasons|0
5430866|NCT02396953|18755844|P2|Overall Study|Personal Reasons|1
5430867|NCT02396953|18755845|P1|Overall Study|Personal Reasons|1
5430868|NCT02396953|18755843|P3|Overall Study|Insulin like Growth Factor-1 increased|2
5430869|NCT02396953|18755844|P2|Overall Study|Insulin like Growth Factor-1 increased|2
5430870|NCT02396953|18755845|P1|Overall Study|Insulin like Growth Factor-1 increased|3
5430871|NCT02396953|18755843|P3|Overall Study|Withdrawal by Subject|1
5430872|NCT02396953|18755844|P2|Overall Study|Withdrawal by Subject|0
5430873|NCT02396953|18755845|P1|Overall Study|Withdrawal by Subject|0
5430874|NCT02396537|18755920|P2|Overall Study|Protocol Violation|1
5430875|NCT02396537|18755921|P1|Overall Study|Protocol Violation|0
5430876|NCT02396420|18755933|P1|Overall Study|Death|1
5430877|NCT02396381|18755957|P2|Overall Study|Randomization/Screening Error|1
5430878|NCT02396381|18755958|P1|Overall Study|Randomization/Screening Error|3
5430879|NCT02396381|18755957|P2|Overall Study|Possible conflict of interest|0
5430880|NCT02396381|18755958|P1|Overall Study|Possible conflict of interest|1
5430881|NCT02396381|18755957|P2|Overall Study|Could not complete visit|0
5430882|NCT02396381|18755958|P1|Overall Study|Could not complete visit|1
5430883|NCT02396381|18755957|P2|Overall Study|Moved out of town/state|3
5430884|NCT02396381|18755958|P1|Overall Study|Moved out of town/state|1
5430885|NCT02396381|18755957|P2|Overall Study|Non-compliance with study procedures|0
5430886|NCT02396381|18755958|P1|Overall Study|Non-compliance with study procedures|1
5430887|NCT02396381|18755957|P2|Overall Study|Pregnancy|0
5430888|NCT02396381|18755958|P1|Overall Study|Pregnancy|2
5430889|NCT02396381|18755957|P2|Overall Study|Physician Decision|5
5430890|NCT02396381|18755958|P1|Overall Study|Physician Decision|5
5430891|NCT02396381|18755957|P2|Overall Study|Site terminated by sponsor|8
5430892|NCT02396381|18755958|P1|Overall Study|Site terminated by sponsor|7
5430893|NCT02396381|18755957|P2|Overall Study|Protocol Violation|0
5430894|NCT02396381|18755958|P1|Overall Study|Protocol Violation|1
5430895|NCT02396381|18755957|P2|Overall Study|Lost to Follow-up|31
5430896|NCT02396381|18755958|P1|Overall Study|Lost to Follow-up|49
5430897|NCT02396381|18755957|P2|Overall Study|Withdrawal by Subject|24
5430898|NCT02396381|18755958|P1|Overall Study|Withdrawal by Subject|33
5430899|NCT02396381|18755957|P2|Overall Study|Adverse Event|2
5430900|NCT02396381|18755958|P1|Overall Study|Adverse Event|3
5430901|NCT02396316|18755997|P2|Overall Study|Treatment unblinded|1
5430902|NCT02396316|18755998|P1|Overall Study|Treatment unblinded|0
5430903|NCT02396316|18755997|P2|Overall Study|Protocol Violation|1
5430904|NCT02396316|18755998|P1|Overall Study|Protocol Violation|0
5430905|NCT02396316|18755997|P2|Overall Study|Progressive disease|3
5430906|NCT02396316|18755998|P1|Overall Study|Progressive disease|6
5430907|NCT02396316|18755997|P2|Overall Study|Physician Decision|0
5430908|NCT02396316|18755998|P1|Overall Study|Physician Decision|1
5430909|NCT02396212|18756017|P1|Overall Study|Lack of Efficacy|2
5430910|NCT02396212|18756017|P1|Overall Study|Adverse Event|1
5430911|NCT02395822|18756170|P1|Overall Study|Death|1
5430912|NCT02395822|18756170|P1|Overall Study|Withdrawal by Subject|1
5430913|NCT02395666|18756191|P2|Overall Study|Withdrawal by Subject|1
5430914|NCT02395666|18756192|P1|Overall Study|Withdrawal by Subject|2
5430915|NCT02395666|18756191|P2|Overall Study|Lost to Follow-up|0
5430916|NCT02395666|18756192|P1|Overall Study|Lost to Follow-up|1
5430917|NCT02395666|18756191|P2|Overall Study|Physician Decision|0
5430918|NCT02395666|18756192|P1|Overall Study|Physician Decision|3
5430919|NCT02395653|18756206|P1|Overall Study|Lost to Follow-up|1
5430920|NCT02395653|18756206|P1|Overall Study|Withdrawal by Subject|1
5430921|NCT02395653|18756206|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
5430922|NCT02395653|18756206|P1|Overall Study|Investigator Decision at Screening|1
5430923|NCT02395653|18756206|P1|Overall Study|SSEC Application But With 0 Dose|1
5430924|NCT02395653|18756206|P1|Overall Study|Consent Withdrawn at Screening|1
5430925|NCT02395653|18756206|P1|Overall Study|Exclusion Criteria Met at Screening|4
5430926|NCT02395627|18756216|P3|Overall Study|Did not receive pembrolizumab|0
5430927|NCT02395627|18756217|P2|Overall Study|Did not receive pembrolizumab|1
5430928|NCT02395627|18756218|P1|Overall Study|Did not receive pembrolizumab|3
5430929|NCT02395627|18756216|P3|Overall Study|Withdrawal by Subject|0
5430930|NCT02395627|18756217|P2|Overall Study|Withdrawal by Subject|2
5430931|NCT02395627|18756218|P1|Overall Study|Withdrawal by Subject|0
5430932|NCT02395536|18756246|P2|Overall Study|Insurance issue|1
5430933|NCT02395536|18756247|P1|Overall Study|Insurance issue|0
5430934|NCT02395536|18756246|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
5430935|NCT02395536|18756247|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
5430936|NCT02395536|18756246|P2|Overall Study|Withdrawal by Subject|17
5430937|NCT02395536|18756247|P1|Overall Study|Withdrawal by Subject|9
5430938|NCT02395536|18756246|P2|Overall Study|Physician Decision|6
5430939|NCT02395536|18756247|P1|Overall Study|Physician Decision|4
5430940|NCT02395536|18756246|P2|Overall Study|Death|0
5430941|NCT02395536|18756247|P1|Overall Study|Death|2
5430942|NCT02395536|18756246|P2|Overall Study|Lost to Follow-up|4
5430943|NCT02395536|18756247|P1|Overall Study|Lost to Follow-up|4
5430944|NCT02395471|18756255|P2|Overall Study|Subject not eligible|0
5430945|NCT02395471|18756256|P1|Overall Study|Subject not eligible|1
5430946|NCT02395471|18756255|P2|Overall Study|Patient did not return for procedure|1
5430947|NCT02395471|18756256|P1|Overall Study|Patient did not return for procedure|0
5430948|NCT02395471|18756255|P2|Overall Study|Failure to swollow sponge twice|0
5430949|NCT02395471|18756256|P1|Overall Study|Failure to swollow sponge twice|1
5430950|NCT02395471|18756255|P2|Overall Study|Protocol Violation|1
5430951|NCT02395471|18756256|P1|Overall Study|Protocol Violation|0
5430952|NCT02395471|18756255|P2|Overall Study|Physician Decision|0
5430953|NCT02395471|18756256|P1|Overall Study|Physician Decision|1
5430954|NCT02395471|18756255|P2|Overall Study|Withdrawal by Subject|1
5430955|NCT02395471|18756256|P1|Overall Study|Withdrawal by Subject|2
5430956|NCT02395471|18756255|P2|Overall Study|Lost to Follow-up|0
5430957|NCT02395471|18756256|P1|Overall Study|Lost to Follow-up|2
5430958|NCT02395302|18756271|P1|Overall Study|Physician Decision|2
5430959|NCT02395302|18756271|P1|Overall Study|Withdrawal by Subject|2
5430960|NCT02395302|18756271|P1|Overall Study|Run In Failure|7
5430961|NCT02395302|18756271|P1|Overall Study|Screen Failure|3
5430962|NCT02395172|18756291|P2|Overall Study|Participants randomized but not treated|31
5430963|NCT02395172|18756292|P1|Overall Study|Participants randomized but not treated|3
5430964|NCT02395133|18756331|P4|Overall Study|Other than specified above|4
5430965|NCT02395133|18756332|P3|Overall Study|Other than specified above|2
5430966|NCT02395133|18756333|P2|Overall Study|Other than specified above|2
5430967|NCT02395133|18756334|P1|Overall Study|Other than specified above|5
5430968|NCT02395133|18756331|P4|Overall Study|Sponsor decision|1
5430969|NCT02395133|18756332|P3|Overall Study|Sponsor decision|0
5430970|NCT02395133|18756333|P2|Overall Study|Sponsor decision|0
5430971|NCT02395133|18756334|P1|Overall Study|Sponsor decision|2
5430972|NCT02395133|18756331|P4|Overall Study|Consent withdrawn with personal reason|3
5430973|NCT02395133|18756332|P3|Overall Study|Consent withdrawn with personal reason|0
5430974|NCT02395133|18756333|P2|Overall Study|Consent withdrawn with personal reason|1
5430975|NCT02395133|18756334|P1|Overall Study|Consent withdrawn with personal reason|0
5430976|NCT02395133|18756331|P4|Overall Study|Consent withdrawn with no reason given|2
5430977|NCT02395133|18756332|P3|Overall Study|Consent withdrawn with no reason given|0
5430978|NCT02395133|18756333|P2|Overall Study|Consent withdrawn with no reason given|3
5430979|NCT02395133|18756334|P1|Overall Study|Consent withdrawn with no reason given|1
5430980|NCT02395133|18756331|P4|Overall Study|Pregnancy|0
5430981|NCT02395133|18756332|P3|Overall Study|Pregnancy|3
5430982|NCT02395133|18756333|P2|Overall Study|Pregnancy|0
5430983|NCT02395133|18756334|P1|Overall Study|Pregnancy|0
5430984|NCT02395133|18756331|P4|Overall Study|Lost to Follow-up|0
5430985|NCT02395133|18756332|P3|Overall Study|Lost to Follow-up|1
5430986|NCT02395133|18756333|P2|Overall Study|Lost to Follow-up|1
5430987|NCT02395133|18756334|P1|Overall Study|Lost to Follow-up|0
5430988|NCT02395133|18756331|P4|Overall Study|Protocol Violation|3
5430989|NCT02395133|18756332|P3|Overall Study|Protocol Violation|0
5430990|NCT02395133|18756333|P2|Overall Study|Protocol Violation|1
5430991|NCT02395133|18756334|P1|Overall Study|Protocol Violation|1
5430992|NCT02395133|18756331|P4|Overall Study|Lack of Efficacy|1
5430993|NCT02395133|18756332|P3|Overall Study|Lack of Efficacy|1
5430994|NCT02395133|18756333|P2|Overall Study|Lack of Efficacy|0
5430995|NCT02395133|18756334|P1|Overall Study|Lack of Efficacy|1
5430996|NCT02395133|18756331|P4|Overall Study|Adverse Event|0
5430997|NCT02395133|18756332|P3|Overall Study|Adverse Event|3
5430998|NCT02395133|18756333|P2|Overall Study|Adverse Event|1
5430999|NCT02395133|18756334|P1|Overall Study|Adverse Event|4
5431000|NCT02395055|18756422|P2|Overall Study|Withdrawal by Subject|3
5431001|NCT02395055|18756423|P1|Overall Study|Withdrawal by Subject|7
5431002|NCT02395042|18756436|P3|Treatment 2 Period|Lack of Efficacy|0
5431003|NCT02395042|18756437|P2|Treatment 2 Period|Lack of Efficacy|1
5431004|NCT02395042|18756438|P1|Treatment 2 Period|Lack of Efficacy|1
5431005|NCT02395042|18756436|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
5431006|NCT02395042|18756437|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
5431007|NCT02395042|18756438|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
5431008|NCT02395042|18756436|P3|Treatment 1 Period|Lost to Follow-up|0
5431009|NCT02395042|18756437|P2|Treatment 1 Period|Lost to Follow-up|0
5431010|NCT02395042|18756438|P1|Treatment 1 Period|Lost to Follow-up|1
5431011|NCT02395042|18756436|P3|Treatment 1 Period|Lack of Efficacy|0
5431012|NCT02395042|18756437|P2|Treatment 1 Period|Lack of Efficacy|1
5431013|NCT02395042|18756438|P1|Treatment 1 Period|Lack of Efficacy|1
5431014|NCT02395042|18756436|P3|Treatment 1 Period|Adverse Event|1
5431015|NCT02395042|18756437|P2|Treatment 1 Period|Adverse Event|3
5431016|NCT02395042|18756438|P1|Treatment 1 Period|Adverse Event|1
5431017|NCT02394925|18756476|P1|Overall Study|Unsatisfactory Visual Response|5
5431018|NCT02394925|18756476|P1|Overall Study|No longer meet eligibility criteria|1
5431019|NCT02394925|18756476|P1|Overall Study|Protocol Violation|5
5431020|NCT02394925|18756476|P1|Overall Study|Lost to Follow-up|9
5431021|NCT02394925|18756476|P1|Overall Study|Lens handling difficulities|5
5431022|NCT02394925|18756476|P1|Overall Study|Lens Discomfort|3
5431023|NCT02394925|18756476|P1|Overall Study|Adverse Event|1
5431024|NCT02394808|18756486|P2|Period 2|Lost to Follow-up|0
5431025|NCT02394808|18756487|P1|Period 2|Lost to Follow-up|1
5431026|NCT02394808|18756486|P2|Period 1|Unsatisfactory lens fitting|1
5431027|NCT02394808|18756487|P1|Period 1|Unsatisfactory lens fitting|0
5431028|NCT02394756|18756495|P6|Period 2|Unsatisfactory Visual Response|0
5431029|NCT02394756|18756496|P5|Period 2|Unsatisfactory Visual Response|1
5431030|NCT02394756|18756497|P4|Period 2|Unsatisfactory Visual Response|0
5431031|NCT02394756|18756498|P3|Period 2|Unsatisfactory Visual Response|0
5431032|NCT02394756|18756499|P2|Period 2|Unsatisfactory Visual Response|0
5431033|NCT02394756|18756500|P1|Period 2|Unsatisfactory Visual Response|0
5431034|NCT02394756|18756495|P6|Period 1|Withdrawal by Subject|0
5431035|NCT02394756|18756496|P5|Period 1|Withdrawal by Subject|0
5431036|NCT02394756|18756497|P4|Period 1|Withdrawal by Subject|1
5431037|NCT02394756|18756498|P3|Period 1|Withdrawal by Subject|1
5431038|NCT02394756|18756499|P2|Period 1|Withdrawal by Subject|1
5431039|NCT02394756|18756500|P1|Period 1|Withdrawal by Subject|0
5431040|NCT02394756|18756495|P6|Period 1|Lens Discomfort|1
5431041|NCT02394756|18756496|P5|Period 1|Lens Discomfort|0
5431042|NCT02394756|18756497|P4|Period 1|Lens Discomfort|0
5431043|NCT02394756|18756498|P3|Period 1|Lens Discomfort|0
5431044|NCT02394756|18756499|P2|Period 1|Lens Discomfort|0
5431045|NCT02394756|18756500|P1|Period 1|Lens Discomfort|0
5431046|NCT02394730|18756513|P2|Overall Study|Withdrawal by Subject|1
5431047|NCT02394730|18756514|P1|Overall Study|Withdrawal by Subject|0
5431048|NCT02394730|18756513|P2|Overall Study|Lost to Follow-up|0
5431049|NCT02394730|18756514|P1|Overall Study|Lost to Follow-up|1
5431050|NCT02394665|18756551|P3|Overall Study|Physician Decision|0
5431051|NCT02394665|18756552|P2|Overall Study|Physician Decision|0
5431052|NCT02394665|18756553|P1|Overall Study|Physician Decision|1
5431053|NCT02394600|18756575|P2|Overall Study|Protocol Violation|0
5431054|NCT02394600|18756576|P1|Overall Study|Protocol Violation|1
5431055|NCT02394600|18756575|P2|Overall Study|Withdrawal by Subject|1
5431056|NCT02394600|18756576|P1|Overall Study|Withdrawal by Subject|0
5431057|NCT02394600|18756575|P2|Overall Study|Lost to Follow-up|1
5431058|NCT02394600|18756576|P1|Overall Study|Lost to Follow-up|0
5431059|NCT02394600|18756575|P2|Overall Study|Adverse Event|0
5431060|NCT02394600|18756576|P1|Overall Study|Adverse Event|3
5431061|NCT02394561|18756586|P2|Extension Phase|Lack of Efficacy|3
5431062|NCT02394561|18756587|P1|Extension Phase|Lack of Efficacy|3
5431063|NCT02394561|18756586|P2|Extension Phase|Withdrawal by Subject|5
5431064|NCT02394561|18756587|P1|Extension Phase|Withdrawal by Subject|0
5431065|NCT02394561|18756586|P2|Extension Phase|Physician Decision|2
5431066|NCT02394561|18756587|P1|Extension Phase|Physician Decision|0
5431067|NCT02394561|18756586|P2|Extension Phase|Lost to Follow-up|0
5431068|NCT02394561|18756587|P1|Extension Phase|Lost to Follow-up|1
5431069|NCT02394561|18756586|P2|Extension Phase|Protocol Violation|0
5431070|NCT02394561|18756587|P1|Extension Phase|Protocol Violation|1
5431071|NCT02394561|18756586|P2|Extension Phase|Death|1
5431072|NCT02394561|18756587|P1|Extension Phase|Death|0
5431073|NCT02394561|18756586|P2|Extension Phase|Adverse Event|1
5431074|NCT02394561|18756587|P1|Extension Phase|Adverse Event|6
5431075|NCT02394561|18756586|P2|CORE Phase|Lack of Efficacy|6
5431076|NCT02394561|18756587|P1|CORE Phase|Lack of Efficacy|1
5431077|NCT02394561|18756586|P2|CORE Phase|Withdrawal by Subject|2
5431078|NCT02394561|18756587|P1|CORE Phase|Withdrawal by Subject|2
5431079|NCT02394561|18756586|P2|CORE Phase|Physician Decision|1
5431080|NCT02394561|18756587|P1|CORE Phase|Physician Decision|1
5431081|NCT02394561|18756586|P2|CORE Phase|Lost to Follow-up|0
5431082|NCT02394561|18756587|P1|CORE Phase|Lost to Follow-up|1
5431083|NCT02394561|18756586|P2|CORE Phase|Pregnancy|0
5431084|NCT02394561|18756587|P1|CORE Phase|Pregnancy|1
5431085|NCT02394561|18756586|P2|CORE Phase|Death|1
5431086|NCT02394561|18756587|P1|CORE Phase|Death|0
5431087|NCT02394561|18756586|P2|CORE Phase|Adverse Event|9
5431088|NCT02394561|18756587|P1|CORE Phase|Adverse Event|7
5431089|NCT02394340|18756634|P1|Overall Study|Adverse Event|1
5431090|NCT02394340|18756634|P1|Overall Study|Failed drug screen test|1
5431091|NCT02393950|18756641|P2|Overall Study|Withdrawal by Subject|1
5431092|NCT02393950|18756642|P1|Overall Study|Withdrawal by Subject|0
5431093|NCT02393950|18756641|P2|Overall Study|Adverse Event|0
5431094|NCT02393950|18756642|P1|Overall Study|Adverse Event|1
5431095|NCT02393859|18756709|P2|Overall Study|Continuing Study|43
5431096|NCT02393859|18756710|P1|Overall Study|Continuing Study|32
5431097|NCT02393859|18756709|P2|Overall Study|Death|8
5431098|NCT02393859|18756710|P1|Overall Study|Death|16
5431099|NCT02393859|18756709|P2|Overall Study|Withdrawal by Subject|2
5431100|NCT02393859|18756710|P1|Overall Study|Withdrawal by Subject|5
5431101|NCT02393859|18756709|P2|Overall Study|Decision by Sponsor|1
5431102|NCT02393859|18756710|P1|Overall Study|Decision by Sponsor|1
5431103|NCT02393755|18756735|P2|Overall Study|Physician Decision|2
5431104|NCT02393755|18756736|P1|Overall Study|Physician Decision|0
5431105|NCT02393755|18756735|P2|Overall Study|Adverse Event|2
5431106|NCT02393755|18756736|P1|Overall Study|Adverse Event|0
5431107|NCT02393755|18756735|P2|Overall Study|Withdrawal by Subject|3
5431108|NCT02393755|18756736|P1|Overall Study|Withdrawal by Subject|0
5431109|NCT02393547|18756755|P1|Overall Study|Lost to Follow-up|1
5431110|NCT02393547|18756755|P1|Overall Study|Withdrawal by Subject|3
5431111|NCT02393547|18756755|P1|Overall Study|Adverse Event|2
5431112|NCT02393209|18756846|P4|Overall Study|Lost to Follow-up|0
5431113|NCT02393209|18756847|P3|Overall Study|Lost to Follow-up|0
5431114|NCT02393209|18756848|P2|Overall Study|Lost to Follow-up|1
5431115|NCT02393209|18756849|P1|Overall Study|Lost to Follow-up|0
5431116|NCT02393209|18756846|P4|Overall Study|Patient Seen by Another Oncologist|0
5431117|NCT02393209|18756847|P3|Overall Study|Patient Seen by Another Oncologist|0
5431118|NCT02393209|18756848|P2|Overall Study|Patient Seen by Another Oncologist|1
5431119|NCT02393209|18756849|P1|Overall Study|Patient Seen by Another Oncologist|0
5431120|NCT02393209|18756846|P4|Overall Study|Death from Legionella Infection|0
5431121|NCT02393209|18756847|P3|Overall Study|Death from Legionella Infection|0
5431122|NCT02393209|18756848|P2|Overall Study|Death from Legionella Infection|1
5431123|NCT02393209|18756849|P1|Overall Study|Death from Legionella Infection|0
5431124|NCT02393209|18756846|P4|Overall Study|Death due to Disease Progression|0
5431125|NCT02393209|18756847|P3|Overall Study|Death due to Disease Progression|0
5431126|NCT02393209|18756848|P2|Overall Study|Death due to Disease Progression|2
5431127|NCT02393209|18756849|P1|Overall Study|Death due to Disease Progression|2
5431128|NCT02393209|18756846|P4|Overall Study|Death|0
5431129|NCT02393209|18756847|P3|Overall Study|Death|0
5431130|NCT02393209|18756848|P2|Overall Study|Death|2
5431131|NCT02393209|18756849|P1|Overall Study|Death|2
5431132|NCT02393209|18756846|P4|Overall Study|Withdrawal by Patient|0
5431133|NCT02393209|18756847|P3|Overall Study|Withdrawal by Patient|0
5431134|NCT02393209|18756848|P2|Overall Study|Withdrawal by Patient|0
5431135|NCT02393209|18756849|P1|Overall Study|Withdrawal by Patient|1
5431136|NCT02393209|18756846|P4|Overall Study|Study Terminated by Sponsor|0
5431137|NCT02393209|18756847|P3|Overall Study|Study Terminated by Sponsor|0
5431138|NCT02393209|18756848|P2|Overall Study|Study Terminated by Sponsor|1
5431139|NCT02393209|18756849|P1|Overall Study|Study Terminated by Sponsor|1
5431140|NCT02392624|18756938|P3|Overall Study|Other|1
5431141|NCT02392624|18756939|P2|Overall Study|Other|1
5431142|NCT02392624|18756940|P1|Overall Study|Other|49
5431143|NCT02392624|18756938|P3|Overall Study|Sponsor/Investigator Decision|0
5431144|NCT02392624|18756939|P2|Overall Study|Sponsor/Investigator Decision|1
5431145|NCT02392624|18756940|P1|Overall Study|Sponsor/Investigator Decision|2
5431146|NCT02392624|18756938|P3|Overall Study|Protocol Violation|1
5431147|NCT02392624|18756939|P2|Overall Study|Protocol Violation|0
5431148|NCT02392624|18756940|P1|Overall Study|Protocol Violation|0
5431149|NCT02392624|18756938|P3|Overall Study|Pregnancy|0
5431150|NCT02392624|18756939|P2|Overall Study|Pregnancy|0
5431151|NCT02392624|18756940|P1|Overall Study|Pregnancy|1
5431152|NCT02392624|18756938|P3|Overall Study|Adverse Event|2
5431153|NCT02392624|18756939|P2|Overall Study|Adverse Event|1
5431154|NCT02392624|18756940|P1|Overall Study|Adverse Event|4
5431155|NCT02392624|18756938|P3|Overall Study|Withdrawal by Subject|9
5431156|NCT02392624|18756939|P2|Overall Study|Withdrawal by Subject|12
5431157|NCT02392624|18756940|P1|Overall Study|Withdrawal by Subject|15
5431158|NCT02392611|18756962|P9|Overall Study|Enrolled, not treated|0
5431159|NCT02392611|18756963|P8|Overall Study|Enrolled, not treated|0
5431160|NCT02392611|18756964|P7|Overall Study|Enrolled, not treated|0
5431161|NCT02392611|18756965|P6|Overall Study|Enrolled, not treated|0
5431162|NCT02392611|18756966|P5|Overall Study|Enrolled, not treated|0
5431163|NCT02392611|18756967|P4|Overall Study|Enrolled, not treated|2
5431164|NCT02392611|18756968|P3|Overall Study|Enrolled, not treated|0
5431165|NCT02392611|18756969|P2|Overall Study|Enrolled, not treated|0
5431166|NCT02392611|18756970|P1|Overall Study|Enrolled, not treated|0
5431167|NCT02392611|18756962|P9|Overall Study|Lost to Follow-up|0
5431168|NCT02392611|18756963|P8|Overall Study|Lost to Follow-up|0
5431169|NCT02392611|18756964|P7|Overall Study|Lost to Follow-up|1
5431170|NCT02392611|18756965|P6|Overall Study|Lost to Follow-up|0
5431171|NCT02392611|18756966|P5|Overall Study|Lost to Follow-up|0
5431172|NCT02392611|18756967|P4|Overall Study|Lost to Follow-up|0
5431173|NCT02392611|18756968|P3|Overall Study|Lost to Follow-up|0
5431174|NCT02392611|18756969|P2|Overall Study|Lost to Follow-up|0
5431175|NCT02392611|18756970|P1|Overall Study|Lost to Follow-up|0
5431176|NCT02392611|18756962|P9|Overall Study|Withdrawal by Subject|0
5431177|NCT02392611|18756963|P8|Overall Study|Withdrawal by Subject|0
5431178|NCT02392611|18756964|P7|Overall Study|Withdrawal by Subject|0
5431179|NCT02392611|18756965|P6|Overall Study|Withdrawal by Subject|0
5431180|NCT02392611|18756966|P5|Overall Study|Withdrawal by Subject|0
5431181|NCT02392611|18756967|P4|Overall Study|Withdrawal by Subject|1
5431182|NCT02392611|18756968|P3|Overall Study|Withdrawal by Subject|0
5431183|NCT02392611|18756969|P2|Overall Study|Withdrawal by Subject|0
5431184|NCT02392611|18756970|P1|Overall Study|Withdrawal by Subject|0
5431185|NCT02392611|18756962|P9|Overall Study|Death|0
5431186|NCT02392611|18756963|P8|Overall Study|Death|0
5431187|NCT02392611|18756964|P7|Overall Study|Death|0
5431188|NCT02392611|18756965|P6|Overall Study|Death|1
5431189|NCT02392611|18756966|P5|Overall Study|Death|0
5431190|NCT02392611|18756967|P4|Overall Study|Death|0
5431191|NCT02392611|18756968|P3|Overall Study|Death|0
5431192|NCT02392611|18756969|P2|Overall Study|Death|0
5431193|NCT02392611|18756970|P1|Overall Study|Death|1
5431194|NCT02392611|18756962|P9|Overall Study|Progressive disease|0
5431195|NCT02392611|18756963|P8|Overall Study|Progressive disease|0
5431196|NCT02392611|18756964|P7|Overall Study|Progressive disease|0
5431197|NCT02392611|18756965|P6|Overall Study|Progressive disease|0
5431198|NCT02392611|18756966|P5|Overall Study|Progressive disease|1
5431199|NCT02392611|18756967|P4|Overall Study|Progressive disease|2
5431200|NCT02392611|18756968|P3|Overall Study|Progressive disease|0
5431201|NCT02392611|18756969|P2|Overall Study|Progressive disease|0
5431202|NCT02392611|18756970|P1|Overall Study|Progressive disease|0
5431203|NCT02392611|18756962|P9|Overall Study|Adverse Event|0
5431204|NCT02392611|18756963|P8|Overall Study|Adverse Event|0
5431205|NCT02392611|18756964|P7|Overall Study|Adverse Event|0
5431206|NCT02392611|18756965|P6|Overall Study|Adverse Event|0
5431207|NCT02392611|18756966|P5|Overall Study|Adverse Event|0
5431208|NCT02392611|18756967|P4|Overall Study|Adverse Event|1
5431209|NCT02392611|18756968|P3|Overall Study|Adverse Event|0
5431210|NCT02392611|18756969|P2|Overall Study|Adverse Event|0
5431211|NCT02392611|18756970|P1|Overall Study|Adverse Event|0
5431212|NCT02392559|18757046|P2|Overall Study|Withdrawal by Subject|1
5431213|NCT02392559|18757047|P1|Overall Study|Withdrawal by Subject|0
5431214|NCT02392507|18757078|P1|Maintenance Regimen|On Study Treatment at Study Conclusion|1
5431215|NCT02392507|18757078|P1|Maintenance Regimen|Death|1
5431216|NCT02392507|18757078|P1|Induction Regimen|Withdrawal by Subject|2
5431217|NCT02392507|18757078|P1|Induction Regimen|Physician Decision|1
5431218|NCT02392507|18757078|P1|Induction Regimen|On Study Treatment at Study Conclusion|1
5431219|NCT02392507|18757078|P1|Induction Regimen|Death|3
5431220|NCT02392481|18757117|P4|Overall Study|Withdrawal by Subject|0
5431221|NCT02392481|18757118|P3|Overall Study|Withdrawal by Subject|1
5431222|NCT02392481|18757119|P2|Overall Study|Withdrawal by Subject|0
5431223|NCT02392481|18757120|P1|Overall Study|Withdrawal by Subject|0
5431224|NCT02392481|18757117|P4|Overall Study|Adverse Event|2
5431225|NCT02392481|18757118|P3|Overall Study|Adverse Event|1
5431226|NCT02392481|18757119|P2|Overall Study|Adverse Event|0
5431227|NCT02392481|18757120|P1|Overall Study|Adverse Event|0
5431228|NCT02392403|18757142|P1|Overall Study|Withdrawal by Subject|1
5431229|NCT02392403|18757142|P1|Overall Study|Death|1
5431230|NCT02392403|18757142|P1|Overall Study|Adverse Event|1
5431231|NCT02392377|18757156|P2|Overall Study|Withdrawal by Subject|1
5431232|NCT02392377|18757157|P1|Overall Study|Withdrawal by Subject|0
5431233|NCT02392247|18757249|P1|Overall Study|Surgery cancelled; no data|1
5431234|NCT02392247|18757249|P1|Overall Study|Withdrawal by Subject|1
5431235|NCT02392234|18757260|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
5431236|NCT02392234|18757261|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
5431237|NCT02392234|18757262|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
5431238|NCT02392234|18757263|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
5431239|NCT02392234|18757264|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
5431240|NCT02392234|18757265|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
5431241|NCT02392234|18757260|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5431242|NCT02392234|18757261|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
5431243|NCT02392234|18757262|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5431244|NCT02392234|18757263|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
5431245|NCT02392234|18757264|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5431246|NCT02392234|18757265|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
5431247|NCT02392234|18757260|P6|Treatment Period 1 (8 Weeks)|Other|0
5431248|NCT02392234|18757261|P5|Treatment Period 1 (8 Weeks)|Other|0
5431249|NCT02392234|18757262|P4|Treatment Period 1 (8 Weeks)|Other|0
5431250|NCT02392234|18757263|P3|Treatment Period 1 (8 Weeks)|Other|0
5431251|NCT02392234|18757264|P2|Treatment Period 1 (8 Weeks)|Other|0
5431252|NCT02392234|18757265|P1|Treatment Period 1 (8 Weeks)|Other|1
5431253|NCT02392234|18757260|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
5431254|NCT02392234|18757261|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
5431255|NCT02392234|18757262|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
5431256|NCT02392234|18757263|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
5431257|NCT02392234|18757264|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
5431258|NCT02392234|18757265|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
5431259|NCT02392234|18757260|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
5431260|NCT02392234|18757261|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
5431261|NCT02392234|18757262|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
5431262|NCT02392234|18757263|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
5431263|NCT02392234|18757264|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
5431264|NCT02392234|18757265|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
5431265|NCT02392234|18757260|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
5431266|NCT02392234|18757261|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5431267|NCT02392234|18757262|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5431268|NCT02392234|18757263|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5431269|NCT02392234|18757264|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5431270|NCT02392234|18757265|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5431271|NCT02392234|18757260|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5431272|NCT02392234|18757261|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
5431273|NCT02392234|18757262|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5431274|NCT02392234|18757263|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5431275|NCT02392234|18757264|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5431276|NCT02392234|18757265|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
5431277|NCT02392234|18757260|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
5431278|NCT02392234|18757261|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
5431279|NCT02392234|18757262|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
5431280|NCT02392234|18757263|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
5431281|NCT02392234|18757264|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
5431282|NCT02392234|18757265|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
5431283|NCT02392195|18757297|P1|Overall Study|Withdrawal by Subject|4
5431284|NCT02392195|18757297|P1|Overall Study|Lost to Follow-up|4
5431285|NCT02392104|18757303|P1|Overall Study|INRs drawn by visiting nurse services|1
5431286|NCT02392104|18757303|P1|Overall Study|admitted to skilled nursing facility|3
5431287|NCT02392104|18757303|P1|Overall Study|INR goal range changed|1
5431288|NCT02392104|18757303|P1|Overall Study|transferred care to another doctor|2
5431289|NCT02392104|18757303|P1|Overall Study|bleeding event|1
5431290|NCT02392104|18757303|P1|Overall Study|discontinuation of warfarin|3
5431291|NCT02392000|18757314|P1|Overall Study|Lost to Follow-up|8
5431292|NCT02392000|18757314|P1|Overall Study|Withdrawal by Subject|1
5431293|NCT02392000|18757314|P1|Overall Study|Greater than mild sleep apnea exclusion|18
5431294|NCT02391961|18757337|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5431295|NCT02391961|18757338|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5431296|NCT02391961|18757337|P2|Washout (2 Weeks)|Withdrawal by Subject|1
5431297|NCT02391961|18757338|P1|Washout (2 Weeks)|Withdrawal by Subject|1
5431298|NCT02391961|18757337|P2|First Intervention (4 Weeks)|Adverse Event|0
5431299|NCT02391961|18757338|P1|First Intervention (4 Weeks)|Adverse Event|2
5431300|NCT02391948|18757361|P5|24-month Assessment|Not able to schedule visit in timeframe|8
5431301|NCT02391948|18757362|P4|24-month Assessment|Not able to schedule visit in timeframe|9
5431302|NCT02391948|18757363|P3|24-month Assessment|Not able to schedule visit in timeframe|2
5431303|NCT02391948|18757364|P2|24-month Assessment|Not able to schedule visit in timeframe|5
5431304|NCT02391948|18757365|P1|24-month Assessment|Not able to schedule visit in timeframe|8
5431305|NCT02391948|18757361|P5|24-month Assessment|Medical issue/illness|0
5431306|NCT02391948|18757362|P4|24-month Assessment|Medical issue/illness|0
5431307|NCT02391948|18757363|P3|24-month Assessment|Medical issue/illness|1
5431308|NCT02391948|18757364|P2|24-month Assessment|Medical issue/illness|0
5431309|NCT02391948|18757365|P1|24-month Assessment|Medical issue/illness|0
5431310|NCT02391948|18757361|P5|24-month Assessment|Lost to Follow-up|0
5431311|NCT02391948|18757362|P4|24-month Assessment|Lost to Follow-up|0
5431312|NCT02391948|18757363|P3|24-month Assessment|Lost to Follow-up|0
5431313|NCT02391948|18757364|P2|24-month Assessment|Lost to Follow-up|4
5431314|NCT02391948|18757365|P1|24-month Assessment|Lost to Follow-up|5
5431315|NCT02391948|18757361|P5|24-month Assessment|Withdrawal by Subject|1
5431316|NCT02391948|18757362|P4|24-month Assessment|Withdrawal by Subject|0
5431317|NCT02391948|18757363|P3|24-month Assessment|Withdrawal by Subject|0
5431318|NCT02391948|18757364|P2|24-month Assessment|Withdrawal by Subject|1
5431319|NCT02391948|18757365|P1|24-month Assessment|Withdrawal by Subject|1
5431320|NCT02391948|18757361|P5|24-month Assessment|Death|1
5431321|NCT02391948|18757362|P4|24-month Assessment|Death|0
5431322|NCT02391948|18757363|P3|24-month Assessment|Death|0
5431323|NCT02391948|18757364|P2|24-month Assessment|Death|0
5431324|NCT02391948|18757365|P1|24-month Assessment|Death|0
5431325|NCT02391948|18757361|P5|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
5431326|NCT02391948|18757362|P4|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
5431327|NCT02391948|18757363|P3|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
5431328|NCT02391948|18757364|P2|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
5431329|NCT02391948|18757365|P1|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
5431330|NCT02391948|18757361|P5|18-month Assessment|Not able to schedule visit in timeframe|4
5431331|NCT02391948|18757362|P4|18-month Assessment|Not able to schedule visit in timeframe|1
5431332|NCT02391948|18757363|P3|18-month Assessment|Not able to schedule visit in timeframe|2
5431333|NCT02391948|18757364|P2|18-month Assessment|Not able to schedule visit in timeframe|3
5431334|NCT02391948|18757365|P1|18-month Assessment|Not able to schedule visit in timeframe|3
5431335|NCT02391948|18757361|P5|18-month Assessment|Lost to Follow-up|3
5431336|NCT02391948|18757362|P4|18-month Assessment|Lost to Follow-up|2
5431337|NCT02391948|18757363|P3|18-month Assessment|Lost to Follow-up|2
5431338|NCT02391948|18757364|P2|18-month Assessment|Lost to Follow-up|6
5431339|NCT02391948|18757365|P1|18-month Assessment|Lost to Follow-up|2
5431340|NCT02391948|18757361|P5|18-month Assessment|Withdrawal by Subject|0
5431341|NCT02391948|18757362|P4|18-month Assessment|Withdrawal by Subject|1
5431342|NCT02391948|18757363|P3|18-month Assessment|Withdrawal by Subject|0
5431343|NCT02391948|18757364|P2|18-month Assessment|Withdrawal by Subject|0
5431344|NCT02391948|18757365|P1|18-month Assessment|Withdrawal by Subject|1
5431345|NCT02391948|18757361|P5|18-month Assessment|Death|1
5431346|NCT02391948|18757362|P4|18-month Assessment|Death|1
5431347|NCT02391948|18757363|P3|18-month Assessment|Death|0
5431348|NCT02391948|18757364|P2|18-month Assessment|Death|0
5431349|NCT02391948|18757365|P1|18-month Assessment|Death|0
5431350|NCT02391948|18757361|P5|12-month Assessment|Not able to schedule visit in timeframe|1
5431351|NCT02391948|18757362|P4|12-month Assessment|Not able to schedule visit in timeframe|2
5431352|NCT02391948|18757363|P3|12-month Assessment|Not able to schedule visit in timeframe|0
5431353|NCT02391948|18757364|P2|12-month Assessment|Not able to schedule visit in timeframe|4
5431354|NCT02391948|18757365|P1|12-month Assessment|Not able to schedule visit in timeframe|2
5431355|NCT02391948|18757361|P5|12-month Assessment|Medical issue/illness|0
5431356|NCT02391948|18757362|P4|12-month Assessment|Medical issue/illness|1
5431357|NCT02391948|18757363|P3|12-month Assessment|Medical issue/illness|0
5431358|NCT02391948|18757364|P2|12-month Assessment|Medical issue/illness|1
5431359|NCT02391948|18757365|P1|12-month Assessment|Medical issue/illness|0
5431360|NCT02391948|18757361|P5|12-month Assessment|Lost to Follow-up|5
5431361|NCT02391948|18757362|P4|12-month Assessment|Lost to Follow-up|4
5431362|NCT02391948|18757363|P3|12-month Assessment|Lost to Follow-up|4
5431363|NCT02391948|18757364|P2|12-month Assessment|Lost to Follow-up|4
5431364|NCT02391948|18757365|P1|12-month Assessment|Lost to Follow-up|5
5431365|NCT02391948|18757361|P5|12-month Assessment|Withdrawal by Subject|0
5431366|NCT02391948|18757362|P4|12-month Assessment|Withdrawal by Subject|1
5431367|NCT02391948|18757363|P3|12-month Assessment|Withdrawal by Subject|0
5431368|NCT02391948|18757364|P2|12-month Assessment|Withdrawal by Subject|0
5431369|NCT02391948|18757365|P1|12-month Assessment|Withdrawal by Subject|1
5431370|NCT02391948|18757361|P5|12-month Assessment|Death|0
5431371|NCT02391948|18757362|P4|12-month Assessment|Death|1
5431372|NCT02391948|18757363|P3|12-month Assessment|Death|0
5431373|NCT02391948|18757364|P2|12-month Assessment|Death|0
5431374|NCT02391948|18757365|P1|12-month Assessment|Death|0
5431375|NCT02391948|18757361|P5|6-month Assessment|In 2-visit study (6-month N/A)|24
5431376|NCT02391948|18757362|P4|6-month Assessment|In 2-visit study (6-month N/A)|35
5431377|NCT02391948|18757363|P3|6-month Assessment|In 2-visit study (6-month N/A)|24
5431378|NCT02391948|18757364|P2|6-month Assessment|In 2-visit study (6-month N/A)|42
5431379|NCT02391948|18757365|P1|6-month Assessment|In 2-visit study (6-month N/A)|68
5431380|NCT02391948|18757361|P5|6-month Assessment|Not able to schedule visit in timeframe|0
5431381|NCT02391948|18757362|P4|6-month Assessment|Not able to schedule visit in timeframe|5
5431382|NCT02391948|18757363|P3|6-month Assessment|Not able to schedule visit in timeframe|4
5431383|NCT02391948|18757364|P2|6-month Assessment|Not able to schedule visit in timeframe|8
5431384|NCT02391948|18757365|P1|6-month Assessment|Not able to schedule visit in timeframe|6
5431385|NCT02391948|18757361|P5|6-month Assessment|Medical issue/illness|0
5431386|NCT02391948|18757362|P4|6-month Assessment|Medical issue/illness|0
5431387|NCT02391948|18757363|P3|6-month Assessment|Medical issue/illness|0
5431388|NCT02391948|18757364|P2|6-month Assessment|Medical issue/illness|1
5431389|NCT02391948|18757365|P1|6-month Assessment|Medical issue/illness|1
5431390|NCT02391948|18757361|P5|6-month Assessment|Lost to Follow-up|1
5431391|NCT02391948|18757362|P4|6-month Assessment|Lost to Follow-up|3
5431392|NCT02391948|18757363|P3|6-month Assessment|Lost to Follow-up|2
5431393|NCT02391948|18757364|P2|6-month Assessment|Lost to Follow-up|5
5431394|NCT02391948|18757365|P1|6-month Assessment|Lost to Follow-up|4
5431395|NCT02391948|18757361|P5|6-month Assessment|Withdrawal by Subject|0
5431396|NCT02391948|18757362|P4|6-month Assessment|Withdrawal by Subject|2
5431397|NCT02391948|18757363|P3|6-month Assessment|Withdrawal by Subject|1
5431398|NCT02391948|18757364|P2|6-month Assessment|Withdrawal by Subject|0
5431399|NCT02391948|18757365|P1|6-month Assessment|Withdrawal by Subject|0
5431400|NCT02391948|18757361|P5|6-month Assessment|Death|1
5431401|NCT02391948|18757362|P4|6-month Assessment|Death|0
5431402|NCT02391948|18757363|P3|6-month Assessment|Death|0
5431403|NCT02391948|18757364|P2|6-month Assessment|Death|0
5431404|NCT02391948|18757365|P1|6-month Assessment|Death|0
5431405|NCT02391584|18757489|P2|12 Month (End of Study)|Lost to Follow-up|0
5431406|NCT02391584|18757490|P1|12 Month (End of Study)|Lost to Follow-up|2
5431407|NCT02391584|18757489|P2|6 Month|Withdrawal by Subject|0
5431408|NCT02391584|18757490|P1|6 Month|Withdrawal by Subject|1
5431409|NCT02391584|18757489|P2|3 Month|Lost to Follow-up|0
5431410|NCT02391584|18757490|P1|3 Month|Lost to Follow-up|1
5431411|NCT02391584|18757489|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
5431412|NCT02391584|18757490|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
5431413|NCT02391584|18757489|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
5431414|NCT02391584|18757490|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
5431415|NCT02391545|18757507|P2|Overall Study|Other Reasons|4
5431416|NCT02391545|18757508|P1|Overall Study|Other Reasons|6
5431417|NCT02391545|18757507|P2|Overall Study|Withdrawal by Subject|1
5431418|NCT02391545|18757508|P1|Overall Study|Withdrawal by Subject|0
5431419|NCT02391545|18757507|P2|Overall Study|Termination of study by sponsor|20
5431420|NCT02391545|18757508|P1|Overall Study|Termination of study by sponsor|20
5431421|NCT02391545|18757507|P2|Overall Study|Lost to Follow-up|1
5431422|NCT02391545|18757508|P1|Overall Study|Lost to Follow-up|0
5431423|NCT02391545|18757507|P2|Overall Study|Death|2
5431424|NCT02391545|18757508|P1|Overall Study|Death|0
5431425|NCT02391363|18757528|P2|Overall Study|Withdrawal by Subject|3
5431426|NCT02391363|18757529|P1|Overall Study|Withdrawal by Subject|6
5431427|NCT02391363|18757528|P2|Overall Study|Lost to Follow-up|5
5431428|NCT02391363|18757529|P1|Overall Study|Lost to Follow-up|5
5431429|NCT02391311|18757614|P2|Overall Study|deemed ineligible after baseline|1
5431430|NCT02391311|18757615|P1|Overall Study|deemed ineligible after baseline|1
5431431|NCT02391311|18757614|P2|Overall Study|Lost to Follow-up|1
5431432|NCT02391311|18757615|P1|Overall Study|Lost to Follow-up|2
5431433|NCT02391116|18757623|P1|Survival Follow-up|Switching to Other Therapy|1
5431434|NCT02391116|18757623|P1|Survival Follow-up|Withdrawal by Subject|3
5431435|NCT02391116|18757623|P1|Active Follow-up|Switching to Other Therapy|2
5431436|NCT02391116|18757623|P1|Active Follow-up|Withdrawal by Subject|1
5431437|NCT02391116|18757623|P1|Safety Follow-up|Deterioration of General Conditions|3
5431438|NCT02391116|18757623|P1|Safety Follow-up|No Follow Up|1
5431439|NCT02391116|18757623|P1|Safety Follow-up|Switching to Other Therapy|4
5431440|NCT02391116|18757623|P1|Safety Follow-up|Withdrawal by Subject|4
5431441|NCT02391116|18757623|P1|Safety Follow-up|Adverse Event|1
5431442|NCT02391116|18757623|P1|Treatment|AE with Clinical PD|3
5431443|NCT02391116|18757623|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
5431444|NCT02391116|18757623|P1|Treatment|Protocol Violation|1
5431445|NCT02391116|18757623|P1|Treatment|Withdrawal by Subject|1
5431446|NCT02391038|18757677|P3|Overall Study|Progressive disease|6
5431447|NCT02391038|18757678|P2|Overall Study|Progressive disease|3
5431448|NCT02391038|18757679|P1|Overall Study|Progressive disease|3
5431449|NCT02390557|18757823|P3|Wave 2|Survey non-respondent|23
5431450|NCT02390557|18757824|P2|Wave 2|Survey non-respondent|41
5431451|NCT02390557|18757825|P1|Wave 2|Survey non-respondent|72
5431452|NCT02390362|18757835|P2|Overall Study|Withdrawal by Subject|1
5431453|NCT02390362|18757836|P1|Overall Study|Withdrawal by Subject|0
5431454|NCT02390219|18757844|P1|Overall Study|Other|2
5431455|NCT02390219|18757844|P1|Overall Study|Lost to Follow-up|2
5431456|NCT02390219|18757844|P1|Overall Study|Withdrawal by Subject|1
5431457|NCT02390219|18757844|P1|Overall Study|Adverse Event|6
5431458|NCT02390219|18757844|P1|Overall Study|Physician Decision|1
5431459|NCT02390219|18757844|P1|Overall Study|Death|1
5431460|NCT02390167|18757854|P1|Overall Study|Lost to Follow-up|1
5431461|NCT02390076|18757876|P3|Overall Study|Lost to Follow-up|4
5431462|NCT02390076|18757877|P2|Overall Study|Lost to Follow-up|1
5431463|NCT02390076|18757878|P1|Overall Study|Lost to Follow-up|2
5431464|NCT02389894|18757907|P3|Overall Study|Lost to Follow-up|1
5431465|NCT02389894|18757908|P2|Overall Study|Lost to Follow-up|1
5431466|NCT02389894|18757909|P1|Overall Study|Lost to Follow-up|2
5431467|NCT02389894|18757907|P3|Overall Study|Withdrawal by Subject|5
5431468|NCT02389894|18757908|P2|Overall Study|Withdrawal by Subject|4
5431469|NCT02389894|18757909|P1|Overall Study|Withdrawal by Subject|2
5431470|NCT02389894|18757907|P3|Overall Study|Death|3
5431471|NCT02389894|18757908|P2|Overall Study|Death|5
5431472|NCT02389894|18757909|P1|Overall Study|Death|4
5431473|NCT02389829|18758041|P2|Overall Study|Lost to Follow-up|1
5431474|NCT02389829|18758042|P1|Overall Study|Lost to Follow-up|0
5431475|NCT02389816|18758057|P3|Overall Study|Reason not Specified|0
5431476|NCT02389816|18758058|P2|Overall Study|Reason not Specified|2
5431477|NCT02389816|18758059|P1|Overall Study|Reason not Specified|0
5431478|NCT02389816|18758057|P3|Overall Study|Non Compliance with Study Drug|1
5431479|NCT02389816|18758058|P2|Overall Study|Non Compliance with Study Drug|1
5431480|NCT02389816|18758059|P1|Overall Study|Non Compliance with Study Drug|1
5431481|NCT02389816|18758057|P3|Overall Study|Lack of Efficacy|0
5431482|NCT02389816|18758058|P2|Overall Study|Lack of Efficacy|0
5431483|NCT02389816|18758059|P1|Overall Study|Lack of Efficacy|1
5431484|NCT02389816|18758057|P3|Overall Study|Withdrawal of Consent|4
5431485|NCT02389816|18758058|P2|Overall Study|Withdrawal of Consent|4
5431486|NCT02389816|18758059|P1|Overall Study|Withdrawal of Consent|6
5431487|NCT02389816|18758057|P3|Overall Study|Lost to Follow-up|0
5431488|NCT02389816|18758058|P2|Overall Study|Lost to Follow-up|0
5431489|NCT02389816|18758059|P1|Overall Study|Lost to Follow-up|1
5431490|NCT02389816|18758057|P3|Overall Study|Major Protocol Deviation|0
5431491|NCT02389816|18758058|P2|Overall Study|Major Protocol Deviation|0
5431492|NCT02389816|18758059|P1|Overall Study|Major Protocol Deviation|1
5431493|NCT02389816|18758057|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|7
5431494|NCT02389816|18758058|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|6
5431495|NCT02389816|18758059|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|4
5431496|NCT02389816|18758057|P3|Overall Study|Randomized but Not Treated|0
5431497|NCT02389816|18758058|P2|Overall Study|Randomized but Not Treated|0
5431498|NCT02389816|18758059|P1|Overall Study|Randomized but Not Treated|1
5431499|NCT02389764|18758091|P1|Overall Study|Lack of Efficacy|9
5431500|NCT02389621|18758126|P2|Posttreatment Period|Other - Miscellaneous|0
5431501|NCT02389621|18758127|P1|Posttreatment Period|Other - Miscellaneous|2
5431502|NCT02389621|18758126|P2|Posttreatment Period|Lost to Follow-up|1
5431503|NCT02389621|18758127|P1|Posttreatment Period|Lost to Follow-up|1
5431504|NCT02389621|18758126|P2|Posttreatment Period|Withdrawal by Subject|2
5431505|NCT02389621|18758127|P1|Posttreatment Period|Withdrawal by Subject|3
5431506|NCT02389621|18758126|P2|Posttreatment Period|Adverse Event|1
5431507|NCT02389621|18758127|P1|Posttreatment Period|Adverse Event|3
5431508|NCT02389621|18758126|P2|Treatment Period|Withdrawal by Subject|1
5431509|NCT02389621|18758127|P1|Treatment Period|Withdrawal by Subject|1
5431510|NCT02389452|18758157|P1|Overall Study|Enrolled but Not Eligible for Study|6
5431511|NCT02389452|18758157|P1|Overall Study|Withdrawal by Subject|5
5431512|NCT02389452|18758157|P1|Overall Study|Adverse Event|1
5431513|NCT02389452|18758157|P1|Overall Study|Lost to Follow-up|13
5431514|NCT02388997|18758269|P2|Overall Study|Tested positive for virus during run-in|1
5431515|NCT02388997|18758270|P1|Overall Study|Tested positive for virus during run-in|0
5431516|NCT02388997|18758269|P2|Overall Study|Lung function exclusion criteria|2
5431517|NCT02388997|18758270|P1|Overall Study|Lung function exclusion criteria|0
5431518|NCT02388997|18758269|P2|Overall Study|Withdrawal by Subject|1
5431519|NCT02388997|18758270|P1|Overall Study|Withdrawal by Subject|2
5431520|NCT02388997|18758269|P2|Overall Study|Adverse Event|2
5431521|NCT02388997|18758270|P1|Overall Study|Adverse Event|1
5431522|NCT02388932|18758288|P1|Overall Study|Death|1
5431523|NCT02388776|18758309|P1|Overall Study|Lost to Follow-up|1
5431524|NCT02388776|18758309|P1|Overall Study|Death|1
5431525|NCT02388763|18758314|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
5431526|NCT02388763|18758315|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
5431527|NCT02388763|18758314|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
5431528|NCT02388763|18758315|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
5431529|NCT02388737|18758329|P3|Overall Study|Reason Not Specified|4
5431530|NCT02388737|18758330|P2|Overall Study|Reason Not Specified|5
5431531|NCT02388737|18758331|P1|Overall Study|Reason Not Specified|5
5431532|NCT02388737|18758329|P3|Overall Study|Lack of Efficacy|3
5431533|NCT02388737|18758330|P2|Overall Study|Lack of Efficacy|0
5431534|NCT02388737|18758331|P1|Overall Study|Lack of Efficacy|3
5431535|NCT02388737|18758329|P3|Overall Study|Voluntary Withdrawal|17
5431536|NCT02388737|18758330|P2|Overall Study|Voluntary Withdrawal|18
5431537|NCT02388737|18758331|P1|Overall Study|Voluntary Withdrawal|10
5431538|NCT02388737|18758329|P3|Overall Study|Lost to Follow-up|4
5431539|NCT02388737|18758330|P2|Overall Study|Lost to Follow-up|1
5431540|NCT02388737|18758331|P1|Overall Study|Lost to Follow-up|5
5431541|NCT02388737|18758329|P3|Overall Study|Major Protocol Deviation|22
5431542|NCT02388737|18758330|P2|Overall Study|Major Protocol Deviation|25
5431543|NCT02388737|18758331|P1|Overall Study|Major Protocol Deviation|18
5431544|NCT02388737|18758329|P3|Overall Study|Pretreatment Event/Adverse Event|12
5431545|NCT02388737|18758330|P2|Overall Study|Pretreatment Event/Adverse Event|11
5431546|NCT02388737|18758331|P1|Overall Study|Pretreatment Event/Adverse Event|13
5431547|NCT02388724|18758365|P2|Overall Study|Randomized but not Treated|2
5431548|NCT02388724|18758366|P1|Overall Study|Randomized but not Treated|0
5431549|NCT02388724|18758365|P2|Overall Study|Voluntary Withdrawal|5
5431550|NCT02388724|18758366|P1|Overall Study|Voluntary Withdrawal|6
5431551|NCT02388724|18758365|P2|Overall Study|Pretreatment Event/Adverse Event|2
5431552|NCT02388724|18758366|P1|Overall Study|Pretreatment Event/Adverse Event|3
5431553|NCT02388724|18758365|P2|Overall Study|Major Protocol Deviation|3
5431554|NCT02388724|18758366|P1|Overall Study|Major Protocol Deviation|3
5431555|NCT02388724|18758365|P2|Overall Study|Reason not Specified|1
5431556|NCT02388724|18758366|P1|Overall Study|Reason not Specified|0
5431557|NCT02388347|18758420|P5|Overall Study|Withdrawal by Subject|0
5431558|NCT02388347|18758421|P4|Overall Study|Withdrawal by Subject|0
5431559|NCT02388347|18758422|P3|Overall Study|Withdrawal by Subject|1
5431560|NCT02388347|18758423|P2|Overall Study|Withdrawal by Subject|0
5431561|NCT02388347|18758424|P1|Overall Study|Withdrawal by Subject|0
5431562|NCT02388295|18758503|P3|Treatment Weeks 3 to 12|Adverse Event|0
5431563|NCT02388295|18758504|P2|Treatment Weeks 3 to 12|Adverse Event|1
5431564|NCT02388295|18758505|P1|Treatment Weeks 3 to 12|Adverse Event|1
5431565|NCT02388295|18758503|P3|Dose Escalation Week 2|Determined not eligible|1
5431566|NCT02388295|18758504|P2|Dose Escalation Week 2|Determined not eligible|1
5431567|NCT02388295|18758505|P1|Dose Escalation Week 2|Determined not eligible|1
5431568|NCT02388295|18758503|P3|Dose Escalation Week 2|Protocol Violation|0
5431569|NCT02388295|18758504|P2|Dose Escalation Week 2|Protocol Violation|1
5431570|NCT02388295|18758505|P1|Dose Escalation Week 2|Protocol Violation|0
5431571|NCT02388295|18758503|P3|Dose Escalation Week 1|Determined not eligible|1
5431572|NCT02388295|18758504|P2|Dose Escalation Week 1|Determined not eligible|1
5431573|NCT02388295|18758505|P1|Dose Escalation Week 1|Determined not eligible|1
5431574|NCT02388295|18758503|P3|Dose Escalation Week 1|Adverse Event|1
5431575|NCT02388295|18758504|P2|Dose Escalation Week 1|Adverse Event|2
5431576|NCT02388295|18758505|P1|Dose Escalation Week 1|Adverse Event|1
5431577|NCT02388269|18758523|P3|Overall Study|Screen Failure|10
5431578|NCT02388269|18758524|P2|Overall Study|Screen Failure|0
5431579|NCT02388269|18758525|P1|Overall Study|Screen Failure|0
5431580|NCT02388269|18758523|P3|Overall Study|Protocol Violation|0
5431581|NCT02388269|18758524|P2|Overall Study|Protocol Violation|0
5431582|NCT02388269|18758525|P1|Overall Study|Protocol Violation|2
5431583|NCT02388269|18758523|P3|Overall Study|no diary data|0
5431584|NCT02388269|18758524|P2|Overall Study|no diary data|0
5431585|NCT02388269|18758525|P1|Overall Study|no diary data|3
5431586|NCT02388269|18758523|P3|Overall Study|less than 50% stimulations|0
5431587|NCT02388269|18758524|P2|Overall Study|less than 50% stimulations|0
5431588|NCT02388269|18758525|P1|Overall Study|less than 50% stimulations|1
5431589|NCT02388269|18758523|P3|Overall Study|Withdrawal by Subject|0
5431590|NCT02388269|18758524|P2|Overall Study|Withdrawal by Subject|2
5431591|NCT02388269|18758525|P1|Overall Study|Withdrawal by Subject|1
5431592|NCT02388269|18758523|P3|Overall Study|Adverse Event|0
5431593|NCT02388269|18758524|P2|Overall Study|Adverse Event|0
5431594|NCT02388269|18758525|P1|Overall Study|Adverse Event|2
5431595|NCT02388191|18758557|P2|Overall Study|Patient did not receive IUD|0
5431596|NCT02388191|18758558|P1|Overall Study|Patient did not receive IUD|1
5431597|NCT02388165|18758574|P2|Overall Study|Did not meet entrance criteria|2
5431598|NCT02388165|18758575|P1|Overall Study|Did not meet entrance criteria|5
5431599|NCT02388165|18758574|P2|Overall Study|Adverse Event|5
5431600|NCT02388165|18758575|P1|Overall Study|Adverse Event|3
5431601|NCT02388165|18758574|P2|Overall Study|Death|10
5431602|NCT02388165|18758575|P1|Overall Study|Death|13
5431603|NCT02388165|18758574|P2|Overall Study|Lost to Follow-up|20
5431604|NCT02388165|18758575|P1|Overall Study|Lost to Follow-up|19
5431605|NCT02388165|18758574|P2|Overall Study|Withdrawal of consent|32
5431606|NCT02388165|18758575|P1|Overall Study|Withdrawal of consent|31
5431607|NCT02388165|18758574|P2|Overall Study|No longer meet eligibility criteria|43
5431608|NCT02388165|18758575|P1|Overall Study|No longer meet eligibility criteria|40
5431609|NCT02388165|18758574|P2|Overall Study|Other|13
5431610|NCT02388165|18758575|P1|Overall Study|Other|11
5431611|NCT02388165|18758574|P2|Overall Study|Study terminated by sponsor|5
5431612|NCT02388165|18758575|P1|Overall Study|Study terminated by sponsor|5
5431613|NCT02388074|18758605|P1|Overall Study|Sample Not Returned|1
5431614|NCT02388074|18758605|P1|Overall Study|Lost in Transit|2
5431615|NCT02387996|18758609|P1|Overall Study|Poor/Non-Compliance|1
5431616|NCT02387996|18758609|P1|Overall Study|Lost to Follow-up|1
5431617|NCT02387996|18758609|P1|Overall Study|Subject Withdrew Consent|1
5431618|NCT02387996|18758609|P1|Overall Study|Subject Request to Discontinue Treatment|9
5431619|NCT02387996|18758609|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
5431620|NCT02387996|18758609|P1|Overall Study|Study Drug Toxicity|14
5431621|NCT02387996|18758609|P1|Overall Study|Disease Progression|144
5431622|NCT02387983|18758620|P1|Overall Study|Withdrawal by Subject|2
5431623|NCT02387983|18758620|P1|Overall Study|Protocol Violation|1
5431624|NCT02387983|18758620|P1|Overall Study|Adverse Event|4
5431625|NCT02387970|18758634|P2|Overall Study|Did not complete 1-year follow up|2
5431626|NCT02387970|18758635|P1|Overall Study|Did not complete 1-year follow up|1
5431627|NCT02387957|18758656|P3|Overall Study|The study was discontinued|20
5431628|NCT02387957|18758657|P2|Overall Study|The study was discontinued|21
5431629|NCT02387957|18758658|P1|Overall Study|The study was discontinued|21
5431630|NCT02387762|18758729|P2|Overall Study|Withdrawal by Subject|0
5431631|NCT02387762|18758730|P1|Overall Study|Withdrawal by Subject|1
5431632|NCT02387580|18758762|P6|Overall Study|Withdrawal by Subject|0
5431633|NCT02387580|18758763|P5|Overall Study|Withdrawal by Subject|0
5431634|NCT02387580|18758764|P4|Overall Study|Withdrawal by Subject|1
5431635|NCT02387580|18758765|P3|Overall Study|Withdrawal by Subject|0
5431636|NCT02387580|18758766|P2|Overall Study|Withdrawal by Subject|0
5431637|NCT02387580|18758767|P1|Overall Study|Withdrawal by Subject|0
5431638|NCT02387372|18758860|P2|Overall Study|Not Treated|0
5431639|NCT02387372|18758861|P1|Overall Study|Not Treated|1
5431640|NCT02387164|18758951|P2|Overall Study|Diagnosed|2
5431641|NCT02387164|18758952|P1|Overall Study|Diagnosed|1
5431642|NCT02387164|18758951|P2|Overall Study|Lost to Follow-up|0
5431643|NCT02387164|18758952|P1|Overall Study|Lost to Follow-up|2
5431644|NCT02386345|18759001|P1|Overall Study|Did not complete 12-month follow-up|72
5431645|NCT02386345|18759001|P1|Overall Study|Repeat Procedure|10
5431646|NCT02386345|18759001|P1|Overall Study|Adverse Event|5
5431647|NCT02386345|18759001|P1|Overall Study|Lost to Follow-up|1
5431648|NCT02386345|18759001|P1|Overall Study|Not treated|14
5431649|NCT02386189|18759011|P2|Overall Study|Death|0
5431650|NCT02386189|18759012|P1|Overall Study|Death|1
5431651|NCT02386189|18759011|P2|Overall Study|Withdrawal by Subject|0
5431652|NCT02386189|18759012|P1|Overall Study|Withdrawal by Subject|1
5431653|NCT02386189|18759011|P2|Overall Study|Lost to Follow-up|3
5431654|NCT02386189|18759012|P1|Overall Study|Lost to Follow-up|2
5431655|NCT02386098|18759035|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
5431656|NCT02386098|18759036|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
5431657|NCT02386098|18759037|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
5431658|NCT02386098|18759038|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
5431659|NCT02386098|18759039|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
5431660|NCT02386098|18759035|P5|Stage 1 (96 Weeks)|Other|0
5431661|NCT02386098|18759036|P4|Stage 1 (96 Weeks)|Other|0
5431662|NCT02386098|18759037|P3|Stage 1 (96 Weeks)|Other|0
5431663|NCT02386098|18759038|P2|Stage 1 (96 Weeks)|Other|0
5431664|NCT02386098|18759039|P1|Stage 1 (96 Weeks)|Other|1
5431665|NCT02386098|18759035|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
5431666|NCT02386098|18759036|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
5431667|NCT02386098|18759037|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
5431668|NCT02386098|18759038|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
5431669|NCT02386098|18759039|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
5431670|NCT02386098|18759035|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5431671|NCT02386098|18759036|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5431672|NCT02386098|18759037|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5431673|NCT02386098|18759038|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
5431674|NCT02386098|18759039|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
5431675|NCT02386098|18759035|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
5431676|NCT02386098|18759036|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
5431677|NCT02386098|18759037|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
5431678|NCT02386098|18759038|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
5431679|NCT02386098|18759039|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
5431680|NCT02386098|18759035|P5|Stage 1 (96 Weeks)|Adverse Event|0
5431681|NCT02386098|18759036|P4|Stage 1 (96 Weeks)|Adverse Event|0
5431682|NCT02386098|18759037|P3|Stage 1 (96 Weeks)|Adverse Event|0
5431683|NCT02386098|18759038|P2|Stage 1 (96 Weeks)|Adverse Event|1
5431684|NCT02386098|18759039|P1|Stage 1 (96 Weeks)|Adverse Event|2
5431685|NCT02386098|18759035|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
5431686|NCT02386098|18759036|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
5431687|NCT02386098|18759037|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
5431688|NCT02386098|18759038|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
5431689|NCT02386098|18759039|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
5431690|NCT02385799|18759118|P2|Overall Study|Withdrawal by Subject|4
5431691|NCT02385799|18759119|P1|Overall Study|Withdrawal by Subject|0
5431692|NCT02385799|18759118|P2|Overall Study|Adverse Event|2
5431693|NCT02385799|18759119|P1|Overall Study|Adverse Event|4
5431694|NCT02385799|18759118|P2|Overall Study|Lost to Follow-up|2
5431695|NCT02385799|18759119|P1|Overall Study|Lost to Follow-up|1
5431696|NCT02385708|18759160|P2|Overall Study|Protocol Violation|1
5431697|NCT02385708|18759161|P1|Overall Study|Protocol Violation|1
5431698|NCT02385708|18759160|P2|Overall Study|Investigator decision|7
5431699|NCT02385708|18759161|P1|Overall Study|Investigator decision|5
5431700|NCT02385708|18759160|P2|Overall Study|Withdrawn - surgery canceled|5
5431701|NCT02385708|18759161|P1|Overall Study|Withdrawn - surgery canceled|2
5431702|NCT02385708|18759160|P2|Overall Study|Withdrawal by Subject|2
5431703|NCT02385708|18759161|P1|Overall Study|Withdrawal by Subject|0
5431704|NCT02385669|18759167|P1|Overall Study|Adverse Event|2
5431705|NCT02385526|18759175|P3|Overall Study|Protocol Violation|0
5431706|NCT02385526|18759176|P2|Overall Study|Protocol Violation|0
5431707|NCT02385526|18759177|P1|Overall Study|Protocol Violation|1
5431708|NCT02385526|18759175|P3|Overall Study|Physician Decision|0
5431709|NCT02385526|18759176|P2|Overall Study|Physician Decision|0
5431710|NCT02385526|18759177|P1|Overall Study|Physician Decision|1
5431711|NCT02385526|18759175|P3|Overall Study|Lost to Follow-up|0
5431712|NCT02385526|18759176|P2|Overall Study|Lost to Follow-up|1
5431713|NCT02385526|18759177|P1|Overall Study|Lost to Follow-up|0
5431714|NCT02385526|18759175|P3|Overall Study|Withdrawal by Subject|0
5431715|NCT02385526|18759176|P2|Overall Study|Withdrawal by Subject|2
5431716|NCT02385526|18759177|P1|Overall Study|Withdrawal by Subject|0
5431717|NCT02385084|18759204|P6|Period 2|Protocol Violation|0
5431718|NCT02385084|18759205|P5|Period 2|Protocol Violation|0
5431719|NCT02385084|18759206|P4|Period 2|Protocol Violation|0
5431720|NCT02385084|18759207|P3|Period 2|Protocol Violation|1
5431721|NCT02385084|18759208|P2|Period 2|Protocol Violation|0
5431722|NCT02385084|18759209|P1|Period 2|Protocol Violation|0
5431723|NCT02384993|18759222|P2|Overall Study|Adverse Event|1
5431724|NCT02384993|18759223|P1|Overall Study|Adverse Event|0
5431725|NCT02384941|18759249|P3|Overall Study|Other than specified above|1
5431726|NCT02384941|18759250|P2|Overall Study|Other than specified above|0
5431727|NCT02384941|18759251|P1|Overall Study|Other than specified above|4
5431728|NCT02384941|18759249|P3|Overall Study|Pregnancy|1
5431729|NCT02384941|18759250|P2|Overall Study|Pregnancy|0
5431730|NCT02384941|18759251|P1|Overall Study|Pregnancy|0
5431731|NCT02384941|18759249|P3|Overall Study|Withdrawal by Subject|20
5431732|NCT02384941|18759250|P2|Overall Study|Withdrawal by Subject|19
5431733|NCT02384941|18759251|P1|Overall Study|Withdrawal by Subject|26
5431734|NCT02384941|18759249|P3|Overall Study|Protocol Violation|0
5431735|NCT02384941|18759250|P2|Overall Study|Protocol Violation|0
5431736|NCT02384941|18759251|P1|Overall Study|Protocol Violation|3
5431737|NCT02384941|18759249|P3|Overall Study|Physician Decision|0
5431738|NCT02384941|18759250|P2|Overall Study|Physician Decision|1
5431739|NCT02384941|18759251|P1|Overall Study|Physician Decision|1
5431740|NCT02384941|18759249|P3|Overall Study|Non-Compliance With Study Drug|1
5431741|NCT02384941|18759250|P2|Overall Study|Non-Compliance With Study Drug|0
5431742|NCT02384941|18759251|P1|Overall Study|Non-Compliance With Study Drug|2
5431743|NCT02384941|18759249|P3|Overall Study|Lost to Follow-up|1
5431744|NCT02384941|18759250|P2|Overall Study|Lost to Follow-up|2
5431745|NCT02384941|18759251|P1|Overall Study|Lost to Follow-up|3
5431746|NCT02384941|18759249|P3|Overall Study|Adverse Event|17
5431747|NCT02384941|18759250|P2|Overall Study|Adverse Event|13
5431748|NCT02384941|18759251|P1|Overall Study|Adverse Event|11
5431749|NCT02384538|18759282|P2|Overall Study|Other|3
5431750|NCT02384538|18759283|P1|Overall Study|Other|1
5431751|NCT02384538|18759282|P2|Overall Study|Withdrew Consent|4
5431752|NCT02384538|18759283|P1|Overall Study|Withdrew Consent|0
5431753|NCT02384538|18759282|P2|Overall Study|Lack of Efficacy|4
5431754|NCT02384538|18759283|P1|Overall Study|Lack of Efficacy|4
5431755|NCT02384538|18759282|P2|Overall Study|Adverse Event|4
5431756|NCT02384538|18759283|P1|Overall Study|Adverse Event|1
5431757|NCT02384460|18759303|P2|Overall Study|Non-compliance|0
5431758|NCT02384460|18759304|P1|Overall Study|Non-compliance|1
5431759|NCT02384460|18759303|P2|Overall Study|Elective medical treatment|0
5431760|NCT02384460|18759304|P1|Overall Study|Elective medical treatment|1
5431761|NCT02384460|18759303|P2|Overall Study|Withdrawal by Subject|3
5431762|NCT02384460|18759304|P1|Overall Study|Withdrawal by Subject|0
5431763|NCT02384460|18759303|P2|Overall Study|Adverse Event|2
5431764|NCT02384460|18759304|P1|Overall Study|Adverse Event|5
5431765|NCT02384460|18759303|P2|Overall Study|Returned to previous therapeutic regimen|1
5431766|NCT02384460|18759304|P1|Overall Study|Returned to previous therapeutic regimen|0
5431767|NCT02384460|18759303|P2|Overall Study|Protocol Violation|1
5431768|NCT02384460|18759304|P1|Overall Study|Protocol Violation|0
5431769|NCT02384382|18759322|P1|Overall Study|Disease progression|16
5431770|NCT02384382|18759322|P1|Overall Study|Adverse Event|1
5431771|NCT02384382|18759322|P1|Overall Study|Death|1
5431772|NCT02384382|18759322|P1|Overall Study|Transitioned to study-NCT02960022|5
5431773|NCT02383966|18759394|P2|Overall Study|Randomized, but not treated|3
5431774|NCT02383966|18759395|P1|Overall Study|Randomized, but not treated|1
5431775|NCT02383966|18759394|P2|Overall Study|Ongoing at clinical cut-off date|4
5431776|NCT02383966|18759395|P1|Overall Study|Ongoing at clinical cut-off date|25
5431777|NCT02383940|18759415|P2|Overall Study|Other than specified above|0
5431778|NCT02383940|18759416|P1|Overall Study|Other than specified above|1
5431779|NCT02383940|18759415|P2|Overall Study|Randomized but not treated|0
5431780|NCT02383940|18759416|P1|Overall Study|Randomized but not treated|2
5431781|NCT02383940|18759415|P2|Overall Study|Withdrawal by Subject|1
5431782|NCT02383940|18759416|P1|Overall Study|Withdrawal by Subject|1
5431783|NCT02383940|18759415|P2|Overall Study|Physician Decision|0
5431784|NCT02383940|18759416|P1|Overall Study|Physician Decision|2
5431785|NCT02383940|18759415|P2|Overall Study|Lost to Follow-up|2
5431786|NCT02383940|18759416|P1|Overall Study|Lost to Follow-up|2
5431787|NCT02383940|18759415|P2|Overall Study|Adverse Event|0
5431788|NCT02383940|18759416|P1|Overall Study|Adverse Event|1
5431789|NCT02383862|18759432|P2|3 Month Follow up|Lost to Follow-up|21
5431790|NCT02383862|18759433|P1|3 Month Follow up|Lost to Follow-up|23
5431791|NCT02383758|18759466|P2|Overall Study|Withdrawal by Subject|2
5431792|NCT02383758|18759467|P1|Overall Study|Withdrawal by Subject|0
5431793|NCT02383589|18759495|P2|Safety Follow-up (SFU)|Treated by not accepted treatment|1
5431794|NCT02383589|18759496|P1|Safety Follow-up (SFU)|Treated by not accepted treatment|0
5431795|NCT02383589|18759495|P2|Safety Follow-up (SFU)|Withdrawal by Subject|0
5431796|NCT02383589|18759496|P1|Safety Follow-up (SFU)|Withdrawal by Subject|5
5431797|NCT02383589|18759495|P2|Safety Follow-up (SFU)|Lost to Follow-up|4
5431798|NCT02383589|18759496|P1|Safety Follow-up (SFU)|Lost to Follow-up|2
5431799|NCT02383589|18759495|P2|Treatment Period|Non-compliance with study drug|1
5431800|NCT02383589|18759496|P1|Treatment Period|Non-compliance with study drug|0
5431801|NCT02383589|18759495|P2|Treatment Period|Withdrawal by Subject|5
5431802|NCT02383589|18759496|P1|Treatment Period|Withdrawal by Subject|0
5431803|NCT02383589|18759495|P2|Treatment Period|Lost to Follow-up|1
5431804|NCT02383589|18759496|P1|Treatment Period|Lost to Follow-up|0
5431805|NCT02383589|18759495|P2|Treatment Period|Adverse Event|3
5431806|NCT02383589|18759496|P1|Treatment Period|Adverse Event|1
5431807|NCT02383576|18759521|P2|Overall Study|Administrative/Other|4
5431808|NCT02383576|18759522|P1|Overall Study|Administrative/Other|2
5431809|NCT02383576|18759521|P2|Overall Study|Investigator's Decision|1
5431810|NCT02383576|18759522|P1|Overall Study|Investigator's Decision|0
5431811|NCT02383576|18759521|P2|Overall Study|Withdrew Consent|6
5431812|NCT02383576|18759522|P1|Overall Study|Withdrew Consent|1
5431813|NCT02383576|18759521|P2|Overall Study|Lost to Follow-up|1
5431814|NCT02383576|18759522|P1|Overall Study|Lost to Follow-up|7
5431815|NCT02383576|18759521|P2|Overall Study|Death|33
5431816|NCT02383576|18759522|P1|Overall Study|Death|53
5431817|NCT02383472|18759538|P2|Overall Study|Withdrawal by Subject|1
5431818|NCT02383472|18759539|P1|Overall Study|Withdrawal by Subject|1
5431819|NCT02383433|18759553|P1|Overall Study|Disease progression|2
5431820|NCT02383355|18759572|P2|Overall Study|Adverse Event|0
5431821|NCT02383355|18759573|P1|Overall Study|Adverse Event|2
5431822|NCT02383173|18759589|P2|Overall Study|Palliative Care Team withdrew|2
5431823|NCT02383173|18759590|P1|Overall Study|Palliative Care Team withdrew|0
5431824|NCT02383056|18759614|P2|Overall Study|Lost to Follow-up|2
5431825|NCT02383056|18759615|P1|Overall Study|Lost to Follow-up|0
5431826|NCT02383056|18759614|P2|Overall Study|Adverse Event|0
5431827|NCT02383056|18759615|P1|Overall Study|Adverse Event|1
5431828|NCT02383017|18759641|P2|Overall Study|Found to be Hypogonadal|0
5431829|NCT02383017|18759642|P1|Overall Study|Found to be Hypogonadal|1
5431830|NCT02383017|18759641|P2|Overall Study|Compliance|2
5431831|NCT02383017|18759642|P1|Overall Study|Compliance|3
5431832|NCT02383017|18759641|P2|Overall Study|Injury Sustained Outside Study|0
5431833|NCT02383017|18759642|P1|Overall Study|Injury Sustained Outside Study|1
5431834|NCT02382991|18759666|P2|Overall Study|Withdrawal by Subject|1
5431835|NCT02382991|18759667|P1|Overall Study|Withdrawal by Subject|0
5431836|NCT02382991|18759666|P2|Overall Study|Lost to Follow-up|0
5431837|NCT02382991|18759667|P1|Overall Study|Lost to Follow-up|1
5431838|NCT02382991|18759666|P2|Overall Study|Adverse Event|2
5431839|NCT02382991|18759667|P1|Overall Study|Adverse Event|1
5431840|NCT02382939|18759679|P2|Overall Study|Withdrawal by Subject|2
5431841|NCT02382939|18759680|P1|Overall Study|Withdrawal by Subject|2
5431842|NCT02382939|18759679|P2|Overall Study|Adverse Event|1
5431843|NCT02382939|18759680|P1|Overall Study|Adverse Event|1
5431844|NCT02382796|18759763|P1|Overall Study|Commercial dacomitinib became available|3
5431845|NCT02382796|18759763|P1|Overall Study|Objective progression or relapse|3
5431846|NCT02382796|18759763|P1|Overall Study|Global deterioration of health status|1
5431847|NCT02382640|18759813|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
5431848|NCT02382640|18759814|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
5431849|NCT02382640|18759815|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
5431850|NCT02382640|18759816|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
5431851|NCT02382276|18759857|P3|Overall Study|Physician Decision|2
5431852|NCT02382276|18759858|P2|Overall Study|Physician Decision|0
5431853|NCT02382276|18759859|P1|Overall Study|Physician Decision|0
5431854|NCT02382276|18759857|P3|Overall Study|Adverse Event|32
5431855|NCT02382276|18759858|P2|Overall Study|Adverse Event|2
5431856|NCT02382276|18759859|P1|Overall Study|Adverse Event|7
5431857|NCT02382276|18759857|P3|Overall Study|Withdrawal by Subject|5
5431858|NCT02382276|18759858|P2|Overall Study|Withdrawal by Subject|8
5431859|NCT02382276|18759859|P1|Overall Study|Withdrawal by Subject|4
5431860|NCT02382133|18759871|P1|Overall Study|pressure injury both sites|1
5431861|NCT02382133|18759871|P1|Overall Study|arterial catheter loss|4
5431862|NCT02382133|18759871|P1|Overall Study|Physician Decision|2
5431863|NCT02382133|18759871|P1|Overall Study|transfer out of ICU|4
5431864|NCT02382133|18759871|P1|Overall Study|Death|22
5431865|NCT02382016|18759878|P2|OL Extension Period|Withdrawal by Subject|0
5431866|NCT02382016|18759879|P1|OL Extension Period|Withdrawal by Subject|1
5431867|NCT02382016|18759878|P2|OL Extension Period|Death|0
5431868|NCT02382016|18759879|P1|OL Extension Period|Death|2
5431869|NCT02382016|18759878|P2|OL Extension Period|Physician Decision|0
5431870|NCT02382016|18759879|P1|OL Extension Period|Physician Decision|3
5431871|NCT02382016|18759878|P2|Open-label (OL) Treatment Period|Death|0
5431872|NCT02382016|18759879|P1|Open-label (OL) Treatment Period|Death|4
5431873|NCT02382016|18759878|P2|Open-label (OL) Treatment Period|Withdrawal by Subject|0
5431874|NCT02382016|18759879|P1|Open-label (OL) Treatment Period|Withdrawal by Subject|2
5431875|NCT02382016|18759878|P2|Open-label (OL) Treatment Period|Physician Decision|0
5431876|NCT02382016|18759879|P1|Open-label (OL) Treatment Period|Physician Decision|3
5431877|NCT02382016|18759878|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
5431878|NCT02382016|18759879|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
5431879|NCT02382016|18759878|P2|Double-blind (DB) Treatment Period|Lack of Efficacy|0
5431880|NCT02382016|18759879|P1|Double-blind (DB) Treatment Period|Lack of Efficacy|1
5431881|NCT02382016|18759878|P2|Double-blind (DB) Treatment Period|Physician Decision|0
5431882|NCT02382016|18759879|P1|Double-blind (DB) Treatment Period|Physician Decision|3
5431883|NCT02381795|18759903|P1|Overall Study|Study Terminated|2
5431884|NCT02381795|18759903|P1|Overall Study|Withdrawal by Subject|1
5431885|NCT02381652|18759918|P3|Overall Study|Withdrawal by Subject|1
5431886|NCT02381652|18759919|P2|Overall Study|Withdrawal by Subject|0
5431887|NCT02381652|18759920|P1|Overall Study|Withdrawal by Subject|0
5431888|NCT02380859|18760023|P2|Overall Study|Withdrawal by Subject|0
5431889|NCT02380859|18760024|P1|Overall Study|Withdrawal by Subject|2
5431890|NCT02380742|18760060|P2|Overall Study|Withdrawal by Subject|0
5431891|NCT02380742|18760061|P1|Overall Study|Withdrawal by Subject|1
5431892|NCT02380703|18760075|P2|Overall Study|Entered Long-term Care|7
5431893|NCT02380703|18760076|P1|Overall Study|Entered Long-term Care|4
5431894|NCT02380703|18760075|P2|Overall Study|Person with dementia (PWD) death|8
5431895|NCT02380703|18760076|P1|Overall Study|Person with dementia (PWD) death|7
5431896|NCT02380703|18760075|P2|Overall Study|Caregiver death|0
5431897|NCT02380703|18760076|P1|Overall Study|Caregiver death|1
5431898|NCT02380703|18760075|P2|Overall Study|Lost to Follow-up|12
5431899|NCT02380703|18760076|P1|Overall Study|Lost to Follow-up|12
5431900|NCT02380703|18760075|P2|Overall Study|Withdrawal by Subject|9
5431901|NCT02380703|18760076|P1|Overall Study|Withdrawal by Subject|12
5431902|NCT02380690|18760098|P2|Overall Study|Withdrawal by Subject|8
5431903|NCT02380690|18760099|P1|Overall Study|Withdrawal by Subject|20
5431904|NCT02380690|18760098|P2|Overall Study|Lost to Follow-up|4
5431905|NCT02380690|18760099|P1|Overall Study|Lost to Follow-up|14
5431906|NCT02380677|18760147|P12|Overall Study|Other|0
5431907|NCT02380677|18760148|P11|Overall Study|Other|0
5431908|NCT02380677|18760149|P10|Overall Study|Other|0
5431909|NCT02380677|18760150|P9|Overall Study|Other|0
5431910|NCT02380677|18760151|P8|Overall Study|Other|0
5431911|NCT02380677|18760152|P7|Overall Study|Other|0
5431912|NCT02380677|18760153|P6|Overall Study|Other|1
5431913|NCT02380677|18760154|P5|Overall Study|Other|1
5431914|NCT02380677|18760155|P4|Overall Study|Other|1
5431915|NCT02380677|18760156|P3|Overall Study|Other|0
5431916|NCT02380677|18760157|P2|Overall Study|Other|0
5431917|NCT02380677|18760158|P1|Overall Study|Other|0
5431918|NCT02380677|18760147|P12|Overall Study|Withdrawal by Subject|3
5431919|NCT02380677|18760148|P11|Overall Study|Withdrawal by Subject|0
5431920|NCT02380677|18760149|P10|Overall Study|Withdrawal by Subject|1
5431921|NCT02380677|18760150|P9|Overall Study|Withdrawal by Subject|0
5431922|NCT02380677|18760151|P8|Overall Study|Withdrawal by Subject|0
5431923|NCT02380677|18760152|P7|Overall Study|Withdrawal by Subject|0
5431924|NCT02380677|18760153|P6|Overall Study|Withdrawal by Subject|0
5431925|NCT02380677|18760154|P5|Overall Study|Withdrawal by Subject|0
5431926|NCT02380677|18760155|P4|Overall Study|Withdrawal by Subject|0
5431927|NCT02380677|18760156|P3|Overall Study|Withdrawal by Subject|0
5431928|NCT02380677|18760157|P2|Overall Study|Withdrawal by Subject|0
5431929|NCT02380677|18760158|P1|Overall Study|Withdrawal by Subject|0
5431930|NCT02380677|18760147|P12|Overall Study|Lack of Efficacy|1
5431931|NCT02380677|18760148|P11|Overall Study|Lack of Efficacy|2
5431932|NCT02380677|18760149|P10|Overall Study|Lack of Efficacy|0
5431933|NCT02380677|18760150|P9|Overall Study|Lack of Efficacy|2
5431934|NCT02380677|18760151|P8|Overall Study|Lack of Efficacy|2
5431935|NCT02380677|18760152|P7|Overall Study|Lack of Efficacy|1
5431936|NCT02380677|18760153|P6|Overall Study|Lack of Efficacy|1
5431937|NCT02380677|18760154|P5|Overall Study|Lack of Efficacy|4
5431938|NCT02380677|18760155|P4|Overall Study|Lack of Efficacy|0
5431939|NCT02380677|18760156|P3|Overall Study|Lack of Efficacy|2
5431940|NCT02380677|18760157|P2|Overall Study|Lack of Efficacy|1
5431941|NCT02380677|18760158|P1|Overall Study|Lack of Efficacy|0
5431942|NCT02380677|18760147|P12|Overall Study|Physician Decision|0
5431943|NCT02380677|18760148|P11|Overall Study|Physician Decision|0
5431944|NCT02380677|18760149|P10|Overall Study|Physician Decision|0
5431945|NCT02380677|18760150|P9|Overall Study|Physician Decision|0
5431946|NCT02380677|18760151|P8|Overall Study|Physician Decision|0
5431947|NCT02380677|18760152|P7|Overall Study|Physician Decision|0
5431948|NCT02380677|18760153|P6|Overall Study|Physician Decision|0
5431949|NCT02380677|18760154|P5|Overall Study|Physician Decision|0
5431950|NCT02380677|18760155|P4|Overall Study|Physician Decision|1
5431951|NCT02380677|18760156|P3|Overall Study|Physician Decision|1
5431952|NCT02380677|18760157|P2|Overall Study|Physician Decision|0
5431953|NCT02380677|18760158|P1|Overall Study|Physician Decision|1
5431954|NCT02380677|18760147|P12|Overall Study|Adverse Event|1
5431955|NCT02380677|18760148|P11|Overall Study|Adverse Event|2
5431956|NCT02380677|18760149|P10|Overall Study|Adverse Event|1
5431957|NCT02380677|18760150|P9|Overall Study|Adverse Event|2
5431958|NCT02380677|18760151|P8|Overall Study|Adverse Event|2
5431959|NCT02380677|18760152|P7|Overall Study|Adverse Event|2
5431960|NCT02380677|18760153|P6|Overall Study|Adverse Event|4
5431961|NCT02380677|18760154|P5|Overall Study|Adverse Event|1
5431962|NCT02380677|18760155|P4|Overall Study|Adverse Event|1
5431963|NCT02380677|18760156|P3|Overall Study|Adverse Event|0
5431964|NCT02380677|18760157|P2|Overall Study|Adverse Event|0
5431965|NCT02380677|18760158|P1|Overall Study|Adverse Event|0
5431966|NCT02380287|18760214|P8|Overall Study|Adverse Event|0
5431967|NCT02380287|18760215|P7|Overall Study|Adverse Event|0
5431968|NCT02380287|18760216|P6|Overall Study|Adverse Event|0
5431969|NCT02380287|18760217|P5|Overall Study|Adverse Event|0
5431970|NCT02380287|18760218|P4|Overall Study|Adverse Event|0
5431971|NCT02380287|18760219|P3|Overall Study|Adverse Event|1
5431972|NCT02380287|18760220|P2|Overall Study|Adverse Event|0
5431973|NCT02380287|18760221|P1|Overall Study|Adverse Event|0
5431974|NCT02380248|18760237|P1|Overall Study|Withdrawal by Subject|3
5431975|NCT02380248|18760237|P1|Overall Study|Lost to Follow-up|11
5431976|NCT02379923|18760253|P1|Overall Study|Death|5
5431977|NCT02379728|18760282|P4|Overall Study|Protocol Violation|0
5431978|NCT02379728|18760283|P3|Overall Study|Protocol Violation|2
5431979|NCT02379728|18760284|P2|Overall Study|Protocol Violation|0
5431980|NCT02379728|18760285|P1|Overall Study|Protocol Violation|0
5431981|NCT02379728|18760282|P4|Overall Study|Withdrawal by Subject|3
5431982|NCT02379728|18760283|P3|Overall Study|Withdrawal by Subject|5
5431983|NCT02379728|18760284|P2|Overall Study|Withdrawal by Subject|0
5431984|NCT02379728|18760285|P1|Overall Study|Withdrawal by Subject|5
5431985|NCT02379728|18760282|P4|Overall Study|Lost to Follow-up|0
5431986|NCT02379728|18760283|P3|Overall Study|Lost to Follow-up|3
5431987|NCT02379728|18760284|P2|Overall Study|Lost to Follow-up|0
5431988|NCT02379728|18760285|P1|Overall Study|Lost to Follow-up|1
5431989|NCT02379637|18760341|P2|Overall Study|Withdrawal by Subject|0
5431990|NCT02379637|18760342|P1|Overall Study|Withdrawal by Subject|1
5431991|NCT02379637|18760341|P2|Overall Study|Adverse Event|0
5431992|NCT02379637|18760342|P1|Overall Study|Adverse Event|1
5431993|NCT02379637|18760341|P2|Overall Study|Protocol Violation|1
5431994|NCT02379637|18760342|P1|Overall Study|Protocol Violation|0
5431995|NCT02379390|18760381|P2|Overall Study|Study Termination|1
5431996|NCT02379390|18760382|P1|Overall Study|Study Termination|0
5431997|NCT02379390|18760381|P2|Overall Study|Investigator's decision|0
5431998|NCT02379390|18760382|P1|Overall Study|Investigator's decision|1
5431999|NCT02379390|18760381|P2|Overall Study|Adverse Event|1
5432000|NCT02379390|18760382|P1|Overall Study|Adverse Event|1
5432001|NCT02379221|18760410|P1|Overall Study|Lost to Follow-up|1
5432002|NCT02379091|18760446|P4|Overall Study|Lack of Efficacy|0
5432003|NCT02379091|18760447|P3|Overall Study|Lack of Efficacy|0
5432004|NCT02379091|18760448|P2|Overall Study|Lack of Efficacy|0
5432005|NCT02379091|18760449|P1|Overall Study|Lack of Efficacy|3
5432006|NCT02379091|18760446|P4|Overall Study|Study Termination|8
5432007|NCT02379091|18760447|P3|Overall Study|Study Termination|5
5432008|NCT02379091|18760448|P2|Overall Study|Study Termination|2
5432009|NCT02379091|18760449|P1|Overall Study|Study Termination|7
5432010|NCT02379091|18760446|P4|Overall Study|Voluntary Withdrawal|4
5432011|NCT02379091|18760447|P3|Overall Study|Voluntary Withdrawal|2
5432012|NCT02379091|18760448|P2|Overall Study|Voluntary Withdrawal|5
5432013|NCT02379091|18760449|P1|Overall Study|Voluntary Withdrawal|2
5432014|NCT02379091|18760446|P4|Overall Study|Lost to Follow-up|1
5432015|NCT02379091|18760447|P3|Overall Study|Lost to Follow-up|0
5432016|NCT02379091|18760448|P2|Overall Study|Lost to Follow-up|0
5432017|NCT02379091|18760449|P1|Overall Study|Lost to Follow-up|0
5432018|NCT02379091|18760446|P4|Overall Study|Principal Investigator Discretion|0
5432019|NCT02379091|18760447|P3|Overall Study|Principal Investigator Discretion|0
5432020|NCT02379091|18760448|P2|Overall Study|Principal Investigator Discretion|1
5432021|NCT02379091|18760449|P1|Overall Study|Principal Investigator Discretion|0
5432022|NCT02379091|18760446|P4|Overall Study|Pretreatment Event/Adverse Event|1
5432023|NCT02379091|18760447|P3|Overall Study|Pretreatment Event/Adverse Event|0
5432024|NCT02379091|18760448|P2|Overall Study|Pretreatment Event/Adverse Event|2
5432025|NCT02379091|18760449|P1|Overall Study|Pretreatment Event/Adverse Event|0
5432026|NCT02379078|18760487|P2|Overall Study|Withdrawal by Subject|5
5432027|NCT02379078|18760488|P1|Overall Study|Withdrawal by Subject|6
5432028|NCT02379078|18760487|P2|Overall Study|Lost to Follow-up|30
5432029|NCT02379078|18760488|P1|Overall Study|Lost to Follow-up|33
5432030|NCT02379052|18760504|P2|Overall Study|Subject was Incarcerated|1
5432031|NCT02379052|18760505|P1|Overall Study|Subject was Incarcerated|0
5432032|NCT02379052|18760504|P2|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
5432033|NCT02379052|18760505|P1|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
5432034|NCT02379052|18760504|P2|Overall Study|Lost to Follow-up|1
5432035|NCT02379052|18760505|P1|Overall Study|Lost to Follow-up|2
5432036|NCT02379052|18760504|P2|Overall Study|Withdrawal by Subject|0
5432037|NCT02379052|18760505|P1|Overall Study|Withdrawal by Subject|2
5432038|NCT02379052|18760504|P2|Overall Study|Physician Decision|1
5432039|NCT02379052|18760505|P1|Overall Study|Physician Decision|1
5432040|NCT02379052|18760504|P2|Overall Study|Adverse Event|1
5432041|NCT02379052|18760505|P1|Overall Study|Adverse Event|0
5432042|NCT02379052|18760504|P2|Overall Study|Protocol Violation|1
5432043|NCT02379052|18760505|P1|Overall Study|Protocol Violation|0
5432044|NCT02378961|18760547|P4|Overall Study|Death|0
5432045|NCT02378961|18760548|P3|Overall Study|Death|1
5432046|NCT02378961|18760549|P2|Overall Study|Death|0
5432047|NCT02378961|18760550|P1|Overall Study|Death|0
5432048|NCT02378961|18760547|P4|Overall Study|Lack of Efficacy|1
5432049|NCT02378961|18760548|P3|Overall Study|Lack of Efficacy|0
5432050|NCT02378961|18760549|P2|Overall Study|Lack of Efficacy|2
5432051|NCT02378961|18760550|P1|Overall Study|Lack of Efficacy|4
5432052|NCT02378935|18760587|P7|Overall Study|Death|0
5432053|NCT02378935|18760588|P6|Overall Study|Death|0
5432054|NCT02378935|18760589|P5|Overall Study|Death|0
5432055|NCT02378935|18760590|P4|Overall Study|Death|0
5432056|NCT02378935|18760591|P3|Overall Study|Death|1
5432057|NCT02378935|18760592|P2|Overall Study|Death|0
5432058|NCT02378935|18760593|P1|Overall Study|Death|0
5432059|NCT02378935|18760587|P7|Overall Study|Lack of Efficacy|0
5432060|NCT02378935|18760588|P6|Overall Study|Lack of Efficacy|0
5432061|NCT02378935|18760589|P5|Overall Study|Lack of Efficacy|0
5432062|NCT02378935|18760590|P4|Overall Study|Lack of Efficacy|6
5432063|NCT02378935|18760591|P3|Overall Study|Lack of Efficacy|2
5432064|NCT02378935|18760592|P2|Overall Study|Lack of Efficacy|0
5432065|NCT02378935|18760593|P1|Overall Study|Lack of Efficacy|10
5432066|NCT02378883|18760644|P1|12 Months Follow-Up|Death|2
5432067|NCT02378883|18760644|P1|12 Months Follow-Up|Lost to Follow-up|3
5432068|NCT02378883|18760644|P1|30 Day Follow-Up|Death|1
5432069|NCT02378883|18760644|P1|30 Day Follow-Up|Missed Visit|2
5432070|NCT02378883|18760644|P1|30 Day Follow-Up|Physician Decision|2
5432071|NCT02378883|18760644|P1|30 Day Follow-Up|Withdrawal by Subject|1
5432072|NCT02378883|18760644|P1|Enrollment|Attempt to use Apollo was not performed|3
5432073|NCT02378883|18760644|P1|Enrollment|Subject did not meet Inclusion criteria|6
5432074|NCT02378662|18760710|P2|Overall Study|Early Discontinuation|0
5432075|NCT02378662|18760711|P1|Overall Study|Early Discontinuation|2
5432076|NCT02378506|18760717|P1|Overall Study|Randomized But Not Treated|1
5432077|NCT02378506|18760717|P1|Overall Study|Adverse Event|14
5432078|NCT02378506|18760717|P1|Overall Study|Death|1
5432079|NCT02378506|18760717|P1|Overall Study|Protocol Violation|2
5432080|NCT02378506|18760717|P1|Overall Study|Withdrawal by Subject|4
5432081|NCT02378506|18760717|P1|Overall Study|Lack of Efficacy|3
5432082|NCT02378480|18760736|P2|Overall Study|Lost to Follow-up|18
5432083|NCT02378480|18760737|P1|Overall Study|Lost to Follow-up|10
5432084|NCT02378480|18760736|P2|Overall Study|Withdrawal by Subject|4
5432085|NCT02378480|18760737|P1|Overall Study|Withdrawal by Subject|9
5432086|NCT02378480|18760736|P2|Overall Study|Missed EOT/PTE Visit|2
5432087|NCT02378480|18760737|P1|Overall Study|Missed EOT/PTE Visit|1
5432088|NCT02378480|18760736|P2|Overall Study|Adverse Event|1
5432089|NCT02378480|18760737|P1|Overall Study|Adverse Event|0
5432090|NCT02378480|18760736|P2|Overall Study|Randomized, but Not Treated|4
5432091|NCT02378480|18760737|P1|Overall Study|Randomized, but Not Treated|6
5432092|NCT02378480|18760736|P2|Overall Study|Death|2
5432093|NCT02378480|18760737|P1|Overall Study|Death|1
5432094|NCT02378480|18760736|P2|Overall Study|Physician Decision|1
5432095|NCT02378480|18760737|P1|Overall Study|Physician Decision|1
5432096|NCT02378220|18760764|P2|Overall Study|Death|1
5432097|NCT02378220|18760765|P1|Overall Study|Death|6
5432098|NCT02377921|18760863|P2|Overall Study|Subject non-compliance|1
5432099|NCT02377921|18760864|P1|Overall Study|Subject non-compliance|1
5432100|NCT02377817|18760888|P2|Overall Study|Unrelated injury prevented lateral sleep|0
5432101|NCT02377817|18760889|P1|Overall Study|Unrelated injury prevented lateral sleep|1
5432102|NCT02377817|18760888|P2|Overall Study|Transportation/childcare barriers.|0
5432103|NCT02377817|18760889|P1|Overall Study|Transportation/childcare barriers.|2
5432104|NCT02377466|18760964|P2|Overall Study|Other: Randomized and not treated|2
5432105|NCT02377466|18760965|P1|Overall Study|Other: Randomized and not treated|0
5432106|NCT02377427|18761083|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5432107|NCT02377427|18761084|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5432108|NCT02377427|18761085|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
5432109|NCT02377427|18761086|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5432110|NCT02377427|18761087|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
5432111|NCT02377427|18761083|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
5432112|NCT02377427|18761084|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
5432113|NCT02377427|18761085|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
5432114|NCT02377427|18761086|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
5432115|NCT02377427|18761087|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
5432116|NCT02377427|18761083|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5432117|NCT02377427|18761084|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5432118|NCT02377427|18761085|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5432119|NCT02377427|18761086|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
5432120|NCT02377427|18761087|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
5432121|NCT02377427|18761083|P5|Part A (Up to Week 20)|Physician Decision|0
5432122|NCT02377427|18761084|P4|Part A (Up to Week 20)|Physician Decision|0
5432123|NCT02377427|18761085|P3|Part A (Up to Week 20)|Physician Decision|0
5432124|NCT02377427|18761086|P2|Part A (Up to Week 20)|Physician Decision|0
5432125|NCT02377427|18761087|P1|Part A (Up to Week 20)|Physician Decision|1
5432126|NCT02377362|18761160|P13|Part B Overall|Withdrawal by Subject|0
5432127|NCT02377362|18761161|P12|Part B Overall|Withdrawal by Subject|1
5432128|NCT02377362|18761162|P11|Part B Overall|Withdrawal by Subject|0
5432129|NCT02377362|18761163|P10|Part B Overall|Withdrawal by Subject|0
5432130|NCT02377362|18761164|P9|Part B Overall|Withdrawal by Subject|0
5432131|NCT02377362|18761165|P8|Part B Overall|Withdrawal by Subject|0
5432132|NCT02377362|18761166|P7|Part B Overall|Withdrawal by Subject|1
5432133|NCT02377362|18761167|P6|Part B Overall|Withdrawal by Subject|0
5432134|NCT02377362|18761168|P5|Part B Overall|Withdrawal by Subject|0
5432135|NCT02377362|18761169|P4|Part B Overall|Withdrawal by Subject|0
5432136|NCT02377362|18761170|P3|Part B Overall|Withdrawal by Subject|0
5432137|NCT02377362|18761171|P2|Part B Overall|Withdrawal by Subject|0
5432138|NCT02377362|18761172|P1|Part B Overall|Withdrawal by Subject|0
5432139|NCT02377362|18761160|P13|Part B Overall|Adverse Event|0
5432140|NCT02377362|18761161|P12|Part B Overall|Adverse Event|0
5432141|NCT02377362|18761162|P11|Part B Overall|Adverse Event|0
5432142|NCT02377362|18761163|P10|Part B Overall|Adverse Event|0
5432143|NCT02377362|18761164|P9|Part B Overall|Adverse Event|0
5432144|NCT02377362|18761165|P8|Part B Overall|Adverse Event|1
5432145|NCT02377362|18761166|P7|Part B Overall|Adverse Event|1
5432146|NCT02377362|18761167|P6|Part B Overall|Adverse Event|0
5432147|NCT02377362|18761168|P5|Part B Overall|Adverse Event|0
5432148|NCT02377362|18761169|P4|Part B Overall|Adverse Event|0
5432149|NCT02377362|18761170|P3|Part B Overall|Adverse Event|0
5432150|NCT02377362|18761171|P2|Part B Overall|Adverse Event|0
5432151|NCT02377362|18761172|P1|Part B Overall|Adverse Event|0
5432152|NCT02377362|18761160|P13|Part B Overall|Protocol Violation|0
5432153|NCT02377362|18761161|P12|Part B Overall|Protocol Violation|0
5432154|NCT02377362|18761162|P11|Part B Overall|Protocol Violation|0
5432155|NCT02377362|18761163|P10|Part B Overall|Protocol Violation|1
5432156|NCT02377362|18761164|P9|Part B Overall|Protocol Violation|0
5432157|NCT02377362|18761165|P8|Part B Overall|Protocol Violation|0
5432158|NCT02377362|18761166|P7|Part B Overall|Protocol Violation|0
5432159|NCT02377362|18761167|P6|Part B Overall|Protocol Violation|0
5432160|NCT02377362|18761168|P5|Part B Overall|Protocol Violation|0
5432161|NCT02377362|18761169|P4|Part B Overall|Protocol Violation|0
5432162|NCT02377362|18761170|P3|Part B Overall|Protocol Violation|0
5432163|NCT02377362|18761171|P2|Part B Overall|Protocol Violation|0
5432164|NCT02377362|18761172|P1|Part B Overall|Protocol Violation|0
5432165|NCT02377362|18761160|P13|Part A Third Treatment|Highest dose level 1200 not used|0
5432166|NCT02377362|18761161|P12|Part A Third Treatment|Highest dose level 1200 not used|0
5432167|NCT02377362|18761162|P11|Part A Third Treatment|Highest dose level 1200 not used|0
5432168|NCT02377362|18761163|P10|Part A Third Treatment|Highest dose level 1200 not used|0
5432169|NCT02377362|18761164|P9|Part A Third Treatment|Highest dose level 1200 not used|0
5432170|NCT02377362|18761165|P8|Part A Third Treatment|Highest dose level 1200 not used|0
5432171|NCT02377362|18761166|P7|Part A Third Treatment|Highest dose level 1200 not used|0
5432172|NCT02377362|18761167|P6|Part A Third Treatment|Highest dose level 1200 not used|4
5432173|NCT02377362|18761168|P5|Part A Third Treatment|Highest dose level 1200 not used|3
5432174|NCT02377362|18761169|P4|Part A Third Treatment|Highest dose level 1200 not used|4
5432175|NCT02377362|18761170|P3|Part A Third Treatment|Highest dose level 1200 not used|0
5432176|NCT02377362|18761171|P2|Part A Third Treatment|Highest dose level 1200 not used|0
5432177|NCT02377362|18761172|P1|Part A Third Treatment|Highest dose level 1200 not used|0
5432178|NCT02377362|18761160|P13|Part A Second Treatment|Protocol Violation|0
5432179|NCT02377362|18761161|P12|Part A Second Treatment|Protocol Violation|0
5432180|NCT02377362|18761162|P11|Part A Second Treatment|Protocol Violation|0
5432181|NCT02377362|18761163|P10|Part A Second Treatment|Protocol Violation|0
5432182|NCT02377362|18761164|P9|Part A Second Treatment|Protocol Violation|0
5432183|NCT02377362|18761165|P8|Part A Second Treatment|Protocol Violation|0
5432184|NCT02377362|18761166|P7|Part A Second Treatment|Protocol Violation|0
5432185|NCT02377362|18761167|P6|Part A Second Treatment|Protocol Violation|0
5432186|NCT02377362|18761168|P5|Part A Second Treatment|Protocol Violation|1
5432187|NCT02377362|18761169|P4|Part A Second Treatment|Protocol Violation|0
5432188|NCT02377362|18761170|P3|Part A Second Treatment|Protocol Violation|0
5432189|NCT02377362|18761171|P2|Part A Second Treatment|Protocol Violation|0
5432190|NCT02377362|18761172|P1|Part A Second Treatment|Protocol Violation|0
5432191|NCT02377349|18761381|P2|Overall Study|Other|1
5432192|NCT02377349|18761382|P1|Overall Study|Other|0
5432193|NCT02377349|18761381|P2|Overall Study|Lost to follow-up (complete vaccination)|5
5432194|NCT02377349|18761382|P1|Overall Study|Lost to follow-up (complete vaccination)|6
5432195|NCT02377349|18761381|P2|Overall Study|Lost to follow-up (partial vaccination)|0
5432196|NCT02377349|18761382|P1|Overall Study|Lost to follow-up (partial vaccination)|1
5432197|NCT02377349|18761381|P2|Overall Study|Withdrawal by Subject|3
5432198|NCT02377349|18761382|P1|Overall Study|Withdrawal by Subject|5
5432199|NCT02377349|18761381|P2|Overall Study|Protocol Violation|2
5432200|NCT02377349|18761382|P1|Overall Study|Protocol Violation|3
5432201|NCT02377349|18761381|P2|Overall Study|Serious Adverse Event|0
5432202|NCT02377349|18761382|P1|Overall Study|Serious Adverse Event|1
5432203|NCT02377063|18761420|P1|Overall Study|Non-compliance|5
5432204|NCT02376790|18761438|P3|Overall Study|Lost to Follow-up|12
5432205|NCT02376790|18761439|P2|Overall Study|Lost to Follow-up|10
5432206|NCT02376790|18761440|P1|Overall Study|Lost to Follow-up|15
5432207|NCT02376790|18761438|P3|Overall Study|Decision by Sponsor|4
5432208|NCT02376790|18761439|P2|Overall Study|Decision by Sponsor|1
5432209|NCT02376790|18761440|P1|Overall Study|Decision by Sponsor|2
5432210|NCT02376790|18761438|P3|Overall Study|Withdrawal by Subject|37
5432211|NCT02376790|18761439|P2|Overall Study|Withdrawal by Subject|36
5432212|NCT02376790|18761440|P1|Overall Study|Withdrawal by Subject|43
5432213|NCT02376166|18761631|P1|Overall Study|Discontinued metformin early|2
5432214|NCT02376166|18761631|P1|Overall Study|Adverse Event|1
5432215|NCT02375971|18761659|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
5432216|NCT02375971|18761660|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
5432217|NCT02375971|18761661|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
5432218|NCT02375971|18761659|P3|Follow-Up Phase (up to Day 169)|Death|4
5432219|NCT02375971|18761660|P2|Follow-Up Phase (up to Day 169)|Death|4
5432220|NCT02375971|18761661|P1|Follow-Up Phase (up to Day 169)|Death|4
5432221|NCT02375971|18761659|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
5432222|NCT02375971|18761660|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
5432223|NCT02375971|18761661|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
5432224|NCT02375971|18761659|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
5432225|NCT02375971|18761660|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
5432226|NCT02375971|18761661|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
5432227|NCT02375971|18761659|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
5432228|NCT02375971|18761660|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
5432229|NCT02375971|18761661|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
5432230|NCT02375971|18761659|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
5432231|NCT02375971|18761660|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
5432232|NCT02375971|18761661|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
5432233|NCT02375971|18761659|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
5432234|NCT02375971|18761660|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
5432235|NCT02375971|18761661|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
5432236|NCT02375971|18761659|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
5432237|NCT02375971|18761660|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
5432238|NCT02375971|18761661|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
5432239|NCT02375724|18761703|P2|Overall Study|Adverse Event|4
5432240|NCT02375724|18761704|P1|Overall Study|Adverse Event|2
5432241|NCT02375724|18761703|P2|Overall Study|Protocol Violation|0
5432242|NCT02375724|18761704|P1|Overall Study|Protocol Violation|1
5432243|NCT02375724|18761703|P2|Overall Study|Lost to Follow-up|0
5432244|NCT02375724|18761704|P1|Overall Study|Lost to Follow-up|1
5432245|NCT02375724|18761703|P2|Overall Study|Withdrawal by Subject|1
5432246|NCT02375724|18761704|P1|Overall Study|Withdrawal by Subject|1
5432247|NCT02375724|18761703|P2|Overall Study|Lack of Efficacy|1
5432248|NCT02375724|18761704|P1|Overall Study|Lack of Efficacy|1
5432249|NCT02375698|18761716|P2|Overall Study|Physician Decision|0
5432250|NCT02375698|18761717|P1|Overall Study|Physician Decision|2
5432251|NCT02375698|18761716|P2|Overall Study|Withdrawal by Subject|2
5432252|NCT02375698|18761717|P1|Overall Study|Withdrawal by Subject|0
5432253|NCT02375373|18761725|P1|Overall Study|Withdrawal by Subject|11
5432254|NCT02375347|18761729|P1|Overall Study|Protocol Violation|1
5432255|NCT02374957|18761735|P2|Overall Study|Patient did not complete forms correctly|0
5432256|NCT02374957|18761736|P1|Overall Study|Patient did not complete forms correctly|1
5432257|NCT02374671|18761765|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
5432258|NCT02374671|18761766|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
5432259|NCT02374671|18761767|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
5432260|NCT02374671|18761765|P3|Implantation- Nonrandomized & Randomized|Adverse Event|1
5432261|NCT02374671|18761766|P2|Implantation- Nonrandomized & Randomized|Adverse Event|0
5432262|NCT02374671|18761767|P1|Implantation- Nonrandomized & Randomized|Adverse Event|7
5432263|NCT02374671|18761765|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
5432264|NCT02374671|18761766|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
5432265|NCT02374671|18761767|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
5432266|NCT02374671|18761765|P3|Observation (Deferred Implantation)|Adverse Event|1
5432267|NCT02374671|18761766|P2|Observation (Deferred Implantation)|Adverse Event|0
5432268|NCT02374671|18761767|P1|Observation (Deferred Implantation)|Adverse Event|0
5432269|NCT02374671|18761765|P3|Observation (Deferred Implantation)|Withdrawal by Subject|4
5432270|NCT02374671|18761766|P2|Observation (Deferred Implantation)|Withdrawal by Subject|0
5432271|NCT02374671|18761767|P1|Observation (Deferred Implantation)|Withdrawal by Subject|0
5432272|NCT02374593|18761775|P2|Overall Study|non-compliant|0
5432273|NCT02374593|18761776|P1|Overall Study|non-compliant|2
5432274|NCT02374463|18761788|P2|Overall Study|Withdrawal by Subject|3
5432275|NCT02374463|18761789|P1|Overall Study|Withdrawal by Subject|3
5432276|NCT02374346|18761838|P1|Overall Study|operated or discharged during weekend|48
5432277|NCT02374307|18761846|P2|6-months Follow-up|Withdrawal by Subject|3
5432278|NCT02374307|18761847|P1|6-months Follow-up|Withdrawal by Subject|0
5432279|NCT02374307|18761846|P2|6-months Follow-up|Death|1
5432280|NCT02374307|18761847|P1|6-months Follow-up|Death|2
5432281|NCT02374307|18761846|P2|6-months Follow-up|Lost to Follow-up|2
5432282|NCT02374307|18761847|P1|6-months Follow-up|Lost to Follow-up|1
5432283|NCT02374307|18761846|P2|3-months Follow-up|Missed first follow-up|1
5432284|NCT02374307|18761847|P1|3-months Follow-up|Missed first follow-up|5
5432285|NCT02374307|18761846|P2|3-months Follow-up|Death|2
5432286|NCT02374307|18761847|P1|3-months Follow-up|Death|1
5432287|NCT02374307|18761846|P2|3-months Follow-up|Withdrawal by Subject|4
5432288|NCT02374307|18761847|P1|3-months Follow-up|Withdrawal by Subject|1
5432289|NCT02374307|18761846|P2|3-months Follow-up|Lost to Follow-up|2
5432290|NCT02374307|18761847|P1|3-months Follow-up|Lost to Follow-up|1
5432291|NCT02374255|18761878|P4|Overall Study|Withdrawal by Subject|0
5432292|NCT02374255|18761879|P3|Overall Study|Withdrawal by Subject|0
5432293|NCT02374255|18761880|P2|Overall Study|Withdrawal by Subject|0
5432294|NCT02374255|18761881|P1|Overall Study|Withdrawal by Subject|2
5432295|NCT02374099|18761982|P2|Overall Study|Study Terminated by Sponsor|4
5432296|NCT02374099|18761983|P1|Overall Study|Study Terminated by Sponsor|3
5432297|NCT02374099|18761982|P2|Overall Study|Randomized, but not treated|1
5432298|NCT02374099|18761983|P1|Overall Study|Randomized, but not treated|2
5432299|NCT02374099|18761982|P2|Overall Study|Miscellaneous|3
5432300|NCT02374099|18761983|P1|Overall Study|Miscellaneous|2
5432301|NCT02374099|18761982|P2|Overall Study|Withdrawal by Subject|1
5432302|NCT02374099|18761983|P1|Overall Study|Withdrawal by Subject|5
5432303|NCT02374099|18761982|P2|Overall Study|Progressive Disease|40
5432304|NCT02374099|18761983|P1|Overall Study|Progressive Disease|35
5432305|NCT02374099|18761982|P2|Overall Study|Adverse Event|0
5432306|NCT02374099|18761983|P1|Overall Study|Adverse Event|1
5432307|NCT02373813|18762075|P4|Double-Blind Treatment Period|Withdrawal by Subject|3
5432308|NCT02373813|18762076|P3|Double-Blind Treatment Period|Withdrawal by Subject|6
5432309|NCT02373813|18762077|P2|Double-Blind Treatment Period|Withdrawal by Subject|10
5432310|NCT02373813|18762078|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5432311|NCT02373813|18762075|P4|Double-Blind Treatment Period|Lost to Follow-up|1
5432312|NCT02373813|18762076|P3|Double-Blind Treatment Period|Lost to Follow-up|1
5432313|NCT02373813|18762077|P2|Double-Blind Treatment Period|Lost to Follow-up|0
5432314|NCT02373813|18762078|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5432315|NCT02373813|18762075|P4|Double-Blind Treatment Period|Protocol Violation|0
5432316|NCT02373813|18762076|P3|Double-Blind Treatment Period|Protocol Violation|0
5432317|NCT02373813|18762077|P2|Double-Blind Treatment Period|Protocol Violation|2
5432318|NCT02373813|18762078|P1|Double-Blind Treatment Period|Protocol Violation|0
5432319|NCT02373813|18762075|P4|Double-Blind Treatment Period|Decision by Sponsor|0
5432320|NCT02373813|18762076|P3|Double-Blind Treatment Period|Decision by Sponsor|2
5432321|NCT02373813|18762077|P2|Double-Blind Treatment Period|Decision by Sponsor|1
5432322|NCT02373813|18762078|P1|Double-Blind Treatment Period|Decision by Sponsor|0
5432323|NCT02373813|18762075|P4|Run-In Period|Ineligibility Determined|0
5432324|NCT02373813|18762076|P3|Run-In Period|Ineligibility Determined|0
5432325|NCT02373813|18762077|P2|Run-In Period|Ineligibility Determined|0
5432326|NCT02373813|18762078|P1|Run-In Period|Ineligibility Determined|3
5432327|NCT02373813|18762075|P4|Run-In Period|Noncompliance|0
5432328|NCT02373813|18762076|P3|Run-In Period|Noncompliance|0
5432329|NCT02373813|18762077|P2|Run-In Period|Noncompliance|0
5432330|NCT02373813|18762078|P1|Run-In Period|Noncompliance|1
5432331|NCT02373813|18762075|P4|Run-In Period|Adverse Event|0
5432332|NCT02373813|18762076|P3|Run-In Period|Adverse Event|0
5432333|NCT02373813|18762077|P2|Run-In Period|Adverse Event|0
5432334|NCT02373813|18762078|P1|Run-In Period|Adverse Event|3
5432335|NCT02373813|18762075|P4|Run-In Period|Lost to Follow-up|0
5432336|NCT02373813|18762076|P3|Run-In Period|Lost to Follow-up|0
5432337|NCT02373813|18762077|P2|Run-In Period|Lost to Follow-up|0
5432338|NCT02373813|18762078|P1|Run-In Period|Lost to Follow-up|2
5432339|NCT02373813|18762075|P4|Run-In Period|Protocol Violation|0
5432340|NCT02373813|18762076|P3|Run-In Period|Protocol Violation|0
5432341|NCT02373813|18762077|P2|Run-In Period|Protocol Violation|0
5432342|NCT02373813|18762078|P1|Run-In Period|Protocol Violation|75
5432343|NCT02373813|18762075|P4|Run-In Period|Decision by Sponsor|0
5432344|NCT02373813|18762076|P3|Run-In Period|Decision by Sponsor|0
5432345|NCT02373813|18762077|P2|Run-In Period|Decision by Sponsor|0
5432346|NCT02373813|18762078|P1|Run-In Period|Decision by Sponsor|11
5432347|NCT02373813|18762075|P4|Run-In Period|Withdrawal by Subject|0
5432348|NCT02373813|18762076|P3|Run-In Period|Withdrawal by Subject|0
5432349|NCT02373813|18762077|P2|Run-In Period|Withdrawal by Subject|0
5432350|NCT02373813|18762078|P1|Run-In Period|Withdrawal by Subject|16
5432351|NCT02373813|18762075|P4|Run-In Period|Other, Not Specified|0
5432352|NCT02373813|18762076|P3|Run-In Period|Other, Not Specified|0
5432353|NCT02373813|18762077|P2|Run-In Period|Other, Not Specified|0
5432354|NCT02373813|18762078|P1|Run-In Period|Other, Not Specified|5
5432355|NCT02373202|18762150|P4|Overall Study|Other|0
5432356|NCT02373202|18762151|P3|Overall Study|Other|0
5432357|NCT02373202|18762152|P2|Overall Study|Other|1
5432358|NCT02373202|18762153|P1|Overall Study|Other|0
5432359|NCT02373202|18762150|P4|Overall Study|Lack of Efficacy|0
5432360|NCT02373202|18762151|P3|Overall Study|Lack of Efficacy|1
5432361|NCT02373202|18762152|P2|Overall Study|Lack of Efficacy|0
5432362|NCT02373202|18762153|P1|Overall Study|Lack of Efficacy|0
5432363|NCT02373202|18762150|P4|Overall Study|Adverse Event|1
5432364|NCT02373202|18762151|P3|Overall Study|Adverse Event|2
5432365|NCT02373202|18762152|P2|Overall Study|Adverse Event|5
5432366|NCT02373202|18762153|P1|Overall Study|Adverse Event|2
5432367|NCT02373098|18762244|P2|Overall Study|Adverse Event|0
5432368|NCT02373098|18762245|P1|Overall Study|Adverse Event|3
5432369|NCT02373098|18762244|P2|Overall Study|Withdrawal by Subject|0
5432370|NCT02373098|18762245|P1|Overall Study|Withdrawal by Subject|5
5432371|NCT02373098|18762244|P2|Overall Study|Protocol Violation|0
5432372|NCT02373098|18762245|P1|Overall Study|Protocol Violation|3
5432373|NCT02373098|18762244|P2|Overall Study|Lost to Follow-up|0
5432374|NCT02373098|18762245|P1|Overall Study|Lost to Follow-up|1
5432375|NCT02372799|18762273|P3|Down-taper Period|Lost to Follow-up|2
5432376|NCT02372799|18762274|P2|Down-taper Period|Lost to Follow-up|2
5432377|NCT02372799|18762275|P1|Down-taper Period|Lost to Follow-up|1
5432378|NCT02372799|18762273|P3|Treatment Period|Miscellaneous Reasons|0
5432379|NCT02372799|18762274|P2|Treatment Period|Miscellaneous Reasons|1
5432380|NCT02372799|18762275|P1|Treatment Period|Miscellaneous Reasons|1
5432381|NCT02372799|18762273|P3|Treatment Period|Non-compliance with study drug|4
5432382|NCT02372799|18762274|P2|Treatment Period|Non-compliance with study drug|4
5432383|NCT02372799|18762275|P1|Treatment Period|Non-compliance with study drug|4
5432384|NCT02372799|18762273|P3|Treatment Period|Protocol Violation|0
5432385|NCT02372799|18762274|P2|Treatment Period|Protocol Violation|0
5432386|NCT02372799|18762275|P1|Treatment Period|Protocol Violation|3
5432387|NCT02372799|18762273|P3|Treatment Period|Lost to Follow-up|3
5432388|NCT02372799|18762274|P2|Treatment Period|Lost to Follow-up|5
5432389|NCT02372799|18762275|P1|Treatment Period|Lost to Follow-up|11
5432390|NCT02372799|18762273|P3|Treatment Period|Withdrawal by Subject|2
5432391|NCT02372799|18762274|P2|Treatment Period|Withdrawal by Subject|10
5432392|NCT02372799|18762275|P1|Treatment Period|Withdrawal by Subject|10
5432393|NCT02372799|18762273|P3|Treatment Period|Insufficient therapeutic response|0
5432394|NCT02372799|18762274|P2|Treatment Period|Insufficient therapeutic response|2
5432395|NCT02372799|18762275|P1|Treatment Period|Insufficient therapeutic response|2
5432396|NCT02372799|18762273|P3|Treatment Period|Adverse Event|6
5432397|NCT02372799|18762274|P2|Treatment Period|Adverse Event|10
5432398|NCT02372799|18762275|P1|Treatment Period|Adverse Event|3
5432399|NCT02372396|18762304|P2|Overall Study|Lost to Follow-up|9
5432400|NCT02372396|18762305|P1|Overall Study|Lost to Follow-up|7
5432401|NCT02372253|18762329|P2|Overall Study|Non Compliance|0
5432402|NCT02372253|18762330|P1|Overall Study|Non Compliance|2
5432403|NCT02372071|18762375|P1|Overall Study|Protocol Violation|18
5432404|NCT02372058|18762380|P1|Overall Study|Withdrawal by Subject|3
5432405|NCT02371980|18762386|P5|Double-blind Period|Missing|0
5432406|NCT02371980|18762387|P4|Double-blind Period|Missing|0
5432407|NCT02371980|18762388|P3|Double-blind Period|Missing|0
5432408|NCT02371980|18762389|P2|Double-blind Period|Missing|1
5432409|NCT02371980|18762390|P1|Double-blind Period|Missing|0
5432410|NCT02371980|18762386|P5|Double-blind Period|Reason not Specified|1
5432411|NCT02371980|18762387|P4|Double-blind Period|Reason not Specified|2
5432412|NCT02371980|18762388|P3|Double-blind Period|Reason not Specified|3
5432413|NCT02371980|18762389|P2|Double-blind Period|Reason not Specified|3
5432414|NCT02371980|18762390|P1|Double-blind Period|Reason not Specified|0
5432415|NCT02371980|18762386|P5|Double-blind Period|Relapse|26
5432416|NCT02371980|18762387|P4|Double-blind Period|Relapse|25
5432417|NCT02371980|18762388|P3|Double-blind Period|Relapse|25
5432418|NCT02371980|18762389|P2|Double-blind Period|Relapse|50
5432419|NCT02371980|18762390|P1|Double-blind Period|Relapse|0
5432420|NCT02371980|18762386|P5|Double-blind Period|Voluntary Withdrawal|11
5432421|NCT02371980|18762387|P4|Double-blind Period|Voluntary Withdrawal|9
5432422|NCT02371980|18762388|P3|Double-blind Period|Voluntary Withdrawal|8
5432423|NCT02371980|18762389|P2|Double-blind Period|Voluntary Withdrawal|12
5432424|NCT02371980|18762390|P1|Double-blind Period|Voluntary Withdrawal|0
5432425|NCT02371980|18762386|P5|Double-blind Period|Lost to Follow-up|5
5432426|NCT02371980|18762387|P4|Double-blind Period|Lost to Follow-up|6
5432427|NCT02371980|18762388|P3|Double-blind Period|Lost to Follow-up|8
5432428|NCT02371980|18762389|P2|Double-blind Period|Lost to Follow-up|8
5432429|NCT02371980|18762390|P1|Double-blind Period|Lost to Follow-up|0
5432430|NCT02371980|18762386|P5|Double-blind Period|Noncompliance with Study Drug|3
5432431|NCT02371980|18762387|P4|Double-blind Period|Noncompliance with Study Drug|2
5432432|NCT02371980|18762388|P3|Double-blind Period|Noncompliance with Study Drug|2
5432433|NCT02371980|18762389|P2|Double-blind Period|Noncompliance with Study Drug|1
5432434|NCT02371980|18762390|P1|Double-blind Period|Noncompliance with Study Drug|0
5432435|NCT02371980|18762386|P5|Double-blind Period|Significant Protocol Deviation|3
5432436|NCT02371980|18762387|P4|Double-blind Period|Significant Protocol Deviation|3
5432437|NCT02371980|18762388|P3|Double-blind Period|Significant Protocol Deviation|7
5432438|NCT02371980|18762389|P2|Double-blind Period|Significant Protocol Deviation|2
5432439|NCT02371980|18762390|P1|Double-blind Period|Significant Protocol Deviation|0
5432440|NCT02371980|18762386|P5|Double-blind Period|Pretreatment Event/Adverse Event|9
5432441|NCT02371980|18762387|P4|Double-blind Period|Pretreatment Event/Adverse Event|2
5432442|NCT02371980|18762388|P3|Double-blind Period|Pretreatment Event/Adverse Event|3
5432443|NCT02371980|18762389|P2|Double-blind Period|Pretreatment Event/Adverse Event|4
5432444|NCT02371980|18762390|P1|Double-blind Period|Pretreatment Event/Adverse Event|0
5432445|NCT02371980|18762386|P5|Open-label Period|Reason not Specified|0
5432446|NCT02371980|18762387|P4|Open-label Period|Reason not Specified|0
5432447|NCT02371980|18762388|P3|Open-label Period|Reason not Specified|0
5432448|NCT02371980|18762389|P2|Open-label Period|Reason not Specified|0
5432449|NCT02371980|18762390|P1|Open-label Period|Reason not Specified|9
5432450|NCT02371980|18762386|P5|Open-label Period|Did not Meet Randomization Criteria|0
5432451|NCT02371980|18762387|P4|Open-label Period|Did not Meet Randomization Criteria|0
5432452|NCT02371980|18762388|P3|Open-label Period|Did not Meet Randomization Criteria|0
5432453|NCT02371980|18762389|P2|Open-label Period|Did not Meet Randomization Criteria|0
5432454|NCT02371980|18762390|P1|Open-label Period|Did not Meet Randomization Criteria|162
5432455|NCT02371980|18762386|P5|Open-label Period|Lack of Efficacy|0
5432456|NCT02371980|18762387|P4|Open-label Period|Lack of Efficacy|0
5432457|NCT02371980|18762388|P3|Open-label Period|Lack of Efficacy|0
5432458|NCT02371980|18762389|P2|Open-label Period|Lack of Efficacy|0
5432459|NCT02371980|18762390|P1|Open-label Period|Lack of Efficacy|116
5432460|NCT02371980|18762386|P5|Open-label Period|Pregnancy|0
5432461|NCT02371980|18762387|P4|Open-label Period|Pregnancy|0
5432462|NCT02371980|18762388|P3|Open-label Period|Pregnancy|0
5432463|NCT02371980|18762389|P2|Open-label Period|Pregnancy|0
5432464|NCT02371980|18762390|P1|Open-label Period|Pregnancy|1
5432465|NCT02371980|18762386|P5|Open-label Period|Voluntary Withdrawal|0
5432466|NCT02371980|18762387|P4|Open-label Period|Voluntary Withdrawal|0
5432467|NCT02371980|18762388|P3|Open-label Period|Voluntary Withdrawal|0
5432468|NCT02371980|18762389|P2|Open-label Period|Voluntary Withdrawal|0
5432469|NCT02371980|18762390|P1|Open-label Period|Voluntary Withdrawal|91
5432470|NCT02371980|18762386|P5|Open-label Period|Lost to Follow-up|0
5432471|NCT02371980|18762387|P4|Open-label Period|Lost to Follow-up|0
5432472|NCT02371980|18762388|P3|Open-label Period|Lost to Follow-up|0
5432473|NCT02371980|18762389|P2|Open-label Period|Lost to Follow-up|0
5432474|NCT02371980|18762390|P1|Open-label Period|Lost to Follow-up|55
5432475|NCT02371980|18762386|P5|Open-label Period|Noncompliance with Study Drug|0
5432476|NCT02371980|18762387|P4|Open-label Period|Noncompliance with Study Drug|0
5432477|NCT02371980|18762388|P3|Open-label Period|Noncompliance with Study Drug|0
5432478|NCT02371980|18762389|P2|Open-label Period|Noncompliance with Study Drug|0
5432479|NCT02371980|18762390|P1|Open-label Period|Noncompliance with Study Drug|10
5432480|NCT02371980|18762386|P5|Open-label Period|Significant Protocol Deviation|0
5432481|NCT02371980|18762387|P4|Open-label Period|Significant Protocol Deviation|0
5432482|NCT02371980|18762388|P3|Open-label Period|Significant Protocol Deviation|0
5432483|NCT02371980|18762389|P2|Open-label Period|Significant Protocol Deviation|0
5432484|NCT02371980|18762390|P1|Open-label Period|Significant Protocol Deviation|19
5432485|NCT02371980|18762386|P5|Open-label Period|Pretreatment Event/Adverse Event|0
5432486|NCT02371980|18762387|P4|Open-label Period|Pretreatment Event/Adverse Event|0
5432487|NCT02371980|18762388|P3|Open-label Period|Pretreatment Event/Adverse Event|0
5432488|NCT02371980|18762389|P2|Open-label Period|Pretreatment Event/Adverse Event|0
5432489|NCT02371980|18762390|P1|Open-label Period|Pretreatment Event/Adverse Event|63
5432490|NCT02371759|18762450|P8|Overall Study|Withdrawal by Subject|1
5432491|NCT02371759|18762451|P7|Overall Study|Withdrawal by Subject|0
5432492|NCT02371759|18762452|P6|Overall Study|Withdrawal by Subject|0
5432493|NCT02371759|18762453|P5|Overall Study|Withdrawal by Subject|0
5432494|NCT02371759|18762454|P4|Overall Study|Withdrawal by Subject|0
5432495|NCT02371759|18762455|P3|Overall Study|Withdrawal by Subject|0
5432496|NCT02371759|18762456|P2|Overall Study|Withdrawal by Subject|0
5432497|NCT02371759|18762457|P1|Overall Study|Withdrawal by Subject|0
5432498|NCT02371759|18762450|P8|Overall Study|Protocol Violation|3
5432499|NCT02371759|18762451|P7|Overall Study|Protocol Violation|0
5432500|NCT02371759|18762452|P6|Overall Study|Protocol Violation|1
5432501|NCT02371759|18762453|P5|Overall Study|Protocol Violation|3
5432502|NCT02371759|18762454|P4|Overall Study|Protocol Violation|0
5432503|NCT02371759|18762455|P3|Overall Study|Protocol Violation|1
5432504|NCT02371759|18762456|P2|Overall Study|Protocol Violation|1
5432505|NCT02371759|18762457|P1|Overall Study|Protocol Violation|3
5432506|NCT02371746|18762674|P7|Overall Study|Consent withdrawn|1
5432507|NCT02371746|18762675|P6|Overall Study|Consent withdrawn|0
5432508|NCT02371746|18762676|P5|Overall Study|Consent withdrawn|0
5432509|NCT02371746|18762677|P4|Overall Study|Consent withdrawn|0
5432510|NCT02371746|18762678|P3|Overall Study|Consent withdrawn|0
5432511|NCT02371746|18762679|P2|Overall Study|Consent withdrawn|0
5432512|NCT02371746|18762680|P1|Overall Study|Consent withdrawn|0
5432513|NCT02371629|18762723|P2|Overall Study|Protocol deviation|1
5432514|NCT02371629|18762724|P1|Overall Study|Protocol deviation|0
5432515|NCT02371629|18762723|P2|Overall Study|Lack of Efficacy|2
5432516|NCT02371629|18762724|P1|Overall Study|Lack of Efficacy|0
5432517|NCT02371629|18762723|P2|Overall Study|Noncompliance with study treatment|0
5432518|NCT02371629|18762724|P1|Overall Study|Noncompliance with study treatment|1
5432519|NCT02371629|18762723|P2|Overall Study|Death|1
5432520|NCT02371629|18762724|P1|Overall Study|Death|1
5432521|NCT02371629|18762723|P2|Overall Study|Physician Decision|3
5432522|NCT02371629|18762724|P1|Overall Study|Physician Decision|2
5432523|NCT02371629|18762723|P2|Overall Study|Adverse Event|8
5432524|NCT02371629|18762724|P1|Overall Study|Adverse Event|8
5432525|NCT02371629|18762723|P2|Overall Study|Patient decision|10
5432526|NCT02371629|18762724|P1|Overall Study|Patient decision|14
5432527|NCT02371616|18762760|P2|Overall Study|Other (Not specified)|5
5432528|NCT02371616|18762761|P1|Overall Study|Other (Not specified)|1
5432529|NCT02371616|18762760|P2|Overall Study|Withdrawal of Consent|0
5432530|NCT02371616|18762761|P1|Overall Study|Withdrawal of Consent|1
5432531|NCT02371616|18762760|P2|Overall Study|Adverse Event|1
5432532|NCT02371616|18762761|P1|Overall Study|Adverse Event|0
5432533|NCT02371616|18762760|P2|Overall Study|Protocol Violation|1
5432534|NCT02371616|18762761|P1|Overall Study|Protocol Violation|2
5432535|NCT02371369|18762779|P2|Part 2|Death|1
5432536|NCT02371369|18762780|P1|Part 2|Death|0
5432537|NCT02371369|18762779|P2|Part 2|Physician Decision|0
5432538|NCT02371369|18762780|P1|Part 2|Physician Decision|1
5432539|NCT02371369|18762779|P2|Part 2|Withdrawal by Subject|1
5432540|NCT02371369|18762780|P1|Part 2|Withdrawal by Subject|5
5432541|NCT02371369|18762779|P2|Part 2|Adverse Event|2
5432542|NCT02371369|18762780|P1|Part 2|Adverse Event|3
5432543|NCT02371369|18762779|P2|Part 1|Protocol Violation|1
5432544|NCT02371369|18762780|P1|Part 1|Protocol Violation|0
5432545|NCT02371369|18762779|P2|Part 1|Disease progression|1
5432546|NCT02371369|18762780|P1|Part 1|Disease progression|0
5432547|NCT02371369|18762779|P2|Part 1|Withdrawal by Subject|6
5432548|NCT02371369|18762780|P1|Part 1|Withdrawal by Subject|1
5432549|NCT02371369|18762779|P2|Part 1|Adverse Event|0
5432550|NCT02371369|18762780|P1|Part 1|Adverse Event|8
5432551|NCT02371369|18762779|P2|Part 1|Physician Decision|3
5432552|NCT02371369|18762780|P1|Part 1|Physician Decision|0
5432553|NCT02370914|18762871|P1|Overall Study|Protocol Violation|2
5432554|NCT02370888|18762879|P1|Overall Study|did not meet chimerism criteria|6
5432555|NCT02370888|18762879|P1|Overall Study|disease progression|2
5432556|NCT02370784|18762889|P2|Overall Study|Patient started prohibited medication|1
5432557|NCT02370784|18762890|P1|Overall Study|Patient started prohibited medication|0
5432558|NCT02370667|18762905|P3|Overall Study|Lost to Follow-up|0
5432559|NCT02370667|18762906|P2|Overall Study|Lost to Follow-up|1
5432560|NCT02370667|18762907|P1|Overall Study|Lost to Follow-up|0
5432561|NCT02370641|18762971|P2|Overall Study|dropped study|2
5432562|NCT02370641|18762972|P1|Overall Study|dropped study|4
5432563|NCT02370615|18762980|P2|Overall Study|Adverse Event|0
5432564|NCT02370615|18762981|P1|Overall Study|Adverse Event|1
5432565|NCT02370602|18763024|P6|Overall Study|Pretreatment Event/Adverse Event|0
5432566|NCT02370602|18763025|P5|Overall Study|Pretreatment Event/Adverse Event|0
5432567|NCT02370602|18763026|P4|Overall Study|Pretreatment Event/Adverse Event|0
5432568|NCT02370602|18763027|P3|Overall Study|Pretreatment Event/Adverse Event|0
5432569|NCT02370602|18763028|P2|Overall Study|Pretreatment Event/Adverse Event|0
5432570|NCT02370602|18763029|P1|Overall Study|Pretreatment Event/Adverse Event|1
5432571|NCT02370537|18763123|P3|Part B|Withdrawal by Subject|0
5432572|NCT02370537|18763124|P2|Part B|Withdrawal by Subject|1
5432573|NCT02370537|18763125|P1|Part B|Withdrawal by Subject|0
5432574|NCT02370537|18763123|P3|Part B|Not randomised to receive treatment|259
5432575|NCT02370537|18763124|P2|Part B|Not randomised to receive treatment|2
5432576|NCT02370537|18763125|P1|Part B|Not randomised to receive treatment|1
5432577|NCT02370537|18763123|P3|Part A (Open-label Recruitment)|Adverse Event|1
5432578|NCT02370537|18763124|P2|Part A (Open-label Recruitment)|Adverse Event|0
5432579|NCT02370537|18763125|P1|Part A (Open-label Recruitment)|Adverse Event|0
5432580|NCT02370537|18763123|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
5432581|NCT02370537|18763124|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
5432582|NCT02370537|18763125|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
5432583|NCT02370498|18763174|P2|Overall Study|Ongoing In Trial|33
5432584|NCT02370498|18763175|P1|Overall Study|Ongoing In Trial|56
5432585|NCT02370498|18763174|P2|Overall Study|Withdrawal by Subject|11
5432586|NCT02370498|18763175|P1|Overall Study|Withdrawal by Subject|6
5432587|NCT02370498|18763174|P2|Overall Study|Protocol Violation|2
5432588|NCT02370498|18763175|P1|Overall Study|Protocol Violation|1
5432589|NCT02370498|18763174|P2|Overall Study|Lost to Follow-up|0
5432590|NCT02370498|18763175|P1|Overall Study|Lost to Follow-up|1
5432591|NCT02370498|18763174|P2|Overall Study|Death|242
5432592|NCT02370498|18763175|P1|Overall Study|Death|222
5432593|NCT02370498|18763174|P2|Overall Study|Adverse Event|8
5432594|NCT02370498|18763175|P1|Overall Study|Adverse Event|10
5432595|NCT02370420|18763229|P2|Overall Study|Lost to Follow-up|9
5432596|NCT02370420|18763230|P1|Overall Study|Lost to Follow-up|11
5432597|NCT02370420|18763229|P2|Overall Study|Physician Decision|3
5432598|NCT02370420|18763230|P1|Overall Study|Physician Decision|3
5432599|NCT02370394|18763267|P2|Overall Study|Withdrawal by Subject|1
5432600|NCT02370394|18763268|P1|Overall Study|Withdrawal by Subject|0
5432601|NCT02370394|18763267|P2|Overall Study|Lost to Follow-up|1
5432602|NCT02370394|18763268|P1|Overall Study|Lost to Follow-up|2
5432603|NCT02370368|18763284|P2|Overall Study|Withdrawal by Subject|4
5432604|NCT02370368|18763285|P1|Overall Study|Withdrawal by Subject|5
5432605|NCT02370368|18763284|P2|Overall Study|Adverse Event|2
5432606|NCT02370368|18763285|P1|Overall Study|Adverse Event|1
5432607|NCT02370251|18763295|P1|Overall Study|Death|4
5432608|NCT02370251|18763295|P1|Overall Study|Received less than 8 days of Omegaven|7
5432609|NCT02370160|18763301|P3|Overall Study|Death|1
5432610|NCT02370160|18763302|P2|Overall Study|Death|4
5432611|NCT02370160|18763303|P1|Overall Study|Death|3
5432612|NCT02370121|18763327|P2|Overall Study|Lost to Follow-up|1
5432613|NCT02370121|18763328|P1|Overall Study|Lost to Follow-up|1
5432614|NCT02370095|18763368|P2|Overall Study|Withdrawal by Subject|1
5432615|NCT02370095|18763369|P1|Overall Study|Withdrawal by Subject|0
5432616|NCT02370043|18763410|P6|Overall Study|Withdrawal by Subject|1
5432617|NCT02370043|18763411|P5|Overall Study|Withdrawal by Subject|1
5432618|NCT02370043|18763412|P4|Overall Study|Withdrawal by Subject|0
5432619|NCT02370043|18763413|P3|Overall Study|Withdrawal by Subject|0
5432620|NCT02370043|18763414|P2|Overall Study|Withdrawal by Subject|0
5432621|NCT02370043|18763415|P1|Overall Study|Withdrawal by Subject|0
5432622|NCT02369874|18763556|P3|Overall Study|Participant Ongoing|32
5432623|NCT02369874|18763557|P2|Overall Study|Participant Ongoing|45
5432624|NCT02369874|18763558|P1|Overall Study|Participant Ongoing|34
5432625|NCT02369874|18763556|P3|Overall Study|Miscellaneous|0
5432626|NCT02369874|18763557|P2|Overall Study|Miscellaneous|1
5432627|NCT02369874|18763558|P1|Overall Study|Miscellaneous|1
5432628|NCT02369874|18763556|P3|Overall Study|Withdrawal by Subject|27
5432629|NCT02369874|18763557|P2|Overall Study|Withdrawal by Subject|9
5432630|NCT02369874|18763558|P1|Overall Study|Withdrawal by Subject|7
5432631|NCT02369874|18763556|P3|Overall Study|Lost to Follow-up|2
5432632|NCT02369874|18763557|P2|Overall Study|Lost to Follow-up|2
5432633|NCT02369874|18763558|P1|Overall Study|Lost to Follow-up|2
5432634|NCT02369848|18763605|P1|Overall Study|Lost to Follow-up|1
5432635|NCT02369848|18763605|P1|Overall Study|Withdrawal by Subject|2
5432636|NCT02369848|18763605|P1|Overall Study|Death|1
5432637|NCT02369510|18763698|P3|Overall Study|Epidural Activation|5
5432638|NCT02369510|18763699|P2|Overall Study|Epidural Activation|1
5432639|NCT02369510|18763700|P1|Overall Study|Epidural Activation|1
5432640|NCT02369510|18763698|P3|Overall Study|Spilled Medication|1
5432641|NCT02369510|18763699|P2|Overall Study|Spilled Medication|2
5432642|NCT02369510|18763700|P1|Overall Study|Spilled Medication|1
5432643|NCT02369341|18763739|P2|Overall Study|Migrated/moved from study area|0
5432644|NCT02369341|18763740|P1|Overall Study|Migrated/moved from study area|1
5432645|NCT02368886|18763916|P4|Overall Study|Ineligible|1
5432646|NCT02368886|18763917|P3|Overall Study|Ineligible|0
5432647|NCT02368886|18763918|P2|Overall Study|Ineligible|0
5432648|NCT02368886|18763919|P1|Overall Study|Ineligible|0
5432649|NCT02368886|18763916|P4|Overall Study|Cancel|3
5432650|NCT02368886|18763917|P3|Overall Study|Cancel|1
5432651|NCT02368886|18763918|P2|Overall Study|Cancel|1
5432652|NCT02368886|18763919|P1|Overall Study|Cancel|1
5432653|NCT02368691|18763937|P1|Overall Study|Physician Decision|4
5432654|NCT02368691|18763937|P1|Overall Study|Lack of Efficacy|15
5432655|NCT02368691|18763937|P1|Overall Study|Death|13
5432656|NCT02368314|18763982|P2|Overall Study|Adverse Event|2
5432657|NCT02368314|18763983|P1|Overall Study|Adverse Event|1
5432658|NCT02368314|18763982|P2|Overall Study|Withdrawal by Subject|1
5432659|NCT02368314|18763983|P1|Overall Study|Withdrawal by Subject|2
5432660|NCT02368210|18763995|P2|Overall Study|Adverse Event|1
5432661|NCT02368210|18763996|P1|Overall Study|Adverse Event|0
5432662|NCT02368210|18763995|P2|Overall Study|Withdrawal by Subject|0
5432663|NCT02368210|18763996|P1|Overall Study|Withdrawal by Subject|1
5432664|NCT02367911|18764023|P2|Overall Study|Lost to Follow-up|2
5432665|NCT02367911|18764024|P1|Overall Study|Lost to Follow-up|2
5432666|NCT02367911|18764023|P2|Overall Study|Withdrawal by Subject|2
5432667|NCT02367911|18764024|P1|Overall Study|Withdrawal by Subject|3
5432668|NCT02367885|18764035|P3|Overall Study|Withdrawal by Subject|0
5432669|NCT02367885|18764036|P2|Overall Study|Withdrawal by Subject|0
5432670|NCT02367885|18764037|P1|Overall Study|Withdrawal by Subject|1
5432671|NCT02367885|18764035|P3|Overall Study|Lost to Follow-up|0
5432672|NCT02367885|18764036|P2|Overall Study|Lost to Follow-up|0
5432673|NCT02367885|18764037|P1|Overall Study|Lost to Follow-up|1
5432674|NCT02367833|18764280|P3|Overall Study|Withdrawal by Subject|0
5432675|NCT02367833|18764281|P2|Overall Study|Withdrawal by Subject|1
5432676|NCT02367833|18764282|P1|Overall Study|Withdrawal by Subject|1
5432677|NCT02367794|18764321|P3|Overall Study|Hypercalcemia prior to C1D1|1
5432678|NCT02367794|18764322|P2|Overall Study|Hypercalcemia prior to C1D1|0
5432679|NCT02367794|18764323|P1|Overall Study|Hypercalcemia prior to C1D1|0
5432680|NCT02367794|18764321|P3|Overall Study|Patient unable to receive carboplatin|1
5432681|NCT02367794|18764322|P2|Overall Study|Patient unable to receive carboplatin|0
5432682|NCT02367794|18764323|P1|Overall Study|Patient unable to receive carboplatin|0
5432683|NCT02367794|18764321|P3|Overall Study|Randomized in error|1
5432684|NCT02367794|18764322|P2|Overall Study|Randomized in error|0
5432685|NCT02367794|18764323|P1|Overall Study|Randomized in error|0
5432686|NCT02367794|18764321|P3|Overall Study|Brain metastasis|0
5432687|NCT02367794|18764322|P2|Overall Study|Brain metastasis|0
5432688|NCT02367794|18764323|P1|Overall Study|Brain metastasis|1
5432689|NCT02367794|18764321|P3|Overall Study|Withdrawal by Subject|14
5432690|NCT02367794|18764322|P2|Overall Study|Withdrawal by Subject|12
5432691|NCT02367794|18764323|P1|Overall Study|Withdrawal by Subject|25
5432692|NCT02367794|18764321|P3|Overall Study|Protocol Violation|1
5432693|NCT02367794|18764322|P2|Overall Study|Protocol Violation|0
5432694|NCT02367794|18764323|P1|Overall Study|Protocol Violation|1
5432695|NCT02367794|18764321|P3|Overall Study|Physician Decision|1
5432696|NCT02367794|18764322|P2|Overall Study|Physician Decision|3
5432697|NCT02367794|18764323|P1|Overall Study|Physician Decision|0
5432698|NCT02367794|18764321|P3|Overall Study|Lost to Follow-up|1
5432699|NCT02367794|18764322|P2|Overall Study|Lost to Follow-up|2
5432700|NCT02367794|18764323|P1|Overall Study|Lost to Follow-up|1
5432701|NCT02367794|18764321|P3|Overall Study|Death|229
5432702|NCT02367794|18764322|P2|Overall Study|Death|223
5432703|NCT02367794|18764323|P1|Overall Study|Death|230
5432704|NCT02367781|18764336|P2|Overall Study|Administrative-Change Facility|0
5432705|NCT02367781|18764337|P1|Overall Study|Administrative-Change Facility|1
5432706|NCT02367781|18764336|P2|Overall Study|Death Prior First Dose|0
5432707|NCT02367781|18764337|P1|Overall Study|Death Prior First Dose|1
5432708|NCT02367781|18764336|P2|Overall Study|Prolonged Hospitalization|0
5432709|NCT02367781|18764337|P1|Overall Study|Prolonged Hospitalization|1
5432710|NCT02367781|18764336|P2|Overall Study|On-going in study|88
5432711|NCT02367781|18764337|P1|Overall Study|On-going in study|214
5432712|NCT02367781|18764336|P2|Overall Study|Death|136
5432713|NCT02367781|18764337|P1|Overall Study|Death|240
5432714|NCT02367781|18764336|P2|Overall Study|Lost to Follow-up|1
5432715|NCT02367781|18764337|P1|Overall Study|Lost to Follow-up|0
5432716|NCT02367781|18764336|P2|Overall Study|Non-Compliance|0
5432717|NCT02367781|18764337|P1|Overall Study|Non-Compliance|1
5432718|NCT02367781|18764336|P2|Overall Study|Randomized in Error|4
5432719|NCT02367781|18764337|P1|Overall Study|Randomized in Error|5
5432720|NCT02367781|18764336|P2|Overall Study|Physician Decision|0
5432721|NCT02367781|18764337|P1|Overall Study|Physician Decision|1
5432722|NCT02367781|18764336|P2|Overall Study|Protocol Violation|1
5432723|NCT02367781|18764337|P1|Overall Study|Protocol Violation|0
5432724|NCT02367781|18764336|P2|Overall Study|Withdrawal by Subject|10
5432725|NCT02367781|18764337|P1|Overall Study|Withdrawal by Subject|19
5432726|NCT02367729|18764347|P2|Overall Study|Withdrawal by Subject|5
5432727|NCT02367729|18764348|P1|Overall Study|Withdrawal by Subject|0
5432728|NCT02367729|18764347|P2|Overall Study|Adverse Event|2
5432729|NCT02367729|18764348|P1|Overall Study|Adverse Event|1
5432730|NCT02367729|18764347|P2|Overall Study|Organic disorder diagnosed|1
5432731|NCT02367729|18764348|P1|Overall Study|Organic disorder diagnosed|2
5432732|NCT02367716|18764364|P1|Overall Study|Patient did not meet inclusion criteria|1
5432733|NCT02367521|18764388|P2|Overall Study|unable to find transportation|0
5432734|NCT02367521|18764389|P1|Overall Study|unable to find transportation|2
5432735|NCT02367521|18764388|P2|Overall Study|severe headache after intervention|0
5432736|NCT02367521|18764389|P1|Overall Study|severe headache after intervention|2
5432737|NCT02367352|18764467|P3|Overall Study|Adverse Event|0
5432738|NCT02367352|18764468|P2|Overall Study|Adverse Event|0
5432739|NCT02367352|18764469|P1|Overall Study|Adverse Event|1
5432740|NCT02367352|18764467|P3|Overall Study|Participant Received Alternative Therapy|0
5432741|NCT02367352|18764468|P2|Overall Study|Participant Received Alternative Therapy|0
5432742|NCT02367352|18764469|P1|Overall Study|Participant Received Alternative Therapy|1
5432743|NCT02367352|18764467|P3|Overall Study|Progressive disease|0
5432744|NCT02367352|18764468|P2|Overall Study|Progressive disease|0
5432745|NCT02367352|18764469|P1|Overall Study|Progressive disease|7
5432746|NCT02367131|18764519|P1|Overall Study|Other than stated above|20
5432747|NCT02367131|18764519|P1|Overall Study|No change/progressive disease|78
5432748|NCT02367131|18764519|P1|Overall Study|Improvement/remission|2
5432749|NCT02367131|18764519|P1|Overall Study|Request by patient|54
5432750|NCT02367131|18764519|P1|Overall Study|No visit since the first visit|4
5432751|NCT02367131|18764519|P1|Overall Study|Adverse Event|64
5432752|NCT02366936|18764780|P1|Overall Study|Physician Decision|2
5432753|NCT02366936|18764780|P1|Overall Study|Lost to Follow-up|4
5432754|NCT02366936|18764780|P1|Overall Study|Withdrawal by Subject|2
5432755|NCT02366923|18764785|P1|Overall Study|High Astigmatism|3
5432756|NCT02366923|18764785|P1|Overall Study|Positive Slit Lamp Findings|2
5432757|NCT02366923|18764785|P1|Overall Study|Withdrawal by Subject|1
5432758|NCT02366910|18764798|P1|Overall Study|Screen Failure|3
5432759|NCT02366910|18764798|P1|Overall Study|Withdrawal by Subject|2
5432760|NCT02366767|18764846|P2|Overall Study|left for home after 1 day at camp|0
5432761|NCT02366767|18764847|P1|Overall Study|left for home after 1 day at camp|1
5432762|NCT02366689|18764860|P3|Overall Study|Pregnancy|1
5432763|NCT02366689|18764861|P2|Overall Study|Pregnancy|1
5432764|NCT02366689|18764862|P1|Overall Study|Pregnancy|0
5432765|NCT02366689|18764860|P3|Overall Study|Lost to Follow-up|0
5432766|NCT02366689|18764861|P2|Overall Study|Lost to Follow-up|2
5432767|NCT02366689|18764862|P1|Overall Study|Lost to Follow-up|3
5432768|NCT02366689|18764860|P3|Overall Study|Withdrawal by Subject|1
5432769|NCT02366689|18764861|P2|Overall Study|Withdrawal by Subject|0
5432770|NCT02366689|18764862|P1|Overall Study|Withdrawal by Subject|1
5432771|NCT02366637|18764914|P2|Second Intervention Period|Study Terminated by Sponsor|1
5432772|NCT02366637|18764915|P1|Second Intervention Period|Study Terminated by Sponsor|1
5432773|NCT02366637|18764914|P2|First Intervention Period|Study Terminated by Sponsor|4
5432774|NCT02366637|18764915|P1|First Intervention Period|Study Terminated by Sponsor|6
5432775|NCT02366637|18764914|P2|First Intervention Period|Adverse Event|1
5432776|NCT02366637|18764915|P1|First Intervention Period|Adverse Event|0
5432777|NCT02366468|18764941|P2|Overall Study|Other|2
5432778|NCT02366468|18764942|P1|Overall Study|Other|0
5432779|NCT02366468|18764941|P2|Overall Study|Death|2
5432780|NCT02366468|18764942|P1|Overall Study|Death|1
5432781|NCT02366468|18764941|P2|Overall Study|Lost to Follow-up|0
5432782|NCT02366468|18764942|P1|Overall Study|Lost to Follow-up|2
5432783|NCT02366468|18764941|P2|Overall Study|Withdrawal by Subject|5
5432784|NCT02366468|18764942|P1|Overall Study|Withdrawal by Subject|1
5432785|NCT02366468|18764941|P2|Overall Study|Adverse Event|0
5432786|NCT02366468|18764942|P1|Overall Study|Adverse Event|2
5432787|NCT02366195|18764973|P1|Overall Study|Death|26
5432788|NCT02366195|18764973|P1|Overall Study|Lost to Follow-up|1
5432789|NCT02366195|18764973|P1|Overall Study|Withdrawal by Subject|6
5432790|NCT02366195|18764973|P1|Overall Study|Continuing Study|79
5432791|NCT02366143|18764994|P3|Overall Study|Ineligible|0
5432792|NCT02366143|18764995|P2|Overall Study|Ineligible|0
5432793|NCT02366143|18764996|P1|Overall Study|Ineligible|1
5432794|NCT02366143|18764994|P3|Overall Study|PI Move and Site Closure|1
5432795|NCT02366143|18764995|P2|Overall Study|PI Move and Site Closure|1
5432796|NCT02366143|18764996|P1|Overall Study|PI Move and Site Closure|0
5432797|NCT02366143|18764994|P3|Overall Study|Randomization Error|1
5432798|NCT02366143|18764995|P2|Overall Study|Randomization Error|0
5432799|NCT02366143|18764996|P1|Overall Study|Randomization Error|0
5432800|NCT02366143|18764994|P3|Overall Study|Increased Microscopic RBCS on Urinalysis|0
5432801|NCT02366143|18764995|P2|Overall Study|Increased Microscopic RBCS on Urinalysis|0
5432802|NCT02366143|18764996|P1|Overall Study|Increased Microscopic RBCS on Urinalysis|1
5432803|NCT02366143|18764994|P3|Overall Study|On-Going in Study|79
5432804|NCT02366143|18764995|P2|Overall Study|On-Going in Study|101
5432805|NCT02366143|18764996|P1|Overall Study|On-Going in Study|107
5432806|NCT02366143|18764994|P3|Overall Study|Withdrawal by Subject|16
5432807|NCT02366143|18764995|P2|Overall Study|Withdrawal by Subject|21
5432808|NCT02366143|18764996|P1|Overall Study|Withdrawal by Subject|15
5432809|NCT02366143|18764994|P3|Overall Study|Protocol Violation|0
5432810|NCT02366143|18764995|P2|Overall Study|Protocol Violation|2
5432811|NCT02366143|18764996|P1|Overall Study|Protocol Violation|0
5432812|NCT02366143|18764994|P3|Overall Study|Physician Decision|1
5432813|NCT02366143|18764995|P2|Overall Study|Physician Decision|1
5432814|NCT02366143|18764996|P1|Overall Study|Physician Decision|2
5432815|NCT02366143|18764994|P3|Overall Study|Lost to Follow-up|1
5432816|NCT02366143|18764995|P2|Overall Study|Lost to Follow-up|1
5432817|NCT02366143|18764996|P1|Overall Study|Lost to Follow-up|2
5432818|NCT02366143|18764994|P3|Overall Study|Death|301
5432819|NCT02366143|18764995|P2|Overall Study|Death|275
5432820|NCT02366143|18764996|P1|Overall Study|Death|272
5432821|NCT02365636|18765100|P3|Overall Study|Other|0
5432822|NCT02365636|18765101|P2|Overall Study|Other|0
5432823|NCT02365636|18765102|P1|Overall Study|Other|2
5432824|NCT02365636|18765100|P3|Overall Study|Lost to Follow-up|1
5432825|NCT02365636|18765101|P2|Overall Study|Lost to Follow-up|0
5432826|NCT02365636|18765102|P1|Overall Study|Lost to Follow-up|0
5432827|NCT02365636|18765100|P3|Overall Study|Protocol Violation|0
5432828|NCT02365636|18765101|P2|Overall Study|Protocol Violation|4
5432829|NCT02365636|18765102|P1|Overall Study|Protocol Violation|1
5432830|NCT02365636|18765100|P3|Overall Study|Adverse Event|2
5432831|NCT02365636|18765101|P2|Overall Study|Adverse Event|3
5432832|NCT02365636|18765102|P1|Overall Study|Adverse Event|3
5432833|NCT02365584|18765148|P2|Overall Study|Disease Progression|12
5432834|NCT02365584|18765149|P1|Overall Study|Disease Progression|9
5432835|NCT02365584|18765148|P2|Overall Study|Withdrawal by Subject|0
5432836|NCT02365584|18765149|P1|Overall Study|Withdrawal by Subject|1
5432837|NCT02365584|18765148|P2|Overall Study|Adverse Event|2
5432838|NCT02365584|18765149|P1|Overall Study|Adverse Event|2
5432839|NCT02365558|18765173|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
5432840|NCT02365558|18765174|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
5432841|NCT02365558|18765173|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
5432842|NCT02365558|18765174|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
5432843|NCT02365519|18765187|P3|Randomized and Treated|Withdrawal by Subject|1
5432844|NCT02365519|18765188|P2|Randomized and Treated|Withdrawal by Subject|1
5432845|NCT02365519|18765189|P1|Randomized and Treated|Withdrawal by Subject|0
5432846|NCT02365519|18765187|P3|Randomized and Treated|Adverse Event|0
5432847|NCT02365519|18765188|P2|Randomized and Treated|Adverse Event|1
5432848|NCT02365519|18765189|P1|Randomized and Treated|Adverse Event|0
5432849|NCT02365506|18765213|P3|Overall Study|Investigator's Discretion|1
5432850|NCT02365506|18765214|P2|Overall Study|Investigator's Discretion|0
5432851|NCT02365506|18765215|P1|Overall Study|Investigator's Discretion|0
5432852|NCT02365298|18765244|P2|Period 2|Protocol Violation|1
5432853|NCT02365298|18765245|P1|Period 2|Protocol Violation|0
5432854|NCT02365298|18765244|P2|Period 2|Test Article longer available|1
5432855|NCT02365298|18765245|P1|Period 2|Test Article longer available|0
5432856|NCT02365298|18765244|P2|Period 2|Discontinued at request of Sponsor|0
5432857|NCT02365298|18765245|P1|Period 2|Discontinued at request of Sponsor|1
5432858|NCT02365298|18765244|P2|Period 2|incorrect Rx dispensed|0
5432859|NCT02365298|18765245|P1|Period 2|incorrect Rx dispensed|1
5432860|NCT02365285|18765265|P4|Overall Study|Adverse Event|2
5432861|NCT02365285|18765266|P3|Overall Study|Adverse Event|0
5432862|NCT02365285|18765267|P2|Overall Study|Adverse Event|0
5432863|NCT02365285|18765268|P1|Overall Study|Adverse Event|0
5432864|NCT02365285|18765265|P4|Overall Study|Physician Decision|0
5432865|NCT02365285|18765266|P3|Overall Study|Physician Decision|1
5432866|NCT02365285|18765267|P2|Overall Study|Physician Decision|1
5432867|NCT02365285|18765268|P1|Overall Study|Physician Decision|0
5432868|NCT02365233|18765285|P3|Overall Study|IRB withheld the data|2
5432869|NCT02365233|18765286|P2|Overall Study|IRB withheld the data|2
5432870|NCT02365233|18765287|P1|Overall Study|IRB withheld the data|1
5432871|NCT02365207|18765295|P1|Overall Study|Physician Decision|1
5432872|NCT02365207|18765295|P1|Overall Study|Withdrawal by Subject|1
5432873|NCT02364999|18765301|P2|Overall Study|Randomized but did not receive treatment|3
5432874|NCT02364999|18765302|P1|Overall Study|Randomized but did not receive treatment|2
5432875|NCT02364999|18765301|P2|Overall Study|Other|1
5432876|NCT02364999|18765302|P1|Overall Study|Other|0
5432877|NCT02364999|18765301|P2|Overall Study|Withdrawal by Subject|14
5432878|NCT02364999|18765302|P1|Overall Study|Withdrawal by Subject|14
5432879|NCT02364999|18765301|P2|Overall Study|Protocol Violation|2
5432880|NCT02364999|18765302|P1|Overall Study|Protocol Violation|3
5432881|NCT02364999|18765301|P2|Overall Study|Lost to Follow-up|15
5432882|NCT02364999|18765302|P1|Overall Study|Lost to Follow-up|10
5432883|NCT02364999|18765301|P2|Overall Study|Death|138
5432884|NCT02364999|18765302|P1|Overall Study|Death|136
5432885|NCT02364947|18765328|P3|Overall Study|Death|0
5432886|NCT02364947|18765329|P2|Overall Study|Death|1
5432887|NCT02364947|18765330|P1|Overall Study|Death|0
5432888|NCT02364947|18765328|P3|Overall Study|Physician Decision|5
5432889|NCT02364947|18765329|P2|Overall Study|Physician Decision|2
5432890|NCT02364947|18765330|P1|Overall Study|Physician Decision|3
5432891|NCT02364947|18765328|P3|Overall Study|Protocol Violation|1
5432892|NCT02364947|18765329|P2|Overall Study|Protocol Violation|1
5432893|NCT02364947|18765330|P1|Overall Study|Protocol Violation|1
5432894|NCT02364947|18765328|P3|Overall Study|Adverse Event|11
5432895|NCT02364947|18765329|P2|Overall Study|Adverse Event|33
5432896|NCT02364947|18765330|P1|Overall Study|Adverse Event|45
5432897|NCT02364947|18765328|P3|Overall Study|Withdrawal by Subject|9
5432898|NCT02364947|18765329|P2|Overall Study|Withdrawal by Subject|8
5432899|NCT02364947|18765330|P1|Overall Study|Withdrawal by Subject|10
5432900|NCT02364388|18765499|P1|Overall Study|No Biopsy|2
5432901|NCT02364388|18765499|P1|Overall Study|No OA/US data|2
5432902|NCT02364388|18765499|P1|Overall Study|Technical Failure|3
5432903|NCT02364388|18765499|P1|Overall Study|Protocol Violation|1
5432904|NCT02364336|18765506|P2|Overall Study|Adverse Event|1
5432905|NCT02364336|18765507|P1|Overall Study|Adverse Event|0
5432906|NCT02364180|18765520|P1|Overall Study|Screen Fail|1
5432907|NCT02364037|18765533|P2|Overall Study|Lost to Follow-up|49
5432908|NCT02364037|18765534|P1|Overall Study|Lost to Follow-up|37
5432909|NCT02364037|18765533|P2|Overall Study|Withdrawal by Subject|4
5432910|NCT02364037|18765534|P1|Overall Study|Withdrawal by Subject|7
5432911|NCT02363959|18765567|P2|Overall Study|Medical instability|0
5432912|NCT02363959|18765568|P1|Overall Study|Medical instability|1
5432913|NCT02363946|18765597|P13|Overall Study|Lost to Follow-up|0
5432914|NCT02363946|18765598|P12|Overall Study|Lost to Follow-up|0
5432915|NCT02363946|18765599|P11|Overall Study|Lost to Follow-up|0
5432916|NCT02363946|18765600|P10|Overall Study|Lost to Follow-up|0
5432917|NCT02363946|18765601|P9|Overall Study|Lost to Follow-up|0
5432918|NCT02363946|18765602|P8|Overall Study|Lost to Follow-up|1
5432919|NCT02363946|18765603|P7|Overall Study|Lost to Follow-up|0
5432920|NCT02363946|18765604|P6|Overall Study|Lost to Follow-up|0
5432921|NCT02363946|18765605|P5|Overall Study|Lost to Follow-up|0
5432922|NCT02363946|18765606|P4|Overall Study|Lost to Follow-up|0
5432923|NCT02363946|18765607|P3|Overall Study|Lost to Follow-up|0
5432924|NCT02363946|18765608|P2|Overall Study|Lost to Follow-up|0
5432925|NCT02363946|18765609|P1|Overall Study|Lost to Follow-up|0
5432926|NCT02363478|18765838|P1|Overall Study|Adverse Event|4
5432927|NCT02363478|18765838|P1|Overall Study|Lost to Follow-up|4
5432928|NCT02363439|18765845|P1|Overall Study|Lack of Efficacy|4
5432929|NCT02363322|18765851|P2|Overall Study|Lost to Follow-up|0
5432930|NCT02363322|18765852|P1|Overall Study|Lost to Follow-up|1
5432931|NCT02363283|18765862|P1|Overall Study|Not eligible due to transaminitis|1
5432932|NCT02363283|18765862|P1|Overall Study|Withdrawal by Subject|1
5432933|NCT02362789|18765881|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
5432934|NCT02362789|18765882|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
5432935|NCT02362789|18765883|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
5432936|NCT02362789|18765881|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
5432937|NCT02362789|18765882|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
5432938|NCT02362789|18765883|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
5432939|NCT02362789|18765881|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
5432940|NCT02362789|18765882|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
5432941|NCT02362789|18765883|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
5432942|NCT02362789|18765881|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
5432943|NCT02362789|18765882|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
5432944|NCT02362789|18765883|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
5432945|NCT02362789|18765881|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
5432946|NCT02362789|18765882|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
5432947|NCT02362789|18765883|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
5432948|NCT02362724|18765892|P2|Overall Study|Adverse Event|0
5432949|NCT02362724|18765893|P1|Overall Study|Adverse Event|3
5432950|NCT02362724|18765892|P2|Overall Study|Withdrawal by Subject|1
5432951|NCT02362724|18765893|P1|Overall Study|Withdrawal by Subject|3
5432952|NCT02362646|18765952|P2|Overall Study|received transplant|14
5432953|NCT02362646|18765953|P1|Overall Study|received transplant|21
5432954|NCT02362646|18765952|P2|Overall Study|Withdrawal by Subject|2
5432955|NCT02362646|18765953|P1|Overall Study|Withdrawal by Subject|2
5432956|NCT02362646|18765952|P2|Overall Study|Death|8
5432957|NCT02362646|18765953|P1|Overall Study|Death|15
5432958|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
5432959|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
5432960|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
5432961|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
5432962|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
5432963|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
5432964|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
5432965|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
5432966|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
5432967|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
5432968|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
5432969|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
5432970|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
5432971|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
5432972|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
5432973|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
5432974|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
5432975|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
5432976|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
5432977|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
5432978|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
5432979|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
5432980|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
5432981|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
5432982|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
5432983|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
5432984|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
5432985|NCT02362503|18765985|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
5432986|NCT02362503|18765986|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
5432987|NCT02362503|18765987|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
5432988|NCT02362503|18765985|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
5432989|NCT02362503|18765986|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
5432990|NCT02362503|18765987|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
5432991|NCT02362503|18765985|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
5432992|NCT02362503|18765986|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
5432993|NCT02362503|18765987|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
5432994|NCT02362503|18765985|P3|Double-blind Period-Up to 8 Days|Death|0
5432995|NCT02362503|18765986|P2|Double-blind Period-Up to 8 Days|Death|1
5432996|NCT02362503|18765987|P1|Double-blind Period-Up to 8 Days|Death|1
5432997|NCT02362503|18765985|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
5432998|NCT02362503|18765986|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
5432999|NCT02362503|18765987|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
5433000|NCT02362425|18766016|P4|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
5433001|NCT02362425|18766017|P3|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
5433002|NCT02362425|18766018|P2|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
5433003|NCT02362425|18766019|P1|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
5433004|NCT02362425|18766016|P4|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
5433005|NCT02362425|18766017|P3|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
5433006|NCT02362425|18766018|P2|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
5433007|NCT02362425|18766019|P1|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
5433008|NCT02362425|18766016|P4|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
5433009|NCT02362425|18766017|P3|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
5433010|NCT02362425|18766018|P2|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
5433011|NCT02362425|18766019|P1|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
5433012|NCT02362425|18766016|P4|Phase 1 (up to 6 Months)|Study closure|0
5433013|NCT02362425|18766017|P3|Phase 1 (up to 6 Months)|Study closure|0
5433014|NCT02362425|18766018|P2|Phase 1 (up to 6 Months)|Study closure|0
5433015|NCT02362425|18766019|P1|Phase 1 (up to 6 Months)|Study closure|9
5433016|NCT02362425|18766016|P4|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
5433017|NCT02362425|18766017|P3|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
5433018|NCT02362425|18766018|P2|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
5433019|NCT02362425|18766019|P1|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
5433020|NCT02362425|18766016|P4|Phase 1 (up to 6 Months)|Screening failure|0
5433021|NCT02362425|18766017|P3|Phase 1 (up to 6 Months)|Screening failure|0
5433022|NCT02362425|18766018|P2|Phase 1 (up to 6 Months)|Screening failure|0
5433023|NCT02362425|18766019|P1|Phase 1 (up to 6 Months)|Screening failure|1
5433024|NCT02362425|18766016|P4|Phase 1 (up to 6 Months)|Medicinal contraindication|0
5433025|NCT02362425|18766017|P3|Phase 1 (up to 6 Months)|Medicinal contraindication|0
5433026|NCT02362425|18766018|P2|Phase 1 (up to 6 Months)|Medicinal contraindication|0
5433027|NCT02362425|18766019|P1|Phase 1 (up to 6 Months)|Medicinal contraindication|1
5433028|NCT02362425|18766016|P4|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
5433029|NCT02362425|18766017|P3|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
5433030|NCT02362425|18766018|P2|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
5433031|NCT02362425|18766019|P1|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
5433032|NCT02362412|18766137|P2|Treatment Period III|Lost to Follow-up|1
5433033|NCT02362412|18766138|P1|Treatment Period III|Lost to Follow-up|0
5433034|NCT02362360|18766172|P2|Period 1|Withdrawal by Subject|1
5433035|NCT02362360|18766173|P1|Period 1|Withdrawal by Subject|2
5433036|NCT02362360|18766172|P2|Period 1|Lack of Efficacy|0
5433037|NCT02362360|18766173|P1|Period 1|Lack of Efficacy|1
5433038|NCT02362282|18766190|P2|Overall Study|Withdrawal by Subject|0
5433039|NCT02362282|18766191|P1|Overall Study|Withdrawal by Subject|1
5433040|NCT02362269|18766199|P2|Overall Study|Lost to Follow-up|6
5433041|NCT02362269|18766200|P1|Overall Study|Lost to Follow-up|0
5433042|NCT02362269|18766199|P2|Overall Study|Moved|0
5433043|NCT02362269|18766200|P1|Overall Study|Moved|1
5433044|NCT02361762|18766222|P2|Overall Study|Lost to Follow-up|1
5433045|NCT02361762|18766223|P1|Overall Study|Lost to Follow-up|0
5433046|NCT02361762|18766222|P2|Overall Study|Withdrawal by Subject|1
5433047|NCT02361762|18766223|P1|Overall Study|Withdrawal by Subject|0
5433048|NCT02361580|18766274|P2|Overall Study|Lost to Follow-up|3
5433049|NCT02361580|18766275|P1|Overall Study|Lost to Follow-up|6
5433050|NCT02361216|18766304|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
5433051|NCT02361216|18766305|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
5433052|NCT02361216|18766304|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
5433053|NCT02361216|18766305|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
5433054|NCT02361216|18766304|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
5433055|NCT02361216|18766305|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
5433056|NCT02361216|18766304|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
5433057|NCT02361216|18766305|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
5433058|NCT02361216|18766304|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
5433059|NCT02361216|18766305|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
5433060|NCT02361216|18766304|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
5433061|NCT02361216|18766305|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
5433062|NCT02360995|18766320|P3|Overall Study|Withdrawal by Subject|0
5433063|NCT02360995|18766321|P2|Overall Study|Withdrawal by Subject|1
5433064|NCT02360995|18766322|P1|Overall Study|Withdrawal by Subject|0
5433065|NCT02360995|18766320|P3|Overall Study|Lost to Follow-up|2
5433066|NCT02360995|18766321|P2|Overall Study|Lost to Follow-up|0
5433067|NCT02360995|18766322|P1|Overall Study|Lost to Follow-up|2
5433068|NCT02360475|18766386|P4|Overall Study|Migrated/moved from study area|1
5433069|NCT02360475|18766387|P3|Overall Study|Migrated/moved from study area|0
5433070|NCT02360475|18766388|P2|Overall Study|Migrated/moved from study area|0
5433071|NCT02360475|18766389|P1|Overall Study|Migrated/moved from study area|0
5433072|NCT02360475|18766386|P4|Overall Study|Withdrawal by Subject|0
5433073|NCT02360475|18766387|P3|Overall Study|Withdrawal by Subject|2
5433074|NCT02360475|18766388|P2|Overall Study|Withdrawal by Subject|1
5433075|NCT02360475|18766389|P1|Overall Study|Withdrawal by Subject|0
5433076|NCT02360475|18766386|P4|Overall Study|Lost to Follow-up|4
5433077|NCT02360475|18766387|P3|Overall Study|Lost to Follow-up|6
5433078|NCT02360475|18766388|P2|Overall Study|Lost to Follow-up|12
5433079|NCT02360475|18766389|P1|Overall Study|Lost to Follow-up|4
5433080|NCT02360397|18766447|P1|Overall Study|Adverse Event|1
5433081|NCT02360397|18766447|P1|Overall Study|Incomplete screening|3
5433082|NCT02360293|18766473|P2|Overall Study|Excluded|0
5433083|NCT02360293|18766474|P1|Overall Study|Excluded|1
5433084|NCT02360293|18766473|P2|Overall Study|Withdrawal by Subject|1
5433085|NCT02360293|18766474|P1|Overall Study|Withdrawal by Subject|2
5433086|NCT02360293|18766473|P2|Overall Study|Lost to Follow-up|95
5433087|NCT02360293|18766474|P1|Overall Study|Lost to Follow-up|73
5433088|NCT02360280|18766488|P2|Overall Study|Lost to Follow-up|0
5433089|NCT02360280|18766489|P1|Overall Study|Lost to Follow-up|1
5433090|NCT02360280|18766488|P2|Overall Study|Adverse Event|1
5433091|NCT02360280|18766489|P1|Overall Study|Adverse Event|0
5433092|NCT02360280|18766488|P2|Overall Study|Withdrawal by Subject|0
5433093|NCT02360280|18766489|P1|Overall Study|Withdrawal by Subject|2
5433094|NCT02360228|18766504|P3|Overall Study|Unstable symptoms during screening|1
5433095|NCT02360228|18766505|P2|Overall Study|Unstable symptoms during screening|0
5433096|NCT02360228|18766506|P1|Overall Study|Unstable symptoms during screening|0
5433097|NCT02360228|18766504|P3|Overall Study|Self-discontinued medication|0
5433098|NCT02360228|18766505|P2|Overall Study|Self-discontinued medication|1
5433099|NCT02360228|18766506|P1|Overall Study|Self-discontinued medication|0
5433100|NCT02360228|18766504|P3|Overall Study|Withdrawal by Subject|0
5433101|NCT02360228|18766505|P2|Overall Study|Withdrawal by Subject|0
5433102|NCT02360228|18766506|P1|Overall Study|Withdrawal by Subject|1
5433103|NCT02360111|18766601|P1|Overall Study|Death|2
5433104|NCT02360098|18766611|P1|Overall Study|Physician Decision|7
5433105|NCT02359903|18766690|P2|Overall Study|Adverse Event|2
5433106|NCT02359903|18766691|P1|Overall Study|Adverse Event|0
5433107|NCT02359890|18766699|P1|Overall Study|Never treated with study catheter|6
5433108|NCT02359890|18766699|P1|Overall Study|Not meeting eligibility|4
5433109|NCT02359877|18766710|P4|Overall Study|Adverse Event|1
5433110|NCT02359877|18766711|P3|Overall Study|Adverse Event|0
5433111|NCT02359877|18766712|P2|Overall Study|Adverse Event|0
5433112|NCT02359877|18766713|P1|Overall Study|Adverse Event|0
5433113|NCT02359877|18766710|P4|Overall Study|Withdrawal by Subject|2
5433114|NCT02359877|18766711|P3|Overall Study|Withdrawal by Subject|0
5433115|NCT02359877|18766712|P2|Overall Study|Withdrawal by Subject|0
5433116|NCT02359877|18766713|P1|Overall Study|Withdrawal by Subject|1
5433117|NCT02359851|18766763|P1|Overall Study|Disease progression|1
5433118|NCT02359851|18766763|P1|Overall Study|Death|1
5433119|NCT02359552|18766773|P2|Overall Study|Lost to Follow-up|4
5433120|NCT02359552|18766774|P1|Overall Study|Lost to Follow-up|3
5433121|NCT02359435|18766796|P2|Overall Study|Lost to Follow-up|4
5433122|NCT02359435|18766797|P1|Overall Study|Lost to Follow-up|4
5433123|NCT02359045|18766857|P2|Overall Study|Adverse Event|1
5433124|NCT02359045|18766858|P1|Overall Study|Adverse Event|0
5433125|NCT02359045|18766857|P2|Overall Study|Lost to Follow-up|1
5433126|NCT02359045|18766858|P1|Overall Study|Lost to Follow-up|1
5433127|NCT02359045|18766857|P2|Overall Study|Eligibility criteria not fulfilled|1
5433128|NCT02359045|18766858|P1|Overall Study|Eligibility criteria not fulfilled|3
5433129|NCT02358863|18767166|P1|Overall Study|Physician Decision|3
5433130|NCT02358668|18767173|P3|Overall Study|Withdrawal by Subject|0
5433131|NCT02358668|18767174|P2|Overall Study|Withdrawal by Subject|1
5433132|NCT02358668|18767175|P1|Overall Study|Withdrawal by Subject|0
5433133|NCT02358668|18767173|P3|Overall Study|Adverse Event|0
5433134|NCT02358668|18767174|P2|Overall Study|Adverse Event|0
5433135|NCT02358668|18767175|P1|Overall Study|Adverse Event|2
5433136|NCT02358473|18767324|P1|Overall Study|Physician Decision|2
5433137|NCT02358473|18767324|P1|Overall Study|Withdrawal by Subject|2
5433138|NCT02358473|18767324|P1|Overall Study|Adverse Event|3
5433139|NCT02358473|18767324|P1|Overall Study|Disease Progession|6
5433140|NCT02358369|18767336|P5|Treatment Period C|Adverse Event|7
5433141|NCT02358369|18767337|P4|Treatment Period C|Adverse Event|0
5433142|NCT02358369|18767338|P3|Treatment Period C|Adverse Event|0
5433143|NCT02358369|18767339|P2|Treatment Period C|Adverse Event|0
5433144|NCT02358369|18767340|P1|Treatment Period C|Adverse Event|0
5433145|NCT02358369|18767336|P5|Treatment Period A/B|Withdrawal by Subject|0
5433146|NCT02358369|18767337|P4|Treatment Period A/B|Withdrawal by Subject|2
5433147|NCT02358369|18767338|P3|Treatment Period A/B|Withdrawal by Subject|0
5433148|NCT02358369|18767339|P2|Treatment Period A/B|Withdrawal by Subject|2
5433149|NCT02358369|18767340|P1|Treatment Period A/B|Withdrawal by Subject|0
5433150|NCT02358369|18767336|P5|Treatment Period A/B|Death|0
5433151|NCT02358369|18767337|P4|Treatment Period A/B|Death|0
5433152|NCT02358369|18767338|P3|Treatment Period A/B|Death|1
5433153|NCT02358369|18767339|P2|Treatment Period A/B|Death|0
5433154|NCT02358369|18767340|P1|Treatment Period A/B|Death|0
5433155|NCT02358369|18767336|P5|Treatment Period A/B|Adverse Event|0
5433156|NCT02358369|18767337|P4|Treatment Period A/B|Adverse Event|2
5433157|NCT02358369|18767338|P3|Treatment Period A/B|Adverse Event|1
5433158|NCT02358369|18767339|P2|Treatment Period A/B|Adverse Event|0
5433159|NCT02358369|18767340|P1|Treatment Period A/B|Adverse Event|0
5433160|NCT02358369|18767336|P5|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5433161|NCT02358369|18767337|P4|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5433162|NCT02358369|18767338|P3|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5433163|NCT02358369|18767339|P2|Pre-Randomization Washout Period|Not Qualified for Randomization|0
5433164|NCT02358369|18767340|P1|Pre-Randomization Washout Period|Not Qualified for Randomization|35
5433165|NCT02358343|18767386|P5|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5433166|NCT02358343|18767387|P4|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5433167|NCT02358343|18767388|P3|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
5433168|NCT02358343|18767389|P2|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5433169|NCT02358343|18767390|P1|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
5433170|NCT02358343|18767386|P5|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
5433171|NCT02358343|18767387|P4|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
5433172|NCT02358343|18767388|P3|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
5433173|NCT02358343|18767389|P2|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
5433174|NCT02358343|18767390|P1|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
5433175|NCT02358343|18767386|P5|Comparative Efficacy Trial / Observation|Death|0
5433176|NCT02358343|18767387|P4|Comparative Efficacy Trial / Observation|Death|0
5433177|NCT02358343|18767388|P3|Comparative Efficacy Trial / Observation|Death|2
5433178|NCT02358343|18767389|P2|Comparative Efficacy Trial / Observation|Death|0
5433179|NCT02358343|18767390|P1|Comparative Efficacy Trial / Observation|Death|0
5433180|NCT02358343|18767386|P5|Screening Intervention|Determined Ineligible|0
5433181|NCT02358343|18767387|P4|Screening Intervention|Determined Ineligible|0
5433182|NCT02358343|18767388|P3|Screening Intervention|Determined Ineligible|0
5433183|NCT02358343|18767389|P2|Screening Intervention|Determined Ineligible|6
5433184|NCT02358343|18767390|P1|Screening Intervention|Determined Ineligible|5
5433185|NCT02358343|18767386|P5|Screening Intervention|Withdrawal by Subject|0
5433186|NCT02358343|18767387|P4|Screening Intervention|Withdrawal by Subject|0
5433187|NCT02358343|18767388|P3|Screening Intervention|Withdrawal by Subject|0
5433188|NCT02358343|18767389|P2|Screening Intervention|Withdrawal by Subject|0
5433189|NCT02358343|18767390|P1|Screening Intervention|Withdrawal by Subject|1
5433190|NCT02358343|18767386|P5|Screening Intervention|Death|0
5433191|NCT02358343|18767387|P4|Screening Intervention|Death|0
5433192|NCT02358343|18767388|P3|Screening Intervention|Death|0
5433193|NCT02358343|18767389|P2|Screening Intervention|Death|2
5433194|NCT02358343|18767390|P1|Screening Intervention|Death|0
5433195|NCT02358044|18767446|P2|Overall Study|Withdrawal by Subject|4
5433196|NCT02358044|18767447|P1|Overall Study|Withdrawal by Subject|0
5433197|NCT02358044|18767446|P2|Overall Study|Physician Decision|1
5433198|NCT02358044|18767447|P1|Overall Study|Physician Decision|0
5433199|NCT02358044|18767446|P2|Overall Study|Lost to Follow-up|1
5433200|NCT02358044|18767447|P1|Overall Study|Lost to Follow-up|2
5433201|NCT02358044|18767446|P2|Overall Study|Adverse Event|1
5433202|NCT02358044|18767447|P1|Overall Study|Adverse Event|0
5433203|NCT02358031|18767466|P3|Overall Study|Ongoing in Study|33
5433204|NCT02358031|18767467|P2|Overall Study|Ongoing in Study|64
5433205|NCT02358031|18767468|P1|Overall Study|Ongoing in Study|61
5433206|NCT02358031|18767466|P3|Overall Study|Withdrawal by Subject|17
5433207|NCT02358031|18767467|P2|Overall Study|Withdrawal by Subject|12
5433208|NCT02358031|18767468|P1|Overall Study|Withdrawal by Subject|14
5433209|NCT02358031|18767466|P3|Overall Study|Lost to Follow-up|1
5433210|NCT02358031|18767467|P2|Overall Study|Lost to Follow-up|1
5433211|NCT02358031|18767468|P1|Overall Study|Lost to Follow-up|0
5433212|NCT02358031|18767466|P3|Overall Study|Death|249
5433213|NCT02358031|18767467|P2|Overall Study|Death|204
5433214|NCT02358031|18767468|P1|Overall Study|Death|226
5433215|NCT02357940|18767595|P2|Overall Study|Investigator's judgement|1
5433216|NCT02357940|18767596|P1|Overall Study|Investigator's judgement|0
5433217|NCT02357940|18767595|P2|Overall Study|Adverse Event|1
5433218|NCT02357940|18767596|P1|Overall Study|Adverse Event|0
5433219|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
5433220|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
5433221|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
5433222|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
5433223|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
5433224|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
5433225|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
5433226|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
5433227|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
5433228|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
5433229|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
5433230|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
5433231|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
5433232|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
5433233|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
5433234|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
5433235|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
5433236|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
5433237|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
5433238|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
5433239|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
5433240|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
5433241|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
5433242|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
5433243|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
5433244|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
5433245|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
5433246|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
5433247|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
5433248|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
5433249|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
5433250|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
5433251|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
5433252|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
5433253|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
5433254|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
5433255|NCT02357901|18767723|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
5433256|NCT02357901|18767724|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
5433257|NCT02357901|18767725|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
5433258|NCT02357901|18767726|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
5433259|NCT02357901|18767723|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
5433260|NCT02357901|18767724|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
5433261|NCT02357901|18767725|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
5433262|NCT02357901|18767726|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
5433263|NCT02357810|18767776|P1|Follow-up at Treatment Discontinuation|Still in Follow-up|11
5433264|NCT02357810|18767776|P1|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
5433265|NCT02357810|18767776|P1|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
5433266|NCT02357810|18767776|P1|12 Week Response and Further Treatment|Wound Complications|1
5433267|NCT02357810|18767776|P1|12 Week Response and Further Treatment|Progressive Disease|15
5433268|NCT02357810|18767776|P1|12 Week Response and Further Treatment|Withdrawal by Subject|1
5433269|NCT02357810|18767776|P1|12 Week Response and Further Treatment|Adverse Event|5
5433270|NCT02357810|18767776|P1|Reached 12 Weeks Response|Other|1
5433271|NCT02357810|18767776|P1|Reached 12 Weeks Response|Physician Decision|1
5433272|NCT02357810|18767776|P1|Reached 12 Weeks Response|Death|1
5433273|NCT02357810|18767776|P1|Reached 12 Weeks Response|Protocol Violation|1
5433274|NCT02357810|18767776|P1|Reached 12 Weeks Response|Withdrawal by Subject|8
5433275|NCT02357810|18767776|P1|Reached 12 Weeks Response|Progressive Disease|39
5433276|NCT02357810|18767776|P1|Reached 12 Weeks Response|Adverse Event|5
5433277|NCT02357810|18767776|P1|Registered and Started Treatment|Found not to be eligible for the study|26
5433278|NCT02357810|18767776|P1|Registered and Started Treatment|Withdrawal by Subject|1
5433279|NCT02357576|18767826|P2|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
5433280|NCT02357576|18767827|P1|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
5433281|NCT02357576|18767826|P2|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
5433282|NCT02357576|18767827|P1|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
5433283|NCT02357576|18767826|P2|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
5433284|NCT02357576|18767827|P1|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
5433285|NCT02357576|18767826|P2|Neurodevelopmental Outcome Follow Up|Scheduling error|1
5433286|NCT02357576|18767827|P1|Neurodevelopmental Outcome Follow Up|Scheduling error|1
5433287|NCT02357576|18767826|P2|Treatment Period|Physician Decision|1
5433288|NCT02357576|18767827|P1|Treatment Period|Physician Decision|0
5433289|NCT02357576|18767826|P2|Treatment Period|Withdrawal by Subject|1
5433290|NCT02357576|18767827|P1|Treatment Period|Withdrawal by Subject|0
5433291|NCT02357459|18767882|P3|Overall Study|Job Commitments|1
5433292|NCT02357459|18767883|P2|Overall Study|Job Commitments|0
5433293|NCT02357459|18767884|P1|Overall Study|Job Commitments|0
5433294|NCT02357459|18767882|P3|Overall Study|Pre-planned Knee surgery|2
5433295|NCT02357459|18767883|P2|Overall Study|Pre-planned Knee surgery|0
5433296|NCT02357459|18767884|P1|Overall Study|Pre-planned Knee surgery|0
5433297|NCT02357459|18767882|P3|Overall Study|Incarceration|1
5433298|NCT02357459|18767883|P2|Overall Study|Incarceration|0
5433299|NCT02357459|18767884|P1|Overall Study|Incarceration|0
5433300|NCT02357459|18767882|P3|Overall Study|Instruction from PCP|0
5433301|NCT02357459|18767883|P2|Overall Study|Instruction from PCP|0
5433302|NCT02357459|18767884|P1|Overall Study|Instruction from PCP|1
5433303|NCT02357459|18767882|P3|Overall Study|Patient Relocated|0
5433304|NCT02357459|18767883|P2|Overall Study|Patient Relocated|0
5433305|NCT02357459|18767884|P1|Overall Study|Patient Relocated|2
5433306|NCT02357459|18767882|P3|Overall Study|Lack of Efficacy|4
5433307|NCT02357459|18767883|P2|Overall Study|Lack of Efficacy|4
5433308|NCT02357459|18767884|P1|Overall Study|Lack of Efficacy|7
5433309|NCT02357459|18767882|P3|Overall Study|Lost to Follow-up|0
5433310|NCT02357459|18767883|P2|Overall Study|Lost to Follow-up|3
5433311|NCT02357459|18767884|P1|Overall Study|Lost to Follow-up|1
5433312|NCT02357459|18767882|P3|Overall Study|Protocol Violation|0
5433313|NCT02357459|18767883|P2|Overall Study|Protocol Violation|1
5433314|NCT02357459|18767884|P1|Overall Study|Protocol Violation|1
5433315|NCT02357459|18767882|P3|Overall Study|Physician Decision|0
5433316|NCT02357459|18767883|P2|Overall Study|Physician Decision|2
5433317|NCT02357459|18767884|P1|Overall Study|Physician Decision|0
5433318|NCT02357459|18767882|P3|Overall Study|Withdrawal by Subject|3
5433319|NCT02357459|18767883|P2|Overall Study|Withdrawal by Subject|3
5433320|NCT02357459|18767884|P1|Overall Study|Withdrawal by Subject|5
5433321|NCT02357459|18767882|P3|Overall Study|Adverse Event|1
5433322|NCT02357459|18767883|P2|Overall Study|Adverse Event|1
5433323|NCT02357459|18767884|P1|Overall Study|Adverse Event|0
5433324|NCT02357420|18767930|P4|Overall Study|Lost to Follow-up|3
5433325|NCT02357420|18767931|P3|Overall Study|Lost to Follow-up|2
5433326|NCT02357420|18767932|P2|Overall Study|Lost to Follow-up|0
5433327|NCT02357420|18767933|P1|Overall Study|Lost to Follow-up|3
5433328|NCT02357420|18767930|P4|Overall Study|Withdrawn Consent|6
5433329|NCT02357420|18767931|P3|Overall Study|Withdrawn Consent|6
5433330|NCT02357420|18767932|P2|Overall Study|Withdrawn Consent|8
5433331|NCT02357420|18767933|P1|Overall Study|Withdrawn Consent|4
5433332|NCT02357420|18767930|P4|Overall Study|Protocol Non-compliance|1
5433333|NCT02357420|18767931|P3|Overall Study|Protocol Non-compliance|0
5433334|NCT02357420|18767932|P2|Overall Study|Protocol Non-compliance|0
5433335|NCT02357420|18767933|P1|Overall Study|Protocol Non-compliance|0
5433336|NCT02357420|18767930|P4|Overall Study|Prohibited Medication|0
5433337|NCT02357420|18767931|P3|Overall Study|Prohibited Medication|0
5433338|NCT02357420|18767932|P2|Overall Study|Prohibited Medication|1
5433339|NCT02357420|18767933|P1|Overall Study|Prohibited Medication|1
5433340|NCT02357420|18767930|P4|Overall Study|Investigator Decision|0
5433341|NCT02357420|18767931|P3|Overall Study|Investigator Decision|0
5433342|NCT02357420|18767932|P2|Overall Study|Investigator Decision|0
5433343|NCT02357420|18767933|P1|Overall Study|Investigator Decision|1
5433344|NCT02357420|18767930|P4|Overall Study|Adverse Event|9
5433345|NCT02357420|18767931|P3|Overall Study|Adverse Event|8
5433346|NCT02357420|18767932|P2|Overall Study|Adverse Event|3
5433347|NCT02357420|18767933|P1|Overall Study|Adverse Event|3
5433348|NCT02357368|18767996|P4|Overall Study|Withdrawal by Subject|2
5433349|NCT02357368|18767997|P3|Overall Study|Withdrawal by Subject|1
5433350|NCT02357368|18767998|P2|Overall Study|Withdrawal by Subject|1
5433351|NCT02357368|18767999|P1|Overall Study|Withdrawal by Subject|3
5433352|NCT02357368|18767996|P4|Overall Study|Pregnancy|0
5433353|NCT02357368|18767997|P3|Overall Study|Pregnancy|0
5433354|NCT02357368|18767998|P2|Overall Study|Pregnancy|2
5433355|NCT02357368|18767999|P1|Overall Study|Pregnancy|3
5433356|NCT02357368|18767996|P4|Overall Study|Lost to Follow-up|1
5433357|NCT02357368|18767997|P3|Overall Study|Lost to Follow-up|0
5433358|NCT02357368|18767998|P2|Overall Study|Lost to Follow-up|0
5433359|NCT02357368|18767999|P1|Overall Study|Lost to Follow-up|0
5433360|NCT02357342|18768023|P2|First 6 Months|Death|0
5433361|NCT02357342|18768024|P1|First 6 Months|Death|2
5433362|NCT02357147|18768072|P2|Maintenance Treatment Phase|Not Treated|0
5433363|NCT02357147|18768073|P1|Maintenance Treatment Phase|Not Treated|1
5433364|NCT02357147|18768072|P2|Maintenance Treatment Phase|Sponsor Decision|15
5433365|NCT02357147|18768073|P1|Maintenance Treatment Phase|Sponsor Decision|0
5433366|NCT02357147|18768072|P2|Maintenance Treatment Phase|Adverse Event|3
5433367|NCT02357147|18768073|P1|Maintenance Treatment Phase|Adverse Event|0
5433368|NCT02357147|18768072|P2|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
5433369|NCT02357147|18768073|P1|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
5433370|NCT02357147|18768072|P2|Maintenance Treatment Phase|Withdrawal by Subject|1
5433371|NCT02357147|18768073|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
5433372|NCT02357147|18768072|P2|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
5433373|NCT02357147|18768073|P1|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
5433374|NCT02357147|18768072|P2|Combination Treatment Phase|Not treated|2
5433375|NCT02357147|18768073|P1|Combination Treatment Phase|Not treated|0
5433376|NCT02357147|18768072|P2|Combination Treatment Phase|Other|0
5433377|NCT02357147|18768073|P1|Combination Treatment Phase|Other|1
5433378|NCT02357147|18768072|P2|Combination Treatment Phase|Sponsor Decision|12
5433379|NCT02357147|18768073|P1|Combination Treatment Phase|Sponsor Decision|0
5433380|NCT02357147|18768072|P2|Combination Treatment Phase|Death|1
5433381|NCT02357147|18768073|P1|Combination Treatment Phase|Death|1
5433382|NCT02357147|18768072|P2|Combination Treatment Phase|Adverse Event|4
5433383|NCT02357147|18768073|P1|Combination Treatment Phase|Adverse Event|12
5433384|NCT02357147|18768072|P2|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
5433385|NCT02357147|18768073|P1|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
5433386|NCT02357147|18768072|P2|Combination Treatment Phase|Withdrawal by Subject|2
5433387|NCT02357147|18768073|P1|Combination Treatment Phase|Withdrawal by Subject|4
5433388|NCT02357147|18768072|P2|Combination Treatment Phase|Investigator Discretion|1
5433389|NCT02357147|18768073|P1|Combination Treatment Phase|Investigator Discretion|1
5433390|NCT02357147|18768072|P2|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
5433391|NCT02357147|18768073|P1|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
5433392|NCT02357147|18768072|P2|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
5433393|NCT02357147|18768073|P1|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
5433394|NCT02356887|18768104|P1|Overall Study|poor compliance|2
5433395|NCT02356783|18768121|P2|Overall Study|Lost to Follow-up|3
5433396|NCT02356783|18768122|P1|Overall Study|Lost to Follow-up|1
5433397|NCT02356588|18768143|P2|Overall Study|Protocol Violation|1
5433398|NCT02356588|18768144|P1|Overall Study|Protocol Violation|0
5433399|NCT02356588|18768143|P2|Overall Study|Withdrawal by Subject|0
5433400|NCT02356588|18768144|P1|Overall Study|Withdrawal by Subject|1
5433401|NCT02356588|18768143|P2|Overall Study|Adverse Event|2
5433402|NCT02356588|18768144|P1|Overall Study|Adverse Event|0
5433403|NCT02356588|18768143|P2|Overall Study|Lack of Efficacy|10
5433404|NCT02356588|18768144|P1|Overall Study|Lack of Efficacy|4
5433405|NCT02356562|18768261|P2|Overall Study|site closure|0
5433406|NCT02356562|18768262|P1|Overall Study|site closure|1
5433407|NCT02356562|18768261|P2|Overall Study|Re-entered treatment in a previous study|0
5433408|NCT02356562|18768262|P1|Overall Study|Re-entered treatment in a previous study|1
5433409|NCT02356562|18768261|P2|Overall Study|Withdrawal by Subject|1
5433410|NCT02356562|18768262|P1|Overall Study|Withdrawal by Subject|0
5433411|NCT02356211|18768291|P2|Overall Study|ineligible|8
5433412|NCT02356211|18768292|P1|Overall Study|ineligible|1
5433413|NCT02356211|18768291|P2|Overall Study|Withdrawal by Subject|2
5433414|NCT02356211|18768292|P1|Overall Study|Withdrawal by Subject|2
5433415|NCT02355743|18768357|P1|Overall Study|Lost to Follow-up|1
5433416|NCT02355743|18768357|P1|Overall Study|Withdrawal by Subject|1
5433417|NCT02355691|18768365|P2|Overall Study|Loss of Research Personnel|9
5433418|NCT02355691|18768366|P1|Overall Study|Loss of Research Personnel|7
5433419|NCT02355665|18768376|P2|Overall Study|Compliance, PI decision, move, eligible|3
5433420|NCT02355665|18768377|P1|Overall Study|Compliance, PI decision, move, eligible|6
5433421|NCT02355665|18768376|P2|Overall Study|Death|2
5433422|NCT02355665|18768377|P1|Overall Study|Death|4
5433423|NCT02355665|18768376|P2|Overall Study|Lost to Follow-up|103
5433424|NCT02355665|18768377|P1|Overall Study|Lost to Follow-up|131
5433425|NCT02355665|18768376|P2|Overall Study|Withdrawal by Subject|100
5433426|NCT02355665|18768377|P1|Overall Study|Withdrawal by Subject|90
5433427|NCT02355665|18768376|P2|Overall Study|Protocol Violation|0
5433428|NCT02355665|18768377|P1|Overall Study|Protocol Violation|2
5433429|NCT02355665|18768376|P2|Overall Study|Adverse Event|24
5433430|NCT02355665|18768377|P1|Overall Study|Adverse Event|16
5433431|NCT02355028|18768835|P2|Overall Study|Deemed ineligible after randomization|4
5433432|NCT02355028|18768836|P1|Overall Study|Deemed ineligible after randomization|8
5433433|NCT02355028|18768835|P2|Overall Study|Withdrawal by Subject|1
5433434|NCT02355028|18768836|P1|Overall Study|Withdrawal by Subject|1
5433435|NCT02355028|18768835|P2|Overall Study|Adverse Event|0
5433436|NCT02355028|18768836|P1|Overall Study|Adverse Event|2
5433437|NCT02354976|18768872|P3|Overall Study|Adverse Event|2
5433438|NCT02354976|18768873|P2|Overall Study|Adverse Event|0
5433439|NCT02354976|18768874|P1|Overall Study|Adverse Event|1
5433440|NCT02354976|18768872|P3|Overall Study|Study-specifc withdrawal criteria|0
5433441|NCT02354976|18768873|P2|Overall Study|Study-specifc withdrawal criteria|1
5433442|NCT02354976|18768874|P1|Overall Study|Study-specifc withdrawal criteria|0
5433443|NCT02354976|18768872|P3|Overall Study|Other - reason not specified|1
5433444|NCT02354976|18768873|P2|Overall Study|Other - reason not specified|0
5433445|NCT02354976|18768874|P1|Overall Study|Other - reason not specified|1
5433446|NCT02354690|18768937|P1|Overall Study|Physician Decision|1
5433447|NCT02354599|18768951|P6|Overall Study|Withdrawal by Subject|0
5433448|NCT02354599|18768952|P5|Overall Study|Withdrawal by Subject|0
5433449|NCT02354599|18768953|P4|Overall Study|Withdrawal by Subject|0
5433450|NCT02354599|18768954|P3|Overall Study|Withdrawal by Subject|0
5433451|NCT02354599|18768955|P2|Overall Study|Withdrawal by Subject|1
5433452|NCT02354599|18768956|P1|Overall Study|Withdrawal by Subject|1
5433453|NCT02354599|18768951|P6|Overall Study|Pretreatment Event/Adverse Event|1
5433454|NCT02354599|18768952|P5|Overall Study|Pretreatment Event/Adverse Event|0
5433455|NCT02354599|18768953|P4|Overall Study|Pretreatment Event/Adverse Event|0
5433456|NCT02354599|18768954|P3|Overall Study|Pretreatment Event/Adverse Event|0
5433457|NCT02354599|18768955|P2|Overall Study|Pretreatment Event/Adverse Event|0
5433458|NCT02354599|18768956|P1|Overall Study|Pretreatment Event/Adverse Event|0
5433459|NCT02354586|18769026|P1|Overall Study|Disease progression|116
5433460|NCT02354586|18769026|P1|Overall Study|Lost to Follow-up|6
5433461|NCT02354586|18769026|P1|Overall Study|Withdrawal by Subject|51
5433462|NCT02354586|18769026|P1|Overall Study|Death|168
5433463|NCT02354508|18769045|P3|Period 3: Post-treatment Follow up Phase|Physician Decision|1
5433464|NCT02354508|18769046|P2|Period 3: Post-treatment Follow up Phase|Physician Decision|0
5433465|NCT02354508|18769047|P1|Period 3: Post-treatment Follow up Phase|Physician Decision|3
5433466|NCT02354508|18769045|P3|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
5433467|NCT02354508|18769046|P2|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
5433468|NCT02354508|18769047|P1|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
5433469|NCT02354508|18769045|P3|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
5433470|NCT02354508|18769046|P2|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
5433471|NCT02354508|18769047|P1|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
5433472|NCT02354508|18769045|P3|Period 2: Extension Phase|Physician Decision|1
5433473|NCT02354508|18769046|P2|Period 2: Extension Phase|Physician Decision|0
5433474|NCT02354508|18769047|P1|Period 2: Extension Phase|Physician Decision|5
5433475|NCT02354508|18769045|P3|Period 2: Extension Phase|Withdrawal by Subject|0
5433476|NCT02354508|18769046|P2|Period 2: Extension Phase|Withdrawal by Subject|1
5433477|NCT02354508|18769047|P1|Period 2: Extension Phase|Withdrawal by Subject|0
5433478|NCT02354508|18769045|P3|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
5433479|NCT02354508|18769046|P2|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
5433480|NCT02354508|18769047|P1|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
5433481|NCT02354508|18769045|P3|Period 1: Core Phase|Withdrawal by Subject|2
5433482|NCT02354508|18769046|P2|Period 1: Core Phase|Withdrawal by Subject|1
5433483|NCT02354508|18769047|P1|Period 1: Core Phase|Withdrawal by Subject|0
5433484|NCT02354508|18769045|P3|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
5433485|NCT02354508|18769046|P2|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
5433486|NCT02354508|18769047|P1|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
5433487|NCT02354508|18769045|P3|Period 1: Core Phase|Adverse Event|2
5433488|NCT02354508|18769046|P2|Period 1: Core Phase|Adverse Event|1
5433489|NCT02354508|18769047|P1|Period 1: Core Phase|Adverse Event|1
5433490|NCT02354417|18769149|P1|Overall Study|Physician Decision|1
5433491|NCT02354235|18769216|P2|Overall Study|Conflict with the stopping criteria|1
5433492|NCT02354235|18769217|P1|Overall Study|Conflict with the stopping criteria|0
5433493|NCT02354235|18769216|P2|Overall Study|Withdrawal by Subject|3
5433494|NCT02354235|18769217|P1|Overall Study|Withdrawal by Subject|1
5433495|NCT02354235|18769216|P2|Overall Study|Physician Decision|1
5433496|NCT02354235|18769217|P1|Overall Study|Physician Decision|0
5433497|NCT02354235|18769216|P2|Overall Study|Adverse Event|2
5433498|NCT02354235|18769217|P1|Overall Study|Adverse Event|2
5433499|NCT02354222|18769233|P2|Overall Study|Conflict with the stopping criteria|4
5433500|NCT02354222|18769234|P1|Overall Study|Conflict with the stopping criteria|0
5433501|NCT02354222|18769233|P2|Overall Study|Withdrawal by Subject|3
5433502|NCT02354222|18769234|P1|Overall Study|Withdrawal by Subject|2
5433503|NCT02354222|18769233|P2|Overall Study|Pregnancy|0
5433504|NCT02354222|18769234|P1|Overall Study|Pregnancy|1
5433505|NCT02354222|18769233|P2|Overall Study|Physician Decision|1
5433506|NCT02354222|18769234|P1|Overall Study|Physician Decision|1
5433507|NCT02354222|18769233|P2|Overall Study|Adverse Event|3
5433508|NCT02354222|18769234|P1|Overall Study|Adverse Event|0
5433509|NCT02353871|18769265|P2|Overall Study|Lost to Follow-up|0
5433510|NCT02353871|18769266|P1|Overall Study|Lost to Follow-up|2
5433511|NCT02353871|18769265|P2|Overall Study|Consent withdrawn|8
5433512|NCT02353871|18769266|P1|Overall Study|Consent withdrawn|1
5433513|NCT02353871|18769265|P2|Overall Study|Protocol deviation|1
5433514|NCT02353871|18769266|P1|Overall Study|Protocol deviation|0
5433515|NCT02353572|18769359|P1|Overall Study|Study terminated|2
5433516|NCT02353572|18769359|P1|Overall Study|Withdrawal by Subject|1
5433517|NCT02353468|18769363|P1|Overall Study|Study terminated|3
5433518|NCT02353442|18769369|P2|Overall Study|Withdrawal by Subject|4
5433519|NCT02353442|18769370|P1|Overall Study|Withdrawal by Subject|3
5433520|NCT02353169|18769425|P4|Overall Study|Pre-op medication|0
5433521|NCT02353169|18769426|P3|Overall Study|Pre-op medication|1
5433522|NCT02353169|18769427|P2|Overall Study|Pre-op medication|0
5433523|NCT02353169|18769428|P1|Overall Study|Pre-op medication|0
5433524|NCT02353169|18769425|P4|Overall Study|ECG data error|2
5433525|NCT02353169|18769426|P3|Overall Study|ECG data error|2
5433526|NCT02353169|18769427|P2|Overall Study|ECG data error|3
5433527|NCT02353169|18769428|P1|Overall Study|ECG data error|0
5433528|NCT02353169|18769425|P4|Overall Study|Inhalational induction|0
5433529|NCT02353169|18769426|P3|Overall Study|Inhalational induction|0
5433530|NCT02353169|18769427|P2|Overall Study|Inhalational induction|2
5433531|NCT02353169|18769428|P1|Overall Study|Inhalational induction|0
5433532|NCT02353169|18769425|P4|Overall Study|OR team declined|0
5433533|NCT02353169|18769426|P3|Overall Study|OR team declined|0
5433534|NCT02353169|18769427|P2|Overall Study|OR team declined|0
5433535|NCT02353169|18769428|P1|Overall Study|OR team declined|2
5433536|NCT02353169|18769425|P4|Overall Study|QTc > 450 msec|1
5433537|NCT02353169|18769426|P3|Overall Study|QTc > 450 msec|1
5433538|NCT02353169|18769427|P2|Overall Study|QTc > 450 msec|1
5433539|NCT02353169|18769428|P1|Overall Study|QTc > 450 msec|1
5433540|NCT02352948|18769520|P6|Overall Study|Other|0
5433541|NCT02352948|18769521|P5|Overall Study|Other|0
5433542|NCT02352948|18769522|P4|Overall Study|Other|0
5433543|NCT02352948|18769523|P3|Overall Study|Other|2
5433544|NCT02352948|18769524|P2|Overall Study|Other|0
5433545|NCT02352948|18769525|P1|Overall Study|Other|0
5433546|NCT02352948|18769520|P6|Overall Study|Eligibility criteria not fulfilled|0
5433547|NCT02352948|18769521|P5|Overall Study|Eligibility criteria not fulfilled|0
5433548|NCT02352948|18769522|P4|Overall Study|Eligibility criteria not fulfilled|1
5433549|NCT02352948|18769523|P3|Overall Study|Eligibility criteria not fulfilled|0
5433550|NCT02352948|18769524|P2|Overall Study|Eligibility criteria not fulfilled|1
5433551|NCT02352948|18769525|P1|Overall Study|Eligibility criteria not fulfilled|0
5433552|NCT02352948|18769520|P6|Overall Study|Withdrawal by Subject|4
5433553|NCT02352948|18769521|P5|Overall Study|Withdrawal by Subject|9
5433554|NCT02352948|18769522|P4|Overall Study|Withdrawal by Subject|23
5433555|NCT02352948|18769523|P3|Overall Study|Withdrawal by Subject|11
5433556|NCT02352948|18769524|P2|Overall Study|Withdrawal by Subject|10
5433557|NCT02352948|18769525|P1|Overall Study|Withdrawal by Subject|1
5433558|NCT02352948|18769520|P6|Overall Study|Lost to Follow-up|1
5433559|NCT02352948|18769521|P5|Overall Study|Lost to Follow-up|2
5433560|NCT02352948|18769522|P4|Overall Study|Lost to Follow-up|1
5433561|NCT02352948|18769523|P3|Overall Study|Lost to Follow-up|2
5433562|NCT02352948|18769524|P2|Overall Study|Lost to Follow-up|0
5433563|NCT02352948|18769525|P1|Overall Study|Lost to Follow-up|1
5433564|NCT02352948|18769520|P6|Overall Study|Death|44
5433565|NCT02352948|18769521|P5|Overall Study|Death|77
5433566|NCT02352948|18769522|P4|Overall Study|Death|74
5433567|NCT02352948|18769523|P3|Overall Study|Death|114
5433568|NCT02352948|18769524|P2|Overall Study|Death|48
5433569|NCT02352948|18769525|P1|Overall Study|Death|47
5433570|NCT02352779|18769650|P3|Overall Study|No Reason|1
5433571|NCT02352779|18769651|P2|Overall Study|No Reason|0
5433572|NCT02352779|18769652|P1|Overall Study|No Reason|0
5433573|NCT02352779|18769650|P3|Overall Study|Other Medical Reason|1
5433574|NCT02352779|18769651|P2|Overall Study|Other Medical Reason|0
5433575|NCT02352779|18769652|P1|Overall Study|Other Medical Reason|0
5433576|NCT02352779|18769650|P3|Overall Study|Absence of Symptoms|0
5433577|NCT02352779|18769651|P2|Overall Study|Absence of Symptoms|0
5433578|NCT02352779|18769652|P1|Overall Study|Absence of Symptoms|1
5433579|NCT02352779|18769650|P3|Overall Study|Study Related Symptoms|0
5433580|NCT02352779|18769651|P2|Overall Study|Study Related Symptoms|0
5433581|NCT02352779|18769652|P1|Overall Study|Study Related Symptoms|1
5433582|NCT02352779|18769650|P3|Overall Study|Changed Mind|0
5433583|NCT02352779|18769651|P2|Overall Study|Changed Mind|0
5433584|NCT02352779|18769652|P1|Overall Study|Changed Mind|1
5433585|NCT02352779|18769650|P3|Overall Study|Disliked Intervention|0
5433586|NCT02352779|18769651|P2|Overall Study|Disliked Intervention|0
5433587|NCT02352779|18769652|P1|Overall Study|Disliked Intervention|1
5433588|NCT02352779|18769650|P3|Overall Study|Feeling Overwhelmed|0
5433589|NCT02352779|18769651|P2|Overall Study|Feeling Overwhelmed|0
5433590|NCT02352779|18769652|P1|Overall Study|Feeling Overwhelmed|1
5433591|NCT02352779|18769650|P3|Overall Study|Too Many Forms|0
5433592|NCT02352779|18769651|P2|Overall Study|Too Many Forms|0
5433593|NCT02352779|18769652|P1|Overall Study|Too Many Forms|2
5433594|NCT02352779|18769650|P3|Overall Study|Personal Issues|0
5433595|NCT02352779|18769651|P2|Overall Study|Personal Issues|1
5433596|NCT02352779|18769652|P1|Overall Study|Personal Issues|1
5433597|NCT02352493|18769678|P18|Overall Study|Lost to Follow-up|0
5433598|NCT02352493|18769679|P17|Overall Study|Lost to Follow-up|0
5433599|NCT02352493|18769680|P16|Overall Study|Lost to Follow-up|0
5433600|NCT02352493|18769681|P15|Overall Study|Lost to Follow-up|0
5433601|NCT02352493|18769682|P14|Overall Study|Lost to Follow-up|2
5433602|NCT02352493|18769683|P13|Overall Study|Lost to Follow-up|1
5433603|NCT02352493|18769684|P12|Overall Study|Lost to Follow-up|0
5433604|NCT02352493|18769685|P11|Overall Study|Lost to Follow-up|0
5433605|NCT02352493|18769686|P10|Overall Study|Lost to Follow-up|1
5433606|NCT02352493|18769687|P9|Overall Study|Lost to Follow-up|0
5433607|NCT02352493|18769688|P8|Overall Study|Lost to Follow-up|0
5433608|NCT02352493|18769689|P7|Overall Study|Lost to Follow-up|0
5433609|NCT02352493|18769690|P6|Overall Study|Lost to Follow-up|0
5433610|NCT02352493|18769691|P5|Overall Study|Lost to Follow-up|0
5433611|NCT02352493|18769692|P4|Overall Study|Lost to Follow-up|0
5433612|NCT02352493|18769693|P3|Overall Study|Lost to Follow-up|0
5433613|NCT02352493|18769694|P2|Overall Study|Lost to Follow-up|0
5433614|NCT02352493|18769695|P1|Overall Study|Lost to Follow-up|0
5433615|NCT02352493|18769678|P18|Overall Study|Withdrawal by Subject|0
5433616|NCT02352493|18769679|P17|Overall Study|Withdrawal by Subject|0
5433617|NCT02352493|18769680|P16|Overall Study|Withdrawal by Subject|0
5433618|NCT02352493|18769681|P15|Overall Study|Withdrawal by Subject|1
5433619|NCT02352493|18769682|P14|Overall Study|Withdrawal by Subject|0
5433620|NCT02352493|18769683|P13|Overall Study|Withdrawal by Subject|0
5433621|NCT02352493|18769684|P12|Overall Study|Withdrawal by Subject|0
5433622|NCT02352493|18769685|P11|Overall Study|Withdrawal by Subject|0
5433623|NCT02352493|18769686|P10|Overall Study|Withdrawal by Subject|0
5433624|NCT02352493|18769687|P9|Overall Study|Withdrawal by Subject|1
5433625|NCT02352493|18769688|P8|Overall Study|Withdrawal by Subject|0
5433626|NCT02352493|18769689|P7|Overall Study|Withdrawal by Subject|0
5433627|NCT02352493|18769690|P6|Overall Study|Withdrawal by Subject|0
5433628|NCT02352493|18769691|P5|Overall Study|Withdrawal by Subject|0
5433629|NCT02352493|18769692|P4|Overall Study|Withdrawal by Subject|0
5433630|NCT02352493|18769693|P3|Overall Study|Withdrawal by Subject|0
5433631|NCT02352493|18769694|P2|Overall Study|Withdrawal by Subject|0
5433632|NCT02352493|18769695|P1|Overall Study|Withdrawal by Subject|0
5433633|NCT02352493|18769678|P18|Overall Study|Pregnancy|0
5433634|NCT02352493|18769679|P17|Overall Study|Pregnancy|0
5433635|NCT02352493|18769680|P16|Overall Study|Pregnancy|0
5433636|NCT02352493|18769681|P15|Overall Study|Pregnancy|0
5433637|NCT02352493|18769682|P14|Overall Study|Pregnancy|0
5433638|NCT02352493|18769683|P13|Overall Study|Pregnancy|0
5433639|NCT02352493|18769684|P12|Overall Study|Pregnancy|0
5433640|NCT02352493|18769685|P11|Overall Study|Pregnancy|0
5433641|NCT02352493|18769686|P10|Overall Study|Pregnancy|0
5433642|NCT02352493|18769687|P9|Overall Study|Pregnancy|1
5433643|NCT02352493|18769688|P8|Overall Study|Pregnancy|0
5433644|NCT02352493|18769689|P7|Overall Study|Pregnancy|1
5433645|NCT02352493|18769690|P6|Overall Study|Pregnancy|0
5433646|NCT02352493|18769691|P5|Overall Study|Pregnancy|0
5433647|NCT02352493|18769692|P4|Overall Study|Pregnancy|0
5433648|NCT02352493|18769693|P3|Overall Study|Pregnancy|0
5433649|NCT02352493|18769694|P2|Overall Study|Pregnancy|0
5433650|NCT02352493|18769695|P1|Overall Study|Pregnancy|0
5433651|NCT02351960|18769928|P2|Overall Study|Significant Protocol Deviation|5
5433652|NCT02351960|18769929|P1|Overall Study|Significant Protocol Deviation|0
5433653|NCT02351960|18769928|P2|Overall Study|Voluntary Withdrawal|4
5433654|NCT02351960|18769929|P1|Overall Study|Voluntary Withdrawal|5
5433655|NCT02351960|18769928|P2|Overall Study|Pretreatment Event/Adverse Event|3
5433656|NCT02351960|18769929|P1|Overall Study|Pretreatment Event/Adverse Event|6
5433657|NCT02351934|18769950|P2|Follow-Up|2 ERAS Components Noncompliant|4
5433658|NCT02351934|18769951|P1|Follow-Up|2 ERAS Components Noncompliant|0
5433659|NCT02351934|18769950|P2|Follow-Up|1 ERAS Component Noncompliant|6
5433660|NCT02351934|18769951|P1|Follow-Up|1 ERAS Component Noncompliant|0
5433661|NCT02351934|18769950|P2|Follow-Up|No documentation|0
5433662|NCT02351934|18769951|P1|Follow-Up|No documentation|2
5433663|NCT02351934|18769950|P2|Follow-Up|Hypotension|0
5433664|NCT02351934|18769951|P1|Follow-Up|Hypotension|3
5433665|NCT02351934|18769950|P2|Follow-Up|Early dismissal|0
5433666|NCT02351934|18769951|P1|Follow-Up|Early dismissal|3
5433667|NCT02351934|18769950|P2|Follow-Up|Acute Kidney Injury|0
5433668|NCT02351934|18769951|P1|Follow-Up|Acute Kidney Injury|1
5433669|NCT02351934|18769950|P2|Follow-Up|POD weight<pre-op weight|0
5433670|NCT02351934|18769951|P1|Follow-Up|POD weight<pre-op weight|3
5433671|NCT02351934|18769950|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
5433672|NCT02351934|18769951|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
5433673|NCT02351934|18769950|P2|Allocation|Hypotension preventing administration|0
5433674|NCT02351934|18769951|P1|Allocation|Hypotension preventing administration|2
5433675|NCT02351934|18769950|P2|Allocation|POD weight<pre-op weight|0
5433676|NCT02351934|18769951|P1|Allocation|POD weight<pre-op weight|3
5433677|NCT02351817|18769967|P2|Period 2|Protocol Violation|0
5433678|NCT02351817|18769968|P1|Period 2|Protocol Violation|1
5433679|NCT02351817|18769967|P2|Period 2|Adverse Event|2
5433680|NCT02351817|18769968|P1|Period 2|Adverse Event|0
5433681|NCT02351817|18769967|P2|Period 1|Lack of Efficacy|1
5433682|NCT02351817|18769968|P1|Period 1|Lack of Efficacy|0
5433683|NCT02351817|18769967|P2|Period 1|Adverse Event|2
5433684|NCT02351817|18769968|P1|Period 1|Adverse Event|1
5433685|NCT02351167|18770029|P3|Overall Study|Withdrawal by Subject|21
5433686|NCT02351167|18770030|P2|Overall Study|Withdrawal by Subject|18
5433687|NCT02351167|18770031|P1|Overall Study|Withdrawal by Subject|19
5433688|NCT02350478|18770219|P2|Overall Study|Lost to Follow-up|1
5433689|NCT02350478|18770220|P1|Overall Study|Lost to Follow-up|5
5433690|NCT02350309|18770242|P6|Treatment Period 4 (2 Days)|Death in the Family|1
5433691|NCT02350309|18770243|P5|Treatment Period 4 (2 Days)|Death in the Family|0
5433692|NCT02350309|18770244|P4|Treatment Period 4 (2 Days)|Death in the Family|0
5433693|NCT02350309|18770245|P3|Treatment Period 4 (2 Days)|Death in the Family|0
5433694|NCT02350309|18770246|P2|Treatment Period 4 (2 Days)|Death in the Family|0
5433695|NCT02350309|18770247|P1|Treatment Period 4 (2 Days)|Death in the Family|0
5433696|NCT02350309|18770242|P6|Treatment Period 1 (2 Days)|Physician Decision|0
5433697|NCT02350309|18770243|P5|Treatment Period 1 (2 Days)|Physician Decision|0
5433698|NCT02350309|18770244|P4|Treatment Period 1 (2 Days)|Physician Decision|0
5433699|NCT02350309|18770245|P3|Treatment Period 1 (2 Days)|Physician Decision|1
5433700|NCT02350309|18770246|P2|Treatment Period 1 (2 Days)|Physician Decision|0
5433701|NCT02350309|18770247|P1|Treatment Period 1 (2 Days)|Physician Decision|0
5433702|NCT02350127|18770288|P2|8-Month Assessment|Withdrawal by Subject|8
5433703|NCT02350127|18770289|P1|8-Month Assessment|Withdrawal by Subject|5
5433704|NCT02350127|18770288|P2|8-Month Assessment|Death|1
5433705|NCT02350127|18770289|P1|8-Month Assessment|Death|1
5433706|NCT02350127|18770288|P2|4-Month Assessment|Death|0
5433707|NCT02350127|18770289|P1|4-Month Assessment|Death|1
5433708|NCT02350127|18770288|P2|4-Month Assessment|Withdrawal by Subject|9
5433709|NCT02350127|18770289|P1|4-Month Assessment|Withdrawal by Subject|10
5433710|NCT02349789|18770328|P1|Overall Study|Withdrawal by Subject|2
5433711|NCT02349711|18770339|P2|Overall Study|Lost to Follow-up|1
5433712|NCT02349711|18770340|P1|Overall Study|Lost to Follow-up|1
5433713|NCT02349711|18770339|P2|Overall Study|Withdrawal by Subject|1
5433714|NCT02349711|18770340|P1|Overall Study|Withdrawal by Subject|2
5433715|NCT02349542|18770373|P1|Overall Study|Withdrawal by Subject|5
5433716|NCT02349451|18770397|P4|Overall Study|Withdrawal by Subject|1
5433717|NCT02349451|18770398|P3|Overall Study|Withdrawal by Subject|2
5433718|NCT02349451|18770399|P2|Overall Study|Withdrawal by Subject|1
5433719|NCT02349451|18770400|P1|Overall Study|Withdrawal by Subject|0
5433720|NCT02349425|18770451|P4|Period 2|Adverse Event|0
5433721|NCT02349425|18770452|P3|Period 2|Adverse Event|1
5433722|NCT02349425|18770453|P2|Period 2|Adverse Event|1
5433723|NCT02349425|18770454|P1|Period 2|Adverse Event|0
5433724|NCT02349425|18770451|P4|Period 1|Adverse Event|0
5433725|NCT02349425|18770452|P3|Period 1|Adverse Event|0
5433726|NCT02349425|18770453|P2|Period 1|Adverse Event|1
5433727|NCT02349425|18770454|P1|Period 1|Adverse Event|1
5433728|NCT02349412|18770628|P2|Overall Study|Withdrawal by Subject|7
5433729|NCT02349412|18770629|P1|Overall Study|Withdrawal by Subject|7
5433730|NCT02349360|18770645|P2|Overall Study|Withdrawal by Subject|1
5433731|NCT02349360|18770646|P1|Overall Study|Withdrawal by Subject|0
5433732|NCT02349295|18770657|P14|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433733|NCT02349295|18770658|P13|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433734|NCT02349295|18770659|P12|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
5433735|NCT02349295|18770660|P11|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433736|NCT02349295|18770661|P10|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433737|NCT02349295|18770662|P9|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433738|NCT02349295|18770663|P8|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433739|NCT02349295|18770664|P7|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433740|NCT02349295|18770665|P6|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433741|NCT02349295|18770666|P5|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433742|NCT02349295|18770667|P4|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433743|NCT02349295|18770668|P3|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433744|NCT02349295|18770669|P2|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433745|NCT02349295|18770670|P1|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
5433746|NCT02349295|18770657|P14|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433747|NCT02349295|18770658|P13|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433748|NCT02349295|18770659|P12|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
5433749|NCT02349295|18770660|P11|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433750|NCT02349295|18770661|P10|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433751|NCT02349295|18770662|P9|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433752|NCT02349295|18770663|P8|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433753|NCT02349295|18770664|P7|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433754|NCT02349295|18770665|P6|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433755|NCT02349295|18770666|P5|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433756|NCT02349295|18770667|P4|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433757|NCT02349295|18770668|P3|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433758|NCT02349295|18770669|P2|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433759|NCT02349295|18770670|P1|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
5433760|NCT02349295|18770657|P14|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433761|NCT02349295|18770658|P13|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
5433762|NCT02349295|18770659|P12|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
5433763|NCT02349295|18770660|P11|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433764|NCT02349295|18770661|P10|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433765|NCT02349295|18770662|P9|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433766|NCT02349295|18770663|P8|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433767|NCT02349295|18770664|P7|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433768|NCT02349295|18770665|P6|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433769|NCT02349295|18770666|P5|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433770|NCT02349295|18770667|P4|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433771|NCT02349295|18770668|P3|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433772|NCT02349295|18770669|P2|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433773|NCT02349295|18770670|P1|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
5433774|NCT02349295|18770657|P14|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433775|NCT02349295|18770658|P13|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
5433776|NCT02349295|18770659|P12|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
5433777|NCT02349295|18770660|P11|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433778|NCT02349295|18770661|P10|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433779|NCT02349295|18770662|P9|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433780|NCT02349295|18770663|P8|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433781|NCT02349295|18770664|P7|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433782|NCT02349295|18770665|P6|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433783|NCT02349295|18770666|P5|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433784|NCT02349295|18770667|P4|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433785|NCT02349295|18770668|P3|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433786|NCT02349295|18770669|P2|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433787|NCT02349295|18770670|P1|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
5433788|NCT02349295|18770657|P14|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
5433789|NCT02349295|18770658|P13|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
5433790|NCT02349295|18770659|P12|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
5433791|NCT02349295|18770660|P11|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433792|NCT02349295|18770661|P10|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433793|NCT02349295|18770662|P9|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433794|NCT02349295|18770663|P8|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433795|NCT02349295|18770664|P7|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433796|NCT02349295|18770665|P6|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433797|NCT02349295|18770666|P5|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433798|NCT02349295|18770667|P4|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433799|NCT02349295|18770668|P3|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433800|NCT02349295|18770669|P2|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433801|NCT02349295|18770670|P1|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
5433802|NCT02349295|18770657|P14|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433803|NCT02349295|18770658|P13|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433804|NCT02349295|18770659|P12|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433805|NCT02349295|18770660|P11|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433806|NCT02349295|18770661|P10|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433807|NCT02349295|18770662|P9|Long-Term Extension Period (Week 24-156)|Physician Decision|2
5433808|NCT02349295|18770663|P8|Long-Term Extension Period (Week 24-156)|Physician Decision|2
5433809|NCT02349295|18770664|P7|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433810|NCT02349295|18770665|P6|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433811|NCT02349295|18770666|P5|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433812|NCT02349295|18770667|P4|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433813|NCT02349295|18770668|P3|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433814|NCT02349295|18770669|P2|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433815|NCT02349295|18770670|P1|Long-Term Extension Period (Week 24-156)|Physician Decision|0
5433816|NCT02349295|18770657|P14|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433817|NCT02349295|18770658|P13|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433818|NCT02349295|18770659|P12|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433819|NCT02349295|18770660|P11|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433820|NCT02349295|18770661|P10|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433821|NCT02349295|18770662|P9|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
5433822|NCT02349295|18770663|P8|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
5433823|NCT02349295|18770664|P7|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433824|NCT02349295|18770665|P6|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433825|NCT02349295|18770666|P5|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433826|NCT02349295|18770667|P4|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433827|NCT02349295|18770668|P3|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433828|NCT02349295|18770669|P2|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433829|NCT02349295|18770670|P1|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
5433830|NCT02349295|18770657|P14|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433831|NCT02349295|18770658|P13|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433832|NCT02349295|18770659|P12|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433833|NCT02349295|18770660|P11|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
5433834|NCT02349295|18770661|P10|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
5433835|NCT02349295|18770662|P9|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
5433836|NCT02349295|18770663|P8|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
5433837|NCT02349295|18770664|P7|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433838|NCT02349295|18770665|P6|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433839|NCT02349295|18770666|P5|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433840|NCT02349295|18770667|P4|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433841|NCT02349295|18770668|P3|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433842|NCT02349295|18770669|P2|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433843|NCT02349295|18770670|P1|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
5433844|NCT02349295|18770657|P14|Long-Term Extension Period (Week 24-156)|Death|0
5433845|NCT02349295|18770658|P13|Long-Term Extension Period (Week 24-156)|Death|0
5433846|NCT02349295|18770659|P12|Long-Term Extension Period (Week 24-156)|Death|0
5433847|NCT02349295|18770660|P11|Long-Term Extension Period (Week 24-156)|Death|0
5433848|NCT02349295|18770661|P10|Long-Term Extension Period (Week 24-156)|Death|1
5433849|NCT02349295|18770662|P9|Long-Term Extension Period (Week 24-156)|Death|1
5433850|NCT02349295|18770663|P8|Long-Term Extension Period (Week 24-156)|Death|1
5433851|NCT02349295|18770664|P7|Long-Term Extension Period (Week 24-156)|Death|0
5433852|NCT02349295|18770665|P6|Long-Term Extension Period (Week 24-156)|Death|0
5433853|NCT02349295|18770666|P5|Long-Term Extension Period (Week 24-156)|Death|0
5433854|NCT02349295|18770667|P4|Long-Term Extension Period (Week 24-156)|Death|0
5433855|NCT02349295|18770668|P3|Long-Term Extension Period (Week 24-156)|Death|0
5433856|NCT02349295|18770669|P2|Long-Term Extension Period (Week 24-156)|Death|0
5433857|NCT02349295|18770670|P1|Long-Term Extension Period (Week 24-156)|Death|0
5433858|NCT02349295|18770657|P14|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433859|NCT02349295|18770658|P13|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433860|NCT02349295|18770659|P12|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433861|NCT02349295|18770660|P11|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433862|NCT02349295|18770661|P10|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
5433863|NCT02349295|18770662|P9|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433864|NCT02349295|18770663|P8|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
5433865|NCT02349295|18770664|P7|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433866|NCT02349295|18770665|P6|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433867|NCT02349295|18770666|P5|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433868|NCT02349295|18770667|P4|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433869|NCT02349295|18770668|P3|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433870|NCT02349295|18770669|P2|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433871|NCT02349295|18770670|P1|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
5433872|NCT02349295|18770657|P14|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433873|NCT02349295|18770658|P13|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433874|NCT02349295|18770659|P12|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433875|NCT02349295|18770660|P11|Long-Term Extension Period (Week 24-156)|Adverse Event|2
5433876|NCT02349295|18770661|P10|Long-Term Extension Period (Week 24-156)|Adverse Event|2
5433877|NCT02349295|18770662|P9|Long-Term Extension Period (Week 24-156)|Adverse Event|9
5433878|NCT02349295|18770663|P8|Long-Term Extension Period (Week 24-156)|Adverse Event|9
5433879|NCT02349295|18770664|P7|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433880|NCT02349295|18770665|P6|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433881|NCT02349295|18770666|P5|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433882|NCT02349295|18770667|P4|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433883|NCT02349295|18770668|P3|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433884|NCT02349295|18770669|P2|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433885|NCT02349295|18770670|P1|Long-Term Extension Period (Week 24-156)|Adverse Event|0
5433886|NCT02349295|18770657|P14|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433887|NCT02349295|18770658|P13|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433888|NCT02349295|18770659|P12|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433889|NCT02349295|18770660|P11|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
5433890|NCT02349295|18770661|P10|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
5433891|NCT02349295|18770662|P9|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
5433892|NCT02349295|18770663|P8|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
5433893|NCT02349295|18770664|P7|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433894|NCT02349295|18770665|P6|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433895|NCT02349295|18770666|P5|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433896|NCT02349295|18770667|P4|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433897|NCT02349295|18770668|P3|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433898|NCT02349295|18770669|P2|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433899|NCT02349295|18770670|P1|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
5433900|NCT02349295|18770657|P14|IR (Week 16-24)|Lack of Efficacy|0
5433901|NCT02349295|18770658|P13|IR (Week 16-24)|Lack of Efficacy|0
5433902|NCT02349295|18770659|P12|IR (Week 16-24)|Lack of Efficacy|0
5433903|NCT02349295|18770660|P11|IR (Week 16-24)|Lack of Efficacy|0
5433904|NCT02349295|18770661|P10|IR (Week 16-24)|Lack of Efficacy|0
5433905|NCT02349295|18770662|P9|IR (Week 16-24)|Lack of Efficacy|0
5433906|NCT02349295|18770663|P8|IR (Week 16-24)|Lack of Efficacy|0
5433907|NCT02349295|18770664|P7|IR (Week 16-24)|Lack of Efficacy|0
5433908|NCT02349295|18770665|P6|IR (Week 16-24)|Lack of Efficacy|0
5433909|NCT02349295|18770666|P5|IR (Week 16-24)|Lack of Efficacy|0
5433910|NCT02349295|18770667|P4|IR (Week 16-24)|Lack of Efficacy|1
5433911|NCT02349295|18770668|P3|IR (Week 16-24)|Lack of Efficacy|0
5433912|NCT02349295|18770669|P2|IR (Week 16-24)|Lack of Efficacy|0
5433913|NCT02349295|18770670|P1|IR (Week 16-24)|Lack of Efficacy|0
5433914|NCT02349295|18770657|P14|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433915|NCT02349295|18770658|P13|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433916|NCT02349295|18770659|P12|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433917|NCT02349295|18770660|P11|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433918|NCT02349295|18770661|P10|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433919|NCT02349295|18770662|P9|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433920|NCT02349295|18770663|P8|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433921|NCT02349295|18770664|P7|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433922|NCT02349295|18770665|P6|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433923|NCT02349295|18770666|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433924|NCT02349295|18770667|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433925|NCT02349295|18770668|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
5433926|NCT02349295|18770669|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
5433927|NCT02349295|18770670|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
5433928|NCT02349295|18770657|P14|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433929|NCT02349295|18770658|P13|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433930|NCT02349295|18770659|P12|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433931|NCT02349295|18770660|P11|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433932|NCT02349295|18770661|P10|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433933|NCT02349295|18770662|P9|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433934|NCT02349295|18770663|P8|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433935|NCT02349295|18770664|P7|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433936|NCT02349295|18770665|P6|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433937|NCT02349295|18770666|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433938|NCT02349295|18770667|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
5433939|NCT02349295|18770668|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
5433940|NCT02349295|18770669|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
5433941|NCT02349295|18770670|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
5433942|NCT02349295|18770657|P14|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433943|NCT02349295|18770658|P13|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433944|NCT02349295|18770659|P12|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433945|NCT02349295|18770660|P11|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5434189|NCT02347631|18771392|P1|First Intervention (2 Months)|Pregnancy|1
5433946|NCT02349295|18770661|P10|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433947|NCT02349295|18770662|P9|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433948|NCT02349295|18770663|P8|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433949|NCT02349295|18770664|P7|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433950|NCT02349295|18770665|P6|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433951|NCT02349295|18770666|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433952|NCT02349295|18770667|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
5433953|NCT02349295|18770668|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
5433954|NCT02349295|18770669|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
5433955|NCT02349295|18770670|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
5433956|NCT02349295|18770657|P14|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433957|NCT02349295|18770658|P13|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433958|NCT02349295|18770659|P12|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433959|NCT02349295|18770660|P11|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433960|NCT02349295|18770661|P10|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433961|NCT02349295|18770662|P9|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433962|NCT02349295|18770663|P8|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433963|NCT02349295|18770664|P7|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433964|NCT02349295|18770665|P6|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433965|NCT02349295|18770666|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433966|NCT02349295|18770667|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
5433967|NCT02349295|18770668|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
5433968|NCT02349295|18770669|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
5433969|NCT02349295|18770670|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
5433970|NCT02349295|18770657|P14|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433971|NCT02349295|18770658|P13|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433972|NCT02349295|18770659|P12|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433973|NCT02349295|18770660|P11|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433974|NCT02349295|18770661|P10|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433975|NCT02349295|18770662|P9|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433976|NCT02349295|18770663|P8|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433977|NCT02349295|18770664|P7|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433978|NCT02349295|18770665|P6|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433979|NCT02349295|18770666|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433980|NCT02349295|18770667|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
5433981|NCT02349295|18770668|P3|Double Blind Treatment (Week 0-24)|Adverse Event|5
5433982|NCT02349295|18770669|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
5433983|NCT02349295|18770670|P1|Double Blind Treatment (Week 0-24)|Adverse Event|7
5433984|NCT02349061|18770810|P3|Study Extension (Week 56 to Week 120)|Physician Decision|1
5433985|NCT02349061|18770811|P2|Study Extension (Week 56 to Week 120)|Physician Decision|0
5433986|NCT02349061|18770812|P1|Study Extension (Week 56 to Week 120)|Physician Decision|0
5433987|NCT02349061|18770810|P3|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
5433988|NCT02349061|18770811|P2|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
5433989|NCT02349061|18770812|P1|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
5433990|NCT02349061|18770810|P3|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
5433991|NCT02349061|18770811|P2|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
5433992|NCT02349061|18770812|P1|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
5433993|NCT02349061|18770810|P3|Study Extension (Week 56 to Week 120)|Adverse Event|0
5433994|NCT02349061|18770811|P2|Study Extension (Week 56 to Week 120)|Adverse Event|3
5433995|NCT02349061|18770812|P1|Study Extension (Week 56 to Week 120)|Adverse Event|0
5433996|NCT02349061|18770810|P3|Main Study: Week 24 to 56|Physician Decision|1
5433997|NCT02349061|18770811|P2|Main Study: Week 24 to 56|Physician Decision|0
5433998|NCT02349061|18770812|P1|Main Study: Week 24 to 56|Physician Decision|0
5433999|NCT02349061|18770810|P3|Main Study: Week 24 to 56|Withdrawal by Subject|1
5434000|NCT02349061|18770811|P2|Main Study: Week 24 to 56|Withdrawal by Subject|0
5434001|NCT02349061|18770812|P1|Main Study: Week 24 to 56|Withdrawal by Subject|0
5434002|NCT02349061|18770810|P3|Main Study: Week 24 to 56|Lack of Efficacy|0
5434003|NCT02349061|18770811|P2|Main Study: Week 24 to 56|Lack of Efficacy|1
5434004|NCT02349061|18770812|P1|Main Study: Week 24 to 56|Lack of Efficacy|0
5434005|NCT02349061|18770810|P3|Main Study: Week 24 to 56|Adverse Event|1
5434006|NCT02349061|18770811|P2|Main Study: Week 24 to 56|Adverse Event|2
5434007|NCT02349061|18770812|P1|Main Study: Week 24 to 56|Adverse Event|0
5434008|NCT02349061|18770810|P3|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
5434009|NCT02349061|18770811|P2|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
5434010|NCT02349061|18770812|P1|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
5434011|NCT02349061|18770810|P3|Main Study: PCP (Up to Week 24)|Other|0
5434012|NCT02349061|18770811|P2|Main Study: PCP (Up to Week 24)|Other|1
5434013|NCT02349061|18770812|P1|Main Study: PCP (Up to Week 24)|Other|1
5434014|NCT02349061|18770810|P3|Main Study: PCP (Up to Week 24)|Physician Decision|0
5434015|NCT02349061|18770811|P2|Main Study: PCP (Up to Week 24)|Physician Decision|0
5434016|NCT02349061|18770812|P1|Main Study: PCP (Up to Week 24)|Physician Decision|1
5434017|NCT02349061|18770810|P3|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
5434018|NCT02349061|18770811|P2|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
5434019|NCT02349061|18770812|P1|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
5434020|NCT02349061|18770810|P3|Main Study: PCP (Up to Week 24)|Adverse Event|0
5434021|NCT02349061|18770811|P2|Main Study: PCP (Up to Week 24)|Adverse Event|3
5434022|NCT02349061|18770812|P1|Main Study: PCP (Up to Week 24)|Adverse Event|4
5434023|NCT02349048|18770832|P2|Overall Study|Lost to Follow-up|0
5434024|NCT02349048|18770833|P1|Overall Study|Lost to Follow-up|1
5434025|NCT02349048|18770832|P2|Overall Study|Withdrawal by Subject|0
5434026|NCT02349048|18770833|P1|Overall Study|Withdrawal by Subject|4
5434027|NCT02348840|18770894|P4|Overall Study|Withdrawal by Subject|0
5434028|NCT02348840|18770895|P3|Overall Study|Withdrawal by Subject|0
5434029|NCT02348840|18770896|P2|Overall Study|Withdrawal by Subject|1
5434030|NCT02348840|18770897|P1|Overall Study|Withdrawal by Subject|2
5434031|NCT02348723|18770911|P2|Overall Study|Adverse Event|1
5434032|NCT02348723|18770912|P1|Overall Study|Adverse Event|3
5434033|NCT02348723|18770911|P2|Overall Study|Reason other than specified|1
5434034|NCT02348723|18770912|P1|Overall Study|Reason other than specified|1
5434035|NCT02348723|18770911|P2|Overall Study|Consent withdrawn|3
5434036|NCT02348723|18770912|P1|Overall Study|Consent withdrawn|1
5434037|NCT02348723|18770911|P2|Overall Study|Lost to Follow-up|1
5434038|NCT02348723|18770912|P1|Overall Study|Lost to Follow-up|1
5434039|NCT02348723|18770911|P2|Overall Study|Non-compliant with Protocol|0
5434040|NCT02348723|18770912|P1|Overall Study|Non-compliant with Protocol|1
5434041|NCT02348723|18770911|P2|Overall Study|No ablation|20
5434042|NCT02348723|18770912|P1|Overall Study|No ablation|21
5434043|NCT02348008|18771138|P3|Overall Study|Symptomatic Deterioration|0
5434044|NCT02348008|18771139|P2|Overall Study|Symptomatic Deterioration|1
5434045|NCT02348008|18771140|P1|Overall Study|Symptomatic Deterioration|0
5434046|NCT02348008|18771138|P3|Overall Study|Withdrawal by Subject|0
5434047|NCT02348008|18771139|P2|Overall Study|Withdrawal by Subject|1
5434048|NCT02348008|18771140|P1|Overall Study|Withdrawal by Subject|0
5434049|NCT02348008|18771138|P3|Overall Study|Disease Progression|16
5434050|NCT02348008|18771139|P2|Overall Study|Disease Progression|5
5434051|NCT02348008|18771140|P1|Overall Study|Disease Progression|1
5434052|NCT02348008|18771138|P3|Overall Study|Adverse Event|3
5434053|NCT02348008|18771139|P2|Overall Study|Adverse Event|3
5434054|NCT02348008|18771140|P1|Overall Study|Adverse Event|2
5434055|NCT02347943|18771156|P3|Overall Study|Study was cancelled|45
5434056|NCT02347943|18771157|P2|Overall Study|Study was cancelled|67
5434057|NCT02347943|18771158|P1|Overall Study|Study was cancelled|140
5434058|NCT02347813|18771168|P2|First Intervention, 24 Weeks|Adverse Event|1
5434059|NCT02347813|18771169|P1|First Intervention, 24 Weeks|Adverse Event|1
5434060|NCT02347813|18771168|P2|First Intervention, 24 Weeks|Withdrawal by Subject|1
5434061|NCT02347813|18771169|P1|First Intervention, 24 Weeks|Withdrawal by Subject|1
5434062|NCT02347787|18771179|P2|9 Month Follow-Up|Withdrawal by Subject|12
5434063|NCT02347787|18771180|P1|9 Month Follow-Up|Withdrawal by Subject|9
5434064|NCT02347787|18771179|P2|9 Month Follow-Up|Lost to Follow-up|59
5434065|NCT02347787|18771180|P1|9 Month Follow-Up|Lost to Follow-up|52
5434066|NCT02347787|18771179|P2|6 Month Follow-Up|Withdrawal by Subject|9
5434067|NCT02347787|18771180|P1|6 Month Follow-Up|Withdrawal by Subject|3
5434068|NCT02347787|18771179|P2|6 Month Follow-Up|Lost to Follow-up|47
5434069|NCT02347787|18771180|P1|6 Month Follow-Up|Lost to Follow-up|63
5434070|NCT02347774|18771242|P3|On Study Treatment|ranomized in error|1
5434071|NCT02347774|18771243|P2|On Study Treatment|ranomized in error|0
5434072|NCT02347774|18771244|P1|On Study Treatment|ranomized in error|0
5434073|NCT02347774|18771242|P3|On Study Treatment|Met Prolonged QT criteria|0
5434074|NCT02347774|18771243|P2|On Study Treatment|Met Prolonged QT criteria|0
5434075|NCT02347774|18771244|P1|On Study Treatment|Met Prolonged QT criteria|1
5434076|NCT02347774|18771242|P3|On Study Treatment|Lost to Follow-up|1
5434077|NCT02347774|18771243|P2|On Study Treatment|Lost to Follow-up|6
5434078|NCT02347774|18771244|P1|On Study Treatment|Lost to Follow-up|2
5434079|NCT02347774|18771242|P3|On Study Treatment|withdrew consent|12
5434080|NCT02347774|18771243|P2|On Study Treatment|withdrew consent|8
5434081|NCT02347774|18771244|P1|On Study Treatment|withdrew consent|9
5434082|NCT02347774|18771242|P3|On Study Treatment|Protocol Violation|1
5434083|NCT02347774|18771243|P2|On Study Treatment|Protocol Violation|0
5434084|NCT02347774|18771244|P1|On Study Treatment|Protocol Violation|0
5434085|NCT02347774|18771242|P3|On Study Treatment|non-complicance with study medication|0
5434086|NCT02347774|18771243|P2|On Study Treatment|non-complicance with study medication|2
5434087|NCT02347774|18771244|P1|On Study Treatment|non-complicance with study medication|0
5434088|NCT02347774|18771242|P3|On Study Treatment|Lack of Efficacy|2
5434089|NCT02347774|18771243|P2|On Study Treatment|Lack of Efficacy|0
5434090|NCT02347774|18771244|P1|On Study Treatment|Lack of Efficacy|3
5434091|NCT02347774|18771242|P3|On Study Treatment|Adverse Event|19
5434092|NCT02347774|18771243|P2|On Study Treatment|Adverse Event|15
5434093|NCT02347774|18771244|P1|On Study Treatment|Adverse Event|9
5434094|NCT02347774|18771242|P3|Study Participation|randomized in error|1
5434095|NCT02347774|18771243|P2|Study Participation|randomized in error|0
5434096|NCT02347774|18771244|P1|Study Participation|randomized in error|0
5434097|NCT02347774|18771242|P3|Study Participation|incarceration|0
5434098|NCT02347774|18771243|P2|Study Participation|incarceration|0
5434099|NCT02347774|18771244|P1|Study Participation|incarceration|1
5434100|NCT02347774|18771242|P3|Study Participation|non-compliance with study drug|0
5434101|NCT02347774|18771243|P2|Study Participation|non-compliance with study drug|1
5434102|NCT02347774|18771244|P1|Study Participation|non-compliance with study drug|0
5434103|NCT02347774|18771242|P3|Study Participation|Met Prolonged QT criteria|0
5434104|NCT02347774|18771243|P2|Study Participation|Met Prolonged QT criteria|0
5434105|NCT02347774|18771244|P1|Study Participation|Met Prolonged QT criteria|1
5434106|NCT02347774|18771242|P3|Study Participation|withdrew consent|1
5434107|NCT02347774|18771243|P2|Study Participation|withdrew consent|1
5434108|NCT02347774|18771244|P1|Study Participation|withdrew consent|1
5434109|NCT02347774|18771242|P3|Study Participation|Adverse Event|6
5434110|NCT02347774|18771243|P2|Study Participation|Adverse Event|4
5434111|NCT02347774|18771244|P1|Study Participation|Adverse Event|1
5434112|NCT02347774|18771242|P3|Study Participation|Withdrawal by Subject|15
5434113|NCT02347774|18771243|P2|Study Participation|Withdrawal by Subject|9
5434114|NCT02347774|18771244|P1|Study Participation|Withdrawal by Subject|8
5434115|NCT02347774|18771242|P3|Study Participation|Lost to Follow-up|2
5434116|NCT02347774|18771243|P2|Study Participation|Lost to Follow-up|6
5434117|NCT02347774|18771244|P1|Study Participation|Lost to Follow-up|3
5434118|NCT02347761|18771300|P3|On Study Treatment|Adverse Event|20
5434119|NCT02347761|18771301|P2|On Study Treatment|Adverse Event|8
5434120|NCT02347761|18771302|P1|On Study Treatment|Adverse Event|10
5434121|NCT02347761|18771300|P3|On Study Treatment|durg not working|1
5434122|NCT02347761|18771301|P2|On Study Treatment|durg not working|1
5434123|NCT02347761|18771302|P1|On Study Treatment|durg not working|0
5434124|NCT02347761|18771300|P3|On Study Treatment|investigator discretion|0
5434125|NCT02347761|18771301|P2|On Study Treatment|investigator discretion|0
5434126|NCT02347761|18771302|P1|On Study Treatment|investigator discretion|2
5434127|NCT02347761|18771300|P3|On Study Treatment|Lost to Follow-up|1
5434128|NCT02347761|18771301|P2|On Study Treatment|Lost to Follow-up|1
5434129|NCT02347761|18771302|P1|On Study Treatment|Lost to Follow-up|2
5434130|NCT02347761|18771300|P3|On Study Treatment|dissastisfaction with device|4
5434131|NCT02347761|18771301|P2|On Study Treatment|dissastisfaction with device|1
5434132|NCT02347761|18771302|P1|On Study Treatment|dissastisfaction with device|2
5434133|NCT02347761|18771300|P3|On Study Treatment|move/travel|5
5434134|NCT02347761|18771301|P2|On Study Treatment|move/travel|6
5434135|NCT02347761|18771302|P1|On Study Treatment|move/travel|2
5434136|NCT02347761|18771300|P3|On Study Treatment|Withdrawal by Subject|5
5434137|NCT02347761|18771301|P2|On Study Treatment|Withdrawal by Subject|3
5434138|NCT02347761|18771302|P1|On Study Treatment|Withdrawal by Subject|7
5434139|NCT02347761|18771300|P3|On Study Treatment|non-compliance with study medication|2
5434140|NCT02347761|18771301|P2|On Study Treatment|non-compliance with study medication|0
5434141|NCT02347761|18771302|P1|On Study Treatment|non-compliance with study medication|0
5434142|NCT02347761|18771300|P3|On Study Treatment|Lack of Efficacy|4
5434143|NCT02347761|18771301|P2|On Study Treatment|Lack of Efficacy|3
5434144|NCT02347761|18771302|P1|On Study Treatment|Lack of Efficacy|2
5434145|NCT02347761|18771300|P3|All Collected|moved/travel|0
5434146|NCT02347761|18771301|P2|All Collected|moved/travel|1
5434147|NCT02347761|18771302|P1|All Collected|moved/travel|0
5434148|NCT02347761|18771300|P3|All Collected|exacerbation of COPD|1
5434149|NCT02347761|18771301|P2|All Collected|exacerbation of COPD|0
5434150|NCT02347761|18771302|P1|All Collected|exacerbation of COPD|0
5434151|NCT02347761|18771300|P3|All Collected|instillation site pain|1
5434152|NCT02347761|18771301|P2|All Collected|instillation site pain|0
5434153|NCT02347761|18771302|P1|All Collected|instillation site pain|0
5434154|NCT02347761|18771300|P3|All Collected|invetigator disretion|0
5434155|NCT02347761|18771301|P2|All Collected|invetigator disretion|0
5434156|NCT02347761|18771302|P1|All Collected|invetigator disretion|2
5434157|NCT02347761|18771300|P3|All Collected|Withdrawal by Subject|22
5434158|NCT02347761|18771301|P2|All Collected|Withdrawal by Subject|11
5434159|NCT02347761|18771302|P1|All Collected|Withdrawal by Subject|11
5434160|NCT02347761|18771300|P3|All Collected|Lost to Follow-up|3
5434161|NCT02347761|18771301|P2|All Collected|Lost to Follow-up|2
5434162|NCT02347761|18771302|P1|All Collected|Lost to Follow-up|3
5434163|NCT02347761|18771300|P3|All Collected|Death|0
5434164|NCT02347761|18771301|P2|All Collected|Death|0
5434165|NCT02347761|18771302|P1|All Collected|Death|1
5434166|NCT02347657|18771363|P2|Overall Study|Other|3
5434167|NCT02347657|18771364|P1|Overall Study|Other|3
5434168|NCT02347657|18771363|P2|Overall Study|Randomized but not treated|0
5434169|NCT02347657|18771364|P1|Overall Study|Randomized but not treated|1
5434170|NCT02347657|18771363|P2|Overall Study|Withdrawal by Subject|7
5434171|NCT02347657|18771364|P1|Overall Study|Withdrawal by Subject|6
5434172|NCT02347657|18771363|P2|Overall Study|Adverse Event|4
5434173|NCT02347657|18771364|P1|Overall Study|Adverse Event|8
5434174|NCT02347657|18771363|P2|Overall Study|Physician Decision|1
5434175|NCT02347657|18771364|P1|Overall Study|Physician Decision|0
5434176|NCT02347631|18771391|P2|Second Intervention (2 Months)|Withdrawal by Subject|0
5434177|NCT02347631|18771392|P1|Second Intervention (2 Months)|Withdrawal by Subject|6
5434178|NCT02347631|18771391|P2|Second Intervention (2 Months)|Lost to Follow-up|4
5434179|NCT02347631|18771392|P1|Second Intervention (2 Months)|Lost to Follow-up|7
5434180|NCT02347631|18771391|P2|Washout 2 (1 Month)|Lost to Follow-up|1
5434181|NCT02347631|18771392|P1|Washout 2 (1 Month)|Lost to Follow-up|0
5434182|NCT02347631|18771391|P2|Washout 2 (1 Month)|Withdrawal by Subject|2
5434183|NCT02347631|18771392|P1|Washout 2 (1 Month)|Withdrawal by Subject|2
5434184|NCT02347631|18771391|P2|First Intervention (2 Months)|Lost to Follow-up|3
5434185|NCT02347631|18771392|P1|First Intervention (2 Months)|Lost to Follow-up|5
5434186|NCT02347631|18771391|P2|First Intervention (2 Months)|Moved out of area|2
5434187|NCT02347631|18771392|P1|First Intervention (2 Months)|Moved out of area|0
5434188|NCT02347631|18771391|P2|First Intervention (2 Months)|Pregnancy|0
5434190|NCT02347631|18771391|P2|First Intervention (2 Months)|Adverse Event|1
5434191|NCT02347631|18771392|P1|First Intervention (2 Months)|Adverse Event|1
5434192|NCT02347332|18771453|P2|Overall Study|Switch Post-Trial program|1
5434193|NCT02347332|18771454|P1|Overall Study|Switch Post-Trial program|0
5434194|NCT02347332|18771453|P2|Overall Study|Protocol requirement|1
5434195|NCT02347332|18771454|P1|Overall Study|Protocol requirement|1
5434196|NCT02347332|18771453|P2|Overall Study|Withdrawal by Subject|14
5434197|NCT02347332|18771454|P1|Overall Study|Withdrawal by Subject|20
5434198|NCT02347332|18771453|P2|Overall Study|Physician Decision|3
5434199|NCT02347332|18771454|P1|Overall Study|Physician Decision|4
5434200|NCT02347332|18771453|P2|Overall Study|Lost to Follow-up|1
5434201|NCT02347332|18771454|P1|Overall Study|Lost to Follow-up|2
5434202|NCT02347332|18771453|P2|Overall Study|Protocol Violation|1
5434203|NCT02347332|18771454|P1|Overall Study|Protocol Violation|1
5434204|NCT02347332|18771453|P2|Overall Study|Death (Unknown, Various reasons)|6
5434205|NCT02347332|18771454|P1|Overall Study|Death (Unknown, Various reasons)|6
5434206|NCT02347332|18771453|P2|Overall Study|Adverse Event|41
5434207|NCT02347332|18771454|P1|Overall Study|Adverse Event|50
5434208|NCT02347332|18771453|P2|Overall Study|Progressive disease|159
5434209|NCT02347332|18771454|P1|Overall Study|Progressive disease|141
5434210|NCT02347332|18771453|P2|Overall Study|Not treated|2
5434211|NCT02347332|18771454|P1|Overall Study|Not treated|5
5434212|NCT02347189|18771468|P1|Overall Study|No primary outcome data available|2
5434213|NCT02347189|18771468|P1|Overall Study|No implant attempted of study device|9
5434214|NCT02347176|18771487|P4|Overall Study|Other|0
5434215|NCT02347176|18771488|P3|Overall Study|Other|2
5434216|NCT02347176|18771489|P2|Overall Study|Other|2
5434217|NCT02347176|18771490|P1|Overall Study|Other|1
5434218|NCT02347176|18771487|P4|Overall Study|Withdrawal by Subject|3
5434219|NCT02347176|18771488|P3|Overall Study|Withdrawal by Subject|5
5434220|NCT02347176|18771489|P2|Overall Study|Withdrawal by Subject|5
5434221|NCT02347176|18771490|P1|Overall Study|Withdrawal by Subject|9
5434222|NCT02347176|18771487|P4|Overall Study|Lost to Follow-up|1
5434223|NCT02347176|18771488|P3|Overall Study|Lost to Follow-up|1
5434224|NCT02347176|18771489|P2|Overall Study|Lost to Follow-up|3
5434225|NCT02347176|18771490|P1|Overall Study|Lost to Follow-up|2
5434226|NCT02347098|18771575|P2|Overall Study|no visit due to illness|1
5434227|NCT02347098|18771576|P1|Overall Study|no visit due to illness|2
5434228|NCT02347098|18771575|P2|Overall Study|Refuse Follow-up Visit|5
5434229|NCT02347098|18771576|P1|Overall Study|Refuse Follow-up Visit|1
5434230|NCT02347098|18771575|P2|Overall Study|Lost to Follow-up|2
5434231|NCT02347098|18771576|P1|Overall Study|Lost to Follow-up|2
5434232|NCT02347098|18771575|P2|Overall Study|Withdrawal by Subject|0
5434233|NCT02347098|18771576|P1|Overall Study|Withdrawal by Subject|1
5434234|NCT02347098|18771575|P2|Overall Study|Death|0
5434235|NCT02347098|18771576|P1|Overall Study|Death|1
5434236|NCT02347085|18771588|P1|Overall Study|Protocol Criteria|2
5434237|NCT02347085|18771588|P1|Overall Study|Lost to Follow-up|1
5434238|NCT02347085|18771588|P1|Overall Study|Withdrawal by Subject|4
5434239|NCT02347085|18771588|P1|Overall Study|Lack of Efficacy|1
5434240|NCT02347085|18771588|P1|Overall Study|Adverse Event|2
5434241|NCT02347072|18771610|P1|Overall Study|Disc due to Protocol-specified Criteria|6
5434242|NCT02347072|18771610|P1|Overall Study|Protocol Violation|1
5434243|NCT02347072|18771610|P1|Overall Study|Lost to Follow-up|2
5434244|NCT02347072|18771610|P1|Overall Study|Physician Decision|1
5434245|NCT02347072|18771610|P1|Overall Study|Withdrawal by Subject|6
5434246|NCT02347072|18771610|P1|Overall Study|Adverse Event|2
5434247|NCT02346877|18771644|P2|Overall Study|Missing|0
5434248|NCT02346877|18771645|P1|Overall Study|Missing|5
5434249|NCT02346877|18771644|P2|Overall Study|Sponsor Decision|0
5434250|NCT02346877|18771645|P1|Overall Study|Sponsor Decision|12
5434251|NCT02346877|18771644|P2|Overall Study|Administrative Decision|0
5434252|NCT02346877|18771645|P1|Overall Study|Administrative Decision|1
5434253|NCT02346877|18771644|P2|Overall Study|Adverse Event|0
5434254|NCT02346877|18771645|P1|Overall Study|Adverse Event|1
5434255|NCT02346721|18771655|P1|Overall Study|Lack of Efficacy|1
5434256|NCT02346721|18771655|P1|Overall Study|Withdrew Consent|3
5434257|NCT02346708|18771666|P2|Overall Study|Protocol Violation|1
5434258|NCT02346708|18771667|P1|Overall Study|Protocol Violation|0
5434259|NCT02346708|18771666|P2|Overall Study|Adverse Event|0
5434260|NCT02346708|18771667|P1|Overall Study|Adverse Event|2
5434261|NCT02346370|18771705|P3|Overall Study|Physician Decision|0
5434262|NCT02346370|18771706|P2|Overall Study|Physician Decision|1
5434263|NCT02346370|18771707|P1|Overall Study|Physician Decision|0
5434264|NCT02346370|18771705|P3|Overall Study|Radiologic progression|1
5434265|NCT02346370|18771706|P2|Overall Study|Radiologic progression|0
5434266|NCT02346370|18771707|P1|Overall Study|Radiologic progression|0
5434267|NCT02346370|18771705|P3|Overall Study|Sponsor discontinued study|2
5434268|NCT02346370|18771706|P2|Overall Study|Sponsor discontinued study|0
5434269|NCT02346370|18771707|P1|Overall Study|Sponsor discontinued study|5
5434270|NCT02346370|18771705|P3|Overall Study|Death|1
5434271|NCT02346370|18771706|P2|Overall Study|Death|3
5434272|NCT02346370|18771707|P1|Overall Study|Death|1
5434273|NCT02346370|18771705|P3|Overall Study|Withdrawal of consent|0
5434274|NCT02346370|18771706|P2|Overall Study|Withdrawal of consent|0
5434275|NCT02346370|18771707|P1|Overall Study|Withdrawal of consent|1
5434276|NCT02346370|18771705|P3|Overall Study|Not treated|0
5434277|NCT02346370|18771706|P2|Overall Study|Not treated|0
5434278|NCT02346370|18771707|P1|Overall Study|Not treated|1
5434279|NCT02346240|18771756|P24|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434280|NCT02346240|18771757|P23|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434281|NCT02346240|18771758|P22|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434282|NCT02346240|18771759|P21|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434283|NCT02346240|18771760|P20|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434284|NCT02346240|18771761|P19|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
5434285|NCT02346240|18771762|P18|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434286|NCT02346240|18771763|P17|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434287|NCT02346240|18771764|P16|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434288|NCT02346240|18771765|P15|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434289|NCT02346240|18771766|P14|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434290|NCT02346240|18771767|P13|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434291|NCT02346240|18771768|P12|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434292|NCT02346240|18771769|P11|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434293|NCT02346240|18771770|P10|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434294|NCT02346240|18771771|P9|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434295|NCT02346240|18771772|P8|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434296|NCT02346240|18771773|P7|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434297|NCT02346240|18771774|P6|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434298|NCT02346240|18771775|P5|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434299|NCT02346240|18771776|P4|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434300|NCT02346240|18771777|P3|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434301|NCT02346240|18771778|P2|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434302|NCT02346240|18771779|P1|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
5434303|NCT02346240|18771756|P24|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
5434304|NCT02346240|18771757|P23|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
5434305|NCT02346240|18771758|P22|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
5434306|NCT02346240|18771759|P21|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434307|NCT02346240|18771760|P20|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434308|NCT02346240|18771761|P19|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
5434309|NCT02346240|18771762|P18|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434310|NCT02346240|18771763|P17|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434311|NCT02346240|18771764|P16|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434312|NCT02346240|18771765|P15|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434313|NCT02346240|18771766|P14|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434314|NCT02346240|18771767|P13|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434315|NCT02346240|18771768|P12|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434316|NCT02346240|18771769|P11|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434317|NCT02346240|18771770|P10|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434318|NCT02346240|18771771|P9|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434319|NCT02346240|18771772|P8|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434320|NCT02346240|18771773|P7|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434321|NCT02346240|18771774|P6|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434322|NCT02346240|18771775|P5|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434323|NCT02346240|18771776|P4|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434324|NCT02346240|18771777|P3|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434325|NCT02346240|18771778|P2|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434326|NCT02346240|18771779|P1|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
5434327|NCT02346240|18771756|P24|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5434328|NCT02346240|18771757|P23|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5434329|NCT02346240|18771758|P22|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
5434330|NCT02346240|18771759|P21|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434331|NCT02346240|18771760|P20|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5434332|NCT02346240|18771761|P19|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
5434333|NCT02346240|18771762|P18|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434334|NCT02346240|18771763|P17|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434335|NCT02346240|18771764|P16|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434336|NCT02346240|18771765|P15|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434337|NCT02346240|18771766|P14|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434338|NCT02346240|18771767|P13|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434339|NCT02346240|18771768|P12|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434340|NCT02346240|18771769|P11|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434341|NCT02346240|18771770|P10|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434342|NCT02346240|18771771|P9|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434343|NCT02346240|18771772|P8|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434961|NCT02345252|18772082|P2|Double-Blind Phase|Lost to Follow-up|10
5434344|NCT02346240|18771773|P7|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434345|NCT02346240|18771774|P6|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434346|NCT02346240|18771775|P5|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434347|NCT02346240|18771776|P4|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434348|NCT02346240|18771777|P3|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434349|NCT02346240|18771778|P2|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434350|NCT02346240|18771779|P1|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5434351|NCT02346240|18771756|P24|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
5434352|NCT02346240|18771757|P23|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
5434353|NCT02346240|18771758|P22|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
5434354|NCT02346240|18771759|P21|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434355|NCT02346240|18771760|P20|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
5434356|NCT02346240|18771761|P19|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
5434357|NCT02346240|18771762|P18|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
5434358|NCT02346240|18771763|P17|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434359|NCT02346240|18771764|P16|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434360|NCT02346240|18771765|P15|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434361|NCT02346240|18771766|P14|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434362|NCT02346240|18771767|P13|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434363|NCT02346240|18771768|P12|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434364|NCT02346240|18771769|P11|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434365|NCT02346240|18771770|P10|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434366|NCT02346240|18771771|P9|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434367|NCT02346240|18771772|P8|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434368|NCT02346240|18771773|P7|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434369|NCT02346240|18771774|P6|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434370|NCT02346240|18771775|P5|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434371|NCT02346240|18771776|P4|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434372|NCT02346240|18771777|P3|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434373|NCT02346240|18771778|P2|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434374|NCT02346240|18771779|P1|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
5434375|NCT02346240|18771756|P24|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434376|NCT02346240|18771757|P23|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434377|NCT02346240|18771758|P22|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
5434378|NCT02346240|18771759|P21|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434379|NCT02346240|18771760|P20|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434380|NCT02346240|18771761|P19|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434381|NCT02346240|18771762|P18|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434382|NCT02346240|18771763|P17|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434383|NCT02346240|18771764|P16|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434384|NCT02346240|18771765|P15|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434385|NCT02346240|18771766|P14|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434386|NCT02346240|18771767|P13|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434387|NCT02346240|18771768|P12|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434388|NCT02346240|18771769|P11|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434389|NCT02346240|18771770|P10|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434390|NCT02346240|18771771|P9|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434391|NCT02346240|18771772|P8|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434392|NCT02346240|18771773|P7|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434393|NCT02346240|18771774|P6|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434394|NCT02346240|18771775|P5|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434395|NCT02346240|18771776|P4|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434396|NCT02346240|18771777|P3|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434397|NCT02346240|18771778|P2|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434398|NCT02346240|18771779|P1|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
5434399|NCT02346240|18771756|P24|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434400|NCT02346240|18771757|P23|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434401|NCT02346240|18771758|P22|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
5434402|NCT02346240|18771759|P21|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434403|NCT02346240|18771760|P20|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434404|NCT02346240|18771761|P19|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
5434405|NCT02346240|18771762|P18|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434406|NCT02346240|18771763|P17|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434407|NCT02346240|18771764|P16|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434408|NCT02346240|18771765|P15|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434409|NCT02346240|18771766|P14|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434410|NCT02346240|18771767|P13|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434411|NCT02346240|18771768|P12|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434412|NCT02346240|18771769|P11|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434962|NCT02345252|18772083|P1|Double-Blind Phase|Lost to Follow-up|8
5434413|NCT02346240|18771770|P10|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434414|NCT02346240|18771771|P9|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434415|NCT02346240|18771772|P8|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434416|NCT02346240|18771773|P7|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434417|NCT02346240|18771774|P6|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434418|NCT02346240|18771775|P5|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434419|NCT02346240|18771776|P4|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434420|NCT02346240|18771777|P3|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434421|NCT02346240|18771778|P2|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434422|NCT02346240|18771779|P1|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
5434423|NCT02346240|18771756|P24|Open-Label Period (Week 48 to Week 144)|Death|0
5434424|NCT02346240|18771757|P23|Open-Label Period (Week 48 to Week 144)|Death|0
5434425|NCT02346240|18771758|P22|Open-Label Period (Week 48 to Week 144)|Death|1
5434426|NCT02346240|18771759|P21|Open-Label Period (Week 48 to Week 144)|Death|0
5434427|NCT02346240|18771760|P20|Open-Label Period (Week 48 to Week 144)|Death|1
5434428|NCT02346240|18771761|P19|Open-Label Period (Week 48 to Week 144)|Death|1
5434429|NCT02346240|18771762|P18|Open-Label Period (Week 48 to Week 144)|Death|0
5434430|NCT02346240|18771763|P17|Open-Label Period (Week 48 to Week 144)|Death|0
5434431|NCT02346240|18771764|P16|Open-Label Period (Week 48 to Week 144)|Death|0
5434432|NCT02346240|18771765|P15|Open-Label Period (Week 48 to Week 144)|Death|0
5434433|NCT02346240|18771766|P14|Open-Label Period (Week 48 to Week 144)|Death|0
5434434|NCT02346240|18771767|P13|Open-Label Period (Week 48 to Week 144)|Death|0
5434435|NCT02346240|18771768|P12|Open-Label Period (Week 48 to Week 144)|Death|0
5434436|NCT02346240|18771769|P11|Open-Label Period (Week 48 to Week 144)|Death|0
5434437|NCT02346240|18771770|P10|Open-Label Period (Week 48 to Week 144)|Death|0
5434438|NCT02346240|18771771|P9|Open-Label Period (Week 48 to Week 144)|Death|0
5434439|NCT02346240|18771772|P8|Open-Label Period (Week 48 to Week 144)|Death|0
5434440|NCT02346240|18771773|P7|Open-Label Period (Week 48 to Week 144)|Death|0
5434441|NCT02346240|18771774|P6|Open-Label Period (Week 48 to Week 144)|Death|0
5434442|NCT02346240|18771775|P5|Open-Label Period (Week 48 to Week 144)|Death|0
5434443|NCT02346240|18771776|P4|Open-Label Period (Week 48 to Week 144)|Death|0
5434444|NCT02346240|18771777|P3|Open-Label Period (Week 48 to Week 144)|Death|0
5434445|NCT02346240|18771778|P2|Open-Label Period (Week 48 to Week 144)|Death|0
5434446|NCT02346240|18771779|P1|Open-Label Period (Week 48 to Week 144)|Death|0
5434447|NCT02346240|18771756|P24|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
5434448|NCT02346240|18771757|P23|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
5434449|NCT02346240|18771758|P22|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
5434450|NCT02346240|18771759|P21|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
5434451|NCT02346240|18771760|P20|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
5434452|NCT02346240|18771761|P19|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
5434453|NCT02346240|18771762|P18|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
5434454|NCT02346240|18771763|P17|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434455|NCT02346240|18771764|P16|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434456|NCT02346240|18771765|P15|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434457|NCT02346240|18771766|P14|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434458|NCT02346240|18771767|P13|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434459|NCT02346240|18771768|P12|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434460|NCT02346240|18771769|P11|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434461|NCT02346240|18771770|P10|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434462|NCT02346240|18771771|P9|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434463|NCT02346240|18771772|P8|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434464|NCT02346240|18771773|P7|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434465|NCT02346240|18771774|P6|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434466|NCT02346240|18771775|P5|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434467|NCT02346240|18771776|P4|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434468|NCT02346240|18771777|P3|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434469|NCT02346240|18771778|P2|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434470|NCT02346240|18771779|P1|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
5434471|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434472|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434473|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434474|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434475|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434476|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434477|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434478|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434479|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434480|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
5434481|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434482|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434483|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434484|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434485|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434486|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434487|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434488|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434489|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434490|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434491|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434492|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434493|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434494|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
5434495|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434496|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434497|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434498|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434499|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434500|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434501|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434502|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434503|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434504|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
5434505|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434506|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434507|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434508|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434509|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434510|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434511|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434512|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434513|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434514|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434515|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434516|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434517|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434518|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
5434519|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434520|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434521|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434522|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434523|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434524|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434525|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434526|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434527|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434528|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
5434529|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434530|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434531|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434532|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434533|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434534|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434535|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434536|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434537|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434538|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434539|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434540|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434541|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434542|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
5434543|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434544|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434545|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434546|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434547|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434548|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434549|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434550|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434551|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434552|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434553|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434554|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434555|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434556|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
5434557|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434558|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434559|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434560|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434561|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434562|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434563|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434564|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434565|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434566|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
5434567|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434568|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434569|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434570|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434571|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434572|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434573|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434574|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434575|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434576|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434577|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434578|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434579|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434580|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434581|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
5434582|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434583|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434584|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434585|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434586|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434587|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434588|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434589|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434590|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
5434591|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434592|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434593|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434594|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434595|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434596|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434597|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434598|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434599|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434600|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5434601|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5434602|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434603|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5434604|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434605|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434606|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
5434607|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434608|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434609|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434610|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434611|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434612|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434613|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434614|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
5434615|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434616|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434617|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434618|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434619|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434620|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434621|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434622|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434623|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434624|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434625|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434626|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434627|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434628|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434629|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434630|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434631|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434632|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
5434633|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434634|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434635|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434636|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434637|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434638|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
5434639|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434640|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434641|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434642|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434643|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434644|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434645|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434646|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
5434647|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
5434648|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
5434649|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
5434650|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434651|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434652|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434653|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434654|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434655|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434656|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434657|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434658|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434659|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434660|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434661|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434662|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5434663|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434664|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434665|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434666|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434667|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434668|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434669|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434670|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5434671|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
5434672|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
5434673|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
5434674|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434675|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
5434676|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5434677|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434678|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5434679|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5434680|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5434681|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5434682|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434683|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434684|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434685|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434686|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5434687|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434688|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434689|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434690|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434691|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434692|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434693|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434694|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434695|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434696|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
5434697|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434698|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434699|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434700|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434701|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434702|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434703|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434704|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434705|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434706|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434707|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434708|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434709|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434710|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5434711|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434712|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434713|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434714|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434715|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434716|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434717|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434718|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434719|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
5434720|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434721|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5434722|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434723|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434724|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434725|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434726|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434727|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434728|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434729|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434730|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434731|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434732|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434733|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434734|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5434735|NCT02346240|18771756|P24|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434736|NCT02346240|18771757|P23|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434737|NCT02346240|18771758|P22|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434738|NCT02346240|18771759|P21|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434739|NCT02346240|18771760|P20|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434740|NCT02346240|18771761|P19|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434741|NCT02346240|18771762|P18|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434742|NCT02346240|18771763|P17|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5434743|NCT02346240|18771764|P16|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5434744|NCT02346240|18771765|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
5434745|NCT02346240|18771766|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5434746|NCT02346240|18771767|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434747|NCT02346240|18771768|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434748|NCT02346240|18771769|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434749|NCT02346240|18771770|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434750|NCT02346240|18771771|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5434751|NCT02346240|18771772|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5434752|NCT02346240|18771773|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434753|NCT02346240|18771774|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434754|NCT02346240|18771775|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434755|NCT02346240|18771776|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434756|NCT02346240|18771777|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434757|NCT02346240|18771778|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434758|NCT02346240|18771779|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5434759|NCT02346240|18771756|P24|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434760|NCT02346240|18771757|P23|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434761|NCT02346240|18771758|P22|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434762|NCT02346240|18771759|P21|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434763|NCT02346240|18771760|P20|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434764|NCT02346240|18771761|P19|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434765|NCT02346240|18771762|P18|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434766|NCT02346240|18771763|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434767|NCT02346240|18771764|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434768|NCT02346240|18771765|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434769|NCT02346240|18771766|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434770|NCT02346240|18771767|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434771|NCT02346240|18771768|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434772|NCT02346240|18771769|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434773|NCT02346240|18771770|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434774|NCT02346240|18771771|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434775|NCT02346240|18771772|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434776|NCT02346240|18771773|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434777|NCT02346240|18771774|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434778|NCT02346240|18771775|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434779|NCT02346240|18771776|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434780|NCT02346240|18771777|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
5434781|NCT02346240|18771778|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434782|NCT02346240|18771779|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
5434783|NCT02346240|18771756|P24|Initial Period (Baseline to Week 16)|Non-compliance|0
5434784|NCT02346240|18771757|P23|Initial Period (Baseline to Week 16)|Non-compliance|0
5434785|NCT02346240|18771758|P22|Initial Period (Baseline to Week 16)|Non-compliance|0
5434786|NCT02346240|18771759|P21|Initial Period (Baseline to Week 16)|Non-compliance|0
5434787|NCT02346240|18771760|P20|Initial Period (Baseline to Week 16)|Non-compliance|0
5434788|NCT02346240|18771761|P19|Initial Period (Baseline to Week 16)|Non-compliance|0
5434789|NCT02346240|18771762|P18|Initial Period (Baseline to Week 16)|Non-compliance|0
5434790|NCT02346240|18771763|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
5434791|NCT02346240|18771764|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
5434792|NCT02346240|18771765|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
5434793|NCT02346240|18771766|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
5434794|NCT02346240|18771767|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
5434795|NCT02346240|18771768|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
5434796|NCT02346240|18771769|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
5434797|NCT02346240|18771770|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
5434798|NCT02346240|18771771|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
5434799|NCT02346240|18771772|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
5434800|NCT02346240|18771773|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
5434801|NCT02346240|18771774|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
5434802|NCT02346240|18771775|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
5434803|NCT02346240|18771776|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
5434804|NCT02346240|18771777|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
5434805|NCT02346240|18771778|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
5434806|NCT02346240|18771779|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
5434807|NCT02346240|18771756|P24|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434808|NCT02346240|18771757|P23|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434809|NCT02346240|18771758|P22|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434810|NCT02346240|18771759|P21|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434811|NCT02346240|18771760|P20|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434812|NCT02346240|18771761|P19|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434813|NCT02346240|18771762|P18|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434814|NCT02346240|18771763|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434815|NCT02346240|18771764|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434816|NCT02346240|18771765|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434817|NCT02346240|18771766|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434818|NCT02346240|18771767|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434819|NCT02346240|18771768|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434820|NCT02346240|18771769|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434821|NCT02346240|18771770|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434822|NCT02346240|18771771|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434823|NCT02346240|18771772|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434824|NCT02346240|18771773|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434825|NCT02346240|18771774|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434826|NCT02346240|18771775|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
5434827|NCT02346240|18771776|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
5434828|NCT02346240|18771777|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
5434829|NCT02346240|18771778|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
5434830|NCT02346240|18771779|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
5434831|NCT02346240|18771756|P24|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434832|NCT02346240|18771757|P23|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434833|NCT02346240|18771758|P22|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434834|NCT02346240|18771759|P21|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434835|NCT02346240|18771760|P20|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434836|NCT02346240|18771761|P19|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434837|NCT02346240|18771762|P18|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434838|NCT02346240|18771763|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434839|NCT02346240|18771764|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434840|NCT02346240|18771765|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434841|NCT02346240|18771766|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434842|NCT02346240|18771767|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434843|NCT02346240|18771768|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434844|NCT02346240|18771769|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434845|NCT02346240|18771770|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434846|NCT02346240|18771771|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434847|NCT02346240|18771772|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434848|NCT02346240|18771773|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434849|NCT02346240|18771774|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434850|NCT02346240|18771775|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
5434851|NCT02346240|18771776|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
5434852|NCT02346240|18771777|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
5434853|NCT02346240|18771778|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
5434854|NCT02346240|18771779|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
5434855|NCT02346240|18771756|P24|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434856|NCT02346240|18771757|P23|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434857|NCT02346240|18771758|P22|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434858|NCT02346240|18771759|P21|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434859|NCT02346240|18771760|P20|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434860|NCT02346240|18771761|P19|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434861|NCT02346240|18771762|P18|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434862|NCT02346240|18771763|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434863|NCT02346240|18771764|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434864|NCT02346240|18771765|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434865|NCT02346240|18771766|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434866|NCT02346240|18771767|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434867|NCT02346240|18771768|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434868|NCT02346240|18771769|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434869|NCT02346240|18771770|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434870|NCT02346240|18771771|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434871|NCT02346240|18771772|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434872|NCT02346240|18771773|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434873|NCT02346240|18771774|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434874|NCT02346240|18771775|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434875|NCT02346240|18771776|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434876|NCT02346240|18771777|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434877|NCT02346240|18771778|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
5434878|NCT02346240|18771779|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
5434879|NCT02346240|18771756|P24|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434880|NCT02346240|18771757|P23|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434881|NCT02346240|18771758|P22|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434882|NCT02346240|18771759|P21|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434883|NCT02346240|18771760|P20|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434884|NCT02346240|18771761|P19|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434885|NCT02346240|18771762|P18|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434886|NCT02346240|18771763|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434887|NCT02346240|18771764|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434888|NCT02346240|18771765|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434889|NCT02346240|18771766|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434890|NCT02346240|18771767|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434891|NCT02346240|18771768|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434892|NCT02346240|18771769|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434893|NCT02346240|18771770|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434894|NCT02346240|18771771|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434895|NCT02346240|18771772|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434896|NCT02346240|18771773|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434897|NCT02346240|18771774|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434898|NCT02346240|18771775|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434899|NCT02346240|18771776|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434900|NCT02346240|18771777|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434901|NCT02346240|18771778|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
5434902|NCT02346240|18771779|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
5434903|NCT02346240|18771756|P24|Initial Period (Baseline to Week 16)|Adverse Event|0
5434904|NCT02346240|18771757|P23|Initial Period (Baseline to Week 16)|Adverse Event|0
5434905|NCT02346240|18771758|P22|Initial Period (Baseline to Week 16)|Adverse Event|0
5434906|NCT02346240|18771759|P21|Initial Period (Baseline to Week 16)|Adverse Event|0
5434907|NCT02346240|18771760|P20|Initial Period (Baseline to Week 16)|Adverse Event|0
5434908|NCT02346240|18771761|P19|Initial Period (Baseline to Week 16)|Adverse Event|0
5434909|NCT02346240|18771762|P18|Initial Period (Baseline to Week 16)|Adverse Event|0
5434910|NCT02346240|18771763|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
5434911|NCT02346240|18771764|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
5434912|NCT02346240|18771765|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
5434913|NCT02346240|18771766|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
5434914|NCT02346240|18771767|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
5434915|NCT02346240|18771768|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
5434916|NCT02346240|18771769|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
5434917|NCT02346240|18771770|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
5434918|NCT02346240|18771771|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
5434919|NCT02346240|18771772|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
5434920|NCT02346240|18771773|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
5434921|NCT02346240|18771774|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
5434922|NCT02346240|18771775|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
5434923|NCT02346240|18771776|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
5434924|NCT02346240|18771777|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
5434925|NCT02346240|18771778|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
5434926|NCT02346240|18771779|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
5434927|NCT02346136|18771818|P2|Overall Study|Study termination|18
5434928|NCT02346136|18771819|P1|Overall Study|Study termination|14
5434929|NCT02346136|18771818|P2|Overall Study|Death|0
5434930|NCT02346136|18771819|P1|Overall Study|Death|1
5434931|NCT02346136|18771818|P2|Overall Study|Withdrawal by Subject|5
5434932|NCT02346136|18771819|P1|Overall Study|Withdrawal by Subject|7
5434933|NCT02345889|18771855|P4|Overall Study|Cecum not intubated|0
5434934|NCT02345889|18771856|P3|Overall Study|Cecum not intubated|0
5434935|NCT02345889|18771857|P2|Overall Study|Cecum not intubated|0
5434936|NCT02345889|18771858|P1|Overall Study|Cecum not intubated|1
5434937|NCT02345889|18771855|P4|Overall Study|Ulcerative Colitis identified|0
5434938|NCT02345889|18771856|P3|Overall Study|Ulcerative Colitis identified|0
5434939|NCT02345889|18771857|P2|Overall Study|Ulcerative Colitis identified|0
5434940|NCT02345889|18771858|P1|Overall Study|Ulcerative Colitis identified|1
5434941|NCT02345889|18771855|P4|Overall Study|Recognized ineligible post-randomization|1
5434942|NCT02345889|18771856|P3|Overall Study|Recognized ineligible post-randomization|2
5434943|NCT02345889|18771857|P2|Overall Study|Recognized ineligible post-randomization|0
5434944|NCT02345889|18771858|P1|Overall Study|Recognized ineligible post-randomization|1
5434945|NCT02345889|18771855|P4|Overall Study|Polyposis identified during procedure|1
5434946|NCT02345889|18771856|P3|Overall Study|Polyposis identified during procedure|0
5434947|NCT02345889|18771857|P2|Overall Study|Polyposis identified during procedure|1
5434948|NCT02345889|18771858|P1|Overall Study|Polyposis identified during procedure|1
5434949|NCT02345889|18771855|P4|Overall Study|Inadequate Bowel Prep|14
5434950|NCT02345889|18771856|P3|Overall Study|Inadequate Bowel Prep|18
5434951|NCT02345889|18771857|P2|Overall Study|Inadequate Bowel Prep|16
5434952|NCT02345889|18771858|P1|Overall Study|Inadequate Bowel Prep|17
5434953|NCT02345811|18771924|P2|First Intervention|Withdrawal by Subject|1
5434954|NCT02345811|18771925|P1|First Intervention|Withdrawal by Subject|1
5434955|NCT02345512|18771976|P1|Overall Study|Withdrawal by Subject|1
5434956|NCT02345512|18771976|P1|Overall Study|Adverse Event|1
5434957|NCT02345330|18772070|P1|Overall Study|Progressive Disease|2
5434958|NCT02345330|18772070|P1|Overall Study|Death|1
5434959|NCT02345252|18772082|P2|Double-Blind Phase|Randomized but Never Treated|2
5434960|NCT02345252|18772083|P1|Double-Blind Phase|Randomized but Never Treated|0
5434963|NCT02345252|18772082|P2|Double-Blind Phase|Withdrew Consent|23
5434964|NCT02345252|18772083|P1|Double-Blind Phase|Withdrew Consent|21
5434965|NCT02345252|18772082|P2|Double-Blind Phase|Protocol Violation|1
5434966|NCT02345252|18772083|P1|Double-Blind Phase|Protocol Violation|2
5434967|NCT02345252|18772082|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
5434968|NCT02345252|18772083|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
5434969|NCT02345252|18772082|P2|Double-Blind Phase|Investigator's Discretion|6
5434970|NCT02345252|18772083|P1|Double-Blind Phase|Investigator's Discretion|4
5434971|NCT02345252|18772082|P2|Double-Blind Phase|Lack of Efficacy|0
5434972|NCT02345252|18772083|P1|Double-Blind Phase|Lack of Efficacy|1
5434973|NCT02345252|18772082|P2|Double-Blind Phase|Death|2
5434974|NCT02345252|18772083|P1|Double-Blind Phase|Death|1
5434975|NCT02345252|18772082|P2|Double-Blind Phase|Adverse Event|3
5434976|NCT02345252|18772083|P1|Double-Blind Phase|Adverse Event|2
5434977|NCT02345226|18772111|P2|Open-Label Extension Phase|Lost to Follow-up|1
5434978|NCT02345226|18772112|P1|Open-Label Extension Phase|Lost to Follow-up|0
5434979|NCT02345226|18772111|P2|Double-Blind Phase|Randomized but Never Treated|4
5434980|NCT02345226|18772112|P1|Double-Blind Phase|Randomized but Never Treated|2
5434981|NCT02345226|18772111|P2|Double-Blind Phase|Lost to Follow-up|16
5434982|NCT02345226|18772112|P1|Double-Blind Phase|Lost to Follow-up|12
5434983|NCT02345226|18772111|P2|Double-Blind Phase|Withdrew Consent|39
5434984|NCT02345226|18772112|P1|Double-Blind Phase|Withdrew Consent|41
5434985|NCT02345226|18772111|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
5434986|NCT02345226|18772112|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
5434987|NCT02345226|18772111|P2|Double-Blind Phase|Investigator's Discretion|3
5434988|NCT02345226|18772112|P1|Double-Blind Phase|Investigator's Discretion|4
5434989|NCT02345226|18772111|P2|Double-Blind Phase|Lack of Efficacy|0
5434990|NCT02345226|18772112|P1|Double-Blind Phase|Lack of Efficacy|1
5434991|NCT02345226|18772111|P2|Double-Blind Phase|Pregnancy|1
5434992|NCT02345226|18772112|P1|Double-Blind Phase|Pregnancy|0
5434993|NCT02345226|18772111|P2|Double-Blind Phase|Death|0
5434994|NCT02345226|18772112|P1|Double-Blind Phase|Death|3
5434995|NCT02345226|18772111|P2|Double-Blind Phase|Adverse Event|6
5434996|NCT02345226|18772112|P1|Double-Blind Phase|Adverse Event|5
5434997|NCT02345161|18772144|P2|Overall Study|Lost to Follow-up|1
5434998|NCT02345161|18772145|P1|Overall Study|Lost to Follow-up|0
5434999|NCT02345161|18772144|P2|Overall Study|Physician Decision|4
5435000|NCT02345161|18772145|P1|Overall Study|Physician Decision|4
5435001|NCT02345161|18772144|P2|Overall Study|Adverse Event|19
5435002|NCT02345161|18772145|P1|Overall Study|Adverse Event|16
5435003|NCT02345161|18772144|P2|Overall Study|Withdrawal by Subject|33
5435004|NCT02345161|18772145|P1|Overall Study|Withdrawal by Subject|25
5435005|NCT02345070|18772250|P3|Overall Study|Other than specified above|7
5435006|NCT02345070|18772251|P2|Overall Study|Other than specified above|3
5435007|NCT02345070|18772252|P1|Overall Study|Other than specified above|6
5435008|NCT02345070|18772250|P3|Overall Study|Poor compliance to protocol|0
5435009|NCT02345070|18772251|P2|Overall Study|Poor compliance to protocol|0
5435010|NCT02345070|18772252|P1|Overall Study|Poor compliance to protocol|2
5435011|NCT02345070|18772250|P3|Overall Study|Adverse Event|16
5435012|NCT02345070|18772251|P2|Overall Study|Adverse Event|8
5435013|NCT02345070|18772252|P1|Overall Study|Adverse Event|12
5435014|NCT02344745|18772285|P2|Overall Study|Data collection sheets were lost|0
5435015|NCT02344745|18772286|P1|Overall Study|Data collection sheets were lost|2
5435016|NCT02344576|18772315|P4|6-Month Follow-Up|Lost to Follow-up|6
5435017|NCT02344576|18772316|P3|6-Month Follow-Up|Lost to Follow-up|13
5435018|NCT02344576|18772317|P2|6-Month Follow-Up|Lost to Follow-up|5
5435019|NCT02344576|18772318|P1|6-Month Follow-Up|Lost to Follow-up|4
5435020|NCT02344576|18772315|P4|6-Month Follow-Up|Withdrawal by Subject|2
5435021|NCT02344576|18772316|P3|6-Month Follow-Up|Withdrawal by Subject|1
5435022|NCT02344576|18772317|P2|6-Month Follow-Up|Withdrawal by Subject|0
5435023|NCT02344576|18772318|P1|6-Month Follow-Up|Withdrawal by Subject|1
5435024|NCT02344576|18772315|P4|6-Month Follow-Up|Death|0
5435025|NCT02344576|18772316|P3|6-Month Follow-Up|Death|0
5435026|NCT02344576|18772317|P2|6-Month Follow-Up|Death|14
5435027|NCT02344576|18772318|P1|6-Month Follow-Up|Death|14
5435028|NCT02344576|18772315|P4|1-Month Follow-Up|Lost to Follow-up|3
5435029|NCT02344576|18772316|P3|1-Month Follow-Up|Lost to Follow-up|11
5435030|NCT02344576|18772317|P2|1-Month Follow-Up|Lost to Follow-up|5
5435031|NCT02344576|18772318|P1|1-Month Follow-Up|Lost to Follow-up|2
5435032|NCT02344576|18772315|P4|1-Month Follow-Up|Withdrawal by Subject|10
5435033|NCT02344576|18772316|P3|1-Month Follow-Up|Withdrawal by Subject|8
5435034|NCT02344576|18772317|P2|1-Month Follow-Up|Withdrawal by Subject|14
5435035|NCT02344576|18772318|P1|1-Month Follow-Up|Withdrawal by Subject|3
5435036|NCT02344576|18772315|P4|1-Month Follow-Up|Death|0
5435037|NCT02344576|18772316|P3|1-Month Follow-Up|Death|0
5435038|NCT02344576|18772317|P2|1-Month Follow-Up|Death|8
5435039|NCT02344576|18772318|P1|1-Month Follow-Up|Death|13
5435040|NCT02344576|18772315|P4|Enrollment|Agreed to Medical Record Review Only|0
5435041|NCT02344576|18772316|P3|Enrollment|Agreed to Medical Record Review Only|0
5435042|NCT02344576|18772317|P2|Enrollment|Agreed to Medical Record Review Only|8
5435043|NCT02344576|18772318|P1|Enrollment|Agreed to Medical Record Review Only|7
5435044|NCT02344342|18772381|P4|Overall Study|Industry partner dropped out|10
5435045|NCT02344342|18772382|P3|Overall Study|Industry partner dropped out|14
5435046|NCT02344342|18772383|P2|Overall Study|Industry partner dropped out|9
5435047|NCT02344342|18772384|P1|Overall Study|Industry partner dropped out|11
5435048|NCT02344173|18772450|P1|12-month Visit|Lost to Follow-up|58
5435049|NCT02344173|18772450|P1|12-month Visit|Withdrawal by Subject|30
5435050|NCT02344173|18772450|P1|12-month Visit|Death|8
5435051|NCT02344173|18772450|P1|Procedure|Ablation Procedure Not Performed|7
5435052|NCT02344004|18772458|P2|Overall Study|Protocol Violation|0
5435053|NCT02344004|18772459|P1|Overall Study|Protocol Violation|1
5435054|NCT02344004|18772458|P2|Overall Study|Other Not Specified|0
5435055|NCT02344004|18772459|P1|Overall Study|Other Not Specified|12
5435056|NCT02344004|18772458|P2|Overall Study|Rescue Medication|0
5435057|NCT02344004|18772459|P1|Overall Study|Rescue Medication|2
5435058|NCT02344004|18772458|P2|Overall Study|Withdrawal by Subject|5
5435059|NCT02344004|18772459|P1|Overall Study|Withdrawal by Subject|22
5435060|NCT02344004|18772458|P2|Overall Study|Physician Decision|1
5435061|NCT02344004|18772459|P1|Overall Study|Physician Decision|4
5435062|NCT02344004|18772458|P2|Overall Study|Death|7
5435063|NCT02344004|18772459|P1|Overall Study|Death|9
5435064|NCT02344004|18772458|P2|Overall Study|Adverse Event|1
5435065|NCT02344004|18772459|P1|Overall Study|Adverse Event|11
5435066|NCT02343939|18772486|P9|Overall Study|Never Treated With ENTO|0
5435067|NCT02343939|18772487|P8|Overall Study|Never Treated With ENTO|2
5435068|NCT02343939|18772488|P7|Overall Study|Never Treated With ENTO|1
5435069|NCT02343939|18772489|P6|Overall Study|Never Treated With ENTO|0
5435070|NCT02343939|18772490|P5|Overall Study|Never Treated With ENTO|0
5435071|NCT02343939|18772491|P4|Overall Study|Never Treated With ENTO|0
5435072|NCT02343939|18772492|P3|Overall Study|Never Treated With ENTO|0
5435073|NCT02343939|18772493|P2|Overall Study|Never Treated With ENTO|0
5435074|NCT02343939|18772494|P1|Overall Study|Never Treated With ENTO|0
5435075|NCT02343939|18772486|P9|Overall Study|Adverse Event|0
5435076|NCT02343939|18772487|P8|Overall Study|Adverse Event|0
5435077|NCT02343939|18772488|P7|Overall Study|Adverse Event|0
5435078|NCT02343939|18772489|P6|Overall Study|Adverse Event|1
5435079|NCT02343939|18772490|P5|Overall Study|Adverse Event|0
5435080|NCT02343939|18772491|P4|Overall Study|Adverse Event|0
5435081|NCT02343939|18772492|P3|Overall Study|Adverse Event|0
5435082|NCT02343939|18772493|P2|Overall Study|Adverse Event|0
5435083|NCT02343939|18772494|P1|Overall Study|Adverse Event|0
5435084|NCT02343939|18772486|P9|Overall Study|Investigator's discretion|0
5435085|NCT02343939|18772487|P8|Overall Study|Investigator's discretion|0
5435086|NCT02343939|18772488|P7|Overall Study|Investigator's discretion|1
5435087|NCT02343939|18772489|P6|Overall Study|Investigator's discretion|0
5435088|NCT02343939|18772490|P5|Overall Study|Investigator's discretion|0
5435089|NCT02343939|18772491|P4|Overall Study|Investigator's discretion|1
5435090|NCT02343939|18772492|P3|Overall Study|Investigator's discretion|0
5435091|NCT02343939|18772493|P2|Overall Study|Investigator's discretion|0
5435092|NCT02343939|18772494|P1|Overall Study|Investigator's discretion|0
5435093|NCT02343939|18772486|P9|Overall Study|Treatment failure|0
5435094|NCT02343939|18772487|P8|Overall Study|Treatment failure|1
5435095|NCT02343939|18772488|P7|Overall Study|Treatment failure|2
5435096|NCT02343939|18772489|P6|Overall Study|Treatment failure|0
5435097|NCT02343939|18772490|P5|Overall Study|Treatment failure|0
5435098|NCT02343939|18772491|P4|Overall Study|Treatment failure|0
5435099|NCT02343939|18772492|P3|Overall Study|Treatment failure|0
5435100|NCT02343939|18772493|P2|Overall Study|Treatment failure|0
5435101|NCT02343939|18772494|P1|Overall Study|Treatment failure|0
5435102|NCT02343939|18772486|P9|Overall Study|Withdrew consent|6
5435103|NCT02343939|18772487|P8|Overall Study|Withdrew consent|8
5435104|NCT02343939|18772488|P7|Overall Study|Withdrew consent|0
5435105|NCT02343939|18772489|P6|Overall Study|Withdrew consent|0
5435106|NCT02343939|18772490|P5|Overall Study|Withdrew consent|2
5435107|NCT02343939|18772491|P4|Overall Study|Withdrew consent|2
5435108|NCT02343939|18772492|P3|Overall Study|Withdrew consent|1
5435109|NCT02343939|18772493|P2|Overall Study|Withdrew consent|6
5435110|NCT02343939|18772494|P1|Overall Study|Withdrew consent|3
5435111|NCT02343939|18772486|P9|Overall Study|Study terminated by sponsor|0
5435112|NCT02343939|18772487|P8|Overall Study|Study terminated by sponsor|4
5435113|NCT02343939|18772488|P7|Overall Study|Study terminated by sponsor|3
5435114|NCT02343939|18772489|P6|Overall Study|Study terminated by sponsor|5
5435115|NCT02343939|18772490|P5|Overall Study|Study terminated by sponsor|1
5435116|NCT02343939|18772491|P4|Overall Study|Study terminated by sponsor|1
5435117|NCT02343939|18772492|P3|Overall Study|Study terminated by sponsor|0
5435118|NCT02343939|18772493|P2|Overall Study|Study terminated by sponsor|27
5435119|NCT02343939|18772494|P1|Overall Study|Study terminated by sponsor|0
5435120|NCT02343939|18772486|P9|Overall Study|Death|1
5435121|NCT02343939|18772487|P8|Overall Study|Death|22
5435122|NCT02343939|18772488|P7|Overall Study|Death|8
5435123|NCT02343939|18772489|P6|Overall Study|Death|11
5435124|NCT02343939|18772490|P5|Overall Study|Death|5
5435125|NCT02343939|18772491|P4|Overall Study|Death|2
5435126|NCT02343939|18772492|P3|Overall Study|Death|4
5435127|NCT02343939|18772493|P2|Overall Study|Death|15
5435128|NCT02343939|18772494|P1|Overall Study|Death|0
5435129|NCT02343458|18772636|P4|Overall Study|Protocol Specified Criteria|8
5435130|NCT02343458|18772637|P3|Overall Study|Protocol Specified Criteria|14
5435131|NCT02343458|18772638|P2|Overall Study|Protocol Specified Criteria|13
5435132|NCT02343458|18772639|P1|Overall Study|Protocol Specified Criteria|17
5435133|NCT02343458|18772636|P4|Overall Study|Protocol Violation|2
5435134|NCT02343458|18772637|P3|Overall Study|Protocol Violation|2
5435135|NCT02343458|18772638|P2|Overall Study|Protocol Violation|5
5435136|NCT02343458|18772639|P1|Overall Study|Protocol Violation|2
5435137|NCT02343458|18772636|P4|Overall Study|Lost to Follow-up|1
5435138|NCT02343458|18772637|P3|Overall Study|Lost to Follow-up|3
5435139|NCT02343458|18772638|P2|Overall Study|Lost to Follow-up|5
5435140|NCT02343458|18772639|P1|Overall Study|Lost to Follow-up|5
5435141|NCT02343458|18772636|P4|Overall Study|Physician Decision|2
5435142|NCT02343458|18772637|P3|Overall Study|Physician Decision|2
5435143|NCT02343458|18772638|P2|Overall Study|Physician Decision|4
5435144|NCT02343458|18772639|P1|Overall Study|Physician Decision|1
5435145|NCT02343458|18772636|P4|Overall Study|Withdrawal by Subject|14
5435146|NCT02343458|18772637|P3|Overall Study|Withdrawal by Subject|23
5435147|NCT02343458|18772638|P2|Overall Study|Withdrawal by Subject|17
5435148|NCT02343458|18772639|P1|Overall Study|Withdrawal by Subject|18
5435149|NCT02343458|18772636|P4|Overall Study|Lack of Efficacy|8
5435150|NCT02343458|18772637|P3|Overall Study|Lack of Efficacy|4
5435151|NCT02343458|18772638|P2|Overall Study|Lack of Efficacy|8
5435152|NCT02343458|18772639|P1|Overall Study|Lack of Efficacy|3
5435153|NCT02343458|18772636|P4|Overall Study|Adverse Event|3
5435154|NCT02343458|18772637|P3|Overall Study|Adverse Event|15
5435155|NCT02343458|18772638|P2|Overall Study|Adverse Event|14
5435156|NCT02343458|18772639|P1|Overall Study|Adverse Event|15
5435157|NCT02343406|18772718|P5|Overall Study|Other, not specified|0
5435158|NCT02343406|18772719|P4|Overall Study|Other, not specified|4
5435159|NCT02343406|18772720|P3|Overall Study|Other, not specified|1
5435160|NCT02343406|18772721|P2|Overall Study|Other, not specified|1
5435161|NCT02343406|18772722|P1|Overall Study|Other, not specified|2
5435162|NCT02343406|18772718|P5|Overall Study|Other primary malignancy|0
5435163|NCT02343406|18772719|P4|Overall Study|Other primary malignancy|0
5435164|NCT02343406|18772720|P3|Overall Study|Other primary malignancy|0
5435165|NCT02343406|18772721|P2|Overall Study|Other primary malignancy|1
5435166|NCT02343406|18772722|P1|Overall Study|Other primary malignancy|0
5435167|NCT02343406|18772718|P5|Overall Study|Start of a new anti-cancer treatment|0
5435168|NCT02343406|18772719|P4|Overall Study|Start of a new anti-cancer treatment|1
5435169|NCT02343406|18772720|P3|Overall Study|Start of a new anti-cancer treatment|0
5435170|NCT02343406|18772721|P2|Overall Study|Start of a new anti-cancer treatment|1
5435171|NCT02343406|18772722|P1|Overall Study|Start of a new anti-cancer treatment|0
5435172|NCT02343406|18772718|P5|Overall Study|Death|0
5435173|NCT02343406|18772719|P4|Overall Study|Death|0
5435174|NCT02343406|18772720|P3|Overall Study|Death|0
5435175|NCT02343406|18772721|P2|Overall Study|Death|1
5435176|NCT02343406|18772722|P1|Overall Study|Death|2
5435177|NCT02343406|18772718|P5|Overall Study|Withdrawal by Subject|0
5435178|NCT02343406|18772719|P4|Overall Study|Withdrawal by Subject|3
5435179|NCT02343406|18772720|P3|Overall Study|Withdrawal by Subject|8
5435180|NCT02343406|18772721|P2|Overall Study|Withdrawal by Subject|4
5435181|NCT02343406|18772722|P1|Overall Study|Withdrawal by Subject|6
5435182|NCT02343406|18772718|P5|Overall Study|Adverse Event|0
5435183|NCT02343406|18772719|P4|Overall Study|Adverse Event|3
5435184|NCT02343406|18772720|P3|Overall Study|Adverse Event|6
5435185|NCT02343406|18772721|P2|Overall Study|Adverse Event|8
5435186|NCT02343406|18772722|P1|Overall Study|Adverse Event|6
5435187|NCT02343406|18772718|P5|Overall Study|Progressive disease|5
5435188|NCT02343406|18772719|P4|Overall Study|Progressive disease|15
5435189|NCT02343406|18772720|P3|Overall Study|Progressive disease|43
5435190|NCT02343406|18772721|P2|Overall Study|Progressive disease|70
5435191|NCT02343406|18772722|P1|Overall Study|Progressive disease|72
5435192|NCT02343263|18772790|P3|Overall Study|Physician Decision|1
5435193|NCT02343263|18772791|P2|Overall Study|Physician Decision|3
5435194|NCT02343263|18772792|P1|Overall Study|Physician Decision|5
5435195|NCT02343159|18772821|P3|Overall Study|Enrollment Error|0
5435196|NCT02343159|18772822|P2|Overall Study|Enrollment Error|0
5435197|NCT02343159|18772823|P1|Overall Study|Enrollment Error|1
5435198|NCT02343159|18772821|P3|Overall Study|Sponsor Decision|0
5435199|NCT02343159|18772822|P2|Overall Study|Sponsor Decision|1
5435200|NCT02343159|18772823|P1|Overall Study|Sponsor Decision|0
5435201|NCT02343159|18772821|P3|Overall Study|Adverse Event|2
5435202|NCT02343159|18772822|P2|Overall Study|Adverse Event|4
5435203|NCT02343159|18772823|P1|Overall Study|Adverse Event|4
5435204|NCT02343159|18772821|P3|Overall Study|Lost to Follow-up|2
5435205|NCT02343159|18772822|P2|Overall Study|Lost to Follow-up|2
5435206|NCT02343159|18772823|P1|Overall Study|Lost to Follow-up|0
5435207|NCT02343159|18772821|P3|Overall Study|Withdrawal by Subject|2
5435208|NCT02343159|18772822|P2|Overall Study|Withdrawal by Subject|0
5435209|NCT02343159|18772823|P1|Overall Study|Withdrawal by Subject|3
5435210|NCT02343159|18772821|P3|Overall Study|Physician Decision|1
5435211|NCT02343159|18772822|P2|Overall Study|Physician Decision|0
5435212|NCT02343159|18772823|P1|Overall Study|Physician Decision|2
5435213|NCT02343159|18772821|P3|Overall Study|Early Study Termination|23
5435214|NCT02343159|18772822|P2|Overall Study|Early Study Termination|19
5435215|NCT02343159|18772823|P1|Overall Study|Early Study Termination|16
5435216|NCT02343003|18772867|P2|Overall Study|terminated by sponsor|0
5435217|NCT02343003|18772868|P1|Overall Study|terminated by sponsor|2
5435218|NCT02343003|18772867|P2|Overall Study|exclusion criteria met|1
5435219|NCT02343003|18772868|P1|Overall Study|exclusion criteria met|1
5435220|NCT02343003|18772867|P2|Overall Study|Death|1
5435221|NCT02343003|18772868|P1|Overall Study|Death|0
5435222|NCT02343003|18772867|P2|Overall Study|Protocol Violation|0
5435223|NCT02343003|18772868|P1|Overall Study|Protocol Violation|1
5435224|NCT02343003|18772867|P2|Overall Study|Lost to Follow-up|1
5435225|NCT02343003|18772868|P1|Overall Study|Lost to Follow-up|5
5435226|NCT02343003|18772867|P2|Overall Study|Withdrawal by Subject|4
5435227|NCT02343003|18772868|P1|Overall Study|Withdrawal by Subject|9
5435228|NCT02342886|18772889|P5|Overall Study|Protocol Violation|0
5435229|NCT02342886|18772890|P4|Overall Study|Protocol Violation|2
5435230|NCT02342886|18772891|P3|Overall Study|Protocol Violation|0
5435231|NCT02342886|18772892|P2|Overall Study|Protocol Violation|0
5435232|NCT02342886|18772893|P1|Overall Study|Protocol Violation|0
5435233|NCT02342886|18772889|P5|Overall Study|Late exclusion: pyrazinamide resistance|0
5435234|NCT02342886|18772890|P4|Overall Study|Late exclusion: pyrazinamide resistance|0
5435235|NCT02342886|18772891|P3|Overall Study|Late exclusion: pyrazinamide resistance|1
5435236|NCT02342886|18772892|P2|Overall Study|Late exclusion: pyrazinamide resistance|0
5435237|NCT02342886|18772893|P1|Overall Study|Late exclusion: pyrazinamide resistance|0
5435238|NCT02342886|18772889|P5|Overall Study|Pregnancy|0
5435239|NCT02342886|18772890|P4|Overall Study|Pregnancy|0
5435240|NCT02342886|18772891|P3|Overall Study|Pregnancy|2
5435241|NCT02342886|18772892|P2|Overall Study|Pregnancy|0
5435242|NCT02342886|18772893|P1|Overall Study|Pregnancy|0
5435243|NCT02342886|18772889|P5|Overall Study|Investigator/sponsor decision|1
5435244|NCT02342886|18772890|P4|Overall Study|Investigator/sponsor decision|3
5435245|NCT02342886|18772891|P3|Overall Study|Investigator/sponsor decision|0
5435246|NCT02342886|18772892|P2|Overall Study|Investigator/sponsor decision|2
5435247|NCT02342886|18772893|P1|Overall Study|Investigator/sponsor decision|0
5435248|NCT02342886|18772889|P5|Overall Study|Withdrawal by Subject|0
5435249|NCT02342886|18772890|P4|Overall Study|Withdrawal by Subject|1
5435250|NCT02342886|18772891|P3|Overall Study|Withdrawal by Subject|0
5435251|NCT02342886|18772892|P2|Overall Study|Withdrawal by Subject|1
5435252|NCT02342886|18772893|P1|Overall Study|Withdrawal by Subject|0
5435253|NCT02342886|18772889|P5|Overall Study|Death|1
5435254|NCT02342886|18772890|P4|Overall Study|Death|0
5435255|NCT02342886|18772891|P3|Overall Study|Death|1
5435256|NCT02342886|18772892|P2|Overall Study|Death|2
5435257|NCT02342886|18772893|P1|Overall Study|Death|1
5435258|NCT02342886|18772889|P5|Overall Study|Lost to Follow-up|0
5435259|NCT02342886|18772890|P4|Overall Study|Lost to Follow-up|0
5435260|NCT02342886|18772891|P3|Overall Study|Lost to Follow-up|0
5435261|NCT02342886|18772892|P2|Overall Study|Lost to Follow-up|0
5435262|NCT02342886|18772893|P1|Overall Study|Lost to Follow-up|1
5435263|NCT02342886|18772889|P5|Overall Study|Adverse event/specific toxicity|1
5435264|NCT02342886|18772890|P4|Overall Study|Adverse event/specific toxicity|2
5435265|NCT02342886|18772891|P3|Overall Study|Adverse event/specific toxicity|11
5435266|NCT02342886|18772892|P2|Overall Study|Adverse event/specific toxicity|3
5435267|NCT02342886|18772893|P1|Overall Study|Adverse event/specific toxicity|4
5435268|NCT02342886|18772889|P5|Overall Study|Late exclusion: rifampicin resistance|0
5435269|NCT02342886|18772890|P4|Overall Study|Late exclusion: rifampicin resistance|0
5435270|NCT02342886|18772891|P3|Overall Study|Late exclusion: rifampicin resistance|0
5435271|NCT02342886|18772892|P2|Overall Study|Late exclusion: rifampicin resistance|0
5435272|NCT02342886|18772893|P1|Overall Study|Late exclusion: rifampicin resistance|1
5435273|NCT02342886|18772889|P5|Overall Study|Treatment non-compliance|0
5435274|NCT02342886|18772890|P4|Overall Study|Treatment non-compliance|1
5435275|NCT02342886|18772891|P3|Overall Study|Treatment non-compliance|0
5435276|NCT02342886|18772892|P2|Overall Study|Treatment non-compliance|0
5435277|NCT02342886|18772893|P1|Overall Study|Treatment non-compliance|1
5435278|NCT02342743|18772910|P1|Treatment Period|Change in prophylactic medication|1
5435279|NCT02342743|18772910|P1|Treatment Period|Lost to Follow-up|8
5435280|NCT02342743|18772910|P1|Treatment Period|Withdrawal by Subject|2
5435281|NCT02342743|18772910|P1|Baseline Period|Screening failure regarding baseline|7
5435282|NCT02342743|18772910|P1|Baseline Period|Change in prophylactic medication|3
5435283|NCT02342743|18772910|P1|Baseline Period|Lost to Follow-up|2
5435284|NCT02342743|18772910|P1|Baseline Period|Withdrawal by Subject|3
5435285|NCT02342704|18772923|P2|Overall Study|Adverse Event|3
5435286|NCT02342704|18772924|P1|Overall Study|Adverse Event|1
5435287|NCT02342704|18772923|P2|Overall Study|Lost to Follow-up|1
5435288|NCT02342704|18772924|P1|Overall Study|Lost to Follow-up|2
5435289|NCT02342704|18772923|P2|Overall Study|Withdrawal by Subject|0
5435290|NCT02342704|18772924|P1|Overall Study|Withdrawal by Subject|1
5435291|NCT02342704|18772923|P2|Overall Study|Other|1
5435292|NCT02342704|18772924|P1|Overall Study|Other|0
5435293|NCT02342704|18772923|P2|Overall Study|Sponsor Termination|43
5435294|NCT02342704|18772924|P1|Overall Study|Sponsor Termination|49
5435295|NCT02342704|18772923|P2|Overall Study|Physician Decision|3
5435296|NCT02342704|18772924|P1|Overall Study|Physician Decision|0
5435297|NCT02342678|18772952|P2|Overall Study|Illness/medical reason|1
5435298|NCT02342678|18772953|P1|Overall Study|Illness/medical reason|1
5435299|NCT02342678|18772952|P2|Overall Study|Family illness/emergency|1
5435300|NCT02342678|18772953|P1|Overall Study|Family illness/emergency|0
5435301|NCT02342678|18772952|P2|Overall Study|Too busy to complete study|2
5435302|NCT02342678|18772953|P1|Overall Study|Too busy to complete study|0
5435303|NCT02342678|18772952|P2|Overall Study|Lost to Follow-up|1
5435304|NCT02342678|18772953|P1|Overall Study|Lost to Follow-up|0
5435305|NCT02342548|18772984|P3|Overall Study|Other|1
5435306|NCT02342548|18772985|P2|Overall Study|Other|1
5435307|NCT02342548|18772986|P1|Overall Study|Other|1
5435308|NCT02342548|18772984|P3|Overall Study|Withdrawal by Subject|4
5435309|NCT02342548|18772985|P2|Overall Study|Withdrawal by Subject|3
5435310|NCT02342548|18772986|P1|Overall Study|Withdrawal by Subject|1
5435311|NCT02342548|18772984|P3|Overall Study|Protocol Violation|0
5435312|NCT02342548|18772985|P2|Overall Study|Protocol Violation|1
5435313|NCT02342548|18772986|P1|Overall Study|Protocol Violation|0
5435314|NCT02342548|18772984|P3|Overall Study|Study terminated by sponsor|25
5435315|NCT02342548|18772985|P2|Overall Study|Study terminated by sponsor|39
5435316|NCT02342548|18772986|P1|Overall Study|Study terminated by sponsor|20
5435317|NCT02342548|18772984|P3|Overall Study|Lost to Follow-up|0
5435318|NCT02342548|18772985|P2|Overall Study|Lost to Follow-up|1
5435319|NCT02342548|18772986|P1|Overall Study|Lost to Follow-up|0
5435320|NCT02342548|18772984|P3|Overall Study|Adverse Event|13
5435321|NCT02342548|18772985|P2|Overall Study|Adverse Event|17
5435322|NCT02342548|18772986|P1|Overall Study|Adverse Event|12
5435323|NCT02342418|18773030|P2|Overall Study|Adverse Event|1
5435324|NCT02342418|18773031|P1|Overall Study|Adverse Event|0
5435325|NCT02342288|18773210|P2|Overall Study|coordinator not available|2
5435326|NCT02342288|18773211|P1|Overall Study|coordinator not available|0
5435327|NCT02342288|18773210|P2|Overall Study|subject cannot tolerate numbing drops|1
5435328|NCT02342288|18773211|P1|Overall Study|subject cannot tolerate numbing drops|0
5435329|NCT02342288|18773210|P2|Overall Study|coordinator contaminated with blood|1
5435330|NCT02342288|18773211|P1|Overall Study|coordinator contaminated with blood|0
5435331|NCT02342288|18773210|P2|Overall Study|Withdrawal by Subject|0
5435332|NCT02342288|18773211|P1|Overall Study|Withdrawal by Subject|1
5435333|NCT02342288|18773210|P2|Overall Study|anesthesia leak in system|0
5435334|NCT02342288|18773211|P1|Overall Study|anesthesia leak in system|1
5435335|NCT02342288|18773210|P2|Overall Study|no protocol anesthesiologist available|2
5435336|NCT02342288|18773211|P1|Overall Study|no protocol anesthesiologist available|3
5435337|NCT02342223|18773217|P1|Overall Study|Lost to Follow-up|1
5435338|NCT02342171|18773237|P2|Overall Study|Missing age data|1
5435339|NCT02342171|18773238|P1|Overall Study|Missing age data|0
5435340|NCT02342171|18773237|P2|Overall Study|Unknown outcome|1
5435341|NCT02342171|18773238|P1|Overall Study|Unknown outcome|0
5435342|NCT02342171|18773237|P2|Overall Study|Missing cycle treshold value|0
5435343|NCT02342171|18773238|P1|Overall Study|Missing cycle treshold value|1
5435344|NCT02342171|18773237|P2|Overall Study|Received favipiravir|0
5435345|NCT02342171|18773238|P1|Overall Study|Received favipiravir|10
5435346|NCT02342171|18773237|P2|Overall Study|Death|87
5435347|NCT02342171|18773238|P1|Overall Study|Death|4
5435348|NCT02341482|18773492|P1|Overall Study|Adverse Event|1
5435349|NCT02341456|18773521|P3|Overall Study|Physician Decision|0
5435350|NCT02341456|18773522|P2|Overall Study|Physician Decision|0
5435351|NCT02341456|18773523|P1|Overall Study|Physician Decision|1
5435352|NCT02341456|18773521|P3|Overall Study|Moved to local access programme.|1
5435353|NCT02341456|18773522|P2|Overall Study|Moved to local access programme.|1
5435354|NCT02341456|18773523|P1|Overall Study|Moved to local access programme.|0
5435355|NCT02341456|18773521|P3|Overall Study|Withdrawal by Subject|1
5435356|NCT02341456|18773522|P2|Overall Study|Withdrawal by Subject|1
5435357|NCT02341456|18773523|P1|Overall Study|Withdrawal by Subject|0
5435358|NCT02341456|18773521|P3|Overall Study|Death|1
5435359|NCT02341456|18773522|P2|Overall Study|Death|1
5435360|NCT02341456|18773523|P1|Overall Study|Death|1
5435361|NCT02341456|18773521|P3|Overall Study|Disease progression|1
5435362|NCT02341456|18773522|P2|Overall Study|Disease progression|3
5435363|NCT02341456|18773523|P1|Overall Study|Disease progression|2
5435364|NCT02341417|18773648|P3|Overall Study|Death|1
5435365|NCT02341417|18773649|P2|Overall Study|Death|0
5435366|NCT02341417|18773650|P1|Overall Study|Death|0
5435367|NCT02341417|18773648|P3|Overall Study|Decision by sponsor|0
5435368|NCT02341417|18773649|P2|Overall Study|Decision by sponsor|0
5435369|NCT02341417|18773650|P1|Overall Study|Decision by sponsor|2
5435370|NCT02341417|18773648|P3|Overall Study|Withdrawal by Subject|0
5435371|NCT02341417|18773649|P2|Overall Study|Withdrawal by Subject|2
5435372|NCT02341417|18773650|P1|Overall Study|Withdrawal by Subject|0
5435373|NCT02340975|18773715|P6|Overall Study|Other|6
5435374|NCT02340975|18773716|P5|Overall Study|Other|0
5435375|NCT02340975|18773717|P4|Overall Study|Other|2
5435376|NCT02340975|18773718|P3|Overall Study|Other|0
5435377|NCT02340975|18773719|P2|Overall Study|Other|4
5435378|NCT02340975|18773720|P1|Overall Study|Other|0
5435379|NCT02340975|18773715|P6|Overall Study|Withdrawal by Subject|0
5435380|NCT02340975|18773716|P5|Overall Study|Withdrawal by Subject|2
5435381|NCT02340975|18773717|P4|Overall Study|Withdrawal by Subject|3
5435382|NCT02340975|18773718|P3|Overall Study|Withdrawal by Subject|3
5435383|NCT02340975|18773719|P2|Overall Study|Withdrawal by Subject|0
5435384|NCT02340975|18773720|P1|Overall Study|Withdrawal by Subject|0
5435385|NCT02340975|18773715|P6|Overall Study|Lost to Follow-up|0
5435386|NCT02340975|18773716|P5|Overall Study|Lost to Follow-up|2
5435387|NCT02340975|18773717|P4|Overall Study|Lost to Follow-up|0
5435388|NCT02340975|18773718|P3|Overall Study|Lost to Follow-up|0
5435389|NCT02340975|18773719|P2|Overall Study|Lost to Follow-up|0
5435390|NCT02340975|18773720|P1|Overall Study|Lost to Follow-up|0
5435391|NCT02340975|18773715|P6|Overall Study|Death|13
5435392|NCT02340975|18773716|P5|Overall Study|Death|21
5435393|NCT02340975|18773717|P4|Overall Study|Death|7
5435394|NCT02340975|18773718|P3|Overall Study|Death|21
5435395|NCT02340975|18773719|P2|Overall Study|Death|23
5435396|NCT02340975|18773720|P1|Overall Study|Death|6
5435397|NCT02340962|18773834|P2|Overall Study|Lost to Follow-up|0
5435398|NCT02340962|18773835|P1|Overall Study|Lost to Follow-up|1
5435399|NCT02340819|18773855|P1|Overall Study|Discontinued with other reason|1
5435400|NCT02340819|18773855|P1|Overall Study|Withdrawal by Subject|2
5435401|NCT02340819|18773855|P1|Overall Study|Adverse Event|1
5435402|NCT02340806|18773884|P2|Overall Study|re-dose < 90 min of CSE|3
5435403|NCT02340806|18773885|P1|Overall Study|re-dose < 90 min of CSE|1
5435404|NCT02340806|18773884|P2|Overall Study|history of chronic pain medication|0
5435405|NCT02340806|18773885|P1|Overall Study|history of chronic pain medication|1
5435406|NCT02340806|18773884|P2|Overall Study|epidural catheter replaced|1
5435407|NCT02340806|18773885|P1|Overall Study|epidural catheter replaced|2
5435408|NCT02340806|18773884|P2|Overall Study|Protocol Violation|0
5435409|NCT02340806|18773885|P1|Overall Study|Protocol Violation|2
5435410|NCT02340780|18773911|P1|Overall Study|Ineligible|1
5435411|NCT02340663|18773979|P2|Overall Study|Withdrawal by Subject|1
5435412|NCT02340663|18773980|P1|Overall Study|Withdrawal by Subject|3
5435413|NCT02340663|18773979|P2|Overall Study|Protocol Violation|0
5435414|NCT02340663|18773980|P1|Overall Study|Protocol Violation|1
5435415|NCT02340663|18773979|P2|Overall Study|Lost to Follow-up|0
5435416|NCT02340663|18773980|P1|Overall Study|Lost to Follow-up|1
5435417|NCT02340520|18774036|P1|Overall Study|Withdrawal by Subject|1
5435418|NCT02340520|18774036|P1|Overall Study|Patient did not take drug as specified|1
5435419|NCT02340520|18774036|P1|Overall Study|Lost to Follow-up|1
5435420|NCT02340221|18774088|P2|Overall Study|Continued on study|290
5435421|NCT02340221|18774089|P1|Overall Study|Continued on study|140
5435422|NCT02340221|18774088|P2|Overall Study|Reason Not Specified|1
5435423|NCT02340221|18774089|P1|Overall Study|Reason Not Specified|0
5435424|NCT02340221|18774088|P2|Overall Study|Lost to Follow-up|3
5435425|NCT02340221|18774089|P1|Overall Study|Lost to Follow-up|2
5435426|NCT02340221|18774088|P2|Overall Study|Withdrawal by Participant|22
5435427|NCT02340221|18774089|P1|Overall Study|Withdrawal by Participant|14
5435428|NCT02340221|18774088|P2|Overall Study|Death|101
5435429|NCT02340221|18774089|P1|Overall Study|Death|58
5435430|NCT02340078|18774123|P1|Overall Study|Protocol Violation|1
5435431|NCT02340000|18774130|P2|Time Period 2|Lost to Follow-up|8
5435432|NCT02340000|18774131|P1|Time Period 2|Lost to Follow-up|10
5435433|NCT02340000|18774130|P2|Time Period 2|Withdrawal by Subject|7
5435434|NCT02340000|18774131|P1|Time Period 2|Withdrawal by Subject|9
5435435|NCT02340000|18774130|P2|Time Period 1|Lost to Follow-up|7
5435436|NCT02340000|18774131|P1|Time Period 1|Lost to Follow-up|6
5435437|NCT02340000|18774130|P2|Time Period 1|Withdrawal by Subject|8
5435438|NCT02340000|18774131|P1|Time Period 1|Withdrawal by Subject|6
5435439|NCT02339909|18774161|P3|Overall Study|Became ineligible after randomisation|71
5435440|NCT02339909|18774162|P2|Overall Study|Became ineligible after randomisation|63
5435441|NCT02339909|18774163|P1|Overall Study|Became ineligible after randomisation|89
5435442|NCT02339584|18774201|P2|Overall Study|Withdrawal by Subject|4
5435443|NCT02339584|18774202|P1|Overall Study|Withdrawal by Subject|2
5435444|NCT02339584|18774201|P2|Overall Study|Protocol Violation|1
5435445|NCT02339584|18774202|P1|Overall Study|Protocol Violation|1
5435446|NCT02339584|18774201|P2|Overall Study|Physician Decision|2
5435447|NCT02339584|18774202|P1|Overall Study|Physician Decision|1
5435448|NCT02339584|18774201|P2|Overall Study|Lack of Efficacy|1
5435449|NCT02339584|18774202|P1|Overall Study|Lack of Efficacy|0
5435450|NCT02339584|18774201|P2|Overall Study|Adverse Event|7
5435451|NCT02339584|18774202|P1|Overall Study|Adverse Event|11
5435452|NCT02339506|18774222|P2|Washout (Period 2)|Withdrawal by Subject|0
5435453|NCT02339506|18774223|P1|Washout (Period 2)|Withdrawal by Subject|2
5435454|NCT02339506|18774222|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
5435455|NCT02339506|18774223|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
5435456|NCT02339285|18774252|P3|Overall Study|Protocol Deviation|0
5435457|NCT02339285|18774253|P2|Overall Study|Protocol Deviation|1
5435458|NCT02339285|18774254|P1|Overall Study|Protocol Deviation|0
5435459|NCT02339285|18774252|P3|Overall Study|Lost to Follow-up|1
5435460|NCT02339285|18774253|P2|Overall Study|Lost to Follow-up|1
5435461|NCT02339285|18774254|P1|Overall Study|Lost to Follow-up|1
5435462|NCT02339285|18774252|P3|Overall Study|Withdrawal by Subject|1
5435463|NCT02339285|18774253|P2|Overall Study|Withdrawal by Subject|1
5435464|NCT02339285|18774254|P1|Overall Study|Withdrawal by Subject|0
5435465|NCT02339155|18774300|P2|Overall Study|Withdrawal by Subject|4
5435466|NCT02339155|18774301|P1|Overall Study|Withdrawal by Subject|4
5435467|NCT02339155|18774300|P2|Overall Study|Physician Decision|1
5435468|NCT02339155|18774301|P1|Overall Study|Physician Decision|2
5435469|NCT02339155|18774300|P2|Overall Study|Lost to Follow-up|9
5435470|NCT02339155|18774301|P1|Overall Study|Lost to Follow-up|8
5435471|NCT02339155|18774300|P2|Overall Study|Death|1
5435472|NCT02339155|18774301|P1|Overall Study|Death|1
5435473|NCT02339155|18774300|P2|Overall Study|Adverse Event|6
5435474|NCT02339155|18774301|P1|Overall Study|Adverse Event|0
5435475|NCT02338882|18774507|P2|Overall Study|Lost to Follow-up|3
5435476|NCT02338882|18774508|P1|Overall Study|Lost to Follow-up|6
5435477|NCT02338882|18774507|P2|Overall Study|Death|0
5435478|NCT02338882|18774508|P1|Overall Study|Death|1
5435479|NCT02338843|18774546|P2|Overall Study|Discontinued prior to randomizat|0
5435480|NCT02338843|18774547|P1|Overall Study|Discontinued prior to randomizat|1
5435481|NCT02338843|18774546|P2|Overall Study|Subject Recovered|2
5435482|NCT02338843|18774547|P1|Overall Study|Subject Recovered|0
5435483|NCT02338843|18774546|P2|Overall Study|Withdrawal by Subject|2
5435484|NCT02338843|18774547|P1|Overall Study|Withdrawal by Subject|0
5435485|NCT02338843|18774546|P2|Overall Study|Physician Decision|0
5435486|NCT02338843|18774547|P1|Overall Study|Physician Decision|1
5435487|NCT02338843|18774546|P2|Overall Study|Death|53
5435488|NCT02338843|18774547|P1|Overall Study|Death|40
5435489|NCT02338843|18774546|P2|Overall Study|Adverse Event|1
5435490|NCT02338843|18774547|P1|Overall Study|Adverse Event|2
5435491|NCT02338492|18774575|P1|Overall Study|Reason not captured above|6
5435492|NCT02338492|18774575|P1|Overall Study|Lost to Follow-up|4
5435493|NCT02338492|18774575|P1|Overall Study|Adverse Event|3
5435494|NCT02338492|18774575|P1|Overall Study|Death|32
5435495|NCT02338362|18774591|P2|Overall Study|Withdrawal by Subject|1
5435496|NCT02338362|18774592|P1|Overall Study|Withdrawal by Subject|1
5435497|NCT02338193|18774622|P3|Overall Study|intolerant of side effects|0
5435498|NCT02338193|18774623|P2|Overall Study|intolerant of side effects|0
5435499|NCT02338193|18774624|P1|Overall Study|intolerant of side effects|1
5435500|NCT02338193|18774622|P3|Overall Study|moved out of state|0
5435501|NCT02338193|18774623|P2|Overall Study|moved out of state|1
5435502|NCT02338193|18774624|P1|Overall Study|moved out of state|0
5435503|NCT02338193|18774622|P3|Overall Study|Noncompliant with visits|7
5435504|NCT02338193|18774623|P2|Overall Study|Noncompliant with visits|2
5435505|NCT02338193|18774624|P1|Overall Study|Noncompliant with visits|2
5435506|NCT02338193|18774622|P3|Overall Study|Pregnancy|1
5435507|NCT02338193|18774623|P2|Overall Study|Pregnancy|1
5435508|NCT02338193|18774624|P1|Overall Study|Pregnancy|0
5435509|NCT02338193|18774622|P3|Overall Study|Withdrawal by Subject|2
5435510|NCT02338193|18774623|P2|Overall Study|Withdrawal by Subject|0
5435511|NCT02338193|18774624|P1|Overall Study|Withdrawal by Subject|0
5435512|NCT02338154|18774677|P1|Overall Study|Missing Exit Reason on Exit Form|1
5435513|NCT02338154|18774677|P1|Overall Study|Patients Without Exit Form|47
5435514|NCT02338154|18774677|P1|Overall Study|Other Reason|3
5435515|NCT02338154|18774677|P1|Overall Study|Lost to Follow-up|8
5435516|NCT02338154|18774677|P1|Overall Study|Withdrawal by Subject or by Investigator|10
5435517|NCT02338154|18774677|P1|Overall Study|Valve Explant|11
5435518|NCT02338154|18774677|P1|Overall Study|Valve Implant Failure|17
5435519|NCT02338154|18774677|P1|Overall Study|Death|46
5435520|NCT02337946|18774801|P3|Protocol Treatment 2 Period|Reason not specified|4
5435521|NCT02337946|18774802|P2|Protocol Treatment 2 Period|Reason not specified|4
5435522|NCT02337946|18774803|P1|Protocol Treatment 2 Period|Reason not specified|0
5435523|NCT02337946|18774801|P3|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
5435524|NCT02337946|18774802|P2|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
5435525|NCT02337946|18774803|P1|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
5435526|NCT02337946|18774801|P3|Protocol Treatment 2 Period|Death During Protocol Treatment|0
5435527|NCT02337946|18774802|P2|Protocol Treatment 2 Period|Death During Protocol Treatment|1
5435528|NCT02337946|18774803|P1|Protocol Treatment 2 Period|Death During Protocol Treatment|0
5435529|NCT02337946|18774801|P3|Protocol Treatment 2 Period|Lack of Efficacy|29
5435530|NCT02337946|18774802|P2|Protocol Treatment 2 Period|Lack of Efficacy|29
5435531|NCT02337946|18774803|P1|Protocol Treatment 2 Period|Lack of Efficacy|0
5435532|NCT02337946|18774801|P3|Protocol Treatment 2 Period|Voluntary Withdrawal|1
5435533|NCT02337946|18774802|P2|Protocol Treatment 2 Period|Voluntary Withdrawal|3
5435534|NCT02337946|18774803|P1|Protocol Treatment 2 Period|Voluntary Withdrawal|0
5435535|NCT02337946|18774801|P3|Protocol Treatment 2 Period|Adverse Event|9
5435536|NCT02337946|18774802|P2|Protocol Treatment 2 Period|Adverse Event|9
5435537|NCT02337946|18774803|P1|Protocol Treatment 2 Period|Adverse Event|0
5435538|NCT02337946|18774801|P3|In-between Period|Without Informed Consent|0
5435539|NCT02337946|18774802|P2|In-between Period|Without Informed Consent|0
5435540|NCT02337946|18774803|P1|In-between Period|Without Informed Consent|1
5435541|NCT02337946|18774801|P3|Protocol Treatment 1 Period|Reason not specified|0
5435542|NCT02337946|18774802|P2|Protocol Treatment 1 Period|Reason not specified|0
5435543|NCT02337946|18774803|P1|Protocol Treatment 1 Period|Reason not specified|8
5435544|NCT02337946|18774801|P3|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
5435545|NCT02337946|18774802|P2|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
5435546|NCT02337946|18774803|P1|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
5435547|NCT02337946|18774801|P3|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
5435548|NCT02337946|18774802|P2|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
5435549|NCT02337946|18774803|P1|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
5435550|NCT02337946|18774801|P3|Protocol Treatment 1 Period|Death During Protocol Treatment|0
5435551|NCT02337946|18774802|P2|Protocol Treatment 1 Period|Death During Protocol Treatment|0
5435552|NCT02337946|18774803|P1|Protocol Treatment 1 Period|Death During Protocol Treatment|3
5435553|NCT02337946|18774801|P3|Protocol Treatment 1 Period|Lack of Efficacy|0
5435554|NCT02337946|18774802|P2|Protocol Treatment 1 Period|Lack of Efficacy|0
5435555|NCT02337946|18774803|P1|Protocol Treatment 1 Period|Lack of Efficacy|15
5435556|NCT02337946|18774801|P3|Protocol Treatment 1 Period|Voluntary Withdrawal|0
5435557|NCT02337946|18774802|P2|Protocol Treatment 1 Period|Voluntary Withdrawal|0
5435558|NCT02337946|18774803|P1|Protocol Treatment 1 Period|Voluntary Withdrawal|6
5435559|NCT02337946|18774801|P3|Protocol Treatment 1 Period|Major Protocol Deviation|0
5435560|NCT02337946|18774802|P2|Protocol Treatment 1 Period|Major Protocol Deviation|0
5435561|NCT02337946|18774803|P1|Protocol Treatment 1 Period|Major Protocol Deviation|1
5435562|NCT02337946|18774801|P3|Protocol Treatment 1 Period|Adverse Event|0
5435563|NCT02337946|18774802|P2|Protocol Treatment 1 Period|Adverse Event|0
5435564|NCT02337946|18774803|P1|Protocol Treatment 1 Period|Adverse Event|7
5435565|NCT02337907|18774864|P6|Overall Study|Adverse Event|0
5435566|NCT02337907|18774865|P5|Overall Study|Adverse Event|4
5435567|NCT02337907|18774866|P4|Overall Study|Adverse Event|1
5435568|NCT02337907|18774867|P3|Overall Study|Adverse Event|1
5435569|NCT02337907|18774868|P2|Overall Study|Adverse Event|1
5435570|NCT02337907|18774869|P1|Overall Study|Adverse Event|1
5435571|NCT02337907|18774864|P6|Overall Study|Lost to Follow-up|1
5435572|NCT02337907|18774865|P5|Overall Study|Lost to Follow-up|0
5435573|NCT02337907|18774866|P4|Overall Study|Lost to Follow-up|0
5435574|NCT02337907|18774867|P3|Overall Study|Lost to Follow-up|0
5435575|NCT02337907|18774868|P2|Overall Study|Lost to Follow-up|0
5435576|NCT02337907|18774869|P1|Overall Study|Lost to Follow-up|0
5435577|NCT02337907|18774864|P6|Overall Study|Withdrawal by Subject|0
5435578|NCT02337907|18774865|P5|Overall Study|Withdrawal by Subject|5
5435579|NCT02337907|18774866|P4|Overall Study|Withdrawal by Subject|2
5435580|NCT02337907|18774867|P3|Overall Study|Withdrawal by Subject|0
5435581|NCT02337907|18774868|P2|Overall Study|Withdrawal by Subject|3
5435582|NCT02337907|18774869|P1|Overall Study|Withdrawal by Subject|2
5435583|NCT02337907|18774864|P6|Overall Study|Other than listed|0
5435584|NCT02337907|18774865|P5|Overall Study|Other than listed|1
5435585|NCT02337907|18774866|P4|Overall Study|Other than listed|1
5435586|NCT02337907|18774867|P3|Overall Study|Other than listed|0
5435587|NCT02337907|18774868|P2|Overall Study|Other than listed|0
5435588|NCT02337907|18774869|P1|Overall Study|Other than listed|1
5435589|NCT02337764|18774904|P1|Overall Study|Lack of Efficacy|2
5435590|NCT02337764|18774904|P1|Overall Study|Voluntary Withdrawal|12
5435591|NCT02337764|18774904|P1|Overall Study|Pretreatment Event/Adverse Event|46
5435592|NCT02337751|18774917|P2|Overall Study|Investigator's Judgement|0
5435593|NCT02337751|18774918|P1|Overall Study|Investigator's Judgement|1
5435594|NCT02337751|18774917|P2|Overall Study|Lack of Efficacy|5
5435595|NCT02337751|18774918|P1|Overall Study|Lack of Efficacy|2
5435596|NCT02337751|18774917|P2|Overall Study|Voluntary Withdrawal|8
5435597|NCT02337751|18774918|P1|Overall Study|Voluntary Withdrawal|6
5435598|NCT02337751|18774917|P2|Overall Study|Pretreatment Event/Adverse Event|3
5435599|NCT02337751|18774918|P1|Overall Study|Pretreatment Event/Adverse Event|2
5435600|NCT02337738|18774937|P3|Overall Study|Investigator's Judgment|3
5435601|NCT02337738|18774938|P2|Overall Study|Investigator's Judgment|1
5435602|NCT02337738|18774939|P1|Overall Study|Investigator's Judgment|1
5435603|NCT02337738|18774937|P3|Overall Study|Lack of Efficacy|0
5435604|NCT02337738|18774938|P2|Overall Study|Lack of Efficacy|4
5435605|NCT02337738|18774939|P1|Overall Study|Lack of Efficacy|2
5435606|NCT02337738|18774937|P3|Overall Study|Voluntary Withdrawal|2
5435607|NCT02337738|18774938|P2|Overall Study|Voluntary Withdrawal|5
5435608|NCT02337738|18774939|P1|Overall Study|Voluntary Withdrawal|10
5435609|NCT02337738|18774937|P3|Overall Study|Major Protocol Deviation (in-Treatment)|0
5435610|NCT02337738|18774938|P2|Overall Study|Major Protocol Deviation (in-Treatment)|1
5435611|NCT02337738|18774939|P1|Overall Study|Major Protocol Deviation (in-Treatment)|0
5435612|NCT02337738|18774937|P3|Overall Study|Pretreatment Event/Adverse Event|21
5435613|NCT02337738|18774938|P2|Overall Study|Pretreatment Event/Adverse Event|18
5435614|NCT02337738|18774939|P1|Overall Study|Pretreatment Event/Adverse Event|9
5435615|NCT02337738|18774937|P3|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
5435616|NCT02337738|18774938|P2|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
5435617|NCT02337738|18774939|P1|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
5435618|NCT02337725|18774979|P2|Overall Study|Lack of Efficacy|0
5435619|NCT02337725|18774980|P1|Overall Study|Lack of Efficacy|4
5435620|NCT02337725|18774979|P2|Overall Study|Voluntary Withdrawal|3
5435621|NCT02337725|18774980|P1|Overall Study|Voluntary Withdrawal|14
5435622|NCT02337725|18774979|P2|Overall Study|Major Protocol Deviation|1
5435623|NCT02337725|18774980|P1|Overall Study|Major Protocol Deviation|0
5435624|NCT02337725|18774979|P2|Overall Study|Pretreatment Event/AE in Treatment|3
5435625|NCT02337725|18774980|P1|Overall Study|Pretreatment Event/AE in Treatment|8
5435626|NCT02337725|18774979|P2|Overall Study|Pretreatment Event/AE before Treatment|1
5435627|NCT02337725|18774980|P1|Overall Study|Pretreatment Event/AE before Treatment|0
5435628|NCT02337491|18775004|P2|Overall Study|On Treatment|0
5435629|NCT02337491|18775005|P1|Overall Study|On Treatment|2
5435630|NCT02337491|18775004|P2|Overall Study|Progressive Disease|28
5435631|NCT02337491|18775005|P1|Overall Study|Progressive Disease|44
5435632|NCT02337491|18775004|P2|Overall Study|Withdrawal by Subject|0
5435633|NCT02337491|18775005|P1|Overall Study|Withdrawal by Subject|3
5435634|NCT02337491|18775004|P2|Overall Study|Adverse Event|1
5435635|NCT02337491|18775005|P1|Overall Study|Adverse Event|0
5435636|NCT02337491|18775004|P2|Overall Study|Death|1
5435637|NCT02337491|18775005|P1|Overall Study|Death|1
5435638|NCT02337478|18775019|P1|Overall Study|Lack of Efficacy|5
5435639|NCT02337387|18775029|P4|Overall Study|Sponsor Decision to Terminate Study|3
5435640|NCT02337387|18775030|P3|Overall Study|Sponsor Decision to Terminate Study|3
5435641|NCT02337387|18775031|P2|Overall Study|Sponsor Decision to Terminate Study|7
5435642|NCT02337387|18775032|P1|Overall Study|Sponsor Decision to Terminate Study|14
5435643|NCT02337387|18775029|P4|Overall Study|Adverse Event|0
5435644|NCT02337387|18775030|P3|Overall Study|Adverse Event|0
5435645|NCT02337387|18775031|P2|Overall Study|Adverse Event|1
5435646|NCT02337387|18775032|P1|Overall Study|Adverse Event|0
5435647|NCT02337361|18775050|P2|6-month Follow-up|Lost to Follow-up|4
5435648|NCT02337361|18775051|P1|6-month Follow-up|Lost to Follow-up|2
5435649|NCT02337361|18775050|P2|3-month Follow-up|Lost to Follow-up|14
5435650|NCT02337361|18775051|P1|3-month Follow-up|Lost to Follow-up|19
5435651|NCT02336815|18775114|P2|Overall Study|Other|5
5435652|NCT02336815|18775115|P1|Overall Study|Other|1
5435653|NCT02336815|18775114|P2|Overall Study|Lost to Follow-up|3
5435654|NCT02336815|18775115|P1|Overall Study|Lost to Follow-up|1
5435655|NCT02336815|18775114|P2|Overall Study|Withdrawal by Subject|2
5435656|NCT02336815|18775115|P1|Overall Study|Withdrawal by Subject|3
5435657|NCT02336815|18775114|P2|Overall Study|Physician Decision|4
5435658|NCT02336815|18775115|P1|Overall Study|Physician Decision|11
5435659|NCT02336815|18775114|P2|Overall Study|Adverse Event|39
5435660|NCT02336815|18775115|P1|Overall Study|Adverse Event|18
5435661|NCT02336815|18775114|P2|Overall Study|Disease Progression|70
5435662|NCT02336815|18775115|P1|Overall Study|Disease Progression|45
5435663|NCT02336737|18775152|P1|Overall Study|Physician Decision|8
5435664|NCT02336737|18775152|P1|Overall Study|Withdrawal by Subject|5
5435665|NCT02336607|18775163|P4|Overall Study|Withdrawal by Subject|20
5435666|NCT02336607|18775164|P3|Overall Study|Withdrawal by Subject|0
5435667|NCT02336607|18775165|P2|Overall Study|Withdrawal by Subject|2
5435668|NCT02336607|18775166|P1|Overall Study|Withdrawal by Subject|0
5435669|NCT02336607|18775163|P4|Overall Study|Adverse Event|26
5435670|NCT02336607|18775164|P3|Overall Study|Adverse Event|2
5435671|NCT02336607|18775165|P2|Overall Study|Adverse Event|2
5435672|NCT02336607|18775166|P1|Overall Study|Adverse Event|0
5435673|NCT02336607|18775163|P4|Overall Study|Protocol Violation|3
5435674|NCT02336607|18775164|P3|Overall Study|Protocol Violation|1
5435675|NCT02336607|18775165|P2|Overall Study|Protocol Violation|1
5435676|NCT02336607|18775166|P1|Overall Study|Protocol Violation|0
5435677|NCT02336607|18775163|P4|Overall Study|Lost to Follow-up|21
5435678|NCT02336607|18775164|P3|Overall Study|Lost to Follow-up|0
5435679|NCT02336607|18775165|P2|Overall Study|Lost to Follow-up|1
5435680|NCT02336607|18775166|P1|Overall Study|Lost to Follow-up|2
5435681|NCT02336607|18775163|P4|Overall Study|Lack of Efficacy|2
5435682|NCT02336607|18775164|P3|Overall Study|Lack of Efficacy|0
5435683|NCT02336607|18775165|P2|Overall Study|Lack of Efficacy|0
5435684|NCT02336607|18775166|P1|Overall Study|Lack of Efficacy|1
5435685|NCT02336607|18775163|P4|Overall Study|Physician Decision|15
5435686|NCT02336607|18775164|P3|Overall Study|Physician Decision|3
5435687|NCT02336607|18775165|P2|Overall Study|Physician Decision|4
5435688|NCT02336607|18775166|P1|Overall Study|Physician Decision|1
5435689|NCT02336555|18775269|P2|Treatment Period 2 (28 Days)|Adverse Event|1
5435690|NCT02336555|18775270|P1|Treatment Period 2 (28 Days)|Adverse Event|0
5435691|NCT02336555|18775269|P2|Treatment Period 1 (28 Days)|Physician Decision|0
5435692|NCT02336555|18775270|P1|Treatment Period 1 (28 Days)|Physician Decision|2
5435693|NCT02336555|18775269|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5435694|NCT02336555|18775270|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5435695|NCT02336451|18775283|P5|Overall Study|Patient/guardian decision|1
5435696|NCT02336451|18775284|P4|Overall Study|Patient/guardian decision|2
5435697|NCT02336451|18775285|P3|Overall Study|Patient/guardian decision|0
5435698|NCT02336451|18775286|P2|Overall Study|Patient/guardian decision|4
5435699|NCT02336451|18775287|P1|Overall Study|Patient/guardian decision|2
5435700|NCT02336451|18775283|P5|Overall Study|Protocol Violation|0
5435701|NCT02336451|18775284|P4|Overall Study|Protocol Violation|0
5435702|NCT02336451|18775285|P3|Overall Study|Protocol Violation|0
5435703|NCT02336451|18775286|P2|Overall Study|Protocol Violation|0
5435704|NCT02336451|18775287|P1|Overall Study|Protocol Violation|1
5435705|NCT02336451|18775283|P5|Overall Study|Progressive disease|4
5435706|NCT02336451|18775284|P4|Overall Study|Progressive disease|14
5435707|NCT02336451|18775285|P3|Overall Study|Progressive disease|2
5435708|NCT02336451|18775286|P2|Overall Study|Progressive disease|26
5435709|NCT02336451|18775287|P1|Overall Study|Progressive disease|23
5435710|NCT02336451|18775283|P5|Overall Study|Physician Decision|3
5435711|NCT02336451|18775284|P4|Overall Study|Physician Decision|16
5435712|NCT02336451|18775285|P3|Overall Study|Physician Decision|7
5435713|NCT02336451|18775286|P2|Overall Study|Physician Decision|6
5435714|NCT02336451|18775287|P1|Overall Study|Physician Decision|9
5435715|NCT02336451|18775283|P5|Overall Study|Death|6
5435716|NCT02336451|18775284|P4|Overall Study|Death|6
5435717|NCT02336451|18775285|P3|Overall Study|Death|3
5435718|NCT02336451|18775286|P2|Overall Study|Death|2
5435719|NCT02336451|18775287|P1|Overall Study|Death|6
5435720|NCT02336451|18775283|P5|Overall Study|Adverse Event|4
5435721|NCT02336451|18775284|P4|Overall Study|Adverse Event|6
5435722|NCT02336451|18775285|P3|Overall Study|Adverse Event|0
5435723|NCT02336451|18775286|P2|Overall Study|Adverse Event|2
5435724|NCT02336451|18775287|P1|Overall Study|Adverse Event|1
5435725|NCT02336425|18775444|P4|Overall Study|Study terminated.|3
5435726|NCT02336425|18775445|P3|Overall Study|Study terminated.|3
5435727|NCT02336425|18775446|P2|Overall Study|Study terminated.|2
5435728|NCT02336425|18775447|P1|Overall Study|Study terminated.|2
5435729|NCT02336373|18775497|P1|Overall Study|Physician Decision|14
5435730|NCT02336373|18775497|P1|Overall Study|Protocol closed early|4
5435731|NCT02336282|18775516|P1|Overall Study|Not enough time to complete sessions|2
5435732|NCT02336282|18775516|P1|Overall Study|Lost to Follow-up|1
5435733|NCT02336282|18775516|P1|Overall Study|Uncomfortable with technology|1
5435734|NCT02336282|18775516|P1|Overall Study|Unrelated illness|1
5435735|NCT02336178|18775540|P1|Overall Study|Other|1
5435736|NCT02336178|18775540|P1|Overall Study|Withdrawal by Subject|1
5435737|NCT02336178|18775540|P1|Overall Study|Protocol Violation|1
5435738|NCT02336178|18775540|P1|Overall Study|Lost to Follow-up|1
5435739|NCT02336165|18775631|P5|Overall Study|Other|0
5435740|NCT02336165|18775632|P4|Overall Study|Other|1
5435741|NCT02336165|18775633|P3|Overall Study|Other|0
5435742|NCT02336165|18775634|P2|Overall Study|Other|0
5435743|NCT02336165|18775635|P1|Overall Study|Other|1
5435744|NCT02336165|18775631|P5|Overall Study|Non-compliance|0
5435745|NCT02336165|18775632|P4|Overall Study|Non-compliance|1
5435746|NCT02336165|18775633|P3|Overall Study|Non-compliance|0
5435747|NCT02336165|18775634|P2|Overall Study|Non-compliance|0
5435748|NCT02336165|18775635|P1|Overall Study|Non-compliance|1
5435749|NCT02336165|18775631|P5|Overall Study|Progressive disease|19
5435750|NCT02336165|18775632|P4|Overall Study|Progressive disease|24
5435751|NCT02336165|18775633|P3|Overall Study|Progressive disease|27
5435752|NCT02336165|18775634|P2|Overall Study|Progressive disease|22
5435753|NCT02336165|18775635|P1|Overall Study|Progressive disease|23
5435754|NCT02336165|18775631|P5|Overall Study|Adverse Event|1
5435755|NCT02336165|18775632|P4|Overall Study|Adverse Event|4
5435756|NCT02336165|18775633|P3|Overall Study|Adverse Event|2
5435757|NCT02336165|18775634|P2|Overall Study|Adverse Event|1
5435758|NCT02336165|18775635|P1|Overall Study|Adverse Event|4
5435759|NCT02336165|18775631|P5|Overall Study|Withdrawal by Subject|1
5435760|NCT02336165|18775632|P4|Overall Study|Withdrawal by Subject|0
5435761|NCT02336165|18775633|P3|Overall Study|Withdrawal by Subject|1
5435762|NCT02336165|18775634|P2|Overall Study|Withdrawal by Subject|0
5435763|NCT02336165|18775635|P1|Overall Study|Withdrawal by Subject|0
5435764|NCT02336165|18775631|P5|Overall Study|Physician Decision|0
5435765|NCT02336165|18775632|P4|Overall Study|Physician Decision|1
5435766|NCT02336165|18775633|P3|Overall Study|Physician Decision|1
5435767|NCT02336165|18775634|P2|Overall Study|Physician Decision|2
5435768|NCT02336165|18775635|P1|Overall Study|Physician Decision|2
5435769|NCT02336165|18775631|P5|Overall Study|Death|1
5435770|NCT02336165|18775632|P4|Overall Study|Death|0
5435771|NCT02336165|18775633|P3|Overall Study|Death|0
5435772|NCT02336165|18775634|P2|Overall Study|Death|0
5435773|NCT02336165|18775635|P1|Overall Study|Death|3
5435774|NCT02336074|18775669|P2|Overall Study|Adverse Event|2
5435775|NCT02336074|18775670|P1|Overall Study|Adverse Event|0
5435776|NCT02335983|18775693|P6|Overall Study|Protocol Specified Criteria|21
5435777|NCT02335983|18775694|P5|Overall Study|Protocol Specified Criteria|5
5435778|NCT02335983|18775695|P4|Overall Study|Protocol Specified Criteria|7
5435779|NCT02335983|18775696|P3|Overall Study|Protocol Specified Criteria|27
5435780|NCT02335983|18775697|P2|Overall Study|Protocol Specified Criteria|7
5435781|NCT02335983|18775698|P1|Overall Study|Protocol Specified Criteria|5
5435782|NCT02335983|18775693|P6|Overall Study|Lost to Follow-up|1
5435783|NCT02335983|18775694|P5|Overall Study|Lost to Follow-up|0
5435784|NCT02335983|18775695|P4|Overall Study|Lost to Follow-up|0
5435785|NCT02335983|18775696|P3|Overall Study|Lost to Follow-up|0
5435786|NCT02335983|18775697|P2|Overall Study|Lost to Follow-up|0
5435787|NCT02335983|18775698|P1|Overall Study|Lost to Follow-up|0
5435788|NCT02335983|18775693|P6|Overall Study|Death|0
5435789|NCT02335983|18775694|P5|Overall Study|Death|0
5435790|NCT02335983|18775695|P4|Overall Study|Death|0
5435791|NCT02335983|18775696|P3|Overall Study|Death|2
5435792|NCT02335983|18775697|P2|Overall Study|Death|0
5435793|NCT02335983|18775698|P1|Overall Study|Death|0
5435794|NCT02335983|18775693|P6|Overall Study|Withdrawal by Subject|9
5435795|NCT02335983|18775694|P5|Overall Study|Withdrawal by Subject|3
5435796|NCT02335983|18775695|P4|Overall Study|Withdrawal by Subject|1
5435797|NCT02335983|18775696|P3|Overall Study|Withdrawal by Subject|2
5435798|NCT02335983|18775697|P2|Overall Study|Withdrawal by Subject|2
5435799|NCT02335983|18775698|P1|Overall Study|Withdrawal by Subject|3
5435800|NCT02335983|18775693|P6|Overall Study|Sponsor Decision|1
5435801|NCT02335983|18775694|P5|Overall Study|Sponsor Decision|0
5435802|NCT02335983|18775695|P4|Overall Study|Sponsor Decision|1
5435803|NCT02335983|18775696|P3|Overall Study|Sponsor Decision|1
5435804|NCT02335983|18775697|P2|Overall Study|Sponsor Decision|0
5435805|NCT02335983|18775698|P1|Overall Study|Sponsor Decision|0
5435806|NCT02335658|18775805|P2|Overall Study|other reason|3
5435807|NCT02335658|18775806|P1|Overall Study|other reason|2
5435808|NCT02335658|18775805|P2|Overall Study|non-compliance|3
5435809|NCT02335658|18775806|P1|Overall Study|non-compliance|2
5435810|NCT02335658|18775805|P2|Overall Study|Withdrawal by Subject|21
5435811|NCT02335658|18775806|P1|Overall Study|Withdrawal by Subject|13
5435812|NCT02335658|18775805|P2|Overall Study|Pregnancy|0
5435813|NCT02335658|18775806|P1|Overall Study|Pregnancy|1
5435814|NCT02335658|18775805|P2|Overall Study|Lack of Efficacy|5
5435815|NCT02335658|18775806|P1|Overall Study|Lack of Efficacy|4
5435816|NCT02335658|18775805|P2|Overall Study|Adverse Event|12
5435817|NCT02335658|18775806|P1|Overall Study|Adverse Event|18
5435818|NCT02335489|18775821|P1|Overall Study|Lack of Efficacy|1
5435819|NCT02335489|18775821|P1|Overall Study|Physician Decision|2
5435820|NCT02335489|18775821|P1|Overall Study|Withdrawal by Subject|2
5435821|NCT02335489|18775821|P1|Overall Study|Lost to Follow-up|1
5435822|NCT02335489|18775821|P1|Overall Study|Sponsor terminated study|4
5435823|NCT02335450|18775825|P1|Overall Study|Pregnancy|1
5435824|NCT02335424|18775829|P1|Overall Study|Not treated|4
5435825|NCT02335424|18775829|P1|Overall Study|Physician Decision|3
5435826|NCT02335424|18775829|P1|Overall Study|Lost to Follow-up|2
5435827|NCT02335424|18775829|P1|Overall Study|Death|239
5435828|NCT02335424|18775829|P1|Overall Study|Adverse Event|25
5435829|NCT02335424|18775829|P1|Overall Study|Ongoing In Study|89
5435830|NCT02335424|18775829|P1|Overall Study|Withdrawal by Subject|12
5435831|NCT02335346|18775862|P1|Overall Study|Withdrawal by Subject|1
5435832|NCT02335346|18775862|P1|Overall Study|Adverse Event|11
5435833|NCT02334748|18776184|P1|Overall Study|Lack of Efficacy|4
5435834|NCT02334748|18776184|P1|Overall Study|Patient no longer required study drug|2
5435835|NCT02334748|18776184|P1|Overall Study|Inclusion in the CACZ8852306 study|1
5435836|NCT02334748|18776184|P1|Overall Study|Adverse Event|1
5435837|NCT02334423|18776215|P2|Overall Study|Protocol Violation|3
5435838|NCT02334423|18776216|P1|Overall Study|Protocol Violation|10
5435839|NCT02334384|18776230|P2|Overall Study|Lost to Follow-up|1
5435840|NCT02334384|18776231|P1|Overall Study|Lost to Follow-up|1
5435841|NCT02334306|18776243|P2|Double-blind Period|Withdrawal by Subject|1
5435842|NCT02334306|18776244|P1|Double-blind Period|Withdrawal by Subject|1
5435843|NCT02334306|18776243|P2|Double-blind Period|Adverse Event|1
5435844|NCT02334306|18776244|P1|Double-blind Period|Adverse Event|0
5435845|NCT02334215|18776282|P3|Overall Study|Incarcerated|7
5435846|NCT02334215|18776283|P2|Overall Study|Incarcerated|0
5435847|NCT02334215|18776284|P1|Overall Study|Incarcerated|0
5435848|NCT02334215|18776282|P3|Overall Study|Not released from incarceration on time|3
5435849|NCT02334215|18776283|P2|Overall Study|Not released from incarceration on time|3
5435850|NCT02334215|18776284|P1|Overall Study|Not released from incarceration on time|3
5435851|NCT02334215|18776282|P3|Overall Study|Withdrawal by Subject|1
5435852|NCT02334215|18776283|P2|Overall Study|Withdrawal by Subject|2
5435853|NCT02334215|18776284|P1|Overall Study|Withdrawal by Subject|2
5435854|NCT02334215|18776282|P3|Overall Study|Lost to Follow-up|4
5435855|NCT02334215|18776283|P2|Overall Study|Lost to Follow-up|0
5435856|NCT02334215|18776284|P1|Overall Study|Lost to Follow-up|1
5435857|NCT02334215|18776282|P3|Overall Study|Death|0
5435858|NCT02334215|18776283|P2|Overall Study|Death|1
5435859|NCT02334215|18776284|P1|Overall Study|Death|1
5435860|NCT02333630|18776364|P2|Overall Study|Lost to Follow-up|2
5435861|NCT02333630|18776365|P1|Overall Study|Lost to Follow-up|5
5435862|NCT02333487|18776380|P3|Overall Study|Adverse Event|0
5435863|NCT02333487|18776381|P2|Overall Study|Adverse Event|2
5435864|NCT02333487|18776382|P1|Overall Study|Adverse Event|0
5435865|NCT02333383|18776393|P1|Overall Study|Transfer to another hospital|2
5435866|NCT02333383|18776393|P1|Overall Study|Withdrawal by Subject|3
5435867|NCT02333383|18776393|P1|Overall Study|Lost to Follow-up|15
5435868|NCT02333383|18776393|P1|Overall Study|Adalimumab discontinuation|21
5435869|NCT02333331|18776407|P4|Overall Study|Patient/Guardian Decision|1
5435870|NCT02333331|18776408|P3|Overall Study|Patient/Guardian Decision|9
5435871|NCT02333331|18776409|P2|Overall Study|Patient/Guardian Decision|2
5435872|NCT02333331|18776410|P1|Overall Study|Patient/Guardian Decision|1
5435873|NCT02333331|18776407|P4|Overall Study|Protocol Deviation|1
5435874|NCT02333331|18776408|P3|Overall Study|Protocol Deviation|2
5435875|NCT02333331|18776409|P2|Overall Study|Protocol Deviation|3
5435876|NCT02333331|18776410|P1|Overall Study|Protocol Deviation|0
5435877|NCT02333331|18776407|P4|Overall Study|Physician Decision|0
5435878|NCT02333331|18776408|P3|Overall Study|Physician Decision|0
5435879|NCT02333331|18776409|P2|Overall Study|Physician Decision|1
5435880|NCT02333331|18776410|P1|Overall Study|Physician Decision|0
5435881|NCT02333331|18776407|P4|Overall Study|Lost to Follow-up|0
5435882|NCT02333331|18776408|P3|Overall Study|Lost to Follow-up|1
5435883|NCT02333331|18776409|P2|Overall Study|Lost to Follow-up|0
5435884|NCT02333331|18776410|P1|Overall Study|Lost to Follow-up|0
5435885|NCT02333331|18776407|P4|Overall Study|Death|0
5435886|NCT02333331|18776408|P3|Overall Study|Death|2
5435887|NCT02333331|18776409|P2|Overall Study|Death|0
5435888|NCT02333331|18776410|P1|Overall Study|Death|0
5435889|NCT02333331|18776407|P4|Overall Study|Adverse Event|1
5435890|NCT02333331|18776408|P3|Overall Study|Adverse Event|4
5435891|NCT02333331|18776409|P2|Overall Study|Adverse Event|0
5435892|NCT02333331|18776410|P1|Overall Study|Adverse Event|1
5435893|NCT02332915|18776490|P2|Overall Study|did not meet inclusion criteria|4
5435894|NCT02332915|18776491|P1|Overall Study|did not meet inclusion criteria|2
5435895|NCT02332915|18776490|P2|Overall Study|Travel distance prohibitive|1
5435896|NCT02332915|18776491|P1|Overall Study|Travel distance prohibitive|0
5435897|NCT02332915|18776490|P2|Overall Study|Unrelated illness|1
5435898|NCT02332915|18776491|P1|Overall Study|Unrelated illness|1
5435899|NCT02332915|18776490|P2|Overall Study|Moved out of region|0
5435900|NCT02332915|18776491|P1|Overall Study|Moved out of region|3
5435901|NCT02332889|18776504|P1|Overall Study|Physician Decision|1
5435902|NCT02332876|18776510|P2|Overall Study|Lost to Follow-up|1
5435903|NCT02332876|18776511|P1|Overall Study|Lost to Follow-up|1
5435904|NCT02332824|18776546|P6|Overall Study|Transfer|0
5435905|NCT02332824|18776547|P5|Overall Study|Transfer|0
5435906|NCT02332824|18776548|P4|Overall Study|Transfer|1
5435907|NCT02332824|18776549|P3|Overall Study|Transfer|1
5435908|NCT02332824|18776550|P2|Overall Study|Transfer|0
5435909|NCT02332824|18776551|P1|Overall Study|Transfer|0
5435910|NCT02332824|18776546|P6|Overall Study|Inconvenient schedule|0
5435911|NCT02332824|18776547|P5|Overall Study|Inconvenient schedule|0
5435912|NCT02332824|18776548|P4|Overall Study|Inconvenient schedule|0
5435913|NCT02332824|18776549|P3|Overall Study|Inconvenient schedule|0
5435914|NCT02332824|18776550|P2|Overall Study|Inconvenient schedule|1
5435915|NCT02332824|18776551|P1|Overall Study|Inconvenient schedule|1
5435916|NCT02332824|18776546|P6|Overall Study|Voluntary Withdrawal|0
5435917|NCT02332824|18776547|P5|Overall Study|Voluntary Withdrawal|0
5435918|NCT02332824|18776548|P4|Overall Study|Voluntary Withdrawal|0
5435919|NCT02332824|18776549|P3|Overall Study|Voluntary Withdrawal|0
5435920|NCT02332824|18776550|P2|Overall Study|Voluntary Withdrawal|0
5435921|NCT02332824|18776551|P1|Overall Study|Voluntary Withdrawal|1
5435922|NCT02332824|18776546|P6|Overall Study|Pretreatment Event/Adverse Event|1
5435923|NCT02332824|18776547|P5|Overall Study|Pretreatment Event/Adverse Event|4
5435924|NCT02332824|18776548|P4|Overall Study|Pretreatment Event/Adverse Event|1
5435925|NCT02332824|18776549|P3|Overall Study|Pretreatment Event/Adverse Event|1
5435926|NCT02332824|18776550|P2|Overall Study|Pretreatment Event/Adverse Event|0
5435927|NCT02332824|18776551|P1|Overall Study|Pretreatment Event/Adverse Event|4
5435928|NCT02332798|18776592|P3|Overall Study|Abnormal Laboratory Findings|0
5435929|NCT02332798|18776593|P2|Overall Study|Abnormal Laboratory Findings|0
5435930|NCT02332798|18776594|P1|Overall Study|Abnormal Laboratory Findings|1
5435931|NCT02332798|18776592|P3|Overall Study|Positive Urine Drug Test|0
5435932|NCT02332798|18776593|P2|Overall Study|Positive Urine Drug Test|1
5435933|NCT02332798|18776594|P1|Overall Study|Positive Urine Drug Test|0
5435934|NCT02332798|18776592|P3|Overall Study|Unwilling to Participate in Study|1
5435935|NCT02332798|18776593|P2|Overall Study|Unwilling to Participate in Study|1
5435936|NCT02332798|18776594|P1|Overall Study|Unwilling to Participate in Study|0
5435937|NCT02332720|18776667|P23|Part A and Part B|Withdrawal by Subject|0
5435938|NCT02332720|18776668|P22|Part A and Part B|Withdrawal by Subject|0
5435939|NCT02332720|18776669|P21|Part A and Part B|Withdrawal by Subject|0
5435940|NCT02332720|18776670|P20|Part A and Part B|Withdrawal by Subject|1
5435941|NCT02332720|18776671|P19|Part A and Part B|Withdrawal by Subject|0
5435942|NCT02332720|18776672|P18|Part A and Part B|Withdrawal by Subject|0
5435943|NCT02332720|18776673|P17|Part A and Part B|Withdrawal by Subject|0
5435944|NCT02332720|18776674|P16|Part A and Part B|Withdrawal by Subject|0
5435945|NCT02332720|18776675|P15|Part A and Part B|Withdrawal by Subject|0
5435946|NCT02332720|18776676|P14|Part A and Part B|Withdrawal by Subject|0
5435947|NCT02332720|18776677|P13|Part A and Part B|Withdrawal by Subject|0
5435948|NCT02332720|18776678|P12|Part A and Part B|Withdrawal by Subject|0
5435949|NCT02332720|18776679|P11|Part A and Part B|Withdrawal by Subject|0
5435950|NCT02332720|18776680|P10|Part A and Part B|Withdrawal by Subject|0
5435951|NCT02332720|18776681|P9|Part A and Part B|Withdrawal by Subject|0
5435952|NCT02332720|18776682|P8|Part A and Part B|Withdrawal by Subject|0
5435953|NCT02332720|18776683|P7|Part A and Part B|Withdrawal by Subject|0
5435954|NCT02332720|18776684|P6|Part A and Part B|Withdrawal by Subject|1
5435955|NCT02332720|18776685|P5|Part A and Part B|Withdrawal by Subject|0
5435956|NCT02332720|18776686|P4|Part A and Part B|Withdrawal by Subject|0
5435957|NCT02332720|18776687|P3|Part A and Part B|Withdrawal by Subject|0
5435958|NCT02332720|18776688|P2|Part A and Part B|Withdrawal by Subject|0
5435959|NCT02332720|18776689|P1|Part A and Part B|Withdrawal by Subject|0
5435960|NCT02332720|18776667|P23|Part A and Part B|Physician Decision|0
5435961|NCT02332720|18776668|P22|Part A and Part B|Physician Decision|0
5435962|NCT02332720|18776669|P21|Part A and Part B|Physician Decision|0
5435963|NCT02332720|18776670|P20|Part A and Part B|Physician Decision|0
5435964|NCT02332720|18776671|P19|Part A and Part B|Physician Decision|1
5435965|NCT02332720|18776672|P18|Part A and Part B|Physician Decision|0
5435966|NCT02332720|18776673|P17|Part A and Part B|Physician Decision|0
5435967|NCT02332720|18776674|P16|Part A and Part B|Physician Decision|0
5435968|NCT02332720|18776675|P15|Part A and Part B|Physician Decision|0
5435969|NCT02332720|18776676|P14|Part A and Part B|Physician Decision|0
5435970|NCT02332720|18776677|P13|Part A and Part B|Physician Decision|0
5435971|NCT02332720|18776678|P12|Part A and Part B|Physician Decision|0
5435972|NCT02332720|18776679|P11|Part A and Part B|Physician Decision|0
5435973|NCT02332720|18776680|P10|Part A and Part B|Physician Decision|0
5435974|NCT02332720|18776681|P9|Part A and Part B|Physician Decision|0
5435975|NCT02332720|18776682|P8|Part A and Part B|Physician Decision|0
5435976|NCT02332720|18776683|P7|Part A and Part B|Physician Decision|0
5435977|NCT02332720|18776684|P6|Part A and Part B|Physician Decision|0
5435978|NCT02332720|18776685|P5|Part A and Part B|Physician Decision|0
5435979|NCT02332720|18776686|P4|Part A and Part B|Physician Decision|0
5435980|NCT02332720|18776687|P3|Part A and Part B|Physician Decision|0
5435981|NCT02332720|18776688|P2|Part A and Part B|Physician Decision|0
5435982|NCT02332720|18776689|P1|Part A and Part B|Physician Decision|0
5435983|NCT02332720|18776667|P23|Part A and Part B|Adverse Event|0
5435984|NCT02332720|18776668|P22|Part A and Part B|Adverse Event|0
5435985|NCT02332720|18776669|P21|Part A and Part B|Adverse Event|0
5435986|NCT02332720|18776670|P20|Part A and Part B|Adverse Event|0
5435987|NCT02332720|18776671|P19|Part A and Part B|Adverse Event|0
5435988|NCT02332720|18776672|P18|Part A and Part B|Adverse Event|1
5435989|NCT02332720|18776673|P17|Part A and Part B|Adverse Event|0
5435990|NCT02332720|18776674|P16|Part A and Part B|Adverse Event|0
5435991|NCT02332720|18776675|P15|Part A and Part B|Adverse Event|0
5435992|NCT02332720|18776676|P14|Part A and Part B|Adverse Event|0
5435993|NCT02332720|18776677|P13|Part A and Part B|Adverse Event|0
5435994|NCT02332720|18776678|P12|Part A and Part B|Adverse Event|0
5435995|NCT02332720|18776679|P11|Part A and Part B|Adverse Event|0
5435996|NCT02332720|18776680|P10|Part A and Part B|Adverse Event|0
5435997|NCT02332720|18776681|P9|Part A and Part B|Adverse Event|0
5435998|NCT02332720|18776682|P8|Part A and Part B|Adverse Event|0
5435999|NCT02332720|18776683|P7|Part A and Part B|Adverse Event|0
5436000|NCT02332720|18776684|P6|Part A and Part B|Adverse Event|0
5436001|NCT02332720|18776685|P5|Part A and Part B|Adverse Event|0
5436002|NCT02332720|18776686|P4|Part A and Part B|Adverse Event|0
5436003|NCT02332720|18776687|P3|Part A and Part B|Adverse Event|0
5436004|NCT02332720|18776688|P2|Part A and Part B|Adverse Event|0
5436005|NCT02332720|18776689|P1|Part A and Part B|Adverse Event|0
5436006|NCT02332720|18776667|P23|Part A and Part B|Lost to Follow-up|0
5436007|NCT02332720|18776668|P22|Part A and Part B|Lost to Follow-up|0
5436008|NCT02332720|18776669|P21|Part A and Part B|Lost to Follow-up|0
5436009|NCT02332720|18776670|P20|Part A and Part B|Lost to Follow-up|0
5436010|NCT02332720|18776671|P19|Part A and Part B|Lost to Follow-up|0
5436011|NCT02332720|18776672|P18|Part A and Part B|Lost to Follow-up|0
5436012|NCT02332720|18776673|P17|Part A and Part B|Lost to Follow-up|0
5436013|NCT02332720|18776674|P16|Part A and Part B|Lost to Follow-up|1
5436014|NCT02332720|18776675|P15|Part A and Part B|Lost to Follow-up|0
5436015|NCT02332720|18776676|P14|Part A and Part B|Lost to Follow-up|0
5436016|NCT02332720|18776677|P13|Part A and Part B|Lost to Follow-up|0
5436017|NCT02332720|18776678|P12|Part A and Part B|Lost to Follow-up|0
5436018|NCT02332720|18776679|P11|Part A and Part B|Lost to Follow-up|0
5436019|NCT02332720|18776680|P10|Part A and Part B|Lost to Follow-up|0
5436020|NCT02332720|18776681|P9|Part A and Part B|Lost to Follow-up|0
5436021|NCT02332720|18776682|P8|Part A and Part B|Lost to Follow-up|1
5436022|NCT02332720|18776683|P7|Part A and Part B|Lost to Follow-up|1
5436023|NCT02332720|18776684|P6|Part A and Part B|Lost to Follow-up|2
5436024|NCT02332720|18776685|P5|Part A and Part B|Lost to Follow-up|0
5436025|NCT02332720|18776686|P4|Part A and Part B|Lost to Follow-up|0
5436026|NCT02332720|18776687|P3|Part A and Part B|Lost to Follow-up|0
5436027|NCT02332720|18776688|P2|Part A and Part B|Lost to Follow-up|0
5436028|NCT02332720|18776689|P1|Part A and Part B|Lost to Follow-up|1
5436029|NCT02332707|18776825|P18|Overall Study|Withdrawal by Subject|0
5436030|NCT02332707|18776826|P17|Overall Study|Withdrawal by Subject|0
5436031|NCT02332707|18776827|P16|Overall Study|Withdrawal by Subject|0
5436032|NCT02332707|18776828|P15|Overall Study|Withdrawal by Subject|0
5436033|NCT02332707|18776829|P14|Overall Study|Withdrawal by Subject|0
5436034|NCT02332707|18776830|P13|Overall Study|Withdrawal by Subject|0
5436035|NCT02332707|18776831|P12|Overall Study|Withdrawal by Subject|0
5436036|NCT02332707|18776832|P11|Overall Study|Withdrawal by Subject|0
5436037|NCT02332707|18776833|P10|Overall Study|Withdrawal by Subject|3
5436038|NCT02332707|18776834|P9|Overall Study|Withdrawal by Subject|0
5436039|NCT02332707|18776835|P8|Overall Study|Withdrawal by Subject|0
5436040|NCT02332707|18776836|P7|Overall Study|Withdrawal by Subject|0
5436041|NCT02332707|18776837|P6|Overall Study|Withdrawal by Subject|0
5436042|NCT02332707|18776838|P5|Overall Study|Withdrawal by Subject|0
5436043|NCT02332707|18776839|P4|Overall Study|Withdrawal by Subject|0
5436044|NCT02332707|18776840|P3|Overall Study|Withdrawal by Subject|1
5436045|NCT02332707|18776841|P2|Overall Study|Withdrawal by Subject|0
5436046|NCT02332707|18776842|P1|Overall Study|Withdrawal by Subject|0
5436047|NCT02332707|18776825|P18|Overall Study|Physician Decision|0
5436048|NCT02332707|18776826|P17|Overall Study|Physician Decision|0
5436049|NCT02332707|18776827|P16|Overall Study|Physician Decision|0
5436050|NCT02332707|18776828|P15|Overall Study|Physician Decision|0
5436051|NCT02332707|18776829|P14|Overall Study|Physician Decision|0
5436052|NCT02332707|18776830|P13|Overall Study|Physician Decision|1
5436053|NCT02332707|18776831|P12|Overall Study|Physician Decision|0
5436054|NCT02332707|18776832|P11|Overall Study|Physician Decision|0
5436055|NCT02332707|18776833|P10|Overall Study|Physician Decision|0
5436056|NCT02332707|18776834|P9|Overall Study|Physician Decision|0
5436057|NCT02332707|18776835|P8|Overall Study|Physician Decision|0
5436058|NCT02332707|18776836|P7|Overall Study|Physician Decision|0
5436059|NCT02332707|18776837|P6|Overall Study|Physician Decision|0
5436060|NCT02332707|18776838|P5|Overall Study|Physician Decision|0
5436061|NCT02332707|18776839|P4|Overall Study|Physician Decision|1
5436062|NCT02332707|18776840|P3|Overall Study|Physician Decision|0
5436063|NCT02332707|18776841|P2|Overall Study|Physician Decision|0
5436064|NCT02332707|18776842|P1|Overall Study|Physician Decision|0
5436065|NCT02332707|18776825|P18|Overall Study|Lost to Follow-up|0
5436066|NCT02332707|18776826|P17|Overall Study|Lost to Follow-up|0
5436067|NCT02332707|18776827|P16|Overall Study|Lost to Follow-up|0
5436068|NCT02332707|18776828|P15|Overall Study|Lost to Follow-up|0
5436069|NCT02332707|18776829|P14|Overall Study|Lost to Follow-up|0
5436070|NCT02332707|18776830|P13|Overall Study|Lost to Follow-up|3
5436071|NCT02332707|18776831|P12|Overall Study|Lost to Follow-up|0
5436072|NCT02332707|18776832|P11|Overall Study|Lost to Follow-up|2
5436073|NCT02332707|18776833|P10|Overall Study|Lost to Follow-up|0
5436074|NCT02332707|18776834|P9|Overall Study|Lost to Follow-up|0
5436075|NCT02332707|18776835|P8|Overall Study|Lost to Follow-up|0
5436076|NCT02332707|18776836|P7|Overall Study|Lost to Follow-up|0
5436077|NCT02332707|18776837|P6|Overall Study|Lost to Follow-up|1
5436078|NCT02332707|18776838|P5|Overall Study|Lost to Follow-up|0
5436079|NCT02332707|18776839|P4|Overall Study|Lost to Follow-up|0
5436080|NCT02332707|18776840|P3|Overall Study|Lost to Follow-up|0
5436081|NCT02332707|18776841|P2|Overall Study|Lost to Follow-up|0
5436082|NCT02332707|18776842|P1|Overall Study|Lost to Follow-up|0
5436083|NCT02332707|18776825|P18|Overall Study|Adverse Event|0
5436084|NCT02332707|18776826|P17|Overall Study|Adverse Event|0
5436085|NCT02332707|18776827|P16|Overall Study|Adverse Event|0
5436086|NCT02332707|18776828|P15|Overall Study|Adverse Event|0
5436087|NCT02332707|18776829|P14|Overall Study|Adverse Event|0
5436088|NCT02332707|18776830|P13|Overall Study|Adverse Event|1
5436089|NCT02332707|18776831|P12|Overall Study|Adverse Event|0
5436090|NCT02332707|18776832|P11|Overall Study|Adverse Event|0
5436091|NCT02332707|18776833|P10|Overall Study|Adverse Event|0
5436092|NCT02332707|18776834|P9|Overall Study|Adverse Event|0
5436093|NCT02332707|18776835|P8|Overall Study|Adverse Event|0
5436094|NCT02332707|18776836|P7|Overall Study|Adverse Event|0
5436095|NCT02332707|18776837|P6|Overall Study|Adverse Event|0
5436096|NCT02332707|18776838|P5|Overall Study|Adverse Event|0
5436097|NCT02332707|18776839|P4|Overall Study|Adverse Event|0
5436098|NCT02332707|18776840|P3|Overall Study|Adverse Event|0
5436099|NCT02332707|18776841|P2|Overall Study|Adverse Event|0
5436100|NCT02332707|18776842|P1|Overall Study|Adverse Event|0
5436101|NCT02332590|18776936|P2|Overall Study|Other than specified above|5
5436102|NCT02332590|18776937|P1|Overall Study|Other than specified above|6
5436103|NCT02332590|18776936|P2|Overall Study|Randomized but not treated|0
5436104|NCT02332590|18776937|P1|Overall Study|Randomized but not treated|1
5436105|NCT02332590|18776936|P2|Overall Study|Poor compliance to protocol|1
5436106|NCT02332590|18776937|P1|Overall Study|Poor compliance to protocol|3
5436107|NCT02332590|18776936|P2|Overall Study|Lack of Efficacy|2
5436108|NCT02332590|18776937|P1|Overall Study|Lack of Efficacy|4
5436109|NCT02332590|18776936|P2|Overall Study|Adverse Event|11
5436110|NCT02332590|18776937|P1|Overall Study|Adverse Event|15
5436111|NCT02332239|18777001|P2|Overall Study|Lost to Follow-up|6
5436112|NCT02332239|18777002|P1|Overall Study|Lost to Follow-up|4
5436113|NCT02331680|18777038|P3|Overall Study|Protocol Violation|3
5436114|NCT02331680|18777039|P2|Overall Study|Protocol Violation|0
5436115|NCT02331680|18777040|P1|Overall Study|Protocol Violation|0
5436116|NCT02331680|18777038|P3|Overall Study|Non-compliance with study drug|1
5436117|NCT02331680|18777039|P2|Overall Study|Non-compliance with study drug|0
5436118|NCT02331680|18777040|P1|Overall Study|Non-compliance with study drug|0
5436119|NCT02331680|18777038|P3|Overall Study|Met withdrawal criteria|5
5436120|NCT02331680|18777039|P2|Overall Study|Met withdrawal criteria|2
5436121|NCT02331680|18777040|P1|Overall Study|Met withdrawal criteria|2
5436122|NCT02331680|18777038|P3|Overall Study|Withdrawal by Subject|2
5436123|NCT02331680|18777039|P2|Overall Study|Withdrawal by Subject|1
5436124|NCT02331680|18777040|P1|Overall Study|Withdrawal by Subject|0
5436125|NCT02331680|18777038|P3|Overall Study|Physician Decision|2
5436126|NCT02331680|18777039|P2|Overall Study|Physician Decision|1
5436127|NCT02331680|18777040|P1|Overall Study|Physician Decision|1
5436128|NCT02331680|18777038|P3|Overall Study|Adverse Event|2
5436129|NCT02331680|18777039|P2|Overall Study|Adverse Event|0
5436130|NCT02331680|18777040|P1|Overall Study|Adverse Event|3
5436131|NCT02331446|18777070|P4|Overall Study|Lost before baseline analysis|0
5436132|NCT02331446|18777071|P3|Overall Study|Lost before baseline analysis|1
5436133|NCT02331446|18777072|P2|Overall Study|Lost before baseline analysis|1
5436134|NCT02331446|18777073|P1|Overall Study|Lost before baseline analysis|0
5436135|NCT02331446|18777070|P4|Overall Study|Physician Decision|1
5436136|NCT02331446|18777071|P3|Overall Study|Physician Decision|0
5436137|NCT02331446|18777072|P2|Overall Study|Physician Decision|1
5436138|NCT02331446|18777073|P1|Overall Study|Physician Decision|0
5436139|NCT02331446|18777070|P4|Overall Study|Disease|1
5436140|NCT02331446|18777071|P3|Overall Study|Disease|2
5436141|NCT02331446|18777072|P2|Overall Study|Disease|2
5436142|NCT02331446|18777073|P1|Overall Study|Disease|0
5436143|NCT02331446|18777070|P4|Overall Study|Personal Problem|0
5436144|NCT02331446|18777071|P3|Overall Study|Personal Problem|0
5436145|NCT02331446|18777072|P2|Overall Study|Personal Problem|0
5436146|NCT02331446|18777073|P1|Overall Study|Personal Problem|2
5436147|NCT02331446|18777070|P4|Overall Study|Lost to Follow-up|1
5436148|NCT02331446|18777071|P3|Overall Study|Lost to Follow-up|0
5436149|NCT02331446|18777072|P2|Overall Study|Lost to Follow-up|1
5436150|NCT02331446|18777073|P1|Overall Study|Lost to Follow-up|2
5436151|NCT02331394|18777149|P1|Overall Study|Disease progression|1
5436152|NCT02331368|18777160|P1|Overall Study|Withdrawal by Subject|3
5436153|NCT02330549|18777285|P2|Overall Study|Failure to meet randomization criteria|0
5436154|NCT02330549|18777286|P1|Overall Study|Failure to meet randomization criteria|1
5436155|NCT02330549|18777285|P2|Overall Study|Subject withdrew consent|1
5436156|NCT02330549|18777286|P1|Overall Study|Subject withdrew consent|2
5436157|NCT02330549|18777285|P2|Overall Study|Adverse Event|0
5436158|NCT02330549|18777286|P1|Overall Study|Adverse Event|1
5436159|NCT02330081|18777502|P1|Overall Study|Protocol Violation|6
5436160|NCT02330081|18777502|P1|Overall Study|Donation did not meet criteria|1
5436161|NCT02330081|18777502|P1|Overall Study|Adverse Event|1
5436162|NCT02330055|18777523|P2|Overall Study|participant did not sleep|1
5436163|NCT02330055|18777524|P1|Overall Study|participant did not sleep|0
5436164|NCT02330055|18777523|P2|Overall Study|data for less than 60 minutes|3
5436165|NCT02330055|18777524|P1|Overall Study|data for less than 60 minutes|3
5436166|NCT02330055|18777523|P2|Overall Study|participant forgot to wear device|5
5436167|NCT02330055|18777524|P1|Overall Study|participant forgot to wear device|5
5436168|NCT02330055|18777523|P2|Overall Study|technical issues|0
5436169|NCT02330055|18777524|P1|Overall Study|technical issues|2
5436170|NCT02329743|18777570|P3|Overall Study|Other|3
5436171|NCT02329743|18777571|P2|Overall Study|Other|2
5436172|NCT02329743|18777572|P1|Overall Study|Other|0
5436173|NCT02329743|18777570|P3|Overall Study|Withdrawal by Subject|1
5436174|NCT02329743|18777571|P2|Overall Study|Withdrawal by Subject|4
5436175|NCT02329743|18777572|P1|Overall Study|Withdrawal by Subject|4
5436176|NCT02329743|18777570|P3|Overall Study|Lost to Follow-up|1
5436177|NCT02329743|18777571|P2|Overall Study|Lost to Follow-up|0
5436178|NCT02329743|18777572|P1|Overall Study|Lost to Follow-up|1
5436179|NCT02329743|18777570|P3|Overall Study|Adverse Event|3
5436180|NCT02329743|18777571|P2|Overall Study|Adverse Event|1
5436181|NCT02329743|18777572|P1|Overall Study|Adverse Event|1
5436182|NCT02329730|18777587|P12|Overall Study|Withdrawal by Subject|0
5436183|NCT02329730|18777588|P11|Overall Study|Withdrawal by Subject|0
5436184|NCT02329730|18777589|P10|Overall Study|Withdrawal by Subject|1
5436185|NCT02329730|18777590|P9|Overall Study|Withdrawal by Subject|1
5436186|NCT02329730|18777591|P8|Overall Study|Withdrawal by Subject|1
5436187|NCT02329730|18777592|P7|Overall Study|Withdrawal by Subject|1
5436188|NCT02329730|18777593|P6|Overall Study|Withdrawal by Subject|0
5436189|NCT02329730|18777594|P5|Overall Study|Withdrawal by Subject|1
5436190|NCT02329730|18777595|P4|Overall Study|Withdrawal by Subject|0
5436191|NCT02329730|18777596|P3|Overall Study|Withdrawal by Subject|0
5436192|NCT02329730|18777597|P2|Overall Study|Withdrawal by Subject|0
5436193|NCT02329730|18777598|P1|Overall Study|Withdrawal by Subject|0
5436194|NCT02329730|18777587|P12|Overall Study|Protocol Violation|0
5436195|NCT02329730|18777588|P11|Overall Study|Protocol Violation|0
5436196|NCT02329730|18777589|P10|Overall Study|Protocol Violation|0
5436197|NCT02329730|18777590|P9|Overall Study|Protocol Violation|0
5436198|NCT02329730|18777591|P8|Overall Study|Protocol Violation|0
5436199|NCT02329730|18777592|P7|Overall Study|Protocol Violation|0
5436200|NCT02329730|18777593|P6|Overall Study|Protocol Violation|2
5436201|NCT02329730|18777594|P5|Overall Study|Protocol Violation|2
5436202|NCT02329730|18777595|P4|Overall Study|Protocol Violation|0
5436203|NCT02329730|18777596|P3|Overall Study|Protocol Violation|0
5436204|NCT02329730|18777597|P2|Overall Study|Protocol Violation|0
5436205|NCT02329730|18777598|P1|Overall Study|Protocol Violation|0
5436206|NCT02329431|18777709|P2|Overall Study|Lost to Follow-up|13
5436207|NCT02329431|18777710|P1|Overall Study|Lost to Follow-up|20
5436208|NCT02329223|18777729|P3|Overall Study|Adverse Event|0
5436209|NCT02329223|18777730|P2|Overall Study|Adverse Event|1
5436210|NCT02329223|18777731|P1|Overall Study|Adverse Event|0
5436211|NCT02329223|18777729|P3|Overall Study|Physician Decision|1
5436212|NCT02329223|18777730|P2|Overall Study|Physician Decision|0
5436213|NCT02329223|18777731|P1|Overall Study|Physician Decision|0
5436214|NCT02329223|18777729|P3|Overall Study|Withdrawal by Subject|5
5436215|NCT02329223|18777730|P2|Overall Study|Withdrawal by Subject|2
5436216|NCT02329223|18777731|P1|Overall Study|Withdrawal by Subject|1
5436217|NCT02328937|18777781|P6|Period 2|Adverse Event|0
5436218|NCT02328937|18777782|P5|Period 2|Adverse Event|0
5436219|NCT02328937|18777783|P4|Period 2|Adverse Event|0
5436220|NCT02328937|18777784|P3|Period 2|Adverse Event|1
5436221|NCT02328937|18777785|P2|Period 2|Adverse Event|0
5436222|NCT02328937|18777786|P1|Period 2|Adverse Event|0
5436223|NCT02328937|18777781|P6|Period 1|Lost to Follow-up|0
5436224|NCT02328937|18777782|P5|Period 1|Lost to Follow-up|0
5436225|NCT02328937|18777783|P4|Period 1|Lost to Follow-up|1
5436226|NCT02328937|18777784|P3|Period 1|Lost to Follow-up|0
5436227|NCT02328937|18777785|P2|Period 1|Lost to Follow-up|0
5436228|NCT02328937|18777786|P1|Period 1|Lost to Follow-up|0
5436229|NCT02328547|18777806|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
5436230|NCT02328547|18777807|P1|First Intervention (12 Weeks)|Withdrawal by Subject|2
5436231|NCT02328547|18777806|P2|First Intervention (12 Weeks)|Lost to Follow-up|0
5436232|NCT02328547|18777807|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
5436233|NCT02328326|18777884|P2|Overall Study|Lost to Follow-up|4
5436234|NCT02328326|18777885|P1|Overall Study|Lost to Follow-up|10
5436235|NCT02328326|18777884|P2|Overall Study|Death|1
5436236|NCT02328326|18777885|P1|Overall Study|Death|2
5436237|NCT02328326|18777884|P2|Overall Study|Withdrawal by Subject|3
5436238|NCT02328326|18777885|P1|Overall Study|Withdrawal by Subject|10
5436239|NCT02328105|18777893|P1|Overall Study|Still On Study in Follow-Up|4
5436240|NCT02328105|18777893|P1|Overall Study|Withdrawal by Subject|1
5436241|NCT02328105|18777893|P1|Overall Study|Death|6
5436242|NCT02328040|18777902|P2|First Intervention (2 Days)|Withdrawal by Subject|1
5436243|NCT02328040|18777903|P1|First Intervention (2 Days)|Withdrawal by Subject|1
5436244|NCT02328027|18777913|P2|Overall Study|Withdrawal by Subject|1
5436245|NCT02328027|18777914|P1|Overall Study|Withdrawal by Subject|0
5436246|NCT02327325|18777973|P3|Overall Study|Excluded by Study Team|1
5436247|NCT02327325|18777974|P2|Overall Study|Excluded by Study Team|0
5436248|NCT02327325|18777975|P1|Overall Study|Excluded by Study Team|0
5436249|NCT02327325|18777973|P3|Overall Study|Withdrawal by Subject|4
5436250|NCT02327325|18777974|P2|Overall Study|Withdrawal by Subject|4
5436251|NCT02327325|18777975|P1|Overall Study|Withdrawal by Subject|1
5436252|NCT02327260|18777998|P3|Overall Study|cognitive concerns|0
5436253|NCT02327260|18777999|P2|Overall Study|cognitive concerns|0
5436254|NCT02327260|18778000|P1|Overall Study|cognitive concerns|1
5436255|NCT02327260|18777998|P3|Overall Study|non-adherence to protocol|0
5436256|NCT02327260|18777999|P2|Overall Study|non-adherence to protocol|0
5436257|NCT02327260|18778000|P1|Overall Study|non-adherence to protocol|2
5436258|NCT02327260|18777998|P3|Overall Study|invalid phone number|0
5436259|NCT02327260|18777999|P2|Overall Study|invalid phone number|1
5436260|NCT02327260|18778000|P1|Overall Study|invalid phone number|1
5436261|NCT02327260|18777998|P3|Overall Study|Lost to Follow-up|2
5436262|NCT02327260|18777999|P2|Overall Study|Lost to Follow-up|3
5436263|NCT02327260|18778000|P1|Overall Study|Lost to Follow-up|2
5436264|NCT02327169|18778047|P15|Overall Study|Lost to Follow-up|0
5436265|NCT02327169|18778048|P14|Overall Study|Lost to Follow-up|0
5436266|NCT02327169|18778049|P13|Overall Study|Lost to Follow-up|0
5436267|NCT02327169|18778050|P12|Overall Study|Lost to Follow-up|0
5436268|NCT02327169|18778051|P11|Overall Study|Lost to Follow-up|0
5436269|NCT02327169|18778052|P10|Overall Study|Lost to Follow-up|0
5436270|NCT02327169|18778053|P9|Overall Study|Lost to Follow-up|0
5436271|NCT02327169|18778054|P8|Overall Study|Lost to Follow-up|0
5436272|NCT02327169|18778055|P7|Overall Study|Lost to Follow-up|0
5436273|NCT02327169|18778056|P6|Overall Study|Lost to Follow-up|0
5436274|NCT02327169|18778057|P5|Overall Study|Lost to Follow-up|1
5436275|NCT02327169|18778058|P4|Overall Study|Lost to Follow-up|0
5436276|NCT02327169|18778059|P3|Overall Study|Lost to Follow-up|0
5436277|NCT02327169|18778060|P2|Overall Study|Lost to Follow-up|0
5436278|NCT02327169|18778061|P1|Overall Study|Lost to Follow-up|0
5436279|NCT02327169|18778047|P15|Overall Study|Withdrawal by Subject|3
5436280|NCT02327169|18778048|P14|Overall Study|Withdrawal by Subject|0
5436281|NCT02327169|18778049|P13|Overall Study|Withdrawal by Subject|0
5436282|NCT02327169|18778050|P12|Overall Study|Withdrawal by Subject|0
5436283|NCT02327169|18778051|P11|Overall Study|Withdrawal by Subject|0
5436284|NCT02327169|18778052|P10|Overall Study|Withdrawal by Subject|0
5436285|NCT02327169|18778053|P9|Overall Study|Withdrawal by Subject|0
5436286|NCT02327169|18778054|P8|Overall Study|Withdrawal by Subject|1
5436287|NCT02327169|18778055|P7|Overall Study|Withdrawal by Subject|0
5436288|NCT02327169|18778056|P6|Overall Study|Withdrawal by Subject|0
5436289|NCT02327169|18778057|P5|Overall Study|Withdrawal by Subject|1
5436290|NCT02327169|18778058|P4|Overall Study|Withdrawal by Subject|0
5436291|NCT02327169|18778059|P3|Overall Study|Withdrawal by Subject|0
5436292|NCT02327169|18778060|P2|Overall Study|Withdrawal by Subject|0
5436293|NCT02327169|18778061|P1|Overall Study|Withdrawal by Subject|1
5436294|NCT02327169|18778047|P15|Overall Study|Reason Not Specified|2
5436295|NCT02327169|18778048|P14|Overall Study|Reason Not Specified|0
5436296|NCT02327169|18778049|P13|Overall Study|Reason Not Specified|0
5436297|NCT02327169|18778050|P12|Overall Study|Reason Not Specified|1
5436298|NCT02327169|18778051|P11|Overall Study|Reason Not Specified|2
5436299|NCT02327169|18778052|P10|Overall Study|Reason Not Specified|1
5436300|NCT02327169|18778053|P9|Overall Study|Reason Not Specified|0
5436301|NCT02327169|18778054|P8|Overall Study|Reason Not Specified|0
5436302|NCT02327169|18778055|P7|Overall Study|Reason Not Specified|0
5436303|NCT02327169|18778056|P6|Overall Study|Reason Not Specified|0
5436304|NCT02327169|18778057|P5|Overall Study|Reason Not Specified|0
5436305|NCT02327169|18778058|P4|Overall Study|Reason Not Specified|0
5436306|NCT02327169|18778059|P3|Overall Study|Reason Not Specified|1
5436307|NCT02327169|18778060|P2|Overall Study|Reason Not Specified|0
5436308|NCT02327169|18778061|P1|Overall Study|Reason Not Specified|0
5436309|NCT02327169|18778047|P15|Overall Study|Symptomatic Deterioration|1
5436310|NCT02327169|18778048|P14|Overall Study|Symptomatic Deterioration|2
5436311|NCT02327169|18778049|P13|Overall Study|Symptomatic Deterioration|0
5436312|NCT02327169|18778050|P12|Overall Study|Symptomatic Deterioration|0
5436313|NCT02327169|18778051|P11|Overall Study|Symptomatic Deterioration|0
5436314|NCT02327169|18778052|P10|Overall Study|Symptomatic Deterioration|1
5436315|NCT02327169|18778053|P9|Overall Study|Symptomatic Deterioration|2
5436316|NCT02327169|18778054|P8|Overall Study|Symptomatic Deterioration|0
5436317|NCT02327169|18778055|P7|Overall Study|Symptomatic Deterioration|0
5436318|NCT02327169|18778056|P6|Overall Study|Symptomatic Deterioration|1
5436319|NCT02327169|18778057|P5|Overall Study|Symptomatic Deterioration|1
5436320|NCT02327169|18778058|P4|Overall Study|Symptomatic Deterioration|0
5436321|NCT02327169|18778059|P3|Overall Study|Symptomatic Deterioration|1
5436322|NCT02327169|18778060|P2|Overall Study|Symptomatic Deterioration|0
5436323|NCT02327169|18778061|P1|Overall Study|Symptomatic Deterioration|0
5436324|NCT02327169|18778047|P15|Overall Study|Adverse Event|1
5436325|NCT02327169|18778048|P14|Overall Study|Adverse Event|2
5436326|NCT02327169|18778049|P13|Overall Study|Adverse Event|0
5436327|NCT02327169|18778050|P12|Overall Study|Adverse Event|3
5436328|NCT02327169|18778051|P11|Overall Study|Adverse Event|0
5436329|NCT02327169|18778052|P10|Overall Study|Adverse Event|2
5436330|NCT02327169|18778053|P9|Overall Study|Adverse Event|0
5436331|NCT02327169|18778054|P8|Overall Study|Adverse Event|0
5436332|NCT02327169|18778055|P7|Overall Study|Adverse Event|0
5436333|NCT02327169|18778056|P6|Overall Study|Adverse Event|0
5436334|NCT02327169|18778057|P5|Overall Study|Adverse Event|1
5436335|NCT02327169|18778058|P4|Overall Study|Adverse Event|0
5436336|NCT02327169|18778059|P3|Overall Study|Adverse Event|1
5436337|NCT02327169|18778060|P2|Overall Study|Adverse Event|0
5436338|NCT02327169|18778061|P1|Overall Study|Adverse Event|2
5436339|NCT02327169|18778047|P15|Overall Study|Progressive Disease|3
5436340|NCT02327169|18778048|P14|Overall Study|Progressive Disease|3
5436341|NCT02327169|18778049|P13|Overall Study|Progressive Disease|1
5436342|NCT02327169|18778050|P12|Overall Study|Progressive Disease|3
5436343|NCT02327169|18778051|P11|Overall Study|Progressive Disease|4
5436344|NCT02327169|18778052|P10|Overall Study|Progressive Disease|4
5436345|NCT02327169|18778053|P9|Overall Study|Progressive Disease|4
5436346|NCT02327169|18778054|P8|Overall Study|Progressive Disease|3
5436347|NCT02327169|18778055|P7|Overall Study|Progressive Disease|3
5436348|NCT02327169|18778056|P6|Overall Study|Progressive Disease|3
5436349|NCT02327169|18778057|P5|Overall Study|Progressive Disease|4
5436350|NCT02327169|18778058|P4|Overall Study|Progressive Disease|3
5436351|NCT02327169|18778059|P3|Overall Study|Progressive Disease|4
5436352|NCT02327169|18778060|P2|Overall Study|Progressive Disease|3
5436353|NCT02327169|18778061|P1|Overall Study|Progressive Disease|1
5436354|NCT02327130|18778291|P1|Overall Study|Met exclusion criteria|3
5436355|NCT02327130|18778291|P1|Overall Study|Incorrectly place ventilator adaptor|1
5436356|NCT02327130|18778291|P1|Overall Study|Unable to provide breath sample|1
5436357|NCT02327130|18778291|P1|Overall Study|Physician Decision|2
5436358|NCT02327130|18778291|P1|Overall Study|Discharged in less than 5 days|5
5436359|NCT02327013|18778310|P5|Overall Study|Withdrawal before treatment|0
5436360|NCT02327013|18778311|P4|Overall Study|Withdrawal before treatment|0
5436361|NCT02327013|18778312|P3|Overall Study|Withdrawal before treatment|5
5436362|NCT02327013|18778313|P2|Overall Study|Withdrawal before treatment|1
5436363|NCT02327013|18778314|P1|Overall Study|Withdrawal before treatment|2
5436364|NCT02327013|18778310|P5|Overall Study|Protocol Violation|1
5436365|NCT02327013|18778311|P4|Overall Study|Protocol Violation|0
5436366|NCT02327013|18778312|P3|Overall Study|Protocol Violation|3
5436367|NCT02327013|18778313|P2|Overall Study|Protocol Violation|0
5436368|NCT02327013|18778314|P1|Overall Study|Protocol Violation|0
5436369|NCT02327013|18778310|P5|Overall Study|Administrative or other reason(s)|1
5436370|NCT02327013|18778311|P4|Overall Study|Administrative or other reason(s)|1
5436371|NCT02327013|18778312|P3|Overall Study|Administrative or other reason(s)|11
5436372|NCT02327013|18778313|P2|Overall Study|Administrative or other reason(s)|5
5436373|NCT02327013|18778314|P1|Overall Study|Administrative or other reason(s)|1
5436374|NCT02327013|18778310|P5|Overall Study|Lost to Follow-up|0
5436375|NCT02327013|18778311|P4|Overall Study|Lost to Follow-up|0
5436376|NCT02327013|18778312|P3|Overall Study|Lost to Follow-up|5
5436377|NCT02327013|18778313|P2|Overall Study|Lost to Follow-up|4
5436378|NCT02327013|18778314|P1|Overall Study|Lost to Follow-up|2
5436379|NCT02327013|18778310|P5|Overall Study|Withdrawal of Consent|0
5436380|NCT02327013|18778311|P4|Overall Study|Withdrawal of Consent|0
5436381|NCT02327013|18778312|P3|Overall Study|Withdrawal of Consent|3
5436382|NCT02327013|18778313|P2|Overall Study|Withdrawal of Consent|0
5436383|NCT02327013|18778314|P1|Overall Study|Withdrawal of Consent|1
5436384|NCT02327013|18778310|P5|Overall Study|Non-compliance with IMP|0
5436385|NCT02327013|18778311|P4|Overall Study|Non-compliance with IMP|0
5436386|NCT02327013|18778312|P3|Overall Study|Non-compliance with IMP|7
5436387|NCT02327013|18778313|P2|Overall Study|Non-compliance with IMP|2
5436388|NCT02327013|18778314|P1|Overall Study|Non-compliance with IMP|1
5436389|NCT02327013|18778310|P5|Overall Study|Lack of Efficacy|1
5436390|NCT02327013|18778311|P4|Overall Study|Lack of Efficacy|0
5436391|NCT02327013|18778312|P3|Overall Study|Lack of Efficacy|5
5436392|NCT02327013|18778313|P2|Overall Study|Lack of Efficacy|0
5436393|NCT02327013|18778314|P1|Overall Study|Lack of Efficacy|2
5436394|NCT02327013|18778310|P5|Overall Study|Adverse Event|1
5436395|NCT02327013|18778311|P4|Overall Study|Adverse Event|0
5436396|NCT02327013|18778312|P3|Overall Study|Adverse Event|3
5436397|NCT02327013|18778313|P2|Overall Study|Adverse Event|4
5436398|NCT02327013|18778314|P1|Overall Study|Adverse Event|4
5436399|NCT02326597|18778502|P2|Overall Study|Lost to Follow-up|32
5436400|NCT02326597|18778503|P1|Overall Study|Lost to Follow-up|42
5436401|NCT02326298|18778549|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
5436402|NCT02326298|18778550|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
5436403|NCT02326298|18778551|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
5436404|NCT02326298|18778552|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436405|NCT02326298|18778553|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436406|NCT02326298|18778554|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436407|NCT02326298|18778555|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436408|NCT02326298|18778556|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436409|NCT02326298|18778557|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436410|NCT02326298|18778558|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436411|NCT02326298|18778559|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436412|NCT02326298|18778560|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436413|NCT02326298|18778561|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436414|NCT02326298|18778562|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436415|NCT02326298|18778549|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
5436416|NCT02326298|18778550|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
5436417|NCT02326298|18778551|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
5436418|NCT02326298|18778552|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436419|NCT02326298|18778553|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436420|NCT02326298|18778554|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436421|NCT02326298|18778555|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436422|NCT02326298|18778556|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436423|NCT02326298|18778557|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436424|NCT02326298|18778558|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436425|NCT02326298|18778559|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436426|NCT02326298|18778560|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436427|NCT02326298|18778561|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436428|NCT02326298|18778562|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436429|NCT02326298|18778549|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
5436430|NCT02326298|18778550|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
5436431|NCT02326298|18778551|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
5436432|NCT02326298|18778552|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436433|NCT02326298|18778553|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436434|NCT02326298|18778554|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436435|NCT02326298|18778555|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436436|NCT02326298|18778556|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436437|NCT02326298|18778557|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5437132|NCT02325739|18778773|P10|Phase II Part|Progressive disease|29
5436438|NCT02326298|18778558|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436439|NCT02326298|18778559|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436440|NCT02326298|18778560|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436441|NCT02326298|18778561|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436442|NCT02326298|18778562|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436443|NCT02326298|18778549|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
5436444|NCT02326298|18778550|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436445|NCT02326298|18778551|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436446|NCT02326298|18778552|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436447|NCT02326298|18778553|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436448|NCT02326298|18778554|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436449|NCT02326298|18778555|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436450|NCT02326298|18778556|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436451|NCT02326298|18778557|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436452|NCT02326298|18778558|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436453|NCT02326298|18778559|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436454|NCT02326298|18778560|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436455|NCT02326298|18778561|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436456|NCT02326298|18778562|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436457|NCT02326298|18778549|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436458|NCT02326298|18778550|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5436459|NCT02326298|18778551|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5436460|NCT02326298|18778552|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436461|NCT02326298|18778553|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436462|NCT02326298|18778554|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436463|NCT02326298|18778555|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436464|NCT02326298|18778556|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436465|NCT02326298|18778557|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436466|NCT02326298|18778558|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436467|NCT02326298|18778559|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436468|NCT02326298|18778560|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436469|NCT02326298|18778561|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436470|NCT02326298|18778562|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436471|NCT02326298|18778549|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436472|NCT02326298|18778550|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
5436473|NCT02326298|18778551|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|3
5436474|NCT02326298|18778552|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436475|NCT02326298|18778553|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436476|NCT02326298|18778554|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436477|NCT02326298|18778555|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436478|NCT02326298|18778556|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436479|NCT02326298|18778557|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436480|NCT02326298|18778558|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436481|NCT02326298|18778559|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436482|NCT02326298|18778560|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436483|NCT02326298|18778561|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436484|NCT02326298|18778562|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436485|NCT02326298|18778549|P14|Open-label Period (Week 48 to Week 144)|Death|0
5436486|NCT02326298|18778550|P13|Open-label Period (Week 48 to Week 144)|Death|0
5436487|NCT02326298|18778551|P12|Open-label Period (Week 48 to Week 144)|Death|1
5436488|NCT02326298|18778552|P11|Open-label Period (Week 48 to Week 144)|Death|0
5436489|NCT02326298|18778553|P10|Open-label Period (Week 48 to Week 144)|Death|0
5436490|NCT02326298|18778554|P9|Open-label Period (Week 48 to Week 144)|Death|0
5436491|NCT02326298|18778555|P8|Open-label Period (Week 48 to Week 144)|Death|0
5436492|NCT02326298|18778556|P7|Open-label Period (Week 48 to Week 144)|Death|0
5436493|NCT02326298|18778557|P6|Open-label Period (Week 48 to Week 144)|Death|0
5436494|NCT02326298|18778558|P5|Open-label Period (Week 48 to Week 144)|Death|0
5436495|NCT02326298|18778559|P4|Open-label Period (Week 48 to Week 144)|Death|0
5436496|NCT02326298|18778560|P3|Open-label Period (Week 48 to Week 144)|Death|0
5436497|NCT02326298|18778561|P2|Open-label Period (Week 48 to Week 144)|Death|0
5436498|NCT02326298|18778562|P1|Open-label Period (Week 48 to Week 144)|Death|0
5436499|NCT02326298|18778549|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436500|NCT02326298|18778550|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436501|NCT02326298|18778551|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436502|NCT02326298|18778552|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436503|NCT02326298|18778553|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436504|NCT02326298|18778554|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436505|NCT02326298|18778555|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436506|NCT02326298|18778556|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436507|NCT02326298|18778557|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
5436508|NCT02326298|18778558|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436509|NCT02326298|18778559|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436510|NCT02326298|18778560|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436511|NCT02326298|18778561|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436512|NCT02326298|18778562|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
5436513|NCT02326298|18778549|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436514|NCT02326298|18778550|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436515|NCT02326298|18778551|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436516|NCT02326298|18778552|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436517|NCT02326298|18778553|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436518|NCT02326298|18778554|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436519|NCT02326298|18778555|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5436520|NCT02326298|18778556|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436521|NCT02326298|18778557|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436522|NCT02326298|18778558|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436523|NCT02326298|18778559|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436524|NCT02326298|18778560|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436525|NCT02326298|18778561|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436526|NCT02326298|18778562|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436527|NCT02326298|18778549|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436528|NCT02326298|18778550|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436529|NCT02326298|18778551|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436530|NCT02326298|18778552|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436531|NCT02326298|18778553|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436532|NCT02326298|18778554|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436533|NCT02326298|18778555|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
5436534|NCT02326298|18778556|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
5436535|NCT02326298|18778557|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436536|NCT02326298|18778558|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436537|NCT02326298|18778559|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436538|NCT02326298|18778560|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436539|NCT02326298|18778561|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436540|NCT02326298|18778562|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436541|NCT02326298|18778549|P14|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436542|NCT02326298|18778550|P13|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436543|NCT02326298|18778551|P12|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436544|NCT02326298|18778552|P11|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436545|NCT02326298|18778553|P10|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436546|NCT02326298|18778554|P9|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436547|NCT02326298|18778555|P8|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
5436548|NCT02326298|18778556|P7|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436549|NCT02326298|18778557|P6|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436550|NCT02326298|18778558|P5|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436551|NCT02326298|18778559|P4|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436552|NCT02326298|18778560|P3|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436553|NCT02326298|18778561|P2|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436554|NCT02326298|18778562|P1|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
5436555|NCT02326298|18778549|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436556|NCT02326298|18778550|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436557|NCT02326298|18778551|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436558|NCT02326298|18778552|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436559|NCT02326298|18778553|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436560|NCT02326298|18778554|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436561|NCT02326298|18778555|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436562|NCT02326298|18778556|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
5436563|NCT02326298|18778557|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436564|NCT02326298|18778558|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436565|NCT02326298|18778559|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436566|NCT02326298|18778560|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436567|NCT02326298|18778561|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436568|NCT02326298|18778562|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436569|NCT02326298|18778549|P14|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436570|NCT02326298|18778550|P13|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436571|NCT02326298|18778551|P12|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436572|NCT02326298|18778552|P11|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436573|NCT02326298|18778553|P10|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5437133|NCT02325739|18778774|P9|Phase II Part|Progressive disease|22
5436574|NCT02326298|18778554|P9|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436575|NCT02326298|18778555|P8|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436576|NCT02326298|18778556|P7|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436577|NCT02326298|18778557|P6|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
5436578|NCT02326298|18778558|P5|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436579|NCT02326298|18778559|P4|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436580|NCT02326298|18778560|P3|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436581|NCT02326298|18778561|P2|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436582|NCT02326298|18778562|P1|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
5436583|NCT02326298|18778549|P14|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436584|NCT02326298|18778550|P13|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436585|NCT02326298|18778551|P12|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436586|NCT02326298|18778552|P11|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436587|NCT02326298|18778553|P10|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436588|NCT02326298|18778554|P9|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
5436589|NCT02326298|18778555|P8|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436590|NCT02326298|18778556|P7|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
5436591|NCT02326298|18778557|P6|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
5436592|NCT02326298|18778558|P5|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436593|NCT02326298|18778559|P4|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436594|NCT02326298|18778560|P3|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436595|NCT02326298|18778561|P2|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436596|NCT02326298|18778562|P1|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
5436597|NCT02326298|18778549|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436598|NCT02326298|18778550|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436599|NCT02326298|18778551|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436600|NCT02326298|18778552|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436601|NCT02326298|18778553|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5436602|NCT02326298|18778554|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5436603|NCT02326298|18778555|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5436604|NCT02326298|18778556|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
5436605|NCT02326298|18778557|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5436606|NCT02326298|18778558|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436607|NCT02326298|18778559|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436608|NCT02326298|18778560|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436609|NCT02326298|18778561|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436610|NCT02326298|18778562|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436611|NCT02326298|18778549|P14|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436612|NCT02326298|18778550|P13|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436613|NCT02326298|18778551|P12|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436614|NCT02326298|18778552|P11|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436615|NCT02326298|18778553|P10|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436616|NCT02326298|18778554|P9|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436617|NCT02326298|18778555|P8|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436618|NCT02326298|18778556|P7|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436619|NCT02326298|18778557|P6|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436620|NCT02326298|18778558|P5|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436621|NCT02326298|18778559|P4|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436622|NCT02326298|18778560|P3|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
5436623|NCT02326298|18778561|P2|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436624|NCT02326298|18778562|P1|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
5436625|NCT02326298|18778549|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436626|NCT02326298|18778550|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436627|NCT02326298|18778551|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436628|NCT02326298|18778552|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436629|NCT02326298|18778553|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436630|NCT02326298|18778554|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436631|NCT02326298|18778555|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436632|NCT02326298|18778556|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436633|NCT02326298|18778557|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436634|NCT02326298|18778558|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436635|NCT02326298|18778559|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436636|NCT02326298|18778560|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5436637|NCT02326298|18778561|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
5436638|NCT02326298|18778562|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
5436639|NCT02326298|18778549|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436640|NCT02326298|18778550|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436641|NCT02326298|18778551|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436642|NCT02326298|18778552|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436643|NCT02326298|18778553|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436644|NCT02326298|18778554|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436645|NCT02326298|18778555|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436646|NCT02326298|18778556|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436647|NCT02326298|18778557|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436648|NCT02326298|18778558|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436649|NCT02326298|18778559|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436650|NCT02326298|18778560|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5436651|NCT02326298|18778561|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
5436652|NCT02326298|18778562|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
5436653|NCT02326298|18778549|P14|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436654|NCT02326298|18778550|P13|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436655|NCT02326298|18778551|P12|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436656|NCT02326298|18778552|P11|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436657|NCT02326298|18778553|P10|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436658|NCT02326298|18778554|P9|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436659|NCT02326298|18778555|P8|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436660|NCT02326298|18778556|P7|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436661|NCT02326298|18778557|P6|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436662|NCT02326298|18778558|P5|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436663|NCT02326298|18778559|P4|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436664|NCT02326298|18778560|P3|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436665|NCT02326298|18778561|P2|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
5436666|NCT02326298|18778562|P1|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
5436667|NCT02326298|18778549|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436668|NCT02326298|18778550|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436669|NCT02326298|18778551|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436670|NCT02326298|18778552|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436671|NCT02326298|18778553|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436672|NCT02326298|18778554|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436673|NCT02326298|18778555|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436674|NCT02326298|18778556|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436675|NCT02326298|18778557|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436676|NCT02326298|18778558|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436677|NCT02326298|18778559|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436678|NCT02326298|18778560|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
5436679|NCT02326298|18778561|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436680|NCT02326298|18778562|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
5436681|NCT02326272|18778585|P15|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436682|NCT02326272|18778586|P14|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436683|NCT02326272|18778587|P13|Open-label Period (Week 48 to Week 144)|Pregnancy|1
5436684|NCT02326272|18778588|P12|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436685|NCT02326272|18778589|P11|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436686|NCT02326272|18778590|P10|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436687|NCT02326272|18778591|P9|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436688|NCT02326272|18778592|P8|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436689|NCT02326272|18778593|P7|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436690|NCT02326272|18778594|P6|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436691|NCT02326272|18778595|P5|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436692|NCT02326272|18778596|P4|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436693|NCT02326272|18778597|P3|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436694|NCT02326272|18778598|P2|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436695|NCT02326272|18778599|P1|Open-label Period (Week 48 to Week 144)|Pregnancy|0
5436696|NCT02326272|18778585|P15|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436697|NCT02326272|18778586|P14|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436698|NCT02326272|18778587|P13|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436699|NCT02326272|18778588|P12|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
5436700|NCT02326272|18778589|P11|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436701|NCT02326272|18778590|P10|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436702|NCT02326272|18778591|P9|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436703|NCT02326272|18778592|P8|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436704|NCT02326272|18778593|P7|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436705|NCT02326272|18778594|P6|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436706|NCT02326272|18778595|P5|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436707|NCT02326272|18778596|P4|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436708|NCT02326272|18778597|P3|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436709|NCT02326272|18778598|P2|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5436710|NCT02326272|18778599|P1|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
5437134|NCT02325739|18778775|P8|Phase II Part|Progressive disease|0
5436711|NCT02326272|18778585|P15|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
5436712|NCT02326272|18778586|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436713|NCT02326272|18778587|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
5436714|NCT02326272|18778588|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
5436715|NCT02326272|18778589|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436716|NCT02326272|18778590|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436717|NCT02326272|18778591|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436718|NCT02326272|18778592|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436719|NCT02326272|18778593|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436720|NCT02326272|18778594|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436721|NCT02326272|18778595|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436722|NCT02326272|18778596|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436723|NCT02326272|18778597|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436724|NCT02326272|18778598|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436725|NCT02326272|18778599|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
5436726|NCT02326272|18778585|P15|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
5436727|NCT02326272|18778586|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436728|NCT02326272|18778587|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436729|NCT02326272|18778588|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
5436730|NCT02326272|18778589|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436731|NCT02326272|18778590|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436732|NCT02326272|18778591|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436733|NCT02326272|18778592|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436734|NCT02326272|18778593|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436735|NCT02326272|18778594|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436736|NCT02326272|18778595|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436737|NCT02326272|18778596|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436738|NCT02326272|18778597|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436739|NCT02326272|18778598|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436740|NCT02326272|18778599|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
5436741|NCT02326272|18778585|P15|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
5436742|NCT02326272|18778586|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436743|NCT02326272|18778587|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
5436744|NCT02326272|18778588|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436745|NCT02326272|18778589|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
5436746|NCT02326272|18778590|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436747|NCT02326272|18778591|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436748|NCT02326272|18778592|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436749|NCT02326272|18778593|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436750|NCT02326272|18778594|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436751|NCT02326272|18778595|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436752|NCT02326272|18778596|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436753|NCT02326272|18778597|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436754|NCT02326272|18778598|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436755|NCT02326272|18778599|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
5436756|NCT02326272|18778585|P15|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436757|NCT02326272|18778586|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436758|NCT02326272|18778587|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436759|NCT02326272|18778588|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
5436760|NCT02326272|18778589|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436761|NCT02326272|18778590|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436762|NCT02326272|18778591|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436763|NCT02326272|18778592|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436764|NCT02326272|18778593|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436765|NCT02326272|18778594|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436766|NCT02326272|18778595|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436767|NCT02326272|18778596|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436768|NCT02326272|18778597|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436769|NCT02326272|18778598|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436770|NCT02326272|18778599|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
5436771|NCT02326272|18778585|P15|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436772|NCT02326272|18778586|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436773|NCT02326272|18778587|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5436774|NCT02326272|18778588|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436775|NCT02326272|18778589|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
5436776|NCT02326272|18778590|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436777|NCT02326272|18778591|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436778|NCT02326272|18778592|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436779|NCT02326272|18778593|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436780|NCT02326272|18778594|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436781|NCT02326272|18778595|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436782|NCT02326272|18778596|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436783|NCT02326272|18778597|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436784|NCT02326272|18778598|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436785|NCT02326272|18778599|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
5436786|NCT02326272|18778585|P15|Open-label Period (Week 48 to Week 144)|Adverse Event|1
5436787|NCT02326272|18778586|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436788|NCT02326272|18778587|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
5436789|NCT02326272|18778588|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|8
5436790|NCT02326272|18778589|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|1
5436791|NCT02326272|18778590|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436792|NCT02326272|18778591|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436793|NCT02326272|18778592|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436794|NCT02326272|18778593|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436795|NCT02326272|18778594|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436796|NCT02326272|18778595|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436797|NCT02326272|18778596|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436798|NCT02326272|18778597|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436799|NCT02326272|18778598|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436800|NCT02326272|18778599|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
5436801|NCT02326272|18778585|P15|Open-label Period (Week 48 to Week 144)|Death|0
5436802|NCT02326272|18778586|P14|Open-label Period (Week 48 to Week 144)|Death|0
5436803|NCT02326272|18778587|P13|Open-label Period (Week 48 to Week 144)|Death|1
5436804|NCT02326272|18778588|P12|Open-label Period (Week 48 to Week 144)|Death|0
5436805|NCT02326272|18778589|P11|Open-label Period (Week 48 to Week 144)|Death|0
5436806|NCT02326272|18778590|P10|Open-label Period (Week 48 to Week 144)|Death|0
5436807|NCT02326272|18778591|P9|Open-label Period (Week 48 to Week 144)|Death|0
5436808|NCT02326272|18778592|P8|Open-label Period (Week 48 to Week 144)|Death|0
5436809|NCT02326272|18778593|P7|Open-label Period (Week 48 to Week 144)|Death|0
5436810|NCT02326272|18778594|P6|Open-label Period (Week 48 to Week 144)|Death|0
5436811|NCT02326272|18778595|P5|Open-label Period (Week 48 to Week 144)|Death|0
5436812|NCT02326272|18778596|P4|Open-label Period (Week 48 to Week 144)|Death|0
5436813|NCT02326272|18778597|P3|Open-label Period (Week 48 to Week 144)|Death|0
5436814|NCT02326272|18778598|P2|Open-label Period (Week 48 to Week 144)|Death|0
5436815|NCT02326272|18778599|P1|Open-label Period (Week 48 to Week 144)|Death|0
5436816|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436817|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436818|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436819|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436820|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436821|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436822|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436823|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436824|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
5436825|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436826|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436827|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436828|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436829|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436830|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
5436831|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436832|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436833|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436834|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436835|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436836|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436837|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436838|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436839|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436840|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
5436841|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436842|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436843|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436844|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436845|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
5436846|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436847|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436848|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436849|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436850|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436851|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436852|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
5436853|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
5436854|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
5436855|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
5436856|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436857|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436858|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436859|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436860|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
5436861|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436862|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436863|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436864|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436865|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436866|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436867|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
5436868|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436869|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436870|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436871|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436872|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436873|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436874|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436875|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
5436876|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436877|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436878|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436879|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436880|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436881|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436882|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436883|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436884|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
5436885|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436886|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436887|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436888|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436889|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436890|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
5436891|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436892|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436893|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436894|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436895|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436896|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436897|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436898|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
5436899|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436900|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436901|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436902|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436903|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436904|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436905|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
5436906|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436907|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436908|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436909|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436910|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436911|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5436912|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436913|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5436914|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5436915|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
5436916|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436917|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
5436918|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436919|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436920|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
5436921|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436922|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436923|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436924|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436925|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436926|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436927|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436928|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
5436929|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436930|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
5436931|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436932|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436933|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436934|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436935|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
5436936|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436937|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436938|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436939|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436940|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436941|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5436942|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5436943|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436944|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
5436945|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
5436946|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436947|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436948|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436949|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436950|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
5436951|NCT02326272|18778585|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436952|NCT02326272|18778586|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436953|NCT02326272|18778587|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436954|NCT02326272|18778588|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436955|NCT02326272|18778589|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436956|NCT02326272|18778590|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436957|NCT02326272|18778591|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
5436958|NCT02326272|18778592|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5436959|NCT02326272|18778593|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
5436960|NCT02326272|18778594|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
5436961|NCT02326272|18778595|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
5436962|NCT02326272|18778596|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436963|NCT02326272|18778597|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436964|NCT02326272|18778598|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436965|NCT02326272|18778599|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
5436966|NCT02326272|18778585|P15|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436967|NCT02326272|18778586|P14|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436968|NCT02326272|18778587|P13|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436969|NCT02326272|18778588|P12|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436970|NCT02326272|18778589|P11|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436971|NCT02326272|18778590|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436972|NCT02326272|18778591|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436973|NCT02326272|18778592|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436974|NCT02326272|18778593|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436975|NCT02326272|18778594|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436976|NCT02326272|18778595|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436977|NCT02326272|18778596|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436978|NCT02326272|18778597|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
5436979|NCT02326272|18778598|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5436980|NCT02326272|18778599|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
5437135|NCT02325739|18778776|P7|Phase II Part|Progressive disease|0
5436981|NCT02326272|18778585|P15|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436982|NCT02326272|18778586|P14|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436983|NCT02326272|18778587|P13|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436984|NCT02326272|18778588|P12|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436985|NCT02326272|18778589|P11|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436986|NCT02326272|18778590|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436987|NCT02326272|18778591|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436988|NCT02326272|18778592|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436989|NCT02326272|18778593|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436990|NCT02326272|18778594|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436991|NCT02326272|18778595|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436992|NCT02326272|18778596|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436993|NCT02326272|18778597|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
5436994|NCT02326272|18778598|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436995|NCT02326272|18778599|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
5436996|NCT02326272|18778585|P15|Initial Period (Week 0 to Week 16)|Missed two doses|0
5436997|NCT02326272|18778586|P14|Initial Period (Week 0 to Week 16)|Missed two doses|0
5436998|NCT02326272|18778587|P13|Initial Period (Week 0 to Week 16)|Missed two doses|0
5436999|NCT02326272|18778588|P12|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437000|NCT02326272|18778589|P11|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437001|NCT02326272|18778590|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437002|NCT02326272|18778591|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437003|NCT02326272|18778592|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437004|NCT02326272|18778593|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437005|NCT02326272|18778594|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437006|NCT02326272|18778595|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437007|NCT02326272|18778596|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437008|NCT02326272|18778597|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
5437009|NCT02326272|18778598|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437010|NCT02326272|18778599|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
5437011|NCT02326272|18778585|P15|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437012|NCT02326272|18778586|P14|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437013|NCT02326272|18778587|P13|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437014|NCT02326272|18778588|P12|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437015|NCT02326272|18778589|P11|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437016|NCT02326272|18778590|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437017|NCT02326272|18778591|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437018|NCT02326272|18778592|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437019|NCT02326272|18778593|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437020|NCT02326272|18778594|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437021|NCT02326272|18778595|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437022|NCT02326272|18778596|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437023|NCT02326272|18778597|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
5437024|NCT02326272|18778598|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437025|NCT02326272|18778599|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
5437026|NCT02326272|18778585|P15|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437027|NCT02326272|18778586|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437028|NCT02326272|18778587|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437029|NCT02326272|18778588|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437030|NCT02326272|18778589|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437031|NCT02326272|18778590|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437032|NCT02326272|18778591|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437033|NCT02326272|18778592|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437034|NCT02326272|18778593|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437035|NCT02326272|18778594|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437036|NCT02326272|18778595|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437037|NCT02326272|18778596|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
5437038|NCT02326272|18778597|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
5437039|NCT02326272|18778598|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
5437040|NCT02326272|18778599|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
5437041|NCT02326272|18778585|P15|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437042|NCT02326272|18778586|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437043|NCT02326272|18778587|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437044|NCT02326272|18778588|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437045|NCT02326272|18778589|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437046|NCT02326272|18778590|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437047|NCT02326272|18778591|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437048|NCT02326272|18778592|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437049|NCT02326272|18778593|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437050|NCT02326272|18778594|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437051|NCT02326272|18778595|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437052|NCT02326272|18778596|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437053|NCT02326272|18778597|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
5437054|NCT02326272|18778598|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
5437055|NCT02326272|18778599|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
5437056|NCT02326272|18778585|P15|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437057|NCT02326272|18778586|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437058|NCT02326272|18778587|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437059|NCT02326272|18778588|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437060|NCT02326272|18778589|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437061|NCT02326272|18778590|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437062|NCT02326272|18778591|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437063|NCT02326272|18778592|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437064|NCT02326272|18778593|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437065|NCT02326272|18778594|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437066|NCT02326272|18778595|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437067|NCT02326272|18778596|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437068|NCT02326272|18778597|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
5437069|NCT02326272|18778598|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
5437070|NCT02326272|18778599|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
5437071|NCT02326220|18778636|P3|Open-label Treatment Period|Lost to Follow-up|1
5437072|NCT02326220|18778637|P2|Open-label Treatment Period|Lost to Follow-up|0
5437073|NCT02326220|18778638|P1|Open-label Treatment Period|Lost to Follow-up|0
5437074|NCT02326220|18778636|P3|Open-label Treatment Period|Withdrawal by Subject|1
5437075|NCT02326220|18778637|P2|Open-label Treatment Period|Withdrawal by Subject|0
5437076|NCT02326220|18778638|P1|Open-label Treatment Period|Withdrawal by Subject|0
5437077|NCT02326220|18778636|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5437078|NCT02326220|18778637|P2|Double-blind Treatment Period|Withdrawal by Subject|1
5437079|NCT02326220|18778638|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5437080|NCT02326220|18778636|P3|Double-blind Treatment Period|Protocol Violation|0
5437081|NCT02326220|18778637|P2|Double-blind Treatment Period|Protocol Violation|1
5437082|NCT02326220|18778638|P1|Double-blind Treatment Period|Protocol Violation|0
5437083|NCT02326220|18778636|P3|Double-blind Treatment Period|Adverse Event|0
5437084|NCT02326220|18778637|P2|Double-blind Treatment Period|Adverse Event|2
5437085|NCT02326220|18778638|P1|Double-blind Treatment Period|Adverse Event|1
5437086|NCT02326025|18778691|P2|Overall Study|Protocol Violation|1
5437087|NCT02326025|18778692|P1|Overall Study|Protocol Violation|0
5437088|NCT02326025|18778691|P2|Overall Study|Withdrawal by Subject|2
5437089|NCT02326025|18778692|P1|Overall Study|Withdrawal by Subject|0
5437090|NCT02326025|18778691|P2|Overall Study|Physician and Participant Decision|0
5437091|NCT02326025|18778692|P1|Overall Study|Physician and Participant Decision|1
5437092|NCT02326025|18778691|P2|Overall Study|Physician Decision|2
5437093|NCT02326025|18778692|P1|Overall Study|Physician Decision|1
5437094|NCT02326025|18778691|P2|Overall Study|Adverse Event|0
5437095|NCT02326025|18778692|P1|Overall Study|Adverse Event|3
5437096|NCT02325791|18778739|P4|Overall Study|Withdrawal by Subject|16
5437097|NCT02325791|18778740|P3|Overall Study|Withdrawal by Subject|8
5437098|NCT02325791|18778741|P2|Overall Study|Withdrawal by Subject|5
5437099|NCT02325791|18778742|P1|Overall Study|Withdrawal by Subject|0
5437100|NCT02325791|18778739|P4|Overall Study|Protocol Violation|0
5437101|NCT02325791|18778740|P3|Overall Study|Protocol Violation|1
5437102|NCT02325791|18778741|P2|Overall Study|Protocol Violation|0
5437103|NCT02325791|18778742|P1|Overall Study|Protocol Violation|0
5437104|NCT02325791|18778739|P4|Overall Study|Physician Decision|0
5437105|NCT02325791|18778740|P3|Overall Study|Physician Decision|1
5437106|NCT02325791|18778741|P2|Overall Study|Physician Decision|1
5437107|NCT02325791|18778742|P1|Overall Study|Physician Decision|0
5437108|NCT02325791|18778739|P4|Overall Study|Lost to Follow-up|9
5437109|NCT02325791|18778740|P3|Overall Study|Lost to Follow-up|14
5437110|NCT02325791|18778741|P2|Overall Study|Lost to Follow-up|15
5437111|NCT02325791|18778742|P1|Overall Study|Lost to Follow-up|0
5437112|NCT02325791|18778739|P4|Overall Study|Death|1
5437113|NCT02325791|18778740|P3|Overall Study|Death|0
5437114|NCT02325791|18778741|P2|Overall Study|Death|3
5437115|NCT02325791|18778742|P1|Overall Study|Death|0
5437116|NCT02325791|18778739|P4|Overall Study|Adverse Event|0
5437117|NCT02325791|18778740|P3|Overall Study|Adverse Event|1
5437118|NCT02325791|18778741|P2|Overall Study|Adverse Event|1
5437119|NCT02325791|18778742|P1|Overall Study|Adverse Event|0
5437120|NCT02325739|18778772|P11|Phase II Part|Subject/guardian decision|1
5437121|NCT02325739|18778773|P10|Phase II Part|Subject/guardian decision|1
5437122|NCT02325739|18778774|P9|Phase II Part|Subject/guardian decision|4
5437123|NCT02325739|18778775|P8|Phase II Part|Subject/guardian decision|0
5437124|NCT02325739|18778776|P7|Phase II Part|Subject/guardian decision|0
5437125|NCT02325739|18778777|P6|Phase II Part|Subject/guardian decision|0
5437126|NCT02325739|18778778|P5|Phase II Part|Subject/guardian decision|0
5437127|NCT02325739|18778779|P4|Phase II Part|Subject/guardian decision|0
5437128|NCT02325739|18778780|P3|Phase II Part|Subject/guardian decision|0
5437129|NCT02325739|18778781|P2|Phase II Part|Subject/guardian decision|0
5437130|NCT02325739|18778782|P1|Phase II Part|Subject/guardian decision|0
5437131|NCT02325739|18778772|P11|Phase II Part|Progressive disease|18
5437136|NCT02325739|18778777|P6|Phase II Part|Progressive disease|0
5437137|NCT02325739|18778778|P5|Phase II Part|Progressive disease|0
5437138|NCT02325739|18778779|P4|Phase II Part|Progressive disease|0
5437139|NCT02325739|18778780|P3|Phase II Part|Progressive disease|0
5437140|NCT02325739|18778781|P2|Phase II Part|Progressive disease|0
5437141|NCT02325739|18778782|P1|Phase II Part|Progressive disease|0
5437142|NCT02325739|18778772|P11|Phase II Part|Physician Decision|0
5437143|NCT02325739|18778773|P10|Phase II Part|Physician Decision|1
5437144|NCT02325739|18778774|P9|Phase II Part|Physician Decision|0
5437145|NCT02325739|18778775|P8|Phase II Part|Physician Decision|0
5437146|NCT02325739|18778776|P7|Phase II Part|Physician Decision|0
5437147|NCT02325739|18778777|P6|Phase II Part|Physician Decision|0
5437148|NCT02325739|18778778|P5|Phase II Part|Physician Decision|0
5437149|NCT02325739|18778779|P4|Phase II Part|Physician Decision|0
5437150|NCT02325739|18778780|P3|Phase II Part|Physician Decision|0
5437151|NCT02325739|18778781|P2|Phase II Part|Physician Decision|0
5437152|NCT02325739|18778782|P1|Phase II Part|Physician Decision|0
5437153|NCT02325739|18778772|P11|Phase II Part|Adverse Event|1
5437154|NCT02325739|18778773|P10|Phase II Part|Adverse Event|5
5437155|NCT02325739|18778774|P9|Phase II Part|Adverse Event|4
5437156|NCT02325739|18778775|P8|Phase II Part|Adverse Event|0
5437157|NCT02325739|18778776|P7|Phase II Part|Adverse Event|0
5437158|NCT02325739|18778777|P6|Phase II Part|Adverse Event|0
5437159|NCT02325739|18778778|P5|Phase II Part|Adverse Event|0
5437160|NCT02325739|18778779|P4|Phase II Part|Adverse Event|0
5437161|NCT02325739|18778780|P3|Phase II Part|Adverse Event|0
5437162|NCT02325739|18778781|P2|Phase II Part|Adverse Event|0
5437163|NCT02325739|18778782|P1|Phase II Part|Adverse Event|0
5437164|NCT02325739|18778772|P11|Phase I Part|Death|0
5437165|NCT02325739|18778773|P10|Phase I Part|Death|0
5437166|NCT02325739|18778774|P9|Phase I Part|Death|0
5437167|NCT02325739|18778775|P8|Phase I Part|Death|0
5437168|NCT02325739|18778776|P7|Phase I Part|Death|0
5437169|NCT02325739|18778777|P6|Phase I Part|Death|0
5437170|NCT02325739|18778778|P5|Phase I Part|Death|2
5437171|NCT02325739|18778779|P4|Phase I Part|Death|0
5437172|NCT02325739|18778780|P3|Phase I Part|Death|0
5437173|NCT02325739|18778781|P2|Phase I Part|Death|0
5437174|NCT02325739|18778782|P1|Phase I Part|Death|0
5437175|NCT02325739|18778772|P11|Phase I Part|Subject/guardian decision|0
5437176|NCT02325739|18778773|P10|Phase I Part|Subject/guardian decision|0
5437177|NCT02325739|18778774|P9|Phase I Part|Subject/guardian decision|0
5437178|NCT02325739|18778775|P8|Phase I Part|Subject/guardian decision|1
5437179|NCT02325739|18778776|P7|Phase I Part|Subject/guardian decision|0
5437180|NCT02325739|18778777|P6|Phase I Part|Subject/guardian decision|0
5437181|NCT02325739|18778778|P5|Phase I Part|Subject/guardian decision|0
5437182|NCT02325739|18778779|P4|Phase I Part|Subject/guardian decision|1
5437183|NCT02325739|18778780|P3|Phase I Part|Subject/guardian decision|1
5437184|NCT02325739|18778781|P2|Phase I Part|Subject/guardian decision|0
5437185|NCT02325739|18778782|P1|Phase I Part|Subject/guardian decision|1
5437186|NCT02325739|18778772|P11|Phase I Part|Progressive disease|0
5437187|NCT02325739|18778773|P10|Phase I Part|Progressive disease|0
5437188|NCT02325739|18778774|P9|Phase I Part|Progressive disease|0
5437189|NCT02325739|18778775|P8|Phase I Part|Progressive disease|3
5437190|NCT02325739|18778776|P7|Phase I Part|Progressive disease|6
5437191|NCT02325739|18778777|P6|Phase I Part|Progressive disease|6
5437192|NCT02325739|18778778|P5|Phase I Part|Progressive disease|14
5437193|NCT02325739|18778779|P4|Phase I Part|Progressive disease|23
5437194|NCT02325739|18778780|P3|Phase I Part|Progressive disease|3
5437195|NCT02325739|18778781|P2|Phase I Part|Progressive disease|6
5437196|NCT02325739|18778782|P1|Phase I Part|Progressive disease|9
5437197|NCT02325739|18778772|P11|Phase I Part|Adverse Event|0
5437198|NCT02325739|18778773|P10|Phase I Part|Adverse Event|0
5437199|NCT02325739|18778774|P9|Phase I Part|Adverse Event|0
5437200|NCT02325739|18778775|P8|Phase I Part|Adverse Event|2
5437201|NCT02325739|18778776|P7|Phase I Part|Adverse Event|0
5437202|NCT02325739|18778777|P6|Phase I Part|Adverse Event|1
5437203|NCT02325739|18778778|P5|Phase I Part|Adverse Event|3
5437204|NCT02325739|18778779|P4|Phase I Part|Adverse Event|2
5437205|NCT02325739|18778780|P3|Phase I Part|Adverse Event|1
5437206|NCT02325739|18778781|P2|Phase I Part|Adverse Event|0
5437207|NCT02325739|18778782|P1|Phase I Part|Adverse Event|1
5437208|NCT02325713|18778912|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437209|NCT02325713|18778913|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437210|NCT02325713|18778914|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437211|NCT02325713|18778915|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437212|NCT02325713|18778916|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437213|NCT02325713|18778917|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437214|NCT02325713|18778918|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
5437215|NCT02325713|18778919|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437216|NCT02325713|18778920|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437217|NCT02325713|18778921|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437218|NCT02325713|18778922|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437219|NCT02325713|18778923|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437220|NCT02325713|18778924|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437221|NCT02325713|18778925|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437222|NCT02325713|18778926|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437223|NCT02325713|18778927|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
5437224|NCT02325713|18778912|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437225|NCT02325713|18778913|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437226|NCT02325713|18778914|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437227|NCT02325713|18778915|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437228|NCT02325713|18778916|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437229|NCT02325713|18778917|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437230|NCT02325713|18778918|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437231|NCT02325713|18778919|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437232|NCT02325713|18778920|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437233|NCT02325713|18778921|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437234|NCT02325713|18778922|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437235|NCT02325713|18778923|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437236|NCT02325713|18778924|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437237|NCT02325713|18778925|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437238|NCT02325713|18778926|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
5437239|NCT02325713|18778927|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
5437240|NCT02325713|18778912|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437241|NCT02325713|18778913|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437242|NCT02325713|18778914|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437243|NCT02325713|18778915|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437244|NCT02325713|18778916|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437245|NCT02325713|18778917|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
5437246|NCT02325713|18778918|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437247|NCT02325713|18778919|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437248|NCT02325713|18778920|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437249|NCT02325713|18778921|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437250|NCT02325713|18778922|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437251|NCT02325713|18778923|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437252|NCT02325713|18778924|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437253|NCT02325713|18778925|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437254|NCT02325713|18778926|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437255|NCT02325713|18778927|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
5437256|NCT02325518|18779041|P2|Overall Study|Withdrawal by Subject|1
5437257|NCT02325518|18779042|P1|Overall Study|Withdrawal by Subject|0
5437258|NCT02325518|18779041|P2|Overall Study|Physician Decision|1
5437259|NCT02325518|18779042|P1|Overall Study|Physician Decision|0
5437260|NCT02325518|18779041|P2|Overall Study|Adverse Event|1
5437261|NCT02325518|18779042|P1|Overall Study|Adverse Event|4
5437262|NCT02325401|18779051|P3|Overall Study|Withdrawal by Subject|1
5437263|NCT02325401|18779052|P2|Overall Study|Withdrawal by Subject|1
5437264|NCT02325401|18779053|P1|Overall Study|Withdrawal by Subject|0
5437265|NCT02325219|18779076|P5|After Controlled Period (Week 16 - 52)|Pregnancy|0
5437266|NCT02325219|18779077|P4|After Controlled Period (Week 16 - 52)|Pregnancy|0
5437267|NCT02325219|18779078|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
5437268|NCT02325219|18779079|P2|After Controlled Period (Week 16 - 52)|Pregnancy|1
5437269|NCT02325219|18779080|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
5437270|NCT02325219|18779076|P5|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5437271|NCT02325219|18779077|P4|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5437272|NCT02325219|18779078|P3|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5437273|NCT02325219|18779079|P2|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
5437274|NCT02325219|18779080|P1|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
5437275|NCT02325219|18779076|P5|After Controlled Period (Week 16 - 52)|Adverse Event|1
5437276|NCT02325219|18779077|P4|After Controlled Period (Week 16 - 52)|Adverse Event|0
5437277|NCT02325219|18779078|P3|After Controlled Period (Week 16 - 52)|Adverse Event|0
5437278|NCT02325219|18779079|P2|After Controlled Period (Week 16 - 52)|Adverse Event|0
5437279|NCT02325219|18779080|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
5437280|NCT02325219|18779076|P5|Controlled Period (Week 0 - 16)|Other|0
5437281|NCT02325219|18779077|P4|Controlled Period (Week 0 - 16)|Other|0
5437282|NCT02325219|18779078|P3|Controlled Period (Week 0 - 16)|Other|1
5437283|NCT02325219|18779079|P2|Controlled Period (Week 0 - 16)|Other|0
5437284|NCT02325219|18779080|P1|Controlled Period (Week 0 - 16)|Other|0
5437285|NCT02325219|18779076|P5|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
5437286|NCT02325219|18779077|P4|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
5437287|NCT02325219|18779078|P3|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
5437288|NCT02325219|18779079|P2|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
5437289|NCT02325219|18779080|P1|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
5437290|NCT02325219|18779076|P5|Controlled Period (Week 0 - 16)|Adverse Event|0
5437291|NCT02325219|18779077|P4|Controlled Period (Week 0 - 16)|Adverse Event|0
5437292|NCT02325219|18779078|P3|Controlled Period (Week 0 - 16)|Adverse Event|0
5437293|NCT02325219|18779079|P2|Controlled Period (Week 0 - 16)|Adverse Event|1
5437294|NCT02325219|18779080|P1|Controlled Period (Week 0 - 16)|Adverse Event|6
5437295|NCT02324842|18779272|P3|Overall Study|Lost to Follow-up|2
5437296|NCT02324842|18779273|P2|Overall Study|Lost to Follow-up|1
5437297|NCT02324842|18779274|P1|Overall Study|Lost to Follow-up|1
5437298|NCT02324699|18779308|P1|Overall Study|study terminated|1
5437299|NCT02324569|18779428|P2|Overall Study|Inconvenient Schedule|0
5437300|NCT02324569|18779429|P1|Overall Study|Inconvenient Schedule|2
5437301|NCT02324569|18779428|P2|Overall Study|Change Insulin Dosage Exceeding Criteria|2
5437302|NCT02324569|18779429|P1|Overall Study|Change Insulin Dosage Exceeding Criteria|0
5437303|NCT02324569|18779428|P2|Overall Study|Lack of Efficacy|3
5437304|NCT02324569|18779429|P1|Overall Study|Lack of Efficacy|2
5437305|NCT02324569|18779428|P2|Overall Study|Voluntary Withdrawal|6
5437306|NCT02324569|18779429|P1|Overall Study|Voluntary Withdrawal|3
5437307|NCT02324569|18779428|P2|Overall Study|Pretreatment Event/Adverse Event|10
5437308|NCT02324569|18779429|P1|Overall Study|Pretreatment Event/Adverse Event|9
5437309|NCT02324465|18779487|P2|Overall Study|device failure|1
5437310|NCT02324465|18779488|P1|Overall Study|device failure|0
5437311|NCT02324361|18779502|P2|Overall Study|Lost to Follow-up|2
5437312|NCT02324361|18779503|P1|Overall Study|Lost to Follow-up|5
5437313|NCT02324270|18779533|P3|Overall Study|Non Compliance with Study Drug|0
5437314|NCT02324270|18779534|P2|Overall Study|Non Compliance with Study Drug|2
5437315|NCT02324270|18779535|P1|Overall Study|Non Compliance with Study Drug|1
5437316|NCT02324270|18779533|P3|Overall Study|Protocol Violation|1
5437317|NCT02324270|18779534|P2|Overall Study|Protocol Violation|1
5437318|NCT02324270|18779535|P1|Overall Study|Protocol Violation|0
5437319|NCT02324270|18779533|P3|Overall Study|Lost to Follow-up|4
5437320|NCT02324270|18779534|P2|Overall Study|Lost to Follow-up|3
5437321|NCT02324270|18779535|P1|Overall Study|Lost to Follow-up|4
5437322|NCT02324270|18779533|P3|Overall Study|Withdrawal by Subject|0
5437323|NCT02324270|18779534|P2|Overall Study|Withdrawal by Subject|1
5437324|NCT02324270|18779535|P1|Overall Study|Withdrawal by Subject|0
5437325|NCT02324205|18779545|P1|Overall Study|Withdrawal by Subject|37
5437326|NCT02324153|18779557|P2|Overall Study|Developed delirium preoperatively|0
5437327|NCT02324153|18779558|P1|Overall Study|Developed delirium preoperatively|1
5437328|NCT02324153|18779557|P2|Overall Study|Surgery postponed after randomization|0
5437329|NCT02324153|18779558|P1|Overall Study|Surgery postponed after randomization|3
5437330|NCT02324153|18779557|P2|Overall Study|Withdrawal by Subject|1
5437331|NCT02324153|18779558|P1|Overall Study|Withdrawal by Subject|4
5437332|NCT02324049|18779589|P1|Part C|Study terminated|11
5437333|NCT02323646|18779602|P3|Treatment Course 2|Non-compliance|1
5437334|NCT02323646|18779603|P2|Treatment Course 2|Non-compliance|1
5437335|NCT02323646|18779604|P1|Treatment Course 2|Non-compliance|0
5437336|NCT02323646|18779602|P3|Treatment Course 2|Lost to Follow-up|1
5437337|NCT02323646|18779603|P2|Treatment Course 2|Lost to Follow-up|0
5437338|NCT02323646|18779604|P1|Treatment Course 2|Lost to Follow-up|0
5437339|NCT02323646|18779602|P3|Treatment Course 2|Adverse Event|1
5437340|NCT02323646|18779603|P2|Treatment Course 2|Adverse Event|0
5437341|NCT02323646|18779604|P1|Treatment Course 2|Adverse Event|1
5437342|NCT02323646|18779602|P3|Treatment Course 1|Withdrawal by Subject|0
5437343|NCT02323646|18779603|P2|Treatment Course 1|Withdrawal by Subject|2
5437344|NCT02323646|18779604|P1|Treatment Course 1|Withdrawal by Subject|0
5437345|NCT02323646|18779602|P3|Treatment Course 1|Lost to Follow-up|2
5437346|NCT02323646|18779603|P2|Treatment Course 1|Lost to Follow-up|0
5437347|NCT02323646|18779604|P1|Treatment Course 1|Lost to Follow-up|1
5437348|NCT02323646|18779602|P3|Treatment Course 1|Heavy Bleeding|0
5437349|NCT02323646|18779603|P2|Treatment Course 1|Heavy Bleeding|1
5437350|NCT02323646|18779604|P1|Treatment Course 1|Heavy Bleeding|1
5437351|NCT02323646|18779602|P3|Treatment Course 1|Adverse Event|1
5437352|NCT02323646|18779603|P2|Treatment Course 1|Adverse Event|0
5437353|NCT02323646|18779604|P1|Treatment Course 1|Adverse Event|1
5437354|NCT02323204|18779652|P4|6-month Follow-up Survey Completion|Withdrawal by Subject|1
5437355|NCT02323204|18779653|P3|6-month Follow-up Survey Completion|Withdrawal by Subject|3
5437356|NCT02323204|18779654|P2|6-month Follow-up Survey Completion|Withdrawal by Subject|0
5437357|NCT02323204|18779655|P1|6-month Follow-up Survey Completion|Withdrawal by Subject|0
5437358|NCT02323204|18779652|P4|6-month Follow-up Survey Completion|Lost to Follow-up|43
5437359|NCT02323204|18779653|P3|6-month Follow-up Survey Completion|Lost to Follow-up|38
5437360|NCT02323204|18779654|P2|6-month Follow-up Survey Completion|Lost to Follow-up|50
5437361|NCT02323204|18779655|P1|6-month Follow-up Survey Completion|Lost to Follow-up|49
5437362|NCT02323204|18779652|P4|3-month Follow-up Survey Completion|Withdrawal by Subject|2
5437363|NCT02323204|18779653|P3|3-month Follow-up Survey Completion|Withdrawal by Subject|0
5437364|NCT02323204|18779654|P2|3-month Follow-up Survey Completion|Withdrawal by Subject|2
5437365|NCT02323204|18779655|P1|3-month Follow-up Survey Completion|Withdrawal by Subject|0
5437366|NCT02323204|18779652|P4|3-month Follow-up Survey Completion|Lost to Follow-up|42
5437367|NCT02323204|18779653|P3|3-month Follow-up Survey Completion|Lost to Follow-up|41
5437368|NCT02323204|18779654|P2|3-month Follow-up Survey Completion|Lost to Follow-up|45
5437369|NCT02323204|18779655|P1|3-month Follow-up Survey Completion|Lost to Follow-up|54
5437370|NCT02323204|18779652|P4|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
5437371|NCT02323204|18779653|P3|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
5437372|NCT02323204|18779654|P2|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
5437373|NCT02323204|18779655|P1|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
5437374|NCT02323204|18779652|P4|6-week Follow-up Intervention Booster|Lost to Follow-up|34
5437375|NCT02323204|18779653|P3|6-week Follow-up Intervention Booster|Lost to Follow-up|0
5437376|NCT02323204|18779654|P2|6-week Follow-up Intervention Booster|Lost to Follow-up|35
5437377|NCT02323204|18779655|P1|6-week Follow-up Intervention Booster|Lost to Follow-up|0
5437378|NCT02323204|18779652|P4|6-week Follow-up Survey Completion|Withdrawal by Subject|2
5437379|NCT02323204|18779653|P3|6-week Follow-up Survey Completion|Withdrawal by Subject|3
5437380|NCT02323204|18779654|P2|6-week Follow-up Survey Completion|Withdrawal by Subject|8
5437381|NCT02323204|18779655|P1|6-week Follow-up Survey Completion|Withdrawal by Subject|12
5437382|NCT02323204|18779652|P4|6-week Follow-up Survey Completion|Lost to Follow-up|35
5437383|NCT02323204|18779653|P3|6-week Follow-up Survey Completion|Lost to Follow-up|39
5437384|NCT02323204|18779654|P2|6-week Follow-up Survey Completion|Lost to Follow-up|28
5437385|NCT02323204|18779655|P1|6-week Follow-up Survey Completion|Lost to Follow-up|29
5437386|NCT02323204|18779652|P4|Baseline Survey Completion|Withdrawal by Subject|3
5437387|NCT02323204|18779653|P3|Baseline Survey Completion|Withdrawal by Subject|5
5437388|NCT02323204|18779654|P2|Baseline Survey Completion|Withdrawal by Subject|9
5437389|NCT02323204|18779655|P1|Baseline Survey Completion|Withdrawal by Subject|10
5437390|NCT02322892|18779728|P2|Overall Study|Protocol Violation|0
5437391|NCT02322892|18779729|P1|Overall Study|Protocol Violation|1
5437392|NCT02322892|18779728|P2|Overall Study|Met exclusion criteria|1
5437393|NCT02322892|18779729|P1|Overall Study|Met exclusion criteria|0
5437394|NCT02322892|18779728|P2|Overall Study|Surgery cancelled|2
5437395|NCT02322892|18779729|P1|Overall Study|Surgery cancelled|1
5437396|NCT02322879|18779745|P2|First Intervention|Physician Decision|0
5437397|NCT02322879|18779746|P1|First Intervention|Physician Decision|1
5437398|NCT02322866|18779754|P2|Overall Study|Other Miscellaneous Reasons|6
5437399|NCT02322866|18779755|P1|Overall Study|Other Miscellaneous Reasons|6
5437400|NCT02322866|18779754|P2|Overall Study|Lack of Efficacy|1
5437401|NCT02322866|18779755|P1|Overall Study|Lack of Efficacy|3
5437402|NCT02322866|18779754|P2|Overall Study|Noncompliance with Treatment|4
5437403|NCT02322866|18779755|P1|Overall Study|Noncompliance with Treatment|3
5437404|NCT02322866|18779754|P2|Overall Study|Protocol Violation|0
5437405|NCT02322866|18779755|P1|Overall Study|Protocol Violation|1
5437406|NCT02322866|18779754|P2|Overall Study|Lost to Follow-up|39
5437407|NCT02322866|18779755|P1|Overall Study|Lost to Follow-up|36
5437408|NCT02322866|18779754|P2|Overall Study|Withdrawal of Consent|25
5437409|NCT02322866|18779755|P1|Overall Study|Withdrawal of Consent|16
5437410|NCT02322866|18779754|P2|Overall Study|Adverse Event|11
5437411|NCT02322866|18779755|P1|Overall Study|Adverse Event|6
5437412|NCT02322814|18779782|P5|Overall Study|Withdrawal by Subject|3
5437413|NCT02322814|18779783|P4|Overall Study|Withdrawal by Subject|1
5437414|NCT02322814|18779784|P3|Overall Study|Withdrawal by Subject|2
5437415|NCT02322814|18779785|P2|Overall Study|Withdrawal by Subject|4
5437416|NCT02322814|18779786|P1|Overall Study|Withdrawal by Subject|5
5437417|NCT02322814|18779782|P5|Overall Study|Death|6
5437418|NCT02322814|18779783|P4|Overall Study|Death|10
5437419|NCT02322814|18779784|P3|Overall Study|Death|30
5437420|NCT02322814|18779785|P2|Overall Study|Death|22
5437421|NCT02322814|18779786|P1|Overall Study|Death|7
5437422|NCT02322814|18779782|P5|Overall Study|Protocol Violation|0
5437423|NCT02322814|18779783|P4|Overall Study|Protocol Violation|0
5437424|NCT02322814|18779784|P3|Overall Study|Protocol Violation|0
5437425|NCT02322814|18779785|P2|Overall Study|Protocol Violation|0
5437426|NCT02322814|18779786|P1|Overall Study|Protocol Violation|1
5437427|NCT02322814|18779782|P5|Overall Study|Other|0
5437428|NCT02322814|18779783|P4|Overall Study|Other|0
5437429|NCT02322814|18779784|P3|Overall Study|Other|0
5437430|NCT02322814|18779785|P2|Overall Study|Other|0
5437431|NCT02322814|18779786|P1|Overall Study|Other|2
5437432|NCT02322814|18779782|P5|Overall Study|Lost to Follow-up|0
5437433|NCT02322814|18779783|P4|Overall Study|Lost to Follow-up|0
5437434|NCT02322814|18779784|P3|Overall Study|Lost to Follow-up|1
5437435|NCT02322814|18779785|P2|Overall Study|Lost to Follow-up|2
5437436|NCT02322814|18779786|P1|Overall Study|Lost to Follow-up|1
5437437|NCT02322814|18779782|P5|Overall Study|Progressive Disease|0
5437438|NCT02322814|18779783|P4|Overall Study|Progressive Disease|1
5437439|NCT02322814|18779784|P3|Overall Study|Progressive Disease|0
5437440|NCT02322814|18779785|P2|Overall Study|Progressive Disease|2
5437441|NCT02322814|18779786|P1|Overall Study|Progressive Disease|0
5437442|NCT02322814|18779782|P5|Overall Study|Ongoing Study|22
5437443|NCT02322814|18779783|P4|Overall Study|Ongoing Study|20
5437444|NCT02322814|18779784|P3|Overall Study|Ongoing Study|14
5437445|NCT02322814|18779785|P2|Overall Study|Ongoing Study|13
5437446|NCT02322814|18779786|P1|Overall Study|Ongoing Study|0
5437447|NCT02322775|18779812|P2|Overall Study|Not willing to perform all FU visits|1
5437448|NCT02322775|18779813|P1|Overall Study|Not willing to perform all FU visits|0
5437449|NCT02322775|18779812|P2|Overall Study|Withdrawal by Subject|4
5437450|NCT02322775|18779813|P1|Overall Study|Withdrawal by Subject|3
5437451|NCT02322775|18779812|P2|Overall Study|Protocol Violation|0
5437452|NCT02322775|18779813|P1|Overall Study|Protocol Violation|1
5437453|NCT02322775|18779812|P2|Overall Study|Lost to Follow-up|1
5437454|NCT02322775|18779813|P1|Overall Study|Lost to Follow-up|0
5437455|NCT02322775|18779812|P2|Overall Study|Adverse Event|0
5437456|NCT02322775|18779813|P1|Overall Study|Adverse Event|1
5437457|NCT02322749|18779839|P6|Period 3|Withdrawal by Subject|0
5437458|NCT02322749|18779840|P5|Period 3|Withdrawal by Subject|0
5437459|NCT02322749|18779841|P4|Period 3|Withdrawal by Subject|0
5437460|NCT02322749|18779842|P3|Period 3|Withdrawal by Subject|1
5437461|NCT02322749|18779843|P2|Period 3|Withdrawal by Subject|0
5437462|NCT02322749|18779844|P1|Period 3|Withdrawal by Subject|0
5437463|NCT02322749|18779839|P6|Period 2|Withdrawal by Subject|0
5437464|NCT02322749|18779840|P5|Period 2|Withdrawal by Subject|0
5437465|NCT02322749|18779841|P4|Period 2|Withdrawal by Subject|1
5437466|NCT02322749|18779842|P3|Period 2|Withdrawal by Subject|0
5437467|NCT02322749|18779843|P2|Period 2|Withdrawal by Subject|0
5437468|NCT02322749|18779844|P1|Period 2|Withdrawal by Subject|0
5437469|NCT02322749|18779839|P6|Period 2|Adverse Event|0
5437470|NCT02322749|18779840|P5|Period 2|Adverse Event|0
5437471|NCT02322749|18779841|P4|Period 2|Adverse Event|1
5437472|NCT02322749|18779842|P3|Period 2|Adverse Event|0
5437473|NCT02322749|18779843|P2|Period 2|Adverse Event|0
5437474|NCT02322749|18779844|P1|Period 2|Adverse Event|0
5437475|NCT02322710|18779869|P2|Overall Study|Protocol Violation|25
5437476|NCT02322710|18779870|P1|Overall Study|Protocol Violation|20
5437477|NCT02322710|18779869|P2|Overall Study|No efficacy assessment post-baseline|1
5437478|NCT02322710|18779870|P1|Overall Study|No efficacy assessment post-baseline|0
5437479|NCT02322411|18779883|P2|Overall Study|Withdrawal by Subject|0
5437480|NCT02322411|18779884|P1|Overall Study|Withdrawal by Subject|1
5437481|NCT02322411|18779883|P2|Overall Study|Lost to Follow-up|7
5437482|NCT02322411|18779884|P1|Overall Study|Lost to Follow-up|4
5437483|NCT02322281|18779953|P3|Overall Study|Miscellaneous|4
5437484|NCT02322281|18779954|P2|Overall Study|Miscellaneous|0
5437485|NCT02322281|18779955|P1|Overall Study|Miscellaneous|0
5437486|NCT02322281|18779953|P3|Overall Study|Missing|1
5437487|NCT02322281|18779954|P2|Overall Study|Missing|0
5437488|NCT02322281|18779955|P1|Overall Study|Missing|0
5437489|NCT02322281|18779953|P3|Overall Study|Study Terminated by Sponsor|0
5437490|NCT02322281|18779954|P2|Overall Study|Study Terminated by Sponsor|0
5437491|NCT02322281|18779955|P1|Overall Study|Study Terminated by Sponsor|2
5437492|NCT02322281|18779953|P3|Overall Study|Physician Decision|5
5437493|NCT02322281|18779954|P2|Overall Study|Physician Decision|0
5437494|NCT02322281|18779955|P1|Overall Study|Physician Decision|2
5437495|NCT02322281|18779953|P3|Overall Study|Withdrawal by Subject|6
5437496|NCT02322281|18779954|P2|Overall Study|Withdrawal by Subject|1
5437497|NCT02322281|18779955|P1|Overall Study|Withdrawal by Subject|1
5437498|NCT02322281|18779953|P3|Overall Study|Death|3
5437499|NCT02322281|18779954|P2|Overall Study|Death|3
5437500|NCT02322281|18779955|P1|Overall Study|Death|3
5437501|NCT02322281|18779953|P3|Overall Study|Adverse Event|6
5437502|NCT02322281|18779954|P2|Overall Study|Adverse Event|4
5437503|NCT02322281|18779955|P1|Overall Study|Adverse Event|3
5437504|NCT02322281|18779953|P3|Overall Study|Progressive Disease|49
5437505|NCT02322281|18779954|P2|Overall Study|Progressive Disease|14
5437506|NCT02322281|18779955|P1|Overall Study|Progressive Disease|42
5437507|NCT02322229|18780003|P1|Overall Study|Physician Decision|2
5437508|NCT02322216|18780015|P2|Overall Study|Withdrawal by Subject|4
5437509|NCT02322216|18780016|P1|Overall Study|Withdrawal by Subject|1
5437510|NCT02322216|18780015|P2|Overall Study|Adverse Event|0
5437511|NCT02322216|18780016|P1|Overall Study|Adverse Event|1
5437512|NCT02322190|18780023|P2|Overall Study|Death on study|0
5437513|NCT02322190|18780024|P1|Overall Study|Death on study|1
5437514|NCT02322047|18780036|P4|Overall Study|Lost to Follow-up|1
5437515|NCT02322047|18780037|P3|Overall Study|Lost to Follow-up|1
5437516|NCT02322047|18780038|P2|Overall Study|Lost to Follow-up|0
5437517|NCT02322047|18780039|P1|Overall Study|Lost to Follow-up|0
5437518|NCT02322047|18780036|P4|Overall Study|Adverse Event|0
5437519|NCT02322047|18780037|P3|Overall Study|Adverse Event|0
5437520|NCT02322047|18780038|P2|Overall Study|Adverse Event|1
5437521|NCT02322047|18780039|P1|Overall Study|Adverse Event|0
5437522|NCT02322047|18780036|P4|Overall Study|Withdrawal by Subject|1
5437523|NCT02322047|18780037|P3|Overall Study|Withdrawal by Subject|0
5437524|NCT02322047|18780038|P2|Overall Study|Withdrawal by Subject|0
5437525|NCT02322047|18780039|P1|Overall Study|Withdrawal by Subject|1
5437526|NCT02322047|18780036|P4|Overall Study|Physician Decision|0
5437527|NCT02322047|18780037|P3|Overall Study|Physician Decision|0
5437528|NCT02322047|18780038|P2|Overall Study|Physician Decision|0
5437529|NCT02322047|18780039|P1|Overall Study|Physician Decision|1
5437530|NCT02321930|18780061|P1|Overall Study|Lost to Follow-up|1
5437531|NCT02321800|18780071|P2|Overall Study|Other, Miscellaneous|1
5437532|NCT02321800|18780072|P1|Overall Study|Other, Miscellaneous|3
5437533|NCT02321800|18780071|P2|Overall Study|Adverse Event|3
5437534|NCT02321800|18780072|P1|Overall Study|Adverse Event|2
5437535|NCT02321800|18780071|P2|Overall Study|Lost to Follow-up|4
5437536|NCT02321800|18780072|P1|Overall Study|Lost to Follow-up|10
5437537|NCT02321800|18780071|P2|Overall Study|Protocol Violation|0
5437538|NCT02321800|18780072|P1|Overall Study|Protocol Violation|1
5437539|NCT02321800|18780071|P2|Overall Study|Death|0
5437540|NCT02321800|18780072|P1|Overall Study|Death|1
5437541|NCT02321800|18780071|P2|Overall Study|Withdrawal by Subject|3
5437542|NCT02321800|18780072|P1|Overall Study|Withdrawal by Subject|3
5437543|NCT02321462|18780161|P2|Overall Study|Subject withdrawn before any treatment|1
5437544|NCT02321462|18780162|P1|Overall Study|Subject withdrawn before any treatment|1
5437545|NCT02321462|18780161|P2|Overall Study|Withdrawal by Subject|2
5437546|NCT02321462|18780162|P1|Overall Study|Withdrawal by Subject|5
5437547|NCT02321436|18780184|P2|Overall Study|Lost to Follow-up|1
5437548|NCT02321436|18780185|P1|Overall Study|Lost to Follow-up|0
5437549|NCT02321436|18780184|P2|Overall Study|Withdrawal by Subject|0
5437550|NCT02321436|18780185|P1|Overall Study|Withdrawal by Subject|1
5437551|NCT02321319|18780201|P1|Overall Study|Product discontinued|5
5437552|NCT02321098|18780233|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
5437553|NCT02321098|18780234|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
5437554|NCT02321098|18780235|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
5437555|NCT02321098|18780233|P3|Additional 15 Months Treatment|Lost to Follow-up|1
5437556|NCT02321098|18780234|P2|Additional 15 Months Treatment|Lost to Follow-up|0
5437557|NCT02321098|18780235|P1|Additional 15 Months Treatment|Lost to Follow-up|0
5437558|NCT02321098|18780233|P3|Additional 15 Months Treatment|Lack of Efficacy|6
5437559|NCT02321098|18780234|P2|Additional 15 Months Treatment|Lack of Efficacy|0
5437560|NCT02321098|18780235|P1|Additional 15 Months Treatment|Lack of Efficacy|0
5437561|NCT02321098|18780233|P3|12 Weeks Treament|Lost to Follow-up|0
5437562|NCT02321098|18780234|P2|12 Weeks Treament|Lost to Follow-up|1
5437563|NCT02321098|18780235|P1|12 Weeks Treament|Lost to Follow-up|1
5437564|NCT02320903|18780247|P3|Overall Study|Lost to Follow-up|5
5437565|NCT02320903|18780248|P2|Overall Study|Lost to Follow-up|5
5437566|NCT02320903|18780249|P1|Overall Study|Lost to Follow-up|0
5437567|NCT02320903|18780247|P3|Overall Study|Exited therapy; no longer eligible|2
5437568|NCT02320903|18780248|P2|Overall Study|Exited therapy; no longer eligible|2
5437569|NCT02320903|18780249|P1|Overall Study|Exited therapy; no longer eligible|8
5437570|NCT02320903|18780247|P3|Overall Study|Withdrawal by Subject|9
5437571|NCT02320903|18780248|P2|Overall Study|Withdrawal by Subject|9
5437572|NCT02320903|18780249|P1|Overall Study|Withdrawal by Subject|0
5437573|NCT02320721|18780374|P2|Overall Study|Other than specified above|20
5437574|NCT02320721|18780375|P1|Overall Study|Other than specified above|15
5437575|NCT02320721|18780374|P2|Overall Study|Hypoglycemia|0
5437576|NCT02320721|18780375|P1|Overall Study|Hypoglycemia|1
5437577|NCT02320721|18780374|P2|Overall Study|Randomized but not treated|1
5437578|NCT02320721|18780375|P1|Overall Study|Randomized but not treated|0
5437579|NCT02320721|18780374|P2|Overall Study|Poor compliance to protocol|7
5437580|NCT02320721|18780375|P1|Overall Study|Poor compliance to protocol|3
5437581|NCT02320721|18780374|P2|Overall Study|Lack of Efficacy|0
5437582|NCT02320721|18780375|P1|Overall Study|Lack of Efficacy|2
5437583|NCT02320721|18780374|P2|Overall Study|Adverse Event|6
5437584|NCT02320721|18780375|P1|Overall Study|Adverse Event|6
5437585|NCT02320487|18780430|P1|Overall Study|Adverse Event|11
5437586|NCT02320487|18780430|P1|Overall Study|Death|3
5437587|NCT02320487|18780430|P1|Overall Study|Withdrawal by Subject|1
5437588|NCT02320487|18780430|P1|Overall Study|Physician Decision|5
5437589|NCT02320487|18780430|P1|Overall Study|Reason not Specified|1
5437590|NCT02320396|18780450|P2|Overall Study|Withdrawal by Subject|0
5437591|NCT02320396|18780451|P1|Overall Study|Withdrawal by Subject|2
5437592|NCT02320396|18780450|P2|Overall Study|Protocol Violation|1
5437593|NCT02320396|18780451|P1|Overall Study|Protocol Violation|0
5437594|NCT02320396|18780450|P2|Overall Study|Pregnancy|1
5437595|NCT02320396|18780451|P1|Overall Study|Pregnancy|0
5437596|NCT02320396|18780450|P2|Overall Study|Adverse Event|2
5437597|NCT02320396|18780451|P1|Overall Study|Adverse Event|2
5437598|NCT02320149|18780510|P2|Overall Study|Other Miscellaneous Reasons|3
5437599|NCT02320149|18780511|P1|Overall Study|Other Miscellaneous Reasons|2
5437600|NCT02320149|18780510|P2|Overall Study|Lack of Efficacy|1
5437601|NCT02320149|18780511|P1|Overall Study|Lack of Efficacy|0
5437602|NCT02320149|18780510|P2|Overall Study|Noncompliance with Study Treatment|2
5437603|NCT02320149|18780511|P1|Overall Study|Noncompliance with Study Treatment|7
5437604|NCT02320149|18780510|P2|Overall Study|Protocol Violation|1
5437605|NCT02320149|18780511|P1|Overall Study|Protocol Violation|2
5437606|NCT02320149|18780510|P2|Overall Study|Lost to Follow-up|34
5437607|NCT02320149|18780511|P1|Overall Study|Lost to Follow-up|21
5437608|NCT02320149|18780510|P2|Overall Study|Withdrawal of Consent|32
5437609|NCT02320149|18780511|P1|Overall Study|Withdrawal of Consent|28
5437610|NCT02320149|18780510|P2|Overall Study|Adverse Event|7
5437611|NCT02320149|18780511|P1|Overall Study|Adverse Event|3
5437612|NCT02320123|18780551|P2|Overall Study|Death|5
5437613|NCT02320123|18780552|P1|Overall Study|Death|6
5437614|NCT02320123|18780551|P2|Overall Study|Lost to Follow-up|6
5437615|NCT02320123|18780552|P1|Overall Study|Lost to Follow-up|4
5437616|NCT02319759|18780643|P5|Week 24 - 56|Lost to Follow-up|1
5437617|NCT02319759|18780644|P4|Week 24 - 56|Lost to Follow-up|0
5437618|NCT02319759|18780645|P3|Week 24 - 56|Lost to Follow-up|0
5437619|NCT02319759|18780646|P2|Week 24 - 56|Lost to Follow-up|0
5437620|NCT02319759|18780647|P1|Week 24 - 56|Lost to Follow-up|0
5437621|NCT02319759|18780643|P5|Week 24 - 56|Withdrawal by Subject|0
5437622|NCT02319759|18780644|P4|Week 24 - 56|Withdrawal by Subject|0
5437623|NCT02319759|18780645|P3|Week 24 - 56|Withdrawal by Subject|0
5437624|NCT02319759|18780646|P2|Week 24 - 56|Withdrawal by Subject|1
5437625|NCT02319759|18780647|P1|Week 24 - 56|Withdrawal by Subject|0
5437626|NCT02319759|18780643|P5|Week 24 - 56|Lack of Efficacy|1
5437627|NCT02319759|18780644|P4|Week 24 - 56|Lack of Efficacy|2
5437628|NCT02319759|18780645|P3|Week 24 - 56|Lack of Efficacy|0
5437629|NCT02319759|18780646|P2|Week 24 - 56|Lack of Efficacy|0
5437630|NCT02319759|18780647|P1|Week 24 - 56|Lack of Efficacy|0
5437631|NCT02319759|18780643|P5|Week 24 - 56|Adverse Event|0
5437632|NCT02319759|18780644|P4|Week 24 - 56|Adverse Event|0
5437633|NCT02319759|18780645|P3|Week 24 - 56|Adverse Event|2
5437634|NCT02319759|18780646|P2|Week 24 - 56|Adverse Event|0
5437635|NCT02319759|18780647|P1|Week 24 - 56|Adverse Event|0
5437636|NCT02319759|18780643|P5|Week 16 - 24|Withdrawal by Subject|0
5437637|NCT02319759|18780644|P4|Week 16 - 24|Withdrawal by Subject|0
5437638|NCT02319759|18780645|P3|Week 16 - 24|Withdrawal by Subject|2
5437639|NCT02319759|18780646|P2|Week 16 - 24|Withdrawal by Subject|0
5437640|NCT02319759|18780647|P1|Week 16 - 24|Withdrawal by Subject|0
5437641|NCT02319759|18780643|P5|Week 16 - 24|Lost to Follow-up|0
5437642|NCT02319759|18780644|P4|Week 16 - 24|Lost to Follow-up|0
5437643|NCT02319759|18780645|P3|Week 16 - 24|Lost to Follow-up|0
5437644|NCT02319759|18780646|P2|Week 16 - 24|Lost to Follow-up|0
5437645|NCT02319759|18780647|P1|Week 16 - 24|Lost to Follow-up|1
5437646|NCT02319759|18780643|P5|Week 16 - 24|Lack of Efficacy|0
5437647|NCT02319759|18780644|P4|Week 16 - 24|Lack of Efficacy|0
5437648|NCT02319759|18780645|P3|Week 16 - 24|Lack of Efficacy|1
5437649|NCT02319759|18780646|P2|Week 16 - 24|Lack of Efficacy|0
5437650|NCT02319759|18780647|P1|Week 16 - 24|Lack of Efficacy|1
5437651|NCT02319759|18780643|P5|Week 0 - 16|Not met all Inclusion Criteria|0
5437652|NCT02319759|18780644|P4|Week 0 - 16|Not met all Inclusion Criteria|0
5437653|NCT02319759|18780645|P3|Week 0 - 16|Not met all Inclusion Criteria|1
5437654|NCT02319759|18780646|P2|Week 0 - 16|Not met all Inclusion Criteria|0
5437655|NCT02319759|18780647|P1|Week 0 - 16|Not met all Inclusion Criteria|0
5437656|NCT02319759|18780643|P5|Week 0 - 16|Lack of Efficacy|0
5437657|NCT02319759|18780644|P4|Week 0 - 16|Lack of Efficacy|0
5437658|NCT02319759|18780645|P3|Week 0 - 16|Lack of Efficacy|0
5437659|NCT02319759|18780646|P2|Week 0 - 16|Lack of Efficacy|0
5437660|NCT02319759|18780647|P1|Week 0 - 16|Lack of Efficacy|1
5437661|NCT02319668|18780744|P2|Overall Study|Other (Not specified)|2
5437662|NCT02319668|18780745|P1|Overall Study|Other (Not specified)|0
5437663|NCT02319642|18780759|P2|Overall Study|Withdrawal by Subject|1
5437664|NCT02319642|18780760|P1|Overall Study|Withdrawal by Subject|1
5437665|NCT02319642|18780759|P2|Overall Study|Lack of Efficacy|1
5437666|NCT02319642|18780760|P1|Overall Study|Lack of Efficacy|1
5437667|NCT02319642|18780759|P2|Overall Study|Adverse Event|4
5437668|NCT02319642|18780760|P1|Overall Study|Adverse Event|2
5437669|NCT02319525|18780780|P2|Overall Study|Withdrawal by Subject|1
5437670|NCT02319525|18780781|P1|Overall Study|Withdrawal by Subject|2
5437671|NCT02319148|18780823|P4|Second Intervention Period|Other|1
5437672|NCT02319148|18780824|P3|Second Intervention Period|Other|0
5437673|NCT02319148|18780825|P2|Second Intervention Period|Other|0
5437674|NCT02319148|18780826|P1|Second Intervention Period|Other|0
5437675|NCT02319148|18780823|P4|Second Intervention Period|No longer willing to participate|0
5437676|NCT02319148|18780824|P3|Second Intervention Period|No longer willing to participate|0
5437677|NCT02319148|18780825|P2|Second Intervention Period|No longer willing to participate|1
5437678|NCT02319148|18780826|P1|Second Intervention Period|No longer willing to participate|0
5437679|NCT02319148|18780823|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
5437680|NCT02319148|18780824|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
5437681|NCT02319148|18780825|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
5437682|NCT02319148|18780826|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
5437683|NCT02319044|18780889|P3|Overall Study|Not treated|2
5437684|NCT02319044|18780890|P2|Overall Study|Not treated|2
5437685|NCT02319044|18780891|P1|Overall Study|Not treated|0
5437686|NCT02319044|18780889|P3|Overall Study|Study specific discontinuation criteria|1
5437687|NCT02319044|18780890|P2|Overall Study|Study specific discontinuation criteria|2
5437688|NCT02319044|18780891|P1|Overall Study|Study specific discontinuation criteria|2
5437689|NCT02319044|18780889|P3|Overall Study|Adverse Event|8
5437690|NCT02319044|18780890|P2|Overall Study|Adverse Event|2
5437691|NCT02319044|18780891|P1|Overall Study|Adverse Event|17
5437692|NCT02319044|18780889|P3|Overall Study|Condition under investigation worsened|46
5437693|NCT02319044|18780890|P2|Overall Study|Condition under investigation worsened|50
5437694|NCT02319044|18780891|P1|Overall Study|Condition under investigation worsened|100
5437695|NCT02319044|18780889|P3|Overall Study|Withdrawal by Subject|6
5437696|NCT02319044|18780890|P2|Overall Study|Withdrawal by Subject|3
5437697|NCT02319044|18780891|P1|Overall Study|Withdrawal by Subject|3
5437698|NCT02319044|18780889|P3|Overall Study|Death, PI/sponsor decision, med history|4
5437699|NCT02319044|18780890|P2|Overall Study|Death, PI/sponsor decision, med history|1
5437700|NCT02319044|18780891|P1|Overall Study|Death, PI/sponsor decision, med history|0
5437701|NCT02319031|18780947|P2|Treatment Period|Death|0
5437702|NCT02319031|18780948|P1|Treatment Period|Death|1
5437703|NCT02318940|18781012|P2|Overall Study|lost the record|0
5437704|NCT02318940|18781013|P1|Overall Study|lost the record|1
5437705|NCT02318797|18781055|P2|Overall Study|Lost to Follow-up|96
5437706|NCT02318797|18781056|P1|Overall Study|Lost to Follow-up|85
5437707|NCT02318797|18781055|P2|Overall Study|Death|6
5437708|NCT02318797|18781056|P1|Overall Study|Death|3
5437709|NCT02318719|18781098|P5|Open-label Extension Phase|Other|7
5437710|NCT02318719|18781099|P4|Open-label Extension Phase|Other|0
5437711|NCT02318719|18781100|P3|Open-label Extension Phase|Other|0
5437712|NCT02318719|18781101|P2|Open-label Extension Phase|Other|0
5437713|NCT02318719|18781102|P1|Open-label Extension Phase|Other|0
5437714|NCT02318719|18781098|P5|Open-label Extension Phase|Withdrawal by Subject|31
5437715|NCT02318719|18781099|P4|Open-label Extension Phase|Withdrawal by Subject|0
5437716|NCT02318719|18781100|P3|Open-label Extension Phase|Withdrawal by Subject|0
5437717|NCT02318719|18781101|P2|Open-label Extension Phase|Withdrawal by Subject|0
5437718|NCT02318719|18781102|P1|Open-label Extension Phase|Withdrawal by Subject|0
5437719|NCT02318719|18781098|P5|Open-label Extension Phase|Lack of Efficacy|1
5437720|NCT02318719|18781099|P4|Open-label Extension Phase|Lack of Efficacy|0
5437721|NCT02318719|18781100|P3|Open-label Extension Phase|Lack of Efficacy|0
5437722|NCT02318719|18781101|P2|Open-label Extension Phase|Lack of Efficacy|0
5437723|NCT02318719|18781102|P1|Open-label Extension Phase|Lack of Efficacy|0
5437724|NCT02318719|18781098|P5|Open-label Extension Phase|Death|1
5437725|NCT02318719|18781099|P4|Open-label Extension Phase|Death|0
5437726|NCT02318719|18781100|P3|Open-label Extension Phase|Death|0
5437727|NCT02318719|18781101|P2|Open-label Extension Phase|Death|0
5437728|NCT02318719|18781102|P1|Open-label Extension Phase|Death|0
5437729|NCT02318719|18781098|P5|Open-label Extension Phase|Adverse Event|15
5437730|NCT02318719|18781099|P4|Open-label Extension Phase|Adverse Event|0
5437731|NCT02318719|18781100|P3|Open-label Extension Phase|Adverse Event|0
5437732|NCT02318719|18781101|P2|Open-label Extension Phase|Adverse Event|0
5437733|NCT02318719|18781102|P1|Open-label Extension Phase|Adverse Event|0
5437734|NCT02318719|18781098|P5|Double-blind Phase|Other|0
5437735|NCT02318719|18781099|P4|Double-blind Phase|Other|0
5437736|NCT02318719|18781100|P3|Double-blind Phase|Other|0
5437737|NCT02318719|18781101|P2|Double-blind Phase|Other|2
5437738|NCT02318719|18781102|P1|Double-blind Phase|Other|1
5437739|NCT02318719|18781098|P5|Double-blind Phase|Withdrawal by Subject|0
5437740|NCT02318719|18781099|P4|Double-blind Phase|Withdrawal by Subject|10
5437741|NCT02318719|18781100|P3|Double-blind Phase|Withdrawal by Subject|9
5437742|NCT02318719|18781101|P2|Double-blind Phase|Withdrawal by Subject|7
5437743|NCT02318719|18781102|P1|Double-blind Phase|Withdrawal by Subject|25
5437744|NCT02318719|18781098|P5|Double-blind Phase|Protocol Violation|0
5437745|NCT02318719|18781099|P4|Double-blind Phase|Protocol Violation|0
5437746|NCT02318719|18781100|P3|Double-blind Phase|Protocol Violation|3
5437747|NCT02318719|18781101|P2|Double-blind Phase|Protocol Violation|1
5437748|NCT02318719|18781102|P1|Double-blind Phase|Protocol Violation|0
5437749|NCT02318719|18781098|P5|Double-blind Phase|Lack of Efficacy|0
5437750|NCT02318719|18781099|P4|Double-blind Phase|Lack of Efficacy|1
5437751|NCT02318719|18781100|P3|Double-blind Phase|Lack of Efficacy|1
5437752|NCT02318719|18781101|P2|Double-blind Phase|Lack of Efficacy|0
5437753|NCT02318719|18781102|P1|Double-blind Phase|Lack of Efficacy|5
5437754|NCT02318719|18781098|P5|Double-blind Phase|Adverse Event|0
5437755|NCT02318719|18781099|P4|Double-blind Phase|Adverse Event|4
5437756|NCT02318719|18781100|P3|Double-blind Phase|Adverse Event|12
5437757|NCT02318719|18781101|P2|Double-blind Phase|Adverse Event|6
5437758|NCT02318719|18781102|P1|Double-blind Phase|Adverse Event|7
5437759|NCT02318706|18781118|P5|Open-label Extension Phase|Withdrawal by Subject|19
5437760|NCT02318706|18781119|P4|Open-label Extension Phase|Withdrawal by Subject|0
5437761|NCT02318706|18781120|P3|Open-label Extension Phase|Withdrawal by Subject|0
5437762|NCT02318706|18781121|P2|Open-label Extension Phase|Withdrawal by Subject|0
5437763|NCT02318706|18781122|P1|Open-label Extension Phase|Withdrawal by Subject|0
5437764|NCT02318706|18781118|P5|Open-label Extension Phase|Death|1
5437765|NCT02318706|18781119|P4|Open-label Extension Phase|Death|0
5437766|NCT02318706|18781120|P3|Open-label Extension Phase|Death|0
5437767|NCT02318706|18781121|P2|Open-label Extension Phase|Death|0
5437768|NCT02318706|18781122|P1|Open-label Extension Phase|Death|0
5437769|NCT02318706|18781118|P5|Open-label Extension Phase|Lack of Efficacy|1
5437770|NCT02318706|18781119|P4|Open-label Extension Phase|Lack of Efficacy|0
5437771|NCT02318706|18781120|P3|Open-label Extension Phase|Lack of Efficacy|0
5437772|NCT02318706|18781121|P2|Open-label Extension Phase|Lack of Efficacy|0
5437773|NCT02318706|18781122|P1|Open-label Extension Phase|Lack of Efficacy|0
5437774|NCT02318706|18781118|P5|Open-label Extension Phase|Adverse Event|21
5437775|NCT02318706|18781119|P4|Open-label Extension Phase|Adverse Event|0
5437776|NCT02318706|18781120|P3|Open-label Extension Phase|Adverse Event|0
5437777|NCT02318706|18781121|P2|Open-label Extension Phase|Adverse Event|0
5437778|NCT02318706|18781122|P1|Open-label Extension Phase|Adverse Event|0
5437779|NCT02318706|18781118|P5|Double-blind Phase|Death|0
5437780|NCT02318706|18781119|P4|Double-blind Phase|Death|0
5437781|NCT02318706|18781120|P3|Double-blind Phase|Death|2
5437782|NCT02318706|18781121|P2|Double-blind Phase|Death|0
5437783|NCT02318706|18781122|P1|Double-blind Phase|Death|0
5437784|NCT02318706|18781118|P5|Double-blind Phase|Other|0
5437785|NCT02318706|18781119|P4|Double-blind Phase|Other|1
5437786|NCT02318706|18781120|P3|Double-blind Phase|Other|2
5437787|NCT02318706|18781121|P2|Double-blind Phase|Other|1
5437788|NCT02318706|18781122|P1|Double-blind Phase|Other|4
5437789|NCT02318706|18781118|P5|Double-blind Phase|Withdrawal by Subject|0
5437790|NCT02318706|18781119|P4|Double-blind Phase|Withdrawal by Subject|10
5437791|NCT02318706|18781120|P3|Double-blind Phase|Withdrawal by Subject|7
5437792|NCT02318706|18781121|P2|Double-blind Phase|Withdrawal by Subject|5
5437793|NCT02318706|18781122|P1|Double-blind Phase|Withdrawal by Subject|9
5437794|NCT02318706|18781118|P5|Double-blind Phase|Protocol Violation|0
5437795|NCT02318706|18781119|P4|Double-blind Phase|Protocol Violation|3
5437796|NCT02318706|18781120|P3|Double-blind Phase|Protocol Violation|4
5437797|NCT02318706|18781121|P2|Double-blind Phase|Protocol Violation|2
5437798|NCT02318706|18781122|P1|Double-blind Phase|Protocol Violation|4
5437799|NCT02318706|18781118|P5|Double-blind Phase|Lost to Follow-up|0
5437800|NCT02318706|18781119|P4|Double-blind Phase|Lost to Follow-up|0
5437801|NCT02318706|18781120|P3|Double-blind Phase|Lost to Follow-up|0
5437802|NCT02318706|18781121|P2|Double-blind Phase|Lost to Follow-up|0
5437803|NCT02318706|18781122|P1|Double-blind Phase|Lost to Follow-up|1
5437804|NCT02318706|18781118|P5|Double-blind Phase|Adverse Event|0
5437805|NCT02318706|18781119|P4|Double-blind Phase|Adverse Event|10
5437806|NCT02318706|18781120|P3|Double-blind Phase|Adverse Event|3
5437807|NCT02318706|18781121|P2|Double-blind Phase|Adverse Event|4
5437808|NCT02318706|18781122|P1|Double-blind Phase|Adverse Event|7
5437809|NCT02318693|18781136|P2|Overall Study|Protocol Violation|1
5437810|NCT02318693|18781137|P1|Overall Study|Protocol Violation|0
5437811|NCT02318667|18781151|P1|Overall Study|Protocol Violation|2
5437812|NCT02318667|18781151|P1|Overall Study|Lack of Efficacy|6
5437813|NCT02318667|18781151|P1|Overall Study|Adverse Event|1
5437814|NCT02318602|18781170|P3|Overall Study|Guardian decision to withdraw|1
5437815|NCT02318602|18781171|P2|Overall Study|Guardian decision to withdraw|0
5437816|NCT02318602|18781172|P1|Overall Study|Guardian decision to withdraw|0
5437817|NCT02318602|18781170|P3|Overall Study|Death|0
5437818|NCT02318602|18781171|P2|Overall Study|Death|0
5437819|NCT02318602|18781172|P1|Overall Study|Death|1
5437820|NCT02318602|18781170|P3|Overall Study|Withdrawal by Subject|0
5437821|NCT02318602|18781171|P2|Overall Study|Withdrawal by Subject|3
5437822|NCT02318602|18781172|P1|Overall Study|Withdrawal by Subject|0
5437823|NCT02318602|18781170|P3|Overall Study|Adverse Event|1
5437824|NCT02318602|18781171|P2|Overall Study|Adverse Event|1
5437825|NCT02318602|18781172|P1|Overall Study|Adverse Event|0
5437826|NCT02318368|18781205|P2|Overall Study|Death|1
5437827|NCT02318368|18781206|P1|Overall Study|Death|0
5437828|NCT02318368|18781205|P2|Overall Study|Study terminated by the sponsor|2
5437829|NCT02318368|18781206|P1|Overall Study|Study terminated by the sponsor|5
5437830|NCT02318368|18781205|P2|Overall Study|Withdrawal by Subject|0
5437831|NCT02318368|18781206|P1|Overall Study|Withdrawal by Subject|2
5437832|NCT02318329|18781224|P10|Overall Study|Other|1
5437833|NCT02318329|18781225|P9|Overall Study|Other|1
5437834|NCT02318329|18781226|P8|Overall Study|Other|0
5437835|NCT02318329|18781227|P7|Overall Study|Other|0
5437836|NCT02318329|18781228|P6|Overall Study|Other|0
5437837|NCT02318329|18781229|P5|Overall Study|Other|0
5437838|NCT02318329|18781230|P4|Overall Study|Other|0
5437839|NCT02318329|18781231|P3|Overall Study|Other|1
5437840|NCT02318329|18781232|P2|Overall Study|Other|1
5437841|NCT02318329|18781233|P1|Overall Study|Other|1
5437842|NCT02318329|18781224|P10|Overall Study|Withdrawal by Subject|6
5437843|NCT02318329|18781225|P9|Overall Study|Withdrawal by Subject|0
5437844|NCT02318329|18781226|P8|Overall Study|Withdrawal by Subject|0
5437845|NCT02318329|18781227|P7|Overall Study|Withdrawal by Subject|0
5437846|NCT02318329|18781228|P6|Overall Study|Withdrawal by Subject|0
5437847|NCT02318329|18781229|P5|Overall Study|Withdrawal by Subject|0
5437848|NCT02318329|18781230|P4|Overall Study|Withdrawal by Subject|0
5437849|NCT02318329|18781231|P3|Overall Study|Withdrawal by Subject|0
5437850|NCT02318329|18781232|P2|Overall Study|Withdrawal by Subject|0
5437851|NCT02318329|18781233|P1|Overall Study|Withdrawal by Subject|0
5437852|NCT02318329|18781224|P10|Overall Study|Lost to Follow-up|1
5437853|NCT02318329|18781225|P9|Overall Study|Lost to Follow-up|0
5437854|NCT02318329|18781226|P8|Overall Study|Lost to Follow-up|0
5437855|NCT02318329|18781227|P7|Overall Study|Lost to Follow-up|0
5437856|NCT02318329|18781228|P6|Overall Study|Lost to Follow-up|0
5437857|NCT02318329|18781229|P5|Overall Study|Lost to Follow-up|0
5437858|NCT02318329|18781230|P4|Overall Study|Lost to Follow-up|0
5437859|NCT02318329|18781231|P3|Overall Study|Lost to Follow-up|0
5437860|NCT02318329|18781232|P2|Overall Study|Lost to Follow-up|0
5437861|NCT02318329|18781233|P1|Overall Study|Lost to Follow-up|0
5437862|NCT02318329|18781224|P10|Overall Study|Death|5
5437863|NCT02318329|18781225|P9|Overall Study|Death|0
5437864|NCT02318329|18781226|P8|Overall Study|Death|0
5437865|NCT02318329|18781227|P7|Overall Study|Death|0
5437866|NCT02318329|18781228|P6|Overall Study|Death|0
5437867|NCT02318329|18781229|P5|Overall Study|Death|0
5437868|NCT02318329|18781230|P4|Overall Study|Death|0
5437869|NCT02318329|18781231|P3|Overall Study|Death|0
5437870|NCT02318329|18781232|P2|Overall Study|Death|0
5437871|NCT02318329|18781233|P1|Overall Study|Death|0
5437872|NCT02318329|18781224|P10|Overall Study|Progressive Disease|39
5437873|NCT02318329|18781225|P9|Overall Study|Progressive Disease|5
5437874|NCT02318329|18781226|P8|Overall Study|Progressive Disease|1
5437875|NCT02318329|18781227|P7|Overall Study|Progressive Disease|1
5437876|NCT02318329|18781228|P6|Overall Study|Progressive Disease|3
5437877|NCT02318329|18781229|P5|Overall Study|Progressive Disease|3
5437878|NCT02318329|18781230|P4|Overall Study|Progressive Disease|3
5437879|NCT02318329|18781231|P3|Overall Study|Progressive Disease|2
5437880|NCT02318329|18781232|P2|Overall Study|Progressive Disease|3
5437881|NCT02318329|18781233|P1|Overall Study|Progressive Disease|2
5437882|NCT02318277|18781326|P8|Overall Study|Participants Ongoing in study|0
5437883|NCT02318277|18781327|P7|Overall Study|Participants Ongoing in study|0
5437884|NCT02318277|18781328|P6|Overall Study|Participants Ongoing in study|1
5437885|NCT02318277|18781329|P5|Overall Study|Participants Ongoing in study|0
5437886|NCT02318277|18781330|P4|Overall Study|Participants Ongoing in study|0
5437887|NCT02318277|18781331|P3|Overall Study|Participants Ongoing in study|0
5437888|NCT02318277|18781332|P2|Overall Study|Participants Ongoing in study|0
5437889|NCT02318277|18781333|P1|Overall Study|Participants Ongoing in study|0
5437890|NCT02318277|18781326|P8|Overall Study|Death|58
5437891|NCT02318277|18781327|P7|Overall Study|Death|34
5437892|NCT02318277|18781328|P6|Overall Study|Death|5
5437893|NCT02318277|18781329|P5|Overall Study|Death|6
5437894|NCT02318277|18781330|P4|Overall Study|Death|4
5437895|NCT02318277|18781331|P3|Overall Study|Death|1
5437896|NCT02318277|18781332|P2|Overall Study|Death|3
5437897|NCT02318277|18781333|P1|Overall Study|Death|5
5437898|NCT02318277|18781326|P8|Overall Study|Lost to Follow-up|4
5437899|NCT02318277|18781327|P7|Overall Study|Lost to Follow-up|3
5437900|NCT02318277|18781328|P6|Overall Study|Lost to Follow-up|0
5437901|NCT02318277|18781329|P5|Overall Study|Lost to Follow-up|0
5437902|NCT02318277|18781330|P4|Overall Study|Lost to Follow-up|0
5437903|NCT02318277|18781331|P3|Overall Study|Lost to Follow-up|1
5437904|NCT02318277|18781332|P2|Overall Study|Lost to Follow-up|0
5437905|NCT02318277|18781333|P1|Overall Study|Lost to Follow-up|1
5437906|NCT02318277|18781326|P8|Overall Study|Participant trial terminated by sponsor|16
5437907|NCT02318277|18781327|P7|Overall Study|Participant trial terminated by sponsor|5
5437908|NCT02318277|18781328|P6|Overall Study|Participant trial terminated by sponsor|2
5437909|NCT02318277|18781329|P5|Overall Study|Participant trial terminated by sponsor|1
5437910|NCT02318277|18781330|P4|Overall Study|Participant trial terminated by sponsor|0
5437911|NCT02318277|18781331|P3|Overall Study|Participant trial terminated by sponsor|1
5437912|NCT02318277|18781332|P2|Overall Study|Participant trial terminated by sponsor|0
5437913|NCT02318277|18781333|P1|Overall Study|Participant trial terminated by sponsor|0
5437914|NCT02318277|18781326|P8|Overall Study|Withdrawal by Subject|14
5437915|NCT02318277|18781327|P7|Overall Study|Withdrawal by Subject|6
5437916|NCT02318277|18781328|P6|Overall Study|Withdrawal by Subject|1
5437917|NCT02318277|18781329|P5|Overall Study|Withdrawal by Subject|1
5437918|NCT02318277|18781330|P4|Overall Study|Withdrawal by Subject|0
5437919|NCT02318277|18781331|P3|Overall Study|Withdrawal by Subject|1
5437920|NCT02318277|18781332|P2|Overall Study|Withdrawal by Subject|0
5437921|NCT02318277|18781333|P1|Overall Study|Withdrawal by Subject|0
5437922|NCT02318277|18781326|P8|Overall Study|Other|0
5437923|NCT02318277|18781327|P7|Overall Study|Other|1
5437924|NCT02318277|18781328|P6|Overall Study|Other|0
5437925|NCT02318277|18781329|P5|Overall Study|Other|0
5437926|NCT02318277|18781330|P4|Overall Study|Other|0
5437927|NCT02318277|18781331|P3|Overall Study|Other|0
5437928|NCT02318277|18781332|P2|Overall Study|Other|0
5437929|NCT02318277|18781333|P1|Overall Study|Other|0
5437930|NCT02318277|18781326|P8|Overall Study|Physician Decision|1
5437931|NCT02318277|18781327|P7|Overall Study|Physician Decision|0
5437932|NCT02318277|18781328|P6|Overall Study|Physician Decision|0
5437933|NCT02318277|18781329|P5|Overall Study|Physician Decision|0
5437934|NCT02318277|18781330|P4|Overall Study|Physician Decision|0
5437935|NCT02318277|18781331|P3|Overall Study|Physician Decision|0
5437936|NCT02318277|18781332|P2|Overall Study|Physician Decision|0
5437937|NCT02318277|18781333|P1|Overall Study|Physician Decision|0
5437938|NCT02317809|18781396|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
5437939|NCT02317809|18781397|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
5437940|NCT02317809|18781396|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
5437941|NCT02317809|18781397|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
5437942|NCT02317614|18781485|P2|Overall Study|Death|1
5437943|NCT02317614|18781486|P1|Overall Study|Death|1
5437944|NCT02317614|18781485|P2|Overall Study|Withdrawal by Subject|0
5437945|NCT02317614|18781486|P1|Overall Study|Withdrawal by Subject|1
5437946|NCT02317614|18781485|P2|Overall Study|Lost to Follow-up|1
5437947|NCT02317614|18781486|P1|Overall Study|Lost to Follow-up|1
5437948|NCT02317575|18781502|P5|Period 1|Withdrawal by Subject|0
5437949|NCT02317575|18781503|P4|Period 1|Withdrawal by Subject|0
5437950|NCT02317575|18781504|P3|Period 1|Withdrawal by Subject|0
5437951|NCT02317575|18781505|P2|Period 1|Withdrawal by Subject|0
5437952|NCT02317575|18781506|P1|Period 1|Withdrawal by Subject|1
5437953|NCT02317575|18781502|P5|Period 1|Difficulty with venous cannulation|0
5437954|NCT02317575|18781503|P4|Period 1|Difficulty with venous cannulation|0
5437955|NCT02317575|18781504|P3|Period 1|Difficulty with venous cannulation|0
5437956|NCT02317575|18781505|P2|Period 1|Difficulty with venous cannulation|1
5437957|NCT02317575|18781506|P1|Period 1|Difficulty with venous cannulation|0
5437958|NCT02317510|18781541|P2|Overall Study|Adverse Event|1
5437959|NCT02317510|18781542|P1|Overall Study|Adverse Event|0
5437960|NCT02317016|18781574|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
5437961|NCT02317016|18781574|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
5437962|NCT02317016|18781574|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
5437963|NCT02317016|18781574|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
5437964|NCT02317016|18781574|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
5437965|NCT02317016|18781574|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
5437966|NCT02317016|18781574|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
5437967|NCT02316847|18781602|P2|Overall Study|Withdrawn due to termination by Sponsor|67
5437968|NCT02316847|18781603|P1|Overall Study|Withdrawn due to termination by Sponsor|7
5437969|NCT02316847|18781602|P2|Overall Study|Noncompliance with study drug|3
5437970|NCT02316847|18781603|P1|Overall Study|Noncompliance with study drug|0
5437971|NCT02316847|18781602|P2|Overall Study|Withdrawal by Subject|9
5437972|NCT02316847|18781603|P1|Overall Study|Withdrawal by Subject|2
5437973|NCT02316847|18781602|P2|Overall Study|Pregnancy|1
5437974|NCT02316847|18781603|P1|Overall Study|Pregnancy|0
5437975|NCT02316847|18781602|P2|Overall Study|Physician Decision|1
5437976|NCT02316847|18781603|P1|Overall Study|Physician Decision|0
5437977|NCT02316847|18781602|P2|Overall Study|Lost to Follow-up|2
5437978|NCT02316847|18781603|P1|Overall Study|Lost to Follow-up|0
5437979|NCT02316847|18781602|P2|Overall Study|Adverse Event|3
5437980|NCT02316847|18781603|P1|Overall Study|Adverse Event|0
5437981|NCT02316769|18781614|P2|Overall Study|Withdrawal by Subject|0
5437982|NCT02316769|18781615|P1|Overall Study|Withdrawal by Subject|1
5437983|NCT02316769|18781614|P2|Overall Study|Physician Decision|0
5437984|NCT02316769|18781615|P1|Overall Study|Physician Decision|1
5437985|NCT02316717|18781626|P3|Overall Study|TBC|0
5437986|NCT02316717|18781627|P2|Overall Study|TBC|0
5437987|NCT02316717|18781628|P1|Overall Study|TBC|1
5437988|NCT02316717|18781626|P3|Overall Study|Physician Decision|0
5437989|NCT02316717|18781627|P2|Overall Study|Physician Decision|1
5437990|NCT02316717|18781628|P1|Overall Study|Physician Decision|0
5437991|NCT02316717|18781626|P3|Overall Study|Death|1
5437992|NCT02316717|18781627|P2|Overall Study|Death|0
5437993|NCT02316717|18781628|P1|Overall Study|Death|0
5437994|NCT02316717|18781626|P3|Overall Study|Withdrawal by Subject|1
5437995|NCT02316717|18781627|P2|Overall Study|Withdrawal by Subject|1
5437996|NCT02316717|18781628|P1|Overall Study|Withdrawal by Subject|2
5437997|NCT02316717|18781626|P3|Overall Study|Protocol Violation|0
5437998|NCT02316717|18781627|P2|Overall Study|Protocol Violation|0
5437999|NCT02316717|18781628|P1|Overall Study|Protocol Violation|2
5438000|NCT02316717|18781626|P3|Overall Study|Non compliance|0
5438001|NCT02316717|18781627|P2|Overall Study|Non compliance|1
5438002|NCT02316717|18781628|P1|Overall Study|Non compliance|3
5438003|NCT02316717|18781626|P3|Overall Study|Lost to Follow-up|1
5438004|NCT02316717|18781627|P2|Overall Study|Lost to Follow-up|2
5438005|NCT02316717|18781628|P1|Overall Study|Lost to Follow-up|1
5438006|NCT02316717|18781626|P3|Overall Study|Adverse Event|0
5438007|NCT02316717|18781627|P2|Overall Study|Adverse Event|2
5438008|NCT02316717|18781628|P1|Overall Study|Adverse Event|2
5438009|NCT02316613|18781765|P1|Overall Study|Did not met selection criteria|14
5438010|NCT02316613|18781765|P1|Overall Study|No data and duplicate cases|5
5438011|NCT02316613|18781765|P1|Overall Study|Participant moved/changed medical team|11
5438012|NCT02316613|18781765|P1|Overall Study|Lymphoma transformation|2
5438013|NCT02316613|18781765|P1|Overall Study|Lost to Follow-up|9
5438014|NCT02316613|18781765|P1|Overall Study|Death|63
5438015|NCT02316548|18781804|P2|Overall Study|Protocol Violation|1
5438016|NCT02316548|18781805|P1|Overall Study|Protocol Violation|0
5438017|NCT02316353|18781935|P2|Overall Study|Withdrawal by Subject|2
5438018|NCT02316353|18781936|P1|Overall Study|Withdrawal by Subject|6
5438019|NCT02316353|18781935|P2|Overall Study|Adverse Event|3
5438020|NCT02316353|18781936|P1|Overall Study|Adverse Event|1
5438021|NCT02316353|18781935|P2|Overall Study|Pregnancy|3
5438022|NCT02316353|18781936|P1|Overall Study|Pregnancy|1
5438023|NCT02316171|18781956|P4|Overall Study|difficulties with urinary catheter|0
5438024|NCT02316171|18781957|P3|Overall Study|difficulties with urinary catheter|0
5438025|NCT02316171|18781958|P2|Overall Study|difficulties with urinary catheter|0
5438026|NCT02316171|18781959|P1|Overall Study|difficulties with urinary catheter|1
5438027|NCT02315703|18782029|P8|Overall Study|Other|2
5438028|NCT02315703|18782030|P7|Overall Study|Other|8
5438029|NCT02315703|18782031|P6|Overall Study|Other|2
5438030|NCT02315703|18782032|P5|Overall Study|Other|1
5438031|NCT02315703|18782033|P4|Overall Study|Other|2
5438032|NCT02315703|18782034|P3|Overall Study|Other|2
5438033|NCT02315703|18782035|P2|Overall Study|Other|2
5438034|NCT02315703|18782036|P1|Overall Study|Other|4
5438035|NCT02315703|18782029|P8|Overall Study|Physician Decision|0
5438036|NCT02315703|18782030|P7|Overall Study|Physician Decision|1
5438037|NCT02315703|18782031|P6|Overall Study|Physician Decision|2
5438038|NCT02315703|18782032|P5|Overall Study|Physician Decision|0
5438039|NCT02315703|18782033|P4|Overall Study|Physician Decision|0
5438040|NCT02315703|18782034|P3|Overall Study|Physician Decision|0
5438041|NCT02315703|18782035|P2|Overall Study|Physician Decision|0
5438042|NCT02315703|18782036|P1|Overall Study|Physician Decision|0
5438043|NCT02315703|18782029|P8|Overall Study|Withdrawal by Subject|2
5438044|NCT02315703|18782030|P7|Overall Study|Withdrawal by Subject|1
5438045|NCT02315703|18782031|P6|Overall Study|Withdrawal by Subject|1
5438046|NCT02315703|18782032|P5|Overall Study|Withdrawal by Subject|4
5438047|NCT02315703|18782033|P4|Overall Study|Withdrawal by Subject|3
5438048|NCT02315703|18782034|P3|Overall Study|Withdrawal by Subject|0
5438049|NCT02315703|18782035|P2|Overall Study|Withdrawal by Subject|3
5438050|NCT02315703|18782036|P1|Overall Study|Withdrawal by Subject|1
5438051|NCT02315703|18782029|P8|Overall Study|Pregnancy|1
5438052|NCT02315703|18782030|P7|Overall Study|Pregnancy|0
5438053|NCT02315703|18782031|P6|Overall Study|Pregnancy|0
5438054|NCT02315703|18782032|P5|Overall Study|Pregnancy|0
5438055|NCT02315703|18782033|P4|Overall Study|Pregnancy|0
5438056|NCT02315703|18782034|P3|Overall Study|Pregnancy|0
5438057|NCT02315703|18782035|P2|Overall Study|Pregnancy|0
5438058|NCT02315703|18782036|P1|Overall Study|Pregnancy|0
5438059|NCT02315703|18782029|P8|Overall Study|Lost to Follow-up|2
5438060|NCT02315703|18782030|P7|Overall Study|Lost to Follow-up|2
5438061|NCT02315703|18782031|P6|Overall Study|Lost to Follow-up|1
5438062|NCT02315703|18782032|P5|Overall Study|Lost to Follow-up|2
5438063|NCT02315703|18782033|P4|Overall Study|Lost to Follow-up|3
5438064|NCT02315703|18782034|P3|Overall Study|Lost to Follow-up|3
5438065|NCT02315703|18782035|P2|Overall Study|Lost to Follow-up|5
5438066|NCT02315703|18782036|P1|Overall Study|Lost to Follow-up|1
5438067|NCT02315703|18782029|P8|Overall Study|Adverse Event|0
5438068|NCT02315703|18782030|P7|Overall Study|Adverse Event|1
5438069|NCT02315703|18782031|P6|Overall Study|Adverse Event|0
5438070|NCT02315703|18782032|P5|Overall Study|Adverse Event|1
5438071|NCT02315703|18782033|P4|Overall Study|Adverse Event|1
5438072|NCT02315703|18782034|P3|Overall Study|Adverse Event|0
5438073|NCT02315703|18782035|P2|Overall Study|Adverse Event|0
5438074|NCT02315703|18782036|P1|Overall Study|Adverse Event|0
5438075|NCT02315664|18782136|P2|Overall Study|Withdrawal by Subject|3
5438076|NCT02315664|18782137|P1|Overall Study|Withdrawal by Subject|0
5438077|NCT02315664|18782136|P2|Overall Study|Lost to Follow-up|1
5438078|NCT02315664|18782137|P1|Overall Study|Lost to Follow-up|1
5438079|NCT02315625|18782159|P2|Second Intervention|Disease Progression|0
5438080|NCT02315625|18782160|P1|Second Intervention|Disease Progression|1
5438081|NCT02315625|18782159|P2|Second Intervention|Study closure|0
5438082|NCT02315625|18782160|P1|Second Intervention|Study closure|1
5438083|NCT02315625|18782159|P2|Second Intervention|Physician Decision|1
5438084|NCT02315625|18782160|P1|Second Intervention|Physician Decision|2
5438085|NCT02315625|18782159|P2|First Intervention|Disease Progression|0
5438086|NCT02315625|18782160|P1|First Intervention|Disease Progression|1
5438087|NCT02315560|18782174|P1|Overall Study|noncompliance by subjects|3
5438088|NCT02314923|18782433|P10|Overall Study|Participant relocation|0
5438089|NCT02314923|18782434|P9|Overall Study|Participant relocation|0
5438090|NCT02314923|18782435|P8|Overall Study|Participant relocation|1
5438091|NCT02314923|18782436|P7|Overall Study|Participant relocation|0
5438092|NCT02314923|18782437|P6|Overall Study|Participant relocation|0
5438093|NCT02314923|18782438|P5|Overall Study|Participant relocation|0
5438094|NCT02314923|18782439|P4|Overall Study|Participant relocation|0
5438095|NCT02314923|18782440|P3|Overall Study|Participant relocation|0
5438096|NCT02314923|18782441|P2|Overall Study|Participant relocation|0
5438097|NCT02314923|18782442|P1|Overall Study|Participant relocation|1
5438098|NCT02314923|18782433|P10|Overall Study|Screen failure|0
5438099|NCT02314923|18782434|P9|Overall Study|Screen failure|0
5438100|NCT02314923|18782435|P8|Overall Study|Screen failure|0
5438101|NCT02314923|18782436|P7|Overall Study|Screen failure|1
5438102|NCT02314923|18782437|P6|Overall Study|Screen failure|0
5438103|NCT02314923|18782438|P5|Overall Study|Screen failure|0
5438104|NCT02314923|18782439|P4|Overall Study|Screen failure|0
5438105|NCT02314923|18782440|P3|Overall Study|Screen failure|0
5438106|NCT02314923|18782441|P2|Overall Study|Screen failure|0
5438107|NCT02314923|18782442|P1|Overall Study|Screen failure|0
5438108|NCT02314923|18782433|P10|Overall Study|Participant unavailable|0
5438109|NCT02314923|18782434|P9|Overall Study|Participant unavailable|0
5438110|NCT02314923|18782435|P8|Overall Study|Participant unavailable|0
5438111|NCT02314923|18782436|P7|Overall Study|Participant unavailable|0
5438112|NCT02314923|18782437|P6|Overall Study|Participant unavailable|1
5438113|NCT02314923|18782438|P5|Overall Study|Participant unavailable|0
5438114|NCT02314923|18782439|P4|Overall Study|Participant unavailable|0
5438115|NCT02314923|18782440|P3|Overall Study|Participant unavailable|0
5438116|NCT02314923|18782441|P2|Overall Study|Participant unavailable|0
5438117|NCT02314923|18782442|P1|Overall Study|Participant unavailable|0
5438118|NCT02314923|18782433|P10|Overall Study|Physician Decision|0
5438119|NCT02314923|18782434|P9|Overall Study|Physician Decision|0
5438120|NCT02314923|18782435|P8|Overall Study|Physician Decision|0
5438121|NCT02314923|18782436|P7|Overall Study|Physician Decision|0
5438122|NCT02314923|18782437|P6|Overall Study|Physician Decision|0
5438123|NCT02314923|18782438|P5|Overall Study|Physician Decision|0
5438124|NCT02314923|18782439|P4|Overall Study|Physician Decision|0
5438125|NCT02314923|18782440|P3|Overall Study|Physician Decision|0
5438126|NCT02314923|18782441|P2|Overall Study|Physician Decision|1
5438127|NCT02314923|18782442|P1|Overall Study|Physician Decision|0
5438128|NCT02314923|18782433|P10|Overall Study|Withdrawal by Subject|0
5438129|NCT02314923|18782434|P9|Overall Study|Withdrawal by Subject|0
5438130|NCT02314923|18782435|P8|Overall Study|Withdrawal by Subject|0
5438131|NCT02314923|18782436|P7|Overall Study|Withdrawal by Subject|1
5438132|NCT02314923|18782437|P6|Overall Study|Withdrawal by Subject|0
5438133|NCT02314923|18782438|P5|Overall Study|Withdrawal by Subject|1
5438134|NCT02314923|18782439|P4|Overall Study|Withdrawal by Subject|0
5438135|NCT02314923|18782440|P3|Overall Study|Withdrawal by Subject|1
5438136|NCT02314923|18782441|P2|Overall Study|Withdrawal by Subject|0
5438137|NCT02314923|18782442|P1|Overall Study|Withdrawal by Subject|0
5438138|NCT02314923|18782433|P10|Overall Study|Lost to Follow-up|0
5438139|NCT02314923|18782434|P9|Overall Study|Lost to Follow-up|2
5438140|NCT02314923|18782435|P8|Overall Study|Lost to Follow-up|4
5438141|NCT02314923|18782436|P7|Overall Study|Lost to Follow-up|3
5438142|NCT02314923|18782437|P6|Overall Study|Lost to Follow-up|0
5438143|NCT02314923|18782438|P5|Overall Study|Lost to Follow-up|0
5438144|NCT02314923|18782439|P4|Overall Study|Lost to Follow-up|0
5438145|NCT02314923|18782440|P3|Overall Study|Lost to Follow-up|1
5438146|NCT02314923|18782441|P2|Overall Study|Lost to Follow-up|3
5438147|NCT02314923|18782442|P1|Overall Study|Lost to Follow-up|2
5438148|NCT02314923|18782433|P10|Overall Study|Death|0
5438149|NCT02314923|18782434|P9|Overall Study|Death|0
5438150|NCT02314923|18782435|P8|Overall Study|Death|0
5438151|NCT02314923|18782436|P7|Overall Study|Death|0
5438152|NCT02314923|18782437|P6|Overall Study|Death|0
5438153|NCT02314923|18782438|P5|Overall Study|Death|0
5438154|NCT02314923|18782439|P4|Overall Study|Death|1
5438155|NCT02314923|18782440|P3|Overall Study|Death|0
5438156|NCT02314923|18782441|P2|Overall Study|Death|0
5438157|NCT02314923|18782442|P1|Overall Study|Death|0
5438158|NCT02314637|18782541|P2|Overall Study|Other Reason|0
5438159|NCT02314637|18782542|P1|Overall Study|Other Reason|1
5438160|NCT02314637|18782541|P2|Overall Study|Withdrawal by Subject|4
5438161|NCT02314637|18782542|P1|Overall Study|Withdrawal by Subject|5
5438162|NCT02314637|18782541|P2|Overall Study|Physician Decision|2
5438163|NCT02314637|18782542|P1|Overall Study|Physician Decision|5
5438164|NCT02314637|18782541|P2|Overall Study|Lack of Efficacy|0
5438165|NCT02314637|18782542|P1|Overall Study|Lack of Efficacy|1
5438166|NCT02314637|18782541|P2|Overall Study|Adverse Event|8
5438167|NCT02314637|18782542|P1|Overall Study|Adverse Event|4
5438168|NCT02314247|18782613|P3|Overall Study|Progression of Disease|0
5438169|NCT02314247|18782614|P2|Overall Study|Progression of Disease|2
5438170|NCT02314247|18782615|P1|Overall Study|Progression of Disease|6
5438171|NCT02314247|18782613|P3|Overall Study|Withdrawal by Subject|1
5438172|NCT02314247|18782614|P2|Overall Study|Withdrawal by Subject|3
5438173|NCT02314247|18782615|P1|Overall Study|Withdrawal by Subject|1
5438174|NCT02314247|18782613|P3|Overall Study|Adverse Event|0
5438175|NCT02314247|18782614|P2|Overall Study|Adverse Event|1
5438176|NCT02314247|18782615|P1|Overall Study|Adverse Event|2
5438177|NCT02314143|18782640|P3|Overall Study|Withdrawal by Subject|1
5438178|NCT02314143|18782641|P2|Overall Study|Withdrawal by Subject|0
5438179|NCT02314143|18782642|P1|Overall Study|Withdrawal by Subject|1
5438180|NCT02314143|18782640|P3|Overall Study|Physician Decision|0
5438181|NCT02314143|18782641|P2|Overall Study|Physician Decision|1
5438182|NCT02314143|18782642|P1|Overall Study|Physician Decision|2
5438183|NCT02314143|18782640|P3|Overall Study|Other (Study Closed/Terminated)|4
5438184|NCT02314143|18782641|P2|Overall Study|Other (Study Closed/Terminated)|3
5438185|NCT02314143|18782642|P1|Overall Study|Other (Study Closed/Terminated)|5
5438186|NCT02314143|18782640|P3|Overall Study|Adverse Event|4
5438187|NCT02314143|18782641|P2|Overall Study|Adverse Event|6
5438188|NCT02314143|18782642|P1|Overall Study|Adverse Event|0
5438189|NCT02314117|18782688|P2|Overall Study|No post-discontinuation follow-up|19
5438190|NCT02314117|18782689|P1|Overall Study|No post-discontinuation follow-up|21
5438191|NCT02314117|18782688|P2|Overall Study|Withdrawal by Subject|2
5438192|NCT02314117|18782689|P1|Overall Study|Withdrawal by Subject|2
5438193|NCT02314117|18782688|P2|Overall Study|On Treatment|6
5438194|NCT02314117|18782689|P1|Overall Study|On Treatment|10
5438195|NCT02314117|18782688|P2|Overall Study|Lost to Follow-up|11
5438196|NCT02314117|18782689|P1|Overall Study|Lost to Follow-up|8
5438197|NCT02314052|18782742|P6|Cycle One|Adverse Event|0
5438198|NCT02314052|18782743|P5|Cycle One|Adverse Event|0
5438199|NCT02314052|18782744|P4|Cycle One|Adverse Event|1
5438200|NCT02314052|18782745|P3|Cycle One|Adverse Event|0
5438201|NCT02314052|18782746|P2|Cycle One|Adverse Event|0
5438202|NCT02314052|18782747|P1|Cycle One|Adverse Event|0
5438203|NCT02314026|18782815|P1|Overall Study|Protocol Violation|28
5438204|NCT02313909|18782833|P2|Overall Study|Lost to Follow-up|17
5438205|NCT02313909|18782834|P1|Overall Study|Lost to Follow-up|24
5438206|NCT02313909|18782833|P2|Overall Study|Consent withdrawn by participant|33
5438207|NCT02313909|18782834|P1|Overall Study|Consent withdrawn by participant|33
5438208|NCT02313766|18782857|P3|Overall Study|Adverse Event|0
5438209|NCT02313766|18782858|P2|Overall Study|Adverse Event|1
5438210|NCT02313766|18782859|P1|Overall Study|Adverse Event|0
5438211|NCT02313766|18782857|P3|Overall Study|Lost to Follow-up|0
5438212|NCT02313766|18782858|P2|Overall Study|Lost to Follow-up|2
5438213|NCT02313766|18782859|P1|Overall Study|Lost to Follow-up|0
5438214|NCT02313766|18782857|P3|Overall Study|surgery cancelled|0
5438215|NCT02313766|18782858|P2|Overall Study|surgery cancelled|0
5438216|NCT02313766|18782859|P1|Overall Study|surgery cancelled|1
5438217|NCT02313558|18782896|P2|Overall Study|Lost to Follow-up|4
5438218|NCT02313558|18782897|P1|Overall Study|Lost to Follow-up|4
5438219|NCT02313558|18782896|P2|Overall Study|Withdrawal by Subject|0
5438220|NCT02313558|18782897|P1|Overall Study|Withdrawal by Subject|2
5438221|NCT02313233|18782943|P2|Overall Study|Administrative reason|1
5438222|NCT02313233|18782944|P1|Overall Study|Administrative reason|1
5438223|NCT02313233|18782943|P2|Overall Study|Withdrawal by Subject|2
5438224|NCT02313233|18782944|P1|Overall Study|Withdrawal by Subject|1
5438225|NCT02313155|18782966|P2|Overall Study|Lost to Follow-up|1
5438226|NCT02313155|18782967|P1|Overall Study|Lost to Follow-up|0
5438227|NCT02312934|18783017|P2|Overall Study|Physician Decision|0
5438228|NCT02312934|18783018|P1|Overall Study|Physician Decision|1
5438229|NCT02312934|18783017|P2|Overall Study|Lost to Follow-up|0
5438230|NCT02312934|18783018|P1|Overall Study|Lost to Follow-up|1
5438231|NCT02312856|18783030|P1|Overall Study|Lost to Follow-up|3
5438232|NCT02312856|18783030|P1|Overall Study|Death|1
5438233|NCT02312687|18783123|P1|Overall Study|Other, Not Specified|1
5438234|NCT02312258|18783215|P2|Overall Study|Participants Ongoing Treatment|83
5438235|NCT02312258|18783216|P1|Overall Study|Participants Ongoing Treatment|43
5438236|NCT02312258|18783215|P2|Overall Study|Reason not Specified|31
5438237|NCT02312258|18783216|P1|Overall Study|Reason not Specified|11
5438238|NCT02312258|18783215|P2|Overall Study|Withdrawal by Subject|9
5438239|NCT02312258|18783216|P1|Overall Study|Withdrawal by Subject|8
5438240|NCT02312258|18783215|P2|Overall Study|Progressive Disease|188
5438241|NCT02312258|18783216|P1|Overall Study|Progressive Disease|174
5438242|NCT02312258|18783215|P2|Overall Study|Lost to Follow-up|1
5438243|NCT02312258|18783216|P1|Overall Study|Lost to Follow-up|0
5438244|NCT02312258|18783215|P2|Overall Study|Adverse Event|47
5438245|NCT02312258|18783216|P1|Overall Study|Adverse Event|15
5438246|NCT02312219|18783224|P2|Overall Study|Not randomized. Ineligible|1
5438247|NCT02312219|18783225|P1|Overall Study|Not randomized. Ineligible|0
5438248|NCT02312219|18783224|P2|Overall Study|Other|1
5438249|NCT02312219|18783225|P1|Overall Study|Other|0
5438250|NCT02312219|18783224|P2|Overall Study|could not schedule imaging in time|2
5438251|NCT02312219|18783225|P1|Overall Study|could not schedule imaging in time|0
5438252|NCT02312219|18783224|P2|Overall Study|Withdrawal by Subject|2
5438253|NCT02312219|18783225|P1|Overall Study|Withdrawal by Subject|1
5438254|NCT02312206|18783235|P2|Overall Study|Subject missed 3 consecutive tx visits|1
5438255|NCT02312206|18783236|P1|Overall Study|Subject missed 3 consecutive tx visits|0
5438256|NCT02312206|18783235|P2|Overall Study|Patient transferred to hospice|1
5438257|NCT02312206|18783236|P1|Overall Study|Patient transferred to hospice|0
5438258|NCT02312206|18783235|P2|Overall Study|Patient progression and new therapy|0
5438259|NCT02312206|18783236|P1|Overall Study|Patient progression and new therapy|1
5438260|NCT02312206|18783235|P2|Overall Study|Disease Progression|0
5438261|NCT02312206|18783236|P1|Overall Study|Disease Progression|1
5438262|NCT02312206|18783235|P2|Overall Study|Study Terminated by Sponsor|74
5438263|NCT02312206|18783236|P1|Overall Study|Study Terminated by Sponsor|81
5438264|NCT02312206|18783235|P2|Overall Study|Death|36
5438265|NCT02312206|18783236|P1|Overall Study|Death|30
5438266|NCT02312206|18783235|P2|Overall Study|Physician Decision|6
5438267|NCT02312206|18783236|P1|Overall Study|Physician Decision|7
5438268|NCT02312206|18783235|P2|Overall Study|Withdrawal by Subject|6
5438269|NCT02312206|18783236|P1|Overall Study|Withdrawal by Subject|7
5438270|NCT02312206|18783235|P2|Overall Study|Adverse Event|6
5438271|NCT02312206|18783236|P1|Overall Study|Adverse Event|3
5438272|NCT02312063|18783259|P2|Overall Study|Withdrawal by Subject|1
5438273|NCT02312063|18783260|P1|Overall Study|Withdrawal by Subject|0
5438274|NCT02311894|18783313|P1|Overall Study|Withdrawal by Subject|1
5438275|NCT02311894|18783313|P1|Overall Study|Adverse Event|1
5438276|NCT02311894|18783313|P1|Overall Study|Lost to Follow-up|1
5438277|NCT02311894|18783313|P1|Overall Study|Discontinued in error|1
5438278|NCT02311881|18783325|P3|Overall Study|Serious Adverse Event|0
5438279|NCT02311881|18783326|P2|Overall Study|Serious Adverse Event|1
5438280|NCT02311881|18783327|P1|Overall Study|Serious Adverse Event|0
5438281|NCT02311881|18783325|P3|Overall Study|Participant taking another medication|1
5438282|NCT02311881|18783326|P2|Overall Study|Participant taking another medication|0
5438283|NCT02311881|18783327|P1|Overall Study|Participant taking another medication|0
5438284|NCT02311881|18783325|P3|Overall Study|Medical Monitor Discretion|1
5438285|NCT02311881|18783326|P2|Overall Study|Medical Monitor Discretion|0
5438286|NCT02311881|18783327|P1|Overall Study|Medical Monitor Discretion|0
5438287|NCT02311881|18783325|P3|Overall Study|Physician Decision|1
5438288|NCT02311881|18783326|P2|Overall Study|Physician Decision|0
5438289|NCT02311881|18783327|P1|Overall Study|Physician Decision|0
5438290|NCT02311881|18783325|P3|Overall Study|Non-Compliance|2
5438291|NCT02311881|18783326|P2|Overall Study|Non-Compliance|0
5438292|NCT02311881|18783327|P1|Overall Study|Non-Compliance|1
5438293|NCT02311881|18783325|P3|Overall Study|Protocol Deviation|0
5438294|NCT02311881|18783326|P2|Overall Study|Protocol Deviation|0
5438295|NCT02311881|18783327|P1|Overall Study|Protocol Deviation|1
5438296|NCT02311881|18783325|P3|Overall Study|Sponsor Decision|1
5438297|NCT02311881|18783326|P2|Overall Study|Sponsor Decision|1
5438298|NCT02311881|18783327|P1|Overall Study|Sponsor Decision|1
5438299|NCT02311881|18783325|P3|Overall Study|Withdrawal by Subject|4
5438300|NCT02311881|18783326|P2|Overall Study|Withdrawal by Subject|1
5438301|NCT02311881|18783327|P1|Overall Study|Withdrawal by Subject|3
5438302|NCT02311881|18783325|P3|Overall Study|Subject has border line pregnancy test|0
5438303|NCT02311881|18783326|P2|Overall Study|Subject has border line pregnancy test|0
5438304|NCT02311881|18783327|P1|Overall Study|Subject has border line pregnancy test|1
5438305|NCT02311881|18783325|P3|Overall Study|Lack of Efficacy|0
5438306|NCT02311881|18783326|P2|Overall Study|Lack of Efficacy|2
5438307|NCT02311881|18783327|P1|Overall Study|Lack of Efficacy|1
5438308|NCT02311881|18783325|P3|Overall Study|Other|1
5438309|NCT02311881|18783326|P2|Overall Study|Other|0
5438310|NCT02311881|18783327|P1|Overall Study|Other|0
5438311|NCT02311881|18783325|P3|Overall Study|Withdrawal of consent|17
5438312|NCT02311881|18783326|P2|Overall Study|Withdrawal of consent|16
5438313|NCT02311881|18783327|P1|Overall Study|Withdrawal of consent|14
5438314|NCT02311881|18783325|P3|Overall Study|Protocol Violation|3
5438315|NCT02311881|18783326|P2|Overall Study|Protocol Violation|2
5438316|NCT02311881|18783327|P1|Overall Study|Protocol Violation|1
5438317|NCT02311881|18783325|P3|Overall Study|Lost to Follow-up|2
5438318|NCT02311881|18783326|P2|Overall Study|Lost to Follow-up|3
5438319|NCT02311881|18783327|P1|Overall Study|Lost to Follow-up|3
5438320|NCT02311881|18783325|P3|Overall Study|Adverse Event|8
5438321|NCT02311881|18783326|P2|Overall Study|Adverse Event|15
5438322|NCT02311881|18783327|P1|Overall Study|Adverse Event|7
5438323|NCT02311881|18783325|P3|Overall Study|Did not meet the study criteria|0
5438324|NCT02311881|18783326|P2|Overall Study|Did not meet the study criteria|2
5438325|NCT02311881|18783327|P1|Overall Study|Did not meet the study criteria|2
5438326|NCT02311478|18783362|P1|Overall Study|Failed IUD Insertion|1
5438327|NCT02311478|18783362|P1|Overall Study|Lost to Follow-up|5
5438328|NCT02311478|18783362|P1|Overall Study|Withdrawal by Subject|1
5438329|NCT02311361|18783371|P4|Overall Study|Did not receive treatment|1
5438330|NCT02311361|18783372|P3|Overall Study|Did not receive treatment|0
5438331|NCT02311361|18783373|P2|Overall Study|Did not receive treatment|1
5438332|NCT02311361|18783374|P1|Overall Study|Did not receive treatment|0
5438333|NCT02311153|18783426|P2|Overall Study|Lost to Follow-up|7
5438334|NCT02311153|18783427|P1|Overall Study|Lost to Follow-up|5
5438335|NCT02310906|18783447|P4|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
5438336|NCT02310906|18783448|P3|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
5438337|NCT02310906|18783449|P2|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
5438338|NCT02310906|18783450|P1|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
5438339|NCT02310906|18783447|P4|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
5438340|NCT02310906|18783448|P3|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
5438341|NCT02310906|18783449|P2|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
5438342|NCT02310906|18783450|P1|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
5438343|NCT02310906|18783447|P4|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
5438344|NCT02310906|18783448|P3|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
5438345|NCT02310906|18783449|P2|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
5438346|NCT02310906|18783450|P1|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
5438347|NCT02310906|18783447|P4|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
5438348|NCT02310906|18783448|P3|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
5438349|NCT02310906|18783449|P2|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
5438350|NCT02310906|18783450|P1|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
5438351|NCT02310789|18783529|P1|Overall Study|Adverse Event|1
5438352|NCT02310763|18783541|P3|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
5438353|NCT02310763|18783542|P2|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
5438354|NCT02310763|18783543|P1|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
5438355|NCT02310763|18783541|P3|Period 1 (Weeks 1 to 48)|Adverse Event|0
5438356|NCT02310763|18783542|P2|Period 1 (Weeks 1 to 48)|Adverse Event|0
5438357|NCT02310763|18783543|P1|Period 1 (Weeks 1 to 48)|Adverse Event|1
5438358|NCT02310763|18783541|P3|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
5438359|NCT02310763|18783542|P2|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
5438360|NCT02310763|18783543|P1|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
5438361|NCT02310763|18783541|P3|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
5438362|NCT02310763|18783542|P2|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
5438363|NCT02310763|18783543|P1|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
5438364|NCT02310763|18783541|P3|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
5438365|NCT02310763|18783542|P2|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
5438366|NCT02310763|18783543|P1|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
5438367|NCT02310750|18783746|P16|HP Washout 2|Lost to Follow-up|0
5438368|NCT02310750|18783747|P15|HP Washout 2|Lost to Follow-up|0
5438369|NCT02310750|18783748|P14|HP Washout 2|Lost to Follow-up|0
5438370|NCT02310750|18783749|P13|HP Washout 2|Lost to Follow-up|0
5438371|NCT02310750|18783750|P12|HP Washout 2|Lost to Follow-up|0
5438372|NCT02310750|18783751|P11|HP Washout 2|Lost to Follow-up|0
5438373|NCT02310750|18783752|P10|HP Washout 2|Lost to Follow-up|0
5438374|NCT02310750|18783753|P9|HP Washout 2|Lost to Follow-up|0
5438375|NCT02310750|18783754|P8|HP Washout 2|Lost to Follow-up|0
5438376|NCT02310750|18783755|P7|HP Washout 2|Lost to Follow-up|7
5438377|NCT02310750|18783756|P6|HP Washout 2|Lost to Follow-up|0
5438378|NCT02310750|18783757|P5|HP Washout 2|Lost to Follow-up|1
5438379|NCT02310750|18783758|P4|HP Washout 2|Lost to Follow-up|0
5438380|NCT02310750|18783759|P3|HP Washout 2|Lost to Follow-up|0
5438381|NCT02310750|18783760|P2|HP Washout 2|Lost to Follow-up|0
5438382|NCT02310750|18783761|P1|HP Washout 2|Lost to Follow-up|0
5438383|NCT02310750|18783746|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438384|NCT02310750|18783747|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438385|NCT02310750|18783748|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438386|NCT02310750|18783749|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438387|NCT02310750|18783750|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438388|NCT02310750|18783751|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438389|NCT02310750|18783752|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438390|NCT02310750|18783753|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
5438391|NCT02310750|18783754|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
5438392|NCT02310750|18783755|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438393|NCT02310750|18783756|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438394|NCT02310750|18783757|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438395|NCT02310750|18783758|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438396|NCT02310750|18783759|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438397|NCT02310750|18783760|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438398|NCT02310750|18783761|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
5438399|NCT02310750|18783746|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438400|NCT02310750|18783747|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438401|NCT02310750|18783748|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438402|NCT02310750|18783749|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438403|NCT02310750|18783750|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438404|NCT02310750|18783751|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438405|NCT02310750|18783752|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
5438406|NCT02310750|18783753|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
5438407|NCT02310750|18783754|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
5438408|NCT02310750|18783755|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438409|NCT02310750|18783756|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438410|NCT02310750|18783757|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438411|NCT02310750|18783758|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438412|NCT02310750|18783759|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438413|NCT02310750|18783760|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438414|NCT02310750|18783761|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
5438415|NCT02310750|18783746|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438416|NCT02310750|18783747|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438417|NCT02310750|18783748|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438418|NCT02310750|18783749|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438419|NCT02310750|18783750|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438420|NCT02310750|18783751|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438421|NCT02310750|18783752|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
5438422|NCT02310750|18783753|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438423|NCT02310750|18783754|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438424|NCT02310750|18783755|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438425|NCT02310750|18783756|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438426|NCT02310750|18783757|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438427|NCT02310750|18783758|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438428|NCT02310750|18783759|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438429|NCT02310750|18783760|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438430|NCT02310750|18783761|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
5438431|NCT02310750|18783746|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438432|NCT02310750|18783747|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438433|NCT02310750|18783748|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438434|NCT02310750|18783749|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438435|NCT02310750|18783750|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438436|NCT02310750|18783751|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438437|NCT02310750|18783752|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
5438438|NCT02310750|18783753|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
5438439|NCT02310750|18783754|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438440|NCT02310750|18783755|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438441|NCT02310750|18783756|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
5438442|NCT02310750|18783757|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438443|NCT02310750|18783758|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
5438444|NCT02310750|18783759|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438445|NCT02310750|18783760|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438446|NCT02310750|18783761|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
5438447|NCT02310750|18783746|P16|HP Washout 1|Lost to Follow-up|0
5438448|NCT02310750|18783747|P15|HP Washout 1|Lost to Follow-up|0
5438449|NCT02310750|18783748|P14|HP Washout 1|Lost to Follow-up|0
5438450|NCT02310750|18783749|P13|HP Washout 1|Lost to Follow-up|0
5438451|NCT02310750|18783750|P12|HP Washout 1|Lost to Follow-up|0
5438452|NCT02310750|18783751|P11|HP Washout 1|Lost to Follow-up|0
5438453|NCT02310750|18783752|P10|HP Washout 1|Lost to Follow-up|0
5438454|NCT02310750|18783753|P9|HP Washout 1|Lost to Follow-up|0
5438455|NCT02310750|18783754|P8|HP Washout 1|Lost to Follow-up|0
5438456|NCT02310750|18783755|P7|HP Washout 1|Lost to Follow-up|3
5438457|NCT02310750|18783756|P6|HP Washout 1|Lost to Follow-up|2
5438458|NCT02310750|18783757|P5|HP Washout 1|Lost to Follow-up|2
5438459|NCT02310750|18783758|P4|HP Washout 1|Lost to Follow-up|1
5438460|NCT02310750|18783759|P3|HP Washout 1|Lost to Follow-up|1
5438461|NCT02310750|18783760|P2|HP Washout 1|Lost to Follow-up|0
5438462|NCT02310750|18783761|P1|HP Washout 1|Lost to Follow-up|0
5438463|NCT02310750|18783746|P16|HP Period 1|Withdrawal by Subject|0
5438464|NCT02310750|18783747|P15|HP Period 1|Withdrawal by Subject|0
5438465|NCT02310750|18783748|P14|HP Period 1|Withdrawal by Subject|0
5438466|NCT02310750|18783749|P13|HP Period 1|Withdrawal by Subject|0
5438467|NCT02310750|18783750|P12|HP Period 1|Withdrawal by Subject|0
5438468|NCT02310750|18783751|P11|HP Period 1|Withdrawal by Subject|0
5438469|NCT02310750|18783752|P10|HP Period 1|Withdrawal by Subject|0
5438470|NCT02310750|18783753|P9|HP Period 1|Withdrawal by Subject|0
5438471|NCT02310750|18783754|P8|HP Period 1|Withdrawal by Subject|0
5438472|NCT02310750|18783755|P7|HP Period 1|Withdrawal by Subject|0
5438473|NCT02310750|18783756|P6|HP Period 1|Withdrawal by Subject|0
5438474|NCT02310750|18783757|P5|HP Period 1|Withdrawal by Subject|0
5438475|NCT02310750|18783758|P4|HP Period 1|Withdrawal by Subject|1
5438476|NCT02310750|18783759|P3|HP Period 1|Withdrawal by Subject|0
5438477|NCT02310750|18783760|P2|HP Period 1|Withdrawal by Subject|0
5438478|NCT02310750|18783761|P1|HP Period 1|Withdrawal by Subject|1
5438479|NCT02310750|18783746|P16|HP Period 1|Lost to Follow-up|0
5438480|NCT02310750|18783747|P15|HP Period 1|Lost to Follow-up|0
5438481|NCT02310750|18783748|P14|HP Period 1|Lost to Follow-up|0
5438482|NCT02310750|18783749|P13|HP Period 1|Lost to Follow-up|0
5438483|NCT02310750|18783750|P12|HP Period 1|Lost to Follow-up|0
5438484|NCT02310750|18783751|P11|HP Period 1|Lost to Follow-up|0
5438485|NCT02310750|18783752|P10|HP Period 1|Lost to Follow-up|0
5438486|NCT02310750|18783753|P9|HP Period 1|Lost to Follow-up|0
5438487|NCT02310750|18783754|P8|HP Period 1|Lost to Follow-up|0
5438488|NCT02310750|18783755|P7|HP Period 1|Lost to Follow-up|1
5438489|NCT02310750|18783756|P6|HP Period 1|Lost to Follow-up|0
5438490|NCT02310750|18783757|P5|HP Period 1|Lost to Follow-up|0
5438491|NCT02310750|18783758|P4|HP Period 1|Lost to Follow-up|0
5438492|NCT02310750|18783759|P3|HP Period 1|Lost to Follow-up|0
5438493|NCT02310750|18783760|P2|HP Period 1|Lost to Follow-up|0
5438494|NCT02310750|18783761|P1|HP Period 1|Lost to Follow-up|0
5438495|NCT02310672|18784200|P1|Overall Study|Sponsor's decision|12
5438496|NCT02310672|18784200|P1|Overall Study|Withdrawal by Subject|1
5438497|NCT02310672|18784200|P1|Overall Study|Lost to Follow-up|1
5438498|NCT02310672|18784200|P1|Overall Study|Death|1
5438499|NCT02310646|18784213|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
5438500|NCT02310646|18784214|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
5438501|NCT02310646|18784213|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
5438502|NCT02310646|18784214|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
5438503|NCT02310581|18784242|P4|Overall Study|Withdrawal by Subject|1
5438504|NCT02310581|18784243|P3|Overall Study|Withdrawal by Subject|0
5438505|NCT02310581|18784244|P2|Overall Study|Withdrawal by Subject|1
5438506|NCT02310581|18784245|P1|Overall Study|Withdrawal by Subject|2
5438507|NCT02310581|18784242|P4|Overall Study|Adverse Event|0
5438508|NCT02310581|18784243|P3|Overall Study|Adverse Event|1
5438509|NCT02310581|18784244|P2|Overall Study|Adverse Event|1
5438510|NCT02310581|18784245|P1|Overall Study|Adverse Event|1
5438511|NCT02310568|18784284|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
5438512|NCT02310568|18784285|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
5438513|NCT02310568|18784286|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
5438514|NCT02310568|18784287|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
5438515|NCT02310568|18784288|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
5438516|NCT02310568|18784284|P5|Stage 2 (4 Weeks)|Protocol Violation|0
5438517|NCT02310568|18784285|P4|Stage 2 (4 Weeks)|Protocol Violation|1
5438518|NCT02310568|18784286|P3|Stage 2 (4 Weeks)|Protocol Violation|0
5438519|NCT02310568|18784287|P2|Stage 2 (4 Weeks)|Protocol Violation|0
5438520|NCT02310568|18784288|P1|Stage 2 (4 Weeks)|Protocol Violation|0
5438521|NCT02310568|18784284|P5|Stage 2 (4 Weeks)|Adverse Event|1
5438522|NCT02310568|18784285|P4|Stage 2 (4 Weeks)|Adverse Event|1
5438523|NCT02310568|18784286|P3|Stage 2 (4 Weeks)|Adverse Event|0
5438524|NCT02310568|18784287|P2|Stage 2 (4 Weeks)|Adverse Event|0
5438525|NCT02310568|18784288|P1|Stage 2 (4 Weeks)|Adverse Event|0
5438526|NCT02310568|18784284|P5|Stage 2 (4 Weeks)|Other|0
5438527|NCT02310568|18784285|P4|Stage 2 (4 Weeks)|Other|0
5438528|NCT02310568|18784286|P3|Stage 2 (4 Weeks)|Other|1
5438529|NCT02310568|18784287|P2|Stage 2 (4 Weeks)|Other|1
5438530|NCT02310568|18784288|P1|Stage 2 (4 Weeks)|Other|0
5438531|NCT02310568|18784284|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
5438532|NCT02310568|18784285|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
5438533|NCT02310568|18784286|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
5438534|NCT02310568|18784287|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
5438535|NCT02310568|18784288|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
5438536|NCT02310568|18784284|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5438537|NCT02310568|18784285|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
5438538|NCT02310568|18784286|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5438539|NCT02310568|18784287|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5438540|NCT02310568|18784288|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
5438541|NCT02310568|18784284|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5438542|NCT02310568|18784285|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
5438543|NCT02310568|18784286|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5438544|NCT02310568|18784287|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5438545|NCT02310568|18784288|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
5438546|NCT02310568|18784284|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
5438547|NCT02310568|18784285|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
5438548|NCT02310568|18784286|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
5438549|NCT02310568|18784287|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
5438550|NCT02310568|18784288|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
5438551|NCT02310568|18784284|P5|Stage 1 ( 4 Weeks)|Other|0
5438552|NCT02310568|18784285|P4|Stage 1 ( 4 Weeks)|Other|0
5438553|NCT02310568|18784286|P3|Stage 1 ( 4 Weeks)|Other|0
5438554|NCT02310568|18784287|P2|Stage 1 ( 4 Weeks)|Other|1
5438555|NCT02310568|18784288|P1|Stage 1 ( 4 Weeks)|Other|1
5438556|NCT02310568|18784284|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5438557|NCT02310568|18784285|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5438558|NCT02310568|18784286|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5438559|NCT02310568|18784287|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
5438560|NCT02310568|18784288|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
5438561|NCT02310568|18784284|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
5438562|NCT02310568|18784285|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5438563|NCT02310568|18784286|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5438564|NCT02310568|18784287|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5438565|NCT02310568|18784288|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
5438566|NCT02310126|18784368|P2|Period 1 (15 Minutes)|Protocol Violation|1
5438567|NCT02310126|18784369|P1|Period 1 (15 Minutes)|Protocol Violation|0
5438568|NCT02310126|18784368|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
5438569|NCT02310126|18784369|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
5438570|NCT02310100|18784375|P1|Overall Study|Lost to Follow-up|2
5438571|NCT02310100|18784375|P1|Overall Study|Visit compliance|1
5438572|NCT02310100|18784375|P1|Overall Study|Unapproved ablation operator|1
5438573|NCT02310100|18784375|P1|Overall Study|Enrollment closure|1
5438574|NCT02310100|18784375|P1|Overall Study|Withdrawal by Subject|10
5438575|NCT02310100|18784375|P1|Overall Study|Physician Decision|3
5438576|NCT02309723|18784394|P3|Overall Study|Withdrawal by Subject|24
5438577|NCT02309723|18784395|P2|Overall Study|Withdrawal by Subject|23
5438578|NCT02309723|18784396|P1|Overall Study|Withdrawal by Subject|24
5438579|NCT02309411|18784439|P3|Overall Study|Withdrawal by Subject|0
5438580|NCT02309411|18784440|P2|Overall Study|Withdrawal by Subject|1
5438581|NCT02309411|18784441|P1|Overall Study|Withdrawal by Subject|1
5438582|NCT02309411|18784439|P3|Overall Study|Physician Decision|0
5438583|NCT02309411|18784440|P2|Overall Study|Physician Decision|0
5438584|NCT02309411|18784441|P1|Overall Study|Physician Decision|1
5438585|NCT02309372|18784462|P2|Overall Study|Lost to Follow-up|2
5438586|NCT02309372|18784463|P1|Overall Study|Lost to Follow-up|3
5438587|NCT02309359|18784480|P5|Overall Study|Other|2
5438588|NCT02309359|18784481|P4|Overall Study|Other|3
5438589|NCT02309359|18784482|P3|Overall Study|Other|2
5438590|NCT02309359|18784483|P2|Overall Study|Other|0
5438591|NCT02309359|18784484|P1|Overall Study|Other|2
5438592|NCT02309359|18784480|P5|Overall Study|Lost to Follow-up|0
5438593|NCT02309359|18784481|P4|Overall Study|Lost to Follow-up|1
5438594|NCT02309359|18784482|P3|Overall Study|Lost to Follow-up|0
5438595|NCT02309359|18784483|P2|Overall Study|Lost to Follow-up|0
5438596|NCT02309359|18784484|P1|Overall Study|Lost to Follow-up|0
5438597|NCT02309359|18784480|P5|Overall Study|Lack of Efficacy|3
5438598|NCT02309359|18784481|P4|Overall Study|Lack of Efficacy|0
5438599|NCT02309359|18784482|P3|Overall Study|Lack of Efficacy|0
5438600|NCT02309359|18784483|P2|Overall Study|Lack of Efficacy|1
5438601|NCT02309359|18784484|P1|Overall Study|Lack of Efficacy|3
5438602|NCT02309359|18784480|P5|Overall Study|Withdrawal by Subject|0
5438603|NCT02309359|18784481|P4|Overall Study|Withdrawal by Subject|4
5438604|NCT02309359|18784482|P3|Overall Study|Withdrawal by Subject|4
5438605|NCT02309359|18784483|P2|Overall Study|Withdrawal by Subject|2
5438606|NCT02309359|18784484|P1|Overall Study|Withdrawal by Subject|2
5438607|NCT02309359|18784480|P5|Overall Study|Death|0
5438608|NCT02309359|18784481|P4|Overall Study|Death|0
5438609|NCT02309359|18784482|P3|Overall Study|Death|0
5438610|NCT02309359|18784483|P2|Overall Study|Death|0
5438611|NCT02309359|18784484|P1|Overall Study|Death|1
5438612|NCT02309359|18784480|P5|Overall Study|Adverse Event|4
5438613|NCT02309359|18784481|P4|Overall Study|Adverse Event|4
5438614|NCT02309359|18784482|P3|Overall Study|Adverse Event|5
5438615|NCT02309359|18784483|P2|Overall Study|Adverse Event|5
5438616|NCT02309359|18784484|P1|Overall Study|Adverse Event|4
5438617|NCT02309294|18784611|P1|Overall Study|Withdrawal by Subject|2
5438618|NCT02309138|18784617|P2|Overall Study|delivered before visit 2|1
5438619|NCT02309138|18784618|P1|Overall Study|delivered before visit 2|0
5438620|NCT02309138|18784617|P2|Overall Study|Protocol Violation|2
5438621|NCT02309138|18784618|P1|Overall Study|Protocol Violation|4
5438622|NCT02309138|18784617|P2|Overall Study|Withdrawal by Subject|15
5438623|NCT02309138|18784618|P1|Overall Study|Withdrawal by Subject|44
5438624|NCT02309112|18784641|P3|Overall Study|Lost to Follow-up|0
5438625|NCT02309112|18784642|P2|Overall Study|Lost to Follow-up|1
5438626|NCT02309112|18784643|P1|Overall Study|Lost to Follow-up|0
5438627|NCT02309112|18784641|P3|Overall Study|Withdrawal by Subject|1
5438628|NCT02309112|18784642|P2|Overall Study|Withdrawal by Subject|0
5438629|NCT02309112|18784643|P1|Overall Study|Withdrawal by Subject|1
5438630|NCT02309099|18784666|P2|Overall Study|Adverse Event|0
5438631|NCT02309099|18784667|P1|Overall Study|Adverse Event|2
5438632|NCT02308748|18784738|P10|Period 5|Adverse Event|0
5438633|NCT02308748|18784739|P9|Period 5|Adverse Event|1
5438634|NCT02308748|18784740|P8|Period 5|Adverse Event|0
5438635|NCT02308748|18784741|P7|Period 5|Adverse Event|0
5438636|NCT02308748|18784742|P6|Period 5|Adverse Event|0
5438637|NCT02308748|18784743|P5|Period 5|Adverse Event|0
5438638|NCT02308748|18784744|P4|Period 5|Adverse Event|0
5438639|NCT02308748|18784745|P3|Period 5|Adverse Event|0
5438640|NCT02308748|18784746|P2|Period 5|Adverse Event|0
5438641|NCT02308748|18784747|P1|Period 5|Adverse Event|1
5438642|NCT02308748|18784738|P10|Period 3|Protocol Violation|1
5438643|NCT02308748|18784739|P9|Period 3|Protocol Violation|0
5438644|NCT02308748|18784740|P8|Period 3|Protocol Violation|0
5438645|NCT02308748|18784741|P7|Period 3|Protocol Violation|0
5438646|NCT02308748|18784742|P6|Period 3|Protocol Violation|0
5438647|NCT02308748|18784743|P5|Period 3|Protocol Violation|0
5438648|NCT02308748|18784744|P4|Period 3|Protocol Violation|0
5438649|NCT02308748|18784745|P3|Period 3|Protocol Violation|0
5438650|NCT02308748|18784746|P2|Period 3|Protocol Violation|0
5438651|NCT02308748|18784747|P1|Period 3|Protocol Violation|0
5438652|NCT02308748|18784738|P10|Period 2|Adverse Event|0
5438653|NCT02308748|18784739|P9|Period 2|Adverse Event|0
5438654|NCT02308748|18784740|P8|Period 2|Adverse Event|1
5438655|NCT02308748|18784741|P7|Period 2|Adverse Event|0
5438656|NCT02308748|18784742|P6|Period 2|Adverse Event|0
5438657|NCT02308748|18784743|P5|Period 2|Adverse Event|0
5438658|NCT02308748|18784744|P4|Period 2|Adverse Event|0
5438659|NCT02308748|18784745|P3|Period 2|Adverse Event|0
5438660|NCT02308748|18784746|P2|Period 2|Adverse Event|0
5438661|NCT02308748|18784747|P1|Period 2|Adverse Event|0
5438662|NCT02308748|18784738|P10|Period 1|Withdrawal by Subject|0
5438663|NCT02308748|18784739|P9|Period 1|Withdrawal by Subject|0
5438664|NCT02308748|18784740|P8|Period 1|Withdrawal by Subject|0
5438665|NCT02308748|18784741|P7|Period 1|Withdrawal by Subject|0
5438666|NCT02308748|18784742|P6|Period 1|Withdrawal by Subject|0
5438667|NCT02308748|18784743|P5|Period 1|Withdrawal by Subject|0
5438668|NCT02308748|18784744|P4|Period 1|Withdrawal by Subject|0
5438669|NCT02308748|18784745|P3|Period 1|Withdrawal by Subject|1
5438670|NCT02308748|18784746|P2|Period 1|Withdrawal by Subject|0
5438671|NCT02308748|18784747|P1|Period 1|Withdrawal by Subject|0
5438672|NCT02308696|18784761|P2|Overall Study|Moved to a Higher Level of Care|6
5438673|NCT02308696|18784762|P1|Overall Study|Moved to a Higher Level of Care|17
5438674|NCT02308696|18784761|P2|Overall Study|Death|4
5438675|NCT02308696|18784762|P1|Overall Study|Death|8
5438676|NCT02308696|18784761|P2|Overall Study|Lost to Follow-up|21
5438677|NCT02308696|18784762|P1|Overall Study|Lost to Follow-up|28
5438678|NCT02308540|18784796|P6|Overall Study|Lost to Follow-up|1
5438679|NCT02308540|18784797|P5|Overall Study|Lost to Follow-up|0
5438680|NCT02308540|18784798|P4|Overall Study|Lost to Follow-up|0
5438681|NCT02308540|18784799|P3|Overall Study|Lost to Follow-up|0
5438682|NCT02308540|18784800|P2|Overall Study|Lost to Follow-up|0
5438683|NCT02308540|18784801|P1|Overall Study|Lost to Follow-up|0
5438684|NCT02308228|18784890|P2|Overall Study|Withdrawal by Subject|3
5438685|NCT02308228|18784891|P1|Overall Study|Withdrawal by Subject|5
5438686|NCT02308228|18784890|P2|Overall Study|Adverse Event|4
5438687|NCT02308228|18784891|P1|Overall Study|Adverse Event|3
5438688|NCT02308163|18784920|P5|Overall Study|Miscellaneous|5
5438689|NCT02308163|18784921|P4|Overall Study|Miscellaneous|0
5438690|NCT02308163|18784922|P3|Overall Study|Miscellaneous|1
5438691|NCT02308163|18784923|P2|Overall Study|Miscellaneous|2
5438692|NCT02308163|18784924|P1|Overall Study|Miscellaneous|2
5438693|NCT02308163|18784920|P5|Overall Study|Lab data met discontinuation criteria|0
5438694|NCT02308163|18784921|P4|Overall Study|Lab data met discontinuation criteria|2
5438695|NCT02308163|18784922|P3|Overall Study|Lab data met discontinuation criteria|0
5438696|NCT02308163|18784923|P2|Overall Study|Lab data met discontinuation criteria|0
5438697|NCT02308163|18784924|P1|Overall Study|Lab data met discontinuation criteria|3
5438698|NCT02308163|18784920|P5|Overall Study|Protocol Violation|5
5438699|NCT02308163|18784921|P4|Overall Study|Protocol Violation|2
5438700|NCT02308163|18784922|P3|Overall Study|Protocol Violation|3
5438701|NCT02308163|18784923|P2|Overall Study|Protocol Violation|3
5438702|NCT02308163|18784924|P1|Overall Study|Protocol Violation|3
5438703|NCT02308163|18784920|P5|Overall Study|Withdrawal of consent|6
5438704|NCT02308163|18784921|P4|Overall Study|Withdrawal of consent|2
5438705|NCT02308163|18784922|P3|Overall Study|Withdrawal of consent|0
5438706|NCT02308163|18784923|P2|Overall Study|Withdrawal of consent|3
5438707|NCT02308163|18784924|P1|Overall Study|Withdrawal of consent|2
5438708|NCT02308163|18784920|P5|Overall Study|Lack of Efficacy|6
5438709|NCT02308163|18784921|P4|Overall Study|Lack of Efficacy|4
5438710|NCT02308163|18784922|P3|Overall Study|Lack of Efficacy|8
5438711|NCT02308163|18784923|P2|Overall Study|Lack of Efficacy|3
5438712|NCT02308163|18784924|P1|Overall Study|Lack of Efficacy|11
5438713|NCT02308163|18784920|P5|Overall Study|Adverse Event|11
5438714|NCT02308163|18784921|P4|Overall Study|Adverse Event|2
5438715|NCT02308163|18784922|P3|Overall Study|Adverse Event|2
5438716|NCT02308163|18784923|P2|Overall Study|Adverse Event|5
5438717|NCT02308163|18784924|P1|Overall Study|Adverse Event|9
5438718|NCT02308163|18784920|P5|Overall Study|Not fulfill eligible criteria|1
5438719|NCT02308163|18784921|P4|Overall Study|Not fulfill eligible criteria|1
5438720|NCT02308163|18784922|P3|Overall Study|Not fulfill eligible criteria|0
5438721|NCT02308163|18784923|P2|Overall Study|Not fulfill eligible criteria|2
5438722|NCT02308163|18784924|P1|Overall Study|Not fulfill eligible criteria|1
5438723|NCT02308124|18785234|P3|Overall Study|Adverse Event|2
5438724|NCT02308124|18785235|P2|Overall Study|Adverse Event|2
5438725|NCT02308124|18785236|P1|Overall Study|Adverse Event|0
5438726|NCT02308124|18785234|P3|Overall Study|Lost to Follow-up|6
5438727|NCT02308124|18785235|P2|Overall Study|Lost to Follow-up|6
5438728|NCT02308124|18785236|P1|Overall Study|Lost to Follow-up|6
5438729|NCT02308046|18785258|P2|Overall Study|Lost to Follow-up|3
5438730|NCT02308046|18785259|P1|Overall Study|Lost to Follow-up|1
5438731|NCT02308046|18785258|P2|Overall Study|Positive for STD at Baseline|2
5438732|NCT02308046|18785259|P1|Overall Study|Positive for STD at Baseline|1
5438733|NCT02308046|18785258|P2|Overall Study|Negative yeast culture at Baseline|33
5438734|NCT02308046|18785259|P1|Overall Study|Negative yeast culture at Baseline|32
5438735|NCT02308033|18785275|P2|Overall Study|Lost to Follow-up|5
5438736|NCT02308033|18785276|P1|Overall Study|Lost to Follow-up|6
5438737|NCT02308033|18785275|P2|Overall Study|Positive for STD at Baseline|4
5438738|NCT02308033|18785276|P1|Overall Study|Positive for STD at Baseline|7
5438739|NCT02308033|18785275|P2|Overall Study|Normal Gram stain at Baseline|10
5438740|NCT02308033|18785276|P1|Overall Study|Normal Gram stain at Baseline|13
5438741|NCT02308020|18785296|P6|Overall Study|Withdrawal by Subject|2
5438742|NCT02308020|18785297|P5|Overall Study|Withdrawal by Subject|1
5438743|NCT02308020|18785298|P4|Overall Study|Withdrawal by Subject|2
5438744|NCT02308020|18785299|P3|Overall Study|Withdrawal by Subject|3
5438745|NCT02308020|18785300|P2|Overall Study|Withdrawal by Subject|5
5438746|NCT02308020|18785301|P1|Overall Study|Withdrawal by Subject|3
5438747|NCT02308020|18785296|P6|Overall Study|Sponsor Decision|1
5438748|NCT02308020|18785297|P5|Overall Study|Sponsor Decision|2
5438749|NCT02308020|18785298|P4|Overall Study|Sponsor Decision|2
5438750|NCT02308020|18785299|P3|Overall Study|Sponsor Decision|0
5438751|NCT02308020|18785300|P2|Overall Study|Sponsor Decision|8
5438752|NCT02308020|18785301|P1|Overall Study|Sponsor Decision|0
5438753|NCT02308020|18785296|P6|Overall Study|Lost to Follow-up|2
5438754|NCT02308020|18785297|P5|Overall Study|Lost to Follow-up|1
5438755|NCT02308020|18785298|P4|Overall Study|Lost to Follow-up|0
5438756|NCT02308020|18785299|P3|Overall Study|Lost to Follow-up|0
5438757|NCT02308020|18785300|P2|Overall Study|Lost to Follow-up|7
5438758|NCT02308020|18785301|P1|Overall Study|Lost to Follow-up|1
5438759|NCT02308007|18785358|P3|Overall Study|Lost to Follow-up|1
5438760|NCT02308007|18785359|P2|Overall Study|Lost to Follow-up|0
5438761|NCT02308007|18785360|P1|Overall Study|Lost to Follow-up|3
5438762|NCT02308007|18785358|P3|Overall Study|Positive for STD at Baseline|7
5438763|NCT02308007|18785359|P2|Overall Study|Positive for STD at Baseline|11
5438764|NCT02308007|18785360|P1|Overall Study|Positive for STD at Baseline|7
5438765|NCT02308007|18785358|P3|Overall Study|Normal Gram stain or neg yeast culture|67
5438766|NCT02308007|18785359|P2|Overall Study|Normal Gram stain or neg yeast culture|64
5438767|NCT02308007|18785360|P1|Overall Study|Normal Gram stain or neg yeast culture|66
5438768|NCT02307682|18785451|P3|Overall Study|Other|0
5438769|NCT02307682|18785452|P2|Overall Study|Other|1
5438770|NCT02307682|18785453|P1|Overall Study|Other|1
5438771|NCT02307682|18785451|P3|Overall Study|Protocol Deviation|2
5438772|NCT02307682|18785452|P2|Overall Study|Protocol Deviation|0
5438773|NCT02307682|18785453|P1|Overall Study|Protocol Deviation|0
5438774|NCT02307682|18785451|P3|Overall Study|Lost to Follow-up|6
5438775|NCT02307682|18785452|P2|Overall Study|Lost to Follow-up|5
5438776|NCT02307682|18785453|P1|Overall Study|Lost to Follow-up|1
5438777|NCT02307682|18785451|P3|Overall Study|Death|12
5438778|NCT02307682|18785452|P2|Overall Study|Death|7
5438779|NCT02307682|18785453|P1|Overall Study|Death|9
5438780|NCT02307682|18785451|P3|Overall Study|Withdrawal by Subject|23
5438781|NCT02307682|18785452|P2|Overall Study|Withdrawal by Subject|34
5438782|NCT02307682|18785453|P1|Overall Study|Withdrawal by Subject|26
5438783|NCT02307682|18785451|P3|Overall Study|Progressive Disease|0
5438784|NCT02307682|18785452|P2|Overall Study|Progressive Disease|0
5438785|NCT02307682|18785453|P1|Overall Study|Progressive Disease|1
5438786|NCT02307682|18785451|P3|Overall Study|Physician Decision|8
5438787|NCT02307682|18785452|P2|Overall Study|Physician Decision|2
5438788|NCT02307682|18785453|P1|Overall Study|Physician Decision|2
5438789|NCT02307682|18785451|P3|Overall Study|Lack of Efficacy|1
5438790|NCT02307682|18785452|P2|Overall Study|Lack of Efficacy|0
5438791|NCT02307682|18785453|P1|Overall Study|Lack of Efficacy|1
5438792|NCT02307682|18785451|P3|Overall Study|Adverse Event|12
5438793|NCT02307682|18785452|P2|Overall Study|Adverse Event|8
5438794|NCT02307682|18785453|P1|Overall Study|Adverse Event|9
5438795|NCT02307513|18785569|P2|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
5438796|NCT02307513|18785570|P1|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
5438797|NCT02307513|18785569|P2|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
5438798|NCT02307513|18785570|P1|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
5438799|NCT02307513|18785569|P2|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
5438800|NCT02307513|18785570|P1|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
5438801|NCT02307513|18785569|P2|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
5438802|NCT02307513|18785570|P1|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
5438803|NCT02307513|18785569|P2|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
5438804|NCT02307513|18785570|P1|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
5438805|NCT02307513|18785569|P2|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
5438806|NCT02307513|18785570|P1|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
5438807|NCT02307513|18785569|P2|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
5438808|NCT02307513|18785570|P1|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
5438809|NCT02307513|18785569|P2|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
5438810|NCT02307513|18785570|P1|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
5438811|NCT02307513|18785569|P2|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
5438812|NCT02307513|18785570|P1|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
5438813|NCT02307513|18785569|P2|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
5438814|NCT02307513|18785570|P1|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
5438815|NCT02307513|18785569|P2|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
5438816|NCT02307513|18785570|P1|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
5438817|NCT02307513|18785569|P2|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
5438818|NCT02307513|18785570|P1|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
5438819|NCT02307266|18785621|P3|Overall Study|Lost to Follow-up|0
5438820|NCT02307266|18785622|P2|Overall Study|Lost to Follow-up|0
5438821|NCT02307266|18785623|P1|Overall Study|Lost to Follow-up|3
5438822|NCT02307266|18785621|P3|Overall Study|Withdrawal by Subject|1
5438823|NCT02307266|18785622|P2|Overall Study|Withdrawal by Subject|0
5438824|NCT02307266|18785623|P1|Overall Study|Withdrawal by Subject|2
5438825|NCT02307266|18785621|P3|Overall Study|Adverse Event|5
5438826|NCT02307266|18785622|P2|Overall Study|Adverse Event|1
5438827|NCT02307266|18785623|P1|Overall Study|Adverse Event|3
5438828|NCT02306850|18785648|P1|Overall Study|Lack of Efficacy|2
5438829|NCT02306694|18785670|P1|Overall Study|Lost to Follow-up|1
5438830|NCT02306694|18785670|P1|Overall Study|Withdrawal by Subject|3
5438831|NCT02306265|18785680|P1|Overall Study|Withdrawal by Subject|1
5438832|NCT02305888|18785689|P3|Overall Study|Adverse Event|0
5438833|NCT02305888|18785690|P2|Overall Study|Adverse Event|1
5438834|NCT02305888|18785691|P1|Overall Study|Adverse Event|0
5438835|NCT02305888|18785689|P3|Overall Study|Lost to Follow-up|1
5438836|NCT02305888|18785690|P2|Overall Study|Lost to Follow-up|0
5438837|NCT02305888|18785691|P1|Overall Study|Lost to Follow-up|0
5438838|NCT02305849|18785711|P4|Overall Study|Not fulfill eligibility criteria|0
5438839|NCT02305849|18785712|P3|Overall Study|Not fulfill eligibility criteria|0
5438840|NCT02305849|18785713|P2|Overall Study|Not fulfill eligibility criteria|1
5438841|NCT02305849|18785714|P1|Overall Study|Not fulfill eligibility criteria|1
5438842|NCT02305849|18785711|P4|Overall Study|Miscellaneous|1
5438843|NCT02305849|18785712|P3|Overall Study|Miscellaneous|4
5438844|NCT02305849|18785713|P2|Overall Study|Miscellaneous|2
5438845|NCT02305849|18785714|P1|Overall Study|Miscellaneous|1
5438846|NCT02305849|18785711|P4|Overall Study|Lab data met discontinuation criteria|1
5438847|NCT02305849|18785712|P3|Overall Study|Lab data met discontinuation criteria|2
5438848|NCT02305849|18785713|P2|Overall Study|Lab data met discontinuation criteria|1
5438849|NCT02305849|18785714|P1|Overall Study|Lab data met discontinuation criteria|0
5438850|NCT02305849|18785711|P4|Overall Study|Protocol Violation|1
5438851|NCT02305849|18785712|P3|Overall Study|Protocol Violation|1
5438852|NCT02305849|18785713|P2|Overall Study|Protocol Violation|2
5438853|NCT02305849|18785714|P1|Overall Study|Protocol Violation|3
5438854|NCT02305849|18785711|P4|Overall Study|Lost to Follow-up|0
5438855|NCT02305849|18785712|P3|Overall Study|Lost to Follow-up|0
5438856|NCT02305849|18785713|P2|Overall Study|Lost to Follow-up|2
5438857|NCT02305849|18785714|P1|Overall Study|Lost to Follow-up|0
5438858|NCT02305849|18785711|P4|Overall Study|Withdrawal by Subject|4
5438859|NCT02305849|18785712|P3|Overall Study|Withdrawal by Subject|1
5438860|NCT02305849|18785713|P2|Overall Study|Withdrawal by Subject|2
5438861|NCT02305849|18785714|P1|Overall Study|Withdrawal by Subject|2
5438862|NCT02305849|18785711|P4|Overall Study|Lack of Efficacy|9
5438863|NCT02305849|18785712|P3|Overall Study|Lack of Efficacy|3
5438864|NCT02305849|18785713|P2|Overall Study|Lack of Efficacy|6
5438865|NCT02305849|18785714|P1|Overall Study|Lack of Efficacy|10
5438866|NCT02305849|18785711|P4|Overall Study|Adverse Event|3
5438867|NCT02305849|18785712|P3|Overall Study|Adverse Event|7
5438868|NCT02305849|18785713|P2|Overall Study|Adverse Event|12
5438869|NCT02305849|18785714|P1|Overall Study|Adverse Event|10
5438870|NCT02305797|18785948|P2|Overall Study|Reason not collected|1
5438871|NCT02305797|18785949|P1|Overall Study|Reason not collected|0
5438872|NCT02305797|18785948|P2|Overall Study|Noncompliance|12
5438873|NCT02305797|18785949|P1|Overall Study|Noncompliance|14
5438874|NCT02305797|18785948|P2|Overall Study|Pregnancy|2
5438875|NCT02305797|18785949|P1|Overall Study|Pregnancy|0
5438876|NCT02305797|18785948|P2|Overall Study|Lost to Follow-up|11
5438877|NCT02305797|18785949|P1|Overall Study|Lost to Follow-up|5
5438878|NCT02305797|18785948|P2|Overall Study|Lack of Efficacy|0
5438879|NCT02305797|18785949|P1|Overall Study|Lack of Efficacy|6
5438880|NCT02305797|18785948|P2|Overall Study|Withdrawal by Subject|10
5438881|NCT02305797|18785949|P1|Overall Study|Withdrawal by Subject|9
5438882|NCT02305797|18785948|P2|Overall Study|Adverse Event|2
5438883|NCT02305797|18785949|P1|Overall Study|Adverse Event|11
5438884|NCT02305758|18785959|P2|Overall Study|Other, not specified|1
5438885|NCT02305758|18785960|P1|Overall Study|Other, not specified|2
5438886|NCT02305758|18785959|P2|Overall Study|Study Terminated by Sponsor|34
5438887|NCT02305758|18785960|P1|Overall Study|Study Terminated by Sponsor|21
5438888|NCT02305758|18785959|P2|Overall Study|Lost to Follow-up|1
5438889|NCT02305758|18785960|P1|Overall Study|Lost to Follow-up|6
5438890|NCT02305758|18785959|P2|Overall Study|Withdrew consent|2
5438891|NCT02305758|18785960|P1|Overall Study|Withdrew consent|9
5438892|NCT02305758|18785959|P2|Overall Study|Death|27
5438893|NCT02305758|18785960|P1|Overall Study|Death|27
5438894|NCT02305446|18785978|P1|Overall Study|Adverse Event|1
5438895|NCT02305381|18785986|P3|Overall Study|Unclassified|7
5438896|NCT02305381|18785987|P2|Overall Study|Unclassified|5
5438897|NCT02305381|18785988|P1|Overall Study|Unclassified|5
5438898|NCT02305238|18786101|P3|Overall Study|Required procedure failed|0
5438899|NCT02305238|18786102|P2|Overall Study|Required procedure failed|1
5438900|NCT02305238|18786103|P1|Overall Study|Required procedure failed|0
5438901|NCT02305238|18786101|P3|Overall Study|Randomized failure|8
5438902|NCT02305238|18786102|P2|Overall Study|Randomized failure|0
5438903|NCT02305238|18786103|P1|Overall Study|Randomized failure|0
5438904|NCT02305238|18786101|P3|Overall Study|Withdrawal by Subject|0
5438905|NCT02305238|18786102|P2|Overall Study|Withdrawal by Subject|4
5438906|NCT02305238|18786103|P1|Overall Study|Withdrawal by Subject|3
5438907|NCT02305238|18786101|P3|Overall Study|Adverse Event|0
5438908|NCT02305238|18786102|P2|Overall Study|Adverse Event|2
5438909|NCT02305238|18786103|P1|Overall Study|Adverse Event|4
5438910|NCT02305238|18786101|P3|Overall Study|Physician Decision|0
5438911|NCT02305238|18786102|P2|Overall Study|Physician Decision|1
5438912|NCT02305238|18786103|P1|Overall Study|Physician Decision|2
5438913|NCT02305238|18786101|P3|Overall Study|Protocol Violation|0
5438914|NCT02305238|18786102|P2|Overall Study|Protocol Violation|3
5438915|NCT02305238|18786103|P1|Overall Study|Protocol Violation|0
5438916|NCT02305238|18786101|P3|Overall Study|Logistical difficulties|0
5438917|NCT02305238|18786102|P2|Overall Study|Logistical difficulties|3
5438918|NCT02305238|18786103|P1|Overall Study|Logistical difficulties|1
5438919|NCT02305238|18786101|P3|Overall Study|Progressive disease|0
5438920|NCT02305238|18786102|P2|Overall Study|Progressive disease|4
5438921|NCT02305238|18786103|P1|Overall Study|Progressive disease|4
5438922|NCT02305238|18786101|P3|Overall Study|Death|0
5438923|NCT02305238|18786102|P2|Overall Study|Death|1
5438924|NCT02305238|18786103|P1|Overall Study|Death|2
5438925|NCT02304926|18786135|P2|Overall Study|Lost to Follow-up|1
5438926|NCT02304926|18786136|P1|Overall Study|Lost to Follow-up|2
5438927|NCT02304705|18786182|P2|Overall Study|Lost to Follow-up|2
5438928|NCT02304705|18786183|P1|Overall Study|Lost to Follow-up|0
5438929|NCT02304705|18786182|P2|Overall Study|Death|1
5438930|NCT02304705|18786183|P1|Overall Study|Death|0
5438931|NCT02304705|18786182|P2|Overall Study|Physician Decision|4
5438932|NCT02304705|18786183|P1|Overall Study|Physician Decision|2
5438933|NCT02304705|18786182|P2|Overall Study|Withdrawal by Subject|0
5438934|NCT02304705|18786183|P1|Overall Study|Withdrawal by Subject|2
5438935|NCT02304484|18786189|P1|Overall Study|Lost to Follow-up|2
5438936|NCT02304484|18786189|P1|Overall Study|Withdrawal by Subject|14
5438937|NCT02304484|18786189|P1|Overall Study|Death|9
5438938|NCT02304380|18786252|P6|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5438939|NCT02304380|18786253|P5|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5438940|NCT02304380|18786254|P4|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
5438941|NCT02304380|18786255|P3|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5438942|NCT02304380|18786256|P2|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5438943|NCT02304380|18786257|P1|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
5438944|NCT02304367|18786307|P1|Overall Study|Ongoing in Study|12
5438945|NCT02304367|18786307|P1|Overall Study|Death|1
5438946|NCT02304367|18786307|P1|Overall Study|Sponsor Decision|3
5438947|NCT02304367|18786307|P1|Overall Study|Lack of Phosphorus Increase|1
5438948|NCT02303704|18786391|P2|Overall Study|Protocol Violation|9
5438949|NCT02303704|18786392|P1|Overall Study|Protocol Violation|5
5438950|NCT02303574|18786420|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5438951|NCT02303574|18786421|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5438952|NCT02303574|18786422|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
5438953|NCT02303574|18786423|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5438954|NCT02303574|18786424|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5438955|NCT02303574|18786425|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5438956|NCT02303574|18786426|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5438957|NCT02303574|18786427|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5438958|NCT02303574|18786428|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5438959|NCT02303574|18786429|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
5438960|NCT02303574|18786420|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5438961|NCT02303574|18786421|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5438962|NCT02303574|18786422|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5438963|NCT02303574|18786423|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5438964|NCT02303574|18786424|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5438965|NCT02303574|18786425|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5438966|NCT02303574|18786426|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5438967|NCT02303574|18786427|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
5438968|NCT02303574|18786428|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5438969|NCT02303574|18786429|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
5438970|NCT02303262|18786650|P1|Overall Study|Withdrawal by Subject|2
5438971|NCT02303041|18786658|P2|Overall Study|Adverse Event|2
5438972|NCT02303041|18786659|P1|Overall Study|Adverse Event|1
5438973|NCT02302859|18786675|P2|Overall Study|Withdrawal by Subject|1
5438974|NCT02302859|18786676|P1|Overall Study|Withdrawal by Subject|0
5438975|NCT02302859|18786675|P2|Overall Study|Lost Phone|1
5438976|NCT02302859|18786676|P1|Overall Study|Lost Phone|1
5438977|NCT02302846|18786682|P1|Overall Study|Withdrawal by Subject|1
5438978|NCT02302807|18786688|P2|Overall Study|Physician Decision|1
5438979|NCT02302807|18786689|P1|Overall Study|Physician Decision|0
5438980|NCT02302807|18786688|P2|Overall Study|Study Terminated By Sponsor|64
5438981|NCT02302807|18786689|P1|Overall Study|Study Terminated By Sponsor|35
5438982|NCT02302807|18786688|P2|Overall Study|Death|385
5438983|NCT02302807|18786689|P1|Overall Study|Death|397
5438984|NCT02302807|18786688|P2|Overall Study|Lost to Follow-up|6
5438985|NCT02302807|18786689|P1|Overall Study|Lost to Follow-up|4
5438986|NCT02302807|18786688|P2|Overall Study|Withdrawal by Subject|11
5438987|NCT02302807|18786689|P1|Overall Study|Withdrawal by Subject|28
5438988|NCT02302716|18786736|P2|Overall Study|Protocol Violation|1
5438989|NCT02302716|18786737|P1|Overall Study|Protocol Violation|0
5438990|NCT02302716|18786736|P2|Overall Study|Withdrawal by Subject|7
5438991|NCT02302716|18786737|P1|Overall Study|Withdrawal by Subject|13
5438992|NCT02302716|18786736|P2|Overall Study|Physician Decision|4
5438993|NCT02302716|18786737|P1|Overall Study|Physician Decision|3
5438994|NCT02302716|18786736|P2|Overall Study|Lost to Follow-up|4
5438995|NCT02302716|18786737|P1|Overall Study|Lost to Follow-up|2
5438996|NCT02302716|18786736|P2|Overall Study|Lack of Efficacy|1
5438997|NCT02302716|18786737|P1|Overall Study|Lack of Efficacy|0
5438998|NCT02302716|18786736|P2|Overall Study|Death|1
5438999|NCT02302716|18786737|P1|Overall Study|Death|0
5439000|NCT02302716|18786736|P2|Overall Study|Adverse Event|1
5439001|NCT02302716|18786737|P1|Overall Study|Adverse Event|1
5439002|NCT02302339|18786785|P4|Overall Study|Withdrawal by Subject|0
5439003|NCT02302339|18786786|P3|Overall Study|Withdrawal by Subject|1
5439004|NCT02302339|18786787|P2|Overall Study|Withdrawal by Subject|2
5439005|NCT02302339|18786788|P1|Overall Study|Withdrawal by Subject|0
5439006|NCT02302339|18786785|P4|Overall Study|Lost to Follow-up|0
5439007|NCT02302339|18786786|P3|Overall Study|Lost to Follow-up|0
5439008|NCT02302339|18786787|P2|Overall Study|Lost to Follow-up|0
5439009|NCT02302339|18786788|P1|Overall Study|Lost to Follow-up|1
5439010|NCT02302222|18786821|P2|Overall Study|Withdrawn prior to any treatment|1
5439011|NCT02302222|18786822|P1|Overall Study|Withdrawn prior to any treatment|0
5439012|NCT02302222|18786821|P2|Overall Study|Treatment discontinued before day 5|1
5439013|NCT02302222|18786822|P1|Overall Study|Treatment discontinued before day 5|0
5439014|NCT02302222|18786821|P2|Overall Study|Lost to Follow-up|0
5439015|NCT02302222|18786822|P1|Overall Study|Lost to Follow-up|1
5439016|NCT02302222|18786821|P2|Overall Study|Physician Decision|4
5439017|NCT02302222|18786822|P1|Overall Study|Physician Decision|0
5439018|NCT02302066|18786861|P4|Overall Study|Reason Not Specified|1
5439019|NCT02302066|18786862|P3|Overall Study|Reason Not Specified|9
5439020|NCT02302066|18786863|P2|Overall Study|Reason Not Specified|1
5439021|NCT02302066|18786864|P1|Overall Study|Reason Not Specified|1
5439022|NCT02302066|18786861|P4|Overall Study|Pregnancy|0
5439023|NCT02302066|18786862|P3|Overall Study|Pregnancy|12
5439024|NCT02302066|18786863|P2|Overall Study|Pregnancy|10
5439025|NCT02302066|18786864|P1|Overall Study|Pregnancy|2
5439026|NCT02302066|18786861|P4|Overall Study|Withdrawal by Subject|33
5439027|NCT02302066|18786862|P3|Overall Study|Withdrawal by Subject|124
5439028|NCT02302066|18786863|P2|Overall Study|Withdrawal by Subject|58
5439029|NCT02302066|18786864|P1|Overall Study|Withdrawal by Subject|25
5439030|NCT02302066|18786861|P4|Overall Study|Lost to Follow-up|7
5439031|NCT02302066|18786862|P3|Overall Study|Lost to Follow-up|24
5439032|NCT02302066|18786863|P2|Overall Study|Lost to Follow-up|5
5439033|NCT02302066|18786864|P1|Overall Study|Lost to Follow-up|4
5439034|NCT02302066|18786861|P4|Overall Study|Adverse Event|0
5439035|NCT02302066|18786862|P3|Overall Study|Adverse Event|3
5439036|NCT02302066|18786863|P2|Overall Study|Adverse Event|1
5439037|NCT02302066|18786864|P1|Overall Study|Adverse Event|1
5439038|NCT02301988|18786908|P2|Overall Study|Adverse Event|1
5439039|NCT02301988|18786909|P1|Overall Study|Adverse Event|1
5439040|NCT02301988|18786908|P2|Overall Study|Death|0
5439041|NCT02301988|18786909|P1|Overall Study|Death|1
5439042|NCT02301988|18786908|P2|Overall Study|Lack of Efficacy|2
5439043|NCT02301988|18786909|P1|Overall Study|Lack of Efficacy|3
5439044|NCT02301988|18786908|P2|Overall Study|Unknown Reason|3
5439045|NCT02301988|18786909|P1|Overall Study|Unknown Reason|1
5439046|NCT02301988|18786908|P2|Overall Study|Physician Decision|2
5439047|NCT02301988|18786909|P1|Overall Study|Physician Decision|2
5439048|NCT02301988|18786908|P2|Overall Study|Withdrawal by Subject|1
5439049|NCT02301988|18786909|P1|Overall Study|Withdrawal by Subject|2
5439050|NCT02301975|18786942|P3|Overall Study|Withdrawal by Subject|11
5439051|NCT02301975|18786943|P2|Overall Study|Withdrawal by Subject|12
5439052|NCT02301975|18786944|P1|Overall Study|Withdrawal by Subject|15
5439053|NCT02301975|18786942|P3|Overall Study|Physician Decision|3
5439054|NCT02301975|18786943|P2|Overall Study|Physician Decision|2
5439055|NCT02301975|18786944|P1|Overall Study|Physician Decision|4
5439056|NCT02301975|18786942|P3|Overall Study|Lost to Follow-up|2
5439057|NCT02301975|18786943|P2|Overall Study|Lost to Follow-up|2
5439058|NCT02301975|18786944|P1|Overall Study|Lost to Follow-up|0
5439059|NCT02301975|18786942|P3|Overall Study|Protocol Violation|3
5439060|NCT02301975|18786943|P2|Overall Study|Protocol Violation|5
5439061|NCT02301975|18786944|P1|Overall Study|Protocol Violation|3
5439062|NCT02301975|18786942|P3|Overall Study|Lack of Efficacy|1
5439063|NCT02301975|18786943|P2|Overall Study|Lack of Efficacy|1
5439064|NCT02301975|18786944|P1|Overall Study|Lack of Efficacy|1
5439065|NCT02301975|18786942|P3|Overall Study|Adverse Event|2
5439066|NCT02301975|18786943|P2|Overall Study|Adverse Event|3
5439067|NCT02301975|18786944|P1|Overall Study|Adverse Event|8
5439068|NCT02301936|18786972|P2|Overall Study|Lost to Follow-up|0
5439069|NCT02301936|18786973|P1|Overall Study|Lost to Follow-up|1
5439070|NCT02301897|18786998|P3|Treatment Course 2|Other Miscellaneous Reasons|0
5439071|NCT02301897|18786999|P2|Treatment Course 2|Other Miscellaneous Reasons|0
5439072|NCT02301897|18787000|P1|Treatment Course 2|Other Miscellaneous Reasons|1
5439073|NCT02301897|18786998|P3|Treatment Course 2|Withdrawal by Subject|0
5439074|NCT02301897|18786999|P2|Treatment Course 2|Withdrawal by Subject|2
5439075|NCT02301897|18787000|P1|Treatment Course 2|Withdrawal by Subject|0
5439076|NCT02301897|18786998|P3|Treatment Course 2|Pregnancy|1
5439077|NCT02301897|18786999|P2|Treatment Course 2|Pregnancy|1
5439078|NCT02301897|18787000|P1|Treatment Course 2|Pregnancy|0
5439079|NCT02301897|18786998|P3|Treatment Course 2|Lost to Follow-up|0
5439080|NCT02301897|18786999|P2|Treatment Course 2|Lost to Follow-up|2
5439081|NCT02301897|18787000|P1|Treatment Course 2|Lost to Follow-up|0
5439082|NCT02301897|18786998|P3|Treatment Course 1|Other Miscellaneous Reasons|0
5439083|NCT02301897|18786999|P2|Treatment Course 1|Other Miscellaneous Reasons|0
5439084|NCT02301897|18787000|P1|Treatment Course 1|Other Miscellaneous Reasons|1
5439085|NCT02301897|18786998|P3|Treatment Course 1|Withdrawal by Subject|2
5439086|NCT02301897|18786999|P2|Treatment Course 1|Withdrawal by Subject|0
5439087|NCT02301897|18787000|P1|Treatment Course 1|Withdrawal by Subject|0
5439088|NCT02301897|18786998|P3|Treatment Course 1|Withdrawal by Sponsor|2
5439089|NCT02301897|18786999|P2|Treatment Course 1|Withdrawal by Sponsor|0
5439090|NCT02301897|18787000|P1|Treatment Course 1|Withdrawal by Sponsor|0
5439091|NCT02301897|18786998|P3|Treatment Course 1|Lost to Follow-up|1
5439092|NCT02301897|18786999|P2|Treatment Course 1|Lost to Follow-up|2
5439093|NCT02301897|18787000|P1|Treatment Course 1|Lost to Follow-up|1
5439094|NCT02301897|18786998|P3|Treatment Course 1|Adverse Event|0
5439095|NCT02301897|18786999|P2|Treatment Course 1|Adverse Event|1
5439096|NCT02301897|18787000|P1|Treatment Course 1|Adverse Event|1
5439097|NCT02301897|18786998|P3|Treatment Course 1|Non-Compliance|1
5439098|NCT02301897|18786999|P2|Treatment Course 1|Non-Compliance|0
5439099|NCT02301897|18787000|P1|Treatment Course 1|Non-Compliance|0
5439100|NCT02301624|18787066|P2|Open-label Maintenance Phase|Participant felt no change in condition|0
5439101|NCT02301624|18787067|P1|Open-label Maintenance Phase|Participant felt no change in condition|1
5439102|NCT02301624|18787066|P2|Open-label Maintenance Phase|Death|1
5439103|NCT02301624|18787067|P1|Open-label Maintenance Phase|Death|2
5439104|NCT02301624|18787066|P2|Open-label Maintenance Phase|Physician Decision|3
5439105|NCT02301624|18787067|P1|Open-label Maintenance Phase|Physician Decision|3
5439106|NCT02301624|18787066|P2|Open-label Maintenance Phase|Adverse Event|5
5439107|NCT02301624|18787067|P1|Open-label Maintenance Phase|Adverse Event|2
5439108|NCT02301624|18787066|P2|Open-label Maintenance Phase|Withdrawal by Subject|8
5439109|NCT02301624|18787067|P1|Open-label Maintenance Phase|Withdrawal by Subject|4
5439110|NCT02301624|18787066|P2|Blind Induction Phase|Withdrawal by Subject|0
5439111|NCT02301624|18787067|P1|Blind Induction Phase|Withdrawal by Subject|1
5439112|NCT02301546|18787078|P2|Long Term Effectiveness (~1 Year)|moved away|2
5439113|NCT02301546|18787079|P1|Long Term Effectiveness (~1 Year)|moved away|1
5439114|NCT02301546|18787078|P2|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
5439115|NCT02301546|18787079|P1|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
5439116|NCT02301546|18787078|P2|Long Term Effectiveness (~1 Year)|Death|0
5439117|NCT02301546|18787079|P1|Long Term Effectiveness (~1 Year)|Death|2
5439118|NCT02301546|18787078|P2|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
5439119|NCT02301546|18787079|P1|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
5439120|NCT02301546|18787078|P2|Short-term Effectiveness (~13 Weeks)|screen fail|0
5439121|NCT02301546|18787079|P1|Short-term Effectiveness (~13 Weeks)|screen fail|1
5439122|NCT02301546|18787078|P2|Short-term Effectiveness (~13 Weeks)|non-compliant|7
5439123|NCT02301546|18787079|P1|Short-term Effectiveness (~13 Weeks)|non-compliant|10
5439124|NCT02301546|18787078|P2|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
5439125|NCT02301546|18787079|P1|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
5439126|NCT02301429|18787085|P1|Overall Study|not acceptable vascular anatomy|3
5439127|NCT02301403|18787131|P2|Overall Study|Withdrawal by Subject|41
5439128|NCT02301403|18787132|P1|Overall Study|Withdrawal by Subject|28
5439129|NCT02301390|18787140|P2|Overall Study|study terminated|0
5439130|NCT02301390|18787141|P1|Overall Study|study terminated|2
5439131|NCT02301390|18787140|P2|Overall Study|Missed multiple visits|1
5439132|NCT02301390|18787141|P1|Overall Study|Missed multiple visits|1
5439133|NCT02301390|18787140|P2|Overall Study|Procedure not completed|4
5439134|NCT02301390|18787141|P1|Overall Study|Procedure not completed|0
5439135|NCT02301390|18787140|P2|Overall Study|Death|2
5439136|NCT02301390|18787141|P1|Overall Study|Death|2
5439137|NCT02301390|18787140|P2|Overall Study|Lost to Follow-up|1
5439138|NCT02301390|18787141|P1|Overall Study|Lost to Follow-up|0
5439139|NCT02301390|18787140|P2|Overall Study|Physician Decision|0
5439140|NCT02301390|18787141|P1|Overall Study|Physician Decision|1
5439141|NCT02301390|18787140|P2|Overall Study|Protocol Violation|0
5439142|NCT02301390|18787141|P1|Overall Study|Protocol Violation|1
5439143|NCT02301390|18787140|P2|Overall Study|Withdrawal by Subject|5
5439144|NCT02301390|18787141|P1|Overall Study|Withdrawal by Subject|3
5439145|NCT02301169|18787182|P2|Overall Study|Adverse Event|0
5439146|NCT02301169|18787183|P1|Overall Study|Adverse Event|1
5439147|NCT02301143|18787197|P2|Investigator's Choice|Unresectable Surgery|1
5439148|NCT02301143|18787198|P1|Investigator's Choice|Unresectable Surgery|0
5439149|NCT02301143|18787197|P2|Investigator's Choice|Other|1
5439150|NCT02301143|18787198|P1|Investigator's Choice|Other|0
5439151|NCT02301143|18787197|P2|Investigator's Choice|Symptomatic Deterioration|1
5439152|NCT02301143|18787198|P1|Investigator's Choice|Symptomatic Deterioration|0
5439153|NCT02301143|18787197|P2|Investigator's Choice|Noncompliance With Study Drug|1
5439154|NCT02301143|18787198|P1|Investigator's Choice|Noncompliance With Study Drug|0
5439155|NCT02301143|18787197|P2|Investigator's Choice|Progressive Disease|3
5439156|NCT02301143|18787198|P1|Investigator's Choice|Progressive Disease|0
5439157|NCT02301143|18787197|P2|Investigator's Choice|Adverse Event|3
5439158|NCT02301143|18787198|P1|Investigator's Choice|Adverse Event|0
5439159|NCT02301143|18787197|P2|Induction Period|Other|0
5439160|NCT02301143|18787198|P1|Induction Period|Other|1
5439161|NCT02301143|18787197|P2|Induction Period|Protocol Violation|0
5439162|NCT02301143|18787198|P1|Induction Period|Protocol Violation|2
5439163|NCT02301143|18787197|P2|Induction Period|Symptomatic Deterioration|0
5439164|NCT02301143|18787198|P1|Induction Period|Symptomatic Deterioration|2
5439165|NCT02301143|18787197|P2|Induction Period|Physician Decision|0
5439166|NCT02301143|18787198|P1|Induction Period|Physician Decision|4
5439167|NCT02301143|18787197|P2|Induction Period|Noncompliance with Study Drug|0
5439168|NCT02301143|18787198|P1|Induction Period|Noncompliance with Study Drug|1
5439169|NCT02301143|18787197|P2|Induction Period|Withdrawal by Subject|0
5439170|NCT02301143|18787198|P1|Induction Period|Withdrawal by Subject|3
5439171|NCT02301143|18787197|P2|Induction Period|Progressive Disease|0
5439172|NCT02301143|18787198|P1|Induction Period|Progressive Disease|8
5439173|NCT02301143|18787197|P2|Induction Period|Adverse Event|0
5439174|NCT02301143|18787198|P1|Induction Period|Adverse Event|22
5439175|NCT02301143|18787197|P2|Induction Period|Death|0
5439176|NCT02301143|18787198|P1|Induction Period|Death|1
5439177|NCT02301143|18787197|P2|Induction Period|Enrolled But Not Treated|0
5439178|NCT02301143|18787198|P1|Induction Period|Enrolled But Not Treated|1
5439179|NCT02300987|18787241|P2|Secondary Phase : Cross-over to LEE011|Adverse Event|1
5439180|NCT02300987|18787242|P1|Secondary Phase : Cross-over to LEE011|Adverse Event|0
5439181|NCT02300987|18787241|P2|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
5439182|NCT02300987|18787242|P1|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
5439183|NCT02300987|18787241|P2|Primary Phase : Prior to Cross-over|progressive disease|2
5439184|NCT02300987|18787242|P1|Primary Phase : Prior to Cross-over|progressive disease|3
5439185|NCT02300987|18787241|P2|Primary Phase : Prior to Cross-over|Physician Decision|0
5439186|NCT02300987|18787242|P1|Primary Phase : Prior to Cross-over|Physician Decision|2
5439187|NCT02300987|18787241|P2|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
5439188|NCT02300987|18787242|P1|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
5439189|NCT02300610|18787289|P3|Overall Study|Withdrawal by Subject|1
5439190|NCT02300610|18787290|P2|Overall Study|Withdrawal by Subject|0
5439191|NCT02300610|18787291|P1|Overall Study|Withdrawal by Subject|1
5439192|NCT02300558|18787306|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
5439193|NCT02300558|18787306|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
5439194|NCT02300558|18787306|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
5439195|NCT02300558|18787306|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
5439196|NCT02300311|18787328|P2|Overall Study|Refused to continue taking medication|0
5439197|NCT02300311|18787329|P1|Overall Study|Refused to continue taking medication|18
5439198|NCT02300311|18787328|P2|Overall Study|Other than the reason specified|0
5439199|NCT02300311|18787329|P1|Overall Study|Other than the reason specified|1
5439200|NCT02300298|18787341|P2|Disposition for Docetaxel|other adverse event|4
5439201|NCT02300298|18787342|P1|Disposition for Docetaxel|other adverse event|0
5439202|NCT02300298|18787341|P2|Disposition for Docetaxel|Progressive disease|6
5439203|NCT02300298|18787342|P1|Disposition for Docetaxel|Progressive disease|0
5439204|NCT02300298|18787341|P2|Disposition for Nintedanib|Progressive disease|0
5439205|NCT02300298|18787342|P1|Disposition for Nintedanib|Progressive disease|10
5439206|NCT02300259|18787355|P3|Period 2|Withdrawal by Subject|1
5439207|NCT02300259|18787356|P2|Period 2|Withdrawal by Subject|0
5439208|NCT02300259|18787357|P1|Period 2|Withdrawal by Subject|0
5439209|NCT02300259|18787355|P3|Period 2|Adverse Event|0
5439210|NCT02300259|18787356|P2|Period 2|Adverse Event|0
5439211|NCT02300259|18787357|P1|Period 2|Adverse Event|1
5439212|NCT02300259|18787355|P3|Period 1|Withdrawal by Subject|1
5439213|NCT02300259|18787356|P2|Period 1|Withdrawal by Subject|0
5439214|NCT02300259|18787357|P1|Period 1|Withdrawal by Subject|0
5439215|NCT02300259|18787355|P3|Period 1|Adverse Event|1
5439216|NCT02300259|18787356|P2|Period 1|Adverse Event|0
5439217|NCT02300259|18787357|P1|Period 1|Adverse Event|0
5439218|NCT02300129|18787386|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
5439219|NCT02300129|18787387|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
5439220|NCT02300129|18787388|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
5439221|NCT02300129|18787389|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
5439222|NCT02300129|18787386|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
5439223|NCT02300129|18787387|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
5439224|NCT02300129|18787388|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
5439225|NCT02300129|18787389|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
5439226|NCT02300129|18787386|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
5439227|NCT02300129|18787387|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
5439228|NCT02300129|18787388|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
5439229|NCT02300129|18787389|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
5439230|NCT02300103|18787399|P1|Overall Study|Withdrew Consent|2
5439231|NCT02300103|18787399|P1|Overall Study|Protocol Violation|1
5439232|NCT02300103|18787399|P1|Overall Study|Lack of Efficacy|3
5439233|NCT02299934|18787479|P1|Overall Study|Termination of study|13
5439234|NCT02299635|18787529|P1|Overall Study|Other|3
5439235|NCT02299635|18787529|P1|Overall Study|Withdrawal by Subject|2
5439236|NCT02299635|18787529|P1|Overall Study|Objective progression or relapse|10
5439237|NCT02299635|18787529|P1|Overall Study|Global deterioration of health status|1
5439238|NCT02299635|18787529|P1|Overall Study|Death|1
5439239|NCT02299635|18787529|P1|Overall Study|Adverse Event|2
5439240|NCT02299427|18787569|P2|Overall Study|not adherent to dog website use|0
5439241|NCT02299427|18787570|P1|Overall Study|not adherent to dog website use|21
5439242|NCT02299427|18787569|P2|Overall Study|Lost to Follow-up|3
5439243|NCT02299427|18787570|P1|Overall Study|Lost to Follow-up|1
5439244|NCT02299427|18787569|P2|Overall Study|Withdrawal by Subject|0
5439245|NCT02299427|18787570|P1|Overall Study|Withdrawal by Subject|1
5439246|NCT02299388|18787580|P2|Overall Study|Withdrawal by Subject|1
5439247|NCT02299388|18787581|P1|Overall Study|Withdrawal by Subject|0
5439248|NCT02299375|18787591|P2|Overall Study|Withdrawal by Subject|4
5439249|NCT02299375|18787592|P1|Overall Study|Withdrawal by Subject|1
5439250|NCT02299375|18787591|P2|Overall Study|Physician Decision|1
5439251|NCT02299375|18787592|P1|Overall Study|Physician Decision|1
5439252|NCT02299375|18787591|P2|Overall Study|Lost to Follow-up|2
5439253|NCT02299375|18787592|P1|Overall Study|Lost to Follow-up|0
5439254|NCT02299375|18787591|P2|Overall Study|Other: Study closed/terminated|55
5439255|NCT02299375|18787592|P1|Overall Study|Other: Study closed/terminated|66
5439256|NCT02299375|18787591|P2|Overall Study|Other: Met stopping criteria|0
5439257|NCT02299375|18787592|P1|Overall Study|Other: Met stopping criteria|1
5439258|NCT02299375|18787591|P2|Overall Study|Protocol Violation|3
5439259|NCT02299375|18787592|P1|Overall Study|Protocol Violation|1
5439260|NCT02299375|18787591|P2|Overall Study|Lack of Efficacy|3
5439261|NCT02299375|18787592|P1|Overall Study|Lack of Efficacy|1
5439262|NCT02299375|18787591|P2|Overall Study|Adverse Event, non-fatal|9
5439263|NCT02299375|18787592|P1|Overall Study|Adverse Event, non-fatal|8
5439264|NCT02299375|18787591|P2|Overall Study|Adverse Event, serious fatal|3
5439265|NCT02299375|18787592|P1|Overall Study|Adverse Event, serious fatal|1
5439266|NCT02299336|18787651|P1|Overall Study|Lost to Follow-up|1
5439267|NCT02299336|18787651|P1|Overall Study|Death|1
5439268|NCT02299336|18787651|P1|Overall Study|Adverse Event|1
5439269|NCT02299336|18787651|P1|Overall Study|Withdrawal by Subject|11
5439270|NCT02299206|18787686|P1|Overall Study|Withdrawal by Subject|1
5439271|NCT02299206|18787686|P1|Overall Study|Lost to Follow-up|1
5439272|NCT02299167|18787694|P1|Overall Study|patients were excluded from the study|11
5439273|NCT02299076|18787755|P2|Overall Study|Fraudulent Entries|14
5439274|NCT02299076|18787756|P1|Overall Study|Fraudulent Entries|20
5439275|NCT02298946|18787777|P2|Overall Study|Unevaluable|1
5439276|NCT02298946|18787778|P1|Overall Study|Unevaluable|2
5439277|NCT02298946|18787777|P2|Overall Study|Did not receive treatment|0
5439278|NCT02298946|18787778|P1|Overall Study|Did not receive treatment|2
5439279|NCT02298868|18787806|P1|Overall Study|Patient underwent transplant|1
5439280|NCT02298868|18787806|P1|Overall Study|Death|1
5439281|NCT02298868|18787806|P1|Overall Study|Adverse Event|1
5439282|NCT02298192|18787884|P2|Overall Study|Adverse Event|2
5439283|NCT02298192|18787885|P1|Overall Study|Adverse Event|6
5439284|NCT02298192|18787884|P2|Overall Study|Lost to Follow-up|1
5439285|NCT02298192|18787885|P1|Overall Study|Lost to Follow-up|2
5439286|NCT02298192|18787884|P2|Overall Study|Withdrawal by Subject|1
5439287|NCT02298192|18787885|P1|Overall Study|Withdrawal by Subject|6
5439288|NCT02298192|18787884|P2|Overall Study|Withdrawal criteria|0
5439289|NCT02298192|18787885|P1|Overall Study|Withdrawal criteria|2
5439290|NCT02298192|18787884|P2|Overall Study|Unclassified|2
5439291|NCT02298192|18787885|P1|Overall Study|Unclassified|3
5439292|NCT02298179|18787909|P12|Overall Study|Lost to Follow-up|0
5439293|NCT02298179|18787910|P11|Overall Study|Lost to Follow-up|0
5439294|NCT02298179|18787911|P10|Overall Study|Lost to Follow-up|0
5439295|NCT02298179|18787912|P9|Overall Study|Lost to Follow-up|0
5439296|NCT02298179|18787913|P8|Overall Study|Lost to Follow-up|1
5439297|NCT02298179|18787914|P7|Overall Study|Lost to Follow-up|0
5439298|NCT02298179|18787915|P6|Overall Study|Lost to Follow-up|0
5439299|NCT02298179|18787916|P5|Overall Study|Lost to Follow-up|0
5439300|NCT02298179|18787917|P4|Overall Study|Lost to Follow-up|0
5439301|NCT02298179|18787918|P3|Overall Study|Lost to Follow-up|1
5439302|NCT02298179|18787919|P2|Overall Study|Lost to Follow-up|0
5439303|NCT02298179|18787920|P1|Overall Study|Lost to Follow-up|0
5439304|NCT02297841|18788162|P1|Overall Study|Protocol Violation|7
5439305|NCT02297841|18788162|P1|Overall Study|Withdrawal by Subject|1
5439306|NCT02297815|18788168|P2|Overall Study|Lost to Follow-up|140
5439307|NCT02297815|18788169|P1|Overall Study|Lost to Follow-up|236
5439308|NCT02297516|18788187|P2|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
5439309|NCT02297516|18788188|P1|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
5439310|NCT02297516|18788187|P2|Single Treatment Phase (6 Months)|Protocol Violation|2
5439311|NCT02297516|18788188|P1|Single Treatment Phase (6 Months)|Protocol Violation|0
5439312|NCT02297516|18788187|P2|Single Treatment Phase (6 Months)|Medical reason|0
5439313|NCT02297516|18788188|P1|Single Treatment Phase (6 Months)|Medical reason|1
5439314|NCT02297503|18788209|P2|Overall Study|Medical reason|1
5439315|NCT02297503|18788210|P1|Overall Study|Medical reason|0
5439316|NCT02297503|18788209|P2|Overall Study|Lost to Follow-up|1
5439317|NCT02297503|18788210|P1|Overall Study|Lost to Follow-up|0
5439318|NCT02297503|18788209|P2|Overall Study|Pregnancy|1
5439319|NCT02297503|18788210|P1|Overall Study|Pregnancy|0
5439320|NCT02297503|18788209|P2|Overall Study|Protocol Violation|0
5439321|NCT02297503|18788210|P1|Overall Study|Protocol Violation|1
5439322|NCT02297503|18788209|P2|Overall Study|Withdrawal by Subject|1
5439323|NCT02297503|18788210|P1|Overall Study|Withdrawal by Subject|1
5439324|NCT02297412|18788237|P2|Overall Study|Canceled|1
5439325|NCT02297412|18788238|P1|Overall Study|Canceled|1
5439326|NCT02296931|18788299|P2|Overall Study|Protocol Violation|2
5439327|NCT02296931|18788300|P1|Overall Study|Protocol Violation|0
5439328|NCT02296892|18788309|P3|Overall Study|Lost to Follow-up|1
5439329|NCT02296892|18788310|P2|Overall Study|Lost to Follow-up|0
5439330|NCT02296892|18788311|P1|Overall Study|Lost to Follow-up|5
5439331|NCT02296892|18788309|P3|Overall Study|Exclusion Criteria at Day of Procedure|4
5439332|NCT02296892|18788310|P2|Overall Study|Exclusion Criteria at Day of Procedure|4
5439333|NCT02296892|18788311|P1|Overall Study|Exclusion Criteria at Day of Procedure|7
5439334|NCT02296840|18788347|P2|Overall Study|Lost to Follow-up|17
5439335|NCT02296840|18788348|P1|Overall Study|Lost to Follow-up|6
5439336|NCT02296840|18788347|P2|Overall Study|Protocol Violation|1
5439337|NCT02296840|18788348|P1|Overall Study|Protocol Violation|2
5439338|NCT02296840|18788347|P2|Overall Study|Adverse Event|1
5439339|NCT02296840|18788348|P1|Overall Study|Adverse Event|1
5439340|NCT02296476|18788456|P3|Overall Study|Disease Progression|2
5439341|NCT02296476|18788457|P2|Overall Study|Disease Progression|4
5439342|NCT02296476|18788458|P1|Overall Study|Disease Progression|6
5439343|NCT02296424|18788513|P4|Part 2|Lost to Follow-up|0
5439344|NCT02296424|18788514|P3|Part 2|Lost to Follow-up|1
5439345|NCT02296424|18788515|P2|Part 2|Lost to Follow-up|0
5439346|NCT02296424|18788516|P1|Part 2|Lost to Follow-up|0
5439347|NCT02296424|18788513|P4|Part 2|Adverse Event|0
5439348|NCT02296424|18788514|P3|Part 2|Adverse Event|1
5439349|NCT02296424|18788515|P2|Part 2|Adverse Event|0
5439350|NCT02296424|18788516|P1|Part 2|Adverse Event|0
5439351|NCT02296424|18788513|P4|Part 2|Lack of Efficacy|0
5439352|NCT02296424|18788514|P3|Part 2|Lack of Efficacy|1
5439353|NCT02296424|18788515|P2|Part 2|Lack of Efficacy|0
5439354|NCT02296424|18788516|P1|Part 2|Lack of Efficacy|0
5439355|NCT02296424|18788513|P4|Part 1|16 directly started part II|0
5439356|NCT02296424|18788514|P3|Part 1|16 directly started part II|0
5439357|NCT02296424|18788515|P2|Part 1|16 directly started part II|0
5439358|NCT02296424|18788516|P1|Part 1|16 directly started part II|16
5439359|NCT02296424|18788513|P4|Part 1|Lack of Efficacy|0
5439360|NCT02296424|18788514|P3|Part 1|Lack of Efficacy|0
5439361|NCT02296424|18788515|P2|Part 1|Lack of Efficacy|17
5439362|NCT02296424|18788516|P1|Part 1|Lack of Efficacy|5
5439363|NCT02296424|18788513|P4|Part 1|Adverse Event|0
5439364|NCT02296424|18788514|P3|Part 1|Adverse Event|0
5439365|NCT02296424|18788515|P2|Part 1|Adverse Event|11
5439366|NCT02296424|18788516|P1|Part 1|Adverse Event|2
5439367|NCT02296424|18788513|P4|Part 1|Study terminated by sponsor|0
5439368|NCT02296424|18788514|P3|Part 1|Study terminated by sponsor|0
5439369|NCT02296424|18788515|P2|Part 1|Study terminated by sponsor|1
5439370|NCT02296424|18788516|P1|Part 1|Study terminated by sponsor|0
5439371|NCT02296424|18788513|P4|Part 1|Withdrawal by Subject|0
5439372|NCT02296424|18788514|P3|Part 1|Withdrawal by Subject|0
5439373|NCT02296424|18788515|P2|Part 1|Withdrawal by Subject|2
5439374|NCT02296424|18788516|P1|Part 1|Withdrawal by Subject|0
5439375|NCT02296424|18788513|P4|Part 1|Protocol Violation|0
5439376|NCT02296424|18788514|P3|Part 1|Protocol Violation|0
5439377|NCT02296424|18788515|P2|Part 1|Protocol Violation|1
5439378|NCT02296424|18788516|P1|Part 1|Protocol Violation|0
5439379|NCT02296424|18788513|P4|Part 1|New therapy for study indication|0
5439380|NCT02296424|18788514|P3|Part 1|New therapy for study indication|0
5439381|NCT02296424|18788515|P2|Part 1|New therapy for study indication|1
5439382|NCT02296424|18788516|P1|Part 1|New therapy for study indication|0
5439383|NCT02296320|18788541|P3|Overall Study|Not - specified|1
5439384|NCT02296320|18788542|P2|Overall Study|Not - specified|0
5439385|NCT02296320|18788543|P1|Overall Study|Not - specified|0
5439386|NCT02296320|18788541|P3|Overall Study|Not treated|0
5439387|NCT02296320|18788542|P2|Overall Study|Not treated|0
5439388|NCT02296320|18788543|P1|Overall Study|Not treated|2
5439389|NCT02296320|18788541|P3|Overall Study|Lost to Follow-up|7
5439390|NCT02296320|18788542|P2|Overall Study|Lost to Follow-up|2
5439391|NCT02296320|18788543|P1|Overall Study|Lost to Follow-up|5
5439392|NCT02296320|18788541|P3|Overall Study|Death|27
5439393|NCT02296320|18788542|P2|Overall Study|Death|3
5439394|NCT02296320|18788543|P1|Overall Study|Death|24
5439395|NCT02296320|18788541|P3|Overall Study|Withdrawal by Subject|2
5439396|NCT02296320|18788542|P2|Overall Study|Withdrawal by Subject|0
5439397|NCT02296320|18788543|P1|Overall Study|Withdrawal by Subject|4
5439398|NCT02296242|18788582|P5|Overall Study|Lack of Efficacy|3
5439399|NCT02296242|18788583|P4|Overall Study|Lack of Efficacy|0
5439400|NCT02296242|18788584|P3|Overall Study|Lack of Efficacy|0
5439401|NCT02296242|18788585|P2|Overall Study|Lack of Efficacy|0
5439402|NCT02296242|18788586|P1|Overall Study|Lack of Efficacy|0
5439403|NCT02296242|18788582|P5|Overall Study|Adverse Event|0
5439404|NCT02296242|18788583|P4|Overall Study|Adverse Event|1
5439405|NCT02296242|18788584|P3|Overall Study|Adverse Event|0
5439406|NCT02296242|18788585|P2|Overall Study|Adverse Event|0
5439407|NCT02296242|18788586|P1|Overall Study|Adverse Event|0
5439408|NCT02296242|18788582|P5|Overall Study|Alternative Treatment|0
5439409|NCT02296242|18788583|P4|Overall Study|Alternative Treatment|1
5439410|NCT02296242|18788584|P3|Overall Study|Alternative Treatment|0
5439411|NCT02296242|18788585|P2|Overall Study|Alternative Treatment|0
5439412|NCT02296242|18788586|P1|Overall Study|Alternative Treatment|0
5439413|NCT02296242|18788582|P5|Overall Study|Physician Decision|0
5439414|NCT02296242|18788583|P4|Overall Study|Physician Decision|1
5439415|NCT02296242|18788584|P3|Overall Study|Physician Decision|0
5439416|NCT02296242|18788585|P2|Overall Study|Physician Decision|1
5439417|NCT02296242|18788586|P1|Overall Study|Physician Decision|0
5439418|NCT02296242|18788582|P5|Overall Study|Screened for Other Protocol|0
5439419|NCT02296242|18788583|P4|Overall Study|Screened for Other Protocol|0
5439420|NCT02296242|18788584|P3|Overall Study|Screened for Other Protocol|0
5439421|NCT02296242|18788585|P2|Overall Study|Screened for Other Protocol|1
5439422|NCT02296242|18788586|P1|Overall Study|Screened for Other Protocol|0
5439423|NCT02296242|18788582|P5|Overall Study|Need for Hydroxyurea|0
5439424|NCT02296242|18788583|P4|Overall Study|Need for Hydroxyurea|0
5439425|NCT02296242|18788584|P3|Overall Study|Need for Hydroxyurea|0
5439426|NCT02296242|18788585|P2|Overall Study|Need for Hydroxyurea|0
5439427|NCT02296242|18788586|P1|Overall Study|Need for Hydroxyurea|2
5439428|NCT02296242|18788582|P5|Overall Study|Lost to Follow-up|0
5439429|NCT02296242|18788583|P4|Overall Study|Lost to Follow-up|0
5439430|NCT02296242|18788584|P3|Overall Study|Lost to Follow-up|0
5439431|NCT02296242|18788585|P2|Overall Study|Lost to Follow-up|0
5439432|NCT02296242|18788586|P1|Overall Study|Lost to Follow-up|1
5439433|NCT02296242|18788582|P5|Overall Study|At Least 3 Drug Interruptions|1
5439434|NCT02296242|18788583|P4|Overall Study|At Least 3 Drug Interruptions|1
5439435|NCT02296242|18788584|P3|Overall Study|At Least 3 Drug Interruptions|1
5439436|NCT02296242|18788585|P2|Overall Study|At Least 3 Drug Interruptions|0
5439437|NCT02296242|18788586|P1|Overall Study|At Least 3 Drug Interruptions|0
5439438|NCT02296242|18788582|P5|Overall Study|Patient Condition Changed|1
5439439|NCT02296242|18788583|P4|Overall Study|Patient Condition Changed|0
5439440|NCT02296242|18788584|P3|Overall Study|Patient Condition Changed|2
5439441|NCT02296242|18788585|P2|Overall Study|Patient Condition Changed|0
5439442|NCT02296242|18788586|P1|Overall Study|Patient Condition Changed|0
5439443|NCT02296242|18788582|P5|Overall Study|Unacceptable Toxicity|1
5439444|NCT02296242|18788583|P4|Overall Study|Unacceptable Toxicity|0
5439445|NCT02296242|18788584|P3|Overall Study|Unacceptable Toxicity|0
5439446|NCT02296242|18788585|P2|Overall Study|Unacceptable Toxicity|0
5439447|NCT02296242|18788586|P1|Overall Study|Unacceptable Toxicity|0
5439448|NCT02296242|18788582|P5|Overall Study|Disease Progression|11
5439449|NCT02296242|18788583|P4|Overall Study|Disease Progression|8
5439450|NCT02296242|18788584|P3|Overall Study|Disease Progression|2
5439451|NCT02296242|18788585|P2|Overall Study|Disease Progression|3
5439452|NCT02296242|18788586|P1|Overall Study|Disease Progression|1
5439453|NCT02296242|18788582|P5|Overall Study|Withdrawal by Subject|3
5439454|NCT02296242|18788583|P4|Overall Study|Withdrawal by Subject|1
5439455|NCT02296242|18788584|P3|Overall Study|Withdrawal by Subject|1
5439456|NCT02296242|18788585|P2|Overall Study|Withdrawal by Subject|0
5439457|NCT02296242|18788586|P1|Overall Study|Withdrawal by Subject|0
5439458|NCT02296242|18788582|P5|Overall Study|Death|1
5439459|NCT02296242|18788583|P4|Overall Study|Death|1
5439460|NCT02296242|18788584|P3|Overall Study|Death|1
5439461|NCT02296242|18788585|P2|Overall Study|Death|1
5439462|NCT02296242|18788586|P1|Overall Study|Death|1
5439463|NCT02296190|18788614|P6|Overall Study|Lab result not available in time|0
5439464|NCT02296190|18788615|P5|Overall Study|Lab result not available in time|0
5439465|NCT02296190|18788616|P4|Overall Study|Lab result not available in time|0
5439466|NCT02296190|18788617|P3|Overall Study|Lab result not available in time|0
5439467|NCT02296190|18788618|P2|Overall Study|Lab result not available in time|0
5439468|NCT02296190|18788619|P1|Overall Study|Lab result not available in time|1
5439469|NCT02296190|18788614|P6|Overall Study|Failed PSVT with mechanism of AVNRT|0
5439470|NCT02296190|18788615|P5|Overall Study|Failed PSVT with mechanism of AVNRT|0
5439471|NCT02296190|18788616|P4|Overall Study|Failed PSVT with mechanism of AVNRT|0
5439472|NCT02296190|18788617|P3|Overall Study|Failed PSVT with mechanism of AVNRT|0
5439473|NCT02296190|18788618|P2|Overall Study|Failed PSVT with mechanism of AVNRT|1
5439474|NCT02296190|18788619|P1|Overall Study|Failed PSVT with mechanism of AVNRT|0
5439475|NCT02296190|18788614|P6|Overall Study|Patient on antiarrhythmic medication|0
5439476|NCT02296190|18788615|P5|Overall Study|Patient on antiarrhythmic medication|0
5439477|NCT02296190|18788616|P4|Overall Study|Patient on antiarrhythmic medication|0
5439478|NCT02296190|18788617|P3|Overall Study|Patient on antiarrhythmic medication|0
5439479|NCT02296190|18788618|P2|Overall Study|Patient on antiarrhythmic medication|0
5439480|NCT02296190|18788619|P1|Overall Study|Patient on antiarrhythmic medication|1
5439481|NCT02296190|18788614|P6|Overall Study|Atrial Tachycardia induced not PSVT|0
5439482|NCT02296190|18788615|P5|Overall Study|Atrial Tachycardia induced not PSVT|0
5439483|NCT02296190|18788616|P4|Overall Study|Atrial Tachycardia induced not PSVT|0
5439484|NCT02296190|18788617|P3|Overall Study|Atrial Tachycardia induced not PSVT|1
5439485|NCT02296190|18788618|P2|Overall Study|Atrial Tachycardia induced not PSVT|1
5439486|NCT02296190|18788619|P1|Overall Study|Atrial Tachycardia induced not PSVT|0
5439487|NCT02296190|18788614|P6|Overall Study|Blood pressure <100 after sedation|0
5439488|NCT02296190|18788615|P5|Overall Study|Blood pressure <100 after sedation|0
5439489|NCT02296190|18788616|P4|Overall Study|Blood pressure <100 after sedation|1
5439490|NCT02296190|18788617|P3|Overall Study|Blood pressure <100 after sedation|0
5439491|NCT02296190|18788618|P2|Overall Study|Blood pressure <100 after sedation|0
5439492|NCT02296190|18788619|P1|Overall Study|Blood pressure <100 after sedation|0
5439493|NCT02296190|18788614|P6|Overall Study|Patient with Atrial Tachycardia|0
5439494|NCT02296190|18788615|P5|Overall Study|Patient with Atrial Tachycardia|0
5439495|NCT02296190|18788616|P4|Overall Study|Patient with Atrial Tachycardia|1
5439496|NCT02296190|18788617|P3|Overall Study|Patient with Atrial Tachycardia|0
5439497|NCT02296190|18788618|P2|Overall Study|Patient with Atrial Tachycardia|0
5439498|NCT02296190|18788619|P1|Overall Study|Patient with Atrial Tachycardia|0
5439499|NCT02296190|18788614|P6|Overall Study|Patient was given Propofol|0
5439500|NCT02296190|18788615|P5|Overall Study|Patient was given Propofol|0
5439501|NCT02296190|18788616|P4|Overall Study|Patient was given Propofol|1
5439502|NCT02296190|18788617|P3|Overall Study|Patient was given Propofol|0
5439503|NCT02296190|18788618|P2|Overall Study|Patient was given Propofol|1
5439504|NCT02296190|18788619|P1|Overall Study|Patient was given Propofol|0
5439505|NCT02296190|18788614|P6|Overall Study|PSVT < 5 minutes|0
5439506|NCT02296190|18788615|P5|Overall Study|PSVT < 5 minutes|5
5439507|NCT02296190|18788616|P4|Overall Study|PSVT < 5 minutes|6
5439508|NCT02296190|18788617|P3|Overall Study|PSVT < 5 minutes|6
5439509|NCT02296190|18788618|P2|Overall Study|PSVT < 5 minutes|6
5439510|NCT02296190|18788619|P1|Overall Study|PSVT < 5 minutes|5
5439511|NCT02296190|18788614|P6|Overall Study|Withdrawal by Subject|0
5439512|NCT02296190|18788615|P5|Overall Study|Withdrawal by Subject|0
5439513|NCT02296190|18788616|P4|Overall Study|Withdrawal by Subject|0
5439514|NCT02296190|18788617|P3|Overall Study|Withdrawal by Subject|0
5439515|NCT02296190|18788618|P2|Overall Study|Withdrawal by Subject|1
5439516|NCT02296190|18788619|P1|Overall Study|Withdrawal by Subject|0
5439517|NCT02296190|18788614|P6|Overall Study|Physician Decision|0
5439518|NCT02296190|18788615|P5|Overall Study|Physician Decision|2
5439519|NCT02296190|18788616|P4|Overall Study|Physician Decision|1
5439520|NCT02296190|18788617|P3|Overall Study|Physician Decision|0
5439521|NCT02296190|18788618|P2|Overall Study|Physician Decision|1
5439522|NCT02296190|18788619|P1|Overall Study|Physician Decision|1
5439523|NCT02296190|18788614|P6|Overall Study|Failure to induce PSVT|0
5439524|NCT02296190|18788615|P5|Overall Study|Failure to induce PSVT|8
5439525|NCT02296190|18788616|P4|Overall Study|Failure to induce PSVT|13
5439526|NCT02296190|18788617|P3|Overall Study|Failure to induce PSVT|5
5439527|NCT02296190|18788618|P2|Overall Study|Failure to induce PSVT|10
5439528|NCT02296190|18788619|P1|Overall Study|Failure to induce PSVT|6
5439529|NCT02296190|18788614|P6|Overall Study|Lost to Follow-up|0
5439530|NCT02296190|18788615|P5|Overall Study|Lost to Follow-up|1
5439531|NCT02296190|18788616|P4|Overall Study|Lost to Follow-up|0
5439532|NCT02296190|18788617|P3|Overall Study|Lost to Follow-up|0
5439533|NCT02296190|18788618|P2|Overall Study|Lost to Follow-up|0
5439534|NCT02296190|18788619|P1|Overall Study|Lost to Follow-up|0
5439535|NCT02296138|18788638|P2|Overall Study|Other than specified|13
5439536|NCT02296138|18788639|P1|Overall Study|Other than specified|15
5439537|NCT02296138|18788638|P2|Overall Study|Patients with data irregularities|11
5439538|NCT02296138|18788639|P1|Overall Study|Patients with data irregularities|10
5439539|NCT02296138|18788638|P2|Overall Study|Not Treated|1
5439540|NCT02296138|18788639|P1|Overall Study|Not Treated|1
5439541|NCT02296138|18788638|P2|Overall Study|Withdrawal by Subject|131
5439542|NCT02296138|18788639|P1|Overall Study|Withdrawal by Subject|184
5439543|NCT02296138|18788638|P2|Overall Study|Lost to Follow-up|12
5439544|NCT02296138|18788639|P1|Overall Study|Lost to Follow-up|9
5439545|NCT02296138|18788638|P2|Overall Study|Protocol Violation|36
5439546|NCT02296138|18788639|P1|Overall Study|Protocol Violation|35
5439547|NCT02296138|18788638|P2|Overall Study|Lack of Efficacy|37
5439548|NCT02296138|18788639|P1|Overall Study|Lack of Efficacy|59
5439549|NCT02296138|18788638|P2|Overall Study|Adverse Event|259
5439550|NCT02296138|18788639|P1|Overall Study|Adverse Event|348
5439551|NCT02296125|18788655|P4|Overall Study|Any reason not specifically recorded|0
5439552|NCT02296125|18788656|P3|Overall Study|Any reason not specifically recorded|2
5439553|NCT02296125|18788657|P2|Overall Study|Any reason not specifically recorded|4
5439554|NCT02296125|18788658|P1|Overall Study|Any reason not specifically recorded|6
5439555|NCT02296125|18788655|P4|Overall Study|Condition under investigation worsened|56
5439556|NCT02296125|18788656|P3|Overall Study|Condition under investigation worsened|39
5439557|NCT02296125|18788657|P2|Overall Study|Condition under investigation worsened|199
5439558|NCT02296125|18788658|P1|Overall Study|Condition under investigation worsened|153
5439559|NCT02296125|18788655|P4|Overall Study|Severe non-compliance to protocol|0
5439560|NCT02296125|18788656|P3|Overall Study|Severe non-compliance to protocol|0
5439561|NCT02296125|18788657|P2|Overall Study|Severe non-compliance to protocol|1
5439562|NCT02296125|18788658|P1|Overall Study|Severe non-compliance to protocol|0
5439563|NCT02296125|18788655|P4|Overall Study|Adverse Event|4
5439564|NCT02296125|18788656|P3|Overall Study|Adverse Event|9
5439565|NCT02296125|18788657|P2|Overall Study|Adverse Event|52
5439566|NCT02296125|18788658|P1|Overall Study|Adverse Event|41
5439567|NCT02296125|18788655|P4|Overall Study|Withdrawal by Subject|2
5439568|NCT02296125|18788656|P3|Overall Study|Withdrawal by Subject|6
5439569|NCT02296125|18788657|P2|Overall Study|Withdrawal by Subject|8
5439570|NCT02296125|18788658|P1|Overall Study|Withdrawal by Subject|18
5439571|NCT02296112|18788710|P1|Overall Study|Began an alternate therapy|1
5439572|NCT02296112|18788710|P1|Overall Study|Toxicity|1
5439573|NCT02296112|18788710|P1|Overall Study|Disease progression|7
5439574|NCT02295995|18788752|P2|Overall Study|Lost to Follow-up|1
5439575|NCT02295995|18788753|P1|Overall Study|Lost to Follow-up|5
5439576|NCT02295774|18788764|P1|Overall Study|Withdrawal by Subject|2
5439577|NCT02295774|18788764|P1|Overall Study|Physician Decision|1
5439578|NCT02295644|18788804|P4|Overall Study|Did not meet inclusion criterion|2
5439579|NCT02295644|18788805|P3|Overall Study|Did not meet inclusion criterion|1
5439580|NCT02295644|18788806|P2|Overall Study|Did not meet inclusion criterion|0
5439581|NCT02295644|18788807|P1|Overall Study|Did not meet inclusion criterion|0
5439582|NCT02295280|18788856|P2|Overall Study|Adverse Event|1
5439583|NCT02295280|18788857|P1|Overall Study|Adverse Event|0
5439584|NCT02295020|18788865|P2|Overall Study|Withdrawal by Subject|2
5439585|NCT02295020|18788866|P1|Overall Study|Withdrawal by Subject|3
5439586|NCT02295020|18788865|P2|Overall Study|Adverse Event|1
5439587|NCT02295020|18788866|P1|Overall Study|Adverse Event|0
5439588|NCT02294981|18788896|P1|Overall Study|Lost to Follow-up|1
5439589|NCT02294786|18788902|P2|Overall Study|Death|3
5439590|NCT02294786|18788903|P1|Overall Study|Death|2
5439591|NCT02294786|18788902|P2|Overall Study|Adverse Event|1
5439592|NCT02294786|18788903|P1|Overall Study|Adverse Event|1
5439593|NCT02294786|18788902|P2|Overall Study|Protocol Violation|0
5439594|NCT02294786|18788903|P1|Overall Study|Protocol Violation|1
5439595|NCT02294786|18788902|P2|Overall Study|Lost to Follow-up|2
5439596|NCT02294786|18788903|P1|Overall Study|Lost to Follow-up|1
5439597|NCT02294786|18788902|P2|Overall Study|Physician Decision|7
5439598|NCT02294786|18788903|P1|Overall Study|Physician Decision|6
5439599|NCT02294786|18788902|P2|Overall Study|Withdrawal by Subject|1
5439600|NCT02294786|18788903|P1|Overall Study|Withdrawal by Subject|0
5439601|NCT02294773|18788950|P2|Overall Study|Withdrawal by Subject|2
5439602|NCT02294773|18788951|P1|Overall Study|Withdrawal by Subject|0
5439603|NCT02294734|18788967|P2|Overall Study|Withdrawal by Subject|2
5439604|NCT02294734|18788968|P1|Overall Study|Withdrawal by Subject|4
5439605|NCT02294734|18788967|P2|Overall Study|Physician Decision|1
5439606|NCT02294734|18788968|P1|Overall Study|Physician Decision|2
5439607|NCT02294734|18788967|P2|Overall Study|Lost to Follow-up|0
5439608|NCT02294734|18788968|P1|Overall Study|Lost to Follow-up|2
5439609|NCT02294734|18788967|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
5439610|NCT02294734|18788968|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
5439611|NCT02294734|18788967|P2|Overall Study|Adverse Event|5
5439612|NCT02294734|18788968|P1|Overall Study|Adverse Event|5
5439613|NCT02294682|18789020|P2|Overall Study|Could not swallow pills|0
5439614|NCT02294682|18789021|P1|Overall Study|Could not swallow pills|1
5439615|NCT02294604|18789064|P3|Overall Study|Culture contamination|0
5439616|NCT02294604|18789065|P2|Overall Study|Culture contamination|2
5439617|NCT02294604|18789066|P1|Overall Study|Culture contamination|1
5439618|NCT02294604|18789064|P3|Overall Study|Did not provide samples for culture|0
5439619|NCT02294604|18789065|P2|Overall Study|Did not provide samples for culture|1
5439620|NCT02294604|18789066|P1|Overall Study|Did not provide samples for culture|0
5439621|NCT02294474|18789085|P2|Overall Study|Other than specified above|12
5439622|NCT02294474|18789086|P1|Overall Study|Other than specified above|12
5439623|NCT02294474|18789085|P2|Overall Study|Protocol Violation|2
5439624|NCT02294474|18789086|P1|Overall Study|Protocol Violation|4
5439625|NCT02294474|18789085|P2|Overall Study|Lack of Efficacy|1
5439626|NCT02294474|18789086|P1|Overall Study|Lack of Efficacy|2
5439627|NCT02294474|18789085|P2|Overall Study|Adverse Event|7
5439628|NCT02294474|18789086|P1|Overall Study|Adverse Event|7
5439629|NCT02294461|18789110|P2|Overall Study|Miscellaneous|32
5439630|NCT02294461|18789111|P1|Overall Study|Miscellaneous|11
5439631|NCT02294461|18789110|P2|Overall Study|Adverse Event|10
5439632|NCT02294461|18789111|P1|Overall Study|Adverse Event|11
5439633|NCT02294461|18789110|P2|Overall Study|Disease Progression|39
5439634|NCT02294461|18789111|P1|Overall Study|Disease Progression|23
5439635|NCT02294461|18789110|P2|Overall Study|Withdrawal by Subject|45
5439636|NCT02294461|18789111|P1|Overall Study|Withdrawal by Subject|14
5439637|NCT02294461|18789110|P2|Overall Study|Protocol Violation|2
5439638|NCT02294461|18789111|P1|Overall Study|Protocol Violation|0
5439639|NCT02294461|18789110|P2|Overall Study|Death|3
5439640|NCT02294461|18789111|P1|Overall Study|Death|3
5439641|NCT02294396|18789167|P4|Overall Study|Miscellaneous|2
5439642|NCT02294396|18789168|P3|Overall Study|Miscellaneous|5
5439643|NCT02294396|18789169|P2|Overall Study|Miscellaneous|0
5439644|NCT02294396|18789170|P1|Overall Study|Miscellaneous|2
5439645|NCT02294396|18789167|P4|Overall Study|Protocol Deviation|1
5439646|NCT02294396|18789168|P3|Overall Study|Protocol Deviation|2
5439647|NCT02294396|18789169|P2|Overall Study|Protocol Deviation|2
5439648|NCT02294396|18789170|P1|Overall Study|Protocol Deviation|3
5439649|NCT02294396|18789167|P4|Overall Study|Lost to Follow-up|1
5439650|NCT02294396|18789168|P3|Overall Study|Lost to Follow-up|1
5439651|NCT02294396|18789169|P2|Overall Study|Lost to Follow-up|0
5439652|NCT02294396|18789170|P1|Overall Study|Lost to Follow-up|0
5439653|NCT02294396|18789167|P4|Overall Study|Withdrawal by Subject|8
5439654|NCT02294396|18789168|P3|Overall Study|Withdrawal by Subject|6
5439655|NCT02294396|18789169|P2|Overall Study|Withdrawal by Subject|6
5439656|NCT02294396|18789170|P1|Overall Study|Withdrawal by Subject|8
5439657|NCT02294396|18789167|P4|Overall Study|Electrocardiogram adviser's judgment|1
5439658|NCT02294396|18789168|P3|Overall Study|Electrocardiogram adviser's judgment|0
5439659|NCT02294396|18789169|P2|Overall Study|Electrocardiogram adviser's judgment|0
5439660|NCT02294396|18789170|P1|Overall Study|Electrocardiogram adviser's judgment|1
5439661|NCT02294396|18789167|P4|Overall Study|Adverse Event|24
5439662|NCT02294396|18789168|P3|Overall Study|Adverse Event|21
5439663|NCT02294396|18789169|P2|Overall Study|Adverse Event|25
5439664|NCT02294396|18789170|P1|Overall Study|Adverse Event|26
5439665|NCT02294318|18789242|P2|Overall Study|Not exposed to intervention|2
5439666|NCT02294318|18789243|P1|Overall Study|Not exposed to intervention|0
5439667|NCT02294318|18789242|P2|Overall Study|Worsening of drinking|0
5439668|NCT02294318|18789243|P1|Overall Study|Worsening of drinking|3
5439669|NCT02294227|18789262|P3|Overall Study|Adverse Event|2
5439670|NCT02294227|18789263|P2|Overall Study|Adverse Event|8
5439671|NCT02294227|18789264|P1|Overall Study|Adverse Event|6
5439672|NCT02294227|18789262|P3|Overall Study|Lack of Efficacy|8
5439673|NCT02294227|18789263|P2|Overall Study|Lack of Efficacy|12
5439674|NCT02294227|18789264|P1|Overall Study|Lack of Efficacy|11
5439675|NCT02294227|18789262|P3|Overall Study|Lost to Follow-up|0
5439676|NCT02294227|18789263|P2|Overall Study|Lost to Follow-up|0
5439677|NCT02294227|18789264|P1|Overall Study|Lost to Follow-up|1
5439678|NCT02294227|18789262|P3|Overall Study|Physician Decision|1
5439679|NCT02294227|18789263|P2|Overall Study|Physician Decision|2
5439680|NCT02294227|18789264|P1|Overall Study|Physician Decision|1
5439681|NCT02294227|18789262|P3|Overall Study|Subject/Guardian Decision|7
5439682|NCT02294227|18789263|P2|Overall Study|Subject/Guardian Decision|3
5439683|NCT02294227|18789264|P1|Overall Study|Subject/Guardian Decision|6
5439684|NCT02294227|18789262|P3|Overall Study|Death|1
5439685|NCT02294227|18789263|P2|Overall Study|Death|0
5439686|NCT02294227|18789264|P1|Overall Study|Death|0
5439687|NCT02294175|18789290|P2|Overall Study|wound healed|2
5439688|NCT02294175|18789291|P1|Overall Study|wound healed|0
5439689|NCT02294175|18789290|P2|Overall Study|Lost to Follow-up|1
5439690|NCT02294175|18789291|P1|Overall Study|Lost to Follow-up|0
5439691|NCT02294175|18789290|P2|Overall Study|Protocol Violation|0
5439692|NCT02294175|18789291|P1|Overall Study|Protocol Violation|1
5439693|NCT02294175|18789290|P2|Overall Study|pt taking excluded medication|1
5439694|NCT02294175|18789291|P1|Overall Study|pt taking excluded medication|3
5439695|NCT02294175|18789290|P2|Overall Study|Withdrawal by Subject|2
5439696|NCT02294175|18789291|P1|Overall Study|Withdrawal by Subject|1
5439697|NCT02294058|18789318|P3|Overall Study|Miscellaneous|1
5439698|NCT02294058|18789319|P2|Overall Study|Miscellaneous|1
5439699|NCT02294058|18789320|P1|Overall Study|Miscellaneous|4
5439700|NCT02294058|18789318|P3|Overall Study|Physician Decision|0
5439701|NCT02294058|18789319|P2|Overall Study|Physician Decision|1
5439702|NCT02294058|18789320|P1|Overall Study|Physician Decision|2
5439703|NCT02294058|18789318|P3|Overall Study|Withdrawal by Subject|13
5439704|NCT02294058|18789319|P2|Overall Study|Withdrawal by Subject|14
5439705|NCT02294058|18789320|P1|Overall Study|Withdrawal by Subject|10
5439706|NCT02294058|18789318|P3|Overall Study|Lost to Follow-up|2
5439707|NCT02294058|18789319|P2|Overall Study|Lost to Follow-up|0
5439708|NCT02294058|18789320|P1|Overall Study|Lost to Follow-up|1
5439709|NCT02294058|18789318|P3|Overall Study|Lack of Efficacy|0
5439710|NCT02294058|18789319|P2|Overall Study|Lack of Efficacy|3
5439711|NCT02294058|18789320|P1|Overall Study|Lack of Efficacy|3
5439712|NCT02294058|18789318|P3|Overall Study|Adverse Event|13
5439713|NCT02294058|18789319|P2|Overall Study|Adverse Event|7
5439714|NCT02294058|18789320|P1|Overall Study|Adverse Event|16
5439715|NCT02294019|18789358|P1|Overall Study|Withdrawal by Subject|1
5439716|NCT02294019|18789358|P1|Overall Study|Other|1
5439717|NCT02294019|18789358|P1|Overall Study|Lost to Follow-up|31
5439718|NCT02294019|18789358|P1|Overall Study|Protocol Violation|68
5439719|NCT02294019|18789358|P1|Overall Study|Adverse Event|2
5439720|NCT02293902|18789366|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
5439721|NCT02293902|18789367|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
5439722|NCT02293902|18789368|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
5439723|NCT02293902|18789369|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
5439724|NCT02293902|18789370|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
5439725|NCT02293902|18789366|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
5439726|NCT02293902|18789367|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
5439727|NCT02293902|18789368|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
5439728|NCT02293902|18789369|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
5439729|NCT02293902|18789370|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
5439730|NCT02293902|18789366|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5439731|NCT02293902|18789367|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5439732|NCT02293902|18789368|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5439733|NCT02293902|18789369|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
5439734|NCT02293902|18789370|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
5439735|NCT02293902|18789366|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
5439736|NCT02293902|18789367|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
5439737|NCT02293902|18789368|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
5439738|NCT02293902|18789369|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
5439739|NCT02293902|18789370|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
5439740|NCT02293902|18789366|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
5439741|NCT02293902|18789367|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
5439742|NCT02293902|18789368|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
5439743|NCT02293902|18789369|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
5439744|NCT02293902|18789370|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
5439745|NCT02293863|18789432|P3|Overall Study|Reason Not Specified|2
5439746|NCT02293863|18789433|P2|Overall Study|Reason Not Specified|2
5439747|NCT02293863|18789434|P1|Overall Study|Reason Not Specified|0
5439748|NCT02293863|18789432|P3|Overall Study|Withdrawal by Subject|1
5439749|NCT02293863|18789433|P2|Overall Study|Withdrawal by Subject|3
5439750|NCT02293863|18789434|P1|Overall Study|Withdrawal by Subject|3
5439751|NCT02293863|18789432|P3|Overall Study|Lost to Follow-up|2
5439752|NCT02293863|18789433|P2|Overall Study|Lost to Follow-up|2
5439753|NCT02293863|18789434|P1|Overall Study|Lost to Follow-up|2
5439754|NCT02293863|18789432|P3|Overall Study|Death|4
5439755|NCT02293863|18789433|P2|Overall Study|Death|6
5439756|NCT02293863|18789434|P1|Overall Study|Death|4
5439757|NCT02293538|18789503|P2|Overall Study|Withdrawal by Subject|1
5439758|NCT02293538|18789504|P1|Overall Study|Withdrawal by Subject|0
5439759|NCT02293538|18789503|P2|Overall Study|Lost to Follow-up|0
5439760|NCT02293538|18789504|P1|Overall Study|Lost to Follow-up|1
5439761|NCT02293538|18789503|P2|Overall Study|Adverse Event|1
5439762|NCT02293538|18789504|P1|Overall Study|Adverse Event|0
5439763|NCT02293460|18789534|P1|Overall Study|Withdrawal by Subject|1
5439764|NCT02293460|18789534|P1|Overall Study|Adverse Event|2
5439765|NCT02293460|18789534|P1|Overall Study|Lack of Efficacy|2
5439766|NCT02293460|18789534|P1|Overall Study|Protocol Violation|1
5439767|NCT02293395|18789540|P2|Overall Study|Withdrawal by Subject|7
5439768|NCT02293395|18789541|P1|Overall Study|Withdrawal by Subject|8
5439769|NCT02293395|18789540|P2|Overall Study|Lost to Follow-up|0
5439770|NCT02293395|18789541|P1|Overall Study|Lost to Follow-up|1
5439771|NCT02292927|18789554|P2|Overall Study|Protocol Violation|7
5439772|NCT02292927|18789555|P1|Overall Study|Protocol Violation|13
5439773|NCT02292849|18789572|P3|Overall Study|Physician Decision|0
5439774|NCT02292849|18789573|P2|Overall Study|Physician Decision|0
5439775|NCT02292849|18789574|P1|Overall Study|Physician Decision|4
5439776|NCT02292849|18789572|P3|Overall Study|Lost to Follow-up|2
5439777|NCT02292849|18789573|P2|Overall Study|Lost to Follow-up|2
5439778|NCT02292849|18789574|P1|Overall Study|Lost to Follow-up|0
5439779|NCT02292784|18789585|P3|Overall Study|Withdrawal by Subject|3
5439780|NCT02292784|18789586|P2|Overall Study|Withdrawal by Subject|3
5439781|NCT02292784|18789587|P1|Overall Study|Withdrawal by Subject|0
5439782|NCT02292784|18789585|P3|Overall Study|Lost to Follow-up|18
5439783|NCT02292784|18789586|P2|Overall Study|Lost to Follow-up|17
5439784|NCT02292784|18789587|P1|Overall Study|Lost to Follow-up|1
5439785|NCT02292771|18789654|P2|Overall Study|Lost to Follow-up|1
5439786|NCT02292771|18789655|P1|Overall Study|Lost to Follow-up|2
5439787|NCT02292771|18789654|P2|Overall Study|Withdrawal by Subject|1
5439788|NCT02292771|18789655|P1|Overall Study|Withdrawal by Subject|2
5439789|NCT02292719|18789778|P6|Overall Study|Subject enrolled in new study.|0
5439790|NCT02292719|18789779|P5|Overall Study|Subject enrolled in new study.|0
5439791|NCT02292719|18789780|P4|Overall Study|Subject enrolled in new study.|0
5439792|NCT02292719|18789781|P3|Overall Study|Subject enrolled in new study.|1
5439793|NCT02292719|18789782|P2|Overall Study|Subject enrolled in new study.|0
5439794|NCT02292719|18789783|P1|Overall Study|Subject enrolled in new study.|0
5439795|NCT02292719|18789778|P6|Overall Study|Withdrawal by Subject|0
5439796|NCT02292719|18789779|P5|Overall Study|Withdrawal by Subject|1
5439797|NCT02292719|18789780|P4|Overall Study|Withdrawal by Subject|1
5439798|NCT02292719|18789781|P3|Overall Study|Withdrawal by Subject|0
5439799|NCT02292719|18789782|P2|Overall Study|Withdrawal by Subject|0
5439800|NCT02292719|18789783|P1|Overall Study|Withdrawal by Subject|0
5439801|NCT02292446|18789846|P1|Overall Study|Withdrawal by Subject|3
5439802|NCT02292446|18789846|P1|Overall Study|Subject/guardian decision|2
5439803|NCT02292446|18789846|P1|Overall Study|Disease progression|2
5439804|NCT02292446|18789846|P1|Overall Study|Death|1
5439805|NCT02292446|18789846|P1|Overall Study|Adverse Event|12
5439806|NCT02292212|18789935|P1|ViE Phase|Protocol Violation|2
5439807|NCT02292212|18789935|P1|ViE Phase|Withdrawal by Subject|1
5439808|NCT02291913|18790004|P1|Overall Study|Protocol Violation|1
5439809|NCT02291913|18790004|P1|Overall Study|Withdrawal by Subject|1
5439810|NCT02291913|18790004|P1|Overall Study|Physician Decision|1
5439811|NCT02291913|18790004|P1|Overall Study|Death|2
5439812|NCT02291913|18790004|P1|Overall Study|Adverse Event|11
5439813|NCT02291913|18790004|P1|Overall Study|Progressive Disease|32
5439814|NCT02291861|18790017|P4|Overall Study|Other|1
5439815|NCT02291861|18790018|P3|Overall Study|Other|0
5439816|NCT02291861|18790019|P2|Overall Study|Other|0
5439817|NCT02291861|18790020|P1|Overall Study|Other|0
5439818|NCT02291861|18790017|P4|Overall Study|Lost to Follow-up|0
5439819|NCT02291861|18790018|P3|Overall Study|Lost to Follow-up|4
5439820|NCT02291861|18790019|P2|Overall Study|Lost to Follow-up|1
5439821|NCT02291861|18790020|P1|Overall Study|Lost to Follow-up|2
5439822|NCT02291861|18790017|P4|Overall Study|Noncompliance|1
5439823|NCT02291861|18790018|P3|Overall Study|Noncompliance|2
5439824|NCT02291861|18790019|P2|Overall Study|Noncompliance|1
5439825|NCT02291861|18790020|P1|Overall Study|Noncompliance|1
5439826|NCT02291861|18790017|P4|Overall Study|Withdrawal by Subject|4
5439827|NCT02291861|18790018|P3|Overall Study|Withdrawal by Subject|1
5439828|NCT02291861|18790019|P2|Overall Study|Withdrawal by Subject|2
5439829|NCT02291861|18790020|P1|Overall Study|Withdrawal by Subject|1
5439830|NCT02291861|18790017|P4|Overall Study|Protocol Violation|1
5439831|NCT02291861|18790018|P3|Overall Study|Protocol Violation|0
5439832|NCT02291861|18790019|P2|Overall Study|Protocol Violation|0
5439833|NCT02291861|18790020|P1|Overall Study|Protocol Violation|1
5439834|NCT02291861|18790017|P4|Overall Study|Death|1
5439835|NCT02291861|18790018|P3|Overall Study|Death|1
5439836|NCT02291861|18790019|P2|Overall Study|Death|0
5439837|NCT02291861|18790020|P1|Overall Study|Death|0
5439838|NCT02291861|18790017|P4|Overall Study|Adverse Event|2
5439839|NCT02291861|18790018|P3|Overall Study|Adverse Event|1
5439840|NCT02291861|18790019|P2|Overall Study|Adverse Event|4
5439841|NCT02291861|18790020|P1|Overall Study|Adverse Event|2
5439842|NCT02291679|18790083|P3|Overall Study|Other|2
5439843|NCT02291679|18790084|P2|Overall Study|Other|4
5439844|NCT02291679|18790085|P1|Overall Study|Other|2
5439845|NCT02291679|18790083|P3|Overall Study|Insufficient Therapeutic Response|7
5439846|NCT02291679|18790084|P2|Overall Study|Insufficient Therapeutic Response|5
5439847|NCT02291679|18790085|P1|Overall Study|Insufficient Therapeutic Response|5
5439848|NCT02291679|18790083|P3|Overall Study|Lost to Follow-up|9
5439849|NCT02291679|18790084|P2|Overall Study|Lost to Follow-up|10
5439850|NCT02291679|18790085|P1|Overall Study|Lost to Follow-up|12
5439851|NCT02291679|18790083|P3|Overall Study|Withdrew Consent|15
5439852|NCT02291679|18790084|P2|Overall Study|Withdrew Consent|10
5439853|NCT02291679|18790085|P1|Overall Study|Withdrew Consent|18
5439854|NCT02291679|18790083|P3|Overall Study|Protocol Violation|7
5439855|NCT02291679|18790084|P2|Overall Study|Protocol Violation|1
5439856|NCT02291679|18790085|P1|Overall Study|Protocol Violation|5
5439857|NCT02291679|18790083|P3|Overall Study|Adverse Event|19
5439858|NCT02291679|18790084|P2|Overall Study|Adverse Event|12
5439859|NCT02291679|18790085|P1|Overall Study|Adverse Event|2
5439860|NCT02291549|18790116|P2|Overall Study|Withdrawal by Subject|1
5439861|NCT02291549|18790117|P1|Overall Study|Withdrawal by Subject|0
5439862|NCT02291549|18790116|P2|Overall Study|Lost to Follow-up|0
5439863|NCT02291549|18790117|P1|Overall Study|Lost to Follow-up|1
5439864|NCT02291510|18790139|P4|Overall Study|Adverse Event|1
5439865|NCT02291510|18790140|P3|Overall Study|Adverse Event|0
5439866|NCT02291510|18790141|P2|Overall Study|Adverse Event|0
5439867|NCT02291510|18790142|P1|Overall Study|Adverse Event|0
5439868|NCT02291419|18790158|P2|Overall Study|Early study termination|5
5439869|NCT02291419|18790159|P1|Overall Study|Early study termination|1
5439870|NCT02291289|18790196|P12|Maintenance Treatment Phase|No Treatment Received|0
5439871|NCT02291289|18790197|P11|Maintenance Treatment Phase|No Treatment Received|1
5439872|NCT02291289|18790198|P10|Maintenance Treatment Phase|No Treatment Received|0
5439873|NCT02291289|18790199|P9|Maintenance Treatment Phase|No Treatment Received|0
5439874|NCT02291289|18790200|P8|Maintenance Treatment Phase|No Treatment Received|0
5439875|NCT02291289|18790201|P7|Maintenance Treatment Phase|No Treatment Received|0
5439876|NCT02291289|18790202|P6|Maintenance Treatment Phase|No Treatment Received|5
5439877|NCT02291289|18790203|P5|Maintenance Treatment Phase|No Treatment Received|4
5439878|NCT02291289|18790204|P4|Maintenance Treatment Phase|No Treatment Received|0
5439879|NCT02291289|18790205|P3|Maintenance Treatment Phase|No Treatment Received|2
5439880|NCT02291289|18790206|P2|Maintenance Treatment Phase|No Treatment Received|0
5439881|NCT02291289|18790207|P1|Maintenance Treatment Phase|No Treatment Received|0
5439882|NCT02291289|18790196|P12|Maintenance Treatment Phase|Multiple Reasons|0
5439883|NCT02291289|18790197|P11|Maintenance Treatment Phase|Multiple Reasons|0
5439884|NCT02291289|18790198|P10|Maintenance Treatment Phase|Multiple Reasons|0
5439885|NCT02291289|18790199|P9|Maintenance Treatment Phase|Multiple Reasons|0
5439886|NCT02291289|18790200|P8|Maintenance Treatment Phase|Multiple Reasons|0
5439887|NCT02291289|18790201|P7|Maintenance Treatment Phase|Multiple Reasons|0
5439888|NCT02291289|18790202|P6|Maintenance Treatment Phase|Multiple Reasons|1
5439889|NCT02291289|18790203|P5|Maintenance Treatment Phase|Multiple Reasons|4
5439890|NCT02291289|18790204|P4|Maintenance Treatment Phase|Multiple Reasons|0
5439891|NCT02291289|18790205|P3|Maintenance Treatment Phase|Multiple Reasons|0
5439892|NCT02291289|18790206|P2|Maintenance Treatment Phase|Multiple Reasons|0
5439893|NCT02291289|18790207|P1|Maintenance Treatment Phase|Multiple Reasons|0
5439894|NCT02291289|18790196|P12|Maintenance Treatment Phase|Physician Decision|1
5439895|NCT02291289|18790197|P11|Maintenance Treatment Phase|Physician Decision|0
5439896|NCT02291289|18790198|P10|Maintenance Treatment Phase|Physician Decision|0
5439897|NCT02291289|18790199|P9|Maintenance Treatment Phase|Physician Decision|0
5439898|NCT02291289|18790200|P8|Maintenance Treatment Phase|Physician Decision|0
5439899|NCT02291289|18790201|P7|Maintenance Treatment Phase|Physician Decision|0
5439900|NCT02291289|18790202|P6|Maintenance Treatment Phase|Physician Decision|0
5439901|NCT02291289|18790203|P5|Maintenance Treatment Phase|Physician Decision|2
5439902|NCT02291289|18790204|P4|Maintenance Treatment Phase|Physician Decision|0
5439903|NCT02291289|18790205|P3|Maintenance Treatment Phase|Physician Decision|0
5439904|NCT02291289|18790206|P2|Maintenance Treatment Phase|Physician Decision|0
5439905|NCT02291289|18790207|P1|Maintenance Treatment Phase|Physician Decision|0
5439906|NCT02291289|18790196|P12|Maintenance Treatment Phase|Other|0
5439907|NCT02291289|18790197|P11|Maintenance Treatment Phase|Other|0
5439908|NCT02291289|18790198|P10|Maintenance Treatment Phase|Other|0
5439909|NCT02291289|18790199|P9|Maintenance Treatment Phase|Other|1
5439910|NCT02291289|18790200|P8|Maintenance Treatment Phase|Other|0
5439911|NCT02291289|18790201|P7|Maintenance Treatment Phase|Other|0
5439912|NCT02291289|18790202|P6|Maintenance Treatment Phase|Other|8
5439913|NCT02291289|18790203|P5|Maintenance Treatment Phase|Other|29
5439914|NCT02291289|18790204|P4|Maintenance Treatment Phase|Other|0
5439915|NCT02291289|18790205|P3|Maintenance Treatment Phase|Other|1
5439916|NCT02291289|18790206|P2|Maintenance Treatment Phase|Other|0
5439917|NCT02291289|18790207|P1|Maintenance Treatment Phase|Other|0
5439918|NCT02291289|18790196|P12|Maintenance Treatment Phase|Lost to Follow-up|1
5439919|NCT02291289|18790197|P11|Maintenance Treatment Phase|Lost to Follow-up|2
5439920|NCT02291289|18790198|P10|Maintenance Treatment Phase|Lost to Follow-up|0
5439921|NCT02291289|18790199|P9|Maintenance Treatment Phase|Lost to Follow-up|0
5439922|NCT02291289|18790200|P8|Maintenance Treatment Phase|Lost to Follow-up|1
5439923|NCT02291289|18790201|P7|Maintenance Treatment Phase|Lost to Follow-up|0
5439924|NCT02291289|18790202|P6|Maintenance Treatment Phase|Lost to Follow-up|3
5439925|NCT02291289|18790203|P5|Maintenance Treatment Phase|Lost to Follow-up|12
5439926|NCT02291289|18790204|P4|Maintenance Treatment Phase|Lost to Follow-up|0
5439927|NCT02291289|18790205|P3|Maintenance Treatment Phase|Lost to Follow-up|0
5439928|NCT02291289|18790206|P2|Maintenance Treatment Phase|Lost to Follow-up|0
5439929|NCT02291289|18790207|P1|Maintenance Treatment Phase|Lost to Follow-up|0
5439930|NCT02291289|18790196|P12|Maintenance Treatment Phase|Adverse Event|0
5439931|NCT02291289|18790197|P11|Maintenance Treatment Phase|Adverse Event|0
5439932|NCT02291289|18790198|P10|Maintenance Treatment Phase|Adverse Event|0
5439933|NCT02291289|18790199|P9|Maintenance Treatment Phase|Adverse Event|0
5439934|NCT02291289|18790200|P8|Maintenance Treatment Phase|Adverse Event|0
5439935|NCT02291289|18790201|P7|Maintenance Treatment Phase|Adverse Event|0
5439936|NCT02291289|18790202|P6|Maintenance Treatment Phase|Adverse Event|0
5439937|NCT02291289|18790203|P5|Maintenance Treatment Phase|Adverse Event|1
5439938|NCT02291289|18790204|P4|Maintenance Treatment Phase|Adverse Event|0
5439939|NCT02291289|18790205|P3|Maintenance Treatment Phase|Adverse Event|0
5439940|NCT02291289|18790206|P2|Maintenance Treatment Phase|Adverse Event|0
5439941|NCT02291289|18790207|P1|Maintenance Treatment Phase|Adverse Event|0
5439942|NCT02291289|18790196|P12|Maintenance Treatment Phase|Death|11
5439943|NCT02291289|18790197|P11|Maintenance Treatment Phase|Death|26
5439944|NCT02291289|18790198|P10|Maintenance Treatment Phase|Death|0
5439945|NCT02291289|18790199|P9|Maintenance Treatment Phase|Death|1
5439946|NCT02291289|18790200|P8|Maintenance Treatment Phase|Death|1
5439947|NCT02291289|18790201|P7|Maintenance Treatment Phase|Death|0
5439948|NCT02291289|18790202|P6|Maintenance Treatment Phase|Death|100
5439949|NCT02291289|18790203|P5|Maintenance Treatment Phase|Death|185
5439950|NCT02291289|18790204|P4|Maintenance Treatment Phase|Death|0
5439951|NCT02291289|18790205|P3|Maintenance Treatment Phase|Death|13
5439952|NCT02291289|18790206|P2|Maintenance Treatment Phase|Death|23
5439953|NCT02291289|18790207|P1|Maintenance Treatment Phase|Death|0
5439954|NCT02291289|18790196|P12|Maintenance Treatment Phase|Protocol Violation|0
5439955|NCT02291289|18790197|P11|Maintenance Treatment Phase|Protocol Violation|0
5439956|NCT02291289|18790198|P10|Maintenance Treatment Phase|Protocol Violation|0
5439957|NCT02291289|18790199|P9|Maintenance Treatment Phase|Protocol Violation|0
5439958|NCT02291289|18790200|P8|Maintenance Treatment Phase|Protocol Violation|0
5439959|NCT02291289|18790201|P7|Maintenance Treatment Phase|Protocol Violation|0
5439960|NCT02291289|18790202|P6|Maintenance Treatment Phase|Protocol Violation|1
5439961|NCT02291289|18790203|P5|Maintenance Treatment Phase|Protocol Violation|2
5439962|NCT02291289|18790204|P4|Maintenance Treatment Phase|Protocol Violation|0
5439963|NCT02291289|18790205|P3|Maintenance Treatment Phase|Protocol Violation|0
5439964|NCT02291289|18790206|P2|Maintenance Treatment Phase|Protocol Violation|1
5439965|NCT02291289|18790207|P1|Maintenance Treatment Phase|Protocol Violation|0
5439966|NCT02291289|18790196|P12|Maintenance Treatment Phase|Withdrawal by Subject|3
5439967|NCT02291289|18790197|P11|Maintenance Treatment Phase|Withdrawal by Subject|2
5439968|NCT02291289|18790198|P10|Maintenance Treatment Phase|Withdrawal by Subject|0
5439969|NCT02291289|18790199|P9|Maintenance Treatment Phase|Withdrawal by Subject|0
5439970|NCT02291289|18790200|P8|Maintenance Treatment Phase|Withdrawal by Subject|0
5439971|NCT02291289|18790201|P7|Maintenance Treatment Phase|Withdrawal by Subject|0
5439972|NCT02291289|18790202|P6|Maintenance Treatment Phase|Withdrawal by Subject|11
5439973|NCT02291289|18790203|P5|Maintenance Treatment Phase|Withdrawal by Subject|13
5439974|NCT02291289|18790204|P4|Maintenance Treatment Phase|Withdrawal by Subject|0
5439975|NCT02291289|18790205|P3|Maintenance Treatment Phase|Withdrawal by Subject|0
5439976|NCT02291289|18790206|P2|Maintenance Treatment Phase|Withdrawal by Subject|0
5439977|NCT02291289|18790207|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
5439978|NCT02291289|18790196|P12|Induction Treatment|Not Dosed|0
5439979|NCT02291289|18790197|P11|Induction Treatment|Not Dosed|0
5439980|NCT02291289|18790198|P10|Induction Treatment|Not Dosed|1
5439981|NCT02291289|18790199|P9|Induction Treatment|Not Dosed|0
5439982|NCT02291289|18790200|P8|Induction Treatment|Not Dosed|0
5439983|NCT02291289|18790201|P7|Induction Treatment|Not Dosed|0
5439984|NCT02291289|18790202|P6|Induction Treatment|Not Dosed|0
5439985|NCT02291289|18790203|P5|Induction Treatment|Not Dosed|0
5439986|NCT02291289|18790204|P4|Induction Treatment|Not Dosed|9
5439987|NCT02291289|18790205|P3|Induction Treatment|Not Dosed|0
5439988|NCT02291289|18790206|P2|Induction Treatment|Not Dosed|0
5439989|NCT02291289|18790207|P1|Induction Treatment|Not Dosed|2
5439990|NCT02291237|18790271|P2|Overall Study|Subject Required Prohibited Medication|0
5439991|NCT02291237|18790272|P1|Overall Study|Subject Required Prohibited Medication|2
5439992|NCT02291237|18790271|P2|Overall Study|Lost to Follow-up|2
5439993|NCT02291237|18790272|P1|Overall Study|Lost to Follow-up|0
5439994|NCT02291237|18790271|P2|Overall Study|Withdrew Consent|11
5439995|NCT02291237|18790272|P1|Overall Study|Withdrew Consent|11
5439996|NCT02291237|18790271|P2|Overall Study|Investigator's Discretion|3
5439997|NCT02291237|18790272|P1|Overall Study|Investigator's Discretion|0
5439998|NCT02291237|18790271|P2|Overall Study|Adverse Event|3
5439999|NCT02291237|18790272|P1|Overall Study|Adverse Event|1
5440000|NCT02291237|18790271|P2|Overall Study|Study Terminated by Sponsor|67
5440001|NCT02291237|18790272|P1|Overall Study|Study Terminated by Sponsor|72
5440002|NCT02291029|18790294|P6|Overall Study|Adverse Event|0
5440003|NCT02291029|18790295|P5|Overall Study|Adverse Event|0
5440004|NCT02291029|18790296|P4|Overall Study|Adverse Event|0
5440005|NCT02291029|18790297|P3|Overall Study|Adverse Event|0
5440006|NCT02291029|18790298|P2|Overall Study|Adverse Event|1
5440007|NCT02291029|18790299|P1|Overall Study|Adverse Event|0
5440008|NCT02291029|18790294|P6|Overall Study|Withdrawal by Subject|0
5440009|NCT02291029|18790295|P5|Overall Study|Withdrawal by Subject|0
5440010|NCT02291029|18790296|P4|Overall Study|Withdrawal by Subject|0
5440011|NCT02291029|18790297|P3|Overall Study|Withdrawal by Subject|1
5440012|NCT02291029|18790298|P2|Overall Study|Withdrawal by Subject|0
5440013|NCT02291029|18790299|P1|Overall Study|Withdrawal by Subject|0
5440014|NCT02290925|18790370|P2|Second Period of 3 Months|insulin started|1
5440015|NCT02290925|18790371|P1|Second Period of 3 Months|insulin started|0
5440016|NCT02290925|18790370|P2|Second Period of 3 Months|Lost to Follow-up|3
5440017|NCT02290925|18790371|P1|Second Period of 3 Months|Lost to Follow-up|1
5440018|NCT02290925|18790370|P2|First Period of Three Months|Insulin Started|1
5440019|NCT02290925|18790371|P1|First Period of Three Months|Insulin Started|1
5440020|NCT02290925|18790370|P2|First Period of Three Months|Death|0
5440021|NCT02290925|18790371|P1|First Period of Three Months|Death|1
5440022|NCT02290925|18790370|P2|First Period of Three Months|Lost to Follow-up|1
5440023|NCT02290925|18790371|P1|First Period of Three Months|Lost to Follow-up|2
5440024|NCT02290873|18790386|P3|Overall Study|Protocol Violation|1
5440025|NCT02290873|18790387|P2|Overall Study|Protocol Violation|0
5440026|NCT02290873|18790388|P1|Overall Study|Protocol Violation|0
5440027|NCT02290873|18790386|P3|Overall Study|Esophagogastroduodenoscopy was added|0
5440028|NCT02290873|18790387|P2|Overall Study|Esophagogastroduodenoscopy was added|0
5440029|NCT02290873|18790388|P1|Overall Study|Esophagogastroduodenoscopy was added|1
5440030|NCT02290873|18790386|P3|Overall Study|Nellcor device error|0
5440031|NCT02290873|18790387|P2|Overall Study|Nellcor device error|0
5440032|NCT02290873|18790388|P1|Overall Study|Nellcor device error|1
5440033|NCT02290873|18790386|P3|Overall Study|Withdrawal by Subject|1
5440034|NCT02290873|18790387|P2|Overall Study|Withdrawal by Subject|1
5440035|NCT02290873|18790388|P1|Overall Study|Withdrawal by Subject|0
5440036|NCT02290821|18790407|P2|Overall Study|Lost to Follow-up|2
5440037|NCT02290821|18790408|P1|Overall Study|Lost to Follow-up|3
5440038|NCT02290821|18790407|P2|Overall Study|Unable or unwilling to cooperate with|0
5440039|NCT02290821|18790408|P1|Overall Study|Unable or unwilling to cooperate with|2
5440040|NCT02290821|18790407|P2|Overall Study|Withdrawal by Subject|1
5440041|NCT02290821|18790408|P1|Overall Study|Withdrawal by Subject|1
5440042|NCT02290691|18790416|P2|Overall Study|Lost to Follow-up|7
5440043|NCT02290691|18790417|P1|Overall Study|Lost to Follow-up|7
5440044|NCT02290691|18790416|P2|Overall Study|Withdrawal by Subject|1
5440045|NCT02290691|18790417|P1|Overall Study|Withdrawal by Subject|1
5440046|NCT02290691|18790416|P2|Overall Study|Noncompliance|1
5440047|NCT02290691|18790417|P1|Overall Study|Noncompliance|0
5440048|NCT02290431|18790530|P1|Overall Study|Physician Decision|2
5440049|NCT02290431|18790530|P1|Overall Study|Study terminated by Sponsor|1
5440050|NCT02290431|18790530|P1|Overall Study|Progressive disease|4
5440051|NCT02290431|18790530|P1|Overall Study|Adverse Event|20
5440052|NCT02290340|18790553|P4|Overall Study|Other|1
5440053|NCT02290340|18790554|P3|Overall Study|Other|0
5440054|NCT02290340|18790555|P2|Overall Study|Other|0
5440055|NCT02290340|18790556|P1|Overall Study|Other|1
5440056|NCT02290340|18790553|P4|Overall Study|Withdrawal by Subject|0
5440057|NCT02290340|18790554|P3|Overall Study|Withdrawal by Subject|0
5440058|NCT02290340|18790555|P2|Overall Study|Withdrawal by Subject|0
5440059|NCT02290340|18790556|P1|Overall Study|Withdrawal by Subject|1
5440060|NCT02290340|18790553|P4|Overall Study|Lost to Follow-up|1
5440061|NCT02290340|18790554|P3|Overall Study|Lost to Follow-up|0
5440062|NCT02290340|18790555|P2|Overall Study|Lost to Follow-up|0
5440063|NCT02290340|18790556|P1|Overall Study|Lost to Follow-up|0
5440064|NCT02290223|18790601|P2|12 Months|Refusal|1
5440065|NCT02290223|18790602|P1|12 Months|Refusal|0
5440066|NCT02290223|18790601|P2|12 Months|Lost to Follow-up|10
5440067|NCT02290223|18790602|P1|12 Months|Lost to Follow-up|16
5440068|NCT02290223|18790601|P2|6 Months|deceased (not related to study)|0
5440069|NCT02290223|18790602|P1|6 Months|deceased (not related to study)|2
5440070|NCT02290223|18790601|P2|6 Months|Withdrawal by Subject|0
5440071|NCT02290223|18790602|P1|6 Months|Withdrawal by Subject|5
5440072|NCT02290223|18790601|P2|6 Months|Lost to Follow-up|6
5440073|NCT02290223|18790602|P1|6 Months|Lost to Follow-up|9
5440074|NCT02289963|18790717|P2|Overall Study|Other than specified above|2
5440075|NCT02289963|18790718|P1|Overall Study|Other than specified above|0
5440076|NCT02289963|18790717|P2|Overall Study|End treatment visit outside visit window|4
5440077|NCT02289963|18790718|P1|Overall Study|End treatment visit outside visit window|0
5440078|NCT02289963|18790717|P2|Overall Study|Last injection missed|2
5440079|NCT02289963|18790718|P1|Overall Study|Last injection missed|2
5440080|NCT02289963|18790717|P2|Overall Study|Withdrawal by Subject|0
5440081|NCT02289963|18790718|P1|Overall Study|Withdrawal by Subject|1
5440082|NCT02289963|18790717|P2|Overall Study|Poor compliance to protocol|0
5440083|NCT02289963|18790718|P1|Overall Study|Poor compliance to protocol|1
5440084|NCT02289963|18790717|P2|Overall Study|Adverse Event|2
5440085|NCT02289963|18790718|P1|Overall Study|Adverse Event|1
5440086|NCT02289898|18790769|P3|Overall Study|Other|10
5440087|NCT02289898|18790770|P2|Overall Study|Other|7
5440088|NCT02289898|18790771|P1|Overall Study|Other|8
5440089|NCT02289898|18790769|P3|Overall Study|Use of another anticancer therapy|1
5440090|NCT02289898|18790770|P2|Overall Study|Use of another anticancer therapy|0
5440091|NCT02289898|18790771|P1|Overall Study|Use of another anticancer therapy|0
5440092|NCT02289898|18790769|P3|Overall Study|Disease progression|34
5440093|NCT02289898|18790770|P2|Overall Study|Disease progression|28
5440094|NCT02289898|18790771|P1|Overall Study|Disease progression|34
5440095|NCT02289898|18790769|P3|Overall Study|Adverse Event|5
5440096|NCT02289898|18790770|P2|Overall Study|Adverse Event|5
5440097|NCT02289898|18790771|P1|Overall Study|Adverse Event|3
5440098|NCT02289898|18790769|P3|Overall Study|Withdrawal by Subject|1
5440099|NCT02289898|18790770|P2|Overall Study|Withdrawal by Subject|4
5440100|NCT02289898|18790771|P1|Overall Study|Withdrawal by Subject|0
5440101|NCT02289898|18790769|P3|Overall Study|Physician Decision|2
5440102|NCT02289898|18790770|P2|Overall Study|Physician Decision|5
5440103|NCT02289898|18790771|P1|Overall Study|Physician Decision|2
5440104|NCT02289898|18790769|P3|Overall Study|Death|3
5440105|NCT02289898|18790770|P2|Overall Study|Death|4
5440106|NCT02289898|18790771|P1|Overall Study|Death|5
5440107|NCT02289833|18790780|P2|Overall Study|Death|16
5440108|NCT02289833|18790781|P1|Overall Study|Death|23
5440109|NCT02289833|18790780|P2|Overall Study|Lost to Follow-up|0
5440110|NCT02289833|18790781|P1|Overall Study|Lost to Follow-up|4
5440111|NCT02289833|18790780|P2|Overall Study|Study discontinuation|1
5440112|NCT02289833|18790781|P1|Overall Study|Study discontinuation|0
5440113|NCT02289820|18790817|P7|Overall Study|withdrawal of consent|0
5440114|NCT02289820|18790818|P6|Overall Study|withdrawal of consent|0
5440115|NCT02289820|18790819|P5|Overall Study|withdrawal of consent|0
5440116|NCT02289820|18790820|P4|Overall Study|withdrawal of consent|0
5440117|NCT02289820|18790821|P3|Overall Study|withdrawal of consent|0
5440118|NCT02289820|18790822|P2|Overall Study|withdrawal of consent|1
5440119|NCT02289820|18790823|P1|Overall Study|withdrawal of consent|0
5440120|NCT02289820|18790817|P7|Overall Study|Lost to Follow-up|1
5440121|NCT02289820|18790818|P6|Overall Study|Lost to Follow-up|1
5440122|NCT02289820|18790819|P5|Overall Study|Lost to Follow-up|0
5440123|NCT02289820|18790820|P4|Overall Study|Lost to Follow-up|1
5440124|NCT02289820|18790821|P3|Overall Study|Lost to Follow-up|3
5440125|NCT02289820|18790822|P2|Overall Study|Lost to Follow-up|0
5440126|NCT02289820|18790823|P1|Overall Study|Lost to Follow-up|0
5440127|NCT02289820|18790817|P7|Overall Study|Death|0
5440128|NCT02289820|18790818|P6|Overall Study|Death|0
5440129|NCT02289820|18790819|P5|Overall Study|Death|0
5440130|NCT02289820|18790820|P4|Overall Study|Death|0
5440131|NCT02289820|18790821|P3|Overall Study|Death|1
5440132|NCT02289820|18790822|P2|Overall Study|Death|0
5440133|NCT02289820|18790823|P1|Overall Study|Death|0
5440134|NCT02289820|18790817|P7|Overall Study|Withdrawal by Subject|1
5440135|NCT02289820|18790818|P6|Overall Study|Withdrawal by Subject|0
5440136|NCT02289820|18790819|P5|Overall Study|Withdrawal by Subject|0
5440137|NCT02289820|18790820|P4|Overall Study|Withdrawal by Subject|1
5440138|NCT02289820|18790821|P3|Overall Study|Withdrawal by Subject|2
5440139|NCT02289820|18790822|P2|Overall Study|Withdrawal by Subject|1
5440140|NCT02289820|18790823|P1|Overall Study|Withdrawal by Subject|2
5440141|NCT02289742|18790941|P4|Third Wear Period|Reason not given|1
5440142|NCT02289742|18790942|P3|Third Wear Period|Reason not given|0
5440143|NCT02289742|18790943|P2|Third Wear Period|Reason not given|0
5440144|NCT02289742|18790944|P1|Third Wear Period|Reason not given|0
5440145|NCT02289742|18790941|P4|Third Wear Period|Adverse Event|0
5440146|NCT02289742|18790942|P3|Third Wear Period|Adverse Event|0
5440147|NCT02289742|18790943|P2|Third Wear Period|Adverse Event|1
5440148|NCT02289742|18790944|P1|Third Wear Period|Adverse Event|0
5440149|NCT02289742|18790941|P4|First Wear Period|Other prior to treatment|1
5440150|NCT02289742|18790942|P3|First Wear Period|Other prior to treatment|0
5440151|NCT02289742|18790943|P2|First Wear Period|Other prior to treatment|0
5440152|NCT02289742|18790944|P1|First Wear Period|Other prior to treatment|0
5440153|NCT02289742|18790941|P4|First Wear Period|Adverse Event|0
5440154|NCT02289742|18790942|P3|First Wear Period|Adverse Event|1
5440155|NCT02289742|18790943|P2|First Wear Period|Adverse Event|0
5440156|NCT02289742|18790944|P1|First Wear Period|Adverse Event|0
5440157|NCT02289742|18790941|P4|First Wear Period|Adverse event prior to treatment|0
5440158|NCT02289742|18790942|P3|First Wear Period|Adverse event prior to treatment|0
5440159|NCT02289742|18790943|P2|First Wear Period|Adverse event prior to treatment|1
5440160|NCT02289742|18790944|P1|First Wear Period|Adverse event prior to treatment|0
5440161|NCT02289729|18790961|P1|Overall Study|Death|1
5440162|NCT02289729|18790961|P1|Overall Study|Withdrawal by Subject|1
5440163|NCT02289729|18790961|P1|Overall Study|Very Narrow Therapeutic Margin|1
5440164|NCT02289729|18790961|P1|Overall Study|Lack of Efficacy|3
5440165|NCT02289690|18791025|P10|Overall Study|Other|1
5440166|NCT02289690|18791026|P9|Overall Study|Other|3
5440167|NCT02289690|18791027|P8|Overall Study|Other|2
5440168|NCT02289690|18791028|P7|Overall Study|Other|1
5440169|NCT02289690|18791029|P6|Overall Study|Other|0
5440170|NCT02289690|18791030|P5|Overall Study|Other|1
5440171|NCT02289690|18791031|P4|Overall Study|Other|1
5440172|NCT02289690|18791032|P3|Overall Study|Other|0
5440173|NCT02289690|18791033|P2|Overall Study|Other|0
5440174|NCT02289690|18791034|P1|Overall Study|Other|0
5440175|NCT02289690|18791025|P10|Overall Study|Sponsor Discontinued Study|15
5440176|NCT02289690|18791026|P9|Overall Study|Sponsor Discontinued Study|7
5440177|NCT02289690|18791027|P8|Overall Study|Sponsor Discontinued Study|9
5440178|NCT02289690|18791028|P7|Overall Study|Sponsor Discontinued Study|0
5440179|NCT02289690|18791029|P6|Overall Study|Sponsor Discontinued Study|0
5440180|NCT02289690|18791030|P5|Overall Study|Sponsor Discontinued Study|0
5440181|NCT02289690|18791031|P4|Overall Study|Sponsor Discontinued Study|0
5440182|NCT02289690|18791032|P3|Overall Study|Sponsor Discontinued Study|0
5440183|NCT02289690|18791033|P2|Overall Study|Sponsor Discontinued Study|0
5440184|NCT02289690|18791034|P1|Overall Study|Sponsor Discontinued Study|0
5440185|NCT02289690|18791025|P10|Overall Study|Death|41
5440186|NCT02289690|18791026|P9|Overall Study|Death|45
5440187|NCT02289690|18791027|P8|Overall Study|Death|49
5440188|NCT02289690|18791028|P7|Overall Study|Death|0
5440189|NCT02289690|18791029|P6|Overall Study|Death|0
5440190|NCT02289690|18791030|P5|Overall Study|Death|0
5440191|NCT02289690|18791031|P4|Overall Study|Death|0
5440192|NCT02289690|18791032|P3|Overall Study|Death|0
5440193|NCT02289690|18791033|P2|Overall Study|Death|0
5440194|NCT02289690|18791034|P1|Overall Study|Death|0
5440195|NCT02289690|18791025|P10|Overall Study|Lost to Follow-up|2
5440196|NCT02289690|18791026|P9|Overall Study|Lost to Follow-up|0
5440197|NCT02289690|18791027|P8|Overall Study|Lost to Follow-up|1
5440198|NCT02289690|18791028|P7|Overall Study|Lost to Follow-up|0
5440199|NCT02289690|18791029|P6|Overall Study|Lost to Follow-up|0
5440200|NCT02289690|18791030|P5|Overall Study|Lost to Follow-up|0
5440201|NCT02289690|18791031|P4|Overall Study|Lost to Follow-up|0
5440202|NCT02289690|18791032|P3|Overall Study|Lost to Follow-up|0
5440203|NCT02289690|18791033|P2|Overall Study|Lost to Follow-up|0
5440204|NCT02289690|18791034|P1|Overall Study|Lost to Follow-up|0
5440205|NCT02289690|18791025|P10|Overall Study|Progressive Disease, Per Protocol|0
5440206|NCT02289690|18791026|P9|Overall Study|Progressive Disease, Per Protocol|0
5440207|NCT02289690|18791027|P8|Overall Study|Progressive Disease, Per Protocol|0
5440208|NCT02289690|18791028|P7|Overall Study|Progressive Disease, Per Protocol|2
5440209|NCT02289690|18791029|P6|Overall Study|Progressive Disease, Per Protocol|13
5440210|NCT02289690|18791030|P5|Overall Study|Progressive Disease, Per Protocol|5
5440211|NCT02289690|18791031|P4|Overall Study|Progressive Disease, Per Protocol|2
5440212|NCT02289690|18791032|P3|Overall Study|Progressive Disease, Per Protocol|3
5440213|NCT02289690|18791033|P2|Overall Study|Progressive Disease, Per Protocol|2
5440214|NCT02289690|18791034|P1|Overall Study|Progressive Disease, Per Protocol|3
5440215|NCT02289690|18791025|P10|Overall Study|Withdrawal by Subject|2
5440216|NCT02289690|18791026|P9|Overall Study|Withdrawal by Subject|4
5440217|NCT02289690|18791027|P8|Overall Study|Withdrawal by Subject|0
5440218|NCT02289690|18791028|P7|Overall Study|Withdrawal by Subject|0
5440219|NCT02289690|18791029|P6|Overall Study|Withdrawal by Subject|1
5440220|NCT02289690|18791030|P5|Overall Study|Withdrawal by Subject|1
5440221|NCT02289690|18791031|P4|Overall Study|Withdrawal by Subject|0
5440222|NCT02289690|18791032|P3|Overall Study|Withdrawal by Subject|0
5440223|NCT02289690|18791033|P2|Overall Study|Withdrawal by Subject|0
5440224|NCT02289690|18791034|P1|Overall Study|Withdrawal by Subject|1
5440225|NCT02289690|18791025|P10|Overall Study|Adverse Event Related to Progression|0
5440226|NCT02289690|18791026|P9|Overall Study|Adverse Event Related to Progression|0
5440227|NCT02289690|18791027|P8|Overall Study|Adverse Event Related to Progression|0
5440228|NCT02289690|18791028|P7|Overall Study|Adverse Event Related to Progression|1
5440229|NCT02289690|18791029|P6|Overall Study|Adverse Event Related to Progression|0
5440230|NCT02289690|18791030|P5|Overall Study|Adverse Event Related to Progression|1
5440231|NCT02289690|18791031|P4|Overall Study|Adverse Event Related to Progression|0
5440232|NCT02289690|18791032|P3|Overall Study|Adverse Event Related to Progression|1
5440233|NCT02289690|18791033|P2|Overall Study|Adverse Event Related to Progression|1
5440234|NCT02289690|18791034|P1|Overall Study|Adverse Event Related to Progression|0
5440235|NCT02289469|18791122|P2|Overall Study|Unable to match a control|0
5440236|NCT02289469|18791123|P1|Overall Study|Unable to match a control|6
5440237|NCT02289456|18791131|P1|Monotherapy Period|Miscellaneous|1
5440238|NCT02289456|18791131|P1|Monotherapy Period|Study Terminated by Sponsor|2
5440239|NCT02289456|18791131|P1|Monotherapy Period|Withdrawal by Subject|2
5440240|NCT02289456|18791131|P1|Monotherapy Period|Symptomatic Deterioration|1
5440241|NCT02289456|18791131|P1|Monotherapy Period|Progressive Disease (PD)|8
5440242|NCT02289456|18791131|P1|Monotherapy Period|Adverse Event|1
5440243|NCT02289456|18791131|P1|Monotherapy Period|Death|1
5440244|NCT02289456|18791131|P1|Induction Period|Miscellaneous|1
5440245|NCT02289456|18791131|P1|Induction Period|Withdrawal by Subject|2
5440246|NCT02289456|18791131|P1|Induction Period|Symptomatic Deterioration|4
5440247|NCT02289456|18791131|P1|Induction Period|Progressive Disease (PD)|4
5440248|NCT02289456|18791131|P1|Induction Period|Adverse Event|11
5440249|NCT02289456|18791131|P1|Induction Period|Death|2
5440250|NCT02289417|18791154|P9|Extension Phase Weeks 52-104|Miscellaneous|0
5440251|NCT02289417|18791155|P8|Extension Phase Weeks 52-104|Miscellaneous|1
5440252|NCT02289417|18791156|P7|Extension Phase Weeks 52-104|Miscellaneous|0
5440253|NCT02289417|18791157|P6|Extension Phase Weeks 52-104|Miscellaneous|0
5440254|NCT02289417|18791158|P5|Extension Phase Weeks 52-104|Miscellaneous|0
5440255|NCT02289417|18791159|P4|Extension Phase Weeks 52-104|Miscellaneous|0
5440256|NCT02289417|18791160|P3|Extension Phase Weeks 52-104|Miscellaneous|0
5440257|NCT02289417|18791161|P2|Extension Phase Weeks 52-104|Miscellaneous|0
5440258|NCT02289417|18791162|P1|Extension Phase Weeks 52-104|Miscellaneous|0
5440259|NCT02289417|18791154|P9|Extension Phase Weeks 52-104|Withdrawal by Subject|1
5440260|NCT02289417|18791155|P8|Extension Phase Weeks 52-104|Withdrawal by Subject|2
5440261|NCT02289417|18791156|P7|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5440262|NCT02289417|18791157|P6|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5440263|NCT02289417|18791158|P5|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5440264|NCT02289417|18791159|P4|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5440265|NCT02289417|18791160|P3|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5440266|NCT02289417|18791161|P2|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5440267|NCT02289417|18791162|P1|Extension Phase Weeks 52-104|Withdrawal by Subject|0
5440268|NCT02289417|18791154|P9|Extension Phase Weeks 52-104|Lack of Efficacy|2
5440269|NCT02289417|18791155|P8|Extension Phase Weeks 52-104|Lack of Efficacy|2
5440270|NCT02289417|18791156|P7|Extension Phase Weeks 52-104|Lack of Efficacy|0
5440271|NCT02289417|18791157|P6|Extension Phase Weeks 52-104|Lack of Efficacy|0
5440272|NCT02289417|18791158|P5|Extension Phase Weeks 52-104|Lack of Efficacy|0
5440273|NCT02289417|18791159|P4|Extension Phase Weeks 52-104|Lack of Efficacy|0
5440274|NCT02289417|18791160|P3|Extension Phase Weeks 52-104|Lack of Efficacy|0
5440275|NCT02289417|18791161|P2|Extension Phase Weeks 52-104|Lack of Efficacy|0
5440276|NCT02289417|18791162|P1|Extension Phase Weeks 52-104|Lack of Efficacy|0
5440277|NCT02289417|18791154|P9|Extension Phase Weeks 52-104|Adverse Event|3
5440278|NCT02289417|18791155|P8|Extension Phase Weeks 52-104|Adverse Event|2
5440279|NCT02289417|18791156|P7|Extension Phase Weeks 52-104|Adverse Event|0
5440280|NCT02289417|18791157|P6|Extension Phase Weeks 52-104|Adverse Event|0
5440281|NCT02289417|18791158|P5|Extension Phase Weeks 52-104|Adverse Event|0
5440282|NCT02289417|18791159|P4|Extension Phase Weeks 52-104|Adverse Event|0
5440283|NCT02289417|18791160|P3|Extension Phase Weeks 52-104|Adverse Event|0
5440284|NCT02289417|18791161|P2|Extension Phase Weeks 52-104|Adverse Event|0
5440285|NCT02289417|18791162|P1|Extension Phase Weeks 52-104|Adverse Event|0
5440286|NCT02289417|18791154|P9|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5440287|NCT02289417|18791155|P8|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5440288|NCT02289417|18791156|P7|Active Treatment Phase Weeks 12-52|Miscellaneous|1
5440289|NCT02289417|18791157|P6|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5440290|NCT02289417|18791158|P5|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5440291|NCT02289417|18791159|P4|Active Treatment Phase Weeks 12-52|Miscellaneous|1
5440292|NCT02289417|18791160|P3|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5440293|NCT02289417|18791161|P2|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5440294|NCT02289417|18791162|P1|Active Treatment Phase Weeks 12-52|Miscellaneous|0
5440295|NCT02289417|18791154|P9|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5440296|NCT02289417|18791155|P8|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5440297|NCT02289417|18791156|P7|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
5440298|NCT02289417|18791157|P6|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5440299|NCT02289417|18791158|P5|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5440300|NCT02289417|18791159|P4|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5440301|NCT02289417|18791160|P3|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5440302|NCT02289417|18791161|P2|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5440303|NCT02289417|18791162|P1|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
5440304|NCT02289417|18791154|P9|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5440305|NCT02289417|18791155|P8|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5440306|NCT02289417|18791156|P7|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5440307|NCT02289417|18791157|P6|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
5440308|NCT02289417|18791158|P5|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
5440309|NCT02289417|18791159|P4|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5440310|NCT02289417|18791160|P3|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
5440311|NCT02289417|18791161|P2|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5440312|NCT02289417|18791162|P1|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
5440313|NCT02289417|18791154|P9|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5440314|NCT02289417|18791155|P8|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5440315|NCT02289417|18791156|P7|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5440316|NCT02289417|18791157|P6|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
5440317|NCT02289417|18791158|P5|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
5440318|NCT02289417|18791159|P4|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
5440319|NCT02289417|18791160|P3|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
5440320|NCT02289417|18791161|P2|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
5440321|NCT02289417|18791162|P1|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
5440322|NCT02289417|18791154|P9|Active Treatment Phase Weeks 12-52|Pregnancy|0
5440323|NCT02289417|18791155|P8|Active Treatment Phase Weeks 12-52|Pregnancy|0
5440324|NCT02289417|18791156|P7|Active Treatment Phase Weeks 12-52|Pregnancy|0
5440325|NCT02289417|18791157|P6|Active Treatment Phase Weeks 12-52|Pregnancy|0
5440326|NCT02289417|18791158|P5|Active Treatment Phase Weeks 12-52|Pregnancy|0
5440327|NCT02289417|18791159|P4|Active Treatment Phase Weeks 12-52|Pregnancy|0
5440328|NCT02289417|18791160|P3|Active Treatment Phase Weeks 12-52|Pregnancy|1
5440329|NCT02289417|18791161|P2|Active Treatment Phase Weeks 12-52|Pregnancy|0
5440330|NCT02289417|18791162|P1|Active Treatment Phase Weeks 12-52|Pregnancy|0
5440331|NCT02289417|18791154|P9|Active Treatment Phase Weeks 12-52|Adverse Event|0
5440332|NCT02289417|18791155|P8|Active Treatment Phase Weeks 12-52|Adverse Event|0
5440333|NCT02289417|18791156|P7|Active Treatment Phase Weeks 12-52|Adverse Event|0
5440334|NCT02289417|18791157|P6|Active Treatment Phase Weeks 12-52|Adverse Event|1
5440335|NCT02289417|18791158|P5|Active Treatment Phase Weeks 12-52|Adverse Event|2
5440336|NCT02289417|18791159|P4|Active Treatment Phase Weeks 12-52|Adverse Event|2
5440337|NCT02289417|18791160|P3|Active Treatment Phase Weeks 12-52|Adverse Event|4
5440338|NCT02289417|18791161|P2|Active Treatment Phase Weeks 12-52|Adverse Event|1
5440339|NCT02289417|18791162|P1|Active Treatment Phase Weeks 12-52|Adverse Event|0
5440340|NCT02289417|18791154|P9|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5440341|NCT02289417|18791155|P8|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5440342|NCT02289417|18791156|P7|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5440343|NCT02289417|18791157|P6|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5440344|NCT02289417|18791158|P5|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5440345|NCT02289417|18791159|P4|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5440346|NCT02289417|18791160|P3|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5440347|NCT02289417|18791161|P2|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
5440348|NCT02289417|18791162|P1|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
5440349|NCT02289417|18791154|P9|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5440350|NCT02289417|18791155|P8|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5440351|NCT02289417|18791156|P7|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5440352|NCT02289417|18791157|P6|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5440353|NCT02289417|18791158|P5|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5440354|NCT02289417|18791159|P4|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5440355|NCT02289417|18791160|P3|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5440356|NCT02289417|18791161|P2|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
5440357|NCT02289417|18791162|P1|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
5440358|NCT02289417|18791154|P9|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5440359|NCT02289417|18791155|P8|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5440360|NCT02289417|18791156|P7|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5440361|NCT02289417|18791157|P6|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5440362|NCT02289417|18791158|P5|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5440363|NCT02289417|18791159|P4|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
5440364|NCT02289417|18791160|P3|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
5440365|NCT02289417|18791161|P2|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
5440366|NCT02289417|18791162|P1|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
5440367|NCT02289417|18791154|P9|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5440368|NCT02289417|18791155|P8|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5440369|NCT02289417|18791156|P7|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5440370|NCT02289417|18791157|P6|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5440371|NCT02289417|18791158|P5|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5440372|NCT02289417|18791159|P4|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5440373|NCT02289417|18791160|P3|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
5440374|NCT02289417|18791161|P2|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
5440375|NCT02289417|18791162|P1|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
5440376|NCT02289352|18791211|P3|Overall Study|Withdrawal by Subject|0
5440377|NCT02289352|18791212|P2|Overall Study|Withdrawal by Subject|1
5440378|NCT02289352|18791213|P1|Overall Study|Withdrawal by Subject|1
5440379|NCT02289079|18791280|P2|Overall Study|Lost to Follow-up|1
5440380|NCT02289079|18791281|P1|Overall Study|Lost to Follow-up|0
5440381|NCT02289079|18791280|P2|Overall Study|Physician Decision|0
5440382|NCT02289079|18791281|P1|Overall Study|Physician Decision|2
5440383|NCT02288559|18791310|P4|Overall Study|Reason Not Specified|0
5440384|NCT02288559|18791311|P3|Overall Study|Reason Not Specified|3
5440385|NCT02288559|18791312|P2|Overall Study|Reason Not Specified|0
5440386|NCT02288559|18791313|P1|Overall Study|Reason Not Specified|0
5440387|NCT02288559|18791310|P4|Overall Study|Withdrawal by Subject|1
5440388|NCT02288559|18791311|P3|Overall Study|Withdrawal by Subject|2
5440389|NCT02288559|18791312|P2|Overall Study|Withdrawal by Subject|0
5440390|NCT02288559|18791313|P1|Overall Study|Withdrawal by Subject|0
5440391|NCT02288559|18791310|P4|Overall Study|Lost to Follow-up|1
5440392|NCT02288559|18791311|P3|Overall Study|Lost to Follow-up|0
5440393|NCT02288559|18791312|P2|Overall Study|Lost to Follow-up|0
5440394|NCT02288559|18791313|P1|Overall Study|Lost to Follow-up|0
5440395|NCT02288559|18791310|P4|Overall Study|Death|0
5440396|NCT02288559|18791311|P3|Overall Study|Death|1
5440397|NCT02288559|18791312|P2|Overall Study|Death|0
5440398|NCT02288559|18791313|P1|Overall Study|Death|0
5440399|NCT02288559|18791310|P4|Overall Study|Adverse Event|0
5440400|NCT02288559|18791311|P3|Overall Study|Adverse Event|5
5440401|NCT02288559|18791312|P2|Overall Study|Adverse Event|1
5440402|NCT02288559|18791313|P1|Overall Study|Adverse Event|1
5440403|NCT02288325|18791364|P3|Double-blind Treatment Period|Multiple Reasons|2
5440404|NCT02288325|18791365|P2|Double-blind Treatment Period|Multiple Reasons|8
5440405|NCT02288325|18791366|P1|Double-blind Treatment Period|Multiple Reasons|0
5440406|NCT02288325|18791364|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
5440407|NCT02288325|18791365|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
5440408|NCT02288325|18791366|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
5440409|NCT02288325|18791364|P3|Double-blind Treatment Period|Protocol Violation|2
5440410|NCT02288325|18791365|P2|Double-blind Treatment Period|Protocol Violation|1
5440411|NCT02288325|18791366|P1|Double-blind Treatment Period|Protocol Violation|0
5440412|NCT02288325|18791364|P3|Double-blind Treatment Period|Lost to Follow-up|5
5440413|NCT02288325|18791365|P2|Double-blind Treatment Period|Lost to Follow-up|4
5440414|NCT02288325|18791366|P1|Double-blind Treatment Period|Lost to Follow-up|0
5440415|NCT02288325|18791364|P3|Double-blind Treatment Period|Withdrawal of Consent|8
5440416|NCT02288325|18791365|P2|Double-blind Treatment Period|Withdrawal of Consent|8
5440417|NCT02288325|18791366|P1|Double-blind Treatment Period|Withdrawal of Consent|0
5440418|NCT02288325|18791364|P3|Double-blind Treatment Period|Adverse Event|5
5440419|NCT02288325|18791365|P2|Double-blind Treatment Period|Adverse Event|2
5440420|NCT02288325|18791366|P1|Double-blind Treatment Period|Adverse Event|0
5440421|NCT02288325|18791364|P3|Stabilization Period|Reason not Specified|0
5440422|NCT02288325|18791365|P2|Stabilization Period|Reason not Specified|0
5440423|NCT02288325|18791366|P1|Stabilization Period|Reason not Specified|15
5440424|NCT02288325|18791364|P3|Stabilization Period|Non-Compliance With Study Drug|0
5440425|NCT02288325|18791365|P2|Stabilization Period|Non-Compliance With Study Drug|0
5440426|NCT02288325|18791366|P1|Stabilization Period|Non-Compliance With Study Drug|5
5440427|NCT02288325|18791364|P3|Stabilization Period|Protocol Violation|0
5440428|NCT02288325|18791365|P2|Stabilization Period|Protocol Violation|0
5440429|NCT02288325|18791366|P1|Stabilization Period|Protocol Violation|8
5440430|NCT02288325|18791364|P3|Stabilization Period|Lost to Follow-up|0
5440431|NCT02288325|18791365|P2|Stabilization Period|Lost to Follow-up|0
5440432|NCT02288325|18791366|P1|Stabilization Period|Lost to Follow-up|12
5440433|NCT02288325|18791364|P3|Stabilization Period|Withdrawal of Consent|0
5440434|NCT02288325|18791365|P2|Stabilization Period|Withdrawal of Consent|0
5440435|NCT02288325|18791366|P1|Stabilization Period|Withdrawal of Consent|23
5440436|NCT02288325|18791364|P3|Stabilization Period|Lack of Efficacy|0
5440437|NCT02288325|18791365|P2|Stabilization Period|Lack of Efficacy|0
5440438|NCT02288325|18791366|P1|Stabilization Period|Lack of Efficacy|22
5440439|NCT02288325|18791364|P3|Stabilization Period|Adverse Event|0
5440440|NCT02288325|18791365|P2|Stabilization Period|Adverse Event|0
5440441|NCT02288325|18791366|P1|Stabilization Period|Adverse Event|13
5440442|NCT02288325|18791364|P3|Run-in Period|Reason not Specified|0
5440443|NCT02288325|18791365|P2|Run-in Period|Reason not Specified|0
5440444|NCT02288325|18791366|P1|Run-in Period|Reason not Specified|8
5440445|NCT02288325|18791364|P3|Run-in Period|Non-Compliance With Study Drug|0
5440446|NCT02288325|18791365|P2|Run-in Period|Non-Compliance With Study Drug|0
5440447|NCT02288325|18791366|P1|Run-in Period|Non-Compliance With Study Drug|3
5440448|NCT02288325|18791364|P3|Run-in Period|Protocol Violation|0
5440449|NCT02288325|18791365|P2|Run-in Period|Protocol Violation|0
5440450|NCT02288325|18791366|P1|Run-in Period|Protocol Violation|17
5440451|NCT02288325|18791364|P3|Run-in Period|Lost to Follow-up|0
5440452|NCT02288325|18791365|P2|Run-in Period|Lost to Follow-up|0
5440453|NCT02288325|18791366|P1|Run-in Period|Lost to Follow-up|25
5440454|NCT02288325|18791364|P3|Run-in Period|Withdrawal of Consent|0
5440455|NCT02288325|18791365|P2|Run-in Period|Withdrawal of Consent|0
5440456|NCT02288325|18791366|P1|Run-in Period|Withdrawal of Consent|28
5440457|NCT02288325|18791364|P3|Run-in Period|Lack of Efficacy|0
5440458|NCT02288325|18791365|P2|Run-in Period|Lack of Efficacy|0
5440459|NCT02288325|18791366|P1|Run-in Period|Lack of Efficacy|16
5440460|NCT02288325|18791364|P3|Run-in Period|Adverse Event|0
5440461|NCT02288325|18791365|P2|Run-in Period|Adverse Event|0
5440462|NCT02288325|18791366|P1|Run-in Period|Adverse Event|48
5440463|NCT02288312|18791376|P3|Overall Study|Pregnancy|0
5440464|NCT02288312|18791377|P2|Overall Study|Pregnancy|0
5440465|NCT02288312|18791378|P1|Overall Study|Pregnancy|1
5440466|NCT02288182|18791418|P2|Overall Study|Lost to Follow-up|1
5440467|NCT02288182|18791419|P1|Overall Study|Lost to Follow-up|0
5440468|NCT02288182|18791418|P2|Overall Study|Adverse Event|1
5440469|NCT02288182|18791419|P1|Overall Study|Adverse Event|0
5440470|NCT02288091|18791431|P1|Overall Study|Screen fail|7
5440471|NCT02288091|18791431|P1|Overall Study|Lost to Follow-up|1
5440472|NCT02287922|18791443|P4|Overall Study|Other|0
5440473|NCT02287922|18791444|P3|Overall Study|Other|2
5440474|NCT02287922|18791445|P2|Overall Study|Other|0
5440475|NCT02287922|18791446|P1|Overall Study|Other|1
5440476|NCT02287922|18791443|P4|Overall Study|Sponsor's decision|1
5440477|NCT02287922|18791444|P3|Overall Study|Sponsor's decision|0
5440478|NCT02287922|18791445|P2|Overall Study|Sponsor's decision|0
5440479|NCT02287922|18791446|P1|Overall Study|Sponsor's decision|0
5440480|NCT02287922|18791443|P4|Overall Study|Lost to Follow-up|0
5440481|NCT02287922|18791444|P3|Overall Study|Lost to Follow-up|1
5440482|NCT02287922|18791445|P2|Overall Study|Lost to Follow-up|0
5440483|NCT02287922|18791446|P1|Overall Study|Lost to Follow-up|0
5440484|NCT02287922|18791443|P4|Overall Study|Withdrawal by Subject|2
5440485|NCT02287922|18791444|P3|Overall Study|Withdrawal by Subject|1
5440486|NCT02287922|18791445|P2|Overall Study|Withdrawal by Subject|1
5440487|NCT02287922|18791446|P1|Overall Study|Withdrawal by Subject|1
5440488|NCT02287922|18791443|P4|Overall Study|Adverse Event|4
5440489|NCT02287922|18791444|P3|Overall Study|Adverse Event|3
5440490|NCT02287922|18791445|P2|Overall Study|Adverse Event|1
5440491|NCT02287922|18791446|P1|Overall Study|Adverse Event|1
5440492|NCT02287896|18791554|P2|Second Injection Visit|Withdrawal by Subject|1
5440493|NCT02287896|18791555|P1|Second Injection Visit|Withdrawal by Subject|0
5440494|NCT02287883|18791573|P2|Overall Study|Non-response to survey|237
5440495|NCT02287883|18791574|P1|Overall Study|Non-response to survey|229
5440496|NCT02287883|18791573|P2|Overall Study|No longer eligible|182
5440497|NCT02287883|18791574|P1|Overall Study|No longer eligible|222
5440498|NCT02287883|18791573|P2|Overall Study|Death|7
5440499|NCT02287883|18791574|P1|Overall Study|Death|8
5440500|NCT02287623|18791785|P2|Overall Study|Protocol Violation|1
5440501|NCT02287623|18791786|P1|Overall Study|Protocol Violation|0
5440502|NCT02287610|18791802|P1|Overall Study|Excluded-investigator non-responsiveness|5
5440503|NCT02287610|18791802|P1|Overall Study|Withdrawal by Subject|8
5440504|NCT02287610|18791802|P1|Overall Study|Lost to Follow-up|3
5440505|NCT02287584|18791838|P6|the Open-label Phase|other reasons|6
5440506|NCT02287584|18791839|P5|the Open-label Phase|other reasons|6
5440507|NCT02287584|18791840|P4|the Open-label Phase|other reasons|3
5440508|NCT02287584|18791841|P3|the Open-label Phase|other reasons|0
5440509|NCT02287584|18791842|P2|the Open-label Phase|other reasons|0
5440510|NCT02287584|18791843|P1|the Open-label Phase|other reasons|0
5440511|NCT02287584|18791838|P6|the Open-label Phase|non-compliance|1
5440512|NCT02287584|18791839|P5|the Open-label Phase|non-compliance|5
5440513|NCT02287584|18791840|P4|the Open-label Phase|non-compliance|2
5440514|NCT02287584|18791841|P3|the Open-label Phase|non-compliance|0
5440515|NCT02287584|18791842|P2|the Open-label Phase|non-compliance|0
5440516|NCT02287584|18791843|P1|the Open-label Phase|non-compliance|0
5440517|NCT02287584|18791838|P6|the Open-label Phase|Withdrawal by Subject|21
5440518|NCT02287584|18791839|P5|the Open-label Phase|Withdrawal by Subject|29
5440519|NCT02287584|18791840|P4|the Open-label Phase|Withdrawal by Subject|18
5440520|NCT02287584|18791841|P3|the Open-label Phase|Withdrawal by Subject|0
5440521|NCT02287584|18791842|P2|the Open-label Phase|Withdrawal by Subject|0
5440522|NCT02287584|18791843|P1|the Open-label Phase|Withdrawal by Subject|0
5440523|NCT02287584|18791838|P6|the Open-label Phase|Lost to Follow-up|2
5440524|NCT02287584|18791839|P5|the Open-label Phase|Lost to Follow-up|1
5440525|NCT02287584|18791840|P4|the Open-label Phase|Lost to Follow-up|4
5440526|NCT02287584|18791841|P3|the Open-label Phase|Lost to Follow-up|0
5440527|NCT02287584|18791842|P2|the Open-label Phase|Lost to Follow-up|0
5440528|NCT02287584|18791843|P1|the Open-label Phase|Lost to Follow-up|0
5440529|NCT02287584|18791838|P6|the Open-label Phase|Lack of Efficacy|7
5440530|NCT02287584|18791839|P5|the Open-label Phase|Lack of Efficacy|3
5440531|NCT02287584|18791840|P4|the Open-label Phase|Lack of Efficacy|8
5440532|NCT02287584|18791841|P3|the Open-label Phase|Lack of Efficacy|0
5440533|NCT02287584|18791842|P2|the Open-label Phase|Lack of Efficacy|0
5440534|NCT02287584|18791843|P1|the Open-label Phase|Lack of Efficacy|0
5440535|NCT02287584|18791838|P6|the Open-label Phase|Adverse Event|16
5440536|NCT02287584|18791839|P5|the Open-label Phase|Adverse Event|12
5440537|NCT02287584|18791840|P4|the Open-label Phase|Adverse Event|15
5440538|NCT02287584|18791841|P3|the Open-label Phase|Adverse Event|0
5440539|NCT02287584|18791842|P2|the Open-label Phase|Adverse Event|0
5440540|NCT02287584|18791843|P1|the Open-label Phase|Adverse Event|0
5440541|NCT02287584|18791838|P6|the Open-label Phase|Did not receive drug|4
5440542|NCT02287584|18791839|P5|the Open-label Phase|Did not receive drug|6
5440543|NCT02287584|18791840|P4|the Open-label Phase|Did not receive drug|7
5440544|NCT02287584|18791841|P3|the Open-label Phase|Did not receive drug|0
5440545|NCT02287584|18791842|P2|the Open-label Phase|Did not receive drug|0
5440546|NCT02287584|18791843|P1|the Open-label Phase|Did not receive drug|0
5440547|NCT02287584|18791838|P6|the Double-blind Phase|other reasons|0
5440548|NCT02287584|18791839|P5|the Double-blind Phase|other reasons|0
5440549|NCT02287584|18791840|P4|the Double-blind Phase|other reasons|0
5440550|NCT02287584|18791841|P3|the Double-blind Phase|other reasons|1
5440551|NCT02287584|18791842|P2|the Double-blind Phase|other reasons|0
5440552|NCT02287584|18791843|P1|the Double-blind Phase|other reasons|0
5440553|NCT02287584|18791838|P6|the Double-blind Phase|Protocol Violation|0
5440554|NCT02287584|18791839|P5|the Double-blind Phase|Protocol Violation|0
5440555|NCT02287584|18791840|P4|the Double-blind Phase|Protocol Violation|0
5440556|NCT02287584|18791841|P3|the Double-blind Phase|Protocol Violation|0
5440557|NCT02287584|18791842|P2|the Double-blind Phase|Protocol Violation|3
5440558|NCT02287584|18791843|P1|the Double-blind Phase|Protocol Violation|0
5440559|NCT02287584|18791838|P6|the Double-blind Phase|Pregnancy|0
5440560|NCT02287584|18791839|P5|the Double-blind Phase|Pregnancy|0
5440561|NCT02287584|18791840|P4|the Double-blind Phase|Pregnancy|0
5440562|NCT02287584|18791841|P3|the Double-blind Phase|Pregnancy|0
5440563|NCT02287584|18791842|P2|the Double-blind Phase|Pregnancy|1
5440564|NCT02287584|18791843|P1|the Double-blind Phase|Pregnancy|0
5440565|NCT02287584|18791838|P6|the Double-blind Phase|Withdrawal by Subject|0
5440566|NCT02287584|18791839|P5|the Double-blind Phase|Withdrawal by Subject|0
5440567|NCT02287584|18791840|P4|the Double-blind Phase|Withdrawal by Subject|0
5440568|NCT02287584|18791841|P3|the Double-blind Phase|Withdrawal by Subject|11
5440569|NCT02287584|18791842|P2|the Double-blind Phase|Withdrawal by Subject|17
5440570|NCT02287584|18791843|P1|the Double-blind Phase|Withdrawal by Subject|17
5440571|NCT02287584|18791838|P6|the Double-blind Phase|Lost to Follow-up|0
5440572|NCT02287584|18791839|P5|the Double-blind Phase|Lost to Follow-up|0
5440573|NCT02287584|18791840|P4|the Double-blind Phase|Lost to Follow-up|0
5440574|NCT02287584|18791841|P3|the Double-blind Phase|Lost to Follow-up|1
5440575|NCT02287584|18791842|P2|the Double-blind Phase|Lost to Follow-up|1
5440576|NCT02287584|18791843|P1|the Double-blind Phase|Lost to Follow-up|0
5440577|NCT02287584|18791838|P6|the Double-blind Phase|Lack of Efficacy|0
5440578|NCT02287584|18791839|P5|the Double-blind Phase|Lack of Efficacy|0
5440579|NCT02287584|18791840|P4|the Double-blind Phase|Lack of Efficacy|0
5440580|NCT02287584|18791841|P3|the Double-blind Phase|Lack of Efficacy|8
5440581|NCT02287584|18791842|P2|the Double-blind Phase|Lack of Efficacy|8
5440582|NCT02287584|18791843|P1|the Double-blind Phase|Lack of Efficacy|18
5440583|NCT02287584|18791838|P6|the Double-blind Phase|Adverse Event|0
5440584|NCT02287584|18791839|P5|the Double-blind Phase|Adverse Event|0
5440585|NCT02287584|18791840|P4|the Double-blind Phase|Adverse Event|0
5440586|NCT02287584|18791841|P3|the Double-blind Phase|Adverse Event|12
5440587|NCT02287584|18791842|P2|the Double-blind Phase|Adverse Event|17
5440588|NCT02287584|18791843|P1|the Double-blind Phase|Adverse Event|17
5440589|NCT02287467|18791862|P2|Overall Study|Protocol Violation|9
5440590|NCT02287467|18791863|P1|Overall Study|Protocol Violation|12
5440591|NCT02287402|18791911|P1|Follow-up|Voluntary Withdrawal|2
5440592|NCT02287402|18791911|P1|Follow-up|Lost to Follow-up|1
5440593|NCT02287402|18791911|P1|Treatment Period|Voluntary Withdrawal|10
5440594|NCT02287402|18791911|P1|Treatment Period|Adverse Event|17
5440595|NCT02287038|18792016|P2|Overall Study|Abnormal ECG after starting medication|0
5440596|NCT02287038|18792017|P1|Overall Study|Abnormal ECG after starting medication|1
5440597|NCT02287038|18792016|P2|Overall Study|Nausea after starting medication|0
5440598|NCT02287038|18792017|P1|Overall Study|Nausea after starting medication|1
5440599|NCT02287038|18792016|P2|Overall Study|Anxiety after starting medication|1
5440600|NCT02287038|18792017|P1|Overall Study|Anxiety after starting medication|0
5440601|NCT02287038|18792016|P2|Overall Study|Stopped attending appointments|2
5440602|NCT02287038|18792017|P1|Overall Study|Stopped attending appointments|3
5440603|NCT02287025|18792027|P2|Overall Study|Screening failed|1
5440604|NCT02287025|18792028|P1|Overall Study|Screening failed|1
5440605|NCT02287025|18792027|P2|Overall Study|Withdrawal by Subject|2
5440606|NCT02287025|18792028|P1|Overall Study|Withdrawal by Subject|2
5440607|NCT02287025|18792027|P2|Overall Study|Adverse Event|4
5440608|NCT02287025|18792028|P1|Overall Study|Adverse Event|2
5440609|NCT02287025|18792027|P2|Overall Study|Progression of disease|2
5440610|NCT02287025|18792028|P1|Overall Study|Progression of disease|3
5440611|NCT02287025|18792027|P2|Overall Study|Not treated|0
5440612|NCT02287025|18792028|P1|Overall Study|Not treated|2
5440613|NCT02286960|18792039|P2|Overall Study|Lost to Follow-up|3
5440614|NCT02286960|18792040|P1|Overall Study|Lost to Follow-up|3
5440615|NCT02286947|18792052|P1|Overall Study|Withdrawal by Subject|2
5440616|NCT02286895|18792098|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
5440617|NCT02286895|18792099|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
5440618|NCT02286895|18792098|P2|Assessed for Measles Seroconversion|Missing measurement|3
5440619|NCT02286895|18792099|P1|Assessed for Measles Seroconversion|Missing measurement|6
5440620|NCT02286895|18792098|P2|Assessed for Measles Seroconversion|Protocol Violation|4
5440621|NCT02286895|18792099|P1|Assessed for Measles Seroconversion|Protocol Violation|1
5440622|NCT02286713|18792143|P2|Six Month Follow-Up|Lost to Follow-up|27
5440623|NCT02286713|18792144|P1|Six Month Follow-Up|Lost to Follow-up|30
5440624|NCT02286713|18792143|P2|Six Month Follow-Up|Death|0
5440625|NCT02286713|18792144|P1|Six Month Follow-Up|Death|2
5440626|NCT02286713|18792143|P2|Three Month Follow-Up|Withdrawal by Subject|1
5440627|NCT02286713|18792144|P1|Three Month Follow-Up|Withdrawal by Subject|1
5440628|NCT02286713|18792143|P2|Three Month Follow-Up|Lost to Follow-up|24
5440629|NCT02286713|18792144|P1|Three Month Follow-Up|Lost to Follow-up|26
5440630|NCT02286713|18792143|P2|Three Month Follow-Up|Death|1
5440631|NCT02286713|18792144|P1|Three Month Follow-Up|Death|1
5440632|NCT02286713|18792143|P2|One Week Follow-Up|Withdrawal by Subject|3
5440633|NCT02286713|18792144|P1|One Week Follow-Up|Withdrawal by Subject|6
5440634|NCT02286713|18792143|P2|One Week Follow-Up|Lost to Follow-up|21
5440635|NCT02286713|18792144|P1|One Week Follow-Up|Lost to Follow-up|17
5440636|NCT02286713|18792143|P2|One Week Follow-Up|Death|0
5440637|NCT02286713|18792144|P1|One Week Follow-Up|Death|1
5440638|NCT02286466|18792325|P2|Overall Study|Declined Clinician Assessment|1
5440639|NCT02286466|18792326|P1|Overall Study|Declined Clinician Assessment|0
5440640|NCT02286466|18792325|P2|Overall Study|Lost to Follow-up|4
5440641|NCT02286466|18792326|P1|Overall Study|Lost to Follow-up|1
5440642|NCT02286466|18792325|P2|Overall Study|Withdrawal by Subject|2
5440643|NCT02286466|18792326|P1|Overall Study|Withdrawal by Subject|5
5440644|NCT02286466|18792325|P2|Overall Study|Death|3
5440645|NCT02286466|18792326|P1|Overall Study|Death|1
5440646|NCT02286193|18792338|P1|Overall Study|Referred: Declined service|38
5440647|NCT02286193|18792338|P1|Overall Study|Referred: unable to reach/resource sent|104
5440648|NCT02286193|18792338|P1|Overall Study|Referred: CRS unable to make contact|62
5440649|NCT02286102|18792345|P2|Overall Study|Screen Failure|1
5440650|NCT02286102|18792346|P1|Overall Study|Screen Failure|1
5440651|NCT02285998|18792358|P2|Overall Study|Other Reasons|10
5440652|NCT02285998|18792359|P1|Overall Study|Other Reasons|7
5440653|NCT02285998|18792358|P2|Overall Study|Withdrawal by Subject|61
5440654|NCT02285998|18792359|P1|Overall Study|Withdrawal by Subject|53
5440655|NCT02285998|18792358|P2|Overall Study|Lost to Follow-up|172
5440656|NCT02285998|18792359|P1|Overall Study|Lost to Follow-up|176
5440657|NCT02285998|18792358|P2|Overall Study|Physician Decision|2
5440658|NCT02285998|18792359|P1|Overall Study|Physician Decision|1
5440659|NCT02285998|18792358|P2|Overall Study|Adverse Event|8
5440660|NCT02285998|18792359|P1|Overall Study|Adverse Event|9
5440661|NCT02285920|18792387|P4|Overall Study|Death|1
5440662|NCT02285920|18792388|P3|Overall Study|Death|2
5440663|NCT02285920|18792389|P2|Overall Study|Death|0
5440664|NCT02285920|18792390|P1|Overall Study|Death|2
5440665|NCT02285920|18792387|P4|Overall Study|Dialysis discontinuation|0
5440666|NCT02285920|18792388|P3|Overall Study|Dialysis discontinuation|0
5440667|NCT02285920|18792389|P2|Overall Study|Dialysis discontinuation|1
5440668|NCT02285920|18792390|P1|Overall Study|Dialysis discontinuation|0
5440669|NCT02285920|18792387|P4|Overall Study|Transfer to non-participating unit|0
5440670|NCT02285920|18792388|P3|Overall Study|Transfer to non-participating unit|0
5440671|NCT02285920|18792389|P2|Overall Study|Transfer to non-participating unit|1
5440672|NCT02285920|18792390|P1|Overall Study|Transfer to non-participating unit|0
5440673|NCT02285920|18792387|P4|Overall Study|Change to peritoneal dialysis|0
5440674|NCT02285920|18792388|P3|Overall Study|Change to peritoneal dialysis|1
5440675|NCT02285920|18792389|P2|Overall Study|Change to peritoneal dialysis|0
5440676|NCT02285920|18792390|P1|Overall Study|Change to peritoneal dialysis|0
5440677|NCT02285920|18792387|P4|Overall Study|Kidney transplantation|0
5440678|NCT02285920|18792388|P3|Overall Study|Kidney transplantation|2
5440679|NCT02285920|18792389|P2|Overall Study|Kidney transplantation|2
5440680|NCT02285920|18792390|P1|Overall Study|Kidney transplantation|2
5440681|NCT02285855|18792480|P2|Overall Study|Withdrawal by Subject|1
5440682|NCT02285855|18792481|P1|Overall Study|Withdrawal by Subject|2
5440683|NCT02285777|18792489|P2|Overall Study|Lost to Follow-up|2
5440684|NCT02285777|18792490|P1|Overall Study|Lost to Follow-up|4
5440685|NCT02285777|18792489|P2|Overall Study|Withdrawal by Subject|1
5440686|NCT02285777|18792490|P1|Overall Study|Withdrawal by Subject|1
5440687|NCT02285270|18792582|P1|Overall Study|Determined to be ineligible|1
5440688|NCT02285270|18792582|P1|Overall Study|Physician Decision|3
5440689|NCT02285270|18792582|P1|Overall Study|Lost to Follow-up|1
5440690|NCT02285153|18792590|P2|Overall Study|Adverse Event|0
5440691|NCT02285153|18792591|P1|Overall Study|Adverse Event|1
5440692|NCT02285062|18792605|P2|Overall Study|Lost to Follow-up|5
5440693|NCT02285062|18792606|P1|Overall Study|Lost to Follow-up|8
5440694|NCT02285062|18792605|P2|Overall Study|Death|62
5440695|NCT02285062|18792606|P1|Overall Study|Death|58
5440696|NCT02285062|18792605|P2|Overall Study|Withdrawal by Subject|17
5440697|NCT02285062|18792606|P1|Overall Study|Withdrawal by Subject|12
5440698|NCT02285010|18792654|P2|Overall Study|Not spinal anesthesia|1
5440699|NCT02285010|18792655|P1|Overall Study|Not spinal anesthesia|3
5440700|NCT02285010|18792654|P2|Overall Study|not abdominal hysterectomy|0
5440701|NCT02285010|18792655|P1|Overall Study|not abdominal hysterectomy|2
5440702|NCT02284906|18792672|P3|Overall Study|Reason not Specified|0
5440703|NCT02284906|18792673|P2|Overall Study|Reason not Specified|1
5440704|NCT02284906|18792674|P1|Overall Study|Reason not Specified|1
5440705|NCT02284906|18792672|P3|Overall Study|Study Termination|14
5440706|NCT02284906|18792673|P2|Overall Study|Study Termination|11
5440707|NCT02284906|18792674|P1|Overall Study|Study Termination|0
5440708|NCT02284906|18792672|P3|Overall Study|Voluntary Withdrawal|5
5440709|NCT02284906|18792673|P2|Overall Study|Voluntary Withdrawal|4
5440710|NCT02284906|18792674|P1|Overall Study|Voluntary Withdrawal|2
5440711|NCT02284906|18792672|P3|Overall Study|Major Protocol Deviation|0
5440712|NCT02284906|18792673|P2|Overall Study|Major Protocol Deviation|1
5440713|NCT02284906|18792674|P1|Overall Study|Major Protocol Deviation|0
5440714|NCT02284906|18792672|P3|Overall Study|Pretreatment Event/Adverse Event|0
5440715|NCT02284906|18792673|P2|Overall Study|Pretreatment Event/Adverse Event|1
5440716|NCT02284906|18792674|P1|Overall Study|Pretreatment Event/Adverse Event|0
5440717|NCT02284893|18792687|P2|52 Week (Long Term)|Non-Compliance|3
5440718|NCT02284893|18792688|P1|52 Week (Long Term)|Non-Compliance|2
5440719|NCT02284893|18792687|P2|52 Week (Long Term)|Lost to Follow-up|2
5440720|NCT02284893|18792688|P1|52 Week (Long Term)|Lost to Follow-up|2
5440721|NCT02284893|18792687|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
5440722|NCT02284893|18792688|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
5440723|NCT02284893|18792687|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
5440724|NCT02284893|18792688|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
5440725|NCT02284893|18792687|P2|52 Week (Long Term)|Adverse Event|1
5440726|NCT02284893|18792688|P1|52 Week (Long Term)|Adverse Event|3
5440727|NCT02284893|18792687|P2|26 Week (Short Term)|Other|1
5440728|NCT02284893|18792688|P1|26 Week (Short Term)|Other|1
5440729|NCT02284893|18792687|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
5440730|NCT02284893|18792688|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
5440731|NCT02284893|18792687|P2|26 Week (Short Term)|Lost to Follow-up|1
5440732|NCT02284893|18792688|P1|26 Week (Short Term)|Lost to Follow-up|3
5440733|NCT02284893|18792687|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
5440734|NCT02284893|18792688|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
5440735|NCT02284893|18792687|P2|26 Week (Short Term)|Discontinuation by the subject|2
5440736|NCT02284893|18792688|P1|26 Week (Short Term)|Discontinuation by the subject|2
5440737|NCT02284893|18792687|P2|26 Week (Short Term)|Adverse Event|9
5440738|NCT02284893|18792688|P1|26 Week (Short Term)|Adverse Event|1
5440739|NCT02284568|18792765|P3|Overall Study|Withdrew before taking study drug|0
5440740|NCT02284568|18792766|P2|Overall Study|Withdrew before taking study drug|1
5440741|NCT02284568|18792767|P1|Overall Study|Withdrew before taking study drug|0
5440742|NCT02284568|18792765|P3|Overall Study|Other|0
5440743|NCT02284568|18792766|P2|Overall Study|Other|2
5440744|NCT02284568|18792767|P1|Overall Study|Other|1
5440745|NCT02284568|18792765|P3|Overall Study|Lack of Efficacy|0
5440746|NCT02284568|18792766|P2|Overall Study|Lack of Efficacy|7
5440747|NCT02284568|18792767|P1|Overall Study|Lack of Efficacy|4
5440748|NCT02284568|18792765|P3|Overall Study|Lost to Follow-up|0
5440749|NCT02284568|18792766|P2|Overall Study|Lost to Follow-up|3
5440750|NCT02284568|18792767|P1|Overall Study|Lost to Follow-up|0
5440751|NCT02284568|18792765|P3|Overall Study|Sponsor requested patient stop treatment|90
5440752|NCT02284568|18792766|P2|Overall Study|Sponsor requested patient stop treatment|0
5440753|NCT02284568|18792767|P1|Overall Study|Sponsor requested patient stop treatment|0
5440754|NCT02284568|18792765|P3|Overall Study|Protocol Violation|0
5440755|NCT02284568|18792766|P2|Overall Study|Protocol Violation|1
5440756|NCT02284568|18792767|P1|Overall Study|Protocol Violation|0
5440757|NCT02284568|18792765|P3|Overall Study|Noncompliance|0
5440758|NCT02284568|18792766|P2|Overall Study|Noncompliance|0
5440759|NCT02284568|18792767|P1|Overall Study|Noncompliance|1
5440760|NCT02284568|18792765|P3|Overall Study|Noncompliance with study drug admin|0
5440761|NCT02284568|18792766|P2|Overall Study|Noncompliance with study drug admin|2
5440762|NCT02284568|18792767|P1|Overall Study|Noncompliance with study drug admin|1
5440763|NCT02284568|18792765|P3|Overall Study|Withdrawal by Subject|1
5440764|NCT02284568|18792766|P2|Overall Study|Withdrawal by Subject|21
5440765|NCT02284568|18792767|P1|Overall Study|Withdrawal by Subject|22
5440766|NCT02284568|18792765|P3|Overall Study|Adverse Event|4
5440767|NCT02284568|18792766|P2|Overall Study|Adverse Event|9
5440768|NCT02284568|18792767|P1|Overall Study|Adverse Event|2
5440769|NCT02284373|18792861|P3|Overall Study|Lost to Follow-up|0
5440770|NCT02284373|18792862|P2|Overall Study|Lost to Follow-up|1
5440771|NCT02284373|18792863|P1|Overall Study|Lost to Follow-up|0
5440772|NCT02284373|18792861|P3|Overall Study|Other|0
5440773|NCT02284373|18792862|P2|Overall Study|Other|1
5440774|NCT02284373|18792863|P1|Overall Study|Other|0
5440775|NCT02284373|18792861|P3|Overall Study|Withdrawal by Subject|0
5440776|NCT02284373|18792862|P2|Overall Study|Withdrawal by Subject|1
5440777|NCT02284373|18792863|P1|Overall Study|Withdrawal by Subject|0
5440778|NCT02284347|18792871|P1|Overall Study|Withdrawn prior to treatment|1
5440779|NCT02284347|18792871|P1|Overall Study|Lost to Follow-up|2
5440780|NCT02284243|18792879|P2|Overall Study|Adverse Event|0
5440781|NCT02284243|18792880|P1|Overall Study|Adverse Event|1
5440782|NCT02284243|18792879|P2|Overall Study|Lack of Efficacy|3
5440783|NCT02284243|18792880|P1|Overall Study|Lack of Efficacy|3
5440784|NCT02284178|18792900|P2|Overall Study|Met exclusion criteria|54
5440785|NCT02284178|18792901|P1|Overall Study|Met exclusion criteria|49
5440786|NCT02284009|18792944|P2|Overall Study|Withdrawal by Subject|5
5440787|NCT02284009|18792945|P1|Overall Study|Withdrawal by Subject|2
5440788|NCT02284009|18792944|P2|Overall Study|Physician Decision|2
5440789|NCT02284009|18792945|P1|Overall Study|Physician Decision|0
5440790|NCT02284009|18792944|P2|Overall Study|Lost to Follow-up|3
5440791|NCT02284009|18792945|P1|Overall Study|Lost to Follow-up|1
5440792|NCT02284009|18792944|P2|Overall Study|Adverse Event|0
5440793|NCT02284009|18792945|P1|Overall Study|Adverse Event|3
5440794|NCT02283788|18793044|P4|Overall Study|Withdrawal by Subject|1
5440795|NCT02283788|18793045|P3|Overall Study|Withdrawal by Subject|0
5440796|NCT02283788|18793046|P2|Overall Study|Withdrawal by Subject|1
5440797|NCT02283788|18793047|P1|Overall Study|Withdrawal by Subject|0
5440798|NCT02283788|18793044|P4|Overall Study|Adverse Event|1
5440799|NCT02283788|18793045|P3|Overall Study|Adverse Event|5
5440800|NCT02283788|18793046|P2|Overall Study|Adverse Event|3
5440801|NCT02283788|18793047|P1|Overall Study|Adverse Event|1
5440802|NCT02283762|18793059|P2|Long-term Extension Phase (LTE)|Physician Decision|2
5440803|NCT02283762|18793060|P1|Long-term Extension Phase (LTE)|Physician Decision|1
5440804|NCT02283762|18793059|P2|Long-term Extension Phase (LTE)|Lost to Follow-up|1
5440805|NCT02283762|18793060|P1|Long-term Extension Phase (LTE)|Lost to Follow-up|0
5440806|NCT02283762|18793059|P2|Long-term Extension Phase (LTE)|Protocol Violation|1
5440807|NCT02283762|18793060|P1|Long-term Extension Phase (LTE)|Protocol Violation|1
5440808|NCT02283762|18793059|P2|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
5440809|NCT02283762|18793060|P1|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
5440896|NCT02281773|18793450|P5|Overall Study|Withdrawal by Subject|8
5440810|NCT02283762|18793059|P2|Long-term Extension Phase (LTE)|Study terminated at site|0
5440811|NCT02283762|18793060|P1|Long-term Extension Phase (LTE)|Study terminated at site|1
5440812|NCT02283762|18793059|P2|Long-term Extension Phase (LTE)|Lack of Efficacy|1
5440813|NCT02283762|18793060|P1|Long-term Extension Phase (LTE)|Lack of Efficacy|1
5440814|NCT02283762|18793059|P2|Long-term Extension Phase (LTE)|Adverse Event|6
5440815|NCT02283762|18793060|P1|Long-term Extension Phase (LTE)|Adverse Event|2
5440816|NCT02283762|18793059|P2|Main Treatment Phase (MT)|Withdrawal by Subject|4
5440817|NCT02283762|18793060|P1|Main Treatment Phase (MT)|Withdrawal by Subject|7
5440818|NCT02283762|18793059|P2|Main Treatment Phase (MT)|Pregnancy|1
5440819|NCT02283762|18793060|P1|Main Treatment Phase (MT)|Pregnancy|0
5440820|NCT02283762|18793059|P2|Main Treatment Phase (MT)|Physician Decision|1
5440821|NCT02283762|18793060|P1|Main Treatment Phase (MT)|Physician Decision|1
5440822|NCT02283762|18793059|P2|Main Treatment Phase (MT)|Lack of Efficacy|0
5440823|NCT02283762|18793060|P1|Main Treatment Phase (MT)|Lack of Efficacy|1
5440824|NCT02283762|18793059|P2|Main Treatment Phase (MT)|Adverse Event|9
5440825|NCT02283762|18793060|P1|Main Treatment Phase (MT)|Adverse Event|9
5440826|NCT02283658|18793084|P1|Overall Study|Withdrawal by Subject|1
5440827|NCT02283411|18793106|P1|Overall Study|Screen Failed|28
5440828|NCT02283411|18793106|P1|Overall Study|Withdrawal by Subject|3
5440829|NCT02283268|18793114|P1|Overall Study|Withdrawal by Subject|1
5440830|NCT02282982|18793175|P1|Overall Study|Other, not specified|18
5440831|NCT02282982|18793175|P1|Overall Study|Palivizumab is ended|11
5440832|NCT02282982|18793175|P1|Overall Study|Lack of product|156
5440833|NCT02282982|18793175|P1|Overall Study|Death|4
5440834|NCT02282982|18793175|P1|Overall Study|Withdrew consent|2
5440835|NCT02282982|18793175|P1|Overall Study|Lost to Follow-up|15
5440836|NCT02282813|18793203|P3|Overall Study|Administrative reasons|0
5440837|NCT02282813|18793204|P2|Overall Study|Administrative reasons|1
5440838|NCT02282813|18793205|P1|Overall Study|Administrative reasons|0
5440839|NCT02282813|18793203|P3|Overall Study|Lack of Efficacy|0
5440840|NCT02282813|18793204|P2|Overall Study|Lack of Efficacy|0
5440841|NCT02282813|18793205|P1|Overall Study|Lack of Efficacy|1
5440842|NCT02282813|18793203|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
5440843|NCT02282813|18793204|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
5440844|NCT02282813|18793205|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
5440845|NCT02282813|18793203|P3|Overall Study|Lost to Follow-up|1
5440846|NCT02282813|18793204|P2|Overall Study|Lost to Follow-up|0
5440847|NCT02282813|18793205|P1|Overall Study|Lost to Follow-up|2
5440848|NCT02282813|18793203|P3|Overall Study|Physician Decision|1
5440849|NCT02282813|18793204|P2|Overall Study|Physician Decision|3
5440850|NCT02282813|18793205|P1|Overall Study|Physician Decision|0
5440851|NCT02282813|18793203|P3|Overall Study|Subject non-compliance|0
5440852|NCT02282813|18793204|P2|Overall Study|Subject non-compliance|4
5440853|NCT02282813|18793205|P1|Overall Study|Subject non-compliance|1
5440854|NCT02282813|18793203|P3|Overall Study|Adverse Event|1
5440855|NCT02282813|18793204|P2|Overall Study|Adverse Event|10
5440856|NCT02282813|18793205|P1|Overall Study|Adverse Event|3
5440857|NCT02282813|18793203|P3|Overall Study|Withdrawal by Subject|0
5440858|NCT02282813|18793204|P2|Overall Study|Withdrawal by Subject|5
5440859|NCT02282813|18793205|P1|Overall Study|Withdrawal by Subject|4
5440860|NCT02282631|18793251|P2|Overall Study|Lost to Follow-up|0
5440861|NCT02282631|18793252|P1|Overall Study|Lost to Follow-up|2
5440862|NCT02282605|18793293|P3|Overall Study|negative SA result on Day -1|0
5440863|NCT02282605|18793294|P2|Overall Study|negative SA result on Day -1|0
5440864|NCT02282605|18793295|P1|Overall Study|negative SA result on Day -1|3
5440865|NCT02282527|18793317|P2|Overall Study|Lack of home health aid|0
5440866|NCT02282527|18793318|P1|Overall Study|Lack of home health aid|1
5440867|NCT02282527|18793317|P2|Overall Study|Lost to Follow-up|1
5440868|NCT02282527|18793318|P1|Overall Study|Lost to Follow-up|0
5440869|NCT02282293|18793330|P2|Overall Study|Moved out of study area|1
5440870|NCT02282293|18793331|P1|Overall Study|Moved out of study area|0
5440871|NCT02282293|18793330|P2|Overall Study|Unable to comply with study procedures|0
5440872|NCT02282293|18793331|P1|Overall Study|Unable to comply with study procedures|1
5440873|NCT02282293|18793330|P2|Overall Study|Lost to Follow-up|2
5440874|NCT02282293|18793331|P1|Overall Study|Lost to Follow-up|2
5440875|NCT02282163|18793349|P1|Overall Study|Protocol Violation|1
5440876|NCT02282020|18793381|P2|Overall Study|Withdrew Consent Prior to Dosing|12
5440877|NCT02282020|18793382|P1|Overall Study|Withdrew Consent Prior to Dosing|0
5440878|NCT02282020|18793381|P2|Overall Study|Developed Discontinuation Criteria|3
5440879|NCT02282020|18793382|P1|Overall Study|Developed Discontinuation Criteria|1
5440880|NCT02282020|18793381|P2|Overall Study|Severe Non-compliance to Protocol|0
5440881|NCT02282020|18793382|P1|Overall Study|Severe Non-compliance to Protocol|1
5440882|NCT02282020|18793381|P2|Overall Study|Miscellaneous|17
5440883|NCT02282020|18793382|P1|Overall Study|Miscellaneous|4
5440884|NCT02282020|18793381|P2|Overall Study|Withdrawal by Subject|10
5440885|NCT02282020|18793382|P1|Overall Study|Withdrawal by Subject|5
5440886|NCT02282020|18793381|P2|Overall Study|Adverse Event|15
5440887|NCT02282020|18793382|P1|Overall Study|Adverse Event|13
5440888|NCT02282020|18793381|P2|Overall Study|Objective Disease Progression|30
5440889|NCT02282020|18793382|P1|Overall Study|Objective Disease Progression|111
5440890|NCT02281955|18793427|P1|Overall Study|Death|1
5440891|NCT02281773|18793450|P5|Overall Study|Other Reason|1
5440892|NCT02281773|18793451|P4|Overall Study|Other Reason|3
5440893|NCT02281773|18793452|P3|Overall Study|Other Reason|2
5440894|NCT02281773|18793453|P2|Overall Study|Other Reason|4
5440895|NCT02281773|18793454|P1|Overall Study|Other Reason|0
5440897|NCT02281773|18793451|P4|Overall Study|Withdrawal by Subject|6
5440898|NCT02281773|18793452|P3|Overall Study|Withdrawal by Subject|6
5440899|NCT02281773|18793453|P2|Overall Study|Withdrawal by Subject|8
5440900|NCT02281773|18793454|P1|Overall Study|Withdrawal by Subject|2
5440901|NCT02281773|18793450|P5|Overall Study|Lost to Follow-up|10
5440902|NCT02281773|18793451|P4|Overall Study|Lost to Follow-up|2
5440903|NCT02281773|18793452|P3|Overall Study|Lost to Follow-up|6
5440904|NCT02281773|18793453|P2|Overall Study|Lost to Follow-up|2
5440905|NCT02281773|18793454|P1|Overall Study|Lost to Follow-up|2
5440906|NCT02281773|18793450|P5|Overall Study|Protocol Violation|2
5440907|NCT02281773|18793451|P4|Overall Study|Protocol Violation|2
5440908|NCT02281773|18793452|P3|Overall Study|Protocol Violation|0
5440909|NCT02281773|18793453|P2|Overall Study|Protocol Violation|0
5440910|NCT02281773|18793454|P1|Overall Study|Protocol Violation|1
5440911|NCT02281773|18793450|P5|Overall Study|Adverse Event|9
5440912|NCT02281773|18793451|P4|Overall Study|Adverse Event|8
5440913|NCT02281773|18793452|P3|Overall Study|Adverse Event|4
5440914|NCT02281773|18793453|P2|Overall Study|Adverse Event|1
5440915|NCT02281773|18793454|P1|Overall Study|Adverse Event|6
5440916|NCT02281552|18793542|P2|Overall Study|Adverse Event|9
5440917|NCT02281552|18793543|P1|Overall Study|Adverse Event|3
5440918|NCT02281552|18793542|P2|Overall Study|Insufficient clinical response|1
5440919|NCT02281552|18793543|P1|Overall Study|Insufficient clinical response|0
5440920|NCT02281552|18793542|P2|Overall Study|Medication error|0
5440921|NCT02281552|18793543|P1|Overall Study|Medication error|1
5440922|NCT02281357|18793665|P2|Overall Study|Withdrawal by Subject|3
5440923|NCT02281357|18793666|P1|Overall Study|Withdrawal by Subject|4
5440924|NCT02281357|18793665|P2|Overall Study|Lost to Follow-up|0
5440925|NCT02281357|18793666|P1|Overall Study|Lost to Follow-up|1
5440926|NCT02281357|18793665|P2|Overall Study|Adverse Event|1
5440927|NCT02281357|18793666|P1|Overall Study|Adverse Event|2
5440928|NCT02281318|18793685|P2|Overall Study|Withdrawal by Subject|2
5440929|NCT02281318|18793686|P1|Overall Study|Withdrawal by Subject|6
5440930|NCT02281318|18793685|P2|Overall Study|Physician Decision|0
5440931|NCT02281318|18793686|P1|Overall Study|Physician Decision|2
5440932|NCT02281318|18793685|P2|Overall Study|Lost to Follow-up|1
5440933|NCT02281318|18793686|P1|Overall Study|Lost to Follow-up|2
5440934|NCT02281318|18793685|P2|Overall Study|Lack of Efficacy|0
5440935|NCT02281318|18793686|P1|Overall Study|Lack of Efficacy|2
5440936|NCT02281318|18793685|P2|Overall Study|Adverse Event|2
5440937|NCT02281318|18793686|P1|Overall Study|Adverse Event|2
5440938|NCT02281084|18793734|P4|Overall Study|Physician Decision|0
5440939|NCT02281084|18793735|P3|Overall Study|Physician Decision|1
5440940|NCT02281084|18793736|P2|Overall Study|Physician Decision|0
5440941|NCT02281084|18793737|P1|Overall Study|Physician Decision|0
5440942|NCT02281084|18793734|P4|Overall Study|Death|5
5440943|NCT02281084|18793735|P3|Overall Study|Death|3
5440944|NCT02281084|18793736|P2|Overall Study|Death|16
5440945|NCT02281084|18793737|P1|Overall Study|Death|20
5440946|NCT02281084|18793734|P4|Overall Study|Withdrawal by Subject|0
5440947|NCT02281084|18793735|P3|Overall Study|Withdrawal by Subject|0
5440948|NCT02281084|18793736|P2|Overall Study|Withdrawal by Subject|2
5440949|NCT02281084|18793737|P1|Overall Study|Withdrawal by Subject|1
5440950|NCT02281084|18793734|P4|Overall Study|Adverse Event|0
5440951|NCT02281084|18793735|P3|Overall Study|Adverse Event|0
5440952|NCT02281084|18793736|P2|Overall Study|Adverse Event|0
5440953|NCT02281084|18793737|P1|Overall Study|Adverse Event|1
5440954|NCT02280863|18793793|P2|Integrated Platform|Met stopping criteria|1
5440955|NCT02280863|18793794|P1|Integrated Platform|Met stopping criteria|0
5440956|NCT02280499|18793878|P1|Overall Study|Adverse Event|5
5440957|NCT02280499|18793878|P1|Overall Study|Lost to Follow-up|42
5440958|NCT02280499|18793878|P1|Overall Study|Death|14
5440959|NCT02280473|18793886|P2|Overall Study|Lost to Follow-up|1
5440960|NCT02280473|18793887|P1|Overall Study|Lost to Follow-up|0
5440961|NCT02280473|18793886|P2|Overall Study|Lack of Efficacy|1
5440962|NCT02280473|18793887|P1|Overall Study|Lack of Efficacy|0
5440963|NCT02280473|18793886|P2|Overall Study|Adverse Event|1
5440964|NCT02280473|18793887|P1|Overall Study|Adverse Event|1
5440965|NCT02280421|18793903|P2|Washout (2 Weeks)|Withdrawal by Subject|0
5440966|NCT02280421|18793904|P1|Washout (2 Weeks)|Withdrawal by Subject|1
5440967|NCT02280421|18793903|P2|Washout (2 Weeks)|Adverse Event|1
5440968|NCT02280421|18793904|P1|Washout (2 Weeks)|Adverse Event|0
5440969|NCT02280408|18793970|P4|Overall Study|Lost to Follow-up|0
5440970|NCT02280408|18793971|P3|Overall Study|Lost to Follow-up|0
5440971|NCT02280408|18793972|P2|Overall Study|Lost to Follow-up|2
5440972|NCT02280408|18793973|P1|Overall Study|Lost to Follow-up|0
5440973|NCT02280304|18794045|P2|Overall Study|Lost to Follow-up|8
5440974|NCT02280304|18794046|P1|Overall Study|Lost to Follow-up|7
5440975|NCT02280291|18794067|P4|Overall Study|Other|0
5440976|NCT02280291|18794068|P3|Overall Study|Other|0
5440977|NCT02280291|18794069|P2|Overall Study|Other|1
5440978|NCT02280291|18794070|P1|Overall Study|Other|1
5440979|NCT02280291|18794067|P4|Overall Study|Protocol Violation|0
5440980|NCT02280291|18794068|P3|Overall Study|Protocol Violation|0
5440981|NCT02280291|18794069|P2|Overall Study|Protocol Violation|0
5440982|NCT02280291|18794070|P1|Overall Study|Protocol Violation|1
5440983|NCT02280291|18794067|P4|Overall Study|Lost to Follow-up|8
5440984|NCT02280291|18794068|P3|Overall Study|Lost to Follow-up|3
5440985|NCT02280291|18794069|P2|Overall Study|Lost to Follow-up|1
5440986|NCT02280291|18794070|P1|Overall Study|Lost to Follow-up|2
5440987|NCT02280187|18794111|P1|Overall Study|Lost to Follow-up|218
5440988|NCT02280096|18794139|P2|Overall Study|Lack of attachment|1
5440989|NCT02280096|18794140|P1|Overall Study|Lack of attachment|0
5440990|NCT02280096|18794139|P2|Overall Study|Functional neurological disorder|0
5440991|NCT02280096|18794140|P1|Overall Study|Functional neurological disorder|1
5440992|NCT02280096|18794139|P2|Overall Study|Pregnancy|0
5440993|NCT02280096|18794140|P1|Overall Study|Pregnancy|1
5440994|NCT02280044|18794170|P2|Overall Study|Planned alternate|2
5440995|NCT02280044|18794171|P1|Overall Study|Planned alternate|0
5440996|NCT02279862|18794181|P2|Overall Study|Withdrawal by Subject|0
5440997|NCT02279862|18794182|P1|Overall Study|Withdrawal by Subject|1
5440998|NCT02279862|18794181|P2|Overall Study|Other|2
5440999|NCT02279862|18794182|P1|Overall Study|Other|1
5441000|NCT02279862|18794181|P2|Overall Study|Study closed by sponsor|13
5441001|NCT02279862|18794182|P1|Overall Study|Study closed by sponsor|16
5441002|NCT02279862|18794181|P2|Overall Study|Disease progression|2
5441003|NCT02279862|18794182|P1|Overall Study|Disease progression|5
5441004|NCT02279862|18794181|P2|Overall Study|Administrative reason by sponsor|1
5441005|NCT02279862|18794182|P1|Overall Study|Administrative reason by sponsor|0
5441006|NCT02279862|18794181|P2|Overall Study|No longer meets criteria|1
5441007|NCT02279862|18794182|P1|Overall Study|No longer meets criteria|0
5441008|NCT02279862|18794181|P2|Overall Study|Study drug toxicity|6
5441009|NCT02279862|18794182|P1|Overall Study|Study drug toxicity|3
5441010|NCT02279732|18794200|P2|Overall Study|Other|3
5441011|NCT02279732|18794201|P1|Overall Study|Other|3
5441012|NCT02279732|18794200|P2|Overall Study|Other|67
5441013|NCT02279732|18794201|P1|Overall Study|Other|53
5441014|NCT02279732|18794200|P2|Overall Study|Subject Requested to Discontinue|1
5441015|NCT02279732|18794201|P1|Overall Study|Subject Requested to Discontinue|0
5441016|NCT02279732|18794200|P2|Overall Study|Maximum Clinical Benefit|0
5441017|NCT02279732|18794201|P1|Overall Study|Maximum Clinical Benefit|1
5441018|NCT02279732|18794200|P2|Overall Study|Lost to Follow-up|1
5441019|NCT02279732|18794201|P1|Overall Study|Lost to Follow-up|0
5441020|NCT02279732|18794200|P2|Overall Study|Study Drug Toxicity|0
5441021|NCT02279732|18794201|P1|Overall Study|Study Drug Toxicity|2
5441022|NCT02279732|18794200|P2|Overall Study|Administrative Reason By Sponsor|2
5441023|NCT02279732|18794201|P1|Overall Study|Administrative Reason By Sponsor|0
5441024|NCT02279732|18794200|P2|Overall Study|Adverse Event|2
5441025|NCT02279732|18794201|P1|Overall Study|Adverse Event|1
5441026|NCT02279732|18794200|P2|Overall Study|Withdrawal by Subject|7
5441027|NCT02279732|18794201|P1|Overall Study|Withdrawal by Subject|2
5441028|NCT02279732|18794200|P2|Overall Study|Disease Progression|3
5441029|NCT02279732|18794201|P1|Overall Study|Disease Progression|13
5441030|NCT02279732|18794200|P2|Overall Study|Death|20
5441031|NCT02279732|18794201|P1|Overall Study|Death|23
5441032|NCT02279498|18794293|P2|Overall Study|Undefined|1
5441033|NCT02279498|18794294|P1|Overall Study|Undefined|2
5441034|NCT02279498|18794293|P2|Overall Study|Withdrawal by Subject|2
5441035|NCT02279498|18794294|P1|Overall Study|Withdrawal by Subject|9
5441036|NCT02279498|18794293|P2|Overall Study|Lost to Follow-up|1
5441037|NCT02279498|18794294|P1|Overall Study|Lost to Follow-up|0
5441038|NCT02279498|18794293|P2|Overall Study|Lack of Efficacy|0
5441039|NCT02279498|18794294|P1|Overall Study|Lack of Efficacy|4
5441040|NCT02279498|18794293|P2|Overall Study|Adverse Event|0
5441041|NCT02279498|18794294|P1|Overall Study|Adverse Event|3
5441042|NCT02279420|18794303|P1|Overall Study|Lost to Follow-up|23
5441043|NCT02279407|18794311|P4|Overall Study|Adverse Event|0
5441044|NCT02279407|18794312|P3|Overall Study|Adverse Event|2
5441045|NCT02279407|18794313|P2|Overall Study|Adverse Event|1
5441046|NCT02279407|18794314|P1|Overall Study|Adverse Event|1
5441047|NCT02279407|18794311|P4|Overall Study|Withdrawal by Subject|1
5441048|NCT02279407|18794312|P3|Overall Study|Withdrawal by Subject|1
5441049|NCT02279407|18794313|P2|Overall Study|Withdrawal by Subject|0
5441050|NCT02279407|18794314|P1|Overall Study|Withdrawal by Subject|1
5441051|NCT02279407|18794311|P4|Overall Study|Couldn't swallow IP; noncompliance|0
5441052|NCT02279407|18794312|P3|Overall Study|Couldn't swallow IP; noncompliance|2
5441053|NCT02279407|18794313|P2|Overall Study|Couldn't swallow IP; noncompliance|0
5441054|NCT02279407|18794314|P1|Overall Study|Couldn't swallow IP; noncompliance|0
5441055|NCT02279173|18794325|P1|Overall Study|Lost to Follow-up|3
5441056|NCT02279173|18794325|P1|Overall Study|Decision by Sponsor|4
5441057|NCT02279173|18794325|P1|Overall Study|Withdrawal by Subject|20
5441058|NCT02279173|18794325|P1|Overall Study|Protocol-specified Criteria|67
5441059|NCT02279043|18794385|P3|Overall Study|Lost to Follow-up|0
5441060|NCT02279043|18794386|P2|Overall Study|Lost to Follow-up|88
5441061|NCT02279043|18794387|P1|Overall Study|Lost to Follow-up|46
5441062|NCT02279043|18794385|P3|Overall Study|Post-rand. exclusion - not eligible|0
5441063|NCT02279043|18794386|P2|Overall Study|Post-rand. exclusion - not eligible|1
5441064|NCT02279043|18794387|P1|Overall Study|Post-rand. exclusion - not eligible|1
5441065|NCT02278952|18794417|P1|Overall Study|Insufficient Sample|6
5441066|NCT02278939|18794429|P2|Overall Study|family emergency unable to commit|0
5441067|NCT02278939|18794430|P1|Overall Study|family emergency unable to commit|2
5441068|NCT02278939|18794429|P2|Overall Study|death in family|0
5441069|NCT02278939|18794430|P1|Overall Study|death in family|1
5441070|NCT02278939|18794429|P2|Overall Study|Lost to Follow-up|1
5441071|NCT02278939|18794430|P1|Overall Study|Lost to Follow-up|1
5441072|NCT02278939|18794429|P2|Overall Study|lack of time|0
5441073|NCT02278939|18794430|P1|Overall Study|lack of time|1
5441074|NCT02278614|18794458|P2|Overall Study|left eye was not eligible|0
5441075|NCT02278614|18794459|P1|Overall Study|left eye was not eligible|1
5441076|NCT02278614|18794458|P2|Overall Study|Adverse Event|0
5441077|NCT02278614|18794459|P1|Overall Study|Adverse Event|1
5441078|NCT02278614|18794458|P2|Overall Study|Withdrawal by Subject|5
5441079|NCT02278614|18794459|P1|Overall Study|Withdrawal by Subject|3
5441080|NCT02278471|18794493|P2|Overall Study|Withdrawal by Subject|3
5441081|NCT02278471|18794494|P1|Overall Study|Withdrawal by Subject|0
5441082|NCT02278471|18794493|P2|Overall Study|Death|2
5441083|NCT02278471|18794494|P1|Overall Study|Death|2
5441084|NCT02278471|18794493|P2|Overall Study|Lost to Follow-up|15
5441085|NCT02278471|18794494|P1|Overall Study|Lost to Follow-up|6
5441086|NCT02278367|18794512|P2|Overall Study|Withdrawal by Subject|0
5441087|NCT02278367|18794513|P1|Overall Study|Withdrawal by Subject|5
5441088|NCT02278367|18794512|P2|Overall Study|Physician Decision|0
5441089|NCT02278367|18794513|P1|Overall Study|Physician Decision|5
5441090|NCT02278354|18794523|P2|Overall Study|<10 professional fights|0
5441091|NCT02278354|18794524|P1|Overall Study|<10 professional fights|2
5441092|NCT02278354|18794523|P2|Overall Study|Withdrawal by Subject|1
5441093|NCT02278354|18794524|P1|Overall Study|Withdrawal by Subject|0
5441094|NCT02278354|18794523|P2|Overall Study|Lost to Follow-up|2
5441095|NCT02278354|18794524|P1|Overall Study|Lost to Follow-up|2
5441096|NCT02278341|18794538|P2|Overall Study|Miscellaneous|14
5441097|NCT02278341|18794539|P1|Overall Study|Miscellaneous|15
5441098|NCT02278341|18794538|P2|Overall Study|Physician Decision|1
5441099|NCT02278341|18794539|P1|Overall Study|Physician Decision|1
5441100|NCT02278341|18794538|P2|Overall Study|Lost to Follow-up|1
5441101|NCT02278341|18794539|P1|Overall Study|Lost to Follow-up|0
5441102|NCT02278341|18794538|P2|Overall Study|Withdrawal by Subject|19
5441103|NCT02278341|18794539|P1|Overall Study|Withdrawal by Subject|30
5441104|NCT02278341|18794538|P2|Overall Study|Death|56
5441105|NCT02278341|18794539|P1|Overall Study|Death|68
5441106|NCT02278341|18794538|P2|Overall Study|Adverse Event|0
5441107|NCT02278341|18794539|P1|Overall Study|Adverse Event|3
5441108|NCT02278341|18794538|P2|Overall Study|Randomized but never received study drug|1
5441109|NCT02278341|18794539|P1|Overall Study|Randomized but never received study drug|1
5441110|NCT02278328|18794633|P3|Neuropsych Screening|incomplete consent|2
5441111|NCT02278328|18794634|P2|Neuropsych Screening|incomplete consent|0
5441112|NCT02278328|18794635|P1|Neuropsych Screening|incomplete consent|0
5441113|NCT02278328|18794633|P3|Neuropsych Screening|Withdrawal by Subject|0
5441114|NCT02278328|18794634|P2|Neuropsych Screening|Withdrawal by Subject|1
5441115|NCT02278328|18794635|P1|Neuropsych Screening|Withdrawal by Subject|0
5441116|NCT02278328|18794633|P3|Neuropsych Screening|found ineligible on neuropsych|0
5441117|NCT02278328|18794634|P2|Neuropsych Screening|found ineligible on neuropsych|0
5441118|NCT02278328|18794635|P1|Neuropsych Screening|found ineligible on neuropsych|1
5441119|NCT02278263|18794648|P3|Overall Study|Protocol Violation|9
5441120|NCT02278263|18794649|P2|Overall Study|Protocol Violation|0
5441121|NCT02278263|18794650|P1|Overall Study|Protocol Violation|7
5441122|NCT02278120|18794695|P2|Overall Study|Protocol Violation|2
5441123|NCT02278120|18794696|P1|Overall Study|Protocol Violation|0
5441124|NCT02278120|18794695|P2|Overall Study|Lost to Follow-up|0
5441125|NCT02278120|18794696|P1|Overall Study|Lost to Follow-up|2
5441126|NCT02278120|18794695|P2|Overall Study|Death|3
5441127|NCT02278120|18794696|P1|Overall Study|Death|3
5441128|NCT02278120|18794695|P2|Overall Study|Physician Decision|19
5441129|NCT02278120|18794696|P1|Overall Study|Physician Decision|8
5441130|NCT02278120|18794695|P2|Overall Study|Adverse Event|10
5441131|NCT02278120|18794696|P1|Overall Study|Adverse Event|12
5441132|NCT02278120|18794695|P2|Overall Study|Patient/guardian decision|8
5441133|NCT02278120|18794696|P1|Overall Study|Patient/guardian decision|14
5441134|NCT02278120|18794695|P2|Overall Study|Progressive disease|174
5441135|NCT02278120|18794696|P1|Overall Study|Progressive disease|122
5441136|NCT02278003|18794712|P2|Overall Study|Recognition task improperly completed|0
5441137|NCT02278003|18794713|P1|Overall Study|Recognition task improperly completed|7
5441138|NCT02278003|18794712|P2|Overall Study|Not Treated|0
5441139|NCT02278003|18794713|P1|Overall Study|Not Treated|1
5441140|NCT02278003|18794712|P2|Overall Study|Withdrawal by Subject|0
5441141|NCT02278003|18794713|P1|Overall Study|Withdrawal by Subject|11
5441142|NCT02277990|18794723|P2|Overall Study|Had other reason|32
5441143|NCT02277990|18794724|P1|Overall Study|Had other reason|26
5441144|NCT02277990|18794723|P2|Overall Study|Lost to Follow-up|69
5441145|NCT02277990|18794724|P1|Overall Study|Lost to Follow-up|66
5441146|NCT02277990|18794723|P2|Overall Study|Physician Decision|34
5441147|NCT02277990|18794724|P1|Overall Study|Physician Decision|40
5441148|NCT02277990|18794723|P2|Overall Study|Withdrawal by Subject|53
5441149|NCT02277990|18794724|P1|Overall Study|Withdrawal by Subject|64
5441150|NCT02277990|18794723|P2|Overall Study|Death|188
5441151|NCT02277990|18794724|P1|Overall Study|Death|170
5441152|NCT02277769|18794752|P3|Overall Study|Other than specified above|5
5441153|NCT02277769|18794753|P2|Overall Study|Other than specified above|8
5441154|NCT02277769|18794754|P1|Overall Study|Other than specified above|12
5441155|NCT02277769|18794752|P3|Overall Study|Adverse Event|4
5441156|NCT02277769|18794753|P2|Overall Study|Adverse Event|2
5441157|NCT02277769|18794754|P1|Overall Study|Adverse Event|14
5441158|NCT02277769|18794752|P3|Overall Study|Lack of Efficacy|4
5441159|NCT02277769|18794753|P2|Overall Study|Lack of Efficacy|0
5441160|NCT02277769|18794754|P1|Overall Study|Lack of Efficacy|17
5441161|NCT02277769|18794752|P3|Overall Study|Protocol Violation|5
5441162|NCT02277769|18794753|P2|Overall Study|Protocol Violation|3
5441163|NCT02277769|18794754|P1|Overall Study|Protocol Violation|3
5441164|NCT02277743|18794825|P3|Overall Study|Other than specified above|16
5441165|NCT02277743|18794826|P2|Overall Study|Other than specified above|5
5441166|NCT02277743|18794827|P1|Overall Study|Other than specified above|18
5441167|NCT02277743|18794825|P3|Overall Study|Lack of Efficacy|3
5441168|NCT02277743|18794826|P2|Overall Study|Lack of Efficacy|4
5441169|NCT02277743|18794827|P1|Overall Study|Lack of Efficacy|11
5441170|NCT02277743|18794825|P3|Overall Study|Adverse Event|6
5441171|NCT02277743|18794826|P2|Overall Study|Adverse Event|6
5441172|NCT02277743|18794827|P1|Overall Study|Adverse Event|10
5441173|NCT02277743|18794825|P3|Overall Study|Protocol Violation|1
5441174|NCT02277743|18794826|P2|Overall Study|Protocol Violation|1
5441175|NCT02277743|18794827|P1|Overall Study|Protocol Violation|1
5441176|NCT02277691|18794895|P1|Overall Study|Used Other Antihypertensive Drug|1
5441177|NCT02277691|18794895|P1|Overall Study|Lack of Efficacy|5
5441178|NCT02277691|18794895|P1|Overall Study|Voluntary Withdrawal|7
5441179|NCT02277691|18794895|P1|Overall Study|Pretreatment Event/Adverse Event|33
5441180|NCT02277444|18794957|P1|Overall Study|Ongoing|113
5441181|NCT02277444|18794957|P1|Overall Study|Enrolled and not Treated|3
5441182|NCT02277444|18794957|P1|Overall Study|Other|1
5441183|NCT02277444|18794957|P1|Overall Study|Withdrawal by Subject|3
5441184|NCT02277444|18794957|P1|Overall Study|Adverse Event|10
5441185|NCT02277119|18794976|P3|Overall Study|Protocol Violation|7
5441186|NCT02277119|18794977|P2|Overall Study|Protocol Violation|3
5441187|NCT02277119|18794978|P1|Overall Study|Protocol Violation|2
5441188|NCT02277119|18794976|P3|Overall Study|Lack of Efficacy|1
5441189|NCT02277119|18794977|P2|Overall Study|Lack of Efficacy|1
5441190|NCT02277119|18794978|P1|Overall Study|Lack of Efficacy|1
5441191|NCT02276872|18795016|P3|Overall Study|Adverse Event|0
5441192|NCT02276872|18795017|P2|Overall Study|Adverse Event|0
5441193|NCT02276872|18795018|P1|Overall Study|Adverse Event|1
5441194|NCT02276807|18795094|P2|Overall Study|Lost to Follow-up|10
5441195|NCT02276807|18795095|P1|Overall Study|Lost to Follow-up|10
5441196|NCT02276807|18795094|P2|Overall Study|Withdrawal by Subject|7
5441197|NCT02276807|18795095|P1|Overall Study|Withdrawal by Subject|8
5441198|NCT02276612|18795130|P2|Overall Study|Lost to Follow-up|0
5441199|NCT02276612|18795131|P1|Overall Study|Lost to Follow-up|1
5441200|NCT02276612|18795130|P2|Overall Study|Withdrew Consent|0
5441201|NCT02276612|18795131|P1|Overall Study|Withdrew Consent|1
5441202|NCT02276612|18795130|P2|Overall Study|Pregnancy|0
5441203|NCT02276612|18795131|P1|Overall Study|Pregnancy|1
5441204|NCT02276612|18795130|P2|Overall Study|Death|0
5441205|NCT02276612|18795131|P1|Overall Study|Death|1
5441206|NCT02276560|18795154|P3|Overall Study|Adverse Event|0
5441207|NCT02276560|18795155|P2|Overall Study|Adverse Event|0
5441208|NCT02276560|18795156|P1|Overall Study|Adverse Event|1
5441209|NCT02276482|18795166|P2|Overall Study|Reason not specified|1
5441210|NCT02276482|18795167|P1|Overall Study|Reason not specified|0
5441211|NCT02276482|18795166|P2|Overall Study|Gram-negative infection|0
5441212|NCT02276482|18795167|P1|Overall Study|Gram-negative infection|1
5441213|NCT02276482|18795166|P2|Overall Study|Withdrawal by Subject|0
5441214|NCT02276482|18795167|P1|Overall Study|Withdrawal by Subject|1
5441215|NCT02276482|18795166|P2|Overall Study|Adverse Event|0
5441216|NCT02276482|18795167|P1|Overall Study|Adverse Event|1
5441217|NCT02276222|18795302|P2|Overall Study|subject withdrew after randomization|0
5441218|NCT02276222|18795303|P1|Overall Study|subject withdrew after randomization|1
5441219|NCT02276222|18795302|P2|Overall Study|sheduling conflict|0
5441220|NCT02276222|18795303|P1|Overall Study|sheduling conflict|1
5441221|NCT02276222|18795302|P2|Overall Study|Physician Decision|1
5441222|NCT02276222|18795303|P1|Overall Study|Physician Decision|2
5441223|NCT02276222|18795302|P2|Overall Study|Lost to Follow-up|5
5441224|NCT02276222|18795303|P1|Overall Study|Lost to Follow-up|15
5441225|NCT02276222|18795302|P2|Overall Study|sponsor decision|3
5441226|NCT02276222|18795303|P1|Overall Study|sponsor decision|0
5441227|NCT02276222|18795302|P2|Overall Study|non compliance with study medication|2
5441228|NCT02276222|18795303|P1|Overall Study|non compliance with study medication|6
5441229|NCT02276222|18795302|P2|Overall Study|Withdrawal by Subject|33
5441230|NCT02276222|18795303|P1|Overall Study|Withdrawal by Subject|79
5441231|NCT02276222|18795302|P2|Overall Study|Protocol Violation|2
5441232|NCT02276222|18795303|P1|Overall Study|Protocol Violation|3
5441233|NCT02276222|18795302|P2|Overall Study|Lack of Efficacy|3
5441234|NCT02276222|18795303|P1|Overall Study|Lack of Efficacy|13
5441235|NCT02276222|18795302|P2|Overall Study|Death|4
5441236|NCT02276222|18795303|P1|Overall Study|Death|3
5441237|NCT02276222|18795302|P2|Overall Study|Adverse Event|11
5441238|NCT02276222|18795303|P1|Overall Study|Adverse Event|62
5441239|NCT02276053|18795327|P1|Overall Study|Patient needs to increase baseline AED|1
5441240|NCT02276053|18795327|P1|Overall Study|Patient does not meet selection criteria|3
5441241|NCT02276053|18795327|P1|Overall Study|Withdrawal by Subject|1
5441242|NCT02276053|18795327|P1|Overall Study|Lack of Efficacy|2
5441243|NCT02276053|18795327|P1|Overall Study|Adverse Event|5
5441244|NCT02276053|18795327|P1|Overall Study|Death|2
5441245|NCT02276040|18795343|P1|Overall Study|Physician Decision|15
5441246|NCT02276027|18795351|P4|Overall Study|Adverse Event|2
5441247|NCT02276027|18795352|P3|Overall Study|Adverse Event|8
5441248|NCT02276027|18795353|P2|Overall Study|Adverse Event|2
5441249|NCT02276027|18795354|P1|Overall Study|Adverse Event|0
5441250|NCT02276027|18795351|P4|Overall Study|Subject/guardian decision|3
5441251|NCT02276027|18795352|P3|Overall Study|Subject/guardian decision|0
5441252|NCT02276027|18795353|P2|Overall Study|Subject/guardian decision|1
5441253|NCT02276027|18795354|P1|Overall Study|Subject/guardian decision|0
5441254|NCT02276027|18795351|P4|Overall Study|Progressive disease|14
5441255|NCT02276027|18795352|P3|Overall Study|Progressive disease|12
5441256|NCT02276027|18795353|P2|Overall Study|Progressive disease|13
5441257|NCT02276027|18795354|P1|Overall Study|Progressive disease|1
5441258|NCT02276027|18795351|P4|Overall Study|Physician Decision|1
5441259|NCT02276027|18795352|P3|Overall Study|Physician Decision|0
5441260|NCT02276027|18795353|P2|Overall Study|Physician Decision|0
5441261|NCT02276027|18795354|P1|Overall Study|Physician Decision|0
5441262|NCT02276027|18795351|P4|Overall Study|Death|2
5441263|NCT02276027|18795352|P3|Overall Study|Death|0
5441264|NCT02276027|18795353|P2|Overall Study|Death|0
5441265|NCT02276027|18795354|P1|Overall Study|Death|1
5441266|NCT02275780|18795403|P2|Extension Study: up to 192 Weeks|Ongoing|233
5441267|NCT02275780|18795404|P1|Extension Study: up to 192 Weeks|Ongoing|260
5441268|NCT02275780|18795403|P2|Base Study: 96 Weeks|Randomized not treated|1
5441269|NCT02275780|18795404|P1|Base Study: 96 Weeks|Randomized not treated|2
5441270|NCT02275780|18795403|P2|Base Study: 96 Weeks|Pregnancy|1
5441271|NCT02275780|18795404|P1|Base Study: 96 Weeks|Pregnancy|2
5441272|NCT02275780|18795403|P2|Base Study: 96 Weeks|Physician Decision|4
5441273|NCT02275780|18795404|P1|Base Study: 96 Weeks|Physician Decision|2
5441274|NCT02275780|18795403|P2|Base Study: 96 Weeks|Noncompliance with drug|6
5441275|NCT02275780|18795404|P1|Base Study: 96 Weeks|Noncompliance with drug|9
5441276|NCT02275780|18795403|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
5441277|NCT02275780|18795404|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
5441278|NCT02275780|18795403|P2|Base Study: 96 Weeks|Protocol Violation|6
5441279|NCT02275780|18795404|P1|Base Study: 96 Weeks|Protocol Violation|1
5441280|NCT02275780|18795403|P2|Base Study: 96 Weeks|Lost to Follow-up|24
5441281|NCT02275780|18795404|P1|Base Study: 96 Weeks|Lost to Follow-up|28
5441282|NCT02275780|18795403|P2|Base Study: 96 Weeks|Lack of Efficacy|32
5441283|NCT02275780|18795404|P1|Base Study: 96 Weeks|Lack of Efficacy|21
5441284|NCT02275780|18795403|P2|Base Study: 96 Weeks|Death|1
5441285|NCT02275780|18795404|P1|Base Study: 96 Weeks|Death|3
5441286|NCT02275780|18795403|P2|Base Study: 96 Weeks|Adverse Event|14
5441287|NCT02275780|18795404|P1|Base Study: 96 Weeks|Adverse Event|6
5441288|NCT02275611|18795460|P4|Inpatient Withdrawal|Withdrawal by Subject|0
5441289|NCT02275611|18795461|P3|Inpatient Withdrawal|Withdrawal by Subject|0
5441290|NCT02275611|18795462|P2|Inpatient Withdrawal|Withdrawal by Subject|0
5441291|NCT02275611|18795463|P1|Inpatient Withdrawal|Withdrawal by Subject|1
5441292|NCT02275546|18795475|P2|Treatment Period 2|Protocol Violation|1
5441293|NCT02275546|18795476|P1|Treatment Period 2|Protocol Violation|0
5441294|NCT02275546|18795475|P2|Treatment Period 2|Withdrawal by Subject|1
5441295|NCT02275546|18795476|P1|Treatment Period 2|Withdrawal by Subject|2
5441296|NCT02275481|18795486|P2|Overall Study|Physician Decision|1
5441297|NCT02275481|18795487|P1|Overall Study|Physician Decision|0
5441298|NCT02275481|18795486|P2|Overall Study|all other reasons combined|1
5441299|NCT02275481|18795487|P1|Overall Study|all other reasons combined|2
5441300|NCT02275481|18795486|P2|Overall Study|Withdrawal by Subject|0
5441301|NCT02275481|18795487|P1|Overall Study|Withdrawal by Subject|3
5441302|NCT02275481|18795486|P2|Overall Study|Lost to Follow-up|0
5441303|NCT02275481|18795487|P1|Overall Study|Lost to Follow-up|2
5441304|NCT02275481|18795486|P2|Overall Study|Death|1
5441305|NCT02275481|18795487|P1|Overall Study|Death|2
5441306|NCT02275364|18795493|P2|Period 1|Other reason|0
5441307|NCT02275364|18795494|P1|Period 1|Other reason|1
5441308|NCT02275364|18795493|P2|Period 1|Withdrawal by Subject|0
5441309|NCT02275364|18795494|P1|Period 1|Withdrawal by Subject|1
5441310|NCT02275338|18795523|P1|Overall Study|Does not meet entry criteria|1
5441311|NCT02275338|18795523|P1|Overall Study|Reason not specified|5
5441312|NCT02275338|18795523|P1|Overall Study|Ineligible to start Phase 2|4
5441313|NCT02275338|18795523|P1|Overall Study|Disease progression (death)|1
5441314|NCT02275338|18795523|P1|Overall Study|Withdrawal by Subject|4
5441315|NCT02275338|18795523|P1|Overall Study|Lack of Efficacy|3
5441316|NCT02275338|18795523|P1|Overall Study|Adverse Event|15
5441317|NCT02275117|18795572|P5|Overall Study|Other|2
5441318|NCT02275117|18795573|P4|Overall Study|Other|0
5441319|NCT02275117|18795574|P3|Overall Study|Other|0
5441320|NCT02275117|18795575|P2|Overall Study|Other|0
5441321|NCT02275117|18795576|P1|Overall Study|Other|1
5441322|NCT02275117|18795572|P5|Overall Study|Study Burden|7
5441323|NCT02275117|18795573|P4|Overall Study|Study Burden|5
5441324|NCT02275117|18795574|P3|Overall Study|Study Burden|7
5441325|NCT02275117|18795575|P2|Overall Study|Study Burden|4
5441326|NCT02275117|18795576|P1|Overall Study|Study Burden|5
5441327|NCT02275117|18795572|P5|Overall Study|Worsening of Study Indication|0
5441328|NCT02275117|18795573|P4|Overall Study|Worsening of Study Indication|0
5441329|NCT02275117|18795574|P3|Overall Study|Worsening of Study Indication|2
5441330|NCT02275117|18795575|P2|Overall Study|Worsening of Study Indication|1
5441331|NCT02275117|18795576|P1|Overall Study|Worsening of Study Indication|0
5441332|NCT02275117|18795572|P5|Overall Study|Terminated by Sponsor|4
5441333|NCT02275117|18795573|P4|Overall Study|Terminated by Sponsor|6
5441334|NCT02275117|18795574|P3|Overall Study|Terminated by Sponsor|4
5441335|NCT02275117|18795575|P2|Overall Study|Terminated by Sponsor|4
5441336|NCT02275117|18795576|P1|Overall Study|Terminated by Sponsor|4
5441337|NCT02275117|18795572|P5|Overall Study|Withdrawal by Subject|3
5441338|NCT02275117|18795573|P4|Overall Study|Withdrawal by Subject|3
5441339|NCT02275117|18795574|P3|Overall Study|Withdrawal by Subject|7
5441340|NCT02275117|18795575|P2|Overall Study|Withdrawal by Subject|4
5441341|NCT02275117|18795576|P1|Overall Study|Withdrawal by Subject|6
5441342|NCT02275117|18795572|P5|Overall Study|Protocol Violation|0
5441343|NCT02275117|18795573|P4|Overall Study|Protocol Violation|1
5441344|NCT02275117|18795574|P3|Overall Study|Protocol Violation|1
5441345|NCT02275117|18795575|P2|Overall Study|Protocol Violation|0
5441346|NCT02275117|18795576|P1|Overall Study|Protocol Violation|1
5441347|NCT02275117|18795572|P5|Overall Study|Physician Decision|1
5441348|NCT02275117|18795573|P4|Overall Study|Physician Decision|0
5441349|NCT02275117|18795574|P3|Overall Study|Physician Decision|1
5441350|NCT02275117|18795575|P2|Overall Study|Physician Decision|1
5441351|NCT02275117|18795576|P1|Overall Study|Physician Decision|0
5441352|NCT02275117|18795572|P5|Overall Study|Lost to Follow-up|8
5441353|NCT02275117|18795573|P4|Overall Study|Lost to Follow-up|16
5441354|NCT02275117|18795574|P3|Overall Study|Lost to Follow-up|15
5441355|NCT02275117|18795575|P2|Overall Study|Lost to Follow-up|16
5441356|NCT02275117|18795576|P1|Overall Study|Lost to Follow-up|11
5441357|NCT02275117|18795572|P5|Overall Study|Lack of Efficacy|10
5441358|NCT02275117|18795573|P4|Overall Study|Lack of Efficacy|2
5441359|NCT02275117|18795574|P3|Overall Study|Lack of Efficacy|5
5441360|NCT02275117|18795575|P2|Overall Study|Lack of Efficacy|7
5441361|NCT02275117|18795576|P1|Overall Study|Lack of Efficacy|6
5441362|NCT02275117|18795572|P5|Overall Study|Adverse Event|1
5441363|NCT02275117|18795573|P4|Overall Study|Adverse Event|0
5441364|NCT02275117|18795574|P3|Overall Study|Adverse Event|0
5441365|NCT02275117|18795575|P2|Overall Study|Adverse Event|0
5441366|NCT02275117|18795576|P1|Overall Study|Adverse Event|0
5441367|NCT02275065|18795688|P5|Overall Study|Randomized but not treated|0
5441368|NCT02275065|18795689|P4|Overall Study|Randomized but not treated|1
5441369|NCT02275065|18795690|P3|Overall Study|Randomized but not treated|1
5441370|NCT02275065|18795691|P2|Overall Study|Randomized but not treated|0
5441371|NCT02275065|18795692|P1|Overall Study|Randomized but not treated|1
5441372|NCT02275052|18795773|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
5441373|NCT02275052|18795774|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5441374|NCT02275052|18795775|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5441375|NCT02275052|18795776|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5441376|NCT02275052|18795773|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
5441377|NCT02275052|18795774|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5441378|NCT02275052|18795775|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
5441379|NCT02275052|18795776|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
5441380|NCT02275052|18795773|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
5441381|NCT02275052|18795774|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5441382|NCT02275052|18795775|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5441383|NCT02275052|18795776|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5441384|NCT02275052|18795773|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
5441385|NCT02275052|18795774|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
5441386|NCT02275052|18795775|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
5441387|NCT02275052|18795776|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
5441388|NCT02275052|18795773|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
5441389|NCT02275052|18795774|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
5441390|NCT02275052|18795775|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
5441391|NCT02275052|18795776|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
5441392|NCT02275052|18795773|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
5441393|NCT02275052|18795774|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
5441394|NCT02275052|18795775|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
5441395|NCT02275052|18795776|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
5441396|NCT02275052|18795773|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
5441397|NCT02275052|18795774|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
5441398|NCT02275052|18795775|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
5441399|NCT02275052|18795776|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
5441400|NCT02275052|18795773|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
5441401|NCT02275052|18795774|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
5441402|NCT02275052|18795775|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
5441403|NCT02275052|18795776|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
5441404|NCT02275052|18795773|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5441405|NCT02275052|18795774|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5441406|NCT02275052|18795775|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
5441407|NCT02275052|18795776|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
5441408|NCT02275052|18795773|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
5441409|NCT02275052|18795774|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
5441410|NCT02275052|18795775|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
5441411|NCT02275052|18795776|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
5441412|NCT02275052|18795773|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5441413|NCT02275052|18795774|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5441414|NCT02275052|18795775|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5441415|NCT02275052|18795776|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5441416|NCT02274948|18795790|P2|Overall Study|Left the area|3
5441417|NCT02274948|18795791|P1|Overall Study|Left the area|4
5441418|NCT02274948|18795790|P2|Overall Study|Stopped on family Practitioner advice|5
5441419|NCT02274948|18795791|P1|Overall Study|Stopped on family Practitioner advice|2
5441420|NCT02274948|18795790|P2|Overall Study|Withdrawal by Subject|58
5441421|NCT02274948|18795791|P1|Overall Study|Withdrawal by Subject|64
5441422|NCT02274948|18795790|P2|Overall Study|Lost to Follow-up|25
5441423|NCT02274948|18795791|P1|Overall Study|Lost to Follow-up|28
5441424|NCT02274857|18795834|P2|Overall Study|Other|0
5441425|NCT02274857|18795835|P1|Overall Study|Other|2
5441426|NCT02274857|18795834|P2|Overall Study|Withdrawal by Subject|2
5441427|NCT02274857|18795835|P1|Overall Study|Withdrawal by Subject|11
5441428|NCT02274857|18795834|P2|Overall Study|Trial screen failure|2
5441429|NCT02274857|18795835|P1|Overall Study|Trial screen failure|0
5441430|NCT02274857|18795834|P2|Overall Study|Physician Decision|0
5441431|NCT02274857|18795835|P1|Overall Study|Physician Decision|2
5441432|NCT02274857|18795834|P2|Overall Study|Lost to Follow-up|0
5441433|NCT02274857|18795835|P1|Overall Study|Lost to Follow-up|3
5441434|NCT02274857|18795834|P2|Overall Study|Death|2
5441435|NCT02274857|18795835|P1|Overall Study|Death|1
5441436|NCT02274857|18795834|P2|Overall Study|Adverse Event|0
5441437|NCT02274857|18795835|P1|Overall Study|Adverse Event|1
5441438|NCT02274792|18795887|P1|Overall Study|Sponsor Decision|2
5441439|NCT02274792|18795887|P1|Overall Study|Protocol Specified Criteria|2
5441440|NCT02274792|18795887|P1|Overall Study|Lost to Follow-up|8
5441441|NCT02274792|18795887|P1|Overall Study|Withdrawal by Subject|13
5441442|NCT02274766|18795897|P2|Overall Study|Adverse Event|1
5441443|NCT02274766|18795898|P1|Overall Study|Adverse Event|0
5441444|NCT02274766|18795897|P2|Overall Study|Subject Unwilling to Proceed|1
5441445|NCT02274766|18795898|P1|Overall Study|Subject Unwilling to Proceed|0
5441446|NCT02274766|18795897|P2|Overall Study|Did Not Receive Study Drug|1
5441447|NCT02274766|18795898|P1|Overall Study|Did Not Receive Study Drug|1
5441448|NCT02274766|18795897|P2|Overall Study|Withdrawal by Subject|6
5441449|NCT02274766|18795898|P1|Overall Study|Withdrawal by Subject|3
5441450|NCT02274558|18795965|P3|Overall Study|Physician Decision|1
5441451|NCT02274558|18795966|P2|Overall Study|Physician Decision|2
5441452|NCT02274558|18795967|P1|Overall Study|Physician Decision|0
5441453|NCT02274558|18795965|P3|Overall Study|Lost to Follow-up|1
5441454|NCT02274558|18795966|P2|Overall Study|Lost to Follow-up|1
5441455|NCT02274558|18795967|P1|Overall Study|Lost to Follow-up|2
5441456|NCT02274558|18795965|P3|Overall Study|Death|1
5441457|NCT02274558|18795966|P2|Overall Study|Death|0
5441458|NCT02274558|18795967|P1|Overall Study|Death|0
5441459|NCT02274558|18795965|P3|Overall Study|Withdrawal by Subject|4
5441460|NCT02274558|18795966|P2|Overall Study|Withdrawal by Subject|5
5441461|NCT02274558|18795967|P1|Overall Study|Withdrawal by Subject|1
5441462|NCT02274558|18795965|P3|Overall Study|Non-compliance|0
5441463|NCT02274558|18795966|P2|Overall Study|Non-compliance|1
5441464|NCT02274558|18795967|P1|Overall Study|Non-compliance|2
5441465|NCT02274558|18795965|P3|Overall Study|Adverse Event|2
5441466|NCT02274558|18795966|P2|Overall Study|Adverse Event|4
5441467|NCT02274558|18795967|P1|Overall Study|Adverse Event|2
5441468|NCT02274493|18795981|P1|Overall Study|Withdrawal by Subject|1
5441469|NCT02274311|18795988|P1|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
5441470|NCT02273973|18795996|P2|Overall Study|Reason not specified|1
5441471|NCT02273973|18795997|P1|Overall Study|Reason not specified|0
5441472|NCT02273973|18795996|P2|Overall Study|Physician Decision|1
5441473|NCT02273973|18795997|P1|Overall Study|Physician Decision|0
5441474|NCT02273973|18795996|P2|Overall Study|Lost to Follow-up|1
5441475|NCT02273973|18795997|P1|Overall Study|Lost to Follow-up|0
5441476|NCT02273973|18795996|P2|Overall Study|Progression of disease|2
5441477|NCT02273973|18795997|P1|Overall Study|Progression of disease|0
5441478|NCT02273973|18795996|P2|Overall Study|Protocol Violation|0
5441479|NCT02273973|18795997|P1|Overall Study|Protocol Violation|1
5441480|NCT02273973|18795996|P2|Overall Study|Non-compliance|0
5441481|NCT02273973|18795997|P1|Overall Study|Non-compliance|1
5441482|NCT02273973|18795996|P2|Overall Study|Death|0
5441483|NCT02273973|18795997|P1|Overall Study|Death|1
5441484|NCT02273973|18795996|P2|Overall Study|Withdrawal by Subject|3
5441485|NCT02273973|18795997|P1|Overall Study|Withdrawal by Subject|2
5441486|NCT02273973|18795996|P2|Overall Study|Adverse Event|0
5441487|NCT02273973|18795997|P1|Overall Study|Adverse Event|4
5441488|NCT02273960|18796041|P4|Long Term Extension|Death|1
5441489|NCT02273960|18796042|P3|Long Term Extension|Death|0
5441490|NCT02273960|18796043|P2|Long Term Extension|Death|0
5441491|NCT02273960|18796044|P1|Long Term Extension|Death|0
5441492|NCT02273960|18796041|P4|Short Term Period|ST complete, not entering LTE|5
5441493|NCT02273960|18796042|P3|Short Term Period|ST complete, not entering LTE|4
5441494|NCT02273960|18796043|P2|Short Term Period|ST complete, not entering LTE|6
5441495|NCT02273960|18796044|P1|Short Term Period|ST complete, not entering LTE|4
5441496|NCT02273960|18796041|P4|Short Term Period|Lack of Efficacy|1
5441497|NCT02273960|18796042|P3|Short Term Period|Lack of Efficacy|0
5441498|NCT02273960|18796043|P2|Short Term Period|Lack of Efficacy|0
5441499|NCT02273960|18796044|P1|Short Term Period|Lack of Efficacy|0
5441500|NCT02273960|18796041|P4|Short Term Period|Lost to Follow-up|0
5441501|NCT02273960|18796042|P3|Short Term Period|Lost to Follow-up|0
5441502|NCT02273960|18796043|P2|Short Term Period|Lost to Follow-up|0
5441503|NCT02273960|18796044|P1|Short Term Period|Lost to Follow-up|1
5441504|NCT02273908|18796088|P2|Overall Study|Withdrawal by Subject|2
5441505|NCT02273908|18796089|P1|Overall Study|Withdrawal by Subject|4
5441506|NCT02273908|18796088|P2|Overall Study|Did not meet entrance criteria|2
5441507|NCT02273908|18796089|P1|Overall Study|Did not meet entrance criteria|3
5441508|NCT02273908|18796088|P2|Overall Study|Lost to Follow-up|1
5441509|NCT02273908|18796089|P1|Overall Study|Lost to Follow-up|10
5441510|NCT02273908|18796088|P2|Overall Study|Adverse Event|0
5441511|NCT02273908|18796089|P1|Overall Study|Adverse Event|16
5441512|NCT02273752|18796111|P1|Overall Study|Trial was terminated early|2
5441513|NCT02273180|18796202|P2|Overall Study|Other than specified above|10
5441514|NCT02273180|18796203|P1|Overall Study|Other than specified above|21
5441515|NCT02273180|18796202|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
5441516|NCT02273180|18796203|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
5441517|NCT02273180|18796202|P2|Overall Study|Randomized but not treated|0
5441518|NCT02273180|18796203|P1|Overall Study|Randomized but not treated|1
5441519|NCT02273180|18796202|P2|Overall Study|Protocol Violation|7
5441520|NCT02273180|18796203|P1|Overall Study|Protocol Violation|1
5441521|NCT02273180|18796202|P2|Overall Study|Lack of Efficacy|0
5441522|NCT02273180|18796203|P1|Overall Study|Lack of Efficacy|1
5441523|NCT02273180|18796202|P2|Overall Study|Adverse Event|2
5441524|NCT02273180|18796203|P1|Overall Study|Adverse Event|2
5441525|NCT02273167|18796228|P3|Overall Study|Various|8
5441526|NCT02273167|18796229|P2|Overall Study|Various|9
5441527|NCT02273167|18796230|P1|Overall Study|Various|10
5441528|NCT02273167|18796228|P3|Overall Study|Withdrawal by Subject|11
5441529|NCT02273167|18796229|P2|Overall Study|Withdrawal by Subject|12
5441530|NCT02273167|18796230|P1|Overall Study|Withdrawal by Subject|10
5441531|NCT02273167|18796228|P3|Overall Study|Lost to Follow-up|1
5441532|NCT02273167|18796229|P2|Overall Study|Lost to Follow-up|1
5441533|NCT02273167|18796230|P1|Overall Study|Lost to Follow-up|0
5441534|NCT02273167|18796228|P3|Overall Study|Protocol Violation|1
5441535|NCT02273167|18796229|P2|Overall Study|Protocol Violation|1
5441536|NCT02273167|18796230|P1|Overall Study|Protocol Violation|3
5441537|NCT02273167|18796228|P3|Overall Study|Adverse Event|0
5441538|NCT02273167|18796229|P2|Overall Study|Adverse Event|0
5441539|NCT02273167|18796230|P1|Overall Study|Adverse Event|1
5441540|NCT02273141|18796255|P2|Overall Study|Various|6
5441541|NCT02273141|18796256|P1|Overall Study|Various|6
5441542|NCT02273141|18796255|P2|Overall Study|Withdrawal by Subject|15
5441543|NCT02273141|18796256|P1|Overall Study|Withdrawal by Subject|10
5441544|NCT02273141|18796255|P2|Overall Study|Lost to Follow-up|3
5441545|NCT02273141|18796256|P1|Overall Study|Lost to Follow-up|1
5441546|NCT02273141|18796255|P2|Overall Study|Adverse Event|1
5441547|NCT02273141|18796256|P1|Overall Study|Adverse Event|0
5441548|NCT02273050|18796329|P3|Overall Study|Protocol Violation|4
5441549|NCT02273050|18796330|P2|Overall Study|Protocol Violation|1
5441550|NCT02273050|18796331|P1|Overall Study|Protocol Violation|3
5441551|NCT02273050|18796329|P3|Overall Study|Lost to Follow-up|3
5441552|NCT02273050|18796330|P2|Overall Study|Lost to Follow-up|2
5441553|NCT02273050|18796331|P1|Overall Study|Lost to Follow-up|0
5441554|NCT02273050|18796329|P3|Overall Study|Withdrawal by Subject|16
5441555|NCT02273050|18796330|P2|Overall Study|Withdrawal by Subject|14
5441556|NCT02273050|18796331|P1|Overall Study|Withdrawal by Subject|17
5441557|NCT02273050|18796329|P3|Overall Study|Lack of Efficacy|1
5441558|NCT02273050|18796330|P2|Overall Study|Lack of Efficacy|1
5441559|NCT02273050|18796331|P1|Overall Study|Lack of Efficacy|0
5441560|NCT02273050|18796329|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
5441561|NCT02273050|18796330|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
5441562|NCT02273050|18796331|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
5441563|NCT02273050|18796329|P3|Overall Study|Death|1
5441564|NCT02273050|18796330|P2|Overall Study|Death|0
5441565|NCT02273050|18796331|P1|Overall Study|Death|0
5441566|NCT02273050|18796329|P3|Overall Study|Adverse Event|3
5441567|NCT02273050|18796330|P2|Overall Study|Adverse Event|3
5441568|NCT02273050|18796331|P1|Overall Study|Adverse Event|4
5441569|NCT02273037|18796359|P2|Overall Study|Other complication|0
5441570|NCT02273037|18796360|P1|Overall Study|Other complication|2
5441571|NCT02273037|18796359|P2|Overall Study|Multiple delivery|2
5441572|NCT02273037|18796360|P1|Overall Study|Multiple delivery|2
5441573|NCT02273037|18796359|P2|Overall Study|Breech delivery|3
5441574|NCT02273037|18796360|P1|Overall Study|Breech delivery|2
5441575|NCT02273037|18796359|P2|Overall Study|Delivered before monitoring initiated|3
5441576|NCT02273037|18796360|P1|Overall Study|Delivered before monitoring initiated|1
5441577|NCT02273037|18796359|P2|Overall Study|Lost to Follow-up|0
5441578|NCT02273037|18796360|P1|Overall Study|Lost to Follow-up|1
5441579|NCT02272985|18796370|P1|Overall Study|kidney transplantation|1
5441580|NCT02272985|18796370|P1|Overall Study|hip fracture|1
5441581|NCT02272985|18796370|P1|Overall Study|Withdrawal by Subject|1
5441582|NCT02272816|18796375|P1|Overall Study|Adverse Event|1
5441583|NCT02272803|18796383|P2|Overall Study|Withdrawal by Subject|0
5441584|NCT02272803|18796384|P1|Overall Study|Withdrawal by Subject|1
5441585|NCT02272803|18796383|P2|Overall Study|Poor/non-compliance|1
5441586|NCT02272803|18796384|P1|Overall Study|Poor/non-compliance|0
5441587|NCT02272803|18796383|P2|Overall Study|Subject moved to care facility|1
5441588|NCT02272803|18796384|P1|Overall Study|Subject moved to care facility|0
5441589|NCT02272803|18796383|P2|Overall Study|Maximum clinical benefit|1
5441590|NCT02272803|18796384|P1|Overall Study|Maximum clinical benefit|1
5441591|NCT02272803|18796383|P2|Overall Study|Subj request to discontinue study trt|4
5441592|NCT02272803|18796384|P1|Overall Study|Subj request to discontinue study trt|1
5441593|NCT02272803|18796383|P2|Overall Study|Study drug toxicity|4
5441594|NCT02272803|18796384|P1|Overall Study|Study drug toxicity|1
5441595|NCT02272803|18796383|P2|Overall Study|Adverse Event unrelated to study drug|4
5441596|NCT02272803|18796384|P1|Overall Study|Adverse Event unrelated to study drug|1
5441597|NCT02272803|18796383|P2|Overall Study|Disease progression|2
5441598|NCT02272803|18796384|P1|Overall Study|Disease progression|4
5441599|NCT02272790|18796401|P6|Overall Study|Physician Decision|0
5441600|NCT02272790|18796402|P5|Overall Study|Physician Decision|0
5441601|NCT02272790|18796403|P4|Overall Study|Physician Decision|0
5441602|NCT02272790|18796404|P3|Overall Study|Physician Decision|0
5441603|NCT02272790|18796405|P2|Overall Study|Physician Decision|1
5441604|NCT02272790|18796406|P1|Overall Study|Physician Decision|0
5441605|NCT02272777|18796542|P2|Overall Study|Other|0
5441606|NCT02272777|18796543|P1|Overall Study|Other|2
5441607|NCT02272777|18796542|P2|Overall Study|Lost to Follow-up|0
5441608|NCT02272777|18796543|P1|Overall Study|Lost to Follow-up|2
5441609|NCT02272777|18796542|P2|Overall Study|Withdrawal by Subject|3
5441610|NCT02272777|18796543|P1|Overall Study|Withdrawal by Subject|0
5441611|NCT02272777|18796542|P2|Overall Study|Adverse Event|1
5441612|NCT02272777|18796543|P1|Overall Study|Adverse Event|0
5441613|NCT02272725|18796551|P2|Overall Study|equipment malfunction|0
5441614|NCT02272725|18796552|P1|Overall Study|equipment malfunction|2
5441615|NCT02272413|18796569|P2|Post-switch Period|Other than listed|5
5441616|NCT02272413|18796570|P1|Post-switch Period|Other than listed|4
5441617|NCT02272413|18796569|P2|Post-switch Period|Study terminated by sponsor|11
5441618|NCT02272413|18796570|P1|Post-switch Period|Study terminated by sponsor|8
5441619|NCT02272413|18796569|P2|Post-switch Period|Progressive disease|21
5441620|NCT02272413|18796570|P1|Post-switch Period|Progressive disease|21
5441621|NCT02272413|18796569|P2|Post-switch Period|Physician Decision|1
5441622|NCT02272413|18796570|P1|Post-switch Period|Physician Decision|1
5441623|NCT02272413|18796569|P2|Post-switch Period|Withdrawal by Subject|2
5441624|NCT02272413|18796570|P1|Post-switch Period|Withdrawal by Subject|1
5441625|NCT02272413|18796569|P2|Post-switch Period|Death|2
5441626|NCT02272413|18796570|P1|Post-switch Period|Death|3
5441627|NCT02272413|18796569|P2|Post-switch Period|Adverse Event|4
5441628|NCT02272413|18796570|P1|Post-switch Period|Adverse Event|4
5441629|NCT02272413|18796569|P2|Pre-switch Period|Other than listed|11
5441630|NCT02272413|18796570|P1|Pre-switch Period|Other than listed|10
5441631|NCT02272413|18796569|P2|Pre-switch Period|Protocol Violation|0
5441632|NCT02272413|18796570|P1|Pre-switch Period|Protocol Violation|1
5441633|NCT02272413|18796569|P2|Pre-switch Period|Lost to Follow-up|2
5441634|NCT02272413|18796570|P1|Pre-switch Period|Lost to Follow-up|0
5441635|NCT02272413|18796569|P2|Pre-switch Period|Progressive disease|173
5441636|NCT02272413|18796570|P1|Pre-switch Period|Progressive disease|185
5441637|NCT02272413|18796569|P2|Pre-switch Period|Physician Decision|18
5441638|NCT02272413|18796570|P1|Pre-switch Period|Physician Decision|6
5441639|NCT02272413|18796569|P2|Pre-switch Period|Withdrawal by Subject|15
5441640|NCT02272413|18796570|P1|Pre-switch Period|Withdrawal by Subject|27
5441641|NCT02272413|18796569|P2|Pre-switch Period|Death|26
5441642|NCT02272413|18796570|P1|Pre-switch Period|Death|26
5441643|NCT02272413|18796569|P2|Pre-switch Period|Adverse Event|37
5441644|NCT02272413|18796570|P1|Pre-switch Period|Adverse Event|38
5441645|NCT02272413|18796569|P2|Randomized Through Treatment Start|Not treated|5
5441646|NCT02272413|18796570|P1|Randomized Through Treatment Start|Not treated|3
5441647|NCT02271984|18796601|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441648|NCT02271984|18796602|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441649|NCT02271984|18796603|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441650|NCT02271984|18796604|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441651|NCT02271984|18796605|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
5441652|NCT02271984|18796606|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441653|NCT02271984|18796607|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
5441654|NCT02271984|18796608|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441655|NCT02271984|18796609|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441656|NCT02271984|18796610|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441657|NCT02271984|18796611|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441658|NCT02271984|18796612|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
5441659|NCT02271945|18796701|P2|Overall Study|Other|1
5441660|NCT02271945|18796702|P1|Overall Study|Other|1
5441661|NCT02271945|18796701|P2|Overall Study|Withdrawal by Subject|1
5441662|NCT02271945|18796702|P1|Overall Study|Withdrawal by Subject|1
5441663|NCT02271945|18796701|P2|Overall Study|Death|3
5441664|NCT02271945|18796702|P1|Overall Study|Death|3
5441665|NCT02271880|18796745|P2|Overall Study|Premature discontinuation of study|4
5441666|NCT02271880|18796746|P1|Overall Study|Premature discontinuation of study|3
5441667|NCT02271854|18796776|P1|Overall Study|Lost to Follow-up|1
5441668|NCT02271854|18796776|P1|Overall Study|Unable or unwilling to cooperate with st|1
5441669|NCT02271854|18796776|P1|Overall Study|Withdrawal by Subject|2
5441670|NCT02271529|18796816|P1|Overall Study|Withdrawal by Subject|1
5441671|NCT02270983|18796937|P3|Overall Study|moved away from study site|0
5441672|NCT02270983|18796938|P2|Overall Study|moved away from study site|1
5441673|NCT02270983|18796939|P1|Overall Study|moved away from study site|0
5441674|NCT02270983|18796937|P3|Overall Study|study procedure non-compliance|0
5441675|NCT02270983|18796938|P2|Overall Study|study procedure non-compliance|0
5441676|NCT02270983|18796939|P1|Overall Study|study procedure non-compliance|1
5441677|NCT02270983|18796937|P3|Overall Study|family emergency|0
5441678|NCT02270983|18796938|P2|Overall Study|family emergency|1
5441679|NCT02270983|18796939|P1|Overall Study|family emergency|0
5441680|NCT02270983|18796937|P3|Overall Study|Protocol Violation|1
5441681|NCT02270983|18796938|P2|Overall Study|Protocol Violation|1
5441682|NCT02270983|18796939|P1|Overall Study|Protocol Violation|1
5441683|NCT02270983|18796937|P3|Overall Study|Lost to Follow-up|2
5441684|NCT02270983|18796938|P2|Overall Study|Lost to Follow-up|1
5441685|NCT02270983|18796939|P1|Overall Study|Lost to Follow-up|1
5441686|NCT02270983|18796937|P3|Overall Study|Withdrawal by Subject|2
5441687|NCT02270983|18796938|P2|Overall Study|Withdrawal by Subject|0
5441688|NCT02270983|18796939|P1|Overall Study|Withdrawal by Subject|1
5441689|NCT02270983|18796937|P3|Overall Study|Lack of Efficacy|1
5441690|NCT02270983|18796938|P2|Overall Study|Lack of Efficacy|1
5441691|NCT02270983|18796939|P1|Overall Study|Lack of Efficacy|2
5441692|NCT02270983|18796937|P3|Overall Study|Adverse Event|6
5441693|NCT02270983|18796938|P2|Overall Study|Adverse Event|2
5441694|NCT02270983|18796939|P1|Overall Study|Adverse Event|3
5441695|NCT02270957|18796964|P2|Overall Study|Adverse Event|0
5441696|NCT02270957|18796965|P1|Overall Study|Adverse Event|2
5441697|NCT02270957|18796964|P2|Overall Study|Lack of Efficacy|4
5441698|NCT02270957|18796965|P1|Overall Study|Lack of Efficacy|2
5441699|NCT02270944|18796977|P2|Overall Study|Withdrawal by Subject|1
5441700|NCT02270944|18796978|P1|Overall Study|Withdrawal by Subject|2
5441701|NCT02270944|18796977|P2|Overall Study|Lost to Follow-up|4
5441702|NCT02270944|18796978|P1|Overall Study|Lost to Follow-up|9
5441703|NCT02270684|18796996|P2|Overall Study|Study terminated|0
5441704|NCT02270684|18796997|P1|Overall Study|Study terminated|1
5441705|NCT02270684|18796996|P2|Overall Study|Lost to Follow-up|3
5441706|NCT02270684|18796997|P1|Overall Study|Lost to Follow-up|0
5441707|NCT02270671|18797005|P2|Overall Study|Lost to Follow-up|1
5441708|NCT02270671|18797006|P1|Overall Study|Lost to Follow-up|2
5441709|NCT02270671|18797005|P2|Overall Study|Missed Post-intervention Data Collection|2
5441710|NCT02270671|18797006|P1|Overall Study|Missed Post-intervention Data Collection|2
5441711|NCT02270671|18797005|P2|Overall Study|Protocol Violation|1
5441712|NCT02270671|18797006|P1|Overall Study|Protocol Violation|0
5441713|NCT02270671|18797005|P2|Overall Study|Withdrawal by Subject|1
5441714|NCT02270671|18797006|P1|Overall Study|Withdrawal by Subject|1
5441715|NCT02270515|18797031|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
5441716|NCT02270515|18797031|P1|Intervention Period 3: 12-18 Months|Death|3
5441717|NCT02270515|18797031|P1|Intervention Period 3: 12-18 Months|Received transplant|2
5441718|NCT02270515|18797031|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
5441719|NCT02270515|18797031|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
5441720|NCT02270515|18797031|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
5441721|NCT02270515|18797031|P1|Intervention Period 2: 6-12 Months|Death|5
5441722|NCT02270515|18797031|P1|Intervention Period 2: 6-12 Months|Received transplant|1
5441723|NCT02270515|18797031|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
5441724|NCT02270515|18797031|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
5441725|NCT02270515|18797031|P1|Intervention Period 1: 0-6 Months|Death|7
5441726|NCT02270515|18797031|P1|Intervention Period 1: 0-6 Months|Received transplant|3
5441727|NCT02270515|18797031|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
5441728|NCT02270515|18797031|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
5441729|NCT02270242|18797059|P2|Overall Study|Physician Decision|1
5441730|NCT02270242|18797060|P1|Overall Study|Physician Decision|0
5441731|NCT02270242|18797059|P2|Overall Study|Lost to Follow-up|27
5441732|NCT02270242|18797060|P1|Overall Study|Lost to Follow-up|41
5441733|NCT02270242|18797059|P2|Overall Study|Withdrawal by Subject|25
5441734|NCT02270242|18797060|P1|Overall Study|Withdrawal by Subject|18
5441735|NCT02269943|18797101|P2|Follow-Up Survival Period|Alive|8
5441736|NCT02269943|18797102|P1|Follow-Up Survival Period|Alive|2
5441737|NCT02269943|18797101|P2|Follow-Up Survival Period|Lost to Follow-up|2
5441738|NCT02269943|18797102|P1|Follow-Up Survival Period|Lost to Follow-up|0
5441739|NCT02269943|18797101|P2|Follow-Up Survival Period|Death|16
5441740|NCT02269943|18797102|P1|Follow-Up Survival Period|Death|3
5441741|NCT02269943|18797101|P2|Treatment Period|Symptomatic Deterioration|2
5441742|NCT02269943|18797102|P1|Treatment Period|Symptomatic Deterioration|0
5441743|NCT02269943|18797101|P2|Treatment Period|Progressive Disease|17
5441744|NCT02269943|18797102|P1|Treatment Period|Progressive Disease|5
5441745|NCT02269943|18797101|P2|Treatment Period|Adverse Event|10
5441746|NCT02269943|18797102|P1|Treatment Period|Adverse Event|1
5441747|NCT02269943|18797101|P2|Treatment Period|Death|1
5441748|NCT02269943|18797102|P1|Treatment Period|Death|0
5441749|NCT02269917|18797132|P2|Overall Study|Randomized but not treated|5
5441750|NCT02269917|18797133|P1|Overall Study|Randomized but not treated|3
5441751|NCT02269917|18797132|P2|Overall Study|Non-compliance with study drug|0
5441752|NCT02269917|18797133|P1|Overall Study|Non-compliance with study drug|2
5441753|NCT02269917|18797132|P2|Overall Study|Adverse Event|4
5441754|NCT02269917|18797133|P1|Overall Study|Adverse Event|11
5441755|NCT02269917|18797132|P2|Overall Study|Withdrawal by Subject|8
5441756|NCT02269917|18797133|P1|Overall Study|Withdrawal by Subject|9
5441757|NCT02269917|18797132|P2|Overall Study|Other|3
5441758|NCT02269917|18797133|P1|Overall Study|Other|6
5441759|NCT02269917|18797132|P2|Overall Study|Ongoing|360
5441760|NCT02269917|18797133|P1|Overall Study|Ongoing|731
5441761|NCT02269917|18797132|P2|Overall Study|Lost to Follow-up|3
5441762|NCT02269917|18797133|P1|Overall Study|Lost to Follow-up|4
5441763|NCT02269787|18797186|P2|Overall Study|Incapacitated|1
5441764|NCT02269787|18797187|P1|Overall Study|Incapacitated|0
5441765|NCT02269787|18797186|P2|Overall Study|Death|3
5441766|NCT02269787|18797187|P1|Overall Study|Death|2
5441767|NCT02269787|18797186|P2|Overall Study|Lost to Follow-up|6
5441768|NCT02269787|18797187|P1|Overall Study|Lost to Follow-up|20
5441769|NCT02269709|18797193|P1|Six Month Follow-up|Lost to Follow-up|12
5441770|NCT02269709|18797193|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
5441771|NCT02269709|18797193|P1|Time of Enrollment|Withdrawal by Subject|3
5441772|NCT02269657|18797198|P1|Overall Study|Protocol Violation|3
5441773|NCT02269475|18797235|P2|Overall Study|Withdrawal by Subject|1
5441774|NCT02269475|18797236|P1|Overall Study|Withdrawal by Subject|0
5441775|NCT02269475|18797235|P2|Overall Study|Meet Exclusion Criteria No. 17|0
5441776|NCT02269475|18797236|P1|Overall Study|Meet Exclusion Criteria No. 17|3
5441777|NCT02269423|18797251|P4|Overall Study|Discontinued due to change in residence|1
5441778|NCT02269423|18797252|P3|Overall Study|Discontinued due to change in residence|0
5441779|NCT02269423|18797253|P2|Overall Study|Discontinued due to change in residence|1
5441780|NCT02269423|18797254|P1|Overall Study|Discontinued due to change in residence|0
5441781|NCT02269241|18797316|P1|Overall Study|Screening failures|546
5441782|NCT02269241|18797316|P1|Overall Study|Several reasons not classified|53
5441783|NCT02269241|18797316|P1|Overall Study|At the specific request of the sponsor|20
5441784|NCT02269241|18797316|P1|Overall Study|Adverse Event|113
5441785|NCT02269241|18797316|P1|Overall Study|Development of an exclusion criteria|16
5441786|NCT02269241|18797316|P1|Overall Study|Wish for pregnancy|5
5441787|NCT02269241|18797316|P1|Overall Study|Pregnancy|15
5441788|NCT02269241|18797316|P1|Overall Study|Physician Decision|7
5441789|NCT02269241|18797316|P1|Overall Study|Protocol Violation|1
5441790|NCT02269241|18797316|P1|Overall Study|Withdrawal by Subject|155
5441791|NCT02269241|18797316|P1|Overall Study|Lost to Follow-up|269
5441792|NCT02269098|18797330|P2|Overall Study|Lost to Follow-up|9
5441793|NCT02269098|18797331|P1|Overall Study|Lost to Follow-up|14
5441794|NCT02268864|18797392|P3|Overall Study|Death|0
5441795|NCT02268864|18797393|P2|Overall Study|Death|1
5441796|NCT02268864|18797394|P1|Overall Study|Death|0
5441797|NCT02268864|18797392|P3|Overall Study|Withdrawal by Subject|0
5441798|NCT02268864|18797393|P2|Overall Study|Withdrawal by Subject|0
5441799|NCT02268864|18797394|P1|Overall Study|Withdrawal by Subject|2
5441800|NCT02268851|18797422|P6|Overall Study|Co-Morbid Condition|1
5441801|NCT02268851|18797423|P5|Overall Study|Co-Morbid Condition|1
5441802|NCT02268851|18797424|P4|Overall Study|Co-Morbid Condition|0
5441803|NCT02268851|18797425|P3|Overall Study|Co-Morbid Condition|0
5441804|NCT02268851|18797426|P2|Overall Study|Co-Morbid Condition|0
5441805|NCT02268851|18797427|P1|Overall Study|Co-Morbid Condition|0
5441806|NCT02268851|18797422|P6|Overall Study|Patient Compliance|1
5441807|NCT02268851|18797423|P5|Overall Study|Patient Compliance|1
5441808|NCT02268851|18797424|P4|Overall Study|Patient Compliance|0
5441809|NCT02268851|18797425|P3|Overall Study|Patient Compliance|0
5441810|NCT02268851|18797426|P2|Overall Study|Patient Compliance|0
5441811|NCT02268851|18797427|P1|Overall Study|Patient Compliance|0
5441812|NCT02268851|18797422|P6|Overall Study|Physician Decision|1
5441813|NCT02268851|18797423|P5|Overall Study|Physician Decision|0
5441814|NCT02268851|18797424|P4|Overall Study|Physician Decision|0
5441815|NCT02268851|18797425|P3|Overall Study|Physician Decision|1
5441816|NCT02268851|18797426|P2|Overall Study|Physician Decision|0
5441817|NCT02268851|18797427|P1|Overall Study|Physician Decision|0
5441818|NCT02268851|18797422|P6|Overall Study|Progressive Disease|4
5441819|NCT02268851|18797423|P5|Overall Study|Progressive Disease|1
5441820|NCT02268851|18797424|P4|Overall Study|Progressive Disease|0
5441821|NCT02268851|18797425|P3|Overall Study|Progressive Disease|0
5441822|NCT02268851|18797426|P2|Overall Study|Progressive Disease|3
5441823|NCT02268851|18797427|P1|Overall Study|Progressive Disease|1
5441824|NCT02268851|18797422|P6|Overall Study|Withdrawal by Subject|1
5441825|NCT02268851|18797423|P5|Overall Study|Withdrawal by Subject|0
5441826|NCT02268851|18797424|P4|Overall Study|Withdrawal by Subject|2
5441827|NCT02268851|18797425|P3|Overall Study|Withdrawal by Subject|0
5441828|NCT02268851|18797426|P2|Overall Study|Withdrawal by Subject|0
5441829|NCT02268851|18797427|P1|Overall Study|Withdrawal by Subject|0
5441830|NCT02268851|18797422|P6|Overall Study|Adverse Event|2
5441831|NCT02268851|18797423|P5|Overall Study|Adverse Event|2
5441832|NCT02268851|18797424|P4|Overall Study|Adverse Event|0
5441833|NCT02268851|18797425|P3|Overall Study|Adverse Event|0
5441834|NCT02268851|18797426|P2|Overall Study|Adverse Event|0
5441835|NCT02268851|18797427|P1|Overall Study|Adverse Event|0
5441836|NCT02268851|18797422|P6|Overall Study|Death|1
5441837|NCT02268851|18797423|P5|Overall Study|Death|2
5441838|NCT02268851|18797424|P4|Overall Study|Death|1
5441839|NCT02268851|18797425|P3|Overall Study|Death|0
5441840|NCT02268851|18797426|P2|Overall Study|Death|0
5441841|NCT02268851|18797427|P1|Overall Study|Death|0
5441842|NCT02268812|18797445|P4|Overall Study|Other|3
5441843|NCT02268812|18797446|P3|Overall Study|Other|1
5441844|NCT02268812|18797447|P2|Overall Study|Other|4
5441845|NCT02268812|18797448|P1|Overall Study|Other|5
5441846|NCT02268812|18797445|P4|Overall Study|Physician Decision|1
5441847|NCT02268812|18797446|P3|Overall Study|Physician Decision|0
5441848|NCT02268812|18797447|P2|Overall Study|Physician Decision|1
5441849|NCT02268812|18797448|P1|Overall Study|Physician Decision|3
5441850|NCT02268812|18797445|P4|Overall Study|Withdrawal by Subject|0
5441851|NCT02268812|18797446|P3|Overall Study|Withdrawal by Subject|0
5441852|NCT02268812|18797447|P2|Overall Study|Withdrawal by Subject|1
5441853|NCT02268812|18797448|P1|Overall Study|Withdrawal by Subject|0
5441854|NCT02268812|18797445|P4|Overall Study|Protocol deviation|0
5441855|NCT02268812|18797446|P3|Overall Study|Protocol deviation|1
5441856|NCT02268812|18797447|P2|Overall Study|Protocol deviation|0
5441857|NCT02268812|18797448|P1|Overall Study|Protocol deviation|0
5441858|NCT02268812|18797445|P4|Overall Study|Adverse Event|10
5441859|NCT02268812|18797446|P3|Overall Study|Adverse Event|7
5441860|NCT02268812|18797447|P2|Overall Study|Adverse Event|26
5441861|NCT02268812|18797448|P1|Overall Study|Adverse Event|8
5441862|NCT02268786|18797480|P2|Overall Study|Protocol Violation|0
5441863|NCT02268786|18797481|P1|Overall Study|Protocol Violation|1
5441864|NCT02268786|18797480|P2|Overall Study|Thaw Failure|4
5441865|NCT02268786|18797481|P1|Overall Study|Thaw Failure|6
5441866|NCT02268786|18797480|P2|Overall Study|Withdrawal by Subject|14
5441867|NCT02268786|18797481|P1|Overall Study|Withdrawal by Subject|7
5441868|NCT02268786|18797480|P2|Overall Study|No Euploid Embryos available|0
5441869|NCT02268786|18797481|P1|Overall Study|No Euploid Embryos available|42
5441870|NCT02268526|18797490|P3|Overall Study|Subject/guardian decision|3
5441871|NCT02268526|18797491|P2|Overall Study|Subject/guardian decision|7
5441872|NCT02268526|18797492|P1|Overall Study|Subject/guardian decision|0
5441873|NCT02268526|18797490|P3|Overall Study|Physician Decision|1
5441874|NCT02268526|18797491|P2|Overall Study|Physician Decision|0
5441875|NCT02268526|18797492|P1|Overall Study|Physician Decision|0
5441876|NCT02268526|18797490|P3|Overall Study|protocol deviation|0
5441877|NCT02268526|18797491|P2|Overall Study|protocol deviation|1
5441878|NCT02268526|18797492|P1|Overall Study|protocol deviation|0
5441879|NCT02268526|18797490|P3|Overall Study|Death|0
5441880|NCT02268526|18797491|P2|Overall Study|Death|11
5441881|NCT02268526|18797492|P1|Overall Study|Death|1
5441882|NCT02268526|18797490|P3|Overall Study|Adverse Event|1
5441883|NCT02268526|18797491|P2|Overall Study|Adverse Event|2
5441884|NCT02268526|18797492|P1|Overall Study|Adverse Event|0
5441885|NCT02268396|18797513|P1|Overall Study|2 Subjects no Day 29 Assessment|2
5441886|NCT02268396|18797513|P1|Overall Study|Protocol-Specified Criteria|2
5441887|NCT02268396|18797513|P1|Overall Study|Lost to Follow-up|2
5441888|NCT02268396|18797513|P1|Overall Study|Withdrawal by Subject|1
5441889|NCT02268396|18797513|P1|Overall Study|Administrative|2
5441890|NCT02268396|18797513|P1|Overall Study|Adverse Event|3
5441891|NCT02268214|18797525|P3|Overall Study|Not entering long-term period|5
5441892|NCT02268214|18797526|P2|Overall Study|Not entering long-term period|3
5441893|NCT02268214|18797527|P1|Overall Study|Not entering long-term period|2
5441894|NCT02268214|18797525|P3|Overall Study|Other reasons|3
5441895|NCT02268214|18797526|P2|Overall Study|Other reasons|3
5441896|NCT02268214|18797527|P1|Overall Study|Other reasons|7
5441897|NCT02268214|18797525|P3|Overall Study|Poor/non-compliance|2
5441898|NCT02268214|18797526|P2|Overall Study|Poor/non-compliance|1
5441899|NCT02268214|18797527|P1|Overall Study|Poor/non-compliance|2
5441900|NCT02268214|18797525|P3|Overall Study|Subject request to discontinue treatment|6
5441901|NCT02268214|18797526|P2|Overall Study|Subject request to discontinue treatment|8
5441902|NCT02268214|18797527|P1|Overall Study|Subject request to discontinue treatment|10
5441903|NCT02268214|18797525|P3|Overall Study|Withdrawal by Subject|10
5441904|NCT02268214|18797526|P2|Overall Study|Withdrawal by Subject|5
5441905|NCT02268214|18797527|P1|Overall Study|Withdrawal by Subject|4
5441906|NCT02268214|18797525|P3|Overall Study|Adverse Event|9
5441907|NCT02268214|18797526|P2|Overall Study|Adverse Event|14
5441908|NCT02268214|18797527|P1|Overall Study|Adverse Event|11
5441909|NCT02268214|18797525|P3|Overall Study|Lack of Efficacy|2
5441910|NCT02268214|18797526|P2|Overall Study|Lack of Efficacy|0
5441911|NCT02268214|18797527|P1|Overall Study|Lack of Efficacy|1
5441912|NCT02268214|18797525|P3|Overall Study|Lost to Follow-up|4
5441913|NCT02268214|18797526|P2|Overall Study|Lost to Follow-up|3
5441914|NCT02268214|18797527|P1|Overall Study|Lost to Follow-up|3
5441915|NCT02268214|18797525|P3|Overall Study|Pregnancy|1
5441916|NCT02268214|18797526|P2|Overall Study|Pregnancy|2
5441917|NCT02268214|18797527|P1|Overall Study|Pregnancy|2
5441918|NCT02268214|18797525|P3|Overall Study|Subject no longer meets study criteria|0
5441919|NCT02268214|18797526|P2|Overall Study|Subject no longer meets study criteria|2
5441920|NCT02268214|18797527|P1|Overall Study|Subject no longer meets study criteria|0
5441921|NCT02268058|18797574|P4|Overall Study|Protocol Violation|0
5441922|NCT02268058|18797575|P3|Overall Study|Protocol Violation|0
5441923|NCT02268058|18797576|P2|Overall Study|Protocol Violation|0
5441924|NCT02268058|18797577|P1|Overall Study|Protocol Violation|1
5441925|NCT02268045|18797601|P2|Overall Study|Protocol Violation|1
5441926|NCT02268045|18797602|P1|Overall Study|Protocol Violation|1
5441927|NCT02268045|18797601|P2|Overall Study|Physician Decision|1
5441928|NCT02268045|18797602|P1|Overall Study|Physician Decision|0
5441929|NCT02268045|18797601|P2|Overall Study|Withdrawal by Subject|6
5441930|NCT02268045|18797602|P1|Overall Study|Withdrawal by Subject|2
5441931|NCT02268045|18797601|P2|Overall Study|Adverse Event|7
5441932|NCT02268045|18797602|P1|Overall Study|Adverse Event|7
5441933|NCT02268045|18797601|P2|Overall Study|Disease Progression|1
5441934|NCT02268045|18797602|P1|Overall Study|Disease Progression|2
5441935|NCT02268045|18797601|P2|Overall Study|Death|4
5441936|NCT02268045|18797602|P1|Overall Study|Death|4
5441937|NCT02267824|18797644|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
5441938|NCT02267824|18797645|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
5441939|NCT02267824|18797644|P2|Overall Study|Protocol Violation|0
5441940|NCT02267824|18797645|P1|Overall Study|Protocol Violation|3
5441941|NCT02267824|18797644|P2|Overall Study|Lost to Follow-up|0
5441942|NCT02267824|18797645|P1|Overall Study|Lost to Follow-up|4
5441943|NCT02267824|18797644|P2|Overall Study|Pregnancy|1
5441944|NCT02267824|18797645|P1|Overall Study|Pregnancy|1
5441945|NCT02267746|18797667|P3|Overall Study|Miscellaneous|1
5441946|NCT02267746|18797668|P2|Overall Study|Miscellaneous|0
5441947|NCT02267746|18797669|P1|Overall Study|Miscellaneous|1
5441948|NCT02267746|18797667|P3|Overall Study|Protocol Violation|1
5441949|NCT02267746|18797668|P2|Overall Study|Protocol Violation|2
5441950|NCT02267746|18797669|P1|Overall Study|Protocol Violation|1
5441951|NCT02267746|18797667|P3|Overall Study|Lack of Efficacy|15
5441952|NCT02267746|18797668|P2|Overall Study|Lack of Efficacy|11
5441953|NCT02267746|18797669|P1|Overall Study|Lack of Efficacy|11
5441954|NCT02267746|18797667|P3|Overall Study|Protocol Violation|3
5441955|NCT02267746|18797668|P2|Overall Study|Protocol Violation|7
5441956|NCT02267746|18797669|P1|Overall Study|Protocol Violation|8
5441957|NCT02267746|18797667|P3|Overall Study|Adverse Event|1
5441958|NCT02267746|18797668|P2|Overall Study|Adverse Event|2
5441959|NCT02267746|18797669|P1|Overall Study|Adverse Event|0
5441960|NCT02267317|18797779|P6|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5441961|NCT02267317|18797780|P5|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5441962|NCT02267317|18797781|P4|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5441963|NCT02267317|18797782|P3|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5441964|NCT02267317|18797783|P2|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
5441965|NCT02267317|18797784|P1|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
5441966|NCT02267317|18797779|P6|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5441967|NCT02267317|18797780|P5|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5441968|NCT02267317|18797781|P4|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5441969|NCT02267317|18797782|P3|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5441970|NCT02267317|18797783|P2|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
5441971|NCT02267317|18797784|P1|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
5441972|NCT02267278|18797834|P1|Overall Study|prescribed prohibited medication|1
5441973|NCT02267278|18797834|P1|Overall Study|Developed new cancer diagnoses|2
5441974|NCT02267278|18797834|P1|Overall Study|transformation to acute leukemia (AML)|1
5441975|NCT02267278|18797834|P1|Overall Study|Proceeded to transplantation (allo-HCT)|1
5441976|NCT02267187|18797858|P1|Overall Study|Screen fail|3
5441977|NCT02267187|18797858|P1|Overall Study|Physician Decision|2
5441978|NCT02267135|18797866|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
5441979|NCT02267135|18797867|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
5441980|NCT02267135|18797866|P2|Period 2 (Randomized Set)|Adverse Event|0
5441981|NCT02267135|18797867|P1|Period 2 (Randomized Set)|Adverse Event|2
5441982|NCT02267135|18797866|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
5441983|NCT02267135|18797867|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
5441984|NCT02267135|18797866|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
5441985|NCT02267135|18797867|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
5441986|NCT02267135|18797866|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
5441987|NCT02267135|18797867|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
5441988|NCT02266888|18797911|P4|Overall Study|Transfer of care|0
5441989|NCT02266888|18797912|P3|Overall Study|Transfer of care|1
5441990|NCT02266888|18797913|P2|Overall Study|Transfer of care|0
5441991|NCT02266888|18797914|P1|Overall Study|Transfer of care|0
5441992|NCT02266888|18797911|P4|Overall Study|Personnel unavailable at transplant|1
5441993|NCT02266888|18797912|P3|Overall Study|Personnel unavailable at transplant|0
5441994|NCT02266888|18797913|P2|Overall Study|Personnel unavailable at transplant|0
5441995|NCT02266888|18797914|P1|Overall Study|Personnel unavailable at transplant|0
5441996|NCT02266888|18797911|P4|Overall Study|Randomization Closed|0
5441997|NCT02266888|18797912|P3|Overall Study|Randomization Closed|4
5441998|NCT02266888|18797913|P2|Overall Study|Randomization Closed|0
5441999|NCT02266888|18797914|P1|Overall Study|Randomization Closed|0
5442000|NCT02266888|18797911|P4|Overall Study|No Longer Eligible|2
5442001|NCT02266888|18797912|P3|Overall Study|No Longer Eligible|0
5442002|NCT02266888|18797913|P2|Overall Study|No Longer Eligible|0
5442003|NCT02266888|18797914|P1|Overall Study|No Longer Eligible|0
5442004|NCT02266888|18797911|P4|Overall Study|Study Terminated|0
5442005|NCT02266888|18797912|P3|Overall Study|Study Terminated|0
5442006|NCT02266888|18797913|P2|Overall Study|Study Terminated|1
5442007|NCT02266888|18797914|P1|Overall Study|Study Terminated|5
5442008|NCT02266888|18797911|P4|Overall Study|Physician Decision|2
5442009|NCT02266888|18797912|P3|Overall Study|Physician Decision|2
5442010|NCT02266888|18797913|P2|Overall Study|Physician Decision|1
5442011|NCT02266888|18797914|P1|Overall Study|Physician Decision|0
5442012|NCT02266888|18797911|P4|Overall Study|Death|2
5442013|NCT02266888|18797912|P3|Overall Study|Death|4
5442014|NCT02266888|18797913|P2|Overall Study|Death|2
5442015|NCT02266888|18797914|P1|Overall Study|Death|2
5442016|NCT02266875|18797948|P2|Overall Study|Lost to Follow-up|0
5442017|NCT02266875|18797949|P1|Overall Study|Lost to Follow-up|2
5442018|NCT02266875|18797948|P2|Overall Study|Withdrawal by Subject|0
5442019|NCT02266875|18797949|P1|Overall Study|Withdrawal by Subject|9
5442020|NCT02266706|18798014|P9|Overall Study|Enrollment in another study|0
5442021|NCT02266706|18798015|P8|Overall Study|Enrollment in another study|0
5442022|NCT02266706|18798016|P7|Overall Study|Enrollment in another study|0
5442023|NCT02266706|18798017|P6|Overall Study|Enrollment in another study|0
5442024|NCT02266706|18798018|P5|Overall Study|Enrollment in another study|0
5442025|NCT02266706|18798019|P4|Overall Study|Enrollment in another study|1
5442026|NCT02266706|18798020|P3|Overall Study|Enrollment in another study|0
5442027|NCT02266706|18798021|P2|Overall Study|Enrollment in another study|0
5442028|NCT02266706|18798022|P1|Overall Study|Enrollment in another study|0
5442029|NCT02266706|18798014|P9|Overall Study|Screen failure|0
5442030|NCT02266706|18798015|P8|Overall Study|Screen failure|0
5442031|NCT02266706|18798016|P7|Overall Study|Screen failure|1
5442032|NCT02266706|18798017|P6|Overall Study|Screen failure|1
5442033|NCT02266706|18798018|P5|Overall Study|Screen failure|0
5442034|NCT02266706|18798019|P4|Overall Study|Screen failure|0
5442035|NCT02266706|18798020|P3|Overall Study|Screen failure|0
5442036|NCT02266706|18798021|P2|Overall Study|Screen failure|0
5442037|NCT02266706|18798022|P1|Overall Study|Screen failure|0
5442038|NCT02266706|18798014|P9|Overall Study|Withdrawal by Subject|0
5442039|NCT02266706|18798015|P8|Overall Study|Withdrawal by Subject|0
5442040|NCT02266706|18798016|P7|Overall Study|Withdrawal by Subject|0
5442041|NCT02266706|18798017|P6|Overall Study|Withdrawal by Subject|1
5442042|NCT02266706|18798018|P5|Overall Study|Withdrawal by Subject|0
5442043|NCT02266706|18798019|P4|Overall Study|Withdrawal by Subject|0
5442044|NCT02266706|18798020|P3|Overall Study|Withdrawal by Subject|1
5442045|NCT02266706|18798021|P2|Overall Study|Withdrawal by Subject|1
5442046|NCT02266706|18798022|P1|Overall Study|Withdrawal by Subject|0
5442047|NCT02266433|18798253|P2|Overall Study|Withdrawal by Subject|7
5442048|NCT02266433|18798254|P1|Overall Study|Withdrawal by Subject|5
5442049|NCT02266433|18798253|P2|Overall Study|Lost to Follow-up|46
5442050|NCT02266433|18798254|P1|Overall Study|Lost to Follow-up|54
5442051|NCT02266381|18798371|P3|Overall Study|Physician Decision|4
5442052|NCT02266381|18798372|P2|Overall Study|Physician Decision|5
5442053|NCT02266381|18798373|P1|Overall Study|Physician Decision|3
5442054|NCT02266225|18798423|P1|Overall Study|Withdrawal by Subject|13
5442055|NCT02266225|18798423|P1|Overall Study|Death|1
5442056|NCT02266225|18798423|P1|Overall Study|Lost to Follow-up|2
5442057|NCT02266147|18798448|P4|PART 2: Dose Expansion|Study Terminated by Sponsor|8
5442058|NCT02266147|18798449|P3|PART 2: Dose Expansion|Study Terminated by Sponsor|0
5442059|NCT02266147|18798450|P2|PART 2: Dose Expansion|Study Terminated by Sponsor|0
5442060|NCT02266147|18798451|P1|PART 2: Dose Expansion|Study Terminated by Sponsor|6
5442061|NCT02266147|18798448|P4|PART 2: Dose Expansion|Lack of Efficacy|1
5442062|NCT02266147|18798449|P3|PART 2: Dose Expansion|Lack of Efficacy|0
5442063|NCT02266147|18798450|P2|PART 2: Dose Expansion|Lack of Efficacy|0
5442064|NCT02266147|18798451|P1|PART 2: Dose Expansion|Lack of Efficacy|1
5442065|NCT02266147|18798448|P4|PART 1: Dose Escalation|Other|0
5442066|NCT02266147|18798449|P3|PART 1: Dose Escalation|Other|0
5442067|NCT02266147|18798450|P2|PART 1: Dose Escalation|Other|1
5442068|NCT02266147|18798451|P1|PART 1: Dose Escalation|Other|1
5442069|NCT02266147|18798448|P4|PART 1: Dose Escalation|Study Terminated by Sponsor|3
5442070|NCT02266147|18798449|P3|PART 1: Dose Escalation|Study Terminated by Sponsor|1
5442071|NCT02266147|18798450|P2|PART 1: Dose Escalation|Study Terminated by Sponsor|0
5442072|NCT02266147|18798451|P1|PART 1: Dose Escalation|Study Terminated by Sponsor|0
5442073|NCT02266147|18798448|P4|PART 1: Dose Escalation|Lack of Efficacy|1
5442074|NCT02266147|18798449|P3|PART 1: Dose Escalation|Lack of Efficacy|1
5442075|NCT02266147|18798450|P2|PART 1: Dose Escalation|Lack of Efficacy|2
5442076|NCT02266147|18798451|P1|PART 1: Dose Escalation|Lack of Efficacy|0
5442077|NCT02266147|18798448|P4|PART 1: Dose Escalation|Physician Decision|0
5442078|NCT02266147|18798449|P3|PART 1: Dose Escalation|Physician Decision|1
5442079|NCT02266147|18798450|P2|PART 1: Dose Escalation|Physician Decision|0
5442080|NCT02266147|18798451|P1|PART 1: Dose Escalation|Physician Decision|0
5442081|NCT02266004|18798494|P1|Overall Study|Physician Decision|1
5442082|NCT02266004|18798494|P1|Overall Study|unrelated adverse event|1
5442083|NCT02265952|18798532|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|1
5442084|NCT02265952|18798533|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
5442085|NCT02265952|18798532|P2|Open Label Extension (OLE) Period|Physician Decision|7
5442086|NCT02265952|18798533|P1|Open Label Extension (OLE) Period|Physician Decision|0
5442087|NCT02265796|18798576|P2|Overall Study|Withdrawal by Subject|1
5442088|NCT02265796|18798577|P1|Overall Study|Withdrawal by Subject|1
5442089|NCT02265796|18798576|P2|Overall Study|started on excluded medication|0
5442090|NCT02265796|18798577|P1|Overall Study|started on excluded medication|1
5442091|NCT02265796|18798576|P2|Overall Study|Death|0
5442092|NCT02265796|18798577|P1|Overall Study|Death|1
5442093|NCT02265744|18798596|P5|Overall Study|Pregnancy|0
5442094|NCT02265744|18798597|P4|Overall Study|Pregnancy|1
5442095|NCT02265744|18798598|P3|Overall Study|Pregnancy|1
5442096|NCT02265744|18798599|P2|Overall Study|Pregnancy|2
5442097|NCT02265744|18798600|P1|Overall Study|Pregnancy|1
5442098|NCT02265744|18798596|P5|Overall Study|Subject no longer meets study criteria|1
5442099|NCT02265744|18798597|P4|Overall Study|Subject no longer meets study criteria|0
5442100|NCT02265744|18798598|P3|Overall Study|Subject no longer meets study criteria|0
5442101|NCT02265744|18798599|P2|Overall Study|Subject no longer meets study criteria|0
5442102|NCT02265744|18798600|P1|Overall Study|Subject no longer meets study criteria|0
5442103|NCT02265744|18798596|P5|Overall Study|Administrative reason by sponsor|3
5442104|NCT02265744|18798597|P4|Overall Study|Administrative reason by sponsor|3
5442105|NCT02265744|18798598|P3|Overall Study|Administrative reason by sponsor|2
5442106|NCT02265744|18798599|P2|Overall Study|Administrative reason by sponsor|2
5442107|NCT02265744|18798600|P1|Overall Study|Administrative reason by sponsor|3
5442108|NCT02265744|18798596|P5|Overall Study|Reason not provided by Investigator|0
5442109|NCT02265744|18798597|P4|Overall Study|Reason not provided by Investigator|2
5442110|NCT02265744|18798598|P3|Overall Study|Reason not provided by Investigator|0
5442111|NCT02265744|18798599|P2|Overall Study|Reason not provided by Investigator|0
5442112|NCT02265744|18798600|P1|Overall Study|Reason not provided by Investigator|1
5442113|NCT02265744|18798596|P5|Overall Study|Lack of Efficacy|5
5442114|NCT02265744|18798597|P4|Overall Study|Lack of Efficacy|4
5442115|NCT02265744|18798598|P3|Overall Study|Lack of Efficacy|3
5442116|NCT02265744|18798599|P2|Overall Study|Lack of Efficacy|4
5442117|NCT02265744|18798600|P1|Overall Study|Lack of Efficacy|2
5442118|NCT02265744|18798596|P5|Overall Study|Adverse Event|2
5442119|NCT02265744|18798597|P4|Overall Study|Adverse Event|8
5442120|NCT02265744|18798598|P3|Overall Study|Adverse Event|9
5442121|NCT02265744|18798599|P2|Overall Study|Adverse Event|4
5442122|NCT02265744|18798600|P1|Overall Study|Adverse Event|8
5442123|NCT02265744|18798596|P5|Overall Study|Participant request to discontinue|0
5442124|NCT02265744|18798597|P4|Overall Study|Participant request to discontinue|0
5442125|NCT02265744|18798598|P3|Overall Study|Participant request to discontinue|2
5442126|NCT02265744|18798599|P2|Overall Study|Participant request to discontinue|2
5442127|NCT02265744|18798600|P1|Overall Study|Participant request to discontinue|2
5442128|NCT02265744|18798596|P5|Overall Study|Withdrawal by Subject|0
5442129|NCT02265744|18798597|P4|Overall Study|Withdrawal by Subject|2
5442130|NCT02265744|18798598|P3|Overall Study|Withdrawal by Subject|0
5442131|NCT02265744|18798599|P2|Overall Study|Withdrawal by Subject|0
5442132|NCT02265744|18798600|P1|Overall Study|Withdrawal by Subject|2
5442133|NCT02265744|18798596|P5|Overall Study|Death|0
5442134|NCT02265744|18798597|P4|Overall Study|Death|2
5442135|NCT02265744|18798598|P3|Overall Study|Death|0
5442136|NCT02265744|18798599|P2|Overall Study|Death|0
5442137|NCT02265744|18798600|P1|Overall Study|Death|0
5442138|NCT02265744|18798596|P5|Overall Study|Lost to Follow-up|0
5442139|NCT02265744|18798597|P4|Overall Study|Lost to Follow-up|1
5442140|NCT02265744|18798598|P3|Overall Study|Lost to Follow-up|0
5442141|NCT02265744|18798599|P2|Overall Study|Lost to Follow-up|0
5442142|NCT02265744|18798600|P1|Overall Study|Lost to Follow-up|0
5442143|NCT02265744|18798596|P5|Overall Study|Poor/Non-compliance|2
5442144|NCT02265744|18798597|P4|Overall Study|Poor/Non-compliance|0
5442145|NCT02265744|18798598|P3|Overall Study|Poor/Non-compliance|0
5442146|NCT02265744|18798599|P2|Overall Study|Poor/Non-compliance|1
5442147|NCT02265744|18798600|P1|Overall Study|Poor/Non-compliance|1
5442148|NCT02265705|18798779|P7|Follow-up Period|Withdrawal by Subject|1
5442149|NCT02265705|18798780|P6|Follow-up Period|Withdrawal by Subject|0
5442150|NCT02265705|18798781|P5|Follow-up Period|Withdrawal by Subject|0
5442151|NCT02265705|18798782|P4|Follow-up Period|Withdrawal by Subject|0
5442152|NCT02265705|18798783|P3|Follow-up Period|Withdrawal by Subject|0
5442153|NCT02265705|18798784|P2|Follow-up Period|Withdrawal by Subject|0
5442154|NCT02265705|18798785|P1|Follow-up Period|Withdrawal by Subject|0
5442155|NCT02265705|18798779|P7|Follow-up Period|Physician Decision|1
5442156|NCT02265705|18798780|P6|Follow-up Period|Physician Decision|0
5442157|NCT02265705|18798781|P5|Follow-up Period|Physician Decision|0
5442158|NCT02265705|18798782|P4|Follow-up Period|Physician Decision|0
5442159|NCT02265705|18798783|P3|Follow-up Period|Physician Decision|0
5442160|NCT02265705|18798784|P2|Follow-up Period|Physician Decision|0
5442161|NCT02265705|18798785|P1|Follow-up Period|Physician Decision|0
5442162|NCT02265705|18798779|P7|Follow-up Period|Adverse Event|3
5442163|NCT02265705|18798780|P6|Follow-up Period|Adverse Event|0
5442164|NCT02265705|18798781|P5|Follow-up Period|Adverse Event|0
5442165|NCT02265705|18798782|P4|Follow-up Period|Adverse Event|0
5442166|NCT02265705|18798783|P3|Follow-up Period|Adverse Event|0
5442167|NCT02265705|18798784|P2|Follow-up Period|Adverse Event|0
5442168|NCT02265705|18798785|P1|Follow-up Period|Adverse Event|0
5442169|NCT02265705|18798779|P7|Follow-up Period|Sponsor Decision|6
5442170|NCT02265705|18798780|P6|Follow-up Period|Sponsor Decision|1
5442171|NCT02265705|18798781|P5|Follow-up Period|Sponsor Decision|0
5442172|NCT02265705|18798782|P4|Follow-up Period|Sponsor Decision|0
5442173|NCT02265705|18798783|P3|Follow-up Period|Sponsor Decision|0
5442174|NCT02265705|18798784|P2|Follow-up Period|Sponsor Decision|0
5442175|NCT02265705|18798785|P1|Follow-up Period|Sponsor Decision|0
5442176|NCT02265705|18798779|P7|Open Label Period|Withdrawal by Subject|0
5442177|NCT02265705|18798780|P6|Open Label Period|Withdrawal by Subject|0
5442178|NCT02265705|18798781|P5|Open Label Period|Withdrawal by Subject|2
5442179|NCT02265705|18798782|P4|Open Label Period|Withdrawal by Subject|0
5442180|NCT02265705|18798783|P3|Open Label Period|Withdrawal by Subject|0
5442181|NCT02265705|18798784|P2|Open Label Period|Withdrawal by Subject|0
5442182|NCT02265705|18798785|P1|Open Label Period|Withdrawal by Subject|0
5442183|NCT02265705|18798779|P7|Open Label Period|Physician Decision|0
5442184|NCT02265705|18798780|P6|Open Label Period|Physician Decision|0
5442185|NCT02265705|18798781|P5|Open Label Period|Physician Decision|1
5442186|NCT02265705|18798782|P4|Open Label Period|Physician Decision|0
5442187|NCT02265705|18798783|P3|Open Label Period|Physician Decision|0
5442188|NCT02265705|18798784|P2|Open Label Period|Physician Decision|0
5442189|NCT02265705|18798785|P1|Open Label Period|Physician Decision|0
5442190|NCT02265705|18798779|P7|Open Label Period|Adverse Event|0
5442191|NCT02265705|18798780|P6|Open Label Period|Adverse Event|0
5442192|NCT02265705|18798781|P5|Open Label Period|Adverse Event|2
5442193|NCT02265705|18798782|P4|Open Label Period|Adverse Event|2
5442194|NCT02265705|18798783|P3|Open Label Period|Adverse Event|0
5442195|NCT02265705|18798784|P2|Open Label Period|Adverse Event|0
5442196|NCT02265705|18798785|P1|Open Label Period|Adverse Event|0
5442197|NCT02265705|18798779|P7|Rescue Period|Lack of Efficacy|0
5442198|NCT02265705|18798780|P6|Rescue Period|Lack of Efficacy|0
5442199|NCT02265705|18798781|P5|Rescue Period|Lack of Efficacy|0
5442200|NCT02265705|18798782|P4|Rescue Period|Lack of Efficacy|0
5442201|NCT02265705|18798783|P3|Rescue Period|Lack of Efficacy|1
5442202|NCT02265705|18798784|P2|Rescue Period|Lack of Efficacy|0
5442203|NCT02265705|18798785|P1|Rescue Period|Lack of Efficacy|0
5442204|NCT02265705|18798779|P7|Rescue Period|Death|0
5442205|NCT02265705|18798780|P6|Rescue Period|Death|0
5442206|NCT02265705|18798781|P5|Rescue Period|Death|0
5442207|NCT02265705|18798782|P4|Rescue Period|Death|0
5442208|NCT02265705|18798783|P3|Rescue Period|Death|1
5442209|NCT02265705|18798784|P2|Rescue Period|Death|0
5442210|NCT02265705|18798785|P1|Rescue Period|Death|0
5442211|NCT02265705|18798779|P7|Rescue Period|Withdrawal by Subject|0
5442212|NCT02265705|18798780|P6|Rescue Period|Withdrawal by Subject|0
5442213|NCT02265705|18798781|P5|Rescue Period|Withdrawal by Subject|0
5442214|NCT02265705|18798782|P4|Rescue Period|Withdrawal by Subject|0
5442215|NCT02265705|18798783|P3|Rescue Period|Withdrawal by Subject|1
5442216|NCT02265705|18798784|P2|Rescue Period|Withdrawal by Subject|0
5442217|NCT02265705|18798785|P1|Rescue Period|Withdrawal by Subject|0
5442218|NCT02265705|18798779|P7|Treatment Period Week 0-24|Lack of Efficacy|0
5442219|NCT02265705|18798780|P6|Treatment Period Week 0-24|Lack of Efficacy|0
5442220|NCT02265705|18798781|P5|Treatment Period Week 0-24|Lack of Efficacy|0
5442221|NCT02265705|18798782|P4|Treatment Period Week 0-24|Lack of Efficacy|0
5442222|NCT02265705|18798783|P3|Treatment Period Week 0-24|Lack of Efficacy|0
5442223|NCT02265705|18798784|P2|Treatment Period Week 0-24|Lack of Efficacy|1
5442224|NCT02265705|18798785|P1|Treatment Period Week 0-24|Lack of Efficacy|0
5442225|NCT02265705|18798779|P7|Treatment Period Week 0-24|Withdrawal by Subject|0
5442226|NCT02265705|18798780|P6|Treatment Period Week 0-24|Withdrawal by Subject|0
5442227|NCT02265705|18798781|P5|Treatment Period Week 0-24|Withdrawal by Subject|0
5442228|NCT02265705|18798782|P4|Treatment Period Week 0-24|Withdrawal by Subject|0
5442229|NCT02265705|18798783|P3|Treatment Period Week 0-24|Withdrawal by Subject|0
5442230|NCT02265705|18798784|P2|Treatment Period Week 0-24|Withdrawal by Subject|5
5442231|NCT02265705|18798785|P1|Treatment Period Week 0-24|Withdrawal by Subject|7
5442232|NCT02265705|18798779|P7|Treatment Period Week 0-24|Physician Decision|0
5442233|NCT02265705|18798780|P6|Treatment Period Week 0-24|Physician Decision|0
5442234|NCT02265705|18798781|P5|Treatment Period Week 0-24|Physician Decision|0
5442235|NCT02265705|18798782|P4|Treatment Period Week 0-24|Physician Decision|0
5442236|NCT02265705|18798783|P3|Treatment Period Week 0-24|Physician Decision|0
5442237|NCT02265705|18798784|P2|Treatment Period Week 0-24|Physician Decision|0
5442238|NCT02265705|18798785|P1|Treatment Period Week 0-24|Physician Decision|1
5442239|NCT02265705|18798779|P7|Treatment Period Week 0-24|Entry Criteria Not Met|0
5442240|NCT02265705|18798780|P6|Treatment Period Week 0-24|Entry Criteria Not Met|0
5442241|NCT02265705|18798781|P5|Treatment Period Week 0-24|Entry Criteria Not Met|0
5442242|NCT02265705|18798782|P4|Treatment Period Week 0-24|Entry Criteria Not Met|0
5442243|NCT02265705|18798783|P3|Treatment Period Week 0-24|Entry Criteria Not Met|0
5442244|NCT02265705|18798784|P2|Treatment Period Week 0-24|Entry Criteria Not Met|1
5442245|NCT02265705|18798785|P1|Treatment Period Week 0-24|Entry Criteria Not Met|1
5442246|NCT02265705|18798779|P7|Treatment Period Week 0-24|Adverse Event|0
5442247|NCT02265705|18798780|P6|Treatment Period Week 0-24|Adverse Event|0
5442248|NCT02265705|18798781|P5|Treatment Period Week 0-24|Adverse Event|0
5442249|NCT02265705|18798782|P4|Treatment Period Week 0-24|Adverse Event|0
5442250|NCT02265705|18798783|P3|Treatment Period Week 0-24|Adverse Event|0
5442251|NCT02265705|18798784|P2|Treatment Period Week 0-24|Adverse Event|2
5442252|NCT02265705|18798785|P1|Treatment Period Week 0-24|Adverse Event|3
5442253|NCT02265510|18798824|P14|Overall Study|Study Terminated by Sponsor|2
5442254|NCT02265510|18798825|P13|Overall Study|Study Terminated by Sponsor|1
5442255|NCT02265510|18798826|P12|Overall Study|Study Terminated by Sponsor|4
5442256|NCT02265510|18798827|P11|Overall Study|Study Terminated by Sponsor|1
5442257|NCT02265510|18798828|P10|Overall Study|Study Terminated by Sponsor|2
5442258|NCT02265510|18798829|P9|Overall Study|Study Terminated by Sponsor|1
5442259|NCT02265510|18798830|P8|Overall Study|Study Terminated by Sponsor|1
5442260|NCT02265510|18798831|P7|Overall Study|Study Terminated by Sponsor|1
5442261|NCT02265510|18798832|P6|Overall Study|Study Terminated by Sponsor|1
5442262|NCT02265510|18798833|P5|Overall Study|Study Terminated by Sponsor|0
5442263|NCT02265510|18798834|P4|Overall Study|Study Terminated by Sponsor|0
5442264|NCT02265510|18798835|P3|Overall Study|Study Terminated by Sponsor|0
5442265|NCT02265510|18798836|P2|Overall Study|Study Terminated by Sponsor|0
5442266|NCT02265510|18798837|P1|Overall Study|Study Terminated by Sponsor|0
5442267|NCT02265510|18798824|P14|Overall Study|Other|0
5442268|NCT02265510|18798825|P13|Overall Study|Other|0
5442269|NCT02265510|18798826|P12|Overall Study|Other|0
5442270|NCT02265510|18798827|P11|Overall Study|Other|0
5442271|NCT02265510|18798828|P10|Overall Study|Other|0
5442272|NCT02265510|18798829|P9|Overall Study|Other|0
5442273|NCT02265510|18798830|P8|Overall Study|Other|0
5442274|NCT02265510|18798831|P7|Overall Study|Other|0
5442275|NCT02265510|18798832|P6|Overall Study|Other|0
5442276|NCT02265510|18798833|P5|Overall Study|Other|0
5442277|NCT02265510|18798834|P4|Overall Study|Other|0
5442278|NCT02265510|18798835|P3|Overall Study|Other|0
5442279|NCT02265510|18798836|P2|Overall Study|Other|1
5442280|NCT02265510|18798837|P1|Overall Study|Other|0
5442281|NCT02265510|18798824|P14|Overall Study|Lost to Follow-up|2
5442282|NCT02265510|18798825|P13|Overall Study|Lost to Follow-up|0
5442283|NCT02265510|18798826|P12|Overall Study|Lost to Follow-up|0
5442284|NCT02265510|18798827|P11|Overall Study|Lost to Follow-up|0
5442285|NCT02265510|18798828|P10|Overall Study|Lost to Follow-up|2
5442286|NCT02265510|18798829|P9|Overall Study|Lost to Follow-up|0
5442287|NCT02265510|18798830|P8|Overall Study|Lost to Follow-up|0
5442288|NCT02265510|18798831|P7|Overall Study|Lost to Follow-up|0
5442289|NCT02265510|18798832|P6|Overall Study|Lost to Follow-up|0
5442290|NCT02265510|18798833|P5|Overall Study|Lost to Follow-up|1
5442291|NCT02265510|18798834|P4|Overall Study|Lost to Follow-up|0
5442292|NCT02265510|18798835|P3|Overall Study|Lost to Follow-up|0
5442293|NCT02265510|18798836|P2|Overall Study|Lost to Follow-up|0
5442294|NCT02265510|18798837|P1|Overall Study|Lost to Follow-up|0
5442295|NCT02265510|18798824|P14|Overall Study|Death|6
5442296|NCT02265510|18798825|P13|Overall Study|Death|7
5442297|NCT02265510|18798826|P12|Overall Study|Death|12
5442298|NCT02265510|18798827|P11|Overall Study|Death|4
5442299|NCT02265510|18798828|P10|Overall Study|Death|3
5442300|NCT02265510|18798829|P9|Overall Study|Death|3
5442301|NCT02265510|18798830|P8|Overall Study|Death|1
5442302|NCT02265510|18798831|P7|Overall Study|Death|2
5442303|NCT02265510|18798832|P6|Overall Study|Death|3
5442304|NCT02265510|18798833|P5|Overall Study|Death|1
5442305|NCT02265510|18798834|P4|Overall Study|Death|2
5442306|NCT02265510|18798835|P3|Overall Study|Death|2
5442307|NCT02265510|18798836|P2|Overall Study|Death|0
5442308|NCT02265510|18798837|P1|Overall Study|Death|2
5442309|NCT02265510|18798824|P14|Overall Study|Disease Progression|0
5442310|NCT02265510|18798825|P13|Overall Study|Disease Progression|0
5442311|NCT02265510|18798826|P12|Overall Study|Disease Progression|0
5442312|NCT02265510|18798827|P11|Overall Study|Disease Progression|0
5442313|NCT02265510|18798828|P10|Overall Study|Disease Progression|0
5442314|NCT02265510|18798829|P9|Overall Study|Disease Progression|0
5442315|NCT02265510|18798830|P8|Overall Study|Disease Progression|0
5442316|NCT02265510|18798831|P7|Overall Study|Disease Progression|0
5442317|NCT02265510|18798832|P6|Overall Study|Disease Progression|0
5442318|NCT02265510|18798833|P5|Overall Study|Disease Progression|1
5442319|NCT02265510|18798834|P4|Overall Study|Disease Progression|1
5442320|NCT02265510|18798835|P3|Overall Study|Disease Progression|2
5442321|NCT02265510|18798836|P2|Overall Study|Disease Progression|1
5442322|NCT02265510|18798837|P1|Overall Study|Disease Progression|0
5442323|NCT02265510|18798824|P14|Overall Study|Withdrawal by Subject|0
5442324|NCT02265510|18798825|P13|Overall Study|Withdrawal by Subject|1
5442325|NCT02265510|18798826|P12|Overall Study|Withdrawal by Subject|0
5442326|NCT02265510|18798827|P11|Overall Study|Withdrawal by Subject|0
5442327|NCT02265510|18798828|P10|Overall Study|Withdrawal by Subject|0
5442328|NCT02265510|18798829|P9|Overall Study|Withdrawal by Subject|0
5442329|NCT02265510|18798830|P8|Overall Study|Withdrawal by Subject|2
5442330|NCT02265510|18798831|P7|Overall Study|Withdrawal by Subject|0
5442331|NCT02265510|18798832|P6|Overall Study|Withdrawal by Subject|2
5442332|NCT02265510|18798833|P5|Overall Study|Withdrawal by Subject|0
5442333|NCT02265510|18798834|P4|Overall Study|Withdrawal by Subject|1
5442334|NCT02265510|18798835|P3|Overall Study|Withdrawal by Subject|2
5442335|NCT02265510|18798836|P2|Overall Study|Withdrawal by Subject|1
5442336|NCT02265510|18798837|P1|Overall Study|Withdrawal by Subject|1
5442337|NCT02265237|18798937|P4|As Treated (Overall Study)|Other|1
5442338|NCT02265237|18798938|P3|As Treated (Overall Study)|Other|3
5442339|NCT02265237|18798939|P2|As Treated (Overall Study)|Other|0
5442340|NCT02265237|18798940|P1|As Treated (Overall Study)|Other|2
5442341|NCT02265237|18798937|P4|As Treated (Overall Study)|Lost to Follow-up|0
5442342|NCT02265237|18798938|P3|As Treated (Overall Study)|Lost to Follow-up|6
5442343|NCT02265237|18798939|P2|As Treated (Overall Study)|Lost to Follow-up|2
5442344|NCT02265237|18798940|P1|As Treated (Overall Study)|Lost to Follow-up|1
5442345|NCT02265237|18798937|P4|As Treated (Overall Study)|Withdrawal by Subject|0
5442346|NCT02265237|18798938|P3|As Treated (Overall Study)|Withdrawal by Subject|1
5442347|NCT02265237|18798939|P2|As Treated (Overall Study)|Withdrawal by Subject|0
5442348|NCT02265237|18798940|P1|As Treated (Overall Study)|Withdrawal by Subject|1
5442349|NCT02265237|18798937|P4|As Treated (Overall Study)|Adverse Event|0
5442350|NCT02265237|18798938|P3|As Treated (Overall Study)|Adverse Event|0
5442351|NCT02265237|18798939|P2|As Treated (Overall Study)|Adverse Event|1
5442352|NCT02265237|18798940|P1|As Treated (Overall Study)|Adverse Event|1
5442353|NCT02264821|18798970|P3|Overall Study|Protocol Violation|6
5442354|NCT02264821|18798971|P2|Overall Study|Protocol Violation|3
5442355|NCT02264821|18798972|P1|Overall Study|Protocol Violation|1
5442356|NCT02264574|18798985|P2|Overall Study|Other, Not Specified|3
5442357|NCT02264574|18798986|P1|Overall Study|Other, Not Specified|0
5442358|NCT02264574|18798985|P2|Overall Study|Withdrawal by Subject|6
5442359|NCT02264574|18798986|P1|Overall Study|Withdrawal by Subject|8
5442360|NCT02264574|18798985|P2|Overall Study|Death|21
5442361|NCT02264574|18798986|P1|Overall Study|Death|21
5442362|NCT02263547|18799082|P1|Overall Study|Lost to Follow-up|2
5442363|NCT02263547|18799082|P1|Overall Study|Adverse Event|1
5442364|NCT02263365|18799089|P2|Overall Study|Physician Decision|18
5442365|NCT02263365|18799090|P1|Overall Study|Physician Decision|22
5442366|NCT02263326|18799104|P2|Overall Study|Lost to Follow-up|1
5442367|NCT02263326|18799105|P1|Overall Study|Lost to Follow-up|1
5442368|NCT02263079|18799178|P3|Overall Study|Withdrawal by Subject|0
5442369|NCT02263079|18799179|P2|Overall Study|Withdrawal by Subject|8
5442370|NCT02263079|18799180|P1|Overall Study|Withdrawal by Subject|2
5442371|NCT02263079|18799178|P3|Overall Study|Physician Decision|0
5442372|NCT02263079|18799179|P2|Overall Study|Physician Decision|0
5442373|NCT02263079|18799180|P1|Overall Study|Physician Decision|1
5442374|NCT02262754|18799251|P3|Overall Study|Other|2
5442375|NCT02262754|18799252|P2|Overall Study|Other|0
5442376|NCT02262754|18799253|P1|Overall Study|Other|4
5442377|NCT02262754|18799251|P3|Overall Study|Withdrawal by Subject|1
5442378|NCT02262754|18799252|P2|Overall Study|Withdrawal by Subject|0
5442379|NCT02262754|18799253|P1|Overall Study|Withdrawal by Subject|1
5442380|NCT02262754|18799251|P3|Overall Study|Protocol Violation|0
5442381|NCT02262754|18799252|P2|Overall Study|Protocol Violation|0
5442382|NCT02262754|18799253|P1|Overall Study|Protocol Violation|1
5442383|NCT02262754|18799251|P3|Overall Study|Study terminated by sponsor|4
5442384|NCT02262754|18799252|P2|Overall Study|Study terminated by sponsor|4
5442385|NCT02262754|18799253|P1|Overall Study|Study terminated by sponsor|5
5442386|NCT02262754|18799251|P3|Overall Study|No longer meets eligibility criteria|0
5442387|NCT02262754|18799252|P2|Overall Study|No longer meets eligibility criteria|1
5442388|NCT02262754|18799253|P1|Overall Study|No longer meets eligibility criteria|0
5442389|NCT02262754|18799251|P3|Overall Study|Lost to Follow-up|1
5442390|NCT02262754|18799252|P2|Overall Study|Lost to Follow-up|0
5442391|NCT02262754|18799253|P1|Overall Study|Lost to Follow-up|0
5442392|NCT02262754|18799251|P3|Overall Study|Lack of Efficacy|1
5442393|NCT02262754|18799252|P2|Overall Study|Lack of Efficacy|0
5442394|NCT02262754|18799253|P1|Overall Study|Lack of Efficacy|2
5442395|NCT02262754|18799251|P3|Overall Study|Adverse Event|0
5442396|NCT02262754|18799252|P2|Overall Study|Adverse Event|4
5442397|NCT02262754|18799253|P1|Overall Study|Adverse Event|3
5442398|NCT02262728|18799328|P2|Follow-up Phase (3 Years)|Withdrawal by Subject|1
5442399|NCT02262728|18799329|P1|Follow-up Phase (3 Years)|Withdrawal by Subject|0
5442400|NCT02262728|18799328|P2|Follow-up Phase (3 Years)|Lost to Follow-up|1
5442401|NCT02262728|18799329|P1|Follow-up Phase (3 Years)|Lost to Follow-up|4
5442402|NCT02262728|18799328|P2|Follow-up Phase (3 Years)|Death|1
5442403|NCT02262728|18799329|P1|Follow-up Phase (3 Years)|Death|0
5442404|NCT02262377|18799366|P2|Overall Study|Withdrawal by Subject|0
5442405|NCT02262377|18799367|P1|Overall Study|Withdrawal by Subject|4
5442406|NCT02262377|18799366|P2|Overall Study|Found ineligible after enrollment|0
5442407|NCT02262377|18799367|P1|Overall Study|Found ineligible after enrollment|3
5442408|NCT02262377|18799366|P2|Overall Study|Lost to Follow-up|6
5442409|NCT02262377|18799367|P1|Overall Study|Lost to Follow-up|5
5442410|NCT02262364|18799382|P1|Blood Draw for Device Processing|Insufficient blood could be drawn|1
5442411|NCT02262260|18799391|P2|Overall Study|Protocol deviation|5
5442412|NCT02262260|18799392|P1|Overall Study|Protocol deviation|2
5442413|NCT02262260|18799391|P2|Overall Study|Lost to Follow-up|2
5442414|NCT02262260|18799392|P1|Overall Study|Lost to Follow-up|1
5442415|NCT02262260|18799391|P2|Overall Study|Withdrawal of consent|2
5442416|NCT02262260|18799392|P1|Overall Study|Withdrawal of consent|4
5442417|NCT02262260|18799391|P2|Overall Study|Adverse Event|1
5442418|NCT02262260|18799392|P1|Overall Study|Adverse Event|4
5442419|NCT02261974|18799450|P2|Overall Study|Adverse Event|0
5442420|NCT02261974|18799451|P1|Overall Study|Adverse Event|1
5442421|NCT02261974|18799450|P2|Overall Study|Lost to Follow-up|0
5442422|NCT02261974|18799451|P1|Overall Study|Lost to Follow-up|2
5442423|NCT02261974|18799450|P2|Overall Study|Received partial treatment; FU to 1 mo|1
5442424|NCT02261974|18799451|P1|Overall Study|Received partial treatment; FU to 1 mo|3
5442425|NCT02261974|18799450|P2|Overall Study|Missed treatment cut-off date|3
5442426|NCT02261974|18799451|P1|Overall Study|Missed treatment cut-off date|6
5442427|NCT02261974|18799450|P2|Overall Study|Pregnancy|1
5442428|NCT02261974|18799451|P1|Overall Study|Pregnancy|0
5442429|NCT02261974|18799450|P2|Overall Study|Withdrawal by Subject|2
5442430|NCT02261974|18799451|P1|Overall Study|Withdrawal by Subject|3
5442431|NCT02261493|18799515|P3|Overall Study|Adverse Event|0
5442432|NCT02261493|18799516|P2|Overall Study|Adverse Event|1
5442433|NCT02261493|18799517|P1|Overall Study|Adverse Event|0
5442434|NCT02261493|18799515|P3|Overall Study|Lack of Efficacy|0
5442435|NCT02261493|18799516|P2|Overall Study|Lack of Efficacy|1
5442436|NCT02261493|18799517|P1|Overall Study|Lack of Efficacy|0
5442437|NCT02261493|18799515|P3|Overall Study|Pregnancy|0
5442438|NCT02261493|18799516|P2|Overall Study|Pregnancy|2
5442439|NCT02261493|18799517|P1|Overall Study|Pregnancy|1
5442440|NCT02261493|18799515|P3|Overall Study|Lost to Follow-up|8
5442441|NCT02261493|18799516|P2|Overall Study|Lost to Follow-up|27
5442442|NCT02261493|18799517|P1|Overall Study|Lost to Follow-up|14
5442443|NCT02261493|18799515|P3|Overall Study|Personal Reasons|16
5442444|NCT02261493|18799516|P2|Overall Study|Personal Reasons|14
5442445|NCT02261493|18799517|P1|Overall Study|Personal Reasons|14
5442446|NCT02261493|18799515|P3|Overall Study|Protocol Violation|0
5442447|NCT02261493|18799516|P2|Overall Study|Protocol Violation|0
5442448|NCT02261493|18799517|P1|Overall Study|Protocol Violation|1
5442449|NCT02261493|18799515|P3|Overall Study|Undisclosed alcohol abuse|0
5442450|NCT02261493|18799516|P2|Overall Study|Undisclosed alcohol abuse|1
5442451|NCT02261493|18799517|P1|Overall Study|Undisclosed alcohol abuse|0
5442452|NCT02261493|18799515|P3|Overall Study|Physician Decision|0
5442453|NCT02261493|18799516|P2|Overall Study|Physician Decision|1
5442454|NCT02261493|18799517|P1|Overall Study|Physician Decision|0
5442455|NCT02261493|18799515|P3|Overall Study|Noncompliance|2
5442456|NCT02261493|18799516|P2|Overall Study|Noncompliance|0
5442457|NCT02261493|18799517|P1|Overall Study|Noncompliance|0
5442458|NCT02261467|18799545|P2|Overall Study|Adverse Event|1
5442459|NCT02261467|18799546|P1|Overall Study|Adverse Event|1
5442460|NCT02261467|18799545|P2|Overall Study|Lost to Follow-up|13
5442461|NCT02261467|18799546|P1|Overall Study|Lost to Follow-up|2
5442462|NCT02261467|18799545|P2|Overall Study|Personal Reasons|22
5442463|NCT02261467|18799546|P1|Overall Study|Personal Reasons|17
5442464|NCT02261467|18799545|P2|Overall Study|Protocol Violation|1
5442465|NCT02261467|18799546|P1|Overall Study|Protocol Violation|0
5442466|NCT02261467|18799545|P2|Overall Study|Enrolled in Error|0
5442467|NCT02261467|18799546|P1|Overall Study|Enrolled in Error|1
5442468|NCT02260986|18799588|P3|Overall Study|Pregnancy|0
5442469|NCT02260986|18799589|P2|Overall Study|Pregnancy|0
5442470|NCT02260986|18799590|P1|Overall Study|Pregnancy|2
5442471|NCT02260986|18799588|P3|Overall Study|Lost to Follow-up|3
5442472|NCT02260986|18799589|P2|Overall Study|Lost to Follow-up|0
5442473|NCT02260986|18799590|P1|Overall Study|Lost to Follow-up|4
5442474|NCT02260986|18799588|P3|Overall Study|Lack of investigation product supply|1
5442475|NCT02260986|18799589|P2|Overall Study|Lack of investigation product supply|0
5442476|NCT02260986|18799590|P1|Overall Study|Lack of investigation product supply|2
5442477|NCT02260986|18799588|P3|Overall Study|Incorrect randomization|0
5442478|NCT02260986|18799589|P2|Overall Study|Incorrect randomization|1
5442479|NCT02260986|18799590|P1|Overall Study|Incorrect randomization|0
5442480|NCT02260986|18799588|P3|Overall Study|Withdrawal by Subject|9
5442481|NCT02260986|18799589|P2|Overall Study|Withdrawal by Subject|4
5442482|NCT02260986|18799590|P1|Overall Study|Withdrawal by Subject|17
5442483|NCT02260986|18799588|P3|Overall Study|Car accident|1
5442484|NCT02260986|18799589|P2|Overall Study|Car accident|0
5442485|NCT02260986|18799590|P1|Overall Study|Car accident|0
5442486|NCT02260986|18799588|P3|Overall Study|Protocol Violation|16
5442487|NCT02260986|18799589|P2|Overall Study|Protocol Violation|5
5442488|NCT02260986|18799590|P1|Overall Study|Protocol Violation|14
5442489|NCT02260986|18799588|P3|Overall Study|Lack of Efficacy|0
5442490|NCT02260986|18799589|P2|Overall Study|Lack of Efficacy|3
5442491|NCT02260986|18799590|P1|Overall Study|Lack of Efficacy|27
5442492|NCT02260986|18799588|P3|Overall Study|Adverse Event|11
5442493|NCT02260986|18799589|P2|Overall Study|Adverse Event|0
5442494|NCT02260986|18799590|P1|Overall Study|Adverse Event|24
5442495|NCT02260934|18799708|P2|Overall Study|Site error|1
5442496|NCT02260934|18799709|P1|Overall Study|Site error|0
5442497|NCT02260934|18799708|P2|Overall Study|Participant Relocated|0
5442498|NCT02260934|18799709|P1|Overall Study|Participant Relocated|1
5442499|NCT02260934|18799708|P2|Overall Study|Withdrawal by Subject|2
5442500|NCT02260934|18799709|P1|Overall Study|Withdrawal by Subject|0
5442501|NCT02260934|18799708|P2|Overall Study|Lost to Follow-up|1
5442502|NCT02260934|18799709|P1|Overall Study|Lost to Follow-up|2
5442503|NCT02260921|18799747|P2|Overall Study|Prohibited Treatment for Knee Pain|0
5442504|NCT02260921|18799748|P1|Overall Study|Prohibited Treatment for Knee Pain|4
5442505|NCT02260921|18799747|P2|Overall Study|Death|0
5442506|NCT02260921|18799748|P1|Overall Study|Death|1
5442507|NCT02260921|18799747|P2|Overall Study|Withdraw Consent|1
5442508|NCT02260921|18799748|P1|Overall Study|Withdraw Consent|4
5442509|NCT02260921|18799747|P2|Overall Study|Lost to Follow-up|3
5442510|NCT02260921|18799748|P1|Overall Study|Lost to Follow-up|4
5442511|NCT02260921|18799747|P2|Overall Study|Adverse Event|0
5442512|NCT02260921|18799748|P1|Overall Study|Adverse Event|1
5442513|NCT02260882|18799772|P2|Overall Study|Protocol Violation|1
5442514|NCT02260882|18799773|P1|Overall Study|Protocol Violation|0
5442515|NCT02260817|18799797|P2|Overall Study|Protocol Violation|14
5442516|NCT02260817|18799798|P1|Overall Study|Protocol Violation|0
5442517|NCT02260817|18799797|P2|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
5442518|NCT02260817|18799798|P1|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
5442519|NCT02260817|18799797|P2|Overall Study|Observation, no biopsy|1
5442520|NCT02260817|18799798|P1|Overall Study|Observation, no biopsy|0
5442521|NCT02260817|18799797|P2|Overall Study|Androgen deprivation therapy, no biopsy|7
5442522|NCT02260817|18799798|P1|Overall Study|Androgen deprivation therapy, no biopsy|0
5442523|NCT02260817|18799797|P2|Overall Study|Lost to Follow-up|14
5442524|NCT02260817|18799798|P1|Overall Study|Lost to Follow-up|0
5442525|NCT02260791|18799846|P2|Overall Study|Protocol deviation|3
5442526|NCT02260791|18799847|P1|Overall Study|Protocol deviation|2
5442527|NCT02260791|18799846|P2|Overall Study|Screen failure|1
5442528|NCT02260791|18799847|P1|Overall Study|Screen failure|0
5442529|NCT02260791|18799846|P2|Overall Study|Withdrawal by Subject|16
5442530|NCT02260791|18799847|P1|Overall Study|Withdrawal by Subject|11
5442531|NCT02260791|18799846|P2|Overall Study|Death|0
5442532|NCT02260791|18799847|P1|Overall Study|Death|1
5442533|NCT02260791|18799846|P2|Overall Study|Adverse Event|9
5442534|NCT02260791|18799847|P1|Overall Study|Adverse Event|13
5442535|NCT02260791|18799846|P2|Overall Study|Lack of Efficacy|1
5442536|NCT02260791|18799847|P1|Overall Study|Lack of Efficacy|2
5442537|NCT02260791|18799846|P2|Overall Study|Lost to Follow-up|4
5442538|NCT02260791|18799847|P1|Overall Study|Lost to Follow-up|4
5442539|NCT02260648|18799886|P3|Overall Study|Discontinue Due to Study Termination|7
5442540|NCT02260648|18799887|P2|Overall Study|Discontinue Due to Study Termination|12
5442541|NCT02260648|18799888|P1|Overall Study|Discontinue Due to Study Termination|13
5442542|NCT02260648|18799886|P3|Overall Study|Protocol Violation|0
5442543|NCT02260648|18799887|P2|Overall Study|Protocol Violation|0
5442544|NCT02260648|18799888|P1|Overall Study|Protocol Violation|1
5442545|NCT02260648|18799886|P3|Overall Study|Withdrawal by Subject|0
5442546|NCT02260648|18799887|P2|Overall Study|Withdrawal by Subject|1
5442547|NCT02260648|18799888|P1|Overall Study|Withdrawal by Subject|1
5442548|NCT02260648|18799886|P3|Overall Study|Adverse Event|1
5442549|NCT02260648|18799887|P2|Overall Study|Adverse Event|0
5442550|NCT02260648|18799888|P1|Overall Study|Adverse Event|3
5442551|NCT02260635|18799916|P2|Open-Label Extension|Withdrawal by Subject|0
5442552|NCT02260635|18799917|P1|Open-Label Extension|Withdrawal by Subject|1
5442553|NCT02260635|18799916|P2|Open-Label Extension|Study Termination|25
5442554|NCT02260635|18799917|P1|Open-Label Extension|Study Termination|25
5442555|NCT02260635|18799916|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
5442556|NCT02260635|18799917|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
5442557|NCT02260492|18799969|P3|Overall Study|Withdrawal by Subject|2
5442558|NCT02260492|18799970|P2|Overall Study|Withdrawal by Subject|2
5442559|NCT02260492|18799971|P1|Overall Study|Withdrawal by Subject|3
5442560|NCT02260492|18799969|P3|Overall Study|Physician Decision|1
5442561|NCT02260492|18799970|P2|Overall Study|Physician Decision|0
5442562|NCT02260492|18799971|P1|Overall Study|Physician Decision|2
5442563|NCT02260492|18799969|P3|Overall Study|Lost to Follow-up|0
5442564|NCT02260492|18799970|P2|Overall Study|Lost to Follow-up|9
5442565|NCT02260492|18799971|P1|Overall Study|Lost to Follow-up|12
5442566|NCT02260492|18799969|P3|Overall Study|Death|0
5442567|NCT02260492|18799970|P2|Overall Study|Death|1
5442568|NCT02260492|18799971|P1|Overall Study|Death|0
5442569|NCT02260492|18799969|P3|Overall Study|Adverse Event|2
5442570|NCT02260492|18799970|P2|Overall Study|Adverse Event|1
5442571|NCT02260492|18799971|P1|Overall Study|Adverse Event|6
5442572|NCT02260388|18800004|P4|Overall Study|Lost to Follow-up|4
5442573|NCT02260388|18800005|P3|Overall Study|Lost to Follow-up|3
5442574|NCT02260388|18800006|P2|Overall Study|Lost to Follow-up|8
5442575|NCT02260388|18800007|P1|Overall Study|Lost to Follow-up|2
5442576|NCT02260180|18800036|P3|Overall Study|Adverse Event|1
5442577|NCT02260180|18800037|P2|Overall Study|Adverse Event|0
5442578|NCT02260180|18800038|P1|Overall Study|Adverse Event|2
5442579|NCT02260154|18800049|P1|Overall Study|Screening failure|2
5442580|NCT02259582|18800089|P3|Overall Study|Lack of Subject Adherence to Protocol|1
5442581|NCT02259582|18800090|P2|Overall Study|Lack of Subject Adherence to Protocol|1
5442582|NCT02259582|18800091|P1|Overall Study|Lack of Subject Adherence to Protocol|1
5442583|NCT02259582|18800089|P3|Overall Study|Disease progression|17
5442584|NCT02259582|18800090|P2|Overall Study|Disease progression|15
5442585|NCT02259582|18800091|P1|Overall Study|Disease progression|14
5442586|NCT02259582|18800089|P3|Overall Study|Withdrawal by Subject|1
5442587|NCT02259582|18800090|P2|Overall Study|Withdrawal by Subject|0
5442588|NCT02259582|18800091|P1|Overall Study|Withdrawal by Subject|0
5442589|NCT02259582|18800089|P3|Overall Study|Adverse Event|1
5442590|NCT02259582|18800090|P2|Overall Study|Adverse Event|0
5442591|NCT02259582|18800091|P1|Overall Study|Adverse Event|1
5442592|NCT02259582|18800089|P3|Overall Study|Death|1
5442593|NCT02259582|18800090|P2|Overall Study|Death|0
5442594|NCT02259582|18800091|P1|Overall Study|Death|0
5442595|NCT02259582|18800089|P3|Overall Study|Physician Decision|0
5442596|NCT02259582|18800090|P2|Overall Study|Physician Decision|1
5442597|NCT02259582|18800091|P1|Overall Study|Physician Decision|0
5442598|NCT02259400|18800101|P2|Overall Study|Death|2
5442599|NCT02259400|18800102|P1|Overall Study|Death|0
5442600|NCT02259348|18800134|P1|Overall Study|Death|4
5442601|NCT02259348|18800134|P1|Overall Study|Donors|6
5442602|NCT02259114|18800151|P5|Overall Study|Not Treated|0
5442603|NCT02259114|18800152|P4|Overall Study|Not Treated|0
5442604|NCT02259114|18800153|P3|Overall Study|Not Treated|0
5442605|NCT02259114|18800154|P2|Overall Study|Not Treated|0
5442606|NCT02259114|18800155|P1|Overall Study|Not Treated|1
5442607|NCT02259114|18800151|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
5442608|NCT02259114|18800152|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
5442609|NCT02259114|18800153|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
5442610|NCT02259114|18800154|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
5442611|NCT02259114|18800155|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
5442612|NCT02259114|18800151|P5|Overall Study|Withdrawal by Subject|0
5442613|NCT02259114|18800152|P4|Overall Study|Withdrawal by Subject|1
5442614|NCT02259114|18800153|P3|Overall Study|Withdrawal by Subject|1
5442615|NCT02259114|18800154|P2|Overall Study|Withdrawal by Subject|0
5442616|NCT02259114|18800155|P1|Overall Study|Withdrawal by Subject|0
5442617|NCT02259114|18800151|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5442618|NCT02259114|18800152|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5442619|NCT02259114|18800153|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
5442620|NCT02259114|18800154|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5442621|NCT02259114|18800155|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
5442622|NCT02259114|18800151|P5|Overall Study|Death|0
5442623|NCT02259114|18800152|P4|Overall Study|Death|0
5442624|NCT02259114|18800153|P3|Overall Study|Death|1
5442625|NCT02259114|18800154|P2|Overall Study|Death|0
5442626|NCT02259114|18800155|P1|Overall Study|Death|3
5442627|NCT02259114|18800151|P5|Overall Study|Adverse Event|1
5442628|NCT02259114|18800152|P4|Overall Study|Adverse Event|0
5442629|NCT02259114|18800153|P3|Overall Study|Adverse Event|0
5442630|NCT02259114|18800154|P2|Overall Study|Adverse Event|1
5442631|NCT02259114|18800155|P1|Overall Study|Adverse Event|2
5442632|NCT02259114|18800151|P5|Overall Study|Progressive Disease|5
5442633|NCT02259114|18800152|P4|Overall Study|Progressive Disease|2
5442634|NCT02259114|18800153|P3|Overall Study|Progressive Disease|10
5442635|NCT02259114|18800154|P2|Overall Study|Progressive Disease|2
5442636|NCT02259114|18800155|P1|Overall Study|Progressive Disease|14
5442637|NCT02259088|18800214|P2|Overall Study|Subject/guardian decision|8
5442638|NCT02259088|18800215|P1|Overall Study|Subject/guardian decision|8
5442639|NCT02259088|18800214|P2|Overall Study|Protocol deviation|0
5442640|NCT02259088|18800215|P1|Overall Study|Protocol deviation|5
5442641|NCT02259088|18800214|P2|Overall Study|Physician Decision|2
5442642|NCT02259088|18800215|P1|Overall Study|Physician Decision|5
5442643|NCT02259088|18800214|P2|Overall Study|Death|0
5442644|NCT02259088|18800215|P1|Overall Study|Death|2
5442645|NCT02259088|18800214|P2|Overall Study|Lost to Follow-up|0
5442646|NCT02259088|18800215|P1|Overall Study|Lost to Follow-up|2
5442647|NCT02259088|18800214|P2|Overall Study|Adverse Event|4
5442648|NCT02259088|18800215|P1|Overall Study|Adverse Event|6
5442649|NCT02259010|18800260|P1|Overall Study|Didn't Completed Dosing; PK Assessment|5
5442650|NCT02258542|18800289|P4|Overall Study|Eligibility criteria not fulfilled|0
5442651|NCT02258542|18800290|P3|Overall Study|Eligibility criteria not fulfilled|0
5442652|NCT02258542|18800291|P2|Overall Study|Eligibility criteria not fulfilled|2
5442653|NCT02258542|18800292|P1|Overall Study|Eligibility criteria not fulfilled|0
5442654|NCT02258542|18800289|P4|Overall Study|Protocol Violation|0
5442655|NCT02258542|18800290|P3|Overall Study|Protocol Violation|0
5442656|NCT02258542|18800291|P2|Overall Study|Protocol Violation|2
5442657|NCT02258542|18800292|P1|Overall Study|Protocol Violation|1
5442658|NCT02258542|18800289|P4|Overall Study|Adverse Event|0
5442659|NCT02258542|18800290|P3|Overall Study|Adverse Event|0
5442660|NCT02258542|18800291|P2|Overall Study|Adverse Event|4
5442661|NCT02258542|18800292|P1|Overall Study|Adverse Event|3
5442662|NCT02258542|18800289|P4|Overall Study|Death|1
5442663|NCT02258542|18800290|P3|Overall Study|Death|0
5442664|NCT02258542|18800291|P2|Overall Study|Death|4
5442665|NCT02258542|18800292|P1|Overall Study|Death|5
5442666|NCT02258542|18800289|P4|Overall Study|Lost to Follow-up|2
5442667|NCT02258542|18800290|P3|Overall Study|Lost to Follow-up|1
5442668|NCT02258542|18800291|P2|Overall Study|Lost to Follow-up|12
5442669|NCT02258542|18800292|P1|Overall Study|Lost to Follow-up|5
5442670|NCT02258542|18800289|P4|Overall Study|Withdrawal by Subject|1
5442671|NCT02258542|18800290|P3|Overall Study|Withdrawal by Subject|7
5442672|NCT02258542|18800291|P2|Overall Study|Withdrawal by Subject|20
5442673|NCT02258542|18800292|P1|Overall Study|Withdrawal by Subject|20
5442674|NCT02258542|18800289|P4|Overall Study|study specific discount. criteria|0
5442675|NCT02258542|18800290|P3|Overall Study|study specific discount. criteria|0
5442676|NCT02258542|18800291|P2|Overall Study|study specific discount. criteria|1
5442677|NCT02258542|18800292|P1|Overall Study|study specific discount. criteria|1
5442678|NCT02258542|18800289|P4|Overall Study|eg. not made to the visit|1
5442679|NCT02258542|18800290|P3|Overall Study|eg. not made to the visit|0
5442680|NCT02258542|18800291|P2|Overall Study|eg. not made to the visit|4
5442681|NCT02258542|18800292|P1|Overall Study|eg. not made to the visit|7
5442682|NCT02258529|18800516|P1|Overall Study|Adverse Event|1
5442683|NCT02258529|18800516|P1|Overall Study|Study Terminated by Sponsor|9
5442684|NCT02258464|18800548|P2|Overall Study|AE related to clinical PD|0
5442685|NCT02258464|18800549|P1|Overall Study|AE related to clinical PD|1
5442686|NCT02258464|18800548|P2|Overall Study|Withdrawal by Subject|4
5442687|NCT02258464|18800549|P1|Overall Study|Withdrawal by Subject|5
5442688|NCT02258464|18800548|P2|Overall Study|AE not related to clinical PD|3
5442689|NCT02258464|18800549|P1|Overall Study|AE not related to clinical PD|1
5442690|NCT02258464|18800548|P2|Overall Study|Study drug never administered|1
5442691|NCT02258464|18800549|P1|Overall Study|Study drug never administered|1
5442692|NCT02258464|18800548|P2|Overall Study|Progressive disease (PD)|17
5442693|NCT02258464|18800549|P1|Overall Study|Progressive disease (PD)|9
5442694|NCT02258334|18800630|P4|Overall Study|Adverse Event|0
5442695|NCT02258334|18800631|P3|Overall Study|Adverse Event|0
5442696|NCT02258334|18800632|P2|Overall Study|Adverse Event|0
5442697|NCT02258334|18800633|P1|Overall Study|Adverse Event|1
5442698|NCT02257918|18800725|P3|Overall Study|Pregnancy|1
5442699|NCT02257918|18800726|P2|Overall Study|Pregnancy|0
5442700|NCT02257918|18800727|P1|Overall Study|Pregnancy|0
5442701|NCT02257918|18800725|P3|Overall Study|Withdrawal by Subject|1
5442702|NCT02257918|18800726|P2|Overall Study|Withdrawal by Subject|0
5442703|NCT02257918|18800727|P1|Overall Study|Withdrawal by Subject|0
5442704|NCT02257918|18800725|P3|Overall Study|Lost to Follow-up|0
5442705|NCT02257918|18800726|P2|Overall Study|Lost to Follow-up|1
5442706|NCT02257918|18800727|P1|Overall Study|Lost to Follow-up|4
5442707|NCT02257684|18800777|P1|Overall Study|Sponsor's Decision|1
5442708|NCT02257684|18800777|P1|Overall Study|Lack of Efficacy|1
5442709|NCT02257684|18800777|P1|Overall Study|Adverse Event|2
5442710|NCT02257632|18800787|P2|Overall Study|Adverse Event|2
5442711|NCT02257632|18800788|P1|Overall Study|Adverse Event|1
5442712|NCT02257632|18800787|P2|Overall Study|Withdrawal by Subject|1
5442713|NCT02257632|18800788|P1|Overall Study|Withdrawal by Subject|0
5442714|NCT02257528|18800828|P1|Overall Study|Never received study treatment|1
5442715|NCT02257489|18800844|P9|Overall Study|Withdrawal by Subject|0
5442716|NCT02257489|18800845|P8|Overall Study|Withdrawal by Subject|0
5442717|NCT02257489|18800846|P7|Overall Study|Withdrawal by Subject|0
5442718|NCT02257489|18800847|P6|Overall Study|Withdrawal by Subject|0
5442719|NCT02257489|18800848|P5|Overall Study|Withdrawal by Subject|0
5442720|NCT02257489|18800849|P4|Overall Study|Withdrawal by Subject|1
5442721|NCT02257489|18800850|P3|Overall Study|Withdrawal by Subject|0
5442722|NCT02257489|18800851|P2|Overall Study|Withdrawal by Subject|0
5442723|NCT02257489|18800852|P1|Overall Study|Withdrawal by Subject|0
5442724|NCT02257385|18800888|P2|Overall Study|Withdrawal by Subject|4
5442725|NCT02257385|18800889|P1|Overall Study|Withdrawal by Subject|4
5442726|NCT02257385|18800888|P2|Overall Study|Lost to Follow-up|1
5442727|NCT02257385|18800889|P1|Overall Study|Lost to Follow-up|0
5442728|NCT02257385|18800888|P2|Overall Study|Protocol Violation|7
5442729|NCT02257385|18800889|P1|Overall Study|Protocol Violation|5
5442730|NCT02257385|18800888|P2|Overall Study|Lack of Efficacy|2
5442731|NCT02257385|18800889|P1|Overall Study|Lack of Efficacy|1
5442732|NCT02257385|18800888|P2|Overall Study|Adverse Event|8
5442733|NCT02257385|18800889|P1|Overall Study|Adverse Event|12
5442734|NCT02257372|18800899|P2|Overall Study|Withdrew consent|0
5442735|NCT02257372|18800900|P1|Overall Study|Withdrew consent|1
5442736|NCT02257372|18800899|P2|Overall Study|Lost to Follow-up|1
5442737|NCT02257372|18800900|P1|Overall Study|Lost to Follow-up|0
5442738|NCT02257372|18800899|P2|Overall Study|Protocol Violation|1
5442739|NCT02257372|18800900|P1|Overall Study|Protocol Violation|1
5442740|NCT02257372|18800899|P2|Overall Study|Lack of Efficacy|1
5442741|NCT02257372|18800900|P1|Overall Study|Lack of Efficacy|2
5442742|NCT02257372|18800899|P2|Overall Study|Adverse Event|7
5442743|NCT02257372|18800900|P1|Overall Study|Adverse Event|3
5442744|NCT02256982|18800917|P2|Overall Study|Disease Progression|1
5442745|NCT02256982|18800918|P1|Overall Study|Disease Progression|0
5442746|NCT02256969|18800927|P3|Overall Study|Screenfailed or withdrew|1
5442747|NCT02256969|18800928|P2|Overall Study|Screenfailed or withdrew|1
5442748|NCT02256969|18800929|P1|Overall Study|Screenfailed or withdrew|2
5442749|NCT02256917|18800946|P1|Prophylactic Treatment Phase II|Discontinued medication|1
5442750|NCT02256917|18800946|P1|Prophylactic Treatment Phase II|Did not attend completion visit|1
5442751|NCT02256917|18800946|P1|Prophylactic Treatment Phase II|Withdrawn Consent|1
5442752|NCT02256917|18800946|P1|Prophylactic Treatment Phase II|Lost to Follow-up|1
5442753|NCT02256917|18800946|P1|Prophylactic Treatment Phase I|Lost to Follow-up|1
5442754|NCT02256891|18800967|P2|Overall Study|Equipment Malfunction|1
5442755|NCT02256891|18800968|P1|Overall Study|Equipment Malfunction|0
5442756|NCT02256891|18800967|P2|Overall Study|Screen Fail|4
5442757|NCT02256891|18800968|P1|Overall Study|Screen Fail|5
5442758|NCT02256891|18800967|P2|Overall Study|Physician Decision|3
5442759|NCT02256891|18800968|P1|Overall Study|Physician Decision|7
5442760|NCT02256891|18800967|P2|Overall Study|Lost to Follow-up|3
5442761|NCT02256891|18800968|P1|Overall Study|Lost to Follow-up|0
5442762|NCT02256891|18800967|P2|Overall Study|Death|2
5442763|NCT02256891|18800968|P1|Overall Study|Death|0
5442764|NCT02256839|18800994|P2|Overall Study|Did not meet Eligibility Criteria|3
5442765|NCT02256839|18800995|P1|Overall Study|Did not meet Eligibility Criteria|2
5442766|NCT02256553|18801001|P1|Period III|Adverse Event|3
5442767|NCT02256553|18801001|P1|Period II|Subject Moved|1
5442768|NCT02256553|18801001|P1|Period II|Adverse Event|1
5442769|NCT02256553|18801001|P1|Period I|Protocol Violation|1
5442770|NCT02256553|18801001|P1|Period I|Adverse Event|5
5442771|NCT02256540|18801010|P3|Overall Study|Back pain preventing exercise|1
5442772|NCT02256540|18801011|P2|Overall Study|Back pain preventing exercise|0
5442773|NCT02256540|18801012|P1|Overall Study|Back pain preventing exercise|0
5442774|NCT02256540|18801010|P3|Overall Study|Withdrawal by Subject|1
5442775|NCT02256540|18801011|P2|Overall Study|Withdrawal by Subject|1
5442776|NCT02256540|18801012|P1|Overall Study|Withdrawal by Subject|0
5442777|NCT02256488|18801030|P4|Overall Study|Withdrawal by Subject|2
5442778|NCT02256488|18801031|P3|Overall Study|Withdrawal by Subject|0
5442779|NCT02256488|18801032|P2|Overall Study|Withdrawal by Subject|0
5442780|NCT02256488|18801033|P1|Overall Study|Withdrawal by Subject|1
5442781|NCT02256488|18801030|P4|Overall Study|OTHER|1
5442782|NCT02256488|18801031|P3|Overall Study|OTHER|1
5442783|NCT02256488|18801032|P2|Overall Study|OTHER|0
5442784|NCT02256488|18801033|P1|Overall Study|OTHER|1
5442785|NCT02256488|18801030|P4|Overall Study|Lost to Follow-up|3
5442786|NCT02256488|18801031|P3|Overall Study|Lost to Follow-up|9
5442787|NCT02256488|18801032|P2|Overall Study|Lost to Follow-up|6
5442788|NCT02256488|18801033|P1|Overall Study|Lost to Follow-up|6
5442789|NCT02256436|18801049|P2|Overall Study|Ongoing in Study|67
5442790|NCT02256436|18801050|P1|Overall Study|Ongoing in Study|108
5442791|NCT02256436|18801049|P2|Overall Study|Withdrawal by Subject|30
5442792|NCT02256436|18801050|P1|Overall Study|Withdrawal by Subject|7
5442793|NCT02256436|18801049|P2|Overall Study|Protocol Violation|0
5442794|NCT02256436|18801050|P1|Overall Study|Protocol Violation|1
5442795|NCT02256436|18801049|P2|Overall Study|Physician Decision|3
5442796|NCT02256436|18801050|P1|Overall Study|Physician Decision|1
5442797|NCT02256436|18801049|P2|Overall Study|Lost to Follow-up|1
5442798|NCT02256436|18801050|P1|Overall Study|Lost to Follow-up|1
5442799|NCT02256436|18801049|P2|Overall Study|Death|158
5442800|NCT02256436|18801050|P1|Overall Study|Death|137
5442801|NCT02256436|18801049|P2|Overall Study|Adverse Event|13
5442802|NCT02256436|18801050|P1|Overall Study|Adverse Event|15
5442803|NCT02256384|18801086|P1|Overall Study|Equipment not capturing data|2
5442804|NCT02256384|18801086|P1|Overall Study|Withdrawal by Subject|12
5442805|NCT02256267|18801119|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
5442806|NCT02256267|18801119|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
5442807|NCT02255981|18801192|P1|Overall Study|Withdrawal by Subject|1
5442808|NCT02255981|18801192|P1|Overall Study|Lost to Follow-up|3
5442809|NCT02255760|18801207|P5|Overall Study|Lost to Follow-up|0
5442810|NCT02255760|18801208|P4|Overall Study|Lost to Follow-up|0
5442811|NCT02255760|18801209|P3|Overall Study|Lost to Follow-up|0
5442812|NCT02255760|18801210|P2|Overall Study|Lost to Follow-up|1
5442813|NCT02255760|18801211|P1|Overall Study|Lost to Follow-up|0
5442814|NCT02255565|18801266|P3|Overall Study|Withdrawal by Subject|0
5442815|NCT02255565|18801267|P2|Overall Study|Withdrawal by Subject|1
5442816|NCT02255565|18801268|P1|Overall Study|Withdrawal by Subject|0
5442817|NCT02255552|18801329|P2|Overall Study|Withdrawal by Subject|4
5442818|NCT02255552|18801330|P1|Overall Study|Withdrawal by Subject|1
5442819|NCT02255552|18801329|P2|Overall Study|Participants enrolled into another study|11
5442820|NCT02255552|18801330|P1|Overall Study|Participants enrolled into another study|0
5442821|NCT02255500|18801347|P2|Overall Study|Withdrawal by Subject|0
5442822|NCT02255500|18801348|P1|Overall Study|Withdrawal by Subject|1
5442823|NCT02255461|18801369|P5|Overall Study|Not meet dose reduction BSA requirement|0
5442824|NCT02255461|18801370|P4|Overall Study|Not meet dose reduction BSA requirement|0
5442825|NCT02255461|18801371|P3|Overall Study|Not meet dose reduction BSA requirement|0
5442826|NCT02255461|18801372|P2|Overall Study|Not meet dose reduction BSA requirement|1
5442827|NCT02255461|18801373|P1|Overall Study|Not meet dose reduction BSA requirement|0
5442828|NCT02255461|18801369|P5|Overall Study|Withdrawal by Subject|1
5442829|NCT02255461|18801370|P4|Overall Study|Withdrawal by Subject|0
5442830|NCT02255461|18801371|P3|Overall Study|Withdrawal by Subject|1
5442831|NCT02255461|18801372|P2|Overall Study|Withdrawal by Subject|0
5442832|NCT02255461|18801373|P1|Overall Study|Withdrawal by Subject|0
5442833|NCT02255461|18801369|P5|Overall Study|Adverse Event|1
5442834|NCT02255461|18801370|P4|Overall Study|Adverse Event|0
5442835|NCT02255461|18801371|P3|Overall Study|Adverse Event|0
5442836|NCT02255461|18801372|P2|Overall Study|Adverse Event|1
5442837|NCT02255461|18801373|P1|Overall Study|Adverse Event|0
5442838|NCT02255422|18801452|P7|Overall Study|Lost to Follow-up|0
5442839|NCT02255422|18801453|P6|Overall Study|Lost to Follow-up|0
5442840|NCT02255422|18801454|P5|Overall Study|Lost to Follow-up|0
5442841|NCT02255422|18801455|P4|Overall Study|Lost to Follow-up|0
5442842|NCT02255422|18801456|P3|Overall Study|Lost to Follow-up|1
5442843|NCT02255422|18801457|P2|Overall Study|Lost to Follow-up|0
5442844|NCT02255422|18801458|P1|Overall Study|Lost to Follow-up|0
5442845|NCT02255422|18801452|P7|Overall Study|Withdrawal by Subject|2
5442846|NCT02255422|18801453|P6|Overall Study|Withdrawal by Subject|0
5442847|NCT02255422|18801454|P5|Overall Study|Withdrawal by Subject|0
5442848|NCT02255422|18801455|P4|Overall Study|Withdrawal by Subject|0
5442849|NCT02255422|18801456|P3|Overall Study|Withdrawal by Subject|0
5442850|NCT02255422|18801457|P2|Overall Study|Withdrawal by Subject|0
5442851|NCT02255422|18801458|P1|Overall Study|Withdrawal by Subject|0
5442852|NCT02255279|18801492|P2|Overall Study|Withdrawal by Subject|6
5442853|NCT02255279|18801493|P1|Overall Study|Withdrawal by Subject|3
5442854|NCT02255279|18801492|P2|Overall Study|Protocol Violation|1
5442855|NCT02255279|18801493|P1|Overall Study|Protocol Violation|0
5442856|NCT02255279|18801492|P2|Overall Study|Lost to Follow-up|2
5442857|NCT02255279|18801493|P1|Overall Study|Lost to Follow-up|2
5442858|NCT02255149|18801546|P1|Overall Study|Implant Failure|1
5442859|NCT02255149|18801546|P1|Overall Study|Withdrawal by PI|1
5442860|NCT02255149|18801546|P1|Overall Study|Withdrawal by Subject|1
5442861|NCT02255149|18801546|P1|Overall Study|Lost to Follow-up|2
5442862|NCT02255097|18801562|P1|Overall Study|Treatment Ongoing|36
5442863|NCT02255097|18801562|P1|Overall Study|Allocated but not treated|1
5442864|NCT02255097|18801562|P1|Overall Study|Withdrawal by Subject|2
5442865|NCT02255097|18801562|P1|Overall Study|Progressive Disease|80
5442866|NCT02255097|18801562|P1|Overall Study|Physician Decision|1
5442867|NCT02255097|18801562|P1|Overall Study|Lost to Follow-up|1
5442868|NCT02255097|18801562|P1|Overall Study|Death|2
5442869|NCT02255097|18801562|P1|Overall Study|Excluded Medication|1
5442870|NCT02255097|18801562|P1|Overall Study|Complete Response|1
5442871|NCT02255097|18801562|P1|Overall Study|Clinical Progression|23
5442872|NCT02255097|18801562|P1|Overall Study|Adverse Event|24
5442873|NCT02254772|18801583|P1|Overall Study|Withdrawal by Subject|1
5442874|NCT02254772|18801583|P1|Overall Study|Ineligible|1
5442875|NCT02254681|18801589|P1|Overall Study|Lack of Efficacy|6
5442876|NCT02254551|18801599|P1|Dose Escalation|Dose-limiting toxicity|2
5442877|NCT02254551|18801599|P1|Dose Escalation|Physician Decision|1
5442878|NCT02254486|18801609|P2|Overall Study|Various|12
5442879|NCT02254486|18801610|P1|Overall Study|Various|12
5442880|NCT02254486|18801609|P2|Overall Study|GFR<60mL/min|21
5442881|NCT02254486|18801610|P1|Overall Study|GFR<60mL/min|16
5442882|NCT02254486|18801609|P2|Overall Study|Withdrawal by Subject|15
5442883|NCT02254486|18801610|P1|Overall Study|Withdrawal by Subject|17
5442884|NCT02254486|18801609|P2|Overall Study|Protocol Violation|2
5442885|NCT02254486|18801610|P1|Overall Study|Protocol Violation|1
5442886|NCT02254486|18801609|P2|Overall Study|Lost to Follow-up|4
5442887|NCT02254486|18801610|P1|Overall Study|Lost to Follow-up|2
5442888|NCT02254486|18801609|P2|Overall Study|Lack of Efficacy|0
5442889|NCT02254486|18801610|P1|Overall Study|Lack of Efficacy|1
5442890|NCT02254486|18801609|P2|Overall Study|Adverse Event|1
5442891|NCT02254486|18801610|P1|Overall Study|Adverse Event|1
5442892|NCT02254460|18801649|P2|Overall Study|Adverse Event|0
5442893|NCT02254460|18801650|P1|Overall Study|Adverse Event|1
5442894|NCT02254421|18801658|P2|Overall Study|Withdrew Consent|1
5442895|NCT02254421|18801659|P1|Overall Study|Withdrew Consent|1
5442896|NCT02254421|18801658|P2|Overall Study|Death|2
5442897|NCT02254421|18801659|P1|Overall Study|Death|0
5442898|NCT02254421|18801658|P2|Overall Study|Randomized but Not Treated|0
5442899|NCT02254421|18801659|P1|Overall Study|Randomized but Not Treated|1
5442900|NCT02254408|18801673|P2|Overall Study|Lost to Follow-up|0
5442901|NCT02254408|18801674|P1|Overall Study|Lost to Follow-up|1
5442902|NCT02254408|18801673|P2|Overall Study|Withdrawal by Subject|3
5442903|NCT02254408|18801674|P1|Overall Study|Withdrawal by Subject|3
5442904|NCT02254408|18801673|P2|Overall Study|Investigator's Discretion|1
5442905|NCT02254408|18801674|P1|Overall Study|Investigator's Discretion|0
5442906|NCT02254408|18801673|P2|Overall Study|Death|3
5442907|NCT02254408|18801674|P1|Overall Study|Death|2
5442908|NCT02254408|18801673|P2|Overall Study|Adverse Event|0
5442909|NCT02254408|18801674|P1|Overall Study|Adverse Event|1
5442910|NCT02254408|18801673|P2|Overall Study|Randomized But Not Treated|3
5442911|NCT02254408|18801674|P1|Overall Study|Randomized But Not Treated|1
5442912|NCT02254304|18801686|P2|Overall Study|Personal decision|0
5442913|NCT02254304|18801687|P1|Overall Study|Personal decision|1
5442914|NCT02254304|18801686|P2|Overall Study|Personal causes|1
5442915|NCT02254304|18801687|P1|Overall Study|Personal causes|4
5442916|NCT02254304|18801686|P2|Overall Study|Injection site pain and Injection fear|0
5442917|NCT02254304|18801687|P1|Overall Study|Injection site pain and Injection fear|1
5442918|NCT02254304|18801686|P2|Overall Study|Withdrawal by Subject|0
5442919|NCT02254304|18801687|P1|Overall Study|Withdrawal by Subject|3
5442920|NCT02254304|18801686|P2|Overall Study|Protocol Violation|0
5442921|NCT02254304|18801687|P1|Overall Study|Protocol Violation|1
5442922|NCT02254304|18801686|P2|Overall Study|Lost to Follow-up|2
5442923|NCT02254304|18801687|P1|Overall Study|Lost to Follow-up|2
5442924|NCT02254304|18801686|P2|Overall Study|Adverse Event|1
5442925|NCT02254304|18801687|P1|Overall Study|Adverse Event|2
5442926|NCT02254291|18801747|P3|Overall Study|Missing follow-up information|1
5442927|NCT02254291|18801748|P2|Overall Study|Missing follow-up information|0
5442928|NCT02254291|18801749|P1|Overall Study|Missing follow-up information|0
5442929|NCT02254291|18801747|P3|Overall Study|Withdrawal by Subject|1
5442930|NCT02254291|18801748|P2|Overall Study|Withdrawal by Subject|3
5442931|NCT02254291|18801749|P1|Overall Study|Withdrawal by Subject|0
5442932|NCT02254278|18801765|P2|Overall Study|Protocol Violation|1
5442933|NCT02254278|18801766|P1|Overall Study|Protocol Violation|1
5442934|NCT02253992|18801827|P3|Overall Study|Other|1
5442935|NCT02253992|18801828|P2|Overall Study|Other|0
5442936|NCT02253992|18801829|P1|Overall Study|Other|0
5442937|NCT02253992|18801827|P3|Overall Study|Completed treatment as per protocol|22
5442938|NCT02253992|18801828|P2|Overall Study|Completed treatment as per protocol|1
5442939|NCT02253992|18801829|P1|Overall Study|Completed treatment as per protocol|0
5442940|NCT02253992|18801827|P3|Overall Study|Subject discontinued study drug|1
5442941|NCT02253992|18801828|P2|Overall Study|Subject discontinued study drug|0
5442942|NCT02253992|18801829|P1|Overall Study|Subject discontinued study drug|1
5442943|NCT02253992|18801827|P3|Overall Study|Death|1
5442944|NCT02253992|18801828|P2|Overall Study|Death|0
5442945|NCT02253992|18801829|P1|Overall Study|Death|0
5442946|NCT02253992|18801827|P3|Overall Study|Adverse Event|8
5442947|NCT02253992|18801828|P2|Overall Study|Adverse Event|0
5442948|NCT02253992|18801829|P1|Overall Study|Adverse Event|0
5442949|NCT02253992|18801827|P3|Overall Study|Withdrawal by Subject|3
5442950|NCT02253992|18801828|P2|Overall Study|Withdrawal by Subject|0
5442951|NCT02253992|18801829|P1|Overall Study|Withdrawal by Subject|0
5442952|NCT02253992|18801827|P3|Overall Study|Disease progression|98
5442953|NCT02253992|18801828|P2|Overall Study|Disease progression|3
5442954|NCT02253992|18801829|P1|Overall Study|Disease progression|4
5442955|NCT02253992|18801827|P3|Overall Study|Study drug toxicity|10
5442956|NCT02253992|18801828|P2|Overall Study|Study drug toxicity|0
5442957|NCT02253992|18801829|P1|Overall Study|Study drug toxicity|1
5442958|NCT02253654|18801895|P2|Overall Study|Did Not Receive Study Treatment|1
5442959|NCT02253654|18801896|P1|Overall Study|Did Not Receive Study Treatment|4
5442960|NCT02253654|18801895|P2|Overall Study|Death|7
5442961|NCT02253654|18801896|P1|Overall Study|Death|4
5442962|NCT02253654|18801895|P2|Overall Study|Lost to Follow-up|5
5442963|NCT02253654|18801896|P1|Overall Study|Lost to Follow-up|2
5442964|NCT02253654|18801895|P2|Overall Study|Decision by Sponsor|1
5442965|NCT02253654|18801896|P1|Overall Study|Decision by Sponsor|1
5442966|NCT02253654|18801895|P2|Overall Study|Withdrawal by Subject|4
5442967|NCT02253654|18801896|P1|Overall Study|Withdrawal by Subject|12
5442968|NCT02253433|18801922|P2|Overall Study|Medical or Other Concerns|2
5442969|NCT02253433|18801923|P1|Overall Study|Medical or Other Concerns|1
5442970|NCT02253433|18801922|P2|Overall Study|Too Busy|4
5442971|NCT02253433|18801923|P1|Overall Study|Too Busy|0
5442972|NCT02253433|18801922|P2|Overall Study|Unstable Housing/Homeless|7
5442973|NCT02253433|18801923|P1|Overall Study|Unstable Housing/Homeless|0
5442974|NCT02253433|18801922|P2|Overall Study|Uncomfortable with home visitors|3
5442975|NCT02253433|18801923|P1|Overall Study|Uncomfortable with home visitors|0
5442976|NCT02253433|18801922|P2|Overall Study|Out of Study Area|7
5442977|NCT02253433|18801923|P1|Overall Study|Out of Study Area|2
5442978|NCT02253433|18801922|P2|Overall Study|No Longer Interested|15
5442979|NCT02253433|18801923|P1|Overall Study|No Longer Interested|3
5442980|NCT02253433|18801922|P2|Overall Study|Death|1
5442981|NCT02253433|18801923|P1|Overall Study|Death|1
5442982|NCT02253433|18801922|P2|Overall Study|Unable to Contact|16
5442983|NCT02253433|18801923|P1|Overall Study|Unable to Contact|9
5442984|NCT02253147|18802182|P1|Overall Study|Withdrawal by Subject|1
5442985|NCT02253147|18802182|P1|Overall Study|Lost to Follow-up|2
5442986|NCT02253147|18802182|P1|Overall Study|Conditional re-treatment at W52|5
5442987|NCT02253147|18802182|P1|Overall Study|Did not consent to study extension|9
5442988|NCT02253147|18802182|P1|Overall Study|Protocol Violation|30
5442989|NCT02252965|18802216|P2|Overall Study|Other|5
5442990|NCT02252965|18802217|P1|Overall Study|Other|4
5442991|NCT02252965|18802216|P2|Overall Study|Withdrawal by Subject|9
5442992|NCT02252965|18802217|P1|Overall Study|Withdrawal by Subject|7
5442993|NCT02252965|18802216|P2|Overall Study|Lack of Efficacy|2
5442994|NCT02252965|18802217|P1|Overall Study|Lack of Efficacy|0
5442995|NCT02252965|18802216|P2|Overall Study|Protocol Violation|5
5442996|NCT02252965|18802217|P1|Overall Study|Protocol Violation|4
5442997|NCT02252965|18802216|P2|Overall Study|Lost to Follow-up|8
5442998|NCT02252965|18802217|P1|Overall Study|Lost to Follow-up|16
5442999|NCT02252965|18802216|P2|Overall Study|Adverse Event|14
5443000|NCT02252965|18802217|P1|Overall Study|Adverse Event|9
5443001|NCT02252939|18802244|P1|Overall Study|Lost to Follow-up|3
5443002|NCT02252588|18802285|P2|Overall Study|Withdrawal by Subject|0
5443003|NCT02252588|18802286|P1|Overall Study|Withdrawal by Subject|4
5443004|NCT02252536|18802314|P2|Overall Study|Lost to Follow-up|3
5443005|NCT02252536|18802315|P1|Overall Study|Lost to Follow-up|5
5443006|NCT02252406|18802376|P2|Titrated to Ranolazine 1000mg BID|Adverse Event|0
5443007|NCT02252406|18802377|P1|Titrated to Ranolazine 1000mg BID|Adverse Event|2
5443008|NCT02252406|18802376|P2|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
5443009|NCT02252406|18802377|P1|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
5443010|NCT02252406|18802376|P2|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
5443011|NCT02252406|18802377|P1|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
5443012|NCT02252406|18802376|P2|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
5443013|NCT02252406|18802377|P1|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
5443014|NCT02252406|18802376|P2|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
5443015|NCT02252406|18802377|P1|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
5443016|NCT02252211|18802435|P3|Overall Study|Serious Adverse Event During Screening|1
5443017|NCT02252211|18802436|P2|Overall Study|Serious Adverse Event During Screening|0
5443018|NCT02252211|18802437|P1|Overall Study|Serious Adverse Event During Screening|1
5443019|NCT02252211|18802435|P3|Overall Study|Withdrawal by Subject|0
5443020|NCT02252211|18802436|P2|Overall Study|Withdrawal by Subject|0
5443021|NCT02252211|18802437|P1|Overall Study|Withdrawal by Subject|1
5443022|NCT02252211|18802435|P3|Overall Study|Progressive disease|0
5443023|NCT02252211|18802436|P2|Overall Study|Progressive disease|2
5443024|NCT02252211|18802437|P1|Overall Study|Progressive disease|3
5443025|NCT02252211|18802435|P3|Overall Study|Adverse Event|0
5443026|NCT02252211|18802436|P2|Overall Study|Adverse Event|1
5443027|NCT02252211|18802437|P1|Overall Study|Adverse Event|0
5443028|NCT02252172|18802474|P2|Overall Study|Ongoing|298
5443029|NCT02252172|18802475|P1|Overall Study|Ongoing|276
5443030|NCT02252172|18802474|P2|Overall Study|Lost to Follow-up|1
5443031|NCT02252172|18802475|P1|Overall Study|Lost to Follow-up|3
5443032|NCT02252146|18802487|P1|Overall Study|Inability to travel to study site|1
5443033|NCT02252146|18802487|P1|Overall Study|Entered hospice care|1
5443034|NCT02252146|18802487|P1|Overall Study|Lack of Efficacy|4
5443035|NCT02252042|18802528|P2|Overall Study|Ongoing in study|35
5443036|NCT02252042|18802529|P1|Overall Study|Ongoing in study|64
5443037|NCT02252042|18802528|P2|Overall Study|Withdrawal by Subject|20
5443038|NCT02252042|18802529|P1|Overall Study|Withdrawal by Subject|13
5443039|NCT02252042|18802528|P2|Overall Study|Physician Decision|1
5443040|NCT02252042|18802529|P1|Overall Study|Physician Decision|0
5443041|NCT02252042|18802528|P2|Overall Study|Death|192
5443042|NCT02252042|18802529|P1|Overall Study|Death|170
5443043|NCT02252016|18802569|P2|Overall Study|Withdrawal by Subject|2
5443044|NCT02252016|18802570|P1|Overall Study|Withdrawal by Subject|0
5443045|NCT02252016|18802569|P2|Overall Study|Physician Decision|0
5443046|NCT02252016|18802570|P1|Overall Study|Physician Decision|1
5443047|NCT02252016|18802569|P2|Overall Study|Lost to Follow-up|1
5443048|NCT02252016|18802570|P1|Overall Study|Lost to Follow-up|2
5443049|NCT02251990|18802584|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
5443050|NCT02251990|18802585|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
5443051|NCT02251990|18802584|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
5443052|NCT02251990|18802585|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
5443053|NCT02251990|18802584|P2|Period 1 (Double-blind [DB])|Not Treated|0
5443054|NCT02251990|18802585|P1|Period 1 (Double-blind [DB])|Not Treated|1
5443055|NCT02251990|18802584|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
5443056|NCT02251990|18802585|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
5443057|NCT02251990|18802584|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
5443058|NCT02251990|18802585|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
5443059|NCT02251990|18802584|P2|Period 1 (Double-blind [DB])|Adverse Event|1
5443060|NCT02251990|18802585|P1|Period 1 (Double-blind [DB])|Adverse Event|1
5443061|NCT02251912|18802613|P2|Overall Study|Adverse Event|2
5443062|NCT02251912|18802614|P1|Overall Study|Adverse Event|0
5443063|NCT02251912|18802613|P2|Overall Study|Withdrawal by Subject|3
5443064|NCT02251912|18802614|P1|Overall Study|Withdrawal by Subject|2
5443065|NCT02251743|18802643|P2|Overall Study|Withdrawal by Subject|1
5443066|NCT02251743|18802644|P1|Overall Study|Withdrawal by Subject|1
5443067|NCT02251717|18802652|P2|Overall Study|Withdrew Consent|0
5443068|NCT02251717|18802653|P1|Overall Study|Withdrew Consent|1
5443069|NCT02251717|18802652|P2|Overall Study|Adverse Event|1
5443070|NCT02251717|18802653|P1|Overall Study|Adverse Event|0
5443071|NCT02251652|18802665|P1|Overall Study|Withdrawal by Subject|1
5443072|NCT02251275|18802721|P5|Overall Study|Withdrawal by Subject|0
5443073|NCT02251275|18802722|P4|Overall Study|Withdrawal by Subject|1
5443074|NCT02251275|18802723|P3|Overall Study|Withdrawal by Subject|35
5443075|NCT02251275|18802724|P2|Overall Study|Withdrawal by Subject|51
5443076|NCT02251275|18802725|P1|Overall Study|Withdrawal by Subject|25
5443077|NCT02251275|18802721|P5|Overall Study|Protocol Deviation|0
5443078|NCT02251275|18802722|P4|Overall Study|Protocol Deviation|0
5443079|NCT02251275|18802723|P3|Overall Study|Protocol Deviation|1
5443080|NCT02251275|18802724|P2|Overall Study|Protocol Deviation|0
5443081|NCT02251275|18802725|P1|Overall Study|Protocol Deviation|0
5443082|NCT02251275|18802721|P5|Overall Study|Physician Decision|1
5443083|NCT02251275|18802722|P4|Overall Study|Physician Decision|0
5443084|NCT02251275|18802723|P3|Overall Study|Physician Decision|26
5443085|NCT02251275|18802724|P2|Overall Study|Physician Decision|30
5443086|NCT02251275|18802725|P1|Overall Study|Physician Decision|19
5443087|NCT02251275|18802721|P5|Overall Study|Lost to Follow-up|0
5443088|NCT02251275|18802722|P4|Overall Study|Lost to Follow-up|0
5443089|NCT02251275|18802723|P3|Overall Study|Lost to Follow-up|4
5443090|NCT02251275|18802724|P2|Overall Study|Lost to Follow-up|6
5443091|NCT02251275|18802725|P1|Overall Study|Lost to Follow-up|5
5443092|NCT02251275|18802721|P5|Overall Study|Adverse Event|0
5443093|NCT02251275|18802722|P4|Overall Study|Adverse Event|0
5443094|NCT02251275|18802723|P3|Overall Study|Adverse Event|28
5443095|NCT02251275|18802724|P2|Overall Study|Adverse Event|60
5443096|NCT02251275|18802725|P1|Overall Study|Adverse Event|23
5443097|NCT02250443|18802829|P1|Overall Study|Adverse Event|3
5443098|NCT02250443|18802829|P1|Overall Study|Administrative problems|7
5443099|NCT02250326|18802858|P3|Follow-Up Period|Lost to Follow-up|3
5443100|NCT02250326|18802859|P2|Follow-Up Period|Lost to Follow-up|1
5443101|NCT02250326|18802860|P1|Follow-Up Period|Lost to Follow-up|1
5443102|NCT02250326|18802858|P3|Follow-Up Period|Unknown or Missing|3
5443103|NCT02250326|18802859|P2|Follow-Up Period|Unknown or Missing|3
5443104|NCT02250326|18802860|P1|Follow-Up Period|Unknown or Missing|2
5443105|NCT02250326|18802858|P3|Follow-Up Period|Death|32
5443106|NCT02250326|18802859|P2|Follow-Up Period|Death|26
5443107|NCT02250326|18802860|P1|Follow-Up Period|Death|46
5443108|NCT02250326|18802858|P3|Treatment Period|Randomized or assigned; not treated|1
5443109|NCT02250326|18802859|P2|Treatment Period|Randomized or assigned; not treated|1
5443110|NCT02250326|18802860|P1|Treatment Period|Randomized or assigned; not treated|2
5443111|NCT02250326|18802858|P3|Treatment Period|Miscellaneous|7
5443112|NCT02250326|18802859|P2|Treatment Period|Miscellaneous|2
5443113|NCT02250326|18802860|P1|Treatment Period|Miscellaneous|8
5443114|NCT02250326|18802858|P3|Treatment Period|Withdrawal by Subject|4
5443115|NCT02250326|18802859|P2|Treatment Period|Withdrawal by Subject|5
5443116|NCT02250326|18802860|P1|Treatment Period|Withdrawal by Subject|11
5443117|NCT02250326|18802858|P3|Treatment Period|Symptomatic Deterioration|10
5443118|NCT02250326|18802859|P2|Treatment Period|Symptomatic Deterioration|4
5443119|NCT02250326|18802860|P1|Treatment Period|Symptomatic Deterioration|9
5443120|NCT02250326|18802858|P3|Treatment Period|Progressive Disease|45
5443121|NCT02250326|18802859|P2|Treatment Period|Progressive Disease|36
5443122|NCT02250326|18802860|P1|Treatment Period|Progressive Disease|42
5443123|NCT02250326|18802858|P3|Treatment Period|Adverse Event|8
5443124|NCT02250326|18802859|P2|Treatment Period|Adverse Event|4
5443125|NCT02250326|18802860|P1|Treatment Period|Adverse Event|8
5443126|NCT02250326|18802858|P3|Treatment Period|Death|2
5443127|NCT02250326|18802859|P2|Treatment Period|Death|12
5443128|NCT02250326|18802860|P1|Treatment Period|Death|1
5443129|NCT02250274|18802893|P2|Overall Study|Insufficient blood draw amount|6
5443130|NCT02250274|18802894|P1|Overall Study|Insufficient blood draw amount|7
5443131|NCT02250183|18802910|P1|Overall Study|Lost to Follow-up|1
5443132|NCT02250183|18802910|P1|Overall Study|Adverse Event|5
5443133|NCT02250183|18802910|P1|Overall Study|Withdrawal by Subject|2
5443134|NCT02249949|18802932|P1|Overall Study|Cancelled prior to treatment|2
5443135|NCT02249832|18802939|P1|Overall Study|Lost to Follow-up|10
5443136|NCT02249832|18802939|P1|Overall Study|Withdrawal by Subject|3
5443137|NCT02249767|18802983|P3|Overall Study|Did not use medication|8
5443138|NCT02249767|18802984|P2|Overall Study|Did not use medication|9
5443139|NCT02249767|18802985|P1|Overall Study|Did not use medication|8
5443140|NCT02249182|18803051|P5|Treatment Phase|Lost to Follow-up|0
5443141|NCT02249182|18803052|P4|Treatment Phase|Lost to Follow-up|0
5443142|NCT02249182|18803053|P3|Treatment Phase|Lost to Follow-up|0
5443143|NCT02249182|18803054|P2|Treatment Phase|Lost to Follow-up|0
5443144|NCT02249182|18803055|P1|Treatment Phase|Lost to Follow-up|4
5443145|NCT02248974|18803205|P2|1-Month Follow-Up|Lost to Follow-up|3
5443146|NCT02248974|18803206|P1|1-Month Follow-Up|Lost to Follow-up|2
5443147|NCT02248974|18803205|P2|1-Week Follow-Up|Lost to Follow-up|8
5443148|NCT02248974|18803206|P1|1-Week Follow-Up|Lost to Follow-up|0
5443149|NCT02248974|18803205|P2|1-Week Follow-Up|Withdrawal by Subject|2
5443150|NCT02248974|18803206|P1|1-Week Follow-Up|Withdrawal by Subject|0
5443151|NCT02248974|18803205|P2|1-Week Follow-Up|Timing: implanted before survey|2
5443152|NCT02248974|18803206|P1|1-Week Follow-Up|Timing: implanted before survey|0
5443153|NCT02248974|18803205|P2|1-Week Follow-Up|Noncompliant with terms of participation|1
5443154|NCT02248974|18803206|P1|1-Week Follow-Up|Noncompliant with terms of participation|0
5443155|NCT02248974|18803205|P2|1-Week Follow-Up|Excluded because of age|1
5443156|NCT02248974|18803206|P1|1-Week Follow-Up|Excluded because of age|0
5443157|NCT02248974|18803205|P2|1-Week Follow-Up|Death|1
5443158|NCT02248974|18803206|P1|1-Week Follow-Up|Death|1
5443159|NCT02248974|18803205|P2|1-Week Follow-Up|Cognitive Difficulty|0
5443160|NCT02248974|18803206|P1|1-Week Follow-Up|Cognitive Difficulty|1
5443161|NCT02248974|18803205|P2|1-Week Follow-Up|Transferred to another facility|0
5443162|NCT02248974|18803206|P1|1-Week Follow-Up|Transferred to another facility|1
5443163|NCT02248974|18803205|P2|1-Week Follow-Up|Enrolled in another study|1
5443164|NCT02248974|18803206|P1|1-Week Follow-Up|Enrolled in another study|1
5443165|NCT02248974|18803205|P2|1-Week Follow-Up|Became ineligible for LVAD|1
5443166|NCT02248974|18803206|P1|1-Week Follow-Up|Became ineligible for LVAD|4
5443167|NCT02248974|18803205|P2|1-Day Follow-Up|Enrolled in another study|0
5443168|NCT02248974|18803206|P1|1-Day Follow-Up|Enrolled in another study|1
5443169|NCT02248974|18803205|P2|1-Day Follow-Up|Withdrawal by Subject|0
5443170|NCT02248974|18803206|P1|1-Day Follow-Up|Withdrawal by Subject|5
5443171|NCT02248974|18803205|P2|1-Day Follow-Up|Lost to Follow-up|0
5443172|NCT02248974|18803206|P1|1-Day Follow-Up|Lost to Follow-up|4
5443173|NCT02248961|18803284|P2|Overall Study|Unmet inclusion/exclusion criteria|0
5443174|NCT02248961|18803285|P1|Overall Study|Unmet inclusion/exclusion criteria|1
5443175|NCT02248961|18803284|P2|Overall Study|Withdrawal by Subject|2
5443176|NCT02248961|18803285|P1|Overall Study|Withdrawal by Subject|1
5443177|NCT02248961|18803284|P2|Overall Study|Adverse Event|0
5443178|NCT02248961|18803285|P1|Overall Study|Adverse Event|1
5443179|NCT02248857|18803320|P3|6 Month|Death|0
5443180|NCT02248857|18803321|P2|6 Month|Death|0
5443181|NCT02248857|18803322|P1|6 Month|Death|1
5443182|NCT02248857|18803320|P3|6 Month|Withdrawal by Subject|2
5443183|NCT02248857|18803321|P2|6 Month|Withdrawal by Subject|2
5443184|NCT02248857|18803322|P1|6 Month|Withdrawal by Subject|0
5443185|NCT02248857|18803320|P3|6 Month|Partially completed, unable to finish|0
5443186|NCT02248857|18803321|P2|6 Month|Partially completed, unable to finish|1
5443187|NCT02248857|18803322|P1|6 Month|Partially completed, unable to finish|0
5443188|NCT02248857|18803320|P3|6 Month|Lost to Follow-up|15
5443189|NCT02248857|18803321|P2|6 Month|Lost to Follow-up|26
5443190|NCT02248857|18803322|P1|6 Month|Lost to Follow-up|27
5443191|NCT02248857|18803320|P3|3 Month|Partially completed, unable to finish|1
5443192|NCT02248857|18803321|P2|3 Month|Partially completed, unable to finish|2
5443193|NCT02248857|18803322|P1|3 Month|Partially completed, unable to finish|2
5443194|NCT02248857|18803320|P3|3 Month|Unable to reach for 3 month|26
5443195|NCT02248857|18803321|P2|3 Month|Unable to reach for 3 month|29
5443196|NCT02248857|18803322|P1|3 Month|Unable to reach for 3 month|35
5443197|NCT02248857|18803320|P3|3 Month|Withdrawal by Subject|4
5443198|NCT02248857|18803321|P2|3 Month|Withdrawal by Subject|3
5443199|NCT02248857|18803322|P1|3 Month|Withdrawal by Subject|9
5443200|NCT02248818|18803359|P9|Randomised Study|Administrative - randomization error|0
5443201|NCT02248818|18803360|P8|Randomised Study|Administrative - randomization error|0
5443202|NCT02248818|18803361|P7|Randomised Study|Administrative - randomization error|0
5443203|NCT02248818|18803362|P6|Randomised Study|Administrative - randomization error|8
5443204|NCT02248818|18803363|P5|Randomised Study|Administrative - randomization error|0
5443205|NCT02248818|18803364|P4|Randomised Study|Administrative - randomization error|0
5443206|NCT02248818|18803365|P3|Randomised Study|Administrative - randomization error|0
5443207|NCT02248818|18803366|P2|Randomised Study|Administrative - randomization error|0
5443208|NCT02248818|18803367|P1|Randomised Study|Administrative - randomization error|0
5443209|NCT02248818|18803359|P9|Screening|Lost to Follow-up|7
5443210|NCT02248818|18803360|P8|Screening|Lost to Follow-up|0
5443211|NCT02248818|18803361|P7|Screening|Lost to Follow-up|0
5443212|NCT02248818|18803362|P6|Screening|Lost to Follow-up|0
5443213|NCT02248818|18803363|P5|Screening|Lost to Follow-up|0
5443214|NCT02248818|18803364|P4|Screening|Lost to Follow-up|0
5443215|NCT02248818|18803365|P3|Screening|Lost to Follow-up|0
5443216|NCT02248818|18803366|P2|Screening|Lost to Follow-up|0
5443217|NCT02248818|18803367|P1|Screening|Lost to Follow-up|0
5443218|NCT02248818|18803359|P9|Screening|Withdrawal by Subject|6
5443219|NCT02248818|18803360|P8|Screening|Withdrawal by Subject|0
5443220|NCT02248818|18803361|P7|Screening|Withdrawal by Subject|0
5443221|NCT02248818|18803362|P6|Screening|Withdrawal by Subject|0
5443222|NCT02248818|18803363|P5|Screening|Withdrawal by Subject|0
5443223|NCT02248818|18803364|P4|Screening|Withdrawal by Subject|0
5443224|NCT02248818|18803365|P3|Screening|Withdrawal by Subject|0
5443225|NCT02248818|18803366|P2|Screening|Withdrawal by Subject|0
5443226|NCT02248818|18803367|P1|Screening|Withdrawal by Subject|0
5443227|NCT02248818|18803359|P9|Screening|Physician Decision|73
5443228|NCT02248818|18803360|P8|Screening|Physician Decision|0
5443229|NCT02248818|18803361|P7|Screening|Physician Decision|0
5443230|NCT02248818|18803362|P6|Screening|Physician Decision|0
5443231|NCT02248818|18803363|P5|Screening|Physician Decision|0
5443232|NCT02248818|18803364|P4|Screening|Physician Decision|0
5443233|NCT02248818|18803365|P3|Screening|Physician Decision|0
5443234|NCT02248818|18803366|P2|Screening|Physician Decision|0
5443235|NCT02248818|18803367|P1|Screening|Physician Decision|0
5443236|NCT02248818|18803359|P9|Screening|Study fully enrolled|14
5443237|NCT02248818|18803360|P8|Screening|Study fully enrolled|0
5443238|NCT02248818|18803361|P7|Screening|Study fully enrolled|0
5443239|NCT02248818|18803362|P6|Screening|Study fully enrolled|0
5443240|NCT02248818|18803363|P5|Screening|Study fully enrolled|0
5443241|NCT02248818|18803364|P4|Screening|Study fully enrolled|0
5443242|NCT02248818|18803365|P3|Screening|Study fully enrolled|0
5443243|NCT02248818|18803366|P2|Screening|Study fully enrolled|0
5443244|NCT02248818|18803367|P1|Screening|Study fully enrolled|0
5443245|NCT02248818|18803359|P9|Screening|Protocol Violation|7
5443246|NCT02248818|18803360|P8|Screening|Protocol Violation|0
5443247|NCT02248818|18803361|P7|Screening|Protocol Violation|0
5443248|NCT02248818|18803362|P6|Screening|Protocol Violation|0
5443249|NCT02248818|18803363|P5|Screening|Protocol Violation|0
5443250|NCT02248818|18803364|P4|Screening|Protocol Violation|0
5443251|NCT02248818|18803365|P3|Screening|Protocol Violation|0
5443252|NCT02248818|18803366|P2|Screening|Protocol Violation|0
5443253|NCT02248818|18803367|P1|Screening|Protocol Violation|0
5443254|NCT02248675|18803582|P2|Overall Study|Lost to Follow-up|1
5443255|NCT02248675|18803583|P1|Overall Study|Lost to Follow-up|3
5443256|NCT02248649|18803610|P2|Overall Study|Lost to Follow-up|10
5443257|NCT02248649|18803611|P1|Overall Study|Lost to Follow-up|14
5443258|NCT02248649|18803610|P2|Overall Study|Death|11
5443259|NCT02248649|18803611|P1|Overall Study|Death|7
5443260|NCT02248480|18803655|P2|Overall Study|Other:Physician Decision|1
5443261|NCT02248480|18803656|P1|Overall Study|Other:Physician Decision|0
5443262|NCT02248480|18803655|P2|Overall Study|Entry Criteria Not Met|1
5443263|NCT02248480|18803656|P1|Overall Study|Entry Criteria Not Met|0
5443264|NCT02248480|18803655|P2|Overall Study|Withdrawal by Subject|4
5443265|NCT02248480|18803656|P1|Overall Study|Withdrawal by Subject|2
5443266|NCT02248480|18803655|P2|Overall Study|Adverse Event|2
5443267|NCT02248480|18803656|P1|Overall Study|Adverse Event|11
5443268|NCT02248480|18803655|P2|Overall Study|Lack of Efficacy|6
5443269|NCT02248480|18803656|P1|Overall Study|Lack of Efficacy|4
5443270|NCT02247960|18803723|P2|Catheter Removed|Lost to Follow-up|10
5443271|NCT02247960|18803724|P1|Catheter Removed|Lost to Follow-up|7
5443272|NCT02247960|18803723|P2|Patient Consent and Randomization|Withdrawal by Subject|4
5443273|NCT02247960|18803724|P1|Patient Consent and Randomization|Withdrawal by Subject|0
5443274|NCT02247960|18803723|P2|Patient Consent and Randomization|Physician Decision|2
5443275|NCT02247960|18803724|P1|Patient Consent and Randomization|Physician Decision|2
5443276|NCT02247804|18803737|P3|Treatment Period 3|Reason not Specified|3
5443277|NCT02247804|18803738|P2|Treatment Period 3|Reason not Specified|1
5443278|NCT02247804|18803739|P1|Treatment Period 3|Reason not Specified|2
5443279|NCT02247804|18803737|P3|Treatment Period 3|Personal Reasons|2
5443280|NCT02247804|18803738|P2|Treatment Period 3|Personal Reasons|3
5443281|NCT02247804|18803739|P1|Treatment Period 3|Personal Reasons|4
5443282|NCT02247804|18803737|P3|Treatment Period 3|Lost to Follow-up|2
5443283|NCT02247804|18803738|P2|Treatment Period 3|Lost to Follow-up|2
5443284|NCT02247804|18803739|P1|Treatment Period 3|Lost to Follow-up|1
5443285|NCT02247804|18803737|P3|Treatment Period 3|Lack of Efficacy|0
5443286|NCT02247804|18803738|P2|Treatment Period 3|Lack of Efficacy|1
5443287|NCT02247804|18803739|P1|Treatment Period 3|Lack of Efficacy|0
5443288|NCT02247804|18803737|P3|Treatment Period 3|Adverse Event|3
5443289|NCT02247804|18803738|P2|Treatment Period 3|Adverse Event|3
5443290|NCT02247804|18803739|P1|Treatment Period 3|Adverse Event|4
5443291|NCT02247804|18803737|P3|Treatment Period 2|Reason not Specified|2
5443292|NCT02247804|18803738|P2|Treatment Period 2|Reason not Specified|0
5443293|NCT02247804|18803739|P1|Treatment Period 2|Reason not Specified|0
5443294|NCT02247804|18803737|P3|Treatment Period 2|Personal Reasons|1
5443295|NCT02247804|18803738|P2|Treatment Period 2|Personal Reasons|1
5443296|NCT02247804|18803739|P1|Treatment Period 2|Personal Reasons|2
5443297|NCT02247804|18803737|P3|Treatment Period 2|Lost to Follow-up|1
5443298|NCT02247804|18803738|P2|Treatment Period 2|Lost to Follow-up|1
5443299|NCT02247804|18803739|P1|Treatment Period 2|Lost to Follow-up|0
5443300|NCT02247804|18803737|P3|Treatment Period 2|Lack of Efficacy|1
5443301|NCT02247804|18803738|P2|Treatment Period 2|Lack of Efficacy|0
5443302|NCT02247804|18803739|P1|Treatment Period 2|Lack of Efficacy|0
5443303|NCT02247804|18803737|P3|Treatment Period 2|Adverse Event|3
5443304|NCT02247804|18803738|P2|Treatment Period 2|Adverse Event|3
5443305|NCT02247804|18803739|P1|Treatment Period 2|Adverse Event|6
5443306|NCT02247804|18803737|P3|Treatment Period 1|Randomized but not Treated|1
5443307|NCT02247804|18803738|P2|Treatment Period 1|Randomized but not Treated|1
5443308|NCT02247804|18803739|P1|Treatment Period 1|Randomized but not Treated|5
5443309|NCT02247804|18803737|P3|Treatment Period 1|Protocol Deviation|1
5443310|NCT02247804|18803738|P2|Treatment Period 1|Protocol Deviation|0
5443311|NCT02247804|18803739|P1|Treatment Period 1|Protocol Deviation|0
5443312|NCT02247804|18803737|P3|Treatment Period 1|Personal Reasons|2
5443313|NCT02247804|18803738|P2|Treatment Period 1|Personal Reasons|1
5443314|NCT02247804|18803739|P1|Treatment Period 1|Personal Reasons|7
5443315|NCT02247804|18803737|P3|Treatment Period 1|Lost to Follow-up|2
5443316|NCT02247804|18803738|P2|Treatment Period 1|Lost to Follow-up|0
5443317|NCT02247804|18803739|P1|Treatment Period 1|Lost to Follow-up|1
5443318|NCT02247804|18803737|P3|Treatment Period 1|Lack of Efficacy|2
5443319|NCT02247804|18803738|P2|Treatment Period 1|Lack of Efficacy|0
5443320|NCT02247804|18803739|P1|Treatment Period 1|Lack of Efficacy|0
5443321|NCT02247804|18803737|P3|Treatment Period 1|Adverse Event|0
5443322|NCT02247804|18803738|P2|Treatment Period 1|Adverse Event|2
5443323|NCT02247804|18803739|P1|Treatment Period 1|Adverse Event|9
5443324|NCT02247531|18803797|P3|Overall Study|Unspecified Reason|4
5443325|NCT02247531|18803798|P2|Overall Study|Unspecified Reason|3
5443326|NCT02247531|18803799|P1|Overall Study|Unspecified Reason|2
5443327|NCT02247531|18803797|P3|Overall Study|Physician Decision|2
5443328|NCT02247531|18803798|P2|Overall Study|Physician Decision|2
5443329|NCT02247531|18803799|P1|Overall Study|Physician Decision|0
5443330|NCT02247531|18803797|P3|Overall Study|Study Terminated by Sponsor|62
5443331|NCT02247531|18803798|P2|Overall Study|Study Terminated by Sponsor|66
5443332|NCT02247531|18803799|P1|Overall Study|Study Terminated by Sponsor|64
5443333|NCT02247531|18803797|P3|Overall Study|Withdrawal by Subject|25
5443334|NCT02247531|18803798|P2|Overall Study|Withdrawal by Subject|31
5443335|NCT02247531|18803799|P1|Overall Study|Withdrawal by Subject|26
5443336|NCT02247531|18803797|P3|Overall Study|Non-compliance|0
5443337|NCT02247531|18803798|P2|Overall Study|Non-compliance|2
5443338|NCT02247531|18803799|P1|Overall Study|Non-compliance|2
5443339|NCT02247531|18803797|P3|Overall Study|Lost to Follow-up|3
5443340|NCT02247531|18803798|P2|Overall Study|Lost to Follow-up|8
5443341|NCT02247531|18803799|P1|Overall Study|Lost to Follow-up|1
5443342|NCT02247531|18803797|P3|Overall Study|Death|5
5443343|NCT02247531|18803798|P2|Overall Study|Death|9
5443344|NCT02247531|18803799|P1|Overall Study|Death|8
5443345|NCT02247531|18803797|P3|Overall Study|Adverse Event|9
5443346|NCT02247531|18803798|P2|Overall Study|Adverse Event|4
5443347|NCT02247531|18803799|P1|Overall Study|Adverse Event|3
5443348|NCT02247479|18803849|P3|Overall Study|Unspecified Reason|2
5443349|NCT02247479|18803850|P2|Overall Study|Unspecified Reason|5
5443350|NCT02247479|18803851|P1|Overall Study|Unspecified Reason|2
5443351|NCT02247479|18803849|P3|Overall Study|Physician Decision|2
5443352|NCT02247479|18803850|P2|Overall Study|Physician Decision|0
5443353|NCT02247479|18803851|P1|Overall Study|Physician Decision|1
5443354|NCT02247479|18803849|P3|Overall Study|Study Terminated by Sponsor|94
5443355|NCT02247479|18803850|P2|Overall Study|Study Terminated by Sponsor|88
5443356|NCT02247479|18803851|P1|Overall Study|Study Terminated by Sponsor|98
5443357|NCT02247479|18803849|P3|Overall Study|Withdrawal by Subject|24
5443358|NCT02247479|18803850|P2|Overall Study|Withdrawal by Subject|29
5443359|NCT02247479|18803851|P1|Overall Study|Withdrawal by Subject|25
5443360|NCT02247479|18803849|P3|Overall Study|Non-compliance|1
5443361|NCT02247479|18803850|P2|Overall Study|Non-compliance|0
5443362|NCT02247479|18803851|P1|Overall Study|Non-compliance|0
5443363|NCT02247479|18803849|P3|Overall Study|Lost to Follow-up|1
5443364|NCT02247479|18803850|P2|Overall Study|Lost to Follow-up|3
5443365|NCT02247479|18803851|P1|Overall Study|Lost to Follow-up|3
5443366|NCT02247479|18803849|P3|Overall Study|Death|6
5443367|NCT02247479|18803850|P2|Overall Study|Death|4
5443368|NCT02247479|18803851|P1|Overall Study|Death|5
5443369|NCT02247479|18803849|P3|Overall Study|Adverse Event|8
5443370|NCT02247479|18803850|P2|Overall Study|Adverse Event|9
5443371|NCT02247479|18803851|P1|Overall Study|Adverse Event|8
5443372|NCT02247466|18803900|P2|Overall Study|Procedure changed to open surgery|3
5443373|NCT02247466|18803901|P1|Overall Study|Procedure changed to open surgery|0
5443374|NCT02247440|18803919|P1|Overall Study|Lack of Efficacy|3
5443375|NCT02247440|18803919|P1|Overall Study|Withdrawal by Subject|1
5443376|NCT02247401|18803932|P3|Overall Study|Lost to Follow-up|1
5443377|NCT02247401|18803933|P2|Overall Study|Lost to Follow-up|1
5443378|NCT02247401|18803934|P1|Overall Study|Lost to Follow-up|1
5443379|NCT02247401|18803932|P3|Overall Study|Withdrawal by Subject|1
5443380|NCT02247401|18803933|P2|Overall Study|Withdrawal by Subject|1
5443381|NCT02247401|18803934|P1|Overall Study|Withdrawal by Subject|4
5443382|NCT02247401|18803932|P3|Overall Study|Adverse Event|0
5443383|NCT02247401|18803933|P2|Overall Study|Adverse Event|0
5443384|NCT02247401|18803934|P1|Overall Study|Adverse Event|1
5443385|NCT02247011|18803981|P1|Overall Study|Poor quality of radiological results|125
5443386|NCT02246998|18804002|P4|Overall Study|Randomized but Never Dosed|1
5443387|NCT02246998|18804003|P3|Overall Study|Randomized but Never Dosed|2
5443388|NCT02246998|18804004|P2|Overall Study|Randomized but Never Dosed|2
5443389|NCT02246998|18804005|P1|Overall Study|Randomized but Never Dosed|1
5443390|NCT02246998|18804002|P4|Overall Study|Lost to Follow-up|1
5443391|NCT02246998|18804003|P3|Overall Study|Lost to Follow-up|0
5443392|NCT02246998|18804004|P2|Overall Study|Lost to Follow-up|0
5443393|NCT02246998|18804005|P1|Overall Study|Lost to Follow-up|1
5443394|NCT02246998|18804002|P4|Overall Study|Adverse Event|0
5443395|NCT02246998|18804003|P3|Overall Study|Adverse Event|1
5443396|NCT02246998|18804004|P2|Overall Study|Adverse Event|1
5443397|NCT02246998|18804005|P1|Overall Study|Adverse Event|0
5443398|NCT02246777|18804115|P1|Overall Study|Change of residence|1
5443399|NCT02246777|18804115|P1|Overall Study|Adverse Event|2
5443400|NCT02246764|18804131|P3|Overall Study|Protocol Violation|1
5443401|NCT02246764|18804132|P2|Overall Study|Protocol Violation|1
5443402|NCT02246764|18804133|P1|Overall Study|Protocol Violation|2
5443403|NCT02246764|18804131|P3|Overall Study|Physician Decision|1
5443404|NCT02246764|18804132|P2|Overall Study|Physician Decision|2
5443405|NCT02246764|18804133|P1|Overall Study|Physician Decision|0
5443406|NCT02246764|18804131|P3|Overall Study|Disallowed Concomitant Medication|0
5443407|NCT02246764|18804132|P2|Overall Study|Disallowed Concomitant Medication|0
5443408|NCT02246764|18804133|P1|Overall Study|Disallowed Concomitant Medication|1
5443409|NCT02246764|18804131|P3|Overall Study|Withdrawal by Subject|1
5443410|NCT02246764|18804132|P2|Overall Study|Withdrawal by Subject|0
5443411|NCT02246764|18804133|P1|Overall Study|Withdrawal by Subject|0
5443412|NCT02246764|18804131|P3|Overall Study|Adverse Event|1
5443413|NCT02246764|18804132|P2|Overall Study|Adverse Event|29
5443414|NCT02246764|18804133|P1|Overall Study|Adverse Event|15
5443415|NCT02246673|18804146|P5|Overall Study|Protocol Violation|0
5443416|NCT02246673|18804147|P4|Overall Study|Protocol Violation|1
5443417|NCT02246673|18804148|P3|Overall Study|Protocol Violation|0
5443418|NCT02246673|18804149|P2|Overall Study|Protocol Violation|0
5443419|NCT02246673|18804150|P1|Overall Study|Protocol Violation|0
5443420|NCT02246673|18804146|P5|Overall Study|Lost to Follow-up|0
5443421|NCT02246673|18804147|P4|Overall Study|Lost to Follow-up|1
5443422|NCT02246673|18804148|P3|Overall Study|Lost to Follow-up|0
5443423|NCT02246673|18804149|P2|Overall Study|Lost to Follow-up|0
5443424|NCT02246673|18804150|P1|Overall Study|Lost to Follow-up|0
5443425|NCT02246673|18804146|P5|Overall Study|Withdrawal by Subject|1
5443426|NCT02246673|18804147|P4|Overall Study|Withdrawal by Subject|0
5443427|NCT02246673|18804148|P3|Overall Study|Withdrawal by Subject|0
5443428|NCT02246673|18804149|P2|Overall Study|Withdrawal by Subject|0
5443429|NCT02246673|18804150|P1|Overall Study|Withdrawal by Subject|0
5443430|NCT02246673|18804146|P5|Overall Study|Sponsor Decision|0
5443431|NCT02246673|18804147|P4|Overall Study|Sponsor Decision|0
5443432|NCT02246673|18804148|P3|Overall Study|Sponsor Decision|0
5443433|NCT02246673|18804149|P2|Overall Study|Sponsor Decision|0
5443434|NCT02246673|18804150|P1|Overall Study|Sponsor Decision|1
5443435|NCT02246660|18804258|P3|Overall Study|Death|1
5443436|NCT02246660|18804259|P2|Overall Study|Death|0
5443437|NCT02246660|18804260|P1|Overall Study|Death|0
5443438|NCT02246660|18804258|P3|Overall Study|Withdrawal by Subject|0
5443439|NCT02246660|18804259|P2|Overall Study|Withdrawal by Subject|1
5443440|NCT02246660|18804260|P1|Overall Study|Withdrawal by Subject|0
5443441|NCT02246647|18804270|P2|Overall Study|Withdrawal by Subject|1
5443442|NCT02246647|18804271|P1|Overall Study|Withdrawal by Subject|1
5443443|NCT02246621|18804305|P2|Overall Study|On Study Treatment/ Follow Up|119
5443444|NCT02246621|18804306|P1|Overall Study|On Study Treatment/ Follow Up|236
5443445|NCT02246621|18804305|P2|Overall Study|Lost to Follow-up|0
5443446|NCT02246621|18804306|P1|Overall Study|Lost to Follow-up|1
5443447|NCT02246621|18804305|P2|Overall Study|Withdrawal by Subject|16
5443448|NCT02246621|18804306|P1|Overall Study|Withdrawal by Subject|28
5443449|NCT02246582|18804343|P2|Overall Study|Withdrawal by Subject|4
5443450|NCT02246582|18804344|P1|Overall Study|Withdrawal by Subject|3
5443451|NCT02246439|18804352|P2|Overall Study|Withdrawal by Subject|0
5443452|NCT02246439|18804353|P1|Overall Study|Withdrawal by Subject|1
5443453|NCT02246439|18804352|P2|Overall Study|Unkonwn|3
5443454|NCT02246439|18804353|P1|Overall Study|Unkonwn|1
5443455|NCT02246439|18804352|P2|Overall Study|Physician Decision|1
5443456|NCT02246439|18804353|P1|Overall Study|Physician Decision|0
5443457|NCT02246439|18804352|P2|Overall Study|Protocol Violation|2
5443458|NCT02246439|18804353|P1|Overall Study|Protocol Violation|0
5443459|NCT02246439|18804352|P2|Overall Study|Lost to Follow-up|5
5443460|NCT02246439|18804353|P1|Overall Study|Lost to Follow-up|7
5443461|NCT02246439|18804352|P2|Overall Study|Adverse Event|0
5443462|NCT02246439|18804353|P1|Overall Study|Adverse Event|3
5443463|NCT02246218|18804485|P2|Overall Study|Lost to Follow-up|0
5443464|NCT02246218|18804486|P1|Overall Study|Lost to Follow-up|1
5443465|NCT02246218|18804485|P2|Overall Study|Adverse Event|1
5443466|NCT02246218|18804486|P1|Overall Study|Adverse Event|1
5443467|NCT02246218|18804485|P2|Overall Study|Stopping Rule: Liver Transplant|4
5443468|NCT02246218|18804486|P1|Overall Study|Stopping Rule: Liver Transplant|2
5443469|NCT02246218|18804485|P2|Overall Study|Withdrawal by Parent/Guardian|1
5443470|NCT02246218|18804486|P1|Overall Study|Withdrawal by Parent/Guardian|0
5443471|NCT02246166|18804546|P2|Overall Study|Protocol Violation|0
5443472|NCT02246166|18804547|P1|Overall Study|Protocol Violation|1
5443473|NCT02246114|18804583|P2|Overall Study|miscarriage|0
5443474|NCT02246114|18804584|P1|Overall Study|miscarriage|1
5443475|NCT02245737|18804635|P3|Overall Study|Sponsor Decision|432
5443476|NCT02245737|18804636|P2|Overall Study|Sponsor Decision|430
5443477|NCT02245737|18804637|P1|Overall Study|Sponsor Decision|445
5443478|NCT02245737|18804635|P3|Overall Study|Withdrawal due to Caregiver Circumstance|22
5443479|NCT02245737|18804636|P2|Overall Study|Withdrawal due to Caregiver Circumstance|20
5443480|NCT02245737|18804637|P1|Overall Study|Withdrawal due to Caregiver Circumstance|10
5443481|NCT02245737|18804635|P3|Overall Study|Withdrawal by Subject|44
5443482|NCT02245737|18804636|P2|Overall Study|Withdrawal by Subject|41
5443483|NCT02245737|18804637|P1|Overall Study|Withdrawal by Subject|40
5443484|NCT02245737|18804635|P3|Overall Study|Protocol Violation|3
5443485|NCT02245737|18804636|P2|Overall Study|Protocol Violation|2
5443486|NCT02245737|18804637|P1|Overall Study|Protocol Violation|3
5443487|NCT02245737|18804635|P3|Overall Study|Physician Decision|6
5443488|NCT02245737|18804636|P2|Overall Study|Physician Decision|3
5443489|NCT02245737|18804637|P1|Overall Study|Physician Decision|6
5443490|NCT02245737|18804635|P3|Overall Study|Other-determined by Investigator|10
5443491|NCT02245737|18804636|P2|Overall Study|Other-determined by Investigator|10
5443492|NCT02245737|18804637|P1|Overall Study|Other-determined by Investigator|9
5443493|NCT02245737|18804635|P3|Overall Study|Lost to Follow-up|4
5443494|NCT02245737|18804636|P2|Overall Study|Lost to Follow-up|5
5443495|NCT02245737|18804637|P1|Overall Study|Lost to Follow-up|2
5443496|NCT02245737|18804635|P3|Overall Study|Initiation of Symptomatic AD medication|0
5443497|NCT02245737|18804636|P2|Overall Study|Initiation of Symptomatic AD medication|0
5443498|NCT02245737|18804637|P1|Overall Study|Initiation of Symptomatic AD medication|2
5443499|NCT02245737|18804635|P3|Overall Study|Eligibility Criteria No Longer Met|4
5443500|NCT02245737|18804636|P2|Overall Study|Eligibility Criteria No Longer Met|4
5443501|NCT02245737|18804637|P1|Overall Study|Eligibility Criteria No Longer Met|2
5443502|NCT02245737|18804635|P3|Overall Study|Death|4
5443503|NCT02245737|18804636|P2|Overall Study|Death|4
5443504|NCT02245737|18804637|P1|Overall Study|Death|2
5443505|NCT02245737|18804635|P3|Overall Study|Condition Worsened|9
5443506|NCT02245737|18804636|P2|Overall Study|Condition Worsened|10
5443507|NCT02245737|18804637|P1|Overall Study|Condition Worsened|9
5443508|NCT02245737|18804635|P3|Overall Study|Adverse Event|33
5443509|NCT02245737|18804636|P2|Overall Study|Adverse Event|26
5443510|NCT02245737|18804637|P1|Overall Study|Adverse Event|23
5443511|NCT02245620|18804694|P2|Overall Study|Physician Decision|1
5443512|NCT02245620|18804695|P1|Overall Study|Physician Decision|1
5443513|NCT02245568|18804707|P1|Overall Study|Lost to Follow-up|5
5443514|NCT02245568|18804707|P1|Overall Study|Intolerance/dosing issues/interruption|5
5443515|NCT02245568|18804707|P1|Overall Study|Worsening dementia/caregiver withdrawal|6
5443516|NCT02245568|18804707|P1|Overall Study|Blue staining|6
5443517|NCT02245568|18804707|P1|Overall Study|Death|9
5443518|NCT02245568|18804707|P1|Overall Study|Non-compliance with study drug|11
5443519|NCT02245568|18804707|P1|Overall Study|Physician Decision|14
5443520|NCT02245568|18804707|P1|Overall Study|Missing (Site closure)|16
5443521|NCT02245568|18804707|P1|Overall Study|Withdrawal by Legal Representative|31
5443522|NCT02245568|18804707|P1|Overall Study|Withdrawal by Subject|77
5443523|NCT02245568|18804707|P1|Overall Study|Withdrawal by Caregiver|85
5443524|NCT02245568|18804707|P1|Overall Study|Lack of Efficacy|98
5443525|NCT02245568|18804707|P1|Overall Study|Adverse Event|144
5443526|NCT02245568|18804707|P1|Overall Study|Study terminated by Sponsor|346
5443527|NCT02245412|18804729|P3|Follow-Up Period|Other - Terminated by Sponsor|1
5443528|NCT02245412|18804730|P2|Follow-Up Period|Other - Terminated by Sponsor|0
5443529|NCT02245412|18804731|P1|Follow-Up Period|Other - Terminated by Sponsor|0
5443530|NCT02245412|18804729|P3|Follow-Up Period|Physician Decision|0
5443531|NCT02245412|18804730|P2|Follow-Up Period|Physician Decision|0
5443532|NCT02245412|18804731|P1|Follow-Up Period|Physician Decision|1
5443533|NCT02245412|18804729|P3|Follow-Up Period|Death|1
5443534|NCT02245412|18804730|P2|Follow-Up Period|Death|2
5443535|NCT02245412|18804731|P1|Follow-Up Period|Death|4
5443536|NCT02245412|18804729|P3|Treatment Period|Biopsy did not confirm GI GVHD|0
5443537|NCT02245412|18804730|P2|Treatment Period|Biopsy did not confirm GI GVHD|0
5443538|NCT02245412|18804731|P1|Treatment Period|Biopsy did not confirm GI GVHD|1
5443539|NCT02245412|18804729|P3|Treatment Period|Withdrawal by Subject|0
5443540|NCT02245412|18804730|P2|Treatment Period|Withdrawal by Subject|1
5443541|NCT02245412|18804731|P1|Treatment Period|Withdrawal by Subject|2
5443542|NCT02245412|18804729|P3|Treatment Period|Physician Decision|0
5443543|NCT02245412|18804730|P2|Treatment Period|Physician Decision|1
5443544|NCT02245412|18804731|P1|Treatment Period|Physician Decision|1
5443545|NCT02245412|18804729|P3|Treatment Period|Death|0
5443546|NCT02245412|18804730|P2|Treatment Period|Death|1
5443547|NCT02245412|18804731|P1|Treatment Period|Death|1
5443548|NCT02244996|18804778|P2|Overall Study|Lack of Efficacy|6
5443549|NCT02244996|18804779|P1|Overall Study|Lack of Efficacy|2
5443550|NCT02244957|18804793|P2|Overall Study|Lack of Efficacy|0
5443551|NCT02244957|18804794|P1|Overall Study|Lack of Efficacy|1
5443552|NCT02244944|18804838|P1|Overall Study|Study Terminated|1
5443553|NCT02244944|18804838|P1|Overall Study|Withdrawal by Subject|1
5443554|NCT02244619|18804869|P2|Overall Study|Did not receive study intervention|21
5443555|NCT02244619|18804870|P1|Overall Study|Did not receive study intervention|8
5443556|NCT02244580|18804888|P1|Overall Study|No cancer tissues available|241
5443557|NCT02244424|18804898|P2|Overall Study|Lost to Follow-up|10
5443558|NCT02244424|18804899|P1|Overall Study|Lost to Follow-up|20
5443559|NCT02243696|18804918|P1|Overall Study|Study Terminated for EP PASSION|961
5443560|NCT02243696|18804918|P1|Overall Study|Subject Withdrawn by Investigator|273
5443561|NCT02243696|18804918|P1|Overall Study|Subject No Longer has Study System|42
5443562|NCT02243696|18804918|P1|Overall Study|Lost to Follow-up|57
5443563|NCT02243696|18804918|P1|Overall Study|Withdrawal by Subject|79
5443564|NCT02243696|18804918|P1|Overall Study|Death|282
5443565|NCT02243605|18804930|P2|Stage 2 - Final Analysis Population|Progression|1
5443566|NCT02243605|18804931|P1|Stage 2 - Final Analysis Population|Progression|0
5443567|NCT02243605|18804930|P2|Stage 2 - Final Analysis Population|Adverse Event|1
5443568|NCT02243605|18804931|P1|Stage 2 - Final Analysis Population|Adverse Event|1
5443569|NCT02243605|18804930|P2|Stage 2 - Final Analysis Population|Protocol Violation|1
5443570|NCT02243605|18804931|P1|Stage 2 - Final Analysis Population|Protocol Violation|5
5443571|NCT02243605|18804930|P2|Stage 1 - Interim Analysis Population|Adverse Event|0
5443572|NCT02243605|18804931|P1|Stage 1 - Interim Analysis Population|Adverse Event|1
5443573|NCT02243605|18804930|P2|Stage 1 - Interim Analysis Population|Protocol Violation|1
5443574|NCT02243605|18804931|P1|Stage 1 - Interim Analysis Population|Protocol Violation|1
5443575|NCT02243371|18804965|P2|Overall Study|Withdrawal by Subject|2
5443576|NCT02243371|18804966|P1|Overall Study|Withdrawal by Subject|0
5443577|NCT02243371|18804965|P2|Overall Study|Lack of Clinical Benefit|1
5443578|NCT02243371|18804966|P1|Overall Study|Lack of Clinical Benefit|0
5443579|NCT02243371|18804965|P2|Overall Study|Adverse Event (unrelated)|1
5443580|NCT02243371|18804966|P1|Overall Study|Adverse Event (unrelated)|0
5443581|NCT02243371|18804965|P2|Overall Study|Death (unrelated)|4
5443582|NCT02243371|18804966|P1|Overall Study|Death (unrelated)|2
5443583|NCT02243371|18804965|P2|Overall Study|Progressive Disease (clinic & radio)|24
5443584|NCT02243371|18804966|P1|Overall Study|Progressive Disease (clinic & radio)|35
5443585|NCT02243306|18804986|P2|Overall Study|Physician Decision|1
5443586|NCT02243306|18804987|P1|Overall Study|Physician Decision|0
5443587|NCT02243306|18804986|P2|Overall Study|Other: Reached stopping criteria|1
5443588|NCT02243306|18804987|P1|Overall Study|Other: Reached stopping criteria|0
5443589|NCT02243306|18804986|P2|Overall Study|Adverse Event|1
5443590|NCT02243306|18804987|P1|Overall Study|Adverse Event|0
5443591|NCT02243293|18805062|P22|Overall Study|Randomized but did'nt receive study drug|0
5443592|NCT02243293|18805063|P21|Overall Study|Randomized but did'nt receive study drug|0
5443672|NCT02243293|18805077|P7|Overall Study|Withdrawal by Subject|0
5443593|NCT02243293|18805064|P20|Overall Study|Randomized but did'nt receive study drug|1
5443594|NCT02243293|18805065|P19|Overall Study|Randomized but did'nt receive study drug|0
5443595|NCT02243293|18805066|P18|Overall Study|Randomized but did'nt receive study drug|0
5443596|NCT02243293|18805067|P17|Overall Study|Randomized but did'nt receive study drug|0
5443597|NCT02243293|18805068|P16|Overall Study|Randomized but did'nt receive study drug|0
5443598|NCT02243293|18805069|P15|Overall Study|Randomized but did'nt receive study drug|0
5443599|NCT02243293|18805070|P14|Overall Study|Randomized but did'nt receive study drug|0
5443600|NCT02243293|18805071|P13|Overall Study|Randomized but did'nt receive study drug|0
5443601|NCT02243293|18805072|P12|Overall Study|Randomized but did'nt receive study drug|0
5443602|NCT02243293|18805073|P11|Overall Study|Randomized but did'nt receive study drug|0
5443603|NCT02243293|18805074|P10|Overall Study|Randomized but did'nt receive study drug|1
5443604|NCT02243293|18805075|P9|Overall Study|Randomized but did'nt receive study drug|0
5443605|NCT02243293|18805076|P8|Overall Study|Randomized but did'nt receive study drug|0
5443606|NCT02243293|18805077|P7|Overall Study|Randomized but did'nt receive study drug|0
5443607|NCT02243293|18805078|P6|Overall Study|Randomized but did'nt receive study drug|0
5443608|NCT02243293|18805079|P5|Overall Study|Randomized but did'nt receive study drug|1
5443609|NCT02243293|18805080|P4|Overall Study|Randomized but did'nt receive study drug|0
5443610|NCT02243293|18805081|P3|Overall Study|Randomized but did'nt receive study drug|0
5443611|NCT02243293|18805082|P2|Overall Study|Randomized but did'nt receive study drug|0
5443612|NCT02243293|18805083|P1|Overall Study|Randomized but did'nt receive study drug|0
5443613|NCT02243293|18805062|P22|Overall Study|Enrolled into a Re-treatment Study|0
5443614|NCT02243293|18805063|P21|Overall Study|Enrolled into a Re-treatment Study|0
5443615|NCT02243293|18805064|P20|Overall Study|Enrolled into a Re-treatment Study|0
5443616|NCT02243293|18805065|P19|Overall Study|Enrolled into a Re-treatment Study|0
5443617|NCT02243293|18805066|P18|Overall Study|Enrolled into a Re-treatment Study|0
5443618|NCT02243293|18805067|P17|Overall Study|Enrolled into a Re-treatment Study|0
5443619|NCT02243293|18805068|P16|Overall Study|Enrolled into a Re-treatment Study|0
5443620|NCT02243293|18805069|P15|Overall Study|Enrolled into a Re-treatment Study|1
5443621|NCT02243293|18805070|P14|Overall Study|Enrolled into a Re-treatment Study|0
5443622|NCT02243293|18805071|P13|Overall Study|Enrolled into a Re-treatment Study|0
5443623|NCT02243293|18805072|P12|Overall Study|Enrolled into a Re-treatment Study|0
5443624|NCT02243293|18805073|P11|Overall Study|Enrolled into a Re-treatment Study|0
5443625|NCT02243293|18805074|P10|Overall Study|Enrolled into a Re-treatment Study|0
5443626|NCT02243293|18805075|P9|Overall Study|Enrolled into a Re-treatment Study|0
5443627|NCT02243293|18805076|P8|Overall Study|Enrolled into a Re-treatment Study|0
5443628|NCT02243293|18805077|P7|Overall Study|Enrolled into a Re-treatment Study|0
5443629|NCT02243293|18805078|P6|Overall Study|Enrolled into a Re-treatment Study|0
5443630|NCT02243293|18805079|P5|Overall Study|Enrolled into a Re-treatment Study|0
5443631|NCT02243293|18805080|P4|Overall Study|Enrolled into a Re-treatment Study|0
5443632|NCT02243293|18805081|P3|Overall Study|Enrolled into a Re-treatment Study|0
5443633|NCT02243293|18805082|P2|Overall Study|Enrolled into a Re-treatment Study|0
5443634|NCT02243293|18805083|P1|Overall Study|Enrolled into a Re-treatment Study|0
5443635|NCT02243293|18805062|P22|Overall Study|Lost to Follow-up|2
5443636|NCT02243293|18805063|P21|Overall Study|Lost to Follow-up|1
5443637|NCT02243293|18805064|P20|Overall Study|Lost to Follow-up|0
5443638|NCT02243293|18805065|P19|Overall Study|Lost to Follow-up|0
5443639|NCT02243293|18805066|P18|Overall Study|Lost to Follow-up|1
5443640|NCT02243293|18805067|P17|Overall Study|Lost to Follow-up|3
5443641|NCT02243293|18805068|P16|Overall Study|Lost to Follow-up|0
5443642|NCT02243293|18805069|P15|Overall Study|Lost to Follow-up|0
5443643|NCT02243293|18805070|P14|Overall Study|Lost to Follow-up|0
5443644|NCT02243293|18805071|P13|Overall Study|Lost to Follow-up|0
5443645|NCT02243293|18805072|P12|Overall Study|Lost to Follow-up|2
5443646|NCT02243293|18805073|P11|Overall Study|Lost to Follow-up|0
5443647|NCT02243293|18805074|P10|Overall Study|Lost to Follow-up|0
5443648|NCT02243293|18805075|P9|Overall Study|Lost to Follow-up|0
5443649|NCT02243293|18805076|P8|Overall Study|Lost to Follow-up|0
5443650|NCT02243293|18805077|P7|Overall Study|Lost to Follow-up|3
5443651|NCT02243293|18805078|P6|Overall Study|Lost to Follow-up|0
5443652|NCT02243293|18805079|P5|Overall Study|Lost to Follow-up|0
5443653|NCT02243293|18805080|P4|Overall Study|Lost to Follow-up|1
5443654|NCT02243293|18805081|P3|Overall Study|Lost to Follow-up|1
5443655|NCT02243293|18805082|P2|Overall Study|Lost to Follow-up|1
5443656|NCT02243293|18805083|P1|Overall Study|Lost to Follow-up|0
5443657|NCT02243293|18805062|P22|Overall Study|Withdrawal by Subject|1
5443658|NCT02243293|18805063|P21|Overall Study|Withdrawal by Subject|0
5443659|NCT02243293|18805064|P20|Overall Study|Withdrawal by Subject|0
5443660|NCT02243293|18805065|P19|Overall Study|Withdrawal by Subject|0
5443661|NCT02243293|18805066|P18|Overall Study|Withdrawal by Subject|0
5443662|NCT02243293|18805067|P17|Overall Study|Withdrawal by Subject|0
5443663|NCT02243293|18805068|P16|Overall Study|Withdrawal by Subject|0
5443664|NCT02243293|18805069|P15|Overall Study|Withdrawal by Subject|0
5443665|NCT02243293|18805070|P14|Overall Study|Withdrawal by Subject|0
5443666|NCT02243293|18805071|P13|Overall Study|Withdrawal by Subject|0
5443667|NCT02243293|18805072|P12|Overall Study|Withdrawal by Subject|1
5443668|NCT02243293|18805073|P11|Overall Study|Withdrawal by Subject|0
5443669|NCT02243293|18805074|P10|Overall Study|Withdrawal by Subject|1
5443670|NCT02243293|18805075|P9|Overall Study|Withdrawal by Subject|0
5443671|NCT02243293|18805076|P8|Overall Study|Withdrawal by Subject|0
5443673|NCT02243293|18805078|P6|Overall Study|Withdrawal by Subject|0
5443674|NCT02243293|18805079|P5|Overall Study|Withdrawal by Subject|0
5443675|NCT02243293|18805080|P4|Overall Study|Withdrawal by Subject|0
5443676|NCT02243293|18805081|P3|Overall Study|Withdrawal by Subject|0
5443677|NCT02243293|18805082|P2|Overall Study|Withdrawal by Subject|0
5443678|NCT02243293|18805083|P1|Overall Study|Withdrawal by Subject|1
5443679|NCT02243293|18805062|P22|Overall Study|Adverse Event|0
5443680|NCT02243293|18805063|P21|Overall Study|Adverse Event|1
5443681|NCT02243293|18805064|P20|Overall Study|Adverse Event|0
5443682|NCT02243293|18805065|P19|Overall Study|Adverse Event|0
5443683|NCT02243293|18805066|P18|Overall Study|Adverse Event|0
5443684|NCT02243293|18805067|P17|Overall Study|Adverse Event|0
5443685|NCT02243293|18805068|P16|Overall Study|Adverse Event|1
5443686|NCT02243293|18805069|P15|Overall Study|Adverse Event|0
5443687|NCT02243293|18805070|P14|Overall Study|Adverse Event|0
5443688|NCT02243293|18805071|P13|Overall Study|Adverse Event|0
5443689|NCT02243293|18805072|P12|Overall Study|Adverse Event|0
5443690|NCT02243293|18805073|P11|Overall Study|Adverse Event|0
5443691|NCT02243293|18805074|P10|Overall Study|Adverse Event|0
5443692|NCT02243293|18805075|P9|Overall Study|Adverse Event|0
5443693|NCT02243293|18805076|P8|Overall Study|Adverse Event|0
5443694|NCT02243293|18805077|P7|Overall Study|Adverse Event|0
5443695|NCT02243293|18805078|P6|Overall Study|Adverse Event|0
5443696|NCT02243293|18805079|P5|Overall Study|Adverse Event|0
5443697|NCT02243293|18805080|P4|Overall Study|Adverse Event|0
5443698|NCT02243293|18805081|P3|Overall Study|Adverse Event|0
5443699|NCT02243293|18805082|P2|Overall Study|Adverse Event|0
5443700|NCT02243293|18805083|P1|Overall Study|Adverse Event|1
5443701|NCT02243280|18805182|P11|Treated|Lost to Follow-up|2
5443702|NCT02243280|18805183|P10|Treated|Lost to Follow-up|0
5443703|NCT02243280|18805184|P9|Treated|Lost to Follow-up|1
5443704|NCT02243280|18805185|P8|Treated|Lost to Follow-up|0
5443705|NCT02243280|18805186|P7|Treated|Lost to Follow-up|0
5443706|NCT02243280|18805187|P6|Treated|Lost to Follow-up|0
5443707|NCT02243280|18805188|P5|Treated|Lost to Follow-up|0
5443708|NCT02243280|18805189|P4|Treated|Lost to Follow-up|0
5443709|NCT02243280|18805190|P3|Treated|Lost to Follow-up|0
5443710|NCT02243280|18805191|P2|Treated|Lost to Follow-up|0
5443711|NCT02243280|18805192|P1|Treated|Lost to Follow-up|0
5443712|NCT02243280|18805182|P11|Treated|Adverse Event|1
5443713|NCT02243280|18805183|P10|Treated|Adverse Event|0
5443714|NCT02243280|18805184|P9|Treated|Adverse Event|0
5443715|NCT02243280|18805185|P8|Treated|Adverse Event|0
5443716|NCT02243280|18805186|P7|Treated|Adverse Event|0
5443717|NCT02243280|18805187|P6|Treated|Adverse Event|0
5443718|NCT02243280|18805188|P5|Treated|Adverse Event|0
5443719|NCT02243280|18805189|P4|Treated|Adverse Event|0
5443720|NCT02243280|18805190|P3|Treated|Adverse Event|0
5443721|NCT02243280|18805191|P2|Treated|Adverse Event|0
5443722|NCT02243280|18805192|P1|Treated|Adverse Event|1
5443723|NCT02243202|18805247|P4|Overall Study|Randomized but not received treatment|1
5443724|NCT02243202|18805248|P3|Overall Study|Randomized but not received treatment|0
5443725|NCT02243202|18805249|P2|Overall Study|Randomized but not received treatment|0
5443726|NCT02243202|18805250|P1|Overall Study|Randomized but not received treatment|0
5443727|NCT02243202|18805247|P4|Overall Study|Other|2
5443728|NCT02243202|18805248|P3|Overall Study|Other|1
5443729|NCT02243202|18805249|P2|Overall Study|Other|3
5443730|NCT02243202|18805250|P1|Overall Study|Other|1
5443731|NCT02243202|18805247|P4|Overall Study|Withdrawal by Subject|4
5443732|NCT02243202|18805248|P3|Overall Study|Withdrawal by Subject|4
5443733|NCT02243202|18805249|P2|Overall Study|Withdrawal by Subject|6
5443734|NCT02243202|18805250|P1|Overall Study|Withdrawal by Subject|7
5443735|NCT02243202|18805247|P4|Overall Study|Protocol Violation|1
5443736|NCT02243202|18805248|P3|Overall Study|Protocol Violation|2
5443737|NCT02243202|18805249|P2|Overall Study|Protocol Violation|1
5443738|NCT02243202|18805250|P1|Overall Study|Protocol Violation|3
5443739|NCT02243202|18805247|P4|Overall Study|Lost to Follow-up|11
5443740|NCT02243202|18805248|P3|Overall Study|Lost to Follow-up|14
5443741|NCT02243202|18805249|P2|Overall Study|Lost to Follow-up|9
5443742|NCT02243202|18805250|P1|Overall Study|Lost to Follow-up|9
5443743|NCT02243202|18805247|P4|Overall Study|Adverse Event|4
5443744|NCT02243202|18805248|P3|Overall Study|Adverse Event|10
5443745|NCT02243202|18805249|P2|Overall Study|Adverse Event|6
5443746|NCT02243202|18805250|P1|Overall Study|Adverse Event|5
5443747|NCT02243176|18805286|P2|Overall Study|Adverse Event|2
5443748|NCT02243176|18805287|P1|Overall Study|Adverse Event|2
5443749|NCT02243176|18805286|P2|Overall Study|Withdrawal by Subject|7
5443750|NCT02243176|18805287|P1|Overall Study|Withdrawal by Subject|8
5443751|NCT02243176|18805286|P2|Overall Study|Protocol Violation|1
5443752|NCT02243176|18805287|P1|Overall Study|Protocol Violation|2
5443753|NCT02243176|18805286|P2|Overall Study|protocol specified withdrawal critera|3
5443754|NCT02243176|18805287|P1|Overall Study|protocol specified withdrawal critera|1
5443755|NCT02243176|18805286|P2|Overall Study|Other reason|2
5443756|NCT02243176|18805287|P1|Overall Study|Other reason|1
5443757|NCT02243046|18805312|P3|Overall Study|Lost to Follow-up|4
5443758|NCT02243046|18805313|P2|Overall Study|Lost to Follow-up|1
5443759|NCT02243046|18805314|P1|Overall Study|Lost to Follow-up|1
5443760|NCT02242981|18805378|P1|Overall Study|Withdrawal by Subject|1
5443761|NCT02242942|18805389|P3|Overall Study|On-going in Study|11
5443762|NCT02242942|18805390|P2|Overall Study|On-going in Study|186
5443763|NCT02242942|18805391|P1|Overall Study|On-going in Study|190
5443764|NCT02242942|18805389|P3|Overall Study|Withdrawal by Subject|0
5443765|NCT02242942|18805390|P2|Overall Study|Withdrawal by Subject|10
5443766|NCT02242942|18805391|P1|Overall Study|Withdrawal by Subject|8
5443767|NCT02242942|18805389|P3|Overall Study|Physician Decision|0
5443768|NCT02242942|18805390|P2|Overall Study|Physician Decision|0
5443769|NCT02242942|18805391|P1|Overall Study|Physician Decision|1
5443770|NCT02242942|18805389|P3|Overall Study|Death|2
5443771|NCT02242942|18805390|P2|Overall Study|Death|20
5443772|NCT02242942|18805391|P1|Overall Study|Death|17
5443773|NCT02242903|18805425|P7|Overall Study|Withdrawal by Subject|0
5443774|NCT02242903|18805426|P6|Overall Study|Withdrawal by Subject|0
5443775|NCT02242903|18805427|P5|Overall Study|Withdrawal by Subject|0
5443776|NCT02242903|18805428|P4|Overall Study|Withdrawal by Subject|0
5443777|NCT02242903|18805429|P3|Overall Study|Withdrawal by Subject|0
5443778|NCT02242903|18805430|P2|Overall Study|Withdrawal by Subject|0
5443779|NCT02242903|18805431|P1|Overall Study|Withdrawal by Subject|1
5443780|NCT02242643|18805461|P2|Overall Study|Withdrawal by subject at Visit 2|1
5443781|NCT02242643|18805462|P1|Overall Study|Withdrawal by subject at Visit 2|0
5443782|NCT02242643|18805461|P2|Overall Study|Language barrier|0
5443783|NCT02242643|18805462|P1|Overall Study|Language barrier|1
5443784|NCT02242643|18805461|P2|Overall Study|Protocol requirements not followed|0
5443785|NCT02242643|18805462|P1|Overall Study|Protocol requirements not followed|1
5443786|NCT02242643|18805461|P2|Overall Study|Consent withdrawal by parent|0
5443787|NCT02242643|18805462|P1|Overall Study|Consent withdrawal by parent|1
5443788|NCT02242643|18805461|P2|Overall Study|Non-compliance|0
5443789|NCT02242643|18805462|P1|Overall Study|Non-compliance|1
5443790|NCT02242643|18805461|P2|Overall Study|Child placed in foster care by family|1
5443791|NCT02242643|18805462|P1|Overall Study|Child placed in foster care by family|0
5443792|NCT02242643|18805461|P2|Overall Study|Lost to Follow-up|61
5443793|NCT02242643|18805462|P1|Overall Study|Lost to Follow-up|54
5443794|NCT02242643|18805461|P2|Overall Study|Migrated/moved from study area|3
5443795|NCT02242643|18805462|P1|Overall Study|Migrated/moved from study area|1
5443796|NCT02242643|18805461|P2|Overall Study|Withdrawal by Subject|10
5443797|NCT02242643|18805462|P1|Overall Study|Withdrawal by Subject|15
5443798|NCT02242643|18805461|P2|Overall Study|Protocol Violation|2
5443799|NCT02242643|18805462|P1|Overall Study|Protocol Violation|1
5443800|NCT02242487|18805517|P2|Overall Study|Withdrawal by Subject|19
5443801|NCT02242487|18805518|P1|Overall Study|Withdrawal by Subject|37
5443802|NCT02242487|18805517|P2|Overall Study|Other - Miscellaneous|6
5443803|NCT02242487|18805518|P1|Overall Study|Other - Miscellaneous|4
5443804|NCT02242487|18805517|P2|Overall Study|Lost to Follow-up|1
5443805|NCT02242487|18805518|P1|Overall Study|Lost to Follow-up|2
5443806|NCT02242487|18805517|P2|Overall Study|Protocol Violation|0
5443807|NCT02242487|18805518|P1|Overall Study|Protocol Violation|2
5443808|NCT02242487|18805517|P2|Overall Study|Lack of Efficacy|6
5443809|NCT02242487|18805518|P1|Overall Study|Lack of Efficacy|4
5443810|NCT02242487|18805517|P2|Overall Study|Adverse Event|15
5443811|NCT02242487|18805518|P1|Overall Study|Adverse Event|13
5443812|NCT02242305|18805534|P2|Overall Study|Lost to Follow-up|0
5443813|NCT02242305|18805535|P1|Overall Study|Lost to Follow-up|2
5443814|NCT02242305|18805534|P2|Overall Study|Subject withdraws inform consent|4
5443815|NCT02242305|18805535|P1|Overall Study|Subject withdraws inform consent|0
5443816|NCT02242305|18805534|P2|Overall Study|Non-compliance dosing regimen or visit|2
5443817|NCT02242305|18805535|P1|Overall Study|Non-compliance dosing regimen or visit|2
5443818|NCT02242305|18805534|P2|Overall Study|Adverse Event|0
5443819|NCT02242305|18805535|P1|Overall Study|Adverse Event|1
5443820|NCT02242305|18805534|P2|Overall Study|Without spasm-like pain during 3 weeks|4
5443821|NCT02242305|18805535|P1|Overall Study|Without spasm-like pain during 3 weeks|1
5443822|NCT02242201|18805556|P3|Overall Study|preoperative opioid consumption|0
5443823|NCT02242201|18805557|P2|Overall Study|preoperative opioid consumption|1
5443824|NCT02242201|18805558|P1|Overall Study|preoperative opioid consumption|0
5443825|NCT02242201|18805556|P3|Overall Study|postponed surgery|1
5443826|NCT02242201|18805557|P2|Overall Study|postponed surgery|0
5443827|NCT02242201|18805558|P1|Overall Study|postponed surgery|0
5443828|NCT02242201|18805556|P3|Overall Study|changed surgical procedure|0
5443829|NCT02242201|18805557|P2|Overall Study|changed surgical procedure|0
5443830|NCT02242201|18805558|P1|Overall Study|changed surgical procedure|1
5443831|NCT02242201|18805556|P3|Overall Study|planned post-op anticoagulation|0
5443832|NCT02242201|18805557|P2|Overall Study|planned post-op anticoagulation|0
5443833|NCT02242201|18805558|P1|Overall Study|planned post-op anticoagulation|1
5443834|NCT02242201|18805556|P3|Overall Study|preoperative identified neuropathy|0
5443835|NCT02242201|18805557|P2|Overall Study|preoperative identified neuropathy|0
5443836|NCT02242201|18805558|P1|Overall Study|preoperative identified neuropathy|2
5443837|NCT02241889|18805596|P6|Overall Study|Withdrawal by Subject|1
5443838|NCT02241889|18805597|P5|Overall Study|Withdrawal by Subject|0
5443839|NCT02241889|18805598|P4|Overall Study|Withdrawal by Subject|0
5443840|NCT02241889|18805599|P3|Overall Study|Withdrawal by Subject|0
5443841|NCT02241889|18805600|P2|Overall Study|Withdrawal by Subject|0
5443842|NCT02241889|18805601|P1|Overall Study|Withdrawal by Subject|0
5443843|NCT02241889|18805596|P6|Overall Study|device issues|0
5443844|NCT02241889|18805597|P5|Overall Study|device issues|0
5443845|NCT02241889|18805598|P4|Overall Study|device issues|0
5443846|NCT02241889|18805599|P3|Overall Study|device issues|1
5443847|NCT02241889|18805600|P2|Overall Study|device issues|0
5443848|NCT02241889|18805601|P1|Overall Study|device issues|0
5443849|NCT02241785|18805636|P1|Overall Study|Adverse Event|1
5443850|NCT02241785|18805636|P1|Overall Study|Lost to Follow-up|2
5443851|NCT02241785|18805636|P1|Overall Study|Withdrawal by Subject|1
5443852|NCT02241785|18805636|P1|Overall Study|Sponsor Termination|43
5443853|NCT02241733|18805646|P2|Overall Study|Death|2
5443854|NCT02241733|18805647|P1|Overall Study|Death|0
5443855|NCT02241733|18805646|P2|Overall Study|Withdrawal by Subject|2
5443856|NCT02241733|18805647|P1|Overall Study|Withdrawal by Subject|0
5443857|NCT02241733|18805646|P2|Overall Study|Physician Decision|2
5443858|NCT02241733|18805647|P1|Overall Study|Physician Decision|6
5443859|NCT02241733|18805646|P2|Overall Study|Lost to Follow-up|4
5443860|NCT02241733|18805647|P1|Overall Study|Lost to Follow-up|9
5443861|NCT02241551|18805686|P2|Overall Study|Adverse Event|0
5443862|NCT02241551|18805687|P1|Overall Study|Adverse Event|1
5443863|NCT02241512|18805709|P2|Overall Study|Pump malfunction, drug not delivered|0
5443864|NCT02241512|18805710|P1|Overall Study|Pump malfunction, drug not delivered|1
5443865|NCT02241343|18805726|P1|Overall Study|Adverse Event|1
5443866|NCT02241187|18805731|P1|Overall Study|Protocol closed due to lack of accrual.|2
5443867|NCT02240706|18805763|P7|Overall Study|Insurance billing concerns|0
5443868|NCT02240706|18805764|P6|Overall Study|Insurance billing concerns|0
5443869|NCT02240706|18805765|P5|Overall Study|Insurance billing concerns|0
5443870|NCT02240706|18805766|P4|Overall Study|Insurance billing concerns|1
5443871|NCT02240706|18805767|P3|Overall Study|Insurance billing concerns|0
5443872|NCT02240706|18805768|P2|Overall Study|Insurance billing concerns|0
5443873|NCT02240706|18805769|P1|Overall Study|Insurance billing concerns|0
5443874|NCT02240706|18805763|P7|Overall Study|Refused to continue taking medication|0
5443875|NCT02240706|18805764|P6|Overall Study|Refused to continue taking medication|0
5443876|NCT02240706|18805765|P5|Overall Study|Refused to continue taking medication|2
5443877|NCT02240706|18805766|P4|Overall Study|Refused to continue taking medication|1
5443878|NCT02240706|18805767|P3|Overall Study|Refused to continue taking medication|3
5443879|NCT02240706|18805768|P2|Overall Study|Refused to continue taking medication|1
5443880|NCT02240706|18805769|P1|Overall Study|Refused to continue taking medication|0
5443881|NCT02240706|18805763|P7|Overall Study|Dose limiting toxicity|0
5443882|NCT02240706|18805764|P6|Overall Study|Dose limiting toxicity|0
5443883|NCT02240706|18805765|P5|Overall Study|Dose limiting toxicity|1
5443884|NCT02240706|18805766|P4|Overall Study|Dose limiting toxicity|0
5443885|NCT02240706|18805767|P3|Overall Study|Dose limiting toxicity|0
5443886|NCT02240706|18805768|P2|Overall Study|Dose limiting toxicity|0
5443887|NCT02240706|18805769|P1|Overall Study|Dose limiting toxicity|0
5443888|NCT02240706|18805763|P7|Overall Study|Progressive disease|0
5443889|NCT02240706|18805764|P6|Overall Study|Progressive disease|0
5443890|NCT02240706|18805765|P5|Overall Study|Progressive disease|1
5443891|NCT02240706|18805766|P4|Overall Study|Progressive disease|0
5443892|NCT02240706|18805767|P3|Overall Study|Progressive disease|0
5443893|NCT02240706|18805768|P2|Overall Study|Progressive disease|0
5443894|NCT02240706|18805769|P1|Overall Study|Progressive disease|0
5443895|NCT02240706|18805763|P7|Overall Study|Adverse Event|0
5443896|NCT02240706|18805764|P6|Overall Study|Adverse Event|0
5443897|NCT02240706|18805765|P5|Overall Study|Adverse Event|2
5443898|NCT02240706|18805766|P4|Overall Study|Adverse Event|0
5443899|NCT02240706|18805767|P3|Overall Study|Adverse Event|1
5443900|NCT02240706|18805768|P2|Overall Study|Adverse Event|0
5443901|NCT02240706|18805769|P1|Overall Study|Adverse Event|1
5443902|NCT02240706|18805763|P7|Overall Study|Lack of Efficacy|0
5443903|NCT02240706|18805764|P6|Overall Study|Lack of Efficacy|0
5443904|NCT02240706|18805765|P5|Overall Study|Lack of Efficacy|5
5443905|NCT02240706|18805766|P4|Overall Study|Lack of Efficacy|2
5443906|NCT02240706|18805767|P3|Overall Study|Lack of Efficacy|2
5443907|NCT02240706|18805768|P2|Overall Study|Lack of Efficacy|2
5443908|NCT02240706|18805769|P1|Overall Study|Lack of Efficacy|2
5443909|NCT02240693|18805829|P5|Overall Study|Other than specified|0
5443910|NCT02240693|18805830|P4|Overall Study|Other than specified|0
5443911|NCT02240693|18805831|P3|Overall Study|Other than specified|2
5443912|NCT02240693|18805832|P2|Overall Study|Other than specified|0
5443913|NCT02240693|18805833|P1|Overall Study|Other than specified|0
5443914|NCT02240693|18805829|P5|Overall Study|Withdrawal by Subject|0
5443915|NCT02240693|18805830|P4|Overall Study|Withdrawal by Subject|1
5443916|NCT02240693|18805831|P3|Overall Study|Withdrawal by Subject|2
5443917|NCT02240693|18805832|P2|Overall Study|Withdrawal by Subject|0
5443918|NCT02240693|18805833|P1|Overall Study|Withdrawal by Subject|0
5443919|NCT02240693|18805829|P5|Overall Study|Adverse Event|1
5443920|NCT02240693|18805830|P4|Overall Study|Adverse Event|0
5443921|NCT02240693|18805831|P3|Overall Study|Adverse Event|0
5443922|NCT02240693|18805832|P2|Overall Study|Adverse Event|0
5443923|NCT02240693|18805833|P1|Overall Study|Adverse Event|0
5443924|NCT02240680|18805869|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
5443925|NCT02240680|18805870|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
5443926|NCT02240680|18805871|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
5443927|NCT02240680|18805872|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
5443928|NCT02240680|18805869|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
5443929|NCT02240680|18805870|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
5443930|NCT02240680|18805871|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
5443931|NCT02240680|18805872|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
5443932|NCT02240680|18805869|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
5443933|NCT02240680|18805870|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
5443934|NCT02240680|18805871|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
5443935|NCT02240680|18805872|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
5443936|NCT02240680|18805869|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
5443937|NCT02240680|18805870|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
5443938|NCT02240680|18805871|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
5443939|NCT02240680|18805872|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
5443940|NCT02240680|18805869|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
5443941|NCT02240680|18805870|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
5443942|NCT02240680|18805871|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
5443943|NCT02240680|18805872|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
5443944|NCT02240680|18805869|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
5443945|NCT02240680|18805870|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
5443946|NCT02240680|18805871|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
5443947|NCT02240680|18805872|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
5443948|NCT02240680|18805869|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
5443949|NCT02240680|18805870|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
5443950|NCT02240680|18805871|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
5443951|NCT02240680|18805872|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
5443952|NCT02240680|18805869|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
5443953|NCT02240680|18805870|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
5443954|NCT02240680|18805871|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
5443955|NCT02240680|18805872|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
5443956|NCT02240628|18805926|P2|Overall Study|Physician Decision|5
5443957|NCT02240628|18805927|P1|Overall Study|Physician Decision|6
5443958|NCT02240368|18805961|P3|Overall Study|Entropy failed to detect more than 50%|1
5443959|NCT02240368|18805962|P2|Overall Study|Entropy failed to detect more than 50%|0
5443960|NCT02240368|18805963|P1|Overall Study|Entropy failed to detect more than 50%|0
5443961|NCT02240368|18805961|P3|Overall Study|Surgery lasted less then 20 minutes|0
5443962|NCT02240368|18805962|P2|Overall Study|Surgery lasted less then 20 minutes|0
5443963|NCT02240368|18805963|P1|Overall Study|Surgery lasted less then 20 minutes|1
5443964|NCT02240121|18805995|P2|Overall Study|Other than specified|3
5443965|NCT02240121|18805996|P1|Overall Study|Other than specified|1
5443966|NCT02240121|18805995|P2|Overall Study|Lost to Follow-up|4
5443967|NCT02240121|18805996|P1|Overall Study|Lost to Follow-up|3
5443968|NCT02240121|18805995|P2|Overall Study|Withdrawal by Subject|2
5443969|NCT02240121|18805996|P1|Overall Study|Withdrawal by Subject|6
5443970|NCT02240121|18805995|P2|Overall Study|Adverse Event|4
5443971|NCT02240121|18805996|P1|Overall Study|Adverse Event|2
5443972|NCT02240121|18805995|P2|Overall Study|Pregnancy|0
5443973|NCT02240121|18805996|P1|Overall Study|Pregnancy|1
5443974|NCT02240121|18805995|P2|Overall Study|Site closed|1
5443975|NCT02240121|18805996|P1|Overall Study|Site closed|1
5443976|NCT02240121|18805995|P2|Overall Study|Lack of Efficacy|3
5443977|NCT02240121|18805996|P1|Overall Study|Lack of Efficacy|2
5443978|NCT02240121|18805995|P2|Overall Study|Change in protocol interpretation|0
5443979|NCT02240121|18805996|P1|Overall Study|Change in protocol interpretation|1
5443980|NCT02240121|18805995|P2|Overall Study|Physician Decision|1
5443981|NCT02240121|18805996|P1|Overall Study|Physician Decision|0
5443982|NCT02240121|18805995|P2|Overall Study|Protocol Violation|2
5443983|NCT02240121|18805996|P1|Overall Study|Protocol Violation|1
5443984|NCT02240108|18806024|P2|Overall Study|StudyTerminated by Sponsor|1
5443985|NCT02240108|18806025|P1|Overall Study|StudyTerminated by Sponsor|0
5443986|NCT02240108|18806024|P2|Overall Study|Withdrawal by Subject|9
5443987|NCT02240108|18806025|P1|Overall Study|Withdrawal by Subject|4
5443988|NCT02240108|18806024|P2|Overall Study|Pregnancy|0
5443989|NCT02240108|18806025|P1|Overall Study|Pregnancy|1
5443990|NCT02240108|18806024|P2|Overall Study|Adverse Event|9
5443991|NCT02240108|18806025|P1|Overall Study|Adverse Event|1
5443992|NCT02240108|18806024|P2|Overall Study|Other than specified|6
5443993|NCT02240108|18806025|P1|Overall Study|Other than specified|8
5443994|NCT02239978|18806080|P2|Overall Study|Withdrawal by Subject|0
5443995|NCT02239978|18806081|P1|Overall Study|Withdrawal by Subject|2
5443996|NCT02239939|18806098|P2|Overall Study|Lost to Follow-up|1
5443997|NCT02239939|18806099|P1|Overall Study|Lost to Follow-up|0
5443998|NCT02239939|18806098|P2|Overall Study|Withdrawal by Subject|1
5443999|NCT02239939|18806099|P1|Overall Study|Withdrawal by Subject|1
5444000|NCT02239939|18806098|P2|Overall Study|Adverse Event|0
5444001|NCT02239939|18806099|P1|Overall Study|Adverse Event|1
5444002|NCT02239926|18806115|P2|Overall Study|Withdrawal by Subject|1
5444003|NCT02239926|18806116|P1|Overall Study|Withdrawal by Subject|0
5444004|NCT02239692|18806178|P2|Overall Study|Other reason|0
5444005|NCT02239692|18806179|P1|Overall Study|Other reason|1
5444006|NCT02239692|18806178|P2|Overall Study|Withdrawal by Subject|5
5444007|NCT02239692|18806179|P1|Overall Study|Withdrawal by Subject|3
5444008|NCT02239692|18806178|P2|Overall Study|Lost to Follow-up|4
5444009|NCT02239692|18806179|P1|Overall Study|Lost to Follow-up|1
5444010|NCT02239692|18806178|P2|Overall Study|Physician Decision|1
5444011|NCT02239692|18806179|P1|Overall Study|Physician Decision|0
5444012|NCT02239692|18806178|P2|Overall Study|Adverse Event|1
5444013|NCT02239692|18806179|P1|Overall Study|Adverse Event|0
5444014|NCT02239692|18806178|P2|Overall Study|Incomplete colonoscopy|2
5444015|NCT02239692|18806179|P1|Overall Study|Incomplete colonoscopy|1
5444016|NCT02239679|18806198|P3|Overall Study|Withdrawal by Subject|1
5444017|NCT02239679|18806199|P2|Overall Study|Withdrawal by Subject|3
5444018|NCT02239679|18806200|P1|Overall Study|Withdrawal by Subject|2
5444019|NCT02239679|18806198|P3|Overall Study|Lost to Follow-up|0
5444020|NCT02239679|18806199|P2|Overall Study|Lost to Follow-up|0
5444021|NCT02239679|18806200|P1|Overall Study|Lost to Follow-up|1
5444022|NCT02239640|18806412|P1|Overall Study|Death|142
5444023|NCT02239640|18806412|P1|Overall Study|Lost to Follow-up|72
5444024|NCT02239640|18806412|P1|Overall Study|Withdrawal by Subject|3
5444025|NCT02239601|18806424|P2|Overall Study|Protocol Violation|2
5444026|NCT02239601|18806425|P1|Overall Study|Protocol Violation|4
5444027|NCT02239601|18806424|P2|Overall Study|Withdrawal by Subject|4
5444028|NCT02239601|18806425|P1|Overall Study|Withdrawal by Subject|3
5444029|NCT02239536|18806478|P2|Overall Study|Non-neoplastic polyp|17
5444030|NCT02239536|18806479|P1|Overall Study|Non-neoplastic polyp|23
5444031|NCT02239510|18806489|P2|Overall Study|Lost to Follow-up|1
5444032|NCT02239510|18806490|P1|Overall Study|Lost to Follow-up|2
5444033|NCT02239328|18806512|P1|Overall Study|Equipment or website malfunction|2
5444034|NCT02239328|18806512|P1|Overall Study|Benign disease noted at time of surgery|6
5444035|NCT02239120|18806537|P2|Overall Study|Lost to Follow-up|14
5444036|NCT02239120|18806538|P1|Overall Study|Lost to Follow-up|19
5444037|NCT02239120|18806537|P2|Overall Study|Death|58
5444038|NCT02239120|18806538|P1|Overall Study|Death|56
5444039|NCT02239094|18806562|P1|Overall Study|Remitted before started|1
5444040|NCT02239094|18806562|P1|Overall Study|Withdrawal by Subject|1
5444041|NCT02238483|18806617|P2|Overall Study|Illness in family member|0
5444042|NCT02238483|18806618|P1|Overall Study|Illness in family member|1
5444043|NCT02238483|18806617|P2|Overall Study|Completion status not recorded|1
5444044|NCT02238483|18806618|P1|Overall Study|Completion status not recorded|1
5444045|NCT02238483|18806617|P2|Overall Study|Withdrawn due to physician decision|0
5444046|NCT02238483|18806618|P1|Overall Study|Withdrawn due to physician decision|1
5444047|NCT02238483|18806617|P2|Overall Study|Adverse Event|3
5444048|NCT02238483|18806618|P1|Overall Study|Adverse Event|7
5444049|NCT02238483|18806617|P2|Overall Study|Death|0
5444050|NCT02238483|18806618|P1|Overall Study|Death|1
5444051|NCT02238483|18806617|P2|Overall Study|Protocol Violation|2
5444052|NCT02238483|18806618|P1|Overall Study|Protocol Violation|1
5444053|NCT02238483|18806617|P2|Overall Study|Lost to Follow-up|1
5444054|NCT02238483|18806618|P1|Overall Study|Lost to Follow-up|1
5444055|NCT02238483|18806617|P2|Overall Study|Withdrawal by Subject|7
5444056|NCT02238483|18806618|P1|Overall Study|Withdrawal by Subject|2
5444057|NCT02238379|18806656|P2|Overall Study|Lost to Follow-up|0
5444058|NCT02238379|18806657|P1|Overall Study|Lost to Follow-up|1
5444059|NCT02238080|18806683|P1|Overall Study|Other|4
5444060|NCT02238080|18806683|P1|Overall Study|Withdrawal by Subject|2
5444061|NCT02238080|18806683|P1|Overall Study|Treatment interrupted|6
5444062|NCT02238080|18806683|P1|Overall Study|Death|13
5444063|NCT02238067|18806697|P1|Overall Study|Not completed survey at Month 6|45
5444064|NCT02237911|18806785|P3|Overall Study|Lost to Follow-up|1
5444065|NCT02237911|18806786|P2|Overall Study|Lost to Follow-up|1
5444066|NCT02237911|18806787|P1|Overall Study|Lost to Follow-up|3
5444067|NCT02237911|18806785|P3|Overall Study|Withdrawal by Subject|2
5444068|NCT02237911|18806786|P2|Overall Study|Withdrawal by Subject|7
5444069|NCT02237911|18806787|P1|Overall Study|Withdrawal by Subject|4
5444070|NCT02237196|18806827|P4|Overall Study|Site Error|2
5444071|NCT02237196|18806828|P3|Overall Study|Site Error|0
5444072|NCT02237196|18806829|P2|Overall Study|Site Error|2
5444073|NCT02237196|18806830|P1|Overall Study|Site Error|1
5444074|NCT02237196|18806827|P4|Overall Study|Withdrawal by Subject|1
5444075|NCT02237196|18806828|P3|Overall Study|Withdrawal by Subject|4
5444076|NCT02237196|18806829|P2|Overall Study|Withdrawal by Subject|1
5444077|NCT02237196|18806830|P1|Overall Study|Withdrawal by Subject|1
5444078|NCT02237196|18806827|P4|Overall Study|Pregnancy|1
5444079|NCT02237196|18806828|P3|Overall Study|Pregnancy|1
5444080|NCT02237196|18806829|P2|Overall Study|Pregnancy|0
5444081|NCT02237196|18806830|P1|Overall Study|Pregnancy|0
5444082|NCT02237196|18806827|P4|Overall Study|Physician Decision|1
5444083|NCT02237196|18806828|P3|Overall Study|Physician Decision|0
5444084|NCT02237196|18806829|P2|Overall Study|Physician Decision|0
5444085|NCT02237196|18806830|P1|Overall Study|Physician Decision|2
5444086|NCT02237196|18806827|P4|Overall Study|Lost to Follow-up|6
5444087|NCT02237196|18806828|P3|Overall Study|Lost to Follow-up|4
5444088|NCT02237196|18806829|P2|Overall Study|Lost to Follow-up|2
5444089|NCT02237196|18806830|P1|Overall Study|Lost to Follow-up|4
5444090|NCT02237196|18806827|P4|Overall Study|Adverse Event|0
5444091|NCT02237196|18806828|P3|Overall Study|Adverse Event|1
5444092|NCT02237196|18806829|P2|Overall Study|Adverse Event|1
5444093|NCT02237196|18806830|P1|Overall Study|Adverse Event|0
5444094|NCT02237118|18806874|P2|Overall Study|consent withdrawn|0
5444095|NCT02237118|18806875|P1|Overall Study|consent withdrawn|1
5444096|NCT02237118|18806874|P2|Overall Study|Protocol Violation|1
5444097|NCT02237118|18806875|P1|Overall Study|Protocol Violation|0
5444098|NCT02237001|18806906|P1|Overall Study|Incarceration|1
5444099|NCT02237001|18806906|P1|Overall Study|Re-operation|4
5444100|NCT02237001|18806906|P1|Overall Study|Eligibility criteria/Late Screen Failure|3
5444101|NCT02237001|18806906|P1|Overall Study|Withdrawal by Subject|1
5444102|NCT02237001|18806906|P1|Overall Study|Lost to Follow-up|2
5444103|NCT02236611|18806924|P2|Overall Study|Withdrew consent|4
5444104|NCT02236611|18806925|P1|Overall Study|Withdrew consent|9
5444105|NCT02236611|18806924|P2|Overall Study|Protocol deviation|5
5444106|NCT02236611|18806925|P1|Overall Study|Protocol deviation|3
5444107|NCT02236611|18806924|P2|Overall Study|Lost to Follow-up|2
5444108|NCT02236611|18806925|P1|Overall Study|Lost to Follow-up|0
5444109|NCT02236611|18806924|P2|Overall Study|Lack of Efficacy|7
5444110|NCT02236611|18806925|P1|Overall Study|Lack of Efficacy|4
5444111|NCT02236611|18806924|P2|Overall Study|Adverse Event|16
5444112|NCT02236611|18806925|P1|Overall Study|Adverse Event|10
5444113|NCT02236598|18806933|P2|Overall Study|Withdrawal by Subject|1
5444114|NCT02236598|18806934|P1|Overall Study|Withdrawal by Subject|0
5444115|NCT02236598|18806933|P2|Overall Study|Adverse Event|1
5444116|NCT02236598|18806934|P1|Overall Study|Adverse Event|0
5444117|NCT02236559|18806948|P2|Overall Study|Withdrawal by Subject|0
5444118|NCT02236559|18806949|P1|Overall Study|Withdrawal by Subject|1
5444119|NCT02236559|18806948|P2|Overall Study|Physician Decision|1
5444120|NCT02236559|18806949|P1|Overall Study|Physician Decision|1
5444121|NCT02236559|18806948|P2|Overall Study|Subject Did Not Consent|2
5444122|NCT02236559|18806949|P1|Overall Study|Subject Did Not Consent|4
5444123|NCT02236559|18806948|P2|Overall Study|Did not Meet Inclusion|3
5444124|NCT02236559|18806949|P1|Overall Study|Did not Meet Inclusion|3
5444125|NCT02236559|18806948|P2|Overall Study|Met Exclusion|6
5444126|NCT02236559|18806949|P1|Overall Study|Met Exclusion|3
5444127|NCT02236520|18806986|P4|Overall Study|Pregnancy|0
5444128|NCT02236520|18806987|P3|Overall Study|Pregnancy|0
5444129|NCT02236520|18806988|P2|Overall Study|Pregnancy|0
5444130|NCT02236520|18806989|P1|Overall Study|Pregnancy|1
5444131|NCT02236520|18806986|P4|Overall Study|Withdrawal by Subject|1
5444132|NCT02236520|18806987|P3|Overall Study|Withdrawal by Subject|0
5444133|NCT02236520|18806988|P2|Overall Study|Withdrawal by Subject|0
5444134|NCT02236520|18806989|P1|Overall Study|Withdrawal by Subject|1
5444135|NCT02236520|18806986|P4|Overall Study|Physician Decision|0
5444136|NCT02236520|18806987|P3|Overall Study|Physician Decision|0
5444137|NCT02236520|18806988|P2|Overall Study|Physician Decision|5
5444138|NCT02236520|18806989|P1|Overall Study|Physician Decision|0
5444139|NCT02236130|18807016|P2|Overall Study|Lost to Follow-up|12
5444140|NCT02236130|18807017|P1|Overall Study|Lost to Follow-up|7
5444141|NCT02235454|18807067|P1|Overall Study|Withdrawal by Subject|2
5444142|NCT02235311|18807073|P2|Overall Study|Protocol Violation|1
5444143|NCT02235311|18807074|P1|Overall Study|Protocol Violation|0
5444144|NCT02235311|18807073|P2|Overall Study|Lost to Follow-up|1
5444145|NCT02235311|18807074|P1|Overall Study|Lost to Follow-up|0
5444146|NCT02235077|18807092|P2|Overall Study|Physician Decision|1
5444147|NCT02235077|18807093|P1|Overall Study|Physician Decision|0
5444148|NCT02235077|18807092|P2|Overall Study|Withdrawal by Subject|5
5444149|NCT02235077|18807093|P1|Overall Study|Withdrawal by Subject|8
5444150|NCT02235077|18807092|P2|Overall Study|Lost to Follow-up|6
5444151|NCT02235077|18807093|P1|Overall Study|Lost to Follow-up|5
5444152|NCT02235077|18807092|P2|Overall Study|Death|7
5444153|NCT02235077|18807093|P1|Overall Study|Death|5
5444154|NCT02234843|18807158|P10|Overall Study|Lost to Follow-up|0
5444155|NCT02234843|18807159|P9|Overall Study|Lost to Follow-up|0
5444156|NCT02234843|18807160|P8|Overall Study|Lost to Follow-up|0
5444157|NCT02234843|18807161|P7|Overall Study|Lost to Follow-up|1
5444158|NCT02234843|18807162|P6|Overall Study|Lost to Follow-up|0
5444159|NCT02234843|18807163|P5|Overall Study|Lost to Follow-up|0
5444160|NCT02234843|18807164|P4|Overall Study|Lost to Follow-up|0
5444161|NCT02234843|18807165|P3|Overall Study|Lost to Follow-up|0
5444162|NCT02234843|18807166|P2|Overall Study|Lost to Follow-up|1
5444163|NCT02234843|18807167|P1|Overall Study|Lost to Follow-up|0
5444164|NCT02234843|18807158|P10|Overall Study|Non-compliance with study drug|0
5444165|NCT02234843|18807159|P9|Overall Study|Non-compliance with study drug|0
5444166|NCT02234843|18807160|P8|Overall Study|Non-compliance with study drug|0
5444167|NCT02234843|18807161|P7|Overall Study|Non-compliance with study drug|1
5444168|NCT02234843|18807162|P6|Overall Study|Non-compliance with study drug|1
5444169|NCT02234843|18807163|P5|Overall Study|Non-compliance with study drug|0
5444170|NCT02234843|18807164|P4|Overall Study|Non-compliance with study drug|0
5444171|NCT02234843|18807165|P3|Overall Study|Non-compliance with study drug|0
5444172|NCT02234843|18807166|P2|Overall Study|Non-compliance with study drug|0
5444173|NCT02234843|18807167|P1|Overall Study|Non-compliance with study drug|1
5444174|NCT02234843|18807158|P10|Overall Study|Adverse Event|0
5444175|NCT02234843|18807159|P9|Overall Study|Adverse Event|1
5444176|NCT02234843|18807160|P8|Overall Study|Adverse Event|0
5444177|NCT02234843|18807161|P7|Overall Study|Adverse Event|0
5444178|NCT02234843|18807162|P6|Overall Study|Adverse Event|1
5444179|NCT02234843|18807163|P5|Overall Study|Adverse Event|2
5444180|NCT02234843|18807164|P4|Overall Study|Adverse Event|3
5444181|NCT02234843|18807165|P3|Overall Study|Adverse Event|1
5444182|NCT02234843|18807166|P2|Overall Study|Adverse Event|1
5444183|NCT02234843|18807167|P1|Overall Study|Adverse Event|5
5444184|NCT02234843|18807158|P10|Overall Study|Physician Decision|0
5444185|NCT02234843|18807159|P9|Overall Study|Physician Decision|0
5444186|NCT02234843|18807160|P8|Overall Study|Physician Decision|1
5444187|NCT02234843|18807161|P7|Overall Study|Physician Decision|0
5444188|NCT02234843|18807162|P6|Overall Study|Physician Decision|0
5444189|NCT02234843|18807163|P5|Overall Study|Physician Decision|0
5444190|NCT02234843|18807164|P4|Overall Study|Physician Decision|1
5444191|NCT02234843|18807165|P3|Overall Study|Physician Decision|0
5444192|NCT02234843|18807166|P2|Overall Study|Physician Decision|1
5444193|NCT02234843|18807167|P1|Overall Study|Physician Decision|4
5444194|NCT02234843|18807158|P10|Overall Study|Other|0
5444195|NCT02234843|18807159|P9|Overall Study|Other|0
5444196|NCT02234843|18807160|P8|Overall Study|Other|1
5444197|NCT02234843|18807161|P7|Overall Study|Other|0
5444198|NCT02234843|18807162|P6|Overall Study|Other|1
5444199|NCT02234843|18807163|P5|Overall Study|Other|0
5444200|NCT02234843|18807164|P4|Overall Study|Other|1
5444201|NCT02234843|18807165|P3|Overall Study|Other|0
5444202|NCT02234843|18807166|P2|Overall Study|Other|2
5444203|NCT02234843|18807167|P1|Overall Study|Other|0
5444204|NCT02234843|18807158|P10|Overall Study|Recovery|0
5444205|NCT02234843|18807159|P9|Overall Study|Recovery|0
5444206|NCT02234843|18807160|P8|Overall Study|Recovery|0
5444207|NCT02234843|18807161|P7|Overall Study|Recovery|0
5444208|NCT02234843|18807162|P6|Overall Study|Recovery|0
5444209|NCT02234843|18807163|P5|Overall Study|Recovery|0
5444210|NCT02234843|18807164|P4|Overall Study|Recovery|0
5444211|NCT02234843|18807165|P3|Overall Study|Recovery|0
5444212|NCT02234843|18807166|P2|Overall Study|Recovery|0
5444213|NCT02234843|18807167|P1|Overall Study|Recovery|1
5444214|NCT02234843|18807158|P10|Overall Study|Withdrawal by Subject|0
5444215|NCT02234843|18807159|P9|Overall Study|Withdrawal by Subject|0
5444216|NCT02234843|18807160|P8|Overall Study|Withdrawal by Subject|0
5444217|NCT02234843|18807161|P7|Overall Study|Withdrawal by Subject|0
5444218|NCT02234843|18807162|P6|Overall Study|Withdrawal by Subject|7
5444219|NCT02234843|18807163|P5|Overall Study|Withdrawal by Subject|0
5444220|NCT02234843|18807164|P4|Overall Study|Withdrawal by Subject|0
5444221|NCT02234843|18807165|P3|Overall Study|Withdrawal by Subject|1
5444222|NCT02234843|18807166|P2|Overall Study|Withdrawal by Subject|1
5444223|NCT02234843|18807167|P1|Overall Study|Withdrawal by Subject|5
5444224|NCT02234843|18807158|P10|Overall Study|Patient convenience|0
5444225|NCT02234843|18807159|P9|Overall Study|Patient convenience|0
5444226|NCT02234843|18807160|P8|Overall Study|Patient convenience|0
5444227|NCT02234843|18807161|P7|Overall Study|Patient convenience|0
5444228|NCT02234843|18807162|P6|Overall Study|Patient convenience|1
5444229|NCT02234843|18807163|P5|Overall Study|Patient convenience|0
5444230|NCT02234843|18807164|P4|Overall Study|Patient convenience|0
5444231|NCT02234843|18807165|P3|Overall Study|Patient convenience|0
5444232|NCT02234843|18807166|P2|Overall Study|Patient convenience|0
5444233|NCT02234843|18807167|P1|Overall Study|Patient convenience|2
5444234|NCT02234843|18807158|P10|Overall Study|Efficacy outcome reached|0
5444235|NCT02234843|18807159|P9|Overall Study|Efficacy outcome reached|0
5444236|NCT02234843|18807160|P8|Overall Study|Efficacy outcome reached|0
5444237|NCT02234843|18807161|P7|Overall Study|Efficacy outcome reached|0
5444238|NCT02234843|18807162|P6|Overall Study|Efficacy outcome reached|2
5444239|NCT02234843|18807163|P5|Overall Study|Efficacy outcome reached|0
5444240|NCT02234843|18807164|P4|Overall Study|Efficacy outcome reached|0
5444241|NCT02234843|18807165|P3|Overall Study|Efficacy outcome reached|0
5444242|NCT02234843|18807166|P2|Overall Study|Efficacy outcome reached|0
5444243|NCT02234843|18807167|P1|Overall Study|Efficacy outcome reached|2
5444244|NCT02234843|18807158|P10|Overall Study|Protocol Violation|0
5444245|NCT02234843|18807159|P9|Overall Study|Protocol Violation|0
5444246|NCT02234843|18807160|P8|Overall Study|Protocol Violation|0
5444247|NCT02234843|18807161|P7|Overall Study|Protocol Violation|0
5444248|NCT02234843|18807162|P6|Overall Study|Protocol Violation|0
5444249|NCT02234843|18807163|P5|Overall Study|Protocol Violation|0
5444250|NCT02234843|18807164|P4|Overall Study|Protocol Violation|0
5444251|NCT02234843|18807165|P3|Overall Study|Protocol Violation|1
5444252|NCT02234843|18807166|P2|Overall Study|Protocol Violation|0
5444253|NCT02234843|18807167|P1|Overall Study|Protocol Violation|1
5444254|NCT02234843|18807158|P10|Overall Study|Death|0
5444255|NCT02234843|18807159|P9|Overall Study|Death|0
5444256|NCT02234843|18807160|P8|Overall Study|Death|0
5444257|NCT02234843|18807161|P7|Overall Study|Death|0
5444258|NCT02234843|18807162|P6|Overall Study|Death|0
5444259|NCT02234843|18807163|P5|Overall Study|Death|0
5444260|NCT02234843|18807164|P4|Overall Study|Death|0
5444261|NCT02234843|18807165|P3|Overall Study|Death|0
5444262|NCT02234843|18807166|P2|Overall Study|Death|0
5444263|NCT02234843|18807167|P1|Overall Study|Death|1
5444264|NCT02234622|18807325|P2|Overall Study|Lost to Follow-up|14
5444265|NCT02234622|18807326|P1|Overall Study|Lost to Follow-up|27
5444266|NCT02234622|18807325|P2|Overall Study|Withdrawal by Subject|22
5444267|NCT02234622|18807326|P1|Overall Study|Withdrawal by Subject|16
5444268|NCT02234583|18807346|P2|Overall Study|Other|97
5444269|NCT02234583|18807347|P1|Overall Study|Other|39
5444270|NCT02234583|18807346|P2|Overall Study|Protocol Violation|42
5444271|NCT02234583|18807347|P1|Overall Study|Protocol Violation|35
5444272|NCT02234583|18807346|P2|Overall Study|Lack of Efficacy|103
5444273|NCT02234583|18807347|P1|Overall Study|Lack of Efficacy|58
5444274|NCT02234583|18807346|P2|Overall Study|Lost to Follow-up|1
5444275|NCT02234583|18807347|P1|Overall Study|Lost to Follow-up|0
5444276|NCT02234583|18807346|P2|Overall Study|Withdrawal by Subject|157
5444277|NCT02234583|18807347|P1|Overall Study|Withdrawal by Subject|109
5444278|NCT02234583|18807346|P2|Overall Study|Adverse Event|156
5444279|NCT02234583|18807347|P1|Overall Study|Adverse Event|172
5444280|NCT02234479|18807466|P2|Overall Study|Withdrawal by Subject|3
5444281|NCT02234479|18807467|P1|Overall Study|Withdrawal by Subject|1
5444282|NCT02234362|18807477|P1|Overall Study|Withdrawal by Subject|3
5444283|NCT02234362|18807477|P1|Overall Study|Lost to Follow-up|6
5444284|NCT02234362|18807477|P1|Overall Study|Not eligible after first screening visit|17
5444285|NCT02234323|18807494|P1|All Treated|Other|7
5444286|NCT02234323|18807494|P1|All Treated|Exceeded lab value limit|2
5444287|NCT02234323|18807494|P1|All Treated|Lack of Efficacy|3
5444288|NCT02234323|18807494|P1|All Treated|Physician Decision|5
5444289|NCT02234323|18807494|P1|All Treated|Death|1
5444290|NCT02234323|18807494|P1|All Enrolled|Not Treated: Exceeded lab value limit|1
5444291|NCT02234323|18807494|P1|All Enrolled|Not Treated:Consent withdrawn by subject|2
5444292|NCT02234323|18807494|P1|All Enrolled|Not Treated: Completed study in database|2
5444293|NCT02234310|18807507|P1|Overall Study|Withdrawal by Subject|2
5444294|NCT02234310|18807507|P1|Overall Study|Eligibility Criteria not fulfilled|2
5444295|NCT02234310|18807507|P1|Overall Study|Adverse Event|1
5444296|NCT02234310|18807507|P1|Overall Study|Physician Decision|1
5444297|NCT02234284|18807521|P2|Overall Study|Lost to Follow-up|7
5444298|NCT02234284|18807522|P1|Overall Study|Lost to Follow-up|20
5444299|NCT02234284|18807521|P2|Overall Study|Withdrawal by Subject|0
5444300|NCT02234284|18807522|P1|Overall Study|Withdrawal by Subject|1
5444301|NCT02234284|18807521|P2|Overall Study|Death|2
5444302|NCT02234284|18807522|P1|Overall Study|Death|4
5444303|NCT02234141|18807581|P7|Long-Term Treatment Period|Study Discontinued by Sponsor|8
5444304|NCT02234141|18807582|P6|Long-Term Treatment Period|Study Discontinued by Sponsor|10
5444305|NCT02234141|18807583|P5|Long-Term Treatment Period|Study Discontinued by Sponsor|9
5444306|NCT02234141|18807584|P4|Long-Term Treatment Period|Study Discontinued by Sponsor|0
5444307|NCT02234141|18807585|P3|Long-Term Treatment Period|Study Discontinued by Sponsor|25
5444308|NCT02234141|18807586|P2|Long-Term Treatment Period|Study Discontinued by Sponsor|27
5444309|NCT02234141|18807587|P1|Long-Term Treatment Period|Study Discontinued by Sponsor|28
5444310|NCT02234141|18807581|P7|Long-Term Treatment Period|Withdrew Consent|0
5444311|NCT02234141|18807582|P6|Long-Term Treatment Period|Withdrew Consent|0
5444312|NCT02234141|18807583|P5|Long-Term Treatment Period|Withdrew Consent|0
5444313|NCT02234141|18807584|P4|Long-Term Treatment Period|Withdrew Consent|0
5444314|NCT02234141|18807585|P3|Long-Term Treatment Period|Withdrew Consent|1
5444315|NCT02234141|18807586|P2|Long-Term Treatment Period|Withdrew Consent|1
5444316|NCT02234141|18807587|P1|Long-Term Treatment Period|Withdrew Consent|0
5444317|NCT02234141|18807581|P7|Long-Term Treatment Period|Adverse Event|1
5444318|NCT02234141|18807582|P6|Long-Term Treatment Period|Adverse Event|1
5444319|NCT02234141|18807583|P5|Long-Term Treatment Period|Adverse Event|1
5444320|NCT02234141|18807584|P4|Long-Term Treatment Period|Adverse Event|0
5444321|NCT02234141|18807585|P3|Long-Term Treatment Period|Adverse Event|5
5444322|NCT02234141|18807586|P2|Long-Term Treatment Period|Adverse Event|0
5444323|NCT02234141|18807587|P1|Long-Term Treatment Period|Adverse Event|4
5444324|NCT02234141|18807581|P7|Long-Term Treatment Period|Investigator's discretion|1
5444325|NCT02234141|18807582|P6|Long-Term Treatment Period|Investigator's discretion|0
5444326|NCT02234141|18807583|P5|Long-Term Treatment Period|Investigator's discretion|0
5444327|NCT02234141|18807584|P4|Long-Term Treatment Period|Investigator's discretion|0
5444328|NCT02234141|18807585|P3|Long-Term Treatment Period|Investigator's discretion|2
5444329|NCT02234141|18807586|P2|Long-Term Treatment Period|Investigator's discretion|3
5444330|NCT02234141|18807587|P1|Long-Term Treatment Period|Investigator's discretion|1
5444331|NCT02234141|18807581|P7|Long-Term Treatment Period|Death|0
5444332|NCT02234141|18807582|P6|Long-Term Treatment Period|Death|1
5444333|NCT02234141|18807583|P5|Long-Term Treatment Period|Death|0
5444334|NCT02234141|18807584|P4|Long-Term Treatment Period|Death|0
5444335|NCT02234141|18807585|P3|Long-Term Treatment Period|Death|0
5444336|NCT02234141|18807586|P2|Long-Term Treatment Period|Death|0
5444337|NCT02234141|18807587|P1|Long-Term Treatment Period|Death|0
5444338|NCT02234141|18807581|P7|Treatment Period (24 Weeks)|Randomized but not treated|0
5444339|NCT02234141|18807582|P6|Treatment Period (24 Weeks)|Randomized but not treated|0
5444340|NCT02234141|18807583|P5|Treatment Period (24 Weeks)|Randomized but not treated|0
5444341|NCT02234141|18807584|P4|Treatment Period (24 Weeks)|Randomized but not treated|0
5444342|NCT02234141|18807585|P3|Treatment Period (24 Weeks)|Randomized but not treated|0
5444343|NCT02234141|18807586|P2|Treatment Period (24 Weeks)|Randomized but not treated|1
5444344|NCT02234141|18807587|P1|Treatment Period (24 Weeks)|Randomized but not treated|0
5444345|NCT02234141|18807581|P7|Treatment Period (24 Weeks)|Adverse Event|0
5444346|NCT02234141|18807582|P6|Treatment Period (24 Weeks)|Adverse Event|0
5444347|NCT02234141|18807583|P5|Treatment Period (24 Weeks)|Adverse Event|0
5444348|NCT02234141|18807584|P4|Treatment Period (24 Weeks)|Adverse Event|3
5444349|NCT02234141|18807585|P3|Treatment Period (24 Weeks)|Adverse Event|2
5444350|NCT02234141|18807586|P2|Treatment Period (24 Weeks)|Adverse Event|1
5444351|NCT02234141|18807587|P1|Treatment Period (24 Weeks)|Adverse Event|3
5444352|NCT02234141|18807581|P7|Treatment Period (24 Weeks)|Death|0
5444353|NCT02234141|18807582|P6|Treatment Period (24 Weeks)|Death|0
5444354|NCT02234141|18807583|P5|Treatment Period (24 Weeks)|Death|0
5444355|NCT02234141|18807584|P4|Treatment Period (24 Weeks)|Death|1
5444356|NCT02234141|18807585|P3|Treatment Period (24 Weeks)|Death|0
5444357|NCT02234141|18807586|P2|Treatment Period (24 Weeks)|Death|2
5444358|NCT02234141|18807587|P1|Treatment Period (24 Weeks)|Death|1
5444359|NCT02234141|18807581|P7|Treatment Period (24 Weeks)|Investigator's discretion|0
5444360|NCT02234141|18807582|P6|Treatment Period (24 Weeks)|Investigator's discretion|0
5444361|NCT02234141|18807583|P5|Treatment Period (24 Weeks)|Investigator's discretion|0
5444362|NCT02234141|18807584|P4|Treatment Period (24 Weeks)|Investigator's discretion|0
5444363|NCT02234141|18807585|P3|Treatment Period (24 Weeks)|Investigator's discretion|0
5444364|NCT02234141|18807586|P2|Treatment Period (24 Weeks)|Investigator's discretion|2
5444365|NCT02234141|18807587|P1|Treatment Period (24 Weeks)|Investigator's discretion|0
5444366|NCT02234141|18807581|P7|Treatment Period (24 Weeks)|Protocol Violation|0
5444367|NCT02234141|18807582|P6|Treatment Period (24 Weeks)|Protocol Violation|0
5444368|NCT02234141|18807583|P5|Treatment Period (24 Weeks)|Protocol Violation|0
5444369|NCT02234141|18807584|P4|Treatment Period (24 Weeks)|Protocol Violation|1
5444370|NCT02234141|18807585|P3|Treatment Period (24 Weeks)|Protocol Violation|0
5444371|NCT02234141|18807586|P2|Treatment Period (24 Weeks)|Protocol Violation|0
5444372|NCT02234141|18807587|P1|Treatment Period (24 Weeks)|Protocol Violation|0
5444373|NCT02234063|18807692|P2|Overall Study|Withdrawal by Subject|1
5444374|NCT02234063|18807693|P1|Overall Study|Withdrawal by Subject|20
5444375|NCT02234063|18807692|P2|Overall Study|Lost to Follow-up|42
5444376|NCT02234063|18807693|P1|Overall Study|Lost to Follow-up|235
5444377|NCT02233803|18807772|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
5444378|NCT02233803|18807773|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
5444379|NCT02233803|18807772|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
5444380|NCT02233803|18807773|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
5444381|NCT02233803|18807772|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
5444382|NCT02233803|18807773|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
5444383|NCT02233803|18807772|P2|Washout Period (4-Wks)|Physician Decision|0
5444384|NCT02233803|18807773|P1|Washout Period (4-Wks)|Physician Decision|1
5444385|NCT02233803|18807772|P2|Washout Period (4-Wks)|Lost to Follow-up|1
5444386|NCT02233803|18807773|P1|Washout Period (4-Wks)|Lost to Follow-up|0
5444387|NCT02233803|18807772|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
5444388|NCT02233803|18807773|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
5444389|NCT02233803|18807772|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
5444390|NCT02233803|18807773|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
5444391|NCT02233803|18807772|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
5444392|NCT02233803|18807773|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
5444393|NCT02233803|18807772|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
5444394|NCT02233803|18807773|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
5444395|NCT02233738|18807806|P2|Overall Study|Did not return after Baseline|2
5444396|NCT02233738|18807807|P1|Overall Study|Did not return after Baseline|3
5444397|NCT02233738|18807806|P2|Overall Study|Withdrawal by Subject|1
5444398|NCT02233738|18807807|P1|Overall Study|Withdrawal by Subject|0
5444399|NCT02233738|18807806|P2|Overall Study|Death|1
5444400|NCT02233738|18807807|P1|Overall Study|Death|0
5444401|NCT02233738|18807806|P2|Overall Study|Lost to Follow-up|12
5444402|NCT02233738|18807807|P1|Overall Study|Lost to Follow-up|5
5444403|NCT02233647|18807977|P1|Overall Study|Adverse Event|1
5444404|NCT02233543|18808006|P2|Period 2|COPD exacerbation|0
5444405|NCT02233543|18808007|P1|Period 2|COPD exacerbation|1
5444406|NCT02233543|18808006|P2|Period 2|Participant required other treatment.|1
5444407|NCT02233543|18808007|P1|Period 2|Participant required other treatment.|0
5444408|NCT02233543|18808006|P2|Period 2|Adverse Event|0
5444409|NCT02233543|18808007|P1|Period 2|Adverse Event|1
5444410|NCT02233543|18808006|P2|Period 1|Participants required other treatment.|3
5444411|NCT02233543|18808007|P1|Period 1|Participants required other treatment.|2
5444412|NCT02233543|18808006|P2|Period 1|Withdrawal by Subject|0
5444413|NCT02233543|18808007|P1|Period 1|Withdrawal by Subject|1
5444414|NCT02233413|18808059|P2|Overall Study|Withdrawal by Subject|5
5444415|NCT02233413|18808060|P1|Overall Study|Withdrawal by Subject|4
5444416|NCT02233413|18808059|P2|Overall Study|Lost to Follow-up|9
5444417|NCT02233413|18808060|P1|Overall Study|Lost to Follow-up|7
5444418|NCT02233309|18808072|P1|Overall Study|Physician Decision|5
5444419|NCT02232984|18808106|P1|Overall Study|Protocol Violation|1
5444420|NCT02232984|18808106|P1|Overall Study|not disclosed by site|7
5444421|NCT02232984|18808106|P1|Overall Study|Device implant unsuccessful|53
5444422|NCT02232984|18808106|P1|Overall Study|Investigator withdrawal|10
5444423|NCT02232984|18808106|P1|Overall Study|Death|1
5444424|NCT02232984|18808106|P1|Overall Study|Withdrawal by Subject|5
5444425|NCT02232893|18808117|P2|Overall Study|Other|3
5444426|NCT02232893|18808118|P1|Overall Study|Other|0
5444427|NCT02232893|18808117|P2|Overall Study|Developed exclusion criteria|1
5444428|NCT02232893|18808118|P1|Overall Study|Developed exclusion criteria|0
5444429|NCT02232893|18808117|P2|Overall Study|Sponsor request early termination|1
5444430|NCT02232893|18808118|P1|Overall Study|Sponsor request early termination|0
5444431|NCT02232893|18808117|P2|Overall Study|Adverse Event|1
5444432|NCT02232893|18808118|P1|Overall Study|Adverse Event|0
5444433|NCT02232893|18808117|P2|Overall Study|Withdrawal by Subject|1
5444434|NCT02232893|18808118|P1|Overall Study|Withdrawal by Subject|4
5444435|NCT02232880|18808124|P1|Overall Study|study stopped prior to randomization|1
5444436|NCT02232802|18808133|P2|Period 1|Adverse Event|1
5444437|NCT02232802|18808134|P1|Period 1|Adverse Event|1
5444438|NCT02232802|18808133|P2|Period 1|Sponsor request|0
5444439|NCT02232802|18808134|P1|Period 1|Sponsor request|1
5444440|NCT02232698|18808200|P2|Overall Study|Withdrawal by Subject|11
5444441|NCT02232698|18808201|P1|Overall Study|Withdrawal by Subject|0
5444442|NCT02232698|18808200|P2|Overall Study|Allocated to control group|3
5444443|NCT02232698|18808201|P1|Overall Study|Allocated to control group|0
5444444|NCT02232698|18808200|P2|Overall Study|Non-compliance with study device|4
5444445|NCT02232698|18808201|P1|Overall Study|Non-compliance with study device|1
5444446|NCT02232698|18808200|P2|Overall Study|Had device-associated symptoms|0
5444447|NCT02232698|18808201|P1|Overall Study|Had device-associated symptoms|7
5444448|NCT02232698|18808200|P2|Overall Study|Met exclusion criteria|1
5444449|NCT02232698|18808201|P1|Overall Study|Met exclusion criteria|1
5444450|NCT02232698|18808200|P2|Overall Study|Pregnancy|1
5444451|NCT02232698|18808201|P1|Overall Study|Pregnancy|1
5444452|NCT02232425|18808224|P2|Overall Study|Lack of Efficacy|0
5444453|NCT02232425|18808225|P1|Overall Study|Lack of Efficacy|1
5444454|NCT02232425|18808224|P2|Overall Study|Withdrawal by Subject|6
5444455|NCT02232425|18808225|P1|Overall Study|Withdrawal by Subject|5
5444456|NCT02232425|18808224|P2|Overall Study|Adverse Event|0
5444457|NCT02232425|18808225|P1|Overall Study|Adverse Event|2
5444458|NCT02232425|18808224|P2|Overall Study|Lost to Follow-up|2
5444459|NCT02232425|18808225|P1|Overall Study|Lost to Follow-up|6
5444460|NCT02232243|18808258|P3|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
5444461|NCT02232243|18808259|P2|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
5444462|NCT02232243|18808260|P1|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
5444463|NCT02232178|18808272|P3|Overall Study|surgical complication|0
5444464|NCT02232178|18808273|P2|Overall Study|surgical complication|0
5444465|NCT02232178|18808274|P1|Overall Study|surgical complication|1
5444466|NCT02232178|18808272|P3|Overall Study|ineligibility|1
5444467|NCT02232178|18808273|P2|Overall Study|ineligibility|0
5444468|NCT02232178|18808274|P1|Overall Study|ineligibility|0
5444469|NCT02232178|18808272|P3|Overall Study|Lost to Follow-up|0
5444470|NCT02232178|18808273|P2|Overall Study|Lost to Follow-up|1
5444471|NCT02232178|18808274|P1|Overall Study|Lost to Follow-up|0
5444472|NCT02232087|18808302|P6|Overall Study|Adverse Event|0
5444473|NCT02232087|18808303|P5|Overall Study|Adverse Event|1
5444474|NCT02232087|18808304|P4|Overall Study|Adverse Event|0
5444475|NCT02232087|18808305|P3|Overall Study|Adverse Event|0
5444476|NCT02232087|18808306|P2|Overall Study|Adverse Event|0
5444477|NCT02232087|18808307|P1|Overall Study|Adverse Event|0
5444478|NCT02232087|18808302|P6|Overall Study|protocol stop criteria|0
5444479|NCT02232087|18808303|P5|Overall Study|protocol stop criteria|0
5444480|NCT02232087|18808304|P4|Overall Study|protocol stop criteria|1
5444481|NCT02232087|18808305|P3|Overall Study|protocol stop criteria|0
5444482|NCT02232087|18808306|P2|Overall Study|protocol stop criteria|1
5444483|NCT02232087|18808307|P1|Overall Study|protocol stop criteria|0
5444484|NCT02232087|18808302|P6|Overall Study|poor inhalation technique|2
5444485|NCT02232087|18808303|P5|Overall Study|poor inhalation technique|0
5444486|NCT02232087|18808304|P4|Overall Study|poor inhalation technique|0
5444487|NCT02232087|18808305|P3|Overall Study|poor inhalation technique|0
5444488|NCT02232087|18808306|P2|Overall Study|poor inhalation technique|1
5444489|NCT02232087|18808307|P1|Overall Study|poor inhalation technique|0
5444490|NCT02232087|18808302|P6|Overall Study|Withdrawal by Subject|1
5444491|NCT02232087|18808303|P5|Overall Study|Withdrawal by Subject|0
5444492|NCT02232087|18808304|P4|Overall Study|Withdrawal by Subject|0
5444493|NCT02232087|18808305|P3|Overall Study|Withdrawal by Subject|0
5444494|NCT02232087|18808306|P2|Overall Study|Withdrawal by Subject|0
5444495|NCT02232087|18808307|P1|Overall Study|Withdrawal by Subject|2
5444496|NCT02232074|18808343|P2|Overall Study|deemed ineligible|1
5444497|NCT02232074|18808344|P1|Overall Study|deemed ineligible|0
5444498|NCT02232074|18808343|P2|Overall Study|No legal concerns at baseline|41
5444499|NCT02232074|18808344|P1|Overall Study|No legal concerns at baseline|36
5444500|NCT02232074|18808343|P2|Overall Study|Withdrawal by Subject|3
5444501|NCT02232074|18808344|P1|Overall Study|Withdrawal by Subject|5
5444502|NCT02231918|18808411|P3|Overall Study|Adverse Event|1
5444503|NCT02231918|18808412|P2|Overall Study|Adverse Event|0
5444504|NCT02231918|18808413|P1|Overall Study|Adverse Event|0
5444505|NCT02231918|18808411|P3|Overall Study|Withdrawal by Subject|0
5444506|NCT02231918|18808412|P2|Overall Study|Withdrawal by Subject|1
5444507|NCT02231918|18808413|P1|Overall Study|Withdrawal by Subject|0
5444508|NCT02231892|18808478|P3|Overall Study|Could not find reliable motor hotspot|1
5444509|NCT02231892|18808479|P2|Overall Study|Could not find reliable motor hotspot|0
5444510|NCT02231892|18808480|P1|Overall Study|Could not find reliable motor hotspot|0
5444511|NCT02231892|18808478|P3|Overall Study|Could not find motor threshold|1
5444512|NCT02231892|18808479|P2|Overall Study|Could not find motor threshold|0
5444513|NCT02231892|18808480|P1|Overall Study|Could not find motor threshold|2
5444514|NCT02231892|18808478|P3|Overall Study|Participant motor threshold was >83%|9
5444515|NCT02231892|18808479|P2|Overall Study|Participant motor threshold was >83%|0
5444516|NCT02231892|18808480|P1|Overall Study|Participant motor threshold was >83%|0
5444517|NCT02231892|18808478|P3|Overall Study|Motor activity when stimulating ante ACC|12
5444518|NCT02231892|18808479|P2|Overall Study|Motor activity when stimulating ante ACC|7
5444519|NCT02231892|18808480|P1|Overall Study|Motor activity when stimulating ante ACC|4
5444520|NCT02231892|18808478|P3|Overall Study|Physician Decision|4
5444521|NCT02231892|18808479|P2|Overall Study|Physician Decision|2
5444522|NCT02231892|18808480|P1|Overall Study|Physician Decision|0
5444523|NCT02231892|18808478|P3|Overall Study|Withdrawal by Subject|15
5444524|NCT02231892|18808479|P2|Overall Study|Withdrawal by Subject|3
5444525|NCT02231892|18808480|P1|Overall Study|Withdrawal by Subject|4
5444526|NCT02231892|18808478|P3|Overall Study|Lost to Follow-up|3
5444527|NCT02231892|18808479|P2|Overall Study|Lost to Follow-up|0
5444528|NCT02231892|18808480|P1|Overall Study|Lost to Follow-up|1
5444529|NCT02231762|18808497|P4|Maintenance Phase|Adverse Event|2
5444530|NCT02231762|18808498|P3|Maintenance Phase|Adverse Event|1
5444531|NCT02231762|18808499|P2|Maintenance Phase|Adverse Event|0
5444532|NCT02231762|18808500|P1|Maintenance Phase|Adverse Event|0
5444533|NCT02231762|18808497|P4|Maintenance Phase|Disease progression|3
5444534|NCT02231762|18808498|P3|Maintenance Phase|Disease progression|4
5444535|NCT02231762|18808499|P2|Maintenance Phase|Disease progression|3
5444536|NCT02231762|18808500|P1|Maintenance Phase|Disease progression|0
5444537|NCT02231762|18808497|P4|Combination Phase|Protocol Violation|0
5444538|NCT02231762|18808498|P3|Combination Phase|Protocol Violation|0
5444539|NCT02231762|18808499|P2|Combination Phase|Protocol Violation|0
5444540|NCT02231762|18808500|P1|Combination Phase|Protocol Violation|1
5444541|NCT02231762|18808497|P4|Combination Phase|Did not meet inclusion criteria|0
5444542|NCT02231762|18808498|P3|Combination Phase|Did not meet inclusion criteria|0
5444543|NCT02231762|18808499|P2|Combination Phase|Did not meet inclusion criteria|0
5444544|NCT02231762|18808500|P1|Combination Phase|Did not meet inclusion criteria|1
5444545|NCT02231762|18808497|P4|Combination Phase|Disease Progression|0
5444546|NCT02231762|18808498|P3|Combination Phase|Disease Progression|0
5444547|NCT02231762|18808499|P2|Combination Phase|Disease Progression|0
5444548|NCT02231762|18808500|P1|Combination Phase|Disease Progression|6
5444549|NCT02231762|18808497|P4|Combination Phase|Withdrawal by Subject|0
5444550|NCT02231762|18808498|P3|Combination Phase|Withdrawal by Subject|0
5444551|NCT02231762|18808499|P2|Combination Phase|Withdrawal by Subject|0
5444552|NCT02231762|18808500|P1|Combination Phase|Withdrawal by Subject|2
5444553|NCT02231762|18808497|P4|Combination Phase|Adverse Event|0
5444554|NCT02231762|18808498|P3|Combination Phase|Adverse Event|0
5444555|NCT02231762|18808499|P2|Combination Phase|Adverse Event|0
5444556|NCT02231762|18808500|P1|Combination Phase|Adverse Event|10
5444557|NCT02231749|18808533|P2|Overall Study|No longer meets Study Criteria|0
5444558|NCT02231749|18808534|P1|Overall Study|No longer meets Study Criteria|1
5444559|NCT02231749|18808533|P2|Overall Study|other|8
5444560|NCT02231749|18808534|P1|Overall Study|other|0
5444561|NCT02231749|18808533|P2|Overall Study|Pregnancy|0
5444562|NCT02231749|18808534|P1|Overall Study|Pregnancy|1
5444563|NCT02231749|18808533|P2|Overall Study|Poor/Non-Compliance|3
5444564|NCT02231749|18808534|P1|Overall Study|Poor/Non-Compliance|0
5444565|NCT02231749|18808533|P2|Overall Study|Maximum Clinical Benefit|8
5444566|NCT02231749|18808534|P1|Overall Study|Maximum Clinical Benefit|5
5444567|NCT02231749|18808533|P2|Overall Study|Lost to Follow-up|2
5444568|NCT02231749|18808534|P1|Overall Study|Lost to Follow-up|1
5444569|NCT02231749|18808533|P2|Overall Study|Participant withdrew Consent|15
5444570|NCT02231749|18808534|P1|Overall Study|Participant withdrew Consent|8
5444571|NCT02231749|18808533|P2|Overall Study|Participant's request to discontinue|21
5444572|NCT02231749|18808534|P1|Overall Study|Participant's request to discontinue|10
5444573|NCT02231749|18808533|P2|Overall Study|AE unrelated to Study drug|31
5444574|NCT02231749|18808534|P1|Overall Study|AE unrelated to Study drug|32
5444575|NCT02231749|18808533|P2|Overall Study|Death|1
5444576|NCT02231749|18808534|P1|Overall Study|Death|1
5444577|NCT02231749|18808533|P2|Overall Study|Study Drug Toxicity|63
5444578|NCT02231749|18808534|P1|Overall Study|Study Drug Toxicity|134
5444579|NCT02231749|18808533|P2|Overall Study|Disease progression|297
5444580|NCT02231749|18808534|P1|Overall Study|Disease progression|229
5444581|NCT02231580|18808552|P2|Overall Study|Adverse Event|0
5444582|NCT02231580|18808553|P1|Overall Study|Adverse Event|5
5444583|NCT02231164|18808670|P2|Overall Study|Withdrawal by Subject|2
5444584|NCT02231164|18808671|P1|Overall Study|Withdrawal by Subject|1
5444585|NCT02231164|18808670|P2|Overall Study|Lack of Efficacy|3
5444586|NCT02231164|18808671|P1|Overall Study|Lack of Efficacy|4
5444587|NCT02231164|18808670|P2|Overall Study|Adverse Event|1
5444588|NCT02231164|18808671|P1|Overall Study|Adverse Event|1
5444589|NCT02230956|18808699|P3|Overall Study|Other Miscellaneous Reason|2
5444590|NCT02230956|18808700|P2|Overall Study|Other Miscellaneous Reason|1
5444591|NCT02230956|18808701|P1|Overall Study|Other Miscellaneous Reason|0
5444592|NCT02230956|18808699|P3|Overall Study|Protocol Violation|1
5444593|NCT02230956|18808700|P2|Overall Study|Protocol Violation|1
5444594|NCT02230956|18808701|P1|Overall Study|Protocol Violation|0
5444595|NCT02230956|18808699|P3|Overall Study|Personal Reasons|1
5444596|NCT02230956|18808700|P2|Overall Study|Personal Reasons|1
5444597|NCT02230956|18808701|P1|Overall Study|Personal Reasons|2
5444598|NCT02230956|18808699|P3|Overall Study|Lost to Follow-up|2
5444599|NCT02230956|18808700|P2|Overall Study|Lost to Follow-up|1
5444600|NCT02230956|18808701|P1|Overall Study|Lost to Follow-up|1
5444601|NCT02230956|18808699|P3|Overall Study|Lack of Efficacy|1
5444602|NCT02230956|18808700|P2|Overall Study|Lack of Efficacy|1
5444603|NCT02230956|18808701|P1|Overall Study|Lack of Efficacy|1
5444604|NCT02230956|18808699|P3|Overall Study|Adverse Event|0
5444605|NCT02230956|18808700|P2|Overall Study|Adverse Event|1
5444606|NCT02230956|18808701|P1|Overall Study|Adverse Event|1
5444607|NCT02230904|18808723|P2|Overall Study|Safety follow up could not take place|1
5444608|NCT02230904|18808724|P1|Overall Study|Safety follow up could not take place|0
5444609|NCT02230683|18808757|P1|Overall Study|Adverse Event|1
5444610|NCT02230670|18808774|P2|Overall Study|Progression to Child-Pugh C|2
5444611|NCT02230670|18808775|P1|Overall Study|Progression to Child-Pugh C|1
5444612|NCT02230670|18808774|P2|Overall Study|Protocol Violation|1
5444613|NCT02230670|18808775|P1|Overall Study|Protocol Violation|0
5444614|NCT02230670|18808774|P2|Overall Study|Physician Decision|1
5444615|NCT02230670|18808775|P1|Overall Study|Physician Decision|0
5444616|NCT02230670|18808774|P2|Overall Study|Withdrawal by Subject|2
5444617|NCT02230670|18808775|P1|Overall Study|Withdrawal by Subject|2
5444618|NCT02230670|18808774|P2|Overall Study|Adverse Event|2
5444619|NCT02230670|18808775|P1|Overall Study|Adverse Event|1
5444620|NCT02230384|18808861|P2|Phase 2 - Switch|Adverse Event|0
5444621|NCT02230384|18808862|P1|Phase 2 - Switch|Adverse Event|2
5444622|NCT02230384|18808861|P2|Phase 2 - Switch|Lost to Follow-up|0
5444623|NCT02230384|18808862|P1|Phase 2 - Switch|Lost to Follow-up|1
5444624|NCT02230384|18808861|P2|Phase 2 - Switch|Withdrawal by Subject|1
5444625|NCT02230384|18808862|P1|Phase 2 - Switch|Withdrawal by Subject|0
5444626|NCT02230384|18808861|P2|Phase 1|Physician Decision|1
5444627|NCT02230384|18808862|P1|Phase 1|Physician Decision|0
5444628|NCT02230384|18808861|P2|Phase 1|Lost to Follow-up|0
5444629|NCT02230384|18808862|P1|Phase 1|Lost to Follow-up|1
5444630|NCT02230332|18808882|P2|Overall Study|Protocol Violation|0
5444631|NCT02230332|18808883|P1|Overall Study|Protocol Violation|1
5444632|NCT02230332|18808882|P2|Overall Study|Lost to Follow-up|0
5444633|NCT02230332|18808883|P1|Overall Study|Lost to Follow-up|1
5444634|NCT02230332|18808882|P2|Overall Study|Adverse Event|1
5444635|NCT02230332|18808883|P1|Overall Study|Adverse Event|2
5444636|NCT02230306|18808899|P1|Overall Study|Did not receive study treatment|1
5444637|NCT02230085|18808910|P1|Overall Study|Withdrawal by Subject|3
5444638|NCT02230085|18808910|P1|Overall Study|Physician Decision|1
5444639|NCT02229864|18808914|P1|Overall Study|Lost to Follow-up|1
5444640|NCT02229864|18808914|P1|Overall Study|Death|2
5444641|NCT02229851|18808938|P7|Extension Phase (Open-label Phase)|Death|1
5444642|NCT02229851|18808939|P6|Extension Phase (Open-label Phase)|Death|1
5444643|NCT02229851|18808940|P5|Extension Phase (Open-label Phase)|Death|0
5444644|NCT02229851|18808941|P4|Extension Phase (Open-label Phase)|Death|1
5444645|NCT02229851|18808942|P3|Extension Phase (Open-label Phase)|Death|0
5444646|NCT02229851|18808943|P2|Extension Phase (Open-label Phase)|Death|0
5444647|NCT02229851|18808944|P1|Extension Phase (Open-label Phase)|Death|0
5444648|NCT02229851|18808938|P7|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
5444649|NCT02229851|18808939|P6|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
5444650|NCT02229851|18808940|P5|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
5444651|NCT02229851|18808941|P4|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
5444652|NCT02229851|18808942|P3|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
5444653|NCT02229851|18808943|P2|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
5444654|NCT02229851|18808944|P1|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
5444655|NCT02229851|18808938|P7|Extension Phase (Open-label Phase)|Lost to Follow-up|1
5444656|NCT02229851|18808939|P6|Extension Phase (Open-label Phase)|Lost to Follow-up|1
5444657|NCT02229851|18808940|P5|Extension Phase (Open-label Phase)|Lost to Follow-up|1
5444658|NCT02229851|18808941|P4|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5444659|NCT02229851|18808942|P3|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5444660|NCT02229851|18808943|P2|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5444661|NCT02229851|18808944|P1|Extension Phase (Open-label Phase)|Lost to Follow-up|0
5444662|NCT02229851|18808938|P7|Main Phase (Double-blind Phase)|Death|0
5444663|NCT02229851|18808939|P6|Main Phase (Double-blind Phase)|Death|0
5444664|NCT02229851|18808940|P5|Main Phase (Double-blind Phase)|Death|0
5444665|NCT02229851|18808941|P4|Main Phase (Double-blind Phase)|Death|0
5444666|NCT02229851|18808942|P3|Main Phase (Double-blind Phase)|Death|0
5444667|NCT02229851|18808943|P2|Main Phase (Double-blind Phase)|Death|1
5444668|NCT02229851|18808944|P1|Main Phase (Double-blind Phase)|Death|1
5444669|NCT02229851|18808938|P7|Main Phase (Double-blind Phase)|Protocol Violation|0
5444670|NCT02229851|18808939|P6|Main Phase (Double-blind Phase)|Protocol Violation|0
5444671|NCT02229851|18808940|P5|Main Phase (Double-blind Phase)|Protocol Violation|0
5444672|NCT02229851|18808941|P4|Main Phase (Double-blind Phase)|Protocol Violation|0
5444673|NCT02229851|18808942|P3|Main Phase (Double-blind Phase)|Protocol Violation|2
5444674|NCT02229851|18808943|P2|Main Phase (Double-blind Phase)|Protocol Violation|0
5444675|NCT02229851|18808944|P1|Main Phase (Double-blind Phase)|Protocol Violation|0
5444676|NCT02229851|18808938|P7|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5444677|NCT02229851|18808939|P6|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5444678|NCT02229851|18808940|P5|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5444679|NCT02229851|18808941|P4|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
5444680|NCT02229851|18808942|P3|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
5444681|NCT02229851|18808943|P2|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
5444682|NCT02229851|18808944|P1|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
5444683|NCT02229851|18808938|P7|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5444684|NCT02229851|18808939|P6|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5444685|NCT02229851|18808940|P5|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5444686|NCT02229851|18808941|P4|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5444687|NCT02229851|18808942|P3|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5444688|NCT02229851|18808943|P2|Main Phase (Double-blind Phase)|Lost to Follow-up|1
5444689|NCT02229851|18808944|P1|Main Phase (Double-blind Phase)|Lost to Follow-up|0
5444690|NCT02229851|18808938|P7|Main Phase (Double-blind Phase)|Unclassified|0
5444691|NCT02229851|18808939|P6|Main Phase (Double-blind Phase)|Unclassified|0
5444692|NCT02229851|18808940|P5|Main Phase (Double-blind Phase)|Unclassified|0
5444693|NCT02229851|18808941|P4|Main Phase (Double-blind Phase)|Unclassified|0
5444694|NCT02229851|18808942|P3|Main Phase (Double-blind Phase)|Unclassified|0
5444695|NCT02229851|18808943|P2|Main Phase (Double-blind Phase)|Unclassified|2
5444696|NCT02229851|18808944|P1|Main Phase (Double-blind Phase)|Unclassified|1
5444697|NCT02229552|18809376|P1|2-Year Follow up|Lost to Follow-up|17
5444698|NCT02229552|18809376|P1|2-Year Follow up|Withdrawal by Subject|9
5444699|NCT02229552|18809376|P1|1-year Follow up|Lost to Follow-up|18
5444700|NCT02229552|18809376|P1|1-year Follow up|Withdrawal by Subject|7
5444701|NCT02229552|18809376|P1|Baseline|Withdrawal by Subject|6
5444702|NCT02229539|18809383|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
5444703|NCT02229539|18809384|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
5444704|NCT02229539|18809385|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
5444705|NCT02229539|18809383|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
5444706|NCT02229539|18809384|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
5444707|NCT02229539|18809385|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
5444708|NCT02229539|18809383|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
5444709|NCT02229539|18809384|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
5444710|NCT02229539|18809385|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
5444711|NCT02229539|18809383|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
5444712|NCT02229539|18809384|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
5444713|NCT02229539|18809385|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
5444714|NCT02229539|18809383|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
5444715|NCT02229539|18809384|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
5444716|NCT02229539|18809385|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
5444717|NCT02229539|18809383|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
5444718|NCT02229539|18809384|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
5444719|NCT02229539|18809385|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
5444720|NCT02229539|18809383|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
5444721|NCT02229539|18809384|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
5444722|NCT02229539|18809385|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
5444723|NCT02229539|18809383|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
5444724|NCT02229539|18809384|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
5444725|NCT02229539|18809385|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
5444726|NCT02229539|18809383|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
5444727|NCT02229539|18809384|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
5444728|NCT02229539|18809385|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
5444729|NCT02229396|18809516|P3|Overall Study|Withdrew; No Record on Termination Page|1
5444730|NCT02229396|18809517|P2|Overall Study|Withdrew; No Record on Termination Page|0
5444731|NCT02229396|18809518|P1|Overall Study|Withdrew; No Record on Termination Page|2
5444732|NCT02229396|18809516|P3|Overall Study|Study-Specific Withdrawal Criteria|3
5444733|NCT02229396|18809517|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5444734|NCT02229396|18809518|P1|Overall Study|Study-Specific Withdrawal Criteria|0
5444735|NCT02229396|18809516|P3|Overall Study|Withdrawal by Subject|41
5444736|NCT02229396|18809517|P2|Overall Study|Withdrawal by Subject|28
5444737|NCT02229396|18809518|P1|Overall Study|Withdrawal by Subject|42
5444738|NCT02229396|18809516|P3|Overall Study|Other|15
5444739|NCT02229396|18809517|P2|Overall Study|Other|18
5444740|NCT02229396|18809518|P1|Overall Study|Other|10
5444741|NCT02229396|18809516|P3|Overall Study|Patient Incorrectly Randomized|1
5444742|NCT02229396|18809517|P2|Overall Study|Patient Incorrectly Randomized|0
5444743|NCT02229396|18809518|P1|Overall Study|Patient Incorrectly Randomized|0
5444744|NCT02229396|18809516|P3|Overall Study|Protocol Violation|0
5444745|NCT02229396|18809517|P2|Overall Study|Protocol Violation|1
5444746|NCT02229396|18809518|P1|Overall Study|Protocol Violation|2
5444747|NCT02229396|18809516|P3|Overall Study|Lost to Follow-up|21
5444748|NCT02229396|18809517|P2|Overall Study|Lost to Follow-up|14
5444749|NCT02229396|18809518|P1|Overall Study|Lost to Follow-up|14
5444750|NCT02229396|18809516|P3|Overall Study|Death|1
5444751|NCT02229396|18809517|P2|Overall Study|Death|3
5444752|NCT02229396|18809518|P1|Overall Study|Death|2
5444753|NCT02229396|18809516|P3|Overall Study|Adverse Event|12
5444754|NCT02229396|18809517|P2|Overall Study|Adverse Event|12
5444755|NCT02229396|18809518|P1|Overall Study|Adverse Event|6
5444756|NCT02229383|18809549|P2|Overall Study|Other|8
5444757|NCT02229383|18809550|P1|Overall Study|Other|3
5444758|NCT02229383|18809549|P2|Overall Study|Did not receive treatment|0
5444759|NCT02229383|18809550|P1|Overall Study|Did not receive treatment|1
5444760|NCT02229383|18809549|P2|Overall Study|Withdrawal by Subject|6
5444761|NCT02229383|18809550|P1|Overall Study|Withdrawal by Subject|4
5444762|NCT02229383|18809549|P2|Overall Study|Lost to Follow-up|3
5444763|NCT02229383|18809550|P1|Overall Study|Lost to Follow-up|5
5444764|NCT02229383|18809549|P2|Overall Study|Death|1
5444765|NCT02229383|18809550|P1|Overall Study|Death|0
5444766|NCT02229383|18809549|P2|Overall Study|Adverse Event|4
5444767|NCT02229383|18809550|P1|Overall Study|Adverse Event|7
5444768|NCT02229227|18809575|P2|Overall Study|Physician Decision|12
5444769|NCT02229227|18809576|P1|Overall Study|Physician Decision|5
5444770|NCT02229227|18809575|P2|Overall Study|Other|1
5444771|NCT02229227|18809576|P1|Overall Study|Other|0
5444772|NCT02229227|18809575|P2|Overall Study|Withdrawal by Subject|12
5444773|NCT02229227|18809576|P1|Overall Study|Withdrawal by Subject|8
5444774|NCT02229227|18809575|P2|Overall Study|Study terminated by sponsor|11
5444775|NCT02229227|18809576|P1|Overall Study|Study terminated by sponsor|11
5444776|NCT02229227|18809575|P2|Overall Study|Lost to Follow-up|3
5444777|NCT02229227|18809576|P1|Overall Study|Lost to Follow-up|3
5444778|NCT02229227|18809575|P2|Overall Study|Protocol defined stopping criteria|3
5444779|NCT02229227|18809576|P1|Overall Study|Protocol defined stopping criteria|1
5444780|NCT02229227|18809575|P2|Overall Study|Protocol Violation|8
5444781|NCT02229227|18809576|P1|Overall Study|Protocol Violation|6
5444782|NCT02229227|18809575|P2|Overall Study|Lack of Efficacy|3
5444783|NCT02229227|18809576|P1|Overall Study|Lack of Efficacy|3
5444784|NCT02229227|18809575|P2|Overall Study|Adverse Event|9
5444785|NCT02229227|18809576|P1|Overall Study|Adverse Event|14
5444786|NCT02229214|18809661|P2|Overall Study|Withdrawal by Subject|0
5444787|NCT02229214|18809662|P1|Overall Study|Withdrawal by Subject|4
5444788|NCT02229214|18809661|P2|Overall Study|Adverse Event|0
5444789|NCT02229214|18809662|P1|Overall Study|Adverse Event|2
5444790|NCT02228980|18809686|P4|Overall Study|Withdrawal by Subject|3
5444791|NCT02228980|18809687|P3|Overall Study|Withdrawal by Subject|2
5444792|NCT02228980|18809688|P2|Overall Study|Withdrawal by Subject|3
5444793|NCT02228980|18809689|P1|Overall Study|Withdrawal by Subject|3
5444794|NCT02228980|18809686|P4|Overall Study|Protocol Violation|0
5444795|NCT02228980|18809687|P3|Overall Study|Protocol Violation|0
5444796|NCT02228980|18809688|P2|Overall Study|Protocol Violation|0
5444797|NCT02228980|18809689|P1|Overall Study|Protocol Violation|7
5444798|NCT02228980|18809686|P4|Overall Study|Adverse Event|0
5444799|NCT02228980|18809687|P3|Overall Study|Adverse Event|0
5444800|NCT02228980|18809688|P2|Overall Study|Adverse Event|0
5444801|NCT02228980|18809689|P1|Overall Study|Adverse Event|14
5444802|NCT02228967|18809713|P2|Overall Study|Withdrawal by Subject|18
5444803|NCT02228967|18809714|P1|Overall Study|Withdrawal by Subject|13
5444804|NCT02228967|18809713|P2|Overall Study|Lost to Follow-up|142
5444805|NCT02228967|18809714|P1|Overall Study|Lost to Follow-up|146
5444806|NCT02228720|18809775|P1|Open Label - Day 30|Lost to Follow-up|1
5444807|NCT02228590|18809798|P1|Overall Study|Withdrawal by Subject|1
5444808|NCT02228564|18809811|P1|Overall Study|Other|6
5444809|NCT02228564|18809811|P1|Overall Study|Lost to Follow-up|17
5444810|NCT02228564|18809811|P1|Overall Study|Physician Decision|5
5444811|NCT02228564|18809811|P1|Overall Study|Death|11
5444812|NCT02228564|18809811|P1|Overall Study|Withdrawal by Subject|10
5444813|NCT02228460|18809835|P1|Overall Study|Lost to Follow-up|1
5444814|NCT02228460|18809835|P1|Overall Study|Adverse Event|1
5444815|NCT02228395|18809858|P3|First Intervention Period|Unable to comply with study dates|1
5444816|NCT02228395|18809859|P2|First Intervention Period|Unable to comply with study dates|1
5444817|NCT02228395|18809860|P1|First Intervention Period|Unable to comply with study dates|0
5444818|NCT02228395|18809858|P3|First Intervention Period|No longer willing to participate|0
5444819|NCT02228395|18809859|P2|First Intervention Period|No longer willing to participate|0
5444820|NCT02228395|18809860|P1|First Intervention Period|No longer willing to participate|1
5444821|NCT02228096|18809946|P1|Overall Study|Enrolled, not infused|11
5444822|NCT02228096|18809946|P1|Overall Study|New therapy for study indication|1
5444823|NCT02228096|18809946|P1|Overall Study|Subject/guardian decision|2
5444824|NCT02228096|18809946|P1|Overall Study|Physician Decision|3
5444825|NCT02228096|18809946|P1|Overall Study|Death|12
5444826|NCT02228096|18809946|P1|Overall Study|Lack of Efficacy|18
5444827|NCT02228096|18809946|P1|Overall Study|Study terminated by Sponsor|24
5444828|NCT02227875|18810048|P2|Overall Study|Lost to Follow-up|10
5444829|NCT02227875|18810049|P1|Overall Study|Lost to Follow-up|10
5444830|NCT02227875|18810048|P2|Overall Study|Withdrawal by Subject|13
5444831|NCT02227875|18810049|P1|Overall Study|Withdrawal by Subject|12
5444832|NCT02227875|18810048|P2|Overall Study|Adverse Event|0
5444833|NCT02227875|18810049|P1|Overall Study|Adverse Event|3
5444834|NCT02227875|18810048|P2|Overall Study|Physician Decision|0
5444835|NCT02227875|18810049|P1|Overall Study|Physician Decision|1
5444836|NCT02227875|18810048|P2|Overall Study|Other|3
5444837|NCT02227875|18810049|P1|Overall Study|Other|1
5444838|NCT02227875|18810048|P2|Overall Study|Protocol Violation|7
5444839|NCT02227875|18810049|P1|Overall Study|Protocol Violation|10
5444840|NCT02227862|18810069|P2|Overall Study|Lost to Follow-up|2
5444841|NCT02227862|18810070|P1|Overall Study|Lost to Follow-up|1
5444842|NCT02227862|18810069|P2|Overall Study|Withdrawal by Subject|6
5444843|NCT02227862|18810070|P1|Overall Study|Withdrawal by Subject|7
5444844|NCT02227862|18810069|P2|Overall Study|Adverse Event|3
5444845|NCT02227862|18810070|P1|Overall Study|Adverse Event|4
5444846|NCT02227862|18810069|P2|Overall Study|Other|2
5444847|NCT02227862|18810070|P1|Overall Study|Other|0
5444848|NCT02227862|18810069|P2|Overall Study|Protocol Violation|9
5444849|NCT02227862|18810070|P1|Overall Study|Protocol Violation|7
5444850|NCT02227849|18810100|P1|Overall Study|Withdrawal by Subject|3
5444851|NCT02227849|18810100|P1|Overall Study|Physician Decision|1
5444852|NCT02227849|18810100|P1|Overall Study|Adverse Event|4
5444853|NCT02227784|18810131|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
5444854|NCT02227784|18810132|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5444855|NCT02227784|18810133|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5444856|NCT02227784|18810134|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5444857|NCT02227784|18810135|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
5444858|NCT02227784|18810131|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
5444859|NCT02227784|18810132|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5444860|NCT02227784|18810133|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5444861|NCT02227784|18810134|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5444862|NCT02227784|18810135|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5444863|NCT02227784|18810131|P5|Open-Label Extension Phase (OLE)|Death|1
5444864|NCT02227784|18810132|P4|Open-Label Extension Phase (OLE)|Death|0
5444865|NCT02227784|18810133|P3|Open-Label Extension Phase (OLE)|Death|0
5444866|NCT02227784|18810134|P2|Open-Label Extension Phase (OLE)|Death|0
5444867|NCT02227784|18810135|P1|Open-Label Extension Phase (OLE)|Death|0
5444868|NCT02227784|18810131|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
5444869|NCT02227784|18810132|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
5444870|NCT02227784|18810133|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
5444871|NCT02227784|18810134|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
5444872|NCT02227784|18810135|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
5444873|NCT02227784|18810131|P5|Double-Blind Phase|Withdrawal by Subject|0
5444874|NCT02227784|18810132|P4|Double-Blind Phase|Withdrawal by Subject|2
5444875|NCT02227784|18810133|P3|Double-Blind Phase|Withdrawal by Subject|5
5444876|NCT02227784|18810134|P2|Double-Blind Phase|Withdrawal by Subject|1
5444877|NCT02227784|18810135|P1|Double-Blind Phase|Withdrawal by Subject|2
5444878|NCT02227784|18810131|P5|Double-Blind Phase|Sponsor Decision|0
5444879|NCT02227784|18810132|P4|Double-Blind Phase|Sponsor Decision|32
5444880|NCT02227784|18810133|P3|Double-Blind Phase|Sponsor Decision|14
5444881|NCT02227784|18810134|P2|Double-Blind Phase|Sponsor Decision|15
5444882|NCT02227784|18810135|P1|Double-Blind Phase|Sponsor Decision|34
5444883|NCT02227784|18810131|P5|Double-Blind Phase|Protocol Violation|0
5444884|NCT02227784|18810132|P4|Double-Blind Phase|Protocol Violation|1
5444885|NCT02227784|18810133|P3|Double-Blind Phase|Protocol Violation|1
5444886|NCT02227784|18810134|P2|Double-Blind Phase|Protocol Violation|0
5444887|NCT02227784|18810135|P1|Double-Blind Phase|Protocol Violation|0
5444888|NCT02227784|18810131|P5|Double-Blind Phase|Physician Decision|0
5444889|NCT02227784|18810132|P4|Double-Blind Phase|Physician Decision|1
5444890|NCT02227784|18810133|P3|Double-Blind Phase|Physician Decision|0
5444891|NCT02227784|18810134|P2|Double-Blind Phase|Physician Decision|0
5444892|NCT02227784|18810135|P1|Double-Blind Phase|Physician Decision|1
5444893|NCT02227784|18810131|P5|Double-Blind Phase|Adverse Event|0
5444894|NCT02227784|18810132|P4|Double-Blind Phase|Adverse Event|3
5444895|NCT02227784|18810133|P3|Double-Blind Phase|Adverse Event|1
5444896|NCT02227784|18810134|P2|Double-Blind Phase|Adverse Event|2
5444897|NCT02227784|18810135|P1|Double-Blind Phase|Adverse Event|3
5444898|NCT02227368|18810309|P2|Overall Study|Adverse Event|0
5444899|NCT02227368|18810310|P1|Overall Study|Adverse Event|1
5444900|NCT02227368|18810309|P2|Overall Study|Lost to Follow-up|0
5444901|NCT02227368|18810310|P1|Overall Study|Lost to Follow-up|1
5444902|NCT02227368|18810309|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
5444903|NCT02227368|18810310|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
5444904|NCT02227238|18810366|P2|Overall Study|Lost to Follow-up|5
5444905|NCT02227238|18810367|P1|Overall Study|Lost to Follow-up|7
5444906|NCT02227238|18810366|P2|Overall Study|Physician Decision|9
5444907|NCT02227238|18810367|P1|Overall Study|Physician Decision|0
5444908|NCT02227238|18810366|P2|Overall Study|Withdrawal by Subject|4
5444909|NCT02227238|18810367|P1|Overall Study|Withdrawal by Subject|5
5444910|NCT02227238|18810366|P2|Overall Study|Protocol Violation|8
5444911|NCT02227238|18810367|P1|Overall Study|Protocol Violation|7
5444912|NCT02227238|18810366|P2|Overall Study|Lack of Efficacy|22
5444913|NCT02227238|18810367|P1|Overall Study|Lack of Efficacy|10
5444914|NCT02227238|18810366|P2|Overall Study|Adverse Event|18
5444915|NCT02227238|18810367|P1|Overall Study|Adverse Event|8
5444916|NCT02227238|18810366|P2|Overall Study|Other: Reached stopping criteria|1
5444917|NCT02227238|18810367|P1|Overall Study|Other: Reached stopping criteria|0
5444918|NCT02227147|18810433|P2|Follow-up Period|Other|5
5444919|NCT02227147|18810434|P1|Follow-up Period|Other|3
5444920|NCT02227147|18810433|P2|Controlled Treatment Period|Other|0
5444921|NCT02227147|18810434|P1|Controlled Treatment Period|Other|2
5444922|NCT02227147|18810433|P2|Controlled Treatment Period|Adverse Event|3
5444923|NCT02227147|18810434|P1|Controlled Treatment Period|Adverse Event|4
5444924|NCT02227108|18810461|P1|Overall Study|Adverse Event|6
5444925|NCT02227108|18810461|P1|Overall Study|Investigator discretion|1
5444926|NCT02227108|18810461|P1|Overall Study|Initiation of alternative therapy|2
5444927|NCT02227108|18810461|P1|Overall Study|Progressive disease|17
5444928|NCT02227108|18810461|P1|Overall Study|Other|3
5444929|NCT02227108|18810461|P1|Overall Study|Did not receive treatment|2
5444930|NCT02226653|18810500|P2|Treatment Period 5 Fed State|Adverse Event|1
5444931|NCT02226653|18810501|P1|Treatment Period 5 Fed State|Adverse Event|0
5444932|NCT02226653|18810500|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
5444933|NCT02226653|18810501|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
5444934|NCT02226562|18810525|P2|Overall Study|Lost to Follow-up|1
5444935|NCT02226562|18810526|P1|Overall Study|Lost to Follow-up|0
5444936|NCT02226549|18810544|P2|Overall Study|Lost to Follow-up|1
5444937|NCT02226549|18810545|P1|Overall Study|Lost to Follow-up|0
5444938|NCT02226549|18810544|P2|Overall Study|Randomized but Never Treated|0
5444939|NCT02226549|18810545|P1|Overall Study|Randomized but Never Treated|1
5444940|NCT02226198|18810555|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
5444941|NCT02226198|18810556|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
5444942|NCT02226198|18810557|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
5444943|NCT02226198|18810555|P3|Lead-in Phase|Protocol Violation|0
5444944|NCT02226198|18810556|P2|Lead-in Phase|Protocol Violation|0
5444945|NCT02226198|18810557|P1|Lead-in Phase|Protocol Violation|1
5444946|NCT02226172|18810630|P1|Overall Study|Adverse Event|6
5444947|NCT02226172|18810630|P1|Overall Study|Study terminated by sponsor|1
5444948|NCT02226172|18810630|P1|Overall Study|Death|1
5444949|NCT02226172|18810630|P1|Overall Study|Other|5
5444950|NCT02226172|18810630|P1|Overall Study|Participant refused further follow-up|4
5444951|NCT02226120|18810694|P1|Overall Study|missing treatment disposition pages|2
5444952|NCT02226120|18810694|P1|Overall Study|Protocol deviation|1
5444953|NCT02226120|18810694|P1|Overall Study|Non-compliance with study drug|10
5444954|NCT02226120|18810694|P1|Overall Study|Withdrawal by parent/guardian|36
5444955|NCT02226120|18810694|P1|Overall Study|Physician Decision|21
5444956|NCT02226120|18810694|P1|Overall Study|Lost to Follow-up|13
5444957|NCT02226120|18810694|P1|Overall Study|Technical problems|4
5444958|NCT02226120|18810694|P1|Overall Study|Study terminated by sponsor|1
5444959|NCT02226120|18810694|P1|Overall Study|Death|172
5444960|NCT02226120|18810694|P1|Overall Study|Adverse Event|60
5444961|NCT02226003|18810701|P3|Overall Study|Withdrawal by Subject|3
5444962|NCT02226003|18810702|P2|Overall Study|Withdrawal by Subject|0
5444963|NCT02226003|18810703|P1|Overall Study|Withdrawal by Subject|0
5444964|NCT02226003|18810701|P3|Overall Study|Lost to Follow-up|3
5444965|NCT02226003|18810702|P2|Overall Study|Lost to Follow-up|1
5444966|NCT02226003|18810703|P1|Overall Study|Lost to Follow-up|2
5444967|NCT02225743|18810759|P1|Overall Study|Withdrawal by Subject|18
5444968|NCT02225587|18810765|P2|Overall Study|Withdrawal by Subject|28
5444969|NCT02225587|18810766|P1|Overall Study|Withdrawal by Subject|13
5444970|NCT02225587|18810765|P2|Overall Study|Participant Moved|0
5444971|NCT02225587|18810766|P1|Overall Study|Participant Moved|1
5444972|NCT02225587|18810765|P2|Overall Study|Protocol Violation|0
5444973|NCT02225587|18810766|P1|Overall Study|Protocol Violation|1
5444974|NCT02225587|18810765|P2|Overall Study|Physician Decision|0
5444975|NCT02225587|18810766|P1|Overall Study|Physician Decision|2
5444976|NCT02225587|18810765|P2|Overall Study|Non-Compliance With Study Drug|0
5444977|NCT02225587|18810766|P1|Overall Study|Non-Compliance With Study Drug|1
5444978|NCT02225587|18810765|P2|Overall Study|Lost to Follow-up|5
5444979|NCT02225587|18810766|P1|Overall Study|Lost to Follow-up|5
5444980|NCT02225587|18810765|P2|Overall Study|Adverse Event|5
5444981|NCT02225587|18810766|P1|Overall Study|Adverse Event|5
5444982|NCT02225353|18810795|P3|Overall Study|Protocol Violation|12
5444983|NCT02225353|18810796|P2|Overall Study|Protocol Violation|5
5444984|NCT02225353|18810797|P1|Overall Study|Protocol Violation|4
5444985|NCT02225353|18810795|P3|Overall Study|Lost to Follow-up|3
5444986|NCT02225353|18810796|P2|Overall Study|Lost to Follow-up|1
5444987|NCT02225353|18810797|P1|Overall Study|Lost to Follow-up|0
5444988|NCT02224846|18810838|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
5444989|NCT02224846|18810839|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
5444990|NCT02224846|18810838|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
5444991|NCT02224846|18810839|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
5444992|NCT02224846|18810838|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
5444993|NCT02224846|18810839|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
5444994|NCT02224846|18810838|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
5444995|NCT02224846|18810839|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
5444996|NCT02224846|18810838|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
5444997|NCT02224846|18810839|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
5444998|NCT02224846|18810838|P2|Period 2 (Month 12 to Month 24)|Death|0
5444999|NCT02224846|18810839|P1|Period 2 (Month 12 to Month 24)|Death|1
5445000|NCT02224846|18810838|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
5445001|NCT02224846|18810839|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
5445002|NCT02224846|18810838|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
5445003|NCT02224846|18810839|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
5445004|NCT02224846|18810838|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
5445005|NCT02224846|18810839|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
5445006|NCT02224846|18810838|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
5445007|NCT02224846|18810839|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
5445008|NCT02224846|18810838|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
5445009|NCT02224846|18810839|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
5445010|NCT02224846|18810838|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
5445011|NCT02224846|18810839|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
5445012|NCT02224846|18810838|P2|Period 1 (Month 3)|Sponsor Decision|1
5445013|NCT02224846|18810839|P1|Period 1 (Month 3)|Sponsor Decision|2
5445014|NCT02224846|18810838|P2|Period 1 (Month 3)|Withdrawal by Subject|18
5445015|NCT02224846|18810839|P1|Period 1 (Month 3)|Withdrawal by Subject|8
5445016|NCT02224846|18810838|P2|Period 1 (Month 3)|Protocol Violation|8
5445017|NCT02224846|18810839|P1|Period 1 (Month 3)|Protocol Violation|4
5445018|NCT02224846|18810838|P2|Period 1 (Month 3)|Lost to Follow-up|8
5445019|NCT02224846|18810839|P1|Period 1 (Month 3)|Lost to Follow-up|3
5445020|NCT02224846|18810838|P2|Period 1 (Month 3)|Adverse Event|1
5445021|NCT02224846|18810839|P1|Period 1 (Month 3)|Adverse Event|2
5445022|NCT02224755|18810869|P2|Two Year Follow up Post-implant|Withdrawn post-implant|6
5445023|NCT02224755|18810870|P1|Two Year Follow up Post-implant|Withdrawn post-implant|15
5445024|NCT02224755|18810869|P2|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
5445025|NCT02224755|18810870|P1|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
5445026|NCT02224755|18810869|P2|Two Year Follow up Post-implant|Heart transplant|119
5445027|NCT02224755|18810870|P1|Two Year Follow up Post-implant|Heart transplant|137
5445028|NCT02224755|18810869|P2|Two Year Follow up Post-implant|Death|98
5445029|NCT02224755|18810870|P1|Two Year Follow up Post-implant|Death|103
5445030|NCT02224755|18810869|P2|Randomization to Device Implant|Withdrawn prior to implant|1
5445031|NCT02224755|18810870|P1|Randomization to Device Implant|Withdrawn prior to implant|7
5445032|NCT02224703|18810905|P3|Overall Study|Lack of Efficacy|0
5445033|NCT02224703|18810906|P2|Overall Study|Lack of Efficacy|0
5445034|NCT02224703|18810907|P1|Overall Study|Lack of Efficacy|1
5445035|NCT02224703|18810905|P3|Overall Study|Withdrawn by parent/guardian|0
5445036|NCT02224703|18810906|P2|Overall Study|Withdrawn by parent/guardian|1
5445037|NCT02224703|18810907|P1|Overall Study|Withdrawn by parent/guardian|0
5445038|NCT02224703|18810905|P3|Overall Study|Advised by medical monitor|0
5445039|NCT02224703|18810906|P2|Overall Study|Advised by medical monitor|0
5445040|NCT02224703|18810907|P1|Overall Study|Advised by medical monitor|1
5445041|NCT02224703|18810905|P3|Overall Study|Withdrawn by investigator|0
5445042|NCT02224703|18810906|P2|Overall Study|Withdrawn by investigator|0
5445043|NCT02224703|18810907|P1|Overall Study|Withdrawn by investigator|1
5445044|NCT02224703|18810905|P3|Overall Study|Adverse Event|0
5445045|NCT02224703|18810906|P2|Overall Study|Adverse Event|5
5445046|NCT02224703|18810907|P1|Overall Study|Adverse Event|0
5445047|NCT02224690|18810926|P2|Overall Study|Did not meet eligibility criteria|0
5445048|NCT02224690|18810927|P1|Overall Study|Did not meet eligibility criteria|1
5445049|NCT02224690|18810926|P2|Overall Study|Use of G-tube|0
5445050|NCT02224690|18810927|P1|Overall Study|Use of G-tube|1
5445051|NCT02224690|18810926|P2|Overall Study|Met Withdrawal Criteria|0
5445052|NCT02224690|18810927|P1|Overall Study|Met Withdrawal Criteria|4
5445053|NCT02224690|18810926|P2|Overall Study|Adverse Event|1
5445054|NCT02224690|18810927|P1|Overall Study|Adverse Event|8
5445055|NCT02224664|18810939|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
5445056|NCT02224664|18810940|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
5445057|NCT02224664|18810941|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
5445058|NCT02224664|18810942|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
5445059|NCT02224664|18810943|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
5445060|NCT02224664|18810939|P5|Dose Escalation Period (21 Days)|Adverse Event|7
5445061|NCT02224664|18810940|P4|Dose Escalation Period (21 Days)|Adverse Event|2
5445062|NCT02224664|18810941|P3|Dose Escalation Period (21 Days)|Adverse Event|2
5445063|NCT02224664|18810942|P2|Dose Escalation Period (21 Days)|Adverse Event|0
5445064|NCT02224664|18810943|P1|Dose Escalation Period (21 Days)|Adverse Event|0
5445065|NCT02224664|18810939|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5445066|NCT02224664|18810940|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5445067|NCT02224664|18810941|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5445068|NCT02224664|18810942|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
5445069|NCT02224664|18810943|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
5445070|NCT02224638|18811025|P2|Overall Study|Adverse Event|1
5445071|NCT02224638|18811026|P1|Overall Study|Adverse Event|1
5445072|NCT02224625|18811034|P1|Sensitization|Adverse Event|55
5445073|NCT02224625|18811034|P1|Irritation|Adverse Event|6
5445074|NCT02224599|18811055|P1|Overall Study|Progression of Disease|1
5445075|NCT02224599|18811055|P1|Overall Study|Physician Decision|1
5445076|NCT02224560|18811064|P3|Overall Study|Withdrawn by Investigator|0
5445077|NCT02224560|18811065|P2|Overall Study|Withdrawn by Investigator|1
5445078|NCT02224560|18811066|P1|Overall Study|Withdrawn by Investigator|1
5445079|NCT02224560|18811064|P3|Overall Study|Adverse Event|1
5445080|NCT02224560|18811065|P2|Overall Study|Adverse Event|1
5445081|NCT02224560|18811066|P1|Overall Study|Adverse Event|4
5445082|NCT02224560|18811064|P3|Overall Study|Met Withdrawal Criteria|0
5445083|NCT02224560|18811065|P2|Overall Study|Met Withdrawal Criteria|0
5445084|NCT02224560|18811066|P1|Overall Study|Met Withdrawal Criteria|1
5445085|NCT02224560|18811064|P3|Overall Study|Withdrawal by Subject|1
5445086|NCT02224560|18811065|P2|Overall Study|Withdrawal by Subject|0
5445087|NCT02224560|18811066|P1|Overall Study|Withdrawal by Subject|2
5445088|NCT02224560|18811064|P3|Overall Study|Protocol Deviation|0
5445089|NCT02224560|18811065|P2|Overall Study|Protocol Deviation|0
5445090|NCT02224560|18811066|P1|Overall Study|Protocol Deviation|1
5445091|NCT02224274|18811114|P2|Overall Study|Death|0
5445092|NCT02224274|18811115|P1|Overall Study|Death|1
5445093|NCT02224157|18811127|P2|Overall Study|Adverse Event|3
5445094|NCT02224157|18811128|P1|Overall Study|Adverse Event|1
5445095|NCT02224157|18811127|P2|Overall Study|Death|1
5445096|NCT02224157|18811128|P1|Overall Study|Death|1
5445097|NCT02224157|18811127|P2|Overall Study|Lost to Follow-up|35
5445098|NCT02224157|18811128|P1|Overall Study|Lost to Follow-up|27
5445099|NCT02224157|18811127|P2|Overall Study|Eligibility criteria not fulfilled|8
5445100|NCT02224157|18811128|P1|Overall Study|Eligibility criteria not fulfilled|4
5445101|NCT02224157|18811127|P2|Overall Study|Prematurely closed site|2
5445102|NCT02224157|18811128|P1|Overall Study|Prematurely closed site|4
5445103|NCT02224157|18811127|P2|Overall Study|Subject decision|50
5445104|NCT02224157|18811128|P1|Overall Study|Subject decision|58
5445105|NCT02224157|18811127|P2|Overall Study|Other|10
5445106|NCT02224157|18811128|P1|Overall Study|Other|13
5445107|NCT02224157|18811127|P2|Overall Study|Severe non-compliance to protocol|2
5445108|NCT02224157|18811128|P1|Overall Study|Severe non-compliance to protocol|2
5445109|NCT02224053|18811152|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
5445110|NCT02224053|18811152|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
5445111|NCT02224053|18811152|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
5445112|NCT02224053|18811152|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
5445113|NCT02224053|18811152|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
5445114|NCT02223858|18811198|P2|Overall Study|Refused|9
5445115|NCT02223858|18811199|P1|Overall Study|Refused|9
5445116|NCT02223858|18811198|P2|Overall Study|Withdrawal by Subject|5
5445117|NCT02223858|18811199|P1|Overall Study|Withdrawal by Subject|8
5445118|NCT02223858|18811198|P2|Overall Study|Lost to Follow-up|11
5445119|NCT02223858|18811199|P1|Overall Study|Lost to Follow-up|6
5445120|NCT02223858|18811198|P2|Overall Study|Death|1
5445121|NCT02223858|18811199|P1|Overall Study|Death|1
5445122|NCT02223793|18811212|P3|Overall Study|Moved/studycenter unable to participate|8
5445123|NCT02223793|18811213|P2|Overall Study|Moved/studycenter unable to participate|6
5445124|NCT02223793|18811214|P1|Overall Study|Moved/studycenter unable to participate|4
5445125|NCT02223793|18811212|P3|Overall Study|Withdrawal by Subject|3
5445126|NCT02223793|18811213|P2|Overall Study|Withdrawal by Subject|2
5445127|NCT02223793|18811214|P1|Overall Study|Withdrawal by Subject|3
5445128|NCT02223793|18811212|P3|Overall Study|Lost to Follow-up|2
5445129|NCT02223793|18811213|P2|Overall Study|Lost to Follow-up|1
5445130|NCT02223793|18811214|P1|Overall Study|Lost to Follow-up|10
5445131|NCT02223754|18811227|P2|Period 2|Test Article No Longer Available|1
5445132|NCT02223754|18811228|P1|Period 2|Test Article No Longer Available|0
5445133|NCT02223754|18811227|P2|Period 2|Lost to Follow-up|0
5445134|NCT02223754|18811228|P1|Period 2|Lost to Follow-up|1
5445135|NCT02223754|18811227|P2|Period 2|Lens Discomfort|1
5445136|NCT02223754|18811228|P1|Period 2|Lens Discomfort|1
5445137|NCT02223754|18811227|P2|Period 2|Protocol Violation|0
5445138|NCT02223754|18811228|P1|Period 2|Protocol Violation|1
5445139|NCT02223754|18811227|P2|Period 2|Adverse Event|1
5445140|NCT02223754|18811228|P1|Period 2|Adverse Event|0
5445141|NCT02223754|18811227|P2|Period 1|Unsatisfactory Visual Response|1
5445142|NCT02223754|18811228|P1|Period 1|Unsatisfactory Visual Response|0
5445143|NCT02223754|18811227|P2|Period 1|Test Article No Longer Available|5
5445144|NCT02223754|18811228|P1|Period 1|Test Article No Longer Available|1
5445145|NCT02223754|18811227|P2|Period 1|Withdrawal by Subject|4
5445146|NCT02223754|18811228|P1|Period 1|Withdrawal by Subject|0
5445147|NCT02223754|18811227|P2|Period 1|Protocol Violation|4
5445148|NCT02223754|18811228|P1|Period 1|Protocol Violation|2
5445149|NCT02223754|18811227|P2|Period 1|Lost to Follow-up|1
5445150|NCT02223754|18811228|P1|Period 1|Lost to Follow-up|0
5445151|NCT02223754|18811227|P2|Period 1|Adverse Event|0
5445152|NCT02223754|18811228|P1|Period 1|Adverse Event|1
5445153|NCT02223715|18811248|P1|Overall Study|Lost to Follow-up|73
5445154|NCT02223715|18811248|P1|Overall Study|Death|31
5445155|NCT02223390|18811391|P2|Overall Study|Lost to Follow-up|4
5445156|NCT02223390|18811392|P1|Overall Study|Lost to Follow-up|9
5445157|NCT02223364|18811403|P3|Overall Study|Physician Decision|0
5445158|NCT02223364|18811404|P2|Overall Study|Physician Decision|0
5445159|NCT02223364|18811405|P1|Overall Study|Physician Decision|1
5445160|NCT02223364|18811403|P3|Overall Study|subject expired before surgery|0
5445161|NCT02223364|18811404|P2|Overall Study|subject expired before surgery|0
5445162|NCT02223364|18811405|P1|Overall Study|subject expired before surgery|1
5445163|NCT02223364|18811403|P3|Overall Study|Protocol Violation|3
5445164|NCT02223364|18811404|P2|Overall Study|Protocol Violation|0
5445165|NCT02223364|18811405|P1|Overall Study|Protocol Violation|3
5445166|NCT02222922|18811571|P9|Overall Study|Participant refused further follow-up|3
5445167|NCT02222922|18811572|P8|Overall Study|Participant refused further follow-up|0
5445168|NCT02222922|18811573|P7|Overall Study|Participant refused further follow-up|0
5445169|NCT02222922|18811574|P6|Overall Study|Participant refused further follow-up|0
5445170|NCT02222922|18811575|P5|Overall Study|Participant refused further follow-up|6
5445171|NCT02222922|18811576|P4|Overall Study|Participant refused further follow-up|1
5445172|NCT02222922|18811577|P3|Overall Study|Participant refused further follow-up|0
5445173|NCT02222922|18811578|P2|Overall Study|Participant refused further follow-up|0
5445174|NCT02222922|18811579|P1|Overall Study|Participant refused further follow-up|1
5445175|NCT02222922|18811571|P9|Overall Study|Other|1
5445176|NCT02222922|18811572|P8|Overall Study|Other|4
5445177|NCT02222922|18811573|P7|Overall Study|Other|2
5445178|NCT02222922|18811574|P6|Overall Study|Other|2
5445179|NCT02222922|18811575|P5|Overall Study|Other|10
5445180|NCT02222922|18811576|P4|Overall Study|Other|2
5445181|NCT02222922|18811577|P3|Overall Study|Other|0
5445182|NCT02222922|18811578|P2|Overall Study|Other|0
5445183|NCT02222922|18811579|P1|Overall Study|Other|0
5445184|NCT02222922|18811571|P9|Overall Study|Lost to Follow-up|0
5445185|NCT02222922|18811572|P8|Overall Study|Lost to Follow-up|0
5445186|NCT02222922|18811573|P7|Overall Study|Lost to Follow-up|0
5445187|NCT02222922|18811574|P6|Overall Study|Lost to Follow-up|1
5445188|NCT02222922|18811575|P5|Overall Study|Lost to Follow-up|9
5445189|NCT02222922|18811576|P4|Overall Study|Lost to Follow-up|0
5445190|NCT02222922|18811577|P3|Overall Study|Lost to Follow-up|1
5445191|NCT02222922|18811578|P2|Overall Study|Lost to Follow-up|0
5445192|NCT02222922|18811579|P1|Overall Study|Lost to Follow-up|0
5445193|NCT02222922|18811571|P9|Overall Study|Death|2
5445194|NCT02222922|18811572|P8|Overall Study|Death|0
5445195|NCT02222922|18811573|P7|Overall Study|Death|0
5445196|NCT02222922|18811574|P6|Overall Study|Death|0
5445197|NCT02222922|18811575|P5|Overall Study|Death|13
5445198|NCT02222922|18811576|P4|Overall Study|Death|0
5445199|NCT02222922|18811577|P3|Overall Study|Death|0
5445200|NCT02222922|18811578|P2|Overall Study|Death|0
5445201|NCT02222922|18811579|P1|Overall Study|Death|0
5445202|NCT02222818|18811946|P2|Period 1|Eligibility criteria not met|3
5445203|NCT02222818|18811947|P1|Period 1|Eligibility criteria not met|0
5445204|NCT02222714|18811959|P5|Overall Study|Withdrawal by Subject|1
5445205|NCT02222714|18811960|P4|Overall Study|Withdrawal by Subject|0
5445206|NCT02222714|18811961|P3|Overall Study|Withdrawal by Subject|1
5445207|NCT02222714|18811962|P2|Overall Study|Withdrawal by Subject|0
5445208|NCT02222714|18811963|P1|Overall Study|Withdrawal by Subject|0
5445209|NCT02222714|18811959|P5|Overall Study|Death|6
5445210|NCT02222714|18811960|P4|Overall Study|Death|4
5445211|NCT02222714|18811961|P3|Overall Study|Death|3
5445212|NCT02222714|18811962|P2|Overall Study|Death|2
5445213|NCT02222714|18811963|P1|Overall Study|Death|0
5445214|NCT02222688|18812009|P7|Overall Study|Disease progression|0
5445215|NCT02222688|18812010|P6|Overall Study|Disease progression|0
5445216|NCT02222688|18812011|P5|Overall Study|Disease progression|0
5445217|NCT02222688|18812012|P4|Overall Study|Disease progression|0
5445218|NCT02222688|18812013|P3|Overall Study|Disease progression|0
5445219|NCT02222688|18812014|P2|Overall Study|Disease progression|0
5445220|NCT02222688|18812015|P1|Overall Study|Disease progression|1
5445221|NCT02222688|18812009|P7|Overall Study|Withdrawal by Subject|1
5445222|NCT02222688|18812010|P6|Overall Study|Withdrawal by Subject|0
5445223|NCT02222688|18812011|P5|Overall Study|Withdrawal by Subject|1
5445224|NCT02222688|18812012|P4|Overall Study|Withdrawal by Subject|2
5445225|NCT02222688|18812013|P3|Overall Study|Withdrawal by Subject|0
5445226|NCT02222688|18812014|P2|Overall Study|Withdrawal by Subject|0
5445227|NCT02222688|18812015|P1|Overall Study|Withdrawal by Subject|0
5445228|NCT02222558|18812053|P6|Period 3|Withdrawal by Subject|1
5445229|NCT02222558|18812054|P5|Period 3|Withdrawal by Subject|0
5445230|NCT02222558|18812055|P4|Period 3|Withdrawal by Subject|0
5445231|NCT02222558|18812056|P3|Period 3|Withdrawal by Subject|0
5445232|NCT02222558|18812057|P2|Period 3|Withdrawal by Subject|0
5445233|NCT02222558|18812058|P1|Period 3|Withdrawal by Subject|0
5445234|NCT02222558|18812053|P6|Period 1: Single Dose|Withdrawal by Subject|0
5445235|NCT02222558|18812054|P5|Period 1: Single Dose|Withdrawal by Subject|0
5445236|NCT02222558|18812055|P4|Period 1: Single Dose|Withdrawal by Subject|0
5445237|NCT02222558|18812056|P3|Period 1: Single Dose|Withdrawal by Subject|0
5445238|NCT02222558|18812057|P2|Period 1: Single Dose|Withdrawal by Subject|0
5445239|NCT02222558|18812058|P1|Period 1: Single Dose|Withdrawal by Subject|4
5445240|NCT02222493|18812074|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
5445241|NCT02222493|18812075|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
5445242|NCT02222493|18812074|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
5445243|NCT02222493|18812075|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
5445244|NCT02222493|18812074|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
5445245|NCT02222493|18812075|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
5445246|NCT02222493|18812074|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
5445247|NCT02222493|18812075|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
5445248|NCT02222493|18812074|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
5445249|NCT02222493|18812075|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
5445250|NCT02222493|18812074|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
5445251|NCT02222493|18812075|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
5445252|NCT02222493|18812074|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
5445253|NCT02222493|18812075|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
5445254|NCT02222493|18812074|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
5445255|NCT02222493|18812075|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
5445256|NCT02222493|18812074|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
5445257|NCT02222493|18812075|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
5445258|NCT02222493|18812074|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
5445259|NCT02222493|18812075|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
5445260|NCT02222493|18812074|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
5445261|NCT02222493|18812075|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
5445262|NCT02222493|18812074|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
5445263|NCT02222493|18812075|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
5445264|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
5445265|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
5445266|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
5445267|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
5445268|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
5445269|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
5445270|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
5445271|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
5445272|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
5445273|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
5445274|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
5445275|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
5445276|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
5445277|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
5445278|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
5445279|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
5445280|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
5445281|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
5445282|NCT02222493|18812074|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
5445283|NCT02222493|18812075|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
5445284|NCT02222246|18812226|P2|Overall Study|Physician Decision|1
5445285|NCT02222246|18812227|P1|Overall Study|Physician Decision|0
5445286|NCT02222246|18812226|P2|Overall Study|No Emergency Department Visits|26
5445287|NCT02222246|18812227|P1|Overall Study|No Emergency Department Visits|27
5445288|NCT02222207|18812255|P1|Overall Study|Adverse Event|1
5445289|NCT02222207|18812255|P1|Overall Study|Other reasons|2
5445290|NCT02222207|18812255|P1|Overall Study|Death|1
5445291|NCT02221882|18812302|P6|Overall Study|Death|0
5445292|NCT02221882|18812303|P5|Overall Study|Death|0
5445293|NCT02221882|18812304|P4|Overall Study|Death|0
5445294|NCT02221882|18812305|P3|Overall Study|Death|0
5445295|NCT02221882|18812306|P2|Overall Study|Death|1
5445296|NCT02221882|18812307|P1|Overall Study|Death|0
5445297|NCT02221882|18812302|P6|Overall Study|Withdrawal by Subject|2
5445298|NCT02221882|18812303|P5|Overall Study|Withdrawal by Subject|2
5445299|NCT02221882|18812304|P4|Overall Study|Withdrawal by Subject|2
5445300|NCT02221882|18812305|P3|Overall Study|Withdrawal by Subject|4
5445301|NCT02221882|18812306|P2|Overall Study|Withdrawal by Subject|0
5445302|NCT02221882|18812307|P1|Overall Study|Withdrawal by Subject|0
5445303|NCT02221674|18812374|P3|Overall Study|Lost to Follow-up|0
5445304|NCT02221674|18812375|P2|Overall Study|Lost to Follow-up|0
5445305|NCT02221674|18812376|P1|Overall Study|Lost to Follow-up|1
5445306|NCT02221648|18812392|P2|Overall Study|Withdrawal by Subject|3
5445307|NCT02221648|18812393|P1|Overall Study|Withdrawal by Subject|3
5445308|NCT02221284|18812422|P1|Overall Study|Protocol Deviation|5
5445309|NCT02221284|18812422|P1|Overall Study|Case Report Forms Uncollected|56
5445310|NCT02221037|18812471|P4|Overall Study|Physician Decision|0
5445311|NCT02221037|18812472|P3|Overall Study|Physician Decision|1
5445312|NCT02221037|18812473|P2|Overall Study|Physician Decision|0
5445313|NCT02221037|18812474|P1|Overall Study|Physician Decision|0
5445314|NCT02220998|18812560|P2|Overall Study|Lost to Follow-up|4
5445315|NCT02220998|18812561|P1|Overall Study|Lost to Follow-up|4
5445316|NCT02220998|18812560|P2|Overall Study|Lack of Efficacy|5
5445317|NCT02220998|18812561|P1|Overall Study|Lack of Efficacy|0
5445318|NCT02220998|18812560|P2|Overall Study|Death|0
5445319|NCT02220998|18812561|P1|Overall Study|Death|2
5445320|NCT02220998|18812560|P2|Overall Study|Randomized but Never Treated|2
5445321|NCT02220998|18812561|P1|Overall Study|Randomized but Never Treated|1
5445322|NCT02220920|18812579|P2|Overall Study|Conflict with the stopping criteria|2
5445323|NCT02220920|18812580|P1|Overall Study|Conflict with the stopping criteria|1
5445324|NCT02220920|18812579|P2|Overall Study|Withdrawal by Subject|0
5445325|NCT02220920|18812580|P1|Overall Study|Withdrawal by Subject|1
5445326|NCT02220920|18812579|P2|Overall Study|Lack of Efficacy|1
5445327|NCT02220920|18812580|P1|Overall Study|Lack of Efficacy|0
5445328|NCT02220920|18812579|P2|Overall Study|Adverse Event|0
5445329|NCT02220920|18812580|P1|Overall Study|Adverse Event|1
5445330|NCT02220907|18812594|P1|Overall Study|Conflict with the stopping criteria|1
5445331|NCT02220907|18812594|P1|Overall Study|Withdrawal by Subject|2
5445332|NCT02220907|18812594|P1|Overall Study|Physician Decision|1
5445333|NCT02220907|18812594|P1|Overall Study|Adverse Event|7
5445334|NCT02220894|18812603|P2|Overall Study|Ongoing in Study|183
5445335|NCT02220894|18812604|P1|Overall Study|Ongoing in Study|265
5445336|NCT02220894|18812603|P2|Overall Study|Withdrawal by Subject|13
5445337|NCT02220894|18812604|P1|Overall Study|Withdrawal by Subject|2
5445338|NCT02220894|18812603|P2|Overall Study|Withdrawal by Parent/Guardian|1
5445339|NCT02220894|18812604|P1|Overall Study|Withdrawal by Parent/Guardian|0
5445340|NCT02220894|18812603|P2|Overall Study|Lost to Follow-up|2
5445341|NCT02220894|18812604|P1|Overall Study|Lost to Follow-up|0
5445342|NCT02220894|18812603|P2|Overall Study|Death|368
5445343|NCT02220894|18812604|P1|Overall Study|Death|252
5445344|NCT02220894|18812603|P2|Overall Study|Adverse Event|70
5445345|NCT02220894|18812604|P1|Overall Study|Adverse Event|118
5445346|NCT02220855|18812630|P1|Overall Study|Withdrawal by Subject|1
5445347|NCT02220855|18812630|P1|Overall Study|Disease Progression|5
5445348|NCT02220855|18812630|P1|Overall Study|Adverse Event|8
5445349|NCT02220764|18812640|P2|Overall Study|Death|0
5445350|NCT02220764|18812641|P1|Overall Study|Death|1
5445351|NCT02220764|18812640|P2|Overall Study|Lost to Follow-up|1
5445352|NCT02220764|18812641|P1|Overall Study|Lost to Follow-up|3
5445353|NCT02220725|18812655|P4|Overall Study|Withdrawal by Subject|1
5445354|NCT02220725|18812656|P3|Overall Study|Withdrawal by Subject|0
5445355|NCT02220725|18812657|P2|Overall Study|Withdrawal by Subject|0
5445356|NCT02220725|18812658|P1|Overall Study|Withdrawal by Subject|0
5445357|NCT02220725|18812655|P4|Overall Study|Lost to Follow-up|1
5445358|NCT02220725|18812656|P3|Overall Study|Lost to Follow-up|0
5445359|NCT02220725|18812657|P2|Overall Study|Lost to Follow-up|0
5445360|NCT02220725|18812658|P1|Overall Study|Lost to Follow-up|0
5445361|NCT02220205|18812688|P2|Overall Study|Withdrawal by Subject|0
5445362|NCT02220205|18812689|P1|Overall Study|Withdrawal by Subject|1
5445363|NCT02219932|18812714|P2|Overall Study|Adverse Event|21
5445364|NCT02219932|18812715|P1|Overall Study|Adverse Event|23
5445365|NCT02219932|18812714|P2|Overall Study|Lost to Follow-up|2
5445366|NCT02219932|18812715|P1|Overall Study|Lost to Follow-up|4
5445367|NCT02219932|18812714|P2|Overall Study|Pregnancy|0
5445368|NCT02219932|18812715|P1|Overall Study|Pregnancy|1
5445369|NCT02219932|18812714|P2|Overall Study|Protocol Violation|6
5445370|NCT02219932|18812715|P1|Overall Study|Protocol Violation|10
5445371|NCT02219932|18812714|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
5445372|NCT02219932|18812715|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
5445373|NCT02219932|18812714|P2|Overall Study|Consent Withdrawn|7
5445374|NCT02219932|18812715|P1|Overall Study|Consent Withdrawn|11
5445375|NCT02219932|18812714|P2|Overall Study|Investigator Decision|1
5445376|NCT02219932|18812715|P1|Overall Study|Investigator Decision|0
5445377|NCT02219932|18812714|P2|Overall Study|Death|1
5445378|NCT02219932|18812715|P1|Overall Study|Death|1
5445379|NCT02219932|18812714|P2|Overall Study|Other|11
5445380|NCT02219932|18812715|P1|Overall Study|Other|5
5445381|NCT02219685|18812731|P2|Blinded Treatment Phase|Withdrew Consent|0
5445382|NCT02219685|18812732|P1|Blinded Treatment Phase|Withdrew Consent|1
5445383|NCT02219685|18812731|P2|Blinded Treatment Phase|Lost to Follow-up|0
5445384|NCT02219685|18812732|P1|Blinded Treatment Phase|Lost to Follow-up|1
5445385|NCT02219477|18812838|P3|Overall Study|Withdrawal by Subject|0
5445386|NCT02219477|18812839|P2|Overall Study|Withdrawal by Subject|1
5445387|NCT02219477|18812840|P1|Overall Study|Withdrawal by Subject|0
5445388|NCT02219477|18812838|P3|Overall Study|Adverse Event|1
5445389|NCT02219477|18812839|P2|Overall Study|Adverse Event|1
5445390|NCT02219477|18812840|P1|Overall Study|Adverse Event|0
5445391|NCT02219464|18812868|P2|Overall Study|catheter malfunction|0
5445392|NCT02219464|18812869|P1|Overall Study|catheter malfunction|1
5445393|NCT02219464|18812868|P2|Overall Study|case cancelled|0
5445394|NCT02219464|18812869|P1|Overall Study|case cancelled|1
5445395|NCT02219464|18812868|P2|Overall Study|Withdrawal by Subject|0
5445396|NCT02219464|18812869|P1|Overall Study|Withdrawal by Subject|1
5445397|NCT02219334|18812879|P2|Overall Study|Protocol Violation|3
5445398|NCT02219334|18812880|P1|Overall Study|Protocol Violation|7
5445399|NCT02219334|18812879|P2|Overall Study|Withdrawal by Subject|0
5445400|NCT02219334|18812880|P1|Overall Study|Withdrawal by Subject|1
5445401|NCT02219308|18812903|P2|Overall Study|Withdrawal by Subject|2
5445402|NCT02219308|18812904|P1|Overall Study|Withdrawal by Subject|1
5445403|NCT02219087|18813064|P2|Overall Study|Randomization envelope pulled out of seq|1
5445404|NCT02219087|18813065|P1|Overall Study|Randomization envelope pulled out of seq|0
5445405|NCT02219048|18813085|P2|Overall Study|Other|1
5445406|NCT02219048|18813086|P1|Overall Study|Other|0
5445407|NCT02219048|18813085|P2|Overall Study|Withdrawal by Subject|0
5445408|NCT02219048|18813086|P1|Overall Study|Withdrawal by Subject|2
5445409|NCT02219048|18813085|P2|Overall Study|Study terminated by sponsor|15
5445410|NCT02219048|18813086|P1|Overall Study|Study terminated by sponsor|16
5445411|NCT02219048|18813085|P2|Overall Study|No longer meets eligibility criteria|0
5445412|NCT02219048|18813086|P1|Overall Study|No longer meets eligibility criteria|1
5445413|NCT02219048|18813085|P2|Overall Study|Adverse Event|5
5445414|NCT02219048|18813086|P1|Overall Study|Adverse Event|2
5445415|NCT02219009|18813112|P2|Overall Study|Physician Decision|1
5445416|NCT02219009|18813113|P1|Overall Study|Physician Decision|0
5445417|NCT02219009|18813112|P2|Overall Study|Protocol deviation|0
5445418|NCT02219009|18813113|P1|Overall Study|Protocol deviation|1
5445419|NCT02219009|18813112|P2|Overall Study|Lost to Follow-up|2
5445420|NCT02219009|18813113|P1|Overall Study|Lost to Follow-up|2
5445421|NCT02219009|18813112|P2|Overall Study|Adverse Event|4
5445422|NCT02219009|18813113|P1|Overall Study|Adverse Event|2
5445423|NCT02219009|18813112|P2|Overall Study|Withdrawal by Subject|1
5445424|NCT02219009|18813113|P1|Overall Study|Withdrawal by Subject|5
5445425|NCT02218736|18813125|P2|Overall Study|Protocol Violation|0
5445426|NCT02218736|18813126|P1|Overall Study|Protocol Violation|2
5445427|NCT02218736|18813125|P2|Overall Study|Withdrawal by Subject|9
5445428|NCT02218736|18813126|P1|Overall Study|Withdrawal by Subject|10
5445429|NCT02218697|18813138|P2|Overall Study|Withdrawal by Subject|3
5445430|NCT02218697|18813139|P1|Overall Study|Withdrawal by Subject|2
5445431|NCT02218697|18813138|P2|Overall Study|Unwilling to be vaccinated in left arm|1
5445432|NCT02218697|18813139|P1|Overall Study|Unwilling to be vaccinated in left arm|0
5445433|NCT02218697|18813138|P2|Overall Study|Adverse Event|2
5445434|NCT02218697|18813139|P1|Overall Study|Adverse Event|0
5445435|NCT02218541|18813179|P2|Overall Study|Implant Failure|1
5445436|NCT02218541|18813180|P1|Overall Study|Implant Failure|4
5445437|NCT02218541|18813179|P2|Overall Study|Lost to Follow-up|1
5445438|NCT02218541|18813180|P1|Overall Study|Lost to Follow-up|2
5445439|NCT02218372|18813226|P2|Overall Study|Withdrawal by Parent/Guardian|1
5445440|NCT02218372|18813227|P1|Overall Study|Withdrawal by Parent/Guardian|0
5445441|NCT02218372|18813226|P2|Overall Study|Randomized but did not receive treatment|3
5445442|NCT02218372|18813227|P1|Overall Study|Randomized but did not receive treatment|2
5445443|NCT02218372|18813226|P2|Overall Study|Miscellaneous|1
5445444|NCT02218372|18813227|P1|Overall Study|Miscellaneous|2
5445445|NCT02218372|18813226|P2|Overall Study|Adverse Event|1
5445446|NCT02218372|18813227|P1|Overall Study|Adverse Event|1
5445447|NCT02218268|18813307|P2|24 Hour Washout|Physician Decision|9
5445448|NCT02218268|18813308|P1|24 Hour Washout|Physician Decision|11
5445449|NCT02218216|18813320|P3|Overall Study|Study terminated before completed|0
5445450|NCT02218216|18813321|P2|Overall Study|Study terminated before completed|0
5445451|NCT02218216|18813322|P1|Overall Study|Study terminated before completed|6
5445452|NCT02218008|18813375|P6|Stage 2 (S2)|Lost to Follow-up|1
5445453|NCT02218008|18813376|P5|Stage 2 (S2)|Lost to Follow-up|0
5445454|NCT02218008|18813377|P4|Stage 2 (S2)|Lost to Follow-up|0
5445455|NCT02218008|18813378|P3|Stage 2 (S2)|Lost to Follow-up|0
5445456|NCT02218008|18813379|P2|Stage 2 (S2)|Lost to Follow-up|0
5445457|NCT02218008|18813380|P1|Stage 2 (S2)|Lost to Follow-up|0
5445458|NCT02218008|18813375|P6|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5445459|NCT02218008|18813376|P5|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5445460|NCT02218008|18813377|P4|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
5445461|NCT02218008|18813378|P3|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5445462|NCT02218008|18813379|P2|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5445463|NCT02218008|18813380|P1|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
5445464|NCT02218008|18813375|P6|Stage 2 (S2)|Lack of Efficacy|2
5445465|NCT02218008|18813376|P5|Stage 2 (S2)|Lack of Efficacy|0
5445466|NCT02218008|18813377|P4|Stage 2 (S2)|Lack of Efficacy|0
5445467|NCT02218008|18813378|P3|Stage 2 (S2)|Lack of Efficacy|0
5445468|NCT02218008|18813379|P2|Stage 2 (S2)|Lack of Efficacy|0
5445469|NCT02218008|18813380|P1|Stage 2 (S2)|Lack of Efficacy|0
5445470|NCT02218008|18813375|P6|Stage 2 (S2)|Withdrawal by Subject|0
5445471|NCT02218008|18813376|P5|Stage 2 (S2)|Withdrawal by Subject|1
5445472|NCT02218008|18813377|P4|Stage 2 (S2)|Withdrawal by Subject|1
5445473|NCT02218008|18813378|P3|Stage 2 (S2)|Withdrawal by Subject|0
5445474|NCT02218008|18813379|P2|Stage 2 (S2)|Withdrawal by Subject|0
5445475|NCT02218008|18813380|P1|Stage 2 (S2)|Withdrawal by Subject|0
5445476|NCT02218008|18813375|P6|Stage 2 (S2)|Adverse Event|3
5445477|NCT02218008|18813376|P5|Stage 2 (S2)|Adverse Event|3
5445478|NCT02218008|18813377|P4|Stage 2 (S2)|Adverse Event|2
5445479|NCT02218008|18813378|P3|Stage 2 (S2)|Adverse Event|0
5445480|NCT02218008|18813379|P2|Stage 2 (S2)|Adverse Event|0
5445481|NCT02218008|18813380|P1|Stage 2 (S2)|Adverse Event|0
5445482|NCT02218008|18813375|P6|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5445483|NCT02218008|18813376|P5|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5445484|NCT02218008|18813377|P4|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5445485|NCT02218008|18813378|P3|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5445486|NCT02218008|18813379|P2|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
5445487|NCT02218008|18813380|P1|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
5445488|NCT02218008|18813375|P6|Stage 1 (S1)|Protocol Violation|0
5445489|NCT02218008|18813376|P5|Stage 1 (S1)|Protocol Violation|0
5445490|NCT02218008|18813377|P4|Stage 1 (S1)|Protocol Violation|0
5445491|NCT02218008|18813378|P3|Stage 1 (S1)|Protocol Violation|1
5445492|NCT02218008|18813379|P2|Stage 1 (S1)|Protocol Violation|0
5445493|NCT02218008|18813380|P1|Stage 1 (S1)|Protocol Violation|0
5445494|NCT02218008|18813375|P6|Stage 1 (S1)|Pregnancy|0
5445495|NCT02218008|18813376|P5|Stage 1 (S1)|Pregnancy|0
5445496|NCT02218008|18813377|P4|Stage 1 (S1)|Pregnancy|0
5445497|NCT02218008|18813378|P3|Stage 1 (S1)|Pregnancy|1
5445498|NCT02218008|18813379|P2|Stage 1 (S1)|Pregnancy|0
5445499|NCT02218008|18813380|P1|Stage 1 (S1)|Pregnancy|0
5445500|NCT02218008|18813375|P6|Stage 1 (S1)|Non-compliance; drug use|0
5445501|NCT02218008|18813376|P5|Stage 1 (S1)|Non-compliance; drug use|0
5445502|NCT02218008|18813377|P4|Stage 1 (S1)|Non-compliance; drug use|0
5445503|NCT02218008|18813378|P3|Stage 1 (S1)|Non-compliance; drug use|0
5445504|NCT02218008|18813379|P2|Stage 1 (S1)|Non-compliance; drug use|0
5445505|NCT02218008|18813380|P1|Stage 1 (S1)|Non-compliance; drug use|1
5445506|NCT02218008|18813375|P6|Stage 1 (S1)|Non-compliance with Study Drug|0
5445507|NCT02218008|18813376|P5|Stage 1 (S1)|Non-compliance with Study Drug|0
5445508|NCT02218008|18813377|P4|Stage 1 (S1)|Non-compliance with Study Drug|0
5445509|NCT02218008|18813378|P3|Stage 1 (S1)|Non-compliance with Study Drug|0
5445510|NCT02218008|18813379|P2|Stage 1 (S1)|Non-compliance with Study Drug|1
5445511|NCT02218008|18813380|P1|Stage 1 (S1)|Non-compliance with Study Drug|2
5445512|NCT02218008|18813375|P6|Stage 1 (S1)|Lost to Follow-up|0
5445513|NCT02218008|18813376|P5|Stage 1 (S1)|Lost to Follow-up|0
5445514|NCT02218008|18813377|P4|Stage 1 (S1)|Lost to Follow-up|0
5445515|NCT02218008|18813378|P3|Stage 1 (S1)|Lost to Follow-up|1
5445516|NCT02218008|18813379|P2|Stage 1 (S1)|Lost to Follow-up|0
5445517|NCT02218008|18813380|P1|Stage 1 (S1)|Lost to Follow-up|3
5445518|NCT02218008|18813375|P6|Stage 1 (S1)|Lack of Efficacy|0
5445519|NCT02218008|18813376|P5|Stage 1 (S1)|Lack of Efficacy|0
5445520|NCT02218008|18813377|P4|Stage 1 (S1)|Lack of Efficacy|0
5445521|NCT02218008|18813378|P3|Stage 1 (S1)|Lack of Efficacy|0
5445522|NCT02218008|18813379|P2|Stage 1 (S1)|Lack of Efficacy|0
5445523|NCT02218008|18813380|P1|Stage 1 (S1)|Lack of Efficacy|3
5445524|NCT02218008|18813375|P6|Stage 1 (S1)|Withdrawal by Subject|0
5445525|NCT02218008|18813376|P5|Stage 1 (S1)|Withdrawal by Subject|0
5445526|NCT02218008|18813377|P4|Stage 1 (S1)|Withdrawal by Subject|0
5445527|NCT02218008|18813378|P3|Stage 1 (S1)|Withdrawal by Subject|1
5445528|NCT02218008|18813379|P2|Stage 1 (S1)|Withdrawal by Subject|1
5445529|NCT02218008|18813380|P1|Stage 1 (S1)|Withdrawal by Subject|6
5445530|NCT02218008|18813375|P6|Stage 1 (S1)|Adverse Event|0
5445531|NCT02218008|18813376|P5|Stage 1 (S1)|Adverse Event|0
5445532|NCT02218008|18813377|P4|Stage 1 (S1)|Adverse Event|0
5445533|NCT02218008|18813378|P3|Stage 1 (S1)|Adverse Event|11
5445534|NCT02218008|18813379|P2|Stage 1 (S1)|Adverse Event|5
5445535|NCT02218008|18813380|P1|Stage 1 (S1)|Adverse Event|6
5445536|NCT02217982|18813426|P2|Overall Study|Adverse Event|1
5445537|NCT02217982|18813427|P1|Overall Study|Adverse Event|0
5445538|NCT02217982|18813426|P2|Overall Study|Trial discontinued|0
5445539|NCT02217982|18813427|P1|Overall Study|Trial discontinued|1
5445540|NCT02217878|18813510|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
5445541|NCT02217878|18813511|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
5445542|NCT02217878|18813510|P2|Overall Study|required morphine due to chest pain|2
5445543|NCT02217878|18813511|P1|Overall Study|required morphine due to chest pain|1
5445544|NCT02217566|18813609|P1|Overall Study|Early study termination|6
5445545|NCT02217566|18813609|P1|Overall Study|Death|3
5445546|NCT02217566|18813609|P1|Overall Study|Lost to Follow-up|2
5445547|NCT02217527|18813620|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
5445548|NCT02217527|18813621|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
5445549|NCT02217527|18813620|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
5445550|NCT02217527|18813621|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
5445551|NCT02217475|18813634|P3|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
5445552|NCT02217475|18813635|P2|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
5445553|NCT02217475|18813636|P1|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
5445554|NCT02217475|18813634|P3|Treatment Period 2 (Year 2)|Physician Decision|2
5445555|NCT02217475|18813635|P2|Treatment Period 2 (Year 2)|Physician Decision|0
5445556|NCT02217475|18813636|P1|Treatment Period 2 (Year 2)|Physician Decision|0
5445557|NCT02217475|18813634|P3|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
5445558|NCT02217475|18813635|P2|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
5445559|NCT02217475|18813636|P1|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
5445560|NCT02217475|18813634|P3|Treatment Period 2 (Year 2)|Lost to Follow-up|2
5445561|NCT02217475|18813635|P2|Treatment Period 2 (Year 2)|Lost to Follow-up|1
5445562|NCT02217475|18813636|P1|Treatment Period 2 (Year 2)|Lost to Follow-up|0
5445563|NCT02217475|18813634|P3|Treatment Period 2 (Year 2)|Adverse Event|5
5445564|NCT02217475|18813635|P2|Treatment Period 2 (Year 2)|Adverse Event|1
5445565|NCT02217475|18813636|P1|Treatment Period 2 (Year 2)|Adverse Event|0
5445566|NCT02217475|18813634|P3|Discontinued After Period 1|Physician Decision|1
5445567|NCT02217475|18813635|P2|Discontinued After Period 1|Physician Decision|0
5445568|NCT02217475|18813636|P1|Discontinued After Period 1|Physician Decision|0
5445569|NCT02217475|18813634|P3|Discontinued After Period 1|Participant Withdrew Consent|2
5445570|NCT02217475|18813635|P2|Discontinued After Period 1|Participant Withdrew Consent|1
5445571|NCT02217475|18813636|P1|Discontinued After Period 1|Participant Withdrew Consent|1
5445572|NCT02217475|18813634|P3|Discontinued After Period 1|Adverse Event|0
5445573|NCT02217475|18813635|P2|Discontinued After Period 1|Adverse Event|2
5445574|NCT02217475|18813636|P1|Discontinued After Period 1|Adverse Event|1
5445575|NCT02217475|18813634|P3|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
5445576|NCT02217475|18813635|P2|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
5445577|NCT02217475|18813636|P1|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
5445578|NCT02217475|18813634|P3|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
5445579|NCT02217475|18813635|P2|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
5445580|NCT02217475|18813636|P1|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
5445581|NCT02217475|18813634|P3|Treatment Period 1 (Year 1)|Lost to Follow-up|0
5445582|NCT02217475|18813635|P2|Treatment Period 1 (Year 1)|Lost to Follow-up|0
5445583|NCT02217475|18813636|P1|Treatment Period 1 (Year 1)|Lost to Follow-up|1
5445584|NCT02217475|18813634|P3|Treatment Period 1 (Year 1)|Adverse Event|9
5445585|NCT02217475|18813635|P2|Treatment Period 1 (Year 1)|Adverse Event|5
5445586|NCT02217475|18813636|P1|Treatment Period 1 (Year 1)|Adverse Event|4
5445587|NCT02217475|18813634|P3|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
5445588|NCT02217475|18813635|P2|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
5445589|NCT02217475|18813636|P1|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
5445590|NCT02217436|18813753|P2|Overall Study|Incomplete data|1
5445591|NCT02217436|18813754|P1|Overall Study|Incomplete data|0
5445592|NCT02217436|18813753|P2|Overall Study|Protocol Violation|1
5445593|NCT02217436|18813754|P1|Overall Study|Protocol Violation|1
5445594|NCT02217410|18813765|P3|Overall Study|Physician Decision|0
5445595|NCT02217410|18813766|P2|Overall Study|Physician Decision|3
5445596|NCT02217410|18813767|P1|Overall Study|Physician Decision|1
5445597|NCT02217410|18813765|P3|Overall Study|Lack of Efficacy|0
5445598|NCT02217410|18813766|P2|Overall Study|Lack of Efficacy|1
5445599|NCT02217410|18813767|P1|Overall Study|Lack of Efficacy|0
5445600|NCT02217410|18813765|P3|Overall Study|Lost to Follow-up|1
5445601|NCT02217410|18813766|P2|Overall Study|Lost to Follow-up|0
5445602|NCT02217410|18813767|P1|Overall Study|Lost to Follow-up|0
5445603|NCT02217410|18813765|P3|Overall Study|Withdrawal by Subject|2
5445604|NCT02217410|18813766|P2|Overall Study|Withdrawal by Subject|0
5445605|NCT02217410|18813767|P1|Overall Study|Withdrawal by Subject|0
5445606|NCT02217410|18813765|P3|Overall Study|Graft Loss|2
5445607|NCT02217410|18813766|P2|Overall Study|Graft Loss|0
5445608|NCT02217410|18813767|P1|Overall Study|Graft Loss|0
5445609|NCT02217280|18813790|P1|Overall Study|Post-consent sceen fail|2
5445610|NCT02217280|18813790|P1|Overall Study|Withdrawal by Subject|2
5445611|NCT02216812|18813797|P2|Overall Study|Lost to Follow-up|5
5445612|NCT02216812|18813798|P1|Overall Study|Lost to Follow-up|10
5445613|NCT02216773|18813814|P2|Overall Study|Abandoned|3
5445614|NCT02216773|18813815|P1|Overall Study|Abandoned|4
5445615|NCT02216773|18813814|P2|Overall Study|Insufficient FLRV|0
5445616|NCT02216773|18813815|P1|Overall Study|Insufficient FLRV|4
5445617|NCT02216773|18813814|P2|Overall Study|Disease progression|2
5445618|NCT02216773|18813815|P1|Overall Study|Disease progression|4
5445619|NCT02216591|18813836|P2|Overall Study|Lost to Follow-up|1
5445620|NCT02216591|18813837|P1|Overall Study|Lost to Follow-up|0
5445621|NCT02216526|18813850|P3|Overall Study|Hospitalization|3
5445622|NCT02216526|18813851|P2|Overall Study|Hospitalization|1
5445623|NCT02216526|18813852|P1|Overall Study|Hospitalization|2
5445624|NCT02216526|18813850|P3|Overall Study|Protocol Violation|2
5445625|NCT02216526|18813851|P2|Overall Study|Protocol Violation|0
5445626|NCT02216526|18813852|P1|Overall Study|Protocol Violation|2
5445627|NCT02216526|18813850|P3|Overall Study|Death|3
5445628|NCT02216526|18813851|P2|Overall Study|Death|1
5445629|NCT02216526|18813852|P1|Overall Study|Death|0
5445630|NCT02216526|18813850|P3|Overall Study|Adverse Event|0
5445631|NCT02216526|18813851|P2|Overall Study|Adverse Event|1
5445632|NCT02216526|18813852|P1|Overall Study|Adverse Event|1
5445633|NCT02216357|18813970|P2|Overall Study|Inclusion or exclusion criteria not met|1
5445634|NCT02216357|18813971|P1|Overall Study|Inclusion or exclusion criteria not met|2
5445635|NCT02216214|18813997|P2|Overall Study|Miscellaneous|1
5445636|NCT02216214|18813998|P1|Overall Study|Miscellaneous|1
5445637|NCT02216214|18813997|P2|Overall Study|Study Terminated By Sponsor|1
5445638|NCT02216214|18813998|P1|Overall Study|Study Terminated By Sponsor|0
5445639|NCT02216214|18813997|P2|Overall Study|Withdrawal by Subject|20
5445640|NCT02216214|18813998|P1|Overall Study|Withdrawal by Subject|22
5445641|NCT02216214|18813997|P2|Overall Study|Protocol Violation|2
5445642|NCT02216214|18813998|P1|Overall Study|Protocol Violation|4
5445643|NCT02216214|18813997|P2|Overall Study|Lost to Follow-up|2
5445644|NCT02216214|18813998|P1|Overall Study|Lost to Follow-up|3
5445645|NCT02216214|18813997|P2|Overall Study|Lack of Efficacy|2
5445646|NCT02216214|18813998|P1|Overall Study|Lack of Efficacy|2
5445647|NCT02216214|18813997|P2|Overall Study|Adverse Event|8
5445648|NCT02216214|18813998|P1|Overall Study|Adverse Event|10
5445649|NCT02216214|18813997|P2|Overall Study|Randomized Never Received Study Drug|0
5445650|NCT02216214|18813998|P1|Overall Study|Randomized Never Received Study Drug|1
5445651|NCT02216123|18814069|P2|Overall Study|Withdrawal by Subject|0
5445652|NCT02216123|18814070|P1|Overall Study|Withdrawal by Subject|2
5445653|NCT02216123|18814069|P2|Overall Study|Lost to Follow-up|2
5445654|NCT02216123|18814070|P1|Overall Study|Lost to Follow-up|4
5445655|NCT02215967|18814163|P4|Overall Study|Patient did not get CAR T-Cells|0
5445656|NCT02215967|18814164|P3|Overall Study|Patient did not get CAR T-Cells|1
5445657|NCT02215967|18814165|P2|Overall Study|Patient did not get CAR T-Cells|0
5445658|NCT02215967|18814166|P1|Overall Study|Patient did not get CAR T-Cells|0
5445659|NCT02215967|18814163|P4|Overall Study|Patient became ineligible for treatment|3
5445660|NCT02215967|18814164|P3|Overall Study|Patient became ineligible for treatment|0
5445661|NCT02215967|18814165|P2|Overall Study|Patient became ineligible for treatment|0
5445662|NCT02215967|18814166|P1|Overall Study|Patient became ineligible for treatment|0
5445663|NCT02215954|18814187|P3|Overall Study|Not exposed|3
5445664|NCT02215954|18814188|P2|Overall Study|Not exposed|1
5445665|NCT02215954|18814189|P1|Overall Study|Not exposed|1
5445666|NCT02215954|18814187|P3|Overall Study|Withdrawal by Subject|2
5445667|NCT02215954|18814188|P2|Overall Study|Withdrawal by Subject|0
5445668|NCT02215954|18814189|P1|Overall Study|Withdrawal by Subject|0
5445669|NCT02215954|18814187|P3|Overall Study|Adverse Event|1
5445670|NCT02215954|18814188|P2|Overall Study|Adverse Event|0
5445671|NCT02215954|18814189|P1|Overall Study|Adverse Event|0
5445672|NCT02215616|18814213|P4|Overall Study|Other than specified|1
5445673|NCT02215616|18814214|P3|Overall Study|Other than specified|1
5445674|NCT02215616|18814215|P2|Overall Study|Other than specified|0
5445675|NCT02215616|18814216|P1|Overall Study|Other than specified|1
5445676|NCT02215616|18814213|P4|Overall Study|Lost to Follow-up|1
5445677|NCT02215616|18814214|P3|Overall Study|Lost to Follow-up|0
5445678|NCT02215616|18814215|P2|Overall Study|Lost to Follow-up|1
5445679|NCT02215616|18814216|P1|Overall Study|Lost to Follow-up|1
5445680|NCT02215616|18814213|P4|Overall Study|Protocol Violation|0
5445681|NCT02215616|18814214|P3|Overall Study|Protocol Violation|0
5445682|NCT02215616|18814215|P2|Overall Study|Protocol Violation|2
5445683|NCT02215616|18814216|P1|Overall Study|Protocol Violation|0
5445684|NCT02215616|18814213|P4|Overall Study|Non-compliance|0
5445685|NCT02215616|18814214|P3|Overall Study|Non-compliance|1
5445686|NCT02215616|18814215|P2|Overall Study|Non-compliance|2
5445687|NCT02215616|18814216|P1|Overall Study|Non-compliance|0
5445688|NCT02215616|18814213|P4|Overall Study|Withdrawal by Subject|5
5445689|NCT02215616|18814214|P3|Overall Study|Withdrawal by Subject|2
5445690|NCT02215616|18814215|P2|Overall Study|Withdrawal by Subject|8
5445691|NCT02215616|18814216|P1|Overall Study|Withdrawal by Subject|1
5445692|NCT02215616|18814213|P4|Overall Study|Adverse Event|2
5445693|NCT02215616|18814214|P3|Overall Study|Adverse Event|9
5445694|NCT02215616|18814215|P2|Overall Study|Adverse Event|4
5445695|NCT02215616|18814216|P1|Overall Study|Adverse Event|7
5445696|NCT02215616|18814213|P4|Overall Study|Death|0
5445697|NCT02215616|18814214|P3|Overall Study|Death|0
5445698|NCT02215616|18814215|P2|Overall Study|Death|0
5445699|NCT02215616|18814216|P1|Overall Study|Death|1
5445700|NCT02215616|18814213|P4|Overall Study|Sponsor requested to stop study drug|4
5445701|NCT02215616|18814214|P3|Overall Study|Sponsor requested to stop study drug|1
5445702|NCT02215616|18814215|P2|Overall Study|Sponsor requested to stop study drug|0
5445703|NCT02215616|18814216|P1|Overall Study|Sponsor requested to stop study drug|0
5445704|NCT02215252|18814238|P3|Overall Study|Other|1
5445705|NCT02215252|18814239|P2|Overall Study|Other|1
5445706|NCT02215252|18814240|P1|Overall Study|Other|0
5445707|NCT02215252|18814238|P3|Overall Study|Withdrawal by Subject|0
5445708|NCT02215252|18814239|P2|Overall Study|Withdrawal by Subject|0
5445709|NCT02215252|18814240|P1|Overall Study|Withdrawal by Subject|1
5445710|NCT02215252|18814238|P3|Overall Study|Protocol Violation|0
5445711|NCT02215252|18814239|P2|Overall Study|Protocol Violation|1
5445712|NCT02215252|18814240|P1|Overall Study|Protocol Violation|0
5445713|NCT02215252|18814238|P3|Overall Study|Does not Meet Entrance Criteria|0
5445714|NCT02215252|18814239|P2|Overall Study|Does not Meet Entrance Criteria|1
5445715|NCT02215252|18814240|P1|Overall Study|Does not Meet Entrance Criteria|0
5445716|NCT02215252|18814238|P3|Overall Study|Lost to Follow-up|1
5445717|NCT02215252|18814239|P2|Overall Study|Lost to Follow-up|0
5445718|NCT02215252|18814240|P1|Overall Study|Lost to Follow-up|0
5445719|NCT02215252|18814238|P3|Overall Study|Adverse Event|2
5445720|NCT02215252|18814239|P2|Overall Study|Adverse Event|5
5445721|NCT02215252|18814240|P1|Overall Study|Adverse Event|1
5445722|NCT02215096|18814328|P5|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
5445723|NCT02215096|18814329|P4|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
5445724|NCT02215096|18814330|P3|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
5445725|NCT02215096|18814331|P2|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
5445726|NCT02215096|18814332|P1|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
5445727|NCT02215096|18814328|P5|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5445728|NCT02215096|18814329|P4|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
5445729|NCT02215096|18814330|P3|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5445730|NCT02215096|18814331|P2|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5445731|NCT02215096|18814332|P1|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
5445732|NCT02215096|18814328|P5|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
5445733|NCT02215096|18814329|P4|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5445734|NCT02215096|18814330|P3|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5445735|NCT02215096|18814331|P2|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5445736|NCT02215096|18814332|P1|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
5445737|NCT02215096|18814328|P5|Run-In Period (Up to Week 2)|Adverse Event|0
5445738|NCT02215096|18814329|P4|Run-In Period (Up to Week 2)|Adverse Event|0
5445739|NCT02215096|18814330|P3|Run-In Period (Up to Week 2)|Adverse Event|0
5445740|NCT02215096|18814331|P2|Run-In Period (Up to Week 2)|Adverse Event|0
5445741|NCT02215096|18814332|P1|Run-In Period (Up to Week 2)|Adverse Event|1
5445742|NCT02214225|18814494|P3|Overall Study|randomized in error, not vaccinated|1
5445743|NCT02214225|18814495|P2|Overall Study|randomized in error, not vaccinated|1
5445744|NCT02214225|18814496|P1|Overall Study|randomized in error, not vaccinated|2
5445745|NCT02214225|18814494|P3|Overall Study|Death|1
5445746|NCT02214225|18814495|P2|Overall Study|Death|0
5445747|NCT02214225|18814496|P1|Overall Study|Death|5
5445748|NCT02214225|18814494|P3|Overall Study|Withdrawal by Subject|2
5445749|NCT02214225|18814495|P2|Overall Study|Withdrawal by Subject|0
5445750|NCT02214225|18814496|P1|Overall Study|Withdrawal by Subject|2
5445751|NCT02214225|18814494|P3|Overall Study|Lost to Follow-up|18
5445752|NCT02214225|18814495|P2|Overall Study|Lost to Follow-up|18
5445753|NCT02214225|18814496|P1|Overall Study|Lost to Follow-up|46
5445754|NCT02214186|18814555|P2|Overall Study|Protocol Violation|1
5445755|NCT02214186|18814556|P1|Overall Study|Protocol Violation|1
5445756|NCT02214186|18814555|P2|Overall Study|Lost to Follow-up|1
5445757|NCT02214186|18814556|P1|Overall Study|Lost to Follow-up|1
5445758|NCT02214121|18814624|P3|Part B|Lost to Follow-up|1
5445759|NCT02214121|18814625|P2|Part B|Lost to Follow-up|0
5445760|NCT02214121|18814626|P1|Part B|Lost to Follow-up|0
5445761|NCT02214121|18814624|P3|Part B|Dev. of study-specific withdrawal crit.|0
5445762|NCT02214121|18814625|P2|Part B|Dev. of study-specific withdrawal crit.|2
5445763|NCT02214121|18814626|P1|Part B|Dev. of study-specific withdrawal crit.|0
5445764|NCT02214121|18814624|P3|Part B|Patient decision|0
5445765|NCT02214121|18814625|P2|Part B|Patient decision|1
5445766|NCT02214121|18814626|P1|Part B|Patient decision|0
5445767|NCT02214121|18814624|P3|Part A|Other|0
5445768|NCT02214121|18814625|P2|Part A|Other|0
5445769|NCT02214121|18814626|P1|Part A|Other|1
5445770|NCT02214121|18814624|P3|Part A|Dev. of study-specific withdrawal crit.|0
5445771|NCT02214121|18814625|P2|Part A|Dev. of study-specific withdrawal crit.|0
5445772|NCT02214121|18814626|P1|Part A|Dev. of study-specific withdrawal crit.|4
5445773|NCT02214121|18814624|P3|Part A|Patient decision|0
5445774|NCT02214121|18814625|P2|Part A|Patient decision|0
5445775|NCT02214121|18814626|P1|Part A|Patient decision|2
5445776|NCT02213666|18814735|P1|Overall Study|Withdrawal by Subject|1
5445777|NCT02213510|18814741|P2|Overall Study|Lost to Follow-up|0
5445778|NCT02213510|18814742|P1|Overall Study|Lost to Follow-up|1
5445779|NCT02213510|18814741|P2|Overall Study|Death|1
5445780|NCT02213510|18814742|P1|Overall Study|Death|0
5445781|NCT02213263|18814770|P2|Overall Study|Adverse Event|3
5445782|NCT02213263|18814771|P1|Overall Study|Adverse Event|1
5445783|NCT02213263|18814770|P2|Overall Study|Protocol Violation|1
5445784|NCT02213263|18814771|P1|Overall Study|Protocol Violation|0
5445785|NCT02213263|18814770|P2|Overall Study|Progressive disease|14
5445786|NCT02213263|18814771|P1|Overall Study|Progressive disease|20
5445787|NCT02213263|18814770|P2|Overall Study|No longer willing to participate|4
5445788|NCT02213263|18814771|P1|Overall Study|No longer willing to participate|3
5445789|NCT02213263|18814770|P2|Overall Study|Lost to Follow-up|1
5445790|NCT02213263|18814771|P1|Overall Study|Lost to Follow-up|0
5445791|NCT02213263|18814770|P2|Overall Study|Insufficient clinical response|3
5445792|NCT02213263|18814771|P1|Overall Study|Insufficient clinical response|4
5445793|NCT02213198|18814839|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
5445794|NCT02213198|18814840|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
5445795|NCT02213198|18814839|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
5445796|NCT02213198|18814840|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
5445797|NCT02213198|18814839|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
5445798|NCT02213198|18814840|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
5445799|NCT02213198|18814839|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
5445800|NCT02213198|18814840|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
5445801|NCT02213198|18814839|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
5445802|NCT02213198|18814840|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
5445803|NCT02213198|18814839|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
5445804|NCT02213198|18814840|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
5445805|NCT02213198|18814839|P2|Baseline|incarcerated,violent|1
5445806|NCT02213198|18814840|P1|Baseline|incarcerated,violent|0
5445807|NCT02213198|18814839|P2|Baseline|Lost to Follow-up|21
5445808|NCT02213198|18814840|P1|Baseline|Lost to Follow-up|40
5445809|NCT02213198|18814839|P2|Baseline|transferred out of clinic|9
5445810|NCT02213198|18814840|P1|Baseline|transferred out of clinic|7
5445811|NCT02213198|18814839|P2|Baseline|Withdrawal by Subject|11
5445812|NCT02213198|18814840|P1|Baseline|Withdrawal by Subject|34
5445813|NCT02213198|18814839|P2|Baseline|No show for intake|9
5445814|NCT02213198|18814840|P1|Baseline|No show for intake|7
5445815|NCT02213133|18814851|P3|Overall Study|Other|0
5445816|NCT02213133|18814852|P2|Overall Study|Other|0
5445817|NCT02213133|18814853|P1|Overall Study|Other|5
5445818|NCT02213133|18814851|P3|Overall Study|Death|1
5445819|NCT02213133|18814852|P2|Overall Study|Death|2
5445820|NCT02213133|18814853|P1|Overall Study|Death|16
5445821|NCT02213133|18814851|P3|Overall Study|Adverse Event (AE)|0
5445822|NCT02213133|18814852|P2|Overall Study|Adverse Event (AE)|0
5445823|NCT02213133|18814853|P1|Overall Study|Adverse Event (AE)|1
5445824|NCT02213133|18814851|P3|Overall Study|Disease progression|0
5445825|NCT02213133|18814852|P2|Overall Study|Disease progression|2
5445826|NCT02213133|18814853|P1|Overall Study|Disease progression|11
5445827|NCT02213133|18814851|P3|Overall Study|Participant withdrew informed consent|2
5445828|NCT02213133|18814852|P2|Overall Study|Participant withdrew informed consent|1
5445829|NCT02213133|18814853|P1|Overall Study|Participant withdrew informed consent|2
5445830|NCT02213133|18814851|P3|Overall Study|Participant discontinued study therapy|0
5445831|NCT02213133|18814852|P2|Overall Study|Participant discontinued study therapy|0
5445832|NCT02213133|18814853|P1|Overall Study|Participant discontinued study therapy|2
5445833|NCT02213094|18814869|P2|Overall Study|Adverse Event|0
5445834|NCT02213094|18814870|P1|Overall Study|Adverse Event|1
5445835|NCT02213055|18814878|P2|Overall Study|Did not Return to School|0
5445836|NCT02213055|18814879|P1|Overall Study|Did not Return to School|5
5445837|NCT02213055|18814878|P2|Overall Study|Did not meet Inclusion Criteria|0
5445838|NCT02213055|18814879|P1|Overall Study|Did not meet Inclusion Criteria|6
5445839|NCT02213055|18814878|P2|Overall Study|Had another Treatment during the Study|0
5445840|NCT02213055|18814879|P1|Overall Study|Had another Treatment during the Study|3
5445841|NCT02213055|18814878|P2|Overall Study|Did not have Live Lice|0
5445842|NCT02213055|18814879|P1|Overall Study|Did not have Live Lice|8
5445843|NCT02213055|18814878|P2|Overall Study|Documentation Issue during Study|0
5445844|NCT02213055|18814879|P1|Overall Study|Documentation Issue during Study|10
5445845|NCT02213055|18814878|P2|Overall Study|Documentation Issue at Enrollment|0
5445846|NCT02213055|18814879|P1|Overall Study|Documentation Issue at Enrollment|1
5445847|NCT02213055|18814878|P2|Overall Study|Protocol was not Followed during Study|0
5445848|NCT02213055|18814879|P1|Overall Study|Protocol was not Followed during Study|1
5445849|NCT02213055|18814878|P2|Overall Study|Protocol was not Followed at Enrollment|0
5445850|NCT02213055|18814879|P1|Overall Study|Protocol was not Followed at Enrollment|5
5445851|NCT02212730|18814913|P2|Overall Study|Disease progression prior to RCC surgery|1
5445852|NCT02212730|18814914|P1|Overall Study|Disease progression prior to RCC surgery|0
5445853|NCT02212730|18814913|P2|Overall Study|Withdrawal by Subject|0
5445854|NCT02212730|18814914|P1|Overall Study|Withdrawal by Subject|1
5445855|NCT02212730|18814913|P2|Overall Study|Tumor not of the required cell histology|0
5445856|NCT02212730|18814914|P1|Overall Study|Tumor not of the required cell histology|1
5445857|NCT02212678|18814936|P1|Overall Study|Adverse Event|1
5445858|NCT02212457|18814956|P6|Overall Study|Other|1
5445859|NCT02212457|18814957|P5|Overall Study|Other|0
5445860|NCT02212457|18814958|P4|Overall Study|Other|1
5445861|NCT02212457|18814959|P3|Overall Study|Other|2
5445862|NCT02212457|18814960|P2|Overall Study|Other|1
5445863|NCT02212457|18814961|P1|Overall Study|Other|2
5445864|NCT02212457|18814956|P6|Overall Study|Protocol Violation|3
5445865|NCT02212457|18814957|P5|Overall Study|Protocol Violation|2
5445866|NCT02212457|18814958|P4|Overall Study|Protocol Violation|1
5445867|NCT02212457|18814959|P3|Overall Study|Protocol Violation|0
5445868|NCT02212457|18814960|P2|Overall Study|Protocol Violation|1
5445869|NCT02212457|18814961|P1|Overall Study|Protocol Violation|2
5445870|NCT02212457|18814956|P6|Overall Study|Lost to Follow-up|4
5445871|NCT02212457|18814957|P5|Overall Study|Lost to Follow-up|8
5445872|NCT02212457|18814958|P4|Overall Study|Lost to Follow-up|1
5445873|NCT02212457|18814959|P3|Overall Study|Lost to Follow-up|4
5445874|NCT02212457|18814960|P2|Overall Study|Lost to Follow-up|7
5445875|NCT02212457|18814961|P1|Overall Study|Lost to Follow-up|6
5445876|NCT02212457|18814956|P6|Overall Study|Withdrawal by Subject|4
5445877|NCT02212457|18814957|P5|Overall Study|Withdrawal by Subject|5
5445878|NCT02212457|18814958|P4|Overall Study|Withdrawal by Subject|6
5445879|NCT02212457|18814959|P3|Overall Study|Withdrawal by Subject|8
5445880|NCT02212457|18814960|P2|Overall Study|Withdrawal by Subject|10
5445881|NCT02212457|18814961|P1|Overall Study|Withdrawal by Subject|8
5445882|NCT02212457|18814956|P6|Overall Study|Adverse Event|1
5445883|NCT02212457|18814957|P5|Overall Study|Adverse Event|0
5445884|NCT02212457|18814958|P4|Overall Study|Adverse Event|2
5445885|NCT02212457|18814959|P3|Overall Study|Adverse Event|2
5445886|NCT02212457|18814960|P2|Overall Study|Adverse Event|2
5445887|NCT02212457|18814961|P1|Overall Study|Adverse Event|1
5445888|NCT02212301|18815085|P2|Period 1|Lost to Follow-up|1
5445889|NCT02212301|18815086|P1|Period 1|Lost to Follow-up|0
5445890|NCT02212197|18815097|P3|Overall Study|Need for radiotherapy|0
5445891|NCT02212197|18815098|P2|Overall Study|Need for radiotherapy|0
5445892|NCT02212197|18815099|P1|Overall Study|Need for radiotherapy|1
5445893|NCT02211638|18815152|P1|Overall Study|Protocol Violation|692
5445894|NCT02211638|18815152|P1|Overall Study|Case Report Forms Uncollected|291
5445895|NCT02211313|18815199|P2|Overall Study|No Follow up Questionnaires|1
5445896|NCT02211313|18815200|P1|Overall Study|No Follow up Questionnaires|1
5445897|NCT02211313|18815199|P2|Overall Study|Treatment Failure|2
5445898|NCT02211313|18815200|P1|Overall Study|Treatment Failure|5
5445899|NCT02211261|18815217|P11|Overall Study|Lost to Follow-up|0
5445900|NCT02211261|18815218|P10|Overall Study|Lost to Follow-up|0
5445901|NCT02211261|18815219|P9|Overall Study|Lost to Follow-up|0
5445902|NCT02211261|18815220|P8|Overall Study|Lost to Follow-up|1
5445903|NCT02211261|18815221|P7|Overall Study|Lost to Follow-up|0
5445904|NCT02211261|18815222|P6|Overall Study|Lost to Follow-up|0
5445905|NCT02211261|18815223|P5|Overall Study|Lost to Follow-up|0
5445906|NCT02211261|18815224|P4|Overall Study|Lost to Follow-up|0
5445907|NCT02211261|18815225|P3|Overall Study|Lost to Follow-up|0
5445908|NCT02211261|18815226|P2|Overall Study|Lost to Follow-up|0
5445909|NCT02211261|18815227|P1|Overall Study|Lost to Follow-up|0
5445910|NCT02211261|18815217|P11|Overall Study|Other|0
5445911|NCT02211261|18815218|P10|Overall Study|Other|2
5445912|NCT02211261|18815219|P9|Overall Study|Other|0
5445913|NCT02211261|18815220|P8|Overall Study|Other|0
5445914|NCT02211261|18815221|P7|Overall Study|Other|0
5445915|NCT02211261|18815222|P6|Overall Study|Other|1
5445916|NCT02211261|18815223|P5|Overall Study|Other|0
5445917|NCT02211261|18815224|P4|Overall Study|Other|0
5445918|NCT02211261|18815225|P3|Overall Study|Other|0
5445919|NCT02211261|18815226|P2|Overall Study|Other|0
5445920|NCT02211261|18815227|P1|Overall Study|Other|0
5445921|NCT02211261|18815217|P11|Overall Study|Withdrawal by Subject|0
5445922|NCT02211261|18815218|P10|Overall Study|Withdrawal by Subject|0
5445923|NCT02211261|18815219|P9|Overall Study|Withdrawal by Subject|0
5445924|NCT02211261|18815220|P8|Overall Study|Withdrawal by Subject|0
5445925|NCT02211261|18815221|P7|Overall Study|Withdrawal by Subject|0
5445926|NCT02211261|18815222|P6|Overall Study|Withdrawal by Subject|0
5445927|NCT02211261|18815223|P5|Overall Study|Withdrawal by Subject|2
5445928|NCT02211261|18815224|P4|Overall Study|Withdrawal by Subject|0
5445929|NCT02211261|18815225|P3|Overall Study|Withdrawal by Subject|1
5445930|NCT02211261|18815226|P2|Overall Study|Withdrawal by Subject|0
5445931|NCT02211261|18815227|P1|Overall Study|Withdrawal by Subject|0
5445932|NCT02211131|18815350|P2|Overall Study|Continuing on Study|60
5445933|NCT02211131|18815351|P1|Overall Study|Continuing on Study|49
5445934|NCT02211131|18815350|P2|Overall Study|Withdrawal by Subject|4
5445935|NCT02211131|18815351|P1|Overall Study|Withdrawal by Subject|3
5445936|NCT02211131|18815350|P2|Overall Study|Decision by Sponsor|1
5445937|NCT02211131|18815351|P1|Overall Study|Decision by Sponsor|1
5445938|NCT02211131|18815350|P2|Overall Study|Lost to Follow-up|0
5445939|NCT02211131|18815351|P1|Overall Study|Lost to Follow-up|1
5445940|NCT02211131|18815350|P2|Overall Study|Death|11
5445941|NCT02211131|18815351|P1|Overall Study|Death|20
5445942|NCT02211014|18815385|P2|Overall Study|In agreement with patient, no benefit|1
5445943|NCT02211014|18815386|P1|Overall Study|In agreement with patient, no benefit|0
5445944|NCT02211014|18815385|P2|Overall Study|Withdrawal by Subject|1
5445945|NCT02211014|18815386|P1|Overall Study|Withdrawal by Subject|0
5445946|NCT02211014|18815385|P2|Overall Study|Started another cancer therapy|0
5445947|NCT02211014|18815386|P1|Overall Study|Started another cancer therapy|1
5445948|NCT02211014|18815385|P2|Overall Study|Physician Decision|2
5445949|NCT02211014|18815386|P1|Overall Study|Physician Decision|1
5445950|NCT02211014|18815385|P2|Overall Study|Adverse Event|2
5445951|NCT02211014|18815386|P1|Overall Study|Adverse Event|0
5445952|NCT02210780|18815412|P2|Overall Study|Other than specified above|1
5445953|NCT02210780|18815413|P1|Overall Study|Other than specified above|0
5445954|NCT02210780|18815412|P2|Overall Study|Protocol Violation|0
5445955|NCT02210780|18815413|P1|Overall Study|Protocol Violation|1
5445956|NCT02210780|18815412|P2|Overall Study|Physician Decision|0
5445957|NCT02210780|18815413|P1|Overall Study|Physician Decision|1
5445958|NCT02210780|18815412|P2|Overall Study|Withdrawal by Subject|1
5445959|NCT02210780|18815413|P1|Overall Study|Withdrawal by Subject|1
5445960|NCT02210780|18815412|P2|Overall Study|Lost to Follow-up|1
5445961|NCT02210780|18815413|P1|Overall Study|Lost to Follow-up|2
5445962|NCT02210780|18815412|P2|Overall Study|Adverse Event|5
5445963|NCT02210780|18815413|P1|Overall Study|Adverse Event|0
5445964|NCT02210689|18815442|P3|Overall Study|Other|8
5445965|NCT02210689|18815443|P2|Overall Study|Other|21
5445966|NCT02210689|18815444|P1|Overall Study|Other|25
5445967|NCT02210689|18815442|P3|Overall Study|Negative Nugent score at baseline|2
5445968|NCT02210689|18815443|P2|Overall Study|Negative Nugent score at baseline|2
5445969|NCT02210689|18815444|P1|Overall Study|Negative Nugent score at baseline|6
5445970|NCT02210689|18815442|P3|Overall Study|Prohibited medication|1
5445971|NCT02210689|18815443|P2|Overall Study|Prohibited medication|8
5445972|NCT02210689|18815444|P1|Overall Study|Prohibited medication|2
5445973|NCT02210689|18815442|P3|Overall Study|Lack of Efficacy|5
5445974|NCT02210689|18815443|P2|Overall Study|Lack of Efficacy|1
5445975|NCT02210689|18815444|P1|Overall Study|Lack of Efficacy|0
5445976|NCT02210689|18815442|P3|Overall Study|Pregnancy|0
5445977|NCT02210689|18815443|P2|Overall Study|Pregnancy|1
5445978|NCT02210689|18815444|P1|Overall Study|Pregnancy|0
5445979|NCT02210689|18815442|P3|Overall Study|Lost to Follow-up|5
5445980|NCT02210689|18815443|P2|Overall Study|Lost to Follow-up|9
5445981|NCT02210689|18815444|P1|Overall Study|Lost to Follow-up|11
5445982|NCT02210689|18815442|P3|Overall Study|Protocol Violation|0
5445983|NCT02210689|18815443|P2|Overall Study|Protocol Violation|0
5445984|NCT02210689|18815444|P1|Overall Study|Protocol Violation|1
5445985|NCT02210689|18815442|P3|Overall Study|Adverse Event|0
5445986|NCT02210689|18815443|P2|Overall Study|Adverse Event|1
5445987|NCT02210689|18815444|P1|Overall Study|Adverse Event|0
5445988|NCT02210689|18815442|P3|Overall Study|Withdrawal by Subject|2
5445989|NCT02210689|18815443|P2|Overall Study|Withdrawal by Subject|4
5445990|NCT02210689|18815444|P1|Overall Study|Withdrawal by Subject|7
5445991|NCT02210221|18815452|P1|Overall Study|Withdrawal by Subject|43
5445992|NCT02210221|18815452|P1|Overall Study|Lack of Efficacy|7
5445993|NCT02210208|18815467|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
5445994|NCT02210208|18815467|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
5445995|NCT02210208|18815467|P1|Period A (Graft Site)|Withdrawal by Subject|1
5445996|NCT02210091|18815487|P2|Overall Study|Withdrawal by Sponsor|1
5445997|NCT02210091|18815488|P1|Overall Study|Withdrawal by Sponsor|0
5445998|NCT02210091|18815487|P2|Overall Study|Physician Decision|1
5445999|NCT02210091|18815488|P1|Overall Study|Physician Decision|0
5446000|NCT02210000|18815575|P2|Overall Study|Physician Decision|1
5446001|NCT02210000|18815576|P1|Overall Study|Physician Decision|0
5446002|NCT02210000|18815575|P2|Overall Study|Lost to Follow-up|2
5446003|NCT02210000|18815576|P1|Overall Study|Lost to Follow-up|0
5446004|NCT02210000|18815575|P2|Overall Study|Adverse Event|5
5446005|NCT02210000|18815576|P1|Overall Study|Adverse Event|1
5446006|NCT02210000|18815575|P2|Overall Study|Withdrawal by Subject|1
5446007|NCT02210000|18815576|P1|Overall Study|Withdrawal by Subject|7
5446008|NCT02210000|18815575|P2|Overall Study|Study Terminated|12
5446009|NCT02210000|18815576|P1|Overall Study|Study Terminated|11
5446010|NCT02209766|18815602|P5|Overall Study|Withdrawal by Subject|0
5446011|NCT02209766|18815603|P4|Overall Study|Withdrawal by Subject|1
5446012|NCT02209766|18815604|P3|Overall Study|Withdrawal by Subject|0
5446013|NCT02209766|18815605|P2|Overall Study|Withdrawal by Subject|0
5446014|NCT02209766|18815606|P1|Overall Study|Withdrawal by Subject|0
5446015|NCT02209597|18815665|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
5446016|NCT02209597|18815665|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
5446017|NCT02209597|18815665|P1|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
5446018|NCT02209597|18815665|P1|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
5446019|NCT02209506|18815710|P5|Overall Study|Withdrawal by Subject|1
5446020|NCT02209506|18815711|P4|Overall Study|Withdrawal by Subject|0
5446021|NCT02209506|18815712|P3|Overall Study|Withdrawal by Subject|0
5446022|NCT02209506|18815713|P2|Overall Study|Withdrawal by Subject|0
5446023|NCT02209506|18815714|P1|Overall Study|Withdrawal by Subject|0
5446024|NCT02209454|18815789|P2|Second Period|Adverse Event|0
5446025|NCT02209454|18815790|P1|Second Period|Adverse Event|1
5446026|NCT02209181|18815840|P4|Overall Study|Withdrawal by Subject|0
5446027|NCT02209181|18815841|P3|Overall Study|Withdrawal by Subject|0
5446028|NCT02209181|18815842|P2|Overall Study|Withdrawal by Subject|1
5446029|NCT02209181|18815843|P1|Overall Study|Withdrawal by Subject|0
5446030|NCT02209181|18815840|P4|Overall Study|Adverse Event|0
5446031|NCT02209181|18815841|P3|Overall Study|Adverse Event|1
5446032|NCT02209181|18815842|P2|Overall Study|Adverse Event|0
5446033|NCT02209181|18815843|P1|Overall Study|Adverse Event|1
5446034|NCT02208999|18816014|P1|Overall Study|Lost to Follow-up|1
5446035|NCT02208843|18816036|P1|Overall Study|Switched to commercial afatinib|20
5446036|NCT02208843|18816036|P1|Overall Study|Withdrawal by Subject|1
5446037|NCT02208843|18816036|P1|Overall Study|Protocol Violation|1
5446038|NCT02208843|18816036|P1|Overall Study|Adverse Event|12
5446039|NCT02208843|18816036|P1|Overall Study|Progression disease according to RECIST|24
5446040|NCT02208843|18816036|P1|Overall Study|Clinical symptoms of progression|2
5446041|NCT02208089|18816107|P2|Overall Study|Lost to Follow-up|0
5446042|NCT02208089|18816108|P1|Overall Study|Lost to Follow-up|6
5446043|NCT02208089|18816107|P2|Overall Study|Withdrawal by Subject|0
5446044|NCT02208089|18816108|P1|Overall Study|Withdrawal by Subject|1
5446045|NCT02208063|18816124|P2|Overall Study|Lost to Follow-up|0
5446046|NCT02208063|18816125|P1|Overall Study|Lost to Follow-up|1
5446047|NCT02208063|18816124|P2|Overall Study|Withdrawal by Subject|2
5446048|NCT02208063|18816125|P1|Overall Study|Withdrawal by Subject|5
5446049|NCT02208063|18816124|P2|Overall Study|Not Specified in report|4
5446050|NCT02208063|18816125|P1|Overall Study|Not Specified in report|3
5446051|NCT02208063|18816124|P2|Overall Study|Death|5
5446052|NCT02208063|18816125|P1|Overall Study|Death|3
5446053|NCT02207907|18816204|P2|Overall Study|Pregnancy|1
5446054|NCT02207907|18816205|P1|Overall Study|Pregnancy|0
5446055|NCT02207907|18816204|P2|Overall Study|Did not meet study criteria|0
5446056|NCT02207907|18816205|P1|Overall Study|Did not meet study criteria|3
5446057|NCT02207907|18816204|P2|Overall Study|Withdrawal by Subject|6
5446058|NCT02207907|18816205|P1|Overall Study|Withdrawal by Subject|5
5446059|NCT02207907|18816204|P2|Overall Study|Lost to Follow-up|1
5446060|NCT02207907|18816205|P1|Overall Study|Lost to Follow-up|3
5446061|NCT02207829|18816223|P2|Overall Study|Withdrew consent|14
5446062|NCT02207829|18816224|P1|Overall Study|Withdrew consent|18
5446063|NCT02207829|18816223|P2|Overall Study|Protocol deviation|4
5446064|NCT02207829|18816224|P1|Overall Study|Protocol deviation|5
5446065|NCT02207829|18816223|P2|Overall Study|Lost to Follow-up|2
5446066|NCT02207829|18816224|P1|Overall Study|Lost to Follow-up|2
5446067|NCT02207829|18816223|P2|Overall Study|Lack of Efficacy|5
5446068|NCT02207829|18816224|P1|Overall Study|Lack of Efficacy|7
5446069|NCT02207829|18816223|P2|Overall Study|Adverse Event|9
5446070|NCT02207829|18816224|P1|Overall Study|Adverse Event|10
5446071|NCT02207816|18816233|P3|Overall Study|Other|4
5446072|NCT02207816|18816234|P2|Overall Study|Other|2
5446073|NCT02207816|18816235|P1|Overall Study|Other|1
5446074|NCT02207816|18816233|P3|Overall Study|Lost to Follow-up|1
5446075|NCT02207816|18816234|P2|Overall Study|Lost to Follow-up|9
5446076|NCT02207816|18816235|P1|Overall Study|Lost to Follow-up|3
5446077|NCT02207816|18816233|P3|Overall Study|Migrated/Moved From Study Area|51
5446078|NCT02207816|18816234|P2|Overall Study|Migrated/Moved From Study Area|60
5446079|NCT02207816|18816235|P1|Overall Study|Migrated/Moved From Study Area|41
5446080|NCT02207816|18816233|P3|Overall Study|Withdrawal by Subject|7
5446081|NCT02207816|18816234|P2|Overall Study|Withdrawal by Subject|9
5446082|NCT02207816|18816235|P1|Overall Study|Withdrawal by Subject|4
5446083|NCT02207816|18816233|P3|Overall Study|Eligibility Criteria Not Fulfilled|2
5446084|NCT02207816|18816234|P2|Overall Study|Eligibility Criteria Not Fulfilled|1
5446085|NCT02207816|18816235|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
5446086|NCT02207816|18816233|P3|Overall Study|Serious Adverse Event|2
5446087|NCT02207816|18816234|P2|Overall Study|Serious Adverse Event|5
5446088|NCT02207816|18816235|P1|Overall Study|Serious Adverse Event|0
5446089|NCT02207725|18816393|P4|Overall Study|Did Not Receive Treatment|1
5446090|NCT02207725|18816394|P3|Overall Study|Did Not Receive Treatment|1
5446091|NCT02207725|18816395|P2|Overall Study|Did Not Receive Treatment|1
5446092|NCT02207725|18816396|P1|Overall Study|Did Not Receive Treatment|0
5446093|NCT02207634|18816426|P2|Overall Study|Lost to Follow-up|0
5446094|NCT02207634|18816427|P1|Overall Study|Lost to Follow-up|1
5446095|NCT02207634|18816426|P2|Overall Study|Withdrawal by Subject|31
5446096|NCT02207634|18816427|P1|Overall Study|Withdrawal by Subject|21
5446097|NCT02207621|18816442|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
5446098|NCT02207621|18816443|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
5446099|NCT02207621|18816444|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
5446100|NCT02207621|18816442|P3|Overall Study|Death|0
5446101|NCT02207621|18816443|P2|Overall Study|Death|0
5446102|NCT02207621|18816444|P1|Overall Study|Death|2
5446103|NCT02207621|18816442|P3|Overall Study|Protocol Violation|6
5446104|NCT02207621|18816443|P2|Overall Study|Protocol Violation|10
5446105|NCT02207621|18816444|P1|Overall Study|Protocol Violation|4
5446106|NCT02207621|18816442|P3|Overall Study|Physician Decision|2
5446107|NCT02207621|18816443|P2|Overall Study|Physician Decision|2
5446108|NCT02207621|18816444|P1|Overall Study|Physician Decision|1
5446109|NCT02207621|18816442|P3|Overall Study|Disallowed Concurrent Medication|2
5446110|NCT02207621|18816443|P2|Overall Study|Disallowed Concurrent Medication|5
5446111|NCT02207621|18816444|P1|Overall Study|Disallowed Concurrent Medication|2
5446112|NCT02207621|18816442|P3|Overall Study|Lack of Efficacy|4
5446113|NCT02207621|18816443|P2|Overall Study|Lack of Efficacy|2
5446114|NCT02207621|18816444|P1|Overall Study|Lack of Efficacy|10
5446115|NCT02207621|18816442|P3|Overall Study|Lost to Follow-up|3
5446116|NCT02207621|18816443|P2|Overall Study|Lost to Follow-up|0
5446117|NCT02207621|18816444|P1|Overall Study|Lost to Follow-up|1
5446118|NCT02207621|18816442|P3|Overall Study|Non-Compliant|1
5446119|NCT02207621|18816443|P2|Overall Study|Non-Compliant|3
5446120|NCT02207621|18816444|P1|Overall Study|Non-Compliant|3
5446121|NCT02207621|18816442|P3|Overall Study|Withdrawal by Subject|13
5446122|NCT02207621|18816443|P2|Overall Study|Withdrawal by Subject|9
5446123|NCT02207621|18816444|P1|Overall Study|Withdrawal by Subject|9
5446124|NCT02207621|18816442|P3|Overall Study|Adverse Event|132
5446125|NCT02207621|18816443|P2|Overall Study|Adverse Event|15
5446126|NCT02207621|18816444|P1|Overall Study|Adverse Event|71
5446127|NCT02207608|18816457|P2|Overall Study|Adverse Event|0
5446128|NCT02207608|18816458|P1|Overall Study|Adverse Event|1
5446129|NCT02207556|18816484|P2|Overall Study|Death|5
5446130|NCT02207556|18816485|P1|Overall Study|Death|0
5446131|NCT02207556|18816484|P2|Overall Study|Withdrawal by Subject|0
5446132|NCT02207556|18816485|P1|Overall Study|Withdrawal by Subject|1
5446133|NCT02207556|18816484|P2|Overall Study|Physician Decision|0
5446134|NCT02207556|18816485|P1|Overall Study|Physician Decision|1
5446135|NCT02207530|18816490|P1|Overall Study|Adverse Event|8
5446136|NCT02207530|18816490|P1|Overall Study|Patient decision to stop study treatment|5
5446137|NCT02207530|18816490|P1|Overall Study|Worsening condition under investigation|78
5446138|NCT02207491|18816504|P2|Overall Study|Protocol Violation|5
5446139|NCT02207491|18816505|P1|Overall Study|Protocol Violation|3
5446140|NCT02207491|18816504|P2|Overall Study|Physician Decision|0
5446141|NCT02207491|18816505|P1|Overall Study|Physician Decision|2
5446142|NCT02207491|18816504|P2|Overall Study|Lack of Efficacy|0
5446143|NCT02207491|18816505|P1|Overall Study|Lack of Efficacy|3
5446144|NCT02207491|18816504|P2|Overall Study|Lost to Follow-up|1
5446145|NCT02207491|18816505|P1|Overall Study|Lost to Follow-up|0
5446146|NCT02207491|18816504|P2|Overall Study|Non-compliant|1
5446147|NCT02207491|18816505|P1|Overall Study|Non-compliant|0
5446148|NCT02207491|18816504|P2|Overall Study|Withdrawal by Subject|2
5446149|NCT02207491|18816505|P1|Overall Study|Withdrawal by Subject|3
5446150|NCT02207491|18816504|P2|Overall Study|Adverse Event|4
5446151|NCT02207491|18816505|P1|Overall Study|Adverse Event|20
5446152|NCT02207413|18816530|P6|Overall Study|Migrated/moved from study area|0
5446153|NCT02207413|18816531|P5|Overall Study|Migrated/moved from study area|1
5446154|NCT02207413|18816532|P4|Overall Study|Migrated/moved from study area|0
5446155|NCT02207413|18816533|P3|Overall Study|Migrated/moved from study area|0
5446156|NCT02207413|18816534|P2|Overall Study|Migrated/moved from study area|0
5446157|NCT02207413|18816535|P1|Overall Study|Migrated/moved from study area|0
5446158|NCT02207413|18816530|P6|Overall Study|Adverse Event|1
5446159|NCT02207413|18816531|P5|Overall Study|Adverse Event|2
5446160|NCT02207413|18816532|P4|Overall Study|Adverse Event|0
5446161|NCT02207413|18816533|P3|Overall Study|Adverse Event|0
5446162|NCT02207413|18816534|P2|Overall Study|Adverse Event|0
5446163|NCT02207413|18816535|P1|Overall Study|Adverse Event|0
5446164|NCT02207413|18816530|P6|Overall Study|Lost to Follow-up|5
5446165|NCT02207413|18816531|P5|Overall Study|Lost to Follow-up|1
5446166|NCT02207413|18816532|P4|Overall Study|Lost to Follow-up|1
5446167|NCT02207413|18816533|P3|Overall Study|Lost to Follow-up|0
5446168|NCT02207413|18816534|P2|Overall Study|Lost to Follow-up|0
5446169|NCT02207413|18816535|P1|Overall Study|Lost to Follow-up|0
5446170|NCT02207413|18816530|P6|Overall Study|Withdrawal by Subject|7
5446171|NCT02207413|18816531|P5|Overall Study|Withdrawal by Subject|3
5446172|NCT02207413|18816532|P4|Overall Study|Withdrawal by Subject|0
5446173|NCT02207413|18816533|P3|Overall Study|Withdrawal by Subject|0
5446174|NCT02207413|18816534|P2|Overall Study|Withdrawal by Subject|0
5446175|NCT02207413|18816535|P1|Overall Study|Withdrawal by Subject|1
5446176|NCT02207400|18816631|P2|Overall Study|Positive Urine Pregnancy Test|1
5446177|NCT02207400|18816632|P1|Overall Study|Positive Urine Pregnancy Test|0
5446178|NCT02207400|18816631|P2|Overall Study|Withdrawal by Subject|4
5446179|NCT02207400|18816632|P1|Overall Study|Withdrawal by Subject|8
5446180|NCT02207400|18816631|P2|Overall Study|Protocol Violation|1
5446181|NCT02207400|18816632|P1|Overall Study|Protocol Violation|1
5446182|NCT02207400|18816631|P2|Overall Study|Lost to Follow-up|7
5446183|NCT02207400|18816632|P1|Overall Study|Lost to Follow-up|6
5446184|NCT02207400|18816631|P2|Overall Study|Adverse Event|1
5446185|NCT02207400|18816632|P1|Overall Study|Adverse Event|1
5446186|NCT02207374|18816653|P3|Overall Study|Missing follow-up information|1
5446187|NCT02207374|18816654|P2|Overall Study|Missing follow-up information|1
5446188|NCT02207374|18816655|P1|Overall Study|Missing follow-up information|0
5446189|NCT02207374|18816653|P3|Overall Study|Death|1
5446190|NCT02207374|18816654|P2|Overall Study|Death|0
5446191|NCT02207374|18816655|P1|Overall Study|Death|1
5446192|NCT02207374|18816653|P3|Overall Study|Withdrawal by Subject|4
5446193|NCT02207374|18816654|P2|Overall Study|Withdrawal by Subject|9
5446194|NCT02207374|18816655|P1|Overall Study|Withdrawal by Subject|5
5446195|NCT02207244|18816719|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
5446196|NCT02207244|18816720|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
5446197|NCT02207244|18816721|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
5446198|NCT02207244|18816722|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
5446199|NCT02207244|18816723|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
5446200|NCT02207244|18816724|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
5446201|NCT02207244|18816725|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
5446202|NCT02207244|18816726|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
5446203|NCT02207244|18816727|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
5446204|NCT02207244|18816719|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5446205|NCT02207244|18816720|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5446206|NCT02207244|18816721|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
5446207|NCT02207244|18816722|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5446208|NCT02207244|18816723|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5446209|NCT02207244|18816724|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5446210|NCT02207244|18816725|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5446211|NCT02207244|18816726|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5446212|NCT02207244|18816727|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
5446213|NCT02207244|18816719|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5446214|NCT02207244|18816720|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5446215|NCT02207244|18816721|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
5446216|NCT02207244|18816722|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5446217|NCT02207244|18816723|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5446218|NCT02207244|18816724|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5446219|NCT02207244|18816725|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5446220|NCT02207244|18816726|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5446221|NCT02207244|18816727|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
5446222|NCT02207244|18816719|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
5446223|NCT02207244|18816720|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
5446224|NCT02207244|18816721|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
5446225|NCT02207244|18816722|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5446226|NCT02207244|18816723|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5446227|NCT02207244|18816724|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5446228|NCT02207244|18816725|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5446229|NCT02207244|18816726|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5446230|NCT02207244|18816727|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
5446231|NCT02207244|18816719|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
5446232|NCT02207244|18816720|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
5446233|NCT02207244|18816721|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
5446234|NCT02207244|18816722|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5446235|NCT02207244|18816723|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5446236|NCT02207244|18816724|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5446237|NCT02207244|18816725|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5446238|NCT02207244|18816726|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5446239|NCT02207244|18816727|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
5446240|NCT02207244|18816719|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
5446241|NCT02207244|18816720|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
5446242|NCT02207244|18816721|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5446243|NCT02207244|18816722|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5446244|NCT02207244|18816723|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5446245|NCT02207244|18816724|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5446246|NCT02207244|18816725|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5446247|NCT02207244|18816726|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5446248|NCT02207244|18816727|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
5446249|NCT02207244|18816719|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5446250|NCT02207244|18816720|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
5446251|NCT02207244|18816721|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5446252|NCT02207244|18816722|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5446253|NCT02207244|18816723|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5446254|NCT02207244|18816724|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5446255|NCT02207244|18816725|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5446256|NCT02207244|18816726|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5446257|NCT02207244|18816727|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
5446258|NCT02207244|18816719|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
5446259|NCT02207244|18816720|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
5446260|NCT02207244|18816721|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
5446261|NCT02207244|18816722|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5446262|NCT02207244|18816723|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5446263|NCT02207244|18816724|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5446264|NCT02207244|18816725|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5446265|NCT02207244|18816726|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5446266|NCT02207244|18816727|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
5446267|NCT02207244|18816719|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
5446268|NCT02207244|18816720|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
5446269|NCT02207244|18816721|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
5446270|NCT02207244|18816722|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
5446271|NCT02207244|18816723|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
5446272|NCT02207244|18816724|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
5446273|NCT02207244|18816725|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
5446274|NCT02207244|18816726|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
5446275|NCT02207244|18816727|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
5446276|NCT02207244|18816719|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5446277|NCT02207244|18816720|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5446278|NCT02207244|18816721|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5446279|NCT02207244|18816722|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
5446280|NCT02207244|18816723|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5446281|NCT02207244|18816724|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
5446282|NCT02207244|18816725|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5446283|NCT02207244|18816726|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5446284|NCT02207244|18816727|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
5446285|NCT02207244|18816719|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5446286|NCT02207244|18816720|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5446287|NCT02207244|18816721|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5446288|NCT02207244|18816722|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
5446289|NCT02207244|18816723|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
5446290|NCT02207244|18816724|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
5446291|NCT02207244|18816725|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5446292|NCT02207244|18816726|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5446293|NCT02207244|18816727|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
5446294|NCT02207244|18816719|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5446295|NCT02207244|18816720|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5446296|NCT02207244|18816721|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5446297|NCT02207244|18816722|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
5446298|NCT02207244|18816723|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
5446299|NCT02207244|18816724|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
5446300|NCT02207244|18816725|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5446301|NCT02207244|18816726|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5446302|NCT02207244|18816727|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
5446303|NCT02207244|18816719|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5446304|NCT02207244|18816720|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5446305|NCT02207244|18816721|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5446306|NCT02207244|18816722|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
5446307|NCT02207244|18816723|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5446308|NCT02207244|18816724|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5446309|NCT02207244|18816725|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5446310|NCT02207244|18816726|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5446311|NCT02207244|18816727|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
5446312|NCT02207244|18816719|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5446313|NCT02207244|18816720|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5446314|NCT02207244|18816721|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5446315|NCT02207244|18816722|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
5446316|NCT02207244|18816723|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
5446317|NCT02207244|18816724|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5446318|NCT02207244|18816725|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5446319|NCT02207244|18816726|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5446320|NCT02207244|18816727|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
5446321|NCT02207244|18816719|P9|Placebo Controlled Period: Week 0 - 16|Other|0
5446322|NCT02207244|18816720|P8|Placebo Controlled Period: Week 0 - 16|Other|0
5446323|NCT02207244|18816721|P7|Placebo Controlled Period: Week 0 - 16|Other|0
5446324|NCT02207244|18816722|P6|Placebo Controlled Period: Week 0 - 16|Other|0
5446325|NCT02207244|18816723|P5|Placebo Controlled Period: Week 0 - 16|Other|0
5446326|NCT02207244|18816724|P4|Placebo Controlled Period: Week 0 - 16|Other|0
5446327|NCT02207244|18816725|P3|Placebo Controlled Period: Week 0 - 16|Other|0
5446328|NCT02207244|18816726|P2|Placebo Controlled Period: Week 0 - 16|Other|1
5446329|NCT02207244|18816727|P1|Placebo Controlled Period: Week 0 - 16|Other|0
5446330|NCT02207244|18816719|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5446331|NCT02207244|18816720|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5446332|NCT02207244|18816721|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5446333|NCT02207244|18816722|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5446334|NCT02207244|18816723|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5446335|NCT02207244|18816724|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5446336|NCT02207244|18816725|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
5446337|NCT02207244|18816726|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
5446338|NCT02207244|18816727|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
5446339|NCT02207244|18816719|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5446340|NCT02207244|18816720|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5446341|NCT02207244|18816721|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5446342|NCT02207244|18816722|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5446343|NCT02207244|18816723|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5446344|NCT02207244|18816724|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5446345|NCT02207244|18816725|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
5446346|NCT02207244|18816726|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
5446347|NCT02207244|18816727|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
5446348|NCT02207244|18816719|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5446349|NCT02207244|18816720|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5446350|NCT02207244|18816721|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5446351|NCT02207244|18816722|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5446352|NCT02207244|18816723|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5446353|NCT02207244|18816724|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5446354|NCT02207244|18816725|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5446355|NCT02207244|18816726|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
5446356|NCT02207244|18816727|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
5446357|NCT02207244|18816719|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5446358|NCT02207244|18816720|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5446359|NCT02207244|18816721|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5446360|NCT02207244|18816722|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5446361|NCT02207244|18816723|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5446362|NCT02207244|18816724|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
5446363|NCT02207244|18816725|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
5446364|NCT02207244|18816726|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
5446365|NCT02207244|18816727|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5446366|NCT02207244|18816719|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5446367|NCT02207244|18816720|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5446368|NCT02207244|18816721|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5446369|NCT02207244|18816722|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5446370|NCT02207244|18816723|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5446371|NCT02207244|18816724|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5446372|NCT02207244|18816725|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
5446373|NCT02207244|18816726|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5446374|NCT02207244|18816727|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
5446375|NCT02207244|18816719|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5446376|NCT02207244|18816720|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5446377|NCT02207244|18816721|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5446378|NCT02207244|18816722|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5446379|NCT02207244|18816723|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5446380|NCT02207244|18816724|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
5446381|NCT02207244|18816725|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
5446382|NCT02207244|18816726|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
5446383|NCT02207244|18816727|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
5446384|NCT02207231|18816768|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
5446385|NCT02207231|18816769|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
5446386|NCT02207231|18816770|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
5446387|NCT02207231|18816768|P3|Active Controlled Period: Week 16 - 48|Other|3
5446388|NCT02207231|18816769|P2|Active Controlled Period: Week 16 - 48|Other|2
5446389|NCT02207231|18816770|P1|Active Controlled Period: Week 16 - 48|Other|0
5446390|NCT02207231|18816768|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
5446391|NCT02207231|18816769|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
5446392|NCT02207231|18816770|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
5446393|NCT02207231|18816768|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
5446394|NCT02207231|18816769|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
5446395|NCT02207231|18816770|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
5446396|NCT02207231|18816768|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
5446397|NCT02207231|18816769|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
5446398|NCT02207231|18816770|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
5446399|NCT02207231|18816768|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
5446400|NCT02207231|18816769|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
5446401|NCT02207231|18816770|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
5446402|NCT02207231|18816768|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
5446403|NCT02207231|18816769|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
5446404|NCT02207231|18816770|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
5446405|NCT02207231|18816768|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
5446406|NCT02207231|18816769|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
5446407|NCT02207231|18816770|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
5446408|NCT02207231|18816768|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
5446409|NCT02207231|18816769|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
5446410|NCT02207231|18816770|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
5446411|NCT02207231|18816768|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
5446412|NCT02207231|18816769|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5446413|NCT02207231|18816770|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
5446414|NCT02207231|18816768|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
5446415|NCT02207231|18816769|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
5446416|NCT02207231|18816770|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
5446417|NCT02207231|18816768|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5446418|NCT02207231|18816769|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5446419|NCT02207231|18816770|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
5446420|NCT02207231|18816768|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
5446421|NCT02207231|18816769|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
5446422|NCT02207231|18816770|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
5446423|NCT02207231|18816768|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
5446424|NCT02207231|18816769|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
5446425|NCT02207231|18816770|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
5446426|NCT02207088|18816802|P1|Overall Study|Adverse Event|2
5446427|NCT02206828|18816808|P1|Overall Study|Lost to Follow-up|7
5446428|NCT02206620|18816844|P2|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
5446429|NCT02206620|18816845|P1|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
5446430|NCT02206620|18816844|P2|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
5446431|NCT02206620|18816845|P1|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
5446432|NCT02206607|18816861|P5|Second Intervention Period|Insufficient Clinical Response|0
5446433|NCT02206607|18816862|P4|Second Intervention Period|Insufficient Clinical Response|1
5446434|NCT02206607|18816863|P3|Second Intervention Period|Insufficient Clinical Response|0
5446435|NCT02206607|18816864|P2|Second Intervention Period|Insufficient Clinical Response|0
5446436|NCT02206607|18816865|P1|Second Intervention Period|Insufficient Clinical Response|0
5446437|NCT02206607|18816861|P5|Open-Label Run-In|Withdrawal by Subject|0
5446438|NCT02206607|18816862|P4|Open-Label Run-In|Withdrawal by Subject|0
5446439|NCT02206607|18816863|P3|Open-Label Run-In|Withdrawal by Subject|0
5446440|NCT02206607|18816864|P2|Open-Label Run-In|Withdrawal by Subject|0
5446441|NCT02206607|18816865|P1|Open-Label Run-In|Withdrawal by Subject|3
5446442|NCT02206152|18816928|P1|Pre-Randomization|Withdrawal by Subject|2
5446443|NCT02205814|18816955|P4|Overall Study|not compliant with study procedures|0
5446444|NCT02205814|18816956|P3|Overall Study|not compliant with study procedures|1
5446445|NCT02205814|18816957|P2|Overall Study|not compliant with study procedures|0
5446446|NCT02205814|18816958|P1|Overall Study|not compliant with study procedures|0
5446447|NCT02205814|18816955|P4|Overall Study|Withdrawal by Subject|1
5446448|NCT02205814|18816956|P3|Overall Study|Withdrawal by Subject|2
5446449|NCT02205814|18816957|P2|Overall Study|Withdrawal by Subject|1
5446450|NCT02205814|18816958|P1|Overall Study|Withdrawal by Subject|0
5446451|NCT02205814|18816955|P4|Overall Study|Protocol Violation|1
5446452|NCT02205814|18816956|P3|Overall Study|Protocol Violation|0
5446453|NCT02205814|18816957|P2|Overall Study|Protocol Violation|0
5446454|NCT02205814|18816958|P1|Overall Study|Protocol Violation|1
5446455|NCT02205814|18816955|P4|Overall Study|Physician Decision|0
5446456|NCT02205814|18816956|P3|Overall Study|Physician Decision|1
5446457|NCT02205814|18816957|P2|Overall Study|Physician Decision|0
5446458|NCT02205814|18816958|P1|Overall Study|Physician Decision|0
5446459|NCT02205814|18816955|P4|Overall Study|Lack of Efficacy|1
5446460|NCT02205814|18816956|P3|Overall Study|Lack of Efficacy|1
5446461|NCT02205814|18816957|P2|Overall Study|Lack of Efficacy|0
5446462|NCT02205814|18816958|P1|Overall Study|Lack of Efficacy|1
5446463|NCT02205814|18816955|P4|Overall Study|Lost to Follow-up|1
5446464|NCT02205814|18816956|P3|Overall Study|Lost to Follow-up|0
5446465|NCT02205814|18816957|P2|Overall Study|Lost to Follow-up|0
5446466|NCT02205814|18816958|P1|Overall Study|Lost to Follow-up|0
5446467|NCT02205476|18817011|P2|Overall Study|Study termination by Sponsor|3
5446468|NCT02205476|18817012|P1|Overall Study|Study termination by Sponsor|7
5446469|NCT02205333|18817051|P9|Overall Study|Withdrawal by Subject|0
5446470|NCT02205333|18817052|P8|Overall Study|Withdrawal by Subject|0
5446471|NCT02205333|18817053|P7|Overall Study|Withdrawal by Subject|2
5446472|NCT02205333|18817054|P6|Overall Study|Withdrawal by Subject|0
5446473|NCT02205333|18817055|P5|Overall Study|Withdrawal by Subject|0
5446474|NCT02205333|18817056|P4|Overall Study|Withdrawal by Subject|1
5446475|NCT02205333|18817057|P3|Overall Study|Withdrawal by Subject|0
5446476|NCT02205333|18817058|P2|Overall Study|Withdrawal by Subject|0
5446477|NCT02205333|18817059|P1|Overall Study|Withdrawal by Subject|1
5446478|NCT02205333|18817051|P9|Overall Study|Death|0
5446479|NCT02205333|18817052|P8|Overall Study|Death|2
5446480|NCT02205333|18817053|P7|Overall Study|Death|3
5446481|NCT02205333|18817054|P6|Overall Study|Death|3
5446482|NCT02205333|18817055|P5|Overall Study|Death|5
5446483|NCT02205333|18817056|P4|Overall Study|Death|6
5446484|NCT02205333|18817057|P3|Overall Study|Death|2
5446485|NCT02205333|18817058|P2|Overall Study|Death|6
5446486|NCT02205333|18817059|P1|Overall Study|Death|5
5446487|NCT02204982|18817258|P2|Overall Study|Termination of Study bySponsor|1
5446488|NCT02204982|18817259|P1|Overall Study|Termination of Study bySponsor|0
5446489|NCT02204982|18817258|P2|Overall Study|Protocol-Specified Disease Progression|4
5446490|NCT02204982|18817259|P1|Overall Study|Protocol-Specified Disease Progression|0
5446491|NCT02204982|18817258|P2|Overall Study|Physician Decision|2
5446492|NCT02204982|18817259|P1|Overall Study|Physician Decision|0
5446493|NCT02204982|18817258|P2|Overall Study|Adverse Event and Investigator decision|0
5446494|NCT02204982|18817259|P1|Overall Study|Adverse Event and Investigator decision|1
5446495|NCT02204982|18817258|P2|Overall Study|Adverse Event|0
5446496|NCT02204982|18817259|P1|Overall Study|Adverse Event|1
5446497|NCT02204982|18817258|P2|Overall Study|Withdrawal by Subject|0
5446498|NCT02204982|18817259|P1|Overall Study|Withdrawal by Subject|1
5446499|NCT02204982|18817258|P2|Overall Study|Patient ineligible-medical monitor|0
5446500|NCT02204982|18817259|P1|Overall Study|Patient ineligible-medical monitor|1
5446501|NCT02204917|18817267|P1|Overall Study|Protocol Violation|1
5446502|NCT02204579|18817304|P1|Overall Study|Screen failures|2
5446503|NCT02204449|18817362|P2|Overall Study|Withdrawal by Subject|1
5446504|NCT02204449|18817363|P1|Overall Study|Withdrawal by Subject|0
5446505|NCT02204449|18817362|P2|Overall Study|Death|1
5446506|NCT02204449|18817363|P1|Overall Study|Death|0
5446507|NCT02204449|18817362|P2|Overall Study|Lost to Follow-up|9
5446508|NCT02204449|18817363|P1|Overall Study|Lost to Follow-up|7
5446509|NCT02204410|18817373|P1|Overall Study|Withdrawal by Subject|3
5446510|NCT02204410|18817373|P1|Overall Study|Protocol Violation|1
5446511|NCT02204410|18817373|P1|Overall Study|Physician Decision|2
5446512|NCT02204410|18817373|P1|Overall Study|Lost to Follow-up|5
5446513|NCT02204371|18817378|P1|Overall Study|Adverse Event|1
5446514|NCT02204319|18817401|P1|Overall Study|Withdrawal by Subject|2
5446515|NCT02204319|18817401|P1|Overall Study|Pregnancy|1
5446516|NCT02204293|18817409|P6|LTE Phase|Study Suspended|7
5446517|NCT02204293|18817410|P5|LTE Phase|Study Suspended|0
5446518|NCT02204293|18817411|P4|LTE Phase|Study Suspended|0
5446519|NCT02204293|18817412|P3|LTE Phase|Study Suspended|0
5446520|NCT02204293|18817413|P2|LTE Phase|Study Suspended|0
5446521|NCT02204293|18817414|P1|LTE Phase|Study Suspended|0
5446522|NCT02204293|18817409|P6|Core Study Part I|Physician Decision|0
5446523|NCT02204293|18817410|P5|Core Study Part I|Physician Decision|0
5446524|NCT02204293|18817411|P4|Core Study Part I|Physician Decision|0
5446525|NCT02204293|18817412|P3|Core Study Part I|Physician Decision|0
5446526|NCT02204293|18817413|P2|Core Study Part I|Physician Decision|3
5446527|NCT02204293|18817414|P1|Core Study Part I|Physician Decision|0
5446528|NCT02204293|18817409|P6|Core Study Part I|Adverse Event|0
5446529|NCT02204293|18817410|P5|Core Study Part I|Adverse Event|0
5446530|NCT02204293|18817411|P4|Core Study Part I|Adverse Event|0
5446531|NCT02204293|18817412|P3|Core Study Part I|Adverse Event|0
5446532|NCT02204293|18817413|P2|Core Study Part I|Adverse Event|0
5446533|NCT02204293|18817414|P1|Core Study Part I|Adverse Event|1
5446534|NCT02204293|18817409|P6|Core Study Part I|Met one or more exclusion criteria|0
5446535|NCT02204293|18817410|P5|Core Study Part I|Met one or more exclusion criteria|0
5446536|NCT02204293|18817411|P4|Core Study Part I|Met one or more exclusion criteria|0
5446537|NCT02204293|18817412|P3|Core Study Part I|Met one or more exclusion criteria|0
5446538|NCT02204293|18817413|P2|Core Study Part I|Met one or more exclusion criteria|0
5446539|NCT02204293|18817414|P1|Core Study Part I|Met one or more exclusion criteria|1
5446540|NCT02204007|18817535|P2|Overall Study|Surgery Canceled|1
5446541|NCT02204007|18817536|P1|Overall Study|Surgery Canceled|1
5446542|NCT02203916|18817547|P3|Overall Study|Reason Not Specified|1
5446543|NCT02203916|18817548|P2|Overall Study|Reason Not Specified|2
5446544|NCT02203916|18817549|P1|Overall Study|Reason Not Specified|0
5446545|NCT02203916|18817547|P3|Overall Study|Lack of Efficacy|0
5446546|NCT02203916|18817548|P2|Overall Study|Lack of Efficacy|0
5446547|NCT02203916|18817549|P1|Overall Study|Lack of Efficacy|3
5446548|NCT02203916|18817547|P3|Overall Study|Voluntary Withdrawal|8
5446549|NCT02203916|18817548|P2|Overall Study|Voluntary Withdrawal|3
5446550|NCT02203916|18817549|P1|Overall Study|Voluntary Withdrawal|3
5446551|NCT02203916|18817547|P3|Overall Study|Lost to Follow-up|0
5446552|NCT02203916|18817548|P2|Overall Study|Lost to Follow-up|1
5446553|NCT02203916|18817549|P1|Overall Study|Lost to Follow-up|0
5446554|NCT02203916|18817547|P3|Overall Study|Major Protocol Deviation|0
5446555|NCT02203916|18817548|P2|Overall Study|Major Protocol Deviation|1
5446556|NCT02203916|18817549|P1|Overall Study|Major Protocol Deviation|1
5446557|NCT02203916|18817547|P3|Overall Study|Pretreatment Event/Adverse Event|2
5446558|NCT02203916|18817548|P2|Overall Study|Pretreatment Event/Adverse Event|3
5446559|NCT02203916|18817549|P1|Overall Study|Pretreatment Event/Adverse Event|1
5446560|NCT02203851|18817569|P1|Overall Study|Other|1
5446561|NCT02203851|18817569|P1|Overall Study|Withdrawal by Subject|6
5446562|NCT02203851|18817569|P1|Overall Study|Lost to Follow-up|4
5446563|NCT02203838|18817607|P4|Overall Study|Other|0
5446564|NCT02203838|18817608|P3|Overall Study|Other|0
5446565|NCT02203838|18817609|P2|Overall Study|Other|0
5446566|NCT02203838|18817610|P1|Overall Study|Other|1
5446567|NCT02203838|18817607|P4|Overall Study|Physician Decision|3
5446568|NCT02203838|18817608|P3|Overall Study|Physician Decision|2
5446569|NCT02203838|18817609|P2|Overall Study|Physician Decision|0
5446570|NCT02203838|18817610|P1|Overall Study|Physician Decision|27
5446571|NCT02203838|18817607|P4|Overall Study|Withdrawal by Subject|11
5446572|NCT02203838|18817608|P3|Overall Study|Withdrawal by Subject|8
5446573|NCT02203838|18817609|P2|Overall Study|Withdrawal by Subject|10
5446574|NCT02203838|18817610|P1|Overall Study|Withdrawal by Subject|83
5446575|NCT02203838|18817607|P4|Overall Study|Protocol Violation|0
5446576|NCT02203838|18817608|P3|Overall Study|Protocol Violation|0
5446577|NCT02203838|18817609|P2|Overall Study|Protocol Violation|3
5446578|NCT02203838|18817610|P1|Overall Study|Protocol Violation|7
5446579|NCT02203838|18817607|P4|Overall Study|Lost to Follow-up|1
5446580|NCT02203838|18817608|P3|Overall Study|Lost to Follow-up|2
5446581|NCT02203838|18817609|P2|Overall Study|Lost to Follow-up|3
5446582|NCT02203838|18817610|P1|Overall Study|Lost to Follow-up|39
5446583|NCT02203838|18817607|P4|Overall Study|Adverse Event|2
5446584|NCT02203838|18817608|P3|Overall Study|Adverse Event|3
5446585|NCT02203838|18817609|P2|Overall Study|Adverse Event|6
5446586|NCT02203838|18817610|P1|Overall Study|Adverse Event|46
5446587|NCT02203838|18817607|P4|Overall Study|Lack of Efficacy|1
5446588|NCT02203838|18817608|P3|Overall Study|Lack of Efficacy|1
5446589|NCT02203838|18817609|P2|Overall Study|Lack of Efficacy|0
5446590|NCT02203838|18817610|P1|Overall Study|Lack of Efficacy|7
5446591|NCT02203721|18817690|P2|Overall Study|Illness|1
5446592|NCT02203721|18817691|P1|Overall Study|Illness|0
5446593|NCT02203721|18817690|P2|Overall Study|Death|2
5446594|NCT02203721|18817691|P1|Overall Study|Death|0
5446595|NCT02203721|18817690|P2|Overall Study|Lost to Follow-up|0
5446596|NCT02203721|18817691|P1|Overall Study|Lost to Follow-up|1
5446597|NCT02203591|18817780|P8|Overall Study|Discontinued early due to compromised test sites|1
5446598|NCT02203591|18817781|P7|Overall Study|Discontinued early due to compromised test sites|0
5446599|NCT02203591|18817782|P6|Overall Study|Discontinued early due to compromised test sites|0
5446600|NCT02203591|18817783|P5|Overall Study|Discontinued early due to compromised test sites|1
5446601|NCT02203591|18817784|P4|Overall Study|Discontinued early due to compromised test sites|0
5446602|NCT02203591|18817785|P3|Overall Study|Discontinued early due to compromised test sites|1
5446603|NCT02203591|18817786|P2|Overall Study|Discontinued early due to compromised test sites|1
5446604|NCT02203591|18817787|P1|Overall Study|Discontinued early due to compromised test sites|0
5446605|NCT02203591|18817780|P8|Overall Study|Did not meet treatment day baseline|12
5446606|NCT02203591|18817781|P7|Overall Study|Did not meet treatment day baseline|29
5446607|NCT02203591|18817782|P6|Overall Study|Did not meet treatment day baseline|35
5446608|NCT02203591|18817783|P5|Overall Study|Did not meet treatment day baseline|33
5446609|NCT02203591|18817784|P4|Overall Study|Did not meet treatment day baseline|45
5446610|NCT02203591|18817785|P3|Overall Study|Did not meet treatment day baseline|150
5446611|NCT02203591|18817786|P2|Overall Study|Did not meet treatment day baseline|141
5446612|NCT02203591|18817787|P1|Overall Study|Did not meet treatment day baseline|147
5446613|NCT02203357|18817891|P3|Overall Study|Lost to Follow-up|70
5446614|NCT02203357|18817892|P2|Overall Study|Lost to Follow-up|66
5446615|NCT02203357|18817893|P1|Overall Study|Lost to Follow-up|58
5446616|NCT02203331|18817916|P6|Overall Study|Lost to Follow-up|0
5446617|NCT02203331|18817917|P5|Overall Study|Lost to Follow-up|1
5446618|NCT02203331|18817918|P4|Overall Study|Lost to Follow-up|0
5446619|NCT02203331|18817919|P3|Overall Study|Lost to Follow-up|0
5446620|NCT02203331|18817920|P2|Overall Study|Lost to Follow-up|0
5446621|NCT02203331|18817921|P1|Overall Study|Lost to Follow-up|0
5446622|NCT02203331|18817916|P6|Overall Study|Protocol Violation|0
5446623|NCT02203331|18817917|P5|Overall Study|Protocol Violation|1
5446624|NCT02203331|18817918|P4|Overall Study|Protocol Violation|1
5446625|NCT02203331|18817919|P3|Overall Study|Protocol Violation|0
5446626|NCT02203331|18817920|P2|Overall Study|Protocol Violation|2
5446627|NCT02203331|18817921|P1|Overall Study|Protocol Violation|0
5446628|NCT02203331|18817916|P6|Overall Study|Lack of Efficacy|1
5446629|NCT02203331|18817917|P5|Overall Study|Lack of Efficacy|0
5446630|NCT02203331|18817918|P4|Overall Study|Lack of Efficacy|0
5446631|NCT02203331|18817919|P3|Overall Study|Lack of Efficacy|1
5446632|NCT02203331|18817920|P2|Overall Study|Lack of Efficacy|2
5446633|NCT02203331|18817921|P1|Overall Study|Lack of Efficacy|0
5446634|NCT02203331|18817916|P6|Overall Study|Other Reasons|0
5446635|NCT02203331|18817917|P5|Overall Study|Other Reasons|0
5446636|NCT02203331|18817918|P4|Overall Study|Other Reasons|2
5446637|NCT02203331|18817919|P3|Overall Study|Other Reasons|0
5446638|NCT02203331|18817920|P2|Overall Study|Other Reasons|2
5446639|NCT02203331|18817921|P1|Overall Study|Other Reasons|1
5446640|NCT02203331|18817916|P6|Overall Study|Adverse Event|3
5446641|NCT02203331|18817917|P5|Overall Study|Adverse Event|3
5446642|NCT02203331|18817918|P4|Overall Study|Adverse Event|4
5446643|NCT02203331|18817919|P3|Overall Study|Adverse Event|3
5446644|NCT02203331|18817920|P2|Overall Study|Adverse Event|8
5446645|NCT02203331|18817921|P1|Overall Study|Adverse Event|4
5446646|NCT02203331|18817916|P6|Overall Study|Withdrawal by Subject|3
5446647|NCT02203331|18817917|P5|Overall Study|Withdrawal by Subject|0
5446648|NCT02203331|18817918|P4|Overall Study|Withdrawal by Subject|0
5446649|NCT02203331|18817919|P3|Overall Study|Withdrawal by Subject|1
5446650|NCT02203331|18817920|P2|Overall Study|Withdrawal by Subject|0
5446651|NCT02203331|18817921|P1|Overall Study|Withdrawal by Subject|1
5446652|NCT02203331|18817916|P6|Overall Study|Pregnancy|0
5446653|NCT02203331|18817917|P5|Overall Study|Pregnancy|2
5446654|NCT02203331|18817918|P4|Overall Study|Pregnancy|0
5446655|NCT02203331|18817919|P3|Overall Study|Pregnancy|0
5446656|NCT02203331|18817920|P2|Overall Study|Pregnancy|0
5446657|NCT02203331|18817921|P1|Overall Study|Pregnancy|1
5446658|NCT02203149|18817980|P5|Part 2|Adverse Event|1
5446659|NCT02203149|18817981|P4|Part 2|Adverse Event|1
5446660|NCT02203149|18817982|P3|Part 2|Adverse Event|0
5446661|NCT02203149|18817983|P2|Part 2|Adverse Event|0
5446662|NCT02203149|18817984|P1|Part 2|Adverse Event|0
5446663|NCT02203149|18817980|P5|Part 2|Withdrawal by Subject|0
5446664|NCT02203149|18817981|P4|Part 2|Withdrawal by Subject|1
5446665|NCT02203149|18817982|P3|Part 2|Withdrawal by Subject|0
5446666|NCT02203149|18817983|P2|Part 2|Withdrawal by Subject|0
5446667|NCT02203149|18817984|P1|Part 2|Withdrawal by Subject|0
5446668|NCT02203149|18817980|P5|Part 2|Death|0
5446669|NCT02203149|18817981|P4|Part 2|Death|1
5446670|NCT02203149|18817982|P3|Part 2|Death|1
5446671|NCT02203149|18817983|P2|Part 2|Death|0
5446672|NCT02203149|18817984|P1|Part 2|Death|0
5446673|NCT02203149|18817980|P5|Part 1|Adverse Event|0
5446674|NCT02203149|18817981|P4|Part 1|Adverse Event|0
5446675|NCT02203149|18817982|P3|Part 1|Adverse Event|0
5446676|NCT02203149|18817983|P2|Part 1|Adverse Event|1
5446677|NCT02203149|18817984|P1|Part 1|Adverse Event|0
5446678|NCT02203071|18818019|P2|Overall Study|Lost to Follow-up|1
5446679|NCT02203071|18818020|P1|Overall Study|Lost to Follow-up|3
5446680|NCT02203032|18818036|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
5446681|NCT02203032|18818037|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
5446682|NCT02203032|18818038|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
5446683|NCT02203032|18818039|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
5446684|NCT02203032|18818036|P4|Blinded Phase (Week 16 to Week 44)|Death|1
5446685|NCT02203032|18818037|P3|Blinded Phase (Week 16 to Week 44)|Death|0
5446686|NCT02203032|18818038|P2|Blinded Phase (Week 16 to Week 44)|Death|0
5446687|NCT02203032|18818039|P1|Blinded Phase (Week 16 to Week 44)|Death|0
5446688|NCT02203032|18818036|P4|Blinded Phase (Week 16 to Week 44)|Other|15
5446689|NCT02203032|18818037|P3|Blinded Phase (Week 16 to Week 44)|Other|1
5446690|NCT02203032|18818038|P2|Blinded Phase (Week 16 to Week 44)|Other|4
5446691|NCT02203032|18818039|P1|Blinded Phase (Week 16 to Week 44)|Other|0
5446692|NCT02203032|18818036|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
5446693|NCT02203032|18818037|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
5446694|NCT02203032|18818038|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
5446695|NCT02203032|18818039|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
5446696|NCT02203032|18818036|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
5446697|NCT02203032|18818037|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
5446698|NCT02203032|18818038|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
5446699|NCT02203032|18818039|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
5446700|NCT02203032|18818036|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
5446701|NCT02203032|18818037|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
5446702|NCT02203032|18818038|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
5446703|NCT02203032|18818039|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
5446704|NCT02203032|18818036|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
5446705|NCT02203032|18818037|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
5446706|NCT02203032|18818038|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
5446707|NCT02203032|18818039|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
5446708|NCT02203032|18818036|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5446709|NCT02203032|18818037|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5446710|NCT02203032|18818038|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5446711|NCT02203032|18818039|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
5446712|NCT02203032|18818036|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5446713|NCT02203032|18818037|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5446714|NCT02203032|18818038|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5446715|NCT02203032|18818039|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
5446716|NCT02203032|18818036|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5446717|NCT02203032|18818037|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5446718|NCT02203032|18818038|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5446719|NCT02203032|18818039|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
5446720|NCT02203032|18818036|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5446721|NCT02203032|18818037|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5446722|NCT02203032|18818038|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5446723|NCT02203032|18818039|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
5446724|NCT02203032|18818036|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5446725|NCT02203032|18818037|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5446726|NCT02203032|18818038|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5446727|NCT02203032|18818039|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
5446728|NCT02202980|18818082|P14|Overall Study|Withdrew Consent|0
5446729|NCT02202980|18818083|P13|Overall Study|Withdrew Consent|0
5446730|NCT02202980|18818084|P12|Overall Study|Withdrew Consent|0
5446731|NCT02202980|18818085|P11|Overall Study|Withdrew Consent|0
5446732|NCT02202980|18818086|P10|Overall Study|Withdrew Consent|0
5446733|NCT02202980|18818087|P9|Overall Study|Withdrew Consent|1
5446734|NCT02202980|18818088|P8|Overall Study|Withdrew Consent|0
5446735|NCT02202980|18818089|P7|Overall Study|Withdrew Consent|0
5446736|NCT02202980|18818090|P6|Overall Study|Withdrew Consent|0
5446737|NCT02202980|18818091|P5|Overall Study|Withdrew Consent|0
5446738|NCT02202980|18818092|P4|Overall Study|Withdrew Consent|0
5446739|NCT02202980|18818093|P3|Overall Study|Withdrew Consent|2
5446740|NCT02202980|18818094|P2|Overall Study|Withdrew Consent|1
5446741|NCT02202980|18818095|P1|Overall Study|Withdrew Consent|0
5446742|NCT02202980|18818082|P14|Overall Study|Lost to Follow-up|0
5446743|NCT02202980|18818083|P13|Overall Study|Lost to Follow-up|1
5446744|NCT02202980|18818084|P12|Overall Study|Lost to Follow-up|0
5446745|NCT02202980|18818085|P11|Overall Study|Lost to Follow-up|0
5446746|NCT02202980|18818086|P10|Overall Study|Lost to Follow-up|0
5446747|NCT02202980|18818087|P9|Overall Study|Lost to Follow-up|1
5446748|NCT02202980|18818088|P8|Overall Study|Lost to Follow-up|1
5446749|NCT02202980|18818089|P7|Overall Study|Lost to Follow-up|0
5446750|NCT02202980|18818090|P6|Overall Study|Lost to Follow-up|0
5446751|NCT02202980|18818091|P5|Overall Study|Lost to Follow-up|0
5446752|NCT02202980|18818092|P4|Overall Study|Lost to Follow-up|1
5446753|NCT02202980|18818093|P3|Overall Study|Lost to Follow-up|1
5446754|NCT02202980|18818094|P2|Overall Study|Lost to Follow-up|1
5446755|NCT02202980|18818095|P1|Overall Study|Lost to Follow-up|0
5446756|NCT02202980|18818082|P14|Overall Study|Protocol Violation|0
5446757|NCT02202980|18818083|P13|Overall Study|Protocol Violation|0
5446758|NCT02202980|18818084|P12|Overall Study|Protocol Violation|0
5446759|NCT02202980|18818085|P11|Overall Study|Protocol Violation|0
5446760|NCT02202980|18818086|P10|Overall Study|Protocol Violation|0
5446761|NCT02202980|18818087|P9|Overall Study|Protocol Violation|0
5446762|NCT02202980|18818088|P8|Overall Study|Protocol Violation|0
5446763|NCT02202980|18818089|P7|Overall Study|Protocol Violation|0
5446764|NCT02202980|18818090|P6|Overall Study|Protocol Violation|0
5446765|NCT02202980|18818091|P5|Overall Study|Protocol Violation|3
5446766|NCT02202980|18818092|P4|Overall Study|Protocol Violation|3
5446767|NCT02202980|18818093|P3|Overall Study|Protocol Violation|0
5446768|NCT02202980|18818094|P2|Overall Study|Protocol Violation|0
5446769|NCT02202980|18818095|P1|Overall Study|Protocol Violation|0
5446770|NCT02202980|18818082|P14|Overall Study|Lack of Efficacy|0
5446771|NCT02202980|18818083|P13|Overall Study|Lack of Efficacy|10
5446772|NCT02202980|18818084|P12|Overall Study|Lack of Efficacy|3
5446773|NCT02202980|18818085|P11|Overall Study|Lack of Efficacy|0
5446774|NCT02202980|18818086|P10|Overall Study|Lack of Efficacy|0
5446775|NCT02202980|18818087|P9|Overall Study|Lack of Efficacy|2
5446776|NCT02202980|18818088|P8|Overall Study|Lack of Efficacy|2
5446777|NCT02202980|18818089|P7|Overall Study|Lack of Efficacy|11
5446778|NCT02202980|18818090|P6|Overall Study|Lack of Efficacy|1
5446779|NCT02202980|18818091|P5|Overall Study|Lack of Efficacy|3
5446780|NCT02202980|18818092|P4|Overall Study|Lack of Efficacy|0
5446781|NCT02202980|18818093|P3|Overall Study|Lack of Efficacy|7
5446782|NCT02202980|18818094|P2|Overall Study|Lack of Efficacy|0
5446783|NCT02202980|18818095|P1|Overall Study|Lack of Efficacy|1
5446784|NCT02202850|18818183|P2|Overall Study|Lost to Follow-up|1
5446785|NCT02202850|18818184|P1|Overall Study|Lost to Follow-up|7
5446786|NCT02202850|18818183|P2|Overall Study|Enbrel treatment discontinued|3
5446787|NCT02202850|18818184|P1|Overall Study|Enbrel treatment discontinued|15
5446788|NCT02202850|18818183|P2|Overall Study|Other|2
5446789|NCT02202850|18818184|P1|Overall Study|Other|2
5446790|NCT02202837|18818236|P2|Overall Study|Lost to Follow-up|1
5446791|NCT02202837|18818237|P1|Overall Study|Lost to Follow-up|7
5446792|NCT02202837|18818236|P2|Overall Study|Other|0
5446793|NCT02202837|18818237|P1|Overall Study|Other|10
5446794|NCT02202837|18818236|P2|Overall Study|Enbrel treatment discontinued|4
5446795|NCT02202837|18818237|P1|Overall Study|Enbrel treatment discontinued|36
5446796|NCT02202785|18818288|P3|Overall Study|Reason not Specified|13
5446797|NCT02202785|18818289|P2|Overall Study|Reason not Specified|7
5446798|NCT02202785|18818290|P1|Overall Study|Reason not Specified|10
5446799|NCT02202785|18818288|P3|Overall Study|Lost to Follow-up|0
5446800|NCT02202785|18818289|P2|Overall Study|Lost to Follow-up|1
5446801|NCT02202785|18818290|P1|Overall Study|Lost to Follow-up|0
5446802|NCT02202785|18818288|P3|Overall Study|Withdrawal by Subject|0
5446803|NCT02202785|18818289|P2|Overall Study|Withdrawal by Subject|1
5446804|NCT02202785|18818290|P1|Overall Study|Withdrawal by Subject|0
5446805|NCT02202785|18818288|P3|Overall Study|Study Terminated by Sponsor|4
5446806|NCT02202785|18818289|P2|Overall Study|Study Terminated by Sponsor|6
5446807|NCT02202785|18818290|P1|Overall Study|Study Terminated by Sponsor|1
5446808|NCT02202759|18818327|P3|Overall Study|Reason not Specified|10
5446809|NCT02202759|18818328|P2|Overall Study|Reason not Specified|11
5446810|NCT02202759|18818329|P1|Overall Study|Reason not Specified|4
5446811|NCT02202759|18818327|P3|Overall Study|Withdrawal by Subject|1
5446812|NCT02202759|18818328|P2|Overall Study|Withdrawal by Subject|1
5446813|NCT02202759|18818329|P1|Overall Study|Withdrawal by Subject|2
5446814|NCT02202759|18818327|P3|Overall Study|Study Terminated by Sponsor|3
5446815|NCT02202759|18818328|P2|Overall Study|Study Terminated by Sponsor|3
5446816|NCT02202759|18818329|P1|Overall Study|Study Terminated by Sponsor|3
5446817|NCT02202616|18818396|P1|Overall Study|Unsatisfactory therapeutic effect|1
5446818|NCT02202616|18818396|P1|Overall Study|Abnormal test procedure result|1
5446819|NCT02202616|18818396|P1|Overall Study|Administrative problems|6
5446820|NCT02202616|18818396|P1|Overall Study|Lost to Follow-up|6
5446821|NCT02202616|18818396|P1|Overall Study|Patient withdrew consent|12
5446822|NCT02202616|18818396|P1|Overall Study|Protocol deviation|18
5446823|NCT02202616|18818396|P1|Overall Study|Adverse Event|32
5446824|NCT02202616|18818396|P1|Overall Study|Screen failed|24
5446825|NCT02202551|18818411|P4|Overall Study|eGFR<50mL/min/m2|1
5446826|NCT02202551|18818412|P3|Overall Study|eGFR<50mL/min/m2|0
5446827|NCT02202551|18818413|P2|Overall Study|eGFR<50mL/min/m2|2
5446828|NCT02202551|18818414|P1|Overall Study|eGFR<50mL/min/m2|2
5446829|NCT02202551|18818411|P4|Overall Study|Subject consent withdrawn|2
5446830|NCT02202551|18818412|P3|Overall Study|Subject consent withdrawn|1
5446831|NCT02202551|18818413|P2|Overall Study|Subject consent withdrawn|3
5446832|NCT02202551|18818414|P1|Overall Study|Subject consent withdrawn|0
5446833|NCT02202551|18818411|P4|Overall Study|Subject unwilling to proceed|5
5446834|NCT02202551|18818412|P3|Overall Study|Subject unwilling to proceed|3
5446835|NCT02202551|18818413|P2|Overall Study|Subject unwilling to proceed|5
5446836|NCT02202551|18818414|P1|Overall Study|Subject unwilling to proceed|1
5446837|NCT02202551|18818411|P4|Overall Study|Sponsor's decision|0
5446838|NCT02202551|18818412|P3|Overall Study|Sponsor's decision|0
5446839|NCT02202551|18818413|P2|Overall Study|Sponsor's decision|0
5446840|NCT02202551|18818414|P1|Overall Study|Sponsor's decision|2
5446841|NCT02202551|18818411|P4|Overall Study|Protocol Violation|0
5446842|NCT02202551|18818412|P3|Overall Study|Protocol Violation|0
5446843|NCT02202551|18818413|P2|Overall Study|Protocol Violation|1
5446844|NCT02202551|18818414|P1|Overall Study|Protocol Violation|0
5446845|NCT02202551|18818411|P4|Overall Study|Worsening Dyskinesia|1
5446846|NCT02202551|18818412|P3|Overall Study|Worsening Dyskinesia|0
5446847|NCT02202551|18818413|P2|Overall Study|Worsening Dyskinesia|0
5446848|NCT02202551|18818414|P1|Overall Study|Worsening Dyskinesia|0
5446849|NCT02202551|18818411|P4|Overall Study|Unable to complete visits per protocol|0
5446850|NCT02202551|18818412|P3|Overall Study|Unable to complete visits per protocol|0
5446851|NCT02202551|18818413|P2|Overall Study|Unable to complete visits per protocol|0
5446852|NCT02202551|18818414|P1|Overall Study|Unable to complete visits per protocol|1
5446853|NCT02202551|18818411|P4|Overall Study|Site closure|1
5446854|NCT02202551|18818412|P3|Overall Study|Site closure|0
5446855|NCT02202551|18818413|P2|Overall Study|Site closure|0
5446856|NCT02202551|18818414|P1|Overall Study|Site closure|3
5446857|NCT02202551|18818411|P4|Overall Study|Physician Decision|0
5446858|NCT02202551|18818412|P3|Overall Study|Physician Decision|0
5446859|NCT02202551|18818413|P2|Overall Study|Physician Decision|0
5446860|NCT02202551|18818414|P1|Overall Study|Physician Decision|1
5446861|NCT02202551|18818411|P4|Overall Study|Lack of Efficacy|0
5446862|NCT02202551|18818412|P3|Overall Study|Lack of Efficacy|0
5446863|NCT02202551|18818413|P2|Overall Study|Lack of Efficacy|1
5446864|NCT02202551|18818414|P1|Overall Study|Lack of Efficacy|0
5446865|NCT02202551|18818411|P4|Overall Study|Dyskinesia upon taper|0
5446866|NCT02202551|18818412|P3|Overall Study|Dyskinesia upon taper|0
5446867|NCT02202551|18818413|P2|Overall Study|Dyskinesia upon taper|0
5446868|NCT02202551|18818414|P1|Overall Study|Dyskinesia upon taper|1
5446869|NCT02202551|18818411|P4|Overall Study|DBS surgery|0
5446870|NCT02202551|18818412|P3|Overall Study|DBS surgery|0
5446871|NCT02202551|18818413|P2|Overall Study|DBS surgery|0
5446872|NCT02202551|18818414|P1|Overall Study|DBS surgery|3
5446873|NCT02202551|18818411|P4|Overall Study|Subject moved away|0
5446874|NCT02202551|18818412|P3|Overall Study|Subject moved away|0
5446875|NCT02202551|18818413|P2|Overall Study|Subject moved away|1
5446876|NCT02202551|18818414|P1|Overall Study|Subject moved away|0
5446877|NCT02202551|18818411|P4|Overall Study|Needed to take excluded medication|1
5446878|NCT02202551|18818412|P3|Overall Study|Needed to take excluded medication|0
5446879|NCT02202551|18818413|P2|Overall Study|Needed to take excluded medication|2
5446880|NCT02202551|18818414|P1|Overall Study|Needed to take excluded medication|0
5446881|NCT02202551|18818411|P4|Overall Study|Lost to Follow-up|1
5446882|NCT02202551|18818412|P3|Overall Study|Lost to Follow-up|0
5446883|NCT02202551|18818413|P2|Overall Study|Lost to Follow-up|1
5446884|NCT02202551|18818414|P1|Overall Study|Lost to Follow-up|0
5446885|NCT02202551|18818411|P4|Overall Study|Death|1
5446886|NCT02202551|18818412|P3|Overall Study|Death|1
5446887|NCT02202551|18818413|P2|Overall Study|Death|2
5446888|NCT02202551|18818414|P1|Overall Study|Death|3
5446889|NCT02202551|18818411|P4|Overall Study|Adverse Event|9
5446890|NCT02202551|18818412|P3|Overall Study|Adverse Event|5
5446891|NCT02202551|18818413|P2|Overall Study|Adverse Event|19
5446892|NCT02202551|18818414|P1|Overall Study|Adverse Event|8
5446893|NCT02202538|18818432|P1|Overall Study|Investigator Decision|1
5446894|NCT02202538|18818432|P1|Overall Study|Did not meet all inclusion criteria|2
5446895|NCT02202538|18818432|P1|Overall Study|Withdrawal by Subject|5
5446896|NCT02202499|18818446|P3|Overall Study|Auto accident|0
5446897|NCT02202499|18818447|P2|Overall Study|Auto accident|0
5446898|NCT02202499|18818448|P1|Overall Study|Auto accident|1
5446899|NCT02202499|18818446|P3|Overall Study|Declined before randomization|0
5446900|NCT02202499|18818447|P2|Overall Study|Declined before randomization|0
5446901|NCT02202499|18818448|P1|Overall Study|Declined before randomization|1
5446902|NCT02202499|18818446|P3|Overall Study|Moved from area|1
5446903|NCT02202499|18818447|P2|Overall Study|Moved from area|0
5446904|NCT02202499|18818448|P1|Overall Study|Moved from area|0
5446905|NCT02202499|18818446|P3|Overall Study|Cancer diagnosis|1
5446906|NCT02202499|18818447|P2|Overall Study|Cancer diagnosis|0
5446907|NCT02202499|18818448|P1|Overall Study|Cancer diagnosis|0
5446908|NCT02202434|18818475|P4|Overall Study|Other|1
5446909|NCT02202434|18818476|P3|Overall Study|Other|0
5446910|NCT02202434|18818477|P2|Overall Study|Other|0
5446911|NCT02202434|18818478|P1|Overall Study|Other|1
5446912|NCT02202434|18818475|P4|Overall Study|Visit Missed|5
5446913|NCT02202434|18818476|P3|Overall Study|Visit Missed|0
5446914|NCT02202434|18818477|P2|Overall Study|Visit Missed|12
5446915|NCT02202434|18818478|P1|Overall Study|Visit Missed|21
5446916|NCT02202434|18818475|P4|Overall Study|Completed Study|0
5446917|NCT02202434|18818476|P3|Overall Study|Completed Study|0
5446918|NCT02202434|18818477|P2|Overall Study|Completed Study|0
5446919|NCT02202434|18818478|P1|Overall Study|Completed Study|1
5446920|NCT02202434|18818475|P4|Overall Study|Withdrawal by Subject|4
5446921|NCT02202434|18818476|P3|Overall Study|Withdrawal by Subject|1
5446922|NCT02202434|18818477|P2|Overall Study|Withdrawal by Subject|14
5446923|NCT02202434|18818478|P1|Overall Study|Withdrawal by Subject|13
5446924|NCT02202434|18818475|P4|Overall Study|Physician Decision|0
5446925|NCT02202434|18818476|P3|Overall Study|Physician Decision|0
5446926|NCT02202434|18818477|P2|Overall Study|Physician Decision|3
5446927|NCT02202434|18818478|P1|Overall Study|Physician Decision|2
5446928|NCT02202434|18818475|P4|Overall Study|Lost to Follow-up|0
5446929|NCT02202434|18818476|P3|Overall Study|Lost to Follow-up|1
5446930|NCT02202434|18818477|P2|Overall Study|Lost to Follow-up|1
5446931|NCT02202434|18818478|P1|Overall Study|Lost to Follow-up|1
5446932|NCT02202434|18818475|P4|Overall Study|Death|27
5446933|NCT02202434|18818476|P3|Overall Study|Death|13
5446934|NCT02202434|18818477|P2|Overall Study|Death|39
5446935|NCT02202434|18818478|P1|Overall Study|Death|70
5446936|NCT02202317|18818602|P1|Overall Study|Lost to Follow-up|1
5446937|NCT02202161|18818629|P8|Overall Study|Withdrawal by Subject|0
5446938|NCT02202161|18818630|P7|Overall Study|Withdrawal by Subject|0
5446939|NCT02202161|18818631|P6|Overall Study|Withdrawal by Subject|0
5446940|NCT02202161|18818632|P5|Overall Study|Withdrawal by Subject|1
5446941|NCT02202161|18818633|P4|Overall Study|Withdrawal by Subject|0
5446942|NCT02202161|18818634|P3|Overall Study|Withdrawal by Subject|0
5446943|NCT02202161|18818635|P2|Overall Study|Withdrawal by Subject|0
5446944|NCT02202161|18818636|P1|Overall Study|Withdrawal by Subject|0
5446945|NCT02202161|18818629|P8|Overall Study|Physician Decision|3
5446946|NCT02202161|18818630|P7|Overall Study|Physician Decision|0
5446947|NCT02202161|18818631|P6|Overall Study|Physician Decision|0
5446948|NCT02202161|18818632|P5|Overall Study|Physician Decision|0
5446949|NCT02202161|18818633|P4|Overall Study|Physician Decision|0
5446950|NCT02202161|18818634|P3|Overall Study|Physician Decision|0
5446951|NCT02202161|18818635|P2|Overall Study|Physician Decision|0
5446952|NCT02202161|18818636|P1|Overall Study|Physician Decision|0
5446953|NCT02202161|18818629|P8|Overall Study|Did not meet continuation criteria|3
5446954|NCT02202161|18818630|P7|Overall Study|Did not meet continuation criteria|0
5446955|NCT02202161|18818631|P6|Overall Study|Did not meet continuation criteria|0
5446956|NCT02202161|18818632|P5|Overall Study|Did not meet continuation criteria|0
5446957|NCT02202161|18818633|P4|Overall Study|Did not meet continuation criteria|0
5446958|NCT02202161|18818634|P3|Overall Study|Did not meet continuation criteria|0
5446959|NCT02202161|18818635|P2|Overall Study|Did not meet continuation criteria|0
5446960|NCT02202161|18818636|P1|Overall Study|Did not meet continuation criteria|0
5446961|NCT02202161|18818629|P8|Overall Study|Adverse Event|0
5446962|NCT02202161|18818630|P7|Overall Study|Adverse Event|0
5446963|NCT02202161|18818631|P6|Overall Study|Adverse Event|1
5446964|NCT02202161|18818632|P5|Overall Study|Adverse Event|0
5446965|NCT02202161|18818633|P4|Overall Study|Adverse Event|0
5446966|NCT02202161|18818634|P3|Overall Study|Adverse Event|0
5446967|NCT02202161|18818635|P2|Overall Study|Adverse Event|1
5446968|NCT02202161|18818636|P1|Overall Study|Adverse Event|1
5446969|NCT02202109|18818796|P2|Overall Study|Withdrawal by Subject|0
5446970|NCT02202109|18818797|P1|Overall Study|Withdrawal by Subject|2
5446971|NCT02202109|18818796|P2|Overall Study|Lost to Follow-up|87
5446972|NCT02202109|18818797|P1|Overall Study|Lost to Follow-up|88
5446973|NCT02202031|18818814|P2|Overall Study|Intolerance/Lack of Improvement|0
5446974|NCT02202031|18818815|P1|Overall Study|Intolerance/Lack of Improvement|3
5446975|NCT02202031|18818814|P2|Overall Study|Illness/Medical Reason|2
5446976|NCT02202031|18818815|P1|Overall Study|Illness/Medical Reason|0
5446977|NCT02202031|18818814|P2|Overall Study|Too Busy|3
5446978|NCT02202031|18818815|P1|Overall Study|Too Busy|1
5446979|NCT02202031|18818814|P2|Overall Study|Lost to Follow-up|0
5446980|NCT02202031|18818815|P1|Overall Study|Lost to Follow-up|1
5446981|NCT02201953|18818863|P2|Overall Study|Death|3
5446982|NCT02201953|18818864|P1|Overall Study|Death|0
5446983|NCT02201953|18818863|P2|Overall Study|Adverse Event|5
5446984|NCT02201953|18818864|P1|Overall Study|Adverse Event|0
5446985|NCT02201953|18818863|P2|Overall Study|Withdrew Consent|5
5446986|NCT02201953|18818864|P1|Overall Study|Withdrew Consent|2
5446987|NCT02201953|18818863|P2|Overall Study|Lost to Follow-up|8
5446988|NCT02201953|18818864|P1|Overall Study|Lost to Follow-up|8
5446989|NCT02201953|18818863|P2|Overall Study|Lack of Efficacy|30
5446990|NCT02201953|18818864|P1|Overall Study|Lack of Efficacy|9
5446991|NCT02201953|18818863|P2|Overall Study|Randomized but Never Treated|5
5446992|NCT02201953|18818864|P1|Overall Study|Randomized but Never Treated|1
5446993|NCT02201940|18818882|P2|Overall Study|Adverse Event|1
5446994|NCT02201940|18818883|P1|Overall Study|Adverse Event|0
5446995|NCT02201940|18818882|P2|Overall Study|Death|0
5446996|NCT02201940|18818883|P1|Overall Study|Death|1
5446997|NCT02201940|18818882|P2|Overall Study|Investigator's Discretion|1
5446998|NCT02201940|18818883|P1|Overall Study|Investigator's Discretion|1
5446999|NCT02201940|18818882|P2|Overall Study|Withdrew Consent|1
5447000|NCT02201940|18818883|P1|Overall Study|Withdrew Consent|2
5447001|NCT02201940|18818882|P2|Overall Study|Lost to Follow-up|0
5447002|NCT02201940|18818883|P1|Overall Study|Lost to Follow-up|5
5447003|NCT02201940|18818882|P2|Overall Study|Lack of Efficacy|113
5447004|NCT02201940|18818883|P1|Overall Study|Lack of Efficacy|2
5447005|NCT02201940|18818882|P2|Overall Study|Randomized/Enrolled but Never Treated|0
5447006|NCT02201940|18818883|P1|Overall Study|Randomized/Enrolled but Never Treated|1
5447007|NCT02201901|18818902|P3|Overall Study|Adverse Event|0
5447008|NCT02201901|18818903|P2|Overall Study|Adverse Event|1
5447009|NCT02201901|18818904|P1|Overall Study|Adverse Event|1
5447010|NCT02201901|18818902|P3|Overall Study|Withdrew Consent|2
5447011|NCT02201901|18818903|P2|Overall Study|Withdrew Consent|0
5447012|NCT02201901|18818904|P1|Overall Study|Withdrew Consent|2
5447013|NCT02201901|18818902|P3|Overall Study|Lost to Follow-up|2
5447014|NCT02201901|18818903|P2|Overall Study|Lost to Follow-up|3
5447015|NCT02201901|18818904|P1|Overall Study|Lost to Follow-up|2
5447016|NCT02201901|18818902|P3|Overall Study|Death|3
5447017|NCT02201901|18818903|P2|Overall Study|Death|3
5447018|NCT02201901|18818904|P1|Overall Study|Death|3
5447019|NCT02201901|18818902|P3|Overall Study|Lack of Efficacy|6
5447020|NCT02201901|18818903|P2|Overall Study|Lack of Efficacy|1
5447021|NCT02201901|18818904|P1|Overall Study|Lack of Efficacy|7
5447022|NCT02201901|18818902|P3|Overall Study|Randomized but never treated|0
5447023|NCT02201901|18818903|P2|Overall Study|Randomized but never treated|1
5447024|NCT02201901|18818904|P1|Overall Study|Randomized but never treated|0
5447025|NCT02201784|18818935|P2|Overall Study|Failure to achieve adequate block|0
5447026|NCT02201784|18818936|P1|Overall Study|Failure to achieve adequate block|2
5447027|NCT02201771|18818953|P3|Overall Study|Protocol Violation|10
5447028|NCT02201771|18818954|P2|Overall Study|Protocol Violation|8
5447029|NCT02201771|18818955|P1|Overall Study|Protocol Violation|10
5447030|NCT02201771|18818953|P3|Overall Study|Death|0
5447031|NCT02201771|18818954|P2|Overall Study|Death|2
5447032|NCT02201771|18818955|P1|Overall Study|Death|3
5447033|NCT02201524|18818982|P4|Overall Study|Other|0
5447034|NCT02201524|18818983|P3|Overall Study|Other|0
5447035|NCT02201524|18818984|P2|Overall Study|Other|1
5447036|NCT02201524|18818985|P1|Overall Study|Other|1
5447037|NCT02201524|18818982|P4|Overall Study|Withdrawal by Subject|1
5447038|NCT02201524|18818983|P3|Overall Study|Withdrawal by Subject|1
5447039|NCT02201524|18818984|P2|Overall Study|Withdrawal by Subject|0
5447040|NCT02201524|18818985|P1|Overall Study|Withdrawal by Subject|0
5447041|NCT02201524|18818982|P4|Overall Study|Protocol Violation|1
5447042|NCT02201524|18818983|P3|Overall Study|Protocol Violation|0
5447043|NCT02201524|18818984|P2|Overall Study|Protocol Violation|0
5447044|NCT02201524|18818985|P1|Overall Study|Protocol Violation|0
5447045|NCT02201524|18818982|P4|Overall Study|No longer meets eligibility criteria|2
5447046|NCT02201524|18818983|P3|Overall Study|No longer meets eligibility criteria|0
5447047|NCT02201524|18818984|P2|Overall Study|No longer meets eligibility criteria|0
5447048|NCT02201524|18818985|P1|Overall Study|No longer meets eligibility criteria|0
5447049|NCT02201524|18818982|P4|Overall Study|Lost to Follow-up|0
5447050|NCT02201524|18818983|P3|Overall Study|Lost to Follow-up|2
5447051|NCT02201524|18818984|P2|Overall Study|Lost to Follow-up|0
5447052|NCT02201524|18818985|P1|Overall Study|Lost to Follow-up|0
5447053|NCT02201524|18818982|P4|Overall Study|Insufficient clinical response|0
5447054|NCT02201524|18818983|P3|Overall Study|Insufficient clinical response|0
5447055|NCT02201524|18818984|P2|Overall Study|Insufficient clinical response|0
5447056|NCT02201524|18818985|P1|Overall Study|Insufficient clinical response|1
5447057|NCT02201524|18818982|P4|Overall Study|Adverse Event|0
5447058|NCT02201524|18818983|P3|Overall Study|Adverse Event|1
5447059|NCT02201524|18818984|P2|Overall Study|Adverse Event|2
5447060|NCT02201524|18818985|P1|Overall Study|Adverse Event|0
5447061|NCT02201472|18819067|P1|Overall Study|Lack of Efficacy|2
5447062|NCT02201329|18819114|P1|Overall Study|Withdrawal by Subject|2
5447063|NCT02201329|18819114|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
5447064|NCT02201290|18819122|P1|Overall Study|Adverse Event|1
5447065|NCT02201290|18819122|P1|Overall Study|Lack of Efficacy|2
5447066|NCT02201290|18819122|P1|Overall Study|Withdrawal by Subject|2
5447067|NCT02201277|18819128|P2|Overall Study|Physician Decision|0
5447068|NCT02201277|18819129|P1|Overall Study|Physician Decision|1
5447069|NCT02201277|18819128|P2|Overall Study|Failed retrieval|0
5447070|NCT02201277|18819129|P1|Overall Study|Failed retrieval|1
5447071|NCT02201277|18819128|P2|Overall Study|Lost to Follow-up|1
5447072|NCT02201277|18819129|P1|Overall Study|Lost to Follow-up|2
5447073|NCT02201277|18819128|P2|Overall Study|Death|4
5447074|NCT02201277|18819129|P1|Overall Study|Death|3
5447075|NCT02201108|18819159|P2|Overall Study|Withdrawal by Subject|0
5447076|NCT02201108|18819160|P1|Overall Study|Withdrawal by Subject|2
5447077|NCT02201108|18819159|P2|Overall Study|Lack of Efficacy|1
5447078|NCT02201108|18819160|P1|Overall Study|Lack of Efficacy|2
5447079|NCT02201108|18819159|P2|Overall Study|Adverse Event|6
5447080|NCT02201108|18819160|P1|Overall Study|Adverse Event|0
5447081|NCT02200770|18819275|P2|Open-label Period (OLP)|Participants ongoing|162
5447082|NCT02200770|18819276|P1|Open-label Period (OLP)|Participants ongoing|51
5447083|NCT02200770|18819275|P2|Randomized-controlled Period (RCP)|Other|2
5447084|NCT02200770|18819276|P1|Randomized-controlled Period (RCP)|Other|1
5447085|NCT02200770|18819275|P2|Randomized-controlled Period (RCP)|Not treated|1
5447086|NCT02200770|18819276|P1|Randomized-controlled Period (RCP)|Not treated|0
5447087|NCT02200770|18819275|P2|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
5447088|NCT02200770|18819276|P1|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
5447089|NCT02200770|18819275|P2|Randomized-controlled Period (RCP)|Adverse Event|2
5447090|NCT02200770|18819276|P1|Randomized-controlled Period (RCP)|Adverse Event|0
5447091|NCT02200614|18819307|P2|Open Label|Protocol deviation|1
5447092|NCT02200614|18819308|P1|Open Label|Protocol deviation|1
5447093|NCT02200614|18819307|P2|Open Label|Personal reason|3
5447094|NCT02200614|18819308|P1|Open Label|Personal reason|29
5447095|NCT02200614|18819307|P2|Open Label|Other reason|1
5447096|NCT02200614|18819308|P1|Open Label|Other reason|6
5447097|NCT02200614|18819307|P2|Open Label|Metastasis by local reading|10
5447098|NCT02200614|18819308|P1|Open Label|Metastasis by local reading|58
5447099|NCT02200614|18819307|P2|Open Label|Judgment of the investigator|0
5447100|NCT02200614|18819308|P1|Open Label|Judgment of the investigator|15
5447101|NCT02200614|18819307|P2|Open Label|Confirmed metastasis|0
5447102|NCT02200614|18819308|P1|Open Label|Confirmed metastasis|1
5447103|NCT02200614|18819307|P2|Open Label|Adverse Event|8
5447104|NCT02200614|18819308|P1|Open Label|Adverse Event|15
5447105|NCT02200614|18819307|P2|Double Blind Treatment|Not treated|0
5447106|NCT02200614|18819308|P1|Double Blind Treatment|Not treated|1
5447107|NCT02200614|18819307|P2|Double Blind Treatment|Protocol deviation|7
5447108|NCT02200614|18819308|P1|Double Blind Treatment|Protocol deviation|14
5447109|NCT02200614|18819307|P2|Double Blind Treatment|Personal reason|85
5447110|NCT02200614|18819308|P1|Double Blind Treatment|Personal reason|77
5447111|NCT02200614|18819307|P2|Double Blind Treatment|Other reason|2
5447112|NCT02200614|18819308|P1|Double Blind Treatment|Other reason|6
5447113|NCT02200614|18819307|P2|Double Blind Treatment|Metastasis by local reading|3
5447114|NCT02200614|18819308|P1|Double Blind Treatment|Metastasis by local reading|1
5447115|NCT02200614|18819307|P2|Double Blind Treatment|Judgment of the investigator|99
5447116|NCT02200614|18819308|P1|Double Blind Treatment|Judgment of the investigator|60
5447117|NCT02200614|18819307|P2|Double Blind Treatment|Confirmed metastasis|140
5447118|NCT02200614|18819308|P1|Double Blind Treatment|Confirmed metastasis|119
5447119|NCT02200614|18819307|P2|Double Blind Treatment|Adverse Event|48
5447120|NCT02200614|18819308|P1|Double Blind Treatment|Adverse Event|86
5447121|NCT02200510|18819357|P2|Overall Study|potential COI - joined study team|0
5447122|NCT02200510|18819358|P1|Overall Study|potential COI - joined study team|1
5447123|NCT02200510|18819357|P2|Overall Study|Lost to Follow-up|1
5447124|NCT02200510|18819358|P1|Overall Study|Lost to Follow-up|7
5447125|NCT02200510|18819357|P2|Overall Study|Protocol Violation|1
5447126|NCT02200510|18819358|P1|Overall Study|Protocol Violation|0
5447127|NCT02200510|18819357|P2|Overall Study|Death|1
5447128|NCT02200510|18819358|P1|Overall Study|Death|1
5447129|NCT02200445|18819371|P3|Overall Study|Adverse Event|0
5447130|NCT02200445|18819372|P2|Overall Study|Adverse Event|2
5447131|NCT02200445|18819373|P1|Overall Study|Adverse Event|0
5447132|NCT02200445|18819371|P3|Overall Study|Lack of Efficacy|2
5447133|NCT02200445|18819372|P2|Overall Study|Lack of Efficacy|2
5447134|NCT02200445|18819373|P1|Overall Study|Lack of Efficacy|1
5447135|NCT02200211|18819402|P4|Overall Study|Withdrawal by Subject|0
5447136|NCT02200211|18819403|P3|Overall Study|Withdrawal by Subject|0
5447137|NCT02200211|18819404|P2|Overall Study|Withdrawal by Subject|0
5447138|NCT02200211|18819405|P1|Overall Study|Withdrawal by Subject|1
5447139|NCT02200211|18819402|P4|Overall Study|Lost to Follow-up|2
5447140|NCT02200211|18819403|P3|Overall Study|Lost to Follow-up|1
5447141|NCT02200211|18819404|P2|Overall Study|Lost to Follow-up|7
5447142|NCT02200211|18819405|P1|Overall Study|Lost to Follow-up|7
5447143|NCT02200042|18819518|P2|Overall Study|Withdrawal by Subject|1
5447144|NCT02200042|18819519|P1|Overall Study|Withdrawal by Subject|0
5447145|NCT02199795|18819548|P2|Overall Study|withdrew due to shoulder pain|0
5447146|NCT02199795|18819549|P1|Overall Study|withdrew due to shoulder pain|1
5447147|NCT02199795|18819548|P2|Overall Study|no longer met inclusion criteria|0
5447148|NCT02199795|18819549|P1|Overall Study|no longer met inclusion criteria|1
5447149|NCT02199691|18819572|P4|Overall Study|Lost to Follow-up|10
5447150|NCT02199691|18819573|P3|Overall Study|Lost to Follow-up|9
5447151|NCT02199691|18819574|P2|Overall Study|Lost to Follow-up|1
5447152|NCT02199691|18819575|P1|Overall Study|Lost to Follow-up|2
5447153|NCT02199691|18819572|P4|Overall Study|Withdrawal by Subject|13
5447154|NCT02199691|18819573|P3|Overall Study|Withdrawal by Subject|12
5447155|NCT02199691|18819574|P2|Overall Study|Withdrawal by Subject|3
5447156|NCT02199691|18819575|P1|Overall Study|Withdrawal by Subject|5
5447157|NCT02199691|18819572|P4|Overall Study|Protocol Violation|7
5447158|NCT02199691|18819573|P3|Overall Study|Protocol Violation|6
5447159|NCT02199691|18819574|P2|Overall Study|Protocol Violation|3
5447160|NCT02199691|18819575|P1|Overall Study|Protocol Violation|3
5447161|NCT02199509|18819617|P2|Overall Study|Misunderstood titration schedule|0
5447162|NCT02199509|18819618|P1|Overall Study|Misunderstood titration schedule|1
5447163|NCT02199509|18819617|P2|Overall Study|Suicidal Ideation|1
5447164|NCT02199509|18819618|P1|Overall Study|Suicidal Ideation|0
5447165|NCT02199314|18819641|P1|Overall Study|Physician Decision|10
5447166|NCT02199314|18819641|P1|Overall Study|Withdrawal by Subject|6
5447167|NCT02199080|18819668|P1|Overall Study|Protocol Violation|12
5447168|NCT02199028|18819693|P2|Week 3|Adverse Event|0
5447169|NCT02199028|18819694|P1|Week 3|Adverse Event|1
5447170|NCT02199028|18819693|P2|Week 1|Adverse Event|0
5447171|NCT02199028|18819694|P1|Week 1|Adverse Event|1
5447172|NCT02198963|18819703|P1|Overall Study|Withdrawal by Subject|6
5447173|NCT02198963|18819703|P1|Overall Study|Adverse Event|1
5447174|NCT02198651|18819727|P5|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5447175|NCT02198651|18819728|P4|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
5447176|NCT02198651|18819729|P3|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5447177|NCT02198651|18819730|P2|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5447178|NCT02198651|18819731|P1|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
5447179|NCT02198651|18819727|P5|Open-label Rescue Period|Withdrew consent|0
5447180|NCT02198651|18819728|P4|Open-label Rescue Period|Withdrew consent|2
5447181|NCT02198651|18819729|P3|Open-label Rescue Period|Withdrew consent|0
5447182|NCT02198651|18819730|P2|Open-label Rescue Period|Withdrew consent|0
5447183|NCT02198651|18819731|P1|Open-label Rescue Period|Withdrew consent|0
5447184|NCT02198651|18819727|P5|Double-blind Period|Other, not specified|0
5447185|NCT02198651|18819728|P4|Double-blind Period|Other, not specified|0
5447186|NCT02198651|18819729|P3|Double-blind Period|Other, not specified|1
5447187|NCT02198651|18819730|P2|Double-blind Period|Other, not specified|4
5447188|NCT02198651|18819731|P1|Double-blind Period|Other, not specified|0
5447189|NCT02198651|18819727|P5|Double-blind Period|Adverse Event|0
5447190|NCT02198651|18819728|P4|Double-blind Period|Adverse Event|0
5447191|NCT02198651|18819729|P3|Double-blind Period|Adverse Event|0
5447192|NCT02198651|18819730|P2|Double-blind Period|Adverse Event|1
5447193|NCT02198651|18819731|P1|Double-blind Period|Adverse Event|0
5447194|NCT02198651|18819727|P5|Double-blind Period|Withdrew consent|0
5447195|NCT02198651|18819728|P4|Double-blind Period|Withdrew consent|0
5447196|NCT02198651|18819729|P3|Double-blind Period|Withdrew consent|0
5447197|NCT02198651|18819730|P2|Double-blind Period|Withdrew consent|4
5447198|NCT02198651|18819731|P1|Double-blind Period|Withdrew consent|0
5447199|NCT02198651|18819727|P5|Lead-in Period|Other, not specified|0
5447200|NCT02198651|18819728|P4|Lead-in Period|Other, not specified|0
5447201|NCT02198651|18819729|P3|Lead-in Period|Other, not specified|0
5447202|NCT02198651|18819730|P2|Lead-in Period|Other, not specified|0
5447203|NCT02198651|18819731|P1|Lead-in Period|Other, not specified|22
5447204|NCT02198651|18819727|P5|Lead-in Period|Adverse Event|0
5447205|NCT02198651|18819728|P4|Lead-in Period|Adverse Event|0
5447206|NCT02198651|18819729|P3|Lead-in Period|Adverse Event|0
5447207|NCT02198651|18819730|P2|Lead-in Period|Adverse Event|0
5447208|NCT02198651|18819731|P1|Lead-in Period|Adverse Event|2
5447209|NCT02198651|18819727|P5|Lead-in Period|Withdrew consent|0
5447210|NCT02198651|18819728|P4|Lead-in Period|Withdrew consent|0
5447211|NCT02198651|18819729|P3|Lead-in Period|Withdrew consent|0
5447212|NCT02198651|18819730|P2|Lead-in Period|Withdrew consent|0
5447213|NCT02198651|18819731|P1|Lead-in Period|Withdrew consent|13
5447214|NCT02198235|18819832|P3|Overall Study|Lost to Follow-up|2
5447215|NCT02198235|18819833|P2|Overall Study|Lost to Follow-up|2
5447216|NCT02198235|18819834|P1|Overall Study|Lost to Follow-up|3
5447217|NCT02198040|18819854|P3|Overall Study|Withdrawal by Subject|1
5447218|NCT02198040|18819855|P2|Overall Study|Withdrawal by Subject|0
5447219|NCT02198040|18819856|P1|Overall Study|Withdrawal by Subject|0
5447220|NCT02198040|18819854|P3|Overall Study|Work reasons|0
5447221|NCT02198040|18819855|P2|Overall Study|Work reasons|1
5447222|NCT02198040|18819856|P1|Overall Study|Work reasons|0
5447223|NCT02197806|18819886|P4|Overall Study|Adverse Event|1
5447224|NCT02197806|18819887|P3|Overall Study|Adverse Event|0
5447225|NCT02197806|18819888|P2|Overall Study|Adverse Event|1
5447226|NCT02197806|18819889|P1|Overall Study|Adverse Event|0
5447227|NCT02197572|18819904|P1|Overall Study|Reason Not Specified|4
5447228|NCT02197572|18819904|P1|Overall Study|Adverse Event|3
5447229|NCT02197572|18819904|P1|Overall Study|Withdrawal by Subject|9
5447230|NCT02197572|18819904|P1|Overall Study|Progressive Disease|28
5447231|NCT02197520|18819921|P2|Period 2|Withdrawal by Subject|0
5447232|NCT02197520|18819922|P1|Period 2|Withdrawal by Subject|1
5447233|NCT02197520|18819921|P2|Period 2|Adverse Event|2
5447234|NCT02197520|18819922|P1|Period 2|Adverse Event|0
5447235|NCT02197520|18819921|P2|Period 1|Withdrawal by Subject|0
5447236|NCT02197520|18819922|P1|Period 1|Withdrawal by Subject|1
5447237|NCT02197416|18819969|P3|Overall Study|Adverse Event|1
5447238|NCT02197416|18819970|P2|Overall Study|Adverse Event|0
5447239|NCT02197416|18819971|P1|Overall Study|Adverse Event|0
5447240|NCT02197416|18819969|P3|Overall Study|Protocol Violation|1
5447241|NCT02197416|18819970|P2|Overall Study|Protocol Violation|0
5447242|NCT02197416|18819971|P1|Overall Study|Protocol Violation|1
5447243|NCT02197416|18819969|P3|Overall Study|Withdrawal by Subject|1
5447244|NCT02197416|18819970|P2|Overall Study|Withdrawal by Subject|2
5447245|NCT02197416|18819971|P1|Overall Study|Withdrawal by Subject|0
5447246|NCT02197416|18819969|P3|Overall Study|Other reasons|5
5447247|NCT02197416|18819970|P2|Overall Study|Other reasons|2
5447248|NCT02197416|18819971|P1|Overall Study|Other reasons|0
5447249|NCT02197377|18820009|P2|Overall Study|Insertion Failure|3
5447250|NCT02197377|18820010|P1|Overall Study|Insertion Failure|0
5447251|NCT02197247|18820031|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
5447252|NCT02197247|18820031|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
5447253|NCT02197247|18820031|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
5447254|NCT02197247|18820031|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
5447255|NCT02197247|18820031|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
5447256|NCT02197247|18820031|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
5447257|NCT02197247|18820031|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
5447258|NCT02197247|18820031|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
5447259|NCT02197234|18820076|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
5447260|NCT02197234|18820076|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
5447261|NCT02197234|18820076|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
5447262|NCT02197234|18820076|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
5447263|NCT02197234|18820076|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
5447264|NCT02197234|18820076|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
5447265|NCT02197234|18820076|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
5447266|NCT02197130|18820098|P3|Overall Study|Other|3
5447267|NCT02197130|18820099|P2|Overall Study|Other|0
5447268|NCT02197130|18820100|P1|Overall Study|Other|1
5447269|NCT02197130|18820098|P3|Overall Study|Withdrawal by Subject|4
5447270|NCT02197130|18820099|P2|Overall Study|Withdrawal by Subject|3
5447271|NCT02197130|18820100|P1|Overall Study|Withdrawal by Subject|0
5447272|NCT02197130|18820098|P3|Overall Study|Does not meet entrance criteria|1
5447273|NCT02197130|18820099|P2|Overall Study|Does not meet entrance criteria|0
5447274|NCT02197130|18820100|P1|Overall Study|Does not meet entrance criteria|0
5447275|NCT02197130|18820098|P3|Overall Study|Lost to Follow-up|1
5447276|NCT02197130|18820099|P2|Overall Study|Lost to Follow-up|0
5447277|NCT02197130|18820100|P1|Overall Study|Lost to Follow-up|2
5447278|NCT02197130|18820098|P3|Overall Study|Death|0
5447279|NCT02197130|18820099|P2|Overall Study|Death|1
5447280|NCT02197130|18820100|P1|Overall Study|Death|0
5447281|NCT02197130|18820098|P3|Overall Study|Adverse Event|23
5447282|NCT02197130|18820099|P2|Overall Study|Adverse Event|4
5447283|NCT02197130|18820100|P1|Overall Study|Adverse Event|13
5447284|NCT02196714|18820346|P4|Overall Study|Protocol Violation|0
5447285|NCT02196714|18820347|P3|Overall Study|Protocol Violation|1
5447286|NCT02196714|18820348|P2|Overall Study|Protocol Violation|0
5447287|NCT02196714|18820349|P1|Overall Study|Protocol Violation|0
5447288|NCT02196701|18820471|P1|Overall Study|Non-adherence to Protocol|1
5447289|NCT02196701|18820471|P1|Overall Study|Lost to Follow-up|1
5447290|NCT02196701|18820471|P1|Overall Study|Adverse Event|1
5447291|NCT02196675|18820545|P3|Overall Study|Death|1
5447292|NCT02196675|18820546|P2|Overall Study|Death|0
5447293|NCT02196675|18820547|P1|Overall Study|Death|0
5447294|NCT02196675|18820545|P3|Overall Study|Protocol Violation|0
5447295|NCT02196675|18820546|P2|Overall Study|Protocol Violation|1
5447296|NCT02196675|18820547|P1|Overall Study|Protocol Violation|0
5447297|NCT02196675|18820545|P3|Overall Study|Intra-operative surgical exclusion|0
5447298|NCT02196675|18820546|P2|Overall Study|Intra-operative surgical exclusion|1
5447299|NCT02196675|18820547|P1|Overall Study|Intra-operative surgical exclusion|1
5447300|NCT02196675|18820545|P3|Overall Study|Withdrawal by Subject|0
5447301|NCT02196675|18820546|P2|Overall Study|Withdrawal by Subject|0
5447302|NCT02196675|18820547|P1|Overall Study|Withdrawal by Subject|1
5447303|NCT02196558|18820570|P3|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
5447304|NCT02196558|18820571|P2|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
5447305|NCT02196558|18820572|P1|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
5447306|NCT02196558|18820570|P3|Extension Phase (40 Weeks)|Adverse Event|0
5447307|NCT02196558|18820571|P2|Extension Phase (40 Weeks)|Adverse Event|2
5447308|NCT02196558|18820572|P1|Extension Phase (40 Weeks)|Adverse Event|1
5447309|NCT02196558|18820570|P3|Treatment Phase (12 Weeks)|Progression of Disease|1
5447310|NCT02196558|18820571|P2|Treatment Phase (12 Weeks)|Progression of Disease|0
5447311|NCT02196558|18820572|P1|Treatment Phase (12 Weeks)|Progression of Disease|0
5447312|NCT02196558|18820570|P3|Treatment Phase (12 Weeks)|Participant Choice|1
5447313|NCT02196558|18820571|P2|Treatment Phase (12 Weeks)|Participant Choice|1
5447314|NCT02196558|18820572|P1|Treatment Phase (12 Weeks)|Participant Choice|0
5447315|NCT02196558|18820570|P3|Treatment Phase (12 Weeks)|Adverse Event|0
5447316|NCT02196558|18820571|P2|Treatment Phase (12 Weeks)|Adverse Event|2
5447317|NCT02196558|18820572|P1|Treatment Phase (12 Weeks)|Adverse Event|0
5447318|NCT02196506|18820588|P4|Phase A+|Participant withdrawn by investigator|1
5447319|NCT02196506|18820589|P3|Phase A+|Participant withdrawn by investigator|0
5447320|NCT02196506|18820590|P2|Phase A+|Participant withdrawn by investigator|0
5447321|NCT02196506|18820591|P1|Phase A+|Participant withdrawn by investigator|0
5447322|NCT02196506|18820588|P4|Phase A+|Lost to Follow-up|6
5447323|NCT02196506|18820589|P3|Phase A+|Lost to Follow-up|0
5447324|NCT02196506|18820590|P2|Phase A+|Lost to Follow-up|0
5447325|NCT02196506|18820591|P1|Phase A+|Lost to Follow-up|0
5447326|NCT02196506|18820588|P4|Phase A+|Adverse Event|1
5447327|NCT02196506|18820589|P3|Phase A+|Adverse Event|0
5447328|NCT02196506|18820590|P2|Phase A+|Adverse Event|0
5447329|NCT02196506|18820591|P1|Phase A+|Adverse Event|0
5447330|NCT02196506|18820588|P4|Phase A+|Withdrawal by Participant|5
5447331|NCT02196506|18820589|P3|Phase A+|Withdrawal by Participant|0
5447332|NCT02196506|18820590|P2|Phase A+|Withdrawal by Participant|0
5447333|NCT02196506|18820591|P1|Phase A+|Withdrawal by Participant|0
5447334|NCT02196506|18820588|P4|Phase A+|Participant Met Withdrawal Criteria|1
5447335|NCT02196506|18820589|P3|Phase A+|Participant Met Withdrawal Criteria|0
5447336|NCT02196506|18820590|P2|Phase A+|Participant Met Withdrawal Criteria|0
5447337|NCT02196506|18820591|P1|Phase A+|Participant Met Withdrawal Criteria|0
5447338|NCT02196506|18820588|P4|Phase B|Lost to Follow-up|0
5447339|NCT02196506|18820589|P3|Phase B|Lost to Follow-up|1
5447340|NCT02196506|18820590|P2|Phase B|Lost to Follow-up|2
5447341|NCT02196506|18820591|P1|Phase B|Lost to Follow-up|0
5447342|NCT02196506|18820588|P4|Phase B|Adverse Event|0
5447343|NCT02196506|18820589|P3|Phase B|Adverse Event|1
5447344|NCT02196506|18820590|P2|Phase B|Adverse Event|4
5447345|NCT02196506|18820591|P1|Phase B|Adverse Event|0
5447346|NCT02196506|18820588|P4|Phase B|Withdrawal by Participant|0
5447347|NCT02196506|18820589|P3|Phase B|Withdrawal by Participant|1
5447348|NCT02196506|18820590|P2|Phase B|Withdrawal by Participant|8
5447349|NCT02196506|18820591|P1|Phase B|Withdrawal by Participant|0
5447350|NCT02196506|18820588|P4|Phase B|Lack of Efficacy|0
5447351|NCT02196506|18820589|P3|Phase B|Lack of Efficacy|2
5447352|NCT02196506|18820590|P2|Phase B|Lack of Efficacy|1
5447353|NCT02196506|18820591|P1|Phase B|Lack of Efficacy|0
5447354|NCT02196506|18820588|P4|Phase B|Participant Met Withdrawal Criteria|0
5447355|NCT02196506|18820589|P3|Phase B|Participant Met Withdrawal Criteria|1
5447356|NCT02196506|18820590|P2|Phase B|Participant Met Withdrawal Criteria|0
5447357|NCT02196506|18820591|P1|Phase B|Participant Met Withdrawal Criteria|0
5447358|NCT02196506|18820588|P4|Phase A|Participant withdrawn by investigator|0
5447359|NCT02196506|18820589|P3|Phase A|Participant withdrawn by investigator|0
5447360|NCT02196506|18820590|P2|Phase A|Participant withdrawn by investigator|0
5447361|NCT02196506|18820591|P1|Phase A|Participant withdrawn by investigator|10
5447362|NCT02196506|18820588|P4|Phase A|Protocol deviation|0
5447363|NCT02196506|18820589|P3|Phase A|Protocol deviation|0
5447364|NCT02196506|18820590|P2|Phase A|Protocol deviation|0
5447365|NCT02196506|18820591|P1|Phase A|Protocol deviation|12
5447366|NCT02196506|18820588|P4|Phase A|Lost to Follow-up|0
5447367|NCT02196506|18820589|P3|Phase A|Lost to Follow-up|0
5447368|NCT02196506|18820590|P2|Phase A|Lost to Follow-up|0
5447369|NCT02196506|18820591|P1|Phase A|Lost to Follow-up|9
5447370|NCT02196506|18820588|P4|Phase A|Adverse Event|0
5447371|NCT02196506|18820589|P3|Phase A|Adverse Event|0
5447372|NCT02196506|18820590|P2|Phase A|Adverse Event|0
5447373|NCT02196506|18820591|P1|Phase A|Adverse Event|22
5447374|NCT02196506|18820588|P4|Phase A|Withdrawal by Subject|0
5447375|NCT02196506|18820589|P3|Phase A|Withdrawal by Subject|0
5447376|NCT02196506|18820590|P2|Phase A|Withdrawal by Subject|0
5447377|NCT02196506|18820591|P1|Phase A|Withdrawal by Subject|34
5447378|NCT02196506|18820588|P4|Phase A|Participant Met Withdrawal Criteria|0
5447379|NCT02196506|18820589|P3|Phase A|Participant Met Withdrawal Criteria|0
5447380|NCT02196506|18820590|P2|Phase A|Participant Met Withdrawal Criteria|0
5447381|NCT02196506|18820591|P1|Phase A|Participant Met Withdrawal Criteria|34
5447382|NCT02196259|18820606|P3|Overall Study|Partial data analysis|0
5447383|NCT02196259|18820607|P2|Overall Study|Partial data analysis|3
5447384|NCT02196259|18820608|P1|Overall Study|Partial data analysis|0
5447385|NCT02196259|18820606|P3|Overall Study|Researcher choice|1
5447386|NCT02196259|18820607|P2|Overall Study|Researcher choice|0
5447387|NCT02196259|18820608|P1|Overall Study|Researcher choice|0
5447388|NCT02196077|18820636|P1|Overall Study|Protocol Violation|24
5447389|NCT02196077|18820636|P1|Overall Study|Lost to Follow-up|3
5447390|NCT02196077|18820636|P1|Overall Study|Physician Decision|1
5447391|NCT02196077|18820636|P1|Overall Study|Withdrawal by Subject|14
5447392|NCT02196077|18820636|P1|Overall Study|Lack of Efficacy|1
5447393|NCT02196077|18820636|P1|Overall Study|Adverse Event|4
5447394|NCT02195986|18820686|P3|Overall Study|Non-compliance|0
5447395|NCT02195986|18820687|P2|Overall Study|Non-compliance|1
5447396|NCT02195986|18820688|P1|Overall Study|Non-compliance|0
5447397|NCT02195986|18820686|P3|Overall Study|Protocol Violation|1
5447398|NCT02195986|18820687|P2|Overall Study|Protocol Violation|1
5447399|NCT02195986|18820688|P1|Overall Study|Protocol Violation|0
5447400|NCT02195986|18820686|P3|Overall Study|Family Emergency|1
5447401|NCT02195986|18820687|P2|Overall Study|Family Emergency|0
5447402|NCT02195986|18820688|P1|Overall Study|Family Emergency|0
5447403|NCT02195986|18820686|P3|Overall Study|Withdrawal by Subject|0
5447404|NCT02195986|18820687|P2|Overall Study|Withdrawal by Subject|3
5447405|NCT02195986|18820688|P1|Overall Study|Withdrawal by Subject|0
5447406|NCT02195986|18820686|P3|Overall Study|Adverse Event|0
5447407|NCT02195986|18820687|P2|Overall Study|Adverse Event|0
5447408|NCT02195986|18820688|P1|Overall Study|Adverse Event|3
5447409|NCT02195869|18820711|P1|Overall Study|Noncompliance with study drug|2
5447410|NCT02195869|18820711|P1|Overall Study|Study Terminated by Sponsor|7
5447411|NCT02195869|18820711|P1|Overall Study|Physician Decision|4
5447412|NCT02195869|18820711|P1|Overall Study|Withdrawal by Subject|7
5447413|NCT02195869|18820711|P1|Overall Study|Adverse Event|15
5447414|NCT02195869|18820711|P1|Overall Study|Malignancy Progression/relapse|2
5447415|NCT02195869|18820711|P1|Overall Study|cGVHD Progression|5
5447416|NCT02195700|18820733|P2|Overall Study|Lost to Follow-up|1
5447417|NCT02195700|18820734|P1|Overall Study|Lost to Follow-up|1
5447418|NCT02195700|18820733|P2|Overall Study|Withdrawal by Subject|2
5447419|NCT02195700|18820734|P1|Overall Study|Withdrawal by Subject|3
5447420|NCT02195700|18820733|P2|Overall Study|Adverse Event|2
5447421|NCT02195700|18820734|P1|Overall Study|Adverse Event|1
5447422|NCT02195700|18820733|P2|Overall Study|Noncompliance|0
5447423|NCT02195700|18820734|P1|Overall Study|Noncompliance|1
5447424|NCT02195700|18820733|P2|Overall Study|Protocol Violation|2
5447425|NCT02195700|18820734|P1|Overall Study|Protocol Violation|0
5447426|NCT02195687|18820756|P2|Overall Study|Lost to Follow-up|1
5447427|NCT02195687|18820757|P1|Overall Study|Lost to Follow-up|4
5447428|NCT02195687|18820756|P2|Overall Study|Personal Reasons|1
5447429|NCT02195687|18820757|P1|Overall Study|Personal Reasons|1
5447430|NCT02195583|18820782|P1|Overall Study|Other Reason|2
5447431|NCT02195583|18820782|P1|Overall Study|Adverse Event|2
5447432|NCT02195583|18820782|P1|Overall Study|Withdrawal by Subject|4
5447433|NCT02195583|18820782|P1|Overall Study|Lost to Follow-up|1
5447434|NCT02195531|18820817|P3|Overall Study|Withdrawal by Subject|1
5447435|NCT02195531|18820818|P2|Overall Study|Withdrawal by Subject|1
5447436|NCT02195531|18820819|P1|Overall Study|Withdrawal by Subject|1
5447437|NCT02195518|18820844|P1|Overall Study|Lost to Follow-up|1
5447438|NCT02195518|18820844|P1|Overall Study|Withdrawal by Subject|1
5447439|NCT02195518|18820844|P1|Overall Study|Pregnancy|2
5447440|NCT02195518|18820844|P1|Overall Study|Protocol Violation|4
5447441|NCT02195518|18820844|P1|Overall Study|Adverse Event|1
5447442|NCT02195479|18820867|P2|Overall Study|Ongoing|297
5447443|NCT02195479|18820868|P1|Overall Study|Ongoing|291
5447444|NCT02195479|18820867|P2|Overall Study|Other|2
5447445|NCT02195479|18820868|P1|Overall Study|Other|2
5447446|NCT02195479|18820867|P2|Overall Study|Withdrawal by Subject|6
5447447|NCT02195479|18820868|P1|Overall Study|Withdrawal by Subject|11
5447448|NCT02195479|18820867|P2|Overall Study|Physician Decision|0
5447449|NCT02195479|18820868|P1|Overall Study|Physician Decision|1
5447450|NCT02195479|18820867|P2|Overall Study|Death|45
5447451|NCT02195479|18820868|P1|Overall Study|Death|48
5447452|NCT02195479|18820867|P2|Overall Study|Lost to Follow-up|0
5447453|NCT02195479|18820868|P1|Overall Study|Lost to Follow-up|3
5447454|NCT02195427|18820906|P2|Overall Study|Conditional re-treatment at W52|1
5447455|NCT02195427|18820907|P1|Overall Study|Conditional re-treatment at W52|2
5447456|NCT02195427|18820906|P2|Overall Study|Protocol Violation|14
5447457|NCT02195427|18820907|P1|Overall Study|Protocol Violation|7
5447458|NCT02195427|18820906|P2|Overall Study|Lost to Follow-up|1
5447459|NCT02195427|18820907|P1|Overall Study|Lost to Follow-up|0
5447460|NCT02195427|18820906|P2|Overall Study|Withdrawal by Subject|2
5447461|NCT02195427|18820907|P1|Overall Study|Withdrawal by Subject|4
5447462|NCT02195427|18820906|P2|Overall Study|Did not consent to study extension|9
5447463|NCT02195427|18820907|P1|Overall Study|Did not consent to study extension|13
5447464|NCT02195011|18821272|P2|Overall Study|Withdrawal by Subject|0
5447465|NCT02195011|18821273|P1|Overall Study|Withdrawal by Subject|3
5447466|NCT02195011|18821272|P2|Overall Study|Progressive Disease|1
5447467|NCT02195011|18821273|P1|Overall Study|Progressive Disease|18
5447468|NCT02195011|18821272|P2|Overall Study|Adverse Event|0
5447469|NCT02195011|18821273|P1|Overall Study|Adverse Event|4
5447470|NCT02194998|18821289|P4|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
5447471|NCT02194998|18821290|P3|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
5447472|NCT02194998|18821291|P2|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
5447473|NCT02194998|18821292|P1|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
5447474|NCT02194998|18821289|P4|On-HCV Treatment|Did not pick up study medication|0
5447475|NCT02194998|18821290|P3|On-HCV Treatment|Did not pick up study medication|0
5447476|NCT02194998|18821291|P2|On-HCV Treatment|Did not pick up study medication|1
5447477|NCT02194998|18821292|P1|On-HCV Treatment|Did not pick up study medication|0
5447478|NCT02194985|18821354|P1|Overall Study|Withdrawal by Subject|2
5447479|NCT02194985|18821354|P1|Overall Study|Lost to Follow-up|1
5447480|NCT02194985|18821354|P1|Overall Study|Physician Decision|4
5447481|NCT02194985|18821354|P1|Overall Study|Met Protocol Defined Stopping Criteria|3
5447482|NCT02194985|18821354|P1|Overall Study|Adverse Event|1
5447483|NCT02194933|18821368|P2|Overall Study|Lack of Efficacy|2
5447484|NCT02194933|18821369|P1|Overall Study|Lack of Efficacy|1
5447485|NCT02194933|18821368|P2|Overall Study|Withdrawal by Subject|2
5447486|NCT02194933|18821369|P1|Overall Study|Withdrawal by Subject|0
5447487|NCT02194933|18821368|P2|Overall Study|Participant met withdrawal criteria|3
5447488|NCT02194933|18821369|P1|Overall Study|Participant met withdrawal criteria|1
5447489|NCT02194933|18821368|P2|Overall Study|Lost to Follow-up|2
5447490|NCT02194933|18821369|P1|Overall Study|Lost to Follow-up|1
5447575|NCT02193776|18821737|P4|Overall Study|Investigator/Sponsor decision|0
5447491|NCT02194699|18821423|P2|With Potential to Receive 52 Weeks of IP|Other|16
5447492|NCT02194699|18821424|P1|With Potential to Receive 52 Weeks of IP|Other|24
5447493|NCT02194699|18821423|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
5447494|NCT02194699|18821424|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
5447495|NCT02194699|18821423|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
5447496|NCT02194699|18821424|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
5447497|NCT02194699|18821423|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
5447498|NCT02194699|18821424|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
5447499|NCT02194699|18821423|P2|With Potential to Receive 52 Weeks of IP|Death|3
5447500|NCT02194699|18821424|P1|With Potential to Receive 52 Weeks of IP|Death|1
5447501|NCT02194699|18821423|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
5447502|NCT02194699|18821424|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
5447503|NCT02194699|18821423|P2|Randomised|Duplicate patient|1
5447504|NCT02194699|18821424|P1|Randomised|Duplicate patient|2
5447505|NCT02194699|18821423|P2|Randomised|Without potential for 52 weeks of IP|5
5447506|NCT02194699|18821424|P1|Randomised|Without potential for 52 weeks of IP|5
5447507|NCT02194699|18821423|P2|Randomised|Did not receive treatment|5
5447508|NCT02194699|18821424|P1|Randomised|Did not receive treatment|1
5447509|NCT02194621|18821532|P3|Overall Study|Withdrawal by Subject|7
5447510|NCT02194621|18821533|P2|Overall Study|Withdrawal by Subject|4
5447511|NCT02194621|18821534|P1|Overall Study|Withdrawal by Subject|4
5447512|NCT02194621|18821532|P3|Overall Study|6 withdrew prior to randomization|2
5447513|NCT02194621|18821533|P2|Overall Study|6 withdrew prior to randomization|2
5447514|NCT02194621|18821534|P1|Overall Study|6 withdrew prior to randomization|2
5447515|NCT02194465|18821558|P7|Overall Study|Discontinued follow-up period|0
5447516|NCT02194465|18821559|P6|Overall Study|Discontinued follow-up period|0
5447517|NCT02194465|18821560|P5|Overall Study|Discontinued follow-up period|2
5447518|NCT02194465|18821561|P4|Overall Study|Discontinued follow-up period|0
5447519|NCT02194465|18821562|P3|Overall Study|Discontinued follow-up period|1
5447520|NCT02194465|18821563|P2|Overall Study|Discontinued follow-up period|2
5447521|NCT02194465|18821564|P1|Overall Study|Discontinued follow-up period|0
5447522|NCT02194465|18821558|P7|Overall Study|Withdrawal by Subject|2
5447523|NCT02194465|18821559|P6|Overall Study|Withdrawal by Subject|1
5447524|NCT02194465|18821560|P5|Overall Study|Withdrawal by Subject|2
5447525|NCT02194465|18821561|P4|Overall Study|Withdrawal by Subject|2
5447526|NCT02194465|18821562|P3|Overall Study|Withdrawal by Subject|1
5447527|NCT02194465|18821563|P2|Overall Study|Withdrawal by Subject|3
5447528|NCT02194465|18821564|P1|Overall Study|Withdrawal by Subject|1
5447529|NCT02194465|18821558|P7|Overall Study|Protocol Violation|0
5447530|NCT02194465|18821559|P6|Overall Study|Protocol Violation|0
5447531|NCT02194465|18821560|P5|Overall Study|Protocol Violation|1
5447532|NCT02194465|18821561|P4|Overall Study|Protocol Violation|1
5447533|NCT02194465|18821562|P3|Overall Study|Protocol Violation|2
5447534|NCT02194465|18821563|P2|Overall Study|Protocol Violation|1
5447535|NCT02194465|18821564|P1|Overall Study|Protocol Violation|1
5447536|NCT02194465|18821558|P7|Overall Study|Physician Decision|0
5447537|NCT02194465|18821559|P6|Overall Study|Physician Decision|0
5447538|NCT02194465|18821560|P5|Overall Study|Physician Decision|0
5447539|NCT02194465|18821561|P4|Overall Study|Physician Decision|0
5447540|NCT02194465|18821562|P3|Overall Study|Physician Decision|0
5447541|NCT02194465|18821563|P2|Overall Study|Physician Decision|0
5447542|NCT02194465|18821564|P1|Overall Study|Physician Decision|1
5447543|NCT02194465|18821558|P7|Overall Study|Lost to Follow-up|0
5447544|NCT02194465|18821559|P6|Overall Study|Lost to Follow-up|1
5447545|NCT02194465|18821560|P5|Overall Study|Lost to Follow-up|0
5447546|NCT02194465|18821561|P4|Overall Study|Lost to Follow-up|1
5447547|NCT02194465|18821562|P3|Overall Study|Lost to Follow-up|0
5447548|NCT02194465|18821563|P2|Overall Study|Lost to Follow-up|0
5447549|NCT02194465|18821564|P1|Overall Study|Lost to Follow-up|0
5447550|NCT02194465|18821558|P7|Overall Study|Adverse Event|0
5447551|NCT02194465|18821559|P6|Overall Study|Adverse Event|2
5447552|NCT02194465|18821560|P5|Overall Study|Adverse Event|4
5447553|NCT02194465|18821561|P4|Overall Study|Adverse Event|4
5447554|NCT02194465|18821562|P3|Overall Study|Adverse Event|4
5447555|NCT02194465|18821563|P2|Overall Study|Adverse Event|1
5447556|NCT02194465|18821564|P1|Overall Study|Adverse Event|6
5447557|NCT02194062|18821621|P3|Overall Study|Lost to Follow-up|5
5447558|NCT02194062|18821622|P2|Overall Study|Lost to Follow-up|2
5447559|NCT02194062|18821623|P1|Overall Study|Lost to Follow-up|2
5447560|NCT02193880|18821634|P1|Overall Study|patients did not collect enough HPC|3
5447561|NCT02193867|18821639|P1|Overall Study|Sponsor Study Termination|2
5447562|NCT02193867|18821639|P1|Overall Study|Death|2
5447563|NCT02193828|18821657|P4|Overall Study|Withdrawal by Subject|1
5447564|NCT02193828|18821658|P3|Overall Study|Withdrawal by Subject|1
5447565|NCT02193828|18821659|P2|Overall Study|Withdrawal by Subject|0
5447566|NCT02193828|18821660|P1|Overall Study|Withdrawal by Subject|0
5447567|NCT02193776|18821737|P4|Overall Study|Adverse event/Specific toxicity|2
5447568|NCT02193776|18821738|P3|Overall Study|Adverse event/Specific toxicity|2
5447569|NCT02193776|18821739|P2|Overall Study|Adverse event/Specific toxicity|5
5447570|NCT02193776|18821740|P1|Overall Study|Adverse event/Specific toxicity|5
5447571|NCT02193776|18821737|P4|Overall Study|Death|0
5447572|NCT02193776|18821738|P3|Overall Study|Death|0
5447573|NCT02193776|18821739|P2|Overall Study|Death|0
5447574|NCT02193776|18821740|P1|Overall Study|Death|1
5447576|NCT02193776|18821738|P3|Overall Study|Investigator/Sponsor decision|0
5447577|NCT02193776|18821739|P2|Overall Study|Investigator/Sponsor decision|1
5447578|NCT02193776|18821740|P1|Overall Study|Investigator/Sponsor decision|1
5447579|NCT02193776|18821737|P4|Overall Study|Failure to comply with protocol|0
5447580|NCT02193776|18821738|P3|Overall Study|Failure to comply with protocol|0
5447581|NCT02193776|18821739|P2|Overall Study|Failure to comply with protocol|1
5447582|NCT02193776|18821740|P1|Overall Study|Failure to comply with protocol|0
5447583|NCT02193776|18821737|P4|Overall Study|Consent withdrawn|0
5447584|NCT02193776|18821738|P3|Overall Study|Consent withdrawn|0
5447585|NCT02193776|18821739|P2|Overall Study|Consent withdrawn|0
5447586|NCT02193776|18821740|P1|Overall Study|Consent withdrawn|1
5447587|NCT02193178|18821767|P1|Overall Study|Dry eyes|1
5447588|NCT02193178|18821767|P1|Overall Study|Lost to Follow-up|1
5447589|NCT02193165|18821817|P3|6 Week Product Use|Lost to Follow-up|0
5447590|NCT02193165|18821818|P2|6 Week Product Use|Lost to Follow-up|1
5447591|NCT02193165|18821819|P1|6 Week Product Use|Lost to Follow-up|0
5447592|NCT02193165|18821817|P3|4 Week Product Use|Lost to Follow-up|1
5447593|NCT02193165|18821818|P2|4 Week Product Use|Lost to Follow-up|1
5447594|NCT02193165|18821819|P1|4 Week Product Use|Lost to Follow-up|1
5447595|NCT02193087|18821854|P4|Overall Study|Did Not Receive Any Vaccination|1
5447596|NCT02193087|18821855|P3|Overall Study|Did Not Receive Any Vaccination|0
5447597|NCT02193087|18821856|P2|Overall Study|Did Not Receive Any Vaccination|3
5447598|NCT02193087|18821857|P1|Overall Study|Did Not Receive Any Vaccination|2
5447599|NCT02193087|18821854|P4|Overall Study|Other Reason Not Specified|9
5447600|NCT02193087|18821855|P3|Overall Study|Other Reason Not Specified|1
5447601|NCT02193087|18821856|P2|Overall Study|Other Reason Not Specified|2
5447602|NCT02193087|18821857|P1|Overall Study|Other Reason Not Specified|7
5447603|NCT02193087|18821854|P4|Overall Study|Withdrawal by Subject|19
5447604|NCT02193087|18821855|P3|Overall Study|Withdrawal by Subject|1
5447605|NCT02193087|18821856|P2|Overall Study|Withdrawal by Subject|3
5447606|NCT02193087|18821857|P1|Overall Study|Withdrawal by Subject|10
5447607|NCT02193087|18821854|P4|Overall Study|Protocol Violation|2
5447608|NCT02193087|18821855|P3|Overall Study|Protocol Violation|1
5447609|NCT02193087|18821856|P2|Overall Study|Protocol Violation|0
5447610|NCT02193087|18821857|P1|Overall Study|Protocol Violation|2
5447611|NCT02193087|18821854|P4|Overall Study|Lost to Follow-up|37
5447612|NCT02193087|18821855|P3|Overall Study|Lost to Follow-up|4
5447613|NCT02193087|18821856|P2|Overall Study|Lost to Follow-up|6
5447614|NCT02193087|18821857|P1|Overall Study|Lost to Follow-up|14
5447615|NCT02193087|18821854|P4|Overall Study|Adverse Event|11
5447616|NCT02193087|18821855|P3|Overall Study|Adverse Event|0
5447617|NCT02193087|18821856|P2|Overall Study|Adverse Event|0
5447618|NCT02193087|18821857|P1|Overall Study|Adverse Event|2
5447619|NCT02193074|18821902|P2|Overall Study|Adverse Event|13
5447620|NCT02193074|18821903|P1|Overall Study|Adverse Event|16
5447621|NCT02193074|18821902|P2|Overall Study|Withdrawal by Subject|2
5447622|NCT02193074|18821903|P1|Overall Study|Withdrawal by Subject|1
5447623|NCT02192905|18821935|P1|Overall Study|Lost to Follow-up|1
5447624|NCT02192606|18822003|P2|Overall Study|3D equipment rep unable to join|1
5447625|NCT02192606|18822004|P1|Overall Study|3D equipment rep unable to join|0
5447626|NCT02192606|18822003|P2|Overall Study|Physician Decision|2
5447627|NCT02192606|18822004|P1|Overall Study|Physician Decision|1
5447628|NCT02192606|18822003|P2|Overall Study|surgery type was changed|1
5447629|NCT02192606|18822004|P1|Overall Study|surgery type was changed|1
5447630|NCT02192190|18822052|P6|Overall Study|Inadequate Pain Relief|0
5447631|NCT02192190|18822053|P5|Overall Study|Inadequate Pain Relief|0
5447632|NCT02192190|18822054|P4|Overall Study|Inadequate Pain Relief|0
5447633|NCT02192190|18822055|P3|Overall Study|Inadequate Pain Relief|1
5447634|NCT02192190|18822056|P2|Overall Study|Inadequate Pain Relief|1
5447635|NCT02192190|18822057|P1|Overall Study|Inadequate Pain Relief|0
5447636|NCT02192190|18822052|P6|Overall Study|Positive Drug Screen|0
5447637|NCT02192190|18822053|P5|Overall Study|Positive Drug Screen|0
5447638|NCT02192190|18822054|P4|Overall Study|Positive Drug Screen|1
5447639|NCT02192190|18822055|P3|Overall Study|Positive Drug Screen|0
5447640|NCT02192190|18822056|P2|Overall Study|Positive Drug Screen|0
5447641|NCT02192190|18822057|P1|Overall Study|Positive Drug Screen|0
5447642|NCT02192190|18822052|P6|Overall Study|Could not Keep Visit Schedule|0
5447643|NCT02192190|18822053|P5|Overall Study|Could not Keep Visit Schedule|0
5447644|NCT02192190|18822054|P4|Overall Study|Could not Keep Visit Schedule|0
5447645|NCT02192190|18822055|P3|Overall Study|Could not Keep Visit Schedule|0
5447646|NCT02192190|18822056|P2|Overall Study|Could not Keep Visit Schedule|0
5447647|NCT02192190|18822057|P1|Overall Study|Could not Keep Visit Schedule|1
5447648|NCT02192190|18822052|P6|Overall Study|Withdrawal by Subject|3
5447649|NCT02192190|18822053|P5|Overall Study|Withdrawal by Subject|5
5447650|NCT02192190|18822054|P4|Overall Study|Withdrawal by Subject|1
5447651|NCT02192190|18822055|P3|Overall Study|Withdrawal by Subject|2
5447652|NCT02192190|18822056|P2|Overall Study|Withdrawal by Subject|1
5447653|NCT02192190|18822057|P1|Overall Study|Withdrawal by Subject|4
5447654|NCT02192190|18822052|P6|Overall Study|Terminated by Sponsor|23
5447655|NCT02192190|18822053|P5|Overall Study|Terminated by Sponsor|21
5447656|NCT02192190|18822054|P4|Overall Study|Terminated by Sponsor|23
5447657|NCT02192190|18822055|P3|Overall Study|Terminated by Sponsor|20
5447658|NCT02192190|18822056|P2|Overall Study|Terminated by Sponsor|23
5447659|NCT02192190|18822057|P1|Overall Study|Terminated by Sponsor|43
5447660|NCT02192190|18822052|P6|Overall Study|Physician Decision|0
5447661|NCT02192190|18822053|P5|Overall Study|Physician Decision|0
5447662|NCT02192190|18822054|P4|Overall Study|Physician Decision|0
5447663|NCT02192190|18822055|P3|Overall Study|Physician Decision|0
5447664|NCT02192190|18822056|P2|Overall Study|Physician Decision|0
5447665|NCT02192190|18822057|P1|Overall Study|Physician Decision|2
5447666|NCT02192190|18822052|P6|Overall Study|Lost to Follow-up|3
5447667|NCT02192190|18822053|P5|Overall Study|Lost to Follow-up|4
5447668|NCT02192190|18822054|P4|Overall Study|Lost to Follow-up|1
5447669|NCT02192190|18822055|P3|Overall Study|Lost to Follow-up|2
5447670|NCT02192190|18822056|P2|Overall Study|Lost to Follow-up|3
5447671|NCT02192190|18822057|P1|Overall Study|Lost to Follow-up|3
5447672|NCT02192190|18822052|P6|Overall Study|Adverse Event|0
5447673|NCT02192190|18822053|P5|Overall Study|Adverse Event|0
5447674|NCT02192190|18822054|P4|Overall Study|Adverse Event|0
5447675|NCT02192190|18822055|P3|Overall Study|Adverse Event|0
5447676|NCT02192190|18822056|P2|Overall Study|Adverse Event|1
5447677|NCT02192190|18822057|P1|Overall Study|Adverse Event|1
5447678|NCT02192164|18822101|P1|Overall Study|Did not meet the exclusion criteria|1
5447679|NCT02192164|18822101|P1|Overall Study|Physician Decision|4
5447680|NCT02192164|18822101|P1|Overall Study|Withdrawal by Subject|1
5447681|NCT02192164|18822101|P1|Overall Study|Other|8
5447682|NCT02192099|18822117|P1|Overall Study|Miscellaneous Reasons|5
5447683|NCT02192099|18822117|P1|Overall Study|Withdrawal by Subject|11
5447684|NCT02192099|18822117|P1|Overall Study|Study Terminated by Sponsor|32
5447685|NCT02192099|18822117|P1|Overall Study|Protocol Violation|8
5447686|NCT02192099|18822117|P1|Overall Study|Pregnancy|1
5447687|NCT02192099|18822117|P1|Overall Study|Physician Decision|1
5447688|NCT02192099|18822117|P1|Overall Study|Lost to Follow-up|2
5447689|NCT02192099|18822117|P1|Overall Study|Adverse Event|1
5447690|NCT02191618|18822146|P1|Overall Study|Missed Visit|4
5447691|NCT02191618|18822146|P1|Overall Study|Withdrawal by Subject|3
5447692|NCT02191605|18822156|P5|Overall Study|Lost to Follow-up|4
5447693|NCT02191605|18822157|P4|Overall Study|Lost to Follow-up|3
5447694|NCT02191605|18822158|P3|Overall Study|Lost to Follow-up|7
5447695|NCT02191605|18822159|P2|Overall Study|Lost to Follow-up|4
5447696|NCT02191605|18822160|P1|Overall Study|Lost to Follow-up|9
5447697|NCT02191579|18822179|P2|Treatment 2|Multiple Reasons Specified|25
5447698|NCT02191579|18822180|P1|Treatment 2|Multiple Reasons Specified|0
5447699|NCT02191579|18822179|P2|Treatment 1|Multiple Reasons Specified|58
5447700|NCT02191579|18822180|P1|Treatment 1|Multiple Reasons Specified|27
5447701|NCT02191397|18822194|P2|Overall Study|Withdrawal by Subject|27
5447702|NCT02191397|18822195|P1|Overall Study|Withdrawal by Subject|22
5447703|NCT02191397|18822194|P2|Overall Study|Physician Decision|3
5447704|NCT02191397|18822195|P1|Overall Study|Physician Decision|8
5447705|NCT02191397|18822194|P2|Overall Study|Lost to Follow-up|11
5447706|NCT02191397|18822195|P1|Overall Study|Lost to Follow-up|10
5447707|NCT02191397|18822194|P2|Overall Study|Met protocol-defined stopping criteria|4
5447708|NCT02191397|18822195|P1|Overall Study|Met protocol-defined stopping criteria|5
5447709|NCT02191397|18822194|P2|Overall Study|Protocol Violation|3
5447710|NCT02191397|18822195|P1|Overall Study|Protocol Violation|0
5447711|NCT02191397|18822194|P2|Overall Study|Lack of Efficacy|5
5447712|NCT02191397|18822195|P1|Overall Study|Lack of Efficacy|10
5447713|NCT02191397|18822194|P2|Overall Study|Adverse Event|17
5447714|NCT02191397|18822195|P1|Overall Study|Adverse Event|28
5447715|NCT02191267|18822256|P3|Overall Study|Withdrawal by Subject|0
5447716|NCT02191267|18822257|P2|Overall Study|Withdrawal by Subject|0
5447717|NCT02191267|18822258|P1|Overall Study|Withdrawal by Subject|1
5447718|NCT02191137|18822269|P1|Follow-up|Adverse Event|1
5447719|NCT02191137|18822269|P1|Follow-up|Ongoing/unknown|2
5447720|NCT02191137|18822269|P1|Follow-up|Lost to Follow-up|2
5447721|NCT02191137|18822269|P1|Treatment|Other|1
5447722|NCT02191137|18822269|P1|Treatment|Adverse Event|2
5447723|NCT02191137|18822269|P1|Treatment|Withdrawal by Subject|3
5447724|NCT02191137|18822269|P1|Treatment|Death|4
5447725|NCT02191046|18822299|P2|Overall Study|low compliance|1
5447726|NCT02191046|18822300|P1|Overall Study|low compliance|5
5447727|NCT02190721|18822407|P3|Overall Study|Patient was out of the city|0
5447728|NCT02190721|18822408|P2|Overall Study|Patient was out of the city|1
5447729|NCT02190721|18822409|P1|Overall Study|Patient was out of the city|0
5447730|NCT02190604|18822532|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447731|NCT02190604|18822533|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447732|NCT02190604|18822534|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447733|NCT02190604|18822535|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447734|NCT02190604|18822536|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447735|NCT02190604|18822537|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
5447736|NCT02190604|18822538|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447737|NCT02190604|18822539|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447738|NCT02190604|18822540|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447739|NCT02190604|18822541|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447740|NCT02190604|18822542|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447741|NCT02190604|18822543|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447742|NCT02190604|18822544|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447743|NCT02190604|18822545|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447744|NCT02190604|18822546|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447745|NCT02190604|18822547|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447746|NCT02190604|18822548|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447747|NCT02190604|18822549|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447748|NCT02190604|18822550|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5447749|NCT02190604|18822532|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447750|NCT02190604|18822533|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447751|NCT02190604|18822534|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447752|NCT02190604|18822535|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447753|NCT02190604|18822536|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
5447754|NCT02190604|18822537|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447755|NCT02190604|18822538|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447756|NCT02190604|18822539|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447757|NCT02190604|18822540|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447758|NCT02190604|18822541|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447759|NCT02190604|18822542|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447760|NCT02190604|18822543|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447761|NCT02190604|18822544|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447762|NCT02190604|18822545|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447763|NCT02190604|18822546|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447764|NCT02190604|18822547|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447765|NCT02190604|18822548|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447766|NCT02190604|18822549|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447767|NCT02190604|18822550|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5447768|NCT02190591|18822741|P2|Overall Study|face presentation so she was ineligible|1
5447769|NCT02190591|18822742|P1|Overall Study|face presentation so she was ineligible|0
5447770|NCT02190591|18822741|P2|Overall Study|did not use peanut ball as instructed|2
5447771|NCT02190591|18822742|P1|Overall Study|did not use peanut ball as instructed|0
5447772|NCT02190591|18822741|P2|Overall Study|Protocol Violation|0
5447773|NCT02190591|18822742|P1|Overall Study|Protocol Violation|1
5447774|NCT02190591|18822741|P2|Overall Study|Withdrawal by Subject|8
5447775|NCT02190591|18822742|P1|Overall Study|Withdrawal by Subject|1
5447776|NCT02190435|18822765|P2|Overall Study|3 consented screen fails|0
5447777|NCT02190435|18822766|P1|Overall Study|3 consented screen fails|3
5447778|NCT02190435|18822765|P2|Overall Study|First 12 patients were lead-ins|0
5447779|NCT02190435|18822766|P1|Overall Study|First 12 patients were lead-ins|12
5447780|NCT02190279|18822777|P3|Overall Study|Screening failure|1
5447781|NCT02190279|18822778|P2|Overall Study|Screening failure|0
5447782|NCT02190279|18822779|P1|Overall Study|Screening failure|0
5447783|NCT02190279|18822777|P3|Overall Study|Refused further treatment|1
5447784|NCT02190279|18822778|P2|Overall Study|Refused further treatment|0
5447785|NCT02190279|18822779|P1|Overall Study|Refused further treatment|0
5447786|NCT02190279|18822777|P3|Overall Study|Lost to Follow-up|0
5447787|NCT02190279|18822778|P2|Overall Study|Lost to Follow-up|0
5447788|NCT02190279|18822779|P1|Overall Study|Lost to Follow-up|2
5447789|NCT02190279|18822777|P3|Overall Study|Withdrawal consent|1
5447790|NCT02190279|18822778|P2|Overall Study|Withdrawal consent|0
5447791|NCT02190279|18822779|P1|Overall Study|Withdrawal consent|1
5447792|NCT02189941|18822818|P3|Overall Study|Non-compliance|1
5447793|NCT02189941|18822819|P2|Overall Study|Non-compliance|0
5447794|NCT02189941|18822820|P1|Overall Study|Non-compliance|0
5447795|NCT02189863|18822865|P2|First 2 Weeks|Motion Sickness|2
5447796|NCT02189863|18822866|P1|First 2 Weeks|Motion Sickness|4
5447797|NCT02189837|18822881|P4|Overall Study|Sponsor Decision|1
5447798|NCT02189837|18822882|P3|Overall Study|Sponsor Decision|0
5447799|NCT02189837|18822883|P2|Overall Study|Sponsor Decision|0
5447800|NCT02189837|18822884|P1|Overall Study|Sponsor Decision|0
5447801|NCT02189837|18822881|P4|Overall Study|Withdrawal by Subject|1
5447802|NCT02189837|18822882|P3|Overall Study|Withdrawal by Subject|3
5447803|NCT02189837|18822883|P2|Overall Study|Withdrawal by Subject|1
5447804|NCT02189837|18822884|P1|Overall Study|Withdrawal by Subject|2
5447805|NCT02189759|18822914|P4|Overall Study|Lost to Follow-up|5
5447806|NCT02189759|18822915|P3|Overall Study|Lost to Follow-up|2
5447807|NCT02189759|18822916|P2|Overall Study|Lost to Follow-up|0
5447808|NCT02189759|18822917|P1|Overall Study|Lost to Follow-up|0
5447809|NCT02189473|18822953|P2|Overall Study|Lost to Follow-up|2
5447810|NCT02189473|18822954|P1|Overall Study|Lost to Follow-up|1
5447811|NCT02189473|18822953|P2|Overall Study|Death|23
5447812|NCT02189473|18822954|P1|Overall Study|Death|22
5447813|NCT02189252|18823002|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5447814|NCT02189252|18823003|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5447815|NCT02189252|18823004|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
5447816|NCT02189252|18823005|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5447817|NCT02189252|18823002|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5447818|NCT02189252|18823003|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5447819|NCT02189252|18823004|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
5447820|NCT02189252|18823005|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5447821|NCT02188849|18823064|P2|Overall Study|Lost to Follow-up|8
5447822|NCT02188849|18823065|P1|Overall Study|Lost to Follow-up|3
5447823|NCT02188784|18823079|P2|Overall Study|Physician Decision|3
5447824|NCT02188784|18823080|P1|Overall Study|Physician Decision|2
5447825|NCT02188784|18823079|P2|Overall Study|Withdrawal by Subject|9
5447826|NCT02188784|18823080|P1|Overall Study|Withdrawal by Subject|3
5447827|NCT02188784|18823079|P2|Overall Study|Lost to Follow-up|0
5447828|NCT02188784|18823080|P1|Overall Study|Lost to Follow-up|1
5447829|NCT02188784|18823079|P2|Overall Study|Death|1
5447830|NCT02188784|18823080|P1|Overall Study|Death|3
5447831|NCT02188719|18823100|P4|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
5447832|NCT02188719|18823101|P3|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
5447833|NCT02188719|18823102|P2|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
5447834|NCT02188719|18823103|P1|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
5447835|NCT02188589|18823127|P1|Overall Study|Withdrawal by Subject|5
5447836|NCT02187861|18823159|P4|Overall Study|Other|1
5447837|NCT02187861|18823160|P3|Overall Study|Other|7
5447838|NCT02187861|18823161|P2|Overall Study|Other|1
5447839|NCT02187861|18823162|P1|Overall Study|Other|0
5447840|NCT02187861|18823159|P4|Overall Study|Withdrawal by Subject|3
5447841|NCT02187861|18823160|P3|Overall Study|Withdrawal by Subject|3
5447842|NCT02187861|18823161|P2|Overall Study|Withdrawal by Subject|0
5447843|NCT02187861|18823162|P1|Overall Study|Withdrawal by Subject|0
5447844|NCT02187861|18823159|P4|Overall Study|Progressive Disease|22
5447845|NCT02187861|18823160|P3|Overall Study|Progressive Disease|19
5447846|NCT02187861|18823161|P2|Overall Study|Progressive Disease|42
5447847|NCT02187861|18823162|P1|Overall Study|Progressive Disease|4
5447848|NCT02187861|18823159|P4|Overall Study|Physician Decision|3
5447849|NCT02187861|18823160|P3|Overall Study|Physician Decision|0
5447850|NCT02187861|18823161|P2|Overall Study|Physician Decision|1
5447851|NCT02187861|18823162|P1|Overall Study|Physician Decision|0
5447852|NCT02187861|18823159|P4|Overall Study|Death|2
5447853|NCT02187861|18823160|P3|Overall Study|Death|1
5447854|NCT02187861|18823161|P2|Overall Study|Death|3
5447855|NCT02187861|18823162|P1|Overall Study|Death|0
5447856|NCT02187861|18823159|P4|Overall Study|Adverse Event|1
5447857|NCT02187861|18823160|P3|Overall Study|Adverse Event|2
5447858|NCT02187861|18823161|P2|Overall Study|Adverse Event|1
5447859|NCT02187861|18823162|P1|Overall Study|Adverse Event|2
5447860|NCT02187809|18823258|P1|Overall Study|The study was terminated|3
5447861|NCT02187783|18823268|P1|Overall Study|Study terminated by sponsor|1
5447862|NCT02187783|18823268|P1|Overall Study|Withdrawal by Subject|9
5447863|NCT02187783|18823268|P1|Overall Study|Physician Decision|2
5447864|NCT02187783|18823268|P1|Overall Study|Protocol Violation|3
5447865|NCT02187783|18823268|P1|Overall Study|Progressive disease|80
5447866|NCT02187783|18823268|P1|Overall Study|Death|3
5447867|NCT02187783|18823268|P1|Overall Study|Adverse Event|8
5447868|NCT02187744|18823279|P2|Treatment|Participant refused continued treatment|1
5447869|NCT02187744|18823280|P1|Treatment|Participant refused continued treatment|1
5447870|NCT02187744|18823279|P2|Treatment|Other|0
5447871|NCT02187744|18823280|P1|Treatment|Other|2
5447872|NCT02187744|18823279|P2|Treatment|Lost to Follow-up|1
5447873|NCT02187744|18823280|P1|Treatment|Lost to Follow-up|0
5447874|NCT02187744|18823279|P2|Treatment|Related adverse event, not serious|2
5447875|NCT02187744|18823280|P1|Treatment|Related adverse event, not serious|0
5447876|NCT02187744|18823279|P2|Treatment|Related adverse event, serious non-fatal|1
5447877|NCT02187744|18823280|P1|Treatment|Related adverse event, serious non-fatal|0
5447878|NCT02187744|18823279|P2|Treatment|Death|0
5447879|NCT02187744|18823280|P1|Treatment|Death|1
5447880|NCT02187744|18823279|P2|Study|Related adverse event, serious non-fatal|1
5447881|NCT02187744|18823280|P1|Study|Related adverse event, serious non-fatal|0
5447882|NCT02187744|18823279|P2|Study|Death|0
5447883|NCT02187744|18823280|P1|Study|Death|1
5447884|NCT02187744|18823279|P2|Study|Related adverse event, not serious|2
5447885|NCT02187744|18823280|P1|Study|Related adverse event, not serious|0
5447886|NCT02187744|18823279|P2|Study|Lost to Follow-up|2
5447887|NCT02187744|18823280|P1|Study|Lost to Follow-up|0
5447888|NCT02187744|18823279|P2|Study|Other|1
5447889|NCT02187744|18823280|P1|Study|Other|2
5447890|NCT02187744|18823279|P2|Study|Participant refused further follow-up|0
5447891|NCT02187744|18823280|P1|Study|Participant refused further follow-up|1
5447892|NCT02187471|18823300|P4|Overall Study|Other|4
5447893|NCT02187471|18823301|P3|Overall Study|Other|3
5447894|NCT02187471|18823302|P2|Overall Study|Other|5
5447895|NCT02187471|18823303|P1|Overall Study|Other|7
5447896|NCT02187471|18823300|P4|Overall Study|Withdrawal by Subject|24
5447897|NCT02187471|18823301|P3|Overall Study|Withdrawal by Subject|22
5447898|NCT02187471|18823302|P2|Overall Study|Withdrawal by Subject|29
5447899|NCT02187471|18823303|P1|Overall Study|Withdrawal by Subject|23
5447900|NCT02187471|18823300|P4|Overall Study|Adverse Event|36
5447901|NCT02187471|18823301|P3|Overall Study|Adverse Event|44
5447902|NCT02187471|18823302|P2|Overall Study|Adverse Event|34
5447903|NCT02187471|18823303|P1|Overall Study|Adverse Event|24
5447904|NCT02187471|18823300|P4|Overall Study|Lack of Efficacy|11
5447905|NCT02187471|18823301|P3|Overall Study|Lack of Efficacy|13
5447906|NCT02187471|18823302|P2|Overall Study|Lack of Efficacy|9
5447907|NCT02187471|18823303|P1|Overall Study|Lack of Efficacy|18
5447908|NCT02187471|18823300|P4|Overall Study|Missing|1
5447909|NCT02187471|18823301|P3|Overall Study|Missing|0
5447910|NCT02187471|18823302|P2|Overall Study|Missing|0
5447911|NCT02187471|18823303|P1|Overall Study|Missing|0
5447912|NCT02187471|18823300|P4|Overall Study|Protocol Violation|4
5447913|NCT02187471|18823301|P3|Overall Study|Protocol Violation|4
5447914|NCT02187471|18823302|P2|Overall Study|Protocol Violation|5
5447915|NCT02187471|18823303|P1|Overall Study|Protocol Violation|4
5447916|NCT02187172|18823359|P2|Overall Study|Physician Decision|1
5447917|NCT02187172|18823360|P1|Overall Study|Physician Decision|1
5447918|NCT02187172|18823359|P2|Overall Study|Adverse Event|1
5447919|NCT02187172|18823360|P1|Overall Study|Adverse Event|0
5447920|NCT02187172|18823359|P2|Overall Study|Lack of Efficacy|2
5447921|NCT02187172|18823360|P1|Overall Study|Lack of Efficacy|1
5447922|NCT02187172|18823359|P2|Overall Study|Lost to Follow-up|2
5447923|NCT02187172|18823360|P1|Overall Study|Lost to Follow-up|1
5447924|NCT02187159|18823528|P4|Overall Study|Other|9
5447925|NCT02187159|18823529|P3|Overall Study|Other|3
5447926|NCT02187159|18823530|P2|Overall Study|Other|7
5447927|NCT02187159|18823531|P1|Overall Study|Other|3
5447928|NCT02187159|18823528|P4|Overall Study|Withdrawal by Subject|26
5447929|NCT02187159|18823529|P3|Overall Study|Withdrawal by Subject|25
5447930|NCT02187159|18823530|P2|Overall Study|Withdrawal by Subject|28
5447931|NCT02187159|18823531|P1|Overall Study|Withdrawal by Subject|24
5447932|NCT02187159|18823528|P4|Overall Study|Adverse Event|50
5447933|NCT02187159|18823529|P3|Overall Study|Adverse Event|42
5447934|NCT02187159|18823530|P2|Overall Study|Adverse Event|33
5447935|NCT02187159|18823531|P1|Overall Study|Adverse Event|28
5447936|NCT02187159|18823528|P4|Overall Study|Lack of Efficacy|7
5447937|NCT02187159|18823529|P3|Overall Study|Lack of Efficacy|4
5447938|NCT02187159|18823530|P2|Overall Study|Lack of Efficacy|5
5447939|NCT02187159|18823531|P1|Overall Study|Lack of Efficacy|10
5447940|NCT02187159|18823528|P4|Overall Study|Protocol Violation|4
5447941|NCT02187159|18823529|P3|Overall Study|Protocol Violation|3
5447942|NCT02187159|18823530|P2|Overall Study|Protocol Violation|6
5447943|NCT02187159|18823531|P1|Overall Study|Protocol Violation|4
5447944|NCT02187055|18823588|P3|Overall Study|Death|0
5447945|NCT02187055|18823589|P2|Overall Study|Death|0
5447946|NCT02187055|18823590|P1|Overall Study|Death|2
5447947|NCT02187055|18823588|P3|Overall Study|Adverse Event|36
5447948|NCT02187055|18823589|P2|Overall Study|Adverse Event|26
5447949|NCT02187055|18823590|P1|Overall Study|Adverse Event|21
5447950|NCT02187055|18823588|P3|Overall Study|Withdrawal by Subject|11
5447951|NCT02187055|18823589|P2|Overall Study|Withdrawal by Subject|11
5447952|NCT02187055|18823590|P1|Overall Study|Withdrawal by Subject|11
5447953|NCT02187055|18823588|P3|Overall Study|Pregnancy|0
5447954|NCT02187055|18823589|P2|Overall Study|Pregnancy|1
5447955|NCT02187055|18823590|P1|Overall Study|Pregnancy|3
5447956|NCT02187055|18823588|P3|Overall Study|Protocol Violation|4
5447957|NCT02187055|18823589|P2|Overall Study|Protocol Violation|9
5447958|NCT02187055|18823590|P1|Overall Study|Protocol Violation|9
5447959|NCT02187055|18823588|P3|Overall Study|Other|3
5447960|NCT02187055|18823589|P2|Overall Study|Other|6
5447961|NCT02187055|18823590|P1|Overall Study|Other|5
5447962|NCT02187055|18823588|P3|Overall Study|No longer willing to participate|10
5447963|NCT02187055|18823589|P2|Overall Study|No longer willing to participate|8
5447964|NCT02187055|18823590|P1|Overall Study|No longer willing to participate|6
5447965|NCT02187055|18823588|P3|Overall Study|No longer meets eligibility criteria|0
5447966|NCT02187055|18823589|P2|Overall Study|No longer meets eligibility criteria|2
5447967|NCT02187055|18823590|P1|Overall Study|No longer meets eligibility criteria|0
5447968|NCT02187055|18823588|P3|Overall Study|Lost to Follow-up|3
5447969|NCT02187055|18823589|P2|Overall Study|Lost to Follow-up|7
5447970|NCT02187055|18823590|P1|Overall Study|Lost to Follow-up|2
5447971|NCT02187055|18823588|P3|Overall Study|Lack of Efficacy|7
5447972|NCT02187055|18823589|P2|Overall Study|Lack of Efficacy|3
5447973|NCT02187055|18823590|P1|Overall Study|Lack of Efficacy|10
5447974|NCT02187042|18823690|P2|Overall Study|Progressive disease|8
5447975|NCT02187042|18823691|P1|Overall Study|Progressive disease|4
5447976|NCT02187042|18823690|P2|Overall Study|Doctor choice|0
5447977|NCT02187042|18823691|P1|Overall Study|Doctor choice|1
5447978|NCT02187042|18823690|P2|Overall Study|Participant choice|0
5447979|NCT02187042|18823691|P1|Overall Study|Participant choice|1
5447980|NCT02187042|18823690|P2|Overall Study|Toxicity|5
5447981|NCT02187042|18823691|P1|Overall Study|Toxicity|6
5447982|NCT02187042|18823690|P2|Overall Study|Death|1
5447983|NCT02187042|18823691|P1|Overall Study|Death|1
5447984|NCT02187029|18823737|P4|Overall Study|Withdrawal by Subject|0
5447985|NCT02187029|18823738|P3|Overall Study|Withdrawal by Subject|0
5447986|NCT02187029|18823739|P2|Overall Study|Withdrawal by Subject|0
5447987|NCT02187029|18823740|P1|Overall Study|Withdrawal by Subject|1
5447988|NCT02187029|18823737|P4|Overall Study|Study Terminated by Sponsor|3
5447989|NCT02187029|18823738|P3|Overall Study|Study Terminated by Sponsor|10
5447990|NCT02187029|18823739|P2|Overall Study|Study Terminated by Sponsor|0
5447991|NCT02187029|18823740|P1|Overall Study|Study Terminated by Sponsor|0
5447992|NCT02187029|18823737|P4|Overall Study|Adverse Event|0
5447993|NCT02187029|18823738|P3|Overall Study|Adverse Event|1
5447994|NCT02187029|18823739|P2|Overall Study|Adverse Event|1
5447995|NCT02187029|18823740|P1|Overall Study|Adverse Event|0
5447996|NCT02186873|18823862|P2|Overall Study|Withdrawal by Subject|2
5447997|NCT02186873|18823863|P1|Overall Study|Withdrawal by Subject|7
5447998|NCT02186873|18823862|P2|Overall Study|Lost to Follow-up|2
5447999|NCT02186873|18823863|P1|Overall Study|Lost to Follow-up|1
5448000|NCT02186873|18823862|P2|Overall Study|Lack of Efficacy|1
5448001|NCT02186873|18823863|P1|Overall Study|Lack of Efficacy|0
5448002|NCT02186873|18823862|P2|Overall Study|Adverse Event|3
5448003|NCT02186873|18823863|P1|Overall Study|Adverse Event|1
5448004|NCT02186847|18823888|P2|Overall Study|Protocol Violation|0
5448005|NCT02186847|18823889|P1|Overall Study|Protocol Violation|3
5448006|NCT02186834|18823903|P6|Treatment at RP2D|Died prior to treatment|1
5448007|NCT02186834|18823904|P5|Treatment at RP2D|Died prior to treatment|0
5448008|NCT02186834|18823905|P4|Treatment at RP2D|Died prior to treatment|0
5448009|NCT02186834|18823906|P3|Treatment at RP2D|Died prior to treatment|0
5448010|NCT02186834|18823907|P2|Treatment at RP2D|Died prior to treatment|0
5448011|NCT02186834|18823908|P1|Treatment at RP2D|Died prior to treatment|0
5448012|NCT02186834|18823903|P6|Dose Escalation|Death|0
5448013|NCT02186834|18823904|P5|Dose Escalation|Death|0
5448014|NCT02186834|18823905|P4|Dose Escalation|Death|1
5448015|NCT02186834|18823906|P3|Dose Escalation|Death|0
5448016|NCT02186834|18823907|P2|Dose Escalation|Death|0
5448017|NCT02186834|18823908|P1|Dose Escalation|Death|0
5448018|NCT02186652|18823944|P2|Overall Study|Lost to Follow-up|0
5448019|NCT02186652|18823945|P1|Overall Study|Lost to Follow-up|2
5448020|NCT02186561|18823978|P1|1- Year Post Index Procedure Visit|Missed|1
5448021|NCT02186561|18823978|P1|1- Year Post Index Procedure Visit|Death|1
5448022|NCT02186561|18823978|P1|30-Day Post Index Procedure Visit|Death|1
5448023|NCT02186561|18823978|P1|Enrollment|Investigator Withdrew Consent|1
5448024|NCT02186561|18823978|P1|Enrollment|Withdrawal by Subject|2
5448025|NCT02186561|18823978|P1|Enrollment|Insurance Denial|2
5448026|NCT02186561|18823978|P1|Enrollment|Enrollment Cap Reached|5
5448027|NCT02186561|18823978|P1|Enrollment|Did Not Meet Inclusion Criteria|46
5448028|NCT02186301|18823998|P3|Overall Study|Other|1
5448029|NCT02186301|18823999|P2|Overall Study|Other|0
5448030|NCT02186301|18824000|P1|Overall Study|Other|0
5448031|NCT02186301|18823998|P3|Overall Study|Missing|2
5448032|NCT02186301|18823999|P2|Overall Study|Missing|0
5448033|NCT02186301|18824000|P1|Overall Study|Missing|0
5448034|NCT02186301|18823998|P3|Overall Study|Protocol Deviation|0
5448035|NCT02186301|18823999|P2|Overall Study|Protocol Deviation|2
5448036|NCT02186301|18824000|P1|Overall Study|Protocol Deviation|0
5448037|NCT02186301|18823998|P3|Overall Study|Study Terminated by Sponsor|11
5448038|NCT02186301|18823999|P2|Overall Study|Study Terminated by Sponsor|0
5448039|NCT02186301|18824000|P1|Overall Study|Study Terminated by Sponsor|1
5448040|NCT02186301|18823998|P3|Overall Study|Physician Decision|1
5448041|NCT02186301|18823999|P2|Overall Study|Physician Decision|0
5448042|NCT02186301|18824000|P1|Overall Study|Physician Decision|1
5448043|NCT02186301|18823998|P3|Overall Study|Withdrawal by Subject|3
5448044|NCT02186301|18823999|P2|Overall Study|Withdrawal by Subject|1
5448045|NCT02186301|18824000|P1|Overall Study|Withdrawal by Subject|5
5448046|NCT02186301|18823998|P3|Overall Study|Death|0
5448047|NCT02186301|18823999|P2|Overall Study|Death|0
5448048|NCT02186301|18824000|P1|Overall Study|Death|1
5448049|NCT02186301|18823998|P3|Overall Study|Adverse Event|5
5448050|NCT02186301|18823999|P2|Overall Study|Adverse Event|5
5448051|NCT02186301|18824000|P1|Overall Study|Adverse Event|5
5448052|NCT02186301|18823998|P3|Overall Study|Progressive Disease|27
5448053|NCT02186301|18823999|P2|Overall Study|Progressive Disease|22
5448054|NCT02186301|18824000|P1|Overall Study|Progressive Disease|7
5448055|NCT02186223|18824016|P1|Overall Study|Device in place less than 48 hours|9
5448056|NCT02186223|18824016|P1|Overall Study|Death|3
5448057|NCT02186223|18824016|P1|Overall Study|Unable to obtain femoral access|3
5448058|NCT02186223|18824016|P1|Overall Study|Not eligible for device placement|6
5448059|NCT02186171|18824038|P2|Overall Study|Protocol-specified Criteria|2
5448060|NCT02186171|18824039|P1|Overall Study|Protocol-specified Criteria|0
5448061|NCT02186171|18824038|P2|Overall Study|Death|2
5448062|NCT02186171|18824039|P1|Overall Study|Death|1
5448063|NCT02186171|18824038|P2|Overall Study|Lost to Follow-up|2
5448064|NCT02186171|18824039|P1|Overall Study|Lost to Follow-up|2
5448065|NCT02186171|18824038|P2|Overall Study|Withdrawal by Subject|9
5448066|NCT02186171|18824039|P1|Overall Study|Withdrawal by Subject|1
5448067|NCT02185794|18824061|P6|Overall Study|Lost to Follow-up|1
5448068|NCT02185794|18824062|P5|Overall Study|Lost to Follow-up|0
5448069|NCT02185794|18824063|P4|Overall Study|Lost to Follow-up|3
5448070|NCT02185794|18824064|P3|Overall Study|Lost to Follow-up|2
5448071|NCT02185794|18824065|P2|Overall Study|Lost to Follow-up|2
5448072|NCT02185794|18824066|P1|Overall Study|Lost to Follow-up|1
5448073|NCT02185794|18824061|P6|Overall Study|Withdrew Consent|0
5448074|NCT02185794|18824062|P5|Overall Study|Withdrew Consent|0
5448075|NCT02185794|18824063|P4|Overall Study|Withdrew Consent|2
5448076|NCT02185794|18824064|P3|Overall Study|Withdrew Consent|10
5448077|NCT02185794|18824065|P2|Overall Study|Withdrew Consent|5
5448078|NCT02185794|18824066|P1|Overall Study|Withdrew Consent|2
5448079|NCT02185794|18824061|P6|Overall Study|Investigator's Discretion|15
5448080|NCT02185794|18824062|P5|Overall Study|Investigator's Discretion|2
5448081|NCT02185794|18824063|P4|Overall Study|Investigator's Discretion|2
5448082|NCT02185794|18824064|P3|Overall Study|Investigator's Discretion|1
5448083|NCT02185794|18824065|P2|Overall Study|Investigator's Discretion|0
5448084|NCT02185794|18824066|P1|Overall Study|Investigator's Discretion|1
5448085|NCT02185794|18824061|P6|Overall Study|Enrolled but Never Dosed|0
5448086|NCT02185794|18824062|P5|Overall Study|Enrolled but Never Dosed|1
5448087|NCT02185794|18824063|P4|Overall Study|Enrolled but Never Dosed|1
5448088|NCT02185794|18824064|P3|Overall Study|Enrolled but Never Dosed|3
5448089|NCT02185794|18824065|P2|Overall Study|Enrolled but Never Dosed|6
5448090|NCT02185794|18824066|P1|Overall Study|Enrolled but Never Dosed|1
5448091|NCT02185534|18824159|P6|First Washout Period|Protocol Violation|1
5448092|NCT02185534|18824160|P5|First Washout Period|Protocol Violation|0
5448093|NCT02185534|18824161|P4|First Washout Period|Protocol Violation|0
5448094|NCT02185534|18824162|P3|First Washout Period|Protocol Violation|0
5448095|NCT02185534|18824163|P2|First Washout Period|Protocol Violation|0
5448096|NCT02185534|18824164|P1|First Washout Period|Protocol Violation|0
5448097|NCT02185534|18824159|P6|First Washout Period|Withdrawal by Subject|0
5448098|NCT02185534|18824160|P5|First Washout Period|Withdrawal by Subject|1
5448099|NCT02185534|18824161|P4|First Washout Period|Withdrawal by Subject|0
5448100|NCT02185534|18824162|P3|First Washout Period|Withdrawal by Subject|0
5448101|NCT02185534|18824163|P2|First Washout Period|Withdrawal by Subject|0
5448102|NCT02185534|18824164|P1|First Washout Period|Withdrawal by Subject|1
5448103|NCT02185534|18824159|P6|First Period|Withdrawal by Subject|0
5448104|NCT02185534|18824160|P5|First Period|Withdrawal by Subject|0
5448105|NCT02185534|18824161|P4|First Period|Withdrawal by Subject|1
5448106|NCT02185534|18824162|P3|First Period|Withdrawal by Subject|0
5448107|NCT02185534|18824163|P2|First Period|Withdrawal by Subject|0
5448108|NCT02185534|18824164|P1|First Period|Withdrawal by Subject|0
5448109|NCT02185521|18824179|P1|Overall Study|Protocol Violation|1
5448110|NCT02185521|18824179|P1|Overall Study|Withdrawal by Subject|1
5448111|NCT02185053|18824267|P3|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
5448112|NCT02185053|18824268|P2|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
5448113|NCT02185053|18824269|P1|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
5448114|NCT02185053|18824267|P3|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
5448115|NCT02185053|18824268|P2|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
5448116|NCT02185053|18824269|P1|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
5448117|NCT02185053|18824267|P3|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
5448118|NCT02185053|18824268|P2|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
5448119|NCT02185053|18824269|P1|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
5448120|NCT02185053|18824267|P3|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
5448121|NCT02185053|18824268|P2|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
5448122|NCT02185053|18824269|P1|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
5448123|NCT02185053|18824267|P3|Donepezil Dose Escalation Phase|Adverse Event|0
5448124|NCT02185053|18824268|P2|Donepezil Dose Escalation Phase|Adverse Event|1
5448125|NCT02185053|18824269|P1|Donepezil Dose Escalation Phase|Adverse Event|0
5448126|NCT02185053|18824267|P3|Donepezil Dose Escalation Phase|Cardiac symptoms|0
5448127|NCT02185053|18824268|P2|Donepezil Dose Escalation Phase|Cardiac symptoms|1
5448128|NCT02185053|18824269|P1|Donepezil Dose Escalation Phase|Cardiac symptoms|0
5448129|NCT02185053|18824267|P3|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
5448130|NCT02185053|18824268|P2|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
5448131|NCT02185053|18824269|P1|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
5448132|NCT02185053|18824267|P3|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
5448133|NCT02185053|18824268|P2|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
5448134|NCT02185053|18824269|P1|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
5448135|NCT02185040|18824283|P7|Active Treatment Extension Phase|Lost to Follow-up|2
5448136|NCT02185040|18824284|P6|Active Treatment Extension Phase|Lost to Follow-up|0
5448137|NCT02185040|18824285|P5|Active Treatment Extension Phase|Lost to Follow-up|0
5448138|NCT02185040|18824286|P4|Active Treatment Extension Phase|Lost to Follow-up|0
5448139|NCT02185040|18824287|P3|Active Treatment Extension Phase|Lost to Follow-up|0
5448140|NCT02185040|18824288|P2|Active Treatment Extension Phase|Lost to Follow-up|0
5448141|NCT02185040|18824289|P1|Active Treatment Extension Phase|Lost to Follow-up|0
5448142|NCT02185040|18824283|P7|Active Treatment Extension Phase|Withdrawal by Subject|1
5448143|NCT02185040|18824284|P6|Active Treatment Extension Phase|Withdrawal by Subject|1
5448144|NCT02185040|18824285|P5|Active Treatment Extension Phase|Withdrawal by Subject|0
5448145|NCT02185040|18824286|P4|Active Treatment Extension Phase|Withdrawal by Subject|0
5448146|NCT02185040|18824287|P3|Active Treatment Extension Phase|Withdrawal by Subject|0
5448147|NCT02185040|18824288|P2|Active Treatment Extension Phase|Withdrawal by Subject|0
5448148|NCT02185040|18824289|P1|Active Treatment Extension Phase|Withdrawal by Subject|0
5448149|NCT02185040|18824283|P7|Active Treatment Extension Phase|Adverse Event|4
5448150|NCT02185040|18824284|P6|Active Treatment Extension Phase|Adverse Event|1
5448151|NCT02185040|18824285|P5|Active Treatment Extension Phase|Adverse Event|0
5448152|NCT02185040|18824286|P4|Active Treatment Extension Phase|Adverse Event|0
5448153|NCT02185040|18824287|P3|Active Treatment Extension Phase|Adverse Event|0
5448154|NCT02185040|18824288|P2|Active Treatment Extension Phase|Adverse Event|0
5448155|NCT02185040|18824289|P1|Active Treatment Extension Phase|Adverse Event|0
5448156|NCT02185040|18824283|P7|Active Treatment Extension Phase|Miscellaneous|0
5448157|NCT02185040|18824284|P6|Active Treatment Extension Phase|Miscellaneous|1
5448158|NCT02185040|18824285|P5|Active Treatment Extension Phase|Miscellaneous|0
5448159|NCT02185040|18824286|P4|Active Treatment Extension Phase|Miscellaneous|0
5448160|NCT02185040|18824287|P3|Active Treatment Extension Phase|Miscellaneous|0
5448161|NCT02185040|18824288|P2|Active Treatment Extension Phase|Miscellaneous|0
5448162|NCT02185040|18824289|P1|Active Treatment Extension Phase|Miscellaneous|0
5448163|NCT02185040|18824283|P7|Part 1 Treatment Phase|Lost to Follow-up|0
5448164|NCT02185040|18824284|P6|Part 1 Treatment Phase|Lost to Follow-up|0
5448165|NCT02185040|18824285|P5|Part 1 Treatment Phase|Lost to Follow-up|0
5448166|NCT02185040|18824286|P4|Part 1 Treatment Phase|Lost to Follow-up|0
5448167|NCT02185040|18824287|P3|Part 1 Treatment Phase|Lost to Follow-up|0
5448168|NCT02185040|18824288|P2|Part 1 Treatment Phase|Lost to Follow-up|1
5448169|NCT02185040|18824289|P1|Part 1 Treatment Phase|Lost to Follow-up|0
5448170|NCT02185040|18824283|P7|Part 1 Treatment Phase|Withdrawal by Subject|0
5448171|NCT02185040|18824284|P6|Part 1 Treatment Phase|Withdrawal by Subject|0
5448172|NCT02185040|18824285|P5|Part 1 Treatment Phase|Withdrawal by Subject|0
5448173|NCT02185040|18824286|P4|Part 1 Treatment Phase|Withdrawal by Subject|0
5448174|NCT02185040|18824287|P3|Part 1 Treatment Phase|Withdrawal by Subject|0
5448175|NCT02185040|18824288|P2|Part 1 Treatment Phase|Withdrawal by Subject|1
5448176|NCT02185040|18824289|P1|Part 1 Treatment Phase|Withdrawal by Subject|0
5448177|NCT02185040|18824283|P7|Part 1 Treatment Phase|Adverse Event|0
5448178|NCT02185040|18824284|P6|Part 1 Treatment Phase|Adverse Event|0
5448179|NCT02185040|18824285|P5|Part 1 Treatment Phase|Adverse Event|3
5448180|NCT02185040|18824286|P4|Part 1 Treatment Phase|Adverse Event|2
5448181|NCT02185040|18824287|P3|Part 1 Treatment Phase|Adverse Event|0
5448182|NCT02185040|18824288|P2|Part 1 Treatment Phase|Adverse Event|0
5448183|NCT02185040|18824289|P1|Part 1 Treatment Phase|Adverse Event|1
5448184|NCT02185040|18824283|P7|Part 1 Treatment Phase|Miscellaneous|0
5448185|NCT02185040|18824284|P6|Part 1 Treatment Phase|Miscellaneous|0
5448186|NCT02185040|18824285|P5|Part 1 Treatment Phase|Miscellaneous|0
5448187|NCT02185040|18824286|P4|Part 1 Treatment Phase|Miscellaneous|0
5448188|NCT02185040|18824287|P3|Part 1 Treatment Phase|Miscellaneous|1
5448189|NCT02185040|18824288|P2|Part 1 Treatment Phase|Miscellaneous|0
5448190|NCT02185040|18824289|P1|Part 1 Treatment Phase|Miscellaneous|0
5448191|NCT02185014|18824343|P1|Overall Study|Other|4
5448192|NCT02185014|18824343|P1|Overall Study|Subject Noncompliance|1
5448193|NCT02185014|18824343|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
5448194|NCT02185014|18824343|P1|Overall Study|Lack of Efficacy|14
5448195|NCT02185014|18824343|P1|Overall Study|Lost to Follow-up|4
5448196|NCT02185014|18824343|P1|Overall Study|Withdrew Consent|8
5448197|NCT02185014|18824343|P1|Overall Study|Adverse Event|18
5448198|NCT02184988|18824347|P1|Overall Study|Lost to Follow-up|32
5448199|NCT02184988|18824347|P1|Overall Study|various other reasons|9
5448200|NCT02184988|18824347|P1|Overall Study|work scheduling issues|4
5448201|NCT02184988|18824347|P1|Overall Study|moving away/travelling/unable to complet|6
5448202|NCT02184988|18824347|P1|Overall Study|Adverse Event|2
5448203|NCT02184988|18824347|P1|Overall Study|Pregnancy|2
5448204|NCT02184611|18824405|P2|Overall Study|Protocol defined stopping criteria|1
5448205|NCT02184611|18824406|P1|Overall Study|Protocol defined stopping criteria|0
5448206|NCT02184611|18824405|P2|Overall Study|Protocol Violation|1
5448207|NCT02184611|18824406|P1|Overall Study|Protocol Violation|1
5448208|NCT02184611|18824405|P2|Overall Study|Adverse Event|5
5448209|NCT02184611|18824406|P1|Overall Study|Adverse Event|4
5448210|NCT02184611|18824405|P2|Overall Study|Withdrawal by Subject|6
5448211|NCT02184611|18824406|P1|Overall Study|Withdrawal by Subject|5
5448212|NCT02184611|18824405|P2|Overall Study|Lack of Efficacy|15
5448213|NCT02184611|18824406|P1|Overall Study|Lack of Efficacy|11
5448214|NCT02184572|18824442|P2|Overall Study|Withdrawal by Subject|9
5448215|NCT02184572|18824443|P1|Overall Study|Withdrawal by Subject|14
5448216|NCT02184572|18824442|P2|Overall Study|Traveling Outside The Country|0
5448217|NCT02184572|18824443|P1|Overall Study|Traveling Outside The Country|1
5448218|NCT02184572|18824442|P2|Overall Study|2nd blooddraw & diary card incomplete|0
5448219|NCT02184572|18824443|P1|Overall Study|2nd blooddraw & diary card incomplete|1
5448220|NCT02184572|18824442|P2|Overall Study|Loss Of Kaiser Insurance|0
5448221|NCT02184572|18824443|P1|Overall Study|Loss Of Kaiser Insurance|1
5448222|NCT02184572|18824442|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
5448223|NCT02184572|18824443|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
5448224|NCT02184572|18824442|P2|Overall Study|Lost to Follow-up|21
5448225|NCT02184572|18824443|P1|Overall Study|Lost to Follow-up|29
5448226|NCT02184455|18824504|P1|Overall Study|Lost to Follow-up|1
5448227|NCT02184442|18824515|P2|Overall Study|Withdrawal by Subject|11
5448228|NCT02184442|18824516|P1|Overall Study|Withdrawal by Subject|3
5448229|NCT02184442|18824515|P2|Overall Study|Death|65
5448230|NCT02184442|18824516|P1|Overall Study|Death|61
5448231|NCT02184195|18824536|P2|Overall Study|Other|2
5448232|NCT02184195|18824537|P1|Overall Study|Other|0
5448233|NCT02184195|18824536|P2|Overall Study|Lost to Follow-up|2
5448234|NCT02184195|18824537|P1|Overall Study|Lost to Follow-up|0
5448235|NCT02184195|18824536|P2|Overall Study|Death|29
5448236|NCT02184195|18824537|P1|Overall Study|Death|40
5448237|NCT02184195|18824536|P2|Overall Study|Eligibility criteria not fulfilled|1
5448238|NCT02184195|18824537|P1|Overall Study|Eligibility criteria not fulfilled|0
5448239|NCT02184195|18824536|P2|Overall Study|Patient decision|1
5448240|NCT02184195|18824537|P1|Overall Study|Patient decision|3
5448241|NCT02184143|18824574|P2|Overall Study|Death|0
5448242|NCT02184143|18824575|P1|Overall Study|Death|1
5448243|NCT02184143|18824574|P2|Overall Study|Lost to Follow-up|3
5448244|NCT02184143|18824575|P1|Overall Study|Lost to Follow-up|5
5448245|NCT02184143|18824574|P2|Overall Study|Withdrawal by Subject|4
5448246|NCT02184143|18824575|P1|Overall Study|Withdrawal by Subject|4
5448247|NCT02183675|18824604|P6|Treatment Period 2 (10 Days)|Adverse Event|2
5448248|NCT02183675|18824605|P5|Treatment Period 2 (10 Days)|Adverse Event|0
5448249|NCT02183675|18824606|P4|Treatment Period 2 (10 Days)|Adverse Event|0
5448250|NCT02183675|18824607|P3|Treatment Period 2 (10 Days)|Adverse Event|0
5448251|NCT02183675|18824608|P2|Treatment Period 2 (10 Days)|Adverse Event|0
5448252|NCT02183675|18824609|P1|Treatment Period 2 (10 Days)|Adverse Event|0
5448253|NCT02183519|18824633|P2|Overall Study|Did not respond to cough inducter|3
5448254|NCT02183519|18824634|P1|Overall Study|Did not respond to cough inducter|0
5448255|NCT02183519|18824633|P2|Overall Study|computer error|0
5448256|NCT02183519|18824634|P1|Overall Study|computer error|3
5448257|NCT02182999|18824642|P2|Overall Study|Physician Decision|0
5448258|NCT02182999|18824643|P1|Overall Study|Physician Decision|1
5448259|NCT02182999|18824642|P2|Overall Study|Adverse Event|3
5448260|NCT02182999|18824643|P1|Overall Study|Adverse Event|4
5448261|NCT02182973|18824659|P2|Overall Study|Withdrawal by Subject|0
5448262|NCT02182973|18824660|P1|Overall Study|Withdrawal by Subject|3
5448263|NCT02182895|18824672|P2|Overall Study|Discharged from hospital within 24 hours|4
5448264|NCT02182895|18824673|P1|Overall Study|Discharged from hospital within 24 hours|2
5448265|NCT02182843|18824693|P1|Overall Study|Adverse Event|1
5448266|NCT02182843|18824693|P1|Overall Study|Lost to Follow-up|2
5448267|NCT02182843|18824693|P1|Overall Study|Withdrawal by Subject|7
5448268|NCT02182830|18824700|P2|Overall Study|Lost to Follow-up|3
5448269|NCT02182830|18824701|P1|Overall Study|Lost to Follow-up|3
5448270|NCT02182830|18824700|P2|Overall Study|Consent withdrawn|8
5448271|NCT02182830|18824701|P1|Overall Study|Consent withdrawn|8
5448272|NCT02182830|18824700|P2|Overall Study|Trial stopped, reason missing|3
5448273|NCT02182830|18824701|P1|Overall Study|Trial stopped, reason missing|3
5448274|NCT02182830|18824700|P2|Overall Study|Not Treated|1
5448275|NCT02182830|18824701|P1|Overall Study|Not Treated|1
5448276|NCT02182440|18824746|P4|Overall Study|different, e.g adm other hospital|10
5448277|NCT02182440|18824747|P3|Overall Study|different, e.g adm other hospital|3
5448278|NCT02182440|18824748|P2|Overall Study|different, e.g adm other hospital|3
5448279|NCT02182440|18824749|P1|Overall Study|different, e.g adm other hospital|12
5448280|NCT02182440|18824746|P4|Overall Study|Withdrawal by Subject|4
5448281|NCT02182440|18824747|P3|Overall Study|Withdrawal by Subject|3
5448282|NCT02182440|18824748|P2|Overall Study|Withdrawal by Subject|1
5448283|NCT02182440|18824749|P1|Overall Study|Withdrawal by Subject|1
5448284|NCT02182440|18824746|P4|Overall Study|Physician Decision|0
5448285|NCT02182440|18824747|P3|Overall Study|Physician Decision|0
5448286|NCT02182440|18824748|P2|Overall Study|Physician Decision|0
5448287|NCT02182440|18824749|P1|Overall Study|Physician Decision|1
5448288|NCT02182440|18824746|P4|Overall Study|Protocol Violation|0
5448289|NCT02182440|18824747|P3|Overall Study|Protocol Violation|0
5448290|NCT02182440|18824748|P2|Overall Study|Protocol Violation|1
5448291|NCT02182440|18824749|P1|Overall Study|Protocol Violation|0
5448292|NCT02182440|18824746|P4|Overall Study|Death|16
5448293|NCT02182440|18824747|P3|Overall Study|Death|5
5448294|NCT02182440|18824748|P2|Overall Study|Death|8
5448295|NCT02182440|18824749|P1|Overall Study|Death|31
5448296|NCT02182440|18824746|P4|Overall Study|Adverse Event|0
5448297|NCT02182440|18824747|P3|Overall Study|Adverse Event|0
5448298|NCT02182440|18824748|P2|Overall Study|Adverse Event|1
5448299|NCT02182440|18824749|P1|Overall Study|Adverse Event|0
5448300|NCT02181842|18824788|P1|Overall Study|Case Report Forms Uncollected|2
5448301|NCT02181816|18824805|P1|Overall Study|Protocol Deviation|21
5448302|NCT02181816|18824805|P1|Overall Study|Case Report Forms Uncollected|38
5448303|NCT02181803|18824820|P9|Overall Study|Adverse Event|0
5448304|NCT02181803|18824821|P8|Overall Study|Adverse Event|0
5448305|NCT02181803|18824822|P7|Overall Study|Adverse Event|1
5448306|NCT02181803|18824823|P6|Overall Study|Adverse Event|0
5448307|NCT02181803|18824824|P5|Overall Study|Adverse Event|0
5448308|NCT02181803|18824825|P4|Overall Study|Adverse Event|1
5448309|NCT02181803|18824826|P3|Overall Study|Adverse Event|0
5448310|NCT02181803|18824827|P2|Overall Study|Adverse Event|2
5448311|NCT02181803|18824828|P1|Overall Study|Adverse Event|0
5448312|NCT02181803|18824820|P9|Overall Study|Physician Decision|0
5448313|NCT02181803|18824821|P8|Overall Study|Physician Decision|1
5448314|NCT02181803|18824822|P7|Overall Study|Physician Decision|0
5448315|NCT02181803|18824823|P6|Overall Study|Physician Decision|0
5448316|NCT02181803|18824824|P5|Overall Study|Physician Decision|0
5448317|NCT02181803|18824825|P4|Overall Study|Physician Decision|1
5448318|NCT02181803|18824826|P3|Overall Study|Physician Decision|0
5448319|NCT02181803|18824827|P2|Overall Study|Physician Decision|0
5448320|NCT02181803|18824828|P1|Overall Study|Physician Decision|0
5448321|NCT02181803|18824820|P9|Overall Study|Withdrawal by Subject|0
5448322|NCT02181803|18824821|P8|Overall Study|Withdrawal by Subject|0
5448323|NCT02181803|18824822|P7|Overall Study|Withdrawal by Subject|0
5448324|NCT02181803|18824823|P6|Overall Study|Withdrawal by Subject|0
5448325|NCT02181803|18824824|P5|Overall Study|Withdrawal by Subject|0
5448326|NCT02181803|18824825|P4|Overall Study|Withdrawal by Subject|0
5448327|NCT02181803|18824826|P3|Overall Study|Withdrawal by Subject|0
5448328|NCT02181803|18824827|P2|Overall Study|Withdrawal by Subject|2
5448329|NCT02181803|18824828|P1|Overall Study|Withdrawal by Subject|0
5448330|NCT02181790|18824979|P2|Overall Study|study terminated|0
5448331|NCT02181790|18824980|P1|Overall Study|study terminated|2
5448332|NCT02181738|18824992|P4|Overall Study|Patient Return to Home Country|0
5448333|NCT02181738|18824993|P3|Overall Study|Patient Return to Home Country|0
5448334|NCT02181738|18824994|P2|Overall Study|Patient Return to Home Country|1
5448335|NCT02181738|18824995|P1|Overall Study|Patient Return to Home Country|0
5448336|NCT02181738|18824992|P4|Overall Study|Lost to Follow-up|0
5448337|NCT02181738|18824993|P3|Overall Study|Lost to Follow-up|2
5448338|NCT02181738|18824994|P2|Overall Study|Lost to Follow-up|4
5448339|NCT02181738|18824995|P1|Overall Study|Lost to Follow-up|0
5448340|NCT02181738|18824992|P4|Overall Study|Subject Withdrew Consent|1
5448341|NCT02181738|18824993|P3|Overall Study|Subject Withdrew Consent|2
5448342|NCT02181738|18824994|P2|Overall Study|Subject Withdrew Consent|3
5448343|NCT02181738|18824995|P1|Overall Study|Subject Withdrew Consent|1
5448344|NCT02181738|18824992|P4|Overall Study|Death|1
5448345|NCT02181738|18824993|P3|Overall Study|Death|6
5448346|NCT02181738|18824994|P2|Overall Study|Death|1
5448347|NCT02181738|18824995|P1|Overall Study|Death|1
5448348|NCT02181673|18825036|P3|Week 24-Week 60|Physician Decision|1
5448349|NCT02181673|18825037|P2|Week 24-Week 60|Physician Decision|0
5448350|NCT02181673|18825038|P1|Week 24-Week 60|Physician Decision|0
5448351|NCT02181673|18825036|P3|Week 24-Week 60|Lost to Follow-up|1
5448352|NCT02181673|18825037|P2|Week 24-Week 60|Lost to Follow-up|0
5448353|NCT02181673|18825038|P1|Week 24-Week 60|Lost to Follow-up|0
5448354|NCT02181673|18825036|P3|Week 24-Week 60|Lack of Efficacy|1
5448355|NCT02181673|18825037|P2|Week 24-Week 60|Lack of Efficacy|0
5448356|NCT02181673|18825038|P1|Week 24-Week 60|Lack of Efficacy|0
5448357|NCT02181673|18825036|P3|Week 24-Week 60|Pregnancy|1
5448358|NCT02181673|18825037|P2|Week 24-Week 60|Pregnancy|0
5448359|NCT02181673|18825038|P1|Week 24-Week 60|Pregnancy|0
5448360|NCT02181673|18825036|P3|Week 24-Week 60|Withdrawal by Subject|2
5448361|NCT02181673|18825037|P2|Week 24-Week 60|Withdrawal by Subject|2
5448362|NCT02181673|18825038|P1|Week 24-Week 60|Withdrawal by Subject|0
5448363|NCT02181673|18825036|P3|Week 24-Week 60|Other|1
5448364|NCT02181673|18825037|P2|Week 24-Week 60|Other|2
5448365|NCT02181673|18825038|P1|Week 24-Week 60|Other|0
5448366|NCT02181673|18825036|P3|Week 24-Week 60|Adverse Event|10
5448367|NCT02181673|18825037|P2|Week 24-Week 60|Adverse Event|4
5448368|NCT02181673|18825038|P1|Week 24-Week 60|Adverse Event|0
5448369|NCT02181673|18825036|P3|Up to Week 24|Randomized not Treated|1
5448370|NCT02181673|18825037|P2|Up to Week 24|Randomized not Treated|0
5448371|NCT02181673|18825038|P1|Up to Week 24|Randomized not Treated|0
5448372|NCT02181673|18825036|P3|Up to Week 24|Other|3
5448373|NCT02181673|18825037|P2|Up to Week 24|Other|0
5448374|NCT02181673|18825038|P1|Up to Week 24|Other|2
5448375|NCT02181673|18825036|P3|Up to Week 24|Withdrawal by Subject|1
5448376|NCT02181673|18825037|P2|Up to Week 24|Withdrawal by Subject|0
5448377|NCT02181673|18825038|P1|Up to Week 24|Withdrawal by Subject|10
5448378|NCT02181673|18825036|P3|Up to Week 24|Physician Decision|3
5448379|NCT02181673|18825037|P2|Up to Week 24|Physician Decision|0
5448380|NCT02181673|18825038|P1|Up to Week 24|Physician Decision|0
5448381|NCT02181673|18825036|P3|Up to Week 24|Lost to Follow-up|0
5448382|NCT02181673|18825037|P2|Up to Week 24|Lost to Follow-up|0
5448383|NCT02181673|18825038|P1|Up to Week 24|Lost to Follow-up|1
5448384|NCT02181673|18825036|P3|Up to Week 24|Lack of Efficacy|0
5448385|NCT02181673|18825037|P2|Up to Week 24|Lack of Efficacy|0
5448386|NCT02181673|18825038|P1|Up to Week 24|Lack of Efficacy|1
5448387|NCT02181673|18825036|P3|Up to Week 24|Death|0
5448388|NCT02181673|18825037|P2|Up to Week 24|Death|0
5448389|NCT02181673|18825038|P1|Up to Week 24|Death|1
5448390|NCT02181673|18825036|P3|Up to Week 24|Adverse Event|3
5448391|NCT02181673|18825037|P2|Up to Week 24|Adverse Event|0
5448392|NCT02181673|18825038|P1|Up to Week 24|Adverse Event|2
5448393|NCT02181634|18825065|P1|Overall Study|Patient opted to proceed to surgery|1
5448394|NCT02181634|18825065|P1|Overall Study|Symptomatic progression|1
5448395|NCT02181634|18825065|P1|Overall Study|Max number of dose reduction|1
5448396|NCT02181634|18825065|P1|Overall Study|Ineligible|1
5448397|NCT02181634|18825065|P1|Overall Study|Treatment delayed greater than 4 weeks|3
5448398|NCT02181634|18825065|P1|Overall Study|Death|2
5448399|NCT02181634|18825065|P1|Overall Study|Withdrawal by Subject|5
5448400|NCT02181634|18825065|P1|Overall Study|Physician Decision|8
5448401|NCT02181634|18825065|P1|Overall Study|Adverse Event|17
5448402|NCT02181634|18825065|P1|Overall Study|Lack of Efficacy|33
5448403|NCT02181504|18825114|P3|Overall Study|Adverse Event|1
5448404|NCT02181504|18825115|P2|Overall Study|Adverse Event|1
5448405|NCT02181504|18825116|P1|Overall Study|Adverse Event|1
5448406|NCT02181413|18825155|P2|Overall Study|Lost to Follow-up|1
5448407|NCT02181413|18825156|P1|Overall Study|Lost to Follow-up|0
5448408|NCT02181413|18825155|P2|Overall Study|Ongoing Study Treatment|1
5448409|NCT02181413|18825156|P1|Overall Study|Ongoing Study Treatment|0
5448410|NCT02181413|18825155|P2|Overall Study|Reason Not Specified|20
5448411|NCT02181413|18825156|P1|Overall Study|Reason Not Specified|19
5448412|NCT02181413|18825155|P2|Overall Study|Withdrawal by Subject|8
5448413|NCT02181413|18825156|P1|Overall Study|Withdrawal by Subject|5
5448414|NCT02181413|18825155|P2|Overall Study|Progressive Disease|143
5448415|NCT02181413|18825156|P1|Overall Study|Progressive Disease|121
5448416|NCT02181413|18825155|P2|Overall Study|Adverse Event|24
5448417|NCT02181413|18825156|P1|Overall Study|Adverse Event|7
5448418|NCT02181296|18825201|P2|Overall Study|Lost to Follow-up|6
5448419|NCT02181296|18825202|P1|Overall Study|Lost to Follow-up|7
5448420|NCT02180867|18825324|P7|Overall Study|Refusal of further protocol therapy|0
5448421|NCT02180867|18825325|P6|Overall Study|Refusal of further protocol therapy|0
5448422|NCT02180867|18825326|P5|Overall Study|Refusal of further protocol therapy|4
5448423|NCT02180867|18825327|P4|Overall Study|Refusal of further protocol therapy|6
5448424|NCT02180867|18825328|P3|Overall Study|Refusal of further protocol therapy|2
5448425|NCT02180867|18825329|P2|Overall Study|Refusal of further protocol therapy|0
5448426|NCT02180867|18825330|P1|Overall Study|Refusal of further protocol therapy|1
5448427|NCT02180867|18825324|P7|Overall Study|Repeat Eligibility Studies|0
5448428|NCT02180867|18825325|P6|Overall Study|Repeat Eligibility Studies|0
5448429|NCT02180867|18825326|P5|Overall Study|Repeat Eligibility Studies|1
5448430|NCT02180867|18825327|P4|Overall Study|Repeat Eligibility Studies|0
5448431|NCT02180867|18825328|P3|Overall Study|Repeat Eligibility Studies|0
5448432|NCT02180867|18825329|P2|Overall Study|Repeat Eligibility Studies|0
5448433|NCT02180867|18825330|P1|Overall Study|Repeat Eligibility Studies|0
5448434|NCT02180867|18825324|P7|Overall Study|Ineligible|0
5448435|NCT02180867|18825325|P6|Overall Study|Ineligible|0
5448436|NCT02180867|18825326|P5|Overall Study|Ineligible|5
5448437|NCT02180867|18825327|P4|Overall Study|Ineligible|3
5448438|NCT02180867|18825328|P3|Overall Study|Ineligible|0
5448439|NCT02180867|18825329|P2|Overall Study|Ineligible|2
5448440|NCT02180867|18825330|P1|Overall Study|Ineligible|1
5448441|NCT02180867|18825324|P7|Overall Study|Withdrawal by Subject|0
5448442|NCT02180867|18825325|P6|Overall Study|Withdrawal by Subject|0
5448443|NCT02180867|18825326|P5|Overall Study|Withdrawal by Subject|1
5448444|NCT02180867|18825327|P4|Overall Study|Withdrawal by Subject|1
5448445|NCT02180867|18825328|P3|Overall Study|Withdrawal by Subject|0
5448446|NCT02180867|18825329|P2|Overall Study|Withdrawal by Subject|0
5448447|NCT02180867|18825330|P1|Overall Study|Withdrawal by Subject|0
5448448|NCT02180867|18825324|P7|Overall Study|Physician Decision|4
5448449|NCT02180867|18825325|P6|Overall Study|Physician Decision|3
5448450|NCT02180867|18825326|P5|Overall Study|Physician Decision|9
5448451|NCT02180867|18825327|P4|Overall Study|Physician Decision|10
5448452|NCT02180867|18825328|P3|Overall Study|Physician Decision|1
5448453|NCT02180867|18825329|P2|Overall Study|Physician Decision|3
5448454|NCT02180867|18825330|P1|Overall Study|Physician Decision|1
5448455|NCT02180867|18825324|P7|Overall Study|Lack of Efficacy|1
5448456|NCT02180867|18825325|P6|Overall Study|Lack of Efficacy|0
5448457|NCT02180867|18825326|P5|Overall Study|Lack of Efficacy|6
5448458|NCT02180867|18825327|P4|Overall Study|Lack of Efficacy|1
5448459|NCT02180867|18825328|P3|Overall Study|Lack of Efficacy|0
5448460|NCT02180867|18825329|P2|Overall Study|Lack of Efficacy|2
5448461|NCT02180867|18825330|P1|Overall Study|Lack of Efficacy|0
5448462|NCT02180867|18825324|P7|Overall Study|Death|0
5448463|NCT02180867|18825325|P6|Overall Study|Death|0
5448464|NCT02180867|18825326|P5|Overall Study|Death|1
5448465|NCT02180867|18825327|P4|Overall Study|Death|0
5448466|NCT02180867|18825328|P3|Overall Study|Death|0
5448467|NCT02180867|18825329|P2|Overall Study|Death|0
5448468|NCT02180867|18825330|P1|Overall Study|Death|0
5448469|NCT02180867|18825324|P7|Overall Study|Adverse Event|0
5448470|NCT02180867|18825325|P6|Overall Study|Adverse Event|0
5448471|NCT02180867|18825326|P5|Overall Study|Adverse Event|0
5448472|NCT02180867|18825327|P4|Overall Study|Adverse Event|5
5448473|NCT02180867|18825328|P3|Overall Study|Adverse Event|1
5448474|NCT02180867|18825329|P2|Overall Study|Adverse Event|4
5448475|NCT02180867|18825330|P1|Overall Study|Adverse Event|3
5448476|NCT02180724|18825386|P2|Overall Study|Ongoing Study|11
5448477|NCT02180724|18825387|P1|Overall Study|Ongoing Study|78
5448478|NCT02180724|18825386|P2|Overall Study|Withdrawal by Subject|2
5448479|NCT02180724|18825387|P1|Overall Study|Withdrawal by Subject|1
5448480|NCT02180724|18825386|P2|Overall Study|Lost to Follow-up|0
5448481|NCT02180724|18825387|P1|Overall Study|Lost to Follow-up|1
5448482|NCT02180724|18825386|P2|Overall Study|Death|1
5448483|NCT02180724|18825387|P1|Overall Study|Death|12
5448484|NCT02180659|18825401|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
5448485|NCT02180659|18825402|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
5448486|NCT02180659|18825401|P2|Overall Study|Withdrawal by Subject|2
5448487|NCT02180659|18825402|P1|Overall Study|Withdrawal by Subject|0
5448488|NCT02180659|18825401|P2|Overall Study|Subject incarcerated during conduct|0
5448489|NCT02180659|18825402|P1|Overall Study|Subject incarcerated during conduct|1
5448490|NCT02180659|18825401|P2|Overall Study|Lost to Follow-up|2
5448491|NCT02180659|18825402|P1|Overall Study|Lost to Follow-up|4
5448492|NCT02180659|18825401|P2|Overall Study|Adverse Event|0
5448493|NCT02180659|18825402|P1|Overall Study|Adverse Event|1
5448494|NCT02180438|18825437|P1|Overall Study|Lost to Follow-up|1
5448495|NCT02180217|18825460|P3|Overall Study|Discontinued Prior to Ext. phase|25
5448496|NCT02180217|18825461|P2|Overall Study|Discontinued Prior to Ext. phase|5
5448497|NCT02180217|18825462|P1|Overall Study|Discontinued Prior to Ext. phase|1
5448498|NCT02180217|18825460|P3|Overall Study|Subject/guardian decision|2
5448499|NCT02180217|18825461|P2|Overall Study|Subject/guardian decision|2
5448500|NCT02180217|18825462|P1|Overall Study|Subject/guardian decision|0
5448501|NCT02180217|18825460|P3|Overall Study|Withdrawal by Subject|0
5448502|NCT02180217|18825461|P2|Overall Study|Withdrawal by Subject|0
5448503|NCT02180217|18825462|P1|Overall Study|Withdrawal by Subject|1
5448504|NCT02180217|18825460|P3|Overall Study|Death|0
5448505|NCT02180217|18825461|P2|Overall Study|Death|1
5448506|NCT02180217|18825462|P1|Overall Study|Death|0
5448507|NCT02180217|18825460|P3|Overall Study|Adverse Event|5
5448508|NCT02180217|18825461|P2|Overall Study|Adverse Event|0
5448509|NCT02180217|18825462|P1|Overall Study|Adverse Event|0
5448510|NCT02180165|18825477|P4|Overall Study|Withdrawal by Subject|1
5448511|NCT02180165|18825478|P3|Overall Study|Withdrawal by Subject|2
5448512|NCT02180165|18825479|P2|Overall Study|Withdrawal by Subject|0
5448513|NCT02180165|18825480|P1|Overall Study|Withdrawal by Subject|3
5448514|NCT02180165|18825477|P4|Overall Study|Physician Decision|0
5448515|NCT02180165|18825478|P3|Overall Study|Physician Decision|5
5448516|NCT02180165|18825479|P2|Overall Study|Physician Decision|0
5448517|NCT02180165|18825480|P1|Overall Study|Physician Decision|1
5448518|NCT02180165|18825477|P4|Overall Study|Lack of Efficacy|2
5448519|NCT02180165|18825478|P3|Overall Study|Lack of Efficacy|3
5448520|NCT02180165|18825479|P2|Overall Study|Lack of Efficacy|1
5448521|NCT02180165|18825480|P1|Overall Study|Lack of Efficacy|0
5448522|NCT02180165|18825477|P4|Overall Study|Adverse Event|3
5448523|NCT02180165|18825478|P3|Overall Study|Adverse Event|18
5448524|NCT02180165|18825479|P2|Overall Study|Adverse Event|0
5448525|NCT02180165|18825480|P1|Overall Study|Adverse Event|7
5448526|NCT02180165|18825477|P4|Overall Study|Not Treated|0
5448527|NCT02180165|18825478|P3|Overall Study|Not Treated|1
5448528|NCT02180165|18825479|P2|Overall Study|Not Treated|0
5448529|NCT02180165|18825480|P1|Overall Study|Not Treated|0
5448530|NCT02180061|18825579|P2|Overall Study|Physician Decision|0
5448531|NCT02180061|18825580|P1|Overall Study|Physician Decision|1
5448532|NCT02180061|18825579|P2|Overall Study|Progressive Disease|5
5448533|NCT02180061|18825580|P1|Overall Study|Progressive Disease|15
5448534|NCT02180061|18825579|P2|Overall Study|Clinical Progression|1
5448535|NCT02180061|18825580|P1|Overall Study|Clinical Progression|5
5448536|NCT02180061|18825579|P2|Overall Study|Adverse Event|2
5448537|NCT02180061|18825580|P1|Overall Study|Adverse Event|4
5448538|NCT02179918|18825599|P5|Overall Study|Subject refused further follow-up|1
5448539|NCT02179918|18825600|P4|Overall Study|Subject refused further follow-up|0
5448540|NCT02179918|18825601|P3|Overall Study|Subject refused further follow-up|0
5448541|NCT02179918|18825602|P2|Overall Study|Subject refused further follow-up|1
5448542|NCT02179918|18825603|P1|Overall Study|Subject refused further follow-up|0
5448543|NCT02179918|18825599|P5|Overall Study|Other|1
5448544|NCT02179918|18825600|P4|Overall Study|Other|0
5448545|NCT02179918|18825601|P3|Overall Study|Other|0
5448546|NCT02179918|18825602|P2|Overall Study|Other|1
5448547|NCT02179918|18825603|P1|Overall Study|Other|0
5448548|NCT02179918|18825599|P5|Overall Study|Progressive Disease|6
5448549|NCT02179918|18825600|P4|Overall Study|Progressive Disease|2
5448550|NCT02179918|18825601|P3|Overall Study|Progressive Disease|1
5448551|NCT02179918|18825602|P2|Overall Study|Progressive Disease|1
5448552|NCT02179918|18825603|P1|Overall Study|Progressive Disease|4
5448553|NCT02179918|18825599|P5|Overall Study|Lost to Follow-up|0
5448554|NCT02179918|18825600|P4|Overall Study|Lost to Follow-up|0
5448555|NCT02179918|18825601|P3|Overall Study|Lost to Follow-up|1
5448556|NCT02179918|18825602|P2|Overall Study|Lost to Follow-up|0
5448557|NCT02179918|18825603|P1|Overall Study|Lost to Follow-up|0
5448558|NCT02179918|18825599|P5|Overall Study|Death|0
5448559|NCT02179918|18825600|P4|Overall Study|Death|1
5448560|NCT02179918|18825601|P3|Overall Study|Death|0
5448561|NCT02179918|18825602|P2|Overall Study|Death|0
5448562|NCT02179918|18825603|P1|Overall Study|Death|0
5448563|NCT02179398|18825816|P2|Overall Study|Lost to Follow-up|1
5448564|NCT02179398|18825817|P1|Overall Study|Lost to Follow-up|0
5448565|NCT02179398|18825816|P2|Overall Study|Lack of obligatory data|3
5448566|NCT02179398|18825817|P1|Overall Study|Lack of obligatory data|3
5448567|NCT02179190|18825835|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
5448568|NCT02179190|18825835|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
5448569|NCT02179190|18825835|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
5448570|NCT02179190|18825835|P1|Follow-Up Post Barrel VRD Implanted|Death|3
5448571|NCT02179190|18825835|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
5448572|NCT02179190|18825835|P1|Enrollment|Exit Prior to Device Attempt|11
5448573|NCT02179177|18825848|P2|Overall Study|Withdrawal by Subject|1
5448574|NCT02179177|18825849|P1|Overall Study|Withdrawal by Subject|1
5448575|NCT02179177|18825848|P2|Overall Study|Lost to Follow-up|1
5448576|NCT02179177|18825849|P1|Overall Study|Lost to Follow-up|1
5448577|NCT02178995|18825889|P9|Open Label|Adverse Event|0
5448578|NCT02178995|18825890|P8|Open Label|Adverse Event|0
5448579|NCT02178995|18825891|P7|Open Label|Adverse Event|0
5448580|NCT02178995|18825892|P6|Open Label|Adverse Event|0
5448581|NCT02178995|18825893|P5|Open Label|Adverse Event|0
5448582|NCT02178995|18825894|P4|Open Label|Adverse Event|0
5448583|NCT02178995|18825895|P3|Open Label|Adverse Event|0
5448584|NCT02178995|18825896|P2|Open Label|Adverse Event|0
5448585|NCT02178995|18825897|P1|Open Label|Adverse Event|2
5448586|NCT02178995|18825889|P9|Double Blind|Lost to Follow-up|0
5448587|NCT02178995|18825890|P8|Double Blind|Lost to Follow-up|1
5448588|NCT02178995|18825891|P7|Double Blind|Lost to Follow-up|0
5448589|NCT02178995|18825892|P6|Double Blind|Lost to Follow-up|0
5448590|NCT02178995|18825893|P5|Double Blind|Lost to Follow-up|0
5448591|NCT02178995|18825894|P4|Double Blind|Lost to Follow-up|0
5448592|NCT02178995|18825895|P3|Double Blind|Lost to Follow-up|0
5448593|NCT02178995|18825896|P2|Double Blind|Lost to Follow-up|1
5448594|NCT02178995|18825897|P1|Double Blind|Lost to Follow-up|0
5448595|NCT02178995|18825889|P9|Double Blind|Adverse Event|1
5448596|NCT02178995|18825890|P8|Double Blind|Adverse Event|1
5448597|NCT02178995|18825891|P7|Double Blind|Adverse Event|0
5448598|NCT02178995|18825892|P6|Double Blind|Adverse Event|1
5448599|NCT02178995|18825893|P5|Double Blind|Adverse Event|0
5448600|NCT02178995|18825894|P4|Double Blind|Adverse Event|0
5448601|NCT02178995|18825895|P3|Double Blind|Adverse Event|0
5448602|NCT02178995|18825896|P2|Double Blind|Adverse Event|0
5448603|NCT02178995|18825897|P1|Double Blind|Adverse Event|0
5448604|NCT02178787|18826005|P2|Overall Study|Physician Decision|0
5448605|NCT02178787|18826006|P1|Overall Study|Physician Decision|1
5448606|NCT02178787|18826005|P2|Overall Study|No TCD window|7
5448607|NCT02178787|18826006|P1|Overall Study|No TCD window|3
5448608|NCT02178787|18826005|P2|Overall Study|Withdrawal by Subject|2
5448609|NCT02178787|18826006|P1|Overall Study|Withdrawal by Subject|0
5448610|NCT02178787|18826005|P2|Overall Study|Lost to Follow-up|0
5448611|NCT02178787|18826006|P1|Overall Study|Lost to Follow-up|1
5448612|NCT02178722|18826019|P5|Overall Study|Participants Ongoing in study|74
5448613|NCT02178722|18826020|P4|Overall Study|Participants Ongoing in study|2
5448614|NCT02178722|18826021|P3|Overall Study|Participants Ongoing in study|4
5448615|NCT02178722|18826022|P2|Overall Study|Participants Ongoing in study|1
5448616|NCT02178722|18826023|P1|Overall Study|Participants Ongoing in study|1
5448617|NCT02178722|18826019|P5|Overall Study|Other Unspecified|1
5448618|NCT02178722|18826020|P4|Overall Study|Other Unspecified|0
5448619|NCT02178722|18826021|P3|Overall Study|Other Unspecified|0
5448620|NCT02178722|18826022|P2|Overall Study|Other Unspecified|0
5448621|NCT02178722|18826023|P1|Overall Study|Other Unspecified|0
5448622|NCT02178722|18826019|P5|Overall Study|Physician Decision|2
5448623|NCT02178722|18826020|P4|Overall Study|Physician Decision|0
5448624|NCT02178722|18826021|P3|Overall Study|Physician Decision|0
5448625|NCT02178722|18826022|P2|Overall Study|Physician Decision|0
5448626|NCT02178722|18826023|P1|Overall Study|Physician Decision|0
5448627|NCT02178722|18826019|P5|Overall Study|Study Terminated by Sponsor|65
5448628|NCT02178722|18826020|P4|Overall Study|Study Terminated by Sponsor|3
5448629|NCT02178722|18826021|P3|Overall Study|Study Terminated by Sponsor|2
5448630|NCT02178722|18826022|P2|Overall Study|Study Terminated by Sponsor|6
5448631|NCT02178722|18826023|P1|Overall Study|Study Terminated by Sponsor|1
5448632|NCT02178722|18826019|P5|Overall Study|Lost to Follow-up|11
5448633|NCT02178722|18826020|P4|Overall Study|Lost to Follow-up|2
5448634|NCT02178722|18826021|P3|Overall Study|Lost to Follow-up|0
5448635|NCT02178722|18826022|P2|Overall Study|Lost to Follow-up|0
5448636|NCT02178722|18826023|P1|Overall Study|Lost to Follow-up|0
5448637|NCT02178722|18826019|P5|Overall Study|Death|199
5448638|NCT02178722|18826020|P4|Overall Study|Death|11
5448639|NCT02178722|18826021|P3|Overall Study|Death|12
5448640|NCT02178722|18826022|P2|Overall Study|Death|13
5448641|NCT02178722|18826023|P1|Overall Study|Death|2
5448642|NCT02178722|18826019|P5|Overall Study|Participant decision|30
5448643|NCT02178722|18826020|P4|Overall Study|Participant decision|2
5448644|NCT02178722|18826021|P3|Overall Study|Participant decision|0
5448645|NCT02178722|18826022|P2|Overall Study|Participant decision|0
5448646|NCT02178722|18826023|P1|Overall Study|Participant decision|0
5448647|NCT02178709|18826035|P1|Overall Study|Disease Progression|5
5448648|NCT02178709|18826035|P1|Overall Study|Physician Decision|2
5448649|NCT02178709|18826035|P1|Overall Study|Withdrawal by Subject|2
5448650|NCT02178709|18826035|P1|Overall Study|Death|2
5448651|NCT02178709|18826035|P1|Overall Study|Adverse Event|5
5448652|NCT02178592|18826062|P2|Overall Study|Physician Decision|0
5448653|NCT02178592|18826063|P1|Overall Study|Physician Decision|1
5448654|NCT02178592|18826062|P2|Overall Study|Lost to Follow-up|3
5448655|NCT02178592|18826063|P1|Overall Study|Lost to Follow-up|11
5448656|NCT02178592|18826062|P2|Overall Study|Withdrawal by Subject|1
5448657|NCT02178592|18826063|P1|Overall Study|Withdrawal by Subject|3
5448658|NCT02178592|18826062|P2|Overall Study|Protocol Violation|2
5448659|NCT02178592|18826063|P1|Overall Study|Protocol Violation|3
5448660|NCT02178592|18826062|P2|Overall Study|Lack of Efficacy|1
5448661|NCT02178592|18826063|P1|Overall Study|Lack of Efficacy|1
5448662|NCT02178592|18826062|P2|Overall Study|Adverse Event|2
5448663|NCT02178592|18826063|P1|Overall Study|Adverse Event|0
5448664|NCT02178553|18826091|P2|Overall Study|Technical problem with injection|3
5448665|NCT02178553|18826092|P1|Overall Study|Technical problem with injection|1
5448666|NCT02178553|18826091|P2|Overall Study|Physician Decision|4
5448667|NCT02178553|18826092|P1|Overall Study|Physician Decision|0
5448668|NCT02178553|18826091|P2|Overall Study|Did not proceed to open thoracotomy|3
5448669|NCT02178553|18826092|P1|Overall Study|Did not proceed to open thoracotomy|7
5448670|NCT02178475|18826111|P1|Overall Study|Protocol-specified Criteria|99
5448671|NCT02178475|18826111|P1|Overall Study|Death|13
5448672|NCT02178475|18826111|P1|Overall Study|Lost to Follow-up|10
5448673|NCT02178475|18826111|P1|Overall Study|Withdrawal by Subject|7
5448674|NCT02178358|18826134|P3|Overall Study|On study treatment at study conclusion|2
5448675|NCT02178358|18826135|P2|Overall Study|On study treatment at study conclusion|1
5448676|NCT02178358|18826136|P1|Overall Study|On study treatment at study conclusion|0
5448677|NCT02178358|18826134|P3|Overall Study|Withdrawal by Subject|2
5448678|NCT02178358|18826135|P2|Overall Study|Withdrawal by Subject|2
5448679|NCT02178358|18826136|P1|Overall Study|Withdrawal by Subject|0
5448680|NCT02178059|18826168|P2|Washout|Physician Decision|0
5448681|NCT02178059|18826169|P1|Washout|Physician Decision|1
5448682|NCT02177942|18826187|P2|Overall Study|Withdrawal by Subject|81
5448683|NCT02177942|18826188|P1|Overall Study|Withdrawal by Subject|71
5448684|NCT02177942|18826187|P2|Overall Study|Protocol Violation|6
5448685|NCT02177942|18826188|P1|Overall Study|Protocol Violation|4
5448686|NCT02177942|18826187|P2|Overall Study|Lost to Follow-up|1
5448687|NCT02177942|18826188|P1|Overall Study|Lost to Follow-up|1
5448688|NCT02177942|18826187|P2|Overall Study|Adverse Event|0
5448689|NCT02177942|18826188|P1|Overall Study|Adverse Event|1
5448690|NCT02177812|18826219|P9|Part 1 (Median of 4 Weeks)|Adverse Event|0
5448691|NCT02177812|18826220|P8|Part 1 (Median of 4 Weeks)|Adverse Event|1
5448692|NCT02177812|18826221|P7|Part 1 (Median of 4 Weeks)|Adverse Event|6
5448693|NCT02177812|18826222|P6|Part 1 (Median of 4 Weeks)|Adverse Event|1
5448694|NCT02177812|18826223|P5|Part 1 (Median of 4 Weeks)|Adverse Event|1
5448695|NCT02177812|18826224|P4|Part 1 (Median of 4 Weeks)|Adverse Event|1
5448696|NCT02177812|18826225|P3|Part 1 (Median of 4 Weeks)|Adverse Event|0
5448697|NCT02177812|18826226|P2|Part 1 (Median of 4 Weeks)|Adverse Event|0
5448698|NCT02177812|18826227|P1|Part 1 (Median of 4 Weeks)|Adverse Event|0
5448699|NCT02177812|18826219|P9|Part 1 (Median of 4 Weeks)|Physician Decision|0
5448700|NCT02177812|18826220|P8|Part 1 (Median of 4 Weeks)|Physician Decision|0
5448701|NCT02177812|18826221|P7|Part 1 (Median of 4 Weeks)|Physician Decision|1
5448702|NCT02177812|18826222|P6|Part 1 (Median of 4 Weeks)|Physician Decision|1
5448703|NCT02177812|18826223|P5|Part 1 (Median of 4 Weeks)|Physician Decision|0
5448704|NCT02177812|18826224|P4|Part 1 (Median of 4 Weeks)|Physician Decision|0
5448705|NCT02177812|18826225|P3|Part 1 (Median of 4 Weeks)|Physician Decision|0
5448706|NCT02177812|18826226|P2|Part 1 (Median of 4 Weeks)|Physician Decision|0
5448707|NCT02177812|18826227|P1|Part 1 (Median of 4 Weeks)|Physician Decision|0
5448708|NCT02177812|18826219|P9|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5448709|NCT02177812|18826220|P8|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
5448710|NCT02177812|18826221|P7|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
5448711|NCT02177812|18826222|P6|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
5448712|NCT02177812|18826223|P5|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5448713|NCT02177812|18826224|P4|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5448714|NCT02177812|18826225|P3|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5448715|NCT02177812|18826226|P2|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5448716|NCT02177812|18826227|P1|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
5448717|NCT02177786|18826444|P4|Overall Study|Missing study completion status|0
5448718|NCT02177786|18826445|P3|Overall Study|Missing study completion status|0
5448719|NCT02177786|18826446|P2|Overall Study|Missing study completion status|1
5448720|NCT02177786|18826447|P1|Overall Study|Missing study completion status|0
5448721|NCT02177786|18826444|P4|Overall Study|Progressive Disease|0
5448722|NCT02177786|18826445|P3|Overall Study|Progressive Disease|0
5448723|NCT02177786|18826446|P2|Overall Study|Progressive Disease|1
5448724|NCT02177786|18826447|P1|Overall Study|Progressive Disease|0
5448725|NCT02177786|18826444|P4|Overall Study|Protocol Violation|0
5448726|NCT02177786|18826445|P3|Overall Study|Protocol Violation|2
5448727|NCT02177786|18826446|P2|Overall Study|Protocol Violation|0
5448728|NCT02177786|18826447|P1|Overall Study|Protocol Violation|0
5448729|NCT02177786|18826444|P4|Overall Study|Non-Compliance with Study Drug|1
5448730|NCT02177786|18826445|P3|Overall Study|Non-Compliance with Study Drug|0
5448731|NCT02177786|18826446|P2|Overall Study|Non-Compliance with Study Drug|1
5448732|NCT02177786|18826447|P1|Overall Study|Non-Compliance with Study Drug|0
5448733|NCT02177786|18826444|P4|Overall Study|Lost to Follow-up|2
5448734|NCT02177786|18826445|P3|Overall Study|Lost to Follow-up|2
5448735|NCT02177786|18826446|P2|Overall Study|Lost to Follow-up|0
5448736|NCT02177786|18826447|P1|Overall Study|Lost to Follow-up|0
5448737|NCT02177786|18826444|P4|Overall Study|Death|1
5448738|NCT02177786|18826445|P3|Overall Study|Death|1
5448739|NCT02177786|18826446|P2|Overall Study|Death|1
5448740|NCT02177786|18826447|P1|Overall Study|Death|1
5448741|NCT02177786|18826444|P4|Overall Study|Adverse Event|3
5448742|NCT02177786|18826445|P3|Overall Study|Adverse Event|2
5448743|NCT02177786|18826446|P2|Overall Study|Adverse Event|1
5448744|NCT02177786|18826447|P1|Overall Study|Adverse Event|1
5448745|NCT02177786|18826444|P4|Overall Study|Progression to End Stage Renal Disease|1
5448746|NCT02177786|18826445|P3|Overall Study|Progression to End Stage Renal Disease|2
5448747|NCT02177786|18826446|P2|Overall Study|Progression to End Stage Renal Disease|3
5448748|NCT02177786|18826447|P1|Overall Study|Progression to End Stage Renal Disease|2
5448749|NCT02177786|18826444|P4|Overall Study|Withdrew Consent|5
5448750|NCT02177786|18826445|P3|Overall Study|Withdrew Consent|9
5448751|NCT02177786|18826446|P2|Overall Study|Withdrew Consent|6
5448752|NCT02177786|18826447|P1|Overall Study|Withdrew Consent|2
5448753|NCT02177266|18826470|P2|Overall Study|Withdrawal by Subject|0
5448754|NCT02177266|18826471|P1|Overall Study|Withdrawal by Subject|1
5448755|NCT02177266|18826470|P2|Overall Study|Adverse Event|1
5448756|NCT02177266|18826471|P1|Overall Study|Adverse Event|0
5448757|NCT02177136|18826493|P3|Overall Study|Protocol Violation|1
5448758|NCT02177136|18826494|P2|Overall Study|Protocol Violation|0
5448759|NCT02177136|18826495|P1|Overall Study|Protocol Violation|0
5448760|NCT02177136|18826493|P3|Overall Study|Adverse Event|3
5448761|NCT02177136|18826494|P2|Overall Study|Adverse Event|2
5448762|NCT02177136|18826495|P1|Overall Study|Adverse Event|3
5448763|NCT02177136|18826493|P3|Overall Study|Discontinued due to pruritus|0
5448764|NCT02177136|18826494|P2|Overall Study|Discontinued due to pruritus|3
5448765|NCT02177136|18826495|P1|Overall Study|Discontinued due to pruritus|1
5448766|NCT02177136|18826493|P3|Overall Study|Withdrawal by Subject|0
5448767|NCT02177136|18826494|P2|Overall Study|Withdrawal by Subject|0
5448768|NCT02177136|18826495|P1|Overall Study|Withdrawal by Subject|2
5448769|NCT02177032|18826528|P4|Overall Study|Withdrawal by Subject|0
5448770|NCT02177032|18826529|P3|Overall Study|Withdrawal by Subject|1
5448771|NCT02177032|18826530|P2|Overall Study|Withdrawal by Subject|0
5448772|NCT02177032|18826531|P1|Overall Study|Withdrawal by Subject|1
5448773|NCT02177032|18826528|P4|Overall Study|OTHER|0
5448774|NCT02177032|18826529|P3|Overall Study|OTHER|1
5448775|NCT02177032|18826530|P2|Overall Study|OTHER|0
5448776|NCT02177032|18826531|P1|Overall Study|OTHER|2
5448777|NCT02177032|18826528|P4|Overall Study|Lost to Follow-up|0
5448778|NCT02177032|18826529|P3|Overall Study|Lost to Follow-up|0
5448779|NCT02177032|18826530|P2|Overall Study|Lost to Follow-up|2
5448780|NCT02177032|18826531|P1|Overall Study|Lost to Follow-up|0
5448781|NCT02177032|18826528|P4|Overall Study|ADMINISTRATIVE REASON|0
5448782|NCT02177032|18826529|P3|Overall Study|ADMINISTRATIVE REASON|1
5448783|NCT02177032|18826530|P2|Overall Study|ADMINISTRATIVE REASON|0
5448784|NCT02177032|18826531|P1|Overall Study|ADMINISTRATIVE REASON|2
5448785|NCT02176928|18826567|P2|Overall Study|Lost to Follow-up|4
5448786|NCT02176928|18826568|P1|Overall Study|Lost to Follow-up|2
5448787|NCT02176655|18826578|P1|Overall Study|Subjects did not treat|6
5448788|NCT02176642|18826601|P2|Overall Study|Withdrawal by Subject|1
5448789|NCT02176642|18826602|P1|Overall Study|Withdrawal by Subject|0
5448790|NCT02176525|18826632|P8|Overall Study|not treated|0
5448791|NCT02176525|18826633|P7|Overall Study|not treated|0
5448792|NCT02176525|18826634|P6|Overall Study|not treated|1
5448793|NCT02176525|18826635|P5|Overall Study|not treated|0
5448794|NCT02176525|18826636|P4|Overall Study|not treated|0
5448795|NCT02176525|18826637|P3|Overall Study|not treated|0
5448796|NCT02176525|18826638|P2|Overall Study|not treated|0
5448797|NCT02176525|18826639|P1|Overall Study|not treated|1
5448798|NCT02176525|18826632|P8|Overall Study|Adverse Event|0
5448799|NCT02176525|18826633|P7|Overall Study|Adverse Event|1
5448800|NCT02176525|18826634|P6|Overall Study|Adverse Event|0
5448801|NCT02176525|18826635|P5|Overall Study|Adverse Event|1
5448802|NCT02176525|18826636|P4|Overall Study|Adverse Event|1
5448803|NCT02176525|18826637|P3|Overall Study|Adverse Event|0
5448804|NCT02176525|18826638|P2|Overall Study|Adverse Event|0
5448805|NCT02176525|18826639|P1|Overall Study|Adverse Event|0
5448806|NCT02176421|18826855|P1|Overall Study|Adverse Event|1
5448807|NCT02176421|18826855|P1|Overall Study|Lost to Follow-up|4
5448808|NCT02176356|18826887|P1|Overall Study|Other Miscellaneous Reasons|2
5448809|NCT02176356|18826887|P1|Overall Study|Personal Reasons|3
5448810|NCT02176356|18826887|P1|Overall Study|Lost to Follow-up|4
5448811|NCT02176356|18826887|P1|Overall Study|Screen Failure|14
5448812|NCT02176291|18826917|P2|Overall Study|Withdrawal by Subject|0
5448813|NCT02176291|18826918|P1|Overall Study|Withdrawal by Subject|2
5448814|NCT02176291|18826917|P2|Overall Study|non compliance with protocol|0
5448815|NCT02176291|18826918|P1|Overall Study|non compliance with protocol|2
5448816|NCT02176291|18826917|P2|Overall Study|Death|0
5448817|NCT02176291|18826918|P1|Overall Study|Death|1
5448818|NCT02176226|18826926|P1|Overall Study|Withdrew prior to treatment|6
5448819|NCT02176226|18826926|P1|Overall Study|Lost to Follow-up|3
5448820|NCT02176018|18826952|P2|Overall Study|Withdrawal by Subject|2
5448821|NCT02176018|18826953|P1|Overall Study|Withdrawal by Subject|1
5448822|NCT02176018|18826952|P2|Overall Study|Protocol Violation|1
5448823|NCT02176018|18826953|P1|Overall Study|Protocol Violation|1
5448824|NCT02176018|18826952|P2|Overall Study|Lost to Follow-up|1
5448825|NCT02176018|18826953|P1|Overall Study|Lost to Follow-up|3
5448826|NCT02176018|18826952|P2|Overall Study|Adverse Event|2
5448827|NCT02176018|18826953|P1|Overall Study|Adverse Event|0
5448828|NCT02175966|18827037|P2|Follow-up Period|Lack of Efficacy|6
5448829|NCT02175966|18827038|P1|Follow-up Period|Lack of Efficacy|10
5448830|NCT02175771|18827066|P9|Treatment Period|Other|0
5448831|NCT02175771|18827067|P8|Treatment Period|Other|2
5448832|NCT02175771|18827068|P7|Treatment Period|Other|0
5448833|NCT02175771|18827069|P6|Treatment Period|Other|0
5448834|NCT02175771|18827070|P5|Treatment Period|Other|1
5448835|NCT02175771|18827071|P4|Treatment Period|Other|3
5448836|NCT02175771|18827072|P3|Treatment Period|Other|0
5448837|NCT02175771|18827073|P2|Treatment Period|Other|1
5448838|NCT02175771|18827074|P1|Treatment Period|Other|0
5448839|NCT02175771|18827066|P9|Treatment Period|Lack of Efficacy|0
5448840|NCT02175771|18827067|P8|Treatment Period|Lack of Efficacy|1
5448841|NCT02175771|18827068|P7|Treatment Period|Lack of Efficacy|0
5448842|NCT02175771|18827069|P6|Treatment Period|Lack of Efficacy|1
5448843|NCT02175771|18827070|P5|Treatment Period|Lack of Efficacy|0
5448844|NCT02175771|18827071|P4|Treatment Period|Lack of Efficacy|0
5448845|NCT02175771|18827072|P3|Treatment Period|Lack of Efficacy|0
5448846|NCT02175771|18827073|P2|Treatment Period|Lack of Efficacy|0
5448847|NCT02175771|18827074|P1|Treatment Period|Lack of Efficacy|0
5448848|NCT02175771|18827066|P9|Treatment Period|Lost to Follow-up|2
5448849|NCT02175771|18827067|P8|Treatment Period|Lost to Follow-up|2
5448850|NCT02175771|18827068|P7|Treatment Period|Lost to Follow-up|1
5448851|NCT02175771|18827069|P6|Treatment Period|Lost to Follow-up|2
5448852|NCT02175771|18827070|P5|Treatment Period|Lost to Follow-up|1
5448853|NCT02175771|18827071|P4|Treatment Period|Lost to Follow-up|3
5448854|NCT02175771|18827072|P3|Treatment Period|Lost to Follow-up|1
5448855|NCT02175771|18827073|P2|Treatment Period|Lost to Follow-up|3
5448856|NCT02175771|18827074|P1|Treatment Period|Lost to Follow-up|0
5448857|NCT02175771|18827066|P9|Treatment Period|Disease progression|0
5448858|NCT02175771|18827067|P8|Treatment Period|Disease progression|2
5448859|NCT02175771|18827068|P7|Treatment Period|Disease progression|0
5448860|NCT02175771|18827069|P6|Treatment Period|Disease progression|0
5448861|NCT02175771|18827070|P5|Treatment Period|Disease progression|0
5448862|NCT02175771|18827071|P4|Treatment Period|Disease progression|0
5448863|NCT02175771|18827072|P3|Treatment Period|Disease progression|0
5448864|NCT02175771|18827073|P2|Treatment Period|Disease progression|0
5448865|NCT02175771|18827074|P1|Treatment Period|Disease progression|0
5448866|NCT02175771|18827066|P9|Treatment Period|Protocol Violation|0
5448867|NCT02175771|18827067|P8|Treatment Period|Protocol Violation|1
5448868|NCT02175771|18827068|P7|Treatment Period|Protocol Violation|0
5448869|NCT02175771|18827069|P6|Treatment Period|Protocol Violation|0
5448870|NCT02175771|18827070|P5|Treatment Period|Protocol Violation|0
5448871|NCT02175771|18827071|P4|Treatment Period|Protocol Violation|0
5448872|NCT02175771|18827072|P3|Treatment Period|Protocol Violation|0
5448873|NCT02175771|18827073|P2|Treatment Period|Protocol Violation|0
5448874|NCT02175771|18827074|P1|Treatment Period|Protocol Violation|0
5448875|NCT02175771|18827066|P9|Treatment Period|Noncompliance|1
5448876|NCT02175771|18827067|P8|Treatment Period|Noncompliance|0
5448877|NCT02175771|18827068|P7|Treatment Period|Noncompliance|0
5448878|NCT02175771|18827069|P6|Treatment Period|Noncompliance|0
5448879|NCT02175771|18827070|P5|Treatment Period|Noncompliance|0
5448880|NCT02175771|18827071|P4|Treatment Period|Noncompliance|0
5448881|NCT02175771|18827072|P3|Treatment Period|Noncompliance|2
5448882|NCT02175771|18827073|P2|Treatment Period|Noncompliance|1
5448883|NCT02175771|18827074|P1|Treatment Period|Noncompliance|0
5448884|NCT02175771|18827066|P9|Treatment Period|Withdrawal by Subject|2
5448885|NCT02175771|18827067|P8|Treatment Period|Withdrawal by Subject|9
5448886|NCT02175771|18827068|P7|Treatment Period|Withdrawal by Subject|2
5448887|NCT02175771|18827069|P6|Treatment Period|Withdrawal by Subject|4
5448888|NCT02175771|18827070|P5|Treatment Period|Withdrawal by Subject|2
5448889|NCT02175771|18827071|P4|Treatment Period|Withdrawal by Subject|6
5448890|NCT02175771|18827072|P3|Treatment Period|Withdrawal by Subject|3
5448891|NCT02175771|18827073|P2|Treatment Period|Withdrawal by Subject|9
5448892|NCT02175771|18827074|P1|Treatment Period|Withdrawal by Subject|0
5448893|NCT02175771|18827066|P9|Treatment Period|Adverse Event|1
5448894|NCT02175771|18827067|P8|Treatment Period|Adverse Event|0
5448895|NCT02175771|18827068|P7|Treatment Period|Adverse Event|2
5448896|NCT02175771|18827069|P6|Treatment Period|Adverse Event|3
5448897|NCT02175771|18827070|P5|Treatment Period|Adverse Event|1
5448898|NCT02175771|18827071|P4|Treatment Period|Adverse Event|1
5448899|NCT02175771|18827072|P3|Treatment Period|Adverse Event|1
5448900|NCT02175771|18827073|P2|Treatment Period|Adverse Event|2
5448901|NCT02175771|18827074|P1|Treatment Period|Adverse Event|0
5448902|NCT02175771|18827066|P9|Run-In Period (Pre-assignment)|Other|0
5448903|NCT02175771|18827067|P8|Run-In Period (Pre-assignment)|Other|0
5448904|NCT02175771|18827068|P7|Run-In Period (Pre-assignment)|Other|0
5448905|NCT02175771|18827069|P6|Run-In Period (Pre-assignment)|Other|0
5448906|NCT02175771|18827070|P5|Run-In Period (Pre-assignment)|Other|0
5448907|NCT02175771|18827071|P4|Run-In Period (Pre-assignment)|Other|0
5448908|NCT02175771|18827072|P3|Run-In Period (Pre-assignment)|Other|0
5448909|NCT02175771|18827073|P2|Run-In Period (Pre-assignment)|Other|0
5448910|NCT02175771|18827074|P1|Run-In Period (Pre-assignment)|Other|8
5448911|NCT02175771|18827066|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5448912|NCT02175771|18827067|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5448913|NCT02175771|18827068|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5448914|NCT02175771|18827069|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5448915|NCT02175771|18827070|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5448916|NCT02175771|18827071|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5448917|NCT02175771|18827072|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5448918|NCT02175771|18827073|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5448919|NCT02175771|18827074|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
5448920|NCT02175771|18827066|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5448921|NCT02175771|18827067|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5448922|NCT02175771|18827068|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5448923|NCT02175771|18827069|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5448924|NCT02175771|18827070|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5448925|NCT02175771|18827071|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5448926|NCT02175771|18827072|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5448927|NCT02175771|18827073|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5448928|NCT02175771|18827074|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
5448929|NCT02175771|18827066|P9|Run-In Period (Pre-assignment)|Adverse Event|0
5448930|NCT02175771|18827067|P8|Run-In Period (Pre-assignment)|Adverse Event|0
5448931|NCT02175771|18827068|P7|Run-In Period (Pre-assignment)|Adverse Event|0
5448932|NCT02175771|18827069|P6|Run-In Period (Pre-assignment)|Adverse Event|0
5448933|NCT02175771|18827070|P5|Run-In Period (Pre-assignment)|Adverse Event|0
5448934|NCT02175771|18827071|P4|Run-In Period (Pre-assignment)|Adverse Event|0
5448935|NCT02175771|18827072|P3|Run-In Period (Pre-assignment)|Adverse Event|0
5448936|NCT02175771|18827073|P2|Run-In Period (Pre-assignment)|Adverse Event|0
5448937|NCT02175771|18827074|P1|Run-In Period (Pre-assignment)|Adverse Event|9
5448938|NCT02175771|18827066|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5448939|NCT02175771|18827067|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5448940|NCT02175771|18827068|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5448941|NCT02175771|18827069|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5448942|NCT02175771|18827070|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5448943|NCT02175771|18827071|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5448944|NCT02175771|18827072|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5448945|NCT02175771|18827073|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5448946|NCT02175771|18827074|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
5448947|NCT02175771|18827066|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5448948|NCT02175771|18827067|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5448949|NCT02175771|18827068|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5448950|NCT02175771|18827069|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5448951|NCT02175771|18827070|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5448952|NCT02175771|18827071|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5448953|NCT02175771|18827072|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5448954|NCT02175771|18827073|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5448955|NCT02175771|18827074|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
5448956|NCT02175771|18827066|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5448957|NCT02175771|18827067|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5448958|NCT02175771|18827068|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5448959|NCT02175771|18827069|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5448960|NCT02175771|18827070|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5448961|NCT02175771|18827071|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5448962|NCT02175771|18827072|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5448963|NCT02175771|18827073|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5448964|NCT02175771|18827074|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
5448965|NCT02175758|18827138|P6|Treatment Phase|Adverse Event|0
5448966|NCT02175758|18827139|P5|Treatment Phase|Adverse Event|1
5448967|NCT02175758|18827140|P4|Treatment Phase|Adverse Event|0
5448968|NCT02175758|18827141|P3|Treatment Phase|Adverse Event|0
5448969|NCT02175758|18827142|P2|Treatment Phase|Adverse Event|0
5448970|NCT02175758|18827143|P1|Treatment Phase|Adverse Event|0
5448971|NCT02175758|18827138|P6|Treatment Phase|Lost to Follow-up|0
5448972|NCT02175758|18827139|P5|Treatment Phase|Lost to Follow-up|0
5448973|NCT02175758|18827140|P4|Treatment Phase|Lost to Follow-up|0
5448974|NCT02175758|18827141|P3|Treatment Phase|Lost to Follow-up|0
5448975|NCT02175758|18827142|P2|Treatment Phase|Lost to Follow-up|1
5448976|NCT02175758|18827143|P1|Treatment Phase|Lost to Follow-up|0
5448977|NCT02175745|18827246|P1|Overall Study|Not Eligible|1
5448978|NCT02175368|18827285|P1|Overall Study|Lost to Follow-up|1
5448979|NCT02175277|18827290|P1|Overall Study|Protocol-specified Criteria|1
5448980|NCT02175225|18827296|P2|Overall Study|Study drug not administered|2
5448981|NCT02175225|18827297|P1|Overall Study|Study drug not administered|1
5448982|NCT02175225|18827296|P2|Overall Study|Lost to Follow-up|7
5448983|NCT02175225|18827297|P1|Overall Study|Lost to Follow-up|6
5448984|NCT02175225|18827296|P2|Overall Study|Withdrawal by Subject|2
5448985|NCT02175225|18827297|P1|Overall Study|Withdrawal by Subject|1
5448986|NCT02175199|18827348|P2|Overall Study|Sponsor Decision|0
5448987|NCT02175199|18827349|P1|Overall Study|Sponsor Decision|1
5448988|NCT02175199|18827348|P2|Overall Study|Randomized in Error|0
5448989|NCT02175199|18827349|P1|Overall Study|Randomized in Error|1
5448990|NCT02175199|18827348|P2|Overall Study|Withdrawal by Subject|5
5448991|NCT02175199|18827349|P1|Overall Study|Withdrawal by Subject|1
5448992|NCT02175121|18827363|P5|Overall Study|Time issues|0
5448993|NCT02175121|18827364|P4|Overall Study|Time issues|0
5448994|NCT02175121|18827365|P3|Overall Study|Time issues|1
5448995|NCT02175121|18827366|P2|Overall Study|Time issues|0
5448996|NCT02175121|18827367|P1|Overall Study|Time issues|0
5448997|NCT02175121|18827363|P5|Overall Study|Schedule conflict|0
5448998|NCT02175121|18827364|P4|Overall Study|Schedule conflict|0
5448999|NCT02175121|18827365|P3|Overall Study|Schedule conflict|1
5449000|NCT02175121|18827366|P2|Overall Study|Schedule conflict|0
5449001|NCT02175121|18827367|P1|Overall Study|Schedule conflict|0
5449002|NCT02175121|18827363|P5|Overall Study|Personal emergency|1
5449003|NCT02175121|18827364|P4|Overall Study|Personal emergency|0
5449004|NCT02175121|18827365|P3|Overall Study|Personal emergency|0
5449005|NCT02175121|18827366|P2|Overall Study|Personal emergency|0
5449006|NCT02175121|18827367|P1|Overall Study|Personal emergency|0
5449007|NCT02175121|18827363|P5|Overall Study|Lost to Follow-up|0
5449008|NCT02175121|18827364|P4|Overall Study|Lost to Follow-up|1
5449009|NCT02175121|18827365|P3|Overall Study|Lost to Follow-up|0
5449010|NCT02175121|18827366|P2|Overall Study|Lost to Follow-up|1
5449011|NCT02175121|18827367|P1|Overall Study|Lost to Follow-up|0
5449012|NCT02175121|18827363|P5|Overall Study|Lack of Efficacy|0
5449013|NCT02175121|18827364|P4|Overall Study|Lack of Efficacy|0
5449014|NCT02175121|18827365|P3|Overall Study|Lack of Efficacy|0
5449015|NCT02175121|18827366|P2|Overall Study|Lack of Efficacy|0
5449016|NCT02175121|18827367|P1|Overall Study|Lack of Efficacy|1
5449017|NCT02174861|18827505|P1|Overall Study|Lost to Follow-up|26
5449018|NCT02174861|18827505|P1|Overall Study|Withdrawal by Subject|124
5449019|NCT02174861|18827505|P1|Overall Study|Decision by sponsor|8
5449020|NCT02174848|18827519|P2|Overall Study|Unable to comply with study requirements|0
5449021|NCT02174848|18827520|P1|Overall Study|Unable to comply with study requirements|1
5449022|NCT02174848|18827519|P2|Overall Study|Worsening of disease|1
5449023|NCT02174848|18827520|P1|Overall Study|Worsening of disease|1
5449024|NCT02174848|18827519|P2|Overall Study|Lost to Follow-up|1
5449025|NCT02174848|18827520|P1|Overall Study|Lost to Follow-up|0
5449026|NCT02174848|18827519|P2|Overall Study|Withdrawal by Subject|3
5449027|NCT02174848|18827520|P1|Overall Study|Withdrawal by Subject|3
5449028|NCT02174848|18827519|P2|Overall Study|Adverse Event|1
5449029|NCT02174848|18827520|P1|Overall Study|Adverse Event|2
5449030|NCT02174731|18827537|P2|Overall Study|Missing|0
5449031|NCT02174731|18827538|P1|Overall Study|Missing|2
5449032|NCT02174731|18827537|P2|Overall Study|Incorrect enrolment before randomization|1
5449033|NCT02174731|18827538|P1|Overall Study|Incorrect enrolment before randomization|0
5449034|NCT02174731|18827537|P2|Overall Study|Participant decision|64
5449035|NCT02174731|18827538|P1|Overall Study|Participant decision|67
5449036|NCT02174627|18827560|P2|Overall Study|Participant decision|128
5449037|NCT02174627|18827561|P1|Overall Study|Participant decision|84
5449038|NCT02174627|18827560|P2|Overall Study|Incorrect enrolment before randomization|1
5449039|NCT02174627|18827561|P1|Overall Study|Incorrect enrolment before randomization|0
5449040|NCT02174627|18827560|P2|Overall Study|Missing|1
5449041|NCT02174627|18827561|P1|Overall Study|Missing|0
5449042|NCT02174562|18827589|P2|Overall Study|Lost to Follow-up|3
5449043|NCT02174562|18827590|P1|Overall Study|Lost to Follow-up|0
5449044|NCT02174562|18827589|P2|Overall Study|Death|0
5449045|NCT02174562|18827590|P1|Overall Study|Death|2
5449046|NCT02174562|18827589|P2|Overall Study|Withdrawal by Subject|2
5449047|NCT02174562|18827590|P1|Overall Study|Withdrawal by Subject|7
5449048|NCT02174523|18827600|P2|Overall Study|Withdrawal by Subject|0
5449049|NCT02174523|18827601|P1|Overall Study|Withdrawal by Subject|1
5449050|NCT02174276|18827686|P4|OTEP (Weeks 48 to 144)|Withdrew Consent|2
5449051|NCT02174276|18827687|P3|OTEP (Weeks 48 to 144)|Withdrew Consent|1
5449052|NCT02174276|18827688|P2|OTEP (Weeks 48 to 144)|Withdrew Consent|0
5449053|NCT02174276|18827689|P1|OTEP (Weeks 48 to 144)|Withdrew Consent|1
5449054|NCT02174276|18827686|P4|OTEP (Weeks 48 to 144)|Pregnancy|0
5449055|NCT02174276|18827687|P3|OTEP (Weeks 48 to 144)|Pregnancy|1
5449056|NCT02174276|18827688|P2|OTEP (Weeks 48 to 144)|Pregnancy|0
5449057|NCT02174276|18827689|P1|OTEP (Weeks 48 to 144)|Pregnancy|0
5449058|NCT02174276|18827686|P4|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
5449059|NCT02174276|18827687|P3|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
5449060|NCT02174276|18827688|P2|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
5449061|NCT02174276|18827689|P1|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
5449062|NCT02174276|18827686|P4|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
5449063|NCT02174276|18827687|P3|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
5449064|NCT02174276|18827688|P2|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
5449065|NCT02174276|18827689|P1|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
5449066|NCT02174276|18827686|P4|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
5449067|NCT02174276|18827687|P3|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
5449068|NCT02174276|18827688|P2|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
5449069|NCT02174276|18827689|P1|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
5449070|NCT02174276|18827686|P4|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
5449071|NCT02174276|18827687|P3|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
5449072|NCT02174276|18827688|P2|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
5449073|NCT02174276|18827689|P1|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
5449074|NCT02173769|18827796|P1|Overall Study|Protocol Violation|4
5449075|NCT02173704|18827809|P2|Overall Study|Withdrawal by Subject|4
5449076|NCT02173704|18827810|P1|Overall Study|Withdrawal by Subject|9
5449077|NCT02173704|18827809|P2|Overall Study|Protocol Violation|0
5449078|NCT02173704|18827810|P1|Overall Study|Protocol Violation|1
5449079|NCT02173704|18827809|P2|Overall Study|Other|0
5449080|NCT02173704|18827810|P1|Overall Study|Other|1
5449081|NCT02173704|18827809|P2|Overall Study|Lost to Follow-up|0
5449082|NCT02173704|18827810|P1|Overall Study|Lost to Follow-up|1
5449083|NCT02173704|18827809|P2|Overall Study|Adverse Event|0
5449084|NCT02173704|18827810|P1|Overall Study|Adverse Event|1
5449085|NCT02173548|18827838|P2|Overall Study|Withdrawal by Subject|0
5449086|NCT02173548|18827839|P1|Overall Study|Withdrawal by Subject|1
5449087|NCT02173548|18827838|P2|Overall Study|Lost to Follow-up|2
5449088|NCT02173548|18827839|P1|Overall Study|Lost to Follow-up|0
5449089|NCT02173379|18827971|P2|Overall Study|Death|22
5449090|NCT02173379|18827972|P1|Overall Study|Death|22
5449091|NCT02173379|18827971|P2|Overall Study|Physician Decision|4
5449092|NCT02173379|18827972|P1|Overall Study|Physician Decision|7
5449093|NCT02173379|18827971|P2|Overall Study|Withdrawal by Subject|17
5449094|NCT02173379|18827972|P1|Overall Study|Withdrawal by Subject|14
5449095|NCT02173379|18827971|P2|Overall Study|Lost to Follow-up|34
5449096|NCT02173379|18827972|P1|Overall Study|Lost to Follow-up|48
5449097|NCT02173158|18828216|P1|Efficacy Phase|Adverse Event|1
5449098|NCT02173054|18828233|P3|Overall Study|Withdrawal by Subject|1
5449099|NCT02173054|18828234|P2|Overall Study|Withdrawal by Subject|0
5449100|NCT02173054|18828235|P1|Overall Study|Withdrawal by Subject|0
5449101|NCT02173054|18828233|P3|Overall Study|lack of compliance|0
5449102|NCT02173054|18828234|P2|Overall Study|lack of compliance|0
5449103|NCT02173054|18828235|P1|Overall Study|lack of compliance|1
5449104|NCT02172664|18828291|P2|Overall Study|Moved out of area|1
5449105|NCT02172664|18828292|P1|Overall Study|Moved out of area|1
5449106|NCT02172664|18828291|P2|Overall Study|Death|1
5449107|NCT02172664|18828292|P1|Overall Study|Death|1
5449108|NCT02172664|18828291|P2|Overall Study|Lost to Follow-up|4
5449109|NCT02172664|18828292|P1|Overall Study|Lost to Follow-up|4
5449110|NCT02172625|18828301|P2|Overall Study|car accident|1
5449111|NCT02172625|18828302|P1|Overall Study|car accident|0
5449112|NCT02172625|18828301|P2|Overall Study|Pregnancy|1
5449113|NCT02172625|18828302|P1|Overall Study|Pregnancy|0
5449114|NCT02172625|18828301|P2|Overall Study|Adverse Event|1
5449115|NCT02172625|18828302|P1|Overall Study|Adverse Event|0
5449116|NCT02172040|18828324|P4|Overall Study|Family emergency abroad|1
5449117|NCT02172040|18828325|P3|Overall Study|Family emergency abroad|0
5449118|NCT02172040|18828326|P2|Overall Study|Family emergency abroad|0
5449119|NCT02172040|18828327|P1|Overall Study|Family emergency abroad|0
5449120|NCT02172040|18828324|P4|Overall Study|Not available for Day 13 & 14 visits|0
5449121|NCT02172040|18828325|P3|Overall Study|Not available for Day 13 & 14 visits|1
5449122|NCT02172040|18828326|P2|Overall Study|Not available for Day 13 & 14 visits|0
5449123|NCT02172040|18828327|P1|Overall Study|Not available for Day 13 & 14 visits|0
5449124|NCT02172040|18828324|P4|Overall Study|Withdrawal by Subject|0
5449125|NCT02172040|18828325|P3|Overall Study|Withdrawal by Subject|1
5449126|NCT02172040|18828326|P2|Overall Study|Withdrawal by Subject|0
5449127|NCT02172040|18828327|P1|Overall Study|Withdrawal by Subject|0
5449128|NCT02172040|18828324|P4|Overall Study|Protocol Violation|0
5449129|NCT02172040|18828325|P3|Overall Study|Protocol Violation|0
5449130|NCT02172040|18828326|P2|Overall Study|Protocol Violation|1
5449131|NCT02172040|18828327|P1|Overall Study|Protocol Violation|0
5449132|NCT02172040|18828324|P4|Overall Study|Adverse Event|0
5449133|NCT02172040|18828325|P3|Overall Study|Adverse Event|0
5449134|NCT02172040|18828326|P2|Overall Study|Adverse Event|2
5449135|NCT02172040|18828327|P1|Overall Study|Adverse Event|0
5449136|NCT02171260|18828490|P4|Overall Study|Evidence of progressive disease|4
5449137|NCT02171260|18828491|P3|Overall Study|Evidence of progressive disease|4
5449138|NCT02171260|18828492|P2|Overall Study|Evidence of progressive disease|6
5449139|NCT02171260|18828493|P1|Overall Study|Evidence of progressive disease|4
5449140|NCT02171260|18828490|P4|Overall Study|Withdrawal by Subject|0
5449141|NCT02171260|18828491|P3|Overall Study|Withdrawal by Subject|0
5449142|NCT02171260|18828492|P2|Overall Study|Withdrawal by Subject|0
5449143|NCT02171260|18828493|P1|Overall Study|Withdrawal by Subject|1
5449144|NCT02171260|18828490|P4|Overall Study|Physician Decision|0
5449145|NCT02171260|18828491|P3|Overall Study|Physician Decision|1
5449146|NCT02171260|18828492|P2|Overall Study|Physician Decision|0
5449147|NCT02171260|18828493|P1|Overall Study|Physician Decision|1
5449148|NCT02171260|18828490|P4|Overall Study|Death|1
5449149|NCT02171260|18828491|P3|Overall Study|Death|0
5449150|NCT02171260|18828492|P2|Overall Study|Death|0
5449151|NCT02171260|18828493|P1|Overall Study|Death|0
5449152|NCT02171130|18828629|P1|Overall Study|Met Exclusion Criteria|1
5449153|NCT02171130|18828629|P1|Overall Study|Lost to Follow-up|1
5449154|NCT02171130|18828629|P1|Overall Study|Physician Decision|1
5449155|NCT02171130|18828629|P1|Overall Study|Withdrawal by Subject|3
5449156|NCT02171130|18828629|P1|Overall Study|Discontinued; Site Termination|5
5449157|NCT02171130|18828629|P1|Overall Study|Discontinued; Clinical Material Issue|16
5449158|NCT02171130|18828629|P1|Overall Study|Death|1
5449159|NCT02170779|18828670|P2|Overall Study|Lost to Follow-up|1
5449160|NCT02170779|18828671|P1|Overall Study|Lost to Follow-up|0
5449161|NCT02170779|18828670|P2|Overall Study|Withdrawal by Subject|0
5449162|NCT02170779|18828671|P1|Overall Study|Withdrawal by Subject|1
5449163|NCT02170727|18828695|P2|Overall Study|Withdrawal by Subject|0
5449164|NCT02170727|18828696|P1|Overall Study|Withdrawal by Subject|2
5449165|NCT02170727|18828695|P2|Overall Study|Lost to Follow-up|0
5449166|NCT02170727|18828696|P1|Overall Study|Lost to Follow-up|1
5449167|NCT02170688|18828727|P5|Overall Study|Physician Decision|0
5449168|NCT02170688|18828728|P4|Overall Study|Physician Decision|0
5449169|NCT02170688|18828729|P3|Overall Study|Physician Decision|1
5449170|NCT02170688|18828730|P2|Overall Study|Physician Decision|0
5449171|NCT02170688|18828731|P1|Overall Study|Physician Decision|0
5449172|NCT02170688|18828727|P5|Overall Study|Full dose not received|0
5449173|NCT02170688|18828728|P4|Overall Study|Full dose not received|0
5449174|NCT02170688|18828729|P3|Overall Study|Full dose not received|0
5449175|NCT02170688|18828730|P2|Overall Study|Full dose not received|1
5449176|NCT02170688|18828731|P1|Overall Study|Full dose not received|0
5449177|NCT02170688|18828727|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
5449178|NCT02170688|18828728|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
5449179|NCT02170688|18828729|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
5449180|NCT02170688|18828730|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
5449181|NCT02170688|18828731|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
5449182|NCT02170389|18828817|P1|Overall Study|Study terminated prior to start of treat|1
5449183|NCT02170298|18828882|P2|Overall Study|unblinded, rerandomized to intervention|0
5449184|NCT02170298|18828883|P1|Overall Study|unblinded, rerandomized to intervention|1
5449185|NCT02170298|18828882|P2|Overall Study|Withdrawal by Subject|1
5449186|NCT02170298|18828883|P1|Overall Study|Withdrawal by Subject|0
5449187|NCT02170207|18828920|P1|Overall Study|Case report forms unavailable|5
5449188|NCT02170077|18828931|P3|Overall Study|Exacerbation of seizures|1
5449189|NCT02170077|18828932|P2|Overall Study|Exacerbation of seizures|2
5449190|NCT02170077|18828933|P1|Overall Study|Exacerbation of seizures|0
5449191|NCT02170077|18828931|P3|Overall Study|Exclusion criteria|5
5449192|NCT02170077|18828932|P2|Overall Study|Exclusion criteria|2
5449193|NCT02170077|18828933|P1|Overall Study|Exclusion criteria|2
5449194|NCT02170077|18828931|P3|Overall Study|Lost to Follow-up|0
5449195|NCT02170077|18828932|P2|Overall Study|Lost to Follow-up|1
5449196|NCT02170077|18828933|P1|Overall Study|Lost to Follow-up|0
5449197|NCT02170077|18828931|P3|Overall Study|Adverse Event|4
5449198|NCT02170077|18828932|P2|Overall Study|Adverse Event|4
5449199|NCT02170077|18828933|P1|Overall Study|Adverse Event|4
5449200|NCT02170077|18828931|P3|Overall Study|Withdrawal by Subject|2
5449201|NCT02170077|18828932|P2|Overall Study|Withdrawal by Subject|4
5449202|NCT02170077|18828933|P1|Overall Study|Withdrawal by Subject|3
5449203|NCT02170064|18828944|P3|Overall Study|Physician Decision|0
5449204|NCT02170064|18828945|P2|Overall Study|Physician Decision|1
5449205|NCT02170064|18828946|P1|Overall Study|Physician Decision|1
5449206|NCT02170064|18828944|P3|Overall Study|Withdrawal by Subject|1
5449207|NCT02170064|18828945|P2|Overall Study|Withdrawal by Subject|1
5449208|NCT02170064|18828946|P1|Overall Study|Withdrawal by Subject|5
5449209|NCT02170051|18828962|P2|Overall Study|Lost to Follow-up|3
5449210|NCT02170051|18828963|P1|Overall Study|Lost to Follow-up|1
5449211|NCT02170051|18828962|P2|Overall Study|Withdrawal by Subject|10
5449212|NCT02170051|18828963|P1|Overall Study|Withdrawal by Subject|10
5449213|NCT02170025|18828983|P2|Overall Study|Adverse Event|0
5449214|NCT02170025|18828984|P1|Overall Study|Adverse Event|2
5449215|NCT02169674|18829028|P2|Overall Study|Lost to Follow-up|1
5449216|NCT02169674|18829029|P1|Overall Study|Lost to Follow-up|0
5449217|NCT02169674|18829028|P2|Overall Study|Seroprotected|76
5449218|NCT02169674|18829029|P1|Overall Study|Seroprotected|30
5449219|NCT02169674|18829028|P2|Overall Study|Withdrawal by Subject|1
5449220|NCT02169674|18829029|P1|Overall Study|Withdrawal by Subject|2
5449221|NCT02169505|18829043|P1|Overall Study|Withdrawal by Subject|1
5449222|NCT02169414|18829171|P4|Overall Study|Adverse Event|0
5449223|NCT02169414|18829172|P3|Overall Study|Adverse Event|0
5449224|NCT02169414|18829173|P2|Overall Study|Adverse Event|1
5449225|NCT02169414|18829174|P1|Overall Study|Adverse Event|0
5449226|NCT02169414|18829171|P4|Overall Study|Withdrawal by Subject|0
5449227|NCT02169414|18829172|P3|Overall Study|Withdrawal by Subject|0
5449228|NCT02169414|18829173|P2|Overall Study|Withdrawal by Subject|0
5449229|NCT02169414|18829174|P1|Overall Study|Withdrawal by Subject|1
5449230|NCT02169336|18829215|P3|Overall Study|Subject declined to continue dosing|1
5449231|NCT02169336|18829216|P2|Overall Study|Subject declined to continue dosing|0
5449232|NCT02169336|18829217|P1|Overall Study|Subject declined to continue dosing|0
5449233|NCT02169336|18829215|P3|Overall Study|Physician Decision|1
5449234|NCT02169336|18829216|P2|Overall Study|Physician Decision|0
5449235|NCT02169336|18829217|P1|Overall Study|Physician Decision|0
5449236|NCT02169336|18829215|P3|Overall Study|Withdrawal by Subject|0
5449237|NCT02169336|18829216|P2|Overall Study|Withdrawal by Subject|0
5449238|NCT02169336|18829217|P1|Overall Study|Withdrawal by Subject|1
5449239|NCT02169336|18829215|P3|Overall Study|Adverse Event|1
5449240|NCT02169336|18829216|P2|Overall Study|Adverse Event|3
5449241|NCT02169336|18829217|P1|Overall Study|Adverse Event|2
5449242|NCT02169336|18829215|P3|Overall Study|Lack of Efficacy|0
5449243|NCT02169336|18829216|P2|Overall Study|Lack of Efficacy|1
5449244|NCT02169336|18829217|P1|Overall Study|Lack of Efficacy|1
5449245|NCT02169284|18829227|P2|Overall Study|Physician Decision|1
5449246|NCT02169284|18829228|P1|Overall Study|Physician Decision|0
5449247|NCT02169271|18829254|P2|Overall Study|Protocol Violation|2
5449248|NCT02169271|18829255|P1|Overall Study|Protocol Violation|1
5449249|NCT02169219|18829277|P1|Overall Study|Lack of Efficacy|6
5449250|NCT02168946|18829321|P2|Overall Study|Subject unable to come back for visits|0
5449251|NCT02168946|18829322|P1|Overall Study|Subject unable to come back for visits|1
5449252|NCT02168946|18829321|P2|Overall Study|Lost to Follow-up|0
5449253|NCT02168946|18829322|P1|Overall Study|Lost to Follow-up|3
5449254|NCT02168946|18829321|P2|Overall Study|Adverse Event|5
5449255|NCT02168946|18829322|P1|Overall Study|Adverse Event|8
5449256|NCT02168842|18829381|P2|Overall Study|Physician Decision|2
5449257|NCT02168842|18829382|P1|Overall Study|Physician Decision|1
5449258|NCT02168842|18829381|P2|Overall Study|Death|1
5449259|NCT02168842|18829382|P1|Overall Study|Death|2
5449260|NCT02168842|18829381|P2|Overall Study|Lost to Follow-up|2
5449261|NCT02168842|18829382|P1|Overall Study|Lost to Follow-up|0
5449262|NCT02168842|18829381|P2|Overall Study|Withdrawal by Subject|3
5449263|NCT02168842|18829382|P1|Overall Study|Withdrawal by Subject|5
5449264|NCT02168816|18829440|P2|Overall Study|Lost to Follow-up|2
5449265|NCT02168816|18829441|P1|Overall Study|Lost to Follow-up|2
5449266|NCT02168803|18829452|P3|Overall Study|Sponsor Decision|1
5449267|NCT02168803|18829453|P2|Overall Study|Sponsor Decision|0
5449268|NCT02168803|18829454|P1|Overall Study|Sponsor Decision|0
5449269|NCT02168803|18829452|P3|Overall Study|Death|1
5449270|NCT02168803|18829453|P2|Overall Study|Death|0
5449271|NCT02168803|18829454|P1|Overall Study|Death|0
5449272|NCT02168803|18829452|P3|Overall Study|Adverse Event|1
5449273|NCT02168803|18829453|P2|Overall Study|Adverse Event|1
5449274|NCT02168803|18829454|P1|Overall Study|Adverse Event|0
5449275|NCT02168803|18829452|P3|Overall Study|Physician Decision|0
5449276|NCT02168803|18829453|P2|Overall Study|Physician Decision|1
5449277|NCT02168803|18829454|P1|Overall Study|Physician Decision|0
5449278|NCT02168803|18829452|P3|Overall Study|Withdrawal by Subject|2
5449279|NCT02168803|18829453|P2|Overall Study|Withdrawal by Subject|1
5449280|NCT02168803|18829454|P1|Overall Study|Withdrawal by Subject|1
5449281|NCT02168803|18829452|P3|Overall Study|Lost to Follow-up|1
5449282|NCT02168803|18829453|P2|Overall Study|Lost to Follow-up|0
5449283|NCT02168803|18829454|P1|Overall Study|Lost to Follow-up|1
5449284|NCT02168777|18829484|P3|Overall Study|Other reason|0
5449285|NCT02168777|18829485|P2|Overall Study|Other reason|1
5449286|NCT02168777|18829486|P1|Overall Study|Other reason|0
5449287|NCT02168777|18829484|P3|Overall Study|Clinical disease progression|2
5449288|NCT02168777|18829485|P2|Overall Study|Clinical disease progression|1
5449289|NCT02168777|18829486|P1|Overall Study|Clinical disease progression|0
5449290|NCT02168777|18829484|P3|Overall Study|Radiological disease progression|5
5449291|NCT02168777|18829485|P2|Overall Study|Radiological disease progression|5
5449292|NCT02168777|18829486|P1|Overall Study|Radiological disease progression|0
5449293|NCT02168777|18829484|P3|Overall Study|Disease recurrence|1
5449294|NCT02168777|18829485|P2|Overall Study|Disease recurrence|0
5449295|NCT02168777|18829486|P1|Overall Study|Disease recurrence|0
5449296|NCT02168777|18829484|P3|Overall Study|Adverse Event|1
5449297|NCT02168777|18829485|P2|Overall Study|Adverse Event|0
5449298|NCT02168777|18829486|P1|Overall Study|Adverse Event|1
5449299|NCT02168777|18829484|P3|Overall Study|Withdrawal by Subject|2
5449300|NCT02168777|18829485|P2|Overall Study|Withdrawal by Subject|0
5449301|NCT02168777|18829486|P1|Overall Study|Withdrawal by Subject|1
5449302|NCT02168491|18829582|P1|Overall Study|Withdrawal by Subject|1
5449303|NCT02168478|18829588|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
5449304|NCT02168478|18829588|P1|Overall Study|Did Not Consent to Participation|2
5449305|NCT02168478|18829588|P1|Overall Study|Withdrawal by Subject|1
5449306|NCT02168439|18829594|P2|Overall Study|Protocol Violation|2
5449307|NCT02168439|18829595|P1|Overall Study|Protocol Violation|0
5449308|NCT02168387|18829613|P2|Overall Study|Death|0
5449309|NCT02168387|18829614|P1|Overall Study|Death|1
5449310|NCT02168387|18829613|P2|Overall Study|Planned exubation|3
5449311|NCT02168387|18829614|P1|Overall Study|Planned exubation|6
5449312|NCT02168270|18829646|P1|Overall Study|Lack of Efficacy|4
5449313|NCT02168101|18829673|P3|Overall Study|Death|1
5449314|NCT02168101|18829674|P2|Overall Study|Death|2
5449315|NCT02168101|18829675|P1|Overall Study|Death|2
5449316|NCT02167893|18829745|P1|Overall Study|Case report forms not collected|68
5449317|NCT02167893|18829745|P1|Overall Study|Investigator health reasons|10
5449318|NCT02167893|18829745|P1|Overall Study|Investigator transferred|85
5449319|NCT02167594|18829780|P3|Overall Study|Death|0
5449320|NCT02167594|18829781|P2|Overall Study|Death|1
5449321|NCT02167594|18829782|P1|Overall Study|Death|0
5449322|NCT02167594|18829780|P3|Overall Study|Withdrawal by Subject|0
5449323|NCT02167594|18829781|P2|Overall Study|Withdrawal by Subject|0
5449324|NCT02167594|18829782|P1|Overall Study|Withdrawal by Subject|2
5449325|NCT02167451|18829791|P1|Overall Study|Withdrawal by Subject|1
5449326|NCT02167256|18829808|P2|Overall Study|Study partner unable to participate|0
5449327|NCT02167256|18829809|P1|Overall Study|Study partner unable to participate|1
5449328|NCT02167256|18829808|P2|Overall Study|non-compliance|0
5449329|NCT02167256|18829809|P1|Overall Study|non-compliance|3
5449330|NCT02167256|18829808|P2|Overall Study|Withdrawal by Subject|4
5449331|NCT02167256|18829809|P1|Overall Study|Withdrawal by Subject|4
5449332|NCT02167256|18829808|P2|Overall Study|Adverse Event|6
5449333|NCT02167256|18829809|P1|Overall Study|Adverse Event|13
5449334|NCT02167139|18829842|P4|Transition-extension|Lost to Follow-up|0
5449335|NCT02167139|18829843|P3|Transition-extension|Lost to Follow-up|0
5449336|NCT02167139|18829844|P2|Transition-extension|Lost to Follow-up|0
5449337|NCT02167139|18829845|P1|Transition-extension|Lost to Follow-up|1
5449338|NCT02167139|18829842|P4|Transition-extension|Other|0
5449339|NCT02167139|18829843|P3|Transition-extension|Other|1
5449340|NCT02167139|18829844|P2|Transition-extension|Other|0
5449341|NCT02167139|18829845|P1|Transition-extension|Other|1
5449342|NCT02167139|18829842|P4|Transition-extension|Lack of Efficacy|1
5449343|NCT02167139|18829843|P3|Transition-extension|Lack of Efficacy|1
5449344|NCT02167139|18829844|P2|Transition-extension|Lack of Efficacy|0
5449345|NCT02167139|18829845|P1|Transition-extension|Lack of Efficacy|0
5449346|NCT02167139|18829842|P4|Transition-extension|Withdrawal by Subject|1
5449347|NCT02167139|18829843|P3|Transition-extension|Withdrawal by Subject|4
5449348|NCT02167139|18829844|P2|Transition-extension|Withdrawal by Subject|0
5449349|NCT02167139|18829845|P1|Transition-extension|Withdrawal by Subject|2
5449350|NCT02167139|18829842|P4|Transition-extension|Adverse Event|3
5449351|NCT02167139|18829843|P3|Transition-extension|Adverse Event|2
5449352|NCT02167139|18829844|P2|Transition-extension|Adverse Event|0
5449353|NCT02167139|18829845|P1|Transition-extension|Adverse Event|2
5449354|NCT02167139|18829842|P4|Randomised, Double-blind|Other|0
5449355|NCT02167139|18829843|P3|Randomised, Double-blind|Other|0
5449356|NCT02167139|18829844|P2|Randomised, Double-blind|Other|0
5449357|NCT02167139|18829845|P1|Randomised, Double-blind|Other|3
5449358|NCT02167139|18829842|P4|Randomised, Double-blind|Lack of Efficacy|0
5449359|NCT02167139|18829843|P3|Randomised, Double-blind|Lack of Efficacy|0
5449360|NCT02167139|18829844|P2|Randomised, Double-blind|Lack of Efficacy|2
5449361|NCT02167139|18829845|P1|Randomised, Double-blind|Lack of Efficacy|1
5449362|NCT02167139|18829842|P4|Randomised, Double-blind|Adverse Event|0
5449363|NCT02167139|18829843|P3|Randomised, Double-blind|Adverse Event|0
5449364|NCT02167139|18829844|P2|Randomised, Double-blind|Adverse Event|9
5449365|NCT02167139|18829845|P1|Randomised, Double-blind|Adverse Event|2
5449366|NCT02167139|18829842|P4|Randomised, Double-blind|Withdrawal by Subject|0
5449367|NCT02167139|18829843|P3|Randomised, Double-blind|Withdrawal by Subject|0
5449368|NCT02167139|18829844|P2|Randomised, Double-blind|Withdrawal by Subject|8
5449369|NCT02167139|18829845|P1|Randomised, Double-blind|Withdrawal by Subject|11
5449370|NCT02167035|18829880|P2|Overall Study|Randomized to incorrect Study Medication|1
5449371|NCT02167035|18829881|P1|Overall Study|Randomized to incorrect Study Medication|0
5449372|NCT02167035|18829880|P2|Overall Study|Lost to Follow-up|3
5449373|NCT02167035|18829881|P1|Overall Study|Lost to Follow-up|3
5449374|NCT02167035|18829880|P2|Overall Study|Adverse Event|2
5449375|NCT02167035|18829881|P1|Overall Study|Adverse Event|2
5449376|NCT02166697|18829889|P1|Overall Study|Protocol Violation|347
5449377|NCT02166606|18829898|P1|Overall Study|Enrolled after End of Enrollment|4
5449378|NCT02166606|18829898|P1|Overall Study|Device upgrade|1
5449379|NCT02166606|18829898|P1|Overall Study|Physician Decision|1
5449380|NCT02166606|18829898|P1|Overall Study|Withdrawal by Subject|1
5449381|NCT02166606|18829898|P1|Overall Study|Lost to Follow-up|30
5449382|NCT02166606|18829898|P1|Overall Study|Protocol Violation|7
5449383|NCT02166606|18829898|P1|Overall Study|Death|31
5449384|NCT02166606|18829898|P1|Overall Study|Adverse Event|3
5449385|NCT02166476|18829905|P2|Overall Study|Unable to Come for Visit|3
5449386|NCT02166476|18829906|P1|Overall Study|Unable to Come for Visit|0
5449387|NCT02166476|18829905|P2|Overall Study|Physician Decision|0
5449388|NCT02166476|18829906|P1|Overall Study|Physician Decision|1
5449389|NCT02166476|18829905|P2|Overall Study|Lost to Follow-up|10
5449390|NCT02166476|18829906|P1|Overall Study|Lost to Follow-up|5
5449391|NCT02166476|18829905|P2|Overall Study|Adverse Event|3
5449392|NCT02166476|18829906|P1|Overall Study|Adverse Event|3
5449393|NCT02166476|18829905|P2|Overall Study|Withdrawal by Subject|7
5449394|NCT02166476|18829906|P1|Overall Study|Withdrawal by Subject|5
5449395|NCT02166047|18829960|P12|Overall Study|Adverse Event|0
5449396|NCT02166047|18829961|P11|Overall Study|Adverse Event|2
5449397|NCT02166047|18829962|P10|Overall Study|Adverse Event|0
5449398|NCT02166047|18829963|P9|Overall Study|Adverse Event|0
5449399|NCT02166047|18829964|P8|Overall Study|Adverse Event|0
5449400|NCT02166047|18829965|P7|Overall Study|Adverse Event|1
5449401|NCT02166047|18829966|P6|Overall Study|Adverse Event|0
5449402|NCT02166047|18829967|P5|Overall Study|Adverse Event|1
5449403|NCT02166047|18829968|P4|Overall Study|Adverse Event|0
5449404|NCT02166047|18829969|P3|Overall Study|Adverse Event|0
5449405|NCT02166047|18829970|P2|Overall Study|Adverse Event|0
5449406|NCT02166047|18829971|P1|Overall Study|Adverse Event|0
5449407|NCT02166047|18829960|P12|Overall Study|Withdrawal by Participant|0
5449408|NCT02166047|18829961|P11|Overall Study|Withdrawal by Participant|0
5449409|NCT02166047|18829962|P10|Overall Study|Withdrawal by Participant|0
5449410|NCT02166047|18829963|P9|Overall Study|Withdrawal by Participant|0
5449411|NCT02166047|18829964|P8|Overall Study|Withdrawal by Participant|0
5449412|NCT02166047|18829965|P7|Overall Study|Withdrawal by Participant|1
5449413|NCT02166047|18829966|P6|Overall Study|Withdrawal by Participant|0
5449414|NCT02166047|18829967|P5|Overall Study|Withdrawal by Participant|0
5449415|NCT02166047|18829968|P4|Overall Study|Withdrawal by Participant|0
5449416|NCT02166047|18829969|P3|Overall Study|Withdrawal by Participant|2
5449417|NCT02166047|18829970|P2|Overall Study|Withdrawal by Participant|1
5449418|NCT02166047|18829971|P1|Overall Study|Withdrawal by Participant|0
5449419|NCT02165826|18830138|P3|Down-Titration Period|Reason Not Specified|2
5449420|NCT02165826|18830139|P2|Down-Titration Period|Reason Not Specified|0
5449421|NCT02165826|18830140|P1|Down-Titration Period|Reason Not Specified|1
5449422|NCT02165826|18830138|P3|Down-Titration Period|Voluntary Withdrawal|2
5449423|NCT02165826|18830139|P2|Down-Titration Period|Voluntary Withdrawal|1
5449424|NCT02165826|18830140|P1|Down-Titration Period|Voluntary Withdrawal|2
5449425|NCT02165826|18830138|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
5449426|NCT02165826|18830139|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
5449427|NCT02165826|18830140|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
5449428|NCT02165826|18830138|P3|Main Treatment Period|Did Not Receive Study Drug|0
5449429|NCT02165826|18830139|P2|Main Treatment Period|Did Not Receive Study Drug|2
5449430|NCT02165826|18830140|P1|Main Treatment Period|Did Not Receive Study Drug|0
5449431|NCT02165826|18830138|P3|Main Treatment Period|Reason Not Specified|16
5449432|NCT02165826|18830139|P2|Main Treatment Period|Reason Not Specified|5
5449433|NCT02165826|18830140|P1|Main Treatment Period|Reason Not Specified|8
5449434|NCT02165826|18830138|P3|Main Treatment Period|Lack of Efficacy|0
5449435|NCT02165826|18830139|P2|Main Treatment Period|Lack of Efficacy|0
5449436|NCT02165826|18830140|P1|Main Treatment Period|Lack of Efficacy|2
5449437|NCT02165826|18830138|P3|Main Treatment Period|Voluntary Withdrawal|21
5449438|NCT02165826|18830139|P2|Main Treatment Period|Voluntary Withdrawal|23
5449439|NCT02165826|18830140|P1|Main Treatment Period|Voluntary Withdrawal|23
5449440|NCT02165826|18830138|P3|Main Treatment Period|Lost to Follow-up|1
5449441|NCT02165826|18830139|P2|Main Treatment Period|Lost to Follow-up|2
5449442|NCT02165826|18830140|P1|Main Treatment Period|Lost to Follow-up|4
5449443|NCT02165826|18830138|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
5449444|NCT02165826|18830139|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
5449445|NCT02165826|18830140|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
5449446|NCT02165826|18830138|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
5449447|NCT02165826|18830139|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
5449448|NCT02165826|18830140|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
5449449|NCT02165735|18830208|P2|Overall Study|Protocol Violation|1
5449450|NCT02165735|18830209|P1|Overall Study|Protocol Violation|0
5449451|NCT02165735|18830208|P2|Overall Study|Participant indicated lack of time|3
5449452|NCT02165735|18830209|P1|Overall Study|Participant indicated lack of time|1
5449453|NCT02165735|18830208|P2|Overall Study|Withdrawal by Subject|0
5449454|NCT02165735|18830209|P1|Overall Study|Withdrawal by Subject|3
5449455|NCT02165735|18830208|P2|Overall Study|Lost to Follow-up|10
5449456|NCT02165735|18830209|P1|Overall Study|Lost to Follow-up|12
5449457|NCT02165397|18830283|P3|Overall Study|Other, Not Specified|1
5449458|NCT02165397|18830284|P2|Overall Study|Other, Not Specified|0
5449459|NCT02165397|18830285|P1|Overall Study|Other, Not Specified|0
5449460|NCT02165397|18830283|P3|Overall Study|Withdrawal by Subject|1
5449461|NCT02165397|18830284|P2|Overall Study|Withdrawal by Subject|6
5449462|NCT02165397|18830285|P1|Overall Study|Withdrawal by Subject|6
5449463|NCT02165397|18830283|P3|Overall Study|Lost to Follow-up|0
5449464|NCT02165397|18830284|P2|Overall Study|Lost to Follow-up|3
5449465|NCT02165397|18830285|P1|Overall Study|Lost to Follow-up|1
5449466|NCT02165397|18830283|P3|Overall Study|Death|8
5449467|NCT02165397|18830284|P2|Overall Study|Death|10
5449468|NCT02165397|18830285|P1|Overall Study|Death|7
5449469|NCT02165202|18830315|P2|Injection Phase|Participant unwilling to comply|0
5449470|NCT02165202|18830316|P1|Injection Phase|Participant unwilling to comply|1
5449471|NCT02165202|18830315|P2|Injection Phase|No longer interested|1
5449472|NCT02165202|18830316|P1|Injection Phase|No longer interested|0
5449473|NCT02165202|18830315|P2|Injection Phase|Study Product related Toxicity|0
5449474|NCT02165202|18830316|P1|Injection Phase|Study Product related Toxicity|1
5449475|NCT02165202|18830315|P2|Injection Phase|End of Study|1
5449476|NCT02165202|18830316|P1|Injection Phase|End of Study|2
5449477|NCT02165202|18830315|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
5449478|NCT02165202|18830316|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
5449479|NCT02165202|18830315|P2|Injection Phase|Unable to attend within Visit Window|0
5449480|NCT02165202|18830316|P1|Injection Phase|Unable to attend within Visit Window|1
5449481|NCT02165202|18830315|P2|Injection Phase|Reactive HIV or HIV Suspected|2
5449482|NCT02165202|18830316|P1|Injection Phase|Reactive HIV or HIV Suspected|0
5449483|NCT02165202|18830315|P2|Injection Phase|Abnormal Lab Value|1
5449484|NCT02165202|18830316|P1|Injection Phase|Abnormal Lab Value|5
5449485|NCT02165202|18830315|P2|Oral Phase|Abnormal EKG|1
5449486|NCT02165202|18830316|P1|Oral Phase|Abnormal EKG|0
5449487|NCT02165202|18830315|P2|Oral Phase|Relocated, no follow-up planned|0
5449488|NCT02165202|18830316|P1|Oral Phase|Relocated, no follow-up planned|1
5449489|NCT02165202|18830315|P2|Oral Phase|CMC advised termination|0
5449490|NCT02165202|18830316|P1|Oral Phase|CMC advised termination|1
5449491|NCT02165202|18830315|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
5449492|NCT02165202|18830316|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
5449493|NCT02165202|18830315|P2|Oral Phase|Clinical reasons|0
5449494|NCT02165202|18830316|P1|Oral Phase|Clinical reasons|1
5449495|NCT02165202|18830315|P2|Oral Phase|Unable to contact Participant|1
5449496|NCT02165202|18830316|P1|Oral Phase|Unable to contact Participant|1
5449497|NCT02165202|18830315|P2|Oral Phase|Study product Related Toxicity|0
5449498|NCT02165202|18830316|P1|Oral Phase|Study product Related Toxicity|1
5449499|NCT02165202|18830315|P2|Oral Phase|Refused further participation|1
5449500|NCT02165202|18830316|P1|Oral Phase|Refused further participation|5
5449501|NCT02164981|18830353|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
5449502|NCT02164981|18830354|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
5449503|NCT02164981|18830355|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
5449504|NCT02164981|18830353|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
5449505|NCT02164981|18830354|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
5449506|NCT02164981|18830355|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
5449507|NCT02164981|18830353|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
5449508|NCT02164981|18830354|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
5449509|NCT02164981|18830355|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
5449510|NCT02164981|18830353|P3|Started|Adverse Event|0
5449511|NCT02164981|18830354|P2|Started|Adverse Event|2
5449512|NCT02164981|18830355|P1|Started|Adverse Event|1
5449513|NCT02164981|18830353|P3|Started|Protocol Violation|0
5449514|NCT02164981|18830354|P2|Started|Protocol Violation|0
5449515|NCT02164981|18830355|P1|Started|Protocol Violation|2
5449516|NCT02164981|18830353|P3|Started|Withdrawal by Subject|0
5449517|NCT02164981|18830354|P2|Started|Withdrawal by Subject|1
5449518|NCT02164981|18830355|P1|Started|Withdrawal by Subject|2
5449519|NCT02164929|18830428|P4|Overall Study|Failed regional block|0
5449520|NCT02164929|18830429|P3|Overall Study|Failed regional block|1
5449521|NCT02164929|18830430|P2|Overall Study|Failed regional block|0
5449522|NCT02164929|18830431|P1|Overall Study|Failed regional block|0
5449523|NCT02164929|18830428|P4|Overall Study|Converted to open procedure|2
5449524|NCT02164929|18830429|P3|Overall Study|Converted to open procedure|0
5449525|NCT02164929|18830430|P2|Overall Study|Converted to open procedure|0
5449526|NCT02164929|18830431|P1|Overall Study|Converted to open procedure|1
5449527|NCT02164916|18830475|P2|Overall Study|Not eligible|5
5449528|NCT02164916|18830476|P1|Overall Study|Not eligible|2
5449529|NCT02164916|18830475|P2|Overall Study|Reason under review|6
5449530|NCT02164916|18830476|P1|Overall Study|Reason under review|1
5449531|NCT02164916|18830475|P2|Overall Study|Not protocol specified|1
5449532|NCT02164916|18830476|P1|Overall Study|Not protocol specified|5
5449533|NCT02164916|18830475|P2|Overall Study|Progression|26
5449534|NCT02164916|18830476|P1|Overall Study|Progression|37
5449535|NCT02164916|18830475|P2|Overall Study|Refusal unrelated to adverse event|7
5449536|NCT02164916|18830476|P1|Overall Study|Refusal unrelated to adverse event|3
5449537|NCT02164916|18830475|P2|Overall Study|Death|1
5449538|NCT02164916|18830476|P1|Overall Study|Death|1
5449539|NCT02164916|18830475|P2|Overall Study|Adverse Event|8
5449540|NCT02164916|18830476|P1|Overall Study|Adverse Event|3
5449541|NCT02164864|18830496|P3|Overall Study|Other than stated|14
5449542|NCT02164864|18830497|P2|Overall Study|Other than stated|4
5449543|NCT02164864|18830498|P1|Overall Study|Other than stated|3
5449544|NCT02164864|18830496|P3|Overall Study|Consent withdrawn, not due to AE|56
5449545|NCT02164864|18830497|P2|Overall Study|Consent withdrawn, not due to AE|8
5449546|NCT02164864|18830498|P1|Overall Study|Consent withdrawn, not due to AE|21
5449547|NCT02164864|18830496|P3|Overall Study|Lost to Follow-up|2
5449548|NCT02164864|18830497|P2|Overall Study|Lost to Follow-up|3
5449549|NCT02164864|18830498|P1|Overall Study|Lost to Follow-up|4
5449550|NCT02164864|18830496|P3|Overall Study|Protocol Violation|1
5449551|NCT02164864|18830497|P2|Overall Study|Protocol Violation|4
5449552|NCT02164864|18830498|P1|Overall Study|Protocol Violation|2
5449553|NCT02164864|18830496|P3|Overall Study|Other Adverse Event (AE)|49
5449554|NCT02164864|18830497|P2|Overall Study|Other Adverse Event (AE)|32
5449555|NCT02164864|18830498|P1|Overall Study|Other Adverse Event (AE)|52
5449556|NCT02164864|18830496|P3|Overall Study|Other pre-existing disease worsening|9
5449557|NCT02164864|18830497|P2|Overall Study|Other pre-existing disease worsening|4
5449558|NCT02164864|18830498|P1|Overall Study|Other pre-existing disease worsening|6
5449559|NCT02164864|18830496|P3|Overall Study|Trial disease worsening|1
5449560|NCT02164864|18830497|P2|Overall Study|Trial disease worsening|5
5449561|NCT02164864|18830498|P1|Overall Study|Trial disease worsening|7
5449562|NCT02164539|18830573|P7|Treatment Phase C (1 Week)|Physician Decision|1
5449563|NCT02164539|18830574|P6|Treatment Phase C (1 Week)|Physician Decision|0
5449564|NCT02164539|18830575|P5|Treatment Phase C (1 Week)|Physician Decision|0
5449565|NCT02164539|18830576|P4|Treatment Phase C (1 Week)|Physician Decision|0
5449566|NCT02164539|18830577|P3|Treatment Phase C (1 Week)|Physician Decision|0
5449567|NCT02164539|18830578|P2|Treatment Phase C (1 Week)|Physician Decision|0
5449568|NCT02164539|18830579|P1|Treatment Phase C (1 Week)|Physician Decision|0
5449569|NCT02164539|18830573|P7|Treatment Phase C (1 Week)|Adverse Event|1
5449570|NCT02164539|18830574|P6|Treatment Phase C (1 Week)|Adverse Event|0
5449571|NCT02164539|18830575|P5|Treatment Phase C (1 Week)|Adverse Event|0
5449572|NCT02164539|18830576|P4|Treatment Phase C (1 Week)|Adverse Event|0
5449573|NCT02164539|18830577|P3|Treatment Phase C (1 Week)|Adverse Event|0
5449574|NCT02164539|18830578|P2|Treatment Phase C (1 Week)|Adverse Event|0
5449575|NCT02164539|18830579|P1|Treatment Phase C (1 Week)|Adverse Event|0
5449576|NCT02164539|18830573|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5449577|NCT02164539|18830574|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5449578|NCT02164539|18830575|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5449579|NCT02164539|18830576|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5449580|NCT02164539|18830577|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5449581|NCT02164539|18830578|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
5449582|NCT02164539|18830579|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
5449583|NCT02164539|18830573|P7|Treatment Phase B (1 Week)|Physician Decision|1
5449584|NCT02164539|18830574|P6|Treatment Phase B (1 Week)|Physician Decision|0
5449585|NCT02164539|18830575|P5|Treatment Phase B (1 Week)|Physician Decision|1
5449586|NCT02164539|18830576|P4|Treatment Phase B (1 Week)|Physician Decision|0
5449587|NCT02164539|18830577|P3|Treatment Phase B (1 Week)|Physician Decision|0
5449588|NCT02164539|18830578|P2|Treatment Phase B (1 Week)|Physician Decision|0
5449589|NCT02164539|18830579|P1|Treatment Phase B (1 Week)|Physician Decision|0
5449590|NCT02164539|18830573|P7|Treatment Phase B (1 Week)|Adverse Event|0
5449591|NCT02164539|18830574|P6|Treatment Phase B (1 Week)|Adverse Event|0
5449592|NCT02164539|18830575|P5|Treatment Phase B (1 Week)|Adverse Event|2
5449593|NCT02164539|18830576|P4|Treatment Phase B (1 Week)|Adverse Event|0
5449594|NCT02164539|18830577|P3|Treatment Phase B (1 Week)|Adverse Event|0
5449595|NCT02164539|18830578|P2|Treatment Phase B (1 Week)|Adverse Event|0
5449596|NCT02164539|18830579|P1|Treatment Phase B (1 Week)|Adverse Event|0
5449597|NCT02164539|18830573|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
5449598|NCT02164539|18830574|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
5449599|NCT02164539|18830575|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
5449600|NCT02164539|18830576|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
5449601|NCT02164539|18830577|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
5449602|NCT02164539|18830578|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
5449603|NCT02164539|18830579|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
5449604|NCT02164513|18830627|P3|Overall Study|Other: Reason not provided by site|0
5449605|NCT02164513|18830628|P2|Overall Study|Other: Reason not provided by site|0
5449606|NCT02164513|18830629|P1|Overall Study|Other: Reason not provided by site|1
5449607|NCT02164513|18830627|P3|Overall Study|Withdrawal by Subject|130
5449608|NCT02164513|18830628|P2|Overall Study|Withdrawal by Subject|261
5449609|NCT02164513|18830629|P1|Overall Study|Withdrawal by Subject|192
5449610|NCT02164513|18830627|P3|Overall Study|Physician Decision|28
5449611|NCT02164513|18830628|P2|Overall Study|Physician Decision|57
5449612|NCT02164513|18830629|P1|Overall Study|Physician Decision|47
5449613|NCT02164513|18830627|P3|Overall Study|Lost to Follow-up|22
5449614|NCT02164513|18830628|P2|Overall Study|Lost to Follow-up|36
5449615|NCT02164513|18830629|P1|Overall Study|Lost to Follow-up|30
5449616|NCT02164513|18830627|P3|Overall Study|Other: Study Closed or terminated|4
5449617|NCT02164513|18830628|P2|Overall Study|Other: Study Closed or terminated|2
5449618|NCT02164513|18830629|P1|Overall Study|Other: Study Closed or terminated|5
5449619|NCT02164513|18830627|P3|Overall Study|Adverse Event|111
5449620|NCT02164513|18830628|P2|Overall Study|Adverse Event|180
5449621|NCT02164513|18830629|P1|Overall Study|Adverse Event|162
5449622|NCT02164383|18830666|P2|Overall Study|Lost to Follow-up|0
5449623|NCT02164383|18830667|P1|Overall Study|Lost to Follow-up|1
5449624|NCT02164318|18830677|P4|Overall Study|Withdrawal by Subject|1
5449625|NCT02164318|18830678|P3|Overall Study|Withdrawal by Subject|0
5449626|NCT02164318|18830679|P2|Overall Study|Withdrawal by Subject|1
5449627|NCT02164318|18830680|P1|Overall Study|Withdrawal by Subject|0
5449628|NCT02163993|18830715|P5|Post-treatment Period|Withdrawal by Subject|2
5449629|NCT02163993|18830716|P4|Post-treatment Period|Withdrawal by Subject|1
5449630|NCT02163993|18830717|P3|Post-treatment Period|Withdrawal by Subject|0
5449631|NCT02163993|18830718|P2|Post-treatment Period|Withdrawal by Subject|4
5449632|NCT02163993|18830719|P1|Post-treatment Period|Withdrawal by Subject|2
5449633|NCT02163993|18830715|P5|Post-treatment Period|Protocol Violation|1
5449634|NCT02163993|18830716|P4|Post-treatment Period|Protocol Violation|0
5449635|NCT02163993|18830717|P3|Post-treatment Period|Protocol Violation|0
5449636|NCT02163993|18830718|P2|Post-treatment Period|Protocol Violation|0
5449637|NCT02163993|18830719|P1|Post-treatment Period|Protocol Violation|0
5449638|NCT02163993|18830715|P5|Post-treatment Period|Lost to Follow-up|0
5449639|NCT02163993|18830716|P4|Post-treatment Period|Lost to Follow-up|1
5449640|NCT02163993|18830717|P3|Post-treatment Period|Lost to Follow-up|3
5449641|NCT02163993|18830718|P2|Post-treatment Period|Lost to Follow-up|2
5449642|NCT02163993|18830719|P1|Post-treatment Period|Lost to Follow-up|2
5449643|NCT02163993|18830715|P5|Post-treatment Period|Adverse Event|0
5449644|NCT02163993|18830716|P4|Post-treatment Period|Adverse Event|0
5449645|NCT02163993|18830717|P3|Post-treatment Period|Adverse Event|1
5449646|NCT02163993|18830718|P2|Post-treatment Period|Adverse Event|0
5449647|NCT02163993|18830719|P1|Post-treatment Period|Adverse Event|0
5449648|NCT02163993|18830715|P5|Treatment Period|Not treated|2
5449649|NCT02163993|18830716|P4|Treatment Period|Not treated|1
5449650|NCT02163993|18830717|P3|Treatment Period|Not treated|0
5449651|NCT02163993|18830718|P2|Treatment Period|Not treated|0
5449652|NCT02163993|18830719|P1|Treatment Period|Not treated|1
5449653|NCT02163993|18830715|P5|Treatment Period|Withdrawal by Subject|1
5449654|NCT02163993|18830716|P4|Treatment Period|Withdrawal by Subject|4
5449655|NCT02163993|18830717|P3|Treatment Period|Withdrawal by Subject|1
5449656|NCT02163993|18830718|P2|Treatment Period|Withdrawal by Subject|4
5449657|NCT02163993|18830719|P1|Treatment Period|Withdrawal by Subject|6
5449658|NCT02163993|18830715|P5|Treatment Period|Protocol Violation|2
5449659|NCT02163993|18830716|P4|Treatment Period|Protocol Violation|1
5449660|NCT02163993|18830717|P3|Treatment Period|Protocol Violation|0
5449661|NCT02163993|18830718|P2|Treatment Period|Protocol Violation|1
5449662|NCT02163993|18830719|P1|Treatment Period|Protocol Violation|2
5449663|NCT02163993|18830715|P5|Treatment Period|Physician Decision|0
5449664|NCT02163993|18830716|P4|Treatment Period|Physician Decision|0
5449665|NCT02163993|18830717|P3|Treatment Period|Physician Decision|0
5449666|NCT02163993|18830718|P2|Treatment Period|Physician Decision|0
5449667|NCT02163993|18830719|P1|Treatment Period|Physician Decision|1
5449668|NCT02163993|18830715|P5|Treatment Period|Lost to Follow-up|1
5449669|NCT02163993|18830716|P4|Treatment Period|Lost to Follow-up|3
5449670|NCT02163993|18830717|P3|Treatment Period|Lost to Follow-up|1
5449671|NCT02163993|18830718|P2|Treatment Period|Lost to Follow-up|3
5449672|NCT02163993|18830719|P1|Treatment Period|Lost to Follow-up|2
5449673|NCT02163993|18830715|P5|Treatment Period|Adverse Event|1
5449674|NCT02163993|18830716|P4|Treatment Period|Adverse Event|0
5449675|NCT02163993|18830717|P3|Treatment Period|Adverse Event|0
5449676|NCT02163993|18830718|P2|Treatment Period|Adverse Event|1
5449677|NCT02163993|18830719|P1|Treatment Period|Adverse Event|0
5449678|NCT02163915|18830822|P5|Overall Study|Physician Decision|0
5449679|NCT02163915|18830823|P4|Overall Study|Physician Decision|1
5449680|NCT02163915|18830824|P3|Overall Study|Physician Decision|0
5449681|NCT02163915|18830825|P2|Overall Study|Physician Decision|0
5449682|NCT02163915|18830826|P1|Overall Study|Physician Decision|0
5449683|NCT02163915|18830822|P5|Overall Study|Study termination|2
5449684|NCT02163915|18830823|P4|Overall Study|Study termination|0
5449685|NCT02163915|18830824|P3|Overall Study|Study termination|0
5449686|NCT02163915|18830825|P2|Overall Study|Study termination|0
5449687|NCT02163915|18830826|P1|Overall Study|Study termination|1
5449688|NCT02163915|18830822|P5|Overall Study|Withdrawal by Subject|2
5449689|NCT02163915|18830823|P4|Overall Study|Withdrawal by Subject|2
5449690|NCT02163915|18830824|P3|Overall Study|Withdrawal by Subject|2
5449691|NCT02163915|18830825|P2|Overall Study|Withdrawal by Subject|0
5449692|NCT02163915|18830826|P1|Overall Study|Withdrawal by Subject|2
5449693|NCT02163902|18830881|P2|Overall Study|Administrative Decision|2
5449694|NCT02163902|18830882|P1|Overall Study|Administrative Decision|2
5449695|NCT02163902|18830881|P2|Overall Study|Lost to Follow-up|7
5449696|NCT02163902|18830882|P1|Overall Study|Lost to Follow-up|6
5449697|NCT02163902|18830881|P2|Overall Study|Subject's Request|4
5449698|NCT02163902|18830882|P1|Overall Study|Subject's Request|3
5449699|NCT02163733|18830959|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
5449700|NCT02163733|18830960|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
5449701|NCT02163733|18830961|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
5449702|NCT02163733|18830959|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
5449703|NCT02163733|18830960|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
5449704|NCT02163733|18830961|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
5449705|NCT02163538|18831063|P2|Overall Study|Physician Decision|1
5449706|NCT02163538|18831064|P1|Overall Study|Physician Decision|0
5449707|NCT02163538|18831063|P2|Overall Study|Protocol Violation|0
5449708|NCT02163538|18831064|P1|Overall Study|Protocol Violation|1
5449709|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Various reasons|16
5449710|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
5449711|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Subject Compliance|17
5449712|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Death|8
5449713|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Protocol Violation|2
5449714|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
5449715|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Physician Decision|8
5449716|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
5449717|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
5449718|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
5449719|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Hypokalemia|9
5449720|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
5449721|NCT02163499|18831080|P1|Extended Dosing Phase: ZS|Adverse Event|51
5449722|NCT02163499|18831080|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
5449723|NCT02163499|18831080|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
5449724|NCT02163499|18831080|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
5449725|NCT02163499|18831080|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
5449726|NCT02163499|18831080|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
5449727|NCT02163447|18831108|P3|Overall Study|Became HIV infected at time of delivery|0
5449892|NCT02160626|18831863|P1|Overall Study|Adverse Event|1
5449728|NCT02163447|18831109|P2|Overall Study|Became HIV infected at time of delivery|0
5449729|NCT02163447|18831110|P1|Overall Study|Became HIV infected at time of delivery|1
5449730|NCT02163447|18831108|P3|Overall Study|Moved out of study area|2
5449731|NCT02163447|18831109|P2|Overall Study|Moved out of study area|3
5449732|NCT02163447|18831110|P1|Overall Study|Moved out of study area|2
5449733|NCT02163447|18831108|P3|Overall Study|Lost to Follow-up|0
5449734|NCT02163447|18831109|P2|Overall Study|Lost to Follow-up|3
5449735|NCT02163447|18831110|P1|Overall Study|Lost to Follow-up|1
5449736|NCT02163447|18831108|P3|Overall Study|Withdrawal by Subject|1
5449737|NCT02163447|18831109|P2|Overall Study|Withdrawal by Subject|0
5449738|NCT02163447|18831110|P1|Overall Study|Withdrawal by Subject|2
5449739|NCT02163395|18831185|P1|Overall Study|Adverse Event|1
5449740|NCT02163395|18831185|P1|Overall Study|Lost to Follow-up|3
5449741|NCT02163395|18831185|P1|Overall Study|Withdrawal by Subject|1
5449742|NCT02163187|18831194|P2|Overall Study|Progressive disease|0
5449743|NCT02163187|18831195|P1|Overall Study|Progressive disease|1
5449744|NCT02163187|18831194|P2|Overall Study|Device removed|0
5449745|NCT02163187|18831195|P1|Overall Study|Device removed|1
5449746|NCT02163057|18831205|P2|Overall Study|Progression of Disease|2
5449747|NCT02163057|18831206|P1|Overall Study|Progression of Disease|1
5449748|NCT02163057|18831205|P2|Overall Study|Participant Significant Noncompliance|1
5449749|NCT02163057|18831206|P1|Overall Study|Participant Significant Noncompliance|0
5449750|NCT02163057|18831205|P2|Overall Study|Participant Refusal to Continue|2
5449751|NCT02163057|18831206|P1|Overall Study|Participant Refusal to Continue|2
5449752|NCT02162862|18831253|P3|Overall Study|Subject did not feel the med was needed|4
5449753|NCT02162862|18831254|P2|Overall Study|Subject did not feel the med was needed|0
5449754|NCT02162862|18831255|P1|Overall Study|Subject did not feel the med was needed|0
5449755|NCT02162862|18831253|P3|Overall Study|Lost to Follow-up|0
5449756|NCT02162862|18831254|P2|Overall Study|Lost to Follow-up|11
5449757|NCT02162862|18831255|P1|Overall Study|Lost to Follow-up|0
5449758|NCT02162771|18831268|P2|Maintenance Study Period (Part 2)|Stable Disease|1
5449759|NCT02162771|18831269|P1|Maintenance Study Period (Part 2)|Stable Disease|0
5449760|NCT02162771|18831268|P2|Maintenance Study Period (Part 2)|Protocol Violation|1
5449761|NCT02162771|18831269|P1|Maintenance Study Period (Part 2)|Protocol Violation|0
5449762|NCT02162771|18831268|P2|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
5449763|NCT02162771|18831269|P1|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
5449764|NCT02162771|18831268|P2|Maintenance Study Period (Part 2)|Death|1
5449765|NCT02162771|18831269|P1|Maintenance Study Period (Part 2)|Death|2
5449766|NCT02162771|18831268|P2|Maintenance Study Period (Part 2)|Adverse Event|3
5449767|NCT02162771|18831269|P1|Maintenance Study Period (Part 2)|Adverse Event|3
5449768|NCT02162771|18831268|P2|Maintenance Study Period (Part 2)|Progressive Disease|13
5449769|NCT02162771|18831269|P1|Maintenance Study Period (Part 2)|Progressive Disease|11
5449770|NCT02162771|18831268|P2|Core Study Period (Part 2)|Death|0
5449771|NCT02162771|18831269|P1|Core Study Period (Part 2)|Death|1
5449772|NCT02162771|18831268|P2|Core Study Period (Part 2)|Physician Decision|2
5449773|NCT02162771|18831269|P1|Core Study Period (Part 2)|Physician Decision|0
5449774|NCT02162771|18831268|P2|Core Study Period (Part 2)|Withdrawal by Subject|2
5449775|NCT02162771|18831269|P1|Core Study Period (Part 2)|Withdrawal by Subject|1
5449776|NCT02162771|18831268|P2|Core Study Period (Part 2)|Adverse Event|1
5449777|NCT02162771|18831269|P1|Core Study Period (Part 2)|Adverse Event|4
5449778|NCT02162771|18831268|P2|Core Study Period (Part 2)|Progressive Disease|3
5449779|NCT02162771|18831269|P1|Core Study Period (Part 2)|Progressive Disease|2
5449780|NCT02162758|18831283|P2|Overall Study|Study termination|1
5449781|NCT02162758|18831284|P1|Overall Study|Study termination|0
5449782|NCT02161757|18831419|P3|Treatment Through Study Completion|Death|1
5449783|NCT02161757|18831420|P2|Treatment Through Study Completion|Death|1
5449784|NCT02161757|18831421|P1|Treatment Through Study Completion|Death|2
5449785|NCT02161757|18831419|P3|Treatment Through Study Completion|Other|12
5449786|NCT02161757|18831420|P2|Treatment Through Study Completion|Other|19
5449787|NCT02161757|18831421|P1|Treatment Through Study Completion|Other|20
5449788|NCT02161757|18831419|P3|Treatment Through Study Completion|Lost to Follow-up|4
5449789|NCT02161757|18831420|P2|Treatment Through Study Completion|Lost to Follow-up|2
5449790|NCT02161757|18831421|P1|Treatment Through Study Completion|Lost to Follow-up|7
5449791|NCT02161757|18831419|P3|Treatment Through Study Completion|Withdrawal by Subject|20
5449792|NCT02161757|18831420|P2|Treatment Through Study Completion|Withdrawal by Subject|19
5449793|NCT02161757|18831421|P1|Treatment Through Study Completion|Withdrawal by Subject|27
5449794|NCT02161757|18831419|P3|Treatment Through Study Completion|Protocol Violation|2
5449795|NCT02161757|18831420|P2|Treatment Through Study Completion|Protocol Violation|1
5449796|NCT02161757|18831421|P1|Treatment Through Study Completion|Protocol Violation|0
5449797|NCT02161757|18831419|P3|Treatment Through Study Completion|Adverse Event|0
5449798|NCT02161757|18831420|P2|Treatment Through Study Completion|Adverse Event|1
5449799|NCT02161757|18831421|P1|Treatment Through Study Completion|Adverse Event|1
5449800|NCT02161757|18831419|P3|Randomised Through Start Treatment|Did not receive treatment|0
5449801|NCT02161757|18831420|P2|Randomised Through Start Treatment|Did not receive treatment|2
5449802|NCT02161757|18831421|P1|Randomised Through Start Treatment|Did not receive treatment|3
5449803|NCT02161731|18831479|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
5449804|NCT02161731|18831480|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
5449805|NCT02161731|18831479|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
5449806|NCT02161731|18831480|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
5449807|NCT02161575|18831508|P1|Overall Study|Adverse Event|2
5449808|NCT02161575|18831508|P1|Overall Study|Lack of Efficacy|1
5449809|NCT02161575|18831508|P1|Overall Study|Protocol Violation|8
5449810|NCT02161562|18831528|P2|Overall Study|Participant moved out of province|0
5449811|NCT02161562|18831529|P1|Overall Study|Participant moved out of province|1
5449812|NCT02161562|18831528|P2|Overall Study|Withdrew due to being out of the country|0
5449813|NCT02161562|18831529|P1|Overall Study|Withdrew due to being out of the country|1
5449814|NCT02161562|18831528|P2|Overall Study|Participant moved back to home country|0
5449815|NCT02161562|18831529|P1|Overall Study|Participant moved back to home country|1
5449816|NCT02161562|18831528|P2|Overall Study|Adverse Event|1
5449817|NCT02161562|18831529|P1|Overall Study|Adverse Event|1
5449818|NCT02161562|18831528|P2|Overall Study|Lack of Efficacy|1
5449819|NCT02161562|18831529|P1|Overall Study|Lack of Efficacy|4
5449820|NCT02161562|18831528|P2|Overall Study|Lost to Follow-up|1
5449821|NCT02161562|18831529|P1|Overall Study|Lost to Follow-up|3
5449822|NCT02161562|18831528|P2|Overall Study|Pregnancy|2
5449823|NCT02161562|18831529|P1|Overall Study|Pregnancy|1
5449824|NCT02161562|18831528|P2|Overall Study|Protocol Violation|4
5449825|NCT02161562|18831529|P1|Overall Study|Protocol Violation|9
5449826|NCT02161562|18831528|P2|Overall Study|Withdrawal by Subject|8
5449827|NCT02161562|18831529|P1|Overall Study|Withdrawal by Subject|5
5449828|NCT02161549|18831557|P2|Overall Study|Physician Decision|2
5449829|NCT02161549|18831558|P1|Overall Study|Physician Decision|6
5449830|NCT02161458|18831606|P4|Overall Study|Lost to Follow-up|0
5449831|NCT02161458|18831607|P3|Overall Study|Lost to Follow-up|1
5449832|NCT02161458|18831608|P2|Overall Study|Lost to Follow-up|2
5449833|NCT02161458|18831609|P1|Overall Study|Lost to Follow-up|0
5449834|NCT02161458|18831606|P4|Overall Study|Withdrawal by Subject|0
5449835|NCT02161458|18831607|P3|Overall Study|Withdrawal by Subject|4
5449836|NCT02161458|18831608|P2|Overall Study|Withdrawal by Subject|4
5449837|NCT02161458|18831609|P1|Overall Study|Withdrawal by Subject|0
5449838|NCT02161406|18831621|P2|Overall Study|relocation|1
5449839|NCT02161406|18831622|P1|Overall Study|relocation|0
5449840|NCT02161406|18831621|P2|Overall Study|Lack of Efficacy|1
5449841|NCT02161406|18831622|P1|Overall Study|Lack of Efficacy|1
5449842|NCT02161406|18831621|P2|Overall Study|investigator withdrew subject|1
5449843|NCT02161406|18831622|P1|Overall Study|investigator withdrew subject|3
5449844|NCT02161406|18831621|P2|Overall Study|Withdrawal by Subject|4
5449845|NCT02161406|18831622|P1|Overall Study|Withdrawal by Subject|2
5449846|NCT02161406|18831621|P2|Overall Study|Lost to Follow-up|1
5449847|NCT02161406|18831622|P1|Overall Study|Lost to Follow-up|2
5449848|NCT02161406|18831621|P2|Overall Study|Death|1
5449849|NCT02161406|18831622|P1|Overall Study|Death|2
5449850|NCT02161185|18831696|P1|Treatment Phase|Administrative/Other|7
5449851|NCT02161146|18831706|P5|Overall Study|Other Miscellaneous Reasons|0
5449852|NCT02161146|18831707|P4|Overall Study|Other Miscellaneous Reasons|0
5449853|NCT02161146|18831708|P3|Overall Study|Other Miscellaneous Reasons|0
5449854|NCT02161146|18831709|P2|Overall Study|Other Miscellaneous Reasons|1
5449855|NCT02161146|18831710|P1|Overall Study|Other Miscellaneous Reasons|0
5449856|NCT02161146|18831706|P5|Overall Study|Personal Reasons|1
5449857|NCT02161146|18831707|P4|Overall Study|Personal Reasons|2
5449858|NCT02161146|18831708|P3|Overall Study|Personal Reasons|0
5449859|NCT02161146|18831709|P2|Overall Study|Personal Reasons|1
5449860|NCT02161146|18831710|P1|Overall Study|Personal Reasons|0
5449861|NCT02161146|18831706|P5|Overall Study|Lost to Follow-up|0
5449862|NCT02161146|18831707|P4|Overall Study|Lost to Follow-up|0
5449863|NCT02161146|18831708|P3|Overall Study|Lost to Follow-up|0
5449864|NCT02161146|18831709|P2|Overall Study|Lost to Follow-up|1
5449865|NCT02161146|18831710|P1|Overall Study|Lost to Follow-up|0
5449866|NCT02161146|18831706|P5|Overall Study|Adverse Event|0
5449867|NCT02161146|18831707|P4|Overall Study|Adverse Event|1
5449868|NCT02161146|18831708|P3|Overall Study|Adverse Event|0
5449869|NCT02161146|18831709|P2|Overall Study|Adverse Event|1
5449870|NCT02161146|18831710|P1|Overall Study|Adverse Event|1
5449871|NCT02161016|18831746|P1|Overall Study|withdrawn by IRB|1
5449872|NCT02160977|18831777|P2|Six Months After Surgery|Lost to Follow-up|1
5449873|NCT02160977|18831778|P1|Six Months After Surgery|Lost to Follow-up|2
5449874|NCT02160977|18831777|P2|Three Months After Surgery|Lost to Follow-up|2
5449875|NCT02160977|18831778|P1|Three Months After Surgery|Lost to Follow-up|0
5449876|NCT02160977|18831777|P2|Six Weeks After Surgery|Lost to Follow-up|0
5449877|NCT02160977|18831778|P1|Six Weeks After Surgery|Lost to Follow-up|1
5449878|NCT02160899|18831794|P6|Overall Study|Adverse Event or Serious Adverse Event|0
5449879|NCT02160899|18831795|P5|Overall Study|Adverse Event or Serious Adverse Event|2
5449880|NCT02160899|18831796|P4|Overall Study|Adverse Event or Serious Adverse Event|1
5449881|NCT02160899|18831797|P3|Overall Study|Adverse Event or Serious Adverse Event|0
5449882|NCT02160899|18831798|P2|Overall Study|Adverse Event or Serious Adverse Event|1
5449883|NCT02160899|18831799|P1|Overall Study|Adverse Event or Serious Adverse Event|0
5449884|NCT02160626|18831861|P3|Overall Study|Withdrawal by Subject|0
5449885|NCT02160626|18831862|P2|Overall Study|Withdrawal by Subject|1
5449886|NCT02160626|18831863|P1|Overall Study|Withdrawal by Subject|0
5449887|NCT02160626|18831861|P3|Overall Study|Schedule not conducive to study visits|1
5449888|NCT02160626|18831862|P2|Overall Study|Schedule not conducive to study visits|0
5449889|NCT02160626|18831863|P1|Overall Study|Schedule not conducive to study visits|0
5449890|NCT02160626|18831861|P3|Overall Study|Adverse Event|0
5449891|NCT02160626|18831862|P2|Overall Study|Adverse Event|0
5449893|NCT02160314|18831886|P2|Overall Study|Lost to Follow-up|1
5449894|NCT02160314|18831887|P1|Overall Study|Lost to Follow-up|0
5449895|NCT02160314|18831886|P2|Overall Study|Withdrawal by Subject|2
5449896|NCT02160314|18831887|P1|Overall Study|Withdrawal by Subject|1
5449897|NCT02160314|18831886|P2|Overall Study|Protocol Violation|4
5449898|NCT02160314|18831887|P1|Overall Study|Protocol Violation|0
5449899|NCT02160314|18831886|P2|Overall Study|Adverse Event|6
5449900|NCT02160314|18831887|P1|Overall Study|Adverse Event|0
5449901|NCT02160145|18831922|P3|Randomized Double-blind Period|Physician Decision|5
5449902|NCT02160145|18831923|P2|Randomized Double-blind Period|Physician Decision|7
5449903|NCT02160145|18831924|P1|Randomized Double-blind Period|Physician Decision|0
5449904|NCT02160145|18831922|P3|Randomized Double-blind Period|Lost to Follow-up|3
5449905|NCT02160145|18831923|P2|Randomized Double-blind Period|Lost to Follow-up|1
5449906|NCT02160145|18831924|P1|Randomized Double-blind Period|Lost to Follow-up|0
5449907|NCT02160145|18831922|P3|Randomized Double-blind Period|Subject decision|20
5449908|NCT02160145|18831923|P2|Randomized Double-blind Period|Subject decision|21
5449909|NCT02160145|18831924|P1|Randomized Double-blind Period|Subject decision|0
5449910|NCT02160145|18831922|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
5449911|NCT02160145|18831923|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
5449912|NCT02160145|18831924|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
5449913|NCT02160145|18831922|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
5449914|NCT02160145|18831923|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
5449915|NCT02160145|18831924|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
5449916|NCT02160041|18831937|P1|Overall Study|study terminated by by sponsor|1
5449917|NCT02160041|18831937|P1|Overall Study|Withdrawal by Subject|8
5449918|NCT02160041|18831937|P1|Overall Study|Physician Decision|3
5449919|NCT02160041|18831937|P1|Overall Study|non-compliance with study|1
5449920|NCT02160041|18831937|P1|Overall Study|Protocol Violation|1
5449921|NCT02160041|18831937|P1|Overall Study|disease progression|57
5449922|NCT02160041|18831937|P1|Overall Study|Death|2
5449923|NCT02160041|18831937|P1|Overall Study|Adverse Event|11
5449924|NCT02160002|18831949|P2|Overall Study|Withdrawal by Subject|1
5449925|NCT02160002|18831950|P1|Overall Study|Withdrawal by Subject|2
5449926|NCT02159950|18831997|P2|Overall Study|Progression|1
5449927|NCT02159950|18831998|P1|Overall Study|Progression|0
5449928|NCT02159950|18831997|P2|Overall Study|Adverse Event|1
5449929|NCT02159950|18831998|P1|Overall Study|Adverse Event|0
5449930|NCT02159807|18832057|P3|Overall Study|elevated blood pressure|1
5449931|NCT02159807|18832058|P2|Overall Study|elevated blood pressure|0
5449932|NCT02159807|18832059|P1|Overall Study|elevated blood pressure|0
5449933|NCT02159807|18832057|P3|Overall Study|No CSF|1
5449934|NCT02159807|18832058|P2|Overall Study|No CSF|1
5449935|NCT02159807|18832059|P1|Overall Study|No CSF|1
5449936|NCT02159807|18832057|P3|Overall Study|Adverse Event|1
5449937|NCT02159807|18832058|P2|Overall Study|Adverse Event|0
5449938|NCT02159807|18832059|P1|Overall Study|Adverse Event|0
5449939|NCT02159729|18832080|P2|Overall Study|Other Unspecified|1
5449940|NCT02159729|18832081|P1|Overall Study|Other Unspecified|3
5449941|NCT02159729|18832080|P2|Overall Study|Non compliance|0
5449942|NCT02159729|18832081|P1|Overall Study|Non compliance|2
5449943|NCT02159729|18832080|P2|Overall Study|Lost to Follow-up|9
5449944|NCT02159729|18832081|P1|Overall Study|Lost to Follow-up|24
5449945|NCT02159729|18832080|P2|Overall Study|Subject's Request|10
5449946|NCT02159729|18832081|P1|Overall Study|Subject's Request|13
5449947|NCT02159729|18832080|P2|Overall Study|Adverse Event|1
5449948|NCT02159729|18832081|P1|Overall Study|Adverse Event|0
5449949|NCT02159521|18832108|P1|Overall Study|Other than specified|1
5449950|NCT02159521|18832108|P1|Overall Study|Death|1
5449951|NCT02159521|18832108|P1|Overall Study|Lost to Follow-up|6
5449952|NCT02159521|18832108|P1|Overall Study|Withdrawal by Subject|7
5449953|NCT02159521|18832108|P1|Overall Study|Enrolled but not treated|3
5449954|NCT02159482|18832129|P1|Overall Study|Physician Decision|3
5449955|NCT02159482|18832129|P1|Overall Study|Withdrawal by Subject|2
5449956|NCT02159469|18832134|P1|Overall Study|Multiple|29
5449957|NCT02159469|18832134|P1|Overall Study|Other|1
5449958|NCT02159469|18832134|P1|Overall Study|Met Stopping Criteria|3
5449959|NCT02159469|18832134|P1|Overall Study|Sponsor's request|2
5449960|NCT02159469|18832134|P1|Overall Study|Lost to Follow-up|1
5449961|NCT02159469|18832134|P1|Overall Study|Withdrawal by Subject|9
5449962|NCT02159469|18832134|P1|Overall Study|Non-compliance|2
5449963|NCT02159469|18832134|P1|Overall Study|Adverse Event|5
5449964|NCT02159469|18832134|P1|Overall Study|Missing Completion status|1
5449965|NCT02159365|18832139|P1|Overall Study|Lost to Follow-up|1
5449966|NCT02159365|18832139|P1|Overall Study|Death|1
5449967|NCT02159365|18832139|P1|Overall Study|Subject withdrew consent|3
5449968|NCT02159365|18832139|P1|Overall Study|Subject request to discontinue treatment|3
5449969|NCT02159365|18832139|P1|Overall Study|Maximum clinical benefit|3
5449970|NCT02159365|18832139|P1|Overall Study|Study drug toxicity|7
5449971|NCT02159365|18832139|P1|Overall Study|Adverse Event unrelated to study drug|9
5449972|NCT02159365|18832139|P1|Overall Study|Administrative reason by Sponsor|9
5449973|NCT02159365|18832139|P1|Overall Study|Other reasons|11
5449974|NCT02159365|18832139|P1|Overall Study|Disease Progression|23
5449975|NCT02159352|18832146|P2|Overall Study|Withdrawal by Subject|1
5449976|NCT02159352|18832147|P1|Overall Study|Withdrawal by Subject|0
5449977|NCT02159352|18832146|P2|Overall Study|Adverse Event|1
5449978|NCT02159352|18832147|P1|Overall Study|Adverse Event|3
5449979|NCT02159183|18832199|P2|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
5449980|NCT02159183|18832200|P1|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
5449981|NCT02159183|18832199|P2|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
5449982|NCT02159183|18832200|P1|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
5449983|NCT02159183|18832199|P2|Analysis After the 36 Months Follow-up|Death|1
5449984|NCT02159183|18832200|P1|Analysis After the 36 Months Follow-up|Death|0
5449985|NCT02159183|18832199|P2|Analysis After the 36 Months Follow-up|Adverse Event|0
5449986|NCT02159183|18832200|P1|Analysis After the 36 Months Follow-up|Adverse Event|1
5449987|NCT02159183|18832199|P2|Analysis After the 36 Months Follow-up|Protocol Violation|1
5449988|NCT02159183|18832200|P1|Analysis After the 36 Months Follow-up|Protocol Violation|2
5449989|NCT02159053|18832273|P3|Overall Study|Participants/guardian decision|6
5449990|NCT02159053|18832274|P2|Overall Study|Participants/guardian decision|10
5449991|NCT02159053|18832275|P1|Overall Study|Participants/guardian decision|8
5449992|NCT02159053|18832273|P3|Overall Study|Adverse Event|5
5449993|NCT02159053|18832274|P2|Overall Study|Adverse Event|6
5449994|NCT02159053|18832275|P1|Overall Study|Adverse Event|7
5449995|NCT02159053|18832273|P3|Overall Study|Lack of Efficacy|7
5449996|NCT02159053|18832274|P2|Overall Study|Lack of Efficacy|4
5449997|NCT02159053|18832275|P1|Overall Study|Lack of Efficacy|3
5449998|NCT02159053|18832273|P3|Overall Study|Physician Decision|1
5449999|NCT02159053|18832274|P2|Overall Study|Physician Decision|1
5450000|NCT02159053|18832275|P1|Overall Study|Physician Decision|0
5450001|NCT02159053|18832273|P3|Overall Study|Death|1
5450002|NCT02159053|18832274|P2|Overall Study|Death|0
5450003|NCT02159053|18832275|P1|Overall Study|Death|2
5450004|NCT02159040|18832312|P1|Overall Study|Death|1
5450005|NCT02158975|18832325|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
5450006|NCT02158949|18832335|P2|Overall Study|Lost to Follow-up|11
5450007|NCT02158949|18832336|P1|Overall Study|Lost to Follow-up|5
5450008|NCT02158949|18832335|P2|Overall Study|Withdrawal by Subject|0
5450009|NCT02158949|18832336|P1|Overall Study|Withdrawal by Subject|1
5450010|NCT02158936|18832352|P2|Overall Study|Lost to Follow-up|1
5450011|NCT02158936|18832353|P1|Overall Study|Lost to Follow-up|0
5450012|NCT02158936|18832352|P2|Overall Study|Physician Decision|13
5450013|NCT02158936|18832353|P1|Overall Study|Physician Decision|15
5450014|NCT02158936|18832352|P2|Overall Study|Withdrawal by Subject|16
5450015|NCT02158936|18832353|P1|Overall Study|Withdrawal by Subject|15
5450016|NCT02158936|18832352|P2|Overall Study|Adverse Event|24
5450017|NCT02158936|18832353|P1|Overall Study|Adverse Event|39
5450018|NCT02158936|18832352|P2|Overall Study|Azacitidine tx discontinued|46
5450019|NCT02158936|18832353|P1|Overall Study|Azacitidine tx discontinued|53
5450020|NCT02158936|18832352|P2|Overall Study|Study closed/ terminated|77
5450021|NCT02158936|18832353|P1|Overall Study|Study closed/ terminated|57
5450022|NCT02158884|18832395|P1|12 Month Assessment|Missed SMFA|17
5450023|NCT02158884|18832395|P1|6 Month Assessment|Missed SMFA|20
5450024|NCT02158884|18832395|P1|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
5450025|NCT02158884|18832395|P1|Intervention: IDEO and PT Program|Did not complete PT intervention|6
5450026|NCT02158884|18832395|P1|Baseline Assessment|Missed SMFA|1
5450027|NCT02158884|18832395|P1|Baseline Assessment|Missed performance assessment|3
5450028|NCT02158806|18832430|P2|Overall Study|Transferred to palliative care|1
5450029|NCT02158806|18832431|P1|Overall Study|Transferred to palliative care|0
5450030|NCT02158806|18832430|P2|Overall Study|Moved out of area|1
5450031|NCT02158806|18832431|P1|Overall Study|Moved out of area|0
5450032|NCT02158806|18832430|P2|Overall Study|Lost to Follow-up|3
5450033|NCT02158806|18832431|P1|Overall Study|Lost to Follow-up|0
5450034|NCT02158806|18832430|P2|Overall Study|Withdrawal by Subject|0
5450035|NCT02158806|18832431|P1|Overall Study|Withdrawal by Subject|2
5450036|NCT02158806|18832430|P2|Overall Study|Death|0
5450037|NCT02158806|18832431|P1|Overall Study|Death|2
5450038|NCT02158728|18832451|P1|Overall Study|no qualified dataset|24
5450039|NCT02158728|18832451|P1|Overall Study|no procedure according to CIP done|3
5450040|NCT02158663|18832457|P2|Overall Study|Withdrawal by Subject|4
5450041|NCT02158663|18832458|P1|Overall Study|Withdrawal by Subject|5
5450042|NCT02158546|18832481|P4|Overall Study|Site Excluded|4
5450043|NCT02158546|18832482|P3|Overall Study|Site Excluded|3
5450044|NCT02158546|18832483|P2|Overall Study|Site Excluded|5
5450045|NCT02158546|18832484|P1|Overall Study|Site Excluded|5
5450046|NCT02158546|18832481|P4|Overall Study|Lost to Follow-up|1
5450047|NCT02158546|18832482|P3|Overall Study|Lost to Follow-up|0
5450048|NCT02158546|18832483|P2|Overall Study|Lost to Follow-up|4
5450049|NCT02158546|18832484|P1|Overall Study|Lost to Follow-up|5
5450050|NCT02158546|18832481|P4|Overall Study|Withdrawal by Subject|0
5450051|NCT02158546|18832482|P3|Overall Study|Withdrawal by Subject|1
5450052|NCT02158546|18832483|P2|Overall Study|Withdrawal by Subject|2
5450053|NCT02158546|18832484|P1|Overall Study|Withdrawal by Subject|6
5450054|NCT02158546|18832481|P4|Overall Study|Adverse Event|0
5450055|NCT02158546|18832482|P3|Overall Study|Adverse Event|0
5450056|NCT02158546|18832483|P2|Overall Study|Adverse Event|2
5450057|NCT02158546|18832484|P1|Overall Study|Adverse Event|2
5450058|NCT02158546|18832481|P4|Overall Study|Lack of Efficacy|0
5450059|NCT02158546|18832482|P3|Overall Study|Lack of Efficacy|0
5450060|NCT02158546|18832483|P2|Overall Study|Lack of Efficacy|1
5450061|NCT02158546|18832484|P1|Overall Study|Lack of Efficacy|1
5450062|NCT02158546|18832481|P4|Overall Study|Failure to meet eligibility criteria|0
5450063|NCT02158546|18832482|P3|Overall Study|Failure to meet eligibility criteria|0
5450064|NCT02158546|18832483|P2|Overall Study|Failure to meet eligibility criteria|1
5450065|NCT02158546|18832484|P1|Overall Study|Failure to meet eligibility criteria|0
5450066|NCT02158546|18832481|P4|Overall Study|Non-compliance|1
5450067|NCT02158546|18832482|P3|Overall Study|Non-compliance|0
5450068|NCT02158546|18832483|P2|Overall Study|Non-compliance|1
5450069|NCT02158546|18832484|P1|Overall Study|Non-compliance|0
5450070|NCT02158546|18832481|P4|Overall Study|Physician Decision|0
5450071|NCT02158546|18832482|P3|Overall Study|Physician Decision|0
5450072|NCT02158546|18832483|P2|Overall Study|Physician Decision|1
5450073|NCT02158546|18832484|P1|Overall Study|Physician Decision|0
5450074|NCT02158533|18832503|P6|Stage 2|Non-adherence with study visits|1
5450075|NCT02158533|18832504|P5|Stage 2|Non-adherence with study visits|0
5450076|NCT02158533|18832505|P4|Stage 2|Non-adherence with study visits|0
5450077|NCT02158533|18832506|P3|Stage 2|Non-adherence with study visits|0
5450078|NCT02158533|18832507|P2|Stage 2|Non-adherence with study visits|0
5450079|NCT02158533|18832508|P1|Stage 2|Non-adherence with study visits|0
5450080|NCT02158533|18832503|P6|Stage 2|Psychiatrist decision to try new tx|0
5450081|NCT02158533|18832504|P5|Stage 2|Psychiatrist decision to try new tx|0
5450082|NCT02158533|18832505|P4|Stage 2|Psychiatrist decision to try new tx|1
5450083|NCT02158533|18832506|P3|Stage 2|Psychiatrist decision to try new tx|0
5450084|NCT02158533|18832507|P2|Stage 2|Psychiatrist decision to try new tx|0
5450085|NCT02158533|18832508|P1|Stage 2|Psychiatrist decision to try new tx|0
5450086|NCT02158533|18832503|P6|Stage 2|Pregnancy|0
5450087|NCT02158533|18832504|P5|Stage 2|Pregnancy|0
5450088|NCT02158533|18832505|P4|Stage 2|Pregnancy|1
5450089|NCT02158533|18832506|P3|Stage 2|Pregnancy|0
5450090|NCT02158533|18832507|P2|Stage 2|Pregnancy|0
5450091|NCT02158533|18832508|P1|Stage 2|Pregnancy|0
5450092|NCT02158533|18832503|P6|Stage 2|Physician Decision|0
5450093|NCT02158533|18832504|P5|Stage 2|Physician Decision|1
5450094|NCT02158533|18832505|P4|Stage 2|Physician Decision|0
5450095|NCT02158533|18832506|P3|Stage 2|Physician Decision|0
5450096|NCT02158533|18832507|P2|Stage 2|Physician Decision|0
5450097|NCT02158533|18832508|P1|Stage 2|Physician Decision|0
5450098|NCT02158533|18832503|P6|Stage 2|Withdrawal by Subject|2
5450099|NCT02158533|18832504|P5|Stage 2|Withdrawal by Subject|1
5450100|NCT02158533|18832505|P4|Stage 2|Withdrawal by Subject|0
5450101|NCT02158533|18832506|P3|Stage 2|Withdrawal by Subject|0
5450102|NCT02158533|18832507|P2|Stage 2|Withdrawal by Subject|0
5450103|NCT02158533|18832508|P1|Stage 2|Withdrawal by Subject|0
5450104|NCT02158533|18832503|P6|Stage 2|Lost to Follow-up|2
5450105|NCT02158533|18832504|P5|Stage 2|Lost to Follow-up|1
5450106|NCT02158533|18832505|P4|Stage 2|Lost to Follow-up|1
5450107|NCT02158533|18832506|P3|Stage 2|Lost to Follow-up|0
5450108|NCT02158533|18832507|P2|Stage 2|Lost to Follow-up|0
5450109|NCT02158533|18832508|P1|Stage 2|Lost to Follow-up|0
5450110|NCT02158533|18832503|P6|Stage 2|Lack of Efficacy|0
5450111|NCT02158533|18832504|P5|Stage 2|Lack of Efficacy|1
5450112|NCT02158533|18832505|P4|Stage 2|Lack of Efficacy|0
5450113|NCT02158533|18832506|P3|Stage 2|Lack of Efficacy|0
5450114|NCT02158533|18832507|P2|Stage 2|Lack of Efficacy|0
5450115|NCT02158533|18832508|P1|Stage 2|Lack of Efficacy|0
5450116|NCT02158533|18832503|P6|Stage 2|Adverse Event|1
5450117|NCT02158533|18832504|P5|Stage 2|Adverse Event|0
5450118|NCT02158533|18832505|P4|Stage 2|Adverse Event|0
5450119|NCT02158533|18832506|P3|Stage 2|Adverse Event|0
5450120|NCT02158533|18832507|P2|Stage 2|Adverse Event|0
5450121|NCT02158533|18832508|P1|Stage 2|Adverse Event|0
5450122|NCT02158533|18832503|P6|Stage 1|Non-compliance with study visits|0
5450123|NCT02158533|18832504|P5|Stage 1|Non-compliance with study visits|0
5450124|NCT02158533|18832505|P4|Stage 1|Non-compliance with study visits|0
5450125|NCT02158533|18832506|P3|Stage 1|Non-compliance with study visits|0
5450126|NCT02158533|18832507|P2|Stage 1|Non-compliance with study visits|0
5450127|NCT02158533|18832508|P1|Stage 1|Non-compliance with study visits|1
5450128|NCT02158533|18832503|P6|Stage 1|Failure to Meet Eligibility Criteria|0
5450129|NCT02158533|18832504|P5|Stage 1|Failure to Meet Eligibility Criteria|0
5450130|NCT02158533|18832505|P4|Stage 1|Failure to Meet Eligibility Criteria|0
5450131|NCT02158533|18832506|P3|Stage 1|Failure to Meet Eligibility Criteria|0
5450132|NCT02158533|18832507|P2|Stage 1|Failure to Meet Eligibility Criteria|1
5450133|NCT02158533|18832508|P1|Stage 1|Failure to Meet Eligibility Criteria|0
5450134|NCT02158533|18832503|P6|Stage 1|Lost to Follow-up|0
5450135|NCT02158533|18832504|P5|Stage 1|Lost to Follow-up|0
5450136|NCT02158533|18832505|P4|Stage 1|Lost to Follow-up|0
5450137|NCT02158533|18832506|P3|Stage 1|Lost to Follow-up|0
5450138|NCT02158533|18832507|P2|Stage 1|Lost to Follow-up|1
5450139|NCT02158533|18832508|P1|Stage 1|Lost to Follow-up|3
5450140|NCT02158533|18832503|P6|Stage 1|Lack of Efficacy|0
5450141|NCT02158533|18832504|P5|Stage 1|Lack of Efficacy|0
5450142|NCT02158533|18832505|P4|Stage 1|Lack of Efficacy|0
5450143|NCT02158533|18832506|P3|Stage 1|Lack of Efficacy|0
5450144|NCT02158533|18832507|P2|Stage 1|Lack of Efficacy|0
5450145|NCT02158533|18832508|P1|Stage 1|Lack of Efficacy|1
5450146|NCT02158533|18832503|P6|Stage 1|Withdrawal by Subject|0
5450147|NCT02158533|18832504|P5|Stage 1|Withdrawal by Subject|0
5450148|NCT02158533|18832505|P4|Stage 1|Withdrawal by Subject|0
5450149|NCT02158533|18832506|P3|Stage 1|Withdrawal by Subject|1
5450150|NCT02158533|18832507|P2|Stage 1|Withdrawal by Subject|2
5450151|NCT02158533|18832508|P1|Stage 1|Withdrawal by Subject|3
5450152|NCT02158533|18832503|P6|Stage 1|Adverse Event|0
5450153|NCT02158533|18832504|P5|Stage 1|Adverse Event|0
5450154|NCT02158533|18832505|P4|Stage 1|Adverse Event|0
5450155|NCT02158533|18832506|P3|Stage 1|Adverse Event|7
5450156|NCT02158533|18832507|P2|Stage 1|Adverse Event|4
5450157|NCT02158533|18832508|P1|Stage 1|Adverse Event|6
5450158|NCT02158442|18832584|P2|Overall Study|Perfusion staff not available|0
5450159|NCT02158442|18832585|P1|Overall Study|Perfusion staff not available|1
5450160|NCT02158442|18832584|P2|Overall Study|Withdrawal by Subject|0
5450161|NCT02158442|18832585|P1|Overall Study|Withdrawal by Subject|1
5450162|NCT02158364|18832591|P1|Overall Study|Protocol Deviation|50
5450163|NCT02158364|18832591|P1|Overall Study|Case report forms uncollected|10
5450164|NCT02158247|18832609|P1|Overall Study|Invisible vocal cords|5
5450165|NCT02158091|18832628|P3|Overall Study|DLT|0
5450166|NCT02158091|18832629|P2|Overall Study|DLT|1
5450167|NCT02158091|18832630|P1|Overall Study|DLT|2
5450168|NCT02158039|18832638|P1|Overall Study|Screen Failure|9
5450169|NCT02158039|18832638|P1|Overall Study|Withdrawal by Subject|1
5450170|NCT02157948|18832645|P2|Overall Study|Decision by Sponsor|1
5450171|NCT02157948|18832646|P1|Overall Study|Decision by Sponsor|0
5450172|NCT02157948|18832645|P2|Overall Study|Protocol Specified Criteria|1
5450173|NCT02157948|18832646|P1|Overall Study|Protocol Specified Criteria|2
5450174|NCT02157948|18832645|P2|Overall Study|Lost to Follow-up|2
5450175|NCT02157948|18832646|P1|Overall Study|Lost to Follow-up|3
5450176|NCT02157948|18832645|P2|Overall Study|Withdrawal by Subject|5
5450177|NCT02157948|18832646|P1|Overall Study|Withdrawal by Subject|4
5450178|NCT02157935|18832658|P2|Overall Study|Adverse Event|5
5450179|NCT02157935|18832659|P1|Overall Study|Adverse Event|3
5450180|NCT02157935|18832658|P2|Overall Study|Death|4
5450181|NCT02157935|18832659|P1|Overall Study|Death|4
5450182|NCT02157935|18832658|P2|Overall Study|Lack of Efficacy|1
5450183|NCT02157935|18832659|P1|Overall Study|Lack of Efficacy|0
5450184|NCT02157935|18832658|P2|Overall Study|Other|12
5450185|NCT02157935|18832659|P1|Overall Study|Other|5
5450186|NCT02157935|18832658|P2|Overall Study|Progressive disease|2
5450187|NCT02157935|18832659|P1|Overall Study|Progressive disease|0
5450188|NCT02157935|18832658|P2|Overall Study|Protocol Violation|0
5450189|NCT02157935|18832659|P1|Overall Study|Protocol Violation|1
5450190|NCT02157935|18832658|P2|Overall Study|Screen failure|2
5450191|NCT02157935|18832659|P1|Overall Study|Screen failure|1
5450192|NCT02157935|18832658|P2|Overall Study|Withdrawal by Subject|39
5450193|NCT02157935|18832659|P1|Overall Study|Withdrawal by Subject|25
5450194|NCT02157883|18832685|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
5450195|NCT02157883|18832685|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
5450196|NCT02157883|18832685|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
5450197|NCT02157883|18832685|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
5450198|NCT02157883|18832685|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
5450199|NCT02157779|18832716|P2|Overall Study|Legal issue|0
5450200|NCT02157779|18832717|P1|Overall Study|Legal issue|1
5450201|NCT02157779|18832716|P2|Overall Study|Medical|0
5450202|NCT02157779|18832717|P1|Overall Study|Medical|1
5450203|NCT02157779|18832716|P2|Overall Study|Moved|0
5450204|NCT02157779|18832717|P1|Overall Study|Moved|1
5450205|NCT02157779|18832716|P2|Overall Study|No response to outreach after Baseline|1
5450206|NCT02157779|18832717|P1|Overall Study|No response to outreach after Baseline|1
5450207|NCT02157779|18832716|P2|Overall Study|Stopped attending, reason unknown|7
5450208|NCT02157779|18832717|P1|Overall Study|Stopped attending, reason unknown|11
5450209|NCT02157779|18832716|P2|Overall Study|Logistical|3
5450210|NCT02157779|18832717|P1|Overall Study|Logistical|9
5450211|NCT02157519|18832751|P2|Overall Study|Lost to Follow-up|0
5450212|NCT02157519|18832752|P1|Overall Study|Lost to Follow-up|1
5450213|NCT02157519|18832751|P2|Overall Study|Withdrawal by Subject|0
5450214|NCT02157519|18832752|P1|Overall Study|Withdrawal by Subject|7
5450215|NCT02157519|18832751|P2|Overall Study|Death|1
5450216|NCT02157519|18832752|P1|Overall Study|Death|3
5450217|NCT02157506|18832775|P5|Overall Study|Lost to Follow-up|0
5450218|NCT02157506|18832776|P4|Overall Study|Lost to Follow-up|0
5450219|NCT02157506|18832777|P3|Overall Study|Lost to Follow-up|1
5450220|NCT02157506|18832778|P2|Overall Study|Lost to Follow-up|0
5450221|NCT02157506|18832779|P1|Overall Study|Lost to Follow-up|0
5450222|NCT02157506|18832775|P5|Overall Study|Adverse Event|0
5450223|NCT02157506|18832776|P4|Overall Study|Adverse Event|0
5450224|NCT02157506|18832777|P3|Overall Study|Adverse Event|0
5450225|NCT02157506|18832778|P2|Overall Study|Adverse Event|1
5450226|NCT02157506|18832779|P1|Overall Study|Adverse Event|0
5450227|NCT02157376|18832838|P2|Overall Study|Investigator's misjudgement|2
5450228|NCT02157376|18832839|P1|Overall Study|Investigator's misjudgement|1
5450229|NCT02157376|18832838|P2|Overall Study|Not treated|3
5450230|NCT02157376|18832839|P1|Overall Study|Not treated|8
5450231|NCT02157376|18832838|P2|Overall Study|Withdrawal by Subject|8
5450232|NCT02157376|18832839|P1|Overall Study|Withdrawal by Subject|3
5450233|NCT02157376|18832838|P2|Overall Study|Eligibility criteria not fulfilled|1
5450234|NCT02157376|18832839|P1|Overall Study|Eligibility criteria not fulfilled|0
5450235|NCT02157376|18832838|P2|Overall Study|Death|4
5450236|NCT02157376|18832839|P1|Overall Study|Death|10
5450237|NCT02157298|18832849|P2|Overall Study|Withdrawal by Subject|0
5450238|NCT02157298|18832850|P1|Overall Study|Withdrawal by Subject|1
5450239|NCT02157298|18832849|P2|Overall Study|Poor/Non-compliance|0
5450240|NCT02157298|18832850|P1|Overall Study|Poor/Non-compliance|1
5450241|NCT02157298|18832849|P2|Overall Study|Subject no longer meets study criteria|2
5450242|NCT02157298|18832850|P1|Overall Study|Subject no longer meets study criteria|1
5450243|NCT02157298|18832849|P2|Overall Study|Adverse Event|0
5450244|NCT02157298|18832850|P1|Overall Study|Adverse Event|1
5450245|NCT02157116|18832889|P1|Overall Study|Failed Screening|2
5450246|NCT02157116|18832889|P1|Overall Study|Physician Decision|3
5450247|NCT02157116|18832889|P1|Overall Study|Withdrawal by Subject|4
5450248|NCT02156804|18832915|P1|Overall Study|Withdrawal by Subject|1
5450249|NCT02156492|18832957|P3|Period 3|Adverse Event|0
5450250|NCT02156492|18832958|P2|Period 3|Adverse Event|1
5450251|NCT02156492|18832959|P1|Period 3|Adverse Event|0
5450252|NCT02156492|18832957|P3|Period 1|No Reason Given|0
5450253|NCT02156492|18832958|P2|Period 1|No Reason Given|1
5450254|NCT02156492|18832959|P1|Period 1|No Reason Given|0
5450255|NCT02156466|18832985|P5|Overall Study|Quantiferon Positivity|0
5450256|NCT02156466|18832986|P4|Overall Study|Quantiferon Positivity|1
5450257|NCT02156466|18832987|P3|Overall Study|Quantiferon Positivity|0
5450258|NCT02156466|18832988|P2|Overall Study|Quantiferon Positivity|0
5450259|NCT02156466|18832989|P1|Overall Study|Quantiferon Positivity|0
5450260|NCT02156466|18832985|P5|Overall Study|Adverse Event|0
5450261|NCT02156466|18832986|P4|Overall Study|Adverse Event|1
5450262|NCT02156466|18832987|P3|Overall Study|Adverse Event|1
5450263|NCT02156466|18832988|P2|Overall Study|Adverse Event|0
5450264|NCT02156466|18832989|P1|Overall Study|Adverse Event|0
5450265|NCT02156271|18833170|P2|Overall Study|Physician Decision|3
5450266|NCT02156271|18833171|P1|Overall Study|Physician Decision|4
5450267|NCT02156076|18833224|P4|Follow-up Period|Withdrawal by Subject|0
5450268|NCT02156076|18833225|P3|Follow-up Period|Withdrawal by Subject|0
5450269|NCT02156076|18833226|P2|Follow-up Period|Withdrawal by Subject|0
5450270|NCT02156076|18833227|P1|Follow-up Period|Withdrawal by Subject|1
5450271|NCT02156076|18833224|P4|Treatment Period|Adverse Event|1
5450272|NCT02156076|18833225|P3|Treatment Period|Adverse Event|0
5450273|NCT02156076|18833226|P2|Treatment Period|Adverse Event|0
5450274|NCT02156076|18833227|P1|Treatment Period|Adverse Event|0
5450275|NCT02156076|18833224|P4|Treatment Period|Subject request to discontinue treatment|0
5450276|NCT02156076|18833225|P3|Treatment Period|Subject request to discontinue treatment|0
5450277|NCT02156076|18833226|P2|Treatment Period|Subject request to discontinue treatment|1
5450278|NCT02156076|18833227|P1|Treatment Period|Subject request to discontinue treatment|0
5450279|NCT02156076|18833224|P4|Treatment Period|Withdrawal by Subject|0
5450280|NCT02156076|18833225|P3|Treatment Period|Withdrawal by Subject|1
5450281|NCT02156076|18833226|P2|Treatment Period|Withdrawal by Subject|0
5450282|NCT02156076|18833227|P1|Treatment Period|Withdrawal by Subject|0
5450283|NCT02156076|18833224|P4|Treatment Period|Lost to Follow-up|1
5450284|NCT02156076|18833225|P3|Treatment Period|Lost to Follow-up|0
5450285|NCT02156076|18833226|P2|Treatment Period|Lost to Follow-up|0
5450286|NCT02156076|18833227|P1|Treatment Period|Lost to Follow-up|0
5450287|NCT02156076|18833224|P4|Treatment Period|Poor/non-compliance|0
5450288|NCT02156076|18833225|P3|Treatment Period|Poor/non-compliance|0
5450289|NCT02156076|18833226|P2|Treatment Period|Poor/non-compliance|1
5450290|NCT02156076|18833227|P1|Treatment Period|Poor/non-compliance|0
5450291|NCT02156076|18833224|P4|Treatment Period|no longer meets study criteria|0
5450292|NCT02156076|18833225|P3|Treatment Period|no longer meets study criteria|1
5450293|NCT02156076|18833226|P2|Treatment Period|no longer meets study criteria|0
5450294|NCT02156076|18833227|P1|Treatment Period|no longer meets study criteria|0
5450295|NCT02155985|18833284|P3|Overall Study|Lost to Follow-up|0
5450296|NCT02155985|18833285|P2|Overall Study|Lost to Follow-up|0
5450297|NCT02155985|18833286|P1|Overall Study|Lost to Follow-up|1
5450298|NCT02155985|18833284|P3|Overall Study|Withdrawal by Subject|1
5450299|NCT02155985|18833285|P2|Overall Study|Withdrawal by Subject|0
5450300|NCT02155985|18833286|P1|Overall Study|Withdrawal by Subject|0
5450301|NCT02155881|18833353|P2|Overall Study|Inappropriately randomized|2
5450302|NCT02155881|18833354|P1|Overall Study|Inappropriately randomized|2
5450303|NCT02155881|18833353|P2|Overall Study|Withdrawal by Subject|2
5450304|NCT02155881|18833354|P1|Overall Study|Withdrawal by Subject|0
5450305|NCT02155829|18833376|P2|Overall Study|Protocol Violation|0
5450306|NCT02155829|18833377|P1|Overall Study|Protocol Violation|2
5450307|NCT02155829|18833376|P2|Overall Study|Withdrawal by Subject|3
5450308|NCT02155829|18833377|P1|Overall Study|Withdrawal by Subject|3
5450309|NCT02155829|18833376|P2|Overall Study|Adverse Event|0
5450310|NCT02155829|18833377|P1|Overall Study|Adverse Event|1
5450311|NCT02155738|18833399|P4|Overall Study|Missing critical information|1
5450312|NCT02155738|18833400|P3|Overall Study|Missing critical information|0
5450313|NCT02155738|18833401|P2|Overall Study|Missing critical information|0
5450314|NCT02155738|18833402|P1|Overall Study|Missing critical information|1
5450315|NCT02155712|18833439|P2|Primary Objective|Withdrawal by Subject|0
5450316|NCT02155712|18833440|P1|Primary Objective|Withdrawal by Subject|21
5450317|NCT02155712|18833439|P2|Primary Objective|Revision/Removal of Tibial Baseplate|0
5450318|NCT02155712|18833440|P1|Primary Objective|Revision/Removal of Tibial Baseplate|1
5450319|NCT02155712|18833439|P2|Primary Objective|No 2-Year Forms but not Terminated|0
5450320|NCT02155712|18833440|P1|Primary Objective|No 2-Year Forms but not Terminated|13
5450321|NCT02155712|18833439|P2|Primary Objective|Lost to Follow-up|0
5450322|NCT02155712|18833440|P1|Primary Objective|Lost to Follow-up|22
5450323|NCT02155712|18833439|P2|Primary Objective|Death|0
5450324|NCT02155712|18833440|P1|Primary Objective|Death|3
5450325|NCT02155660|18833450|P4|Overall Study|Withdrawal by Subject|21
5450326|NCT02155660|18833451|P3|Overall Study|Withdrawal by Subject|24
5450327|NCT02155660|18833452|P2|Overall Study|Withdrawal by Subject|31
5450328|NCT02155660|18833453|P1|Overall Study|Withdrawal by Subject|28
5450329|NCT02155660|18833450|P4|Overall Study|Death|19
5450330|NCT02155660|18833451|P3|Overall Study|Death|17
5450331|NCT02155660|18833452|P2|Overall Study|Death|19
5450332|NCT02155660|18833453|P1|Overall Study|Death|17
5450333|NCT02155660|18833450|P4|Overall Study|Lost to Follow-up|8
5450334|NCT02155660|18833451|P3|Overall Study|Lost to Follow-up|5
5450335|NCT02155660|18833452|P2|Overall Study|Lost to Follow-up|6
5450336|NCT02155660|18833453|P1|Overall Study|Lost to Follow-up|3
5450337|NCT02155660|18833450|P4|Overall Study|Adverse Event|1
5450338|NCT02155660|18833451|P3|Overall Study|Adverse Event|3
5450339|NCT02155660|18833452|P2|Overall Study|Adverse Event|6
5450340|NCT02155660|18833453|P1|Overall Study|Adverse Event|2
5450341|NCT02155660|18833450|P4|Overall Study|Severe non-compliance|1
5450342|NCT02155660|18833451|P3|Overall Study|Severe non-compliance|0
5450343|NCT02155660|18833452|P2|Overall Study|Severe non-compliance|4
5450344|NCT02155660|18833453|P1|Overall Study|Severe non-compliance|0
5450345|NCT02155660|18833450|P4|Overall Study|Study-specific withdrawal criteria|1
5450346|NCT02155660|18833451|P3|Overall Study|Study-specific withdrawal criteria|1
5450347|NCT02155660|18833452|P2|Overall Study|Study-specific withdrawal criteria|1
5450348|NCT02155660|18833453|P1|Overall Study|Study-specific withdrawal criteria|0
5450349|NCT02155660|18833450|P4|Overall Study|Other Reason|10
5450350|NCT02155660|18833451|P3|Overall Study|Other Reason|10
5450351|NCT02155660|18833452|P2|Overall Study|Other Reason|6
5450352|NCT02155660|18833453|P1|Overall Study|Other Reason|8
5450353|NCT02155647|18833536|P2|Overall Study|Off-Treatment, but follow up ongoing|26
5450354|NCT02155647|18833537|P1|Overall Study|Off-Treatment, but follow up ongoing|15
5450355|NCT02155647|18833536|P2|Overall Study|Still on Treatment|26
5450356|NCT02155647|18833537|P1|Overall Study|Still on Treatment|26
5450357|NCT02155608|18833565|P2|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
5450358|NCT02155608|18833566|P1|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
5450359|NCT02155608|18833565|P2|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
5450360|NCT02155608|18833566|P1|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
5450361|NCT02155322|18833663|P1|Overall Study|Withdrawal by Subject|4
5450362|NCT02155322|18833663|P1|Overall Study|Relapse/Recurrence|8
5450363|NCT02155322|18833663|P1|Overall Study|Physician Decision|1
5450364|NCT02155322|18833663|P1|Overall Study|Adverse Event|1
5450365|NCT02155309|18833670|P3|Overall Study|Protocol Violation|1
5450366|NCT02155309|18833671|P2|Overall Study|Protocol Violation|0
5450367|NCT02155309|18833672|P1|Overall Study|Protocol Violation|0
5450368|NCT02155283|18833679|P1|Overall Study|Protocol Violation|3
5450369|NCT02155283|18833679|P1|Overall Study|Withdrawal by Subject|1
5450370|NCT02155283|18833679|P1|Overall Study|Lost to Follow-up|3
5450371|NCT02154581|18833855|P2|Overall Study|Lost to Follow-up|8
5450372|NCT02154581|18833856|P1|Overall Study|Lost to Follow-up|7
5450373|NCT02154425|18833881|P1|Screening Period|Adverse Event|1
5450374|NCT02154347|18833926|P2|Open-label Period|Withdrawal by Subject|1
5450375|NCT02154347|18833927|P1|Open-label Period|Withdrawal by Subject|0
5450376|NCT02154347|18833926|P2|Open-label Period|Protocol Violation|1
5450377|NCT02154347|18833927|P1|Open-label Period|Protocol Violation|0
5450378|NCT02154347|18833926|P2|Open-label Period|Lack of Efficacy|19
5450379|NCT02154347|18833927|P1|Open-label Period|Lack of Efficacy|4
5450380|NCT02154347|18833926|P2|Open-label Period|Adverse Event|4
5450381|NCT02154347|18833927|P1|Open-label Period|Adverse Event|3
5450382|NCT02154347|18833926|P2|Double-blind Period|Withdrawal by Subject|1
5450383|NCT02154347|18833927|P1|Double-blind Period|Withdrawal by Subject|1
5450384|NCT02154347|18833926|P2|Double-blind Period|Physician Decision|1
5450385|NCT02154347|18833927|P1|Double-blind Period|Physician Decision|0
5450386|NCT02154347|18833926|P2|Double-blind Period|Lack of Efficacy|0
5450387|NCT02154347|18833927|P1|Double-blind Period|Lack of Efficacy|1
5450388|NCT02154347|18833926|P2|Double-blind Period|Adverse Event|2
5450389|NCT02154347|18833927|P1|Double-blind Period|Adverse Event|1
5450390|NCT02154139|18833950|P1|Overall Study|Investigator transferred|3
5450391|NCT02154139|18833950|P1|Overall Study|Other|2
5450392|NCT02154139|18833950|P1|Overall Study|Injection not administered|2
5450393|NCT02154087|18833958|P1|Overall Study|Study Termination|1
5450394|NCT02154061|18833964|P2|Overall Study|enrolled but not vaccinated|0
5450395|NCT02154061|18833965|P1|Overall Study|enrolled but not vaccinated|1
5450396|NCT02154061|18833964|P2|Overall Study|Pregnancy|0
5450397|NCT02154061|18833965|P1|Overall Study|Pregnancy|1
5450398|NCT02153918|18834012|P1|Overall Study|Refused further treatment|1
5450399|NCT02153905|18834023|P2|Overall Study|Death|0
5450400|NCT02153905|18834024|P1|Overall Study|Death|1
5450401|NCT02153827|18834042|P2|Overall Study|Lost to Follow-up|9
5450402|NCT02153827|18834043|P1|Overall Study|Lost to Follow-up|3
5450403|NCT02153788|18834059|P2|Overall Study|Physician Decision|1
5450404|NCT02153788|18834060|P1|Overall Study|Physician Decision|2
5450405|NCT02153736|18834080|P2|Overall Study|Withdrawal by Subject|1
5450406|NCT02153736|18834081|P1|Overall Study|Withdrawal by Subject|0
5450407|NCT02153736|18834080|P2|Overall Study|Death|1
5450408|NCT02153736|18834081|P1|Overall Study|Death|0
5450409|NCT02153736|18834080|P2|Overall Study|Medical status change made ineligible|0
5450410|NCT02153736|18834081|P1|Overall Study|Medical status change made ineligible|1
5450411|NCT02153736|18834080|P2|Overall Study|Lost to Follow-up|0
5450412|NCT02153736|18834081|P1|Overall Study|Lost to Follow-up|1
5450413|NCT02153398|18834308|P5|Overall Study|Adverse Event|0
5450414|NCT02153398|18834309|P4|Overall Study|Adverse Event|1
5450415|NCT02153398|18834310|P3|Overall Study|Adverse Event|1
5450416|NCT02153398|18834311|P2|Overall Study|Adverse Event|0
5450417|NCT02153398|18834312|P1|Overall Study|Adverse Event|0
5450418|NCT02153398|18834308|P5|Overall Study|Withdrawal by Subject|0
5450419|NCT02153398|18834309|P4|Overall Study|Withdrawal by Subject|0
5450420|NCT02153398|18834310|P3|Overall Study|Withdrawal by Subject|0
5450421|NCT02153398|18834311|P2|Overall Study|Withdrawal by Subject|0
5450422|NCT02153398|18834312|P1|Overall Study|Withdrawal by Subject|1
5450423|NCT02153359|18834434|P2|Intervention 2 (1 Month)|Lost to Follow-up|2
5450424|NCT02153359|18834435|P1|Intervention 2 (1 Month)|Lost to Follow-up|0
5450425|NCT02153346|18834469|P1|Overall Study|Lost to Follow-up|11
5450426|NCT02153112|18834486|P10|Overall Study|Reason not Specified|1
5450427|NCT02153112|18834487|P9|Overall Study|Reason not Specified|1
5450428|NCT02153112|18834488|P8|Overall Study|Reason not Specified|0
5450429|NCT02153112|18834489|P7|Overall Study|Reason not Specified|0
5450430|NCT02153112|18834490|P6|Overall Study|Reason not Specified|0
5450431|NCT02153112|18834491|P5|Overall Study|Reason not Specified|0
5450432|NCT02153112|18834492|P4|Overall Study|Reason not Specified|0
5450433|NCT02153112|18834493|P3|Overall Study|Reason not Specified|0
5450434|NCT02153112|18834494|P2|Overall Study|Reason not Specified|0
5450435|NCT02153112|18834495|P1|Overall Study|Reason not Specified|0
5450436|NCT02153112|18834486|P10|Overall Study|Withdrawal by Subject|12
5450437|NCT02153112|18834487|P9|Overall Study|Withdrawal by Subject|13
5450438|NCT02153112|18834488|P8|Overall Study|Withdrawal by Subject|2
5450439|NCT02153112|18834489|P7|Overall Study|Withdrawal by Subject|7
5450440|NCT02153112|18834490|P6|Overall Study|Withdrawal by Subject|1
5450441|NCT02153112|18834491|P5|Overall Study|Withdrawal by Subject|1
5450442|NCT02153112|18834492|P4|Overall Study|Withdrawal by Subject|2
5450443|NCT02153112|18834493|P3|Overall Study|Withdrawal by Subject|2
5450444|NCT02153112|18834494|P2|Overall Study|Withdrawal by Subject|1
5450445|NCT02153112|18834495|P1|Overall Study|Withdrawal by Subject|3
5450446|NCT02153112|18834486|P10|Overall Study|Lost to Follow-up|1
5450447|NCT02153112|18834487|P9|Overall Study|Lost to Follow-up|1
5450448|NCT02153112|18834488|P8|Overall Study|Lost to Follow-up|0
5450449|NCT02153112|18834489|P7|Overall Study|Lost to Follow-up|1
5450450|NCT02153112|18834490|P6|Overall Study|Lost to Follow-up|1
5450451|NCT02153112|18834491|P5|Overall Study|Lost to Follow-up|2
5450452|NCT02153112|18834492|P4|Overall Study|Lost to Follow-up|0
5450453|NCT02153112|18834493|P3|Overall Study|Lost to Follow-up|0
5450454|NCT02153112|18834494|P2|Overall Study|Lost to Follow-up|1
5450455|NCT02153112|18834495|P1|Overall Study|Lost to Follow-up|1
5450456|NCT02153112|18834486|P10|Overall Study|Adverse Event|0
5450457|NCT02153112|18834487|P9|Overall Study|Adverse Event|0
5450458|NCT02153112|18834488|P8|Overall Study|Adverse Event|0
5450459|NCT02153112|18834489|P7|Overall Study|Adverse Event|0
5450460|NCT02153112|18834490|P6|Overall Study|Adverse Event|0
5450461|NCT02153112|18834491|P5|Overall Study|Adverse Event|0
5450462|NCT02153112|18834492|P4|Overall Study|Adverse Event|0
5450463|NCT02153112|18834493|P3|Overall Study|Adverse Event|1
5450464|NCT02153112|18834494|P2|Overall Study|Adverse Event|0
5450465|NCT02153112|18834495|P1|Overall Study|Adverse Event|0
5450466|NCT02153086|18834834|P1|Overall Study|Other|2
5450467|NCT02153086|18834834|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
5450468|NCT02153073|18834848|P1|Overall Study|Protocol Deviation|68
5450469|NCT02153073|18834848|P1|Overall Study|Case Report Forms Uncollected|230
5450470|NCT02152761|18834876|P4|Epoch: Post-treatment Follow-up Epoch|Death|1
5450471|NCT02152761|18834877|P3|Epoch: Post-treatment Follow-up Epoch|Death|0
5450472|NCT02152761|18834878|P2|Epoch: Post-treatment Follow-up Epoch|Death|0
5450473|NCT02152761|18834879|P1|Epoch: Post-treatment Follow-up Epoch|Death|1
5450474|NCT02152761|18834876|P4|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
5450475|NCT02152761|18834877|P3|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
5450476|NCT02152761|18834878|P2|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
5450477|NCT02152761|18834879|P1|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
5450478|NCT02152761|18834876|P4|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
5450479|NCT02152761|18834877|P3|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
5450480|NCT02152761|18834878|P2|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
5450481|NCT02152761|18834879|P1|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
5450482|NCT02152761|18834876|P4|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
5450483|NCT02152761|18834877|P3|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
5450484|NCT02152761|18834878|P2|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
5450485|NCT02152761|18834879|P1|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
5450486|NCT02152761|18834876|P4|Epoch: Treatment Epoch|Non-compliance with treatment|0
5450487|NCT02152761|18834877|P3|Epoch: Treatment Epoch|Non-compliance with treatment|0
5450488|NCT02152761|18834878|P2|Epoch: Treatment Epoch|Non-compliance with treatment|1
5450489|NCT02152761|18834879|P1|Epoch: Treatment Epoch|Non-compliance with treatment|1
5450490|NCT02152761|18834876|P4|Epoch: Treatment Epoch|Death|0
5450491|NCT02152761|18834877|P3|Epoch: Treatment Epoch|Death|1
5450492|NCT02152761|18834878|P2|Epoch: Treatment Epoch|Death|3
5450493|NCT02152761|18834879|P1|Epoch: Treatment Epoch|Death|0
5450494|NCT02152761|18834876|P4|Epoch: Treatment Epoch|Adverse Event|2
5450495|NCT02152761|18834877|P3|Epoch: Treatment Epoch|Adverse Event|1
5450496|NCT02152761|18834878|P2|Epoch: Treatment Epoch|Adverse Event|6
5450497|NCT02152761|18834879|P1|Epoch: Treatment Epoch|Adverse Event|3
5450498|NCT02152761|18834876|P4|Epoch: Treatment Epoch|Withdrawal by Subject|5
5450499|NCT02152761|18834877|P3|Epoch: Treatment Epoch|Withdrawal by Subject|3
5450500|NCT02152761|18834878|P2|Epoch: Treatment Epoch|Withdrawal by Subject|8
5450501|NCT02152761|18834879|P1|Epoch: Treatment Epoch|Withdrawal by Subject|7
5450502|NCT02152761|18834876|P4|Epoch: Treatment Epoch|Lost to Follow-up|0
5450503|NCT02152761|18834877|P3|Epoch: Treatment Epoch|Lost to Follow-up|0
5450504|NCT02152761|18834878|P2|Epoch: Treatment Epoch|Lost to Follow-up|2
5450505|NCT02152761|18834879|P1|Epoch: Treatment Epoch|Lost to Follow-up|0
5450506|NCT02152761|18834876|P4|Epoch: Treatment Epoch|Technical problems|1
5450507|NCT02152761|18834877|P3|Epoch: Treatment Epoch|Technical problems|0
5450508|NCT02152761|18834878|P2|Epoch: Treatment Epoch|Technical problems|0
5450509|NCT02152761|18834879|P1|Epoch: Treatment Epoch|Technical problems|0
5450510|NCT02152631|18834919|P2|Overall Study|On Treatment|3
5450511|NCT02152631|18834920|P1|Overall Study|On Treatment|19
5450512|NCT02152631|18834919|P2|Overall Study|Lost to Follow-up|1
5450513|NCT02152631|18834920|P1|Overall Study|Lost to Follow-up|0
5450514|NCT02152631|18834919|P2|Overall Study|Physician Decision|2
5450515|NCT02152631|18834920|P1|Overall Study|Physician Decision|1
5450516|NCT02152631|18834919|P2|Overall Study|Noncompliance with study drug|0
5450517|NCT02152631|18834920|P1|Overall Study|Noncompliance with study drug|1
5450518|NCT02152631|18834919|P2|Overall Study|Withdrawal by Subject|16
5450519|NCT02152631|18834920|P1|Overall Study|Withdrawal by Subject|13
5450520|NCT02152631|18834919|P2|Overall Study|Adverse Event|4
5450521|NCT02152631|18834920|P1|Overall Study|Adverse Event|32
5450522|NCT02152605|18834939|P2|Overall Study|Withdrew consent|2
5450523|NCT02152605|18834940|P1|Overall Study|Withdrew consent|4
5450524|NCT02152605|18834939|P2|Overall Study|Lost to Follow-up|0
5450525|NCT02152605|18834940|P1|Overall Study|Lost to Follow-up|1
5450526|NCT02152605|18834939|P2|Overall Study|Protocol deviation|4
5450527|NCT02152605|18834940|P1|Overall Study|Protocol deviation|1
5450528|NCT02152605|18834939|P2|Overall Study|Lack of Efficacy|4
5450529|NCT02152605|18834940|P1|Overall Study|Lack of Efficacy|7
5450530|NCT02152605|18834939|P2|Overall Study|Adverse Event|8
5450531|NCT02152605|18834940|P1|Overall Study|Adverse Event|6
5450532|NCT02152566|18834950|P1|Overall Study|Withdrawal by Subject|2
5450533|NCT02152566|18834950|P1|Overall Study|Lost to Follow-up|1
5450534|NCT02152384|18834963|P2|Period 1|Adverse Event|1
5450535|NCT02152384|18834964|P1|Period 1|Adverse Event|1
5450536|NCT02152384|18834963|P2|Period 1|Withdrawal by Subject|1
5450537|NCT02152384|18834964|P1|Period 1|Withdrawal by Subject|0
5450538|NCT02152371|18834984|P2|Overall Study|Reason Not Given|1
5450539|NCT02152371|18834985|P1|Overall Study|Reason Not Given|0
5450540|NCT02152371|18834984|P2|Overall Study|Physician Decision|2
5450541|NCT02152371|18834985|P1|Overall Study|Physician Decision|0
5450542|NCT02152371|18834984|P2|Overall Study|Lack of Efficacy|1
5450543|NCT02152371|18834985|P1|Overall Study|Lack of Efficacy|0
5450544|NCT02152371|18834984|P2|Overall Study|Lost to Follow-up|0
5450545|NCT02152371|18834985|P1|Overall Study|Lost to Follow-up|1
5450546|NCT02152371|18834984|P2|Overall Study|Protocol Violation|3
5450547|NCT02152371|18834985|P1|Overall Study|Protocol Violation|2
5450548|NCT02152371|18834984|P2|Overall Study|Withdrawal by Subject|7
5450549|NCT02152371|18834985|P1|Overall Study|Withdrawal by Subject|3
5450550|NCT02152371|18834984|P2|Overall Study|Adverse Event|2
5450551|NCT02152371|18834985|P1|Overall Study|Adverse Event|6
5450552|NCT02152345|18835023|P2|Overall Study|Withdrawal by Subject|1
5450553|NCT02152345|18835024|P1|Overall Study|Withdrawal by Subject|2
5450554|NCT02152345|18835023|P2|Overall Study|Case Cancellations|4
5450555|NCT02152345|18835024|P1|Overall Study|Case Cancellations|2
5450556|NCT02152137|18835036|P1|Overall Study|Originally assigned to Arm B|3
5450557|NCT02152137|18835036|P1|Overall Study|Withdrawal by Subject|1
5450558|NCT02152007|18835044|P1|Overall Study|Withdrawal by Subject|1
5450559|NCT02151981|18835105|P2|Overall Study|Eligibility criteria not fulfilled|1
5450560|NCT02151981|18835106|P1|Overall Study|Eligibility criteria not fulfilled|0
5450561|NCT02151981|18835105|P2|Overall Study|Ongoing Study at Data Cut-off|95
5450562|NCT02151981|18835106|P1|Overall Study|Ongoing Study at Data Cut-off|224
5450563|NCT02151981|18835105|P2|Overall Study|Withdrawal by Subject|18
5450564|NCT02151981|18835106|P1|Overall Study|Withdrawal by Subject|19
5450565|NCT02151981|18835105|P2|Overall Study|Lost to Follow-up|0
5450566|NCT02151981|18835106|P1|Overall Study|Lost to Follow-up|1
5450567|NCT02151981|18835105|P2|Overall Study|Death|26
5450568|NCT02151981|18835106|P1|Overall Study|Death|35
5450569|NCT02151903|18835124|P2|Overall Study|Progressive disease|1
5450570|NCT02151903|18835125|P1|Overall Study|Progressive disease|2
5450571|NCT02151903|18835124|P2|Overall Study|Withdrawal by Subject|0
5450572|NCT02151903|18835125|P1|Overall Study|Withdrawal by Subject|1
5450573|NCT02151851|18835162|P2|Overall Study|Adverse Event|28
5450574|NCT02151851|18835163|P1|Overall Study|Adverse Event|6
5450575|NCT02151851|18835162|P2|Overall Study|Subject entered into study in error|1
5450576|NCT02151851|18835163|P1|Overall Study|Subject entered into study in error|0
5450577|NCT02151851|18835162|P2|Overall Study|Low compliance to study visits|1
5450578|NCT02151851|18835163|P1|Overall Study|Low compliance to study visits|0
5450579|NCT02151851|18835162|P2|Overall Study|Medical impairment|0
5450580|NCT02151851|18835163|P1|Overall Study|Medical impairment|1
5450581|NCT02151851|18835162|P2|Overall Study|Withdrawal by Subject|5
5450582|NCT02151851|18835163|P1|Overall Study|Withdrawal by Subject|2
5450583|NCT02151851|18835162|P2|Overall Study|Protocol Violation|1
5450584|NCT02151851|18835163|P1|Overall Study|Protocol Violation|0
5450585|NCT02151851|18835162|P2|Overall Study|Lack of Efficacy|94
5450586|NCT02151851|18835163|P1|Overall Study|Lack of Efficacy|67
5450587|NCT02151786|18835175|P1|Overall Study|Unavailability of Information|8
5450588|NCT02151786|18835175|P1|Overall Study|Randomized, not Treated|1
5450589|NCT02151786|18835175|P1|Overall Study|Outside the Contract Period|1
5450590|NCT02151786|18835175|P1|Overall Study|Unavailability of Case Report Form|26
5450591|NCT02151773|18835186|P1|Overall Study|Protocol Deviation|64
5450592|NCT02151682|18835193|P6|Part 2: Observ. Aft. Tapent. Extension|Various other|2
5450593|NCT02151682|18835194|P5|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5450594|NCT02151682|18835195|P4|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5450595|NCT02151682|18835196|P3|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5450596|NCT02151682|18835197|P2|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5450597|NCT02151682|18835198|P1|Part 2: Observ. Aft. Tapent. Extension|Various other|0
5450598|NCT02151682|18835193|P6|Part 2: Observ. Aft. Tapent. Extension|Missing|3
5450599|NCT02151682|18835194|P5|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5450600|NCT02151682|18835195|P4|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5450601|NCT02151682|18835196|P3|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5450602|NCT02151682|18835197|P2|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5450603|NCT02151682|18835198|P1|Part 2: Observ. Aft. Tapent. Extension|Missing|0
5450604|NCT02151682|18835193|P6|Part 2: Observ. Aft. Tapent. Extension|Death|1
5450605|NCT02151682|18835194|P5|Part 2: Observ. Aft. Tapent. Extension|Death|0
5450606|NCT02151682|18835195|P4|Part 2: Observ. Aft. Tapent. Extension|Death|0
5450607|NCT02151682|18835196|P3|Part 2: Observ. Aft. Tapent. Extension|Death|0
5450608|NCT02151682|18835197|P2|Part 2: Observ. Aft. Tapent. Extension|Death|0
5450609|NCT02151682|18835198|P1|Part 2: Observ. Aft. Tapent. Extension|Death|0
5450610|NCT02151682|18835193|P6|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
5450611|NCT02151682|18835194|P5|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5450612|NCT02151682|18835195|P4|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5450613|NCT02151682|18835196|P3|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5450614|NCT02151682|18835197|P2|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5450615|NCT02151682|18835198|P1|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
5450616|NCT02151682|18835193|P6|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5450617|NCT02151682|18835194|P5|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5450618|NCT02151682|18835195|P4|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5450619|NCT02151682|18835196|P3|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
5450620|NCT02151682|18835197|P2|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5450621|NCT02151682|18835198|P1|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
5450622|NCT02151682|18835193|P6|Part 2: Tapent. Extension or Observation|Various other|0
5450623|NCT02151682|18835194|P5|Part 2: Tapent. Extension or Observation|Various other|0
5450624|NCT02151682|18835195|P4|Part 2: Tapent. Extension or Observation|Various other|0
5450625|NCT02151682|18835196|P3|Part 2: Tapent. Extension or Observation|Various other|6
5450626|NCT02151682|18835197|P2|Part 2: Tapent. Extension or Observation|Various other|0
5450627|NCT02151682|18835198|P1|Part 2: Tapent. Extension or Observation|Various other|0
5450628|NCT02151682|18835193|P6|Part 2: Tapent. Extension or Observation|Missing|0
5450629|NCT02151682|18835194|P5|Part 2: Tapent. Extension or Observation|Missing|0
5450630|NCT02151682|18835195|P4|Part 2: Tapent. Extension or Observation|Missing|1
5450631|NCT02151682|18835196|P3|Part 2: Tapent. Extension or Observation|Missing|0
5450632|NCT02151682|18835197|P2|Part 2: Tapent. Extension or Observation|Missing|0
5450633|NCT02151682|18835198|P1|Part 2: Tapent. Extension or Observation|Missing|0
5450634|NCT02151682|18835193|P6|Part 2: Tapent. Extension or Observation|No need for opioid|0
5450635|NCT02151682|18835194|P5|Part 2: Tapent. Extension or Observation|No need for opioid|0
5450636|NCT02151682|18835195|P4|Part 2: Tapent. Extension or Observation|No need for opioid|0
5450637|NCT02151682|18835196|P3|Part 2: Tapent. Extension or Observation|No need for opioid|13
5450638|NCT02151682|18835197|P2|Part 2: Tapent. Extension or Observation|No need for opioid|0
5450639|NCT02151682|18835198|P1|Part 2: Tapent. Extension or Observation|No need for opioid|0
5450640|NCT02151682|18835193|P6|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5450641|NCT02151682|18835194|P5|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5450642|NCT02151682|18835195|P4|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5450643|NCT02151682|18835196|P3|Part 2: Tapent. Extension or Observation|Protocol Violation|1
5450644|NCT02151682|18835197|P2|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5450645|NCT02151682|18835198|P1|Part 2: Tapent. Extension or Observation|Protocol Violation|0
5450646|NCT02151682|18835193|P6|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5450647|NCT02151682|18835194|P5|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5450648|NCT02151682|18835195|P4|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5450649|NCT02151682|18835196|P3|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
5450650|NCT02151682|18835197|P2|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5450651|NCT02151682|18835198|P1|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
5450652|NCT02151682|18835193|P6|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5450653|NCT02151682|18835194|P5|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5450654|NCT02151682|18835195|P4|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
5450655|NCT02151682|18835196|P3|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
5450656|NCT02151682|18835197|P2|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5450657|NCT02151682|18835198|P1|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
5450658|NCT02151682|18835193|P6|Part 2: Tapent. Extension or Observation|Death|0
5450659|NCT02151682|18835194|P5|Part 2: Tapent. Extension or Observation|Death|0
5450660|NCT02151682|18835195|P4|Part 2: Tapent. Extension or Observation|Death|2
5450661|NCT02151682|18835196|P3|Part 2: Tapent. Extension or Observation|Death|0
5450662|NCT02151682|18835197|P2|Part 2: Tapent. Extension or Observation|Death|0
5450663|NCT02151682|18835198|P1|Part 2: Tapent. Extension or Observation|Death|0
5450664|NCT02151682|18835193|P6|Part 2: Tapent. Extension or Observation|Adverse Event|0
5450665|NCT02151682|18835194|P5|Part 2: Tapent. Extension or Observation|Adverse Event|0
5450666|NCT02151682|18835195|P4|Part 2: Tapent. Extension or Observation|Adverse Event|0
5450667|NCT02151682|18835196|P3|Part 2: Tapent. Extension or Observation|Adverse Event|3
5450668|NCT02151682|18835197|P2|Part 2: Tapent. Extension or Observation|Adverse Event|0
5450669|NCT02151682|18835198|P1|Part 2: Tapent. Extension or Observation|Adverse Event|0
5450670|NCT02151682|18835193|P6|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5450671|NCT02151682|18835194|P5|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5450672|NCT02151682|18835195|P4|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5450673|NCT02151682|18835196|P3|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5450674|NCT02151682|18835197|P2|Part 1: 14 Days Morphine or Tapentadol|Missing|0
5450675|NCT02151682|18835198|P1|Part 1: 14 Days Morphine or Tapentadol|Missing|1
5450676|NCT02151682|18835193|P6|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5450677|NCT02151682|18835194|P5|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5450678|NCT02151682|18835195|P4|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5450679|NCT02151682|18835196|P3|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
5450680|NCT02151682|18835197|P2|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
5450681|NCT02151682|18835198|P1|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
5450682|NCT02151682|18835193|P6|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5450683|NCT02151682|18835194|P5|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5450684|NCT02151682|18835195|P4|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5450685|NCT02151682|18835196|P3|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5450686|NCT02151682|18835197|P2|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
5450687|NCT02151682|18835198|P1|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
5450688|NCT02151682|18835193|P6|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5450689|NCT02151682|18835194|P5|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5450690|NCT02151682|18835195|P4|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5450691|NCT02151682|18835196|P3|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5450692|NCT02151682|18835197|P2|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
5450693|NCT02151682|18835198|P1|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
5450694|NCT02151682|18835193|P6|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5450695|NCT02151682|18835194|P5|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5450696|NCT02151682|18835195|P4|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5450697|NCT02151682|18835196|P3|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5450698|NCT02151682|18835197|P2|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
5450699|NCT02151682|18835198|P1|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
5450700|NCT02151643|18835248|P5|Overall Study|High Ferritin levels|1
5450701|NCT02151643|18835249|P4|Overall Study|High Ferritin levels|2
5450702|NCT02151643|18835250|P3|Overall Study|High Ferritin levels|2
5450703|NCT02151643|18835251|P2|Overall Study|High Ferritin levels|3
5450704|NCT02151643|18835252|P1|Overall Study|High Ferritin levels|3
5450705|NCT02151643|18835248|P5|Overall Study|Hyperphosphataemia|1
5450706|NCT02151643|18835249|P4|Overall Study|Hyperphosphataemia|0
5450707|NCT02151643|18835250|P3|Overall Study|Hyperphosphataemia|0
5450708|NCT02151643|18835251|P2|Overall Study|Hyperphosphataemia|0
5450709|NCT02151643|18835252|P1|Overall Study|Hyperphosphataemia|1
5450710|NCT02151643|18835248|P5|Overall Study|Withdrawal by Subject|1
5450711|NCT02151643|18835249|P4|Overall Study|Withdrawal by Subject|1
5450712|NCT02151643|18835250|P3|Overall Study|Withdrawal by Subject|1
5450713|NCT02151643|18835251|P2|Overall Study|Withdrawal by Subject|1
5450714|NCT02151643|18835252|P1|Overall Study|Withdrawal by Subject|0
5450715|NCT02151643|18835248|P5|Overall Study|Adverse Event|0
5450716|NCT02151643|18835249|P4|Overall Study|Adverse Event|4
5450717|NCT02151643|18835250|P3|Overall Study|Adverse Event|1
5450718|NCT02151643|18835251|P2|Overall Study|Adverse Event|0
5450719|NCT02151643|18835252|P1|Overall Study|Adverse Event|2
5450720|NCT02151591|18835291|P2|Overall Study|Lost to Follow-up|3
5450721|NCT02151591|18835292|P1|Overall Study|Lost to Follow-up|6
5450722|NCT02151461|18835363|P4|Overall Study|Treatment discontinuation|0
5450723|NCT02151461|18835364|P3|Overall Study|Treatment discontinuation|1
5450724|NCT02151461|18835365|P2|Overall Study|Treatment discontinuation|0
5450725|NCT02151461|18835366|P1|Overall Study|Treatment discontinuation|0
5450726|NCT02151461|18835363|P4|Overall Study|Withdrawal by Subject|1
5450727|NCT02151461|18835364|P3|Overall Study|Withdrawal by Subject|1
5450728|NCT02151461|18835365|P2|Overall Study|Withdrawal by Subject|0
5450729|NCT02151461|18835366|P1|Overall Study|Withdrawal by Subject|1
5450730|NCT02151461|18835363|P4|Overall Study|Lost to Follow-up|1
5450731|NCT02151461|18835364|P3|Overall Study|Lost to Follow-up|1
5450732|NCT02151461|18835365|P2|Overall Study|Lost to Follow-up|0
5450733|NCT02151461|18835366|P1|Overall Study|Lost to Follow-up|0
5450734|NCT02151461|18835363|P4|Overall Study|Adverse Event|2
5450735|NCT02151461|18835364|P3|Overall Study|Adverse Event|0
5450736|NCT02151461|18835365|P2|Overall Study|Adverse Event|1
5450737|NCT02151461|18835366|P1|Overall Study|Adverse Event|5
5450738|NCT02151266|18835498|P3|Overall Study|Not able to exercise|4
5450739|NCT02151266|18835499|P2|Overall Study|Not able to exercise|5
5450740|NCT02151266|18835500|P1|Overall Study|Not able to exercise|4
5450741|NCT02151266|18835498|P3|Overall Study|Did NOT receive intervention|2
5450742|NCT02151266|18835499|P2|Overall Study|Did NOT receive intervention|6
5450743|NCT02151266|18835500|P1|Overall Study|Did NOT receive intervention|3
5450744|NCT02151266|18835498|P3|Overall Study|Lost to Follow-up|1
5450745|NCT02151266|18835499|P2|Overall Study|Lost to Follow-up|4
5450746|NCT02151266|18835500|P1|Overall Study|Lost to Follow-up|1
5450747|NCT02151149|18835543|P2|Follow-Up Period|Death|34
5450748|NCT02151149|18835544|P1|Follow-Up Period|Death|37
5450749|NCT02151149|18835543|P2|Follow-Up Period|Lost to Follow-up|3
5450750|NCT02151149|18835544|P1|Follow-Up Period|Lost to Follow-up|2
5450751|NCT02151149|18835543|P2|Treatment Period|Participants randomized but not treated|2
5450752|NCT02151149|18835544|P1|Treatment Period|Participants randomized but not treated|3
5450753|NCT02151149|18835543|P2|Treatment Period|Miscellaneous|7
5450754|NCT02151149|18835544|P1|Treatment Period|Miscellaneous|8
5450755|NCT02151149|18835543|P2|Treatment Period|Withdrawal by Subject|11
5450756|NCT02151149|18835544|P1|Treatment Period|Withdrawal by Subject|13
5450757|NCT02151149|18835543|P2|Treatment Period|Symptomatic Deterioration|10
5450758|NCT02151149|18835544|P1|Treatment Period|Symptomatic Deterioration|2
5450759|NCT02151149|18835543|P2|Treatment Period|Progressive Disease|24
5450760|NCT02151149|18835544|P1|Treatment Period|Progressive Disease|25
5450761|NCT02151149|18835543|P2|Treatment Period|Adverse Event|14
5450762|NCT02151149|18835544|P1|Treatment Period|Adverse Event|17
5450763|NCT02151149|18835543|P2|Treatment Period|Death|3
5450764|NCT02151149|18835544|P1|Treatment Period|Death|2
5450765|NCT02151110|18835576|P8|Overall Study|Lost to Follow-up|2
5450766|NCT02151110|18835577|P7|Overall Study|Lost to Follow-up|0
5450767|NCT02151110|18835578|P6|Overall Study|Lost to Follow-up|0
5450768|NCT02151110|18835579|P5|Overall Study|Lost to Follow-up|0
5450769|NCT02151110|18835580|P4|Overall Study|Lost to Follow-up|0
5450770|NCT02151110|18835581|P3|Overall Study|Lost to Follow-up|0
5450771|NCT02151110|18835582|P2|Overall Study|Lost to Follow-up|0
5450772|NCT02151110|18835583|P1|Overall Study|Lost to Follow-up|0
5450773|NCT02151110|18835576|P8|Overall Study|Withdrawal by Subject|1
5450774|NCT02151110|18835577|P7|Overall Study|Withdrawal by Subject|0
5450775|NCT02151110|18835578|P6|Overall Study|Withdrawal by Subject|0
5450776|NCT02151110|18835579|P5|Overall Study|Withdrawal by Subject|0
5450777|NCT02151110|18835580|P4|Overall Study|Withdrawal by Subject|0
5450778|NCT02151110|18835581|P3|Overall Study|Withdrawal by Subject|0
5450779|NCT02151110|18835582|P2|Overall Study|Withdrawal by Subject|0
5450780|NCT02151110|18835583|P1|Overall Study|Withdrawal by Subject|0
5450781|NCT02151058|18835676|P3|Overall Study|Lost to Follow-up|2
5450782|NCT02151058|18835677|P2|Overall Study|Lost to Follow-up|0
5450783|NCT02151058|18835678|P1|Overall Study|Lost to Follow-up|1
5450784|NCT02151058|18835676|P3|Overall Study|Withdrawal by Subject|3
5450785|NCT02151058|18835677|P2|Overall Study|Withdrawal by Subject|1
5450786|NCT02151058|18835678|P1|Overall Study|Withdrawal by Subject|1
5450787|NCT02150954|18835712|P2|Overall Study|Protocol Violation|0
5450788|NCT02150954|18835713|P1|Overall Study|Protocol Violation|1
5450789|NCT02150863|18835738|P3|Overall Study|Lost to Follow-up|0
5450790|NCT02150863|18835739|P2|Overall Study|Lost to Follow-up|1
5450791|NCT02150863|18835740|P1|Overall Study|Lost to Follow-up|0
5450792|NCT02150343|18835986|P4|Overall Study|Other|2
5450793|NCT02150343|18835987|P3|Overall Study|Other|0
5450794|NCT02150343|18835988|P2|Overall Study|Other|6
5450795|NCT02150343|18835989|P1|Overall Study|Other|2
5450796|NCT02150343|18835986|P4|Overall Study|Lost to Follow-up|3
5450797|NCT02150343|18835987|P3|Overall Study|Lost to Follow-up|2
5450798|NCT02150343|18835988|P2|Overall Study|Lost to Follow-up|4
5450799|NCT02150343|18835989|P1|Overall Study|Lost to Follow-up|4
5450800|NCT02150343|18835986|P4|Overall Study|Withdrawal by Subject|4
5450801|NCT02150343|18835987|P3|Overall Study|Withdrawal by Subject|9
5450802|NCT02150343|18835988|P2|Overall Study|Withdrawal by Subject|10
5450803|NCT02150343|18835989|P1|Overall Study|Withdrawal by Subject|13
5450804|NCT02150343|18835986|P4|Overall Study|Adverse Event|1
5450805|NCT02150343|18835987|P3|Overall Study|Adverse Event|1
5450806|NCT02150343|18835988|P2|Overall Study|Adverse Event|0
5450807|NCT02150343|18835989|P1|Overall Study|Adverse Event|2
5450808|NCT02150213|18836027|P1|Overall Study|Withdrawal by Subject|1
5450809|NCT02150213|18836027|P1|Overall Study|Lost to Follow-up|1
5450810|NCT02150057|18836046|P2|Overall Study|Lost to Follow-up|4
5450811|NCT02150057|18836047|P1|Overall Study|Lost to Follow-up|6
5450812|NCT02149875|18836062|P3|Overall Study|Physician Decision|2
5450813|NCT02149875|18836063|P2|Overall Study|Physician Decision|2
5450814|NCT02149875|18836064|P1|Overall Study|Physician Decision|1
5450815|NCT02149875|18836062|P3|Overall Study|Withdrawal by Subject|2
5450816|NCT02149875|18836063|P2|Overall Study|Withdrawal by Subject|2
5450817|NCT02149875|18836064|P1|Overall Study|Withdrawal by Subject|3
5450818|NCT02149875|18836062|P3|Overall Study|Lost to Follow-up|5
5450819|NCT02149875|18836063|P2|Overall Study|Lost to Follow-up|4
5450820|NCT02149875|18836064|P1|Overall Study|Lost to Follow-up|3
5450821|NCT02149836|18836075|P1|Overall Study|Withdrawal by Subject|1
5450822|NCT02149420|18836102|P3|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
5450823|NCT02149420|18836103|P2|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
5450824|NCT02149420|18836104|P1|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
5450825|NCT02149420|18836102|P3|Core Study|Administrative problems|2
5450826|NCT02149420|18836103|P2|Core Study|Administrative problems|1
5450827|NCT02149420|18836104|P1|Core Study|Administrative problems|0
5450828|NCT02149264|18836180|P1|Overall Study|Protocol Violation|1
5450829|NCT02149264|18836180|P1|Overall Study|Physician Decision|3
5450830|NCT02149264|18836180|P1|Overall Study|Adverse Event|7
5450831|NCT02149264|18836180|P1|Overall Study|Withdrawal by Subject|9
5450832|NCT02149199|18836196|P3|Overall Study|Adverse Event|9
5450833|NCT02149199|18836197|P2|Overall Study|Adverse Event|15
5450834|NCT02149199|18836198|P1|Overall Study|Adverse Event|6
5450835|NCT02149199|18836196|P3|Overall Study|Death|1
5450836|NCT02149199|18836197|P2|Overall Study|Death|0
5450837|NCT02149199|18836198|P1|Overall Study|Death|0
5450838|NCT02149199|18836196|P3|Overall Study|Lost to Follow-up|11
5450839|NCT02149199|18836197|P2|Overall Study|Lost to Follow-up|12
5450840|NCT02149199|18836198|P1|Overall Study|Lost to Follow-up|3
5450841|NCT02149199|18836196|P3|Overall Study|Protocol Violation|15
5450842|NCT02149199|18836197|P2|Overall Study|Protocol Violation|13
5450843|NCT02149199|18836198|P1|Overall Study|Protocol Violation|16
5450844|NCT02149199|18836196|P3|Overall Study|Withdrawal by Subject|77
5450845|NCT02149199|18836197|P2|Overall Study|Withdrawal by Subject|93
5450846|NCT02149199|18836198|P1|Overall Study|Withdrawal by Subject|75
5450847|NCT02149199|18836196|P3|Overall Study|Eligibility criteria not fulfilled|8
5450848|NCT02149199|18836197|P2|Overall Study|Eligibility criteria not fulfilled|14
5450849|NCT02149199|18836198|P1|Overall Study|Eligibility criteria not fulfilled|9
5450850|NCT02149199|18836196|P3|Overall Study|Other|20
5450851|NCT02149199|18836197|P2|Overall Study|Other|25
5450852|NCT02149199|18836198|P1|Overall Study|Other|20
5450853|NCT02149199|18836196|P3|Overall Study|Study specific withdrawal criteria|6
5450854|NCT02149199|18836197|P2|Overall Study|Study specific withdrawal criteria|21
5450855|NCT02149199|18836198|P1|Overall Study|Study specific withdrawal criteria|4
5450856|NCT02149108|18836277|P2|Overall Study|Lost to Follow-up|0
5450857|NCT02149108|18836278|P1|Overall Study|Lost to Follow-up|1
5450858|NCT02149108|18836277|P2|Overall Study|Refusal to continue trial medication|11
5450859|NCT02149108|18836278|P1|Overall Study|Refusal to continue trial medication|15
5450860|NCT02149108|18836277|P2|Overall Study|Other not defined above|2
5450861|NCT02149108|18836278|P1|Overall Study|Other not defined above|0
5450862|NCT02149108|18836277|P2|Overall Study|Other Adverse Event (AE)|18
5450863|NCT02149108|18836278|P1|Overall Study|Other Adverse Event (AE)|8
5450864|NCT02149108|18836277|P2|Overall Study|Worsening/adverse event cancer disease|32
5450865|NCT02149108|18836278|P1|Overall Study|Worsening/adverse event cancer disease|31
5450866|NCT02149108|18836277|P2|Overall Study|Progressive Disease (PD)|318
5450867|NCT02149108|18836278|P1|Overall Study|Progressive Disease (PD)|324
5450868|NCT02149108|18836277|P2|Overall Study|Not treated|2
5450869|NCT02149108|18836278|P1|Overall Study|Not treated|1
5450870|NCT02148952|18836292|P2|Follow-Up|Withdrawal by Subject|48
5450871|NCT02148952|18836293|P1|Follow-Up|Withdrawal by Subject|46
5450872|NCT02148952|18836292|P2|Follow-Up|Lost to Follow-up|231
5450873|NCT02148952|18836293|P1|Follow-Up|Lost to Follow-up|219
5450874|NCT02148952|18836292|P2|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
5450875|NCT02148952|18836293|P1|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
5450876|NCT02148952|18836292|P2|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
5450877|NCT02148952|18836293|P1|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
5450878|NCT02148718|18836376|P1|Overall Study|Discontinued Study Prematurely|5
5450879|NCT02148718|18836376|P1|Overall Study|Protocol Violation|26
5450880|NCT02148445|18836424|P2|Overall Study|Death|3
5450881|NCT02148445|18836425|P1|Overall Study|Death|1
5450882|NCT02148250|18836476|P2|Screening|Withdrawal by Subject|0
5450883|NCT02148250|18836477|P1|Screening|Withdrawal by Subject|5
5450884|NCT02148211|18836491|P1|Overall Study|Lost to Follow-up|352
5450885|NCT02148133|18836500|P1|Overall Study|Protocol-defined stopping criteria|2
5450886|NCT02148133|18836500|P1|Overall Study|Protocol deviation|1
5450887|NCT02148133|18836500|P1|Overall Study|Lack of Efficacy|1
5450888|NCT02148133|18836500|P1|Overall Study|Investigator discretion|1
5450889|NCT02147691|18836649|P2|Overall Study|Lost to Follow-up|1
5450890|NCT02147691|18836650|P1|Overall Study|Lost to Follow-up|0
5450891|NCT02147691|18836649|P2|Overall Study|Adverse Event|0
5450892|NCT02147691|18836650|P1|Overall Study|Adverse Event|2
5450893|NCT02147691|18836649|P2|Overall Study|Withdrawal by Subject|0
5450894|NCT02147691|18836650|P1|Overall Study|Withdrawal by Subject|2
5450895|NCT02147587|18836709|P2|Overall Study|Lack of Efficacy|1
5450896|NCT02147587|18836710|P1|Overall Study|Lack of Efficacy|2
5450897|NCT02147587|18836709|P2|Overall Study|Adverse Event|4
5450898|NCT02147587|18836710|P1|Overall Study|Adverse Event|9
5450899|NCT02147561|18836730|P1|Overall Study|Subjects who didn't receive BOTOX|1
5450900|NCT02147561|18836730|P1|Overall Study|Lost to Follow-up|3
5450901|NCT02147353|18836751|P2|Overall Study|medication noncompliance|0
5450902|NCT02147353|18836752|P1|Overall Study|medication noncompliance|3
5450903|NCT02147353|18836751|P2|Overall Study|unable to make visits|0
5450904|NCT02147353|18836752|P1|Overall Study|unable to make visits|4
5450905|NCT02147353|18836751|P2|Overall Study|Lost to Follow-up|0
5450906|NCT02147353|18836752|P1|Overall Study|Lost to Follow-up|2
5450907|NCT02147288|18836785|P10|Overall Study|complications from concurrent hernia rep|0
5450908|NCT02147288|18836786|P9|Overall Study|complications from concurrent hernia rep|0
5450909|NCT02147288|18836787|P8|Overall Study|complications from concurrent hernia rep|0
5450910|NCT02147288|18836788|P7|Overall Study|complications from concurrent hernia rep|0
5450911|NCT02147288|18836789|P6|Overall Study|complications from concurrent hernia rep|0
5450912|NCT02147288|18836790|P5|Overall Study|complications from concurrent hernia rep|0
5450913|NCT02147288|18836791|P4|Overall Study|complications from concurrent hernia rep|0
5450914|NCT02147288|18836792|P3|Overall Study|complications from concurrent hernia rep|0
5450915|NCT02147288|18836793|P2|Overall Study|complications from concurrent hernia rep|1
5450916|NCT02147288|18836794|P1|Overall Study|complications from concurrent hernia rep|0
5450917|NCT02147288|18836785|P10|Overall Study|post-operative hematoma|0
5450918|NCT02147288|18836786|P9|Overall Study|post-operative hematoma|0
5450919|NCT02147288|18836787|P8|Overall Study|post-operative hematoma|0
5450920|NCT02147288|18836788|P7|Overall Study|post-operative hematoma|0
5450921|NCT02147288|18836789|P6|Overall Study|post-operative hematoma|0
5450922|NCT02147288|18836790|P5|Overall Study|post-operative hematoma|0
5450923|NCT02147288|18836791|P4|Overall Study|post-operative hematoma|0
5450924|NCT02147288|18836792|P3|Overall Study|post-operative hematoma|0
5450925|NCT02147288|18836793|P2|Overall Study|post-operative hematoma|1
5450926|NCT02147288|18836794|P1|Overall Study|post-operative hematoma|1
5450927|NCT02147197|18836803|P3|Overall Study|Other Miscellaneous Reasons|3
5450928|NCT02147197|18836804|P2|Overall Study|Other Miscellaneous Reasons|0
5450929|NCT02147197|18836805|P1|Overall Study|Other Miscellaneous Reasons|1
5450930|NCT02147197|18836803|P3|Overall Study|Protocol Violation|3
5450931|NCT02147197|18836804|P2|Overall Study|Protocol Violation|0
5450932|NCT02147197|18836805|P1|Overall Study|Protocol Violation|1
5450933|NCT02147197|18836803|P3|Overall Study|Lost to Follow-up|1
5450934|NCT02147197|18836804|P2|Overall Study|Lost to Follow-up|3
5450935|NCT02147197|18836805|P1|Overall Study|Lost to Follow-up|2
5450936|NCT02147197|18836803|P3|Overall Study|Withdrawal of Consent|2
5450937|NCT02147197|18836804|P2|Overall Study|Withdrawal of Consent|3
5450938|NCT02147197|18836805|P1|Overall Study|Withdrawal of Consent|4
5450939|NCT02147197|18836803|P3|Overall Study|Adverse Event|0
5450940|NCT02147197|18836804|P2|Overall Study|Adverse Event|0
5450941|NCT02147197|18836805|P1|Overall Study|Adverse Event|1
5450942|NCT02147184|18836824|P2|Overall Study|Other|0
5450943|NCT02147184|18836825|P1|Overall Study|Other|1
5450944|NCT02147184|18836824|P2|Overall Study|Physician Decision|2
5450945|NCT02147184|18836825|P1|Overall Study|Physician Decision|0
5450946|NCT02147184|18836824|P2|Overall Study|Moved out of state|3
5450947|NCT02147184|18836825|P1|Overall Study|Moved out of state|3
5450948|NCT02147184|18836824|P2|Overall Study|Pregnancy|0
5450949|NCT02147184|18836825|P1|Overall Study|Pregnancy|6
5450950|NCT02147184|18836824|P2|Overall Study|Study Burden|7
5450951|NCT02147184|18836825|P1|Overall Study|Study Burden|11
5450952|NCT02147184|18836824|P2|Overall Study|Lost to Follow-up|15
5450953|NCT02147184|18836825|P1|Overall Study|Lost to Follow-up|28
5450954|NCT02147158|18836849|P6|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
5450955|NCT02147158|18836850|P5|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
5450956|NCT02147158|18836851|P4|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
5450957|NCT02147158|18836852|P3|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
5450958|NCT02147158|18836853|P2|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
5450959|NCT02147158|18836854|P1|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
5450960|NCT02147158|18836849|P6|Off-Treatment Interval 2|Protocol Violation|0
5450961|NCT02147158|18836850|P5|Off-Treatment Interval 2|Protocol Violation|0
5450962|NCT02147158|18836851|P4|Off-Treatment Interval 2|Protocol Violation|1
5450963|NCT02147158|18836852|P3|Off-Treatment Interval 2|Protocol Violation|0
5450964|NCT02147158|18836853|P2|Off-Treatment Interval 2|Protocol Violation|0
5450965|NCT02147158|18836854|P1|Off-Treatment Interval 2|Protocol Violation|0
5450966|NCT02147158|18836849|P6|Off-Treatment Interval 2|Lost to Follow-up|2
5450967|NCT02147158|18836850|P5|Off-Treatment Interval 2|Lost to Follow-up|2
5450968|NCT02147158|18836851|P4|Off-Treatment Interval 2|Lost to Follow-up|2
5450969|NCT02147158|18836852|P3|Off-Treatment Interval 2|Lost to Follow-up|3
5450970|NCT02147158|18836853|P2|Off-Treatment Interval 2|Lost to Follow-up|0
5450971|NCT02147158|18836854|P1|Off-Treatment Interval 2|Lost to Follow-up|0
5450972|NCT02147158|18836849|P6|Off-Treatment Interval 2|Withdrawal of Consent|1
5450973|NCT02147158|18836850|P5|Off-Treatment Interval 2|Withdrawal of Consent|0
5450974|NCT02147158|18836851|P4|Off-Treatment Interval 2|Withdrawal of Consent|4
5450975|NCT02147158|18836852|P3|Off-Treatment Interval 2|Withdrawal of Consent|5
5450976|NCT02147158|18836853|P2|Off-Treatment Interval 2|Withdrawal of Consent|0
5450977|NCT02147158|18836854|P1|Off-Treatment Interval 2|Withdrawal of Consent|4
5450978|NCT02147158|18836849|P6|Off-Treatment Interval 2|Lack of Efficacy|0
5450979|NCT02147158|18836850|P5|Off-Treatment Interval 2|Lack of Efficacy|0
5450980|NCT02147158|18836851|P4|Off-Treatment Interval 2|Lack of Efficacy|0
5450981|NCT02147158|18836852|P3|Off-Treatment Interval 2|Lack of Efficacy|1
5450982|NCT02147158|18836853|P2|Off-Treatment Interval 2|Lack of Efficacy|1
5450983|NCT02147158|18836854|P1|Off-Treatment Interval 2|Lack of Efficacy|0
5450984|NCT02147158|18836849|P6|Treatment Course 2|Lost to Follow-up|1
5450985|NCT02147158|18836850|P5|Treatment Course 2|Lost to Follow-up|0
5450986|NCT02147158|18836851|P4|Treatment Course 2|Lost to Follow-up|1
5450987|NCT02147158|18836852|P3|Treatment Course 2|Lost to Follow-up|1
5450988|NCT02147158|18836853|P2|Treatment Course 2|Lost to Follow-up|0
5450989|NCT02147158|18836854|P1|Treatment Course 2|Lost to Follow-up|1
5450990|NCT02147158|18836849|P6|Treatment Course 2|Withdrawal of Consent|0
5450991|NCT02147158|18836850|P5|Treatment Course 2|Withdrawal of Consent|0
5450992|NCT02147158|18836851|P4|Treatment Course 2|Withdrawal of Consent|3
5450993|NCT02147158|18836852|P3|Treatment Course 2|Withdrawal of Consent|2
5450994|NCT02147158|18836853|P2|Treatment Course 2|Withdrawal of Consent|1
5450995|NCT02147158|18836854|P1|Treatment Course 2|Withdrawal of Consent|0
5450996|NCT02147158|18836849|P6|Treatment Course 2|Adverse Event|1
5450997|NCT02147158|18836850|P5|Treatment Course 2|Adverse Event|0
5450998|NCT02147158|18836851|P4|Treatment Course 2|Adverse Event|1
5450999|NCT02147158|18836852|P3|Treatment Course 2|Adverse Event|2
5451000|NCT02147158|18836853|P2|Treatment Course 2|Adverse Event|4
5451001|NCT02147158|18836854|P1|Treatment Course 2|Adverse Event|0
5451002|NCT02147158|18836849|P6|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
5451003|NCT02147158|18836850|P5|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
5451004|NCT02147158|18836851|P4|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
5451005|NCT02147158|18836852|P3|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
5451006|NCT02147158|18836853|P2|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
5451007|NCT02147158|18836854|P1|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
5451008|NCT02147158|18836849|P6|Off-Treatment Interval 1|Lack of Efficacy|0
5451009|NCT02147158|18836850|P5|Off-Treatment Interval 1|Lack of Efficacy|1
5451010|NCT02147158|18836851|P4|Off-Treatment Interval 1|Lack of Efficacy|0
5451011|NCT02147158|18836852|P3|Off-Treatment Interval 1|Lack of Efficacy|2
5451012|NCT02147158|18836853|P2|Off-Treatment Interval 1|Lack of Efficacy|0
5451013|NCT02147158|18836854|P1|Off-Treatment Interval 1|Lack of Efficacy|0
5451014|NCT02147158|18836849|P6|Off-Treatment Interval 1|Withdrawal of Consent|3
5451015|NCT02147158|18836850|P5|Off-Treatment Interval 1|Withdrawal of Consent|2
5451016|NCT02147158|18836851|P4|Off-Treatment Interval 1|Withdrawal of Consent|10
5451017|NCT02147158|18836852|P3|Off-Treatment Interval 1|Withdrawal of Consent|5
5451018|NCT02147158|18836853|P2|Off-Treatment Interval 1|Withdrawal of Consent|3
5451019|NCT02147158|18836854|P1|Off-Treatment Interval 1|Withdrawal of Consent|4
5451020|NCT02147158|18836849|P6|Off-Treatment Interval 1|Protocol Violation|0
5451021|NCT02147158|18836850|P5|Off-Treatment Interval 1|Protocol Violation|1
5451022|NCT02147158|18836851|P4|Off-Treatment Interval 1|Protocol Violation|0
5451023|NCT02147158|18836852|P3|Off-Treatment Interval 1|Protocol Violation|2
5451024|NCT02147158|18836853|P2|Off-Treatment Interval 1|Protocol Violation|0
5451025|NCT02147158|18836854|P1|Off-Treatment Interval 1|Protocol Violation|1
5451026|NCT02147158|18836849|P6|Off-Treatment Interval 1|Lost to Follow-up|2
5451027|NCT02147158|18836850|P5|Off-Treatment Interval 1|Lost to Follow-up|4
5451028|NCT02147158|18836851|P4|Off-Treatment Interval 1|Lost to Follow-up|2
5451029|NCT02147158|18836852|P3|Off-Treatment Interval 1|Lost to Follow-up|3
5451030|NCT02147158|18836853|P2|Off-Treatment Interval 1|Lost to Follow-up|1
5451031|NCT02147158|18836854|P1|Off-Treatment Interval 1|Lost to Follow-up|2
5451032|NCT02147158|18836849|P6|Off-Treatment Interval 1|Adverse Event|0
5451033|NCT02147158|18836850|P5|Off-Treatment Interval 1|Adverse Event|0
5451034|NCT02147158|18836851|P4|Off-Treatment Interval 1|Adverse Event|1
5451035|NCT02147158|18836852|P3|Off-Treatment Interval 1|Adverse Event|0
5451036|NCT02147158|18836853|P2|Off-Treatment Interval 1|Adverse Event|0
5451037|NCT02147158|18836854|P1|Off-Treatment Interval 1|Adverse Event|1
5451038|NCT02147158|18836849|P6|Treatment Course 1|Withdrawal of Consent|2
5451039|NCT02147158|18836850|P5|Treatment Course 1|Withdrawal of Consent|3
5451040|NCT02147158|18836851|P4|Treatment Course 1|Withdrawal of Consent|5
5451041|NCT02147158|18836852|P3|Treatment Course 1|Withdrawal of Consent|1
5451042|NCT02147158|18836853|P2|Treatment Course 1|Withdrawal of Consent|1
5451043|NCT02147158|18836854|P1|Treatment Course 1|Withdrawal of Consent|1
5451044|NCT02147158|18836849|P6|Treatment Course 1|Protocol Violation|0
5451045|NCT02147158|18836850|P5|Treatment Course 1|Protocol Violation|0
5451046|NCT02147158|18836851|P4|Treatment Course 1|Protocol Violation|1
5451047|NCT02147158|18836852|P3|Treatment Course 1|Protocol Violation|1
5451048|NCT02147158|18836853|P2|Treatment Course 1|Protocol Violation|0
5451049|NCT02147158|18836854|P1|Treatment Course 1|Protocol Violation|0
5451050|NCT02147158|18836849|P6|Treatment Course 1|Lost to Follow-up|4
5451051|NCT02147158|18836850|P5|Treatment Course 1|Lost to Follow-up|2
5451052|NCT02147158|18836851|P4|Treatment Course 1|Lost to Follow-up|3
5451053|NCT02147158|18836852|P3|Treatment Course 1|Lost to Follow-up|3
5451054|NCT02147158|18836853|P2|Treatment Course 1|Lost to Follow-up|4
5451055|NCT02147158|18836854|P1|Treatment Course 1|Lost to Follow-up|2
5451056|NCT02147158|18836849|P6|Treatment Course 1|Adverse Event|2
5451057|NCT02147158|18836850|P5|Treatment Course 1|Adverse Event|1
5451058|NCT02147158|18836851|P4|Treatment Course 1|Adverse Event|4
5451059|NCT02147158|18836852|P3|Treatment Course 1|Adverse Event|3
5451060|NCT02147158|18836853|P2|Treatment Course 1|Adverse Event|4
5451061|NCT02147158|18836854|P1|Treatment Course 1|Adverse Event|1
5451062|NCT02147132|18836883|P4|Overall Study|Lost to Follow-up|0
5451063|NCT02147132|18836884|P3|Overall Study|Lost to Follow-up|0
5451064|NCT02147132|18836885|P2|Overall Study|Lost to Follow-up|0
5451065|NCT02147132|18836886|P1|Overall Study|Lost to Follow-up|1
5451066|NCT02147093|18836906|P2|Period 2|Protocol Violation|0
5451067|NCT02147093|18836907|P1|Period 2|Protocol Violation|2
5451068|NCT02147093|18836906|P2|Period 1|Lost to Follow-up|1
5451069|NCT02147093|18836907|P1|Period 1|Lost to Follow-up|0
5451070|NCT02147067|18836917|P2|Overall Study|Withdrawal by Subject|2
5451071|NCT02147067|18836918|P1|Overall Study|Withdrawal by Subject|2
5451072|NCT02146599|18836944|P1|Overall Study|Failed to meet inclusion criteria|5
5451073|NCT02146430|18836961|P4|Overall Study|Withdrawal by Subject|34
5451074|NCT02146430|18836962|P3|Overall Study|Withdrawal by Subject|30
5451075|NCT02146430|18836963|P2|Overall Study|Withdrawal by Subject|29
5451076|NCT02146430|18836964|P1|Overall Study|Withdrawal by Subject|27
5451077|NCT02146430|18836961|P4|Overall Study|Reason missing or not reported|5
5451078|NCT02146430|18836962|P3|Overall Study|Reason missing or not reported|4
5451079|NCT02146430|18836963|P2|Overall Study|Reason missing or not reported|3
5451080|NCT02146430|18836964|P1|Overall Study|Reason missing or not reported|2
5451081|NCT02146430|18836961|P4|Overall Study|Adverse Event|49
5451082|NCT02146430|18836962|P3|Overall Study|Adverse Event|32
5451083|NCT02146430|18836963|P2|Overall Study|Adverse Event|40
5451084|NCT02146430|18836964|P1|Overall Study|Adverse Event|20
5451085|NCT02146430|18836961|P4|Overall Study|Lack of Efficacy|5
5451086|NCT02146430|18836962|P3|Overall Study|Lack of Efficacy|8
5451087|NCT02146430|18836963|P2|Overall Study|Lack of Efficacy|11
5451088|NCT02146430|18836964|P1|Overall Study|Lack of Efficacy|13
5451089|NCT02146430|18836961|P4|Overall Study|Protocol Violation|6
5451090|NCT02146430|18836962|P3|Overall Study|Protocol Violation|8
5451091|NCT02146430|18836963|P2|Overall Study|Protocol Violation|4
5451092|NCT02146430|18836964|P1|Overall Study|Protocol Violation|5
5451093|NCT02146365|18837024|P8|Overall Study|Other|0
5451094|NCT02146365|18837025|P7|Overall Study|Other|0
5451095|NCT02146365|18837026|P6|Overall Study|Other|0
5451096|NCT02146365|18837027|P5|Overall Study|Other|0
5451097|NCT02146365|18837028|P4|Overall Study|Other|1
5451098|NCT02146365|18837029|P3|Overall Study|Other|2
5451099|NCT02146365|18837030|P2|Overall Study|Other|0
5451100|NCT02146365|18837031|P1|Overall Study|Other|1
5451101|NCT02146365|18837024|P8|Overall Study|Unable to Comply with Protocol|0
5451102|NCT02146365|18837025|P7|Overall Study|Unable to Comply with Protocol|0
5451103|NCT02146365|18837026|P6|Overall Study|Unable to Comply with Protocol|0
5451104|NCT02146365|18837027|P5|Overall Study|Unable to Comply with Protocol|0
5451105|NCT02146365|18837028|P4|Overall Study|Unable to Comply with Protocol|0
5451106|NCT02146365|18837029|P3|Overall Study|Unable to Comply with Protocol|1
5451107|NCT02146365|18837030|P2|Overall Study|Unable to Comply with Protocol|1
5451108|NCT02146365|18837031|P1|Overall Study|Unable to Comply with Protocol|0
5451109|NCT02146365|18837024|P8|Overall Study|Withdrawal by Subject|0
5451110|NCT02146365|18837025|P7|Overall Study|Withdrawal by Subject|0
5451111|NCT02146365|18837026|P6|Overall Study|Withdrawal by Subject|0
5451112|NCT02146365|18837027|P5|Overall Study|Withdrawal by Subject|1
5451113|NCT02146365|18837028|P4|Overall Study|Withdrawal by Subject|5
5451114|NCT02146365|18837029|P3|Overall Study|Withdrawal by Subject|1
5451115|NCT02146365|18837030|P2|Overall Study|Withdrawal by Subject|2
5451116|NCT02146365|18837031|P1|Overall Study|Withdrawal by Subject|1
5451117|NCT02146365|18837024|P8|Overall Study|Lost to Follow-up|1
5451118|NCT02146365|18837025|P7|Overall Study|Lost to Follow-up|0
5451119|NCT02146365|18837026|P6|Overall Study|Lost to Follow-up|1
5451120|NCT02146365|18837027|P5|Overall Study|Lost to Follow-up|1
5451121|NCT02146365|18837028|P4|Overall Study|Lost to Follow-up|3
5451122|NCT02146365|18837029|P3|Overall Study|Lost to Follow-up|3
5451123|NCT02146365|18837030|P2|Overall Study|Lost to Follow-up|1
5451124|NCT02146365|18837031|P1|Overall Study|Lost to Follow-up|2
5451125|NCT02146352|18837157|P1|Overall Study|Patient entered hospice care|1
5451126|NCT02146352|18837157|P1|Overall Study|Death|1
5451127|NCT02146326|18837175|P4|Overall Study|Unable to complete interview|6
5451128|NCT02146326|18837176|P3|Overall Study|Unable to complete interview|10
5451129|NCT02146326|18837177|P2|Overall Study|Unable to complete interview|0
5451130|NCT02146326|18837178|P1|Overall Study|Unable to complete interview|0
5451131|NCT02146326|18837175|P4|Overall Study|Death|4
5451132|NCT02146326|18837176|P3|Overall Study|Death|4
5451133|NCT02146326|18837177|P2|Overall Study|Death|0
5451134|NCT02146326|18837178|P1|Overall Study|Death|0
5451135|NCT02146326|18837175|P4|Overall Study|Incarcerated|8
5451136|NCT02146326|18837176|P3|Overall Study|Incarcerated|3
5451137|NCT02146326|18837177|P2|Overall Study|Incarcerated|0
5451138|NCT02146326|18837178|P1|Overall Study|Incarcerated|0
5451139|NCT02146326|18837175|P4|Overall Study|Separated from mental health center|0
5451140|NCT02146326|18837176|P3|Overall Study|Separated from mental health center|0
5451141|NCT02146326|18837177|P2|Overall Study|Separated from mental health center|33
5451142|NCT02146326|18837178|P1|Overall Study|Separated from mental health center|23
5451143|NCT02146326|18837175|P4|Overall Study|Withdrawal by Subject|11
5451144|NCT02146326|18837176|P3|Overall Study|Withdrawal by Subject|15
5451145|NCT02146326|18837177|P2|Overall Study|Withdrawal by Subject|1
5451146|NCT02146326|18837178|P1|Overall Study|Withdrawal by Subject|2
5451147|NCT02146326|18837175|P4|Overall Study|Lost to Follow-up|19
5451148|NCT02146326|18837176|P3|Overall Study|Lost to Follow-up|11
5451149|NCT02146326|18837177|P2|Overall Study|Lost to Follow-up|3
5451150|NCT02146326|18837178|P1|Overall Study|Lost to Follow-up|3
5451151|NCT02146274|18837340|P1|Overall Study|Protocol Violation|73
5451152|NCT02146248|18837347|P1|Overall Study|Withdrawal by Subject|2
5451153|NCT02146131|18837357|P2|Overall Study|Physician Decision|56
5451154|NCT02146131|18837358|P1|Overall Study|Physician Decision|61
5451155|NCT02146105|18837364|P1|Overall Study|Withdrawal by Subject|5
5451156|NCT02146105|18837364|P1|Overall Study|Adverse Event|1
5451157|NCT02145468|18837415|P2|Overall Study|Withdrawal by Subject|8
5451158|NCT02145468|18837416|P1|Overall Study|Withdrawal by Subject|5
5451159|NCT02145429|18837474|P2|Overall Study|Withdrawal by Subject|3
5451160|NCT02145429|18837475|P1|Overall Study|Withdrawal by Subject|8
5451161|NCT02145429|18837474|P2|Overall Study|Lost to Follow-up|3
5451162|NCT02145429|18837475|P1|Overall Study|Lost to Follow-up|4
5451163|NCT02145429|18837474|P2|Overall Study|Death|5
5451164|NCT02145429|18837475|P1|Overall Study|Death|4
5451165|NCT02145390|18837506|P1|Overall Study|Withdrawal by Subject|1
5451166|NCT02145182|18837555|P2|Overall Study|Withdrawal by Subject|4
5451167|NCT02145182|18837556|P1|Overall Study|Withdrawal by Subject|5
5451168|NCT02145182|18837555|P2|Overall Study|Pre-transplant Withdrawal|2
5451169|NCT02145182|18837556|P1|Overall Study|Pre-transplant Withdrawal|0
5451170|NCT02145182|18837555|P2|Overall Study|Lost to Follow-up|2
5451171|NCT02145182|18837556|P1|Overall Study|Lost to Follow-up|2
5451172|NCT02145182|18837555|P2|Overall Study|Death|7
5451173|NCT02145182|18837556|P1|Overall Study|Death|7
5451174|NCT02145182|18837555|P2|Overall Study|Adverse Event|1
5451175|NCT02145182|18837556|P1|Overall Study|Adverse Event|4
5451176|NCT02145156|18837589|P3|Overall Study|No match to vaccination records|41
5451177|NCT02145156|18837590|P2|Overall Study|No match to vaccination records|52
5451178|NCT02145156|18837591|P1|Overall Study|No match to vaccination records|60
5451179|NCT02145078|18837632|P1|Overall Study|Reason not given|3
5451180|NCT02145078|18837632|P1|Overall Study|Death|1
5451181|NCT02145026|18837649|P1|Overall Study|Physician Decision|4
5451182|NCT02145026|18837649|P1|Overall Study|Withdrawal by Subject|2
5451183|NCT02145026|18837649|P1|Overall Study|Death|4
5451184|NCT02145026|18837649|P1|Overall Study|Adverse Event|2
5451185|NCT02144701|18837680|P2|Overall Study|development of relapse, GVHD or death|3
5451186|NCT02144701|18837681|P1|Overall Study|development of relapse, GVHD or death|9
5451187|NCT02144610|18837708|P2|Overall Study|Other|1
5451188|NCT02144610|18837709|P1|Overall Study|Other|0
5451189|NCT02144610|18837708|P2|Overall Study|Study Discontinuation by Sponsor|14
5451190|NCT02144610|18837709|P1|Overall Study|Study Discontinuation by Sponsor|19
5451191|NCT02144610|18837708|P2|Overall Study|Death|2
5451192|NCT02144610|18837709|P1|Overall Study|Death|2
5451193|NCT02144610|18837708|P2|Overall Study|Withdrawal by Subject|5
5451194|NCT02144610|18837709|P1|Overall Study|Withdrawal by Subject|1
5451195|NCT02144610|18837708|P2|Overall Study|Physician Decision|0
5451196|NCT02144610|18837709|P1|Overall Study|Physician Decision|1
5451197|NCT02144337|18837750|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
5451198|NCT02144337|18837751|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
5451199|NCT02144337|18837750|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
5451200|NCT02144337|18837751|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
5451201|NCT02144337|18837750|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
5451202|NCT02144337|18837751|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
5451203|NCT02144337|18837750|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
5451204|NCT02144337|18837751|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
5451205|NCT02144337|18837750|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
5451206|NCT02144337|18837751|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
5451207|NCT02144285|18837771|P10|Overall Study|Withdrawal by Subject|0
5451208|NCT02144285|18837772|P9|Overall Study|Withdrawal by Subject|0
5451209|NCT02144285|18837773|P8|Overall Study|Withdrawal by Subject|0
5451210|NCT02144285|18837774|P7|Overall Study|Withdrawal by Subject|0
5451211|NCT02144285|18837775|P6|Overall Study|Withdrawal by Subject|0
5451212|NCT02144285|18837776|P5|Overall Study|Withdrawal by Subject|1
5451213|NCT02144285|18837777|P4|Overall Study|Withdrawal by Subject|0
5451214|NCT02144285|18837778|P3|Overall Study|Withdrawal by Subject|0
5451215|NCT02144285|18837779|P2|Overall Study|Withdrawal by Subject|0
5451216|NCT02144285|18837780|P1|Overall Study|Withdrawal by Subject|0
5451217|NCT02144220|18837906|P1|Overall Study|Protocol Violation|1
5451218|NCT02144220|18837906|P1|Overall Study|Withdrawal by Subject|2
5451219|NCT02144220|18837906|P1|Overall Study|Physician Decision|3
5451220|NCT02144220|18837906|P1|Overall Study|Lack of Efficacy|4
5451221|NCT02144220|18837906|P1|Overall Study|technology incompatibility|9
5451222|NCT02144077|18837925|P2|Overall Study|no visits 7 & 8/no visits after visit 4|0
5451223|NCT02144077|18837926|P1|Overall Study|no visits 7 & 8/no visits after visit 4|2
5451224|NCT02144077|18837925|P2|Overall Study|Death|1
5451225|NCT02144077|18837926|P1|Overall Study|Death|0
5451226|NCT02144077|18837925|P2|Overall Study|Protocol Violation|2
5451227|NCT02144077|18837926|P1|Overall Study|Protocol Violation|1
5451228|NCT02144077|18837925|P2|Overall Study|Lost to Follow-up|2
5451229|NCT02144077|18837926|P1|Overall Study|Lost to Follow-up|2
5451230|NCT02144077|18837925|P2|Overall Study|Adverse Event|3
5451231|NCT02144077|18837926|P1|Overall Study|Adverse Event|2
5451232|NCT02144077|18837925|P2|Overall Study|Withdrawal by Subject|3
5451233|NCT02144077|18837926|P1|Overall Study|Withdrawal by Subject|3
5451234|NCT02144012|18837944|P2|Overall Study|Other|0
5451235|NCT02144012|18837945|P1|Overall Study|Other|3
5451236|NCT02144012|18837944|P2|Overall Study|Study Terminated by Sponsor|12
5451237|NCT02144012|18837945|P1|Overall Study|Study Terminated by Sponsor|18
5451238|NCT02144012|18837944|P2|Overall Study|Withdrawal by Subject|3
5451239|NCT02144012|18837945|P1|Overall Study|Withdrawal by Subject|11
5451240|NCT02144012|18837944|P2|Overall Study|Death|0
5451241|NCT02144012|18837945|P1|Overall Study|Death|1
5451242|NCT02144012|18837944|P2|Overall Study|Adverse Event|0
5451243|NCT02144012|18837945|P1|Overall Study|Adverse Event|1
5451244|NCT02143947|18837986|P2|Overall Study|Lost to Follow-up|2
5451245|NCT02143947|18837987|P1|Overall Study|Lost to Follow-up|4
5451246|NCT02143843|18837999|P1|Overall Study|Withdrawal by Subject|2
5451247|NCT02143843|18837999|P1|Overall Study|Lack of Efficacy|2
5451248|NCT02143843|18837999|P1|Overall Study|Adverse Event|8
5451249|NCT02143778|18838004|P1|Overall Study|Device malfunction|1
5451250|NCT02143778|18838004|P1|Overall Study|Withdrawal by Subject|2
5451251|NCT02143713|18838013|P4|Post-treatment Follow-up (12 Months)|Other|7
5451252|NCT02143713|18838014|P3|Post-treatment Follow-up (12 Months)|Other|7
5451253|NCT02143713|18838015|P2|Post-treatment Follow-up (12 Months)|Other|4
5451254|NCT02143713|18838016|P1|Post-treatment Follow-up (12 Months)|Other|3
5451255|NCT02143713|18838013|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
5451256|NCT02143713|18838014|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
5451257|NCT02143713|18838015|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
5451258|NCT02143713|18838016|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
5451259|NCT02143713|18838013|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
5451260|NCT02143713|18838014|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
5451261|NCT02143713|18838015|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
5451262|NCT02143713|18838016|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
5451263|NCT02143713|18838013|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
5451264|NCT02143713|18838014|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
5451265|NCT02143713|18838015|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
5451266|NCT02143713|18838016|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
5451267|NCT02143713|18838013|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
5451268|NCT02143713|18838014|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
5451269|NCT02143713|18838015|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
5451270|NCT02143713|18838016|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
5451271|NCT02143713|18838013|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
5451272|NCT02143713|18838014|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
5451273|NCT02143713|18838015|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
5451274|NCT02143713|18838016|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
5451275|NCT02143713|18838013|P4|Treatment Period (6 Months)|Lack of Efficacy|1
5451276|NCT02143713|18838014|P3|Treatment Period (6 Months)|Lack of Efficacy|0
5451277|NCT02143713|18838015|P2|Treatment Period (6 Months)|Lack of Efficacy|0
5451278|NCT02143713|18838016|P1|Treatment Period (6 Months)|Lack of Efficacy|1
5451279|NCT02143713|18838013|P4|Treatment Period (6 Months)|Exclusionary Medication|0
5451280|NCT02143713|18838014|P3|Treatment Period (6 Months)|Exclusionary Medication|0
5451281|NCT02143713|18838015|P2|Treatment Period (6 Months)|Exclusionary Medication|0
5451282|NCT02143713|18838016|P1|Treatment Period (6 Months)|Exclusionary Medication|2
5451283|NCT02143713|18838013|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
5451284|NCT02143713|18838014|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
5451285|NCT02143713|18838015|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
5451286|NCT02143713|18838016|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
5451287|NCT02143713|18838013|P4|Treatment Period (6 Months)|Other|2
5451288|NCT02143713|18838014|P3|Treatment Period (6 Months)|Other|3
5451289|NCT02143713|18838015|P2|Treatment Period (6 Months)|Other|0
5451290|NCT02143713|18838016|P1|Treatment Period (6 Months)|Other|3
5451291|NCT02143713|18838013|P4|Treatment Period (6 Months)|Non-compliance|3
5451292|NCT02143713|18838014|P3|Treatment Period (6 Months)|Non-compliance|0
5451293|NCT02143713|18838015|P2|Treatment Period (6 Months)|Non-compliance|0
5451294|NCT02143713|18838016|P1|Treatment Period (6 Months)|Non-compliance|1
5451295|NCT02143713|18838013|P4|Treatment Period (6 Months)|Pregnancy|0
5451296|NCT02143713|18838014|P3|Treatment Period (6 Months)|Pregnancy|2
5451297|NCT02143713|18838015|P2|Treatment Period (6 Months)|Pregnancy|2
5451298|NCT02143713|18838016|P1|Treatment Period (6 Months)|Pregnancy|0
5451299|NCT02143713|18838013|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
5451300|NCT02143713|18838014|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
5451301|NCT02143713|18838015|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
5451302|NCT02143713|18838016|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
5451303|NCT02143713|18838013|P4|Treatment Period (6 Months)|Lost to Follow-up|3
5451304|NCT02143713|18838014|P3|Treatment Period (6 Months)|Lost to Follow-up|4
5451305|NCT02143713|18838015|P2|Treatment Period (6 Months)|Lost to Follow-up|0
5451306|NCT02143713|18838016|P1|Treatment Period (6 Months)|Lost to Follow-up|3
5451307|NCT02143713|18838013|P4|Treatment Period (6 Months)|Adverse Event|9
5451308|NCT02143713|18838014|P3|Treatment Period (6 Months)|Adverse Event|8
5451309|NCT02143713|18838015|P2|Treatment Period (6 Months)|Adverse Event|8
5451310|NCT02143713|18838016|P1|Treatment Period (6 Months)|Adverse Event|7
5451311|NCT02143713|18838013|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
5451312|NCT02143713|18838014|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
5451313|NCT02143713|18838015|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
5451314|NCT02143713|18838016|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
5451315|NCT02143583|18838110|P3|Overall Study|husband illness|1
5451316|NCT02143583|18838111|P2|Overall Study|husband illness|0
5451317|NCT02143583|18838112|P1|Overall Study|husband illness|0
5451318|NCT02143583|18838110|P3|Overall Study|Withdrawal by Subject|1
5451319|NCT02143583|18838111|P2|Overall Study|Withdrawal by Subject|0
5451320|NCT02143583|18838112|P1|Overall Study|Withdrawal by Subject|1
5451321|NCT02143141|18838135|P2|Overall Study|pain scores at 24 hours not collected|0
5451322|NCT02143141|18838136|P1|Overall Study|pain scores at 24 hours not collected|1
5451323|NCT02143102|18838148|P2|Overall Study|Lost to Follow-up|0
5451324|NCT02143102|18838149|P1|Overall Study|Lost to Follow-up|11
5451325|NCT02143024|18838159|P2|Overall Study|Withdrawal by Subject|0
5451326|NCT02143024|18838160|P1|Overall Study|Withdrawal by Subject|1
5451327|NCT02143024|18838159|P2|Overall Study|Lost to Follow-up|1
5451328|NCT02143024|18838160|P1|Overall Study|Lost to Follow-up|1
5451329|NCT02142894|18838166|P1|Overall Study|Protocol Violation|8
5451330|NCT02142738|18838172|P2|Overall Study|Ongoing in Study|82
5451331|NCT02142738|18838173|P1|Overall Study|Ongoing in Study|107
5451332|NCT02142738|18838172|P2|Overall Study|Withdrawal by Subject|5
5451333|NCT02142738|18838173|P1|Overall Study|Withdrawal by Subject|5
5451334|NCT02142738|18838172|P2|Overall Study|Progressive Disease|1
5451335|NCT02142738|18838173|P1|Overall Study|Progressive Disease|0
5451336|NCT02142738|18838172|P2|Overall Study|Death|55
5451337|NCT02142738|18838173|P1|Overall Study|Death|33
5451338|NCT02142738|18838172|P2|Overall Study|Adverse Event|8
5451339|NCT02142738|18838173|P1|Overall Study|Adverse Event|9
5451340|NCT02142712|18838186|P4|Overall Study|Lost to Follow-up|0
5451341|NCT02142712|18838187|P3|Overall Study|Lost to Follow-up|1
5451342|NCT02142712|18838188|P2|Overall Study|Lost to Follow-up|1
5451343|NCT02142712|18838189|P1|Overall Study|Lost to Follow-up|1
5451344|NCT02142504|18838217|P3|Overall Study|Reason Not Specified|4
5451345|NCT02142504|18838218|P2|Overall Study|Reason Not Specified|5
5451346|NCT02142504|18838219|P1|Overall Study|Reason Not Specified|4
5451347|NCT02142504|18838217|P3|Overall Study|Physician Decision|3
5451348|NCT02142504|18838218|P2|Overall Study|Physician Decision|1
5451349|NCT02142504|18838219|P1|Overall Study|Physician Decision|0
5451350|NCT02142504|18838217|P3|Overall Study|Pregnancy|2
5451351|NCT02142504|18838218|P2|Overall Study|Pregnancy|4
5451352|NCT02142504|18838219|P1|Overall Study|Pregnancy|4
5451353|NCT02142504|18838217|P3|Overall Study|Withdrawal by Subject|11
5451354|NCT02142504|18838218|P2|Overall Study|Withdrawal by Subject|9
5451355|NCT02142504|18838219|P1|Overall Study|Withdrawal by Subject|7
5451356|NCT02142504|18838217|P3|Overall Study|Lost to Follow-up|17
5451357|NCT02142504|18838218|P2|Overall Study|Lost to Follow-up|19
5451358|NCT02142504|18838219|P1|Overall Study|Lost to Follow-up|12
5451359|NCT02142504|18838217|P3|Overall Study|Adverse Event|4
5451360|NCT02142504|18838218|P2|Overall Study|Adverse Event|3
5451361|NCT02142504|18838219|P1|Overall Study|Adverse Event|2
5451362|NCT02142504|18838217|P3|Overall Study|Protocol Violation|2
5451363|NCT02142504|18838218|P2|Overall Study|Protocol Violation|1
5451364|NCT02142504|18838219|P1|Overall Study|Protocol Violation|2
5451365|NCT02142387|18838307|P2|Overall Study|occurred not at home|2474
5451366|NCT02142387|18838308|P1|Overall Study|occurred not at home|298
5451367|NCT02142387|18838307|P2|Overall Study|incomplete data|9
5451368|NCT02142387|18838308|P1|Overall Study|incomplete data|1
5451369|NCT02142387|18838307|P2|Overall Study|witnessed by paramedic|917
5451370|NCT02142387|18838308|P1|Overall Study|witnessed by paramedic|139
5451371|NCT02142387|18838307|P2|Overall Study|CPR not performed|473
5451372|NCT02142387|18838308|P1|Overall Study|CPR not performed|74
5451373|NCT02142387|18838307|P2|Overall Study|non-cardiac etiology|3431
5451374|NCT02142387|18838308|P1|Overall Study|non-cardiac etiology|504
5451375|NCT02142387|18838307|P2|Overall Study|<19 years old|326
5451376|NCT02142387|18838308|P1|Overall Study|<19 years old|49
5451377|NCT02142283|18838421|P2|Overall Study|Withdrawal by Subject|3
5451378|NCT02142283|18838422|P1|Overall Study|Withdrawal by Subject|1
5451379|NCT02142283|18838421|P2|Overall Study|Death|18
5451380|NCT02142283|18838422|P1|Overall Study|Death|20
5451381|NCT02141997|18838531|P4|Overall Study|Other|0
5451382|NCT02141997|18838532|P3|Overall Study|Other|0
5451383|NCT02141997|18838533|P2|Overall Study|Other|4
5451384|NCT02141997|18838534|P1|Overall Study|Other|1
5451385|NCT02141997|18838531|P4|Overall Study|Withdrew consent|0
5451386|NCT02141997|18838532|P3|Overall Study|Withdrew consent|3
5451387|NCT02141997|18838533|P2|Overall Study|Withdrew consent|0
5451388|NCT02141997|18838534|P1|Overall Study|Withdrew consent|1
5451389|NCT02141997|18838531|P4|Overall Study|Participant noncompliance|0
5451390|NCT02141997|18838532|P3|Overall Study|Participant noncompliance|0
5451391|NCT02141997|18838533|P2|Overall Study|Participant noncompliance|0
5451392|NCT02141997|18838534|P1|Overall Study|Participant noncompliance|1
5451393|NCT02141997|18838531|P4|Overall Study|Adverse Event|1
5451394|NCT02141997|18838532|P3|Overall Study|Adverse Event|0
5451395|NCT02141997|18838533|P2|Overall Study|Adverse Event|2
5451396|NCT02141997|18838534|P1|Overall Study|Adverse Event|0
5451397|NCT02141984|18838572|P1|Overall Study|Lack of Efficacy|2
5451398|NCT02141854|18838591|P6|Treatment Period|Lost to Follow-up|1
5451399|NCT02141854|18838592|P5|Treatment Period|Lost to Follow-up|0
5451400|NCT02141854|18838593|P4|Treatment Period|Lost to Follow-up|1
5451401|NCT02141854|18838594|P3|Treatment Period|Lost to Follow-up|1
5451402|NCT02141854|18838595|P2|Treatment Period|Lost to Follow-up|1
5451403|NCT02141854|18838596|P1|Treatment Period|Lost to Follow-up|0
5451404|NCT02141854|18838591|P6|Treatment Period|Disease progression|18
5451405|NCT02141854|18838592|P5|Treatment Period|Disease progression|0
5451406|NCT02141854|18838593|P4|Treatment Period|Disease progression|3
5451407|NCT02141854|18838594|P3|Treatment Period|Disease progression|1
5451408|NCT02141854|18838595|P2|Treatment Period|Disease progression|2
5451409|NCT02141854|18838596|P1|Treatment Period|Disease progression|0
5451410|NCT02141854|18838591|P6|Treatment Period|Withdrawal by Subject|7
5451411|NCT02141854|18838592|P5|Treatment Period|Withdrawal by Subject|4
5451412|NCT02141854|18838593|P4|Treatment Period|Withdrawal by Subject|3
5451413|NCT02141854|18838594|P3|Treatment Period|Withdrawal by Subject|3
5451414|NCT02141854|18838595|P2|Treatment Period|Withdrawal by Subject|2
5451415|NCT02141854|18838596|P1|Treatment Period|Withdrawal by Subject|0
5451416|NCT02141854|18838591|P6|Treatment Period|Adverse Event|2
5451417|NCT02141854|18838592|P5|Treatment Period|Adverse Event|2
5451418|NCT02141854|18838593|P4|Treatment Period|Adverse Event|0
5451419|NCT02141854|18838594|P3|Treatment Period|Adverse Event|2
5451420|NCT02141854|18838595|P2|Treatment Period|Adverse Event|2
5451421|NCT02141854|18838596|P1|Treatment Period|Adverse Event|0
5451422|NCT02141854|18838591|P6|Treatment Period|Other|2
5451423|NCT02141854|18838592|P5|Treatment Period|Other|1
5451424|NCT02141854|18838593|P4|Treatment Period|Other|0
5451425|NCT02141854|18838594|P3|Treatment Period|Other|2
5451426|NCT02141854|18838595|P2|Treatment Period|Other|1
5451427|NCT02141854|18838596|P1|Treatment Period|Other|0
5451428|NCT02141854|18838591|P6|Treatment Period|Pregnancy|0
5451429|NCT02141854|18838592|P5|Treatment Period|Pregnancy|0
5451430|NCT02141854|18838593|P4|Treatment Period|Pregnancy|0
5451431|NCT02141854|18838594|P3|Treatment Period|Pregnancy|0
5451432|NCT02141854|18838595|P2|Treatment Period|Pregnancy|1
5451433|NCT02141854|18838596|P1|Treatment Period|Pregnancy|0
5451434|NCT02141854|18838591|P6|Treatment Period|Lack of Efficacy|7
5451435|NCT02141854|18838592|P5|Treatment Period|Lack of Efficacy|1
5451436|NCT02141854|18838593|P4|Treatment Period|Lack of Efficacy|1
5451437|NCT02141854|18838594|P3|Treatment Period|Lack of Efficacy|0
5451438|NCT02141854|18838595|P2|Treatment Period|Lack of Efficacy|0
5451439|NCT02141854|18838596|P1|Treatment Period|Lack of Efficacy|0
5451440|NCT02141854|18838591|P6|Treatment Period|Noncompliance|0
5451441|NCT02141854|18838592|P5|Treatment Period|Noncompliance|0
5451442|NCT02141854|18838593|P4|Treatment Period|Noncompliance|1
5451443|NCT02141854|18838594|P3|Treatment Period|Noncompliance|0
5451444|NCT02141854|18838595|P2|Treatment Period|Noncompliance|0
5451445|NCT02141854|18838596|P1|Treatment Period|Noncompliance|0
5451446|NCT02141854|18838591|P6|Treatment Period|Protocol Violation|1
5451447|NCT02141854|18838592|P5|Treatment Period|Protocol Violation|2
5451448|NCT02141854|18838593|P4|Treatment Period|Protocol Violation|2
5451449|NCT02141854|18838594|P3|Treatment Period|Protocol Violation|0
5451450|NCT02141854|18838595|P2|Treatment Period|Protocol Violation|1
5451451|NCT02141854|18838596|P1|Treatment Period|Protocol Violation|0
5451452|NCT02141854|18838591|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451453|NCT02141854|18838592|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451454|NCT02141854|18838593|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451455|NCT02141854|18838594|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451456|NCT02141854|18838595|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451457|NCT02141854|18838596|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
5451458|NCT02141854|18838591|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451459|NCT02141854|18838592|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451460|NCT02141854|18838593|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451461|NCT02141854|18838594|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451462|NCT02141854|18838595|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451463|NCT02141854|18838596|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
5451464|NCT02141854|18838591|P6|Run-In Period (Pre-assignment)|Adverse Event|0
5451465|NCT02141854|18838592|P5|Run-In Period (Pre-assignment)|Adverse Event|0
5451466|NCT02141854|18838593|P4|Run-In Period (Pre-assignment)|Adverse Event|0
5451467|NCT02141854|18838594|P3|Run-In Period (Pre-assignment)|Adverse Event|0
5451468|NCT02141854|18838595|P2|Run-In Period (Pre-assignment)|Adverse Event|0
5451469|NCT02141854|18838596|P1|Run-In Period (Pre-assignment)|Adverse Event|10
5451470|NCT02141854|18838591|P6|Run-In Period (Pre-assignment)|Other|0
5451471|NCT02141854|18838592|P5|Run-In Period (Pre-assignment)|Other|0
5451472|NCT02141854|18838593|P4|Run-In Period (Pre-assignment)|Other|0
5451473|NCT02141854|18838594|P3|Run-In Period (Pre-assignment)|Other|0
5451474|NCT02141854|18838595|P2|Run-In Period (Pre-assignment)|Other|0
5451475|NCT02141854|18838596|P1|Run-In Period (Pre-assignment)|Other|14
5451476|NCT02141854|18838591|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451477|NCT02141854|18838592|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451478|NCT02141854|18838593|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451479|NCT02141854|18838594|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451480|NCT02141854|18838595|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451481|NCT02141854|18838596|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
5451482|NCT02141854|18838591|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451483|NCT02141854|18838592|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451484|NCT02141854|18838593|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451485|NCT02141854|18838594|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451486|NCT02141854|18838595|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451487|NCT02141854|18838596|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
5451488|NCT02141854|18838591|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451489|NCT02141854|18838592|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451490|NCT02141854|18838593|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451491|NCT02141854|18838594|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451492|NCT02141854|18838595|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451493|NCT02141854|18838596|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
5451494|NCT02141659|18838654|P6|Overall Study|Pretreatment Event/ Adverse Event|1
5451495|NCT02141659|18838655|P5|Overall Study|Pretreatment Event/ Adverse Event|2
5451496|NCT02141659|18838656|P4|Overall Study|Pretreatment Event/ Adverse Event|0
5451497|NCT02141659|18838657|P3|Overall Study|Pretreatment Event/ Adverse Event|0
5451498|NCT02141659|18838658|P2|Overall Study|Pretreatment Event/ Adverse Event|0
5451499|NCT02141659|18838659|P1|Overall Study|Pretreatment Event/ Adverse Event|0
5451500|NCT02141659|18838654|P6|Overall Study|Lack of Efficacy|1
5451501|NCT02141659|18838655|P5|Overall Study|Lack of Efficacy|0
5451502|NCT02141659|18838656|P4|Overall Study|Lack of Efficacy|0
5451503|NCT02141659|18838657|P3|Overall Study|Lack of Efficacy|0
5451504|NCT02141659|18838658|P2|Overall Study|Lack of Efficacy|0
5451505|NCT02141659|18838659|P1|Overall Study|Lack of Efficacy|0
5451506|NCT02141659|18838654|P6|Overall Study|Major Protocol Deviation|0
5451507|NCT02141659|18838655|P5|Overall Study|Major Protocol Deviation|0
5451508|NCT02141659|18838656|P4|Overall Study|Major Protocol Deviation|0
5451509|NCT02141659|18838657|P3|Overall Study|Major Protocol Deviation|0
5451510|NCT02141659|18838658|P2|Overall Study|Major Protocol Deviation|1
5451511|NCT02141659|18838659|P1|Overall Study|Major Protocol Deviation|0
5451512|NCT02141633|18838715|P2|Overall Study|Physician Decision|0
5451513|NCT02141633|18838716|P1|Overall Study|Physician Decision|1
5451514|NCT02141620|18838724|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
5451515|NCT02141620|18838725|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
5451516|NCT02141516|18838817|P3|Overall Study|Other|0
5451517|NCT02141516|18838818|P2|Overall Study|Other|3
5451518|NCT02141516|18838819|P1|Overall Study|Other|0
5451519|NCT02141516|18838817|P3|Overall Study|Lost to Follow-up|0
5451520|NCT02141516|18838818|P2|Overall Study|Lost to Follow-up|1
5451521|NCT02141516|18838819|P1|Overall Study|Lost to Follow-up|0
5451522|NCT02141516|18838817|P3|Overall Study|Adverse Event|0
5451523|NCT02141516|18838818|P2|Overall Study|Adverse Event|1
5451524|NCT02141516|18838819|P1|Overall Study|Adverse Event|0
5451525|NCT02141490|18838870|P3|Overall Study|Screening failures|0
5451526|NCT02141490|18838871|P2|Overall Study|Screening failures|0
5451527|NCT02141490|18838872|P1|Overall Study|Screening failures|4
5451528|NCT02141399|18838917|P1|Overall Study|Failure to meet eligibility criteria|14
5451529|NCT02141399|18838917|P1|Overall Study|Withdrawal by Subject|238
5451530|NCT02141399|18838917|P1|Overall Study|Protocol Violation|38
5451531|NCT02141399|18838917|P1|Overall Study|Pregnancy|3
5451532|NCT02141399|18838917|P1|Overall Study|Physician Decision|17
5451533|NCT02141399|18838917|P1|Overall Study|Other|45
5451534|NCT02141399|18838917|P1|Overall Study|Non-compliance with study drug|18
5451535|NCT02141399|18838917|P1|Overall Study|Lost to Follow-up|151
5451536|NCT02141399|18838917|P1|Overall Study|Lack of Efficacy|62
5451537|NCT02141399|18838917|P1|Overall Study|Adverse Event|158
5451538|NCT02141360|18838923|P3|Overall Study|Study Terminated before Visit|0
5451539|NCT02141360|18838924|P2|Overall Study|Study Terminated before Visit|0
5451540|NCT02141360|18838925|P1|Overall Study|Study Terminated before Visit|1
5451541|NCT02141360|18838923|P3|Overall Study|Withdrawal by Subject|0
5451542|NCT02141360|18838924|P2|Overall Study|Withdrawal by Subject|0
5451543|NCT02141360|18838925|P1|Overall Study|Withdrawal by Subject|6
5451544|NCT02141295|18838936|P3|Overall Study|Withdrawal by Subject|4
5451545|NCT02141295|18838937|P2|Overall Study|Withdrawal by Subject|9
5451546|NCT02141295|18838938|P1|Overall Study|Withdrawal by Subject|0
5451547|NCT02141295|18838936|P3|Overall Study|Reason not specified|10
5451548|NCT02141295|18838937|P2|Overall Study|Reason not specified|9
5451549|NCT02141295|18838938|P1|Overall Study|Reason not specified|0
5451550|NCT02141295|18838936|P3|Overall Study|Progressive disease|50
5451551|NCT02141295|18838937|P2|Overall Study|Progressive disease|32
5451552|NCT02141295|18838938|P1|Overall Study|Progressive disease|3
5451553|NCT02141295|18838936|P3|Overall Study|Non-compliance|0
5451554|NCT02141295|18838937|P2|Overall Study|Non-compliance|1
5451555|NCT02141295|18838938|P1|Overall Study|Non-compliance|0
5451556|NCT02141295|18838936|P3|Overall Study|Study terminated by sponsor|6
5451557|NCT02141295|18838937|P2|Overall Study|Study terminated by sponsor|6
5451558|NCT02141295|18838938|P1|Overall Study|Study terminated by sponsor|0
5451559|NCT02141295|18838936|P3|Overall Study|Physician Decision|14
5451560|NCT02141295|18838937|P2|Overall Study|Physician Decision|19
5451561|NCT02141295|18838938|P1|Overall Study|Physician Decision|2
5451562|NCT02141295|18838936|P3|Overall Study|Adverse Event|11
5451563|NCT02141295|18838937|P2|Overall Study|Adverse Event|18
5451564|NCT02141295|18838938|P1|Overall Study|Adverse Event|1
5451565|NCT02141217|18838974|P2|Overall Study|Surgical Intervention|1
5451566|NCT02141217|18838975|P1|Overall Study|Surgical Intervention|1
5451567|NCT02141217|18838974|P2|Overall Study|Physician Decision|0
5451568|NCT02141217|18838975|P1|Overall Study|Physician Decision|1
5451569|NCT02141217|18838974|P2|Overall Study|Lost to Follow-up|1
5451570|NCT02141217|18838975|P1|Overall Study|Lost to Follow-up|1
5451571|NCT02141217|18838974|P2|Overall Study|Withdrawal by Subject|0
5451572|NCT02141217|18838975|P1|Overall Study|Withdrawal by Subject|6
5451573|NCT02141217|18838974|P2|Overall Study|Protocol Violation|4
5451574|NCT02141217|18838975|P1|Overall Study|Protocol Violation|1
5451575|NCT02141217|18838974|P2|Overall Study|Adverse Event|2
5451576|NCT02141217|18838975|P1|Overall Study|Adverse Event|1
5451577|NCT02141204|18838995|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7
5451578|NCT02141204|18838996|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9
5451579|NCT02141204|18838995|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5
5451580|NCT02141204|18838996|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
5451581|NCT02141204|18838995|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2
5451582|NCT02141204|18838996|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1
5451583|NCT02141204|18838995|P2|Overall Study|Lost to Follow-up|1
5451584|NCT02141204|18838996|P1|Overall Study|Lost to Follow-up|2
5451585|NCT02140775|18839054|P2|Overall Study|Withdrawal by Subject|7
5451586|NCT02140775|18839055|P1|Overall Study|Withdrawal by Subject|30
5451587|NCT02140762|18839067|P2|Overall Study|Other|1
5451588|NCT02140762|18839068|P1|Overall Study|Other|0
5451589|NCT02140762|18839067|P2|Overall Study|Withdrawal by Subject|4
5451590|NCT02140762|18839068|P1|Overall Study|Withdrawal by Subject|6
5451591|NCT02140762|18839067|P2|Overall Study|Protocol Violation|1
5451592|NCT02140762|18839068|P1|Overall Study|Protocol Violation|1
5451593|NCT02140762|18839067|P2|Overall Study|Lost to Follow-up|5
5451594|NCT02140762|18839068|P1|Overall Study|Lost to Follow-up|9
5451595|NCT02140762|18839067|P2|Overall Study|Adverse Event|1
5451596|NCT02140762|18839068|P1|Overall Study|Adverse Event|1
5451597|NCT02140645|18839134|P6|Overall Study|Not linked|70896
5451598|NCT02140645|18839135|P5|Overall Study|Not linked|3286
5451599|NCT02140645|18839136|P4|Overall Study|Not linked|13833
5451600|NCT02140645|18839137|P3|Overall Study|Not linked|4236
5451601|NCT02140645|18839138|P2|Overall Study|Not linked|61654
5451602|NCT02140645|18839139|P1|Overall Study|Not linked|5489
5451603|NCT02140567|18839237|P1|Overall Study|Problems with recording equipment|6
5451604|NCT02140411|18839242|P1|Overall Study|Adverse Event|1
5451605|NCT02140164|18839262|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
5451606|NCT02140060|18839283|P6|Overall Study|Lack of Efficacy|0
5451607|NCT02140060|18839284|P5|Overall Study|Lack of Efficacy|0
5451608|NCT02140060|18839285|P4|Overall Study|Lack of Efficacy|1
5451609|NCT02140060|18839286|P3|Overall Study|Lack of Efficacy|0
5451610|NCT02140060|18839287|P2|Overall Study|Lack of Efficacy|0
5451611|NCT02140060|18839288|P1|Overall Study|Lack of Efficacy|0
5451612|NCT02140060|18839283|P6|Overall Study|Adverse Event|1
5451613|NCT02140060|18839284|P5|Overall Study|Adverse Event|1
5451614|NCT02140060|18839285|P4|Overall Study|Adverse Event|1
5451615|NCT02140060|18839286|P3|Overall Study|Adverse Event|0
5451616|NCT02140060|18839287|P2|Overall Study|Adverse Event|0
5451617|NCT02140060|18839288|P1|Overall Study|Adverse Event|0
5451618|NCT02139982|18839313|P10|Overall Study|Lack of Efficacy|0
5451619|NCT02139982|18839314|P9|Overall Study|Lack of Efficacy|0
5451620|NCT02139982|18839315|P8|Overall Study|Lack of Efficacy|0
5451621|NCT02139982|18839316|P7|Overall Study|Lack of Efficacy|0
5451622|NCT02139982|18839317|P6|Overall Study|Lack of Efficacy|0
5451623|NCT02139982|18839318|P5|Overall Study|Lack of Efficacy|0
5451624|NCT02139982|18839319|P4|Overall Study|Lack of Efficacy|1
5451625|NCT02139982|18839320|P3|Overall Study|Lack of Efficacy|0
5451626|NCT02139982|18839321|P2|Overall Study|Lack of Efficacy|1
5451627|NCT02139982|18839322|P1|Overall Study|Lack of Efficacy|0
5451628|NCT02139943|18839386|P3|Overall Study|eGFR Withdrawal Criteria|1
5451629|NCT02139943|18839387|P2|Overall Study|eGFR Withdrawal Criteria|0
5451630|NCT02139943|18839388|P1|Overall Study|eGFR Withdrawal Criteria|0
5451631|NCT02139943|18839386|P3|Overall Study|Participant in Poor Compliance|1
5451632|NCT02139943|18839387|P2|Overall Study|Participant in Poor Compliance|0
5451633|NCT02139943|18839388|P1|Overall Study|Participant in Poor Compliance|1
5451634|NCT02139943|18839386|P3|Overall Study|Participant wishes to discontinue|0
5451635|NCT02139943|18839387|P2|Overall Study|Participant wishes to discontinue|0
5451636|NCT02139943|18839388|P1|Overall Study|Participant wishes to discontinue|2
5451637|NCT02139943|18839386|P3|Overall Study|Other|1
5451638|NCT02139943|18839387|P2|Overall Study|Other|0
5451639|NCT02139943|18839388|P1|Overall Study|Other|0
5451640|NCT02139943|18839386|P3|Overall Study|Withdrawal by Subject|0
5451641|NCT02139943|18839387|P2|Overall Study|Withdrawal by Subject|3
5451642|NCT02139943|18839388|P1|Overall Study|Withdrawal by Subject|4
5451643|NCT02139943|18839386|P3|Overall Study|Lost to Follow-up|2
5451644|NCT02139943|18839387|P2|Overall Study|Lost to Follow-up|2
5451645|NCT02139943|18839388|P1|Overall Study|Lost to Follow-up|3
5451646|NCT02139943|18839386|P3|Overall Study|Adverse Event|2
5451647|NCT02139943|18839387|P2|Overall Study|Adverse Event|1
5451648|NCT02139943|18839388|P1|Overall Study|Adverse Event|0
5451649|NCT02139826|18839408|P1|Overall Study|Adverse Event|1
5451650|NCT02139644|18839453|P6|Treatment Period|Other|1
5451651|NCT02139644|18839454|P5|Treatment Period|Other|0
5451652|NCT02139644|18839455|P4|Treatment Period|Other|1
5451653|NCT02139644|18839456|P3|Treatment Period|Other|1
5451654|NCT02139644|18839457|P2|Treatment Period|Other|3
5451655|NCT02139644|18839458|P1|Treatment Period|Other|0
5451656|NCT02139644|18839453|P6|Treatment Period|Lack of Efficacy|4
5451657|NCT02139644|18839454|P5|Treatment Period|Lack of Efficacy|1
5451658|NCT02139644|18839455|P4|Treatment Period|Lack of Efficacy|0
5451659|NCT02139644|18839456|P3|Treatment Period|Lack of Efficacy|1
5451660|NCT02139644|18839457|P2|Treatment Period|Lack of Efficacy|0
5451661|NCT02139644|18839458|P1|Treatment Period|Lack of Efficacy|0
5451662|NCT02139644|18839453|P6|Treatment Period|Lost to Follow-up|1
5451663|NCT02139644|18839454|P5|Treatment Period|Lost to Follow-up|1
5451664|NCT02139644|18839455|P4|Treatment Period|Lost to Follow-up|1
5451665|NCT02139644|18839456|P3|Treatment Period|Lost to Follow-up|1
5451666|NCT02139644|18839457|P2|Treatment Period|Lost to Follow-up|0
5451667|NCT02139644|18839458|P1|Treatment Period|Lost to Follow-up|0
5451668|NCT02139644|18839453|P6|Treatment Period|Disease progression|2
5451669|NCT02139644|18839454|P5|Treatment Period|Disease progression|1
5451670|NCT02139644|18839455|P4|Treatment Period|Disease progression|1
5451671|NCT02139644|18839456|P3|Treatment Period|Disease progression|0
5451672|NCT02139644|18839457|P2|Treatment Period|Disease progression|0
5451673|NCT02139644|18839458|P1|Treatment Period|Disease progression|0
5451674|NCT02139644|18839453|P6|Treatment Period|Protocol Violation|1
5451675|NCT02139644|18839454|P5|Treatment Period|Protocol Violation|1
5451676|NCT02139644|18839455|P4|Treatment Period|Protocol Violation|1
5451677|NCT02139644|18839456|P3|Treatment Period|Protocol Violation|0
5451678|NCT02139644|18839457|P2|Treatment Period|Protocol Violation|0
5451679|NCT02139644|18839458|P1|Treatment Period|Protocol Violation|0
5451680|NCT02139644|18839453|P6|Treatment Period|Non-compliance|0
5451681|NCT02139644|18839454|P5|Treatment Period|Non-compliance|0
5451682|NCT02139644|18839455|P4|Treatment Period|Non-compliance|1
5451683|NCT02139644|18839456|P3|Treatment Period|Non-compliance|0
5451684|NCT02139644|18839457|P2|Treatment Period|Non-compliance|0
5451685|NCT02139644|18839458|P1|Treatment Period|Non-compliance|0
5451686|NCT02139644|18839453|P6|Treatment Period|Withdrawal by Subject|2
5451687|NCT02139644|18839454|P5|Treatment Period|Withdrawal by Subject|3
5451688|NCT02139644|18839455|P4|Treatment Period|Withdrawal by Subject|2
5451689|NCT02139644|18839456|P3|Treatment Period|Withdrawal by Subject|2
5451690|NCT02139644|18839457|P2|Treatment Period|Withdrawal by Subject|0
5451691|NCT02139644|18839458|P1|Treatment Period|Withdrawal by Subject|0
5451692|NCT02139644|18839453|P6|Treatment Period|Adverse Event|6
5451693|NCT02139644|18839454|P5|Treatment Period|Adverse Event|1
5451694|NCT02139644|18839455|P4|Treatment Period|Adverse Event|2
5451695|NCT02139644|18839456|P3|Treatment Period|Adverse Event|3
5451696|NCT02139644|18839457|P2|Treatment Period|Adverse Event|0
5451697|NCT02139644|18839458|P1|Treatment Period|Adverse Event|0
5451698|NCT02139644|18839453|P6|Run-In Period (Pre-assignment)|Other|0
5451699|NCT02139644|18839454|P5|Run-In Period (Pre-assignment)|Other|0
5451700|NCT02139644|18839455|P4|Run-In Period (Pre-assignment)|Other|0
5451701|NCT02139644|18839456|P3|Run-In Period (Pre-assignment)|Other|0
5451702|NCT02139644|18839457|P2|Run-In Period (Pre-assignment)|Other|0
5451703|NCT02139644|18839458|P1|Run-In Period (Pre-assignment)|Other|6
5451704|NCT02139644|18839453|P6|Run-In Period (Pre-assignment)|Adverse Event|0
5451705|NCT02139644|18839454|P5|Run-In Period (Pre-assignment)|Adverse Event|0
5451706|NCT02139644|18839455|P4|Run-In Period (Pre-assignment)|Adverse Event|0
5451707|NCT02139644|18839456|P3|Run-In Period (Pre-assignment)|Adverse Event|0
5451708|NCT02139644|18839457|P2|Run-In Period (Pre-assignment)|Adverse Event|0
5451709|NCT02139644|18839458|P1|Run-In Period (Pre-assignment)|Adverse Event|3
5451710|NCT02139644|18839453|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451711|NCT02139644|18839454|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451712|NCT02139644|18839455|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451713|NCT02139644|18839456|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451714|NCT02139644|18839457|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
5451715|NCT02139644|18839458|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
5451716|NCT02139644|18839453|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451717|NCT02139644|18839454|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451718|NCT02139644|18839455|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451719|NCT02139644|18839456|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451720|NCT02139644|18839457|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
5451721|NCT02139644|18839458|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
5451722|NCT02139644|18839453|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451723|NCT02139644|18839454|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451724|NCT02139644|18839455|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451725|NCT02139644|18839456|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451726|NCT02139644|18839457|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
5451727|NCT02139644|18839458|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
5451728|NCT02139644|18839453|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451729|NCT02139644|18839454|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451730|NCT02139644|18839455|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451731|NCT02139644|18839456|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451732|NCT02139644|18839457|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
5451733|NCT02139644|18839458|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
5451734|NCT02139644|18839453|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451735|NCT02139644|18839454|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451736|NCT02139644|18839455|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451737|NCT02139644|18839456|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451738|NCT02139644|18839457|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
5451739|NCT02139644|18839458|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
5451740|NCT02139592|18839510|P1|Overall Study|Case Report Forms Uncollected|8
5451741|NCT02139306|18839536|P2|Overall Study|Protocol Violation|0
5451742|NCT02139306|18839537|P1|Overall Study|Protocol Violation|4
5451743|NCT02139306|18839536|P2|Overall Study|Other Unspecified|3
5451744|NCT02139306|18839537|P1|Overall Study|Other Unspecified|2
5451745|NCT02139306|18839536|P2|Overall Study|Physician Decision|1
5451746|NCT02139306|18839537|P1|Overall Study|Physician Decision|0
5451747|NCT02139306|18839536|P2|Overall Study|Adverse Event|4
5451748|NCT02139306|18839537|P1|Overall Study|Adverse Event|3
5451749|NCT02139306|18839536|P2|Overall Study|Withdrawal by Subject|6
5451750|NCT02139306|18839537|P1|Overall Study|Withdrawal by Subject|4
5451751|NCT02139124|18839607|P5|Overall Study|Lost to Follow-up|4
5451752|NCT02139124|18839608|P4|Overall Study|Lost to Follow-up|5
5451753|NCT02139124|18839609|P3|Overall Study|Lost to Follow-up|0
5451754|NCT02139124|18839610|P2|Overall Study|Lost to Follow-up|2
5451755|NCT02139124|18839611|P1|Overall Study|Lost to Follow-up|3
5451756|NCT02139124|18839607|P5|Overall Study|subject moved|0
5451757|NCT02139124|18839608|P4|Overall Study|subject moved|0
5451758|NCT02139124|18839609|P3|Overall Study|subject moved|0
5451759|NCT02139124|18839610|P2|Overall Study|subject moved|0
5451760|NCT02139124|18839611|P1|Overall Study|subject moved|1
5451761|NCT02139124|18839607|P5|Overall Study|incarceration|0
5451762|NCT02139124|18839608|P4|Overall Study|incarceration|0
5451763|NCT02139124|18839609|P3|Overall Study|incarceration|1
5451764|NCT02139124|18839610|P2|Overall Study|incarceration|0
5451765|NCT02139124|18839611|P1|Overall Study|incarceration|0
5451766|NCT02139124|18839607|P5|Overall Study|non-compliant|0
5451767|NCT02139124|18839608|P4|Overall Study|non-compliant|2
5451768|NCT02139124|18839609|P3|Overall Study|non-compliant|0
5451769|NCT02139124|18839610|P2|Overall Study|non-compliant|0
5451770|NCT02139124|18839611|P1|Overall Study|non-compliant|1
5451771|NCT02139124|18839607|P5|Overall Study|Protocol Violation|1
5451772|NCT02139124|18839608|P4|Overall Study|Protocol Violation|1
5451773|NCT02139124|18839609|P3|Overall Study|Protocol Violation|0
5451774|NCT02139124|18839610|P2|Overall Study|Protocol Violation|0
5451775|NCT02139124|18839611|P1|Overall Study|Protocol Violation|0
5451776|NCT02139124|18839607|P5|Overall Study|Withdrawal by Subject|3
5451777|NCT02139124|18839608|P4|Overall Study|Withdrawal by Subject|2
5451778|NCT02139124|18839609|P3|Overall Study|Withdrawal by Subject|2
5451779|NCT02139124|18839610|P2|Overall Study|Withdrawal by Subject|2
5451780|NCT02139124|18839611|P1|Overall Study|Withdrawal by Subject|2
5451781|NCT02139124|18839607|P5|Overall Study|Adverse Event|5
5451782|NCT02139124|18839608|P4|Overall Study|Adverse Event|2
5451783|NCT02139124|18839609|P3|Overall Study|Adverse Event|1
5451784|NCT02139124|18839610|P2|Overall Study|Adverse Event|0
5451785|NCT02139124|18839611|P1|Overall Study|Adverse Event|2
5451786|NCT02139046|18839628|P5|Overall Study|Other Miscellaneous Reasons|12
5451787|NCT02139046|18839629|P4|Overall Study|Other Miscellaneous Reasons|9
5451788|NCT02139046|18839630|P3|Overall Study|Other Miscellaneous Reasons|4
5451789|NCT02139046|18839631|P2|Overall Study|Other Miscellaneous Reasons|9
5451790|NCT02139046|18839632|P1|Overall Study|Other Miscellaneous Reasons|10
5451791|NCT02139046|18839628|P5|Overall Study|Withdrawal due to a Gout Flare|1
5451792|NCT02139046|18839629|P4|Overall Study|Withdrawal due to a Gout Flare|0
5451793|NCT02139046|18839630|P3|Overall Study|Withdrawal due to a Gout Flare|1
5451794|NCT02139046|18839631|P2|Overall Study|Withdrawal due to a Gout Flare|1
5451795|NCT02139046|18839632|P1|Overall Study|Withdrawal due to a Gout Flare|1
5451796|NCT02139046|18839628|P5|Overall Study|Lack of Efficacy|2
5451797|NCT02139046|18839629|P4|Overall Study|Lack of Efficacy|1
5451798|NCT02139046|18839630|P3|Overall Study|Lack of Efficacy|2
5451799|NCT02139046|18839631|P2|Overall Study|Lack of Efficacy|1
5451800|NCT02139046|18839632|P1|Overall Study|Lack of Efficacy|0
5451801|NCT02139046|18839628|P5|Overall Study|Voluntary Withdrawal|16
5451802|NCT02139046|18839629|P4|Overall Study|Voluntary Withdrawal|15
5451803|NCT02139046|18839630|P3|Overall Study|Voluntary Withdrawal|10
5451804|NCT02139046|18839631|P2|Overall Study|Voluntary Withdrawal|8
5451805|NCT02139046|18839632|P1|Overall Study|Voluntary Withdrawal|20
5451806|NCT02139046|18839628|P5|Overall Study|Lost to Follow-up|13
5451807|NCT02139046|18839629|P4|Overall Study|Lost to Follow-up|18
5451808|NCT02139046|18839630|P3|Overall Study|Lost to Follow-up|16
5451809|NCT02139046|18839631|P2|Overall Study|Lost to Follow-up|16
5451810|NCT02139046|18839632|P1|Overall Study|Lost to Follow-up|13
5451811|NCT02139046|18839628|P5|Overall Study|Major Protocol Deviation|6
5451812|NCT02139046|18839629|P4|Overall Study|Major Protocol Deviation|12
5451813|NCT02139046|18839630|P3|Overall Study|Major Protocol Deviation|16
5451814|NCT02139046|18839631|P2|Overall Study|Major Protocol Deviation|10
5451815|NCT02139046|18839632|P1|Overall Study|Major Protocol Deviation|9
5451816|NCT02139046|18839628|P5|Overall Study|Pretreatment Event/Adverse Event|7
5451817|NCT02139046|18839629|P4|Overall Study|Pretreatment Event/Adverse Event|13
5451818|NCT02139046|18839630|P3|Overall Study|Pretreatment Event/Adverse Event|10
5451819|NCT02139046|18839631|P2|Overall Study|Pretreatment Event/Adverse Event|9
5451820|NCT02139046|18839632|P1|Overall Study|Pretreatment Event/Adverse Event|9
5451821|NCT02138916|18839673|P3|Overall Study|Adverse Event|3
5451822|NCT02138916|18839674|P2|Overall Study|Adverse Event|4
5451823|NCT02138916|18839675|P1|Overall Study|Adverse Event|4
5451824|NCT02138916|18839673|P3|Overall Study|Lost to Follow-up|3
5451825|NCT02138916|18839674|P2|Overall Study|Lost to Follow-up|2
5451826|NCT02138916|18839675|P1|Overall Study|Lost to Follow-up|4
5451827|NCT02138916|18839673|P3|Overall Study|Severe non-compliance|1
5451828|NCT02138916|18839674|P2|Overall Study|Severe non-compliance|2
5451829|NCT02138916|18839675|P1|Overall Study|Severe non-compliance|1
5451830|NCT02138916|18839673|P3|Overall Study|incorrect enrolment|0
5451831|NCT02138916|18839674|P2|Overall Study|incorrect enrolment|1
5451832|NCT02138916|18839675|P1|Overall Study|incorrect enrolment|1
5451833|NCT02138916|18839673|P3|Overall Study|Study specific withdrawal criteria|1
5451834|NCT02138916|18839674|P2|Overall Study|Study specific withdrawal criteria|0
5451835|NCT02138916|18839675|P1|Overall Study|Study specific withdrawal criteria|0
5451836|NCT02138916|18839673|P3|Overall Study|Withdrawal by Subject|32
5451837|NCT02138916|18839674|P2|Overall Study|Withdrawal by Subject|31
5451838|NCT02138916|18839675|P1|Overall Study|Withdrawal by Subject|27
5451839|NCT02138916|18839673|P3|Overall Study|Death|12
5451840|NCT02138916|18839674|P2|Overall Study|Death|11
5451841|NCT02138916|18839675|P1|Overall Study|Death|14
5451842|NCT02138916|18839673|P3|Overall Study|eg., meds change, lack of efficacy, etc.|7
5451843|NCT02138916|18839674|P2|Overall Study|eg., meds change, lack of efficacy, etc.|9
5451844|NCT02138916|18839675|P1|Overall Study|eg., meds change, lack of efficacy, etc.|6
5451845|NCT02138890|18839738|P2|Overall Study|Adverse Event|0
5451846|NCT02138890|18839739|P1|Overall Study|Adverse Event|1
5451847|NCT02138838|18839781|P2|Overall Study|Withdrawal by Subject|5
5451848|NCT02138838|18839782|P1|Overall Study|Withdrawal by Subject|1
5451849|NCT02138838|18839781|P2|Overall Study|Study Closure|6
5451850|NCT02138838|18839782|P1|Overall Study|Study Closure|7
5451851|NCT02138825|18839800|P2|Safety Follow-up|withdrawn due to lung transplant|1
5451852|NCT02138825|18839801|P1|Safety Follow-up|withdrawn due to lung transplant|0
5451853|NCT02138825|18839800|P2|Safety Follow-up|treatment unblinded|1
5451854|NCT02138825|18839801|P1|Safety Follow-up|treatment unblinded|0
5451855|NCT02138825|18839800|P2|Safety Follow-up|too unwell to attend the visit|1
5451856|NCT02138825|18839801|P1|Safety Follow-up|too unwell to attend the visit|0
5451857|NCT02138825|18839800|P2|Safety Follow-up|progressive disease|2
5451858|NCT02138825|18839801|P1|Safety Follow-up|progressive disease|0
5451859|NCT02138825|18839800|P2|Safety Follow-up|logistical difficulties|1
5451860|NCT02138825|18839801|P1|Safety Follow-up|logistical difficulties|0
5451861|NCT02138825|18839800|P2|Safety Follow-up|withdrawal by PI|0
5451862|NCT02138825|18839801|P1|Safety Follow-up|withdrawal by PI|1
5451863|NCT02138825|18839800|P2|Safety Follow-up|clinic worsening|0
5451864|NCT02138825|18839801|P1|Safety Follow-up|clinic worsening|1
5451865|NCT02138825|18839800|P2|Safety Follow-up|Withdrawal by Subject|3
5451866|NCT02138825|18839801|P1|Safety Follow-up|Withdrawal by Subject|5
5451867|NCT02138825|18839800|P2|Safety Follow-up|Death|5
5451868|NCT02138825|18839801|P1|Safety Follow-up|Death|11
5451869|NCT02138825|18839800|P2|Safety Follow-up|Adverse Event|3
5451870|NCT02138825|18839801|P1|Safety Follow-up|Adverse Event|4
5451871|NCT02138825|18839800|P2|Long-term Extension|Study termination by sponsor|38
5451872|NCT02138825|18839801|P1|Long-term Extension|Study termination by sponsor|32
5451873|NCT02138825|18839800|P2|Main Study Treatment|Medical decision|0
5451874|NCT02138825|18839801|P1|Main Study Treatment|Medical decision|1
5451875|NCT02138825|18839800|P2|Main Study Treatment|Withdrawal by Subject|1
5451876|NCT02138825|18839801|P1|Main Study Treatment|Withdrawal by Subject|3
5451877|NCT02138825|18839800|P2|Main Study Treatment|Study terminated by sponsor|9
5451878|NCT02138825|18839801|P1|Main Study Treatment|Study terminated by sponsor|10
5451879|NCT02138825|18839800|P2|Main Study Treatment|Sponsor decision|18
5451880|NCT02138825|18839801|P1|Main Study Treatment|Sponsor decision|12
5451881|NCT02138825|18839800|P2|Main Study Treatment|Protocol Violation|2
5451882|NCT02138825|18839801|P1|Main Study Treatment|Protocol Violation|2
5451883|NCT02138825|18839800|P2|Main Study Treatment|Death|2
5451884|NCT02138825|18839801|P1|Main Study Treatment|Death|1
5451885|NCT02138825|18839800|P2|Main Study Treatment|Adverse Event|3
5451886|NCT02138825|18839801|P1|Main Study Treatment|Adverse Event|11
5451887|NCT02138786|18839818|P3|Overall Study|Non-Compliance|1
5451888|NCT02138786|18839819|P2|Overall Study|Non-Compliance|0
5451889|NCT02138786|18839820|P1|Overall Study|Non-Compliance|0
5451890|NCT02138786|18839818|P3|Overall Study|Sponsor Terminated Study|1
5451891|NCT02138786|18839819|P2|Overall Study|Sponsor Terminated Study|1
5451892|NCT02138786|18839820|P1|Overall Study|Sponsor Terminated Study|0
5451893|NCT02138786|18839818|P3|Overall Study|Patient's Wish|0
5451894|NCT02138786|18839819|P2|Overall Study|Patient's Wish|2
5451895|NCT02138786|18839820|P1|Overall Study|Patient's Wish|0
5451896|NCT02138786|18839818|P3|Overall Study|Withdrawal by Subject|0
5451897|NCT02138786|18839819|P2|Overall Study|Withdrawal by Subject|2
5451898|NCT02138786|18839820|P1|Overall Study|Withdrawal by Subject|1
5451899|NCT02138786|18839818|P3|Overall Study|Disease Progression|3
5451900|NCT02138786|18839819|P2|Overall Study|Disease Progression|1
5451901|NCT02138786|18839820|P1|Overall Study|Disease Progression|1
5451902|NCT02138786|18839818|P3|Overall Study|Death|2
5451903|NCT02138786|18839819|P2|Overall Study|Death|7
5451904|NCT02138786|18839820|P1|Overall Study|Death|1
5451905|NCT02138786|18839818|P3|Overall Study|Adverse Event|1
5451906|NCT02138786|18839819|P2|Overall Study|Adverse Event|2
5451907|NCT02138786|18839820|P1|Overall Study|Adverse Event|0
5451908|NCT02138747|18839837|P4|Treatment Period 2|Other - Miscellaneous|0
5451909|NCT02138747|18839838|P3|Treatment Period 2|Other - Miscellaneous|0
5451910|NCT02138747|18839839|P2|Treatment Period 2|Other - Miscellaneous|0
5451911|NCT02138747|18839840|P1|Treatment Period 2|Other - Miscellaneous|3
5451912|NCT02138747|18839837|P4|Treatment Period 2|Withdrawal by Subject|2
5451913|NCT02138747|18839838|P3|Treatment Period 2|Withdrawal by Subject|1
5451914|NCT02138747|18839839|P2|Treatment Period 2|Withdrawal by Subject|4
5451915|NCT02138747|18839840|P1|Treatment Period 2|Withdrawal by Subject|5
5451916|NCT02138747|18839837|P4|Treatment Period 2|Protocol Violation|0
5451917|NCT02138747|18839838|P3|Treatment Period 2|Protocol Violation|0
5451918|NCT02138747|18839839|P2|Treatment Period 2|Protocol Violation|0
5451919|NCT02138747|18839840|P1|Treatment Period 2|Protocol Violation|1
5451920|NCT02138747|18839837|P4|Treatment Period 2|Lost to Follow-up|0
5451921|NCT02138747|18839838|P3|Treatment Period 2|Lost to Follow-up|0
5451922|NCT02138747|18839839|P2|Treatment Period 2|Lost to Follow-up|0
5451923|NCT02138747|18839840|P1|Treatment Period 2|Lost to Follow-up|2
5451924|NCT02138747|18839837|P4|Treatment Period 2|Adverse Event|1
5451925|NCT02138747|18839838|P3|Treatment Period 2|Adverse Event|1
5451926|NCT02138747|18839839|P2|Treatment Period 2|Adverse Event|3
5451927|NCT02138747|18839840|P1|Treatment Period 2|Adverse Event|6
5451928|NCT02138747|18839837|P4|Treatment Period 1|Other - Miscellaneous|0
5451929|NCT02138747|18839838|P3|Treatment Period 1|Other - Miscellaneous|0
5451930|NCT02138747|18839839|P2|Treatment Period 1|Other - Miscellaneous|4
5451931|NCT02138747|18839840|P1|Treatment Period 1|Other - Miscellaneous|2
5451932|NCT02138747|18839837|P4|Treatment Period 1|Withdrawal by Subject|3
5451933|NCT02138747|18839838|P3|Treatment Period 1|Withdrawal by Subject|1
5451934|NCT02138747|18839839|P2|Treatment Period 1|Withdrawal by Subject|4
5451935|NCT02138747|18839840|P1|Treatment Period 1|Withdrawal by Subject|8
5451936|NCT02138747|18839837|P4|Treatment Period 1|Protocol Violation|0
5451937|NCT02138747|18839838|P3|Treatment Period 1|Protocol Violation|0
5451938|NCT02138747|18839839|P2|Treatment Period 1|Protocol Violation|2
5451939|NCT02138747|18839840|P1|Treatment Period 1|Protocol Violation|0
5451940|NCT02138747|18839837|P4|Treatment Period 1|Lost to Follow-up|0
5451941|NCT02138747|18839838|P3|Treatment Period 1|Lost to Follow-up|1
5451942|NCT02138747|18839839|P2|Treatment Period 1|Lost to Follow-up|1
5451943|NCT02138747|18839840|P1|Treatment Period 1|Lost to Follow-up|0
5451944|NCT02138747|18839837|P4|Treatment Period 1|Adverse Event|1
5451945|NCT02138747|18839838|P3|Treatment Period 1|Adverse Event|2
5451946|NCT02138747|18839839|P2|Treatment Period 1|Adverse Event|14
5451947|NCT02138747|18839840|P1|Treatment Period 1|Adverse Event|10
5451948|NCT02138253|18839914|P2|Overall Study|Withdrawal by Subject|0
5451949|NCT02138253|18839915|P1|Overall Study|Withdrawal by Subject|1
5451950|NCT02138253|18839914|P2|Overall Study|Non compliance|0
5451951|NCT02138253|18839915|P1|Overall Study|Non compliance|1
5451952|NCT02138253|18839914|P2|Overall Study|Physician Decision|0
5451953|NCT02138253|18839915|P1|Overall Study|Physician Decision|2
5451954|NCT02138253|18839914|P2|Overall Study|Lost to Follow-up|1
5451955|NCT02138253|18839915|P1|Overall Study|Lost to Follow-up|2
5451956|NCT02138253|18839914|P2|Overall Study|Adverse Event|3
5451957|NCT02138253|18839915|P1|Overall Study|Adverse Event|3
5451958|NCT02138214|18839990|P3|Overall Study|Screen Failure|0
5451959|NCT02138214|18839991|P2|Overall Study|Screen Failure|1
5451960|NCT02138214|18839992|P1|Overall Study|Screen Failure|0
5451961|NCT02138214|18839990|P3|Overall Study|Lost to Follow-up|4
5451962|NCT02138214|18839991|P2|Overall Study|Lost to Follow-up|2
5451963|NCT02138214|18839992|P1|Overall Study|Lost to Follow-up|0
5451964|NCT02138214|18839990|P3|Overall Study|Withdrawal by Subject|0
5451965|NCT02138214|18839991|P2|Overall Study|Withdrawal by Subject|1
5451966|NCT02138214|18839992|P1|Overall Study|Withdrawal by Subject|0
5451967|NCT02138136|18840013|P1|Overall Study|Withdrawn by Sponsor|5
5451968|NCT02138136|18840013|P1|Overall Study|Lost to Follow-up|32
5451969|NCT02138136|18840013|P1|Overall Study|Withdrawal by Subject|36
5451970|NCT02138136|18840013|P1|Overall Study|Adverse Event|18
5451971|NCT02138136|18840013|P1|Overall Study|Pregnancy|2
5451972|NCT02138136|18840013|P1|Overall Study|Lack of Efficacy|35
5451973|NCT02138136|18840013|P1|Overall Study|Physician Decision|7
5451974|NCT02138136|18840013|P1|Overall Study|Protocol Violation|4
5451975|NCT02138110|18840020|P1|Overall Scaffold Implantation|Death|3
5451976|NCT02138110|18840020|P1|Enrolled for Scaffold Implantation|Physician Decision|1
5451977|NCT02137785|18840252|P2|Overall Study|subject moved out of state|0
5451978|NCT02137785|18840253|P1|Overall Study|subject moved out of state|1
5451979|NCT02137785|18840252|P2|Overall Study|Withdrawal by Subject|4
5451980|NCT02137785|18840253|P1|Overall Study|Withdrawal by Subject|1
5451981|NCT02137785|18840252|P2|Overall Study|Lost to Follow-up|0
5451982|NCT02137785|18840253|P1|Overall Study|Lost to Follow-up|1
5451983|NCT02137772|18840361|P2|Overall Study|Not treated|2
5451984|NCT02137772|18840362|P1|Overall Study|Not treated|3
5451985|NCT02137772|18840361|P2|Overall Study|Non-compliance with study drug|0
5451986|NCT02137772|18840362|P1|Overall Study|Non-compliance with study drug|1
5451987|NCT02137772|18840361|P2|Overall Study|Withdrawal by Subject|17
5451988|NCT02137772|18840362|P1|Overall Study|Withdrawal by Subject|28
5451989|NCT02137772|18840361|P2|Overall Study|Physician Decision|5
5451990|NCT02137772|18840362|P1|Overall Study|Physician Decision|15
5451991|NCT02137772|18840361|P2|Overall Study|Lost to Follow-up|4
5451992|NCT02137772|18840362|P1|Overall Study|Lost to Follow-up|8
5451993|NCT02137772|18840361|P2|Overall Study|Death|44
5451994|NCT02137772|18840362|P1|Overall Study|Death|71
5451995|NCT02137772|18840361|P2|Overall Study|Adverse Event|3
5451996|NCT02137772|18840362|P1|Overall Study|Adverse Event|6
5451997|NCT02137369|18840620|P2|Overall Study|Moved away|0
5451998|NCT02137369|18840621|P1|Overall Study|Moved away|2
5451999|NCT02137369|18840620|P2|Overall Study|Lost to Follow-up|0
5452000|NCT02137369|18840621|P1|Overall Study|Lost to Follow-up|1
5452001|NCT02137369|18840620|P2|Overall Study|Adverse Event|0
5452002|NCT02137369|18840621|P1|Overall Study|Adverse Event|2
5452003|NCT02137369|18840620|P2|Overall Study|Withdrawal by Subject|2
5452004|NCT02137369|18840621|P1|Overall Study|Withdrawal by Subject|3
5452005|NCT02137226|18840631|P5|Period 2 (Re - Randomization)|Other Reason|1
5452006|NCT02137226|18840632|P4|Period 2 (Re - Randomization)|Other Reason|1
5452007|NCT02137226|18840633|P3|Period 2 (Re - Randomization)|Other Reason|1
5452008|NCT02137226|18840634|P2|Period 2 (Re - Randomization)|Other Reason|0
5452009|NCT02137226|18840635|P1|Period 2 (Re - Randomization)|Other Reason|0
5452010|NCT02137226|18840631|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
5452011|NCT02137226|18840632|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
5452012|NCT02137226|18840633|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
5452013|NCT02137226|18840634|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
5452014|NCT02137226|18840635|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
5452015|NCT02137226|18840631|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
5452016|NCT02137226|18840632|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
5452017|NCT02137226|18840633|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
5452018|NCT02137226|18840634|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
5452019|NCT02137226|18840635|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
5452020|NCT02137226|18840631|P5|Period 2 (Re - Randomization)|Physician Decision|0
5452021|NCT02137226|18840632|P4|Period 2 (Re - Randomization)|Physician Decision|1
5452022|NCT02137226|18840633|P3|Period 2 (Re - Randomization)|Physician Decision|0
5452023|NCT02137226|18840634|P2|Period 2 (Re - Randomization)|Physician Decision|0
5452024|NCT02137226|18840635|P1|Period 2 (Re - Randomization)|Physician Decision|0
5452025|NCT02137226|18840631|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
5452026|NCT02137226|18840632|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
5452027|NCT02137226|18840633|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
5452028|NCT02137226|18840634|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
5452029|NCT02137226|18840635|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
5452030|NCT02137226|18840631|P5|Period 2 (Re - Randomization)|Adverse Event|4
5452031|NCT02137226|18840632|P4|Period 2 (Re - Randomization)|Adverse Event|1
5452032|NCT02137226|18840633|P3|Period 2 (Re - Randomization)|Adverse Event|3
5452033|NCT02137226|18840634|P2|Period 2 (Re - Randomization)|Adverse Event|0
5452034|NCT02137226|18840635|P1|Period 2 (Re - Randomization)|Adverse Event|0
5452035|NCT02137226|18840631|P5|Period 1 (Initial Randomization)|Other Reason|0
5452036|NCT02137226|18840632|P4|Period 1 (Initial Randomization)|Other Reason|0
5452037|NCT02137226|18840633|P3|Period 1 (Initial Randomization)|Other Reason|0
5452038|NCT02137226|18840634|P2|Period 1 (Initial Randomization)|Other Reason|3
5452039|NCT02137226|18840635|P1|Period 1 (Initial Randomization)|Other Reason|1
5452040|NCT02137226|18840631|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
5452041|NCT02137226|18840632|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
5452042|NCT02137226|18840633|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
5452043|NCT02137226|18840634|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
5452044|NCT02137226|18840635|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
5452045|NCT02137226|18840631|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
5452046|NCT02137226|18840632|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
5452047|NCT02137226|18840633|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
5452048|NCT02137226|18840634|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
5452049|NCT02137226|18840635|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
5452050|NCT02137226|18840631|P5|Period 1 (Initial Randomization)|Physician Decision|0
5452051|NCT02137226|18840632|P4|Period 1 (Initial Randomization)|Physician Decision|0
5452052|NCT02137226|18840633|P3|Period 1 (Initial Randomization)|Physician Decision|0
5452053|NCT02137226|18840634|P2|Period 1 (Initial Randomization)|Physician Decision|3
5452054|NCT02137226|18840635|P1|Period 1 (Initial Randomization)|Physician Decision|1
5452055|NCT02137226|18840631|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
5452056|NCT02137226|18840632|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
5452057|NCT02137226|18840633|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
5452058|NCT02137226|18840634|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
5452059|NCT02137226|18840635|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
5452060|NCT02137226|18840631|P5|Period 1 (Initial Randomization)|Adverse Event|0
5452061|NCT02137226|18840632|P4|Period 1 (Initial Randomization)|Adverse Event|0
5452062|NCT02137226|18840633|P3|Period 1 (Initial Randomization)|Adverse Event|0
5452063|NCT02137226|18840634|P2|Period 1 (Initial Randomization)|Adverse Event|3
5452064|NCT02137226|18840635|P1|Period 1 (Initial Randomization)|Adverse Event|3
5452065|NCT02136914|18840653|P2|Overall Study|Death|1
5452066|NCT02136914|18840654|P1|Overall Study|Death|0
5452067|NCT02136914|18840653|P2|Overall Study|Lack of Efficacy|0
5452068|NCT02136914|18840654|P1|Overall Study|Lack of Efficacy|1
5452069|NCT02136914|18840653|P2|Overall Study|Did Not Receive Study Drug|0
5452070|NCT02136914|18840654|P1|Overall Study|Did Not Receive Study Drug|2
5452071|NCT02136914|18840653|P2|Overall Study|Lost to Follow-up|1
5452072|NCT02136914|18840654|P1|Overall Study|Lost to Follow-up|1
5452073|NCT02136914|18840653|P2|Overall Study|Subject Unwilling to Proceed|2
5452074|NCT02136914|18840654|P1|Overall Study|Subject Unwilling to Proceed|7
5452075|NCT02136914|18840653|P2|Overall Study|Withdrawal by Subject|10
5452076|NCT02136914|18840654|P1|Overall Study|Withdrawal by Subject|3
5452077|NCT02136914|18840653|P2|Overall Study|Sponsor's Decision to Stop the Study|7
5452078|NCT02136914|18840654|P1|Overall Study|Sponsor's Decision to Stop the Study|7
5452079|NCT02136680|18840674|P2|Overall Study|Study ended before interview due|3
5452080|NCT02136680|18840675|P1|Overall Study|Study ended before interview due|6
5452081|NCT02136680|18840674|P2|Overall Study|Unable to schedule|16
5452082|NCT02136680|18840675|P1|Overall Study|Unable to schedule|17
5452083|NCT02136680|18840674|P2|Overall Study|Moved away|4
5452084|NCT02136680|18840675|P1|Overall Study|Moved away|5
5452085|NCT02136680|18840674|P2|Overall Study|No longer receiving care at clinic|5
5452086|NCT02136680|18840675|P1|Overall Study|No longer receiving care at clinic|3
5452087|NCT02136680|18840674|P2|Overall Study|No Longer Interested|1
5452088|NCT02136680|18840675|P1|Overall Study|No Longer Interested|1
5452089|NCT02136576|18840692|P3|Overall Study|Lost to Follow-up|0
5452090|NCT02136576|18840693|P2|Overall Study|Lost to Follow-up|0
5452091|NCT02136576|18840694|P1|Overall Study|Lost to Follow-up|2
5452092|NCT02136134|18840763|P2|Overall Study|Subjects randomized but not treated|8
5452093|NCT02136134|18840764|P1|Overall Study|Subjects randomized but not treated|10
5452094|NCT02136134|18840763|P2|Overall Study|Ongoing|207
5452095|NCT02136134|18840764|P1|Overall Study|Ongoing|185
5452096|NCT02136134|18840763|P2|Overall Study|Other|3
5452097|NCT02136134|18840764|P1|Overall Study|Other|3
5452098|NCT02136134|18840763|P2|Overall Study|Withdrawal by Subject|4
5452099|NCT02136134|18840764|P1|Overall Study|Withdrawal by Subject|14
5452100|NCT02136134|18840763|P2|Overall Study|Death|29
5452101|NCT02136134|18840764|P1|Overall Study|Death|35
5452102|NCT02135848|18840826|P2|Overall Study|Withdrawal by Subject|1
5452103|NCT02135848|18840827|P1|Overall Study|Withdrawal by Subject|1
5452104|NCT02135848|18840826|P2|Overall Study|Adverse Event|0
5452105|NCT02135848|18840827|P1|Overall Study|Adverse Event|2
5452106|NCT02135692|18840885|P1|Overall Study|Withdrawal by Subject|15
5452107|NCT02135692|18840885|P1|Overall Study|Lost to Follow-up|4
5452108|NCT02135692|18840885|P1|Overall Study|Study closed/terminated|153
5452109|NCT02135692|18840885|P1|Overall Study|Product commercially available|159
5452110|NCT02135692|18840885|P1|Overall Study|Subject met Liver Stopping Criteria|1
5452111|NCT02135692|18840885|P1|Overall Study|Protocol Violation|2
5452112|NCT02135692|18840885|P1|Overall Study|Lack of Efficacy|2
5452113|NCT02135692|18840885|P1|Overall Study|Adverse Event|3
5452114|NCT02135614|18840904|P2|Overall Study|Lost to Follow-up|0
5452115|NCT02135614|18840905|P1|Overall Study|Lost to Follow-up|3
5452116|NCT02135614|18840904|P2|Overall Study|Withdrew Consent|2
5452117|NCT02135614|18840905|P1|Overall Study|Withdrew Consent|2
5452118|NCT02135614|18840904|P2|Overall Study|Investigator's Discretion|1
5452119|NCT02135614|18840905|P1|Overall Study|Investigator's Discretion|0
5452120|NCT02135614|18840904|P2|Overall Study|Death|0
5452121|NCT02135614|18840905|P1|Overall Study|Death|1
5452122|NCT02135614|18840904|P2|Overall Study|Adverse Event|1
5452123|NCT02135614|18840905|P1|Overall Study|Adverse Event|0
5452124|NCT02135614|18840904|P2|Overall Study|Randomized but Not Treated|1
5452125|NCT02135614|18840905|P1|Overall Study|Randomized but Not Treated|2
5452126|NCT02135445|18840919|P2|Overall Study|Withdrawal by Subject|0
5452127|NCT02135445|18840920|P1|Overall Study|Withdrawal by Subject|1
5452128|NCT02135445|18840919|P2|Overall Study|Lost to Follow-up|0
5452129|NCT02135445|18840920|P1|Overall Study|Lost to Follow-up|1
5452130|NCT02135107|18841005|P4|Maintenance Therapy Period|Other|8
5452131|NCT02135107|18841006|P3|Maintenance Therapy Period|Other|7
5452132|NCT02135107|18841007|P2|Maintenance Therapy Period|Other|0
5452133|NCT02135107|18841008|P1|Maintenance Therapy Period|Other|0
5452134|NCT02135107|18841005|P4|Maintenance Therapy Period|Pregnancy|1
5452135|NCT02135107|18841006|P3|Maintenance Therapy Period|Pregnancy|0
5452136|NCT02135107|18841007|P2|Maintenance Therapy Period|Pregnancy|0
5452137|NCT02135107|18841008|P1|Maintenance Therapy Period|Pregnancy|0
5452138|NCT02135107|18841005|P4|Maintenance Therapy Period|Withdrawal by Subject|4
5452139|NCT02135107|18841006|P3|Maintenance Therapy Period|Withdrawal by Subject|5
5452140|NCT02135107|18841007|P2|Maintenance Therapy Period|Withdrawal by Subject|0
5452141|NCT02135107|18841008|P1|Maintenance Therapy Period|Withdrawal by Subject|0
5452142|NCT02135107|18841005|P4|Maintenance Therapy Period|Adverse Event|7
5452143|NCT02135107|18841006|P3|Maintenance Therapy Period|Adverse Event|3
5452144|NCT02135107|18841007|P2|Maintenance Therapy Period|Adverse Event|0
5452145|NCT02135107|18841008|P1|Maintenance Therapy Period|Adverse Event|0
5452146|NCT02135107|18841005|P4|Treatment Period|Other|0
5452147|NCT02135107|18841006|P3|Treatment Period|Other|0
5452148|NCT02135107|18841007|P2|Treatment Period|Other|24
5452149|NCT02135107|18841008|P1|Treatment Period|Other|115
5452150|NCT02135107|18841005|P4|Treatment Period|Pregnancy|0
5452151|NCT02135107|18841006|P3|Treatment Period|Pregnancy|0
5452152|NCT02135107|18841007|P2|Treatment Period|Pregnancy|0
5452153|NCT02135107|18841008|P1|Treatment Period|Pregnancy|1
5452154|NCT02135107|18841005|P4|Treatment Period|Adverse Event|0
5452155|NCT02135107|18841006|P3|Treatment Period|Adverse Event|0
5452156|NCT02135107|18841007|P2|Treatment Period|Adverse Event|2
5452157|NCT02135107|18841008|P1|Treatment Period|Adverse Event|5
5452158|NCT02135107|18841005|P4|Treatment Period|Withdrawal by Subject|0
5452159|NCT02135107|18841006|P3|Treatment Period|Withdrawal by Subject|0
5452160|NCT02135107|18841007|P2|Treatment Period|Withdrawal by Subject|0
5452161|NCT02135107|18841008|P1|Treatment Period|Withdrawal by Subject|11
5452162|NCT02135029|18841054|P3|Overall Study|Death|0
5452163|NCT02135029|18841055|P2|Overall Study|Death|1
5452164|NCT02135029|18841056|P1|Overall Study|Death|0
5452165|NCT02135029|18841054|P3|Overall Study|Other|0
5452166|NCT02135029|18841055|P2|Overall Study|Other|1
5452167|NCT02135029|18841056|P1|Overall Study|Other|0
5452168|NCT02135029|18841054|P3|Overall Study|Withdrawal by Subject|1
5452169|NCT02135029|18841055|P2|Overall Study|Withdrawal by Subject|0
5452170|NCT02135029|18841056|P1|Overall Study|Withdrawal by Subject|2
5452171|NCT02135029|18841054|P3|Overall Study|Lost to Follow-up|0
5452172|NCT02135029|18841055|P2|Overall Study|Lost to Follow-up|1
5452173|NCT02135029|18841056|P1|Overall Study|Lost to Follow-up|0
5452174|NCT02135029|18841054|P3|Overall Study|Adverse Event|2
5452175|NCT02135029|18841055|P2|Overall Study|Adverse Event|2
5452176|NCT02135029|18841056|P1|Overall Study|Adverse Event|2
5452177|NCT02134977|18841161|P1|Overall Study|Protocol Deviation|102
5452178|NCT02134925|18841195|P2|Overall Study|Cancel|6
5452179|NCT02134925|18841196|P1|Overall Study|Cancel|1
5452180|NCT02134925|18841195|P2|Overall Study|Withdrawal by Subject|0
5452181|NCT02134925|18841196|P1|Overall Study|Withdrawal by Subject|1
5452182|NCT02134587|18841250|P1|Overall Study|Did not completed all meetings|30
5452183|NCT02134353|18841266|P2|Overall Study|Other - Patient's Choice|1
5452184|NCT02134353|18841267|P1|Overall Study|Other - Patient's Choice|0
5452185|NCT02134353|18841266|P2|Overall Study|Relocation|0
5452186|NCT02134353|18841267|P1|Overall Study|Relocation|1
5452187|NCT02134353|18841266|P2|Overall Study|Pregnancy|1
5452188|NCT02134353|18841267|P1|Overall Study|Pregnancy|0
5452189|NCT02134353|18841266|P2|Overall Study|Death|1
5452190|NCT02134353|18841267|P1|Overall Study|Death|0
5452191|NCT02134353|18841266|P2|Overall Study|Withdrawal by Subject|13
5452192|NCT02134353|18841267|P1|Overall Study|Withdrawal by Subject|12
5452193|NCT02134353|18841266|P2|Overall Study|Lack of Efficacy|1
5452194|NCT02134353|18841267|P1|Overall Study|Lack of Efficacy|2
5452195|NCT02134353|18841266|P2|Overall Study|Lost to Follow-up|1
5452196|NCT02134353|18841267|P1|Overall Study|Lost to Follow-up|1
5452197|NCT02134353|18841266|P2|Overall Study|Adverse Event|6
5452198|NCT02134353|18841267|P1|Overall Study|Adverse Event|10
5452199|NCT02134028|18841422|P8|Overall Study|Adverse Event|2
5452200|NCT02134028|18841423|P7|Overall Study|Adverse Event|1
5452201|NCT02134028|18841424|P6|Overall Study|Adverse Event|5
5452202|NCT02134028|18841425|P5|Overall Study|Adverse Event|4
5452203|NCT02134028|18841426|P4|Overall Study|Adverse Event|32
5452204|NCT02134028|18841427|P3|Overall Study|Adverse Event|13
5452205|NCT02134028|18841428|P2|Overall Study|Adverse Event|19
5452206|NCT02134028|18841429|P1|Overall Study|Adverse Event|3
5452207|NCT02134028|18841422|P8|Overall Study|Other unspecified|1
5452208|NCT02134028|18841423|P7|Overall Study|Other unspecified|2
5452209|NCT02134028|18841424|P6|Overall Study|Other unspecified|6
5452210|NCT02134028|18841425|P5|Overall Study|Other unspecified|8
5452211|NCT02134028|18841426|P4|Overall Study|Other unspecified|64
5452212|NCT02134028|18841427|P3|Overall Study|Other unspecified|33
5452213|NCT02134028|18841428|P2|Overall Study|Other unspecified|22
5452214|NCT02134028|18841429|P1|Overall Study|Other unspecified|4
5452215|NCT02134028|18841422|P8|Overall Study|Poor compliance to protocol|0
5452216|NCT02134028|18841423|P7|Overall Study|Poor compliance to protocol|0
5452217|NCT02134028|18841424|P6|Overall Study|Poor compliance to protocol|1
5452218|NCT02134028|18841425|P5|Overall Study|Poor compliance to protocol|1
5452219|NCT02134028|18841426|P4|Overall Study|Poor compliance to protocol|7
5452220|NCT02134028|18841427|P3|Overall Study|Poor compliance to protocol|3
5452221|NCT02134028|18841428|P2|Overall Study|Poor compliance to protocol|1
5452222|NCT02134028|18841429|P1|Overall Study|Poor compliance to protocol|1
5452223|NCT02134028|18841422|P8|Overall Study|Lack of Efficacy|0
5452224|NCT02134028|18841423|P7|Overall Study|Lack of Efficacy|1
5452225|NCT02134028|18841424|P6|Overall Study|Lack of Efficacy|2
5452226|NCT02134028|18841425|P5|Overall Study|Lack of Efficacy|1
5452227|NCT02134028|18841426|P4|Overall Study|Lack of Efficacy|2
5452228|NCT02134028|18841427|P3|Overall Study|Lack of Efficacy|3
5452229|NCT02134028|18841428|P2|Overall Study|Lack of Efficacy|0
5452230|NCT02134028|18841429|P1|Overall Study|Lack of Efficacy|1
5452231|NCT02134015|18841587|P2|Overall Study|Withdrawal by Subject|7
5452232|NCT02134015|18841588|P1|Overall Study|Withdrawal by Subject|3
5452233|NCT02134015|18841587|P2|Overall Study|Adverse Event|10
5452234|NCT02134015|18841588|P1|Overall Study|Adverse Event|9
5452235|NCT02134015|18841587|P2|Overall Study|Study terminated by sponsor|3
5452236|NCT02134015|18841588|P1|Overall Study|Study terminated by sponsor|2
5452237|NCT02134015|18841587|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
5452238|NCT02134015|18841588|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
5452239|NCT02134015|18841587|P2|Overall Study|Clinical progression|7
5452240|NCT02134015|18841588|P1|Overall Study|Clinical progression|14
5452241|NCT02134015|18841587|P2|Overall Study|Reason not provided|2
5452242|NCT02134015|18841588|P1|Overall Study|Reason not provided|1
5452243|NCT02134015|18841587|P2|Overall Study|Death|1
5452244|NCT02134015|18841588|P1|Overall Study|Death|2
5452245|NCT02134015|18841587|P2|Overall Study|Protocol Violation|1
5452246|NCT02134015|18841588|P1|Overall Study|Protocol Violation|0
5452247|NCT02133742|18841624|P1|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
5452248|NCT02133742|18841624|P1|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
5452249|NCT02133742|18841624|P1|Period 2:Dose Expansion Phase (1344days)|Death|13
5452250|NCT02133742|18841624|P1|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
5452251|NCT02133742|18841624|P1|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
5452252|NCT02133664|18841653|P2|Overall Study|Adverse Event|6
5452253|NCT02133664|18841654|P1|Overall Study|Adverse Event|3
5452254|NCT02133664|18841653|P2|Overall Study|Lost to Follow-up|1
5452255|NCT02133664|18841654|P1|Overall Study|Lost to Follow-up|2
5452256|NCT02133508|18841670|P1|Overall Study|Lost to Follow-up|2
5452257|NCT02133508|18841670|P1|Overall Study|Death|12
5452258|NCT02133508|18841670|P1|Overall Study|Decision of Investigator or Sponsor|1
5452259|NCT02133352|18841678|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
5452260|NCT02133131|18841709|P7|Overall Study|Protocol Violation|1
5452261|NCT02133131|18841710|P6|Overall Study|Protocol Violation|0
5452262|NCT02133131|18841711|P5|Overall Study|Protocol Violation|0
5452263|NCT02133131|18841712|P4|Overall Study|Protocol Violation|0
5452264|NCT02133131|18841713|P3|Overall Study|Protocol Violation|0
5452265|NCT02133131|18841714|P2|Overall Study|Protocol Violation|0
5452266|NCT02133131|18841715|P1|Overall Study|Protocol Violation|0
5452267|NCT02133131|18841709|P7|Overall Study|Ongoing in study|11
5452268|NCT02133131|18841710|P6|Overall Study|Ongoing in study|14
5452269|NCT02133131|18841711|P5|Overall Study|Ongoing in study|15
5452270|NCT02133131|18841712|P4|Overall Study|Ongoing in study|0
5452271|NCT02133131|18841713|P3|Overall Study|Ongoing in study|0
5452272|NCT02133131|18841714|P2|Overall Study|Ongoing in study|0
5452273|NCT02133131|18841715|P1|Overall Study|Ongoing in study|0
5452274|NCT02133131|18841709|P7|Overall Study|Status not recorded|0
5452275|NCT02133131|18841710|P6|Overall Study|Status not recorded|0
5452276|NCT02133131|18841711|P5|Overall Study|Status not recorded|0
5452277|NCT02133131|18841712|P4|Overall Study|Status not recorded|4
5452278|NCT02133131|18841713|P3|Overall Study|Status not recorded|1
5452279|NCT02133131|18841714|P2|Overall Study|Status not recorded|5
5452280|NCT02133131|18841715|P1|Overall Study|Status not recorded|4
5452281|NCT02133131|18841709|P7|Overall Study|Lost to Follow-up|0
5452282|NCT02133131|18841710|P6|Overall Study|Lost to Follow-up|0
5452283|NCT02133131|18841711|P5|Overall Study|Lost to Follow-up|0
5452284|NCT02133131|18841712|P4|Overall Study|Lost to Follow-up|1
5452285|NCT02133131|18841713|P3|Overall Study|Lost to Follow-up|0
5452286|NCT02133131|18841714|P2|Overall Study|Lost to Follow-up|0
5452287|NCT02133131|18841715|P1|Overall Study|Lost to Follow-up|1
5452288|NCT02133131|18841709|P7|Overall Study|Adverse Event|0
5452289|NCT02133131|18841710|P6|Overall Study|Adverse Event|0
5452290|NCT02133131|18841711|P5|Overall Study|Adverse Event|0
5452291|NCT02133131|18841712|P4|Overall Study|Adverse Event|1
5452292|NCT02133131|18841713|P3|Overall Study|Adverse Event|0
5452293|NCT02133131|18841714|P2|Overall Study|Adverse Event|0
5452294|NCT02133131|18841715|P1|Overall Study|Adverse Event|0
5452295|NCT02133001|18841769|P2|Follow-Up Phase (Day 26-81)|Other|1
5452296|NCT02133001|18841770|P1|Follow-Up Phase (Day 26-81)|Other|0
5452297|NCT02133001|18841769|P2|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
5452298|NCT02133001|18841770|P1|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
5452299|NCT02133001|18841769|P2|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
5452300|NCT02133001|18841770|P1|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
5452301|NCT02133001|18841769|P2|Double Blind (Day 1-25)|Withdrawal by Subject|1
5452302|NCT02133001|18841770|P1|Double Blind (Day 1-25)|Withdrawal by Subject|1
5452303|NCT02133001|18841769|P2|Double Blind (Day 1-25)|Other|2
5452304|NCT02133001|18841770|P1|Double Blind (Day 1-25)|Other|2
5452305|NCT02133001|18841769|P2|Double Blind (Day 1-25)|Lost to Follow-up|0
5452306|NCT02133001|18841770|P1|Double Blind (Day 1-25)|Lost to Follow-up|2
5452307|NCT02133001|18841769|P2|Double Blind (Day 1-25)|Lack of Efficacy|1
5452308|NCT02133001|18841770|P1|Double Blind (Day 1-25)|Lack of Efficacy|4
5452309|NCT02133001|18841769|P2|Double Blind (Day 1-25)|Adverse Event|5
5452310|NCT02133001|18841770|P1|Double Blind (Day 1-25)|Adverse Event|1
5452311|NCT02132949|18841818|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
5452312|NCT02132949|18841819|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
5452313|NCT02132949|18841818|P2|Adjuvant Treatment Period|Protocol Deviation|0
5452314|NCT02132949|18841819|P1|Adjuvant Treatment Period|Protocol Deviation|1
5452315|NCT02132949|18841818|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
5452316|NCT02132949|18841819|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
5452317|NCT02132949|18841818|P2|Adjuvant Treatment Period|Physician Decision|0
5452318|NCT02132949|18841819|P1|Adjuvant Treatment Period|Physician Decision|1
5452319|NCT02132949|18841818|P2|Adjuvant Treatment Period|Disease Relapse|1
5452320|NCT02132949|18841819|P1|Adjuvant Treatment Period|Disease Relapse|0
5452321|NCT02132949|18841818|P2|Adjuvant Treatment Period|Disease Progression|1
5452322|NCT02132949|18841819|P1|Adjuvant Treatment Period|Disease Progression|0
5452323|NCT02132949|18841818|P2|Adjuvant Treatment Period|Reason unspecified|1
5452324|NCT02132949|18841819|P1|Adjuvant Treatment Period|Reason unspecified|0
5452325|NCT02132949|18841818|P2|Adjuvant Treatment Period|Adverse Event|6
5452326|NCT02132949|18841819|P1|Adjuvant Treatment Period|Adverse Event|4
5452327|NCT02132949|18841818|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
5452328|NCT02132949|18841819|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
5452329|NCT02132949|18841818|P2|Neoadjuvant Treatment Period|Adverse Event|3
5452330|NCT02132949|18841819|P1|Neoadjuvant Treatment Period|Adverse Event|6
5452331|NCT02132949|18841818|P2|Neoadjuvant Treatment Period|Disease Progression|1
5452332|NCT02132949|18841819|P1|Neoadjuvant Treatment Period|Disease Progression|1
5452333|NCT02132949|18841818|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
5452334|NCT02132949|18841819|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
5452335|NCT02132949|18841818|P2|Neoadjuvant Treatment Period|Physician Decision|0
5452336|NCT02132949|18841819|P1|Neoadjuvant Treatment Period|Physician Decision|2
5452337|NCT02132949|18841818|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
5452338|NCT02132949|18841819|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
5452339|NCT02132949|18841818|P2|Neoadjuvant Treatment Period|Reason unspecified|1
5452340|NCT02132949|18841819|P1|Neoadjuvant Treatment Period|Reason unspecified|3
5452341|NCT02132949|18841818|P2|Neoadjuvant Treatment Period|Early surgery|3
5452342|NCT02132949|18841819|P1|Neoadjuvant Treatment Period|Early surgery|4
5452343|NCT02132767|18841931|P2|Overall Study|Lost to Follow-up|4
5452344|NCT02132767|18841932|P1|Overall Study|Lost to Follow-up|4
5452345|NCT02132767|18841931|P2|Overall Study|Withdrawal by Subject|9
5452346|NCT02132767|18841932|P1|Overall Study|Withdrawal by Subject|10
5452347|NCT02132767|18841931|P2|Overall Study|Death|2
5452348|NCT02132767|18841932|P1|Overall Study|Death|3
5452349|NCT02132754|18841986|P34|Overall Study|Withdrawal by Subject|2
5452350|NCT02132754|18841987|P33|Overall Study|Withdrawal by Subject|0
5452351|NCT02132754|18841988|P32|Overall Study|Withdrawal by Subject|1
5452352|NCT02132754|18841989|P31|Overall Study|Withdrawal by Subject|0
5452353|NCT02132754|18841990|P30|Overall Study|Withdrawal by Subject|0
5452354|NCT02132754|18841991|P29|Overall Study|Withdrawal by Subject|0
5452355|NCT02132754|18841992|P28|Overall Study|Withdrawal by Subject|1
5452356|NCT02132754|18841993|P27|Overall Study|Withdrawal by Subject|0
5452357|NCT02132754|18841994|P26|Overall Study|Withdrawal by Subject|0
5452358|NCT02132754|18841995|P25|Overall Study|Withdrawal by Subject|1
5452359|NCT02132754|18841996|P24|Overall Study|Withdrawal by Subject|0
5452360|NCT02132754|18841997|P23|Overall Study|Withdrawal by Subject|0
5452361|NCT02132754|18841998|P22|Overall Study|Withdrawal by Subject|0
5452362|NCT02132754|18841999|P21|Overall Study|Withdrawal by Subject|1
5452363|NCT02132754|18842000|P20|Overall Study|Withdrawal by Subject|0
5452364|NCT02132754|18842001|P19|Overall Study|Withdrawal by Subject|0
5452365|NCT02132754|18842002|P18|Overall Study|Withdrawal by Subject|0
5452366|NCT02132754|18842003|P17|Overall Study|Withdrawal by Subject|1
5452367|NCT02132754|18842004|P16|Overall Study|Withdrawal by Subject|2
5452368|NCT02132754|18842005|P15|Overall Study|Withdrawal by Subject|1
5452369|NCT02132754|18842006|P14|Overall Study|Withdrawal by Subject|0
5452370|NCT02132754|18842007|P13|Overall Study|Withdrawal by Subject|1
5452371|NCT02132754|18842008|P12|Overall Study|Withdrawal by Subject|0
5452372|NCT02132754|18842009|P11|Overall Study|Withdrawal by Subject|0
5452373|NCT02132754|18842010|P10|Overall Study|Withdrawal by Subject|1
5452374|NCT02132754|18842011|P9|Overall Study|Withdrawal by Subject|0
5452375|NCT02132754|18842012|P8|Overall Study|Withdrawal by Subject|0
5452376|NCT02132754|18842013|P7|Overall Study|Withdrawal by Subject|0
5452377|NCT02132754|18842014|P6|Overall Study|Withdrawal by Subject|0
5452378|NCT02132754|18842015|P5|Overall Study|Withdrawal by Subject|0
5452379|NCT02132754|18842016|P4|Overall Study|Withdrawal by Subject|0
5452380|NCT02132754|18842017|P3|Overall Study|Withdrawal by Subject|0
5452381|NCT02132754|18842018|P2|Overall Study|Withdrawal by Subject|0
5452382|NCT02132754|18842019|P1|Overall Study|Withdrawal by Subject|0
5452383|NCT02132754|18841986|P34|Overall Study|Transferred to Extension Study|6
5452384|NCT02132754|18841987|P33|Overall Study|Transferred to Extension Study|0
5452385|NCT02132754|18841988|P32|Overall Study|Transferred to Extension Study|0
5452386|NCT02132754|18841989|P31|Overall Study|Transferred to Extension Study|0
5452387|NCT02132754|18841990|P30|Overall Study|Transferred to Extension Study|0
5452388|NCT02132754|18841991|P29|Overall Study|Transferred to Extension Study|0
5452389|NCT02132754|18841992|P28|Overall Study|Transferred to Extension Study|0
5452390|NCT02132754|18841993|P27|Overall Study|Transferred to Extension Study|0
5452391|NCT02132754|18841994|P26|Overall Study|Transferred to Extension Study|0
5452392|NCT02132754|18841995|P25|Overall Study|Transferred to Extension Study|0
5452393|NCT02132754|18841996|P24|Overall Study|Transferred to Extension Study|0
5452394|NCT02132754|18841997|P23|Overall Study|Transferred to Extension Study|0
5452395|NCT02132754|18841998|P22|Overall Study|Transferred to Extension Study|0
5452396|NCT02132754|18841999|P21|Overall Study|Transferred to Extension Study|0
5452397|NCT02132754|18842000|P20|Overall Study|Transferred to Extension Study|0
5452398|NCT02132754|18842001|P19|Overall Study|Transferred to Extension Study|0
5452399|NCT02132754|18842002|P18|Overall Study|Transferred to Extension Study|0
5452400|NCT02132754|18842003|P17|Overall Study|Transferred to Extension Study|0
5452401|NCT02132754|18842004|P16|Overall Study|Transferred to Extension Study|0
5452402|NCT02132754|18842005|P15|Overall Study|Transferred to Extension Study|0
5452403|NCT02132754|18842006|P14|Overall Study|Transferred to Extension Study|0
5452404|NCT02132754|18842007|P13|Overall Study|Transferred to Extension Study|0
5452405|NCT02132754|18842008|P12|Overall Study|Transferred to Extension Study|0
5452406|NCT02132754|18842009|P11|Overall Study|Transferred to Extension Study|0
5452407|NCT02132754|18842010|P10|Overall Study|Transferred to Extension Study|0
5452408|NCT02132754|18842011|P9|Overall Study|Transferred to Extension Study|0
5452409|NCT02132754|18842012|P8|Overall Study|Transferred to Extension Study|0
5452410|NCT02132754|18842013|P7|Overall Study|Transferred to Extension Study|0
5452411|NCT02132754|18842014|P6|Overall Study|Transferred to Extension Study|0
5452412|NCT02132754|18842015|P5|Overall Study|Transferred to Extension Study|0
5452413|NCT02132754|18842016|P4|Overall Study|Transferred to Extension Study|0
5452414|NCT02132754|18842017|P3|Overall Study|Transferred to Extension Study|0
5452415|NCT02132754|18842018|P2|Overall Study|Transferred to Extension Study|0
5452416|NCT02132754|18842019|P1|Overall Study|Transferred to Extension Study|0
5452417|NCT02132754|18841986|P34|Overall Study|Screen Failure|0
5452418|NCT02132754|18841987|P33|Overall Study|Screen Failure|0
5452419|NCT02132754|18841988|P32|Overall Study|Screen Failure|0
5452420|NCT02132754|18841989|P31|Overall Study|Screen Failure|0
5452421|NCT02132754|18841990|P30|Overall Study|Screen Failure|0
5452422|NCT02132754|18841991|P29|Overall Study|Screen Failure|0
5452423|NCT02132754|18841992|P28|Overall Study|Screen Failure|0
5452424|NCT02132754|18841993|P27|Overall Study|Screen Failure|0
5452425|NCT02132754|18841994|P26|Overall Study|Screen Failure|0
5452426|NCT02132754|18841995|P25|Overall Study|Screen Failure|0
5452427|NCT02132754|18841996|P24|Overall Study|Screen Failure|0
5452428|NCT02132754|18841997|P23|Overall Study|Screen Failure|0
5452429|NCT02132754|18841998|P22|Overall Study|Screen Failure|1
5452430|NCT02132754|18841999|P21|Overall Study|Screen Failure|0
5452431|NCT02132754|18842000|P20|Overall Study|Screen Failure|1
5452432|NCT02132754|18842001|P19|Overall Study|Screen Failure|0
5452433|NCT02132754|18842002|P18|Overall Study|Screen Failure|0
5452434|NCT02132754|18842003|P17|Overall Study|Screen Failure|0
5452435|NCT02132754|18842004|P16|Overall Study|Screen Failure|0
5452436|NCT02132754|18842005|P15|Overall Study|Screen Failure|0
5452437|NCT02132754|18842006|P14|Overall Study|Screen Failure|0
5452438|NCT02132754|18842007|P13|Overall Study|Screen Failure|0
5452439|NCT02132754|18842008|P12|Overall Study|Screen Failure|0
5452440|NCT02132754|18842009|P11|Overall Study|Screen Failure|0
5452441|NCT02132754|18842010|P10|Overall Study|Screen Failure|0
5452442|NCT02132754|18842011|P9|Overall Study|Screen Failure|0
5452443|NCT02132754|18842012|P8|Overall Study|Screen Failure|0
5452444|NCT02132754|18842013|P7|Overall Study|Screen Failure|0
5452445|NCT02132754|18842014|P6|Overall Study|Screen Failure|0
5452446|NCT02132754|18842015|P5|Overall Study|Screen Failure|0
5452447|NCT02132754|18842016|P4|Overall Study|Screen Failure|0
5452448|NCT02132754|18842017|P3|Overall Study|Screen Failure|0
5452449|NCT02132754|18842018|P2|Overall Study|Screen Failure|0
5452450|NCT02132754|18842019|P1|Overall Study|Screen Failure|0
5452451|NCT02132754|18841986|P34|Overall Study|Progressive Disease|6
5452452|NCT02132754|18841987|P33|Overall Study|Progressive Disease|3
5452453|NCT02132754|18841988|P32|Overall Study|Progressive Disease|1
5452454|NCT02132754|18841989|P31|Overall Study|Progressive Disease|1
5452455|NCT02132754|18841990|P30|Overall Study|Progressive Disease|3
5452456|NCT02132754|18841991|P29|Overall Study|Progressive Disease|2
5452457|NCT02132754|18841992|P28|Overall Study|Progressive Disease|1
5452458|NCT02132754|18841993|P27|Overall Study|Progressive Disease|2
5452459|NCT02132754|18841994|P26|Overall Study|Progressive Disease|1
5452460|NCT02132754|18841995|P25|Overall Study|Progressive Disease|0
5452461|NCT02132754|18841996|P24|Overall Study|Progressive Disease|3
5452462|NCT02132754|18841997|P23|Overall Study|Progressive Disease|2
5452463|NCT02132754|18841998|P22|Overall Study|Progressive Disease|3
5452464|NCT02132754|18841999|P21|Overall Study|Progressive Disease|1
5452465|NCT02132754|18842000|P20|Overall Study|Progressive Disease|1
5452466|NCT02132754|18842001|P19|Overall Study|Progressive Disease|3
5452467|NCT02132754|18842002|P18|Overall Study|Progressive Disease|1
5452468|NCT02132754|18842003|P17|Overall Study|Progressive Disease|2
5452469|NCT02132754|18842004|P16|Overall Study|Progressive Disease|1
5452470|NCT02132754|18842005|P15|Overall Study|Progressive Disease|2
5452471|NCT02132754|18842006|P14|Overall Study|Progressive Disease|3
5452472|NCT02132754|18842007|P13|Overall Study|Progressive Disease|2
5452473|NCT02132754|18842008|P12|Overall Study|Progressive Disease|2
5452474|NCT02132754|18842009|P11|Overall Study|Progressive Disease|3
5452475|NCT02132754|18842010|P10|Overall Study|Progressive Disease|3
5452476|NCT02132754|18842011|P9|Overall Study|Progressive Disease|1
5452477|NCT02132754|18842012|P8|Overall Study|Progressive Disease|1
5452478|NCT02132754|18842013|P7|Overall Study|Progressive Disease|1
5452479|NCT02132754|18842014|P6|Overall Study|Progressive Disease|1
5452480|NCT02132754|18842015|P5|Overall Study|Progressive Disease|1
5452481|NCT02132754|18842016|P4|Overall Study|Progressive Disease|1
5452482|NCT02132754|18842017|P3|Overall Study|Progressive Disease|1
5452483|NCT02132754|18842018|P2|Overall Study|Progressive Disease|1
5452484|NCT02132754|18842019|P1|Overall Study|Progressive Disease|1
5452485|NCT02132754|18841986|P34|Overall Study|Physician Decision|3
5452486|NCT02132754|18841987|P33|Overall Study|Physician Decision|0
5452487|NCT02132754|18841988|P32|Overall Study|Physician Decision|1
5452488|NCT02132754|18841989|P31|Overall Study|Physician Decision|0
5452489|NCT02132754|18841990|P30|Overall Study|Physician Decision|0
5452490|NCT02132754|18841991|P29|Overall Study|Physician Decision|0
5452491|NCT02132754|18841992|P28|Overall Study|Physician Decision|0
5452492|NCT02132754|18841993|P27|Overall Study|Physician Decision|0
5452493|NCT02132754|18841994|P26|Overall Study|Physician Decision|0
5452494|NCT02132754|18841995|P25|Overall Study|Physician Decision|1
5452495|NCT02132754|18841996|P24|Overall Study|Physician Decision|0
5452496|NCT02132754|18841997|P23|Overall Study|Physician Decision|0
5452497|NCT02132754|18841998|P22|Overall Study|Physician Decision|0
5452498|NCT02132754|18841999|P21|Overall Study|Physician Decision|0
5452499|NCT02132754|18842000|P20|Overall Study|Physician Decision|0
5452500|NCT02132754|18842001|P19|Overall Study|Physician Decision|0
5452501|NCT02132754|18842002|P18|Overall Study|Physician Decision|0
5452502|NCT02132754|18842003|P17|Overall Study|Physician Decision|0
5452503|NCT02132754|18842004|P16|Overall Study|Physician Decision|1
5452504|NCT02132754|18842005|P15|Overall Study|Physician Decision|0
5452505|NCT02132754|18842006|P14|Overall Study|Physician Decision|0
5452506|NCT02132754|18842007|P13|Overall Study|Physician Decision|1
5452507|NCT02132754|18842008|P12|Overall Study|Physician Decision|1
5452508|NCT02132754|18842009|P11|Overall Study|Physician Decision|0
5452509|NCT02132754|18842010|P10|Overall Study|Physician Decision|1
5452510|NCT02132754|18842011|P9|Overall Study|Physician Decision|0
5452511|NCT02132754|18842012|P8|Overall Study|Physician Decision|0
5452512|NCT02132754|18842013|P7|Overall Study|Physician Decision|0
5452513|NCT02132754|18842014|P6|Overall Study|Physician Decision|0
5452514|NCT02132754|18842015|P5|Overall Study|Physician Decision|0
5452515|NCT02132754|18842016|P4|Overall Study|Physician Decision|0
5452516|NCT02132754|18842017|P3|Overall Study|Physician Decision|0
5452517|NCT02132754|18842018|P2|Overall Study|Physician Decision|0
5452518|NCT02132754|18842019|P1|Overall Study|Physician Decision|0
5452519|NCT02132754|18841986|P34|Overall Study|Excluded Medication|1
5452520|NCT02132754|18841987|P33|Overall Study|Excluded Medication|0
5452521|NCT02132754|18841988|P32|Overall Study|Excluded Medication|0
5452522|NCT02132754|18841989|P31|Overall Study|Excluded Medication|0
5452523|NCT02132754|18841990|P30|Overall Study|Excluded Medication|0
5452524|NCT02132754|18841991|P29|Overall Study|Excluded Medication|0
5452525|NCT02132754|18841992|P28|Overall Study|Excluded Medication|0
5452526|NCT02132754|18841993|P27|Overall Study|Excluded Medication|0
5452527|NCT02132754|18841994|P26|Overall Study|Excluded Medication|0
5452528|NCT02132754|18841995|P25|Overall Study|Excluded Medication|0
5452529|NCT02132754|18841996|P24|Overall Study|Excluded Medication|0
5452530|NCT02132754|18841997|P23|Overall Study|Excluded Medication|0
5452531|NCT02132754|18841998|P22|Overall Study|Excluded Medication|0
5452532|NCT02132754|18841999|P21|Overall Study|Excluded Medication|1
5452533|NCT02132754|18842000|P20|Overall Study|Excluded Medication|0
5452534|NCT02132754|18842001|P19|Overall Study|Excluded Medication|0
5452535|NCT02132754|18842002|P18|Overall Study|Excluded Medication|0
5452536|NCT02132754|18842003|P17|Overall Study|Excluded Medication|0
5452537|NCT02132754|18842004|P16|Overall Study|Excluded Medication|0
5452538|NCT02132754|18842005|P15|Overall Study|Excluded Medication|0
5452539|NCT02132754|18842006|P14|Overall Study|Excluded Medication|0
5452540|NCT02132754|18842007|P13|Overall Study|Excluded Medication|0
5452541|NCT02132754|18842008|P12|Overall Study|Excluded Medication|0
5452542|NCT02132754|18842009|P11|Overall Study|Excluded Medication|0
5452543|NCT02132754|18842010|P10|Overall Study|Excluded Medication|0
5452544|NCT02132754|18842011|P9|Overall Study|Excluded Medication|0
5452545|NCT02132754|18842012|P8|Overall Study|Excluded Medication|0
5452546|NCT02132754|18842013|P7|Overall Study|Excluded Medication|0
5452547|NCT02132754|18842014|P6|Overall Study|Excluded Medication|0
5452548|NCT02132754|18842015|P5|Overall Study|Excluded Medication|0
5452549|NCT02132754|18842016|P4|Overall Study|Excluded Medication|0
5452550|NCT02132754|18842017|P3|Overall Study|Excluded Medication|0
5452551|NCT02132754|18842018|P2|Overall Study|Excluded Medication|0
5452552|NCT02132754|18842019|P1|Overall Study|Excluded Medication|0
5452553|NCT02132754|18841986|P34|Overall Study|Death|2
5452554|NCT02132754|18841987|P33|Overall Study|Death|0
5452555|NCT02132754|18841988|P32|Overall Study|Death|0
5452556|NCT02132754|18841989|P31|Overall Study|Death|0
5452557|NCT02132754|18841990|P30|Overall Study|Death|0
5452558|NCT02132754|18841991|P29|Overall Study|Death|0
5452559|NCT02132754|18841992|P28|Overall Study|Death|0
5452560|NCT02132754|18841993|P27|Overall Study|Death|1
5452561|NCT02132754|18841994|P26|Overall Study|Death|0
5452562|NCT02132754|18841995|P25|Overall Study|Death|0
5452563|NCT02132754|18841996|P24|Overall Study|Death|0
5452564|NCT02132754|18841997|P23|Overall Study|Death|0
5452565|NCT02132754|18841998|P22|Overall Study|Death|1
5452566|NCT02132754|18841999|P21|Overall Study|Death|0
5452567|NCT02132754|18842000|P20|Overall Study|Death|1
5452568|NCT02132754|18842001|P19|Overall Study|Death|0
5452569|NCT02132754|18842002|P18|Overall Study|Death|0
5452570|NCT02132754|18842003|P17|Overall Study|Death|0
5452571|NCT02132754|18842004|P16|Overall Study|Death|1
5452572|NCT02132754|18842005|P15|Overall Study|Death|0
5452573|NCT02132754|18842006|P14|Overall Study|Death|0
5452574|NCT02132754|18842007|P13|Overall Study|Death|0
5452575|NCT02132754|18842008|P12|Overall Study|Death|0
5452576|NCT02132754|18842009|P11|Overall Study|Death|0
5452577|NCT02132754|18842010|P10|Overall Study|Death|0
5452578|NCT02132754|18842011|P9|Overall Study|Death|0
5452579|NCT02132754|18842012|P8|Overall Study|Death|0
5452580|NCT02132754|18842013|P7|Overall Study|Death|0
5452581|NCT02132754|18842014|P6|Overall Study|Death|0
5452582|NCT02132754|18842015|P5|Overall Study|Death|0
5452583|NCT02132754|18842016|P4|Overall Study|Death|0
5452584|NCT02132754|18842017|P3|Overall Study|Death|0
5452585|NCT02132754|18842018|P2|Overall Study|Death|0
5452586|NCT02132754|18842019|P1|Overall Study|Death|0
5452587|NCT02132754|18841986|P34|Overall Study|Clinical Progression|2
5452588|NCT02132754|18841987|P33|Overall Study|Clinical Progression|0
5452589|NCT02132754|18841988|P32|Overall Study|Clinical Progression|0
5452590|NCT02132754|18841989|P31|Overall Study|Clinical Progression|1
5452591|NCT02132754|18841990|P30|Overall Study|Clinical Progression|0
5452592|NCT02132754|18841991|P29|Overall Study|Clinical Progression|1
5452593|NCT02132754|18841992|P28|Overall Study|Clinical Progression|1
5452594|NCT02132754|18841993|P27|Overall Study|Clinical Progression|0
5452595|NCT02132754|18841994|P26|Overall Study|Clinical Progression|1
5452596|NCT02132754|18841995|P25|Overall Study|Clinical Progression|1
5452597|NCT02132754|18841996|P24|Overall Study|Clinical Progression|0
5452598|NCT02132754|18841997|P23|Overall Study|Clinical Progression|1
5452599|NCT02132754|18841998|P22|Overall Study|Clinical Progression|0
5452600|NCT02132754|18841999|P21|Overall Study|Clinical Progression|0
5452601|NCT02132754|18842000|P20|Overall Study|Clinical Progression|1
5452602|NCT02132754|18842001|P19|Overall Study|Clinical Progression|0
5452603|NCT02132754|18842002|P18|Overall Study|Clinical Progression|1
5452604|NCT02132754|18842003|P17|Overall Study|Clinical Progression|1
5452605|NCT02132754|18842004|P16|Overall Study|Clinical Progression|0
5452606|NCT02132754|18842005|P15|Overall Study|Clinical Progression|0
5452607|NCT02132754|18842006|P14|Overall Study|Clinical Progression|0
5452608|NCT02132754|18842007|P13|Overall Study|Clinical Progression|0
5452609|NCT02132754|18842008|P12|Overall Study|Clinical Progression|0
5452610|NCT02132754|18842009|P11|Overall Study|Clinical Progression|0
5452611|NCT02132754|18842010|P10|Overall Study|Clinical Progression|1
5452612|NCT02132754|18842011|P9|Overall Study|Clinical Progression|0
5452613|NCT02132754|18842012|P8|Overall Study|Clinical Progression|0
5452614|NCT02132754|18842013|P7|Overall Study|Clinical Progression|0
5452615|NCT02132754|18842014|P6|Overall Study|Clinical Progression|0
5452616|NCT02132754|18842015|P5|Overall Study|Clinical Progression|0
5452617|NCT02132754|18842016|P4|Overall Study|Clinical Progression|0
5452618|NCT02132754|18842017|P3|Overall Study|Clinical Progression|0
5452619|NCT02132754|18842018|P2|Overall Study|Clinical Progression|0
5452620|NCT02132754|18842019|P1|Overall Study|Clinical Progression|0
5452621|NCT02132754|18841986|P34|Overall Study|Adverse Event|1
5452622|NCT02132754|18841987|P33|Overall Study|Adverse Event|1
5452623|NCT02132754|18841988|P32|Overall Study|Adverse Event|0
5452624|NCT02132754|18841989|P31|Overall Study|Adverse Event|1
5452625|NCT02132754|18841990|P30|Overall Study|Adverse Event|0
5452626|NCT02132754|18841991|P29|Overall Study|Adverse Event|0
5452627|NCT02132754|18841992|P28|Overall Study|Adverse Event|0
5452628|NCT02132754|18841993|P27|Overall Study|Adverse Event|1
5452629|NCT02132754|18841994|P26|Overall Study|Adverse Event|1
5452630|NCT02132754|18841995|P25|Overall Study|Adverse Event|0
5452631|NCT02132754|18841996|P24|Overall Study|Adverse Event|0
5452632|NCT02132754|18841997|P23|Overall Study|Adverse Event|0
5452633|NCT02132754|18841998|P22|Overall Study|Adverse Event|0
5452634|NCT02132754|18841999|P21|Overall Study|Adverse Event|0
5452635|NCT02132754|18842000|P20|Overall Study|Adverse Event|0
5452636|NCT02132754|18842001|P19|Overall Study|Adverse Event|0
5452637|NCT02132754|18842002|P18|Overall Study|Adverse Event|1
5452638|NCT02132754|18842003|P17|Overall Study|Adverse Event|0
5452639|NCT02132754|18842004|P16|Overall Study|Adverse Event|0
5452640|NCT02132754|18842005|P15|Overall Study|Adverse Event|0
5452641|NCT02132754|18842006|P14|Overall Study|Adverse Event|0
5452642|NCT02132754|18842007|P13|Overall Study|Adverse Event|0
5452643|NCT02132754|18842008|P12|Overall Study|Adverse Event|0
5452644|NCT02132754|18842009|P11|Overall Study|Adverse Event|0
5452645|NCT02132754|18842010|P10|Overall Study|Adverse Event|0
5452646|NCT02132754|18842011|P9|Overall Study|Adverse Event|0
5452647|NCT02132754|18842012|P8|Overall Study|Adverse Event|0
5452648|NCT02132754|18842013|P7|Overall Study|Adverse Event|0
5452649|NCT02132754|18842014|P6|Overall Study|Adverse Event|0
5452650|NCT02132754|18842015|P5|Overall Study|Adverse Event|0
5452651|NCT02132754|18842016|P4|Overall Study|Adverse Event|0
5452652|NCT02132754|18842017|P3|Overall Study|Adverse Event|0
5452653|NCT02132754|18842018|P2|Overall Study|Adverse Event|0
5452654|NCT02132754|18842019|P1|Overall Study|Adverse Event|0
5452655|NCT02132637|18842787|P2|Study Period 2 (Crossover)|Physician Decision|0
5452656|NCT02132637|18842788|P1|Study Period 2 (Crossover)|Physician Decision|2
5452657|NCT02132637|18842787|P2|Study Period 2 (Crossover)|Adverse Event|1
5452658|NCT02132637|18842788|P1|Study Period 2 (Crossover)|Adverse Event|0
5452659|NCT02132637|18842787|P2|Study Period 1|Physician Decision|0
5452660|NCT02132637|18842788|P1|Study Period 1|Physician Decision|1
5452661|NCT02132637|18842787|P2|Study Period 1|Withdrawal by Subject|4
5452662|NCT02132637|18842788|P1|Study Period 1|Withdrawal by Subject|0
5452663|NCT02132611|18842812|P1|Overall Study|Death|2
5452664|NCT02132247|18842875|P2|Overall Study|Protocol Violation|0
5452665|NCT02132247|18842876|P1|Overall Study|Protocol Violation|1
5452666|NCT02132195|18842891|P3|Rescue Therapy|Adverse Event|2
5452667|NCT02132195|18842892|P2|Rescue Therapy|Adverse Event|0
5452668|NCT02132195|18842893|P1|Rescue Therapy|Adverse Event|0
5452669|NCT02132195|18842891|P3|Rescue Therapy|Withdrawal by Subject|1
5452670|NCT02132195|18842892|P2|Rescue Therapy|Withdrawal by Subject|0
5452671|NCT02132195|18842893|P1|Rescue Therapy|Withdrawal by Subject|0
5452672|NCT02132195|18842891|P3|Rescue Therapy|Physician Decision|1
5452673|NCT02132195|18842892|P2|Rescue Therapy|Physician Decision|0
5452674|NCT02132195|18842893|P1|Rescue Therapy|Physician Decision|0
5452675|NCT02132195|18842891|P3|Rescue Therapy|Relapsed|7
5452676|NCT02132195|18842892|P2|Rescue Therapy|Relapsed|0
5452677|NCT02132195|18842893|P1|Rescue Therapy|Relapsed|0
5452678|NCT02132195|18842891|P3|Initial Assignment|Relapsed|0
5452679|NCT02132195|18842892|P2|Initial Assignment|Relapsed|0
5452680|NCT02132195|18842893|P1|Initial Assignment|Relapsed|14
5452681|NCT02132117|18842924|P2|Overall Study|Other Miscellaneous Reasons|0
5452682|NCT02132117|18842925|P1|Overall Study|Other Miscellaneous Reasons|2
5452683|NCT02132117|18842924|P2|Overall Study|Personal Reasons|2
5452684|NCT02132117|18842925|P1|Overall Study|Personal Reasons|1
5452685|NCT02132117|18842924|P2|Overall Study|Lost to Follow-up|2
5452686|NCT02132117|18842925|P1|Overall Study|Lost to Follow-up|2
5452687|NCT02132117|18842924|P2|Overall Study|Adverse Event|1
5452688|NCT02132117|18842925|P1|Overall Study|Adverse Event|6
5452689|NCT02131766|18842941|P1|Overall Study|Withdrawal by Subject|4
5452690|NCT02131662|18842957|P5|Overall Study|Not treated|3
5452691|NCT02131662|18842958|P4|Overall Study|Not treated|2
5452692|NCT02131662|18842959|P3|Overall Study|Not treated|2
5452693|NCT02131662|18842960|P2|Overall Study|Not treated|0
5452694|NCT02131662|18842961|P1|Overall Study|Not treated|2
5452695|NCT02131662|18842957|P5|Overall Study|Lost to Follow-up|0
5452696|NCT02131662|18842958|P4|Overall Study|Lost to Follow-up|9
5452697|NCT02131662|18842959|P3|Overall Study|Lost to Follow-up|0
5452698|NCT02131662|18842960|P2|Overall Study|Lost to Follow-up|3
5452699|NCT02131662|18842961|P1|Overall Study|Lost to Follow-up|1
5452700|NCT02131662|18842957|P5|Overall Study|Withdrawal by Subject|6
5452701|NCT02131662|18842958|P4|Overall Study|Withdrawal by Subject|5
5452702|NCT02131662|18842959|P3|Overall Study|Withdrawal by Subject|1
5452703|NCT02131662|18842960|P2|Overall Study|Withdrawal by Subject|5
5452704|NCT02131662|18842961|P1|Overall Study|Withdrawal by Subject|1
5452705|NCT02131662|18842957|P5|Overall Study|Lack of Efficacy|1
5452706|NCT02131662|18842958|P4|Overall Study|Lack of Efficacy|0
5452707|NCT02131662|18842959|P3|Overall Study|Lack of Efficacy|0
5452708|NCT02131662|18842960|P2|Overall Study|Lack of Efficacy|0
5452709|NCT02131662|18842961|P1|Overall Study|Lack of Efficacy|1
5452710|NCT02131662|18842957|P5|Overall Study|Wish for pregnancy|1
5452711|NCT02131662|18842958|P4|Overall Study|Wish for pregnancy|0
5452712|NCT02131662|18842959|P3|Overall Study|Wish for pregnancy|0
5452713|NCT02131662|18842960|P2|Overall Study|Wish for pregnancy|0
5452714|NCT02131662|18842961|P1|Overall Study|Wish for pregnancy|0
5452715|NCT02131662|18842957|P5|Overall Study|Pregnancy|0
5452716|NCT02131662|18842958|P4|Overall Study|Pregnancy|1
5452717|NCT02131662|18842959|P3|Overall Study|Pregnancy|0
5452718|NCT02131662|18842960|P2|Overall Study|Pregnancy|1
5452719|NCT02131662|18842961|P1|Overall Study|Pregnancy|0
5452720|NCT02131662|18842957|P5|Overall Study|Adverse Event|3
5452721|NCT02131662|18842958|P4|Overall Study|Adverse Event|1
5452722|NCT02131662|18842959|P3|Overall Study|Adverse Event|1
5452723|NCT02131662|18842960|P2|Overall Study|Adverse Event|1
5452724|NCT02131662|18842961|P1|Overall Study|Adverse Event|0
5452725|NCT02131662|18842957|P5|Overall Study|Other|4
5452726|NCT02131662|18842958|P4|Overall Study|Other|3
5452727|NCT02131662|18842959|P3|Overall Study|Other|3
5452728|NCT02131662|18842960|P2|Overall Study|Other|4
5452729|NCT02131662|18842961|P1|Overall Study|Other|2
5452730|NCT02131662|18842957|P5|Overall Study|Protocol Violation|0
5452731|NCT02131662|18842958|P4|Overall Study|Protocol Violation|0
5452732|NCT02131662|18842959|P3|Overall Study|Protocol Violation|0
5452733|NCT02131662|18842960|P2|Overall Study|Protocol Violation|0
5452734|NCT02131662|18842961|P1|Overall Study|Protocol Violation|1
5452735|NCT02131636|18843007|P2|Overall Study|Adverse Event|1
5452736|NCT02131636|18843008|P1|Overall Study|Adverse Event|4
5452737|NCT02131636|18843007|P2|Overall Study|Lost to Follow-up|0
5452738|NCT02131636|18843008|P1|Overall Study|Lost to Follow-up|4
5452739|NCT02131636|18843007|P2|Overall Study|Personal Reasons|4
5452740|NCT02131636|18843008|P1|Overall Study|Personal Reasons|4
5452741|NCT02131532|18843024|P1|Overall Study|Other health conditions|2
5452742|NCT02131532|18843024|P1|Overall Study|Physician Decision|1
5452743|NCT02131532|18843024|P1|Overall Study|Withdrawal by Subject|1
5452744|NCT02131324|18843116|P2|Overall Study|Lost to Follow-up|1
5452745|NCT02131324|18843117|P1|Overall Study|Lost to Follow-up|1
5452746|NCT02131324|18843116|P2|Overall Study|Withdrawal by Subject|2
5452747|NCT02131324|18843117|P1|Overall Study|Withdrawal by Subject|1
5452748|NCT02131311|18843123|P1|Overall Study|Lost to Follow-up|1
5452749|NCT02131311|18843123|P1|Overall Study|Protocol Violation|1
5452750|NCT02131311|18843123|P1|Overall Study|Adverse Event|2
5452751|NCT02131272|18843135|P2|Overall Study|Withdrawal Criteria|0
5452752|NCT02131272|18843136|P1|Overall Study|Withdrawal Criteria|1
5452753|NCT02131272|18843135|P2|Overall Study|Withdrawal by Subject|1
5452754|NCT02131272|18843136|P1|Overall Study|Withdrawal by Subject|0
5452755|NCT02131272|18843135|P2|Overall Study|Withdrawal by parent|1
5452756|NCT02131272|18843136|P1|Overall Study|Withdrawal by parent|0
5452757|NCT02131259|18843154|P1|Overall Study|Missing|3
5452758|NCT02131259|18843154|P1|Overall Study|Progressive disease/AE/other|1
5452759|NCT02131259|18843154|P1|Overall Study|AE/other|1
5452760|NCT02131259|18843154|P1|Overall Study|AE/lost to follow-up|1
5452761|NCT02131259|18843154|P1|Overall Study|Progressive disease/other|2
5452762|NCT02131259|18843154|P1|Overall Study|Progressive disease/relocation|1
5452763|NCT02131259|18843154|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
5452764|NCT02131259|18843154|P1|Overall Study|Other|63
5452765|NCT02131259|18843154|P1|Overall Study|Relocation|32
5452766|NCT02131259|18843154|P1|Overall Study|Lost to Follow-up|7
5452767|NCT02131259|18843154|P1|Overall Study|Adverse Event|341
5452768|NCT02131259|18843154|P1|Overall Study|Progressive disease|751
5452769|NCT02131233|18843161|P2|Overall Study|Withdrawal by Subject|11
5452770|NCT02131233|18843162|P1|Overall Study|Withdrawal by Subject|18
5452771|NCT02131233|18843161|P2|Overall Study|Pregnancy|0
5452772|NCT02131233|18843162|P1|Overall Study|Pregnancy|4
5452773|NCT02131233|18843161|P2|Overall Study|Physician Decision|0
5452774|NCT02131233|18843162|P1|Overall Study|Physician Decision|7
5452775|NCT02131233|18843161|P2|Overall Study|Non-Compliance With Study Drug|5
5452776|NCT02131233|18843162|P1|Overall Study|Non-Compliance With Study Drug|8
5452777|NCT02131233|18843161|P2|Overall Study|Lost to Follow-up|13
5452778|NCT02131233|18843162|P1|Overall Study|Lost to Follow-up|14
5452779|NCT02131233|18843161|P2|Overall Study|Lack of Efficacy|3
5452780|NCT02131233|18843162|P1|Overall Study|Lack of Efficacy|6
5452781|NCT02131233|18843161|P2|Overall Study|Death|1
5452782|NCT02131233|18843162|P1|Overall Study|Death|0
5452783|NCT02131233|18843161|P2|Overall Study|Adverse Event|6
5452784|NCT02131233|18843162|P1|Overall Study|Adverse Event|7
5452785|NCT02131233|18843161|P2|Overall Study|Not Treated|3
5452786|NCT02131233|18843162|P1|Overall Study|Not Treated|2
5452787|NCT02131155|18843196|P2|Overall Study|Study early termination|10
5452788|NCT02131155|18843197|P1|Overall Study|Study early termination|20
5452789|NCT02131155|18843196|P2|Overall Study|Refused to continue study medication|0
5452790|NCT02131155|18843197|P1|Overall Study|Refused to continue study medication|1
5452791|NCT02131155|18843196|P2|Overall Study|Primary tumour recurrence|1
5452792|NCT02131155|18843197|P1|Overall Study|Primary tumour recurrence|2
5452793|NCT02131155|18843196|P2|Overall Study|Treatment completed|0
5452794|NCT02131155|18843197|P1|Overall Study|Treatment completed|1
5452795|NCT02131155|18843196|P2|Overall Study|Adverse Event|0
5452796|NCT02131155|18843197|P1|Overall Study|Adverse Event|1
5452797|NCT02131129|18843211|P2|Overall Study|Withdrawal by Subject|0
5452798|NCT02131129|18843212|P1|Overall Study|Withdrawal by Subject|1
5452799|NCT02131064|18843230|P2|Overall Study|Other|2
5452800|NCT02131064|18843231|P1|Overall Study|Other|2
5452801|NCT02131064|18843230|P2|Overall Study|Withdrawal by Subject|18
5452802|NCT02131064|18843231|P1|Overall Study|Withdrawal by Subject|14
5452803|NCT02131064|18843230|P2|Overall Study|Lost to Follow-up|8
5452804|NCT02131064|18843231|P1|Overall Study|Lost to Follow-up|4
5452805|NCT02131064|18843230|P2|Overall Study|Death|6
5452806|NCT02131064|18843231|P1|Overall Study|Death|5
5452807|NCT02130986|18843300|P2|Overall Study|Lost to Follow-up|160
5452808|NCT02130986|18843301|P1|Overall Study|Lost to Follow-up|151
5452809|NCT02130986|18843300|P2|Overall Study|Withdrawal by Subject|4
5452810|NCT02130986|18843301|P1|Overall Study|Withdrawal by Subject|4
5452811|NCT02130765|18843315|P4|Overall Study|Did not receive treatment|0
5452812|NCT02130765|18843316|P3|Overall Study|Did not receive treatment|0
5452813|NCT02130765|18843317|P2|Overall Study|Did not receive treatment|0
5452814|NCT02130765|18843318|P1|Overall Study|Did not receive treatment|4
5452815|NCT02130570|18843564|P2|Overall Study|Part of practice that discontinued study|5
5452816|NCT02130570|18843565|P1|Overall Study|Part of practice that discontinued study|0
5452817|NCT02130570|18843564|P2|Overall Study|Withdrawal by Subject|3
5452818|NCT02130570|18843565|P1|Overall Study|Withdrawal by Subject|6
5452819|NCT02130570|18843564|P2|Overall Study|Death|5
5452820|NCT02130570|18843565|P1|Overall Study|Death|3
5452821|NCT02130557|18843583|P2|Overall Study|Ongoing|255
5452822|NCT02130557|18843584|P1|Overall Study|Ongoing|260
5452823|NCT02130557|18843583|P2|Overall Study|Deceased|6
5452824|NCT02130557|18843584|P1|Overall Study|Deceased|1
5452825|NCT02130557|18843583|P2|Overall Study|Lost to Follow-up|2
5452826|NCT02130557|18843584|P1|Overall Study|Lost to Follow-up|2
5452827|NCT02130557|18843583|P2|Overall Study|Withdrawal by Subject|2
5452828|NCT02130557|18843584|P1|Overall Study|Withdrawal by Subject|5
5452829|NCT02130557|18843583|P2|Overall Study|Randomized, not treated|3
5452830|NCT02130557|18843584|P1|Overall Study|Randomized, not treated|0
5452831|NCT02130284|18843616|P1|Overall Study|Screen Failure|1
5452832|NCT02130284|18843616|P1|Overall Study|Subject was screened as backup for study|3
5452833|NCT02130284|18843616|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
5452834|NCT02130284|18843616|P1|Overall Study|Subject Withdrew Consent|1
5452835|NCT02130284|18843616|P1|Overall Study|Withdrawal by Subject|3
5452836|NCT02130193|18843642|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
5452837|NCT02130193|18843643|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
5452838|NCT02130193|18843644|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
5452839|NCT02130193|18843642|P3|Part B: 52-week Double-blind Period|Physician Decision|1
5452840|NCT02130193|18843643|P2|Part B: 52-week Double-blind Period|Physician Decision|0
5452841|NCT02130193|18843644|P1|Part B: 52-week Double-blind Period|Physician Decision|0
5452842|NCT02130193|18843642|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
5452843|NCT02130193|18843643|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
5452844|NCT02130193|18843644|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
5452845|NCT02130193|18843642|P3|Part B: 52-week Double-blind Period|Adverse Event|3
5452846|NCT02130193|18843643|P2|Part B: 52-week Double-blind Period|Adverse Event|5
5452847|NCT02130193|18843644|P1|Part B: 52-week Double-blind Period|Adverse Event|0
5452848|NCT02130024|18843725|P2|Overall Study|Subject Withdrew Consent|14
5452849|NCT02130024|18843726|P1|Overall Study|Subject Withdrew Consent|6
5452850|NCT02130024|18843725|P2|Overall Study|Site Administration Problems|0
5452851|NCT02130024|18843726|P1|Overall Study|Site Administration Problems|1
5452852|NCT02130024|18843725|P2|Overall Study|Protocol Deviation|0
5452853|NCT02130024|18843726|P1|Overall Study|Protocol Deviation|4
5452854|NCT02130024|18843725|P2|Overall Study|Physician Decision|3
5452855|NCT02130024|18843726|P1|Overall Study|Physician Decision|1
5452856|NCT02130024|18843725|P2|Overall Study|Lost to Follow-up|1
5452857|NCT02130024|18843726|P1|Overall Study|Lost to Follow-up|1
5452858|NCT02130024|18843725|P2|Overall Study|Death|2
5452859|NCT02130024|18843726|P1|Overall Study|Death|2
5452860|NCT02130024|18843725|P2|Overall Study|Adverse Event|11
5452861|NCT02130024|18843726|P1|Overall Study|Adverse Event|10
5452862|NCT02129777|18843763|P7|Open-Label Period|Study Termination|39
5452863|NCT02129777|18843764|P6|Open-Label Period|Study Termination|10
5452864|NCT02129777|18843765|P5|Open-Label Period|Study Termination|0
5452865|NCT02129777|18843766|P4|Open-Label Period|Study Termination|0
5452866|NCT02129777|18843767|P3|Open-Label Period|Study Termination|0
5452867|NCT02129777|18843768|P2|Open-Label Period|Study Termination|0
5452868|NCT02129777|18843769|P1|Open-Label Period|Study Termination|0
5452869|NCT02129777|18843763|P7|Open-Label Period|Withdrawal by Subject|3
5452870|NCT02129777|18843764|P6|Open-Label Period|Withdrawal by Subject|1
5452871|NCT02129777|18843765|P5|Open-Label Period|Withdrawal by Subject|0
5452872|NCT02129777|18843766|P4|Open-Label Period|Withdrawal by Subject|0
5452873|NCT02129777|18843767|P3|Open-Label Period|Withdrawal by Subject|0
5452874|NCT02129777|18843768|P2|Open-Label Period|Withdrawal by Subject|0
5452875|NCT02129777|18843769|P1|Open-Label Period|Withdrawal by Subject|0
5452876|NCT02129777|18843763|P7|Open-Label Period|Lost to Follow-up|1
5452877|NCT02129777|18843764|P6|Open-Label Period|Lost to Follow-up|1
5452878|NCT02129777|18843765|P5|Open-Label Period|Lost to Follow-up|0
5452879|NCT02129777|18843766|P4|Open-Label Period|Lost to Follow-up|0
5452880|NCT02129777|18843767|P3|Open-Label Period|Lost to Follow-up|0
5452881|NCT02129777|18843768|P2|Open-Label Period|Lost to Follow-up|0
5452882|NCT02129777|18843769|P1|Open-Label Period|Lost to Follow-up|0
5452883|NCT02129777|18843763|P7|Open-Label Period|Lack of Efficacy|5
5452884|NCT02129777|18843764|P6|Open-Label Period|Lack of Efficacy|0
5452885|NCT02129777|18843765|P5|Open-Label Period|Lack of Efficacy|0
5452886|NCT02129777|18843766|P4|Open-Label Period|Lack of Efficacy|0
5452887|NCT02129777|18843767|P3|Open-Label Period|Lack of Efficacy|0
5452888|NCT02129777|18843768|P2|Open-Label Period|Lack of Efficacy|0
5452889|NCT02129777|18843769|P1|Open-Label Period|Lack of Efficacy|0
5452890|NCT02129777|18843763|P7|Double-Blind Period|Other|0
5452891|NCT02129777|18843764|P6|Double-Blind Period|Other|0
5452892|NCT02129777|18843765|P5|Double-Blind Period|Other|0
5452893|NCT02129777|18843766|P4|Double-Blind Period|Other|0
5452894|NCT02129777|18843767|P3|Double-Blind Period|Other|0
5452895|NCT02129777|18843768|P2|Double-Blind Period|Other|2
5452896|NCT02129777|18843769|P1|Double-Blind Period|Other|1
5452897|NCT02129777|18843763|P7|Double-Blind Period|Lack of Efficacy|0
5452898|NCT02129777|18843764|P6|Double-Blind Period|Lack of Efficacy|0
5452899|NCT02129777|18843765|P5|Double-Blind Period|Lack of Efficacy|2
5452900|NCT02129777|18843766|P4|Double-Blind Period|Lack of Efficacy|3
5452901|NCT02129777|18843767|P3|Double-Blind Period|Lack of Efficacy|0
5452902|NCT02129777|18843768|P2|Double-Blind Period|Lack of Efficacy|1
5452903|NCT02129777|18843769|P1|Double-Blind Period|Lack of Efficacy|3
5452904|NCT02129777|18843763|P7|Double-Blind Period|Pregnancy|0
5452905|NCT02129777|18843764|P6|Double-Blind Period|Pregnancy|0
5452906|NCT02129777|18843765|P5|Double-Blind Period|Pregnancy|1
5452907|NCT02129777|18843766|P4|Double-Blind Period|Pregnancy|0
5452908|NCT02129777|18843767|P3|Double-Blind Period|Pregnancy|0
5452909|NCT02129777|18843768|P2|Double-Blind Period|Pregnancy|0
5452910|NCT02129777|18843769|P1|Double-Blind Period|Pregnancy|0
5452911|NCT02129777|18843763|P7|Double-Blind Period|Withdrawal by Subject|0
5452912|NCT02129777|18843764|P6|Double-Blind Period|Withdrawal by Subject|0
5452913|NCT02129777|18843765|P5|Double-Blind Period|Withdrawal by Subject|3
5452914|NCT02129777|18843766|P4|Double-Blind Period|Withdrawal by Subject|2
5452915|NCT02129777|18843767|P3|Double-Blind Period|Withdrawal by Subject|3
5452916|NCT02129777|18843768|P2|Double-Blind Period|Withdrawal by Subject|4
5452917|NCT02129777|18843769|P1|Double-Blind Period|Withdrawal by Subject|2
5452918|NCT02129777|18843763|P7|Double-Blind Period|Lost to Follow-up|0
5452919|NCT02129777|18843764|P6|Double-Blind Period|Lost to Follow-up|0
5452920|NCT02129777|18843765|P5|Double-Blind Period|Lost to Follow-up|0
5452921|NCT02129777|18843766|P4|Double-Blind Period|Lost to Follow-up|2
5452922|NCT02129777|18843767|P3|Double-Blind Period|Lost to Follow-up|1
5452923|NCT02129777|18843768|P2|Double-Blind Period|Lost to Follow-up|1
5452924|NCT02129777|18843769|P1|Double-Blind Period|Lost to Follow-up|1
5452925|NCT02129777|18843763|P7|Double-Blind Period|Adverse Event|0
5452926|NCT02129777|18843764|P6|Double-Blind Period|Adverse Event|0
5452927|NCT02129777|18843765|P5|Double-Blind Period|Adverse Event|1
5452928|NCT02129777|18843766|P4|Double-Blind Period|Adverse Event|0
5452929|NCT02129777|18843767|P3|Double-Blind Period|Adverse Event|0
5452930|NCT02129777|18843768|P2|Double-Blind Period|Adverse Event|0
5452931|NCT02129777|18843769|P1|Double-Blind Period|Adverse Event|0
5452932|NCT02129608|18843936|P3|Overall Study|Withdrawal by Subject|2
5452933|NCT02129608|18843937|P2|Overall Study|Withdrawal by Subject|0
5452934|NCT02129608|18843938|P1|Overall Study|Withdrawal by Subject|0
5452935|NCT02129608|18843936|P3|Overall Study|Lost to Follow-up|1
5452936|NCT02129608|18843937|P2|Overall Study|Lost to Follow-up|1
5452937|NCT02129608|18843938|P1|Overall Study|Lost to Follow-up|0
5452938|NCT02129205|18843995|P10|Overall Study|Other|0
5452939|NCT02129205|18843996|P9|Overall Study|Other|1
5452940|NCT02129205|18843997|P8|Overall Study|Other|2
5452941|NCT02129205|18843998|P7|Overall Study|Other|3
5452942|NCT02129205|18843999|P6|Overall Study|Other|3
5452943|NCT02129205|18844000|P5|Overall Study|Other|2
5452944|NCT02129205|18844001|P4|Overall Study|Other|0
5452945|NCT02129205|18844002|P3|Overall Study|Other|0
5452946|NCT02129205|18844003|P2|Overall Study|Other|0
5452947|NCT02129205|18844004|P1|Overall Study|Other|1
5452948|NCT02129205|18843995|P10|Overall Study|Withdrawal by Subject|0
5452949|NCT02129205|18843996|P9|Overall Study|Withdrawal by Subject|1
5452950|NCT02129205|18843997|P8|Overall Study|Withdrawal by Subject|0
5452951|NCT02129205|18843998|P7|Overall Study|Withdrawal by Subject|1
5452952|NCT02129205|18843999|P6|Overall Study|Withdrawal by Subject|1
5452953|NCT02129205|18844000|P5|Overall Study|Withdrawal by Subject|1
5452954|NCT02129205|18844001|P4|Overall Study|Withdrawal by Subject|0
5452955|NCT02129205|18844002|P3|Overall Study|Withdrawal by Subject|0
5452956|NCT02129205|18844003|P2|Overall Study|Withdrawal by Subject|0
5452957|NCT02129205|18844004|P1|Overall Study|Withdrawal by Subject|0
5452958|NCT02129192|18844157|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
5452959|NCT02129192|18844158|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
5452960|NCT02129062|18844175|P1|Overall Study|Disease Progression|2
5452961|NCT02129062|18844175|P1|Overall Study|Death|1
5452962|NCT02128997|18844182|P2|Overall Study|Lost to Follow-up|11
5452963|NCT02128997|18844183|P1|Overall Study|Lost to Follow-up|6
5452964|NCT02128932|18844198|P3|Overall Study|No reason for withdrawal|7
5452965|NCT02128932|18844199|P2|Overall Study|No reason for withdrawal|11
5452966|NCT02128932|18844200|P1|Overall Study|No reason for withdrawal|12
5452967|NCT02128932|18844198|P3|Overall Study|Lost to Follow-up|1
5452968|NCT02128932|18844199|P2|Overall Study|Lost to Follow-up|1
5452969|NCT02128932|18844200|P1|Overall Study|Lost to Follow-up|2
5452970|NCT02128932|18844198|P3|Overall Study|Death|2
5452971|NCT02128932|18844199|P2|Overall Study|Death|0
5452972|NCT02128932|18844200|P1|Overall Study|Death|2
5452973|NCT02128932|18844198|P3|Overall Study|Withdrawal by Subject|8
5452974|NCT02128932|18844199|P2|Overall Study|Withdrawal by Subject|7
5452975|NCT02128932|18844200|P1|Overall Study|Withdrawal by Subject|11
5452976|NCT02128763|18844261|P2|Overall Study|Lost to Follow-up|16
5452977|NCT02128763|18844262|P1|Overall Study|Lost to Follow-up|19
5452978|NCT02128763|18844261|P2|Overall Study|Death|0
5452979|NCT02128763|18844262|P1|Overall Study|Death|1
5452980|NCT02128724|18844308|P4|Overall Study|Withdrawal by Subject|1
5452981|NCT02128724|18844309|P3|Overall Study|Withdrawal by Subject|0
5452982|NCT02128724|18844310|P2|Overall Study|Withdrawal by Subject|0
5452983|NCT02128724|18844311|P1|Overall Study|Withdrawal by Subject|0
5452984|NCT02128724|18844308|P4|Overall Study|Physician Decision|2
5452985|NCT02128724|18844309|P3|Overall Study|Physician Decision|0
5452986|NCT02128724|18844310|P2|Overall Study|Physician Decision|0
5452987|NCT02128724|18844311|P1|Overall Study|Physician Decision|0
5452988|NCT02128724|18844308|P4|Overall Study|Adverse Event|0
5452989|NCT02128724|18844309|P3|Overall Study|Adverse Event|0
5452990|NCT02128724|18844310|P2|Overall Study|Adverse Event|1
5452991|NCT02128724|18844311|P1|Overall Study|Adverse Event|0
5452992|NCT02128724|18844308|P4|Overall Study|Death|0
5452993|NCT02128724|18844309|P3|Overall Study|Death|0
5452994|NCT02128724|18844310|P2|Overall Study|Death|0
5452995|NCT02128724|18844311|P1|Overall Study|Death|1
5452996|NCT02128542|18844366|P2|Overall Study|Withdrew Consent|0
5452997|NCT02128542|18844367|P1|Overall Study|Withdrew Consent|1
5452998|NCT02128542|18844366|P2|Overall Study|Lost to Follow-up|0
5452999|NCT02128542|18844367|P1|Overall Study|Lost to Follow-up|3
5453000|NCT02128490|18844385|P5|Overall Study|Other Miscellaneous Reasons|1
5453001|NCT02128490|18844386|P4|Overall Study|Other Miscellaneous Reasons|1
5453002|NCT02128490|18844387|P3|Overall Study|Other Miscellaneous Reasons|2
5453003|NCT02128490|18844388|P2|Overall Study|Other Miscellaneous Reasons|0
5453004|NCT02128490|18844389|P1|Overall Study|Other Miscellaneous Reasons|0
5453005|NCT02128490|18844385|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
5453006|NCT02128490|18844386|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
5453007|NCT02128490|18844387|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
5453008|NCT02128490|18844388|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
5453009|NCT02128490|18844389|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
5453010|NCT02128490|18844385|P5|Overall Study|Lack of Efficacy|0
5453011|NCT02128490|18844386|P4|Overall Study|Lack of Efficacy|0
5453012|NCT02128490|18844387|P3|Overall Study|Lack of Efficacy|0
5453013|NCT02128490|18844388|P2|Overall Study|Lack of Efficacy|1
5453014|NCT02128490|18844389|P1|Overall Study|Lack of Efficacy|0
5453015|NCT02128490|18844385|P5|Overall Study|Voluntary Withdrawal|2
5453016|NCT02128490|18844386|P4|Overall Study|Voluntary Withdrawal|1
5453017|NCT02128490|18844387|P3|Overall Study|Voluntary Withdrawal|1
5453018|NCT02128490|18844388|P2|Overall Study|Voluntary Withdrawal|3
5453019|NCT02128490|18844389|P1|Overall Study|Voluntary Withdrawal|3
5453020|NCT02128490|18844385|P5|Overall Study|Lost to Follow-up|1
5453021|NCT02128490|18844386|P4|Overall Study|Lost to Follow-up|1
5453022|NCT02128490|18844387|P3|Overall Study|Lost to Follow-up|1
5453023|NCT02128490|18844388|P2|Overall Study|Lost to Follow-up|0
5453024|NCT02128490|18844389|P1|Overall Study|Lost to Follow-up|0
5453025|NCT02128490|18844385|P5|Overall Study|Major Protocol Deviation|2
5453026|NCT02128490|18844386|P4|Overall Study|Major Protocol Deviation|2
5453027|NCT02128490|18844387|P3|Overall Study|Major Protocol Deviation|0
5453028|NCT02128490|18844388|P2|Overall Study|Major Protocol Deviation|2
5453029|NCT02128490|18844389|P1|Overall Study|Major Protocol Deviation|1
5453030|NCT02128490|18844385|P5|Overall Study|Pretreatment Event/Adverse Event|0
5453031|NCT02128490|18844386|P4|Overall Study|Pretreatment Event/Adverse Event|1
5453032|NCT02128490|18844387|P3|Overall Study|Pretreatment Event/Adverse Event|1
5453033|NCT02128490|18844388|P2|Overall Study|Pretreatment Event/Adverse Event|0
5453034|NCT02128490|18844389|P1|Overall Study|Pretreatment Event/Adverse Event|1
5453035|NCT02128269|18844411|P1|Treatment Period|Physician Decision|1
5453036|NCT02128269|18844411|P1|Treatment Period|Adverse Event|1
5453037|NCT02128217|18844417|P2|Overall Study|Lost to Follow-up|1
5453038|NCT02128217|18844418|P1|Overall Study|Lost to Follow-up|0
5453039|NCT02127970|18844466|P2|Overall Study|Subject Withdrew Consent|3
5453040|NCT02127970|18844467|P1|Overall Study|Subject Withdrew Consent|5
5453041|NCT02127970|18844466|P2|Overall Study|Pregnancy|1
5453042|NCT02127970|18844467|P1|Overall Study|Pregnancy|0
5453043|NCT02127970|18844466|P2|Overall Study|Reason not Specified|7
5453044|NCT02127970|18844467|P1|Overall Study|Reason not Specified|4
5453045|NCT02127970|18844466|P2|Overall Study|Lost to Follow-up|14
5453046|NCT02127970|18844467|P1|Overall Study|Lost to Follow-up|14
5453047|NCT02127970|18844466|P2|Overall Study|Death|1
5453048|NCT02127970|18844467|P1|Overall Study|Death|1
5453049|NCT02127970|18844466|P2|Overall Study|Adverse Event|1
5453050|NCT02127970|18844467|P1|Overall Study|Adverse Event|2
5453051|NCT02127931|18844489|P1|Overall Study|Glitch in Game|1
5453052|NCT02127372|18844615|P2|Overall Study|Withdrawal by Subject|0
5453053|NCT02127372|18844616|P1|Overall Study|Withdrawal by Subject|1
5453054|NCT02127307|18844626|P1|Overall Study|Other than specified above|169
5453055|NCT02127307|18844626|P1|Overall Study|Death|101
5453056|NCT02127307|18844626|P1|Overall Study|Lost to Follow-up|2
5453057|NCT02127307|18844626|P1|Overall Study|Protocol Violation|36
5453058|NCT02127281|18844632|P2|Overall Study|Lost to Follow-up|0
5453059|NCT02127281|18844633|P1|Overall Study|Lost to Follow-up|1
5453060|NCT02127125|18844668|P9|Overall Study|Physician Decision|0
5453061|NCT02127125|18844669|P8|Overall Study|Physician Decision|0
5453062|NCT02127125|18844670|P7|Overall Study|Physician Decision|0
5453063|NCT02127125|18844671|P6|Overall Study|Physician Decision|2
5453064|NCT02127125|18844672|P5|Overall Study|Physician Decision|1
5453065|NCT02127125|18844673|P4|Overall Study|Physician Decision|0
5453066|NCT02127125|18844674|P3|Overall Study|Physician Decision|1
5453067|NCT02127125|18844675|P2|Overall Study|Physician Decision|0
5453068|NCT02127125|18844676|P1|Overall Study|Physician Decision|0
5453069|NCT02127125|18844668|P9|Overall Study|Withdrawal by Subject|0
5453070|NCT02127125|18844669|P8|Overall Study|Withdrawal by Subject|0
5453071|NCT02127125|18844670|P7|Overall Study|Withdrawal by Subject|0
5453072|NCT02127125|18844671|P6|Overall Study|Withdrawal by Subject|0
5453073|NCT02127125|18844672|P5|Overall Study|Withdrawal by Subject|0
5453074|NCT02127125|18844673|P4|Overall Study|Withdrawal by Subject|1
5453075|NCT02127125|18844674|P3|Overall Study|Withdrawal by Subject|0
5453076|NCT02127125|18844675|P2|Overall Study|Withdrawal by Subject|0
5453077|NCT02127125|18844676|P1|Overall Study|Withdrawal by Subject|0
5453078|NCT02127125|18844668|P9|Overall Study|Lost to Follow-up|0
5453079|NCT02127125|18844669|P8|Overall Study|Lost to Follow-up|0
5453080|NCT02127125|18844670|P7|Overall Study|Lost to Follow-up|0
5453081|NCT02127125|18844671|P6|Overall Study|Lost to Follow-up|1
5453082|NCT02127125|18844672|P5|Overall Study|Lost to Follow-up|2
5453083|NCT02127125|18844673|P4|Overall Study|Lost to Follow-up|0
5453084|NCT02127125|18844674|P3|Overall Study|Lost to Follow-up|0
5453085|NCT02127125|18844675|P2|Overall Study|Lost to Follow-up|0
5453086|NCT02127125|18844676|P1|Overall Study|Lost to Follow-up|0
5453087|NCT02126969|18844716|P2|Overall Study|Withdrawal by Subject|2
5453088|NCT02126969|18844717|P1|Overall Study|Withdrawal by Subject|1
5453089|NCT02126839|18844729|P2|Overall Study|Other|5
5453090|NCT02126839|18844730|P1|Overall Study|Other|5
5453091|NCT02126839|18844729|P2|Overall Study|Lost to Follow-up|4
5453092|NCT02126839|18844730|P1|Overall Study|Lost to Follow-up|1
5453093|NCT02126839|18844729|P2|Overall Study|Sponsor request|1
5453094|NCT02126839|18844730|P1|Overall Study|Sponsor request|0
5453095|NCT02126839|18844729|P2|Overall Study|Protocol Violation|3
5453096|NCT02126839|18844730|P1|Overall Study|Protocol Violation|2
5453097|NCT02126839|18844729|P2|Overall Study|Withdrawal by parent/guardian|0
5453098|NCT02126839|18844730|P1|Overall Study|Withdrawal by parent/guardian|1
5453099|NCT02126839|18844729|P2|Overall Study|Withdrawal by Subject|0
5453100|NCT02126839|18844730|P1|Overall Study|Withdrawal by Subject|1
5453101|NCT02126839|18844729|P2|Overall Study|Adverse Event|1
5453102|NCT02126839|18844730|P1|Overall Study|Adverse Event|0
5453103|NCT02126826|18844747|P7|Overall Study|Withdrawal by Subject|0
5453104|NCT02126826|18844748|P6|Overall Study|Withdrawal by Subject|0
5453105|NCT02126826|18844749|P5|Overall Study|Withdrawal by Subject|0
5453106|NCT02126826|18844750|P4|Overall Study|Withdrawal by Subject|1
5453107|NCT02126826|18844751|P3|Overall Study|Withdrawal by Subject|0
5453108|NCT02126826|18844752|P2|Overall Study|Withdrawal by Subject|0
5453109|NCT02126826|18844753|P1|Overall Study|Withdrawal by Subject|0
5453110|NCT02126670|18844821|P4|Overall Study|Withdrawal by Subject|1
5453111|NCT02126670|18844822|P3|Overall Study|Withdrawal by Subject|0
5453112|NCT02126670|18844823|P2|Overall Study|Withdrawal by Subject|0
5453113|NCT02126670|18844824|P1|Overall Study|Withdrawal by Subject|1
5453114|NCT02125877|18844876|P2|Overall Study|Adverse Event|4
5453115|NCT02125877|18844877|P1|Overall Study|Adverse Event|6
5453116|NCT02125877|18844876|P2|Overall Study|Protocol deviation|1
5453117|NCT02125877|18844877|P1|Overall Study|Protocol deviation|4
5453118|NCT02125877|18844876|P2|Overall Study|Withdrawal by Subject|1
5453119|NCT02125877|18844877|P1|Overall Study|Withdrawal by Subject|2
5453120|NCT02125877|18844876|P2|Overall Study|Participant/guardian decision|2
5453121|NCT02125877|18844877|P1|Overall Study|Participant/guardian decision|0
5453122|NCT02125877|18844876|P2|Overall Study|Administrative problems|1
5453123|NCT02125877|18844877|P1|Overall Study|Administrative problems|0
5453124|NCT02125877|18844876|P2|Overall Study|Death|1
5453125|NCT02125877|18844877|P1|Overall Study|Death|0
5453126|NCT02125877|18844876|P2|Overall Study|Physician Decision|0
5453127|NCT02125877|18844877|P1|Overall Study|Physician Decision|1
5453128|NCT02125838|18844907|P2|Overall Study|Lost to Follow-up|4
5453129|NCT02125838|18844908|P1|Overall Study|Lost to Follow-up|4
5453130|NCT02125734|18844926|P2|Period 2|Adverse Event|1
5453131|NCT02125734|18844927|P1|Period 2|Adverse Event|0
5453132|NCT02125604|18844937|P1|Overall Study|Adverse Event|20
5453133|NCT02125604|18844937|P1|Overall Study|Consent Withdrawn|4
5453134|NCT02125604|18844937|P1|Overall Study|Lost to Follow-up|2
5453135|NCT02125604|18844937|P1|Overall Study|Investigator Decision|1
5453136|NCT02125604|18844937|P1|Overall Study|Other|4
5453137|NCT02125461|18844953|P2|Overall Study|Death|115
5453138|NCT02125461|18844954|P1|Overall Study|Death|180
5453139|NCT02125461|18844953|P2|Overall Study|Lost to Follow-up|0
5453140|NCT02125461|18844954|P1|Overall Study|Lost to Follow-up|1
5453141|NCT02125461|18844953|P2|Overall Study|Withdrawal by Subject|14
5453142|NCT02125461|18844954|P1|Overall Study|Withdrawal by Subject|22
5453143|NCT02125331|18844985|P2|Overall Study|screen failure|0
5453144|NCT02125331|18844986|P1|Overall Study|screen failure|2
5453145|NCT02125331|18844985|P2|Overall Study|technical problem|0
5453146|NCT02125331|18844986|P1|Overall Study|technical problem|2
5453147|NCT02125331|18844985|P2|Overall Study|Protocol Violation|0
5453148|NCT02125331|18844986|P1|Overall Study|Protocol Violation|1
5453149|NCT02125279|18845018|P1|Overall Study|Lost to Follow-up|4
5453150|NCT02125279|18845018|P1|Overall Study|Protocol Violation|1
5453151|NCT02125279|18845018|P1|Overall Study|Withdrawal by Subject|6
5453152|NCT02125279|18845018|P1|Overall Study|Lack of Efficacy|2
5453153|NCT02124811|18845062|P2|Overall Study|Withdrawal by Subject|0
5453154|NCT02124811|18845063|P1|Overall Study|Withdrawal by Subject|1
5453155|NCT02124811|18845062|P2|Overall Study|Early termination|2
5453156|NCT02124811|18845063|P1|Overall Study|Early termination|2
5453157|NCT02124798|18845079|P1|Overall Study|Lost to Follow-up|1
5453158|NCT02124798|18845079|P1|Overall Study|Adverse Event|3
5453159|NCT02124707|18845085|P1|Overall Study|Death|1
5453160|NCT02124707|18845085|P1|Overall Study|Physician Decision|1
5453161|NCT02124707|18845085|P1|Overall Study|Adverse Event|5
5453162|NCT02124564|18845099|P1|Treatment Period|Withdrawal by Subject|2
5453163|NCT02124564|18845099|P1|Treatment Period|Lack of Efficacy|3
5453164|NCT02124564|18845099|P1|Treatment Period|Adverse Event|2
5453165|NCT02124265|18845164|P1|Overall Study|Adverse Event|1
5453166|NCT02124161|18845170|P2|Overall Study|Lost to Follow-up|4
5453167|NCT02124161|18845171|P1|Overall Study|Lost to Follow-up|3
5453168|NCT02124161|18845170|P2|Overall Study|No longer meets eligibility criteria|4
5453169|NCT02124161|18845171|P1|Overall Study|No longer meets eligibility criteria|5
5453170|NCT02124161|18845170|P2|Overall Study|Does not meet entrance criteria|3
5453171|NCT02124161|18845171|P1|Overall Study|Does not meet entrance criteria|2
5453172|NCT02124161|18845170|P2|Overall Study|Adverse Event|0
5453173|NCT02124161|18845171|P1|Overall Study|Adverse Event|2
5453174|NCT02124161|18845170|P2|Overall Study|Withdrawal by Subject|2
5453175|NCT02124161|18845171|P1|Overall Study|Withdrawal by Subject|1
5453176|NCT02124161|18845170|P2|Overall Study|Protocol Violation|1
5453177|NCT02124161|18845171|P1|Overall Study|Protocol Violation|2
5453178|NCT02124161|18845170|P2|Overall Study|Death|0
5453179|NCT02124161|18845171|P1|Overall Study|Death|1
5453180|NCT02124161|18845170|P2|Overall Study|Other unspecified|1
5453181|NCT02124161|18845171|P1|Overall Study|Other unspecified|0
5453182|NCT02123966|18845246|P1|Overall Study|Intercurrent Illness|1
5453183|NCT02123797|18845280|P5|6-month Follow up (Cumulative Counts)|Relocation|0
5453184|NCT02123797|18845281|P4|6-month Follow up (Cumulative Counts)|Relocation|0
5453185|NCT02123797|18845282|P3|6-month Follow up (Cumulative Counts)|Relocation|0
5453186|NCT02123797|18845283|P2|6-month Follow up (Cumulative Counts)|Relocation|2
5453187|NCT02123797|18845284|P1|6-month Follow up (Cumulative Counts)|Relocation|0
5453188|NCT02123797|18845280|P5|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5453189|NCT02123797|18845281|P4|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5453190|NCT02123797|18845282|P3|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5453191|NCT02123797|18845283|P2|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
5453192|NCT02123797|18845284|P1|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
5453193|NCT02123797|18845280|P5|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
5453194|NCT02123797|18845281|P4|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
5453195|NCT02123797|18845282|P3|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
5453196|NCT02123797|18845283|P2|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
5453197|NCT02123797|18845284|P1|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
5453198|NCT02123797|18845280|P5|6-month Follow up (Cumulative Counts)|Death|0
5453199|NCT02123797|18845281|P4|6-month Follow up (Cumulative Counts)|Death|0
5453200|NCT02123797|18845282|P3|6-month Follow up (Cumulative Counts)|Death|0
5453201|NCT02123797|18845283|P2|6-month Follow up (Cumulative Counts)|Death|97
5453202|NCT02123797|18845284|P1|6-month Follow up (Cumulative Counts)|Death|51
5453203|NCT02123797|18845280|P5|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
5453204|NCT02123797|18845281|P4|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
5453205|NCT02123797|18845282|P3|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
5453206|NCT02123797|18845283|P2|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
5453207|NCT02123797|18845284|P1|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
5453208|NCT02123797|18845280|P5|3-month Follow up (Cumulative Counts)|Relocation|0
5453209|NCT02123797|18845281|P4|3-month Follow up (Cumulative Counts)|Relocation|0
5453210|NCT02123797|18845282|P3|3-month Follow up (Cumulative Counts)|Relocation|0
5453211|NCT02123797|18845283|P2|3-month Follow up (Cumulative Counts)|Relocation|1
5453212|NCT02123797|18845284|P1|3-month Follow up (Cumulative Counts)|Relocation|0
5453213|NCT02123797|18845280|P5|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5453214|NCT02123797|18845281|P4|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5453215|NCT02123797|18845282|P3|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
5453216|NCT02123797|18845283|P2|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
5453217|NCT02123797|18845284|P1|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
5453218|NCT02123797|18845280|P5|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
5453219|NCT02123797|18845281|P4|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
5453220|NCT02123797|18845282|P3|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
5453221|NCT02123797|18845283|P2|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
5453222|NCT02123797|18845284|P1|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
5453223|NCT02123797|18845280|P5|3-month Follow up (Cumulative Counts)|Death|0
5453224|NCT02123797|18845281|P4|3-month Follow up (Cumulative Counts)|Death|0
5453225|NCT02123797|18845282|P3|3-month Follow up (Cumulative Counts)|Death|0
5453226|NCT02123797|18845283|P2|3-month Follow up (Cumulative Counts)|Death|57
5453227|NCT02123797|18845284|P1|3-month Follow up (Cumulative Counts)|Death|33
5453228|NCT02123797|18845280|P5|Baseline Intervention|Other Disease|0
5453229|NCT02123797|18845281|P4|Baseline Intervention|Other Disease|0
5453230|NCT02123797|18845282|P3|Baseline Intervention|Other Disease|0
5453231|NCT02123797|18845283|P2|Baseline Intervention|Other Disease|0
5453232|NCT02123797|18845284|P1|Baseline Intervention|Other Disease|3
5453233|NCT02123797|18845280|P5|Baseline Intervention|Lost to Follow-up|0
5453234|NCT02123797|18845281|P4|Baseline Intervention|Lost to Follow-up|0
5453235|NCT02123797|18845282|P3|Baseline Intervention|Lost to Follow-up|0
5453236|NCT02123797|18845283|P2|Baseline Intervention|Lost to Follow-up|5
5453237|NCT02123797|18845284|P1|Baseline Intervention|Lost to Follow-up|0
5453238|NCT02123797|18845280|P5|Baseline Intervention|Out of window for initial survey|0
5453239|NCT02123797|18845281|P4|Baseline Intervention|Out of window for initial survey|0
5453240|NCT02123797|18845282|P3|Baseline Intervention|Out of window for initial survey|0
5453241|NCT02123797|18845283|P2|Baseline Intervention|Out of window for initial survey|13
5453242|NCT02123797|18845284|P1|Baseline Intervention|Out of window for initial survey|6
5453243|NCT02123797|18845280|P5|Baseline Intervention|Relocation|0
5453244|NCT02123797|18845281|P4|Baseline Intervention|Relocation|0
5453245|NCT02123797|18845282|P3|Baseline Intervention|Relocation|0
5453246|NCT02123797|18845283|P2|Baseline Intervention|Relocation|0
5453247|NCT02123797|18845284|P1|Baseline Intervention|Relocation|2
5453248|NCT02123797|18845280|P5|Baseline Intervention|Withdrawal by Subject|0
5453249|NCT02123797|18845281|P4|Baseline Intervention|Withdrawal by Subject|0
5453250|NCT02123797|18845282|P3|Baseline Intervention|Withdrawal by Subject|0
5453251|NCT02123797|18845283|P2|Baseline Intervention|Withdrawal by Subject|8
5453252|NCT02123797|18845284|P1|Baseline Intervention|Withdrawal by Subject|2
5453253|NCT02123797|18845280|P5|Baseline Intervention|Death|0
5453254|NCT02123797|18845281|P4|Baseline Intervention|Death|0
5453255|NCT02123797|18845282|P3|Baseline Intervention|Death|0
5453256|NCT02123797|18845283|P2|Baseline Intervention|Death|16
5453257|NCT02123797|18845284|P1|Baseline Intervention|Death|9
5453258|NCT02123576|18845393|P2|Overall Study|Adverse Event|0
5453259|NCT02123576|18845394|P1|Overall Study|Adverse Event|1
5453260|NCT02123511|18845412|P2|Overall Study|Ineligible|1
5453261|NCT02123511|18845413|P1|Overall Study|Ineligible|0
5453262|NCT02123511|18845412|P2|Overall Study|Incomplete data|3
5453263|NCT02123511|18845413|P1|Overall Study|Incomplete data|1
5453264|NCT02123511|18845412|P2|Overall Study|Cancelled treatment|0
5453265|NCT02123511|18845413|P1|Overall Study|Cancelled treatment|1
5453266|NCT02123472|18845437|P2|Period 2 (7 Days)|Withdrawal by Subject|1
5453267|NCT02123472|18845438|P1|Period 2 (7 Days)|Withdrawal by Subject|0
5453268|NCT02123459|18845448|P2|Washout Period (1 Day)|Adverse Event|0
5453269|NCT02123459|18845449|P1|Washout Period (1 Day)|Adverse Event|1
5453270|NCT02123446|18845459|P2|Washout Period (1 Day)|Physician Decision|0
5453271|NCT02123446|18845460|P1|Washout Period (1 Day)|Physician Decision|1
5453272|NCT02123251|18845501|P2|Overall Study|Switched Managed Care Organization (MCO)|4
5453273|NCT02123251|18845502|P1|Overall Study|Switched Managed Care Organization (MCO)|4
5453274|NCT02123251|18845501|P2|Overall Study|Lost Medicaid eligibility|22
5453275|NCT02123251|18845502|P1|Overall Study|Lost Medicaid eligibility|29
5453276|NCT02123251|18845501|P2|Overall Study|Withdrawal by Subject|3
5453277|NCT02123251|18845502|P1|Overall Study|Withdrawal by Subject|0
5453278|NCT02123251|18845501|P2|Overall Study|Death|1
5453279|NCT02123251|18845502|P1|Overall Study|Death|1
5453280|NCT02123134|18845528|P2|Overall Study|Administrative decision|1
5453281|NCT02123134|18845529|P1|Overall Study|Administrative decision|0
5453282|NCT02123134|18845528|P2|Overall Study|Withdrawal of consent|2
5453283|NCT02123134|18845529|P1|Overall Study|Withdrawal of consent|3
5453284|NCT02122887|18845586|P2|Overall Study|Withdrawal by Subject|2
5453285|NCT02122887|18845587|P1|Overall Study|Withdrawal by Subject|20
5453286|NCT02122783|18845625|P2|Overall Study|Adverse Event|1
5453287|NCT02122783|18845626|P1|Overall Study|Adverse Event|0
5453288|NCT02122770|18845640|P6|Part B: Standard of Care|Progressive Disease|8
5453289|NCT02122770|18845641|P5|Part B: Standard of Care|Progressive Disease|10
5453290|NCT02122770|18845642|P4|Part B: Standard of Care|Progressive Disease|0
5453291|NCT02122770|18845643|P3|Part B: Standard of Care|Progressive Disease|0
5453292|NCT02122770|18845644|P2|Part B: Standard of Care|Progressive Disease|0
5453293|NCT02122770|18845645|P1|Part B: Standard of Care|Progressive Disease|0
5453294|NCT02122770|18845640|P6|Part B: Standard of Care|Symptomatic Deterioration|0
5453295|NCT02122770|18845641|P5|Part B: Standard of Care|Symptomatic Deterioration|5
5453296|NCT02122770|18845642|P4|Part B: Standard of Care|Symptomatic Deterioration|0
5453297|NCT02122770|18845643|P3|Part B: Standard of Care|Symptomatic Deterioration|0
5453298|NCT02122770|18845644|P2|Part B: Standard of Care|Symptomatic Deterioration|0
5453299|NCT02122770|18845645|P1|Part B: Standard of Care|Symptomatic Deterioration|0
5453300|NCT02122770|18845640|P6|Part B: Standard of Care|Withdrawal by Subject|2
5453301|NCT02122770|18845641|P5|Part B: Standard of Care|Withdrawal by Subject|4
5453302|NCT02122770|18845642|P4|Part B: Standard of Care|Withdrawal by Subject|0
5453303|NCT02122770|18845643|P3|Part B: Standard of Care|Withdrawal by Subject|0
5453304|NCT02122770|18845644|P2|Part B: Standard of Care|Withdrawal by Subject|0
5453305|NCT02122770|18845645|P1|Part B: Standard of Care|Withdrawal by Subject|0
5453306|NCT02122770|18845640|P6|Part B: Standard of Care|Other|2
5453307|NCT02122770|18845641|P5|Part B: Standard of Care|Other|0
5453308|NCT02122770|18845642|P4|Part B: Standard of Care|Other|0
5453309|NCT02122770|18845643|P3|Part B: Standard of Care|Other|0
5453310|NCT02122770|18845644|P2|Part B: Standard of Care|Other|0
5453311|NCT02122770|18845645|P1|Part B: Standard of Care|Other|0
5453312|NCT02122770|18845640|P6|Part B: Standard of Care|Adverse Event|1
5453313|NCT02122770|18845641|P5|Part B: Standard of Care|Adverse Event|4
5453314|NCT02122770|18845642|P4|Part B: Standard of Care|Adverse Event|0
5453315|NCT02122770|18845643|P3|Part B: Standard of Care|Adverse Event|0
5453316|NCT02122770|18845644|P2|Part B: Standard of Care|Adverse Event|0
5453317|NCT02122770|18845645|P1|Part B: Standard of Care|Adverse Event|0
5453318|NCT02122770|18845640|P6|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
5453319|NCT02122770|18845641|P5|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
5453320|NCT02122770|18845642|P4|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
5453321|NCT02122770|18845643|P3|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
5453322|NCT02122770|18845644|P2|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
5453323|NCT02122770|18845645|P1|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
5453324|NCT02122770|18845640|P6|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5453325|NCT02122770|18845641|P5|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5453326|NCT02122770|18845642|P4|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5453327|NCT02122770|18845643|P3|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5453328|NCT02122770|18845644|P2|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
5453329|NCT02122770|18845645|P1|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
5453330|NCT02122770|18845640|P6|Part A: Drug-drug Interaction 2|Other|0
5453331|NCT02122770|18845641|P5|Part A: Drug-drug Interaction 2|Other|0
5453332|NCT02122770|18845642|P4|Part A: Drug-drug Interaction 2|Other|0
5453333|NCT02122770|18845643|P3|Part A: Drug-drug Interaction 2|Other|1
5453334|NCT02122770|18845644|P2|Part A: Drug-drug Interaction 2|Other|0
5453335|NCT02122770|18845645|P1|Part A: Drug-drug Interaction 2|Other|0
5453336|NCT02122770|18845640|P6|Part A: Drug-drug Interaction 2|Adverse Event|0
5453337|NCT02122770|18845641|P5|Part A: Drug-drug Interaction 2|Adverse Event|0
5453338|NCT02122770|18845642|P4|Part A: Drug-drug Interaction 2|Adverse Event|2
5453339|NCT02122770|18845643|P3|Part A: Drug-drug Interaction 2|Adverse Event|1
5453340|NCT02122770|18845644|P2|Part A: Drug-drug Interaction 2|Adverse Event|0
5453341|NCT02122770|18845645|P1|Part A: Drug-drug Interaction 2|Adverse Event|3
5453342|NCT02122380|18845765|P2|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
5453343|NCT02122380|18845766|P1|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
5453344|NCT02122380|18845765|P2|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
5453345|NCT02122380|18845766|P1|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
5453346|NCT02122380|18845765|P2|Washout (8 Weeks)|Lost to Follow-up|0
5453347|NCT02122380|18845766|P1|Washout (8 Weeks)|Lost to Follow-up|1
5453348|NCT02122380|18845765|P2|First Intervention (30 Days)|Physician Decision|1
5453349|NCT02122380|18845766|P1|First Intervention (30 Days)|Physician Decision|0
5453350|NCT02122380|18845765|P2|First Intervention (30 Days)|Adverse Event|0
5453351|NCT02122380|18845766|P1|First Intervention (30 Days)|Adverse Event|1
5453352|NCT02122146|18845805|P8|Part 1: Dose Escalation|Other|2
5453353|NCT02122146|18845806|P7|Part 1: Dose Escalation|Other|1
5453354|NCT02122146|18845807|P6|Part 1: Dose Escalation|Other|1
5453355|NCT02122146|18845808|P5|Part 1: Dose Escalation|Other|0
5453356|NCT02122146|18845809|P4|Part 1: Dose Escalation|Other|0
5453357|NCT02122146|18845810|P3|Part 1: Dose Escalation|Other|0
5453358|NCT02122146|18845811|P2|Part 1: Dose Escalation|Other|0
5453359|NCT02122146|18845812|P1|Part 1: Dose Escalation|Other|1
5453360|NCT02122146|18845805|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
5453361|NCT02122146|18845806|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
5453362|NCT02122146|18845807|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
5453363|NCT02122146|18845808|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
5453364|NCT02122146|18845809|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
5453365|NCT02122146|18845810|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
5453366|NCT02122146|18845811|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
5453367|NCT02122146|18845812|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
5453368|NCT02122146|18845805|P8|Part 1: Dose Escalation|Lost to Follow-up|0
5453369|NCT02122146|18845806|P7|Part 1: Dose Escalation|Lost to Follow-up|0
5453370|NCT02122146|18845807|P6|Part 1: Dose Escalation|Lost to Follow-up|0
5453371|NCT02122146|18845808|P5|Part 1: Dose Escalation|Lost to Follow-up|1
5453372|NCT02122146|18845809|P4|Part 1: Dose Escalation|Lost to Follow-up|0
5453373|NCT02122146|18845810|P3|Part 1: Dose Escalation|Lost to Follow-up|1
5453374|NCT02122146|18845811|P2|Part 1: Dose Escalation|Lost to Follow-up|0
5453375|NCT02122146|18845812|P1|Part 1: Dose Escalation|Lost to Follow-up|0
5453376|NCT02122146|18845805|P8|Part 1: Dose Escalation|Death|0
5453377|NCT02122146|18845806|P7|Part 1: Dose Escalation|Death|0
5453378|NCT02122146|18845807|P6|Part 1: Dose Escalation|Death|0
5453379|NCT02122146|18845808|P5|Part 1: Dose Escalation|Death|0
5453380|NCT02122146|18845809|P4|Part 1: Dose Escalation|Death|0
5453381|NCT02122146|18845810|P3|Part 1: Dose Escalation|Death|1
5453382|NCT02122146|18845811|P2|Part 1: Dose Escalation|Death|1
5453383|NCT02122146|18845812|P1|Part 1: Dose Escalation|Death|0
5453384|NCT02121847|18846086|P1|Overall Study|Adverse Event|2
5453385|NCT02121847|18846086|P1|Overall Study|Administrative Reasons|1
5453386|NCT02121834|18846112|P7|Overall Study|Lost to Follow-up|0
5453387|NCT02121834|18846113|P6|Overall Study|Lost to Follow-up|0
5453388|NCT02121834|18846114|P5|Overall Study|Lost to Follow-up|0
5453389|NCT02121834|18846115|P4|Overall Study|Lost to Follow-up|0
5453390|NCT02121834|18846116|P3|Overall Study|Lost to Follow-up|1
5453391|NCT02121834|18846117|P2|Overall Study|Lost to Follow-up|0
5453392|NCT02121834|18846118|P1|Overall Study|Lost to Follow-up|0
5453393|NCT02121834|18846112|P7|Overall Study|Withdrawal by Subject|0
5453394|NCT02121834|18846113|P6|Overall Study|Withdrawal by Subject|0
5453395|NCT02121834|18846114|P5|Overall Study|Withdrawal by Subject|0
5453396|NCT02121834|18846115|P4|Overall Study|Withdrawal by Subject|0
5453397|NCT02121834|18846116|P3|Overall Study|Withdrawal by Subject|1
5453398|NCT02121834|18846117|P2|Overall Study|Withdrawal by Subject|1
5453399|NCT02121834|18846118|P1|Overall Study|Withdrawal by Subject|0
5453400|NCT02121834|18846112|P7|Overall Study|Protocol Violation|0
5453401|NCT02121834|18846113|P6|Overall Study|Protocol Violation|0
5453402|NCT02121834|18846114|P5|Overall Study|Protocol Violation|0
5453403|NCT02121834|18846115|P4|Overall Study|Protocol Violation|0
5453404|NCT02121834|18846116|P3|Overall Study|Protocol Violation|0
5453405|NCT02121834|18846117|P2|Overall Study|Protocol Violation|1
5453406|NCT02121834|18846118|P1|Overall Study|Protocol Violation|0
5453407|NCT02121808|18846144|P1|Overall Study|Technical problem|3
5453408|NCT02121795|18846155|P2|Open-Label Phase|Lost to Follow-up|0
5453409|NCT02121795|18846156|P1|Open-Label Phase|Lost to Follow-up|1
5453410|NCT02121795|18846155|P2|Open-Label Phase|Withdrawal by Subject|2
5453411|NCT02121795|18846156|P1|Open-Label Phase|Withdrawal by Subject|3
5453412|NCT02121795|18846155|P2|Open-Label Phase|Physician Decision|8
5453413|NCT02121795|18846156|P1|Open-Label Phase|Physician Decision|8
5453414|NCT02121795|18846155|P2|Double-Blind Phase|Death|1
5453415|NCT02121795|18846156|P1|Double-Blind Phase|Death|1
5453416|NCT02121795|18846155|P2|Double-Blind Phase|Protocol Violation|3
5453417|NCT02121795|18846156|P1|Double-Blind Phase|Protocol Violation|0
5453418|NCT02121795|18846155|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5453419|NCT02121795|18846156|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
5453420|NCT02121795|18846155|P2|Double-Blind Phase|Adverse Event|0
5453421|NCT02121795|18846156|P1|Double-Blind Phase|Adverse Event|5
5453422|NCT02121795|18846155|P2|Double-Blind Phase|Physician Decision|5
5453423|NCT02121795|18846156|P1|Double-Blind Phase|Physician Decision|2
5453424|NCT02121795|18846155|P2|Double-Blind Phase|Lost to Follow-up|4
5453425|NCT02121795|18846156|P1|Double-Blind Phase|Lost to Follow-up|7
5453426|NCT02121795|18846155|P2|Double-Blind Phase|Withdrawal by Subject|16
5453427|NCT02121795|18846156|P1|Double-Blind Phase|Withdrawal by Subject|19
5453428|NCT02121795|18846155|P2|Double-Blind Phase|Randomized but Never Treated|4
5453429|NCT02121795|18846156|P1|Double-Blind Phase|Randomized but Never Treated|1
5453430|NCT02121756|18846184|P2|Overall Study|Physician Decision|1
5453431|NCT02121756|18846185|P1|Overall Study|Physician Decision|2
5453432|NCT02121756|18846184|P2|Overall Study|Protocol Violation|1
5453433|NCT02121756|18846185|P1|Overall Study|Protocol Violation|1
5453434|NCT02121756|18846184|P2|Overall Study|Adverse Event|0
5453435|NCT02121756|18846185|P1|Overall Study|Adverse Event|3
5453436|NCT02121535|18846222|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
5453437|NCT02121535|18846223|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
5453438|NCT02121535|18846222|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
5453439|NCT02121535|18846223|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
5453440|NCT02121522|18846246|P1|Overall Study|Adverse Event|1
5453441|NCT02121509|18846253|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
5453442|NCT02121509|18846254|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
5453443|NCT02121509|18846255|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
5453444|NCT02121509|18846256|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
5453445|NCT02121509|18846253|P4|Washout Period (35 Days)|Withdrawal by Subject|0
5453446|NCT02121509|18846254|P3|Washout Period (35 Days)|Withdrawal by Subject|0
5453447|NCT02121509|18846255|P2|Washout Period (35 Days)|Withdrawal by Subject|3
5453448|NCT02121509|18846256|P1|Washout Period (35 Days)|Withdrawal by Subject|0
5453449|NCT02121509|18846253|P4|Washout Period (35 Days)|Adverse Event|0
5453450|NCT02121509|18846254|P3|Washout Period (35 Days)|Adverse Event|0
5453451|NCT02121509|18846255|P2|Washout Period (35 Days)|Adverse Event|1
5453452|NCT02121509|18846256|P1|Washout Period (35 Days)|Adverse Event|1
5453453|NCT02121392|18846327|P2|After Placement of AC Block vs Sham|Lost to Follow-up|1
5453454|NCT02121392|18846328|P1|After Placement of AC Block vs Sham|Lost to Follow-up|0
5453455|NCT02121392|18846327|P2|After Placement of AC Block vs Sham|Protocol Violation|2
5453456|NCT02121392|18846328|P1|After Placement of AC Block vs Sham|Protocol Violation|3
5453457|NCT02121392|18846327|P2|Prior to Intervention|Withdrawal by Subject|6
5453458|NCT02121392|18846328|P1|Prior to Intervention|Withdrawal by Subject|8
5453459|NCT02121392|18846327|P2|Prior to Intervention|Protocol Violation|35
5453460|NCT02121392|18846328|P1|Prior to Intervention|Protocol Violation|40
5453461|NCT02121301|18846353|P3|Overall Study|Protocol Violation|1
5453462|NCT02121301|18846354|P2|Overall Study|Protocol Violation|4
5453463|NCT02121301|18846355|P1|Overall Study|Protocol Violation|1
5453464|NCT02121262|18846368|P2|Overall Study|Consent Withdrawn|0
5453465|NCT02121262|18846369|P1|Overall Study|Consent Withdrawn|1
5453466|NCT02121262|18846368|P2|Overall Study|Participant was Deemed Unsuitable|0
5453467|NCT02121262|18846369|P1|Overall Study|Participant was Deemed Unsuitable|1
5453468|NCT02121262|18846368|P2|Overall Study|Participant Dropped-out|1
5453469|NCT02121262|18846369|P1|Overall Study|Participant Dropped-out|0
5453470|NCT02121262|18846368|P2|Overall Study|Protocol Violation|1
5453471|NCT02121262|18846369|P1|Overall Study|Protocol Violation|1
5453472|NCT02121262|18846368|P2|Overall Study|Personal Reasons|5
5453473|NCT02121262|18846369|P1|Overall Study|Personal Reasons|19
5453474|NCT02121262|18846368|P2|Overall Study|Lack of Efficacy|0
5453475|NCT02121262|18846369|P1|Overall Study|Lack of Efficacy|3
5453476|NCT02121262|18846368|P2|Overall Study|Adverse Event|3
5453477|NCT02121262|18846369|P1|Overall Study|Adverse Event|6
5453478|NCT02121210|18846383|P2|Overall Study|Other than specified above|2
5453479|NCT02121210|18846384|P1|Overall Study|Other than specified above|0
5453480|NCT02121210|18846383|P2|Overall Study|Lack of Efficacy|0
5453481|NCT02121210|18846384|P1|Overall Study|Lack of Efficacy|2
5453482|NCT02121210|18846383|P2|Overall Study|Adverse Event|7
5453483|NCT02121210|18846384|P1|Overall Study|Adverse Event|5
5453484|NCT02120950|18846409|P3|Overall Study|Lost to Follow-up|1
5453485|NCT02120950|18846410|P2|Overall Study|Lost to Follow-up|2
5453486|NCT02120950|18846411|P1|Overall Study|Lost to Follow-up|0
5453487|NCT02120950|18846409|P3|Overall Study|Other reasons|1
5453488|NCT02120950|18846410|P2|Overall Study|Other reasons|4
5453489|NCT02120950|18846411|P1|Overall Study|Other reasons|5
5453490|NCT02120950|18846409|P3|Overall Study|Protocol Violation|7
5453491|NCT02120950|18846410|P2|Overall Study|Protocol Violation|1
5453492|NCT02120950|18846411|P1|Overall Study|Protocol Violation|1
5453493|NCT02120950|18846409|P3|Overall Study|Withdrawal by Subject|2
5453494|NCT02120950|18846410|P2|Overall Study|Withdrawal by Subject|3
5453495|NCT02120950|18846411|P1|Overall Study|Withdrawal by Subject|6
5453496|NCT02120950|18846409|P3|Overall Study|Death|1
5453497|NCT02120950|18846410|P2|Overall Study|Death|0
5453498|NCT02120950|18846411|P1|Overall Study|Death|3
5453499|NCT02120950|18846409|P3|Overall Study|Adverse Event|3
5453500|NCT02120950|18846410|P2|Overall Study|Adverse Event|4
5453501|NCT02120950|18846411|P1|Overall Study|Adverse Event|5
5453502|NCT02120924|18846447|P3|Overall Study|Compliance with IP|1
5453503|NCT02120924|18846448|P2|Overall Study|Compliance with IP|1
5453504|NCT02120924|18846449|P1|Overall Study|Compliance with IP|5
5453505|NCT02120924|18846447|P3|Overall Study|Death|0
5453506|NCT02120924|18846448|P2|Overall Study|Death|0
5453507|NCT02120924|18846449|P1|Overall Study|Death|1
5453508|NCT02120924|18846447|P3|Overall Study|Physician Decision|1
5453509|NCT02120924|18846448|P2|Overall Study|Physician Decision|1
5453510|NCT02120924|18846449|P1|Overall Study|Physician Decision|0
5453511|NCT02120924|18846447|P3|Overall Study|Protocol Violation|2
5453512|NCT02120924|18846448|P2|Overall Study|Protocol Violation|7
5453513|NCT02120924|18846449|P1|Overall Study|Protocol Violation|3
5453514|NCT02120924|18846447|P3|Overall Study|Pregnancy|0
5453515|NCT02120924|18846448|P2|Overall Study|Pregnancy|0
5453516|NCT02120924|18846449|P1|Overall Study|Pregnancy|2
5453517|NCT02120924|18846447|P3|Overall Study|Lost to Follow-up|11
5453518|NCT02120924|18846448|P2|Overall Study|Lost to Follow-up|14
5453519|NCT02120924|18846449|P1|Overall Study|Lost to Follow-up|14
5453520|NCT02120924|18846447|P3|Overall Study|Withdrawal by Subject|8
5453521|NCT02120924|18846448|P2|Overall Study|Withdrawal by Subject|20
5453522|NCT02120924|18846449|P1|Overall Study|Withdrawal by Subject|16
5453523|NCT02120924|18846447|P3|Overall Study|Adverse Event|3
5453524|NCT02120924|18846448|P2|Overall Study|Adverse Event|1
5453525|NCT02120924|18846449|P1|Overall Study|Adverse Event|0
5453526|NCT02120924|18846447|P3|Overall Study|Lack of Efficacy|3
5453527|NCT02120924|18846448|P2|Overall Study|Lack of Efficacy|2
5453528|NCT02120924|18846449|P1|Overall Study|Lack of Efficacy|1
5453529|NCT02120898|18846463|P3|Overall Study|Lost to Follow-up|1
5453530|NCT02120898|18846464|P2|Overall Study|Lost to Follow-up|0
5453531|NCT02120898|18846465|P1|Overall Study|Lost to Follow-up|0
5453532|NCT02120898|18846463|P3|Overall Study|Protocol Violation|0
5453533|NCT02120898|18846464|P2|Overall Study|Protocol Violation|2
5453534|NCT02120898|18846465|P1|Overall Study|Protocol Violation|1
5453535|NCT02120898|18846463|P3|Overall Study|Adverse Event|1
5453536|NCT02120898|18846464|P2|Overall Study|Adverse Event|2
5453537|NCT02120898|18846465|P1|Overall Study|Adverse Event|1
5453538|NCT02120898|18846463|P3|Overall Study|Non-compliance with study drug|0
5453539|NCT02120898|18846464|P2|Overall Study|Non-compliance with study drug|0
5453540|NCT02120898|18846465|P1|Overall Study|Non-compliance with study drug|3
5453541|NCT02120898|18846463|P3|Overall Study|Withdrawal by Subject|2
5453542|NCT02120898|18846464|P2|Overall Study|Withdrawal by Subject|2
5453543|NCT02120898|18846465|P1|Overall Study|Withdrawal by Subject|4
5453544|NCT02120833|18846487|P2|Overall Study|Lost to Follow-up|1
5453545|NCT02120833|18846488|P1|Overall Study|Lost to Follow-up|1
5453546|NCT02120833|18846487|P2|Overall Study|Withdrawal by Subject|0
5453547|NCT02120833|18846488|P1|Overall Study|Withdrawal by Subject|2
5453548|NCT02120833|18846487|P2|Overall Study|Adverse Event|0
5453549|NCT02120833|18846488|P1|Overall Study|Adverse Event|1
5453550|NCT02120794|18846642|P1|Overall Study|Due to insurance coverage|1
5453551|NCT02120794|18846642|P1|Overall Study|Physician Decision|4
5453552|NCT02120794|18846642|P1|Overall Study|Adverse Event|10
5453553|NCT02120794|18846642|P1|Overall Study|Withdrawal by Subject|43
5453554|NCT02120664|18846666|P5|Overall Study|Withdrawal by Subject|0
5453555|NCT02120664|18846667|P4|Overall Study|Withdrawal by Subject|1
5453556|NCT02120664|18846668|P3|Overall Study|Withdrawal by Subject|0
5453557|NCT02120664|18846669|P2|Overall Study|Withdrawal by Subject|0
5453558|NCT02120664|18846670|P1|Overall Study|Withdrawal by Subject|0
5453559|NCT02120625|18846688|P1|Overall Study|Physician Decision|2
5453560|NCT02120456|18846704|P9|Part 2 Double-blind Phase|Unable to attend visit due to work|1
5453561|NCT02120456|18846705|P8|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5453562|NCT02120456|18846706|P7|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5453563|NCT02120456|18846707|P6|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5453564|NCT02120456|18846708|P5|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5453565|NCT02120456|18846709|P4|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5453566|NCT02120456|18846710|P3|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5453567|NCT02120456|18846711|P2|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5453568|NCT02120456|18846712|P1|Part 2 Double-blind Phase|Unable to attend visit due to work|0
5453569|NCT02120456|18846704|P9|Part 2 Double-blind Phase|Withdrawal of consent|0
5453570|NCT02120456|18846705|P8|Part 2 Double-blind Phase|Withdrawal of consent|0
5453571|NCT02120456|18846706|P7|Part 2 Double-blind Phase|Withdrawal of consent|1
5453572|NCT02120456|18846707|P6|Part 2 Double-blind Phase|Withdrawal of consent|0
5453573|NCT02120456|18846708|P5|Part 2 Double-blind Phase|Withdrawal of consent|0
5453574|NCT02120456|18846709|P4|Part 2 Double-blind Phase|Withdrawal of consent|0
5453575|NCT02120456|18846710|P3|Part 2 Double-blind Phase|Withdrawal of consent|0
5453576|NCT02120456|18846711|P2|Part 2 Double-blind Phase|Withdrawal of consent|0
5453577|NCT02120456|18846712|P1|Part 2 Double-blind Phase|Withdrawal of consent|0
5453578|NCT02120456|18846704|P9|Part 2 Double-blind Phase|Lost to Follow-up|0
5453579|NCT02120456|18846705|P8|Part 2 Double-blind Phase|Lost to Follow-up|0
5453580|NCT02120456|18846706|P7|Part 2 Double-blind Phase|Lost to Follow-up|1
5453581|NCT02120456|18846707|P6|Part 2 Double-blind Phase|Lost to Follow-up|0
5453582|NCT02120456|18846708|P5|Part 2 Double-blind Phase|Lost to Follow-up|0
5453583|NCT02120456|18846709|P4|Part 2 Double-blind Phase|Lost to Follow-up|0
5453584|NCT02120456|18846710|P3|Part 2 Double-blind Phase|Lost to Follow-up|0
5453585|NCT02120456|18846711|P2|Part 2 Double-blind Phase|Lost to Follow-up|0
5453586|NCT02120456|18846712|P1|Part 2 Double-blind Phase|Lost to Follow-up|0
5453587|NCT02120417|18846746|P2|Overall Study|Other unspecified|4
5453588|NCT02120417|18846747|P1|Overall Study|Other unspecified|5
5453589|NCT02120417|18846746|P2|Overall Study|Physician Decision|3
5453590|NCT02120417|18846747|P1|Overall Study|Physician Decision|2
5453591|NCT02120417|18846746|P2|Overall Study|Noncompliance with study treatment|2
5453592|NCT02120417|18846747|P1|Overall Study|Noncompliance with study treatment|0
5453593|NCT02120417|18846746|P2|Overall Study|Disease progression|45
5453594|NCT02120417|18846747|P1|Overall Study|Disease progression|41
5453595|NCT02120417|18846746|P2|Overall Study|Participant decision|4
5453596|NCT02120417|18846747|P1|Overall Study|Participant decision|4
5453597|NCT02120417|18846746|P2|Overall Study|Adverse Event|9
5453598|NCT02120417|18846747|P1|Overall Study|Adverse Event|3
5453599|NCT02120417|18846746|P2|Overall Study|Death|1
5453600|NCT02120417|18846747|P1|Overall Study|Death|5
5453601|NCT02120352|18846765|P4|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
5453602|NCT02120352|18846766|P3|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
5453603|NCT02120352|18846767|P2|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
5453604|NCT02120352|18846768|P1|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
5453605|NCT02120352|18846765|P4|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
5453606|NCT02120352|18846766|P3|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
5453607|NCT02120352|18846767|P2|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
5453608|NCT02120352|18846768|P1|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
5453609|NCT02120352|18846765|P4|Maintenance Period (32 Weeks)|Lost to Follow-up|1
5453610|NCT02120352|18846766|P3|Maintenance Period (32 Weeks)|Lost to Follow-up|0
5453611|NCT02120352|18846767|P2|Maintenance Period (32 Weeks)|Lost to Follow-up|0
5453612|NCT02120352|18846768|P1|Maintenance Period (32 Weeks)|Lost to Follow-up|0
5453613|NCT02120352|18846765|P4|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
5453614|NCT02120352|18846766|P3|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
5453615|NCT02120352|18846767|P2|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
5453616|NCT02120352|18846768|P1|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
5453617|NCT02120352|18846765|P4|Maintenance Period (32 Weeks)|Protocol Violation|0
5453618|NCT02120352|18846766|P3|Maintenance Period (32 Weeks)|Protocol Violation|2
5453619|NCT02120352|18846767|P2|Maintenance Period (32 Weeks)|Protocol Violation|0
5453620|NCT02120352|18846768|P1|Maintenance Period (32 Weeks)|Protocol Violation|0
5453621|NCT02120352|18846765|P4|Maintenance Period (32 Weeks)|Lack of Efficacy|1
5453622|NCT02120352|18846766|P3|Maintenance Period (32 Weeks)|Lack of Efficacy|0
5453623|NCT02120352|18846767|P2|Maintenance Period (32 Weeks)|Lack of Efficacy|1
5453624|NCT02120352|18846768|P1|Maintenance Period (32 Weeks)|Lack of Efficacy|0
5453625|NCT02120352|18846765|P4|Maintenance Period (32 Weeks)|Adverse Event|1
5453626|NCT02120352|18846766|P3|Maintenance Period (32 Weeks)|Adverse Event|6
5453627|NCT02120352|18846767|P2|Maintenance Period (32 Weeks)|Adverse Event|0
5453628|NCT02120352|18846768|P1|Maintenance Period (32 Weeks)|Adverse Event|0
5453629|NCT02120352|18846765|P4|Induction Period (20 Weeks)|Physician Decision|0
5453630|NCT02120352|18846766|P3|Induction Period (20 Weeks)|Physician Decision|0
5453631|NCT02120352|18846767|P2|Induction Period (20 Weeks)|Physician Decision|0
5453632|NCT02120352|18846768|P1|Induction Period (20 Weeks)|Physician Decision|1
5453633|NCT02120352|18846765|P4|Induction Period (20 Weeks)|Withdrawal by Subject|0
5453634|NCT02120352|18846766|P3|Induction Period (20 Weeks)|Withdrawal by Subject|0
5453635|NCT02120352|18846767|P2|Induction Period (20 Weeks)|Withdrawal by Subject|0
5453636|NCT02120352|18846768|P1|Induction Period (20 Weeks)|Withdrawal by Subject|5
5453637|NCT02120352|18846765|P4|Induction Period (20 Weeks)|Lost to Follow-up|0
5453638|NCT02120352|18846766|P3|Induction Period (20 Weeks)|Lost to Follow-up|0
5453639|NCT02120352|18846767|P2|Induction Period (20 Weeks)|Lost to Follow-up|0
5453640|NCT02120352|18846768|P1|Induction Period (20 Weeks)|Lost to Follow-up|2
5453641|NCT02120352|18846765|P4|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
5453642|NCT02120352|18846766|P3|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
5453643|NCT02120352|18846767|P2|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
5453644|NCT02120352|18846768|P1|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
5453645|NCT02120352|18846765|P4|Induction Period (20 Weeks)|Protocol Violation|0
5453646|NCT02120352|18846766|P3|Induction Period (20 Weeks)|Protocol Violation|0
5453647|NCT02120352|18846767|P2|Induction Period (20 Weeks)|Protocol Violation|0
5453648|NCT02120352|18846768|P1|Induction Period (20 Weeks)|Protocol Violation|2
5453649|NCT02120352|18846765|P4|Induction Period (20 Weeks)|Lack of Efficacy|0
5453650|NCT02120352|18846766|P3|Induction Period (20 Weeks)|Lack of Efficacy|0
5453651|NCT02120352|18846767|P2|Induction Period (20 Weeks)|Lack of Efficacy|0
5453652|NCT02120352|18846768|P1|Induction Period (20 Weeks)|Lack of Efficacy|5
5453653|NCT02120352|18846765|P4|Induction Period (20 Weeks)|Adverse Event|0
5453654|NCT02120352|18846766|P3|Induction Period (20 Weeks)|Adverse Event|0
5453655|NCT02120352|18846767|P2|Induction Period (20 Weeks)|Adverse Event|0
5453656|NCT02120352|18846768|P1|Induction Period (20 Weeks)|Adverse Event|3
5453657|NCT02120300|18846919|P4|Overall Study|Lost to Follow-up|0
5453658|NCT02120300|18846920|P3|Overall Study|Lost to Follow-up|0
5453659|NCT02120300|18846921|P2|Overall Study|Lost to Follow-up|0
5453660|NCT02120300|18846922|P1|Overall Study|Lost to Follow-up|1
5453661|NCT02120300|18846919|P4|Overall Study|Lack of Efficacy|1
5453662|NCT02120300|18846920|P3|Overall Study|Lack of Efficacy|0
5453663|NCT02120300|18846921|P2|Overall Study|Lack of Efficacy|0
5453664|NCT02120300|18846922|P1|Overall Study|Lack of Efficacy|0
5453665|NCT02120300|18846919|P4|Overall Study|Enrolled but Never Treated|0
5453666|NCT02120300|18846920|P3|Overall Study|Enrolled but Never Treated|0
5453667|NCT02120300|18846921|P2|Overall Study|Enrolled but Never Treated|0
5453668|NCT02120300|18846922|P1|Overall Study|Enrolled but Never Treated|2
5453669|NCT02120157|18846993|P2|Overall Study|Graft Failure before Day 100|0
5453670|NCT02120157|18846994|P1|Overall Study|Graft Failure before Day 100|2
5453671|NCT02120157|18846993|P2|Overall Study|Death|2
5453672|NCT02120157|18846994|P1|Overall Study|Death|4
5453673|NCT02120027|18847004|P2|Overall Study|Withdrawal by Subject|25
5453674|NCT02120027|18847005|P1|Overall Study|Withdrawal by Subject|33
5453675|NCT02120027|18847004|P2|Overall Study|Study terminated by Sponsor|47
5453676|NCT02120027|18847005|P1|Overall Study|Study terminated by Sponsor|45
5453677|NCT02120027|18847004|P2|Overall Study|Protocol Violation|21
5453678|NCT02120027|18847005|P1|Overall Study|Protocol Violation|18
5453679|NCT02120027|18847004|P2|Overall Study|Physician Decision|3
5453680|NCT02120027|18847005|P1|Overall Study|Physician Decision|4
5453681|NCT02120027|18847004|P2|Overall Study|Other|0
5453682|NCT02120027|18847005|P1|Overall Study|Other|4
5453683|NCT02120027|18847004|P2|Overall Study|Lost to Follow-up|13
5453684|NCT02120027|18847005|P1|Overall Study|Lost to Follow-up|5
5453685|NCT02120027|18847004|P2|Overall Study|Lack of Efficacy|5
5453686|NCT02120027|18847005|P1|Overall Study|Lack of Efficacy|3
5453687|NCT02120027|18847004|P2|Overall Study|Adverse Event|5
5453688|NCT02120027|18847005|P1|Overall Study|Adverse Event|4
5453689|NCT02119936|18847030|P1|Overall Study|Lost to Follow-up|10
5453690|NCT02119676|18847064|P4|Overall Study|Did not receive study med|5
5453691|NCT02119676|18847065|P3|Overall Study|Did not receive study med|4
5453692|NCT02119676|18847066|P2|Overall Study|Did not receive study med|2
5453693|NCT02119676|18847067|P1|Overall Study|Did not receive study med|2
5453694|NCT02119676|18847064|P4|Overall Study|Other, unspecified|4
5453695|NCT02119676|18847065|P3|Overall Study|Other, unspecified|3
5453696|NCT02119676|18847066|P2|Overall Study|Other, unspecified|1
5453697|NCT02119676|18847067|P1|Overall Study|Other, unspecified|2
5453698|NCT02119676|18847064|P4|Overall Study|Protocol deviation|0
5453699|NCT02119676|18847065|P3|Overall Study|Protocol deviation|1
5453700|NCT02119676|18847066|P2|Overall Study|Protocol deviation|0
5453701|NCT02119676|18847067|P1|Overall Study|Protocol deviation|0
5453702|NCT02119676|18847064|P4|Overall Study|Lost to Follow-up|0
5453703|NCT02119676|18847065|P3|Overall Study|Lost to Follow-up|1
5453704|NCT02119676|18847066|P2|Overall Study|Lost to Follow-up|0
5453705|NCT02119676|18847067|P1|Overall Study|Lost to Follow-up|0
5453706|NCT02119676|18847064|P4|Overall Study|Noncompliance|0
5453707|NCT02119676|18847065|P3|Overall Study|Noncompliance|0
5453708|NCT02119676|18847066|P2|Overall Study|Noncompliance|1
5453709|NCT02119676|18847067|P1|Overall Study|Noncompliance|0
5453710|NCT02119676|18847064|P4|Overall Study|Death|1
5453711|NCT02119676|18847065|P3|Overall Study|Death|2
5453712|NCT02119676|18847066|P2|Overall Study|Death|3
5453713|NCT02119676|18847067|P1|Overall Study|Death|9
5453714|NCT02119676|18847064|P4|Overall Study|Physician Decision|2
5453715|NCT02119676|18847065|P3|Overall Study|Physician Decision|3
5453716|NCT02119676|18847066|P2|Overall Study|Physician Decision|2
5453717|NCT02119676|18847067|P1|Overall Study|Physician Decision|4
5453718|NCT02119676|18847064|P4|Overall Study|Patient decision, inc. consent withdrawn|6
5453719|NCT02119676|18847065|P3|Overall Study|Patient decision, inc. consent withdrawn|5
5453720|NCT02119676|18847066|P2|Overall Study|Patient decision, inc. consent withdrawn|5
5453721|NCT02119676|18847067|P1|Overall Study|Patient decision, inc. consent withdrawn|4
5453722|NCT02119676|18847064|P4|Overall Study|Disease progression|73
5453723|NCT02119676|18847065|P3|Overall Study|Disease progression|68
5453724|NCT02119676|18847066|P2|Overall Study|Disease progression|55
5453725|NCT02119676|18847067|P1|Overall Study|Disease progression|53
5453726|NCT02119676|18847064|P4|Overall Study|Adverse Event|10
5453727|NCT02119676|18847065|P3|Overall Study|Adverse Event|10
5453728|NCT02119676|18847066|P2|Overall Study|Adverse Event|17
5453729|NCT02119676|18847067|P1|Overall Study|Adverse Event|9
5453730|NCT02119663|18847099|P2|Overall Study|Study Terminated by the Sponsor|4
5453731|NCT02119663|18847100|P1|Overall Study|Study Terminated by the Sponsor|3
5453732|NCT02119663|18847099|P2|Overall Study|Subject decision|1
5453733|NCT02119663|18847100|P1|Overall Study|Subject decision|0
5453734|NCT02119663|18847099|P2|Overall Study|Other unspecified|0
5453735|NCT02119663|18847100|P1|Overall Study|Other unspecified|2
5453736|NCT02119663|18847099|P2|Overall Study|Physician Decision|2
5453737|NCT02119663|18847100|P1|Overall Study|Physician Decision|1
5453738|NCT02119663|18847099|P2|Overall Study|Death|2
5453739|NCT02119663|18847100|P1|Overall Study|Death|3
5453740|NCT02119663|18847099|P2|Overall Study|Adverse Event|5
5453741|NCT02119663|18847100|P1|Overall Study|Adverse Event|5
5453742|NCT02119663|18847099|P2|Overall Study|Disease progression|27
5453743|NCT02119663|18847100|P1|Overall Study|Disease progression|26
5453744|NCT02119650|18847118|P2|Overall Study|Multiple reasons for termination|1
5453745|NCT02119650|18847119|P1|Overall Study|Multiple reasons for termination|2
5453746|NCT02119650|18847118|P2|Overall Study|Physician Decision|2
5453747|NCT02119650|18847119|P1|Overall Study|Physician Decision|0
5453748|NCT02119650|18847118|P2|Overall Study|Study terminated by the sponsor|0
5453749|NCT02119650|18847119|P1|Overall Study|Study terminated by the sponsor|1
5453750|NCT02119650|18847118|P2|Overall Study|Noncompliance with study treatment|1
5453751|NCT02119650|18847119|P1|Overall Study|Noncompliance with study treatment|1
5453752|NCT02119650|18847118|P2|Overall Study|Death|1
5453753|NCT02119650|18847119|P1|Overall Study|Death|5
5453754|NCT02119650|18847118|P2|Overall Study|Disease progression|14
5453755|NCT02119650|18847119|P1|Overall Study|Disease progression|11
5453756|NCT02119650|18847118|P2|Overall Study|Subject decision|3
5453757|NCT02119650|18847119|P1|Overall Study|Subject decision|2
5453758|NCT02119650|18847118|P2|Overall Study|Adverse Event|4
5453759|NCT02119650|18847119|P1|Overall Study|Adverse Event|3
5453760|NCT02119325|18847154|P2|Washout Period 1|Adverse Event|1
5453761|NCT02119325|18847155|P1|Washout Period 1|Adverse Event|0
5453762|NCT02119299|18847199|P1|Overall Study|Pregnancy|1
5453763|NCT02119299|18847199|P1|Overall Study|Lack of Efficacy|1
5453764|NCT02119299|18847199|P1|Overall Study|Withdrawal by Subject|7
5453765|NCT02119286|18847213|P3|Overall Study|Withdrawal by Subject|0
5453766|NCT02119286|18847214|P2|Overall Study|Withdrawal by Subject|1
5453767|NCT02119286|18847215|P1|Overall Study|Withdrawal by Subject|4
5453768|NCT02119286|18847213|P3|Overall Study|Lost to Follow-up|1
5453769|NCT02119286|18847214|P2|Overall Study|Lost to Follow-up|0
5453770|NCT02119286|18847215|P1|Overall Study|Lost to Follow-up|2
5453771|NCT02119286|18847213|P3|Overall Study|Lack of Efficacy|4
5453772|NCT02119286|18847214|P2|Overall Study|Lack of Efficacy|3
5453773|NCT02119286|18847215|P1|Overall Study|Lack of Efficacy|11
5453774|NCT02119286|18847213|P3|Overall Study|Adverse Event|2
5453775|NCT02119286|18847214|P2|Overall Study|Adverse Event|7
5453776|NCT02119286|18847215|P1|Overall Study|Adverse Event|9
5453777|NCT02119260|18847233|P7|Overall Study|Withdrew consent|0
5453778|NCT02119260|18847234|P6|Overall Study|Withdrew consent|0
5453779|NCT02119260|18847235|P5|Overall Study|Withdrew consent|0
5453780|NCT02119260|18847236|P4|Overall Study|Withdrew consent|0
5453781|NCT02119260|18847237|P3|Overall Study|Withdrew consent|1
5453782|NCT02119260|18847238|P2|Overall Study|Withdrew consent|1
5453783|NCT02119260|18847239|P1|Overall Study|Withdrew consent|0
5453784|NCT02119260|18847233|P7|Overall Study|Adverse Event|0
5453785|NCT02119260|18847234|P6|Overall Study|Adverse Event|0
5453786|NCT02119260|18847235|P5|Overall Study|Adverse Event|0
5453787|NCT02119260|18847236|P4|Overall Study|Adverse Event|0
5453788|NCT02119260|18847237|P3|Overall Study|Adverse Event|0
5453789|NCT02119260|18847238|P2|Overall Study|Adverse Event|0
5453790|NCT02119260|18847239|P1|Overall Study|Adverse Event|1
5453791|NCT02119156|18847312|P3|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
5453792|NCT02119156|18847313|P2|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
5453793|NCT02119156|18847314|P1|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
5453794|NCT02119156|18847312|P3|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
5453795|NCT02119156|18847313|P2|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
5453796|NCT02119156|18847314|P1|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
5453797|NCT02119156|18847312|P3|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
5453798|NCT02119156|18847313|P2|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
5453799|NCT02119156|18847314|P1|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
5453800|NCT02119156|18847312|P3|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
5453801|NCT02119156|18847313|P2|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
5453802|NCT02119156|18847314|P1|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
5453803|NCT02119156|18847312|P3|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
5453804|NCT02119156|18847313|P2|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
5453805|NCT02119156|18847314|P1|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
5453806|NCT02119104|18847372|P1|Overall Study|Protocol Violation|16
5453807|NCT02119026|18847378|P2|2nd-line Treatment|Adverse Event|1
5453808|NCT02119026|18847379|P1|2nd-line Treatment|Adverse Event|4
5453809|NCT02119026|18847378|P2|2nd-line Treatment|Withdrawal by Subject|1
5453810|NCT02119026|18847379|P1|2nd-line Treatment|Withdrawal by Subject|3
5453811|NCT02119026|18847378|P2|2nd-line Treatment|Lost to Follow-up|0
5453812|NCT02119026|18847379|P1|2nd-line Treatment|Lost to Follow-up|2
5453813|NCT02119026|18847378|P2|1st-line Treatment|Death|1
5453814|NCT02119026|18847379|P1|1st-line Treatment|Death|2
5453815|NCT02119026|18847378|P2|1st-line Treatment|Surgery of metastases|1
5453816|NCT02119026|18847379|P1|1st-line Treatment|Surgery of metastases|2
5453817|NCT02119026|18847378|P2|1st-line Treatment|Patient condition or compliance|4
5453818|NCT02119026|18847379|P1|1st-line Treatment|Patient condition or compliance|6
5453819|NCT02119026|18847378|P2|1st-line Treatment|Withdrawal by Subject|10
5453820|NCT02119026|18847379|P1|1st-line Treatment|Withdrawal by Subject|4
5453821|NCT02119026|18847378|P2|1st-line Treatment|Physician Decision|8
5453822|NCT02119026|18847379|P1|1st-line Treatment|Physician Decision|3
5453823|NCT02119026|18847378|P2|1st-line Treatment|Adverse Event|14
5453824|NCT02119026|18847379|P1|1st-line Treatment|Adverse Event|9
5453825|NCT02118961|18847403|P2|Overall Study|Withdrawal by Subject|0
5453826|NCT02118961|18847404|P1|Overall Study|Withdrawal by Subject|1
5453827|NCT02118896|18847432|P10|Overall Study|Miscellaneous|0
5453828|NCT02118896|18847433|P9|Overall Study|Miscellaneous|0
5453829|NCT02118896|18847434|P8|Overall Study|Miscellaneous|0
5453830|NCT02118896|18847435|P7|Overall Study|Miscellaneous|0
5453831|NCT02118896|18847436|P6|Overall Study|Miscellaneous|4
5453832|NCT02118896|18847437|P5|Overall Study|Miscellaneous|0
5453833|NCT02118896|18847438|P4|Overall Study|Miscellaneous|2
5453834|NCT02118896|18847439|P3|Overall Study|Miscellaneous|0
5453835|NCT02118896|18847440|P2|Overall Study|Miscellaneous|2
5453836|NCT02118896|18847441|P1|Overall Study|Miscellaneous|1
5453837|NCT02118896|18847432|P10|Overall Study|Prohibited medication|0
5453838|NCT02118896|18847433|P9|Overall Study|Prohibited medication|0
5453839|NCT02118896|18847434|P8|Overall Study|Prohibited medication|0
5453840|NCT02118896|18847435|P7|Overall Study|Prohibited medication|0
5453841|NCT02118896|18847436|P6|Overall Study|Prohibited medication|3
5453842|NCT02118896|18847437|P5|Overall Study|Prohibited medication|1
5453843|NCT02118896|18847438|P4|Overall Study|Prohibited medication|0
5453844|NCT02118896|18847439|P3|Overall Study|Prohibited medication|0
5453845|NCT02118896|18847440|P2|Overall Study|Prohibited medication|0
5453846|NCT02118896|18847441|P1|Overall Study|Prohibited medication|0
5453847|NCT02118896|18847432|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
5453848|NCT02118896|18847433|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
5453849|NCT02118896|18847434|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
5453850|NCT02118896|18847435|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
5453851|NCT02118896|18847436|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
5453852|NCT02118896|18847437|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
5453853|NCT02118896|18847438|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
5453854|NCT02118896|18847439|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
5453855|NCT02118896|18847440|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
5453856|NCT02118896|18847441|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
5453857|NCT02118896|18847432|P10|Overall Study|Lost to Follow-up|0
5453858|NCT02118896|18847433|P9|Overall Study|Lost to Follow-up|0
5453859|NCT02118896|18847434|P8|Overall Study|Lost to Follow-up|0
5453860|NCT02118896|18847435|P7|Overall Study|Lost to Follow-up|0
5453861|NCT02118896|18847436|P6|Overall Study|Lost to Follow-up|1
5453862|NCT02118896|18847437|P5|Overall Study|Lost to Follow-up|2
5453863|NCT02118896|18847438|P4|Overall Study|Lost to Follow-up|0
5453864|NCT02118896|18847439|P3|Overall Study|Lost to Follow-up|1
5453865|NCT02118896|18847440|P2|Overall Study|Lost to Follow-up|2
5453866|NCT02118896|18847441|P1|Overall Study|Lost to Follow-up|1
5453867|NCT02118896|18847432|P10|Overall Study|Pregnancy|0
5453868|NCT02118896|18847433|P9|Overall Study|Pregnancy|0
5453869|NCT02118896|18847434|P8|Overall Study|Pregnancy|0
5453870|NCT02118896|18847435|P7|Overall Study|Pregnancy|1
5453871|NCT02118896|18847436|P6|Overall Study|Pregnancy|3
5453872|NCT02118896|18847437|P5|Overall Study|Pregnancy|1
5453873|NCT02118896|18847438|P4|Overall Study|Pregnancy|0
5453874|NCT02118896|18847439|P3|Overall Study|Pregnancy|0
5453875|NCT02118896|18847440|P2|Overall Study|Pregnancy|1
5453876|NCT02118896|18847441|P1|Overall Study|Pregnancy|1
5453877|NCT02118896|18847432|P10|Overall Study|Non-compliance|0
5453878|NCT02118896|18847433|P9|Overall Study|Non-compliance|0
5453879|NCT02118896|18847434|P8|Overall Study|Non-compliance|1
5453880|NCT02118896|18847435|P7|Overall Study|Non-compliance|0
5453881|NCT02118896|18847436|P6|Overall Study|Non-compliance|1
5453882|NCT02118896|18847437|P5|Overall Study|Non-compliance|0
5453883|NCT02118896|18847438|P4|Overall Study|Non-compliance|5
5453884|NCT02118896|18847439|P3|Overall Study|Non-compliance|1
5453885|NCT02118896|18847440|P2|Overall Study|Non-compliance|1
5453886|NCT02118896|18847441|P1|Overall Study|Non-compliance|2
5453887|NCT02118896|18847432|P10|Overall Study|Consent withdrawn|0
5453888|NCT02118896|18847433|P9|Overall Study|Consent withdrawn|0
5453889|NCT02118896|18847434|P8|Overall Study|Consent withdrawn|0
5453890|NCT02118896|18847435|P7|Overall Study|Consent withdrawn|0
5453891|NCT02118896|18847436|P6|Overall Study|Consent withdrawn|4
5453892|NCT02118896|18847437|P5|Overall Study|Consent withdrawn|1
5453893|NCT02118896|18847438|P4|Overall Study|Consent withdrawn|4
5453894|NCT02118896|18847439|P3|Overall Study|Consent withdrawn|3
5453895|NCT02118896|18847440|P2|Overall Study|Consent withdrawn|0
5453896|NCT02118896|18847441|P1|Overall Study|Consent withdrawn|2
5453897|NCT02118896|18847432|P10|Overall Study|Adverse Event|0
5453898|NCT02118896|18847433|P9|Overall Study|Adverse Event|4
5453899|NCT02118896|18847434|P8|Overall Study|Adverse Event|1
5453900|NCT02118896|18847435|P7|Overall Study|Adverse Event|1
5453901|NCT02118896|18847436|P6|Overall Study|Adverse Event|9
5453902|NCT02118896|18847437|P5|Overall Study|Adverse Event|5
5453903|NCT02118896|18847438|P4|Overall Study|Adverse Event|5
5453904|NCT02118896|18847439|P3|Overall Study|Adverse Event|4
5453905|NCT02118896|18847440|P2|Overall Study|Adverse Event|4
5453906|NCT02118896|18847441|P1|Overall Study|Adverse Event|5
5453907|NCT02118896|18847432|P10|Overall Study|Death|0
5453908|NCT02118896|18847433|P9|Overall Study|Death|0
5453909|NCT02118896|18847434|P8|Overall Study|Death|0
5453910|NCT02118896|18847435|P7|Overall Study|Death|0
5453911|NCT02118896|18847436|P6|Overall Study|Death|1
5453912|NCT02118896|18847437|P5|Overall Study|Death|3
5453913|NCT02118896|18847438|P4|Overall Study|Death|6
5453914|NCT02118896|18847439|P3|Overall Study|Death|4
5453915|NCT02118896|18847440|P2|Overall Study|Death|0
5453916|NCT02118896|18847441|P1|Overall Study|Death|4
5453917|NCT02118792|18847531|P2|Overall Study|Randomised but not treated|0
5453918|NCT02118792|18847532|P1|Overall Study|Randomised but not treated|1
5453919|NCT02118792|18847531|P2|Overall Study|Other|6
5453920|NCT02118792|18847532|P1|Overall Study|Other|1
5453921|NCT02118792|18847531|P2|Overall Study|Withdrawal by parent/guardian|20
5453922|NCT02118792|18847532|P1|Overall Study|Withdrawal by parent/guardian|14
5453923|NCT02118792|18847531|P2|Overall Study|Adverse Event|4
5453924|NCT02118792|18847532|P1|Overall Study|Adverse Event|5
5453925|NCT02118792|18847531|P2|Overall Study|Lost to Follow-up|4
5453926|NCT02118792|18847532|P1|Overall Study|Lost to Follow-up|4
5453927|NCT02118792|18847531|P2|Overall Study|Withdrawal by Subject|3
5453928|NCT02118792|18847532|P1|Overall Study|Withdrawal by Subject|6
5453929|NCT02118766|18847574|P2|Overall Study|Other|1
5453930|NCT02118766|18847575|P1|Overall Study|Other|3
5453931|NCT02118766|18847574|P2|Overall Study|Withdrawal by parent/guardian|18
5453932|NCT02118766|18847575|P1|Overall Study|Withdrawal by parent/guardian|12
5453933|NCT02118766|18847574|P2|Overall Study|Lost to Follow-up|4
5453934|NCT02118766|18847575|P1|Overall Study|Lost to Follow-up|5
5453935|NCT02118766|18847574|P2|Overall Study|Withdrawal by Subject|6
5453936|NCT02118766|18847575|P1|Overall Study|Withdrawal by Subject|3
5453937|NCT02118766|18847574|P2|Overall Study|Adverse Event|2
5453938|NCT02118766|18847575|P1|Overall Study|Adverse Event|7
5453939|NCT02118714|18847597|P1|Overall Study|Protocol Violation|1
5453940|NCT02118714|18847597|P1|Overall Study|Lost to Follow-up|2
5453941|NCT02118597|18847622|P1|Overall Study|Investigator's decision|1
5453942|NCT02118597|18847622|P1|Overall Study|Serious Adverse Event|1
5453943|NCT02118597|18847622|P1|Overall Study|Sponsor terminated the study|14
5453944|NCT02118428|18847653|P3|Overall Study|Screen Failure or Became Inelegible|1
5453945|NCT02118428|18847654|P2|Overall Study|Screen Failure or Became Inelegible|0
5453946|NCT02118428|18847655|P1|Overall Study|Screen Failure or Became Inelegible|1
5453947|NCT02118428|18847653|P3|Overall Study|Lost to Follow-up|0
5453948|NCT02118428|18847654|P2|Overall Study|Lost to Follow-up|1
5453949|NCT02118428|18847655|P1|Overall Study|Lost to Follow-up|3
5453950|NCT02118428|18847653|P3|Overall Study|Death|0
5453951|NCT02118428|18847654|P2|Overall Study|Death|5
5453952|NCT02118428|18847655|P1|Overall Study|Death|7
5453953|NCT02118428|18847653|P3|Overall Study|Withdrawal by Subject|0
5453954|NCT02118428|18847654|P2|Overall Study|Withdrawal by Subject|2
5453955|NCT02118428|18847655|P1|Overall Study|Withdrawal by Subject|2
5453956|NCT02118428|18847653|P3|Overall Study|Physician Decision|0
5453957|NCT02118428|18847654|P2|Overall Study|Physician Decision|1
5453958|NCT02118428|18847655|P1|Overall Study|Physician Decision|0
5453959|NCT02118012|18847695|P2|Overall Study|Physician Decision|1
5453960|NCT02118012|18847696|P1|Overall Study|Physician Decision|0
5453961|NCT02118012|18847695|P2|Overall Study|Adverse Event|1
5453962|NCT02118012|18847696|P1|Overall Study|Adverse Event|0
5453963|NCT02117687|18847740|P2|Overall Study|Other Reasons|1
5453964|NCT02117687|18847741|P1|Overall Study|Other Reasons|1
5453965|NCT02117687|18847740|P2|Overall Study|Adverse Event|2
5453966|NCT02117687|18847741|P1|Overall Study|Adverse Event|0
5453967|NCT02117687|18847740|P2|Overall Study|Lost to Follow-up|1
5453968|NCT02117687|18847741|P1|Overall Study|Lost to Follow-up|0
5453969|NCT02117648|18847773|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
5453970|NCT02117648|18847773|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
5453971|NCT02117648|18847773|P1|Abemaciclib Safety-Extension Phase|Death|3
5453972|NCT02117648|18847773|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
5453973|NCT02117648|18847773|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
5453974|NCT02117648|18847773|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
5453975|NCT02117648|18847773|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
5453976|NCT02117648|18847773|P1|Abemaciclib + Clarithromycin Period 2|Death|1
5453977|NCT02117648|18847773|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
5453978|NCT02117648|18847773|P1|Abemaciclib Alone Period 1|Adverse Event|1
5453979|NCT02117648|18847773|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
5453980|NCT02117570|18847786|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
5453981|NCT02117570|18847787|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
5453982|NCT02117570|18847788|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
5453983|NCT02117570|18847786|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
5453984|NCT02117570|18847787|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
5453985|NCT02117570|18847788|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
5453986|NCT02117570|18847786|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
5453987|NCT02117570|18847787|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
5453988|NCT02117570|18847788|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
5453989|NCT02117570|18847786|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
5453990|NCT02117570|18847787|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
5453991|NCT02117570|18847788|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
5453992|NCT02117570|18847786|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
5453993|NCT02117570|18847787|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
5453994|NCT02117570|18847788|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
5453995|NCT02117570|18847786|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
5453996|NCT02117570|18847787|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
5453997|NCT02117570|18847788|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
5453998|NCT02117570|18847786|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
5453999|NCT02117570|18847787|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
5454000|NCT02117570|18847788|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
5454001|NCT02117544|18847838|P2|Period 1|Lost to follow-up (prior to treatment)|0
5454002|NCT02117544|18847839|P1|Period 1|Lost to follow-up (prior to treatment)|2
5454003|NCT02117479|18847854|P2|Overall Study|Other unspecified|7
5454004|NCT02117479|18847855|P1|Overall Study|Other unspecified|11
5454005|NCT02117479|18847854|P2|Overall Study|Physician Decision|2
5454006|NCT02117479|18847855|P1|Overall Study|Physician Decision|7
5454007|NCT02117479|18847854|P2|Overall Study|Study terminated by the sponsor|6
5454008|NCT02117479|18847855|P1|Overall Study|Study terminated by the sponsor|4
5454009|NCT02117479|18847854|P2|Overall Study|Noncompliance with study treatment|0
5454010|NCT02117479|18847855|P1|Overall Study|Noncompliance with study treatment|1
5454011|NCT02117479|18847854|P2|Overall Study|Disease progression|108
5454012|NCT02117479|18847855|P1|Overall Study|Disease progression|104
5454013|NCT02117479|18847854|P2|Overall Study|Subject decision|9
5454014|NCT02117479|18847855|P1|Overall Study|Subject decision|8
5454015|NCT02117479|18847854|P2|Overall Study|Adverse Event|16
5454016|NCT02117479|18847855|P1|Overall Study|Adverse Event|8
5454017|NCT02117479|18847854|P2|Overall Study|Death|8
5454018|NCT02117479|18847855|P1|Overall Study|Death|13
5454019|NCT02117427|18847874|P3|Overall Study|Death|0
5454020|NCT02117427|18847875|P2|Overall Study|Death|1
5454021|NCT02117427|18847876|P1|Overall Study|Death|0
5454022|NCT02117427|18847874|P3|Overall Study|No longer meets inclusion criteria|0
5454023|NCT02117427|18847875|P2|Overall Study|No longer meets inclusion criteria|1
5454024|NCT02117427|18847876|P1|Overall Study|No longer meets inclusion criteria|0
5454025|NCT02117427|18847874|P3|Overall Study|Physician Decision|0
5454026|NCT02117427|18847875|P2|Overall Study|Physician Decision|2
5454027|NCT02117427|18847876|P1|Overall Study|Physician Decision|0
5454028|NCT02117427|18847874|P3|Overall Study|Permanent need for exogenous ESA Tx|0
5454029|NCT02117427|18847875|P2|Overall Study|Permanent need for exogenous ESA Tx|1
5454030|NCT02117427|18847876|P1|Overall Study|Permanent need for exogenous ESA Tx|3
5454031|NCT02117427|18847874|P3|Overall Study|Permanent need for exogenous EPO Tx|0
5454032|NCT02117427|18847875|P2|Overall Study|Permanent need for exogenous EPO Tx|0
5454033|NCT02117427|18847876|P1|Overall Study|Permanent need for exogenous EPO Tx|2
5454034|NCT02117414|18847886|P2|Overall Study|Withdrawal by Subject|4
5454035|NCT02117414|18847887|P1|Overall Study|Withdrawal by Subject|10
5454036|NCT02117414|18847886|P2|Overall Study|Death|2
5454037|NCT02117414|18847887|P1|Overall Study|Death|5
5454038|NCT02117349|18847907|P2|Overall Study|Death|0
5454039|NCT02117349|18847908|P1|Overall Study|Death|1
5454040|NCT02117349|18847907|P2|Overall Study|Lost to Follow-up|1
5454041|NCT02117349|18847908|P1|Overall Study|Lost to Follow-up|1
5454042|NCT02117349|18847907|P2|Overall Study|Withdrawal by Subject|0
5454043|NCT02117349|18847908|P1|Overall Study|Withdrawal by Subject|1
5454044|NCT02117050|18847944|P1|Overall Study|Subject Enrolled but not Dosed|1
5454045|NCT02117024|18847958|P2|Overall Study|Physician Decision|2
5454046|NCT02117024|18847959|P1|Overall Study|Physician Decision|0
5454047|NCT02117024|18847958|P2|Overall Study|Patient took treatment break|1
5454048|NCT02117024|18847959|P1|Overall Study|Patient took treatment break|0
5454049|NCT02117024|18847958|P2|Overall Study|Patient returned to primary oncologist|1
5454050|NCT02117024|18847959|P1|Overall Study|Patient returned to primary oncologist|0
5454051|NCT02117024|18847958|P2|Overall Study|Randomized in Error|0
5454052|NCT02117024|18847959|P1|Overall Study|Randomized in Error|1
5454053|NCT02117024|18847958|P2|Overall Study|Adverse Event|2
5454054|NCT02117024|18847959|P1|Overall Study|Adverse Event|1
5454055|NCT02117024|18847958|P2|Overall Study|Protocol Violation|0
5454056|NCT02117024|18847959|P1|Overall Study|Protocol Violation|1
5454057|NCT02117024|18847958|P2|Overall Study|Withdrawal by Subject|1
5454058|NCT02117024|18847959|P1|Overall Study|Withdrawal by Subject|3
5454059|NCT02117024|18847958|P2|Overall Study|Death|0
5454060|NCT02117024|18847959|P1|Overall Study|Death|5
5454061|NCT02117024|18847958|P2|Overall Study|Significant Clinical Progression|4
5454062|NCT02117024|18847959|P1|Overall Study|Significant Clinical Progression|7
5454063|NCT02117024|18847958|P2|Overall Study|Progressive Disease|9
5454064|NCT02117024|18847959|P1|Overall Study|Progressive Disease|26
5454065|NCT02116972|18847986|P3|Overall Study|scheduling conflicts and relocation|6
5454066|NCT02116972|18847987|P2|Overall Study|scheduling conflicts and relocation|3
5454067|NCT02116972|18847988|P1|Overall Study|scheduling conflicts and relocation|3
5454068|NCT02116972|18847986|P3|Overall Study|Lack of Efficacy|5
5454069|NCT02116972|18847987|P2|Overall Study|Lack of Efficacy|6
5454070|NCT02116972|18847988|P1|Overall Study|Lack of Efficacy|6
5454071|NCT02116972|18847986|P3|Overall Study|Lost to Follow-up|1
5454072|NCT02116972|18847987|P2|Overall Study|Lost to Follow-up|3
5454073|NCT02116972|18847988|P1|Overall Study|Lost to Follow-up|4
5454074|NCT02116972|18847986|P3|Overall Study|Protocol Violation|1
5454075|NCT02116972|18847987|P2|Overall Study|Protocol Violation|0
5454076|NCT02116972|18847988|P1|Overall Study|Protocol Violation|1
5454077|NCT02116972|18847986|P3|Overall Study|Withdrawal by Subject|5
5454078|NCT02116972|18847987|P2|Overall Study|Withdrawal by Subject|1
5454079|NCT02116972|18847988|P1|Overall Study|Withdrawal by Subject|1
5454080|NCT02116972|18847986|P3|Overall Study|Adverse Event|1
5454081|NCT02116972|18847987|P2|Overall Study|Adverse Event|4
5454082|NCT02116972|18847988|P1|Overall Study|Adverse Event|4
5454083|NCT02116803|18848020|P2|Overall Study|Death|0
5454084|NCT02116803|18848021|P1|Overall Study|Death|1
5454085|NCT02116803|18848020|P2|Overall Study|Study terminated by sponsor|1
5454086|NCT02116803|18848021|P1|Overall Study|Study terminated by sponsor|2
5454087|NCT02116803|18848020|P2|Overall Study|Progressive disease|0
5454088|NCT02116803|18848021|P1|Overall Study|Progressive disease|4
5454089|NCT02116803|18848020|P2|Overall Study|Physician Decision|0
5454090|NCT02116803|18848021|P1|Overall Study|Physician Decision|1
5454091|NCT02116803|18848020|P2|Overall Study|Adverse Event|1
5454092|NCT02116803|18848021|P1|Overall Study|Adverse Event|2
5454093|NCT02116660|18848029|P2|Overall Study|Organization reason|0
5454094|NCT02116660|18848030|P1|Overall Study|Organization reason|1
5454095|NCT02116660|18848029|P2|Overall Study|Withdrawal by Subject|2
5454096|NCT02116660|18848030|P1|Overall Study|Withdrawal by Subject|0
5454097|NCT02116660|18848029|P2|Overall Study|Adverse Event|1
5454098|NCT02116660|18848030|P1|Overall Study|Adverse Event|1
5454099|NCT02116660|18848029|P2|Overall Study|Deteriorating renal function|1
5454100|NCT02116660|18848030|P1|Overall Study|Deteriorating renal function|0
5454101|NCT02116621|18848074|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
5454102|NCT02116621|18848075|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
5454103|NCT02116621|18848074|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
5454104|NCT02116621|18848075|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
5454105|NCT02116621|18848074|P2|Twelve Month Follow-up|Lost to Follow-up|1
5454106|NCT02116621|18848075|P1|Twelve Month Follow-up|Lost to Follow-up|0
5454107|NCT02116621|18848074|P2|Twelve Month Follow-up|Withdrawal by Subject|0
5454108|NCT02116621|18848075|P1|Twelve Month Follow-up|Withdrawal by Subject|1
5454109|NCT02116621|18848074|P2|Six Month Follow-up|Did not complete follow-up survey|1
5454110|NCT02116621|18848075|P1|Six Month Follow-up|Did not complete follow-up survey|1
5454111|NCT02116621|18848074|P2|Six Month Follow-up|Lost to Follow-up|1
5454112|NCT02116621|18848075|P1|Six Month Follow-up|Lost to Follow-up|2
5454113|NCT02116621|18848074|P2|Six Month Follow-up|Withdrawal by Subject|1
5454114|NCT02116621|18848075|P1|Six Month Follow-up|Withdrawal by Subject|1
5454115|NCT02116621|18848074|P2|Three Month Follow-up|Did not complete follow-up survey|4
5454116|NCT02116621|18848075|P1|Three Month Follow-up|Did not complete follow-up survey|14
5454117|NCT02116621|18848074|P2|Three Month Follow-up|Lost to Follow-up|1
5454118|NCT02116621|18848075|P1|Three Month Follow-up|Lost to Follow-up|0
5454119|NCT02116621|18848074|P2|Three Month Follow-up|Withdrawal by Subject|1
5454120|NCT02116621|18848075|P1|Three Month Follow-up|Withdrawal by Subject|4
5454121|NCT02116621|18848074|P2|Three Month Follow-up|Death|1
5454122|NCT02116621|18848075|P1|Three Month Follow-up|Death|1
5454123|NCT02116621|18848074|P2|Baseline|Withdrawal by Subject|4
5454124|NCT02116621|18848075|P1|Baseline|Withdrawal by Subject|0
5454125|NCT02116582|18848163|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
5454126|NCT02116582|18848163|P1|Overall Study|Lost to Follow-up|1
5454127|NCT02116582|18848163|P1|Overall Study|Other: Miscellaneous|11
5454128|NCT02116582|18848163|P1|Overall Study|Withdrawal by Subject|8
5454129|NCT02116582|18848163|P1|Overall Study|Protocol Violation|3
5454130|NCT02116582|18848163|P1|Overall Study|Progressive Disease|148
5454131|NCT02116582|18848163|P1|Overall Study|Death|9
5454132|NCT02116582|18848163|P1|Overall Study|Adverse Event|22
5454133|NCT02116582|18848163|P1|Overall Study|Enrolled but Never Received Study Drug|1
5454134|NCT02116530|18848173|P2|Overall Study|Other Medical Problems|2
5454135|NCT02116530|18848174|P1|Overall Study|Other Medical Problems|2
5454136|NCT02116530|18848173|P2|Overall Study|Lost to Follow-up|0
5454137|NCT02116530|18848174|P1|Overall Study|Lost to Follow-up|1
5454138|NCT02116530|18848173|P2|Overall Study|Physician Decision|0
5454139|NCT02116530|18848174|P1|Overall Study|Physician Decision|1
5454140|NCT02116530|18848173|P2|Overall Study|Adverse Event|0
5454141|NCT02116530|18848174|P1|Overall Study|Adverse Event|4
5454142|NCT02116530|18848173|P2|Overall Study|Withdrawal by Subject|2
5454143|NCT02116530|18848174|P1|Overall Study|Withdrawal by Subject|1
5454144|NCT02116361|18848192|P4|Overall Study|Investigator Decision - Relapse|5
5454145|NCT02116361|18848193|P3|Overall Study|Investigator Decision - Relapse|8
5454146|NCT02116361|18848194|P2|Overall Study|Investigator Decision - Relapse|7
5454147|NCT02116361|18848195|P1|Overall Study|Investigator Decision - Relapse|9
5454148|NCT02116361|18848192|P4|Overall Study|Personal Reasons|9
5454149|NCT02116361|18848193|P3|Overall Study|Personal Reasons|4
5454150|NCT02116361|18848194|P2|Overall Study|Personal Reasons|6
5454151|NCT02116361|18848195|P1|Overall Study|Personal Reasons|6
5454152|NCT02116361|18848192|P4|Overall Study|Lost to Follow-up|5
5454153|NCT02116361|18848193|P3|Overall Study|Lost to Follow-up|7
5454154|NCT02116361|18848194|P2|Overall Study|Lost to Follow-up|5
5454155|NCT02116361|18848195|P1|Overall Study|Lost to Follow-up|4
5454156|NCT02116361|18848192|P4|Overall Study|Lack of Efficacy|3
5454157|NCT02116361|18848193|P3|Overall Study|Lack of Efficacy|4
5454158|NCT02116361|18848194|P2|Overall Study|Lack of Efficacy|7
5454159|NCT02116361|18848195|P1|Overall Study|Lack of Efficacy|5
5454160|NCT02116361|18848192|P4|Overall Study|Other Reasons|3
5454161|NCT02116361|18848193|P3|Overall Study|Other Reasons|3
5454162|NCT02116361|18848194|P2|Overall Study|Other Reasons|3
5454163|NCT02116361|18848195|P1|Overall Study|Other Reasons|3
5454164|NCT02116361|18848192|P4|Overall Study|Adverse Event|3
5454165|NCT02116361|18848193|P3|Overall Study|Adverse Event|0
5454166|NCT02116361|18848194|P2|Overall Study|Adverse Event|0
5454167|NCT02116361|18848195|P1|Overall Study|Adverse Event|1
5454168|NCT02116361|18848192|P4|Overall Study|Physician Decision|0
5454169|NCT02116361|18848193|P3|Overall Study|Physician Decision|0
5454170|NCT02116361|18848194|P2|Overall Study|Physician Decision|3
5454171|NCT02116361|18848195|P1|Overall Study|Physician Decision|2
5454172|NCT02116361|18848192|P4|Overall Study|Protocol Violation|2
5454173|NCT02116361|18848193|P3|Overall Study|Protocol Violation|0
5454174|NCT02116361|18848194|P2|Overall Study|Protocol Violation|0
5454175|NCT02116361|18848195|P1|Overall Study|Protocol Violation|1
5454176|NCT02116361|18848192|P4|Overall Study|Pregnancy|1
5454177|NCT02116361|18848193|P3|Overall Study|Pregnancy|0
5454178|NCT02116361|18848194|P2|Overall Study|Pregnancy|0
5454179|NCT02116361|18848195|P1|Overall Study|Pregnancy|0
5454180|NCT02116309|18848232|P2|Overall Study|Lost to Follow-up|1
5454181|NCT02116309|18848233|P1|Overall Study|Lost to Follow-up|0
5454182|NCT02116205|18848245|P4|Overall Study|Exclusion criteria|0
5454183|NCT02116205|18848246|P3|Overall Study|Exclusion criteria|1
5454184|NCT02116205|18848247|P2|Overall Study|Exclusion criteria|0
5454185|NCT02116205|18848248|P1|Overall Study|Exclusion criteria|0
5454186|NCT02116205|18848245|P4|Overall Study|Physician Decision|1
5454187|NCT02116205|18848246|P3|Overall Study|Physician Decision|1
5454188|NCT02116205|18848247|P2|Overall Study|Physician Decision|1
5454189|NCT02116205|18848248|P1|Overall Study|Physician Decision|0
5454190|NCT02116205|18848245|P4|Overall Study|Lost to Follow-up|2
5454191|NCT02116205|18848246|P3|Overall Study|Lost to Follow-up|1
5454192|NCT02116205|18848247|P2|Overall Study|Lost to Follow-up|2
5454193|NCT02116205|18848248|P1|Overall Study|Lost to Follow-up|0
5454194|NCT02116205|18848245|P4|Overall Study|Withdrawal by Subject|3
5454195|NCT02116205|18848246|P3|Overall Study|Withdrawal by Subject|1
5454196|NCT02116205|18848247|P2|Overall Study|Withdrawal by Subject|4
5454197|NCT02116205|18848248|P1|Overall Study|Withdrawal by Subject|2
5454198|NCT02115815|18848290|P7|Overall Study|Missed appointment, randomized in error|0
5454199|NCT02115815|18848291|P6|Overall Study|Missed appointment, randomized in error|1
5454200|NCT02115815|18848292|P5|Overall Study|Missed appointment, randomized in error|0
5454201|NCT02115815|18848293|P4|Overall Study|Missed appointment, randomized in error|0
5454202|NCT02115815|18848294|P3|Overall Study|Missed appointment, randomized in error|0
5454203|NCT02115815|18848295|P2|Overall Study|Missed appointment, randomized in error|0
5454204|NCT02115815|18848296|P1|Overall Study|Missed appointment, randomized in error|0
5454205|NCT02115815|18848290|P7|Overall Study|Not enough drug to dose participant|0
5454206|NCT02115815|18848291|P6|Overall Study|Not enough drug to dose participant|1
5454207|NCT02115815|18848292|P5|Overall Study|Not enough drug to dose participant|0
5454208|NCT02115815|18848293|P4|Overall Study|Not enough drug to dose participant|0
5454209|NCT02115815|18848294|P3|Overall Study|Not enough drug to dose participant|0
5454210|NCT02115815|18848295|P2|Overall Study|Not enough drug to dose participant|0
5454211|NCT02115815|18848296|P1|Overall Study|Not enough drug to dose participant|0
5454212|NCT02115815|18848290|P7|Overall Study|Withdrawal by Subject|0
5454213|NCT02115815|18848291|P6|Overall Study|Withdrawal by Subject|0
5454214|NCT02115815|18848292|P5|Overall Study|Withdrawal by Subject|0
5454215|NCT02115815|18848293|P4|Overall Study|Withdrawal by Subject|0
5454216|NCT02115815|18848294|P3|Overall Study|Withdrawal by Subject|0
5454217|NCT02115815|18848295|P2|Overall Study|Withdrawal by Subject|0
5454218|NCT02115815|18848296|P1|Overall Study|Withdrawal by Subject|2
5454219|NCT02115607|18848438|P1|Overall Study|Withdrawal by Subject|1
5454220|NCT02115386|18848464|P1|Overall Study|Administrative - trial was terminated|6
5454221|NCT02115386|18848464|P1|Overall Study|Protocol Violation|1
5454222|NCT02115321|18848567|P2|Overall Study|Death|0
5454223|NCT02115321|18848568|P1|Overall Study|Death|1
5454224|NCT02115308|18848590|P2|Overall Study|Safety Screening|2
5454225|NCT02115308|18848591|P1|Overall Study|Safety Screening|2
5454226|NCT02115269|18848607|P1|Overall Study|Didn't take study drug|2
5454227|NCT02115269|18848607|P1|Overall Study|Withdrawal by Subject|2
5454228|NCT02115269|18848607|P1|Overall Study|Moved to another city|7
5454229|NCT02115269|18848607|P1|Overall Study|Did not complete patient diary|3
5454230|NCT02115269|18848607|P1|Overall Study|Lost to Follow-up|43
5454231|NCT02115256|18848627|P2|Overall Study|Withdrawal by Subject|1
5454232|NCT02115256|18848628|P1|Overall Study|Withdrawal by Subject|0
5454233|NCT02115113|18848640|P3|Participants Randomized|Death|0
5454234|NCT02115113|18848641|P2|Participants Randomized|Death|0
5454235|NCT02115113|18848642|P1|Participants Randomized|Death|1
5454236|NCT02115113|18848640|P3|Participants Randomized|Lost to Follow-up|0
5454237|NCT02115113|18848641|P2|Participants Randomized|Lost to Follow-up|0
5454238|NCT02115113|18848642|P1|Participants Randomized|Lost to Follow-up|1
5454239|NCT02115113|18848640|P3|Participants in Run-in Period|Withdrawal by Subject|3
5454240|NCT02115113|18848641|P2|Participants in Run-in Period|Withdrawal by Subject|0
5454241|NCT02115113|18848642|P1|Participants in Run-in Period|Withdrawal by Subject|0
5454242|NCT02115113|18848640|P3|Participants in Run-in Period|Lost to Follow-up|5
5454243|NCT02115113|18848641|P2|Participants in Run-in Period|Lost to Follow-up|0
5454244|NCT02115113|18848642|P1|Participants in Run-in Period|Lost to Follow-up|0
5454245|NCT02115113|18848640|P3|Participants in Run-in Period|Administrative problems|1
5454246|NCT02115113|18848641|P2|Participants in Run-in Period|Administrative problems|0
5454247|NCT02115113|18848642|P1|Participants in Run-in Period|Administrative problems|0
5454248|NCT02115113|18848640|P3|Participants in Run-in Period|Death|1
5454249|NCT02115113|18848641|P2|Participants in Run-in Period|Death|0
5454250|NCT02115113|18848642|P1|Participants in Run-in Period|Death|0
5454251|NCT02114931|18848674|P2|Overall Study|Other|1
5454252|NCT02114931|18848675|P1|Overall Study|Other|2
5454253|NCT02114931|18848674|P2|Overall Study|Physician Decision|2
5454254|NCT02114931|18848675|P1|Overall Study|Physician Decision|1
5454255|NCT02114931|18848674|P2|Overall Study|Lost to Follow-up|3
5454256|NCT02114931|18848675|P1|Overall Study|Lost to Follow-up|3
5454257|NCT02114931|18848674|P2|Overall Study|Adverse Event|6
5454258|NCT02114931|18848675|P1|Overall Study|Adverse Event|4
5454259|NCT02114931|18848674|P2|Overall Study|Withdrawal by Subject|18
5454260|NCT02114931|18848675|P1|Overall Study|Withdrawal by Subject|15
5454261|NCT02114892|18848691|P2|Overall Study|Lost to Follow-up|2
5454262|NCT02114892|18848692|P1|Overall Study|Lost to Follow-up|1
5454263|NCT02114879|18848728|P2|Overall Study|Physician Decision|2
5454264|NCT02114879|18848729|P1|Overall Study|Physician Decision|0
5454265|NCT02114879|18848728|P2|Overall Study|Lost to Follow-up|6
5454266|NCT02114879|18848729|P1|Overall Study|Lost to Follow-up|4
5454267|NCT02114879|18848728|P2|Overall Study|Death|11
5454268|NCT02114879|18848729|P1|Overall Study|Death|6
5454269|NCT02114879|18848728|P2|Overall Study|Withdrawal by Subject|5
5454270|NCT02114879|18848729|P1|Overall Study|Withdrawal by Subject|9
5454271|NCT02114697|18848747|P2|Overall Study|Study terminated|4
5454272|NCT02114697|18848748|P1|Overall Study|Study terminated|5
5454273|NCT02114684|18848756|P2|Overall Study|Patient Incarcerated|0
5454274|NCT02114684|18848757|P1|Overall Study|Patient Incarcerated|1
5454275|NCT02114684|18848756|P2|Overall Study|Rifampicin resistant on culture|1
5454276|NCT02114684|18848757|P1|Overall Study|Rifampicin resistant on culture|0
5454277|NCT02114684|18848756|P2|Overall Study|Relocation|1
5454278|NCT02114684|18848757|P1|Overall Study|Relocation|3
5454279|NCT02114684|18848756|P2|Overall Study|Withdrawal by Subject|2
5454280|NCT02114684|18848757|P1|Overall Study|Withdrawal by Subject|1
5454281|NCT02114684|18848756|P2|Overall Study|Lost to Follow-up|2
5454282|NCT02114684|18848757|P1|Overall Study|Lost to Follow-up|1
5454283|NCT02114684|18848756|P2|Overall Study|Death|4
5454284|NCT02114684|18848757|P1|Overall Study|Death|6
5454285|NCT02114515|18848775|P2|Overall Study|Other|61
5454286|NCT02114515|18848776|P1|Overall Study|Other|65
5454287|NCT02114515|18848775|P2|Overall Study|Withdrawal by Subject|22
5454288|NCT02114515|18848776|P1|Overall Study|Withdrawal by Subject|4
5454289|NCT02114515|18848775|P2|Overall Study|Death|12
5454290|NCT02114515|18848776|P1|Overall Study|Death|12
5454291|NCT02114515|18848775|P2|Overall Study|Lost to Follow-up|55
5454292|NCT02114515|18848776|P1|Overall Study|Lost to Follow-up|52
5454293|NCT02114385|18848822|P2|Overall Study|Lost to Follow-up|6
5454294|NCT02114385|18848823|P1|Overall Study|Lost to Follow-up|0
5454295|NCT02114385|18848822|P2|Overall Study|Withdrawal by Subject|2
5454296|NCT02114385|18848823|P1|Overall Study|Withdrawal by Subject|3
5454297|NCT02114268|18848864|P6|Overall Study|Withdrawn by site due to noncompliance|0
5454298|NCT02114268|18848865|P5|Overall Study|Withdrawn by site due to noncompliance|0
5454299|NCT02114268|18848866|P4|Overall Study|Withdrawn by site due to noncompliance|0
5454300|NCT02114268|18848867|P3|Overall Study|Withdrawn by site due to noncompliance|0
5454301|NCT02114268|18848868|P2|Overall Study|Withdrawn by site due to noncompliance|0
5454302|NCT02114268|18848869|P1|Overall Study|Withdrawn by site due to noncompliance|1
5454303|NCT02114268|18848864|P6|Overall Study|Withdrawal by Subject|1
5454304|NCT02114268|18848865|P5|Overall Study|Withdrawal by Subject|0
5454305|NCT02114268|18848866|P4|Overall Study|Withdrawal by Subject|0
5454306|NCT02114268|18848867|P3|Overall Study|Withdrawal by Subject|0
5454307|NCT02114268|18848868|P2|Overall Study|Withdrawal by Subject|0
5454308|NCT02114268|18848869|P1|Overall Study|Withdrawal by Subject|1
5454309|NCT02114268|18848864|P6|Overall Study|Lost to Follow-up|2
5454310|NCT02114268|18848865|P5|Overall Study|Lost to Follow-up|0
5454311|NCT02114268|18848866|P4|Overall Study|Lost to Follow-up|0
5454312|NCT02114268|18848867|P3|Overall Study|Lost to Follow-up|1
5454313|NCT02114268|18848868|P2|Overall Study|Lost to Follow-up|1
5454314|NCT02114268|18848869|P1|Overall Study|Lost to Follow-up|4
5454315|NCT02114203|18848938|P3|Overall Study|Withdrawal by Subject|0
5454316|NCT02114203|18848939|P2|Overall Study|Withdrawal by Subject|1
5454317|NCT02114203|18848940|P1|Overall Study|Withdrawal by Subject|0
5454318|NCT02114203|18848938|P3|Overall Study|Adverse Event|0
5454319|NCT02114203|18848939|P2|Overall Study|Adverse Event|1
5454320|NCT02114203|18848940|P1|Overall Study|Adverse Event|0
5454321|NCT02114177|18848974|P2|Overall Study|Other|1
5454322|NCT02114177|18848975|P1|Overall Study|Other|2
5454323|NCT02114177|18848974|P2|Overall Study|Withdrawal by Subject|1
5454324|NCT02114177|18848975|P1|Overall Study|Withdrawal by Subject|6
5454325|NCT02114177|18848974|P2|Overall Study|Lost to Follow-up|2
5454326|NCT02114177|18848975|P1|Overall Study|Lost to Follow-up|1
5454327|NCT02114151|18848999|P1|Overall Study|Withdrawal by Subject|5
5454328|NCT02114151|18848999|P1|Overall Study|Lost to Follow-up|1
5454329|NCT02114151|18848999|P1|Overall Study|Death|1
5454330|NCT02113956|18849016|P2|3 Month Post-intervention|Lost to Follow-up|2
5454331|NCT02113956|18849017|P1|3 Month Post-intervention|Lost to Follow-up|4
5454332|NCT02113956|18849016|P2|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
5454333|NCT02113956|18849017|P1|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
5454334|NCT02113956|18849016|P2|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
5454335|NCT02113956|18849017|P1|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
5454336|NCT02113579|18849051|P2|Overall Study|Lost to Follow-up|2
5454337|NCT02113579|18849052|P1|Overall Study|Lost to Follow-up|6
5454338|NCT02113579|18849051|P2|Overall Study|Withdrawal by Subject|2
5454339|NCT02113579|18849052|P1|Overall Study|Withdrawal by Subject|3
5454340|NCT02113579|18849051|P2|Overall Study|Adverse Event|0
5454341|NCT02113579|18849052|P1|Overall Study|Adverse Event|1
5454342|NCT02113449|18849076|P1|Overall Study|Adverse Event|4
5454343|NCT02113436|18849092|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
5454344|NCT02113436|18849093|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
5454345|NCT02113436|18849094|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
5454346|NCT02113436|18849095|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
5454347|NCT02113436|18849092|P4|Period 2: 16 Weeks|Physician Decision|0
5454348|NCT02113436|18849093|P3|Period 2: 16 Weeks|Physician Decision|2
5454349|NCT02113436|18849094|P2|Period 2: 16 Weeks|Physician Decision|0
5454350|NCT02113436|18849095|P1|Period 2: 16 Weeks|Physician Decision|0
5454351|NCT02113436|18849092|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
5454352|NCT02113436|18849093|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
5454353|NCT02113436|18849094|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
5454354|NCT02113436|18849095|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
5454355|NCT02113436|18849092|P4|Period 2: 16 Weeks|Adverse Event|5
5454356|NCT02113436|18849093|P3|Period 2: 16 Weeks|Adverse Event|4
5454357|NCT02113436|18849094|P2|Period 2: 16 Weeks|Adverse Event|0
5454358|NCT02113436|18849095|P1|Period 2: 16 Weeks|Adverse Event|0
5454359|NCT02113436|18849092|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
5454360|NCT02113436|18849093|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
5454361|NCT02113436|18849094|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
5454362|NCT02113436|18849095|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
5454363|NCT02113436|18849092|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
5454364|NCT02113436|18849093|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
5454365|NCT02113436|18849094|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
5454366|NCT02113436|18849095|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
5454367|NCT02113436|18849092|P4|Period 1: 8 Weeks|Protocol Violation|0
5454368|NCT02113436|18849093|P3|Period 1: 8 Weeks|Protocol Violation|0
5454369|NCT02113436|18849094|P2|Period 1: 8 Weeks|Protocol Violation|0
5454370|NCT02113436|18849095|P1|Period 1: 8 Weeks|Protocol Violation|1
5454371|NCT02113436|18849092|P4|Period 1: 8 Weeks|Adverse Event|0
5454372|NCT02113436|18849093|P3|Period 1: 8 Weeks|Adverse Event|0
5454373|NCT02113436|18849094|P2|Period 1: 8 Weeks|Adverse Event|0
5454374|NCT02113436|18849095|P1|Period 1: 8 Weeks|Adverse Event|1
5454375|NCT02113189|18849201|P3|Overall Study|Lost to follow up|3
5454376|NCT02113189|18849202|P2|Overall Study|Lost to follow up|1
5454377|NCT02113189|18849203|P1|Overall Study|Lost to follow up|2
5454378|NCT02113124|18849219|P2|Overall Study|Unable to retrieve blood sample|1
5454379|NCT02113124|18849220|P1|Overall Study|Unable to retrieve blood sample|1
5454380|NCT02113007|18849226|P1|Overall Study|Progressive disease|2
5454381|NCT02112994|18849232|P3|Overall Study|Withdrawal by Subject|1
5454382|NCT02112994|18849233|P2|Overall Study|Withdrawal by Subject|0
5454383|NCT02112994|18849234|P1|Overall Study|Withdrawal by Subject|0
5454384|NCT02112994|18849232|P3|Overall Study|Liver Transplant|0
5454385|NCT02112994|18849233|P2|Overall Study|Liver Transplant|1
5454386|NCT02112994|18849234|P1|Overall Study|Liver Transplant|0
5454387|NCT02112994|18849232|P3|Overall Study|Pregnancy|1
5454388|NCT02112994|18849233|P2|Overall Study|Pregnancy|1
5454389|NCT02112994|18849234|P1|Overall Study|Pregnancy|0
5454390|NCT02112994|18849232|P3|Overall Study|Progressive Disease|1
5454391|NCT02112994|18849233|P2|Overall Study|Progressive Disease|0
5454392|NCT02112994|18849234|P1|Overall Study|Progressive Disease|0
5454393|NCT02112877|18849252|P2|Overall Study|Visit Missed|6
5454394|NCT02112877|18849253|P1|Overall Study|Visit Missed|1
5454395|NCT02112877|18849252|P2|Overall Study|Withdrawal by Subject|7
5454396|NCT02112877|18849253|P1|Overall Study|Withdrawal by Subject|1
5454397|NCT02112448|18849341|P2|Overall Study|required heparin so could not use ketoro|0
5454398|NCT02112448|18849342|P1|Overall Study|required heparin so could not use ketoro|1
5454399|NCT02112448|18849341|P2|Overall Study|Physician Decision|6
5454400|NCT02112448|18849342|P1|Overall Study|Physician Decision|4
5454401|NCT02112448|18849341|P2|Overall Study|Protocol Violation|2
5454402|NCT02112448|18849342|P1|Overall Study|Protocol Violation|1
5454403|NCT02112448|18849341|P2|Overall Study|lab values precluding use of ketorolac|2
5454404|NCT02112448|18849342|P1|Overall Study|lab values precluding use of ketorolac|2
5454405|NCT02112045|18849375|P2|Overall Study|Withdrawal by Subject|0
5454406|NCT02112045|18849376|P1|Overall Study|Withdrawal by Subject|1
5454407|NCT02111993|18849396|P2|Overall Study|Physician Decision|4
5454408|NCT02111993|18849397|P1|Overall Study|Physician Decision|5
5454409|NCT02111811|18849438|P2|Follow up Period (Aim 2)|Death|0
5454410|NCT02111811|18849439|P1|Follow up Period (Aim 2)|Death|2
5454411|NCT02111811|18849438|P2|Follow up Period (Aim 2)|Lost to Follow-up|17
5454412|NCT02111811|18849439|P1|Follow up Period (Aim 2)|Lost to Follow-up|26
5454413|NCT02111811|18849438|P2|Treatment Phase|Death|0
5454414|NCT02111811|18849439|P1|Treatment Phase|Death|2
5454415|NCT02111811|18849438|P2|Treatment Phase|Lost to Follow-up|18
5454416|NCT02111811|18849439|P1|Treatment Phase|Lost to Follow-up|22
5454417|NCT02111785|18849452|P4|Overall Study|Death|0
5454418|NCT02111785|18849453|P3|Overall Study|Death|0
5454419|NCT02111785|18849454|P2|Overall Study|Death|1
5454420|NCT02111785|18849455|P1|Overall Study|Death|0
5454421|NCT02111603|18849517|P1|Overall Study|Withdrawal by Subject|1
5454422|NCT02111564|18849528|P2|Overall Study|Withdrawal by Subject|20
5454423|NCT02111564|18849529|P1|Overall Study|Withdrawal by Subject|20
5454424|NCT02111564|18849528|P2|Overall Study|Lost to Follow-up|3
5454425|NCT02111564|18849529|P1|Overall Study|Lost to Follow-up|2
5454426|NCT02111564|18849528|P2|Overall Study|Death|120
5454427|NCT02111564|18849529|P1|Overall Study|Death|109
5454428|NCT02111369|18849568|P1|Overall Study|Withdrawal by Subject|1
5454429|NCT02111369|18849568|P1|Overall Study|Lost to Follow-up|2
5454430|NCT02111213|18849592|P2|Overall Study|Lost to Follow-up|4
5454431|NCT02111213|18849593|P1|Overall Study|Lost to Follow-up|3
5454432|NCT02111213|18849592|P2|Overall Study|Withdrawal by Subject|2
5454433|NCT02111213|18849593|P1|Overall Study|Withdrawal by Subject|3
5454434|NCT02111174|18849641|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
5454435|NCT02111174|18849642|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
5454436|NCT02111174|18849641|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
5454437|NCT02111174|18849642|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
5454438|NCT02111174|18849641|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
5454439|NCT02111174|18849642|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
5454440|NCT02111174|18849641|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
5454441|NCT02111174|18849642|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
5454442|NCT02111096|18849671|P3|Overall Study|Withdrawal by Subject|8
5454443|NCT02111096|18849672|P2|Overall Study|Withdrawal by Subject|2
5454444|NCT02111096|18849673|P1|Overall Study|Withdrawal by Subject|4
5454445|NCT02111096|18849671|P3|Overall Study|Terminated by Sponsor|54
5454446|NCT02111096|18849672|P2|Overall Study|Terminated by Sponsor|35
5454447|NCT02111096|18849673|P1|Overall Study|Terminated by Sponsor|53
5454448|NCT02111096|18849671|P3|Overall Study|Protocol Violation|1
5454449|NCT02111096|18849672|P2|Overall Study|Protocol Violation|0
5454450|NCT02111096|18849673|P1|Overall Study|Protocol Violation|1
5454451|NCT02111096|18849671|P3|Overall Study|Physician Decision|0
5454452|NCT02111096|18849672|P2|Overall Study|Physician Decision|1
5454453|NCT02111096|18849673|P1|Overall Study|Physician Decision|0
5454454|NCT02111096|18849671|P3|Overall Study|Lost to Follow Up|1
5454455|NCT02111096|18849672|P2|Overall Study|Lost to Follow Up|1
5454456|NCT02111096|18849673|P1|Overall Study|Lost to Follow Up|1
5454457|NCT02111096|18849671|P3|Overall Study|Non-Compliance with Study Drug|0
5454458|NCT02111096|18849672|P2|Overall Study|Non-Compliance with Study Drug|1
5454459|NCT02111096|18849673|P1|Overall Study|Non-Compliance with Study Drug|1
5454460|NCT02111096|18849671|P3|Overall Study|Adverse Event|2
5454461|NCT02111096|18849672|P2|Overall Study|Adverse Event|1
5454462|NCT02111096|18849673|P1|Overall Study|Adverse Event|4
5454463|NCT02111083|18849721|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
5454464|NCT02111083|18849722|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
5454465|NCT02110901|18849742|P2|Overall Study|received a kidney transplant|0
5454466|NCT02110901|18849743|P1|Overall Study|received a kidney transplant|5
5454467|NCT02110901|18849742|P2|Overall Study|Withdrawal by Subject|3
5454468|NCT02110901|18849743|P1|Overall Study|Withdrawal by Subject|7
5454469|NCT02110901|18849742|P2|Overall Study|Lost to Follow-up|8
5454470|NCT02110901|18849743|P1|Overall Study|Lost to Follow-up|12
5454471|NCT02110901|18849742|P2|Overall Study|Death|3
5454472|NCT02110901|18849743|P1|Overall Study|Death|6
5454473|NCT02110706|18849757|P2|Overall Study|Patients who didn't receive 2nd infusion|1
5454474|NCT02110706|18849758|P1|Overall Study|Patients who didn't receive 2nd infusion|3
5454475|NCT02110706|18849757|P2|Overall Study|Adverse Event|3
5454476|NCT02110706|18849758|P1|Overall Study|Adverse Event|2
5454477|NCT02110693|18849770|P2|Overall Study|Other|0
5454478|NCT02110693|18849771|P1|Overall Study|Other|1
5454479|NCT02110693|18849770|P2|Overall Study|technical difficulties|4
5454480|NCT02110693|18849771|P1|Overall Study|technical difficulties|6
5454481|NCT02110693|18849770|P2|Overall Study|skipped assessment|18
5454482|NCT02110693|18849771|P1|Overall Study|skipped assessment|15
5454483|NCT02110693|18849770|P2|Overall Study|Withdrawal by Subject|7
5454484|NCT02110693|18849771|P1|Overall Study|Withdrawal by Subject|6
5454485|NCT02110238|18849852|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
5454486|NCT02110238|18849853|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
5454487|NCT02110238|18849852|P2|14 Week Blinded Extension Phase|Protocol Violation|3
5454488|NCT02110238|18849853|P1|14 Week Blinded Extension Phase|Protocol Violation|2
5454489|NCT02110238|18849852|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
5454490|NCT02110238|18849853|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
5454491|NCT02110238|18849852|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
5454492|NCT02110238|18849853|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
5454493|NCT02110238|18849852|P2|14 Week Blinded Extension Phase|Adverse Event|1
5454494|NCT02110238|18849853|P1|14 Week Blinded Extension Phase|Adverse Event|1
5454495|NCT02110238|18849852|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
5454496|NCT02110238|18849853|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
5454497|NCT02110238|18849852|P2|12 Week Pivotal Phase|Protocol Violation|1
5454498|NCT02110238|18849853|P1|12 Week Pivotal Phase|Protocol Violation|0
5454499|NCT02110238|18849852|P2|12 Week Pivotal Phase|Physician Decision|2
5454500|NCT02110238|18849853|P1|12 Week Pivotal Phase|Physician Decision|0
5454501|NCT02110238|18849852|P2|12 Week Pivotal Phase|Lost to Follow-up|0
5454502|NCT02110238|18849853|P1|12 Week Pivotal Phase|Lost to Follow-up|2
5454503|NCT02110238|18849852|P2|12 Week Pivotal Phase|Lack of Efficacy|3
5454504|NCT02110238|18849853|P1|12 Week Pivotal Phase|Lack of Efficacy|2
5454505|NCT02110238|18849852|P2|12 Week Pivotal Phase|Adverse Event|0
5454506|NCT02110238|18849853|P1|12 Week Pivotal Phase|Adverse Event|3
5454507|NCT02110225|18849862|P3|Overall Study|Lost to Follow-up|0
5454508|NCT02110225|18849863|P2|Overall Study|Lost to Follow-up|1
5454509|NCT02110225|18849864|P1|Overall Study|Lost to Follow-up|0
5454510|NCT02109562|18849979|P3|Overall Study|Physician Decision|5
5454511|NCT02109562|18849980|P2|Overall Study|Physician Decision|4
5454512|NCT02109562|18849981|P1|Overall Study|Physician Decision|3
5454513|NCT02109562|18849979|P3|Overall Study|Withdrawal by Subject|21
5454514|NCT02109562|18849980|P2|Overall Study|Withdrawal by Subject|25
5454515|NCT02109562|18849981|P1|Overall Study|Withdrawal by Subject|20
5454516|NCT02109562|18849979|P3|Overall Study|Protocol Violation|1
5454517|NCT02109562|18849980|P2|Overall Study|Protocol Violation|3
5454518|NCT02109562|18849981|P1|Overall Study|Protocol Violation|0
5454519|NCT02109562|18849979|P3|Overall Study|Lost to Follow-up|1
5454520|NCT02109562|18849980|P2|Overall Study|Lost to Follow-up|0
5454521|NCT02109562|18849981|P1|Overall Study|Lost to Follow-up|1
5454522|NCT02109562|18849979|P3|Overall Study|Adverse Event|3
5454523|NCT02109562|18849980|P2|Overall Study|Adverse Event|2
5454524|NCT02109562|18849981|P1|Overall Study|Adverse Event|0
5454525|NCT02109562|18849979|P3|Overall Study|Insufficient clinical response|4
5454526|NCT02109562|18849980|P2|Overall Study|Insufficient clinical response|0
5454527|NCT02109562|18849981|P1|Overall Study|Insufficient clinical response|2
5454528|NCT02109484|18850008|P8|Overall Study|Moved away from study area|1
5454529|NCT02109484|18850009|P7|Overall Study|Moved away from study area|1
5454530|NCT02109484|18850010|P6|Overall Study|Moved away from study area|0
5454531|NCT02109484|18850011|P5|Overall Study|Moved away from study area|0
5454532|NCT02109484|18850012|P4|Overall Study|Moved away from study area|0
5454533|NCT02109484|18850013|P3|Overall Study|Moved away from study area|0
5454534|NCT02109484|18850014|P2|Overall Study|Moved away from study area|0
5454535|NCT02109484|18850015|P1|Overall Study|Moved away from study area|0
5454536|NCT02109484|18850008|P8|Overall Study|Death|2
5454537|NCT02109484|18850009|P7|Overall Study|Death|0
5454538|NCT02109484|18850010|P6|Overall Study|Death|0
5454539|NCT02109484|18850011|P5|Overall Study|Death|0
5454540|NCT02109484|18850012|P4|Overall Study|Death|0
5454541|NCT02109484|18850013|P3|Overall Study|Death|0
5454542|NCT02109484|18850014|P2|Overall Study|Death|0
5454543|NCT02109484|18850015|P1|Overall Study|Death|0
5454544|NCT02109484|18850008|P8|Overall Study|Physician Decision|0
5454545|NCT02109484|18850009|P7|Overall Study|Physician Decision|0
5454546|NCT02109484|18850010|P6|Overall Study|Physician Decision|0
5454547|NCT02109484|18850011|P5|Overall Study|Physician Decision|2
5454548|NCT02109484|18850012|P4|Overall Study|Physician Decision|0
5454549|NCT02109484|18850013|P3|Overall Study|Physician Decision|0
5454550|NCT02109484|18850014|P2|Overall Study|Physician Decision|0
5454551|NCT02109484|18850015|P1|Overall Study|Physician Decision|0
5454552|NCT02109484|18850008|P8|Overall Study|Withdrawal by Subject|0
5454553|NCT02109484|18850009|P7|Overall Study|Withdrawal by Subject|1
5454554|NCT02109484|18850010|P6|Overall Study|Withdrawal by Subject|1
5454555|NCT02109484|18850011|P5|Overall Study|Withdrawal by Subject|1
5454556|NCT02109484|18850012|P4|Overall Study|Withdrawal by Subject|0
5454557|NCT02109484|18850013|P3|Overall Study|Withdrawal by Subject|0
5454558|NCT02109484|18850014|P2|Overall Study|Withdrawal by Subject|0
5454559|NCT02109484|18850015|P1|Overall Study|Withdrawal by Subject|0
5454560|NCT02109484|18850008|P8|Overall Study|Lost to Follow-up|0
5454561|NCT02109484|18850009|P7|Overall Study|Lost to Follow-up|1
5454562|NCT02109484|18850010|P6|Overall Study|Lost to Follow-up|0
5454563|NCT02109484|18850011|P5|Overall Study|Lost to Follow-up|1
5454564|NCT02109484|18850012|P4|Overall Study|Lost to Follow-up|1
5454565|NCT02109484|18850013|P3|Overall Study|Lost to Follow-up|0
5454566|NCT02109484|18850014|P2|Overall Study|Lost to Follow-up|0
5454567|NCT02109484|18850015|P1|Overall Study|Lost to Follow-up|0
5454568|NCT02109445|18850071|P1|Overall Study|Adverse Event|1
5454569|NCT02109445|18850071|P1|Overall Study|Symptomatic deterioration|2
5454570|NCT02109432|18850104|P1|Overall Study|Withdrawal by Subject|1
5454571|NCT02109172|18850114|P6|Overall Study|Death|0
5454572|NCT02109172|18850115|P5|Overall Study|Death|1
5454573|NCT02109172|18850116|P4|Overall Study|Death|0
5454574|NCT02109172|18850117|P3|Overall Study|Death|0
5454575|NCT02109172|18850118|P2|Overall Study|Death|0
5454576|NCT02109172|18850119|P1|Overall Study|Death|0
5454577|NCT02109172|18850114|P6|Overall Study|Adverse Event|1
5454578|NCT02109172|18850115|P5|Overall Study|Adverse Event|0
5454579|NCT02109172|18850116|P4|Overall Study|Adverse Event|0
5454580|NCT02109172|18850117|P3|Overall Study|Adverse Event|1
5454581|NCT02109172|18850118|P2|Overall Study|Adverse Event|0
5454582|NCT02109172|18850119|P1|Overall Study|Adverse Event|0
5454583|NCT02109172|18850114|P6|Overall Study|Withdrawal by Subject|0
5454584|NCT02109172|18850115|P5|Overall Study|Withdrawal by Subject|0
5454585|NCT02109172|18850116|P4|Overall Study|Withdrawal by Subject|1
5454586|NCT02109172|18850117|P3|Overall Study|Withdrawal by Subject|0
5454587|NCT02109172|18850118|P2|Overall Study|Withdrawal by Subject|0
5454588|NCT02109172|18850119|P1|Overall Study|Withdrawal by Subject|1
5454589|NCT02109133|18850140|P2|Overall Study|Lost to Follow-up|0
5454590|NCT02109133|18850141|P1|Overall Study|Lost to Follow-up|1
5454591|NCT02109107|18850153|P1|Overall Study|Lost to Follow-up|2
5454592|NCT02109042|18850160|P1|Overall Study|Sponsor Decision|15
5454593|NCT02109029|18850169|P6|Part B|Adverse Event|1
5454594|NCT02109029|18850170|P5|Part B|Adverse Event|1
5454595|NCT02109029|18850171|P4|Part B|Adverse Event|0
5454596|NCT02109029|18850172|P3|Part B|Adverse Event|0
5454597|NCT02109029|18850173|P2|Part B|Adverse Event|0
5454598|NCT02109029|18850174|P1|Part B|Adverse Event|0
5454599|NCT02108964|18850211|P8|Overall Study|Subject/Guardian decision|1
5454600|NCT02108964|18850212|P7|Overall Study|Subject/Guardian decision|1
5454601|NCT02108964|18850213|P6|Overall Study|Subject/Guardian decision|0
5454602|NCT02108964|18850214|P5|Overall Study|Subject/Guardian decision|2
5454603|NCT02108964|18850215|P4|Overall Study|Subject/Guardian decision|0
5454604|NCT02108964|18850216|P3|Overall Study|Subject/Guardian decision|3
5454605|NCT02108964|18850217|P2|Overall Study|Subject/Guardian decision|1
5454606|NCT02108964|18850218|P1|Overall Study|Subject/Guardian decision|0
5454607|NCT02108964|18850211|P8|Overall Study|Death|1
5454608|NCT02108964|18850212|P7|Overall Study|Death|0
5454609|NCT02108964|18850213|P6|Overall Study|Death|0
5454610|NCT02108964|18850214|P5|Overall Study|Death|3
5454611|NCT02108964|18850215|P4|Overall Study|Death|0
5454612|NCT02108964|18850216|P3|Overall Study|Death|2
5454613|NCT02108964|18850217|P2|Overall Study|Death|1
5454614|NCT02108964|18850218|P1|Overall Study|Death|1
5454615|NCT02108964|18850211|P8|Overall Study|Adverse Event|1
5454616|NCT02108964|18850212|P7|Overall Study|Adverse Event|3
5454617|NCT02108964|18850213|P6|Overall Study|Adverse Event|0
5454618|NCT02108964|18850214|P5|Overall Study|Adverse Event|1
5454619|NCT02108964|18850215|P4|Overall Study|Adverse Event|0
5454620|NCT02108964|18850216|P3|Overall Study|Adverse Event|4
5454621|NCT02108964|18850217|P2|Overall Study|Adverse Event|0
5454622|NCT02108964|18850218|P1|Overall Study|Adverse Event|0
5454623|NCT02108964|18850211|P8|Overall Study|Physician Decision|0
5454624|NCT02108964|18850212|P7|Overall Study|Physician Decision|0
5454625|NCT02108964|18850213|P6|Overall Study|Physician Decision|0
5454626|NCT02108964|18850214|P5|Overall Study|Physician Decision|1
5454627|NCT02108964|18850215|P4|Overall Study|Physician Decision|0
5454628|NCT02108964|18850216|P3|Overall Study|Physician Decision|6
5454629|NCT02108964|18850217|P2|Overall Study|Physician Decision|5
5454630|NCT02108964|18850218|P1|Overall Study|Physician Decision|1
5454631|NCT02108964|18850211|P8|Overall Study|Progressive disease|9
5454632|NCT02108964|18850212|P7|Overall Study|Progressive disease|7
5454633|NCT02108964|18850213|P6|Overall Study|Progressive disease|5
5454634|NCT02108964|18850214|P5|Overall Study|Progressive disease|18
5454635|NCT02108964|18850215|P4|Overall Study|Progressive disease|6
5454636|NCT02108964|18850216|P3|Overall Study|Progressive disease|50
5454637|NCT02108964|18850217|P2|Overall Study|Progressive disease|25
5454638|NCT02108964|18850218|P1|Overall Study|Progressive disease|12
5454639|NCT02108951|18850237|P1|Overall Study|Study Terminated by Sponsor|14
5454640|NCT02108951|18850237|P1|Overall Study|Patient's/guardian's decision|1
5454641|NCT02108951|18850237|P1|Overall Study|Lost to Follow-up|1
5454642|NCT02108912|18850256|P2|Overall Study|high blood pressure|0
5454643|NCT02108912|18850257|P1|Overall Study|high blood pressure|1
5454644|NCT02108912|18850256|P2|Overall Study|lack of transportation|0
5454645|NCT02108912|18850257|P1|Overall Study|lack of transportation|1
5454646|NCT02108912|18850256|P2|Overall Study|Lost to Follow-up|1
5454647|NCT02108912|18850257|P1|Overall Study|Lost to Follow-up|1
5454648|NCT02108652|18850286|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
5454649|NCT02108652|18850286|P1|Overall Study|Withdrawal by Subject|8
5454650|NCT02108652|18850286|P1|Overall Study|Lost to Follow-up|2
5454651|NCT02108652|18850286|P1|Overall Study|Death|226
5454652|NCT02107898|18850464|P2|Overall Study|Randomized but not treated|1
5454653|NCT02107898|18850465|P1|Overall Study|Randomized but not treated|0
5454654|NCT02107898|18850464|P2|Overall Study|Consent withdrawn by participant|1
5454655|NCT02107898|18850465|P1|Overall Study|Consent withdrawn by participant|2
5454656|NCT02107898|18850464|P2|Overall Study|Participant moved|2
5454657|NCT02107898|18850465|P1|Overall Study|Participant moved|0
5454658|NCT02107898|18850464|P2|Overall Study|Poor compliance to protocol|1
5454659|NCT02107898|18850465|P1|Overall Study|Poor compliance to protocol|0
5454660|NCT02107898|18850464|P2|Overall Study|Adverse Event|7
5454661|NCT02107898|18850465|P1|Overall Study|Adverse Event|4
5454662|NCT02107859|18850517|P1|Overall Study|Other than specified|3
5454663|NCT02107859|18850517|P1|Overall Study|Study closure|41
5454664|NCT02107859|18850517|P1|Overall Study|Adverse Event|3
5454665|NCT02107859|18850517|P1|Overall Study|Withdrawal by Subject|14
5454666|NCT02107703|18850533|P2|Overall Study|On study treatment/follow up|152
5454667|NCT02107703|18850534|P1|Overall Study|On study treatment/follow up|319
5454668|NCT02107703|18850533|P2|Overall Study|Lost to Follow-up|4
5454669|NCT02107703|18850534|P1|Overall Study|Lost to Follow-up|6
5454670|NCT02107703|18850533|P2|Overall Study|Withdrawal by Subject|19
5454671|NCT02107703|18850534|P1|Overall Study|Withdrawal by Subject|36
5454672|NCT02107482|18850566|P1|Overall Study|Lack of Efficacy|1
5454673|NCT02107482|18850566|P1|Overall Study|Lost to Follow-up|1
5454674|NCT02107482|18850566|P1|Overall Study|inconveinence|2
5454675|NCT02107443|18850574|P2|Overall Study|Withdrawal: Personal Issues|3
5454676|NCT02107443|18850575|P1|Overall Study|Withdrawal: Personal Issues|0
5454677|NCT02107443|18850574|P2|Overall Study|Withdrawal: Disease Progression|2
5454678|NCT02107443|18850575|P1|Overall Study|Withdrawal: Disease Progression|4
5454679|NCT02107443|18850574|P2|Overall Study|Withdrawal: Other Medical|5
5454680|NCT02107443|18850575|P1|Overall Study|Withdrawal: Other Medical|9
5454681|NCT02107443|18850574|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
5454682|NCT02107443|18850575|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
5454683|NCT02107443|18850574|P2|Overall Study|Withdrawal: Too Time Consuming|6
5454684|NCT02107443|18850575|P1|Overall Study|Withdrawal: Too Time Consuming|3
5454685|NCT02107443|18850574|P2|Overall Study|Withdrawal: Too Many Forms|1
5454686|NCT02107443|18850575|P1|Overall Study|Withdrawal: Too Many Forms|3
5454687|NCT02107443|18850574|P2|Overall Study|Withdrawal: Changed MD/Facility|3
5454688|NCT02107443|18850575|P1|Overall Study|Withdrawal: Changed MD/Facility|1
5454689|NCT02107443|18850574|P2|Overall Study|Withdrawal: Changed Mind|0
5454690|NCT02107443|18850575|P1|Overall Study|Withdrawal: Changed Mind|2
5454691|NCT02107443|18850574|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
5454692|NCT02107443|18850575|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
5454693|NCT02107443|18850574|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
5454694|NCT02107443|18850575|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
5454695|NCT02107443|18850574|P2|Overall Study|Registered but Not Eligible|1
5454696|NCT02107443|18850575|P1|Overall Study|Registered but Not Eligible|0
5454697|NCT02107443|18850574|P2|Overall Study|Study Protocol Violation|1
5454698|NCT02107443|18850575|P1|Overall Study|Study Protocol Violation|3
5454699|NCT02107443|18850574|P2|Overall Study|Death|30
5454700|NCT02107443|18850575|P1|Overall Study|Death|42
5454701|NCT02107313|18850628|P2|Overall Study|One participant did not do the FED cohor|1
5454702|NCT02107313|18850629|P1|Overall Study|One participant did not do the FED cohor|0
5454703|NCT02107274|18850650|P2|Control Phase|Adverse Event|1
5454704|NCT02107274|18850651|P1|Control Phase|Adverse Event|0
5454705|NCT02107274|18850650|P2|Control Phase|Death|0
5454706|NCT02107274|18850651|P1|Control Phase|Death|2
5454707|NCT02107274|18850650|P2|Control Phase|Lost to Follow-up|1
5454708|NCT02107274|18850651|P1|Control Phase|Lost to Follow-up|1
5454709|NCT02107274|18850650|P2|Treatment vs. Placebo|Lost to Follow-up|2
5454710|NCT02107274|18850651|P1|Treatment vs. Placebo|Lost to Follow-up|0
5454711|NCT02107274|18850650|P2|Treatment vs. Placebo|Adverse Event|0
5454712|NCT02107274|18850651|P1|Treatment vs. Placebo|Adverse Event|3
5454713|NCT02107196|18850665|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
5454714|NCT02107196|18850666|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
5454715|NCT02107196|18850665|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
5454716|NCT02107196|18850666|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
5454717|NCT02107196|18850665|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
5454718|NCT02107196|18850666|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
5454719|NCT02107196|18850665|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
5454720|NCT02107196|18850666|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
5454721|NCT02107196|18850665|P2|12-week Treatment Period|Reason Missing|8
5454722|NCT02107196|18850666|P1|12-week Treatment Period|Reason Missing|11
5454723|NCT02107196|18850665|P2|12-week Treatment Period|Protocol Violation|8
5454724|NCT02107196|18850666|P1|12-week Treatment Period|Protocol Violation|7
5454725|NCT02107196|18850665|P2|12-week Treatment Period|Withdrawal by Subject|12
5454726|NCT02107196|18850666|P1|12-week Treatment Period|Withdrawal by Subject|15
5454727|NCT02107196|18850665|P2|12-week Treatment Period|Physician Decision|1
5454728|NCT02107196|18850666|P1|12-week Treatment Period|Physician Decision|0
5454729|NCT02107196|18850665|P2|12-week Treatment Period|Lost to Follow-up|6
5454730|NCT02107196|18850666|P1|12-week Treatment Period|Lost to Follow-up|3
5454731|NCT02107196|18850665|P2|12-week Treatment Period|Lack of Efficacy|1
5454732|NCT02107196|18850666|P1|12-week Treatment Period|Lack of Efficacy|2
5454733|NCT02107196|18850665|P2|12-week Treatment Period|Adverse Event|3
5454734|NCT02107196|18850666|P1|12-week Treatment Period|Adverse Event|6
5454735|NCT02107131|18850681|P2|Overall Study|Protocol Violation|4
5454736|NCT02107131|18850682|P1|Overall Study|Protocol Violation|0
5454737|NCT02107131|18850681|P2|Overall Study|Death|1
5454738|NCT02107131|18850682|P1|Overall Study|Death|0
5454739|NCT02107131|18850681|P2|Overall Study|mental instability|0
5454740|NCT02107131|18850682|P1|Overall Study|mental instability|1
5454741|NCT02107131|18850681|P2|Overall Study|Withdrawal by Subject|0
5454742|NCT02107131|18850682|P1|Overall Study|Withdrawal by Subject|2
5454743|NCT02107131|18850681|P2|Overall Study|Physician Decision|0
5454744|NCT02107131|18850682|P1|Overall Study|Physician Decision|1
5454745|NCT02107131|18850681|P2|Overall Study|Lost to Follow-up|4
5454746|NCT02107131|18850682|P1|Overall Study|Lost to Follow-up|4
5454747|NCT02107092|18850694|P1|Overall Study|Expected progression of CKD|12
5454748|NCT02107092|18850694|P1|Overall Study|Adverse Event|7
5454749|NCT02107092|18850694|P1|Overall Study|Withdrawal by Subject|9
5454750|NCT02107092|18850694|P1|Overall Study|Lost to Follow-up|2
5454751|NCT02107092|18850694|P1|Overall Study|Physician Decision|3
5454752|NCT02107092|18850694|P1|Overall Study|Met ECG withdrawal criteria|3
5454753|NCT02107092|18850694|P1|Overall Study|Hypo-or hyperkalemia|2
5454754|NCT02107092|18850694|P1|Overall Study|Subject compliance|3
5454755|NCT02107092|18850694|P1|Overall Study|Miscellaneous|3
5454756|NCT02107014|18850699|P1|Overall Study|Withdrew before drug: moving interstate|1
5454757|NCT02106975|18850769|P2|Overall Study|Death|39
5454758|NCT02106975|18850770|P1|Overall Study|Death|25
5454759|NCT02106923|18850830|P6|Overall Study|Protocol Violation|1
5454760|NCT02106923|18850831|P5|Overall Study|Protocol Violation|0
5454761|NCT02106923|18850832|P4|Overall Study|Protocol Violation|0
5454762|NCT02106923|18850833|P3|Overall Study|Protocol Violation|0
5454763|NCT02106923|18850834|P2|Overall Study|Protocol Violation|0
5454764|NCT02106923|18850835|P1|Overall Study|Protocol Violation|0
5454765|NCT02106910|18850881|P2|Overall Study|Lost to Follow-up|1
5454766|NCT02106910|18850882|P1|Overall Study|Lost to Follow-up|1
5454767|NCT02106884|18850898|P2|Overall Study|Change of diagnosis/exclusion|1
5454768|NCT02106884|18850899|P1|Overall Study|Change of diagnosis/exclusion|0
5454769|NCT02106832|18850923|P4|Overall Study|Technical problems|0
5454770|NCT02106832|18850924|P3|Overall Study|Technical problems|0
5454771|NCT02106832|18850925|P2|Overall Study|Technical problems|1
5454772|NCT02106832|18850926|P1|Overall Study|Technical problems|0
5454773|NCT02106832|18850923|P4|Overall Study|Withdrawal by Subject|7
5454774|NCT02106832|18850924|P3|Overall Study|Withdrawal by Subject|10
5454775|NCT02106832|18850925|P2|Overall Study|Withdrawal by Subject|17
5454776|NCT02106832|18850926|P1|Overall Study|Withdrawal by Subject|17
5454777|NCT02106832|18850923|P4|Overall Study|Protocol Violation|1
5454778|NCT02106832|18850924|P3|Overall Study|Protocol Violation|0
5454779|NCT02106832|18850925|P2|Overall Study|Protocol Violation|0
5454780|NCT02106832|18850926|P1|Overall Study|Protocol Violation|0
5454781|NCT02106832|18850923|P4|Overall Study|Physician Decision|0
5454782|NCT02106832|18850924|P3|Overall Study|Physician Decision|0
5454783|NCT02106832|18850925|P2|Overall Study|Physician Decision|0
5454784|NCT02106832|18850926|P1|Overall Study|Physician Decision|1
5454785|NCT02106832|18850923|P4|Overall Study|Lost to Follow-up|3
5454786|NCT02106832|18850924|P3|Overall Study|Lost to Follow-up|1
5454787|NCT02106832|18850925|P2|Overall Study|Lost to Follow-up|1
5454788|NCT02106832|18850926|P1|Overall Study|Lost to Follow-up|0
5454789|NCT02106832|18850923|P4|Overall Study|Deterioration of general conditions|0
5454790|NCT02106832|18850924|P3|Overall Study|Deterioration of general conditions|1
5454791|NCT02106832|18850925|P2|Overall Study|Deterioration of general conditions|0
5454792|NCT02106832|18850926|P1|Overall Study|Deterioration of general conditions|0
5454793|NCT02106832|18850923|P4|Overall Study|Death|4
5454794|NCT02106832|18850924|P3|Overall Study|Death|1
5454795|NCT02106832|18850925|P2|Overall Study|Death|4
5454796|NCT02106832|18850926|P1|Overall Study|Death|4
5454797|NCT02106832|18850923|P4|Overall Study|Adverse Event|0
5454798|NCT02106832|18850924|P3|Overall Study|Adverse Event|3
5454799|NCT02106832|18850925|P2|Overall Study|Adverse Event|2
5454800|NCT02106832|18850926|P1|Overall Study|Adverse Event|1
5454801|NCT02106455|18850993|P1|Overall Study|Protocol Deviation|2
5454802|NCT02106455|18850993|P1|Overall Study|Case Report Form Uncollected|6
5454803|NCT02106442|18851007|P1|Overall Study|Protocol Deviation|30
5454804|NCT02106442|18851007|P1|Overall Study|Case Report Forms Uncollected|7
5454805|NCT02106403|18851025|P6|Follow-Up Visit 3|Other Reason|1
5454806|NCT02106403|18851026|P5|Follow-Up Visit 3|Other Reason|0
5454807|NCT02106403|18851027|P4|Follow-Up Visit 3|Other Reason|0
5454808|NCT02106403|18851028|P3|Follow-Up Visit 3|Other Reason|0
5454809|NCT02106403|18851029|P2|Follow-Up Visit 3|Other Reason|0
5454810|NCT02106403|18851030|P1|Follow-Up Visit 3|Other Reason|0
5454811|NCT02106390|18851053|P3|Overall Study|Protocol Violation|0
5454812|NCT02106390|18851054|P2|Overall Study|Protocol Violation|1
5454813|NCT02106390|18851055|P1|Overall Study|Protocol Violation|0
5454814|NCT02106390|18851053|P3|Overall Study|Adverse Event|1
5454815|NCT02106390|18851054|P2|Overall Study|Adverse Event|2
5454816|NCT02106390|18851055|P1|Overall Study|Adverse Event|0
5454817|NCT02106390|18851053|P3|Overall Study|Other: Unspecified|2
5454818|NCT02106390|18851054|P2|Overall Study|Other: Unspecified|4
5454819|NCT02106390|18851055|P1|Overall Study|Other: Unspecified|1
5454820|NCT02106390|18851053|P3|Overall Study|Other: Administrative Reason|12
5454821|NCT02106390|18851054|P2|Overall Study|Other: Administrative Reason|5
5454822|NCT02106390|18851055|P1|Overall Study|Other: Administrative Reason|8
5454823|NCT02106390|18851053|P3|Overall Study|Lost to Follow-up|13
5454824|NCT02106390|18851054|P2|Overall Study|Lost to Follow-up|20
5454825|NCT02106390|18851055|P1|Overall Study|Lost to Follow-up|25
5454826|NCT02106390|18851053|P3|Overall Study|Withdrawal by Subject|15
5454827|NCT02106390|18851054|P2|Overall Study|Withdrawal by Subject|16
5454828|NCT02106390|18851055|P1|Overall Study|Withdrawal by Subject|15
5454829|NCT02106351|18851132|P3|Treatment Cycle 4|Other|0
5454830|NCT02106351|18851133|P2|Treatment Cycle 4|Other|1
5454831|NCT02106351|18851134|P1|Treatment Cycle 4|Other|0
5454832|NCT02106351|18851132|P3|Treatment Cycle 4|Consent withdrawn|2
5454833|NCT02106351|18851133|P2|Treatment Cycle 4|Consent withdrawn|0
5454834|NCT02106351|18851134|P1|Treatment Cycle 4|Consent withdrawn|0
5454835|NCT02106351|18851132|P3|Treatment Cycle 3|Other|3
5454836|NCT02106351|18851133|P2|Treatment Cycle 3|Other|2
5454837|NCT02106351|18851134|P1|Treatment Cycle 3|Other|0
5454838|NCT02106351|18851132|P3|Treatment Cycle 3|Lost to Follow-up|0
5454839|NCT02106351|18851133|P2|Treatment Cycle 3|Lost to Follow-up|1
5454840|NCT02106351|18851134|P1|Treatment Cycle 3|Lost to Follow-up|0
5454841|NCT02106351|18851132|P3|Treatment Cycle 3|Consent withdrawn|2
5454842|NCT02106351|18851133|P2|Treatment Cycle 3|Consent withdrawn|0
5454843|NCT02106351|18851134|P1|Treatment Cycle 3|Consent withdrawn|0
5454844|NCT02106351|18851132|P3|Treatment Cycle 3|Adverse Event|0
5454845|NCT02106351|18851133|P2|Treatment Cycle 3|Adverse Event|1
5454846|NCT02106351|18851134|P1|Treatment Cycle 3|Adverse Event|0
5454847|NCT02106351|18851132|P3|Treatment Cycle 2|Other|2
5454848|NCT02106351|18851133|P2|Treatment Cycle 2|Other|2
5454849|NCT02106351|18851134|P1|Treatment Cycle 2|Other|0
5454850|NCT02106351|18851132|P3|Treatment Cycle 2|Consent withdrawn|1
5454851|NCT02106351|18851133|P2|Treatment Cycle 2|Consent withdrawn|1
5454852|NCT02106351|18851134|P1|Treatment Cycle 2|Consent withdrawn|0
5454853|NCT02106351|18851132|P3|Treatment Cycle 2|Adverse Event|0
5454854|NCT02106351|18851133|P2|Treatment Cycle 2|Adverse Event|2
5454855|NCT02106351|18851134|P1|Treatment Cycle 2|Adverse Event|0
5454856|NCT02106351|18851132|P3|Treatment Cycle 1|Randomised but not treated|1
5454857|NCT02106351|18851133|P2|Treatment Cycle 1|Randomised but not treated|0
5454858|NCT02106351|18851134|P1|Treatment Cycle 1|Randomised but not treated|1
5454859|NCT02106351|18851132|P3|Treatment Cycle 1|Other|1
5454860|NCT02106351|18851133|P2|Treatment Cycle 1|Other|3
5454861|NCT02106351|18851134|P1|Treatment Cycle 1|Other|0
5454862|NCT02106351|18851132|P3|Treatment Cycle 1|Lost to Follow-up|0
5454863|NCT02106351|18851133|P2|Treatment Cycle 1|Lost to Follow-up|0
5454864|NCT02106351|18851134|P1|Treatment Cycle 1|Lost to Follow-up|1
5454865|NCT02106351|18851132|P3|Treatment Cycle 1|Consent withdrawn|2
5454866|NCT02106351|18851133|P2|Treatment Cycle 1|Consent withdrawn|0
5454867|NCT02106351|18851134|P1|Treatment Cycle 1|Consent withdrawn|1
5454868|NCT02106351|18851132|P3|Treatment Cycle 1|Adverse Event|0
5454869|NCT02106351|18851133|P2|Treatment Cycle 1|Adverse Event|0
5454870|NCT02106351|18851134|P1|Treatment Cycle 1|Adverse Event|2
5454871|NCT02106325|18851177|P2|Phase 3|Lost to Follow-up|1
5454872|NCT02106325|18851178|P1|Phase 3|Lost to Follow-up|2
5454873|NCT02106325|18851177|P2|Phase 2|Lost to Follow-up|3
5454874|NCT02106325|18851178|P1|Phase 2|Lost to Follow-up|2
5454875|NCT02106325|18851177|P2|Phase 1|Lost to Follow-up|2
5454876|NCT02106325|18851178|P1|Phase 1|Lost to Follow-up|2
5454877|NCT02106156|18851203|P3|Overall Study|Relocation/Change of Physician|0
5454878|NCT02106156|18851204|P2|Overall Study|Relocation/Change of Physician|1
5454879|NCT02106156|18851205|P1|Overall Study|Relocation/Change of Physician|40
5454880|NCT02106156|18851203|P3|Overall Study|Hospitalization/Surgical Intervention|0
5454881|NCT02106156|18851204|P2|Overall Study|Hospitalization/Surgical Intervention|0
5454882|NCT02106156|18851205|P1|Overall Study|Hospitalization/Surgical Intervention|6
5454883|NCT02106156|18851203|P3|Overall Study|Change of Laboratory Parameter|0
5454884|NCT02106156|18851204|P2|Overall Study|Change of Laboratory Parameter|0
5454885|NCT02106156|18851205|P1|Overall Study|Change of Laboratory Parameter|10
5454886|NCT02106156|18851203|P3|Overall Study|Unplanned Event|0
5454887|NCT02106156|18851204|P2|Overall Study|Unplanned Event|2
5454888|NCT02106156|18851205|P1|Overall Study|Unplanned Event|82
5454889|NCT02106156|18851203|P3|Overall Study|Lost to Follow-up|0
5454890|NCT02106156|18851204|P2|Overall Study|Lost to Follow-up|8
5454891|NCT02106156|18851205|P1|Overall Study|Lost to Follow-up|451
5454892|NCT02106156|18851203|P3|Overall Study|Patients Request|0
5454893|NCT02106156|18851204|P2|Overall Study|Patients Request|9
5454894|NCT02106156|18851205|P1|Overall Study|Patients Request|307
5454895|NCT02106156|18851203|P3|Overall Study|Lack of Compliance|0
5454896|NCT02106156|18851204|P2|Overall Study|Lack of Compliance|7
5454897|NCT02106156|18851205|P1|Overall Study|Lack of Compliance|211
5454898|NCT02106156|18851203|P3|Overall Study|Concomitant Disease|0
5454899|NCT02106156|18851204|P2|Overall Study|Concomitant Disease|2
5454900|NCT02106156|18851205|P1|Overall Study|Concomitant Disease|74
5454901|NCT02106156|18851203|P3|Overall Study|Lack of Virological Response|0
5454902|NCT02106156|18851204|P2|Overall Study|Lack of Virological Response|8
5454903|NCT02106156|18851205|P1|Overall Study|Lack of Virological Response|1044
5454904|NCT02106156|18851203|P3|Overall Study|Lack of Tolerability|0
5454905|NCT02106156|18851204|P2|Overall Study|Lack of Tolerability|3
5454906|NCT02106156|18851205|P1|Overall Study|Lack of Tolerability|305
5454907|NCT02106156|18851203|P3|Overall Study|Patient Died|0
5454908|NCT02106156|18851204|P2|Overall Study|Patient Died|0
5454909|NCT02106156|18851205|P1|Overall Study|Patient Died|19
5454910|NCT02105987|18851229|P6|Continuation Phase|Protocol Violation|0
5454911|NCT02105987|18851230|P5|Continuation Phase|Protocol Violation|1
5454912|NCT02105987|18851231|P4|Continuation Phase|Protocol Violation|0
5454913|NCT02105987|18851232|P3|Continuation Phase|Protocol Violation|0
5454914|NCT02105987|18851233|P2|Continuation Phase|Protocol Violation|0
5454915|NCT02105987|18851234|P1|Continuation Phase|Protocol Violation|0
5454916|NCT02105987|18851229|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
5454917|NCT02105987|18851230|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
5454918|NCT02105987|18851231|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
5454919|NCT02105987|18851232|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
5454920|NCT02105987|18851233|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
5454921|NCT02105987|18851234|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
5454922|NCT02105987|18851229|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5454923|NCT02105987|18851230|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5454924|NCT02105987|18851231|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
5454925|NCT02105987|18851232|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5454926|NCT02105987|18851233|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5454927|NCT02105987|18851234|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
5454928|NCT02105987|18851229|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
5454929|NCT02105987|18851230|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
5454930|NCT02105987|18851231|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
5454931|NCT02105987|18851232|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
5454932|NCT02105987|18851233|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
5454933|NCT02105987|18851234|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
5454934|NCT02105987|18851229|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5454935|NCT02105987|18851230|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5454936|NCT02105987|18851231|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
5454937|NCT02105987|18851232|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
5454938|NCT02105987|18851233|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5454939|NCT02105987|18851234|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
5454940|NCT02105987|18851229|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5454941|NCT02105987|18851230|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5454942|NCT02105987|18851231|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
5454943|NCT02105987|18851232|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
5454944|NCT02105987|18851233|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5454945|NCT02105987|18851234|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
5454946|NCT02105987|18851229|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
5454947|NCT02105987|18851230|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
5454948|NCT02105987|18851231|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
5454949|NCT02105987|18851232|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
5454950|NCT02105987|18851233|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
5454951|NCT02105987|18851234|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
5454952|NCT02105987|18851229|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
5454953|NCT02105987|18851230|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
5454954|NCT02105987|18851231|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
5454955|NCT02105987|18851232|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
5454956|NCT02105987|18851233|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
5454957|NCT02105987|18851234|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
5454958|NCT02105987|18851229|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5454959|NCT02105987|18851230|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5454960|NCT02105987|18851231|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5454961|NCT02105987|18851232|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5454962|NCT02105987|18851233|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
5454963|NCT02105987|18851234|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
5454964|NCT02105987|18851229|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
5454965|NCT02105987|18851230|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
5454966|NCT02105987|18851231|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
5454967|NCT02105987|18851232|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
5454968|NCT02105987|18851233|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
5454969|NCT02105987|18851234|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
5454970|NCT02105987|18851229|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5454971|NCT02105987|18851230|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5454972|NCT02105987|18851231|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5454973|NCT02105987|18851232|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
5454974|NCT02105987|18851233|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
5454975|NCT02105987|18851234|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
5454976|NCT02105987|18851229|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5454977|NCT02105987|18851230|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5454978|NCT02105987|18851231|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5454979|NCT02105987|18851232|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
5454980|NCT02105987|18851233|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
5454981|NCT02105987|18851234|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
5454982|NCT02105987|18851229|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
5454983|NCT02105987|18851230|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
5454984|NCT02105987|18851231|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
5454985|NCT02105987|18851232|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
5454986|NCT02105987|18851233|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
5454987|NCT02105987|18851234|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
5454988|NCT02105987|18851229|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
5454989|NCT02105987|18851230|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
5454990|NCT02105987|18851231|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
5454991|NCT02105987|18851232|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
5454992|NCT02105987|18851233|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
5454993|NCT02105987|18851234|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
5454994|NCT02105974|18851288|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
5454995|NCT02105974|18851289|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
5454996|NCT02105974|18851290|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
5454997|NCT02105974|18851288|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
5454998|NCT02105974|18851289|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
5454999|NCT02105974|18851290|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
5455000|NCT02105974|18851288|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
5455001|NCT02105974|18851289|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
5455002|NCT02105974|18851290|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
5455003|NCT02105974|18851288|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
5455004|NCT02105974|18851289|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
5455005|NCT02105974|18851290|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
5455006|NCT02105974|18851288|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
5455007|NCT02105974|18851289|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
5455008|NCT02105974|18851290|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
5455009|NCT02105974|18851288|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
5455010|NCT02105974|18851289|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
5455011|NCT02105974|18851290|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
5455012|NCT02105974|18851288|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
5455013|NCT02105974|18851289|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
5455014|NCT02105974|18851290|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
5455015|NCT02105974|18851288|P3|2 Week Run-in Period|Investigator discretion|0
5455016|NCT02105974|18851289|P2|2 Week Run-in Period|Investigator discretion|0
5455017|NCT02105974|18851290|P1|2 Week Run-in Period|Investigator discretion|8
5455018|NCT02105974|18851288|P3|2 Week Run-in Period|Withdrew consent|0
5455019|NCT02105974|18851289|P2|2 Week Run-in Period|Withdrew consent|0
5455020|NCT02105974|18851290|P1|2 Week Run-in Period|Withdrew consent|23
5455021|NCT02105974|18851288|P3|2 Week Run-in Period|Lost to Follow-up|0
5455022|NCT02105974|18851289|P2|2 Week Run-in Period|Lost to Follow-up|0
5455023|NCT02105974|18851290|P1|2 Week Run-in Period|Lost to Follow-up|2
5455024|NCT02105974|18851288|P3|2 Week Run-in Period|Study closed/terminated|0
5455025|NCT02105974|18851289|P2|2 Week Run-in Period|Study closed/terminated|0
5455026|NCT02105974|18851290|P1|2 Week Run-in Period|Study closed/terminated|1
5455027|NCT02105974|18851288|P3|2 Week Run-in Period|Adverse Event|0
5455028|NCT02105974|18851289|P2|2 Week Run-in Period|Adverse Event|0
5455029|NCT02105974|18851290|P1|2 Week Run-in Period|Adverse Event|6
5455030|NCT02105974|18851288|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
5455031|NCT02105974|18851289|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
5455032|NCT02105974|18851290|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
5455033|NCT02105974|18851288|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
5455034|NCT02105974|18851289|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
5455035|NCT02105974|18851290|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
5455036|NCT02105961|18851303|P3|Overall Study|Withdrawal by Subject|11
5455037|NCT02105961|18851304|P2|Overall Study|Withdrawal by Subject|7
5455038|NCT02105961|18851305|P1|Overall Study|Withdrawal by Subject|15
5455039|NCT02105961|18851303|P3|Overall Study|Physician Decision|2
5455040|NCT02105961|18851304|P2|Overall Study|Physician Decision|3
5455041|NCT02105961|18851305|P1|Overall Study|Physician Decision|3
5455042|NCT02105961|18851303|P3|Overall Study|Lost to Follow-up|1
5455043|NCT02105961|18851304|P2|Overall Study|Lost to Follow-up|0
5455044|NCT02105961|18851305|P1|Overall Study|Lost to Follow-up|2
5455045|NCT02105961|18851303|P3|Overall Study|Lack of Efficacy|3
5455046|NCT02105961|18851304|P2|Overall Study|Lack of Efficacy|0
5455047|NCT02105961|18851305|P1|Overall Study|Lack of Efficacy|3
5455048|NCT02105961|18851303|P3|Overall Study|Adverse Event|13
5455049|NCT02105961|18851304|P2|Overall Study|Adverse Event|7
5455050|NCT02105961|18851305|P1|Overall Study|Adverse Event|18
5455051|NCT02105948|18851329|P4|Overall Study|Withdrawal by Subject|11
5455052|NCT02105948|18851330|P3|Overall Study|Withdrawal by Subject|10
5455053|NCT02105948|18851331|P2|Overall Study|Withdrawal by Subject|10
5455054|NCT02105948|18851332|P1|Overall Study|Withdrawal by Subject|15
5455055|NCT02105948|18851329|P4|Overall Study|Physician Decision|2
5455056|NCT02105948|18851330|P3|Overall Study|Physician Decision|2
5455057|NCT02105948|18851331|P2|Overall Study|Physician Decision|2
5455058|NCT02105948|18851332|P1|Overall Study|Physician Decision|2
5455059|NCT02105948|18851329|P4|Overall Study|Lost to Follow-up|1
5455060|NCT02105948|18851330|P3|Overall Study|Lost to Follow-up|2
5455061|NCT02105948|18851331|P2|Overall Study|Lost to Follow-up|0
5455062|NCT02105948|18851332|P1|Overall Study|Lost to Follow-up|0
5455063|NCT02105948|18851329|P4|Overall Study|Lack of Efficacy|2
5455064|NCT02105948|18851330|P3|Overall Study|Lack of Efficacy|3
5455065|NCT02105948|18851331|P2|Overall Study|Lack of Efficacy|1
5455066|NCT02105948|18851332|P1|Overall Study|Lack of Efficacy|0
5455067|NCT02105948|18851329|P4|Overall Study|Adverse Event|11
5455068|NCT02105948|18851330|P3|Overall Study|Adverse Event|11
5455069|NCT02105948|18851331|P2|Overall Study|Adverse Event|7
5455070|NCT02105948|18851332|P1|Overall Study|Adverse Event|10
5455071|NCT02105701|18851373|P4|Overall Study|Death|0
5455072|NCT02105701|18851374|P3|Overall Study|Death|0
5455073|NCT02105701|18851375|P2|Overall Study|Death|0
5455074|NCT02105701|18851376|P1|Overall Study|Death|1
5455075|NCT02105701|18851373|P4|Overall Study|Withdrawal by Subject|1
5455076|NCT02105701|18851374|P3|Overall Study|Withdrawal by Subject|0
5455077|NCT02105701|18851375|P2|Overall Study|Withdrawal by Subject|1
5455078|NCT02105701|18851376|P1|Overall Study|Withdrawal by Subject|2
5455079|NCT02105701|18851373|P4|Overall Study|Protocol Violation|0
5455080|NCT02105701|18851374|P3|Overall Study|Protocol Violation|1
5455081|NCT02105701|18851375|P2|Overall Study|Protocol Violation|0
5455082|NCT02105701|18851376|P1|Overall Study|Protocol Violation|0
5455083|NCT02105701|18851373|P4|Overall Study|Lost to Follow-up|1
5455084|NCT02105701|18851374|P3|Overall Study|Lost to Follow-up|2
5455085|NCT02105701|18851375|P2|Overall Study|Lost to Follow-up|0
5455086|NCT02105701|18851376|P1|Overall Study|Lost to Follow-up|1
5455087|NCT02105688|18851400|P2|Part B: Observational Follow-up|Physician Decision|1
5455088|NCT02105688|18851401|P1|Part B: Observational Follow-up|Physician Decision|3
5455089|NCT02105688|18851400|P2|Part B: Observational Follow-up|Withdrawal by Subject|3
5455090|NCT02105688|18851401|P1|Part B: Observational Follow-up|Withdrawal by Subject|9
5455091|NCT02105688|18851400|P2|Part B: Observational Follow-up|Lost to Follow-up|15
5455092|NCT02105688|18851401|P1|Part B: Observational Follow-up|Lost to Follow-up|23
5455093|NCT02105688|18851400|P2|Part B: Observational Follow-up|Death|1
5455094|NCT02105688|18851401|P1|Part B: Observational Follow-up|Death|2
5455095|NCT02105688|18851400|P2|Part A: Double-Blind|Withdrawal by Subject|2
5455096|NCT02105688|18851401|P1|Part A: Double-Blind|Withdrawal by Subject|4
5455097|NCT02105688|18851400|P2|Part A: Double-Blind|Status Unknown|2
5455098|NCT02105688|18851401|P1|Part A: Double-Blind|Status Unknown|0
5455099|NCT02105688|18851400|P2|Part A: Double-Blind|Physician Decision|1
5455100|NCT02105688|18851401|P1|Part A: Double-Blind|Physician Decision|0
5455101|NCT02105688|18851400|P2|Part A: Double-Blind|Lost to Follow-up|11
5455102|NCT02105688|18851401|P1|Part A: Double-Blind|Lost to Follow-up|15
5455103|NCT02105688|18851400|P2|Part A: Double-Blind|Death|1
5455104|NCT02105688|18851401|P1|Part A: Double-Blind|Death|0
5455105|NCT02105688|18851400|P2|Part A: Double-Blind|Adverse Event|0
5455106|NCT02105688|18851401|P1|Part A: Double-Blind|Adverse Event|1
5455107|NCT02105662|18851414|P1|Overall Study|Withdrawal by Subject|1
5455108|NCT02105662|18851414|P1|Overall Study|Lost to Follow-up|5
5455109|NCT02105636|18851423|P2|Overall Study|Not Reported|0
5455110|NCT02105636|18851424|P1|Overall Study|Not Reported|3
5455111|NCT02105636|18851423|P2|Overall Study|Reason Not Specified|2
5455112|NCT02105636|18851424|P1|Overall Study|Reason Not Specified|0
5455113|NCT02105636|18851423|P2|Overall Study|Poor/Non-compliance|1
5455114|NCT02105636|18851424|P1|Overall Study|Poor/Non-compliance|0
5455115|NCT02105636|18851423|P2|Overall Study|Maximum Clinical Benefit|1
5455116|NCT02105636|18851424|P1|Overall Study|Maximum Clinical Benefit|1
5455117|NCT02105636|18851423|P2|Overall Study|Subject Withdrew Consent|1
5455118|NCT02105636|18851424|P1|Overall Study|Subject Withdrew Consent|4
5455119|NCT02105636|18851423|P2|Overall Study|Subject Request to Discontinue Treatment|6
5455120|NCT02105636|18851424|P1|Overall Study|Subject Request to Discontinue Treatment|4
5455121|NCT02105636|18851423|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
5455122|NCT02105636|18851424|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
5455123|NCT02105636|18851423|P2|Overall Study|Study Drug Toxicity|11
5455124|NCT02105636|18851424|P1|Overall Study|Study Drug Toxicity|9
5455125|NCT02105636|18851423|P2|Overall Study|Disease Progression|83
5455126|NCT02105636|18851424|P1|Overall Study|Disease Progression|162
5455127|NCT02105467|18851467|P2|Period 3|Lost to Follow-up|1
5455128|NCT02105467|18851468|P1|Period 3|Lost to Follow-up|0
5455129|NCT02105467|18851467|P2|Period 2|Withdrawal by Subject|2
5455130|NCT02105467|18851468|P1|Period 2|Withdrawal by Subject|0
5455131|NCT02105467|18851467|P2|Period 2|Death|0
5455132|NCT02105467|18851468|P1|Period 2|Death|1
5455133|NCT02105467|18851467|P2|Period 2|Lost to Follow-up|0
5455134|NCT02105467|18851468|P1|Period 2|Lost to Follow-up|1
5455135|NCT02105467|18851467|P2|Period 1|Death|0
5455136|NCT02105467|18851468|P1|Period 1|Death|1
5455137|NCT02105467|18851467|P2|Period 1|Lost to Follow-up|0
5455138|NCT02105467|18851468|P1|Period 1|Lost to Follow-up|1
5455139|NCT02105454|18851480|P1|Overall Study|Withdrawal by Subject|1
5455140|NCT02105285|18851592|P3|Overall Study|Withdrawal by Subject|0
5455141|NCT02105285|18851593|P2|Overall Study|Withdrawal by Subject|0
5455142|NCT02105285|18851594|P1|Overall Study|Withdrawal by Subject|1
5455143|NCT02105285|18851592|P3|Overall Study|Protocol Violation|0
5455144|NCT02105285|18851593|P2|Overall Study|Protocol Violation|1
5455145|NCT02105285|18851594|P1|Overall Study|Protocol Violation|0
5455146|NCT02105285|18851592|P3|Overall Study|Adverse Event|0
5455147|NCT02105285|18851593|P2|Overall Study|Adverse Event|1
5455148|NCT02105285|18851594|P1|Overall Study|Adverse Event|1
5455149|NCT02105272|18851613|P2|Overall Study|Withdrawal by Subject|0
5455150|NCT02105272|18851614|P1|Overall Study|Withdrawal by Subject|2
5455151|NCT02105272|18851613|P2|Overall Study|Protocol Violation|0
5455152|NCT02105272|18851614|P1|Overall Study|Protocol Violation|2
5455153|NCT02105272|18851613|P2|Overall Study|Physician Decision|1
5455154|NCT02105272|18851614|P1|Overall Study|Physician Decision|0
5455155|NCT02105272|18851613|P2|Overall Study|Adverse Event|2
5455156|NCT02105272|18851614|P1|Overall Study|Adverse Event|1
5455157|NCT02105116|18851643|P1|Overall Study|Death|1
5455158|NCT02105116|18851643|P1|Overall Study|not eligible for step 2 of trial|5
5455159|NCT02105012|18851650|P1|Overall Study|Lack of Efficacy|1
5455160|NCT02105012|18851650|P1|Overall Study|Adverse Event|1
5455161|NCT02105012|18851650|P1|Overall Study|Physician Decision|3
5455162|NCT02105012|18851650|P1|Overall Study|Protocol Violation|4
5455163|NCT02105012|18851650|P1|Overall Study|Lost to Follow-up|4
5455164|NCT02105012|18851650|P1|Overall Study|Protocol Specified Criteria|9
5455165|NCT02105012|18851650|P1|Overall Study|Withdrawal by Subject|11
5455166|NCT02104947|18851684|P2|Overall Study|Other than stated above|3
5455167|NCT02104947|18851685|P1|Overall Study|Other than stated above|2
5455168|NCT02104947|18851684|P2|Overall Study|Adverse Event|38
5455169|NCT02104947|18851685|P1|Overall Study|Adverse Event|57
5455170|NCT02104947|18851684|P2|Overall Study|Protocol Violation|8
5455171|NCT02104947|18851685|P1|Overall Study|Protocol Violation|6
5455172|NCT02104947|18851684|P2|Overall Study|Lost to Follow-up|4
5455173|NCT02104947|18851685|P1|Overall Study|Lost to Follow-up|4
5455174|NCT02104947|18851684|P2|Overall Study|Withdrawal by Subject|3
5455175|NCT02104947|18851685|P1|Overall Study|Withdrawal by Subject|10
5455176|NCT02104895|18851703|P2|Overall Study|Withdrawal by Subject|14
5455177|NCT02104895|18851704|P1|Overall Study|Withdrawal by Subject|0
5455178|NCT02104804|18851744|P2|Overall Study|Withdrawal by Subject|12
5455179|NCT02104804|18851745|P1|Overall Study|Withdrawal by Subject|4
5455180|NCT02104804|18851744|P2|Overall Study|Adverse Event|3
5455181|NCT02104804|18851745|P1|Overall Study|Adverse Event|4
5455182|NCT02104804|18851744|P2|Overall Study|Protocol Violation|1
5455183|NCT02104804|18851745|P1|Overall Study|Protocol Violation|0
5455184|NCT02104804|18851744|P2|Overall Study|Other listed|1
5455185|NCT02104804|18851745|P1|Overall Study|Other listed|2
5455186|NCT02104804|18851744|P2|Overall Study|Study specific discontinuation criteria|1
5455187|NCT02104804|18851745|P1|Overall Study|Study specific discontinuation criteria|6
5455188|NCT02104804|18851744|P2|Overall Study|Did not take study medication|1
5455189|NCT02104804|18851745|P1|Overall Study|Did not take study medication|0
5455190|NCT02104765|18851768|P7|Overall Study|Withdrawal by Subject|1
5455191|NCT02104765|18851769|P6|Overall Study|Withdrawal by Subject|0
5455192|NCT02104765|18851770|P5|Overall Study|Withdrawal by Subject|1
5455193|NCT02104765|18851771|P4|Overall Study|Withdrawal by Subject|1
5455194|NCT02104765|18851772|P3|Overall Study|Withdrawal by Subject|0
5455195|NCT02104765|18851773|P2|Overall Study|Withdrawal by Subject|0
5455196|NCT02104765|18851774|P1|Overall Study|Withdrawal by Subject|0
5455197|NCT02104765|18851768|P7|Overall Study|Lost to Follow-up|0
5455198|NCT02104765|18851769|P6|Overall Study|Lost to Follow-up|0
5455199|NCT02104765|18851770|P5|Overall Study|Lost to Follow-up|0
5455200|NCT02104765|18851771|P4|Overall Study|Lost to Follow-up|0
5455201|NCT02104765|18851772|P3|Overall Study|Lost to Follow-up|1
5455202|NCT02104765|18851773|P2|Overall Study|Lost to Follow-up|0
5455203|NCT02104765|18851774|P1|Overall Study|Lost to Follow-up|0
5455204|NCT02104752|18851802|P2|Overall Study|Weight gain; unrelated anxiety|2
5455205|NCT02104752|18851803|P1|Overall Study|Weight gain; unrelated anxiety|0
5455206|NCT02104752|18851802|P2|Overall Study|Withdrawal by Subject|0
5455207|NCT02104752|18851803|P1|Overall Study|Withdrawal by Subject|1
5455208|NCT02104583|18851886|P5|Overall Study|Randomized but Never Treated|0
5455209|NCT02104583|18851887|P4|Overall Study|Randomized but Never Treated|1
5455210|NCT02104583|18851888|P3|Overall Study|Randomized but Never Treated|0
5455211|NCT02104583|18851889|P2|Overall Study|Randomized but Never Treated|0
5455212|NCT02104583|18851890|P1|Overall Study|Randomized but Never Treated|0
5455213|NCT02104583|18851886|P5|Overall Study|Lost to Follow-up|0
5455214|NCT02104583|18851887|P4|Overall Study|Lost to Follow-up|0
5455215|NCT02104583|18851888|P3|Overall Study|Lost to Follow-up|0
5455216|NCT02104583|18851889|P2|Overall Study|Lost to Follow-up|0
5455217|NCT02104583|18851890|P1|Overall Study|Lost to Follow-up|1
5455218|NCT02104583|18851886|P5|Overall Study|Adverse Event|1
5455219|NCT02104583|18851887|P4|Overall Study|Adverse Event|6
5455220|NCT02104583|18851888|P3|Overall Study|Adverse Event|6
5455221|NCT02104583|18851889|P2|Overall Study|Adverse Event|3
5455222|NCT02104583|18851890|P1|Overall Study|Adverse Event|3
5455223|NCT02104583|18851886|P5|Overall Study|Protocol Violation|0
5455224|NCT02104583|18851887|P4|Overall Study|Protocol Violation|0
5455225|NCT02104583|18851888|P3|Overall Study|Protocol Violation|1
5455226|NCT02104583|18851889|P2|Overall Study|Protocol Violation|0
5455227|NCT02104583|18851890|P1|Overall Study|Protocol Violation|0
5455228|NCT02104583|18851886|P5|Overall Study|Investigator's Discretion|0
5455229|NCT02104583|18851887|P4|Overall Study|Investigator's Discretion|0
5455230|NCT02104583|18851888|P3|Overall Study|Investigator's Discretion|0
5455231|NCT02104583|18851889|P2|Overall Study|Investigator's Discretion|0
5455232|NCT02104583|18851890|P1|Overall Study|Investigator's Discretion|1
5455233|NCT02104583|18851886|P5|Overall Study|Withdrew Consent|1
5455234|NCT02104583|18851887|P4|Overall Study|Withdrew Consent|2
5455235|NCT02104583|18851888|P3|Overall Study|Withdrew Consent|0
5455236|NCT02104583|18851889|P2|Overall Study|Withdrew Consent|2
5455237|NCT02104583|18851890|P1|Overall Study|Withdrew Consent|3
5455238|NCT02104583|18851886|P5|Overall Study|Subject required prohibited medication|1
5455239|NCT02104583|18851887|P4|Overall Study|Subject required prohibited medication|0
5455240|NCT02104583|18851888|P3|Overall Study|Subject required prohibited medication|1
5455241|NCT02104583|18851889|P2|Overall Study|Subject required prohibited medication|1
5455242|NCT02104583|18851890|P1|Overall Study|Subject required prohibited medication|0
5455243|NCT02104583|18851886|P5|Overall Study|Subject required cardiac ablation|4
5455244|NCT02104583|18851887|P4|Overall Study|Subject required cardiac ablation|5
5455245|NCT02104583|18851888|P3|Overall Study|Subject required cardiac ablation|4
5455246|NCT02104583|18851889|P2|Overall Study|Subject required cardiac ablation|4
5455247|NCT02104583|18851890|P1|Overall Study|Subject required cardiac ablation|6
5455248|NCT02104583|18851886|P5|Overall Study|Death|5
5455249|NCT02104583|18851887|P4|Overall Study|Death|3
5455250|NCT02104583|18851888|P3|Overall Study|Death|3
5455251|NCT02104583|18851889|P2|Overall Study|Death|1
5455252|NCT02104583|18851890|P1|Overall Study|Death|2
5455253|NCT02104583|18851886|P5|Overall Study|New ICD or CRT-D implanted|0
5455254|NCT02104583|18851887|P4|Overall Study|New ICD or CRT-D implanted|0
5455255|NCT02104583|18851888|P3|Overall Study|New ICD or CRT-D implanted|1
5455256|NCT02104583|18851889|P2|Overall Study|New ICD or CRT-D implanted|0
5455257|NCT02104583|18851890|P1|Overall Study|New ICD or CRT-D implanted|2
5455258|NCT02104505|18851953|P2|Second Intervention (14 Days)|Adverse Event|0
5455259|NCT02104505|18851954|P1|Second Intervention (14 Days)|Adverse Event|2
5455260|NCT02104505|18851953|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
5455261|NCT02104505|18851954|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
5455262|NCT02104505|18851953|P2|First Intervention (14 Days)|exclusionary condition|1
5455263|NCT02104505|18851954|P1|First Intervention (14 Days)|exclusionary condition|0
5455264|NCT02104505|18851953|P2|First Intervention (14 Days)|Lost to Follow-up|1
5455265|NCT02104505|18851954|P1|First Intervention (14 Days)|Lost to Follow-up|0
5455266|NCT02104505|18851953|P2|First Intervention (14 Days)|Withdrawal by Subject|1
5455267|NCT02104505|18851954|P1|First Intervention (14 Days)|Withdrawal by Subject|0
5455268|NCT02104505|18851953|P2|First Intervention (14 Days)|Adverse Event|0
5455269|NCT02104505|18851954|P1|First Intervention (14 Days)|Adverse Event|2
5455270|NCT02104180|18852026|P2|Overall Study|Protocol Violation|0
5455271|NCT02104180|18852027|P1|Overall Study|Protocol Violation|1
5455272|NCT02103478|18852068|P9|Overall Study|Other|2
5455273|NCT02103478|18852069|P8|Overall Study|Other|4
5455274|NCT02103478|18852070|P7|Overall Study|Other|8
5455275|NCT02103478|18852071|P6|Overall Study|Other|8
5455276|NCT02103478|18852072|P5|Overall Study|Other|3
5455277|NCT02103478|18852073|P4|Overall Study|Other|0
5455278|NCT02103478|18852074|P3|Overall Study|Other|2
5455279|NCT02103478|18852075|P2|Overall Study|Other|3
5455280|NCT02103478|18852076|P1|Overall Study|Other|1
5455281|NCT02103478|18852068|P9|Overall Study|Lost to Follow-up|0
5455282|NCT02103478|18852069|P8|Overall Study|Lost to Follow-up|1
5455283|NCT02103478|18852070|P7|Overall Study|Lost to Follow-up|0
5455284|NCT02103478|18852071|P6|Overall Study|Lost to Follow-up|0
5455285|NCT02103478|18852072|P5|Overall Study|Lost to Follow-up|0
5455286|NCT02103478|18852073|P4|Overall Study|Lost to Follow-up|0
5455287|NCT02103478|18852074|P3|Overall Study|Lost to Follow-up|0
5455288|NCT02103478|18852075|P2|Overall Study|Lost to Follow-up|0
5455289|NCT02103478|18852076|P1|Overall Study|Lost to Follow-up|0
5455290|NCT02103478|18852068|P9|Overall Study|Withdrawal by Subject|0
5455291|NCT02103478|18852069|P8|Overall Study|Withdrawal by Subject|1
5455292|NCT02103478|18852070|P7|Overall Study|Withdrawal by Subject|1
5455293|NCT02103478|18852071|P6|Overall Study|Withdrawal by Subject|0
5455294|NCT02103478|18852072|P5|Overall Study|Withdrawal by Subject|0
5455295|NCT02103478|18852073|P4|Overall Study|Withdrawal by Subject|4
5455296|NCT02103478|18852074|P3|Overall Study|Withdrawal by Subject|0
5455297|NCT02103478|18852075|P2|Overall Study|Withdrawal by Subject|0
5455298|NCT02103478|18852076|P1|Overall Study|Withdrawal by Subject|2
5455299|NCT02103478|18852068|P9|Overall Study|Progressive Disease|1
5455300|NCT02103478|18852069|P8|Overall Study|Progressive Disease|0
5455301|NCT02103478|18852070|P7|Overall Study|Progressive Disease|2
5455302|NCT02103478|18852071|P6|Overall Study|Progressive Disease|1
5455303|NCT02103478|18852072|P5|Overall Study|Progressive Disease|9
5455304|NCT02103478|18852073|P4|Overall Study|Progressive Disease|0
5455305|NCT02103478|18852074|P3|Overall Study|Progressive Disease|2
5455306|NCT02103478|18852075|P2|Overall Study|Progressive Disease|1
5455307|NCT02103478|18852076|P1|Overall Study|Progressive Disease|2
5455308|NCT02103478|18852068|P9|Overall Study|Death|11
5455309|NCT02103478|18852069|P8|Overall Study|Death|10
5455310|NCT02103478|18852070|P7|Overall Study|Death|14
5455311|NCT02103478|18852071|P6|Overall Study|Death|15
5455312|NCT02103478|18852072|P5|Overall Study|Death|5
5455313|NCT02103478|18852073|P4|Overall Study|Death|1
5455314|NCT02103478|18852074|P3|Overall Study|Death|1
5455315|NCT02103478|18852075|P2|Overall Study|Death|2
5455316|NCT02103478|18852076|P1|Overall Study|Death|2
5455317|NCT02103478|18852068|P9|Overall Study|Adverse Event|0
5455318|NCT02103478|18852069|P8|Overall Study|Adverse Event|0
5455319|NCT02103478|18852070|P7|Overall Study|Adverse Event|0
5455320|NCT02103478|18852071|P6|Overall Study|Adverse Event|1
5455321|NCT02103478|18852072|P5|Overall Study|Adverse Event|2
5455322|NCT02103478|18852073|P4|Overall Study|Adverse Event|1
5455323|NCT02103478|18852074|P3|Overall Study|Adverse Event|1
5455324|NCT02103478|18852075|P2|Overall Study|Adverse Event|0
5455325|NCT02103478|18852076|P1|Overall Study|Adverse Event|0
5455326|NCT02103439|18852185|P2|Overall Study|Withdrawal by Subject|1
5455327|NCT02103439|18852186|P1|Overall Study|Withdrawal by Subject|3
5455328|NCT02103439|18852185|P2|Overall Study|Adverse Event|2
5455329|NCT02103439|18852186|P1|Overall Study|Adverse Event|0
5455330|NCT02103062|18852352|P2|Overall Study|Death|1
5455331|NCT02103062|18852353|P1|Overall Study|Death|0
5455332|NCT02103062|18852352|P2|Overall Study|Progressive Disease|20
5455333|NCT02103062|18852353|P1|Overall Study|Progressive Disease|17
5455334|NCT02103062|18852352|P2|Overall Study|Adverse Event|2
5455335|NCT02103062|18852353|P1|Overall Study|Adverse Event|1
5455336|NCT02102724|18852446|P2|Overall Study|surgery for brain aneurysm|1
5455337|NCT02102724|18852447|P1|Overall Study|surgery for brain aneurysm|1
5455338|NCT02102724|18852446|P2|Overall Study|Lost to Follow-up|0
5455339|NCT02102724|18852447|P1|Overall Study|Lost to Follow-up|1
5455340|NCT02102490|18852453|P1|Overall Study|Lost to Follow-up|1
5455341|NCT02102490|18852453|P1|Overall Study|Death|6
5455342|NCT02102464|18852467|P3|Randomized Study|Withdrawal by Subject|0
5455343|NCT02102464|18852468|P2|Randomized Study|Withdrawal by Subject|1
5455344|NCT02102464|18852469|P1|Randomized Study|Withdrawal by Subject|0
5455345|NCT02102399|18852488|P2|Overall Study|Withdrawal by Subject|4
5455346|NCT02102399|18852489|P1|Overall Study|Withdrawal by Subject|6
5455347|NCT02102204|18852559|P1|Overall Study|Ongoing|5
5455348|NCT02102204|18852559|P1|Overall Study|Sponsor Decision|5
5455349|NCT02102204|18852559|P1|Overall Study|Lost to Follow-up|65
5455350|NCT02102204|18852559|P1|Overall Study|Death|92
5455351|NCT02102204|18852559|P1|Overall Study|Withdrawal by Subject|137
5455352|NCT02101983|18852579|P2|Overall Study|Physician Decision|0
5455353|NCT02101983|18852580|P1|Overall Study|Physician Decision|1
5455354|NCT02101554|18852626|P3|Overall Study|Withdrawl by Parents/Guardians|0
5455355|NCT02101554|18852627|P2|Overall Study|Withdrawl by Parents/Guardians|0
5455356|NCT02101554|18852628|P1|Overall Study|Withdrawl by Parents/Guardians|1
5455357|NCT02101554|18852626|P3|Overall Study|Lost to Follow-up|0
5455358|NCT02101554|18852627|P2|Overall Study|Lost to Follow-up|1
5455359|NCT02101554|18852628|P1|Overall Study|Lost to Follow-up|0
5455360|NCT02101554|18852626|P3|Overall Study|Adverse Event|1
5455361|NCT02101554|18852627|P2|Overall Study|Adverse Event|1
5455362|NCT02101554|18852628|P1|Overall Study|Adverse Event|2
5455363|NCT02101554|18852626|P3|Overall Study|Insufficient Clinical Response|0
5455364|NCT02101554|18852627|P2|Overall Study|Insufficient Clinical Response|2
5455365|NCT02101554|18852628|P1|Overall Study|Insufficient Clinical Response|0
5455366|NCT02101554|18852626|P3|Overall Study|Protocol Violation|0
5455367|NCT02101554|18852627|P2|Overall Study|Protocol Violation|1
5455368|NCT02101554|18852628|P1|Overall Study|Protocol Violation|0
5455369|NCT02101359|18852781|P2|Overall Study|Protocol Violation|2
5455370|NCT02101359|18852782|P1|Overall Study|Protocol Violation|0
5455371|NCT02101359|18852781|P2|Overall Study|Lost to Follow-up|0
5455372|NCT02101359|18852782|P1|Overall Study|Lost to Follow-up|1
5455373|NCT02101359|18852781|P2|Overall Study|Withdrawal by Subject|4
5455374|NCT02101359|18852782|P1|Overall Study|Withdrawal by Subject|5
5455375|NCT02101359|18852781|P2|Overall Study|Not included|13
5455376|NCT02101359|18852782|P1|Overall Study|Not included|23
5455377|NCT02101294|18852788|P1|Overall Study|Lost to Follow-up|6
5455378|NCT02101294|18852788|P1|Overall Study|Withdrawal by Subject|5
5455379|NCT02101281|18852797|P2|Overall Study|Adverse Event|1
5455380|NCT02101281|18852798|P1|Overall Study|Adverse Event|0
5455381|NCT02101112|18852851|P6|Overall Study|Withdrawal by Subject|0
5455382|NCT02101112|18852852|P5|Overall Study|Withdrawal by Subject|1
5455383|NCT02101112|18852853|P4|Overall Study|Withdrawal by Subject|0
5455384|NCT02101112|18852854|P3|Overall Study|Withdrawal by Subject|0
5455385|NCT02101112|18852855|P2|Overall Study|Withdrawal by Subject|0
5455386|NCT02101112|18852856|P1|Overall Study|Withdrawal by Subject|0
5455387|NCT02101112|18852851|P6|Overall Study|Adverse Event|0
5455388|NCT02101112|18852852|P5|Overall Study|Adverse Event|0
5455389|NCT02101112|18852853|P4|Overall Study|Adverse Event|0
5455390|NCT02101112|18852854|P3|Overall Study|Adverse Event|1
5455391|NCT02101112|18852855|P2|Overall Study|Adverse Event|0
5455392|NCT02101112|18852856|P1|Overall Study|Adverse Event|0
5455393|NCT02101021|18852886|P5|Overall Study|Study Terminated by Sponsor|1
5455394|NCT02101021|18852887|P4|Overall Study|Study Terminated by Sponsor|1
5455395|NCT02101021|18852888|P3|Overall Study|Study Terminated by Sponsor|1
5455396|NCT02101021|18852889|P2|Overall Study|Study Terminated by Sponsor|0
5455397|NCT02101021|18852890|P1|Overall Study|Study Terminated by Sponsor|1
5455398|NCT02101021|18852886|P5|Overall Study|Lost to Follow-up|0
5455399|NCT02101021|18852887|P4|Overall Study|Lost to Follow-up|0
5455400|NCT02101021|18852888|P3|Overall Study|Lost to Follow-up|0
5455401|NCT02101021|18852889|P2|Overall Study|Lost to Follow-up|0
5455402|NCT02101021|18852890|P1|Overall Study|Lost to Follow-up|1
5455403|NCT02101021|18852886|P5|Overall Study|Withdrew Consent from study|0
5455404|NCT02101021|18852887|P4|Overall Study|Withdrew Consent from study|2
5455405|NCT02101021|18852888|P3|Overall Study|Withdrew Consent from study|0
5455406|NCT02101021|18852889|P2|Overall Study|Withdrew Consent from study|1
5455407|NCT02101021|18852890|P1|Overall Study|Withdrew Consent from study|1
5455408|NCT02101021|18852886|P5|Overall Study|Death|3
5455409|NCT02101021|18852887|P4|Overall Study|Death|0
5455410|NCT02101021|18852888|P3|Overall Study|Death|6
5455411|NCT02101021|18852889|P2|Overall Study|Death|3
5455412|NCT02101021|18852890|P1|Overall Study|Death|4
5455413|NCT02100969|18852937|P1|Overall Study|Did not pass screening phase|1
5455414|NCT02100839|18852956|P2|Multiple Ascending Dose|Withdrawal by Subject|0
5455415|NCT02100839|18852957|P1|Multiple Ascending Dose|Withdrawal by Subject|2
5455416|NCT02100839|18852956|P2|Multiple Ascending Dose|Adverse Event|0
5455417|NCT02100839|18852957|P1|Multiple Ascending Dose|Adverse Event|2
5455418|NCT02100813|18852988|P8|Overall Study|Adverse Event|1
5455419|NCT02100813|18852989|P7|Overall Study|Adverse Event|0
5455420|NCT02100813|18852990|P6|Overall Study|Adverse Event|0
5455421|NCT02100813|18852991|P5|Overall Study|Adverse Event|0
5455422|NCT02100813|18852992|P4|Overall Study|Adverse Event|0
5455423|NCT02100813|18852993|P3|Overall Study|Adverse Event|0
5455424|NCT02100813|18852994|P2|Overall Study|Adverse Event|0
5455425|NCT02100813|18852995|P1|Overall Study|Adverse Event|0
5455426|NCT02100670|18853072|P4|Overall Study|Withdrawal by Subject|0
5455427|NCT02100670|18853073|P3|Overall Study|Withdrawal by Subject|0
5455428|NCT02100670|18853074|P2|Overall Study|Withdrawal by Subject|0
5455429|NCT02100670|18853075|P1|Overall Study|Withdrawal by Subject|1
5455430|NCT02100670|18853072|P4|Overall Study|Physician Decision|0
5455431|NCT02100670|18853073|P3|Overall Study|Physician Decision|0
5455432|NCT02100670|18853074|P2|Overall Study|Physician Decision|1
5455433|NCT02100670|18853075|P1|Overall Study|Physician Decision|0
5455434|NCT02100670|18853072|P4|Overall Study|Poor Efficacy|0
5455435|NCT02100670|18853073|P3|Overall Study|Poor Efficacy|0
5455436|NCT02100670|18853074|P2|Overall Study|Poor Efficacy|1
5455437|NCT02100670|18853075|P1|Overall Study|Poor Efficacy|0
5455438|NCT02100670|18853072|P4|Overall Study|No swelling no pain|0
5455439|NCT02100670|18853073|P3|Overall Study|No swelling no pain|0
5455440|NCT02100670|18853074|P2|Overall Study|No swelling no pain|0
5455441|NCT02100670|18853075|P1|Overall Study|No swelling no pain|1
5455442|NCT02100670|18853072|P4|Overall Study|Withdrawal of Consent|0
5455443|NCT02100670|18853073|P3|Overall Study|Withdrawal of Consent|1
5455444|NCT02100670|18853074|P2|Overall Study|Withdrawal of Consent|1
5455445|NCT02100670|18853075|P1|Overall Study|Withdrawal of Consent|0
5455446|NCT02100670|18853072|P4|Overall Study|Protocol Violation|1
5455447|NCT02100670|18853073|P3|Overall Study|Protocol Violation|0
5455448|NCT02100670|18853074|P2|Overall Study|Protocol Violation|1
5455449|NCT02100670|18853075|P1|Overall Study|Protocol Violation|0
5455450|NCT02100670|18853072|P4|Overall Study|Lost to Follow-up|0
5455451|NCT02100670|18853073|P3|Overall Study|Lost to Follow-up|0
5455452|NCT02100670|18853074|P2|Overall Study|Lost to Follow-up|0
5455453|NCT02100670|18853075|P1|Overall Study|Lost to Follow-up|1
5455454|NCT02100670|18853072|P4|Overall Study|Adverse Event|0
5455455|NCT02100670|18853073|P3|Overall Study|Adverse Event|3
5455456|NCT02100670|18853074|P2|Overall Study|Adverse Event|3
5455457|NCT02100670|18853075|P1|Overall Study|Adverse Event|10
5455458|NCT02100657|18853138|P3|Cohort 3: Dose Level 3|Withdrawal by Subject|3
5455459|NCT02100657|18853139|P2|Cohort 3: Dose Level 3|Withdrawal by Subject|0
5455460|NCT02100657|18853140|P1|Cohort 3: Dose Level 3|Withdrawal by Subject|0
5455461|NCT02100657|18853138|P3|Cohort 3: Dose Level 3|Treatment-related adverse event|3
5455462|NCT02100657|18853139|P2|Cohort 3: Dose Level 3|Treatment-related adverse event|0
5455463|NCT02100657|18853140|P1|Cohort 3: Dose Level 3|Treatment-related adverse event|0
5455464|NCT02100657|18853138|P3|Cohort 3: Dose Level 3|Never were treated|3
5455465|NCT02100657|18853139|P2|Cohort 3: Dose Level 3|Never were treated|0
5455466|NCT02100657|18853140|P1|Cohort 3: Dose Level 3|Never were treated|0
5455467|NCT02100657|18853138|P3|Cohort 3: Dose Level 3|Physician Decision|1
5455468|NCT02100657|18853139|P2|Cohort 3: Dose Level 3|Physician Decision|0
5455469|NCT02100657|18853140|P1|Cohort 3: Dose Level 3|Physician Decision|0
5455470|NCT02100657|18853138|P3|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
5455471|NCT02100657|18853139|P2|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
5455472|NCT02100657|18853140|P1|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
5455473|NCT02100657|18853138|P3|Cohort 3: Dose Level 3|Death|1
5455474|NCT02100657|18853139|P2|Cohort 3: Dose Level 3|Death|0
5455475|NCT02100657|18853140|P1|Cohort 3: Dose Level 3|Death|0
5455476|NCT02100657|18853138|P3|Cohort 3: Dose Level 3|Progressive disease|15
5455477|NCT02100657|18853139|P2|Cohort 3: Dose Level 3|Progressive disease|0
5455478|NCT02100657|18853140|P1|Cohort 3: Dose Level 3|Progressive disease|0
5455479|NCT02100657|18853138|P3|Cohort 2: Dose Level 2|Treatment-related adverse event|0
5455480|NCT02100657|18853139|P2|Cohort 2: Dose Level 2|Treatment-related adverse event|1
5455481|NCT02100657|18853140|P1|Cohort 2: Dose Level 2|Treatment-related adverse event|0
5455482|NCT02100657|18853138|P3|Cohort 2: Dose Level 2|Physician Decision|0
5455483|NCT02100657|18853139|P2|Cohort 2: Dose Level 2|Physician Decision|1
5455484|NCT02100657|18853140|P1|Cohort 2: Dose Level 2|Physician Decision|0
5455485|NCT02100657|18853138|P3|Cohort 2: Dose Level 2|Progressive disease|0
5455486|NCT02100657|18853139|P2|Cohort 2: Dose Level 2|Progressive disease|2
5455487|NCT02100657|18853140|P1|Cohort 2: Dose Level 2|Progressive disease|0
5455488|NCT02100657|18853138|P3|Cohort 1: Dose Level 1|Withdrawal by Subject|0
5455489|NCT02100657|18853139|P2|Cohort 1: Dose Level 1|Withdrawal by Subject|0
5455490|NCT02100657|18853140|P1|Cohort 1: Dose Level 1|Withdrawal by Subject|1
5455491|NCT02100657|18853138|P3|Cohort 1: Dose Level 1|Treatment-related adverse event|0
5455492|NCT02100657|18853139|P2|Cohort 1: Dose Level 1|Treatment-related adverse event|0
5455493|NCT02100657|18853140|P1|Cohort 1: Dose Level 1|Treatment-related adverse event|1
5455494|NCT02100657|18853138|P3|Cohort 1: Dose Level 1|Progressive disease|0
5455495|NCT02100657|18853139|P2|Cohort 1: Dose Level 1|Progressive disease|0
5455496|NCT02100657|18853140|P1|Cohort 1: Dose Level 1|Progressive disease|6
5455497|NCT02100644|18853178|P3|LTG Escalation Phase|Withdrawal by Subject|0
5455498|NCT02100644|18853179|P2|LTG Escalation Phase|Withdrawal by Subject|0
5455499|NCT02100644|18853180|P1|LTG Escalation Phase|Withdrawal by Subject|3
5455500|NCT02100644|18853178|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
5455501|NCT02100644|18853179|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
5455502|NCT02100644|18853180|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
5455503|NCT02100644|18853178|P3|LTG Escalation Phase|Adverse Event|0
5455504|NCT02100644|18853179|P2|LTG Escalation Phase|Adverse Event|0
5455505|NCT02100644|18853180|P1|LTG Escalation Phase|Adverse Event|9
5455506|NCT02100514|18853205|P5|Extension Period|Withdrew consent|0
5455507|NCT02100514|18853206|P4|Extension Period|Withdrew consent|0
5455508|NCT02100514|18853207|P3|Extension Period|Withdrew consent|2
5455509|NCT02100514|18853208|P2|Extension Period|Withdrew consent|0
5455510|NCT02100514|18853209|P1|Extension Period|Withdrew consent|0
5455511|NCT02100514|18853205|P5|Treatment Period|Other|0
5455512|NCT02100514|18853206|P4|Treatment Period|Other|0
5455513|NCT02100514|18853207|P3|Treatment Period|Other|0
5455514|NCT02100514|18853208|P2|Treatment Period|Other|11
5455515|NCT02100514|18853209|P1|Treatment Period|Other|9
5455516|NCT02100514|18853205|P5|Treatment Period|Withdrawal by Subject|0
5455517|NCT02100514|18853206|P4|Treatment Period|Withdrawal by Subject|0
5455518|NCT02100514|18853207|P3|Treatment Period|Withdrawal by Subject|0
5455519|NCT02100514|18853208|P2|Treatment Period|Withdrawal by Subject|37
5455520|NCT02100514|18853209|P1|Treatment Period|Withdrawal by Subject|12
5455521|NCT02100514|18853205|P5|Treatment Period|Protocol Violation|0
5455522|NCT02100514|18853206|P4|Treatment Period|Protocol Violation|0
5455523|NCT02100514|18853207|P3|Treatment Period|Protocol Violation|0
5455524|NCT02100514|18853208|P2|Treatment Period|Protocol Violation|1
5455525|NCT02100514|18853209|P1|Treatment Period|Protocol Violation|1
5455526|NCT02100514|18853205|P5|Treatment Period|Did Not Meet Entrance Criteria|0
5455527|NCT02100514|18853206|P4|Treatment Period|Did Not Meet Entrance Criteria|0
5455528|NCT02100514|18853207|P3|Treatment Period|Did Not Meet Entrance Criteria|0
5455529|NCT02100514|18853208|P2|Treatment Period|Did Not Meet Entrance Criteria|1
5455530|NCT02100514|18853209|P1|Treatment Period|Did Not Meet Entrance Criteria|0
5455531|NCT02100514|18853205|P5|Treatment Period|Lost to Follow-up|0
5455532|NCT02100514|18853206|P4|Treatment Period|Lost to Follow-up|0
5455533|NCT02100514|18853207|P3|Treatment Period|Lost to Follow-up|0
5455534|NCT02100514|18853208|P2|Treatment Period|Lost to Follow-up|17
5455535|NCT02100514|18853209|P1|Treatment Period|Lost to Follow-up|5
5455536|NCT02100514|18853205|P5|Treatment Period|Death|0
5455537|NCT02100514|18853206|P4|Treatment Period|Death|0
5455538|NCT02100514|18853207|P3|Treatment Period|Death|0
5455539|NCT02100514|18853208|P2|Treatment Period|Death|2
5455540|NCT02100514|18853209|P1|Treatment Period|Death|2
5455541|NCT02100514|18853205|P5|Treatment Period|Adverse Event|0
5455542|NCT02100514|18853206|P4|Treatment Period|Adverse Event|0
5455543|NCT02100514|18853207|P3|Treatment Period|Adverse Event|0
5455544|NCT02100514|18853208|P2|Treatment Period|Adverse Event|5
5455545|NCT02100514|18853209|P1|Treatment Period|Adverse Event|0
5455546|NCT02100475|18853277|P2|Overall Study|Withdrawal criteria|0
5455547|NCT02100475|18853278|P1|Overall Study|Withdrawal criteria|1
5455548|NCT02100475|18853277|P2|Overall Study|Unclassified|2
5455549|NCT02100475|18853278|P1|Overall Study|Unclassified|1
5455550|NCT02100319|18853309|P1|Overall Study|Protocol Deviation|5
5455551|NCT02100319|18853309|P1|Overall Study|Case Report Forms Uncollected|11
5455552|NCT02100228|18853337|P2|Overall Study|Death|1
5455553|NCT02100228|18853338|P1|Overall Study|Death|1
5455554|NCT02100228|18853337|P2|Overall Study|Adverse Event|12
5455555|NCT02100228|18853338|P1|Overall Study|Adverse Event|16
5455556|NCT02100228|18853337|P2|Overall Study|Withdrawal by Subject|37
5455557|NCT02100228|18853338|P1|Overall Study|Withdrawal by Subject|27
5455558|NCT02100228|18853337|P2|Overall Study|Lost to Follow-up|1
5455559|NCT02100228|18853338|P1|Overall Study|Lost to Follow-up|0
5455560|NCT02100228|18853337|P2|Overall Study|Non-compliance|3
5455561|NCT02100228|18853338|P1|Overall Study|Non-compliance|0
5455562|NCT02100228|18853337|P2|Overall Study|Inclusion/Exclusion criteria not met|16
5455563|NCT02100228|18853338|P1|Overall Study|Inclusion/Exclusion criteria not met|12
5455564|NCT02100228|18853337|P2|Overall Study|Administrative reason|1
5455565|NCT02100228|18853338|P1|Overall Study|Administrative reason|0
5455566|NCT02100228|18853337|P2|Overall Study|Other|19
5455567|NCT02100228|18853338|P1|Overall Study|Other|19
5455568|NCT02100124|18853374|P3|Overall Study|Withdrawal by Subject|0
5455569|NCT02100124|18853375|P2|Overall Study|Withdrawal by Subject|0
5455570|NCT02100124|18853376|P1|Overall Study|Withdrawal by Subject|1
5455571|NCT02100124|18853374|P3|Overall Study|Lost to Follow-up|3
5455572|NCT02100124|18853375|P2|Overall Study|Lost to Follow-up|11
5455573|NCT02100124|18853376|P1|Overall Study|Lost to Follow-up|5
5455574|NCT02099838|18853410|P2|Overall Study|Withdrawal by Subject|1
5455575|NCT02099838|18853411|P1|Overall Study|Withdrawal by Subject|0
5455576|NCT02099838|18853410|P2|Overall Study|Lost to Follow-up|1
5455577|NCT02099838|18853411|P1|Overall Study|Lost to Follow-up|3
5455578|NCT02099838|18853410|P2|Overall Study|Death|0
5455579|NCT02099838|18853411|P1|Overall Study|Death|1
5455580|NCT02099708|18853479|P1|Overall Study|Other|29
5455581|NCT02099708|18853479|P1|Overall Study|Lost to Follow-up|141
5455582|NCT02099708|18853479|P1|Overall Study|Data Not Available|30
5455583|NCT02099682|18853490|P1|Overall Study|Other|29
5455584|NCT02099682|18853490|P1|Overall Study|Lost to Follow-up|31
5455585|NCT02099682|18853490|P1|Overall Study|Data Not Available|51
5455586|NCT02099344|18853516|P2|Overall Study|Physician Decision|0
5455587|NCT02099344|18853517|P1|Overall Study|Physician Decision|1
5455588|NCT02099110|18853554|P5|Overall Study|Physician Decision|1
5455589|NCT02099110|18853555|P4|Overall Study|Physician Decision|2
5455590|NCT02099110|18853556|P3|Overall Study|Physician Decision|1
5455591|NCT02099110|18853557|P2|Overall Study|Physician Decision|0
5455592|NCT02099110|18853558|P1|Overall Study|Physician Decision|3
5455593|NCT02099110|18853554|P5|Overall Study|Non-compliance with study drug|1
5455594|NCT02099110|18853555|P4|Overall Study|Non-compliance with study drug|0
5455595|NCT02099110|18853556|P3|Overall Study|Non-compliance with study drug|0
5455596|NCT02099110|18853557|P2|Overall Study|Non-compliance with study drug|0
5455597|NCT02099110|18853558|P1|Overall Study|Non-compliance with study drug|2
5455598|NCT02099110|18853554|P5|Overall Study|Screen failure|1
5455599|NCT02099110|18853555|P4|Overall Study|Screen failure|0
5455600|NCT02099110|18853556|P3|Overall Study|Screen failure|0
5455601|NCT02099110|18853557|P2|Overall Study|Screen failure|0
5455602|NCT02099110|18853558|P1|Overall Study|Screen failure|0
5455603|NCT02099110|18853554|P5|Overall Study|Death|0
5455604|NCT02099110|18853555|P4|Overall Study|Death|0
5455605|NCT02099110|18853556|P3|Overall Study|Death|0
5455606|NCT02099110|18853557|P2|Overall Study|Death|1
5455607|NCT02099110|18853558|P1|Overall Study|Death|0
5455608|NCT02099110|18853554|P5|Overall Study|Lost to Follow-up|6
5455609|NCT02099110|18853555|P4|Overall Study|Lost to Follow-up|5
5455610|NCT02099110|18853556|P3|Overall Study|Lost to Follow-up|11
5455611|NCT02099110|18853557|P2|Overall Study|Lost to Follow-up|12
5455612|NCT02099110|18853558|P1|Overall Study|Lost to Follow-up|6
5455613|NCT02099110|18853554|P5|Overall Study|Adverse Event|2
5455614|NCT02099110|18853555|P4|Overall Study|Adverse Event|3
5455615|NCT02099110|18853556|P3|Overall Study|Adverse Event|2
5455616|NCT02099110|18853557|P2|Overall Study|Adverse Event|5
5455617|NCT02099110|18853558|P1|Overall Study|Adverse Event|3
5455618|NCT02099110|18853554|P5|Overall Study|Withdrawal by Subject|13
5455619|NCT02099110|18853555|P4|Overall Study|Withdrawal by Subject|9
5455620|NCT02099110|18853556|P3|Overall Study|Withdrawal by Subject|13
5455621|NCT02099110|18853557|P2|Overall Study|Withdrawal by Subject|11
5455622|NCT02099110|18853558|P1|Overall Study|Withdrawal by Subject|7
5455623|NCT02099110|18853554|P5|Overall Study|Participant moved|2
5455624|NCT02099110|18853555|P4|Overall Study|Participant moved|0
5455625|NCT02099110|18853556|P3|Overall Study|Participant moved|1
5455626|NCT02099110|18853557|P2|Overall Study|Participant moved|1
5455627|NCT02099110|18853558|P1|Overall Study|Participant moved|1
5455628|NCT02099110|18853554|P5|Overall Study|Protocol Violation|1
5455629|NCT02099110|18853555|P4|Overall Study|Protocol Violation|3
5455630|NCT02099110|18853556|P3|Overall Study|Protocol Violation|0
5455631|NCT02099110|18853557|P2|Overall Study|Protocol Violation|1
5455632|NCT02099110|18853558|P1|Overall Study|Protocol Violation|2
5455633|NCT02098746|18853659|P1|Overall Study|Data Not Available After Treatment|1
5455634|NCT02098746|18853659|P1|Overall Study|Enrolled 15 Days After the First Dose|1
5455635|NCT02098746|18853659|P1|Overall Study|Other Miscellaneous Reasons|1
5455636|NCT02098746|18853659|P1|Overall Study|Changes of Investigator|2
5455637|NCT02098733|18853667|P1|Overall Study|Lost to Follow-up|5
5455638|NCT02098733|18853667|P1|Overall Study|Data Not Available|5
5455639|NCT02098395|18853681|P4|Overall Study|Unclassified|2
5455640|NCT02098395|18853682|P3|Overall Study|Unclassified|3
5455641|NCT02098395|18853683|P2|Overall Study|Unclassified|0
5455642|NCT02098395|18853684|P1|Overall Study|Unclassified|0
5455643|NCT02098395|18853681|P4|Overall Study|Lost to Follow-up|3
5455644|NCT02098395|18853682|P3|Overall Study|Lost to Follow-up|0
5455645|NCT02098395|18853683|P2|Overall Study|Lost to Follow-up|1
5455646|NCT02098395|18853684|P1|Overall Study|Lost to Follow-up|2
5455647|NCT02098395|18853681|P4|Overall Study|Adverse Event|2
5455648|NCT02098395|18853682|P3|Overall Study|Adverse Event|34
5455649|NCT02098395|18853683|P2|Overall Study|Adverse Event|19
5455650|NCT02098395|18853684|P1|Overall Study|Adverse Event|12
5455651|NCT02098395|18853681|P4|Overall Study|Withdrawal by Subject|13
5455652|NCT02098395|18853682|P3|Overall Study|Withdrawal by Subject|5
5455653|NCT02098395|18853683|P2|Overall Study|Withdrawal by Subject|10
5455654|NCT02098395|18853684|P1|Overall Study|Withdrawal by Subject|10
5455655|NCT02098395|18853681|P4|Overall Study|Protocol Violation|7
5455656|NCT02098395|18853682|P3|Overall Study|Protocol Violation|0
5455657|NCT02098395|18853683|P2|Overall Study|Protocol Violation|2
5455658|NCT02098395|18853684|P1|Overall Study|Protocol Violation|2
5455659|NCT02098369|18853705|P3|Overall Study|Other|1
5455660|NCT02098369|18853706|P2|Overall Study|Other|2
5455661|NCT02098369|18853707|P1|Overall Study|Other|0
5455662|NCT02098369|18853705|P3|Overall Study|Death|1
5455663|NCT02098369|18853706|P2|Overall Study|Death|1
5455664|NCT02098369|18853707|P1|Overall Study|Death|1
5455665|NCT02098369|18853705|P3|Overall Study|Lost to Follow-up|3
5455666|NCT02098369|18853706|P2|Overall Study|Lost to Follow-up|1
5455667|NCT02098369|18853707|P1|Overall Study|Lost to Follow-up|5
5455668|NCT02098369|18853705|P3|Overall Study|Withdrawal by Subject|0
5455669|NCT02098369|18853706|P2|Overall Study|Withdrawal by Subject|5
5455670|NCT02098369|18853707|P1|Overall Study|Withdrawal by Subject|1
5455671|NCT02098109|18853745|P2|Overall Study|Protocol Violation|0
5455672|NCT02098109|18853746|P1|Overall Study|Protocol Violation|3
5455673|NCT02097823|18853824|P2|Overall Study|Withdrawal by Subject|1
5455674|NCT02097823|18853825|P1|Overall Study|Withdrawal by Subject|1
5455675|NCT02097745|18853840|P1|Overall Study|Reason Not Specified|96
5455676|NCT02097745|18853840|P1|Overall Study|Administrative/Other|27
5455677|NCT02097745|18853840|P1|Overall Study|Failure to Return|14
5455678|NCT02097745|18853840|P1|Overall Study|Death|16
5455679|NCT02097745|18853840|P1|Overall Study|Adverse Event|25
5455680|NCT02097719|18853878|P2|Overall Study|Adverse Event|0
5455681|NCT02097719|18853879|P1|Overall Study|Adverse Event|2
5455682|NCT02097719|18853878|P2|Overall Study|Lost to Follow-up|1
5455683|NCT02097719|18853879|P1|Overall Study|Lost to Follow-up|0
5455684|NCT02097719|18853878|P2|Overall Study|Subject Withdrew Consent|0
5455685|NCT02097719|18853879|P1|Overall Study|Subject Withdrew Consent|1
5455686|NCT02097472|18853944|P8|Received Vaccination 2|Adverse Event|0
5455687|NCT02097472|18853945|P7|Received Vaccination 2|Adverse Event|1
5455688|NCT02097472|18853946|P6|Received Vaccination 2|Adverse Event|0
5455689|NCT02097472|18853947|P5|Received Vaccination 2|Adverse Event|0
5455690|NCT02097472|18853948|P4|Received Vaccination 2|Adverse Event|0
5455691|NCT02097472|18853949|P3|Received Vaccination 2|Adverse Event|0
5455692|NCT02097472|18853950|P2|Received Vaccination 2|Adverse Event|0
5455693|NCT02097472|18853951|P1|Received Vaccination 2|Adverse Event|0
5455694|NCT02097420|18854372|P1|Overall Study|Not reached 12-month visit|7
5455695|NCT02097420|18854372|P1|Overall Study|Device explanted|3
5455696|NCT02097420|18854372|P1|Overall Study|Death|4
5455697|NCT02097290|18854395|P1|Overall Study|Attempt|8
5455698|NCT02097290|18854395|P1|Overall Study|Total Withdrawals|3
5455699|NCT02097290|18854395|P1|Overall Study|Death|6
5455700|NCT02097277|18854410|P5|Overall Study|Adverse Event|0
5455701|NCT02097277|18854411|P4|Overall Study|Adverse Event|2
5455702|NCT02097277|18854412|P3|Overall Study|Adverse Event|1
5455703|NCT02097277|18854413|P2|Overall Study|Adverse Event|0
5455704|NCT02097277|18854414|P1|Overall Study|Adverse Event|0
5455705|NCT02097277|18854410|P5|Overall Study|Withdrawal by Subject|0
5455706|NCT02097277|18854411|P4|Overall Study|Withdrawal by Subject|1
5455707|NCT02097277|18854412|P3|Overall Study|Withdrawal by Subject|0
5455708|NCT02097277|18854413|P2|Overall Study|Withdrawal by Subject|1
5455709|NCT02097277|18854414|P1|Overall Study|Withdrawal by Subject|2
5455710|NCT02097277|18854410|P5|Overall Study|Lost to Follow-up|0
5455711|NCT02097277|18854411|P4|Overall Study|Lost to Follow-up|0
5455712|NCT02097277|18854412|P3|Overall Study|Lost to Follow-up|1
5455713|NCT02097277|18854413|P2|Overall Study|Lost to Follow-up|1
5455714|NCT02097277|18854414|P1|Overall Study|Lost to Follow-up|0
5455715|NCT02097277|18854410|P5|Overall Study|Subject request to discontinue treatment|1
5455716|NCT02097277|18854411|P4|Overall Study|Subject request to discontinue treatment|0
5455717|NCT02097277|18854412|P3|Overall Study|Subject request to discontinue treatment|0
5455718|NCT02097277|18854413|P2|Overall Study|Subject request to discontinue treatment|0
5455719|NCT02097277|18854414|P1|Overall Study|Subject request to discontinue treatment|0
5455720|NCT02097277|18854410|P5|Overall Study|Subject no longer meets study criteria|0
5455721|NCT02097277|18854411|P4|Overall Study|Subject no longer meets study criteria|1
5455722|NCT02097277|18854412|P3|Overall Study|Subject no longer meets study criteria|0
5455723|NCT02097277|18854413|P2|Overall Study|Subject no longer meets study criteria|1
5455724|NCT02097277|18854414|P1|Overall Study|Subject no longer meets study criteria|0
5455725|NCT02097238|18854497|P1|Overall Study|Progressive Disease|17
5455726|NCT02097238|18854497|P1|Overall Study|Physician Decision|1
5455727|NCT02097238|18854497|P1|Overall Study|Death|1
5455728|NCT02097134|18854506|P1|Overall Study|Refusal of Further Protocol Therapy|1
5455729|NCT02097134|18854506|P1|Overall Study|Progressive Disease|3
5455730|NCT02097134|18854506|P1|Overall Study|Non-Protocol Therapy|1
5455731|NCT02097134|18854506|P1|Overall Study|Physician Decision|4
5455732|NCT02097108|18854514|P1|Overall Study|patient was abroad for 6 months|1
5455733|NCT02097108|18854514|P1|Overall Study|Adverse Event|1
5455734|NCT02097056|18854521|P1|Overall Study|Other|2
5455735|NCT02097056|18854521|P1|Overall Study|Adverse Event|37
5455736|NCT02097056|18854521|P1|Overall Study|Lost to Follow-up|2
5455737|NCT02097056|18854521|P1|Overall Study|Withdrawal by Subject|15
5455738|NCT02097056|18854521|P1|Overall Study|Protocol Violation|2
5455739|NCT02097030|18854529|P2|First Intervention (3 Days)|Visual Acuity|1
5455740|NCT02097030|18854530|P1|First Intervention (3 Days)|Visual Acuity|0
5455741|NCT02097030|18854529|P2|First Intervention (3 Days)|Lost to Follow-up|0
5455742|NCT02097030|18854530|P1|First Intervention (3 Days)|Lost to Follow-up|1
5455743|NCT02096952|18854591|P1|Overall Study|Adverse Event|1
5455744|NCT02096900|18854597|P2|Overall Study|Surgery cancelled- medication received|1
5455745|NCT02096900|18854598|P1|Overall Study|Surgery cancelled- medication received|1
5455746|NCT02096900|18854597|P2|Overall Study|Did not receive medication|1
5455747|NCT02096900|18854598|P1|Overall Study|Did not receive medication|3
5455748|NCT02096835|18854650|P3|Overall Study|Lost to Follow-up|1
5455749|NCT02096835|18854651|P2|Overall Study|Lost to Follow-up|0
5455750|NCT02096835|18854652|P1|Overall Study|Lost to Follow-up|1
5455751|NCT02096835|18854650|P3|Overall Study|converted to open procedures|0
5455752|NCT02096835|18854651|P2|Overall Study|converted to open procedures|0
5455753|NCT02096835|18854652|P1|Overall Study|converted to open procedures|1
5455754|NCT02096835|18854650|P3|Overall Study|Withdrawal by Subject|0
5455755|NCT02096835|18854651|P2|Overall Study|Withdrawal by Subject|0
5455756|NCT02096835|18854652|P1|Overall Study|Withdrawal by Subject|1
5455757|NCT02096744|18854669|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
5455758|NCT02096744|18854670|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
5455759|NCT02096744|18854669|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
5455760|NCT02096744|18854670|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
5455761|NCT02096744|18854669|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
5455762|NCT02096744|18854670|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
5455763|NCT02096705|18854724|P2|Follow-up|Subjects not reporting status|2
5455764|NCT02096705|18854725|P1|Follow-up|Subjects not reporting status|1
5455765|NCT02096705|18854724|P2|Follow-up|Adverse Event|2
5455766|NCT02096705|18854725|P1|Follow-up|Adverse Event|2
5455767|NCT02096705|18854724|P2|Follow-up|Withdrawal by Subject|0
5455768|NCT02096705|18854725|P1|Follow-up|Withdrawal by Subject|1
5455769|NCT02096705|18854724|P2|Treatment|Other|1
5455770|NCT02096705|18854725|P1|Treatment|Other|1
5455771|NCT02096705|18854724|P2|Treatment|Withdrawal by Subject|0
5455772|NCT02096705|18854725|P1|Treatment|Withdrawal by Subject|1
5455773|NCT02096705|18854724|P2|Treatment|Subject request to discontinue treatment|1
5455774|NCT02096705|18854725|P1|Treatment|Subject request to discontinue treatment|1
5455775|NCT02096705|18854724|P2|Treatment|Adverse Event|3
5455776|NCT02096705|18854725|P1|Treatment|Adverse Event|6
5455777|NCT02096588|18854768|P2|Overall Study|Withdrawal by Subject|1
5455778|NCT02096588|18854769|P1|Overall Study|Withdrawal by Subject|0
5455779|NCT02096588|18854768|P2|Overall Study|Lack of Efficacy|0
5455780|NCT02096588|18854769|P1|Overall Study|Lack of Efficacy|2
5455781|NCT02096471|18854795|P1|Overall Study|Non-Compliant|2
5455782|NCT02096471|18854795|P1|Overall Study|Withdrawal by Subject|3
5455783|NCT02096471|18854795|P1|Overall Study|Lack of Efficacy|7
5455784|NCT02096471|18854795|P1|Overall Study|Adverse Event|1
5455785|NCT02096263|18854822|P3|Overall Study|Withdrawal by Subject|8
5455786|NCT02096263|18854823|P2|Overall Study|Withdrawal by Subject|7
5455787|NCT02096263|18854824|P1|Overall Study|Withdrawal by Subject|5
5455788|NCT02096263|18854822|P3|Overall Study|Protocol Violation|8
5455789|NCT02096263|18854823|P2|Overall Study|Protocol Violation|2
5455790|NCT02096263|18854824|P1|Overall Study|Protocol Violation|7
5455791|NCT02096263|18854822|P3|Overall Study|Sponsor study termination|1
5455792|NCT02096263|18854823|P2|Overall Study|Sponsor study termination|0
5455793|NCT02096263|18854824|P1|Overall Study|Sponsor study termination|0
5455794|NCT02096263|18854822|P3|Overall Study|Other|6
5455795|NCT02096263|18854823|P2|Overall Study|Other|9
5455796|NCT02096263|18854824|P1|Overall Study|Other|7
5455797|NCT02096263|18854822|P3|Overall Study|Lost to Follow-up|15
5455798|NCT02096263|18854823|P2|Overall Study|Lost to Follow-up|18
5455799|NCT02096263|18854824|P1|Overall Study|Lost to Follow-up|14
5455800|NCT02096263|18854822|P3|Overall Study|Adverse Event|1
5455801|NCT02096263|18854823|P2|Overall Study|Adverse Event|0
5455802|NCT02096263|18854824|P1|Overall Study|Adverse Event|1
5455803|NCT02096042|18855012|P3|Overall Study|Disease Progression|0
5455804|NCT02096042|18855013|P2|Overall Study|Disease Progression|0
5455805|NCT02096042|18855014|P1|Overall Study|Disease Progression|1
5455806|NCT02096003|18855036|P2|Overall Study|additional surgery|1
5455807|NCT02096003|18855037|P1|Overall Study|additional surgery|2
5455808|NCT02096003|18855036|P2|Overall Study|Protocol Violation|2
5455809|NCT02096003|18855037|P1|Overall Study|Protocol Violation|0
5455810|NCT02095951|18855053|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
5455811|NCT02095951|18855054|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
5455812|NCT02095873|18855074|P2|Second Intervention (8 Weeks)|Protocol Violation|0
5455813|NCT02095873|18855075|P1|Second Intervention (8 Weeks)|Protocol Violation|1
5455814|NCT02095873|18855074|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
5455815|NCT02095873|18855075|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
5455816|NCT02095873|18855074|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
5455817|NCT02095873|18855075|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
5455818|NCT02095691|18855087|P1|Overall Study|Physician Decision|1
5455819|NCT02095535|18855119|P1|Recruitment|Protocol Violation|2
5455820|NCT02095223|18855141|P2|Overall Study|Withdrawal by Subject|0
5455821|NCT02095223|18855142|P1|Overall Study|Withdrawal by Subject|1
5455822|NCT02095197|18855152|P2|Overall Study|Lost to Follow-up|3
5455823|NCT02095197|18855153|P1|Overall Study|Lost to Follow-up|0
5455824|NCT02095158|18855165|P1|Overall Study|Other Miscellaneous Reasons|1
5455825|NCT02095158|18855165|P1|Overall Study|Protocol Violation|1
5455826|NCT02095158|18855165|P1|Overall Study|Personal Reasons|35
5455827|NCT02095158|18855165|P1|Overall Study|Lost to Follow-up|20
5455828|NCT02095158|18855165|P1|Overall Study|Pregnancy|1
5455829|NCT02095158|18855165|P1|Overall Study|Lack of Efficacy|3
5455830|NCT02095158|18855165|P1|Overall Study|Adverse Event|14
5455831|NCT02095145|18855172|P2|Overall Study|Withdrawal by Subject|0
5455832|NCT02095145|18855173|P1|Overall Study|Withdrawal by Subject|1
5455833|NCT02095106|18855219|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
5455834|NCT02095106|18855220|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
5455835|NCT02094937|18855236|P4|12 Weeks in Period 2|Randomized incorrectly|0
5455836|NCT02094937|18855237|P3|12 Weeks in Period 2|Randomized incorrectly|0
5455837|NCT02094937|18855238|P2|12 Weeks in Period 2|Randomized incorrectly|1
5455838|NCT02094937|18855239|P1|12 Weeks in Period 2|Randomized incorrectly|0
5455839|NCT02094937|18855236|P4|12 Weeks in Period 2|Withdrawal by Subject|0
5455840|NCT02094937|18855237|P3|12 Weeks in Period 2|Withdrawal by Subject|2
5455841|NCT02094937|18855238|P2|12 Weeks in Period 2|Withdrawal by Subject|2
5455842|NCT02094937|18855239|P1|12 Weeks in Period 2|Withdrawal by Subject|0
5455843|NCT02094937|18855236|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
5455844|NCT02094937|18855237|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
5455845|NCT02094937|18855238|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
5455846|NCT02094937|18855239|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
5455847|NCT02094937|18855236|P4|12 Weeks in Period 2|Lack of Efficacy|0
5455848|NCT02094937|18855237|P3|12 Weeks in Period 2|Lack of Efficacy|0
5455849|NCT02094937|18855238|P2|12 Weeks in Period 2|Lack of Efficacy|1
5455850|NCT02094937|18855239|P1|12 Weeks in Period 2|Lack of Efficacy|0
5455851|NCT02094937|18855236|P4|12 Weeks in Period 2|Adverse Event|1
5455852|NCT02094937|18855237|P3|12 Weeks in Period 2|Adverse Event|4
5455853|NCT02094937|18855238|P2|12 Weeks in Period 2|Adverse Event|2
5455854|NCT02094937|18855239|P1|12 Weeks in Period 2|Adverse Event|0
5455855|NCT02094937|18855236|P4|8 Weeks in Period 1|Withdrawal by Subject|0
5455856|NCT02094937|18855237|P3|8 Weeks in Period 1|Withdrawal by Subject|0
5455857|NCT02094937|18855238|P2|8 Weeks in Period 1|Withdrawal by Subject|0
5455858|NCT02094937|18855239|P1|8 Weeks in Period 1|Withdrawal by Subject|4
5455859|NCT02094937|18855236|P4|8 Weeks in Period 1|Physician Decision|0
5455860|NCT02094937|18855237|P3|8 Weeks in Period 1|Physician Decision|0
5455861|NCT02094937|18855238|P2|8 Weeks in Period 1|Physician Decision|0
5455862|NCT02094937|18855239|P1|8 Weeks in Period 1|Physician Decision|1
5455863|NCT02094937|18855236|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
5455864|NCT02094937|18855237|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
5455865|NCT02094937|18855238|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
5455866|NCT02094937|18855239|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
5455867|NCT02094937|18855236|P4|8 Weeks in Period 1|Protocol Violation|0
5455868|NCT02094937|18855237|P3|8 Weeks in Period 1|Protocol Violation|0
5455869|NCT02094937|18855238|P2|8 Weeks in Period 1|Protocol Violation|0
5455870|NCT02094937|18855239|P1|8 Weeks in Period 1|Protocol Violation|2
5455871|NCT02094937|18855236|P4|8 Weeks in Period 1|Lack of Efficacy|0
5455872|NCT02094937|18855237|P3|8 Weeks in Period 1|Lack of Efficacy|0
5455873|NCT02094937|18855238|P2|8 Weeks in Period 1|Lack of Efficacy|0
5455874|NCT02094937|18855239|P1|8 Weeks in Period 1|Lack of Efficacy|3
5455875|NCT02094937|18855236|P4|8 Weeks in Period 1|Adverse Event|0
5455876|NCT02094937|18855237|P3|8 Weeks in Period 1|Adverse Event|0
5455877|NCT02094937|18855238|P2|8 Weeks in Period 1|Adverse Event|0
5455878|NCT02094937|18855239|P1|8 Weeks in Period 1|Adverse Event|9
5455879|NCT02094898|18855269|P1|Overall Study|Lack of Efficacy|1
5455880|NCT02094898|18855269|P1|Overall Study|Adverse Event|2
5455881|NCT02094898|18855269|P1|Overall Study|Clinical Worsening|2
5455882|NCT02094885|18855316|P2|Overall Study|Withdrawn due to age|0
5455883|NCT02094885|18855317|P1|Overall Study|Withdrawn due to age|1
5455884|NCT02094885|18855316|P2|Overall Study|Death|5
5455885|NCT02094885|18855317|P1|Overall Study|Death|1
5455886|NCT02094677|18855340|P2|Overall Study|Screening|1
5455887|NCT02094677|18855341|P1|Overall Study|Screening|3
5455888|NCT02094612|18855420|P2|Overall Study|Never started ADHD medication|23
5455889|NCT02094612|18855421|P1|Overall Study|Never started ADHD medication|32
5455890|NCT02094612|18855420|P2|Overall Study|Lost to Follow-up|47
5455891|NCT02094612|18855421|P1|Overall Study|Lost to Follow-up|47
5455892|NCT02094573|18855441|P2|Overall Study|Ongoing|76
5455893|NCT02094573|18855442|P1|Overall Study|Ongoing|64
5455894|NCT02094573|18855441|P2|Overall Study|Randomized but not treated|0
5455895|NCT02094573|18855442|P1|Overall Study|Randomized but not treated|3
5455896|NCT02094573|18855441|P2|Overall Study|Withdrawal by Subject|4
5455897|NCT02094573|18855442|P1|Overall Study|Withdrawal by Subject|2
5455898|NCT02094573|18855441|P2|Overall Study|Non-compliance with study drug|1
5455899|NCT02094573|18855442|P1|Overall Study|Non-compliance with study drug|0
5455900|NCT02094573|18855441|P2|Overall Study|Death|1
5455901|NCT02094573|18855442|P1|Overall Study|Death|7
5455902|NCT02094573|18855441|P2|Overall Study|Adverse Event|9
5455903|NCT02094573|18855442|P1|Overall Study|Adverse Event|3
5455904|NCT02094573|18855441|P2|Overall Study|Clinical Progressive Disease|3
5455905|NCT02094573|18855442|P1|Overall Study|Clinical Progressive Disease|4
5455906|NCT02094573|18855441|P2|Overall Study|Documented Progressive Disease|16
5455907|NCT02094573|18855442|P1|Overall Study|Documented Progressive Disease|29
5455908|NCT02094300|18855524|P1|Overall Study|Still be eligible for follow-up|3
5455909|NCT02094300|18855524|P1|Overall Study|Lost to Follow-up|10
5455910|NCT02094300|18855524|P1|Overall Study|Death|7
5455911|NCT02094261|18855528|P1|Overall Study|Ongoing Study at Data Cut-off|181
5455912|NCT02094261|18855528|P1|Overall Study|Withdrawal by Subject|4
5455913|NCT02094261|18855528|P1|Overall Study|Lost to Follow-up|1
5455914|NCT02094261|18855528|P1|Overall Study|Death|24
5455915|NCT02093923|18855570|P5|Overall Study|Screen failure after randomization|0
5455916|NCT02093923|18855571|P4|Overall Study|Screen failure after randomization|1
5455917|NCT02093923|18855572|P3|Overall Study|Screen failure after randomization|0
5455918|NCT02093923|18855573|P2|Overall Study|Screen failure after randomization|0
5455919|NCT02093923|18855574|P1|Overall Study|Screen failure after randomization|0
5455920|NCT02093923|18855570|P5|Overall Study|Lost to Follow-up|0
5455921|NCT02093923|18855571|P4|Overall Study|Lost to Follow-up|1
5455922|NCT02093923|18855572|P3|Overall Study|Lost to Follow-up|0
5455923|NCT02093923|18855573|P2|Overall Study|Lost to Follow-up|0
5455924|NCT02093923|18855574|P1|Overall Study|Lost to Follow-up|0
5455925|NCT02093897|18855629|P1|Overall Study|Adverse event, non-fatal|1
5455926|NCT02093897|18855629|P1|Overall Study|Planned age group closure - no's reached|17
5455927|NCT02093897|18855629|P1|Overall Study|Physician Decision|1
5455928|NCT02093689|18855745|P3|Overall Study|Physician Decision|0
5455929|NCT02093689|18855746|P2|Overall Study|Physician Decision|0
5455930|NCT02093689|18855747|P1|Overall Study|Physician Decision|4
5455931|NCT02093663|18855753|P5|Double Blind Maintenance Phase(26 Weeks)|Missing|1
5455932|NCT02093663|18855754|P4|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5455933|NCT02093663|18855755|P3|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5455934|NCT02093663|18855756|P2|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5455935|NCT02093663|18855757|P1|Double Blind Maintenance Phase(26 Weeks)|Missing|0
5455936|NCT02093663|18855753|P5|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
5455937|NCT02093663|18855754|P4|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
5455938|NCT02093663|18855755|P3|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
5455939|NCT02093663|18855756|P2|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
5455940|NCT02093663|18855757|P1|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
5455941|NCT02093663|18855753|P5|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
5455942|NCT02093663|18855754|P4|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
5455943|NCT02093663|18855755|P3|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
5455944|NCT02093663|18855756|P2|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
5455945|NCT02093663|18855757|P1|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
5455946|NCT02093663|18855753|P5|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
5455947|NCT02093663|18855754|P4|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
5455948|NCT02093663|18855755|P3|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
5455949|NCT02093663|18855756|P2|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
5455950|NCT02093663|18855757|P1|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
5455951|NCT02093663|18855753|P5|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5455952|NCT02093663|18855754|P4|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5455953|NCT02093663|18855755|P3|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
5455954|NCT02093663|18855756|P2|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5455955|NCT02093663|18855757|P1|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
5455956|NCT02093663|18855753|P5|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5455957|NCT02093663|18855754|P4|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5455958|NCT02093663|18855755|P3|Open Label Acute Phase (8 Weeks)|Adverse Event|1
5455959|NCT02093663|18855756|P2|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5455960|NCT02093663|18855757|P1|Open Label Acute Phase (8 Weeks)|Adverse Event|0
5455961|NCT02093663|18855753|P5|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
5455962|NCT02093663|18855754|P4|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
5455963|NCT02093663|18855755|P3|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
5455964|NCT02093663|18855756|P2|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
5455965|NCT02093663|18855757|P1|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
5455966|NCT02093663|18855753|P5|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5455967|NCT02093663|18855754|P4|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5455968|NCT02093663|18855755|P3|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5455969|NCT02093663|18855756|P2|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
5455970|NCT02093663|18855757|P1|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
5455971|NCT02093663|18855753|P5|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5455972|NCT02093663|18855754|P4|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5455973|NCT02093663|18855755|P3|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5455974|NCT02093663|18855756|P2|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
5455975|NCT02093663|18855757|P1|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
5455976|NCT02093520|18855786|P2|Overall Study|Not treated|22
5455977|NCT02093520|18855787|P1|Overall Study|Not treated|6
5455978|NCT02093390|18855799|P2|Overall Study|Withdrawal by Subject|1
5455979|NCT02093390|18855800|P1|Overall Study|Withdrawal by Subject|0
5455980|NCT02093351|18855839|P4|Part B|Death|1
5455981|NCT02093351|18855840|P3|Part B|Death|0
5455982|NCT02093351|18855841|P2|Part B|Death|0
5455983|NCT02093351|18855842|P1|Part B|Death|0
5455984|NCT02093351|18855839|P4|Part B|Adverse Event|2
5455985|NCT02093351|18855840|P3|Part B|Adverse Event|0
5455986|NCT02093351|18855841|P2|Part B|Adverse Event|0
5455987|NCT02093351|18855842|P1|Part B|Adverse Event|0
5455988|NCT02093351|18855839|P4|Part B|Condition under investigation worsened|39
5455989|NCT02093351|18855840|P3|Part B|Condition under investigation worsened|0
5455990|NCT02093351|18855841|P2|Part B|Condition under investigation worsened|0
5455991|NCT02093351|18855842|P1|Part B|Condition under investigation worsened|0
5455992|NCT02093351|18855839|P4|Part B|Lack of therapeutic response|12
5455993|NCT02093351|18855840|P3|Part B|Lack of therapeutic response|0
5455994|NCT02093351|18855841|P2|Part B|Lack of therapeutic response|0
5455995|NCT02093351|18855842|P1|Part B|Lack of therapeutic response|0
5455996|NCT02093351|18855839|P4|Part B|Adverse event + disease progression|1
5455997|NCT02093351|18855840|P3|Part B|Adverse event + disease progression|0
5455998|NCT02093351|18855841|P2|Part B|Adverse event + disease progression|0
5455999|NCT02093351|18855842|P1|Part B|Adverse event + disease progression|0
5456000|NCT02093351|18855839|P4|Part B|Complete response|1
5456001|NCT02093351|18855840|P3|Part B|Complete response|0
5456002|NCT02093351|18855841|P2|Part B|Complete response|0
5456003|NCT02093351|18855842|P1|Part B|Complete response|0
5456004|NCT02093351|18855839|P4|Part B|Disease progression|4
5456005|NCT02093351|18855840|P3|Part B|Disease progression|0
5456006|NCT02093351|18855841|P2|Part B|Disease progression|0
5456007|NCT02093351|18855842|P1|Part B|Disease progression|0
5456008|NCT02093351|18855839|P4|Part B|Patient decision|3
5456009|NCT02093351|18855840|P3|Part B|Patient decision|0
5456010|NCT02093351|18855841|P2|Part B|Patient decision|0
5456011|NCT02093351|18855842|P1|Part B|Patient decision|0
5456012|NCT02093351|18855839|P4|Part A|Death|0
5456013|NCT02093351|18855840|P3|Part A|Death|0
5456014|NCT02093351|18855841|P2|Part A|Death|1
5456015|NCT02093351|18855842|P1|Part A|Death|0
5456016|NCT02093351|18855839|P4|Part A|Condition under investigation worsened|0
5456017|NCT02093351|18855840|P3|Part A|Condition under investigation worsened|2
5456018|NCT02093351|18855841|P2|Part A|Condition under investigation worsened|0
5456019|NCT02093351|18855842|P1|Part A|Condition under investigation worsened|2
5456020|NCT02093351|18855839|P4|Part A|Adverse Event|0
5456021|NCT02093351|18855840|P3|Part A|Adverse Event|1
5456022|NCT02093351|18855841|P2|Part A|Adverse Event|1
5456023|NCT02093351|18855842|P1|Part A|Adverse Event|0
5456024|NCT02093221|18855899|P5|Overall Study|Study termination|7
5456025|NCT02093221|18855900|P4|Overall Study|Study termination|6
5456026|NCT02093221|18855901|P3|Overall Study|Study termination|4
5456027|NCT02093221|18855902|P2|Overall Study|Study termination|5
5456028|NCT02093221|18855903|P1|Overall Study|Study termination|6
5456029|NCT02093221|18855899|P5|Overall Study|Protocol Violation|0
5456030|NCT02093221|18855900|P4|Overall Study|Protocol Violation|0
5456031|NCT02093221|18855901|P3|Overall Study|Protocol Violation|0
5456032|NCT02093221|18855902|P2|Overall Study|Protocol Violation|1
5456033|NCT02093221|18855903|P1|Overall Study|Protocol Violation|0
5456034|NCT02093221|18855899|P5|Overall Study|Death|0
5456035|NCT02093221|18855900|P4|Overall Study|Death|0
5456036|NCT02093221|18855901|P3|Overall Study|Death|0
5456037|NCT02093221|18855902|P2|Overall Study|Death|1
5456038|NCT02093221|18855903|P1|Overall Study|Death|0
5456039|NCT02093221|18855899|P5|Overall Study|Lost to Follow-up|0
5456040|NCT02093221|18855900|P4|Overall Study|Lost to Follow-up|1
5456041|NCT02093221|18855901|P3|Overall Study|Lost to Follow-up|1
5456042|NCT02093221|18855902|P2|Overall Study|Lost to Follow-up|0
5456043|NCT02093221|18855903|P1|Overall Study|Lost to Follow-up|2
5456044|NCT02093221|18855899|P5|Overall Study|Withdrawal by Subject|1
5456045|NCT02093221|18855900|P4|Overall Study|Withdrawal by Subject|1
5456046|NCT02093221|18855901|P3|Overall Study|Withdrawal by Subject|4
5456047|NCT02093221|18855902|P2|Overall Study|Withdrawal by Subject|1
5456048|NCT02093221|18855903|P1|Overall Study|Withdrawal by Subject|1
5456049|NCT02093221|18855899|P5|Overall Study|Adverse Event|0
5456050|NCT02093221|18855900|P4|Overall Study|Adverse Event|0
5456051|NCT02093221|18855901|P3|Overall Study|Adverse Event|0
5456052|NCT02093221|18855902|P2|Overall Study|Adverse Event|0
5456053|NCT02093221|18855903|P1|Overall Study|Adverse Event|1
5456054|NCT02093026|18855940|P1|Overall Study|Other|157
5456055|NCT02093026|18855940|P1|Overall Study|Death|10
5456056|NCT02093026|18855940|P1|Overall Study|Adverse Event|26
5456057|NCT02092961|18855962|P3|Overall Study|Adverse Event|0
5456058|NCT02092961|18855963|P2|Overall Study|Adverse Event|4
5456059|NCT02092961|18855964|P1|Overall Study|Adverse Event|2
5456060|NCT02092961|18855962|P3|Overall Study|Dev. of study specific discont. criteria|0
5456061|NCT02092961|18855963|P2|Overall Study|Dev. of study specific discont. criteria|0
5456062|NCT02092961|18855964|P1|Overall Study|Dev. of study specific discont. criteria|3
5456063|NCT02092961|18855962|P3|Overall Study|Lack of therapeutic response|3
5456064|NCT02092961|18855963|P2|Overall Study|Lack of therapeutic response|1
5456065|NCT02092961|18855964|P1|Overall Study|Lack of therapeutic response|2
5456066|NCT02092961|18855962|P3|Overall Study|Study stopped|12
5456067|NCT02092961|18855963|P2|Overall Study|Study stopped|9
5456068|NCT02092961|18855964|P1|Overall Study|Study stopped|13
5456069|NCT02092961|18855962|P3|Overall Study|Not reported|1
5456070|NCT02092961|18855963|P2|Overall Study|Not reported|0
5456071|NCT02092961|18855964|P1|Overall Study|Not reported|1
5456072|NCT02092909|18855989|P4|Overall Study|Miscellaneous|1
5456073|NCT02092909|18855990|P3|Overall Study|Miscellaneous|2
5456074|NCT02092909|18855991|P2|Overall Study|Miscellaneous|1
5456075|NCT02092909|18855992|P1|Overall Study|Miscellaneous|1
5456076|NCT02092909|18855989|P4|Overall Study|Study terminated by Sponsor|2
5456077|NCT02092909|18855990|P3|Overall Study|Study terminated by Sponsor|0
5456078|NCT02092909|18855991|P2|Overall Study|Study terminated by Sponsor|0
5456079|NCT02092909|18855992|P1|Overall Study|Study terminated by Sponsor|0
5456080|NCT02092909|18855989|P4|Overall Study|Withdrawal by Subject|1
5456081|NCT02092909|18855990|P3|Overall Study|Withdrawal by Subject|2
5456082|NCT02092909|18855991|P2|Overall Study|Withdrawal by Subject|0
5456083|NCT02092909|18855992|P1|Overall Study|Withdrawal by Subject|0
5456084|NCT02092909|18855989|P4|Overall Study|Lack of Efficacy|0
5456085|NCT02092909|18855990|P3|Overall Study|Lack of Efficacy|1
5456086|NCT02092909|18855991|P2|Overall Study|Lack of Efficacy|2
5456087|NCT02092909|18855992|P1|Overall Study|Lack of Efficacy|0
5456088|NCT02092909|18855989|P4|Overall Study|Adverse Event|2
5456089|NCT02092909|18855990|P3|Overall Study|Adverse Event|4
5456090|NCT02092909|18855991|P2|Overall Study|Adverse Event|0
5456091|NCT02092909|18855992|P1|Overall Study|Adverse Event|0
5456092|NCT02092662|18856033|P2|Overall Study|Lost to Follow-up|0
5456093|NCT02092662|18856034|P1|Overall Study|Lost to Follow-up|13
5456094|NCT02092389|18856093|P1|Overall Study|Other|5
5456095|NCT02092389|18856093|P1|Overall Study|Adverse Event|1
5456096|NCT02092350|18856105|P2|Overall Study|Withdrawal by Subject|2
5456097|NCT02092350|18856106|P1|Overall Study|Withdrawal by Subject|2
5456098|NCT02092350|18856105|P2|Overall Study|Screen Failure|0
5456099|NCT02092350|18856106|P1|Overall Study|Screen Failure|1
5456100|NCT02092350|18856105|P2|Overall Study|Physician Decision|1
5456101|NCT02092350|18856106|P1|Overall Study|Physician Decision|1
5456102|NCT02092350|18856105|P2|Overall Study|Protocol Violation|0
5456103|NCT02092350|18856106|P1|Overall Study|Protocol Violation|1
5456104|NCT02092350|18856105|P2|Overall Study|Lost to Follow-up|1
5456105|NCT02092350|18856106|P1|Overall Study|Lost to Follow-up|3
5456106|NCT02092350|18856105|P2|Overall Study|Death|5
5456107|NCT02092350|18856106|P1|Overall Study|Death|2
5456108|NCT02092350|18856105|P2|Overall Study|Adverse Event|3
5456109|NCT02092350|18856106|P1|Overall Study|Adverse Event|0
5456110|NCT02092324|18856123|P1|Overall Study|Misdiagnosis|2
5456111|NCT02092324|18856123|P1|Overall Study|Physician Decision|7
5456112|NCT02092324|18856123|P1|Overall Study|Proceed to Transplant|3
5456113|NCT02092324|18856123|P1|Overall Study|Lack of Efficacy|6
5456114|NCT02092324|18856123|P1|Overall Study|Adverse Event|1
5456115|NCT02092285|18856154|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
5456116|NCT02092285|18856154|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
5456117|NCT02092285|18856154|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
5456118|NCT02092285|18856154|P1|Maintenance Phase & Follow-up|Protocol Violation|11
5456119|NCT02092285|18856154|P1|Maintenance Phase & Follow-up|Pregnancy|1
5456120|NCT02092285|18856154|P1|Maintenance Phase & Follow-up|Physician Decision|10
5456121|NCT02092285|18856154|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
5456122|NCT02092285|18856154|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
5456123|NCT02092285|18856154|P1|Maintenance Phase & Follow-up|Adverse Event|22
5456124|NCT02092285|18856154|P1|Induction Phase|Lack of Efficacy|14
5456125|NCT02092285|18856154|P1|Induction Phase|Withdrawal by Subject|2
5456126|NCT02092285|18856154|P1|Induction Phase|Relapse/Recurrence|7
5456127|NCT02092285|18856154|P1|Induction Phase|Pregnancy|1
5456128|NCT02092285|18856154|P1|Induction Phase|Physician Decision|4
5456129|NCT02092285|18856154|P1|Induction Phase|Adverse Event|7
5456130|NCT02092220|18856158|P2|Period 2|Nausea, Anxiety, Inconvenience|1
5456131|NCT02092220|18856159|P1|Period 2|Nausea, Anxiety, Inconvenience|0
5456132|NCT02092220|18856158|P2|Period 2|Severe Hypoglycaemia|0
5456133|NCT02092220|18856159|P1|Period 2|Severe Hypoglycaemia|1
5456134|NCT02092220|18856158|P2|Period 1|Unrelated Illness|2
5456135|NCT02092220|18856159|P1|Period 1|Unrelated Illness|0
5456136|NCT02092116|18856232|P2|Overall Study|Adverse Event|1
5456137|NCT02092116|18856233|P1|Overall Study|Adverse Event|0
5456138|NCT02092116|18856232|P2|Overall Study|Withdrawal by Subject|3
5456139|NCT02092116|18856233|P1|Overall Study|Withdrawal by Subject|0
5456140|NCT02092025|18856242|P1|Overall Study|Protocol Deviation|24
5456141|NCT02092025|18856242|P1|Overall Study|Case Report Forms Uncollected|44
5456142|NCT02091986|18856251|P3|Overall Study|Adverse Event|2
5456143|NCT02091986|18856252|P2|Overall Study|Adverse Event|0
5456144|NCT02091986|18856253|P1|Overall Study|Adverse Event|0
5456145|NCT02091986|18856251|P3|Overall Study|Withdrawal by Subject|3
5456146|NCT02091986|18856252|P2|Overall Study|Withdrawal by Subject|8
5456147|NCT02091986|18856253|P1|Overall Study|Withdrawal by Subject|4
5456148|NCT02091986|18856251|P3|Overall Study|Lost to Follow-up|0
5456149|NCT02091986|18856252|P2|Overall Study|Lost to Follow-up|0
5456150|NCT02091986|18856253|P1|Overall Study|Lost to Follow-up|1
5456151|NCT02091986|18856251|P3|Overall Study|7 rand in error 1 patient decision|3
5456152|NCT02091986|18856252|P2|Overall Study|7 rand in error 1 patient decision|3
5456153|NCT02091986|18856253|P1|Overall Study|7 rand in error 1 patient decision|2
5456154|NCT02091960|18856300|P1|Overall Study|On Study at Data Cut-off|12
5456155|NCT02091960|18856300|P1|Overall Study|Miscellaneous Reasons|31
5456156|NCT02091960|18856300|P1|Overall Study|Withdrawal by Subject|1
5456157|NCT02091960|18856300|P1|Overall Study|Death|7
5456158|NCT02091921|18856311|P1|Overall Study|Adverse Event|3
5456159|NCT02091869|18856320|P2|Overall Study|Withdrawal by Subject|3
5456160|NCT02091869|18856321|P1|Overall Study|Withdrawal by Subject|0
5456161|NCT02091752|18856362|P1|Overall Study|Adverse Event|1
5456162|NCT02091752|18856362|P1|Overall Study|Study terminated by Sponsor|2
5456163|NCT02091739|18856376|P5|EP: 48 Weeks|Withdrawal by Subject|6
5456164|NCT02091739|18856377|P4|EP: 48 Weeks|Withdrawal by Subject|2
5456165|NCT02091739|18856378|P3|EP: 48 Weeks|Withdrawal by Subject|0
5456166|NCT02091739|18856379|P2|EP: 48 Weeks|Withdrawal by Subject|0
5456167|NCT02091739|18856380|P1|EP: 48 Weeks|Withdrawal by Subject|0
5456168|NCT02091739|18856376|P5|EP: 48 Weeks|Adverse Event|6
5456169|NCT02091739|18856377|P4|EP: 48 Weeks|Adverse Event|2
5456170|NCT02091739|18856378|P3|EP: 48 Weeks|Adverse Event|0
5456171|NCT02091739|18856379|P2|EP: 48 Weeks|Adverse Event|0
5456172|NCT02091739|18856380|P1|EP: 48 Weeks|Adverse Event|0
5456173|NCT02091739|18856376|P5|EP: 48 Weeks|Death|2
5456174|NCT02091739|18856377|P4|EP: 48 Weeks|Death|3
5456175|NCT02091739|18856378|P3|EP: 48 Weeks|Death|0
5456176|NCT02091739|18856379|P2|EP: 48 Weeks|Death|0
5456177|NCT02091739|18856380|P1|EP: 48 Weeks|Death|0
5456178|NCT02091739|18856376|P5|EP: 48 Weeks|Other|0
5456179|NCT02091739|18856377|P4|EP: 48 Weeks|Other|1
5456180|NCT02091739|18856378|P3|EP: 48 Weeks|Other|0
5456181|NCT02091739|18856379|P2|EP: 48 Weeks|Other|0
5456182|NCT02091739|18856380|P1|EP: 48 Weeks|Other|0
5456183|NCT02091739|18856376|P5|MP: 16 Weeks|Lost to Follow-up|0
5456184|NCT02091739|18856377|P4|MP: 16 Weeks|Lost to Follow-up|0
5456185|NCT02091739|18856378|P3|MP: 16 Weeks|Lost to Follow-up|1
5456186|NCT02091739|18856379|P2|MP: 16 Weeks|Lost to Follow-up|0
5456187|NCT02091739|18856380|P1|MP: 16 Weeks|Lost to Follow-up|0
5456188|NCT02091739|18856376|P5|MP: 16 Weeks|Withdrawal by Subject|0
5456189|NCT02091739|18856377|P4|MP: 16 Weeks|Withdrawal by Subject|0
5456190|NCT02091739|18856378|P3|MP: 16 Weeks|Withdrawal by Subject|0
5456191|NCT02091739|18856379|P2|MP: 16 Weeks|Withdrawal by Subject|4
5456192|NCT02091739|18856380|P1|MP: 16 Weeks|Withdrawal by Subject|3
5456193|NCT02091739|18856376|P5|MP: 16 Weeks|Adverse Event|0
5456194|NCT02091739|18856377|P4|MP: 16 Weeks|Adverse Event|0
5456195|NCT02091739|18856378|P3|MP: 16 Weeks|Adverse Event|1
5456196|NCT02091739|18856379|P2|MP: 16 Weeks|Adverse Event|1
5456197|NCT02091739|18856380|P1|MP: 16 Weeks|Adverse Event|1
5456198|NCT02091726|18856399|P1|Overall Study|Lost to Follow-up|6
5456199|NCT02091440|18856422|P1|Overall Study|Death|2
5456200|NCT02091414|18856432|P1|Overall Study|Death|2
5456201|NCT02091414|18856432|P1|Overall Study|Withdrawal by Subject|2
5456202|NCT02091375|18856446|P2|Overall Study|Withdrawn by the investigator|0
5456203|NCT02091375|18856447|P1|Overall Study|Withdrawn by the investigator|1
5456204|NCT02091375|18856446|P2|Overall Study|Withdrawal by Subject|1
5456205|NCT02091375|18856447|P1|Overall Study|Withdrawal by Subject|0
5456206|NCT02091375|18856446|P2|Overall Study|Lost to Follow-up|1
5456207|NCT02091375|18856447|P1|Overall Study|Lost to Follow-up|0
5456208|NCT02091375|18856446|P2|Overall Study|Adverse Event|1
5456209|NCT02091375|18856447|P1|Overall Study|Adverse Event|8
5456210|NCT02091362|18856477|P2|Period 2|Withdrawal by Subject|1
5456211|NCT02091362|18856478|P1|Period 2|Withdrawal by Subject|1
5456212|NCT02091362|18856477|P2|Period 2|Lost to Follow-up|1
5456213|NCT02091362|18856478|P1|Period 2|Lost to Follow-up|0
5456214|NCT02091362|18856477|P2|Period 2|Adverse Event|0
5456215|NCT02091362|18856478|P1|Period 2|Adverse Event|1
5456216|NCT02091362|18856477|P2|Wash-out|Withdrawal by Subject|2
5456217|NCT02091362|18856478|P1|Wash-out|Withdrawal by Subject|0
5456218|NCT02091362|18856477|P2|Wash-out|Lost to Follow-up|1
5456219|NCT02091362|18856478|P1|Wash-out|Lost to Follow-up|1
5456220|NCT02091362|18856477|P2|Period 1|Adverse Event|0
5456221|NCT02091362|18856478|P1|Period 1|Adverse Event|2
5456222|NCT02091362|18856477|P2|Period 1|Lost to Follow-up|1
5456223|NCT02091362|18856478|P1|Period 1|Lost to Follow-up|0
5456224|NCT02091362|18856477|P2|Period 1|Withdrawal by Subject|3
5456225|NCT02091362|18856478|P1|Period 1|Withdrawal by Subject|2
5456226|NCT02091362|18856477|P2|Period 1|Protocol Violation|0
5456227|NCT02091362|18856478|P1|Period 1|Protocol Violation|1
5456228|NCT02091284|18856500|P2|Overall Study|unreliable data|0
5456229|NCT02091284|18856501|P1|Overall Study|unreliable data|1
5456230|NCT02091284|18856500|P2|Overall Study|Withdrawal by Subject|1
5456231|NCT02091284|18856501|P1|Overall Study|Withdrawal by Subject|2
5456232|NCT02091206|18856523|P4|Taper Period|Lost to Follow-up|1
5456233|NCT02091206|18856524|P3|Taper Period|Lost to Follow-up|0
5456234|NCT02091206|18856525|P2|Taper Period|Lost to Follow-up|0
5456235|NCT02091206|18856526|P1|Taper Period|Lost to Follow-up|0
5456236|NCT02091206|18856523|P4|Taper Period|Participant refused study drug|1
5456237|NCT02091206|18856524|P3|Taper Period|Participant refused study drug|0
5456238|NCT02091206|18856525|P2|Taper Period|Participant refused study drug|0
5456239|NCT02091206|18856526|P1|Taper Period|Participant refused study drug|1
5456240|NCT02091206|18856523|P4|Treatment Period|Met withdrawal criteria|0
5456241|NCT02091206|18856524|P3|Treatment Period|Met withdrawal criteria|1
5456242|NCT02091206|18856525|P2|Treatment Period|Met withdrawal criteria|0
5456243|NCT02091206|18856526|P1|Treatment Period|Met withdrawal criteria|0
5456244|NCT02091206|18856523|P4|Treatment Period|Adverse Event|0
5456245|NCT02091206|18856524|P3|Treatment Period|Adverse Event|0
5456246|NCT02091206|18856525|P2|Treatment Period|Adverse Event|1
5456247|NCT02091206|18856526|P1|Treatment Period|Adverse Event|0
5456248|NCT02091167|18856545|P2|Overall Study|Lost to Follow-up|2
5456249|NCT02091167|18856546|P1|Overall Study|Lost to Follow-up|0
5456250|NCT02091089|18856562|P1|Overall Study|Lost to Follow-up|2
5456251|NCT02090959|18856570|P1|Overall Study|Other than specified|2
5456252|NCT02090959|18856570|P1|Overall Study|Switched to commercial supply|88
5456253|NCT02090959|18856570|P1|Overall Study|Entered in to other study|34
5456254|NCT02090959|18856570|P1|Overall Study|Move to medical need program|3
5456255|NCT02090959|18856570|P1|Overall Study|Transfer for compassionate use medicine|4
5456256|NCT02090959|18856570|P1|Overall Study|Enrolled but not treated|1
5456257|NCT02090959|18856570|P1|Overall Study|Study termination|6
5456258|NCT02090959|18856570|P1|Overall Study|Investigator decision|2
5456259|NCT02090959|18856570|P1|Overall Study|Adverse Event|1
5456260|NCT02090959|18856570|P1|Overall Study|Withdrawal by Subject|10
5456261|NCT02090855|18856597|P1|Overall Study|no evaluable Standard of Truth results|2
5456262|NCT02090764|18856610|P2|Overall Study|Lost to Follow-up|2
5456263|NCT02090764|18856611|P1|Overall Study|Lost to Follow-up|2
5456264|NCT02090764|18856610|P2|Overall Study|Intercurrent illness and other|1
5456265|NCT02090764|18856611|P1|Overall Study|Intercurrent illness and other|1
5456266|NCT02090764|18856610|P2|Overall Study|Withdrawal by Subject|1
5456267|NCT02090764|18856611|P1|Overall Study|Withdrawal by Subject|2
5456268|NCT02090764|18856610|P2|Overall Study|Lack of Efficacy|13
5456269|NCT02090764|18856611|P1|Overall Study|Lack of Efficacy|0
5456270|NCT02090764|18856610|P2|Overall Study|Adverse Event|3
5456271|NCT02090764|18856611|P1|Overall Study|Adverse Event|1
5456272|NCT02090725|18856617|P1|Overall Study|participants moved from area|3
5456273|NCT02090725|18856617|P1|Overall Study|Withdrawal by Subject|1
5456274|NCT02090426|18856623|P2|Overall Study|Lost to Follow-up|6
5456275|NCT02090426|18856624|P1|Overall Study|Lost to Follow-up|12
5456276|NCT02090413|18856655|P3|Overall Study|Lost to Follow-up|0
5456277|NCT02090413|18856656|P2|Overall Study|Lost to Follow-up|1
5456278|NCT02090413|18856657|P1|Overall Study|Lost to Follow-up|1
5456279|NCT02090413|18856655|P3|Overall Study|Other|0
5456280|NCT02090413|18856656|P2|Overall Study|Other|1
5456281|NCT02090413|18856657|P1|Overall Study|Other|2
5456282|NCT02090413|18856655|P3|Overall Study|Investigator Decision|0
5456283|NCT02090413|18856656|P2|Overall Study|Investigator Decision|1
5456284|NCT02090413|18856657|P1|Overall Study|Investigator Decision|1
5456285|NCT02090413|18856655|P3|Overall Study|Withdrawal by Subject|2
5456286|NCT02090413|18856656|P2|Overall Study|Withdrawal by Subject|2
5456287|NCT02090413|18856657|P1|Overall Study|Withdrawal by Subject|2
5456288|NCT02090413|18856655|P3|Overall Study|Flushing event|1
5456289|NCT02090413|18856656|P2|Overall Study|Flushing event|0
5456290|NCT02090413|18856657|P1|Overall Study|Flushing event|2
5456291|NCT02090413|18856655|P3|Overall Study|Adverse Event|20
5456292|NCT02090413|18856656|P2|Overall Study|Adverse Event|15
5456293|NCT02090413|18856657|P1|Overall Study|Adverse Event|11
5456294|NCT02090283|18856734|P3|Overall Study|Protocol Violation|0
5456295|NCT02090283|18856735|P2|Overall Study|Protocol Violation|0
5456296|NCT02090283|18856736|P1|Overall Study|Protocol Violation|2
5456297|NCT02090283|18856734|P3|Overall Study|Adverse Event|0
5456298|NCT02090283|18856735|P2|Overall Study|Adverse Event|1
5456299|NCT02090283|18856736|P1|Overall Study|Adverse Event|1
5456300|NCT02090283|18856734|P3|Overall Study|Lost to Follow-up|3
5456301|NCT02090283|18856735|P2|Overall Study|Lost to Follow-up|2
5456302|NCT02090283|18856736|P1|Overall Study|Lost to Follow-up|2
5456303|NCT02090283|18856734|P3|Overall Study|Sponsor Terminated Study|1
5456304|NCT02090283|18856735|P2|Overall Study|Sponsor Terminated Study|6
5456305|NCT02090283|18856736|P1|Overall Study|Sponsor Terminated Study|6
5456306|NCT02090283|18856734|P3|Overall Study|Withdrawal by Subject|6
5456307|NCT02090283|18856735|P2|Overall Study|Withdrawal by Subject|6
5456308|NCT02090283|18856736|P1|Overall Study|Withdrawal by Subject|6
5456309|NCT02089997|18856770|P1|Overall Study|Protocol Violation|147
5456310|NCT02089997|18856770|P1|Overall Study|Case report forms uncollected|99
5456311|NCT02089737|18856785|P1|Overall Study|Not treated|1
5456312|NCT02089737|18856785|P1|Overall Study|Survey form not completed|5
5456313|NCT02089347|18856835|P2|Overall Study|Protocol Violation|0
5456314|NCT02089347|18856836|P1|Overall Study|Protocol Violation|1
5456315|NCT02089334|18856862|P4|Overall Study|Physician Decision|1
5456316|NCT02089334|18856863|P3|Overall Study|Physician Decision|1
5456317|NCT02089334|18856864|P2|Overall Study|Physician Decision|0
5456318|NCT02089334|18856865|P1|Overall Study|Physician Decision|0
5456319|NCT02089334|18856862|P4|Overall Study|Progressive disease|2
5456320|NCT02089334|18856863|P3|Overall Study|Progressive disease|0
5456321|NCT02089334|18856864|P2|Overall Study|Progressive disease|0
5456322|NCT02089334|18856865|P1|Overall Study|Progressive disease|0
5456323|NCT02089334|18856862|P4|Overall Study|Adverse Event|2
5456324|NCT02089334|18856863|P3|Overall Study|Adverse Event|0
5456325|NCT02089334|18856864|P2|Overall Study|Adverse Event|0
5456326|NCT02089334|18856865|P1|Overall Study|Adverse Event|0
5456327|NCT02089334|18856862|P4|Overall Study|Withdrawal by Subject|2
5456328|NCT02089334|18856863|P3|Overall Study|Withdrawal by Subject|0
5456329|NCT02089334|18856864|P2|Overall Study|Withdrawal by Subject|0
5456330|NCT02089334|18856865|P1|Overall Study|Withdrawal by Subject|0
5456331|NCT02088957|18856902|P2|Overall Study|Lack of Efficacy|0
5456332|NCT02088957|18856903|P1|Overall Study|Lack of Efficacy|1
5456333|NCT02088905|18856921|P2|Overall Study|Withdrawal by Subject|1
5456334|NCT02088905|18856922|P1|Overall Study|Withdrawal by Subject|5
5456335|NCT02088541|18856958|P5|Overall Study|Other|1
5456336|NCT02088541|18856959|P4|Overall Study|Other|1
5456337|NCT02088541|18856960|P3|Overall Study|Other|3
5456338|NCT02088541|18856961|P2|Overall Study|Other|1
5456339|NCT02088541|18856962|P1|Overall Study|Other|2
5456340|NCT02088541|18856958|P5|Overall Study|Withdrawal by Subject|10
5456341|NCT02088541|18856959|P4|Overall Study|Withdrawal by Subject|7
5456342|NCT02088541|18856960|P3|Overall Study|Withdrawal by Subject|9
5456343|NCT02088541|18856961|P2|Overall Study|Withdrawal by Subject|2
5456344|NCT02088541|18856962|P1|Overall Study|Withdrawal by Subject|3
5456345|NCT02088541|18856958|P5|Overall Study|Study terminated by sponsor|6
5456346|NCT02088541|18856959|P4|Overall Study|Study terminated by sponsor|2
5456347|NCT02088541|18856960|P3|Overall Study|Study terminated by sponsor|12
5456348|NCT02088541|18856961|P2|Overall Study|Study terminated by sponsor|1
5456349|NCT02088541|18856962|P1|Overall Study|Study terminated by sponsor|1
5456350|NCT02088541|18856958|P5|Overall Study|Disease progression|1
5456351|NCT02088541|18856959|P4|Overall Study|Disease progression|3
5456352|NCT02088541|18856960|P3|Overall Study|Disease progression|2
5456353|NCT02088541|18856961|P2|Overall Study|Disease progression|1
5456354|NCT02088541|18856962|P1|Overall Study|Disease progression|7
5456355|NCT02088541|18856958|P5|Overall Study|Physician Decision|2
5456356|NCT02088541|18856959|P4|Overall Study|Physician Decision|0
5456357|NCT02088541|18856960|P3|Overall Study|Physician Decision|2
5456358|NCT02088541|18856961|P2|Overall Study|Physician Decision|1
5456359|NCT02088541|18856962|P1|Overall Study|Physician Decision|2
5456360|NCT02088541|18856958|P5|Overall Study|Lost to Follow-up|0
5456361|NCT02088541|18856959|P4|Overall Study|Lost to Follow-up|0
5456362|NCT02088541|18856960|P3|Overall Study|Lost to Follow-up|1
5456363|NCT02088541|18856961|P2|Overall Study|Lost to Follow-up|0
5456364|NCT02088541|18856962|P1|Overall Study|Lost to Follow-up|2
5456365|NCT02088541|18856958|P5|Overall Study|Death|38
5456366|NCT02088541|18856959|P4|Overall Study|Death|28
5456367|NCT02088541|18856960|P3|Overall Study|Death|85
5456368|NCT02088541|18856961|P2|Overall Study|Death|21
5456369|NCT02088541|18856962|P1|Overall Study|Death|51
5456370|NCT02088541|18856958|P5|Overall Study|Adverse Event|0
5456371|NCT02088541|18856959|P4|Overall Study|Adverse Event|3
5456372|NCT02088541|18856960|P3|Overall Study|Adverse Event|3
5456373|NCT02088541|18856961|P2|Overall Study|Adverse Event|0
5456374|NCT02088541|18856962|P1|Overall Study|Adverse Event|3
5456375|NCT02088177|18857033|P1|Overall Study|Lost to Follow-up|3
5456376|NCT02088073|18857043|P5|Maintanance Phase|Subject compliance|0
5456377|NCT02088073|18857044|P4|Maintanance Phase|Subject compliance|0
5456378|NCT02088073|18857045|P3|Maintanance Phase|Subject compliance|0
5456379|NCT02088073|18857046|P2|Maintanance Phase|Subject compliance|1
5456380|NCT02088073|18857047|P1|Maintanance Phase|Subject compliance|0
5456381|NCT02088073|18857043|P5|Maintanance Phase|Met ECG withdrawal criteria|2
5456382|NCT02088073|18857044|P4|Maintanance Phase|Met ECG withdrawal criteria|0
5456383|NCT02088073|18857045|P3|Maintanance Phase|Met ECG withdrawal criteria|1
5456384|NCT02088073|18857046|P2|Maintanance Phase|Met ECG withdrawal criteria|0
5456385|NCT02088073|18857047|P1|Maintanance Phase|Met ECG withdrawal criteria|0
5456386|NCT02088073|18857043|P5|Maintanance Phase|Miscellaneous|1
5456387|NCT02088073|18857044|P4|Maintanance Phase|Miscellaneous|2
5456388|NCT02088073|18857045|P3|Maintanance Phase|Miscellaneous|1
5456389|NCT02088073|18857046|P2|Maintanance Phase|Miscellaneous|2
5456390|NCT02088073|18857047|P1|Maintanance Phase|Miscellaneous|0
5456391|NCT02088073|18857043|P5|Maintanance Phase|Hypo- or hyperkalemia|1
5456392|NCT02088073|18857044|P4|Maintanance Phase|Hypo- or hyperkalemia|3
5456393|NCT02088073|18857045|P3|Maintanance Phase|Hypo- or hyperkalemia|0
5456394|NCT02088073|18857046|P2|Maintanance Phase|Hypo- or hyperkalemia|3
5456395|NCT02088073|18857047|P1|Maintanance Phase|Hypo- or hyperkalemia|0
5456396|NCT02088073|18857043|P5|Maintanance Phase|Sponsor's decision|1
5456397|NCT02088073|18857044|P4|Maintanance Phase|Sponsor's decision|2
5456398|NCT02088073|18857045|P3|Maintanance Phase|Sponsor's decision|0
5456399|NCT02088073|18857046|P2|Maintanance Phase|Sponsor's decision|2
5456400|NCT02088073|18857047|P1|Maintanance Phase|Sponsor's decision|0
5456401|NCT02088073|18857043|P5|Maintanance Phase|Physician Decision|1
5456402|NCT02088073|18857044|P4|Maintanance Phase|Physician Decision|0
5456403|NCT02088073|18857045|P3|Maintanance Phase|Physician Decision|0
5456404|NCT02088073|18857046|P2|Maintanance Phase|Physician Decision|0
5456405|NCT02088073|18857047|P1|Maintanance Phase|Physician Decision|0
5456406|NCT02088073|18857043|P5|Maintanance Phase|Adverse Event|1
5456407|NCT02088073|18857044|P4|Maintanance Phase|Adverse Event|0
5456408|NCT02088073|18857045|P3|Maintanance Phase|Adverse Event|3
5456409|NCT02088073|18857046|P2|Maintanance Phase|Adverse Event|0
5456410|NCT02088073|18857047|P1|Maintanance Phase|Adverse Event|0
5456411|NCT02088073|18857043|P5|Maintanance Phase|Withdrawal by Subject|0
5456412|NCT02088073|18857044|P4|Maintanance Phase|Withdrawal by Subject|0
5456413|NCT02088073|18857045|P3|Maintanance Phase|Withdrawal by Subject|0
5456414|NCT02088073|18857046|P2|Maintanance Phase|Withdrawal by Subject|2
5456415|NCT02088073|18857047|P1|Maintanance Phase|Withdrawal by Subject|0
5456416|NCT02088073|18857043|P5|Acute Phase|Hyperkalemia|0
5456417|NCT02088073|18857044|P4|Acute Phase|Hyperkalemia|0
5456418|NCT02088073|18857045|P3|Acute Phase|Hyperkalemia|0
5456419|NCT02088073|18857046|P2|Acute Phase|Hyperkalemia|0
5456420|NCT02088073|18857047|P1|Acute Phase|Hyperkalemia|2
5456421|NCT02088073|18857043|P5|Acute Phase|Withdrawal by Subject|0
5456422|NCT02088073|18857044|P4|Acute Phase|Withdrawal by Subject|0
5456423|NCT02088073|18857045|P3|Acute Phase|Withdrawal by Subject|0
5456424|NCT02088073|18857046|P2|Acute Phase|Withdrawal by Subject|0
5456425|NCT02088073|18857047|P1|Acute Phase|Withdrawal by Subject|5
5456426|NCT02088047|18857101|P2|Overall Study|Withdrawal by Subject|0
5456427|NCT02088047|18857102|P1|Overall Study|Withdrawal by Subject|1
5456428|NCT02088034|18857111|P3|Overall Study|Pregnancy|2
5456429|NCT02088034|18857112|P2|Overall Study|Pregnancy|1
5456430|NCT02088034|18857113|P1|Overall Study|Pregnancy|2
5456431|NCT02088034|18857111|P3|Overall Study|Lost to Follow-up|0
5456432|NCT02088034|18857112|P2|Overall Study|Lost to Follow-up|1
5456433|NCT02088034|18857113|P1|Overall Study|Lost to Follow-up|1
5456434|NCT02087943|18857143|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
5456435|NCT02087943|18857144|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
5456436|NCT02087943|18857145|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
5456437|NCT02087943|18857146|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
5456438|NCT02087943|18857147|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
5456439|NCT02087943|18857143|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
5456440|NCT02087943|18857144|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5456441|NCT02087943|18857145|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5456442|NCT02087943|18857146|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5456443|NCT02087943|18857147|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
5456444|NCT02087943|18857143|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5456445|NCT02087943|18857144|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5456446|NCT02087943|18857145|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
5456447|NCT02087943|18857146|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5456448|NCT02087943|18857147|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
5456449|NCT02087943|18857143|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
5456450|NCT02087943|18857144|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
5456451|NCT02087943|18857145|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
5456452|NCT02087943|18857146|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
5456453|NCT02087943|18857147|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
5456454|NCT02087943|18857143|P5|Active Treatment Phase Week 12-24|Adverse Event|1
5456455|NCT02087943|18857144|P4|Active Treatment Phase Week 12-24|Adverse Event|0
5456456|NCT02087943|18857145|P3|Active Treatment Phase Week 12-24|Adverse Event|2
5456457|NCT02087943|18857146|P2|Active Treatment Phase Week 12-24|Adverse Event|1
5456458|NCT02087943|18857147|P1|Active Treatment Phase Week 12-24|Adverse Event|0
5456459|NCT02087943|18857143|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5456460|NCT02087943|18857144|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5456461|NCT02087943|18857145|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5456462|NCT02087943|18857146|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
5456463|NCT02087943|18857147|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
5456464|NCT02087943|18857143|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
5456465|NCT02087943|18857144|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
5456466|NCT02087943|18857145|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
5456467|NCT02087943|18857146|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
5456468|NCT02087943|18857147|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
5456469|NCT02087943|18857143|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
5456470|NCT02087943|18857144|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
5456471|NCT02087943|18857145|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
5456472|NCT02087943|18857146|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
5456473|NCT02087943|18857147|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
5456474|NCT02087943|18857143|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
5456475|NCT02087943|18857144|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
5456476|NCT02087943|18857145|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
5456477|NCT02087943|18857146|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
5456478|NCT02087943|18857147|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
5456479|NCT02087943|18857143|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
5456480|NCT02087943|18857144|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
5456481|NCT02087943|18857145|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
5456482|NCT02087943|18857146|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
5456483|NCT02087943|18857147|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
5456484|NCT02087904|18857175|P4|Overall Study|Lost to Follow-up|2
5456485|NCT02087904|18857176|P3|Overall Study|Lost to Follow-up|2
5456486|NCT02087904|18857177|P2|Overall Study|Lost to Follow-up|4
5456487|NCT02087904|18857178|P1|Overall Study|Lost to Follow-up|0
5456488|NCT02087904|18857175|P4|Overall Study|Withdrawal by Subject|4
5456489|NCT02087904|18857176|P3|Overall Study|Withdrawal by Subject|7
5456490|NCT02087904|18857177|P2|Overall Study|Withdrawal by Subject|3
5456491|NCT02087904|18857178|P1|Overall Study|Withdrawal by Subject|8
5456492|NCT02087904|18857175|P4|Overall Study|Other|4
5456493|NCT02087904|18857176|P3|Overall Study|Other|4
5456494|NCT02087904|18857177|P2|Overall Study|Other|2
5456495|NCT02087904|18857178|P1|Overall Study|Other|6
5456496|NCT02087904|18857175|P4|Overall Study|Lack of Efficacy|2
5456497|NCT02087904|18857176|P3|Overall Study|Lack of Efficacy|3
5456498|NCT02087904|18857177|P2|Overall Study|Lack of Efficacy|6
5456499|NCT02087904|18857178|P1|Overall Study|Lack of Efficacy|3
5456500|NCT02087904|18857175|P4|Overall Study|Adverse Event|12
5456501|NCT02087904|18857176|P3|Overall Study|Adverse Event|4
5456502|NCT02087904|18857177|P2|Overall Study|Adverse Event|4
5456503|NCT02087904|18857178|P1|Overall Study|Adverse Event|8
5456504|NCT02087904|18857175|P4|Overall Study|Did Not Receive Study Drug|1
5456505|NCT02087904|18857176|P3|Overall Study|Did Not Receive Study Drug|2
5456506|NCT02087904|18857177|P2|Overall Study|Did Not Receive Study Drug|0
5456507|NCT02087904|18857178|P1|Overall Study|Did Not Receive Study Drug|0
5456508|NCT02087774|18857294|P2|Overall Study|Were absent day of data collection|20
5456509|NCT02087774|18857295|P1|Overall Study|Were absent day of data collection|8
5456510|NCT02087670|18857315|P2|Overall Study|Withdrawal by Subject|2
5456511|NCT02087670|18857316|P1|Overall Study|Withdrawal by Subject|3
5456512|NCT02087423|18857352|P3|Overall Study|Terminated from study at final DCO|25
5456513|NCT02087423|18857353|P2|Overall Study|Terminated from study at final DCO|36
5456514|NCT02087423|18857354|P1|Overall Study|Terminated from study at final DCO|23
5456515|NCT02087423|18857352|P3|Overall Study|Lost to Follow-up|0
5456516|NCT02087423|18857353|P2|Overall Study|Lost to Follow-up|2
5456517|NCT02087423|18857354|P1|Overall Study|Lost to Follow-up|0
5456518|NCT02087423|18857352|P3|Overall Study|Death|40
5456519|NCT02087423|18857353|P2|Overall Study|Death|207
5456520|NCT02087423|18857354|P1|Overall Study|Death|68
5456521|NCT02087423|18857352|P3|Overall Study|Withdrawal by Subject|3
5456522|NCT02087423|18857353|P2|Overall Study|Withdrawal by Subject|20
5456523|NCT02087423|18857354|P1|Overall Study|Withdrawal by Subject|20
5456524|NCT02087241|18857383|P4|Overall Study|Study Terminated by Sponsor|4
5456525|NCT02087241|18857384|P3|Overall Study|Study Terminated by Sponsor|0
5456526|NCT02087241|18857385|P2|Overall Study|Study Terminated by Sponsor|2
5456527|NCT02087241|18857386|P1|Overall Study|Study Terminated by Sponsor|0
5456528|NCT02087241|18857383|P4|Overall Study|Progressive Disease|1
5456529|NCT02087241|18857384|P3|Overall Study|Progressive Disease|0
5456530|NCT02087241|18857385|P2|Overall Study|Progressive Disease|0
5456531|NCT02087241|18857386|P1|Overall Study|Progressive Disease|0
5456532|NCT02087241|18857383|P4|Overall Study|Withdrawal by Subject|1
5456533|NCT02087241|18857384|P3|Overall Study|Withdrawal by Subject|0
5456534|NCT02087241|18857385|P2|Overall Study|Withdrawal by Subject|0
5456535|NCT02087241|18857386|P1|Overall Study|Withdrawal by Subject|1
5456536|NCT02087241|18857383|P4|Overall Study|Death|1
5456537|NCT02087241|18857384|P3|Overall Study|Death|1
5456538|NCT02087241|18857385|P2|Overall Study|Death|1
5456539|NCT02087241|18857386|P1|Overall Study|Death|2
5456540|NCT02087176|18857412|P1|Overall Study|Study Terminated by Sponsor|2
5456541|NCT02087176|18857412|P1|Overall Study|Censored|19
5456542|NCT02087176|18857412|P1|Overall Study|Death|10
5456543|NCT02087176|18857412|P1|Overall Study|Withdrawal by Subject|1
5456544|NCT02087150|18857425|P3|Overall Study|Pt moved out of town|0
5456545|NCT02087150|18857426|P2|Overall Study|Pt moved out of town|1
5456546|NCT02087150|18857427|P1|Overall Study|Pt moved out of town|0
5456547|NCT02087150|18857425|P3|Overall Study|Other|0
5456548|NCT02087150|18857426|P2|Overall Study|Other|0
5456549|NCT02087150|18857427|P1|Overall Study|Other|1
5456550|NCT02087150|18857425|P3|Overall Study|F/U not completed w/in study window|1
5456551|NCT02087150|18857426|P2|Overall Study|F/U not completed w/in study window|0
5456552|NCT02087150|18857427|P1|Overall Study|F/U not completed w/in study window|0
5456553|NCT02087150|18857425|P3|Overall Study|Procedure not done|0
5456554|NCT02087150|18857426|P2|Overall Study|Procedure not done|13
5456555|NCT02087150|18857427|P1|Overall Study|Procedure not done|1
5456556|NCT02087150|18857425|P3|Overall Study|Physician Decision|0
5456557|NCT02087150|18857426|P2|Overall Study|Physician Decision|1
5456558|NCT02087150|18857427|P1|Overall Study|Physician Decision|0
5456559|NCT02087150|18857425|P3|Overall Study|Withdrawal by Subject|3
5456560|NCT02087150|18857426|P2|Overall Study|Withdrawal by Subject|5
5456561|NCT02087150|18857427|P1|Overall Study|Withdrawal by Subject|2
5456562|NCT02087150|18857425|P3|Overall Study|Lost to Follow-up|7
5456563|NCT02087150|18857426|P2|Overall Study|Lost to Follow-up|13
5456564|NCT02087150|18857427|P1|Overall Study|Lost to Follow-up|6
5456565|NCT02087150|18857425|P3|Overall Study|Death|0
5456566|NCT02087150|18857426|P2|Overall Study|Death|1
5456567|NCT02087150|18857427|P1|Overall Study|Death|0
5456568|NCT02087085|18857446|P2|Overall Study|Other Miscellaneous Reasons|4
5456569|NCT02087085|18857447|P1|Overall Study|Other Miscellaneous Reasons|3
5456570|NCT02087085|18857446|P2|Overall Study|Study Terminated by Sponsor|80
5456571|NCT02087085|18857447|P1|Overall Study|Study Terminated by Sponsor|87
5456572|NCT02087085|18857446|P2|Overall Study|Protocol Violation|0
5456573|NCT02087085|18857447|P1|Overall Study|Protocol Violation|1
5456574|NCT02087085|18857446|P2|Overall Study|Withdrawal by Subject|11
5456575|NCT02087085|18857447|P1|Overall Study|Withdrawal by Subject|9
5456576|NCT02087085|18857446|P2|Overall Study|Lost to Follow-up|4
5456577|NCT02087085|18857447|P1|Overall Study|Lost to Follow-up|6
5456578|NCT02087085|18857446|P2|Overall Study|Lack of Efficacy|3
5456579|NCT02087085|18857447|P1|Overall Study|Lack of Efficacy|4
5456580|NCT02087085|18857446|P2|Overall Study|Adverse Event|14
5456581|NCT02087085|18857447|P1|Overall Study|Adverse Event|10
5456582|NCT02087059|18857457|P1|Overall Study|Lost to Follow-up|1
5456583|NCT02087059|18857457|P1|Overall Study|Adverse Event|5
5456584|NCT02087059|18857457|P1|Overall Study|Disease Progression|1
5456585|NCT02086968|18857467|P2|Overall Study|Withdrawal by Subject|4
5456586|NCT02086968|18857468|P1|Overall Study|Withdrawal by Subject|1
5456587|NCT02086968|18857467|P2|Overall Study|Physician Decision|0
5456588|NCT02086968|18857468|P1|Overall Study|Physician Decision|4
5456589|NCT02086968|18857467|P2|Overall Study|Study drug received outside protocol|1
5456590|NCT02086968|18857468|P1|Overall Study|Study drug received outside protocol|0
5456591|NCT02086968|18857467|P2|Overall Study|Lost to Follow-up|3
5456592|NCT02086968|18857468|P1|Overall Study|Lost to Follow-up|2
5456593|NCT02086968|18857467|P2|Overall Study|Adverse Event|5
5456594|NCT02086968|18857468|P1|Overall Study|Adverse Event|1
5456595|NCT02086591|18857522|P1|Overall Study|protocol terminated|3
5456596|NCT02086591|18857522|P1|Overall Study|Withdrawal by Subject|1
5456597|NCT02086591|18857522|P1|Overall Study|Adverse Event|1
5456598|NCT02086565|18857530|P2|Overall Study|withdrawn by research team|2
5456599|NCT02086565|18857531|P1|Overall Study|withdrawn by research team|2
5456600|NCT02086565|18857530|P2|Overall Study|Death|2
5456601|NCT02086565|18857531|P1|Overall Study|Death|3
5456602|NCT02086565|18857530|P2|Overall Study|Withdrawal by Subject|1
5456603|NCT02086565|18857531|P1|Overall Study|Withdrawal by Subject|2
5456604|NCT02086565|18857530|P2|Overall Study|Lost to Follow-up|7
5456605|NCT02086565|18857531|P1|Overall Study|Lost to Follow-up|9
5456606|NCT02086552|18857545|P1|Overall Study|Withdrawal by Subject|1
5456607|NCT02086162|18857588|P2|Overall Study|Death|0
5456608|NCT02086162|18857589|P1|Overall Study|Death|1
5456609|NCT02086162|18857588|P2|Overall Study|Lost to Follow-up|2
5456610|NCT02086162|18857589|P1|Overall Study|Lost to Follow-up|4
5456611|NCT02086162|18857588|P2|Overall Study|moved|1
5456612|NCT02086162|18857589|P1|Overall Study|moved|1
5456613|NCT02086162|18857588|P2|Overall Study|Withdrawal by Subject|4
5456614|NCT02086162|18857589|P1|Overall Study|Withdrawal by Subject|4
5456615|NCT02086110|18857601|P2|Overall Study|Withdrawal by Subject|1
5456616|NCT02086110|18857602|P1|Overall Study|Withdrawal by Subject|1
5456617|NCT02085785|18857613|P2|Overall Study|Lost to Follow-up|1
5456618|NCT02085785|18857614|P1|Overall Study|Lost to Follow-up|0
5456619|NCT02085785|18857613|P2|Overall Study|Withdrawal by Subject|1
5456620|NCT02085785|18857614|P1|Overall Study|Withdrawal by Subject|2
5456621|NCT02085252|18857768|P2|Overall Study|Reason Unknown|1
5456622|NCT02085252|18857769|P1|Overall Study|Reason Unknown|0
5456623|NCT02085252|18857768|P2|Overall Study|Reason Not Specified|1
5456624|NCT02085252|18857769|P1|Overall Study|Reason Not Specified|0
5456625|NCT02085252|18857768|P2|Overall Study|Discontinuation Due to Patient Decision|1
5456626|NCT02085252|18857769|P1|Overall Study|Discontinuation Due to Patient Decision|0
5456627|NCT02085252|18857768|P2|Overall Study|Adverse Event|1
5456628|NCT02085252|18857769|P1|Overall Study|Adverse Event|0
5456629|NCT02085252|18857768|P2|Overall Study|Withdrawal of Consent|0
5456630|NCT02085252|18857769|P1|Overall Study|Withdrawal of Consent|1
5456631|NCT02085161|18857793|P4|Overall Study|Other Reason|1
5456632|NCT02085161|18857794|P3|Overall Study|Other Reason|1
5456633|NCT02085161|18857795|P2|Overall Study|Other Reason|0
5456634|NCT02085161|18857796|P1|Overall Study|Other Reason|1
5456635|NCT02085161|18857793|P4|Overall Study|Withdrawal by Subject|3
5456636|NCT02085161|18857794|P3|Overall Study|Withdrawal by Subject|0
5456637|NCT02085161|18857795|P2|Overall Study|Withdrawal by Subject|4
5456638|NCT02085161|18857796|P1|Overall Study|Withdrawal by Subject|2
5456639|NCT02085161|18857793|P4|Overall Study|Protocol Violation|1
5456640|NCT02085161|18857794|P3|Overall Study|Protocol Violation|0
5456641|NCT02085161|18857795|P2|Overall Study|Protocol Violation|1
5456642|NCT02085161|18857796|P1|Overall Study|Protocol Violation|0
5456643|NCT02085161|18857793|P4|Overall Study|Adverse Event|5
5456644|NCT02085161|18857794|P3|Overall Study|Adverse Event|4
5456645|NCT02085161|18857795|P2|Overall Study|Adverse Event|5
5456646|NCT02085161|18857796|P1|Overall Study|Adverse Event|8
5456647|NCT02085161|18857793|P4|Overall Study|Not Treated|0
5456648|NCT02085161|18857794|P3|Overall Study|Not Treated|0
5456649|NCT02085161|18857795|P2|Overall Study|Not Treated|0
5456650|NCT02085161|18857796|P1|Overall Study|Not Treated|1
5456651|NCT02085135|18857837|P2|Overall Study|Lack of Efficacy|0
5456652|NCT02085135|18857838|P1|Overall Study|Lack of Efficacy|2
5456653|NCT02085135|18857837|P2|Overall Study|Withdrawal by Subject|0
5456654|NCT02085135|18857838|P1|Overall Study|Withdrawal by Subject|3
5456655|NCT02085135|18857837|P2|Overall Study|Lost to Follow-up|2
5456656|NCT02085135|18857838|P1|Overall Study|Lost to Follow-up|2
5456657|NCT02085135|18857837|P2|Overall Study|Adverse Event|7
5456658|NCT02085135|18857838|P1|Overall Study|Adverse Event|4
5456659|NCT02084238|18857910|P1|Overall Study|Lost to Follow-up|2
5456660|NCT02084134|18857935|P2|Overall Study|Death|1
5456661|NCT02084134|18857936|P1|Overall Study|Death|0
5456662|NCT02084134|18857935|P2|Overall Study|Protocol Violation|2
5456663|NCT02084134|18857936|P1|Overall Study|Protocol Violation|4
5456664|NCT02084082|18857946|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
5456665|NCT02084082|18857947|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5456666|NCT02084082|18857948|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5456667|NCT02084082|18857949|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5456668|NCT02084082|18857946|P4|Washout Period 1 (35 Days)|Adverse Event|1
5456669|NCT02084082|18857947|P3|Washout Period 1 (35 Days)|Adverse Event|1
5456670|NCT02084082|18857948|P2|Washout Period 1 (35 Days)|Adverse Event|0
5456671|NCT02084082|18857949|P1|Washout Period 1 (35 Days)|Adverse Event|0
5456672|NCT02084056|18857990|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5456673|NCT02084056|18857991|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5456674|NCT02084056|18857992|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
5456675|NCT02084056|18857993|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
5456676|NCT02084056|18857990|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5456677|NCT02084056|18857991|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5456678|NCT02084056|18857992|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5456679|NCT02084056|18857993|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5456680|NCT02083965|18858025|P2|Treatment Period|Other|0
5456681|NCT02083965|18858026|P1|Treatment Period|Other|1
5456682|NCT02083783|18858108|P2|Overall Study|Withdrawal by Subject|0
5456683|NCT02083783|18858109|P1|Overall Study|Withdrawal by Subject|1
5456684|NCT02083653|18858141|P3|Overall Study|Reason Missing|4
5456685|NCT02083653|18858142|P2|Overall Study|Reason Missing|0
5456686|NCT02083653|18858143|P1|Overall Study|Reason Missing|0
5456687|NCT02083653|18858141|P3|Overall Study|Other Events|2
5456688|NCT02083653|18858142|P2|Overall Study|Other Events|2
5456689|NCT02083653|18858143|P1|Overall Study|Other Events|0
5456690|NCT02083653|18858141|P3|Overall Study|Withdrawal by Subject|2
5456691|NCT02083653|18858142|P2|Overall Study|Withdrawal by Subject|1
5456692|NCT02083653|18858143|P1|Overall Study|Withdrawal by Subject|2
5456693|NCT02083653|18858141|P3|Overall Study|Progressive Disease|63
5456694|NCT02083653|18858142|P2|Overall Study|Progressive Disease|73
5456695|NCT02083653|18858143|P1|Overall Study|Progressive Disease|65
5456696|NCT02083653|18858141|P3|Overall Study|Death|2
5456697|NCT02083653|18858142|P2|Overall Study|Death|2
5456698|NCT02083653|18858143|P1|Overall Study|Death|2
5456699|NCT02083653|18858141|P3|Overall Study|Lost to Follow-up|0
5456700|NCT02083653|18858142|P2|Overall Study|Lost to Follow-up|0
5456701|NCT02083653|18858143|P1|Overall Study|Lost to Follow-up|1
5456702|NCT02083653|18858141|P3|Overall Study|Adverse Event|4
5456703|NCT02083653|18858142|P2|Overall Study|Adverse Event|5
5456704|NCT02083653|18858143|P1|Overall Study|Adverse Event|12
5456705|NCT02083653|18858141|P3|Overall Study|Randomized but not Treated|7
5456706|NCT02083653|18858142|P2|Overall Study|Randomized but not Treated|2
5456707|NCT02083653|18858143|P1|Overall Study|Randomized but not Treated|0
5456708|NCT02083380|18858211|P3|Overall Study|Other|6
5456709|NCT02083380|18858212|P2|Overall Study|Other|4
5456710|NCT02083380|18858213|P1|Overall Study|Other|8
5456711|NCT02083380|18858211|P3|Overall Study|Lost to Follow-up|3
5456712|NCT02083380|18858212|P2|Overall Study|Lost to Follow-up|3
5456713|NCT02083380|18858213|P1|Overall Study|Lost to Follow-up|5
5456714|NCT02083380|18858211|P3|Overall Study|Adverse Event|1
5456715|NCT02083380|18858212|P2|Overall Study|Adverse Event|0
5456716|NCT02083380|18858213|P1|Overall Study|Adverse Event|0
5456717|NCT02083380|18858211|P3|Overall Study|Physician Decision|3
5456718|NCT02083380|18858212|P2|Overall Study|Physician Decision|6
5456719|NCT02083380|18858213|P1|Overall Study|Physician Decision|1
5456720|NCT02083380|18858211|P3|Overall Study|Withdrawal by Subject|7
5456721|NCT02083380|18858212|P2|Overall Study|Withdrawal by Subject|3
5456722|NCT02083380|18858213|P1|Overall Study|Withdrawal by Subject|9
5456723|NCT02083380|18858211|P3|Overall Study|Lack of Efficacy|64
5456724|NCT02083380|18858212|P2|Overall Study|Lack of Efficacy|79
5456725|NCT02083380|18858213|P1|Overall Study|Lack of Efficacy|68
5456726|NCT02083185|18858318|P3|Overall Study|Did not Receive Study Drug|0
5456727|NCT02083185|18858319|P2|Overall Study|Did not Receive Study Drug|2
5456728|NCT02083185|18858320|P1|Overall Study|Did not Receive Study Drug|0
5456729|NCT02083185|18858318|P3|Overall Study|Study Terminated by Sponsor|0
5456730|NCT02083185|18858319|P2|Overall Study|Study Terminated by Sponsor|1
5456731|NCT02083185|18858320|P1|Overall Study|Study Terminated by Sponsor|0
5456732|NCT02083185|18858318|P3|Overall Study|Reason not Specified|5
5456733|NCT02083185|18858319|P2|Overall Study|Reason not Specified|6
5456734|NCT02083185|18858320|P1|Overall Study|Reason not Specified|9
5456735|NCT02083185|18858318|P3|Overall Study|Death|1
5456736|NCT02083185|18858319|P2|Overall Study|Death|2
5456737|NCT02083185|18858320|P1|Overall Study|Death|2
5456738|NCT02083185|18858318|P3|Overall Study|Withdrawal by Subject|1
5456739|NCT02083185|18858319|P2|Overall Study|Withdrawal by Subject|15
5456740|NCT02083185|18858320|P1|Overall Study|Withdrawal by Subject|9
5456741|NCT02083185|18858318|P3|Overall Study|Lost to Follow-up|0
5456742|NCT02083185|18858319|P2|Overall Study|Lost to Follow-up|3
5456743|NCT02083185|18858320|P1|Overall Study|Lost to Follow-up|0
5456744|NCT02082977|18858425|P10|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5456745|NCT02082977|18858426|P9|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5456746|NCT02082977|18858427|P8|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
5456747|NCT02082977|18858428|P7|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5456748|NCT02082977|18858429|P6|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5456749|NCT02082977|18858430|P5|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5456750|NCT02082977|18858431|P4|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5456751|NCT02082977|18858432|P3|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5456752|NCT02082977|18858433|P2|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5456753|NCT02082977|18858434|P1|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
5456754|NCT02082977|18858425|P10|Part 1 (Up to 3.2 Years)|Physician Decision|0
5456755|NCT02082977|18858426|P9|Part 1 (Up to 3.2 Years)|Physician Decision|2
5456756|NCT02082977|18858427|P8|Part 1 (Up to 3.2 Years)|Physician Decision|1
5456757|NCT02082977|18858428|P7|Part 1 (Up to 3.2 Years)|Physician Decision|4
5456758|NCT02082977|18858429|P6|Part 1 (Up to 3.2 Years)|Physician Decision|1
5456759|NCT02082977|18858430|P5|Part 1 (Up to 3.2 Years)|Physician Decision|1
5456760|NCT02082977|18858431|P4|Part 1 (Up to 3.2 Years)|Physician Decision|0
5456761|NCT02082977|18858432|P3|Part 1 (Up to 3.2 Years)|Physician Decision|0
5456762|NCT02082977|18858433|P2|Part 1 (Up to 3.2 Years)|Physician Decision|0
5456763|NCT02082977|18858434|P1|Part 1 (Up to 3.2 Years)|Physician Decision|0
5456764|NCT02082977|18858425|P10|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5456765|NCT02082977|18858426|P9|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5456766|NCT02082977|18858427|P8|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5456767|NCT02082977|18858428|P7|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5456768|NCT02082977|18858429|P6|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
5456769|NCT02082977|18858430|P5|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5456770|NCT02082977|18858431|P4|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5456771|NCT02082977|18858432|P3|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5456772|NCT02082977|18858433|P2|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5456773|NCT02082977|18858434|P1|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
5456774|NCT02082977|18858425|P10|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5456775|NCT02082977|18858426|P9|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5456776|NCT02082977|18858427|P8|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
5456777|NCT02082977|18858428|P7|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5456778|NCT02082977|18858429|P6|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5456779|NCT02082977|18858430|P5|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5456780|NCT02082977|18858431|P4|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5456781|NCT02082977|18858432|P3|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5456782|NCT02082977|18858433|P2|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5456783|NCT02082977|18858434|P1|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
5456784|NCT02082977|18858425|P10|Part 1 (Up to 3.2 Years)|Death|0
5456785|NCT02082977|18858426|P9|Part 1 (Up to 3.2 Years)|Death|1
5456786|NCT02082977|18858427|P8|Part 1 (Up to 3.2 Years)|Death|0
5456787|NCT02082977|18858428|P7|Part 1 (Up to 3.2 Years)|Death|2
5456788|NCT02082977|18858429|P6|Part 1 (Up to 3.2 Years)|Death|1
5456789|NCT02082977|18858430|P5|Part 1 (Up to 3.2 Years)|Death|0
5456790|NCT02082977|18858431|P4|Part 1 (Up to 3.2 Years)|Death|0
5456791|NCT02082977|18858432|P3|Part 1 (Up to 3.2 Years)|Death|0
5456792|NCT02082977|18858433|P2|Part 1 (Up to 3.2 Years)|Death|0
5456793|NCT02082977|18858434|P1|Part 1 (Up to 3.2 Years)|Death|1
5456794|NCT02082912|18858688|P2|Overall Study|Physician Decision|1
5456795|NCT02082912|18858689|P1|Overall Study|Physician Decision|0
5456796|NCT02082522|18858737|P2|Overall Study|Chemotherapy change|3
5456797|NCT02082522|18858738|P1|Overall Study|Chemotherapy change|1
5456798|NCT02082522|18858737|P2|Overall Study|Disease progression|2
5456799|NCT02082522|18858738|P1|Overall Study|Disease progression|2
5456800|NCT02082522|18858737|P2|Overall Study|Physician Decision|1
5456801|NCT02082522|18858738|P1|Overall Study|Physician Decision|3
5456802|NCT02082522|18858737|P2|Overall Study|Lost to Follow-up|0
5456803|NCT02082522|18858738|P1|Overall Study|Lost to Follow-up|1
5456804|NCT02082522|18858737|P2|Overall Study|Death|0
5456805|NCT02082522|18858738|P1|Overall Study|Death|1
5456806|NCT02082522|18858737|P2|Overall Study|Withdrawal by Subject|4
5456807|NCT02082522|18858738|P1|Overall Study|Withdrawal by Subject|2
5456808|NCT02082522|18858737|P2|Overall Study|Sponsor termination|3
5456809|NCT02082522|18858738|P1|Overall Study|Sponsor termination|5
5456810|NCT02082483|18858788|P2|Overall Study|Death|3
5456811|NCT02082483|18858789|P1|Overall Study|Death|2
5456812|NCT02082483|18858788|P2|Overall Study|Physician Decision|1
5456813|NCT02082483|18858789|P1|Overall Study|Physician Decision|1
5456814|NCT02082483|18858788|P2|Overall Study|Withdrawal by Subject|1
5456815|NCT02082483|18858789|P1|Overall Study|Withdrawal by Subject|2
5456816|NCT02082483|18858788|P2|Overall Study|Lost to Follow-up|1
5456817|NCT02082483|18858789|P1|Overall Study|Lost to Follow-up|1
5456818|NCT02082340|18858841|P2|Overall Study|Lost to Follow-up|1
5456819|NCT02082340|18858842|P1|Overall Study|Lost to Follow-up|1
5456820|NCT02082262|18858852|P1|Overall Study|Adverse Event|48
5456821|NCT02082262|18858852|P1|Overall Study|Withdrawal by Subject|3
5456822|NCT02082210|18858862|P6|Overall Study|Physician Decision|0
5456823|NCT02082210|18858863|P5|Overall Study|Physician Decision|0
5456824|NCT02082210|18858864|P4|Overall Study|Physician Decision|1
5456825|NCT02082210|18858865|P3|Overall Study|Physician Decision|1
5456826|NCT02082210|18858866|P2|Overall Study|Physician Decision|0
5456827|NCT02082210|18858867|P1|Overall Study|Physician Decision|0
5456828|NCT02082210|18858862|P6|Overall Study|No Post-Baseline Tumor Assesment|0
5456829|NCT02082210|18858863|P5|Overall Study|No Post-Baseline Tumor Assesment|0
5456830|NCT02082210|18858864|P4|Overall Study|No Post-Baseline Tumor Assesment|2
5456831|NCT02082210|18858865|P3|Overall Study|No Post-Baseline Tumor Assesment|1
5456832|NCT02082210|18858866|P2|Overall Study|No Post-Baseline Tumor Assesment|0
5456833|NCT02082210|18858867|P1|Overall Study|No Post-Baseline Tumor Assesment|0
5456834|NCT02082210|18858862|P6|Overall Study|Clinical Progression|0
5456835|NCT02082210|18858863|P5|Overall Study|Clinical Progression|0
5456836|NCT02082210|18858864|P4|Overall Study|Clinical Progression|1
5456837|NCT02082210|18858865|P3|Overall Study|Clinical Progression|0
5456838|NCT02082210|18858866|P2|Overall Study|Clinical Progression|0
5456839|NCT02082210|18858867|P1|Overall Study|Clinical Progression|0
5456840|NCT02082210|18858862|P6|Overall Study|Withdrawal by Subject|2
5456841|NCT02082210|18858863|P5|Overall Study|Withdrawal by Subject|2
5456842|NCT02082210|18858864|P4|Overall Study|Withdrawal by Subject|1
5456843|NCT02082210|18858865|P3|Overall Study|Withdrawal by Subject|0
5456844|NCT02082210|18858866|P2|Overall Study|Withdrawal by Subject|0
5456845|NCT02082210|18858867|P1|Overall Study|Withdrawal by Subject|0
5456846|NCT02082210|18858862|P6|Overall Study|Death|0
5456847|NCT02082210|18858863|P5|Overall Study|Death|1
5456848|NCT02082210|18858864|P4|Overall Study|Death|1
5456849|NCT02082210|18858865|P3|Overall Study|Death|1
5456850|NCT02082210|18858866|P2|Overall Study|Death|0
5456851|NCT02082210|18858867|P1|Overall Study|Death|0
5456852|NCT02082184|18858915|P2|Overall Study|Subject non-compliance|1
5456853|NCT02082184|18858916|P1|Overall Study|Subject non-compliance|0
5456854|NCT02082184|18858915|P2|Overall Study|Lost to Follow-up|2
5456855|NCT02082184|18858916|P1|Overall Study|Lost to Follow-up|0
5456856|NCT02082184|18858915|P2|Overall Study|Protocol Violation|6
5456857|NCT02082184|18858916|P1|Overall Study|Protocol Violation|0
5456858|NCT02082184|18858915|P2|Overall Study|Withdrawal by Subject|2
5456859|NCT02082184|18858916|P1|Overall Study|Withdrawal by Subject|3
5456860|NCT02082184|18858915|P2|Overall Study|Device associated symptoms|0
5456861|NCT02082184|18858916|P1|Overall Study|Device associated symptoms|5
5456862|NCT02082184|18858915|P2|Overall Study|Medical diagnosis|2
5456863|NCT02082184|18858916|P1|Overall Study|Medical diagnosis|1
5456864|NCT02082184|18858915|P2|Overall Study|Adverse Event|0
5456865|NCT02082184|18858916|P1|Overall Study|Adverse Event|1
5456866|NCT02082158|18858941|P6|Overall Study|Failed Fit-testing|7
5456867|NCT02082158|18858942|P5|Overall Study|Failed Fit-testing|3
5456868|NCT02082158|18858943|P4|Overall Study|Failed Fit-testing|4
5456869|NCT02082158|18858944|P3|Overall Study|Failed Fit-testing|14
5456870|NCT02082158|18858945|P2|Overall Study|Failed Fit-testing|8
5456871|NCT02082158|18858946|P1|Overall Study|Failed Fit-testing|8
5456872|NCT02082158|18858941|P6|Overall Study|Withdrawal by Subject|0
5456873|NCT02082158|18858942|P5|Overall Study|Withdrawal by Subject|1
5456874|NCT02082158|18858943|P4|Overall Study|Withdrawal by Subject|0
5456875|NCT02082158|18858944|P3|Overall Study|Withdrawal by Subject|0
5456876|NCT02082158|18858945|P2|Overall Study|Withdrawal by Subject|0
5456877|NCT02082158|18858946|P1|Overall Study|Withdrawal by Subject|0
5456878|NCT02081859|18859076|P2|Overall Study|Other reasons|0
5456879|NCT02081859|18859077|P1|Overall Study|Other reasons|2
5456880|NCT02081859|18859076|P2|Overall Study|< 4 embryos|23
5456881|NCT02081859|18859077|P1|Overall Study|< 4 embryos|27
5456882|NCT02081859|18859076|P2|Overall Study|Unanticipated freeze all cycle|6
5456883|NCT02081859|18859077|P1|Overall Study|Unanticipated freeze all cycle|2
5456884|NCT02081859|18859076|P2|Overall Study|No sperm|0
5456885|NCT02081859|18859077|P1|Overall Study|No sperm|1
5456886|NCT02081859|18859076|P2|Overall Study|No fertilization|2
5456887|NCT02081859|18859077|P1|Overall Study|No fertilization|2
5456888|NCT02081846|18859087|P2|Overall Study|invalid consent|0
5456889|NCT02081846|18859088|P1|Overall Study|invalid consent|1
5456890|NCT02081846|18859087|P2|Overall Study|Withdrawal by Subject|0
5456891|NCT02081846|18859088|P1|Overall Study|Withdrawal by Subject|1
5456892|NCT02081690|18859257|P1|Overall Study|Withdrawal by Subject|1
5456893|NCT02081690|18859257|P1|Overall Study|Physician Decision|3
5456894|NCT02081690|18859257|P1|Overall Study|Death|3
5456895|NCT02081677|18859268|P4|Overall Study|Unsatisfactory Lens Fitting|0
5456896|NCT02081677|18859269|P3|Overall Study|Unsatisfactory Lens Fitting|0
5456897|NCT02081677|18859270|P2|Overall Study|Unsatisfactory Lens Fitting|1
5456898|NCT02081677|18859271|P1|Overall Study|Unsatisfactory Lens Fitting|0
5456899|NCT02081677|18859268|P4|Overall Study|Not comfortable with lens care system|0
5456900|NCT02081677|18859269|P3|Overall Study|Not comfortable with lens care system|0
5456901|NCT02081677|18859270|P2|Overall Study|Not comfortable with lens care system|0
5456902|NCT02081677|18859271|P1|Overall Study|Not comfortable with lens care system|1
5456903|NCT02081677|18859268|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5456904|NCT02081677|18859269|P3|Overall Study|No Longer Meets Eligibility Criteria|1
5456905|NCT02081677|18859270|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5456906|NCT02081677|18859271|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5456907|NCT02081677|18859268|P4|Overall Study|Adverse Event|0
5456908|NCT02081677|18859269|P3|Overall Study|Adverse Event|1
5456909|NCT02081677|18859270|P2|Overall Study|Adverse Event|0
5456910|NCT02081677|18859271|P1|Overall Study|Adverse Event|0
5456911|NCT02081599|18859376|P2|Period 2：Open-label Period|Withdrawal by Subject|0
5456912|NCT02081599|18859377|P1|Period 2：Open-label Period|Withdrawal by Subject|2
5456913|NCT02081599|18859376|P2|Period 2：Open-label Period|Physician Decision|0
5456914|NCT02081599|18859377|P1|Period 2：Open-label Period|Physician Decision|1
5456915|NCT02081599|18859376|P2|Period 2：Open-label Period|Lack of Efficacy|4
5456916|NCT02081599|18859377|P1|Period 2：Open-label Period|Lack of Efficacy|2
5456917|NCT02081599|18859376|P2|Period 2：Open-label Period|Adverse Event|0
5456918|NCT02081599|18859377|P1|Period 2：Open-label Period|Adverse Event|1
5456919|NCT02081599|18859376|P2|Period 1：Double-blind Period|stopping criteria|0
5456920|NCT02081599|18859377|P1|Period 1：Double-blind Period|stopping criteria|1
5456921|NCT02081599|18859376|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
5456922|NCT02081599|18859377|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
5456923|NCT02081599|18859376|P2|Period 1：Double-blind Period|Protocol Violation|1
5456924|NCT02081599|18859377|P1|Period 1：Double-blind Period|Protocol Violation|0
5456925|NCT02081599|18859376|P2|Period 1：Double-blind Period|Physician Decision|0
5456926|NCT02081599|18859377|P1|Period 1：Double-blind Period|Physician Decision|1
5456927|NCT02081599|18859376|P2|Period 1：Double-blind Period|Lack of Efficacy|1
5456928|NCT02081599|18859377|P1|Period 1：Double-blind Period|Lack of Efficacy|2
5456929|NCT02081599|18859376|P2|Period 1：Double-blind Period|Adverse Event|0
5456930|NCT02081599|18859377|P1|Period 1：Double-blind Period|Adverse Event|3
5456931|NCT02081586|18859395|P4|Overall Study|Head injury not related to study|0
5456932|NCT02081586|18859396|P3|Overall Study|Head injury not related to study|1
5456933|NCT02081586|18859397|P2|Overall Study|Head injury not related to study|0
5456934|NCT02081586|18859398|P1|Overall Study|Head injury not related to study|0
5456935|NCT02081586|18859395|P4|Overall Study|Lost to Follow-up|1
5456936|NCT02081586|18859396|P3|Overall Study|Lost to Follow-up|0
5456937|NCT02081586|18859397|P2|Overall Study|Lost to Follow-up|1
5456938|NCT02081586|18859398|P1|Overall Study|Lost to Follow-up|0
5456939|NCT02081534|18859441|P7|Overall Study|Lost to Follow-up|0
5456940|NCT02081534|18859442|P6|Overall Study|Lost to Follow-up|1
5456941|NCT02081534|18859443|P5|Overall Study|Lost to Follow-up|1
5456942|NCT02081534|18859444|P4|Overall Study|Lost to Follow-up|2
5456943|NCT02081534|18859445|P3|Overall Study|Lost to Follow-up|0
5456944|NCT02081534|18859446|P2|Overall Study|Lost to Follow-up|0
5456945|NCT02081534|18859447|P1|Overall Study|Lost to Follow-up|0
5456946|NCT02081534|18859441|P7|Overall Study|Protocol Violation|1
5456947|NCT02081534|18859442|P6|Overall Study|Protocol Violation|0
5456948|NCT02081534|18859443|P5|Overall Study|Protocol Violation|0
5456949|NCT02081534|18859444|P4|Overall Study|Protocol Violation|0
5456950|NCT02081534|18859445|P3|Overall Study|Protocol Violation|0
5456951|NCT02081534|18859446|P2|Overall Study|Protocol Violation|3
5456952|NCT02081534|18859447|P1|Overall Study|Protocol Violation|0
5456953|NCT02081534|18859441|P7|Overall Study|Withdrawal by Subject|1
5456954|NCT02081534|18859442|P6|Overall Study|Withdrawal by Subject|0
5456955|NCT02081534|18859443|P5|Overall Study|Withdrawal by Subject|1
5456956|NCT02081534|18859444|P4|Overall Study|Withdrawal by Subject|1
5456957|NCT02081534|18859445|P3|Overall Study|Withdrawal by Subject|1
5456958|NCT02081534|18859446|P2|Overall Study|Withdrawal by Subject|1
5456959|NCT02081534|18859447|P1|Overall Study|Withdrawal by Subject|0
5456960|NCT02081534|18859441|P7|Overall Study|Adverse Event|2
5456961|NCT02081534|18859442|P6|Overall Study|Adverse Event|8
5456962|NCT02081534|18859443|P5|Overall Study|Adverse Event|2
5456963|NCT02081534|18859444|P4|Overall Study|Adverse Event|10
5456964|NCT02081534|18859445|P3|Overall Study|Adverse Event|3
5456965|NCT02081534|18859446|P2|Overall Study|Adverse Event|4
5456966|NCT02081534|18859447|P1|Overall Study|Adverse Event|5
5456967|NCT02081417|18859500|P2|Overall Study|Did not start treatment|21
5456968|NCT02081417|18859501|P1|Overall Study|Did not start treatment|17
5456969|NCT02081417|18859500|P2|Overall Study|Admitted to Residential Treatment|0
5456970|NCT02081417|18859501|P1|Overall Study|Admitted to Residential Treatment|2
5456971|NCT02081417|18859500|P2|Overall Study|Withdrawal by Subject|0
5456972|NCT02081417|18859501|P1|Overall Study|Withdrawal by Subject|4
5456973|NCT02081417|18859500|P2|Overall Study|Death|3
5456974|NCT02081417|18859501|P1|Overall Study|Death|4
5456975|NCT02081417|18859500|P2|Overall Study|Incarcerated|2
5456976|NCT02081417|18859501|P1|Overall Study|Incarcerated|2
5456977|NCT02081417|18859500|P2|Overall Study|Moved Away|2
5456978|NCT02081417|18859501|P1|Overall Study|Moved Away|1
5456979|NCT02081417|18859500|P2|Overall Study|Lost to Follow-up|23
5456980|NCT02081417|18859501|P1|Overall Study|Lost to Follow-up|26
5456981|NCT02081391|18859521|P4|24-hour Treatment and Trial Completion|Further reasons|0
5456982|NCT02081391|18859522|P3|24-hour Treatment and Trial Completion|Further reasons|0
5456983|NCT02081391|18859523|P2|24-hour Treatment and Trial Completion|Further reasons|4
5456984|NCT02081391|18859524|P1|24-hour Treatment and Trial Completion|Further reasons|3
5456985|NCT02081391|18859521|P4|24-hour Treatment and Trial Completion|Technical Problems|0
5456986|NCT02081391|18859522|P3|24-hour Treatment and Trial Completion|Technical Problems|0
5456987|NCT02081391|18859523|P2|24-hour Treatment and Trial Completion|Technical Problems|1
5456988|NCT02081391|18859524|P1|24-hour Treatment and Trial Completion|Technical Problems|1
5456989|NCT02081391|18859521|P4|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
5456990|NCT02081391|18859522|P3|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
5456991|NCT02081391|18859523|P2|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
5456992|NCT02081391|18859524|P1|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
5456993|NCT02081391|18859521|P4|24-hour Treatment and Trial Completion|Adverse Event|0
5456994|NCT02081391|18859522|P3|24-hour Treatment and Trial Completion|Adverse Event|0
5456995|NCT02081391|18859523|P2|24-hour Treatment and Trial Completion|Adverse Event|0
5456996|NCT02081391|18859524|P1|24-hour Treatment and Trial Completion|Adverse Event|1
5456997|NCT02081391|18859521|P4|24-hour Treatment and Trial Completion|Lack of Efficacy|0
5456998|NCT02081391|18859522|P3|24-hour Treatment and Trial Completion|Lack of Efficacy|0
5456999|NCT02081391|18859523|P2|24-hour Treatment and Trial Completion|Lack of Efficacy|3
5457000|NCT02081391|18859524|P1|24-hour Treatment and Trial Completion|Lack of Efficacy|1
5457001|NCT02081391|18859521|P4|24-hour Treatment and Trial Completion|Physician Decision|0
5457002|NCT02081391|18859522|P3|24-hour Treatment and Trial Completion|Physician Decision|0
5457003|NCT02081391|18859523|P2|24-hour Treatment and Trial Completion|Physician Decision|5
5457004|NCT02081391|18859524|P1|24-hour Treatment and Trial Completion|Physician Decision|10
5457005|NCT02081391|18859521|P4|12-hour Treatment|Further reasons|0
5457006|NCT02081391|18859522|P3|12-hour Treatment|Further reasons|0
5457007|NCT02081391|18859523|P2|12-hour Treatment|Further reasons|1
5457008|NCT02081391|18859524|P1|12-hour Treatment|Further reasons|2
5457009|NCT02081391|18859521|P4|12-hour Treatment|Recovery (opioid no longer needed)|0
5457010|NCT02081391|18859522|P3|12-hour Treatment|Recovery (opioid no longer needed)|1
5457011|NCT02081391|18859523|P2|12-hour Treatment|Recovery (opioid no longer needed)|0
5457012|NCT02081391|18859524|P1|12-hour Treatment|Recovery (opioid no longer needed)|2
5457013|NCT02081391|18859521|P4|12-hour Treatment|Adverse Event|0
5457014|NCT02081391|18859522|P3|12-hour Treatment|Adverse Event|0
5457015|NCT02081391|18859523|P2|12-hour Treatment|Adverse Event|2
5457016|NCT02081391|18859524|P1|12-hour Treatment|Adverse Event|4
5457017|NCT02081391|18859521|P4|12-hour Treatment|Lack of Efficacy|0
5457018|NCT02081391|18859522|P3|12-hour Treatment|Lack of Efficacy|0
5457019|NCT02081391|18859523|P2|12-hour Treatment|Lack of Efficacy|0
5457020|NCT02081391|18859524|P1|12-hour Treatment|Lack of Efficacy|3
5457021|NCT02081391|18859521|P4|12-hour Treatment|Physician Decision|0
5457022|NCT02081391|18859522|P3|12-hour Treatment|Physician Decision|0
5457023|NCT02081391|18859523|P2|12-hour Treatment|Physician Decision|1
5457024|NCT02081391|18859524|P1|12-hour Treatment|Physician Decision|4
5457025|NCT02081391|18859521|P4|12-hour Treatment|Withdrawal by Subject|0
5457026|NCT02081391|18859522|P3|12-hour Treatment|Withdrawal by Subject|0
5457027|NCT02081391|18859523|P2|12-hour Treatment|Withdrawal by Subject|2
5457028|NCT02081391|18859524|P1|12-hour Treatment|Withdrawal by Subject|3
5457029|NCT02081183|18859618|P2|Overall Study|Other|3
5457030|NCT02081183|18859619|P1|Overall Study|Other|3
5457031|NCT02081183|18859618|P2|Overall Study|Protocol Violation|0
5457032|NCT02081183|18859619|P1|Overall Study|Protocol Violation|1
5457033|NCT02081183|18859618|P2|Overall Study|Lost to Follow-up|1
5457034|NCT02081183|18859619|P1|Overall Study|Lost to Follow-up|0
5457035|NCT02081079|18859635|P2|Overall Study|Lost to Follow-up|0
5457036|NCT02081079|18859636|P1|Overall Study|Lost to Follow-up|1
5457037|NCT02081079|18859635|P2|Overall Study|Lack of Efficacy|2
5457038|NCT02081079|18859636|P1|Overall Study|Lack of Efficacy|3
5457039|NCT02081001|18859709|P12|Overall Study|Adverse Event|0
5457040|NCT02081001|18859710|P11|Overall Study|Adverse Event|0
5457041|NCT02081001|18859711|P10|Overall Study|Adverse Event|0
5457042|NCT02081001|18859712|P9|Overall Study|Adverse Event|0
5457043|NCT02081001|18859713|P8|Overall Study|Adverse Event|0
5457044|NCT02081001|18859714|P7|Overall Study|Adverse Event|0
5457045|NCT02081001|18859715|P6|Overall Study|Adverse Event|0
5457046|NCT02081001|18859716|P5|Overall Study|Adverse Event|1
5457047|NCT02081001|18859717|P4|Overall Study|Adverse Event|0
5457048|NCT02081001|18859718|P3|Overall Study|Adverse Event|0
5457049|NCT02081001|18859719|P2|Overall Study|Adverse Event|0
5457050|NCT02081001|18859720|P1|Overall Study|Adverse Event|0
5457051|NCT02080871|18859784|P1|Overall Study|Lost to Follow-up|1
5457052|NCT02080871|18859784|P1|Overall Study|Death|1
5457053|NCT02080832|18859868|P3|Overall Study|Lost to Follow-up|2
5457054|NCT02080832|18859869|P2|Overall Study|Lost to Follow-up|2
5457055|NCT02080832|18859870|P1|Overall Study|Lost to Follow-up|0
5457056|NCT02080832|18859868|P3|Overall Study|Excluded from analysis by MRI|14
5457057|NCT02080832|18859869|P2|Overall Study|Excluded from analysis by MRI|10
5457058|NCT02080832|18859870|P1|Overall Study|Excluded from analysis by MRI|9
5457059|NCT02080481|18859942|P2|Overall Study|Never received a block.|0
5457060|NCT02080481|18859943|P1|Overall Study|Never received a block.|1
5457061|NCT02080260|18860129|P1|Overall Study|Withdrawal by Subject|1
5457062|NCT02080260|18860129|P1|Overall Study|Death|18
5457063|NCT02080091|18860146|P1|Overall Study|Other|1
5457064|NCT02080091|18860146|P1|Overall Study|Withdrawal by Subject|1
5457065|NCT02080091|18860146|P1|Overall Study|Death|1
5457066|NCT02080091|18860146|P1|Overall Study|Study Terminated|22
5457067|NCT02079909|18860174|P3|Overall Study|Relocation etc.|3
5457068|NCT02079909|18860175|P2|Overall Study|Relocation etc.|2
5457069|NCT02079909|18860176|P1|Overall Study|Relocation etc.|2
5457070|NCT02079909|18860174|P3|Overall Study|Physician Decision|1
5457071|NCT02079909|18860175|P2|Overall Study|Physician Decision|1
5457072|NCT02079909|18860176|P1|Overall Study|Physician Decision|0
5457073|NCT02079909|18860174|P3|Overall Study|Protocol Violation|1
5457074|NCT02079909|18860175|P2|Overall Study|Protocol Violation|1
5457075|NCT02079909|18860176|P1|Overall Study|Protocol Violation|0
5457076|NCT02079909|18860174|P3|Overall Study|Lack of Efficacy|1
5457077|NCT02079909|18860175|P2|Overall Study|Lack of Efficacy|0
5457078|NCT02079909|18860176|P1|Overall Study|Lack of Efficacy|0
5457079|NCT02079909|18860174|P3|Overall Study|Death|0
5457080|NCT02079909|18860175|P2|Overall Study|Death|2
5457081|NCT02079909|18860176|P1|Overall Study|Death|2
5457082|NCT02079909|18860174|P3|Overall Study|Lost to Follow-up|1
5457083|NCT02079909|18860175|P2|Overall Study|Lost to Follow-up|3
5457084|NCT02079909|18860176|P1|Overall Study|Lost to Follow-up|2
5457085|NCT02079909|18860174|P3|Overall Study|Withdrawal by Subject|4
5457086|NCT02079909|18860175|P2|Overall Study|Withdrawal by Subject|17
5457087|NCT02079909|18860176|P1|Overall Study|Withdrawal by Subject|9
5457088|NCT02079909|18860174|P3|Overall Study|Adverse Event|7
5457089|NCT02079909|18860175|P2|Overall Study|Adverse Event|23
5457090|NCT02079909|18860176|P1|Overall Study|Adverse Event|23
5457091|NCT02079844|18860193|P3|Treatment Period 2|Voluntary Withdrawal|0
5457092|NCT02079844|18860194|P2|Treatment Period 2|Voluntary Withdrawal|1
5457093|NCT02079844|18860195|P1|Treatment Period 2|Voluntary Withdrawal|0
5457094|NCT02079844|18860193|P3|Treatment Period 1|Voluntary Withdrawal|2
5457095|NCT02079844|18860194|P2|Treatment Period 1|Voluntary Withdrawal|0
5457096|NCT02079844|18860195|P1|Treatment Period 1|Voluntary Withdrawal|0
5457097|NCT02079805|18860253|P2|Overall Study|Voluntary Withdrawal|1
5457098|NCT02079805|18860254|P1|Overall Study|Voluntary Withdrawal|0
5457099|NCT02079805|18860253|P2|Overall Study|Pretreatment Event/Adverse Event|1
5457100|NCT02079805|18860254|P1|Overall Study|Pretreatment Event/Adverse Event|0
5457101|NCT02079766|18860274|P2|Overall Study|Withdrawal by Subject|0
5457102|NCT02079766|18860275|P1|Overall Study|Withdrawal by Subject|1
5457103|NCT02079766|18860274|P2|Overall Study|Physician Decision|0
5457104|NCT02079766|18860275|P1|Overall Study|Physician Decision|1
5457105|NCT02079649|18860286|P4|Overall Study|Randomization error (prior to treatment)|0
5457106|NCT02079649|18860287|P3|Overall Study|Randomization error (prior to treatment)|1
5457107|NCT02079649|18860288|P2|Overall Study|Randomization error (prior to treatment)|0
5457108|NCT02079649|18860289|P1|Overall Study|Randomization error (prior to treatment)|1
5457109|NCT02079649|18860286|P4|Overall Study|Withdrawal by Subject|1
5457110|NCT02079649|18860287|P3|Overall Study|Withdrawal by Subject|0
5457111|NCT02079649|18860288|P2|Overall Study|Withdrawal by Subject|0
5457112|NCT02079649|18860289|P1|Overall Study|Withdrawal by Subject|0
5457113|NCT02079649|18860286|P4|Overall Study|Lost to Follow-up|1
5457114|NCT02079649|18860287|P3|Overall Study|Lost to Follow-up|0
5457115|NCT02079649|18860288|P2|Overall Study|Lost to Follow-up|0
5457116|NCT02079649|18860289|P1|Overall Study|Lost to Follow-up|0
5457117|NCT02079636|18860319|P15|Overall Study|Lost to Follow-up|0
5457118|NCT02079636|18860320|P14|Overall Study|Lost to Follow-up|0
5457119|NCT02079636|18860321|P13|Overall Study|Lost to Follow-up|0
5457120|NCT02079636|18860322|P12|Overall Study|Lost to Follow-up|0
5457121|NCT02079636|18860323|P11|Overall Study|Lost to Follow-up|0
5457122|NCT02079636|18860324|P10|Overall Study|Lost to Follow-up|0
5457123|NCT02079636|18860325|P9|Overall Study|Lost to Follow-up|0
5457124|NCT02079636|18860326|P8|Overall Study|Lost to Follow-up|1
5457125|NCT02079636|18860327|P7|Overall Study|Lost to Follow-up|0
5457126|NCT02079636|18860328|P6|Overall Study|Lost to Follow-up|0
5457127|NCT02079636|18860329|P5|Overall Study|Lost to Follow-up|0
5457128|NCT02079636|18860330|P4|Overall Study|Lost to Follow-up|0
5457129|NCT02079636|18860331|P3|Overall Study|Lost to Follow-up|0
5457130|NCT02079636|18860332|P2|Overall Study|Lost to Follow-up|0
5457131|NCT02079636|18860333|P1|Overall Study|Lost to Follow-up|0
5457132|NCT02079636|18860319|P15|Overall Study|Physician Decision|1
5457133|NCT02079636|18860320|P14|Overall Study|Physician Decision|0
5457134|NCT02079636|18860321|P13|Overall Study|Physician Decision|0
5457135|NCT02079636|18860322|P12|Overall Study|Physician Decision|0
5457136|NCT02079636|18860323|P11|Overall Study|Physician Decision|1
5457137|NCT02079636|18860324|P10|Overall Study|Physician Decision|1
5457138|NCT02079636|18860325|P9|Overall Study|Physician Decision|0
5457139|NCT02079636|18860326|P8|Overall Study|Physician Decision|0
5457140|NCT02079636|18860327|P7|Overall Study|Physician Decision|0
5457141|NCT02079636|18860328|P6|Overall Study|Physician Decision|1
5457142|NCT02079636|18860329|P5|Overall Study|Physician Decision|0
5457143|NCT02079636|18860330|P4|Overall Study|Physician Decision|0
5457144|NCT02079636|18860331|P3|Overall Study|Physician Decision|0
5457145|NCT02079636|18860332|P2|Overall Study|Physician Decision|0
5457146|NCT02079636|18860333|P1|Overall Study|Physician Decision|0
5457147|NCT02079636|18860319|P15|Overall Study|Withdrawal by Subject|2
5457148|NCT02079636|18860320|P14|Overall Study|Withdrawal by Subject|0
5457149|NCT02079636|18860321|P13|Overall Study|Withdrawal by Subject|1
5457150|NCT02079636|18860322|P12|Overall Study|Withdrawal by Subject|1
5457151|NCT02079636|18860323|P11|Overall Study|Withdrawal by Subject|1
5457152|NCT02079636|18860324|P10|Overall Study|Withdrawal by Subject|2
5457153|NCT02079636|18860325|P9|Overall Study|Withdrawal by Subject|0
5457154|NCT02079636|18860326|P8|Overall Study|Withdrawal by Subject|0
5457155|NCT02079636|18860327|P7|Overall Study|Withdrawal by Subject|0
5457156|NCT02079636|18860328|P6|Overall Study|Withdrawal by Subject|1
5457157|NCT02079636|18860329|P5|Overall Study|Withdrawal by Subject|0
5457158|NCT02079636|18860330|P4|Overall Study|Withdrawal by Subject|4
5457159|NCT02079636|18860331|P3|Overall Study|Withdrawal by Subject|0
5457160|NCT02079636|18860332|P2|Overall Study|Withdrawal by Subject|0
5457161|NCT02079636|18860333|P1|Overall Study|Withdrawal by Subject|0
5457162|NCT02079636|18860319|P15|Overall Study|Progressive disease|0
5457163|NCT02079636|18860320|P14|Overall Study|Progressive disease|0
5457164|NCT02079636|18860321|P13|Overall Study|Progressive disease|1
5457165|NCT02079636|18860322|P12|Overall Study|Progressive disease|0
5457166|NCT02079636|18860323|P11|Overall Study|Progressive disease|0
5457167|NCT02079636|18860324|P10|Overall Study|Progressive disease|0
5457168|NCT02079636|18860325|P9|Overall Study|Progressive disease|0
5457169|NCT02079636|18860326|P8|Overall Study|Progressive disease|0
5457170|NCT02079636|18860327|P7|Overall Study|Progressive disease|0
5457171|NCT02079636|18860328|P6|Overall Study|Progressive disease|0
5457172|NCT02079636|18860329|P5|Overall Study|Progressive disease|0
5457173|NCT02079636|18860330|P4|Overall Study|Progressive disease|2
5457174|NCT02079636|18860331|P3|Overall Study|Progressive disease|0
5457175|NCT02079636|18860332|P2|Overall Study|Progressive disease|0
5457176|NCT02079636|18860333|P1|Overall Study|Progressive disease|0
5457177|NCT02079636|18860319|P15|Overall Study|Adverse Event|0
5457178|NCT02079636|18860320|P14|Overall Study|Adverse Event|0
5457179|NCT02079636|18860321|P13|Overall Study|Adverse Event|0
5457180|NCT02079636|18860322|P12|Overall Study|Adverse Event|0
5457181|NCT02079636|18860323|P11|Overall Study|Adverse Event|0
5457182|NCT02079636|18860324|P10|Overall Study|Adverse Event|0
5457183|NCT02079636|18860325|P9|Overall Study|Adverse Event|0
5457184|NCT02079636|18860326|P8|Overall Study|Adverse Event|0
5457185|NCT02079636|18860327|P7|Overall Study|Adverse Event|0
5457186|NCT02079636|18860328|P6|Overall Study|Adverse Event|2
5457187|NCT02079636|18860329|P5|Overall Study|Adverse Event|1
5457188|NCT02079636|18860330|P4|Overall Study|Adverse Event|1
5457189|NCT02079636|18860331|P3|Overall Study|Adverse Event|0
5457190|NCT02079636|18860332|P2|Overall Study|Adverse Event|1
5457191|NCT02079636|18860333|P1|Overall Study|Adverse Event|1
5457192|NCT02079636|18860319|P15|Overall Study|Death|2
5457193|NCT02079636|18860320|P14|Overall Study|Death|0
5457194|NCT02079636|18860321|P13|Overall Study|Death|1
5457195|NCT02079636|18860322|P12|Overall Study|Death|1
5457196|NCT02079636|18860323|P11|Overall Study|Death|0
5457197|NCT02079636|18860324|P10|Overall Study|Death|0
5457198|NCT02079636|18860325|P9|Overall Study|Death|0
5457199|NCT02079636|18860326|P8|Overall Study|Death|0
5457200|NCT02079636|18860327|P7|Overall Study|Death|1
5457201|NCT02079636|18860328|P6|Overall Study|Death|2
5457202|NCT02079636|18860329|P5|Overall Study|Death|1
5457203|NCT02079636|18860330|P4|Overall Study|Death|5
5457204|NCT02079636|18860331|P3|Overall Study|Death|0
5457205|NCT02079636|18860332|P2|Overall Study|Death|1
5457206|NCT02079636|18860333|P1|Overall Study|Death|2
5457207|NCT02079610|18860444|P2|Overall Study|Withdrawal by Subject|1
5457208|NCT02079610|18860445|P1|Overall Study|Withdrawal by Subject|1
5457209|NCT02079532|18860455|P1|Overall Study|Other|3
5457210|NCT02079532|18860455|P1|Overall Study|Inclusion into ReFIRST|3
5457211|NCT02079532|18860455|P1|Overall Study|Administrative problems|1
5457212|NCT02079532|18860455|P1|Overall Study|Withdrawal by Subject|1
5457213|NCT02079532|18860455|P1|Overall Study|Protocol Violation|3
5457214|NCT02079532|18860455|P1|Overall Study|Lack of Efficacy|9
5457215|NCT02079532|18860455|P1|Overall Study|Additional or changed therapy|2
5457216|NCT02079532|18860455|P1|Overall Study|Adverse Event|7
5457217|NCT02079519|18860477|P1|Overall Study|Adverse Event|1
5457218|NCT02079519|18860477|P1|Overall Study|Disease Progression|9
5457219|NCT02079246|18860490|P2|OLEX-MEM|Other: Moved to nursing home|3
5457220|NCT02079246|18860491|P1|OLEX-MEM|Other: Moved to nursing home|0
5457221|NCT02079246|18860490|P2|OLEX-MEM|Lost to Follow-up|1
5457222|NCT02079246|18860491|P1|OLEX-MEM|Lost to Follow-up|0
5457223|NCT02079246|18860490|P2|OLEX-MEM|Protocol Violation|2
5457224|NCT02079246|18860491|P1|OLEX-MEM|Protocol Violation|0
5457225|NCT02079246|18860490|P2|OLEX-MEM|Withdrawal by Subject|7
5457226|NCT02079246|18860491|P1|OLEX-MEM|Withdrawal by Subject|0
5457227|NCT02079246|18860490|P2|OLEX-MEM|Adverse Event|6
5457228|NCT02079246|18860491|P1|OLEX-MEM|Adverse Event|0
5457229|NCT02079246|18860490|P2|OLEX|Other: Withdrawal of caregiver consent|0
5457230|NCT02079246|18860491|P1|OLEX|Other: Withdrawal of caregiver consent|1
5457231|NCT02079246|18860490|P2|OLEX|Other: Moved to nursing home|0
5457232|NCT02079246|18860491|P1|OLEX|Other: Moved to nursing home|1
5457233|NCT02079246|18860490|P2|OLEX|Other: Worsening of condition|0
5457234|NCT02079246|18860491|P1|OLEX|Other: Worsening of condition|1
5457235|NCT02079246|18860490|P2|OLEX|Other: Coordinator decision|0
5457236|NCT02079246|18860491|P1|OLEX|Other: Coordinator decision|1
5457237|NCT02079246|18860490|P2|OLEX|Other: Caregiver unavailable|0
5457238|NCT02079246|18860491|P1|OLEX|Other: Caregiver unavailable|3
5457239|NCT02079246|18860490|P2|OLEX|Other: Insufficient compliance|0
5457240|NCT02079246|18860491|P1|OLEX|Other: Insufficient compliance|2
5457241|NCT02079246|18860490|P2|OLEX|Other: Disallowed medication|0
5457242|NCT02079246|18860491|P1|OLEX|Other: Disallowed medication|8
5457243|NCT02079246|18860490|P2|OLEX|Results of the lead-in studies|0
5457244|NCT02079246|18860491|P1|OLEX|Results of the lead-in studies|58
5457245|NCT02079246|18860490|P2|OLEX|Lack of Efficacy|0
5457246|NCT02079246|18860491|P1|OLEX|Lack of Efficacy|3
5457247|NCT02079246|18860490|P2|OLEX|Protocol Violation|0
5457248|NCT02079246|18860491|P1|OLEX|Protocol Violation|6
5457249|NCT02079246|18860490|P2|OLEX|Lost to Follow-up|0
5457250|NCT02079246|18860491|P1|OLEX|Lost to Follow-up|6
5457251|NCT02079246|18860490|P2|OLEX|Withdrawal by Subject|0
5457252|NCT02079246|18860491|P1|OLEX|Withdrawal by Subject|60
5457253|NCT02079246|18860490|P2|OLEX|Adverse Event|0
5457254|NCT02079246|18860491|P1|OLEX|Adverse Event|66
5457255|NCT02079246|18860490|P2|OLEX|Death|0
5457256|NCT02079246|18860491|P1|OLEX|Death|11
5457257|NCT02079246|18860490|P2|OLEX|Withdrawal before treatment|0
5457258|NCT02079246|18860491|P1|OLEX|Withdrawal before treatment|1
5457259|NCT02079077|18860510|P2|Overall Study|Became STIs Positive|2
5457260|NCT02079077|18860511|P1|Overall Study|Became STIs Positive|1
5457261|NCT02079077|18860510|P2|Overall Study|Lost to Follow-up|7
5457262|NCT02079077|18860511|P1|Overall Study|Lost to Follow-up|5
5457263|NCT02079038|18860521|P2|Completed 6 Months|Lost to Follow-up|1
5457264|NCT02079038|18860522|P1|Completed 6 Months|Lost to Follow-up|2
5457265|NCT02079038|18860521|P2|Modified Intent to Treat Population|Death|0
5457266|NCT02079038|18860522|P1|Modified Intent to Treat Population|Death|1
5457267|NCT02079038|18860521|P2|Modified Intent to Treat Population|Withdrawal by Subject|5
5457268|NCT02079038|18860522|P1|Modified Intent to Treat Population|Withdrawal by Subject|6
5457269|NCT02078960|18860543|P3|Follow-up Period|Lost to Follow-up|0
5457270|NCT02078960|18860544|P2|Follow-up Period|Lost to Follow-up|1
5457271|NCT02078960|18860545|P1|Follow-up Period|Lost to Follow-up|0
5457272|NCT02078960|18860543|P3|Follow-up Period|Death|0
5457273|NCT02078960|18860544|P2|Follow-up Period|Death|0
5457274|NCT02078960|18860545|P1|Follow-up Period|Death|2
5457275|NCT02078960|18860543|P3|Treatment Period|Death|1
5457276|NCT02078960|18860544|P2|Treatment Period|Death|0
5457277|NCT02078960|18860545|P1|Treatment Period|Death|0
5457278|NCT02078960|18860543|P3|Treatment Period|Adverse Event|0
5457279|NCT02078960|18860544|P2|Treatment Period|Adverse Event|0
5457280|NCT02078960|18860545|P1|Treatment Period|Adverse Event|1
5457281|NCT02078960|18860543|P3|Treatment Period|Withdrawal by Subject|1
5457282|NCT02078960|18860544|P2|Treatment Period|Withdrawal by Subject|1
5457283|NCT02078960|18860545|P1|Treatment Period|Withdrawal by Subject|0
5457284|NCT02078960|18860543|P3|Treatment Period|Disease progression - blast phase|0
5457285|NCT02078960|18860544|P2|Treatment Period|Disease progression - blast phase|0
5457286|NCT02078960|18860545|P1|Treatment Period|Disease progression - blast phase|1
5457287|NCT02078960|18860543|P3|Treatment Period|Disease progression - accelerated phase|0
5457288|NCT02078960|18860544|P2|Treatment Period|Disease progression - accelerated phase|1
5457289|NCT02078960|18860545|P1|Treatment Period|Disease progression - accelerated phase|0
5457290|NCT02078960|18860543|P3|Treatment Period|Lack of Efficacy|0
5457291|NCT02078960|18860544|P2|Treatment Period|Lack of Efficacy|1
5457292|NCT02078960|18860545|P1|Treatment Period|Lack of Efficacy|0
5457293|NCT02078960|18860543|P3|Treatment Period|Other|1
5457294|NCT02078960|18860544|P2|Treatment Period|Other|0
5457295|NCT02078960|18860545|P1|Treatment Period|Other|0
5457296|NCT02078817|18860579|P1|Overall Study|Withdrawal by Subject|1
5457297|NCT02078752|18860601|P10|Overall Study|Study terminated by sponsor|5
5457298|NCT02078752|18860602|P9|Overall Study|Study terminated by sponsor|0
5457299|NCT02078752|18860603|P8|Overall Study|Study terminated by sponsor|0
5457300|NCT02078752|18860604|P7|Overall Study|Study terminated by sponsor|0
5457301|NCT02078752|18860605|P6|Overall Study|Study terminated by sponsor|0
5457302|NCT02078752|18860606|P5|Overall Study|Study terminated by sponsor|0
5457303|NCT02078752|18860607|P4|Overall Study|Study terminated by sponsor|0
5457304|NCT02078752|18860608|P3|Overall Study|Study terminated by sponsor|0
5457305|NCT02078752|18860609|P2|Overall Study|Study terminated by sponsor|0
5457306|NCT02078752|18860610|P1|Overall Study|Study terminated by sponsor|0
5457307|NCT02078752|18860601|P10|Overall Study|Other|0
5457308|NCT02078752|18860602|P9|Overall Study|Other|0
5457309|NCT02078752|18860603|P8|Overall Study|Other|1
5457310|NCT02078752|18860604|P7|Overall Study|Other|0
5457311|NCT02078752|18860605|P6|Overall Study|Other|0
5457312|NCT02078752|18860606|P5|Overall Study|Other|1
5457313|NCT02078752|18860607|P4|Overall Study|Other|0
5457314|NCT02078752|18860608|P3|Overall Study|Other|0
5457315|NCT02078752|18860609|P2|Overall Study|Other|3
5457316|NCT02078752|18860610|P1|Overall Study|Other|0
5457317|NCT02078752|18860601|P10|Overall Study|Withdrawal by Subject|1
5457318|NCT02078752|18860602|P9|Overall Study|Withdrawal by Subject|0
5457319|NCT02078752|18860603|P8|Overall Study|Withdrawal by Subject|1
5457320|NCT02078752|18860604|P7|Overall Study|Withdrawal by Subject|2
5457321|NCT02078752|18860605|P6|Overall Study|Withdrawal by Subject|3
5457322|NCT02078752|18860606|P5|Overall Study|Withdrawal by Subject|0
5457323|NCT02078752|18860607|P4|Overall Study|Withdrawal by Subject|1
5457324|NCT02078752|18860608|P3|Overall Study|Withdrawal by Subject|1
5457325|NCT02078752|18860609|P2|Overall Study|Withdrawal by Subject|1
5457326|NCT02078752|18860610|P1|Overall Study|Withdrawal by Subject|1
5457327|NCT02078752|18860601|P10|Overall Study|Lost to Follow-up|0
5457328|NCT02078752|18860602|P9|Overall Study|Lost to Follow-up|0
5457329|NCT02078752|18860603|P8|Overall Study|Lost to Follow-up|0
5457330|NCT02078752|18860604|P7|Overall Study|Lost to Follow-up|0
5457331|NCT02078752|18860605|P6|Overall Study|Lost to Follow-up|0
5457332|NCT02078752|18860606|P5|Overall Study|Lost to Follow-up|0
5457333|NCT02078752|18860607|P4|Overall Study|Lost to Follow-up|1
5457334|NCT02078752|18860608|P3|Overall Study|Lost to Follow-up|0
5457335|NCT02078752|18860609|P2|Overall Study|Lost to Follow-up|0
5457336|NCT02078752|18860610|P1|Overall Study|Lost to Follow-up|1
5457337|NCT02078752|18860601|P10|Overall Study|Death|4
5457338|NCT02078752|18860602|P9|Overall Study|Death|0
5457339|NCT02078752|18860603|P8|Overall Study|Death|1
5457340|NCT02078752|18860604|P7|Overall Study|Death|0
5457341|NCT02078752|18860605|P6|Overall Study|Death|1
5457342|NCT02078752|18860606|P5|Overall Study|Death|0
5457343|NCT02078752|18860607|P4|Overall Study|Death|0
5457344|NCT02078752|18860608|P3|Overall Study|Death|0
5457345|NCT02078752|18860609|P2|Overall Study|Death|3
5457346|NCT02078752|18860610|P1|Overall Study|Death|0
5457347|NCT02078713|18860886|P4|Overall Study|Enrolled twice|0
5457348|NCT02078713|18860887|P3|Overall Study|Enrolled twice|0
5457349|NCT02078713|18860888|P2|Overall Study|Enrolled twice|1
5457350|NCT02078713|18860889|P1|Overall Study|Enrolled twice|0
5457351|NCT02078713|18860886|P4|Overall Study|Pregnant at baseline|0
5457352|NCT02078713|18860887|P3|Overall Study|Pregnant at baseline|0
5457353|NCT02078713|18860888|P2|Overall Study|Pregnant at baseline|5
5457354|NCT02078713|18860889|P1|Overall Study|Pregnant at baseline|3
5457355|NCT02078713|18860886|P4|Overall Study|Lost to Follow-up|0
5457356|NCT02078713|18860887|P3|Overall Study|Lost to Follow-up|0
5457357|NCT02078713|18860888|P2|Overall Study|Lost to Follow-up|55
5457358|NCT02078713|18860889|P1|Overall Study|Lost to Follow-up|49
5457359|NCT02078219|18860974|P5|Overall Study|Adverse Event|0
5457360|NCT02078219|18860975|P4|Overall Study|Adverse Event|1
5457361|NCT02078219|18860976|P3|Overall Study|Adverse Event|3
5457362|NCT02078219|18860977|P2|Overall Study|Adverse Event|1
5457363|NCT02078219|18860978|P1|Overall Study|Adverse Event|1
5457364|NCT02078219|18860974|P5|Overall Study|Death|0
5457365|NCT02078219|18860975|P4|Overall Study|Death|1
5457366|NCT02078219|18860976|P3|Overall Study|Death|0
5457367|NCT02078219|18860977|P2|Overall Study|Death|0
5457368|NCT02078219|18860978|P1|Overall Study|Death|0
5457369|NCT02078219|18860974|P5|Overall Study|Protocol Violation|0
5457370|NCT02078219|18860975|P4|Overall Study|Protocol Violation|1
5457371|NCT02078219|18860976|P3|Overall Study|Protocol Violation|0
5457372|NCT02078219|18860977|P2|Overall Study|Protocol Violation|0
5457373|NCT02078219|18860978|P1|Overall Study|Protocol Violation|0
5457374|NCT02078219|18860974|P5|Overall Study|Withdrawal by Subject|1
5457375|NCT02078219|18860975|P4|Overall Study|Withdrawal by Subject|1
5457376|NCT02078219|18860976|P3|Overall Study|Withdrawal by Subject|0
5457377|NCT02078219|18860977|P2|Overall Study|Withdrawal by Subject|1
5457378|NCT02078219|18860978|P1|Overall Study|Withdrawal by Subject|0
5457379|NCT02078219|18860974|P5|Overall Study|Other|1
5457380|NCT02078219|18860975|P4|Overall Study|Other|0
5457381|NCT02078219|18860976|P3|Overall Study|Other|3
5457382|NCT02078219|18860977|P2|Overall Study|Other|2
5457383|NCT02078219|18860978|P1|Overall Study|Other|2
5457384|NCT02077465|18861028|P2|Overall Study|Lost to Follow-up|0
5457385|NCT02077465|18861029|P1|Overall Study|Lost to Follow-up|1
5457386|NCT02077465|18861028|P2|Overall Study|Withdrew Consent|1
5457387|NCT02077465|18861029|P1|Overall Study|Withdrew Consent|0
5457388|NCT02077374|18861052|P2|Overall Study|Protocol Violation|1
5457389|NCT02077374|18861053|P1|Overall Study|Protocol Violation|0
5457390|NCT02077374|18861052|P2|Overall Study|Withdrawal by Subject|1
5457391|NCT02077374|18861053|P1|Overall Study|Withdrawal by Subject|0
5457392|NCT02077140|18861074|P5|Overall Study|Withdrawal by Subject|2
5457393|NCT02077140|18861075|P4|Overall Study|Withdrawal by Subject|2
5457394|NCT02077140|18861076|P3|Overall Study|Withdrawal by Subject|0
5457395|NCT02077140|18861077|P2|Overall Study|Withdrawal by Subject|1
5457396|NCT02077140|18861078|P1|Overall Study|Withdrawal by Subject|0
5457397|NCT02077140|18861074|P5|Overall Study|Lost to Follow-up|3
5457398|NCT02077140|18861075|P4|Overall Study|Lost to Follow-up|2
5457399|NCT02077140|18861076|P3|Overall Study|Lost to Follow-up|2
5457400|NCT02077140|18861077|P2|Overall Study|Lost to Follow-up|1
5457401|NCT02077140|18861078|P1|Overall Study|Lost to Follow-up|4
5457402|NCT02076334|18861356|P4|Overall Study|muscle soreness|1
5457403|NCT02076334|18861357|P3|Overall Study|muscle soreness|0
5457404|NCT02076334|18861358|P2|Overall Study|muscle soreness|0
5457405|NCT02076334|18861359|P1|Overall Study|muscle soreness|0
5457406|NCT02076334|18861356|P4|Overall Study|Lost to Follow-up|0
5457407|NCT02076334|18861357|P3|Overall Study|Lost to Follow-up|1
5457408|NCT02076334|18861358|P2|Overall Study|Lost to Follow-up|1
5457409|NCT02076334|18861359|P1|Overall Study|Lost to Follow-up|0
5457410|NCT02076334|18861356|P4|Overall Study|Protocol Violation|0
5457411|NCT02076334|18861357|P3|Overall Study|Protocol Violation|0
5457412|NCT02076334|18861358|P2|Overall Study|Protocol Violation|0
5457413|NCT02076334|18861359|P1|Overall Study|Protocol Violation|1
5457414|NCT02076178|18861392|P2|Injection Phase|Lost to Follow-up|1
5457415|NCT02076178|18861393|P1|Injection Phase|Lost to Follow-up|0
5457416|NCT02076178|18861392|P2|Injection Phase|Physician Decision|3
5457417|NCT02076178|18861393|P1|Injection Phase|Physician Decision|0
5457418|NCT02076178|18861392|P2|Injection Phase|Withdrawal by Subject|3
5457419|NCT02076178|18861393|P1|Injection Phase|Withdrawal by Subject|0
5457420|NCT02076178|18861392|P2|Injection Phase|Protocol defined stopping criteria|0
5457421|NCT02076178|18861393|P1|Injection Phase|Protocol defined stopping criteria|1
5457422|NCT02076178|18861392|P2|Oral Phase|Physician Decision|1
5457423|NCT02076178|18861393|P1|Oral Phase|Physician Decision|0
5457424|NCT02076178|18861392|P2|Oral Phase|Withdrawal by Subject|4
5457425|NCT02076178|18861393|P1|Oral Phase|Withdrawal by Subject|0
5457426|NCT02076178|18861392|P2|Oral Phase|Adverse Event|7
5457427|NCT02076178|18861393|P1|Oral Phase|Adverse Event|0
5457428|NCT02076165|18861427|P2|Overall Study|Refused follow-up assessment|1
5457429|NCT02076165|18861428|P1|Overall Study|Refused follow-up assessment|1
5457430|NCT02076165|18861427|P2|Overall Study|Lost to Follow-up|5
5457431|NCT02076165|18861428|P1|Overall Study|Lost to Follow-up|7
5457432|NCT02076022|18861498|P2|Overall Study|Withdrawal by Subject|0
5457433|NCT02076022|18861499|P1|Overall Study|Withdrawal by Subject|2
5457434|NCT02076009|18861511|P2|Overall Study|Subjects randomized but not treated|3
5457435|NCT02076009|18861512|P1|Overall Study|Subjects randomized but not treated|2
5457436|NCT02076009|18861511|P2|Overall Study|Ongoing|249
5457437|NCT02076009|18861512|P1|Overall Study|Ongoing|226
5457438|NCT02076009|18861511|P2|Overall Study|Progressive disease|0
5457439|NCT02076009|18861512|P1|Overall Study|Progressive disease|1
5457440|NCT02076009|18861511|P2|Overall Study|Lost to Follow-up|1
5457441|NCT02076009|18861512|P1|Overall Study|Lost to Follow-up|1
5457442|NCT02076009|18861511|P2|Overall Study|Withdrawal by Subject|3
5457443|NCT02076009|18861512|P1|Overall Study|Withdrawal by Subject|9
5457444|NCT02076009|18861511|P2|Overall Study|Death|30
5457445|NCT02076009|18861512|P1|Overall Study|Death|44
5457446|NCT02075840|18861534|P2|Overall Study|Ongoing at CCOD|82
5457447|NCT02075840|18861535|P1|Overall Study|Ongoing at CCOD|99
5457448|NCT02075840|18861534|P2|Overall Study|Physician Decision|3
5457449|NCT02075840|18861535|P1|Overall Study|Physician Decision|1
5457450|NCT02075840|18861534|P2|Overall Study|Lost to Follow-up|2
5457451|NCT02075840|18861535|P1|Overall Study|Lost to Follow-up|3
5457452|NCT02075840|18861534|P2|Overall Study|Death|40
5457453|NCT02075840|18861535|P1|Overall Study|Death|35
5457454|NCT02075840|18861534|P2|Overall Study|Adverse Event|2
5457455|NCT02075840|18861535|P1|Overall Study|Adverse Event|0
5457456|NCT02075840|18861534|P2|Overall Study|Reason not specified|0
5457457|NCT02075840|18861535|P1|Overall Study|Reason not specified|1
5457458|NCT02075840|18861534|P2|Overall Study|Withdrawal by Subject|22
5457459|NCT02075840|18861535|P1|Overall Study|Withdrawal by Subject|13
5457460|NCT02075658|18861591|P2|Overall Study|Physician Decision|2
5457461|NCT02075658|18861592|P1|Overall Study|Physician Decision|2
5457462|NCT02075632|18861602|P2|Overall Study|Withdrawal by Subject|1
5457463|NCT02075632|18861603|P1|Overall Study|Withdrawal by Subject|0
5457464|NCT02075632|18861602|P2|Overall Study|Lost to Follow-up|3
5457465|NCT02075632|18861603|P1|Overall Study|Lost to Follow-up|0
5457466|NCT02075632|18861602|P2|Overall Study|Adverse Event|1
5457467|NCT02075632|18861603|P1|Overall Study|Adverse Event|1
5457468|NCT02075606|18861613|P1|Overall Study|Increasing Symptoms|1
5457469|NCT02075606|18861613|P1|Overall Study|Symptom management|1
5457470|NCT02075606|18861613|P1|Overall Study|Investigator's decision|1
5457471|NCT02075606|18861613|P1|Overall Study|Death|1
5457472|NCT02075606|18861613|P1|Overall Study|Withdrawal by Subject|1
5457473|NCT02075606|18861613|P1|Overall Study|Adverse Event|5
5457474|NCT02075541|18861637|P2|Overall Study|Other- unable to perform study procedure|0
5457475|NCT02075541|18861638|P1|Overall Study|Other- unable to perform study procedure|1
5457476|NCT02075541|18861637|P2|Overall Study|Sponsor study termination|1
5457477|NCT02075541|18861638|P1|Overall Study|Sponsor study termination|0
5457478|NCT02075541|18861637|P2|Overall Study|Withdrawal by Subject|3
5457479|NCT02075541|18861638|P1|Overall Study|Withdrawal by Subject|1
5457480|NCT02075541|18861637|P2|Overall Study|Protocol Violation|0
5457481|NCT02075541|18861638|P1|Overall Study|Protocol Violation|1
5457482|NCT02075541|18861637|P2|Overall Study|Serious Adverse Event|4
5457483|NCT02075541|18861638|P1|Overall Study|Serious Adverse Event|1
5457484|NCT02075515|18861687|P3|Overall Study|Lost to Follow-up|6
5457485|NCT02075515|18861688|P2|Overall Study|Lost to Follow-up|3
5457486|NCT02075515|18861689|P1|Overall Study|Lost to Follow-up|1
5457487|NCT02075515|18861687|P3|Overall Study|Withdrawal by Subject|1
5457488|NCT02075515|18861688|P2|Overall Study|Withdrawal by Subject|0
5457489|NCT02075515|18861689|P1|Overall Study|Withdrawal by Subject|2
5457490|NCT02075515|18861687|P3|Overall Study|Non-Serious Adverse Event|0
5457491|NCT02075515|18861688|P2|Overall Study|Non-Serious Adverse Event|1
5457492|NCT02075515|18861689|P1|Overall Study|Non-Serious Adverse Event|0
5457493|NCT02075515|18861687|P3|Overall Study|Serious Adverse Event|1
5457494|NCT02075515|18861688|P2|Overall Study|Serious Adverse Event|1
5457495|NCT02075515|18861689|P1|Overall Study|Serious Adverse Event|1
5457496|NCT02075476|18861726|P2|Overall Study|Lost to Follow-up|3
5457497|NCT02075476|18861727|P1|Overall Study|Lost to Follow-up|1
5457498|NCT02075476|18861726|P2|Overall Study|Death|2
5457499|NCT02075476|18861727|P1|Overall Study|Death|2
5457500|NCT02075463|18861737|P1|Overall Study|Withdrawal by Subject|1
5457501|NCT02075463|18861737|P1|Overall Study|Par. reached stopping criteria|4
5457502|NCT02075463|18861737|P1|Overall Study|Adverse Event|3
5457503|NCT02075320|18861787|P1|Overall Study|Withdrawal by Subject|2
5457504|NCT02075255|18861797|P3|Overall Study|Death|0
5457505|NCT02075255|18861798|P2|Overall Study|Death|2
5457506|NCT02075255|18861799|P1|Overall Study|Death|0
5457507|NCT02075255|18861797|P3|Overall Study|Adverse Event|1
5457508|NCT02075255|18861798|P2|Overall Study|Adverse Event|0
5457509|NCT02075255|18861799|P1|Overall Study|Adverse Event|0
5457510|NCT02075255|18861797|P3|Overall Study|Lost to Follow-up|1
5457511|NCT02075255|18861798|P2|Overall Study|Lost to Follow-up|0
5457512|NCT02075255|18861799|P1|Overall Study|Lost to Follow-up|0
5457513|NCT02075255|18861797|P3|Overall Study|Withdrawal by Subject|0
5457514|NCT02075255|18861798|P2|Overall Study|Withdrawal by Subject|1
5457515|NCT02075255|18861799|P1|Overall Study|Withdrawal by Subject|4
5457516|NCT02075255|18861797|P3|Overall Study|Study specific withdrawal criteria|1
5457517|NCT02075255|18861798|P2|Overall Study|Study specific withdrawal criteria|1
5457518|NCT02075255|18861799|P1|Overall Study|Study specific withdrawal criteria|0
5457519|NCT02075203|18861909|P3|Overall Study|participant refused to use contraception|0
5457520|NCT02075203|18861910|P2|Overall Study|participant refused to use contraception|0
5457521|NCT02075203|18861911|P1|Overall Study|participant refused to use contraception|1
5457522|NCT02075203|18861909|P3|Overall Study|Adverse Event|0
5457523|NCT02075203|18861910|P2|Overall Study|Adverse Event|0
5457524|NCT02075203|18861911|P1|Overall Study|Adverse Event|1
5457525|NCT02075203|18861909|P3|Overall Study|Withdrawal by Subject|1
5457526|NCT02075203|18861910|P2|Overall Study|Withdrawal by Subject|0
5457527|NCT02075203|18861911|P1|Overall Study|Withdrawal by Subject|1
5457528|NCT02075073|18861952|P3|Overall Study|Withdrawal by Subject|0
5457529|NCT02075073|18861953|P2|Overall Study|Withdrawal by Subject|1
5457530|NCT02075073|18861954|P1|Overall Study|Withdrawal by Subject|0
5457531|NCT02075008|18861976|P1|Overall Study|Study terminated by Sponsor|159
5457532|NCT02075008|18861976|P1|Overall Study|Withdrawal by Subject|6
5457533|NCT02075008|18861976|P1|Overall Study|Adverse Event|5
5457534|NCT02075008|18861976|P1|Overall Study|Death|1
5457535|NCT02075008|18861976|P1|Overall Study|Lack of Efficacy|1
5457536|NCT02075008|18861976|P1|Overall Study|Lost to Follow-up|1
5457537|NCT02075008|18861976|P1|Overall Study|Physician Decision|1
5457538|NCT02075008|18861976|P1|Overall Study|Pregnancy|1
5457539|NCT02075008|18861976|P1|Overall Study|Technical problems|1
5457540|NCT02074982|18861999|P2|Overall Study|Death|2
5457541|NCT02074982|18862000|P1|Overall Study|Death|0
5457542|NCT02074982|18861999|P2|Overall Study|Subject/guardian decision|24
5457543|NCT02074982|18862000|P1|Overall Study|Subject/guardian decision|15
5457544|NCT02074982|18861999|P2|Overall Study|Technical problems|2
5457545|NCT02074982|18862000|P1|Overall Study|Technical problems|0
5457546|NCT02074982|18861999|P2|Overall Study|Protocol deviation|3
5457547|NCT02074982|18862000|P1|Overall Study|Protocol deviation|4
5457548|NCT02074982|18861999|P2|Overall Study|Pregnancy|2
5457549|NCT02074982|18862000|P1|Overall Study|Pregnancy|1
5457550|NCT02074982|18861999|P2|Overall Study|Physician Decision|1
5457551|NCT02074982|18862000|P1|Overall Study|Physician Decision|1
5457552|NCT02074982|18861999|P2|Overall Study|Non-compliance with study treatment|2
5457553|NCT02074982|18862000|P1|Overall Study|Non-compliance with study treatment|0
5457554|NCT02074982|18861999|P2|Overall Study|Lost to Follow-up|10
5457555|NCT02074982|18862000|P1|Overall Study|Lost to Follow-up|9
5457556|NCT02074982|18861999|P2|Overall Study|Lack of Efficacy|1
5457557|NCT02074982|18862000|P1|Overall Study|Lack of Efficacy|6
5457558|NCT02074982|18861999|P2|Overall Study|Adverse Event|7
5457559|NCT02074982|18862000|P1|Overall Study|Adverse Event|15
5457560|NCT02074553|18862047|P8|Washout Period 3|Physician Decision|1
5457561|NCT02074553|18862048|P7|Washout Period 3|Physician Decision|0
5457562|NCT02074553|18862049|P6|Washout Period 3|Physician Decision|0
5457563|NCT02074553|18862050|P5|Washout Period 3|Physician Decision|0
5457564|NCT02074553|18862051|P4|Washout Period 3|Physician Decision|0
5457565|NCT02074553|18862052|P3|Washout Period 3|Physician Decision|0
5457566|NCT02074553|18862053|P2|Washout Period 3|Physician Decision|0
5457567|NCT02074553|18862054|P1|Washout Period 3|Physician Decision|0
5457568|NCT02074553|18862047|P8|Washout Period 2|Lost to Follow-up|0
5457569|NCT02074553|18862048|P7|Washout Period 2|Lost to Follow-up|0
5457570|NCT02074553|18862049|P6|Washout Period 2|Lost to Follow-up|0
5457571|NCT02074553|18862050|P5|Washout Period 2|Lost to Follow-up|0
5457572|NCT02074553|18862051|P4|Washout Period 2|Lost to Follow-up|0
5457573|NCT02074553|18862052|P3|Washout Period 2|Lost to Follow-up|1
5457574|NCT02074553|18862053|P2|Washout Period 2|Lost to Follow-up|0
5457575|NCT02074553|18862054|P1|Washout Period 2|Lost to Follow-up|0
5457576|NCT02074553|18862047|P8|Washout Period 2|Physician Decision|0
5457577|NCT02074553|18862048|P7|Washout Period 2|Physician Decision|0
5457578|NCT02074553|18862049|P6|Washout Period 2|Physician Decision|1
5457579|NCT02074553|18862050|P5|Washout Period 2|Physician Decision|0
5457580|NCT02074553|18862051|P4|Washout Period 2|Physician Decision|0
5457581|NCT02074553|18862052|P3|Washout Period 2|Physician Decision|0
5457582|NCT02074553|18862053|P2|Washout Period 2|Physician Decision|0
5457583|NCT02074553|18862054|P1|Washout Period 2|Physician Decision|0
5457584|NCT02074553|18862047|P8|Washout Period 2|Adverse Event|0
5457585|NCT02074553|18862048|P7|Washout Period 2|Adverse Event|1
5457586|NCT02074553|18862049|P6|Washout Period 2|Adverse Event|0
5457587|NCT02074553|18862050|P5|Washout Period 2|Adverse Event|0
5457588|NCT02074553|18862051|P4|Washout Period 2|Adverse Event|0
5457589|NCT02074553|18862052|P3|Washout Period 2|Adverse Event|0
5457590|NCT02074553|18862053|P2|Washout Period 2|Adverse Event|0
5457591|NCT02074553|18862054|P1|Washout Period 2|Adverse Event|0
5457592|NCT02074553|18862047|P8|Washout Period 1|Other|0
5457593|NCT02074553|18862048|P7|Washout Period 1|Other|0
5457594|NCT02074553|18862049|P6|Washout Period 1|Other|1
5457595|NCT02074553|18862050|P5|Washout Period 1|Other|0
5457596|NCT02074553|18862051|P4|Washout Period 1|Other|0
5457597|NCT02074553|18862052|P3|Washout Period 1|Other|0
5457598|NCT02074553|18862053|P2|Washout Period 1|Other|0
5457599|NCT02074553|18862054|P1|Washout Period 1|Other|0
5457600|NCT02074553|18862047|P8|Washout Period 1|Physician Decision|0
5457601|NCT02074553|18862048|P7|Washout Period 1|Physician Decision|0
5457602|NCT02074553|18862049|P6|Washout Period 1|Physician Decision|0
5457603|NCT02074553|18862050|P5|Washout Period 1|Physician Decision|0
5457604|NCT02074553|18862051|P4|Washout Period 1|Physician Decision|1
5457605|NCT02074553|18862052|P3|Washout Period 1|Physician Decision|0
5457606|NCT02074553|18862053|P2|Washout Period 1|Physician Decision|0
5457607|NCT02074553|18862054|P1|Washout Period 1|Physician Decision|0
5457608|NCT02074553|18862047|P8|Washout Period 1|Adverse Event|0
5457609|NCT02074553|18862048|P7|Washout Period 1|Adverse Event|0
5457610|NCT02074553|18862049|P6|Washout Period 1|Adverse Event|0
5457611|NCT02074553|18862050|P5|Washout Period 1|Adverse Event|0
5457612|NCT02074553|18862051|P4|Washout Period 1|Adverse Event|0
5457613|NCT02074553|18862052|P3|Washout Period 1|Adverse Event|0
5457614|NCT02074553|18862053|P2|Washout Period 1|Adverse Event|0
5457615|NCT02074553|18862054|P1|Washout Period 1|Adverse Event|1
5457616|NCT02074553|18862047|P8|Intervention Period 1|Family Emergency|0
5457617|NCT02074553|18862048|P7|Intervention Period 1|Family Emergency|0
5457618|NCT02074553|18862049|P6|Intervention Period 1|Family Emergency|0
5457619|NCT02074553|18862050|P5|Intervention Period 1|Family Emergency|0
5457620|NCT02074553|18862051|P4|Intervention Period 1|Family Emergency|1
5457621|NCT02074553|18862052|P3|Intervention Period 1|Family Emergency|0
5457622|NCT02074553|18862053|P2|Intervention Period 1|Family Emergency|0
5457623|NCT02074553|18862054|P1|Intervention Period 1|Family Emergency|0
5457624|NCT02074514|18862236|P2|Overall Study|Withdrew Consent|1
5457625|NCT02074514|18862237|P1|Overall Study|Withdrew Consent|0
5457626|NCT02074514|18862236|P2|Overall Study|Lost to Follow-up|1
5457627|NCT02074514|18862237|P1|Overall Study|Lost to Follow-up|0
5457628|NCT02074514|18862236|P2|Overall Study|Lack of Efficacy|2
5457629|NCT02074514|18862237|P1|Overall Study|Lack of Efficacy|3
5457630|NCT02074059|18862378|P6|Overall Study|Death|1
5457631|NCT02074059|18862379|P5|Overall Study|Death|1
5457632|NCT02074059|18862380|P4|Overall Study|Death|0
5457633|NCT02074059|18862381|P3|Overall Study|Death|0
5457634|NCT02074059|18862382|P2|Overall Study|Death|0
5457635|NCT02074059|18862383|P1|Overall Study|Death|0
5457636|NCT02073929|18862427|P2|Overall Study|Withdrawal by Subject|1
5457637|NCT02073929|18862428|P1|Overall Study|Withdrawal by Subject|0
5457638|NCT02073929|18862427|P2|Overall Study|Adverse Event|1
5457639|NCT02073929|18862428|P1|Overall Study|Adverse Event|2
5457640|NCT02073929|18862427|P2|Overall Study|Lost to Follow-up|1
5457641|NCT02073929|18862428|P1|Overall Study|Lost to Follow-up|2
5457642|NCT02073682|18862465|P2|Overall Study|ID: Benefit/Risk Judgment|46
5457643|NCT02073682|18862466|P1|Overall Study|ID: Benefit/Risk Judgment|32
5457644|NCT02073682|18862465|P2|Overall Study|Lost to Follow-up|1
5457645|NCT02073682|18862466|P1|Overall Study|Lost to Follow-up|1
5457646|NCT02073682|18862465|P2|Overall Study|PD: Inconvenience of Dosing|78
5457647|NCT02073682|18862466|P1|Overall Study|PD: Inconvenience of Dosing|21
5457648|NCT02073682|18862465|P2|Overall Study|No reason provided|9
5457649|NCT02073682|18862466|P1|Overall Study|No reason provided|11
5457650|NCT02073682|18862465|P2|Overall Study|Adverse Event|62
5457651|NCT02073682|18862466|P1|Overall Study|Adverse Event|79
5457652|NCT02073682|18862465|P2|Overall Study|Protocol Violation|0
5457653|NCT02073682|18862466|P1|Overall Study|Protocol Violation|1
5457654|NCT02073682|18862465|P2|Overall Study|Cancer Progression|33
5457655|NCT02073682|18862466|P1|Overall Study|Cancer Progression|53
5457656|NCT02073682|18862465|P2|Overall Study|Start of New Chemotherapy Regimen|3
5457657|NCT02073682|18862466|P1|Overall Study|Start of New Chemotherapy Regimen|6
5457658|NCT02073682|18862465|P2|Overall Study|Withdrawal by Subject|8
5457659|NCT02073682|18862466|P1|Overall Study|Withdrawal by Subject|6
5457660|NCT02073682|18862465|P2|Overall Study|Surgery/Medical Procedure|1
5457661|NCT02073682|18862466|P1|Overall Study|Surgery/Medical Procedure|3
5457662|NCT02073682|18862465|P2|Overall Study|Platelet Count <50,000/mL|2
5457663|NCT02073682|18862466|P1|Overall Study|Platelet Count <50,000/mL|1
5457664|NCT02073682|18862465|P2|Overall Study|Prohibited Concomitant Medication Use|1
5457665|NCT02073682|18862466|P1|Overall Study|Prohibited Concomitant Medication Use|0
5457666|NCT02073682|18862465|P2|Overall Study|ID: Palliative Treatment Only|7
5457667|NCT02073682|18862466|P1|Overall Study|ID: Palliative Treatment Only|10
5457668|NCT02073682|18862465|P2|Overall Study|ID: Patient Noncompliance|2
5457669|NCT02073682|18862466|P1|Overall Study|ID: Patient Noncompliance|1
5457670|NCT02073682|18862465|P2|Overall Study|Cancer Cured|15
5457671|NCT02073682|18862466|P1|Overall Study|Cancer Cured|10
5457672|NCT02073682|18862465|P2|Overall Study|Death|100
5457673|NCT02073682|18862466|P1|Overall Study|Death|86
5457674|NCT02073682|18862465|P2|Overall Study|Low Creatinine Clearance|2
5457675|NCT02073682|18862466|P1|Overall Study|Low Creatinine Clearance|1
5457676|NCT02073656|18862484|P1|Primary Study|Withdrew Consent|1
5457677|NCT02073656|18862484|P1|Primary Study|Death|1
5457678|NCT02073656|18862484|P1|Primary Study|Lost to Follow-up|6
5457679|NCT02073643|18862500|P1|Overall Study|Lost to Follow-up|24
5457680|NCT02073565|18862511|P2|Cohort C|Lost to Follow-up|2
5457681|NCT02073565|18862512|P1|Cohort C|Lost to Follow-up|0
5457682|NCT02073565|18862511|P2|Cohort C|Withdrawal by Subject|2
5457683|NCT02073565|18862512|P1|Cohort C|Withdrawal by Subject|0
5457684|NCT02073565|18862511|P2|Cohort B|Withdrawal by Subject|2
5457685|NCT02073565|18862512|P1|Cohort B|Withdrawal by Subject|1
5457686|NCT02073565|18862511|P2|Cohort A|Withdrawal by Subject|0
5457687|NCT02073565|18862512|P1|Cohort A|Withdrawal by Subject|1
5457688|NCT02073279|18862603|P2|Open-label Extension Period|On-going in Study|13
5457689|NCT02073279|18862604|P1|Open-label Extension Period|On-going in Study|14
5457690|NCT02073279|18862603|P2|Open-label Extension Period|Reason Not Specified|1
5457691|NCT02073279|18862604|P1|Open-label Extension Period|Reason Not Specified|1
5457692|NCT02073279|18862603|P2|Open-label Extension Period|Withdrawal by Subject|1
5457693|NCT02073279|18862604|P1|Open-label Extension Period|Withdrawal by Subject|1
5457694|NCT02073279|18862603|P2|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1
5457695|NCT02073279|18862604|P1|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0
5457696|NCT02073279|18862603|P2|Open-label Extension Period|Lack of Efficacy|0
5457697|NCT02073279|18862604|P1|Open-label Extension Period|Lack of Efficacy|1
5457698|NCT02073279|18862603|P2|Double-blind Period|On-going in Study|40
5457699|NCT02073279|18862604|P1|Double-blind Period|On-going in Study|11
5457700|NCT02073279|18862603|P2|Double-blind Period|Refused Treatment/Did Not Cooperate|1
5457701|NCT02073279|18862604|P1|Double-blind Period|Refused Treatment/Did Not Cooperate|0
5457702|NCT02073279|18862603|P2|Double-blind Period|Reason Not Specified|2
5457703|NCT02073279|18862604|P1|Double-blind Period|Reason Not Specified|1
5457704|NCT02073279|18862603|P2|Double-blind Period|Withdrawal by Subject|2
5457705|NCT02073279|18862604|P1|Double-blind Period|Withdrawal by Subject|2
5457706|NCT02073279|18862603|P2|Double-blind Period|Protocol Deviation|1
5457707|NCT02073279|18862604|P1|Double-blind Period|Protocol Deviation|0
5457708|NCT02073279|18862603|P2|Double-blind Period|Adverse Event|1
5457709|NCT02073279|18862604|P1|Double-blind Period|Adverse Event|1
5457710|NCT02072980|18862707|P2|Period 2, Second Wear|Adverse Event|1
5457711|NCT02072980|18862708|P1|Period 2, Second Wear|Adverse Event|0
5457712|NCT02072941|18862716|P2|Overall Study|Removed by Study Staff|2
5457713|NCT02072941|18862717|P1|Overall Study|Removed by Study Staff|2
5457714|NCT02072941|18862716|P2|Overall Study|Death|2
5457715|NCT02072941|18862717|P1|Overall Study|Death|3
5457716|NCT02072941|18862716|P2|Overall Study|Lost to Follow-up|4
5457717|NCT02072941|18862717|P1|Overall Study|Lost to Follow-up|4
5457718|NCT02072941|18862716|P2|Overall Study|Withdrawal by Subject|21
5457719|NCT02072941|18862717|P1|Overall Study|Withdrawal by Subject|29
5457720|NCT02072824|18862732|P3|Overall Study|Adverse Event|1
5457721|NCT02072824|18862733|P2|Overall Study|Adverse Event|0
5457722|NCT02072824|18862734|P1|Overall Study|Adverse Event|0
5457723|NCT02072824|18862732|P3|Overall Study|Medication error|0
5457724|NCT02072824|18862733|P2|Overall Study|Medication error|1
5457725|NCT02072824|18862734|P1|Overall Study|Medication error|0
5457726|NCT02072824|18862732|P3|Overall Study|No longer willing to participate|1
5457727|NCT02072824|18862733|P2|Overall Study|No longer willing to participate|0
5457728|NCT02072824|18862734|P1|Overall Study|No longer willing to participate|1
5457729|NCT02072824|18862732|P3|Overall Study|Insufficient clinical response|1
5457730|NCT02072824|18862733|P2|Overall Study|Insufficient clinical response|0
5457731|NCT02072824|18862734|P1|Overall Study|Insufficient clinical response|1
5457732|NCT02072668|18862769|P2|Second Intervention|Lost to Follow-up|0
5457733|NCT02072668|18862770|P1|Second Intervention|Lost to Follow-up|1
5457734|NCT02072434|18862810|P2|Overall Study|Lost to Follow-up|1
5457735|NCT02072434|18862811|P1|Overall Study|Lost to Follow-up|0
5457736|NCT02072434|18862810|P2|Overall Study|Other|29
5457737|NCT02072434|18862811|P1|Overall Study|Other|14
5457738|NCT02072434|18862810|P2|Overall Study|Withdrawal by Subject|29
5457739|NCT02072434|18862811|P1|Overall Study|Withdrawal by Subject|17
5457740|NCT02072434|18862810|P2|Overall Study|Adverse Event|6
5457741|NCT02072434|18862811|P1|Overall Study|Adverse Event|7
5457742|NCT02072434|18862810|P2|Overall Study|Adverse event, serious fatal|6
5457743|NCT02072434|18862811|P1|Overall Study|Adverse event, serious fatal|1
5457744|NCT02072434|18862810|P2|Overall Study|Physician Decision|10
5457745|NCT02072434|18862811|P1|Overall Study|Physician Decision|5
5457746|NCT02072434|18862810|P2|Overall Study|Protocol Violation|9
5457747|NCT02072434|18862811|P1|Overall Study|Protocol Violation|10
5457748|NCT02072226|18862831|P2|Overall Study|Patient Withdrawal of Consent|0
5457749|NCT02072226|18862832|P1|Overall Study|Patient Withdrawal of Consent|1
5457750|NCT02072226|18862831|P2|Overall Study|Death|0
5457751|NCT02072226|18862832|P1|Overall Study|Death|1
5457752|NCT02072226|18862831|P2|Overall Study|Patient Non-compliance|3
5457753|NCT02072226|18862832|P1|Overall Study|Patient Non-compliance|2
5457754|NCT02072226|18862831|P2|Overall Study|Lost to Follow-up|7
5457755|NCT02072226|18862832|P1|Overall Study|Lost to Follow-up|11
5457756|NCT02072174|18862862|P2|Overall Study|Non-compliance with protocol requirement|0
5457757|NCT02072174|18862863|P1|Overall Study|Non-compliance with protocol requirement|2
5457758|NCT02072174|18862862|P2|Overall Study|Physician Decision|1
5457759|NCT02072174|18862863|P1|Overall Study|Physician Decision|0
5457760|NCT02072174|18862862|P2|Overall Study|Protocol Violation|23
5457761|NCT02072174|18862863|P1|Overall Study|Protocol Violation|16
5457762|NCT02072174|18862862|P2|Overall Study|Did Not Meet In-/Exclusion Criteria|15
5457763|NCT02072174|18862863|P1|Overall Study|Did Not Meet In-/Exclusion Criteria|14
5457764|NCT02072096|18862887|P2|Overall Study|Lost to Follow-up|0
5457765|NCT02072096|18862888|P1|Overall Study|Lost to Follow-up|1
5457766|NCT02072096|18862887|P2|Overall Study|Study Terminated by Sponsor|30
5457767|NCT02072096|18862888|P1|Overall Study|Study Terminated by Sponsor|43
5457768|NCT02072096|18862887|P2|Overall Study|Physician Decision|1
5457769|NCT02072096|18862888|P1|Overall Study|Physician Decision|0
5457770|NCT02072096|18862887|P2|Overall Study|Death|0
5457771|NCT02072096|18862888|P1|Overall Study|Death|2
5457772|NCT02072096|18862887|P2|Overall Study|No Reason Provided|2
5457773|NCT02072096|18862888|P1|Overall Study|No Reason Provided|4
5457774|NCT02072096|18862887|P2|Overall Study|Adverse Event|2
5457775|NCT02072096|18862888|P1|Overall Study|Adverse Event|5
5457776|NCT02072096|18862887|P2|Overall Study|Withdrawal by Subject|7
5457777|NCT02072096|18862888|P1|Overall Study|Withdrawal by Subject|5
5457778|NCT02072096|18862887|P2|Overall Study|Protocol Violation|7
5457779|NCT02072096|18862888|P1|Overall Study|Protocol Violation|7
5457780|NCT02072096|18862887|P2|Overall Study|Lack of Efficacy|29
5457781|NCT02072096|18862888|P1|Overall Study|Lack of Efficacy|18
5457782|NCT02071849|18862939|P1|2-year Extended Follow-up|Adverse Event|1
5457783|NCT02071849|18862939|P1|6-month Primary Endpoint|Adverse Event|1
5457784|NCT02071849|18862939|P1|6-month Primary Endpoint|Did not receive device|4
5457785|NCT02071771|18863005|P2|Period 1: First 10 Days|Unavailable lens power|0
5457786|NCT02071771|18863006|P1|Period 1: First 10 Days|Unavailable lens power|1
5457787|NCT02071771|18863005|P2|Period 1: First 10 Days|Unacceptable lens fit|0
5457788|NCT02071771|18863006|P1|Period 1: First 10 Days|Unacceptable lens fit|1
5457789|NCT02071706|18863014|P1|Overall Study|Withdrawal by Subject|2
5457790|NCT02071706|18863014|P1|Overall Study|Adverse Event|1
5457791|NCT02071290|18863030|P2|Overall Study|Physician Decision|1
5457792|NCT02071290|18863031|P1|Overall Study|Physician Decision|0
5457793|NCT02071290|18863030|P2|Overall Study|Protocol Violation|5
5457794|NCT02071290|18863031|P1|Overall Study|Protocol Violation|3
5457795|NCT02071290|18863030|P2|Overall Study|Withdrawal by Subject|1
5457796|NCT02071290|18863031|P1|Overall Study|Withdrawal by Subject|0
5457797|NCT02071290|18863030|P2|Overall Study|Death|0
5457798|NCT02071290|18863031|P1|Overall Study|Death|1
5457799|NCT02071225|18863085|P1|Overall Study|Death|25
5457800|NCT02071225|18863085|P1|Overall Study|Lost to Follow-up|2
5457801|NCT02071225|18863085|P1|Overall Study|Protocol Deviation|1
5457802|NCT02071225|18863085|P1|Overall Study|Withdrawal of Consent|2
5457803|NCT02071082|18863160|P2|Overall Study|Lost to Follow-up|1
5457804|NCT02071082|18863161|P1|Overall Study|Lost to Follow-up|1
5457805|NCT02071082|18863160|P2|Overall Study|Withdrew Consent|4
5457806|NCT02071082|18863161|P1|Overall Study|Withdrew Consent|0
5457807|NCT02071082|18863160|P2|Overall Study|Adverse Event|1
5457808|NCT02071082|18863161|P1|Overall Study|Adverse Event|0
5457809|NCT02071082|18863160|P2|Overall Study|Enrolled and Never Treated|1
5457810|NCT02071082|18863161|P1|Overall Study|Enrolled and Never Treated|1
5457811|NCT02070991|18863191|P2|Overall Study|Withdrawal by Subject|0
5457812|NCT02070991|18863192|P1|Overall Study|Withdrawal by Subject|1
5457813|NCT02070991|18863191|P2|Overall Study|Death|0
5457814|NCT02070991|18863192|P1|Overall Study|Death|2
5457815|NCT02070978|18863215|P3|Overall Study|Terminated by Sponsor|39
5457816|NCT02070978|18863216|P2|Overall Study|Terminated by Sponsor|40
5457817|NCT02070978|18863217|P1|Overall Study|Terminated by Sponsor|33
5457818|NCT02070978|18863215|P3|Overall Study|Un-specified|2
5457819|NCT02070978|18863216|P2|Overall Study|Un-specified|2
5457820|NCT02070978|18863217|P1|Overall Study|Un-specified|3
5457821|NCT02070978|18863215|P3|Overall Study|Death|2
5457822|NCT02070978|18863216|P2|Overall Study|Death|0
5457823|NCT02070978|18863217|P1|Overall Study|Death|0
5457824|NCT02070978|18863215|P3|Overall Study|Lack of Efficacy|0
5457825|NCT02070978|18863216|P2|Overall Study|Lack of Efficacy|1
5457826|NCT02070978|18863217|P1|Overall Study|Lack of Efficacy|0
5457827|NCT02070978|18863215|P3|Overall Study|Protocol Violation|3
5457828|NCT02070978|18863216|P2|Overall Study|Protocol Violation|0
5457829|NCT02070978|18863217|P1|Overall Study|Protocol Violation|1
5457830|NCT02070978|18863215|P3|Overall Study|Withdrawal by Subject|3
5457831|NCT02070978|18863216|P2|Overall Study|Withdrawal by Subject|5
5457832|NCT02070978|18863217|P1|Overall Study|Withdrawal by Subject|3
5457833|NCT02070978|18863215|P3|Overall Study|Lost to Follow-up|4
5457834|NCT02070978|18863216|P2|Overall Study|Lost to Follow-up|3
5457835|NCT02070978|18863217|P1|Overall Study|Lost to Follow-up|1
5457836|NCT02070978|18863215|P3|Overall Study|Adverse Event|0
5457837|NCT02070978|18863216|P2|Overall Study|Adverse Event|2
5457838|NCT02070978|18863217|P1|Overall Study|Adverse Event|6
5457839|NCT02070965|18863279|P3|Overall Study|Subject moved|0
5457840|NCT02070965|18863280|P2|Overall Study|Subject moved|0
5457841|NCT02070965|18863281|P1|Overall Study|Subject moved|1
5457842|NCT02070965|18863279|P3|Overall Study|Withdrawal by Subject|1
5457843|NCT02070965|18863280|P2|Overall Study|Withdrawal by Subject|1
5457844|NCT02070965|18863281|P1|Overall Study|Withdrawal by Subject|1
5457845|NCT02070965|18863279|P3|Overall Study|Lost to Follow-up|0
5457846|NCT02070965|18863280|P2|Overall Study|Lost to Follow-up|1
5457847|NCT02070965|18863281|P1|Overall Study|Lost to Follow-up|0
5457848|NCT02070757|18863291|P2|Overall Study|Discharged from Study Hospital|2
5457849|NCT02070757|18863292|P1|Overall Study|Discharged from Study Hospital|2
5457850|NCT02070757|18863291|P2|Overall Study|Investigator Decision|2
5457851|NCT02070757|18863292|P1|Overall Study|Investigator Decision|0
5457852|NCT02070757|18863291|P2|Overall Study|Withdrawal by Subject|3
5457853|NCT02070757|18863292|P1|Overall Study|Withdrawal by Subject|1
5457854|NCT02070757|18863291|P2|Overall Study|Protocol Violation|4
5457855|NCT02070757|18863292|P1|Overall Study|Protocol Violation|0
5457856|NCT02070757|18863291|P2|Overall Study|Lost to Follow-up|4
5457857|NCT02070757|18863292|P1|Overall Study|Lost to Follow-up|7
5457858|NCT02070757|18863291|P2|Overall Study|Adverse Event|99
5457859|NCT02070757|18863292|P1|Overall Study|Adverse Event|107
5457860|NCT02070744|18863326|P5|OLE Phase (48 Weeks)|Other|1
5457861|NCT02070744|18863327|P4|OLE Phase (48 Weeks)|Other|0
5457862|NCT02070744|18863328|P3|OLE Phase (48 Weeks)|Other|0
5457863|NCT02070744|18863329|P2|OLE Phase (48 Weeks)|Other|0
5457864|NCT02070744|18863330|P1|OLE Phase (48 Weeks)|Other|0
5457865|NCT02070744|18863326|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
5457866|NCT02070744|18863327|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5457867|NCT02070744|18863328|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5457868|NCT02070744|18863329|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5457869|NCT02070744|18863330|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
5457870|NCT02070744|18863326|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
5457871|NCT02070744|18863327|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
5457872|NCT02070744|18863328|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
5457873|NCT02070744|18863329|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
5457874|NCT02070744|18863330|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
5457875|NCT02070588|18863413|P3|Overall Study|Adverse Event|0
5457876|NCT02070588|18863414|P2|Overall Study|Adverse Event|0
5457877|NCT02070588|18863415|P1|Overall Study|Adverse Event|1
5457878|NCT02070588|18863413|P3|Overall Study|Writhdrawal due to early termination|0
5457879|NCT02070588|18863414|P2|Overall Study|Writhdrawal due to early termination|0
5457880|NCT02070588|18863415|P1|Overall Study|Writhdrawal due to early termination|9
5457881|NCT02070588|18863413|P3|Overall Study|Withdrawal by Subject|0
5457882|NCT02070588|18863414|P2|Overall Study|Withdrawal by Subject|1
5457883|NCT02070588|18863415|P1|Overall Study|Withdrawal by Subject|29
5457884|NCT02070484|18863431|P2|Overall Study|Withdrawal by Subject|0
5457885|NCT02070484|18863432|P1|Overall Study|Withdrawal by Subject|1
5457886|NCT02070380|18863454|P4|Second Injection|Protocol Violation|5
5457887|NCT02070380|18863455|P3|Second Injection|Protocol Violation|1
5457888|NCT02070380|18863456|P2|Second Injection|Protocol Violation|1
5457889|NCT02070380|18863457|P1|Second Injection|Protocol Violation|0
5457890|NCT02070380|18863454|P4|Second Injection|Image sets missing or technically inadeq|0
5457891|NCT02070380|18863455|P3|Second Injection|Image sets missing or technically inadeq|0
5457892|NCT02070380|18863456|P2|Second Injection|Image sets missing or technically inadeq|1
5457893|NCT02070380|18863457|P1|Second Injection|Image sets missing or technically inadeq|0
5457894|NCT02070380|18863454|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
5457895|NCT02070380|18863455|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
5457896|NCT02070380|18863456|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
5457897|NCT02070380|18863457|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
5457898|NCT02069392|18863599|P2|Overall Study|Withdrawal by Subject|2
5457899|NCT02069392|18863600|P1|Overall Study|Withdrawal by Subject|4
5457900|NCT02069379|18863624|P4|Second Treatment Arm|Lost to Follow-up|0
5457901|NCT02069379|18863625|P3|Second Treatment Arm|Lost to Follow-up|1
5457902|NCT02069379|18863626|P2|Second Treatment Arm|Lost to Follow-up|0
5457903|NCT02069379|18863627|P1|Second Treatment Arm|Lost to Follow-up|0
5457904|NCT02069379|18863624|P4|Washout Period (4 Weeks)|Unrelated event|0
5457905|NCT02069379|18863625|P3|Washout Period (4 Weeks)|Unrelated event|0
5457906|NCT02069379|18863626|P2|Washout Period (4 Weeks)|Unrelated event|1
5457907|NCT02069379|18863627|P1|Washout Period (4 Weeks)|Unrelated event|0
5457908|NCT02069379|18863624|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
5457909|NCT02069379|18863625|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
5457910|NCT02069379|18863626|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
5457911|NCT02069379|18863627|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
5457912|NCT02069379|18863624|P4|First Treatment Arm|Lost to Follow-up|0
5457913|NCT02069379|18863625|P3|First Treatment Arm|Lost to Follow-up|1
5457914|NCT02069379|18863626|P2|First Treatment Arm|Lost to Follow-up|1
5457915|NCT02069379|18863627|P1|First Treatment Arm|Lost to Follow-up|0
5457916|NCT02069379|18863624|P4|Baseline Measurements|Ineligible based on initial assessments|2
5457917|NCT02069379|18863625|P3|Baseline Measurements|Ineligible based on initial assessments|0
5457918|NCT02069379|18863626|P2|Baseline Measurements|Ineligible based on initial assessments|0
5457919|NCT02069379|18863627|P1|Baseline Measurements|Ineligible based on initial assessments|2
5457920|NCT02069379|18863624|P4|Baseline Measurements|Lost to Follow-up|0
5457921|NCT02069379|18863625|P3|Baseline Measurements|Lost to Follow-up|0
5457922|NCT02069379|18863626|P2|Baseline Measurements|Lost to Follow-up|0
5457923|NCT02069379|18863627|P1|Baseline Measurements|Lost to Follow-up|1
5457924|NCT02069093|18863714|P1|Overall Study|Adverse Event|10
5457925|NCT02069093|18863714|P1|Overall Study|Abnormal laboratory values|1
5457926|NCT02069093|18863714|P1|Overall Study|Withdrawal by Subject|2
5457927|NCT02069093|18863714|P1|Overall Study|Administrative problems|1
5457928|NCT02069093|18863714|P1|Overall Study|Death|1
5457929|NCT02069093|18863714|P1|Overall Study|New cancer therapy|1
5457930|NCT02069093|18863714|P1|Overall Study|Disease progression|14
5457931|NCT02069015|18863733|P2|Overall Study|Withdrawal by Subject|1
5457932|NCT02069015|18863734|P1|Overall Study|Withdrawal by Subject|1
5457933|NCT02069015|18863733|P2|Overall Study|Lost to Follow-up|32
5457934|NCT02069015|18863734|P1|Overall Study|Lost to Follow-up|39
5457935|NCT02068885|18863744|P3|Overall Study|Withdrew|8
5457936|NCT02068885|18863745|P2|Overall Study|Withdrew|5
5457937|NCT02068885|18863746|P1|Overall Study|Withdrew|3
5457938|NCT02068768|18863824|P1|Overall Study|Early Termination by Sponsor|2
5457939|NCT02068768|18863824|P1|Overall Study|Lost to Follow-up|5
5457940|NCT02068599|18863833|P3|Overall Study|Noncompliance|1
5457941|NCT02068599|18863834|P2|Overall Study|Noncompliance|0
5457942|NCT02068599|18863835|P1|Overall Study|Noncompliance|0
5457943|NCT02068599|18863833|P3|Overall Study|Lack of Efficacy|3
5457944|NCT02068599|18863834|P2|Overall Study|Lack of Efficacy|0
5457945|NCT02068599|18863835|P1|Overall Study|Lack of Efficacy|0
5457946|NCT02068599|18863833|P3|Overall Study|Lost to Follow-up|0
5457947|NCT02068599|18863834|P2|Overall Study|Lost to Follow-up|0
5457948|NCT02068599|18863835|P1|Overall Study|Lost to Follow-up|1
5457949|NCT02068599|18863833|P3|Overall Study|Protocol Violation|3
5457950|NCT02068599|18863834|P2|Overall Study|Protocol Violation|2
5457951|NCT02068599|18863835|P1|Overall Study|Protocol Violation|4
5457952|NCT02068599|18863833|P3|Overall Study|Withdrawal by Subject|5
5457953|NCT02068599|18863834|P2|Overall Study|Withdrawal by Subject|7
5457954|NCT02068599|18863835|P1|Overall Study|Withdrawal by Subject|2
5457955|NCT02068599|18863833|P3|Overall Study|Adverse Event|1
5457956|NCT02068599|18863834|P2|Overall Study|Adverse Event|1
5457957|NCT02068599|18863835|P1|Overall Study|Adverse Event|4
5457958|NCT02068547|18863875|P2|Overall Study|Physician Decision|0
5457959|NCT02068547|18863876|P1|Overall Study|Physician Decision|1
5457960|NCT02068547|18863875|P2|Overall Study|Lost to Follow-up|3
5457961|NCT02068547|18863876|P1|Overall Study|Lost to Follow-up|3
5457962|NCT02068508|18863886|P1|Overall Study|Protocol Violation|4
5457963|NCT02068508|18863886|P1|Overall Study|Patient did not visit the study site|1
5457964|NCT02068508|18863886|P1|Overall Study|Case report forms uncollected|27
5457965|NCT02068495|18863896|P1|Overall Study|Protocol Deviation|49
5457966|NCT02068495|18863896|P1|Overall Study|Case Report Forms Uncollected|60
5457967|NCT02068443|18863908|P3|Overall Study|Other Reason Not Specified|0
5457968|NCT02068443|18863909|P2|Overall Study|Other Reason Not Specified|0
5457969|NCT02068443|18863910|P1|Overall Study|Other Reason Not Specified|1
5457970|NCT02068443|18863908|P3|Overall Study|Lack of Efficacy|0
5457971|NCT02068443|18863909|P2|Overall Study|Lack of Efficacy|1
5457972|NCT02068443|18863910|P1|Overall Study|Lack of Efficacy|2
5457973|NCT02068443|18863908|P3|Overall Study|Voluntary Withdrawal|1
5457974|NCT02068443|18863909|P2|Overall Study|Voluntary Withdrawal|0
5457975|NCT02068443|18863910|P1|Overall Study|Voluntary Withdrawal|4
5457976|NCT02068443|18863908|P3|Overall Study|Pretreatment Event/Adverse Event|2
5457977|NCT02068443|18863909|P2|Overall Study|Pretreatment Event/Adverse Event|5
5457978|NCT02068443|18863910|P1|Overall Study|Pretreatment Event/Adverse Event|0
5457979|NCT02068222|18863945|P1|Overall Study|Lost to Follow-up|1
5457980|NCT02067728|18863976|P2|6 Month Measurements|Unable to attend|97
5457981|NCT02067728|18863977|P1|6 Month Measurements|Unable to attend|114
5457982|NCT02067728|18863976|P2|6 Month Follow up Survey|Lost to Follow-up|60
5457983|NCT02067728|18863977|P1|6 Month Follow up Survey|Lost to Follow-up|48
5457984|NCT02067728|18863976|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
5457985|NCT02067728|18863977|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
5457986|NCT02067676|18864011|P6|Overall Study|Withdrawal by Subject|0
5457987|NCT02067676|18864012|P5|Overall Study|Withdrawal by Subject|0
5457988|NCT02067676|18864013|P4|Overall Study|Withdrawal by Subject|0
5457989|NCT02067676|18864014|P3|Overall Study|Withdrawal by Subject|0
5457990|NCT02067676|18864015|P2|Overall Study|Withdrawal by Subject|0
5457991|NCT02067676|18864016|P1|Overall Study|Withdrawal by Subject|1
5457992|NCT02067663|18864056|P2|Overall Study|Lost to Follow-up|14
5457993|NCT02067663|18864057|P1|Overall Study|Lost to Follow-up|13
5457994|NCT02067533|18864156|P2|Overall Study|Lost to Follow-up|2
5457995|NCT02067533|18864157|P1|Overall Study|Lost to Follow-up|4
5457996|NCT02067104|18864208|P2|Overall Study|Study termination due to low accrual|5
5457997|NCT02067104|18864209|P1|Overall Study|Study termination due to low accrual|4
5457998|NCT02066922|18864238|P1|Overall Study|Adverse Event|1
5457999|NCT02066467|18864307|P1|Overall Study|Not defined|4
5458000|NCT02066467|18864307|P1|Overall Study|Physician Decision|2
5458001|NCT02066467|18864307|P1|Overall Study|Withdrawal by Subject|16
5458002|NCT02066467|18864307|P1|Overall Study|Adverse Event|20
5458003|NCT02066467|18864307|P1|Overall Study|Lost to Follow-up|51
5458004|NCT02066467|18864307|P1|Overall Study|Death|54
5458005|NCT02066467|18864307|P1|Overall Study|Consent ineligible|1
5458006|NCT02066467|18864307|P1|Overall Study|Attempted to implant withoput success|43
5458007|NCT02066467|18864307|P1|Overall Study|Did not undergo implant procedure|24
5458008|NCT02066415|18864316|P3|Overall Study|Lost to Follow-up|2
5458009|NCT02066415|18864317|P2|Overall Study|Lost to Follow-up|2
5458010|NCT02066415|18864318|P1|Overall Study|Lost to Follow-up|7
5458011|NCT02066415|18864316|P3|Overall Study|Withdrawal by Subject|4
5458012|NCT02066415|18864317|P2|Overall Study|Withdrawal by Subject|1
5458013|NCT02066415|18864318|P1|Overall Study|Withdrawal by Subject|9
5458014|NCT02066415|18864316|P3|Overall Study|Decision by Sponsor|2
5458015|NCT02066415|18864317|P2|Overall Study|Decision by Sponsor|4
5458016|NCT02066415|18864318|P1|Overall Study|Decision by Sponsor|5
5458017|NCT02066402|18864343|P2|Overall Study|Protocol driven decision point|1
5458018|NCT02066402|18864344|P1|Overall Study|Protocol driven decision point|0
5458019|NCT02066402|18864343|P2|Overall Study|Progressive disease-clinical progression|1
5458020|NCT02066402|18864344|P1|Overall Study|Progressive disease-clinical progression|0
5458021|NCT02066402|18864343|P2|Overall Study|Withdrawal by Subject|11
5458022|NCT02066402|18864344|P1|Overall Study|Withdrawal by Subject|14
5458023|NCT02066402|18864343|P2|Overall Study|Lost to Follow-up|8
5458024|NCT02066402|18864344|P1|Overall Study|Lost to Follow-up|11
5458025|NCT02066402|18864343|P2|Overall Study|Adverse Event|2
5458026|NCT02066402|18864344|P1|Overall Study|Adverse Event|1
5458027|NCT02066389|18864376|P6|Overall Study|Randomized in Error|1
5458028|NCT02066389|18864377|P5|Overall Study|Randomized in Error|0
5458029|NCT02066389|18864378|P4|Overall Study|Randomized in Error|0
5458030|NCT02066389|18864379|P3|Overall Study|Randomized in Error|0
5458031|NCT02066389|18864380|P2|Overall Study|Randomized in Error|0
5458032|NCT02066389|18864381|P1|Overall Study|Randomized in Error|0
5458033|NCT02066389|18864376|P6|Overall Study|Lost to Follow-up|1
5458034|NCT02066389|18864377|P5|Overall Study|Lost to Follow-up|1
5458035|NCT02066389|18864378|P4|Overall Study|Lost to Follow-up|1
5458036|NCT02066389|18864379|P3|Overall Study|Lost to Follow-up|0
5458037|NCT02066389|18864380|P2|Overall Study|Lost to Follow-up|0
5458038|NCT02066389|18864381|P1|Overall Study|Lost to Follow-up|0
5458039|NCT02066389|18864376|P6|Overall Study|Withdrawal by Subject|2
5458040|NCT02066389|18864377|P5|Overall Study|Withdrawal by Subject|1
5458041|NCT02066389|18864378|P4|Overall Study|Withdrawal by Subject|1
5458042|NCT02066389|18864379|P3|Overall Study|Withdrawal by Subject|5
5458043|NCT02066389|18864380|P2|Overall Study|Withdrawal by Subject|0
5458044|NCT02066389|18864381|P1|Overall Study|Withdrawal by Subject|4
5458045|NCT02066389|18864376|P6|Overall Study|Adverse Event|1
5458046|NCT02066389|18864377|P5|Overall Study|Adverse Event|5
5458047|NCT02066389|18864378|P4|Overall Study|Adverse Event|1
5458048|NCT02066389|18864379|P3|Overall Study|Adverse Event|1
5458049|NCT02066389|18864380|P2|Overall Study|Adverse Event|1
5458050|NCT02066389|18864381|P1|Overall Study|Adverse Event|1
5458051|NCT02066311|18864431|P1|Overall Study|Withdrawal by Subject|1
5458052|NCT02066311|18864431|P1|Overall Study|Adverse Event|4
5458053|NCT02066298|18864441|P6|Overall Study|Physician Decision|0
5458054|NCT02066298|18864442|P5|Overall Study|Physician Decision|1
5458055|NCT02066298|18864443|P4|Overall Study|Physician Decision|0
5458056|NCT02066298|18864444|P3|Overall Study|Physician Decision|1
5458057|NCT02066298|18864445|P2|Overall Study|Physician Decision|0
5458058|NCT02066298|18864446|P1|Overall Study|Physician Decision|0
5458059|NCT02066298|18864441|P6|Overall Study|Withdrawal by Subject|8
5458060|NCT02066298|18864442|P5|Overall Study|Withdrawal by Subject|5
5458061|NCT02066298|18864443|P4|Overall Study|Withdrawal by Subject|4
5458062|NCT02066298|18864444|P3|Overall Study|Withdrawal by Subject|6
5458063|NCT02066298|18864445|P2|Overall Study|Withdrawal by Subject|6
5458064|NCT02066298|18864446|P1|Overall Study|Withdrawal by Subject|6
5458065|NCT02066298|18864441|P6|Overall Study|Lost to Follow-up|4
5458066|NCT02066298|18864442|P5|Overall Study|Lost to Follow-up|3
5458067|NCT02066298|18864443|P4|Overall Study|Lost to Follow-up|2
5458068|NCT02066298|18864444|P3|Overall Study|Lost to Follow-up|3
5458069|NCT02066298|18864445|P2|Overall Study|Lost to Follow-up|2
5458070|NCT02066298|18864446|P1|Overall Study|Lost to Follow-up|3
5458071|NCT02066233|18864470|P2|EG Scan II (Day 1)|difficulty intubating subject|6
5458072|NCT02066233|18864471|P1|EG Scan II (Day 1)|difficulty intubating subject|6
5458073|NCT02066181|18864481|P2|Overall Study|Withdrawal by Subject|1
5458074|NCT02066181|18864482|P1|Overall Study|Withdrawal by Subject|1
5458075|NCT02066129|18864504|P2|Overall Study|Physician Decision|1
5458076|NCT02066129|18864505|P1|Overall Study|Physician Decision|1
5458077|NCT02066129|18864504|P2|Overall Study|Lack of Efficacy|10
5458078|NCT02066129|18864505|P1|Overall Study|Lack of Efficacy|8
5458079|NCT02066129|18864504|P2|Overall Study|Withdrawal by Subject|10
5458080|NCT02066129|18864505|P1|Overall Study|Withdrawal by Subject|7
5458081|NCT02066129|18864504|P2|Overall Study|Lost to Follow-up|12
5458082|NCT02066129|18864505|P1|Overall Study|Lost to Follow-up|13
5458083|NCT02066051|18864519|P1|Overall Study|Subject developed active GVHD|1
5458084|NCT02065895|18864524|P6|Overall Study|Scheduling conflicts|0
5458085|NCT02065895|18864525|P5|Overall Study|Scheduling conflicts|0
5458086|NCT02065895|18864526|P4|Overall Study|Scheduling conflicts|0
5458087|NCT02065895|18864527|P3|Overall Study|Scheduling conflicts|0
5458088|NCT02065895|18864528|P2|Overall Study|Scheduling conflicts|1
5458089|NCT02065895|18864529|P1|Overall Study|Scheduling conflicts|0
5458090|NCT02065895|18864524|P6|Overall Study|Protocol Violation|0
5458091|NCT02065895|18864525|P5|Overall Study|Protocol Violation|0
5458092|NCT02065895|18864526|P4|Overall Study|Protocol Violation|1
5458093|NCT02065895|18864527|P3|Overall Study|Protocol Violation|0
5458094|NCT02065895|18864528|P2|Overall Study|Protocol Violation|0
5458095|NCT02065895|18864529|P1|Overall Study|Protocol Violation|1
5458096|NCT02065791|18864548|P2|Overall Study|Lost to Follow-up|9
5458097|NCT02065791|18864549|P1|Overall Study|Lost to Follow-up|13
5458098|NCT02065791|18864548|P2|Overall Study|Withdrawal by Subject|5
5458099|NCT02065791|18864549|P1|Overall Study|Withdrawal by Subject|11
5458100|NCT02065791|18864548|P2|Overall Study|Closed Site|1
5458101|NCT02065791|18864549|P1|Overall Study|Closed Site|1
5458102|NCT02065713|18864571|P2|Overall Study|Unsatisfactory therapeutic effect|0
5458103|NCT02065713|18864572|P1|Overall Study|Unsatisfactory therapeutic effect|1
5458104|NCT02065713|18864571|P2|Overall Study|Adverse Event|1
5458105|NCT02065713|18864572|P1|Overall Study|Adverse Event|0
5458106|NCT02065622|18864580|P5|Maintenance Study|Unknown Reason|0
5458107|NCT02065622|18864581|P4|Maintenance Study|Unknown Reason|1
5458108|NCT02065622|18864582|P3|Maintenance Study|Unknown Reason|0
5458109|NCT02065622|18864583|P2|Maintenance Study|Unknown Reason|0
5458110|NCT02065622|18864584|P1|Maintenance Study|Unknown Reason|0
5458111|NCT02065622|18864580|P5|Maintenance Study|Other, Not Specified|2
5458112|NCT02065622|18864581|P4|Maintenance Study|Other, Not Specified|14
5458113|NCT02065622|18864582|P3|Maintenance Study|Other, Not Specified|6
5458114|NCT02065622|18864583|P2|Maintenance Study|Other, Not Specified|0
5458115|NCT02065622|18864584|P1|Maintenance Study|Other, Not Specified|0
5458116|NCT02065622|18864580|P5|Maintenance Study|Subject Non-Compliance|2
5458117|NCT02065622|18864581|P4|Maintenance Study|Subject Non-Compliance|3
5458118|NCT02065622|18864582|P3|Maintenance Study|Subject Non-Compliance|1
5458119|NCT02065622|18864583|P2|Maintenance Study|Subject Non-Compliance|0
5458120|NCT02065622|18864584|P1|Maintenance Study|Subject Non-Compliance|0
5458121|NCT02065622|18864580|P5|Maintenance Study|Requires Alternative/Prohibited Therapy|4
5458122|NCT02065622|18864581|P4|Maintenance Study|Requires Alternative/Prohibited Therapy|3
5458123|NCT02065622|18864582|P3|Maintenance Study|Requires Alternative/Prohibited Therapy|7
5458124|NCT02065622|18864583|P2|Maintenance Study|Requires Alternative/Prohibited Therapy|0
5458125|NCT02065622|18864584|P1|Maintenance Study|Requires Alternative/Prohibited Therapy|0
5458126|NCT02065622|18864580|P5|Maintenance Study|Lack of Efficacy|19
5458127|NCT02065622|18864581|P4|Maintenance Study|Lack of Efficacy|55
5458128|NCT02065622|18864582|P3|Maintenance Study|Lack of Efficacy|70
5458129|NCT02065622|18864583|P2|Maintenance Study|Lack of Efficacy|0
5458130|NCT02065622|18864584|P1|Maintenance Study|Lack of Efficacy|0
5458131|NCT02065622|18864580|P5|Maintenance Study|Lost to Follow-up|1
5458132|NCT02065622|18864581|P4|Maintenance Study|Lost to Follow-up|1
5458133|NCT02065622|18864582|P3|Maintenance Study|Lost to Follow-up|4
5458134|NCT02065622|18864583|P2|Maintenance Study|Lost to Follow-up|0
5458135|NCT02065622|18864584|P1|Maintenance Study|Lost to Follow-up|0
5458136|NCT02065622|18864580|P5|Maintenance Study|Withdrawal by Subject|7
5458137|NCT02065622|18864581|P4|Maintenance Study|Withdrawal by Subject|5
5458138|NCT02065622|18864582|P3|Maintenance Study|Withdrawal by Subject|11
5458139|NCT02065622|18864583|P2|Maintenance Study|Withdrawal by Subject|0
5458140|NCT02065622|18864584|P1|Maintenance Study|Withdrawal by Subject|0
5458141|NCT02065622|18864580|P5|Maintenance Study|Adverse Event|11
5458142|NCT02065622|18864581|P4|Maintenance Study|Adverse Event|22
5458143|NCT02065622|18864582|P3|Maintenance Study|Adverse Event|25
5458144|NCT02065622|18864583|P2|Maintenance Study|Adverse Event|0
5458145|NCT02065622|18864584|P1|Maintenance Study|Adverse Event|0
5458146|NCT02065622|18864580|P5|Induction Study|Other, Not Specified|0
5458147|NCT02065622|18864581|P4|Induction Study|Other, Not Specified|0
5458148|NCT02065622|18864582|P3|Induction Study|Other, Not Specified|0
5458149|NCT02065622|18864583|P2|Induction Study|Other, Not Specified|2
5458150|NCT02065622|18864584|P1|Induction Study|Other, Not Specified|3
5458151|NCT02065622|18864580|P5|Induction Study|Subject Noncompliance|0
5458152|NCT02065622|18864581|P4|Induction Study|Subject Noncompliance|0
5458153|NCT02065622|18864582|P3|Induction Study|Subject Noncompliance|0
5458154|NCT02065622|18864583|P2|Induction Study|Subject Noncompliance|1
5458155|NCT02065622|18864584|P1|Induction Study|Subject Noncompliance|1
5458156|NCT02065622|18864580|P5|Induction Study|Requires Alternative/Prohibited Therapy|0
5458157|NCT02065622|18864581|P4|Induction Study|Requires Alternative/Prohibited Therapy|0
5458158|NCT02065622|18864582|P3|Induction Study|Requires Alternative/Prohibited Therapy|0
5458159|NCT02065622|18864583|P2|Induction Study|Requires Alternative/Prohibited Therapy|5
5458160|NCT02065622|18864584|P1|Induction Study|Requires Alternative/Prohibited Therapy|4
5458161|NCT02065622|18864580|P5|Induction Study|Lack of Efficacy|0
5458162|NCT02065622|18864581|P4|Induction Study|Lack of Efficacy|0
5458163|NCT02065622|18864582|P3|Induction Study|Lack of Efficacy|0
5458164|NCT02065622|18864583|P2|Induction Study|Lack of Efficacy|27
5458165|NCT02065622|18864584|P1|Induction Study|Lack of Efficacy|22
5458166|NCT02065622|18864580|P5|Induction Study|Lost to Follow-up|0
5458167|NCT02065622|18864581|P4|Induction Study|Lost to Follow-up|0
5458168|NCT02065622|18864582|P3|Induction Study|Lost to Follow-up|0
5458169|NCT02065622|18864583|P2|Induction Study|Lost to Follow-up|0
5458170|NCT02065622|18864584|P1|Induction Study|Lost to Follow-up|1
5458171|NCT02065622|18864580|P5|Induction Study|Withdrawal by Subject|0
5458172|NCT02065622|18864581|P4|Induction Study|Withdrawal by Subject|0
5458173|NCT02065622|18864582|P3|Induction Study|Withdrawal by Subject|0
5458174|NCT02065622|18864583|P2|Induction Study|Withdrawal by Subject|5
5458175|NCT02065622|18864584|P1|Induction Study|Withdrawal by Subject|3
5458176|NCT02065622|18864580|P5|Induction Study|Adverse Event|0
5458177|NCT02065622|18864581|P4|Induction Study|Adverse Event|0
5458178|NCT02065622|18864582|P3|Induction Study|Adverse Event|0
5458179|NCT02065622|18864583|P2|Induction Study|Adverse Event|19
5458180|NCT02065622|18864584|P1|Induction Study|Adverse Event|13
5458181|NCT02065557|18864686|P6|Maintenance Period|Subject Non-Compliance|1
5458182|NCT02065557|18864687|P5|Maintenance Period|Subject Non-Compliance|0
5458183|NCT02065557|18864688|P4|Maintenance Period|Subject Non-Compliance|0
5458184|NCT02065557|18864689|P3|Maintenance Period|Subject Non-Compliance|0
5458185|NCT02065557|18864690|P2|Maintenance Period|Subject Non-Compliance|0
5458186|NCT02065557|18864691|P1|Maintenance Period|Subject Non-Compliance|0
5458187|NCT02065557|18864686|P6|Maintenance Period|Lack of Efficacy|2
5458188|NCT02065557|18864687|P5|Maintenance Period|Lack of Efficacy|5
5458189|NCT02065557|18864688|P4|Maintenance Period|Lack of Efficacy|0
5458190|NCT02065557|18864689|P3|Maintenance Period|Lack of Efficacy|0
5458191|NCT02065557|18864690|P2|Maintenance Period|Lack of Efficacy|0
5458192|NCT02065557|18864691|P1|Maintenance Period|Lack of Efficacy|0
5458193|NCT02065557|18864686|P6|Maintenance Period|Withdrawal by Subject|1
5458194|NCT02065557|18864687|P5|Maintenance Period|Withdrawal by Subject|2
5458195|NCT02065557|18864688|P4|Maintenance Period|Withdrawal by Subject|0
5458196|NCT02065557|18864689|P3|Maintenance Period|Withdrawal by Subject|0
5458197|NCT02065557|18864690|P2|Maintenance Period|Withdrawal by Subject|0
5458198|NCT02065557|18864691|P1|Maintenance Period|Withdrawal by Subject|0
5458199|NCT02065557|18864686|P6|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5458200|NCT02065557|18864687|P5|Maintenance Period|Requires Alternative/Prohibited Therapy|1
5458201|NCT02065557|18864688|P4|Maintenance Period|Requires Alternative/Prohibited Therapy|1
5458202|NCT02065557|18864689|P3|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5458203|NCT02065557|18864690|P2|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5458204|NCT02065557|18864691|P1|Maintenance Period|Requires Alternative/Prohibited Therapy|0
5458205|NCT02065557|18864686|P6|Induction Period|Adverse Event|0
5458206|NCT02065557|18864687|P5|Induction Period|Adverse Event|0
5458207|NCT02065557|18864688|P4|Induction Period|Adverse Event|0
5458208|NCT02065557|18864689|P3|Induction Period|Adverse Event|0
5458209|NCT02065557|18864690|P2|Induction Period|Adverse Event|1
5458210|NCT02065557|18864691|P1|Induction Period|Adverse Event|1
5458211|NCT02065557|18864686|P6|Induction Period|Non-Responder at Week 8|0
5458212|NCT02065557|18864687|P5|Induction Period|Non-Responder at Week 8|0
5458213|NCT02065557|18864688|P4|Induction Period|Non-Responder at Week 8|0
5458214|NCT02065557|18864689|P3|Induction Period|Non-Responder at Week 8|0
5458215|NCT02065557|18864690|P2|Induction Period|Non-Responder at Week 8|4
5458216|NCT02065557|18864691|P1|Induction Period|Non-Responder at Week 8|4
5458217|NCT02065557|18864686|P6|Induction Period|Requires Alternative/Prohibited Therapy|0
5458218|NCT02065557|18864687|P5|Induction Period|Requires Alternative/Prohibited Therapy|0
5458219|NCT02065557|18864688|P4|Induction Period|Requires Alternative/Prohibited Therapy|0
5458220|NCT02065557|18864689|P3|Induction Period|Requires Alternative/Prohibited Therapy|1
5458221|NCT02065557|18864690|P2|Induction Period|Requires Alternative/Prohibited Therapy|1
5458222|NCT02065557|18864691|P1|Induction Period|Requires Alternative/Prohibited Therapy|1
5458223|NCT02065557|18864686|P6|Induction Period|Lack of Efficacy|0
5458224|NCT02065557|18864687|P5|Induction Period|Lack of Efficacy|0
5458225|NCT02065557|18864688|P4|Induction Period|Lack of Efficacy|0
5458226|NCT02065557|18864689|P3|Induction Period|Lack of Efficacy|1
5458227|NCT02065557|18864690|P2|Induction Period|Lack of Efficacy|1
5458228|NCT02065557|18864691|P1|Induction Period|Lack of Efficacy|2
5458229|NCT02065557|18864686|P6|Induction Period|Withdrawal by Subject|0
5458230|NCT02065557|18864687|P5|Induction Period|Withdrawal by Subject|0
5458231|NCT02065557|18864688|P4|Induction Period|Withdrawal by Subject|0
5458232|NCT02065557|18864689|P3|Induction Period|Withdrawal by Subject|0
5458233|NCT02065557|18864690|P2|Induction Period|Withdrawal by Subject|1
5458234|NCT02065557|18864691|P1|Induction Period|Withdrawal by Subject|2
5458235|NCT02065518|18864752|P4|Overall Study|Withdrawal by Subject|2
5458236|NCT02065518|18864753|P3|Overall Study|Withdrawal by Subject|9
5458237|NCT02065518|18864754|P2|Overall Study|Withdrawal by Subject|4
5458238|NCT02065518|18864755|P1|Overall Study|Withdrawal by Subject|3
5458239|NCT02065518|18864752|P4|Overall Study|Lost to Follow-up|3
5458240|NCT02065518|18864753|P3|Overall Study|Lost to Follow-up|0
5458241|NCT02065518|18864754|P2|Overall Study|Lost to Follow-up|4
5458242|NCT02065518|18864755|P1|Overall Study|Lost to Follow-up|3
5458243|NCT02065336|18864830|P10|Extension Phase|Study Terminated by Sponsor|8
5458244|NCT02065336|18864831|P9|Extension Phase|Study Terminated by Sponsor|2
5458245|NCT02065336|18864832|P8|Extension Phase|Study Terminated by Sponsor|0
5458246|NCT02065336|18864833|P7|Extension Phase|Study Terminated by Sponsor|0
5458247|NCT02065336|18864834|P6|Extension Phase|Study Terminated by Sponsor|0
5458248|NCT02065336|18864835|P5|Extension Phase|Study Terminated by Sponsor|0
5458249|NCT02065336|18864836|P4|Extension Phase|Study Terminated by Sponsor|0
5458250|NCT02065336|18864837|P3|Extension Phase|Study Terminated by Sponsor|0
5458251|NCT02065336|18864838|P2|Extension Phase|Study Terminated by Sponsor|0
5458252|NCT02065336|18864839|P1|Extension Phase|Study Terminated by Sponsor|0
5458253|NCT02064920|18865116|P2|Overall Study|Withdrawal by Subject|3
5458254|NCT02064920|18865117|P1|Overall Study|Withdrawal by Subject|1
5458255|NCT02064920|18865116|P2|Overall Study|Technical Problems|1
5458256|NCT02064920|18865117|P1|Overall Study|Technical Problems|0
5458257|NCT02064920|18865116|P2|Overall Study|Physician Decision|1
5458258|NCT02064920|18865117|P1|Overall Study|Physician Decision|0
5458259|NCT02064920|18865116|P2|Overall Study|Adverse Event|4
5458260|NCT02064920|18865117|P1|Overall Study|Adverse Event|0
5458261|NCT02064894|18865147|P3|Overall Study|Withdrawal by Subject|115
5458262|NCT02064894|18865148|P2|Overall Study|Withdrawal by Subject|102
5458263|NCT02064894|18865149|P1|Overall Study|Withdrawal by Subject|43
5458264|NCT02064868|18865162|P2|Overall Study|Technical Problems or Missing|2
5458265|NCT02064868|18865163|P1|Overall Study|Technical Problems or Missing|5
5458266|NCT02064868|18865162|P2|Overall Study|Withdrawal by Subject|3
5458267|NCT02064868|18865163|P1|Overall Study|Withdrawal by Subject|14
5458268|NCT02064868|18865162|P2|Overall Study|Physician Decision|0
5458269|NCT02064868|18865163|P1|Overall Study|Physician Decision|1
5458270|NCT02064868|18865162|P2|Overall Study|Lost to Follow-up|8
5458271|NCT02064868|18865163|P1|Overall Study|Lost to Follow-up|14
5458272|NCT02064816|18865183|P2|Overall Study|Other|3
5458273|NCT02064816|18865184|P1|Overall Study|Other|1
5458274|NCT02064816|18865183|P2|Overall Study|Therapeutic failure|1
5458275|NCT02064816|18865184|P1|Overall Study|Therapeutic failure|0
5458276|NCT02064816|18865183|P2|Overall Study|Lost to Follow-up|1
5458277|NCT02064816|18865184|P1|Overall Study|Lost to Follow-up|2
5458278|NCT02064816|18865183|P2|Overall Study|Withdrawal by Subject|1
5458279|NCT02064816|18865184|P1|Overall Study|Withdrawal by Subject|2
5458280|NCT02064816|18865183|P2|Overall Study|Adverse Event|2
5458281|NCT02064816|18865184|P1|Overall Study|Adverse Event|3
5458282|NCT02064439|18865230|P3|Overall Study|Other|7
5458283|NCT02064439|18865231|P2|Overall Study|Other|2
5458284|NCT02064439|18865232|P1|Overall Study|Other|2
5458285|NCT02064439|18865230|P3|Overall Study|Safety outcome reached|10
5458286|NCT02064439|18865231|P2|Overall Study|Safety outcome reached|20
5458287|NCT02064439|18865232|P1|Overall Study|Safety outcome reached|12
5458288|NCT02064439|18865230|P3|Overall Study|Efficacy outcome reached|57
5458289|NCT02064439|18865231|P2|Overall Study|Efficacy outcome reached|16
5458290|NCT02064439|18865232|P1|Overall Study|Efficacy outcome reached|18
5458291|NCT02064439|18865230|P3|Overall Study|Logistical difficulties|2
5458292|NCT02064439|18865231|P2|Overall Study|Logistical difficulties|5
5458293|NCT02064439|18865232|P1|Overall Study|Logistical difficulties|6
5458294|NCT02064439|18865230|P3|Overall Study|Physician Decision|1
5458295|NCT02064439|18865231|P2|Overall Study|Physician Decision|1
5458296|NCT02064439|18865232|P1|Overall Study|Physician Decision|0
5458297|NCT02064439|18865230|P3|Overall Study|Non-compliance with study medication|23
5458298|NCT02064439|18865231|P2|Overall Study|Non-compliance with study medication|19
5458299|NCT02064439|18865232|P1|Overall Study|Non-compliance with study medication|21
5458300|NCT02064439|18865230|P3|Overall Study|Lost to Follow-up|4
5458301|NCT02064439|18865231|P2|Overall Study|Lost to Follow-up|3
5458302|NCT02064439|18865232|P1|Overall Study|Lost to Follow-up|1
5458303|NCT02064439|18865230|P3|Overall Study|Protocol Violation|3
5458304|NCT02064439|18865231|P2|Overall Study|Protocol Violation|5
5458305|NCT02064439|18865232|P1|Overall Study|Protocol Violation|3
5458306|NCT02064439|18865230|P3|Overall Study|Withdrawal by Subject|26
5458307|NCT02064439|18865231|P2|Overall Study|Withdrawal by Subject|18
5458308|NCT02064439|18865232|P1|Overall Study|Withdrawal by Subject|29
5458309|NCT02064439|18865230|P3|Overall Study|Death|3
5458310|NCT02064439|18865231|P2|Overall Study|Death|2
5458311|NCT02064439|18865232|P1|Overall Study|Death|0
5458312|NCT02064439|18865230|P3|Overall Study|Adverse Event|46
5458313|NCT02064439|18865231|P2|Overall Study|Adverse Event|47
5458314|NCT02064439|18865232|P1|Overall Study|Adverse Event|51
5458315|NCT02064387|18865261|P12|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458316|NCT02064387|18865262|P11|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
5458317|NCT02064387|18865263|P10|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458318|NCT02064387|18865264|P9|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458319|NCT02064387|18865265|P8|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458320|NCT02064387|18865266|P7|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458321|NCT02064387|18865267|P6|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458322|NCT02064387|18865268|P5|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458323|NCT02064387|18865269|P4|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458324|NCT02064387|18865270|P3|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458325|NCT02064387|18865271|P2|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458326|NCT02064387|18865272|P1|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
5458327|NCT02064387|18865261|P12|Part 2 Max 35 Months Followup Duration|Death|3
5458328|NCT02064387|18865262|P11|Part 2 Max 35 Months Followup Duration|Death|5
5458329|NCT02064387|18865263|P10|Part 2 Max 35 Months Followup Duration|Death|0
5458330|NCT02064387|18865264|P9|Part 2 Max 35 Months Followup Duration|Death|0
5458331|NCT02064387|18865265|P8|Part 2 Max 35 Months Followup Duration|Death|0
5458332|NCT02064387|18865266|P7|Part 2 Max 35 Months Followup Duration|Death|0
5458333|NCT02064387|18865267|P6|Part 2 Max 35 Months Followup Duration|Death|0
5458334|NCT02064387|18865268|P5|Part 2 Max 35 Months Followup Duration|Death|0
5458335|NCT02064387|18865269|P4|Part 2 Max 35 Months Followup Duration|Death|0
5458336|NCT02064387|18865270|P3|Part 2 Max 35 Months Followup Duration|Death|0
5458337|NCT02064387|18865271|P2|Part 2 Max 35 Months Followup Duration|Death|0
5458338|NCT02064387|18865272|P1|Part 2 Max 35 Months Followup Duration|Death|0
5458339|NCT02064387|18865261|P12|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458340|NCT02064387|18865262|P11|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458341|NCT02064387|18865263|P10|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458342|NCT02064387|18865264|P9|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
5458343|NCT02064387|18865265|P8|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458344|NCT02064387|18865266|P7|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458345|NCT02064387|18865267|P6|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458346|NCT02064387|18865268|P5|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458347|NCT02064387|18865269|P4|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458348|NCT02064387|18865270|P3|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458349|NCT02064387|18865271|P2|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458350|NCT02064387|18865272|P1|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
5458351|NCT02064387|18865261|P12|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458352|NCT02064387|18865262|P11|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458353|NCT02064387|18865263|P10|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458354|NCT02064387|18865264|P9|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458355|NCT02064387|18865265|P8|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
5458356|NCT02064387|18865266|P7|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458357|NCT02064387|18865267|P6|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458358|NCT02064387|18865268|P5|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458359|NCT02064387|18865269|P4|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458360|NCT02064387|18865270|P3|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458361|NCT02064387|18865271|P2|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458362|NCT02064387|18865272|P1|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
5458363|NCT02064387|18865261|P12|Part 1 Max 23.5 Months Followup Duration|Death|0
5458364|NCT02064387|18865262|P11|Part 1 Max 23.5 Months Followup Duration|Death|0
5458365|NCT02064387|18865263|P10|Part 1 Max 23.5 Months Followup Duration|Death|1
5458366|NCT02064387|18865264|P9|Part 1 Max 23.5 Months Followup Duration|Death|0
5458367|NCT02064387|18865265|P8|Part 1 Max 23.5 Months Followup Duration|Death|1
5458368|NCT02064387|18865266|P7|Part 1 Max 23.5 Months Followup Duration|Death|0
5458369|NCT02064387|18865267|P6|Part 1 Max 23.5 Months Followup Duration|Death|0
5458370|NCT02064387|18865268|P5|Part 1 Max 23.5 Months Followup Duration|Death|0
5458371|NCT02064387|18865269|P4|Part 1 Max 23.5 Months Followup Duration|Death|0
5458372|NCT02064387|18865270|P3|Part 1 Max 23.5 Months Followup Duration|Death|0
5458373|NCT02064387|18865271|P2|Part 1 Max 23.5 Months Followup Duration|Death|0
5458374|NCT02064387|18865272|P1|Part 1 Max 23.5 Months Followup Duration|Death|0
5458375|NCT02064231|18865601|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
5458376|NCT02064231|18865602|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
5458377|NCT02064231|18865603|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
5458378|NCT02064231|18865604|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
5458379|NCT02064231|18865601|P4|First Test Period (Test A or Test C)|Adverse Event|0
5458380|NCT02064231|18865602|P3|First Test Period (Test A or Test C)|Adverse Event|1
5458381|NCT02064231|18865603|P2|First Test Period (Test A or Test C)|Adverse Event|0
5458382|NCT02064231|18865604|P1|First Test Period (Test A or Test C)|Adverse Event|1
5458383|NCT02064231|18865601|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
5458384|NCT02064231|18865602|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
5458385|NCT02064231|18865603|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
5458386|NCT02064231|18865604|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
5458387|NCT02064231|18865601|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
5458388|NCT02064231|18865602|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
5458389|NCT02064231|18865603|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
5458390|NCT02064231|18865604|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
5458391|NCT02064205|18865616|P1|Overall Study|Withdrawal by Subject|1
5458392|NCT02064166|18865634|P2|Overall Study|Adverse Event|0
5458393|NCT02064166|18865635|P1|Overall Study|Adverse Event|1
5458394|NCT02063880|18865665|P2|Overall Study|Ineligible|2
5458395|NCT02063880|18865666|P1|Overall Study|Ineligible|0
5458396|NCT02063880|18865665|P2|Overall Study|Lost to Follow-up|7
5458397|NCT02063880|18865666|P1|Overall Study|Lost to Follow-up|7
5458398|NCT02063880|18865665|P2|Overall Study|Death|18
5458399|NCT02063880|18865666|P1|Overall Study|Death|21
5458400|NCT02063854|18865704|P7|Overall Study|Did Not Receive Study Drug|0
5458401|NCT02063854|18865705|P6|Overall Study|Did Not Receive Study Drug|1
5458402|NCT02063854|18865706|P5|Overall Study|Did Not Receive Study Drug|0
5458403|NCT02063854|18865707|P4|Overall Study|Did Not Receive Study Drug|0
5458404|NCT02063854|18865708|P3|Overall Study|Did Not Receive Study Drug|0
5458405|NCT02063854|18865709|P2|Overall Study|Did Not Receive Study Drug|0
5458406|NCT02063854|18865710|P1|Overall Study|Did Not Receive Study Drug|0
5458407|NCT02063854|18865704|P7|Overall Study|Reason Not Specified|0
5458408|NCT02063854|18865705|P6|Overall Study|Reason Not Specified|0
5458409|NCT02063854|18865706|P5|Overall Study|Reason Not Specified|0
5458410|NCT02063854|18865707|P4|Overall Study|Reason Not Specified|0
5458411|NCT02063854|18865708|P3|Overall Study|Reason Not Specified|0
5458412|NCT02063854|18865709|P2|Overall Study|Reason Not Specified|0
5458413|NCT02063854|18865710|P1|Overall Study|Reason Not Specified|1
5458414|NCT02063854|18865704|P7|Overall Study|Surgical Dental Work Performed/Planned|1
5458415|NCT02063854|18865705|P6|Overall Study|Surgical Dental Work Performed/Planned|6
5458416|NCT02063854|18865706|P5|Overall Study|Surgical Dental Work Performed/Planned|1
5458417|NCT02063854|18865707|P4|Overall Study|Surgical Dental Work Performed/Planned|1
5458418|NCT02063854|18865708|P3|Overall Study|Surgical Dental Work Performed/Planned|6
5458419|NCT02063854|18865709|P2|Overall Study|Surgical Dental Work Performed/Planned|2
5458420|NCT02063854|18865710|P1|Overall Study|Surgical Dental Work Performed/Planned|5
5458421|NCT02063854|18865704|P7|Overall Study|Voluntary Withdrawal|1
5458422|NCT02063854|18865705|P6|Overall Study|Voluntary Withdrawal|6
5458423|NCT02063854|18865706|P5|Overall Study|Voluntary Withdrawal|3
5458424|NCT02063854|18865707|P4|Overall Study|Voluntary Withdrawal|1
5458425|NCT02063854|18865708|P3|Overall Study|Voluntary Withdrawal|8
5458426|NCT02063854|18865709|P2|Overall Study|Voluntary Withdrawal|0
5458427|NCT02063854|18865710|P1|Overall Study|Voluntary Withdrawal|2
5458428|NCT02063854|18865704|P7|Overall Study|Major Protocol Deviation|0
5458429|NCT02063854|18865705|P6|Overall Study|Major Protocol Deviation|0
5458430|NCT02063854|18865706|P5|Overall Study|Major Protocol Deviation|0
5458431|NCT02063854|18865707|P4|Overall Study|Major Protocol Deviation|0
5458432|NCT02063854|18865708|P3|Overall Study|Major Protocol Deviation|3
5458433|NCT02063854|18865709|P2|Overall Study|Major Protocol Deviation|0
5458434|NCT02063854|18865710|P1|Overall Study|Major Protocol Deviation|0
5458435|NCT02063854|18865704|P7|Overall Study|Pretreatment Event/Adverse Event|4
5458436|NCT02063854|18865705|P6|Overall Study|Pretreatment Event/Adverse Event|18
5458437|NCT02063854|18865706|P5|Overall Study|Pretreatment Event/Adverse Event|7
5458438|NCT02063854|18865707|P4|Overall Study|Pretreatment Event/Adverse Event|8
5458439|NCT02063854|18865708|P3|Overall Study|Pretreatment Event/Adverse Event|13
5458440|NCT02063854|18865709|P2|Overall Study|Pretreatment Event/Adverse Event|10
5458441|NCT02063854|18865710|P1|Overall Study|Pretreatment Event/Adverse Event|13
5458442|NCT02063737|18865794|P2|Overall Study|Lost to Follow-up|4
5458443|NCT02063737|18865795|P1|Overall Study|Lost to Follow-up|11
5458444|NCT02063724|18865827|P1|Overall Study|Disease progression|1
5458445|NCT02063698|18865835|P2|Overall Study|did not complete booklet for days 2-8|2
5458446|NCT02063698|18865836|P1|Overall Study|did not complete booklet for days 2-8|1
5458447|NCT02063672|18865860|P2|Overall Study|Withdrawal by Subject|2
5458448|NCT02063672|18865861|P1|Overall Study|Withdrawal by Subject|2
5458449|NCT02063672|18865860|P2|Overall Study|Lost to Follow-up|3
5458450|NCT02063672|18865861|P1|Overall Study|Lost to Follow-up|1
5458451|NCT02063672|18865860|P2|Overall Study|Death|3
5458452|NCT02063672|18865861|P1|Overall Study|Death|5
5458453|NCT02063672|18865860|P2|Overall Study|Ongoing Follow-up|14
5458454|NCT02063672|18865861|P1|Overall Study|Ongoing Follow-up|27
5458455|NCT02063659|18865908|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
5458456|NCT02063659|18865909|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
5458457|NCT02063659|18865910|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
5458458|NCT02063659|18865911|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
5458459|NCT02063659|18865908|P4|Open-Label Extension Period (OLE)|Adverse Event|7
5458460|NCT02063659|18865909|P3|Open-Label Extension Period (OLE)|Adverse Event|0
5458461|NCT02063659|18865910|P2|Open-Label Extension Period (OLE)|Adverse Event|0
5458462|NCT02063659|18865911|P1|Open-Label Extension Period (OLE)|Adverse Event|0
5458463|NCT02063659|18865908|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
5458464|NCT02063659|18865909|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5458465|NCT02063659|18865910|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5458466|NCT02063659|18865911|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5458467|NCT02063659|18865908|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
5458468|NCT02063659|18865909|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5458469|NCT02063659|18865910|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5458470|NCT02063659|18865911|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5458471|NCT02063659|18865908|P4|Open-Label Extension Period (OLE)|Physician Decision|1
5458472|NCT02063659|18865909|P3|Open-Label Extension Period (OLE)|Physician Decision|0
5458473|NCT02063659|18865910|P2|Open-Label Extension Period (OLE)|Physician Decision|0
5458474|NCT02063659|18865911|P1|Open-Label Extension Period (OLE)|Physician Decision|0
5458475|NCT02063659|18865908|P4|Double-Blind Treatment Period|Withdrawal of consent|0
5458564|NCT02060383|18866776|P1|Extension Phase|Death|0
5458476|NCT02063659|18865909|P3|Double-Blind Treatment Period|Withdrawal of consent|3
5458477|NCT02063659|18865910|P2|Double-Blind Treatment Period|Withdrawal of consent|1
5458478|NCT02063659|18865911|P1|Double-Blind Treatment Period|Withdrawal of consent|0
5458479|NCT02063659|18865908|P4|Double-Blind Treatment Period|Physician Decision|0
5458480|NCT02063659|18865909|P3|Double-Blind Treatment Period|Physician Decision|0
5458481|NCT02063659|18865910|P2|Double-Blind Treatment Period|Physician Decision|0
5458482|NCT02063659|18865911|P1|Double-Blind Treatment Period|Physician Decision|1
5458483|NCT02063659|18865908|P4|Double-Blind Treatment Period|Adverse Event|0
5458484|NCT02063659|18865909|P3|Double-Blind Treatment Period|Adverse Event|0
5458485|NCT02063659|18865910|P2|Double-Blind Treatment Period|Adverse Event|2
5458486|NCT02063659|18865911|P1|Double-Blind Treatment Period|Adverse Event|1
5458487|NCT02063217|18865994|P3|Overall Study|Withdrawal by Subject|0
5458488|NCT02063217|18865995|P2|Overall Study|Withdrawal by Subject|0
5458489|NCT02063217|18865996|P1|Overall Study|Withdrawal by Subject|1
5458490|NCT02062879|18866072|P2|Overall Study|Withdrawal by Subject|1
5458491|NCT02062879|18866073|P1|Overall Study|Withdrawal by Subject|4
5458492|NCT02062658|18866109|P1|Overall Study|Lack of Efficacy|1
5458493|NCT02062658|18866109|P1|Overall Study|Withdrawal by Subject|1
5458494|NCT02062645|18866113|P1|Overall Study|Lost to Follow-up|5
5458495|NCT02062645|18866113|P1|Overall Study|Protocol Violation|8
5458496|NCT02062645|18866113|P1|Overall Study|Adverse Event|2
5458497|NCT02062632|18866121|P1|Overall Study|No treatment data|1
5458498|NCT02062450|18866162|P1|Overall Study|No follow-up visit|124
5458499|NCT02062437|18866176|P1|Overall Study|Pt. couldn't come due to med. condition|1
5458500|NCT02062437|18866176|P1|Overall Study|Death|2
5458501|NCT02062437|18866176|P1|Overall Study|Patient not available for the 2y visit|18
5458502|NCT02062437|18866176|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
5458503|NCT02062398|18866185|P1|Overall Study|Implant removal|1
5458504|NCT02062385|18866197|P4|Overall Study|Lost to Follow-up|0
5458505|NCT02062385|18866198|P3|Overall Study|Lost to Follow-up|1
5458506|NCT02062385|18866199|P2|Overall Study|Lost to Follow-up|0
5458507|NCT02062385|18866200|P1|Overall Study|Lost to Follow-up|0
5458508|NCT02062385|18866197|P4|Overall Study|Death|1
5458509|NCT02062385|18866198|P3|Overall Study|Death|0
5458510|NCT02062385|18866199|P2|Overall Study|Death|0
5458511|NCT02062385|18866200|P1|Overall Study|Death|0
5458512|NCT02062385|18866197|P4|Overall Study|Withdrawn by parent/guardian|8
5458513|NCT02062385|18866198|P3|Overall Study|Withdrawn by parent/guardian|9
5458514|NCT02062385|18866199|P2|Overall Study|Withdrawn by parent/guardian|41
5458515|NCT02062385|18866200|P1|Overall Study|Withdrawn by parent/guardian|46
5458516|NCT02062385|18866197|P4|Overall Study|Moved|0
5458517|NCT02062385|18866198|P3|Overall Study|Moved|1
5458518|NCT02062385|18866199|P2|Overall Study|Moved|11
5458519|NCT02062385|18866200|P1|Overall Study|Moved|10
5458520|NCT02062385|18866197|P4|Overall Study|Incomplete EPI by database lock|0
5458521|NCT02062385|18866198|P3|Overall Study|Incomplete EPI by database lock|0
5458522|NCT02062385|18866199|P2|Overall Study|Incomplete EPI by database lock|0
5458523|NCT02062385|18866200|P1|Overall Study|Incomplete EPI by database lock|2
5458524|NCT02062385|18866197|P4|Overall Study|Protocol Violation|0
5458525|NCT02062385|18866198|P3|Overall Study|Protocol Violation|0
5458526|NCT02062385|18866199|P2|Overall Study|Protocol Violation|0
5458527|NCT02062385|18866200|P1|Overall Study|Protocol Violation|1
5458528|NCT02062385|18866197|P4|Overall Study|Adverse Event|0
5458529|NCT02062385|18866198|P3|Overall Study|Adverse Event|1
5458530|NCT02062385|18866199|P2|Overall Study|Adverse Event|13
5458531|NCT02062385|18866200|P1|Overall Study|Adverse Event|19
5458532|NCT02062151|18866244|P1|Overall Study|screen failure|1
5458533|NCT02061592|18866404|P2|Period 2|Lost to Follow-up|1
5458534|NCT02061592|18866405|P1|Period 2|Lost to Follow-up|0
5458535|NCT02061592|18866404|P2|Period 1|Protocol Violation|0
5458536|NCT02061592|18866405|P1|Period 1|Protocol Violation|1
5458537|NCT02061592|18866404|P2|Period 1|Withdrawal by Subject|0
5458538|NCT02061592|18866405|P1|Period 1|Withdrawal by Subject|1
5458539|NCT02061540|18866417|P1|Overall Study|Withdrawal by Subject|2
5458540|NCT02061540|18866417|P1|Overall Study|Adverse Event|2
5458541|NCT02061280|18866590|P2|Overall Study|Lost to Follow-up|1
5458542|NCT02061280|18866591|P1|Overall Study|Lost to Follow-up|5
5458543|NCT02061280|18866590|P2|Overall Study|Withdrawal by Subject|2
5458544|NCT02061280|18866591|P1|Overall Study|Withdrawal by Subject|1
5458545|NCT02061280|18866590|P2|Overall Study|moved out of state|1
5458546|NCT02061280|18866591|P1|Overall Study|moved out of state|0
5458547|NCT02061280|18866590|P2|Overall Study|Protocol Violation|8
5458548|NCT02061280|18866591|P1|Overall Study|Protocol Violation|12
5458549|NCT02061202|18866623|P2|Overall Study|Lost to Follow-up|1
5458550|NCT02061202|18866624|P1|Overall Study|Lost to Follow-up|1
5458551|NCT02060903|18866650|P2|Overall Study|Withdrawal by Subject|7
5458552|NCT02060903|18866651|P1|Overall Study|Withdrawal by Subject|0
5458553|NCT02060903|18866650|P2|Overall Study|Lost to Follow-up|0
5458554|NCT02060903|18866651|P1|Overall Study|Lost to Follow-up|4
5458555|NCT02060383|18866772|P5|Extension Phase|Protocol Violation|1
5458556|NCT02060383|18866773|P4|Extension Phase|Protocol Violation|0
5458557|NCT02060383|18866774|P3|Extension Phase|Protocol Violation|0
5458558|NCT02060383|18866775|P2|Extension Phase|Protocol Violation|0
5458559|NCT02060383|18866776|P1|Extension Phase|Protocol Violation|0
5458560|NCT02060383|18866772|P5|Extension Phase|Death|1
5458561|NCT02060383|18866773|P4|Extension Phase|Death|0
5458562|NCT02060383|18866774|P3|Extension Phase|Death|1
5458563|NCT02060383|18866775|P2|Extension Phase|Death|0
5458565|NCT02060383|18866772|P5|Extension Phase|Administrative problems|0
5458566|NCT02060383|18866773|P4|Extension Phase|Administrative problems|0
5458567|NCT02060383|18866774|P3|Extension Phase|Administrative problems|0
5458568|NCT02060383|18866775|P2|Extension Phase|Administrative problems|0
5458569|NCT02060383|18866776|P1|Extension Phase|Administrative problems|1
5458570|NCT02060383|18866772|P5|Extension Phase|Withdrawal by Subject|2
5458571|NCT02060383|18866773|P4|Extension Phase|Withdrawal by Subject|0
5458572|NCT02060383|18866774|P3|Extension Phase|Withdrawal by Subject|0
5458573|NCT02060383|18866775|P2|Extension Phase|Withdrawal by Subject|1
5458574|NCT02060383|18866776|P1|Extension Phase|Withdrawal by Subject|0
5458575|NCT02060383|18866772|P5|Extension Phase|Adverse Event|1
5458576|NCT02060383|18866773|P4|Extension Phase|Adverse Event|0
5458577|NCT02060383|18866774|P3|Extension Phase|Adverse Event|2
5458578|NCT02060383|18866775|P2|Extension Phase|Adverse Event|1
5458579|NCT02060383|18866776|P1|Extension Phase|Adverse Event|1
5458580|NCT02060383|18866772|P5|Extension Phase|Unsatisfactory therapeutic effect|2
5458581|NCT02060383|18866773|P4|Extension Phase|Unsatisfactory therapeutic effect|2
5458582|NCT02060383|18866774|P3|Extension Phase|Unsatisfactory therapeutic effect|0
5458583|NCT02060383|18866775|P2|Extension Phase|Unsatisfactory therapeutic effect|1
5458584|NCT02060383|18866776|P1|Extension Phase|Unsatisfactory therapeutic effect|1
5458585|NCT02060383|18866772|P5|Core Phase|Withdrawal by Subject|2
5458586|NCT02060383|18866773|P4|Core Phase|Withdrawal by Subject|4
5458587|NCT02060383|18866774|P3|Core Phase|Withdrawal by Subject|0
5458588|NCT02060383|18866775|P2|Core Phase|Withdrawal by Subject|0
5458589|NCT02060383|18866776|P1|Core Phase|Withdrawal by Subject|0
5458590|NCT02060383|18866772|P5|Core Phase|Protocol Violation|0
5458591|NCT02060383|18866773|P4|Core Phase|Protocol Violation|1
5458592|NCT02060383|18866774|P3|Core Phase|Protocol Violation|0
5458593|NCT02060383|18866775|P2|Core Phase|Protocol Violation|0
5458594|NCT02060383|18866776|P1|Core Phase|Protocol Violation|0
5458595|NCT02060383|18866772|P5|Core Phase|Administrative problems|0
5458596|NCT02060383|18866773|P4|Core Phase|Administrative problems|0
5458597|NCT02060383|18866774|P3|Core Phase|Administrative problems|0
5458598|NCT02060383|18866775|P2|Core Phase|Administrative problems|1
5458599|NCT02060383|18866776|P1|Core Phase|Administrative problems|0
5458600|NCT02060383|18866772|P5|Core Phase|Adverse Event|6
5458601|NCT02060383|18866773|P4|Core Phase|Adverse Event|2
5458602|NCT02060383|18866774|P3|Core Phase|Adverse Event|0
5458603|NCT02060383|18866775|P2|Core Phase|Adverse Event|0
5458604|NCT02060383|18866776|P1|Core Phase|Adverse Event|2
5458605|NCT02060383|18866772|P5|Core Phase|Unsatisfactory therapeutic effect|0
5458606|NCT02060383|18866773|P4|Core Phase|Unsatisfactory therapeutic effect|0
5458607|NCT02060383|18866774|P3|Core Phase|Unsatisfactory therapeutic effect|0
5458608|NCT02060383|18866775|P2|Core Phase|Unsatisfactory therapeutic effect|5
5458609|NCT02060383|18866776|P1|Core Phase|Unsatisfactory therapeutic effect|1
5458610|NCT02060370|18866802|P1|Overall Study|Physician Decision|1
5458611|NCT02059980|18866843|P2|Overall Study|Lost to Follow-up|1
5458612|NCT02059980|18866844|P1|Overall Study|Lost to Follow-up|2
5458613|NCT02059434|18866889|P9|Washout Between Periods 7 and 8|Withdrawal by Subject|1
5458614|NCT02059434|18866890|P8|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5458615|NCT02059434|18866891|P7|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5458616|NCT02059434|18866892|P6|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5458617|NCT02059434|18866893|P5|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5458618|NCT02059434|18866894|P4|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5458619|NCT02059434|18866895|P3|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5458620|NCT02059434|18866896|P2|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5458621|NCT02059434|18866897|P1|Washout Between Periods 7 and 8|Withdrawal by Subject|0
5458622|NCT02059434|18866889|P9|Washout Between Periods 7 and 8|Adverse Event|1
5458623|NCT02059434|18866890|P8|Washout Between Periods 7 and 8|Adverse Event|0
5458624|NCT02059434|18866891|P7|Washout Between Periods 7 and 8|Adverse Event|0
5458625|NCT02059434|18866892|P6|Washout Between Periods 7 and 8|Adverse Event|0
5458626|NCT02059434|18866893|P5|Washout Between Periods 7 and 8|Adverse Event|0
5458627|NCT02059434|18866894|P4|Washout Between Periods 7 and 8|Adverse Event|0
5458628|NCT02059434|18866895|P3|Washout Between Periods 7 and 8|Adverse Event|0
5458629|NCT02059434|18866896|P2|Washout Between Periods 7 and 8|Adverse Event|0
5458630|NCT02059434|18866897|P1|Washout Between Periods 7 and 8|Adverse Event|0
5458631|NCT02059434|18866889|P9|Washout Between Periods 6 and 7|Physician Decision|1
5458632|NCT02059434|18866890|P8|Washout Between Periods 6 and 7|Physician Decision|0
5458633|NCT02059434|18866891|P7|Washout Between Periods 6 and 7|Physician Decision|0
5458634|NCT02059434|18866892|P6|Washout Between Periods 6 and 7|Physician Decision|0
5458635|NCT02059434|18866893|P5|Washout Between Periods 6 and 7|Physician Decision|0
5458636|NCT02059434|18866894|P4|Washout Between Periods 6 and 7|Physician Decision|0
5458637|NCT02059434|18866895|P3|Washout Between Periods 6 and 7|Physician Decision|0
5458638|NCT02059434|18866896|P2|Washout Between Periods 6 and 7|Physician Decision|0
5458639|NCT02059434|18866897|P1|Washout Between Periods 6 and 7|Physician Decision|0
5458640|NCT02059434|18866889|P9|Washout Between Periods 4 and 5|Adverse Event|1
5458641|NCT02059434|18866890|P8|Washout Between Periods 4 and 5|Adverse Event|0
5458642|NCT02059434|18866891|P7|Washout Between Periods 4 and 5|Adverse Event|0
5458643|NCT02059434|18866892|P6|Washout Between Periods 4 and 5|Adverse Event|0
5458644|NCT02059434|18866893|P5|Washout Between Periods 4 and 5|Adverse Event|0
5458645|NCT02059434|18866894|P4|Washout Between Periods 4 and 5|Adverse Event|0
5458646|NCT02059434|18866895|P3|Washout Between Periods 4 and 5|Adverse Event|0
5458647|NCT02059434|18866896|P2|Washout Between Periods 4 and 5|Adverse Event|0
5458648|NCT02059434|18866897|P1|Washout Between Periods 4 and 5|Adverse Event|0
5458649|NCT02059434|18866889|P9|Washout Between Periods 1 and 2|Physician Decision|0
5458650|NCT02059434|18866890|P8|Washout Between Periods 1 and 2|Physician Decision|1
5458651|NCT02059434|18866891|P7|Washout Between Periods 1 and 2|Physician Decision|0
5458652|NCT02059434|18866892|P6|Washout Between Periods 1 and 2|Physician Decision|0
5458653|NCT02059434|18866893|P5|Washout Between Periods 1 and 2|Physician Decision|0
5458654|NCT02059434|18866894|P4|Washout Between Periods 1 and 2|Physician Decision|0
5458655|NCT02059434|18866895|P3|Washout Between Periods 1 and 2|Physician Decision|0
5458656|NCT02059434|18866896|P2|Washout Between Periods 1 and 2|Physician Decision|0
5458657|NCT02059434|18866897|P1|Washout Between Periods 1 and 2|Physician Decision|0
5458658|NCT02059408|18866962|P3|Overall Study|Did not get tested|358
5458659|NCT02059408|18866963|P2|Overall Study|Did not get tested|330
5458660|NCT02059408|18866964|P1|Overall Study|Did not get tested|0
5458661|NCT02059395|18866983|P2|Overall Study|Lost to Follow-up|4
5458662|NCT02059395|18866984|P1|Overall Study|Lost to Follow-up|2
5458663|NCT02059291|18866999|P25|Epoch 4|Lack of Efficacy|0
5458664|NCT02059291|18867000|P24|Epoch 4|Lack of Efficacy|1
5458665|NCT02059291|18867001|P23|Epoch 4|Lack of Efficacy|0
5458666|NCT02059291|18867002|P22|Epoch 4|Lack of Efficacy|0
5458667|NCT02059291|18867003|P21|Epoch 4|Lack of Efficacy|0
5458668|NCT02059291|18867004|P20|Epoch 4|Lack of Efficacy|0
5458669|NCT02059291|18867005|P19|Epoch 4|Lack of Efficacy|0
5458670|NCT02059291|18867006|P18|Epoch 4|Lack of Efficacy|0
5458671|NCT02059291|18867007|P17|Epoch 4|Lack of Efficacy|0
5458672|NCT02059291|18867008|P16|Epoch 4|Lack of Efficacy|0
5458673|NCT02059291|18867009|P15|Epoch 4|Lack of Efficacy|0
5458674|NCT02059291|18867010|P14|Epoch 4|Lack of Efficacy|0
5458675|NCT02059291|18867011|P13|Epoch 4|Lack of Efficacy|0
5458676|NCT02059291|18867012|P12|Epoch 4|Lack of Efficacy|0
5458677|NCT02059291|18867013|P11|Epoch 4|Lack of Efficacy|0
5458678|NCT02059291|18867014|P10|Epoch 4|Lack of Efficacy|0
5458679|NCT02059291|18867015|P9|Epoch 4|Lack of Efficacy|0
5458680|NCT02059291|18867016|P8|Epoch 4|Lack of Efficacy|0
5458681|NCT02059291|18867017|P7|Epoch 4|Lack of Efficacy|0
5458682|NCT02059291|18867018|P6|Epoch 4|Lack of Efficacy|0
5458683|NCT02059291|18867019|P5|Epoch 4|Lack of Efficacy|0
5458684|NCT02059291|18867020|P4|Epoch 4|Lack of Efficacy|0
5458685|NCT02059291|18867021|P3|Epoch 4|Lack of Efficacy|0
5458686|NCT02059291|18867022|P2|Epoch 4|Lack of Efficacy|0
5458687|NCT02059291|18867023|P1|Epoch 4|Lack of Efficacy|0
5458688|NCT02059291|18866999|P25|Epoch 4|Withdrawal by Subject|0
5458689|NCT02059291|18867000|P24|Epoch 4|Withdrawal by Subject|0
5458690|NCT02059291|18867001|P23|Epoch 4|Withdrawal by Subject|0
5458691|NCT02059291|18867002|P22|Epoch 4|Withdrawal by Subject|0
5458692|NCT02059291|18867003|P21|Epoch 4|Withdrawal by Subject|1
5458693|NCT02059291|18867004|P20|Epoch 4|Withdrawal by Subject|0
5458694|NCT02059291|18867005|P19|Epoch 4|Withdrawal by Subject|0
5458695|NCT02059291|18867006|P18|Epoch 4|Withdrawal by Subject|0
5458696|NCT02059291|18867007|P17|Epoch 4|Withdrawal by Subject|0
5458697|NCT02059291|18867008|P16|Epoch 4|Withdrawal by Subject|0
5458698|NCT02059291|18867009|P15|Epoch 4|Withdrawal by Subject|0
5458699|NCT02059291|18867010|P14|Epoch 4|Withdrawal by Subject|0
5458700|NCT02059291|18867011|P13|Epoch 4|Withdrawal by Subject|0
5458701|NCT02059291|18867012|P12|Epoch 4|Withdrawal by Subject|0
5458702|NCT02059291|18867013|P11|Epoch 4|Withdrawal by Subject|0
5458703|NCT02059291|18867014|P10|Epoch 4|Withdrawal by Subject|0
5458704|NCT02059291|18867015|P9|Epoch 4|Withdrawal by Subject|0
5458705|NCT02059291|18867016|P8|Epoch 4|Withdrawal by Subject|0
5458706|NCT02059291|18867017|P7|Epoch 4|Withdrawal by Subject|0
5458707|NCT02059291|18867018|P6|Epoch 4|Withdrawal by Subject|0
5458708|NCT02059291|18867019|P5|Epoch 4|Withdrawal by Subject|0
5458709|NCT02059291|18867020|P4|Epoch 4|Withdrawal by Subject|0
5458710|NCT02059291|18867021|P3|Epoch 4|Withdrawal by Subject|0
5458711|NCT02059291|18867022|P2|Epoch 4|Withdrawal by Subject|0
5458712|NCT02059291|18867023|P1|Epoch 4|Withdrawal by Subject|0
5458713|NCT02059291|18866999|P25|Epoch 4|Pregnancy|0
5458714|NCT02059291|18867000|P24|Epoch 4|Pregnancy|0
5458715|NCT02059291|18867001|P23|Epoch 4|Pregnancy|0
5458716|NCT02059291|18867002|P22|Epoch 4|Pregnancy|0
5458717|NCT02059291|18867003|P21|Epoch 4|Pregnancy|0
5458718|NCT02059291|18867004|P20|Epoch 4|Pregnancy|0
5458719|NCT02059291|18867005|P19|Epoch 4|Pregnancy|0
5458720|NCT02059291|18867006|P18|Epoch 4|Pregnancy|0
5458721|NCT02059291|18867007|P17|Epoch 4|Pregnancy|1
5458722|NCT02059291|18867008|P16|Epoch 4|Pregnancy|0
5458723|NCT02059291|18867009|P15|Epoch 4|Pregnancy|0
5458724|NCT02059291|18867010|P14|Epoch 4|Pregnancy|0
5458725|NCT02059291|18867011|P13|Epoch 4|Pregnancy|0
5458726|NCT02059291|18867012|P12|Epoch 4|Pregnancy|0
5458727|NCT02059291|18867013|P11|Epoch 4|Pregnancy|0
5458728|NCT02059291|18867014|P10|Epoch 4|Pregnancy|0
5458729|NCT02059291|18867015|P9|Epoch 4|Pregnancy|0
5458730|NCT02059291|18867016|P8|Epoch 4|Pregnancy|0
5458731|NCT02059291|18867017|P7|Epoch 4|Pregnancy|0
5458732|NCT02059291|18867018|P6|Epoch 4|Pregnancy|0
5458733|NCT02059291|18867019|P5|Epoch 4|Pregnancy|0
5458734|NCT02059291|18867020|P4|Epoch 4|Pregnancy|0
5458735|NCT02059291|18867021|P3|Epoch 4|Pregnancy|0
5458736|NCT02059291|18867022|P2|Epoch 4|Pregnancy|0
5458737|NCT02059291|18867023|P1|Epoch 4|Pregnancy|0
5458738|NCT02059291|18866999|P25|Epoch 4|Adverse Event|0
5458739|NCT02059291|18867000|P24|Epoch 4|Adverse Event|0
5458740|NCT02059291|18867001|P23|Epoch 4|Adverse Event|1
5458741|NCT02059291|18867002|P22|Epoch 4|Adverse Event|0
5458742|NCT02059291|18867003|P21|Epoch 4|Adverse Event|0
5458743|NCT02059291|18867004|P20|Epoch 4|Adverse Event|0
5458744|NCT02059291|18867005|P19|Epoch 4|Adverse Event|0
5458745|NCT02059291|18867006|P18|Epoch 4|Adverse Event|0
5458746|NCT02059291|18867007|P17|Epoch 4|Adverse Event|1
5458747|NCT02059291|18867008|P16|Epoch 4|Adverse Event|0
5458748|NCT02059291|18867009|P15|Epoch 4|Adverse Event|0
5458749|NCT02059291|18867010|P14|Epoch 4|Adverse Event|0
5458750|NCT02059291|18867011|P13|Epoch 4|Adverse Event|0
5458751|NCT02059291|18867012|P12|Epoch 4|Adverse Event|0
5458752|NCT02059291|18867013|P11|Epoch 4|Adverse Event|0
5458753|NCT02059291|18867014|P10|Epoch 4|Adverse Event|0
5458754|NCT02059291|18867015|P9|Epoch 4|Adverse Event|0
5458755|NCT02059291|18867016|P8|Epoch 4|Adverse Event|0
5458756|NCT02059291|18867017|P7|Epoch 4|Adverse Event|0
5458757|NCT02059291|18867018|P6|Epoch 4|Adverse Event|0
5458758|NCT02059291|18867019|P5|Epoch 4|Adverse Event|0
5458759|NCT02059291|18867020|P4|Epoch 4|Adverse Event|0
5458760|NCT02059291|18867021|P3|Epoch 4|Adverse Event|0
5458761|NCT02059291|18867022|P2|Epoch 4|Adverse Event|0
5458762|NCT02059291|18867023|P1|Epoch 4|Adverse Event|0
5458763|NCT02059291|18866999|P25|Epoch 3|Withdrawal by Subject|0
5458764|NCT02059291|18867000|P24|Epoch 3|Withdrawal by Subject|0
5458765|NCT02059291|18867001|P23|Epoch 3|Withdrawal by Subject|0
5458766|NCT02059291|18867002|P22|Epoch 3|Withdrawal by Subject|0
5458767|NCT02059291|18867003|P21|Epoch 3|Withdrawal by Subject|0
5458768|NCT02059291|18867004|P20|Epoch 3|Withdrawal by Subject|0
5458769|NCT02059291|18867005|P19|Epoch 3|Withdrawal by Subject|0
5458770|NCT02059291|18867006|P18|Epoch 3|Withdrawal by Subject|0
5458771|NCT02059291|18867007|P17|Epoch 3|Withdrawal by Subject|0
5458772|NCT02059291|18867008|P16|Epoch 3|Withdrawal by Subject|1
5458773|NCT02059291|18867009|P15|Epoch 3|Withdrawal by Subject|0
5458774|NCT02059291|18867010|P14|Epoch 3|Withdrawal by Subject|0
5458775|NCT02059291|18867011|P13|Epoch 3|Withdrawal by Subject|0
5458776|NCT02059291|18867012|P12|Epoch 3|Withdrawal by Subject|0
5458777|NCT02059291|18867013|P11|Epoch 3|Withdrawal by Subject|0
5458778|NCT02059291|18867014|P10|Epoch 3|Withdrawal by Subject|0
5458779|NCT02059291|18867015|P9|Epoch 3|Withdrawal by Subject|0
5458780|NCT02059291|18867016|P8|Epoch 3|Withdrawal by Subject|0
5458781|NCT02059291|18867017|P7|Epoch 3|Withdrawal by Subject|0
5458782|NCT02059291|18867018|P6|Epoch 3|Withdrawal by Subject|0
5458783|NCT02059291|18867019|P5|Epoch 3|Withdrawal by Subject|0
5458784|NCT02059291|18867020|P4|Epoch 3|Withdrawal by Subject|0
5458785|NCT02059291|18867021|P3|Epoch 3|Withdrawal by Subject|0
5458786|NCT02059291|18867022|P2|Epoch 3|Withdrawal by Subject|0
5458787|NCT02059291|18867023|P1|Epoch 3|Withdrawal by Subject|0
5458788|NCT02059291|18866999|P25|Epoch 3|Lack of Efficacy|0
5458789|NCT02059291|18867000|P24|Epoch 3|Lack of Efficacy|0
5458790|NCT02059291|18867001|P23|Epoch 3|Lack of Efficacy|0
5458791|NCT02059291|18867002|P22|Epoch 3|Lack of Efficacy|0
5458792|NCT02059291|18867003|P21|Epoch 3|Lack of Efficacy|0
5458793|NCT02059291|18867004|P20|Epoch 3|Lack of Efficacy|0
5458794|NCT02059291|18867005|P19|Epoch 3|Lack of Efficacy|0
5458795|NCT02059291|18867006|P18|Epoch 3|Lack of Efficacy|0
5458796|NCT02059291|18867007|P17|Epoch 3|Lack of Efficacy|0
5458797|NCT02059291|18867008|P16|Epoch 3|Lack of Efficacy|3
5458798|NCT02059291|18867009|P15|Epoch 3|Lack of Efficacy|0
5458799|NCT02059291|18867010|P14|Epoch 3|Lack of Efficacy|0
5458800|NCT02059291|18867011|P13|Epoch 3|Lack of Efficacy|0
5458801|NCT02059291|18867012|P12|Epoch 3|Lack of Efficacy|0
5458802|NCT02059291|18867013|P11|Epoch 3|Lack of Efficacy|0
5458803|NCT02059291|18867014|P10|Epoch 3|Lack of Efficacy|0
5458804|NCT02059291|18867015|P9|Epoch 3|Lack of Efficacy|0
5458805|NCT02059291|18867016|P8|Epoch 3|Lack of Efficacy|0
5458806|NCT02059291|18867017|P7|Epoch 3|Lack of Efficacy|0
5458807|NCT02059291|18867018|P6|Epoch 3|Lack of Efficacy|0
5458808|NCT02059291|18867019|P5|Epoch 3|Lack of Efficacy|0
5458809|NCT02059291|18867020|P4|Epoch 3|Lack of Efficacy|0
5458810|NCT02059291|18867021|P3|Epoch 3|Lack of Efficacy|0
5458811|NCT02059291|18867022|P2|Epoch 3|Lack of Efficacy|0
5458812|NCT02059291|18867023|P1|Epoch 3|Lack of Efficacy|0
5458813|NCT02059291|18866999|P25|Epoch 3|Adverse Event|0
5458814|NCT02059291|18867000|P24|Epoch 3|Adverse Event|0
5458815|NCT02059291|18867001|P23|Epoch 3|Adverse Event|0
5458816|NCT02059291|18867002|P22|Epoch 3|Adverse Event|0
5458817|NCT02059291|18867003|P21|Epoch 3|Adverse Event|0
5458818|NCT02059291|18867004|P20|Epoch 3|Adverse Event|0
5458819|NCT02059291|18867005|P19|Epoch 3|Adverse Event|0
5458820|NCT02059291|18867006|P18|Epoch 3|Adverse Event|0
5458821|NCT02059291|18867007|P17|Epoch 3|Adverse Event|0
5458822|NCT02059291|18867008|P16|Epoch 3|Adverse Event|1
5458823|NCT02059291|18867009|P15|Epoch 3|Adverse Event|0
5458824|NCT02059291|18867010|P14|Epoch 3|Adverse Event|0
5458825|NCT02059291|18867011|P13|Epoch 3|Adverse Event|0
5458826|NCT02059291|18867012|P12|Epoch 3|Adverse Event|0
5458827|NCT02059291|18867013|P11|Epoch 3|Adverse Event|0
5458828|NCT02059291|18867014|P10|Epoch 3|Adverse Event|0
5458829|NCT02059291|18867015|P9|Epoch 3|Adverse Event|0
5458830|NCT02059291|18867016|P8|Epoch 3|Adverse Event|0
5458831|NCT02059291|18867017|P7|Epoch 3|Adverse Event|0
5458832|NCT02059291|18867018|P6|Epoch 3|Adverse Event|0
5458833|NCT02059291|18867019|P5|Epoch 3|Adverse Event|0
5458834|NCT02059291|18867020|P4|Epoch 3|Adverse Event|0
5458835|NCT02059291|18867021|P3|Epoch 3|Adverse Event|0
5458836|NCT02059291|18867022|P2|Epoch 3|Adverse Event|0
5458837|NCT02059291|18867023|P1|Epoch 3|Adverse Event|0
5458838|NCT02059291|18866999|P25|Epoch 3|Physician Decision|0
5458839|NCT02059291|18867000|P24|Epoch 3|Physician Decision|0
5458840|NCT02059291|18867001|P23|Epoch 3|Physician Decision|0
5458841|NCT02059291|18867002|P22|Epoch 3|Physician Decision|0
5458842|NCT02059291|18867003|P21|Epoch 3|Physician Decision|0
5458843|NCT02059291|18867004|P20|Epoch 3|Physician Decision|0
5458844|NCT02059291|18867005|P19|Epoch 3|Physician Decision|0
5458845|NCT02059291|18867006|P18|Epoch 3|Physician Decision|0
5458846|NCT02059291|18867007|P17|Epoch 3|Physician Decision|0
5458847|NCT02059291|18867008|P16|Epoch 3|Physician Decision|1
5458848|NCT02059291|18867009|P15|Epoch 3|Physician Decision|0
5458849|NCT02059291|18867010|P14|Epoch 3|Physician Decision|1
5458850|NCT02059291|18867011|P13|Epoch 3|Physician Decision|0
5458851|NCT02059291|18867012|P12|Epoch 3|Physician Decision|0
5458852|NCT02059291|18867013|P11|Epoch 3|Physician Decision|0
5458853|NCT02059291|18867014|P10|Epoch 3|Physician Decision|0
5458854|NCT02059291|18867015|P9|Epoch 3|Physician Decision|0
5458855|NCT02059291|18867016|P8|Epoch 3|Physician Decision|0
5458856|NCT02059291|18867017|P7|Epoch 3|Physician Decision|0
5458857|NCT02059291|18867018|P6|Epoch 3|Physician Decision|0
5458858|NCT02059291|18867019|P5|Epoch 3|Physician Decision|0
5458859|NCT02059291|18867020|P4|Epoch 3|Physician Decision|0
5458860|NCT02059291|18867021|P3|Epoch 3|Physician Decision|0
5458861|NCT02059291|18867022|P2|Epoch 3|Physician Decision|0
5458862|NCT02059291|18867023|P1|Epoch 3|Physician Decision|0
5458863|NCT02059291|18866999|P25|Epoch 2|Withdrawal by Subject|0
5458864|NCT02059291|18867000|P24|Epoch 2|Withdrawal by Subject|0
5458865|NCT02059291|18867001|P23|Epoch 2|Withdrawal by Subject|0
5458866|NCT02059291|18867002|P22|Epoch 2|Withdrawal by Subject|0
5458867|NCT02059291|18867003|P21|Epoch 2|Withdrawal by Subject|0
5458868|NCT02059291|18867004|P20|Epoch 2|Withdrawal by Subject|0
5458869|NCT02059291|18867005|P19|Epoch 2|Withdrawal by Subject|0
5458870|NCT02059291|18867006|P18|Epoch 2|Withdrawal by Subject|0
5458871|NCT02059291|18867007|P17|Epoch 2|Withdrawal by Subject|0
5458872|NCT02059291|18867008|P16|Epoch 2|Withdrawal by Subject|0
5458873|NCT02059291|18867009|P15|Epoch 2|Withdrawal by Subject|0
5458874|NCT02059291|18867010|P14|Epoch 2|Withdrawal by Subject|0
5458875|NCT02059291|18867011|P13|Epoch 2|Withdrawal by Subject|0
5458876|NCT02059291|18867012|P12|Epoch 2|Withdrawal by Subject|0
5458877|NCT02059291|18867013|P11|Epoch 2|Withdrawal by Subject|0
5458878|NCT02059291|18867014|P10|Epoch 2|Withdrawal by Subject|0
5458879|NCT02059291|18867015|P9|Epoch 2|Withdrawal by Subject|1
5458880|NCT02059291|18867016|P8|Epoch 2|Withdrawal by Subject|0
5458881|NCT02059291|18867017|P7|Epoch 2|Withdrawal by Subject|0
5458882|NCT02059291|18867018|P6|Epoch 2|Withdrawal by Subject|1
5458883|NCT02059291|18867019|P5|Epoch 2|Withdrawal by Subject|0
5458884|NCT02059291|18867020|P4|Epoch 2|Withdrawal by Subject|0
5458885|NCT02059291|18867021|P3|Epoch 2|Withdrawal by Subject|0
5458886|NCT02059291|18867022|P2|Epoch 2|Withdrawal by Subject|1
5458887|NCT02059291|18867023|P1|Epoch 2|Withdrawal by Subject|0
5458888|NCT02059291|18866999|P25|Epoch 2|Adverse Event|0
5458889|NCT02059291|18867000|P24|Epoch 2|Adverse Event|0
5458890|NCT02059291|18867001|P23|Epoch 2|Adverse Event|0
5458891|NCT02059291|18867002|P22|Epoch 2|Adverse Event|0
5458892|NCT02059291|18867003|P21|Epoch 2|Adverse Event|0
5458893|NCT02059291|18867004|P20|Epoch 2|Adverse Event|0
5458894|NCT02059291|18867005|P19|Epoch 2|Adverse Event|0
5458895|NCT02059291|18867006|P18|Epoch 2|Adverse Event|0
5458896|NCT02059291|18867007|P17|Epoch 2|Adverse Event|0
5458897|NCT02059291|18867008|P16|Epoch 2|Adverse Event|0
5458898|NCT02059291|18867009|P15|Epoch 2|Adverse Event|0
5458899|NCT02059291|18867010|P14|Epoch 2|Adverse Event|0
5458900|NCT02059291|18867011|P13|Epoch 2|Adverse Event|0
5458901|NCT02059291|18867012|P12|Epoch 2|Adverse Event|0
5458902|NCT02059291|18867013|P11|Epoch 2|Adverse Event|0
5458903|NCT02059291|18867014|P10|Epoch 2|Adverse Event|0
5458904|NCT02059291|18867015|P9|Epoch 2|Adverse Event|1
5458905|NCT02059291|18867016|P8|Epoch 2|Adverse Event|1
5458906|NCT02059291|18867017|P7|Epoch 2|Adverse Event|0
5458907|NCT02059291|18867018|P6|Epoch 2|Adverse Event|0
5458908|NCT02059291|18867019|P5|Epoch 2|Adverse Event|0
5458909|NCT02059291|18867020|P4|Epoch 2|Adverse Event|1
5458910|NCT02059291|18867021|P3|Epoch 2|Adverse Event|1
5458911|NCT02059291|18867022|P2|Epoch 2|Adverse Event|0
5458912|NCT02059291|18867023|P1|Epoch 2|Adverse Event|0
5458913|NCT02059291|18866999|P25|Epoch 2|Lack of Efficacy|0
5458914|NCT02059291|18867000|P24|Epoch 2|Lack of Efficacy|0
5458915|NCT02059291|18867001|P23|Epoch 2|Lack of Efficacy|0
5458916|NCT02059291|18867002|P22|Epoch 2|Lack of Efficacy|0
5458917|NCT02059291|18867003|P21|Epoch 2|Lack of Efficacy|0
5458918|NCT02059291|18867004|P20|Epoch 2|Lack of Efficacy|0
5458919|NCT02059291|18867005|P19|Epoch 2|Lack of Efficacy|0
5458920|NCT02059291|18867006|P18|Epoch 2|Lack of Efficacy|0
5458921|NCT02059291|18867007|P17|Epoch 2|Lack of Efficacy|0
5458922|NCT02059291|18867008|P16|Epoch 2|Lack of Efficacy|0
5458923|NCT02059291|18867009|P15|Epoch 2|Lack of Efficacy|0
5458924|NCT02059291|18867010|P14|Epoch 2|Lack of Efficacy|0
5458925|NCT02059291|18867011|P13|Epoch 2|Lack of Efficacy|0
5458926|NCT02059291|18867012|P12|Epoch 2|Lack of Efficacy|0
5458927|NCT02059291|18867013|P11|Epoch 2|Lack of Efficacy|0
5458928|NCT02059291|18867014|P10|Epoch 2|Lack of Efficacy|0
5458929|NCT02059291|18867015|P9|Epoch 2|Lack of Efficacy|0
5458930|NCT02059291|18867016|P8|Epoch 2|Lack of Efficacy|0
5458931|NCT02059291|18867017|P7|Epoch 2|Lack of Efficacy|0
5458932|NCT02059291|18867018|P6|Epoch 2|Lack of Efficacy|1
5458933|NCT02059291|18867019|P5|Epoch 2|Lack of Efficacy|0
5458934|NCT02059291|18867020|P4|Epoch 2|Lack of Efficacy|1
5458935|NCT02059291|18867021|P3|Epoch 2|Lack of Efficacy|0
5458936|NCT02059291|18867022|P2|Epoch 2|Lack of Efficacy|0
5458937|NCT02059291|18867023|P1|Epoch 2|Lack of Efficacy|0
5458938|NCT02059278|18867077|P2|Overall Study|Ran out of IP and decided to discontinue|0
5458939|NCT02059278|18867078|P1|Overall Study|Ran out of IP and decided to discontinue|1
5458940|NCT02059278|18867077|P2|Overall Study|Withdrawal by Subject|3
5458941|NCT02059278|18867078|P1|Overall Study|Withdrawal by Subject|0
5458942|NCT02059278|18867077|P2|Overall Study|Lost to Follow-up|0
5458943|NCT02059278|18867078|P1|Overall Study|Lost to Follow-up|1
5458944|NCT02059278|18867077|P2|Overall Study|Adverse Event|1
5458945|NCT02059278|18867078|P1|Overall Study|Adverse Event|1
5458946|NCT02059265|18867092|P1|Overall Study|Ineligible|4
5458947|NCT02059187|18867124|P2|Overall Study|Withdrawal by Subject|8
5458948|NCT02059187|18867125|P1|Overall Study|Withdrawal by Subject|12
5458949|NCT02059187|18867124|P2|Overall Study|Protocol Violation|0
5458950|NCT02059187|18867125|P1|Overall Study|Protocol Violation|1
5458951|NCT02059187|18867124|P2|Overall Study|Physician Decision|2
5458952|NCT02059187|18867125|P1|Overall Study|Physician Decision|1
5458953|NCT02059187|18867124|P2|Overall Study|Non-compliance with study drug|0
5458954|NCT02059187|18867125|P1|Overall Study|Non-compliance with study drug|1
5458955|NCT02059187|18867124|P2|Overall Study|Lost to Follow-up|8
5458956|NCT02059187|18867125|P1|Overall Study|Lost to Follow-up|9
5458957|NCT02059187|18867124|P2|Overall Study|Death|1
5458958|NCT02059187|18867125|P1|Overall Study|Death|1
5458959|NCT02059187|18867124|P2|Overall Study|Adverse Event|3
5458960|NCT02059187|18867125|P1|Overall Study|Adverse Event|0
5458961|NCT02059174|18867151|P2|Period 3|Physician Decision|0
5458962|NCT02059174|18867152|P1|Period 3|Physician Decision|1
5458963|NCT02059174|18867151|P2|Period 2|Protocol Violation|0
5458964|NCT02059174|18867152|P1|Period 2|Protocol Violation|1
5458965|NCT02059174|18867151|P2|Period 2|Withdrawal by Subject|2
5458966|NCT02059174|18867152|P1|Period 2|Withdrawal by Subject|0
5458967|NCT02059174|18867151|P2|Period 1|Withdrawal by Subject|2
5458968|NCT02059174|18867152|P1|Period 1|Withdrawal by Subject|0
5458969|NCT02059161|18867176|P2|Overall Study|Non-compliance with study drug|2
5458970|NCT02059161|18867177|P1|Overall Study|Non-compliance with study drug|6
5458971|NCT02059161|18867176|P2|Overall Study|Randomized in error, no study drug|1
5458972|NCT02059161|18867177|P1|Overall Study|Randomized in error, no study drug|0
5458973|NCT02059161|18867176|P2|Overall Study|Withdrawal by Subject|13
5458974|NCT02059161|18867177|P1|Overall Study|Withdrawal by Subject|16
5458975|NCT02059161|18867176|P2|Overall Study|Protocol Violation|1
5458976|NCT02059161|18867177|P1|Overall Study|Protocol Violation|1
5458977|NCT02059161|18867176|P2|Overall Study|Physician Decision|4
5458978|NCT02059161|18867177|P1|Overall Study|Physician Decision|4
5458979|NCT02059161|18867176|P2|Overall Study|Lost to Follow-up|12
5458980|NCT02059161|18867177|P1|Overall Study|Lost to Follow-up|20
5458981|NCT02059161|18867176|P2|Overall Study|Adverse Event|6
5458982|NCT02059161|18867177|P1|Overall Study|Adverse Event|2
5458983|NCT02059161|18867176|P2|Overall Study|Pregnancy|2
5458984|NCT02059161|18867177|P1|Overall Study|Pregnancy|0
5458985|NCT02059148|18867237|P6|Treatment 1|Protocol Violation|1
5458986|NCT02059148|18867238|P5|Treatment 1|Protocol Violation|0
5458987|NCT02059148|18867239|P4|Treatment 1|Protocol Violation|0
5458988|NCT02059148|18867240|P3|Treatment 1|Protocol Violation|0
5458989|NCT02059148|18867241|P2|Treatment 1|Protocol Violation|0
5458990|NCT02059148|18867242|P1|Treatment 1|Protocol Violation|0
5458991|NCT02059135|18867261|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
5458992|NCT02059135|18867262|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
5458993|NCT02059135|18867261|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
5458994|NCT02059135|18867262|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
5458995|NCT02059135|18867261|P2|Neonatal Follow-up (Safety Population)|Death|2
5458996|NCT02059135|18867262|P1|Neonatal Follow-up (Safety Population)|Death|3
5458997|NCT02059135|18867261|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
5458998|NCT02059135|18867262|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
5458999|NCT02059135|18867261|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
5459000|NCT02059135|18867262|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
5459001|NCT02059135|18867261|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
5459002|NCT02059135|18867262|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
5459003|NCT02059135|18867261|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
5459004|NCT02059135|18867262|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
5459005|NCT02059135|18867261|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
5459006|NCT02059135|18867262|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
5459007|NCT02059005|18867298|P2|Overall Study|Inpatient|1
5459008|NCT02059005|18867299|P1|Overall Study|Inpatient|0
5459009|NCT02059005|18867298|P2|Overall Study|Incarceration|1
5459010|NCT02059005|18867299|P1|Overall Study|Incarceration|0
5459011|NCT02059005|18867298|P2|Overall Study|Lost to Follow-up|19
5459012|NCT02059005|18867299|P1|Overall Study|Lost to Follow-up|19
5459013|NCT02059005|18867298|P2|Overall Study|Death|3
5459014|NCT02059005|18867299|P1|Overall Study|Death|1
5459015|NCT02058992|18867309|P1|Overall Study|CRF Uncollected|20
5459016|NCT02058992|18867309|P1|Overall Study|Protocol Violation|92
5459017|NCT02058992|18867309|P1|Overall Study|Lost to Follow-up|4
5459018|NCT02058966|18867318|P1|First Intervention|Withdrawal by Subject|1
5459019|NCT02058966|18867318|P1|Open-Label Methamphetamine|Adverse Event|1
5459020|NCT02058940|18867345|P1|Overall Study|Discharged from Critical Care Unit|1
5459021|NCT02058849|18867369|P2|Overall Study|Withdrawal by Subject|0
5459022|NCT02058849|18867370|P1|Overall Study|Withdrawal by Subject|4
5459023|NCT02058849|18867369|P2|Overall Study|Lost to Follow-up|0
5459024|NCT02058849|18867370|P1|Overall Study|Lost to Follow-up|1
5459025|NCT02058849|18867369|P2|Overall Study|Death|0
5459026|NCT02058849|18867370|P1|Overall Study|Death|1
5459027|NCT02058849|18867369|P2|Overall Study|Hospitalization|1
5459028|NCT02058849|18867370|P1|Overall Study|Hospitalization|1
5459029|NCT02058836|18867398|P2|Overall Study|Withdrawal by Subject|1
5459030|NCT02058836|18867399|P1|Overall Study|Withdrawal by Subject|1
5459031|NCT02058628|18867429|P2|Overall Study|Non compliance|0
5459032|NCT02058628|18867430|P1|Overall Study|Non compliance|1
5459033|NCT02058628|18867429|P2|Overall Study|A lot of time for study for participant|0
5459034|NCT02058628|18867430|P1|Overall Study|A lot of time for study for participant|1
5459035|NCT02058628|18867429|P2|Overall Study|The visit date was not in timeline|1
5459036|NCT02058628|18867430|P1|Overall Study|The visit date was not in timeline|0
5459037|NCT02058628|18867429|P2|Overall Study|Not in time schedule|1
5459038|NCT02058628|18867430|P1|Overall Study|Not in time schedule|0
5459039|NCT02058628|18867429|P2|Overall Study|Lost to Follow-up|4
5459040|NCT02058628|18867430|P1|Overall Study|Lost to Follow-up|2
5459041|NCT02058628|18867429|P2|Overall Study|Withdrawal by Subject|2
5459042|NCT02058628|18867430|P1|Overall Study|Withdrawal by Subject|2
5459043|NCT02058628|18867429|P2|Overall Study|Adverse Event|0
5459044|NCT02058628|18867430|P1|Overall Study|Adverse Event|1
5459045|NCT02058589|18867462|P2|Overall Study|Withdrawal by Subject|1
5459046|NCT02058589|18867463|P1|Overall Study|Withdrawal by Subject|0
5459047|NCT02058589|18867462|P2|Overall Study|Non-Serious Adverse Event|0
5459048|NCT02058589|18867463|P1|Overall Study|Non-Serious Adverse Event|1
5459049|NCT02058589|18867462|P2|Overall Study|Serious Adverse Event|1
5459050|NCT02058589|18867463|P1|Overall Study|Serious Adverse Event|1
5459051|NCT02058563|18867505|P2|Overall Study|Other (patient incarcerated)|1
5459052|NCT02058563|18867506|P1|Overall Study|Other (patient incarcerated)|0
5459053|NCT02058563|18867505|P2|Overall Study|Consent Withdrawal|1
5459054|NCT02058563|18867506|P1|Overall Study|Consent Withdrawal|1
5459055|NCT02058563|18867505|P2|Overall Study|Other (vaccinated later as new subject)|0
5459056|NCT02058563|18867506|P1|Overall Study|Other (vaccinated later as new subject)|1
5459057|NCT02058563|18867505|P2|Overall Study|Lost to Follow-up|22
5459058|NCT02058563|18867506|P1|Overall Study|Lost to Follow-up|26
5459059|NCT02058537|18867542|P1|Overall Study|Withdrawal by Subject|1
5459060|NCT02058498|18867553|P1|Overall Study|Withdrawal by Subject|4
5459061|NCT02058368|18867561|P2|Overall Study|Withdrawal by Subject|26
5459062|NCT02058368|18867562|P1|Overall Study|Withdrawal by Subject|22
5459063|NCT02058368|18867561|P2|Overall Study|Physician Decision|3
5459064|NCT02058368|18867562|P1|Overall Study|Physician Decision|2
5459065|NCT02058368|18867561|P2|Overall Study|Lost to Follow-up|0
5459066|NCT02058368|18867562|P1|Overall Study|Lost to Follow-up|2
5459067|NCT02058368|18867561|P2|Overall Study|Protocol Violation|4
5459068|NCT02058368|18867562|P1|Overall Study|Protocol Violation|0
5459069|NCT02058368|18867561|P2|Overall Study|Lack of Efficacy|1
5459070|NCT02058368|18867562|P1|Overall Study|Lack of Efficacy|0
5459071|NCT02058368|18867561|P2|Overall Study|Adverse Event|20
5459072|NCT02058368|18867562|P1|Overall Study|Adverse Event|15
5459073|NCT02058290|18867614|P2|Overall Study|Withdrawal by Subject|1
5459074|NCT02058290|18867615|P1|Overall Study|Withdrawal by Subject|0
5459075|NCT02058290|18867614|P2|Overall Study|Didn't meet intraoperative criteria|7
5459076|NCT02058290|18867615|P1|Overall Study|Didn't meet intraoperative criteria|8
5459077|NCT02058290|18867614|P2|Overall Study|Physician Decision|0
5459078|NCT02058290|18867615|P1|Overall Study|Physician Decision|1
5459079|NCT02058290|18867614|P2|Overall Study|Protocol Violation|1
5459080|NCT02058290|18867615|P1|Overall Study|Protocol Violation|2
5459081|NCT02058160|18867642|P2|Overall Study|Other than specified above|6
5459082|NCT02058160|18867643|P1|Overall Study|Other than specified above|12
5459083|NCT02058160|18867642|P2|Overall Study|Lost to Follow-up|0
5459084|NCT02058160|18867643|P1|Overall Study|Lost to Follow-up|1
5459085|NCT02058160|18867642|P2|Overall Study|Adverse Event|3
5459086|NCT02058160|18867643|P1|Overall Study|Adverse Event|12
5459087|NCT02058160|18867642|P2|Overall Study|Poor compliance to protocol|1
5459088|NCT02058160|18867643|P1|Overall Study|Poor compliance to protocol|4
5459089|NCT02058160|18867642|P2|Overall Study|Randomized but not treated|4
5459090|NCT02058160|18867643|P1|Overall Study|Randomized but not treated|2
5459091|NCT02058147|18867680|P3|Overall Study|Other than specified|0
5459092|NCT02058147|18867681|P2|Overall Study|Other than specified|9
5459093|NCT02058147|18867682|P1|Overall Study|Other than specified|8
5459094|NCT02058147|18867680|P3|Overall Study|Poor compliance to protocol|4
5459095|NCT02058147|18867681|P2|Overall Study|Poor compliance to protocol|9
5459096|NCT02058147|18867682|P1|Overall Study|Poor compliance to protocol|8
5459097|NCT02058147|18867680|P3|Overall Study|Lack of Efficacy|3
5459098|NCT02058147|18867681|P2|Overall Study|Lack of Efficacy|0
5459099|NCT02058147|18867682|P1|Overall Study|Lack of Efficacy|1
5459100|NCT02058147|18867680|P3|Overall Study|Adverse Event|21
5459101|NCT02058147|18867681|P2|Overall Study|Adverse Event|9
5459102|NCT02058147|18867682|P1|Overall Study|Adverse Event|12
5459103|NCT02058147|18867680|P3|Overall Study|Randomized but not treated|1
5459104|NCT02058147|18867681|P2|Overall Study|Randomized but not treated|0
5459105|NCT02058147|18867682|P1|Overall Study|Randomized but not treated|0
5459106|NCT02058108|18867733|P2|Overall Study|Protocol Violation|1
5459107|NCT02058108|18867734|P1|Overall Study|Protocol Violation|0
5459108|NCT02058108|18867733|P2|Overall Study|Administrative problems|3
5459109|NCT02058108|18867734|P1|Overall Study|Administrative problems|3
5459110|NCT02058108|18867733|P2|Overall Study|Withdrawal by Subject|0
5459111|NCT02058108|18867734|P1|Overall Study|Withdrawal by Subject|1
5459112|NCT02058108|18867733|P2|Overall Study|No longer requires study drug|1
5459113|NCT02058108|18867734|P1|Overall Study|No longer requires study drug|0
5459114|NCT02058108|18867733|P2|Overall Study|Unsatisfactory therapeutic effect|4
5459115|NCT02058108|18867734|P1|Overall Study|Unsatisfactory therapeutic effect|37
5459116|NCT02058108|18867733|P2|Overall Study|Abnormal Laboratory Values|1
5459117|NCT02058108|18867734|P1|Overall Study|Abnormal Laboratory Values|0
5459118|NCT02058095|18867760|P2|Overall Study|Adverse Event|0
5459119|NCT02058095|18867761|P1|Overall Study|Adverse Event|1
5459120|NCT02058069|18867771|P1|Overall Study|Withdrawal by Subject|6
5459121|NCT02058069|18867771|P1|Overall Study|Exclusion due to implant size|5
5459122|NCT02057874|18867830|P1|Overall Study|participant did not return for scan|1
5459123|NCT02057835|18867848|P10|Overall Study|Withdrawal by Subject|0
5459124|NCT02057835|18867849|P9|Overall Study|Withdrawal by Subject|0
5459125|NCT02057835|18867850|P8|Overall Study|Withdrawal by Subject|0
5459126|NCT02057835|18867851|P7|Overall Study|Withdrawal by Subject|0
5459127|NCT02057835|18867852|P6|Overall Study|Withdrawal by Subject|0
5459128|NCT02057835|18867853|P5|Overall Study|Withdrawal by Subject|0
5459129|NCT02057835|18867854|P4|Overall Study|Withdrawal by Subject|0
5459130|NCT02057835|18867855|P3|Overall Study|Withdrawal by Subject|0
5459131|NCT02057835|18867856|P2|Overall Study|Withdrawal by Subject|2
5459132|NCT02057835|18867857|P1|Overall Study|Withdrawal by Subject|0
5459133|NCT02057757|18867936|P2|Overall Study|Non-compliance|0
5459134|NCT02057757|18867937|P1|Overall Study|Non-compliance|1
5459135|NCT02057757|18867936|P2|Overall Study|Lost to Follow-up|3
5459136|NCT02057757|18867937|P1|Overall Study|Lost to Follow-up|8
5459137|NCT02057757|18867936|P2|Overall Study|Death|0
5459138|NCT02057757|18867937|P1|Overall Study|Death|2
5459139|NCT02057757|18867936|P2|Overall Study|Withdrawal by Subject|5
5459140|NCT02057757|18867937|P1|Overall Study|Withdrawal by Subject|3
5459141|NCT02057692|18867991|P4|Overall Study|Lost to Follow-up|1
5459142|NCT02057692|18867992|P3|Overall Study|Lost to Follow-up|0
5459143|NCT02057692|18867993|P2|Overall Study|Lost to Follow-up|0
5459144|NCT02057692|18867994|P1|Overall Study|Lost to Follow-up|0
5459145|NCT02057692|18867991|P4|Overall Study|Adverse Event|0
5459146|NCT02057692|18867992|P3|Overall Study|Adverse Event|0
5459147|NCT02057692|18867993|P2|Overall Study|Adverse Event|0
5459148|NCT02057692|18867994|P1|Overall Study|Adverse Event|1
5459149|NCT02057575|18868040|P4|Overall Study|Protocol Violation|0
5459150|NCT02057575|18868041|P3|Overall Study|Protocol Violation|0
5459151|NCT02057575|18868042|P2|Overall Study|Protocol Violation|1
5459152|NCT02057575|18868043|P1|Overall Study|Protocol Violation|0
5459153|NCT02057575|18868040|P4|Overall Study|Dissallowed Concurrent Medication|0
5459154|NCT02057575|18868041|P3|Overall Study|Dissallowed Concurrent Medication|0
5459155|NCT02057575|18868042|P2|Overall Study|Dissallowed Concurrent Medication|1
5459156|NCT02057575|18868043|P1|Overall Study|Dissallowed Concurrent Medication|0
5459157|NCT02057575|18868040|P4|Overall Study|Withdrawal by Subject|0
5459158|NCT02057575|18868041|P3|Overall Study|Withdrawal by Subject|0
5459159|NCT02057575|18868042|P2|Overall Study|Withdrawal by Subject|0
5459160|NCT02057575|18868043|P1|Overall Study|Withdrawal by Subject|1
5459161|NCT02057575|18868040|P4|Overall Study|Adverse Event|1
5459162|NCT02057575|18868041|P3|Overall Study|Adverse Event|0
5459163|NCT02057575|18868042|P2|Overall Study|Adverse Event|2
5459164|NCT02057575|18868043|P1|Overall Study|Adverse Event|0
5459165|NCT02057549|18868055|P2|Overall Study|Withdrawal by Subject|0
5459166|NCT02057549|18868056|P1|Overall Study|Withdrawal by Subject|1
5459167|NCT02057549|18868055|P2|Overall Study|Physician Decision|0
5459168|NCT02057549|18868056|P1|Overall Study|Physician Decision|1
5459169|NCT02057549|18868055|P2|Overall Study|Lost to Follow-up|0
5459170|NCT02057549|18868056|P1|Overall Study|Lost to Follow-up|1
5459171|NCT02057523|18868076|P1|Overall Study|Lack of Efficacy|1
5459172|NCT02057523|18868076|P1|Overall Study|Withdrawal by Subject|1
5459173|NCT02057458|18868081|P3|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
5459174|NCT02057458|18868082|P2|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
5459175|NCT02057458|18868083|P1|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
5459176|NCT02057458|18868081|P3|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
5459177|NCT02057458|18868082|P2|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
5459178|NCT02057458|18868083|P1|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
5459179|NCT02057458|18868081|P3|Met Inclusion Criteria|Prior history of migraine headaches|0
5459180|NCT02057458|18868082|P2|Met Inclusion Criteria|Prior history of migraine headaches|1
5459181|NCT02057458|18868083|P1|Met Inclusion Criteria|Prior history of migraine headaches|0
5459182|NCT02057406|18868121|P3|Overall Study|Patient transportation issues|1
5459183|NCT02057406|18868122|P2|Overall Study|Patient transportation issues|0
5459184|NCT02057406|18868123|P1|Overall Study|Patient transportation issues|0
5459185|NCT02057406|18868121|P3|Overall Study|Protocol Violation|0
5459186|NCT02057406|18868122|P2|Overall Study|Protocol Violation|1
5459187|NCT02057406|18868123|P1|Overall Study|Protocol Violation|0
5459188|NCT02057406|18868121|P3|Overall Study|Death|0
5459189|NCT02057406|18868122|P2|Overall Study|Death|0
5459190|NCT02057406|18868123|P1|Overall Study|Death|1
5459191|NCT02057406|18868121|P3|Overall Study|Lost to Follow-up|1
5459192|NCT02057406|18868122|P2|Overall Study|Lost to Follow-up|0
5459193|NCT02057406|18868123|P1|Overall Study|Lost to Follow-up|0
5459194|NCT02057406|18868121|P3|Overall Study|Withdrawal by Subject|0
5459195|NCT02057406|18868122|P2|Overall Study|Withdrawal by Subject|2
5459196|NCT02057406|18868123|P1|Overall Study|Withdrawal by Subject|0
5459197|NCT02057406|18868121|P3|Overall Study|Physician Decision|2
5459198|NCT02057406|18868122|P2|Overall Study|Physician Decision|0
5459199|NCT02057406|18868123|P1|Overall Study|Physician Decision|0
5459200|NCT02057393|18868134|P1|Overall Study|Patient did not meet criteria|1
5459201|NCT02057393|18868134|P1|Overall Study|Withdrawal by Subject|1
5459202|NCT02057250|18868155|P5|Extension Phase|Other than specified above|7
5459203|NCT02057250|18868156|P4|Extension Phase|Other than specified above|0
5459204|NCT02057250|18868157|P3|Extension Phase|Other than specified above|0
5459205|NCT02057250|18868158|P2|Extension Phase|Other than specified above|0
5459206|NCT02057250|18868159|P1|Extension Phase|Other than specified above|0
5459207|NCT02057250|18868155|P5|Extension Phase|Entered in this period but not treated|4
5459208|NCT02057250|18868156|P4|Extension Phase|Entered in this period but not treated|0
5459209|NCT02057250|18868157|P3|Extension Phase|Entered in this period but not treated|0
5459210|NCT02057250|18868158|P2|Extension Phase|Entered in this period but not treated|0
5459211|NCT02057250|18868159|P1|Extension Phase|Entered in this period but not treated|0
5459212|NCT02057250|18868155|P5|Extension Phase|Lack of Efficacy|10
5459213|NCT02057250|18868156|P4|Extension Phase|Lack of Efficacy|0
5459214|NCT02057250|18868157|P3|Extension Phase|Lack of Efficacy|0
5459215|NCT02057250|18868158|P2|Extension Phase|Lack of Efficacy|0
5459216|NCT02057250|18868159|P1|Extension Phase|Lack of Efficacy|0
5459217|NCT02057250|18868155|P5|Extension Phase|Adverse Event|15
5459218|NCT02057250|18868156|P4|Extension Phase|Adverse Event|0
5459219|NCT02057250|18868157|P3|Extension Phase|Adverse Event|0
5459220|NCT02057250|18868158|P2|Extension Phase|Adverse Event|0
5459221|NCT02057250|18868159|P1|Extension Phase|Adverse Event|0
5459222|NCT02057250|18868155|P5|AID Assessment Phase|Other than specified above|0
5459223|NCT02057250|18868156|P4|AID Assessment Phase|Other than specified above|1
5459224|NCT02057250|18868157|P3|AID Assessment Phase|Other than specified above|1
5459225|NCT02057250|18868158|P2|AID Assessment Phase|Other than specified above|1
5459226|NCT02057250|18868159|P1|AID Assessment Phase|Other than specified above|1
5459227|NCT02057250|18868155|P5|AID Assessment Phase|Adverse Event|0
5459228|NCT02057250|18868156|P4|AID Assessment Phase|Adverse Event|1
5459229|NCT02057250|18868157|P3|AID Assessment Phase|Adverse Event|6
5459230|NCT02057250|18868158|P2|AID Assessment Phase|Adverse Event|2
5459231|NCT02057250|18868159|P1|AID Assessment Phase|Adverse Event|3
5459232|NCT02057198|18868180|P3|Overall Study|Discharged early; lost to followup|0
5459233|NCT02057198|18868181|P2|Overall Study|Discharged early; lost to followup|1
5459234|NCT02057198|18868182|P1|Overall Study|Discharged early; lost to followup|0
5459235|NCT02057198|18868180|P3|Overall Study|Death|1
5459236|NCT02057198|18868181|P2|Overall Study|Death|0
5459237|NCT02057198|18868182|P1|Overall Study|Death|0
5459238|NCT02057068|18868218|P2|Overall Study|Lost to Follow-up|2
5459239|NCT02057068|18868219|P1|Overall Study|Lost to Follow-up|2
5459240|NCT02057068|18868218|P2|Overall Study|Carepartner (CP) Health|2
5459241|NCT02057068|18868219|P1|Overall Study|Carepartner (CP) Health|4
5459242|NCT02057068|18868218|P2|Overall Study|Caregiver (CG) Health|2
5459243|NCT02057068|18868219|P1|Overall Study|Caregiver (CG) Health|0
5459244|NCT02057068|18868218|P2|Overall Study|Withdrawal by Subject|2
5459245|NCT02057068|18868219|P1|Overall Study|Withdrawal by Subject|2
5459246|NCT02056834|18868248|P1|Overall Study|Lost to Follow-up|7
5459247|NCT02056652|18868269|P2|Overall Study|Lost to Follow-up|3
5459248|NCT02056652|18868270|P1|Overall Study|Lost to Follow-up|0
5459249|NCT02056652|18868269|P2|Overall Study|Withdrawal by Subject|0
5459250|NCT02056652|18868270|P1|Overall Study|Withdrawal by Subject|1
5459251|NCT02056626|18868307|P4|Overall Study|patient did not follow directions|0
5459252|NCT02056626|18868308|P3|Overall Study|patient did not follow directions|0
5459253|NCT02056626|18868309|P2|Overall Study|patient did not follow directions|1
5459254|NCT02056626|18868310|P1|Overall Study|patient did not follow directions|3
5459255|NCT02056392|18868345|P6|Overall Study|Withdrawal by Subject|0
5459256|NCT02056392|18868346|P5|Overall Study|Withdrawal by Subject|1
5459257|NCT02056392|18868347|P4|Overall Study|Withdrawal by Subject|0
5459258|NCT02056392|18868348|P3|Overall Study|Withdrawal by Subject|0
5459259|NCT02056392|18868349|P2|Overall Study|Withdrawal by Subject|0
5459260|NCT02056392|18868350|P1|Overall Study|Withdrawal by Subject|1
5459261|NCT02056392|18868345|P6|Overall Study|Protocol Violation|0
5459262|NCT02056392|18868346|P5|Overall Study|Protocol Violation|0
5459263|NCT02056392|18868347|P4|Overall Study|Protocol Violation|0
5459264|NCT02056392|18868348|P3|Overall Study|Protocol Violation|1
5459265|NCT02056392|18868349|P2|Overall Study|Protocol Violation|0
5459266|NCT02056392|18868350|P1|Overall Study|Protocol Violation|1
5459267|NCT02056392|18868345|P6|Overall Study|Lost to Follow-up|0
5459268|NCT02056392|18868346|P5|Overall Study|Lost to Follow-up|0
5459269|NCT02056392|18868347|P4|Overall Study|Lost to Follow-up|0
5459270|NCT02056392|18868348|P3|Overall Study|Lost to Follow-up|2
5459271|NCT02056392|18868349|P2|Overall Study|Lost to Follow-up|1
5459272|NCT02056392|18868350|P1|Overall Study|Lost to Follow-up|0
5459273|NCT02056340|18868387|P2|Overall Study|Withdrawal by Subject|6
5459274|NCT02056340|18868388|P1|Overall Study|Withdrawal by Subject|2
5459275|NCT02056340|18868387|P2|Overall Study|Lost to Follow-up|5
5459276|NCT02056340|18868388|P1|Overall Study|Lost to Follow-up|5
5459277|NCT02056301|18868398|P2|Overall Study|Issues with epidural|3
5459278|NCT02056301|18868399|P1|Overall Study|Issues with epidural|0
5459279|NCT02056301|18868398|P2|Overall Study|Withdrawal by Subject|1
5459280|NCT02056301|18868399|P1|Overall Study|Withdrawal by Subject|0
5459281|NCT02056301|18868398|P2|Overall Study|Surgical complications req. 2nd surgery|0
5459282|NCT02056301|18868399|P1|Overall Study|Surgical complications req. 2nd surgery|1
5459283|NCT02056301|18868398|P2|Overall Study|Protocol Violation|2
5459284|NCT02056301|18868399|P1|Overall Study|Protocol Violation|1
5459285|NCT02055976|18868431|P9|Overall Study|Lost to Follow-up|0
5459286|NCT02055976|18868432|P8|Overall Study|Lost to Follow-up|0
5459287|NCT02055976|18868433|P7|Overall Study|Lost to Follow-up|0
5459288|NCT02055976|18868434|P6|Overall Study|Lost to Follow-up|0
5459289|NCT02055976|18868435|P5|Overall Study|Lost to Follow-up|0
5459290|NCT02055976|18868436|P4|Overall Study|Lost to Follow-up|1
5459291|NCT02055976|18868437|P3|Overall Study|Lost to Follow-up|0
5459292|NCT02055976|18868438|P2|Overall Study|Lost to Follow-up|0
5459293|NCT02055976|18868439|P1|Overall Study|Lost to Follow-up|0
5459294|NCT02055976|18868431|P9|Overall Study|Does not meet entrance criteria|0
5459295|NCT02055976|18868432|P8|Overall Study|Does not meet entrance criteria|0
5459296|NCT02055976|18868433|P7|Overall Study|Does not meet entrance criteria|1
5459297|NCT02055976|18868434|P6|Overall Study|Does not meet entrance criteria|0
5459298|NCT02055976|18868435|P5|Overall Study|Does not meet entrance criteria|0
5459299|NCT02055976|18868436|P4|Overall Study|Does not meet entrance criteria|0
5459300|NCT02055976|18868437|P3|Overall Study|Does not meet entrance criteria|0
5459301|NCT02055976|18868438|P2|Overall Study|Does not meet entrance criteria|0
5459302|NCT02055976|18868439|P1|Overall Study|Does not meet entrance criteria|0
5459303|NCT02055976|18868431|P9|Overall Study|Adverse Event|0
5459304|NCT02055976|18868432|P8|Overall Study|Adverse Event|0
5459305|NCT02055976|18868433|P7|Overall Study|Adverse Event|1
5459306|NCT02055976|18868434|P6|Overall Study|Adverse Event|1
5459307|NCT02055976|18868435|P5|Overall Study|Adverse Event|0
5459308|NCT02055976|18868436|P4|Overall Study|Adverse Event|0
5459309|NCT02055976|18868437|P3|Overall Study|Adverse Event|0
5459310|NCT02055976|18868438|P2|Overall Study|Adverse Event|0
5459311|NCT02055976|18868439|P1|Overall Study|Adverse Event|0
5459312|NCT02055976|18868431|P9|Overall Study|Other|0
5459313|NCT02055976|18868432|P8|Overall Study|Other|0
5459314|NCT02055976|18868433|P7|Overall Study|Other|0
5459315|NCT02055976|18868434|P6|Overall Study|Other|0
5459316|NCT02055976|18868435|P5|Overall Study|Other|0
5459317|NCT02055976|18868436|P4|Overall Study|Other|0
5459318|NCT02055976|18868437|P3|Overall Study|Other|1
5459319|NCT02055976|18868438|P2|Overall Study|Other|0
5459320|NCT02055976|18868439|P1|Overall Study|Other|0
5459321|NCT02055898|18868860|P2|First Intervention (5 Days)|Withdrawal by Subject|1
5459322|NCT02055898|18868861|P1|First Intervention (5 Days)|Withdrawal by Subject|0
5459323|NCT02055898|18868860|P2|First Intervention (5 Days)|Physician Decision|0
5459324|NCT02055898|18868861|P1|First Intervention (5 Days)|Physician Decision|2
5459325|NCT02055820|18868883|P10|Phase II: Expansion|Withdrawal by Subject|0
5459326|NCT02055820|18868884|P9|Phase II: Expansion|Withdrawal by Subject|0
5459327|NCT02055820|18868885|P8|Phase II: Expansion|Withdrawal by Subject|0
5459328|NCT02055820|18868886|P7|Phase II: Expansion|Withdrawal by Subject|0
5459329|NCT02055820|18868887|P6|Phase II: Expansion|Withdrawal by Subject|0
5459330|NCT02055820|18868888|P5|Phase II: Expansion|Withdrawal by Subject|12
5459331|NCT02055820|18868889|P4|Phase II: Expansion|Withdrawal by Subject|0
5459332|NCT02055820|18868890|P3|Phase II: Expansion|Withdrawal by Subject|0
5459333|NCT02055820|18868891|P2|Phase II: Expansion|Withdrawal by Subject|0
5459334|NCT02055820|18868892|P1|Phase II: Expansion|Withdrawal by Subject|0
5459335|NCT02055820|18868883|P10|Phase II: Expansion|Lost to Follow-up|0
5459336|NCT02055820|18868884|P9|Phase II: Expansion|Lost to Follow-up|0
5459337|NCT02055820|18868885|P8|Phase II: Expansion|Lost to Follow-up|0
5459338|NCT02055820|18868886|P7|Phase II: Expansion|Lost to Follow-up|0
5459339|NCT02055820|18868887|P6|Phase II: Expansion|Lost to Follow-up|0
5459340|NCT02055820|18868888|P5|Phase II: Expansion|Lost to Follow-up|4
5459341|NCT02055820|18868889|P4|Phase II: Expansion|Lost to Follow-up|0
5459342|NCT02055820|18868890|P3|Phase II: Expansion|Lost to Follow-up|0
5459343|NCT02055820|18868891|P2|Phase II: Expansion|Lost to Follow-up|0
5459344|NCT02055820|18868892|P1|Phase II: Expansion|Lost to Follow-up|0
5459345|NCT02055820|18868883|P10|Phase II: Expansion|Death|0
5459346|NCT02055820|18868884|P9|Phase II: Expansion|Death|0
5459347|NCT02055820|18868885|P8|Phase II: Expansion|Death|0
5459348|NCT02055820|18868886|P7|Phase II: Expansion|Death|0
5459349|NCT02055820|18868887|P6|Phase II: Expansion|Death|0
5459350|NCT02055820|18868888|P5|Phase II: Expansion|Death|33
5459351|NCT02055820|18868889|P4|Phase II: Expansion|Death|0
5459352|NCT02055820|18868890|P3|Phase II: Expansion|Death|0
5459353|NCT02055820|18868891|P2|Phase II: Expansion|Death|0
5459354|NCT02055820|18868892|P1|Phase II: Expansion|Death|0
5459355|NCT02055820|18868883|P10|Phase I: Dose-Finding|Lost to Follow-up|0
5459356|NCT02055820|18868884|P9|Phase I: Dose-Finding|Lost to Follow-up|0
5459357|NCT02055820|18868885|P8|Phase I: Dose-Finding|Lost to Follow-up|0
5459358|NCT02055820|18868886|P7|Phase I: Dose-Finding|Lost to Follow-up|1
5459359|NCT02055820|18868887|P6|Phase I: Dose-Finding|Lost to Follow-up|0
5459360|NCT02055820|18868888|P5|Phase I: Dose-Finding|Lost to Follow-up|0
5459361|NCT02055820|18868889|P4|Phase I: Dose-Finding|Lost to Follow-up|1
5459362|NCT02055820|18868890|P3|Phase I: Dose-Finding|Lost to Follow-up|0
5459363|NCT02055820|18868891|P2|Phase I: Dose-Finding|Lost to Follow-up|0
5459364|NCT02055820|18868892|P1|Phase I: Dose-Finding|Lost to Follow-up|0
5459365|NCT02055820|18868883|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
5459366|NCT02055820|18868884|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
5459367|NCT02055820|18868885|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
5459368|NCT02055820|18868886|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
5459369|NCT02055820|18868887|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
5459370|NCT02055820|18868888|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
5459371|NCT02055820|18868889|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
5459372|NCT02055820|18868890|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
5459373|NCT02055820|18868891|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
5459374|NCT02055820|18868892|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
5459375|NCT02055820|18868883|P10|Phase I: Dose-Finding|Death|0
5459376|NCT02055820|18868884|P9|Phase I: Dose-Finding|Death|0
5459377|NCT02055820|18868885|P8|Phase I: Dose-Finding|Death|0
5459378|NCT02055820|18868886|P7|Phase I: Dose-Finding|Death|1
5459379|NCT02055820|18868887|P6|Phase I: Dose-Finding|Death|1
5459380|NCT02055820|18868888|P5|Phase I: Dose-Finding|Death|0
5459381|NCT02055820|18868889|P4|Phase I: Dose-Finding|Death|2
5459382|NCT02055820|18868890|P3|Phase I: Dose-Finding|Death|1
5459383|NCT02055820|18868891|P2|Phase I: Dose-Finding|Death|0
5459384|NCT02055820|18868892|P1|Phase I: Dose-Finding|Death|1
5459385|NCT02055547|18869003|P19|Overall Study|Lost to Follow-up|0
5459386|NCT02055547|18869004|P18|Overall Study|Lost to Follow-up|0
5459387|NCT02055547|18869005|P17|Overall Study|Lost to Follow-up|0
5459388|NCT02055547|18869006|P16|Overall Study|Lost to Follow-up|0
5459389|NCT02055547|18869007|P15|Overall Study|Lost to Follow-up|0
5459390|NCT02055547|18869008|P14|Overall Study|Lost to Follow-up|0
5459391|NCT02055547|18869009|P13|Overall Study|Lost to Follow-up|0
5459392|NCT02055547|18869010|P12|Overall Study|Lost to Follow-up|0
5459393|NCT02055547|18869011|P11|Overall Study|Lost to Follow-up|0
5459394|NCT02055547|18869012|P10|Overall Study|Lost to Follow-up|0
5459395|NCT02055547|18869013|P9|Overall Study|Lost to Follow-up|0
5459396|NCT02055547|18869014|P8|Overall Study|Lost to Follow-up|0
5459397|NCT02055547|18869015|P7|Overall Study|Lost to Follow-up|0
5459398|NCT02055547|18869016|P6|Overall Study|Lost to Follow-up|0
5459399|NCT02055547|18869017|P5|Overall Study|Lost to Follow-up|0
5459400|NCT02055547|18869018|P4|Overall Study|Lost to Follow-up|0
5459401|NCT02055547|18869019|P3|Overall Study|Lost to Follow-up|1
5459402|NCT02055547|18869020|P2|Overall Study|Lost to Follow-up|0
5459403|NCT02055547|18869021|P1|Overall Study|Lost to Follow-up|0
5459404|NCT02055547|18869003|P19|Overall Study|Withdrawal by Subject|0
5459405|NCT02055547|18869004|P18|Overall Study|Withdrawal by Subject|0
5459406|NCT02055547|18869005|P17|Overall Study|Withdrawal by Subject|0
5459407|NCT02055547|18869006|P16|Overall Study|Withdrawal by Subject|1
5459408|NCT02055547|18869007|P15|Overall Study|Withdrawal by Subject|0
5459409|NCT02055547|18869008|P14|Overall Study|Withdrawal by Subject|1
5459410|NCT02055547|18869009|P13|Overall Study|Withdrawal by Subject|0
5459411|NCT02055547|18869010|P12|Overall Study|Withdrawal by Subject|0
5459412|NCT02055547|18869011|P11|Overall Study|Withdrawal by Subject|0
5459413|NCT02055547|18869012|P10|Overall Study|Withdrawal by Subject|0
5459414|NCT02055547|18869013|P9|Overall Study|Withdrawal by Subject|1
5459415|NCT02055547|18869014|P8|Overall Study|Withdrawal by Subject|0
5459416|NCT02055547|18869015|P7|Overall Study|Withdrawal by Subject|0
5459417|NCT02055547|18869016|P6|Overall Study|Withdrawal by Subject|1
5459418|NCT02055547|18869017|P5|Overall Study|Withdrawal by Subject|0
5459419|NCT02055547|18869018|P4|Overall Study|Withdrawal by Subject|0
5459420|NCT02055547|18869019|P3|Overall Study|Withdrawal by Subject|0
5459421|NCT02055547|18869020|P2|Overall Study|Withdrawal by Subject|0
5459422|NCT02055547|18869021|P1|Overall Study|Withdrawal by Subject|0
5459423|NCT02055547|18869003|P19|Overall Study|Adverse Event|0
5459424|NCT02055547|18869004|P18|Overall Study|Adverse Event|0
5459425|NCT02055547|18869005|P17|Overall Study|Adverse Event|0
5459426|NCT02055547|18869006|P16|Overall Study|Adverse Event|0
5459427|NCT02055547|18869007|P15|Overall Study|Adverse Event|0
5459428|NCT02055547|18869008|P14|Overall Study|Adverse Event|0
5459429|NCT02055547|18869009|P13|Overall Study|Adverse Event|0
5459430|NCT02055547|18869010|P12|Overall Study|Adverse Event|0
5459431|NCT02055547|18869011|P11|Overall Study|Adverse Event|0
5459432|NCT02055547|18869012|P10|Overall Study|Adverse Event|0
5459433|NCT02055547|18869013|P9|Overall Study|Adverse Event|1
5459434|NCT02055547|18869014|P8|Overall Study|Adverse Event|0
5459435|NCT02055547|18869015|P7|Overall Study|Adverse Event|1
5459436|NCT02055547|18869016|P6|Overall Study|Adverse Event|0
5459437|NCT02055547|18869017|P5|Overall Study|Adverse Event|0
5459438|NCT02055547|18869018|P4|Overall Study|Adverse Event|0
5459439|NCT02055547|18869019|P3|Overall Study|Adverse Event|0
5459440|NCT02055547|18869020|P2|Overall Study|Adverse Event|0
5459441|NCT02055547|18869021|P1|Overall Study|Adverse Event|0
5459442|NCT02055547|18869003|P19|Overall Study|Physician Decision|0
5459443|NCT02055547|18869004|P18|Overall Study|Physician Decision|0
5459444|NCT02055547|18869005|P17|Overall Study|Physician Decision|0
5459445|NCT02055547|18869006|P16|Overall Study|Physician Decision|0
5459446|NCT02055547|18869007|P15|Overall Study|Physician Decision|0
5459447|NCT02055547|18869008|P14|Overall Study|Physician Decision|0
5459448|NCT02055547|18869009|P13|Overall Study|Physician Decision|0
5459449|NCT02055547|18869010|P12|Overall Study|Physician Decision|0
5459450|NCT02055547|18869011|P11|Overall Study|Physician Decision|1
5459451|NCT02055547|18869012|P10|Overall Study|Physician Decision|1
5459452|NCT02055547|18869013|P9|Overall Study|Physician Decision|0
5459453|NCT02055547|18869014|P8|Overall Study|Physician Decision|0
5459454|NCT02055547|18869015|P7|Overall Study|Physician Decision|0
5459455|NCT02055547|18869016|P6|Overall Study|Physician Decision|0
5459456|NCT02055547|18869017|P5|Overall Study|Physician Decision|1
5459457|NCT02055547|18869018|P4|Overall Study|Physician Decision|0
5459458|NCT02055547|18869019|P3|Overall Study|Physician Decision|1
5459459|NCT02055547|18869020|P2|Overall Study|Physician Decision|1
5459460|NCT02055547|18869021|P1|Overall Study|Physician Decision|0
5459461|NCT02055547|18869003|P19|Overall Study|Protocol Violation|0
5459462|NCT02055547|18869004|P18|Overall Study|Protocol Violation|0
5459463|NCT02055547|18869005|P17|Overall Study|Protocol Violation|0
5459464|NCT02055547|18869006|P16|Overall Study|Protocol Violation|0
5459465|NCT02055547|18869007|P15|Overall Study|Protocol Violation|0
5459466|NCT02055547|18869008|P14|Overall Study|Protocol Violation|0
5459467|NCT02055547|18869009|P13|Overall Study|Protocol Violation|0
5459468|NCT02055547|18869010|P12|Overall Study|Protocol Violation|0
5459469|NCT02055547|18869011|P11|Overall Study|Protocol Violation|0
5459470|NCT02055547|18869012|P10|Overall Study|Protocol Violation|0
5459471|NCT02055547|18869013|P9|Overall Study|Protocol Violation|0
5459472|NCT02055547|18869014|P8|Overall Study|Protocol Violation|0
5459473|NCT02055547|18869015|P7|Overall Study|Protocol Violation|1
5459474|NCT02055547|18869016|P6|Overall Study|Protocol Violation|0
5459475|NCT02055547|18869017|P5|Overall Study|Protocol Violation|0
5459476|NCT02055547|18869018|P4|Overall Study|Protocol Violation|0
5459477|NCT02055547|18869019|P3|Overall Study|Protocol Violation|1
5459478|NCT02055547|18869020|P2|Overall Study|Protocol Violation|0
5459479|NCT02055547|18869021|P1|Overall Study|Protocol Violation|0
5459480|NCT02055365|18869190|P1|Overall Study|Prematurely Withdrawn|1
5459481|NCT02055352|18869203|P2|Overall Study|Reason unknown|5
5459482|NCT02055352|18869204|P1|Overall Study|Reason unknown|1
5459483|NCT02055352|18869203|P2|Overall Study|Withdrawal of informed consent|0
5459484|NCT02055352|18869204|P1|Overall Study|Withdrawal of informed consent|1
5459485|NCT02055352|18869203|P2|Overall Study|AE, study drug would be detrimental|3
5459486|NCT02055352|18869204|P1|Overall Study|AE, study drug would be detrimental|1
5459487|NCT02055352|18869203|P2|Overall Study|Use of prohibited treatment|3
5459488|NCT02055352|18869204|P1|Overall Study|Use of prohibited treatment|0
5459489|NCT02055352|18869203|P2|Overall Study|Patient decision|1
5459490|NCT02055352|18869204|P1|Overall Study|Patient decision|1
5459491|NCT02055352|18869203|P2|Overall Study|Death|2
5459492|NCT02055352|18869204|P1|Overall Study|Death|1
5459493|NCT02055352|18869203|P2|Overall Study|Poor compliance|1
5459494|NCT02055352|18869204|P1|Overall Study|Poor compliance|1
5459495|NCT02055352|18869203|P2|Overall Study|Non-eligible|1
5459496|NCT02055352|18869204|P1|Overall Study|Non-eligible|0
5459497|NCT02055352|18869203|P2|Overall Study|Adverse Event|1
5459498|NCT02055352|18869204|P1|Overall Study|Adverse Event|0
5459499|NCT02055118|18869221|P3|Overall Study|Withdrawal by Subject|0
5459500|NCT02055118|18869222|P2|Overall Study|Withdrawal by Subject|2
5459501|NCT02055118|18869223|P1|Overall Study|Withdrawal by Subject|0
5459502|NCT02054910|18869293|P2|Overall Study|Lost to Follow-up|1
5459503|NCT02054910|18869294|P1|Overall Study|Lost to Follow-up|4
5459504|NCT02054897|18869313|P3|Overall Study|Randomized but not exposed|0
5459505|NCT02054897|18869314|P2|Overall Study|Randomized but not exposed|0
5459506|NCT02054897|18869315|P1|Overall Study|Randomized but not exposed|1
5459507|NCT02054897|18869313|P3|Overall Study|Lost to Follow-up|7
5459508|NCT02054897|18869314|P2|Overall Study|Lost to Follow-up|2
5459509|NCT02054897|18869315|P1|Overall Study|Lost to Follow-up|4
5459510|NCT02054897|18869313|P3|Overall Study|Missing follow-up information|3
5459511|NCT02054897|18869314|P2|Overall Study|Missing follow-up information|5
5459512|NCT02054897|18869315|P1|Overall Study|Missing follow-up information|3
5459513|NCT02054897|18869313|P3|Overall Study|Withdrawal by Subject|2
5459514|NCT02054897|18869314|P2|Overall Study|Withdrawal by Subject|0
5459515|NCT02054897|18869315|P1|Overall Study|Withdrawal by Subject|2
5459516|NCT02054715|18869362|P2|Follow-up 2|Treatment Change or Delay|0
5459517|NCT02054715|18869363|P1|Follow-up 2|Treatment Change or Delay|1
5459518|NCT02054715|18869362|P2|Follow-up 2|No Reason|0
5459519|NCT02054715|18869363|P1|Follow-up 2|No Reason|2
5459520|NCT02054715|18869362|P2|Follow-up 2|Changed Mind|1
5459521|NCT02054715|18869363|P1|Follow-up 2|Changed Mind|0
5459522|NCT02054715|18869362|P2|Follow-up 2|Changed MD/Facility|1
5459523|NCT02054715|18869363|P1|Follow-up 2|Changed MD/Facility|0
5459524|NCT02054715|18869362|P2|Follow-up 2|Hospitalization|2
5459525|NCT02054715|18869363|P1|Follow-up 2|Hospitalization|0
5459526|NCT02054715|18869362|P2|Follow-up 2|Death|3
5459527|NCT02054715|18869363|P1|Follow-up 2|Death|3
5459528|NCT02054715|18869362|P2|Follow-up 2|Ineligible|5
5459529|NCT02054715|18869363|P1|Follow-up 2|Ineligible|4
5459530|NCT02054715|18869362|P2|Follow-up 2|Followup Not Completed|4
5459531|NCT02054715|18869363|P1|Follow-up 2|Followup Not Completed|3
5459532|NCT02054715|18869362|P2|Follow-up 2|Refused|2
5459533|NCT02054715|18869363|P1|Follow-up 2|Refused|3
5459534|NCT02054715|18869362|P2|Follow-up 2|Lost to Followup|1
5459535|NCT02054715|18869363|P1|Follow-up 2|Lost to Followup|3
5459536|NCT02054715|18869362|P2|Baseline/Follow-up 1|Changed Mind|0
5459537|NCT02054715|18869363|P1|Baseline/Follow-up 1|Changed Mind|1
5459538|NCT02054715|18869362|P2|Baseline/Follow-up 1|Hospitalization|0
5459539|NCT02054715|18869363|P1|Baseline/Follow-up 1|Hospitalization|1
5459540|NCT02054715|18869362|P2|Baseline/Follow-up 1|Ineligible|0
5459541|NCT02054715|18869363|P1|Baseline/Follow-up 1|Ineligible|3
5459542|NCT02054715|18869362|P2|Baseline/Follow-up 1|Overwhelmed|0
5459543|NCT02054715|18869363|P1|Baseline/Follow-up 1|Overwhelmed|2
5459544|NCT02054715|18869362|P2|Baseline/Follow-up 1|No Reason|1
5459545|NCT02054715|18869363|P1|Baseline/Follow-up 1|No Reason|0
5459546|NCT02054715|18869362|P2|Baseline/Follow-up 1|Disliked Procedure|1
5459547|NCT02054715|18869363|P1|Baseline/Follow-up 1|Disliked Procedure|0
5459548|NCT02054715|18869362|P2|Baseline/Follow-up 1|Changed MD/Facility|1
5459549|NCT02054715|18869363|P1|Baseline/Follow-up 1|Changed MD/Facility|0
5459550|NCT02054715|18869362|P2|Baseline/Follow-up 1|Medical|1
5459551|NCT02054715|18869363|P1|Baseline/Follow-up 1|Medical|0
5459552|NCT02054715|18869362|P2|Baseline/Follow-up 1|Refused|3
5459553|NCT02054715|18869363|P1|Baseline/Follow-up 1|Refused|1
5459554|NCT02054702|18869377|P2|Overall Study|Withdrawal by Subject|4
5459555|NCT02054702|18869378|P1|Overall Study|Withdrawal by Subject|14
5459556|NCT02054702|18869377|P2|Overall Study|Physician Decision|1
5459557|NCT02054702|18869378|P1|Overall Study|Physician Decision|0
5459558|NCT02054702|18869377|P2|Overall Study|Met Withdrawal Criteria|1
5459559|NCT02054702|18869378|P1|Overall Study|Met Withdrawal Criteria|4
5459560|NCT02054702|18869377|P2|Overall Study|Adverse Event|1
5459561|NCT02054702|18869378|P1|Overall Study|Adverse Event|3
5459562|NCT02054702|18869377|P2|Overall Study|Lost to Follow-up|5
5459563|NCT02054702|18869378|P1|Overall Study|Lost to Follow-up|3
5459564|NCT02054520|18869435|P6|Overall Study|Study terminated by Sponsor|0
5459565|NCT02054520|18869436|P5|Overall Study|Study terminated by Sponsor|0
5459566|NCT02054520|18869437|P4|Overall Study|Study terminated by Sponsor|1
5459567|NCT02054520|18869438|P3|Overall Study|Study terminated by Sponsor|2
5459568|NCT02054520|18869439|P2|Overall Study|Study terminated by Sponsor|0
5459569|NCT02054520|18869440|P1|Overall Study|Study terminated by Sponsor|0
5459570|NCT02054520|18869435|P6|Overall Study|Physician Decision|1
5459571|NCT02054520|18869436|P5|Overall Study|Physician Decision|0
5459572|NCT02054520|18869437|P4|Overall Study|Physician Decision|1
5459573|NCT02054520|18869438|P3|Overall Study|Physician Decision|0
5459574|NCT02054520|18869439|P2|Overall Study|Physician Decision|1
5459575|NCT02054520|18869440|P1|Overall Study|Physician Decision|0
5459576|NCT02054520|18869435|P6|Overall Study|Withdrawal by Subject|0
5459577|NCT02054520|18869436|P5|Overall Study|Withdrawal by Subject|1
5459578|NCT02054520|18869437|P4|Overall Study|Withdrawal by Subject|2
5459579|NCT02054520|18869438|P3|Overall Study|Withdrawal by Subject|0
5459580|NCT02054520|18869439|P2|Overall Study|Withdrawal by Subject|0
5459581|NCT02054520|18869440|P1|Overall Study|Withdrawal by Subject|1
5459582|NCT02054520|18869435|P6|Overall Study|Lack of Efficacy|2
5459583|NCT02054520|18869436|P5|Overall Study|Lack of Efficacy|3
5459584|NCT02054520|18869437|P4|Overall Study|Lack of Efficacy|1
5459585|NCT02054520|18869438|P3|Overall Study|Lack of Efficacy|2
5459586|NCT02054520|18869439|P2|Overall Study|Lack of Efficacy|0
5459587|NCT02054520|18869440|P1|Overall Study|Lack of Efficacy|7
5459588|NCT02054520|18869435|P6|Overall Study|Adverse Event|0
5459589|NCT02054520|18869436|P5|Overall Study|Adverse Event|1
5459590|NCT02054520|18869437|P4|Overall Study|Adverse Event|1
5459591|NCT02054520|18869438|P3|Overall Study|Adverse Event|2
5459592|NCT02054520|18869439|P2|Overall Study|Adverse Event|4
5459593|NCT02054520|18869440|P1|Overall Study|Adverse Event|1
5459594|NCT02054481|18869464|P4|Overall Study|Other reason|0
5459595|NCT02054481|18869465|P3|Overall Study|Other reason|2
5459596|NCT02054481|18869466|P2|Overall Study|Other reason|1
5459597|NCT02054481|18869467|P1|Overall Study|Other reason|2
5459598|NCT02054481|18869464|P4|Overall Study|Lost to Follow-up|0
5459599|NCT02054481|18869465|P3|Overall Study|Lost to Follow-up|0
5459600|NCT02054481|18869466|P2|Overall Study|Lost to Follow-up|0
5459601|NCT02054481|18869467|P1|Overall Study|Lost to Follow-up|1
5459602|NCT02054481|18869464|P4|Overall Study|Adverse Event|1
5459603|NCT02054481|18869465|P3|Overall Study|Adverse Event|0
5459604|NCT02054481|18869466|P2|Overall Study|Adverse Event|1
5459605|NCT02054481|18869467|P1|Overall Study|Adverse Event|1
5459606|NCT02054325|18869528|P2|Overall Study|Lost to Follow-up|5
5459607|NCT02054325|18869529|P1|Overall Study|Lost to Follow-up|8
5459608|NCT02054130|18869556|P4|Overall Study|Missed dose|10
5459609|NCT02054130|18869557|P3|Overall Study|Missed dose|7
5459610|NCT02054130|18869558|P2|Overall Study|Missed dose|6
5459611|NCT02054130|18869559|P1|Overall Study|Missed dose|4
5459612|NCT02054130|18869556|P4|Overall Study|Lost to Follow-up|2
5459613|NCT02054130|18869557|P3|Overall Study|Lost to Follow-up|1
5459614|NCT02054130|18869558|P2|Overall Study|Lost to Follow-up|0
5459615|NCT02054130|18869559|P1|Overall Study|Lost to Follow-up|0
5459616|NCT02054130|18869556|P4|Overall Study|Death|0
5459617|NCT02054130|18869557|P3|Overall Study|Death|0
5459618|NCT02054130|18869558|P2|Overall Study|Death|1
5459619|NCT02054130|18869559|P1|Overall Study|Death|0
5459620|NCT02054130|18869556|P4|Overall Study|Withdrawal by Subject|10
5459621|NCT02054130|18869557|P3|Overall Study|Withdrawal by Subject|7
5459622|NCT02054130|18869558|P2|Overall Study|Withdrawal by Subject|4
5459623|NCT02054130|18869559|P1|Overall Study|Withdrawal by Subject|4
5459624|NCT02053753|18869653|P2|Overall Study|Lost to Follow-up|3
5459625|NCT02053753|18869654|P1|Overall Study|Lost to Follow-up|4
5459626|NCT02053753|18869653|P2|Overall Study|Decision by Sponsor|1
5459627|NCT02053753|18869654|P1|Overall Study|Decision by Sponsor|1
5459628|NCT02053753|18869653|P2|Overall Study|Withdrawal by Subject|4
5459629|NCT02053753|18869654|P1|Overall Study|Withdrawal by Subject|2
5459630|NCT02053610|18869678|P2|Overall Study|Violation of Selection Criteria|0
5459631|NCT02053610|18869679|P1|Overall Study|Violation of Selection Criteria|1
5459632|NCT02053610|18869678|P2|Overall Study|Insufficient Therapeutic Response|1
5459633|NCT02053610|18869679|P1|Overall Study|Insufficient Therapeutic Response|1
5459634|NCT02053610|18869678|P2|Overall Study|Did not Receive Treatment|2
5459635|NCT02053610|18869679|P1|Overall Study|Did not Receive Treatment|4
5459636|NCT02053610|18869678|P2|Overall Study|Refused treatment/Did not cooperate|3
5459637|NCT02053610|18869679|P1|Overall Study|Refused treatment/Did not cooperate|1
5459638|NCT02053610|18869678|P2|Overall Study|Disease Progression|3
5459639|NCT02053610|18869679|P1|Overall Study|Disease Progression|2
5459640|NCT02053610|18869678|P2|Overall Study|Administrative/Other|1
5459641|NCT02053610|18869679|P1|Overall Study|Administrative/Other|1
5459642|NCT02053610|18869678|P2|Overall Study|Death|5
5459643|NCT02053610|18869679|P1|Overall Study|Death|5
5459644|NCT02053610|18869678|P2|Overall Study|Withdrew Consent|9
5459645|NCT02053610|18869679|P1|Overall Study|Withdrew Consent|2
5459646|NCT02053610|18869678|P2|Overall Study|Adverse Event/Intercurrent Illness|43
5459647|NCT02053610|18869679|P1|Overall Study|Adverse Event/Intercurrent Illness|25
5459648|NCT02053493|18869711|P2|Overall Study|Withdrawal by Subject|1
5459649|NCT02053493|18869712|P1|Overall Study|Withdrawal by Subject|1
5459650|NCT02053168|18869778|P1|Overall Study|Lost to Follow-up|1
5459651|NCT02053168|18869778|P1|Overall Study|Physician Decision|1
5459652|NCT02053168|18869778|P1|Overall Study|Withdrawal by Subject|1
5459653|NCT02052596|18869857|P2|Safety Phase|Lost due to Crohn's disease|1
5459654|NCT02052596|18869858|P1|Safety Phase|Lost due to Crohn's disease|0
5459655|NCT02052596|18869857|P2|Safety Phase|Enrolled in error|0
5459656|NCT02052596|18869858|P1|Safety Phase|Enrolled in error|1
5459657|NCT02052596|18869857|P2|Safety Phase|Withdrawal by Subject|11
5459658|NCT02052596|18869858|P1|Safety Phase|Withdrawal by Subject|8
5459659|NCT02052596|18869857|P2|Safety Phase|Protocol Violation|2
5459660|NCT02052596|18869858|P1|Safety Phase|Protocol Violation|1
5459661|NCT02052596|18869857|P2|Safety Phase|Lost to Follow-up|18
5459662|NCT02052596|18869858|P1|Safety Phase|Lost to Follow-up|11
5459663|NCT02052596|18869857|P2|Safety Phase|Adverse Event|3
5459664|NCT02052596|18869858|P1|Safety Phase|Adverse Event|6
5459665|NCT02052596|18869857|P2|Active Phase|Lost due to Crohn's disease|1
5459666|NCT02052596|18869858|P1|Active Phase|Lost due to Crohn's disease|0
5459667|NCT02052596|18869857|P2|Active Phase|Enrolled in error|0
5459668|NCT02052596|18869858|P1|Active Phase|Enrolled in error|1
5459669|NCT02052596|18869857|P2|Active Phase|Withdrawal by Subject|4
5459670|NCT02052596|18869858|P1|Active Phase|Withdrawal by Subject|3
5459671|NCT02052596|18869857|P2|Active Phase|Protocol Violation|2
5459672|NCT02052596|18869858|P1|Active Phase|Protocol Violation|1
5459673|NCT02052596|18869857|P2|Active Phase|Lost to Follow-up|11
5459674|NCT02052596|18869858|P1|Active Phase|Lost to Follow-up|8
5459675|NCT02052596|18869857|P2|Active Phase|Adverse Event|2
5459676|NCT02052596|18869858|P1|Active Phase|Adverse Event|3
5459677|NCT02052466|18869888|P1|Overall Study|Acromial fracture|1
5459678|NCT02052466|18869888|P1|Overall Study|Withdrawal by Subject|1
5459679|NCT02052440|18869905|P2|Overall Study|Withdrawal by Subject|1
5459680|NCT02052440|18869906|P1|Overall Study|Withdrawal by Subject|0
5459681|NCT02052414|18869918|P1|Overall Study|Withdrawal by Subject|3
5459682|NCT02052414|18869918|P1|Overall Study|Lack of Efficacy|2
5459683|NCT02052414|18869918|P1|Overall Study|Adverse Event|12
5459684|NCT02052011|18869953|P2|Overall Study|Withdrawal by Subject|2
5459685|NCT02052011|18869954|P1|Overall Study|Withdrawal by Subject|1
5459686|NCT02052011|18869953|P2|Overall Study|Lost to Follow-up|0
5459687|NCT02052011|18869954|P1|Overall Study|Lost to Follow-up|3
5459688|NCT02051764|18870011|P2|Overall Study|Study terminated by sponsor|7
5459689|NCT02051764|18870012|P1|Overall Study|Study terminated by sponsor|0
5459690|NCT02051296|18870118|P2|Overall Study|withdraw prior to treatment|7
5459691|NCT02051296|18870119|P1|Overall Study|withdraw prior to treatment|7
5459692|NCT02051296|18870118|P2|Overall Study|Lost to Follow-up|2
5459693|NCT02051296|18870119|P1|Overall Study|Lost to Follow-up|1
5459694|NCT02050321|18870179|P1|Overall Study|Adverse Event|1
5459695|NCT02050321|18870179|P1|Overall Study|Withdrawal by Subject|1
5459696|NCT02050048|18870195|P2|Overall Study|Ineligible after ERCP|1
5459697|NCT02050048|18870196|P1|Overall Study|Ineligible after ERCP|4
5459698|NCT02050048|18870195|P2|Overall Study|Death|0
5459699|NCT02050048|18870196|P1|Overall Study|Death|1
5459700|NCT02050048|18870195|P2|Overall Study|Lost to Follow-up|1
5459701|NCT02050048|18870196|P1|Overall Study|Lost to Follow-up|0
5459702|NCT02049957|18870211|P9|Overall Study|Physician Decision|0
5459703|NCT02049957|18870212|P8|Overall Study|Physician Decision|0
5459704|NCT02049957|18870213|P7|Overall Study|Physician Decision|0
5459705|NCT02049957|18870214|P6|Overall Study|Physician Decision|1
5459706|NCT02049957|18870215|P5|Overall Study|Physician Decision|0
5459707|NCT02049957|18870216|P4|Overall Study|Physician Decision|0
5459708|NCT02049957|18870217|P3|Overall Study|Physician Decision|0
5459709|NCT02049957|18870218|P2|Overall Study|Physician Decision|0
5459710|NCT02049957|18870219|P1|Overall Study|Physician Decision|0
5459711|NCT02049957|18870211|P9|Overall Study|Withdrawal by Subject|1
5459712|NCT02049957|18870212|P8|Overall Study|Withdrawal by Subject|3
5459713|NCT02049957|18870213|P7|Overall Study|Withdrawal by Subject|0
5459714|NCT02049957|18870214|P6|Overall Study|Withdrawal by Subject|2
5459715|NCT02049957|18870215|P5|Overall Study|Withdrawal by Subject|0
5459716|NCT02049957|18870216|P4|Overall Study|Withdrawal by Subject|1
5459717|NCT02049957|18870217|P3|Overall Study|Withdrawal by Subject|0
5459718|NCT02049957|18870218|P2|Overall Study|Withdrawal by Subject|0
5459719|NCT02049957|18870219|P1|Overall Study|Withdrawal by Subject|0
5459720|NCT02049957|18870211|P9|Overall Study|Study Terminated by Sponsor|0
5459721|NCT02049957|18870212|P8|Overall Study|Study Terminated by Sponsor|0
5459722|NCT02049957|18870213|P7|Overall Study|Study Terminated by Sponsor|1
5459723|NCT02049957|18870214|P6|Overall Study|Study Terminated by Sponsor|0
5459724|NCT02049957|18870215|P5|Overall Study|Study Terminated by Sponsor|0
5459725|NCT02049957|18870216|P4|Overall Study|Study Terminated by Sponsor|0
5459726|NCT02049957|18870217|P3|Overall Study|Study Terminated by Sponsor|0
5459727|NCT02049957|18870218|P2|Overall Study|Study Terminated by Sponsor|1
5459728|NCT02049957|18870219|P1|Overall Study|Study Terminated by Sponsor|0
5459729|NCT02049957|18870211|P9|Overall Study|Adverse Event|1
5459730|NCT02049957|18870212|P8|Overall Study|Adverse Event|6
5459731|NCT02049957|18870213|P7|Overall Study|Adverse Event|0
5459732|NCT02049957|18870214|P6|Overall Study|Adverse Event|5
5459733|NCT02049957|18870215|P5|Overall Study|Adverse Event|0
5459734|NCT02049957|18870216|P4|Overall Study|Adverse Event|0
5459735|NCT02049957|18870217|P3|Overall Study|Adverse Event|1
5459736|NCT02049957|18870218|P2|Overall Study|Adverse Event|1
5459737|NCT02049957|18870219|P1|Overall Study|Adverse Event|1
5459738|NCT02049957|18870211|P9|Overall Study|Progressive Disease|6
5459739|NCT02049957|18870212|P8|Overall Study|Progressive Disease|26
5459740|NCT02049957|18870213|P7|Overall Study|Progressive Disease|7
5459741|NCT02049957|18870214|P6|Overall Study|Progressive Disease|35
5459742|NCT02049957|18870215|P5|Overall Study|Progressive Disease|6
5459743|NCT02049957|18870216|P4|Overall Study|Progressive Disease|2
5459744|NCT02049957|18870217|P3|Overall Study|Progressive Disease|2
5459745|NCT02049957|18870218|P2|Overall Study|Progressive Disease|4
5459746|NCT02049957|18870219|P1|Overall Study|Progressive Disease|5
5459747|NCT02049814|18870311|P2|Overall Study|Voluntary withdrawal|8
5459748|NCT02049814|18870312|P1|Overall Study|Voluntary withdrawal|9
5459749|NCT02049814|18870311|P2|Overall Study|Pretreatment event/Adverse Event (AE)|5
5459750|NCT02049814|18870312|P1|Overall Study|Pretreatment event/Adverse Event (AE)|8
5459751|NCT02049814|18870311|P2|Overall Study|Study Termination|1
5459752|NCT02049814|18870312|P1|Overall Study|Study Termination|0
5459753|NCT02049814|18870311|P2|Overall Study|Serious Protocol Violation|7
5459754|NCT02049814|18870312|P1|Overall Study|Serious Protocol Violation|5
5459755|NCT02049814|18870311|P2|Overall Study|Lost to Follow-up|3
5459756|NCT02049814|18870312|P1|Overall Study|Lost to Follow-up|2
5459757|NCT02049814|18870311|P2|Overall Study|Pregnancy|0
5459758|NCT02049814|18870312|P1|Overall Study|Pregnancy|1
5459759|NCT02049814|18870311|P2|Overall Study|Reason not Specified|3
5459760|NCT02049814|18870312|P1|Overall Study|Reason not Specified|4
5459761|NCT02049450|18870361|P1|Overall Study|Patients/guardian decision|1
5459762|NCT02049450|18870361|P1|Overall Study|Withdrawal by Subject|1
5459763|NCT02049450|18870361|P1|Overall Study|Adverse Event|2
5459764|NCT02049437|18870377|P2|Period 1|Adverse Event|0
5459765|NCT02049437|18870378|P1|Period 1|Adverse Event|1
5459766|NCT02049437|18870377|P2|Period 1|Adverse Event|1
5459767|NCT02049437|18870378|P1|Period 1|Adverse Event|1
5459768|NCT02048904|18870423|P1|Overall Study|Physician Decision|70
5459769|NCT02048904|18870423|P1|Overall Study|Withdrawal by Subject|7
5459770|NCT02048722|18870455|P1|Follow up for 5 Years|Still in follow up|4
5459771|NCT02048722|18870455|P1|Follow up for 5 Years|Withdrawal by Subject|3
5459772|NCT02048722|18870455|P1|Follow up for 5 Years|Death|22
5459773|NCT02048722|18870455|P1|Reached 1st Response/Continued Treatment|Progressive Disease|10
5459774|NCT02048722|18870455|P1|2 Cycles of Treatment|Progressive Disease|2
5459775|NCT02048722|18870455|P1|2 Cycles of Treatment|Withdrawal by Subject|4
5459776|NCT02048722|18870455|P1|2 Cycles of Treatment|Adverse Event|2
5459777|NCT02048241|18870478|P2|Overall Study|Withdrawal by Subject|1
5459778|NCT02048241|18870479|P1|Overall Study|Withdrawal by Subject|0
5459779|NCT02048072|18870485|P1|Overall Study|Lost to Follow-up|1
5459780|NCT02048072|18870485|P1|Overall Study|Adverse Event|3
5459781|NCT02047903|18870524|P1|Overall Study|Not Treated|9
5459782|NCT02047903|18870524|P1|Overall Study|Reason not listed|6
5459783|NCT02047903|18870524|P1|Overall Study|Lost to Follow-up|4
5459784|NCT02047903|18870524|P1|Overall Study|Withdrawal by Subject|16
5459785|NCT02047903|18870524|P1|Overall Study|Serious adverse event|10
5459786|NCT02047903|18870524|P1|Overall Study|Adverse Event|14
5459787|NCT02047253|18870579|P1|Overall Study|Lost to Follow-up|8
5459788|NCT02047227|18870589|P2|Overall Study|Other|9
5459789|NCT02047227|18870590|P1|Overall Study|Other|10
5459790|NCT02047227|18870589|P2|Overall Study|All embryos discarded|11
5459791|NCT02047227|18870590|P1|Overall Study|All embryos discarded|12
5459792|NCT02047227|18870589|P2|Overall Study|Intention to freeze all embryos|0
5459793|NCT02047227|18870590|P1|Overall Study|Intention to freeze all embryos|1
5459794|NCT02047227|18870589|P2|Overall Study|No fertilization|51
5459795|NCT02047227|18870590|P1|Overall Study|No fertilization|61
5459796|NCT02047227|18870589|P2|Overall Study|No oocytes retrieved|20
5459797|NCT02047227|18870590|P1|Overall Study|No oocytes retrieved|21
5459798|NCT02047227|18870589|P2|Overall Study|Lack of ovarian response to stimulation|32
5459799|NCT02047227|18870590|P1|Overall Study|Lack of ovarian response to stimulation|35
5459800|NCT02047227|18870589|P2|Overall Study|Spontaneous pregnancy|0
5459801|NCT02047227|18870590|P1|Overall Study|Spontaneous pregnancy|1
5459802|NCT02047227|18870589|P2|Overall Study|Protocol Violation|0
5459803|NCT02047227|18870590|P1|Overall Study|Protocol Violation|1
5459804|NCT02047227|18870589|P2|Overall Study|Lost to Follow-up|3
5459805|NCT02047227|18870590|P1|Overall Study|Lost to Follow-up|0
5459806|NCT02047227|18870589|P2|Overall Study|Adverse Event|4
5459807|NCT02047227|18870590|P1|Overall Study|Adverse Event|2
5459808|NCT02047110|18870610|P4|OLE Treatment Period|Other than specified|0
5459809|NCT02047110|18870611|P3|OLE Treatment Period|Other than specified|1
5459810|NCT02047110|18870612|P2|OLE Treatment Period|Other than specified|0
5459811|NCT02047110|18870613|P1|OLE Treatment Period|Other than specified|0
5459812|NCT02047110|18870610|P4|Escape Treatment Period|Other than specified|1
5459813|NCT02047110|18870611|P3|Escape Treatment Period|Other than specified|0
5459814|NCT02047110|18870612|P2|Escape Treatment Period|Other than specified|2
5459815|NCT02047110|18870613|P1|Escape Treatment Period|Other than specified|1
5459816|NCT02047110|18870610|P4|Escape Treatment Period|Adverse Event|0
5459817|NCT02047110|18870611|P3|Escape Treatment Period|Adverse Event|2
5459818|NCT02047110|18870612|P2|Escape Treatment Period|Adverse Event|2
5459819|NCT02047110|18870613|P1|Escape Treatment Period|Adverse Event|1
5459820|NCT02047110|18870610|P4|Escape Treatment Period|Withdrawal by Subject|1
5459821|NCT02047110|18870611|P3|Escape Treatment Period|Withdrawal by Subject|1
5459822|NCT02047110|18870612|P2|Escape Treatment Period|Withdrawal by Subject|2
5459823|NCT02047110|18870613|P1|Escape Treatment Period|Withdrawal by Subject|1
5459824|NCT02047110|18870610|P4|DB (Week 12 up to Week 24)|Other than specified|0
5459825|NCT02047110|18870611|P3|DB (Week 12 up to Week 24)|Other than specified|1
5459826|NCT02047110|18870612|P2|DB (Week 12 up to Week 24)|Other than specified|1
5459827|NCT02047110|18870613|P1|DB (Week 12 up to Week 24)|Other than specified|0
5459828|NCT02047110|18870610|P4|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
5459829|NCT02047110|18870611|P3|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
5459830|NCT02047110|18870612|P2|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
5459831|NCT02047110|18870613|P1|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
5459832|NCT02047110|18870610|P4|DB Treatment Period up to Week 24|Other than specified|1
5459833|NCT02047110|18870611|P3|DB Treatment Period up to Week 24|Other than specified|3
5459834|NCT02047110|18870612|P2|DB Treatment Period up to Week 24|Other than specified|2
5459835|NCT02047110|18870613|P1|DB Treatment Period up to Week 24|Other than specified|1
5459836|NCT02047110|18870610|P4|DB Treatment Period up to Week 24|Withdrawal by Subject|1
5459837|NCT02047110|18870611|P3|DB Treatment Period up to Week 24|Withdrawal by Subject|0
5459838|NCT02047110|18870612|P2|DB Treatment Period up to Week 24|Withdrawal by Subject|0
5459839|NCT02047110|18870613|P1|DB Treatment Period up to Week 24|Withdrawal by Subject|1
5459840|NCT02047110|18870610|P4|DB Treatment Period up to Week 24|Protocol Violation|0
5459841|NCT02047110|18870611|P3|DB Treatment Period up to Week 24|Protocol Violation|0
5459842|NCT02047110|18870612|P2|DB Treatment Period up to Week 24|Protocol Violation|0
5459843|NCT02047110|18870613|P1|DB Treatment Period up to Week 24|Protocol Violation|1
5459844|NCT02047110|18870610|P4|DB Treatment Period up to Week 24|Lost to Follow-up|0
5459845|NCT02047110|18870611|P3|DB Treatment Period up to Week 24|Lost to Follow-up|0
5459846|NCT02047110|18870612|P2|DB Treatment Period up to Week 24|Lost to Follow-up|0
5459847|NCT02047110|18870613|P1|DB Treatment Period up to Week 24|Lost to Follow-up|1
5459848|NCT02047110|18870610|P4|DB Treatment Period up to Week 24|Adverse Event|0
5459849|NCT02047110|18870611|P3|DB Treatment Period up to Week 24|Adverse Event|0
5459850|NCT02047110|18870612|P2|DB Treatment Period up to Week 24|Adverse Event|0
5459851|NCT02047110|18870613|P1|DB Treatment Period up to Week 24|Adverse Event|1
5459852|NCT02047045|18870656|P2|Treatment Period (8 Weeks )|Withdrawal by Subject|2
5459853|NCT02047045|18870657|P1|Treatment Period (8 Weeks )|Withdrawal by Subject|4
5459854|NCT02047045|18870656|P2|Treatment Period (8 Weeks )|Lost to Follow-up|0
5459855|NCT02047045|18870657|P1|Treatment Period (8 Weeks )|Lost to Follow-up|1
5459856|NCT02047045|18870656|P2|Treatment Period (8 Weeks )|Adverse Event|1
5459857|NCT02047045|18870657|P1|Treatment Period (8 Weeks )|Adverse Event|2
5459858|NCT02047045|18870656|P2|Baseline|Withdrawal by Subject|15
5459859|NCT02047045|18870657|P1|Baseline|Withdrawal by Subject|8
5459860|NCT02046993|18870721|P2|Overall Study|Lost to Follow-up|1
5459861|NCT02046993|18870722|P1|Overall Study|Lost to Follow-up|1
5459862|NCT02046993|18870721|P2|Overall Study|Withdrawal by Subject|10
5459863|NCT02046993|18870722|P1|Overall Study|Withdrawal by Subject|2
5459864|NCT02046616|18870794|P1|8-Week FU Period|Lost to Follow-up|1
5459865|NCT02046616|18870794|P1|24-Week Treatment Period|Other|1
5459866|NCT02046616|18870794|P1|24-Week Treatment Period|Physician Decision|3
5459867|NCT02046616|18870794|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
5459868|NCT02046616|18870794|P1|24-Week Treatment Period|Any Other Adverse Event|13
5459869|NCT02046616|18870794|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
5459870|NCT02046603|18870816|P2|Overall Study|Adverse Event|1
5459871|NCT02046603|18870817|P1|Overall Study|Adverse Event|0
5459872|NCT02046603|18870816|P2|Overall Study|Death|1
5459873|NCT02046603|18870817|P1|Overall Study|Death|0
5459874|NCT02046603|18870816|P2|Overall Study|Lost to Follow-up|2
5459875|NCT02046603|18870817|P1|Overall Study|Lost to Follow-up|1
5459876|NCT02046603|18870816|P2|Overall Study|Physician Decision|1
5459877|NCT02046603|18870817|P1|Overall Study|Physician Decision|2
5459878|NCT02046603|18870816|P2|Overall Study|Participant/legal guardian decision|3
5459879|NCT02046603|18870817|P1|Overall Study|Participant/legal guardian decision|1
5459880|NCT02046603|18870816|P2|Overall Study|Protocol Violation|1
5459881|NCT02046603|18870817|P1|Overall Study|Protocol Violation|0
5459882|NCT02046603|18870816|P2|Overall Study|Other|66
5459883|NCT02046603|18870817|P1|Overall Study|Other|11
5459884|NCT02046564|18870896|P2|Overall Study|Subject met withdrawal criteria|5
5459885|NCT02046564|18870897|P1|Overall Study|Subject met withdrawal criteria|2
5459886|NCT02046564|18870896|P2|Overall Study|Withdrawal by Subject|10
5459887|NCT02046564|18870897|P1|Overall Study|Withdrawal by Subject|4
5459888|NCT02046564|18870896|P2|Overall Study|Protocol Violation|1
5459889|NCT02046564|18870897|P1|Overall Study|Protocol Violation|3
5459890|NCT02046564|18870896|P2|Overall Study|Physician Decision|1
5459891|NCT02046564|18870897|P1|Overall Study|Physician Decision|0
5459892|NCT02046564|18870896|P2|Overall Study|Adverse Event|3
5459893|NCT02046564|18870897|P1|Overall Study|Adverse Event|6
5459894|NCT02046369|18870945|P2|Overall Study|non compliance|0
5459895|NCT02046369|18870946|P1|Overall Study|non compliance|1
5459896|NCT02046369|18870945|P2|Overall Study|never received study drug|1
5459897|NCT02046369|18870946|P1|Overall Study|never received study drug|0
5459898|NCT02046369|18870945|P2|Overall Study|Withdrawal by Subject|6
5459899|NCT02046369|18870946|P1|Overall Study|Withdrawal by Subject|3
5459900|NCT02046369|18870945|P2|Overall Study|Protocol Violation|2
5459901|NCT02046369|18870946|P1|Overall Study|Protocol Violation|1
5459902|NCT02046369|18870945|P2|Overall Study|Lost to Follow-up|3
5459903|NCT02046369|18870946|P1|Overall Study|Lost to Follow-up|3
5459904|NCT02046369|18870945|P2|Overall Study|Lack of Efficacy|3
5459905|NCT02046369|18870946|P1|Overall Study|Lack of Efficacy|3
5459906|NCT02046369|18870945|P2|Overall Study|Adverse Event|3
5459907|NCT02046369|18870946|P1|Overall Study|Adverse Event|3
5459908|NCT02046226|18870990|P1|Overall Study|Lost to Follow-up|7
5459909|NCT02046148|18871038|P2|Overall Study|Withdrawal by Subject|2
5459910|NCT02046148|18871039|P1|Overall Study|Withdrawal by Subject|0
5459911|NCT02046148|18871038|P2|Overall Study|Lost to Follow-up|1
5459912|NCT02046148|18871039|P1|Overall Study|Lost to Follow-up|1
5459913|NCT02046122|18871116|P1|Overall Study|Withdrawal by Subject|1
5459914|NCT02046122|18871116|P1|Overall Study|Physician Decision|8
5459915|NCT02046070|18871130|P3|Overall Study|Reason not Specified|6
5459916|NCT02046070|18871131|P2|Overall Study|Reason not Specified|4
5459917|NCT02046070|18871132|P1|Overall Study|Reason not Specified|4
5459918|NCT02046070|18871130|P3|Overall Study|Study Terminated by Sponsor|1
5459919|NCT02046070|18871131|P2|Overall Study|Study Terminated by Sponsor|1
5459920|NCT02046070|18871132|P1|Overall Study|Study Terminated by Sponsor|1
5459921|NCT02046070|18871130|P3|Overall Study|Withdrawal by Subject|6
5459922|NCT02046070|18871131|P2|Overall Study|Withdrawal by Subject|2
5459923|NCT02046070|18871132|P1|Overall Study|Withdrawal by Subject|1
5459924|NCT02046070|18871130|P3|Overall Study|Adverse Event|17
5459925|NCT02046070|18871131|P2|Overall Study|Adverse Event|10
5459926|NCT02046070|18871132|P1|Overall Study|Adverse Event|8
5459927|NCT02046070|18871130|P3|Overall Study|Progressive Disease|40
5459928|NCT02046070|18871131|P2|Overall Study|Progressive Disease|11
5459929|NCT02046070|18871132|P1|Overall Study|Progressive Disease|18
5459930|NCT02045979|18871192|P3|Overall Study|not specified above|0
5459931|NCT02045979|18871193|P2|Overall Study|not specified above|1
5459932|NCT02045979|18871194|P1|Overall Study|not specified above|0
5459933|NCT02045979|18871192|P3|Overall Study|Informed Consent Withdrawn|1
5459934|NCT02045979|18871193|P2|Overall Study|Informed Consent Withdrawn|0
5459935|NCT02045979|18871194|P1|Overall Study|Informed Consent Withdrawn|2
5459936|NCT02045875|18871231|P2|Overall Study|Withdrawal by Subject|3
5459937|NCT02045875|18871232|P1|Overall Study|Withdrawal by Subject|4
5459938|NCT02045875|18871231|P2|Overall Study|Lost to Follow-up|0
5459939|NCT02045875|18871232|P1|Overall Study|Lost to Follow-up|3
5459940|NCT02045862|18871243|P3|Overall Study|Lost to Follow-up|6
5459941|NCT02045862|18871244|P2|Overall Study|Lost to Follow-up|2
5459942|NCT02045862|18871245|P1|Overall Study|Lost to Follow-up|1
5459943|NCT02045862|18871243|P3|Overall Study|Adverse Event|27
5459944|NCT02045862|18871244|P2|Overall Study|Adverse Event|5
5459945|NCT02045862|18871245|P1|Overall Study|Adverse Event|7
5459946|NCT02045862|18871243|P3|Overall Study|Randomized but not Received Study Drug|8
5459947|NCT02045862|18871244|P2|Overall Study|Randomized but not Received Study Drug|2
5459948|NCT02045862|18871245|P1|Overall Study|Randomized but not Received Study Drug|0
5459949|NCT02045862|18871243|P3|Overall Study|Lack of Efficacy|13
5459950|NCT02045862|18871244|P2|Overall Study|Lack of Efficacy|4
5459951|NCT02045862|18871245|P1|Overall Study|Lack of Efficacy|8
5459952|NCT02045862|18871243|P3|Overall Study|Protocol Violation|6
5459953|NCT02045862|18871244|P2|Overall Study|Protocol Violation|0
5459954|NCT02045862|18871245|P1|Overall Study|Protocol Violation|0
5459955|NCT02045862|18871243|P3|Overall Study|Withdrawal by Patient|57
5459956|NCT02045862|18871244|P2|Overall Study|Withdrawal by Patient|27
5459957|NCT02045862|18871245|P1|Overall Study|Withdrawal by Patient|18
5459958|NCT02045862|18871243|P3|Overall Study|Miscellaneous|8
5459959|NCT02045862|18871244|P2|Overall Study|Miscellaneous|0
5459960|NCT02045862|18871245|P1|Overall Study|Miscellaneous|5
5459961|NCT02045862|18871243|P3|Overall Study|Death|1
5459962|NCT02045862|18871244|P2|Overall Study|Death|0
5459963|NCT02045862|18871245|P1|Overall Study|Death|0
5459964|NCT02045836|18871426|P2|Overall Study|Migrated from study area|2
5459965|NCT02045836|18871427|P1|Overall Study|Migrated from study area|0
5459966|NCT02045836|18871426|P2|Overall Study|Lost to Follow-up|7
5459967|NCT02045836|18871427|P1|Overall Study|Lost to Follow-up|4
5459968|NCT02045836|18871426|P2|Overall Study|Withdrawal by Subject|1
5459969|NCT02045836|18871427|P1|Overall Study|Withdrawal by Subject|1
5459970|NCT02045836|18871426|P2|Overall Study|Adverse Event|4
5459971|NCT02045836|18871427|P1|Overall Study|Adverse Event|4
5459972|NCT02045797|18871459|P3|Overall Study|Withdrawal by Subject|0
5459973|NCT02045797|18871460|P2|Overall Study|Withdrawal by Subject|2
5459974|NCT02045797|18871461|P1|Overall Study|Withdrawal by Subject|1
5459975|NCT02045797|18871459|P3|Overall Study|Physician Decision|0
5459976|NCT02045797|18871460|P2|Overall Study|Physician Decision|1
5459977|NCT02045797|18871461|P1|Overall Study|Physician Decision|0
5459978|NCT02045797|18871459|P3|Overall Study|Lost to Follow-up|1
5459979|NCT02045797|18871460|P2|Overall Study|Lost to Follow-up|3
5459980|NCT02045797|18871461|P1|Overall Study|Lost to Follow-up|2
5459981|NCT02045797|18871459|P3|Overall Study|Lack of Efficacy|0
5459982|NCT02045797|18871460|P2|Overall Study|Lack of Efficacy|0
5459983|NCT02045797|18871461|P1|Overall Study|Lack of Efficacy|1
5459984|NCT02045797|18871459|P3|Overall Study|Adverse Event|0
5459985|NCT02045797|18871460|P2|Overall Study|Adverse Event|1
5459986|NCT02045797|18871461|P1|Overall Study|Adverse Event|3
5459987|NCT02045732|18871606|P2|Overall Study|At the discretion of the investigator|1
5459988|NCT02045732|18871607|P1|Overall Study|At the discretion of the investigator|1
5459989|NCT02045433|18871644|P1|Overall Study|Withdrawal by Subject|1
5459990|NCT02045212|18871697|P2|Overall Study|Finished 13 weeks, chose not to extend|0
5459991|NCT02045212|18871698|P1|Overall Study|Finished 13 weeks, chose not to extend|1
5459992|NCT02045212|18871697|P2|Overall Study|Withdrawal by Subject|0
5459993|NCT02045212|18871698|P1|Overall Study|Withdrawal by Subject|1
5459994|NCT02045212|18871697|P2|Overall Study|Adverse Event|1
5459995|NCT02045212|18871698|P1|Overall Study|Adverse Event|0
5459996|NCT02045095|18871763|P7|Overall Study|Adverse Event|0
5459997|NCT02045095|18871764|P6|Overall Study|Adverse Event|2
5459998|NCT02045095|18871765|P5|Overall Study|Adverse Event|0
5459999|NCT02045095|18871766|P4|Overall Study|Adverse Event|0
5460000|NCT02045095|18871767|P3|Overall Study|Adverse Event|1
5460001|NCT02045095|18871768|P2|Overall Study|Adverse Event|1
5460002|NCT02045095|18871769|P1|Overall Study|Adverse Event|0
5460003|NCT02045095|18871763|P7|Overall Study|Withdrawal by Subject|0
5460004|NCT02045095|18871764|P6|Overall Study|Withdrawal by Subject|0
5460005|NCT02045095|18871765|P5|Overall Study|Withdrawal by Subject|3
5460006|NCT02045095|18871766|P4|Overall Study|Withdrawal by Subject|0
5460007|NCT02045095|18871767|P3|Overall Study|Withdrawal by Subject|0
5460008|NCT02045095|18871768|P2|Overall Study|Withdrawal by Subject|0
5460009|NCT02045095|18871769|P1|Overall Study|Withdrawal by Subject|0
5460010|NCT02045095|18871763|P7|Overall Study|Progressive Disease|1
5460011|NCT02045095|18871764|P6|Overall Study|Progressive Disease|4
5460012|NCT02045095|18871765|P5|Overall Study|Progressive Disease|2
5460013|NCT02045095|18871766|P4|Overall Study|Progressive Disease|4
5460014|NCT02045095|18871767|P3|Overall Study|Progressive Disease|2
5460015|NCT02045095|18871768|P2|Overall Study|Progressive Disease|3
5460016|NCT02045095|18871769|P1|Overall Study|Progressive Disease|3
5460017|NCT02045095|18871763|P7|Overall Study|Other|0
5460018|NCT02045095|18871764|P6|Overall Study|Other|2
5460019|NCT02045095|18871765|P5|Overall Study|Other|0
5460020|NCT02045095|18871766|P4|Overall Study|Other|0
5460021|NCT02045095|18871767|P3|Overall Study|Other|1
5460022|NCT02045095|18871768|P2|Overall Study|Other|0
5460023|NCT02045095|18871769|P1|Overall Study|Other|0
5460024|NCT02044874|18871927|P3|Overall Study|Other|8
5460025|NCT02044874|18871928|P2|Overall Study|Other|3
5460026|NCT02044874|18871929|P1|Overall Study|Other|7
5460027|NCT02044874|18871927|P3|Overall Study|Sponsor Decision|1
5460028|NCT02044874|18871928|P2|Overall Study|Sponsor Decision|1
5460029|NCT02044874|18871929|P1|Overall Study|Sponsor Decision|0
5460030|NCT02044874|18871927|P3|Overall Study|Lost to Follow-up|21
5460031|NCT02044874|18871928|P2|Overall Study|Lost to Follow-up|27
5460032|NCT02044874|18871929|P1|Overall Study|Lost to Follow-up|10
5460033|NCT02044874|18871927|P3|Overall Study|Physician Decision|1
5460034|NCT02044874|18871928|P2|Overall Study|Physician Decision|2
5460035|NCT02044874|18871929|P1|Overall Study|Physician Decision|0
5460036|NCT02044874|18871927|P3|Overall Study|Withdrawal by Subject|23
5460037|NCT02044874|18871928|P2|Overall Study|Withdrawal by Subject|16
5460038|NCT02044874|18871929|P1|Overall Study|Withdrawal by Subject|8
5460039|NCT02044874|18871927|P3|Overall Study|Adverse Event|6
5460040|NCT02044874|18871928|P2|Overall Study|Adverse Event|6
5460041|NCT02044874|18871929|P1|Overall Study|Adverse Event|5
5460042|NCT02044848|18871951|P2|Overall Study|Administrative Problems|3
5460043|NCT02044848|18871952|P1|Overall Study|Administrative Problems|2
5460044|NCT02044822|18871958|P1|Overall Study|Lost to Follow-up|1
5460045|NCT02044822|18871958|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
5460046|NCT02044822|18871958|P1|Overall Study|Withdrew Consent|3
5460047|NCT02044822|18871958|P1|Overall Study|Investigator's Discretion|10
5460048|NCT02044822|18871958|P1|Overall Study|Study Terminated by Sponsor|77
5460049|NCT02044510|18872000|P2|Overall Study|Adverse Event|2
5460050|NCT02044510|18872001|P1|Overall Study|Adverse Event|1
5460051|NCT02044458|18872009|P2|Overall Study|Protocol Violation|8
5460052|NCT02044458|18872010|P1|Overall Study|Protocol Violation|3
5460053|NCT02044302|18872096|P2|Overall Study|study terminated|0
5460054|NCT02044302|18872097|P1|Overall Study|study terminated|2
5460055|NCT02044159|18872105|P2|Overall Study|Nurse declined to give study drug|0
5460056|NCT02044159|18872106|P1|Overall Study|Nurse declined to give study drug|1
5460057|NCT02044159|18872105|P2|Overall Study|No longer eligible, drug not given|0
5460058|NCT02044159|18872106|P1|Overall Study|No longer eligible, drug not given|1
5460059|NCT02044159|18872105|P2|Overall Study|Consent declined (deferred consent)|4
5460060|NCT02044159|18872106|P1|Overall Study|Consent declined (deferred consent)|2
5460061|NCT02044094|18872119|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
5460062|NCT02044094|18872119|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
5460063|NCT02044094|18872119|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
5460064|NCT02044094|18872119|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
5460065|NCT02044094|18872119|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
5460066|NCT02044094|18872119|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
5460067|NCT02044094|18872119|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
5460068|NCT02044094|18872119|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
5460069|NCT02043938|18872176|P1|Overall Study|Investigator decision|1
5460070|NCT02043938|18872176|P1|Overall Study|No show by subject|1
5460071|NCT02043938|18872176|P1|Overall Study|Unable to place EEG sensors on patient|1
5460072|NCT02043938|18872176|P1|Overall Study|Withdrawal by Subject|7
5460073|NCT02043782|18872231|P6|Period 1|Adverse Event|0
5460074|NCT02043782|18872232|P5|Period 1|Adverse Event|0
5460075|NCT02043782|18872233|P4|Period 1|Adverse Event|0
5460076|NCT02043782|18872234|P3|Period 1|Adverse Event|1
5460077|NCT02043782|18872235|P2|Period 1|Adverse Event|0
5460078|NCT02043782|18872236|P1|Period 1|Adverse Event|0
5460079|NCT02043678|18872279|P2|Overall Study|Ongoing with treatment|104
5460080|NCT02043678|18872280|P1|Overall Study|Ongoing with treatment|87
5460081|NCT02043678|18872279|P2|Overall Study|Withdrawal by Subject|13
5460082|NCT02043678|18872280|P1|Overall Study|Withdrawal by Subject|10
5460083|NCT02043678|18872279|P2|Overall Study|Protocol-driven decision point|45
5460084|NCT02043678|18872280|P1|Overall Study|Protocol-driven decision point|53
5460085|NCT02043678|18872279|P2|Overall Study|Radiological PD|67
5460086|NCT02043678|18872280|P1|Overall Study|Radiological PD|78
5460087|NCT02043678|18872279|P2|Overall Study|Clinical PD|112
5460088|NCT02043678|18872280|P1|Overall Study|Clinical PD|88
5460089|NCT02043678|18872279|P2|Overall Study|Other|8
5460090|NCT02043678|18872280|P1|Overall Study|Other|15
5460091|NCT02043678|18872279|P2|Overall Study|Lost to Follow-up|1
5460092|NCT02043678|18872280|P1|Overall Study|Lost to Follow-up|1
5460093|NCT02043678|18872279|P2|Overall Study|AE without clinical PD|31
5460094|NCT02043678|18872280|P1|Overall Study|AE without clinical PD|41
5460095|NCT02043678|18872279|P2|Overall Study|AE with clinical progressive disease(PD)|15
5460096|NCT02043678|18872280|P1|Overall Study|AE with clinical progressive disease(PD)|17
5460097|NCT02043678|18872279|P2|Overall Study|Never treated|9
5460098|NCT02043678|18872280|P1|Overall Study|Never treated|11
5460099|NCT02043548|18872316|P2|Overall Study|Adverse Event|1
5460100|NCT02043548|18872317|P1|Overall Study|Adverse Event|0
5460101|NCT02043548|18872316|P2|Overall Study|Lack of Efficacy|0
5460102|NCT02043548|18872317|P1|Overall Study|Lack of Efficacy|1
5460103|NCT02043509|18872335|P2|Baseline to 2nd Follow-up|Withdrawal by Subject|5
5460104|NCT02043509|18872336|P1|Baseline to 2nd Follow-up|Withdrawal by Subject|7
5460105|NCT02043509|18872335|P2|Baseline to 2nd Follow-up|Lost to Follow-up|67
5460106|NCT02043509|18872336|P1|Baseline to 2nd Follow-up|Lost to Follow-up|67
5460107|NCT02043509|18872335|P2|Baseline to 1st Follow-up|Withdrawal by Subject|0
5460108|NCT02043509|18872336|P1|Baseline to 1st Follow-up|Withdrawal by Subject|4
5460109|NCT02043509|18872335|P2|Baseline to 1st Follow-up|Lost to Follow-up|47
5460110|NCT02043509|18872336|P1|Baseline to 1st Follow-up|Lost to Follow-up|61
5460111|NCT02043366|18872424|P6|Overall Study|Lost to Follow-up|2
5460112|NCT02043366|18872425|P5|Overall Study|Lost to Follow-up|2
5460113|NCT02043366|18872426|P4|Overall Study|Lost to Follow-up|2
5460114|NCT02043366|18872427|P3|Overall Study|Lost to Follow-up|2
5460115|NCT02043366|18872428|P2|Overall Study|Lost to Follow-up|2
5460116|NCT02043366|18872429|P1|Overall Study|Lost to Follow-up|2
5460117|NCT02043301|18872452|P3|Overall Study|Discontinued|0
5460118|NCT02043301|18872453|P2|Overall Study|Discontinued|1
5460119|NCT02043301|18872454|P1|Overall Study|Discontinued|0
5460120|NCT02043132|18872551|P2|Overall Study|screen failures|8
5460121|NCT02043132|18872552|P1|Overall Study|screen failures|4
5460122|NCT02043132|18872551|P2|Overall Study|Lost to Follow-up|1
5460123|NCT02043132|18872552|P1|Overall Study|Lost to Follow-up|1
5460124|NCT02043015|18872572|P1|Overall Study|Incarceration|1
5460125|NCT02043015|18872572|P1|Overall Study|Participant moved away from study city|4
5460126|NCT02043015|18872572|P1|Overall Study|Removed once target enrollment reached|15
5460127|NCT02043015|18872572|P1|Overall Study|Withdrawal by Subject|4
5460128|NCT02043015|18872572|P1|Overall Study|Lost to Follow-up|4
5460129|NCT02042950|18872585|P1|Overall Study|Progressive Disease|4
5460130|NCT02042924|18872591|P1|Overall Study|Early Death|1
5460131|NCT02042443|18872639|P2|Overall Study|Not eligible/not analyzable|6
5460132|NCT02042443|18872640|P1|Overall Study|Not eligible/not analyzable|3
5460133|NCT02042443|18872639|P2|Overall Study|not protocol specified|1
5460134|NCT02042443|18872640|P1|Overall Study|not protocol specified|1
5460135|NCT02042443|18872639|P2|Overall Study|Progression|17
5460136|NCT02042443|18872640|P1|Overall Study|Progression|21
5460137|NCT02042443|18872639|P2|Overall Study|Withdrawal by Subject|1
5460138|NCT02042443|18872640|P1|Overall Study|Withdrawal by Subject|0
5460139|NCT02042443|18872639|P2|Overall Study|Adverse Event|1
5460140|NCT02042443|18872640|P1|Overall Study|Adverse Event|2
5460141|NCT02042404|18872652|P2|Overall Study|Inability to meet time requirements|0
5460142|NCT02042404|18872653|P1|Overall Study|Inability to meet time requirements|1
5460143|NCT02042404|18872652|P2|Overall Study|Unrelated Adverse Event|0
5460144|NCT02042404|18872653|P1|Overall Study|Unrelated Adverse Event|3
5460145|NCT02042404|18872652|P2|Overall Study|Death|0
5460146|NCT02042404|18872653|P1|Overall Study|Death|1
5460147|NCT02042183|18872671|P2|Overall Study|Lost to Follow-up|2
5460148|NCT02042183|18872672|P1|Overall Study|Lost to Follow-up|9
5460149|NCT02042183|18872671|P2|Overall Study|Site Terminated by Sponsor|1
5460150|NCT02042183|18872672|P1|Overall Study|Site Terminated by Sponsor|2
5460151|NCT02042183|18872671|P2|Overall Study|Withdrawal by Subject|16
5460152|NCT02042183|18872672|P1|Overall Study|Withdrawal by Subject|21
5460153|NCT02042183|18872671|P2|Overall Study|Other|3
5460154|NCT02042183|18872672|P1|Overall Study|Other|3
5460155|NCT02042183|18872671|P2|Overall Study|Adverse Event|6
5460156|NCT02042183|18872672|P1|Overall Study|Adverse Event|17
5460157|NCT02042183|18872671|P2|Overall Study|Non-compliance with Study Drug|3
5460158|NCT02042183|18872672|P1|Overall Study|Non-compliance with Study Drug|2
5460159|NCT02042183|18872671|P2|Overall Study|Lack of Efficacy|3
5460160|NCT02042183|18872672|P1|Overall Study|Lack of Efficacy|4
5460161|NCT02042183|18872671|P2|Overall Study|Physician Decision|2
5460162|NCT02042183|18872672|P1|Overall Study|Physician Decision|7
5460163|NCT02042014|18872702|P1|Overall Study|Physician Decision|7
5460164|NCT02042014|18872702|P1|Overall Study|Adverse Event|1
5460165|NCT02041962|18872708|P2|Overall Study|Withdrawal by Subject|11
5460166|NCT02041962|18872709|P1|Overall Study|Withdrawal by Subject|0
5460167|NCT02041962|18872708|P2|Overall Study|Lost to Follow-up|32
5460168|NCT02041962|18872709|P1|Overall Study|Lost to Follow-up|37
5460169|NCT02041962|18872708|P2|Overall Study|Death|1
5460170|NCT02041962|18872709|P1|Overall Study|Death|1
5460171|NCT02041962|18872708|P2|Overall Study|Lost Aetna Coverage|40
5460172|NCT02041962|18872709|P1|Overall Study|Lost Aetna Coverage|43
5460173|NCT02041702|18872719|P2|Overall Study|Cardiac Resynchronization Therapy|0
5460174|NCT02041702|18872720|P1|Overall Study|Cardiac Resynchronization Therapy|1
5460175|NCT02041702|18872719|P2|Overall Study|Patient not confirmed as MRI compatible|0
5460176|NCT02041702|18872720|P1|Overall Study|Patient not confirmed as MRI compatible|1
5460177|NCT02041702|18872719|P2|Overall Study|Withdrawal by Subject|3
5460178|NCT02041702|18872720|P1|Overall Study|Withdrawal by Subject|4
5460179|NCT02041702|18872719|P2|Overall Study|Death|0
5460180|NCT02041702|18872720|P1|Overall Study|Death|4
5460181|NCT02041702|18872719|P2|Overall Study|Lost to Follow-up|6
5460182|NCT02041702|18872720|P1|Overall Study|Lost to Follow-up|1
5460183|NCT02041533|18872735|P2|Overall Study|Randomized, not treated|7
5460184|NCT02041533|18872736|P1|Overall Study|Randomized, not treated|4
5460185|NCT02041533|18872735|P2|Overall Study|Completed max number of chemo cycles|29
5460186|NCT02041533|18872736|P1|Overall Study|Completed max number of chemo cycles|0
5460187|NCT02041533|18872735|P2|Overall Study|Other reasons|1
5460188|NCT02041533|18872736|P1|Overall Study|Other reasons|0
5460189|NCT02041533|18872735|P2|Overall Study|Poor/non-compliance|0
5460190|NCT02041533|18872736|P1|Overall Study|Poor/non-compliance|1
5460191|NCT02041533|18872735|P2|Overall Study|Maximum clinical benefit|18
5460192|NCT02041533|18872736|P1|Overall Study|Maximum clinical benefit|0
5460193|NCT02041533|18872735|P2|Overall Study|Withdrawal by Subject|1
5460194|NCT02041533|18872736|P1|Overall Study|Withdrawal by Subject|2
5460195|NCT02041533|18872735|P2|Overall Study|Subject request to discontinue treatment|9
5460196|NCT02041533|18872736|P1|Overall Study|Subject request to discontinue treatment|5
5460197|NCT02041533|18872735|P2|Overall Study|Adverse Event unrelated to study drug|21
5460198|NCT02041533|18872736|P1|Overall Study|Adverse Event unrelated to study drug|20
5460199|NCT02041533|18872735|P2|Overall Study|Death|0
5460200|NCT02041533|18872736|P1|Overall Study|Death|1
5460201|NCT02041533|18872735|P2|Overall Study|Study drug toxicity|30
5460202|NCT02041533|18872736|P1|Overall Study|Study drug toxicity|27
5460203|NCT02041533|18872735|P2|Overall Study|Disease Progression|142
5460204|NCT02041533|18872736|P1|Overall Study|Disease Progression|168
5460205|NCT02041520|18872758|P2|Overall Study|Hypothiroidism identified during follow-|1
5460206|NCT02041520|18872759|P1|Overall Study|Hypothiroidism identified during follow-|0
5460207|NCT02041520|18872758|P2|Overall Study|Lost to Follow-up|1
5460208|NCT02041520|18872759|P1|Overall Study|Lost to Follow-up|0
5460209|NCT02041520|18872758|P2|Overall Study|Protocol Violation|0
5460210|NCT02041520|18872759|P1|Overall Study|Protocol Violation|1
5460211|NCT02041520|18872758|P2|Overall Study|Withdrawal by Subject|4
5460212|NCT02041520|18872759|P1|Overall Study|Withdrawal by Subject|3
5460213|NCT02041520|18872758|P2|Overall Study|Adverse Event|1
5460214|NCT02041520|18872759|P1|Overall Study|Adverse Event|2
5460215|NCT02041286|18872802|P1|Overall Study|Adverse Event|1
5460216|NCT02041104|18872837|P2|Overall Study|discomfort during OGTT|3
5460217|NCT02041104|18872838|P1|Overall Study|discomfort during OGTT|0
5460218|NCT02041104|18872837|P2|Overall Study|Lost to Follow-up|4
5460219|NCT02041104|18872838|P1|Overall Study|Lost to Follow-up|1
5460220|NCT02041091|18872878|P2|Optional Safety Extension Period|Lost to Follow-up|3
5460221|NCT02041091|18872879|P1|Optional Safety Extension Period|Lost to Follow-up|2
5460222|NCT02041091|18872878|P2|Optional Safety Extension Period|Sponsor Decision|74
5460223|NCT02041091|18872879|P1|Optional Safety Extension Period|Sponsor Decision|70
5460224|NCT02041091|18872878|P2|Optional Safety Extension Period|Physician Decision|1
5460225|NCT02041091|18872879|P1|Optional Safety Extension Period|Physician Decision|2
5460226|NCT02041091|18872878|P2|Optional Safety Extension Period|Protocol Violation|0
5460227|NCT02041091|18872879|P1|Optional Safety Extension Period|Protocol Violation|2
5460228|NCT02041091|18872878|P2|Optional Safety Extension Period|Withdrawal by Subject|2
5460229|NCT02041091|18872879|P1|Optional Safety Extension Period|Withdrawal by Subject|5
5460230|NCT02041091|18872878|P2|Optional Safety Extension Period|Adverse Event|2
5460231|NCT02041091|18872879|P1|Optional Safety Extension Period|Adverse Event|4
5460232|NCT02041091|18872878|P2|Treatment|Lost to Follow-up|0
5460233|NCT02041091|18872879|P1|Treatment|Lost to Follow-up|1
5460234|NCT02041091|18872878|P2|Treatment|Sponsor Decision|16
5460235|NCT02041091|18872879|P1|Treatment|Sponsor Decision|15
5460236|NCT02041091|18872878|P2|Treatment|Physician Decision|0
5460237|NCT02041091|18872879|P1|Treatment|Physician Decision|1
5460238|NCT02041091|18872878|P2|Treatment|Withdrawal by Subject|4
5460239|NCT02041091|18872879|P1|Treatment|Withdrawal by Subject|2
5460240|NCT02041091|18872878|P2|Treatment|Adverse Event|3
5460241|NCT02041091|18872879|P1|Treatment|Adverse Event|3
5460242|NCT02040870|18872901|P1|Overall Study|Death|13
5460243|NCT02040870|18872901|P1|Overall Study|Lost to Follow-up|3
5460244|NCT02040870|18872901|P1|Overall Study|Subject/guardian decision|10
5460245|NCT02040870|18872901|P1|Overall Study|Physician Decision|6
5460246|NCT02040870|18872901|P1|Overall Study|Progressive disease|58
5460247|NCT02040870|18872901|P1|Overall Study|Adverse Event|7
5460248|NCT02040870|18872901|P1|Overall Study|Completed treatment phase|6
5460249|NCT02040857|18872922|P1|Overall Study|ineligible|1
5460250|NCT02040857|18872922|P1|Overall Study|recurrence|4
5460251|NCT02040857|18872922|P1|Overall Study|Lost to Follow-up|2
5460252|NCT02040857|18872922|P1|Overall Study|patient non-compliance|3
5460253|NCT02040857|18872922|P1|Overall Study|Withdrawal by Subject|31
5460254|NCT02040857|18872922|P1|Overall Study|Physician Decision|5
5460255|NCT02040857|18872922|P1|Overall Study|Adverse Event|14
5460256|NCT02040844|18872935|P3|Overall Study|Concomitant medication|1
5460257|NCT02040844|18872936|P2|Overall Study|Concomitant medication|3
5460258|NCT02040844|18872937|P1|Overall Study|Concomitant medication|1
5460259|NCT02040844|18872935|P3|Overall Study|Non-specified|5
5460260|NCT02040844|18872936|P2|Overall Study|Non-specified|2
5460261|NCT02040844|18872937|P1|Overall Study|Non-specified|8
5460262|NCT02040844|18872935|P3|Overall Study|Missing|2
5460263|NCT02040844|18872936|P2|Overall Study|Missing|3
5460264|NCT02040844|18872937|P1|Overall Study|Missing|13
5460265|NCT02040844|18872935|P3|Overall Study|Lost to Follow-up|13
5460266|NCT02040844|18872936|P2|Overall Study|Lost to Follow-up|9
5460267|NCT02040844|18872937|P1|Overall Study|Lost to Follow-up|12
5460268|NCT02040844|18872935|P3|Overall Study|Withdrawal by Subject|25
5460269|NCT02040844|18872936|P2|Overall Study|Withdrawal by Subject|22
5460270|NCT02040844|18872937|P1|Overall Study|Withdrawal by Subject|16
5460271|NCT02040844|18872935|P3|Overall Study|Adverse Event|1
5460272|NCT02040844|18872936|P2|Overall Study|Adverse Event|0
5460273|NCT02040844|18872937|P1|Overall Study|Adverse Event|0
5460274|NCT02040805|18872962|P2|Overall Study|Withdrawal by Subject|41
5460275|NCT02040805|18872963|P1|Overall Study|Withdrawal by Subject|28
5460276|NCT02040805|18872962|P2|Overall Study|Lost to Follow-up|9
5460277|NCT02040805|18872963|P1|Overall Study|Lost to Follow-up|14
5460278|NCT02040779|18872999|P3|Overall Study|Lack of Efficacy|0
5460279|NCT02040779|18873000|P2|Overall Study|Lack of Efficacy|2
5460280|NCT02040779|18873001|P1|Overall Study|Lack of Efficacy|4
5460281|NCT02040779|18872999|P3|Overall Study|Lost to Follow-up|1
5460282|NCT02040779|18873000|P2|Overall Study|Lost to Follow-up|2
5460283|NCT02040779|18873001|P1|Overall Study|Lost to Follow-up|1
5460284|NCT02040779|18872999|P3|Overall Study|Protocol Violation|0
5460285|NCT02040779|18873000|P2|Overall Study|Protocol Violation|1
5460286|NCT02040779|18873001|P1|Overall Study|Protocol Violation|2
5460287|NCT02040779|18872999|P3|Overall Study|Non-compliance|0
5460288|NCT02040779|18873000|P2|Overall Study|Non-compliance|1
5460289|NCT02040779|18873001|P1|Overall Study|Non-compliance|0
5460290|NCT02040779|18872999|P3|Overall Study|Withdrawal by Subject|3
5460291|NCT02040779|18873000|P2|Overall Study|Withdrawal by Subject|1
5460292|NCT02040779|18873001|P1|Overall Study|Withdrawal by Subject|4
5460293|NCT02040779|18872999|P3|Overall Study|Adverse Event|0
5460294|NCT02040779|18873000|P2|Overall Study|Adverse Event|0
5460295|NCT02040779|18873001|P1|Overall Study|Adverse Event|1
5460296|NCT02040766|18873041|P5|Overall Study|Lack of Efficacy|5
5460297|NCT02040766|18873042|P4|Overall Study|Lack of Efficacy|6
5460298|NCT02040766|18873043|P3|Overall Study|Lack of Efficacy|4
5460299|NCT02040766|18873044|P2|Overall Study|Lack of Efficacy|3
5460300|NCT02040766|18873045|P1|Overall Study|Lack of Efficacy|6
5460301|NCT02040766|18873041|P5|Overall Study|Not reported|0
5460302|NCT02040766|18873042|P4|Overall Study|Not reported|0
5460303|NCT02040766|18873043|P3|Overall Study|Not reported|0
5460304|NCT02040766|18873044|P2|Overall Study|Not reported|0
5460305|NCT02040766|18873045|P1|Overall Study|Not reported|1
5460306|NCT02040766|18873041|P5|Overall Study|Lost to Follow-up|4
5460307|NCT02040766|18873042|P4|Overall Study|Lost to Follow-up|1
5460308|NCT02040766|18873043|P3|Overall Study|Lost to Follow-up|3
5460309|NCT02040766|18873044|P2|Overall Study|Lost to Follow-up|1
5460310|NCT02040766|18873045|P1|Overall Study|Lost to Follow-up|4
5460311|NCT02040766|18873041|P5|Overall Study|Protocol Violation|0
5460312|NCT02040766|18873042|P4|Overall Study|Protocol Violation|3
5460313|NCT02040766|18873043|P3|Overall Study|Protocol Violation|2
5460314|NCT02040766|18873044|P2|Overall Study|Protocol Violation|1
5460315|NCT02040766|18873045|P1|Overall Study|Protocol Violation|2
5460316|NCT02040766|18873041|P5|Overall Study|Non-compliance|0
5460317|NCT02040766|18873042|P4|Overall Study|Non-compliance|0
5460318|NCT02040766|18873043|P3|Overall Study|Non-compliance|0
5460319|NCT02040766|18873044|P2|Overall Study|Non-compliance|1
5460320|NCT02040766|18873045|P1|Overall Study|Non-compliance|0
5460321|NCT02040766|18873041|P5|Overall Study|Withdrawal by Subject|2
5460322|NCT02040766|18873042|P4|Overall Study|Withdrawal by Subject|3
5460323|NCT02040766|18873043|P3|Overall Study|Withdrawal by Subject|2
5460324|NCT02040766|18873044|P2|Overall Study|Withdrawal by Subject|3
5460325|NCT02040766|18873045|P1|Overall Study|Withdrawal by Subject|4
5460326|NCT02040766|18873041|P5|Overall Study|Adverse Event|2
5460327|NCT02040766|18873042|P4|Overall Study|Adverse Event|0
5460328|NCT02040766|18873043|P3|Overall Study|Adverse Event|1
5460329|NCT02040766|18873044|P2|Overall Study|Adverse Event|1
5460330|NCT02040766|18873045|P1|Overall Study|Adverse Event|1
5460331|NCT02040584|18873098|P2|Overall Study|Immunosuppressant/prohibited med use|10
5460332|NCT02040584|18873099|P1|Overall Study|Immunosuppressant/prohibited med use|7
5460333|NCT02040584|18873098|P2|Overall Study|Transplant rejection/retransplant|1
5460334|NCT02040584|18873099|P1|Overall Study|Transplant rejection/retransplant|0
5460335|NCT02040584|18873098|P2|Overall Study|Death|3
5460336|NCT02040584|18873099|P1|Overall Study|Death|6
5460337|NCT02040584|18873098|P2|Overall Study|Unsatisfactory therapeutic effect|1
5460338|NCT02040584|18873099|P1|Overall Study|Unsatisfactory therapeutic effect|0
5460339|NCT02040584|18873098|P2|Overall Study|Protocol Violation|11
5460340|NCT02040584|18873099|P1|Overall Study|Protocol Violation|9
5460341|NCT02040584|18873098|P2|Overall Study|Adverse Event|6
5460342|NCT02040584|18873099|P1|Overall Study|Adverse Event|13
5460343|NCT02040532|18873132|P1|Overall Study|Withdrawal by Subject|3
5460344|NCT02040532|18873132|P1|Overall Study|Adverse Event|4
5460345|NCT02040532|18873132|P1|Overall Study|Physician Decision|4
5460346|NCT02040532|18873132|P1|Overall Study|Lost to Follow-up|1
5460347|NCT02040428|18873145|P2|Overall Study|Withdrawal by Subject|1
5460348|NCT02040428|18873146|P1|Overall Study|Withdrawal by Subject|1
5460349|NCT02040428|18873145|P2|Overall Study|Death|3
5460350|NCT02040428|18873146|P1|Overall Study|Death|4
5460351|NCT02040259|18873158|P1|Overall Study|Withdrawal by Subject|4
5460352|NCT02040259|18873158|P1|Overall Study|Assessment not completed|3
5460353|NCT02040259|18873158|P1|Overall Study|Lost to Follow-up|76
5460354|NCT02040259|18873158|P1|Overall Study|Death|280
5460355|NCT02039908|18873232|P4|Phase 2-School Year|Withdrawal by Subject|5
5460356|NCT02039908|18873233|P3|Phase 2-School Year|Withdrawal by Subject|8
5460357|NCT02039908|18873234|P2|Phase 2-School Year|Withdrawal by Subject|0
5460358|NCT02039908|18873235|P1|Phase 2-School Year|Withdrawal by Subject|0
5460359|NCT02039908|18873232|P4|Phase 2-School Year|Protocol Violation|0
5460360|NCT02039908|18873233|P3|Phase 2-School Year|Protocol Violation|3
5460361|NCT02039908|18873234|P2|Phase 2-School Year|Protocol Violation|0
5460362|NCT02039908|18873235|P1|Phase 2-School Year|Protocol Violation|0
5460363|NCT02039908|18873232|P4|Phase 2-School Year|Lost to Follow-up|3
5460364|NCT02039908|18873233|P3|Phase 2-School Year|Lost to Follow-up|1
5460365|NCT02039908|18873234|P2|Phase 2-School Year|Lost to Follow-up|0
5460366|NCT02039908|18873235|P1|Phase 2-School Year|Lost to Follow-up|0
5460367|NCT02039908|18873232|P4|Phase 1-Summer|Protocol Violation|0
5460368|NCT02039908|18873233|P3|Phase 1-Summer|Protocol Violation|0
5460369|NCT02039908|18873234|P2|Phase 1-Summer|Protocol Violation|0
5460370|NCT02039908|18873235|P1|Phase 1-Summer|Protocol Violation|6
5460371|NCT02039908|18873232|P4|Phase 1-Summer|Withdrawal by Subject|0
5460372|NCT02039908|18873233|P3|Phase 1-Summer|Withdrawal by Subject|0
5460373|NCT02039908|18873234|P2|Phase 1-Summer|Withdrawal by Subject|6
5460374|NCT02039908|18873235|P1|Phase 1-Summer|Withdrawal by Subject|7
5460375|NCT02039856|18873249|P2|Overall Study|Withdrawal by Subject|618
5460376|NCT02039856|18873250|P1|Overall Study|Withdrawal by Subject|1573
5460377|NCT02039856|18873249|P2|Overall Study|Lost to Follow-up|206
5460378|NCT02039856|18873250|P1|Overall Study|Lost to Follow-up|388
5460379|NCT02039856|18873249|P2|Overall Study|Partial survey completion|26
5460380|NCT02039856|18873250|P1|Overall Study|Partial survey completion|61
5460381|NCT02039856|18873249|P2|Overall Study|Death|3
5460382|NCT02039856|18873250|P1|Overall Study|Death|5
5460383|NCT02039778|18873282|P1|Overall Study|Never started the protocol treatment|1
5460384|NCT02039778|18873282|P1|Overall Study|Withdrawal by Subject|1
5460385|NCT02039778|18873282|P1|Overall Study|Death|2
5460386|NCT02039687|18873305|P4|Overall Study|treatment assignment could not be confir|0
5460387|NCT02039687|18873306|P3|Overall Study|treatment assignment could not be confir|2
5460388|NCT02039687|18873307|P2|Overall Study|treatment assignment could not be confir|0
5460389|NCT02039687|18873308|P1|Overall Study|treatment assignment could not be confir|0
5460390|NCT02039687|18873305|P4|Overall Study|Withdrawal by Subject|0
5460391|NCT02039687|18873306|P3|Overall Study|Withdrawal by Subject|0
5460392|NCT02039687|18873307|P2|Overall Study|Withdrawal by Subject|1
5460393|NCT02039687|18873308|P1|Overall Study|Withdrawal by Subject|0
5460394|NCT02039687|18873305|P4|Overall Study|Adverse Event|0
5460395|NCT02039687|18873306|P3|Overall Study|Adverse Event|1
5460396|NCT02039687|18873307|P2|Overall Study|Adverse Event|0
5460397|NCT02039687|18873308|P1|Overall Study|Adverse Event|0
5460398|NCT02039674|18873348|P14|Overall Study|Ongoing in Study|3
5460399|NCT02039674|18873349|P13|Overall Study|Ongoing in Study|33
5460400|NCT02039674|18873350|P12|Overall Study|Ongoing in Study|34
5460401|NCT02039674|18873351|P11|Overall Study|Ongoing in Study|1
5460402|NCT02039674|18873352|P10|Overall Study|Ongoing in Study|6
5460403|NCT02039674|18873353|P9|Overall Study|Ongoing in Study|1
5460404|NCT02039674|18873354|P8|Overall Study|Ongoing in Study|0
5460405|NCT02039674|18873355|P7|Overall Study|Ongoing in Study|2
5460406|NCT02039674|18873356|P6|Overall Study|Ongoing in Study|1
5460407|NCT02039674|18873357|P5|Overall Study|Ongoing in Study|3
5460408|NCT02039674|18873358|P4|Overall Study|Ongoing in Study|2
5460409|NCT02039674|18873359|P3|Overall Study|Ongoing in Study|3
5460410|NCT02039674|18873360|P2|Overall Study|Ongoing in Study|2
5460411|NCT02039674|18873361|P1|Overall Study|Ongoing in Study|5
5460412|NCT02039674|18873348|P14|Overall Study|Withdrawal by Subject|2
5460413|NCT02039674|18873349|P13|Overall Study|Withdrawal by Subject|5
5460414|NCT02039674|18873350|P12|Overall Study|Withdrawal by Subject|3
5460415|NCT02039674|18873351|P11|Overall Study|Withdrawal by Subject|1
5460416|NCT02039674|18873352|P10|Overall Study|Withdrawal by Subject|2
5460417|NCT02039674|18873353|P9|Overall Study|Withdrawal by Subject|0
5460418|NCT02039674|18873354|P8|Overall Study|Withdrawal by Subject|0
5460419|NCT02039674|18873355|P7|Overall Study|Withdrawal by Subject|0
5460420|NCT02039674|18873356|P6|Overall Study|Withdrawal by Subject|0
5460421|NCT02039674|18873357|P5|Overall Study|Withdrawal by Subject|1
5460422|NCT02039674|18873358|P4|Overall Study|Withdrawal by Subject|0
5460423|NCT02039674|18873359|P3|Overall Study|Withdrawal by Subject|1
5460424|NCT02039674|18873360|P2|Overall Study|Withdrawal by Subject|2
5460425|NCT02039674|18873361|P1|Overall Study|Withdrawal by Subject|0
5460426|NCT02039674|18873348|P14|Overall Study|Progressive Disease|16
5460427|NCT02039674|18873349|P13|Overall Study|Progressive Disease|18
5460428|NCT02039674|18873350|P12|Overall Study|Progressive Disease|17
5460429|NCT02039674|18873351|P11|Overall Study|Progressive Disease|0
5460430|NCT02039674|18873352|P10|Overall Study|Progressive Disease|2
5460431|NCT02039674|18873353|P9|Overall Study|Progressive Disease|7
5460432|NCT02039674|18873354|P8|Overall Study|Progressive Disease|3
5460433|NCT02039674|18873355|P7|Overall Study|Progressive Disease|1
5460434|NCT02039674|18873356|P6|Overall Study|Progressive Disease|10
5460435|NCT02039674|18873357|P5|Overall Study|Progressive Disease|8
5460436|NCT02039674|18873358|P4|Overall Study|Progressive Disease|7
5460437|NCT02039674|18873359|P3|Overall Study|Progressive Disease|6
5460438|NCT02039674|18873360|P2|Overall Study|Progressive Disease|7
5460439|NCT02039674|18873361|P1|Overall Study|Progressive Disease|6
5460440|NCT02039674|18873348|P14|Overall Study|Physician Decision|0
5460441|NCT02039674|18873349|P13|Overall Study|Physician Decision|0
5460442|NCT02039674|18873350|P12|Overall Study|Physician Decision|1
5460443|NCT02039674|18873351|P11|Overall Study|Physician Decision|0
5460444|NCT02039674|18873352|P10|Overall Study|Physician Decision|0
5460445|NCT02039674|18873353|P9|Overall Study|Physician Decision|0
5460446|NCT02039674|18873354|P8|Overall Study|Physician Decision|0
5460447|NCT02039674|18873355|P7|Overall Study|Physician Decision|0
5460448|NCT02039674|18873356|P6|Overall Study|Physician Decision|0
5460449|NCT02039674|18873357|P5|Overall Study|Physician Decision|0
5460450|NCT02039674|18873358|P4|Overall Study|Physician Decision|0
5460451|NCT02039674|18873359|P3|Overall Study|Physician Decision|0
5460452|NCT02039674|18873360|P2|Overall Study|Physician Decision|0
5460453|NCT02039674|18873361|P1|Overall Study|Physician Decision|0
5460454|NCT02039674|18873348|P14|Overall Study|Lost to Follow-up|0
5460455|NCT02039674|18873349|P13|Overall Study|Lost to Follow-up|1
5460456|NCT02039674|18873350|P12|Overall Study|Lost to Follow-up|0
5460457|NCT02039674|18873351|P11|Overall Study|Lost to Follow-up|0
5460458|NCT02039674|18873352|P10|Overall Study|Lost to Follow-up|0
5460459|NCT02039674|18873353|P9|Overall Study|Lost to Follow-up|0
5460460|NCT02039674|18873354|P8|Overall Study|Lost to Follow-up|0
5460461|NCT02039674|18873355|P7|Overall Study|Lost to Follow-up|0
5460462|NCT02039674|18873356|P6|Overall Study|Lost to Follow-up|0
5460463|NCT02039674|18873357|P5|Overall Study|Lost to Follow-up|0
5460464|NCT02039674|18873358|P4|Overall Study|Lost to Follow-up|0
5460465|NCT02039674|18873359|P3|Overall Study|Lost to Follow-up|0
5460466|NCT02039674|18873360|P2|Overall Study|Lost to Follow-up|0
5460467|NCT02039674|18873361|P1|Overall Study|Lost to Follow-up|0
5460468|NCT02039674|18873348|P14|Overall Study|Excluded Medication|3
5460469|NCT02039674|18873349|P13|Overall Study|Excluded Medication|4
5460470|NCT02039674|18873350|P12|Overall Study|Excluded Medication|2
5460471|NCT02039674|18873351|P11|Overall Study|Excluded Medication|4
5460472|NCT02039674|18873352|P10|Overall Study|Excluded Medication|2
5460473|NCT02039674|18873353|P9|Overall Study|Excluded Medication|2
5460474|NCT02039674|18873354|P8|Overall Study|Excluded Medication|0
5460475|NCT02039674|18873355|P7|Overall Study|Excluded Medication|0
5460476|NCT02039674|18873356|P6|Overall Study|Excluded Medication|1
5460477|NCT02039674|18873357|P5|Overall Study|Excluded Medication|0
5460478|NCT02039674|18873358|P4|Overall Study|Excluded Medication|1
5460479|NCT02039674|18873359|P3|Overall Study|Excluded Medication|0
5460480|NCT02039674|18873360|P2|Overall Study|Excluded Medication|1
5460481|NCT02039674|18873361|P1|Overall Study|Excluded Medication|1
5460482|NCT02039674|18873348|P14|Overall Study|Death|8
5460483|NCT02039674|18873349|P13|Overall Study|Death|0
5460484|NCT02039674|18873350|P12|Overall Study|Death|1
5460485|NCT02039674|18873351|P11|Overall Study|Death|1
5460486|NCT02039674|18873352|P10|Overall Study|Death|0
5460487|NCT02039674|18873353|P9|Overall Study|Death|0
5460488|NCT02039674|18873354|P8|Overall Study|Death|0
5460489|NCT02039674|18873355|P7|Overall Study|Death|0
5460490|NCT02039674|18873356|P6|Overall Study|Death|0
5460491|NCT02039674|18873357|P5|Overall Study|Death|0
5460492|NCT02039674|18873358|P4|Overall Study|Death|2
5460493|NCT02039674|18873359|P3|Overall Study|Death|1
5460494|NCT02039674|18873360|P2|Overall Study|Death|0
5460495|NCT02039674|18873361|P1|Overall Study|Death|0
5460496|NCT02039674|18873348|P14|Overall Study|Adverse Event|1
5460497|NCT02039674|18873349|P13|Overall Study|Adverse Event|2
5460498|NCT02039674|18873350|P12|Overall Study|Adverse Event|2
5460499|NCT02039674|18873351|P11|Overall Study|Adverse Event|0
5460500|NCT02039674|18873352|P10|Overall Study|Adverse Event|0
5460501|NCT02039674|18873353|P9|Overall Study|Adverse Event|2
5460502|NCT02039674|18873354|P8|Overall Study|Adverse Event|0
5460503|NCT02039674|18873355|P7|Overall Study|Adverse Event|0
5460504|NCT02039674|18873356|P6|Overall Study|Adverse Event|0
5460505|NCT02039674|18873357|P5|Overall Study|Adverse Event|0
5460506|NCT02039674|18873358|P4|Overall Study|Adverse Event|1
5460507|NCT02039674|18873359|P3|Overall Study|Adverse Event|1
5460508|NCT02039674|18873360|P2|Overall Study|Adverse Event|0
5460509|NCT02039674|18873361|P1|Overall Study|Adverse Event|0
5460510|NCT02039505|18873403|P7|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
5460511|NCT02039505|18873404|P6|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5460512|NCT02039505|18873405|P5|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5460513|NCT02039505|18873406|P4|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5460514|NCT02039505|18873407|P3|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5460515|NCT02039505|18873408|P2|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5460516|NCT02039505|18873409|P1|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
5460517|NCT02039505|18873403|P7|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
5460518|NCT02039505|18873404|P6|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5460519|NCT02039505|18873405|P5|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5460520|NCT02039505|18873406|P4|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5460521|NCT02039505|18873407|P3|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5460522|NCT02039505|18873408|P2|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5460523|NCT02039505|18873409|P1|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
5460524|NCT02039505|18873403|P7|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
5460525|NCT02039505|18873404|P6|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5460526|NCT02039505|18873405|P5|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5460527|NCT02039505|18873406|P4|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5460528|NCT02039505|18873407|P3|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5460529|NCT02039505|18873408|P2|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5460530|NCT02039505|18873409|P1|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
5460531|NCT02039505|18873403|P7|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
5460532|NCT02039505|18873404|P6|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5460533|NCT02039505|18873405|P5|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5460534|NCT02039505|18873406|P4|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5460535|NCT02039505|18873407|P3|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5460536|NCT02039505|18873408|P2|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5460537|NCT02039505|18873409|P1|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
5460538|NCT02039505|18873403|P7|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5460539|NCT02039505|18873404|P6|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5460540|NCT02039505|18873405|P5|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5460541|NCT02039505|18873406|P4|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
5460542|NCT02039505|18873407|P3|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5460543|NCT02039505|18873408|P2|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5460544|NCT02039505|18873409|P1|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
5460545|NCT02039505|18873403|P7|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5460546|NCT02039505|18873404|P6|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
5460547|NCT02039505|18873405|P5|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
5460548|NCT02039505|18873406|P4|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
5460549|NCT02039505|18873407|P3|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5460550|NCT02039505|18873408|P2|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5460551|NCT02039505|18873409|P1|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
5460552|NCT02039505|18873403|P7|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5460553|NCT02039505|18873404|P6|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
5460554|NCT02039505|18873405|P5|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
5460555|NCT02039505|18873406|P4|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
5460556|NCT02039505|18873407|P3|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5460557|NCT02039505|18873408|P2|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5460558|NCT02039505|18873409|P1|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
5460559|NCT02039505|18873403|P7|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5460560|NCT02039505|18873404|P6|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
5460561|NCT02039505|18873405|P5|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
5460562|NCT02039505|18873406|P4|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
5460563|NCT02039505|18873407|P3|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5460564|NCT02039505|18873408|P2|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5460565|NCT02039505|18873409|P1|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
5460566|NCT02039505|18873403|P7|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5460567|NCT02039505|18873404|P6|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5460568|NCT02039505|18873405|P5|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5460569|NCT02039505|18873406|P4|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5460570|NCT02039505|18873407|P3|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5460571|NCT02039505|18873408|P2|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
5460572|NCT02039505|18873409|P1|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
5460573|NCT02039505|18873403|P7|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5460574|NCT02039505|18873404|P6|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5460575|NCT02039505|18873405|P5|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5460576|NCT02039505|18873406|P4|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
5460577|NCT02039505|18873407|P3|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
5460578|NCT02039505|18873408|P2|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
5460579|NCT02039505|18873409|P1|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
5460580|NCT02039505|18873403|P7|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5460581|NCT02039505|18873404|P6|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5460582|NCT02039505|18873405|P5|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5460583|NCT02039505|18873406|P4|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
5460584|NCT02039505|18873407|P3|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
5460585|NCT02039505|18873408|P2|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
5460586|NCT02039505|18873409|P1|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
5460587|NCT02039427|18873485|P4|Overall Study|Steroid Use|0
5460588|NCT02039427|18873486|P3|Overall Study|Steroid Use|0
5460589|NCT02039427|18873487|P2|Overall Study|Steroid Use|0
5460590|NCT02039427|18873488|P1|Overall Study|Steroid Use|1
5460591|NCT02039427|18873485|P4|Overall Study|Loss of follow - up|4
5460592|NCT02039427|18873486|P3|Overall Study|Loss of follow - up|2
5460593|NCT02039427|18873487|P2|Overall Study|Loss of follow - up|0
5460594|NCT02039427|18873488|P1|Overall Study|Loss of follow - up|1
5460595|NCT02039427|18873485|P4|Overall Study|Cancellation of surgery|0
5460596|NCT02039427|18873486|P3|Overall Study|Cancellation of surgery|1
5460597|NCT02039427|18873487|P2|Overall Study|Cancellation of surgery|0
5460598|NCT02039427|18873488|P1|Overall Study|Cancellation of surgery|0
5460599|NCT02039427|18873485|P4|Overall Study|Withdrawal on concent|1
5460600|NCT02039427|18873486|P3|Overall Study|Withdrawal on concent|0
5460601|NCT02039427|18873487|P2|Overall Study|Withdrawal on concent|0
5460602|NCT02039427|18873488|P1|Overall Study|Withdrawal on concent|0
5460603|NCT02039427|18873485|P4|Overall Study|Duration of surgery > 3h|0
5460604|NCT02039427|18873486|P3|Overall Study|Duration of surgery > 3h|0
5460605|NCT02039427|18873487|P2|Overall Study|Duration of surgery > 3h|1
5460606|NCT02039427|18873488|P1|Overall Study|Duration of surgery > 3h|1
5460607|NCT02039414|18873508|P2|Overall Study|Protocol Violation|1
5460608|NCT02039414|18873509|P1|Overall Study|Protocol Violation|3
5460609|NCT02039414|18873508|P2|Overall Study|Lost to Follow-up|0
5460610|NCT02039414|18873509|P1|Overall Study|Lost to Follow-up|2
5460611|NCT02039414|18873508|P2|Overall Study|Delivered|1
5460612|NCT02039414|18873509|P1|Overall Study|Delivered|1
5460613|NCT02039375|18873521|P1|Overall Study|Lost to Follow-up|2
5460614|NCT02039219|18873532|P2|Follow up|Adverse Event|1
5460615|NCT02039219|18873533|P1|Follow up|Adverse Event|0
5460616|NCT02039219|18873532|P2|Treatment|Death|0
5460617|NCT02039219|18873533|P1|Treatment|Death|1
5460618|NCT02039219|18873532|P2|Treatment|Protocol Violation|0
5460619|NCT02039219|18873533|P1|Treatment|Protocol Violation|1
5460620|NCT02039219|18873532|P2|Treatment|Lost to Follow-up|1
5460621|NCT02039219|18873533|P1|Treatment|Lost to Follow-up|0
5460622|NCT02039219|18873532|P2|Treatment|Physician Decision|0
5460623|NCT02039219|18873533|P1|Treatment|Physician Decision|1
5460624|NCT02039219|18873532|P2|Treatment|Adverse Event|1
5460625|NCT02039219|18873533|P1|Treatment|Adverse Event|0
5460626|NCT02039219|18873532|P2|Treatment|Withdrawal by Subject|0
5460627|NCT02039219|18873533|P1|Treatment|Withdrawal by Subject|1
5460628|NCT02038959|18873582|P2|Overall Study|Withdrawal by Subject|8
5460629|NCT02038959|18873583|P1|Overall Study|Withdrawal by Subject|6
5460630|NCT02038946|18873609|P1|Overall Study|Other reasons|1
5460631|NCT02038946|18873609|P1|Overall Study|Lost to Follow-up|2
5460632|NCT02038946|18873609|P1|Overall Study|Withdrawal by Subject|3
5460633|NCT02038946|18873609|P1|Overall Study|Death|5
5460634|NCT02038933|18873620|P1|Follow-up|Disease Progression|2
5460635|NCT02038933|18873620|P1|Follow-up|Withdrawal by Subject|1
5460636|NCT02038933|18873620|P1|Follow-up|Lost to Follow-up|1
5460637|NCT02038933|18873620|P1|Follow-up|Adverse event unrelated to study drug|4
5460638|NCT02038933|18873620|P1|Follow-up|Death|11
5460639|NCT02038933|18873620|P1|Treatment|Withdrawal by Subject|1
5460640|NCT02038933|18873620|P1|Treatment|Disease Progression|101
5460641|NCT02038933|18873620|P1|Treatment|Study Drug Toxicity|4
5460642|NCT02038933|18873620|P1|Treatment|Adverse Event Unrelated to Study Drug|6
5460643|NCT02038933|18873620|P1|Treatment|Lost to Follow-up|1
5460644|NCT02038933|18873620|P1|Treatment|No longer meets study criteria|1
5460645|NCT02038920|18873641|P6|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
5460646|NCT02038920|18873642|P5|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5460647|NCT02038920|18873643|P4|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5460648|NCT02038920|18873644|P3|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5460649|NCT02038920|18873645|P2|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5460650|NCT02038920|18873646|P1|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
5460651|NCT02038920|18873641|P6|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
5460652|NCT02038920|18873642|P5|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5460653|NCT02038920|18873643|P4|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5460654|NCT02038920|18873644|P3|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5460655|NCT02038920|18873645|P2|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5460656|NCT02038920|18873646|P1|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
5460657|NCT02038920|18873641|P6|Open Label Cohort (Week 10 to 154)|Pregnancy|1
5460658|NCT02038920|18873642|P5|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5460659|NCT02038920|18873643|P4|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5460660|NCT02038920|18873644|P3|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5460661|NCT02038920|18873645|P2|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5460662|NCT02038920|18873646|P1|Open Label Cohort (Week 10 to 154)|Pregnancy|0
5460663|NCT02038920|18873641|P6|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
5460664|NCT02038920|18873642|P5|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5460665|NCT02038920|18873643|P4|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5460666|NCT02038920|18873644|P3|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5460667|NCT02038920|18873645|P2|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5460668|NCT02038920|18873646|P1|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
5460669|NCT02038920|18873641|P6|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
5460670|NCT02038920|18873642|P5|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5460671|NCT02038920|18873643|P4|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5460672|NCT02038920|18873644|P3|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5460673|NCT02038920|18873645|P2|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5460674|NCT02038920|18873646|P1|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
5460675|NCT02038920|18873641|P6|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
5460676|NCT02038920|18873642|P5|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5460677|NCT02038920|18873643|P4|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5460678|NCT02038920|18873644|P3|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5460679|NCT02038920|18873645|P2|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5460680|NCT02038920|18873646|P1|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
5460681|NCT02038920|18873641|P6|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
5460682|NCT02038920|18873642|P5|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
5460683|NCT02038920|18873643|P4|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
5460684|NCT02038920|18873644|P3|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
5460685|NCT02038920|18873645|P2|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
5460686|NCT02038920|18873646|P1|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
5460687|NCT02038920|18873641|P6|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5460688|NCT02038920|18873642|P5|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5460689|NCT02038920|18873643|P4|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5460690|NCT02038920|18873644|P3|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
5460691|NCT02038920|18873645|P2|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5460692|NCT02038920|18873646|P1|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
5460693|NCT02038920|18873641|P6|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
5460694|NCT02038920|18873642|P5|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
5460695|NCT02038920|18873643|P4|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
5460696|NCT02038920|18873644|P3|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
5460697|NCT02038920|18873645|P2|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
5460698|NCT02038920|18873646|P1|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
5460699|NCT02038920|18873641|P6|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5460700|NCT02038920|18873642|P5|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5460701|NCT02038920|18873643|P4|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5460702|NCT02038920|18873644|P3|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
5460703|NCT02038920|18873645|P2|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
5460704|NCT02038920|18873646|P1|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
5460705|NCT02038920|18873641|P6|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5460706|NCT02038920|18873642|P5|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5460707|NCT02038920|18873643|P4|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5460708|NCT02038920|18873644|P3|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5460709|NCT02038920|18873645|P2|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
5460710|NCT02038920|18873646|P1|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
5460711|NCT02038920|18873641|P6|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5460712|NCT02038920|18873642|P5|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5460713|NCT02038920|18873643|P4|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5460714|NCT02038920|18873644|P3|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
5460715|NCT02038920|18873645|P2|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
5460716|NCT02038920|18873646|P1|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
5460717|NCT02038907|18873723|P14|Overall Study|Withdrawal by Subject|0
5460718|NCT02038907|18873724|P13|Overall Study|Withdrawal by Subject|0
5460719|NCT02038907|18873725|P12|Overall Study|Withdrawal by Subject|0
5460720|NCT02038907|18873726|P11|Overall Study|Withdrawal by Subject|1
5460721|NCT02038907|18873727|P10|Overall Study|Withdrawal by Subject|0
5460722|NCT02038907|18873728|P9|Overall Study|Withdrawal by Subject|0
5460723|NCT02038907|18873729|P8|Overall Study|Withdrawal by Subject|0
5460724|NCT02038907|18873730|P7|Overall Study|Withdrawal by Subject|0
5460725|NCT02038907|18873731|P6|Overall Study|Withdrawal by Subject|0
5460726|NCT02038907|18873732|P5|Overall Study|Withdrawal by Subject|0
5460727|NCT02038907|18873733|P4|Overall Study|Withdrawal by Subject|0
5460728|NCT02038907|18873734|P3|Overall Study|Withdrawal by Subject|0
5460729|NCT02038907|18873735|P2|Overall Study|Withdrawal by Subject|0
5460730|NCT02038907|18873736|P1|Overall Study|Withdrawal by Subject|0
5460731|NCT02038907|18873723|P14|Overall Study|Protocol Violation|0
5460732|NCT02038907|18873724|P13|Overall Study|Protocol Violation|0
5460733|NCT02038907|18873725|P12|Overall Study|Protocol Violation|0
5460734|NCT02038907|18873726|P11|Overall Study|Protocol Violation|1
5460735|NCT02038907|18873727|P10|Overall Study|Protocol Violation|0
5460736|NCT02038907|18873728|P9|Overall Study|Protocol Violation|0
5460737|NCT02038907|18873729|P8|Overall Study|Protocol Violation|0
5460738|NCT02038907|18873730|P7|Overall Study|Protocol Violation|0
5460739|NCT02038907|18873731|P6|Overall Study|Protocol Violation|0
5460740|NCT02038907|18873732|P5|Overall Study|Protocol Violation|0
5460741|NCT02038907|18873733|P4|Overall Study|Protocol Violation|0
5460742|NCT02038907|18873734|P3|Overall Study|Protocol Violation|0
5460743|NCT02038907|18873735|P2|Overall Study|Protocol Violation|0
5460744|NCT02038907|18873736|P1|Overall Study|Protocol Violation|0
5460745|NCT02038881|18874287|P3|Overall Study|incarcerated|0
5460746|NCT02038881|18874288|P2|Overall Study|incarcerated|0
5460747|NCT02038881|18874289|P1|Overall Study|incarcerated|1
5460748|NCT02038881|18874287|P3|Overall Study|Lost to Follow-up|0
5460749|NCT02038881|18874288|P2|Overall Study|Lost to Follow-up|0
5460750|NCT02038881|18874289|P1|Overall Study|Lost to Follow-up|2
5460751|NCT02038881|18874287|P3|Overall Study|Withdrawal by Subject|1
5460752|NCT02038881|18874288|P2|Overall Study|Withdrawal by Subject|0
5460753|NCT02038881|18874289|P1|Overall Study|Withdrawal by Subject|0
5460754|NCT02038829|18874362|P12|Treatment Period 6|Adverse Event|0
5460755|NCT02038829|18874363|P11|Treatment Period 6|Adverse Event|0
5460756|NCT02038829|18874364|P10|Treatment Period 6|Adverse Event|0
5460757|NCT02038829|18874365|P9|Treatment Period 6|Adverse Event|0
5460758|NCT02038829|18874366|P8|Treatment Period 6|Adverse Event|0
5460759|NCT02038829|18874367|P7|Treatment Period 6|Adverse Event|0
5460760|NCT02038829|18874368|P6|Treatment Period 6|Adverse Event|0
5460761|NCT02038829|18874369|P5|Treatment Period 6|Adverse Event|0
5460762|NCT02038829|18874370|P4|Treatment Period 6|Adverse Event|0
5460763|NCT02038829|18874371|P3|Treatment Period 6|Adverse Event|1
5460764|NCT02038829|18874372|P2|Treatment Period 6|Adverse Event|0
5460765|NCT02038829|18874373|P1|Treatment Period 6|Adverse Event|0
5460766|NCT02038829|18874362|P12|Washout Period 4|Adverse Event|0
5460767|NCT02038829|18874363|P11|Washout Period 4|Adverse Event|0
5460768|NCT02038829|18874364|P10|Washout Period 4|Adverse Event|0
5460769|NCT02038829|18874365|P9|Washout Period 4|Adverse Event|0
5460770|NCT02038829|18874366|P8|Washout Period 4|Adverse Event|0
5460771|NCT02038829|18874367|P7|Washout Period 4|Adverse Event|1
5460772|NCT02038829|18874368|P6|Washout Period 4|Adverse Event|0
5460773|NCT02038829|18874369|P5|Washout Period 4|Adverse Event|0
5460774|NCT02038829|18874370|P4|Washout Period 4|Adverse Event|0
5460775|NCT02038829|18874371|P3|Washout Period 4|Adverse Event|0
5460776|NCT02038829|18874372|P2|Washout Period 4|Adverse Event|0
5460777|NCT02038829|18874373|P1|Washout Period 4|Adverse Event|0
5460778|NCT02038829|18874362|P12|Treatment Period 4|Adverse Event|0
5460779|NCT02038829|18874363|P11|Treatment Period 4|Adverse Event|0
5460780|NCT02038829|18874364|P10|Treatment Period 4|Adverse Event|0
5460781|NCT02038829|18874365|P9|Treatment Period 4|Adverse Event|0
5460782|NCT02038829|18874366|P8|Treatment Period 4|Adverse Event|0
5460783|NCT02038829|18874367|P7|Treatment Period 4|Adverse Event|0
5460784|NCT02038829|18874368|P6|Treatment Period 4|Adverse Event|0
5460785|NCT02038829|18874369|P5|Treatment Period 4|Adverse Event|0
5460786|NCT02038829|18874370|P4|Treatment Period 4|Adverse Event|0
5460787|NCT02038829|18874371|P3|Treatment Period 4|Adverse Event|0
5460788|NCT02038829|18874372|P2|Treatment Period 4|Adverse Event|1
5460789|NCT02038829|18874373|P1|Treatment Period 4|Adverse Event|0
5460790|NCT02038829|18874362|P12|Washout Period 2|Withdrawal by Subject|0
5460791|NCT02038829|18874363|P11|Washout Period 2|Withdrawal by Subject|0
5460792|NCT02038829|18874364|P10|Washout Period 2|Withdrawal by Subject|0
5460793|NCT02038829|18874365|P9|Washout Period 2|Withdrawal by Subject|0
5460794|NCT02038829|18874366|P8|Washout Period 2|Withdrawal by Subject|0
5460795|NCT02038829|18874367|P7|Washout Period 2|Withdrawal by Subject|0
5460796|NCT02038829|18874368|P6|Washout Period 2|Withdrawal by Subject|1
5460797|NCT02038829|18874369|P5|Washout Period 2|Withdrawal by Subject|0
5460798|NCT02038829|18874370|P4|Washout Period 2|Withdrawal by Subject|0
5460799|NCT02038829|18874371|P3|Washout Period 2|Withdrawal by Subject|0
5460800|NCT02038829|18874372|P2|Washout Period 2|Withdrawal by Subject|0
5460801|NCT02038829|18874373|P1|Washout Period 2|Withdrawal by Subject|0
5460802|NCT02038829|18874362|P12|Washout Period 2|Adverse Event|0
5460803|NCT02038829|18874363|P11|Washout Period 2|Adverse Event|0
5460804|NCT02038829|18874364|P10|Washout Period 2|Adverse Event|0
5460805|NCT02038829|18874365|P9|Washout Period 2|Adverse Event|1
5460806|NCT02038829|18874366|P8|Washout Period 2|Adverse Event|0
5460807|NCT02038829|18874367|P7|Washout Period 2|Adverse Event|0
5460808|NCT02038829|18874368|P6|Washout Period 2|Adverse Event|0
5460809|NCT02038829|18874369|P5|Washout Period 2|Adverse Event|0
5460810|NCT02038829|18874370|P4|Washout Period 2|Adverse Event|0
5460811|NCT02038829|18874371|P3|Washout Period 2|Adverse Event|0
5460812|NCT02038829|18874372|P2|Washout Period 2|Adverse Event|0
5460813|NCT02038829|18874373|P1|Washout Period 2|Adverse Event|0
5460814|NCT02038829|18874362|P12|Treatment Period 2|Withdrawal by Subject|0
5460815|NCT02038829|18874363|P11|Treatment Period 2|Withdrawal by Subject|0
5460816|NCT02038829|18874364|P10|Treatment Period 2|Withdrawal by Subject|0
5460817|NCT02038829|18874365|P9|Treatment Period 2|Withdrawal by Subject|0
5460818|NCT02038829|18874366|P8|Treatment Period 2|Withdrawal by Subject|0
5460819|NCT02038829|18874367|P7|Treatment Period 2|Withdrawal by Subject|0
5460820|NCT02038829|18874368|P6|Treatment Period 2|Withdrawal by Subject|0
5460821|NCT02038829|18874369|P5|Treatment Period 2|Withdrawal by Subject|0
5460822|NCT02038829|18874370|P4|Treatment Period 2|Withdrawal by Subject|0
5460823|NCT02038829|18874371|P3|Treatment Period 2|Withdrawal by Subject|0
5460824|NCT02038829|18874372|P2|Treatment Period 2|Withdrawal by Subject|0
5460825|NCT02038829|18874373|P1|Treatment Period 2|Withdrawal by Subject|1
5460826|NCT02038829|18874362|P12|Treatment Period 2|Adverse Event|0
5460827|NCT02038829|18874363|P11|Treatment Period 2|Adverse Event|1
5460828|NCT02038829|18874364|P10|Treatment Period 2|Adverse Event|0
5460829|NCT02038829|18874365|P9|Treatment Period 2|Adverse Event|0
5460830|NCT02038829|18874366|P8|Treatment Period 2|Adverse Event|0
5460831|NCT02038829|18874367|P7|Treatment Period 2|Adverse Event|0
5460832|NCT02038829|18874368|P6|Treatment Period 2|Adverse Event|0
5460833|NCT02038829|18874369|P5|Treatment Period 2|Adverse Event|0
5460834|NCT02038829|18874370|P4|Treatment Period 2|Adverse Event|0
5460835|NCT02038829|18874371|P3|Treatment Period 2|Adverse Event|0
5460836|NCT02038829|18874372|P2|Treatment Period 2|Adverse Event|0
5460837|NCT02038829|18874373|P1|Treatment Period 2|Adverse Event|0
5460838|NCT02038829|18874362|P12|Washout Period 1|Death|0
5460839|NCT02038829|18874363|P11|Washout Period 1|Death|0
5460840|NCT02038829|18874364|P10|Washout Period 1|Death|0
5460841|NCT02038829|18874365|P9|Washout Period 1|Death|0
5460842|NCT02038829|18874366|P8|Washout Period 1|Death|0
5460843|NCT02038829|18874367|P7|Washout Period 1|Death|0
5460844|NCT02038829|18874368|P6|Washout Period 1|Death|0
5460845|NCT02038829|18874369|P5|Washout Period 1|Death|1
5460846|NCT02038829|18874370|P4|Washout Period 1|Death|0
5460847|NCT02038829|18874371|P3|Washout Period 1|Death|0
5460848|NCT02038829|18874372|P2|Washout Period 1|Death|0
5460849|NCT02038829|18874373|P1|Washout Period 1|Death|0
5460850|NCT02038790|18874407|P2|Day 0 - First Treatment|Withdrawal by Subject|1
5460851|NCT02038790|18874408|P1|Day 0 - First Treatment|Withdrawal by Subject|1
5460852|NCT02038764|18874444|P5|Overall Study|Other|0
5460853|NCT02038764|18874445|P4|Overall Study|Other|0
5460854|NCT02038764|18874446|P3|Overall Study|Other|1
5460855|NCT02038764|18874447|P2|Overall Study|Other|0
5460856|NCT02038764|18874448|P1|Overall Study|Other|1
5460857|NCT02038764|18874444|P5|Overall Study|Withdrawal by Subject|1
5460858|NCT02038764|18874445|P4|Overall Study|Withdrawal by Subject|0
5460859|NCT02038764|18874446|P3|Overall Study|Withdrawal by Subject|0
5460860|NCT02038764|18874447|P2|Overall Study|Withdrawal by Subject|0
5460861|NCT02038764|18874448|P1|Overall Study|Withdrawal by Subject|0
5460862|NCT02038764|18874444|P5|Overall Study|Lost to Follow-up|0
5460863|NCT02038764|18874445|P4|Overall Study|Lost to Follow-up|0
5460864|NCT02038764|18874446|P3|Overall Study|Lost to Follow-up|0
5460865|NCT02038764|18874447|P2|Overall Study|Lost to Follow-up|1
5460866|NCT02038764|18874448|P1|Overall Study|Lost to Follow-up|0
5460867|NCT02038764|18874444|P5|Overall Study|Adverse Event|0
5460868|NCT02038764|18874445|P4|Overall Study|Adverse Event|0
5460869|NCT02038764|18874446|P3|Overall Study|Adverse Event|1
5460870|NCT02038764|18874447|P2|Overall Study|Adverse Event|0
5460871|NCT02038764|18874448|P1|Overall Study|Adverse Event|0
5460872|NCT02038647|18874550|P2|Overall Study|Ongoing at Datacut|10
5460873|NCT02038647|18874551|P1|Overall Study|Ongoing at Datacut|9
5460874|NCT02038647|18874550|P2|Overall Study|Not Reported|1
5460875|NCT02038647|18874551|P1|Overall Study|Not Reported|0
5460876|NCT02038647|18874550|P2|Overall Study|Withdrawal by Subject|2
5460877|NCT02038647|18874551|P1|Overall Study|Withdrawal by Subject|5
5460878|NCT02038647|18874550|P2|Overall Study|Symptomatic Deterioration|7
5460879|NCT02038647|18874551|P1|Overall Study|Symptomatic Deterioration|7
5460880|NCT02038647|18874550|P2|Overall Study|Adverse Event|10
5460881|NCT02038647|18874551|P1|Overall Study|Adverse Event|18
5460882|NCT02038647|18874550|P2|Overall Study|Progressive Disease|59
5460883|NCT02038647|18874551|P1|Overall Study|Progressive Disease|50
5460884|NCT02038543|18874614|P4|Overall Study|Withdrawal by Subject|1
5460885|NCT02038543|18874615|P3|Overall Study|Withdrawal by Subject|0
5460886|NCT02038543|18874616|P2|Overall Study|Withdrawal by Subject|0
5460887|NCT02038543|18874617|P1|Overall Study|Withdrawal by Subject|0
5460888|NCT02038543|18874614|P4|Overall Study|Screen Failure|1
5460889|NCT02038543|18874615|P3|Overall Study|Screen Failure|0
5460890|NCT02038543|18874616|P2|Overall Study|Screen Failure|0
5460891|NCT02038543|18874617|P1|Overall Study|Screen Failure|0
5460892|NCT02038153|18874653|P1|Overall Study|Withdrawal by Subject|1
5460893|NCT02038075|18874660|P2|Overall Study|Withdrawal by Subject|0
5460894|NCT02038075|18874661|P1|Overall Study|Withdrawal by Subject|3
5460895|NCT02038049|18874669|P2|Overall Study|Lost to Follow-up|0
5460896|NCT02038049|18874670|P1|Overall Study|Lost to Follow-up|1
5460897|NCT02038010|18874699|P4|Follow Up|Other|0
5460898|NCT02038010|18874700|P3|Follow Up|Other|0
5460899|NCT02038010|18874701|P2|Follow Up|Other|0
5460900|NCT02038010|18874702|P1|Follow Up|Other|3
5460901|NCT02038010|18874699|P4|Follow Up|Death|0
5460902|NCT02038010|18874700|P3|Follow Up|Death|0
5460903|NCT02038010|18874701|P2|Follow Up|Death|3
5460904|NCT02038010|18874702|P1|Follow Up|Death|4
5460905|NCT02038010|18874699|P4|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
5460906|NCT02038010|18874700|P3|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
5460907|NCT02038010|18874701|P2|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
5460908|NCT02038010|18874702|P1|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
5460909|NCT02038010|18874699|P4|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
5460910|NCT02038010|18874700|P3|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
5460911|NCT02038010|18874701|P2|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
5460912|NCT02038010|18874702|P1|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
5460913|NCT02038010|18874699|P4|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
5460914|NCT02038010|18874700|P3|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
5460915|NCT02038010|18874701|P2|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
5460916|NCT02038010|18874702|P1|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
5460917|NCT02038010|18874699|P4|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
5460918|NCT02038010|18874700|P3|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
5460919|NCT02038010|18874701|P2|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
5460920|NCT02038010|18874702|P1|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
5460921|NCT02037984|18874729|P8|Overall Study|Withdrawal by Subject|1
5460922|NCT02037984|18874730|P7|Overall Study|Withdrawal by Subject|0
5460923|NCT02037984|18874731|P6|Overall Study|Withdrawal by Subject|3
5460924|NCT02037984|18874732|P5|Overall Study|Withdrawal by Subject|1
5460925|NCT02037984|18874733|P4|Overall Study|Withdrawal by Subject|1
5460926|NCT02037984|18874734|P3|Overall Study|Withdrawal by Subject|0
5460927|NCT02037984|18874735|P2|Overall Study|Withdrawal by Subject|0
5460928|NCT02037984|18874736|P1|Overall Study|Withdrawal by Subject|0
5460929|NCT02037984|18874729|P8|Overall Study|Withdrawal by Parent/Guardian|2
5460930|NCT02037984|18874730|P7|Overall Study|Withdrawal by Parent/Guardian|4
5460931|NCT02037984|18874731|P6|Overall Study|Withdrawal by Parent/Guardian|1
5460932|NCT02037984|18874732|P5|Overall Study|Withdrawal by Parent/Guardian|5
5460933|NCT02037984|18874733|P4|Overall Study|Withdrawal by Parent/Guardian|2
5460934|NCT02037984|18874734|P3|Overall Study|Withdrawal by Parent/Guardian|3
5460935|NCT02037984|18874735|P2|Overall Study|Withdrawal by Parent/Guardian|0
5460936|NCT02037984|18874736|P1|Overall Study|Withdrawal by Parent/Guardian|0
5460937|NCT02037984|18874729|P8|Overall Study|Technical Problems|2
5460938|NCT02037984|18874730|P7|Overall Study|Technical Problems|4
5460939|NCT02037984|18874731|P6|Overall Study|Technical Problems|3
5460940|NCT02037984|18874732|P5|Overall Study|Technical Problems|2
5460941|NCT02037984|18874733|P4|Overall Study|Technical Problems|3
5460942|NCT02037984|18874734|P3|Overall Study|Technical Problems|3
5460943|NCT02037984|18874735|P2|Overall Study|Technical Problems|0
5460944|NCT02037984|18874736|P1|Overall Study|Technical Problems|0
5460945|NCT02037984|18874729|P8|Overall Study|Protocol Violation|0
5460946|NCT02037984|18874730|P7|Overall Study|Protocol Violation|2
5460947|NCT02037984|18874731|P6|Overall Study|Protocol Violation|1
5460948|NCT02037984|18874732|P5|Overall Study|Protocol Violation|0
5460949|NCT02037984|18874733|P4|Overall Study|Protocol Violation|0
5460950|NCT02037984|18874734|P3|Overall Study|Protocol Violation|0
5460951|NCT02037984|18874735|P2|Overall Study|Protocol Violation|0
5460952|NCT02037984|18874736|P1|Overall Study|Protocol Violation|0
5460953|NCT02037984|18874729|P8|Overall Study|Physician Decision|0
5460954|NCT02037984|18874730|P7|Overall Study|Physician Decision|1
5460955|NCT02037984|18874731|P6|Overall Study|Physician Decision|0
5460956|NCT02037984|18874732|P5|Overall Study|Physician Decision|0
5460957|NCT02037984|18874733|P4|Overall Study|Physician Decision|0
5460958|NCT02037984|18874734|P3|Overall Study|Physician Decision|0
5460959|NCT02037984|18874735|P2|Overall Study|Physician Decision|0
5460960|NCT02037984|18874736|P1|Overall Study|Physician Decision|0
5460961|NCT02037984|18874729|P8|Overall Study|Lost to Follow-up|4
5460962|NCT02037984|18874730|P7|Overall Study|Lost to Follow-up|2
5460963|NCT02037984|18874731|P6|Overall Study|Lost to Follow-up|2
5460964|NCT02037984|18874732|P5|Overall Study|Lost to Follow-up|2
5460965|NCT02037984|18874733|P4|Overall Study|Lost to Follow-up|5
5460966|NCT02037984|18874734|P3|Overall Study|Lost to Follow-up|3
5460967|NCT02037984|18874735|P2|Overall Study|Lost to Follow-up|0
5460968|NCT02037984|18874736|P1|Overall Study|Lost to Follow-up|1
5460969|NCT02037984|18874729|P8|Overall Study|Lack of Efficacy|3
5460970|NCT02037984|18874730|P7|Overall Study|Lack of Efficacy|4
5460971|NCT02037984|18874731|P6|Overall Study|Lack of Efficacy|2
5460972|NCT02037984|18874732|P5|Overall Study|Lack of Efficacy|2
5460973|NCT02037984|18874733|P4|Overall Study|Lack of Efficacy|10
5460974|NCT02037984|18874734|P3|Overall Study|Lack of Efficacy|3
5460975|NCT02037984|18874735|P2|Overall Study|Lack of Efficacy|0
5460976|NCT02037984|18874736|P1|Overall Study|Lack of Efficacy|0
5460977|NCT02037568|18874881|P2|Overall Study|Patient did not receive transplant|1
5460978|NCT02037568|18874882|P1|Overall Study|Patient did not receive transplant|0
5460979|NCT02037568|18874881|P2|Overall Study|Screen Failure|1
5460980|NCT02037568|18874882|P1|Overall Study|Screen Failure|3
5460981|NCT02037568|18874881|P2|Overall Study|Lost to Follow-up|13
5460982|NCT02037568|18874882|P1|Overall Study|Lost to Follow-up|16
5460983|NCT02037568|18874881|P2|Overall Study|Withdrawal by Subject|24
5460984|NCT02037568|18874882|P1|Overall Study|Withdrawal by Subject|17
5460985|NCT02037477|18874917|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5460986|NCT02037477|18874918|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
5460987|NCT02037477|18874919|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5460988|NCT02037477|18874920|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5460989|NCT02037295|18875015|P4|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
5460990|NCT02037295|18875016|P3|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
5460991|NCT02037295|18875017|P2|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
5460992|NCT02037295|18875018|P1|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
5460993|NCT02037165|18875074|P5|Washout Period 4 (6 Days)|Withdrawal by Subject|1
5460994|NCT02037165|18875075|P4|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5460995|NCT02037165|18875076|P3|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5460996|NCT02037165|18875077|P2|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5460997|NCT02037165|18875078|P1|Washout Period 4 (6 Days)|Withdrawal by Subject|0
5460998|NCT02036775|18875138|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
5460999|NCT02036775|18875139|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5461000|NCT02036775|18875140|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5461001|NCT02036775|18875141|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5461002|NCT02036775|18875142|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5461003|NCT02036775|18875143|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5461004|NCT02036645|18875193|P12|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461005|NCT02036645|18875194|P11|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461006|NCT02036645|18875195|P10|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461007|NCT02036645|18875196|P9|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461008|NCT02036645|18875197|P8|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461009|NCT02036645|18875198|P7|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461010|NCT02036645|18875199|P6|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461011|NCT02036645|18875200|P5|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461012|NCT02036645|18875201|P4|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
5461013|NCT02036645|18875202|P3|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461014|NCT02036645|18875203|P2|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461015|NCT02036645|18875204|P1|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
5461016|NCT02036645|18875193|P12|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461017|NCT02036645|18875194|P11|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461018|NCT02036645|18875195|P10|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461019|NCT02036645|18875196|P9|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461020|NCT02036645|18875197|P8|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461021|NCT02036645|18875198|P7|SAD Cohorts : Study Part 1|Lost to Follow-up|1
5461022|NCT02036645|18875199|P6|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461023|NCT02036645|18875200|P5|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461024|NCT02036645|18875201|P4|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461025|NCT02036645|18875202|P3|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461026|NCT02036645|18875203|P2|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461027|NCT02036645|18875204|P1|SAD Cohorts : Study Part 1|Lost to Follow-up|0
5461028|NCT02036580|18875309|P3|Overall Study|Adverse Event|0
5461029|NCT02036580|18875310|P2|Overall Study|Adverse Event|0
5461030|NCT02036580|18875311|P1|Overall Study|Adverse Event|1
5461031|NCT02036580|18875309|P3|Overall Study|Withdrawal by Subject|0
5461032|NCT02036580|18875310|P2|Overall Study|Withdrawal by Subject|1
5461033|NCT02036580|18875311|P1|Overall Study|Withdrawal by Subject|0
5461034|NCT02036515|18875332|P3|Overall Study|Hyperglycemia|1
5461035|NCT02036515|18875333|P2|Overall Study|Hyperglycemia|0
5461036|NCT02036515|18875334|P1|Overall Study|Hyperglycemia|0
5461037|NCT02036515|18875332|P3|Overall Study|Withdrawal by Subject|9
5461038|NCT02036515|18875333|P2|Overall Study|Withdrawal by Subject|7
5461039|NCT02036515|18875334|P1|Overall Study|Withdrawal by Subject|4
5461040|NCT02036515|18875332|P3|Overall Study|Screen failure|0
5461041|NCT02036515|18875333|P2|Overall Study|Screen failure|2
5461042|NCT02036515|18875334|P1|Overall Study|Screen failure|0
5461043|NCT02036515|18875332|P3|Overall Study|Non-compliance with study drug|2
5461044|NCT02036515|18875333|P2|Overall Study|Non-compliance with study drug|0
5461045|NCT02036515|18875334|P1|Overall Study|Non-compliance with study drug|0
5461046|NCT02036515|18875332|P3|Overall Study|Lost to Follow-up|0
5461047|NCT02036515|18875333|P2|Overall Study|Lost to Follow-up|2
5461048|NCT02036515|18875334|P1|Overall Study|Lost to Follow-up|0
5461049|NCT02036515|18875332|P3|Overall Study|Adverse Event|2
5461050|NCT02036515|18875333|P2|Overall Study|Adverse Event|1
5461051|NCT02036515|18875334|P1|Overall Study|Adverse Event|1
5461052|NCT02036294|18875435|P2|Overall Study|Withdrawal by Subject|3
5461053|NCT02036294|18875436|P1|Overall Study|Withdrawal by Subject|2
5461054|NCT02036294|18875435|P2|Overall Study|Death|8
5461055|NCT02036294|18875436|P1|Overall Study|Death|7
5461056|NCT02035748|18875452|P1|Overall Study|Progressive Disease|1
5461057|NCT02035748|18875452|P1|Overall Study|Withdrawal by Subject|6
5461058|NCT02035748|18875452|P1|Overall Study|Physician Decision|3
5461059|NCT02035748|18875452|P1|Overall Study|Lost to Follow-up|2
5461060|NCT02035748|18875452|P1|Overall Study|Death|3
5461061|NCT02035748|18875452|P1|Overall Study|Adverse Event|5
5461062|NCT02035696|18875466|P4|Overall Study|Withdrawal by Subject|1
5461063|NCT02035696|18875467|P3|Overall Study|Withdrawal by Subject|2
5461064|NCT02035696|18875468|P2|Overall Study|Withdrawal by Subject|0
5461065|NCT02035696|18875469|P1|Overall Study|Withdrawal by Subject|3
5461066|NCT02035696|18875466|P4|Overall Study|Lost to Follow-up|2
5461067|NCT02035696|18875467|P3|Overall Study|Lost to Follow-up|1
5461068|NCT02035696|18875468|P2|Overall Study|Lost to Follow-up|3
5461069|NCT02035696|18875469|P1|Overall Study|Lost to Follow-up|0
5461070|NCT02035553|18875525|P2|Overall Study|Other Reason|4
5461071|NCT02035553|18875526|P1|Overall Study|Other Reason|0
5461072|NCT02035553|18875525|P2|Overall Study|Lost to Follow-up|1
5461073|NCT02035553|18875526|P1|Overall Study|Lost to Follow-up|0
5461074|NCT02035553|18875525|P2|Overall Study|Non-compliance with Study Drug|1
5461075|NCT02035553|18875526|P1|Overall Study|Non-compliance with Study Drug|0
5461076|NCT02035553|18875525|P2|Overall Study|Withdrawal by Subject|7
5461077|NCT02035553|18875526|P1|Overall Study|Withdrawal by Subject|4
5461078|NCT02035553|18875525|P2|Overall Study|Lack of Efficacy|1
5461079|NCT02035553|18875526|P1|Overall Study|Lack of Efficacy|1
5461080|NCT02035553|18875525|P2|Overall Study|Physician Decision|2
5461081|NCT02035553|18875526|P1|Overall Study|Physician Decision|3
5461082|NCT02035553|18875525|P2|Overall Study|Adverse Event|6
5461083|NCT02035553|18875526|P1|Overall Study|Adverse Event|10
5461084|NCT02035553|18875525|P2|Overall Study|Death (See All-Cause Mortality Table)|1
5461085|NCT02035553|18875526|P1|Overall Study|Death (See All-Cause Mortality Table)|0
5461086|NCT02035475|18875532|P1|Overall Study|Equipment Error|1
5461087|NCT02035475|18875532|P1|Overall Study|Physician Decision|1
5461088|NCT02035475|18875532|P1|Overall Study|Withdrawal by Subject|4
5461089|NCT02035332|18875543|P1|Overall Study|Procedure Aborted due to Uterine Width|1
5461090|NCT02035267|18875553|P4|Overall Study|Other unspecified|0
5461091|NCT02035267|18875554|P3|Overall Study|Other unspecified|0
5461092|NCT02035267|18875555|P2|Overall Study|Other unspecified|1
5461093|NCT02035267|18875556|P1|Overall Study|Other unspecified|0
5461094|NCT02035267|18875553|P4|Overall Study|Lost to Follow-up|1
5461095|NCT02035267|18875554|P3|Overall Study|Lost to Follow-up|0
5461096|NCT02035267|18875555|P2|Overall Study|Lost to Follow-up|0
5461097|NCT02035267|18875556|P1|Overall Study|Lost to Follow-up|0
5461098|NCT02035267|18875553|P4|Overall Study|Adverse Event|0
5461099|NCT02035267|18875554|P3|Overall Study|Adverse Event|1
5461100|NCT02035267|18875555|P2|Overall Study|Adverse Event|0
5461101|NCT02035267|18875556|P1|Overall Study|Adverse Event|0
5461102|NCT02035267|18875553|P4|Overall Study|Withdrawal consent-subject convenience|0
5461103|NCT02035267|18875554|P3|Overall Study|Withdrawal consent-subject convenience|1
5461104|NCT02035267|18875555|P2|Overall Study|Withdrawal consent-subject convenience|0
5461105|NCT02035267|18875556|P1|Overall Study|Withdrawal consent-subject convenience|0
5461106|NCT02035202|18875587|P3|Overall Study|Lost to Follow-up|2
5461107|NCT02035202|18875588|P2|Overall Study|Lost to Follow-up|16
5461108|NCT02035202|18875589|P1|Overall Study|Lost to Follow-up|8
5461109|NCT02034916|18875605|P2|Overall Study|Study terminated by sponsor|5
5461110|NCT02034916|18875606|P1|Overall Study|Study terminated by sponsor|4
5461111|NCT02034916|18875605|P2|Overall Study|Lost to Follow-up|1
5461112|NCT02034916|18875606|P1|Overall Study|Lost to Follow-up|4
5461113|NCT02034916|18875605|P2|Overall Study|Withdrawal by Subject|1
5461114|NCT02034916|18875606|P1|Overall Study|Withdrawal by Subject|2
5461115|NCT02034916|18875605|P2|Overall Study|Death|28
5461116|NCT02034916|18875606|P1|Overall Study|Death|39
5461117|NCT02034877|18875643|P2|Overall Study|No Longer Willing to Participate|3
5461118|NCT02034877|18875644|P1|Overall Study|No Longer Willing to Participate|0
5461119|NCT02034877|18875643|P2|Overall Study|Lost to Follow-up|3
5461120|NCT02034877|18875644|P1|Overall Study|Lost to Follow-up|0
5461121|NCT02034799|18875662|P2|Overall Study|Death|1
5461122|NCT02034799|18875663|P1|Overall Study|Death|2
5461123|NCT02034799|18875662|P2|Overall Study|Lost to Follow-up|1
5461124|NCT02034799|18875663|P1|Overall Study|Lost to Follow-up|0
5461125|NCT02034799|18875662|P2|Overall Study|Withdrawal by Subject|2
5461126|NCT02034799|18875663|P1|Overall Study|Withdrawal by Subject|0
5461127|NCT02034708|18875677|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
5461128|NCT02034708|18875678|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
5461129|NCT02034708|18875677|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
5461130|NCT02034708|18875678|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
5461131|NCT02034708|18875677|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
5461132|NCT02034708|18875678|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
5461133|NCT02034708|18875677|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
5461134|NCT02034708|18875678|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
5461135|NCT02034591|18875689|P6|Overall Study|Withdrawal by Subject|0
5461136|NCT02034591|18875690|P5|Overall Study|Withdrawal by Subject|1
5461137|NCT02034591|18875691|P4|Overall Study|Withdrawal by Subject|0
5461138|NCT02034591|18875692|P3|Overall Study|Withdrawal by Subject|0
5461139|NCT02034591|18875693|P2|Overall Study|Withdrawal by Subject|0
5461140|NCT02034591|18875694|P1|Overall Study|Withdrawal by Subject|0
5461141|NCT02034565|18875749|P2|Overall Study|Adverse Event|0
5461142|NCT02034565|18875750|P1|Overall Study|Adverse Event|1
5461143|NCT02034552|18875767|P3|Overall Study|Clinical progression|9
5461144|NCT02034552|18875768|P2|Overall Study|Clinical progression|7
5461145|NCT02034552|18875769|P1|Overall Study|Clinical progression|5
5461146|NCT02034552|18875767|P3|Overall Study|Non-compliance with study drug|1
5461147|NCT02034552|18875768|P2|Overall Study|Non-compliance with study drug|0
5461148|NCT02034552|18875769|P1|Overall Study|Non-compliance with study drug|0
5461149|NCT02034552|18875767|P3|Overall Study|Withdrawal by Subject|1
5461150|NCT02034552|18875768|P2|Overall Study|Withdrawal by Subject|1
5461151|NCT02034552|18875769|P1|Overall Study|Withdrawal by Subject|2
5461152|NCT02034552|18875767|P3|Overall Study|AE associated with disease progression|0
5461153|NCT02034552|18875768|P2|Overall Study|AE associated with disease progression|1
5461154|NCT02034552|18875769|P1|Overall Study|AE associated with disease progression|0
5461155|NCT02034552|18875767|P3|Overall Study|AE not assoc. with disease progression|2
5461156|NCT02034552|18875768|P2|Overall Study|AE not assoc. with disease progression|4
5461157|NCT02034552|18875769|P1|Overall Study|AE not assoc. with disease progression|1
5461158|NCT02034552|18875767|P3|Overall Study|Radiological progression|4
5461159|NCT02034552|18875768|P2|Overall Study|Radiological progression|5
5461160|NCT02034552|18875769|P1|Overall Study|Radiological progression|3
5461161|NCT02034552|18875767|P3|Overall Study|Never treated|0
5461162|NCT02034552|18875768|P2|Overall Study|Never treated|2
5461163|NCT02034552|18875769|P1|Overall Study|Never treated|3
5461164|NCT02034513|18875800|P2|Overall Study|Unclassified|1
5461165|NCT02034513|18875801|P1|Overall Study|Unclassified|0
5461166|NCT02034513|18875800|P2|Overall Study|Withdrawal by Subject|25
5461167|NCT02034513|18875801|P1|Overall Study|Withdrawal by Subject|25
5461168|NCT02034513|18875800|P2|Overall Study|Protocol Violation|10
5461169|NCT02034513|18875801|P1|Overall Study|Protocol Violation|7
5461170|NCT02034513|18875800|P2|Overall Study|Pregnancy|3
5461171|NCT02034513|18875801|P1|Overall Study|Pregnancy|0
5461172|NCT02034513|18875800|P2|Overall Study|Lost to Follow-up|7
5461173|NCT02034513|18875801|P1|Overall Study|Lost to Follow-up|6
5461174|NCT02034513|18875800|P2|Overall Study|Lack of Efficacy|1
5461175|NCT02034513|18875801|P1|Overall Study|Lack of Efficacy|0
5461176|NCT02034513|18875800|P2|Overall Study|Adverse Event|10
5461177|NCT02034513|18875801|P1|Overall Study|Adverse Event|11
5461178|NCT02034474|18875819|P2|Overall Study|Withdrawal by Subject|2
5461179|NCT02034474|18875820|P1|Overall Study|Withdrawal by Subject|1
5461180|NCT02034474|18875819|P2|Overall Study|Adverse Event|2
5461181|NCT02034474|18875820|P1|Overall Study|Adverse Event|3
5461182|NCT02034435|18875832|P4|Overall Study|Inadequate IV access|1
5461183|NCT02034435|18875833|P3|Overall Study|Inadequate IV access|0
5461184|NCT02034435|18875834|P2|Overall Study|Inadequate IV access|0
5461185|NCT02034435|18875835|P1|Overall Study|Inadequate IV access|1
5461186|NCT02034435|18875832|P4|Overall Study|Illness|0
5461187|NCT02034435|18875833|P3|Overall Study|Illness|0
5461188|NCT02034435|18875834|P2|Overall Study|Illness|2
5461189|NCT02034435|18875835|P1|Overall Study|Illness|0
5461190|NCT02034435|18875832|P4|Overall Study|Withdrawal by Subject|0
5461191|NCT02034435|18875833|P3|Overall Study|Withdrawal by Subject|0
5461192|NCT02034435|18875834|P2|Overall Study|Withdrawal by Subject|0
5461193|NCT02034435|18875835|P1|Overall Study|Withdrawal by Subject|1
5461194|NCT02034162|18875855|P3|Double-blind|Withdrawal by Subject|0
5461195|NCT02034162|18875856|P2|Double-blind|Withdrawal by Subject|7
5461196|NCT02034162|18875857|P1|Double-blind|Withdrawal by Subject|5
5461197|NCT02034162|18875855|P3|Double-blind|Protocol Violation|0
5461198|NCT02034162|18875856|P2|Double-blind|Protocol Violation|1
5461199|NCT02034162|18875857|P1|Double-blind|Protocol Violation|0
5461200|NCT02034162|18875855|P3|Double-blind|Physician Decision|0
5461201|NCT02034162|18875856|P2|Double-blind|Physician Decision|0
5461202|NCT02034162|18875857|P1|Double-blind|Physician Decision|1
5461203|NCT02034162|18875855|P3|Double-blind|Lost to Follow-up|0
5461204|NCT02034162|18875856|P2|Double-blind|Lost to Follow-up|0
5461205|NCT02034162|18875857|P1|Double-blind|Lost to Follow-up|3
5461206|NCT02034123|18875903|P18|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461207|NCT02034123|18875904|P17|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461208|NCT02034123|18875905|P16|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461209|NCT02034123|18875906|P15|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461210|NCT02034123|18875907|P14|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461211|NCT02034123|18875908|P13|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461212|NCT02034123|18875909|P12|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461213|NCT02034123|18875910|P11|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461214|NCT02034123|18875911|P10|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461215|NCT02034123|18875912|P9|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461216|NCT02034123|18875913|P8|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461217|NCT02034123|18875914|P7|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461218|NCT02034123|18875915|P6|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461219|NCT02034123|18875916|P5|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
5461220|NCT02034123|18875917|P4|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
5461221|NCT02034123|18875918|P3|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461222|NCT02034123|18875919|P2|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461223|NCT02034123|18875920|P1|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
5461224|NCT02034123|18875903|P18|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461225|NCT02034123|18875904|P17|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461226|NCT02034123|18875905|P16|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461227|NCT02034123|18875906|P15|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461228|NCT02034123|18875907|P14|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461229|NCT02034123|18875908|P13|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461230|NCT02034123|18875909|P12|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461231|NCT02034123|18875910|P11|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461232|NCT02034123|18875911|P10|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461309|NCT02033850|18876490|P2|Overall Study|Death|0
5461233|NCT02034123|18875912|P9|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
5461234|NCT02034123|18875913|P8|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461235|NCT02034123|18875914|P7|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461236|NCT02034123|18875915|P6|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461237|NCT02034123|18875916|P5|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461238|NCT02034123|18875917|P4|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461239|NCT02034123|18875918|P3|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461240|NCT02034123|18875919|P2|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461241|NCT02034123|18875920|P1|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
5461242|NCT02034123|18875903|P18|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461243|NCT02034123|18875904|P17|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461244|NCT02034123|18875905|P16|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461245|NCT02034123|18875906|P15|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461246|NCT02034123|18875907|P14|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461247|NCT02034123|18875908|P13|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461248|NCT02034123|18875909|P12|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461249|NCT02034123|18875910|P11|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461250|NCT02034123|18875911|P10|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461251|NCT02034123|18875912|P9|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461252|NCT02034123|18875913|P8|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461253|NCT02034123|18875914|P7|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461254|NCT02034123|18875915|P6|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461255|NCT02034123|18875916|P5|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461256|NCT02034123|18875917|P4|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
5461257|NCT02034123|18875918|P3|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461258|NCT02034123|18875919|P2|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461259|NCT02034123|18875920|P1|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
5461260|NCT02034123|18875903|P18|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461261|NCT02034123|18875904|P17|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461262|NCT02034123|18875905|P16|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461263|NCT02034123|18875906|P15|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461264|NCT02034123|18875907|P14|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461265|NCT02034123|18875908|P13|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461266|NCT02034123|18875909|P12|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461267|NCT02034123|18875910|P11|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461268|NCT02034123|18875911|P10|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461269|NCT02034123|18875912|P9|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
5461270|NCT02034123|18875913|P8|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
5461271|NCT02034123|18875914|P7|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461272|NCT02034123|18875915|P6|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461273|NCT02034123|18875916|P5|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
5461274|NCT02034123|18875917|P4|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461275|NCT02034123|18875918|P3|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461276|NCT02034123|18875919|P2|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461277|NCT02034123|18875920|P1|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
5461278|NCT02034058|18876239|P1|Overall Study|Death|3
5461279|NCT02034006|18876260|P1|Overall Study|Pregnancy|1
5461280|NCT02034006|18876260|P1|Overall Study|Death|1
5461281|NCT02034006|18876260|P1|Overall Study|Lost to Follow-up|5
5461282|NCT02034006|18876260|P1|Overall Study|Withdrawal by Subject|7
5461283|NCT02033889|18876311|P3|Overall Study|Withdrawal by Subject|13
5461284|NCT02033889|18876312|P2|Overall Study|Withdrawal by Subject|10
5461285|NCT02033889|18876313|P1|Overall Study|Withdrawal by Subject|18
5461286|NCT02033889|18876311|P3|Overall Study|Participant moved|0
5461287|NCT02033889|18876312|P2|Overall Study|Participant moved|1
5461288|NCT02033889|18876313|P1|Overall Study|Participant moved|0
5461289|NCT02033889|18876311|P3|Overall Study|Physician Decision|1
5461290|NCT02033889|18876312|P2|Overall Study|Physician Decision|1
5461291|NCT02033889|18876313|P1|Overall Study|Physician Decision|0
5461292|NCT02033889|18876311|P3|Overall Study|Non-Compliance With Study Drug|0
5461293|NCT02033889|18876312|P2|Overall Study|Non-Compliance With Study Drug|0
5461294|NCT02033889|18876313|P1|Overall Study|Non-Compliance With Study Drug|1
5461295|NCT02033889|18876311|P3|Overall Study|Lost to Follow-up|6
5461296|NCT02033889|18876312|P2|Overall Study|Lost to Follow-up|5
5461297|NCT02033889|18876313|P1|Overall Study|Lost to Follow-up|8
5461298|NCT02033889|18876311|P3|Overall Study|Excluded Medication|0
5461299|NCT02033889|18876312|P2|Overall Study|Excluded Medication|1
5461300|NCT02033889|18876313|P1|Overall Study|Excluded Medication|1
5461301|NCT02033889|18876311|P3|Overall Study|Death|2
5461302|NCT02033889|18876312|P2|Overall Study|Death|1
5461303|NCT02033889|18876313|P1|Overall Study|Death|3
5461304|NCT02033889|18876311|P3|Overall Study|Adverse Event|3
5461305|NCT02033889|18876312|P2|Overall Study|Adverse Event|1
5461306|NCT02033889|18876313|P1|Overall Study|Adverse Event|3
5461307|NCT02033850|18876490|P2|Overall Study|unrelated medical reason|1
5461308|NCT02033850|18876491|P1|Overall Study|unrelated medical reason|1
5461310|NCT02033850|18876491|P1|Overall Study|Death|1
5461311|NCT02033759|18876515|P2|Overall Study|Protocol Violation|1
5461312|NCT02033759|18876516|P1|Overall Study|Protocol Violation|1
5461313|NCT02033759|18876515|P2|Overall Study|Withdrawal by Subject|1
5461314|NCT02033759|18876516|P1|Overall Study|Withdrawal by Subject|2
5461315|NCT02033369|18876576|P2|Overall Study|Protocol Violation|0
5461316|NCT02033369|18876577|P1|Overall Study|Protocol Violation|2
5461317|NCT02033369|18876576|P2|Overall Study|Lost to Follow-up|0
5461318|NCT02033369|18876577|P1|Overall Study|Lost to Follow-up|1
5461319|NCT02033369|18876576|P2|Overall Study|Withdrawal by Subject|1
5461320|NCT02033369|18876577|P1|Overall Study|Withdrawal by Subject|1
5461321|NCT02033369|18876576|P2|Overall Study|Not a good demographic match|2
5461322|NCT02033369|18876577|P1|Overall Study|Not a good demographic match|0
5461323|NCT02033369|18876576|P2|Overall Study|Physician Decision|2
5461324|NCT02033369|18876577|P1|Overall Study|Physician Decision|1
5461325|NCT02032901|18876671|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
5461326|NCT02032901|18876672|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
5461327|NCT02032901|18876671|P2|Treatment Period (12 Weeks)|Pregnancy|0
5461328|NCT02032901|18876672|P1|Treatment Period (12 Weeks)|Pregnancy|1
5461329|NCT02032888|18876696|P3|Follow-up Period|Other|0
5461330|NCT02032888|18876697|P2|Follow-up Period|Other|0
5461331|NCT02032888|18876698|P1|Follow-up Period|Other|1
5461332|NCT02032888|18876696|P3|Follow-up Period|Death|0
5461333|NCT02032888|18876697|P2|Follow-up Period|Death|1
5461334|NCT02032888|18876698|P1|Follow-up Period|Death|1
5461335|NCT02032888|18876696|P3|Follow-up Period|Lost to Follow-up|0
5461336|NCT02032888|18876697|P2|Follow-up Period|Lost to Follow-up|1
5461337|NCT02032888|18876698|P1|Follow-up Period|Lost to Follow-up|1
5461338|NCT02032888|18876696|P3|Treatment Period|Other|0
5461339|NCT02032888|18876697|P2|Treatment Period|Other|1
5461340|NCT02032888|18876698|P1|Treatment Period|Other|1
5461341|NCT02032888|18876696|P3|Treatment Period|Poor compliance/noncompliance|0
5461342|NCT02032888|18876697|P2|Treatment Period|Poor compliance/noncompliance|1
5461343|NCT02032888|18876698|P1|Treatment Period|Poor compliance/noncompliance|1
5461344|NCT02032875|18876729|P2|Follow-up Period|Virologic Relapse|10
5461345|NCT02032875|18876730|P1|Follow-up Period|Virologic Relapse|3
5461346|NCT02032875|18876729|P2|Follow-up Period|Death|1
5461347|NCT02032875|18876730|P1|Follow-up Period|Death|0
5461348|NCT02032875|18876729|P2|Treatment Period|Liver transplant, Treatment extension|3
5461349|NCT02032875|18876730|P1|Treatment Period|Liver transplant, Treatment extension|0
5461350|NCT02032875|18876729|P2|Treatment Period|Liver transplant, No extension needed|1
5461351|NCT02032875|18876730|P1|Treatment Period|Liver transplant, No extension needed|0
5461352|NCT02032875|18876729|P2|Treatment Period|Adverse Event|0
5461353|NCT02032875|18876730|P1|Treatment Period|Adverse Event|1
5461354|NCT02032706|18876773|P1|Overall Study|Protocol Violation|1
5461355|NCT02032706|18876773|P1|Overall Study|Did not qualify|5
5461356|NCT02032407|18876956|P1|Overall Study|Other Miscellaneous Reasons|2
5461357|NCT02032407|18876956|P1|Overall Study|Pregnancy|1
5461358|NCT02032407|18876956|P1|Overall Study|Lost to Follow-up|2
5461359|NCT02032238|18876969|P2|Overall Study|Lost to Follow-up|0
5461360|NCT02032238|18876970|P1|Overall Study|Lost to Follow-up|2
5461361|NCT02032173|18877009|P1|Overall Study|Discontinuation due to sponsor decision|31
5461362|NCT02031679|18877031|P2|Overall Study|Lack of Efficacy|1
5461363|NCT02031679|18877032|P1|Overall Study|Lack of Efficacy|0
5461364|NCT02031679|18877031|P2|Overall Study|Protocol Violation|1
5461365|NCT02031679|18877032|P1|Overall Study|Protocol Violation|0
5461366|NCT02031640|18877047|P6|Double-blind Treatment Period|Lost to Follow-up|0
5461367|NCT02031640|18877048|P5|Double-blind Treatment Period|Lost to Follow-up|1
5461368|NCT02031640|18877049|P4|Double-blind Treatment Period|Lost to Follow-up|0
5461369|NCT02031640|18877050|P3|Double-blind Treatment Period|Lost to Follow-up|0
5461370|NCT02031640|18877051|P2|Double-blind Treatment Period|Lost to Follow-up|3
5461371|NCT02031640|18877052|P1|Double-blind Treatment Period|Lost to Follow-up|0
5461372|NCT02031640|18877047|P6|Double-blind Treatment Period|Withdrawal by Subject|1
5461373|NCT02031640|18877048|P5|Double-blind Treatment Period|Withdrawal by Subject|1
5461374|NCT02031640|18877049|P4|Double-blind Treatment Period|Withdrawal by Subject|1
5461375|NCT02031640|18877050|P3|Double-blind Treatment Period|Withdrawal by Subject|3
5461376|NCT02031640|18877051|P2|Double-blind Treatment Period|Withdrawal by Subject|2
5461377|NCT02031640|18877052|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5461378|NCT02031640|18877047|P6|Double-blind Treatment Period|Adverse Event|0
5461379|NCT02031640|18877048|P5|Double-blind Treatment Period|Adverse Event|0
5461380|NCT02031640|18877049|P4|Double-blind Treatment Period|Adverse Event|2
5461381|NCT02031640|18877050|P3|Double-blind Treatment Period|Adverse Event|0
5461382|NCT02031640|18877051|P2|Double-blind Treatment Period|Adverse Event|0
5461383|NCT02031640|18877052|P1|Double-blind Treatment Period|Adverse Event|0
5461384|NCT02031640|18877047|P6|Double-blind Treatment Period|Non-compliance|0
5461385|NCT02031640|18877048|P5|Double-blind Treatment Period|Non-compliance|1
5461386|NCT02031640|18877049|P4|Double-blind Treatment Period|Non-compliance|1
5461387|NCT02031640|18877050|P3|Double-blind Treatment Period|Non-compliance|0
5461388|NCT02031640|18877051|P2|Double-blind Treatment Period|Non-compliance|1
5461389|NCT02031640|18877052|P1|Double-blind Treatment Period|Non-compliance|0
5461390|NCT02031640|18877047|P6|Double-blind Treatment Period|Lack of Efficacy|1
5461391|NCT02031640|18877048|P5|Double-blind Treatment Period|Lack of Efficacy|5
5461392|NCT02031640|18877049|P4|Double-blind Treatment Period|Lack of Efficacy|2
5461393|NCT02031640|18877050|P3|Double-blind Treatment Period|Lack of Efficacy|3
5461394|NCT02031640|18877051|P2|Double-blind Treatment Period|Lack of Efficacy|14
5461395|NCT02031640|18877052|P1|Double-blind Treatment Period|Lack of Efficacy|0
5461396|NCT02031640|18877047|P6|Double-blind Treatment Period|Protocol deviation|1
5461397|NCT02031640|18877048|P5|Double-blind Treatment Period|Protocol deviation|3
5461398|NCT02031640|18877049|P4|Double-blind Treatment Period|Protocol deviation|1
5461399|NCT02031640|18877050|P3|Double-blind Treatment Period|Protocol deviation|0
5461400|NCT02031640|18877051|P2|Double-blind Treatment Period|Protocol deviation|2
5461401|NCT02031640|18877052|P1|Double-blind Treatment Period|Protocol deviation|0
5461402|NCT02031640|18877047|P6|Run-In Period|Various administrative reasons|0
5461403|NCT02031640|18877048|P5|Run-In Period|Various administrative reasons|0
5461404|NCT02031640|18877049|P4|Run-In Period|Various administrative reasons|0
5461405|NCT02031640|18877050|P3|Run-In Period|Various administrative reasons|0
5461406|NCT02031640|18877051|P2|Run-In Period|Various administrative reasons|0
5461407|NCT02031640|18877052|P1|Run-In Period|Various administrative reasons|17
5461408|NCT02031640|18877047|P6|Run-In Period|Randomization criteria not met|0
5461409|NCT02031640|18877048|P5|Run-In Period|Randomization criteria not met|0
5461410|NCT02031640|18877049|P4|Run-In Period|Randomization criteria not met|0
5461411|NCT02031640|18877050|P3|Run-In Period|Randomization criteria not met|0
5461412|NCT02031640|18877051|P2|Run-In Period|Randomization criteria not met|0
5461413|NCT02031640|18877052|P1|Run-In Period|Randomization criteria not met|85
5461414|NCT02031640|18877047|P6|Run-In Period|Exclusion criteria met|0
5461415|NCT02031640|18877048|P5|Run-In Period|Exclusion criteria met|0
5461416|NCT02031640|18877049|P4|Run-In Period|Exclusion criteria met|0
5461417|NCT02031640|18877050|P3|Run-In Period|Exclusion criteria met|0
5461418|NCT02031640|18877051|P2|Run-In Period|Exclusion criteria met|0
5461419|NCT02031640|18877052|P1|Run-In Period|Exclusion criteria met|8
5461420|NCT02031640|18877047|P6|Run-In Period|Inclusion criteria not met|0
5461421|NCT02031640|18877048|P5|Run-In Period|Inclusion criteria not met|0
5461422|NCT02031640|18877049|P4|Run-In Period|Inclusion criteria not met|0
5461423|NCT02031640|18877050|P3|Run-In Period|Inclusion criteria not met|0
5461424|NCT02031640|18877051|P2|Run-In Period|Inclusion criteria not met|0
5461425|NCT02031640|18877052|P1|Run-In Period|Inclusion criteria not met|38
5461426|NCT02031640|18877047|P6|Run-In Period|Withdrawal by Subject|0
5461427|NCT02031640|18877048|P5|Run-In Period|Withdrawal by Subject|0
5461428|NCT02031640|18877049|P4|Run-In Period|Withdrawal by Subject|0
5461429|NCT02031640|18877050|P3|Run-In Period|Withdrawal by Subject|0
5461430|NCT02031640|18877051|P2|Run-In Period|Withdrawal by Subject|0
5461431|NCT02031640|18877052|P1|Run-In Period|Withdrawal by Subject|17
5461432|NCT02031640|18877047|P6|Run-In Period|Adverse Event|0
5461433|NCT02031640|18877048|P5|Run-In Period|Adverse Event|0
5461434|NCT02031640|18877049|P4|Run-In Period|Adverse Event|0
5461435|NCT02031640|18877050|P3|Run-In Period|Adverse Event|0
5461436|NCT02031640|18877051|P2|Run-In Period|Adverse Event|0
5461437|NCT02031640|18877052|P1|Run-In Period|Adverse Event|4
5461438|NCT02031640|18877047|P6|Screening Period|Enrollment closed|0
5461439|NCT02031640|18877048|P5|Screening Period|Enrollment closed|0
5461440|NCT02031640|18877049|P4|Screening Period|Enrollment closed|0
5461441|NCT02031640|18877050|P3|Screening Period|Enrollment closed|0
5461442|NCT02031640|18877051|P2|Screening Period|Enrollment closed|0
5461443|NCT02031640|18877052|P1|Screening Period|Enrollment closed|26
5461444|NCT02031640|18877047|P6|Screening Period|Lost to Follow-up|0
5461445|NCT02031640|18877048|P5|Screening Period|Lost to Follow-up|0
5461446|NCT02031640|18877049|P4|Screening Period|Lost to Follow-up|0
5461447|NCT02031640|18877050|P3|Screening Period|Lost to Follow-up|0
5461448|NCT02031640|18877051|P2|Screening Period|Lost to Follow-up|0
5461449|NCT02031640|18877052|P1|Screening Period|Lost to Follow-up|14
5461450|NCT02031640|18877047|P6|Screening Period|Exclusion criteria met|0
5461451|NCT02031640|18877048|P5|Screening Period|Exclusion criteria met|0
5461452|NCT02031640|18877049|P4|Screening Period|Exclusion criteria met|0
5461453|NCT02031640|18877050|P3|Screening Period|Exclusion criteria met|0
5461454|NCT02031640|18877051|P2|Screening Period|Exclusion criteria met|0
5461455|NCT02031640|18877052|P1|Screening Period|Exclusion criteria met|30
5461456|NCT02031640|18877047|P6|Screening Period|Inclusion criteria not met|0
5461457|NCT02031640|18877048|P5|Screening Period|Inclusion criteria not met|0
5461458|NCT02031640|18877049|P4|Screening Period|Inclusion criteria not met|0
5461459|NCT02031640|18877050|P3|Screening Period|Inclusion criteria not met|0
5461460|NCT02031640|18877051|P2|Screening Period|Inclusion criteria not met|0
5461461|NCT02031640|18877052|P1|Screening Period|Inclusion criteria not met|312
5461462|NCT02031640|18877047|P6|Screening Period|Withdrawal by Subject|0
5461463|NCT02031640|18877048|P5|Screening Period|Withdrawal by Subject|0
5461464|NCT02031640|18877049|P4|Screening Period|Withdrawal by Subject|0
5461465|NCT02031640|18877050|P3|Screening Period|Withdrawal by Subject|0
5461466|NCT02031640|18877051|P2|Screening Period|Withdrawal by Subject|0
5461467|NCT02031640|18877052|P1|Screening Period|Withdrawal by Subject|29
5461468|NCT02031640|18877047|P6|Screening Period|Adverse Event|0
5461469|NCT02031640|18877048|P5|Screening Period|Adverse Event|0
5461470|NCT02031640|18877049|P4|Screening Period|Adverse Event|0
5461471|NCT02031640|18877050|P3|Screening Period|Adverse Event|0
5461472|NCT02031640|18877051|P2|Screening Period|Adverse Event|0
5461473|NCT02031640|18877052|P1|Screening Period|Adverse Event|1
5461474|NCT02031536|18877097|P2|Overall Study|ineligible|0
5461475|NCT02031536|18877098|P1|Overall Study|ineligible|1
5461476|NCT02031471|18877106|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
5461477|NCT02031471|18877106|P1|Long Term Extension (LTE) Period|Adverse Event|1
5461478|NCT02031471|18877106|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
5461479|NCT02031471|18877106|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
5461480|NCT02031471|18877106|P1|24 Week Treatment Period|Protocol Violation|1
5461481|NCT02031471|18877106|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
5461482|NCT02031471|18877106|P1|24 Week Treatment Period|Adverse Event|6
5461483|NCT02031458|18877139|P3|Baseline to May 8, 2015|Lost to Follow-up|2
5461484|NCT02031458|18877140|P2|Baseline to May 8, 2015|Lost to Follow-up|1
5461485|NCT02031458|18877141|P1|Baseline to May 8, 2015|Lost to Follow-up|1
5461486|NCT02031458|18877139|P3|Baseline to May 8, 2015|On Treatment|73
5461487|NCT02031458|18877140|P2|Baseline to May 8, 2015|On Treatment|81
5461488|NCT02031458|18877141|P1|Baseline to May 8, 2015|On Treatment|43
5461489|NCT02031458|18877139|P3|Baseline to May 8, 2015|On Survival Follow-Up|73
5461490|NCT02031458|18877140|P2|Baseline to May 8, 2015|On Survival Follow-Up|83
5461491|NCT02031458|18877141|P1|Baseline to May 8, 2015|On Survival Follow-Up|46
5461492|NCT02031458|18877139|P3|Baseline to May 8, 2015|Withdrawal by Subject|3
5461493|NCT02031458|18877140|P2|Baseline to May 8, 2015|Withdrawal by Subject|9
5461494|NCT02031458|18877141|P1|Baseline to May 8, 2015|Withdrawal by Subject|6
5461495|NCT02031458|18877139|P3|Baseline to May 8, 2015|Unknown Reason|2
5461496|NCT02031458|18877140|P2|Baseline to May 8, 2015|Unknown Reason|1
5461497|NCT02031458|18877141|P1|Baseline to May 8, 2015|Unknown Reason|0
5461498|NCT02031458|18877139|P3|Baseline to May 8, 2015|Physician Decision|0
5461499|NCT02031458|18877140|P2|Baseline to May 8, 2015|Physician Decision|1
5461500|NCT02031458|18877141|P1|Baseline to May 8, 2015|Physician Decision|0
5461501|NCT02031458|18877139|P3|Baseline to May 8, 2015|Protocol Violation|0
5461502|NCT02031458|18877140|P2|Baseline to May 8, 2015|Protocol Violation|4
5461503|NCT02031458|18877141|P1|Baseline to May 8, 2015|Protocol Violation|7
5461504|NCT02031458|18877139|P3|Baseline to May 8, 2015|Death|100
5461505|NCT02031458|18877140|P2|Baseline to May 8, 2015|Death|87
5461506|NCT02031458|18877141|P1|Baseline to May 8, 2015|Death|36
5461507|NCT02031458|18877139|P3|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
5461508|NCT02031458|18877140|P2|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
5461509|NCT02031458|18877141|P1|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
5461510|NCT02031458|18877139|P3|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
5461511|NCT02031458|18877140|P2|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
5461512|NCT02031458|18877141|P1|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
5461513|NCT02031458|18877139|P3|May 8, 2015 to January 11, 2019|Protocol Violation|0
5461514|NCT02031458|18877140|P2|May 8, 2015 to January 11, 2019|Protocol Violation|4
5461515|NCT02031458|18877141|P1|May 8, 2015 to January 11, 2019|Protocol Violation|7
5461516|NCT02031458|18877139|P3|May 8, 2015 to January 11, 2019|Physician Decision|3
5461517|NCT02031458|18877140|P2|May 8, 2015 to January 11, 2019|Physician Decision|3
5461518|NCT02031458|18877141|P1|May 8, 2015 to January 11, 2019|Physician Decision|2
5461519|NCT02031458|18877139|P3|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
5461520|NCT02031458|18877140|P2|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
5461521|NCT02031458|18877141|P1|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
5461522|NCT02031458|18877139|P3|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
5461523|NCT02031458|18877140|P2|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
5461524|NCT02031458|18877141|P1|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
5461525|NCT02031458|18877139|P3|May 8, 2015 to January 11, 2019|Death|198
5461526|NCT02031458|18877140|P2|May 8, 2015 to January 11, 2019|Death|193
5461527|NCT02031458|18877141|P1|May 8, 2015 to January 11, 2019|Death|89
5461528|NCT02031432|18877235|P1|Overall Study|Death|10
5461529|NCT02031432|18877235|P1|Overall Study|Inclusion/Exclusion criteria not met|5
5461530|NCT02031432|18877235|P1|Overall Study|Lost to Follow-up|1
5461531|NCT02031432|18877235|P1|Overall Study|Withdrawal by Subject|5
5461532|NCT02031432|18877235|P1|Overall Study|Adverse Event|8
5461533|NCT02031432|18877235|P1|Overall Study|Withdrawn as forbidden meds required|1
5461534|NCT02031432|18877235|P1|Overall Study|Cancer Progression|2
5461535|NCT02031432|18877235|P1|Overall Study|Lack of Efficacy|5
5461536|NCT02031432|18877235|P1|Overall Study|Protocol Violation|1
5461537|NCT02031302|18877262|P2|Overall Study|Lost to Follow-up|0
5461538|NCT02031302|18877263|P1|Overall Study|Lost to Follow-up|4
5461539|NCT02031302|18877262|P2|Overall Study|Missed Follow Up|0
5461540|NCT02031302|18877263|P1|Overall Study|Missed Follow Up|27
5461541|NCT02031302|18877262|P2|Overall Study|Not treated with study valve system|0
5461542|NCT02031302|18877263|P1|Overall Study|Not treated with study valve system|18
5461543|NCT02031302|18877262|P2|Overall Study|Death|0
5461544|NCT02031302|18877263|P1|Overall Study|Death|115
5461545|NCT02031276|18877284|P3|Period 3 Open-label Risankizumab SC|Other|1
5461546|NCT02031276|18877285|P2|Period 3 Open-label Risankizumab SC|Other|0
5461547|NCT02031276|18877286|P1|Period 3 Open-label Risankizumab SC|Other|0
5461548|NCT02031276|18877284|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
5461549|NCT02031276|18877285|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
5461550|NCT02031276|18877286|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
5461551|NCT02031276|18877284|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
5461552|NCT02031276|18877285|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
5461553|NCT02031276|18877286|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
5461554|NCT02031276|18877284|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
5461555|NCT02031276|18877285|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
5461556|NCT02031276|18877286|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
5461557|NCT02031276|18877284|P3|Period 2 Open-label Risankizumab IV|Other|1
5461558|NCT02031276|18877285|P2|Period 2 Open-label Risankizumab IV|Other|2
5461559|NCT02031276|18877286|P1|Period 2 Open-label Risankizumab IV|Other|0
5461560|NCT02031276|18877284|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
5461561|NCT02031276|18877285|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
5461562|NCT02031276|18877286|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
5461563|NCT02031276|18877284|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
5461564|NCT02031276|18877285|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
5461565|NCT02031276|18877286|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
5461566|NCT02031276|18877284|P3|Period 1 Double-blind IV|Other|0
5461567|NCT02031276|18877285|P2|Period 1 Double-blind IV|Other|1
5461568|NCT02031276|18877286|P1|Period 1 Double-blind IV|Other|0
5461569|NCT02031276|18877284|P3|Period 1 Double-blind IV|Adverse Event|1
5461570|NCT02031276|18877285|P2|Period 1 Double-blind IV|Adverse Event|5
5461571|NCT02031276|18877286|P1|Period 1 Double-blind IV|Adverse Event|6
5461572|NCT02031237|18877320|P3|Overall Study|Alternate Treatment Given|3
5461573|NCT02031237|18877321|P2|Overall Study|Alternate Treatment Given|0
5461574|NCT02031237|18877322|P1|Overall Study|Alternate Treatment Given|0
5461575|NCT02031237|18877320|P3|Overall Study|Protocol Violation|0
5461576|NCT02031237|18877321|P2|Overall Study|Protocol Violation|6
5461577|NCT02031237|18877322|P1|Overall Study|Protocol Violation|2
5461578|NCT02031237|18877320|P3|Overall Study|Withdrawal by Subject|0
5461579|NCT02031237|18877321|P2|Overall Study|Withdrawal by Subject|2
5461580|NCT02031237|18877322|P1|Overall Study|Withdrawal by Subject|2
5461581|NCT02031237|18877320|P3|Overall Study|Physician Decision|0
5461582|NCT02031237|18877321|P2|Overall Study|Physician Decision|1
5461583|NCT02031237|18877322|P1|Overall Study|Physician Decision|0
5461584|NCT02031237|18877320|P3|Overall Study|Death|0
5461585|NCT02031237|18877321|P2|Overall Study|Death|5
5461586|NCT02031237|18877322|P1|Overall Study|Death|1
5461587|NCT02030847|18877342|P1|Overall Study|Withdrawal by Subject|1
5461588|NCT02030847|18877342|P1|Overall Study|Physician Decision|3
5461589|NCT02030847|18877342|P1|Overall Study|New Cancer Therapy|8
5461590|NCT02030847|18877342|P1|Overall Study|Disease Progression|15
5461591|NCT02030847|18877342|P1|Overall Study|Death|10
5461592|NCT02030834|18877350|P3|Overall Study|Lack of funding|0
5461593|NCT02030834|18877351|P2|Overall Study|Lack of funding|0
5461594|NCT02030834|18877352|P1|Overall Study|Lack of funding|1
5461595|NCT02030834|18877350|P3|Overall Study|Withdrawal by Subject|0
5461596|NCT02030834|18877351|P2|Overall Study|Withdrawal by Subject|0
5461597|NCT02030834|18877352|P1|Overall Study|Withdrawal by Subject|1
5461598|NCT02030834|18877350|P3|Overall Study|Lost to Follow-up|0
5461599|NCT02030834|18877351|P2|Overall Study|Lost to Follow-up|0
5461600|NCT02030834|18877352|P1|Overall Study|Lost to Follow-up|1
5461601|NCT02030834|18877350|P3|Overall Study|Disease progression|2
5461602|NCT02030834|18877351|P2|Overall Study|Disease progression|0
5461603|NCT02030834|18877352|P1|Overall Study|Disease progression|2
5461604|NCT02030834|18877350|P3|Overall Study|Manufacturing failure|1
5461605|NCT02030834|18877351|P2|Overall Study|Manufacturing failure|0
5461606|NCT02030834|18877352|P1|Overall Study|Manufacturing failure|2
5461607|NCT02030834|18877350|P3|Overall Study|Death|0
5461608|NCT02030834|18877351|P2|Overall Study|Death|0
5461609|NCT02030834|18877352|P1|Overall Study|Death|4
5461610|NCT02030821|18877364|P4|Overall Study|Physician Decision|2
5461611|NCT02030821|18877365|P3|Overall Study|Physician Decision|5
5461612|NCT02030821|18877366|P2|Overall Study|Physician Decision|2
5461613|NCT02030821|18877367|P1|Overall Study|Physician Decision|2
5461614|NCT02030600|18877395|P2|Treatment Period 2|Unclassified|0
5461615|NCT02030600|18877396|P1|Treatment Period 2|Unclassified|1
5461616|NCT02030600|18877395|P2|Treatment Period 2|Withdrawal by Subject|9
5461617|NCT02030600|18877396|P1|Treatment Period 2|Withdrawal by Subject|13
5461618|NCT02030600|18877395|P2|Treatment Period 2|Protocol Violation|2
5461619|NCT02030600|18877396|P1|Treatment Period 2|Protocol Violation|1
5461620|NCT02030600|18877395|P2|Treatment Period 2|Lost to Follow-up|2
5461621|NCT02030600|18877396|P1|Treatment Period 2|Lost to Follow-up|4
5461622|NCT02030600|18877395|P2|Treatment Period 2|Lack of Efficacy|1
5461623|NCT02030600|18877396|P1|Treatment Period 2|Lack of Efficacy|2
5461624|NCT02030600|18877395|P2|Treatment Period 2|Adverse Event|4
5461625|NCT02030600|18877396|P1|Treatment Period 2|Adverse Event|4
5461626|NCT02030600|18877395|P2|Treatment Period 1|Unclassified|0
5461627|NCT02030600|18877396|P1|Treatment Period 1|Unclassified|1
5461628|NCT02030600|18877395|P2|Treatment Period 1|Casebook Unsigned|0
5461629|NCT02030600|18877396|P1|Treatment Period 1|Casebook Unsigned|1
5461630|NCT02030600|18877395|P2|Treatment Period 1|Withdrawal by Subject|17
5461631|NCT02030600|18877396|P1|Treatment Period 1|Withdrawal by Subject|13
5461632|NCT02030600|18877395|P2|Treatment Period 1|Protocol Violation|17
5461633|NCT02030600|18877396|P1|Treatment Period 1|Protocol Violation|22
5461634|NCT02030600|18877395|P2|Treatment Period 1|Lost to Follow-up|3
5461635|NCT02030600|18877396|P1|Treatment Period 1|Lost to Follow-up|11
5461636|NCT02030600|18877395|P2|Treatment Period 1|Lack of Efficacy|1
5461637|NCT02030600|18877396|P1|Treatment Period 1|Lack of Efficacy|0
5461638|NCT02030600|18877395|P2|Treatment Period 1|Adverse Event|7
5461639|NCT02030600|18877396|P1|Treatment Period 1|Adverse Event|5
5461640|NCT02030535|18877417|P1|Washout Period 1 (21 Days)|Adverse Event|1
5461641|NCT02030405|18877485|P1|Overall Study|Lost to Follow-up|1
5461642|NCT02030405|18877485|P1|Overall Study|Withdrawal by Subject|1
5461643|NCT02030119|18877511|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
5461644|NCT02030119|18877512|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
5461645|NCT02030119|18877513|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
5461646|NCT02030119|18877514|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
5461647|NCT02030119|18877511|P4|Overall Study|Withdrawal by Subject|3
5461648|NCT02030119|18877512|P3|Overall Study|Withdrawal by Subject|5
5461649|NCT02030119|18877513|P2|Overall Study|Withdrawal by Subject|1
5461650|NCT02030119|18877514|P1|Overall Study|Withdrawal by Subject|3
5461651|NCT02030041|18877552|P3|Overall Study|Withdrawal by Subject|1
5461652|NCT02030041|18877553|P2|Overall Study|Withdrawal by Subject|2
5461653|NCT02030041|18877554|P1|Overall Study|Withdrawal by Subject|2
5461654|NCT02029989|18877567|P2|Overall Study|Protocol Violation|0
5461655|NCT02029989|18877568|P1|Overall Study|Protocol Violation|1
5461656|NCT02029989|18877567|P2|Overall Study|Death|1
5461657|NCT02029989|18877568|P1|Overall Study|Death|0
5461658|NCT02029989|18877567|P2|Overall Study|Lost to Follow-up|7
5461659|NCT02029989|18877568|P1|Overall Study|Lost to Follow-up|9
5461660|NCT02029989|18877567|P2|Overall Study|Physician Decision|0
5461661|NCT02029989|18877568|P1|Overall Study|Physician Decision|2
5461662|NCT02029989|18877567|P2|Overall Study|Change of location|3
5461663|NCT02029989|18877568|P1|Overall Study|Change of location|2
5461664|NCT02029989|18877567|P2|Overall Study|Withdrawal: Fear of needles|0
5461665|NCT02029989|18877568|P1|Overall Study|Withdrawal: Fear of needles|1
5461666|NCT02029989|18877567|P2|Overall Study|Withdrawal by Subject|0
5461667|NCT02029989|18877568|P1|Overall Study|Withdrawal by Subject|1
5461668|NCT02029976|18877576|P2|YR-2 Follow Up vs Baseline|Moved from area|2
5461669|NCT02029976|18877577|P1|YR-2 Follow Up vs Baseline|Moved from area|0
5461670|NCT02029976|18877576|P2|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
5461671|NCT02029976|18877577|P1|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
5461672|NCT02029976|18877576|P2|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
5461673|NCT02029976|18877577|P1|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
5461674|NCT02029976|18877576|P2|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
5461675|NCT02029976|18877577|P1|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
5461676|NCT02029846|18877606|P2|Overall Study|n=1 each arm|1
5461677|NCT02029846|18877607|P1|Overall Study|n=1 each arm|1
5461678|NCT02029638|18877645|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
5461679|NCT02029638|18877646|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
5461680|NCT02029638|18877647|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
5461681|NCT02029638|18877645|P3|Overall Study|Death|1
5461682|NCT02029638|18877646|P2|Overall Study|Death|0
5461683|NCT02029638|18877647|P1|Overall Study|Death|0
5461684|NCT02029521|18877676|P2|Overall Study|Withdrawal by Subject|1
5461685|NCT02029521|18877677|P1|Overall Study|Withdrawal by Subject|1
5461686|NCT02029521|18877676|P2|Overall Study|Protocol Violation|0
5461687|NCT02029521|18877677|P1|Overall Study|Protocol Violation|1
5461688|NCT02029417|18877775|P1|Overall Study|Adverse Event|1
5461689|NCT02029417|18877775|P1|Overall Study|Death|1
5461690|NCT02029274|18877784|P4|Overall Study|Adverse Event|2
5461691|NCT02029274|18877785|P3|Overall Study|Adverse Event|2
5461692|NCT02029274|18877786|P2|Overall Study|Adverse Event|0
5461693|NCT02029274|18877787|P1|Overall Study|Adverse Event|1
5461694|NCT02029235|18877819|P2|Overall Study|Non-compliance with study meds or diary|1
5461695|NCT02029235|18877820|P1|Overall Study|Non-compliance with study meds or diary|4
5461696|NCT02028884|18877852|P2|Open-label Extension Period|On-going in Study|14
5461697|NCT02028884|18877853|P1|Open-label Extension Period|On-going in Study|19
5461698|NCT02028884|18877852|P2|Open-label Extension Period|Withdrawal by Subject|2
5461699|NCT02028884|18877853|P1|Open-label Extension Period|Withdrawal by Subject|0
5461700|NCT02028884|18877852|P2|Open-label Extension Period|Non-Compliance With Study Drug|1
5461701|NCT02028884|18877853|P1|Open-label Extension Period|Non-Compliance With Study Drug|0
5461702|NCT02028884|18877852|P2|Open-label Extension Period|Lack of Efficacy|0
5461703|NCT02028884|18877853|P1|Open-label Extension Period|Lack of Efficacy|3
5461704|NCT02028884|18877852|P2|Open-label Extension Period|Adverse Event|1
5461705|NCT02028884|18877853|P1|Open-label Extension Period|Adverse Event|2
5461706|NCT02028884|18877852|P2|Double-blind Period|On-going in Study|20
5461707|NCT02028884|18877853|P1|Double-blind Period|On-going in Study|8
5461708|NCT02028884|18877852|P2|Double-blind Period|Withdrawal by Subject|0
5461709|NCT02028884|18877853|P1|Double-blind Period|Withdrawal by Subject|2
5461710|NCT02028884|18877852|P2|Double-blind Period|Non-Compliance With Study Drug|0
5461711|NCT02028884|18877853|P1|Double-blind Period|Non-Compliance With Study Drug|2
5461712|NCT02028884|18877852|P2|Double-blind Period|Eligibility Violation|0
5461713|NCT02028884|18877853|P1|Double-blind Period|Eligibility Violation|1
5461714|NCT02028884|18877852|P2|Double-blind Period|Adverse Event|3
5461715|NCT02028884|18877853|P1|Double-blind Period|Adverse Event|5
5461716|NCT02028871|18877923|P2|Overall Study|Current Illness|0
5461717|NCT02028871|18877924|P1|Overall Study|Current Illness|1
5461718|NCT02028871|18877923|P2|Overall Study|IV placement difficulty|0
5461719|NCT02028871|18877924|P1|Overall Study|IV placement difficulty|1
5461720|NCT02028871|18877923|P2|Overall Study|Withdrawal by Subject|2
5461721|NCT02028871|18877924|P1|Overall Study|Withdrawal by Subject|1
5461722|NCT02028871|18877923|P2|Overall Study|Positive urine drug screen|1
5461723|NCT02028871|18877924|P1|Overall Study|Positive urine drug screen|1
5461808|NCT02027428|18878513|P1|Maintenance|Symptomatic deterioration|0
5461724|NCT02028767|18878021|P2|Treatment Period 2|Reason other than those specified above|0
5461725|NCT02028767|18878022|P1|Treatment Period 2|Reason other than those specified above|1
5461726|NCT02028767|18878021|P2|Treatment Period 2|Non compliant with protocol|0
5461727|NCT02028767|18878022|P1|Treatment Period 2|Non compliant with protocol|1
5461728|NCT02028715|18878055|P2|Overall Study|Did not complete satisfaction surveys|2
5461729|NCT02028715|18878056|P1|Overall Study|Did not complete satisfaction surveys|2
5461730|NCT02028715|18878055|P2|Overall Study|Physician Decision|0
5461731|NCT02028715|18878056|P1|Overall Study|Physician Decision|1
5461732|NCT02028715|18878055|P2|Overall Study|Adverse Event|2
5461733|NCT02028715|18878056|P1|Overall Study|Adverse Event|2
5461734|NCT02028182|18878284|P1|Overall Study|Protocol Violation|2
5461735|NCT02028169|18878290|P1|Overall Study|Concomitant Medication Usage|1
5461736|NCT02028169|18878290|P1|Overall Study|Cessation of Drug|1
5461737|NCT02028169|18878290|P1|Overall Study|Adverse Event|1
5461738|NCT02028169|18878290|P1|Overall Study|Withdrawal by Subject|2
5461739|NCT02028169|18878290|P1|Overall Study|Lack of Efficacy|2
5461740|NCT02028169|18878290|P1|Overall Study|Lost to Follow-up|21
5461741|NCT02028065|18878316|P3|Treatment Through Study Completion|Adverse Event|5
5461742|NCT02028065|18878317|P2|Treatment Through Study Completion|Adverse Event|3
5461743|NCT02028065|18878318|P1|Treatment Through Study Completion|Adverse Event|3
5461744|NCT02028065|18878316|P3|Treatment Through Study Completion|Withdrawal by Subject|3
5461745|NCT02028065|18878317|P2|Treatment Through Study Completion|Withdrawal by Subject|4
5461746|NCT02028065|18878318|P1|Treatment Through Study Completion|Withdrawal by Subject|5
5461747|NCT02028065|18878316|P3|Treatment Through Study Completion|Protocol Violation|0
5461748|NCT02028065|18878317|P2|Treatment Through Study Completion|Protocol Violation|4
5461749|NCT02028065|18878318|P1|Treatment Through Study Completion|Protocol Violation|1
5461750|NCT02028065|18878316|P3|Treatment Through Study Completion|Physician Decision|0
5461751|NCT02028065|18878317|P2|Treatment Through Study Completion|Physician Decision|0
5461752|NCT02028065|18878318|P1|Treatment Through Study Completion|Physician Decision|1
5461753|NCT02028065|18878316|P3|Treatment Through Study Completion|Lost to Follow-up|6
5461754|NCT02028065|18878317|P2|Treatment Through Study Completion|Lost to Follow-up|4
5461755|NCT02028065|18878318|P1|Treatment Through Study Completion|Lost to Follow-up|2
5461756|NCT02028065|18878316|P3|Randomization Through Start Treatment|Not treated|3
5461757|NCT02028065|18878317|P2|Randomization Through Start Treatment|Not treated|3
5461758|NCT02028065|18878318|P1|Randomization Through Start Treatment|Not treated|1
5461759|NCT02027844|18878345|P3|Overall Study|Incomlete data|0
5461760|NCT02027844|18878346|P2|Overall Study|Incomlete data|0
5461761|NCT02027844|18878347|P1|Overall Study|Incomlete data|2
5461762|NCT02027844|18878345|P3|Overall Study|Protocol Violation|0
5461763|NCT02027844|18878346|P2|Overall Study|Protocol Violation|2
5461764|NCT02027844|18878347|P1|Overall Study|Protocol Violation|0
5461765|NCT02027844|18878345|P3|Overall Study|Lost to Follow-up|1
5461766|NCT02027844|18878346|P2|Overall Study|Lost to Follow-up|2
5461767|NCT02027844|18878347|P1|Overall Study|Lost to Follow-up|0
5461768|NCT02027844|18878345|P3|Overall Study|Withdrawal by Subject|1
5461769|NCT02027844|18878346|P2|Overall Study|Withdrawal by Subject|2
5461770|NCT02027844|18878347|P1|Overall Study|Withdrawal by Subject|3
5461771|NCT02027701|18878364|P1|Overall Study|Withdrawal by Subject|3
5461772|NCT02027701|18878364|P1|Overall Study|Physician Decision|2
5461773|NCT02027701|18878364|P1|Overall Study|Lack of Efficacy|8
5461774|NCT02027701|18878364|P1|Overall Study|Adverse Event|3
5461775|NCT02027623|18878382|P2|Overall Study|Withdrawal by Subject|9
5461776|NCT02027623|18878383|P1|Overall Study|Withdrawal by Subject|6
5461777|NCT02027623|18878382|P2|Overall Study|Lost to Follow-up|3
5461778|NCT02027623|18878383|P1|Overall Study|Lost to Follow-up|3
5461779|NCT02027558|18878479|P2|Overall Study|Refused assessment|0
5461780|NCT02027558|18878480|P1|Overall Study|Refused assessment|3
5461781|NCT02027558|18878479|P2|Overall Study|Lost to Follow-up|1
5461782|NCT02027558|18878480|P1|Overall Study|Lost to Follow-up|4
5461783|NCT02027558|18878479|P2|Overall Study|Withdrawal by Subject|0
5461784|NCT02027558|18878480|P1|Overall Study|Withdrawal by Subject|2
5461785|NCT02027558|18878479|P2|Overall Study|Death|1
5461786|NCT02027558|18878480|P1|Overall Study|Death|0
5461787|NCT02027545|18878498|P2|Overall Study|Failed to attend study visit|0
5461788|NCT02027545|18878499|P1|Overall Study|Failed to attend study visit|2
5461789|NCT02027545|18878498|P2|Overall Study|Failed to sign HIPAA|2
5461790|NCT02027545|18878499|P1|Overall Study|Failed to sign HIPAA|0
5461791|NCT02027428|18878511|P3|Survival Follow-up|Lost to Follow-up|1
5461792|NCT02027428|18878512|P2|Survival Follow-up|Lost to Follow-up|1
5461793|NCT02027428|18878513|P1|Survival Follow-up|Lost to Follow-up|0
5461794|NCT02027428|18878511|P3|Survival Follow-up|Death|45
5461795|NCT02027428|18878512|P2|Survival Follow-up|Death|78
5461796|NCT02027428|18878513|P1|Survival Follow-up|Death|0
5461797|NCT02027428|18878511|P3|Maintenance|Other|3
5461798|NCT02027428|18878512|P2|Maintenance|Other|6
5461799|NCT02027428|18878513|P1|Maintenance|Other|0
5461800|NCT02027428|18878511|P3|Maintenance|Protocol Violation|1
5461801|NCT02027428|18878512|P2|Maintenance|Protocol Violation|0
5461802|NCT02027428|18878513|P1|Maintenance|Protocol Violation|0
5461803|NCT02027428|18878511|P3|Maintenance|Withdrawal by Subject|5
5461804|NCT02027428|18878512|P2|Maintenance|Withdrawal by Subject|6
5461805|NCT02027428|18878513|P1|Maintenance|Withdrawal by Subject|0
5461806|NCT02027428|18878511|P3|Maintenance|Symptomatic deterioration|1
5461807|NCT02027428|18878512|P2|Maintenance|Symptomatic deterioration|4
5461809|NCT02027428|18878511|P3|Maintenance|Progressive disease|47
5461810|NCT02027428|18878512|P2|Maintenance|Progressive disease|84
5461811|NCT02027428|18878513|P1|Maintenance|Progressive disease|0
5461812|NCT02027428|18878511|P3|Maintenance|Adverse Event|1
5461813|NCT02027428|18878512|P2|Maintenance|Adverse Event|21
5461814|NCT02027428|18878513|P1|Maintenance|Adverse Event|0
5461815|NCT02027428|18878511|P3|Maintenance|Death|2
5461816|NCT02027428|18878512|P2|Maintenance|Death|3
5461817|NCT02027428|18878513|P1|Maintenance|Death|0
5461818|NCT02027428|18878511|P3|Induction|Induction Treatment Ongoing|0
5461819|NCT02027428|18878512|P2|Induction|Induction Treatment Ongoing|0
5461820|NCT02027428|18878513|P1|Induction|Induction Treatment Ongoing|4
5461821|NCT02027428|18878511|P3|Induction|Miscellaneous|0
5461822|NCT02027428|18878512|P2|Induction|Miscellaneous|0
5461823|NCT02027428|18878513|P1|Induction|Miscellaneous|14
5461824|NCT02027428|18878511|P3|Induction|Protocol Violation|0
5461825|NCT02027428|18878512|P2|Induction|Protocol Violation|0
5461826|NCT02027428|18878513|P1|Induction|Protocol Violation|1
5461827|NCT02027428|18878511|P3|Induction|Study terminated by sponsor|0
5461828|NCT02027428|18878512|P2|Induction|Study terminated by sponsor|0
5461829|NCT02027428|18878513|P1|Induction|Study terminated by sponsor|12
5461830|NCT02027428|18878511|P3|Induction|Symptomatic deterioration|0
5461831|NCT02027428|18878512|P2|Induction|Symptomatic deterioration|0
5461832|NCT02027428|18878513|P1|Induction|Symptomatic deterioration|16
5461833|NCT02027428|18878511|P3|Induction|Death|0
5461834|NCT02027428|18878512|P2|Induction|Death|0
5461835|NCT02027428|18878513|P1|Induction|Death|21
5461836|NCT02027428|18878511|P3|Induction|Withdrawal by Subject|0
5461837|NCT02027428|18878512|P2|Induction|Withdrawal by Subject|0
5461838|NCT02027428|18878513|P1|Induction|Withdrawal by Subject|22
5461839|NCT02027428|18878511|P3|Induction|Adverse Event|0
5461840|NCT02027428|18878512|P2|Induction|Adverse Event|0
5461841|NCT02027428|18878513|P1|Induction|Adverse Event|51
5461842|NCT02027428|18878511|P3|Induction|Progressive disease|0
5461843|NCT02027428|18878512|P2|Induction|Progressive disease|0
5461844|NCT02027428|18878513|P1|Induction|Progressive disease|77
5461845|NCT02027428|18878511|P3|Induction|Never treated|0
5461846|NCT02027428|18878512|P2|Induction|Never treated|0
5461847|NCT02027428|18878513|P1|Induction|Never treated|7
5461848|NCT02027402|18878551|P2|Overall Study|Withdrawal by Subject|1
5461849|NCT02027402|18878552|P1|Overall Study|Withdrawal by Subject|4
5461850|NCT02027376|18878564|P3|Overall Study|Death|0
5461851|NCT02027376|18878565|P2|Overall Study|Death|0
5461852|NCT02027376|18878566|P1|Overall Study|Death|1
5461853|NCT02027311|18878592|P2|Overall Study|Protocol Violation|2
5461854|NCT02027311|18878593|P1|Overall Study|Protocol Violation|3
5461855|NCT02027025|18878613|P3|Overall Study|Sponsor's decision|0
5461856|NCT02027025|18878614|P2|Overall Study|Sponsor's decision|1
5461857|NCT02027025|18878615|P1|Overall Study|Sponsor's decision|0
5461858|NCT02027025|18878613|P3|Overall Study|Withdrawal by Subject|0
5461859|NCT02027025|18878614|P2|Overall Study|Withdrawal by Subject|1
5461860|NCT02027025|18878615|P1|Overall Study|Withdrawal by Subject|0
5461861|NCT02027025|18878613|P3|Overall Study|Lost to Follow-up|0
5461862|NCT02027025|18878614|P2|Overall Study|Lost to Follow-up|2
5461863|NCT02027025|18878615|P1|Overall Study|Lost to Follow-up|0
5461864|NCT02027025|18878613|P3|Overall Study|Protocol Violation|0
5461865|NCT02027025|18878614|P2|Overall Study|Protocol Violation|0
5461866|NCT02027025|18878615|P1|Overall Study|Protocol Violation|1
5461867|NCT02027025|18878613|P3|Overall Study|Adverse Event|1
5461868|NCT02027025|18878614|P2|Overall Study|Adverse Event|1
5461869|NCT02027025|18878615|P1|Overall Study|Adverse Event|0
5461870|NCT02026258|18878678|P2|Recieved Allocated Intervention|Lost to Follow-up|1
5461871|NCT02026258|18878679|P1|Recieved Allocated Intervention|Lost to Follow-up|0
5461872|NCT02026258|18878678|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
5461873|NCT02026258|18878679|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
5461874|NCT02026258|18878678|P2|Randomized|Presence of periodontal disease|1
5461875|NCT02026258|18878679|P1|Randomized|Presence of periodontal disease|1
5461876|NCT02026258|18878678|P2|Randomized|Change in treatment plan|0
5461877|NCT02026258|18878679|P1|Randomized|Change in treatment plan|1
5461878|NCT02026258|18878678|P2|Randomized|Did not start treatment|1
5461879|NCT02026258|18878679|P1|Randomized|Did not start treatment|2
5461880|NCT02026141|18878713|P2|Overall Study|Protocol Violation|1
5461881|NCT02026141|18878714|P1|Overall Study|Protocol Violation|0
5461882|NCT02026063|18878722|P2|Overall Study|Reason not Specified|7
5461883|NCT02026063|18878723|P1|Overall Study|Reason not Specified|2
5461884|NCT02026063|18878722|P2|Overall Study|Lost to Follow-up|1
5461885|NCT02026063|18878723|P1|Overall Study|Lost to Follow-up|0
5461886|NCT02026063|18878722|P2|Overall Study|Lack of Efficacy|4
5461887|NCT02026063|18878723|P1|Overall Study|Lack of Efficacy|0
5461888|NCT02026063|18878722|P2|Overall Study|Adverse Event|20
5461889|NCT02026063|18878723|P1|Overall Study|Adverse Event|5
5461890|NCT02026063|18878722|P2|Overall Study|Withdrawal of Consent|6
5461891|NCT02026063|18878723|P1|Overall Study|Withdrawal of Consent|1
5461892|NCT02026063|18878722|P2|Overall Study|Noncompliance with Study Drug|1
5461893|NCT02026063|18878723|P1|Overall Study|Noncompliance with Study Drug|1
5461894|NCT02026063|18878722|P2|Overall Study|Physician Decision|10
5461895|NCT02026063|18878723|P1|Overall Study|Physician Decision|0
5461896|NCT02026011|18878735|P2|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
5461897|NCT02026011|18878736|P1|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
5461898|NCT02026011|18878735|P2|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
5461899|NCT02026011|18878736|P1|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
5461900|NCT02026011|18878735|P2|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
5461901|NCT02026011|18878736|P1|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
5461902|NCT02026011|18878735|P2|Allocation 1 (First Set of Medication)|Side Effects|0
5461903|NCT02026011|18878736|P1|Allocation 1 (First Set of Medication)|Side Effects|6
5461904|NCT02025907|18878762|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
5461905|NCT02025907|18878763|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
5461906|NCT02025907|18878762|P2|Overall Study|Adverse Event|1
5461907|NCT02025907|18878763|P1|Overall Study|Adverse Event|3
5461908|NCT02025907|18878762|P2|Overall Study|Lost to Follow-up|2
5461909|NCT02025907|18878763|P1|Overall Study|Lost to Follow-up|2
5461910|NCT02025907|18878762|P2|Overall Study|Physician Decision|0
5461911|NCT02025907|18878763|P1|Overall Study|Physician Decision|2
5461912|NCT02025907|18878762|P2|Overall Study|Protocol Violation|0
5461913|NCT02025907|18878763|P1|Overall Study|Protocol Violation|2
5461914|NCT02025907|18878762|P2|Overall Study|Withdrawal by Subject|8
5461915|NCT02025907|18878763|P1|Overall Study|Withdrawal by Subject|15
5461916|NCT02025907|18878762|P2|Overall Study|Lack of Efficacy|0
5461917|NCT02025907|18878763|P1|Overall Study|Lack of Efficacy|1
5461918|NCT02025751|18878791|P2|Overall Study|Withdrawal by Subject|1
5461919|NCT02025751|18878792|P1|Overall Study|Withdrawal by Subject|0
5461920|NCT02025751|18878791|P2|Overall Study|Physician Decision|1
5461921|NCT02025751|18878792|P1|Overall Study|Physician Decision|0
5461922|NCT02025751|18878791|P2|Overall Study|Adverse Event|1
5461923|NCT02025751|18878792|P1|Overall Study|Adverse Event|0
5461924|NCT02025751|18878791|P2|Overall Study|Lost to Follow-up|0
5461925|NCT02025751|18878792|P1|Overall Study|Lost to Follow-up|1
5461926|NCT02025725|18878800|P2|Overall Study|Post-dose QTcB > 270 msec|1
5461927|NCT02025725|18878801|P1|Overall Study|Post-dose QTcB > 270 msec|0
5461928|NCT02025725|18878800|P2|Overall Study|Withdrawal by Subject|2
5461929|NCT02025725|18878801|P1|Overall Study|Withdrawal by Subject|3
5461930|NCT02025725|18878800|P2|Overall Study|Protocol Violation|1
5461931|NCT02025725|18878801|P1|Overall Study|Protocol Violation|1
5461932|NCT02025725|18878800|P2|Overall Study|Lost to Follow-up|0
5461933|NCT02025725|18878801|P1|Overall Study|Lost to Follow-up|2
5461934|NCT02025725|18878800|P2|Overall Study|Adverse Event|0
5461935|NCT02025725|18878801|P1|Overall Study|Adverse Event|5
5461936|NCT02025621|18878853|P2|Overall Study|Surgery initiated before infusion|3
5461937|NCT02025621|18878854|P1|Overall Study|Surgery initiated before infusion|3
5461938|NCT02025621|18878853|P2|Overall Study|No longer eligible|15
5461939|NCT02025621|18878854|P1|Overall Study|No longer eligible|10
5461940|NCT02025621|18878853|P2|Overall Study|Death|1
5461941|NCT02025621|18878854|P1|Overall Study|Death|0
5461942|NCT02025621|18878853|P2|Overall Study|Withdrawal by Subject|0
5461943|NCT02025621|18878854|P1|Overall Study|Withdrawal by Subject|1
5461944|NCT02025530|18878874|P2|Overall Study|No longer met elligibility criteria|1
5461945|NCT02025530|18878875|P1|Overall Study|No longer met elligibility criteria|5
5461946|NCT02025205|18878921|P2|Overall Study|Death|1
5461947|NCT02025205|18878922|P1|Overall Study|Death|0
5461948|NCT02025205|18878921|P2|Overall Study|Protocol Violation|1
5461949|NCT02025205|18878922|P1|Overall Study|Protocol Violation|2
5461950|NCT02025205|18878921|P2|Overall Study|Withdrawal by Subject|1
5461951|NCT02025205|18878922|P1|Overall Study|Withdrawal by Subject|1
5461952|NCT02025179|18878966|P3|Overall Study|Lost to Follow-up|1
5461953|NCT02025179|18878967|P2|Overall Study|Lost to Follow-up|0
5461954|NCT02025179|18878968|P1|Overall Study|Lost to Follow-up|0
5461955|NCT02024971|18879018|P1|Overall Study|Lost to Follow-up|6
5461956|NCT02024971|18879018|P1|Overall Study|Data Not Available|30
5461957|NCT02024932|18879031|P6|Overall Study|Abnormal laboratory value|0
5461958|NCT02024932|18879032|P5|Overall Study|Abnormal laboratory value|0
5461959|NCT02024932|18879033|P4|Overall Study|Abnormal laboratory value|2
5461960|NCT02024932|18879034|P3|Overall Study|Abnormal laboratory value|0
5461961|NCT02024932|18879035|P2|Overall Study|Abnormal laboratory value|0
5461962|NCT02024932|18879036|P1|Overall Study|Abnormal laboratory value|0
5461963|NCT02024932|18879031|P6|Overall Study|Adverse Event|0
5461964|NCT02024932|18879032|P5|Overall Study|Adverse Event|2
5461965|NCT02024932|18879033|P4|Overall Study|Adverse Event|0
5461966|NCT02024932|18879034|P3|Overall Study|Adverse Event|0
5461967|NCT02024932|18879035|P2|Overall Study|Adverse Event|3
5461968|NCT02024932|18879036|P1|Overall Study|Adverse Event|2
5461969|NCT02024867|18879095|P2|Overall Study|Lost to Follow-up|4
5461970|NCT02024867|18879096|P1|Overall Study|Lost to Follow-up|6
5461971|NCT02024867|18879095|P2|Overall Study|Protocol Violation|3
5461972|NCT02024867|18879096|P1|Overall Study|Protocol Violation|3
5461973|NCT02024750|18879114|P2|Overall Study|Withdrawal by Subject|1
5461974|NCT02024750|18879115|P1|Overall Study|Withdrawal by Subject|2
5461975|NCT02024698|18879151|P2|First Intervention (7 Days)|Withdrawal by Subject|1
5461976|NCT02024698|18879152|P1|First Intervention (7 Days)|Withdrawal by Subject|0
5461977|NCT02024555|18879193|P2|Overall Study|Withdrawal by Subject|1
5461978|NCT02024555|18879194|P1|Overall Study|Withdrawal by Subject|5
5461979|NCT02024555|18879193|P2|Overall Study|Lost to Follow-up|1
5461980|NCT02024555|18879194|P1|Overall Study|Lost to Follow-up|1
5461981|NCT02023879|18879321|P3|Extension Open Label Treatment|Other than specified above|2
5461982|NCT02023879|18879322|P2|Extension Open Label Treatment|Other than specified above|7
5462058|NCT02023697|18879436|P1|Treatment Period|Safety outcome reached|0
5461983|NCT02023879|18879323|P1|Extension Open Label Treatment|Other than specified above|2
5461984|NCT02023879|18879321|P3|Extension Open Label Treatment|Participant moved|0
5461985|NCT02023879|18879322|P2|Extension Open Label Treatment|Participant moved|2
5461986|NCT02023879|18879323|P1|Extension Open Label Treatment|Participant moved|1
5461987|NCT02023879|18879321|P3|Extension Open Label Treatment|Poor compliance to protocol|0
5461988|NCT02023879|18879322|P2|Extension Open Label Treatment|Poor compliance to protocol|1
5461989|NCT02023879|18879323|P1|Extension Open Label Treatment|Poor compliance to protocol|1
5461990|NCT02023879|18879321|P3|Extension Open Label Treatment|Adverse Event|3
5461991|NCT02023879|18879322|P2|Extension Open Label Treatment|Adverse Event|7
5461992|NCT02023879|18879323|P1|Extension Open Label Treatment|Adverse Event|1
5461993|NCT02023879|18879321|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
5461994|NCT02023879|18879322|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
5461995|NCT02023879|18879323|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
5461996|NCT02023879|18879321|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
5461997|NCT02023879|18879322|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
5461998|NCT02023879|18879323|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
5461999|NCT02023879|18879321|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
5462000|NCT02023879|18879322|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
5462001|NCT02023879|18879323|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
5462002|NCT02023879|18879321|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
5462003|NCT02023879|18879322|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
5462004|NCT02023879|18879323|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
5462005|NCT02023879|18879321|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
5462006|NCT02023879|18879322|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
5462007|NCT02023879|18879323|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
5462008|NCT02023879|18879321|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
5462009|NCT02023879|18879322|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
5462010|NCT02023879|18879323|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
5462011|NCT02023866|18879412|P1|Overall Study|Withdrawal by Subject|1
5462012|NCT02023866|18879412|P1|Overall Study|Adverse Event|3
5462013|NCT02023866|18879412|P1|Overall Study|Non-compliance|2
5462014|NCT02023697|18879434|P3|Long-term Follow-up Period|Other unspecified|5
5462015|NCT02023697|18879435|P2|Long-term Follow-up Period|Other unspecified|3
5462016|NCT02023697|18879436|P1|Long-term Follow-up Period|Other unspecified|6
5462017|NCT02023697|18879434|P3|Long-term Follow-up Period|Technical problems|1
5462018|NCT02023697|18879435|P2|Long-term Follow-up Period|Technical problems|0
5462019|NCT02023697|18879436|P1|Long-term Follow-up Period|Technical problems|0
5462020|NCT02023697|18879434|P3|Long-term Follow-up Period|Entered the long-term follow-up study|6
5462021|NCT02023697|18879435|P2|Long-term Follow-up Period|Entered the long-term follow-up study|9
5462022|NCT02023697|18879436|P1|Long-term Follow-up Period|Entered the long-term follow-up study|6
5462023|NCT02023697|18879434|P3|Long-term Follow-up Period|Lost to Follow-up|1
5462024|NCT02023697|18879435|P2|Long-term Follow-up Period|Lost to Follow-up|0
5462025|NCT02023697|18879436|P1|Long-term Follow-up Period|Lost to Follow-up|1
5462026|NCT02023697|18879434|P3|Long-term Follow-up Period|Withdrawal by Subject|0
5462027|NCT02023697|18879435|P2|Long-term Follow-up Period|Withdrawal by Subject|3
5462028|NCT02023697|18879436|P1|Long-term Follow-up Period|Withdrawal by Subject|6
5462029|NCT02023697|18879434|P3|Long-term Follow-up Period|Death|4
5462030|NCT02023697|18879435|P2|Long-term Follow-up Period|Death|6
5462031|NCT02023697|18879436|P1|Long-term Follow-up Period|Death|9
5462032|NCT02023697|18879434|P3|Active Follow-up Period|Death|87
5462033|NCT02023697|18879435|P2|Active Follow-up Period|Death|82
5462034|NCT02023697|18879436|P1|Active Follow-up Period|Death|83
5462035|NCT02023697|18879434|P3|Active Follow-up Period|Radiological progression|1
5462036|NCT02023697|18879435|P2|Active Follow-up Period|Radiological progression|0
5462037|NCT02023697|18879436|P1|Active Follow-up Period|Radiological progression|0
5462038|NCT02023697|18879434|P3|Active Follow-up Period|Clinical progression|1
5462039|NCT02023697|18879435|P2|Active Follow-up Period|Clinical progression|2
5462040|NCT02023697|18879436|P1|Active Follow-up Period|Clinical progression|0
5462041|NCT02023697|18879434|P3|Active Follow-up Period|Other unspecified|1
5462042|NCT02023697|18879435|P2|Active Follow-up Period|Other unspecified|0
5462043|NCT02023697|18879436|P1|Active Follow-up Period|Other unspecified|2
5462044|NCT02023697|18879434|P3|Active Follow-up Period|Deterioration of general condition|1
5462045|NCT02023697|18879435|P2|Active Follow-up Period|Deterioration of general condition|1
5462046|NCT02023697|18879436|P1|Active Follow-up Period|Deterioration of general condition|1
5462047|NCT02023697|18879434|P3|Active Follow-up Period|Lost to Follow-up|1
5462048|NCT02023697|18879435|P2|Active Follow-up Period|Lost to Follow-up|1
5462049|NCT02023697|18879436|P1|Active Follow-up Period|Lost to Follow-up|1
5462050|NCT02023697|18879434|P3|Active Follow-up Period|Withdrawal by Subject|7
5462051|NCT02023697|18879435|P2|Active Follow-up Period|Withdrawal by Subject|13
5462052|NCT02023697|18879436|P1|Active Follow-up Period|Withdrawal by Subject|5
5462053|NCT02023697|18879434|P3|Treatment Period|Physician Decision|1
5462054|NCT02023697|18879435|P2|Treatment Period|Physician Decision|0
5462055|NCT02023697|18879436|P1|Treatment Period|Physician Decision|0
5462056|NCT02023697|18879434|P3|Treatment Period|Safety outcome reached|0
5462057|NCT02023697|18879435|P2|Treatment Period|Safety outcome reached|1
5462059|NCT02023697|18879434|P3|Treatment Period|Withdrawal by Subject|13
5462060|NCT02023697|18879435|P2|Treatment Period|Withdrawal by Subject|5
5462061|NCT02023697|18879436|P1|Treatment Period|Withdrawal by Subject|4
5462062|NCT02023697|18879434|P3|Treatment Period|Clinical progression|28
5462063|NCT02023697|18879435|P2|Treatment Period|Clinical progression|8
5462064|NCT02023697|18879436|P1|Treatment Period|Clinical progression|10
5462065|NCT02023697|18879434|P3|Treatment Period|Logistical difficulties|1
5462066|NCT02023697|18879435|P2|Treatment Period|Logistical difficulties|1
5462067|NCT02023697|18879436|P1|Treatment Period|Logistical difficulties|1
5462068|NCT02023697|18879434|P3|Treatment Period|Adverse Event|23
5462069|NCT02023697|18879435|P2|Treatment Period|Adverse Event|25
5462070|NCT02023697|18879436|P1|Treatment Period|Adverse Event|13
5462071|NCT02023697|18879434|P3|Treatment Period|Never Treated|10
5462072|NCT02023697|18879435|P2|Treatment Period|Never Treated|6
5462073|NCT02023697|18879436|P1|Treatment Period|Never Treated|5
5462074|NCT02023697|18879434|P3|Treatment Period|Radiological progression|26
5462075|NCT02023697|18879435|P2|Treatment Period|Radiological progression|17
5462076|NCT02023697|18879436|P1|Treatment Period|Radiological progression|13
5462077|NCT02023268|18879560|P2|Overall Study|Withdrawal by Subject|1
5462078|NCT02023268|18879561|P1|Overall Study|Withdrawal by Subject|0
5462079|NCT02023268|18879560|P2|Overall Study|Adverse Event|2
5462080|NCT02023268|18879561|P1|Overall Study|Adverse Event|0
5462081|NCT02023268|18879560|P2|Overall Study|Lack of Efficacy|1
5462082|NCT02023268|18879561|P1|Overall Study|Lack of Efficacy|0
5462083|NCT02023242|18879569|P2|Overall Study|Death|1
5462084|NCT02023242|18879570|P1|Overall Study|Death|0
5462085|NCT02023242|18879569|P2|Overall Study|Lost to Follow-up|1
5462086|NCT02023242|18879570|P1|Overall Study|Lost to Follow-up|3
5462087|NCT02023151|18879584|P1|Overall Study|Lost to Follow-up|4
5462088|NCT02023112|18879654|P2|Overall Study|Withdrawal by Subject|1
5462089|NCT02023112|18879655|P1|Overall Study|Withdrawal by Subject|2
5462090|NCT02023099|18879676|P3|Overall Study|Non-treatment-emergent Fatal AE|1
5462091|NCT02023099|18879677|P2|Overall Study|Non-treatment-emergent Fatal AE|0
5462092|NCT02023099|18879678|P1|Overall Study|Non-treatment-emergent Fatal AE|0
5462093|NCT02023099|18879676|P3|Overall Study|Withdrawn Consent|1
5462094|NCT02023099|18879677|P2|Overall Study|Withdrawn Consent|0
5462095|NCT02023099|18879678|P1|Overall Study|Withdrawn Consent|3
5462096|NCT02023099|18879676|P3|Overall Study|Non-fatal Adverse Event (AE)|1
5462097|NCT02023099|18879677|P2|Overall Study|Non-fatal Adverse Event (AE)|0
5462098|NCT02023099|18879678|P1|Overall Study|Non-fatal Adverse Event (AE)|0
5462099|NCT02022748|18879701|P3|Overall Study|Withdrawal by Subject|0
5462100|NCT02022748|18879702|P2|Overall Study|Withdrawal by Subject|1
5462101|NCT02022748|18879703|P1|Overall Study|Withdrawal by Subject|0
5462102|NCT02022748|18879701|P3|Overall Study|Adverse Event|0
5462103|NCT02022748|18879702|P2|Overall Study|Adverse Event|1
5462104|NCT02022748|18879703|P1|Overall Study|Adverse Event|1
5462105|NCT02022670|18879729|P3|Overall Study|Adverse Event|1
5462106|NCT02022670|18879730|P2|Overall Study|Adverse Event|0
5462107|NCT02022670|18879731|P1|Overall Study|Adverse Event|1
5462108|NCT02022657|18879745|P6|Overall Study|Physician Decision|1
5462109|NCT02022657|18879746|P5|Overall Study|Physician Decision|0
5462110|NCT02022657|18879747|P4|Overall Study|Physician Decision|0
5462111|NCT02022657|18879748|P3|Overall Study|Physician Decision|0
5462112|NCT02022657|18879749|P2|Overall Study|Physician Decision|0
5462113|NCT02022657|18879750|P1|Overall Study|Physician Decision|0
5462114|NCT02022657|18879745|P6|Overall Study|Withdrawal by Subject|0
5462115|NCT02022657|18879746|P5|Overall Study|Withdrawal by Subject|0
5462116|NCT02022657|18879747|P4|Overall Study|Withdrawal by Subject|0
5462117|NCT02022657|18879748|P3|Overall Study|Withdrawal by Subject|1
5462118|NCT02022657|18879749|P2|Overall Study|Withdrawal by Subject|0
5462119|NCT02022657|18879750|P1|Overall Study|Withdrawal by Subject|2
5462120|NCT02022007|18879800|P3|Overall Study|Noncompliant|1
5462121|NCT02022007|18879801|P2|Overall Study|Noncompliant|0
5462122|NCT02022007|18879802|P1|Overall Study|Noncompliant|0
5462123|NCT02022007|18879800|P3|Overall Study|Withdrawal by Subject|1
5462124|NCT02022007|18879801|P2|Overall Study|Withdrawal by Subject|1
5462125|NCT02022007|18879802|P1|Overall Study|Withdrawal by Subject|1
5462126|NCT02021656|18879885|P1|Overall Study|Withdrew Consent|2
5462127|NCT02021656|18879885|P1|Overall Study|Lost to Follow-up|1
5462128|NCT02021656|18879885|P1|Overall Study|Lack of Efficacy|2
5462129|NCT02021656|18879885|P1|Overall Study|Adverse Event|1
5462130|NCT02021643|18879905|P4|Overall Study|Withdrew Consent|0
5462131|NCT02021643|18879906|P3|Overall Study|Withdrew Consent|0
5462132|NCT02021643|18879907|P2|Overall Study|Withdrew Consent|1
5462133|NCT02021643|18879908|P1|Overall Study|Withdrew Consent|0
5462134|NCT02021643|18879905|P4|Overall Study|Lost to Follow-up|0
5462135|NCT02021643|18879906|P3|Overall Study|Lost to Follow-up|0
5462136|NCT02021643|18879907|P2|Overall Study|Lost to Follow-up|1
5462137|NCT02021643|18879908|P1|Overall Study|Lost to Follow-up|0
5462138|NCT02021643|18879905|P4|Overall Study|Lack of Efficacy|12
5462139|NCT02021643|18879906|P3|Overall Study|Lack of Efficacy|0
5462140|NCT02021643|18879907|P2|Overall Study|Lack of Efficacy|6
5462141|NCT02021643|18879908|P1|Overall Study|Lack of Efficacy|7
5462142|NCT02021643|18879905|P4|Overall Study|Investigator's Discretion|0
5462143|NCT02021643|18879906|P3|Overall Study|Investigator's Discretion|0
5462144|NCT02021643|18879907|P2|Overall Study|Investigator's Discretion|0
5462145|NCT02021643|18879908|P1|Overall Study|Investigator's Discretion|1
5462146|NCT02021643|18879905|P4|Overall Study|Death|0
5462147|NCT02021643|18879906|P3|Overall Study|Death|0
5462148|NCT02021643|18879907|P2|Overall Study|Death|1
5462149|NCT02021643|18879908|P1|Overall Study|Death|0
5462150|NCT02021643|18879905|P4|Overall Study|Adverse Event|0
5462151|NCT02021643|18879906|P3|Overall Study|Adverse Event|0
5462152|NCT02021643|18879907|P2|Overall Study|Adverse Event|1
5462153|NCT02021643|18879908|P1|Overall Study|Adverse Event|0
5462154|NCT02021643|18879905|P4|Overall Study|Enrolled but Never Treated|0
5462155|NCT02021643|18879906|P3|Overall Study|Enrolled but Never Treated|0
5462156|NCT02021643|18879907|P2|Overall Study|Enrolled but Never Treated|0
5462157|NCT02021643|18879908|P1|Overall Study|Enrolled but Never Treated|1
5462158|NCT02021565|18879950|P2|3-month Follow-up|Protocol Violation|2
5462159|NCT02021565|18879951|P1|3-month Follow-up|Protocol Violation|3
5462160|NCT02021565|18879950|P2|3-month Follow-up|Withdrawal by Subject|0
5462161|NCT02021565|18879951|P1|3-month Follow-up|Withdrawal by Subject|4
5462162|NCT02021565|18879950|P2|3-month Follow-up|Death|0
5462163|NCT02021565|18879951|P1|3-month Follow-up|Death|3
5462164|NCT02021565|18879950|P2|Baseline Through Intervention|Lost to Follow-up|2
5462165|NCT02021565|18879951|P1|Baseline Through Intervention|Lost to Follow-up|4
5462166|NCT02021565|18879950|P2|Baseline Through Intervention|Protocol Violation|7
5462167|NCT02021565|18879951|P1|Baseline Through Intervention|Protocol Violation|0
5462168|NCT02021565|18879950|P2|Baseline Through Intervention|Withdrawal by Subject|8
5462169|NCT02021565|18879951|P1|Baseline Through Intervention|Withdrawal by Subject|8
5462170|NCT02021565|18879950|P2|Baseline Through Intervention|Death|1
5462171|NCT02021565|18879951|P1|Baseline Through Intervention|Death|0
5462172|NCT02021331|18879971|P2|Overall Study|Adverse Event|2
5462173|NCT02021331|18879972|P1|Overall Study|Adverse Event|0
5462174|NCT02021292|18879984|P2|Overall Study|Death|1
5462175|NCT02021292|18879985|P1|Overall Study|Death|0
5462176|NCT02021292|18879984|P2|Overall Study|Lost to Follow-up|1
5462177|NCT02021292|18879985|P1|Overall Study|Lost to Follow-up|0
5462178|NCT02021292|18879984|P2|Overall Study|Physician Decision|1
5462179|NCT02021292|18879985|P1|Overall Study|Physician Decision|0
5462180|NCT02020941|18880015|P1|Overall Study|Disease Progression|4
5462181|NCT02020941|18880015|P1|Overall Study|Withdrawal by Subject|1
5462182|NCT02020941|18880015|P1|Overall Study|Physician Decision|2
5462183|NCT02020941|18880015|P1|Overall Study|Adverse Event|1
5462184|NCT02020889|18880026|P2|Overall Study|Withdrawal by Subject|2
5462185|NCT02020889|18880027|P1|Overall Study|Withdrawal by Subject|3
5462186|NCT02020889|18880026|P2|Overall Study|Physician Decision|0
5462187|NCT02020889|18880027|P1|Overall Study|Physician Decision|2
5462188|NCT02020889|18880026|P2|Overall Study|Lost to Follow-up|0
5462189|NCT02020889|18880027|P1|Overall Study|Lost to Follow-up|1
5462190|NCT02020889|18880026|P2|Overall Study|Lack of Efficacy|0
5462191|NCT02020889|18880027|P1|Overall Study|Lack of Efficacy|1
5462192|NCT02020889|18880026|P2|Overall Study|Adverse Event|1
5462193|NCT02020889|18880027|P1|Overall Study|Adverse Event|0
5462194|NCT02020863|18880081|P1|Overall Study|Team chose not to place an a line|1
5462195|NCT02020863|18880081|P1|Overall Study|Discovery of Metastatic disease|4
5462196|NCT02020616|18880111|P7|Overall Study|Lack of Efficacy|0
5462197|NCT02020616|18880112|P6|Overall Study|Lack of Efficacy|0
5462198|NCT02020616|18880113|P5|Overall Study|Lack of Efficacy|1
5462199|NCT02020616|18880114|P4|Overall Study|Lack of Efficacy|0
5462200|NCT02020616|18880115|P3|Overall Study|Lack of Efficacy|0
5462201|NCT02020616|18880116|P2|Overall Study|Lack of Efficacy|0
5462202|NCT02020616|18880117|P1|Overall Study|Lack of Efficacy|0
5462203|NCT02020616|18880111|P7|Overall Study|Randomized in Error|0
5462204|NCT02020616|18880112|P6|Overall Study|Randomized in Error|0
5462205|NCT02020616|18880113|P5|Overall Study|Randomized in Error|0
5462206|NCT02020616|18880114|P4|Overall Study|Randomized in Error|1
5462207|NCT02020616|18880115|P3|Overall Study|Randomized in Error|0
5462208|NCT02020616|18880116|P2|Overall Study|Randomized in Error|0
5462209|NCT02020616|18880117|P1|Overall Study|Randomized in Error|0
5462210|NCT02020616|18880111|P7|Overall Study|Early Termination Criteria Met|0
5462211|NCT02020616|18880112|P6|Overall Study|Early Termination Criteria Met|1
5462212|NCT02020616|18880113|P5|Overall Study|Early Termination Criteria Met|0
5462213|NCT02020616|18880114|P4|Overall Study|Early Termination Criteria Met|0
5462214|NCT02020616|18880115|P3|Overall Study|Early Termination Criteria Met|1
5462215|NCT02020616|18880116|P2|Overall Study|Early Termination Criteria Met|0
5462216|NCT02020616|18880117|P1|Overall Study|Early Termination Criteria Met|0
5462217|NCT02020616|18880111|P7|Overall Study|Lost to Follow-up|0
5462218|NCT02020616|18880112|P6|Overall Study|Lost to Follow-up|1
5462219|NCT02020616|18880113|P5|Overall Study|Lost to Follow-up|1
5462220|NCT02020616|18880114|P4|Overall Study|Lost to Follow-up|1
5462221|NCT02020616|18880115|P3|Overall Study|Lost to Follow-up|0
5462222|NCT02020616|18880116|P2|Overall Study|Lost to Follow-up|1
5462223|NCT02020616|18880117|P1|Overall Study|Lost to Follow-up|0
5462224|NCT02020616|18880111|P7|Overall Study|Withdrawal by Subject|1
5462225|NCT02020616|18880112|P6|Overall Study|Withdrawal by Subject|1
5462226|NCT02020616|18880113|P5|Overall Study|Withdrawal by Subject|0
5462227|NCT02020616|18880114|P4|Overall Study|Withdrawal by Subject|0
5462228|NCT02020616|18880115|P3|Overall Study|Withdrawal by Subject|1
5462229|NCT02020616|18880116|P2|Overall Study|Withdrawal by Subject|0
5462230|NCT02020616|18880117|P1|Overall Study|Withdrawal by Subject|0
5462231|NCT02020616|18880111|P7|Overall Study|Physician Decision|2
5462232|NCT02020616|18880112|P6|Overall Study|Physician Decision|1
5462233|NCT02020616|18880113|P5|Overall Study|Physician Decision|0
5462234|NCT02020616|18880114|P4|Overall Study|Physician Decision|0
5462235|NCT02020616|18880115|P3|Overall Study|Physician Decision|0
5462236|NCT02020616|18880116|P2|Overall Study|Physician Decision|0
5462237|NCT02020616|18880117|P1|Overall Study|Physician Decision|0
5462238|NCT02020616|18880111|P7|Overall Study|Adverse Event|1
5462239|NCT02020616|18880112|P6|Overall Study|Adverse Event|1
5462240|NCT02020616|18880113|P5|Overall Study|Adverse Event|0
5462241|NCT02020616|18880114|P4|Overall Study|Adverse Event|0
5462242|NCT02020616|18880115|P3|Overall Study|Adverse Event|0
5462243|NCT02020616|18880116|P2|Overall Study|Adverse Event|0
5462244|NCT02020616|18880117|P1|Overall Study|Adverse Event|0
5462245|NCT02020577|18880210|P2|Overall Study|Other than stated above|1
5462246|NCT02020577|18880211|P1|Overall Study|Other than stated above|0
5462247|NCT02020577|18880210|P2|Overall Study|Withdrawal by Subject|1
5462248|NCT02020577|18880211|P1|Overall Study|Withdrawal by Subject|0
5462249|NCT02020577|18880210|P2|Overall Study|Other AE or clinical progression|15
5462250|NCT02020577|18880211|P1|Overall Study|Other AE or clinical progression|0
5462251|NCT02020577|18880210|P2|Overall Study|Progressive disease|38
5462252|NCT02020577|18880211|P1|Overall Study|Progressive disease|3
5462253|NCT02020512|18880238|P1|Overall Study|Protocol Violation|4
5462254|NCT02020512|18880238|P1|Overall Study|Lost to Follow-up|3
5462255|NCT02020512|18880238|P1|Overall Study|Adverse Event|1
5462256|NCT02020031|18880317|P2|Overall Study|Physician Decision|1
5462257|NCT02020031|18880318|P1|Overall Study|Physician Decision|1
5462258|NCT02019979|18880339|P1|Overall Study|study terminated|14
5462259|NCT02019927|18880355|P6|Overall Study|Lost to Follow-up|1
5462260|NCT02019927|18880356|P5|Overall Study|Lost to Follow-up|3
5462261|NCT02019927|18880357|P4|Overall Study|Lost to Follow-up|2
5462262|NCT02019927|18880358|P3|Overall Study|Lost to Follow-up|1
5462263|NCT02019927|18880359|P2|Overall Study|Lost to Follow-up|4
5462264|NCT02019927|18880360|P1|Overall Study|Lost to Follow-up|2
5462265|NCT02019719|18880460|P5|Overall Study|Physician Decision|0
5462266|NCT02019719|18880461|P4|Overall Study|Physician Decision|0
5462267|NCT02019719|18880462|P3|Overall Study|Physician Decision|0
5462268|NCT02019719|18880463|P2|Overall Study|Physician Decision|0
5462269|NCT02019719|18880464|P1|Overall Study|Physician Decision|2
5462270|NCT02019719|18880460|P5|Overall Study|Protocol defined stopping criteria|1
5462271|NCT02019719|18880461|P4|Overall Study|Protocol defined stopping criteria|1
5462272|NCT02019719|18880462|P3|Overall Study|Protocol defined stopping criteria|0
5462273|NCT02019719|18880463|P2|Overall Study|Protocol defined stopping criteria|0
5462274|NCT02019719|18880464|P1|Overall Study|Protocol defined stopping criteria|2
5462275|NCT02019719|18880460|P5|Overall Study|Protocol Violation|0
5462276|NCT02019719|18880461|P4|Overall Study|Protocol Violation|0
5462277|NCT02019719|18880462|P3|Overall Study|Protocol Violation|0
5462278|NCT02019719|18880463|P2|Overall Study|Protocol Violation|1
5462279|NCT02019719|18880464|P1|Overall Study|Protocol Violation|1
5462280|NCT02019719|18880460|P5|Overall Study|Adverse Event|1
5462281|NCT02019719|18880461|P4|Overall Study|Adverse Event|1
5462282|NCT02019719|18880462|P3|Overall Study|Adverse Event|0
5462283|NCT02019719|18880463|P2|Overall Study|Adverse Event|0
5462284|NCT02019719|18880464|P1|Overall Study|Adverse Event|1
5462285|NCT02019667|18880561|P2|2nd Intervention (6 Months)|Physician Decision|1
5462286|NCT02019667|18880562|P1|2nd Intervention (6 Months)|Physician Decision|0
5462287|NCT02019667|18880561|P2|2nd Intervention (6 Months)|Adverse Event|1
5462288|NCT02019667|18880562|P1|2nd Intervention (6 Months)|Adverse Event|0
5462289|NCT02019667|18880561|P2|First Intervention (6 Months)|Adverse Event|1
5462290|NCT02019667|18880562|P1|First Intervention (6 Months)|Adverse Event|0
5462291|NCT02019602|18880582|P2|Screening Period|Adverse Event|0
5462292|NCT02019602|18880583|P1|Screening Period|Adverse Event|1
5462293|NCT02019602|18880582|P2|Screening Period|Ineligibility|0
5462294|NCT02019602|18880583|P1|Screening Period|Ineligibility|4
5462295|NCT02019550|18880612|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
5462296|NCT02019550|18880613|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
5462297|NCT02019472|18880654|P3|Overall Study|Other|6
5462298|NCT02019472|18880655|P2|Overall Study|Other|8
5462299|NCT02019472|18880656|P1|Overall Study|Other|3
5462300|NCT02019472|18880654|P3|Overall Study|Withdrawal by Subject|11
5462301|NCT02019472|18880655|P2|Overall Study|Withdrawal by Subject|10
5462302|NCT02019472|18880656|P1|Overall Study|Withdrawal by Subject|11
5462303|NCT02019472|18880654|P3|Overall Study|Pregnancy|2
5462304|NCT02019472|18880655|P2|Overall Study|Pregnancy|2
5462305|NCT02019472|18880656|P1|Overall Study|Pregnancy|1
5462306|NCT02019472|18880654|P3|Overall Study|Physician Decision|0
5462307|NCT02019472|18880655|P2|Overall Study|Physician Decision|2
5462308|NCT02019472|18880656|P1|Overall Study|Physician Decision|1
5462309|NCT02019472|18880654|P3|Overall Study|Lost to Follow-up|1
5462310|NCT02019472|18880655|P2|Overall Study|Lost to Follow-up|2
5462311|NCT02019472|18880656|P1|Overall Study|Lost to Follow-up|0
5462312|NCT02019472|18880654|P3|Overall Study|Lack of Efficacy|4
5462313|NCT02019472|18880655|P2|Overall Study|Lack of Efficacy|4
5462314|NCT02019472|18880656|P1|Overall Study|Lack of Efficacy|7
5462315|NCT02019472|18880654|P3|Overall Study|Death|1
5462316|NCT02019472|18880655|P2|Overall Study|Death|1
5462317|NCT02019472|18880656|P1|Overall Study|Death|0
5462318|NCT02019472|18880654|P3|Overall Study|Adverse Event|17
5462319|NCT02019472|18880655|P2|Overall Study|Adverse Event|23
5462320|NCT02019472|18880656|P1|Overall Study|Adverse Event|14
5462321|NCT02019420|18880679|P2|Overall Study|Transferred to other care facility|1
5462322|NCT02019420|18880680|P1|Overall Study|Transferred to other care facility|1
5462323|NCT02019420|18880679|P2|Overall Study|Death|99
5462324|NCT02019420|18880680|P1|Overall Study|Death|104
5462325|NCT02019420|18880679|P2|Overall Study|At request of sponsor or investigator|1
5462326|NCT02019420|18880680|P1|Overall Study|At request of sponsor or investigator|0
5462327|NCT02019420|18880679|P2|Overall Study|Withdrawal by Subject|3
5462328|NCT02019420|18880680|P1|Overall Study|Withdrawal by Subject|1
5462329|NCT02019420|18880679|P2|Overall Study|Did not receive study drug|2
5462330|NCT02019420|18880680|P1|Overall Study|Did not receive study drug|2
5462331|NCT02019277|18880708|P1|Overall Study|Adverse Event|1
5462332|NCT02019277|18880708|P1|Overall Study|Did no Cooperate|1
5462333|NCT02019277|18880708|P1|Overall Study|Death|7
5462334|NCT02019277|18880708|P1|Overall Study|Withdrawal by Subject|3
5462335|NCT02019264|18880727|P2|Overall Study|Missing|11
5462336|NCT02019264|18880728|P1|Overall Study|Missing|14
5462337|NCT02019264|18880727|P2|Overall Study|Administrative reason|28
5462338|NCT02019264|18880728|P1|Overall Study|Administrative reason|36
5462339|NCT02019264|18880727|P2|Overall Study|Withdrawal by Subject|117
5462340|NCT02019264|18880728|P1|Overall Study|Withdrawal by Subject|142
5462341|NCT02019264|18880727|P2|Overall Study|Lost to Follow-up|47
5462342|NCT02019264|18880728|P1|Overall Study|Lost to Follow-up|50
5462343|NCT02019264|18880727|P2|Overall Study|Not treated|4
5462344|NCT02019264|18880728|P1|Overall Study|Not treated|6
5462345|NCT02019108|18880764|P2|Overall Study|Lost to Follow-up|7
5462346|NCT02019108|18880765|P1|Overall Study|Lost to Follow-up|5
5462347|NCT02018887|18880807|P11|Part C: Cohort 8 Overall|Physician Decision|1
5462348|NCT02018887|18880808|P10|Part C: Cohort 8 Overall|Physician Decision|0
5462349|NCT02018887|18880809|P9|Part C: Cohort 8 Overall|Physician Decision|2
5462350|NCT02018887|18880810|P8|Part C: Cohort 8 Overall|Physician Decision|0
5462351|NCT02018887|18880811|P7|Part C: Cohort 8 Overall|Physician Decision|0
5462352|NCT02018887|18880812|P6|Part C: Cohort 8 Overall|Physician Decision|0
5462353|NCT02018887|18880813|P5|Part C: Cohort 8 Overall|Physician Decision|0
5462354|NCT02018887|18880814|P4|Part C: Cohort 8 Overall|Physician Decision|0
5462355|NCT02018887|18880815|P3|Part C: Cohort 8 Overall|Physician Decision|0
5462356|NCT02018887|18880816|P2|Part C: Cohort 8 Overall|Physician Decision|0
5462357|NCT02018887|18880817|P1|Part C: Cohort 8 Overall|Physician Decision|0
5462358|NCT02018887|18880807|P11|Part C: Cohort 8 Overall|Adverse Event|0
5462359|NCT02018887|18880808|P10|Part C: Cohort 8 Overall|Adverse Event|3
5462360|NCT02018887|18880809|P9|Part C: Cohort 8 Overall|Adverse Event|1
5462361|NCT02018887|18880810|P8|Part C: Cohort 8 Overall|Adverse Event|0
5462362|NCT02018887|18880811|P7|Part C: Cohort 8 Overall|Adverse Event|0
5462363|NCT02018887|18880812|P6|Part C: Cohort 8 Overall|Adverse Event|0
5462364|NCT02018887|18880813|P5|Part C: Cohort 8 Overall|Adverse Event|0
5462365|NCT02018887|18880814|P4|Part C: Cohort 8 Overall|Adverse Event|0
5462366|NCT02018887|18880815|P3|Part C: Cohort 8 Overall|Adverse Event|0
5462367|NCT02018887|18880816|P2|Part C: Cohort 8 Overall|Adverse Event|0
5462368|NCT02018887|18880817|P1|Part C: Cohort 8 Overall|Adverse Event|0
5462369|NCT02018887|18880807|P11|Part B: Cohorts 3-7 Overall|Adverse Event|0
5462370|NCT02018887|18880808|P10|Part B: Cohorts 3-7 Overall|Adverse Event|0
5462371|NCT02018887|18880809|P9|Part B: Cohorts 3-7 Overall|Adverse Event|0
5462372|NCT02018887|18880810|P8|Part B: Cohorts 3-7 Overall|Adverse Event|4
5462373|NCT02018887|18880811|P7|Part B: Cohorts 3-7 Overall|Adverse Event|1
5462374|NCT02018887|18880812|P6|Part B: Cohorts 3-7 Overall|Adverse Event|0
5462375|NCT02018887|18880813|P5|Part B: Cohorts 3-7 Overall|Adverse Event|1
5462376|NCT02018887|18880814|P4|Part B: Cohorts 3-7 Overall|Adverse Event|0
5462377|NCT02018887|18880815|P3|Part B: Cohorts 3-7 Overall|Adverse Event|0
5462378|NCT02018887|18880816|P2|Part B: Cohorts 3-7 Overall|Adverse Event|0
5462379|NCT02018887|18880817|P1|Part B: Cohorts 3-7 Overall|Adverse Event|0
5462380|NCT02018887|18880807|P11|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462381|NCT02018887|18880808|P10|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462382|NCT02018887|18880809|P9|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462383|NCT02018887|18880810|P8|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462384|NCT02018887|18880811|P7|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462385|NCT02018887|18880812|P6|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462386|NCT02018887|18880813|P5|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462387|NCT02018887|18880814|P4|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462388|NCT02018887|18880815|P3|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462389|NCT02018887|18880816|P2|Part A: Cohorts 1-2: Period 3|Adverse Event|0
5462390|NCT02018887|18880817|P1|Part A: Cohorts 1-2: Period 3|Adverse Event|1
5462391|NCT02018822|18880906|P3|Overall Study|Lost to Follow-up|5
5462392|NCT02018822|18880907|P2|Overall Study|Lost to Follow-up|6
5462393|NCT02018822|18880908|P1|Overall Study|Lost to Follow-up|6
5462394|NCT02018822|18880906|P3|Overall Study|Physician Decision|1
5462395|NCT02018822|18880907|P2|Overall Study|Physician Decision|1
5462396|NCT02018822|18880908|P1|Overall Study|Physician Decision|0
5462397|NCT02018822|18880906|P3|Overall Study|filling replaced by crown|0
5462398|NCT02018822|18880907|P2|Overall Study|filling replaced by crown|1
5462399|NCT02018822|18880908|P1|Overall Study|filling replaced by crown|0
5462400|NCT02018562|18880988|P2|Overall Study|Discharged prior to study completion|0
5462401|NCT02018562|18880989|P1|Overall Study|Discharged prior to study completion|1
5462402|NCT02018562|18880988|P2|Overall Study|Withdrawal by Subject|0
5462403|NCT02018562|18880989|P1|Overall Study|Withdrawal by Subject|2
5462404|NCT02018458|18881007|P1|Overall Study|Death|4
5462405|NCT02018042|18881034|P1|Overall Study|Withdrawal by Subject|1
5462406|NCT02017964|18881040|P1|Overall Study|Patient deemed ineligible|1
5462407|NCT02017899|18881054|P6|Overall Study|Withdrawal by Subject|0
5462408|NCT02017899|18881055|P5|Overall Study|Withdrawal by Subject|1
5462409|NCT02017899|18881056|P4|Overall Study|Withdrawal by Subject|1
5462410|NCT02017899|18881057|P3|Overall Study|Withdrawal by Subject|0
5462411|NCT02017899|18881058|P2|Overall Study|Withdrawal by Subject|0
5462412|NCT02017899|18881059|P1|Overall Study|Withdrawal by Subject|0
5462413|NCT02017860|18881133|P1|Overall Study|Withdrawal by Subject|1
5462414|NCT02017860|18881133|P1|Overall Study|Adverse Event|1
5462415|NCT02017535|18881152|P4|Overall Study|Withdrawal by Subject|0
5462416|NCT02017535|18881153|P3|Overall Study|Withdrawal by Subject|0
5462417|NCT02017535|18881154|P2|Overall Study|Withdrawal by Subject|0
5462418|NCT02017535|18881155|P1|Overall Study|Withdrawal by Subject|1
5462419|NCT02017522|18881177|P1|Overall Study|Withdrawal by Subject|1
5462420|NCT02017223|18881195|P1|Overall Study|Algorithm problems|2
5462421|NCT02017171|18881241|P2|Overall Study|Miscellaneous|3
5462422|NCT02017171|18881242|P1|Overall Study|Miscellaneous|2
5462423|NCT02017171|18881241|P2|Overall Study|ESKD|2
5462424|NCT02017171|18881242|P1|Overall Study|ESKD|6
5462425|NCT02017171|18881241|P2|Overall Study|Lost to Follow-up|20
5462426|NCT02017171|18881242|P1|Overall Study|Lost to Follow-up|21
5462427|NCT02017171|18881241|P2|Overall Study|Withdrawal by Subject|17
5462428|NCT02017171|18881242|P1|Overall Study|Withdrawal by Subject|23
5462429|NCT02017171|18881241|P2|Overall Study|Death|4
5462430|NCT02017171|18881242|P1|Overall Study|Death|10
5462431|NCT02017015|18881275|P1|Overall Study|Physician Decision|2
5462432|NCT02017015|18881275|P1|Overall Study|Non-compliance with study drug|2
5462433|NCT02017015|18881275|P1|Overall Study|Progressive Disease|31
5462434|NCT02017015|18881275|P1|Overall Study|Death|4
5462435|NCT02017015|18881275|P1|Overall Study|Withdrawal by Subject|21
5462436|NCT02017015|18881275|P1|Overall Study|Adverse Event|9
5462437|NCT02016898|18881300|P2|Overall Study|Lost to Follow-up|4
5462438|NCT02016898|18881301|P1|Overall Study|Lost to Follow-up|4
5462439|NCT02016898|18881300|P2|Overall Study|Death|1
5462440|NCT02016898|18881301|P1|Overall Study|Death|1
5462441|NCT02016716|18881358|P3|Overall Study|Lost to Follow-up|1
5462442|NCT02016716|18881359|P2|Overall Study|Lost to Follow-up|2
5462443|NCT02016716|18881360|P1|Overall Study|Lost to Follow-up|1
5462444|NCT02016716|18881358|P3|Overall Study|Protocol-specified Criteria|0
5462445|NCT02016716|18881359|P2|Overall Study|Protocol-specified Criteria|1
5462446|NCT02016716|18881360|P1|Overall Study|Protocol-specified Criteria|0
5462447|NCT02016716|18881358|P3|Overall Study|Withdrawal by Subject|5
5462448|NCT02016716|18881359|P2|Overall Study|Withdrawal by Subject|5
5462449|NCT02016716|18881360|P1|Overall Study|Withdrawal by Subject|5
5462450|NCT02016690|18881381|P1|Overall Study|Hospitalized for RSV at study start|3
5462451|NCT02016690|18881381|P1|Overall Study|Did not meet inclusion criteria|13
5462452|NCT02016690|18881381|P1|Overall Study|Excluded from SAS: Ineligible for study|2
5462453|NCT02016690|18881381|P1|Overall Study|Excluded from SAS: Early treatment|2
5462454|NCT02016690|18881381|P1|Overall Study|Excluded from SAS: Duplication|2
5462455|NCT02016690|18881381|P1|Overall Study|Excluded from SAS: Enrollment violation|2
5462456|NCT02016625|18881394|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
5462457|NCT02016625|18881395|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
5462458|NCT02016625|18881394|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
5462459|NCT02016625|18881395|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
5462460|NCT02016625|18881394|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
5462461|NCT02016625|18881395|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
5462462|NCT02016482|18881483|P2|Period B|Required Alternative/Prohibited Therapy|2
5462463|NCT02016482|18881484|P1|Period B|Required Alternative/Prohibited Therapy|0
5462464|NCT02016482|18881483|P2|Period B|Other|0
5462465|NCT02016482|18881484|P1|Period B|Other|4
5462466|NCT02016482|18881483|P2|Period B|Lack of Efficacy|4
5462467|NCT02016482|18881484|P1|Period B|Lack of Efficacy|6
5462468|NCT02016482|18881483|P2|Period B|Lost to Follow-up|0
5462469|NCT02016482|18881484|P1|Period B|Lost to Follow-up|2
5462470|NCT02016482|18881483|P2|Period B|Withdrawal by Subject|1
5462471|NCT02016482|18881484|P1|Period B|Withdrawal by Subject|1
5462472|NCT02016482|18881483|P2|Period A|Required Alternative/Prohibited Therapy|1
5462473|NCT02016482|18881484|P1|Period A|Required Alternative/Prohibited Therapy|0
5462474|NCT02016482|18881483|P2|Period A|Protocol Violation|1
5462475|NCT02016482|18881484|P1|Period A|Protocol Violation|0
5462476|NCT02016482|18881483|P2|Period A|Other|0
5462477|NCT02016482|18881484|P1|Period A|Other|3
5462478|NCT02016482|18881483|P2|Period A|Lack of Efficacy|1
5462479|NCT02016482|18881484|P1|Period A|Lack of Efficacy|2
5462480|NCT02016482|18881483|P2|Period A|Lost to Follow-up|3
5462481|NCT02016482|18881484|P1|Period A|Lost to Follow-up|3
5462482|NCT02016482|18881483|P2|Period A|Withdrawal by Subject|4
5462483|NCT02016482|18881484|P1|Period A|Withdrawal by Subject|3
5462484|NCT02016482|18881483|P2|Period A|Adverse Event|5
5462485|NCT02016482|18881484|P1|Period A|Adverse Event|3
5462486|NCT02016300|18881574|P2|Overall Study|Lost to Follow-up|3
5462487|NCT02016300|18881575|P1|Overall Study|Lost to Follow-up|0
5462488|NCT02016183|18881606|P1|Overall Study|Protocol Violation|52
5462489|NCT02016183|18881606|P1|Overall Study|Case Report Forms Uncollected|13
5462490|NCT02016170|18881616|P3|Overall Study|Protocol Violation|0
5462491|NCT02016170|18881617|P2|Overall Study|Protocol Violation|0
5462492|NCT02016170|18881618|P1|Overall Study|Protocol Violation|1
5462493|NCT02016170|18881616|P3|Overall Study|Adverse Event|0
5462494|NCT02016170|18881617|P2|Overall Study|Adverse Event|1
5462495|NCT02016170|18881618|P1|Overall Study|Adverse Event|1
5462496|NCT02016105|18881629|P6|EXTENSION PERIOD|Lost to Follow-up|2
5462497|NCT02016105|18881630|P5|EXTENSION PERIOD|Lost to Follow-up|0
5462498|NCT02016105|18881631|P4|EXTENSION PERIOD|Lost to Follow-up|0
5462499|NCT02016105|18881632|P3|EXTENSION PERIOD|Lost to Follow-up|0
5462500|NCT02016105|18881633|P2|EXTENSION PERIOD|Lost to Follow-up|0
5462501|NCT02016105|18881634|P1|EXTENSION PERIOD|Lost to Follow-up|0
5462502|NCT02016105|18881629|P6|EXTENSION PERIOD|Non-compliance with study indication|0
5462503|NCT02016105|18881630|P5|EXTENSION PERIOD|Non-compliance with study indication|1
5462504|NCT02016105|18881631|P4|EXTENSION PERIOD|Non-compliance with study indication|0
5462505|NCT02016105|18881632|P3|EXTENSION PERIOD|Non-compliance with study indication|0
5462506|NCT02016105|18881633|P2|EXTENSION PERIOD|Non-compliance with study indication|0
5462507|NCT02016105|18881634|P1|EXTENSION PERIOD|Non-compliance with study indication|0
5462508|NCT02016105|18881629|P6|EXTENSION PERIOD|Withdrawal by Subject|2
5462509|NCT02016105|18881630|P5|EXTENSION PERIOD|Withdrawal by Subject|2
5462510|NCT02016105|18881631|P4|EXTENSION PERIOD|Withdrawal by Subject|2
5462511|NCT02016105|18881632|P3|EXTENSION PERIOD|Withdrawal by Subject|2
5462512|NCT02016105|18881633|P2|EXTENSION PERIOD|Withdrawal by Subject|0
5462513|NCT02016105|18881634|P1|EXTENSION PERIOD|Withdrawal by Subject|0
5462514|NCT02016105|18881629|P6|EXTENSION PERIOD|Adverse Event|0
5462515|NCT02016105|18881630|P5|EXTENSION PERIOD|Adverse Event|1
5462516|NCT02016105|18881631|P4|EXTENSION PERIOD|Adverse Event|0
5462517|NCT02016105|18881632|P3|EXTENSION PERIOD|Adverse Event|2
5462518|NCT02016105|18881633|P2|EXTENSION PERIOD|Adverse Event|0
5462519|NCT02016105|18881634|P1|EXTENSION PERIOD|Adverse Event|0
5462520|NCT02016105|18881629|P6|EXTENSION PERIOD|Lack of Efficacy|1
5462521|NCT02016105|18881630|P5|EXTENSION PERIOD|Lack of Efficacy|1
5462522|NCT02016105|18881631|P4|EXTENSION PERIOD|Lack of Efficacy|3
5462523|NCT02016105|18881632|P3|EXTENSION PERIOD|Lack of Efficacy|1
5462524|NCT02016105|18881633|P2|EXTENSION PERIOD|Lack of Efficacy|0
5462525|NCT02016105|18881634|P1|EXTENSION PERIOD|Lack of Efficacy|0
5462526|NCT02016105|18881629|P6|EXTENSION PERIOD|New therapy for study indication|1
5462527|NCT02016105|18881630|P5|EXTENSION PERIOD|New therapy for study indication|1
5462528|NCT02016105|18881631|P4|EXTENSION PERIOD|New therapy for study indication|0
5462529|NCT02016105|18881632|P3|EXTENSION PERIOD|New therapy for study indication|0
5462530|NCT02016105|18881633|P2|EXTENSION PERIOD|New therapy for study indication|0
5462531|NCT02016105|18881634|P1|EXTENSION PERIOD|New therapy for study indication|0
5462532|NCT02016105|18881629|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
5462533|NCT02016105|18881630|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
5462534|NCT02016105|18881631|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
5462535|NCT02016105|18881632|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
5462536|NCT02016105|18881633|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
5462537|NCT02016105|18881634|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
5462538|NCT02016105|18881629|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
5462539|NCT02016105|18881630|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
5462540|NCT02016105|18881631|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
5462541|NCT02016105|18881632|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
5462542|NCT02016105|18881633|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
5462543|NCT02016105|18881634|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
5462544|NCT02016105|18881629|P6|TREATMENT PERIOD 2|Adverse Event|1
5462545|NCT02016105|18881630|P5|TREATMENT PERIOD 2|Adverse Event|0
5462546|NCT02016105|18881631|P4|TREATMENT PERIOD 2|Adverse Event|4
5462547|NCT02016105|18881632|P3|TREATMENT PERIOD 2|Adverse Event|0
5462548|NCT02016105|18881633|P2|TREATMENT PERIOD 2|Adverse Event|0
5462549|NCT02016105|18881634|P1|TREATMENT PERIOD 2|Adverse Event|0
5462550|NCT02016105|18881629|P6|TREATMENT PERIOD 2|Death|1
5462551|NCT02016105|18881630|P5|TREATMENT PERIOD 2|Death|0
5462552|NCT02016105|18881631|P4|TREATMENT PERIOD 2|Death|0
5462553|NCT02016105|18881632|P3|TREATMENT PERIOD 2|Death|0
5462554|NCT02016105|18881633|P2|TREATMENT PERIOD 2|Death|0
5462555|NCT02016105|18881634|P1|TREATMENT PERIOD 2|Death|0
5462556|NCT02016105|18881629|P6|TREATMENT PERIOD 2|Pregnancy|1
5462557|NCT02016105|18881630|P5|TREATMENT PERIOD 2|Pregnancy|0
5462558|NCT02016105|18881631|P4|TREATMENT PERIOD 2|Pregnancy|0
5462559|NCT02016105|18881632|P3|TREATMENT PERIOD 2|Pregnancy|0
5462560|NCT02016105|18881633|P2|TREATMENT PERIOD 2|Pregnancy|0
5462561|NCT02016105|18881634|P1|TREATMENT PERIOD 2|Pregnancy|0
5462562|NCT02016105|18881629|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
5462563|NCT02016105|18881630|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
5462564|NCT02016105|18881631|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
5462565|NCT02016105|18881632|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
5462566|NCT02016105|18881633|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
5462567|NCT02016105|18881634|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
5462568|NCT02016105|18881629|P6|TREATMENT PERIOD 2|Non compliance study medication|1
5462569|NCT02016105|18881630|P5|TREATMENT PERIOD 2|Non compliance study medication|0
5462570|NCT02016105|18881631|P4|TREATMENT PERIOD 2|Non compliance study medication|0
5462571|NCT02016105|18881632|P3|TREATMENT PERIOD 2|Non compliance study medication|0
5462572|NCT02016105|18881633|P2|TREATMENT PERIOD 2|Non compliance study medication|0
5462573|NCT02016105|18881634|P1|TREATMENT PERIOD 2|Non compliance study medication|0
5462574|NCT02016105|18881629|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
5462575|NCT02016105|18881630|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
5462576|NCT02016105|18881631|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
5462577|NCT02016105|18881632|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
5462578|NCT02016105|18881633|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
5462579|NCT02016105|18881634|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
5462580|NCT02016105|18881629|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
5462581|NCT02016105|18881630|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
5462582|NCT02016105|18881631|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
5462583|NCT02016105|18881632|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
5462584|NCT02016105|18881633|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
5462585|NCT02016105|18881634|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
5462586|NCT02016105|18881629|P6|TREATMENT PERIOD 1|Adverse Event|0
5462587|NCT02016105|18881630|P5|TREATMENT PERIOD 1|Adverse Event|0
5462588|NCT02016105|18881631|P4|TREATMENT PERIOD 1|Adverse Event|0
5462589|NCT02016105|18881632|P3|TREATMENT PERIOD 1|Adverse Event|0
5462590|NCT02016105|18881633|P2|TREATMENT PERIOD 1|Adverse Event|5
5462591|NCT02016105|18881634|P1|TREATMENT PERIOD 1|Adverse Event|3
5462592|NCT02016105|18881629|P6|TREATMENT PERIOD 1|Pregnancy|0
5462593|NCT02016105|18881630|P5|TREATMENT PERIOD 1|Pregnancy|0
5462594|NCT02016105|18881631|P4|TREATMENT PERIOD 1|Pregnancy|0
5462595|NCT02016105|18881632|P3|TREATMENT PERIOD 1|Pregnancy|0
5462596|NCT02016105|18881633|P2|TREATMENT PERIOD 1|Pregnancy|1
5462597|NCT02016105|18881634|P1|TREATMENT PERIOD 1|Pregnancy|0
5462598|NCT02016105|18881629|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
5462599|NCT02016105|18881630|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
5462600|NCT02016105|18881631|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
5462601|NCT02016105|18881632|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
5462602|NCT02016105|18881633|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
5462603|NCT02016105|18881634|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
5462604|NCT02016105|18881629|P6|TREATMENT PERIOD 1|Physician Decision|0
5462605|NCT02016105|18881630|P5|TREATMENT PERIOD 1|Physician Decision|0
5462606|NCT02016105|18881631|P4|TREATMENT PERIOD 1|Physician Decision|0
5462607|NCT02016105|18881632|P3|TREATMENT PERIOD 1|Physician Decision|0
5462608|NCT02016105|18881633|P2|TREATMENT PERIOD 1|Physician Decision|2
5462609|NCT02016105|18881634|P1|TREATMENT PERIOD 1|Physician Decision|0
5462610|NCT02016105|18881629|P6|TREATMENT PERIOD 1|Protocol Violation|0
5462611|NCT02016105|18881630|P5|TREATMENT PERIOD 1|Protocol Violation|0
5462612|NCT02016105|18881631|P4|TREATMENT PERIOD 1|Protocol Violation|0
5462613|NCT02016105|18881632|P3|TREATMENT PERIOD 1|Protocol Violation|0
5462614|NCT02016105|18881633|P2|TREATMENT PERIOD 1|Protocol Violation|8
5462615|NCT02016105|18881634|P1|TREATMENT PERIOD 1|Protocol Violation|2
5462616|NCT02015793|18881693|P2|Overall Study|Withdrawal by Subject|1
5462617|NCT02015793|18881694|P1|Overall Study|Withdrawal by Subject|1
5462618|NCT02015793|18881693|P2|Overall Study|Adverse Event|3
5462619|NCT02015793|18881694|P1|Overall Study|Adverse Event|3
5462620|NCT02015754|18881724|P1|Overall Study|Lost to Follow-up|1
5462621|NCT02015754|18881724|P1|Overall Study|Change in treatment modality|5
5462622|NCT02015754|18881724|P1|Overall Study|Disease progression|5
5462623|NCT02015676|18881744|P3|Overall Study|Disease progression|1
5462624|NCT02015676|18881745|P2|Overall Study|Disease progression|1
5462625|NCT02015676|18881746|P1|Overall Study|Disease progression|3
5462626|NCT02015676|18881744|P3|Overall Study|Death|0
5462627|NCT02015676|18881745|P2|Overall Study|Death|1
5462628|NCT02015676|18881746|P1|Overall Study|Death|0
5462629|NCT02015676|18881744|P3|Overall Study|Administrative reasons|1
5462630|NCT02015676|18881745|P2|Overall Study|Administrative reasons|3
5462631|NCT02015676|18881746|P1|Overall Study|Administrative reasons|0
5462632|NCT02015676|18881744|P3|Overall Study|Withdrawal by Subject|1
5462633|NCT02015676|18881745|P2|Overall Study|Withdrawal by Subject|7
5462634|NCT02015676|18881746|P1|Overall Study|Withdrawal by Subject|1
5462635|NCT02015676|18881744|P3|Overall Study|Protocol Violation|0
5462636|NCT02015676|18881745|P2|Overall Study|Protocol Violation|0
5462637|NCT02015676|18881746|P1|Overall Study|Protocol Violation|1
5462638|NCT02015676|18881744|P3|Overall Study|Lack of Efficacy|0
5462639|NCT02015676|18881745|P2|Overall Study|Lack of Efficacy|4
5462640|NCT02015676|18881746|P1|Overall Study|Lack of Efficacy|2
5462641|NCT02015676|18881744|P3|Overall Study|Adverse Event|0
5462642|NCT02015676|18881745|P2|Overall Study|Adverse Event|18
5462643|NCT02015676|18881746|P1|Overall Study|Adverse Event|2
5462644|NCT02015663|18881762|P2|Overall Study|Administrative problems|11
5462645|NCT02015663|18881763|P1|Overall Study|Administrative problems|10
5462646|NCT02015663|18881762|P2|Overall Study|Adverse Event|0
5462647|NCT02015663|18881763|P1|Overall Study|Adverse Event|3
5462648|NCT02015663|18881762|P2|Overall Study|Protocol Violation|1
5462649|NCT02015663|18881763|P1|Overall Study|Protocol Violation|0
5462650|NCT02015663|18881762|P2|Overall Study|Withdrawal by Subject|0
5462651|NCT02015663|18881763|P1|Overall Study|Withdrawal by Subject|1
5462652|NCT02015663|18881762|P2|Overall Study|unsatisfactory therapeutic effect|0
5462653|NCT02015663|18881763|P1|Overall Study|unsatisfactory therapeutic effect|1
5462654|NCT02015637|18881794|P2|Overall Study|Did not take study drug|0
5462655|NCT02015637|18881795|P1|Overall Study|Did not take study drug|2
5462656|NCT02015637|18881794|P2|Overall Study|Adverse Event|0
5462657|NCT02015637|18881795|P1|Overall Study|Adverse Event|3
5462658|NCT02015637|18881794|P2|Overall Study|Lost to Follow-up|5
5462659|NCT02015637|18881795|P1|Overall Study|Lost to Follow-up|3
5462660|NCT02015546|18881806|P3|Overall Study|Screem Failure|3
5462661|NCT02015546|18881807|P2|Overall Study|Screem Failure|1
5462662|NCT02015546|18881808|P1|Overall Study|Screem Failure|2
5462663|NCT02015546|18881806|P3|Overall Study|Withdrawal by Subject|1
5462664|NCT02015546|18881807|P2|Overall Study|Withdrawal by Subject|1
5462665|NCT02015546|18881808|P1|Overall Study|Withdrawal by Subject|1
5462666|NCT02015481|18881840|P1|Overall Study|Death|1
5462667|NCT02015221|18881873|P2|Overall Study|Lost to Follow-up|0
5462668|NCT02015221|18881874|P1|Overall Study|Lost to Follow-up|1
5462669|NCT02015221|18881873|P2|Overall Study|Withdrawal by Subject|6
5462670|NCT02015221|18881874|P1|Overall Study|Withdrawal by Subject|8
5462671|NCT02015195|18881887|P7|Overall Study|Adverse Event|0
5462672|NCT02015195|18881888|P6|Overall Study|Adverse Event|0
5462673|NCT02015195|18881889|P5|Overall Study|Adverse Event|0
5462674|NCT02015195|18881890|P4|Overall Study|Adverse Event|1
5462675|NCT02015195|18881891|P3|Overall Study|Adverse Event|0
5462676|NCT02015195|18881892|P2|Overall Study|Adverse Event|0
5462677|NCT02015195|18881893|P1|Overall Study|Adverse Event|0
5462678|NCT02015104|18881916|P2|Overall Study|Withdrew consent prior to treatment|1
5462679|NCT02015104|18881917|P1|Overall Study|Withdrew consent prior to treatment|0
5462680|NCT02015104|18881916|P2|Overall Study|Withdrew consent after first dose drug|0
5462681|NCT02015104|18881917|P1|Overall Study|Withdrew consent after first dose drug|1
5462682|NCT02015065|18881934|P3|Overall Study|Death on study|1
5462683|NCT02015065|18881935|P2|Overall Study|Death on study|2
5462684|NCT02015065|18881936|P1|Overall Study|Death on study|1
5462685|NCT02015039|18881958|P2|Overall Study|Not eligible|1
5462686|NCT02015039|18881959|P1|Overall Study|Not eligible|0
5462687|NCT02014740|18881979|P2|Overall Study|Withdrawal by Subject|1
5462688|NCT02014740|18881980|P1|Overall Study|Withdrawal by Subject|2
5462689|NCT02014740|18881979|P2|Overall Study|Lost to Follow-up|4
5462690|NCT02014740|18881980|P1|Overall Study|Lost to Follow-up|4
5462691|NCT02014597|18881988|P2|Overall Study|Unable to record log contrast sensitivity|1
5462692|NCT02014597|18881989|P1|Overall Study|Unable to record log contrast sensitivity|2
5462693|NCT02014584|18882005|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5462694|NCT02014584|18882006|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
5462695|NCT02014584|18882007|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5462696|NCT02014584|18882008|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5462697|NCT02014584|18882009|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5462698|NCT02014584|18882010|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
5462699|NCT02014584|18882005|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5462700|NCT02014584|18882006|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5462701|NCT02014584|18882007|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
5462702|NCT02014584|18882008|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
5462703|NCT02014584|18882009|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5462704|NCT02014584|18882010|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
5462705|NCT02014584|18882005|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5462706|NCT02014584|18882006|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5462707|NCT02014584|18882007|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5462708|NCT02014584|18882008|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
5462709|NCT02014584|18882009|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5462710|NCT02014584|18882010|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
5462711|NCT02014584|18882005|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5462712|NCT02014584|18882006|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5462713|NCT02014584|18882007|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5462714|NCT02014584|18882008|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
5462715|NCT02014584|18882009|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
5462716|NCT02014584|18882010|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
5462717|NCT02014584|18882005|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
5462718|NCT02014584|18882006|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
5462719|NCT02014584|18882007|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
5462720|NCT02014584|18882008|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
5462721|NCT02014584|18882009|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
5462722|NCT02014584|18882010|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
5462723|NCT02014558|18882140|P13|Overall Study|Miscellaneous|1
5462724|NCT02014558|18882141|P12|Overall Study|Miscellaneous|11
5462725|NCT02014558|18882142|P11|Overall Study|Miscellaneous|12
5462726|NCT02014558|18882143|P10|Overall Study|Miscellaneous|3
5462727|NCT02014558|18882144|P9|Overall Study|Miscellaneous|1
5462728|NCT02014558|18882145|P8|Overall Study|Miscellaneous|1
5462729|NCT02014558|18882146|P7|Overall Study|Miscellaneous|0
5462730|NCT02014558|18882147|P6|Overall Study|Miscellaneous|1
5462731|NCT02014558|18882148|P5|Overall Study|Miscellaneous|0
5462732|NCT02014558|18882149|P4|Overall Study|Miscellaneous|1
5462733|NCT02014558|18882150|P3|Overall Study|Miscellaneous|1
5462734|NCT02014558|18882151|P2|Overall Study|Miscellaneous|1
5462735|NCT02014558|18882152|P1|Overall Study|Miscellaneous|2
5462736|NCT02014558|18882140|P13|Overall Study|Withdrawal by Subject|0
5462737|NCT02014558|18882141|P12|Overall Study|Withdrawal by Subject|10
5462738|NCT02014558|18882142|P11|Overall Study|Withdrawal by Subject|6
5462739|NCT02014558|18882143|P10|Overall Study|Withdrawal by Subject|2
5462740|NCT02014558|18882144|P9|Overall Study|Withdrawal by Subject|0
5462741|NCT02014558|18882145|P8|Overall Study|Withdrawal by Subject|0
5462742|NCT02014558|18882146|P7|Overall Study|Withdrawal by Subject|0
5462743|NCT02014558|18882147|P6|Overall Study|Withdrawal by Subject|0
5462744|NCT02014558|18882148|P5|Overall Study|Withdrawal by Subject|1
5462745|NCT02014558|18882149|P4|Overall Study|Withdrawal by Subject|0
5462746|NCT02014558|18882150|P3|Overall Study|Withdrawal by Subject|0
5462747|NCT02014558|18882151|P2|Overall Study|Withdrawal by Subject|0
5462748|NCT02014558|18882152|P1|Overall Study|Withdrawal by Subject|0
5462749|NCT02014558|18882140|P13|Overall Study|Progressive Disease|6
5462750|NCT02014558|18882141|P12|Overall Study|Progressive Disease|31
5462751|NCT02014558|18882142|P11|Overall Study|Progressive Disease|22
5462752|NCT02014558|18882143|P10|Overall Study|Progressive Disease|6
5462753|NCT02014558|18882144|P9|Overall Study|Progressive Disease|5
5462754|NCT02014558|18882145|P8|Overall Study|Progressive Disease|6
5462755|NCT02014558|18882146|P7|Overall Study|Progressive Disease|1
5462756|NCT02014558|18882147|P6|Overall Study|Progressive Disease|2
5462757|NCT02014558|18882148|P5|Overall Study|Progressive Disease|1
5462758|NCT02014558|18882149|P4|Overall Study|Progressive Disease|1
5462759|NCT02014558|18882150|P3|Overall Study|Progressive Disease|1
5462760|NCT02014558|18882151|P2|Overall Study|Progressive Disease|0
5462761|NCT02014558|18882152|P1|Overall Study|Progressive Disease|1
5462762|NCT02014558|18882140|P13|Overall Study|Lost to Follow-up|0
5462763|NCT02014558|18882141|P12|Overall Study|Lost to Follow-up|0
5462764|NCT02014558|18882142|P11|Overall Study|Lost to Follow-up|1
5462765|NCT02014558|18882143|P10|Overall Study|Lost to Follow-up|0
5462766|NCT02014558|18882144|P9|Overall Study|Lost to Follow-up|0
5462767|NCT02014558|18882145|P8|Overall Study|Lost to Follow-up|0
5462768|NCT02014558|18882146|P7|Overall Study|Lost to Follow-up|0
5462769|NCT02014558|18882147|P6|Overall Study|Lost to Follow-up|0
5462770|NCT02014558|18882148|P5|Overall Study|Lost to Follow-up|0
5462771|NCT02014558|18882149|P4|Overall Study|Lost to Follow-up|0
5462772|NCT02014558|18882150|P3|Overall Study|Lost to Follow-up|0
5462773|NCT02014558|18882151|P2|Overall Study|Lost to Follow-up|0
5462774|NCT02014558|18882152|P1|Overall Study|Lost to Follow-up|0
5462775|NCT02014558|18882140|P13|Overall Study|Lack of Efficacy|5
5462776|NCT02014558|18882141|P12|Overall Study|Lack of Efficacy|8
5462777|NCT02014558|18882142|P11|Overall Study|Lack of Efficacy|16
5462778|NCT02014558|18882143|P10|Overall Study|Lack of Efficacy|3
5462779|NCT02014558|18882144|P9|Overall Study|Lack of Efficacy|3
5462780|NCT02014558|18882145|P8|Overall Study|Lack of Efficacy|3
5462781|NCT02014558|18882146|P7|Overall Study|Lack of Efficacy|1
5462782|NCT02014558|18882147|P6|Overall Study|Lack of Efficacy|0
5462783|NCT02014558|18882148|P5|Overall Study|Lack of Efficacy|0
5462784|NCT02014558|18882149|P4|Overall Study|Lack of Efficacy|1
5462785|NCT02014558|18882150|P3|Overall Study|Lack of Efficacy|1
5462786|NCT02014558|18882151|P2|Overall Study|Lack of Efficacy|2
5462787|NCT02014558|18882152|P1|Overall Study|Lack of Efficacy|1
5462788|NCT02014558|18882140|P13|Overall Study|Death|2
5462789|NCT02014558|18882141|P12|Overall Study|Death|19
5462790|NCT02014558|18882142|P11|Overall Study|Death|5
5462791|NCT02014558|18882143|P10|Overall Study|Death|5
5462792|NCT02014558|18882144|P9|Overall Study|Death|2
5462793|NCT02014558|18882145|P8|Overall Study|Death|1
5462794|NCT02014558|18882146|P7|Overall Study|Death|1
5462795|NCT02014558|18882147|P6|Overall Study|Death|0
5462796|NCT02014558|18882148|P5|Overall Study|Death|0
5462797|NCT02014558|18882149|P4|Overall Study|Death|0
5462798|NCT02014558|18882150|P3|Overall Study|Death|0
5462799|NCT02014558|18882151|P2|Overall Study|Death|0
5462800|NCT02014558|18882152|P1|Overall Study|Death|1
5462801|NCT02014558|18882140|P13|Overall Study|Adverse Event|3
5462802|NCT02014558|18882141|P12|Overall Study|Adverse Event|21
5462803|NCT02014558|18882142|P11|Overall Study|Adverse Event|5
5462804|NCT02014558|18882143|P10|Overall Study|Adverse Event|2
5462805|NCT02014558|18882144|P9|Overall Study|Adverse Event|2
5462806|NCT02014558|18882145|P8|Overall Study|Adverse Event|0
5462807|NCT02014558|18882146|P7|Overall Study|Adverse Event|0
5462808|NCT02014558|18882147|P6|Overall Study|Adverse Event|0
5462809|NCT02014558|18882148|P5|Overall Study|Adverse Event|1
5462810|NCT02014558|18882149|P4|Overall Study|Adverse Event|0
5462811|NCT02014558|18882150|P3|Overall Study|Adverse Event|0
5462812|NCT02014558|18882151|P2|Overall Study|Adverse Event|0
5462813|NCT02014558|18882152|P1|Overall Study|Adverse Event|0
5462814|NCT02014558|18882140|P13|Overall Study|Never Received Study Drug|0
5462815|NCT02014558|18882141|P12|Overall Study|Never Received Study Drug|2
5462816|NCT02014558|18882142|P11|Overall Study|Never Received Study Drug|2
5462817|NCT02014558|18882143|P10|Overall Study|Never Received Study Drug|0
5462818|NCT02014558|18882144|P9|Overall Study|Never Received Study Drug|2
5462819|NCT02014558|18882145|P8|Overall Study|Never Received Study Drug|0
5462820|NCT02014558|18882146|P7|Overall Study|Never Received Study Drug|1
5462821|NCT02014558|18882147|P6|Overall Study|Never Received Study Drug|0
5462822|NCT02014558|18882148|P5|Overall Study|Never Received Study Drug|1
5462823|NCT02014558|18882149|P4|Overall Study|Never Received Study Drug|0
5462824|NCT02014558|18882150|P3|Overall Study|Never Received Study Drug|0
5462825|NCT02014558|18882151|P2|Overall Study|Never Received Study Drug|0
5462826|NCT02014558|18882152|P1|Overall Study|Never Received Study Drug|0
5462827|NCT02014480|18882517|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
5462828|NCT02014480|18882518|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5462829|NCT02014480|18882519|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5462830|NCT02014480|18882520|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5462831|NCT02014480|18882521|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5462832|NCT02014480|18882522|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5462833|NCT02014480|18882517|P6|Treatment Period 3 (14 Days)|Adverse Event|1
5462834|NCT02014480|18882518|P5|Treatment Period 3 (14 Days)|Adverse Event|0
5462835|NCT02014480|18882519|P4|Treatment Period 3 (14 Days)|Adverse Event|0
5462836|NCT02014480|18882520|P3|Treatment Period 3 (14 Days)|Adverse Event|1
5462837|NCT02014480|18882521|P2|Treatment Period 3 (14 Days)|Adverse Event|0
5462838|NCT02014480|18882522|P1|Treatment Period 3 (14 Days)|Adverse Event|0
5462839|NCT02014480|18882517|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5462840|NCT02014480|18882518|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5462841|NCT02014480|18882519|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5462842|NCT02014480|18882520|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5462843|NCT02014480|18882521|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
5462844|NCT02014480|18882522|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5462845|NCT02014480|18882517|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
5462846|NCT02014480|18882518|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
5462847|NCT02014480|18882519|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
5462848|NCT02014480|18882520|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
5462849|NCT02014480|18882521|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
5462850|NCT02014480|18882522|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
5462851|NCT02014480|18882517|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5462852|NCT02014480|18882518|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5462853|NCT02014480|18882519|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5462854|NCT02014480|18882520|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
5462855|NCT02014480|18882521|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5462856|NCT02014480|18882522|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5462857|NCT02014480|18882517|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5462858|NCT02014480|18882518|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5462859|NCT02014480|18882519|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
5462860|NCT02014480|18882520|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5462861|NCT02014480|18882521|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5462862|NCT02014480|18882522|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5462863|NCT02014480|18882517|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5462864|NCT02014480|18882518|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5462865|NCT02014480|18882519|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5462866|NCT02014480|18882520|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
5462867|NCT02014480|18882521|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5462868|NCT02014480|18882522|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5462869|NCT02014467|18882541|P2|Overall Study|Withdrawal by Subject|4
5462870|NCT02014467|18882542|P1|Overall Study|Withdrawal by Subject|16
5462871|NCT02014467|18882541|P2|Overall Study|Physician Decision|3
5462872|NCT02014467|18882542|P1|Overall Study|Physician Decision|2
5462873|NCT02014467|18882541|P2|Overall Study|Protocol Violation|0
5462874|NCT02014467|18882542|P1|Overall Study|Protocol Violation|3
5462875|NCT02014467|18882541|P2|Overall Study|Adverse Event|0
5462876|NCT02014467|18882542|P1|Overall Study|Adverse Event|4
5462877|NCT02014441|18882602|P1|Overall Study|Withdrawal by Subject|12
5462878|NCT02014402|18882698|P4|Overall Study|Lost to Follow-up|2
5462879|NCT02014402|18882699|P3|Overall Study|Lost to Follow-up|1
5462880|NCT02014402|18882700|P2|Overall Study|Lost to Follow-up|0
5462881|NCT02014402|18882701|P1|Overall Study|Lost to Follow-up|0
5462882|NCT02014402|18882698|P4|Overall Study|Subject did not have transportation|0
5462883|NCT02014402|18882699|P3|Overall Study|Subject did not have transportation|0
5462884|NCT02014402|18882700|P2|Overall Study|Subject did not have transportation|1
5462885|NCT02014402|18882701|P1|Overall Study|Subject did not have transportation|0
5462886|NCT02014402|18882698|P4|Overall Study|Withdrawal by Subject|1
5462887|NCT02014402|18882699|P3|Overall Study|Withdrawal by Subject|2
5462888|NCT02014402|18882700|P2|Overall Study|Withdrawal by Subject|2
5462889|NCT02014402|18882701|P1|Overall Study|Withdrawal by Subject|1
5462890|NCT02014402|18882698|P4|Overall Study|Adverse Event|0
5462891|NCT02014402|18882699|P3|Overall Study|Adverse Event|0
5462892|NCT02014402|18882700|P2|Overall Study|Adverse Event|0
5462893|NCT02014402|18882701|P1|Overall Study|Adverse Event|1
5462894|NCT02014376|18882731|P3|Overall Study|Lost to Follow-up|0
5462895|NCT02014376|18882732|P2|Overall Study|Lost to Follow-up|0
5462896|NCT02014376|18882733|P1|Overall Study|Lost to Follow-up|2
5462897|NCT02014376|18882731|P3|Overall Study|Adverse Event|0
5462898|NCT02014376|18882732|P2|Overall Study|Adverse Event|1
5462899|NCT02014376|18882733|P1|Overall Study|Adverse Event|1
5462900|NCT02014272|18882769|P2|Intervention Period 1|Adverse Event|1
5462901|NCT02014272|18882770|P1|Intervention Period 1|Adverse Event|0
5462902|NCT02014272|18882769|P2|Intervention Period 1|Withdrawal by Subject|0
5462903|NCT02014272|18882770|P1|Intervention Period 1|Withdrawal by Subject|1
5462904|NCT02014116|18882819|P9|Overall Study|Physician Decision|1
5462905|NCT02014116|18882820|P8|Overall Study|Physician Decision|0
5462906|NCT02014116|18882821|P7|Overall Study|Physician Decision|0
5462907|NCT02014116|18882822|P6|Overall Study|Physician Decision|0
5462908|NCT02014116|18882823|P5|Overall Study|Physician Decision|0
5462909|NCT02014116|18882824|P4|Overall Study|Physician Decision|0
5462910|NCT02014116|18882825|P3|Overall Study|Physician Decision|0
5462911|NCT02014116|18882826|P2|Overall Study|Physician Decision|0
5462912|NCT02014116|18882827|P1|Overall Study|Physician Decision|0
5462913|NCT02014116|18882819|P9|Overall Study|Withdrawal Caregiver Decision|0
5462914|NCT02014116|18882820|P8|Overall Study|Withdrawal Caregiver Decision|0
5462915|NCT02014116|18882821|P7|Overall Study|Withdrawal Caregiver Decision|0
5462916|NCT02014116|18882822|P6|Overall Study|Withdrawal Caregiver Decision|1
5462917|NCT02014116|18882823|P5|Overall Study|Withdrawal Caregiver Decision|0
5462918|NCT02014116|18882824|P4|Overall Study|Withdrawal Caregiver Decision|0
5462919|NCT02014116|18882825|P3|Overall Study|Withdrawal Caregiver Decision|0
5462920|NCT02014116|18882826|P2|Overall Study|Withdrawal Caregiver Decision|0
5462921|NCT02014116|18882827|P1|Overall Study|Withdrawal Caregiver Decision|0
5462922|NCT02014116|18882819|P9|Overall Study|Withdrawal by Subject|0
5462923|NCT02014116|18882820|P8|Overall Study|Withdrawal by Subject|0
5462924|NCT02014116|18882821|P7|Overall Study|Withdrawal by Subject|0
5462925|NCT02014116|18882822|P6|Overall Study|Withdrawal by Subject|1
5462926|NCT02014116|18882823|P5|Overall Study|Withdrawal by Subject|0
5462927|NCT02014116|18882824|P4|Overall Study|Withdrawal by Subject|1
5462928|NCT02014116|18882825|P3|Overall Study|Withdrawal by Subject|1
5462929|NCT02014116|18882826|P2|Overall Study|Withdrawal by Subject|0
5462930|NCT02014116|18882827|P1|Overall Study|Withdrawal by Subject|0
5462931|NCT02014116|18882819|P9|Overall Study|Death|1
5462932|NCT02014116|18882820|P8|Overall Study|Death|1
5462933|NCT02014116|18882821|P7|Overall Study|Death|0
5462934|NCT02014116|18882822|P6|Overall Study|Death|0
5462935|NCT02014116|18882823|P5|Overall Study|Death|0
5462936|NCT02014116|18882824|P4|Overall Study|Death|0
5462937|NCT02014116|18882825|P3|Overall Study|Death|0
5462938|NCT02014116|18882826|P2|Overall Study|Death|0
5462939|NCT02014116|18882827|P1|Overall Study|Death|0
5462940|NCT02014116|18882819|P9|Overall Study|Lost to Follow-up|1
5462941|NCT02014116|18882820|P8|Overall Study|Lost to Follow-up|0
5462942|NCT02014116|18882821|P7|Overall Study|Lost to Follow-up|0
5462943|NCT02014116|18882822|P6|Overall Study|Lost to Follow-up|1
5462944|NCT02014116|18882823|P5|Overall Study|Lost to Follow-up|0
5462945|NCT02014116|18882824|P4|Overall Study|Lost to Follow-up|0
5462946|NCT02014116|18882825|P3|Overall Study|Lost to Follow-up|0
5462947|NCT02014116|18882826|P2|Overall Study|Lost to Follow-up|0
5462948|NCT02014116|18882827|P1|Overall Study|Lost to Follow-up|0
5462949|NCT02014116|18882819|P9|Overall Study|Adverse Event|0
5462950|NCT02014116|18882820|P8|Overall Study|Adverse Event|1
5462951|NCT02014116|18882821|P7|Overall Study|Adverse Event|0
5462952|NCT02014116|18882822|P6|Overall Study|Adverse Event|0
5462953|NCT02014116|18882823|P5|Overall Study|Adverse Event|1
5462954|NCT02014116|18882824|P4|Overall Study|Adverse Event|0
5462955|NCT02014116|18882825|P3|Overall Study|Adverse Event|0
5462956|NCT02014116|18882826|P2|Overall Study|Adverse Event|0
5462957|NCT02014116|18882827|P1|Overall Study|Adverse Event|0
5462958|NCT02014116|18882819|P9|Overall Study|Progressive Disease|7
5462959|NCT02014116|18882820|P8|Overall Study|Progressive Disease|3
5462960|NCT02014116|18882821|P7|Overall Study|Progressive Disease|1
5462961|NCT02014116|18882822|P6|Overall Study|Progressive Disease|13
5462962|NCT02014116|18882823|P5|Overall Study|Progressive Disease|1
5462963|NCT02014116|18882824|P4|Overall Study|Progressive Disease|6
5462964|NCT02014116|18882825|P3|Overall Study|Progressive Disease|2
5462965|NCT02014116|18882826|P2|Overall Study|Progressive Disease|4
5462966|NCT02014116|18882827|P1|Overall Study|Progressive Disease|3
5462967|NCT02013830|18882892|P1|Overall Study|Refused treatment|1
5462968|NCT02013830|18882892|P1|Overall Study|Insufficient therapeutic response|25
5462969|NCT02013830|18882892|P1|Overall Study|Death|1
5462970|NCT02013830|18882892|P1|Overall Study|Adverse Event|3
5462971|NCT02013817|18882903|P1|Overall Study|Other|9
5462972|NCT02013817|18882903|P1|Overall Study|Death|2
5462973|NCT02013817|18882903|P1|Overall Study|Withdrawal by Subject|4
5462974|NCT02013817|18882903|P1|Overall Study|Adverse Event|12
5462975|NCT02013791|18882921|P9|Period 1|Other Miscellaneous Reasons|0
5462976|NCT02013791|18882922|P8|Period 1|Other Miscellaneous Reasons|0
5462977|NCT02013791|18882923|P7|Period 1|Other Miscellaneous Reasons|0
5462978|NCT02013791|18882924|P6|Period 1|Other Miscellaneous Reasons|0
5462979|NCT02013791|18882925|P5|Period 1|Other Miscellaneous Reasons|0
5462980|NCT02013791|18882926|P4|Period 1|Other Miscellaneous Reasons|0
5462981|NCT02013791|18882927|P3|Period 1|Other Miscellaneous Reasons|0
5462982|NCT02013791|18882928|P2|Period 1|Other Miscellaneous Reasons|2
5462983|NCT02013791|18882929|P1|Period 1|Other Miscellaneous Reasons|0
5462984|NCT02013791|18882921|P9|Period 1|Lost to Follow-up|0
5462985|NCT02013791|18882922|P8|Period 1|Lost to Follow-up|1
5462986|NCT02013791|18882923|P7|Period 1|Lost to Follow-up|1
5462987|NCT02013791|18882924|P6|Period 1|Lost to Follow-up|0
5462988|NCT02013791|18882925|P5|Period 1|Lost to Follow-up|0
5462989|NCT02013791|18882926|P4|Period 1|Lost to Follow-up|1
5462990|NCT02013791|18882927|P3|Period 1|Lost to Follow-up|0
5462991|NCT02013791|18882928|P2|Period 1|Lost to Follow-up|0
5462992|NCT02013791|18882929|P1|Period 1|Lost to Follow-up|0
5462993|NCT02013778|18882950|P1|Overall Study|Adverse Event|1
5462994|NCT02013778|18882950|P1|Overall Study|Physician Decision|1
5462995|NCT02013778|18882950|P1|Overall Study|Withdrawal by Subject|1
5462996|NCT02013778|18882950|P1|Overall Study|Death|4
5462997|NCT02013765|18882954|P1|Overall Study|Trial was terminated by sponsor|1
5462998|NCT02013687|18882968|P4|Overall Study|Missed visits due to patient travel|0
5462999|NCT02013687|18882969|P3|Overall Study|Missed visits due to patient travel|1
5463000|NCT02013687|18882970|P2|Overall Study|Missed visits due to patient travel|0
5463001|NCT02013687|18882971|P1|Overall Study|Missed visits due to patient travel|0
5463002|NCT02013687|18882968|P4|Overall Study|Withdrawal by Subject|1
5463003|NCT02013687|18882969|P3|Overall Study|Withdrawal by Subject|0
5463004|NCT02013687|18882970|P2|Overall Study|Withdrawal by Subject|0
5463005|NCT02013687|18882971|P1|Overall Study|Withdrawal by Subject|0
5463006|NCT02013687|18882968|P4|Overall Study|Protocol Violation|1
5463007|NCT02013687|18882969|P3|Overall Study|Protocol Violation|0
5463008|NCT02013687|18882970|P2|Overall Study|Protocol Violation|0
5463009|NCT02013687|18882971|P1|Overall Study|Protocol Violation|0
5463010|NCT02013687|18882968|P4|Overall Study|Lost to Follow-up|0
5463011|NCT02013687|18882969|P3|Overall Study|Lost to Follow-up|1
5463012|NCT02013687|18882970|P2|Overall Study|Lost to Follow-up|0
5463013|NCT02013687|18882971|P1|Overall Study|Lost to Follow-up|0
5463014|NCT02013674|18883003|P2|Overall Study|Lost to Follow-up|0
5463015|NCT02013674|18883004|P1|Overall Study|Lost to Follow-up|1
5463016|NCT02013674|18883003|P2|Overall Study|Death|1
5463017|NCT02013674|18883004|P1|Overall Study|Death|0
5463018|NCT02013622|18883054|P1|Overall Study|Lack of Efficacy|1
5463019|NCT02013622|18883054|P1|Overall Study|Protocol Deviation|1
5463020|NCT02013622|18883054|P1|Overall Study|Withdrawal by Subject|6
5463021|NCT02013622|18883054|P1|Overall Study|Met Withdrawal Criteria|3
5463022|NCT02013622|18883054|P1|Overall Study|Adverse Event|3
5463023|NCT02013622|18883054|P1|Overall Study|Lost to Follow-up|10
5463024|NCT02013609|18883074|P1|Overall Study|Met Withdrawal Criteria|3
5463025|NCT02013609|18883074|P1|Overall Study|Adverse Event|3
5463026|NCT02013609|18883074|P1|Overall Study|Lost to Follow-up|3
5463027|NCT02013609|18883074|P1|Overall Study|Withdrawal by Subject|9
5463028|NCT02013544|18883099|P2|Overall Study|Entry criteria not met/non-compliance|3
5463029|NCT02013544|18883100|P1|Overall Study|Entry criteria not met/non-compliance|2
5463030|NCT02013544|18883099|P2|Overall Study|Physician Decision|1
5463031|NCT02013544|18883100|P1|Overall Study|Physician Decision|0
5463032|NCT02013544|18883099|P2|Overall Study|Withdrawal by Subject|8
5463033|NCT02013544|18883100|P1|Overall Study|Withdrawal by Subject|2
5463034|NCT02013544|18883099|P2|Overall Study|Lost to Follow-up|3
5463035|NCT02013544|18883100|P1|Overall Study|Lost to Follow-up|2
5463036|NCT02013544|18883099|P2|Overall Study|Adverse Event|5
5463037|NCT02013544|18883100|P1|Overall Study|Adverse Event|5
5463038|NCT02013531|18883122|P1|Overall Study|Withdrawal by Subject|1
5463039|NCT02013531|18883122|P1|Overall Study|Met Withdrawal Criteria|1
5463040|NCT02013531|18883122|P1|Overall Study|Lost to Follow-up|3
5463041|NCT02013388|18883158|P8|Overall Study|work emergency|0
5463042|NCT02013388|18883159|P7|Overall Study|work emergency|0
5463043|NCT02013388|18883160|P6|Overall Study|work emergency|0
5463044|NCT02013388|18883161|P5|Overall Study|work emergency|1
5463045|NCT02013388|18883162|P4|Overall Study|work emergency|0
5463046|NCT02013388|18883163|P3|Overall Study|work emergency|0
5463047|NCT02013388|18883164|P2|Overall Study|work emergency|0
5463048|NCT02013388|18883165|P1|Overall Study|work emergency|1
5463049|NCT02013375|18883199|P1|Overall Study|Did not engraft|1
5463050|NCT02013375|18883199|P1|Overall Study|Did not engraft|1
5463051|NCT02013206|18883229|P2|Overall Study|Other reasons off treatment|2
5463052|NCT02013206|18883230|P1|Overall Study|Other reasons off treatment|5
5463053|NCT02013206|18883229|P2|Overall Study|Death|2
5463054|NCT02013206|18883230|P1|Overall Study|Death|1
5463055|NCT02013206|18883229|P2|Overall Study|Patient non-compliance|0
5463056|NCT02013206|18883230|P1|Overall Study|Patient non-compliance|1
5463057|NCT02013206|18883229|P2|Overall Study|Patient refusal|0
5463058|NCT02013206|18883230|P1|Overall Study|Patient refusal|2
5463059|NCT02013206|18883229|P2|Overall Study|Adverse Event|0
5463060|NCT02013206|18883230|P1|Overall Study|Adverse Event|1
5463061|NCT02013206|18883229|P2|Overall Study|Symptomatic deterioration|1
5463062|NCT02013206|18883230|P1|Overall Study|Symptomatic deterioration|3
5463063|NCT02013206|18883229|P2|Overall Study|Progressive disease (PD)|17
5463064|NCT02013206|18883230|P1|Overall Study|Progressive disease (PD)|14
5463065|NCT02013167|18883261|P2|Overall Study|Death|160
5463066|NCT02013167|18883262|P1|Overall Study|Death|85
5463067|NCT02013167|18883261|P2|Overall Study|Lost to Follow-up|1
5463068|NCT02013167|18883262|P1|Overall Study|Lost to Follow-up|0
5463069|NCT02013167|18883261|P2|Overall Study|Sponsor Decision|3
5463070|NCT02013167|18883262|P1|Overall Study|Sponsor Decision|1
5463071|NCT02013167|18883261|P2|Overall Study|Withdrawal by Subject|14
5463072|NCT02013167|18883262|P1|Overall Study|Withdrawal by Subject|15
5463073|NCT02012959|18883338|P5|Treatment Phase A|Adverse Event|0
5463074|NCT02012959|18883339|P4|Treatment Phase A|Adverse Event|0
5463075|NCT02012959|18883340|P3|Treatment Phase A|Adverse Event|0
5463076|NCT02012959|18883341|P2|Treatment Phase A|Adverse Event|0
5463077|NCT02012959|18883342|P1|Treatment Phase A|Adverse Event|2
5463078|NCT02012686|18883355|P2|Overall Study|electrocardiography monitoring noise|1
5463079|NCT02012686|18883356|P1|Overall Study|electrocardiography monitoring noise|0
5463080|NCT02012686|18883355|P2|Overall Study|muscle contraction|1
5463081|NCT02012686|18883356|P1|Overall Study|muscle contraction|0
5463082|NCT02012491|18883418|P2|Overall Study|Withdrawal by Subject|0
5463083|NCT02012491|18883419|P1|Overall Study|Withdrawal by Subject|1
5463084|NCT02012491|18883418|P2|Overall Study|Protocol Violation|1
5463085|NCT02012491|18883419|P1|Overall Study|Protocol Violation|0
5463086|NCT02012491|18883418|P2|Overall Study|Lost to Follow-up|0
5463087|NCT02012491|18883419|P1|Overall Study|Lost to Follow-up|1
5463088|NCT02012452|18883437|P2|Overall Study|Withdrawal by Subject|0
5463089|NCT02012452|18883438|P1|Overall Study|Withdrawal by Subject|4
5463090|NCT02012452|18883437|P2|Overall Study|Lost to Follow-up|1
5463091|NCT02012452|18883438|P1|Overall Study|Lost to Follow-up|2
5463092|NCT02012218|18883481|P5|Overall Study|Protocol Deviation|0
5463093|NCT02012218|18883482|P4|Overall Study|Protocol Deviation|0
5463094|NCT02012218|18883483|P3|Overall Study|Protocol Deviation|0
5463095|NCT02012218|18883484|P2|Overall Study|Protocol Deviation|0
5463096|NCT02012218|18883485|P1|Overall Study|Protocol Deviation|1
5463097|NCT02012218|18883481|P5|Overall Study|Protocol Specified|0
5463098|NCT02012218|18883482|P4|Overall Study|Protocol Specified|0
5463099|NCT02012218|18883483|P3|Overall Study|Protocol Specified|0
5463100|NCT02012218|18883484|P2|Overall Study|Protocol Specified|0
5463101|NCT02012218|18883485|P1|Overall Study|Protocol Specified|1
5463102|NCT02012218|18883481|P5|Overall Study|Lost to Follow-up|0
5463103|NCT02012218|18883482|P4|Overall Study|Lost to Follow-up|0
5463104|NCT02012218|18883483|P3|Overall Study|Lost to Follow-up|1
5463105|NCT02012218|18883484|P2|Overall Study|Lost to Follow-up|1
5463106|NCT02012218|18883485|P1|Overall Study|Lost to Follow-up|0
5463107|NCT02012218|18883481|P5|Overall Study|Adverse Event|0
5463108|NCT02012218|18883482|P4|Overall Study|Adverse Event|1
5463109|NCT02012218|18883483|P3|Overall Study|Adverse Event|0
5463110|NCT02012218|18883484|P2|Overall Study|Adverse Event|0
5463111|NCT02012218|18883485|P1|Overall Study|Adverse Event|1
5463112|NCT02012218|18883481|P5|Overall Study|Withdrawal by Subject|1
5463113|NCT02012218|18883482|P4|Overall Study|Withdrawal by Subject|1
5463114|NCT02012218|18883483|P3|Overall Study|Withdrawal by Subject|1
5463115|NCT02012218|18883484|P2|Overall Study|Withdrawal by Subject|0
5463116|NCT02012218|18883485|P1|Overall Study|Withdrawal by Subject|1
5463117|NCT02011945|18883509|P3|Overall Study|Sub-Optimal Response to dasatinib|0
5463118|NCT02011945|18883510|P2|Overall Study|Sub-Optimal Response to dasatinib|0
5463119|NCT02011945|18883511|P1|Overall Study|Sub-Optimal Response to dasatinib|1
5463120|NCT02011945|18883509|P3|Overall Study|Proceeded to stem cell transplant|1
5463121|NCT02011945|18883510|P2|Overall Study|Proceeded to stem cell transplant|0
5463122|NCT02011945|18883511|P1|Overall Study|Proceeded to stem cell transplant|0
5463123|NCT02011945|18883509|P3|Overall Study|No Longer Meets Study Criteria|0
5463124|NCT02011945|18883510|P2|Overall Study|No Longer Meets Study Criteria|0
5463125|NCT02011945|18883511|P1|Overall Study|No Longer Meets Study Criteria|1
5463126|NCT02011945|18883509|P3|Overall Study|Treatment Failure|6
5463127|NCT02011945|18883510|P2|Overall Study|Treatment Failure|7
5463128|NCT02011945|18883511|P1|Overall Study|Treatment Failure|0
5463129|NCT02011945|18883509|P3|Overall Study|Study Drug Toxicity|1
5463130|NCT02011945|18883510|P2|Overall Study|Study Drug Toxicity|0
5463131|NCT02011945|18883511|P1|Overall Study|Study Drug Toxicity|0
5463132|NCT02011945|18883509|P3|Overall Study|Adverse Event unrelated to Drug|1
5463133|NCT02011945|18883510|P2|Overall Study|Adverse Event unrelated to Drug|2
5463134|NCT02011945|18883511|P1|Overall Study|Adverse Event unrelated to Drug|0
5463135|NCT02011945|18883509|P3|Overall Study|Participant requested to Discontinue|1
5463136|NCT02011945|18883510|P2|Overall Study|Participant requested to Discontinue|1
5463137|NCT02011945|18883511|P1|Overall Study|Participant requested to Discontinue|0
5463138|NCT02011893|18883588|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
5463139|NCT02011893|18883589|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
5463140|NCT02011893|18883590|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
5463141|NCT02011893|18883588|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
5463142|NCT02011893|18883589|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
5463143|NCT02011893|18883590|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
5463144|NCT02011893|18883588|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
5463145|NCT02011893|18883589|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
5463146|NCT02011893|18883590|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
5463147|NCT02011893|18883588|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
5463148|NCT02011893|18883589|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
5463149|NCT02011893|18883590|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
5463150|NCT02011893|18883588|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
5463151|NCT02011893|18883589|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
5463152|NCT02011893|18883590|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
5463153|NCT02011893|18883588|P3|Enrollment to Randomization|Screening Failure|0
5463154|NCT02011893|18883589|P2|Enrollment to Randomization|Screening Failure|0
5463155|NCT02011893|18883590|P1|Enrollment to Randomization|Screening Failure|29
5463156|NCT02011893|18883588|P3|Enrollment to Randomization|Withdrawal by Subject|0
5463157|NCT02011893|18883589|P2|Enrollment to Randomization|Withdrawal by Subject|0
5463158|NCT02011893|18883590|P1|Enrollment to Randomization|Withdrawal by Subject|21
5463159|NCT02011893|18883588|P3|Enrollment to Randomization|Physician Decision|0
5463160|NCT02011893|18883589|P2|Enrollment to Randomization|Physician Decision|0
5463161|NCT02011893|18883590|P1|Enrollment to Randomization|Physician Decision|10
5463162|NCT02011893|18883588|P3|Enrollment to Randomization|Adverse Event|0
5463163|NCT02011893|18883589|P2|Enrollment to Randomization|Adverse Event|0
5463164|NCT02011893|18883590|P1|Enrollment to Randomization|Adverse Event|2
5463165|NCT02011542|18883601|P1|Overall Study|Physician Decision|1
5463166|NCT02011386|18883732|P1|Overall Study|Lack of Efficacy|3
5463167|NCT02011386|18883732|P1|Overall Study|Non-compliance|2
5463168|NCT02011113|18883746|P1|Overall Study|Study terminated by sponsor|11
5463169|NCT02011113|18883746|P1|Overall Study|Investigator's judgement- DP|3
5463170|NCT02011113|18883746|P1|Overall Study|Insufficient effect of Pomalidomide|1
5463171|NCT02011113|18883746|P1|Overall Study|Death|1
5463172|NCT02011113|18883746|P1|Overall Study|Disease Progression (DP)|16
5463173|NCT02011113|18883746|P1|Overall Study|Adverse Event|4
5463174|NCT02010775|18883778|P5|Overall Study|Personal Reasons|4
5463175|NCT02010775|18883779|P4|Overall Study|Personal Reasons|2
5463176|NCT02010775|18883780|P3|Overall Study|Personal Reasons|1
5463177|NCT02010775|18883781|P2|Overall Study|Personal Reasons|3
5463178|NCT02010775|18883782|P1|Overall Study|Personal Reasons|3
5463179|NCT02010775|18883778|P5|Overall Study|Lost to Follow-up|1
5463180|NCT02010775|18883779|P4|Overall Study|Lost to Follow-up|1
5463181|NCT02010775|18883780|P3|Overall Study|Lost to Follow-up|0
5463182|NCT02010775|18883781|P2|Overall Study|Lost to Follow-up|0
5463183|NCT02010775|18883782|P1|Overall Study|Lost to Follow-up|2
5463184|NCT02010775|18883778|P5|Overall Study|Pregnancy|0
5463185|NCT02010775|18883779|P4|Overall Study|Pregnancy|0
5463186|NCT02010775|18883780|P3|Overall Study|Pregnancy|2
5463187|NCT02010775|18883781|P2|Overall Study|Pregnancy|0
5463188|NCT02010775|18883782|P1|Overall Study|Pregnancy|0
5463189|NCT02010775|18883778|P5|Overall Study|Adverse Event|1
5463190|NCT02010775|18883779|P4|Overall Study|Adverse Event|0
5463191|NCT02010775|18883780|P3|Overall Study|Adverse Event|0
5463192|NCT02010775|18883781|P2|Overall Study|Adverse Event|0
5463193|NCT02010775|18883782|P1|Overall Study|Adverse Event|0
5463194|NCT02010684|18883823|P2|Overall Study|Withdrawal by Subject|5
5463195|NCT02010684|18883824|P1|Overall Study|Withdrawal by Subject|4
5463196|NCT02010684|18883823|P2|Overall Study|Lost to Follow-up|18
5463197|NCT02010684|18883824|P1|Overall Study|Lost to Follow-up|8
5463198|NCT02010632|18883846|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
5463199|NCT02010632|18883847|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
5463200|NCT02010567|18883858|P5|Overall Study|Adverse Event|1
5463201|NCT02010567|18883859|P4|Overall Study|Adverse Event|0
5463202|NCT02010567|18883860|P3|Overall Study|Adverse Event|1
5463203|NCT02010567|18883861|P2|Overall Study|Adverse Event|0
5463204|NCT02010567|18883862|P1|Overall Study|Adverse Event|0
5463205|NCT02010255|18883918|P14|Overall Study|Randomized but Not Treated|1
5463206|NCT02010255|18883919|P13|Overall Study|Randomized but Not Treated|0
5463207|NCT02010255|18883920|P12|Overall Study|Randomized but Not Treated|0
5463208|NCT02010255|18883921|P11|Overall Study|Randomized but Not Treated|0
5463209|NCT02010255|18883922|P10|Overall Study|Randomized but Not Treated|0
5463210|NCT02010255|18883923|P9|Overall Study|Randomized but Not Treated|0
5463211|NCT02010255|18883924|P8|Overall Study|Randomized but Not Treated|0
5463212|NCT02010255|18883925|P7|Overall Study|Randomized but Not Treated|0
5463213|NCT02010255|18883926|P6|Overall Study|Randomized but Not Treated|0
5463214|NCT02010255|18883927|P5|Overall Study|Randomized but Not Treated|0
5463215|NCT02010255|18883928|P4|Overall Study|Randomized but Not Treated|0
5463216|NCT02010255|18883929|P3|Overall Study|Randomized but Not Treated|0
5463217|NCT02010255|18883930|P2|Overall Study|Randomized but Not Treated|0
5463218|NCT02010255|18883931|P1|Overall Study|Randomized but Not Treated|0
5463219|NCT02010255|18883918|P14|Overall Study|Lost to Follow-up|0
5463220|NCT02010255|18883919|P13|Overall Study|Lost to Follow-up|0
5463221|NCT02010255|18883920|P12|Overall Study|Lost to Follow-up|0
5463222|NCT02010255|18883921|P11|Overall Study|Lost to Follow-up|0
5463223|NCT02010255|18883922|P10|Overall Study|Lost to Follow-up|0
5463224|NCT02010255|18883923|P9|Overall Study|Lost to Follow-up|0
5463225|NCT02010255|18883924|P8|Overall Study|Lost to Follow-up|0
5463226|NCT02010255|18883925|P7|Overall Study|Lost to Follow-up|0
5463227|NCT02010255|18883926|P6|Overall Study|Lost to Follow-up|0
5463228|NCT02010255|18883927|P5|Overall Study|Lost to Follow-up|1
5463229|NCT02010255|18883928|P4|Overall Study|Lost to Follow-up|0
5463230|NCT02010255|18883929|P3|Overall Study|Lost to Follow-up|1
5463231|NCT02010255|18883930|P2|Overall Study|Lost to Follow-up|0
5463232|NCT02010255|18883931|P1|Overall Study|Lost to Follow-up|0
5463233|NCT02010255|18883918|P14|Overall Study|Adverse Event|0
5463234|NCT02010255|18883919|P13|Overall Study|Adverse Event|0
5463235|NCT02010255|18883920|P12|Overall Study|Adverse Event|0
5463236|NCT02010255|18883921|P11|Overall Study|Adverse Event|0
5463237|NCT02010255|18883922|P10|Overall Study|Adverse Event|0
5463238|NCT02010255|18883923|P9|Overall Study|Adverse Event|0
5463239|NCT02010255|18883924|P8|Overall Study|Adverse Event|0
5463240|NCT02010255|18883925|P7|Overall Study|Adverse Event|0
5463241|NCT02010255|18883926|P6|Overall Study|Adverse Event|0
5463242|NCT02010255|18883927|P5|Overall Study|Adverse Event|0
5463243|NCT02010255|18883928|P4|Overall Study|Adverse Event|0
5463244|NCT02010255|18883929|P3|Overall Study|Adverse Event|0
5463245|NCT02010255|18883930|P2|Overall Study|Adverse Event|0
5463246|NCT02010255|18883931|P1|Overall Study|Adverse Event|1
5463247|NCT02010255|18883918|P14|Overall Study|Withdrew Consent|0
5463248|NCT02010255|18883919|P13|Overall Study|Withdrew Consent|0
5463249|NCT02010255|18883920|P12|Overall Study|Withdrew Consent|0
5463250|NCT02010255|18883921|P11|Overall Study|Withdrew Consent|0
5463251|NCT02010255|18883922|P10|Overall Study|Withdrew Consent|0
5463252|NCT02010255|18883923|P9|Overall Study|Withdrew Consent|0
5463253|NCT02010255|18883924|P8|Overall Study|Withdrew Consent|0
5463254|NCT02010255|18883925|P7|Overall Study|Withdrew Consent|0
5463255|NCT02010255|18883926|P6|Overall Study|Withdrew Consent|0
5463256|NCT02010255|18883927|P5|Overall Study|Withdrew Consent|0
5463257|NCT02010255|18883928|P4|Overall Study|Withdrew Consent|1
5463258|NCT02010255|18883929|P3|Overall Study|Withdrew Consent|0
5463259|NCT02010255|18883930|P2|Overall Study|Withdrew Consent|0
5463260|NCT02010255|18883931|P1|Overall Study|Withdrew Consent|1
5463261|NCT02010255|18883918|P14|Overall Study|Lack of Efficacy|0
5463262|NCT02010255|18883919|P13|Overall Study|Lack of Efficacy|0
5463263|NCT02010255|18883920|P12|Overall Study|Lack of Efficacy|0
5463264|NCT02010255|18883921|P11|Overall Study|Lack of Efficacy|1
5463265|NCT02010255|18883922|P10|Overall Study|Lack of Efficacy|0
5463266|NCT02010255|18883923|P9|Overall Study|Lack of Efficacy|0
5463267|NCT02010255|18883924|P8|Overall Study|Lack of Efficacy|0
5463268|NCT02010255|18883925|P7|Overall Study|Lack of Efficacy|0
5463269|NCT02010255|18883926|P6|Overall Study|Lack of Efficacy|0
5463270|NCT02010255|18883927|P5|Overall Study|Lack of Efficacy|1
5463271|NCT02010255|18883928|P4|Overall Study|Lack of Efficacy|1
5463272|NCT02010255|18883929|P3|Overall Study|Lack of Efficacy|2
5463273|NCT02010255|18883930|P2|Overall Study|Lack of Efficacy|1
5463274|NCT02010255|18883931|P1|Overall Study|Lack of Efficacy|4
5463275|NCT02010255|18883918|P14|Overall Study|Death|0
5463276|NCT02010255|18883919|P13|Overall Study|Death|0
5463277|NCT02010255|18883920|P12|Overall Study|Death|1
5463278|NCT02010255|18883921|P11|Overall Study|Death|1
5463279|NCT02010255|18883922|P10|Overall Study|Death|0
5463280|NCT02010255|18883923|P9|Overall Study|Death|1
5463281|NCT02010255|18883924|P8|Overall Study|Death|1
5463282|NCT02010255|18883925|P7|Overall Study|Death|1
5463283|NCT02010255|18883926|P6|Overall Study|Death|0
5463284|NCT02010255|18883927|P5|Overall Study|Death|2
5463285|NCT02010255|18883928|P4|Overall Study|Death|4
5463286|NCT02010255|18883929|P3|Overall Study|Death|4
5463287|NCT02010255|18883930|P2|Overall Study|Death|1
5463288|NCT02010255|18883931|P1|Overall Study|Death|0
5463289|NCT02009930|18884376|P1|Overall Study|withdrawn|5
5463290|NCT02009878|18884401|P3|Overall Study|Participant Met Withdrawal Criteria|0
5463291|NCT02009878|18884402|P2|Overall Study|Participant Met Withdrawal Criteria|1
5463292|NCT02009878|18884403|P1|Overall Study|Participant Met Withdrawal Criteria|0
5463293|NCT02009865|18884437|P2|Overall Study|Withdrawal by Subject|1
5463294|NCT02009865|18884438|P1|Overall Study|Withdrawal by Subject|1
5463295|NCT02009865|18884437|P2|Overall Study|Protocol Violation|2
5463296|NCT02009865|18884438|P1|Overall Study|Protocol Violation|0
5463297|NCT02009865|18884437|P2|Overall Study|Adverse Event|2
5463298|NCT02009865|18884438|P1|Overall Study|Adverse Event|0
5463299|NCT02009722|18884454|P2|Overall Study|Did not receive intervention|1
5463300|NCT02009722|18884455|P1|Overall Study|Did not receive intervention|0
5463301|NCT02009722|18884454|P2|Overall Study|Protocol Violation|2
5463302|NCT02009722|18884455|P1|Overall Study|Protocol Violation|1
5463303|NCT02009696|18884479|P1|Overall Study|Withdrawal by Subject|2
5463304|NCT02009163|18884496|P3|Randomized-withdrawal Period|Other|5
5463305|NCT02009163|18884497|P2|Randomized-withdrawal Period|Other|9
5463306|NCT02009163|18884498|P1|Randomized-withdrawal Period|Other|0
5463307|NCT02009163|18884496|P3|Randomized-withdrawal Period|Pregnancy|2
5463308|NCT02009163|18884497|P2|Randomized-withdrawal Period|Pregnancy|0
5463309|NCT02009163|18884498|P1|Randomized-withdrawal Period|Pregnancy|0
5463310|NCT02009163|18884496|P3|Randomized-withdrawal Period|Protocol Violation|2
5463311|NCT02009163|18884497|P2|Randomized-withdrawal Period|Protocol Violation|1
5463312|NCT02009163|18884498|P1|Randomized-withdrawal Period|Protocol Violation|0
5463313|NCT02009163|18884496|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
5463314|NCT02009163|18884497|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
5463315|NCT02009163|18884498|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
5463316|NCT02009163|18884496|P3|Randomized-withdrawal Period|Adverse Event|6
5463317|NCT02009163|18884497|P2|Randomized-withdrawal Period|Adverse Event|0
5463318|NCT02009163|18884498|P1|Randomized-withdrawal Period|Adverse Event|0
5463319|NCT02009163|18884496|P3|Randomized-withdrawal Period|Lost to Follow-up|6
5463320|NCT02009163|18884497|P2|Randomized-withdrawal Period|Lost to Follow-up|13
5463321|NCT02009163|18884498|P1|Randomized-withdrawal Period|Lost to Follow-up|0
5463322|NCT02009163|18884496|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
5463323|NCT02009163|18884497|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
5463324|NCT02009163|18884498|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
5463325|NCT02009163|18884496|P3|Open-label Period (Non-randomized)|Other|0
5463326|NCT02009163|18884497|P2|Open-label Period (Non-randomized)|Other|0
5463327|NCT02009163|18884498|P1|Open-label Period (Non-randomized)|Other|13
5463328|NCT02009163|18884496|P3|Open-label Period (Non-randomized)|Pregnancy|0
5463329|NCT02009163|18884497|P2|Open-label Period (Non-randomized)|Pregnancy|0
5463330|NCT02009163|18884498|P1|Open-label Period (Non-randomized)|Pregnancy|1
5463331|NCT02009163|18884496|P3|Open-label Period (Non-randomized)|Protocol Violation|0
5463332|NCT02009163|18884497|P2|Open-label Period (Non-randomized)|Protocol Violation|0
5463333|NCT02009163|18884498|P1|Open-label Period (Non-randomized)|Protocol Violation|10
5463334|NCT02009163|18884496|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
5463335|NCT02009163|18884497|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
5463336|NCT02009163|18884498|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
5463337|NCT02009163|18884496|P3|Open-label Period (Non-randomized)|Adverse Event|0
5463338|NCT02009163|18884497|P2|Open-label Period (Non-randomized)|Adverse Event|0
5463339|NCT02009163|18884498|P1|Open-label Period (Non-randomized)|Adverse Event|22
5463340|NCT02009163|18884496|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
5463341|NCT02009163|18884497|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
5463342|NCT02009163|18884498|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
5463343|NCT02009163|18884496|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
5463344|NCT02009163|18884497|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
5463345|NCT02009163|18884498|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
5463346|NCT02009046|18884533|P2|Overall Study|Lost to Follow-up|206
5463347|NCT02009046|18884534|P1|Overall Study|Lost to Follow-up|256
5463348|NCT02008916|18884594|P3|Week 16 - 156|Physician Decision|0
5463349|NCT02008916|18884595|P2|Week 16 - 156|Physician Decision|1
5463350|NCT02008916|18884596|P1|Week 16 - 156|Physician Decision|0
5463351|NCT02008916|18884594|P3|Week 16 - 156|Pregnancy|0
5463352|NCT02008916|18884595|P2|Week 16 - 156|Pregnancy|1
5463353|NCT02008916|18884596|P1|Week 16 - 156|Pregnancy|0
5463354|NCT02008916|18884594|P3|Week 16 - 156|Lack of Efficacy|2
5463355|NCT02008916|18884595|P2|Week 16 - 156|Lack of Efficacy|5
5463356|NCT02008916|18884596|P1|Week 16 - 156|Lack of Efficacy|3
5463357|NCT02008916|18884594|P3|Week 16 - 156|Lost to Follow-up|0
5463358|NCT02008916|18884595|P2|Week 16 - 156|Lost to Follow-up|0
5463359|NCT02008916|18884596|P1|Week 16 - 156|Lost to Follow-up|5
5463360|NCT02008916|18884594|P3|Week 16 - 156|No longer requires treatment|0
5463361|NCT02008916|18884595|P2|Week 16 - 156|No longer requires treatment|1
5463362|NCT02008916|18884596|P1|Week 16 - 156|No longer requires treatment|0
5463363|NCT02008916|18884594|P3|Week 16 - 156|Withdrawal by Subject|5
5463364|NCT02008916|18884595|P2|Week 16 - 156|Withdrawal by Subject|3
5463365|NCT02008916|18884596|P1|Week 16 - 156|Withdrawal by Subject|7
5463366|NCT02008916|18884594|P3|Week 16 - 156|Adverse Event|3
5463367|NCT02008916|18884595|P2|Week 16 - 156|Adverse Event|2
5463368|NCT02008916|18884596|P1|Week 16 - 156|Adverse Event|4
5463369|NCT02008916|18884594|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
5463370|NCT02008916|18884595|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
5463371|NCT02008916|18884596|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
5463372|NCT02008890|18884632|P5|Extension Period|Adverse Event|2
5463373|NCT02008890|18884633|P4|Extension Period|Adverse Event|0
5463374|NCT02008890|18884634|P3|Extension Period|Adverse Event|0
5463375|NCT02008890|18884635|P2|Extension Period|Adverse Event|3
5463376|NCT02008890|18884636|P1|Extension Period|Adverse Event|1
5463377|NCT02008890|18884632|P5|Extension Period|Lost to Follow-up|0
5463378|NCT02008890|18884633|P4|Extension Period|Lost to Follow-up|0
5463379|NCT02008890|18884634|P3|Extension Period|Lost to Follow-up|0
5463380|NCT02008890|18884635|P2|Extension Period|Lost to Follow-up|0
5463381|NCT02008890|18884636|P1|Extension Period|Lost to Follow-up|1
5463382|NCT02008890|18884632|P5|Extension Period|Withdrawal by Subject|2
5463383|NCT02008890|18884633|P4|Extension Period|Withdrawal by Subject|4
5463384|NCT02008890|18884634|P3|Extension Period|Withdrawal by Subject|0
5463385|NCT02008890|18884635|P2|Extension Period|Withdrawal by Subject|2
5463386|NCT02008890|18884636|P1|Extension Period|Withdrawal by Subject|3
5463387|NCT02008890|18884632|P5|Period 2|Lost to Follow-up|0
5463388|NCT02008890|18884633|P4|Period 2|Lost to Follow-up|0
5463389|NCT02008890|18884634|P3|Period 2|Lost to Follow-up|1
5463390|NCT02008890|18884635|P2|Period 2|Lost to Follow-up|0
5463391|NCT02008890|18884636|P1|Period 2|Lost to Follow-up|0
5463392|NCT02008890|18884632|P5|Period 2|Physician Decision|1
5463393|NCT02008890|18884633|P4|Period 2|Physician Decision|2
5463394|NCT02008890|18884634|P3|Period 2|Physician Decision|0
5463395|NCT02008890|18884635|P2|Period 2|Physician Decision|0
5463396|NCT02008890|18884636|P1|Period 2|Physician Decision|4
5463397|NCT02008890|18884632|P5|Period 2|Withdrawal by Subject|2
5463398|NCT02008890|18884633|P4|Period 2|Withdrawal by Subject|7
5463399|NCT02008890|18884634|P3|Period 2|Withdrawal by Subject|0
5463400|NCT02008890|18884635|P2|Period 2|Withdrawal by Subject|8
5463401|NCT02008890|18884636|P1|Period 2|Withdrawal by Subject|11
5463402|NCT02008890|18884632|P5|Period 2|Adverse Event|5
5463403|NCT02008890|18884633|P4|Period 2|Adverse Event|5
5463404|NCT02008890|18884634|P3|Period 2|Adverse Event|0
5463405|NCT02008890|18884635|P2|Period 2|Adverse Event|7
5463406|NCT02008890|18884636|P1|Period 2|Adverse Event|12
5463407|NCT02008890|18884632|P5|Period 1|Adverse Event|0
5463408|NCT02008890|18884633|P4|Period 1|Adverse Event|0
5463409|NCT02008890|18884634|P3|Period 1|Adverse Event|6
5463410|NCT02008890|18884635|P2|Period 1|Adverse Event|8
5463411|NCT02008890|18884636|P1|Period 1|Adverse Event|6
5463412|NCT02008890|18884632|P5|Period 1|Physician Decision|0
5463413|NCT02008890|18884633|P4|Period 1|Physician Decision|0
5463414|NCT02008890|18884634|P3|Period 1|Physician Decision|1
5463415|NCT02008890|18884635|P2|Period 1|Physician Decision|0
5463416|NCT02008890|18884636|P1|Period 1|Physician Decision|1
5463417|NCT02008890|18884632|P5|Period 1|Pregnancy|0
5463418|NCT02008890|18884633|P4|Period 1|Pregnancy|0
5463419|NCT02008890|18884634|P3|Period 1|Pregnancy|0
5463420|NCT02008890|18884635|P2|Period 1|Pregnancy|0
5463421|NCT02008890|18884636|P1|Period 1|Pregnancy|1
5463422|NCT02008890|18884632|P5|Period 1|Withdrawal by Subject|0
5463423|NCT02008890|18884633|P4|Period 1|Withdrawal by Subject|0
5463424|NCT02008890|18884634|P3|Period 1|Withdrawal by Subject|5
5463425|NCT02008890|18884635|P2|Period 1|Withdrawal by Subject|7
5463426|NCT02008890|18884636|P1|Period 1|Withdrawal by Subject|7
5463427|NCT02008877|18884672|P3|Overall Study|Inevaluable|0
5463428|NCT02008877|18884673|P2|Overall Study|Inevaluable|1
5463429|NCT02008877|18884674|P1|Overall Study|Inevaluable|0
5463430|NCT02008773|18884693|P4|Overall Study|Lost to Follow-up|2
5463431|NCT02008773|18884694|P3|Overall Study|Lost to Follow-up|3
5463432|NCT02008773|18884695|P2|Overall Study|Lost to Follow-up|1
5463433|NCT02008773|18884696|P1|Overall Study|Lost to Follow-up|0
5463434|NCT02008773|18884693|P4|Overall Study|Withdrawal by Subject|6
5463435|NCT02008773|18884694|P3|Overall Study|Withdrawal by Subject|7
5463436|NCT02008773|18884695|P2|Overall Study|Withdrawal by Subject|4
5463437|NCT02008773|18884696|P1|Overall Study|Withdrawal by Subject|8
5463438|NCT02008773|18884693|P4|Overall Study|Medication Non-compliance|2
5463439|NCT02008773|18884694|P3|Overall Study|Medication Non-compliance|3
5463440|NCT02008773|18884695|P2|Overall Study|Medication Non-compliance|1
5463441|NCT02008773|18884696|P1|Overall Study|Medication Non-compliance|2
5463442|NCT02008773|18884693|P4|Overall Study|Adverse Event|2
5463443|NCT02008773|18884694|P3|Overall Study|Adverse Event|1
5463444|NCT02008773|18884695|P2|Overall Study|Adverse Event|3
5463445|NCT02008773|18884696|P1|Overall Study|Adverse Event|3
5463446|NCT02008565|18884762|P4|Overall Study|Protocol Violation|0
5463447|NCT02008565|18884763|P3|Overall Study|Protocol Violation|2
5463448|NCT02008565|18884764|P2|Overall Study|Protocol Violation|1
5463449|NCT02008565|18884765|P1|Overall Study|Protocol Violation|1
5463450|NCT02008526|18884826|P3|Overall Study|Lost to Follow-up|6
5463451|NCT02008526|18884827|P2|Overall Study|Lost to Follow-up|9
5463452|NCT02008526|18884828|P1|Overall Study|Lost to Follow-up|5
5463453|NCT02008526|18884826|P3|Overall Study|Withdrawal by Subject|2
5463454|NCT02008526|18884827|P2|Overall Study|Withdrawal by Subject|3
5463455|NCT02008526|18884828|P1|Overall Study|Withdrawal by Subject|3
5463456|NCT02008526|18884826|P3|Overall Study|Death|1
5463457|NCT02008526|18884827|P2|Overall Study|Death|2
5463458|NCT02008526|18884828|P1|Overall Study|Death|0
5463459|NCT02008396|18884841|P2|Overall Study|Protocol Violation|1
5463460|NCT02008396|18884842|P1|Overall Study|Protocol Violation|0
5463461|NCT02008370|18884852|P1|Overall Study|Lost to Follow-up|7
5463462|NCT02008318|18884860|P2|Overall Study|Withdrawal by Subject|0
5463463|NCT02008318|18884861|P1|Overall Study|Withdrawal by Subject|3
5463464|NCT02008318|18884860|P2|Overall Study|Protocol Violation|1
5463465|NCT02008318|18884861|P1|Overall Study|Protocol Violation|1
5463466|NCT02008318|18884860|P2|Overall Study|Progressive Disease|0
5463467|NCT02008318|18884861|P1|Overall Study|Progressive Disease|2
5463468|NCT02008318|18884860|P2|Overall Study|Physician Decision|0
5463469|NCT02008318|18884861|P1|Overall Study|Physician Decision|2
5463470|NCT02008318|18884860|P2|Overall Study|Adverse Event|0
5463471|NCT02008318|18884861|P1|Overall Study|Adverse Event|4
5463472|NCT02008227|18884882|P2|Overall Study|Study Terminated By Sponsor|83
5463473|NCT02008227|18884883|P1|Overall Study|Study Terminated By Sponsor|44
5463474|NCT02008227|18884882|P2|Overall Study|Withdrawal by Subject|36
5463475|NCT02008227|18884883|P1|Overall Study|Withdrawal by Subject|67
5463476|NCT02008227|18884882|P2|Overall Study|Death|485
5463477|NCT02008227|18884883|P1|Overall Study|Death|494
5463478|NCT02008227|18884882|P2|Overall Study|Lost to Follow-up|9
5463479|NCT02008227|18884883|P1|Overall Study|Lost to Follow-up|7
5463480|NCT02007954|18884971|P1|Overall Study|Death|1
5463481|NCT02007954|18884971|P1|Overall Study|Disease progression and unrelated AE|1
5463482|NCT02007954|18884971|P1|Overall Study|Switch in treatment modality|2
5463483|NCT02007954|18884971|P1|Overall Study|Received liver transplant|3
5463484|NCT02007720|18884990|P2|Overall Study|patient followd less than 165 days|5
5463485|NCT02007720|18884991|P1|Overall Study|patient followd less than 165 days|11
5463486|NCT02007720|18884990|P2|Overall Study|technical problem|2
5463487|NCT02007720|18884991|P1|Overall Study|technical problem|4
5463488|NCT02007720|18884990|P2|Overall Study|study terminated by sponsor|54
5463489|NCT02007720|18884991|P1|Overall Study|study terminated by sponsor|58
5463490|NCT02007720|18884990|P2|Overall Study|Withdrawal by Subject|11
5463491|NCT02007720|18884991|P1|Overall Study|Withdrawal by Subject|9
5463492|NCT02007577|18885026|P2|Overall Study|Withdrawal by Subject|1
5463493|NCT02007577|18885027|P1|Overall Study|Withdrawal by Subject|0
5463494|NCT02007577|18885026|P2|Overall Study|Adverse Event|0
5463495|NCT02007577|18885027|P1|Overall Study|Adverse Event|1
5463496|NCT02007512|18885039|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
5463497|NCT02007512|18885040|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
5463498|NCT02007512|18885041|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
5463499|NCT02007512|18885042|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
5463500|NCT02007512|18885039|P4|Open Label Treatment Period|Disease progression|11
5463501|NCT02007512|18885040|P3|Open Label Treatment Period|Disease progression|0
5463502|NCT02007512|18885041|P2|Open Label Treatment Period|Disease progression|17
5463503|NCT02007512|18885042|P1|Open Label Treatment Period|Disease progression|0
5463504|NCT02007512|18885039|P4|Open Label Treatment Period|Other|1
5463505|NCT02007512|18885040|P3|Open Label Treatment Period|Other|0
5463506|NCT02007512|18885041|P2|Open Label Treatment Period|Other|0
5463507|NCT02007512|18885042|P1|Open Label Treatment Period|Other|0
5463508|NCT02007512|18885039|P4|Open Label Treatment Period|Adverse Event|0
5463509|NCT02007512|18885040|P3|Open Label Treatment Period|Adverse Event|0
5463510|NCT02007512|18885041|P2|Open Label Treatment Period|Adverse Event|1
5463511|NCT02007512|18885042|P1|Open Label Treatment Period|Adverse Event|0
5463512|NCT02007512|18885039|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
5463513|NCT02007512|18885040|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
5463514|NCT02007512|18885041|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
5463515|NCT02007512|18885042|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
5463516|NCT02007512|18885039|P4|Double Blind Treatment Period|Other|2
5463517|NCT02007512|18885040|P3|Double Blind Treatment Period|Other|1
5463518|NCT02007512|18885041|P2|Double Blind Treatment Period|Other|0
5463519|NCT02007512|18885042|P1|Double Blind Treatment Period|Other|0
5463520|NCT02007512|18885039|P4|Double Blind Treatment Period|Protocol Violation|1
5463521|NCT02007512|18885040|P3|Double Blind Treatment Period|Protocol Violation|0
5463522|NCT02007512|18885041|P2|Double Blind Treatment Period|Protocol Violation|0
5463523|NCT02007512|18885042|P1|Double Blind Treatment Period|Protocol Violation|0
5463524|NCT02007512|18885039|P4|Double Blind Treatment Period|Withdrawal by Subject|3
5463525|NCT02007512|18885040|P3|Double Blind Treatment Period|Withdrawal by Subject|3
5463526|NCT02007512|18885041|P2|Double Blind Treatment Period|Withdrawal by Subject|2
5463527|NCT02007512|18885042|P1|Double Blind Treatment Period|Withdrawal by Subject|4
5463528|NCT02007512|18885039|P4|Double Blind Treatment Period|Disease progression|51
5463529|NCT02007512|18885040|P3|Double Blind Treatment Period|Disease progression|45
5463530|NCT02007512|18885041|P2|Double Blind Treatment Period|Disease progression|49
5463531|NCT02007512|18885042|P1|Double Blind Treatment Period|Disease progression|44
5463532|NCT02007512|18885039|P4|Double Blind Treatment Period|Death|0
5463533|NCT02007512|18885040|P3|Double Blind Treatment Period|Death|0
5463534|NCT02007512|18885041|P2|Double Blind Treatment Period|Death|0
5463535|NCT02007512|18885042|P1|Double Blind Treatment Period|Death|1
5463536|NCT02007512|18885039|P4|Double Blind Treatment Period|Adverse Event|2
5463537|NCT02007512|18885040|P3|Double Blind Treatment Period|Adverse Event|6
5463538|NCT02007512|18885041|P2|Double Blind Treatment Period|Adverse Event|2
5463539|NCT02007512|18885042|P1|Double Blind Treatment Period|Adverse Event|4
5463540|NCT02007434|18885120|P8|Overall Study|Non-compliance|0
5463541|NCT02007434|18885121|P7|Overall Study|Non-compliance|0
5463542|NCT02007434|18885122|P6|Overall Study|Non-compliance|0
5463543|NCT02007434|18885123|P5|Overall Study|Non-compliance|0
5463544|NCT02007434|18885124|P4|Overall Study|Non-compliance|0
5463545|NCT02007434|18885125|P3|Overall Study|Non-compliance|1
5463546|NCT02007434|18885126|P2|Overall Study|Non-compliance|0
5463547|NCT02007434|18885127|P1|Overall Study|Non-compliance|1
5463548|NCT02007434|18885120|P8|Overall Study|Lost to Follow-up|0
5463549|NCT02007434|18885121|P7|Overall Study|Lost to Follow-up|0
5463550|NCT02007434|18885122|P6|Overall Study|Lost to Follow-up|0
5463551|NCT02007434|18885123|P5|Overall Study|Lost to Follow-up|0
5463552|NCT02007434|18885124|P4|Overall Study|Lost to Follow-up|0
5463553|NCT02007434|18885125|P3|Overall Study|Lost to Follow-up|0
5463554|NCT02007434|18885126|P2|Overall Study|Lost to Follow-up|1
5463555|NCT02007434|18885127|P1|Overall Study|Lost to Follow-up|0
5463556|NCT02007278|18885258|P2|Overall Study|Mis-randomization|1
5463557|NCT02007278|18885259|P1|Overall Study|Mis-randomization|1
5463558|NCT02007278|18885258|P2|Overall Study|Incorrect medication administration|0
5463559|NCT02007278|18885259|P1|Overall Study|Incorrect medication administration|1
5463560|NCT02007278|18885258|P2|Overall Study|Ingestion of drugs not allowed in study|1
5463561|NCT02007278|18885259|P1|Overall Study|Ingestion of drugs not allowed in study|0
5463562|NCT02007278|18885258|P2|Overall Study|Failure to comply with an eligibility|1
5463563|NCT02007278|18885259|P1|Overall Study|Failure to comply with an eligibility|0
5463564|NCT02007252|18885281|P2|Overall Study|Adverse Event|4
5463565|NCT02007252|18885282|P1|Overall Study|Adverse Event|7
5463566|NCT02007252|18885281|P2|Overall Study|Abnormal laboratory value(s)|0
5463567|NCT02007252|18885282|P1|Overall Study|Abnormal laboratory value(s)|1
5463568|NCT02007252|18885281|P2|Overall Study|Administrative problems|7
5463569|NCT02007252|18885282|P1|Overall Study|Administrative problems|3
5463570|NCT02007109|18885295|P1|Overall Study|Excluded - Age<7yo|9
5463571|NCT02007109|18885295|P1|Overall Study|Diary not returned or excluded|102
5463572|NCT02007096|18885304|P2|Overall Study|no mesh placed|1
5463573|NCT02007096|18885305|P1|Overall Study|no mesh placed|0
5463574|NCT02007096|18885304|P2|Overall Study|converted to open surgery|1
5463575|NCT02007096|18885305|P1|Overall Study|converted to open surgery|1
5463576|NCT02007096|18885304|P2|Overall Study|did not follow postoperative protocol|11
5463577|NCT02007096|18885305|P1|Overall Study|did not follow postoperative protocol|8
5463578|NCT02007096|18885304|P2|Overall Study|did not inject saline|3
5463579|NCT02007096|18885305|P1|Overall Study|did not inject saline|0
5463580|NCT02007096|18885304|P2|Overall Study|medication not available|0
5463581|NCT02007096|18885305|P1|Overall Study|medication not available|2
5463582|NCT02007070|18885317|P1|Overall Study|Progressive Disease|21
5463583|NCT02007070|18885317|P1|Overall Study|Physician Decision|1
5463584|NCT02007070|18885317|P1|Overall Study|Protocol Violation|2
5463585|NCT02007070|18885317|P1|Overall Study|Death|1
5463586|NCT02007070|18885317|P1|Overall Study|Clinical Progression|4
5463587|NCT02007070|18885317|P1|Overall Study|Adverse Event|4
5463588|NCT02006979|18885338|P2|Overall Study|Protocol Violation|1
5463589|NCT02006979|18885339|P1|Overall Study|Protocol Violation|0
5463590|NCT02006979|18885338|P2|Overall Study|Withdrawal by Subject|1
5463591|NCT02006979|18885339|P1|Overall Study|Withdrawal by Subject|1
5463592|NCT02006927|18885351|P1|Overall Study|Withdrawal by Subject|1
5463593|NCT02006927|18885351|P1|Overall Study|Adverse Event|2
5463594|NCT02006758|18885390|P1|Overall Study|Other|2
5463595|NCT02006758|18885390|P1|Overall Study|Procedurally excluded|1
5463596|NCT02006758|18885390|P1|Overall Study|Withdrawal by Subject|4
5463597|NCT02006758|18885390|P1|Overall Study|Lost to Follow-up|4
5463598|NCT02006758|18885390|P1|Overall Study|Death|1
5463599|NCT02006758|18885390|P1|Overall Study|Protocol Violation|1
5463600|NCT02006732|18885421|P4|Overall Study|Withdrawal by Subject|1
5463601|NCT02006732|18885422|P3|Overall Study|Withdrawal by Subject|4
5463602|NCT02006732|18885423|P2|Overall Study|Withdrawal by Subject|0
5463603|NCT02006732|18885424|P1|Overall Study|Withdrawal by Subject|3
5463604|NCT02006732|18885421|P4|Overall Study|Lost to Follow-up|0
5463605|NCT02006732|18885422|P3|Overall Study|Lost to Follow-up|0
5463606|NCT02006732|18885423|P2|Overall Study|Lost to Follow-up|1
5463607|NCT02006732|18885424|P1|Overall Study|Lost to Follow-up|0
5463608|NCT02006732|18885421|P4|Overall Study|Protocol Violation|0
5463609|NCT02006732|18885422|P3|Overall Study|Protocol Violation|0
5463610|NCT02006732|18885423|P2|Overall Study|Protocol Violation|1
5463611|NCT02006732|18885424|P1|Overall Study|Protocol Violation|1
5463612|NCT02006732|18885421|P4|Overall Study|Lack of Efficacy|1
5463613|NCT02006732|18885422|P3|Overall Study|Lack of Efficacy|1
5463614|NCT02006732|18885423|P2|Overall Study|Lack of Efficacy|3
5463615|NCT02006732|18885424|P1|Overall Study|Lack of Efficacy|6
5463616|NCT02006732|18885421|P4|Overall Study|Adverse Event|2
5463617|NCT02006732|18885422|P3|Overall Study|Adverse Event|4
5463618|NCT02006732|18885423|P2|Overall Study|Adverse Event|7
5463619|NCT02006732|18885424|P1|Overall Study|Adverse Event|10
5463620|NCT02006719|18885464|P2|Overall Study|Other/Unknown|1
5463621|NCT02006719|18885465|P1|Overall Study|Other/Unknown|0
5463622|NCT02006719|18885464|P2|Overall Study|Adverse Event|1
5463623|NCT02006719|18885465|P1|Overall Study|Adverse Event|1
5463624|NCT02006719|18885464|P2|Overall Study|Protocol Violation|0
5463625|NCT02006719|18885465|P1|Overall Study|Protocol Violation|2
5463626|NCT02006719|18885464|P2|Overall Study|Lost to Follow-up|1
5463627|NCT02006719|18885465|P1|Overall Study|Lost to Follow-up|5
5463628|NCT02006719|18885464|P2|Overall Study|Withdrawal by Subject|2
5463629|NCT02006719|18885465|P1|Overall Study|Withdrawal by Subject|10
5463630|NCT02006706|18885495|P1|Overall Study|Lost to Follow-up|1
5463631|NCT02006693|18885502|P2|Overall Study|Patient Decision|0
5463632|NCT02006693|18885503|P1|Overall Study|Patient Decision|4
5463633|NCT02006693|18885502|P2|Overall Study|Lost to Follow-up|1
5463634|NCT02006693|18885503|P1|Overall Study|Lost to Follow-up|4
5463635|NCT02006693|18885502|P2|Overall Study|Death|2
5463636|NCT02006693|18885503|P1|Overall Study|Death|2
5463637|NCT02006693|18885502|P2|Overall Study|XEN Implant Explantation|1
5463638|NCT02006693|18885503|P1|Overall Study|XEN Implant Explantation|0
5463639|NCT02006693|18885502|P2|Overall Study|Another Glaucoma-related Surgery|1
5463640|NCT02006693|18885503|P1|Overall Study|Another Glaucoma-related Surgery|12
5463641|NCT02006693|18885502|P2|Overall Study|No Reason Specified|8
5463642|NCT02006693|18885503|P1|Overall Study|No Reason Specified|6
5463643|NCT02006667|18885515|P1|Overall Study|Withdrawal by Subject|1
5463644|NCT02006667|18885515|P1|Overall Study|Death|2
5463645|NCT02006667|18885515|P1|Overall Study|Adverse Event|3
5463646|NCT02006654|18885527|P2|Overall Study|moving out of state|1
5463647|NCT02006654|18885528|P1|Overall Study|moving out of state|0
5463648|NCT02006654|18885527|P2|Overall Study|disallowed medication|0
5463649|NCT02006654|18885528|P1|Overall Study|disallowed medication|1
5463650|NCT02006654|18885527|P2|Overall Study|mood disorder|1
5463651|NCT02006654|18885528|P1|Overall Study|mood disorder|0
5463652|NCT02006654|18885527|P2|Overall Study|faecal incontinence|1
5463653|NCT02006654|18885528|P1|Overall Study|faecal incontinence|0
5463654|NCT02006654|18885527|P2|Overall Study|worsening cognitive condition|1
5463655|NCT02006654|18885528|P1|Overall Study|worsening cognitive condition|0
5463656|NCT02006654|18885527|P2|Overall Study|insufficient compliance|0
5463657|NCT02006654|18885528|P1|Overall Study|insufficient compliance|1
5463658|NCT02006654|18885527|P2|Overall Study|patient's will|1
5463659|NCT02006654|18885528|P1|Overall Study|patient's will|2
5463660|NCT02006654|18885527|P2|Overall Study|Lost to Follow-up|0
5463661|NCT02006654|18885528|P1|Overall Study|Lost to Follow-up|1
5463662|NCT02006654|18885527|P2|Overall Study|Protocol Violation|8
5463663|NCT02006654|18885528|P1|Overall Study|Protocol Violation|5
5463664|NCT02006654|18885527|P2|Overall Study|Withdrawal by Subject|12
5463665|NCT02006654|18885528|P1|Overall Study|Withdrawal by Subject|14
5463666|NCT02006654|18885527|P2|Overall Study|Death|0
5463667|NCT02006654|18885528|P1|Overall Study|Death|1
5463668|NCT02006654|18885527|P2|Overall Study|Adverse Event|17
5463669|NCT02006654|18885528|P1|Overall Study|Adverse Event|16
5463670|NCT02006654|18885527|P2|Overall Study|Withdrawal before treatment|2
5463671|NCT02006654|18885528|P1|Overall Study|Withdrawal before treatment|4
5463672|NCT02006641|18885557|P3|Overall Study|Other reason: protocol non-compliance|1
5463673|NCT02006641|18885558|P2|Overall Study|Other reason: protocol non-compliance|0
5463674|NCT02006641|18885559|P1|Overall Study|Other reason: protocol non-compliance|0
5463675|NCT02006641|18885557|P3|Overall Study|Other reason: caregiver impossibility|1
5463676|NCT02006641|18885558|P2|Overall Study|Other reason: caregiver impossibility|0
5463677|NCT02006641|18885559|P1|Overall Study|Other reason: caregiver impossibility|0
5463678|NCT02006641|18885557|P3|Overall Study|Other reason: hospitalisation|0
5463679|NCT02006641|18885558|P2|Overall Study|Other reason: hospitalisation|1
5463680|NCT02006641|18885559|P1|Overall Study|Other reason: hospitalisation|0
5463681|NCT02006641|18885557|P3|Overall Study|Other reason: patient's wife has died|1
5463682|NCT02006641|18885558|P2|Overall Study|Other reason: patient's wife has died|0
5463683|NCT02006641|18885559|P1|Overall Study|Other reason: patient's wife has died|0
5463684|NCT02006641|18885557|P3|Overall Study|Other reason: caregiver in hospital|0
5463685|NCT02006641|18885558|P2|Overall Study|Other reason: caregiver in hospital|1
5463686|NCT02006641|18885559|P1|Overall Study|Other reason: caregiver in hospital|0
5463687|NCT02006641|18885557|P3|Overall Study|Other reason: patient has moved|1
5463688|NCT02006641|18885558|P2|Overall Study|Other reason: patient has moved|0
5463689|NCT02006641|18885559|P1|Overall Study|Other reason: patient has moved|1
5463690|NCT02006641|18885557|P3|Overall Study|Other reason:patient didn't want to come|1
5463691|NCT02006641|18885558|P2|Overall Study|Other reason:patient didn't want to come|0
5463692|NCT02006641|18885559|P1|Overall Study|Other reason:patient didn't want to come|0
5463693|NCT02006641|18885557|P3|Overall Study|Other reason: patient didn't show up|0
5463694|NCT02006641|18885558|P2|Overall Study|Other reason: patient didn't show up|0
5463695|NCT02006641|18885559|P1|Overall Study|Other reason: patient didn't show up|1
5463696|NCT02006641|18885557|P3|Overall Study|Withdrawal by Subject|11
5463697|NCT02006641|18885558|P2|Overall Study|Withdrawal by Subject|12
5463698|NCT02006641|18885559|P1|Overall Study|Withdrawal by Subject|7
5463699|NCT02006641|18885557|P3|Overall Study|Lost to Follow-up|0
5463700|NCT02006641|18885558|P2|Overall Study|Lost to Follow-up|1
5463701|NCT02006641|18885559|P1|Overall Study|Lost to Follow-up|0
5463702|NCT02006641|18885557|P3|Overall Study|Protocol Violation|2
5463703|NCT02006641|18885558|P2|Overall Study|Protocol Violation|2
5463704|NCT02006641|18885559|P1|Overall Study|Protocol Violation|0
5463705|NCT02006641|18885557|P3|Overall Study|Adverse Event|15
5463706|NCT02006641|18885558|P2|Overall Study|Adverse Event|11
5463707|NCT02006641|18885559|P1|Overall Study|Adverse Event|15
5463708|NCT02006641|18885557|P3|Overall Study|Withdrawal before treatment|3
5463709|NCT02006641|18885558|P2|Overall Study|Withdrawal before treatment|5
5463710|NCT02006641|18885559|P1|Overall Study|Withdrawal before treatment|2
5463711|NCT02006628|18885599|P2|Overall Study|Withdrawal by Subject|1
5463712|NCT02006628|18885600|P1|Overall Study|Withdrawal by Subject|2
5463713|NCT02006628|18885599|P2|Overall Study|Adverse Event|1
5463714|NCT02006628|18885600|P1|Overall Study|Adverse Event|1
5463715|NCT02006576|18885625|P3|Overall Study|Screen Failure, too sick, other|13
5463716|NCT02006576|18885626|P2|Overall Study|Screen Failure, too sick, other|1
5463717|NCT02006576|18885627|P1|Overall Study|Screen Failure, too sick, other|13
5463718|NCT02006576|18885625|P3|Overall Study|Lost to Follow-up|1
5463719|NCT02006576|18885626|P2|Overall Study|Lost to Follow-up|0
5463720|NCT02006576|18885627|P1|Overall Study|Lost to Follow-up|1
5463721|NCT02006576|18885625|P3|Overall Study|Death|1
5463722|NCT02006576|18885626|P2|Overall Study|Death|0
5463723|NCT02006576|18885627|P1|Overall Study|Death|0
5463724|NCT02006576|18885625|P3|Overall Study|Withdrawal by Subject|2
5463725|NCT02006576|18885626|P2|Overall Study|Withdrawal by Subject|6
5463726|NCT02006576|18885627|P1|Overall Study|Withdrawal by Subject|4
5463727|NCT02006121|18885710|P2|Open Label Phase|Non-compliance with study drug|0
5463728|NCT02006121|18885711|P1|Open Label Phase|Non-compliance with study drug|3
5463729|NCT02006121|18885710|P2|Open Label Phase|Withdrawal by Subject|0
5463730|NCT02006121|18885711|P1|Open Label Phase|Withdrawal by Subject|3
5463731|NCT02006121|18885710|P2|Open Label Phase|Protocol Violation|0
5463732|NCT02006121|18885711|P1|Open Label Phase|Protocol Violation|2
5463733|NCT02006121|18885710|P2|Open Label Phase|Lack of Efficacy|0
5463734|NCT02006121|18885711|P1|Open Label Phase|Lack of Efficacy|2
5463735|NCT02006121|18885710|P2|Open Label Phase|Adverse Event|0
5463736|NCT02006121|18885711|P1|Open Label Phase|Adverse Event|15
5463737|NCT02006121|18885710|P2|Double Blind Phase|Inconvenience of infusion system|1
5463738|NCT02006121|18885711|P1|Double Blind Phase|Inconvenience of infusion system|0
5463739|NCT02006121|18885710|P2|Double Blind Phase|Minimum infusion rate poorly tolerated|0
5463740|NCT02006121|18885711|P1|Double Blind Phase|Minimum infusion rate poorly tolerated|1
5463741|NCT02006121|18885710|P2|Double Blind Phase|Non-compliance with study drug|3
5463742|NCT02006121|18885711|P1|Double Blind Phase|Non-compliance with study drug|1
5463743|NCT02006121|18885710|P2|Double Blind Phase|Withdrawal by Subject|4
5463744|NCT02006121|18885711|P1|Double Blind Phase|Withdrawal by Subject|3
5463745|NCT02006121|18885710|P2|Double Blind Phase|Lack of Efficacy|16
5463746|NCT02006121|18885711|P1|Double Blind Phase|Lack of Efficacy|1
5463747|NCT02006121|18885710|P2|Double Blind Phase|Adverse Event|0
5463748|NCT02006121|18885711|P1|Double Blind Phase|Adverse Event|6
5463749|NCT02005887|18885744|P2|Overall Study|Protocol Violation|2
5463750|NCT02005887|18885745|P1|Overall Study|Protocol Violation|0
5463751|NCT02005692|18885763|P1|Overall Study|Discharged earlier than anticipated|5
5463752|NCT02005692|18885763|P1|Overall Study|Withdrawal by Subject|1
5463753|NCT02005692|18885763|P1|Overall Study|Protocol Violation|1
5463754|NCT02005627|18885789|P2|Overall Study|Withdrawal by Subject|2
5463755|NCT02005627|18885790|P1|Overall Study|Withdrawal by Subject|1
5463756|NCT02005627|18885789|P2|Overall Study|Lost to Follow-up|2
5463757|NCT02005627|18885790|P1|Overall Study|Lost to Follow-up|1
5463758|NCT02005562|18885819|P2|Overall Study|Physician Decision|1
5463759|NCT02005562|18885820|P1|Overall Study|Physician Decision|0
5463760|NCT02005562|18885819|P2|Overall Study|No transplant|4
5463761|NCT02005562|18885820|P1|Overall Study|No transplant|1
5463762|NCT02005562|18885819|P2|Overall Study|Withdrawal by Subject|2
5463763|NCT02005562|18885820|P1|Overall Study|Withdrawal by Subject|2
5463764|NCT02005562|18885819|P2|Overall Study|Graft loss|6
5463765|NCT02005562|18885820|P1|Overall Study|Graft loss|7
5463766|NCT02005562|18885819|P2|Overall Study|Death|2
5463767|NCT02005562|18885820|P1|Overall Study|Death|2
5463768|NCT02005484|18885881|P1|Overall Study|Sponsor decision|1
5463769|NCT02005484|18885881|P1|Overall Study|Changed to a Different Study|1
5463770|NCT02005484|18885881|P1|Overall Study|Disease progression|1
5463771|NCT02005484|18885881|P1|Overall Study|Death|1
5463772|NCT02005471|18885893|P2|Overall Study|Withdrawal by Subject|7
5463773|NCT02005471|18885894|P1|Overall Study|Withdrawal by Subject|18
5463774|NCT02005471|18885893|P2|Overall Study|Progressive Disease|0
5463775|NCT02005471|18885894|P1|Overall Study|Progressive Disease|3
5463776|NCT02005471|18885893|P2|Overall Study|Physician Decision|1
5463777|NCT02005471|18885894|P1|Overall Study|Physician Decision|2
5463778|NCT02005471|18885893|P2|Overall Study|Lost to Follow-up|0
5463779|NCT02005471|18885894|P1|Overall Study|Lost to Follow-up|1
5463780|NCT02005471|18885893|P2|Overall Study|Death|15
5463781|NCT02005471|18885894|P1|Overall Study|Death|26
5463782|NCT02005471|18885893|P2|Overall Study|Adverse Event|0
5463783|NCT02005471|18885894|P1|Overall Study|Adverse Event|1
5463784|NCT02005471|18885893|P2|Overall Study|Ongoing in Study|171
5463785|NCT02005471|18885894|P1|Overall Study|Ongoing in Study|144
5463786|NCT02005445|18885949|P2|Overall Study|Dual study enrollment|1
5463787|NCT02005445|18885950|P1|Overall Study|Dual study enrollment|0
5463788|NCT02005276|18885973|P4|Overall Study|No longer interested|3
5463789|NCT02005276|18885974|P3|Overall Study|No longer interested|3
5463790|NCT02005276|18885975|P2|Overall Study|No longer interested|2
5463791|NCT02005276|18885976|P1|Overall Study|No longer interested|5
5463792|NCT02005250|18885992|P2|Overall Study|Lost to Follow-up|5
5463793|NCT02005250|18885993|P1|Overall Study|Lost to Follow-up|15
5463794|NCT02005211|18886006|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5463795|NCT02005211|18886007|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5463796|NCT02005211|18886008|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
5463797|NCT02005211|18886009|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5463798|NCT02005211|18886010|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5463799|NCT02005211|18886011|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5463800|NCT02005211|18886012|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
5463801|NCT02005029|18886047|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
5463802|NCT02005029|18886048|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
5463803|NCT02004886|18886105|P4|Overall Study|Unable to attend future visits|0
5463804|NCT02004886|18886106|P3|Overall Study|Unable to attend future visits|0
5463805|NCT02004886|18886107|P2|Overall Study|Unable to attend future visits|0
5463806|NCT02004886|18886108|P1|Overall Study|Unable to attend future visits|1
5463807|NCT02004886|18886105|P4|Overall Study|Adverse Event|0
5463808|NCT02004886|18886106|P3|Overall Study|Adverse Event|0
5463809|NCT02004886|18886107|P2|Overall Study|Adverse Event|1
5463810|NCT02004886|18886108|P1|Overall Study|Adverse Event|0
5463811|NCT02004873|18886158|P1|Overall Study|Withdrawal by Subject|1
5463812|NCT02004873|18886158|P1|Overall Study|Death|23
5463813|NCT02004873|18886158|P1|Overall Study|Missed 6-month visit|4
5463814|NCT02004873|18886158|P1|Overall Study|Awaiting 6-month visit|390
5463815|NCT02004873|18886158|P1|Overall Study|Implant unsuccessful|6
5463816|NCT02004847|18886167|P2|Overall Study|Protocol Violation|1
5463817|NCT02004847|18886168|P1|Overall Study|Protocol Violation|1
5463818|NCT02004522|18886214|P2|Overall Study|Completed Treatrment Cycles Per Protocol|103
5463819|NCT02004522|18886215|P1|Overall Study|Completed Treatrment Cycles Per Protocol|1
5463820|NCT02004522|18886214|P2|Overall Study|Disease Progression|31
5463821|NCT02004522|18886215|P1|Overall Study|Disease Progression|35
5463822|NCT02004522|18886214|P2|Overall Study|Never Dosed|4
5463823|NCT02004522|18886215|P1|Overall Study|Never Dosed|2
5463824|NCT02004522|18886214|P2|Overall Study|Other is reason listed by PI.|1
5463825|NCT02004522|18886215|P1|Overall Study|Other is reason listed by PI.|4
5463826|NCT02004522|18886214|P2|Overall Study|Protocol Violation|0
5463827|NCT02004522|18886215|P1|Overall Study|Protocol Violation|1
5463828|NCT02004522|18886214|P2|Overall Study|Physician Decision|4
5463829|NCT02004522|18886215|P1|Overall Study|Physician Decision|3
5463830|NCT02004522|18886214|P2|Overall Study|Death|3
5463831|NCT02004522|18886215|P1|Overall Study|Death|12
5463832|NCT02004522|18886214|P2|Overall Study|Withdrawal by Subject|7
5463833|NCT02004522|18886215|P1|Overall Study|Withdrawal by Subject|13
5463834|NCT02004522|18886214|P2|Overall Study|Adverse Event|6
5463835|NCT02004522|18886215|P1|Overall Study|Adverse Event|55
5463836|NCT02004262|18886336|P6|Overall Study|Study Terminated by Sponsor|5
5463837|NCT02004262|18886337|P5|Overall Study|Study Terminated by Sponsor|1
5463838|NCT02004262|18886338|P4|Overall Study|Study Terminated by Sponsor|1
5463839|NCT02004262|18886339|P3|Overall Study|Study Terminated by Sponsor|2
5463840|NCT02004262|18886340|P2|Overall Study|Study Terminated by Sponsor|3
5463841|NCT02004262|18886341|P1|Overall Study|Study Terminated by Sponsor|4
5463842|NCT02004262|18886336|P6|Overall Study|Lost to Follow-up|0
5463843|NCT02004262|18886337|P5|Overall Study|Lost to Follow-up|0
5463844|NCT02004262|18886338|P4|Overall Study|Lost to Follow-up|0
5463845|NCT02004262|18886339|P3|Overall Study|Lost to Follow-up|0
5463846|NCT02004262|18886340|P2|Overall Study|Lost to Follow-up|1
5463847|NCT02004262|18886341|P1|Overall Study|Lost to Follow-up|1
5463848|NCT02004262|18886336|P6|Overall Study|Withdrawal by Subject|3
5463849|NCT02004262|18886337|P5|Overall Study|Withdrawal by Subject|1
5463850|NCT02004262|18886338|P4|Overall Study|Withdrawal by Subject|0
5463851|NCT02004262|18886339|P3|Overall Study|Withdrawal by Subject|4
5463852|NCT02004262|18886340|P2|Overall Study|Withdrawal by Subject|0
5463853|NCT02004262|18886341|P1|Overall Study|Withdrawal by Subject|1
5463854|NCT02004262|18886336|P6|Overall Study|Death|22
5463855|NCT02004262|18886337|P5|Overall Study|Death|29
5463856|NCT02004262|18886338|P4|Overall Study|Death|28
5463857|NCT02004262|18886339|P3|Overall Study|Death|66
5463858|NCT02004262|18886340|P2|Overall Study|Death|64
5463859|NCT02004262|18886341|P1|Overall Study|Death|67
5463860|NCT02004236|18886361|P3|Overall Study|Lack of Efficacy|16
5463861|NCT02004236|18886362|P2|Overall Study|Lack of Efficacy|0
5463862|NCT02004236|18886363|P1|Overall Study|Lack of Efficacy|0
5463863|NCT02004093|18886423|P2|Overall Study|Other|1
5463864|NCT02004093|18886424|P1|Overall Study|Other|3
5463865|NCT02004093|18886423|P2|Overall Study|Withdrawal by Subject|7
5463866|NCT02004093|18886424|P1|Overall Study|Withdrawal by Subject|3
5463867|NCT02004093|18886423|P2|Overall Study|Lost to Follow-up|1
5463868|NCT02004093|18886424|P1|Overall Study|Lost to Follow-up|0
5463869|NCT02004093|18886423|P2|Overall Study|Protocol Violation|1
5463870|NCT02004093|18886424|P1|Overall Study|Protocol Violation|0
5463871|NCT02004093|18886423|P2|Overall Study|Lack of Efficacy|62
5463872|NCT02004093|18886424|P1|Overall Study|Lack of Efficacy|66
5463873|NCT02004093|18886423|P2|Overall Study|Death|1
5463874|NCT02004093|18886424|P1|Overall Study|Death|2
5463875|NCT02003963|18886456|P2|Overall Study|Lost to Follow-up|1
5463876|NCT02003963|18886457|P1|Overall Study|Lost to Follow-up|2
5463877|NCT02003924|18886479|P3|Long-term Follow-up Phase|Other|1
5463878|NCT02003924|18886480|P2|Long-term Follow-up Phase|Other|2
5463879|NCT02003924|18886481|P1|Long-term Follow-up Phase|Other|5
5463880|NCT02003924|18886479|P3|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
5463881|NCT02003924|18886480|P2|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
5463882|NCT02003924|18886481|P1|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
5463883|NCT02003924|18886479|P3|Long-term Follow-up Phase|Lost to Follow-up|1
5463884|NCT02003924|18886480|P2|Long-term Follow-up Phase|Lost to Follow-up|6
5463885|NCT02003924|18886481|P1|Long-term Follow-up Phase|Lost to Follow-up|8
5463886|NCT02003924|18886479|P3|Long-term Follow-up Phase|Death|4
5463887|NCT02003924|18886480|P2|Long-term Follow-up Phase|Death|174
5463888|NCT02003924|18886481|P1|Long-term Follow-up Phase|Death|288
5463889|NCT02003924|18886479|P3|Open-label Phase|Other|0
5463890|NCT02003924|18886480|P2|Open-label Phase|Other|0
5463891|NCT02003924|18886481|P1|Open-label Phase|Other|7
5463892|NCT02003924|18886479|P3|Open-label Phase|Adverse Event|10
5463893|NCT02003924|18886480|P2|Open-label Phase|Adverse Event|0
5463894|NCT02003924|18886481|P1|Open-label Phase|Adverse Event|25
5463895|NCT02003924|18886479|P3|Open-label Phase|Disease Progression|5
5463896|NCT02003924|18886480|P2|Open-label Phase|Disease Progression|0
5463897|NCT02003924|18886481|P1|Open-label Phase|Disease Progression|59
5463898|NCT02003924|18886479|P3|Open-label Phase|Withdrawal Consent to Continue Treatment|1
5463899|NCT02003924|18886480|P2|Open-label Phase|Withdrawal Consent to Continue Treatment|0
5463900|NCT02003924|18886481|P1|Open-label Phase|Withdrawal Consent to Continue Treatment|9
5463901|NCT02003924|18886479|P3|Open-label Phase|Lost to Follow-up|1
5463902|NCT02003924|18886480|P2|Open-label Phase|Lost to Follow-up|0
5463903|NCT02003924|18886481|P1|Open-label Phase|Lost to Follow-up|0
5463904|NCT02003924|18886479|P3|Double-blind Phase|Other|0
5463905|NCT02003924|18886480|P2|Double-blind Phase|Other|50
5463906|NCT02003924|18886481|P1|Double-blind Phase|Other|29
5463907|NCT02003924|18886479|P3|Double-blind Phase|Randomized But not Treated|0
5463908|NCT02003924|18886480|P2|Double-blind Phase|Randomized But not Treated|3
5463909|NCT02003924|18886481|P1|Double-blind Phase|Randomized But not Treated|3
5463910|NCT02003924|18886479|P3|Double-blind Phase|Adverse Event|0
5463911|NCT02003924|18886480|P2|Double-blind Phase|Adverse Event|31
5463912|NCT02003924|18886481|P1|Double-blind Phase|Adverse Event|120
5463913|NCT02003924|18886479|P3|Double-blind Phase|Disease Progression|0
5463914|NCT02003924|18886480|P2|Double-blind Phase|Disease Progression|247
5463915|NCT02003924|18886481|P1|Double-blind Phase|Disease Progression|229
5463916|NCT02003924|18886479|P3|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
5463917|NCT02003924|18886480|P2|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
5463918|NCT02003924|18886481|P1|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
5463919|NCT02003924|18886479|P3|Double-blind Phase|Protocol Violation|0
5463920|NCT02003924|18886480|P2|Double-blind Phase|Protocol Violation|2
5463921|NCT02003924|18886481|P1|Double-blind Phase|Protocol Violation|1
5463922|NCT02003924|18886479|P3|Double-blind Phase|Lost to Follow-up|0
5463923|NCT02003924|18886480|P2|Double-blind Phase|Lost to Follow-up|1
5463924|NCT02003924|18886481|P1|Double-blind Phase|Lost to Follow-up|2
5463925|NCT02003898|18886603|P1|Overall Study|Withdrawal by Subject|52
5463926|NCT02003898|18886603|P1|Overall Study|Lost to Follow-up|12
5463927|NCT02003898|18886603|P1|Overall Study|Death|3
5463928|NCT02003638|18886612|P2|Overall Study|Withdrawal by Subject|0
5463929|NCT02003638|18886613|P1|Overall Study|Withdrawal by Subject|1
5463930|NCT02003573|18886643|P3|Overall Study|Other than specified|3
5463931|NCT02003573|18886644|P2|Overall Study|Other than specified|2
5463932|NCT02003573|18886645|P1|Overall Study|Other than specified|1
5463933|NCT02003573|18886643|P3|Overall Study|Refuse to take trial medication|1
5463934|NCT02003573|18886644|P2|Overall Study|Refuse to take trial medication|1
5463935|NCT02003573|18886645|P1|Overall Study|Refuse to take trial medication|0
5463936|NCT02003573|18886643|P3|Overall Study|Other Adverse event|1
5463937|NCT02003573|18886644|P2|Overall Study|Other Adverse event|1
5463938|NCT02003573|18886645|P1|Overall Study|Other Adverse event|0
5463939|NCT02003573|18886643|P3|Overall Study|Progressive disease|1
5463940|NCT02003573|18886644|P2|Overall Study|Progressive disease|0
5463941|NCT02003573|18886645|P1|Overall Study|Progressive disease|2
5463942|NCT02003534|18886655|P1|Overall Study|Lost to Follow-up|47
5463943|NCT02003391|18886676|P2|Overall Study|Adverse Event|0
5463944|NCT02003391|18886677|P1|Overall Study|Adverse Event|1
5463945|NCT02003391|18886676|P2|Overall Study|Protocol Violation|1
5463946|NCT02003391|18886677|P1|Overall Study|Protocol Violation|0
5463947|NCT02003391|18886676|P2|Overall Study|Withdrawal by Subject|1
5463948|NCT02003391|18886677|P1|Overall Study|Withdrawal by Subject|2
5463949|NCT02003365|18886690|P3|Overall Study|Lost to Follow-up|1
5463950|NCT02003365|18886691|P2|Overall Study|Lost to Follow-up|0
5463951|NCT02003365|18886692|P1|Overall Study|Lost to Follow-up|0
5463952|NCT02003183|18886709|P2|Overall Study|Lost to Follow-up|2
5463953|NCT02003183|18886710|P1|Overall Study|Lost to Follow-up|0
5463954|NCT02003014|18886725|P1|Overall Study|Investigator's transfer|4
5463955|NCT02003014|18886725|P1|Overall Study|Patient did not visit the study site|5
5463956|NCT02003014|18886725|P1|Overall Study|Treatment started after contract period|1
5463957|NCT02003014|18886725|P1|Overall Study|Case report forms uncollected|9
5463958|NCT02002975|18886735|P1|Overall Study|Protocol Deviation|437
5463959|NCT02002975|18886735|P1|Overall Study|Case Report Forms Uncollected|135
5463960|NCT02002884|18886763|P4|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
5463961|NCT02002884|18886764|P3|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
5463962|NCT02002884|18886765|P2|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
5463963|NCT02002884|18886766|P1|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
5463964|NCT02002884|18886763|P4|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
5463965|NCT02002884|18886764|P3|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
5463966|NCT02002884|18886765|P2|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
5463967|NCT02002884|18886766|P1|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
5463968|NCT02002884|18886763|P4|Open-Label Extension Period (OLEX)|Adverse Event|5
5463969|NCT02002884|18886764|P3|Open-Label Extension Period (OLEX)|Adverse Event|0
5463970|NCT02002884|18886765|P2|Open-Label Extension Period (OLEX)|Adverse Event|0
5463971|NCT02002884|18886766|P1|Open-Label Extension Period (OLEX)|Adverse Event|0
5463972|NCT02002884|18886763|P4|Open-Label Extension Period (OLEX)|Physician Decision|1
5463973|NCT02002884|18886764|P3|Open-Label Extension Period (OLEX)|Physician Decision|0
5463974|NCT02002884|18886765|P2|Open-Label Extension Period (OLEX)|Physician Decision|0
5463975|NCT02002884|18886766|P1|Open-Label Extension Period (OLEX)|Physician Decision|0
5463976|NCT02002884|18886763|P4|Open-Label Extension Period (OLEX)|Other|24
5463977|NCT02002884|18886764|P3|Open-Label Extension Period (OLEX)|Other|0
5463978|NCT02002884|18886765|P2|Open-Label Extension Period (OLEX)|Other|0
5463979|NCT02002884|18886766|P1|Open-Label Extension Period (OLEX)|Other|0
5463980|NCT02002884|18886763|P4|Main Period (MP)|Lost to Follow-up|0
5463981|NCT02002884|18886764|P3|Main Period (MP)|Lost to Follow-up|2
5463982|NCT02002884|18886765|P2|Main Period (MP)|Lost to Follow-up|0
5463983|NCT02002884|18886766|P1|Main Period (MP)|Lost to Follow-up|0
5463984|NCT02002884|18886763|P4|Main Period (MP)|Withdrawal by Subject|0
5463985|NCT02002884|18886764|P3|Main Period (MP)|Withdrawal by Subject|2
5463986|NCT02002884|18886765|P2|Main Period (MP)|Withdrawal by Subject|2
5463987|NCT02002884|18886766|P1|Main Period (MP)|Withdrawal by Subject|6
5463988|NCT02002884|18886763|P4|Main Period (MP)|Adverse Event|0
5463989|NCT02002884|18886764|P3|Main Period (MP)|Adverse Event|1
5463990|NCT02002884|18886765|P2|Main Period (MP)|Adverse Event|1
5463991|NCT02002884|18886766|P1|Main Period (MP)|Adverse Event|0
5463992|NCT02002884|18886763|P4|Main Period (MP)|Other|0
5463993|NCT02002884|18886764|P3|Main Period (MP)|Other|3
5463994|NCT02002884|18886765|P2|Main Period (MP)|Other|3
5463995|NCT02002884|18886766|P1|Main Period (MP)|Other|0
5463996|NCT02002689|18886918|P1|Overall Study|Adverse Event|3
5463997|NCT02002689|18886918|P1|Overall Study|Disease Progression|7
5463998|NCT02002533|18886937|P2|Overall Study|Lost to Follow-up|1
5463999|NCT02002533|18886938|P1|Overall Study|Lost to Follow-up|0
5464000|NCT02002533|18886937|P2|Overall Study|Adverse Event|3
5464001|NCT02002533|18886938|P1|Overall Study|Adverse Event|0
5464002|NCT02002533|18886937|P2|Overall Study|Protocol Violation|1
5464003|NCT02002533|18886938|P1|Overall Study|Protocol Violation|0
5464004|NCT02002533|18886937|P2|Overall Study|Withdrawal by Subject|13
5464005|NCT02002533|18886938|P1|Overall Study|Withdrawal by Subject|6
5464006|NCT02002221|18886978|P2|Overall Study|Patient withdrew consent|1
5464007|NCT02002221|18886979|P1|Overall Study|Patient withdrew consent|0
5464008|NCT02002221|18886978|P2|Overall Study|Unsatisfactory therapeutic effect|1
5464009|NCT02002221|18886979|P1|Overall Study|Unsatisfactory therapeutic effect|0
5464010|NCT02002221|18886978|P2|Overall Study|Adverse Event|1
5464011|NCT02002221|18886979|P1|Overall Study|Adverse Event|2
5464012|NCT02002182|18887006|P2|Overall Study|Death|0
5464013|NCT02002182|18887007|P1|Overall Study|Death|1
5464014|NCT02002182|18887006|P2|Overall Study|Health Reasons|0
5464015|NCT02002182|18887007|P1|Overall Study|Health Reasons|1
5464016|NCT02002182|18887006|P2|Overall Study|Withdraw from study|1
5464017|NCT02002182|18887007|P1|Overall Study|Withdraw from study|3
5464018|NCT02002091|18887019|P2|Screening|Death|2
5464019|NCT02002091|18887020|P1|Screening|Death|3
5464020|NCT02002091|18887019|P2|Screening|Lost to Follow-up|12
5464021|NCT02002091|18887020|P1|Screening|Lost to Follow-up|10
5464022|NCT02001987|18887055|P1|LTE Period (52 Weeks)|Other|3
5464023|NCT02001987|18887055|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
5464024|NCT02001987|18887055|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
5464025|NCT02001987|18887055|P1|LTE Period (52 Weeks)|Physician Decision|2
5464026|NCT02001987|18887055|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
5464027|NCT02001987|18887055|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
5464028|NCT02001987|18887055|P1|Core Study Period (24 Weeks)|Protocol Violation|3
5464029|NCT02001987|18887055|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
5464030|NCT02001987|18887055|P1|Core Study Period (24 Weeks)|Physician Decision|1
5464031|NCT02001987|18887055|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
5464032|NCT02001987|18887055|P1|Core Study Period (24 Weeks)|Death|1
5464033|NCT02001987|18887055|P1|Core Study Period (24 Weeks)|Adverse Event|9
5464034|NCT02001688|18887141|P3|Overall Study|Adverse Event|0
5464035|NCT02001688|18887142|P2|Overall Study|Adverse Event|1
5464036|NCT02001688|18887143|P1|Overall Study|Adverse Event|0
5464037|NCT02001688|18887141|P3|Overall Study|Withdrawal by Subject|1
5464038|NCT02001688|18887142|P2|Overall Study|Withdrawal by Subject|0
5464039|NCT02001688|18887143|P1|Overall Study|Withdrawal by Subject|0
5464040|NCT02001558|18887162|P2|Overall Study|Lost to Follow-up|14
5464041|NCT02001558|18887163|P1|Overall Study|Lost to Follow-up|8
5464042|NCT02001194|18887199|P4|Follow-Up Period (13 Weeks)|No longer interested|0
5464043|NCT02001194|18887200|P3|Follow-Up Period (13 Weeks)|No longer interested|1
5464044|NCT02001194|18887201|P2|Follow-Up Period (13 Weeks)|No longer interested|2
5464045|NCT02001194|18887202|P1|Follow-Up Period (13 Weeks)|No longer interested|3
5464046|NCT02001194|18887199|P4|Intervention Period (13 Weeks)|No longer interested|2
5464047|NCT02001194|18887200|P3|Intervention Period (13 Weeks)|No longer interested|2
5464048|NCT02001194|18887201|P2|Intervention Period (13 Weeks)|No longer interested|0
5464049|NCT02001194|18887202|P1|Intervention Period (13 Weeks)|No longer interested|1
5464050|NCT02001181|18887218|P2|Overall Study|Withdrawal by Subject|1
5464051|NCT02001181|18887219|P1|Overall Study|Withdrawal by Subject|0
5464052|NCT02001181|18887218|P2|Overall Study|Lost to Follow-up|0
5464053|NCT02001181|18887219|P1|Overall Study|Lost to Follow-up|1
5464054|NCT02001181|18887218|P2|Overall Study|Adverse Event|2
5464055|NCT02001181|18887219|P1|Overall Study|Adverse Event|0
5464056|NCT02001051|18887235|P2|Overall Study|Deemed not eligible following enrollment|1
5464057|NCT02001051|18887236|P1|Overall Study|Deemed not eligible following enrollment|0
5464058|NCT02000921|18887288|P3|Overall Study|Physician Decision|0
5464059|NCT02000921|18887289|P2|Overall Study|Physician Decision|2
5464060|NCT02000921|18887290|P1|Overall Study|Physician Decision|0
5464061|NCT02000921|18887288|P3|Overall Study|Lost to Follow-up|5
5464062|NCT02000921|18887289|P2|Overall Study|Lost to Follow-up|4
5464063|NCT02000921|18887290|P1|Overall Study|Lost to Follow-up|2
5464064|NCT02000921|18887288|P3|Overall Study|Withdrawal by Subject|5
5464065|NCT02000921|18887289|P2|Overall Study|Withdrawal by Subject|10
5464066|NCT02000921|18887290|P1|Overall Study|Withdrawal by Subject|3
5464067|NCT02000817|18887320|P4|Overall Study|Lost to Follow-up|0
5464068|NCT02000817|18887321|P3|Overall Study|Lost to Follow-up|1
5464069|NCT02000817|18887322|P2|Overall Study|Lost to Follow-up|0
5464070|NCT02000817|18887323|P1|Overall Study|Lost to Follow-up|0
5464071|NCT02000817|18887320|P4|Overall Study|Adverse Event|0
5464072|NCT02000817|18887321|P3|Overall Study|Adverse Event|0
5464073|NCT02000817|18887322|P2|Overall Study|Adverse Event|1
5464074|NCT02000817|18887323|P1|Overall Study|Adverse Event|0
5464075|NCT02000817|18887320|P4|Overall Study|Withdrawal by Subject|0
5464076|NCT02000817|18887321|P3|Overall Study|Withdrawal by Subject|0
5464077|NCT02000817|18887322|P2|Overall Study|Withdrawal by Subject|0
5464078|NCT02000817|18887323|P1|Overall Study|Withdrawal by Subject|2
5464079|NCT02000752|18887418|P2|Overall Study|Shift Changes|5
5464080|NCT02000752|18887419|P1|Overall Study|Shift Changes|12
5464081|NCT02000752|18887418|P2|Overall Study|Dystocic delivery|8
5464082|NCT02000752|18887419|P1|Overall Study|Dystocic delivery|19
5464083|NCT02000622|18887433|P2|Overall Study|Withdrawn due to site closure|0
5464084|NCT02000622|18887434|P1|Overall Study|Withdrawn due to site closure|1
5464085|NCT02000622|18887433|P2|Overall Study|Death|73
5464086|NCT02000622|18887434|P1|Overall Study|Death|159
5464087|NCT02000622|18887433|P2|Overall Study|Lost to Follow-up|0
5464088|NCT02000622|18887434|P1|Overall Study|Lost to Follow-up|4
5464089|NCT02000622|18887433|P2|Overall Study|Withdrawal by Subject|7
5464090|NCT02000622|18887434|P1|Overall Study|Withdrawal by Subject|5
5464091|NCT02000531|18887477|P2|Overall Study|Discontinued due to data cut-off|8
5464092|NCT02000531|18887478|P1|Overall Study|Discontinued due to data cut-off|3
5464093|NCT02000531|18887477|P2|Overall Study|Lost to Follow-up|0
5464094|NCT02000531|18887478|P1|Overall Study|Lost to Follow-up|1
5464095|NCT02000440|18887486|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
5464096|NCT02000440|18887486|P1|Overall Study|Adverse Event|3
5464097|NCT02000427|18887506|P1|Overall Study|Death|22
5464098|NCT01999972|18887560|P6|Dose Expansion Part|Changed to standard of care|0
5464099|NCT01999972|18887561|P5|Dose Expansion Part|Changed to standard of care|1
5464100|NCT01999972|18887562|P4|Dose Expansion Part|Changed to standard of care|0
5464101|NCT01999972|18887563|P3|Dose Expansion Part|Changed to standard of care|0
5464102|NCT01999972|18887564|P2|Dose Expansion Part|Changed to standard of care|0
5464103|NCT01999972|18887565|P1|Dose Expansion Part|Changed to standard of care|0
5464104|NCT01999972|18887560|P6|Dose Expansion Part|Participant refused further follow-up|0
5464105|NCT01999972|18887561|P5|Dose Expansion Part|Participant refused further follow-up|4
5464106|NCT01999972|18887562|P4|Dose Expansion Part|Participant refused further follow-up|0
5464107|NCT01999972|18887563|P3|Dose Expansion Part|Participant refused further follow-up|0
5464108|NCT01999972|18887564|P2|Dose Expansion Part|Participant refused further follow-up|0
5464109|NCT01999972|18887565|P1|Dose Expansion Part|Participant refused further follow-up|0
5464110|NCT01999972|18887560|P6|Dose Expansion Part|Participant's non-compliance|1
5464111|NCT01999972|18887561|P5|Dose Expansion Part|Participant's non-compliance|0
5464112|NCT01999972|18887562|P4|Dose Expansion Part|Participant's non-compliance|0
5464113|NCT01999972|18887563|P3|Dose Expansion Part|Participant's non-compliance|0
5464114|NCT01999972|18887564|P2|Dose Expansion Part|Participant's non-compliance|0
5464115|NCT01999972|18887565|P1|Dose Expansion Part|Participant's non-compliance|0
5464116|NCT01999972|18887560|P6|Dose Expansion Part|Adverse Event|2
5464117|NCT01999972|18887561|P5|Dose Expansion Part|Adverse Event|4
5464118|NCT01999972|18887562|P4|Dose Expansion Part|Adverse Event|0
5464119|NCT01999972|18887563|P3|Dose Expansion Part|Adverse Event|0
5464120|NCT01999972|18887564|P2|Dose Expansion Part|Adverse Event|0
5464121|NCT01999972|18887565|P1|Dose Expansion Part|Adverse Event|0
5464122|NCT01999972|18887560|P6|Dose Expansion Part|Sponsor decision|0
5464123|NCT01999972|18887561|P5|Dose Expansion Part|Sponsor decision|1
5464124|NCT01999972|18887562|P4|Dose Expansion Part|Sponsor decision|0
5464125|NCT01999972|18887563|P3|Dose Expansion Part|Sponsor decision|0
5464126|NCT01999972|18887564|P2|Dose Expansion Part|Sponsor decision|0
5464127|NCT01999972|18887565|P1|Dose Expansion Part|Sponsor decision|0
5464128|NCT01999972|18887560|P6|Dose Expansion Part|Disease progression|3
5464129|NCT01999972|18887561|P5|Dose Expansion Part|Disease progression|9
5464130|NCT01999972|18887562|P4|Dose Expansion Part|Disease progression|0
5464131|NCT01999972|18887563|P3|Dose Expansion Part|Disease progression|0
5464132|NCT01999972|18887564|P2|Dose Expansion Part|Disease progression|0
5464133|NCT01999972|18887565|P1|Dose Expansion Part|Disease progression|0
5464134|NCT01999972|18887560|P6|Dose Expansion Part|Death|1
5464135|NCT01999972|18887561|P5|Dose Expansion Part|Death|2
5464136|NCT01999972|18887562|P4|Dose Expansion Part|Death|0
5464137|NCT01999972|18887563|P3|Dose Expansion Part|Death|0
5464138|NCT01999972|18887564|P2|Dose Expansion Part|Death|0
5464139|NCT01999972|18887565|P1|Dose Expansion Part|Death|0
5464140|NCT01999972|18887560|P6|Dose Escalation Part|Global deterioration of health status|0
5464141|NCT01999972|18887561|P5|Dose Escalation Part|Global deterioration of health status|0
5464142|NCT01999972|18887562|P4|Dose Escalation Part|Global deterioration of health status|1
5464143|NCT01999972|18887563|P3|Dose Escalation Part|Global deterioration of health status|0
5464144|NCT01999972|18887564|P2|Dose Escalation Part|Global deterioration of health status|0
5464145|NCT01999972|18887565|P1|Dose Escalation Part|Global deterioration of health status|1
5464146|NCT01999972|18887560|P6|Dose Escalation Part|Adverse Event|0
5464147|NCT01999972|18887561|P5|Dose Escalation Part|Adverse Event|0
5464148|NCT01999972|18887562|P4|Dose Escalation Part|Adverse Event|2
5464149|NCT01999972|18887563|P3|Dose Escalation Part|Adverse Event|0
5464150|NCT01999972|18887564|P2|Dose Escalation Part|Adverse Event|0
5464151|NCT01999972|18887565|P1|Dose Escalation Part|Adverse Event|0
5464152|NCT01999972|18887560|P6|Dose Escalation Part|Disease progression|0
5464153|NCT01999972|18887561|P5|Dose Escalation Part|Disease progression|0
5464154|NCT01999972|18887562|P4|Dose Escalation Part|Disease progression|6
5464155|NCT01999972|18887563|P3|Dose Escalation Part|Disease progression|3
5464156|NCT01999972|18887564|P2|Dose Escalation Part|Disease progression|2
5464157|NCT01999972|18887565|P1|Dose Escalation Part|Disease progression|3
5464158|NCT01999972|18887560|P6|Dose Escalation Part|Enrolled but not treated|0
5464159|NCT01999972|18887561|P5|Dose Escalation Part|Enrolled but not treated|0
5464160|NCT01999972|18887562|P4|Dose Escalation Part|Enrolled but not treated|1
5464161|NCT01999972|18887563|P3|Dose Escalation Part|Enrolled but not treated|1
5464162|NCT01999972|18887564|P2|Dose Escalation Part|Enrolled but not treated|0
5464163|NCT01999972|18887565|P1|Dose Escalation Part|Enrolled but not treated|0
5464164|NCT01999972|18887560|P6|Dose Escalation Part|Death|0
5464165|NCT01999972|18887561|P5|Dose Escalation Part|Death|0
5464166|NCT01999972|18887562|P4|Dose Escalation Part|Death|0
5464167|NCT01999972|18887563|P3|Dose Escalation Part|Death|0
5464168|NCT01999972|18887564|P2|Dose Escalation Part|Death|1
5464169|NCT01999972|18887565|P1|Dose Escalation Part|Death|0
5464170|NCT01999972|18887560|P6|Dose Escalation Part|Participant refused further follow-up|0
5464171|NCT01999972|18887561|P5|Dose Escalation Part|Participant refused further follow-up|0
5464172|NCT01999972|18887562|P4|Dose Escalation Part|Participant refused further follow-up|1
5464173|NCT01999972|18887563|P3|Dose Escalation Part|Participant refused further follow-up|1
5464174|NCT01999972|18887564|P2|Dose Escalation Part|Participant refused further follow-up|0
5464175|NCT01999972|18887565|P1|Dose Escalation Part|Participant refused further follow-up|1
5464176|NCT01999946|18887680|P3|Overall Study|Not included in primary outcome analysis|79
5464177|NCT01999946|18887681|P2|Overall Study|Not included in primary outcome analysis|0
5464178|NCT01999946|18887682|P1|Overall Study|Not included in primary outcome analysis|0
5464179|NCT01999946|18887680|P3|Overall Study|Participant not released from jail|0
5464180|NCT01999946|18887681|P2|Overall Study|Participant not released from jail|2
5464181|NCT01999946|18887682|P1|Overall Study|Participant not released from jail|2
5464182|NCT01999894|18887708|P1|Overall Study|Inclusion/exclusion criteria not met|1
5464183|NCT01999894|18887708|P1|Overall Study|Other Reason|3
5464184|NCT01999894|18887708|P1|Overall Study|Lost to Follow-up|10
5464185|NCT01999894|18887708|P1|Overall Study|Withdrawal by Subject|7
5464186|NCT01999894|18887708|P1|Overall Study|Protocol Violation|1
5464187|NCT01999894|18887708|P1|Overall Study|Lack of Efficacy|5
5464188|NCT01999894|18887708|P1|Overall Study|Adverse Event|9
5464189|NCT01999868|18887716|P3|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
5464190|NCT01999868|18887717|P2|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
5464191|NCT01999868|18887718|P1|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
5464192|NCT01999868|18887716|P3|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
5464193|NCT01999868|18887717|P2|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
5464194|NCT01999868|18887718|P1|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
5464195|NCT01999868|18887716|P3|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
5464196|NCT01999868|18887717|P2|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
5464197|NCT01999868|18887718|P1|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
5464198|NCT01999868|18887716|P3|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
5464199|NCT01999868|18887717|P2|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
5464200|NCT01999868|18887718|P1|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
5464201|NCT01999868|18887716|P3|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
5464202|NCT01999868|18887717|P2|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
5464203|NCT01999868|18887718|P1|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
5464204|NCT01999868|18887716|P3|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
5464205|NCT01999868|18887717|P2|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
5464206|NCT01999868|18887718|P1|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
5464207|NCT01999868|18887716|P3|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
5464208|NCT01999868|18887717|P2|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
5464209|NCT01999868|18887718|P1|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
5464210|NCT01999868|18887716|P3|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
5464211|NCT01999868|18887717|P2|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
5464212|NCT01999868|18887718|P1|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
5464213|NCT01999868|18887716|P3|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
5464214|NCT01999868|18887717|P2|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
5464215|NCT01999868|18887718|P1|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
5464216|NCT01999868|18887716|P3|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
5464217|NCT01999868|18887717|P2|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
5464218|NCT01999868|18887718|P1|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
5464219|NCT01999868|18887716|P3|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
5464220|NCT01999868|18887717|P2|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
5464221|NCT01999868|18887718|P1|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
5464222|NCT01999868|18887716|P3|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
5464223|NCT01999868|18887717|P2|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
5464224|NCT01999868|18887718|P1|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
5464225|NCT01999868|18887716|P3|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
5464226|NCT01999868|18887717|P2|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
5464227|NCT01999868|18887718|P1|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
5464228|NCT01999868|18887716|P3|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
5464229|NCT01999868|18887717|P2|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
5464230|NCT01999868|18887718|P1|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
5464231|NCT01999868|18887716|P3|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
5464232|NCT01999868|18887717|P2|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
5464233|NCT01999868|18887718|P1|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
5464234|NCT01999465|18887769|P2|Overall Study|Protocol Violation|1
5464235|NCT01999465|18887770|P1|Overall Study|Protocol Violation|0
5464236|NCT01999465|18887769|P2|Overall Study|Lost to Follow-up|2
5464237|NCT01999465|18887770|P1|Overall Study|Lost to Follow-up|0
5464238|NCT01999322|18887815|P2|Overall Study|Adverse Event|0
5464239|NCT01999322|18887816|P1|Overall Study|Adverse Event|1
5464240|NCT01999218|18887868|P3|Overall Study|Treated but excluded at 1 trial site|2
5464241|NCT01999218|18887869|P2|Overall Study|Treated but excluded at 1 trial site|5
5464242|NCT01999218|18887870|P1|Overall Study|Treated but excluded at 1 trial site|3
5464243|NCT01999218|18887868|P3|Overall Study|Adverse Event|7
5464244|NCT01999218|18887869|P2|Overall Study|Adverse Event|7
5464245|NCT01999218|18887870|P1|Overall Study|Adverse Event|9
5464246|NCT01999218|18887868|P3|Overall Study|Excluded Medication|2
5464247|NCT01999218|18887869|P2|Overall Study|Excluded Medication|1
5464248|NCT01999218|18887870|P1|Overall Study|Excluded Medication|1
5464249|NCT01999218|18887868|P3|Overall Study|Death|2
5464250|NCT01999218|18887869|P2|Overall Study|Death|1
5464251|NCT01999218|18887870|P1|Overall Study|Death|7
5464252|NCT01999218|18887868|P3|Overall Study|Creatinine/eGFR|1
5464253|NCT01999218|18887869|P2|Overall Study|Creatinine/eGFR|0
5464254|NCT01999218|18887870|P1|Overall Study|Creatinine/eGFR|0
5464255|NCT01999218|18887868|P3|Overall Study|Withdrawal by Subject|34
5464256|NCT01999218|18887869|P2|Overall Study|Withdrawal by Subject|29
5464257|NCT01999218|18887870|P1|Overall Study|Withdrawal by Subject|28
5464258|NCT01999218|18887868|P3|Overall Study|Participant moves|3
5464259|NCT01999218|18887869|P2|Overall Study|Participant moves|5
5464260|NCT01999218|18887870|P1|Overall Study|Participant moves|2
5464261|NCT01999218|18887868|P3|Overall Study|Study Terminated By Sponsor|12
5464262|NCT01999218|18887869|P2|Overall Study|Study Terminated By Sponsor|5
5464263|NCT01999218|18887870|P1|Overall Study|Study Terminated By Sponsor|7
5464264|NCT01999218|18887868|P3|Overall Study|Screen failure|0
5464265|NCT01999218|18887869|P2|Overall Study|Screen failure|1
5464266|NCT01999218|18887870|P1|Overall Study|Screen failure|0
5464267|NCT01999218|18887868|P3|Overall Study|Protocol Violation|4
5464268|NCT01999218|18887869|P2|Overall Study|Protocol Violation|5
5464269|NCT01999218|18887870|P1|Overall Study|Protocol Violation|4
5464270|NCT01999218|18887868|P3|Overall Study|Physician Decision|6
5464271|NCT01999218|18887869|P2|Overall Study|Physician Decision|4
5464272|NCT01999218|18887870|P1|Overall Study|Physician Decision|1
5464273|NCT01999218|18887868|P3|Overall Study|Non-Compliance With Study Drug|1
5464274|NCT01999218|18887869|P2|Overall Study|Non-Compliance With Study Drug|4
5464275|NCT01999218|18887870|P1|Overall Study|Non-Compliance With Study Drug|6
5464276|NCT01999218|18887868|P3|Overall Study|Lost to Follow-up|18
5464277|NCT01999218|18887869|P2|Overall Study|Lost to Follow-up|17
5464278|NCT01999218|18887870|P1|Overall Study|Lost to Follow-up|22
5464279|NCT01999218|18887868|P3|Overall Study|Lack of Efficacy|1
5464280|NCT01999218|18887869|P2|Overall Study|Lack of Efficacy|0
5464281|NCT01999218|18887870|P1|Overall Study|Lack of Efficacy|1
5464282|NCT01999218|18887868|P3|Overall Study|Hyperglycemia|17
5464283|NCT01999218|18887869|P2|Overall Study|Hyperglycemia|17
5464284|NCT01999218|18887870|P1|Overall Study|Hyperglycemia|18
5464285|NCT01999114|18887915|P5|Overall Study|Administrative|2
5464286|NCT01999114|18887916|P4|Overall Study|Administrative|1
5464287|NCT01999114|18887917|P3|Overall Study|Administrative|1
5464288|NCT01999114|18887918|P2|Overall Study|Administrative|0
5464289|NCT01999114|18887919|P1|Overall Study|Administrative|0
5464290|NCT01999114|18887915|P5|Overall Study|Lost to Follow-up|0
5464291|NCT01999114|18887916|P4|Overall Study|Lost to Follow-up|0
5464292|NCT01999114|18887917|P3|Overall Study|Lost to Follow-up|1
5464293|NCT01999114|18887918|P2|Overall Study|Lost to Follow-up|0
5464294|NCT01999114|18887919|P1|Overall Study|Lost to Follow-up|0
5464295|NCT01999114|18887915|P5|Overall Study|Withdrawal by Subject|1
5464296|NCT01999114|18887916|P4|Overall Study|Withdrawal by Subject|0
5464297|NCT01999114|18887917|P3|Overall Study|Withdrawal by Subject|1
5464298|NCT01999114|18887918|P2|Overall Study|Withdrawal by Subject|0
5464299|NCT01999114|18887919|P1|Overall Study|Withdrawal by Subject|0
5464300|NCT01999114|18887915|P5|Overall Study|Adverse Event|1
5464301|NCT01999114|18887916|P4|Overall Study|Adverse Event|2
5464302|NCT01999114|18887917|P3|Overall Study|Adverse Event|2
5464303|NCT01999114|18887918|P2|Overall Study|Adverse Event|7
5464304|NCT01999114|18887919|P1|Overall Study|Adverse Event|8
5464305|NCT01998984|18887987|P4|Overall Study|Other|1
5464306|NCT01998984|18887988|P3|Overall Study|Other|0
5464307|NCT01998984|18887989|P2|Overall Study|Other|0
5464308|NCT01998984|18887990|P1|Overall Study|Other|0
5464309|NCT01998984|18887987|P4|Overall Study|Withdrawal by Subject|0
5464310|NCT01998984|18887988|P3|Overall Study|Withdrawal by Subject|1
5464311|NCT01998984|18887989|P2|Overall Study|Withdrawal by Subject|0
5464312|NCT01998984|18887990|P1|Overall Study|Withdrawal by Subject|0
5464313|NCT01998984|18887987|P4|Overall Study|Lost to Follow-up|1
5464314|NCT01998984|18887988|P3|Overall Study|Lost to Follow-up|0
5464315|NCT01998984|18887989|P2|Overall Study|Lost to Follow-up|1
5464316|NCT01998984|18887990|P1|Overall Study|Lost to Follow-up|0
5464317|NCT01998984|18887987|P4|Overall Study|Adverse Event|1
5464318|NCT01998984|18887988|P3|Overall Study|Adverse Event|0
5464319|NCT01998984|18887989|P2|Overall Study|Adverse Event|0
5464320|NCT01998984|18887990|P1|Overall Study|Adverse Event|0
5464321|NCT01998958|18888015|P32|Open Label Phase (Optional)|Withdrawal by Subject|0
5464322|NCT01998958|18888016|P31|Open Label Phase (Optional)|Withdrawal by Subject|0
5464323|NCT01998958|18888017|P30|Open Label Phase (Optional)|Withdrawal by Subject|0
5464324|NCT01998958|18888018|P29|Open Label Phase (Optional)|Withdrawal by Subject|0
5464325|NCT01998958|18888019|P28|Open Label Phase (Optional)|Withdrawal by Subject|0
5464326|NCT01998958|18888020|P27|Open Label Phase (Optional)|Withdrawal by Subject|0
5464327|NCT01998958|18888021|P26|Open Label Phase (Optional)|Withdrawal by Subject|0
5464328|NCT01998958|18888022|P25|Open Label Phase (Optional)|Withdrawal by Subject|0
5464329|NCT01998958|18888023|P24|Open Label Phase (Optional)|Withdrawal by Subject|2
5464330|NCT01998958|18888024|P23|Open Label Phase (Optional)|Withdrawal by Subject|1
5464331|NCT01998958|18888025|P22|Open Label Phase (Optional)|Withdrawal by Subject|2
5464332|NCT01998958|18888026|P21|Open Label Phase (Optional)|Withdrawal by Subject|0
5464333|NCT01998958|18888027|P20|Open Label Phase (Optional)|Withdrawal by Subject|0
5464334|NCT01998958|18888028|P19|Open Label Phase (Optional)|Withdrawal by Subject|0
5464335|NCT01998958|18888029|P18|Open Label Phase (Optional)|Withdrawal by Subject|0
5464336|NCT01998958|18888030|P17|Open Label Phase (Optional)|Withdrawal by Subject|0
5464337|NCT01998958|18888031|P16|Open Label Phase (Optional)|Withdrawal by Subject|0
5464338|NCT01998958|18888032|P15|Open Label Phase (Optional)|Withdrawal by Subject|0
5464339|NCT01998958|18888033|P14|Open Label Phase (Optional)|Withdrawal by Subject|0
5464340|NCT01998958|18888034|P13|Open Label Phase (Optional)|Withdrawal by Subject|0
5464341|NCT01998958|18888035|P12|Open Label Phase (Optional)|Withdrawal by Subject|0
5464342|NCT01998958|18888036|P11|Open Label Phase (Optional)|Withdrawal by Subject|0
5464343|NCT01998958|18888037|P10|Open Label Phase (Optional)|Withdrawal by Subject|0
5464344|NCT01998958|18888038|P9|Open Label Phase (Optional)|Withdrawal by Subject|0
5464345|NCT01998958|18888039|P8|Open Label Phase (Optional)|Withdrawal by Subject|0
5464346|NCT01998958|18888040|P7|Open Label Phase (Optional)|Withdrawal by Subject|0
5464347|NCT01998958|18888041|P6|Open Label Phase (Optional)|Withdrawal by Subject|0
5464348|NCT01998958|18888042|P5|Open Label Phase (Optional)|Withdrawal by Subject|0
5464349|NCT01998958|18888043|P4|Open Label Phase (Optional)|Withdrawal by Subject|0
5464350|NCT01998958|18888044|P3|Open Label Phase (Optional)|Withdrawal by Subject|0
5464351|NCT01998958|18888045|P2|Open Label Phase (Optional)|Withdrawal by Subject|0
5464352|NCT01998958|18888046|P1|Open Label Phase (Optional)|Withdrawal by Subject|0
5464353|NCT01998958|18888015|P32|Open Label Phase (Optional)|Lack of Efficacy|0
5464354|NCT01998958|18888016|P31|Open Label Phase (Optional)|Lack of Efficacy|0
5464355|NCT01998958|18888017|P30|Open Label Phase (Optional)|Lack of Efficacy|0
5464356|NCT01998958|18888018|P29|Open Label Phase (Optional)|Lack of Efficacy|0
5464357|NCT01998958|18888019|P28|Open Label Phase (Optional)|Lack of Efficacy|0
5464358|NCT01998958|18888020|P27|Open Label Phase (Optional)|Lack of Efficacy|0
5464359|NCT01998958|18888021|P26|Open Label Phase (Optional)|Lack of Efficacy|0
5464360|NCT01998958|18888022|P25|Open Label Phase (Optional)|Lack of Efficacy|0
5464361|NCT01998958|18888023|P24|Open Label Phase (Optional)|Lack of Efficacy|0
5464362|NCT01998958|18888024|P23|Open Label Phase (Optional)|Lack of Efficacy|2
5464363|NCT01998958|18888025|P22|Open Label Phase (Optional)|Lack of Efficacy|1
5464364|NCT01998958|18888026|P21|Open Label Phase (Optional)|Lack of Efficacy|0
5464365|NCT01998958|18888027|P20|Open Label Phase (Optional)|Lack of Efficacy|0
5464366|NCT01998958|18888028|P19|Open Label Phase (Optional)|Lack of Efficacy|0
5464367|NCT01998958|18888029|P18|Open Label Phase (Optional)|Lack of Efficacy|0
5464368|NCT01998958|18888030|P17|Open Label Phase (Optional)|Lack of Efficacy|0
5464369|NCT01998958|18888031|P16|Open Label Phase (Optional)|Lack of Efficacy|0
5464370|NCT01998958|18888032|P15|Open Label Phase (Optional)|Lack of Efficacy|0
5464371|NCT01998958|18888033|P14|Open Label Phase (Optional)|Lack of Efficacy|0
5464372|NCT01998958|18888034|P13|Open Label Phase (Optional)|Lack of Efficacy|0
5464373|NCT01998958|18888035|P12|Open Label Phase (Optional)|Lack of Efficacy|0
5464374|NCT01998958|18888036|P11|Open Label Phase (Optional)|Lack of Efficacy|0
5464375|NCT01998958|18888037|P10|Open Label Phase (Optional)|Lack of Efficacy|0
5464376|NCT01998958|18888038|P9|Open Label Phase (Optional)|Lack of Efficacy|0
5464377|NCT01998958|18888039|P8|Open Label Phase (Optional)|Lack of Efficacy|0
5464378|NCT01998958|18888040|P7|Open Label Phase (Optional)|Lack of Efficacy|0
5464379|NCT01998958|18888041|P6|Open Label Phase (Optional)|Lack of Efficacy|0
5464380|NCT01998958|18888042|P5|Open Label Phase (Optional)|Lack of Efficacy|0
5464381|NCT01998958|18888043|P4|Open Label Phase (Optional)|Lack of Efficacy|0
5464382|NCT01998958|18888044|P3|Open Label Phase (Optional)|Lack of Efficacy|0
5464383|NCT01998958|18888045|P2|Open Label Phase (Optional)|Lack of Efficacy|0
5464384|NCT01998958|18888046|P1|Open Label Phase (Optional)|Lack of Efficacy|0
5464385|NCT01998958|18888015|P32|Open Label Phase (Optional)|Lost to Follow-up|0
5464386|NCT01998958|18888016|P31|Open Label Phase (Optional)|Lost to Follow-up|0
5464387|NCT01998958|18888017|P30|Open Label Phase (Optional)|Lost to Follow-up|0
5464388|NCT01998958|18888018|P29|Open Label Phase (Optional)|Lost to Follow-up|0
5464389|NCT01998958|18888019|P28|Open Label Phase (Optional)|Lost to Follow-up|0
5464390|NCT01998958|18888020|P27|Open Label Phase (Optional)|Lost to Follow-up|0
5464391|NCT01998958|18888021|P26|Open Label Phase (Optional)|Lost to Follow-up|0
5464392|NCT01998958|18888022|P25|Open Label Phase (Optional)|Lost to Follow-up|0
5464393|NCT01998958|18888023|P24|Open Label Phase (Optional)|Lost to Follow-up|0
5464394|NCT01998958|18888024|P23|Open Label Phase (Optional)|Lost to Follow-up|1
5464395|NCT01998958|18888025|P22|Open Label Phase (Optional)|Lost to Follow-up|0
5464396|NCT01998958|18888026|P21|Open Label Phase (Optional)|Lost to Follow-up|0
5464397|NCT01998958|18888027|P20|Open Label Phase (Optional)|Lost to Follow-up|0
5464398|NCT01998958|18888028|P19|Open Label Phase (Optional)|Lost to Follow-up|0
5464399|NCT01998958|18888029|P18|Open Label Phase (Optional)|Lost to Follow-up|0
5464400|NCT01998958|18888030|P17|Open Label Phase (Optional)|Lost to Follow-up|0
5464401|NCT01998958|18888031|P16|Open Label Phase (Optional)|Lost to Follow-up|0
5464402|NCT01998958|18888032|P15|Open Label Phase (Optional)|Lost to Follow-up|0
5464403|NCT01998958|18888033|P14|Open Label Phase (Optional)|Lost to Follow-up|0
5464404|NCT01998958|18888034|P13|Open Label Phase (Optional)|Lost to Follow-up|0
5464405|NCT01998958|18888035|P12|Open Label Phase (Optional)|Lost to Follow-up|0
5464406|NCT01998958|18888036|P11|Open Label Phase (Optional)|Lost to Follow-up|0
5464407|NCT01998958|18888037|P10|Open Label Phase (Optional)|Lost to Follow-up|0
5464408|NCT01998958|18888038|P9|Open Label Phase (Optional)|Lost to Follow-up|0
5464409|NCT01998958|18888039|P8|Open Label Phase (Optional)|Lost to Follow-up|0
5464410|NCT01998958|18888040|P7|Open Label Phase (Optional)|Lost to Follow-up|0
5464411|NCT01998958|18888041|P6|Open Label Phase (Optional)|Lost to Follow-up|0
5464412|NCT01998958|18888042|P5|Open Label Phase (Optional)|Lost to Follow-up|0
5464413|NCT01998958|18888043|P4|Open Label Phase (Optional)|Lost to Follow-up|0
5464414|NCT01998958|18888044|P3|Open Label Phase (Optional)|Lost to Follow-up|0
5464415|NCT01998958|18888045|P2|Open Label Phase (Optional)|Lost to Follow-up|0
5464416|NCT01998958|18888046|P1|Open Label Phase (Optional)|Lost to Follow-up|0
5464417|NCT01998958|18888015|P32|Open Label Phase (Optional)|Other|0
5464418|NCT01998958|18888016|P31|Open Label Phase (Optional)|Other|0
5464419|NCT01998958|18888017|P30|Open Label Phase (Optional)|Other|0
5464420|NCT01998958|18888018|P29|Open Label Phase (Optional)|Other|0
5464421|NCT01998958|18888019|P28|Open Label Phase (Optional)|Other|0
5464422|NCT01998958|18888020|P27|Open Label Phase (Optional)|Other|0
5464423|NCT01998958|18888021|P26|Open Label Phase (Optional)|Other|0
5464424|NCT01998958|18888022|P25|Open Label Phase (Optional)|Other|0
5464425|NCT01998958|18888023|P24|Open Label Phase (Optional)|Other|1
5464426|NCT01998958|18888024|P23|Open Label Phase (Optional)|Other|5
5464427|NCT01998958|18888025|P22|Open Label Phase (Optional)|Other|0
5464428|NCT01998958|18888026|P21|Open Label Phase (Optional)|Other|0
5464429|NCT01998958|18888027|P20|Open Label Phase (Optional)|Other|0
5464430|NCT01998958|18888028|P19|Open Label Phase (Optional)|Other|0
5464431|NCT01998958|18888029|P18|Open Label Phase (Optional)|Other|0
5464432|NCT01998958|18888030|P17|Open Label Phase (Optional)|Other|0
5464433|NCT01998958|18888031|P16|Open Label Phase (Optional)|Other|0
5464434|NCT01998958|18888032|P15|Open Label Phase (Optional)|Other|0
5464435|NCT01998958|18888033|P14|Open Label Phase (Optional)|Other|0
5464436|NCT01998958|18888034|P13|Open Label Phase (Optional)|Other|0
5464437|NCT01998958|18888035|P12|Open Label Phase (Optional)|Other|0
5464438|NCT01998958|18888036|P11|Open Label Phase (Optional)|Other|0
5464439|NCT01998958|18888037|P10|Open Label Phase (Optional)|Other|0
5464440|NCT01998958|18888038|P9|Open Label Phase (Optional)|Other|0
5464441|NCT01998958|18888039|P8|Open Label Phase (Optional)|Other|0
5464442|NCT01998958|18888040|P7|Open Label Phase (Optional)|Other|0
5464443|NCT01998958|18888041|P6|Open Label Phase (Optional)|Other|0
5464444|NCT01998958|18888042|P5|Open Label Phase (Optional)|Other|0
5464445|NCT01998958|18888043|P4|Open Label Phase (Optional)|Other|0
5464446|NCT01998958|18888044|P3|Open Label Phase (Optional)|Other|0
5464447|NCT01998958|18888045|P2|Open Label Phase (Optional)|Other|0
5464448|NCT01998958|18888046|P1|Open Label Phase (Optional)|Other|0
5464449|NCT01998958|18888015|P32|Open Label Phase (Optional)|Adverse Event|0
5464450|NCT01998958|18888016|P31|Open Label Phase (Optional)|Adverse Event|0
5464451|NCT01998958|18888017|P30|Open Label Phase (Optional)|Adverse Event|0
5464452|NCT01998958|18888018|P29|Open Label Phase (Optional)|Adverse Event|0
5464453|NCT01998958|18888019|P28|Open Label Phase (Optional)|Adverse Event|0
5464454|NCT01998958|18888020|P27|Open Label Phase (Optional)|Adverse Event|0
5464455|NCT01998958|18888021|P26|Open Label Phase (Optional)|Adverse Event|0
5464456|NCT01998958|18888022|P25|Open Label Phase (Optional)|Adverse Event|0
5464457|NCT01998958|18888023|P24|Open Label Phase (Optional)|Adverse Event|1
5464458|NCT01998958|18888024|P23|Open Label Phase (Optional)|Adverse Event|0
5464459|NCT01998958|18888025|P22|Open Label Phase (Optional)|Adverse Event|0
5464460|NCT01998958|18888026|P21|Open Label Phase (Optional)|Adverse Event|0
5464461|NCT01998958|18888027|P20|Open Label Phase (Optional)|Adverse Event|0
5464462|NCT01998958|18888028|P19|Open Label Phase (Optional)|Adverse Event|0
5464463|NCT01998958|18888029|P18|Open Label Phase (Optional)|Adverse Event|0
5464464|NCT01998958|18888030|P17|Open Label Phase (Optional)|Adverse Event|0
5464465|NCT01998958|18888031|P16|Open Label Phase (Optional)|Adverse Event|0
5464466|NCT01998958|18888032|P15|Open Label Phase (Optional)|Adverse Event|0
5464467|NCT01998958|18888033|P14|Open Label Phase (Optional)|Adverse Event|0
5464468|NCT01998958|18888034|P13|Open Label Phase (Optional)|Adverse Event|0
5464469|NCT01998958|18888035|P12|Open Label Phase (Optional)|Adverse Event|0
5464470|NCT01998958|18888036|P11|Open Label Phase (Optional)|Adverse Event|0
5464471|NCT01998958|18888037|P10|Open Label Phase (Optional)|Adverse Event|0
5464472|NCT01998958|18888038|P9|Open Label Phase (Optional)|Adverse Event|0
5464473|NCT01998958|18888039|P8|Open Label Phase (Optional)|Adverse Event|0
5464474|NCT01998958|18888040|P7|Open Label Phase (Optional)|Adverse Event|0
5464475|NCT01998958|18888041|P6|Open Label Phase (Optional)|Adverse Event|0
5464476|NCT01998958|18888042|P5|Open Label Phase (Optional)|Adverse Event|0
5464477|NCT01998958|18888043|P4|Open Label Phase (Optional)|Adverse Event|0
5464478|NCT01998958|18888044|P3|Open Label Phase (Optional)|Adverse Event|0
5464479|NCT01998958|18888045|P2|Open Label Phase (Optional)|Adverse Event|0
5464480|NCT01998958|18888046|P1|Open Label Phase (Optional)|Adverse Event|0
5464481|NCT01998958|18888015|P32|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464482|NCT01998958|18888016|P31|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464483|NCT01998958|18888017|P30|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464484|NCT01998958|18888018|P29|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464485|NCT01998958|18888019|P28|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464486|NCT01998958|18888020|P27|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464487|NCT01998958|18888021|P26|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464488|NCT01998958|18888022|P25|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464489|NCT01998958|18888023|P24|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464490|NCT01998958|18888024|P23|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464491|NCT01998958|18888025|P22|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464492|NCT01998958|18888026|P21|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464493|NCT01998958|18888027|P20|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464494|NCT01998958|18888028|P19|Period 2 (Panel A and B)|Withdrawal by Subject|1
5464495|NCT01998958|18888029|P18|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464496|NCT01998958|18888030|P17|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464497|NCT01998958|18888031|P16|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464498|NCT01998958|18888032|P15|Period 2 (Panel A and B)|Withdrawal by Subject|1
5464499|NCT01998958|18888033|P14|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464500|NCT01998958|18888034|P13|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464501|NCT01998958|18888035|P12|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464502|NCT01998958|18888036|P11|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464503|NCT01998958|18888037|P10|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464504|NCT01998958|18888038|P9|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464505|NCT01998958|18888039|P8|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464506|NCT01998958|18888040|P7|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464507|NCT01998958|18888041|P6|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464508|NCT01998958|18888042|P5|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464509|NCT01998958|18888043|P4|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464510|NCT01998958|18888044|P3|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464511|NCT01998958|18888045|P2|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464512|NCT01998958|18888046|P1|Period 2 (Panel A and B)|Withdrawal by Subject|0
5464513|NCT01998958|18888015|P32|Period 2 (Panel A and B)|Adverse Event|0
5464514|NCT01998958|18888016|P31|Period 2 (Panel A and B)|Adverse Event|0
5464515|NCT01998958|18888017|P30|Period 2 (Panel A and B)|Adverse Event|0
5464516|NCT01998958|18888018|P29|Period 2 (Panel A and B)|Adverse Event|0
5464517|NCT01998958|18888019|P28|Period 2 (Panel A and B)|Adverse Event|0
5464518|NCT01998958|18888020|P27|Period 2 (Panel A and B)|Adverse Event|0
5464519|NCT01998958|18888021|P26|Period 2 (Panel A and B)|Adverse Event|0
5464520|NCT01998958|18888022|P25|Period 2 (Panel A and B)|Adverse Event|0
5464521|NCT01998958|18888023|P24|Period 2 (Panel A and B)|Adverse Event|0
5464522|NCT01998958|18888024|P23|Period 2 (Panel A and B)|Adverse Event|0
5464523|NCT01998958|18888025|P22|Period 2 (Panel A and B)|Adverse Event|0
5464524|NCT01998958|18888026|P21|Period 2 (Panel A and B)|Adverse Event|0
5464525|NCT01998958|18888027|P20|Period 2 (Panel A and B)|Adverse Event|0
5464526|NCT01998958|18888028|P19|Period 2 (Panel A and B)|Adverse Event|0
5464527|NCT01998958|18888029|P18|Period 2 (Panel A and B)|Adverse Event|0
5464528|NCT01998958|18888030|P17|Period 2 (Panel A and B)|Adverse Event|0
5464529|NCT01998958|18888031|P16|Period 2 (Panel A and B)|Adverse Event|0
5464530|NCT01998958|18888032|P15|Period 2 (Panel A and B)|Adverse Event|1
5464531|NCT01998958|18888033|P14|Period 2 (Panel A and B)|Adverse Event|0
5464532|NCT01998958|18888034|P13|Period 2 (Panel A and B)|Adverse Event|0
5464533|NCT01998958|18888035|P12|Period 2 (Panel A and B)|Adverse Event|0
5464534|NCT01998958|18888036|P11|Period 2 (Panel A and B)|Adverse Event|1
5464535|NCT01998958|18888037|P10|Period 2 (Panel A and B)|Adverse Event|0
5464536|NCT01998958|18888038|P9|Period 2 (Panel A and B)|Adverse Event|0
5464537|NCT01998958|18888039|P8|Period 2 (Panel A and B)|Adverse Event|0
5464538|NCT01998958|18888040|P7|Period 2 (Panel A and B)|Adverse Event|0
5464539|NCT01998958|18888041|P6|Period 2 (Panel A and B)|Adverse Event|0
5464540|NCT01998958|18888042|P5|Period 2 (Panel A and B)|Adverse Event|0
5464541|NCT01998958|18888043|P4|Period 2 (Panel A and B)|Adverse Event|0
5464542|NCT01998958|18888044|P3|Period 2 (Panel A and B)|Adverse Event|0
5464543|NCT01998958|18888045|P2|Period 2 (Panel A and B)|Adverse Event|0
5464544|NCT01998958|18888046|P1|Period 2 (Panel A and B)|Adverse Event|0
5464545|NCT01998958|18888015|P32|Period 1 (Panel A and B)|Other|0
5464546|NCT01998958|18888016|P31|Period 1 (Panel A and B)|Other|0
5464547|NCT01998958|18888017|P30|Period 1 (Panel A and B)|Other|0
5464548|NCT01998958|18888018|P29|Period 1 (Panel A and B)|Other|0
5464549|NCT01998958|18888019|P28|Period 1 (Panel A and B)|Other|0
5464550|NCT01998958|18888020|P27|Period 1 (Panel A and B)|Other|0
5464551|NCT01998958|18888021|P26|Period 1 (Panel A and B)|Other|0
5464552|NCT01998958|18888022|P25|Period 1 (Panel A and B)|Other|0
5464553|NCT01998958|18888023|P24|Period 1 (Panel A and B)|Other|0
5464554|NCT01998958|18888024|P23|Period 1 (Panel A and B)|Other|0
5464555|NCT01998958|18888025|P22|Period 1 (Panel A and B)|Other|0
5464556|NCT01998958|18888026|P21|Period 1 (Panel A and B)|Other|0
5464557|NCT01998958|18888027|P20|Period 1 (Panel A and B)|Other|0
5464558|NCT01998958|18888028|P19|Period 1 (Panel A and B)|Other|0
5464559|NCT01998958|18888029|P18|Period 1 (Panel A and B)|Other|0
5464560|NCT01998958|18888030|P17|Period 1 (Panel A and B)|Other|0
5464561|NCT01998958|18888031|P16|Period 1 (Panel A and B)|Other|0
5464562|NCT01998958|18888032|P15|Period 1 (Panel A and B)|Other|0
5464563|NCT01998958|18888033|P14|Period 1 (Panel A and B)|Other|0
5464564|NCT01998958|18888034|P13|Period 1 (Panel A and B)|Other|0
5464565|NCT01998958|18888035|P12|Period 1 (Panel A and B)|Other|0
5464566|NCT01998958|18888036|P11|Period 1 (Panel A and B)|Other|0
5464567|NCT01998958|18888037|P10|Period 1 (Panel A and B)|Other|0
5464568|NCT01998958|18888038|P9|Period 1 (Panel A and B)|Other|0
5464569|NCT01998958|18888039|P8|Period 1 (Panel A and B)|Other|0
5464570|NCT01998958|18888040|P7|Period 1 (Panel A and B)|Other|0
5464571|NCT01998958|18888041|P6|Period 1 (Panel A and B)|Other|0
5464572|NCT01998958|18888042|P5|Period 1 (Panel A and B)|Other|0
5464573|NCT01998958|18888043|P4|Period 1 (Panel A and B)|Other|0
5464574|NCT01998958|18888044|P3|Period 1 (Panel A and B)|Other|0
5464575|NCT01998958|18888045|P2|Period 1 (Panel A and B)|Other|0
5464576|NCT01998958|18888046|P1|Period 1 (Panel A and B)|Other|1
5464577|NCT01998958|18888015|P32|Period 1 (Panel A and B)|Adverse Event|0
5464578|NCT01998958|18888016|P31|Period 1 (Panel A and B)|Adverse Event|0
5464579|NCT01998958|18888017|P30|Period 1 (Panel A and B)|Adverse Event|0
5464580|NCT01998958|18888018|P29|Period 1 (Panel A and B)|Adverse Event|0
5464581|NCT01998958|18888019|P28|Period 1 (Panel A and B)|Adverse Event|0
5464582|NCT01998958|18888020|P27|Period 1 (Panel A and B)|Adverse Event|0
5464583|NCT01998958|18888021|P26|Period 1 (Panel A and B)|Adverse Event|0
5464584|NCT01998958|18888022|P25|Period 1 (Panel A and B)|Adverse Event|0
5464585|NCT01998958|18888023|P24|Period 1 (Panel A and B)|Adverse Event|0
5464586|NCT01998958|18888024|P23|Period 1 (Panel A and B)|Adverse Event|0
5464587|NCT01998958|18888025|P22|Period 1 (Panel A and B)|Adverse Event|0
5464588|NCT01998958|18888026|P21|Period 1 (Panel A and B)|Adverse Event|0
5464589|NCT01998958|18888027|P20|Period 1 (Panel A and B)|Adverse Event|0
5464590|NCT01998958|18888028|P19|Period 1 (Panel A and B)|Adverse Event|0
5464591|NCT01998958|18888029|P18|Period 1 (Panel A and B)|Adverse Event|0
5464592|NCT01998958|18888030|P17|Period 1 (Panel A and B)|Adverse Event|0
5464593|NCT01998958|18888031|P16|Period 1 (Panel A and B)|Adverse Event|0
5464594|NCT01998958|18888032|P15|Period 1 (Panel A and B)|Adverse Event|0
5464595|NCT01998958|18888033|P14|Period 1 (Panel A and B)|Adverse Event|0
5464596|NCT01998958|18888034|P13|Period 1 (Panel A and B)|Adverse Event|0
5464597|NCT01998958|18888035|P12|Period 1 (Panel A and B)|Adverse Event|0
5464598|NCT01998958|18888036|P11|Period 1 (Panel A and B)|Adverse Event|0
5464599|NCT01998958|18888037|P10|Period 1 (Panel A and B)|Adverse Event|0
5464600|NCT01998958|18888038|P9|Period 1 (Panel A and B)|Adverse Event|0
5464601|NCT01998958|18888039|P8|Period 1 (Panel A and B)|Adverse Event|0
5464602|NCT01998958|18888040|P7|Period 1 (Panel A and B)|Adverse Event|0
5464603|NCT01998958|18888041|P6|Period 1 (Panel A and B)|Adverse Event|0
5464604|NCT01998958|18888042|P5|Period 1 (Panel A and B)|Adverse Event|0
5464605|NCT01998958|18888043|P4|Period 1 (Panel A and B)|Adverse Event|0
5464606|NCT01998958|18888044|P3|Period 1 (Panel A and B)|Adverse Event|0
5464607|NCT01998958|18888045|P2|Period 1 (Panel A and B)|Adverse Event|1
5464608|NCT01998958|18888046|P1|Period 1 (Panel A and B)|Adverse Event|0
5464609|NCT01998958|18888015|P32|Period 1 (Panel A and B)|Lack of Efficacy|0
5464610|NCT01998958|18888016|P31|Period 1 (Panel A and B)|Lack of Efficacy|0
5464611|NCT01998958|18888017|P30|Period 1 (Panel A and B)|Lack of Efficacy|0
5464612|NCT01998958|18888018|P29|Period 1 (Panel A and B)|Lack of Efficacy|0
5464613|NCT01998958|18888019|P28|Period 1 (Panel A and B)|Lack of Efficacy|0
5464614|NCT01998958|18888020|P27|Period 1 (Panel A and B)|Lack of Efficacy|0
5464615|NCT01998958|18888021|P26|Period 1 (Panel A and B)|Lack of Efficacy|0
5464616|NCT01998958|18888022|P25|Period 1 (Panel A and B)|Lack of Efficacy|0
5464617|NCT01998958|18888023|P24|Period 1 (Panel A and B)|Lack of Efficacy|0
5464618|NCT01998958|18888024|P23|Period 1 (Panel A and B)|Lack of Efficacy|0
5464619|NCT01998958|18888025|P22|Period 1 (Panel A and B)|Lack of Efficacy|0
5464620|NCT01998958|18888026|P21|Period 1 (Panel A and B)|Lack of Efficacy|0
5464621|NCT01998958|18888027|P20|Period 1 (Panel A and B)|Lack of Efficacy|0
5464622|NCT01998958|18888028|P19|Period 1 (Panel A and B)|Lack of Efficacy|0
5464623|NCT01998958|18888029|P18|Period 1 (Panel A and B)|Lack of Efficacy|0
5464624|NCT01998958|18888030|P17|Period 1 (Panel A and B)|Lack of Efficacy|0
5464625|NCT01998958|18888031|P16|Period 1 (Panel A and B)|Lack of Efficacy|0
5464626|NCT01998958|18888032|P15|Period 1 (Panel A and B)|Lack of Efficacy|0
5464627|NCT01998958|18888033|P14|Period 1 (Panel A and B)|Lack of Efficacy|0
5464628|NCT01998958|18888034|P13|Period 1 (Panel A and B)|Lack of Efficacy|0
5464629|NCT01998958|18888035|P12|Period 1 (Panel A and B)|Lack of Efficacy|0
5464630|NCT01998958|18888036|P11|Period 1 (Panel A and B)|Lack of Efficacy|0
5464631|NCT01998958|18888037|P10|Period 1 (Panel A and B)|Lack of Efficacy|0
5464632|NCT01998958|18888038|P9|Period 1 (Panel A and B)|Lack of Efficacy|0
5464633|NCT01998958|18888039|P8|Period 1 (Panel A and B)|Lack of Efficacy|0
5464634|NCT01998958|18888040|P7|Period 1 (Panel A and B)|Lack of Efficacy|0
5464635|NCT01998958|18888041|P6|Period 1 (Panel A and B)|Lack of Efficacy|0
5464636|NCT01998958|18888042|P5|Period 1 (Panel A and B)|Lack of Efficacy|0
5464637|NCT01998958|18888043|P4|Period 1 (Panel A and B)|Lack of Efficacy|0
5464638|NCT01998958|18888044|P3|Period 1 (Panel A and B)|Lack of Efficacy|0
5464639|NCT01998958|18888045|P2|Period 1 (Panel A and B)|Lack of Efficacy|1
5464640|NCT01998958|18888046|P1|Period 1 (Panel A and B)|Lack of Efficacy|0
5464641|NCT01998958|18888015|P32|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464642|NCT01998958|18888016|P31|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464643|NCT01998958|18888017|P30|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464644|NCT01998958|18888018|P29|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464645|NCT01998958|18888019|P28|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464646|NCT01998958|18888020|P27|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464647|NCT01998958|18888021|P26|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464648|NCT01998958|18888022|P25|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464649|NCT01998958|18888023|P24|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464650|NCT01998958|18888024|P23|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464651|NCT01998958|18888025|P22|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464652|NCT01998958|18888026|P21|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464653|NCT01998958|18888027|P20|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464654|NCT01998958|18888028|P19|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464655|NCT01998958|18888029|P18|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464656|NCT01998958|18888030|P17|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464657|NCT01998958|18888031|P16|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464658|NCT01998958|18888032|P15|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464659|NCT01998958|18888033|P14|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464660|NCT01998958|18888034|P13|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464661|NCT01998958|18888035|P12|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464662|NCT01998958|18888036|P11|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464663|NCT01998958|18888037|P10|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464664|NCT01998958|18888038|P9|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464665|NCT01998958|18888039|P8|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464666|NCT01998958|18888040|P7|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464667|NCT01998958|18888041|P6|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464668|NCT01998958|18888042|P5|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464669|NCT01998958|18888043|P4|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464670|NCT01998958|18888044|P3|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464671|NCT01998958|18888045|P2|Period 1 (Panel A and B)|Withdrawal by Subject|1
5464672|NCT01998958|18888046|P1|Period 1 (Panel A and B)|Withdrawal by Subject|0
5464673|NCT01998919|18888185|P2|Overall Study|Other|2
5464674|NCT01998919|18888186|P1|Overall Study|Other|5
5464675|NCT01998919|18888185|P2|Overall Study|Lost to Follow-up|0
5464676|NCT01998919|18888186|P1|Overall Study|Lost to Follow-up|2
5464677|NCT01998919|18888185|P2|Overall Study|Withdrawal by Subject|4
5464678|NCT01998919|18888186|P1|Overall Study|Withdrawal by Subject|2
5464679|NCT01998919|18888185|P2|Overall Study|Disease progression|22
5464680|NCT01998919|18888186|P1|Overall Study|Disease progression|31
5464681|NCT01998919|18888185|P2|Overall Study|Adverse Event|5
5464682|NCT01998919|18888186|P1|Overall Study|Adverse Event|0
5464683|NCT01998919|18888185|P2|Overall Study|Death|2
5464684|NCT01998919|18888186|P1|Overall Study|Death|2
5464685|NCT01998906|18888207|P3|Overall Study|Other|4
5464686|NCT01998906|18888208|P2|Overall Study|Other|8
5464687|NCT01998906|18888209|P1|Overall Study|Other|3
5464688|NCT01998906|18888207|P3|Overall Study|Administrative/Other|3
5464689|NCT01998906|18888208|P2|Overall Study|Administrative/Other|1
5464690|NCT01998906|18888209|P1|Overall Study|Administrative/Other|2
5464691|NCT01998906|18888207|P3|Overall Study|Withdrawal by Subject|3
5464692|NCT01998906|18888208|P2|Overall Study|Withdrawal by Subject|4
5464693|NCT01998906|18888209|P1|Overall Study|Withdrawal by Subject|1
5464694|NCT01998906|18888207|P3|Overall Study|Violation of Selection Criteria|1
5464870|NCT01995838|18889016|P3|Overall Study|Adverse Event|0
5464695|NCT01998906|18888208|P2|Overall Study|Violation of Selection Criteria|0
5464696|NCT01998906|18888209|P1|Overall Study|Violation of Selection Criteria|0
5464697|NCT01998906|18888207|P3|Overall Study|Failure to return|4
5464698|NCT01998906|18888208|P2|Overall Study|Failure to return|2
5464699|NCT01998906|18888209|P1|Overall Study|Failure to return|0
5464700|NCT01998906|18888207|P3|Overall Study|Lack of Efficacy|8
5464701|NCT01998906|18888208|P2|Overall Study|Lack of Efficacy|9
5464702|NCT01998906|18888209|P1|Overall Study|Lack of Efficacy|10
5464703|NCT01998906|18888207|P3|Overall Study|Death|17
5464704|NCT01998906|18888208|P2|Overall Study|Death|30
5464705|NCT01998906|18888209|P1|Overall Study|Death|21
5464706|NCT01998906|18888207|P3|Overall Study|Participants ongoing in follow-up|58
5464707|NCT01998906|18888208|P2|Overall Study|Participants ongoing in follow-up|60
5464708|NCT01998906|18888209|P1|Overall Study|Participants ongoing in follow-up|77
5464709|NCT01998893|18888253|P1|Overall Study|Transformation to high-grade lymphoma|1
5464710|NCT01998893|18888253|P1|Overall Study|Withdrawal by Subject|1
5464711|NCT01998893|18888253|P1|Overall Study|Protocol Violation|2
5464712|NCT01998893|18888253|P1|Overall Study|Physician Decision|2
5464713|NCT01998893|18888253|P1|Overall Study|Lost to Follow-up|8
5464714|NCT01998893|18888253|P1|Overall Study|Death|1
5464715|NCT01998893|18888253|P1|Overall Study|Adverse Event|2
5464716|NCT01998880|18888265|P2|Overall Study|Did Not Receive Treatment|2
5464717|NCT01998880|18888266|P1|Overall Study|Did Not Receive Treatment|3
5464718|NCT01998880|18888265|P2|Overall Study|Violation of Selection Criteria at Entry|1
5464719|NCT01998880|18888266|P1|Overall Study|Violation of Selection Criteria at Entry|0
5464720|NCT01998880|18888265|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
5464721|NCT01998880|18888266|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
5464722|NCT01998880|18888265|P2|Overall Study|Administrative/Other|1
5464723|NCT01998880|18888266|P1|Overall Study|Administrative/Other|1
5464724|NCT01998880|18888265|P2|Overall Study|Insufficient Therapeutic Response|5
5464725|NCT01998880|18888266|P1|Overall Study|Insufficient Therapeutic Response|1
5464726|NCT01998880|18888265|P2|Overall Study|Death|6
5464727|NCT01998880|18888266|P1|Overall Study|Death|3
5464728|NCT01998880|18888265|P2|Overall Study|Withdrew Consent|1
5464729|NCT01998880|18888266|P1|Overall Study|Withdrew Consent|2
5464730|NCT01998880|18888265|P2|Overall Study|Disease Progression|8
5464731|NCT01998880|18888266|P1|Overall Study|Disease Progression|1
5464732|NCT01998880|18888265|P2|Overall Study|Adverse Events or Intercurrent Illness|16
5464733|NCT01998880|18888266|P1|Overall Study|Adverse Events or Intercurrent Illness|16
5464734|NCT01998737|18888298|P2|Overall Study|Corrupted database|0
5464735|NCT01998737|18888299|P1|Overall Study|Corrupted database|23
5464736|NCT01998633|18888311|P1|Overall Study|Death|1
5464737|NCT01998581|18888329|P2|Overall Study|Randomized but withdrew before treatment|0
5464738|NCT01998581|18888330|P1|Overall Study|Randomized but withdrew before treatment|1
5464739|NCT01998581|18888329|P2|Overall Study|Other reasons|2
5464740|NCT01998581|18888330|P1|Overall Study|Other reasons|3
5464741|NCT01998581|18888329|P2|Overall Study|Adverse Event|1
5464742|NCT01998581|18888330|P1|Overall Study|Adverse Event|1
5464743|NCT01998581|18888329|P2|Overall Study|Lost to Follow-up|4
5464744|NCT01998581|18888330|P1|Overall Study|Lost to Follow-up|12
5464745|NCT01998581|18888329|P2|Overall Study|Withdrawal by Subject|1
5464746|NCT01998581|18888330|P1|Overall Study|Withdrawal by Subject|8
5464747|NCT01998581|18888329|P2|Overall Study|Protocol Violation|0
5464748|NCT01998581|18888330|P1|Overall Study|Protocol Violation|1
5464749|NCT01998581|18888329|P2|Overall Study|Refused repeat treatment|4
5464750|NCT01998581|18888330|P1|Overall Study|Refused repeat treatment|20
5464751|NCT01998477|18888343|P2|Overall Study|Withdrawal by Subject|0
5464752|NCT01998477|18888344|P1|Overall Study|Withdrawal by Subject|6
5464753|NCT01998477|18888343|P2|Overall Study|Lost to Follow-up|5
5464754|NCT01998477|18888344|P1|Overall Study|Lost to Follow-up|4
5464755|NCT01998399|18888390|P2|Overall Study|Withdrawal by Subject|1
5464756|NCT01998399|18888391|P1|Overall Study|Withdrawal by Subject|0
5464757|NCT01998399|18888390|P2|Overall Study|Study stopped before dosing completed|3
5464758|NCT01998399|18888391|P1|Overall Study|Study stopped before dosing completed|3
5464759|NCT01998399|18888390|P2|Overall Study|Death|2
5464760|NCT01998399|18888391|P1|Overall Study|Death|4
5464761|NCT01998399|18888390|P2|Overall Study|Lost to Follow-up|3
5464762|NCT01998399|18888391|P1|Overall Study|Lost to Follow-up|1
5464763|NCT01998243|18888446|P2|Overall Study|Withdrawal by Subject|4
5464764|NCT01998243|18888447|P1|Overall Study|Withdrawal by Subject|3
5464765|NCT01998243|18888446|P2|Overall Study|Protocol Violation|2
5464766|NCT01998243|18888447|P1|Overall Study|Protocol Violation|5
5464767|NCT01998243|18888446|P2|Overall Study|Pregnancy|1
5464768|NCT01998243|18888447|P1|Overall Study|Pregnancy|0
5464769|NCT01997892|18888470|P1|Overall Study|Study completion data not recorded|35
5464770|NCT01997892|18888470|P1|Overall Study|Other|3
5464771|NCT01997892|18888470|P1|Overall Study|Renal transplant|8
5464772|NCT01997892|18888470|P1|Overall Study|Death|14
5464773|NCT01997892|18888470|P1|Overall Study|Lost to Follow-up|6
5464774|NCT01997892|18888470|P1|Overall Study|Physician Decision|2
5464775|NCT01997333|18888644|P2|Survival Follow up|Various|2
5464776|NCT01997333|18888645|P1|Survival Follow up|Various|1
5464777|NCT01997333|18888644|P2|Survival Follow up|Lost to Follow-up|6
5464778|NCT01997333|18888645|P1|Survival Follow up|Lost to Follow-up|0
5464779|NCT01997333|18888644|P2|Survival Follow up|Withdrawal by Subject|6
5464780|NCT01997333|18888645|P1|Survival Follow up|Withdrawal by Subject|15
5464781|NCT01997333|18888644|P2|Randomization and Treatment|Did not receive treatment|5
5464782|NCT01997333|18888645|P1|Randomization and Treatment|Did not receive treatment|17
5464783|NCT01997333|18888644|P2|Randomization and Treatment|Withdrawal by Subject|3
5464784|NCT01997333|18888645|P1|Randomization and Treatment|Withdrawal by Subject|6
5464785|NCT01997333|18888644|P2|Randomization and Treatment|Physician Decision|4
5464786|NCT01997333|18888645|P1|Randomization and Treatment|Physician Decision|0
5464787|NCT01997333|18888644|P2|Randomization and Treatment|Adverse Event|32
5464788|NCT01997333|18888645|P1|Randomization and Treatment|Adverse Event|10
5464789|NCT01997333|18888644|P2|Randomization and Treatment|Disease Progression|159
5464790|NCT01997333|18888645|P1|Randomization and Treatment|Disease Progression|70
5464791|NCT01997281|18888662|P2|Overall Study|Withdrawal by Subject|0
5464792|NCT01997281|18888663|P1|Overall Study|Withdrawal by Subject|1
5464793|NCT01996982|18888689|P1|Overall Study|PI/team left institution|7
5464794|NCT01996904|18888705|P2|Overall Study|Lost to Follow-up|27
5464795|NCT01996904|18888706|P1|Overall Study|Lost to Follow-up|38
5464796|NCT01996826|18888791|P2|Overall Study|Physician Decision|1
5464797|NCT01996826|18888792|P1|Overall Study|Physician Decision|1
5464798|NCT01996826|18888791|P2|Overall Study|Lost to Follow-up|2
5464799|NCT01996826|18888792|P1|Overall Study|Lost to Follow-up|6
5464800|NCT01996748|18888815|P2|Overall Study|Lost to Follow-up|1
5464801|NCT01996748|18888816|P1|Overall Study|Lost to Follow-up|4
5464802|NCT01996748|18888815|P2|Overall Study|Withdrawal by Subject|1
5464803|NCT01996748|18888816|P1|Overall Study|Withdrawal by Subject|0
5464804|NCT01996748|18888815|P2|Overall Study|Adverse Event|4
5464805|NCT01996748|18888816|P1|Overall Study|Adverse Event|1
5464806|NCT01996748|18888815|P2|Overall Study|Physician Decision|0
5464807|NCT01996748|18888816|P1|Overall Study|Physician Decision|2
5464808|NCT01996748|18888815|P2|Overall Study|Personal reason|0
5464809|NCT01996748|18888816|P1|Overall Study|Personal reason|1
5464810|NCT01996709|18888830|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
5464811|NCT01996709|18888831|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
5464812|NCT01996709|18888830|P2|Overall Study|Subject Non-Compliant|0
5464813|NCT01996709|18888831|P1|Overall Study|Subject Non-Compliant|1
5464814|NCT01996709|18888830|P2|Overall Study|Lost to Follow-up|0
5464815|NCT01996709|18888831|P1|Overall Study|Lost to Follow-up|3
5464816|NCT01996709|18888830|P2|Overall Study|Withdrawal by Subject|0
5464817|NCT01996709|18888831|P1|Overall Study|Withdrawal by Subject|1
5464818|NCT01996592|18888878|P1|Overall Study|change in mode of delivery|4
5464819|NCT01996592|18888878|P1|Overall Study|Withdrawal by Subject|5
5464820|NCT01996592|18888878|P1|Overall Study|change in surgical date|4
5464821|NCT01996592|18888878|P1|Overall Study|no response to text/no diary entry|32
5464822|NCT01996332|18888914|P1|Overall Study|Lost to Follow-up|34
5464823|NCT01996332|18888914|P1|Overall Study|Physician Decision|17
5464824|NCT01996332|18888914|P1|Overall Study|Clinical Deterioration|28
5464825|NCT01996332|18888914|P1|Overall Study|Other|20
5464826|NCT01996332|18888914|P1|Overall Study|Withdrawal by Subject|71
5464827|NCT01996332|18888914|P1|Overall Study|Protocol Violation|9
5464828|NCT01996332|18888914|P1|Overall Study|Death|264
5464829|NCT01996332|18888914|P1|Overall Study|Lack of Efficacy|1245
5464830|NCT01996332|18888914|P1|Overall Study|Adverse Event|117
5464831|NCT01996319|18888922|P2|Overall Study|Adverse Event|2
5464832|NCT01996319|18888923|P1|Overall Study|Adverse Event|2
5464833|NCT01996319|18888922|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
5464834|NCT01996319|18888923|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
5464835|NCT01996319|18888922|P2|Overall Study|Protocol Violation|0
5464836|NCT01996319|18888923|P1|Overall Study|Protocol Violation|1
5464837|NCT01996254|18888945|P3|Overall Study|Lost to Follow-up|4
5464838|NCT01996254|18888946|P2|Overall Study|Lost to Follow-up|0
5464839|NCT01996254|18888947|P1|Overall Study|Lost to Follow-up|1
5464840|NCT01996254|18888945|P3|Overall Study|Withdrawal by Subject|4
5464841|NCT01996254|18888946|P2|Overall Study|Withdrawal by Subject|3
5464842|NCT01996254|18888947|P1|Overall Study|Withdrawal by Subject|0
5464843|NCT01996254|18888945|P3|Overall Study|Change in Eligibility|0
5464844|NCT01996254|18888946|P2|Overall Study|Change in Eligibility|2
5464845|NCT01996254|18888947|P1|Overall Study|Change in Eligibility|0
5464846|NCT01996241|18888975|P2|Overall Study|Lost to Follow-up|235
5464847|NCT01996241|18888976|P1|Overall Study|Lost to Follow-up|252
5464848|NCT01996033|18888992|P1|Overall Study|Lost to Follow-up|3
5464849|NCT01996033|18888992|P1|Overall Study|Withdrawal by Subject|4
5464850|NCT01996033|18888992|P1|Overall Study|Physician Decision|1
5464851|NCT01996033|18888992|P1|Overall Study|Death|1
5464852|NCT01995838|18889012|P7|Overall Study|Other|2
5464853|NCT01995838|18889013|P6|Overall Study|Other|1
5464854|NCT01995838|18889014|P5|Overall Study|Other|1
5464855|NCT01995838|18889015|P4|Overall Study|Other|2
5464856|NCT01995838|18889016|P3|Overall Study|Other|0
5464857|NCT01995838|18889017|P2|Overall Study|Other|1
5464858|NCT01995838|18889018|P1|Overall Study|Other|3
5464859|NCT01995838|18889012|P7|Overall Study|Withdrawal by Subject|0
5464860|NCT01995838|18889013|P6|Overall Study|Withdrawal by Subject|0
5464861|NCT01995838|18889014|P5|Overall Study|Withdrawal by Subject|1
5464862|NCT01995838|18889015|P4|Overall Study|Withdrawal by Subject|0
5464863|NCT01995838|18889016|P3|Overall Study|Withdrawal by Subject|0
5464864|NCT01995838|18889017|P2|Overall Study|Withdrawal by Subject|0
5464865|NCT01995838|18889018|P1|Overall Study|Withdrawal by Subject|0
5464866|NCT01995838|18889012|P7|Overall Study|Adverse Event|1
5464867|NCT01995838|18889013|P6|Overall Study|Adverse Event|0
5464868|NCT01995838|18889014|P5|Overall Study|Adverse Event|0
5464869|NCT01995838|18889015|P4|Overall Study|Adverse Event|0
5464871|NCT01995838|18889017|P2|Overall Study|Adverse Event|0
5464872|NCT01995838|18889018|P1|Overall Study|Adverse Event|0
5464873|NCT01995838|18889012|P7|Overall Study|Participant choice|1
5464874|NCT01995838|18889013|P6|Overall Study|Participant choice|1
5464875|NCT01995838|18889014|P5|Overall Study|Participant choice|0
5464876|NCT01995838|18889015|P4|Overall Study|Participant choice|0
5464877|NCT01995838|18889016|P3|Overall Study|Participant choice|0
5464878|NCT01995838|18889017|P2|Overall Study|Participant choice|0
5464879|NCT01995838|18889018|P1|Overall Study|Participant choice|2
5464880|NCT01995838|18889012|P7|Overall Study|Lost to Follow-up|1
5464881|NCT01995838|18889013|P6|Overall Study|Lost to Follow-up|0
5464882|NCT01995838|18889014|P5|Overall Study|Lost to Follow-up|0
5464883|NCT01995838|18889015|P4|Overall Study|Lost to Follow-up|0
5464884|NCT01995838|18889016|P3|Overall Study|Lost to Follow-up|0
5464885|NCT01995838|18889017|P2|Overall Study|Lost to Follow-up|1
5464886|NCT01995838|18889018|P1|Overall Study|Lost to Follow-up|0
5464887|NCT01995825|18889119|P2|Overall Study|Withdrawal by Subject|0
5464888|NCT01995825|18889120|P1|Overall Study|Withdrawal by Subject|1
5464889|NCT01995552|18889128|P1|Overall Study|Death|1
5464890|NCT01995552|18889128|P1|Overall Study|Lack of Efficacy|15
5464891|NCT01995552|18889128|P1|Overall Study|Protocol Violation|1
5464892|NCT01995539|18889134|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
5464893|NCT01995539|18889134|P1|Overall Study|Lost to Follow-up|5
5464894|NCT01995539|18889134|P1|Overall Study|Withdrawal by Subject|11
5464895|NCT01995539|18889134|P1|Overall Study|Withdrawal by Investigator|15
5464896|NCT01995539|18889134|P1|Overall Study|Screening Failure|1
5464897|NCT01995526|18889139|P1|Overall Study|Physician Decision|1
5464898|NCT01995513|18889147|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
5464899|NCT01995513|18889148|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
5464900|NCT01995513|18889149|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
5464901|NCT01995513|18889147|P3|Double Blind Treatment Period|Disease Progression|93
5464902|NCT01995513|18889148|P2|Double Blind Treatment Period|Disease Progression|82
5464903|NCT01995513|18889149|P1|Double Blind Treatment Period|Disease Progression|0
5464904|NCT01995513|18889147|P3|Double Blind Treatment Period|Death|1
5464905|NCT01995513|18889148|P2|Double Blind Treatment Period|Death|0
5464906|NCT01995513|18889149|P1|Double Blind Treatment Period|Death|0
5464907|NCT01995513|18889147|P3|Double Blind Treatment Period|Withdrawal by Subject|6
5464908|NCT01995513|18889148|P2|Double Blind Treatment Period|Withdrawal by Subject|4
5464909|NCT01995513|18889149|P1|Double Blind Treatment Period|Withdrawal by Subject|0
5464910|NCT01995513|18889147|P3|Double Blind Treatment Period|Other|2
5464911|NCT01995513|18889148|P2|Double Blind Treatment Period|Other|1
5464912|NCT01995513|18889149|P1|Double Blind Treatment Period|Other|0
5464913|NCT01995513|18889147|P3|Double Blind Treatment Period|Adverse Event|5
5464914|NCT01995513|18889148|P2|Double Blind Treatment Period|Adverse Event|12
5464915|NCT01995513|18889149|P1|Double Blind Treatment Period|Adverse Event|0
5464916|NCT01995513|18889147|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
5464917|NCT01995513|18889148|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
5464918|NCT01995513|18889149|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
5464919|NCT01995513|18889147|P3|Open Label Treatment Period|Death|0
5464920|NCT01995513|18889148|P2|Open Label Treatment Period|Death|0
5464921|NCT01995513|18889149|P1|Open Label Treatment Period|Death|8
5464922|NCT01995513|18889147|P3|Open Label Treatment Period|Adverse Event|0
5464923|NCT01995513|18889148|P2|Open Label Treatment Period|Adverse Event|0
5464924|NCT01995513|18889149|P1|Open Label Treatment Period|Adverse Event|35
5464925|NCT01995513|18889147|P3|Open Label Treatment Period|No PSA response at week 13|0
5464926|NCT01995513|18889148|P2|Open Label Treatment Period|No PSA response at week 13|0
5464927|NCT01995513|18889149|P1|Open Label Treatment Period|No PSA response at week 13|43
5464928|NCT01995513|18889147|P3|Open Label Treatment Period|Disease Progression|0
5464929|NCT01995513|18889148|P2|Open Label Treatment Period|Disease Progression|0
5464930|NCT01995513|18889149|P1|Open Label Treatment Period|Disease Progression|64
5464931|NCT01995513|18889147|P3|Open Label Treatment Period|Protocol Violation|0
5464932|NCT01995513|18889148|P2|Open Label Treatment Period|Protocol Violation|0
5464933|NCT01995513|18889149|P1|Open Label Treatment Period|Protocol Violation|1
5464934|NCT01995513|18889147|P3|Open Label Treatment Period|Withdrawal by Subject|0
5464935|NCT01995513|18889148|P2|Open Label Treatment Period|Withdrawal by Subject|0
5464936|NCT01995513|18889149|P1|Open Label Treatment Period|Withdrawal by Subject|14
5464937|NCT01995513|18889147|P3|Open Label Treatment Period|Other|0
5464938|NCT01995513|18889148|P2|Open Label Treatment Period|Other|0
5464939|NCT01995513|18889149|P1|Open Label Treatment Period|Other|9
5464940|NCT01995461|18889192|P1|Overall Study|Withdrawal by Subject|2
5464941|NCT01995461|18889192|P1|Overall Study|Lost to Follow-up|2
5464942|NCT01995461|18889192|P1|Overall Study|Death|1
5464943|NCT01995357|18889198|P6|Period 5|Adverse Event|0
5464944|NCT01995357|18889199|P5|Period 5|Adverse Event|0
5464945|NCT01995357|18889200|P4|Period 5|Adverse Event|0
5464946|NCT01995357|18889201|P3|Period 5|Adverse Event|1
5464947|NCT01995357|18889202|P2|Period 5|Adverse Event|0
5464948|NCT01995357|18889203|P1|Period 5|Adverse Event|1
5464949|NCT01995357|18889198|P6|Period 5|Lack of Efficacy|0
5464950|NCT01995357|18889199|P5|Period 5|Lack of Efficacy|0
5464951|NCT01995357|18889200|P4|Period 5|Lack of Efficacy|0
5464952|NCT01995357|18889201|P3|Period 5|Lack of Efficacy|0
5464953|NCT01995357|18889202|P2|Period 5|Lack of Efficacy|0
5464954|NCT01995357|18889203|P1|Period 5|Lack of Efficacy|1
5464955|NCT01995266|18889219|P1|Overall Study|Adverse Event|2
5464956|NCT01995266|18889219|P1|Overall Study|Lack of Efficacy|6
5464957|NCT01995266|18889219|P1|Overall Study|Death|1
5464958|NCT01995201|18889234|P7|From Week 24 Until Week 48|Protocol Violation|0
5464959|NCT01995201|18889235|P6|From Week 24 Until Week 48|Protocol Violation|0
5464960|NCT01995201|18889236|P5|From Week 24 Until Week 48|Protocol Violation|2
5464961|NCT01995201|18889237|P4|From Week 24 Until Week 48|Protocol Violation|0
5464962|NCT01995201|18889238|P3|From Week 24 Until Week 48|Protocol Violation|1
5464963|NCT01995201|18889239|P2|From Week 24 Until Week 48|Protocol Violation|0
5464964|NCT01995201|18889240|P1|From Week 24 Until Week 48|Protocol Violation|0
5464965|NCT01995201|18889234|P7|From Week 24 Until Week 48|Physician Decision|0
5464966|NCT01995201|18889235|P6|From Week 24 Until Week 48|Physician Decision|0
5464967|NCT01995201|18889236|P5|From Week 24 Until Week 48|Physician Decision|1
5464968|NCT01995201|18889237|P4|From Week 24 Until Week 48|Physician Decision|0
5464969|NCT01995201|18889238|P3|From Week 24 Until Week 48|Physician Decision|0
5464970|NCT01995201|18889239|P2|From Week 24 Until Week 48|Physician Decision|0
5464971|NCT01995201|18889240|P1|From Week 24 Until Week 48|Physician Decision|0
5464972|NCT01995201|18889234|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
5464973|NCT01995201|18889235|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
5464974|NCT01995201|18889236|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
5464975|NCT01995201|18889237|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
5464976|NCT01995201|18889238|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
5464977|NCT01995201|18889239|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
5464978|NCT01995201|18889240|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
5464979|NCT01995201|18889234|P7|From Week 24 Until Week 48|Lost to Follow-up|0
5464980|NCT01995201|18889235|P6|From Week 24 Until Week 48|Lost to Follow-up|1
5464981|NCT01995201|18889236|P5|From Week 24 Until Week 48|Lost to Follow-up|1
5464982|NCT01995201|18889237|P4|From Week 24 Until Week 48|Lost to Follow-up|0
5464983|NCT01995201|18889238|P3|From Week 24 Until Week 48|Lost to Follow-up|0
5464984|NCT01995201|18889239|P2|From Week 24 Until Week 48|Lost to Follow-up|0
5464985|NCT01995201|18889240|P1|From Week 24 Until Week 48|Lost to Follow-up|0
5464986|NCT01995201|18889234|P7|From Week 24 Until Week 48|Lack of Efficacy|1
5464987|NCT01995201|18889235|P6|From Week 24 Until Week 48|Lack of Efficacy|2
5464988|NCT01995201|18889236|P5|From Week 24 Until Week 48|Lack of Efficacy|0
5464989|NCT01995201|18889237|P4|From Week 24 Until Week 48|Lack of Efficacy|0
5464990|NCT01995201|18889238|P3|From Week 24 Until Week 48|Lack of Efficacy|1
5464991|NCT01995201|18889239|P2|From Week 24 Until Week 48|Lack of Efficacy|0
5464992|NCT01995201|18889240|P1|From Week 24 Until Week 48|Lack of Efficacy|0
5464993|NCT01995201|18889234|P7|From Week 24 Until Week 48|Death|0
5464994|NCT01995201|18889235|P6|From Week 24 Until Week 48|Death|2
5464995|NCT01995201|18889236|P5|From Week 24 Until Week 48|Death|0
5464996|NCT01995201|18889237|P4|From Week 24 Until Week 48|Death|0
5464997|NCT01995201|18889238|P3|From Week 24 Until Week 48|Death|0
5464998|NCT01995201|18889239|P2|From Week 24 Until Week 48|Death|0
5464999|NCT01995201|18889240|P1|From Week 24 Until Week 48|Death|0
5465000|NCT01995201|18889234|P7|From Week 24 Until Week 48|Adverse Event|1
5465001|NCT01995201|18889235|P6|From Week 24 Until Week 48|Adverse Event|3
5465002|NCT01995201|18889236|P5|From Week 24 Until Week 48|Adverse Event|1
5465003|NCT01995201|18889237|P4|From Week 24 Until Week 48|Adverse Event|1
5465004|NCT01995201|18889238|P3|From Week 24 Until Week 48|Adverse Event|2
5465005|NCT01995201|18889239|P2|From Week 24 Until Week 48|Adverse Event|0
5465006|NCT01995201|18889240|P1|From Week 24 Until Week 48|Adverse Event|0
5465007|NCT01995201|18889234|P7|From Baseline Until Week 24|Protocol Violation|0
5465008|NCT01995201|18889235|P6|From Baseline Until Week 24|Protocol Violation|0
5465009|NCT01995201|18889236|P5|From Baseline Until Week 24|Protocol Violation|0
5465010|NCT01995201|18889237|P4|From Baseline Until Week 24|Protocol Violation|0
5465011|NCT01995201|18889238|P3|From Baseline Until Week 24|Protocol Violation|0
5465012|NCT01995201|18889239|P2|From Baseline Until Week 24|Protocol Violation|9
5465013|NCT01995201|18889240|P1|From Baseline Until Week 24|Protocol Violation|0
5465014|NCT01995201|18889234|P7|From Baseline Until Week 24|Physician Decision|0
5465015|NCT01995201|18889235|P6|From Baseline Until Week 24|Physician Decision|0
5465016|NCT01995201|18889236|P5|From Baseline Until Week 24|Physician Decision|0
5465017|NCT01995201|18889237|P4|From Baseline Until Week 24|Physician Decision|0
5465018|NCT01995201|18889238|P3|From Baseline Until Week 24|Physician Decision|0
5465019|NCT01995201|18889239|P2|From Baseline Until Week 24|Physician Decision|2
5465020|NCT01995201|18889240|P1|From Baseline Until Week 24|Physician Decision|0
5465021|NCT01995201|18889234|P7|From Baseline Until Week 24|Withdrawal by Subject|0
5465022|NCT01995201|18889235|P6|From Baseline Until Week 24|Withdrawal by Subject|0
5465023|NCT01995201|18889236|P5|From Baseline Until Week 24|Withdrawal by Subject|0
5465024|NCT01995201|18889237|P4|From Baseline Until Week 24|Withdrawal by Subject|0
5465025|NCT01995201|18889238|P3|From Baseline Until Week 24|Withdrawal by Subject|0
5465026|NCT01995201|18889239|P2|From Baseline Until Week 24|Withdrawal by Subject|8
5465027|NCT01995201|18889240|P1|From Baseline Until Week 24|Withdrawal by Subject|2
5465028|NCT01995201|18889234|P7|From Baseline Until Week 24|Lost to Follow-up|0
5465029|NCT01995201|18889235|P6|From Baseline Until Week 24|Lost to Follow-up|0
5465030|NCT01995201|18889236|P5|From Baseline Until Week 24|Lost to Follow-up|0
5465031|NCT01995201|18889237|P4|From Baseline Until Week 24|Lost to Follow-up|0
5465032|NCT01995201|18889238|P3|From Baseline Until Week 24|Lost to Follow-up|0
5465033|NCT01995201|18889239|P2|From Baseline Until Week 24|Lost to Follow-up|3
5465034|NCT01995201|18889240|P1|From Baseline Until Week 24|Lost to Follow-up|2
5465035|NCT01995201|18889234|P7|From Baseline Until Week 24|Lack of Efficacy|0
5465036|NCT01995201|18889235|P6|From Baseline Until Week 24|Lack of Efficacy|0
5465037|NCT01995201|18889236|P5|From Baseline Until Week 24|Lack of Efficacy|0
5465038|NCT01995201|18889237|P4|From Baseline Until Week 24|Lack of Efficacy|0
5465039|NCT01995201|18889238|P3|From Baseline Until Week 24|Lack of Efficacy|0
5465040|NCT01995201|18889239|P2|From Baseline Until Week 24|Lack of Efficacy|5
5465041|NCT01995201|18889240|P1|From Baseline Until Week 24|Lack of Efficacy|2
5465042|NCT01995201|18889234|P7|From Baseline Until Week 24|Death|0
5465043|NCT01995201|18889235|P6|From Baseline Until Week 24|Death|0
5465044|NCT01995201|18889236|P5|From Baseline Until Week 24|Death|0
5465045|NCT01995201|18889237|P4|From Baseline Until Week 24|Death|0
5465046|NCT01995201|18889238|P3|From Baseline Until Week 24|Death|0
5465047|NCT01995201|18889239|P2|From Baseline Until Week 24|Death|1
5465048|NCT01995201|18889240|P1|From Baseline Until Week 24|Death|0
5465049|NCT01995201|18889234|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5465050|NCT01995201|18889235|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5465051|NCT01995201|18889236|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5465052|NCT01995201|18889237|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5465053|NCT01995201|18889238|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5465054|NCT01995201|18889239|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
5465055|NCT01995201|18889240|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
5465056|NCT01995201|18889234|P7|From Baseline Until Week 24|Adverse Event|0
5465057|NCT01995201|18889235|P6|From Baseline Until Week 24|Adverse Event|0
5465058|NCT01995201|18889236|P5|From Baseline Until Week 24|Adverse Event|0
5465059|NCT01995201|18889237|P4|From Baseline Until Week 24|Adverse Event|0
5465060|NCT01995201|18889238|P3|From Baseline Until Week 24|Adverse Event|0
5465061|NCT01995201|18889239|P2|From Baseline Until Week 24|Adverse Event|15
5465062|NCT01995201|18889240|P1|From Baseline Until Week 24|Adverse Event|4
5465063|NCT01995175|18889349|P1|Overall Study|Migrated / moved from the study area|49
5465064|NCT01995175|18889349|P1|Overall Study|Other|67
5465065|NCT01995175|18889349|P1|Overall Study|Lost to Follow-up|102
5465066|NCT01995175|18889349|P1|Overall Study|Withdrawal by Subject|35
5465067|NCT01995136|18889364|P1|Overall Study|Change in residence|1
5465068|NCT01995071|18889393|P12|Overall Study|Incarcerated|0
5465069|NCT01995071|18889394|P11|Overall Study|Incarcerated|0
5465070|NCT01995071|18889395|P10|Overall Study|Incarcerated|0
5465071|NCT01995071|18889396|P9|Overall Study|Incarcerated|0
5465072|NCT01995071|18889397|P8|Overall Study|Incarcerated|1
5465073|NCT01995071|18889398|P7|Overall Study|Incarcerated|0
5465074|NCT01995071|18889399|P6|Overall Study|Incarcerated|0
5465075|NCT01995071|18889400|P5|Overall Study|Incarcerated|0
5465076|NCT01995071|18889401|P4|Overall Study|Incarcerated|0
5465077|NCT01995071|18889402|P3|Overall Study|Incarcerated|0
5465078|NCT01995071|18889403|P2|Overall Study|Incarcerated|0
5465079|NCT01995071|18889404|P1|Overall Study|Incarcerated|0
5465080|NCT01995071|18889393|P12|Overall Study|Lost to Follow-up|0
5465081|NCT01995071|18889394|P11|Overall Study|Lost to Follow-up|0
5465082|NCT01995071|18889395|P10|Overall Study|Lost to Follow-up|0
5465083|NCT01995071|18889396|P9|Overall Study|Lost to Follow-up|1
5465084|NCT01995071|18889397|P8|Overall Study|Lost to Follow-up|1
5465085|NCT01995071|18889398|P7|Overall Study|Lost to Follow-up|0
5465086|NCT01995071|18889399|P6|Overall Study|Lost to Follow-up|0
5465087|NCT01995071|18889400|P5|Overall Study|Lost to Follow-up|0
5465088|NCT01995071|18889401|P4|Overall Study|Lost to Follow-up|0
5465089|NCT01995071|18889402|P3|Overall Study|Lost to Follow-up|0
5465090|NCT01995071|18889403|P2|Overall Study|Lost to Follow-up|0
5465091|NCT01995071|18889404|P1|Overall Study|Lost to Follow-up|1
5465092|NCT01995071|18889393|P12|Overall Study|Moved|0
5465093|NCT01995071|18889394|P11|Overall Study|Moved|1
5465094|NCT01995071|18889395|P10|Overall Study|Moved|0
5465095|NCT01995071|18889396|P9|Overall Study|Moved|0
5465096|NCT01995071|18889397|P8|Overall Study|Moved|0
5465097|NCT01995071|18889398|P7|Overall Study|Moved|0
5465098|NCT01995071|18889399|P6|Overall Study|Moved|0
5465099|NCT01995071|18889400|P5|Overall Study|Moved|1
5465100|NCT01995071|18889401|P4|Overall Study|Moved|0
5465101|NCT01995071|18889402|P3|Overall Study|Moved|1
5465102|NCT01995071|18889403|P2|Overall Study|Moved|0
5465103|NCT01995071|18889404|P1|Overall Study|Moved|0
5465104|NCT01995071|18889393|P12|Overall Study|Adverse Event|0
5465105|NCT01995071|18889394|P11|Overall Study|Adverse Event|0
5465106|NCT01995071|18889395|P10|Overall Study|Adverse Event|0
5465107|NCT01995071|18889396|P9|Overall Study|Adverse Event|0
5465108|NCT01995071|18889397|P8|Overall Study|Adverse Event|0
5465109|NCT01995071|18889398|P7|Overall Study|Adverse Event|1
5465110|NCT01995071|18889399|P6|Overall Study|Adverse Event|0
5465111|NCT01995071|18889400|P5|Overall Study|Adverse Event|0
5465112|NCT01995071|18889401|P4|Overall Study|Adverse Event|0
5465113|NCT01995071|18889402|P3|Overall Study|Adverse Event|0
5465114|NCT01995071|18889403|P2|Overall Study|Adverse Event|0
5465115|NCT01995071|18889404|P1|Overall Study|Adverse Event|0
5465116|NCT01994954|18889541|P2|Overall Study|6 Month Follow-up Not Complete|4
5465117|NCT01994954|18889542|P1|Overall Study|6 Month Follow-up Not Complete|5
5465118|NCT01994954|18889541|P2|Overall Study|Lost to Follow-up|10
5465119|NCT01994954|18889542|P1|Overall Study|Lost to Follow-up|8
5465120|NCT01994954|18889541|P2|Overall Study|Physician Decision|2
5465121|NCT01994954|18889542|P1|Overall Study|Physician Decision|2
5465122|NCT01994954|18889541|P2|Overall Study|Withdrawal by Subject|14
5465123|NCT01994954|18889542|P1|Overall Study|Withdrawal by Subject|9
5465124|NCT01994954|18889541|P2|Overall Study|Death|0
5465125|NCT01994954|18889542|P1|Overall Study|Death|1
5465126|NCT01994902|18889560|P2|Test Period 2|Other|3
5465127|NCT01994902|18889561|P1|Test Period 2|Other|0
5465128|NCT01994902|18889560|P2|Test Period 2|Lack of Efficacy|1
5465129|NCT01994902|18889561|P1|Test Period 2|Lack of Efficacy|0
5465130|NCT01994902|18889560|P2|Test Period 2|Withdrawal by Subject|2
5465131|NCT01994902|18889561|P1|Test Period 2|Withdrawal by Subject|0
5465132|NCT01994902|18889560|P2|Test Period 1|bag too small|0
5465133|NCT01994902|18889561|P1|Test Period 1|bag too small|1
5465134|NCT01994902|18889560|P2|Test Period 1|Lack of Efficacy|1
5465135|NCT01994902|18889561|P1|Test Period 1|Lack of Efficacy|0
5465136|NCT01994902|18889560|P2|Test Period 1|Adverse Event|1
5465137|NCT01994902|18889561|P1|Test Period 1|Adverse Event|2
5465138|NCT01994902|18889560|P2|Test Period 1|device deficiency with adverse event|1
5465139|NCT01994902|18889561|P1|Test Period 1|device deficiency with adverse event|0
5465140|NCT01994902|18889560|P2|Test Period 1|Withdrawal by Subject|0
5465141|NCT01994902|18889561|P1|Test Period 1|Withdrawal by Subject|3
5465142|NCT01994889|18889570|P3|Overall Study|Death|38
5465143|NCT01994889|18889571|P2|Overall Study|Death|25
5465144|NCT01994889|18889572|P1|Overall Study|Death|14
5465145|NCT01994889|18889570|P3|Overall Study|Protocol Violation|1
5465146|NCT01994889|18889571|P2|Overall Study|Protocol Violation|1
5465147|NCT01994889|18889572|P1|Overall Study|Protocol Violation|0
5465148|NCT01994889|18889570|P3|Overall Study|Lost to Follow-up|0
5465149|NCT01994889|18889571|P2|Overall Study|Lost to Follow-up|1
5465150|NCT01994889|18889572|P1|Overall Study|Lost to Follow-up|0
5465151|NCT01994889|18889570|P3|Overall Study|No longer willing to participate|37
5465152|NCT01994889|18889571|P2|Overall Study|No longer willing to participate|17
5465153|NCT01994889|18889572|P1|Overall Study|No longer willing to participate|8
5465154|NCT01994889|18889570|P3|Overall Study|Organ Transplantation|5
5465155|NCT01994889|18889571|P2|Overall Study|Organ Transplantation|5
5465156|NCT01994889|18889572|P1|Overall Study|Organ Transplantation|1
5465157|NCT01994889|18889570|P3|Overall Study|Cardiac Device Implantation|0
5465158|NCT01994889|18889571|P2|Overall Study|Cardiac Device Implantation|2
5465159|NCT01994889|18889572|P1|Overall Study|Cardiac Device Implantation|0
5465160|NCT01994889|18889570|P3|Overall Study|Adverse Event|11
5465161|NCT01994889|18889571|P2|Overall Study|Adverse Event|12
5465162|NCT01994889|18889572|P1|Overall Study|Adverse Event|5
5465163|NCT01994876|18889591|P2|Test Period 2|Protocol Violation|1
5465164|NCT01994876|18889592|P1|Test Period 2|Protocol Violation|0
5465165|NCT01994876|18889591|P2|Test Period 2|Adverse Event|0
5465166|NCT01994876|18889592|P1|Test Period 2|Adverse Event|1
5465167|NCT01994876|18889591|P2|Test Period 1|Adverse Event|1
5465168|NCT01994876|18889592|P1|Test Period 1|Adverse Event|0
5465169|NCT01994876|18889591|P2|Test Period 1|Withdrawal by Subject|1
5465170|NCT01994876|18889592|P1|Test Period 1|Withdrawal by Subject|0
5465171|NCT01994863|18889600|P2|Period 2|Withdrawal by Subject|1
5465172|NCT01994863|18889601|P1|Period 2|Withdrawal by Subject|1
5465173|NCT01994863|18889600|P2|Period 2|Lack of Efficacy|2
5465174|NCT01994863|18889601|P1|Period 2|Lack of Efficacy|0
5465175|NCT01994863|18889600|P2|Period 2|Adverse Event|1
5465176|NCT01994863|18889601|P1|Period 2|Adverse Event|0
5465177|NCT01994863|18889600|P2|Period 1|Lack of Efficacy|0
5465178|NCT01994863|18889601|P1|Period 1|Lack of Efficacy|1
5465179|NCT01994863|18889600|P2|Period 1|Trial stopped by sponsor|3
5465180|NCT01994863|18889601|P1|Period 1|Trial stopped by sponsor|1
5465181|NCT01994863|18889600|P2|Period 1|Withdrawal by Subject|0
5465182|NCT01994863|18889601|P1|Period 1|Withdrawal by Subject|1
5465183|NCT01994863|18889600|P2|Period 1|Adverse Event|0
5465184|NCT01994863|18889601|P1|Period 1|Adverse Event|4
5465185|NCT01994850|18889607|P1|Overall Study|Withdrawal by Subject|1
5465186|NCT01994850|18889607|P1|Overall Study|Physician Decision|1
5465187|NCT01994837|18889612|P1|Overall Study|Removed from study due to no response|1
5465188|NCT01994837|18889612|P1|Overall Study|Proceeded to transplant|1
5465189|NCT01994837|18889612|P1|Overall Study|Chose palliative care|1
5465190|NCT01994837|18889612|P1|Overall Study|Adverse event not related to progression|1
5465191|NCT01994837|18889612|P1|Overall Study|Fatal progressive disease|2
5465192|NCT01994837|18889612|P1|Overall Study|Adv event related to progressive disease|3
5465193|NCT01994837|18889612|P1|Overall Study|Progressive disease per protocol|23
5465194|NCT01994720|18889669|P2|Overall Study|Withdrawal by Subject|56
5465195|NCT01994720|18889670|P1|Overall Study|Withdrawal by Subject|46
5465196|NCT01994629|18889712|P2|Overall Study|Lost to Follow-up|3
5465197|NCT01994629|18889713|P1|Overall Study|Lost to Follow-up|0
5465198|NCT01994629|18889712|P2|Overall Study|Withdrawal by Subject|0
5465199|NCT01994629|18889713|P1|Overall Study|Withdrawal by Subject|1
5465200|NCT01994590|18889737|P1|Overall Study|Trial Terminated|1
5465201|NCT01994590|18889737|P1|Overall Study|Adverse Event|1
5465202|NCT01994395|18889765|P2|Overall Study|Withdrawal by Subject|2
5465203|NCT01994395|18889766|P1|Overall Study|Withdrawal by Subject|1
5465204|NCT01994291|18889791|P3|Overall Study|Other|0
5465205|NCT01994291|18889792|P2|Overall Study|Other|2
5465206|NCT01994291|18889793|P1|Overall Study|Other|1
5465207|NCT01994291|18889791|P3|Overall Study|Withdrawal by Subject|5
5465208|NCT01994291|18889792|P2|Overall Study|Withdrawal by Subject|3
5465209|NCT01994291|18889793|P1|Overall Study|Withdrawal by Subject|6
5465210|NCT01994291|18889791|P3|Overall Study|Protocol Violation|0
5465211|NCT01994291|18889792|P2|Overall Study|Protocol Violation|0
5465212|NCT01994291|18889793|P1|Overall Study|Protocol Violation|1
5465213|NCT01994291|18889791|P3|Overall Study|Medication error without associated AE|1
5465214|NCT01994291|18889792|P2|Overall Study|Medication error without associated AE|0
5465215|NCT01994291|18889793|P1|Overall Study|Medication error without associated AE|1
5465216|NCT01994291|18889791|P3|Overall Study|Does not meet entrance criteria|0
5465217|NCT01994291|18889792|P2|Overall Study|Does not meet entrance criteria|0
5465218|NCT01994291|18889793|P1|Overall Study|Does not meet entrance criteria|1
5465219|NCT01994291|18889791|P3|Overall Study|Lost to Follow-up|0
5465220|NCT01994291|18889792|P2|Overall Study|Lost to Follow-up|1
5465221|NCT01994291|18889793|P1|Overall Study|Lost to Follow-up|1
5465222|NCT01994291|18889791|P3|Overall Study|Adverse Event|3
5465223|NCT01994291|18889792|P2|Overall Study|Adverse Event|1
5465224|NCT01994291|18889793|P1|Overall Study|Adverse Event|4
5465225|NCT01994226|18889849|P2|Overall Study|Early Cessation of treatment|11
5465226|NCT01994226|18889850|P1|Overall Study|Early Cessation of treatment|6
5465227|NCT01994226|18889849|P2|Overall Study|Protocol Violation|10
5465228|NCT01994226|18889850|P1|Overall Study|Protocol Violation|13
5465229|NCT01993940|18889876|P2|Overall Study|Other - Miscellaneous|1
5465230|NCT01993940|18889877|P1|Overall Study|Other - Miscellaneous|1
5465231|NCT01993940|18889876|P2|Overall Study|Death|0
5465232|NCT01993940|18889877|P1|Overall Study|Death|1
5465233|NCT01993940|18889876|P2|Overall Study|Protocol Violation|8
5465234|NCT01993940|18889877|P1|Overall Study|Protocol Violation|5
5465235|NCT01993940|18889876|P2|Overall Study|Lost to Follow-up|5
5465236|NCT01993940|18889877|P1|Overall Study|Lost to Follow-up|2
5465237|NCT01993940|18889876|P2|Overall Study|Withdrawal by Subject|19
5465238|NCT01993940|18889877|P1|Overall Study|Withdrawal by Subject|15
5465239|NCT01993940|18889876|P2|Overall Study|Adverse Event|11
5465240|NCT01993940|18889877|P1|Overall Study|Adverse Event|16
5465241|NCT01993927|18889891|P1|Overall Study|Protocol Violation|11
5465242|NCT01993927|18889891|P1|Overall Study|Case Report Forms Uncollected|18
5465243|NCT01993888|18889899|P2|Overall Study|Withdrawal by Subject|1
5465244|NCT01993888|18889900|P1|Overall Study|Withdrawal by Subject|0
5465245|NCT01993888|18889899|P2|Overall Study|Lost to Follow-up|1
5465246|NCT01993888|18889900|P1|Overall Study|Lost to Follow-up|1
5465247|NCT01993888|18889899|P2|Overall Study|Death|1
5465248|NCT01993888|18889900|P1|Overall Study|Death|1
5465249|NCT01993836|18889949|P3|Overall Study|Withdrawal by Subject|5
5465250|NCT01993836|18889950|P2|Overall Study|Withdrawal by Subject|10
5465251|NCT01993836|18889951|P1|Overall Study|Withdrawal by Subject|12
5465252|NCT01993836|18889949|P3|Overall Study|Death|0
5465253|NCT01993836|18889950|P2|Overall Study|Death|2
5465254|NCT01993836|18889951|P1|Overall Study|Death|0
5465255|NCT01993836|18889949|P3|Overall Study|Physician Decision|0
5465256|NCT01993836|18889950|P2|Overall Study|Physician Decision|1
5465257|NCT01993836|18889951|P1|Overall Study|Physician Decision|2
5465258|NCT01993836|18889949|P3|Overall Study|Surgery Cancelled|0
5465259|NCT01993836|18889950|P2|Overall Study|Surgery Cancelled|0
5465260|NCT01993836|18889951|P1|Overall Study|Surgery Cancelled|3
5465261|NCT01993823|18889967|P2|Overall Study|Lost to Follow-up|4
5465262|NCT01993823|18889968|P1|Overall Study|Lost to Follow-up|1
5465263|NCT01993823|18889967|P2|Overall Study|Protocol Violation|1
5465264|NCT01993823|18889968|P1|Overall Study|Protocol Violation|0
5465265|NCT01993823|18889967|P2|Overall Study|Requested by the patient|11
5465266|NCT01993823|18889968|P1|Overall Study|Requested by the patient|6
5465267|NCT01993667|18889978|P2|Overall Study|Lost to Follow-up|2
5465268|NCT01993667|18889979|P1|Overall Study|Lost to Follow-up|2
5465269|NCT01993667|18889978|P2|Overall Study|Insufficient altitude reached|1
5465270|NCT01993667|18889979|P1|Overall Study|Insufficient altitude reached|3
5465271|NCT01993667|18889978|P2|Overall Study|Insufficient data to analyze|16
5465272|NCT01993667|18889979|P1|Overall Study|Insufficient data to analyze|16
5465273|NCT01993615|18889989|P2|Overall Study|Death|0
5465274|NCT01993615|18889990|P1|Overall Study|Death|1
5465275|NCT01993186|18890009|P2|Open-Label Extension Period|Subject Non-Compliance|0
5465276|NCT01993186|18890010|P1|Open-Label Extension Period|Subject Non-Compliance|1
5465277|NCT01993186|18890009|P2|Open-Label Extension Period|Withdrawal by Subject|5
5465278|NCT01993186|18890010|P1|Open-Label Extension Period|Withdrawal by Subject|4
5465279|NCT01993186|18890009|P2|Open-Label Extension Period|Principal Investigator Decision|0
5465280|NCT01993186|18890010|P1|Open-Label Extension Period|Principal Investigator Decision|1
5465281|NCT01993186|18890009|P2|Open-Label Extension Period|Adverse Event|0
5465282|NCT01993186|18890010|P1|Open-Label Extension Period|Adverse Event|1
5465283|NCT01993186|18890009|P2|Open-Label Extension Period|Other, Not Specified|1
5465284|NCT01993186|18890010|P1|Open-Label Extension Period|Other, Not Specified|0
5465285|NCT01993186|18890009|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
5465286|NCT01993186|18890010|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
5465287|NCT01993186|18890009|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
5465288|NCT01993186|18890010|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|1
5465289|NCT01993030|18890087|P2|Overall Study|Adverse Event|4
5465290|NCT01993030|18890088|P1|Overall Study|Adverse Event|0
5465291|NCT01993017|18890105|P3|Overall Study|Ineligible after randomization|5
5465292|NCT01993017|18890106|P2|Overall Study|Ineligible after randomization|5
5465293|NCT01993017|18890107|P1|Overall Study|Ineligible after randomization|4
5465294|NCT01993017|18890105|P3|Overall Study|Other reasons|7
5465295|NCT01993017|18890106|P2|Overall Study|Other reasons|11
5465296|NCT01993017|18890107|P1|Overall Study|Other reasons|17
5465297|NCT01993017|18890105|P3|Overall Study|Dropped out|11
5465298|NCT01993017|18890106|P2|Overall Study|Dropped out|6
5465299|NCT01993017|18890107|P1|Overall Study|Dropped out|19
5465300|NCT01993017|18890105|P3|Overall Study|Could not be contacted|38
5465301|NCT01993017|18890106|P2|Overall Study|Could not be contacted|42
5465302|NCT01993017|18890107|P1|Overall Study|Could not be contacted|43
5465303|NCT01993017|18890105|P3|Overall Study|Death|18
5465304|NCT01993017|18890106|P2|Overall Study|Death|26
5465305|NCT01993017|18890107|P1|Overall Study|Death|23
5465306|NCT01992757|18890148|P1|Overall Study|2 patients excluded due to FFP given.|2
5465307|NCT01992653|18890161|P8|Overall Study|Disease Progression|0
5465308|NCT01992653|18890162|P7|Overall Study|Disease Progression|4
5465309|NCT01992653|18890163|P6|Overall Study|Disease Progression|0
5465310|NCT01992653|18890164|P5|Overall Study|Disease Progression|0
5465311|NCT01992653|18890165|P4|Overall Study|Disease Progression|0
5465312|NCT01992653|18890166|P3|Overall Study|Disease Progression|0
5465313|NCT01992653|18890167|P2|Overall Study|Disease Progression|0
5465314|NCT01992653|18890168|P1|Overall Study|Disease Progression|0
5465315|NCT01992653|18890161|P8|Overall Study|Study Completed|1
5465316|NCT01992653|18890162|P7|Overall Study|Study Completed|0
5465317|NCT01992653|18890163|P6|Overall Study|Study Completed|0
5465318|NCT01992653|18890164|P5|Overall Study|Study Completed|0
5465319|NCT01992653|18890165|P4|Overall Study|Study Completed|0
5465320|NCT01992653|18890166|P3|Overall Study|Study Completed|0
5465321|NCT01992653|18890167|P2|Overall Study|Study Completed|0
5465322|NCT01992653|18890168|P1|Overall Study|Study Completed|0
5465323|NCT01992653|18890161|P8|Overall Study|Lost to Follow-up|1
5465324|NCT01992653|18890162|P7|Overall Study|Lost to Follow-up|0
5465325|NCT01992653|18890163|P6|Overall Study|Lost to Follow-up|0
5465326|NCT01992653|18890164|P5|Overall Study|Lost to Follow-up|0
5465327|NCT01992653|18890165|P4|Overall Study|Lost to Follow-up|0
5465328|NCT01992653|18890166|P3|Overall Study|Lost to Follow-up|0
5465329|NCT01992653|18890167|P2|Overall Study|Lost to Follow-up|0
5465330|NCT01992653|18890168|P1|Overall Study|Lost to Follow-up|0
5465331|NCT01992653|18890161|P8|Overall Study|Death|2
5465332|NCT01992653|18890162|P7|Overall Study|Death|4
5465333|NCT01992653|18890163|P6|Overall Study|Death|0
5465334|NCT01992653|18890164|P5|Overall Study|Death|1
5465335|NCT01992653|18890165|P4|Overall Study|Death|0
5465336|NCT01992653|18890166|P3|Overall Study|Death|1
5465337|NCT01992653|18890167|P2|Overall Study|Death|0
5465338|NCT01992653|18890168|P1|Overall Study|Death|0
5465339|NCT01992549|18890394|P1|Overall Study|Product Switch to Extend Half Life|1
5465340|NCT01992549|18890394|P1|Overall Study|Serious Adverse Event|1
5465341|NCT01992549|18890394|P1|Overall Study|Lost to Follow-up|2
5465342|NCT01992536|18890414|P10|Overall Study|Withdrawal by Subject|0
5465343|NCT01992536|18890415|P9|Overall Study|Withdrawal by Subject|0
5465344|NCT01992536|18890416|P8|Overall Study|Withdrawal by Subject|0
5465345|NCT01992536|18890417|P7|Overall Study|Withdrawal by Subject|0
5465346|NCT01992536|18890418|P6|Overall Study|Withdrawal by Subject|0
5465347|NCT01992536|18890419|P5|Overall Study|Withdrawal by Subject|0
5465348|NCT01992536|18890420|P4|Overall Study|Withdrawal by Subject|2
5465349|NCT01992536|18890421|P3|Overall Study|Withdrawal by Subject|0
5465350|NCT01992536|18890422|P2|Overall Study|Withdrawal by Subject|1
5465351|NCT01992536|18890423|P1|Overall Study|Withdrawal by Subject|0
5465352|NCT01992536|18890414|P10|Overall Study|Lost to Follow-up|1
5465353|NCT01992536|18890415|P9|Overall Study|Lost to Follow-up|1
5465354|NCT01992536|18890416|P8|Overall Study|Lost to Follow-up|0
5465355|NCT01992536|18890417|P7|Overall Study|Lost to Follow-up|0
5465356|NCT01992536|18890418|P6|Overall Study|Lost to Follow-up|1
5465357|NCT01992536|18890419|P5|Overall Study|Lost to Follow-up|0
5465358|NCT01992536|18890420|P4|Overall Study|Lost to Follow-up|0
5465359|NCT01992536|18890421|P3|Overall Study|Lost to Follow-up|1
5465360|NCT01992536|18890422|P2|Overall Study|Lost to Follow-up|2
5465361|NCT01992536|18890423|P1|Overall Study|Lost to Follow-up|4
5465362|NCT01992536|18890414|P10|Overall Study|Administrative Reason|0
5465363|NCT01992536|18890415|P9|Overall Study|Administrative Reason|0
5465364|NCT01992536|18890416|P8|Overall Study|Administrative Reason|0
5465365|NCT01992536|18890417|P7|Overall Study|Administrative Reason|7
5465366|NCT01992536|18890418|P6|Overall Study|Administrative Reason|0
5465367|NCT01992536|18890419|P5|Overall Study|Administrative Reason|0
5465368|NCT01992536|18890420|P4|Overall Study|Administrative Reason|0
5465369|NCT01992536|18890421|P3|Overall Study|Administrative Reason|0
5465370|NCT01992536|18890422|P2|Overall Study|Administrative Reason|0
5465371|NCT01992536|18890423|P1|Overall Study|Administrative Reason|0
5465372|NCT01992159|18890692|P4|Overall Study|Death|0
5465373|NCT01992159|18890693|P3|Overall Study|Death|1
5465374|NCT01992159|18890694|P2|Overall Study|Death|0
5465375|NCT01992159|18890695|P1|Overall Study|Death|0
5465376|NCT01992159|18890692|P4|Overall Study|Adverse Event|1
5465377|NCT01992159|18890693|P3|Overall Study|Adverse Event|0
5465378|NCT01992159|18890694|P2|Overall Study|Adverse Event|1
5465379|NCT01992159|18890695|P1|Overall Study|Adverse Event|0
5465380|NCT01992159|18890692|P4|Overall Study|Withdrawal by Subject|3
5465381|NCT01992159|18890693|P3|Overall Study|Withdrawal by Subject|0
5465382|NCT01992159|18890694|P2|Overall Study|Withdrawal by Subject|7
5465383|NCT01992159|18890695|P1|Overall Study|Withdrawal by Subject|4
5465384|NCT01992107|18890748|P3|Overall Study|Withdrawal by Subject|8
5465385|NCT01992107|18890749|P2|Overall Study|Withdrawal by Subject|7
5465386|NCT01992107|18890750|P1|Overall Study|Withdrawal by Subject|13
5465387|NCT01992107|18890748|P3|Overall Study|noncompliance and were unavailable|2
5465388|NCT01992107|18890749|P2|Overall Study|noncompliance and were unavailable|3
5465389|NCT01992107|18890750|P1|Overall Study|noncompliance and were unavailable|7
5465390|NCT01992107|18890748|P3|Overall Study|Lost to Follow-up|26
5465391|NCT01992107|18890749|P2|Overall Study|Lost to Follow-up|22
5465392|NCT01992107|18890750|P1|Overall Study|Lost to Follow-up|46
5465393|NCT01992107|18890748|P3|Overall Study|Adverse Event|0
5465394|NCT01992107|18890749|P2|Overall Study|Adverse Event|1
5465395|NCT01992107|18890750|P1|Overall Study|Adverse Event|0
5465396|NCT01992107|18890748|P3|Overall Study|Administrative reasons|0
5465397|NCT01992107|18890749|P2|Overall Study|Administrative reasons|0
5465398|NCT01992107|18890750|P1|Overall Study|Administrative reasons|2
5465399|NCT01992094|18890806|P3|Overall Study|Withdrawal by Subject|4
5465400|NCT01992094|18890807|P2|Overall Study|Withdrawal by Subject|3
5465401|NCT01992094|18890808|P1|Overall Study|Withdrawal by Subject|7
5465402|NCT01992094|18890806|P3|Overall Study|Protocol Violation|1
5465403|NCT01992094|18890807|P2|Overall Study|Protocol Violation|0
5465404|NCT01992094|18890808|P1|Overall Study|Protocol Violation|1
5465405|NCT01992094|18890806|P3|Overall Study|OTHER|0
5465406|NCT01992094|18890807|P2|Overall Study|OTHER|0
5465407|NCT01992094|18890808|P1|Overall Study|OTHER|4
5465408|NCT01992094|18890806|P3|Overall Study|Lost to Follow-up|13
5465409|NCT01992094|18890807|P2|Overall Study|Lost to Follow-up|9
5465410|NCT01992094|18890808|P1|Overall Study|Lost to Follow-up|26
5465411|NCT01992094|18890806|P3|Overall Study|Death|2
5465412|NCT01992094|18890807|P2|Overall Study|Death|5
5465413|NCT01992094|18890808|P1|Overall Study|Death|5
5465414|NCT01992094|18890806|P3|Overall Study|Adverse Event|0
5465415|NCT01992094|18890807|P2|Overall Study|Adverse Event|0
5465416|NCT01992094|18890808|P1|Overall Study|Adverse Event|1
5465417|NCT01992094|18890806|P3|Overall Study|ADMINISTRATIVE REASON|1
5465418|NCT01992094|18890807|P2|Overall Study|ADMINISTRATIVE REASON|7
5465419|NCT01992094|18890808|P1|Overall Study|ADMINISTRATIVE REASON|6
5465420|NCT01991977|18890916|P1|Overall Study|Withdrew after start of treatment|5
5465421|NCT01991977|18890916|P1|Overall Study|Withdrew prior to receiving treatment|7
5465422|NCT01991795|18890968|P2|Overall Study|Site prematurely closed by sponsor|25
5465423|NCT01991795|18890969|P1|Overall Study|Site prematurely closed by sponsor|26
5465424|NCT01991795|18890968|P2|Overall Study|Withdrawal by Subject|94
5465425|NCT01991795|18890969|P1|Overall Study|Withdrawal by Subject|117
5465426|NCT01991795|18890968|P2|Overall Study|Lost to Follow-up|4
5465427|NCT01991795|18890969|P1|Overall Study|Lost to Follow-up|6
5465428|NCT01991743|18890995|P4|Overall Study|external cephalic version not performed|0
5465429|NCT01991743|18890996|P3|Overall Study|external cephalic version not performed|1
5465430|NCT01991743|18890997|P2|Overall Study|external cephalic version not performed|0
5465431|NCT01991743|18890998|P1|Overall Study|external cephalic version not performed|0
5465432|NCT01991483|18891043|P4|Dose Level 1000 mg|Protocol Violation|1
5465433|NCT01991483|18891044|P3|Dose Level 1000 mg|Protocol Violation|0
5465434|NCT01991483|18891045|P2|Dose Level 1000 mg|Protocol Violation|0
5465435|NCT01991483|18891046|P1|Dose Level 1000 mg|Protocol Violation|0
5465436|NCT01991483|18891043|P4|Dose Level 600 mg|Physician Decision|0
5465437|NCT01991483|18891044|P3|Dose Level 600 mg|Physician Decision|1
5465438|NCT01991483|18891045|P2|Dose Level 600 mg|Physician Decision|0
5465439|NCT01991483|18891046|P1|Dose Level 600 mg|Physician Decision|0
5465440|NCT01991483|18891043|P4|Dose Level 600 mg|Withdrawal by Subject|0
5465441|NCT01991483|18891044|P3|Dose Level 600 mg|Withdrawal by Subject|1
5465442|NCT01991483|18891045|P2|Dose Level 600 mg|Withdrawal by Subject|0
5465443|NCT01991483|18891046|P1|Dose Level 600 mg|Withdrawal by Subject|0
5465444|NCT01991470|18891112|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
5465445|NCT01991470|18891112|P1|Enlite 3 Period|Physician Decision|8
5465446|NCT01991470|18891112|P1|Enlite 3 Period|Physician Decision|2
5465447|NCT01991470|18891112|P1|Enlite 3 Period|Lost to Follow-up|1
5465448|NCT01991470|18891112|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
5465449|NCT01991470|18891112|P1|Enlite 1 Period|Adverse Event|1
5465450|NCT01991470|18891112|P1|Enlite 1 Period|Withdrawal by Subject|18
5465451|NCT01991314|18891126|P2|Overall Study|Lost to Follow-up|10
5465452|NCT01991314|18891127|P1|Overall Study|Lost to Follow-up|6
5465453|NCT01991314|18891126|P2|Overall Study|Adverse Event|1
5465454|NCT01991314|18891127|P1|Overall Study|Adverse Event|5
5465455|NCT01991197|18891147|P2|Overall Study|Withdrawal by Subject|0
5465456|NCT01991197|18891148|P1|Overall Study|Withdrawal by Subject|2
5465457|NCT01991197|18891147|P2|Overall Study|Physician Decision|2
5465458|NCT01991197|18891148|P1|Overall Study|Physician Decision|0
5465459|NCT01991197|18891147|P2|Overall Study|Lost to Follow-up|1
5465460|NCT01991197|18891148|P1|Overall Study|Lost to Follow-up|1
5465461|NCT01991067|18891186|P2|Overall Study|Lost to Follow-up|5
5465462|NCT01991067|18891187|P1|Overall Study|Lost to Follow-up|6
5465463|NCT01990859|18891201|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
5465464|NCT01990859|18891201|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
5465465|NCT01990768|18891336|P3|6-Month Follow-up|Patient at psychiatric hospital|0
5465466|NCT01990768|18891337|P2|6-Month Follow-up|Patient at psychiatric hospital|0
5465467|NCT01990768|18891338|P1|6-Month Follow-up|Patient at psychiatric hospital|1
5465468|NCT01990768|18891336|P3|6-Month Follow-up|Prisoner at time of follow-up|0
5465469|NCT01990768|18891337|P2|6-Month Follow-up|Prisoner at time of follow-up|2
5465470|NCT01990768|18891338|P1|6-Month Follow-up|Prisoner at time of follow-up|0
5465471|NCT01990768|18891336|P3|6-Month Follow-up|Prisoner at time of enrollment|1
5465472|NCT01990768|18891337|P2|6-Month Follow-up|Prisoner at time of enrollment|0
5465473|NCT01990768|18891338|P1|6-Month Follow-up|Prisoner at time of enrollment|0
5465474|NCT01990768|18891336|P3|6-Month Follow-up|Homeless|6
5465475|NCT01990768|18891337|P2|6-Month Follow-up|Homeless|3
5465476|NCT01990768|18891338|P1|6-Month Follow-up|Homeless|4
5465477|NCT01990768|18891336|P3|6-Month Follow-up|No contact information|5
5465478|NCT01990768|18891337|P2|6-Month Follow-up|No contact information|6
5465479|NCT01990768|18891338|P1|6-Month Follow-up|No contact information|5
5465480|NCT01990768|18891336|P3|6-Month Follow-up|Calls unreturned or refused contact|20
5465481|NCT01990768|18891337|P2|6-Month Follow-up|Calls unreturned or refused contact|15
5465482|NCT01990768|18891338|P1|6-Month Follow-up|Calls unreturned or refused contact|4
5465483|NCT01990768|18891336|P3|6-Month Follow-up|Withdrawal by Subject|26
5465484|NCT01990768|18891337|P2|6-Month Follow-up|Withdrawal by Subject|25
5465485|NCT01990768|18891338|P1|6-Month Follow-up|Withdrawal by Subject|25
5465486|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Unknown if completed|1
5465487|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Unknown if completed|0
5465488|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Unknown if completed|0
5465489|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Other procoagulant administered|2
5465490|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Other procoagulant administered|1
5465491|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Other procoagulant administered|0
5465492|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
5465493|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
5465494|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
5465495|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Found not to be injured|1
5465496|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Found not to be injured|1
5465497|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Found not to be injured|1
5465498|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Taken into police custody|3
5465499|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Taken into police custody|0
5465500|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Taken into police custody|4
5465501|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Other safety concern|3
5465502|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Other safety concern|2
5465503|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Other safety concern|4
5465504|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Required CPR|1
5465505|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Required CPR|7
5465506|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Required CPR|3
5465507|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
5465508|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
5465509|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
5465510|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
5465511|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
5465512|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
5465513|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Emergency unblinding|7
5465514|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Emergency unblinding|4
5465515|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Emergency unblinding|11
5465516|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Death or comfort care|6
5465517|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Death or comfort care|11
5465518|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Death or comfort care|12
5465519|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
5465520|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
5465521|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
5465522|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Protocol non-compliance|10
5465523|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Protocol non-compliance|17
5465524|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Protocol non-compliance|14
5465525|NCT01990768|18891336|P3|In-Hospital Study Drug Infusion|Discharged|13
5465526|NCT01990768|18891337|P2|In-Hospital Study Drug Infusion|Discharged|18
5465527|NCT01990768|18891338|P1|In-Hospital Study Drug Infusion|Discharged|19
5465528|NCT01990768|18891336|P3|Prehospital Study Drug Infusion|Unknown if completed|2
5465529|NCT01990768|18891337|P2|Prehospital Study Drug Infusion|Unknown if completed|4
5465530|NCT01990768|18891338|P1|Prehospital Study Drug Infusion|Unknown if completed|1
5465531|NCT01990768|18891336|P3|Prehospital Study Drug Infusion|Emergency unblinding|1
5465532|NCT01990768|18891337|P2|Prehospital Study Drug Infusion|Emergency unblinding|0
5465533|NCT01990768|18891338|P1|Prehospital Study Drug Infusion|Emergency unblinding|0
5465534|NCT01990768|18891336|P3|Prehospital Study Drug Infusion|Withdrawal by Subject|0
5465535|NCT01990768|18891337|P2|Prehospital Study Drug Infusion|Withdrawal by Subject|0
5465536|NCT01990768|18891338|P1|Prehospital Study Drug Infusion|Withdrawal by Subject|1
5465537|NCT01990768|18891336|P3|Prehospital Study Drug Infusion|Discharged|0
5465538|NCT01990768|18891337|P2|Prehospital Study Drug Infusion|Discharged|1
5465539|NCT01990768|18891338|P1|Prehospital Study Drug Infusion|Discharged|2
5465540|NCT01990768|18891336|P3|Prehospital Study Drug Infusion|Death|1
5465541|NCT01990768|18891337|P2|Prehospital Study Drug Infusion|Death|1
5465542|NCT01990768|18891338|P1|Prehospital Study Drug Infusion|Death|3
5465543|NCT01990768|18891336|P3|Prehospital Study Drug Infusion|Other safety concern|1
5465544|NCT01990768|18891337|P2|Prehospital Study Drug Infusion|Other safety concern|1
5465545|NCT01990768|18891338|P1|Prehospital Study Drug Infusion|Other safety concern|2
5465546|NCT01990768|18891336|P3|Prehospital Study Drug Infusion|Required CPR|0
5465547|NCT01990768|18891337|P2|Prehospital Study Drug Infusion|Required CPR|6
5465548|NCT01990768|18891338|P1|Prehospital Study Drug Infusion|Required CPR|2
5465549|NCT01990768|18891336|P3|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
5465550|NCT01990768|18891337|P2|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
5465551|NCT01990768|18891338|P1|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
5465552|NCT01990768|18891336|P3|Prehospital Study Drug Infusion|Protocol non-compliance|10
5465553|NCT01990768|18891337|P2|Prehospital Study Drug Infusion|Protocol non-compliance|11
5465554|NCT01990768|18891338|P1|Prehospital Study Drug Infusion|Protocol non-compliance|4
5465555|NCT01990768|18891336|P3|Intervention Started|Discovered to be pregnant|0
5465556|NCT01990768|18891337|P2|Intervention Started|Discovered to be pregnant|1
5465557|NCT01990768|18891338|P1|Intervention Started|Discovered to be pregnant|0
5465558|NCT01990768|18891336|P3|Intervention Started|Seizure or hx of seizure|2
5465559|NCT01990768|18891337|P2|Intervention Started|Seizure or hx of seizure|0
5465560|NCT01990768|18891338|P1|Intervention Started|Seizure or hx of seizure|0
5465561|NCT01990768|18891336|P3|Intervention Started|Required CPR|0
5465562|NCT01990768|18891337|P2|Intervention Started|Required CPR|1
5465563|NCT01990768|18891338|P1|Intervention Started|Required CPR|1
5465564|NCT01990768|18891336|P3|Intervention Started|IV lost|2
5465565|NCT01990768|18891337|P2|Intervention Started|IV lost|2
5465566|NCT01990768|18891338|P1|Intervention Started|IV lost|2
5465567|NCT01990768|18891336|P3|Intervention Started|Patient care priority|3
5465568|NCT01990768|18891337|P2|Intervention Started|Patient care priority|2
5465569|NCT01990768|18891338|P1|Intervention Started|Patient care priority|1
5465570|NCT01990768|18891336|P3|Intervention Started|Not enough time for EMS to enroll|0
5465571|NCT01990768|18891337|P2|Intervention Started|Not enough time for EMS to enroll|3
5465572|NCT01990768|18891338|P1|Intervention Started|Not enough time for EMS to enroll|4
5465573|NCT01990768|18891336|P3|Intervention Started|Patient became ineligible due to vitals|2
5465574|NCT01990768|18891337|P2|Intervention Started|Patient became ineligible due to vitals|5
5465575|NCT01990768|18891338|P1|Intervention Started|Patient became ineligible due to vitals|5
5465576|NCT01990768|18891336|P3|Intervention Started|Study drug issue or kit malfunction|7
5465577|NCT01990768|18891337|P2|Intervention Started|Study drug issue or kit malfunction|6
5465578|NCT01990768|18891338|P1|Intervention Started|Study drug issue or kit malfunction|9
5465579|NCT01990768|18891336|P3|Intervention Started|Found to be ineligible|11
5465580|NCT01990768|18891337|P2|Intervention Started|Found to be ineligible|13
5465581|NCT01990768|18891338|P1|Intervention Started|Found to be ineligible|14
5465582|NCT01990742|18891403|P2|Overall Study|Facility closed|270
5465583|NCT01990742|18891404|P1|Overall Study|Facility closed|0
5465584|NCT01990742|18891403|P2|Overall Study|Withdrawal by facility|1083
5465585|NCT01990742|18891404|P1|Overall Study|Withdrawal by facility|407
5465586|NCT01990664|18891440|P2|Overall Study|Unsatisfactory Visual Response|1
5465587|NCT01990664|18891441|P1|Overall Study|Unsatisfactory Visual Response|0
5465588|NCT01990664|18891440|P2|Overall Study|Lens Handling Difficulties|0
5465589|NCT01990664|18891441|P1|Overall Study|Lens Handling Difficulties|1
5465590|NCT01990664|18891440|P2|Overall Study|Lens Discomfort|1
5465591|NCT01990664|18891441|P1|Overall Study|Lens Discomfort|1
5465592|NCT01990664|18891440|P2|Overall Study|Protocol Violation|0
5465593|NCT01990664|18891441|P1|Overall Study|Protocol Violation|1
5465594|NCT01990664|18891440|P2|Overall Study|Withdrawal by Subject|3
5465595|NCT01990664|18891441|P1|Overall Study|Withdrawal by Subject|2
5465596|NCT01990664|18891440|P2|Overall Study|Lost to Follow-up|6
5465597|NCT01990664|18891441|P1|Overall Study|Lost to Follow-up|2
5465598|NCT01990612|18891449|P2|Overall Study|Withdrawal by Subject|2
5465599|NCT01990612|18891450|P1|Overall Study|Withdrawal by Subject|5
5465600|NCT01990612|18891449|P2|Overall Study|Lost to Follow-up|1
5465601|NCT01990612|18891450|P1|Overall Study|Lost to Follow-up|2
5465602|NCT01990573|18891531|P3|Overall Study|Physician Decision|1
5465603|NCT01990573|18891532|P2|Overall Study|Physician Decision|0
5465604|NCT01990573|18891533|P1|Overall Study|Physician Decision|0
5465605|NCT01990560|18891546|P1|Overall Study|Withdrawal by Subject|1
5465606|NCT01990534|18891560|P1|Overall Study|Overall Survival Follow-up|25
5465607|NCT01990534|18891560|P1|Overall Study|Progression Free Survival Follow-up|11
5465608|NCT01990534|18891560|P1|Overall Study|Reason Not Specified|2
5465609|NCT01990534|18891560|P1|Overall Study|Withdrawal by Subject|3
5465610|NCT01990534|18891560|P1|Overall Study|Symptomatic Deterioration|1
5465611|NCT01990534|18891560|P1|Overall Study|Withdrawal of Informed Consent|2
5465612|NCT01990534|18891560|P1|Overall Study|Protocol Violation|1
5465613|NCT01990534|18891560|P1|Overall Study|Progressive disease|3
5465614|NCT01990534|18891560|P1|Overall Study|Death|12
5465615|NCT01990339|18891576|P1|Overall Study|Lost to Follow-up|861
5465616|NCT01990339|18891576|P1|Overall Study|Voluntary Withdrawal|1402
5465617|NCT01990339|18891576|P1|Overall Study|Data Not Available|49
5465618|NCT01990313|18891581|P1|Overall Study|Lost to Follow-up|1
5465619|NCT01990300|18891586|P1|Overall Study|Protocol Deviation|53
5465620|NCT01990300|18891586|P1|Overall Study|Case Report Forms Uncollected|89
5465621|NCT01990261|18891592|P1|Overall Study|Lost to Follow-up|2
5465622|NCT01990261|18891592|P1|Overall Study|Dossier not Approved|1
5465623|NCT01990261|18891592|P1|Overall Study|PD Before Treatment Start|1
5465624|NCT01990261|18891592|P1|Overall Study|Disease Progression (PD)|8
5465625|NCT01990261|18891592|P1|Overall Study|Death From other Causes|1
5465626|NCT01990261|18891592|P1|Overall Study|Death due to Disease Progression (PD)|10
5465627|NCT01990261|18891592|P1|Overall Study|Death Before Treatment Start|2
5465628|NCT01989754|18891649|P2|Overall Study|Closed Site|1
5465629|NCT01989754|18891650|P1|Overall Study|Closed Site|1
5465630|NCT01989754|18891649|P2|Overall Study|Lost to Follow-up|20
5465631|NCT01989754|18891650|P1|Overall Study|Lost to Follow-up|28
5465632|NCT01989754|18891649|P2|Overall Study|Withdrawal by Subject|14
5465633|NCT01989754|18891650|P1|Overall Study|Withdrawal by Subject|10
5465634|NCT01989689|18891662|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
5465635|NCT01989689|18891663|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
5465636|NCT01989689|18891662|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
5465637|NCT01989689|18891663|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
5465638|NCT01989676|18891675|P2|Overall Study|Discontinued|68
5465639|NCT01989676|18891676|P1|Overall Study|Discontinued|59
5465640|NCT01989676|18891675|P2|Overall Study|Ongoing at data cutoff|279
5465641|NCT01989676|18891676|P1|Overall Study|Ongoing at data cutoff|279
5465642|NCT01989572|18891702|P6|Overall Study|alternative therapy|3
5465643|NCT01989572|18891703|P5|Overall Study|alternative therapy|1
5465644|NCT01989572|18891704|P4|Overall Study|alternative therapy|0
5465645|NCT01989572|18891705|P3|Overall Study|alternative therapy|0
5465646|NCT01989572|18891706|P2|Overall Study|alternative therapy|0
5465647|NCT01989572|18891707|P1|Overall Study|alternative therapy|3
5465648|NCT01989572|18891702|P6|Overall Study|not start protocol therapy|18
5465649|NCT01989572|18891703|P5|Overall Study|not start protocol therapy|4
5465650|NCT01989572|18891704|P4|Overall Study|not start protocol therapy|3
5465651|NCT01989572|18891705|P3|Overall Study|not start protocol therapy|2
5465652|NCT01989572|18891706|P2|Overall Study|not start protocol therapy|1
5465653|NCT01989572|18891707|P1|Overall Study|not start protocol therapy|5
5465654|NCT01989572|18891702|P6|Overall Study|unknown/not specify|5
5465655|NCT01989572|18891703|P5|Overall Study|unknown/not specify|3
5465656|NCT01989572|18891704|P4|Overall Study|unknown/not specify|3
5465657|NCT01989572|18891705|P3|Overall Study|unknown/not specify|1
5465658|NCT01989572|18891706|P2|Overall Study|unknown/not specify|4
5465659|NCT01989572|18891707|P1|Overall Study|unknown/not specify|3
5465660|NCT01989572|18891702|P6|Overall Study|maximum dose reached|0
5465661|NCT01989572|18891703|P5|Overall Study|maximum dose reached|1
5465662|NCT01989572|18891704|P4|Overall Study|maximum dose reached|0
5465663|NCT01989572|18891705|P3|Overall Study|maximum dose reached|0
5465664|NCT01989572|18891706|P2|Overall Study|maximum dose reached|1
5465665|NCT01989572|18891707|P1|Overall Study|maximum dose reached|0
5465666|NCT01989572|18891702|P6|Overall Study|error|1
5465667|NCT01989572|18891703|P5|Overall Study|error|1
5465668|NCT01989572|18891704|P4|Overall Study|error|1
5465669|NCT01989572|18891705|P3|Overall Study|error|1
5465670|NCT01989572|18891706|P2|Overall Study|error|1
5465671|NCT01989572|18891707|P1|Overall Study|error|2
5465672|NCT01989572|18891702|P6|Overall Study|complicating disease|0
5465673|NCT01989572|18891703|P5|Overall Study|complicating disease|1
5465674|NCT01989572|18891704|P4|Overall Study|complicating disease|0
5465675|NCT01989572|18891705|P3|Overall Study|complicating disease|2
5465676|NCT01989572|18891706|P2|Overall Study|complicating disease|1
5465677|NCT01989572|18891707|P1|Overall Study|complicating disease|1
5465678|NCT01989572|18891702|P6|Overall Study|Withdrawal by Subject|4
5465679|NCT01989572|18891703|P5|Overall Study|Withdrawal by Subject|12
5465680|NCT01989572|18891704|P4|Overall Study|Withdrawal by Subject|1
5465681|NCT01989572|18891705|P3|Overall Study|Withdrawal by Subject|5
5465682|NCT01989572|18891706|P2|Overall Study|Withdrawal by Subject|1
5465683|NCT01989572|18891707|P1|Overall Study|Withdrawal by Subject|4
5465684|NCT01989572|18891702|P6|Overall Study|Death|0
5465685|NCT01989572|18891703|P5|Overall Study|Death|1
5465686|NCT01989572|18891704|P4|Overall Study|Death|0
5465687|NCT01989572|18891705|P3|Overall Study|Death|0
5465688|NCT01989572|18891706|P2|Overall Study|Death|0
5465689|NCT01989572|18891707|P1|Overall Study|Death|0
5465690|NCT01989572|18891702|P6|Overall Study|Adverse Event|0
5465691|NCT01989572|18891703|P5|Overall Study|Adverse Event|3
5465692|NCT01989572|18891704|P4|Overall Study|Adverse Event|0
5465693|NCT01989572|18891705|P3|Overall Study|Adverse Event|3
5465694|NCT01989572|18891706|P2|Overall Study|Adverse Event|1
5465695|NCT01989572|18891707|P1|Overall Study|Adverse Event|2
5465696|NCT01989572|18891702|P6|Overall Study|Lack of Efficacy|79
5465697|NCT01989572|18891703|P5|Overall Study|Lack of Efficacy|71
5465698|NCT01989572|18891704|P4|Overall Study|Lack of Efficacy|43
5465699|NCT01989572|18891705|P3|Overall Study|Lack of Efficacy|48
5465700|NCT01989572|18891706|P2|Overall Study|Lack of Efficacy|48
5465701|NCT01989572|18891707|P1|Overall Study|Lack of Efficacy|35
5465702|NCT01989468|18891738|P5|Overall Study|Death|0
5465703|NCT01989468|18891739|P4|Overall Study|Death|0
5465704|NCT01989468|18891740|P3|Overall Study|Death|1
5465705|NCT01989468|18891741|P2|Overall Study|Death|0
5465706|NCT01989468|18891742|P1|Overall Study|Death|3
5465707|NCT01989468|18891738|P5|Overall Study|Subject Guardian Decision|1
5465708|NCT01989468|18891739|P4|Overall Study|Subject Guardian Decision|4
5465709|NCT01989468|18891740|P3|Overall Study|Subject Guardian Decision|4
5465710|NCT01989468|18891741|P2|Overall Study|Subject Guardian Decision|6
5465711|NCT01989468|18891742|P1|Overall Study|Subject Guardian Decision|11
5465712|NCT01989468|18891738|P5|Overall Study|Technical Problems|0
5465713|NCT01989468|18891739|P4|Overall Study|Technical Problems|1
5465714|NCT01989468|18891740|P3|Overall Study|Technical Problems|3
5465715|NCT01989468|18891741|P2|Overall Study|Technical Problems|1
5465716|NCT01989468|18891742|P1|Overall Study|Technical Problems|3
5465717|NCT01989468|18891738|P5|Overall Study|Pregnancy|0
5465718|NCT01989468|18891739|P4|Overall Study|Pregnancy|0
5465719|NCT01989468|18891740|P3|Overall Study|Pregnancy|0
5465720|NCT01989468|18891741|P2|Overall Study|Pregnancy|1
5465721|NCT01989468|18891742|P1|Overall Study|Pregnancy|0
5465722|NCT01989468|18891738|P5|Overall Study|Physician Decision|0
5465723|NCT01989468|18891739|P4|Overall Study|Physician Decision|1
5465724|NCT01989468|18891740|P3|Overall Study|Physician Decision|0
5465725|NCT01989468|18891741|P2|Overall Study|Physician Decision|1
5465726|NCT01989468|18891742|P1|Overall Study|Physician Decision|4
5465727|NCT01989468|18891738|P5|Overall Study|Lost to Follow-up|1
5465728|NCT01989468|18891739|P4|Overall Study|Lost to Follow-up|1
5465729|NCT01989468|18891740|P3|Overall Study|Lost to Follow-up|0
5465730|NCT01989468|18891741|P2|Overall Study|Lost to Follow-up|2
5465731|NCT01989468|18891742|P1|Overall Study|Lost to Follow-up|5
5465732|NCT01989468|18891738|P5|Overall Study|Lack of Efficacy|2
5465733|NCT01989468|18891739|P4|Overall Study|Lack of Efficacy|4
5465734|NCT01989468|18891740|P3|Overall Study|Lack of Efficacy|7
5465735|NCT01989468|18891741|P2|Overall Study|Lack of Efficacy|11
5465736|NCT01989468|18891742|P1|Overall Study|Lack of Efficacy|11
5465737|NCT01989468|18891738|P5|Overall Study|Adverse Event|4
5465738|NCT01989468|18891739|P4|Overall Study|Adverse Event|5
5465739|NCT01989468|18891740|P3|Overall Study|Adverse Event|4
5465740|NCT01989468|18891741|P2|Overall Study|Adverse Event|15
5465741|NCT01989468|18891742|P1|Overall Study|Adverse Event|10
5465742|NCT01989455|18891784|P5|Overall Study|Technical problems with infusion|1
5465743|NCT01989455|18891785|P4|Overall Study|Technical problems with infusion|0
5465744|NCT01989455|18891786|P3|Overall Study|Technical problems with infusion|1
5465745|NCT01989455|18891787|P2|Overall Study|Technical problems with infusion|0
5465746|NCT01989455|18891788|P1|Overall Study|Technical problems with infusion|0
5465747|NCT01989455|18891784|P5|Overall Study|Withdrawal by Subject|0
5465748|NCT01989455|18891785|P4|Overall Study|Withdrawal by Subject|0
5465749|NCT01989455|18891786|P3|Overall Study|Withdrawal by Subject|0
5465750|NCT01989455|18891787|P2|Overall Study|Withdrawal by Subject|1
5465751|NCT01989455|18891788|P1|Overall Study|Withdrawal by Subject|0
5465752|NCT01989455|18891784|P5|Overall Study|Adverse Event|0
5465753|NCT01989455|18891785|P4|Overall Study|Adverse Event|0
5465754|NCT01989455|18891786|P3|Overall Study|Adverse Event|0
5465755|NCT01989455|18891787|P2|Overall Study|Adverse Event|1
5465756|NCT01989455|18891788|P1|Overall Study|Adverse Event|0
5465757|NCT01989208|18891824|P2|200 mg (7 Days)|Protocol Violation|1
5465758|NCT01989208|18891825|P1|200 mg (7 Days)|Protocol Violation|0
5465759|NCT01989169|18891853|P2|Period 2|Adverse Event|1
5465760|NCT01989169|18891854|P1|Period 2|Adverse Event|0
5465761|NCT01989156|18891867|P3|End of Study (Population at Day 90)|Employment Conflict|0
5465762|NCT01989156|18891868|P2|End of Study (Population at Day 90)|Employment Conflict|1
5465763|NCT01989156|18891869|P1|End of Study (Population at Day 90)|Employment Conflict|0
5465764|NCT01989156|18891867|P3|End of Study (Population at Day 90)|Moved out of state|0
5465765|NCT01989156|18891868|P2|End of Study (Population at Day 90)|Moved out of state|0
5465766|NCT01989156|18891869|P1|End of Study (Population at Day 90)|Moved out of state|1
5465767|NCT01989156|18891867|P3|End of Study (Population at Day 90)|Physician Decision|1
5465768|NCT01989156|18891868|P2|End of Study (Population at Day 90)|Physician Decision|0
5465769|NCT01989156|18891869|P1|End of Study (Population at Day 90)|Physician Decision|1
5465770|NCT01989156|18891867|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
5465771|NCT01989156|18891868|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
5465772|NCT01989156|18891869|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
5465773|NCT01989156|18891867|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
5465774|NCT01989156|18891868|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
5465775|NCT01989156|18891869|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
5465776|NCT01989156|18891867|P3|Confinement Period (Population at Day 5)|Adverse Event|1
5465777|NCT01989156|18891868|P2|Confinement Period (Population at Day 5)|Adverse Event|0
5465778|NCT01989156|18891869|P1|Confinement Period (Population at Day 5)|Adverse Event|0
5465779|NCT01989156|18891867|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
5465780|NCT01989156|18891868|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
5465781|NCT01989156|18891869|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
5465782|NCT01989156|18891867|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
5465783|NCT01989156|18891868|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5465784|NCT01989156|18891869|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
5465785|NCT01988779|18891929|P2|Overall Study|Protocol Violation|0
5465786|NCT01988779|18891930|P1|Overall Study|Protocol Violation|1
5465787|NCT01988779|18891929|P2|Overall Study|Withdrawal by Subject|2
5465788|NCT01988779|18891930|P1|Overall Study|Withdrawal by Subject|2
5465789|NCT01988662|18891946|P2|Overall Study|Adverse Event|1
5465790|NCT01988662|18891947|P1|Overall Study|Adverse Event|3
5465791|NCT01988662|18891946|P2|Overall Study|Subject/guardian decision|1
5465792|NCT01988662|18891947|P1|Overall Study|Subject/guardian decision|1
5465793|NCT01988493|18891969|P5|Overall Study|Ongoing|0
5465794|NCT01988493|18891970|P4|Overall Study|Ongoing|2
5465795|NCT01988493|18891971|P3|Overall Study|Ongoing|0
5465796|NCT01988493|18891972|P2|Overall Study|Ongoing|0
5465797|NCT01988493|18891973|P1|Overall Study|Ongoing|0
5465798|NCT01988493|18891969|P5|Overall Study|Randomized but not treated|1
5465799|NCT01988493|18891970|P4|Overall Study|Randomized but not treated|0
5465800|NCT01988493|18891971|P3|Overall Study|Randomized but not treated|0
5465801|NCT01988493|18891972|P2|Overall Study|Randomized but not treated|0
5465802|NCT01988493|18891973|P1|Overall Study|Randomized but not treated|0
5465803|NCT01988402|18892052|P2|Overall Study|Withdrawal by Subject|0
5465804|NCT01988402|18892053|P1|Overall Study|Withdrawal by Subject|1
5465805|NCT01988402|18892052|P2|Overall Study|Adverse Event|2
5465806|NCT01988402|18892053|P1|Overall Study|Adverse Event|1
5465807|NCT01988103|18892120|P5|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
5465808|NCT01988103|18892121|P4|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
5465809|NCT01988103|18892122|P3|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
5465810|NCT01988103|18892123|P2|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
5465811|NCT01988103|18892124|P1|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
5465812|NCT01988103|18892120|P5|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
5465813|NCT01988103|18892121|P4|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
5465814|NCT01988103|18892122|P3|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
5465815|NCT01988103|18892123|P2|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
5465816|NCT01988103|18892124|P1|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
5465817|NCT01988103|18892120|P5|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
5465818|NCT01988103|18892121|P4|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
5465819|NCT01988103|18892122|P3|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
5465820|NCT01988103|18892123|P2|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
5465821|NCT01988103|18892124|P1|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
5465822|NCT01988103|18892120|P5|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
5465823|NCT01988103|18892121|P4|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
5465824|NCT01988103|18892122|P3|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
5465825|NCT01988103|18892123|P2|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
5465826|NCT01988103|18892124|P1|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
5465827|NCT01988103|18892120|P5|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
5465828|NCT01988103|18892121|P4|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
5465829|NCT01988103|18892122|P3|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
5465830|NCT01988103|18892123|P2|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
5465831|NCT01988103|18892124|P1|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
5465832|NCT01988103|18892120|P5|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
5465833|NCT01988103|18892121|P4|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
5465834|NCT01988103|18892122|P3|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
5465835|NCT01988103|18892123|P2|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
5465836|NCT01988103|18892124|P1|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
5465837|NCT01988103|18892120|P5|Placebo-Controlled Phase Week 0-16|Adverse Event|0
5465838|NCT01988103|18892121|P4|Placebo-Controlled Phase Week 0-16|Adverse Event|0
5465839|NCT01988103|18892122|P3|Placebo-Controlled Phase Week 0-16|Adverse Event|6
5465840|NCT01988103|18892123|P2|Placebo-Controlled Phase Week 0-16|Adverse Event|10
5465841|NCT01988103|18892124|P1|Placebo-Controlled Phase Week 0-16|Adverse Event|3
5465842|NCT01988090|18892171|P2|Complete Study After Start|Protocol Violation|1
5465843|NCT01988090|18892172|P1|Complete Study After Start|Protocol Violation|1
5465844|NCT01988090|18892171|P2|Complete Study After Start|Withdrawal by Subject|0
5465845|NCT01988090|18892172|P1|Complete Study After Start|Withdrawal by Subject|2
5465846|NCT01988090|18892171|P2|Start Treament After Randomization|Protocol Violation|1
5465847|NCT01988090|18892172|P1|Start Treament After Randomization|Protocol Violation|0
5465848|NCT01988090|18892171|P2|Start Treament After Randomization|Withdrawal by Subject|3
5465849|NCT01988090|18892172|P1|Start Treament After Randomization|Withdrawal by Subject|2
5465850|NCT01988012|18892182|P1|Overall Study|Protocol Violation|1
5465851|NCT01988012|18892182|P1|Overall Study|Physician Decision|1
5465852|NCT01988012|18892182|P1|Overall Study|Lost to Follow-up|1
5465853|NCT01988012|18892182|P1|Overall Study|Patient Withdrawal of Consent|4
5465854|NCT01988012|18892182|P1|Overall Study|Insufficient Therapeutic Response|3
5465855|NCT01988012|18892182|P1|Overall Study|Adverse Event|5
5465856|NCT01987986|18892208|P4|Overall Study|Adverse Event|0
5465857|NCT01987986|18892209|P3|Overall Study|Adverse Event|2
5465858|NCT01987986|18892210|P2|Overall Study|Adverse Event|0
5465859|NCT01987986|18892211|P1|Overall Study|Adverse Event|1
5465860|NCT01987986|18892208|P4|Overall Study|Lost to Follow-up|0
5465861|NCT01987986|18892209|P3|Overall Study|Lost to Follow-up|0
5465862|NCT01987986|18892210|P2|Overall Study|Lost to Follow-up|0
5465863|NCT01987986|18892211|P1|Overall Study|Lost to Follow-up|1
5465864|NCT01987960|18892251|P4|Period 3|Administrative or other reason|43
5465865|NCT01987960|18892252|P3|Period 3|Administrative or other reason|0
5465866|NCT01987960|18892253|P2|Period 3|Administrative or other reason|0
5465867|NCT01987960|18892254|P1|Period 3|Administrative or other reason|0
5465868|NCT01987960|18892251|P4|Period 3|Lost to Follow-up|5
5465869|NCT01987960|18892252|P3|Period 3|Lost to Follow-up|0
5465870|NCT01987960|18892253|P2|Period 3|Lost to Follow-up|0
5465871|NCT01987960|18892254|P1|Period 3|Lost to Follow-up|0
5465872|NCT01987960|18892251|P4|Period 3|Withdrawal by Subject|9
5465873|NCT01987960|18892252|P3|Period 3|Withdrawal by Subject|0
5465874|NCT01987960|18892253|P2|Period 3|Withdrawal by Subject|0
5465875|NCT01987960|18892254|P1|Period 3|Withdrawal by Subject|0
5465876|NCT01987960|18892251|P4|Period 3|Protocol Violation|6
5465877|NCT01987960|18892252|P3|Period 3|Protocol Violation|0
5465878|NCT01987960|18892253|P2|Period 3|Protocol Violation|0
5465879|NCT01987960|18892254|P1|Period 3|Protocol Violation|0
5465880|NCT01987960|18892251|P4|Period 3|Non-compliance with IMP|1
5465881|NCT01987960|18892252|P3|Period 3|Non-compliance with IMP|0
5465882|NCT01987960|18892253|P2|Period 3|Non-compliance with IMP|0
5465883|NCT01987960|18892254|P1|Period 3|Non-compliance with IMP|0
5465884|NCT01987960|18892251|P4|Period 3|Adverse Event|7
5465885|NCT01987960|18892252|P3|Period 3|Adverse Event|0
5465886|NCT01987960|18892253|P2|Period 3|Adverse Event|0
5465887|NCT01987960|18892254|P1|Period 3|Adverse Event|0
5465888|NCT01987960|18892251|P4|Period 2|Administrative or other reason|0
5465889|NCT01987960|18892252|P3|Period 2|Administrative or other reason|7
5465890|NCT01987960|18892253|P2|Period 2|Administrative or other reason|5
5465891|NCT01987960|18892254|P1|Period 2|Administrative or other reason|0
5465892|NCT01987960|18892251|P4|Period 2|Withdrawal by Subject|0
5465893|NCT01987960|18892252|P3|Period 2|Withdrawal by Subject|1
5465894|NCT01987960|18892253|P2|Period 2|Withdrawal by Subject|0
5465895|NCT01987960|18892254|P1|Period 2|Withdrawal by Subject|0
5465896|NCT01987960|18892251|P4|Period 2|Adverse Event|0
5465897|NCT01987960|18892252|P3|Period 2|Adverse Event|1
5465898|NCT01987960|18892253|P2|Period 2|Adverse Event|0
5465899|NCT01987960|18892254|P1|Period 2|Adverse Event|0
5465900|NCT01987960|18892251|P4|Period 1|Withdrawal of consent before treatment|0
5465901|NCT01987960|18892252|P3|Period 1|Withdrawal of consent before treatment|0
5465902|NCT01987960|18892253|P2|Period 1|Withdrawal of consent before treatment|0
5465903|NCT01987960|18892254|P1|Period 1|Withdrawal of consent before treatment|4
5465904|NCT01987960|18892251|P4|Period 1|administrative or other reason|0
5465905|NCT01987960|18892252|P3|Period 1|administrative or other reason|0
5465906|NCT01987960|18892253|P2|Period 1|administrative or other reason|0
5465907|NCT01987960|18892254|P1|Period 1|administrative or other reason|75
5465908|NCT01987960|18892251|P4|Period 1|Lost to Follow-up|0
5465909|NCT01987960|18892252|P3|Period 1|Lost to Follow-up|0
5465910|NCT01987960|18892253|P2|Period 1|Lost to Follow-up|0
5465911|NCT01987960|18892254|P1|Period 1|Lost to Follow-up|40
5465912|NCT01987960|18892251|P4|Period 1|Withdrawal by Subject|0
5465913|NCT01987960|18892252|P3|Period 1|Withdrawal by Subject|0
5465914|NCT01987960|18892253|P2|Period 1|Withdrawal by Subject|0
5465915|NCT01987960|18892254|P1|Period 1|Withdrawal by Subject|21
5465916|NCT01987960|18892251|P4|Period 1|Protocol Violation|0
5465917|NCT01987960|18892252|P3|Period 1|Protocol Violation|0
5465918|NCT01987960|18892253|P2|Period 1|Protocol Violation|0
5465919|NCT01987960|18892254|P1|Period 1|Protocol Violation|12
5465920|NCT01987960|18892251|P4|Period 1|Non-compliance with IMP|0
5465921|NCT01987960|18892252|P3|Period 1|Non-compliance with IMP|0
5465922|NCT01987960|18892253|P2|Period 1|Non-compliance with IMP|0
5465923|NCT01987960|18892254|P1|Period 1|Non-compliance with IMP|6
5465924|NCT01987960|18892251|P4|Period 1|Lack of Efficacy|0
5465925|NCT01987960|18892252|P3|Period 1|Lack of Efficacy|0
5465926|NCT01987960|18892253|P2|Period 1|Lack of Efficacy|0
5465927|NCT01987960|18892254|P1|Period 1|Lack of Efficacy|4
5465928|NCT01987960|18892251|P4|Period 1|Adverse Event|0
5465929|NCT01987960|18892252|P3|Period 1|Adverse Event|0
5465930|NCT01987960|18892253|P2|Period 1|Adverse Event|0
5465931|NCT01987960|18892254|P1|Period 1|Adverse Event|24
5465932|NCT01987908|18892266|P3|Post-Treatment Observation Period|Other: Bad Veins|0
5465933|NCT01987908|18892267|P2|Post-Treatment Observation Period|Other: Bad Veins|1
5465934|NCT01987908|18892268|P1|Post-Treatment Observation Period|Other: Bad Veins|0
5465935|NCT01987908|18892266|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
5465936|NCT01987908|18892267|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
5465937|NCT01987908|18892268|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
5465938|NCT01987908|18892266|P3|Treatment Period|Adverse Event|1
5465939|NCT01987908|18892267|P2|Treatment Period|Adverse Event|1
5465940|NCT01987908|18892268|P1|Treatment Period|Adverse Event|0
5465941|NCT01987908|18892266|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
5465942|NCT01987908|18892267|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
5465943|NCT01987908|18892268|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
5465944|NCT01987908|18892266|P3|Placebo Lead-in Period|Withdrawal by Subject|0
5465945|NCT01987908|18892267|P2|Placebo Lead-in Period|Withdrawal by Subject|0
5465946|NCT01987908|18892268|P1|Placebo Lead-in Period|Withdrawal by Subject|1
5465947|NCT01987908|18892266|P3|Placebo Lead-in Period|Physician Decision|0
5465948|NCT01987908|18892267|P2|Placebo Lead-in Period|Physician Decision|0
5465949|NCT01987908|18892268|P1|Placebo Lead-in Period|Physician Decision|2
5465950|NCT01987908|18892266|P3|Placebo Lead-in Period|Adverse Event|0
5465951|NCT01987908|18892267|P2|Placebo Lead-in Period|Adverse Event|0
5465952|NCT01987908|18892268|P1|Placebo Lead-in Period|Adverse Event|2
5465953|NCT01987895|18892351|P2|Overall Study|randomized before giving IC|1
5465954|NCT01987895|18892352|P1|Overall Study|randomized before giving IC|0
5465955|NCT01987895|18892351|P2|Overall Study|Lost to Follow-up|5
5465956|NCT01987895|18892352|P1|Overall Study|Lost to Follow-up|3
5465957|NCT01987895|18892351|P2|Overall Study|Death|7
5465958|NCT01987895|18892352|P1|Overall Study|Death|7
5465959|NCT01987895|18892351|P2|Overall Study|Physician Decision|10
5465960|NCT01987895|18892352|P1|Overall Study|Physician Decision|8
5465961|NCT01987895|18892351|P2|Overall Study|Withdrawal by Subject|7
5465962|NCT01987895|18892352|P1|Overall Study|Withdrawal by Subject|12
5465963|NCT01987830|18892376|P1|Overall Study|Never received baseline scan|1
5465964|NCT01987765|18892380|P1|Overall Study|Lost to Follow-up|37
5465965|NCT01987765|18892380|P1|Overall Study|Protocol Violation|65
5465966|NCT01987609|18892390|P1|Overall Study|Adverse Event|1
5465967|NCT01987596|18892423|P2|Overall Study|Progressive Disease; missing all period|1
5465968|NCT01987596|18892424|P1|Overall Study|Progressive Disease; missing all period|0
5465969|NCT01987596|18892423|P2|Overall Study|Physician Decision|0
5465970|NCT01987596|18892424|P1|Overall Study|Physician Decision|1
5465971|NCT01987557|18892450|P3|Overall Study|Adverse Event|0
5465972|NCT01987557|18892451|P2|Overall Study|Adverse Event|2
5465973|NCT01987557|18892452|P1|Overall Study|Adverse Event|0
5465974|NCT01987557|18892450|P3|Overall Study|Withdrawal by Subject|2
5465975|NCT01987557|18892451|P2|Overall Study|Withdrawal by Subject|1
5465976|NCT01987557|18892452|P1|Overall Study|Withdrawal by Subject|2
5465977|NCT01987557|18892450|P3|Overall Study|Protocol Violation|1
5465978|NCT01987557|18892451|P2|Overall Study|Protocol Violation|0
5465979|NCT01987557|18892452|P1|Overall Study|Protocol Violation|1
5465980|NCT01987505|18892462|P1|Overall Study|Death|4
5465981|NCT01987505|18892462|P1|Overall Study|Investigator Decision|2
5465982|NCT01987505|18892462|P1|Overall Study|Lost to Follow-up|15
5465983|NCT01987505|18892462|P1|Overall Study|Other Reason|2
5465984|NCT01987505|18892462|P1|Overall Study|Withdrawal by Subject|2
5465985|NCT01987505|18892462|P1|Overall Study|Other|9
5465986|NCT01987479|18892492|P1|Overall Study|Adverse Event|7
5465987|NCT01987479|18892492|P1|Overall Study|Lost to Follow-up|1
5465988|NCT01987479|18892492|P1|Overall Study|Other|5
5465989|NCT01987479|18892492|P1|Overall Study|Participant/legal guardian decision|1
5465990|NCT01987479|18892492|P1|Overall Study|Physician Decision|2
5465991|NCT01987479|18892492|P1|Overall Study|Protocol Violation|1
5465992|NCT01987453|18892520|P3|Overall Study|Lack of Efficacy|0
5465993|NCT01987453|18892521|P2|Overall Study|Lack of Efficacy|12
5465994|NCT01987453|18892522|P1|Overall Study|Lack of Efficacy|1
5465995|NCT01987453|18892520|P3|Overall Study|Death|1
5465996|NCT01987453|18892521|P2|Overall Study|Death|0
5465997|NCT01987453|18892522|P1|Overall Study|Death|0
5465998|NCT01987427|18892548|P3|Overall Study|Other|0
5465999|NCT01987427|18892549|P2|Overall Study|Other|1
5466000|NCT01987427|18892550|P1|Overall Study|Other|1
5466001|NCT01987427|18892548|P3|Overall Study|Lack of Efficacy|0
5466002|NCT01987427|18892549|P2|Overall Study|Lack of Efficacy|0
5466003|NCT01987427|18892550|P1|Overall Study|Lack of Efficacy|1
5466004|NCT01987427|18892548|P3|Overall Study|Withdrawal by Subject|3
5466005|NCT01987427|18892549|P2|Overall Study|Withdrawal by Subject|1
5466006|NCT01987427|18892550|P1|Overall Study|Withdrawal by Subject|2
5466007|NCT01987427|18892548|P3|Overall Study|Lost to Follow-up|9
5466008|NCT01987427|18892549|P2|Overall Study|Lost to Follow-up|6
5466009|NCT01987427|18892550|P1|Overall Study|Lost to Follow-up|6
5466010|NCT01987427|18892548|P3|Overall Study|Adverse Event|8
5466011|NCT01987427|18892549|P2|Overall Study|Adverse Event|2
5466012|NCT01987427|18892550|P1|Overall Study|Adverse Event|4
5466013|NCT01987232|18892687|P5|Overall Study|Ongoing in Study|0
5466014|NCT01987232|18892688|P4|Overall Study|Ongoing in Study|1
5466015|NCT01987232|18892689|P3|Overall Study|Ongoing in Study|0
5466016|NCT01987232|18892690|P2|Overall Study|Ongoing in Study|0
5466017|NCT01987232|18892691|P1|Overall Study|Ongoing in Study|0
5466018|NCT01987102|18892780|P2|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
5466019|NCT01987102|18892781|P1|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
5466020|NCT01987102|18892780|P2|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
5466021|NCT01987102|18892781|P1|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
5466022|NCT01987102|18892780|P2|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
5466023|NCT01987102|18892781|P1|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
5466024|NCT01987102|18892780|P2|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
5466025|NCT01987102|18892781|P1|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
5466026|NCT01987102|18892780|P2|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
5466027|NCT01987102|18892781|P1|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
5466028|NCT01987102|18892780|P2|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
5466029|NCT01987102|18892781|P1|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
5466030|NCT01986985|18892828|P1|Overall Study|Scan not completed due to malfunction|3
5466031|NCT01986985|18892828|P1|Overall Study|Withdrawal by Subject|4
5466032|NCT01986920|18892865|P4|Placebo|Withdrawal by Subject|1
5466033|NCT01986920|18892866|P3|Placebo|Withdrawal by Subject|0
5466034|NCT01986920|18892867|P2|Placebo|Withdrawal by Subject|0
5466035|NCT01986920|18892868|P1|Placebo|Withdrawal by Subject|0
5466036|NCT01986920|18892865|P4|A-101 40%|Withdrawal by Subject|0
5466037|NCT01986920|18892866|P3|A-101 40%|Withdrawal by Subject|1
5466038|NCT01986920|18892867|P2|A-101 40%|Withdrawal by Subject|0
5466039|NCT01986920|18892868|P1|A-101 40%|Withdrawal by Subject|0
5466040|NCT01986920|18892865|P4|A-101 32.5%|Withdrawal by Subject|0
5466041|NCT01986920|18892866|P3|A-101 32.5%|Withdrawal by Subject|0
5466042|NCT01986920|18892867|P2|A-101 32.5%|Withdrawal by Subject|1
5466043|NCT01986920|18892868|P1|A-101 32.5%|Withdrawal by Subject|0
5466044|NCT01986920|18892865|P4|A- 101 25%|Withdrawal by Subject|0
5466045|NCT01986920|18892866|P3|A- 101 25%|Withdrawal by Subject|0
5466046|NCT01986920|18892867|P2|A- 101 25%|Withdrawal by Subject|0
5466047|NCT01986920|18892868|P1|A- 101 25%|Withdrawal by Subject|1
5466048|NCT01986907|18892882|P1|Overall Study|Death|9
5466049|NCT01986907|18892882|P1|Overall Study|Lost to Follow-up|38
5466050|NCT01986907|18892882|P1|Overall Study|Withdrawal by Subject|76
5466051|NCT01986907|18892882|P1|Overall Study|Protocol Violation|4
5466052|NCT01986907|18892882|P1|Overall Study|Unsatisfactory therapeutic effect|24
5466053|NCT01986907|18892882|P1|Overall Study|Adverse Event|11
5466054|NCT01986855|18892895|P3|Overall Study|Withdrawal by Subject|5
5466055|NCT01986855|18892896|P2|Overall Study|Withdrawal by Subject|8
5466056|NCT01986855|18892897|P1|Overall Study|Withdrawal by Subject|7
5466057|NCT01986855|18892895|P3|Overall Study|Participant Moved|2
5466058|NCT01986855|18892896|P2|Overall Study|Participant Moved|0
5466059|NCT01986855|18892897|P1|Overall Study|Participant Moved|0
5466060|NCT01986855|18892895|P3|Overall Study|Screen Failure|0
5466061|NCT01986855|18892896|P2|Overall Study|Screen Failure|1
5466062|NCT01986855|18892897|P1|Overall Study|Screen Failure|0
5466063|NCT01986855|18892895|P3|Overall Study|Lost to Follow-up|0
5466064|NCT01986855|18892896|P2|Overall Study|Lost to Follow-up|1
5466065|NCT01986855|18892897|P1|Overall Study|Lost to Follow-up|2
5466066|NCT01986855|18892895|P3|Overall Study|Death|4
5466067|NCT01986855|18892896|P2|Overall Study|Death|4
5466068|NCT01986855|18892897|P1|Overall Study|Death|3
5466069|NCT01986855|18892895|P3|Overall Study|Adverse Event|0
5466070|NCT01986855|18892896|P2|Overall Study|Adverse Event|0
5466071|NCT01986855|18892897|P1|Overall Study|Adverse Event|1
5466072|NCT01986829|18892926|P1|Overall Study|Death|1
5466073|NCT01986751|18892974|P2|Overall Study|improperly consented|2
5466074|NCT01986751|18892975|P1|Overall Study|improperly consented|10
5466075|NCT01986647|18893008|P4|Overall Study|Health|4
5466076|NCT01986647|18893009|P3|Overall Study|Health|6
5466077|NCT01986647|18893010|P2|Overall Study|Health|3
5466078|NCT01986647|18893011|P1|Overall Study|Health|5
5466079|NCT01986647|18893008|P4|Overall Study|Withdrawal by Subject|3
5466080|NCT01986647|18893009|P3|Overall Study|Withdrawal by Subject|2
5466081|NCT01986647|18893010|P2|Overall Study|Withdrawal by Subject|3
5466082|NCT01986647|18893011|P1|Overall Study|Withdrawal by Subject|1
5466083|NCT01986647|18893008|P4|Overall Study|Lost to Follow-up|4
5466084|NCT01986647|18893009|P3|Overall Study|Lost to Follow-up|4
5466085|NCT01986647|18893010|P2|Overall Study|Lost to Follow-up|1
5466086|NCT01986647|18893011|P1|Overall Study|Lost to Follow-up|4
5466087|NCT01986231|18893106|P1|Overall Study|Adverse Event|1
5466088|NCT01986140|18893113|P2|Overall Study|progression disease|1
5466089|NCT01986140|18893114|P1|Overall Study|progression disease|0
5466090|NCT01986140|18893113|P2|Overall Study|Adverse Event|1
5466091|NCT01986140|18893114|P1|Overall Study|Adverse Event|0
5466092|NCT01986140|18893113|P2|Overall Study|found not eligible|0
5466093|NCT01986140|18893114|P1|Overall Study|found not eligible|3
5466094|NCT01986140|18893113|P2|Overall Study|alternative treatment|1
5466095|NCT01986140|18893114|P1|Overall Study|alternative treatment|1
5466096|NCT01986140|18893113|P2|Overall Study|Withdrawal by Subject|25
5466097|NCT01986140|18893114|P1|Overall Study|Withdrawal by Subject|31
5466098|NCT01986114|18893120|P1|Overall Study|Other reason|7
5466099|NCT01986114|18893120|P1|Overall Study|Lost to Follow-up|5
5466100|NCT01986114|18893120|P1|Overall Study|Protocol Violation|1
5466101|NCT01986114|18893120|P1|Overall Study|Noncompliance|3
5466102|NCT01986114|18893120|P1|Overall Study|Withdrawal by Subject|58
5466103|NCT01986114|18893120|P1|Overall Study|Lack of Efficacy|23
5466104|NCT01986114|18893120|P1|Overall Study|Adverse Event|59
5466105|NCT01986062|18893159|P2|Overall Study|Withdrawal by Subject|1
5466106|NCT01986062|18893160|P1|Overall Study|Withdrawal by Subject|0
5466107|NCT01986062|18893159|P2|Overall Study|Lost to Follow-up|0
5466108|NCT01986062|18893160|P1|Overall Study|Lost to Follow-up|1
5466109|NCT01985360|18893258|P2|Overall Study|Lost to Follow-up|3
5466110|NCT01985360|18893259|P1|Overall Study|Lost to Follow-up|5
5466111|NCT01985360|18893258|P2|Overall Study|Withdrawal by Subject|0
5466112|NCT01985360|18893259|P1|Overall Study|Withdrawal by Subject|4
5466113|NCT01985334|18893275|P8|Overall Study|Lost to Follow-up|3
5466114|NCT01985334|18893276|P7|Overall Study|Lost to Follow-up|0
5466115|NCT01985334|18893277|P6|Overall Study|Lost to Follow-up|4
5466116|NCT01985334|18893278|P5|Overall Study|Lost to Follow-up|1
5466117|NCT01985334|18893279|P4|Overall Study|Lost to Follow-up|3
5466118|NCT01985334|18893280|P3|Overall Study|Lost to Follow-up|0
5466119|NCT01985334|18893281|P2|Overall Study|Lost to Follow-up|2
5466120|NCT01985334|18893282|P1|Overall Study|Lost to Follow-up|0
5466121|NCT01985334|18893275|P8|Overall Study|Investigator decision|4
5466122|NCT01985334|18893276|P7|Overall Study|Investigator decision|0
5466123|NCT01985334|18893277|P6|Overall Study|Investigator decision|1
5466124|NCT01985334|18893278|P5|Overall Study|Investigator decision|1
5466125|NCT01985334|18893279|P4|Overall Study|Investigator decision|7
5466126|NCT01985334|18893280|P3|Overall Study|Investigator decision|0
5466127|NCT01985334|18893281|P2|Overall Study|Investigator decision|3
5466128|NCT01985334|18893282|P1|Overall Study|Investigator decision|0
5466129|NCT01985334|18893275|P8|Overall Study|Use of prohibited treatment|0
5466130|NCT01985334|18893276|P7|Overall Study|Use of prohibited treatment|2
5466131|NCT01985334|18893277|P6|Overall Study|Use of prohibited treatment|6
5466132|NCT01985334|18893278|P5|Overall Study|Use of prohibited treatment|1
5466133|NCT01985334|18893279|P4|Overall Study|Use of prohibited treatment|2
5466134|NCT01985334|18893280|P3|Overall Study|Use of prohibited treatment|1
5466135|NCT01985334|18893281|P2|Overall Study|Use of prohibited treatment|4
5466136|NCT01985334|18893282|P1|Overall Study|Use of prohibited treatment|1
5466137|NCT01985334|18893275|P8|Overall Study|Medication non-compliance|3
5466138|NCT01985334|18893276|P7|Overall Study|Medication non-compliance|1
5466139|NCT01985334|18893277|P6|Overall Study|Medication non-compliance|3
5466140|NCT01985334|18893278|P5|Overall Study|Medication non-compliance|2
5466141|NCT01985334|18893279|P4|Overall Study|Medication non-compliance|6
5466142|NCT01985334|18893280|P3|Overall Study|Medication non-compliance|1
5466143|NCT01985334|18893281|P2|Overall Study|Medication non-compliance|4
5466144|NCT01985334|18893282|P1|Overall Study|Medication non-compliance|0
5466145|NCT01985334|18893275|P8|Overall Study|Other|2
5466146|NCT01985334|18893276|P7|Overall Study|Other|2
5466147|NCT01985334|18893277|P6|Overall Study|Other|6
5466148|NCT01985334|18893278|P5|Overall Study|Other|1
5466149|NCT01985334|18893279|P4|Overall Study|Other|10
5466150|NCT01985334|18893280|P3|Overall Study|Other|3
5466151|NCT01985334|18893281|P2|Overall Study|Other|2
5466152|NCT01985334|18893282|P1|Overall Study|Other|4
5466153|NCT01985334|18893275|P8|Overall Study|Adverse Event|15
5466154|NCT01985334|18893276|P7|Overall Study|Adverse Event|3
5466155|NCT01985334|18893277|P6|Overall Study|Adverse Event|18
5466156|NCT01985334|18893278|P5|Overall Study|Adverse Event|3
5466157|NCT01985334|18893279|P4|Overall Study|Adverse Event|26
5466158|NCT01985334|18893280|P3|Overall Study|Adverse Event|2
5466159|NCT01985334|18893281|P2|Overall Study|Adverse Event|8
5466160|NCT01985334|18893282|P1|Overall Study|Adverse Event|0
5466161|NCT01985334|18893275|P8|Overall Study|Subject withdrawal of consent|20
5466162|NCT01985334|18893276|P7|Overall Study|Subject withdrawal of consent|0
5466163|NCT01985334|18893277|P6|Overall Study|Subject withdrawal of consent|19
5466164|NCT01985334|18893278|P5|Overall Study|Subject withdrawal of consent|4
5466165|NCT01985334|18893279|P4|Overall Study|Subject withdrawal of consent|28
5466166|NCT01985334|18893280|P3|Overall Study|Subject withdrawal of consent|2
5466167|NCT01985334|18893281|P2|Overall Study|Subject withdrawal of consent|6
5466168|NCT01985334|18893282|P1|Overall Study|Subject withdrawal of consent|3
5466169|NCT01985334|18893275|P8|Overall Study|Moderate / severe COPD exacerbation|19
5466170|NCT01985334|18893276|P7|Overall Study|Moderate / severe COPD exacerbation|8
5466171|NCT01985334|18893277|P6|Overall Study|Moderate / severe COPD exacerbation|40
5466172|NCT01985334|18893278|P5|Overall Study|Moderate / severe COPD exacerbation|6
5466173|NCT01985334|18893279|P4|Overall Study|Moderate / severe COPD exacerbation|40
5466174|NCT01985334|18893280|P3|Overall Study|Moderate / severe COPD exacerbation|12
5466175|NCT01985334|18893281|P2|Overall Study|Moderate / severe COPD exacerbation|14
5466176|NCT01985334|18893282|P1|Overall Study|Moderate / severe COPD exacerbation|5
5466177|NCT01985334|18893275|P8|Overall Study|Protocol deviation|42
5466178|NCT01985334|18893276|P7|Overall Study|Protocol deviation|15
5466179|NCT01985334|18893277|P6|Overall Study|Protocol deviation|47
5466180|NCT01985334|18893278|P5|Overall Study|Protocol deviation|17
5466181|NCT01985334|18893279|P4|Overall Study|Protocol deviation|84
5466182|NCT01985334|18893280|P3|Overall Study|Protocol deviation|25
5466183|NCT01985334|18893281|P2|Overall Study|Protocol deviation|31
5466184|NCT01985334|18893282|P1|Overall Study|Protocol deviation|6
5466185|NCT01985334|18893275|P8|Overall Study|Other|7
5466186|NCT01985334|18893276|P7|Overall Study|Other|4
5466187|NCT01985334|18893277|P6|Overall Study|Other|8
5466188|NCT01985334|18893278|P5|Overall Study|Other|4
5466189|NCT01985334|18893279|P4|Overall Study|Other|17
5466190|NCT01985334|18893280|P3|Overall Study|Other|7
5466191|NCT01985334|18893281|P2|Overall Study|Other|9
5466192|NCT01985334|18893282|P1|Overall Study|Other|2
5466193|NCT01985334|18893275|P8|Overall Study|Worsening of disease|1
5466194|NCT01985334|18893276|P7|Overall Study|Worsening of disease|0
5466195|NCT01985334|18893277|P6|Overall Study|Worsening of disease|3
5466196|NCT01985334|18893278|P5|Overall Study|Worsening of disease|0
5466197|NCT01985334|18893279|P4|Overall Study|Worsening of disease|1
5466198|NCT01985334|18893280|P3|Overall Study|Worsening of disease|0
5466199|NCT01985334|18893281|P2|Overall Study|Worsening of disease|0
5466200|NCT01985334|18893282|P1|Overall Study|Worsening of disease|0
5466201|NCT01985334|18893275|P8|Overall Study|Death|2
5466202|NCT01985334|18893276|P7|Overall Study|Death|1
5466203|NCT01985334|18893277|P6|Overall Study|Death|0
5466204|NCT01985334|18893278|P5|Overall Study|Death|0
5466205|NCT01985334|18893279|P4|Overall Study|Death|3
5466206|NCT01985334|18893280|P3|Overall Study|Death|0
5466207|NCT01985334|18893281|P2|Overall Study|Death|0
5466208|NCT01985334|18893282|P1|Overall Study|Death|1
5466209|NCT01985334|18893275|P8|Overall Study|Administrative problems|3
5466210|NCT01985334|18893276|P7|Overall Study|Administrative problems|1
5466211|NCT01985334|18893277|P6|Overall Study|Administrative problems|1
5466212|NCT01985334|18893278|P5|Overall Study|Administrative problems|0
5466213|NCT01985334|18893279|P4|Overall Study|Administrative problems|2
5466214|NCT01985334|18893280|P3|Overall Study|Administrative problems|0
5466215|NCT01985334|18893281|P2|Overall Study|Administrative problems|1
5466216|NCT01985334|18893282|P1|Overall Study|Administrative problems|1
5466217|NCT01985321|18893350|P2|Overall Study|Subject treated wrong type of sore|0
5466218|NCT01985321|18893351|P1|Overall Study|Subject treated wrong type of sore|1
5466219|NCT01985321|18893350|P2|Overall Study|Lost to Follow-up|2
5466220|NCT01985321|18893351|P1|Overall Study|Lost to Follow-up|5
5466221|NCT01985321|18893350|P2|Overall Study|Withdrawal by Subject|0
5466222|NCT01985321|18893351|P1|Overall Study|Withdrawal by Subject|1
5466223|NCT01985321|18893350|P2|Overall Study|Protocol Violation|3
5466224|NCT01985321|18893351|P1|Overall Study|Protocol Violation|4
5466225|NCT01985126|18893361|P2|Overall Study|Withdrawal by Subject|7
5466226|NCT01985126|18893362|P1|Overall Study|Withdrawal by Subject|2
5466227|NCT01985126|18893361|P2|Overall Study|Study Terminated By Sponsor|22
5466228|NCT01985126|18893362|P1|Overall Study|Study Terminated By Sponsor|1
5466229|NCT01985126|18893361|P2|Overall Study|Lost to Follow-up|8
5466230|NCT01985126|18893362|P1|Overall Study|Lost to Follow-up|0
5466231|NCT01985126|18893361|P2|Overall Study|Death|69
5466232|NCT01985126|18893362|P1|Overall Study|Death|15
5466233|NCT01984892|18893380|P1|Overall Study|Progressive disease|7
5466234|NCT01984697|18893391|P5|Overall Study|Pregnancy|1
5466235|NCT01984697|18893392|P4|Overall Study|Pregnancy|0
5466236|NCT01984697|18893393|P3|Overall Study|Pregnancy|1
5466237|NCT01984697|18893394|P2|Overall Study|Pregnancy|0
5466238|NCT01984697|18893395|P1|Overall Study|Pregnancy|2
5466239|NCT01984697|18893391|P5|Overall Study|Death|0
5466240|NCT01984697|18893392|P4|Overall Study|Death|1
5466241|NCT01984697|18893393|P3|Overall Study|Death|0
5466242|NCT01984697|18893394|P2|Overall Study|Death|0
5466243|NCT01984697|18893395|P1|Overall Study|Death|0
5466244|NCT01984697|18893391|P5|Overall Study|Missed last follow-up visit|0
5466245|NCT01984697|18893392|P4|Overall Study|Missed last follow-up visit|0
5466246|NCT01984697|18893393|P3|Overall Study|Missed last follow-up visit|0
5466247|NCT01984697|18893394|P2|Overall Study|Missed last follow-up visit|0
5466248|NCT01984697|18893395|P1|Overall Study|Missed last follow-up visit|1
5466249|NCT01984697|18893391|P5|Overall Study|Withdrawal by Subject|13
5466250|NCT01984697|18893392|P4|Overall Study|Withdrawal by Subject|11
5466251|NCT01984697|18893393|P3|Overall Study|Withdrawal by Subject|13
5466252|NCT01984697|18893394|P2|Overall Study|Withdrawal by Subject|21
5466253|NCT01984697|18893395|P1|Overall Study|Withdrawal by Subject|15
5466254|NCT01984697|18893391|P5|Overall Study|Protocol Violation|0
5466255|NCT01984697|18893392|P4|Overall Study|Protocol Violation|2
5466256|NCT01984697|18893393|P3|Overall Study|Protocol Violation|3
5466257|NCT01984697|18893394|P2|Overall Study|Protocol Violation|5
5466258|NCT01984697|18893395|P1|Overall Study|Protocol Violation|8
5466259|NCT01984697|18893391|P5|Overall Study|Physician Decision|0
5466260|NCT01984697|18893392|P4|Overall Study|Physician Decision|1
5466261|NCT01984697|18893393|P3|Overall Study|Physician Decision|0
5466262|NCT01984697|18893394|P2|Overall Study|Physician Decision|0
5466263|NCT01984697|18893395|P1|Overall Study|Physician Decision|3
5466264|NCT01984697|18893391|P5|Overall Study|Lost to Follow-up|21
5466265|NCT01984697|18893392|P4|Overall Study|Lost to Follow-up|6
5466266|NCT01984697|18893393|P3|Overall Study|Lost to Follow-up|10
5466267|NCT01984697|18893394|P2|Overall Study|Lost to Follow-up|5
5466268|NCT01984697|18893395|P1|Overall Study|Lost to Follow-up|14
5466269|NCT01984697|18893391|P5|Overall Study|Adverse Event|0
5466270|NCT01984697|18893392|P4|Overall Study|Adverse Event|0
5466271|NCT01984697|18893393|P3|Overall Study|Adverse Event|2
5466272|NCT01984697|18893394|P2|Overall Study|Adverse Event|0
5466273|NCT01984697|18893395|P1|Overall Study|Adverse Event|0
5466274|NCT01984684|18893514|P2|Overall Study|Subject had inadequate IV access|1
5466275|NCT01984684|18893515|P1|Overall Study|Subject had inadequate IV access|0
5466276|NCT01984684|18893514|P2|Overall Study|Study drug not available at site|1
5466277|NCT01984684|18893515|P1|Overall Study|Study drug not available at site|1
5466278|NCT01984684|18893514|P2|Overall Study|Subject incarcerated|0
5466279|NCT01984684|18893515|P1|Overall Study|Subject incarcerated|1
5466280|NCT01984684|18893514|P2|Overall Study|Noncompliance with study drug|1
5466281|NCT01984684|18893515|P1|Overall Study|Noncompliance with study drug|2
5466282|NCT01984684|18893514|P2|Overall Study|Death|1
5466283|NCT01984684|18893515|P1|Overall Study|Death|0
5466284|NCT01984684|18893514|P2|Overall Study|Protocol Violation|2
5466285|NCT01984684|18893515|P1|Overall Study|Protocol Violation|4
5466286|NCT01984684|18893514|P2|Overall Study|Physician Decision|2
5466287|NCT01984684|18893515|P1|Overall Study|Physician Decision|4
5466288|NCT01984684|18893514|P2|Overall Study|Lack of Efficacy|6
5466289|NCT01984684|18893515|P1|Overall Study|Lack of Efficacy|3
5466290|NCT01984684|18893514|P2|Overall Study|Withdrawal by Subject|9
5466291|NCT01984684|18893515|P1|Overall Study|Withdrawal by Subject|9
5466292|NCT01984684|18893514|P2|Overall Study|Adverse Event|12
5466293|NCT01984684|18893515|P1|Overall Study|Adverse Event|8
5466294|NCT01984684|18893514|P2|Overall Study|Lost to Follow-up|24
5466295|NCT01984684|18893515|P1|Overall Study|Lost to Follow-up|25
5466296|NCT01984424|18893533|P2|Overall Study|Lost to Follow-up|1
5466297|NCT01984424|18893534|P1|Overall Study|Lost to Follow-up|0
5466298|NCT01984424|18893533|P2|Overall Study|Sponsor Decision|1
5466299|NCT01984424|18893534|P1|Overall Study|Sponsor Decision|0
5466300|NCT01984424|18893533|P2|Overall Study|Withdrawal by Subject|5
5466301|NCT01984424|18893534|P1|Overall Study|Withdrawal by Subject|3
5466302|NCT01984294|18893604|P3|Overall Study|Adverse Event|0
5466303|NCT01984294|18893605|P2|Overall Study|Adverse Event|1
5466304|NCT01984294|18893606|P1|Overall Study|Adverse Event|0
5466305|NCT01984294|18893604|P3|Overall Study|Lack of Efficacy|6
5466306|NCT01984294|18893605|P2|Overall Study|Lack of Efficacy|2
5466307|NCT01984294|18893606|P1|Overall Study|Lack of Efficacy|4
5466308|NCT01984294|18893604|P3|Overall Study|Randomized but Never Treated|1
5466309|NCT01984294|18893605|P2|Overall Study|Randomized but Never Treated|0
5466310|NCT01984294|18893606|P1|Overall Study|Randomized but Never Treated|0
5466311|NCT01984242|18893629|P3|Overall Study|Disease Progression|1
5466312|NCT01984242|18893630|P2|Overall Study|Disease Progression|0
5466313|NCT01984242|18893631|P1|Overall Study|Disease Progression|0
5466314|NCT01984242|18893629|P3|Overall Study|Study terminated by Sponsor|34
5466315|NCT01984242|18893630|P2|Overall Study|Study terminated by Sponsor|50
5466316|NCT01984242|18893631|P1|Overall Study|Study terminated by Sponsor|38
5466317|NCT01984242|18893629|P3|Overall Study|Non-Compliance|0
5466318|NCT01984242|18893630|P2|Overall Study|Non-Compliance|0
5466319|NCT01984242|18893631|P1|Overall Study|Non-Compliance|1
5466320|NCT01984242|18893629|P3|Overall Study|Sponsor Decision|0
5466321|NCT01984242|18893630|P2|Overall Study|Sponsor Decision|0
5466322|NCT01984242|18893631|P1|Overall Study|Sponsor Decision|1
5466323|NCT01984242|18893629|P3|Overall Study|Lost to Follow-up|3
5466324|NCT01984242|18893630|P2|Overall Study|Lost to Follow-up|0
5466325|NCT01984242|18893631|P1|Overall Study|Lost to Follow-up|4
5466326|NCT01984242|18893629|P3|Overall Study|Physician Decision|1
5466327|NCT01984242|18893630|P2|Overall Study|Physician Decision|0
5466328|NCT01984242|18893631|P1|Overall Study|Physician Decision|0
5466329|NCT01984242|18893629|P3|Overall Study|Withdrawal by Subject|10
5466330|NCT01984242|18893630|P2|Overall Study|Withdrawal by Subject|3
5466331|NCT01984242|18893631|P1|Overall Study|Withdrawal by Subject|5
5466332|NCT01984242|18893629|P3|Overall Study|Death|52
5466333|NCT01984242|18893630|P2|Overall Study|Death|50
5466334|NCT01984242|18893631|P1|Overall Study|Death|52
5466335|NCT01984229|18893781|P2|Safety Follow-up Period|Lost to Follow-up|0
5466336|NCT01984229|18893782|P1|Safety Follow-up Period|Lost to Follow-up|1
5466337|NCT01984229|18893781|P2|Safety Follow-up Period|Adverse Event|1
5466338|NCT01984229|18893782|P1|Safety Follow-up Period|Adverse Event|1
5466339|NCT01983969|18893835|P3|Overall Study|Disease Progression|0
5466340|NCT01983969|18893836|P2|Overall Study|Disease Progression|1
5466341|NCT01983969|18893837|P1|Overall Study|Disease Progression|0
5466342|NCT01983930|18893851|P2|Overall Study|Adverse Event|1
5466343|NCT01983930|18893852|P1|Overall Study|Adverse Event|0
5466344|NCT01983930|18893851|P2|Overall Study|Withdrawal by Subject|8
5466345|NCT01983930|18893852|P1|Overall Study|Withdrawal by Subject|9
5466346|NCT01983683|18893926|P2|Overall Study|Sponsor Decision|1
5466347|NCT01983683|18893927|P1|Overall Study|Sponsor Decision|1
5466348|NCT01983683|18893926|P2|Overall Study|Lost to Follow-up|8
5466349|NCT01983683|18893927|P1|Overall Study|Lost to Follow-up|4
5466350|NCT01983683|18893926|P2|Overall Study|Physician Decision|9
5466351|NCT01983683|18893927|P1|Overall Study|Physician Decision|8
5466352|NCT01983683|18893926|P2|Overall Study|Death|15
5466353|NCT01983683|18893927|P1|Overall Study|Death|11
5466354|NCT01983683|18893926|P2|Overall Study|Withdrawal by Subject|18
5466355|NCT01983683|18893927|P1|Overall Study|Withdrawal by Subject|14
5466356|NCT01983293|18894014|P2|Overall Study|Missing NYHA/Patient Global Assessment|1
5466357|NCT01983293|18894015|P1|Overall Study|Missing NYHA/Patient Global Assessment|1
5466358|NCT01983293|18894014|P2|Overall Study|Missing 12-month visit|3
5466359|NCT01983293|18894015|P1|Overall Study|Missing 12-month visit|3
5466360|NCT01983293|18894014|P2|Overall Study|Withdrawal by Subject|15
5466361|NCT01983293|18894015|P1|Overall Study|Withdrawal by Subject|29
5466362|NCT01983254|18894023|P2|Overall Study|too ill|8
5466363|NCT01983254|18894024|P1|Overall Study|too ill|11
5466364|NCT01983254|18894023|P2|Overall Study|Lost to Follow-up|16
5466365|NCT01983254|18894024|P1|Overall Study|Lost to Follow-up|17
5466366|NCT01983254|18894023|P2|Overall Study|Death|6
5466367|NCT01983254|18894024|P1|Overall Study|Death|6
5466368|NCT01983111|18894036|P2|Overall Study|Protocol Violation|1
5466369|NCT01983111|18894037|P1|Overall Study|Protocol Violation|0
5466370|NCT01983111|18894036|P2|Overall Study|Adverse Event|0
5466371|NCT01983111|18894037|P1|Overall Study|Adverse Event|4
5466372|NCT01983111|18894036|P2|Overall Study|Withdrawal by Subject|6
5466373|NCT01983111|18894037|P1|Overall Study|Withdrawal by Subject|8
5466374|NCT01982955|18894075|P5|Overall Study|Ongoing|0
5466375|NCT01982955|18894076|P4|Overall Study|Ongoing|0
5466376|NCT01982955|18894077|P3|Overall Study|Ongoing|4
5466377|NCT01982955|18894078|P2|Overall Study|Ongoing|0
5466378|NCT01982955|18894079|P1|Overall Study|Ongoing|0
5466379|NCT01982955|18894075|P5|Overall Study|Randomized but not treated|0
5466380|NCT01982955|18894076|P4|Overall Study|Randomized but not treated|1
5466381|NCT01982955|18894077|P3|Overall Study|Randomized but not treated|0
5466382|NCT01982955|18894078|P2|Overall Study|Randomized but not treated|0
5466383|NCT01982955|18894079|P1|Overall Study|Randomized but not treated|0
5466384|NCT01982942|18894181|P2|Overall Study|Subject bedridden, rapidly declining|1
5466385|NCT01982942|18894182|P1|Overall Study|Subject bedridden, rapidly declining|0
5466386|NCT01982942|18894181|P2|Overall Study|Chose to join a stem cell trial|1
5466387|NCT01982942|18894182|P1|Overall Study|Chose to join a stem cell trial|0
5466388|NCT01982942|18894181|P2|Overall Study|MS Relapse|1
5466389|NCT01982942|18894182|P1|Overall Study|MS Relapse|0
5466390|NCT01982942|18894181|P2|Overall Study|Too many pills|0
5466391|NCT01982942|18894182|P1|Overall Study|Too many pills|1
5466392|NCT01982942|18894181|P2|Overall Study|Left geographical area|0
5466393|NCT01982942|18894182|P1|Overall Study|Left geographical area|2
5466394|NCT01982942|18894181|P2|Overall Study|Subject declined future visits|1
5466395|NCT01982942|18894182|P1|Overall Study|Subject declined future visits|0
5466396|NCT01982942|18894181|P2|Overall Study|Wanted to try therapy not permitted|0
5466397|NCT01982942|18894182|P1|Overall Study|Wanted to try therapy not permitted|1
5466398|NCT01982942|18894181|P2|Overall Study|Multiple sclerosis progression|2
5466399|NCT01982942|18894182|P1|Overall Study|Multiple sclerosis progression|3
5466400|NCT01982942|18894181|P2|Overall Study|Lost to Follow-up|3
5466401|NCT01982942|18894182|P1|Overall Study|Lost to Follow-up|4
5466402|NCT01982942|18894181|P2|Overall Study|Adverse Event|5
5466403|NCT01982942|18894182|P1|Overall Study|Adverse Event|10
5466404|NCT01982812|18894200|P2|Overall Study|Adverse Event|5
5466405|NCT01982812|18894201|P1|Overall Study|Adverse Event|0
5466406|NCT01982812|18894200|P2|Overall Study|Death|5
5466407|NCT01982812|18894201|P1|Overall Study|Death|1
5466408|NCT01982773|18894230|P2|Overall Study|Lost to Follow-up|1
5466409|NCT01982773|18894231|P1|Overall Study|Lost to Follow-up|7
5466410|NCT01982773|18894230|P2|Overall Study|Withdrawal by Subject|3
5466411|NCT01982773|18894231|P1|Overall Study|Withdrawal by Subject|1
5466412|NCT01982682|18894252|P1|Overall Study|Physician Decision|1
5466413|NCT01982435|18894272|P2|Overall Study|Adverse Event|0
5466414|NCT01982435|18894273|P1|Overall Study|Adverse Event|1
5466415|NCT01982331|18894312|P2|Completed Study (Day 112)|Withdrawal by Subject|0
5466416|NCT01982331|18894313|P1|Completed Study (Day 112)|Withdrawal by Subject|2
5466417|NCT01982331|18894312|P2|Received Vaccination 2|Withdrawal by Subject|1
5466418|NCT01982331|18894313|P1|Received Vaccination 2|Withdrawal by Subject|0
5466419|NCT01982331|18894312|P2|Received Vaccination 2|Adverse Event|2
5466420|NCT01982331|18894313|P1|Received Vaccination 2|Adverse Event|1
5466421|NCT01982292|18894349|P2|Overall Study|Technical Problems|0
5466422|NCT01982292|18894350|P1|Overall Study|Technical Problems|2
5466423|NCT01982292|18894349|P2|Overall Study|Patient/Guardian Decision|1
5466424|NCT01982292|18894350|P1|Overall Study|Patient/Guardian Decision|3
5466425|NCT01982292|18894349|P2|Overall Study|Protocol Deviation|0
5466426|NCT01982292|18894350|P1|Overall Study|Protocol Deviation|1
5466427|NCT01982292|18894349|P2|Overall Study|Non-Compliance With Study Treatment|0
5466428|NCT01982292|18894350|P1|Overall Study|Non-Compliance With Study Treatment|1
5466429|NCT01982292|18894349|P2|Overall Study|Lost to Follow-up|0
5466430|NCT01982292|18894350|P1|Overall Study|Lost to Follow-up|2
5466431|NCT01982292|18894349|P2|Overall Study|Death|0
5466432|NCT01982292|18894350|P1|Overall Study|Death|1
5466433|NCT01982292|18894349|P2|Overall Study|Adverse Event|0
5466434|NCT01982292|18894350|P1|Overall Study|Adverse Event|2
5466435|NCT01982253|18894371|P3|Overall Study|Study terminated by sponsor|4
5466436|NCT01982253|18894372|P2|Overall Study|Study terminated by sponsor|4
5466437|NCT01982253|18894373|P1|Overall Study|Study terminated by sponsor|1
5466438|NCT01982253|18894371|P3|Overall Study|Withdrawal by Subject|0
5466439|NCT01982253|18894372|P2|Overall Study|Withdrawal by Subject|0
5466440|NCT01982253|18894373|P1|Overall Study|Withdrawal by Subject|1
5466441|NCT01981954|18894427|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
5466442|NCT01981954|18894427|P1|Titration Period|Protocol Deviation|1
5466443|NCT01981616|18894511|P2|Overall Study|Protocol Violation|0
5466444|NCT01981616|18894512|P1|Overall Study|Protocol Violation|1
5466445|NCT01981616|18894511|P2|Overall Study|Adverse Event|1
5466446|NCT01981616|18894512|P1|Overall Study|Adverse Event|0
5466447|NCT01981551|18894542|P1|Overall Study|Adverse Event|1
5466448|NCT01981551|18894542|P1|Overall Study|Refused further treatment|8
5466449|NCT01981473|18894552|P3|Overall Study|Received treatment for >24 months|6
5466450|NCT01981473|18894553|P2|Overall Study|Received treatment for >24 months|0
5466451|NCT01981473|18894554|P1|Overall Study|Received treatment for >24 months|2
5466452|NCT01981473|18894552|P3|Overall Study|Received treatment for < 6 months|1
5466453|NCT01981473|18894553|P2|Overall Study|Received treatment for < 6 months|0
5466454|NCT01981473|18894554|P1|Overall Study|Received treatment for < 6 months|0
5466455|NCT01981473|18894552|P3|Overall Study|Incorrect diagnosis of RA|1
5466456|NCT01981473|18894553|P2|Overall Study|Incorrect diagnosis of RA|0
5466457|NCT01981473|18894554|P1|Overall Study|Incorrect diagnosis of RA|0
5466458|NCT01981356|18894595|P2|Overall Study|Protocol Violation|0
5466459|NCT01981356|18894596|P1|Overall Study|Protocol Violation|2
5466460|NCT01981356|18894595|P2|Overall Study|Withdrawal by Subject|1
5466461|NCT01981356|18894596|P1|Overall Study|Withdrawal by Subject|1
5466462|NCT01981356|18894595|P2|Overall Study|Lost to Follow-up|1
5466463|NCT01981356|18894596|P1|Overall Study|Lost to Follow-up|4
5466464|NCT01981122|18894623|P2|Overall Study|Death|15
5466465|NCT01981122|18894624|P1|Overall Study|Death|14
5466466|NCT01981122|18894623|P2|Overall Study|Investigator Or Dendreon Discretion|1
5466467|NCT01981122|18894624|P1|Overall Study|Investigator Or Dendreon Discretion|0
5466468|NCT01981122|18894623|P2|Overall Study|Lost to Follow-up|1
5466469|NCT01981122|18894624|P1|Overall Study|Lost to Follow-up|0
5466470|NCT01981122|18894623|P2|Overall Study|Protocol Violation|1
5466471|NCT01981122|18894624|P1|Overall Study|Protocol Violation|0
5466472|NCT01981122|18894623|P2|Overall Study|Withdrawal by Subject|2
5466473|NCT01981122|18894624|P1|Overall Study|Withdrawal by Subject|0
5466474|NCT01981109|18894630|P1|Overall Study|No data available|2
5466475|NCT01981109|18894630|P1|Overall Study|Study Termination|100
5466476|NCT01981109|18894630|P1|Overall Study|No Discontinuation Documentation|37
5466477|NCT01981109|18894630|P1|Overall Study|Lost to Follow-up|9
5466478|NCT01981109|18894630|P1|Overall Study|Withdrawal by Subject|40
5466479|NCT01981109|18894630|P1|Overall Study|Death|36
5466480|NCT01981096|18894637|P2|Overall Study|Lost to Follow-up|0
5466481|NCT01981096|18894638|P1|Overall Study|Lost to Follow-up|2
5466482|NCT01981096|18894637|P2|Overall Study|Withdrawal by Subject|1
5466483|NCT01981096|18894638|P1|Overall Study|Withdrawal by Subject|0
5466484|NCT01981096|18894637|P2|Overall Study|Parent illness|0
5466485|NCT01981096|18894638|P1|Overall Study|Parent illness|1
5466486|NCT01980992|18894659|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
5466487|NCT01980992|18894660|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
5466488|NCT01980992|18894659|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
5466489|NCT01980992|18894660|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
5466490|NCT01980992|18894659|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
5466491|NCT01980992|18894660|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
5466492|NCT01980992|18894659|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
5466493|NCT01980992|18894660|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
5466494|NCT01980992|18894659|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
5466495|NCT01980992|18894660|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
5466496|NCT01980992|18894659|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
5466497|NCT01980992|18894660|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
5466498|NCT01980940|18894685|P8|Overall Study|Protocol Violation|0
5466499|NCT01980940|18894686|P7|Overall Study|Protocol Violation|0
5466500|NCT01980940|18894687|P6|Overall Study|Protocol Violation|2
5466501|NCT01980940|18894688|P5|Overall Study|Protocol Violation|0
5466502|NCT01980940|18894689|P4|Overall Study|Protocol Violation|0
5466503|NCT01980940|18894690|P3|Overall Study|Protocol Violation|0
5466504|NCT01980940|18894691|P2|Overall Study|Protocol Violation|0
5466505|NCT01980940|18894692|P1|Overall Study|Protocol Violation|0
5466506|NCT01980888|18894751|P2|Overall Study|Non-Compliance with Study Drug|2
5466507|NCT01980888|18894752|P1|Overall Study|Non-Compliance with Study Drug|3
5466508|NCT01980888|18894751|P2|Overall Study|Investigator's Discretion|3
5466509|NCT01980888|18894752|P1|Overall Study|Investigator's Discretion|8
5466510|NCT01980888|18894751|P2|Overall Study|Withdrew Consent|6
5466511|NCT01980888|18894752|P1|Overall Study|Withdrew Consent|17
5466512|NCT01980888|18894751|P2|Overall Study|Study Terminated by Sponsor|122
5466513|NCT01980888|18894752|P1|Overall Study|Study Terminated by Sponsor|116
5466514|NCT01980875|18894771|P3|Overall Study|Lost to Follow-up|1
5466515|NCT01980875|18894772|P2|Overall Study|Lost to Follow-up|0
5466516|NCT01980875|18894773|P1|Overall Study|Lost to Follow-up|0
5466517|NCT01980875|18894771|P3|Overall Study|Study Terminated by Sponsor|22
5466518|NCT01980875|18894772|P2|Overall Study|Study Terminated by Sponsor|24
5466519|NCT01980875|18894773|P1|Overall Study|Study Terminated by Sponsor|7
5466520|NCT01980875|18894771|P3|Overall Study|Withdrew Consent|1
5466521|NCT01980875|18894772|P2|Overall Study|Withdrew Consent|1
5466522|NCT01980875|18894773|P1|Overall Study|Withdrew Consent|1
5466523|NCT01980706|18894808|P3|Overall Study|miscellaneous|3
5466524|NCT01980706|18894809|P2|Overall Study|miscellaneous|5
5466525|NCT01980706|18894810|P1|Overall Study|miscellaneous|4
5466526|NCT01980706|18894808|P3|Overall Study|Lost to Follow-up|3
5466527|NCT01980706|18894809|P2|Overall Study|Lost to Follow-up|4
5466528|NCT01980706|18894810|P1|Overall Study|Lost to Follow-up|3
5466529|NCT01980706|18894808|P3|Overall Study|Adverse Event|5
5466530|NCT01980706|18894809|P2|Overall Study|Adverse Event|2
5466531|NCT01980706|18894810|P1|Overall Study|Adverse Event|1
5466532|NCT01980706|18894808|P3|Overall Study|Withdrawal by Subject|2
5466533|NCT01980706|18894809|P2|Overall Study|Withdrawal by Subject|6
5466534|NCT01980706|18894810|P1|Overall Study|Withdrawal by Subject|9
5466535|NCT01980628|18894850|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
5466536|NCT01980628|18894850|P1|Overall Study|Withdrawal by Subject|4
5466537|NCT01980628|18894850|P1|Overall Study|Physician Decision|5
5466538|NCT01980628|18894850|P1|Overall Study|Adverse Event|12
5466539|NCT01980095|18894909|P2|Overall Study|Randomized by mistake|0
5466540|NCT01980095|18894910|P1|Overall Study|Randomized by mistake|1
5466541|NCT01980095|18894909|P2|Overall Study|Study drug discontinued|0
5466542|NCT01980095|18894910|P1|Overall Study|Study drug discontinued|1
5466543|NCT01980095|18894909|P2|Overall Study|Safety issue|1
5466544|NCT01980095|18894910|P1|Overall Study|Safety issue|0
5466545|NCT01980095|18894909|P2|Overall Study|Poor compliance|0
5466546|NCT01980095|18894910|P1|Overall Study|Poor compliance|5
5466547|NCT01980095|18894909|P2|Overall Study|Withdrawal by Subject|3
5466548|NCT01980095|18894910|P1|Overall Study|Withdrawal by Subject|2
5466549|NCT01980095|18894909|P2|Overall Study|Lost to Follow-up|7
5466550|NCT01980095|18894910|P1|Overall Study|Lost to Follow-up|6
5466551|NCT01980056|18894921|P3|Overall Study|Death|0
5466552|NCT01980056|18894922|P2|Overall Study|Death|1
5466553|NCT01980056|18894923|P1|Overall Study|Death|1
5466554|NCT01979952|18894937|P2|Overall Study|Other than specified above|0
5466555|NCT01979952|18894938|P1|Overall Study|Other than specified above|1
5466556|NCT01979952|18894937|P2|Overall Study|Withdrawal by Subject|1
5466557|NCT01979952|18894938|P1|Overall Study|Withdrawal by Subject|2
5466558|NCT01979952|18894937|P2|Overall Study|Protocol Violation|0
5466559|NCT01979952|18894938|P1|Overall Study|Protocol Violation|1
5466560|NCT01979952|18894937|P2|Overall Study|Adverse Event|5
5466561|NCT01979952|18894938|P1|Overall Study|Adverse Event|4
5466562|NCT01979835|18894966|P1|Follow-up|Lost to Follow-up|32
5466563|NCT01979835|18894966|P1|Primary Outcome SA Measurment|failed insertion|18
5466564|NCT01979614|18894973|P2|Overall Study|Adverse Event|1
5466565|NCT01979614|18894974|P1|Overall Study|Adverse Event|1
5466566|NCT01979523|18894996|P2|Overall Study|Withdrawal by Subject|0
5466567|NCT01979523|18894997|P1|Overall Study|Withdrawal by Subject|1
5466568|NCT01979185|18895057|P2|Period 2|Other|1
5466569|NCT01979185|18895058|P1|Period 2|Other|0
5466570|NCT01979016|18895106|P2|Overall Study|Adverse Event|1
5466571|NCT01979016|18895107|P1|Overall Study|Adverse Event|0
5466572|NCT01979016|18895106|P2|Overall Study|Withdrawal by Subject|0
5466573|NCT01979016|18895107|P1|Overall Study|Withdrawal by Subject|2
5466574|NCT01978938|18895141|P2|Overall Study|Previously scheduled procedure|1
5466575|NCT01978938|18895142|P1|Overall Study|Previously scheduled procedure|0
5466576|NCT01978938|18895141|P2|Overall Study|Did not meet inclusion criteria|1
5466577|NCT01978938|18895142|P1|Overall Study|Did not meet inclusion criteria|0
5466578|NCT01978938|18895141|P2|Overall Study|Participant noncompliance|1
5466579|NCT01978938|18895142|P1|Overall Study|Participant noncompliance|1
5466580|NCT01978938|18895141|P2|Overall Study|Adverse Event, non-fatal|1
5466581|NCT01978938|18895142|P1|Overall Study|Adverse Event, non-fatal|2
5466582|NCT01978938|18895141|P2|Overall Study|Withdrawal by Subject|4
5466583|NCT01978938|18895142|P1|Overall Study|Withdrawal by Subject|8
5466584|NCT01978938|18895141|P2|Overall Study|Lost to Follow-up|6
5466585|NCT01978938|18895142|P1|Overall Study|Lost to Follow-up|12
5466586|NCT01978912|18895156|P4|Overall Study|Intradiscal Steroid Injection|0
5466587|NCT01978912|18895157|P3|Overall Study|Intradiscal Steroid Injection|0
5466588|NCT01978912|18895158|P2|Overall Study|Intradiscal Steroid Injection|1
5466589|NCT01978912|18895159|P1|Overall Study|Intradiscal Steroid Injection|0
5466590|NCT01978912|18895156|P4|Overall Study|Lumbar Surgery|0
5466591|NCT01978912|18895157|P3|Overall Study|Lumbar Surgery|1
5466592|NCT01978912|18895158|P2|Overall Study|Lumbar Surgery|0
5466593|NCT01978912|18895159|P1|Overall Study|Lumbar Surgery|1
5466594|NCT01978912|18895156|P4|Overall Study|Withdrawal by Subject|2
5466595|NCT01978912|18895157|P3|Overall Study|Withdrawal by Subject|2
5466596|NCT01978912|18895158|P2|Overall Study|Withdrawal by Subject|0
5466597|NCT01978912|18895159|P1|Overall Study|Withdrawal by Subject|1
5466598|NCT01978912|18895156|P4|Overall Study|Lost to Follow-up|1
5466599|NCT01978912|18895157|P3|Overall Study|Lost to Follow-up|0
5466600|NCT01978912|18895158|P2|Overall Study|Lost to Follow-up|1
5466601|NCT01978912|18895159|P1|Overall Study|Lost to Follow-up|1
5466602|NCT01978912|18895156|P4|Overall Study|Adverse Event|0
5466603|NCT01978912|18895157|P3|Overall Study|Adverse Event|0
5466604|NCT01978912|18895158|P2|Overall Study|Adverse Event|1
5466605|NCT01978912|18895159|P1|Overall Study|Adverse Event|0
5466606|NCT01978262|18895352|P1|Overall Study|Lost to Follow-up|2
5466607|NCT01978262|18895352|P1|Overall Study|Withdrawal by Subject|9
5466608|NCT01978236|18895357|P1|Overall Study|Discontinued due to study close|2
5466609|NCT01978184|18895378|P2|Overall Study|Withdrew- toxicities or physical decline|8
5466610|NCT01978184|18895379|P1|Overall Study|Withdrew- toxicities or physical decline|4
5466611|NCT01978184|18895378|P2|Overall Study|Death|0
5466612|NCT01978184|18895379|P1|Overall Study|Death|1
5466613|NCT01978184|18895378|P2|Overall Study|Noncompliance|2
5466614|NCT01978184|18895379|P1|Overall Study|Noncompliance|1
5466615|NCT01978184|18895378|P2|Overall Study|Physician Decision|3
5466616|NCT01978184|18895379|P1|Overall Study|Physician Decision|0
5466617|NCT01978184|18895378|P2|Overall Study|Other than PDA|2
5466618|NCT01978184|18895379|P1|Overall Study|Other than PDA|2
5466619|NCT01978184|18895378|P2|Overall Study|Progressive disease|5
5466620|NCT01978184|18895379|P1|Overall Study|Progressive disease|5
5466621|NCT01978145|18895405|P2|Treatment Period 2|Par. reached defined stopping criteria|5
5466622|NCT01978145|18895406|P1|Treatment Period 2|Par. reached defined stopping criteria|8
5466623|NCT01978145|18895405|P2|Treatment Period 2|Withdrawal by Subject|4
5466624|NCT01978145|18895406|P1|Treatment Period 2|Withdrawal by Subject|7
5466625|NCT01978145|18895405|P2|Treatment Period 2|Lost to Follow-up|1
5466626|NCT01978145|18895406|P1|Treatment Period 2|Lost to Follow-up|1
5466627|NCT01978145|18895405|P2|Treatment Period 2|Protocol Violation|1
5466628|NCT01978145|18895406|P1|Treatment Period 2|Protocol Violation|0
5466629|NCT01978145|18895405|P2|Treatment Period 2|Adverse Event|3
5466630|NCT01978145|18895406|P1|Treatment Period 2|Adverse Event|3
5466631|NCT01978145|18895405|P2|Washout Period 1|Par. reached defined stopping criteria|1
5466632|NCT01978145|18895406|P1|Washout Period 1|Par. reached defined stopping criteria|0
5466633|NCT01978145|18895405|P2|Washout Period 1|Withdrawal by Subject|1
5466634|NCT01978145|18895406|P1|Washout Period 1|Withdrawal by Subject|1
5466635|NCT01978145|18895405|P2|Washout Period 1|Adverse Event|1
5466636|NCT01978145|18895406|P1|Washout Period 1|Adverse Event|0
5466637|NCT01978145|18895405|P2|Treatment Period 1|Par. reached defined stopping criteria|3
5466638|NCT01978145|18895406|P1|Treatment Period 1|Par. reached defined stopping criteria|2
5466639|NCT01978145|18895405|P2|Treatment Period 1|Withdrawal by Subject|4
5466640|NCT01978145|18895406|P1|Treatment Period 1|Withdrawal by Subject|5
5466641|NCT01978145|18895405|P2|Treatment Period 1|Physician Decision|0
5466642|NCT01978145|18895406|P1|Treatment Period 1|Physician Decision|1
5466643|NCT01978145|18895405|P2|Treatment Period 1|Adverse Event|9
5466644|NCT01978145|18895406|P1|Treatment Period 1|Adverse Event|1
5466645|NCT01978119|18895422|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
5466646|NCT01978119|18895423|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5466647|NCT01978119|18895422|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5466648|NCT01978119|18895423|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5466649|NCT01978119|18895422|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
5466650|NCT01978119|18895423|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
5466651|NCT01978093|18895449|P2|Overall Study|N/A for vaccine administration|1
5466652|NCT01978093|18895450|P1|Overall Study|N/A for vaccine administration|0
5466653|NCT01978093|18895449|P2|Overall Study|Child was in care of grandmother|1
5466654|NCT01978093|18895450|P1|Overall Study|Child was in care of grandmother|0
5466655|NCT01978093|18895449|P2|Overall Study|Mother lost custody of child|1
5466656|NCT01978093|18895450|P1|Overall Study|Mother lost custody of child|0
5466657|NCT01978093|18895449|P2|Overall Study|Lost kaiser health plan unable to contac|0
5466658|NCT01978093|18895450|P1|Overall Study|Lost kaiser health plan unable to contac|1
5466659|NCT01978093|18895449|P2|Overall Study|Loss of kaiser coverage|10
5466660|NCT01978093|18895450|P1|Overall Study|Loss of kaiser coverage|4
5466661|NCT01978093|18895449|P2|Overall Study|Migrated/moved from study area|13
5466662|NCT01978093|18895450|P1|Overall Study|Migrated/moved from study area|11
5466663|NCT01978093|18895449|P2|Overall Study|Lost to Follow-up|15
5466664|NCT01978093|18895450|P1|Overall Study|Lost to Follow-up|11
5466665|NCT01978093|18895449|P2|Overall Study|Withdrawal by Subject|25
5466666|NCT01978093|18895450|P1|Overall Study|Withdrawal by Subject|29
5466667|NCT01978093|18895449|P2|Overall Study|Protocol Violation|2
5466668|NCT01978093|18895450|P1|Overall Study|Protocol Violation|8
5466669|NCT01978093|18895449|P2|Overall Study|Adverse Event|5
5466670|NCT01978093|18895450|P1|Overall Study|Adverse Event|0
5466671|NCT01978093|18895449|P2|Overall Study|Death|0
5466672|NCT01978093|18895450|P1|Overall Study|Death|1
5466673|NCT01977937|18895494|P2|Overall Study|Physician Decision|1
5466674|NCT01977937|18895495|P1|Overall Study|Physician Decision|0
5466675|NCT01977937|18895494|P2|Overall Study|Adverse Event|0
5466676|NCT01977937|18895495|P1|Overall Study|Adverse Event|1
5466677|NCT01977937|18895494|P2|Overall Study|Withdrawal by Subject|1
5466678|NCT01977937|18895495|P1|Overall Study|Withdrawal by Subject|2
5466679|NCT01977846|18895505|P2|Total Study - Prospective|Protocol Violation|1
5466680|NCT01977846|18895506|P1|Total Study - Prospective|Protocol Violation|0
5466681|NCT01977846|18895505|P2|Total Study - Prospective|No show|1
5466682|NCT01977846|18895506|P1|Total Study - Prospective|No show|0
5466683|NCT01977846|18895505|P2|Total Study - Prospective|Not available at time of visit|5
5466684|NCT01977846|18895506|P1|Total Study - Prospective|Not available at time of visit|0
5466685|NCT01977846|18895505|P2|Total Study - Prospective|Withdrawal by Subject|13
5466686|NCT01977846|18895506|P1|Total Study - Prospective|Withdrawal by Subject|0
5466687|NCT01977846|18895505|P2|Total Study - Prospective|Lost to Follow-up|8
5466688|NCT01977846|18895506|P1|Total Study - Prospective|Lost to Follow-up|0
5466689|NCT01977846|18895505|P2|Total Study - Prospective|Death|1
5466690|NCT01977846|18895506|P1|Total Study - Prospective|Death|0
5466691|NCT01977820|18895524|P2|Overall Study|Sponsor terminated the study|1
5466692|NCT01977820|18895525|P1|Overall Study|Sponsor terminated the study|1
5466693|NCT01977794|18895533|P2|Overall Study|Other|1
5466694|NCT01977794|18895534|P1|Overall Study|Other|0
5466695|NCT01977794|18895533|P2|Overall Study|Withdrew consent|1
5466696|NCT01977794|18895534|P1|Overall Study|Withdrew consent|2
5466697|NCT01977794|18895533|P2|Overall Study|Death|1
5466698|NCT01977794|18895534|P1|Overall Study|Death|1
5466699|NCT01977794|18895533|P2|Overall Study|Protocol Violation|0
5466700|NCT01977794|18895534|P1|Overall Study|Protocol Violation|1
5466701|NCT01977794|18895533|P2|Overall Study|Lost to Follow-up|1
5466702|NCT01977794|18895534|P1|Overall Study|Lost to Follow-up|2
5466703|NCT01977794|18895533|P2|Overall Study|Adverse Event|2
5466704|NCT01977794|18895534|P1|Overall Study|Adverse Event|2
5466705|NCT01977729|18895569|P1|Overall Study|Study terminated|1
5466706|NCT01977690|18895581|P2|Overall Study|Withdrawal by Subject|4
5466707|NCT01977690|18895582|P1|Overall Study|Withdrawal by Subject|0
5466708|NCT01977677|18895591|P3|Overall Study|Unrelated Adverse Event|1
5466709|NCT01977677|18895592|P2|Overall Study|Unrelated Adverse Event|0
5466710|NCT01977677|18895593|P1|Overall Study|Unrelated Adverse Event|0
5466711|NCT01977651|18895604|P1|Post 1 Year Extension Period|Miscellaneous|49
5466712|NCT01977651|18895604|P1|Post 1 Year Extension Period|Physician Decision|4
5466713|NCT01977651|18895604|P1|Post 1 Year Extension Period|Withdrawal by Subject|13
5466714|NCT01977651|18895604|P1|Post 1 Year Extension Period|Progressive Disease|60
5466715|NCT01977651|18895604|P1|Post 1 Year Extension Period|Death|13
5466716|NCT01977651|18895604|P1|Post 1 Year Extension Period|Adverse Event|5
5466717|NCT01977651|18895604|P1|1 Year Extension Period|Miscellaneous|1
5466718|NCT01977651|18895604|P1|1 Year Extension Period|Physician Decision|6
5466719|NCT01977651|18895604|P1|1 Year Extension Period|Withdrawal by Subject|11
5466720|NCT01977651|18895604|P1|1 Year Extension Period|Progressive Disease|86
5466721|NCT01977651|18895604|P1|1 Year Extension Period|Lost to Follow-up|2
5466722|NCT01977651|18895604|P1|1 Year Extension Period|Death|10
5466723|NCT01977651|18895604|P1|1 Year Extension Period|Adverse Event|14
5466724|NCT01977651|18895604|P1|4 Month Treatment Period|Physician Decision|4
5466725|NCT01977651|18895604|P1|4 Month Treatment Period|Withdrawal by Subject|17
5466726|NCT01977651|18895604|P1|4 Month Treatment Period|Progressive Disease|43
5466727|NCT01977651|18895604|P1|4 Month Treatment Period|Death|3
5466728|NCT01977651|18895604|P1|4 Month Treatment Period|Adverse Event|34
5466729|NCT01977625|18895608|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
5466730|NCT01977625|18895609|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5466731|NCT01977625|18895608|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
5466732|NCT01977625|18895609|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
5466733|NCT01977612|18895619|P2|Overall Study|Lost to Follow-up|1
5466734|NCT01977612|18895620|P1|Overall Study|Lost to Follow-up|1
5466735|NCT01977573|18895642|P4|Overall Study|Withdrawal by Subject|1
5466736|NCT01977573|18895643|P3|Overall Study|Withdrawal by Subject|1
5466737|NCT01977573|18895644|P2|Overall Study|Withdrawal by Subject|1
5466738|NCT01977573|18895645|P1|Overall Study|Withdrawal by Subject|6
5466739|NCT01977573|18895642|P4|Overall Study|Reached Defined Stopping Criteria|0
5466740|NCT01977573|18895643|P3|Overall Study|Reached Defined Stopping Criteria|1
5466741|NCT01977573|18895644|P2|Overall Study|Reached Defined Stopping Criteria|1
5466742|NCT01977573|18895645|P1|Overall Study|Reached Defined Stopping Criteria|2
5466743|NCT01977573|18895642|P4|Overall Study|Protocol Violation|0
5466744|NCT01977573|18895643|P3|Overall Study|Protocol Violation|0
5466745|NCT01977573|18895644|P2|Overall Study|Protocol Violation|1
5466746|NCT01977573|18895645|P1|Overall Study|Protocol Violation|3
5466747|NCT01977573|18895642|P4|Overall Study|Physician Decision|0
5466748|NCT01977573|18895643|P3|Overall Study|Physician Decision|0
5466749|NCT01977573|18895644|P2|Overall Study|Physician Decision|0
5466750|NCT01977573|18895645|P1|Overall Study|Physician Decision|1
5466751|NCT01977573|18895642|P4|Overall Study|Lost to Follow-up|1
5466752|NCT01977573|18895643|P3|Overall Study|Lost to Follow-up|0
5466753|NCT01977573|18895644|P2|Overall Study|Lost to Follow-up|0
5466754|NCT01977573|18895645|P1|Overall Study|Lost to Follow-up|1
5466755|NCT01977573|18895642|P4|Overall Study|Adverse Event|1
5466756|NCT01977573|18895643|P3|Overall Study|Adverse Event|2
5466757|NCT01977573|18895644|P2|Overall Study|Adverse Event|0
5466758|NCT01977573|18895645|P1|Overall Study|Adverse Event|7
5466759|NCT01977482|18895759|P6|Overall Study|Withdrawal by Subject|5
5466760|NCT01977482|18895760|P5|Overall Study|Withdrawal by Subject|1
5466761|NCT01977482|18895761|P4|Overall Study|Withdrawal by Subject|3
5466762|NCT01977482|18895762|P3|Overall Study|Withdrawal by Subject|1
5466763|NCT01977482|18895763|P2|Overall Study|Withdrawal by Subject|4
5466764|NCT01977482|18895764|P1|Overall Study|Withdrawal by Subject|2
5466765|NCT01977482|18895759|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
5466766|NCT01977482|18895760|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
5466767|NCT01977482|18895761|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
5466768|NCT01977482|18895762|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
5466769|NCT01977482|18895763|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
5466770|NCT01977482|18895764|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
5466771|NCT01977482|18895759|P6|Overall Study|Protocol Violation|0
5466772|NCT01977482|18895760|P5|Overall Study|Protocol Violation|0
5466773|NCT01977482|18895761|P4|Overall Study|Protocol Violation|0
5466774|NCT01977482|18895762|P3|Overall Study|Protocol Violation|1
5466775|NCT01977482|18895763|P2|Overall Study|Protocol Violation|0
5466776|NCT01977482|18895764|P1|Overall Study|Protocol Violation|0
5466777|NCT01977482|18895759|P6|Overall Study|Physician Decision|0
5466778|NCT01977482|18895760|P5|Overall Study|Physician Decision|0
5466779|NCT01977482|18895761|P4|Overall Study|Physician Decision|0
5466780|NCT01977482|18895762|P3|Overall Study|Physician Decision|0
5466781|NCT01977482|18895763|P2|Overall Study|Physician Decision|1
5466782|NCT01977482|18895764|P1|Overall Study|Physician Decision|0
5466783|NCT01977482|18895759|P6|Overall Study|Lost to Follow-up|0
5466784|NCT01977482|18895760|P5|Overall Study|Lost to Follow-up|0
5466785|NCT01977482|18895761|P4|Overall Study|Lost to Follow-up|0
5466786|NCT01977482|18895762|P3|Overall Study|Lost to Follow-up|0
5466787|NCT01977482|18895763|P2|Overall Study|Lost to Follow-up|0
5466788|NCT01977482|18895764|P1|Overall Study|Lost to Follow-up|1
5466789|NCT01977482|18895759|P6|Overall Study|Adverse Event|0
5466790|NCT01977482|18895760|P5|Overall Study|Adverse Event|2
5466791|NCT01977482|18895761|P4|Overall Study|Adverse Event|0
5466792|NCT01977482|18895762|P3|Overall Study|Adverse Event|1
5466793|NCT01977482|18895763|P2|Overall Study|Adverse Event|1
5466794|NCT01977482|18895764|P1|Overall Study|Adverse Event|0
5466795|NCT01977456|18895879|P1|Overall Study|Death|5
5466796|NCT01977352|18895888|P2|Overall Study|Lost to Follow-up|2
5466797|NCT01977352|18895889|P1|Overall Study|Lost to Follow-up|1
5466798|NCT01977222|18895907|P1|Overall Study|Withdrawal by Subject|1
5466799|NCT01977092|18895920|P2|Overall Study|In prison|11
5466800|NCT01977092|18895921|P1|Overall Study|In prison|3
5466801|NCT01977092|18895920|P2|Overall Study|Withdrawal by Subject|1
5466802|NCT01977092|18895921|P1|Overall Study|Withdrawal by Subject|2
5466803|NCT01977092|18895920|P2|Overall Study|Lost to Follow-up|14
5466804|NCT01977092|18895921|P1|Overall Study|Lost to Follow-up|23
5466805|NCT01977092|18895920|P2|Overall Study|Death|4
5466806|NCT01977092|18895921|P1|Overall Study|Death|3
5466807|NCT01977040|18895931|P1|Overall Study|Vasa previa not confirmed|2
5466808|NCT01976845|18895985|P3|Overall Study|Physician Decision|3
5466809|NCT01976845|18895986|P2|Overall Study|Physician Decision|8
5466810|NCT01976845|18895987|P1|Overall Study|Physician Decision|8
5466811|NCT01976806|18896012|P2|Overall Study|Withdrawal by Subject|1
5466812|NCT01976806|18896013|P1|Overall Study|Withdrawal by Subject|1
5466813|NCT01976806|18896012|P2|Overall Study|Adverse Event|1
5466814|NCT01976806|18896013|P1|Overall Study|Adverse Event|1
5466815|NCT01976806|18896012|P2|Overall Study|Lost to Follow-up|4
5466816|NCT01976806|18896013|P1|Overall Study|Lost to Follow-up|1
5466817|NCT01976741|18896051|P10|Overall Study|Adverse Event|4
5466818|NCT01976741|18896052|P9|Overall Study|Adverse Event|1
5466819|NCT01976741|18896053|P8|Overall Study|Adverse Event|8
5466820|NCT01976741|18896054|P7|Overall Study|Adverse Event|3
5466821|NCT01976741|18896055|P6|Overall Study|Adverse Event|0
5466822|NCT01976741|18896056|P5|Overall Study|Adverse Event|0
5466823|NCT01976741|18896057|P4|Overall Study|Adverse Event|0
5466824|NCT01976741|18896058|P3|Overall Study|Adverse Event|2
5466825|NCT01976741|18896059|P2|Overall Study|Adverse Event|0
5466826|NCT01976741|18896060|P1|Overall Study|Adverse Event|0
5466827|NCT01976741|18896051|P10|Overall Study|Withdrawal by Subject|0
5466828|NCT01976741|18896052|P9|Overall Study|Withdrawal by Subject|0
5466829|NCT01976741|18896053|P8|Overall Study|Withdrawal by Subject|4
5466830|NCT01976741|18896054|P7|Overall Study|Withdrawal by Subject|1
5466831|NCT01976741|18896055|P6|Overall Study|Withdrawal by Subject|0
5466832|NCT01976741|18896056|P5|Overall Study|Withdrawal by Subject|0
5466833|NCT01976741|18896057|P4|Overall Study|Withdrawal by Subject|1
5466834|NCT01976741|18896058|P3|Overall Study|Withdrawal by Subject|1
5466835|NCT01976741|18896059|P2|Overall Study|Withdrawal by Subject|0
5466836|NCT01976741|18896060|P1|Overall Study|Withdrawal by Subject|1
5466837|NCT01976663|18896298|P1|Overall Study|Lost to Follow-up|3
5466838|NCT01976663|18896298|P1|Overall Study|Adverse Event|2
5466839|NCT01976663|18896298|P1|Overall Study|Screen Failure|3
5466840|NCT01976663|18896298|P1|Overall Study|Withdrawal by Subject|4
5466841|NCT01976663|18896298|P1|Overall Study|Personal Reasons|6
5466842|NCT01976663|18896298|P1|Overall Study|Completed 18 mos but no repeat treatment|24
5466843|NCT01976624|18896317|P1|Overall Study|Participants age less than 19 years|12
5466844|NCT01976624|18896317|P1|Overall Study|Participants contraindicated|2
5466845|NCT01976507|18896345|P1|Overall Study|ablation not done, drug not given|1
5466846|NCT01976507|18896345|P1|Overall Study|Adverse Event|6
5466847|NCT01976364|18896376|P3|Sub-study (12 Months)|Adverse Event|3
5466848|NCT01976364|18896377|P2|Sub-study (12 Months)|Adverse Event|4
5466849|NCT01976364|18896378|P1|Sub-study (12 Months)|Adverse Event|0
5466850|NCT01976364|18896376|P3|Sub-study (12 Months)|Protocol Violation|1
5466851|NCT01976364|18896377|P2|Sub-study (12 Months)|Protocol Violation|1
5466852|NCT01976364|18896378|P1|Sub-study (12 Months)|Protocol Violation|0
5466853|NCT01976364|18896376|P3|Sub-study (12 Months)|Withdrawal by Subject|1
5466854|NCT01976364|18896377|P2|Sub-study (12 Months)|Withdrawal by Subject|0
5466855|NCT01976364|18896378|P1|Sub-study (12 Months)|Withdrawal by Subject|0
5466856|NCT01976364|18896376|P3|Sub-study (12 Months)|Lost to Follow-up|0
5466857|NCT01976364|18896377|P2|Sub-study (12 Months)|Lost to Follow-up|1
5466858|NCT01976364|18896378|P1|Sub-study (12 Months)|Lost to Follow-up|0
5466859|NCT01976364|18896376|P3|Main Study (36 Months)|Death|0
5466860|NCT01976364|18896377|P2|Main Study (36 Months)|Death|0
5466861|NCT01976364|18896378|P1|Main Study (36 Months)|Death|5
5466862|NCT01976364|18896376|P3|Main Study (36 Months)|Withdrawal by Subject|0
5466863|NCT01976364|18896377|P2|Main Study (36 Months)|Withdrawal by Subject|0
5466864|NCT01976364|18896378|P1|Main Study (36 Months)|Withdrawal by Subject|69
5466865|NCT01976364|18896376|P3|Main Study (36 Months)|Protocol Violation|0
5466866|NCT01976364|18896377|P2|Main Study (36 Months)|Protocol Violation|0
5466867|NCT01976364|18896378|P1|Main Study (36 Months)|Protocol Violation|13
5466868|NCT01976364|18896376|P3|Main Study (36 Months)|Lack of Efficacy|0
5466869|NCT01976364|18896377|P2|Main Study (36 Months)|Lack of Efficacy|0
5466870|NCT01976364|18896378|P1|Main Study (36 Months)|Lack of Efficacy|40
5466871|NCT01976364|18896376|P3|Main Study (36 Months)|Lost to Follow-up|0
5466872|NCT01976364|18896377|P2|Main Study (36 Months)|Lost to Follow-up|0
5466873|NCT01976364|18896378|P1|Main Study (36 Months)|Lost to Follow-up|10
5466874|NCT01976364|18896376|P3|Main Study (36 Months)|Medication error|0
5466875|NCT01976364|18896377|P2|Main Study (36 Months)|Medication error|0
5466876|NCT01976364|18896378|P1|Main Study (36 Months)|Medication error|1
5466877|NCT01976364|18896376|P3|Main Study (36 Months)|No longer met eligibility criteria|0
5466878|NCT01976364|18896377|P2|Main Study (36 Months)|No longer met eligibility criteria|0
5466879|NCT01976364|18896378|P1|Main Study (36 Months)|No longer met eligibility criteria|2
5466880|NCT01976364|18896376|P3|Main Study (36 Months)|Other|0
5466881|NCT01976364|18896377|P2|Main Study (36 Months)|Other|0
5466882|NCT01976364|18896378|P1|Main Study (36 Months)|Other|13
5466883|NCT01976364|18896376|P3|Main Study (36 Months)|Withdrawn due to pregnancy|0
5466884|NCT01976364|18896377|P2|Main Study (36 Months)|Withdrawn due to pregnancy|0
5466885|NCT01976364|18896378|P1|Main Study (36 Months)|Withdrawn due to pregnancy|5
5466886|NCT01976364|18896376|P3|Main Study (36 Months)|Adverse Event|0
5466887|NCT01976364|18896377|P2|Main Study (36 Months)|Adverse Event|0
5466888|NCT01976364|18896378|P1|Main Study (36 Months)|Adverse Event|63
5466889|NCT01976338|18896498|P2|Overall Study|Adverse Event|1
5466890|NCT01976338|18896499|P1|Overall Study|Adverse Event|5
5466891|NCT01976338|18896498|P2|Overall Study|Withdrawal by Subject|2
5466892|NCT01976338|18896499|P1|Overall Study|Withdrawal by Subject|5
5466893|NCT01976338|18896498|P2|Overall Study|Lost to Follow-up|0
5466894|NCT01976338|18896499|P1|Overall Study|Lost to Follow-up|3
5466895|NCT01976338|18896498|P2|Overall Study|Physician Decision|1
5466896|NCT01976338|18896499|P1|Overall Study|Physician Decision|0
5466897|NCT01976312|18896526|P2|Overall Study|Protocol Violation|0
5466898|NCT01976312|18896527|P1|Overall Study|Protocol Violation|2
5466899|NCT01976312|18896526|P2|Overall Study|Adverse Event|6
5466900|NCT01976312|18896527|P1|Overall Study|Adverse Event|6
5466901|NCT01976312|18896526|P2|Overall Study|Withdrawal by Subject|2
5466902|NCT01976312|18896527|P1|Overall Study|Withdrawal by Subject|7
5466903|NCT01976312|18896526|P2|Overall Study|Lost to Follow-up|0
5466904|NCT01976312|18896527|P1|Overall Study|Lost to Follow-up|2
5466905|NCT01976312|18896526|P2|Overall Study|Pregnancy|1
5466906|NCT01976312|18896527|P1|Overall Study|Pregnancy|0
5466907|NCT01976299|18896548|P2|Overall Study|See clarification above in comments|2
5466908|NCT01976299|18896549|P1|Overall Study|See clarification above in comments|9
5466909|NCT01976299|18896548|P2|Overall Study|Lost to Follow-up|1
5466910|NCT01976299|18896549|P1|Overall Study|Lost to Follow-up|7
5466911|NCT01976299|18896548|P2|Overall Study|Death|2
5466912|NCT01976299|18896549|P1|Overall Study|Death|4
5466913|NCT01976299|18896548|P2|Overall Study|Withdrawal by Subject|1
5466914|NCT01976299|18896549|P1|Overall Study|Withdrawal by Subject|3
5466915|NCT01976104|18896576|P4|Overall Study|Other|0
5466916|NCT01976104|18896577|P3|Overall Study|Other|0
5466917|NCT01976104|18896578|P2|Overall Study|Other|1
5466918|NCT01976104|18896579|P1|Overall Study|Other|0
5466919|NCT01976104|18896576|P4|Overall Study|Withdrawal by Subject|1
5466920|NCT01976104|18896577|P3|Overall Study|Withdrawal by Subject|0
5466921|NCT01976104|18896578|P2|Overall Study|Withdrawal by Subject|0
5466922|NCT01976104|18896579|P1|Overall Study|Withdrawal by Subject|3
5466923|NCT01976104|18896576|P4|Overall Study|Subject Choice|1
5466924|NCT01976104|18896577|P3|Overall Study|Subject Choice|0
5466925|NCT01976104|18896578|P2|Overall Study|Subject Choice|1
5466926|NCT01976104|18896579|P1|Overall Study|Subject Choice|0
5466927|NCT01976104|18896576|P4|Overall Study|Lost to Follow-up|1
5466928|NCT01976104|18896577|P3|Overall Study|Lost to Follow-up|1
5466929|NCT01976104|18896578|P2|Overall Study|Lost to Follow-up|0
5466930|NCT01976104|18896579|P1|Overall Study|Lost to Follow-up|3
5466931|NCT01976104|18896576|P4|Overall Study|Adverse Event|0
5466932|NCT01976104|18896577|P3|Overall Study|Adverse Event|1
5466933|NCT01976104|18896578|P2|Overall Study|Adverse Event|0
5466934|NCT01976104|18896579|P1|Overall Study|Adverse Event|0
5466935|NCT01975948|18896613|P4|Overall Study|Withdrawal by Subject|6
5466936|NCT01975948|18896614|P3|Overall Study|Withdrawal by Subject|7
5466937|NCT01975948|18896615|P2|Overall Study|Withdrawal by Subject|21
5466938|NCT01975948|18896616|P1|Overall Study|Withdrawal by Subject|17
5466939|NCT01975831|18896692|P9|Overall Study|Unable to Treat Within Protocol Windows|1
5466940|NCT01975831|18896693|P8|Overall Study|Unable to Treat Within Protocol Windows|0
5466941|NCT01975831|18896694|P7|Overall Study|Unable to Treat Within Protocol Windows|1
5466942|NCT01975831|18896695|P6|Overall Study|Unable to Treat Within Protocol Windows|0
5466943|NCT01975831|18896696|P5|Overall Study|Unable to Treat Within Protocol Windows|0
5466944|NCT01975831|18896697|P4|Overall Study|Unable to Treat Within Protocol Windows|0
5466945|NCT01975831|18896698|P3|Overall Study|Unable to Treat Within Protocol Windows|0
5466946|NCT01975831|18896699|P2|Overall Study|Unable to Treat Within Protocol Windows|0
5466947|NCT01975831|18896700|P1|Overall Study|Unable to Treat Within Protocol Windows|0
5466948|NCT01975831|18896692|P9|Overall Study|Entered Hospice|0
5466949|NCT01975831|18896693|P8|Overall Study|Entered Hospice|0
5466950|NCT01975831|18896694|P7|Overall Study|Entered Hospice|0
5466951|NCT01975831|18896695|P6|Overall Study|Entered Hospice|1
5466952|NCT01975831|18896696|P5|Overall Study|Entered Hospice|0
5466953|NCT01975831|18896697|P4|Overall Study|Entered Hospice|0
5466954|NCT01975831|18896698|P3|Overall Study|Entered Hospice|0
5466955|NCT01975831|18896699|P2|Overall Study|Entered Hospice|0
5466956|NCT01975831|18896700|P1|Overall Study|Entered Hospice|0
5466957|NCT01975831|18896692|P9|Overall Study|Initiation of Subsequent Therapy|0
5466958|NCT01975831|18896693|P8|Overall Study|Initiation of Subsequent Therapy|2
5466959|NCT01975831|18896694|P7|Overall Study|Initiation of Subsequent Therapy|0
5466960|NCT01975831|18896695|P6|Overall Study|Initiation of Subsequent Therapy|1
5466961|NCT01975831|18896696|P5|Overall Study|Initiation of Subsequent Therapy|0
5466962|NCT01975831|18896697|P4|Overall Study|Initiation of Subsequent Therapy|0
5466963|NCT01975831|18896698|P3|Overall Study|Initiation of Subsequent Therapy|0
5466964|NCT01975831|18896699|P2|Overall Study|Initiation of Subsequent Therapy|0
5466965|NCT01975831|18896700|P1|Overall Study|Initiation of Subsequent Therapy|0
5466966|NCT01975831|18896692|P9|Overall Study|Physician Decision|0
5466967|NCT01975831|18896693|P8|Overall Study|Physician Decision|1
5466968|NCT01975831|18896694|P7|Overall Study|Physician Decision|0
5466969|NCT01975831|18896695|P6|Overall Study|Physician Decision|1
5466970|NCT01975831|18896696|P5|Overall Study|Physician Decision|0
5466971|NCT01975831|18896697|P4|Overall Study|Physician Decision|0
5466972|NCT01975831|18896698|P3|Overall Study|Physician Decision|0
5466973|NCT01975831|18896699|P2|Overall Study|Physician Decision|0
5466974|NCT01975831|18896700|P1|Overall Study|Physician Decision|0
5466975|NCT01975831|18896692|P9|Overall Study|Withdrawal by Subject|0
5466976|NCT01975831|18896693|P8|Overall Study|Withdrawal by Subject|0
5466977|NCT01975831|18896694|P7|Overall Study|Withdrawal by Subject|1
5466978|NCT01975831|18896695|P6|Overall Study|Withdrawal by Subject|1
5466979|NCT01975831|18896696|P5|Overall Study|Withdrawal by Subject|3
5466980|NCT01975831|18896697|P4|Overall Study|Withdrawal by Subject|0
5466981|NCT01975831|18896698|P3|Overall Study|Withdrawal by Subject|0
5466982|NCT01975831|18896699|P2|Overall Study|Withdrawal by Subject|3
5466983|NCT01975831|18896700|P1|Overall Study|Withdrawal by Subject|0
5466984|NCT01975831|18896692|P9|Overall Study|Progressive Disease|10
5466985|NCT01975831|18896693|P8|Overall Study|Progressive Disease|8
5466986|NCT01975831|18896694|P7|Overall Study|Progressive Disease|10
5466987|NCT01975831|18896695|P6|Overall Study|Progressive Disease|9
5466988|NCT01975831|18896696|P5|Overall Study|Progressive Disease|13
5466989|NCT01975831|18896697|P4|Overall Study|Progressive Disease|4
5466990|NCT01975831|18896698|P3|Overall Study|Progressive Disease|2
5466991|NCT01975831|18896699|P2|Overall Study|Progressive Disease|3
5466992|NCT01975831|18896700|P1|Overall Study|Progressive Disease|1
5466993|NCT01975831|18896692|P9|Overall Study|Death|0
5466994|NCT01975831|18896693|P8|Overall Study|Death|0
5466995|NCT01975831|18896694|P7|Overall Study|Death|1
5466996|NCT01975831|18896695|P6|Overall Study|Death|0
5466997|NCT01975831|18896696|P5|Overall Study|Death|1
5466998|NCT01975831|18896697|P4|Overall Study|Death|0
5466999|NCT01975831|18896698|P3|Overall Study|Death|0
5467000|NCT01975831|18896699|P2|Overall Study|Death|1
5467001|NCT01975831|18896700|P1|Overall Study|Death|1
5467002|NCT01975831|18896692|P9|Overall Study|Adverse Event|1
5467003|NCT01975831|18896693|P8|Overall Study|Adverse Event|4
5467004|NCT01975831|18896694|P7|Overall Study|Adverse Event|3
5467005|NCT01975831|18896695|P6|Overall Study|Adverse Event|1
5467006|NCT01975831|18896696|P5|Overall Study|Adverse Event|1
5467007|NCT01975831|18896697|P4|Overall Study|Adverse Event|0
5467008|NCT01975831|18896698|P3|Overall Study|Adverse Event|2
5467009|NCT01975831|18896699|P2|Overall Study|Adverse Event|2
5467010|NCT01975831|18896700|P1|Overall Study|Adverse Event|1
5467011|NCT01975701|18896765|P1|Overall Study|Physician Decision|1
5467012|NCT01975701|18896765|P1|Overall Study|Death|23
5467013|NCT01975701|18896765|P1|Overall Study|Lost to Follow-up|1
5467014|NCT01975675|18896776|P4|Overall Study|Death|0
5467015|NCT01975675|18896777|P3|Overall Study|Death|0
5467016|NCT01975675|18896778|P2|Overall Study|Death|1
5467017|NCT01975675|18896779|P1|Overall Study|Death|0
5467018|NCT01975389|18896830|P2|Overall Study|Randomized, not treated|5
5467019|NCT01975389|18896831|P1|Overall Study|Randomized, not treated|4
5467020|NCT01975389|18896830|P2|Overall Study|Other|9
5467021|NCT01975389|18896831|P1|Overall Study|Other|6
5467022|NCT01975389|18896830|P2|Overall Study|Withdrawal by Subject|76
5467023|NCT01975389|18896831|P1|Overall Study|Withdrawal by Subject|90
5467024|NCT01975389|18896830|P2|Overall Study|Lost to Follow-up|86
5467025|NCT01975389|18896831|P1|Overall Study|Lost to Follow-up|81
5467026|NCT01975389|18896830|P2|Overall Study|Death|54
5467027|NCT01975389|18896831|P1|Overall Study|Death|61
5467028|NCT01975389|18896830|P2|Overall Study|Adverse Event|6
5467029|NCT01975389|18896831|P1|Overall Study|Adverse Event|10
5467030|NCT01975376|18896891|P2|Overall Study|Randomized, Not Treated|8
5467031|NCT01975376|18896892|P1|Overall Study|Randomized, Not Treated|16
5467032|NCT01975376|18896891|P2|Overall Study|Other|4
5467033|NCT01975376|18896892|P1|Overall Study|Other|2
5467034|NCT01975376|18896891|P2|Overall Study|Withdrew consent|62
5467035|NCT01975376|18896892|P1|Overall Study|Withdrew consent|68
5467036|NCT01975376|18896891|P2|Overall Study|Lost to Follow-up|66
5467037|NCT01975376|18896892|P1|Overall Study|Lost to Follow-up|70
5467038|NCT01975376|18896891|P2|Overall Study|Death|72
5467039|NCT01975376|18896892|P1|Overall Study|Death|65
5467040|NCT01975376|18896891|P2|Overall Study|Adverse Event|5
5467041|NCT01975376|18896892|P1|Overall Study|Adverse Event|5
5467042|NCT01975285|18896952|P2|Overall Study|Failed Block and follow up|2
5467043|NCT01975285|18896953|P1|Overall Study|Failed Block and follow up|2
5467044|NCT01975246|18896969|P2|Overall Study|Other than stated|1
5467045|NCT01975246|18896970|P1|Overall Study|Other than stated|0
5467046|NCT01975246|18896969|P2|Overall Study|Protocol Violation|0
5467047|NCT01975246|18896970|P1|Overall Study|Protocol Violation|1
5467048|NCT01975246|18896969|P2|Overall Study|Lack of Efficacy|0
5467049|NCT01975246|18896970|P1|Overall Study|Lack of Efficacy|1
5467050|NCT01975246|18896969|P2|Overall Study|Adverse Event|1
5467051|NCT01975246|18896970|P1|Overall Study|Adverse Event|2
5467052|NCT01975220|18896983|P6|Test Period 1|Not treated|0
5467053|NCT01975220|18896984|P5|Test Period 1|Not treated|0
5467054|NCT01975220|18896985|P4|Test Period 1|Not treated|0
5467055|NCT01975220|18896986|P3|Test Period 1|Not treated|0
5467056|NCT01975220|18896987|P2|Test Period 1|Not treated|1
5467057|NCT01975220|18896988|P1|Test Period 1|Not treated|0
5467058|NCT01974895|18897044|P2|Overall Study|Other (Reason unknown)|8
5467059|NCT01974895|18897045|P1|Overall Study|Other (Reason unknown)|9
5467060|NCT01974895|18897044|P2|Overall Study|Other (Missed Visit)|0
5467061|NCT01974895|18897045|P1|Overall Study|Other (Missed Visit)|1
5467062|NCT01974895|18897044|P2|Overall Study|Withdrawal by Subject|1
5467063|NCT01974895|18897045|P1|Overall Study|Withdrawal by Subject|0
5467064|NCT01974895|18897044|P2|Overall Study|Lost to Follow-up|6
5467065|NCT01974895|18897045|P1|Overall Study|Lost to Follow-up|4
5467066|NCT01974895|18897044|P2|Overall Study|Protocol Violation|0
5467067|NCT01974895|18897045|P1|Overall Study|Protocol Violation|1
5467068|NCT01974817|18897075|P1|Overall Study|Protocol Violation|2
5467069|NCT01974817|18897075|P1|Overall Study|Lost to Follow-up|2
5467070|NCT01974817|18897075|P1|Overall Study|Death|4
5467071|NCT01974752|18897081|P2|Overall Study|Other Eligibility Criteria|1
5467072|NCT01974752|18897082|P1|Overall Study|Other Eligibility Criteria|0
5467073|NCT01974752|18897081|P2|Overall Study|Withdrawal by Subject|3
5467074|NCT01974752|18897082|P1|Overall Study|Withdrawal by Subject|2
5467075|NCT01974752|18897081|P2|Overall Study|Lost to Follow-up|0
5467076|NCT01974752|18897082|P1|Overall Study|Lost to Follow-up|2
5467077|NCT01974752|18897081|P2|Overall Study|Death|11
5467078|NCT01974752|18897082|P1|Overall Study|Death|33
5467079|NCT01974323|18897510|P2|Overall Study|Adverse Event|2
5467080|NCT01974323|18897511|P1|Overall Study|Adverse Event|2
5467081|NCT01974323|18897510|P2|Overall Study|Lack of Efficacy|1
5467082|NCT01974323|18897511|P1|Overall Study|Lack of Efficacy|1
5467083|NCT01974323|18897510|P2|Overall Study|Pregnancy|1
5467084|NCT01974323|18897511|P1|Overall Study|Pregnancy|2
5467085|NCT01974323|18897510|P2|Overall Study|Lost to Follow-up|40
5467086|NCT01974323|18897511|P1|Overall Study|Lost to Follow-up|45
5467087|NCT01974323|18897510|P2|Overall Study|Personal Reasons|19
5467088|NCT01974323|18897511|P1|Overall Study|Personal Reasons|15
5467089|NCT01974323|18897510|P2|Overall Study|Protocol Violation|2
5467090|NCT01974323|18897511|P1|Overall Study|Protocol Violation|2
5467091|NCT01974323|18897510|P2|Overall Study|Other Reasons|28
5467092|NCT01974323|18897511|P1|Overall Study|Other Reasons|25
5467093|NCT01974141|18897551|P2|Overall Study|Adverse Event|5
5467094|NCT01974141|18897552|P1|Overall Study|Adverse Event|4
5467095|NCT01974141|18897551|P2|Overall Study|Lack of Efficacy|1
5467096|NCT01974141|18897552|P1|Overall Study|Lack of Efficacy|0
5467097|NCT01974141|18897551|P2|Overall Study|Pregnancy|3
5467098|NCT01974141|18897552|P1|Overall Study|Pregnancy|3
5467099|NCT01974141|18897551|P2|Overall Study|Lost to Follow-up|29
5467100|NCT01974141|18897552|P1|Overall Study|Lost to Follow-up|38
5467101|NCT01974141|18897551|P2|Overall Study|Personal Reasons|20
5467102|NCT01974141|18897552|P1|Overall Study|Personal Reasons|21
5467103|NCT01974141|18897551|P2|Overall Study|Protocol Violation|6
5467104|NCT01974141|18897552|P1|Overall Study|Protocol Violation|2
5467105|NCT01974141|18897551|P2|Overall Study|Other Reasons|18
5467106|NCT01974141|18897552|P1|Overall Study|Other Reasons|28
5467107|NCT01973998|18897596|P2|Overall Study|Death|2
5467108|NCT01973998|18897597|P1|Overall Study|Death|2
5467109|NCT01973595|18897659|P4|Washout|Withdrawal by Subject|0
5467110|NCT01973595|18897660|P3|Washout|Withdrawal by Subject|1
5467111|NCT01973595|18897661|P2|Washout|Withdrawal by Subject|0
5467112|NCT01973595|18897662|P1|Washout|Withdrawal by Subject|1
5467113|NCT01973569|18897679|P3|Overall Study|Did not receive study drug|3
5467114|NCT01973569|18897680|P2|Overall Study|Did not receive study drug|3
5467115|NCT01973569|18897681|P1|Overall Study|Did not receive study drug|6
5467116|NCT01973569|18897679|P3|Overall Study|Other|0
5467117|NCT01973569|18897680|P2|Overall Study|Other|1
5467118|NCT01973569|18897681|P1|Overall Study|Other|1
5467119|NCT01973569|18897679|P3|Overall Study|Disease progression|0
5467120|NCT01973569|18897680|P2|Overall Study|Disease progression|3
5467121|NCT01973569|18897681|P1|Overall Study|Disease progression|0
5467122|NCT01973569|18897679|P3|Overall Study|Prohibited concomitant d|0
5467123|NCT01973569|18897680|P2|Overall Study|Prohibited concomitant d|5
5467124|NCT01973569|18897681|P1|Overall Study|Prohibited concomitant d|1
5467125|NCT01973569|18897679|P3|Overall Study|Invasive dental treatment|6
5467126|NCT01973569|18897680|P2|Overall Study|Invasive dental treatment|5
5467127|NCT01973569|18897681|P1|Overall Study|Invasive dental treatment|3
5467128|NCT01973569|18897679|P3|Overall Study|Withdrawal by Subject|2
5467129|NCT01973569|18897680|P2|Overall Study|Withdrawal by Subject|5
5467130|NCT01973569|18897681|P1|Overall Study|Withdrawal by Subject|7
5467131|NCT01973569|18897679|P3|Overall Study|Protocol Violation|3
5467132|NCT01973569|18897680|P2|Overall Study|Protocol Violation|1
5467133|NCT01973569|18897681|P1|Overall Study|Protocol Violation|2
5467134|NCT01973569|18897679|P3|Overall Study|Adverse Event|4
5467135|NCT01973569|18897680|P2|Overall Study|Adverse Event|2
5467136|NCT01973569|18897681|P1|Overall Study|Adverse Event|9
5467137|NCT01973491|18897707|P1|Treatment Period (16 Weeks)|Adverse Event|1
5467138|NCT01973491|18897707|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
5467139|NCT01973491|18897707|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
5467140|NCT01973439|18897723|P1|Overall Study|PK curve incomplete|2
5467141|NCT01973439|18897723|P1|Overall Study|Vomiting after commencing once daily|1
5467142|NCT01973439|18897723|P1|Overall Study|Lost samples from one PK Day|2
5467143|NCT01973387|18897745|P2|Overall Study|Randomized, not treated|2
5467144|NCT01973387|18897746|P1|Overall Study|Randomized, not treated|2
5467145|NCT01973387|18897745|P2|Overall Study|Death|3
5467146|NCT01973387|18897746|P1|Overall Study|Death|4
5467147|NCT01973387|18897745|P2|Overall Study|Progressive disease or relapse|5
5467148|NCT01973387|18897746|P1|Overall Study|Progressive disease or relapse|16
5467149|NCT01973387|18897745|P2|Overall Study|Study terminated by sponsor|0
5467150|NCT01973387|18897746|P1|Overall Study|Study terminated by sponsor|63
5467151|NCT01973387|18897745|P2|Overall Study|Withdrawal by Subject|4
5467152|NCT01973387|18897746|P1|Overall Study|Withdrawal by Subject|7
5467153|NCT01973387|18897745|P2|Overall Study|Adverse Event|4
5467154|NCT01973387|18897746|P1|Overall Study|Adverse Event|14
5467155|NCT01973231|18897828|P2|Overall Study|Withdrawal by Subject|9
5467156|NCT01973231|18897829|P1|Overall Study|Withdrawal by Subject|7
5467157|NCT01973231|18897828|P2|Overall Study|unclassified|1
5467158|NCT01973231|18897829|P1|Overall Study|unclassified|2
5467159|NCT01973231|18897828|P2|Overall Study|Lost to Follow-up|1
5467160|NCT01973231|18897829|P1|Overall Study|Lost to Follow-up|1
5467161|NCT01973231|18897828|P2|Overall Study|Protocol Violation|1
5467162|NCT01973231|18897829|P1|Overall Study|Protocol Violation|1
5467163|NCT01973218|18897849|P2|Overall Study|Withdrawal by Subject|0
5467164|NCT01973218|18897850|P1|Overall Study|Withdrawal by Subject|1
5467165|NCT01973218|18897849|P2|Overall Study|Adverse Event|0
5467166|NCT01973218|18897850|P1|Overall Study|Adverse Event|1
5467167|NCT01972841|18897943|P6|Overall Study|Did not have end of treatment page|0
5467168|NCT01972841|18897944|P5|Overall Study|Did not have end of treatment page|1
5467169|NCT01972841|18897945|P4|Overall Study|Did not have end of treatment page|0
5467170|NCT01972841|18897946|P3|Overall Study|Did not have end of treatment page|0
5467171|NCT01972841|18897947|P2|Overall Study|Did not have end of treatment page|0
5467172|NCT01972841|18897948|P1|Overall Study|Did not have end of treatment page|0
5467173|NCT01972841|18897943|P6|Overall Study|Miscellaneous|4
5467174|NCT01972841|18897944|P5|Overall Study|Miscellaneous|0
5467175|NCT01972841|18897945|P4|Overall Study|Miscellaneous|1
5467176|NCT01972841|18897946|P3|Overall Study|Miscellaneous|4
5467177|NCT01972841|18897947|P2|Overall Study|Miscellaneous|0
5467178|NCT01972841|18897948|P1|Overall Study|Miscellaneous|0
5467179|NCT01972841|18897943|P6|Overall Study|Withdrawal by participants|34
5467180|NCT01972841|18897944|P5|Overall Study|Withdrawal by participants|33
5467181|NCT01972841|18897945|P4|Overall Study|Withdrawal by participants|16
5467182|NCT01972841|18897946|P3|Overall Study|Withdrawal by participants|23
5467183|NCT01972841|18897947|P2|Overall Study|Withdrawal by participants|27
5467184|NCT01972841|18897948|P1|Overall Study|Withdrawal by participants|21
5467185|NCT01972841|18897943|P6|Overall Study|Protocol Violation|4
5467186|NCT01972841|18897944|P5|Overall Study|Protocol Violation|9
5467187|NCT01972841|18897945|P4|Overall Study|Protocol Violation|5
5467188|NCT01972841|18897946|P3|Overall Study|Protocol Violation|3
5467189|NCT01972841|18897947|P2|Overall Study|Protocol Violation|2
5467190|NCT01972841|18897948|P1|Overall Study|Protocol Violation|2
5467191|NCT01972841|18897943|P6|Overall Study|Lost to Follow-up|3
5467192|NCT01972841|18897944|P5|Overall Study|Lost to Follow-up|9
5467193|NCT01972841|18897945|P4|Overall Study|Lost to Follow-up|2
5467194|NCT01972841|18897946|P3|Overall Study|Lost to Follow-up|4
5467195|NCT01972841|18897947|P2|Overall Study|Lost to Follow-up|2
5467196|NCT01972841|18897948|P1|Overall Study|Lost to Follow-up|4
5467197|NCT01972841|18897943|P6|Overall Study|Lack of Efficacy|1
5467198|NCT01972841|18897944|P5|Overall Study|Lack of Efficacy|4
5467199|NCT01972841|18897945|P4|Overall Study|Lack of Efficacy|2
5467200|NCT01972841|18897946|P3|Overall Study|Lack of Efficacy|0
5467201|NCT01972841|18897947|P2|Overall Study|Lack of Efficacy|0
5467202|NCT01972841|18897948|P1|Overall Study|Lack of Efficacy|1
5467203|NCT01972841|18897943|P6|Overall Study|Adverse Event|26
5467204|NCT01972841|18897944|P5|Overall Study|Adverse Event|21
5467205|NCT01972841|18897945|P4|Overall Study|Adverse Event|9
5467206|NCT01972841|18897946|P3|Overall Study|Adverse Event|12
5467207|NCT01972841|18897947|P2|Overall Study|Adverse Event|8
5467208|NCT01972841|18897948|P1|Overall Study|Adverse Event|13
5467209|NCT01972841|18897943|P6|Overall Study|Randomized but Never Received Treatment|13
5467210|NCT01972841|18897944|P5|Overall Study|Randomized but Never Received Treatment|6
5467211|NCT01972841|18897945|P4|Overall Study|Randomized but Never Received Treatment|2
5467212|NCT01972841|18897946|P3|Overall Study|Randomized but Never Received Treatment|4
5467213|NCT01972841|18897947|P2|Overall Study|Randomized but Never Received Treatment|5
5467214|NCT01972841|18897948|P1|Overall Study|Randomized but Never Received Treatment|2
5467215|NCT01972789|18898378|P2|Overall Study|Physician Decision|2
5467216|NCT01972789|18898379|P1|Overall Study|Physician Decision|3
5467217|NCT01972789|18898378|P2|Overall Study|Protocol deviation|0
5467218|NCT01972789|18898379|P1|Overall Study|Protocol deviation|1
5467219|NCT01972789|18898378|P2|Overall Study|Death|5
5467220|NCT01972789|18898379|P1|Overall Study|Death|7
5467221|NCT01972789|18898378|P2|Overall Study|Lost to Follow-up|7
5467222|NCT01972789|18898379|P1|Overall Study|Lost to Follow-up|4
5467223|NCT01972789|18898378|P2|Overall Study|Subject withdrew consent|12
5467224|NCT01972789|18898379|P1|Overall Study|Subject withdrew consent|14
5467225|NCT01972789|18898378|P2|Overall Study|Adverse Event|4
5467226|NCT01972789|18898379|P1|Overall Study|Adverse Event|11
5467227|NCT01972776|18898413|P6|Part 2|Administrative problems|7
5467228|NCT01972776|18898414|P5|Part 2|Administrative problems|10
5467229|NCT01972776|18898415|P4|Part 2|Administrative problems|0
5467230|NCT01972776|18898416|P3|Part 2|Administrative problems|0
5467231|NCT01972776|18898417|P2|Part 2|Administrative problems|0
5467232|NCT01972776|18898418|P1|Part 2|Administrative problems|0
5467233|NCT01972776|18898413|P6|Part 2|Adverse Event|0
5467234|NCT01972776|18898414|P5|Part 2|Adverse Event|3
5467235|NCT01972776|18898415|P4|Part 2|Adverse Event|0
5467236|NCT01972776|18898416|P3|Part 2|Adverse Event|0
5467237|NCT01972776|18898417|P2|Part 2|Adverse Event|0
5467238|NCT01972776|18898418|P1|Part 2|Adverse Event|0
5467239|NCT01972776|18898413|P6|Part 1|Adverse Event|0
5467240|NCT01972776|18898414|P5|Part 1|Adverse Event|0
5467241|NCT01972776|18898415|P4|Part 1|Adverse Event|1
5467242|NCT01972776|18898416|P3|Part 1|Adverse Event|1
5467243|NCT01972776|18898417|P2|Part 1|Adverse Event|0
5467244|NCT01972776|18898418|P1|Part 1|Adverse Event|0
5467245|NCT01972776|18898413|P6|Part 1|Withdrawal by Subject|0
5467246|NCT01972776|18898414|P5|Part 1|Withdrawal by Subject|0
5467247|NCT01972776|18898415|P4|Part 1|Withdrawal by Subject|0
5467248|NCT01972776|18898416|P3|Part 1|Withdrawal by Subject|1
5467249|NCT01972776|18898417|P2|Part 1|Withdrawal by Subject|0
5467250|NCT01972776|18898418|P1|Part 1|Withdrawal by Subject|0
5467251|NCT01972724|18898489|P3|Open-Label|Significant Protocol Deviation|2
5467252|NCT01972724|18898490|P2|Open-Label|Significant Protocol Deviation|0
5467253|NCT01972724|18898491|P1|Open-Label|Significant Protocol Deviation|0
5467254|NCT01972724|18898489|P3|Open-Label|Withdrew Consent|3
5467255|NCT01972724|18898490|P2|Open-Label|Withdrew Consent|0
5467256|NCT01972724|18898491|P1|Open-Label|Withdrew Consent|0
5467257|NCT01972724|18898489|P3|Double-Blind|Significant Protocol Deviation|0
5467258|NCT01972724|18898490|P2|Double-Blind|Significant Protocol Deviation|8
5467259|NCT01972724|18898491|P1|Double-Blind|Significant Protocol Deviation|5
5467260|NCT01972724|18898489|P3|Double-Blind|Withdrawal of Consent|0
5467261|NCT01972724|18898490|P2|Double-Blind|Withdrawal of Consent|1
5467262|NCT01972724|18898491|P1|Double-Blind|Withdrawal of Consent|2
5467263|NCT01972724|18898489|P3|Double-Blind|Adverse Event|0
5467264|NCT01972724|18898490|P2|Double-Blind|Adverse Event|0
5467265|NCT01972724|18898491|P1|Double-Blind|Adverse Event|1
5467266|NCT01972724|18898489|P3|Double-Blind|Rescue Criteria Met|0
5467267|NCT01972724|18898490|P2|Double-Blind|Rescue Criteria Met|0
5467268|NCT01972724|18898491|P1|Double-Blind|Rescue Criteria Met|1
5467269|NCT01972659|18898504|P2|Overall Study|problems realted to acceleromyograph|1
5467270|NCT01972659|18898505|P1|Overall Study|problems realted to acceleromyograph|2
5467271|NCT01972659|18898504|P2|Overall Study|Protocol Violation|2
5467272|NCT01972659|18898505|P1|Overall Study|Protocol Violation|2
5467273|NCT01972568|18898514|P3|Overall Study|Adverse Event|5
5467274|NCT01972568|18898515|P2|Overall Study|Adverse Event|6
5467275|NCT01972568|18898516|P1|Overall Study|Adverse Event|5
5467276|NCT01972568|18898514|P3|Overall Study|Lost to Follow-up|0
5467277|NCT01972568|18898515|P2|Overall Study|Lost to Follow-up|0
5467278|NCT01972568|18898516|P1|Overall Study|Lost to Follow-up|1
5467279|NCT01972568|18898514|P3|Overall Study|Withdrawal by Subject|7
5467280|NCT01972568|18898515|P2|Overall Study|Withdrawal by Subject|3
5467281|NCT01972568|18898516|P1|Overall Study|Withdrawal by Subject|6
5467282|NCT01972568|18898514|P3|Overall Study|Protocol Violation|2
5467283|NCT01972568|18898515|P2|Overall Study|Protocol Violation|2
5467284|NCT01972568|18898516|P1|Overall Study|Protocol Violation|1
5467285|NCT01972568|18898514|P3|Overall Study|Lack of Efficacy|2
5467286|NCT01972568|18898515|P2|Overall Study|Lack of Efficacy|1
5467287|NCT01972568|18898516|P1|Overall Study|Lack of Efficacy|0
5467288|NCT01972568|18898514|P3|Overall Study|Other events|0
5467289|NCT01972568|18898515|P2|Overall Study|Other events|0
5467290|NCT01972568|18898516|P1|Overall Study|Other events|3
5467291|NCT01972529|18898555|P4|Overall Study|Not treated|1
5467292|NCT01972529|18898556|P3|Overall Study|Not treated|2
5467293|NCT01972529|18898557|P2|Overall Study|Not treated|1
5467294|NCT01972529|18898558|P1|Overall Study|Not treated|0
5467295|NCT01972529|18898555|P4|Overall Study|Other|2
5467296|NCT01972529|18898556|P3|Overall Study|Other|0
5467297|NCT01972529|18898557|P2|Overall Study|Other|0
5467298|NCT01972529|18898558|P1|Overall Study|Other|0
5467299|NCT01972529|18898555|P4|Overall Study|Withdrawl of Consent|1
5467300|NCT01972529|18898556|P3|Overall Study|Withdrawl of Consent|0
5467301|NCT01972529|18898557|P2|Overall Study|Withdrawl of Consent|2
5467302|NCT01972529|18898558|P1|Overall Study|Withdrawl of Consent|1
5467303|NCT01972529|18898555|P4|Overall Study|Participant Choice|0
5467304|NCT01972529|18898556|P3|Overall Study|Participant Choice|0
5467305|NCT01972529|18898557|P2|Overall Study|Participant Choice|1
5467306|NCT01972529|18898558|P1|Overall Study|Participant Choice|0
5467307|NCT01972529|18898555|P4|Overall Study|Lost to Follow-up|0
5467308|NCT01972529|18898556|P3|Overall Study|Lost to Follow-up|0
5467309|NCT01972529|18898557|P2|Overall Study|Lost to Follow-up|0
5467310|NCT01972529|18898558|P1|Overall Study|Lost to Follow-up|1
5467311|NCT01972529|18898555|P4|Overall Study|Adverse Event|0
5467312|NCT01972529|18898556|P3|Overall Study|Adverse Event|0
5467313|NCT01972529|18898557|P2|Overall Study|Adverse Event|1
5467314|NCT01972529|18898558|P1|Overall Study|Adverse Event|0
5467315|NCT01972464|18898603|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
5467316|NCT01972464|18898604|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
5467317|NCT01972464|18898603|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
5467318|NCT01972464|18898604|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
5467319|NCT01972464|18898603|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
5467320|NCT01972464|18898604|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
5467321|NCT01972464|18898603|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
5467322|NCT01972464|18898604|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
5467323|NCT01972438|18898620|P2|Post Month 12 Study Period|Early Study Closure|4
5467324|NCT01972438|18898621|P1|Post Month 12 Study Period|Early Study Closure|3
5467325|NCT01972438|18898620|P2|Months 6-12 Study Period|Early Study Closure|2
5467326|NCT01972438|18898621|P1|Months 6-12 Study Period|Early Study Closure|2
5467327|NCT01972438|18898620|P2|Months 6-12 Study Period|Death|0
5467328|NCT01972438|18898621|P1|Months 6-12 Study Period|Death|1
5467329|NCT01972438|18898620|P2|Months 3-6 Crossover Period|Early Study Closure|1
5467330|NCT01972438|18898621|P1|Months 3-6 Crossover Period|Early Study Closure|0
5467331|NCT01972438|18898620|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
5467332|NCT01972438|18898621|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
5467333|NCT01972438|18898620|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
5467334|NCT01972438|18898621|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
5467335|NCT01972438|18898620|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
5467336|NCT01972438|18898621|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
5467337|NCT01972438|18898620|P2|Baseline-Month 3 Crossover Period|Death|0
5467338|NCT01972438|18898621|P1|Baseline-Month 3 Crossover Period|Death|1
5467339|NCT01972308|18898675|P2|Overall Study|Death|1
5467340|NCT01972308|18898676|P1|Overall Study|Death|4
5467341|NCT01972308|18898675|P2|Overall Study|Lost to Follow-up|6
5467342|NCT01972308|18898676|P1|Overall Study|Lost to Follow-up|4
5467343|NCT01972308|18898675|P2|Overall Study|Withdrawal by Subject|1
5467344|NCT01972308|18898676|P1|Overall Study|Withdrawal by Subject|0
5467345|NCT01972217|18898702|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
5467346|NCT01972217|18898703|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
5467347|NCT01972217|18898704|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
5467348|NCT01972217|18898705|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
5467349|NCT01972217|18898702|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
5467350|NCT01972217|18898703|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
5467351|NCT01972217|18898704|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
5467352|NCT01972217|18898705|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
5467353|NCT01972217|18898702|P4|Part B Double-blind, Randomised Period|Screen failure|1
5467354|NCT01972217|18898703|P3|Part B Double-blind, Randomised Period|Screen failure|0
5467355|NCT01972217|18898704|P2|Part B Double-blind, Randomised Period|Screen failure|0
5467356|NCT01972217|18898705|P1|Part B Double-blind, Randomised Period|Screen failure|0
5467357|NCT01972217|18898702|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
5467358|NCT01972217|18898703|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
5467359|NCT01972217|18898704|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
5467360|NCT01972217|18898705|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
5467361|NCT01972217|18898702|P4|Part B Double-blind, Randomised Period|Death|44
5467362|NCT01972217|18898703|P3|Part B Double-blind, Randomised Period|Death|43
5467363|NCT01972217|18898704|P2|Part B Double-blind, Randomised Period|Death|0
5467364|NCT01972217|18898705|P1|Part B Double-blind, Randomised Period|Death|0
5467365|NCT01972217|18898702|P4|Part A: Open-label Safety Run-in Period|Death|0
5467366|NCT01972217|18898703|P3|Part A: Open-label Safety Run-in Period|Death|0
5467367|NCT01972217|18898704|P2|Part A: Open-label Safety Run-in Period|Death|1
5467368|NCT01972217|18898705|P1|Part A: Open-label Safety Run-in Period|Death|0
5467369|NCT01972217|18898702|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
5467370|NCT01972217|18898703|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
5467371|NCT01972217|18898704|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
5467372|NCT01972217|18898705|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
5467373|NCT01972217|18898702|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
5467374|NCT01972217|18898703|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
5467375|NCT01972217|18898704|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
5467376|NCT01972217|18898705|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
5467377|NCT01972217|18898702|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
5467378|NCT01972217|18898703|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
5467379|NCT01972217|18898704|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
5467380|NCT01972217|18898705|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
5467381|NCT01972152|18898766|P6|Second Treatment Visit|Protocol Violation|0
5467382|NCT01972152|18898767|P5|Second Treatment Visit|Protocol Violation|0
5467383|NCT01972152|18898768|P4|Second Treatment Visit|Protocol Violation|0
5467384|NCT01972152|18898769|P3|Second Treatment Visit|Protocol Violation|0
5467385|NCT01972152|18898770|P2|Second Treatment Visit|Protocol Violation|1
5467386|NCT01972152|18898771|P1|Second Treatment Visit|Protocol Violation|0
5467387|NCT01972152|18898766|P6|First Treatment Visit|Lost to Follow-up|0
5467388|NCT01972152|18898767|P5|First Treatment Visit|Lost to Follow-up|0
5467389|NCT01972152|18898768|P4|First Treatment Visit|Lost to Follow-up|0
5467390|NCT01972152|18898769|P3|First Treatment Visit|Lost to Follow-up|0
5467391|NCT01972152|18898770|P2|First Treatment Visit|Lost to Follow-up|1
5467392|NCT01972152|18898771|P1|First Treatment Visit|Lost to Follow-up|0
5467393|NCT01972074|18898809|P3|Overall Study|Scanner Unavailable|1
5467394|NCT01972074|18898810|P2|Overall Study|Scanner Unavailable|0
5467395|NCT01972074|18898811|P1|Overall Study|Scanner Unavailable|0
5467396|NCT01972074|18898809|P3|Overall Study|Withdrawal by Subject|1
5467397|NCT01972074|18898810|P2|Overall Study|Withdrawal by Subject|1
5467398|NCT01972074|18898811|P1|Overall Study|Withdrawal by Subject|1
5467399|NCT01972074|18898809|P3|Overall Study|Lost to Follow-up|1
5467400|NCT01972074|18898810|P2|Overall Study|Lost to Follow-up|1
5467401|NCT01972074|18898811|P1|Overall Study|Lost to Follow-up|0
5467402|NCT01972074|18898809|P3|Overall Study|Lack of Efficacy|0
5467403|NCT01972074|18898810|P2|Overall Study|Lack of Efficacy|1
5467404|NCT01972074|18898811|P1|Overall Study|Lack of Efficacy|1
5467405|NCT01972074|18898809|P3|Overall Study|Adverse Event|0
5467406|NCT01972074|18898810|P2|Overall Study|Adverse Event|1
5467407|NCT01972074|18898811|P1|Overall Study|Adverse Event|4
5467408|NCT01971723|18898837|P2|Overall Study|Protocol Violation|2
5467409|NCT01971723|18898838|P1|Overall Study|Protocol Violation|1
5467410|NCT01971723|18898837|P2|Overall Study|Withdrawal by Subject|1
5467411|NCT01971723|18898838|P1|Overall Study|Withdrawal by Subject|1
5467412|NCT01971645|18898871|P3|Overall Study|Protocol Violation|1
5467413|NCT01971645|18898872|P2|Overall Study|Protocol Violation|0
5467414|NCT01971645|18898873|P1|Overall Study|Protocol Violation|0
5467415|NCT01971645|18898871|P3|Overall Study|Lost to Follow-up|1
5467416|NCT01971645|18898872|P2|Overall Study|Lost to Follow-up|0
5467417|NCT01971645|18898873|P1|Overall Study|Lost to Follow-up|1
5467418|NCT01971645|18898871|P3|Overall Study|Adverse Event|0
5467419|NCT01971645|18898872|P2|Overall Study|Adverse Event|0
5467420|NCT01971645|18898873|P1|Overall Study|Adverse Event|1
5467421|NCT01971567|18898907|P2|Overall Study|Lost to Follow-up|0
5467422|NCT01971567|18898908|P1|Overall Study|Lost to Follow-up|1
5467423|NCT01971567|18898907|P2|Overall Study|Withdrawal by Subject|2
5467424|NCT01971567|18898908|P1|Overall Study|Withdrawal by Subject|3
5467425|NCT01971554|18898934|P4|Overall Study|Lost to Follow-up|0
5467426|NCT01971554|18898935|P3|Overall Study|Lost to Follow-up|0
5467427|NCT01971554|18898936|P2|Overall Study|Lost to Follow-up|0
5467428|NCT01971554|18898937|P1|Overall Study|Lost to Follow-up|1
5467429|NCT01971476|18898974|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
5467430|NCT01971476|18898975|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
5467431|NCT01971476|18898976|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
5467432|NCT01971476|18898974|P3|Cohort 2: 12 to <18 Years|Other not defined|0
5467433|NCT01971476|18898975|P2|Cohort 2: 12 to <18 Years|Other not defined|3
5467434|NCT01971476|18898976|P1|Cohort 2: 12 to <18 Years|Other not defined|6
5467435|NCT01971476|18898974|P3|Cohort 1: 2 to <12 Years|Other not defined|6
5467436|NCT01971476|18898975|P2|Cohort 1: 2 to <12 Years|Other not defined|3
5467437|NCT01971476|18898976|P1|Cohort 1: 2 to <12 Years|Other not defined|3
5467438|NCT01971346|18899070|P1|Overall Study|Physician Decision|1
5467439|NCT01971346|18899070|P1|Overall Study|Withdrawal by Subject|2
5467440|NCT01971346|18899070|P1|Overall Study|Lost to Follow-up|2
5467441|NCT01971346|18899070|P1|Overall Study|Protocol Violation|3
5467442|NCT01971203|18899103|P2|Overall Study|Adverse Event|0
5467443|NCT01971203|18899104|P1|Overall Study|Adverse Event|1
5467444|NCT01971203|18899103|P2|Overall Study|Withdrawal by Subject|6
5467445|NCT01971203|18899104|P1|Overall Study|Withdrawal by Subject|5
5467446|NCT01971203|18899103|P2|Overall Study|Protocol Violation|2
5467447|NCT01971203|18899104|P1|Overall Study|Protocol Violation|3
5467448|NCT01970995|18899131|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
5467449|NCT01970995|18899132|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
5467450|NCT01970995|18899133|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
5467451|NCT01970995|18899131|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5467452|NCT01970995|18899132|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5467453|NCT01970995|18899133|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
5467454|NCT01970982|18899156|P3|Overall Study|Withdrawal by Subject|2
5467455|NCT01970982|18899157|P2|Overall Study|Withdrawal by Subject|0
5467456|NCT01970982|18899158|P1|Overall Study|Withdrawal by Subject|0
5467457|NCT01970878|18899193|P4|Overall Study|No Completion Status|0
5467458|NCT01970878|18899194|P3|Overall Study|No Completion Status|0
5467459|NCT01970878|18899195|P2|Overall Study|No Completion Status|1
5467460|NCT01970878|18899196|P1|Overall Study|No Completion Status|0
5467461|NCT01970878|18899193|P4|Overall Study|Physician Decision|0
5467462|NCT01970878|18899194|P3|Overall Study|Physician Decision|1
5467463|NCT01970878|18899195|P2|Overall Study|Physician Decision|1
5467464|NCT01970878|18899196|P1|Overall Study|Physician Decision|0
5467465|NCT01970878|18899193|P4|Overall Study|Protocol Specified Criteria|6
5467466|NCT01970878|18899194|P3|Overall Study|Protocol Specified Criteria|3
5467467|NCT01970878|18899195|P2|Overall Study|Protocol Specified Criteria|4
5467468|NCT01970878|18899196|P1|Overall Study|Protocol Specified Criteria|10
5467469|NCT01970878|18899193|P4|Overall Study|Adverse Event|3
5467470|NCT01970878|18899194|P3|Overall Study|Adverse Event|4
5467471|NCT01970878|18899195|P2|Overall Study|Adverse Event|7
5467472|NCT01970878|18899196|P1|Overall Study|Adverse Event|12
5467473|NCT01970878|18899193|P4|Overall Study|Lack of Efficacy|0
5467474|NCT01970878|18899194|P3|Overall Study|Lack of Efficacy|2
5467475|NCT01970878|18899195|P2|Overall Study|Lack of Efficacy|1
5467476|NCT01970878|18899196|P1|Overall Study|Lack of Efficacy|2
5467477|NCT01970878|18899193|P4|Overall Study|Administrative Reasons|4
5467478|NCT01970878|18899194|P3|Overall Study|Administrative Reasons|0
5467479|NCT01970878|18899195|P2|Overall Study|Administrative Reasons|0
5467480|NCT01970878|18899196|P1|Overall Study|Administrative Reasons|1
5467481|NCT01970878|18899193|P4|Overall Study|Lost to Follow-up|4
5467482|NCT01970878|18899194|P3|Overall Study|Lost to Follow-up|2
5467483|NCT01970878|18899195|P2|Overall Study|Lost to Follow-up|3
5467484|NCT01970878|18899196|P1|Overall Study|Lost to Follow-up|1
5467485|NCT01970878|18899193|P4|Overall Study|Withdrawal by Subject|7
5467486|NCT01970878|18899194|P3|Overall Study|Withdrawal by Subject|14
5467487|NCT01970878|18899195|P2|Overall Study|Withdrawal by Subject|10
5467488|NCT01970878|18899196|P1|Overall Study|Withdrawal by Subject|11
5467489|NCT01970865|18899239|P17|Overall Study|Study ongoing|2
5467490|NCT01970865|18899240|P16|Overall Study|Study ongoing|29
5467491|NCT01970865|18899241|P15|Overall Study|Study ongoing|29
5467492|NCT01970865|18899242|P14|Overall Study|Study ongoing|41
5467493|NCT01970865|18899243|P13|Overall Study|Study ongoing|43
5467494|NCT01970865|18899244|P12|Overall Study|Study ongoing|22
5467495|NCT01970865|18899245|P11|Overall Study|Study ongoing|29
5467496|NCT01970865|18899246|P10|Overall Study|Study ongoing|3
5467497|NCT01970865|18899247|P9|Overall Study|Study ongoing|1
5467498|NCT01970865|18899248|P8|Overall Study|Study ongoing|0
5467499|NCT01970865|18899249|P7|Overall Study|Study ongoing|2
5467500|NCT01970865|18899250|P6|Overall Study|Study ongoing|0
5467501|NCT01970865|18899251|P5|Overall Study|Study ongoing|8
5467502|NCT01970865|18899252|P4|Overall Study|Study ongoing|6
5467503|NCT01970865|18899253|P3|Overall Study|Study ongoing|0
5467504|NCT01970865|18899254|P2|Overall Study|Study ongoing|2
5467505|NCT01970865|18899255|P1|Overall Study|Study ongoing|0
5467506|NCT01970865|18899239|P17|Overall Study|Other|0
5467507|NCT01970865|18899240|P16|Overall Study|Other|1
5467508|NCT01970865|18899241|P15|Overall Study|Other|0
5467509|NCT01970865|18899242|P14|Overall Study|Other|1
5467510|NCT01970865|18899243|P13|Overall Study|Other|0
5467511|NCT01970865|18899244|P12|Overall Study|Other|0
5467512|NCT01970865|18899245|P11|Overall Study|Other|0
5467513|NCT01970865|18899246|P10|Overall Study|Other|0
5467514|NCT01970865|18899247|P9|Overall Study|Other|0
5467515|NCT01970865|18899248|P8|Overall Study|Other|0
5467516|NCT01970865|18899249|P7|Overall Study|Other|0
5467517|NCT01970865|18899250|P6|Overall Study|Other|0
5467518|NCT01970865|18899251|P5|Overall Study|Other|0
5467519|NCT01970865|18899252|P4|Overall Study|Other|1
5467520|NCT01970865|18899253|P3|Overall Study|Other|0
5467521|NCT01970865|18899254|P2|Overall Study|Other|0
5467522|NCT01970865|18899255|P1|Overall Study|Other|0
5467523|NCT01970865|18899239|P17|Overall Study|Withdrawal by Subject|0
5467524|NCT01970865|18899240|P16|Overall Study|Withdrawal by Subject|7
5467525|NCT01970865|18899241|P15|Overall Study|Withdrawal by Subject|2
5467526|NCT01970865|18899242|P14|Overall Study|Withdrawal by Subject|5
5467527|NCT01970865|18899243|P13|Overall Study|Withdrawal by Subject|2
5467528|NCT01970865|18899244|P12|Overall Study|Withdrawal by Subject|1
5467529|NCT01970865|18899245|P11|Overall Study|Withdrawal by Subject|0
5467530|NCT01970865|18899246|P10|Overall Study|Withdrawal by Subject|0
5467531|NCT01970865|18899247|P9|Overall Study|Withdrawal by Subject|0
5467532|NCT01970865|18899248|P8|Overall Study|Withdrawal by Subject|0
5467533|NCT01970865|18899249|P7|Overall Study|Withdrawal by Subject|0
5467534|NCT01970865|18899250|P6|Overall Study|Withdrawal by Subject|0
5467535|NCT01970865|18899251|P5|Overall Study|Withdrawal by Subject|2
5467536|NCT01970865|18899252|P4|Overall Study|Withdrawal by Subject|1
5467537|NCT01970865|18899253|P3|Overall Study|Withdrawal by Subject|0
5467538|NCT01970865|18899254|P2|Overall Study|Withdrawal by Subject|0
5467539|NCT01970865|18899255|P1|Overall Study|Withdrawal by Subject|0
5467540|NCT01970865|18899239|P17|Overall Study|Lost to Follow-up|0
5467541|NCT01970865|18899240|P16|Overall Study|Lost to Follow-up|0
5467542|NCT01970865|18899241|P15|Overall Study|Lost to Follow-up|0
5467543|NCT01970865|18899242|P14|Overall Study|Lost to Follow-up|0
5467544|NCT01970865|18899243|P13|Overall Study|Lost to Follow-up|1
5467545|NCT01970865|18899244|P12|Overall Study|Lost to Follow-up|0
5467546|NCT01970865|18899245|P11|Overall Study|Lost to Follow-up|0
5467547|NCT01970865|18899246|P10|Overall Study|Lost to Follow-up|0
5467548|NCT01970865|18899247|P9|Overall Study|Lost to Follow-up|0
5467549|NCT01970865|18899248|P8|Overall Study|Lost to Follow-up|0
5467550|NCT01970865|18899249|P7|Overall Study|Lost to Follow-up|0
5467551|NCT01970865|18899250|P6|Overall Study|Lost to Follow-up|0
5467552|NCT01970865|18899251|P5|Overall Study|Lost to Follow-up|1
5467553|NCT01970865|18899252|P4|Overall Study|Lost to Follow-up|1
5467554|NCT01970865|18899253|P3|Overall Study|Lost to Follow-up|0
5467555|NCT01970865|18899254|P2|Overall Study|Lost to Follow-up|0
5467556|NCT01970865|18899255|P1|Overall Study|Lost to Follow-up|0
5467557|NCT01970865|18899239|P17|Overall Study|Death|1
5467558|NCT01970865|18899240|P16|Overall Study|Death|10
5467559|NCT01970865|18899241|P15|Overall Study|Death|15
5467560|NCT01970865|18899242|P14|Overall Study|Death|19
5467561|NCT01970865|18899243|P13|Overall Study|Death|14
5467562|NCT01970865|18899244|P12|Overall Study|Death|4
5467563|NCT01970865|18899245|P11|Overall Study|Death|1
5467564|NCT01970865|18899246|P10|Overall Study|Death|1
5467565|NCT01970865|18899247|P9|Overall Study|Death|2
5467566|NCT01970865|18899248|P8|Overall Study|Death|3
5467567|NCT01970865|18899249|P7|Overall Study|Death|1
5467568|NCT01970865|18899250|P6|Overall Study|Death|3
5467569|NCT01970865|18899251|P5|Overall Study|Death|6
5467570|NCT01970865|18899252|P4|Overall Study|Death|4
5467571|NCT01970865|18899253|P3|Overall Study|Death|3
5467572|NCT01970865|18899254|P2|Overall Study|Death|1
5467573|NCT01970865|18899255|P1|Overall Study|Death|3
5467574|NCT01970592|18899687|P1|Overall Study|Adverse Event|1
5467575|NCT01970592|18899687|P1|Overall Study|Physician Decision|1
5467576|NCT01970592|18899687|P1|Overall Study|Withdrawal by Subject|4
5467577|NCT01970540|18899695|P3|Overall Study|Clinical deterioration|0
5467578|NCT01970540|18899696|P2|Overall Study|Clinical deterioration|0
5467579|NCT01970540|18899697|P1|Overall Study|Clinical deterioration|1
5467580|NCT01970540|18899695|P3|Overall Study|Withdrawal by Subject|1
5467581|NCT01970540|18899696|P2|Overall Study|Withdrawal by Subject|0
5467582|NCT01970540|18899697|P1|Overall Study|Withdrawal by Subject|4
5467583|NCT01970540|18899695|P3|Overall Study|Treatment-related AE|2
5467584|NCT01970540|18899696|P2|Overall Study|Treatment-related AE|0
5467585|NCT01970540|18899697|P1|Overall Study|Treatment-related AE|4
5467586|NCT01970540|18899695|P3|Overall Study|Adverse Event|1
5467587|NCT01970540|18899696|P2|Overall Study|Adverse Event|2
5467588|NCT01970540|18899697|P1|Overall Study|Adverse Event|0
5467589|NCT01970540|18899695|P3|Overall Study|End of study|2
5467590|NCT01970540|18899696|P2|Overall Study|End of study|0
5467591|NCT01970540|18899697|P1|Overall Study|End of study|2
5467592|NCT01970540|18899695|P3|Overall Study|Clinical progression|1
5467593|NCT01970540|18899696|P2|Overall Study|Clinical progression|1
5467594|NCT01970540|18899697|P1|Overall Study|Clinical progression|0
5467595|NCT01970540|18899695|P3|Overall Study|Physician Decision|0
5467596|NCT01970540|18899696|P2|Overall Study|Physician Decision|2
5467597|NCT01970540|18899697|P1|Overall Study|Physician Decision|7
5467598|NCT01970540|18899695|P3|Overall Study|Treatment delay over protocol|1
5467599|NCT01970540|18899696|P2|Overall Study|Treatment delay over protocol|0
5467600|NCT01970540|18899697|P1|Overall Study|Treatment delay over protocol|0
5467601|NCT01970540|18899695|P3|Overall Study|Progressive disease|10
5467602|NCT01970540|18899696|P2|Overall Study|Progressive disease|23
5467603|NCT01970540|18899697|P1|Overall Study|Progressive disease|55
5467604|NCT01970540|18899695|P3|Overall Study|Non-treatment-related AE|1
5467605|NCT01970540|18899696|P2|Overall Study|Non-treatment-related AE|0
5467606|NCT01970540|18899697|P1|Overall Study|Non-treatment-related AE|0
5467607|NCT01970527|18899728|P2|Follow-up Clinic Visit|Lost to Follow-up|1
5467608|NCT01970527|18899729|P1|Follow-up Clinic Visit|Lost to Follow-up|0
5467609|NCT01970527|18899728|P2|Follow-up Clinic Visit|Withdrawal by Subject|1
5467610|NCT01970527|18899729|P1|Follow-up Clinic Visit|Withdrawal by Subject|0
5467611|NCT01970527|18899728|P2|Follow-up Clinic Visit|Disease progression|1
5467612|NCT01970527|18899729|P1|Follow-up Clinic Visit|Disease progression|1
5467613|NCT01970527|18899728|P2|Treatment|Death|1
5467614|NCT01970527|18899729|P1|Treatment|Death|0
5467615|NCT01970527|18899728|P2|Treatment|Participant did not tolerate Ipilimumab|1
5467616|NCT01970527|18899729|P1|Treatment|Participant did not tolerate Ipilimumab|0
5467617|NCT01970527|18899728|P2|Treatment|Disease progression|1
5467618|NCT01970527|18899729|P1|Treatment|Disease progression|0
5467619|NCT01970527|18899728|P2|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
5467620|NCT01970527|18899729|P1|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
5467621|NCT01970488|18899742|P5|Part 2: Post Week 16|Lost to Follow-up|2
5467622|NCT01970488|18899743|P4|Part 2: Post Week 16|Lost to Follow-up|1
5467623|NCT01970488|18899744|P3|Part 2: Post Week 16|Lost to Follow-up|1
5467624|NCT01970488|18899745|P2|Part 2: Post Week 16|Lost to Follow-up|0
5467625|NCT01970488|18899746|P1|Part 2: Post Week 16|Lost to Follow-up|0
5467626|NCT01970488|18899742|P5|Part 2: Post Week 16|Withdrawal by Subject|3
5467627|NCT01970488|18899743|P4|Part 2: Post Week 16|Withdrawal by Subject|3
5467628|NCT01970488|18899744|P3|Part 2: Post Week 16|Withdrawal by Subject|8
5467629|NCT01970488|18899745|P2|Part 2: Post Week 16|Withdrawal by Subject|0
5467630|NCT01970488|18899746|P1|Part 2: Post Week 16|Withdrawal by Subject|0
5467631|NCT01970488|18899742|P5|Part 2: Post Week 16|Adverse Event|1
5467632|NCT01970488|18899743|P4|Part 2: Post Week 16|Adverse Event|1
5467633|NCT01970488|18899744|P3|Part 2: Post Week 16|Adverse Event|5
5467634|NCT01970488|18899745|P2|Part 2: Post Week 16|Adverse Event|0
5467635|NCT01970488|18899746|P1|Part 2: Post Week 16|Adverse Event|0
5467636|NCT01970488|18899742|P5|Part 2: Post Week 16|Lack of Efficacy|1
5467637|NCT01970488|18899743|P4|Part 2: Post Week 16|Lack of Efficacy|3
5467638|NCT01970488|18899744|P3|Part 2: Post Week 16|Lack of Efficacy|2
5467639|NCT01970488|18899745|P2|Part 2: Post Week 16|Lack of Efficacy|0
5467640|NCT01970488|18899746|P1|Part 2: Post Week 16|Lack of Efficacy|0
5467641|NCT01970488|18899742|P5|Part 2: Post Week 16|Non-compliance|0
5467642|NCT01970488|18899743|P4|Part 2: Post Week 16|Non-compliance|0
5467643|NCT01970488|18899744|P3|Part 2: Post Week 16|Non-compliance|1
5467644|NCT01970488|18899745|P2|Part 2: Post Week 16|Non-compliance|0
5467645|NCT01970488|18899746|P1|Part 2: Post Week 16|Non-compliance|0
5467646|NCT01970488|18899742|P5|Part 2: Post Week 16|Physician Decision|1
5467647|NCT01970488|18899743|P4|Part 2: Post Week 16|Physician Decision|0
5467648|NCT01970488|18899744|P3|Part 2: Post Week 16|Physician Decision|0
5467649|NCT01970488|18899745|P2|Part 2: Post Week 16|Physician Decision|0
5467650|NCT01970488|18899746|P1|Part 2: Post Week 16|Physician Decision|0
5467651|NCT01970488|18899742|P5|Part 1: Through Week 16|Lost to Follow-up|0
5467652|NCT01970488|18899743|P4|Part 1: Through Week 16|Lost to Follow-up|0
5467653|NCT01970488|18899744|P3|Part 1: Through Week 16|Lost to Follow-up|0
5467654|NCT01970488|18899745|P2|Part 1: Through Week 16|Lost to Follow-up|2
5467655|NCT01970488|18899746|P1|Part 1: Through Week 16|Lost to Follow-up|0
5467656|NCT01970488|18899742|P5|Part 1: Through Week 16|Withdrawal by Subject|0
5467657|NCT01970488|18899743|P4|Part 1: Through Week 16|Withdrawal by Subject|0
5467658|NCT01970488|18899744|P3|Part 1: Through Week 16|Withdrawal by Subject|0
5467659|NCT01970488|18899745|P2|Part 1: Through Week 16|Withdrawal by Subject|2
5467660|NCT01970488|18899746|P1|Part 1: Through Week 16|Withdrawal by Subject|3
5467661|NCT01970488|18899742|P5|Part 1: Through Week 16|Adverse Event|0
5467662|NCT01970488|18899743|P4|Part 1: Through Week 16|Adverse Event|0
5467663|NCT01970488|18899744|P3|Part 1: Through Week 16|Adverse Event|0
5467664|NCT01970488|18899745|P2|Part 1: Through Week 16|Adverse Event|5
5467665|NCT01970488|18899746|P1|Part 1: Through Week 16|Adverse Event|6
5467666|NCT01970488|18899742|P5|Part 1: Through Week 16|Protocol Violation|0
5467667|NCT01970488|18899743|P4|Part 1: Through Week 16|Protocol Violation|0
5467668|NCT01970488|18899744|P3|Part 1: Through Week 16|Protocol Violation|0
5467669|NCT01970488|18899745|P2|Part 1: Through Week 16|Protocol Violation|2
5467670|NCT01970488|18899746|P1|Part 1: Through Week 16|Protocol Violation|1
5467671|NCT01970488|18899742|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
5467672|NCT01970488|18899743|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
5467673|NCT01970488|18899744|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
5467674|NCT01970488|18899745|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
5467675|NCT01970488|18899746|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
5467676|NCT01970475|18899813|P2|Overall Study|Protocol Violation|0
5467677|NCT01970475|18899814|P1|Overall Study|Protocol Violation|1
5467678|NCT01970475|18899813|P2|Overall Study|Lost to Follow-up|2
5467679|NCT01970475|18899814|P1|Overall Study|Lost to Follow-up|2
5467680|NCT01970475|18899813|P2|Overall Study|Adverse Event|3
5467681|NCT01970475|18899814|P1|Overall Study|Adverse Event|7
5467682|NCT01970475|18899813|P2|Overall Study|Withdrawal by Subject|6
5467683|NCT01970475|18899814|P1|Overall Study|Withdrawal by Subject|11
5467684|NCT01970462|18899834|P2|Overall Study|Lost to Follow-up|2
5467685|NCT01970462|18899835|P1|Overall Study|Lost to Follow-up|0
5467686|NCT01970397|18899849|P2|Overall Study|Protocol Violation|1
5467687|NCT01970397|18899850|P1|Overall Study|Protocol Violation|1
5467688|NCT01970397|18899849|P2|Overall Study|Personal Reasons|2
5467689|NCT01970397|18899850|P1|Overall Study|Personal Reasons|1
5467690|NCT01970397|18899849|P2|Overall Study|Lost to Follow-up|1
5467691|NCT01970397|18899850|P1|Overall Study|Lost to Follow-up|0
5467692|NCT01970397|18899849|P2|Overall Study|Adverse Event|1
5467693|NCT01970397|18899850|P1|Overall Study|Adverse Event|0
5467694|NCT01970371|18899863|P3|Overall Study|Lost to Follow-up|1
5467695|NCT01970371|18899864|P2|Overall Study|Lost to Follow-up|0
5467696|NCT01970371|18899865|P1|Overall Study|Lost to Follow-up|0
5467697|NCT01970371|18899863|P3|Overall Study|Death|12
5467698|NCT01970371|18899864|P2|Overall Study|Death|13
5467699|NCT01970371|18899865|P1|Overall Study|Death|8
5467700|NCT01970241|18899890|P2|Overall Study|Steroid d/c;discharge<48 hrs.|8
5467701|NCT01970241|18899891|P1|Overall Study|Steroid d/c;discharge<48 hrs.|15
5467702|NCT01970241|18899890|P2|Overall Study|Withdrawal by Subject|0
5467703|NCT01970241|18899891|P1|Overall Study|Withdrawal by Subject|2
5467704|NCT01969851|18899951|P3|Overall Study|Sponsor decision|1
5467705|NCT01969851|18899952|P2|Overall Study|Sponsor decision|0
5467706|NCT01969851|18899953|P1|Overall Study|Sponsor decision|0
5467707|NCT01969851|18899951|P3|Overall Study|No effective dose in Titration period|1
5467708|NCT01969851|18899952|P2|Overall Study|No effective dose in Titration period|0
5467709|NCT01969851|18899953|P1|Overall Study|No effective dose in Titration period|0
5467710|NCT01969851|18899951|P3|Overall Study|Withdrawal by Subject|1
5467711|NCT01969851|18899952|P2|Overall Study|Withdrawal by Subject|0
5467712|NCT01969851|18899953|P1|Overall Study|Withdrawal by Subject|1
5467713|NCT01969851|18899951|P3|Overall Study|Lack of Efficacy|1
5467714|NCT01969851|18899952|P2|Overall Study|Lack of Efficacy|3
5467715|NCT01969851|18899953|P1|Overall Study|Lack of Efficacy|0
5467716|NCT01969851|18899951|P3|Overall Study|Adverse Event|3
5467717|NCT01969851|18899952|P2|Overall Study|Adverse Event|0
5467718|NCT01969851|18899953|P1|Overall Study|Adverse Event|0
5467719|NCT01969799|18899975|P2|Overall Study|Physician Decision|0
5467720|NCT01969799|18899976|P1|Overall Study|Physician Decision|1
5467721|NCT01969799|18899975|P2|Overall Study|Lost to Follow-up|2
5467722|NCT01969799|18899976|P1|Overall Study|Lost to Follow-up|0
5467723|NCT01969799|18899975|P2|Overall Study|Death|11
5467724|NCT01969799|18899976|P1|Overall Study|Death|16
5467725|NCT01969799|18899975|P2|Overall Study|Adverse Event|1
5467726|NCT01969799|18899976|P1|Overall Study|Adverse Event|0
5467727|NCT01969721|18900013|P4|Overall Study|Discontinued during washout periods.|2
5467728|NCT01969721|18900014|P3|Overall Study|Discontinued during washout periods.|1
5467729|NCT01969721|18900015|P2|Overall Study|Discontinued during washout periods.|1
5467730|NCT01969721|18900016|P1|Overall Study|Discontinued during washout periods.|0
5467731|NCT01969721|18900013|P4|Overall Study|Other not defined above|0
5467732|NCT01969721|18900014|P3|Overall Study|Other not defined above|0
5467733|NCT01969721|18900015|P2|Overall Study|Other not defined above|2
5467734|NCT01969721|18900016|P1|Overall Study|Other not defined above|0
5467735|NCT01969721|18900013|P4|Overall Study|Non compliant with protocol|2
5467736|NCT01969721|18900014|P3|Overall Study|Non compliant with protocol|0
5467737|NCT01969721|18900015|P2|Overall Study|Non compliant with protocol|1
5467738|NCT01969721|18900016|P1|Overall Study|Non compliant with protocol|1
5467739|NCT01969721|18900013|P4|Overall Study|Lack of Efficacy|0
5467740|NCT01969721|18900014|P3|Overall Study|Lack of Efficacy|1
5467741|NCT01969721|18900015|P2|Overall Study|Lack of Efficacy|0
5467742|NCT01969721|18900016|P1|Overall Study|Lack of Efficacy|0
5467743|NCT01969721|18900013|P4|Overall Study|Adverse Event|2
5467744|NCT01969721|18900014|P3|Overall Study|Adverse Event|3
5467745|NCT01969721|18900015|P2|Overall Study|Adverse Event|8
5467746|NCT01969721|18900016|P1|Overall Study|Adverse Event|3
5467747|NCT01969565|18900061|P1|Overall Study|Withdrawal by Subject|1
5467748|NCT01969500|18900075|P2|Overall Study|extended hospitalization|1
5467749|NCT01969500|18900076|P1|Overall Study|extended hospitalization|1
5467750|NCT01969500|18900075|P2|Overall Study|Death|1
5467751|NCT01969500|18900076|P1|Overall Study|Death|0
5467752|NCT01969084|18900197|P2|Overall Study|Adverse Event|1
5467753|NCT01969084|18900198|P1|Overall Study|Adverse Event|0
5467754|NCT01969058|18900214|P2|Overall Study|Adverse Event|0
5467755|NCT01969058|18900215|P1|Overall Study|Adverse Event|1
5467756|NCT01969058|18900214|P2|Overall Study|Withdrawal by Subject|0
5467757|NCT01969058|18900215|P1|Overall Study|Withdrawal by Subject|2
5467758|NCT01968980|18900259|P2|Overall Study|Other unspecified|2
5467759|NCT01968980|18900260|P1|Overall Study|Other unspecified|1
5467760|NCT01968980|18900259|P2|Overall Study|Withdrawal by Subject|5
5467761|NCT01968980|18900260|P1|Overall Study|Withdrawal by Subject|13
5467762|NCT01968980|18900259|P2|Overall Study|Does not meet entry criteria|3
5467763|NCT01968980|18900260|P1|Overall Study|Does not meet entry criteria|1
5467764|NCT01968980|18900259|P2|Overall Study|Adverse Event|3
5467765|NCT01968980|18900260|P1|Overall Study|Adverse Event|1
5467766|NCT01968980|18900259|P2|Overall Study|Death|1
5467767|NCT01968980|18900260|P1|Overall Study|Death|0
5467768|NCT01968967|18900322|P5|Extension Period|Withdrew Consent|5
5467769|NCT01968967|18900323|P4|Extension Period|Withdrew Consent|0
5467770|NCT01968967|18900324|P3|Extension Period|Withdrew Consent|2
5467771|NCT01968967|18900325|P2|Extension Period|Withdrew Consent|0
5467772|NCT01968967|18900326|P1|Extension Period|Withdrew Consent|0
5467773|NCT01968967|18900322|P5|Treatment Period|Randomized Not Treated|0
5467774|NCT01968967|18900323|P4|Treatment Period|Randomized Not Treated|0
5467775|NCT01968967|18900324|P3|Treatment Period|Randomized Not Treated|0
5467776|NCT01968967|18900325|P2|Treatment Period|Randomized Not Treated|5
5467777|NCT01968967|18900326|P1|Treatment Period|Randomized Not Treated|6
5467778|NCT01968967|18900322|P5|Treatment Period|Death|0
5467779|NCT01968967|18900323|P4|Treatment Period|Death|0
5467780|NCT01968967|18900324|P3|Treatment Period|Death|0
5467781|NCT01968967|18900325|P2|Treatment Period|Death|2
5467782|NCT01968967|18900326|P1|Treatment Period|Death|9
5467783|NCT01968967|18900322|P5|Treatment Period|Adverse Event|0
5467784|NCT01968967|18900323|P4|Treatment Period|Adverse Event|0
5467785|NCT01968967|18900324|P3|Treatment Period|Adverse Event|0
5467786|NCT01968967|18900325|P2|Treatment Period|Adverse Event|8
5467787|NCT01968967|18900326|P1|Treatment Period|Adverse Event|9
5467788|NCT01968967|18900322|P5|Treatment Period|Protocol Violation|0
5467789|NCT01968967|18900323|P4|Treatment Period|Protocol Violation|0
5467790|NCT01968967|18900324|P3|Treatment Period|Protocol Violation|0
5467791|NCT01968967|18900325|P2|Treatment Period|Protocol Violation|2
5467792|NCT01968967|18900326|P1|Treatment Period|Protocol Violation|1
5467793|NCT01968967|18900322|P5|Treatment Period|Lost to Follow-up|0
5467794|NCT01968967|18900323|P4|Treatment Period|Lost to Follow-up|0
5467795|NCT01968967|18900324|P3|Treatment Period|Lost to Follow-up|0
5467796|NCT01968967|18900325|P2|Treatment Period|Lost to Follow-up|31
5467797|NCT01968967|18900326|P1|Treatment Period|Lost to Follow-up|26
5467798|NCT01968967|18900322|P5|Treatment Period|Did Not Meet Entrance Criteria|0
5467799|NCT01968967|18900323|P4|Treatment Period|Did Not Meet Entrance Criteria|0
5467800|NCT01968967|18900324|P3|Treatment Period|Did Not Meet Entrance Criteria|0
5467801|NCT01968967|18900325|P2|Treatment Period|Did Not Meet Entrance Criteria|3
5467802|NCT01968967|18900326|P1|Treatment Period|Did Not Meet Entrance Criteria|2
5467803|NCT01968967|18900322|P5|Treatment Period|Withdrawal by Subject|0
5467804|NCT01968967|18900323|P4|Treatment Period|Withdrawal by Subject|0
5467805|NCT01968967|18900324|P3|Treatment Period|Withdrawal by Subject|0
5467806|NCT01968967|18900325|P2|Treatment Period|Withdrawal by Subject|61
5467807|NCT01968967|18900326|P1|Treatment Period|Withdrawal by Subject|71
5467808|NCT01968967|18900322|P5|Treatment Period|Other|0
5467809|NCT01968967|18900323|P4|Treatment Period|Other|0
5467810|NCT01968967|18900324|P3|Treatment Period|Other|0
5467811|NCT01968967|18900325|P2|Treatment Period|Other|22
5467812|NCT01968967|18900326|P1|Treatment Period|Other|22
5467813|NCT01968954|18900395|P2|Overall Study|Did not met inclusion criteria|2
5467814|NCT01968954|18900396|P1|Overall Study|Did not met inclusion criteria|0
5467815|NCT01968954|18900395|P2|Overall Study|Protocol Violation|1
5467816|NCT01968954|18900396|P1|Overall Study|Protocol Violation|0
5467817|NCT01968954|18900395|P2|Overall Study|Other|8
5467818|NCT01968954|18900396|P1|Overall Study|Other|7
5467819|NCT01968954|18900395|P2|Overall Study|Withdrawal by Subject|23
5467820|NCT01968954|18900396|P1|Overall Study|Withdrawal by Subject|20
5467821|NCT01968954|18900395|P2|Overall Study|Lost to Follow-up|4
5467822|NCT01968954|18900396|P1|Overall Study|Lost to Follow-up|6
5467823|NCT01968954|18900395|P2|Overall Study|Death|2
5467824|NCT01968954|18900396|P1|Overall Study|Death|1
5467825|NCT01968954|18900395|P2|Overall Study|Adverse Event|3
5467826|NCT01968954|18900396|P1|Overall Study|Adverse Event|6
5467827|NCT01968811|18900460|P1|Overall Study|post op.ref. of subject to other hospita|1
5467828|NCT01968811|18900460|P1|Overall Study|Protocol Violation|4
5467829|NCT01968694|18900467|P2|Washout (1 Month)|Lost to Follow-up|1
5467830|NCT01968694|18900468|P1|Washout (1 Month)|Lost to Follow-up|0
5467831|NCT01968551|18900485|P3|Extension Phase|Lost to Follow-up|1
5467832|NCT01968551|18900486|P2|Extension Phase|Lost to Follow-up|0
5467833|NCT01968551|18900487|P1|Extension Phase|Lost to Follow-up|1
5467834|NCT01968551|18900485|P3|Extension Phase|Withdrew Consent|1
5467835|NCT01968551|18900486|P2|Extension Phase|Withdrew Consent|0
5467836|NCT01968551|18900487|P1|Extension Phase|Withdrew Consent|0
5467837|NCT01968551|18900485|P3|Extension Phase|Death|0
5467838|NCT01968551|18900486|P2|Extension Phase|Death|1
5467839|NCT01968551|18900487|P1|Extension Phase|Death|0
5467840|NCT01968551|18900485|P3|Extension Phase|Adverse Event|2
5467841|NCT01968551|18900486|P2|Extension Phase|Adverse Event|0
5467842|NCT01968551|18900487|P1|Extension Phase|Adverse Event|0
5467843|NCT01968551|18900485|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
5467844|NCT01968551|18900486|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
5467845|NCT01968551|18900487|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
5467846|NCT01968551|18900485|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
5467847|NCT01968551|18900486|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
5467848|NCT01968551|18900487|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
5467849|NCT01968551|18900485|P3|Open Label Phase (48 Weeks)|Investigator's Discretion|0
5467850|NCT01968551|18900486|P2|Open Label Phase (48 Weeks)|Investigator's Discretion|1
5467851|NCT01968551|18900487|P1|Open Label Phase (48 Weeks)|Investigator's Discretion|0
5467852|NCT01968551|18900485|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
5467853|NCT01968551|18900486|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
5467854|NCT01968551|18900487|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
5467855|NCT01968434|18900524|P2|Overall Study|Lost to Follow-up|6
5467856|NCT01968434|18900525|P1|Overall Study|Lost to Follow-up|3
5467857|NCT01968226|18900593|P1|Overall Study|[F-18] RDG-K5 was not available|2
5467858|NCT01968213|18900599|P2|Overall Study|Ongoing|9
5467859|NCT01968213|18900600|P1|Overall Study|Ongoing|90
5467860|NCT01968070|18900642|P18|Period 2|Withdrawal by Subject|0
5467861|NCT01968070|18900643|P17|Period 2|Withdrawal by Subject|0
5467862|NCT01968070|18900644|P16|Period 2|Withdrawal by Subject|0
5467863|NCT01968070|18900645|P15|Period 2|Withdrawal by Subject|0
5467864|NCT01968070|18900646|P14|Period 2|Withdrawal by Subject|0
5467865|NCT01968070|18900647|P13|Period 2|Withdrawal by Subject|0
5467866|NCT01968070|18900648|P12|Period 2|Withdrawal by Subject|0
5467867|NCT01968070|18900649|P11|Period 2|Withdrawal by Subject|0
5467868|NCT01968070|18900650|P10|Period 2|Withdrawal by Subject|0
5467869|NCT01968070|18900651|P9|Period 2|Withdrawal by Subject|0
5467870|NCT01968070|18900652|P8|Period 2|Withdrawal by Subject|0
5467871|NCT01968070|18900653|P7|Period 2|Withdrawal by Subject|0
5467872|NCT01968070|18900654|P6|Period 2|Withdrawal by Subject|0
5467873|NCT01968070|18900655|P5|Period 2|Withdrawal by Subject|1
5467874|NCT01968070|18900656|P4|Period 2|Withdrawal by Subject|0
5467875|NCT01968070|18900657|P3|Period 2|Withdrawal by Subject|0
5467876|NCT01968070|18900658|P2|Period 2|Withdrawal by Subject|0
5467877|NCT01968070|18900659|P1|Period 2|Withdrawal by Subject|0
5467878|NCT01968070|18900642|P18|Period 1|Physician Decision|0
5467879|NCT01968070|18900643|P17|Period 1|Physician Decision|0
5467880|NCT01968070|18900644|P16|Period 1|Physician Decision|0
5467881|NCT01968070|18900645|P15|Period 1|Physician Decision|0
5467882|NCT01968070|18900646|P14|Period 1|Physician Decision|0
5467883|NCT01968070|18900647|P13|Period 1|Physician Decision|0
5467884|NCT01968070|18900648|P12|Period 1|Physician Decision|1
5467885|NCT01968070|18900649|P11|Period 1|Physician Decision|0
5467886|NCT01968070|18900650|P10|Period 1|Physician Decision|0
5467887|NCT01968070|18900651|P9|Period 1|Physician Decision|0
5467888|NCT01968070|18900652|P8|Period 1|Physician Decision|0
5467889|NCT01968070|18900653|P7|Period 1|Physician Decision|0
5467890|NCT01968070|18900654|P6|Period 1|Physician Decision|0
5467891|NCT01968070|18900655|P5|Period 1|Physician Decision|0
5467892|NCT01968070|18900656|P4|Period 1|Physician Decision|0
5467893|NCT01968070|18900657|P3|Period 1|Physician Decision|0
5467894|NCT01968070|18900658|P2|Period 1|Physician Decision|0
5467895|NCT01968070|18900659|P1|Period 1|Physician Decision|0
5467896|NCT01968070|18900642|P18|Period 1|Adverse Event|0
5467897|NCT01968070|18900643|P17|Period 1|Adverse Event|0
5467898|NCT01968070|18900644|P16|Period 1|Adverse Event|0
5467899|NCT01968070|18900645|P15|Period 1|Adverse Event|0
5467900|NCT01968070|18900646|P14|Period 1|Adverse Event|0
5467901|NCT01968070|18900647|P13|Period 1|Adverse Event|0
5467902|NCT01968070|18900648|P12|Period 1|Adverse Event|0
5467903|NCT01968070|18900649|P11|Period 1|Adverse Event|0
5467904|NCT01968070|18900650|P10|Period 1|Adverse Event|0
5467905|NCT01968070|18900651|P9|Period 1|Adverse Event|0
5467906|NCT01968070|18900652|P8|Period 1|Adverse Event|0
5467907|NCT01968070|18900653|P7|Period 1|Adverse Event|1
5467908|NCT01968070|18900654|P6|Period 1|Adverse Event|0
5467909|NCT01968070|18900655|P5|Period 1|Adverse Event|0
5467910|NCT01968070|18900656|P4|Period 1|Adverse Event|0
5467911|NCT01968070|18900657|P3|Period 1|Adverse Event|0
5467912|NCT01968070|18900658|P2|Period 1|Adverse Event|0
5467913|NCT01968070|18900659|P1|Period 1|Adverse Event|0
5467914|NCT01968070|18900642|P18|Period 1|Lost to Follow-up|0
5467915|NCT01968070|18900643|P17|Period 1|Lost to Follow-up|0
5467916|NCT01968070|18900644|P16|Period 1|Lost to Follow-up|0
5467917|NCT01968070|18900645|P15|Period 1|Lost to Follow-up|0
5467918|NCT01968070|18900646|P14|Period 1|Lost to Follow-up|0
5467919|NCT01968070|18900647|P13|Period 1|Lost to Follow-up|0
5467920|NCT01968070|18900648|P12|Period 1|Lost to Follow-up|0
5467921|NCT01968070|18900649|P11|Period 1|Lost to Follow-up|0
5467922|NCT01968070|18900650|P10|Period 1|Lost to Follow-up|0
5467923|NCT01968070|18900651|P9|Period 1|Lost to Follow-up|0
5467924|NCT01968070|18900652|P8|Period 1|Lost to Follow-up|0
5467925|NCT01968070|18900653|P7|Period 1|Lost to Follow-up|0
5467926|NCT01968070|18900654|P6|Period 1|Lost to Follow-up|0
5467927|NCT01968070|18900655|P5|Period 1|Lost to Follow-up|0
5467928|NCT01968070|18900656|P4|Period 1|Lost to Follow-up|1
5467929|NCT01968070|18900657|P3|Period 1|Lost to Follow-up|0
5467930|NCT01968070|18900658|P2|Period 1|Lost to Follow-up|0
5467931|NCT01968070|18900659|P1|Period 1|Lost to Follow-up|0
5467932|NCT01968070|18900642|P18|Period 1|Protocol Violation|0
5467933|NCT01968070|18900643|P17|Period 1|Protocol Violation|0
5467934|NCT01968070|18900644|P16|Period 1|Protocol Violation|0
5467935|NCT01968070|18900645|P15|Period 1|Protocol Violation|0
5467936|NCT01968070|18900646|P14|Period 1|Protocol Violation|0
5467937|NCT01968070|18900647|P13|Period 1|Protocol Violation|0
5467938|NCT01968070|18900648|P12|Period 1|Protocol Violation|0
5467939|NCT01968070|18900649|P11|Period 1|Protocol Violation|0
5467940|NCT01968070|18900650|P10|Period 1|Protocol Violation|0
5467941|NCT01968070|18900651|P9|Period 1|Protocol Violation|0
5467942|NCT01968070|18900652|P8|Period 1|Protocol Violation|0
5467943|NCT01968070|18900653|P7|Period 1|Protocol Violation|0
5467944|NCT01968070|18900654|P6|Period 1|Protocol Violation|0
5467945|NCT01968070|18900655|P5|Period 1|Protocol Violation|1
5467946|NCT01968070|18900656|P4|Period 1|Protocol Violation|1
5467947|NCT01968070|18900657|P3|Period 1|Protocol Violation|0
5467948|NCT01968070|18900658|P2|Period 1|Protocol Violation|0
5467949|NCT01968070|18900659|P1|Period 1|Protocol Violation|0
5467950|NCT01968070|18900642|P18|Period 1|Withdrawal by Subject|0
5467951|NCT01968070|18900643|P17|Period 1|Withdrawal by Subject|0
5467952|NCT01968070|18900644|P16|Period 1|Withdrawal by Subject|1
5467953|NCT01968070|18900645|P15|Period 1|Withdrawal by Subject|0
5467954|NCT01968070|18900646|P14|Period 1|Withdrawal by Subject|0
5467955|NCT01968070|18900647|P13|Period 1|Withdrawal by Subject|0
5467956|NCT01968070|18900648|P12|Period 1|Withdrawal by Subject|0
5467957|NCT01968070|18900649|P11|Period 1|Withdrawal by Subject|0
5467958|NCT01968070|18900650|P10|Period 1|Withdrawal by Subject|0
5467959|NCT01968070|18900651|P9|Period 1|Withdrawal by Subject|0
5467960|NCT01968070|18900652|P8|Period 1|Withdrawal by Subject|0
5467961|NCT01968070|18900653|P7|Period 1|Withdrawal by Subject|1
5467962|NCT01968070|18900654|P6|Period 1|Withdrawal by Subject|0
5467963|NCT01968070|18900655|P5|Period 1|Withdrawal by Subject|0
5467964|NCT01968070|18900656|P4|Period 1|Withdrawal by Subject|0
5467965|NCT01968070|18900657|P3|Period 1|Withdrawal by Subject|0
5467966|NCT01968070|18900658|P2|Period 1|Withdrawal by Subject|1
5467967|NCT01968070|18900659|P1|Period 1|Withdrawal by Subject|0
5467968|NCT01968031|18900730|P3|Overall Study|Prohibited concomitant medication|0
5467969|NCT01968031|18900731|P2|Overall Study|Prohibited concomitant medication|0
5467970|NCT01968031|18900732|P1|Overall Study|Prohibited concomitant medication|1
5467971|NCT01968031|18900730|P3|Overall Study|Death|1
5467972|NCT01968031|18900731|P2|Overall Study|Death|0
5467973|NCT01968031|18900732|P1|Overall Study|Death|0
5467974|NCT01968031|18900730|P3|Overall Study|Failed inclusion criteria|0
5467975|NCT01968031|18900731|P2|Overall Study|Failed inclusion criteria|2
5467976|NCT01968031|18900732|P1|Overall Study|Failed inclusion criteria|0
5467977|NCT01968031|18900730|P3|Overall Study|Noncompliance|2
5467978|NCT01968031|18900731|P2|Overall Study|Noncompliance|0
5467979|NCT01968031|18900732|P1|Overall Study|Noncompliance|0
5467980|NCT01968031|18900730|P3|Overall Study|Did not meet entry criteria|1
5467981|NCT01968031|18900731|P2|Overall Study|Did not meet entry criteria|1
5467982|NCT01968031|18900732|P1|Overall Study|Did not meet entry criteria|1
5467983|NCT01968031|18900730|P3|Overall Study|Withdrawal by Subject|3
5467984|NCT01968031|18900731|P2|Overall Study|Withdrawal by Subject|7
5467985|NCT01968031|18900732|P1|Overall Study|Withdrawal by Subject|3
5467986|NCT01968031|18900730|P3|Overall Study|Adverse Event|22
5467987|NCT01968031|18900731|P2|Overall Study|Adverse Event|10
5467988|NCT01968031|18900732|P1|Overall Study|Adverse Event|13
5467989|NCT01967940|18900776|P4|Part 2|Unknown Reason|1
5467990|NCT01967940|18900777|P3|Part 2|Unknown Reason|0
5467991|NCT01967940|18900778|P2|Part 2|Unknown Reason|0
5467992|NCT01967940|18900779|P1|Part 2|Unknown Reason|0
5467993|NCT01967940|18900776|P4|Part 2|Adverse Event|1
5467994|NCT01967940|18900777|P3|Part 2|Adverse Event|0
5467995|NCT01967940|18900778|P2|Part 2|Adverse Event|0
5467996|NCT01967940|18900779|P1|Part 2|Adverse Event|0
5467997|NCT01967940|18900776|P4|Part 2|Enrolled in Part 2 and Never Treated|1
5467998|NCT01967940|18900777|P3|Part 2|Enrolled in Part 2 and Never Treated|0
5467999|NCT01967940|18900778|P2|Part 2|Enrolled in Part 2 and Never Treated|0
5468000|NCT01967940|18900779|P1|Part 2|Enrolled in Part 2 and Never Treated|0
5468001|NCT01967888|18900807|P2|Overall Study|Subject Unable To Comply With Final Day|1
5468002|NCT01967888|18900808|P1|Overall Study|Subject Unable To Comply With Final Day|0
5468003|NCT01967888|18900807|P2|Overall Study|Patient didn't proceed to pancreatectomy|1
5468004|NCT01967888|18900808|P1|Overall Study|Patient didn't proceed to pancreatectomy|0
5468005|NCT01967888|18900807|P2|Overall Study|Subject excluded after randomization|0
5468006|NCT01967888|18900808|P1|Overall Study|Subject excluded after randomization|1
5468007|NCT01967888|18900807|P2|Overall Study|Research visit not done, data recorded|0
5468008|NCT01967888|18900808|P1|Overall Study|Research visit not done, data recorded|1
5468009|NCT01967888|18900807|P2|Overall Study|Did Not Have Transplant|0
5468010|NCT01967888|18900808|P1|Overall Study|Did Not Have Transplant|1
5468011|NCT01967888|18900807|P2|Overall Study|Withdrawal by Subject|1
5468012|NCT01967888|18900808|P1|Overall Study|Withdrawal by Subject|1
5468013|NCT01967888|18900807|P2|Overall Study|Lost to Follow-up|4
5468014|NCT01967888|18900808|P1|Overall Study|Lost to Follow-up|6
5468015|NCT01967732|18900896|P4|First Intervention (Day 1)|Poor venous access|0
5468016|NCT01967732|18900897|P3|First Intervention (Day 1)|Poor venous access|0
5468017|NCT01967732|18900898|P2|First Intervention (Day 1)|Poor venous access|1
5468018|NCT01967732|18900899|P1|First Intervention (Day 1)|Poor venous access|0
5468019|NCT01967732|18900896|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
5468020|NCT01967732|18900897|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
5468021|NCT01967732|18900898|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
5468022|NCT01967732|18900899|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
5468023|NCT01967719|18900913|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
5468024|NCT01967719|18900914|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
5468025|NCT01967719|18900915|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
5468026|NCT01967719|18900916|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
5468027|NCT01967719|18900913|P4|First Intervention (Day 1)|Withdrawal by Subject|1
5468028|NCT01967719|18900914|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5468029|NCT01967719|18900915|P2|First Intervention (Day 1)|Withdrawal by Subject|1
5468030|NCT01967719|18900916|P1|First Intervention (Day 1)|Withdrawal by Subject|0
5468031|NCT01967706|18900931|P4|First Intervention (Day 1)|Withdrawal by Subject|0
5468032|NCT01967706|18900932|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5468033|NCT01967706|18900933|P2|First Intervention (Day 1)|Withdrawal by Subject|0
5468034|NCT01967706|18900934|P1|First Intervention (Day 1)|Withdrawal by Subject|1
5468035|NCT01967628|18900955|P2|Overall Study|Low protein concentration in sample|25
5468036|NCT01967628|18900956|P1|Overall Study|Low protein concentration in sample|20
5468037|NCT01967628|18900955|P2|Overall Study|Lost to Follow-up|0
5468038|NCT01967628|18900956|P1|Overall Study|Lost to Follow-up|1
5468039|NCT01967628|18900955|P2|Overall Study|Unable to complete bronchoscopy|6
5468040|NCT01967628|18900956|P1|Overall Study|Unable to complete bronchoscopy|4
5468041|NCT01967628|18900955|P2|Overall Study|Withdrawal by Subject|0
5468042|NCT01967628|18900956|P1|Overall Study|Withdrawal by Subject|2
5468043|NCT01967576|18900962|P1|Overall Study|Refused further treatment|1
5468044|NCT01967576|18900962|P1|Overall Study|Adverse Event|1
5468045|NCT01967576|18900962|P1|Overall Study|Study closing at site|1
5468046|NCT01967576|18900962|P1|Overall Study|Progressed/Removed from treatment|1
5468047|NCT01967576|18900962|P1|Overall Study|Withdrawal by Subject|3
5468048|NCT01967550|18900973|P2|Overall Study|Non Compliance|1
5468049|NCT01967550|18900974|P1|Overall Study|Non Compliance|0
5468050|NCT01967550|18900973|P2|Overall Study|Protocol Violation|1
5468051|NCT01967550|18900974|P1|Overall Study|Protocol Violation|2
5468052|NCT01967550|18900973|P2|Overall Study|Adverse Event|0
5468053|NCT01967550|18900974|P1|Overall Study|Adverse Event|2
5468054|NCT01967550|18900973|P2|Overall Study|Withdrawal by Subject|0
5468055|NCT01967550|18900974|P1|Overall Study|Withdrawal by Subject|1
5468056|NCT01967537|18900980|P1|Overall Study|Lost to Follow-up|6
5468057|NCT01967537|18900980|P1|Overall Study|Refuse treatment|2
5468058|NCT01967537|18900980|P1|Overall Study|Withdrawal by Subject|52
5468059|NCT01967277|18901034|P2|Overall Study|Unrelated illness|1
5468060|NCT01967277|18901035|P1|Overall Study|Unrelated illness|0
5468061|NCT01967277|18901034|P2|Overall Study|Lost to Follow-up|2
5468062|NCT01967277|18901035|P1|Overall Study|Lost to Follow-up|1
5468063|NCT01967225|18901047|P2|Overall Study|Protocol Violation|0
5468064|NCT01967225|18901048|P1|Overall Study|Protocol Violation|2
5468065|NCT01967225|18901047|P2|Overall Study|Logistical difficulties|0
5468066|NCT01967225|18901048|P1|Overall Study|Logistical difficulties|1
5468067|NCT01967225|18901047|P2|Overall Study|Protocol driven decision point|0
5468068|NCT01967225|18901048|P1|Overall Study|Protocol driven decision point|1
5468069|NCT01967225|18901047|P2|Overall Study|Switching to other therapy|0
5468070|NCT01967225|18901048|P1|Overall Study|Switching to other therapy|2
5468071|NCT01967225|18901047|P2|Overall Study|Lack of Efficacy|1
5468072|NCT01967225|18901048|P1|Overall Study|Lack of Efficacy|1
5468073|NCT01967225|18901047|P2|Overall Study|Withdrawal by Subject|1
5468074|NCT01967225|18901048|P1|Overall Study|Withdrawal by Subject|2
5468075|NCT01967225|18901047|P2|Overall Study|Adverse Event|1
5468076|NCT01967225|18901048|P1|Overall Study|Adverse Event|3
5468077|NCT01967173|18901080|P8|Overall Study|Withdrawal by Subject|12
5468078|NCT01967173|18901081|P7|Overall Study|Withdrawal by Subject|10
5468079|NCT01967173|18901082|P6|Overall Study|Withdrawal by Subject|9
5468080|NCT01967173|18901083|P5|Overall Study|Withdrawal by Subject|8
5468081|NCT01967173|18901084|P4|Overall Study|Withdrawal by Subject|7
5468082|NCT01967173|18901085|P3|Overall Study|Withdrawal by Subject|10
5468083|NCT01967173|18901086|P2|Overall Study|Withdrawal by Subject|14
5468084|NCT01967173|18901087|P1|Overall Study|Withdrawal by Subject|15
5468085|NCT01967173|18901080|P8|Overall Study|Adverse Event|1
5468086|NCT01967173|18901081|P7|Overall Study|Adverse Event|0
5468087|NCT01967173|18901082|P6|Overall Study|Adverse Event|0
5468088|NCT01967173|18901083|P5|Overall Study|Adverse Event|0
5468089|NCT01967173|18901084|P4|Overall Study|Adverse Event|0
5468090|NCT01967173|18901085|P3|Overall Study|Adverse Event|0
5468091|NCT01967173|18901086|P2|Overall Study|Adverse Event|0
5468092|NCT01967173|18901087|P1|Overall Study|Adverse Event|0
5468093|NCT01967173|18901080|P8|Overall Study|Pregnancy|1
5468094|NCT01967173|18901081|P7|Overall Study|Pregnancy|1
5468095|NCT01967173|18901082|P6|Overall Study|Pregnancy|0
5468096|NCT01967173|18901083|P5|Overall Study|Pregnancy|0
5468097|NCT01967173|18901084|P4|Overall Study|Pregnancy|0
5468098|NCT01967173|18901085|P3|Overall Study|Pregnancy|0
5468099|NCT01967173|18901086|P2|Overall Study|Pregnancy|0
5468100|NCT01967173|18901087|P1|Overall Study|Pregnancy|0
5468101|NCT01967173|18901080|P8|Overall Study|Lack of Efficacy|2
5468102|NCT01967173|18901081|P7|Overall Study|Lack of Efficacy|0
5468103|NCT01967173|18901082|P6|Overall Study|Lack of Efficacy|1
5468104|NCT01967173|18901083|P5|Overall Study|Lack of Efficacy|0
5468105|NCT01967173|18901084|P4|Overall Study|Lack of Efficacy|2
5468106|NCT01967173|18901085|P3|Overall Study|Lack of Efficacy|2
5468107|NCT01967173|18901086|P2|Overall Study|Lack of Efficacy|0
5468108|NCT01967173|18901087|P1|Overall Study|Lack of Efficacy|2
5468109|NCT01967173|18901080|P8|Overall Study|Physician Decision|0
5468110|NCT01967173|18901081|P7|Overall Study|Physician Decision|1
5468111|NCT01967173|18901082|P6|Overall Study|Physician Decision|1
5468112|NCT01967173|18901083|P5|Overall Study|Physician Decision|1
5468113|NCT01967173|18901084|P4|Overall Study|Physician Decision|1
5468114|NCT01967173|18901085|P3|Overall Study|Physician Decision|2
5468115|NCT01967173|18901086|P2|Overall Study|Physician Decision|0
5468116|NCT01967173|18901087|P1|Overall Study|Physician Decision|2
5468117|NCT01967173|18901080|P8|Overall Study|Lost to Follow-up|8
5468118|NCT01967173|18901081|P7|Overall Study|Lost to Follow-up|6
5468119|NCT01967173|18901082|P6|Overall Study|Lost to Follow-up|12
5468120|NCT01967173|18901083|P5|Overall Study|Lost to Follow-up|8
5468121|NCT01967173|18901084|P4|Overall Study|Lost to Follow-up|4
5468122|NCT01967173|18901085|P3|Overall Study|Lost to Follow-up|2
5468123|NCT01967173|18901086|P2|Overall Study|Lost to Follow-up|3
5468124|NCT01967173|18901087|P1|Overall Study|Lost to Follow-up|5
5468125|NCT01967147|18901101|P2|Overall Study|Other|5
5468126|NCT01967147|18901102|P1|Overall Study|Other|4
5468127|NCT01967147|18901101|P2|Overall Study|Non-compliance with Study Drug|3
5468128|NCT01967147|18901102|P1|Overall Study|Non-compliance with Study Drug|0
5468129|NCT01967147|18901101|P2|Overall Study|Withdrawal by Subject|4
5468130|NCT01967147|18901102|P1|Overall Study|Withdrawal by Subject|2
5468131|NCT01967147|18901101|P2|Overall Study|Lost to Follow-up|2
5468132|NCT01967147|18901102|P1|Overall Study|Lost to Follow-up|1
5468133|NCT01967147|18901101|P2|Overall Study|Lack of Efficacy|4
5468134|NCT01967147|18901102|P1|Overall Study|Lack of Efficacy|1
5468135|NCT01967147|18901101|P2|Overall Study|Adverse Event|2
5468136|NCT01967147|18901102|P1|Overall Study|Adverse Event|5
5468137|NCT01967134|18901120|P3|Overall Study|Lost to Follow-up|0
5468138|NCT01967134|18901121|P2|Overall Study|Lost to Follow-up|1
5468139|NCT01967134|18901122|P1|Overall Study|Lost to Follow-up|0
5468140|NCT01967069|18901157|P2|Overall Study|Lack of Efficacy|1
5468141|NCT01967069|18901158|P1|Overall Study|Lack of Efficacy|0
5468142|NCT01967069|18901157|P2|Overall Study|Withdrawal by Subject|3
5468143|NCT01967069|18901158|P1|Overall Study|Withdrawal by Subject|1
5468144|NCT01967069|18901157|P2|Overall Study|Lost to Follow-up|2
5468145|NCT01967069|18901158|P1|Overall Study|Lost to Follow-up|5
5468146|NCT01967069|18901157|P2|Overall Study|Adverse Event|2
5468147|NCT01967069|18901158|P1|Overall Study|Adverse Event|2
5468148|NCT01966731|18901356|P1|Overall Study|Found to be ineligible|1
5468149|NCT01966731|18901356|P1|Overall Study|Screening Failure|29
5468150|NCT01966731|18901356|P1|Overall Study|Follow up is not complete|600
5468151|NCT01966731|18901356|P1|Overall Study|Physician Decision|2
5468152|NCT01966731|18901356|P1|Overall Study|Lost to Follow-up|1
5468153|NCT01966731|18901356|P1|Overall Study|Death|2
5468154|NCT01966445|18901386|P7|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
5468155|NCT01966445|18901387|P6|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5468156|NCT01966445|18901388|P5|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5468157|NCT01966445|18901389|P4|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5468158|NCT01966445|18901390|P3|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5468159|NCT01966445|18901391|P2|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5468160|NCT01966445|18901392|P1|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
5468161|NCT01966445|18901386|P7|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
5468162|NCT01966445|18901387|P6|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5468163|NCT01966445|18901388|P5|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5468164|NCT01966445|18901389|P4|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5468165|NCT01966445|18901390|P3|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5468166|NCT01966445|18901391|P2|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5468167|NCT01966445|18901392|P1|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
5468168|NCT01966445|18901386|P7|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5468169|NCT01966445|18901387|P6|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5468170|NCT01966445|18901388|P5|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
5468171|NCT01966445|18901389|P4|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5468172|NCT01966445|18901390|P3|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
5468173|NCT01966445|18901391|P2|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
5468174|NCT01966445|18901392|P1|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
5468175|NCT01966445|18901386|P7|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5468176|NCT01966445|18901387|P6|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5468177|NCT01966445|18901388|P5|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
5468178|NCT01966445|18901389|P4|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
5468179|NCT01966445|18901390|P3|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5468180|NCT01966445|18901391|P2|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
5468181|NCT01966445|18901392|P1|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
5468182|NCT01966445|18901386|P7|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5468183|NCT01966445|18901387|P6|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
5468184|NCT01966445|18901388|P5|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5468185|NCT01966445|18901389|P4|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
5468186|NCT01966445|18901390|P3|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5468187|NCT01966445|18901391|P2|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5468188|NCT01966445|18901392|P1|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
5468189|NCT01966432|18901502|P3|Overall Study|SBIRT program ended|20
5468190|NCT01966432|18901503|P2|Overall Study|SBIRT program ended|8
5468191|NCT01966432|18901504|P1|Overall Study|SBIRT program ended|1
5468192|NCT01966432|18901502|P3|Overall Study|Subject Incarcerated|1
5468193|NCT01966432|18901503|P2|Overall Study|Subject Incarcerated|0
5468194|NCT01966432|18901504|P1|Overall Study|Subject Incarcerated|0
5468195|NCT01966432|18901502|P3|Overall Study|Withdrawal by Subject|0
5468196|NCT01966432|18901503|P2|Overall Study|Withdrawal by Subject|3
5468197|NCT01966432|18901504|P1|Overall Study|Withdrawal by Subject|1
5468198|NCT01966432|18901502|P3|Overall Study|Lost to Follow-up|5
5468199|NCT01966432|18901503|P2|Overall Study|Lost to Follow-up|2
5468200|NCT01966432|18901504|P1|Overall Study|Lost to Follow-up|3
5468201|NCT01966120|18901574|P2|Overall Study|Lost to Follow-up|1
5468202|NCT01966120|18901575|P1|Overall Study|Lost to Follow-up|1
5468203|NCT01966120|18901574|P2|Overall Study|Withdrawal by Subject|5
5468204|NCT01966120|18901575|P1|Overall Study|Withdrawal by Subject|0
5468205|NCT01966107|18901599|P2|Overall Study|withdrew from the study|303
5468206|NCT01966107|18901600|P1|Overall Study|withdrew from the study|272
5468207|NCT01966107|18901599|P2|Overall Study|due to study closure|186
5468208|NCT01966107|18901600|P1|Overall Study|due to study closure|164
5468209|NCT01966107|18901599|P2|Overall Study|discontinued treatment|372
5468210|NCT01966107|18901600|P1|Overall Study|discontinued treatment|345
5468211|NCT01966107|18901599|P2|Overall Study|excluded from FAS|20
5468212|NCT01966107|18901600|P1|Overall Study|excluded from FAS|21
5468213|NCT01966068|18901614|P1|Overall Study|Lost to Follow-up|81
5468214|NCT01966068|18901614|P1|Overall Study|Withdrawal by Subject|57
5468215|NCT01966042|18901619|P1|Overall Study|Death|2
5468216|NCT01966003|18901628|P2|Overall Study|Other|1
5468217|NCT01966003|18901629|P1|Overall Study|Other|1
5468218|NCT01966003|18901628|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
5468219|NCT01966003|18901629|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
5468220|NCT01966003|18901628|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
5468221|NCT01966003|18901629|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
5468222|NCT01966003|18901628|P2|Overall Study|Withdrawal by Subject|19
5468223|NCT01966003|18901629|P1|Overall Study|Withdrawal by Subject|29
5468224|NCT01966003|18901628|P2|Overall Study|Physician Decision|13
5468225|NCT01966003|18901629|P1|Overall Study|Physician Decision|12
5468226|NCT01966003|18901628|P2|Overall Study|Lost to Follow-up|3
5468227|NCT01966003|18901629|P1|Overall Study|Lost to Follow-up|4
5468228|NCT01966003|18901628|P2|Overall Study|Protocol Violation|4
5468229|NCT01966003|18901629|P1|Overall Study|Protocol Violation|6
5468230|NCT01966003|18901628|P2|Overall Study|Death|36
5468231|NCT01966003|18901629|P1|Overall Study|Death|43
5468232|NCT01965938|18901647|P2|Overall Study|Withdrawal by Subject|0
5468233|NCT01965938|18901648|P1|Overall Study|Withdrawal by Subject|1
5468234|NCT01965834|18901679|P1|Overall Study|Lack of Efficacy|4
5468235|NCT01965652|18901720|P2|Overall Study|Pregnancy|1
5468236|NCT01965652|18901721|P1|Overall Study|Pregnancy|0
5468237|NCT01965652|18901720|P2|Overall Study|Other - Miscellaneous|21
5468238|NCT01965652|18901721|P1|Overall Study|Other - Miscellaneous|18
5468239|NCT01965652|18901720|P2|Overall Study|Death|4
5468240|NCT01965652|18901721|P1|Overall Study|Death|3
5468241|NCT01965652|18901720|P2|Overall Study|Protocol Violation|38
5468242|NCT01965652|18901721|P1|Overall Study|Protocol Violation|34
5468243|NCT01965652|18901720|P2|Overall Study|Lost to Follow-up|40
5468244|NCT01965652|18901721|P1|Overall Study|Lost to Follow-up|53
5468245|NCT01965652|18901720|P2|Overall Study|Withdrawal by Subject|69
5468246|NCT01965652|18901721|P1|Overall Study|Withdrawal by Subject|62
5468247|NCT01965652|18901720|P2|Overall Study|Adverse Event|37
5468248|NCT01965652|18901721|P1|Overall Study|Adverse Event|40
5468249|NCT01965600|18901751|P4|Second Intervention|Study terminated by Sponsor|2
5468250|NCT01965600|18901752|P3|Second Intervention|Study terminated by Sponsor|2
5468251|NCT01965600|18901753|P2|Second Intervention|Study terminated by Sponsor|0
5468252|NCT01965600|18901754|P1|Second Intervention|Study terminated by Sponsor|0
5468253|NCT01965600|18901751|P4|Washout Period of Approximately 15 Days|Adverse Event|1
5468254|NCT01965600|18901752|P3|Washout Period of Approximately 15 Days|Adverse Event|0
5468255|NCT01965600|18901753|P2|Washout Period of Approximately 15 Days|Adverse Event|0
5468256|NCT01965600|18901754|P1|Washout Period of Approximately 15 Days|Adverse Event|0
5468257|NCT01965600|18901751|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
5468258|NCT01965600|18901752|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
5468259|NCT01965600|18901753|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
5468260|NCT01965600|18901754|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
5468261|NCT01965600|18901751|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
5468262|NCT01965600|18901752|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
5468263|NCT01965600|18901753|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
5468264|NCT01965600|18901754|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
5468265|NCT01965600|18901751|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
5468266|NCT01965600|18901752|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
5468267|NCT01965600|18901753|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
5468268|NCT01965600|18901754|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
5468269|NCT01965535|18901811|P2|Overall Study|Lack of Efficacy|1
5468270|NCT01965535|18901812|P1|Overall Study|Lack of Efficacy|2
5468271|NCT01965431|18901826|P6|Overall Study|Other than stated above|6
5468272|NCT01965431|18901827|P5|Overall Study|Other than stated above|6
5468273|NCT01965431|18901828|P4|Overall Study|Other than stated above|6
5468274|NCT01965431|18901829|P3|Overall Study|Other than stated above|6
5468275|NCT01965431|18901830|P2|Overall Study|Other than stated above|5
5468276|NCT01965431|18901831|P1|Overall Study|Other than stated above|6
5468277|NCT01965431|18901826|P6|Overall Study|Adverse Event|0
5468278|NCT01965431|18901827|P5|Overall Study|Adverse Event|0
5468279|NCT01965431|18901828|P4|Overall Study|Adverse Event|0
5468280|NCT01965431|18901829|P3|Overall Study|Adverse Event|0
5468281|NCT01965431|18901830|P2|Overall Study|Adverse Event|1
5468282|NCT01965431|18901831|P1|Overall Study|Adverse Event|0
5468283|NCT01965327|18901855|P1|Overall Study|Physician Decision|2
5468284|NCT01965262|18902069|P2|Second Intervention (7 Days)|Poor visual acuity|0
5468285|NCT01965262|18902070|P1|Second Intervention (7 Days)|Poor visual acuity|1
5468286|NCT01965262|18902069|P2|Second Intervention (7 Days)|Poor lens fit|9
5468287|NCT01965262|18902070|P1|Second Intervention (7 Days)|Poor lens fit|0
5468288|NCT01965262|18902069|P2|Second Intervention (7 Days)|Discontinued|1
5468289|NCT01965262|18902070|P1|Second Intervention (7 Days)|Discontinued|0
5468290|NCT01965158|18902134|P2|Overall Study|Other - Miscellaneous|0
5468291|NCT01965158|18902135|P1|Overall Study|Other - Miscellaneous|3
5468292|NCT01965158|18902134|P2|Overall Study|Protocol Violation|1
5468293|NCT01965158|18902135|P1|Overall Study|Protocol Violation|1
5468294|NCT01965158|18902134|P2|Overall Study|Lost to Follow-up|5
5468295|NCT01965158|18902135|P1|Overall Study|Lost to Follow-up|7
5468296|NCT01965158|18902134|P2|Overall Study|Withdrawal by Subject|24
5468297|NCT01965158|18902135|P1|Overall Study|Withdrawal by Subject|16
5468298|NCT01965158|18902134|P2|Overall Study|Adverse Event|5
5468299|NCT01965158|18902135|P1|Overall Study|Adverse Event|14
5468300|NCT01964976|18902176|P1|Overall Study|Protocol Violation|31
5468301|NCT01964963|18902188|P1|Overall Study|Data Reliability was not Assured|5
5468302|NCT01964963|18902188|P1|Overall Study|Protocol Deviation|50
5468303|NCT01964963|18902188|P1|Overall Study|Case Report Forms Uncollected|888
5468304|NCT01964950|18902196|P1|Overall Study|Protocol Violation|25
5468305|NCT01964924|18902208|P2|Trametinib Monotherapy|Progression|0
5468306|NCT01964924|18902209|P1|Trametinib Monotherapy|Progression|19
5468307|NCT01964898|18902233|P2|Overall Study|Withdrawal by Subject|0
5468308|NCT01964898|18902234|P1|Overall Study|Withdrawal by Subject|1
5468309|NCT01964898|18902233|P2|Overall Study|Lost to Follow-up|5
5468310|NCT01964898|18902234|P1|Overall Study|Lost to Follow-up|3
5468311|NCT01964898|18902233|P2|Overall Study|did not receive the allocated interventi|1
5468312|NCT01964898|18902234|P1|Overall Study|did not receive the allocated interventi|2
5468313|NCT01964898|18902233|P2|Overall Study|ineligible post-randomization|1
5468314|NCT01964898|18902234|P1|Overall Study|ineligible post-randomization|1
5468315|NCT01964755|18902254|P1|Overall Study|Death|2
5468316|NCT01964716|18902269|P2|Overall Study|Death|0
5468317|NCT01964716|18902270|P1|Overall Study|Death|1
5468318|NCT01964716|18902269|P2|Overall Study|No longer met eligibility criteria|1
5468319|NCT01964716|18902270|P1|Overall Study|No longer met eligibility criteria|1
5468320|NCT01964716|18902269|P2|Overall Study|Lost to Follow-up|2
5468321|NCT01964716|18902270|P1|Overall Study|Lost to Follow-up|1
5468322|NCT01964716|18902269|P2|Overall Study|Withdrawal by Subject|3
5468323|NCT01964716|18902270|P1|Overall Study|Withdrawal by Subject|2
5468324|NCT01964547|18902308|P2|Overall Study|Withdrawal by Investigator|1
5468325|NCT01964547|18902309|P1|Overall Study|Withdrawal by Investigator|0
5468326|NCT01964547|18902308|P2|Overall Study|Lost to Follow-up|1
5468327|NCT01964547|18902309|P1|Overall Study|Lost to Follow-up|0
5468328|NCT01964547|18902308|P2|Overall Study|Withdrawal by Subject|7
5468329|NCT01964547|18902309|P1|Overall Study|Withdrawal by Subject|4
5468330|NCT01964547|18902308|P2|Overall Study|Adverse Event|2
5468331|NCT01964547|18902309|P1|Overall Study|Adverse Event|8
5468332|NCT01964521|18902333|P1|Overall Study|Lost to Follow-up|4
5468333|NCT01964430|18902340|P2|Overall Study|Randomized but not Treated|11
5468334|NCT01964430|18902341|P1|Overall Study|Randomized but not Treated|3
5468335|NCT01964430|18902340|P2|Overall Study|Miscellaneous|3
5468336|NCT01964430|18902341|P1|Overall Study|Miscellaneous|1
5468337|NCT01964430|18902340|P2|Overall Study|Disease Relapse|38
5468338|NCT01964430|18902341|P1|Overall Study|Disease Relapse|28
5468339|NCT01964430|18902340|P2|Overall Study|Physician Decision|4
5468340|NCT01964430|18902341|P1|Overall Study|Physician Decision|5
5468341|NCT01964430|18902340|P2|Overall Study|Protocol Deviation|1
5468342|NCT01964430|18902341|P1|Overall Study|Protocol Deviation|0
5468343|NCT01964430|18902340|P2|Overall Study|Death|3
5468344|NCT01964430|18902341|P1|Overall Study|Death|1
5468345|NCT01964430|18902340|P2|Overall Study|Withdrawal by Subject|27
5468346|NCT01964430|18902341|P1|Overall Study|Withdrawal by Subject|36
5468347|NCT01964430|18902340|P2|Overall Study|Adverse Event|37
5468348|NCT01964430|18902341|P1|Overall Study|Adverse Event|71
5468349|NCT01964378|18902353|P2|Overall Study|Other|2
5468350|NCT01964378|18902354|P1|Overall Study|Other|1
5468351|NCT01964378|18902353|P2|Overall Study|Inclusion/exclusion criteria not met|3
5468352|NCT01964378|18902354|P1|Overall Study|Inclusion/exclusion criteria not met|1
5468353|NCT01964378|18902353|P2|Overall Study|Withdrawal by Subject|5
5468354|NCT01964378|18902354|P1|Overall Study|Withdrawal by Subject|7
5468355|NCT01964378|18902353|P2|Overall Study|Lost to Follow-up|1
5468356|NCT01964378|18902354|P1|Overall Study|Lost to Follow-up|0
5468357|NCT01964378|18902353|P2|Overall Study|Protocol Violation|1
5468358|NCT01964378|18902354|P1|Overall Study|Protocol Violation|0
5468359|NCT01964378|18902353|P2|Overall Study|Lack of Efficacy|1
5468360|NCT01964378|18902354|P1|Overall Study|Lack of Efficacy|0
5468361|NCT01964378|18902353|P2|Overall Study|Adverse Event|5
5468362|NCT01964378|18902354|P1|Overall Study|Adverse Event|12
5468363|NCT01964378|18902353|P2|Overall Study|Death|2
5468364|NCT01964378|18902354|P1|Overall Study|Death|3
5468365|NCT01964378|18902353|P2|Overall Study|Disc. due to AE before first dosing|0
5468366|NCT01964378|18902354|P1|Overall Study|Disc. due to AE before first dosing|1
5468367|NCT01964378|18902353|P2|Overall Study|Disc. due to death before first dosing|1
5468368|NCT01964378|18902354|P1|Overall Study|Disc. due to death before first dosing|0
5468369|NCT01964352|18902390|P4|Overall Study|Other than stated above|2
5468370|NCT01964352|18902391|P3|Overall Study|Other than stated above|1
5468371|NCT01964352|18902392|P2|Overall Study|Other than stated above|2
5468372|NCT01964352|18902393|P1|Overall Study|Other than stated above|0
5468373|NCT01964352|18902390|P4|Overall Study|Withdrawal by Subject|0
5468374|NCT01964352|18902391|P3|Overall Study|Withdrawal by Subject|1
5468375|NCT01964352|18902392|P2|Overall Study|Withdrawal by Subject|2
5468376|NCT01964352|18902393|P1|Overall Study|Withdrawal by Subject|4
5468377|NCT01964352|18902390|P4|Overall Study|Lost to Follow-up|1
5468378|NCT01964352|18902391|P3|Overall Study|Lost to Follow-up|0
5468379|NCT01964352|18902392|P2|Overall Study|Lost to Follow-up|0
5468380|NCT01964352|18902393|P1|Overall Study|Lost to Follow-up|1
5468381|NCT01964352|18902390|P4|Overall Study|Protocol Violation|2
5468382|NCT01964352|18902391|P3|Overall Study|Protocol Violation|0
5468383|NCT01964352|18902392|P2|Overall Study|Protocol Violation|4
5468384|NCT01964352|18902393|P1|Overall Study|Protocol Violation|2
5468385|NCT01964352|18902390|P4|Overall Study|Lack of Efficacy|0
5468386|NCT01964352|18902391|P3|Overall Study|Lack of Efficacy|0
5468387|NCT01964352|18902392|P2|Overall Study|Lack of Efficacy|0
5468388|NCT01964352|18902393|P1|Overall Study|Lack of Efficacy|6
5468389|NCT01964352|18902390|P4|Overall Study|Adverse Event|3
5468390|NCT01964352|18902391|P3|Overall Study|Adverse Event|4
5468391|NCT01964352|18902392|P2|Overall Study|Adverse Event|3
5468392|NCT01964352|18902393|P1|Overall Study|Adverse Event|13
5468393|NCT01964326|18902423|P1|Overall Study|Did not meet eligibility criteria|1
5468394|NCT01964326|18902423|P1|Overall Study|Other|9
5468395|NCT01964326|18902423|P1|Overall Study|Investigator Discretion|1
5468396|NCT01964326|18902423|P1|Overall Study|Physician Decision|55
5468397|NCT01964326|18902423|P1|Overall Study|No Longer Meets Eligibility Criteria|1
5468398|NCT01964326|18902423|P1|Overall Study|Pregnancy|1
5468399|NCT01964326|18902423|P1|Overall Study|Withdrawal by Subject|87
5468400|NCT01964326|18902423|P1|Overall Study|Lost to Follow-up|88
5468401|NCT01964326|18902423|P1|Overall Study|Protocol Violation|4
5468402|NCT01964326|18902423|P1|Overall Study|Death|2
5468403|NCT01964326|18902423|P1|Overall Study|Adverse Event|48
5468404|NCT01964300|18902432|P2|Overall Study|Weight criteria not met|1
5468405|NCT01964300|18902433|P1|Overall Study|Weight criteria not met|0
5468406|NCT01964300|18902432|P2|Overall Study|Enlargement of cyst requiring drainage|0
5468407|NCT01964300|18902433|P1|Overall Study|Enlargement of cyst requiring drainage|1
5468408|NCT01964300|18902432|P2|Overall Study|To receive alternative therapy|2
5468409|NCT01964300|18902433|P1|Overall Study|To receive alternative therapy|1
5468410|NCT01964300|18902432|P2|Overall Study|Withdrawal by Subject|1
5468411|NCT01964300|18902433|P1|Overall Study|Withdrawal by Subject|0
5468412|NCT01964300|18902432|P2|Overall Study|Lack of Efficacy|5
5468413|NCT01964300|18902433|P1|Overall Study|Lack of Efficacy|3
5468414|NCT01964300|18902432|P2|Overall Study|Adverse Event|1
5468415|NCT01964300|18902433|P1|Overall Study|Adverse Event|1
5468416|NCT01964300|18902432|P2|Overall Study|Ineligible after enrollment|1
5468417|NCT01964300|18902433|P1|Overall Study|Ineligible after enrollment|0
5468418|NCT01964222|18902447|P2|Overall Study|Screening Failure|0
5468419|NCT01964222|18902448|P1|Overall Study|Screening Failure|2
5468420|NCT01964222|18902447|P2|Overall Study|Withdrawal by Subject|6
5468421|NCT01964222|18902448|P1|Overall Study|Withdrawal by Subject|6
5468422|NCT01964222|18902447|P2|Overall Study|Lost to Follow-up|5
5468423|NCT01964222|18902448|P1|Overall Study|Lost to Follow-up|7
5468424|NCT01964105|18902465|P3|Overall Study|Lost to Follow-up|0
5468425|NCT01964105|18902466|P2|Overall Study|Lost to Follow-up|13
5468426|NCT01964105|18902467|P1|Overall Study|Lost to Follow-up|2
5468427|NCT01963767|18902526|P2|Overall Study|Adverse Event|0
5468428|NCT01963767|18902527|P1|Overall Study|Adverse Event|2
5468429|NCT01963767|18902526|P2|Overall Study|Withdrawal by Subject|2
5468430|NCT01963767|18902527|P1|Overall Study|Withdrawal by Subject|4
5468431|NCT01963676|18902537|P2|Overall Study|Withdrawal by Subject|0
5468432|NCT01963676|18902538|P1|Overall Study|Withdrawal by Subject|1
5468433|NCT01963611|18902551|P5|Overall Study|Other|45
5468434|NCT01963611|18902552|P4|Overall Study|Other|45
5468435|NCT01963611|18902553|P3|Overall Study|Other|48
5468436|NCT01963611|18902554|P2|Overall Study|Other|46
5468437|NCT01963611|18902555|P1|Overall Study|Other|47
5468438|NCT01963611|18902551|P5|Overall Study|Withdrawal by Subject|3
5468439|NCT01963611|18902552|P4|Overall Study|Withdrawal by Subject|1
5468440|NCT01963611|18902553|P3|Overall Study|Withdrawal by Subject|1
5468441|NCT01963611|18902554|P2|Overall Study|Withdrawal by Subject|2
5468442|NCT01963611|18902555|P1|Overall Study|Withdrawal by Subject|3
5468443|NCT01963611|18902551|P5|Overall Study|Lack of Efficacy|0
5468444|NCT01963611|18902552|P4|Overall Study|Lack of Efficacy|1
5468445|NCT01963611|18902553|P3|Overall Study|Lack of Efficacy|0
5468446|NCT01963611|18902554|P2|Overall Study|Lack of Efficacy|0
5468447|NCT01963611|18902555|P1|Overall Study|Lack of Efficacy|0
5468448|NCT01963611|18902551|P5|Overall Study|Protocol Violation|0
5468449|NCT01963611|18902552|P4|Overall Study|Protocol Violation|1
5468450|NCT01963611|18902553|P3|Overall Study|Protocol Violation|0
5468451|NCT01963611|18902554|P2|Overall Study|Protocol Violation|0
5468452|NCT01963611|18902555|P1|Overall Study|Protocol Violation|0
5468453|NCT01963611|18902551|P5|Overall Study|Adverse Event|3
5468454|NCT01963611|18902552|P4|Overall Study|Adverse Event|4
5468455|NCT01963611|18902553|P3|Overall Study|Adverse Event|3
5468456|NCT01963611|18902554|P2|Overall Study|Adverse Event|1
5468457|NCT01963611|18902555|P1|Overall Study|Adverse Event|1
5468458|NCT01963403|18902620|P2|Overall Study|Implant removal|1
5468459|NCT01963403|18902621|P1|Overall Study|Implant removal|0
5468460|NCT01963403|18902620|P2|Overall Study|Lost to Follow-up|3
5468461|NCT01963403|18902621|P1|Overall Study|Lost to Follow-up|2
5468462|NCT01963260|18902643|P10|Overall Study|Withdrawal by Subject|0
5468463|NCT01963260|18902644|P9|Overall Study|Withdrawal by Subject|0
5468464|NCT01963260|18902645|P8|Overall Study|Withdrawal by Subject|0
5468465|NCT01963260|18902646|P7|Overall Study|Withdrawal by Subject|0
5468466|NCT01963260|18902647|P6|Overall Study|Withdrawal by Subject|0
5468467|NCT01963260|18902648|P5|Overall Study|Withdrawal by Subject|2
5468468|NCT01963260|18902649|P4|Overall Study|Withdrawal by Subject|1
5468469|NCT01963260|18902650|P3|Overall Study|Withdrawal by Subject|0
5468470|NCT01963260|18902651|P2|Overall Study|Withdrawal by Subject|0
5468471|NCT01963260|18902652|P1|Overall Study|Withdrawal by Subject|2
5468472|NCT01963117|18902766|P1|Overall Study|Death|1
5468473|NCT01962987|18902808|P3|Overall Study|Randomized in Error|2
5468474|NCT01962987|18902809|P2|Overall Study|Randomized in Error|2
5468475|NCT01962987|18902810|P1|Overall Study|Randomized in Error|4
5468476|NCT01962987|18902808|P3|Overall Study|Withdrawal by Subject|6
5468477|NCT01962987|18902809|P2|Overall Study|Withdrawal by Subject|10
5468478|NCT01962987|18902810|P1|Overall Study|Withdrawal by Subject|11
5468479|NCT01962987|18902808|P3|Overall Study|Serious Adverse Event|0
5468480|NCT01962987|18902809|P2|Overall Study|Serious Adverse Event|0
5468481|NCT01962987|18902810|P1|Overall Study|Serious Adverse Event|1
5468482|NCT01962987|18902808|P3|Overall Study|Restricted medication|1
5468483|NCT01962987|18902809|P2|Overall Study|Restricted medication|1
5468484|NCT01962987|18902810|P1|Overall Study|Restricted medication|5
5468485|NCT01962987|18902808|P3|Overall Study|Miscellaneous|2
5468486|NCT01962987|18902809|P2|Overall Study|Miscellaneous|9
5468487|NCT01962987|18902810|P1|Overall Study|Miscellaneous|1
5468488|NCT01962987|18902808|P3|Overall Study|Non compliance with dosing requirements|0
5468489|NCT01962987|18902809|P2|Overall Study|Non compliance with dosing requirements|2
5468490|NCT01962987|18902810|P1|Overall Study|Non compliance with dosing requirements|4
5468491|NCT01962987|18902808|P3|Overall Study|Lost to Follow-up|1
5468492|NCT01962987|18902809|P2|Overall Study|Lost to Follow-up|0
5468493|NCT01962987|18902810|P1|Overall Study|Lost to Follow-up|0
5468494|NCT01962987|18902808|P3|Overall Study|Adverse Event|0
5468495|NCT01962987|18902809|P2|Overall Study|Adverse Event|4
5468496|NCT01962987|18902810|P1|Overall Study|Adverse Event|4
5468497|NCT01962974|18902818|P1|Overall Study|Study termination|7
5468498|NCT01962922|18902845|P2|Extendion Portion (up to Month 6)|Physician Decision|0
5468499|NCT01962922|18902846|P1|Extendion Portion (up to Month 6)|Physician Decision|1
5468500|NCT01962922|18902845|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
5468501|NCT01962922|18902846|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
5468502|NCT01962922|18902845|P2|PK Portion Day 7|non-compliance|0
5468503|NCT01962922|18902846|P1|PK Portion Day 7|non-compliance|1
5468504|NCT01962922|18902845|P2|PK Portion Day 7|Withdrawal by Subject|0
5468505|NCT01962922|18902846|P1|PK Portion Day 7|Withdrawal by Subject|3
5468506|NCT01962896|18902868|P1|Overall Study|Lack of Efficacy|4
5468507|NCT01962493|18902990|P2|Overall Study|Withdrawal by Subject|2
5468508|NCT01962493|18902991|P1|Overall Study|Withdrawal by Subject|4
5468509|NCT01962493|18902990|P2|Overall Study|Protocol Violation|1
5468510|NCT01962493|18902991|P1|Overall Study|Protocol Violation|0
5468511|NCT01962493|18902990|P2|Overall Study|Adverse Event|2
5468512|NCT01962493|18902991|P1|Overall Study|Adverse Event|1
5468513|NCT01962441|18903014|P3|Retreatment Substudy|Lost to Follow-up|0
5468514|NCT01962441|18903015|P2|Retreatment Substudy|Lost to Follow-up|0
5468515|NCT01962441|18903016|P1|Retreatment Substudy|Lost to Follow-up|1
5468516|NCT01962441|18903014|P3|Retreatment Substudy|Lack of Efficacy|0
5468517|NCT01962441|18903015|P2|Retreatment Substudy|Lack of Efficacy|0
5468518|NCT01962441|18903016|P1|Retreatment Substudy|Lack of Efficacy|1
5468519|NCT01962441|18903014|P3|Randomized Period|Protocol Violation|0
5468520|NCT01962441|18903015|P2|Randomized Period|Protocol Violation|1
5468521|NCT01962441|18903016|P1|Randomized Period|Protocol Violation|0
5468522|NCT01962441|18903014|P3|Randomized Period|Death|2
5468523|NCT01962441|18903015|P2|Randomized Period|Death|0
5468524|NCT01962441|18903016|P1|Randomized Period|Death|0
5468525|NCT01962441|18903014|P3|Randomized Period|Adverse Event|0
5468526|NCT01962441|18903015|P2|Randomized Period|Adverse Event|1
5468527|NCT01962441|18903016|P1|Randomized Period|Adverse Event|1
5468528|NCT01962441|18903014|P3|Randomized Period|Withdrew Consent|2
5468529|NCT01962441|18903015|P2|Randomized Period|Withdrew Consent|3
5468530|NCT01962441|18903016|P1|Randomized Period|Withdrew Consent|3
5468531|NCT01962441|18903014|P3|Randomized Period|Lost to Follow-up|4
5468532|NCT01962441|18903015|P2|Randomized Period|Lost to Follow-up|4
5468533|NCT01962441|18903016|P1|Randomized Period|Lost to Follow-up|2
5468534|NCT01962441|18903014|P3|Randomized Period|Randomized but Never Treated|3
5468535|NCT01962441|18903015|P2|Randomized Period|Randomized but Never Treated|2
5468536|NCT01962441|18903016|P1|Randomized Period|Randomized but Never Treated|4
5468537|NCT01962298|18903060|P5|Overall Study|Physician Decision|1
5468538|NCT01962298|18903061|P4|Overall Study|Physician Decision|0
5468539|NCT01962298|18903062|P3|Overall Study|Physician Decision|0
5468540|NCT01962298|18903063|P2|Overall Study|Physician Decision|1
5468541|NCT01962298|18903064|P1|Overall Study|Physician Decision|0
5468542|NCT01962298|18903060|P5|Overall Study|Incorrect data recorded|0
5468543|NCT01962298|18903061|P4|Overall Study|Incorrect data recorded|0
5468544|NCT01962298|18903062|P3|Overall Study|Incorrect data recorded|0
5468545|NCT01962298|18903063|P2|Overall Study|Incorrect data recorded|1
5468546|NCT01962298|18903064|P1|Overall Study|Incorrect data recorded|0
5468547|NCT01962298|18903060|P5|Overall Study|Insufficient data|1
5468548|NCT01962298|18903061|P4|Overall Study|Insufficient data|0
5468549|NCT01962298|18903062|P3|Overall Study|Insufficient data|1
5468550|NCT01962298|18903063|P2|Overall Study|Insufficient data|2
5468551|NCT01962298|18903064|P1|Overall Study|Insufficient data|0
5468552|NCT01962298|18903060|P5|Overall Study|Data quality insufficient|4
5468553|NCT01962298|18903061|P4|Overall Study|Data quality insufficient|1
5468554|NCT01962298|18903062|P3|Overall Study|Data quality insufficient|3
5468555|NCT01962298|18903063|P2|Overall Study|Data quality insufficient|0
5468556|NCT01962298|18903064|P1|Overall Study|Data quality insufficient|2
5468557|NCT01962298|18903060|P5|Overall Study|Protocol Violation|0
5468558|NCT01962298|18903061|P4|Overall Study|Protocol Violation|1
5468559|NCT01962298|18903062|P3|Overall Study|Protocol Violation|1
5468560|NCT01962298|18903063|P2|Overall Study|Protocol Violation|0
5468561|NCT01962298|18903064|P1|Overall Study|Protocol Violation|1
5468562|NCT01962207|18903085|P4|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
5468563|NCT01962207|18903086|P3|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
5468564|NCT01962207|18903087|P2|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
5468565|NCT01962207|18903088|P1|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
5468566|NCT01962207|18903085|P4|Persistence Phase (5 Years)|Adverse Event|0
5468567|NCT01962207|18903086|P3|Persistence Phase (5 Years)|Adverse Event|1
5468568|NCT01962207|18903087|P2|Persistence Phase (5 Years)|Adverse Event|0
5468569|NCT01962207|18903088|P1|Persistence Phase (5 Years)|Adverse Event|0
5468570|NCT01962207|18903085|P4|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
5468571|NCT01962207|18903086|P3|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
5468572|NCT01962207|18903087|P2|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
5468573|NCT01962207|18903088|P1|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
5468574|NCT01962207|18903085|P4|Persistence Phase (5 Years)|Withdrawal by Subject|4
5468575|NCT01962207|18903086|P3|Persistence Phase (5 Years)|Withdrawal by Subject|18
5468576|NCT01962207|18903087|P2|Persistence Phase (5 Years)|Withdrawal by Subject|5
5468577|NCT01962207|18903088|P1|Persistence Phase (5 Years)|Withdrawal by Subject|4
5468578|NCT01962207|18903085|P4|Persistence Phase (5 Years)|Migrated/moved from study area|0
5468579|NCT01962207|18903086|P3|Persistence Phase (5 Years)|Migrated/moved from study area|4
5468580|NCT01962207|18903087|P2|Persistence Phase (5 Years)|Migrated/moved from study area|0
5468581|NCT01962207|18903088|P1|Persistence Phase (5 Years)|Migrated/moved from study area|2
5468582|NCT01962207|18903085|P4|Persistence Phase (5 Years)|Lost to Follow-up|2
5468583|NCT01962207|18903086|P3|Persistence Phase (5 Years)|Lost to Follow-up|5
5468584|NCT01962207|18903087|P2|Persistence Phase (5 Years)|Lost to Follow-up|1
5468585|NCT01962207|18903088|P1|Persistence Phase (5 Years)|Lost to Follow-up|2
5468586|NCT01962103|18903199|P9|Phase 2|Symptomatic Deterioration|0
5468587|NCT01962103|18903200|P8|Phase 2|Symptomatic Deterioration|2
5468588|NCT01962103|18903201|P7|Phase 2|Symptomatic Deterioration|2
5468589|NCT01962103|18903202|P6|Phase 2|Symptomatic Deterioration|0
5468590|NCT01962103|18903203|P5|Phase 2|Symptomatic Deterioration|0
5468591|NCT01962103|18903204|P4|Phase 2|Symptomatic Deterioration|0
5468592|NCT01962103|18903205|P3|Phase 2|Symptomatic Deterioration|0
5468593|NCT01962103|18903206|P2|Phase 2|Symptomatic Deterioration|0
5468594|NCT01962103|18903207|P1|Phase 2|Symptomatic Deterioration|0
5468595|NCT01962103|18903199|P9|Phase 2|Progressive Disease|11
5468596|NCT01962103|18903200|P8|Phase 2|Progressive Disease|12
5468597|NCT01962103|18903201|P7|Phase 2|Progressive Disease|11
5468598|NCT01962103|18903202|P6|Phase 2|Progressive Disease|0
5468599|NCT01962103|18903203|P5|Phase 2|Progressive Disease|0
5468600|NCT01962103|18903204|P4|Phase 2|Progressive Disease|0
5468601|NCT01962103|18903205|P3|Phase 2|Progressive Disease|0
5468602|NCT01962103|18903206|P2|Phase 2|Progressive Disease|0
5468603|NCT01962103|18903207|P1|Phase 2|Progressive Disease|0
5468604|NCT01962103|18903199|P9|Phase 2|Adverse Event|3
5468605|NCT01962103|18903200|P8|Phase 2|Adverse Event|0
5468606|NCT01962103|18903201|P7|Phase 2|Adverse Event|1
5468607|NCT01962103|18903202|P6|Phase 2|Adverse Event|0
5468608|NCT01962103|18903203|P5|Phase 2|Adverse Event|0
5468609|NCT01962103|18903204|P4|Phase 2|Adverse Event|0
5468610|NCT01962103|18903205|P3|Phase 2|Adverse Event|0
5468611|NCT01962103|18903206|P2|Phase 2|Adverse Event|0
5468612|NCT01962103|18903207|P1|Phase 2|Adverse Event|0
5468613|NCT01962103|18903199|P9|Phase 1|Miscellaneous|0
5468614|NCT01962103|18903200|P8|Phase 1|Miscellaneous|0
5468615|NCT01962103|18903201|P7|Phase 1|Miscellaneous|0
5468616|NCT01962103|18903202|P6|Phase 1|Miscellaneous|0
5468617|NCT01962103|18903203|P5|Phase 1|Miscellaneous|0
5468618|NCT01962103|18903204|P4|Phase 1|Miscellaneous|0
5468619|NCT01962103|18903205|P3|Phase 1|Miscellaneous|0
5468620|NCT01962103|18903206|P2|Phase 1|Miscellaneous|0
5468621|NCT01962103|18903207|P1|Phase 1|Miscellaneous|1
5468622|NCT01962103|18903199|P9|Phase 1|Symptomatic Deterioration|0
5468623|NCT01962103|18903200|P8|Phase 1|Symptomatic Deterioration|0
5468624|NCT01962103|18903201|P7|Phase 1|Symptomatic Deterioration|0
5468625|NCT01962103|18903202|P6|Phase 1|Symptomatic Deterioration|1
5468626|NCT01962103|18903203|P5|Phase 1|Symptomatic Deterioration|1
5468627|NCT01962103|18903204|P4|Phase 1|Symptomatic Deterioration|2
5468628|NCT01962103|18903205|P3|Phase 1|Symptomatic Deterioration|2
5468629|NCT01962103|18903206|P2|Phase 1|Symptomatic Deterioration|2
5468630|NCT01962103|18903207|P1|Phase 1|Symptomatic Deterioration|3
5468631|NCT01962103|18903199|P9|Phase 1|Physician Decision|0
5468632|NCT01962103|18903200|P8|Phase 1|Physician Decision|0
5468633|NCT01962103|18903201|P7|Phase 1|Physician Decision|0
5468634|NCT01962103|18903202|P6|Phase 1|Physician Decision|0
5468635|NCT01962103|18903203|P5|Phase 1|Physician Decision|0
5468636|NCT01962103|18903204|P4|Phase 1|Physician Decision|1
5468637|NCT01962103|18903205|P3|Phase 1|Physician Decision|0
5468638|NCT01962103|18903206|P2|Phase 1|Physician Decision|0
5468639|NCT01962103|18903207|P1|Phase 1|Physician Decision|0
5468640|NCT01962103|18903199|P9|Phase 1|Withdrawal by Parent/Guardian|0
5468641|NCT01962103|18903200|P8|Phase 1|Withdrawal by Parent/Guardian|0
5468642|NCT01962103|18903201|P7|Phase 1|Withdrawal by Parent/Guardian|0
5468643|NCT01962103|18903202|P6|Phase 1|Withdrawal by Parent/Guardian|0
5468644|NCT01962103|18903203|P5|Phase 1|Withdrawal by Parent/Guardian|0
5468645|NCT01962103|18903204|P4|Phase 1|Withdrawal by Parent/Guardian|1
5468646|NCT01962103|18903205|P3|Phase 1|Withdrawal by Parent/Guardian|2
5468647|NCT01962103|18903206|P2|Phase 1|Withdrawal by Parent/Guardian|0
5468648|NCT01962103|18903207|P1|Phase 1|Withdrawal by Parent/Guardian|0
5468649|NCT01962103|18903199|P9|Phase 1|Withdrawal by Subject|0
5468650|NCT01962103|18903200|P8|Phase 1|Withdrawal by Subject|0
5468651|NCT01962103|18903201|P7|Phase 1|Withdrawal by Subject|0
5468652|NCT01962103|18903202|P6|Phase 1|Withdrawal by Subject|0
5468653|NCT01962103|18903203|P5|Phase 1|Withdrawal by Subject|0
5468654|NCT01962103|18903204|P4|Phase 1|Withdrawal by Subject|2
5468655|NCT01962103|18903205|P3|Phase 1|Withdrawal by Subject|0
5468656|NCT01962103|18903206|P2|Phase 1|Withdrawal by Subject|0
5468657|NCT01962103|18903207|P1|Phase 1|Withdrawal by Subject|0
5468658|NCT01962103|18903199|P9|Phase 1|Progressive Disease|0
5468659|NCT01962103|18903200|P8|Phase 1|Progressive Disease|0
5468660|NCT01962103|18903201|P7|Phase 1|Progressive Disease|0
5468661|NCT01962103|18903202|P6|Phase 1|Progressive Disease|4
5468662|NCT01962103|18903203|P5|Phase 1|Progressive Disease|5
5468663|NCT01962103|18903204|P4|Phase 1|Progressive Disease|4
5468664|NCT01962103|18903205|P3|Phase 1|Progressive Disease|8
5468665|NCT01962103|18903206|P2|Phase 1|Progressive Disease|6
5468666|NCT01962103|18903207|P1|Phase 1|Progressive Disease|8
5468667|NCT01962103|18903199|P9|Phase 1|Adverse Event|0
5468668|NCT01962103|18903200|P8|Phase 1|Adverse Event|0
5468669|NCT01962103|18903201|P7|Phase 1|Adverse Event|0
5468670|NCT01962103|18903202|P6|Phase 1|Adverse Event|2
5468671|NCT01962103|18903203|P5|Phase 1|Adverse Event|2
5468672|NCT01962103|18903204|P4|Phase 1|Adverse Event|1
5468673|NCT01962103|18903205|P3|Phase 1|Adverse Event|2
5468674|NCT01962103|18903206|P2|Phase 1|Adverse Event|0
5468675|NCT01962103|18903207|P1|Phase 1|Adverse Event|4
5468676|NCT01961609|18903336|P4|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
5468677|NCT01961609|18903337|P3|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
5468678|NCT01961609|18903338|P2|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
5468679|NCT01961609|18903339|P1|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
5468680|NCT01961609|18903336|P4|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
5468681|NCT01961609|18903337|P3|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
5468682|NCT01961609|18903338|P2|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
5468683|NCT01961609|18903339|P1|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
5468684|NCT01961609|18903336|P4|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
5468685|NCT01961609|18903337|P3|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
5468686|NCT01961609|18903338|P2|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
5468687|NCT01961609|18903339|P1|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
5468688|NCT01961609|18903336|P4|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
5468689|NCT01961609|18903337|P3|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
5468690|NCT01961609|18903338|P2|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
5468691|NCT01961609|18903339|P1|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
5468692|NCT01961609|18903336|P4|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
5468693|NCT01961609|18903337|P3|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
5468694|NCT01961609|18903338|P2|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
5468695|NCT01961609|18903339|P1|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
5468696|NCT01961609|18903336|P4|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
5468697|NCT01961609|18903337|P3|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
5468698|NCT01961609|18903338|P2|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
5468699|NCT01961609|18903339|P1|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
5468700|NCT01961609|18903336|P4|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
5468701|NCT01961609|18903337|P3|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
5468702|NCT01961609|18903338|P2|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
5468703|NCT01961609|18903339|P1|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
5468704|NCT01961609|18903336|P4|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
5468705|NCT01961609|18903337|P3|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
5468706|NCT01961609|18903338|P2|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
5468707|NCT01961609|18903339|P1|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
5468708|NCT01961609|18903336|P4|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
5468709|NCT01961609|18903337|P3|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
5468710|NCT01961609|18903338|P2|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
5468711|NCT01961609|18903339|P1|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
5468712|NCT01961609|18903336|P4|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
5468713|NCT01961609|18903337|P3|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
5468714|NCT01961609|18903338|P2|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
5468715|NCT01961609|18903339|P1|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
5468716|NCT01961609|18903336|P4|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
5468717|NCT01961609|18903337|P3|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
5468718|NCT01961609|18903338|P2|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
5468719|NCT01961609|18903339|P1|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
5468720|NCT01961609|18903336|P4|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
5468721|NCT01961609|18903337|P3|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
5468722|NCT01961609|18903338|P2|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
5468723|NCT01961609|18903339|P1|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
5468724|NCT01961609|18903336|P4|Initiation|Randomized but not treated|0
5468725|NCT01961609|18903337|P3|Initiation|Randomized but not treated|0
5468726|NCT01961609|18903338|P2|Initiation|Randomized but not treated|1
5468727|NCT01961609|18903339|P1|Initiation|Randomized but not treated|1
5468728|NCT01961609|18903336|P4|Initiation|Adverse Event|0
5468729|NCT01961609|18903337|P3|Initiation|Adverse Event|0
5468730|NCT01961609|18903338|P2|Initiation|Adverse Event|5
5468731|NCT01961609|18903339|P1|Initiation|Adverse Event|3
5468732|NCT01961609|18903336|P4|Initiation|Abnormal lab values|0
5468733|NCT01961609|18903337|P3|Initiation|Abnormal lab values|0
5468734|NCT01961609|18903338|P2|Initiation|Abnormal lab values|1
5468735|NCT01961609|18903339|P1|Initiation|Abnormal lab values|0
5468736|NCT01961609|18903336|P4|Initiation|Lack of Efficacy|0
5468737|NCT01961609|18903337|P3|Initiation|Lack of Efficacy|0
5468738|NCT01961609|18903338|P2|Initiation|Lack of Efficacy|1
5468739|NCT01961609|18903339|P1|Initiation|Lack of Efficacy|2
5468740|NCT01961609|18903336|P4|Initiation|Withdrawal by Subject|0
5468741|NCT01961609|18903337|P3|Initiation|Withdrawal by Subject|0
5468742|NCT01961609|18903338|P2|Initiation|Withdrawal by Subject|2
5468743|NCT01961609|18903339|P1|Initiation|Withdrawal by Subject|1
5468744|NCT01961609|18903336|P4|Initiation|Administrative problems|0
5468745|NCT01961609|18903337|P3|Initiation|Administrative problems|0
5468746|NCT01961609|18903338|P2|Initiation|Administrative problems|0
5468747|NCT01961609|18903339|P1|Initiation|Administrative problems|1
5468748|NCT01961609|18903336|P4|Initiation|Death|0
5468749|NCT01961609|18903337|P3|Initiation|Death|0
5468750|NCT01961609|18903338|P2|Initiation|Death|1
5468751|NCT01961609|18903339|P1|Initiation|Death|0
5468752|NCT01961609|18903336|P4|Initiation|Protocol deviation|0
5468753|NCT01961609|18903337|P3|Initiation|Protocol deviation|0
5468754|NCT01961609|18903338|P2|Initiation|Protocol deviation|0
5468755|NCT01961609|18903339|P1|Initiation|Protocol deviation|1
5468756|NCT01961609|18903336|P4|Initiation|Missing|0
5468757|NCT01961609|18903337|P3|Initiation|Missing|0
5468758|NCT01961609|18903338|P2|Initiation|Missing|2
5468759|NCT01961609|18903339|P1|Initiation|Missing|3
5468760|NCT01961544|18903391|P1|Overall Study|Aggravation of Steral Pain|1
5468761|NCT01961544|18903391|P1|Overall Study|Poor Tolerance|1
5468762|NCT01961544|18903391|P1|Overall Study|Physician Decision|2
5468763|NCT01961544|18903391|P1|Overall Study|Adverse Event|1
5468764|NCT01961544|18903391|P1|Overall Study|Withdrawal by Subject|7
5468765|NCT01961544|18903391|P1|Overall Study|Protocol Violation|1
5468766|NCT01961349|18903410|P3|Overall Study|registration error, personal reason etc|1
5468767|NCT01961349|18903411|P2|Overall Study|registration error, personal reason etc|2
5468768|NCT01961349|18903412|P1|Overall Study|registration error, personal reason etc|2
5468769|NCT01961349|18903410|P3|Overall Study|Adverse Event|1
5468770|NCT01961349|18903411|P2|Overall Study|Adverse Event|0
5468771|NCT01961349|18903412|P1|Overall Study|Adverse Event|0
5468772|NCT01961349|18903410|P3|Overall Study|Withdrawal by Subject|0
5468773|NCT01961349|18903411|P2|Overall Study|Withdrawal by Subject|4
5468774|NCT01961349|18903412|P1|Overall Study|Withdrawal by Subject|1
5468775|NCT01961323|18903423|P1|Overall Study|screen failure|34
5468776|NCT01961323|18903423|P1|Overall Study|Lost to Follow-up|8
5468777|NCT01961323|18903423|P1|Overall Study|Withdrawal by Subject|7
5468778|NCT01961297|18903431|P2|Overall Study|unconfirmed diagnosis of SD|1
5468779|NCT01961297|18903432|P1|Overall Study|unconfirmed diagnosis of SD|2
5468780|NCT01961115|18903496|P3|Overall Study|Adverse Event|1
5468781|NCT01961115|18903497|P2|Overall Study|Adverse Event|0
5468782|NCT01961115|18903498|P1|Overall Study|Adverse Event|1
5468783|NCT01961115|18903496|P3|Overall Study|Disease Progression|3
5468784|NCT01961115|18903497|P2|Overall Study|Disease Progression|0
5468785|NCT01961115|18903498|P1|Overall Study|Disease Progression|1
5468786|NCT01960907|18903541|P2|Overall Study|Withdrawal by Subject|42
5468787|NCT01960907|18903542|P1|Overall Study|Withdrawal by Subject|32
5468788|NCT01960907|18903541|P2|Overall Study|Death|3
5468789|NCT01960907|18903542|P1|Overall Study|Death|4
5468790|NCT01960855|18903557|P5|Overall Study|Lost to Follow-up|2
5468791|NCT01960855|18903558|P4|Overall Study|Lost to Follow-up|0
5468792|NCT01960855|18903559|P3|Overall Study|Lost to Follow-up|0
5468793|NCT01960855|18903560|P2|Overall Study|Lost to Follow-up|1
5468794|NCT01960855|18903561|P1|Overall Study|Lost to Follow-up|2
5468795|NCT01960855|18903557|P5|Overall Study|Consent withdrawn by subject|1
5468796|NCT01960855|18903558|P4|Overall Study|Consent withdrawn by subject|1
5468797|NCT01960855|18903559|P3|Overall Study|Consent withdrawn by subject|2
5468798|NCT01960855|18903560|P2|Overall Study|Consent withdrawn by subject|1
5468799|NCT01960855|18903561|P1|Overall Study|Consent withdrawn by subject|3
5468800|NCT01960855|18903557|P5|Overall Study|Other|0
5468801|NCT01960855|18903558|P4|Overall Study|Other|1
5468802|NCT01960855|18903559|P3|Overall Study|Other|1
5468803|NCT01960855|18903560|P2|Overall Study|Other|1
5468804|NCT01960855|18903561|P1|Overall Study|Other|2
5468805|NCT01960855|18903557|P5|Overall Study|Lack of Efficacy|0
5468806|NCT01960855|18903558|P4|Overall Study|Lack of Efficacy|0
5468807|NCT01960855|18903559|P3|Overall Study|Lack of Efficacy|0
5468808|NCT01960855|18903560|P2|Overall Study|Lack of Efficacy|1
5468809|NCT01960855|18903561|P1|Overall Study|Lack of Efficacy|1
5468810|NCT01960855|18903557|P5|Overall Study|Adverse Event|2
5468811|NCT01960855|18903558|P4|Overall Study|Adverse Event|2
5468812|NCT01960855|18903559|P3|Overall Study|Adverse Event|6
5468813|NCT01960855|18903560|P2|Overall Study|Adverse Event|0
5468814|NCT01960855|18903561|P1|Overall Study|Adverse Event|2
5468815|NCT01960855|18903557|P5|Overall Study|Subject noncompliant|0
5468816|NCT01960855|18903558|P4|Overall Study|Subject noncompliant|0
5468817|NCT01960855|18903559|P3|Overall Study|Subject noncompliant|0
5468818|NCT01960855|18903560|P2|Overall Study|Subject noncompliant|0
5468819|NCT01960855|18903561|P1|Overall Study|Subject noncompliant|1
5468820|NCT01960842|18903593|P1|Overall Study|Withdrawal by Subject|2
5468821|NCT01960842|18903593|P1|Overall Study|Adverse Event|1
5468822|NCT01960816|18903616|P1|Overall Study|Lost to Follow-up|1
5468823|NCT01960790|18903622|P1|Overall Study|Unevaluable for safety|1
5468824|NCT01960790|18903622|P1|Overall Study|Transferred to another hospital|4
5468825|NCT01960790|18903622|P1|Overall Study|Treat with Humira outside survey period|3
5468826|NCT01960790|18903622|P1|Overall Study|Survey forms could not be recovered|3
5468827|NCT01960725|18903634|P2|Overall Study|unable to obtain blood sample|2
5468828|NCT01960725|18903635|P1|Overall Study|unable to obtain blood sample|1
5468829|NCT01960725|18903634|P2|Overall Study|Withdrawal by Subject|0
5468830|NCT01960725|18903635|P1|Overall Study|Withdrawal by Subject|1
5468831|NCT01960725|18903634|P2|Overall Study|Lost to Follow-up|3
5468832|NCT01960725|18903635|P1|Overall Study|Lost to Follow-up|4
5468833|NCT01960413|18903705|P2|Overall Study|Lost to Follow-up|0
5468834|NCT01960413|18903706|P1|Overall Study|Lost to Follow-up|2
5468835|NCT01960413|18903705|P2|Overall Study|Physician Decision|0
5468836|NCT01960413|18903706|P1|Overall Study|Physician Decision|1
5468837|NCT01960413|18903705|P2|Overall Study|Withdrawal by Subject|1
5468838|NCT01960413|18903706|P1|Overall Study|Withdrawal by Subject|1
5468839|NCT01960348|18903736|P2|Overall Study|Protocol Violation|0
5468840|NCT01960348|18903737|P1|Overall Study|Protocol Violation|1
5468841|NCT01960348|18903736|P2|Overall Study|Physician Decision|1
5468842|NCT01960348|18903737|P1|Overall Study|Physician Decision|0
5468843|NCT01960348|18903736|P2|Overall Study|Withdrawal by Subject|11
5468844|NCT01960348|18903737|P1|Overall Study|Withdrawal by Subject|1
5468845|NCT01960348|18903736|P2|Overall Study|Adverse event, serious non-fatal|3
5468846|NCT01960348|18903737|P1|Overall Study|Adverse event, serious non-fatal|0
5468847|NCT01960348|18903736|P2|Overall Study|Adverse event, serious fatal|5
5468848|NCT01960348|18903737|P1|Overall Study|Adverse event, serious fatal|6
5468849|NCT01960348|18903736|P2|Overall Study|Adverse event, not serious|2
5468850|NCT01960348|18903737|P1|Overall Study|Adverse event, not serious|2
5468851|NCT01960296|18903757|P2|Overall Study|Received different procedure|3
5468852|NCT01960296|18903758|P1|Overall Study|Received different procedure|1
5468853|NCT01960296|18903757|P2|Overall Study|Postponed surgery|0
5468854|NCT01960296|18903758|P1|Overall Study|Postponed surgery|1
5468855|NCT01960140|18903778|P1|Period 2 (Days 3-18)|Adverse Event|2
5468856|NCT01960114|18903789|P2|Overall Study|Could not swallow study medication|1
5468857|NCT01960114|18903790|P1|Overall Study|Could not swallow study medication|0
5468858|NCT01960114|18903789|P2|Overall Study|Adverse Event|0
5468859|NCT01960114|18903790|P1|Overall Study|Adverse Event|1
5468860|NCT01959932|18903897|P3|Overall Study|Withdrawal by Subject|0
5468861|NCT01959932|18903898|P2|Overall Study|Withdrawal by Subject|0
5468862|NCT01959932|18903899|P1|Overall Study|Withdrawal by Subject|1
5468863|NCT01959919|18903917|P1|Overall Study|Did not meet the eligibility criteria|2
5468864|NCT01959880|18903931|P4|Overall Study|Study completed early-FDA approved|152
5468865|NCT01959880|18903932|P3|Overall Study|Study completed early-FDA approved|179
5468866|NCT01959880|18903933|P2|Overall Study|Study completed early-FDA approved|311
5468867|NCT01959880|18903934|P1|Overall Study|Study completed early-FDA approved|1003
5468868|NCT01959880|18903931|P4|Overall Study|Explantation w/o study device reimplant.|12
5468869|NCT01959880|18903932|P3|Overall Study|Explantation w/o study device reimplant.|5
5468870|NCT01959880|18903933|P2|Overall Study|Explantation w/o study device reimplant.|17
5468871|NCT01959880|18903934|P1|Overall Study|Explantation w/o study device reimplant.|22
5468872|NCT01959880|18903931|P4|Overall Study|Lost to Follow-up|8
5468873|NCT01959880|18903932|P3|Overall Study|Lost to Follow-up|15
5468874|NCT01959880|18903933|P2|Overall Study|Lost to Follow-up|18
5468875|NCT01959880|18903934|P1|Overall Study|Lost to Follow-up|95
5468876|NCT01959880|18903931|P4|Overall Study|Death|2
5468877|NCT01959880|18903932|P3|Overall Study|Death|1
5468878|NCT01959880|18903933|P2|Overall Study|Death|10
5468879|NCT01959880|18903934|P1|Overall Study|Death|1
5468880|NCT01959880|18903931|P4|Overall Study|Withdrawal by Subject|7
5468881|NCT01959880|18903932|P3|Overall Study|Withdrawal by Subject|8
5468882|NCT01959880|18903933|P2|Overall Study|Withdrawal by Subject|13
5468883|NCT01959880|18903934|P1|Overall Study|Withdrawal by Subject|11
5468884|NCT01959841|18903959|P3|Overall Study|Platelet count below on day1 or 4|11
5468885|NCT01959841|18903960|P2|Overall Study|Platelet count below on day1 or 4|15
5468886|NCT01959841|18903961|P1|Overall Study|Platelet count below on day1 or 4|11
5468887|NCT01959841|18903959|P3|Overall Study|Clinical laboratory value|6
5468888|NCT01959841|18903960|P2|Overall Study|Clinical laboratory value|6
5468889|NCT01959841|18903961|P1|Overall Study|Clinical laboratory value|2
5468890|NCT01959841|18903959|P3|Overall Study|Withdrawal by Subject|5
5468891|NCT01959841|18903960|P2|Overall Study|Withdrawal by Subject|7
5468892|NCT01959841|18903961|P1|Overall Study|Withdrawal by Subject|7
5468893|NCT01959841|18903959|P3|Overall Study|Protocol Violation|16
5468894|NCT01959841|18903960|P2|Overall Study|Protocol Violation|23
5468895|NCT01959841|18903961|P1|Overall Study|Protocol Violation|16
5468896|NCT01959841|18903959|P3|Overall Study|Physician Decision|3
5468897|NCT01959841|18903960|P2|Overall Study|Physician Decision|2
5468898|NCT01959841|18903961|P1|Overall Study|Physician Decision|0
5468899|NCT01959841|18903959|P3|Overall Study|Lost to Follow-up|0
5468900|NCT01959841|18903960|P2|Overall Study|Lost to Follow-up|1
5468901|NCT01959841|18903961|P1|Overall Study|Lost to Follow-up|1
5468902|NCT01959841|18903959|P3|Overall Study|Lack of Efficacy|0
5468903|NCT01959841|18903960|P2|Overall Study|Lack of Efficacy|0
5468904|NCT01959841|18903961|P1|Overall Study|Lack of Efficacy|5
5468905|NCT01959841|18903959|P3|Overall Study|Adverse Event|2
5468906|NCT01959841|18903960|P2|Overall Study|Adverse Event|3
5468907|NCT01959841|18903961|P1|Overall Study|Adverse Event|1
5468908|NCT01959672|18903989|P1|Overall Study|Death|1
5468909|NCT01959607|18904000|P4|First Intervention (Day 1)|Withdrawal by Subject|0
5468910|NCT01959607|18904001|P3|First Intervention (Day 1)|Withdrawal by Subject|0
5468911|NCT01959607|18904002|P2|First Intervention (Day 1)|Withdrawal by Subject|1
5468912|NCT01959607|18904003|P1|First Intervention (Day 1)|Withdrawal by Subject|1
5468913|NCT01959581|18904016|P1|Overall Study|Lost to Follow-up|5
5468914|NCT01959529|18904027|P2|Overall Study|Lack of glycaemic control|1
5468915|NCT01959529|18904028|P1|Overall Study|Lack of glycaemic control|1
5468916|NCT01959529|18904027|P2|Overall Study|Hypoglycaemia|1
5468917|NCT01959529|18904028|P1|Overall Study|Hypoglycaemia|1
5468918|NCT01959529|18904027|P2|Overall Study|Other|68
5468919|NCT01959529|18904028|P1|Overall Study|Other|70
5468920|NCT01959529|18904027|P2|Overall Study|Lost to Follow-up|1
5468921|NCT01959529|18904028|P1|Overall Study|Lost to Follow-up|4
5468922|NCT01959529|18904027|P2|Overall Study|Adverse event (not hypoglycaemia)|1
5468923|NCT01959529|18904028|P1|Overall Study|Adverse event (not hypoglycaemia)|0
5468924|NCT01959516|18904040|P2|Epoch 2|Moderate or severe COPD exacerbation|1
5468925|NCT01959516|18904041|P1|Epoch 2|Moderate or severe COPD exacerbation|0
5468926|NCT01959516|18904040|P2|Epoch 2|Subject withdrew consent|0
5468927|NCT01959516|18904041|P1|Epoch 2|Subject withdrew consent|1
5468928|NCT01959516|18904040|P2|Epoch 2|unsatisfactory therapeutic effect|0
5468929|NCT01959516|18904041|P1|Epoch 2|unsatisfactory therapeutic effect|1
5468930|NCT01959516|18904040|P2|Epoch 1|Protocol deviation|1
5468931|NCT01959516|18904041|P1|Epoch 1|Protocol deviation|0
5468932|NCT01959516|18904040|P2|Epoch 1|Moderate or severe COPD exacerbation|1
5468933|NCT01959516|18904041|P1|Epoch 1|Moderate or severe COPD exacerbation|0
5468934|NCT01959516|18904040|P2|Epoch 1|Use of prohibited treatment|0
5468935|NCT01959516|18904041|P1|Epoch 1|Use of prohibited treatment|1
5468936|NCT01959516|18904040|P2|Epoch 1|Administrative problems|0
5468937|NCT01959516|18904041|P1|Epoch 1|Administrative problems|1
5468938|NCT01959516|18904040|P2|Epoch 1|Subject withdrew consent|2
5468939|NCT01959516|18904041|P1|Epoch 1|Subject withdrew consent|3
5468940|NCT01959516|18904040|P2|Epoch 1|unsatisfactory therapeutic effect|0
5468941|NCT01959516|18904041|P1|Epoch 1|unsatisfactory therapeutic effect|1
5468942|NCT01959516|18904040|P2|Epoch 1|Adverse Event|1
5468943|NCT01959516|18904041|P1|Epoch 1|Adverse Event|4
5468944|NCT01959503|18904051|P2|Overall Study|Randomized but not treated|1
5468945|NCT01959503|18904052|P1|Overall Study|Randomized but not treated|1
5468946|NCT01959503|18904051|P2|Overall Study|Death|1
5468947|NCT01959503|18904052|P1|Overall Study|Death|2
5468948|NCT01959425|18904105|P2|Overall Study|Discontinued Subjects|4
5468949|NCT01959425|18904106|P1|Overall Study|Discontinued Subjects|6
5468950|NCT01959425|18904105|P2|Overall Study|Lost to Follow-up|0
5468951|NCT01959425|18904106|P1|Overall Study|Lost to Follow-up|1
5468952|NCT01959425|18904105|P2|Overall Study|Withdrawal by Subject|4
5468953|NCT01959425|18904106|P1|Overall Study|Withdrawal by Subject|5
5468954|NCT01959412|18904126|P6|Overall Study|Adverse Event|0
5468955|NCT01959412|18904127|P5|Overall Study|Adverse Event|0
5468956|NCT01959412|18904128|P4|Overall Study|Adverse Event|1
5468957|NCT01959412|18904129|P3|Overall Study|Adverse Event|0
5468958|NCT01959412|18904130|P2|Overall Study|Adverse Event|0
5468959|NCT01959412|18904131|P1|Overall Study|Adverse Event|0
5468960|NCT01959412|18904126|P6|Overall Study|Protocol deviation|0
5468961|NCT01959412|18904127|P5|Overall Study|Protocol deviation|3
5468962|NCT01959412|18904128|P4|Overall Study|Protocol deviation|1
5468963|NCT01959412|18904129|P3|Overall Study|Protocol deviation|0
5468964|NCT01959412|18904130|P2|Overall Study|Protocol deviation|1
5468965|NCT01959412|18904131|P1|Overall Study|Protocol deviation|1
5468966|NCT01959347|18904171|P2|Overall Study|Protocol Violation|7
5468967|NCT01959347|18904172|P1|Overall Study|Protocol Violation|9
5468968|NCT01959334|18904278|P2|Third Dose|Adverse Event|1
5468969|NCT01959334|18904279|P1|Third Dose|Adverse Event|0
5468970|NCT01959334|18904278|P2|Second Dose|Adverse Event|0
5468971|NCT01959334|18904279|P1|Second Dose|Adverse Event|1
5468972|NCT01959243|18904291|P2|Overall Study|Lost to Follow-up|1
5468973|NCT01959243|18904292|P1|Overall Study|Lost to Follow-up|3
5468974|NCT01959243|18904291|P2|Overall Study|Administrative reasons|1
5468975|NCT01959243|18904292|P1|Overall Study|Administrative reasons|2
5468976|NCT01959243|18904291|P2|Overall Study|Adverse Event|2
5468977|NCT01959243|18904292|P1|Overall Study|Adverse Event|5
5468978|NCT01959243|18904291|P2|Overall Study|Investigator Decision|0
5468979|NCT01959243|18904292|P1|Overall Study|Investigator Decision|3
5468980|NCT01959230|18904304|P2|Overall Study|Withdrawal by Subject|0
5468981|NCT01959230|18904305|P1|Overall Study|Withdrawal by Subject|2
5468982|NCT01959230|18904304|P2|Overall Study|Administrative reasons|0
5468983|NCT01959230|18904305|P1|Overall Study|Administrative reasons|2
5468984|NCT01959230|18904304|P2|Overall Study|Failure to follow study procedures|1
5468985|NCT01959230|18904305|P1|Overall Study|Failure to follow study procedures|0
5468986|NCT01959165|18904328|P4|Overall Study|Welfare recipient|0
5468987|NCT01959165|18904329|P3|Overall Study|Welfare recipient|0
5468988|NCT01959165|18904330|P2|Overall Study|Welfare recipient|1
5468989|NCT01959165|18904331|P1|Overall Study|Welfare recipient|0
5468990|NCT01959165|18904328|P4|Overall Study|overdose|1
5468991|NCT01959165|18904329|P3|Overall Study|overdose|0
5468992|NCT01959165|18904330|P2|Overall Study|overdose|0
5468993|NCT01959165|18904331|P1|Overall Study|overdose|0
5468994|NCT01959165|18904328|P4|Overall Study|Lack of Efficacy|0
5468995|NCT01959165|18904329|P3|Overall Study|Lack of Efficacy|0
5468996|NCT01959165|18904330|P2|Overall Study|Lack of Efficacy|0
5468997|NCT01959165|18904331|P1|Overall Study|Lack of Efficacy|1
5468998|NCT01959165|18904328|P4|Overall Study|Adverse Event|1
5468999|NCT01959165|18904329|P3|Overall Study|Adverse Event|0
5469000|NCT01959165|18904330|P2|Overall Study|Adverse Event|0
5469001|NCT01959165|18904331|P1|Overall Study|Adverse Event|0
5469002|NCT01959139|18904357|P4|Phase II|On treatment|0
5469003|NCT01959139|18904358|P3|Phase II|On treatment|4
5469004|NCT01959139|18904359|P2|Phase II|On treatment|0
5469005|NCT01959139|18904360|P1|Phase II|On treatment|0
5469006|NCT01959139|18904357|P4|Phase II|Other/Unknown|5
5469007|NCT01959139|18904358|P3|Phase II|Other/Unknown|8
5469008|NCT01959139|18904359|P2|Phase II|Other/Unknown|0
5469009|NCT01959139|18904360|P1|Phase II|Other/Unknown|0
5469010|NCT01959139|18904357|P4|Phase II|Death|1
5469011|NCT01959139|18904358|P3|Phase II|Death|3
5469012|NCT01959139|18904359|P2|Phase II|Death|0
5469013|NCT01959139|18904360|P1|Phase II|Death|0
5469014|NCT01959139|18904357|P4|Phase II|Patient Refusal|4
5469015|NCT01959139|18904358|P3|Phase II|Patient Refusal|5
5469016|NCT01959139|18904359|P2|Phase II|Patient Refusal|0
5469017|NCT01959139|18904360|P1|Phase II|Patient Refusal|0
5469018|NCT01959139|18904357|P4|Phase II|Adverse Event|11
5469019|NCT01959139|18904358|P3|Phase II|Adverse Event|10
5469020|NCT01959139|18904359|P2|Phase II|Adverse Event|0
5469021|NCT01959139|18904360|P1|Phase II|Adverse Event|0
5469022|NCT01959139|18904357|P4|Phase II|Disease progression|34
5469023|NCT01959139|18904358|P3|Phase II|Disease progression|26
5469024|NCT01959139|18904359|P2|Phase II|Disease progression|0
5469025|NCT01959139|18904360|P1|Phase II|Disease progression|0
5469026|NCT01959035|18904393|P1|Overall Study|Other (no primary reason given)|1
5469027|NCT01959035|18904393|P1|Overall Study|Lost to Follow-up|1
5469028|NCT01959035|18904393|P1|Overall Study|Withdrawal by Subject|4
5469029|NCT01959035|18904393|P1|Overall Study|Adverse Event|5
5469030|NCT01958918|18904421|P2|Overall Study|administrative problems|2
5469031|NCT01958918|18904422|P1|Overall Study|administrative problems|0
5469032|NCT01958918|18904421|P2|Overall Study|Adverse Event|12
5469033|NCT01958918|18904422|P1|Overall Study|Adverse Event|12
5469034|NCT01958918|18904421|P2|Overall Study|Lack of Efficacy|10
5469035|NCT01958918|18904422|P1|Overall Study|Lack of Efficacy|13
5469036|NCT01958918|18904421|P2|Overall Study|Withdrawal by Subject|8
5469037|NCT01958918|18904422|P1|Overall Study|Withdrawal by Subject|13
5469038|NCT01958918|18904421|P2|Overall Study|Lost to Follow-up|7
5469039|NCT01958918|18904422|P1|Overall Study|Lost to Follow-up|4
5469040|NCT01958918|18904421|P2|Overall Study|Death|3
5469041|NCT01958918|18904422|P1|Overall Study|Death|1
5469042|NCT01958827|18904436|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
5469043|NCT01958827|18904436|P1|Overall Study|Lack of Efficacy|6
5469044|NCT01958827|18904436|P1|Overall Study|Adverse Event|3
5469045|NCT01958671|18904467|P3|Overall Study|Withdrawal by Subject|13
5469046|NCT01958671|18904468|P2|Overall Study|Withdrawal by Subject|10
5469047|NCT01958671|18904469|P1|Overall Study|Withdrawal by Subject|8
5469048|NCT01958671|18904467|P3|Overall Study|Participant moved|1
5469049|NCT01958671|18904468|P2|Overall Study|Participant moved|0
5469050|NCT01958671|18904469|P1|Overall Study|Participant moved|0
5469051|NCT01958671|18904467|P3|Overall Study|Study site terminated by sponsor|1
5469052|NCT01958671|18904468|P2|Overall Study|Study site terminated by sponsor|0
5469053|NCT01958671|18904469|P1|Overall Study|Study site terminated by sponsor|1
5469054|NCT01958671|18904467|P3|Overall Study|Protocol Violation|0
5469055|NCT01958671|18904468|P2|Overall Study|Protocol Violation|1
5469056|NCT01958671|18904469|P1|Overall Study|Protocol Violation|0
5469057|NCT01958671|18904467|P3|Overall Study|Pregnancy|1
5469058|NCT01958671|18904468|P2|Overall Study|Pregnancy|0
5469059|NCT01958671|18904469|P1|Overall Study|Pregnancy|0
5469060|NCT01958671|18904467|P3|Overall Study|Non-compliance with study drug|1
5469061|NCT01958671|18904468|P2|Overall Study|Non-compliance with study drug|1
5469062|NCT01958671|18904469|P1|Overall Study|Non-compliance with study drug|1
5469063|NCT01958671|18904467|P3|Overall Study|Lost to Follow-up|7
5469064|NCT01958671|18904468|P2|Overall Study|Lost to Follow-up|11
5469065|NCT01958671|18904469|P1|Overall Study|Lost to Follow-up|7
5469066|NCT01958671|18904467|P3|Overall Study|Hyperglycemia|2
5469067|NCT01958671|18904468|P2|Overall Study|Hyperglycemia|0
5469068|NCT01958671|18904469|P1|Overall Study|Hyperglycemia|0
5469069|NCT01958671|18904467|P3|Overall Study|Excluded medication|1
5469070|NCT01958671|18904468|P2|Overall Study|Excluded medication|0
5469071|NCT01958671|18904469|P1|Overall Study|Excluded medication|0
5469072|NCT01958671|18904467|P3|Overall Study|Death|0
5469073|NCT01958671|18904468|P2|Overall Study|Death|0
5469074|NCT01958671|18904469|P1|Overall Study|Death|1
5469075|NCT01958671|18904467|P3|Overall Study|Adverse Event|5
5469076|NCT01958671|18904468|P2|Overall Study|Adverse Event|1
5469077|NCT01958671|18904469|P1|Overall Study|Adverse Event|1
5469078|NCT01958619|18904543|P4|Overall Study|Protocol Violation|0
5469079|NCT01958619|18904544|P3|Overall Study|Protocol Violation|1
5469080|NCT01958619|18904545|P2|Overall Study|Protocol Violation|0
5469081|NCT01958619|18904546|P1|Overall Study|Protocol Violation|2
5469082|NCT01958489|18904607|P2|Period 2|Adverse Event|1
5469083|NCT01958489|18904608|P1|Period 2|Adverse Event|0
5469084|NCT01958476|18904624|P2|Overall Study|Parent requested exclusion from analysis|0
5469085|NCT01958476|18904625|P1|Overall Study|Parent requested exclusion from analysis|1
5469086|NCT01958437|18904655|P4|Overall Study|Incidental MRI findings|1
5469087|NCT01958437|18904656|P3|Overall Study|Incidental MRI findings|1
5469088|NCT01958437|18904657|P2|Overall Study|Incidental MRI findings|0
5469089|NCT01958437|18904658|P1|Overall Study|Incidental MRI findings|0
5469090|NCT01958294|18904722|P1|Overall Study|Clinical Circumstances|2
5469091|NCT01958281|18904731|P3|Overall Study|Withdrew Consent|0
5469092|NCT01958281|18904732|P2|Overall Study|Withdrew Consent|0
5469093|NCT01958281|18904733|P1|Overall Study|Withdrew Consent|1
5469094|NCT01958281|18904731|P3|Overall Study|Adverse Event|0
5469095|NCT01958281|18904732|P2|Overall Study|Adverse Event|2
5469096|NCT01958281|18904733|P1|Overall Study|Adverse Event|0
5469097|NCT01958281|18904731|P3|Overall Study|Lack of Efficacy|0
5469098|NCT01958281|18904732|P2|Overall Study|Lack of Efficacy|2
5469099|NCT01958281|18904733|P1|Overall Study|Lack of Efficacy|5
5469100|NCT01958164|18904809|P2|Overall Study|Lost to Follow-up|3
5469101|NCT01958164|18904810|P1|Overall Study|Lost to Follow-up|2
5469102|NCT01958164|18904809|P2|Overall Study|Adverse Event|2
5469103|NCT01958164|18904810|P1|Overall Study|Adverse Event|0
5469104|NCT01958125|18904825|P2|Overall Study|No headache attacks|2
5469105|NCT01958125|18904826|P1|Overall Study|No headache attacks|0
5469106|NCT01958125|18904825|P2|Overall Study|Missing diary data|6
5469107|NCT01958125|18904826|P1|Overall Study|Missing diary data|2
5469108|NCT01958060|18904889|P6|Overall Study|Not treated|0
5469109|NCT01958060|18904890|P5|Overall Study|Not treated|1
5469110|NCT01958060|18904891|P4|Overall Study|Not treated|0
5469111|NCT01958060|18904892|P3|Overall Study|Not treated|0
5469112|NCT01958060|18904893|P2|Overall Study|Not treated|0
5469113|NCT01958060|18904894|P1|Overall Study|Not treated|2
5469114|NCT01958021|18904919|P2|Overall Study|Death|0
5469115|NCT01958021|18904920|P1|Overall Study|Death|2
5469116|NCT01958021|18904919|P2|Overall Study|Protocol Violation|1
5469117|NCT01958021|18904920|P1|Overall Study|Protocol Violation|3
5469118|NCT01958021|18904919|P2|Overall Study|Physician Decision|13
5469119|NCT01958021|18904920|P1|Overall Study|Physician Decision|10
5469120|NCT01958021|18904919|P2|Overall Study|Subject/guardian decision|13
5469121|NCT01958021|18904920|P1|Overall Study|Subject/guardian decision|12
5469122|NCT01958021|18904919|P2|Overall Study|Adverse Event|7
5469123|NCT01958021|18904920|P1|Overall Study|Adverse Event|25
5469124|NCT01958021|18904919|P2|Overall Study|Progressive disease|146
5469125|NCT01958021|18904920|P1|Overall Study|Progressive disease|87
5469126|NCT01958008|18904932|P4|Overall Study|Other adverse event|0
5469127|NCT01958008|18904933|P3|Overall Study|Other adverse event|0
5469128|NCT01958008|18904934|P2|Overall Study|Other adverse event|0
5469129|NCT01958008|18904935|P1|Overall Study|Other adverse event|1
5469130|NCT01958008|18904932|P4|Overall Study|Worsening of disease under study|0
5469131|NCT01958008|18904933|P3|Overall Study|Worsening of disease under study|1
5469132|NCT01958008|18904934|P2|Overall Study|Worsening of disease under study|0
5469133|NCT01958008|18904935|P1|Overall Study|Worsening of disease under study|0
5469134|NCT01957865|18904978|P3|Overall Study|Lost to Follow-up|2
5469135|NCT01957865|18904979|P2|Overall Study|Lost to Follow-up|2
5469136|NCT01957865|18904980|P1|Overall Study|Lost to Follow-up|0
5469137|NCT01957865|18904978|P3|Overall Study|Found HIV negative|1
5469138|NCT01957865|18904979|P2|Overall Study|Found HIV negative|0
5469139|NCT01957865|18904980|P1|Overall Study|Found HIV negative|0
5469140|NCT01957787|18904991|P1|Overall Study|Local therapy, not cryoablation|6
5469141|NCT01957787|18904991|P1|Overall Study|Index Tumor was Primary Lung Cancer|2
5469142|NCT01957787|18904991|P1|Overall Study|Index Tumor(s) Resected|2
5469143|NCT01957787|18904991|P1|Overall Study|Entered Hospice or Similar Program|2
5469144|NCT01957787|18904991|P1|Overall Study|Withdrawal by Subject|3
5469145|NCT01957787|18904991|P1|Overall Study|Lost to Follow-up|3
5469146|NCT01957787|18904991|P1|Overall Study|Death|18
5469147|NCT01957709|18905010|P1|Overall Study|Patient refused to complete post-tx bx|1
5469148|NCT01957644|18905035|P5|Overall Study|Protocol Violation|0
5469149|NCT01957644|18905036|P4|Overall Study|Protocol Violation|0
5469150|NCT01957644|18905037|P3|Overall Study|Protocol Violation|0
5469151|NCT01957644|18905038|P2|Overall Study|Protocol Violation|1
5469152|NCT01957644|18905039|P1|Overall Study|Protocol Violation|0
5469153|NCT01957644|18905035|P5|Overall Study|Withdrawal by Subject|0
5469154|NCT01957644|18905036|P4|Overall Study|Withdrawal by Subject|0
5469155|NCT01957644|18905037|P3|Overall Study|Withdrawal by Subject|0
5469156|NCT01957644|18905038|P2|Overall Study|Withdrawal by Subject|0
5469157|NCT01957644|18905039|P1|Overall Study|Withdrawal by Subject|1
5469158|NCT01957644|18905035|P5|Overall Study|Other reason|0
5469159|NCT01957644|18905036|P4|Overall Study|Other reason|1
5469160|NCT01957644|18905037|P3|Overall Study|Other reason|1
5469161|NCT01957644|18905038|P2|Overall Study|Other reason|2
5469162|NCT01957644|18905039|P1|Overall Study|Other reason|1
5469163|NCT01957644|18905035|P5|Overall Study|Progressive disease / relapse|0
5469164|NCT01957644|18905036|P4|Overall Study|Progressive disease / relapse|1
5469165|NCT01957644|18905037|P3|Overall Study|Progressive disease / relapse|0
5469166|NCT01957644|18905038|P2|Overall Study|Progressive disease / relapse|1
5469167|NCT01957644|18905039|P1|Overall Study|Progressive disease / relapse|0
5469168|NCT01957644|18905035|P5|Overall Study|Adverse Event|1
5469169|NCT01957644|18905036|P4|Overall Study|Adverse Event|0
5469170|NCT01957644|18905037|P3|Overall Study|Adverse Event|0
5469171|NCT01957644|18905038|P2|Overall Study|Adverse Event|2
5469172|NCT01957644|18905039|P1|Overall Study|Adverse Event|4
5469173|NCT01957579|18905063|P4|Overall Study|Death|0
5469174|NCT01957579|18905064|P3|Overall Study|Death|2
5469175|NCT01957579|18905065|P2|Overall Study|Death|0
5469176|NCT01957579|18905066|P1|Overall Study|Death|0
5469177|NCT01957579|18905063|P4|Overall Study|Withdrawal of concent|0
5469178|NCT01957579|18905064|P3|Overall Study|Withdrawal of concent|0
5469179|NCT01957579|18905065|P2|Overall Study|Withdrawal of concent|1
5469180|NCT01957579|18905066|P1|Overall Study|Withdrawal of concent|0
5469181|NCT01957553|18905133|P2|Test Period 2 (21 +- 1 Days)|Other|0
5469182|NCT01957553|18905134|P1|Test Period 2 (21 +- 1 Days)|Other|1
5469183|NCT01957553|18905133|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
5469184|NCT01957553|18905134|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
5469185|NCT01957553|18905133|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
5469186|NCT01957553|18905134|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
5469187|NCT01957553|18905133|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
5469188|NCT01957553|18905134|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
5469189|NCT01957553|18905133|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
5469190|NCT01957553|18905134|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
5469191|NCT01957553|18905133|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
5469192|NCT01957553|18905134|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
5469193|NCT01957553|18905133|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
5469194|NCT01957553|18905134|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
5469195|NCT01957553|18905133|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
5469196|NCT01957553|18905134|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
5469197|NCT01957553|18905133|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
5469198|NCT01957553|18905134|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
5469199|NCT01957488|18905140|P6|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5469200|NCT01957488|18905141|P5|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5469201|NCT01957488|18905142|P4|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5469202|NCT01957488|18905143|P3|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5469203|NCT01957488|18905144|P2|Test Period 3 (2 Weeks)|Lack of Efficacy|1
5469204|NCT01957488|18905145|P1|Test Period 3 (2 Weeks)|Lack of Efficacy|0
5469205|NCT01957488|18905140|P6|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5469206|NCT01957488|18905141|P5|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5469207|NCT01957488|18905142|P4|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5469208|NCT01957488|18905143|P3|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5469209|NCT01957488|18905144|P2|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
5469210|NCT01957488|18905145|P1|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
5469211|NCT01957488|18905140|P6|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
5469212|NCT01957488|18905141|P5|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5469213|NCT01957488|18905142|P4|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5469214|NCT01957488|18905143|P3|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5469215|NCT01957488|18905144|P2|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5469216|NCT01957488|18905145|P1|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
5469217|NCT01957488|18905140|P6|Test Period 2 (2 Weeks)|Adverse Event|0
5469218|NCT01957488|18905141|P5|Test Period 2 (2 Weeks)|Adverse Event|2
5469219|NCT01957488|18905142|P4|Test Period 2 (2 Weeks)|Adverse Event|0
5469220|NCT01957488|18905143|P3|Test Period 2 (2 Weeks)|Adverse Event|0
5469221|NCT01957488|18905144|P2|Test Period 2 (2 Weeks)|Adverse Event|0
5469222|NCT01957488|18905145|P1|Test Period 2 (2 Weeks)|Adverse Event|0
5469223|NCT01957488|18905140|P6|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5469224|NCT01957488|18905141|P5|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5469225|NCT01957488|18905142|P4|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5469226|NCT01957488|18905143|P3|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5469227|NCT01957488|18905144|P2|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
5469228|NCT01957488|18905145|P1|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
5469229|NCT01957488|18905140|P6|Test Period 2 (2 Weeks)|Other|0
5469230|NCT01957488|18905141|P5|Test Period 2 (2 Weeks)|Other|0
5469231|NCT01957488|18905142|P4|Test Period 2 (2 Weeks)|Other|0
5469232|NCT01957488|18905143|P3|Test Period 2 (2 Weeks)|Other|0
5469233|NCT01957488|18905144|P2|Test Period 2 (2 Weeks)|Other|0
5469234|NCT01957488|18905145|P1|Test Period 2 (2 Weeks)|Other|1
5469235|NCT01957488|18905140|P6|Test Period 2 (2 Weeks)|Protocol Violation|0
5469236|NCT01957488|18905141|P5|Test Period 2 (2 Weeks)|Protocol Violation|0
5469237|NCT01957488|18905142|P4|Test Period 2 (2 Weeks)|Protocol Violation|1
5469238|NCT01957488|18905143|P3|Test Period 2 (2 Weeks)|Protocol Violation|1
5469239|NCT01957488|18905144|P2|Test Period 2 (2 Weeks)|Protocol Violation|0
5469240|NCT01957488|18905145|P1|Test Period 2 (2 Weeks)|Protocol Violation|2
5469241|NCT01957488|18905140|P6|Test Period 1 (2 Weeks)|screen failure|1
5469242|NCT01957488|18905141|P5|Test Period 1 (2 Weeks)|screen failure|0
5469243|NCT01957488|18905142|P4|Test Period 1 (2 Weeks)|screen failure|0
5469244|NCT01957488|18905143|P3|Test Period 1 (2 Weeks)|screen failure|0
5469245|NCT01957488|18905144|P2|Test Period 1 (2 Weeks)|screen failure|0
5469246|NCT01957488|18905145|P1|Test Period 1 (2 Weeks)|screen failure|0
5469247|NCT01957488|18905140|P6|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5469248|NCT01957488|18905141|P5|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
5469249|NCT01957488|18905142|P4|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5469250|NCT01957488|18905143|P3|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5469251|NCT01957488|18905144|P2|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5469252|NCT01957488|18905145|P1|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
5469253|NCT01957488|18905140|P6|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
5469254|NCT01957488|18905141|P5|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
5469255|NCT01957488|18905142|P4|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
5469256|NCT01957488|18905143|P3|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
5469257|NCT01957488|18905144|P2|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
5469258|NCT01957488|18905145|P1|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
5469259|NCT01957488|18905140|P6|Test Period 1 (2 Weeks)|Adverse Event|0
5469260|NCT01957488|18905141|P5|Test Period 1 (2 Weeks)|Adverse Event|1
5469261|NCT01957488|18905142|P4|Test Period 1 (2 Weeks)|Adverse Event|0
5469262|NCT01957488|18905143|P3|Test Period 1 (2 Weeks)|Adverse Event|1
5469263|NCT01957488|18905144|P2|Test Period 1 (2 Weeks)|Adverse Event|1
5469264|NCT01957488|18905145|P1|Test Period 1 (2 Weeks)|Adverse Event|0
5469265|NCT01957488|18905140|P6|Test Period 1 (2 Weeks)|Protocol Violation|3
5469266|NCT01957488|18905141|P5|Test Period 1 (2 Weeks)|Protocol Violation|0
5469267|NCT01957488|18905142|P4|Test Period 1 (2 Weeks)|Protocol Violation|1
5469268|NCT01957488|18905143|P3|Test Period 1 (2 Weeks)|Protocol Violation|2
5469269|NCT01957488|18905144|P2|Test Period 1 (2 Weeks)|Protocol Violation|2
5469270|NCT01957488|18905145|P1|Test Period 1 (2 Weeks)|Protocol Violation|1
5469271|NCT01957488|18905140|P6|Test Period 1 (2 Weeks)|Lost to Follow-up|0
5469272|NCT01957488|18905141|P5|Test Period 1 (2 Weeks)|Lost to Follow-up|0
5469273|NCT01957488|18905142|P4|Test Period 1 (2 Weeks)|Lost to Follow-up|1
5469274|NCT01957488|18905143|P3|Test Period 1 (2 Weeks)|Lost to Follow-up|1
5469275|NCT01957488|18905144|P2|Test Period 1 (2 Weeks)|Lost to Follow-up|0
5469276|NCT01957488|18905145|P1|Test Period 1 (2 Weeks)|Lost to Follow-up|2
5469277|NCT01957475|18905153|P2|Test Period 2|Adverse Event|0
5469278|NCT01957475|18905154|P1|Test Period 2|Adverse Event|1
5469279|NCT01957475|18905153|P2|Test Period 1|Lack of Efficacy|1
5469280|NCT01957475|18905154|P1|Test Period 1|Lack of Efficacy|0
5469281|NCT01957475|18905153|P2|Test Period 1|Other|0
5469282|NCT01957475|18905154|P1|Test Period 1|Other|1
5469283|NCT01957475|18905153|P2|Test Period 1|Withdrawal by Subject|0
5469284|NCT01957475|18905154|P1|Test Period 1|Withdrawal by Subject|1
5469285|NCT01957462|18905160|P2|Test Period 1|Adverse Event|0
5469286|NCT01957462|18905161|P1|Test Period 1|Adverse Event|1
5469287|NCT01957462|18905160|P2|Test Period 1|Withdrawal by Subject|0
5469288|NCT01957462|18905161|P1|Test Period 1|Withdrawal by Subject|1
5469289|NCT01957397|18905172|P2|Test Period 3|the adhesive did not work|0
5469290|NCT01957397|18905173|P1|Test Period 3|the adhesive did not work|1
5469291|NCT01957397|18905172|P2|Test Period 3|Adverse Event|2
5469292|NCT01957397|18905173|P1|Test Period 3|Adverse Event|1
5469293|NCT01957397|18905172|P2|Test Period 2|Adverse Event|1
5469294|NCT01957397|18905173|P1|Test Period 2|Adverse Event|0
5469295|NCT01957397|18905172|P2|Test Period 1|Withdrawal by Subject|0
5469296|NCT01957397|18905173|P1|Test Period 1|Withdrawal by Subject|1
5469297|NCT01957397|18905172|P2|Test Period 1|sudden leakage/small bag|1
5469298|NCT01957397|18905173|P1|Test Period 1|sudden leakage/small bag|1
5469299|NCT01957215|18905198|P2|Overall Study|Withdrawal by Subject|5
5469300|NCT01957215|18905199|P1|Overall Study|Withdrawal by Subject|7
5469301|NCT01957215|18905198|P2|Overall Study|Protocol Violation|2
5469302|NCT01957215|18905199|P1|Overall Study|Protocol Violation|1
5469303|NCT01957215|18905198|P2|Overall Study|Lost to Follow-up|3
5469304|NCT01957215|18905199|P1|Overall Study|Lost to Follow-up|3
5469305|NCT01957215|18905198|P2|Overall Study|Adverse Event|2
5469306|NCT01957215|18905199|P1|Overall Study|Adverse Event|2
5469307|NCT01957202|18905227|P18|Treatment Period 3 (8 Days)|Adverse Event|0
5469308|NCT01957202|18905228|P17|Treatment Period 3 (8 Days)|Adverse Event|1
5469309|NCT01957202|18905229|P16|Treatment Period 3 (8 Days)|Adverse Event|0
5469310|NCT01957202|18905230|P15|Treatment Period 3 (8 Days)|Adverse Event|0
5469311|NCT01957202|18905231|P14|Treatment Period 3 (8 Days)|Adverse Event|0
5469312|NCT01957202|18905232|P13|Treatment Period 3 (8 Days)|Adverse Event|0
5469313|NCT01957202|18905233|P12|Treatment Period 3 (8 Days)|Adverse Event|0
5469314|NCT01957202|18905234|P11|Treatment Period 3 (8 Days)|Adverse Event|0
5469315|NCT01957202|18905235|P10|Treatment Period 3 (8 Days)|Adverse Event|0
5469316|NCT01957202|18905236|P9|Treatment Period 3 (8 Days)|Adverse Event|0
5469317|NCT01957202|18905237|P8|Treatment Period 3 (8 Days)|Adverse Event|0
5469318|NCT01957202|18905238|P7|Treatment Period 3 (8 Days)|Adverse Event|0
5469319|NCT01957202|18905239|P6|Treatment Period 3 (8 Days)|Adverse Event|0
5469320|NCT01957202|18905240|P5|Treatment Period 3 (8 Days)|Adverse Event|0
5469321|NCT01957202|18905241|P4|Treatment Period 3 (8 Days)|Adverse Event|0
5469322|NCT01957202|18905242|P3|Treatment Period 3 (8 Days)|Adverse Event|0
5469323|NCT01957202|18905243|P2|Treatment Period 3 (8 Days)|Adverse Event|0
5469324|NCT01957202|18905244|P1|Treatment Period 3 (8 Days)|Adverse Event|0
5469325|NCT01957202|18905227|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469326|NCT01957202|18905228|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
5469327|NCT01957202|18905229|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469328|NCT01957202|18905230|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469329|NCT01957202|18905231|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469330|NCT01957202|18905232|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469331|NCT01957202|18905233|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469332|NCT01957202|18905234|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469333|NCT01957202|18905235|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469334|NCT01957202|18905236|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469335|NCT01957202|18905237|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469336|NCT01957202|18905238|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469337|NCT01957202|18905239|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469338|NCT01957202|18905240|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469339|NCT01957202|18905241|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469340|NCT01957202|18905242|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469341|NCT01957202|18905243|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
5469342|NCT01957202|18905244|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
5469343|NCT01957163|18905269|P3|Overall Study|Withdrawal by Subject|4
5469344|NCT01957163|18905270|P2|Overall Study|Withdrawal by Subject|2
5469345|NCT01957163|18905271|P1|Overall Study|Withdrawal by Subject|4
5469346|NCT01957163|18905269|P3|Overall Study|Lost to Follow-up|0
5469347|NCT01957163|18905270|P2|Overall Study|Lost to Follow-up|1
5469348|NCT01957163|18905271|P1|Overall Study|Lost to Follow-up|0
5469349|NCT01957163|18905269|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
5469350|NCT01957163|18905270|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
5469351|NCT01957163|18905271|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
5469352|NCT01957163|18905269|P3|Overall Study|Protocol Violation|0
5469353|NCT01957163|18905270|P2|Overall Study|Protocol Violation|2
5469354|NCT01957163|18905271|P1|Overall Study|Protocol Violation|1
5469355|NCT01957163|18905269|P3|Overall Study|Lack of Efficacy|9
5469356|NCT01957163|18905270|P2|Overall Study|Lack of Efficacy|4
5469357|NCT01957163|18905271|P1|Overall Study|Lack of Efficacy|5
5469358|NCT01957163|18905269|P3|Overall Study|Adverse Event|4
5469359|NCT01957163|18905270|P2|Overall Study|Adverse Event|2
5469360|NCT01957163|18905271|P1|Overall Study|Adverse Event|5
5469361|NCT01957150|18905284|P2|Overall Study|Lack of Efficacy|11
5469362|NCT01957150|18905285|P1|Overall Study|Lack of Efficacy|11
5469363|NCT01957150|18905284|P2|Overall Study|Protocol Violation|0
5469364|NCT01957150|18905285|P1|Overall Study|Protocol Violation|1
5469365|NCT01957150|18905284|P2|Overall Study|Lost to Follow-up|4
5469366|NCT01957150|18905285|P1|Overall Study|Lost to Follow-up|4
5469367|NCT01957150|18905284|P2|Overall Study|Physician Decision|6
5469368|NCT01957150|18905285|P1|Overall Study|Physician Decision|3
5469369|NCT01957150|18905284|P2|Overall Study|Withdrawal by Subject|17
5469370|NCT01957150|18905285|P1|Overall Study|Withdrawal by Subject|13
5469371|NCT01957150|18905284|P2|Overall Study|Adverse Event|20
5469372|NCT01957150|18905285|P1|Overall Study|Adverse Event|23
5469373|NCT01957137|18905301|P1|Randomized Portion|Withdrawal by Subject|1
5469374|NCT01957137|18905301|P1|Randomized Portion|Adverse Event|1
5469375|NCT01957111|18905331|P2|Overall Study|Withdrawal by Subject|1
5469376|NCT01957111|18905332|P1|Overall Study|Withdrawal by Subject|1
5469377|NCT01956773|18905351|P2|Overall Study|Lost to Follow-up|1
5469378|NCT01956773|18905352|P1|Overall Study|Lost to Follow-up|628
5469379|NCT01956669|18905370|P7|Overall Study|Withdrawal by Subject|1
5469380|NCT01956669|18905371|P6|Overall Study|Withdrawal by Subject|0
5469381|NCT01956669|18905372|P5|Overall Study|Withdrawal by Subject|0
5469382|NCT01956669|18905373|P4|Overall Study|Withdrawal by Subject|1
5469383|NCT01956669|18905374|P3|Overall Study|Withdrawal by Subject|1
5469384|NCT01956669|18905375|P2|Overall Study|Withdrawal by Subject|0
5469385|NCT01956669|18905376|P1|Overall Study|Withdrawal by Subject|0
5469386|NCT01956669|18905370|P7|Overall Study|Physician Decision|0
5469387|NCT01956669|18905371|P6|Overall Study|Physician Decision|1
5469388|NCT01956669|18905372|P5|Overall Study|Physician Decision|0
5469389|NCT01956669|18905373|P4|Overall Study|Physician Decision|0
5469390|NCT01956669|18905374|P3|Overall Study|Physician Decision|0
5469391|NCT01956669|18905375|P2|Overall Study|Physician Decision|2
5469392|NCT01956669|18905376|P1|Overall Study|Physician Decision|0
5469393|NCT01956669|18905370|P7|Overall Study|Adverse Event|0
5469394|NCT01956669|18905371|P6|Overall Study|Adverse Event|0
5469395|NCT01956669|18905372|P5|Overall Study|Adverse Event|0
5469396|NCT01956669|18905373|P4|Overall Study|Adverse Event|1
5469397|NCT01956669|18905374|P3|Overall Study|Adverse Event|2
5469398|NCT01956669|18905375|P2|Overall Study|Adverse Event|2
5469399|NCT01956669|18905376|P1|Overall Study|Adverse Event|0
5469400|NCT01956669|18905370|P7|Overall Study|Disease Progression|5
5469401|NCT01956669|18905371|P6|Overall Study|Disease Progression|3
5469402|NCT01956669|18905372|P5|Overall Study|Disease Progression|4
5469403|NCT01956669|18905373|P4|Overall Study|Disease Progression|8
5469404|NCT01956669|18905374|P3|Overall Study|Disease Progression|7
5469405|NCT01956669|18905375|P2|Overall Study|Disease Progression|7
5469406|NCT01956669|18905376|P1|Overall Study|Disease Progression|12
5469407|NCT01956240|18905498|P2|Overall Study|Adverse Event|4
5469408|NCT01956240|18905499|P1|Overall Study|Adverse Event|17
5469409|NCT01956240|18905498|P2|Overall Study|Lost to Follow-up|20
5469410|NCT01956240|18905499|P1|Overall Study|Lost to Follow-up|6
5469411|NCT01956123|18905509|P4|COS Cycle 3|Withdrawal by Subject|1
5469412|NCT01956123|18905510|P3|COS Cycle 3|Withdrawal by Subject|0
5469413|NCT01956123|18905511|P2|COS Cycle 3|Withdrawal by Subject|0
5469414|NCT01956123|18905512|P1|COS Cycle 3|Withdrawal by Subject|0
5469415|NCT01956123|18905509|P4|COS Cycle 3|Personal Reasons|0
5469416|NCT01956123|18905510|P3|COS Cycle 3|Personal Reasons|1
5469417|NCT01956123|18905511|P2|COS Cycle 3|Personal Reasons|0
5469418|NCT01956123|18905512|P1|COS Cycle 3|Personal Reasons|0
5469419|NCT01956123|18905509|P4|COS Cycle 3|Adverse Event|0
5469420|NCT01956123|18905510|P3|COS Cycle 3|Adverse Event|3
5469421|NCT01956123|18905511|P2|COS Cycle 3|Adverse Event|0
5469422|NCT01956123|18905512|P1|COS Cycle 3|Adverse Event|0
5469423|NCT01956123|18905509|P4|COS Cycle 3|Protocol Violation|1
5469424|NCT01956123|18905510|P3|COS Cycle 3|Protocol Violation|2
5469425|NCT01956123|18905511|P2|COS Cycle 3|Protocol Violation|0
5469426|NCT01956123|18905512|P1|COS Cycle 3|Protocol Violation|0
5469427|NCT01956123|18905509|P4|COS Cycle 2|Withdrawal by Subject|0
5469428|NCT01956123|18905510|P3|COS Cycle 2|Withdrawal by Subject|0
5469429|NCT01956123|18905511|P2|COS Cycle 2|Withdrawal by Subject|0
5469430|NCT01956123|18905512|P1|COS Cycle 2|Withdrawal by Subject|1
5469431|NCT01956123|18905509|P4|COS Cycle 2|Personal Reasons|0
5469432|NCT01956123|18905510|P3|COS Cycle 2|Personal Reasons|0
5469433|NCT01956123|18905511|P2|COS Cycle 2|Personal Reasons|0
5469434|NCT01956123|18905512|P1|COS Cycle 2|Personal Reasons|2
5469435|NCT01956123|18905509|P4|COS Cycle 2|Adverse Event|0
5469436|NCT01956123|18905510|P3|COS Cycle 2|Adverse Event|0
5469437|NCT01956123|18905511|P2|COS Cycle 2|Adverse Event|4
5469438|NCT01956123|18905512|P1|COS Cycle 2|Adverse Event|3
5469439|NCT01956123|18905509|P4|COS Cycle 2|Protocol Violation|0
5469440|NCT01956123|18905510|P3|COS Cycle 2|Protocol Violation|0
5469441|NCT01956123|18905511|P2|COS Cycle 2|Protocol Violation|3
5469442|NCT01956123|18905512|P1|COS Cycle 2|Protocol Violation|8
5469443|NCT01956110|18905564|P2|Overall Study|Personal reasons|1
5469444|NCT01956110|18905565|P1|Overall Study|Personal reasons|1
5469445|NCT01956110|18905564|P2|Overall Study|Adverse Event|10
5469446|NCT01956110|18905565|P1|Overall Study|Adverse Event|9
5469447|NCT01956110|18905564|P2|Overall Study|Protocol Violation|11
5469448|NCT01956110|18905565|P1|Overall Study|Protocol Violation|25
5469449|NCT01955733|18905731|P3|Period 2|Other not defined above|2
5469450|NCT01955733|18905732|P2|Period 2|Other not defined above|2
5469451|NCT01955733|18905733|P1|Period 2|Other not defined above|0
5469452|NCT01955733|18905731|P3|Period 2|Lost to Follow-up|0
5469453|NCT01955733|18905732|P2|Period 2|Lost to Follow-up|0
5469454|NCT01955733|18905733|P1|Period 2|Lost to Follow-up|2
5469455|NCT01955733|18905731|P3|Period 2|Study terminated by sponsor|16
5469456|NCT01955733|18905732|P2|Period 2|Study terminated by sponsor|14
5469457|NCT01955733|18905733|P1|Period 2|Study terminated by sponsor|8
5469458|NCT01955733|18905731|P3|Period 2|Withdrawal by Subject|2
5469459|NCT01955733|18905732|P2|Period 2|Withdrawal by Subject|3
5469460|NCT01955733|18905733|P1|Period 2|Withdrawal by Subject|1
5469461|NCT01955733|18905731|P3|Period 2|Physician Decision|1
5469462|NCT01955733|18905732|P2|Period 2|Physician Decision|0
5469463|NCT01955733|18905733|P1|Period 2|Physician Decision|0
5469464|NCT01955733|18905731|P3|Period 2|Adverse Event|0
5469465|NCT01955733|18905732|P2|Period 2|Adverse Event|0
5469466|NCT01955733|18905733|P1|Period 2|Adverse Event|1
5469467|NCT01955733|18905731|P3|Period 1|Lost to Follow-up|0
5469468|NCT01955733|18905732|P2|Period 1|Lost to Follow-up|0
5469469|NCT01955733|18905733|P1|Period 1|Lost to Follow-up|1
5469470|NCT01955707|18905826|P2|Overall Study|Other|2
5469471|NCT01955707|18905827|P1|Overall Study|Other|4
5469472|NCT01955707|18905826|P2|Overall Study|Death|14
5469473|NCT01955707|18905827|P1|Overall Study|Death|13
5469474|NCT01955707|18905826|P2|Overall Study|Withdrawal by Subject|3
5469475|NCT01955707|18905827|P1|Overall Study|Withdrawal by Subject|0
5469476|NCT01955707|18905826|P2|Overall Study|Lost to Follow-up|1
5469477|NCT01955707|18905827|P1|Overall Study|Lost to Follow-up|2
5469478|NCT01955707|18905826|P2|Overall Study|Adverse Event|2
5469479|NCT01955707|18905827|P1|Overall Study|Adverse Event|1
5469480|NCT01955161|18906095|P3|Overall Study|Other reason: patient's will|1
5469481|NCT01955161|18906096|P2|Overall Study|Other reason: patient's will|0
5469482|NCT01955161|18906097|P1|Overall Study|Other reason: patient's will|0
5469483|NCT01955161|18906095|P3|Overall Study|Other reason: primary biliary cirrhosis|0
5469484|NCT01955161|18906096|P2|Overall Study|Other reason: primary biliary cirrhosis|0
5469485|NCT01955161|18906097|P1|Overall Study|Other reason: primary biliary cirrhosis|1
5469486|NCT01955161|18906095|P3|Overall Study|Other reason: insufficient compliance|1
5469487|NCT01955161|18906096|P2|Overall Study|Other reason: insufficient compliance|0
5469488|NCT01955161|18906097|P1|Overall Study|Other reason: insufficient compliance|0
5469489|NCT01955161|18906095|P3|Overall Study|Other reason: moved to nursing home|0
5469490|NCT01955161|18906096|P2|Overall Study|Other reason: moved to nursing home|1
5469491|NCT01955161|18906097|P1|Overall Study|Other reason: moved to nursing home|0
5469492|NCT01955161|18906095|P3|Overall Study|Other reason: caregiver unavailable|0
5469493|NCT01955161|18906096|P2|Overall Study|Other reason: caregiver unavailable|0
5469494|NCT01955161|18906097|P1|Overall Study|Other reason: caregiver unavailable|1
5469495|NCT01955161|18906095|P3|Overall Study|Other reason: disallowed medication|1
5469496|NCT01955161|18906096|P2|Overall Study|Other reason: disallowed medication|0
5469497|NCT01955161|18906097|P1|Overall Study|Other reason: disallowed medication|1
5469498|NCT01955161|18906095|P3|Overall Study|Other reason: physician decision|1
5469499|NCT01955161|18906096|P2|Overall Study|Other reason: physician decision|1
5469500|NCT01955161|18906097|P1|Overall Study|Other reason: physician decision|0
5469501|NCT01955161|18906095|P3|Overall Study|Protocol Violation|0
5469502|NCT01955161|18906096|P2|Overall Study|Protocol Violation|0
5469503|NCT01955161|18906097|P1|Overall Study|Protocol Violation|2
5469504|NCT01955161|18906095|P3|Overall Study|Withdrawal by Subject|12
5469505|NCT01955161|18906096|P2|Overall Study|Withdrawal by Subject|8
5469506|NCT01955161|18906097|P1|Overall Study|Withdrawal by Subject|9
5469507|NCT01955161|18906095|P3|Overall Study|Death|3
5469508|NCT01955161|18906096|P2|Overall Study|Death|1
5469509|NCT01955161|18906097|P1|Overall Study|Death|1
5469510|NCT01955161|18906095|P3|Overall Study|Adverse Event|15
5469511|NCT01955161|18906096|P2|Overall Study|Adverse Event|14
5469512|NCT01955161|18906097|P1|Overall Study|Adverse Event|10
5469513|NCT01955161|18906095|P3|Overall Study|Withdrawal before treatment|1
5469514|NCT01955161|18906096|P2|Overall Study|Withdrawal before treatment|0
5469515|NCT01955161|18906097|P1|Overall Study|Withdrawal before treatment|2
5469516|NCT01955122|18906137|P2|Overall Study|Physician Decision|5
5469517|NCT01955122|18906138|P1|Overall Study|Physician Decision|5
5469518|NCT01955083|18906158|P2|Overall Study|Lost to Follow-up|1
5469519|NCT01955083|18906159|P1|Overall Study|Lost to Follow-up|1
5469520|NCT01955044|18906192|P3|Overall Study|Death|0
5469521|NCT01955044|18906193|P2|Overall Study|Death|1
5469522|NCT01955044|18906194|P1|Overall Study|Death|1
5469523|NCT01955005|18906207|P2|Overall Study|Withdrawal by Subject|5
5469524|NCT01955005|18906208|P1|Overall Study|Withdrawal by Subject|3
5469525|NCT01954927|18906220|P2|Overall Study|Withdrawal by Subject|1
5469526|NCT01954927|18906221|P1|Overall Study|Withdrawal by Subject|3
5469527|NCT01954771|18906242|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
5469528|NCT01954771|18906243|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
5469529|NCT01954771|18906244|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
5469530|NCT01954771|18906242|P3|Overall Study|Missing CGMS of end-point|0
5469531|NCT01954771|18906243|P2|Overall Study|Missing CGMS of end-point|1
5469532|NCT01954771|18906244|P1|Overall Study|Missing CGMS of end-point|1
5469533|NCT01954771|18906242|P3|Overall Study|Missing HbA1c of end-point|0
5469534|NCT01954771|18906243|P2|Overall Study|Missing HbA1c of end-point|1
5469535|NCT01954771|18906244|P1|Overall Study|Missing HbA1c of end-point|1
5469536|NCT01954745|18906261|P1|Overall Study|Death|1
5469537|NCT01954745|18906261|P1|Overall Study|Adverse Event|2
5469538|NCT01954745|18906261|P1|Overall Study|Clinical Progression|5
5469539|NCT01954745|18906261|P1|Overall Study|Radiological Progression|11
5469540|NCT01954394|18906292|P2|Overall Study|Other than specified above|21
5469541|NCT01954394|18906293|P1|Overall Study|Other than specified above|10
5469542|NCT01954394|18906292|P2|Overall Study|Related to Study Drug administration|2
5469543|NCT01954394|18906293|P1|Overall Study|Related to Study Drug administration|2
5469544|NCT01954394|18906292|P2|Overall Study|Participant Moved|4
5469545|NCT01954394|18906293|P1|Overall Study|Participant Moved|0
5469546|NCT01954394|18906292|P2|Overall Study|Poor compliance to protocol|7
5469547|NCT01954394|18906293|P1|Overall Study|Poor compliance to protocol|7
5469548|NCT01954394|18906292|P2|Overall Study|Adverse Event|23
5469549|NCT01954394|18906293|P1|Overall Study|Adverse Event|10
5469550|NCT01954394|18906292|P2|Overall Study|Enrolled but not treated|0
5469551|NCT01954394|18906293|P1|Overall Study|Enrolled but not treated|1
5469552|NCT01954342|18906347|P4|Overall Study|Unreliable Data|2
5469553|NCT01954342|18906348|P3|Overall Study|Unreliable Data|0
5469554|NCT01954342|18906349|P2|Overall Study|Unreliable Data|0
5469555|NCT01954342|18906350|P1|Overall Study|Unreliable Data|0
5469556|NCT01954342|18906347|P4|Overall Study|Pre-eclampsia|4
5469557|NCT01954342|18906348|P3|Overall Study|Pre-eclampsia|0
5469558|NCT01954342|18906349|P2|Overall Study|Pre-eclampsia|0
5469559|NCT01954342|18906350|P1|Overall Study|Pre-eclampsia|0
5469560|NCT01954342|18906347|P4|Overall Study|Preterm delivery|3
5469561|NCT01954342|18906348|P3|Overall Study|Preterm delivery|0
5469562|NCT01954342|18906349|P2|Overall Study|Preterm delivery|0
5469563|NCT01954342|18906350|P1|Overall Study|Preterm delivery|0
5469564|NCT01954342|18906347|P4|Overall Study|Lost to Follow-up|5
5469565|NCT01954342|18906348|P3|Overall Study|Lost to Follow-up|0
5469566|NCT01954342|18906349|P2|Overall Study|Lost to Follow-up|0
5469567|NCT01954342|18906350|P1|Overall Study|Lost to Follow-up|0
5469568|NCT01954342|18906347|P4|Overall Study|Miscarriage|3
5469569|NCT01954342|18906348|P3|Overall Study|Miscarriage|0
5469570|NCT01954342|18906349|P2|Overall Study|Miscarriage|0
5469571|NCT01954342|18906350|P1|Overall Study|Miscarriage|0
5469572|NCT01954342|18906347|P4|Overall Study|Missing data from 13-16week study visit|1
5469573|NCT01954342|18906348|P3|Overall Study|Missing data from 13-16week study visit|0
5469574|NCT01954342|18906349|P2|Overall Study|Missing data from 13-16week study visit|0
5469575|NCT01954342|18906350|P1|Overall Study|Missing data from 13-16week study visit|0
5469576|NCT01954251|18906452|P2|Overall Study|Withdrawal by Subject|6
5469577|NCT01954251|18906453|P1|Overall Study|Withdrawal by Subject|2
5469578|NCT01954251|18906452|P2|Overall Study|Lost to Follow-up|6
5469579|NCT01954251|18906453|P1|Overall Study|Lost to Follow-up|6
5469580|NCT01954251|18906452|P2|Overall Study|Adverse Event|7
5469581|NCT01954251|18906453|P1|Overall Study|Adverse Event|5
5469582|NCT01954121|18906550|P2|Overall Study|Subject did not follow instructions|2
5469583|NCT01954121|18906551|P1|Overall Study|Subject did not follow instructions|0
5469584|NCT01954121|18906550|P2|Overall Study|Non-compliant patient|1
5469585|NCT01954121|18906551|P1|Overall Study|Non-compliant patient|1
5469586|NCT01954121|18906550|P2|Overall Study|Non-compliant with study procedures|0
5469587|NCT01954121|18906551|P1|Overall Study|Non-compliant with study procedures|1
5469588|NCT01954121|18906550|P2|Overall Study|SAE, non-fatal|4
5469589|NCT01954121|18906551|P1|Overall Study|SAE, non-fatal|1
5469590|NCT01954121|18906550|P2|Overall Study|AE, non-serious non-fatal|22
5469591|NCT01954121|18906551|P1|Overall Study|AE, non-serious non-fatal|5
5469592|NCT01954121|18906550|P2|Overall Study|AE, serious fatal|0
5469593|NCT01954121|18906551|P1|Overall Study|AE, serious fatal|1
5469594|NCT01954121|18906550|P2|Overall Study|Pregnancy|1
5469595|NCT01954121|18906551|P1|Overall Study|Pregnancy|1
5469596|NCT01954121|18906550|P2|Overall Study|Withdrawal by Subject|12
5469597|NCT01954121|18906551|P1|Overall Study|Withdrawal by Subject|18
5469598|NCT01954121|18906550|P2|Overall Study|Lost to Follow-up|6
5469599|NCT01954121|18906551|P1|Overall Study|Lost to Follow-up|5
5469600|NCT01954121|18906550|P2|Overall Study|Protocol Violation|2
5469601|NCT01954121|18906551|P1|Overall Study|Protocol Violation|0
5469602|NCT01954121|18906550|P2|Overall Study|Lack of Efficacy|41
5469603|NCT01954121|18906551|P1|Overall Study|Lack of Efficacy|94
5469604|NCT01954082|18906567|P2|Overall Study|Randomized not Treated|2
5469605|NCT01954082|18906568|P1|Overall Study|Randomized not Treated|4
5469606|NCT01954082|18906567|P2|Overall Study|Infant Moved|1
5469607|NCT01954082|18906568|P1|Overall Study|Infant Moved|0
5469608|NCT01954082|18906567|P2|Overall Study|Comfort Care|1
5469609|NCT01954082|18906568|P1|Overall Study|Comfort Care|0
5469610|NCT01954082|18906567|P2|Overall Study|Miscalculation of Final Dose Day|3
5469611|NCT01954082|18906568|P1|Overall Study|Miscalculation of Final Dose Day|0
5469612|NCT01954082|18906567|P2|Overall Study|Redirection of Care|2
5469613|NCT01954082|18906568|P1|Overall Study|Redirection of Care|0
5469614|NCT01954082|18906567|P2|Overall Study|Discontinued Early Prior to Transfer|2
5469615|NCT01954082|18906568|P1|Overall Study|Discontinued Early Prior to Transfer|3
5469616|NCT01954082|18906567|P2|Overall Study|Withdrawal by Subject|1
5469617|NCT01954082|18906568|P1|Overall Study|Withdrawal by Subject|0
5469618|NCT01954082|18906567|P2|Overall Study|Parent Decision|0
5469619|NCT01954082|18906568|P1|Overall Study|Parent Decision|1
5469620|NCT01954082|18906567|P2|Overall Study|Physician Decision|0
5469621|NCT01954082|18906568|P1|Overall Study|Physician Decision|2
5469622|NCT01954082|18906567|P2|Overall Study|Non-compliance|4
5469623|NCT01954082|18906568|P1|Overall Study|Non-compliance|6
5469624|NCT01954082|18906567|P2|Overall Study|Intolerance|1
5469625|NCT01954082|18906568|P1|Overall Study|Intolerance|0
5469626|NCT01954082|18906567|P2|Overall Study|Adverse Event|4
5469627|NCT01954082|18906568|P1|Overall Study|Adverse Event|10
5469628|NCT01954082|18906567|P2|Overall Study|Study Suspension|36
5469629|NCT01954082|18906568|P1|Overall Study|Study Suspension|42
5469630|NCT01954056|18906588|P2|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
5469631|NCT01954056|18906589|P1|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
5469632|NCT01954017|18906634|P3|Overall Study|All other reasons|7
5469633|NCT01954017|18906635|P2|Overall Study|All other reasons|2
5469634|NCT01954017|18906636|P1|Overall Study|All other reasons|2
5469635|NCT01954017|18906634|P3|Overall Study|Enteral intake stopped >7 days|1
5469636|NCT01954017|18906635|P2|Overall Study|Enteral intake stopped >7 days|1
5469637|NCT01954017|18906636|P1|Overall Study|Enteral intake stopped >7 days|0
5469638|NCT01954017|18906634|P3|Overall Study|Necrotizing enterocolitis|1
5469639|NCT01954017|18906635|P2|Overall Study|Necrotizing enterocolitis|0
5469640|NCT01954017|18906636|P1|Overall Study|Necrotizing enterocolitis|1
5469641|NCT01954017|18906634|P3|Overall Study|Protocol Violation|2
5469642|NCT01954017|18906635|P2|Overall Study|Protocol Violation|3
5469643|NCT01954017|18906636|P1|Overall Study|Protocol Violation|0
5469644|NCT01954017|18906634|P3|Overall Study|Withdrawal by Subject|0
5469645|NCT01954017|18906635|P2|Overall Study|Withdrawal by Subject|1
5469646|NCT01954017|18906636|P1|Overall Study|Withdrawal by Subject|0
5469647|NCT01954017|18906634|P3|Overall Study|Death|1
5469648|NCT01954017|18906635|P2|Overall Study|Death|1
5469649|NCT01954017|18906636|P1|Overall Study|Death|2
5469650|NCT01954017|18906634|P3|Overall Study|Adverse Event|1
5469651|NCT01954017|18906635|P2|Overall Study|Adverse Event|0
5469652|NCT01954017|18906636|P1|Overall Study|Adverse Event|0
5469653|NCT01953913|18906862|P1|Overall Study|Not Treated|1
5469654|NCT01953913|18906862|P1|Overall Study|Other than listed|108
5469655|NCT01953913|18906862|P1|Overall Study|Withdrawal by Subject|32
5469656|NCT01953913|18906862|P1|Overall Study|Lost to Follow-up|4
5469657|NCT01953913|18906862|P1|Overall Study|Protocol Violation|6
5469658|NCT01953913|18906862|P1|Overall Study|Adverse Event|20
5469659|NCT01953913|18906862|P1|Overall Study|Worsening of underlying cancer|22
5469660|NCT01953913|18906862|P1|Overall Study|Disease Progression|349
5469661|NCT01953783|18906914|P1|Overall Study|Progressive disease|2
5469662|NCT01953601|18906939|P3|Part 2 (Extension Study)|Withdrawal by Subject|2
5469663|NCT01953601|18906940|P2|Part 2 (Extension Study)|Withdrawal by Subject|4
5469664|NCT01953601|18906941|P1|Part 2 (Extension Study)|Withdrawal by Subject|5
5469665|NCT01953601|18906939|P3|Part 2 (Extension Study)|Subject moved|1
5469666|NCT01953601|18906940|P2|Part 2 (Extension Study)|Subject moved|0
5469667|NCT01953601|18906941|P1|Part 2 (Extension Study)|Subject moved|0
5469668|NCT01953601|18906939|P3|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
5469669|NCT01953601|18906940|P2|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
5469670|NCT01953601|18906941|P1|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
5469671|NCT01953601|18906939|P3|Part 2 (Extension Study)|Study terminated by sponsor|187
5469672|NCT01953601|18906940|P2|Part 2 (Extension Study)|Study terminated by sponsor|178
5469673|NCT01953601|18906941|P1|Part 2 (Extension Study)|Study terminated by sponsor|185
5469674|NCT01953601|18906939|P3|Part 2 (Extension Study)|Site discontinued study participation|1
5469675|NCT01953601|18906940|P2|Part 2 (Extension Study)|Site discontinued study participation|1
5469676|NCT01953601|18906941|P1|Part 2 (Extension Study)|Site discontinued study participation|0
5469677|NCT01953601|18906939|P3|Part 2 (Extension Study)|Physician Decision|2
5469678|NCT01953601|18906940|P2|Part 2 (Extension Study)|Physician Decision|0
5469679|NCT01953601|18906941|P1|Part 2 (Extension Study)|Physician Decision|2
5469680|NCT01953601|18906939|P3|Part 2 (Extension Study)|Lost to Follow-up|1
5469681|NCT01953601|18906940|P2|Part 2 (Extension Study)|Lost to Follow-up|1
5469682|NCT01953601|18906941|P1|Part 2 (Extension Study)|Lost to Follow-up|2
5469683|NCT01953601|18906939|P3|Part 2 (Extension Study)|Lack of Efficacy|0
5469684|NCT01953601|18906940|P2|Part 2 (Extension Study)|Lack of Efficacy|0
5469685|NCT01953601|18906941|P1|Part 2 (Extension Study)|Lack of Efficacy|2
5469686|NCT01953601|18906939|P3|Part 2 (Extension Study)|Death|0
5469687|NCT01953601|18906940|P2|Part 2 (Extension Study)|Death|3
5469688|NCT01953601|18906941|P1|Part 2 (Extension Study)|Death|0
5469689|NCT01953601|18906939|P3|Part 2 (Extension Study)|Adverse Event|10
5469690|NCT01953601|18906940|P2|Part 2 (Extension Study)|Adverse Event|1
5469691|NCT01953601|18906941|P1|Part 2 (Extension Study)|Adverse Event|1
5469692|NCT01953601|18906939|P3|Part 1 (Base Study)|Withdrawal by Subject|22
5469693|NCT01953601|18906940|P2|Part 1 (Base Study)|Withdrawal by Subject|23
5469694|NCT01953601|18906941|P1|Part 1 (Base Study)|Withdrawal by Subject|32
5469695|NCT01953601|18906939|P3|Part 1 (Base Study)|Subject moved|1
5469696|NCT01953601|18906940|P2|Part 1 (Base Study)|Subject moved|2
5469697|NCT01953601|18906941|P1|Part 1 (Base Study)|Subject moved|2
5469698|NCT01953601|18906939|P3|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
5469699|NCT01953601|18906940|P2|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
5469700|NCT01953601|18906941|P1|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
5469701|NCT01953601|18906939|P3|Part 1 (Base Study)|Study terminated by sponsor|179
5469702|NCT01953601|18906940|P2|Part 1 (Base Study)|Study terminated by sponsor|169
5469703|NCT01953601|18906941|P1|Part 1 (Base Study)|Study terminated by sponsor|174
5469704|NCT01953601|18906939|P3|Part 1 (Base Study)|Site discontinued study participation|0
5469705|NCT01953601|18906940|P2|Part 1 (Base Study)|Site discontinued study participation|0
5469706|NCT01953601|18906941|P1|Part 1 (Base Study)|Site discontinued study participation|2
5469707|NCT01953601|18906939|P3|Part 1 (Base Study)|Screen failure|1
5469708|NCT01953601|18906940|P2|Part 1 (Base Study)|Screen failure|0
5469709|NCT01953601|18906941|P1|Part 1 (Base Study)|Screen failure|1
5469710|NCT01953601|18906939|P3|Part 1 (Base Study)|Physician Decision|4
5469711|NCT01953601|18906940|P2|Part 1 (Base Study)|Physician Decision|7
5469712|NCT01953601|18906941|P1|Part 1 (Base Study)|Physician Decision|3
5469713|NCT01953601|18906939|P3|Part 1 (Base Study)|Non-compliance with study drug|1
5469714|NCT01953601|18906940|P2|Part 1 (Base Study)|Non-compliance with study drug|3
5469715|NCT01953601|18906941|P1|Part 1 (Base Study)|Non-compliance with study drug|0
5469716|NCT01953601|18906939|P3|Part 1 (Base Study)|Lost to Follow-up|6
5469717|NCT01953601|18906940|P2|Part 1 (Base Study)|Lost to Follow-up|3
5469718|NCT01953601|18906941|P1|Part 1 (Base Study)|Lost to Follow-up|1
5469719|NCT01953601|18906939|P3|Part 1 (Base Study)|Lack of Efficacy|4
5469720|NCT01953601|18906940|P2|Part 1 (Base Study)|Lack of Efficacy|1
5469721|NCT01953601|18906941|P1|Part 1 (Base Study)|Lack of Efficacy|3
5469722|NCT01953601|18906939|P3|Part 1 (Base Study)|Death|3
5469723|NCT01953601|18906940|P2|Part 1 (Base Study)|Death|0
5469724|NCT01953601|18906941|P1|Part 1 (Base Study)|Death|2
5469725|NCT01953601|18906939|P3|Part 1 (Base Study)|Adverse Event|15
5469726|NCT01953601|18906940|P2|Part 1 (Base Study)|Adverse Event|37
5469727|NCT01953601|18906941|P1|Part 1 (Base Study)|Adverse Event|24
5469728|NCT01953354|18907012|P2|Overall Study|Disease Exacerbation|0
5469729|NCT01953354|18907013|P1|Overall Study|Disease Exacerbation|1
5469730|NCT01953354|18907012|P2|Overall Study|Decision of Sponsor|1
5469731|NCT01953354|18907013|P1|Overall Study|Decision of Sponsor|0
5469732|NCT01953354|18907012|P2|Overall Study|Withdrawal by Subject|1
5469733|NCT01953354|18907013|P1|Overall Study|Withdrawal by Subject|0
5469734|NCT01953328|18907041|P8|Overall Study|Lost to Follow-up|0
5469735|NCT01953328|18907042|P7|Overall Study|Lost to Follow-up|0
5469736|NCT01953328|18907043|P6|Overall Study|Lost to Follow-up|0
5469737|NCT01953328|18907044|P5|Overall Study|Lost to Follow-up|1
5469738|NCT01953328|18907045|P4|Overall Study|Lost to Follow-up|0
5469739|NCT01953328|18907046|P3|Overall Study|Lost to Follow-up|0
5469740|NCT01953328|18907047|P2|Overall Study|Lost to Follow-up|0
5469741|NCT01953328|18907048|P1|Overall Study|Lost to Follow-up|0
5469742|NCT01953328|18907041|P8|Overall Study|Withdrawal by Subject|0
5469743|NCT01953328|18907042|P7|Overall Study|Withdrawal by Subject|0
5469744|NCT01953328|18907043|P6|Overall Study|Withdrawal by Subject|0
5469745|NCT01953328|18907044|P5|Overall Study|Withdrawal by Subject|1
5469746|NCT01953328|18907045|P4|Overall Study|Withdrawal by Subject|0
5469747|NCT01953328|18907046|P3|Overall Study|Withdrawal by Subject|0
5469748|NCT01953328|18907047|P2|Overall Study|Withdrawal by Subject|0
5469749|NCT01953328|18907048|P1|Overall Study|Withdrawal by Subject|0
5469750|NCT01953224|18907261|P2|Overall Study|Withdrawal by Subject|2
5469751|NCT01953224|18907262|P1|Overall Study|Withdrawal by Subject|1
5469752|NCT01953224|18907261|P2|Overall Study|Lost to Follow-up|1
5469753|NCT01953224|18907262|P1|Overall Study|Lost to Follow-up|1
5469754|NCT01953003|18907311|P2|Overall Study|Withdrawal by Subject|4
5469755|NCT01953003|18907312|P1|Overall Study|Withdrawal by Subject|14
5469756|NCT01953003|18907311|P2|Overall Study|Protocol Violation|1
5469757|NCT01953003|18907312|P1|Overall Study|Protocol Violation|0
5469758|NCT01953003|18907311|P2|Overall Study|Non-related adverse events|2
5469759|NCT01953003|18907312|P1|Overall Study|Non-related adverse events|0
5469760|NCT01953003|18907311|P2|Overall Study|Related Adverse events|2
5469761|NCT01953003|18907312|P1|Overall Study|Related Adverse events|7
5469762|NCT01953003|18907311|P2|Overall Study|Progressive disease|45
5469763|NCT01953003|18907312|P1|Overall Study|Progressive disease|35
5469764|NCT01953003|18907311|P2|Overall Study|Not treated|1
5469765|NCT01953003|18907312|P1|Overall Study|Not treated|0
5469766|NCT01952834|18907318|P1|Overall Study|Adverse Event|1
5469767|NCT01952691|18907325|P1|Overall Study|Lost to Follow-up|2
5469768|NCT01952665|18907352|P2|Overall Study|Protocol Violation|1
5469769|NCT01952665|18907353|P1|Overall Study|Protocol Violation|0
5469770|NCT01952665|18907352|P2|Overall Study|Adverse Event|1
5469771|NCT01952665|18907353|P1|Overall Study|Adverse Event|2
5469772|NCT01952665|18907352|P2|Overall Study|Lost to Follow-up|2
5469773|NCT01952665|18907353|P1|Overall Study|Lost to Follow-up|1
5469774|NCT01952665|18907352|P2|Overall Study|Physician Decision|2
5469775|NCT01952665|18907353|P1|Overall Study|Physician Decision|3
5469776|NCT01952574|18907508|P7|Clinical Home Use Substudy|Decision by Sponsor|1
5469777|NCT01952574|18907509|P6|Clinical Home Use Substudy|Decision by Sponsor|2
5469778|NCT01952574|18907510|P5|Clinical Home Use Substudy|Decision by Sponsor|0
5469779|NCT01952574|18907511|P4|Clinical Home Use Substudy|Decision by Sponsor|0
5469780|NCT01952574|18907512|P3|Clinical Home Use Substudy|Decision by Sponsor|0
5469781|NCT01952574|18907513|P2|Clinical Home Use Substudy|Decision by Sponsor|0
5469782|NCT01952574|18907514|P1|Clinical Home Use Substudy|Decision by Sponsor|0
5469783|NCT01952574|18907508|P7|Clinical Home Use Substudy|Withdrawal by Subject|0
5469784|NCT01952574|18907509|P6|Clinical Home Use Substudy|Withdrawal by Subject|1
5469785|NCT01952574|18907510|P5|Clinical Home Use Substudy|Withdrawal by Subject|0
5469786|NCT01952574|18907511|P4|Clinical Home Use Substudy|Withdrawal by Subject|0
5469787|NCT01952574|18907512|P3|Clinical Home Use Substudy|Withdrawal by Subject|0
5469788|NCT01952574|18907513|P2|Clinical Home Use Substudy|Withdrawal by Subject|0
5469789|NCT01952574|18907514|P1|Clinical Home Use Substudy|Withdrawal by Subject|0
5469790|NCT01952574|18907508|P7|Open-label Treatment Phase|Death|0
5469791|NCT01952574|18907509|P6|Open-label Treatment Phase|Death|0
5469792|NCT01952574|18907510|P5|Open-label Treatment Phase|Death|1
5469793|NCT01952574|18907511|P4|Open-label Treatment Phase|Death|0
5469794|NCT01952574|18907512|P3|Open-label Treatment Phase|Death|0
5469795|NCT01952574|18907513|P2|Open-label Treatment Phase|Death|0
5469796|NCT01952574|18907514|P1|Open-label Treatment Phase|Death|0
5469797|NCT01952574|18907508|P7|Open-label Treatment Phase|Lost to Follow-up|0
5469798|NCT01952574|18907509|P6|Open-label Treatment Phase|Lost to Follow-up|0
5469799|NCT01952574|18907510|P5|Open-label Treatment Phase|Lost to Follow-up|19
5469800|NCT01952574|18907511|P4|Open-label Treatment Phase|Lost to Follow-up|0
5469801|NCT01952574|18907512|P3|Open-label Treatment Phase|Lost to Follow-up|0
5469802|NCT01952574|18907513|P2|Open-label Treatment Phase|Lost to Follow-up|0
5469803|NCT01952574|18907514|P1|Open-label Treatment Phase|Lost to Follow-up|0
5469804|NCT01952574|18907508|P7|Open-label Treatment Phase|Missing|0
5469805|NCT01952574|18907509|P6|Open-label Treatment Phase|Missing|0
5469806|NCT01952574|18907510|P5|Open-label Treatment Phase|Missing|4
5469807|NCT01952574|18907511|P4|Open-label Treatment Phase|Missing|0
5469808|NCT01952574|18907512|P3|Open-label Treatment Phase|Missing|0
5469809|NCT01952574|18907513|P2|Open-label Treatment Phase|Missing|0
5469810|NCT01952574|18907514|P1|Open-label Treatment Phase|Missing|0
5469811|NCT01952574|18907508|P7|Open-label Treatment Phase|Decision by Sponsor|0
5469812|NCT01952574|18907509|P6|Open-label Treatment Phase|Decision by Sponsor|0
5469813|NCT01952574|18907510|P5|Open-label Treatment Phase|Decision by Sponsor|17
5469814|NCT01952574|18907511|P4|Open-label Treatment Phase|Decision by Sponsor|0
5469815|NCT01952574|18907512|P3|Open-label Treatment Phase|Decision by Sponsor|0
5469816|NCT01952574|18907513|P2|Open-label Treatment Phase|Decision by Sponsor|0
5469817|NCT01952574|18907514|P1|Open-label Treatment Phase|Decision by Sponsor|0
5469818|NCT01952574|18907508|P7|Open-label Treatment Phase|Withdrawal by Subject|0
5469819|NCT01952574|18907509|P6|Open-label Treatment Phase|Withdrawal by Subject|0
5469820|NCT01952574|18907510|P5|Open-label Treatment Phase|Withdrawal by Subject|121
5469821|NCT01952574|18907511|P4|Open-label Treatment Phase|Withdrawal by Subject|0
5469822|NCT01952574|18907512|P3|Open-label Treatment Phase|Withdrawal by Subject|0
5469823|NCT01952574|18907513|P2|Open-label Treatment Phase|Withdrawal by Subject|0
5469824|NCT01952574|18907514|P1|Open-label Treatment Phase|Withdrawal by Subject|0
5469825|NCT01952574|18907508|P7|Double-blind Treatment Phase|Lost to Follow-up|0
5469826|NCT01952574|18907509|P6|Double-blind Treatment Phase|Lost to Follow-up|0
5469827|NCT01952574|18907510|P5|Double-blind Treatment Phase|Lost to Follow-up|0
5469828|NCT01952574|18907511|P4|Double-blind Treatment Phase|Lost to Follow-up|0
5469829|NCT01952574|18907512|P3|Double-blind Treatment Phase|Lost to Follow-up|1
5469830|NCT01952574|18907513|P2|Double-blind Treatment Phase|Lost to Follow-up|0
5469831|NCT01952574|18907514|P1|Double-blind Treatment Phase|Lost to Follow-up|2
5469832|NCT01952574|18907508|P7|Double-blind Treatment Phase|Sponsor Decision|0
5469833|NCT01952574|18907509|P6|Double-blind Treatment Phase|Sponsor Decision|0
5469834|NCT01952574|18907510|P5|Double-blind Treatment Phase|Sponsor Decision|0
5469835|NCT01952574|18907511|P4|Double-blind Treatment Phase|Sponsor Decision|2
5469836|NCT01952574|18907512|P3|Double-blind Treatment Phase|Sponsor Decision|5
5469837|NCT01952574|18907513|P2|Double-blind Treatment Phase|Sponsor Decision|0
5469838|NCT01952574|18907514|P1|Double-blind Treatment Phase|Sponsor Decision|6
5469839|NCT01952574|18907508|P7|Double-blind Treatment Phase|Withdrawal by Subject|0
5469840|NCT01952574|18907509|P6|Double-blind Treatment Phase|Withdrawal by Subject|0
5469841|NCT01952574|18907510|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
5469842|NCT01952574|18907511|P4|Double-blind Treatment Phase|Withdrawal by Subject|4
5469843|NCT01952574|18907512|P3|Double-blind Treatment Phase|Withdrawal by Subject|3
5469844|NCT01952574|18907513|P2|Double-blind Treatment Phase|Withdrawal by Subject|3
5469845|NCT01952574|18907514|P1|Double-blind Treatment Phase|Withdrawal by Subject|9
5469846|NCT01952366|18907638|P1|Overall Study|Withdrawal by Subject|9
5469847|NCT01952366|18907638|P1|Overall Study|Death|22
5469848|NCT01952145|18907653|P2|Overall Study|Unclassified|1
5469849|NCT01952145|18907654|P1|Overall Study|Unclassified|1
5469850|NCT01952145|18907653|P2|Overall Study|Withdrawal Criteria|11
5469851|NCT01952145|18907654|P1|Overall Study|Withdrawal Criteria|16
5469852|NCT01952145|18907653|P2|Overall Study|Adverse Event|0
5469853|NCT01952145|18907654|P1|Overall Study|Adverse Event|9
5469854|NCT01952145|18907653|P2|Overall Study|Death|1
5469855|NCT01952145|18907654|P1|Overall Study|Death|0
5469856|NCT01952145|18907653|P2|Overall Study|Protocol Violation|1
5469857|NCT01952145|18907654|P1|Overall Study|Protocol Violation|2
5469858|NCT01952080|18907668|P4|Overall Study|Protocol Non-compliance|0
5469859|NCT01952080|18907669|P3|Overall Study|Protocol Non-compliance|0
5469860|NCT01952080|18907670|P2|Overall Study|Protocol Non-compliance|1
5469861|NCT01952080|18907671|P1|Overall Study|Protocol Non-compliance|0
5469862|NCT01952080|18907668|P4|Overall Study|Withdrawal by Subject|1
5469863|NCT01952080|18907669|P3|Overall Study|Withdrawal by Subject|0
5469864|NCT01952080|18907670|P2|Overall Study|Withdrawal by Subject|0
5469865|NCT01952080|18907671|P1|Overall Study|Withdrawal by Subject|0
5469866|NCT01952054|18907717|P1|Overall Study|Physician Decision|1
5469867|NCT01952041|18907725|P2|Overall Study|Death|0
5469868|NCT01952041|18907726|P1|Overall Study|Death|1
5469869|NCT01952041|18907725|P2|Overall Study|Withdrawal by Subject|5
5469870|NCT01952041|18907726|P1|Overall Study|Withdrawal by Subject|7
5469871|NCT01952041|18907725|P2|Overall Study|Lost to Follow-up|16
5469872|NCT01952041|18907726|P1|Overall Study|Lost to Follow-up|9
5469873|NCT01952015|18907740|P1|Treatment Period 3|Physician Decision|9
5469874|NCT01952015|18907740|P1|Maintenance|Adverse Event|2
5469875|NCT01952015|18907740|P1|Induction|Protocol Violation|1
5469876|NCT01951703|18907807|P2|Second Intervention|Unsatisfactory Lens fitting|1
5469877|NCT01951703|18907808|P1|Second Intervention|Unsatisfactory Lens fitting|0
5469878|NCT01951703|18907807|P2|Second Intervention|Protocol Violation|1
5469879|NCT01951703|18907808|P1|Second Intervention|Protocol Violation|0
5469880|NCT01951703|18907807|P2|First Intervention|Physician Decision|0
5469881|NCT01951703|18907808|P1|First Intervention|Physician Decision|1
5469882|NCT01951703|18907807|P2|First Intervention|Subject was not compliant|1
5469883|NCT01951703|18907808|P1|First Intervention|Subject was not compliant|1
5469884|NCT01951703|18907807|P2|First Intervention|Withdrawal by Subject|0
5469885|NCT01951703|18907808|P1|First Intervention|Withdrawal by Subject|1
5469886|NCT01951586|18907833|P2|Overall Study|Sponsor Decision|10
5469887|NCT01951586|18907834|P1|Overall Study|Sponsor Decision|9
5469888|NCT01951586|18907833|P2|Overall Study|Lost to Follow-up|1
5469889|NCT01951586|18907834|P1|Overall Study|Lost to Follow-up|0
5469890|NCT01951586|18907833|P2|Overall Study|Withdrawal by Subject|17
5469891|NCT01951586|18907834|P1|Overall Study|Withdrawal by Subject|8
5469892|NCT01951586|18907833|P2|Overall Study|Death|120
5469893|NCT01951586|18907834|P1|Overall Study|Death|61
5469894|NCT01951573|18907858|P2|Washout Period|Adverse Event|1
5469895|NCT01951573|18907859|P1|Washout Period|Adverse Event|0
5469896|NCT01951417|18907869|P1|Overall Study|Lost to Follow-up|6
5469897|NCT01951417|18907869|P1|Overall Study|Protocol Violation|2
5469898|NCT01951417|18907869|P1|Overall Study|Withdrawal by Subject|1
5469899|NCT01951378|18907905|P2|Overall Study|Study Terminated-Not completed|17
5469900|NCT01951378|18907906|P1|Overall Study|Study Terminated-Not completed|23
5469901|NCT01951261|18907983|P2|Overall Study|Protocol Violation|3
5469902|NCT01951261|18907984|P1|Overall Study|Protocol Violation|4
5469903|NCT01951261|18907983|P2|Overall Study|Lost to Follow-up|3
5469904|NCT01951261|18907984|P1|Overall Study|Lost to Follow-up|4
5469905|NCT01951261|18907983|P2|Overall Study|Death|0
5469906|NCT01951261|18907984|P1|Overall Study|Death|1
5469907|NCT01951170|18908002|P1|Overall Study|Investigator decision|1
5469908|NCT01951157|18908028|P3|Overall Study|Treatment-related death|0
5469909|NCT01951157|18908029|P2|Overall Study|Treatment-related death|2
5469910|NCT01951157|18908030|P1|Overall Study|Treatment-related death|0
5469911|NCT01951157|18908028|P3|Overall Study|Consent withdrawn by subject|3
5469912|NCT01951157|18908029|P2|Overall Study|Consent withdrawn by subject|1
5469913|NCT01951157|18908030|P1|Overall Study|Consent withdrawn by subject|0
5469914|NCT01951157|18908028|P3|Overall Study|Treatment-related AE|4
5469915|NCT01951157|18908029|P2|Overall Study|Treatment-related AE|0
5469916|NCT01951157|18908030|P1|Overall Study|Treatment-related AE|2
5469917|NCT01951157|18908028|P3|Overall Study|No treated|0
5469918|NCT01951157|18908029|P2|Overall Study|No treated|1
5469919|NCT01951157|18908030|P1|Overall Study|No treated|0
5469920|NCT01951157|18908028|P3|Overall Study|Non-treatmentrelated death|2
5469921|NCT01951157|18908029|P2|Overall Study|Non-treatmentrelated death|2
5469922|NCT01951157|18908030|P1|Overall Study|Non-treatmentrelated death|2
5469923|NCT01951157|18908028|P3|Overall Study|Physician Decision|2
5469924|NCT01951157|18908029|P2|Overall Study|Physician Decision|3
5469925|NCT01951157|18908030|P1|Overall Study|Physician Decision|5
5469926|NCT01951157|18908028|P3|Overall Study|Study Termination|1
5469927|NCT01951157|18908029|P2|Overall Study|Study Termination|0
5469928|NCT01951157|18908030|P1|Overall Study|Study Termination|0
5469929|NCT01951157|18908028|P3|Overall Study|Treatment-unrelated AE|3
5469930|NCT01951157|18908029|P2|Overall Study|Treatment-unrelated AE|0
5469931|NCT01951157|18908030|P1|Overall Study|Treatment-unrelated AE|1
5469932|NCT01951157|18908028|P3|Overall Study|Progressive Disease|10
5469933|NCT01951157|18908029|P2|Overall Study|Progressive Disease|13
5469934|NCT01951157|18908030|P1|Overall Study|Progressive Disease|12
5469935|NCT01951105|18908081|P3|Overall Study|Withdrawal by Subject|1
5469936|NCT01951105|18908082|P2|Overall Study|Withdrawal by Subject|3
5469937|NCT01951105|18908083|P1|Overall Study|Withdrawal by Subject|0
5469938|NCT01951105|18908081|P3|Overall Study|Protocol Violation|1
5469939|NCT01951105|18908082|P2|Overall Study|Protocol Violation|1
5469940|NCT01951105|18908083|P1|Overall Study|Protocol Violation|1
5469941|NCT01951105|18908081|P3|Overall Study|Lost to Follow-up|0
5469942|NCT01951105|18908082|P2|Overall Study|Lost to Follow-up|1
5469943|NCT01951105|18908083|P1|Overall Study|Lost to Follow-up|0
5469944|NCT01951105|18908081|P3|Overall Study|Adverse Event|0
5469945|NCT01951105|18908082|P2|Overall Study|Adverse Event|5
5469946|NCT01951105|18908083|P1|Overall Study|Adverse Event|0
5469947|NCT01951092|18908097|P1|Overall Study|Transfer of Care|1
5469948|NCT01951092|18908097|P1|Overall Study|Incarceration|1
5469949|NCT01951092|18908097|P1|Overall Study|Lost to Follow-up|10
5469950|NCT01950819|18908110|P2|Overall Study|Lost to Follow-up|17
5469951|NCT01950819|18908111|P1|Overall Study|Lost to Follow-up|9
5469952|NCT01950819|18908110|P2|Overall Study|Pregnancy|2
5469953|NCT01950819|18908111|P1|Overall Study|Pregnancy|0
5469954|NCT01950819|18908110|P2|Overall Study|technical problems|0
5469955|NCT01950819|18908111|P1|Overall Study|technical problems|2
5469956|NCT01950819|18908110|P2|Overall Study|Subject / Gardian decision|51
5469957|NCT01950819|18908111|P1|Overall Study|Subject / Gardian decision|54
5469958|NCT01950819|18908110|P2|Overall Study|Death|34
5469959|NCT01950819|18908111|P1|Overall Study|Death|29
5469960|NCT01950819|18908110|P2|Overall Study|Graft Loss|30
5469961|NCT01950819|18908111|P1|Overall Study|Graft Loss|35
5469962|NCT01950741|18908164|P1|Overall Study|Withdrawal by Subject|1
5469963|NCT01950741|18908164|P1|Overall Study|Death|1
5469964|NCT01950741|18908164|P1|Overall Study|Lost to Follow-up|1
5469965|NCT01950364|18908179|P2|Overall Study|Protocol Violation|1
5469966|NCT01950364|18908180|P1|Overall Study|Protocol Violation|0
5469967|NCT01950364|18908179|P2|Overall Study|Withdrawal by Subject|1
5469968|NCT01950364|18908180|P1|Overall Study|Withdrawal by Subject|0
5469969|NCT01950364|18908179|P2|Overall Study|Disease Progression|2
5469970|NCT01950364|18908180|P1|Overall Study|Disease Progression|5
5469971|NCT01950364|18908179|P2|Overall Study|Stem Cell Transplant|6
5469972|NCT01950364|18908180|P1|Overall Study|Stem Cell Transplant|2
5469973|NCT01950364|18908179|P2|Overall Study|Adverse Event|0
5469974|NCT01950364|18908180|P1|Overall Study|Adverse Event|3
5469975|NCT01950273|18908302|P2|Overall Study|Other not defined above|0
5469976|NCT01950273|18908303|P1|Overall Study|Other not defined above|1
5469977|NCT01950273|18908302|P2|Overall Study|Withdrawal by Subject|0
5469978|NCT01950273|18908303|P1|Overall Study|Withdrawal by Subject|2
5469979|NCT01950273|18908302|P2|Overall Study|Protocol Violation|0
5469980|NCT01950273|18908303|P1|Overall Study|Protocol Violation|1
5469981|NCT01950013|18908350|P3|Overall Study|Withdrawal by Subject|0
5469982|NCT01950013|18908351|P2|Overall Study|Withdrawal by Subject|2
5469983|NCT01950013|18908352|P1|Overall Study|Withdrawal by Subject|0
5469984|NCT01949870|18908363|P1|Overall Study|Eligibility requirements not fulfilled|2
5469985|NCT01949870|18908363|P1|Overall Study|Study termination|1
5469986|NCT01949870|18908363|P1|Overall Study|Adverse Event|1
5469987|NCT01949870|18908363|P1|Overall Study|Lack of Efficacy|2
5469988|NCT01949662|18908379|P2|Overall Study|Ineligible|1
5469989|NCT01949662|18908380|P1|Overall Study|Ineligible|0
5469990|NCT01949662|18908379|P2|Overall Study|Dropped out|3
5469991|NCT01949662|18908380|P1|Overall Study|Dropped out|1
5469992|NCT01949662|18908379|P2|Overall Study|Discharged before an agitation event|3
5469993|NCT01949662|18908380|P1|Overall Study|Discharged before an agitation event|8
5469994|NCT01949662|18908379|P2|Overall Study|Death|7
5469995|NCT01949662|18908380|P1|Overall Study|Death|9
5469996|NCT01949532|18908547|P2|Overall Study|On-study at the Data Cut-off Date|3
5469997|NCT01949532|18908548|P1|Overall Study|On-study at the Data Cut-off Date|3
5469998|NCT01949480|18908618|P2|Overall Study|Physician Decision|8
5469999|NCT01949480|18908619|P1|Overall Study|Physician Decision|5
5470000|NCT01949155|18908665|P2|Overall Study|Protocol Violation|0
5470001|NCT01949155|18908666|P1|Overall Study|Protocol Violation|1
5470002|NCT01949155|18908665|P2|Overall Study|Lost to Follow-up|0
5470003|NCT01949155|18908666|P1|Overall Study|Lost to Follow-up|1
5470004|NCT01949142|18908678|P2|Overall Study|Parent changed their mind|0
5470005|NCT01949142|18908679|P1|Overall Study|Parent changed their mind|1
5470006|NCT01949142|18908678|P2|Overall Study|Lost to Follow-up|1
5470007|NCT01949142|18908679|P1|Overall Study|Lost to Follow-up|1
5470008|NCT01949142|18908678|P2|Overall Study|Withdrawal of consent|0
5470009|NCT01949142|18908679|P1|Overall Study|Withdrawal of consent|1
5470010|NCT01949116|18908691|P2|Overall Study|Withdrawal by Subject|3
5470011|NCT01949116|18908692|P1|Overall Study|Withdrawal by Subject|5
5470012|NCT01949116|18908691|P2|Overall Study|Lost to Follow-up|3
5470013|NCT01949116|18908692|P1|Overall Study|Lost to Follow-up|1
5470014|NCT01949116|18908691|P2|Overall Study|Death|0
5470015|NCT01949116|18908692|P1|Overall Study|Death|2
5470016|NCT01949090|18908729|P5|Overall Study|Lost to Follow-up|1
5470017|NCT01949090|18908730|P4|Overall Study|Lost to Follow-up|1
5470018|NCT01949090|18908731|P3|Overall Study|Lost to Follow-up|0
5470019|NCT01949090|18908732|P2|Overall Study|Lost to Follow-up|1
5470020|NCT01949090|18908733|P1|Overall Study|Lost to Follow-up|2
5470021|NCT01949090|18908729|P5|Overall Study|Protocol non-compliance|1
5470022|NCT01949090|18908730|P4|Overall Study|Protocol non-compliance|0
5470023|NCT01949090|18908731|P3|Overall Study|Protocol non-compliance|0
5470024|NCT01949090|18908732|P2|Overall Study|Protocol non-compliance|0
5470025|NCT01949090|18908733|P1|Overall Study|Protocol non-compliance|0
5470026|NCT01949090|18908729|P5|Overall Study|Withdrawal by Subject|1
5470027|NCT01949090|18908730|P4|Overall Study|Withdrawal by Subject|0
5470028|NCT01949090|18908731|P3|Overall Study|Withdrawal by Subject|0
5470029|NCT01949090|18908732|P2|Overall Study|Withdrawal by Subject|0
5470030|NCT01949090|18908733|P1|Overall Study|Withdrawal by Subject|2
5470031|NCT01949090|18908729|P5|Overall Study|Serious Adverse Event|1
5470032|NCT01949090|18908730|P4|Overall Study|Serious Adverse Event|0
5470033|NCT01949090|18908731|P3|Overall Study|Serious Adverse Event|2
5470034|NCT01949090|18908732|P2|Overall Study|Serious Adverse Event|1
5470035|NCT01949090|18908733|P1|Overall Study|Serious Adverse Event|0
5470036|NCT01949051|18908910|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5470037|NCT01949051|18908911|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5470038|NCT01949051|18908912|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5470039|NCT01949051|18908913|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
5470040|NCT01949051|18908914|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5470041|NCT01949051|18908915|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
5470042|NCT01949051|18908910|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5470043|NCT01949051|18908911|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5470044|NCT01949051|18908912|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5470045|NCT01949051|18908913|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5470046|NCT01949051|18908914|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
5470047|NCT01949051|18908915|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
5470048|NCT01949051|18908910|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
5470049|NCT01949051|18908911|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
5470050|NCT01949051|18908912|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
5470051|NCT01949051|18908913|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
5470052|NCT01949051|18908914|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
5470053|NCT01949051|18908915|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
5470054|NCT01949051|18908910|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5470055|NCT01949051|18908911|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5470056|NCT01949051|18908912|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5470057|NCT01949051|18908913|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5470058|NCT01949051|18908914|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5470059|NCT01949051|18908915|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
5470060|NCT01949051|18908910|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
5470061|NCT01949051|18908911|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
5470062|NCT01949051|18908912|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
5470063|NCT01949051|18908913|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
5470064|NCT01949051|18908914|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
5470065|NCT01949051|18908915|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
5470066|NCT01948908|18909110|P3|Overall Study|Protocol Violation|2
5470067|NCT01948908|18909111|P2|Overall Study|Protocol Violation|0
5470068|NCT01948908|18909112|P1|Overall Study|Protocol Violation|1
5470069|NCT01948830|18909128|P2|Overall Study|Death|4
5470070|NCT01948830|18909129|P1|Overall Study|Death|3
5470071|NCT01948830|18909128|P2|Overall Study|Adverse Event|2
5470072|NCT01948830|18909129|P1|Overall Study|Adverse Event|9
5470073|NCT01948830|18909128|P2|Overall Study|Withdrawal by Subject|17
5470074|NCT01948830|18909129|P1|Overall Study|Withdrawal by Subject|14
5470075|NCT01948830|18909128|P2|Overall Study|Lost to Follow-up|4
5470076|NCT01948830|18909129|P1|Overall Study|Lost to Follow-up|5
5470077|NCT01948830|18909128|P2|Overall Study|Protocol deviation|2
5470078|NCT01948830|18909129|P1|Overall Study|Protocol deviation|1
5470079|NCT01948830|18909128|P2|Overall Study|Physician Decision|3
5470080|NCT01948830|18909129|P1|Overall Study|Physician Decision|1
5470081|NCT01948791|18909161|P1|Overall Study|Screening failure|35
5470082|NCT01948791|18909161|P1|Overall Study|Others|7
5470083|NCT01948791|18909161|P1|Overall Study|Management issues|1
5470084|NCT01948791|18909161|P1|Overall Study|Lost to Follow-up|6
5470085|NCT01948791|18909161|P1|Overall Study|Withdrawal by Subject|5
5470086|NCT01948791|18909161|P1|Overall Study|Protocol Violation|2
5470087|NCT01948791|18909161|P1|Overall Study|Lack of Efficacy|3
5470088|NCT01948791|18909161|P1|Overall Study|Adverse Event|12
5470089|NCT01948258|18909221|P1|Overall Study|Removed from statistical analysis|2
5470090|NCT01948258|18909221|P1|Overall Study|Health Care Professional|43
5470091|NCT01948258|18909221|P1|Overall Study|Withdrawal by Subject|6
5470092|NCT01948258|18909221|P1|Overall Study|Withdrawal by SPD|8
5470093|NCT01948258|18909221|P1|Overall Study|Lost to Follow-up|27
5470094|NCT01948258|18909221|P1|Overall Study|Did not complete by cut-off date|35
5470095|NCT01948258|18909221|P1|Overall Study|Pregnancy|41
5470096|NCT01948193|18909227|P1|Overall Study|Lost to Follow-up|7
5470097|NCT01948193|18909227|P1|Overall Study|Serious event|2
5470098|NCT01948076|18909249|P2|Overall Study|Withdrawal by Subject|1
5470099|NCT01948076|18909250|P1|Overall Study|Withdrawal by Subject|0
5470100|NCT01948063|18909260|P2|Overall Study|Blood samples were accidentally thawed|0
5470101|NCT01948063|18909261|P1|Overall Study|Blood samples were accidentally thawed|1
5470102|NCT01948063|18909260|P2|Overall Study|Discovered an enrollment in other study|1
5470103|NCT01948063|18909261|P1|Overall Study|Discovered an enrollment in other study|0
5470104|NCT01948063|18909260|P2|Overall Study|Boston MCI halted research protocol|1
5470105|NCT01948063|18909261|P1|Overall Study|Boston MCI halted research protocol|0
5470106|NCT01948050|18909269|P2|Overall Study|Withdrawal by Subject|1
5470107|NCT01948050|18909270|P1|Overall Study|Withdrawal by Subject|0
5470108|NCT01947894|18909338|P3|Overall Study|Switched to other growth hormone brand|23
5470109|NCT01947894|18909339|P2|Overall Study|Switched to other growth hormone brand|8
5470110|NCT01947894|18909340|P1|Overall Study|Switched to other growth hormone brand|53
5470111|NCT01947894|18909338|P3|Overall Study|Adverse Event|0
5470112|NCT01947894|18909339|P2|Overall Study|Adverse Event|1
5470113|NCT01947894|18909340|P1|Overall Study|Adverse Event|5
5470114|NCT01947894|18909338|P3|Overall Study|Physician Decision|0
5470115|NCT01947894|18909339|P2|Overall Study|Physician Decision|0
5470116|NCT01947894|18909340|P1|Overall Study|Physician Decision|2
5470117|NCT01947894|18909338|P3|Overall Study|Death|0
5470118|NCT01947894|18909339|P2|Overall Study|Death|1
5470119|NCT01947894|18909340|P1|Overall Study|Death|12
5470120|NCT01947894|18909338|P3|Overall Study|Withdrawal by Subject|1
5470121|NCT01947894|18909339|P2|Overall Study|Withdrawal by Subject|4
5470122|NCT01947894|18909340|P1|Overall Study|Withdrawal by Subject|12
5470123|NCT01947894|18909338|P3|Overall Study|Other|3
5470124|NCT01947894|18909339|P2|Overall Study|Other|4
5470125|NCT01947894|18909340|P1|Overall Study|Other|3
5470126|NCT01947855|18909405|P3|Overall Study|Withdrawal by Subject|0
5470127|NCT01947855|18909406|P2|Overall Study|Withdrawal by Subject|0
5470128|NCT01947855|18909407|P1|Overall Study|Withdrawal by Subject|1
5470129|NCT01947582|18909442|P1|Overall Study|Withdrawal by Subject|1
5470130|NCT01947517|18909451|P2|Overall Study|Withdrawal by Subject|1
5470131|NCT01947517|18909452|P1|Overall Study|Withdrawal by Subject|1
5470132|NCT01947491|18909470|P4|Overall Study|Adverse Event|2
5470133|NCT01947491|18909471|P3|Overall Study|Adverse Event|0
5470134|NCT01947491|18909472|P2|Overall Study|Adverse Event|1
5470135|NCT01947491|18909473|P1|Overall Study|Adverse Event|0
5470136|NCT01947491|18909470|P4|Overall Study|Worsening of condition|0
5470137|NCT01947491|18909471|P3|Overall Study|Worsening of condition|0
5470138|NCT01947491|18909472|P2|Overall Study|Worsening of condition|1
5470139|NCT01947491|18909473|P1|Overall Study|Worsening of condition|0
5470140|NCT01947491|18909470|P4|Overall Study|Withdrawal by Subject|0
5470141|NCT01947491|18909471|P3|Overall Study|Withdrawal by Subject|1
5470142|NCT01947491|18909472|P2|Overall Study|Withdrawal by Subject|1
5470143|NCT01947491|18909473|P1|Overall Study|Withdrawal by Subject|1
5470144|NCT01947491|18909470|P4|Overall Study|Protocol Violation|0
5470145|NCT01947491|18909471|P3|Overall Study|Protocol Violation|0
5470146|NCT01947491|18909472|P2|Overall Study|Protocol Violation|0
5470147|NCT01947491|18909473|P1|Overall Study|Protocol Violation|1
5470148|NCT01947491|18909470|P4|Overall Study|Lack of Efficacy|1
5470149|NCT01947491|18909471|P3|Overall Study|Lack of Efficacy|0
5470150|NCT01947491|18909472|P2|Overall Study|Lack of Efficacy|0
5470151|NCT01947491|18909473|P1|Overall Study|Lack of Efficacy|1
5470152|NCT01947491|18909470|P4|Overall Study|Lost to Follow-up|2
5470153|NCT01947491|18909471|P3|Overall Study|Lost to Follow-up|1
5470154|NCT01947491|18909472|P2|Overall Study|Lost to Follow-up|3
5470155|NCT01947491|18909473|P1|Overall Study|Lost to Follow-up|5
5470156|NCT01947283|18909503|P7|Overall Study|No patients were enrolled in study|1
5470157|NCT01947283|18909504|P6|Overall Study|No patients were enrolled in study|3
5470158|NCT01947283|18909505|P5|Overall Study|No patients were enrolled in study|0
5470159|NCT01947283|18909506|P4|Overall Study|No patients were enrolled in study|0
5470160|NCT01947283|18909507|P3|Overall Study|No patients were enrolled in study|0
5470161|NCT01947283|18909508|P2|Overall Study|No patients were enrolled in study|0
5470162|NCT01947283|18909509|P1|Overall Study|No patients were enrolled in study|0
5470163|NCT01947283|18909503|P7|Overall Study|Missing Follow-up Assessment|0
5470164|NCT01947283|18909504|P6|Overall Study|Missing Follow-up Assessment|2
5470165|NCT01947283|18909505|P5|Overall Study|Missing Follow-up Assessment|0
5470166|NCT01947283|18909506|P4|Overall Study|Missing Follow-up Assessment|0
5470167|NCT01947283|18909507|P3|Overall Study|Missing Follow-up Assessment|3
5470168|NCT01947283|18909508|P2|Overall Study|Missing Follow-up Assessment|2
5470169|NCT01947283|18909509|P1|Overall Study|Missing Follow-up Assessment|2
5470170|NCT01947283|18909503|P7|Overall Study|Non-coding Clinical Recording language|0
5470171|NCT01947283|18909504|P6|Overall Study|Non-coding Clinical Recording language|0
5470172|NCT01947283|18909505|P5|Overall Study|Non-coding Clinical Recording language|0
5470173|NCT01947283|18909506|P4|Overall Study|Non-coding Clinical Recording language|1
5470174|NCT01947283|18909507|P3|Overall Study|Non-coding Clinical Recording language|0
5470175|NCT01947283|18909508|P2|Overall Study|Non-coding Clinical Recording language|0
5470176|NCT01947283|18909509|P1|Overall Study|Non-coding Clinical Recording language|0
5470177|NCT01947283|18909503|P7|Overall Study|No Clinical Recording|0
5470178|NCT01947283|18909504|P6|Overall Study|No Clinical Recording|0
5470179|NCT01947283|18909505|P5|Overall Study|No Clinical Recording|0
5470180|NCT01947283|18909506|P4|Overall Study|No Clinical Recording|10
5470181|NCT01947283|18909507|P3|Overall Study|No Clinical Recording|8
5470182|NCT01947283|18909508|P2|Overall Study|No Clinical Recording|6
5470183|NCT01947283|18909509|P1|Overall Study|No Clinical Recording|12
5470184|NCT01947283|18909503|P7|Overall Study|Withdrawal by Subject|2
5470185|NCT01947283|18909504|P6|Overall Study|Withdrawal by Subject|0
5470186|NCT01947283|18909505|P5|Overall Study|Withdrawal by Subject|0
5470187|NCT01947283|18909506|P4|Overall Study|Withdrawal by Subject|1
5470188|NCT01947283|18909507|P3|Overall Study|Withdrawal by Subject|4
5470189|NCT01947283|18909508|P2|Overall Study|Withdrawal by Subject|8
5470190|NCT01947283|18909509|P1|Overall Study|Withdrawal by Subject|10
5470191|NCT01947283|18909503|P7|Overall Study|Lost to Follow-up|5
5470192|NCT01947283|18909504|P6|Overall Study|Lost to Follow-up|2
5470193|NCT01947283|18909505|P5|Overall Study|Lost to Follow-up|0
5470194|NCT01947283|18909506|P4|Overall Study|Lost to Follow-up|5
5470195|NCT01947283|18909507|P3|Overall Study|Lost to Follow-up|5
5470196|NCT01947283|18909508|P2|Overall Study|Lost to Follow-up|6
5470197|NCT01947283|18909509|P1|Overall Study|Lost to Follow-up|4
5470198|NCT01947283|18909503|P7|Overall Study|Death|0
5470199|NCT01947283|18909504|P6|Overall Study|Death|0
5470200|NCT01947283|18909505|P5|Overall Study|Death|0
5470201|NCT01947283|18909506|P4|Overall Study|Death|0
5470202|NCT01947283|18909507|P3|Overall Study|Death|1
5470203|NCT01947283|18909508|P2|Overall Study|Death|1
5470204|NCT01947283|18909509|P1|Overall Study|Death|1
5470205|NCT01947127|18909581|P2|Overall Study|Data loss|4
5470206|NCT01947127|18909582|P1|Overall Study|Data loss|4
5470207|NCT01947127|18909581|P2|Overall Study|Withdrawal by Subject|1
5470208|NCT01947127|18909582|P1|Overall Study|Withdrawal by Subject|1
5470209|NCT01947127|18909581|P2|Overall Study|Protocol Violation|38
5470210|NCT01947127|18909582|P1|Overall Study|Protocol Violation|18
5470211|NCT01946880|18909594|P2|Overall Study|Personal and Family Issues|0
5470212|NCT01946880|18909595|P1|Overall Study|Personal and Family Issues|1
5470213|NCT01946880|18909594|P2|Overall Study|Met Primary Endpoint|0
5470214|NCT01946880|18909595|P1|Overall Study|Met Primary Endpoint|1
5470215|NCT01946880|18909594|P2|Overall Study|Withdrawal by Subject|2
5470216|NCT01946880|18909595|P1|Overall Study|Withdrawal by Subject|3
5470217|NCT01946880|18909594|P2|Overall Study|Physician Decision|1
5470218|NCT01946880|18909595|P1|Overall Study|Physician Decision|1
5470219|NCT01946880|18909594|P2|Overall Study|Lost to Follow-up|0
5470220|NCT01946880|18909595|P1|Overall Study|Lost to Follow-up|1
5470221|NCT01946529|18909685|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
5470222|NCT01946529|18909686|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
5470223|NCT01946529|18909687|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
5470224|NCT01946529|18909685|P3|End of Window Therapy (2 Courses)|Physician Decision|0
5470225|NCT01946529|18909686|P2|End of Window Therapy (2 Courses)|Physician Decision|1
5470226|NCT01946529|18909687|P1|End of Window Therapy (2 Courses)|Physician Decision|0
5470227|NCT01946438|18909698|P4|Overall Study|Withdrawal by Subject|0
5470228|NCT01946438|18909699|P3|Overall Study|Withdrawal by Subject|0
5470229|NCT01946438|18909700|P2|Overall Study|Withdrawal by Subject|0
5470230|NCT01946438|18909701|P1|Overall Study|Withdrawal by Subject|1
5470231|NCT01946438|18909698|P4|Overall Study|Protocol Violation|0
5470232|NCT01946438|18909699|P3|Overall Study|Protocol Violation|1
5470233|NCT01946438|18909700|P2|Overall Study|Protocol Violation|0
5470234|NCT01946438|18909701|P1|Overall Study|Protocol Violation|0
5470235|NCT01946438|18909698|P4|Overall Study|Serious Adverse event|0
5470236|NCT01946438|18909699|P3|Overall Study|Serious Adverse event|0
5470237|NCT01946438|18909700|P2|Overall Study|Serious Adverse event|0
5470238|NCT01946438|18909701|P1|Overall Study|Serious Adverse event|1
5470239|NCT01946438|18909698|P4|Overall Study|Adverse Event|1
5470240|NCT01946438|18909699|P3|Overall Study|Adverse Event|0
5470241|NCT01946438|18909700|P2|Overall Study|Adverse Event|0
5470242|NCT01946438|18909701|P1|Overall Study|Adverse Event|0
5470243|NCT01946425|18909729|P2|Overall Study|Withdrawal by Subject|0
5470244|NCT01946425|18909730|P1|Overall Study|Withdrawal by Subject|1
5470245|NCT01946425|18909729|P2|Overall Study|Protocol Violation|0
5470246|NCT01946425|18909730|P1|Overall Study|Protocol Violation|1
5470247|NCT01946412|18909744|P1|Overall Study|Difficulty in swallowing|1
5470248|NCT01946412|18909744|P1|Overall Study|Continued with commercial Kalydeco|2
5470249|NCT01946412|18909744|P1|Overall Study|Non-Compliance|1
5470250|NCT01946412|18909744|P1|Overall Study|Adverse Event|1
5470251|NCT01946282|18909769|P3|Year 3|Did not return FIT kit|30
5470252|NCT01946282|18909770|P2|Year 3|Did not return FIT kit|43
5470253|NCT01946282|18909771|P1|Year 3|Did not return FIT kit|288
5470254|NCT01946282|18909769|P3|Year 2|Did not return FIT kit|115
5470255|NCT01946282|18909770|P2|Year 2|Did not return FIT kit|131
5470256|NCT01946282|18909771|P1|Year 2|Did not return FIT kit|803
5470257|NCT01946282|18909769|P3|Year 1|Did not return FIT kit|654
5470258|NCT01946282|18909770|P2|Year 1|Did not return FIT kit|608
5470259|NCT01946282|18909771|P1|Year 1|Did not return FIT kit|4186
5470260|NCT01946204|18909804|P2|Overall Study|Other|3
5470261|NCT01946204|18909805|P1|Overall Study|Other|7
5470262|NCT01946204|18909804|P2|Overall Study|Ongoing|687
5470263|NCT01946204|18909805|P1|Overall Study|Ongoing|316
5470264|NCT01946204|18909804|P2|Overall Study|Lost to Follow-up|7
5470265|NCT01946204|18909805|P1|Overall Study|Lost to Follow-up|3
5470266|NCT01946204|18909804|P2|Overall Study|Withdrawal by Subject|50
5470267|NCT01946204|18909805|P1|Overall Study|Withdrawal by Subject|37
5470268|NCT01946204|18909804|P2|Overall Study|Death|59
5470269|NCT01946204|18909805|P1|Overall Study|Death|38
5470270|NCT01946191|18909823|P2|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
5470271|NCT01946191|18909824|P1|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
5470272|NCT01946191|18909823|P2|Follow-Up, 24-mo Endpoint|Protocol Violation|1
5470273|NCT01946191|18909824|P1|Follow-Up, 24-mo Endpoint|Protocol Violation|0
5470274|NCT01946191|18909823|P2|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
5470275|NCT01946191|18909824|P1|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
5470276|NCT01946191|18909823|P2|Allocation|Did not complete orientation|1
5470277|NCT01946191|18909824|P1|Allocation|Did not complete orientation|1
5470278|NCT01946178|18909850|P1|Overall Study|Lost to Follow-up|1
5470279|NCT01946178|18909850|P1|Overall Study|Pregnancy|1
5470280|NCT01946165|18909860|P2|Overall Study|Withdrawal by Subject|2
5470281|NCT01946165|18909861|P1|Overall Study|Withdrawal by Subject|0
5470282|NCT01946165|18909860|P2|Overall Study|Physician Decision|0
5470283|NCT01946165|18909861|P1|Overall Study|Physician Decision|2
5470284|NCT01945996|18909888|P2|Overall Study|Lost to Follow-up|5
5470285|NCT01945996|18909889|P1|Overall Study|Lost to Follow-up|3
5470286|NCT01945944|18909965|P2|Overall Study|Withdrawal by Subject|1
5470287|NCT01945944|18909966|P1|Overall Study|Withdrawal by Subject|0
5470288|NCT01945944|18909965|P2|Overall Study|Physician Decision|0
5470289|NCT01945944|18909966|P1|Overall Study|Physician Decision|1
5470290|NCT01945944|18909965|P2|Overall Study|Adverse Event|2
5470291|NCT01945944|18909966|P1|Overall Study|Adverse Event|0
5470292|NCT01945866|18909990|P2|Overall Study|Eyes did not complete or were dropped|0
5470293|NCT01945866|18909991|P1|Overall Study|Eyes did not complete or were dropped|2
5470294|NCT01945775|18910012|P2|Overall Study|Ongoing|19
5470295|NCT01945775|18910013|P1|Overall Study|Ongoing|56
5470296|NCT01945775|18910012|P2|Overall Study|Withdrawal by Subject|21
5470297|NCT01945775|18910013|P1|Overall Study|Withdrawal by Subject|10
5470298|NCT01945775|18910012|P2|Overall Study|Lost to Follow-up|7
5470299|NCT01945775|18910013|P1|Overall Study|Lost to Follow-up|11
5470300|NCT01945775|18910012|P2|Overall Study|Death|97
5470301|NCT01945775|18910013|P1|Overall Study|Death|210
5470302|NCT01945710|18910049|P7|Overall Study|Withdrawal by Subject|0
5470303|NCT01945710|18910050|P6|Overall Study|Withdrawal by Subject|0
5470304|NCT01945710|18910051|P5|Overall Study|Withdrawal by Subject|1
5470305|NCT01945710|18910052|P4|Overall Study|Withdrawal by Subject|0
5470306|NCT01945710|18910053|P3|Overall Study|Withdrawal by Subject|1
5470307|NCT01945710|18910054|P2|Overall Study|Withdrawal by Subject|1
5470308|NCT01945710|18910055|P1|Overall Study|Withdrawal by Subject|0
5470309|NCT01945710|18910049|P7|Overall Study|Other|4
5470310|NCT01945710|18910050|P6|Overall Study|Other|0
5470311|NCT01945710|18910051|P5|Overall Study|Other|1
5470312|NCT01945710|18910052|P4|Overall Study|Other|1
5470313|NCT01945710|18910053|P3|Overall Study|Other|3
5470314|NCT01945710|18910054|P2|Overall Study|Other|0
5470315|NCT01945710|18910055|P1|Overall Study|Other|2
5470316|NCT01945710|18910049|P7|Overall Study|Adverse Event|0
5470317|NCT01945710|18910050|P6|Overall Study|Adverse Event|0
5470318|NCT01945710|18910051|P5|Overall Study|Adverse Event|0
5470319|NCT01945710|18910052|P4|Overall Study|Adverse Event|0
5470320|NCT01945710|18910053|P3|Overall Study|Adverse Event|0
5470321|NCT01945710|18910054|P2|Overall Study|Adverse Event|1
5470322|NCT01945710|18910055|P1|Overall Study|Adverse Event|0
5470323|NCT01945710|18910049|P7|Overall Study|Progressive Disease|19
5470324|NCT01945710|18910050|P6|Overall Study|Progressive Disease|3
5470325|NCT01945710|18910051|P5|Overall Study|Progressive Disease|7
5470326|NCT01945710|18910052|P4|Overall Study|Progressive Disease|2
5470327|NCT01945710|18910053|P3|Overall Study|Progressive Disease|3
5470328|NCT01945710|18910054|P2|Overall Study|Progressive Disease|4
5470329|NCT01945710|18910055|P1|Overall Study|Progressive Disease|5
5470330|NCT01945593|18910174|P4|Overall Study|Other: Screen Failure|0
5470331|NCT01945593|18910175|P3|Overall Study|Other: Screen Failure|0
5470332|NCT01945593|18910176|P2|Overall Study|Other: Screen Failure|2
5470333|NCT01945593|18910177|P1|Overall Study|Other: Screen Failure|0
5470334|NCT01945593|18910174|P4|Overall Study|Other: Surgical Procedure|6
5470335|NCT01945593|18910175|P3|Overall Study|Other: Surgical Procedure|0
5470336|NCT01945593|18910176|P2|Overall Study|Other: Surgical Procedure|2
5470337|NCT01945593|18910177|P1|Overall Study|Other: Surgical Procedure|0
5470338|NCT01945593|18910174|P4|Overall Study|Other: Terminated|1
5470339|NCT01945593|18910175|P3|Overall Study|Other: Terminated|0
5470340|NCT01945593|18910176|P2|Overall Study|Other: Terminated|0
5470341|NCT01945593|18910177|P1|Overall Study|Other: Terminated|0
5470342|NCT01945593|18910174|P4|Overall Study|Death|0
5470343|NCT01945593|18910175|P3|Overall Study|Death|1
5470344|NCT01945593|18910176|P2|Overall Study|Death|0
5470345|NCT01945593|18910177|P1|Overall Study|Death|0
5470346|NCT01945593|18910174|P4|Overall Study|Protocol Violation|3
5470347|NCT01945593|18910175|P3|Overall Study|Protocol Violation|1
5470348|NCT01945593|18910176|P2|Overall Study|Protocol Violation|2
5470349|NCT01945593|18910177|P1|Overall Study|Protocol Violation|0
5470350|NCT01945593|18910174|P4|Overall Study|Withdrawal by Subject|4
5470351|NCT01945593|18910175|P3|Overall Study|Withdrawal by Subject|0
5470352|NCT01945593|18910176|P2|Overall Study|Withdrawal by Subject|2
5470353|NCT01945593|18910177|P1|Overall Study|Withdrawal by Subject|0
5470354|NCT01945593|18910174|P4|Overall Study|Physician Decision|1
5470355|NCT01945593|18910175|P3|Overall Study|Physician Decision|1
5470356|NCT01945593|18910176|P2|Overall Study|Physician Decision|0
5470357|NCT01945593|18910177|P1|Overall Study|Physician Decision|0
5470358|NCT01945593|18910174|P4|Overall Study|Adverse Event|5
5470359|NCT01945593|18910175|P3|Overall Study|Adverse Event|0
5470360|NCT01945593|18910176|P2|Overall Study|Adverse Event|0
5470361|NCT01945593|18910177|P1|Overall Study|Adverse Event|0
5470362|NCT01945489|18910259|P2|Cycle 2|Lost to Follow-up|1
5470363|NCT01945489|18910260|P1|Cycle 2|Lost to Follow-up|0
5470364|NCT01945489|18910259|P2|Cycle 2|Adverse Event|0
5470365|NCT01945489|18910260|P1|Cycle 2|Adverse Event|1
5470366|NCT01945489|18910259|P2|Cycle 1|Other Miscellaneous Reasons|1
5470367|NCT01945489|18910260|P1|Cycle 1|Other Miscellaneous Reasons|3
5470368|NCT01945489|18910259|P2|Cycle 1|Protocol Violation|1
5470369|NCT01945489|18910260|P1|Cycle 1|Protocol Violation|0
5470370|NCT01945489|18910259|P2|Cycle 1|Personal Reasons|2
5470371|NCT01945489|18910260|P1|Cycle 1|Personal Reasons|4
5470372|NCT01945489|18910259|P2|Cycle 1|Lost to Follow-up|0
5470373|NCT01945489|18910260|P1|Cycle 1|Lost to Follow-up|4
5470374|NCT01945489|18910259|P2|Cycle 1|Adverse Event|0
5470375|NCT01945489|18910260|P1|Cycle 1|Adverse Event|2
5470376|NCT01945281|18910314|P2|Overall Study|Technical Problems|0
5470377|NCT01945281|18910315|P1|Overall Study|Technical Problems|1
5470378|NCT01945281|18910314|P2|Overall Study|Physician Decision|1
5470379|NCT01945281|18910315|P1|Overall Study|Physician Decision|1
5470380|NCT01945281|18910314|P2|Overall Study|Death|3
5470381|NCT01945281|18910315|P1|Overall Study|Death|3
5470382|NCT01945281|18910314|P2|Overall Study|Adverse Event|0
5470383|NCT01945281|18910315|P1|Overall Study|Adverse Event|1
5470384|NCT01945242|18910327|P2|Overall Study|Physician Decision|3
5470385|NCT01945242|18910328|P1|Overall Study|Physician Decision|3
5470386|NCT01945216|18910343|P1|Overall Study|CRF not assured by investigators|5
5470387|NCT01945216|18910343|P1|Overall Study|Protocol Violation|42
5470388|NCT01945216|18910343|P1|Overall Study|Case report forms (CRF) uncollected|52
5470389|NCT01945086|18910401|P3|Overall Study|Adverse Event|1
5470390|NCT01945086|18910402|P2|Overall Study|Adverse Event|0
5470391|NCT01945086|18910403|P1|Overall Study|Adverse Event|0
5470392|NCT01945086|18910401|P3|Overall Study|Withdrawal by Subject|1
5470393|NCT01945086|18910402|P2|Overall Study|Withdrawal by Subject|0
5470394|NCT01945086|18910403|P1|Overall Study|Withdrawal by Subject|1
5470395|NCT01945034|18910447|P3|Overall Study|Protocol Violation|1
5470396|NCT01945034|18910448|P2|Overall Study|Protocol Violation|0
5470397|NCT01945034|18910449|P1|Overall Study|Protocol Violation|1
5470398|NCT01945034|18910447|P3|Overall Study|Lost to Follow-up|2
5470399|NCT01945034|18910448|P2|Overall Study|Lost to Follow-up|0
5470400|NCT01945034|18910449|P1|Overall Study|Lost to Follow-up|0
5470401|NCT01945034|18910447|P3|Overall Study|Other|3
5470402|NCT01945034|18910448|P2|Overall Study|Other|1
5470403|NCT01945034|18910449|P1|Overall Study|Other|0
5470404|NCT01945034|18910447|P3|Overall Study|Withdrawal by Subject|1
5470405|NCT01945034|18910448|P2|Overall Study|Withdrawal by Subject|3
5470406|NCT01945034|18910449|P1|Overall Study|Withdrawal by Subject|0
5470407|NCT01945034|18910447|P3|Overall Study|Medication Error|0
5470408|NCT01945034|18910448|P2|Overall Study|Medication Error|1
5470409|NCT01945034|18910449|P1|Overall Study|Medication Error|0
5470410|NCT01945021|18910499|P1|Overall Study|Non-RECIST disease progression|1
5470411|NCT01945021|18910499|P1|Overall Study|Withdrawal of consent|3
5470412|NCT01945021|18910499|P1|Overall Study|Withdrawal by Subject|2
5470413|NCT01945021|18910499|P1|Overall Study|Global deterioration of health-related s|1
5470414|NCT01945021|18910499|P1|Overall Study|Disease progression by RECIST v1.1|30
5470415|NCT01945021|18910499|P1|Overall Study|Pregnancy|1
5470416|NCT01945021|18910499|P1|Overall Study|Death|1
5470417|NCT01945021|18910499|P1|Overall Study|Adverse Event|8
5470418|NCT01944969|18910513|P1|Overall Study|Administrative or other reasons|23
5470419|NCT01944969|18910513|P1|Overall Study|Non-compliance with IMP|1
5470420|NCT01944969|18910513|P1|Overall Study|Lack of Efficacy|1
5470421|NCT01944969|18910513|P1|Overall Study|Adverse Event|1
5470422|NCT01944839|18910537|P2|Overall Study|Subject non-compliance|3
5470423|NCT01944839|18910538|P1|Overall Study|Subject non-compliance|0
5470424|NCT01944839|18910537|P2|Overall Study|Lost to Follow-up|0
5470425|NCT01944839|18910538|P1|Overall Study|Lost to Follow-up|1
5470426|NCT01944839|18910537|P2|Overall Study|Withdrawal by Subject|17
5470427|NCT01944839|18910538|P1|Overall Study|Withdrawal by Subject|9
5470428|NCT01944839|18910537|P2|Overall Study|Adverse Event|5
5470429|NCT01944839|18910538|P1|Overall Study|Adverse Event|10
5470430|NCT01944839|18910537|P2|Overall Study|Protocol Violation|1
5470431|NCT01944839|18910538|P1|Overall Study|Protocol Violation|0
5470432|NCT01944839|18910537|P2|Overall Study|Physician Decision|2
5470433|NCT01944839|18910538|P1|Overall Study|Physician Decision|2
5470434|NCT01944774|18910547|P3|Overall Study|Lost to Follow-up|0
5470435|NCT01944774|18910548|P2|Overall Study|Lost to Follow-up|1
5470436|NCT01944774|18910549|P1|Overall Study|Lost to Follow-up|0
5470437|NCT01944774|18910547|P3|Overall Study|Lack of Efficacy|2
5470438|NCT01944774|18910548|P2|Overall Study|Lack of Efficacy|2
5470439|NCT01944774|18910549|P1|Overall Study|Lack of Efficacy|1
5470440|NCT01944774|18910547|P3|Overall Study|Adverse Event|3
5470441|NCT01944774|18910548|P2|Overall Study|Adverse Event|2
5470442|NCT01944774|18910549|P1|Overall Study|Adverse Event|3
5470443|NCT01944774|18910547|P3|Overall Study|Withdrawal by Subject|3
5470444|NCT01944774|18910548|P2|Overall Study|Withdrawal by Subject|3
5470445|NCT01944774|18910549|P1|Overall Study|Withdrawal by Subject|2
5470446|NCT01944722|18910592|P1|Overall Study|>ASCUS Cytology|1122
5470447|NCT01944722|18910592|P1|Overall Study|Unsatisfactory Cytology Result|63
5470448|NCT01944722|18910592|P1|Overall Study|NILM Subjects <30 years old|8106
5470449|NCT01944722|18910592|P1|Overall Study|Withdrawal by Subject|8
5470450|NCT01944722|18910592|P1|Overall Study|Specimens Mislabeled|2
5470451|NCT01944722|18910592|P1|Overall Study|Missing Specimens|3
5470452|NCT01944722|18910592|P1|Overall Study|Insufficient Volume for Test|1
5470453|NCT01944722|18910592|P1|Overall Study|Improper Storage/Transport|5
5470454|NCT01944722|18910592|P1|Overall Study|Specimen Shipping Issues|34
5470455|NCT01944722|18910592|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
5470456|NCT01944670|18910626|P1|Overall Study|Lost to Follow-up|2
5470457|NCT01944631|18910648|P2|Overall Study|Withdrawal by Subject|1
5470458|NCT01944631|18910649|P1|Overall Study|Withdrawal by Subject|0
5470459|NCT01944631|18910648|P2|Overall Study|Lost to Follow-up|1
5470460|NCT01944631|18910649|P1|Overall Study|Lost to Follow-up|3
5470461|NCT01944631|18910648|P2|Overall Study|Adverse Event|0
5470462|NCT01944631|18910649|P1|Overall Study|Adverse Event|1
5470463|NCT01944462|18910665|P1|PPPP Educational Program|Lost to Follow-up|60
5470464|NCT01944098|18910728|P2|Overall Study|Physician Decision|0
5470465|NCT01944098|18910729|P1|Overall Study|Physician Decision|1
5470466|NCT01944059|18910741|P1|Overall Study|Adverse Event|2
5470467|NCT01944059|18910741|P1|Overall Study|Withdrawal by Subject|1
5470468|NCT01944059|18910741|P1|Overall Study|Physician Decision|3
5470469|NCT01944059|18910741|P1|Overall Study|Lost to Follow-up|1
5470470|NCT01943825|18910782|P4|Overall Study|Other than specified above|1
5470471|NCT01943825|18910783|P3|Overall Study|Other than specified above|0
5470472|NCT01943825|18910784|P2|Overall Study|Other than specified above|1
5470473|NCT01943825|18910785|P1|Overall Study|Other than specified above|0
5470474|NCT01943825|18910782|P4|Overall Study|Withdrawal by Subject|2
5470475|NCT01943825|18910783|P3|Overall Study|Withdrawal by Subject|3
5470476|NCT01943825|18910784|P2|Overall Study|Withdrawal by Subject|0
5470477|NCT01943825|18910785|P1|Overall Study|Withdrawal by Subject|1
5470478|NCT01943825|18910782|P4|Overall Study|Lost to Follow-up|8
5470479|NCT01943825|18910783|P3|Overall Study|Lost to Follow-up|12
5470480|NCT01943825|18910784|P2|Overall Study|Lost to Follow-up|3
5470481|NCT01943825|18910785|P1|Overall Study|Lost to Follow-up|9
5470482|NCT01943799|18910827|P4|Overall Study|Withdrawal by Subject|0
5470483|NCT01943799|18910828|P3|Overall Study|Withdrawal by Subject|1
5470484|NCT01943799|18910829|P2|Overall Study|Withdrawal by Subject|2
5470485|NCT01943799|18910830|P1|Overall Study|Withdrawal by Subject|4
5470486|NCT01943799|18910827|P4|Overall Study|Protocol Violation|0
5470487|NCT01943799|18910828|P3|Overall Study|Protocol Violation|0
5470488|NCT01943799|18910829|P2|Overall Study|Protocol Violation|0
5470489|NCT01943799|18910830|P1|Overall Study|Protocol Violation|1
5470490|NCT01943799|18910827|P4|Overall Study|Lost to Follow-up|0
5470491|NCT01943799|18910828|P3|Overall Study|Lost to Follow-up|1
5470492|NCT01943799|18910829|P2|Overall Study|Lost to Follow-up|1
5470493|NCT01943799|18910830|P1|Overall Study|Lost to Follow-up|0
5470494|NCT01943591|18910870|P2|Overall Study|Death|7
5470495|NCT01943591|18910871|P1|Overall Study|Death|2
5470496|NCT01943591|18910870|P2|Overall Study|Lost to Follow-up|4
5470497|NCT01943591|18910871|P1|Overall Study|Lost to Follow-up|3
5470498|NCT01943552|18910929|P2|Overall Study|Other Reasons|17
5470499|NCT01943552|18910930|P1|Overall Study|Other Reasons|16
5470500|NCT01943552|18910929|P2|Overall Study|Withdrawal by Subject|6
5470501|NCT01943552|18910930|P1|Overall Study|Withdrawal by Subject|6
5470502|NCT01943552|18910929|P2|Overall Study|Adverse Event|2
5470503|NCT01943552|18910930|P1|Overall Study|Adverse Event|3
5470504|NCT01943539|18910946|P2|Overall Study|Non-compliance with at-home intervention|0
5470505|NCT01943539|18910947|P1|Overall Study|Non-compliance with at-home intervention|4
5470506|NCT01943435|18911044|P3|6 Month Follow up|Lost to Follow-up|15
5470507|NCT01943435|18911045|P2|6 Month Follow up|Lost to Follow-up|7
5470508|NCT01943435|18911046|P1|6 Month Follow up|Lost to Follow-up|12
5470509|NCT01943435|18911044|P3|2 Month Follow up|Lost to Follow-up|0
5470510|NCT01943435|18911045|P2|2 Month Follow up|Lost to Follow-up|3
5470511|NCT01943435|18911046|P1|2 Month Follow up|Lost to Follow-up|2
5470512|NCT01943435|18911044|P3|Intervention Period|Withdrawal by Subject|4
5470513|NCT01943435|18911045|P2|Intervention Period|Withdrawal by Subject|3
5470514|NCT01943435|18911046|P1|Intervention Period|Withdrawal by Subject|3
5470515|NCT01943435|18911044|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
5470516|NCT01943435|18911045|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
5470517|NCT01943435|18911046|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
5470518|NCT01943292|18911069|P3|Overall Study|Withdrawal by Subject|0
5470519|NCT01943292|18911070|P2|Overall Study|Withdrawal by Subject|0
5470520|NCT01943292|18911071|P1|Overall Study|Withdrawal by Subject|1
5470521|NCT01942993|18911107|P1|Overall Study|Physician Decision|1
5470522|NCT01942993|18911107|P1|Overall Study|Lost to Follow-up|1
5470523|NCT01942785|18911124|P1|Overall Study|Protocol Violation|1
5470524|NCT01942785|18911124|P1|Overall Study|Withdrawal by Subject|1
5470525|NCT01942785|18911124|P1|Overall Study|Adverse Event|2
5470526|NCT01942733|18911153|P1|Overall Study|Administrative|1
5470527|NCT01942733|18911153|P1|Overall Study|Non-compliance with IMP|1
5470528|NCT01942733|18911153|P1|Overall Study|Lost to Follow-up|1
5470529|NCT01942590|18912294|P2|Overall Study|Adverse Event|0
5470530|NCT01942590|18912295|P1|Overall Study|Adverse Event|1
5470531|NCT01942590|18912294|P2|Overall Study|Withdrawal by Subject|1
5470532|NCT01942590|18912295|P1|Overall Study|Withdrawal by Subject|0
5470533|NCT01942486|18912325|P1|Overall Study|Lost to Follow-up|27
5470534|NCT01942161|18912332|P3|Overall Study|Withdrawal by Subject|1
5470535|NCT01942161|18912333|P2|Overall Study|Withdrawal by Subject|3
5470536|NCT01942161|18912334|P1|Overall Study|Withdrawal by Subject|3
5470537|NCT01942161|18912332|P3|Overall Study|Protocol Violation|0
5470538|NCT01942161|18912333|P2|Overall Study|Protocol Violation|0
5470539|NCT01942161|18912334|P1|Overall Study|Protocol Violation|1
5470540|NCT01942161|18912332|P3|Overall Study|Physician Decision|0
5470541|NCT01942161|18912333|P2|Overall Study|Physician Decision|1
5470542|NCT01942161|18912334|P1|Overall Study|Physician Decision|3
5470543|NCT01942161|18912332|P3|Overall Study|Adverse Event|5
5470544|NCT01942161|18912333|P2|Overall Study|Adverse Event|2
5470545|NCT01942161|18912334|P1|Overall Study|Adverse Event|1
5470546|NCT01942148|18912354|P1|Overall Study|Use of the prohibition medicine|1
5470547|NCT01942148|18912354|P1|Overall Study|Withdrawal by Subject|8
5470548|NCT01942148|18912354|P1|Overall Study|Protocol Violation|1
5470549|NCT01942148|18912354|P1|Overall Study|Physician Decision|11
5470550|NCT01942148|18912354|P1|Overall Study|Lack of Efficacy|2
5470551|NCT01942148|18912354|P1|Overall Study|Adverse Event|4
5470552|NCT01942135|18912362|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
5470553|NCT01942135|18912363|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
5470554|NCT01942135|18912362|P2|Overall Study|Withdrawal by Subject|2
5470555|NCT01942135|18912363|P1|Overall Study|Withdrawal by Subject|4
5470556|NCT01942135|18912362|P2|Overall Study|Participant Refused toContinue Treatment|1
5470557|NCT01942135|18912363|P1|Overall Study|Participant Refused toContinue Treatment|1
5470558|NCT01942135|18912362|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
5470559|NCT01942135|18912363|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
5470560|NCT01942135|18912362|P2|Overall Study|Death|1
5470561|NCT01942135|18912363|P1|Overall Study|Death|0
5470562|NCT01942135|18912362|P2|Overall Study|Randomized Not Treated|2
5470563|NCT01942135|18912363|P1|Overall Study|Randomized Not Treated|2
5470564|NCT01942135|18912362|P2|Overall Study|Global deterioration of health status|3
5470565|NCT01942135|18912363|P1|Overall Study|Global deterioration of health status|8
5470566|NCT01942135|18912362|P2|Overall Study|Adverse Event|3
5470567|NCT01942135|18912363|P1|Overall Study|Adverse Event|9
5470568|NCT01941940|18912400|P1|Overall Study|Other|1
5470569|NCT01941940|18912400|P1|Overall Study|Other|1
5470570|NCT01941940|18912400|P1|Overall Study|Death|1
5470571|NCT01941940|18912400|P1|Overall Study|Withdrawal by Subject|15
5470572|NCT01941940|18912400|P1|Overall Study|Physician Decision|2
5470573|NCT01941940|18912400|P1|Overall Study|Lost to Follow-up|2
5470574|NCT01941940|18912400|P1|Overall Study|Adverse Event|11
5470575|NCT01941537|18912508|P2|Overall Study|Withdrawal by Subject|1
5470576|NCT01941537|18912509|P1|Overall Study|Withdrawal by Subject|0
5470577|NCT01941537|18912508|P2|Overall Study|Adverse Event|0
5470578|NCT01941537|18912509|P1|Overall Study|Adverse Event|1
5470579|NCT01941537|18912508|P2|Overall Study|Pregnancy|0
5470580|NCT01941537|18912509|P1|Overall Study|Pregnancy|1
5470581|NCT01941537|18912508|P2|Overall Study|Lost to Follow-up|0
5470582|NCT01941537|18912509|P1|Overall Study|Lost to Follow-up|1
5470583|NCT01941537|18912508|P2|Overall Study|Lack of Efficacy|2
5470584|NCT01941537|18912509|P1|Overall Study|Lack of Efficacy|1
5470585|NCT01941498|18912521|P1|Overall Study|Relocated out of state|1
5470586|NCT01941186|18912639|P2|Follow-up|Lost to Follow-up|0
5470587|NCT01941186|18912640|P1|Follow-up|Lost to Follow-up|1
5470588|NCT01941095|18912666|P1|Overall Study|Lost to Follow-up|10
5470589|NCT01941095|18912666|P1|Overall Study|Withdrawal by Subject|17
5470590|NCT01941095|18912666|P1|Overall Study|Physician Decision|3
5470591|NCT01941095|18912666|P1|Overall Study|Adverse Event|11
5470592|NCT01941095|18912666|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
5470593|NCT01941095|18912666|P1|Overall Study|Insufficient therapeutic response|13
5470594|NCT01941030|18912691|P2|Overall Study|Withdrawal by Subject|6
5470595|NCT01941030|18912692|P1|Overall Study|Withdrawal by Subject|4
5470596|NCT01941030|18912691|P2|Overall Study|Lost to Follow-up|5
5470597|NCT01941030|18912692|P1|Overall Study|Lost to Follow-up|6
5470598|NCT01941030|18912691|P2|Overall Study|Death|2
5470599|NCT01941030|18912692|P1|Overall Study|Death|3
5470600|NCT01940939|18912714|P2|Overall Study|Withdrawal by Subject|8
5470601|NCT01940939|18912715|P1|Overall Study|Withdrawal by Subject|2
5470602|NCT01940900|18912727|P2|Overall Study|other|0
5470603|NCT01940900|18912728|P1|Overall Study|other|1
5470604|NCT01940900|18912727|P2|Overall Study|subject non-compliance|1
5470605|NCT01940900|18912728|P1|Overall Study|subject non-compliance|1
5470606|NCT01940900|18912727|P2|Overall Study|Sponsor Decision|0
5470607|NCT01940900|18912728|P1|Overall Study|Sponsor Decision|1
5470608|NCT01940900|18912727|P2|Overall Study|Lost to Follow-up|0
5470609|NCT01940900|18912728|P1|Overall Study|Lost to Follow-up|1
5470610|NCT01940900|18912727|P2|Overall Study|Withdrawal by Subject|15
5470611|NCT01940900|18912728|P1|Overall Study|Withdrawal by Subject|11
5470612|NCT01940900|18912727|P2|Overall Study|Adverse Event|15
5470613|NCT01940900|18912728|P1|Overall Study|Adverse Event|10
5470614|NCT01940900|18912727|P2|Overall Study|Physician Decision|0
5470615|NCT01940900|18912728|P1|Overall Study|Physician Decision|4
5470616|NCT01940887|18912736|P2|Year 2|Lost to Follow-up|6
5470617|NCT01940887|18912737|P1|Year 2|Lost to Follow-up|1
5470618|NCT01940887|18912736|P2|Year 2|Withdrawal by Subject|8
5470619|NCT01940887|18912737|P1|Year 2|Withdrawal by Subject|8
5470620|NCT01940887|18912736|P2|Year 2|Adverse Event|2
5470621|NCT01940887|18912737|P1|Year 2|Adverse Event|8
5470622|NCT01940887|18912736|P2|Year 2|Sponsor Decision, early termination|203
5470623|NCT01940887|18912737|P1|Year 2|Sponsor Decision, early termination|192
5470624|NCT01940887|18912736|P2|Year 2|Death|2
5470625|NCT01940887|18912737|P1|Year 2|Death|0
5470626|NCT01940887|18912736|P2|Year 2|Physician Decision|1
5470627|NCT01940887|18912737|P1|Year 2|Physician Decision|8
5470628|NCT01940887|18912736|P2|Year 1|Lost to Follow-up|1
5470629|NCT01940887|18912737|P1|Year 1|Lost to Follow-up|2
5470630|NCT01940887|18912736|P2|Year 1|Withdrawal by Subject|9
5470631|NCT01940887|18912737|P1|Year 1|Withdrawal by Subject|18
5470632|NCT01940887|18912736|P2|Year 1|Adverse Event|6
5470633|NCT01940887|18912737|P1|Year 1|Adverse Event|7
5470634|NCT01940887|18912736|P2|Year 1|Death|3
5470635|NCT01940887|18912737|P1|Year 1|Death|5
5470636|NCT01940887|18912736|P2|Year 1|Physician Decision|3
5470637|NCT01940887|18912737|P1|Year 1|Physician Decision|7
5470638|NCT01940887|18912736|P2|Year 1|Protocol Violation|1
5470639|NCT01940887|18912737|P1|Year 1|Protocol Violation|0
5470640|NCT01940705|18912747|P4|Overall Study|Withdrawal by team - hearing aid change|0
5470641|NCT01940705|18912748|P3|Overall Study|Withdrawal by team - hearing aid change|0
5470642|NCT01940705|18912749|P2|Overall Study|Withdrawal by team - hearing aid change|0
5470643|NCT01940705|18912750|P1|Overall Study|Withdrawal by team - hearing aid change|1
5470644|NCT01940705|18912747|P4|Overall Study|Intervention not given|0
5470645|NCT01940705|18912748|P3|Overall Study|Intervention not given|3
5470646|NCT01940705|18912749|P2|Overall Study|Intervention not given|3
5470647|NCT01940705|18912750|P1|Overall Study|Intervention not given|0
5470648|NCT01940705|18912747|P4|Overall Study|Withdrawal by Subject|2
5470649|NCT01940705|18912748|P3|Overall Study|Withdrawal by Subject|3
5470650|NCT01940705|18912749|P2|Overall Study|Withdrawal by Subject|2
5470651|NCT01940705|18912750|P1|Overall Study|Withdrawal by Subject|2
5470652|NCT01940705|18912747|P4|Overall Study|Lost to Follow-up|2
5470653|NCT01940705|18912748|P3|Overall Study|Lost to Follow-up|2
5470654|NCT01940705|18912749|P2|Overall Study|Lost to Follow-up|3
5470655|NCT01940705|18912750|P1|Overall Study|Lost to Follow-up|1
5470656|NCT01940497|18912814|P2|Overall Study|Administrative/Other|1
5470657|NCT01940497|18912815|P1|Overall Study|Administrative/Other|1
5470658|NCT01940497|18912814|P2|Overall Study|Withdrew Consent|2
5470659|NCT01940497|18912815|P1|Overall Study|Withdrew Consent|6
5470660|NCT01940497|18912814|P2|Overall Study|Refused Treatment|3
5470661|NCT01940497|18912815|P1|Overall Study|Refused Treatment|1
5470662|NCT01940497|18912814|P2|Overall Study|Violation of Entry Criteria|1
5470663|NCT01940497|18912815|P1|Overall Study|Violation of Entry Criteria|1
5470664|NCT01940497|18912814|P2|Overall Study|Recurrence of Disease Postsurgery|3
5470665|NCT01940497|18912815|P1|Overall Study|Recurrence of Disease Postsurgery|1
5470666|NCT01940497|18912814|P2|Overall Study|Adverse Event/Intercurrent Illness|8
5470667|NCT01940497|18912815|P1|Overall Study|Adverse Event/Intercurrent Illness|11
5470668|NCT01940484|18912856|P1|Overall Study|Adverse Event|1
5470669|NCT01940484|18912856|P1|Overall Study|Death|2
5470670|NCT01940484|18912856|P1|Overall Study|Underwent transplantation|4
5470671|NCT01940484|18912856|P1|Overall Study|Withdrawal by Subject|3
5470672|NCT01940471|18912876|P2|Open-Label Extension|Still in Open-Label Extension Phase|8
5470673|NCT01940471|18912877|P1|Open-Label Extension|Still in Open-Label Extension Phase|14
5470674|NCT01940471|18912876|P2|Double-Blind Phase|Still in Double-Blind Phase|270
5470675|NCT01940471|18912877|P1|Double-Blind Phase|Still in Double-Blind Phase|539
5470676|NCT01940471|18912876|P2|Double-Blind Phase|Protocol Violation|1
5470677|NCT01940471|18912877|P1|Double-Blind Phase|Protocol Violation|0
5470678|NCT01940471|18912876|P2|Double-Blind Phase|Lack of Efficacy|0
5470679|NCT01940471|18912877|P1|Double-Blind Phase|Lack of Efficacy|1
5470680|NCT01940471|18912876|P2|Double-Blind Phase|Death|0
5470681|NCT01940471|18912877|P1|Double-Blind Phase|Death|1
5470682|NCT01940471|18912876|P2|Double-Blind Phase|Protocol-Specified Criteria|0
5470683|NCT01940471|18912877|P1|Double-Blind Phase|Protocol-Specified Criteria|1
5470684|NCT01940471|18912876|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5470685|NCT01940471|18912877|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
5470686|NCT01940471|18912876|P2|Double-Blind Phase|Investigator's Discretion|0
5470687|NCT01940471|18912877|P1|Double-Blind Phase|Investigator's Discretion|5
5470688|NCT01940471|18912876|P2|Double-Blind Phase|Pregnancy|1
5470689|NCT01940471|18912877|P1|Double-Blind Phase|Pregnancy|2
5470690|NCT01940471|18912876|P2|Double-Blind Phase|Lost to Follow-up|2
5470691|NCT01940471|18912877|P1|Double-Blind Phase|Lost to Follow-up|3
5470692|NCT01940471|18912876|P2|Double-Blind Phase|Adverse Event|2
5470693|NCT01940471|18912877|P1|Double-Blind Phase|Adverse Event|1
5470694|NCT01940471|18912876|P2|Double-Blind Phase|Withdrew Consent|7
5470695|NCT01940471|18912877|P1|Double-Blind Phase|Withdrew Consent|13
5470696|NCT01940471|18912876|P2|Double-Blind Phase|Randomized but Never Treated|1
5470697|NCT01940471|18912877|P1|Double-Blind Phase|Randomized but Never Treated|1
5470698|NCT01940354|18912895|P2|Overall Study|Withdrawal by Subject|2
5470699|NCT01940354|18912896|P1|Overall Study|Withdrawal by Subject|4
5470700|NCT01940341|18912908|P2|Open-label Extension Phase|Still on Study|1
5470701|NCT01940341|18912909|P1|Open-label Extension Phase|Still on Study|4
5470702|NCT01940341|18912908|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
5470703|NCT01940341|18912909|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
5470704|NCT01940341|18912908|P2|Double-Blind Phase|Protocol Specified Criteria|0
5470705|NCT01940341|18912909|P1|Double-Blind Phase|Protocol Specified Criteria|1
5470706|NCT01940341|18912908|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
5470707|NCT01940341|18912909|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
5470708|NCT01940341|18912908|P2|Double-Blind Phase|Investigator's Discretion|0
5470709|NCT01940341|18912909|P1|Double-Blind Phase|Investigator's Discretion|1
5470710|NCT01940341|18912908|P2|Double-Blind Phase|Pregnancy|1
5470711|NCT01940341|18912909|P1|Double-Blind Phase|Pregnancy|0
5470712|NCT01940341|18912908|P2|Double-Blind Phase|Lost to Follow-up|1
5470713|NCT01940341|18912909|P1|Double-Blind Phase|Lost to Follow-up|4
5470714|NCT01940341|18912908|P2|Double-Blind Phase|Withdrew Consent|2
5470715|NCT01940341|18912909|P1|Double-Blind Phase|Withdrew Consent|3
5470716|NCT01940341|18912908|P2|Double-Blind Phase|Adverse Event|2
5470717|NCT01940341|18912909|P1|Double-Blind Phase|Adverse Event|3
5470718|NCT01940341|18912908|P2|Double-Blind Phase|Randomized but Never Treated|1
5470719|NCT01940341|18912909|P1|Double-Blind Phase|Randomized but Never Treated|0
5470720|NCT01940120|18912959|P1|Overall Study|Withdrawal by Subject|8
5470721|NCT01940120|18912959|P1|Overall Study|Death|40
5470722|NCT01939977|18913115|P2|Overall Study|Did not receive study medication|1
5470723|NCT01939977|18913116|P1|Overall Study|Did not receive study medication|0
5470724|NCT01939977|18913115|P2|Overall Study|Did not meet inclusion criteria|0
5470725|NCT01939977|18913116|P1|Overall Study|Did not meet inclusion criteria|1
5470726|NCT01939977|18913115|P2|Overall Study|Withdrawal by Subject|2
5470727|NCT01939977|18913116|P1|Overall Study|Withdrawal by Subject|0
5470728|NCT01939977|18913115|P2|Overall Study|Physician Decision|1
5470729|NCT01939977|18913116|P1|Overall Study|Physician Decision|1
5470730|NCT01939977|18913115|P2|Overall Study|Lack of Efficacy|0
5470731|NCT01939977|18913116|P1|Overall Study|Lack of Efficacy|3
5470732|NCT01939977|18913115|P2|Overall Study|Adverse Event|3
5470733|NCT01939977|18913116|P1|Overall Study|Adverse Event|4
5470734|NCT01939899|18913163|P5|Phase 2|Disease Progression|1
5470735|NCT01939899|18913164|P4|Phase 2|Disease Progression|9
5470736|NCT01939899|18913165|P3|Phase 2|Disease Progression|0
5470737|NCT01939899|18913166|P2|Phase 2|Disease Progression|0
5470738|NCT01939899|18913167|P1|Phase 2|Disease Progression|0
5470739|NCT01939899|18913163|P5|Phase 2|Withdrawal by Subject|0
5470740|NCT01939899|18913164|P4|Phase 2|Withdrawal by Subject|2
5470741|NCT01939899|18913165|P3|Phase 2|Withdrawal by Subject|0
5470742|NCT01939899|18913166|P2|Phase 2|Withdrawal by Subject|0
5470743|NCT01939899|18913167|P1|Phase 2|Withdrawal by Subject|0
5470744|NCT01939899|18913163|P5|Lead-in Dose Finding Phase|Other|0
5470745|NCT01939899|18913164|P4|Lead-in Dose Finding Phase|Other|0
5470746|NCT01939899|18913165|P3|Lead-in Dose Finding Phase|Other|1
5470747|NCT01939899|18913166|P2|Lead-in Dose Finding Phase|Other|0
5470748|NCT01939899|18913167|P1|Lead-in Dose Finding Phase|Other|0
5470749|NCT01939899|18913163|P5|Lead-in Dose Finding Phase|Disease Progression|0
5470750|NCT01939899|18913164|P4|Lead-in Dose Finding Phase|Disease Progression|0
5470751|NCT01939899|18913165|P3|Lead-in Dose Finding Phase|Disease Progression|3
5470752|NCT01939899|18913166|P2|Lead-in Dose Finding Phase|Disease Progression|4
5470753|NCT01939899|18913167|P1|Lead-in Dose Finding Phase|Disease Progression|2
5470754|NCT01939899|18913163|P5|Lead-in Dose Finding Phase|Death|0
5470755|NCT01939899|18913164|P4|Lead-in Dose Finding Phase|Death|0
5470756|NCT01939899|18913165|P3|Lead-in Dose Finding Phase|Death|1
5470757|NCT01939899|18913166|P2|Lead-in Dose Finding Phase|Death|3
5470758|NCT01939899|18913167|P1|Lead-in Dose Finding Phase|Death|0
5470759|NCT01939548|18913214|P3|Overall Study|Did not complete follow-up|0
5470760|NCT01939548|18913215|P2|Overall Study|Did not complete follow-up|1
5470761|NCT01939548|18913216|P1|Overall Study|Did not complete follow-up|0
5470762|NCT01939548|18913214|P3|Overall Study|Participant withdrew consent|0
5470763|NCT01939548|18913215|P2|Overall Study|Participant withdrew consent|2
5470764|NCT01939548|18913216|P1|Overall Study|Participant withdrew consent|0
5470765|NCT01939548|18913214|P3|Overall Study|Participant unwilling to continue|0
5470766|NCT01939548|18913215|P2|Overall Study|Participant unwilling to continue|1
5470767|NCT01939548|18913216|P1|Overall Study|Participant unwilling to continue|0
5470768|NCT01939548|18913214|P3|Overall Study|Participant dropped|1
5470769|NCT01939548|18913215|P2|Overall Study|Participant dropped|0
5470770|NCT01939548|18913216|P1|Overall Study|Participant dropped|0
5470771|NCT01939548|18913214|P3|Overall Study|Death|1
5470772|NCT01939548|18913215|P2|Overall Study|Death|0
5470773|NCT01939548|18913216|P1|Overall Study|Death|0
5470774|NCT01939548|18913214|P3|Overall Study|Adverse Event|7
5470775|NCT01939548|18913215|P2|Overall Study|Adverse Event|9
5470776|NCT01939548|18913216|P1|Overall Study|Adverse Event|2
5470777|NCT01939548|18913214|P3|Overall Study|Lost to Follow-up|3
5470778|NCT01939548|18913215|P2|Overall Study|Lost to Follow-up|5
5470779|NCT01939548|18913216|P1|Overall Study|Lost to Follow-up|5
5470780|NCT01939548|18913214|P3|Overall Study|Protocol Violation|5
5470781|NCT01939548|18913215|P2|Overall Study|Protocol Violation|6
5470782|NCT01939548|18913216|P1|Overall Study|Protocol Violation|7
5470783|NCT01939548|18913214|P3|Overall Study|Withdrawal by Subject|1
5470784|NCT01939548|18913215|P2|Overall Study|Withdrawal by Subject|4
5470785|NCT01939548|18913216|P1|Overall Study|Withdrawal by Subject|4
5470786|NCT01939548|18913214|P3|Overall Study|Did Not Meet Entrance Criteria|0
5470787|NCT01939548|18913215|P2|Overall Study|Did Not Meet Entrance Criteria|0
5470788|NCT01939548|18913216|P1|Overall Study|Did Not Meet Entrance Criteria|1
5470789|NCT01939548|18913214|P3|Overall Study|Insufficient Clinical Response|0
5470790|NCT01939548|18913215|P2|Overall Study|Insufficient Clinical Response|0
5470791|NCT01939548|18913216|P1|Overall Study|Insufficient Clinical Response|1
5470792|NCT01939548|18913214|P3|Overall Study|Study Terminated by Sponsor|12
5470793|NCT01939548|18913215|P2|Overall Study|Study Terminated by Sponsor|19
5470794|NCT01939548|18913216|P1|Overall Study|Study Terminated by Sponsor|17
5470795|NCT01939548|18913214|P3|Overall Study|Non compliance|0
5470796|NCT01939548|18913215|P2|Overall Study|Non compliance|2
5470797|NCT01939548|18913216|P1|Overall Study|Non compliance|0
5470798|NCT01939496|18913290|P3|Overall Study|Other|1
5470799|NCT01939496|18913291|P2|Overall Study|Other|0
5470800|NCT01939496|18913292|P1|Overall Study|Other|2
5470801|NCT01939496|18913290|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
5470802|NCT01939496|18913291|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
5470803|NCT01939496|18913292|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
5470804|NCT01939496|18913290|P3|Overall Study|Withdrawal by Subject|1
5470805|NCT01939496|18913291|P2|Overall Study|Withdrawal by Subject|1
5470806|NCT01939496|18913292|P1|Overall Study|Withdrawal by Subject|0
5470807|NCT01939496|18913290|P3|Overall Study|Protocol Violation|0
5470808|NCT01939496|18913291|P2|Overall Study|Protocol Violation|0
5470809|NCT01939496|18913292|P1|Overall Study|Protocol Violation|3
5470810|NCT01939496|18913290|P3|Overall Study|Physician Decision|0
5470811|NCT01939496|18913291|P2|Overall Study|Physician Decision|0
5470812|NCT01939496|18913292|P1|Overall Study|Physician Decision|1
5470813|NCT01939496|18913290|P3|Overall Study|Lost to Follow-up|0
5470814|NCT01939496|18913291|P2|Overall Study|Lost to Follow-up|1
5470815|NCT01939496|18913292|P1|Overall Study|Lost to Follow-up|1
5470816|NCT01939496|18913290|P3|Overall Study|Adverse Event|0
5470817|NCT01939496|18913291|P2|Overall Study|Adverse Event|0
5470818|NCT01939496|18913292|P1|Overall Study|Adverse Event|2
5470819|NCT01939366|18913362|P5|Overall Study|GCP non-compliance at site|3
5470820|NCT01939366|18913363|P4|Overall Study|GCP non-compliance at site|3
5470821|NCT01939366|18913364|P3|Overall Study|GCP non-compliance at site|2
5470822|NCT01939366|18913365|P2|Overall Study|GCP non-compliance at site|3
5470823|NCT01939366|18913366|P1|Overall Study|GCP non-compliance at site|2
5470824|NCT01939366|18913362|P5|Overall Study|Sponsor decision|2
5470825|NCT01939366|18913363|P4|Overall Study|Sponsor decision|0
5470826|NCT01939366|18913364|P3|Overall Study|Sponsor decision|0
5470827|NCT01939366|18913365|P2|Overall Study|Sponsor decision|0
5470828|NCT01939366|18913366|P1|Overall Study|Sponsor decision|0
5470829|NCT01939366|18913362|P5|Overall Study|Protocol Violation|0
5470830|NCT01939366|18913363|P4|Overall Study|Protocol Violation|1
5470831|NCT01939366|18913364|P3|Overall Study|Protocol Violation|0
5470832|NCT01939366|18913365|P2|Overall Study|Protocol Violation|0
5470833|NCT01939366|18913366|P1|Overall Study|Protocol Violation|0
5470834|NCT01939366|18913362|P5|Overall Study|Other|1
5470835|NCT01939366|18913363|P4|Overall Study|Other|2
5470836|NCT01939366|18913364|P3|Overall Study|Other|2
5470837|NCT01939366|18913365|P2|Overall Study|Other|0
5470838|NCT01939366|18913366|P1|Overall Study|Other|0
5470839|NCT01939366|18913362|P5|Overall Study|Inclusion criteria not met|1
5470840|NCT01939366|18913363|P4|Overall Study|Inclusion criteria not met|0
5470841|NCT01939366|18913364|P3|Overall Study|Inclusion criteria not met|1
5470842|NCT01939366|18913365|P2|Overall Study|Inclusion criteria not met|1
5470843|NCT01939366|18913366|P1|Overall Study|Inclusion criteria not met|0
5470844|NCT01939366|18913362|P5|Overall Study|Withdrawal by Subject|3
5470845|NCT01939366|18913363|P4|Overall Study|Withdrawal by Subject|2
5470846|NCT01939366|18913364|P3|Overall Study|Withdrawal by Subject|2
5470847|NCT01939366|18913365|P2|Overall Study|Withdrawal by Subject|0
5470848|NCT01939366|18913366|P1|Overall Study|Withdrawal by Subject|1
5470849|NCT01939366|18913362|P5|Overall Study|Lost to Follow-up|0
5470850|NCT01939366|18913363|P4|Overall Study|Lost to Follow-up|0
5470851|NCT01939366|18913364|P3|Overall Study|Lost to Follow-up|0
5470852|NCT01939366|18913365|P2|Overall Study|Lost to Follow-up|1
5470853|NCT01939366|18913366|P1|Overall Study|Lost to Follow-up|1
5470854|NCT01939366|18913362|P5|Overall Study|Lack of Efficacy|3
5470855|NCT01939366|18913363|P4|Overall Study|Lack of Efficacy|1
5470856|NCT01939366|18913364|P3|Overall Study|Lack of Efficacy|1
5470857|NCT01939366|18913365|P2|Overall Study|Lack of Efficacy|1
5470858|NCT01939366|18913366|P1|Overall Study|Lack of Efficacy|2
5470859|NCT01939366|18913362|P5|Overall Study|Adverse Event|5
5470860|NCT01939366|18913363|P4|Overall Study|Adverse Event|8
5470861|NCT01939366|18913364|P3|Overall Study|Adverse Event|30
5470862|NCT01939366|18913365|P2|Overall Study|Adverse Event|17
5470863|NCT01939366|18913366|P1|Overall Study|Adverse Event|8
5470864|NCT01939314|18913380|P2|Overall Study|Lost to Follow-up|6
5470865|NCT01939314|18913381|P1|Overall Study|Lost to Follow-up|5
5470866|NCT01939314|18913380|P2|Overall Study|Pregnancy|1
5470867|NCT01939314|18913381|P1|Overall Study|Pregnancy|0
5470868|NCT01939314|18913380|P2|Overall Study|Protocol Violation|0
5470869|NCT01939314|18913381|P1|Overall Study|Protocol Violation|1
5470870|NCT01939314|18913380|P2|Overall Study|Withdrawal by Subject|1
5470871|NCT01939314|18913381|P1|Overall Study|Withdrawal by Subject|3
5470872|NCT01939223|18913415|P2|Overall Study|Withdrawal by Subject|0
5470873|NCT01939223|18913416|P1|Overall Study|Withdrawal by Subject|6
5470874|NCT01939223|18913415|P2|Overall Study|Study stopped by Sponsor|7
5470875|NCT01939223|18913416|P1|Overall Study|Study stopped by Sponsor|5
5470876|NCT01939223|18913415|P2|Overall Study|Disease recurrence (radiological)|3
5470877|NCT01939223|18913416|P1|Overall Study|Disease recurrence (radiological)|1
5470878|NCT01939223|18913415|P2|Overall Study|AE not assoc. with disease recurrence|1
5470879|NCT01939223|18913416|P1|Overall Study|AE not assoc. with disease recurrence|1
5470880|NCT01939197|18913431|P7|Overall Study|Lost to Follow-up|2
5470881|NCT01939197|18913432|P6|Overall Study|Lost to Follow-up|1
5470882|NCT01939197|18913433|P5|Overall Study|Lost to Follow-up|3
5470883|NCT01939197|18913434|P4|Overall Study|Lost to Follow-up|1
5470884|NCT01939197|18913435|P3|Overall Study|Lost to Follow-up|0
5470885|NCT01939197|18913436|P2|Overall Study|Lost to Follow-up|1
5470886|NCT01939197|18913437|P1|Overall Study|Lost to Follow-up|0
5470887|NCT01939197|18913431|P7|Overall Study|Withdrawal by Subject|0
5470888|NCT01939197|18913432|P6|Overall Study|Withdrawal by Subject|0
5470889|NCT01939197|18913433|P5|Overall Study|Withdrawal by Subject|1
5470890|NCT01939197|18913434|P4|Overall Study|Withdrawal by Subject|0
5470891|NCT01939197|18913435|P3|Overall Study|Withdrawal by Subject|0
5470892|NCT01939197|18913436|P2|Overall Study|Withdrawal by Subject|0
5470893|NCT01939197|18913437|P1|Overall Study|Withdrawal by Subject|1
5470894|NCT01939028|18913506|P1|Overall Study|Physician Decision|7
5470895|NCT01939028|18913506|P1|Overall Study|Withdrawal by Subject|5
5470896|NCT01939002|18913519|P2|Overall Study|Other|2
5470897|NCT01939002|18913520|P1|Overall Study|Other|1
5470898|NCT01939002|18913519|P2|Overall Study|Withdrawal by Subject|3
5470899|NCT01939002|18913520|P1|Overall Study|Withdrawal by Subject|5
5470900|NCT01939002|18913519|P2|Overall Study|Adverse Event|13
5470901|NCT01939002|18913520|P1|Overall Study|Adverse Event|13
5470902|NCT01938846|18913596|P3|Overall Study|Other than listed|4
5470903|NCT01938846|18913597|P2|Overall Study|Other than listed|1
5470904|NCT01938846|18913598|P1|Overall Study|Other than listed|5
5470905|NCT01938846|18913596|P3|Overall Study|Withdrawal by Subject|1
5470906|NCT01938846|18913597|P2|Overall Study|Withdrawal by Subject|2
5470907|NCT01938846|18913598|P1|Overall Study|Withdrawal by Subject|2
5470908|NCT01938846|18913596|P3|Overall Study|Adverse Event|3
5470909|NCT01938846|18913597|P2|Overall Study|Adverse Event|4
5470910|NCT01938846|18913598|P1|Overall Study|Adverse Event|8
5470911|NCT01938846|18913596|P3|Overall Study|Progressive disease|16
5470912|NCT01938846|18913597|P2|Overall Study|Progressive disease|18
5470913|NCT01938846|18913598|P1|Overall Study|Progressive disease|26
5470914|NCT01938716|18913798|P1|Overall Study|Withdrawal by Subject|2
5470915|NCT01938716|18913798|P1|Overall Study|Physician Decision|2
5470916|NCT01938625|18913821|P2|Overall Study|Adverse Event|1
5470917|NCT01938625|18913822|P1|Overall Study|Adverse Event|0
5470918|NCT01938625|18913821|P2|Overall Study|Withdrawal by Subject|1
5470919|NCT01938625|18913822|P1|Overall Study|Withdrawal by Subject|0
5470920|NCT01938573|18913842|P2|Overall Study|Operation at other hospital|0
5470921|NCT01938573|18913843|P1|Overall Study|Operation at other hospital|1
5470922|NCT01938573|18913842|P2|Overall Study|Lack of Efficacy|0
5470923|NCT01938573|18913843|P1|Overall Study|Lack of Efficacy|1
5470924|NCT01938430|18913863|P14|Overall Study|Withdrew Consent|0
5470925|NCT01938430|18913864|P13|Overall Study|Withdrew Consent|0
5470926|NCT01938430|18913865|P12|Overall Study|Withdrew Consent|0
5470927|NCT01938430|18913866|P11|Overall Study|Withdrew Consent|0
5470928|NCT01938430|18913867|P10|Overall Study|Withdrew Consent|0
5470929|NCT01938430|18913868|P9|Overall Study|Withdrew Consent|1
5470930|NCT01938430|18913869|P8|Overall Study|Withdrew Consent|0
5470931|NCT01938430|18913870|P7|Overall Study|Withdrew Consent|0
5470932|NCT01938430|18913871|P6|Overall Study|Withdrew Consent|0
5470933|NCT01938430|18913872|P5|Overall Study|Withdrew Consent|0
5470934|NCT01938430|18913873|P4|Overall Study|Withdrew Consent|0
5470935|NCT01938430|18913874|P3|Overall Study|Withdrew Consent|0
5470936|NCT01938430|18913875|P2|Overall Study|Withdrew Consent|0
5470937|NCT01938430|18913876|P1|Overall Study|Withdrew Consent|0
5470938|NCT01938430|18913863|P14|Overall Study|Lost to Follow-up|0
5470939|NCT01938430|18913864|P13|Overall Study|Lost to Follow-up|0
5470940|NCT01938430|18913865|P12|Overall Study|Lost to Follow-up|0
5470941|NCT01938430|18913866|P11|Overall Study|Lost to Follow-up|0
5470942|NCT01938430|18913867|P10|Overall Study|Lost to Follow-up|0
5470943|NCT01938430|18913868|P9|Overall Study|Lost to Follow-up|0
5470944|NCT01938430|18913869|P8|Overall Study|Lost to Follow-up|0
5470945|NCT01938430|18913870|P7|Overall Study|Lost to Follow-up|0
5470946|NCT01938430|18913871|P6|Overall Study|Lost to Follow-up|1
5470947|NCT01938430|18913872|P5|Overall Study|Lost to Follow-up|0
5470948|NCT01938430|18913873|P4|Overall Study|Lost to Follow-up|0
5470949|NCT01938430|18913874|P3|Overall Study|Lost to Follow-up|1
5470950|NCT01938430|18913875|P2|Overall Study|Lost to Follow-up|0
5470951|NCT01938430|18913876|P1|Overall Study|Lost to Follow-up|0
5470952|NCT01938430|18913863|P14|Overall Study|Lack of Efficacy|0
5470953|NCT01938430|18913864|P13|Overall Study|Lack of Efficacy|0
5470954|NCT01938430|18913865|P12|Overall Study|Lack of Efficacy|1
5470955|NCT01938430|18913866|P11|Overall Study|Lack of Efficacy|2
5470956|NCT01938430|18913867|P10|Overall Study|Lack of Efficacy|0
5470957|NCT01938430|18913868|P9|Overall Study|Lack of Efficacy|1
5470958|NCT01938430|18913869|P8|Overall Study|Lack of Efficacy|0
5470959|NCT01938430|18913870|P7|Overall Study|Lack of Efficacy|0
5470960|NCT01938430|18913871|P6|Overall Study|Lack of Efficacy|0
5470961|NCT01938430|18913872|P5|Overall Study|Lack of Efficacy|0
5470962|NCT01938430|18913873|P4|Overall Study|Lack of Efficacy|1
5470963|NCT01938430|18913874|P3|Overall Study|Lack of Efficacy|1
5470964|NCT01938430|18913875|P2|Overall Study|Lack of Efficacy|1
5470965|NCT01938430|18913876|P1|Overall Study|Lack of Efficacy|3
5470966|NCT01938430|18913863|P14|Overall Study|Investigator's Discretion|0
5470967|NCT01938430|18913864|P13|Overall Study|Investigator's Discretion|0
5470968|NCT01938430|18913865|P12|Overall Study|Investigator's Discretion|0
5470969|NCT01938430|18913866|P11|Overall Study|Investigator's Discretion|0
5470970|NCT01938430|18913867|P10|Overall Study|Investigator's Discretion|0
5470971|NCT01938430|18913868|P9|Overall Study|Investigator's Discretion|0
5470972|NCT01938430|18913869|P8|Overall Study|Investigator's Discretion|0
5470973|NCT01938430|18913870|P7|Overall Study|Investigator's Discretion|0
5470974|NCT01938430|18913871|P6|Overall Study|Investigator's Discretion|0
5470975|NCT01938430|18913872|P5|Overall Study|Investigator's Discretion|0
5470976|NCT01938430|18913873|P4|Overall Study|Investigator's Discretion|0
5470977|NCT01938430|18913874|P3|Overall Study|Investigator's Discretion|1
5470978|NCT01938430|18913875|P2|Overall Study|Investigator's Discretion|0
5470979|NCT01938430|18913876|P1|Overall Study|Investigator's Discretion|0
5470980|NCT01938430|18913863|P14|Overall Study|Death|0
5470981|NCT01938430|18913864|P13|Overall Study|Death|0
5470982|NCT01938430|18913865|P12|Overall Study|Death|0
5470983|NCT01938430|18913866|P11|Overall Study|Death|0
5470984|NCT01938430|18913867|P10|Overall Study|Death|3
5470985|NCT01938430|18913868|P9|Overall Study|Death|2
5470986|NCT01938430|18913869|P8|Overall Study|Death|1
5470987|NCT01938430|18913870|P7|Overall Study|Death|1
5470988|NCT01938430|18913871|P6|Overall Study|Death|0
5470989|NCT01938430|18913872|P5|Overall Study|Death|0
5470990|NCT01938430|18913873|P4|Overall Study|Death|1
5470991|NCT01938430|18913874|P3|Overall Study|Death|2
5470992|NCT01938430|18913875|P2|Overall Study|Death|2
5470993|NCT01938430|18913876|P1|Overall Study|Death|1
5470994|NCT01938430|18913863|P14|Overall Study|Adverse Event|0
5470995|NCT01938430|18913864|P13|Overall Study|Adverse Event|0
5470996|NCT01938430|18913865|P12|Overall Study|Adverse Event|0
5470997|NCT01938430|18913866|P11|Overall Study|Adverse Event|0
5470998|NCT01938430|18913867|P10|Overall Study|Adverse Event|0
5470999|NCT01938430|18913868|P9|Overall Study|Adverse Event|0
5471000|NCT01938430|18913869|P8|Overall Study|Adverse Event|0
5471001|NCT01938430|18913870|P7|Overall Study|Adverse Event|1
5471002|NCT01938430|18913871|P6|Overall Study|Adverse Event|0
5471003|NCT01938430|18913872|P5|Overall Study|Adverse Event|0
5471004|NCT01938430|18913873|P4|Overall Study|Adverse Event|0
5471005|NCT01938430|18913874|P3|Overall Study|Adverse Event|0
5471006|NCT01938430|18913875|P2|Overall Study|Adverse Event|0
5471007|NCT01938430|18913876|P1|Overall Study|Adverse Event|0
5471008|NCT01938430|18913863|P14|Overall Study|Randomized but Not Treated|1
5471009|NCT01938430|18913864|P13|Overall Study|Randomized but Not Treated|0
5471010|NCT01938430|18913865|P12|Overall Study|Randomized but Not Treated|0
5471011|NCT01938430|18913866|P11|Overall Study|Randomized but Not Treated|1
5471012|NCT01938430|18913867|P10|Overall Study|Randomized but Not Treated|0
5471013|NCT01938430|18913868|P9|Overall Study|Randomized but Not Treated|0
5471014|NCT01938430|18913869|P8|Overall Study|Randomized but Not Treated|0
5471015|NCT01938430|18913870|P7|Overall Study|Randomized but Not Treated|0
5471016|NCT01938430|18913871|P6|Overall Study|Randomized but Not Treated|0
5471017|NCT01938430|18913872|P5|Overall Study|Randomized but Not Treated|0
5471018|NCT01938430|18913873|P4|Overall Study|Randomized but Not Treated|0
5471019|NCT01938430|18913874|P3|Overall Study|Randomized but Not Treated|0
5471020|NCT01938430|18913875|P2|Overall Study|Randomized but Not Treated|0
5471021|NCT01938430|18913876|P1|Overall Study|Randomized but Not Treated|0
5471022|NCT01938391|18914201|P1|12 Month Follow up|Withdrawal by Subject|1
5471023|NCT01938391|18914201|P1|12 Month Follow up|Physician Decision|1
5471024|NCT01938391|18914201|P1|6 Month Follow up|Withdrawal by Subject|1
5471025|NCT01938001|18914335|P2|Overall Study|Death|26
5471026|NCT01938001|18914336|P1|Overall Study|Death|16
5471027|NCT01938001|18914335|P2|Overall Study|Lost to Follow-up|3
5471028|NCT01938001|18914336|P1|Overall Study|Lost to Follow-up|1
5471029|NCT01938001|18914335|P2|Overall Study|Participant Moved|1
5471030|NCT01938001|18914336|P1|Overall Study|Participant Moved|0
5471031|NCT01938001|18914335|P2|Overall Study|Non-compliant|0
5471032|NCT01938001|18914336|P1|Overall Study|Non-compliant|1
5471033|NCT01938001|18914335|P2|Overall Study|Withdrawal by Subject|17
5471034|NCT01938001|18914336|P1|Overall Study|Withdrawal by Subject|25
5471035|NCT01937871|18914415|P3|Overall Study|Entry Criteria Not Met|1
5471036|NCT01937871|18914416|P2|Overall Study|Entry Criteria Not Met|2
5471037|NCT01937871|18914417|P1|Overall Study|Entry Criteria Not Met|1
5471038|NCT01937871|18914415|P3|Overall Study|Physician Decision|0
5471039|NCT01937871|18914416|P2|Overall Study|Physician Decision|1
5471040|NCT01937871|18914417|P1|Overall Study|Physician Decision|0
5471041|NCT01937871|18914415|P3|Overall Study|Withdrawal by Subject|4
5471042|NCT01937871|18914416|P2|Overall Study|Withdrawal by Subject|6
5471043|NCT01937871|18914417|P1|Overall Study|Withdrawal by Subject|9
5471044|NCT01937871|18914415|P3|Overall Study|Lost to Follow-up|4
5471045|NCT01937871|18914416|P2|Overall Study|Lost to Follow-up|2
5471046|NCT01937871|18914417|P1|Overall Study|Lost to Follow-up|8
5471047|NCT01937871|18914415|P3|Overall Study|Adverse Event|2
5471048|NCT01937871|18914416|P2|Overall Study|Adverse Event|6
5471049|NCT01937871|18914417|P1|Overall Study|Adverse Event|6
5471050|NCT01937715|18914493|P5|Overall Study|Other|0
5471051|NCT01937715|18914494|P4|Overall Study|Other|3
5471052|NCT01937715|18914495|P3|Overall Study|Other|0
5471053|NCT01937715|18914496|P2|Overall Study|Other|0
5471054|NCT01937715|18914497|P1|Overall Study|Other|0
5471055|NCT01937715|18914493|P5|Overall Study|Withdrawal by Subject|2
5471056|NCT01937715|18914494|P4|Overall Study|Withdrawal by Subject|0
5471057|NCT01937715|18914495|P3|Overall Study|Withdrawal by Subject|0
5471058|NCT01937715|18914496|P2|Overall Study|Withdrawal by Subject|1
5471059|NCT01937715|18914497|P1|Overall Study|Withdrawal by Subject|0
5471060|NCT01937715|18914493|P5|Overall Study|Death|0
5471061|NCT01937715|18914494|P4|Overall Study|Death|1
5471062|NCT01937715|18914495|P3|Overall Study|Death|0
5471063|NCT01937715|18914496|P2|Overall Study|Death|0
5471064|NCT01937715|18914497|P1|Overall Study|Death|0
5471065|NCT01937559|18914649|P3|Overall Study|screen fail|0
5471066|NCT01937559|18914650|P2|Overall Study|screen fail|4
5471067|NCT01937559|18914651|P1|Overall Study|screen fail|2
5471068|NCT01937559|18914649|P3|Overall Study|Withdrawal by Subject|0
5471069|NCT01937559|18914650|P2|Overall Study|Withdrawal by Subject|4
5471070|NCT01937559|18914651|P1|Overall Study|Withdrawal by Subject|6
5471071|NCT01937559|18914649|P3|Overall Study|Physician Decision|0
5471072|NCT01937559|18914650|P2|Overall Study|Physician Decision|3
5471073|NCT01937559|18914651|P1|Overall Study|Physician Decision|3
5471074|NCT01937390|18914721|P1|Overall Study|Fail to return|21
5471075|NCT01937390|18914721|P1|Overall Study|Withdrawal by Subject|5
5471076|NCT01937390|18914721|P1|Overall Study|Lost to Follow-up|7
5471077|NCT01937390|18914721|P1|Overall Study|Death|2
5471078|NCT01937364|18914731|P2|Overall Study|Adverse Event|1
5471079|NCT01937364|18914732|P1|Overall Study|Adverse Event|2
5471080|NCT01937351|18914744|P2|Overall Study|Not treated w device, per protocol fail|0
5471081|NCT01937351|18914745|P1|Overall Study|Not treated w device, per protocol fail|4
5471082|NCT01937351|18914744|P2|Overall Study|Death|0
5471083|NCT01937351|18914745|P1|Overall Study|Death|1
5471084|NCT01937351|18914744|P2|Overall Study|Withdrawal by Subject|2
5471085|NCT01937351|18914745|P1|Overall Study|Withdrawal by Subject|4
5471086|NCT01937312|18914753|P2|Overall Study|Withdrawal of subject prior to treatment|1
5471087|NCT01937312|18914754|P1|Overall Study|Withdrawal of subject prior to treatment|1
5471088|NCT01937312|18914753|P2|Overall Study|Lack of Efficacy|1
5471089|NCT01937312|18914754|P1|Overall Study|Lack of Efficacy|0
5471090|NCT01937312|18914753|P2|Overall Study|Adverse Event|1
5471091|NCT01937312|18914754|P1|Overall Study|Adverse Event|10
5471092|NCT01937299|18914769|P2|Overall Study|Withdrawal by Subject|0
5471093|NCT01937299|18914770|P1|Overall Study|Withdrawal by Subject|1
5471094|NCT01937299|18914769|P2|Overall Study|Lack of Efficacy|4
5471095|NCT01937299|18914770|P1|Overall Study|Lack of Efficacy|0
5471096|NCT01937299|18914769|P2|Overall Study|Adverse Event|0
5471097|NCT01937299|18914770|P1|Overall Study|Adverse Event|13
5471098|NCT01937130|18914805|P4|Overall Study|Patient lost to FU due to death|0
5471099|NCT01937130|18914806|P3|Overall Study|Patient lost to FU due to death|0
5471100|NCT01937130|18914807|P2|Overall Study|Patient lost to FU due to death|0
5471101|NCT01937130|18914808|P1|Overall Study|Patient lost to FU due to death|2
5471102|NCT01937130|18914805|P4|Overall Study|Patients unable to swallow|0
5471103|NCT01937130|18914806|P3|Overall Study|Patients unable to swallow|0
5471104|NCT01937130|18914807|P2|Overall Study|Patients unable to swallow|1
5471105|NCT01937130|18914808|P1|Overall Study|Patients unable to swallow|0
5471106|NCT01937130|18914805|P4|Overall Study|Physician Decision|0
5471107|NCT01937130|18914806|P3|Overall Study|Physician Decision|0
5471108|NCT01937130|18914807|P2|Overall Study|Physician Decision|1
5471109|NCT01937130|18914808|P1|Overall Study|Physician Decision|0
5471110|NCT01937130|18914805|P4|Overall Study|Lost to Follow-up|0
5471111|NCT01937130|18914806|P3|Overall Study|Lost to Follow-up|2
5471112|NCT01937130|18914807|P2|Overall Study|Lost to Follow-up|0
5471113|NCT01937130|18914808|P1|Overall Study|Lost to Follow-up|2
5471114|NCT01937130|18914805|P4|Overall Study|Death|0
5471115|NCT01937130|18914806|P3|Overall Study|Death|1
5471116|NCT01937130|18914807|P2|Overall Study|Death|1
5471117|NCT01937130|18914808|P1|Overall Study|Death|1
5471118|NCT01937130|18914805|P4|Overall Study|Adverse Event|1
5471119|NCT01937130|18914806|P3|Overall Study|Adverse Event|0
5471120|NCT01937130|18914807|P2|Overall Study|Adverse Event|1
5471121|NCT01937130|18914808|P1|Overall Study|Adverse Event|0
5471122|NCT01937130|18914805|P4|Overall Study|Withdrawal by Subject|1
5471123|NCT01937130|18914806|P3|Overall Study|Withdrawal by Subject|0
5471124|NCT01937130|18914807|P2|Overall Study|Withdrawal by Subject|0
5471125|NCT01937130|18914808|P1|Overall Study|Withdrawal by Subject|0
5471126|NCT01937117|18914835|P1|Overall Study|Adverse Event|2
5471127|NCT01937117|18914835|P1|Overall Study|Physician Decision|4
5471128|NCT01937117|18914835|P1|Overall Study|Disease Progression|7
5471129|NCT01936974|18914850|P2|Overall Study|Physician Decision|5
5471130|NCT01936974|18914851|P1|Overall Study|Physician Decision|2
5471131|NCT01936870|18914881|P1|Overall Study|No Drug Administration|1
5471132|NCT01936870|18914881|P1|Overall Study|Protocol Violation|12
5471133|NCT01936870|18914881|P1|Overall Study|No Visit After Treatment|176
5471134|NCT01936857|18914896|P2|Overall Study|Other|2
5471135|NCT01936857|18914897|P1|Overall Study|Other|2
5471136|NCT01936857|18914896|P2|Overall Study|Side effect of medication|0
5471137|NCT01936857|18914897|P1|Overall Study|Side effect of medication|1
5471138|NCT01936857|18914896|P2|Overall Study|Withdrawal by Subject|0
5471139|NCT01936857|18914897|P1|Overall Study|Withdrawal by Subject|1
5471140|NCT01936857|18914896|P2|Overall Study|Moved|1
5471141|NCT01936857|18914897|P1|Overall Study|Moved|2
5471142|NCT01936857|18914896|P2|Overall Study|Death|3
5471143|NCT01936857|18914897|P1|Overall Study|Death|7
5471144|NCT01936857|18914896|P2|Overall Study|Lost to Follow-up|7
5471145|NCT01936857|18914897|P1|Overall Study|Lost to Follow-up|10
5471146|NCT01936857|18914896|P2|Overall Study|Sent to prison or 06 center|12
5471147|NCT01936857|18914897|P1|Overall Study|Sent to prison or 06 center|11
5471148|NCT01936649|18914927|P1|Overall Study|Other than specified above|5
5471149|NCT01936649|18914927|P1|Overall Study|Protocol Violation|2
5471150|NCT01936649|18914927|P1|Overall Study|Physician Decision|2
5471151|NCT01936649|18914927|P1|Overall Study|Withdrawal by Subject|4
5471152|NCT01936623|18914934|P2|Overall Study|Lost to Follow-up|5
5471153|NCT01936623|18914935|P1|Overall Study|Lost to Follow-up|0
5471154|NCT01936181|18915043|P4|Transition-extension|Withdrawal by Subject|1
5471155|NCT01936181|18915044|P3|Transition-extension|Withdrawal by Subject|2
5471156|NCT01936181|18915045|P2|Transition-extension|Withdrawal by Subject|0
5471157|NCT01936181|18915046|P1|Transition-extension|Withdrawal by Subject|7
5471158|NCT01936181|18915043|P4|Transition-extension|Physician Decision|1
5471159|NCT01936181|18915044|P3|Transition-extension|Physician Decision|0
5471160|NCT01936181|18915045|P2|Transition-extension|Physician Decision|0
5471161|NCT01936181|18915046|P1|Transition-extension|Physician Decision|2
5471162|NCT01936181|18915043|P4|Transition-extension|Lost to Follow-up|2
5471163|NCT01936181|18915044|P3|Transition-extension|Lost to Follow-up|1
5471164|NCT01936181|18915045|P2|Transition-extension|Lost to Follow-up|0
5471165|NCT01936181|18915046|P1|Transition-extension|Lost to Follow-up|3
5471166|NCT01936181|18915043|P4|Transition-extension|Adverse Event|1
5471167|NCT01936181|18915044|P3|Transition-extension|Adverse Event|3
5471168|NCT01936181|18915045|P2|Transition-extension|Adverse Event|0
5471169|NCT01936181|18915046|P1|Transition-extension|Adverse Event|3
5471170|NCT01936181|18915043|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
5471171|NCT01936181|18915044|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
5471172|NCT01936181|18915045|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
5471173|NCT01936181|18915046|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
5471174|NCT01936181|18915043|P4|Randomised, Double-blind|Withdrawal by Subject|0
5471175|NCT01936181|18915044|P3|Randomised, Double-blind|Withdrawal by Subject|0
5471176|NCT01936181|18915045|P2|Randomised, Double-blind|Withdrawal by Subject|26
5471177|NCT01936181|18915046|P1|Randomised, Double-blind|Withdrawal by Subject|23
5471178|NCT01936181|18915043|P4|Randomised, Double-blind|Physician Decision|0
5471179|NCT01936181|18915044|P3|Randomised, Double-blind|Physician Decision|0
5471180|NCT01936181|18915045|P2|Randomised, Double-blind|Physician Decision|4
5471181|NCT01936181|18915046|P1|Randomised, Double-blind|Physician Decision|4
5471182|NCT01936181|18915043|P4|Randomised, Double-blind|Pregnancy|0
5471183|NCT01936181|18915044|P3|Randomised, Double-blind|Pregnancy|0
5471184|NCT01936181|18915045|P2|Randomised, Double-blind|Pregnancy|1
5471185|NCT01936181|18915046|P1|Randomised, Double-blind|Pregnancy|0
5471186|NCT01936181|18915043|P4|Randomised, Double-blind|Lost to Follow-up|0
5471187|NCT01936181|18915044|P3|Randomised, Double-blind|Lost to Follow-up|0
5471188|NCT01936181|18915045|P2|Randomised, Double-blind|Lost to Follow-up|1
5471189|NCT01936181|18915046|P1|Randomised, Double-blind|Lost to Follow-up|0
5471190|NCT01936181|18915043|P4|Randomised, Double-blind|Lack of Efficacy|0
5471191|NCT01936181|18915044|P3|Randomised, Double-blind|Lack of Efficacy|0
5471192|NCT01936181|18915045|P2|Randomised, Double-blind|Lack of Efficacy|6
5471193|NCT01936181|18915046|P1|Randomised, Double-blind|Lack of Efficacy|5
5471194|NCT01936181|18915043|P4|Randomised, Double-blind|Protocol Violation|0
5471195|NCT01936181|18915044|P3|Randomised, Double-blind|Protocol Violation|0
5471196|NCT01936181|18915045|P2|Randomised, Double-blind|Protocol Violation|5
5471197|NCT01936181|18915046|P1|Randomised, Double-blind|Protocol Violation|1
5471198|NCT01936181|18915043|P4|Randomised, Double-blind|Adverse Event|0
5471199|NCT01936181|18915044|P3|Randomised, Double-blind|Adverse Event|0
5471200|NCT01936181|18915045|P2|Randomised, Double-blind|Adverse Event|21
5471201|NCT01936181|18915046|P1|Randomised, Double-blind|Adverse Event|27
5471202|NCT01935947|18915060|P3|Overall Study|Death|0
5471203|NCT01935947|18915061|P2|Overall Study|Death|0
5471204|NCT01935947|18915062|P1|Overall Study|Death|1
5471205|NCT01935947|18915060|P3|Overall Study|Diease Progression|2
5471206|NCT01935947|18915061|P2|Overall Study|Diease Progression|2
5471207|NCT01935947|18915062|P1|Overall Study|Diease Progression|2
5471208|NCT01935947|18915060|P3|Overall Study|Adverse Event|0
5471209|NCT01935947|18915061|P2|Overall Study|Adverse Event|2
5471210|NCT01935947|18915062|P1|Overall Study|Adverse Event|0
5471211|NCT01935700|18915097|P2|Overall Study|Physician Decision|0
5471212|NCT01935700|18915098|P1|Overall Study|Physician Decision|4
5471213|NCT01935700|18915097|P2|Overall Study|Withdrawal by Subject|0
5471214|NCT01935700|18915098|P1|Overall Study|Withdrawal by Subject|1
5471215|NCT01934972|18915142|P2|Overall Study|Withdrawal by Subject|6
5471216|NCT01934972|18915143|P1|Overall Study|Withdrawal by Subject|9
5471217|NCT01934894|18915173|P2|Overall Study|Progressive Disease|2
5471218|NCT01934894|18915174|P1|Overall Study|Progressive Disease|3
5471219|NCT01934894|18915173|P2|Overall Study|Withdrawal by Subject|1
5471220|NCT01934894|18915174|P1|Overall Study|Withdrawal by Subject|0
5471221|NCT01934894|18915173|P2|Overall Study|Death|0
5471222|NCT01934894|18915174|P1|Overall Study|Death|2
5471223|NCT01934894|18915173|P2|Overall Study|Adverse Event|2
5471224|NCT01934894|18915174|P1|Overall Study|Adverse Event|1
5471225|NCT01934790|18915189|P1|Active Follow up|Other reason|1
5471226|NCT01934790|18915189|P1|Active Follow up|Progressive disease|1
5471227|NCT01934790|18915189|P1|Active Follow up|Physician Decision|2
5471228|NCT01934790|18915189|P1|Active Follow up|Death|20
5471229|NCT01934790|18915189|P1|Treatment|Study drug never administered|1
5471230|NCT01934790|18915189|P1|Treatment|Withdrawal by Subject|2
5471231|NCT01934790|18915189|P1|Treatment|Radiological progression|4
5471232|NCT01934790|18915189|P1|Treatment|Clinical progression|6
5471233|NCT01934790|18915189|P1|Treatment|Adverse Event|3
5471234|NCT01934556|18915247|P3|Overall Study|Death|2
5471235|NCT01934556|18915248|P2|Overall Study|Death|5
5471236|NCT01934556|18915249|P1|Overall Study|Death|1
5471237|NCT01934556|18915247|P3|Overall Study|Lost to Follow-up|7
5471238|NCT01934556|18915248|P2|Overall Study|Lost to Follow-up|10
5471239|NCT01934556|18915249|P1|Overall Study|Lost to Follow-up|4
5471240|NCT01934556|18915247|P3|Overall Study|Withdrawal by Subject|1
5471241|NCT01934556|18915248|P2|Overall Study|Withdrawal by Subject|1
5471242|NCT01934556|18915249|P1|Overall Study|Withdrawal by Subject|0
5471243|NCT01934504|18915293|P4|Overall Study|Study Terminated by Sponsor|5
5471244|NCT01934504|18915294|P3|Overall Study|Study Terminated by Sponsor|5
5471245|NCT01934504|18915295|P2|Overall Study|Study Terminated by Sponsor|0
5471246|NCT01934504|18915296|P1|Overall Study|Study Terminated by Sponsor|1
5471247|NCT01934504|18915293|P4|Overall Study|Protocol Deviation|2
5471248|NCT01934504|18915294|P3|Overall Study|Protocol Deviation|0
5471249|NCT01934504|18915295|P2|Overall Study|Protocol Deviation|0
5471250|NCT01934504|18915296|P1|Overall Study|Protocol Deviation|0
5471251|NCT01934218|18915329|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
5471252|NCT01934218|18915330|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
5471253|NCT01934218|18915329|P2|Open-Label Phase|Noncompliance with Study Protocol|2
5471254|NCT01934218|18915330|P1|Open-Label Phase|Noncompliance with Study Protocol|4
5471255|NCT01934218|18915329|P2|Open-Label Phase|Withdrawal by Subject|11
5471256|NCT01934218|18915330|P1|Open-Label Phase|Withdrawal by Subject|13
5471257|NCT01934218|18915329|P2|Open-Label Phase|Protocol Violation|0
5471258|NCT01934218|18915330|P1|Open-Label Phase|Protocol Violation|1
5471259|NCT01934218|18915329|P2|Open-Label Phase|Physician Decision|0
5471260|NCT01934218|18915330|P1|Open-Label Phase|Physician Decision|1
5471261|NCT01934218|18915329|P2|Open-Label Phase|Lost to Follow-up|2
5471262|NCT01934218|18915330|P1|Open-Label Phase|Lost to Follow-up|4
5471263|NCT01934218|18915329|P2|Open-Label Phase|Lack of Efficacy|4
5471264|NCT01934218|18915330|P1|Open-Label Phase|Lack of Efficacy|1
5471265|NCT01934218|18915329|P2|Open-Label Phase|Adverse Event|4
5471266|NCT01934218|18915330|P1|Open-Label Phase|Adverse Event|2
5471267|NCT01934218|18915329|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
5471268|NCT01934218|18915330|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
5471269|NCT01934218|18915329|P2|Double-blind Phase|Noncompliance with Study Protocol|8
5471270|NCT01934218|18915330|P1|Double-blind Phase|Noncompliance with Study Protocol|5
5471271|NCT01934218|18915329|P2|Double-blind Phase|Withdrawal by Subject|13
5471272|NCT01934218|18915330|P1|Double-blind Phase|Withdrawal by Subject|16
5471273|NCT01934218|18915329|P2|Double-blind Phase|Protocol Violation|0
5471274|NCT01934218|18915330|P1|Double-blind Phase|Protocol Violation|4
5471275|NCT01934218|18915329|P2|Double-blind Phase|Physician Decision|2
5471276|NCT01934218|18915330|P1|Double-blind Phase|Physician Decision|1
5471277|NCT01934218|18915329|P2|Double-blind Phase|Lost to Follow-up|14
5471278|NCT01934218|18915330|P1|Double-blind Phase|Lost to Follow-up|7
5471279|NCT01934218|18915329|P2|Double-blind Phase|Lack of Efficacy|7
5471280|NCT01934218|18915330|P1|Double-blind Phase|Lack of Efficacy|6
5471281|NCT01934218|18915329|P2|Double-blind Phase|Adverse Event|8
5471282|NCT01934218|18915330|P1|Double-blind Phase|Adverse Event|8
5471283|NCT01934192|18915341|P4|Overall Study|Physician Decision|0
5471284|NCT01934192|18915342|P3|Overall Study|Physician Decision|0
5471285|NCT01934192|18915343|P2|Overall Study|Physician Decision|2
5471286|NCT01934192|18915344|P1|Overall Study|Physician Decision|3
5471287|NCT01934192|18915341|P4|Overall Study|Other: reached stopping criteria|0
5471288|NCT01934192|18915342|P3|Overall Study|Other: reached stopping criteria|1
5471289|NCT01934192|18915343|P2|Overall Study|Other: reached stopping criteria|5
5471290|NCT01934192|18915344|P1|Overall Study|Other: reached stopping criteria|6
5471291|NCT01934192|18915341|P4|Overall Study|Protocol Violation|1
5471292|NCT01934192|18915342|P3|Overall Study|Protocol Violation|0
5471293|NCT01934192|18915343|P2|Overall Study|Protocol Violation|0
5471294|NCT01934192|18915344|P1|Overall Study|Protocol Violation|0
5471295|NCT01934140|18915480|P2|Booster Phase (6 Months)|Migrated/moved from study area|2
5471296|NCT01934140|18915481|P1|Booster Phase (6 Months)|Migrated/moved from study area|2
5471297|NCT01934140|18915480|P2|Booster Phase (6 Months)|Missed at least 1 booster visit|1
5471298|NCT01934140|18915481|P1|Booster Phase (6 Months)|Missed at least 1 booster visit|2
5471299|NCT01934140|18915480|P2|Booster Phase (6 Months)|Lost to Follow-up|0
5471300|NCT01934140|18915481|P1|Booster Phase (6 Months)|Lost to Follow-up|1
5471301|NCT01934140|18915480|P2|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
5471302|NCT01934140|18915481|P1|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
5471303|NCT01934140|18915480|P2|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
5471304|NCT01934140|18915481|P1|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
5471305|NCT01934140|18915480|P2|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
5471306|NCT01934140|18915481|P1|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
5471307|NCT01934140|18915480|P2|Persistence Phase (Year 6-10)|Lost to Follow-up|2
5471308|NCT01934140|18915481|P1|Persistence Phase (Year 6-10)|Lost to Follow-up|5
5471309|NCT01934140|18915480|P2|Persistence Phase (Year 6-10)|Other|6
5471310|NCT01934140|18915481|P1|Persistence Phase (Year 6-10)|Other|24
5471311|NCT01934010|18915532|P3|Overall Study|Lost to Follow-up|0
5471312|NCT01934010|18915533|P2|Overall Study|Lost to Follow-up|4
5471313|NCT01934010|18915534|P1|Overall Study|Lost to Follow-up|7
5471314|NCT01934010|18915532|P3|Overall Study|Withdrawal by Subject|2
5471315|NCT01934010|18915533|P2|Overall Study|Withdrawal by Subject|6
5471316|NCT01934010|18915534|P1|Overall Study|Withdrawal by Subject|15
5471317|NCT01934010|18915532|P3|Overall Study|Adverse Event|0
5471318|NCT01934010|18915533|P2|Overall Study|Adverse Event|1
5471319|NCT01934010|18915534|P1|Overall Study|Adverse Event|1
5471320|NCT01933932|18915576|P2|Overall Study|Eligibility criteria not fulfilled|1
5471321|NCT01933932|18915577|P1|Overall Study|Eligibility criteria not fulfilled|0
5471322|NCT01933932|18915576|P2|Overall Study|Withdrawal by Subject|14
5471323|NCT01933932|18915577|P1|Overall Study|Withdrawal by Subject|11
5471324|NCT01933932|18915576|P2|Overall Study|Death|163
5471325|NCT01933932|18915577|P1|Overall Study|Death|173
5471326|NCT01933919|18915595|P2|Open-label Long-term Phase|Other|2
5471327|NCT01933919|18915596|P1|Open-label Long-term Phase|Other|1
5471328|NCT01933919|18915595|P2|Open-label Long-term Phase|Lost to Follow-up|0
5471329|NCT01933919|18915596|P1|Open-label Long-term Phase|Lost to Follow-up|1
5471330|NCT01933919|18915595|P2|Open-label Long-term Phase|Withdrawal by Subject|4
5471331|NCT01933919|18915596|P1|Open-label Long-term Phase|Withdrawal by Subject|3
5471332|NCT01933919|18915595|P2|Open-label Long-term Phase|Adverse Event|0
5471333|NCT01933919|18915596|P1|Open-label Long-term Phase|Adverse Event|2
5471334|NCT01933919|18915595|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
5471335|NCT01933919|18915596|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
5471336|NCT01933919|18915595|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
5471337|NCT01933919|18915596|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
5471338|NCT01933919|18915595|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
5471339|NCT01933919|18915596|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
5471340|NCT01933880|18915632|P2|Overall Study|Protocol Violation|0
5471341|NCT01933880|18915633|P1|Overall Study|Protocol Violation|1
5471342|NCT01933880|18915632|P2|Overall Study|Other|0
5471343|NCT01933880|18915633|P1|Overall Study|Other|4
5471344|NCT01933880|18915632|P2|Overall Study|Followup exceeded 4 days to visit window|0
5471345|NCT01933880|18915633|P1|Overall Study|Followup exceeded 4 days to visit window|19
5471346|NCT01933880|18915632|P2|Overall Study|Concomitant medication Interference|1
5471347|NCT01933880|18915633|P1|Overall Study|Concomitant medication Interference|0
5471348|NCT01933880|18915632|P2|Overall Study|Lack of Efficacy|0
5471349|NCT01933880|18915633|P1|Overall Study|Lack of Efficacy|1
5471350|NCT01933880|18915632|P2|Overall Study|Withdrawal by Subject|0
5471351|NCT01933880|18915633|P1|Overall Study|Withdrawal by Subject|5
5471352|NCT01933789|18915707|P9|Overall Study|Became Ineligible|0
5471353|NCT01933789|18915708|P8|Overall Study|Became Ineligible|6
5471354|NCT01933789|18915709|P7|Overall Study|Became Ineligible|13
5471355|NCT01933789|18915710|P6|Overall Study|Became Ineligible|10
5471356|NCT01933789|18915711|P5|Overall Study|Became Ineligible|13
5471357|NCT01933789|18915712|P4|Overall Study|Became Ineligible|0
5471358|NCT01933789|18915713|P3|Overall Study|Became Ineligible|0
5471359|NCT01933789|18915714|P2|Overall Study|Became Ineligible|0
5471360|NCT01933789|18915715|P1|Overall Study|Became Ineligible|4
5471361|NCT01933789|18915707|P9|Overall Study|Withdrawal by Subject|0
5471362|NCT01933789|18915708|P8|Overall Study|Withdrawal by Subject|4
5471363|NCT01933789|18915709|P7|Overall Study|Withdrawal by Subject|1
5471364|NCT01933789|18915710|P6|Overall Study|Withdrawal by Subject|16
5471365|NCT01933789|18915711|P5|Overall Study|Withdrawal by Subject|17
5471366|NCT01933789|18915712|P4|Overall Study|Withdrawal by Subject|0
5471367|NCT01933789|18915713|P3|Overall Study|Withdrawal by Subject|0
5471368|NCT01933789|18915714|P2|Overall Study|Withdrawal by Subject|1
5471369|NCT01933789|18915715|P1|Overall Study|Withdrawal by Subject|2
5471370|NCT01933789|18915707|P9|Overall Study|Lost to Follow-up|0
5471371|NCT01933789|18915708|P8|Overall Study|Lost to Follow-up|4
5471372|NCT01933789|18915709|P7|Overall Study|Lost to Follow-up|1
5471373|NCT01933789|18915710|P6|Overall Study|Lost to Follow-up|9
5471374|NCT01933789|18915711|P5|Overall Study|Lost to Follow-up|8
5471375|NCT01933789|18915712|P4|Overall Study|Lost to Follow-up|1
5471376|NCT01933789|18915713|P3|Overall Study|Lost to Follow-up|0
5471377|NCT01933789|18915714|P2|Overall Study|Lost to Follow-up|0
5471378|NCT01933789|18915715|P1|Overall Study|Lost to Follow-up|0
5471379|NCT01933789|18915707|P9|Overall Study|Death|0
5471380|NCT01933789|18915708|P8|Overall Study|Death|0
5471381|NCT01933789|18915709|P7|Overall Study|Death|0
5471382|NCT01933789|18915710|P6|Overall Study|Death|32
5471383|NCT01933789|18915711|P5|Overall Study|Death|21
5471384|NCT01933789|18915712|P4|Overall Study|Death|0
5471385|NCT01933789|18915713|P3|Overall Study|Death|0
5471386|NCT01933789|18915714|P2|Overall Study|Death|0
5471387|NCT01933789|18915715|P1|Overall Study|Death|0
5471388|NCT01933672|18916025|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5471389|NCT01933672|18916026|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5471390|NCT01933672|18916027|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5471391|NCT01933672|18916028|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5471392|NCT01933672|18916029|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5471393|NCT01933672|18916030|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
5471394|NCT01933672|18916031|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
5471395|NCT01933672|18916025|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5471396|NCT01933672|18916026|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5471397|NCT01933672|18916027|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5471398|NCT01933672|18916028|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
5471399|NCT01933672|18916029|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5471400|NCT01933672|18916030|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5471401|NCT01933672|18916031|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
5471402|NCT01933672|18916025|P7|Second Intervention Period (12-16 Days)|Other|0
5471403|NCT01933672|18916026|P6|Second Intervention Period (12-16 Days)|Other|0
5471404|NCT01933672|18916027|P5|Second Intervention Period (12-16 Days)|Other|0
5471405|NCT01933672|18916028|P4|Second Intervention Period (12-16 Days)|Other|0
5471406|NCT01933672|18916029|P3|Second Intervention Period (12-16 Days)|Other|1
5471407|NCT01933672|18916030|P2|Second Intervention Period (12-16 Days)|Other|1
5471408|NCT01933672|18916031|P1|Second Intervention Period (12-16 Days)|Other|0
5471409|NCT01933672|18916025|P7|First Intervention Period (12-16 Days)|Other|0
5471410|NCT01933672|18916026|P6|First Intervention Period (12-16 Days)|Other|1
5471411|NCT01933672|18916027|P5|First Intervention Period (12-16 Days)|Other|0
5471412|NCT01933672|18916028|P4|First Intervention Period (12-16 Days)|Other|0
5471413|NCT01933672|18916029|P3|First Intervention Period (12-16 Days)|Other|1
5471414|NCT01933672|18916030|P2|First Intervention Period (12-16 Days)|Other|0
5471415|NCT01933672|18916031|P1|First Intervention Period (12-16 Days)|Other|0
5471416|NCT01933672|18916025|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5471417|NCT01933672|18916026|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5471418|NCT01933672|18916027|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
5471419|NCT01933672|18916028|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5471420|NCT01933672|18916029|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5471421|NCT01933672|18916030|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5471422|NCT01933672|18916031|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
5471423|NCT01933672|18916025|P7|Metformin Run-in Period|Other|0
5471424|NCT01933672|18916026|P6|Metformin Run-in Period|Other|0
5471425|NCT01933672|18916027|P5|Metformin Run-in Period|Other|0
5471426|NCT01933672|18916028|P4|Metformin Run-in Period|Other|0
5471427|NCT01933672|18916029|P3|Metformin Run-in Period|Other|0
5471428|NCT01933672|18916030|P2|Metformin Run-in Period|Other|0
5471429|NCT01933672|18916031|P1|Metformin Run-in Period|Other|5
5471430|NCT01933672|18916025|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
5471431|NCT01933672|18916026|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
5471432|NCT01933672|18916027|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
5471433|NCT01933672|18916028|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
5471434|NCT01933672|18916029|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
5471435|NCT01933672|18916030|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
5471436|NCT01933672|18916031|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
5471437|NCT01933672|18916025|P7|Metformin Run-in Period|Adverse Event|0
5471438|NCT01933672|18916026|P6|Metformin Run-in Period|Adverse Event|0
5471439|NCT01933672|18916027|P5|Metformin Run-in Period|Adverse Event|0
5471440|NCT01933672|18916028|P4|Metformin Run-in Period|Adverse Event|0
5471441|NCT01933672|18916029|P3|Metformin Run-in Period|Adverse Event|0
5471442|NCT01933672|18916030|P2|Metformin Run-in Period|Adverse Event|0
5471443|NCT01933672|18916031|P1|Metformin Run-in Period|Adverse Event|1
5471444|NCT01933594|18916083|P6|Overall Study|Ineligible for subsequent study step|0
5471445|NCT01933594|18916084|P5|Overall Study|Ineligible for subsequent study step|1
5471446|NCT01933594|18916085|P4|Overall Study|Ineligible for subsequent study step|0
5471447|NCT01933594|18916086|P3|Overall Study|Ineligible for subsequent study step|0
5471448|NCT01933594|18916087|P2|Overall Study|Ineligible for subsequent study step|0
5471449|NCT01933594|18916088|P1|Overall Study|Ineligible for subsequent study step|0
5471450|NCT01933594|18916083|P6|Overall Study|Lost to Follow-up|0
5471451|NCT01933594|18916084|P5|Overall Study|Lost to Follow-up|1
5471452|NCT01933594|18916085|P4|Overall Study|Lost to Follow-up|0
5471453|NCT01933594|18916086|P3|Overall Study|Lost to Follow-up|0
5471454|NCT01933594|18916087|P2|Overall Study|Lost to Follow-up|0
5471455|NCT01933594|18916088|P1|Overall Study|Lost to Follow-up|1
5471456|NCT01933334|18916222|P2|Overall Study|Withdrawal by Subject|1
5471457|NCT01933334|18916223|P1|Overall Study|Withdrawal by Subject|0
5471458|NCT01933334|18916222|P2|Overall Study|Adverse Event|1
5471459|NCT01933334|18916223|P1|Overall Study|Adverse Event|5
5471460|NCT01933217|18916252|P2|Randomization (4 Weeks)|Lost to Follow-up|1
5471461|NCT01933217|18916253|P1|Randomization (4 Weeks)|Lost to Follow-up|1
5471462|NCT01933217|18916252|P2|Randomization (4 Weeks)|Withdrawal by Subject|3
5471463|NCT01933217|18916253|P1|Randomization (4 Weeks)|Withdrawal by Subject|1
5471464|NCT01933113|18916265|P1|Overall Study|Fractured nonfunctioning lead.|1
5471465|NCT01933048|18916271|P2|Overall Study|unknown reasons|1
5471466|NCT01933048|18916272|P1|Overall Study|unknown reasons|1
5471467|NCT01933048|18916271|P2|Overall Study|Physician Decision|0
5471468|NCT01933048|18916272|P1|Overall Study|Physician Decision|1
5471469|NCT01933048|18916271|P2|Overall Study|Protocol Violation|8
5471470|NCT01933048|18916272|P1|Overall Study|Protocol Violation|7
5471471|NCT01933048|18916271|P2|Overall Study|personal reasons|1
5471472|NCT01933048|18916272|P1|Overall Study|personal reasons|1
5471473|NCT01933048|18916271|P2|Overall Study|Lost to Follow-up|18
5471474|NCT01933048|18916272|P1|Overall Study|Lost to Follow-up|15
5471475|NCT01932996|18916287|P2|Overall Study|Protocol Violation|0
5471476|NCT01932996|18916288|P1|Overall Study|Protocol Violation|2
5471477|NCT01932970|18916298|P1|Overall Study|Protocol Specified Criteria|10
5471478|NCT01932970|18916298|P1|Overall Study|Lost to Follow-up|2
5471479|NCT01932970|18916298|P1|Overall Study|Death|1
5471480|NCT01932970|18916298|P1|Overall Study|Withdrawal by Subject|5
5471481|NCT01932788|18916308|P2|Overall Study|Withdrawal by Subject|5
5471482|NCT01932788|18916309|P1|Overall Study|Withdrawal by Subject|0
5471483|NCT01932788|18916308|P2|Overall Study|Lack of Efficacy|0
5471484|NCT01932788|18916309|P1|Overall Study|Lack of Efficacy|2
5471485|NCT01932788|18916308|P2|Overall Study|Lost to Follow-up|46
5471486|NCT01932788|18916309|P1|Overall Study|Lost to Follow-up|18
5471487|NCT01932788|18916308|P2|Overall Study|Protocol Violation|0
5471488|NCT01932788|18916309|P1|Overall Study|Protocol Violation|18
5471489|NCT01932762|18916319|P4|Overall Study|Physician Decision|0
5471490|NCT01932762|18916320|P3|Overall Study|Physician Decision|0
5471491|NCT01932762|18916321|P2|Overall Study|Physician Decision|0
5471492|NCT01932762|18916322|P1|Overall Study|Physician Decision|1
5471493|NCT01932762|18916319|P4|Overall Study|Lost to Follow-up|1
5471494|NCT01932762|18916320|P3|Overall Study|Lost to Follow-up|0
5471495|NCT01932762|18916321|P2|Overall Study|Lost to Follow-up|0
5471496|NCT01932762|18916322|P1|Overall Study|Lost to Follow-up|4
5471497|NCT01932762|18916319|P4|Overall Study|Withdrawal by Subject|0
5471498|NCT01932762|18916320|P3|Overall Study|Withdrawal by Subject|0
5471499|NCT01932762|18916321|P2|Overall Study|Withdrawal by Subject|2
5471500|NCT01932762|18916322|P1|Overall Study|Withdrawal by Subject|1
5471501|NCT01932697|18916358|P2|Overall Study|Ineligible|0
5471502|NCT01932697|18916359|P1|Overall Study|Ineligible|1
5471503|NCT01932697|18916358|P2|Overall Study|Received a different amount of tx|0
5471504|NCT01932697|18916359|P1|Overall Study|Received a different amount of tx|1
5471505|NCT01932437|18916426|P6|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
5471506|NCT01932437|18916427|P5|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5471507|NCT01932437|18916428|P4|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5471508|NCT01932437|18916429|P3|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5471509|NCT01932437|18916430|P2|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5471510|NCT01932437|18916431|P1|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
5471511|NCT01932294|18916481|P1|Overall Study|Transferred to other hospitals|12
5471512|NCT01932294|18916481|P1|Overall Study|Heart Transplantation|16
5471513|NCT01932294|18916481|P1|Overall Study|VAD Implantation|20
5471514|NCT01932294|18916481|P1|Overall Study|Lost to Follow-up|8
5471515|NCT01932294|18916481|P1|Overall Study|Death|43
5471516|NCT01931956|18916558|P4|Overall Study|Not due|0
5471517|NCT01931956|18916559|P3|Overall Study|Not due|21
5471518|NCT01931956|18916560|P2|Overall Study|Not due|0
5471519|NCT01931956|18916561|P1|Overall Study|Not due|0
5471520|NCT01931956|18916558|P4|Overall Study|Expected|0
5471521|NCT01931956|18916559|P3|Overall Study|Expected|6
5471522|NCT01931956|18916560|P2|Overall Study|Expected|0
5471523|NCT01931956|18916561|P1|Overall Study|Expected|2
5471524|NCT01931956|18916558|P4|Overall Study|Lost to Follow-up|7
5471525|NCT01931956|18916559|P3|Overall Study|Lost to Follow-up|11
5471526|NCT01931956|18916560|P2|Overall Study|Lost to Follow-up|0
5471527|NCT01931956|18916561|P1|Overall Study|Lost to Follow-up|2
5471528|NCT01931956|18916558|P4|Overall Study|Withdrawal by Subject|30
5471529|NCT01931956|18916559|P3|Overall Study|Withdrawal by Subject|70
5471530|NCT01931956|18916560|P2|Overall Study|Withdrawal by Subject|0
5471531|NCT01931956|18916561|P1|Overall Study|Withdrawal by Subject|5
5471532|NCT01931956|18916558|P4|Overall Study|Death|96
5471533|NCT01931956|18916559|P3|Overall Study|Death|379
5471534|NCT01931956|18916560|P2|Overall Study|Death|7
5471535|NCT01931956|18916561|P1|Overall Study|Death|42
5471536|NCT01931865|18916928|P1|Overall Study|Withdrawal by Subject|2
5471537|NCT01931865|18916928|P1|Overall Study|Lost to Follow-up|2
5471538|NCT01931839|18916941|P7|Overall Study|Other|0
5471539|NCT01931839|18916942|P6|Overall Study|Other|0
5471540|NCT01931839|18916943|P5|Overall Study|Other|0
5471541|NCT01931839|18916944|P4|Overall Study|Other|0
5471542|NCT01931839|18916945|P3|Overall Study|Other|6
5471543|NCT01931839|18916946|P2|Overall Study|Other|2
5471544|NCT01931839|18916947|P1|Overall Study|Other|4
5471545|NCT01931839|18916941|P7|Overall Study|Lost to Follow-up|0
5471546|NCT01931839|18916942|P6|Overall Study|Lost to Follow-up|0
5471547|NCT01931839|18916943|P5|Overall Study|Lost to Follow-up|0
5471548|NCT01931839|18916944|P4|Overall Study|Lost to Follow-up|5
5471549|NCT01931839|18916945|P3|Overall Study|Lost to Follow-up|4
5471550|NCT01931839|18916946|P2|Overall Study|Lost to Follow-up|2
5471551|NCT01931839|18916947|P1|Overall Study|Lost to Follow-up|1
5471552|NCT01931839|18916941|P7|Overall Study|Other non-compliance|0
5471553|NCT01931839|18916942|P6|Overall Study|Other non-compliance|3
5471554|NCT01931839|18916943|P5|Overall Study|Other non-compliance|0
5471555|NCT01931839|18916944|P4|Overall Study|Other non-compliance|3
5471556|NCT01931839|18916945|P3|Overall Study|Other non-compliance|12
5471557|NCT01931839|18916946|P2|Overall Study|Other non-compliance|9
5471558|NCT01931839|18916947|P1|Overall Study|Other non-compliance|15
5471559|NCT01931839|18916941|P7|Overall Study|Withdrawal of consent (not due to AE)|2
5471560|NCT01931839|18916942|P6|Overall Study|Withdrawal of consent (not due to AE)|2
5471561|NCT01931839|18916943|P5|Overall Study|Withdrawal of consent (not due to AE)|0
5471562|NCT01931839|18916944|P4|Overall Study|Withdrawal of consent (not due to AE)|3
5471563|NCT01931839|18916945|P3|Overall Study|Withdrawal of consent (not due to AE)|13
5471564|NCT01931839|18916946|P2|Overall Study|Withdrawal of consent (not due to AE)|8
5471565|NCT01931839|18916947|P1|Overall Study|Withdrawal of consent (not due to AE)|11
5471566|NCT01931839|18916941|P7|Overall Study|Adverse Event|1
5471567|NCT01931839|18916942|P6|Overall Study|Adverse Event|0
5471568|NCT01931839|18916943|P5|Overall Study|Adverse Event|0
5471569|NCT01931839|18916944|P4|Overall Study|Adverse Event|3
5471570|NCT01931839|18916945|P3|Overall Study|Adverse Event|1
5471571|NCT01931839|18916946|P2|Overall Study|Adverse Event|4
5471572|NCT01931839|18916947|P1|Overall Study|Adverse Event|9
5471573|NCT01931839|18916941|P7|Overall Study|Withdrawal of consent|0
5471574|NCT01931839|18916942|P6|Overall Study|Withdrawal of consent|0
5471575|NCT01931839|18916943|P5|Overall Study|Withdrawal of consent|1
5471576|NCT01931839|18916944|P4|Overall Study|Withdrawal of consent|0
5471577|NCT01931839|18916945|P3|Overall Study|Withdrawal of consent|0
5471578|NCT01931839|18916946|P2|Overall Study|Withdrawal of consent|0
5471579|NCT01931839|18916947|P1|Overall Study|Withdrawal of consent|0
5471580|NCT01931839|18916941|P7|Overall Study|Physician Decision|1
5471581|NCT01931839|18916942|P6|Overall Study|Physician Decision|0
5471582|NCT01931839|18916943|P5|Overall Study|Physician Decision|0
5471583|NCT01931839|18916944|P4|Overall Study|Physician Decision|0
5471584|NCT01931839|18916945|P3|Overall Study|Physician Decision|1
5471585|NCT01931839|18916946|P2|Overall Study|Physician Decision|0
5471586|NCT01931839|18916947|P1|Overall Study|Physician Decision|1
5471587|NCT01931839|18916941|P7|Overall Study|Death|0
5471588|NCT01931839|18916942|P6|Overall Study|Death|0
5471589|NCT01931839|18916943|P5|Overall Study|Death|0
5471590|NCT01931839|18916944|P4|Overall Study|Death|0
5471591|NCT01931839|18916945|P3|Overall Study|Death|2
5471592|NCT01931839|18916946|P2|Overall Study|Death|1
5471593|NCT01931839|18916947|P1|Overall Study|Death|0
5471594|NCT01931735|18917019|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
5471595|NCT01931735|18917020|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
5471596|NCT01931735|18917021|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
5471597|NCT01931735|18917022|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
5471598|NCT01931735|18917019|P4|Observational Non-Randomized Phase|Adverse Event|1
5471599|NCT01931735|18917020|P3|Observational Non-Randomized Phase|Adverse Event|0
5471600|NCT01931735|18917021|P2|Observational Non-Randomized Phase|Adverse Event|0
5471601|NCT01931735|18917022|P1|Observational Non-Randomized Phase|Adverse Event|0
5471602|NCT01931735|18917019|P4|Randomized Phase|Lost to Follow-up|0
5471603|NCT01931735|18917020|P3|Randomized Phase|Lost to Follow-up|5
5471604|NCT01931735|18917021|P2|Randomized Phase|Lost to Follow-up|2
5471605|NCT01931735|18917022|P1|Randomized Phase|Lost to Follow-up|2
5471606|NCT01931670|18917069|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
5471607|NCT01931670|18917070|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
5471608|NCT01931670|18917071|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
5471609|NCT01931670|18917069|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
5471610|NCT01931670|18917070|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
5471611|NCT01931670|18917071|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
5471612|NCT01931670|18917069|P3|Post-Treatment Follow-Up (PTFU) Period|Other|3
5471613|NCT01931670|18917070|P2|Post-Treatment Follow-Up (PTFU) Period|Other|3
5471614|NCT01931670|18917071|P1|Post-Treatment Follow-Up (PTFU) Period|Other|6
5471615|NCT01931670|18917069|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
5471616|NCT01931670|18917070|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
5471617|NCT01931670|18917071|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
5471618|NCT01931670|18917069|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
5471619|NCT01931670|18917070|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
5471620|NCT01931670|18917071|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
5471621|NCT01931670|18917069|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
5471622|NCT01931670|18917070|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
5471623|NCT01931670|18917071|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
5471624|NCT01931670|18917069|P3|Treatment Period|Lost to Follow-up|7
5471625|NCT01931670|18917070|P2|Treatment Period|Lost to Follow-up|5
5471626|NCT01931670|18917071|P1|Treatment Period|Lost to Follow-up|19
5471627|NCT01931670|18917069|P3|Treatment Period|Consent Withdrawn by Subject|7
5471628|NCT01931670|18917070|P2|Treatment Period|Consent Withdrawn by Subject|12
5471629|NCT01931670|18917071|P1|Treatment Period|Consent Withdrawn by Subject|17
5471630|NCT01931670|18917069|P3|Treatment Period|Other|2
5471631|NCT01931670|18917070|P2|Treatment Period|Other|7
5471632|NCT01931670|18917071|P1|Treatment Period|Other|8
5471633|NCT01931670|18917069|P3|Treatment Period|Pregnancy|0
5471634|NCT01931670|18917070|P2|Treatment Period|Pregnancy|2
5471635|NCT01931670|18917071|P1|Treatment Period|Pregnancy|7
5471636|NCT01931670|18917069|P3|Treatment Period|Lack of Efficacy|2
5471637|NCT01931670|18917070|P2|Treatment Period|Lack of Efficacy|2
5471638|NCT01931670|18917071|P1|Treatment Period|Lack of Efficacy|11
5471639|NCT01931670|18917069|P3|Treatment Period|Adverse Event|21
5471640|NCT01931670|18917070|P2|Treatment Period|Adverse Event|8
5471641|NCT01931670|18917071|P1|Treatment Period|Adverse Event|19
5471642|NCT01931670|18917069|P3|Treatment Period|Subject Noncompliant|5
5471643|NCT01931670|18917070|P2|Treatment Period|Subject Noncompliant|9
5471644|NCT01931670|18917071|P1|Treatment Period|Subject Noncompliant|4
5471645|NCT01931670|18917069|P3|Treatment Period|Surgery/Invasive Intervention|0
5471646|NCT01931670|18917070|P2|Treatment Period|Surgery/Invasive Intervention|2
5471647|NCT01931670|18917071|P1|Treatment Period|Surgery/Invasive Intervention|4
5471648|NCT01931670|18917069|P3|Treatment Period|Exclusionary Medication Received|1
5471649|NCT01931670|18917070|P2|Treatment Period|Exclusionary Medication Received|1
5471650|NCT01931670|18917071|P1|Treatment Period|Exclusionary Medication Received|1
5471651|NCT01931566|18917172|P3|Overall Study|Missing|1
5471652|NCT01931566|18917173|P2|Overall Study|Missing|0
5471653|NCT01931566|18917174|P1|Overall Study|Missing|0
5471654|NCT01931566|18917172|P3|Overall Study|Reason Not Specified|53
5471655|NCT01931566|18917173|P2|Overall Study|Reason Not Specified|47
5471656|NCT01931566|18917174|P1|Overall Study|Reason Not Specified|11
5471657|NCT01931566|18917172|P3|Overall Study|Study Termination|1037
5471658|NCT01931566|18917173|P2|Overall Study|Study Termination|968
5471659|NCT01931566|18917174|P1|Overall Study|Study Termination|289
5471660|NCT01931566|18917172|P3|Overall Study|Voluntary Withdrawal|225
5471661|NCT01931566|18917173|P2|Overall Study|Voluntary Withdrawal|245
5471662|NCT01931566|18917174|P1|Overall Study|Voluntary Withdrawal|78
5471663|NCT01931566|18917172|P3|Overall Study|Lost to Follow-up|23
5471664|NCT01931566|18917173|P2|Overall Study|Lost to Follow-up|26
5471665|NCT01931566|18917174|P1|Overall Study|Lost to Follow-up|3
5471666|NCT01931566|18917172|P3|Overall Study|Major Protocol Deviation|21
5471667|NCT01931566|18917173|P2|Overall Study|Major Protocol Deviation|14
5471668|NCT01931566|18917174|P1|Overall Study|Major Protocol Deviation|5
5471669|NCT01931566|18917172|P3|Overall Study|Adverse Event|132
5471670|NCT01931566|18917173|P2|Overall Study|Adverse Event|167
5471671|NCT01931566|18917174|P1|Overall Study|Adverse Event|37
5471672|NCT01931566|18917172|P3|Overall Study|Randomized But Not Treated|14
5471673|NCT01931566|18917173|P2|Overall Study|Randomized But Not Treated|9
5471674|NCT01931566|18917174|P1|Overall Study|Randomized But Not Treated|6
5471675|NCT01931475|18917212|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
5471676|NCT01931475|18917213|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
5471677|NCT01931475|18917212|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
5471678|NCT01931475|18917213|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
5471679|NCT01931475|18917212|P2|Period 2: Extension Treatment Phase|Physician Decision|1
5471680|NCT01931475|18917213|P1|Period 2: Extension Treatment Phase|Physician Decision|1
5471681|NCT01931475|18917212|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
5471682|NCT01931475|18917213|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
5471683|NCT01931475|18917212|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
5471684|NCT01931475|18917213|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
5471685|NCT01931475|18917212|P2|Period 2: Extension Treatment Phase|Adverse Event|8
5471686|NCT01931475|18917213|P1|Period 2: Extension Treatment Phase|Adverse Event|0
5471687|NCT01931475|18917212|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
5471688|NCT01931475|18917213|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
5471689|NCT01931475|18917212|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
5471690|NCT01931475|18917213|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
5471691|NCT01931475|18917212|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
5471692|NCT01931475|18917213|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
5471693|NCT01931475|18917212|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
5471694|NCT01931475|18917213|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
5471695|NCT01931475|18917212|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
5471696|NCT01931475|18917213|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
5471697|NCT01931462|18917240|P1|Overall Study|Withdrawal by Subject|1
5471698|NCT01931397|18917251|P1|Overall Study|moved out of state|1
5471699|NCT01931397|18917251|P1|Overall Study|Withdrawal by Subject|8
5471700|NCT01931397|18917251|P1|Overall Study|Physician Decision|2
5471701|NCT01931202|18917263|P3|Overall Study|Lost to Follow-up|2
5471702|NCT01931202|18917264|P2|Overall Study|Lost to Follow-up|5
5471703|NCT01931202|18917265|P1|Overall Study|Lost to Follow-up|0
5471704|NCT01931202|18917263|P3|Overall Study|Withdrawal by Subject|2
5471705|NCT01931202|18917264|P2|Overall Study|Withdrawal by Subject|0
5471706|NCT01931202|18917265|P1|Overall Study|Withdrawal by Subject|0
5471707|NCT01931150|18917311|P2|Overall Study|Withdrawal by Subject|2
5471708|NCT01931150|18917312|P1|Overall Study|Withdrawal by Subject|1
5471709|NCT01931098|18917320|P2|Overall Study|Refused further treatment|1
5471710|NCT01931098|18917321|P1|Overall Study|Refused further treatment|0
5471711|NCT01931098|18917320|P2|Overall Study|Unable to begin trmt:active infection|1
5471712|NCT01931098|18917321|P1|Overall Study|Unable to begin trmt:active infection|0
5471713|NCT01931098|18917320|P2|Overall Study|Enrolled in different protocol|1
5471714|NCT01931098|18917321|P1|Overall Study|Enrolled in different protocol|0
5471715|NCT01931098|18917320|P2|Overall Study|Withdrawal by Subject|1
5471716|NCT01931098|18917321|P1|Overall Study|Withdrawal by Subject|0
5471717|NCT01931059|18917337|P2|Day3|Lost to Follow-up|0
5471718|NCT01931059|18917338|P1|Day3|Lost to Follow-up|1
5471719|NCT01931059|18917337|P2|Day 1|Pregnancy|1
5471720|NCT01931059|18917338|P1|Day 1|Pregnancy|0
5471721|NCT01930890|18917354|P4|Overall Study|Adverse Event|0
5471722|NCT01930890|18917355|P3|Overall Study|Adverse Event|0
5471723|NCT01930890|18917356|P2|Overall Study|Adverse Event|1
5471724|NCT01930890|18917357|P1|Overall Study|Adverse Event|0
5471725|NCT01930890|18917354|P4|Overall Study|Consent Withdrawn|1
5471726|NCT01930890|18917355|P3|Overall Study|Consent Withdrawn|0
5471727|NCT01930890|18917356|P2|Overall Study|Consent Withdrawn|3
5471728|NCT01930890|18917357|P1|Overall Study|Consent Withdrawn|0
5471729|NCT01930890|18917354|P4|Overall Study|Investigator Decision|0
5471730|NCT01930890|18917355|P3|Overall Study|Investigator Decision|0
5471731|NCT01930890|18917356|P2|Overall Study|Investigator Decision|1
5471732|NCT01930890|18917357|P1|Overall Study|Investigator Decision|0
5471733|NCT01930890|18917354|P4|Overall Study|Death|1
5471734|NCT01930890|18917355|P3|Overall Study|Death|0
5471735|NCT01930890|18917356|P2|Overall Study|Death|0
5471736|NCT01930890|18917357|P1|Overall Study|Death|0
5471737|NCT01930890|18917354|P4|Overall Study|Study Termination|25
5471738|NCT01930890|18917355|P3|Overall Study|Study Termination|13
5471739|NCT01930890|18917356|P2|Overall Study|Study Termination|28
5471740|NCT01930890|18917357|P1|Overall Study|Study Termination|14
5471741|NCT01930799|18917371|P1|Overall Study|Lost to Follow-up|5
5471742|NCT01930799|18917371|P1|Overall Study|Withdrawal by Subject|3
5471743|NCT01930214|18917510|P3|Overall Study|Physician Decision|0
5471744|NCT01930214|18917511|P2|Overall Study|Physician Decision|0
5471745|NCT01930214|18917512|P1|Overall Study|Physician Decision|2
5471746|NCT01930214|18917510|P3|Overall Study|Voluntary withdrawal of infomed consent|2
5471747|NCT01930214|18917511|P2|Overall Study|Voluntary withdrawal of infomed consent|4
5471748|NCT01930214|18917512|P1|Overall Study|Voluntary withdrawal of infomed consent|2
5471749|NCT01930214|18917510|P3|Overall Study|Lost to Follow-up|12
5471750|NCT01930214|18917511|P2|Overall Study|Lost to Follow-up|13
5471751|NCT01930214|18917512|P1|Overall Study|Lost to Follow-up|12
5471752|NCT01930214|18917510|P3|Overall Study|Death|11
5471753|NCT01930214|18917511|P2|Overall Study|Death|4
5471754|NCT01930214|18917512|P1|Overall Study|Death|4
5471755|NCT01930188|18917532|P3|Overall Study|Withdrawal by Subject|8
5471756|NCT01930188|18917533|P2|Overall Study|Withdrawal by Subject|11
5471757|NCT01930188|18917534|P1|Overall Study|Withdrawal by Subject|9
5471758|NCT01930188|18917532|P3|Overall Study|Death|3
5471759|NCT01930188|18917533|P2|Overall Study|Death|1
5471760|NCT01930188|18917534|P1|Overall Study|Death|2
5471761|NCT01930188|18917532|P3|Overall Study|Lost to Follow-up|2
5471762|NCT01930188|18917533|P2|Overall Study|Lost to Follow-up|2
5471763|NCT01930188|18917534|P1|Overall Study|Lost to Follow-up|5
5471764|NCT01930188|18917532|P3|Overall Study|Missing follow-up information|3
5471765|NCT01930188|18917533|P2|Overall Study|Missing follow-up information|2
5471766|NCT01930188|18917534|P1|Overall Study|Missing follow-up information|2
5471767|NCT01930188|18917532|P3|Overall Study|unclassified|3
5471768|NCT01930188|18917533|P2|Overall Study|unclassified|5
5471769|NCT01930188|18917534|P1|Overall Study|unclassified|4
5471770|NCT01930175|18917561|P3|Core Study|Adverse Event|1
5471771|NCT01930175|18917562|P2|Core Study|Adverse Event|0
5471772|NCT01930175|18917563|P1|Core Study|Adverse Event|0
5471773|NCT01930175|18917561|P3|Core Study|Lost to Follow-up|0
5471774|NCT01930175|18917562|P2|Core Study|Lost to Follow-up|1
5471775|NCT01930175|18917563|P1|Core Study|Lost to Follow-up|0
5471776|NCT01930162|18917593|P1|Overall Study|Death|1
5471777|NCT01930162|18917593|P1|Overall Study|Abnormal test procedure result(s)|4
5471778|NCT01930045|18917629|P6|Pause (up to 37 Days)|Protocol Violation|1
5471779|NCT01930045|18917630|P5|Pause (up to 37 Days)|Protocol Violation|0
5471780|NCT01930045|18917631|P4|Pause (up to 37 Days)|Protocol Violation|0
5471781|NCT01930045|18917632|P3|Pause (up to 37 Days)|Protocol Violation|0
5471782|NCT01930045|18917633|P2|Pause (up to 37 Days)|Protocol Violation|0
5471783|NCT01930045|18917634|P1|Pause (up to 37 Days)|Protocol Violation|0
5471784|NCT01930045|18917629|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
5471785|NCT01930045|18917630|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
5471786|NCT01930045|18917631|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
5471787|NCT01930045|18917632|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
5471788|NCT01930045|18917633|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
5471789|NCT01930045|18917634|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
5471790|NCT01929993|18917661|P2|Overall Study|Absent CIN, invasion present or artifact|22
5471791|NCT01929993|18917662|P1|Overall Study|Absent CIN, invasion present or artifact|26
5471792|NCT01929993|18917661|P2|Overall Study|Protocol Violation|6
5471793|NCT01929993|18917662|P1|Overall Study|Protocol Violation|4
5471794|NCT01929980|18917668|P1|Overall Study|Physician Decision|1
5471795|NCT01929876|18917676|P1|Period 2|Non-Compliance|1
5471796|NCT01929863|18917689|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
5471797|NCT01929863|18917690|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
5471798|NCT01929863|18917689|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
5471799|NCT01929863|18917690|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
5471800|NCT01929863|18917689|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
5471801|NCT01929863|18917690|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
5471802|NCT01929707|18917745|P8|Intervention Period 2|Withdrawal by Subject|0
5471803|NCT01929707|18917746|P7|Intervention Period 2|Withdrawal by Subject|0
5471804|NCT01929707|18917747|P6|Intervention Period 2|Withdrawal by Subject|2
5471805|NCT01929707|18917748|P5|Intervention Period 2|Withdrawal by Subject|0
5471806|NCT01929707|18917749|P4|Intervention Period 2|Withdrawal by Subject|0
5471807|NCT01929707|18917750|P3|Intervention Period 2|Withdrawal by Subject|0
5471808|NCT01929707|18917751|P2|Intervention Period 2|Withdrawal by Subject|0
5471809|NCT01929707|18917752|P1|Intervention Period 2|Withdrawal by Subject|0
5471810|NCT01929707|18917745|P8|Intervention Period 1|Withdrawal by Subject|0
5471811|NCT01929707|18917746|P7|Intervention Period 1|Withdrawal by Subject|0
5471812|NCT01929707|18917747|P6|Intervention Period 1|Withdrawal by Subject|0
5471813|NCT01929707|18917748|P5|Intervention Period 1|Withdrawal by Subject|0
5471814|NCT01929707|18917749|P4|Intervention Period 1|Withdrawal by Subject|2
5471815|NCT01929707|18917750|P3|Intervention Period 1|Withdrawal by Subject|0
5471816|NCT01929707|18917751|P2|Intervention Period 1|Withdrawal by Subject|0
5471817|NCT01929707|18917752|P1|Intervention Period 1|Withdrawal by Subject|0
5471818|NCT01929707|18917745|P8|Intervention Period 1|Lost to Follow-up|0
5471819|NCT01929707|18917746|P7|Intervention Period 1|Lost to Follow-up|0
5471820|NCT01929707|18917747|P6|Intervention Period 1|Lost to Follow-up|0
5471821|NCT01929707|18917748|P5|Intervention Period 1|Lost to Follow-up|0
5471822|NCT01929707|18917749|P4|Intervention Period 1|Lost to Follow-up|1
5471823|NCT01929707|18917750|P3|Intervention Period 1|Lost to Follow-up|0
5471824|NCT01929707|18917751|P2|Intervention Period 1|Lost to Follow-up|0
5471825|NCT01929707|18917752|P1|Intervention Period 1|Lost to Follow-up|0
5471826|NCT01929681|18917784|P2|Overall Study|Physician Decision|1
5471827|NCT01929681|18917785|P1|Overall Study|Physician Decision|1
5471828|NCT01929681|18917784|P2|Overall Study|Withdrawal by Subject|0
5471829|NCT01929681|18917785|P1|Overall Study|Withdrawal by Subject|1
5471830|NCT01929408|18917828|P1|Overall Study|received HCT as initial treatment|8
5471831|NCT01929395|18917836|P3|Overall Study|Screen Fail|1
5471832|NCT01929395|18917837|P2|Overall Study|Screen Fail|0
5471833|NCT01929395|18917838|P1|Overall Study|Screen Fail|0
5471834|NCT01929395|18917836|P3|Overall Study|Withdrawal by Subject|0
5471835|NCT01929395|18917837|P2|Overall Study|Withdrawal by Subject|1
5471836|NCT01929395|18917838|P1|Overall Study|Withdrawal by Subject|0
5471837|NCT01929395|18917836|P3|Overall Study|Did not complete - non-related toxicity|0
5471838|NCT01929395|18917837|P2|Overall Study|Did not complete - non-related toxicity|0
5471839|NCT01929395|18917838|P1|Overall Study|Did not complete - non-related toxicity|1
5471840|NCT01929343|18917851|P3|Overall Study|Withdrawal by Subject|0
5471841|NCT01929343|18917852|P2|Overall Study|Withdrawal by Subject|0
5471842|NCT01929343|18917853|P1|Overall Study|Withdrawal by Subject|1
5471843|NCT01929343|18917851|P3|Overall Study|Physician Decision|0
5471844|NCT01929343|18917852|P2|Overall Study|Physician Decision|2
5471845|NCT01929343|18917853|P1|Overall Study|Physician Decision|0
5471846|NCT01929317|18917881|P2|Long-term Phase|Study Closed/Terminated|3
5471847|NCT01929317|18917882|P1|Long-term Phase|Study Closed/Terminated|5
5471848|NCT01929317|18917881|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
5471849|NCT01929317|18917882|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
5471850|NCT01929317|18917881|P2|Long-term Phase|Protocol Violation|0
5471851|NCT01929317|18917882|P1|Long-term Phase|Protocol Violation|1
5471852|NCT01929317|18917881|P2|Long-term Phase|Withdrawal by Subject|0
5471853|NCT01929317|18917882|P1|Long-term Phase|Withdrawal by Subject|4
5471854|NCT01929317|18917881|P2|Long-term Phase|Physician Decision|0
5471855|NCT01929317|18917882|P1|Long-term Phase|Physician Decision|3
5471856|NCT01929317|18917881|P2|Long-term Phase|Adverse Event|1
5471857|NCT01929317|18917882|P1|Long-term Phase|Adverse Event|5
5471858|NCT01929317|18917881|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
5471859|NCT01929317|18917882|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
5471860|NCT01929317|18917881|P2|Dose Increase Effect Verification Phase|Physician Decision|0
5471861|NCT01929317|18917882|P1|Dose Increase Effect Verification Phase|Physician Decision|1
5471862|NCT01929317|18917881|P2|Dose Increase Effect Verification Phase|Adverse Event|1
5471863|NCT01929317|18917882|P1|Dose Increase Effect Verification Phase|Adverse Event|5
5471864|NCT01929226|18917957|P2|Overall Study|Withdrawal by Subject|1
5471865|NCT01929226|18917958|P1|Overall Study|Withdrawal by Subject|1
5471866|NCT01929226|18917957|P2|Overall Study|Lost to Follow-up|0
5471867|NCT01929226|18917958|P1|Overall Study|Lost to Follow-up|4
5471868|NCT01929135|18917984|P2|Overall Study|Lost to Follow-up|1
5471869|NCT01929135|18917985|P1|Overall Study|Lost to Follow-up|1
5471870|NCT01929109|18918004|P5|Period 1 (All Groups)|Deviation from protocol|0
5471871|NCT01929109|18918005|P4|Period 1 (All Groups)|Deviation from protocol|0
5471872|NCT01929109|18918006|P3|Period 1 (All Groups)|Deviation from protocol|1
5471873|NCT01929109|18918007|P2|Period 1 (All Groups)|Deviation from protocol|0
5471874|NCT01929109|18918008|P1|Period 1 (All Groups)|Deviation from protocol|0
5471875|NCT01929083|18918027|P2|Intervention 2|Adverse Event|1
5471876|NCT01929083|18918028|P1|Intervention 2|Adverse Event|0
5471877|NCT01929083|18918027|P2|Intervention 1|Nonadherent to study medications|0
5471878|NCT01929083|18918028|P1|Intervention 1|Nonadherent to study medications|1
5471879|NCT01929083|18918027|P2|Intervention 1|Lost to Follow-up|0
5471880|NCT01929083|18918028|P1|Intervention 1|Lost to Follow-up|2
5471881|NCT01929044|18918065|P2|Overall Study|Not Treated|3
5471882|NCT01929044|18918066|P1|Overall Study|Not Treated|1
5471883|NCT01929044|18918065|P2|Overall Study|Protocol Violation|14
5471884|NCT01929044|18918066|P1|Overall Study|Protocol Violation|9
5471885|NCT01929044|18918065|P2|Overall Study|Adverse Event|0
5471886|NCT01929044|18918066|P1|Overall Study|Adverse Event|1
5471887|NCT01929031|18918088|P6|Overall Study|Reason other than specified above|0
5471888|NCT01929031|18918089|P5|Overall Study|Reason other than specified above|1
5471889|NCT01929031|18918090|P4|Overall Study|Reason other than specified above|0
5471890|NCT01929031|18918091|P3|Overall Study|Reason other than specified above|0
5471891|NCT01929031|18918092|P2|Overall Study|Reason other than specified above|1
5471892|NCT01929031|18918093|P1|Overall Study|Reason other than specified above|0
5471893|NCT01929031|18918088|P6|Overall Study|Protocol Violation|1
5471894|NCT01929031|18918089|P5|Overall Study|Protocol Violation|0
5471895|NCT01929031|18918090|P4|Overall Study|Protocol Violation|0
5471896|NCT01929031|18918091|P3|Overall Study|Protocol Violation|0
5471897|NCT01929031|18918092|P2|Overall Study|Protocol Violation|0
5471898|NCT01929031|18918093|P1|Overall Study|Protocol Violation|1
5471899|NCT01929031|18918088|P6|Overall Study|Adverse Event|0
5471900|NCT01929031|18918089|P5|Overall Study|Adverse Event|0
5471901|NCT01929031|18918090|P4|Overall Study|Adverse Event|0
5471902|NCT01929031|18918091|P3|Overall Study|Adverse Event|1
5471903|NCT01929031|18918092|P2|Overall Study|Adverse Event|1
5471904|NCT01929031|18918093|P1|Overall Study|Adverse Event|3
5471905|NCT01929018|18918117|P2|Overall Study|Hospitalization|1
5471906|NCT01929018|18918118|P1|Overall Study|Hospitalization|0
5471907|NCT01929018|18918117|P2|Overall Study|Lost to Follow-up|0
5471908|NCT01929018|18918118|P1|Overall Study|Lost to Follow-up|1
5471909|NCT01928940|18918142|P2|Overall Study|Adverse Event|1
5471910|NCT01928940|18918143|P1|Overall Study|Adverse Event|0
5471911|NCT01928927|18918186|P2|Overall Study|Withdrawal by Subject|1
5471912|NCT01928927|18918187|P1|Overall Study|Withdrawal by Subject|1
5471913|NCT01928927|18918186|P2|Overall Study|Lost to Follow-up|0
5471914|NCT01928927|18918187|P1|Overall Study|Lost to Follow-up|1
5471915|NCT01928862|18918328|P5|Overall Study|Lost to Follow-up|1
5471916|NCT01928862|18918329|P4|Overall Study|Lost to Follow-up|0
5471917|NCT01928862|18918330|P3|Overall Study|Lost to Follow-up|0
5471918|NCT01928862|18918331|P2|Overall Study|Lost to Follow-up|0
5471919|NCT01928862|18918332|P1|Overall Study|Lost to Follow-up|1
5471920|NCT01928771|18918406|P3|Overall Study|Severe Non-Compliance to Protocol|2
5471921|NCT01928771|18918407|P2|Overall Study|Severe Non-Compliance to Protocol|2
5471922|NCT01928771|18918408|P1|Overall Study|Severe Non-Compliance to Protocol|4
5471923|NCT01928771|18918406|P3|Overall Study|Other Reasons|14
5471924|NCT01928771|18918407|P2|Overall Study|Other Reasons|9
5471925|NCT01928771|18918408|P1|Overall Study|Other Reasons|9
5471926|NCT01928771|18918406|P3|Overall Study|Study-Specific Withdrawal Criteria|1
5471927|NCT01928771|18918407|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5471928|NCT01928771|18918408|P1|Overall Study|Study-Specific Withdrawal Criteria|0
5471929|NCT01928771|18918406|P3|Overall Study|Withdrawal by Subject|17
5471930|NCT01928771|18918407|P2|Overall Study|Withdrawal by Subject|15
5471931|NCT01928771|18918408|P1|Overall Study|Withdrawal by Subject|20
5471932|NCT01928771|18918406|P3|Overall Study|Lost to Follow-up|3
5471933|NCT01928771|18918407|P2|Overall Study|Lost to Follow-up|6
5471934|NCT01928771|18918408|P1|Overall Study|Lost to Follow-up|5
5471935|NCT01928771|18918406|P3|Overall Study|Death|2
5471936|NCT01928771|18918407|P2|Overall Study|Death|2
5471937|NCT01928771|18918408|P1|Overall Study|Death|2
5471938|NCT01928771|18918406|P3|Overall Study|Adverse Event|1
5471939|NCT01928771|18918407|P2|Overall Study|Adverse Event|5
5471940|NCT01928771|18918408|P1|Overall Study|Adverse Event|6
5471941|NCT01928758|18918487|P2|Overall Study|Protocol Violation|4
5471942|NCT01928758|18918488|P1|Overall Study|Protocol Violation|3
5471943|NCT01928758|18918487|P2|Overall Study|Adverse Event|5
5471944|NCT01928758|18918488|P1|Overall Study|Adverse Event|3
5471945|NCT01928758|18918487|P2|Overall Study|Withdrawal by Subject|2
5471946|NCT01928758|18918488|P1|Overall Study|Withdrawal by Subject|5
5471947|NCT01928758|18918487|P2|Overall Study|Lost to Follow-up|9
5471948|NCT01928758|18918488|P1|Overall Study|Lost to Follow-up|14
5471949|NCT01928719|18918506|P2|Overall Study|Adverse Event|0
5471950|NCT01928719|18918507|P1|Overall Study|Adverse Event|1
5471951|NCT01928719|18918506|P2|Overall Study|Protocol Violation|1
5471952|NCT01928719|18918507|P1|Overall Study|Protocol Violation|3
5471953|NCT01928719|18918506|P2|Overall Study|Withdrawal by Subject|7
5471954|NCT01928719|18918507|P1|Overall Study|Withdrawal by Subject|22
5471955|NCT01928719|18918506|P2|Overall Study|Lost to Follow-up|11
5471956|NCT01928719|18918507|P1|Overall Study|Lost to Follow-up|26
5471957|NCT01928615|18918559|P1|Overall Study|Study Terminated by Sponsor|2
5471958|NCT01928485|18918576|P2|Overall Study|Physician Decision|1
5471959|NCT01928485|18918577|P1|Overall Study|Physician Decision|0
5471960|NCT01928472|18918629|P4|Overall Study|Unclassified|0
5471961|NCT01928472|18918630|P3|Overall Study|Unclassified|1
5471962|NCT01928472|18918631|P2|Overall Study|Unclassified|0
5471963|NCT01928472|18918632|P1|Overall Study|Unclassified|0
5471964|NCT01928472|18918629|P4|Overall Study|Administrative Reason|0
5471965|NCT01928472|18918630|P3|Overall Study|Administrative Reason|0
5471966|NCT01928472|18918631|P2|Overall Study|Administrative Reason|1
5471967|NCT01928472|18918632|P1|Overall Study|Administrative Reason|2
5471968|NCT01928472|18918629|P4|Overall Study|Lost to Follow-up|0
5471969|NCT01928472|18918630|P3|Overall Study|Lost to Follow-up|4
5471970|NCT01928472|18918631|P2|Overall Study|Lost to Follow-up|3
5471971|NCT01928472|18918632|P1|Overall Study|Lost to Follow-up|2
5471972|NCT01928472|18918629|P4|Overall Study|Withdrawal by Subject|2
5471973|NCT01928472|18918630|P3|Overall Study|Withdrawal by Subject|1
5471974|NCT01928472|18918631|P2|Overall Study|Withdrawal by Subject|4
5471975|NCT01928472|18918632|P1|Overall Study|Withdrawal by Subject|4
5471976|NCT01928472|18918629|P4|Overall Study|Death|0
5471977|NCT01928472|18918630|P3|Overall Study|Death|1
5471978|NCT01928472|18918631|P2|Overall Study|Death|0
5471979|NCT01928472|18918632|P1|Overall Study|Death|0
5471980|NCT01928433|18918702|P3|Overall Study|Other reasons|4
5471981|NCT01928433|18918703|P2|Overall Study|Other reasons|3
5471982|NCT01928433|18918704|P1|Overall Study|Other reasons|3
5471983|NCT01928433|18918702|P3|Overall Study|Lost to Follow-up|3
5471984|NCT01928433|18918703|P2|Overall Study|Lost to Follow-up|2
5471985|NCT01928433|18918704|P1|Overall Study|Lost to Follow-up|0
5471986|NCT01928433|18918702|P3|Overall Study|Negative screening urine culture|10
5471987|NCT01928433|18918703|P2|Overall Study|Negative screening urine culture|6
5471988|NCT01928433|18918704|P1|Overall Study|Negative screening urine culture|7
5471989|NCT01928433|18918702|P3|Overall Study|Withdrawal by Subject|0
5471990|NCT01928433|18918703|P2|Overall Study|Withdrawal by Subject|4
5471991|NCT01928433|18918704|P1|Overall Study|Withdrawal by Subject|0
5471992|NCT01928433|18918702|P3|Overall Study|Lack of Efficacy|4
5471993|NCT01928433|18918703|P2|Overall Study|Lack of Efficacy|4
5471994|NCT01928433|18918704|P1|Overall Study|Lack of Efficacy|5
5471995|NCT01928433|18918702|P3|Overall Study|Protocol Violation|2
5471996|NCT01928433|18918703|P2|Overall Study|Protocol Violation|0
5471997|NCT01928433|18918704|P1|Overall Study|Protocol Violation|0
5471998|NCT01928433|18918702|P3|Overall Study|Adverse Event|5
5471999|NCT01928433|18918703|P2|Overall Study|Adverse Event|2
5472000|NCT01928433|18918704|P1|Overall Study|Adverse Event|5
5472001|NCT01928394|18918750|P23|Follow-up Period|Lost to Follow-up|1
5472002|NCT01928394|18918751|P22|Follow-up Period|Lost to Follow-up|0
5472003|NCT01928394|18918752|P21|Follow-up Period|Lost to Follow-up|0
5472004|NCT01928394|18918753|P20|Follow-up Period|Lost to Follow-up|0
5472005|NCT01928394|18918754|P19|Follow-up Period|Lost to Follow-up|0
5472006|NCT01928394|18918755|P18|Follow-up Period|Lost to Follow-up|0
5472007|NCT01928394|18918756|P17|Follow-up Period|Lost to Follow-up|1
5472008|NCT01928394|18918757|P16|Follow-up Period|Lost to Follow-up|0
5472009|NCT01928394|18918758|P15|Follow-up Period|Lost to Follow-up|1
5472010|NCT01928394|18918759|P14|Follow-up Period|Lost to Follow-up|0
5472011|NCT01928394|18918760|P13|Follow-up Period|Lost to Follow-up|1
5472012|NCT01928394|18918761|P12|Follow-up Period|Lost to Follow-up|1
5472013|NCT01928394|18918762|P11|Follow-up Period|Lost to Follow-up|0
5472014|NCT01928394|18918763|P10|Follow-up Period|Lost to Follow-up|0
5472015|NCT01928394|18918764|P9|Follow-up Period|Lost to Follow-up|0
5472016|NCT01928394|18918765|P8|Follow-up Period|Lost to Follow-up|0
5472017|NCT01928394|18918766|P7|Follow-up Period|Lost to Follow-up|0
5472018|NCT01928394|18918767|P6|Follow-up Period|Lost to Follow-up|0
5472019|NCT01928394|18918768|P5|Follow-up Period|Lost to Follow-up|0
5472020|NCT01928394|18918769|P4|Follow-up Period|Lost to Follow-up|0
5472021|NCT01928394|18918770|P3|Follow-up Period|Lost to Follow-up|0
5472022|NCT01928394|18918771|P2|Follow-up Period|Lost to Follow-up|0
5472023|NCT01928394|18918772|P1|Follow-up Period|Lost to Follow-up|0
5472024|NCT01928394|18918750|P23|Follow-up Period|other reason|1
5472025|NCT01928394|18918751|P22|Follow-up Period|other reason|0
5472026|NCT01928394|18918752|P21|Follow-up Period|other reason|0
5472027|NCT01928394|18918753|P20|Follow-up Period|other reason|1
5472028|NCT01928394|18918754|P19|Follow-up Period|other reason|1
5472029|NCT01928394|18918755|P18|Follow-up Period|other reason|0
5472030|NCT01928394|18918756|P17|Follow-up Period|other reason|2
5472031|NCT01928394|18918757|P16|Follow-up Period|other reason|0
5472032|NCT01928394|18918758|P15|Follow-up Period|other reason|4
5472033|NCT01928394|18918759|P14|Follow-up Period|other reason|1
5472034|NCT01928394|18918760|P13|Follow-up Period|other reason|0
5472035|NCT01928394|18918761|P12|Follow-up Period|other reason|1
5472036|NCT01928394|18918762|P11|Follow-up Period|other reason|2
5472037|NCT01928394|18918763|P10|Follow-up Period|other reason|0
5472038|NCT01928394|18918764|P9|Follow-up Period|other reason|0
5472039|NCT01928394|18918765|P8|Follow-up Period|other reason|3
5472040|NCT01928394|18918766|P7|Follow-up Period|other reason|1
5472041|NCT01928394|18918767|P6|Follow-up Period|other reason|0
5472042|NCT01928394|18918768|P5|Follow-up Period|other reason|0
5472043|NCT01928394|18918769|P4|Follow-up Period|other reason|0
5472044|NCT01928394|18918770|P3|Follow-up Period|other reason|0
5472045|NCT01928394|18918771|P2|Follow-up Period|other reason|0
5472046|NCT01928394|18918772|P1|Follow-up Period|other reason|0
5472047|NCT01928394|18918750|P23|Follow-up Period|Death|2
5472048|NCT01928394|18918751|P22|Follow-up Period|Death|3
5472049|NCT01928394|18918752|P21|Follow-up Period|Death|5
5472050|NCT01928394|18918753|P20|Follow-up Period|Death|13
5472051|NCT01928394|18918754|P19|Follow-up Period|Death|13
5472052|NCT01928394|18918755|P18|Follow-up Period|Death|5
5472053|NCT01928394|18918756|P17|Follow-up Period|Death|6
5472054|NCT01928394|18918757|P16|Follow-up Period|Death|0
5472055|NCT01928394|18918758|P15|Follow-up Period|Death|18
5472056|NCT01928394|18918759|P14|Follow-up Period|Death|25
5472057|NCT01928394|18918760|P13|Follow-up Period|Death|11
5472058|NCT01928394|18918761|P12|Follow-up Period|Death|12
5472059|NCT01928394|18918762|P11|Follow-up Period|Death|4
5472060|NCT01928394|18918763|P10|Follow-up Period|Death|2
5472061|NCT01928394|18918764|P9|Follow-up Period|Death|1
5472062|NCT01928394|18918765|P8|Follow-up Period|Death|2
5472063|NCT01928394|18918766|P7|Follow-up Period|Death|6
5472064|NCT01928394|18918767|P6|Follow-up Period|Death|6
5472065|NCT01928394|18918768|P5|Follow-up Period|Death|0
5472066|NCT01928394|18918769|P4|Follow-up Period|Death|6
5472067|NCT01928394|18918770|P3|Follow-up Period|Death|2
5472068|NCT01928394|18918771|P2|Follow-up Period|Death|0
5472069|NCT01928394|18918772|P1|Follow-up Period|Death|0
5472070|NCT01928394|18918750|P23|Follow-up Period|Participant withdrew consent|2
5472071|NCT01928394|18918751|P22|Follow-up Period|Participant withdrew consent|6
5472072|NCT01928394|18918752|P21|Follow-up Period|Participant withdrew consent|4
5472073|NCT01928394|18918753|P20|Follow-up Period|Participant withdrew consent|7
5472074|NCT01928394|18918754|P19|Follow-up Period|Participant withdrew consent|2
5472075|NCT01928394|18918755|P18|Follow-up Period|Participant withdrew consent|3
5472076|NCT01928394|18918756|P17|Follow-up Period|Participant withdrew consent|5
5472077|NCT01928394|18918757|P16|Follow-up Period|Participant withdrew consent|0
5472078|NCT01928394|18918758|P15|Follow-up Period|Participant withdrew consent|7
5472079|NCT01928394|18918759|P14|Follow-up Period|Participant withdrew consent|12
5472080|NCT01928394|18918760|P13|Follow-up Period|Participant withdrew consent|2
5472081|NCT01928394|18918761|P12|Follow-up Period|Participant withdrew consent|8
5472082|NCT01928394|18918762|P11|Follow-up Period|Participant withdrew consent|5
5472083|NCT01928394|18918763|P10|Follow-up Period|Participant withdrew consent|0
5472084|NCT01928394|18918764|P9|Follow-up Period|Participant withdrew consent|0
5472085|NCT01928394|18918765|P8|Follow-up Period|Participant withdrew consent|1
5472086|NCT01928394|18918766|P7|Follow-up Period|Participant withdrew consent|5
5472087|NCT01928394|18918767|P6|Follow-up Period|Participant withdrew consent|2
5472088|NCT01928394|18918768|P5|Follow-up Period|Participant withdrew consent|0
5472089|NCT01928394|18918769|P4|Follow-up Period|Participant withdrew consent|4
5472090|NCT01928394|18918770|P3|Follow-up Period|Participant withdrew consent|1
5472091|NCT01928394|18918771|P2|Follow-up Period|Participant withdrew consent|0
5472092|NCT01928394|18918772|P1|Follow-up Period|Participant withdrew consent|3
5472093|NCT01928394|18918750|P23|Treatment Period|Death|0
5472094|NCT01928394|18918751|P22|Treatment Period|Death|0
5472095|NCT01928394|18918752|P21|Treatment Period|Death|0
5472096|NCT01928394|18918753|P20|Treatment Period|Death|0
5472097|NCT01928394|18918754|P19|Treatment Period|Death|0
5472098|NCT01928394|18918755|P18|Treatment Period|Death|0
5472099|NCT01928394|18918756|P17|Treatment Period|Death|0
5472100|NCT01928394|18918757|P16|Treatment Period|Death|0
5472101|NCT01928394|18918758|P15|Treatment Period|Death|2
5472102|NCT01928394|18918759|P14|Treatment Period|Death|1
5472103|NCT01928394|18918760|P13|Treatment Period|Death|0
5472104|NCT01928394|18918761|P12|Treatment Period|Death|0
5472105|NCT01928394|18918762|P11|Treatment Period|Death|0
5472106|NCT01928394|18918763|P10|Treatment Period|Death|0
5472107|NCT01928394|18918764|P9|Treatment Period|Death|0
5472108|NCT01928394|18918765|P8|Treatment Period|Death|0
5472109|NCT01928394|18918766|P7|Treatment Period|Death|0
5472110|NCT01928394|18918767|P6|Treatment Period|Death|0
5472111|NCT01928394|18918768|P5|Treatment Period|Death|0
5472112|NCT01928394|18918769|P4|Treatment Period|Death|0
5472113|NCT01928394|18918770|P3|Treatment Period|Death|0
5472114|NCT01928394|18918771|P2|Treatment Period|Death|0
5472115|NCT01928394|18918772|P1|Treatment Period|Death|0
5472116|NCT01928394|18918750|P23|Treatment Period|Lost to Follow-up|1
5472117|NCT01928394|18918751|P22|Treatment Period|Lost to Follow-up|0
5472118|NCT01928394|18918752|P21|Treatment Period|Lost to Follow-up|0
5472119|NCT01928394|18918753|P20|Treatment Period|Lost to Follow-up|0
5472120|NCT01928394|18918754|P19|Treatment Period|Lost to Follow-up|0
5472121|NCT01928394|18918755|P18|Treatment Period|Lost to Follow-up|0
5472122|NCT01928394|18918756|P17|Treatment Period|Lost to Follow-up|0
5472123|NCT01928394|18918757|P16|Treatment Period|Lost to Follow-up|0
5472124|NCT01928394|18918758|P15|Treatment Period|Lost to Follow-up|0
5472125|NCT01928394|18918759|P14|Treatment Period|Lost to Follow-up|0
5472126|NCT01928394|18918760|P13|Treatment Period|Lost to Follow-up|0
5472127|NCT01928394|18918761|P12|Treatment Period|Lost to Follow-up|0
5472128|NCT01928394|18918762|P11|Treatment Period|Lost to Follow-up|0
5472129|NCT01928394|18918763|P10|Treatment Period|Lost to Follow-up|0
5472130|NCT01928394|18918764|P9|Treatment Period|Lost to Follow-up|0
5472131|NCT01928394|18918765|P8|Treatment Period|Lost to Follow-up|0
5472132|NCT01928394|18918766|P7|Treatment Period|Lost to Follow-up|0
5472133|NCT01928394|18918767|P6|Treatment Period|Lost to Follow-up|0
5472134|NCT01928394|18918768|P5|Treatment Period|Lost to Follow-up|0
5472135|NCT01928394|18918769|P4|Treatment Period|Lost to Follow-up|0
5472136|NCT01928394|18918770|P3|Treatment Period|Lost to Follow-up|0
5472137|NCT01928394|18918771|P2|Treatment Period|Lost to Follow-up|0
5472138|NCT01928394|18918772|P1|Treatment Period|Lost to Follow-up|0
5472139|NCT01928394|18918750|P23|Treatment Period|Maximum clinical benefit|0
5472140|NCT01928394|18918751|P22|Treatment Period|Maximum clinical benefit|0
5472141|NCT01928394|18918752|P21|Treatment Period|Maximum clinical benefit|2
5472142|NCT01928394|18918753|P20|Treatment Period|Maximum clinical benefit|0
5472143|NCT01928394|18918754|P19|Treatment Period|Maximum clinical benefit|1
5472144|NCT01928394|18918755|P18|Treatment Period|Maximum clinical benefit|1
5472145|NCT01928394|18918756|P17|Treatment Period|Maximum clinical benefit|0
5472146|NCT01928394|18918757|P16|Treatment Period|Maximum clinical benefit|0
5472147|NCT01928394|18918758|P15|Treatment Period|Maximum clinical benefit|1
5472148|NCT01928394|18918759|P14|Treatment Period|Maximum clinical benefit|0
5472149|NCT01928394|18918760|P13|Treatment Period|Maximum clinical benefit|0
5472150|NCT01928394|18918761|P12|Treatment Period|Maximum clinical benefit|1
5472151|NCT01928394|18918762|P11|Treatment Period|Maximum clinical benefit|1
5472152|NCT01928394|18918763|P10|Treatment Period|Maximum clinical benefit|0
5472153|NCT01928394|18918764|P9|Treatment Period|Maximum clinical benefit|0
5472154|NCT01928394|18918765|P8|Treatment Period|Maximum clinical benefit|0
5472155|NCT01928394|18918766|P7|Treatment Period|Maximum clinical benefit|0
5472156|NCT01928394|18918767|P6|Treatment Period|Maximum clinical benefit|0
5472157|NCT01928394|18918768|P5|Treatment Period|Maximum clinical benefit|0
5472158|NCT01928394|18918769|P4|Treatment Period|Maximum clinical benefit|0
5472159|NCT01928394|18918770|P3|Treatment Period|Maximum clinical benefit|0
5472160|NCT01928394|18918771|P2|Treatment Period|Maximum clinical benefit|0
5472161|NCT01928394|18918772|P1|Treatment Period|Maximum clinical benefit|0
5472162|NCT01928394|18918750|P23|Treatment Period|other reason|0
5472163|NCT01928394|18918751|P22|Treatment Period|other reason|0
5472164|NCT01928394|18918752|P21|Treatment Period|other reason|0
5472165|NCT01928394|18918753|P20|Treatment Period|other reason|2
5472166|NCT01928394|18918754|P19|Treatment Period|other reason|2
5472167|NCT01928394|18918755|P18|Treatment Period|other reason|0
5472168|NCT01928394|18918756|P17|Treatment Period|other reason|0
5472169|NCT01928394|18918757|P16|Treatment Period|other reason|0
5472170|NCT01928394|18918758|P15|Treatment Period|other reason|1
5472171|NCT01928394|18918759|P14|Treatment Period|other reason|0
5472172|NCT01928394|18918760|P13|Treatment Period|other reason|1
5472173|NCT01928394|18918761|P12|Treatment Period|other reason|1
5472174|NCT01928394|18918762|P11|Treatment Period|other reason|1
5472175|NCT01928394|18918763|P10|Treatment Period|other reason|0
5472176|NCT01928394|18918764|P9|Treatment Period|other reason|0
5472177|NCT01928394|18918765|P8|Treatment Period|other reason|0
5472178|NCT01928394|18918766|P7|Treatment Period|other reason|0
5472179|NCT01928394|18918767|P6|Treatment Period|other reason|0
5472180|NCT01928394|18918768|P5|Treatment Period|other reason|0
5472181|NCT01928394|18918769|P4|Treatment Period|other reason|0
5472182|NCT01928394|18918770|P3|Treatment Period|other reason|0
5472183|NCT01928394|18918771|P2|Treatment Period|other reason|0
5472184|NCT01928394|18918772|P1|Treatment Period|other reason|0
5472185|NCT01928394|18918750|P23|Treatment Period|Poor/non-compliance|0
5472186|NCT01928394|18918751|P22|Treatment Period|Poor/non-compliance|0
5472187|NCT01928394|18918752|P21|Treatment Period|Poor/non-compliance|0
5472188|NCT01928394|18918753|P20|Treatment Period|Poor/non-compliance|1
5472189|NCT01928394|18918754|P19|Treatment Period|Poor/non-compliance|0
5472190|NCT01928394|18918755|P18|Treatment Period|Poor/non-compliance|1
5472191|NCT01928394|18918756|P17|Treatment Period|Poor/non-compliance|0
5472192|NCT01928394|18918757|P16|Treatment Period|Poor/non-compliance|0
5472193|NCT01928394|18918758|P15|Treatment Period|Poor/non-compliance|1
5472194|NCT01928394|18918759|P14|Treatment Period|Poor/non-compliance|0
5472195|NCT01928394|18918760|P13|Treatment Period|Poor/non-compliance|1
5472196|NCT01928394|18918761|P12|Treatment Period|Poor/non-compliance|0
5472197|NCT01928394|18918762|P11|Treatment Period|Poor/non-compliance|0
5472198|NCT01928394|18918763|P10|Treatment Period|Poor/non-compliance|0
5472199|NCT01928394|18918764|P9|Treatment Period|Poor/non-compliance|0
5472200|NCT01928394|18918765|P8|Treatment Period|Poor/non-compliance|0
5472201|NCT01928394|18918766|P7|Treatment Period|Poor/non-compliance|0
5472202|NCT01928394|18918767|P6|Treatment Period|Poor/non-compliance|0
5472203|NCT01928394|18918768|P5|Treatment Period|Poor/non-compliance|0
5472204|NCT01928394|18918769|P4|Treatment Period|Poor/non-compliance|1
5472205|NCT01928394|18918770|P3|Treatment Period|Poor/non-compliance|0
5472206|NCT01928394|18918771|P2|Treatment Period|Poor/non-compliance|0
5472207|NCT01928394|18918772|P1|Treatment Period|Poor/non-compliance|0
5472208|NCT01928394|18918750|P23|Treatment Period|Participant withdrew consent|0
5472209|NCT01928394|18918751|P22|Treatment Period|Participant withdrew consent|2
5472210|NCT01928394|18918752|P21|Treatment Period|Participant withdrew consent|0
5472211|NCT01928394|18918753|P20|Treatment Period|Participant withdrew consent|1
5472212|NCT01928394|18918754|P19|Treatment Period|Participant withdrew consent|1
5472213|NCT01928394|18918755|P18|Treatment Period|Participant withdrew consent|1
5472214|NCT01928394|18918756|P17|Treatment Period|Participant withdrew consent|2
5472215|NCT01928394|18918757|P16|Treatment Period|Participant withdrew consent|0
5472216|NCT01928394|18918758|P15|Treatment Period|Participant withdrew consent|2
5472217|NCT01928394|18918759|P14|Treatment Period|Participant withdrew consent|0
5472218|NCT01928394|18918760|P13|Treatment Period|Participant withdrew consent|1
5472219|NCT01928394|18918761|P12|Treatment Period|Participant withdrew consent|1
5472220|NCT01928394|18918762|P11|Treatment Period|Participant withdrew consent|1
5472221|NCT01928394|18918763|P10|Treatment Period|Participant withdrew consent|0
5472222|NCT01928394|18918764|P9|Treatment Period|Participant withdrew consent|0
5472223|NCT01928394|18918765|P8|Treatment Period|Participant withdrew consent|1
5472224|NCT01928394|18918766|P7|Treatment Period|Participant withdrew consent|0
5472225|NCT01928394|18918767|P6|Treatment Period|Participant withdrew consent|1
5472226|NCT01928394|18918768|P5|Treatment Period|Participant withdrew consent|0
5472227|NCT01928394|18918769|P4|Treatment Period|Participant withdrew consent|1
5472228|NCT01928394|18918770|P3|Treatment Period|Participant withdrew consent|1
5472229|NCT01928394|18918771|P2|Treatment Period|Participant withdrew consent|0
5472230|NCT01928394|18918772|P1|Treatment Period|Participant withdrew consent|0
5472231|NCT01928394|18918750|P23|Treatment Period|Participant request to stop therapy|3
5472232|NCT01928394|18918751|P22|Treatment Period|Participant request to stop therapy|1
5472233|NCT01928394|18918752|P21|Treatment Period|Participant request to stop therapy|3
5472234|NCT01928394|18918753|P20|Treatment Period|Participant request to stop therapy|1
5472235|NCT01928394|18918754|P19|Treatment Period|Participant request to stop therapy|1
5472236|NCT01928394|18918755|P18|Treatment Period|Participant request to stop therapy|3
5472237|NCT01928394|18918756|P17|Treatment Period|Participant request to stop therapy|1
5472238|NCT01928394|18918757|P16|Treatment Period|Participant request to stop therapy|0
5472239|NCT01928394|18918758|P15|Treatment Period|Participant request to stop therapy|4
5472240|NCT01928394|18918759|P14|Treatment Period|Participant request to stop therapy|2
5472241|NCT01928394|18918760|P13|Treatment Period|Participant request to stop therapy|1
5472242|NCT01928394|18918761|P12|Treatment Period|Participant request to stop therapy|2
5472243|NCT01928394|18918762|P11|Treatment Period|Participant request to stop therapy|3
5472244|NCT01928394|18918763|P10|Treatment Period|Participant request to stop therapy|0
5472245|NCT01928394|18918764|P9|Treatment Period|Participant request to stop therapy|0
5472246|NCT01928394|18918765|P8|Treatment Period|Participant request to stop therapy|0
5472247|NCT01928394|18918766|P7|Treatment Period|Participant request to stop therapy|3
5472248|NCT01928394|18918767|P6|Treatment Period|Participant request to stop therapy|3
5472249|NCT01928394|18918768|P5|Treatment Period|Participant request to stop therapy|0
5472250|NCT01928394|18918769|P4|Treatment Period|Participant request to stop therapy|0
5472251|NCT01928394|18918770|P3|Treatment Period|Participant request to stop therapy|0
5472252|NCT01928394|18918771|P2|Treatment Period|Participant request to stop therapy|0
5472253|NCT01928394|18918772|P1|Treatment Period|Participant request to stop therapy|0
5472254|NCT01928394|18918750|P23|Treatment Period|AE unrelated to study drug|0
5472255|NCT01928394|18918751|P22|Treatment Period|AE unrelated to study drug|1
5472256|NCT01928394|18918752|P21|Treatment Period|AE unrelated to study drug|1
5472257|NCT01928394|18918753|P20|Treatment Period|AE unrelated to study drug|5
5472258|NCT01928394|18918754|P19|Treatment Period|AE unrelated to study drug|3
5472259|NCT01928394|18918755|P18|Treatment Period|AE unrelated to study drug|6
5472260|NCT01928394|18918756|P17|Treatment Period|AE unrelated to study drug|1
5472261|NCT01928394|18918757|P16|Treatment Period|AE unrelated to study drug|1
5472262|NCT01928394|18918758|P15|Treatment Period|AE unrelated to study drug|6
5472263|NCT01928394|18918759|P14|Treatment Period|AE unrelated to study drug|13
5472264|NCT01928394|18918760|P13|Treatment Period|AE unrelated to study drug|6
5472265|NCT01928394|18918761|P12|Treatment Period|AE unrelated to study drug|12
5472266|NCT01928394|18918762|P11|Treatment Period|AE unrelated to study drug|0
5472267|NCT01928394|18918763|P10|Treatment Period|AE unrelated to study drug|2
5472268|NCT01928394|18918764|P9|Treatment Period|AE unrelated to study drug|0
5472269|NCT01928394|18918765|P8|Treatment Period|AE unrelated to study drug|0
5472270|NCT01928394|18918766|P7|Treatment Period|AE unrelated to study drug|1
5472271|NCT01928394|18918767|P6|Treatment Period|AE unrelated to study drug|5
5472272|NCT01928394|18918768|P5|Treatment Period|AE unrelated to study drug|0
5472273|NCT01928394|18918769|P4|Treatment Period|AE unrelated to study drug|3
5472274|NCT01928394|18918770|P3|Treatment Period|AE unrelated to study drug|2
5472275|NCT01928394|18918771|P2|Treatment Period|AE unrelated to study drug|0
5472276|NCT01928394|18918772|P1|Treatment Period|AE unrelated to study drug|0
5472277|NCT01928394|18918750|P23|Treatment Period|Study drug toxicity|4
5472278|NCT01928394|18918751|P22|Treatment Period|Study drug toxicity|7
5472279|NCT01928394|18918752|P21|Treatment Period|Study drug toxicity|4
5472280|NCT01928394|18918753|P20|Treatment Period|Study drug toxicity|15
5472281|NCT01928394|18918754|P19|Treatment Period|Study drug toxicity|12
5472282|NCT01928394|18918755|P18|Treatment Period|Study drug toxicity|3
5472283|NCT01928394|18918756|P17|Treatment Period|Study drug toxicity|3
5472284|NCT01928394|18918757|P16|Treatment Period|Study drug toxicity|0
5472285|NCT01928394|18918758|P15|Treatment Period|Study drug toxicity|12
5472286|NCT01928394|18918759|P14|Treatment Period|Study drug toxicity|5
5472287|NCT01928394|18918760|P13|Treatment Period|Study drug toxicity|7
5472288|NCT01928394|18918761|P12|Treatment Period|Study drug toxicity|3
5472289|NCT01928394|18918762|P11|Treatment Period|Study drug toxicity|2
5472290|NCT01928394|18918763|P10|Treatment Period|Study drug toxicity|5
5472291|NCT01928394|18918764|P9|Treatment Period|Study drug toxicity|0
5472292|NCT01928394|18918765|P8|Treatment Period|Study drug toxicity|1
5472293|NCT01928394|18918766|P7|Treatment Period|Study drug toxicity|7
5472294|NCT01928394|18918767|P6|Treatment Period|Study drug toxicity|9
5472295|NCT01928394|18918768|P5|Treatment Period|Study drug toxicity|0
5472296|NCT01928394|18918769|P4|Treatment Period|Study drug toxicity|3
5472297|NCT01928394|18918770|P3|Treatment Period|Study drug toxicity|3
5472298|NCT01928394|18918771|P2|Treatment Period|Study drug toxicity|1
5472299|NCT01928394|18918772|P1|Treatment Period|Study drug toxicity|1
5472300|NCT01928394|18918750|P23|Treatment Period|Disease progression|31
5472301|NCT01928394|18918751|P22|Treatment Period|Disease progression|31
5472302|NCT01928394|18918752|P21|Treatment Period|Disease progression|30
5472303|NCT01928394|18918753|P20|Treatment Period|Disease progression|71
5472304|NCT01928394|18918754|P19|Treatment Period|Disease progression|50
5472305|NCT01928394|18918755|P18|Treatment Period|Disease progression|56
5472306|NCT01928394|18918756|P17|Treatment Period|Disease progression|43
5472307|NCT01928394|18918757|P16|Treatment Period|Disease progression|1
5472308|NCT01928394|18918758|P15|Treatment Period|Disease progression|59
5472309|NCT01928394|18918759|P14|Treatment Period|Disease progression|118
5472310|NCT01928394|18918760|P13|Treatment Period|Disease progression|38
5472311|NCT01928394|18918761|P12|Treatment Period|Disease progression|73
5472312|NCT01928394|18918762|P11|Treatment Period|Disease progression|22
5472313|NCT01928394|18918763|P10|Treatment Period|Disease progression|11
5472314|NCT01928394|18918764|P9|Treatment Period|Disease progression|3
5472315|NCT01928394|18918765|P8|Treatment Period|Disease progression|16
5472316|NCT01928394|18918766|P7|Treatment Period|Disease progression|38
5472317|NCT01928394|18918767|P6|Treatment Period|Disease progression|25
5472318|NCT01928394|18918768|P5|Treatment Period|Disease progression|3
5472319|NCT01928394|18918769|P4|Treatment Period|Disease progression|48
5472320|NCT01928394|18918770|P3|Treatment Period|Disease progression|12
5472321|NCT01928394|18918771|P2|Treatment Period|Disease progression|2
5472322|NCT01928394|18918772|P1|Treatment Period|Disease progression|17
5472323|NCT01928381|18918820|P7|Part 2 - Post Third Intervention|Protocol Violation|0
5472324|NCT01928381|18918821|P6|Part 2 - Post Third Intervention|Protocol Violation|0
5472325|NCT01928381|18918822|P5|Part 2 - Post Third Intervention|Protocol Violation|0
5472326|NCT01928381|18918823|P4|Part 2 - Post Third Intervention|Protocol Violation|0
5472327|NCT01928381|18918824|P3|Part 2 - Post Third Intervention|Protocol Violation|1
5472328|NCT01928381|18918825|P2|Part 2 - Post Third Intervention|Protocol Violation|0
5472329|NCT01928381|18918826|P1|Part 2 - Post Third Intervention|Protocol Violation|0
5472330|NCT01928381|18918820|P7|Part 2 - Second Intervention|Lost to Follow-up|0
5472331|NCT01928381|18918821|P6|Part 2 - Second Intervention|Lost to Follow-up|0
5472332|NCT01928381|18918822|P5|Part 2 - Second Intervention|Lost to Follow-up|0
5472333|NCT01928381|18918823|P4|Part 2 - Second Intervention|Lost to Follow-up|1
5472334|NCT01928381|18918824|P3|Part 2 - Second Intervention|Lost to Follow-up|0
5472335|NCT01928381|18918825|P2|Part 2 - Second Intervention|Lost to Follow-up|1
5472336|NCT01928381|18918826|P1|Part 2 - Second Intervention|Lost to Follow-up|0
5472337|NCT01928381|18918820|P7|Washout First Intervention|Protocol Violation|0
5472338|NCT01928381|18918821|P6|Washout First Intervention|Protocol Violation|0
5472339|NCT01928381|18918822|P5|Washout First Intervention|Protocol Violation|1
5472340|NCT01928381|18918823|P4|Washout First Intervention|Protocol Violation|0
5472341|NCT01928381|18918824|P3|Washout First Intervention|Protocol Violation|0
5472342|NCT01928381|18918825|P2|Washout First Intervention|Protocol Violation|0
5472343|NCT01928381|18918826|P1|Washout First Intervention|Protocol Violation|0
5472344|NCT01928381|18918820|P7|Part 2 - First Intervention|Lost to Follow-up|0
5472345|NCT01928381|18918821|P6|Part 2 - First Intervention|Lost to Follow-up|0
5472346|NCT01928381|18918822|P5|Part 2 - First Intervention|Lost to Follow-up|0
5472347|NCT01928381|18918823|P4|Part 2 - First Intervention|Lost to Follow-up|1
5472348|NCT01928381|18918824|P3|Part 2 - First Intervention|Lost to Follow-up|0
5472349|NCT01928381|18918825|P2|Part 2 - First Intervention|Lost to Follow-up|0
5472350|NCT01928381|18918826|P1|Part 2 - First Intervention|Lost to Follow-up|0
5472351|NCT01928381|18918820|P7|Part 2 - First Intervention|Eligibility criterion not met|1
5472352|NCT01928381|18918821|P6|Part 2 - First Intervention|Eligibility criterion not met|1
5472353|NCT01928381|18918822|P5|Part 2 - First Intervention|Eligibility criterion not met|0
5472354|NCT01928381|18918823|P4|Part 2 - First Intervention|Eligibility criterion not met|0
5472355|NCT01928381|18918824|P3|Part 2 - First Intervention|Eligibility criterion not met|0
5472356|NCT01928381|18918825|P2|Part 2 - First Intervention|Eligibility criterion not met|0
5472357|NCT01928381|18918826|P1|Part 2 - First Intervention|Eligibility criterion not met|0
5472358|NCT01928381|18918820|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
5472359|NCT01928381|18918821|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
5472360|NCT01928381|18918822|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
5472361|NCT01928381|18918823|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
5472362|NCT01928381|18918824|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
5472363|NCT01928381|18918825|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
5472364|NCT01928381|18918826|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
5472365|NCT01928381|18918820|P7|Part 2 - First Intervention|Withdrawal by Subject|0
5472366|NCT01928381|18918821|P6|Part 2 - First Intervention|Withdrawal by Subject|0
5472367|NCT01928381|18918822|P5|Part 2 - First Intervention|Withdrawal by Subject|0
5472368|NCT01928381|18918823|P4|Part 2 - First Intervention|Withdrawal by Subject|0
5472369|NCT01928381|18918824|P3|Part 2 - First Intervention|Withdrawal by Subject|1
5472370|NCT01928381|18918825|P2|Part 2 - First Intervention|Withdrawal by Subject|0
5472371|NCT01928381|18918826|P1|Part 2 - First Intervention|Withdrawal by Subject|0
5472372|NCT01928381|18918820|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5472373|NCT01928381|18918821|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5472374|NCT01928381|18918822|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5472375|NCT01928381|18918823|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5472376|NCT01928381|18918824|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5472377|NCT01928381|18918825|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
5472378|NCT01928381|18918826|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
5472379|NCT01928381|18918820|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5472380|NCT01928381|18918821|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5472381|NCT01928381|18918822|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5472382|NCT01928381|18918823|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5472383|NCT01928381|18918824|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5472384|NCT01928381|18918825|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
5472385|NCT01928381|18918826|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
5472386|NCT01928381|18918820|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5472387|NCT01928381|18918821|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5472388|NCT01928381|18918822|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5472389|NCT01928381|18918823|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5472390|NCT01928381|18918824|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5472391|NCT01928381|18918825|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
5472392|NCT01928381|18918826|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
5472393|NCT01928381|18918820|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5472394|NCT01928381|18918821|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5472395|NCT01928381|18918822|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5472396|NCT01928381|18918823|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5472397|NCT01928381|18918824|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5472398|NCT01928381|18918825|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
5472399|NCT01928381|18918826|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
5472400|NCT01928381|18918820|P7|Part 1 - Pain Training|Protocol Violation|0
5472401|NCT01928381|18918821|P6|Part 1 - Pain Training|Protocol Violation|0
5472402|NCT01928381|18918822|P5|Part 1 - Pain Training|Protocol Violation|0
5472403|NCT01928381|18918823|P4|Part 1 - Pain Training|Protocol Violation|0
5472404|NCT01928381|18918824|P3|Part 1 - Pain Training|Protocol Violation|0
5472405|NCT01928381|18918825|P2|Part 1 - Pain Training|Protocol Violation|0
5472406|NCT01928381|18918826|P1|Part 1 - Pain Training|Protocol Violation|1
5472407|NCT01928381|18918820|P7|Part 1 - Pain Training|Lost to Follow-up|0
5472408|NCT01928381|18918821|P6|Part 1 - Pain Training|Lost to Follow-up|0
5472409|NCT01928381|18918822|P5|Part 1 - Pain Training|Lost to Follow-up|0
5472410|NCT01928381|18918823|P4|Part 1 - Pain Training|Lost to Follow-up|0
5472411|NCT01928381|18918824|P3|Part 1 - Pain Training|Lost to Follow-up|0
5472412|NCT01928381|18918825|P2|Part 1 - Pain Training|Lost to Follow-up|0
5472413|NCT01928381|18918826|P1|Part 1 - Pain Training|Lost to Follow-up|4
5472414|NCT01928381|18918820|P7|Part 1 - Pain Training|Withdrawal by Subject|0
5472415|NCT01928381|18918821|P6|Part 1 - Pain Training|Withdrawal by Subject|0
5472416|NCT01928381|18918822|P5|Part 1 - Pain Training|Withdrawal by Subject|0
5472417|NCT01928381|18918823|P4|Part 1 - Pain Training|Withdrawal by Subject|0
5472418|NCT01928381|18918824|P3|Part 1 - Pain Training|Withdrawal by Subject|0
5472419|NCT01928381|18918825|P2|Part 1 - Pain Training|Withdrawal by Subject|0
5472420|NCT01928381|18918826|P1|Part 1 - Pain Training|Withdrawal by Subject|1
5472421|NCT01928381|18918820|P7|Part 1 - Pain Training|Pain training criteria not met|0
5472422|NCT01928381|18918821|P6|Part 1 - Pain Training|Pain training criteria not met|0
5472423|NCT01928381|18918822|P5|Part 1 - Pain Training|Pain training criteria not met|0
5472424|NCT01928381|18918823|P4|Part 1 - Pain Training|Pain training criteria not met|0
5472425|NCT01928381|18918824|P3|Part 1 - Pain Training|Pain training criteria not met|0
5472426|NCT01928381|18918825|P2|Part 1 - Pain Training|Pain training criteria not met|0
5472427|NCT01928381|18918826|P1|Part 1 - Pain Training|Pain training criteria not met|29
5472428|NCT01928381|18918820|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5472429|NCT01928381|18918821|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5472430|NCT01928381|18918822|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5472431|NCT01928381|18918823|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5472432|NCT01928381|18918824|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5472433|NCT01928381|18918825|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
5472434|NCT01928381|18918826|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
5472435|NCT01928329|18918841|P2|Overall Study|Physician Decision|1
5472436|NCT01928329|18918842|P1|Overall Study|Physician Decision|1
5472437|NCT01928329|18918841|P2|Overall Study|Withdrawal by Subject|5
5472438|NCT01928329|18918842|P1|Overall Study|Withdrawal by Subject|1
5472439|NCT01928329|18918841|P2|Overall Study|Stopping Rule: Lost Greater than 5kg|1
5472440|NCT01928329|18918842|P1|Overall Study|Stopping Rule: Lost Greater than 5kg|4
5472441|NCT01928329|18918841|P2|Overall Study|Adverse Event|3
5472442|NCT01928329|18918842|P1|Overall Study|Adverse Event|5
5472443|NCT01928329|18918841|P2|Overall Study|Removed from Study Prior to Receiving Dr|1
5472444|NCT01928329|18918842|P1|Overall Study|Removed from Study Prior to Receiving Dr|0
5472445|NCT01928329|18918841|P2|Overall Study|Withdrew Consent Prior to Receiving Drug|3
5472446|NCT01928329|18918842|P1|Overall Study|Withdrew Consent Prior to Receiving Drug|1
5472447|NCT01928225|18918877|P2|Overall Study|Lost to Follow-up|3
5472448|NCT01928225|18918878|P1|Overall Study|Lost to Follow-up|1
5472449|NCT01928225|18918877|P2|Overall Study|basaloid cervical cancer|0
5472450|NCT01928225|18918878|P1|Overall Study|basaloid cervical cancer|1
5472451|NCT01928225|18918877|P2|Overall Study|Pregnancy|0
5472452|NCT01928225|18918878|P1|Overall Study|Pregnancy|1
5472453|NCT01928082|18918900|P1|Overall Study|Study terminated.|1
5472454|NCT01927861|18918934|P2|Extension Phase (104 Weeks)|Unclassified|1
5472455|NCT01927861|18918935|P1|Extension Phase (104 Weeks)|Unclassified|0
5472456|NCT01927861|18918934|P2|Extension Phase (104 Weeks)|Adverse Event|2
5472457|NCT01927861|18918935|P1|Extension Phase (104 Weeks)|Adverse Event|0
5472458|NCT01927757|18919073|P1|Overall Study|Ethical Reasons|4
5472459|NCT01927757|18919073|P1|Overall Study|Other|1
5472460|NCT01927757|18919073|P1|Overall Study|Decision by Sponsor|2
5472461|NCT01927757|18919073|P1|Overall Study|Lost to Follow-up|2
5472462|NCT01927757|18919073|P1|Overall Study|Withdrawal by Subject|14
5472463|NCT01927627|18919095|P1|Overall Study|Financial Concerns|1
5472464|NCT01927627|18919095|P1|Overall Study|Lack of Efficacy|1
5472465|NCT01927627|18919095|P1|Overall Study|Adverse Event|3
5472466|NCT01927562|18919108|P1|Overall Study|Physician Decision|5
5472467|NCT01927562|18919108|P1|Overall Study|Withdrawal by Subject|3
5472468|NCT01927562|18919108|P1|Overall Study|Lost to Follow-up|30
5472469|NCT01927419|18919114|P2|Overall Study|Not reported|0
5472470|NCT01927419|18919115|P1|Overall Study|Not reported|1
5472471|NCT01927419|18919114|P2|Overall Study|Other|1
5472472|NCT01927419|18919115|P1|Overall Study|Other|2
5472473|NCT01927419|18919114|P2|Overall Study|Withdrawal by Subject|1
5472474|NCT01927419|18919115|P1|Overall Study|Withdrawal by Subject|3
5472475|NCT01927419|18919114|P2|Overall Study|Adverse event unrelated to study drug|1
5472476|NCT01927419|18919115|P1|Overall Study|Adverse event unrelated to study drug|6
5472477|NCT01927419|18919114|P2|Overall Study|Death|1
5472478|NCT01927419|18919115|P1|Overall Study|Death|0
5472479|NCT01927419|18919114|P2|Overall Study|Study drug toxicity|7
5472480|NCT01927419|18919115|P1|Overall Study|Study drug toxicity|43
5472481|NCT01927419|18919114|P2|Overall Study|Disease progression|17
5472482|NCT01927419|18919115|P1|Overall Study|Disease progression|15
5472483|NCT01927367|18919133|P2|Overall Study|No baseline data|1
5472484|NCT01927367|18919134|P1|Overall Study|No baseline data|0
5472485|NCT01927367|18919133|P2|Overall Study|Withdrawal by Subject|4
5472486|NCT01927367|18919134|P1|Overall Study|Withdrawal by Subject|7
5472487|NCT01927055|18919166|P3|Double-Blind|Extended Vacation|0
5472488|NCT01927055|18919167|P2|Double-Blind|Extended Vacation|1
5472489|NCT01927055|18919168|P1|Double-Blind|Extended Vacation|0
5472490|NCT01927055|18919166|P3|Double-Blind|Supine Hypertension|1
5472491|NCT01927055|18919167|P2|Double-Blind|Supine Hypertension|0
5472492|NCT01927055|18919168|P1|Double-Blind|Supine Hypertension|0
5472493|NCT01927055|18919166|P3|Double-Blind|Study Stopped|7
5472494|NCT01927055|18919167|P2|Double-Blind|Study Stopped|7
5472495|NCT01927055|18919168|P1|Double-Blind|Study Stopped|0
5472496|NCT01927055|18919166|P3|Double-Blind|Withdrawal by Subject|3
5472497|NCT01927055|18919167|P2|Double-Blind|Withdrawal by Subject|2
5472498|NCT01927055|18919168|P1|Double-Blind|Withdrawal by Subject|0
5472499|NCT01927055|18919166|P3|Double-Blind|Protocol Violation|1
5472500|NCT01927055|18919167|P2|Double-Blind|Protocol Violation|0
5472501|NCT01927055|18919168|P1|Double-Blind|Protocol Violation|0
5472502|NCT01927055|18919166|P3|Double-Blind|Adverse Event|1
5472503|NCT01927055|18919167|P2|Double-Blind|Adverse Event|1
5472504|NCT01927055|18919168|P1|Double-Blind|Adverse Event|0
5472505|NCT01927055|18919166|P3|Open-label|Difficulty attending study visits|0
5472506|NCT01927055|18919167|P2|Open-label|Difficulty attending study visits|0
5472507|NCT01927055|18919168|P1|Open-label|Difficulty attending study visits|1
5472508|NCT01927055|18919166|P3|Open-label|Supine Hypertension|0
5472509|NCT01927055|18919167|P2|Open-label|Supine Hypertension|0
5472510|NCT01927055|18919168|P1|Open-label|Supine Hypertension|4
5472511|NCT01927055|18919166|P3|Open-label|Study Stopped|0
5472512|NCT01927055|18919167|P2|Open-label|Study Stopped|0
5472513|NCT01927055|18919168|P1|Open-label|Study Stopped|4
5472514|NCT01927055|18919166|P3|Open-label|Withdrawal by Subject|0
5472515|NCT01927055|18919167|P2|Open-label|Withdrawal by Subject|0
5472516|NCT01927055|18919168|P1|Open-label|Withdrawal by Subject|1
5472517|NCT01927055|18919166|P3|Open-label|Adverse Event|0
5472518|NCT01927055|18919167|P2|Open-label|Adverse Event|0
5472519|NCT01927055|18919168|P1|Open-label|Adverse Event|6
5472520|NCT01926886|18919186|P2|Overall Study|Did not cooperate|0
5472521|NCT01926886|18919187|P1|Overall Study|Did not cooperate|1
5472522|NCT01926886|18919186|P2|Overall Study|Death|0
5472523|NCT01926886|18919187|P1|Overall Study|Death|1
5472524|NCT01926886|18919186|P2|Overall Study|Progression of disease|0
5472525|NCT01926886|18919187|P1|Overall Study|Progression of disease|2
5472526|NCT01926886|18919186|P2|Overall Study|Recurrence of disease|0
5472527|NCT01926886|18919187|P1|Overall Study|Recurrence of disease|1
5472528|NCT01926886|18919186|P2|Overall Study|Failure to return|0
5472529|NCT01926886|18919187|P1|Overall Study|Failure to return|3
5472530|NCT01926886|18919186|P2|Overall Study|Withdrawal by Subject|0
5472531|NCT01926886|18919187|P1|Overall Study|Withdrawal by Subject|15
5472532|NCT01926886|18919186|P2|Overall Study|Disease progression/recurrence|0
5472533|NCT01926886|18919187|P1|Overall Study|Disease progression/recurrence|4
5472534|NCT01926886|18919186|P2|Overall Study|Adverse event/intercurrent illness|0
5472535|NCT01926886|18919187|P1|Overall Study|Adverse event/intercurrent illness|4
5472536|NCT01926886|18919186|P2|Overall Study|Administrative/other|0
5472537|NCT01926886|18919187|P1|Overall Study|Administrative/other|1
5472538|NCT01926782|18919206|P6|Overall Study|Related to study drug administration|2
5472539|NCT01926782|18919207|P5|Overall Study|Related to study drug administration|0
5472540|NCT01926782|18919208|P4|Overall Study|Related to study drug administration|0
5472541|NCT01926782|18919209|P3|Overall Study|Related to study drug administration|0
5472542|NCT01926782|18919210|P2|Overall Study|Related to study drug administration|0
5472543|NCT01926782|18919211|P1|Overall Study|Related to study drug administration|0
5472544|NCT01926782|18919206|P6|Overall Study|Withdrawal by Subject|5
5472545|NCT01926782|18919207|P5|Overall Study|Withdrawal by Subject|0
5472546|NCT01926782|18919208|P4|Overall Study|Withdrawal by Subject|1
5472547|NCT01926782|18919209|P3|Overall Study|Withdrawal by Subject|8
5472548|NCT01926782|18919210|P2|Overall Study|Withdrawal by Subject|1
5472549|NCT01926782|18919211|P1|Overall Study|Withdrawal by Subject|6
5472550|NCT01926782|18919206|P6|Overall Study|Randomized and not treated|0
5472551|NCT01926782|18919207|P5|Overall Study|Randomized and not treated|0
5472552|NCT01926782|18919208|P4|Overall Study|Randomized and not treated|1
5472553|NCT01926782|18919209|P3|Overall Study|Randomized and not treated|0
5472554|NCT01926782|18919210|P2|Overall Study|Randomized and not treated|0
5472555|NCT01926782|18919211|P1|Overall Study|Randomized and not treated|0
5472556|NCT01926782|18919206|P6|Overall Study|Poor compliance to protocol|6
5472557|NCT01926782|18919207|P5|Overall Study|Poor compliance to protocol|1
5472558|NCT01926782|18919208|P4|Overall Study|Poor compliance to protocol|0
5472559|NCT01926782|18919209|P3|Overall Study|Poor compliance to protocol|8
5472560|NCT01926782|18919210|P2|Overall Study|Poor compliance to protocol|3
5472561|NCT01926782|18919211|P1|Overall Study|Poor compliance to protocol|5
5472562|NCT01926782|18919206|P6|Overall Study|Adverse Event|14
5472563|NCT01926782|18919207|P5|Overall Study|Adverse Event|3
5472564|NCT01926782|18919208|P4|Overall Study|Adverse Event|4
5472565|NCT01926782|18919209|P3|Overall Study|Adverse Event|17
5472566|NCT01926782|18919210|P2|Overall Study|Adverse Event|4
5472567|NCT01926782|18919211|P1|Overall Study|Adverse Event|13
5472568|NCT01926782|18919206|P6|Overall Study|Other than specified|11
5472569|NCT01926782|18919207|P5|Overall Study|Other than specified|4
5472570|NCT01926782|18919208|P4|Overall Study|Other than specified|12
5472571|NCT01926782|18919209|P3|Overall Study|Other than specified|5
5472572|NCT01926782|18919210|P2|Overall Study|Other than specified|3
5472573|NCT01926782|18919211|P1|Overall Study|Other than specified|2
5472574|NCT01926782|18919206|P6|Overall Study|Physician Decision|0
5472575|NCT01926782|18919207|P5|Overall Study|Physician Decision|0
5472576|NCT01926782|18919208|P4|Overall Study|Physician Decision|1
5472577|NCT01926782|18919209|P3|Overall Study|Physician Decision|1
5472578|NCT01926782|18919210|P2|Overall Study|Physician Decision|2
5472579|NCT01926782|18919211|P1|Overall Study|Physician Decision|0
5472580|NCT01926782|18919206|P6|Overall Study|Participant moved|3
5472581|NCT01926782|18919207|P5|Overall Study|Participant moved|0
5472582|NCT01926782|18919208|P4|Overall Study|Participant moved|1
5472583|NCT01926782|18919209|P3|Overall Study|Participant moved|1
5472584|NCT01926782|18919210|P2|Overall Study|Participant moved|0
5472585|NCT01926782|18919211|P1|Overall Study|Participant moved|2
5472586|NCT01926626|18919360|P1|Overall Study|Lost to Follow-up|7
5472587|NCT01926626|18919360|P1|Overall Study|Withdrawal by Subject|15
5472588|NCT01926509|18919374|P4|Overall Study|vital sign met discontinuation criteria|0
5472589|NCT01926509|18919375|P3|Overall Study|vital sign met discontinuation criteria|0
5472590|NCT01926509|18919376|P2|Overall Study|vital sign met discontinuation criteria|0
5472591|NCT01926509|18919377|P1|Overall Study|vital sign met discontinuation criteria|1
5472592|NCT01926444|18919417|P4|Overall Study|Colonoscopy not performed|2
5472593|NCT01926444|18919418|P3|Overall Study|Colonoscopy not performed|4
5472594|NCT01926444|18919419|P2|Overall Study|Colonoscopy not performed|0
5472595|NCT01926444|18919420|P1|Overall Study|Colonoscopy not performed|0
5472596|NCT01926119|18919462|P1|Overall Study|Withdrawal by Subject|1
5472769|NCT01924689|18920129|P1|Overall Study|Death|0
5472597|NCT01926028|18919475|P3|Overall Study|Non compliance or other reasons|0
5472598|NCT01926028|18919476|P2|Overall Study|Non compliance or other reasons|2
5472599|NCT01926028|18919477|P1|Overall Study|Non compliance or other reasons|4
5472600|NCT01926028|18919475|P3|Overall Study|Withdrawal by Subject|2
5472601|NCT01926028|18919476|P2|Overall Study|Withdrawal by Subject|9
5472602|NCT01926028|18919477|P1|Overall Study|Withdrawal by Subject|9
5472603|NCT01926028|18919475|P3|Overall Study|Physician Decision|0
5472604|NCT01926028|18919476|P2|Overall Study|Physician Decision|5
5472605|NCT01926028|18919477|P1|Overall Study|Physician Decision|1
5472606|NCT01926028|18919475|P3|Overall Study|Lost to Follow-up|0
5472607|NCT01926028|18919476|P2|Overall Study|Lost to Follow-up|6
5472608|NCT01926028|18919477|P1|Overall Study|Lost to Follow-up|7
5472609|NCT01926015|18919513|P2|Overall Study|Randomized not treated|0
5472610|NCT01926015|18919514|P1|Overall Study|Randomized not treated|2
5472611|NCT01926015|18919513|P2|Overall Study|Withdrawal by parent/guardian|1
5472612|NCT01926015|18919514|P1|Overall Study|Withdrawal by parent/guardian|0
5472613|NCT01925989|18919546|P3|Period 1|Withdrawal by Subject|0
5472614|NCT01925989|18919547|P2|Period 1|Withdrawal by Subject|1
5472615|NCT01925989|18919548|P1|Period 1|Withdrawal by Subject|0
5472616|NCT01925989|18919546|P3|Period 1|Sponsor Decision|0
5472617|NCT01925989|18919547|P2|Period 1|Sponsor Decision|1
5472618|NCT01925989|18919548|P1|Period 1|Sponsor Decision|1
5472619|NCT01925950|18919568|P2|Part 2|Withdrawal by Subject|0
5472620|NCT01925950|18919569|P1|Part 2|Withdrawal by Subject|1
5472621|NCT01925768|18919588|P2|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
5472622|NCT01925768|18919589|P1|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
5472623|NCT01925768|18919588|P2|ActiveTreatment/Extension (Weeks 24-104)|Death|1
5472624|NCT01925768|18919589|P1|ActiveTreatment/Extension (Weeks 24-104)|Death|0
5472625|NCT01925768|18919588|P2|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
5472626|NCT01925768|18919589|P1|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
5472627|NCT01925768|18919588|P2|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
5472628|NCT01925768|18919589|P1|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
5472629|NCT01925768|18919588|P2|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
5472630|NCT01925768|18919589|P1|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
5472631|NCT01925768|18919588|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
5472632|NCT01925768|18919589|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
5472633|NCT01925768|18919588|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
5472634|NCT01925768|18919589|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
5472635|NCT01925768|18919588|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
5472636|NCT01925768|18919589|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
5472637|NCT01925768|18919588|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
5472638|NCT01925768|18919589|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
5472639|NCT01925768|18919588|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
5472640|NCT01925768|18919589|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5472641|NCT01925768|18919588|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5472642|NCT01925768|18919589|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5472643|NCT01925703|18919637|P1|Overall Study|Discharge prior to full iron repletion|1
5472644|NCT01925703|18919637|P1|Overall Study|Lost to Follow-up|2
5472645|NCT01925703|18919637|P1|Overall Study|Physician Decision|1
5472646|NCT01925612|18919655|P5|Overall Study|Adverse Event|2
5472647|NCT01925612|18919656|P4|Overall Study|Adverse Event|1
5472648|NCT01925612|18919657|P3|Overall Study|Adverse Event|0
5472649|NCT01925612|18919658|P2|Overall Study|Adverse Event|3
5472650|NCT01925612|18919659|P1|Overall Study|Adverse Event|3
5472651|NCT01925612|18919655|P5|Overall Study|Progressive Disease|0
5472652|NCT01925612|18919656|P4|Overall Study|Progressive Disease|0
5472653|NCT01925612|18919657|P3|Overall Study|Progressive Disease|1
5472654|NCT01925612|18919658|P2|Overall Study|Progressive Disease|1
5472655|NCT01925612|18919659|P1|Overall Study|Progressive Disease|1
5472656|NCT01925417|18919709|P1|Overall Study|Death|1
5472657|NCT01925417|18919709|P1|Overall Study|Withdrawal by Subject|2
5472658|NCT01925339|18919740|P2|Overall Study|Adverse Event|0
5472659|NCT01925339|18919741|P1|Overall Study|Adverse Event|2
5472660|NCT01925274|18919752|P3|Overall Study|Protocol amendment|6
5472661|NCT01925274|18919753|P2|Overall Study|Protocol amendment|3
5472662|NCT01925274|18919754|P1|Overall Study|Protocol amendment|1
5472663|NCT01925274|18919752|P3|Overall Study|Study terminated by sponsor|0
5472664|NCT01925274|18919753|P2|Overall Study|Study terminated by sponsor|0
5472665|NCT01925274|18919754|P1|Overall Study|Study terminated by sponsor|4
5472666|NCT01925274|18919752|P3|Overall Study|Withdrawal by Subject|0
5472667|NCT01925274|18919753|P2|Overall Study|Withdrawal by Subject|2
5472668|NCT01925274|18919754|P1|Overall Study|Withdrawal by Subject|1
5472669|NCT01925274|18919752|P3|Overall Study|Lost to Follow-up|0
5472670|NCT01925274|18919753|P2|Overall Study|Lost to Follow-up|1
5472671|NCT01925274|18919754|P1|Overall Study|Lost to Follow-up|0
5472672|NCT01925274|18919752|P3|Overall Study|Death|0
5472673|NCT01925274|18919753|P2|Overall Study|Death|0
5472674|NCT01925274|18919754|P1|Overall Study|Death|1
5472675|NCT01925209|18919835|P4|Follow-up|Withdrawal by Subject|2
5472676|NCT01925209|18919836|P3|Follow-up|Withdrawal by Subject|0
5472677|NCT01925209|18919837|P2|Follow-up|Withdrawal by Subject|2
5472678|NCT01925209|18919838|P1|Follow-up|Withdrawal by Subject|0
5472679|NCT01925209|18919835|P4|Follow-up|Non-compliance with study treatment|1
5472680|NCT01925209|18919836|P3|Follow-up|Non-compliance with study treatment|0
5472681|NCT01925209|18919837|P2|Follow-up|Non-compliance with study treatment|0
5472682|NCT01925209|18919838|P1|Follow-up|Non-compliance with study treatment|0
5472683|NCT01925209|18919835|P4|Follow-up|Physician Decision|0
5472684|NCT01925209|18919836|P3|Follow-up|Physician Decision|1
5472685|NCT01925209|18919837|P2|Follow-up|Physician Decision|0
5472686|NCT01925209|18919838|P1|Follow-up|Physician Decision|0
5472687|NCT01925209|18919835|P4|Follow-up|Adverse Event|1
5472688|NCT01925209|18919836|P3|Follow-up|Adverse Event|0
5472689|NCT01925209|18919837|P2|Follow-up|Adverse Event|4
5472690|NCT01925209|18919838|P1|Follow-up|Adverse Event|1
5472691|NCT01925209|18919835|P4|Maintenance Treatment Epoch|Adverse Event|0
5472692|NCT01925209|18919836|P3|Maintenance Treatment Epoch|Adverse Event|1
5472693|NCT01925209|18919837|P2|Maintenance Treatment Epoch|Adverse Event|0
5472694|NCT01925209|18919838|P1|Maintenance Treatment Epoch|Adverse Event|0
5472695|NCT01925209|18919835|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
5472696|NCT01925209|18919836|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
5472697|NCT01925209|18919837|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
5472698|NCT01925209|18919838|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
5472699|NCT01925209|18919835|P4|Treatment Epoch|Adverse Event|1
5472700|NCT01925209|18919836|P3|Treatment Epoch|Adverse Event|3
5472701|NCT01925209|18919837|P2|Treatment Epoch|Adverse Event|5
5472702|NCT01925209|18919838|P1|Treatment Epoch|Adverse Event|3
5472703|NCT01925209|18919835|P4|Treatment Epoch|Withdrawal by Subject|2
5472704|NCT01925209|18919836|P3|Treatment Epoch|Withdrawal by Subject|3
5472705|NCT01925209|18919837|P2|Treatment Epoch|Withdrawal by Subject|3
5472706|NCT01925209|18919838|P1|Treatment Epoch|Withdrawal by Subject|4
5472707|NCT01925209|18919835|P4|Treatment Epoch|Protocol deviation|1
5472708|NCT01925209|18919836|P3|Treatment Epoch|Protocol deviation|1
5472709|NCT01925209|18919837|P2|Treatment Epoch|Protocol deviation|0
5472710|NCT01925209|18919838|P1|Treatment Epoch|Protocol deviation|0
5472711|NCT01925209|18919835|P4|Treatment Epoch|Death|0
5472712|NCT01925209|18919836|P3|Treatment Epoch|Death|0
5472713|NCT01925209|18919837|P2|Treatment Epoch|Death|0
5472714|NCT01925209|18919838|P1|Treatment Epoch|Death|1
5472715|NCT01925209|18919835|P4|Treatment Epoch|Non-compliance with study treatment|1
5472716|NCT01925209|18919836|P3|Treatment Epoch|Non-compliance with study treatment|0
5472717|NCT01925209|18919837|P2|Treatment Epoch|Non-compliance with study treatment|0
5472718|NCT01925209|18919838|P1|Treatment Epoch|Non-compliance with study treatment|0
5472719|NCT01925209|18919835|P4|Treatment Epoch|Physician Decision|0
5472720|NCT01925209|18919836|P3|Treatment Epoch|Physician Decision|0
5472721|NCT01925209|18919837|P2|Treatment Epoch|Physician Decision|0
5472722|NCT01925209|18919838|P1|Treatment Epoch|Physician Decision|1
5472723|NCT01925183|18919870|P2|Overall Study|Adverse Event|0
5472724|NCT01925183|18919871|P1|Overall Study|Adverse Event|1
5472725|NCT01925170|18919879|P1|Overall Study|Unverified cancer status|53
5472726|NCT01925014|18919910|P2|Overall Study|Withdrawal by Subject|13
5472727|NCT01925014|18919911|P1|Overall Study|Withdrawal by Subject|5
5472728|NCT01925014|18919910|P2|Overall Study|Inappropriate enrollment|6
5472729|NCT01925014|18919911|P1|Overall Study|Inappropriate enrollment|4
5472730|NCT01924845|18919986|P1|Overall Study|Protocol Violation|1
5472731|NCT01924845|18919986|P1|Overall Study|Withdrawal by Subject|2
5472732|NCT01924845|18919986|P1|Overall Study|Adverse Event|3
5472733|NCT01924806|18919996|P2|Overall Study|Physician Decision|1
5472734|NCT01924806|18919997|P1|Overall Study|Physician Decision|2
5472735|NCT01924767|18920014|P5|Overall Study|Adverse Event|0
5472736|NCT01924767|18920015|P4|Overall Study|Adverse Event|0
5472737|NCT01924767|18920016|P3|Overall Study|Adverse Event|1
5472738|NCT01924767|18920017|P2|Overall Study|Adverse Event|0
5472739|NCT01924767|18920018|P1|Overall Study|Adverse Event|1
5472740|NCT01924689|18920124|P6|Overall Study|Other|0
5472741|NCT01924689|18920125|P5|Overall Study|Other|1
5472742|NCT01924689|18920126|P4|Overall Study|Other|0
5472743|NCT01924689|18920127|P3|Overall Study|Other|0
5472744|NCT01924689|18920128|P2|Overall Study|Other|0
5472745|NCT01924689|18920129|P1|Overall Study|Other|0
5472746|NCT01924689|18920124|P6|Overall Study|Withdrawal of consent|0
5472747|NCT01924689|18920125|P5|Overall Study|Withdrawal of consent|0
5472748|NCT01924689|18920126|P4|Overall Study|Withdrawal of consent|1
5472749|NCT01924689|18920127|P3|Overall Study|Withdrawal of consent|1
5472750|NCT01924689|18920128|P2|Overall Study|Withdrawal of consent|0
5472751|NCT01924689|18920129|P1|Overall Study|Withdrawal of consent|0
5472752|NCT01924689|18920124|P6|Overall Study|New therapy or study|0
5472753|NCT01924689|18920125|P5|Overall Study|New therapy or study|2
5472754|NCT01924689|18920126|P4|Overall Study|New therapy or study|4
5472755|NCT01924689|18920127|P3|Overall Study|New therapy or study|1
5472756|NCT01924689|18920128|P2|Overall Study|New therapy or study|2
5472757|NCT01924689|18920129|P1|Overall Study|New therapy or study|3
5472758|NCT01924689|18920124|P6|Overall Study|Disease progression|2
5472759|NCT01924689|18920125|P5|Overall Study|Disease progression|3
5472760|NCT01924689|18920126|P4|Overall Study|Disease progression|0
5472761|NCT01924689|18920127|P3|Overall Study|Disease progression|2
5472762|NCT01924689|18920128|P2|Overall Study|Disease progression|0
5472763|NCT01924689|18920129|P1|Overall Study|Disease progression|0
5472764|NCT01924689|18920124|P6|Overall Study|Death|0
5472765|NCT01924689|18920125|P5|Overall Study|Death|0
5472766|NCT01924689|18920126|P4|Overall Study|Death|1
5472767|NCT01924689|18920127|P3|Overall Study|Death|0
5472768|NCT01924689|18920128|P2|Overall Study|Death|1
5472770|NCT01924533|18920203|P2|Overall Study|Other Eligibility criteria|1
5472771|NCT01924533|18920204|P1|Overall Study|Other Eligibility criteria|1
5472772|NCT01924533|18920203|P2|Overall Study|Withdrawal by Subject|3
5472773|NCT01924533|18920204|P1|Overall Study|Withdrawal by Subject|7
5472774|NCT01924533|18920203|P2|Overall Study|Lost to Follow-up|1
5472775|NCT01924533|18920204|P1|Overall Study|Lost to Follow-up|0
5472776|NCT01924533|18920203|P2|Overall Study|Death|200
5472777|NCT01924533|18920204|P1|Overall Study|Death|181
5472778|NCT01924429|18920245|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
5472779|NCT01924429|18920246|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
5472780|NCT01924364|18920289|P1|Overall Study|Physician Decision|3
5472781|NCT01924299|18920306|P2|Period 2|Adverse Event|1
5472782|NCT01924299|18920307|P1|Period 2|Adverse Event|0
5472783|NCT01924299|18920306|P2|Period 2|Withdrawal by Subject|0
5472784|NCT01924299|18920307|P1|Period 2|Withdrawal by Subject|1
5472785|NCT01924182|18920329|P2|Overall Study|Withdrawal by Subject|0
5472786|NCT01924182|18920330|P1|Overall Study|Withdrawal by Subject|1
5472787|NCT01923896|18920371|P2|Overall Study|Adverse Event|0
5472788|NCT01923896|18920372|P1|Overall Study|Adverse Event|1
5472789|NCT01923740|18920395|P2|Overall Study|Withdrawal by Subject|0
5472790|NCT01923740|18920396|P1|Overall Study|Withdrawal by Subject|2
5472791|NCT01923740|18920395|P2|Overall Study|Lost to Follow-up|9
5472792|NCT01923740|18920396|P1|Overall Study|Lost to Follow-up|4
5472793|NCT01923467|18920821|P1|Overall Study|Subject non-interest|479
5472794|NCT01923467|18920821|P1|Overall Study|Lost to Follow-up|62
5472795|NCT01923428|18920829|P4|Overall Study|Lack of Efficacy|1
5472796|NCT01923428|18920830|P3|Overall Study|Lack of Efficacy|1
5472797|NCT01923428|18920831|P2|Overall Study|Lack of Efficacy|0
5472798|NCT01923428|18920832|P1|Overall Study|Lack of Efficacy|0
5472799|NCT01923428|18920829|P4|Overall Study|Non Compliance to treatment|1
5472800|NCT01923428|18920830|P3|Overall Study|Non Compliance to treatment|0
5472801|NCT01923428|18920831|P2|Overall Study|Non Compliance to treatment|2
5472802|NCT01923428|18920832|P1|Overall Study|Non Compliance to treatment|1
5472803|NCT01923428|18920829|P4|Overall Study|Protocol Violation|1
5472804|NCT01923428|18920830|P3|Overall Study|Protocol Violation|2
5472805|NCT01923428|18920831|P2|Overall Study|Protocol Violation|0
5472806|NCT01923428|18920832|P1|Overall Study|Protocol Violation|3
5472807|NCT01923428|18920829|P4|Overall Study|Lost to Follow-up|0
5472808|NCT01923428|18920830|P3|Overall Study|Lost to Follow-up|5
5472809|NCT01923428|18920831|P2|Overall Study|Lost to Follow-up|1
5472810|NCT01923428|18920832|P1|Overall Study|Lost to Follow-up|2
5472811|NCT01923428|18920829|P4|Overall Study|Withdrawal by Subject|4
5472812|NCT01923428|18920830|P3|Overall Study|Withdrawal by Subject|0
5472813|NCT01923428|18920831|P2|Overall Study|Withdrawal by Subject|3
5472814|NCT01923428|18920832|P1|Overall Study|Withdrawal by Subject|5
5472815|NCT01923428|18920829|P4|Overall Study|Adverse Event|3
5472816|NCT01923428|18920830|P3|Overall Study|Adverse Event|3
5472817|NCT01923428|18920831|P2|Overall Study|Adverse Event|6
5472818|NCT01923428|18920832|P1|Overall Study|Adverse Event|8
5472819|NCT01923389|18920844|P2|Overall Study|Protocol Violation|0
5472820|NCT01923389|18920845|P1|Overall Study|Protocol Violation|1
5472821|NCT01923363|18920867|P1|Overall Study|Protocol Violation|1
5472822|NCT01923311|18920876|P2|Overall Study|Study Terminated by Sponsor|0
5472823|NCT01923311|18920877|P1|Overall Study|Study Terminated by Sponsor|12
5472824|NCT01923311|18920876|P2|Overall Study|Withdrew Consent|0
5472825|NCT01923311|18920877|P1|Overall Study|Withdrew Consent|1
5472826|NCT01923311|18920876|P2|Overall Study|Non-Compliance with Study Drug|1
5472827|NCT01923311|18920877|P1|Overall Study|Non-Compliance with Study Drug|2
5472828|NCT01923311|18920876|P2|Overall Study|Investigator's Discretion|0
5472829|NCT01923311|18920877|P1|Overall Study|Investigator's Discretion|1
5472830|NCT01923311|18920876|P2|Overall Study|Pregnancy|0
5472831|NCT01923311|18920877|P1|Overall Study|Pregnancy|1
5472832|NCT01923285|18920922|P2|Overall Study|Withdrawal by Subject|6
5472833|NCT01923285|18920923|P1|Overall Study|Withdrawal by Subject|7
5472834|NCT01923181|18920944|P9|Overall Study|Lost to Follow-up|1
5472835|NCT01923181|18920945|P8|Overall Study|Lost to Follow-up|3
5472836|NCT01923181|18920946|P7|Overall Study|Lost to Follow-up|3
5472837|NCT01923181|18920947|P6|Overall Study|Lost to Follow-up|1
5472838|NCT01923181|18920948|P5|Overall Study|Lost to Follow-up|2
5472839|NCT01923181|18920949|P4|Overall Study|Lost to Follow-up|1
5472840|NCT01923181|18920950|P3|Overall Study|Lost to Follow-up|2
5472841|NCT01923181|18920951|P2|Overall Study|Lost to Follow-up|3
5472842|NCT01923181|18920952|P1|Overall Study|Lost to Follow-up|0
5472843|NCT01923181|18920944|P9|Overall Study|Other|0
5472844|NCT01923181|18920945|P8|Overall Study|Other|0
5472845|NCT01923181|18920946|P7|Overall Study|Other|0
5472846|NCT01923181|18920947|P6|Overall Study|Other|0
5472847|NCT01923181|18920948|P5|Overall Study|Other|0
5472848|NCT01923181|18920949|P4|Overall Study|Other|1
5472849|NCT01923181|18920950|P3|Overall Study|Other|0
5472850|NCT01923181|18920951|P2|Overall Study|Other|0
5472851|NCT01923181|18920952|P1|Overall Study|Other|1
5472852|NCT01923181|18920944|P9|Overall Study|Withdrawal by Subject|1
5472853|NCT01923181|18920945|P8|Overall Study|Withdrawal by Subject|3
5472854|NCT01923181|18920946|P7|Overall Study|Withdrawal by Subject|4
5472855|NCT01923181|18920947|P6|Overall Study|Withdrawal by Subject|2
5472856|NCT01923181|18920948|P5|Overall Study|Withdrawal by Subject|4
5472857|NCT01923181|18920949|P4|Overall Study|Withdrawal by Subject|1
5472858|NCT01923181|18920950|P3|Overall Study|Withdrawal by Subject|0
5472859|NCT01923181|18920951|P2|Overall Study|Withdrawal by Subject|1
5472860|NCT01923181|18920952|P1|Overall Study|Withdrawal by Subject|0
5472861|NCT01923181|18920944|P9|Overall Study|Protocol Violation|1
5472862|NCT01923181|18920945|P8|Overall Study|Protocol Violation|2
5472863|NCT01923181|18920946|P7|Overall Study|Protocol Violation|1
5472864|NCT01923181|18920947|P6|Overall Study|Protocol Violation|1
5472865|NCT01923181|18920948|P5|Overall Study|Protocol Violation|2
5472866|NCT01923181|18920949|P4|Overall Study|Protocol Violation|2
5472867|NCT01923181|18920950|P3|Overall Study|Protocol Violation|0
5472868|NCT01923181|18920951|P2|Overall Study|Protocol Violation|2
5472869|NCT01923181|18920952|P1|Overall Study|Protocol Violation|2
5472870|NCT01923168|18921030|P3|Overall Study|Death|1
5472871|NCT01923168|18921031|P2|Overall Study|Death|0
5472872|NCT01923168|18921032|P1|Overall Study|Death|0
5472873|NCT01923168|18921030|P3|Overall Study|Progressive disease|7
5472874|NCT01923168|18921031|P2|Overall Study|Progressive disease|3
5472875|NCT01923168|18921032|P1|Overall Study|Progressive disease|4
5472876|NCT01923168|18921030|P3|Overall Study|Physician Decision|5
5472877|NCT01923168|18921031|P2|Overall Study|Physician Decision|9
5472878|NCT01923168|18921032|P1|Overall Study|Physician Decision|6
5472879|NCT01923168|18921030|P3|Overall Study|Adverse Event|0
5472880|NCT01923168|18921031|P2|Overall Study|Adverse Event|12
5472881|NCT01923168|18921032|P1|Overall Study|Adverse Event|12
5472882|NCT01923168|18921030|P3|Overall Study|Subject/guardian decision|4
5472883|NCT01923168|18921031|P2|Overall Study|Subject/guardian decision|14
5472884|NCT01923168|18921032|P1|Overall Study|Subject/guardian decision|14
5472885|NCT01923168|18921030|P3|Overall Study|Protocol Violation|0
5472886|NCT01923168|18921031|P2|Overall Study|Protocol Violation|1
5472887|NCT01923168|18921032|P1|Overall Study|Protocol Violation|1
5472888|NCT01922934|18921115|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
5472889|NCT01922934|18921116|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
5472890|NCT01922934|18921115|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
5472891|NCT01922934|18921116|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
5472892|NCT01922934|18921115|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
5472893|NCT01922934|18921116|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
5472894|NCT01922934|18921115|P2|Eligible Patients|Did not meet inclusion criteria|81
5472895|NCT01922934|18921116|P1|Eligible Patients|Did not meet inclusion criteria|36
5472896|NCT01922934|18921115|P2|Eligible Patients|Physician Decision|0
5472897|NCT01922934|18921116|P1|Eligible Patients|Physician Decision|17
5472898|NCT01922934|18921115|P2|Eligible Patients|Death|7
5472899|NCT01922934|18921116|P1|Eligible Patients|Death|0
5472900|NCT01922739|18921128|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
5472901|NCT01922739|18921128|P1|Open-label Treatment Period|Physician Decision|1
5472902|NCT01922739|18921128|P1|Open-label Treatment Period|Lost to Follow-up|2
5472903|NCT01922739|18921128|P1|Open-label Treatment Period|Noncompliance to study procedures|1
5472904|NCT01922739|18921128|P1|Open-label Treatment Period|Pregnancy|1
5472905|NCT01922739|18921128|P1|Open-label Treatment Period|Protocol Violation|5
5472906|NCT01922739|18921128|P1|Open-label Treatment Period|Noncompliance to study medication|3
5472907|NCT01922739|18921128|P1|Open-label Treatment Period|Withdrawal by Subject|14
5472908|NCT01922739|18921128|P1|Open-label Treatment Period|Adverse Event|6
5472909|NCT01922739|18921128|P1|Titration/Adjustment Period|Lack of Efficacy|3
5472910|NCT01922739|18921128|P1|Titration/Adjustment Period|Lost to Follow-up|1
5472911|NCT01922739|18921128|P1|Titration/Adjustment Period|Withdrawal by Subject|5
5472912|NCT01922739|18921128|P1|Titration/Adjustment Period|Adverse Event|3
5472913|NCT01922349|18921157|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
5472914|NCT01922349|18921158|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
5472915|NCT01922349|18921159|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
5472916|NCT01922349|18921160|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
5472917|NCT01922271|18921289|P2|WASHOUT Period|Withdrawal by Subject|0
5472918|NCT01922271|18921290|P1|WASHOUT Period|Withdrawal by Subject|1
5472919|NCT01922258|18921310|P2|Overall Study|Withdrawal by participant|5
5472920|NCT01922258|18921311|P1|Overall Study|Withdrawal by participant|5
5472921|NCT01922258|18921310|P2|Overall Study|Withdrawn by the Investigator|4
5472922|NCT01922258|18921311|P1|Overall Study|Withdrawn by the Investigator|1
5472923|NCT01922258|18921310|P2|Overall Study|Met Withdrawal Criteria|4
5472924|NCT01922258|18921311|P1|Overall Study|Met Withdrawal Criteria|0
5472925|NCT01922258|18921310|P2|Overall Study|Adverse Event|2
5472926|NCT01922258|18921311|P1|Overall Study|Adverse Event|9
5472927|NCT01922258|18921310|P2|Overall Study|Lost to Follow-up|1
5472928|NCT01922258|18921311|P1|Overall Study|Lost to Follow-up|1
5472929|NCT01922102|18921343|P3|Overall Study|Administrative problems|0
5472930|NCT01922102|18921344|P2|Overall Study|Administrative problems|2
5472931|NCT01922102|18921345|P1|Overall Study|Administrative problems|0
5472932|NCT01922102|18921343|P3|Overall Study|Lost to Follow-up|0
5472933|NCT01922102|18921344|P2|Overall Study|Lost to Follow-up|0
5472934|NCT01922102|18921345|P1|Overall Study|Lost to Follow-up|1
5472935|NCT01922102|18921343|P3|Overall Study|Adverse Event|0
5472936|NCT01922102|18921344|P2|Overall Study|Adverse Event|2
5472937|NCT01922102|18921345|P1|Overall Study|Adverse Event|1
5472938|NCT01922102|18921343|P3|Overall Study|Physician Decision|1
5472939|NCT01922102|18921344|P2|Overall Study|Physician Decision|2
5472940|NCT01922102|18921345|P1|Overall Study|Physician Decision|0
5472941|NCT01922102|18921343|P3|Overall Study|Withdrawal by Subject|7
5472942|NCT01922102|18921344|P2|Overall Study|Withdrawal by Subject|3
5472943|NCT01922102|18921345|P1|Overall Study|Withdrawal by Subject|7
5472944|NCT01922089|18921381|P2|Overall Study|Lost to Follow-up|1
5472945|NCT01922089|18921382|P1|Overall Study|Lost to Follow-up|0
5472946|NCT01922089|18921381|P2|Overall Study|Death|1
5472947|NCT01922089|18921382|P1|Overall Study|Death|2
5472948|NCT01922089|18921381|P2|Overall Study|Physician Decision|3
5472949|NCT01922089|18921382|P1|Overall Study|Physician Decision|2
5472950|NCT01922089|18921381|P2|Overall Study|administrative problems|1
5472951|NCT01922089|18921382|P1|Overall Study|administrative problems|4
5472952|NCT01922089|18921381|P2|Overall Study|Withdrawal by Subject|4
5472953|NCT01922089|18921382|P1|Overall Study|Withdrawal by Subject|3
5472954|NCT01922089|18921381|P2|Overall Study|Protocol Deviation|7
5472955|NCT01922089|18921382|P1|Overall Study|Protocol Deviation|10
5472956|NCT01922089|18921381|P2|Overall Study|Adverse Event|13
5472957|NCT01922089|18921382|P1|Overall Study|Adverse Event|18
5472958|NCT01922037|18921459|P2|Overall Study|Other unspecified|66
5472959|NCT01922037|18921460|P1|Overall Study|Other unspecified|2
5472960|NCT01922037|18921459|P2|Overall Study|Investigator/Sponsor decision|4
5472961|NCT01922037|18921460|P1|Overall Study|Investigator/Sponsor decision|1
5472962|NCT01922037|18921459|P2|Overall Study|Participant non-compliance|46
5472963|NCT01922037|18921460|P1|Overall Study|Participant non-compliance|4
5472964|NCT01922037|18921459|P2|Overall Study|Pregnancy|2
5472965|NCT01922037|18921460|P1|Overall Study|Pregnancy|0
5472966|NCT01922037|18921459|P2|Overall Study|Death|5
5472967|NCT01922037|18921460|P1|Overall Study|Death|0
5472968|NCT01922037|18921459|P2|Overall Study|Adverse Event|7
5472969|NCT01922037|18921460|P1|Overall Study|Adverse Event|1
5472970|NCT01922037|18921459|P2|Overall Study|Withdrawal by Subject|44
5472971|NCT01922037|18921460|P1|Overall Study|Withdrawal by Subject|2
5472972|NCT01922011|18921563|P2|Overall Study|Randomized in error|0
5472973|NCT01922011|18921564|P1|Overall Study|Randomized in error|1
5472974|NCT01922011|18921563|P2|Overall Study|Lack of willing home health agency|0
5472975|NCT01922011|18921564|P1|Overall Study|Lack of willing home health agency|1
5472976|NCT01922011|18921563|P2|Overall Study|Not Treated|0
5472977|NCT01922011|18921564|P1|Overall Study|Not Treated|1
5472978|NCT01922011|18921563|P2|Overall Study|Missed Test-of-Cure Visit|2
5472979|NCT01922011|18921564|P1|Overall Study|Missed Test-of-Cure Visit|0
5472980|NCT01922011|18921563|P2|Overall Study|Lost to Follow-up|1
5472981|NCT01922011|18921564|P1|Overall Study|Lost to Follow-up|0
5472982|NCT01922011|18921563|P2|Overall Study|Parent/Guardian Decision|0
5472983|NCT01922011|18921564|P1|Overall Study|Parent/Guardian Decision|3
5472984|NCT01922011|18921563|P2|Overall Study|Physician Decision|1
5472985|NCT01922011|18921564|P1|Overall Study|Physician Decision|0
5472986|NCT01922011|18921563|P2|Overall Study|Protocol Violation|1
5472987|NCT01922011|18921564|P1|Overall Study|Protocol Violation|0
5472988|NCT01921829|18921631|P2|Overall Study|Withdrawal by Subject|1
5472989|NCT01921829|18921632|P1|Overall Study|Withdrawal by Subject|0
5472990|NCT01921517|18921708|P2|Overall Study|Subject missed final imaging|4
5472991|NCT01921517|18921709|P1|Overall Study|Subject missed final imaging|1
5472992|NCT01921517|18921708|P2|Overall Study|Withdrawal by Subject|3
5472993|NCT01921517|18921709|P1|Overall Study|Withdrawal by Subject|7
5472994|NCT01921517|18921708|P2|Overall Study|Physician Decision|2
5472995|NCT01921517|18921709|P1|Overall Study|Physician Decision|0
5472996|NCT01921517|18921708|P2|Overall Study|Newly diagnosed health concern|0
5472997|NCT01921517|18921709|P1|Overall Study|Newly diagnosed health concern|2
5472998|NCT01921517|18921708|P2|Overall Study|Lost to Follow-up|0
5472999|NCT01921517|18921709|P1|Overall Study|Lost to Follow-up|5
5473000|NCT01921387|18921720|P1|Overall Study|Adverse Event|1
5473001|NCT01921348|18921729|P2|Overall Study|Lost to Follow-up|2
5473002|NCT01921348|18921730|P1|Overall Study|Lost to Follow-up|0
5473003|NCT01921348|18921729|P2|Overall Study|Withdrawal by Subject|0
5473004|NCT01921348|18921730|P1|Overall Study|Withdrawal by Subject|1
5473005|NCT01921270|18921759|P1|Overall Study|Withdrawal by Subject|1
5473006|NCT01921257|18921775|P1|Overall Study|Withdrawal by Subject|1
5473007|NCT01921257|18921775|P1|Overall Study|Protocol Violation|1
5473008|NCT01921257|18921775|P1|Overall Study|Adverse Event|1
5473009|NCT01921205|18921782|P2|Overall Study|Non Compliance Of Child|1
5473010|NCT01921205|18921783|P1|Overall Study|Non Compliance Of Child|0
5473011|NCT01921205|18921782|P2|Overall Study|Non Compliance Of The Parent|1
5473012|NCT01921205|18921783|P1|Overall Study|Non Compliance Of The Parent|0
5473013|NCT01921205|18921782|P2|Overall Study|The Excessive Use Of Rescue Medication|1
5473014|NCT01921205|18921783|P1|Overall Study|The Excessive Use Of Rescue Medication|0
5473015|NCT01921205|18921782|P2|Overall Study|Use Of Prohibited Medication|1
5473016|NCT01921205|18921783|P1|Overall Study|Use Of Prohibited Medication|0
5473017|NCT01921205|18921782|P2|Overall Study|Withdrawal by Subject|5
5473018|NCT01921205|18921783|P1|Overall Study|Withdrawal by Subject|6
5473019|NCT01921205|18921782|P2|Overall Study|Lost to Follow-up|1
5473020|NCT01921205|18921783|P1|Overall Study|Lost to Follow-up|1
5473021|NCT01921205|18921782|P2|Overall Study|Protocol Violation|3
5473022|NCT01921205|18921783|P1|Overall Study|Protocol Violation|1
5473023|NCT01921205|18921782|P2|Overall Study|Lack of Efficacy|0
5473024|NCT01921205|18921783|P1|Overall Study|Lack of Efficacy|1
5473025|NCT01921205|18921782|P2|Overall Study|Adverse Event|7
5473026|NCT01921205|18921783|P1|Overall Study|Adverse Event|12
5473027|NCT01921179|18921813|P2|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
5473028|NCT01921179|18921814|P1|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
5473029|NCT01921179|18921813|P2|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
5473030|NCT01921179|18921814|P1|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
5473031|NCT01921101|18921851|P2|Overall Study|Death|6
5473032|NCT01921101|18921852|P1|Overall Study|Death|16
5473033|NCT01920958|18921860|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
5473034|NCT01920893|18921878|P2|Overall Study|Lack of Efficacy|0
5473035|NCT01920893|18921879|P1|Overall Study|Lack of Efficacy|2
5473036|NCT01920893|18921878|P2|Overall Study|Adverse Event|2
5473037|NCT01920893|18921879|P1|Overall Study|Adverse Event|5
5473038|NCT01920854|18921912|P7|Overall Study|Withdrawal by Subject|1
5473039|NCT01920854|18921913|P6|Overall Study|Withdrawal by Subject|0
5473040|NCT01920854|18921914|P5|Overall Study|Withdrawal by Subject|1
5473041|NCT01920854|18921915|P4|Overall Study|Withdrawal by Subject|0
5473042|NCT01920854|18921916|P3|Overall Study|Withdrawal by Subject|0
5473043|NCT01920854|18921917|P2|Overall Study|Withdrawal by Subject|0
5473044|NCT01920854|18921918|P1|Overall Study|Withdrawal by Subject|1
5473045|NCT01920711|18922078|P2|Overall Study|Withdrawal by Subject|3
5473046|NCT01920711|18922079|P1|Overall Study|Withdrawal by Subject|4
5473047|NCT01920711|18922078|P2|Overall Study|Lost to Follow-up|14
5473048|NCT01920711|18922079|P1|Overall Study|Lost to Follow-up|13
5473049|NCT01920711|18922078|P2|Overall Study|Death|356
5473050|NCT01920711|18922079|P1|Overall Study|Death|347
5473051|NCT01920594|18922096|P2|Overall Study|Investigator discretion|1
5473052|NCT01920594|18922097|P1|Overall Study|Investigator discretion|0
5473053|NCT01920594|18922096|P2|Overall Study|Recovery|0
5473054|NCT01920594|18922097|P1|Overall Study|Recovery|2
5473055|NCT01920594|18922096|P2|Overall Study|Lost to Follow-up|0
5473056|NCT01920594|18922097|P1|Overall Study|Lost to Follow-up|1
5473057|NCT01920594|18922096|P2|Overall Study|Adverse Event|2
5473058|NCT01920594|18922097|P1|Overall Study|Adverse Event|4
5473059|NCT01920568|18922147|P2|Overall Study|Death due to disease progression|12
5473060|NCT01920568|18922148|P1|Overall Study|Death due to disease progression|25
5473061|NCT01920568|18922147|P2|Overall Study|Withdrawal by Subject|55
5473062|NCT01920568|18922148|P1|Overall Study|Withdrawal by Subject|79
5473063|NCT01920568|18922147|P2|Overall Study|Physician Decision|4
5473064|NCT01920568|18922148|P1|Overall Study|Physician Decision|13
5473065|NCT01920568|18922147|P2|Overall Study|Lost to Follow-up|2
5473066|NCT01920568|18922148|P1|Overall Study|Lost to Follow-up|2
5473067|NCT01920568|18922147|P2|Overall Study|Protocol Violation|3
5473068|NCT01920568|18922148|P1|Overall Study|Protocol Violation|5
5473069|NCT01920568|18922147|P2|Overall Study|Adverse Event|8
5473070|NCT01920568|18922148|P1|Overall Study|Adverse Event|27
5473071|NCT01920555|18922174|P5|Overall Study|Lost to Follow-up|0
5473072|NCT01920555|18922175|P4|Overall Study|Lost to Follow-up|1
5473073|NCT01920555|18922176|P3|Overall Study|Lost to Follow-up|0
5473074|NCT01920555|18922177|P2|Overall Study|Lost to Follow-up|1
5473075|NCT01920555|18922178|P1|Overall Study|Lost to Follow-up|0
5473076|NCT01920555|18922174|P5|Overall Study|Travel Difficulties|1
5473077|NCT01920555|18922175|P4|Overall Study|Travel Difficulties|0
5473078|NCT01920555|18922176|P3|Overall Study|Travel Difficulties|0
5473079|NCT01920555|18922177|P2|Overall Study|Travel Difficulties|1
5473080|NCT01920555|18922178|P1|Overall Study|Travel Difficulties|1
5473081|NCT01920555|18922174|P5|Overall Study|Lack of Efficacy|0
5473082|NCT01920555|18922175|P4|Overall Study|Lack of Efficacy|0
5473083|NCT01920555|18922176|P3|Overall Study|Lack of Efficacy|0
5473084|NCT01920555|18922177|P2|Overall Study|Lack of Efficacy|0
5473085|NCT01920555|18922178|P1|Overall Study|Lack of Efficacy|2
5473086|NCT01920555|18922174|P5|Overall Study|Physician Decision|0
5473087|NCT01920555|18922175|P4|Overall Study|Physician Decision|2
5473088|NCT01920555|18922176|P3|Overall Study|Physician Decision|1
5473089|NCT01920555|18922177|P2|Overall Study|Physician Decision|2
5473090|NCT01920555|18922178|P1|Overall Study|Physician Decision|1
5473091|NCT01920477|18922237|P2|Overall Study|Withdrawal by Subject|1
5473092|NCT01920477|18922238|P1|Overall Study|Withdrawal by Subject|0
5473093|NCT01920477|18922237|P2|Overall Study|Study closed/terminated|15
5473094|NCT01920477|18922238|P1|Overall Study|Study closed/terminated|14
5473095|NCT01920477|18922237|P2|Overall Study|Lack of Efficacy|0
5473096|NCT01920477|18922238|P1|Overall Study|Lack of Efficacy|1
5473097|NCT01920477|18922237|P2|Overall Study|Adverse Event|1
5473098|NCT01920477|18922238|P1|Overall Study|Adverse Event|0
5473099|NCT01920178|18922287|P2|Overall Study|Lost to Follow-up|1
5473100|NCT01920178|18922288|P1|Overall Study|Lost to Follow-up|2
5473101|NCT01919970|18922306|P2|Overall Study|Withdrawal by Subject|0
5473102|NCT01919970|18922307|P1|Overall Study|Withdrawal by Subject|3
5473103|NCT01919814|18922315|P2|Overall Study|Withdrawal by Subject|0
5473104|NCT01919814|18922316|P1|Overall Study|Withdrawal by Subject|1
5473105|NCT01919814|18922315|P2|Overall Study|Protocol Violation|0
5473106|NCT01919814|18922316|P1|Overall Study|Protocol Violation|1
5473107|NCT01919814|18922315|P2|Overall Study|Adverse Event|0
5473108|NCT01919814|18922316|P1|Overall Study|Adverse Event|1
5473109|NCT01919801|18922328|P2|Overall Study|Other|1
5473110|NCT01919801|18922329|P1|Overall Study|Other|0
5473111|NCT01919801|18922328|P2|Overall Study|Lost to Follow-up|1
5473112|NCT01919801|18922329|P1|Overall Study|Lost to Follow-up|0
5473113|NCT01919801|18922328|P2|Overall Study|Physician Decision|1
5473114|NCT01919801|18922329|P1|Overall Study|Physician Decision|0
5473115|NCT01919801|18922328|P2|Overall Study|Withdrawal by Subject|0
5473116|NCT01919801|18922329|P1|Overall Study|Withdrawal by Subject|1
5473117|NCT01919723|18922354|P2|Overall Study|Blood Samples Hemolyzed|2
5473118|NCT01919723|18922355|P1|Overall Study|Blood Samples Hemolyzed|2
5473119|NCT01919411|18922428|P2|Overall Study|Protocol Violation|1
5473120|NCT01919411|18922429|P1|Overall Study|Protocol Violation|2
5473121|NCT01919411|18922428|P2|Overall Study|Physician Decision|0
5473122|NCT01919411|18922429|P1|Overall Study|Physician Decision|1
5473123|NCT01919411|18922428|P2|Overall Study|Lost to Follow-up|4
5473124|NCT01919411|18922429|P1|Overall Study|Lost to Follow-up|2
5473125|NCT01919398|18922448|P3|Overall Study|Progressive Disease|4
5473126|NCT01919398|18922449|P2|Overall Study|Progressive Disease|0
5473127|NCT01919398|18922450|P1|Overall Study|Progressive Disease|0
5473128|NCT01919307|18922470|P1|Overall Study|Withdrawal by Subject|9
5473129|NCT01919229|18922480|P3|Overall Study|Subject/guardian decision|1
5473130|NCT01919229|18922481|P2|Overall Study|Subject/guardian decision|0
5473131|NCT01919229|18922482|P1|Overall Study|Subject/guardian decision|0
5473132|NCT01919164|18922529|P5|Overall Study|Other Un-specified|15
5473133|NCT01919164|18922530|P4|Overall Study|Other Un-specified|7
5473134|NCT01919164|18922531|P3|Overall Study|Other Un-specified|8
5473135|NCT01919164|18922532|P2|Overall Study|Other Un-specified|9
5473136|NCT01919164|18922533|P1|Overall Study|Other Un-specified|13
5473137|NCT01919164|18922529|P5|Overall Study|Withdrew consent|9
5473138|NCT01919164|18922530|P4|Overall Study|Withdrew consent|14
5473139|NCT01919164|18922531|P3|Overall Study|Withdrew consent|14
5473140|NCT01919164|18922532|P2|Overall Study|Withdrew consent|13
5473141|NCT01919164|18922533|P1|Overall Study|Withdrew consent|13
5473142|NCT01919164|18922529|P5|Overall Study|Disease progression|1
5473143|NCT01919164|18922530|P4|Overall Study|Disease progression|2
5473144|NCT01919164|18922531|P3|Overall Study|Disease progression|1
5473145|NCT01919164|18922532|P2|Overall Study|Disease progression|2
5473146|NCT01919164|18922533|P1|Overall Study|Disease progression|2
5473147|NCT01919164|18922529|P5|Overall Study|Protocol Violation|2
5473148|NCT01919164|18922530|P4|Overall Study|Protocol Violation|2
5473149|NCT01919164|18922531|P3|Overall Study|Protocol Violation|3
5473150|NCT01919164|18922532|P2|Overall Study|Protocol Violation|0
5473151|NCT01919164|18922533|P1|Overall Study|Protocol Violation|6
5473152|NCT01919164|18922529|P5|Overall Study|Death|0
5473153|NCT01919164|18922530|P4|Overall Study|Death|0
5473154|NCT01919164|18922531|P3|Overall Study|Death|0
5473155|NCT01919164|18922532|P2|Overall Study|Death|0
5473156|NCT01919164|18922533|P1|Overall Study|Death|1
5473157|NCT01919164|18922529|P5|Overall Study|Lost to Follow-up|4
5473158|NCT01919164|18922530|P4|Overall Study|Lost to Follow-up|0
5473159|NCT01919164|18922531|P3|Overall Study|Lost to Follow-up|2
5473160|NCT01919164|18922532|P2|Overall Study|Lost to Follow-up|2
5473161|NCT01919164|18922533|P1|Overall Study|Lost to Follow-up|2
5473162|NCT01919164|18922529|P5|Overall Study|Adverse Event|2
5473163|NCT01919164|18922530|P4|Overall Study|Adverse Event|3
5473164|NCT01919164|18922531|P3|Overall Study|Adverse Event|9
5473165|NCT01919164|18922532|P2|Overall Study|Adverse Event|4
5473166|NCT01919164|18922533|P1|Overall Study|Adverse Event|6
5473167|NCT01919112|18922588|P3|Secondary Analysis-day 30|Lost to Follow-up|0
5473168|NCT01919112|18922589|P2|Secondary Analysis-day 30|Lost to Follow-up|0
5473169|NCT01919112|18922590|P1|Secondary Analysis-day 30|Lost to Follow-up|1
5473170|NCT01919112|18922588|P3|Secondary Analysis-day 30|Death|1
5473171|NCT01919112|18922589|P2|Secondary Analysis-day 30|Death|1
5473172|NCT01919112|18922590|P1|Secondary Analysis-day 30|Death|1
5473173|NCT01918774|18922649|P1|Overall Study|Lost to Follow-up|1
5473174|NCT01918774|18922649|P1|Overall Study|Lost prior to first CBTw session|4
5473175|NCT01918371|18922673|P2|Overall Study|Missing Data|1
5473176|NCT01918371|18922674|P1|Overall Study|Missing Data|1
5473177|NCT01918332|18922752|P4|Overall Study|lipid result by central lab did not meet|0
5473178|NCT01918332|18922753|P3|Overall Study|lipid result by central lab did not meet|1
5473179|NCT01918332|18922754|P2|Overall Study|lipid result by central lab did not meet|0
5473180|NCT01918332|18922755|P1|Overall Study|lipid result by central lab did not meet|0
5473181|NCT01918332|18922752|P4|Overall Study|Protocol Violation|3
5473182|NCT01918332|18922753|P3|Overall Study|Protocol Violation|6
5473183|NCT01918332|18922754|P2|Overall Study|Protocol Violation|2
5473184|NCT01918332|18922755|P1|Overall Study|Protocol Violation|6
5473185|NCT01918332|18922752|P4|Overall Study|Withdrawal by Subject|3
5473186|NCT01918332|18922753|P3|Overall Study|Withdrawal by Subject|2
5473187|NCT01918332|18922754|P2|Overall Study|Withdrawal by Subject|3
5473188|NCT01918332|18922755|P1|Overall Study|Withdrawal by Subject|2
5473189|NCT01918332|18922752|P4|Overall Study|Adverse Event|1
5473190|NCT01918332|18922753|P3|Overall Study|Adverse Event|0
5473191|NCT01918332|18922754|P2|Overall Study|Adverse Event|0
5473192|NCT01918332|18922755|P1|Overall Study|Adverse Event|0
5473193|NCT01918306|18922767|P4|Overall Study|progress disease, crossover|0
5473194|NCT01918306|18922768|P3|Overall Study|progress disease, crossover|1
5473195|NCT01918306|18922769|P2|Overall Study|progress disease, crossover|0
5473196|NCT01918306|18922770|P1|Overall Study|progress disease, crossover|0
5473197|NCT01918306|18922767|P4|Overall Study|Lack of Efficacy|0
5473198|NCT01918306|18922768|P3|Overall Study|Lack of Efficacy|0
5473199|NCT01918306|18922769|P2|Overall Study|Lack of Efficacy|0
5473200|NCT01918306|18922770|P1|Overall Study|Lack of Efficacy|1
5473201|NCT01918306|18922767|P4|Overall Study|neutropenia|0
5473202|NCT01918306|18922768|P3|Overall Study|neutropenia|0
5473203|NCT01918306|18922769|P2|Overall Study|neutropenia|0
5473204|NCT01918306|18922770|P1|Overall Study|neutropenia|1
5473205|NCT01918306|18922767|P4|Overall Study|Withdrawal by Subject|2
5473206|NCT01918306|18922768|P3|Overall Study|Withdrawal by Subject|0
5473207|NCT01918306|18922769|P2|Overall Study|Withdrawal by Subject|0
5473208|NCT01918306|18922770|P1|Overall Study|Withdrawal by Subject|0
5473209|NCT01918306|18922767|P4|Overall Study|progresive disease|1
5473210|NCT01918306|18922768|P3|Overall Study|progresive disease|1
5473211|NCT01918306|18922769|P2|Overall Study|progresive disease|0
5473212|NCT01918306|18922770|P1|Overall Study|progresive disease|4
5473213|NCT01918085|18922801|P2|Test Period 1: Strata Strip|Adverse Event|1
5473214|NCT01918085|18922802|P1|Test Period 1: Strata Strip|Adverse Event|0
5473215|NCT01918033|18922826|P3|Overall Study|Withdrawal by Subject|0
5473216|NCT01918033|18922827|P2|Overall Study|Withdrawal by Subject|1
5473217|NCT01918033|18922828|P1|Overall Study|Withdrawal by Subject|2
5473218|NCT01918033|18922826|P3|Overall Study|Protocol Violation|1
5473219|NCT01918033|18922827|P2|Overall Study|Protocol Violation|0
5473220|NCT01918033|18922828|P1|Overall Study|Protocol Violation|2
5473221|NCT01918033|18922826|P3|Overall Study|Lost to Follow-up|0
5473222|NCT01918033|18922827|P2|Overall Study|Lost to Follow-up|1
5473223|NCT01918033|18922828|P1|Overall Study|Lost to Follow-up|0
5473224|NCT01918033|18922826|P3|Overall Study|Adverse Event|2
5473225|NCT01918033|18922827|P2|Overall Study|Adverse Event|0
5473226|NCT01918033|18922828|P1|Overall Study|Adverse Event|1
5473227|NCT01917747|18922899|P2|Overall Study|Lost to Follow-up|9
5473228|NCT01917747|18922900|P1|Overall Study|Lost to Follow-up|18
5473229|NCT01917747|18922899|P2|Overall Study|Withdrawal by Subject|2
5473230|NCT01917747|18922900|P1|Overall Study|Withdrawal by Subject|1
5473231|NCT01917656|18922929|P2|Overall Study|Lost to Follow-up|4
5473232|NCT01917656|18922930|P1|Overall Study|Lost to Follow-up|3
5473233|NCT01917656|18922929|P2|Overall Study|Withdrawal by Subject|3
5473234|NCT01917656|18922930|P1|Overall Study|Withdrawal by Subject|4
5473235|NCT01917656|18922929|P2|Overall Study|Unclassified|3
5473236|NCT01917656|18922930|P1|Overall Study|Unclassified|0
5473237|NCT01917656|18922929|P2|Overall Study|Withdrawal criteria|14
5473238|NCT01917656|18922930|P1|Overall Study|Withdrawal criteria|8
5473239|NCT01917656|18922929|P2|Overall Study|Adverse Event|0
5473240|NCT01917656|18922930|P1|Overall Study|Adverse Event|11
5473241|NCT01917526|18922956|P2|Overall Study|Protocol Violation|1
5473242|NCT01917526|18922957|P1|Overall Study|Protocol Violation|1
5473243|NCT01917344|18922974|P1|Overall Study|Withdrawal by Subject|1
5473244|NCT01917318|18922980|P2|First Treatment|Withdrawal by Subject|1
5473245|NCT01917318|18922981|P1|First Treatment|Withdrawal by Subject|0
5473246|NCT01917006|18923034|P8|Open-label Period|Lost to Follow-up|1
5473247|NCT01917006|18923035|P7|Open-label Period|Lost to Follow-up|0
5473248|NCT01917006|18923036|P6|Open-label Period|Lost to Follow-up|0
5473249|NCT01917006|18923037|P5|Open-label Period|Lost to Follow-up|0
5473250|NCT01917006|18923038|P4|Open-label Period|Lost to Follow-up|0
5473251|NCT01917006|18923039|P3|Open-label Period|Lost to Follow-up|0
5473252|NCT01917006|18923040|P2|Open-label Period|Lost to Follow-up|0
5473253|NCT01917006|18923041|P1|Open-label Period|Lost to Follow-up|0
5473254|NCT01917006|18923034|P8|Open-label Period|Adverse Event|1
5473255|NCT01917006|18923035|P7|Open-label Period|Adverse Event|0
5473256|NCT01917006|18923036|P6|Open-label Period|Adverse Event|0
5473257|NCT01917006|18923037|P5|Open-label Period|Adverse Event|0
5473258|NCT01917006|18923038|P4|Open-label Period|Adverse Event|0
5473259|NCT01917006|18923039|P3|Open-label Period|Adverse Event|0
5473260|NCT01917006|18923040|P2|Open-label Period|Adverse Event|0
5473261|NCT01917006|18923041|P1|Open-label Period|Adverse Event|0
5473262|NCT01917006|18923034|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
5473263|NCT01917006|18923035|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
5473264|NCT01917006|18923036|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
5473265|NCT01917006|18923037|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
5473266|NCT01917006|18923038|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
5473267|NCT01917006|18923039|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
5473268|NCT01917006|18923040|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
5473269|NCT01917006|18923041|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
5473270|NCT01917006|18923034|P8|Randomized-treatment Period|Protocol Violation|0
5473271|NCT01917006|18923035|P7|Randomized-treatment Period|Protocol Violation|0
5473272|NCT01917006|18923036|P6|Randomized-treatment Period|Protocol Violation|0
5473273|NCT01917006|18923037|P5|Randomized-treatment Period|Protocol Violation|0
5473274|NCT01917006|18923038|P4|Randomized-treatment Period|Protocol Violation|0
5473275|NCT01917006|18923039|P3|Randomized-treatment Period|Protocol Violation|0
5473276|NCT01917006|18923040|P2|Randomized-treatment Period|Protocol Violation|0
5473277|NCT01917006|18923041|P1|Randomized-treatment Period|Protocol Violation|1
5473278|NCT01917006|18923034|P8|Randomized-treatment Period|Personal Reasons|0
5473279|NCT01917006|18923035|P7|Randomized-treatment Period|Personal Reasons|0
5473280|NCT01917006|18923036|P6|Randomized-treatment Period|Personal Reasons|1
5473281|NCT01917006|18923037|P5|Randomized-treatment Period|Personal Reasons|0
5473282|NCT01917006|18923038|P4|Randomized-treatment Period|Personal Reasons|0
5473283|NCT01917006|18923039|P3|Randomized-treatment Period|Personal Reasons|0
5473284|NCT01917006|18923040|P2|Randomized-treatment Period|Personal Reasons|0
5473285|NCT01917006|18923041|P1|Randomized-treatment Period|Personal Reasons|0
5473286|NCT01917006|18923034|P8|Randomized-treatment Period|Lost to Follow-up|0
5473287|NCT01917006|18923035|P7|Randomized-treatment Period|Lost to Follow-up|0
5473288|NCT01917006|18923036|P6|Randomized-treatment Period|Lost to Follow-up|0
5473289|NCT01917006|18923037|P5|Randomized-treatment Period|Lost to Follow-up|0
5473290|NCT01917006|18923038|P4|Randomized-treatment Period|Lost to Follow-up|1
5473291|NCT01917006|18923039|P3|Randomized-treatment Period|Lost to Follow-up|0
5473292|NCT01917006|18923040|P2|Randomized-treatment Period|Lost to Follow-up|0
5473293|NCT01917006|18923041|P1|Randomized-treatment Period|Lost to Follow-up|1
5473294|NCT01916980|18923074|P2|Overall Study|Withdrawal by Subject|0
5473295|NCT01916980|18923075|P1|Overall Study|Withdrawal by Subject|1
5473296|NCT01916980|18923074|P2|Overall Study|Lack of Efficacy|2
5473297|NCT01916980|18923075|P1|Overall Study|Lack of Efficacy|2
5473298|NCT01916980|18923074|P2|Overall Study|Adverse Event|2
5473299|NCT01916980|18923075|P1|Overall Study|Adverse Event|4
5473300|NCT01916967|18923094|P3|Overall Study|Protocol Violation|0
5473301|NCT01916967|18923095|P2|Overall Study|Protocol Violation|1
5473302|NCT01916967|18923096|P1|Overall Study|Protocol Violation|0
5473303|NCT01916967|18923094|P3|Overall Study|Physician Decision|1
5473304|NCT01916967|18923095|P2|Overall Study|Physician Decision|0
5473305|NCT01916967|18923096|P1|Overall Study|Physician Decision|0
5473306|NCT01916967|18923094|P3|Overall Study|Lack of Efficacy|6
5473307|NCT01916967|18923095|P2|Overall Study|Lack of Efficacy|0
5473308|NCT01916967|18923096|P1|Overall Study|Lack of Efficacy|0
5473309|NCT01916967|18923094|P3|Overall Study|Adverse Event|2
5473310|NCT01916967|18923095|P2|Overall Study|Adverse Event|0
5473311|NCT01916967|18923096|P1|Overall Study|Adverse Event|0
5473312|NCT01916824|18923152|P2|Overall Study|Withdrawal by Subject|3
5473313|NCT01916824|18923153|P1|Overall Study|Withdrawal by Subject|2
5473314|NCT01916824|18923152|P2|Overall Study|Physician Decision|0
5473315|NCT01916824|18923153|P1|Overall Study|Physician Decision|2
5473316|NCT01916824|18923152|P2|Overall Study|Lost to Follow-up|6
5473317|NCT01916824|18923153|P1|Overall Study|Lost to Follow-up|3
5473318|NCT01916304|18923235|P1|Overall Study|Screening failure|17
5473319|NCT01916226|18923247|P4|Overall Study|Physician Decision|1
5473320|NCT01916226|18923248|P3|Overall Study|Physician Decision|0
5473321|NCT01916226|18923249|P2|Overall Study|Physician Decision|0
5473322|NCT01916226|18923250|P1|Overall Study|Physician Decision|0
5473323|NCT01916226|18923247|P4|Overall Study|Protocol Violation|1
5473324|NCT01916226|18923248|P3|Overall Study|Protocol Violation|0
5473325|NCT01916226|18923249|P2|Overall Study|Protocol Violation|1
5473326|NCT01916226|18923250|P1|Overall Study|Protocol Violation|0
5473327|NCT01916226|18923247|P4|Overall Study|Lack of Efficacy|1
5473328|NCT01916226|18923248|P3|Overall Study|Lack of Efficacy|2
5473329|NCT01916226|18923249|P2|Overall Study|Lack of Efficacy|0
5473330|NCT01916226|18923250|P1|Overall Study|Lack of Efficacy|0
5473331|NCT01916226|18923247|P4|Overall Study|Adverse Event|1
5473332|NCT01916226|18923248|P3|Overall Study|Adverse Event|1
5473333|NCT01916226|18923249|P2|Overall Study|Adverse Event|0
5473334|NCT01916226|18923250|P1|Overall Study|Adverse Event|1
5473335|NCT01916109|18923284|P1|Overall Study|Withdrawal by Subject|1
5473336|NCT01915940|18923290|P3|Treatment Period|Other Miscellaneous Reasons|0
5473337|NCT01915940|18923291|P2|Treatment Period|Other Miscellaneous Reasons|1
5473338|NCT01915940|18923292|P1|Treatment Period|Other Miscellaneous Reasons|0
5473339|NCT01915940|18923290|P3|Treatment Period|Adverse Event|1
5473340|NCT01915940|18923291|P2|Treatment Period|Adverse Event|9
5473341|NCT01915940|18923292|P1|Treatment Period|Adverse Event|0
5473342|NCT01915940|18923290|P3|Treatment Period|Decision of Participant|3
5473343|NCT01915940|18923291|P2|Treatment Period|Decision of Participant|1
5473344|NCT01915940|18923292|P1|Treatment Period|Decision of Participant|0
5473345|NCT01915940|18923290|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
5473346|NCT01915940|18923291|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
5473347|NCT01915940|18923292|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
5473348|NCT01915914|18923308|P4|Follow-up Phase|Physician Decision|1
5473349|NCT01915914|18923309|P3|Follow-up Phase|Physician Decision|0
5473350|NCT01915914|18923310|P2|Follow-up Phase|Physician Decision|0
5473351|NCT01915914|18923311|P1|Follow-up Phase|Physician Decision|0
5473352|NCT01915914|18923308|P4|Follow-up Phase|Withdrawal by Subject|1
5473353|NCT01915914|18923309|P3|Follow-up Phase|Withdrawal by Subject|0
5473354|NCT01915914|18923310|P2|Follow-up Phase|Withdrawal by Subject|0
5473355|NCT01915914|18923311|P1|Follow-up Phase|Withdrawal by Subject|0
5473356|NCT01915914|18923308|P4|Maintenance Phase|Missing|0
5473357|NCT01915914|18923309|P3|Maintenance Phase|Missing|0
5473358|NCT01915914|18923310|P2|Maintenance Phase|Missing|1
5473359|NCT01915914|18923311|P1|Maintenance Phase|Missing|0
5473360|NCT01915914|18923308|P4|Maintenance Phase|Lost to Follow-up|0
5473361|NCT01915914|18923309|P3|Maintenance Phase|Lost to Follow-up|1
5473362|NCT01915914|18923310|P2|Maintenance Phase|Lost to Follow-up|4
5473363|NCT01915914|18923311|P1|Maintenance Phase|Lost to Follow-up|0
5473364|NCT01915914|18923308|P4|Maintenance Phase|Withdrawal by Subject|0
5473365|NCT01915914|18923309|P3|Maintenance Phase|Withdrawal by Subject|1
5473366|NCT01915914|18923310|P2|Maintenance Phase|Withdrawal by Subject|1
5473367|NCT01915914|18923311|P1|Maintenance Phase|Withdrawal by Subject|0
5473368|NCT01915914|18923308|P4|Acute Phase|Missing|0
5473369|NCT01915914|18923309|P3|Acute Phase|Missing|0
5473370|NCT01915914|18923310|P2|Acute Phase|Missing|0
5473371|NCT01915914|18923311|P1|Acute Phase|Missing|1
5473372|NCT01915914|18923308|P4|Acute Phase|"Not Achieved treatment success"|0
5473373|NCT01915914|18923309|P3|Acute Phase|"Not Achieved treatment success"|0
5473374|NCT01915914|18923310|P2|Acute Phase|"Not Achieved treatment success"|0
5473375|NCT01915914|18923311|P1|Acute Phase|"Not Achieved treatment success"|1
5473376|NCT01915914|18923308|P4|Acute Phase|Accepted Other Topic Therapies|0
5473377|NCT01915914|18923309|P3|Acute Phase|Accepted Other Topic Therapies|0
5473378|NCT01915914|18923310|P2|Acute Phase|Accepted Other Topic Therapies|0
5473379|NCT01915914|18923311|P1|Acute Phase|Accepted Other Topic Therapies|1
5473380|NCT01915914|18923308|P4|Acute Phase|Physician Decision|0
5473381|NCT01915914|18923309|P3|Acute Phase|Physician Decision|0
5473382|NCT01915914|18923310|P2|Acute Phase|Physician Decision|0
5473383|NCT01915914|18923311|P1|Acute Phase|Physician Decision|1
5473384|NCT01915914|18923308|P4|Acute Phase|Lost to Follow-up|0
5473385|NCT01915914|18923309|P3|Acute Phase|Lost to Follow-up|0
5473386|NCT01915914|18923310|P2|Acute Phase|Lost to Follow-up|0
5473387|NCT01915914|18923311|P1|Acute Phase|Lost to Follow-up|4
5473388|NCT01915914|18923308|P4|Acute Phase|Withdrawal by Subject|0
5473389|NCT01915914|18923309|P3|Acute Phase|Withdrawal by Subject|0
5473390|NCT01915914|18923310|P2|Acute Phase|Withdrawal by Subject|0
5473391|NCT01915914|18923311|P1|Acute Phase|Withdrawal by Subject|4
5473392|NCT01915849|18923343|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5473393|NCT01915849|18923344|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5473394|NCT01915849|18923345|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
5473395|NCT01915849|18923346|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5473396|NCT01915849|18923343|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
5473397|NCT01915849|18923344|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
5473398|NCT01915849|18923345|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
5473399|NCT01915849|18923346|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
5473400|NCT01915771|18923369|P1|Day 15|Withdrawal by Subject|1
5473401|NCT01915771|18923369|P1|Day 1|Withdrawal by Subject|1
5473402|NCT01915732|18923393|P2|Overall Study|Poor Conscious Effect|1
5473403|NCT01915732|18923394|P1|Overall Study|Poor Conscious Effect|0
5473404|NCT01915732|18923393|P2|Overall Study|Improper Facial Procedure|1
5473405|NCT01915732|18923394|P1|Overall Study|Improper Facial Procedure|0
5473406|NCT01915732|18923393|P2|Overall Study|Job Transfer|1
5473407|NCT01915732|18923394|P1|Overall Study|Job Transfer|0
5473408|NCT01915732|18923393|P2|Overall Study|Par. Refused to Hospital Visits|1
5473409|NCT01915732|18923394|P1|Overall Study|Par. Refused to Hospital Visits|0
5473410|NCT01915732|18923393|P2|Overall Study|Par. not Willing to Continue Treatment|1
5473411|NCT01915732|18923394|P1|Overall Study|Par. not Willing to Continue Treatment|0
5473412|NCT01915732|18923393|P2|Overall Study|Got Well|1
5473413|NCT01915732|18923394|P1|Overall Study|Got Well|0
5473414|NCT01915732|18923393|P2|Overall Study|Par. Unable to Come to the Hospital|1
5473415|NCT01915732|18923394|P1|Overall Study|Par. Unable to Come to the Hospital|0
5473416|NCT01915732|18923393|P2|Overall Study|Poor Perceived Efficacy|0
5473417|NCT01915732|18923394|P1|Overall Study|Poor Perceived Efficacy|1
5473418|NCT01915732|18923393|P2|Overall Study|Pregnancy|0
5473419|NCT01915732|18923394|P1|Overall Study|Pregnancy|1
5473420|NCT01915732|18923393|P2|Overall Study|Recovered|0
5473421|NCT01915732|18923394|P1|Overall Study|Recovered|1
5473422|NCT01915732|18923393|P2|Overall Study|Drug Release Error|0
5473423|NCT01915732|18923394|P1|Overall Study|Drug Release Error|1
5473424|NCT01915732|18923393|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
5473425|NCT01915732|18923394|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
5473426|NCT01915732|18923393|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
5473427|NCT01915732|18923394|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
5473428|NCT01915732|18923393|P2|Overall Study|Lost to Follow-up|26
5473429|NCT01915732|18923394|P1|Overall Study|Lost to Follow-up|22
5473430|NCT01915732|18923393|P2|Overall Study|Lack of Efficacy|11
5473431|NCT01915732|18923394|P1|Overall Study|Lack of Efficacy|6
5473432|NCT01915732|18923393|P2|Overall Study|Protocol Violation|5
5473433|NCT01915732|18923394|P1|Overall Study|Protocol Violation|5
5473434|NCT01915732|18923393|P2|Overall Study|Adverse Event|4
5473435|NCT01915732|18923394|P1|Overall Study|Adverse Event|12
5473436|NCT01915732|18923393|P2|Overall Study|Failure to Meet Randomization Criteria|0
5473437|NCT01915732|18923394|P1|Overall Study|Failure to Meet Randomization Criteria|1
5473438|NCT01915732|18923393|P2|Overall Study|Withdrawal by Subject|18
5473439|NCT01915732|18923394|P1|Overall Study|Withdrawal by Subject|18
5473440|NCT01915498|18923447|P19|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
5473441|NCT01915498|18923448|P18|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473442|NCT01915498|18923449|P17|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473443|NCT01915498|18923450|P16|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473444|NCT01915498|18923451|P15|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473445|NCT01915498|18923452|P14|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473446|NCT01915498|18923453|P13|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473447|NCT01915498|18923454|P12|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473448|NCT01915498|18923455|P11|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473449|NCT01915498|18923456|P10|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473450|NCT01915498|18923457|P9|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473451|NCT01915498|18923458|P8|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473452|NCT01915498|18923459|P7|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473453|NCT01915498|18923460|P6|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473454|NCT01915498|18923461|P5|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473455|NCT01915498|18923462|P4|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473456|NCT01915498|18923463|P3|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473457|NCT01915498|18923464|P2|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473753|NCT01913483|18924365|P1|Overall Study|Withdrawal by Subject|1
5473458|NCT01915498|18923465|P1|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
5473459|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473460|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5473461|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5473462|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
5473463|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5473464|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
5473465|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473466|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473467|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473468|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
5473469|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473470|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473471|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473472|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
5473473|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473474|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473475|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473476|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473477|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
5473478|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473479|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
5473480|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473481|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473482|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
5473483|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473484|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473485|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473486|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473487|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473488|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473489|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473490|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473491|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
5473492|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473493|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473494|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473495|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
5473496|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
5473497|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473498|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5473499|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5473500|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473501|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473502|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5473503|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473504|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473505|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
5473506|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473507|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473508|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473509|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473510|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473511|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473512|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473513|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473514|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473515|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
5473516|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5473517|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
5473518|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
5473519|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
5473520|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
5473521|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
5473522|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5473754|NCT01913470|18924377|P2|Overall Study|Withdrawal by Subject|1
5473523|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5473524|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5473525|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5473526|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5473527|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5473528|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5473529|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5473530|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5473531|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5473532|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
5473533|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
5473534|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
5473535|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5473536|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
5473537|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
5473538|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5473539|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5473540|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5473541|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5473542|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5473543|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5473544|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5473545|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5473546|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5473547|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5473548|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5473549|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5473550|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5473551|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
5473552|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
5473553|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
5473554|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473555|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473556|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473557|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473558|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473559|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473560|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473561|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473562|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473563|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
5473564|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473565|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473566|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473567|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473568|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
5473569|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473570|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473571|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473572|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
5473573|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5473574|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Death|16
5473575|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Death|3
5473576|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Death|4
5473577|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5473578|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Death|4
5473579|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5473580|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5473581|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Death|2
5473582|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5473583|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5473584|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5473585|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Death|0
5473586|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Death|2
5473587|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5473588|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5473589|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5473590|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Death|1
5473591|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Death|2
5473592|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473593|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473594|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473595|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473596|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473597|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473598|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473599|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473600|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
5473601|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473602|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473603|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473604|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473605|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473606|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473607|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473608|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473609|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473610|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
5473611|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
5473612|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
5473613|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
5473614|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
5473615|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
5473616|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
5473617|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5473618|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
5473619|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5473620|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
5473621|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
5473622|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
5473623|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
5473624|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
5473625|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
5473626|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
5473627|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5473628|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
5473629|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
5473630|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5473631|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
5473632|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5473633|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
5473634|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5473635|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
5473636|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5473637|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5473638|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5473639|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5473640|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5473641|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
5473642|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5473643|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5473644|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5473645|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5473646|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
5473647|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
5473648|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
5473649|NCT01915498|18923447|P19|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473650|NCT01915498|18923448|P18|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
5473651|NCT01915498|18923449|P17|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
5473652|NCT01915498|18923450|P16|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
5473653|NCT01915498|18923451|P15|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5473654|NCT01915498|18923452|P14|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
5473655|NCT01915498|18923453|P13|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5473656|NCT01915498|18923454|P12|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473657|NCT01915498|18923455|P11|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473658|NCT01915498|18923456|P10|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5473659|NCT01915498|18923457|P9|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473660|NCT01915498|18923458|P8|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473661|NCT01915498|18923459|P7|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473662|NCT01915498|18923460|P6|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473663|NCT01915498|18923461|P5|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5473664|NCT01915498|18923462|P4|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
5473665|NCT01915498|18923463|P3|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473666|NCT01915498|18923464|P2|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473667|NCT01915498|18923465|P1|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
5473668|NCT01915303|18923989|P1|Extension Phase|Protocol Violation|1
5473669|NCT01915303|18923989|P1|Extension Phase|Death|1
5473670|NCT01915303|18923989|P1|Extension Phase|Adverse Event|3
5473671|NCT01915303|18923989|P1|Extension Phase|Withdrawal by Subject|4
5473672|NCT01915303|18923989|P1|Extension Phase|Unsatisfactory therapeutic effect|8
5473673|NCT01915303|18923989|P1|Core Phase|Withdrawal by Subject|1
5473674|NCT01915303|18923989|P1|Core Phase|Abnormal lab value|1
5473675|NCT01915303|18923989|P1|Core Phase|Protocol Violation|2
5473676|NCT01915303|18923989|P1|Core Phase|Death|2
5473677|NCT01915303|18923989|P1|Core Phase|Unsatisfactory therapeutic effect|3
5473678|NCT01915303|18923989|P1|Core Phase|Adverse Event|7
5473679|NCT01915095|18924063|P5|Overall Study|Some subjects were unable to commit to the training study.|6
5473680|NCT01915095|18924064|P4|Overall Study|Some subjects were unable to commit to the training study.|4
5473681|NCT01915095|18924065|P3|Overall Study|Some subjects were unable to commit to the training study.|0
5473682|NCT01915095|18924066|P2|Overall Study|Some subjects were unable to commit to the training study.|0
5473683|NCT01915095|18924067|P1|Overall Study|Some subjects were unable to commit to the training study.|0
5473684|NCT01914926|18924090|P2|Overall Study|uncooperative, agitated and removed|1
5473685|NCT01914926|18924091|P1|Overall Study|uncooperative, agitated and removed|0
5473686|NCT01914926|18924090|P2|Overall Study|Adverse Event|0
5473687|NCT01914926|18924091|P1|Overall Study|Adverse Event|1
5473688|NCT01914757|18924100|P3|Overall Study|Other reasons|4
5473689|NCT01914757|18924101|P2|Overall Study|Other reasons|9
5473690|NCT01914757|18924102|P1|Overall Study|Other reasons|5
5473691|NCT01914757|18924100|P3|Overall Study|Eligibility criteria not fulfilled|2
5473692|NCT01914757|18924101|P2|Overall Study|Eligibility criteria not fulfilled|0
5473693|NCT01914757|18924102|P1|Overall Study|Eligibility criteria not fulfilled|2
5473694|NCT01914757|18924100|P3|Overall Study|Study specific withdrawal criteria|0
5473695|NCT01914757|18924101|P2|Overall Study|Study specific withdrawal criteria|1
5473696|NCT01914757|18924102|P1|Overall Study|Study specific withdrawal criteria|0
5473697|NCT01914757|18924100|P3|Overall Study|Adverse Event|4
5473698|NCT01914757|18924101|P2|Overall Study|Adverse Event|3
5473699|NCT01914757|18924102|P1|Overall Study|Adverse Event|4
5473700|NCT01914757|18924100|P3|Overall Study|Death|1
5473701|NCT01914757|18924101|P2|Overall Study|Death|2
5473702|NCT01914757|18924102|P1|Overall Study|Death|2
5473703|NCT01914757|18924100|P3|Overall Study|Withdrawal by Subject|19
5473704|NCT01914757|18924101|P2|Overall Study|Withdrawal by Subject|27
5473705|NCT01914757|18924102|P1|Overall Study|Withdrawal by Subject|15
5473706|NCT01914757|18924100|P3|Overall Study|Lost to Follow-up|6
5473707|NCT01914757|18924101|P2|Overall Study|Lost to Follow-up|8
5473708|NCT01914757|18924102|P1|Overall Study|Lost to Follow-up|5
5473709|NCT01914757|18924100|P3|Overall Study|Severe non-compliance to protocol|2
5473710|NCT01914757|18924101|P2|Overall Study|Severe non-compliance to protocol|1
5473711|NCT01914757|18924102|P1|Overall Study|Severe non-compliance to protocol|3
5473712|NCT01914679|18924176|P1|Overall Study|Sponsor terminated study|4
5473713|NCT01914679|18924176|P1|Overall Study|Lack of Efficacy|1
5473714|NCT01914666|18924183|P3|Treatment Period|Physician Decision|2
5473715|NCT01914666|18924184|P2|Treatment Period|Physician Decision|0
5473716|NCT01914666|18924185|P1|Treatment Period|Physician Decision|0
5473717|NCT01914666|18924183|P3|Treatment Period|Withdrawal by Subject|2
5473718|NCT01914666|18924184|P2|Treatment Period|Withdrawal by Subject|2
5473719|NCT01914666|18924185|P1|Treatment Period|Withdrawal by Subject|3
5473720|NCT01914666|18924183|P3|Treatment Period|Adverse Event|2
5473721|NCT01914666|18924184|P2|Treatment Period|Adverse Event|4
5473722|NCT01914666|18924185|P1|Treatment Period|Adverse Event|10
5473723|NCT01914666|18924183|P3|Treatment Period|Lack of Efficacy|2
5473724|NCT01914666|18924184|P2|Treatment Period|Lack of Efficacy|0
5473725|NCT01914666|18924185|P1|Treatment Period|Lack of Efficacy|0
5473726|NCT01914393|18924228|P3|Overall Study|subject never dosed|1
5473727|NCT01914393|18924229|P2|Overall Study|subject never dosed|0
5473728|NCT01914393|18924230|P1|Overall Study|subject never dosed|0
5473729|NCT01914393|18924228|P3|Overall Study|Lost to Follow-up|19
5473730|NCT01914393|18924229|P2|Overall Study|Lost to Follow-up|6
5473731|NCT01914393|18924230|P1|Overall Study|Lost to Follow-up|12
5473732|NCT01914393|18924228|P3|Overall Study|Withdrawal by Subject|47
5473733|NCT01914393|18924229|P2|Overall Study|Withdrawal by Subject|20
5473734|NCT01914393|18924230|P1|Overall Study|Withdrawal by Subject|38
5473735|NCT01914393|18924228|P3|Overall Study|Adverse Event|31
5473736|NCT01914393|18924229|P2|Overall Study|Adverse Event|18
5473737|NCT01914393|18924230|P1|Overall Study|Adverse Event|29
5473738|NCT01914393|18924228|P3|Overall Study|no reason given|16
5473739|NCT01914393|18924229|P2|Overall Study|no reason given|8
5473740|NCT01914393|18924230|P1|Overall Study|no reason given|14
5473741|NCT01914393|18924228|P3|Overall Study|Lack of Efficacy|5
5473742|NCT01914393|18924229|P2|Overall Study|Lack of Efficacy|16
5473743|NCT01914393|18924230|P1|Overall Study|Lack of Efficacy|11
5473744|NCT01914393|18924228|P3|Overall Study|Protocol Violation|19
5473745|NCT01914393|18924229|P2|Overall Study|Protocol Violation|3
5473746|NCT01914393|18924230|P1|Overall Study|Protocol Violation|11
5473747|NCT01913639|18924298|P1|Overall Study|Not Eligible|3
5473748|NCT01913483|18924364|P2|Overall Study|Death|17
5473749|NCT01913483|18924365|P1|Overall Study|Death|14
5473750|NCT01913483|18924364|P2|Overall Study|Lost to Follow-up|3
5473751|NCT01913483|18924365|P1|Overall Study|Lost to Follow-up|6
5473752|NCT01913483|18924364|P2|Overall Study|Withdrawal by Subject|2
5473755|NCT01913470|18924378|P1|Overall Study|Withdrawal by Subject|0
5473756|NCT01913470|18924377|P2|Overall Study|Physician Decision|1
5473757|NCT01913470|18924378|P1|Overall Study|Physician Decision|0
5473758|NCT01913470|18924377|P2|Overall Study|Lost to Follow-up|1
5473759|NCT01913470|18924378|P1|Overall Study|Lost to Follow-up|0
5473760|NCT01913405|18924396|P1|Overall Study|Adverse Event|1
5473761|NCT01913405|18924396|P1|Overall Study|Withdrawal by Subject|1
5473762|NCT01913353|18924452|P2|Overall Study|multiple reasons|7
5473763|NCT01913353|18924453|P1|Overall Study|multiple reasons|10
5473764|NCT01913353|18924452|P2|Overall Study|Withdrawal by Subject|6
5473765|NCT01913353|18924453|P1|Overall Study|Withdrawal by Subject|20
5473766|NCT01913353|18924452|P2|Overall Study|Physician Decision|2
5473767|NCT01913353|18924453|P1|Overall Study|Physician Decision|0
5473768|NCT01913353|18924452|P2|Overall Study|Adverse Event|0
5473769|NCT01913353|18924453|P1|Overall Study|Adverse Event|2
5473770|NCT01913340|18924523|P2|Overall Study|Lost to Follow-up|1
5473771|NCT01913340|18924524|P1|Overall Study|Lost to Follow-up|1
5473772|NCT01913340|18924523|P2|Overall Study|Death|5
5473773|NCT01913340|18924524|P1|Overall Study|Death|2
5473774|NCT01913327|18924548|P2|Overall Study|Withdrawal by Subject|1
5473775|NCT01913327|18924549|P1|Overall Study|Withdrawal by Subject|0
5473776|NCT01913041|18924574|P1|Overall Study|Physician Decision|1
5473777|NCT01913041|18924574|P1|Overall Study|Withdrawal by Subject|3
5473778|NCT01913041|18924574|P1|Overall Study|Protocol Violation|35
5473779|NCT01912963|18924581|P3|Overall Study|Sought treatment locally|0
5473780|NCT01912963|18924582|P2|Overall Study|Sought treatment locally|1
5473781|NCT01912963|18924583|P1|Overall Study|Sought treatment locally|0
5473782|NCT01912963|18924581|P3|Overall Study|Withdrawal by Subject|0
5473783|NCT01912963|18924582|P2|Overall Study|Withdrawal by Subject|1
5473784|NCT01912963|18924583|P1|Overall Study|Withdrawal by Subject|0
5473785|NCT01912963|18924581|P3|Overall Study|Adverse Event|1
5473786|NCT01912963|18924582|P2|Overall Study|Adverse Event|1
5473787|NCT01912963|18924583|P1|Overall Study|Adverse Event|0
5473788|NCT01912963|18924581|P3|Overall Study|Disease Progression (not RECIST1.1)|1
5473789|NCT01912963|18924582|P2|Overall Study|Disease Progression (not RECIST1.1)|7
5473790|NCT01912963|18924583|P1|Overall Study|Disease Progression (not RECIST1.1)|0
5473791|NCT01912963|18924581|P3|Overall Study|Disease Progression (RECIST1.1)|5
5473792|NCT01912963|18924582|P2|Overall Study|Disease Progression (RECIST1.1)|9
5473793|NCT01912963|18924583|P1|Overall Study|Disease Progression (RECIST1.1)|6
5473794|NCT01912872|18924606|P4|Overall Study|Missing|1
5473795|NCT01912872|18924607|P3|Overall Study|Missing|0
5473796|NCT01912872|18924608|P2|Overall Study|Missing|0
5473797|NCT01912872|18924609|P1|Overall Study|Missing|0
5473798|NCT01912872|18924606|P4|Overall Study|Withdrawal of study medication|2
5473799|NCT01912872|18924607|P3|Overall Study|Withdrawal of study medication|0
5473800|NCT01912872|18924608|P2|Overall Study|Withdrawal of study medication|0
5473801|NCT01912872|18924609|P1|Overall Study|Withdrawal of study medication|0
5473802|NCT01912872|18924606|P4|Overall Study|Unsatisfactory therapeutic effect|2
5473803|NCT01912872|18924607|P3|Overall Study|Unsatisfactory therapeutic effect|0
5473804|NCT01912872|18924608|P2|Overall Study|Unsatisfactory therapeutic effect|0
5473805|NCT01912872|18924609|P1|Overall Study|Unsatisfactory therapeutic effect|0
5473806|NCT01912872|18924606|P4|Overall Study|Protocol Violation|0
5473807|NCT01912872|18924607|P3|Overall Study|Protocol Violation|1
5473808|NCT01912872|18924608|P2|Overall Study|Protocol Violation|0
5473809|NCT01912872|18924609|P1|Overall Study|Protocol Violation|0
5473810|NCT01912872|18924606|P4|Overall Study|Non-compliance with lab inc/exclusion|1
5473811|NCT01912872|18924607|P3|Overall Study|Non-compliance with lab inc/exclusion|0
5473812|NCT01912872|18924608|P2|Overall Study|Non-compliance with lab inc/exclusion|0
5473813|NCT01912872|18924609|P1|Overall Study|Non-compliance with lab inc/exclusion|0
5473814|NCT01912872|18924606|P4|Overall Study|Informed consent withdrawn|1
5473815|NCT01912872|18924607|P3|Overall Study|Informed consent withdrawn|1
5473816|NCT01912872|18924608|P2|Overall Study|Informed consent withdrawn|0
5473817|NCT01912872|18924609|P1|Overall Study|Informed consent withdrawn|0
5473818|NCT01912872|18924606|P4|Overall Study|Other unspecified|0
5473819|NCT01912872|18924607|P3|Overall Study|Other unspecified|3
5473820|NCT01912872|18924608|P2|Overall Study|Other unspecified|1
5473821|NCT01912872|18924609|P1|Overall Study|Other unspecified|3
5473822|NCT01912872|18924606|P4|Overall Study|Lost to Follow-up|5
5473823|NCT01912872|18924607|P3|Overall Study|Lost to Follow-up|5
5473824|NCT01912872|18924608|P2|Overall Study|Lost to Follow-up|3
5473825|NCT01912872|18924609|P1|Overall Study|Lost to Follow-up|2
5473826|NCT01912781|18924653|P2|Overall Study|Withdrawal by Subject|0
5473827|NCT01912781|18924654|P1|Overall Study|Withdrawal by Subject|2
5473828|NCT01912768|18924685|P2|Overall Study|Randomized in error|0
5473829|NCT01912768|18924686|P1|Overall Study|Randomized in error|1
5473830|NCT01912768|18924685|P2|Overall Study|Withdrawal by Subject|3
5473831|NCT01912768|18924686|P1|Overall Study|Withdrawal by Subject|5
5473832|NCT01912768|18924685|P2|Overall Study|Lost to Follow-up|1
5473833|NCT01912768|18924686|P1|Overall Study|Lost to Follow-up|2
5473834|NCT01912768|18924685|P2|Overall Study|Adverse Event|0
5473835|NCT01912768|18924686|P1|Overall Study|Adverse Event|2
5473836|NCT01912729|18924717|P2|Overall Study|Withdrawal by Subject|1
5473837|NCT01912729|18924718|P1|Overall Study|Withdrawal by Subject|0
5473838|NCT01912612|18924741|P3|Overall Study|Study design change|3
5473839|NCT01912612|18924742|P2|Overall Study|Study design change|0
5473840|NCT01912612|18924743|P1|Overall Study|Study design change|0
5473841|NCT01912612|18924741|P3|Overall Study|Withdrew consent|0
5473842|NCT01912612|18924742|P2|Overall Study|Withdrew consent|0
5473843|NCT01912612|18924743|P1|Overall Study|Withdrew consent|1
5473844|NCT01912612|18924741|P3|Overall Study|Adverse Event|0
5473845|NCT01912612|18924742|P2|Overall Study|Adverse Event|0
5473846|NCT01912612|18924743|P1|Overall Study|Adverse Event|4
5473847|NCT01912599|18924787|P2|Overall Study|Withdrawal by Subject|1
5473848|NCT01912599|18924788|P1|Overall Study|Withdrawal by Subject|0
5473849|NCT01912404|18924813|P2|Overall Study|Due to personal reasons|0
5473850|NCT01912404|18924814|P1|Overall Study|Due to personal reasons|1
5473851|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
5473852|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
5473853|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
5473854|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
5473855|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
5473856|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
5473857|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
5473858|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
5473859|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
5473860|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
5473861|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
5473862|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
5473863|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
5473864|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
5473865|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
5473866|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
5473867|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
5473868|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
5473869|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
5473870|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
5473871|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
5473872|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
5473873|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
5473874|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
5473875|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
5473876|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
5473877|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
5473878|NCT01912339|18924827|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
5473879|NCT01912339|18924828|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
5473880|NCT01912339|18924829|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
5473881|NCT01912339|18924827|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
5473882|NCT01912339|18924828|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
5473883|NCT01912339|18924829|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
5473884|NCT01912339|18924827|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
5473885|NCT01912339|18924828|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
5473886|NCT01912339|18924829|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
5473887|NCT01912339|18924827|P3|Blinded (0 to 3 Months)|Declined to participate|0
5473888|NCT01912339|18924828|P2|Blinded (0 to 3 Months)|Declined to participate|0
5473889|NCT01912339|18924829|P1|Blinded (0 to 3 Months)|Declined to participate|1
5473890|NCT01912287|18924846|P3|Overall Study|Scheduling/change in availability|8
5473891|NCT01912287|18924847|P2|Overall Study|Scheduling/change in availability|10
5473892|NCT01912287|18924848|P1|Overall Study|Scheduling/change in availability|17
5473893|NCT01912287|18924846|P3|Overall Study|Missed Assesment|1
5473894|NCT01912287|18924847|P2|Overall Study|Missed Assesment|1
5473895|NCT01912287|18924848|P1|Overall Study|Missed Assesment|1
5473896|NCT01912287|18924846|P3|Overall Study|Uknown reason - subject drop out|3
5473897|NCT01912287|18924847|P2|Overall Study|Uknown reason - subject drop out|7
5473898|NCT01912287|18924848|P1|Overall Study|Uknown reason - subject drop out|5
5473899|NCT01912287|18924846|P3|Overall Study|Lost Interest|0
5473900|NCT01912287|18924847|P2|Overall Study|Lost Interest|0
5473901|NCT01912287|18924848|P1|Overall Study|Lost Interest|1
5473902|NCT01912287|18924846|P3|Overall Study|Life circumstances|0
5473903|NCT01912287|18924847|P2|Overall Study|Life circumstances|2
5473904|NCT01912287|18924848|P1|Overall Study|Life circumstances|4
5473905|NCT01912287|18924846|P3|Overall Study|Felt treatment no longer needed|0
5473906|NCT01912287|18924847|P2|Overall Study|Felt treatment no longer needed|1
5473907|NCT01912287|18924848|P1|Overall Study|Felt treatment no longer needed|0
5473908|NCT01912287|18924846|P3|Overall Study|Dissatisfaction with assigned treatment|1
5473909|NCT01912287|18924847|P2|Overall Study|Dissatisfaction with assigned treatment|2
5473910|NCT01912287|18924848|P1|Overall Study|Dissatisfaction with assigned treatment|4
5473911|NCT01912287|18924846|P3|Overall Study|No-show|1
5473912|NCT01912287|18924847|P2|Overall Study|No-show|0
5473913|NCT01912287|18924848|P1|Overall Study|No-show|0
5473914|NCT01912287|18924846|P3|Overall Study|Ineligible|1
5473915|NCT01912287|18924847|P2|Overall Study|Ineligible|0
5473916|NCT01912287|18924848|P1|Overall Study|Ineligible|1
5473917|NCT01912222|18924859|P3|Part B: Treatment Period|Withdrawal by Subject|2
5473918|NCT01912222|18924860|P2|Part B: Treatment Period|Withdrawal by Subject|1
5473919|NCT01912222|18924861|P1|Part B: Treatment Period|Withdrawal by Subject|2
5473920|NCT01912222|18924859|P3|Part B: Treatment Period|Adverse Event|3
5473921|NCT01912222|18924860|P2|Part B: Treatment Period|Adverse Event|2
5473922|NCT01912222|18924861|P1|Part B: Treatment Period|Adverse Event|1
5473923|NCT01912222|18924859|P3|Part B: Treatment Period|Progressive disease|15
5473924|NCT01912222|18924860|P2|Part B: Treatment Period|Progressive disease|12
5473925|NCT01912222|18924861|P1|Part B: Treatment Period|Progressive disease|10
5473926|NCT01912222|18924859|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
5473927|NCT01912222|18924860|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
5473928|NCT01912222|18924861|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
5473929|NCT01911845|18924919|P1|Overall Study|Other (not specified)|3
5473930|NCT01911845|18924919|P1|Overall Study|Lost to Follow-up|1
5473931|NCT01911845|18924919|P1|Overall Study|Adverse Event|2
5473932|NCT01911819|18924936|P3|Overall Study|Withdrawal by Subject|0
5473933|NCT01911819|18924937|P2|Overall Study|Withdrawal by Subject|1
5473934|NCT01911819|18924938|P1|Overall Study|Withdrawal by Subject|1
5473935|NCT01911819|18924936|P3|Overall Study|Adverse Event|0
5473936|NCT01911819|18924937|P2|Overall Study|Adverse Event|1
5473937|NCT01911819|18924938|P1|Overall Study|Adverse Event|0
5473938|NCT01911793|18924951|P2|Overall Study|Physician Decision|5
5473939|NCT01911793|18924952|P1|Overall Study|Physician Decision|1
5473940|NCT01911780|18924976|P2|Extension Period (52 Weeks)|Personal reason|1
5473941|NCT01911780|18924977|P1|Extension Period (52 Weeks)|Personal reason|1
5473942|NCT01911780|18924976|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
5473943|NCT01911780|18924977|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
5473944|NCT01911780|18924976|P2|Extension Period (52 Weeks)|Adverse Event|0
5473945|NCT01911780|18924977|P1|Extension Period (52 Weeks)|Adverse Event|3
5473946|NCT01911780|18924976|P2|Double-blind Period (8 Weeks)|Personal reason|0
5473947|NCT01911780|18924977|P1|Double-blind Period (8 Weeks)|Personal reason|1
5473948|NCT01911780|18924976|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
5473949|NCT01911780|18924977|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
5473950|NCT01911780|18924976|P2|Double-blind Period (8 Weeks)|Adverse Event|2
5473951|NCT01911780|18924977|P1|Double-blind Period (8 Weeks)|Adverse Event|1
5473952|NCT01911546|18925011|P1|Overall Study|Everolimus was discontinued|5
5473953|NCT01911546|18925011|P1|Overall Study|Lost to Follow-up|1
5473954|NCT01911442|18925021|P3|Overall Study|Mother's Work Schedule|0
5473955|NCT01911442|18925022|P2|Overall Study|Mother's Work Schedule|1
5473956|NCT01911442|18925023|P1|Overall Study|Mother's Work Schedule|0
5473957|NCT01911442|18925021|P3|Overall Study|Withdrawal by Subject|6
5473958|NCT01911442|18925022|P2|Overall Study|Withdrawal by Subject|0
5473959|NCT01911442|18925023|P1|Overall Study|Withdrawal by Subject|1
5473960|NCT01911442|18925021|P3|Overall Study|Lost to Follow-up|1
5473961|NCT01911442|18925022|P2|Overall Study|Lost to Follow-up|0
5473962|NCT01911442|18925023|P1|Overall Study|Lost to Follow-up|2
5473963|NCT01911442|18925021|P3|Overall Study|Lack of Efficacy|1
5473964|NCT01911442|18925022|P2|Overall Study|Lack of Efficacy|1
5473965|NCT01911442|18925023|P1|Overall Study|Lack of Efficacy|1
5473966|NCT01911442|18925021|P3|Overall Study|Adverse Event|4
5473967|NCT01911442|18925022|P2|Overall Study|Adverse Event|2
5473968|NCT01911442|18925023|P1|Overall Study|Adverse Event|2
5473969|NCT01911429|18925052|P3|Overall Study|subject left study|0
5473970|NCT01911429|18925053|P2|Overall Study|subject left study|0
5473971|NCT01911429|18925054|P1|Overall Study|subject left study|1
5473972|NCT01911429|18925052|P3|Overall Study|Accidental randomization|1
5473973|NCT01911429|18925053|P2|Overall Study|Accidental randomization|0
5473974|NCT01911429|18925054|P1|Overall Study|Accidental randomization|0
5473975|NCT01911429|18925052|P3|Overall Study|Withdrawal by Subject|4
5473976|NCT01911429|18925053|P2|Overall Study|Withdrawal by Subject|5
5473977|NCT01911429|18925054|P1|Overall Study|Withdrawal by Subject|5
5473978|NCT01911429|18925052|P3|Overall Study|Protocol Violation|1
5473979|NCT01911429|18925053|P2|Overall Study|Protocol Violation|0
5473980|NCT01911429|18925054|P1|Overall Study|Protocol Violation|0
5473981|NCT01911429|18925052|P3|Overall Study|Lost to Follow-up|1
5473982|NCT01911429|18925053|P2|Overall Study|Lost to Follow-up|0
5473983|NCT01911429|18925054|P1|Overall Study|Lost to Follow-up|0
5473984|NCT01911429|18925052|P3|Overall Study|Lack of Efficacy|4
5473985|NCT01911429|18925053|P2|Overall Study|Lack of Efficacy|2
5473986|NCT01911429|18925054|P1|Overall Study|Lack of Efficacy|1
5473987|NCT01911429|18925052|P3|Overall Study|Adverse Event|9
5473988|NCT01911429|18925053|P2|Overall Study|Adverse Event|3
5473989|NCT01911429|18925054|P1|Overall Study|Adverse Event|5
5473990|NCT01911273|18925146|P2|Overall Study|Withdrawal by Subject|2
5473991|NCT01911273|18925147|P1|Overall Study|Withdrawal by Subject|0
5473992|NCT01911273|18925146|P2|Overall Study|Progression of Disease|0
5473993|NCT01911273|18925147|P1|Overall Study|Progression of Disease|1
5473994|NCT01911260|18925181|P4|Follow-up Period|transference or evasion of school|12
5473995|NCT01911260|18925182|P3|Follow-up Period|transference or evasion of school|15
5473996|NCT01911260|18925183|P2|Follow-up Period|transference or evasion of school|20
5473997|NCT01911260|18925184|P1|Follow-up Period|transference or evasion of school|13
5473998|NCT01911260|18925181|P4|Supplementation Period|less than 12 weeks supplementation|2
5473999|NCT01911260|18925182|P3|Supplementation Period|less than 12 weeks supplementation|1
5474000|NCT01911260|18925183|P2|Supplementation Period|less than 12 weeks supplementation|3
5474087|NCT01910116|18925493|P2|Overall Study|Adverse Event|3
5474001|NCT01911260|18925184|P1|Supplementation Period|less than 12 weeks supplementation|0
5474002|NCT01911260|18925181|P4|Supplementation Period|refused to receive supplement|0
5474003|NCT01911260|18925182|P3|Supplementation Period|refused to receive supplement|1
5474004|NCT01911260|18925183|P2|Supplementation Period|refused to receive supplement|0
5474005|NCT01911260|18925184|P1|Supplementation Period|refused to receive supplement|1
5474006|NCT01911260|18925181|P4|Supplementation Period|Adverse Event|0
5474007|NCT01911260|18925182|P3|Supplementation Period|Adverse Event|1
5474008|NCT01911260|18925183|P2|Supplementation Period|Adverse Event|0
5474009|NCT01911260|18925184|P1|Supplementation Period|Adverse Event|2
5474010|NCT01911260|18925181|P4|Supplementation Period|transference or evasion of school|6
5474011|NCT01911260|18925182|P3|Supplementation Period|transference or evasion of school|7
5474012|NCT01911260|18925183|P2|Supplementation Period|transference or evasion of school|9
5474013|NCT01911260|18925184|P1|Supplementation Period|transference or evasion of school|7
5474014|NCT01910519|18925270|P2|Overall Study|Adverse Event|0
5474015|NCT01910519|18925271|P1|Overall Study|Adverse Event|2
5474016|NCT01910519|18925270|P2|Overall Study|Withdrawal by Subject|0
5474017|NCT01910519|18925271|P1|Overall Study|Withdrawal by Subject|2
5474018|NCT01910441|18925297|P2|Overall Study|Physician Decision|1
5474019|NCT01910441|18925298|P1|Overall Study|Physician Decision|0
5474020|NCT01910441|18925297|P2|Overall Study|Adverse Event|0
5474021|NCT01910441|18925298|P1|Overall Study|Adverse Event|1
5474022|NCT01910441|18925297|P2|Overall Study|Non-compliance|1
5474023|NCT01910441|18925298|P1|Overall Study|Non-compliance|0
5474024|NCT01910441|18925297|P2|Overall Study|Withdrawal by Subject|1
5474025|NCT01910441|18925298|P1|Overall Study|Withdrawal by Subject|0
5474026|NCT01910441|18925297|P2|Overall Study|Lost to Follow-up|5
5474027|NCT01910441|18925298|P1|Overall Study|Lost to Follow-up|6
5474028|NCT01910441|18925297|P2|Overall Study|Sponsor decision|2
5474029|NCT01910441|18925298|P1|Overall Study|Sponsor decision|0
5474030|NCT01910402|18925306|P2|Continuation Phase|Withdrawal by Subject|0
5474031|NCT01910402|18925307|P1|Continuation Phase|Withdrawal by Subject|2
5474032|NCT01910402|18925306|P2|Continuation Phase|Protocol Violation|0
5474033|NCT01910402|18925307|P1|Continuation Phase|Protocol Violation|3
5474034|NCT01910402|18925306|P2|Continuation Phase|Adverse Event|0
5474035|NCT01910402|18925307|P1|Continuation Phase|Adverse Event|1
5474036|NCT01910402|18925306|P2|Continuation Phase|Ongoing|0
5474037|NCT01910402|18925307|P1|Continuation Phase|Ongoing|84
5474038|NCT01910402|18925306|P2|Randomized Phase|Withdrawal by Subject|7
5474039|NCT01910402|18925307|P1|Randomized Phase|Withdrawal by Subject|5
5474040|NCT01910402|18925306|P2|Randomized Phase|Protocol Violation|13
5474041|NCT01910402|18925307|P1|Randomized Phase|Protocol Violation|10
5474042|NCT01910402|18925306|P2|Randomized Phase|Lost to Follow-up|13
5474043|NCT01910402|18925307|P1|Randomized Phase|Lost to Follow-up|11
5474044|NCT01910402|18925306|P2|Randomized Phase|Lack of Efficacy|4
5474045|NCT01910402|18925307|P1|Randomized Phase|Lack of Efficacy|5
5474046|NCT01910402|18925306|P2|Randomized Phase|Physician Decision|0
5474047|NCT01910402|18925307|P1|Randomized Phase|Physician Decision|1
5474048|NCT01910402|18925306|P2|Randomized Phase|Adverse Event|18
5474049|NCT01910402|18925307|P1|Randomized Phase|Adverse Event|10
5474050|NCT01910389|18925377|P2|Overall Study|Study Closed|8
5474051|NCT01910389|18925378|P1|Overall Study|Study Closed|13
5474052|NCT01910389|18925377|P2|Overall Study|Withdrawal by Subject|0
5474053|NCT01910389|18925378|P1|Overall Study|Withdrawal by Subject|2
5474054|NCT01910298|18925421|P2|Overall Study|Other Miscellaneous Reasons|2
5474055|NCT01910298|18925422|P1|Overall Study|Other Miscellaneous Reasons|0
5474056|NCT01910298|18925421|P2|Overall Study|Study Terminated by Sponsor|17
5474057|NCT01910298|18925422|P1|Overall Study|Study Terminated by Sponsor|1
5474058|NCT01910298|18925421|P2|Overall Study|Lost to Follow-up|1
5474059|NCT01910298|18925422|P1|Overall Study|Lost to Follow-up|1
5474060|NCT01910298|18925421|P2|Overall Study|Protocol Deviation|5
5474061|NCT01910298|18925422|P1|Overall Study|Protocol Deviation|0
5474062|NCT01910298|18925421|P2|Overall Study|Withdrawal by Subject|7
5474063|NCT01910298|18925422|P1|Overall Study|Withdrawal by Subject|2
5474064|NCT01910298|18925421|P2|Overall Study|Adverse Event|0
5474065|NCT01910298|18925422|P1|Overall Study|Adverse Event|1
5474066|NCT01910181|18925440|P1|Overall Study|Study Terminated by Sponsor|6
5474067|NCT01910181|18925440|P1|Overall Study|Lost to Follow-up|3
5474068|NCT01910181|18925440|P1|Overall Study|Death|37
5474069|NCT01910129|18925467|P3|Randomized Phase 3|Withdrawal by Subject|0
5474070|NCT01910129|18925468|P2|Randomized Phase 3|Withdrawal by Subject|1
5474071|NCT01910129|18925469|P1|Randomized Phase 3|Withdrawal by Subject|0
5474072|NCT01910129|18925467|P3|Randomized Phase 2|Withdrawal by Subject|0
5474073|NCT01910129|18925468|P2|Randomized Phase 2|Withdrawal by Subject|1
5474074|NCT01910129|18925469|P1|Randomized Phase 2|Withdrawal by Subject|2
5474075|NCT01910116|18925493|P2|Overall Study|incomplete data|1
5474076|NCT01910116|18925494|P1|Overall Study|incomplete data|0
5474077|NCT01910116|18925493|P2|Overall Study|uncertain allocation|3
5474078|NCT01910116|18925494|P1|Overall Study|uncertain allocation|1
5474079|NCT01910116|18925493|P2|Overall Study|Withdrawal by Subject|3
5474080|NCT01910116|18925494|P1|Overall Study|Withdrawal by Subject|8
5474081|NCT01910116|18925493|P2|Overall Study|Protocol Violation|2
5474082|NCT01910116|18925494|P1|Overall Study|Protocol Violation|1
5474083|NCT01910116|18925493|P2|Overall Study|Lost to Follow-up|0
5474084|NCT01910116|18925494|P1|Overall Study|Lost to Follow-up|1
5474085|NCT01910116|18925493|P2|Overall Study|Lack of Efficacy|4
5474086|NCT01910116|18925494|P1|Overall Study|Lack of Efficacy|3
5474088|NCT01910116|18925494|P1|Overall Study|Adverse Event|0
5474089|NCT01909973|18925581|P2|Overall Study|Lost to Follow-up|0
5474090|NCT01909973|18925582|P1|Overall Study|Lost to Follow-up|1
5474091|NCT01909804|18925602|P12|Overall Study|Protocol Violation|1
5474092|NCT01909804|18925603|P11|Overall Study|Protocol Violation|0
5474093|NCT01909804|18925604|P10|Overall Study|Protocol Violation|0
5474094|NCT01909804|18925605|P9|Overall Study|Protocol Violation|0
5474095|NCT01909804|18925606|P8|Overall Study|Protocol Violation|0
5474096|NCT01909804|18925607|P7|Overall Study|Protocol Violation|0
5474097|NCT01909804|18925608|P6|Overall Study|Protocol Violation|0
5474098|NCT01909804|18925609|P5|Overall Study|Protocol Violation|0
5474099|NCT01909804|18925610|P4|Overall Study|Protocol Violation|0
5474100|NCT01909804|18925611|P3|Overall Study|Protocol Violation|0
5474101|NCT01909804|18925612|P2|Overall Study|Protocol Violation|0
5474102|NCT01909804|18925613|P1|Overall Study|Protocol Violation|0
5474103|NCT01909804|18925602|P12|Overall Study|Withdrew Consent|0
5474104|NCT01909804|18925603|P11|Overall Study|Withdrew Consent|0
5474105|NCT01909804|18925604|P10|Overall Study|Withdrew Consent|0
5474106|NCT01909804|18925605|P9|Overall Study|Withdrew Consent|0
5474107|NCT01909804|18925606|P8|Overall Study|Withdrew Consent|0
5474108|NCT01909804|18925607|P7|Overall Study|Withdrew Consent|0
5474109|NCT01909804|18925608|P6|Overall Study|Withdrew Consent|1
5474110|NCT01909804|18925609|P5|Overall Study|Withdrew Consent|1
5474111|NCT01909804|18925610|P4|Overall Study|Withdrew Consent|0
5474112|NCT01909804|18925611|P3|Overall Study|Withdrew Consent|0
5474113|NCT01909804|18925612|P2|Overall Study|Withdrew Consent|0
5474114|NCT01909804|18925613|P1|Overall Study|Withdrew Consent|0
5474115|NCT01909804|18925602|P12|Overall Study|Lack of Efficacy|1
5474116|NCT01909804|18925603|P11|Overall Study|Lack of Efficacy|0
5474117|NCT01909804|18925604|P10|Overall Study|Lack of Efficacy|1
5474118|NCT01909804|18925605|P9|Overall Study|Lack of Efficacy|0
5474119|NCT01909804|18925606|P8|Overall Study|Lack of Efficacy|1
5474120|NCT01909804|18925607|P7|Overall Study|Lack of Efficacy|1
5474121|NCT01909804|18925608|P6|Overall Study|Lack of Efficacy|3
5474122|NCT01909804|18925609|P5|Overall Study|Lack of Efficacy|7
5474123|NCT01909804|18925610|P4|Overall Study|Lack of Efficacy|0
5474124|NCT01909804|18925611|P3|Overall Study|Lack of Efficacy|0
5474125|NCT01909804|18925612|P2|Overall Study|Lack of Efficacy|1
5474126|NCT01909804|18925613|P1|Overall Study|Lack of Efficacy|4
5474127|NCT01909804|18925602|P12|Overall Study|Death|0
5474128|NCT01909804|18925603|P11|Overall Study|Death|1
5474129|NCT01909804|18925604|P10|Overall Study|Death|0
5474130|NCT01909804|18925605|P9|Overall Study|Death|0
5474131|NCT01909804|18925606|P8|Overall Study|Death|0
5474132|NCT01909804|18925607|P7|Overall Study|Death|0
5474133|NCT01909804|18925608|P6|Overall Study|Death|0
5474134|NCT01909804|18925609|P5|Overall Study|Death|0
5474135|NCT01909804|18925610|P4|Overall Study|Death|0
5474136|NCT01909804|18925611|P3|Overall Study|Death|0
5474137|NCT01909804|18925612|P2|Overall Study|Death|0
5474138|NCT01909804|18925613|P1|Overall Study|Death|0
5474139|NCT01909804|18925602|P12|Overall Study|Randomized but Never Treated|1
5474140|NCT01909804|18925603|P11|Overall Study|Randomized but Never Treated|0
5474141|NCT01909804|18925604|P10|Overall Study|Randomized but Never Treated|0
5474142|NCT01909804|18925605|P9|Overall Study|Randomized but Never Treated|0
5474143|NCT01909804|18925606|P8|Overall Study|Randomized but Never Treated|0
5474144|NCT01909804|18925607|P7|Overall Study|Randomized but Never Treated|1
5474145|NCT01909804|18925608|P6|Overall Study|Randomized but Never Treated|0
5474146|NCT01909804|18925609|P5|Overall Study|Randomized but Never Treated|0
5474147|NCT01909804|18925610|P4|Overall Study|Randomized but Never Treated|0
5474148|NCT01909804|18925611|P3|Overall Study|Randomized but Never Treated|0
5474149|NCT01909804|18925612|P2|Overall Study|Randomized but Never Treated|0
5474150|NCT01909804|18925613|P1|Overall Study|Randomized but Never Treated|0
5474151|NCT01909791|18925662|P3|Overall Study|Missed Visit|1
5474152|NCT01909791|18925663|P2|Overall Study|Missed Visit|0
5474153|NCT01909791|18925664|P1|Overall Study|Missed Visit|2
5474154|NCT01909791|18925662|P3|Overall Study|Lost to Follow-up|10
5474155|NCT01909791|18925663|P2|Overall Study|Lost to Follow-up|11
5474156|NCT01909791|18925664|P1|Overall Study|Lost to Follow-up|5
5474157|NCT01909791|18925662|P3|Overall Study|Withdrawal by Subject|13
5474158|NCT01909791|18925663|P2|Overall Study|Withdrawal by Subject|9
5474159|NCT01909791|18925664|P1|Overall Study|Withdrawal by Subject|5
5474160|NCT01909791|18925662|P3|Overall Study|Death|4
5474161|NCT01909791|18925663|P2|Overall Study|Death|8
5474162|NCT01909791|18925664|P1|Overall Study|Death|9
5474163|NCT01909778|18925722|P1|Overall Study|failed screening|1
5474164|NCT01909674|18925801|P2|Overall Study|Withdrawal by Subject|2
5474165|NCT01909674|18925802|P1|Overall Study|Withdrawal by Subject|5
5474166|NCT01909466|18925821|P2|Overall Study|Lack of Efficacy|0
5474167|NCT01909466|18925822|P1|Overall Study|Lack of Efficacy|1
5474168|NCT01909466|18925821|P2|Overall Study|Withdrawal by Subject|9
5474169|NCT01909466|18925822|P1|Overall Study|Withdrawal by Subject|11
5474170|NCT01909466|18925821|P2|Overall Study|Physician Decision|0
5474171|NCT01909466|18925822|P1|Overall Study|Physician Decision|2
5474172|NCT01909466|18925821|P2|Overall Study|Met Withdrawal Criteria|3
5474173|NCT01909466|18925822|P1|Overall Study|Met Withdrawal Criteria|0
5474174|NCT01909466|18925821|P2|Overall Study|Adverse Event|4
5474175|NCT01909466|18925822|P1|Overall Study|Adverse Event|3
5474176|NCT01909466|18925821|P2|Overall Study|Lost to Follow-up|7
5474177|NCT01909466|18925822|P1|Overall Study|Lost to Follow-up|5
5474178|NCT01909336|18925845|P3|Overall Study|Physician Decision|1
5474179|NCT01909336|18925846|P2|Overall Study|Physician Decision|1
5474180|NCT01909336|18925847|P1|Overall Study|Physician Decision|0
5474181|NCT01909336|18925845|P3|Overall Study|Lost to Follow-up|2
5474182|NCT01909336|18925846|P2|Overall Study|Lost to Follow-up|2
5474183|NCT01909336|18925847|P1|Overall Study|Lost to Follow-up|4
5474184|NCT01908907|18925945|P2|Overall Study|Protocol Violation|0
5474185|NCT01908907|18925946|P1|Overall Study|Protocol Violation|1
5474186|NCT01908907|18925945|P2|Overall Study|Physician Decision|0
5474187|NCT01908907|18925946|P1|Overall Study|Physician Decision|1
5474188|NCT01908829|18925990|P3|Overall Study|Withdrawal by Subject|22
5474189|NCT01908829|18925991|P2|Overall Study|Withdrawal by Subject|29
5474190|NCT01908829|18925992|P1|Overall Study|Withdrawal by Subject|26
5474191|NCT01908829|18925990|P3|Overall Study|Lack of Efficacy|2
5474192|NCT01908829|18925991|P2|Overall Study|Lack of Efficacy|3
5474193|NCT01908829|18925992|P1|Overall Study|Lack of Efficacy|1
5474194|NCT01908829|18925990|P3|Overall Study|Protocol Violation|0
5474195|NCT01908829|18925991|P2|Overall Study|Protocol Violation|2
5474196|NCT01908829|18925992|P1|Overall Study|Protocol Violation|2
5474197|NCT01908829|18925990|P3|Overall Study|Miscellaneous|0
5474198|NCT01908829|18925991|P2|Overall Study|Miscellaneous|2
5474199|NCT01908829|18925992|P1|Overall Study|Miscellaneous|0
5474200|NCT01908829|18925990|P3|Overall Study|Discontinued (no EoT page)|0
5474201|NCT01908829|18925991|P2|Overall Study|Discontinued (no EoT page)|0
5474202|NCT01908829|18925992|P1|Overall Study|Discontinued (no EoT page)|2
5474203|NCT01908829|18925990|P3|Overall Study|Randomized no double-blind drug received|1
5474204|NCT01908829|18925991|P2|Overall Study|Randomized no double-blind drug received|0
5474205|NCT01908829|18925992|P1|Overall Study|Randomized no double-blind drug received|1
5474206|NCT01908829|18925990|P3|Overall Study|Lost to Follow-up|1
5474207|NCT01908829|18925991|P2|Overall Study|Lost to Follow-up|2
5474208|NCT01908829|18925992|P1|Overall Study|Lost to Follow-up|4
5474209|NCT01908829|18925990|P3|Overall Study|Adverse Event|13
5474210|NCT01908829|18925991|P2|Overall Study|Adverse Event|11
5474211|NCT01908829|18925992|P1|Overall Study|Adverse Event|13
5474212|NCT01908816|18926109|P4|Overall Study|Early termination|28
5474213|NCT01908816|18926110|P3|Overall Study|Early termination|43
5474214|NCT01908816|18926111|P2|Overall Study|Early termination|60
5474215|NCT01908816|18926112|P1|Overall Study|Early termination|87
5474216|NCT01908816|18926109|P4|Overall Study|Unsatisfactory therapeutic effect|0
5474217|NCT01908816|18926110|P3|Overall Study|Unsatisfactory therapeutic effect|1
5474218|NCT01908816|18926111|P2|Overall Study|Unsatisfactory therapeutic effect|13
5474219|NCT01908816|18926112|P1|Overall Study|Unsatisfactory therapeutic effect|1
5474220|NCT01908816|18926109|P4|Overall Study|Death|1
5474221|NCT01908816|18926110|P3|Overall Study|Death|7
5474222|NCT01908816|18926111|P2|Overall Study|Death|0
5474223|NCT01908816|18926112|P1|Overall Study|Death|1
5474224|NCT01908816|18926109|P4|Overall Study|Lost to Follow-up|2
5474225|NCT01908816|18926110|P3|Overall Study|Lost to Follow-up|4
5474226|NCT01908816|18926111|P2|Overall Study|Lost to Follow-up|5
5474227|NCT01908816|18926112|P1|Overall Study|Lost to Follow-up|3
5474228|NCT01908816|18926109|P4|Overall Study|Withdrawal by Subject|2
5474229|NCT01908816|18926110|P3|Overall Study|Withdrawal by Subject|2
5474230|NCT01908816|18926111|P2|Overall Study|Withdrawal by Subject|4
5474231|NCT01908816|18926112|P1|Overall Study|Withdrawal by Subject|0
5474232|NCT01908816|18926109|P4|Overall Study|Protocol deviation|1
5474233|NCT01908816|18926110|P3|Overall Study|Protocol deviation|1
5474234|NCT01908816|18926111|P2|Overall Study|Protocol deviation|2
5474235|NCT01908816|18926112|P1|Overall Study|Protocol deviation|1
5474236|NCT01908816|18926109|P4|Overall Study|Subject's no longer requires study drug|1
5474237|NCT01908816|18926110|P3|Overall Study|Subject's no longer requires study drug|0
5474238|NCT01908816|18926111|P2|Overall Study|Subject's no longer requires study drug|0
5474239|NCT01908816|18926112|P1|Overall Study|Subject's no longer requires study drug|0
5474240|NCT01908803|18926137|P2|Overall Study|Adverse Event (pre-treatment)|0
5474241|NCT01908803|18926138|P1|Overall Study|Adverse Event (pre-treatment)|1
5474242|NCT01908803|18926137|P2|Overall Study|Randomization Error|0
5474243|NCT01908803|18926138|P1|Overall Study|Randomization Error|1
5474244|NCT01908803|18926137|P2|Overall Study|Withdrawal by Subject|0
5474245|NCT01908803|18926138|P1|Overall Study|Withdrawal by Subject|1
5474246|NCT01908803|18926137|P2|Overall Study|Physician Decision|1
5474247|NCT01908803|18926138|P1|Overall Study|Physician Decision|0
5474248|NCT01908803|18926137|P2|Overall Study|Adverse Event|0
5474249|NCT01908803|18926138|P1|Overall Study|Adverse Event|1
5474250|NCT01908699|18926192|P2|Overall Study|Progressive Disease|29
5474251|NCT01908699|18926193|P1|Overall Study|Progressive Disease|30
5474252|NCT01908699|18926192|P2|Overall Study|Death|12
5474253|NCT01908699|18926193|P1|Overall Study|Death|9
5474254|NCT01908699|18926192|P2|Overall Study|Randomized in Error|0
5474255|NCT01908699|18926193|P1|Overall Study|Randomized in Error|1
5474256|NCT01908699|18926192|P2|Overall Study|Pregnancy|1
5474257|NCT01908699|18926193|P1|Overall Study|Pregnancy|0
5474258|NCT01908699|18926192|P2|Overall Study|Withdrawal by Subject|10
5474259|NCT01908699|18926193|P1|Overall Study|Withdrawal by Subject|15
5474260|NCT01908699|18926192|P2|Overall Study|Physician Decision|8
5474261|NCT01908699|18926193|P1|Overall Study|Physician Decision|8
5474262|NCT01908699|18926192|P2|Overall Study|Lost to Follow-up|4
5474263|NCT01908699|18926193|P1|Overall Study|Lost to Follow-up|2
5474264|NCT01908699|18926192|P2|Overall Study|Lack of Efficacy|2
5474265|NCT01908699|18926193|P1|Overall Study|Lack of Efficacy|2
5474266|NCT01908699|18926192|P2|Overall Study|Adverse Event|12
5474267|NCT01908699|18926193|P1|Overall Study|Adverse Event|8
5474268|NCT01908582|18926209|P1|Period 2|Withdrawal by Subject|1
5474269|NCT01908582|18926209|P1|Period 2|Physician Decision|1
5474270|NCT01908426|18926253|P2|Overall Study|No Study Treatment Given|0
5474271|NCT01908426|18926254|P1|Overall Study|No Study Treatment Given|3
5474272|NCT01908426|18926253|P2|Overall Study|Protocol Violation|0
5474273|NCT01908426|18926254|P1|Overall Study|Protocol Violation|1
5474274|NCT01908426|18926253|P2|Overall Study|Progressive Disease|152
5474275|NCT01908426|18926254|P1|Overall Study|Progressive Disease|206
5474276|NCT01908426|18926253|P2|Overall Study|Withdrawal by Subject|6
5474277|NCT01908426|18926254|P1|Overall Study|Withdrawal by Subject|11
5474278|NCT01908426|18926253|P2|Overall Study|Physician Decision|3
5474279|NCT01908426|18926254|P1|Overall Study|Physician Decision|3
5474280|NCT01908426|18926253|P2|Overall Study|Lost to Follow-up|1
5474281|NCT01908426|18926254|P1|Overall Study|Lost to Follow-up|0
5474282|NCT01908426|18926253|P2|Overall Study|Lack of Efficacy|0
5474283|NCT01908426|18926254|P1|Overall Study|Lack of Efficacy|3
5474284|NCT01908426|18926253|P2|Overall Study|Clinical Deterioration|38
5474285|NCT01908426|18926254|P1|Overall Study|Clinical Deterioration|72
5474286|NCT01908426|18926253|P2|Overall Study|Adverse Event|11
5474287|NCT01908426|18926254|P1|Overall Study|Adverse Event|98
5474288|NCT01908205|18926266|P2|Overall Study|Withdrawal by Subject|1
5474289|NCT01908205|18926267|P1|Overall Study|Withdrawal by Subject|3
5474290|NCT01908205|18926266|P2|Overall Study|Lost to Follow-up|0
5474291|NCT01908205|18926267|P1|Overall Study|Lost to Follow-up|2
5474292|NCT01908140|18926295|P2|Overall Study|Adverse Event|23
5474293|NCT01908140|18926296|P1|Overall Study|Adverse Event|22
5474294|NCT01908140|18926295|P2|Overall Study|Protocol Violation|9
5474295|NCT01908140|18926296|P1|Overall Study|Protocol Violation|8
5474296|NCT01908140|18926295|P2|Overall Study|Lost to Follow-up|6
5474297|NCT01908140|18926296|P1|Overall Study|Lost to Follow-up|1
5474298|NCT01908140|18926295|P2|Overall Study|Withdrawal by Subject|24
5474299|NCT01908140|18926296|P1|Overall Study|Withdrawal by Subject|23
5474300|NCT01908140|18926295|P2|Overall Study|Lack of Efficacy|5
5474301|NCT01908140|18926296|P1|Overall Study|Lack of Efficacy|7
5474302|NCT01908140|18926295|P2|Overall Study|Other or Progressive Disease|12
5474303|NCT01908140|18926296|P1|Overall Study|Other or Progressive Disease|5
5474304|NCT01908101|18926315|P1|Overall Study|Did not complete the first cycle|4
5474305|NCT01908101|18926315|P1|Overall Study|Incorrect Starting Dose|1
5474306|NCT01908101|18926315|P1|Overall Study|Incorrect Diagnosis|2
5474307|NCT01908101|18926315|P1|Overall Study|Withdrawal by Subject|1
5474308|NCT01908101|18926315|P1|Overall Study|Physician Decision|1
5474309|NCT01907906|18926349|P2|Overall Study|Physician Decision|1
5474310|NCT01907906|18926350|P1|Overall Study|Physician Decision|3
5474311|NCT01907906|18926349|P2|Overall Study|Withdrawal by Subject|0
5474312|NCT01907906|18926350|P1|Overall Study|Withdrawal by Subject|1
5474313|NCT01907854|18926430|P2|Overall Study|Unclassified|3
5474314|NCT01907854|18926431|P1|Overall Study|Unclassified|4
5474315|NCT01907854|18926430|P2|Overall Study|Lost to Follow-up|2
5474316|NCT01907854|18926431|P1|Overall Study|Lost to Follow-up|2
5474317|NCT01907854|18926430|P2|Overall Study|Withdrawal by Subject|7
5474318|NCT01907854|18926431|P1|Overall Study|Withdrawal by Subject|9
5474319|NCT01907854|18926430|P2|Overall Study|Protocol Violation|1
5474320|NCT01907854|18926431|P1|Overall Study|Protocol Violation|1
5474321|NCT01907828|18926451|P2|Overall Study|Participant met exclusion criteria|1
5474322|NCT01907828|18926452|P1|Overall Study|Participant met exclusion criteria|0
5474323|NCT01907828|18926451|P2|Overall Study|Participant refused 24-month follow-up|0
5474324|NCT01907828|18926452|P1|Overall Study|Participant refused 24-month follow-up|1
5474325|NCT01907828|18926451|P2|Overall Study|Lost to Follow-up|0
5474326|NCT01907828|18926452|P1|Overall Study|Lost to Follow-up|3
5474327|NCT01907828|18926451|P2|Overall Study|Withdrawal by Subject|4
5474328|NCT01907828|18926452|P1|Overall Study|Withdrawal by Subject|3
5474329|NCT01907828|18926451|P2|Overall Study|Exclusion criteria not met|1
5474330|NCT01907828|18926452|P1|Overall Study|Exclusion criteria not met|0
5474331|NCT01907815|18926480|P2|Overall Study|Withdrawal by Subject|0
5474332|NCT01907815|18926481|P1|Overall Study|Withdrawal by Subject|1
5474333|NCT01907737|18926495|P1|Overall Study|Withdrawal by Subject|1
5474334|NCT01907516|18926507|P2|First Intervention (3 Weeks)|Developed DKA during study|0
5474335|NCT01907516|18926508|P1|First Intervention (3 Weeks)|Developed DKA during study|1
5474336|NCT01907516|18926507|P2|First Intervention (3 Weeks)|Delivered before second arm|4
5474337|NCT01907516|18926508|P1|First Intervention (3 Weeks)|Delivered before second arm|3
5474338|NCT01907516|18926507|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
5474339|NCT01907516|18926508|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
5474340|NCT01907516|18926507|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
5474341|NCT01907516|18926508|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
5474342|NCT01907217|18926552|P2|Overall Study|Withdrawal by Subject|2
5474343|NCT01907217|18926553|P1|Overall Study|Withdrawal by Subject|0
5474344|NCT01907100|18926665|P4|Overall Study|Worsening/AE underlying cancer disease|8
5474345|NCT01907100|18926666|P3|Overall Study|Worsening/AE underlying cancer disease|8
5474346|NCT01907100|18926667|P2|Overall Study|Worsening/AE underlying cancer disease|0
5474347|NCT01907100|18926668|P1|Overall Study|Worsening/AE underlying cancer disease|0
5474348|NCT01907100|18926665|P4|Overall Study|Adverse event (AE)|23
5474349|NCT01907100|18926666|P3|Overall Study|Adverse event (AE)|22
5474350|NCT01907100|18926667|P2|Overall Study|Adverse event (AE)|3
5474351|NCT01907100|18926668|P1|Overall Study|Adverse event (AE)|6
5474352|NCT01907100|18926665|P4|Overall Study|Other than reasons specified|6
5474353|NCT01907100|18926666|P3|Overall Study|Other than reasons specified|10
5474354|NCT01907100|18926667|P2|Overall Study|Other than reasons specified|0
5474355|NCT01907100|18926668|P1|Overall Study|Other than reasons specified|1
5474356|NCT01907100|18926665|P4|Overall Study|Not treated|2
5474357|NCT01907100|18926666|P3|Overall Study|Not treated|1
5474358|NCT01907100|18926667|P2|Overall Study|Not treated|0
5474359|NCT01907100|18926668|P1|Overall Study|Not treated|2
5474360|NCT01907100|18926665|P4|Overall Study|Lost to Follow-up|1
5474361|NCT01907100|18926666|P3|Overall Study|Lost to Follow-up|0
5474362|NCT01907100|18926667|P2|Overall Study|Lost to Follow-up|0
5474363|NCT01907100|18926668|P1|Overall Study|Lost to Follow-up|0
5474364|NCT01907100|18926665|P4|Overall Study|Protocol Violation|1
5474365|NCT01907100|18926666|P3|Overall Study|Protocol Violation|1
5474366|NCT01907100|18926667|P2|Overall Study|Protocol Violation|0
5474367|NCT01907100|18926668|P1|Overall Study|Protocol Violation|0
5474368|NCT01907100|18926665|P4|Overall Study|Withdrawal by Subject|13
5474369|NCT01907100|18926666|P3|Overall Study|Withdrawal by Subject|10
5474370|NCT01907100|18926667|P2|Overall Study|Withdrawal by Subject|5
5474371|NCT01907100|18926668|P1|Overall Study|Withdrawal by Subject|2
5474372|NCT01907100|18926665|P4|Overall Study|PD based on modified RECIST criteria|92
5474373|NCT01907100|18926666|P3|Overall Study|PD based on modified RECIST criteria|95
5474374|NCT01907100|18926667|P2|Overall Study|PD based on modified RECIST criteria|32
5474375|NCT01907100|18926668|P1|Overall Study|PD based on modified RECIST criteria|31
5474376|NCT01907087|18926682|P1|Overall Study|Withdrawal by Subject|1
5474377|NCT01906476|18926745|P2|Overall Study|Lost to Follow-up|16
5474378|NCT01906476|18926746|P1|Overall Study|Lost to Follow-up|17
5474379|NCT01906372|18926754|P1|Overall Study|Withdrawal by Subject|2
5474380|NCT01906346|18926759|P1|Overall Study|AEs|1
5474381|NCT01906008|18926767|P2|Overall Study|Adverse Event|3
5474382|NCT01906008|18926768|P1|Overall Study|Adverse Event|0
5474383|NCT01906008|18926767|P2|Overall Study|Lack of compliance of study med|3
5474384|NCT01906008|18926768|P1|Overall Study|Lack of compliance of study med|5
5474385|NCT01906008|18926767|P2|Overall Study|Physician Decision|3
5474386|NCT01906008|18926768|P1|Overall Study|Physician Decision|3
5474387|NCT01906008|18926767|P2|Overall Study|Hospice|0
5474388|NCT01906008|18926768|P1|Overall Study|Hospice|1
5474389|NCT01906008|18926767|P2|Overall Study|Oxaliplatin stops|8
5474390|NCT01906008|18926768|P1|Overall Study|Oxaliplatin stops|10
5474391|NCT01906008|18926767|P2|Overall Study|Did not start study med|4
5474392|NCT01906008|18926768|P1|Overall Study|Did not start study med|3
5474393|NCT01906008|18926767|P2|Overall Study|Withdrawal by Subject|5
5474394|NCT01906008|18926768|P1|Overall Study|Withdrawal by Subject|1
5474395|NCT01906008|18926767|P2|Overall Study|Protocol Violation|1
5474396|NCT01906008|18926768|P1|Overall Study|Protocol Violation|0
5474397|NCT01906008|18926767|P2|Overall Study|Oxaliplatin toxicity|0
5474398|NCT01906008|18926768|P1|Overall Study|Oxaliplatin toxicity|2
5474399|NCT01906008|18926767|P2|Overall Study|Lost to Follow-up|0
5474400|NCT01906008|18926768|P1|Overall Study|Lost to Follow-up|2
5474401|NCT01905943|18926801|P1|Overall Study|Other|12
5474402|NCT01905943|18926801|P1|Overall Study|Adverse Event|3
5474403|NCT01905943|18926801|P1|Overall Study|Death|186
5474404|NCT01905943|18926801|P1|Overall Study|Investigator discretion|7
5474405|NCT01905943|18926801|P1|Overall Study|Lost to Follow-up|16
5474406|NCT01905943|18926801|P1|Overall Study|Withdrawal of consent|90
5474407|NCT01905683|18926918|P1|Overall Study|Lost to Follow-up|4
5474408|NCT01905683|18926918|P1|Overall Study|Adverse Event|4
5474409|NCT01905683|18926918|P1|Overall Study|Withdrawal by Subject|20
5474410|NCT01905683|18926918|P1|Overall Study|Lack of Efficacy|8
5474411|NCT01905683|18926918|P1|Overall Study|Physician Decision|1
5474412|NCT01905683|18926918|P1|Overall Study|Re-injection criteria not met; others|13
5474413|NCT01905683|18926918|P1|Overall Study|Protocol Violation|1
5474414|NCT01905657|18926934|P3|Overall Study|Excluded from Efficacy Analysis|0
5474415|NCT01905657|18926935|P2|Overall Study|Excluded from Efficacy Analysis|0
5474416|NCT01905657|18926936|P1|Overall Study|Excluded from Efficacy Analysis|1
5474417|NCT01905657|18926934|P3|Overall Study|Continuing in Study|11
5474418|NCT01905657|18926935|P2|Overall Study|Continuing in Study|74
5474419|NCT01905657|18926936|P1|Overall Study|Continuing in Study|74
5474420|NCT01905657|18926934|P3|Overall Study|Withdrawal by Subject|45
5474421|NCT01905657|18926935|P2|Overall Study|Withdrawal by Subject|10
5474422|NCT01905657|18926936|P1|Overall Study|Withdrawal by Subject|5
5474423|NCT01905657|18926934|P3|Overall Study|Protocol Violation|1
5474424|NCT01905657|18926935|P2|Overall Study|Protocol Violation|1
5474425|NCT01905657|18926936|P1|Overall Study|Protocol Violation|2
5474426|NCT01905657|18926934|P3|Overall Study|Progressive Disease|89
5474427|NCT01905657|18926935|P2|Overall Study|Progressive Disease|126
5474428|NCT01905657|18926936|P1|Overall Study|Progressive Disease|124
5474429|NCT01905657|18926934|P3|Overall Study|Physician Decision|113
5474430|NCT01905657|18926935|P2|Overall Study|Physician Decision|74
5474431|NCT01905657|18926936|P1|Overall Study|Physician Decision|82
5474432|NCT01905657|18926934|P3|Overall Study|Other|1
5474433|NCT01905657|18926935|P2|Overall Study|Other|7
5474434|NCT01905657|18926936|P1|Overall Study|Other|3
5474435|NCT01905657|18926934|P3|Overall Study|Death|21
5474436|NCT01905657|18926935|P2|Overall Study|Death|21
5474437|NCT01905657|18926936|P1|Overall Study|Death|21
5474438|NCT01905657|18926934|P3|Overall Study|Adverse Event|47
5474439|NCT01905657|18926935|P2|Overall Study|Adverse Event|32
5474440|NCT01905657|18926936|P1|Overall Study|Adverse Event|33
5474441|NCT01905657|18926934|P3|Overall Study|Not Treated|0
5474442|NCT01905657|18926935|P2|Overall Study|Not Treated|1
5474443|NCT01905657|18926936|P1|Overall Study|Not Treated|0
5474444|NCT01905592|18926961|P2|Overall Study|Withdrawal by Subject|2
5474445|NCT01905592|18926962|P1|Overall Study|Withdrawal by Subject|10
5474446|NCT01905592|18926961|P2|Overall Study|Ongoing in Study|7
5474447|NCT01905592|18926962|P1|Overall Study|Ongoing in Study|0
5474448|NCT01905592|18926961|P2|Overall Study|Not treated|3
5474449|NCT01905592|18926962|P1|Overall Study|Not treated|7
5474450|NCT01905592|18926961|P2|Overall Study|Sponsor's decision|0
5474451|NCT01905592|18926962|P1|Overall Study|Sponsor's decision|1
5474452|NCT01905592|18926961|P2|Overall Study|Protocol Violation|1
5474453|NCT01905592|18926962|P1|Overall Study|Protocol Violation|0
5474454|NCT01905592|18926961|P2|Overall Study|New anti-cancer|0
5474455|NCT01905592|18926962|P1|Overall Study|New anti-cancer|1
5474456|NCT01905592|18926961|P2|Overall Study|Physician Decision|2
5474457|NCT01905592|18926962|P1|Overall Study|Physician Decision|0
5474458|NCT01905592|18926961|P2|Overall Study|Toxicity|16
5474459|NCT01905592|18926962|P1|Overall Study|Toxicity|1
5474460|NCT01905592|18926961|P2|Overall Study|Disease Progression|104
5474461|NCT01905592|18926962|P1|Overall Study|Disease Progression|51
5474462|NCT01905553|18926976|P2|Period 2|Adverse Event|0
5474463|NCT01905553|18926977|P1|Period 2|Adverse Event|1
5474464|NCT01905540|18926991|P4|Period 3|Other|1
5474465|NCT01905540|18926992|P3|Period 3|Other|1
5474466|NCT01905540|18926993|P2|Period 3|Other|0
5474467|NCT01905540|18926994|P1|Period 3|Other|1
5474468|NCT01905267|18927060|P2|Overall Study|Physician Decision|2
5474469|NCT01905267|18927061|P1|Overall Study|Physician Decision|2
5474470|NCT01904773|18927082|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5474471|NCT01904773|18927083|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5474472|NCT01904773|18927084|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5474473|NCT01904773|18927085|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5474474|NCT01904773|18927086|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5474475|NCT01904773|18927087|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5474476|NCT01904773|18927088|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5474477|NCT01904773|18927089|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
5474478|NCT01904773|18927090|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
5474479|NCT01904773|18927082|P9|Fifth Intervention|Adverse Event|0
5474480|NCT01904773|18927083|P8|Fifth Intervention|Adverse Event|1
5474481|NCT01904773|18927084|P7|Fifth Intervention|Adverse Event|0
5474482|NCT01904773|18927085|P6|Fifth Intervention|Adverse Event|0
5474483|NCT01904773|18927086|P5|Fifth Intervention|Adverse Event|0
5474484|NCT01904773|18927087|P4|Fifth Intervention|Adverse Event|0
5474485|NCT01904773|18927088|P3|Fifth Intervention|Adverse Event|0
5474486|NCT01904773|18927089|P2|Fifth Intervention|Adverse Event|0
5474487|NCT01904773|18927090|P1|Fifth Intervention|Adverse Event|0
5474488|NCT01904773|18927082|P9|Placebo Washout First Intervention|Condition worsened|0
5474489|NCT01904773|18927083|P8|Placebo Washout First Intervention|Condition worsened|0
5474490|NCT01904773|18927084|P7|Placebo Washout First Intervention|Condition worsened|0
5474491|NCT01904773|18927085|P6|Placebo Washout First Intervention|Condition worsened|0
5474492|NCT01904773|18927086|P5|Placebo Washout First Intervention|Condition worsened|0
5474493|NCT01904773|18927087|P4|Placebo Washout First Intervention|Condition worsened|0
5474494|NCT01904773|18927088|P3|Placebo Washout First Intervention|Condition worsened|0
5474495|NCT01904773|18927089|P2|Placebo Washout First Intervention|Condition worsened|1
5474496|NCT01904773|18927090|P1|Placebo Washout First Intervention|Condition worsened|0
5474497|NCT01904773|18927082|P9|First Intervention|Adverse Event|0
5474498|NCT01904773|18927083|P8|First Intervention|Adverse Event|0
5474499|NCT01904773|18927084|P7|First Intervention|Adverse Event|1
5474500|NCT01904773|18927085|P6|First Intervention|Adverse Event|0
5474501|NCT01904773|18927086|P5|First Intervention|Adverse Event|0
5474502|NCT01904773|18927087|P4|First Intervention|Adverse Event|0
5474503|NCT01904773|18927088|P3|First Intervention|Adverse Event|0
5474504|NCT01904773|18927089|P2|First Intervention|Adverse Event|0
5474505|NCT01904773|18927090|P1|First Intervention|Adverse Event|0
5474506|NCT01904773|18927082|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5474507|NCT01904773|18927083|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5474508|NCT01904773|18927084|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5474509|NCT01904773|18927085|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5474510|NCT01904773|18927086|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5474511|NCT01904773|18927087|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5474512|NCT01904773|18927088|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5474513|NCT01904773|18927089|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
5474514|NCT01904773|18927090|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
5474515|NCT01904773|18927082|P9|Screen|Withdrawal by Subject|0
5474516|NCT01904773|18927083|P8|Screen|Withdrawal by Subject|0
5474517|NCT01904773|18927084|P7|Screen|Withdrawal by Subject|0
5474518|NCT01904773|18927085|P6|Screen|Withdrawal by Subject|0
5474519|NCT01904773|18927086|P5|Screen|Withdrawal by Subject|0
5474520|NCT01904773|18927087|P4|Screen|Withdrawal by Subject|0
5474521|NCT01904773|18927088|P3|Screen|Withdrawal by Subject|0
5474522|NCT01904773|18927089|P2|Screen|Withdrawal by Subject|0
5474523|NCT01904773|18927090|P1|Screen|Withdrawal by Subject|1
5474524|NCT01904773|18927082|P9|Screen|Screen failure|0
5474525|NCT01904773|18927083|P8|Screen|Screen failure|0
5474526|NCT01904773|18927084|P7|Screen|Screen failure|0
5474527|NCT01904773|18927085|P6|Screen|Screen failure|0
5474528|NCT01904773|18927086|P5|Screen|Screen failure|0
5474529|NCT01904773|18927087|P4|Screen|Screen failure|0
5474530|NCT01904773|18927088|P3|Screen|Screen failure|0
5474531|NCT01904773|18927089|P2|Screen|Screen failure|0
5474532|NCT01904773|18927090|P1|Screen|Screen failure|3
5474533|NCT01904760|18927107|P2|Overall Study|Protocol Violation|0
5474534|NCT01904760|18927108|P1|Overall Study|Protocol Violation|1
5474535|NCT01904721|18927123|P7|Overall Study|Adverse Event|0
5474536|NCT01904721|18927124|P6|Overall Study|Adverse Event|1
5474537|NCT01904721|18927125|P5|Overall Study|Adverse Event|3
5474538|NCT01904721|18927126|P4|Overall Study|Adverse Event|0
5474539|NCT01904721|18927127|P3|Overall Study|Adverse Event|0
5474540|NCT01904721|18927128|P2|Overall Study|Adverse Event|0
5474541|NCT01904721|18927129|P1|Overall Study|Adverse Event|0
5474542|NCT01904721|18927123|P7|Overall Study|Lack of Efficacy|1
5474543|NCT01904721|18927124|P6|Overall Study|Lack of Efficacy|0
5474544|NCT01904721|18927125|P5|Overall Study|Lack of Efficacy|0
5474545|NCT01904721|18927126|P4|Overall Study|Lack of Efficacy|0
5474546|NCT01904721|18927127|P3|Overall Study|Lack of Efficacy|0
5474547|NCT01904721|18927128|P2|Overall Study|Lack of Efficacy|0
5474548|NCT01904721|18927129|P1|Overall Study|Lack of Efficacy|0
5474549|NCT01904721|18927123|P7|Overall Study|Lost to Follow-up|1
5474550|NCT01904721|18927124|P6|Overall Study|Lost to Follow-up|3
5474551|NCT01904721|18927125|P5|Overall Study|Lost to Follow-up|1
5474552|NCT01904721|18927126|P4|Overall Study|Lost to Follow-up|0
5474553|NCT01904721|18927127|P3|Overall Study|Lost to Follow-up|0
5474554|NCT01904721|18927128|P2|Overall Study|Lost to Follow-up|0
5474555|NCT01904721|18927129|P1|Overall Study|Lost to Follow-up|0
5474556|NCT01904721|18927123|P7|Overall Study|Personal Reasons|3
5474557|NCT01904721|18927124|P6|Overall Study|Personal Reasons|3
5474558|NCT01904721|18927125|P5|Overall Study|Personal Reasons|2
5474559|NCT01904721|18927126|P4|Overall Study|Personal Reasons|0
5474560|NCT01904721|18927127|P3|Overall Study|Personal Reasons|0
5474561|NCT01904721|18927128|P2|Overall Study|Personal Reasons|0
5474562|NCT01904721|18927129|P1|Overall Study|Personal Reasons|0
5474563|NCT01904721|18927123|P7|Overall Study|Other Reasons|2
5474564|NCT01904721|18927124|P6|Overall Study|Other Reasons|2
5474565|NCT01904721|18927125|P5|Overall Study|Other Reasons|2
5474566|NCT01904721|18927126|P4|Overall Study|Other Reasons|1
5474567|NCT01904721|18927127|P3|Overall Study|Other Reasons|1
5474568|NCT01904721|18927128|P2|Overall Study|Other Reasons|0
5474569|NCT01904721|18927129|P1|Overall Study|Other Reasons|0
5474570|NCT01904604|18927159|P3|Overall Study|Lost to Follow-up|1
5474571|NCT01904604|18927160|P2|Overall Study|Lost to Follow-up|0
5474572|NCT01904604|18927161|P1|Overall Study|Lost to Follow-up|0
5474573|NCT01904604|18927159|P3|Overall Study|Participant Relocated|1
5474574|NCT01904604|18927160|P2|Overall Study|Participant Relocated|1
5474575|NCT01904604|18927161|P1|Overall Study|Participant Relocated|1
5474576|NCT01904604|18927159|P3|Overall Study|Withdrawal by Subject|0
5474577|NCT01904604|18927160|P2|Overall Study|Withdrawal by Subject|2
5474578|NCT01904604|18927161|P1|Overall Study|Withdrawal by Subject|1
5474579|NCT01904604|18927159|P3|Overall Study|Passed Week 52 OFC|0
5474580|NCT01904604|18927160|P2|Overall Study|Passed Week 52 OFC|0
5474581|NCT01904604|18927161|P1|Overall Study|Passed Week 52 OFC|1
5474582|NCT01904604|18927159|P3|Overall Study|Unrelated illness|0
5474583|NCT01904604|18927160|P2|Overall Study|Unrelated illness|1
5474584|NCT01904604|18927161|P1|Overall Study|Unrelated illness|0
5474585|NCT01904604|18927159|P3|Overall Study|Increased syncope|0
5474586|NCT01904604|18927160|P2|Overall Study|Increased syncope|1
5474587|NCT01904604|18927161|P1|Overall Study|Increased syncope|0
5474588|NCT01904604|18927159|P3|Overall Study|Patch site reactions|0
5474589|NCT01904604|18927160|P2|Overall Study|Patch site reactions|1
5474590|NCT01904604|18927161|P1|Overall Study|Patch site reactions|1
5474591|NCT01904604|18927159|P3|Overall Study|Anxiety about OFC/Refused OFC|0
5474592|NCT01904604|18927160|P2|Overall Study|Anxiety about OFC/Refused OFC|0
5474593|NCT01904604|18927161|P1|Overall Study|Anxiety about OFC/Refused OFC|2
5474594|NCT01904604|18927159|P3|Overall Study|Non-compliance|0
5474595|NCT01904604|18927160|P2|Overall Study|Non-compliance|0
5474596|NCT01904604|18927161|P1|Overall Study|Non-compliance|1
5474597|NCT01904604|18927159|P3|Overall Study|Withdrew before receiving dosing|0
5474598|NCT01904604|18927160|P2|Overall Study|Withdrew before receiving dosing|1
5474599|NCT01904604|18927161|P1|Overall Study|Withdrew before receiving dosing|0
5474600|NCT01904383|18927226|P1|Overall Study|No patient visit after entry|54
5474601|NCT01904383|18927226|P1|Overall Study|Adverse Event|271
5474602|NCT01904383|18927226|P1|Overall Study|Improvement|141
5474603|NCT01904383|18927226|P1|Overall Study|Lack of Efficacy|370
5474604|NCT01904383|18927226|P1|Overall Study|Lost to Follow-up|674
5474605|NCT01904383|18927226|P1|Overall Study|Reason not listed|147
5474606|NCT01904383|18927226|P1|Overall Study|CRF not collected|117
5474607|NCT01904279|18927233|P2|Overall Study|Withdrawal by Subject|0
5474608|NCT01904279|18927234|P1|Overall Study|Withdrawal by Subject|1
5474609|NCT01904279|18927233|P2|Overall Study|Lack of Efficacy|3
5474610|NCT01904279|18927234|P1|Overall Study|Lack of Efficacy|2
5474611|NCT01904149|18927260|P6|Overall Study|non compliance with study drug|0
5474612|NCT01904149|18927261|P5|Overall Study|non compliance with study drug|0
5474613|NCT01904149|18927262|P4|Overall Study|non compliance with study drug|0
5474614|NCT01904149|18927263|P3|Overall Study|non compliance with study drug|0
5474615|NCT01904149|18927264|P2|Overall Study|non compliance with study drug|0
5474616|NCT01904149|18927265|P1|Overall Study|non compliance with study drug|1
5474617|NCT01904149|18927260|P6|Overall Study|Protocol Violation|0
5474618|NCT01904149|18927261|P5|Overall Study|Protocol Violation|0
5474619|NCT01904149|18927262|P4|Overall Study|Protocol Violation|0
5474620|NCT01904149|18927263|P3|Overall Study|Protocol Violation|0
5474621|NCT01904149|18927264|P2|Overall Study|Protocol Violation|1
5474622|NCT01904149|18927265|P1|Overall Study|Protocol Violation|0
5474623|NCT01904149|18927260|P6|Overall Study|Withdrawal by Subject|0
5474624|NCT01904149|18927261|P5|Overall Study|Withdrawal by Subject|1
5474625|NCT01904149|18927262|P4|Overall Study|Withdrawal by Subject|0
5474626|NCT01904149|18927263|P3|Overall Study|Withdrawal by Subject|1
5474627|NCT01904149|18927264|P2|Overall Study|Withdrawal by Subject|3
5474628|NCT01904149|18927265|P1|Overall Study|Withdrawal by Subject|1
5474629|NCT01904149|18927260|P6|Overall Study|Lack of Efficacy|1
5474630|NCT01904149|18927261|P5|Overall Study|Lack of Efficacy|3
5474631|NCT01904149|18927262|P4|Overall Study|Lack of Efficacy|3
5474632|NCT01904149|18927263|P3|Overall Study|Lack of Efficacy|1
5474633|NCT01904149|18927264|P2|Overall Study|Lack of Efficacy|3
5474634|NCT01904149|18927265|P1|Overall Study|Lack of Efficacy|0
5474635|NCT01904149|18927260|P6|Overall Study|Adverse Event|2
5474636|NCT01904149|18927261|P5|Overall Study|Adverse Event|1
5474637|NCT01904149|18927262|P4|Overall Study|Adverse Event|1
5474638|NCT01904149|18927263|P3|Overall Study|Adverse Event|0
5474639|NCT01904149|18927264|P2|Overall Study|Adverse Event|4
5474640|NCT01904149|18927265|P1|Overall Study|Adverse Event|3
5474641|NCT01904058|18927316|P4|Overall Study|Pregnancy|1
5474642|NCT01904058|18927317|P3|Overall Study|Pregnancy|0
5474643|NCT01904058|18927318|P2|Overall Study|Pregnancy|0
5474644|NCT01904058|18927319|P1|Overall Study|Pregnancy|0
5474645|NCT01904058|18927316|P4|Overall Study|Withdrawal by Subject|0
5474646|NCT01904058|18927317|P3|Overall Study|Withdrawal by Subject|1
5474647|NCT01904058|18927318|P2|Overall Study|Withdrawal by Subject|0
5474648|NCT01904058|18927319|P1|Overall Study|Withdrawal by Subject|1
5474649|NCT01904058|18927316|P4|Overall Study|Adverse Event|0
5474650|NCT01904058|18927317|P3|Overall Study|Adverse Event|0
5474651|NCT01904058|18927318|P2|Overall Study|Adverse Event|0
5474652|NCT01904058|18927319|P1|Overall Study|Adverse Event|2
5474653|NCT01903993|18927359|P2|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
5474654|NCT01903993|18927360|P1|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
5474655|NCT01903993|18927359|P2|Overall Study|Study Terminated by Sponsor|14
5474656|NCT01903993|18927360|P1|Overall Study|Study Terminated by Sponsor|8
5474657|NCT01903993|18927359|P2|Overall Study|Lost to Follow-up|3
5474658|NCT01903993|18927360|P1|Overall Study|Lost to Follow-up|2
5474659|NCT01903993|18927359|P2|Overall Study|Withdrawal by Subject|4
5474660|NCT01903993|18927360|P1|Overall Study|Withdrawal by Subject|15
5474661|NCT01903993|18927359|P2|Overall Study|Death|121
5474662|NCT01903993|18927360|P1|Overall Study|Death|118
5474663|NCT01903876|18927377|P2|Six-Month Follow-up Period|Lost to Follow-up|145
5474664|NCT01903876|18927378|P1|Six-Month Follow-up Period|Lost to Follow-up|91
5474665|NCT01903876|18927377|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
5474666|NCT01903876|18927378|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
5474667|NCT01903863|18927388|P2|Overall Study|Physician Decision|0
5474668|NCT01903863|18927389|P1|Overall Study|Physician Decision|2
5474669|NCT01903811|18927411|P2|Overall Study|Withdrawal by Subject|1
5474670|NCT01903811|18927412|P1|Overall Study|Withdrawal by Subject|0
5474671|NCT01903811|18927411|P2|Overall Study|Baseline lab missing/incomplete/untimely|11
5474672|NCT01903811|18927412|P1|Overall Study|Baseline lab missing/incomplete/untimely|6
5474673|NCT01903811|18927411|P2|Overall Study|Incomplete/discontinued prior therapy|1
5474674|NCT01903811|18927412|P1|Overall Study|Incomplete/discontinued prior therapy|1
5474675|NCT01903811|18927411|P2|Overall Study|No measurable disease|1
5474676|NCT01903811|18927412|P1|Overall Study|No measurable disease|1
5474677|NCT01903720|18927446|P1|Overall Study|Treatment with alternative drug|1
5474678|NCT01903720|18927446|P1|Overall Study|Lost to Follow-up|2
5474679|NCT01903720|18927446|P1|Overall Study|Rescinding of informed consent|2
5474680|NCT01903720|18927446|P1|Overall Study|Adverse Event|1
5474681|NCT01903720|18927446|P1|Overall Study|Inclusion / exclusion criteria not met|6
5474682|NCT01903460|18927484|P4|Overall Study|Adverse Event|1
5474683|NCT01903460|18927485|P3|Overall Study|Adverse Event|0
5474684|NCT01903460|18927486|P2|Overall Study|Adverse Event|0
5474685|NCT01903460|18927487|P1|Overall Study|Adverse Event|0
5474686|NCT01903434|18927504|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
5474687|NCT01903434|18927505|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
5474688|NCT01903434|18927504|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
5474689|NCT01903434|18927505|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
5474690|NCT01903356|18927513|P1|Overall Study|Violated the dosage and administration|3
5474691|NCT01903356|18927513|P1|Overall Study|Violated inclusion/exclusion criteria|5
5474692|NCT01903356|18927513|P1|Overall Study|Lost to Follow-up|7
5474693|NCT01903252|18927540|P6|Maintenance, Open-Label|Other|2
5474694|NCT01903252|18927541|P5|Maintenance, Open-Label|Other|6
5474695|NCT01903252|18927542|P4|Maintenance, Open-Label|Other|2
5474696|NCT01903252|18927543|P3|Maintenance, Open-Label|Other|0
5474697|NCT01903252|18927544|P2|Maintenance, Open-Label|Other|0
5474698|NCT01903252|18927545|P1|Maintenance, Open-Label|Other|0
5474699|NCT01903252|18927540|P6|Maintenance, Open-Label|Withdrawal by Subject|2
5474700|NCT01903252|18927541|P5|Maintenance, Open-Label|Withdrawal by Subject|6
5474701|NCT01903252|18927542|P4|Maintenance, Open-Label|Withdrawal by Subject|1
5474702|NCT01903252|18927543|P3|Maintenance, Open-Label|Withdrawal by Subject|0
5474703|NCT01903252|18927544|P2|Maintenance, Open-Label|Withdrawal by Subject|0
5474704|NCT01903252|18927545|P1|Maintenance, Open-Label|Withdrawal by Subject|0
5474705|NCT01903252|18927540|P6|Maintenance, Open-Label|Adverse Event|14
5474706|NCT01903252|18927541|P5|Maintenance, Open-Label|Adverse Event|9
5474707|NCT01903252|18927542|P4|Maintenance, Open-Label|Adverse Event|3
5474708|NCT01903252|18927543|P3|Maintenance, Open-Label|Adverse Event|0
5474709|NCT01903252|18927544|P2|Maintenance, Open-Label|Adverse Event|0
5474710|NCT01903252|18927545|P1|Maintenance, Open-Label|Adverse Event|0
5474711|NCT01903252|18927540|P6|Extended Induction, Open-Label|Physician Decision|0
5474712|NCT01903252|18927541|P5|Extended Induction, Open-Label|Physician Decision|0
5474713|NCT01903252|18927542|P4|Extended Induction, Open-Label|Physician Decision|0
5474714|NCT01903252|18927543|P3|Extended Induction, Open-Label|Physician Decision|1
5474715|NCT01903252|18927544|P2|Extended Induction, Open-Label|Physician Decision|0
5474716|NCT01903252|18927545|P1|Extended Induction, Open-Label|Physician Decision|0
5474717|NCT01903252|18927540|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
5474718|NCT01903252|18927541|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
5474719|NCT01903252|18927542|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
5474720|NCT01903252|18927543|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
5474721|NCT01903252|18927544|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
5474722|NCT01903252|18927545|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
5474723|NCT01903252|18927540|P6|Extended Induction, Open-Label|Adverse Event|0
5474724|NCT01903252|18927541|P5|Extended Induction, Open-Label|Adverse Event|0
5474725|NCT01903252|18927542|P4|Extended Induction, Open-Label|Adverse Event|0
5474726|NCT01903252|18927543|P3|Extended Induction, Open-Label|Adverse Event|17
5474727|NCT01903252|18927544|P2|Extended Induction, Open-Label|Adverse Event|0
5474728|NCT01903252|18927545|P1|Extended Induction, Open-Label|Adverse Event|0
5474729|NCT01903252|18927540|P6|Double-Blind Induction|non-compliance,|0
5474730|NCT01903252|18927541|P5|Double-Blind Induction|non-compliance,|0
5474731|NCT01903252|18927542|P4|Double-Blind Induction|non-compliance,|0
5474732|NCT01903252|18927543|P3|Double-Blind Induction|non-compliance,|0
5474733|NCT01903252|18927544|P2|Double-Blind Induction|non-compliance,|7
5474734|NCT01903252|18927545|P1|Double-Blind Induction|non-compliance,|7
5474735|NCT01903252|18927540|P6|Double-Blind Induction|Physician Decision|0
5474736|NCT01903252|18927541|P5|Double-Blind Induction|Physician Decision|0
5474737|NCT01903252|18927542|P4|Double-Blind Induction|Physician Decision|0
5474738|NCT01903252|18927543|P3|Double-Blind Induction|Physician Decision|0
5474739|NCT01903252|18927544|P2|Double-Blind Induction|Physician Decision|3
5474740|NCT01903252|18927545|P1|Double-Blind Induction|Physician Decision|2
5474741|NCT01903252|18927540|P6|Double-Blind Induction|Withdrawal by Subject|0
5474742|NCT01903252|18927541|P5|Double-Blind Induction|Withdrawal by Subject|0
5474743|NCT01903252|18927542|P4|Double-Blind Induction|Withdrawal by Subject|0
5474744|NCT01903252|18927543|P3|Double-Blind Induction|Withdrawal by Subject|0
5474745|NCT01903252|18927544|P2|Double-Blind Induction|Withdrawal by Subject|13
5474746|NCT01903252|18927545|P1|Double-Blind Induction|Withdrawal by Subject|10
5474747|NCT01903252|18927540|P6|Double-Blind Induction|Adverse Event|0
5474748|NCT01903252|18927541|P5|Double-Blind Induction|Adverse Event|0
5474749|NCT01903252|18927542|P4|Double-Blind Induction|Adverse Event|0
5474750|NCT01903252|18927543|P3|Double-Blind Induction|Adverse Event|0
5474751|NCT01903252|18927544|P2|Double-Blind Induction|Adverse Event|18
5474752|NCT01903252|18927545|P1|Double-Blind Induction|Adverse Event|20
5474753|NCT01903031|18927658|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
5474754|NCT01903031|18927659|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
5474755|NCT01903031|18927660|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
5474756|NCT01903031|18927658|P3|Overall Study|Lost to Follow-up|1
5474757|NCT01903031|18927659|P2|Overall Study|Lost to Follow-up|0
5474758|NCT01903031|18927660|P1|Overall Study|Lost to Follow-up|0
5474759|NCT01903031|18927658|P3|Overall Study|Protocol Violation|2
5474760|NCT01903031|18927659|P2|Overall Study|Protocol Violation|0
5474761|NCT01903031|18927660|P1|Overall Study|Protocol Violation|0
5474762|NCT01903031|18927658|P3|Overall Study|Withdrawal by Subject|1
5474763|NCT01903031|18927659|P2|Overall Study|Withdrawal by Subject|1
5474764|NCT01903031|18927660|P1|Overall Study|Withdrawal by Subject|0
5474765|NCT01903031|18927658|P3|Overall Study|Adverse Event|0
5474766|NCT01903031|18927659|P2|Overall Study|Adverse Event|1
5474767|NCT01903031|18927660|P1|Overall Study|Adverse Event|0
5474768|NCT01903031|18927658|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
5474769|NCT01903031|18927659|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
5474770|NCT01903031|18927660|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
5474771|NCT01903031|18927658|P3|Overall Study|Not Able to Attend Clinic|0
5474772|NCT01903031|18927659|P2|Overall Study|Not Able to Attend Clinic|1
5474773|NCT01903031|18927660|P1|Overall Study|Not Able to Attend Clinic|1
5474774|NCT01902888|18927734|P1|Overall Study|Study Terminated|3
5474775|NCT01902628|18927748|P1|Overall Study|Lost to Follow-up|35
5474776|NCT01902628|18927748|P1|Overall Study|Adverse Event|41
5474777|NCT01902628|18927748|P1|Overall Study|Withdrawal of participant's consent|7
5474778|NCT01902303|18927776|P2|Overall Study|Did not develop a cold sore|19
5474779|NCT01902303|18927777|P1|Overall Study|Did not develop a cold sore|21
5474780|NCT01902303|18927776|P2|Overall Study|subject lost investigational product|1
5474781|NCT01902303|18927777|P1|Overall Study|subject lost investigational product|0
5474782|NCT01902303|18927776|P2|Overall Study|Protocol Violation|2
5474783|NCT01902303|18927777|P1|Overall Study|Protocol Violation|2
5474784|NCT01902303|18927776|P2|Overall Study|Lost to Follow-up|1
5474785|NCT01902303|18927777|P1|Overall Study|Lost to Follow-up|0
5474786|NCT01902303|18927776|P2|Overall Study|Adverse Event|1
5474787|NCT01902303|18927777|P1|Overall Study|Adverse Event|0
5474788|NCT01902173|18927791|P6|Phase 1 Triplet Regimen Cohort 4|Death|1
5474789|NCT01902173|18927792|P5|Phase 1 Triplet Regimen Cohort 4|Death|0
5474790|NCT01902173|18927793|P4|Phase 1 Triplet Regimen Cohort 4|Death|0
5474791|NCT01902173|18927794|P3|Phase 1 Triplet Regimen Cohort 4|Death|0
5474792|NCT01902173|18927795|P2|Phase 1 Triplet Regimen Cohort 4|Death|0
5474793|NCT01902173|18927796|P1|Phase 1 Triplet Regimen Cohort 4|Death|0
5474794|NCT01902173|18927791|P6|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
5474795|NCT01902173|18927792|P5|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5474796|NCT01902173|18927793|P4|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5474797|NCT01902173|18927794|P3|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5474798|NCT01902173|18927795|P2|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5474799|NCT01902173|18927796|P1|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
5474800|NCT01902173|18927791|P6|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
5474801|NCT01902173|18927792|P5|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5474802|NCT01902173|18927793|P4|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5474803|NCT01902173|18927794|P3|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5474804|NCT01902173|18927795|P2|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5474805|NCT01902173|18927796|P1|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
5474806|NCT01902173|18927791|P6|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5474807|NCT01902173|18927792|P5|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
5474808|NCT01902173|18927793|P4|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5474809|NCT01902173|18927794|P3|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5474810|NCT01902173|18927795|P2|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5474811|NCT01902173|18927796|P1|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
5474812|NCT01902173|18927791|P6|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5474813|NCT01902173|18927792|P5|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
5474814|NCT01902173|18927793|P4|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5474815|NCT01902173|18927794|P3|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5474816|NCT01902173|18927795|P2|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5474817|NCT01902173|18927796|P1|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
5474818|NCT01902173|18927791|P6|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5474819|NCT01902173|18927792|P5|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5474820|NCT01902173|18927793|P4|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
5474821|NCT01902173|18927794|P3|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5474822|NCT01902173|18927795|P2|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5474823|NCT01902173|18927796|P1|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
5474824|NCT01902173|18927791|P6|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5474825|NCT01902173|18927792|P5|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5474826|NCT01902173|18927793|P4|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
5474827|NCT01902173|18927794|P3|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5474828|NCT01902173|18927795|P2|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5474829|NCT01902173|18927796|P1|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
5474830|NCT01902173|18927791|P6|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5474831|NCT01902173|18927792|P5|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5474832|NCT01902173|18927793|P4|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5474833|NCT01902173|18927794|P3|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
5474834|NCT01902173|18927795|P2|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5474835|NCT01902173|18927796|P1|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
5474836|NCT01902173|18927791|P6|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5474837|NCT01902173|18927792|P5|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5474838|NCT01902173|18927793|P4|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5474839|NCT01902173|18927794|P3|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
5474840|NCT01902173|18927795|P2|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5474841|NCT01902173|18927796|P1|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
5474842|NCT01902173|18927791|P6|Phase 1 Doublet Regimen Cohort 2|No treated|0
5474843|NCT01902173|18927792|P5|Phase 1 Doublet Regimen Cohort 2|No treated|0
5474844|NCT01902173|18927793|P4|Phase 1 Doublet Regimen Cohort 2|No treated|0
5474845|NCT01902173|18927794|P3|Phase 1 Doublet Regimen Cohort 2|No treated|0
5474846|NCT01902173|18927795|P2|Phase 1 Doublet Regimen Cohort 2|No treated|3
5474847|NCT01902173|18927796|P1|Phase 1 Doublet Regimen Cohort 2|No treated|0
5474848|NCT01902173|18927791|P6|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5474849|NCT01902173|18927792|P5|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5474850|NCT01902173|18927793|P4|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5474851|NCT01902173|18927794|P3|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5474852|NCT01902173|18927795|P2|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
5474853|NCT01902173|18927796|P1|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
5474854|NCT01902173|18927791|P6|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5474855|NCT01902173|18927792|P5|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5474856|NCT01902173|18927793|P4|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5474857|NCT01902173|18927794|P3|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5474858|NCT01902173|18927795|P2|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
5474859|NCT01902173|18927796|P1|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
5474860|NCT01902173|18927791|P6|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5474861|NCT01902173|18927792|P5|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5474862|NCT01902173|18927793|P4|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5474863|NCT01902173|18927794|P3|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5474864|NCT01902173|18927795|P2|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
5474865|NCT01902173|18927796|P1|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
5474866|NCT01902173|18927791|P6|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5474867|NCT01902173|18927792|P5|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5474868|NCT01902173|18927793|P4|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5474869|NCT01902173|18927794|P3|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5474870|NCT01902173|18927795|P2|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
5474871|NCT01902173|18927796|P1|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
5474872|NCT01902134|18927819|P6|Overall Study|Other|0
5474873|NCT01902134|18927820|P5|Overall Study|Other|1
5474874|NCT01902134|18927821|P4|Overall Study|Other|0
5474875|NCT01902134|18927822|P3|Overall Study|Other|2
5474876|NCT01902134|18927823|P2|Overall Study|Other|1
5474877|NCT01902134|18927824|P1|Overall Study|Other|0
5474878|NCT01902134|18927819|P6|Overall Study|no compliance|0
5474879|NCT01902134|18927820|P5|Overall Study|no compliance|0
5474880|NCT01902134|18927821|P4|Overall Study|no compliance|0
5474881|NCT01902134|18927822|P3|Overall Study|no compliance|0
5474882|NCT01902134|18927823|P2|Overall Study|no compliance|0
5474883|NCT01902134|18927824|P1|Overall Study|no compliance|1
5474884|NCT01902134|18927819|P6|Overall Study|Withdrawal by Subject|4
5474885|NCT01902134|18927820|P5|Overall Study|Withdrawal by Subject|5
5474886|NCT01902134|18927821|P4|Overall Study|Withdrawal by Subject|1
5474887|NCT01902134|18927822|P3|Overall Study|Withdrawal by Subject|9
5474888|NCT01902134|18927823|P2|Overall Study|Withdrawal by Subject|8
5474889|NCT01902134|18927824|P1|Overall Study|Withdrawal by Subject|4
5474890|NCT01902134|18927819|P6|Overall Study|Protocol Violation|1
5474891|NCT01902134|18927820|P5|Overall Study|Protocol Violation|0
5474892|NCT01902134|18927821|P4|Overall Study|Protocol Violation|0
5474893|NCT01902134|18927822|P3|Overall Study|Protocol Violation|0
5474894|NCT01902134|18927823|P2|Overall Study|Protocol Violation|0
5474895|NCT01902134|18927824|P1|Overall Study|Protocol Violation|0
5474896|NCT01902134|18927819|P6|Overall Study|Physician Decision|0
5474897|NCT01902134|18927820|P5|Overall Study|Physician Decision|0
5474898|NCT01902134|18927821|P4|Overall Study|Physician Decision|0
5474899|NCT01902134|18927822|P3|Overall Study|Physician Decision|0
5474900|NCT01902134|18927823|P2|Overall Study|Physician Decision|1
5474901|NCT01902134|18927824|P1|Overall Study|Physician Decision|0
5474902|NCT01902134|18927819|P6|Overall Study|Lack of Efficacy|1
5474903|NCT01902134|18927820|P5|Overall Study|Lack of Efficacy|0
5474904|NCT01902134|18927821|P4|Overall Study|Lack of Efficacy|0
5474905|NCT01902134|18927822|P3|Overall Study|Lack of Efficacy|2
5474906|NCT01902134|18927823|P2|Overall Study|Lack of Efficacy|0
5474907|NCT01902134|18927824|P1|Overall Study|Lack of Efficacy|0
5474908|NCT01902134|18927819|P6|Overall Study|Adverse Event|3
5474909|NCT01902134|18927820|P5|Overall Study|Adverse Event|1
5474910|NCT01902134|18927821|P4|Overall Study|Adverse Event|1
5474911|NCT01902134|18927822|P3|Overall Study|Adverse Event|2
5474912|NCT01902134|18927823|P2|Overall Study|Adverse Event|1
5474913|NCT01902134|18927824|P1|Overall Study|Adverse Event|3
5474914|NCT01901874|18927861|P1|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
5474915|NCT01901874|18927861|P1|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
5474916|NCT01901874|18927861|P1|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
5474917|NCT01901874|18927861|P1|1-Year (365-Day) MAE Evaluation|Death|7
5474918|NCT01901874|18927861|P1|30-Day MAE Evaluation|Insufficient Follow-up|1
5474919|NCT01901874|18927861|P1|Screening Committee Retrospective Review|Protocol Violation|47
5474920|NCT01901848|18927876|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
5474921|NCT01901848|18927877|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
5474922|NCT01901848|18927876|P2|Randomized and Treated|Lost to Follow-up|6
5474923|NCT01901848|18927877|P1|Randomized and Treated|Lost to Follow-up|3
5474924|NCT01901653|18927919|P13|Overall Study|Alive at Study Termination by Sponsor|1
5474925|NCT01901653|18927920|P12|Overall Study|Alive at Study Termination by Sponsor|1
5474926|NCT01901653|18927921|P11|Overall Study|Alive at Study Termination by Sponsor|0
5474927|NCT01901653|18927922|P10|Overall Study|Alive at Study Termination by Sponsor|2
5474928|NCT01901653|18927923|P9|Overall Study|Alive at Study Termination by Sponsor|0
5474929|NCT01901653|18927924|P8|Overall Study|Alive at Study Termination by Sponsor|0
5474930|NCT01901653|18927925|P7|Overall Study|Alive at Study Termination by Sponsor|0
5474931|NCT01901653|18927926|P6|Overall Study|Alive at Study Termination by Sponsor|0
5474932|NCT01901653|18927927|P5|Overall Study|Alive at Study Termination by Sponsor|0
5474933|NCT01901653|18927928|P4|Overall Study|Alive at Study Termination by Sponsor|0
5474934|NCT01901653|18927929|P3|Overall Study|Alive at Study Termination by Sponsor|1
5474935|NCT01901653|18927930|P2|Overall Study|Alive at Study Termination by Sponsor|0
5474936|NCT01901653|18927931|P1|Overall Study|Alive at Study Termination by Sponsor|0
5474937|NCT01901653|18927919|P13|Overall Study|Withdrawal by Subject|0
5474938|NCT01901653|18927920|P12|Overall Study|Withdrawal by Subject|0
5474939|NCT01901653|18927921|P11|Overall Study|Withdrawal by Subject|0
5474940|NCT01901653|18927922|P10|Overall Study|Withdrawal by Subject|0
5474941|NCT01901653|18927923|P9|Overall Study|Withdrawal by Subject|0
5474942|NCT01901653|18927924|P8|Overall Study|Withdrawal by Subject|0
5474943|NCT01901653|18927925|P7|Overall Study|Withdrawal by Subject|1
5474944|NCT01901653|18927926|P6|Overall Study|Withdrawal by Subject|0
5474945|NCT01901653|18927927|P5|Overall Study|Withdrawal by Subject|0
5474946|NCT01901653|18927928|P4|Overall Study|Withdrawal by Subject|0
5474947|NCT01901653|18927929|P3|Overall Study|Withdrawal by Subject|0
5474948|NCT01901653|18927930|P2|Overall Study|Withdrawal by Subject|0
5474949|NCT01901653|18927931|P1|Overall Study|Withdrawal by Subject|0
5474950|NCT01901653|18927919|P13|Overall Study|Lost to Follow-up|0
5474951|NCT01901653|18927920|P12|Overall Study|Lost to Follow-up|0
5474952|NCT01901653|18927921|P11|Overall Study|Lost to Follow-up|0
5474953|NCT01901653|18927922|P10|Overall Study|Lost to Follow-up|0
5474954|NCT01901653|18927923|P9|Overall Study|Lost to Follow-up|0
5474955|NCT01901653|18927924|P8|Overall Study|Lost to Follow-up|1
5474956|NCT01901653|18927925|P7|Overall Study|Lost to Follow-up|0
5474957|NCT01901653|18927926|P6|Overall Study|Lost to Follow-up|1
5474958|NCT01901653|18927927|P5|Overall Study|Lost to Follow-up|0
5474959|NCT01901653|18927928|P4|Overall Study|Lost to Follow-up|0
5474960|NCT01901653|18927929|P3|Overall Study|Lost to Follow-up|2
5474961|NCT01901653|18927930|P2|Overall Study|Lost to Follow-up|0
5474962|NCT01901653|18927931|P1|Overall Study|Lost to Follow-up|1
5474963|NCT01901653|18927919|P13|Overall Study|Death|4
5474964|NCT01901653|18927920|P12|Overall Study|Death|15
5474965|NCT01901653|18927921|P11|Overall Study|Death|2
5474966|NCT01901653|18927922|P10|Overall Study|Death|16
5474967|NCT01901653|18927923|P9|Overall Study|Death|1
5474968|NCT01901653|18927924|P8|Overall Study|Death|9
5474969|NCT01901653|18927925|P7|Overall Study|Death|6
5474970|NCT01901653|18927926|P6|Overall Study|Death|2
5474971|NCT01901653|18927927|P5|Overall Study|Death|2
5474972|NCT01901653|18927928|P4|Overall Study|Death|3
5474973|NCT01901653|18927929|P3|Overall Study|Death|8
5474974|NCT01901653|18927930|P2|Overall Study|Death|1
5474975|NCT01901653|18927931|P1|Overall Study|Death|2
5474976|NCT01901614|18927975|P2|Overall Study|Screen Fail|0
5474977|NCT01901614|18927976|P1|Overall Study|Screen Fail|1
5474978|NCT01901614|18927975|P2|Overall Study|Lost to Follow-up|0
5474979|NCT01901614|18927976|P1|Overall Study|Lost to Follow-up|1
5474980|NCT01901614|18927975|P2|Overall Study|Adverse Event|1
5474981|NCT01901614|18927976|P1|Overall Study|Adverse Event|0
5474982|NCT01901432|18928011|P5|Overall Study|Patient decision to stop study drug|1
5474983|NCT01901432|18928012|P4|Overall Study|Patient decision to stop study drug|0
5474984|NCT01901432|18928013|P3|Overall Study|Patient decision to stop study drug|0
5474985|NCT01901432|18928014|P2|Overall Study|Patient decision to stop study drug|0
5474986|NCT01901432|18928015|P1|Overall Study|Patient decision to stop study drug|0
5474987|NCT01901432|18928011|P5|Overall Study|Physician Decision|2
5474988|NCT01901432|18928012|P4|Overall Study|Physician Decision|0
5474989|NCT01901432|18928013|P3|Overall Study|Physician Decision|0
5474990|NCT01901432|18928014|P2|Overall Study|Physician Decision|0
5474991|NCT01901432|18928015|P1|Overall Study|Physician Decision|0
5474992|NCT01901432|18928011|P5|Overall Study|Withdrawal by Subject|5
5474993|NCT01901432|18928012|P4|Overall Study|Withdrawal by Subject|0
5474994|NCT01901432|18928013|P3|Overall Study|Withdrawal by Subject|1
5474995|NCT01901432|18928014|P2|Overall Study|Withdrawal by Subject|0
5474996|NCT01901432|18928015|P1|Overall Study|Withdrawal by Subject|0
5474997|NCT01901432|18928011|P5|Overall Study|Adverse Event|1
5474998|NCT01901432|18928012|P4|Overall Study|Adverse Event|0
5474999|NCT01901432|18928013|P3|Overall Study|Adverse Event|1
5475000|NCT01901432|18928014|P2|Overall Study|Adverse Event|1
5475001|NCT01901432|18928015|P1|Overall Study|Adverse Event|0
5475002|NCT01901419|18928067|P2|Overall Study|unavailable researchers|3
5475003|NCT01901419|18928068|P1|Overall Study|unavailable researchers|6
5475004|NCT01901419|18928067|P2|Overall Study|Protocol Violation|6
5475005|NCT01901419|18928068|P1|Overall Study|Protocol Violation|2
5475006|NCT01901393|18928134|P2|Overall Study|Adverse Event|0
5475007|NCT01901393|18928135|P1|Overall Study|Adverse Event|1
5475008|NCT01901341|18928153|P2|Overall Study|Withdrawal by Subject|1
5475009|NCT01901341|18928154|P1|Overall Study|Withdrawal by Subject|1
5475010|NCT01901341|18928153|P2|Overall Study|Study Terminated by Sponsor|15
5475011|NCT01901341|18928154|P1|Overall Study|Study Terminated by Sponsor|13
5475012|NCT01901341|18928153|P2|Overall Study|Protocol Violation|0
5475013|NCT01901341|18928154|P1|Overall Study|Protocol Violation|2
5475014|NCT01901341|18928153|P2|Overall Study|Lost to Follow-up|1
5475015|NCT01901341|18928154|P1|Overall Study|Lost to Follow-up|0
5475016|NCT01901341|18928153|P2|Overall Study|Lack of Efficacy|2
5475017|NCT01901341|18928154|P1|Overall Study|Lack of Efficacy|0
5475018|NCT01901341|18928153|P2|Overall Study|Adverse Event|2
5475019|NCT01901341|18928154|P1|Overall Study|Adverse Event|4
5475020|NCT01901328|18928168|P2|Overall Study|Lack of Efficacy|1
5475021|NCT01901328|18928169|P1|Overall Study|Lack of Efficacy|0
5475022|NCT01901328|18928168|P2|Overall Study|Withdrawal by Subject|2
5475023|NCT01901328|18928169|P1|Overall Study|Withdrawal by Subject|1
5475024|NCT01901328|18928168|P2|Overall Study|Study Terminated by Sponsor|16
5475025|NCT01901328|18928169|P1|Overall Study|Study Terminated by Sponsor|19
5475026|NCT01901328|18928168|P2|Overall Study|Protocol Violation|1
5475027|NCT01901328|18928169|P1|Overall Study|Protocol Violation|1
5475028|NCT01901328|18928168|P2|Overall Study|Physician Decision|1
5475029|NCT01901328|18928169|P1|Overall Study|Physician Decision|0
5475030|NCT01901328|18928168|P2|Overall Study|Lost to Follow-up|0
5475031|NCT01901328|18928169|P1|Overall Study|Lost to Follow-up|1
5475032|NCT01901302|18928183|P2|Overall Study|Withdrawal by Subject|0
5475033|NCT01901302|18928184|P1|Overall Study|Withdrawal by Subject|2
5475034|NCT01901302|18928183|P2|Overall Study|Study Terminated by Sponsor|20
5475035|NCT01901302|18928184|P1|Overall Study|Study Terminated by Sponsor|23
5475036|NCT01901302|18928183|P2|Overall Study|Lack of Efficacy|2
5475037|NCT01901302|18928184|P1|Overall Study|Lack of Efficacy|0
5475038|NCT01901302|18928183|P2|Overall Study|Adverse Event|1
5475039|NCT01901302|18928184|P1|Overall Study|Adverse Event|2
5475040|NCT01901224|18928209|P1|Overall Study|study was not funded and terminated|2
5475041|NCT01901185|18928244|P1|Overall Study|Withdrawal by Subject|2
5475042|NCT01901146|18928253|P5|Adjuvant Phase|Withdrawal by Subject|4
5475043|NCT01901146|18928254|P4|Adjuvant Phase|Withdrawal by Subject|1
5475044|NCT01901146|18928255|P3|Adjuvant Phase|Withdrawal by Subject|4
5475045|NCT01901146|18928256|P2|Adjuvant Phase|Withdrawal by Subject|0
5475046|NCT01901146|18928257|P1|Adjuvant Phase|Withdrawal by Subject|0
5475047|NCT01901146|18928253|P5|Adjuvant Phase|Physician Decision|4
5475048|NCT01901146|18928254|P4|Adjuvant Phase|Physician Decision|2
5475049|NCT01901146|18928255|P3|Adjuvant Phase|Physician Decision|9
5475050|NCT01901146|18928256|P2|Adjuvant Phase|Physician Decision|0
5475051|NCT01901146|18928257|P1|Adjuvant Phase|Physician Decision|0
5475052|NCT01901146|18928253|P5|Adjuvant Phase|Disease Progression or Recurrence|3
5475053|NCT01901146|18928254|P4|Adjuvant Phase|Disease Progression or Recurrence|4
5475054|NCT01901146|18928255|P3|Adjuvant Phase|Disease Progression or Recurrence|12
5475055|NCT01901146|18928256|P2|Adjuvant Phase|Disease Progression or Recurrence|0
5475056|NCT01901146|18928257|P1|Adjuvant Phase|Disease Progression or Recurrence|0
5475057|NCT01901146|18928253|P5|Adjuvant Phase|Death|3
5475058|NCT01901146|18928254|P4|Adjuvant Phase|Death|0
5475059|NCT01901146|18928255|P3|Adjuvant Phase|Death|0
5475060|NCT01901146|18928256|P2|Adjuvant Phase|Death|0
5475061|NCT01901146|18928257|P1|Adjuvant Phase|Death|0
5475062|NCT01901146|18928253|P5|Adjuvant Phase|Other|0
5475063|NCT01901146|18928254|P4|Adjuvant Phase|Other|0
5475064|NCT01901146|18928255|P3|Adjuvant Phase|Other|1
5475065|NCT01901146|18928256|P2|Adjuvant Phase|Other|0
5475066|NCT01901146|18928257|P1|Adjuvant Phase|Other|0
5475067|NCT01901146|18928253|P5|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5475068|NCT01901146|18928254|P4|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5475069|NCT01901146|18928255|P3|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5475070|NCT01901146|18928256|P2|Neoadjuvant Phase|Requirement for Alternative Therapy|1
5475071|NCT01901146|18928257|P1|Neoadjuvant Phase|Requirement for Alternative Therapy|0
5475072|NCT01901146|18928253|P5|Neoadjuvant Phase|Withdrawal by Subject|0
5475073|NCT01901146|18928254|P4|Neoadjuvant Phase|Withdrawal by Subject|0
5475074|NCT01901146|18928255|P3|Neoadjuvant Phase|Withdrawal by Subject|0
5475075|NCT01901146|18928256|P2|Neoadjuvant Phase|Withdrawal by Subject|5
5475076|NCT01901146|18928257|P1|Neoadjuvant Phase|Withdrawal by Subject|2
5475077|NCT01901146|18928253|P5|Neoadjuvant Phase|Physician Decision|0
5475078|NCT01901146|18928254|P4|Neoadjuvant Phase|Physician Decision|0
5475079|NCT01901146|18928255|P3|Neoadjuvant Phase|Physician Decision|0
5475080|NCT01901146|18928256|P2|Neoadjuvant Phase|Physician Decision|2
5475081|NCT01901146|18928257|P1|Neoadjuvant Phase|Physician Decision|1
5475082|NCT01901146|18928253|P5|Neoadjuvant Phase|Lost to Follow-up|0
5475083|NCT01901146|18928254|P4|Neoadjuvant Phase|Lost to Follow-up|0
5475084|NCT01901146|18928255|P3|Neoadjuvant Phase|Lost to Follow-up|0
5475085|NCT01901146|18928256|P2|Neoadjuvant Phase|Lost to Follow-up|1
5475086|NCT01901146|18928257|P1|Neoadjuvant Phase|Lost to Follow-up|0
5475087|NCT01901146|18928253|P5|Neoadjuvant Phase|Disease Progression or Recurrence|0
5475088|NCT01901146|18928254|P4|Neoadjuvant Phase|Disease Progression or Recurrence|0
5475089|NCT01901146|18928255|P3|Neoadjuvant Phase|Disease Progression or Recurrence|0
5475090|NCT01901146|18928256|P2|Neoadjuvant Phase|Disease Progression or Recurrence|3
5475091|NCT01901146|18928257|P1|Neoadjuvant Phase|Disease Progression or Recurrence|2
5475092|NCT01901146|18928253|P5|Neoadjuvant Phase|Death|0
5475093|NCT01901146|18928254|P4|Neoadjuvant Phase|Death|0
5475094|NCT01901146|18928255|P3|Neoadjuvant Phase|Death|0
5475095|NCT01901146|18928256|P2|Neoadjuvant Phase|Death|2
5475096|NCT01901146|18928257|P1|Neoadjuvant Phase|Death|1
5475097|NCT01900899|18928272|P2|Overall Study|Migrated from study area|0
5475098|NCT01900899|18928273|P1|Overall Study|Migrated from study area|2
5475099|NCT01900899|18928272|P2|Overall Study|Withdrawal by Subject|1
5475100|NCT01900899|18928273|P1|Overall Study|Withdrawal by Subject|7
5475101|NCT01900730|18928299|P2|Overall Study|Screen Failure|0
5475102|NCT01900730|18928300|P1|Overall Study|Screen Failure|1
5475103|NCT01900730|18928299|P2|Overall Study|Withdrawal by Subject|0
5475104|NCT01900730|18928300|P1|Overall Study|Withdrawal by Subject|1
5475105|NCT01900665|18928324|P2|Open Label Period|Withdrawal by Subject|28
5475106|NCT01900665|18928325|P1|Open Label Period|Withdrawal by Subject|20
5475107|NCT01900665|18928324|P2|Open Label Period|Sponsor Decision|765
5475108|NCT01900665|18928325|P1|Open Label Period|Sponsor Decision|802
5475109|NCT01900665|18928324|P2|Open Label Period|Protocol Violation|1
5475110|NCT01900665|18928325|P1|Open Label Period|Protocol Violation|0
5475111|NCT01900665|18928324|P2|Open Label Period|Physician Decision|4
5475112|NCT01900665|18928325|P1|Open Label Period|Physician Decision|4
5475113|NCT01900665|18928324|P2|Open Label Period|Parent/Caregiver Decision|34
5475114|NCT01900665|18928325|P1|Open Label Period|Parent/Caregiver Decision|33
5475115|NCT01900665|18928324|P2|Open Label Period|Lost to Follow-up|1
5475116|NCT01900665|18928325|P1|Open Label Period|Lost to Follow-up|1
5475117|NCT01900665|18928324|P2|Open Label Period|Death|6
5475118|NCT01900665|18928325|P1|Open Label Period|Death|5
5475119|NCT01900665|18928324|P2|Open Label Period|Adverse Event|20
5475120|NCT01900665|18928325|P1|Open Label Period|Adverse Event|16
5475121|NCT01900665|18928324|P2|Placebo Controlled Period|Entry Criteria Not Met|9
5475122|NCT01900665|18928325|P1|Placebo Controlled Period|Entry Criteria Not Met|5
5475123|NCT01900665|18928324|P2|Placebo Controlled Period|Caregiver Decision|41
5475124|NCT01900665|18928325|P1|Placebo Controlled Period|Caregiver Decision|33
5475125|NCT01900665|18928324|P2|Placebo Controlled Period|Lost to Follow-up|0
5475126|NCT01900665|18928325|P1|Placebo Controlled Period|Lost to Follow-up|3
5475127|NCT01900665|18928324|P2|Placebo Controlled Period|Physician Decision|7
5475128|NCT01900665|18928325|P1|Placebo Controlled Period|Physician Decision|11
5475129|NCT01900665|18928324|P2|Placebo Controlled Period|Withdrawal by Subject|45
5475130|NCT01900665|18928325|P1|Placebo Controlled Period|Withdrawal by Subject|33
5475131|NCT01900665|18928324|P2|Placebo Controlled Period|Protocol Violation|7
5475132|NCT01900665|18928325|P1|Placebo Controlled Period|Protocol Violation|1
5475133|NCT01900665|18928324|P2|Placebo Controlled Period|Adverse Event|39
5475134|NCT01900665|18928325|P1|Placebo Controlled Period|Adverse Event|48
5475135|NCT01900665|18928324|P2|Placebo Controlled Period|Death|16
5475136|NCT01900665|18928325|P1|Placebo Controlled Period|Death|9
5475137|NCT01900652|18928368|P2|Overall Study|Physician Decision|1
5475138|NCT01900652|18928369|P1|Overall Study|Physician Decision|1
5475139|NCT01900652|18928368|P2|Overall Study|Adverse Event|1
5475140|NCT01900652|18928369|P1|Overall Study|Adverse Event|2
5475141|NCT01900652|18928368|P2|Overall Study|Death|0
5475142|NCT01900652|18928369|P1|Overall Study|Death|3
5475143|NCT01900652|18928368|P2|Overall Study|Consent withdrawn by subject|1
5475144|NCT01900652|18928369|P1|Overall Study|Consent withdrawn by subject|1
5475145|NCT01900652|18928368|P2|Overall Study|Progressive Disease|0
5475146|NCT01900652|18928369|P1|Overall Study|Progressive Disease|1
5475147|NCT01900626|18928405|P2|Overall Study|study was closed due to low enrollment|1
5475148|NCT01900626|18928406|P1|Overall Study|study was closed due to low enrollment|1
5475149|NCT01900444|18928485|P1|Overall Study|Lost to Follow-up|1
5475150|NCT01900444|18928485|P1|Overall Study|Protocol Violation|2
5475151|NCT01900431|18928498|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
5475152|NCT01900431|18928499|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
5475153|NCT01900431|18928500|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
5475154|NCT01900431|18928498|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
5475155|NCT01900431|18928499|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
5475156|NCT01900431|18928500|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
5475157|NCT01900431|18928498|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
5475158|NCT01900431|18928499|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
5475159|NCT01900431|18928500|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
5475160|NCT01900431|18928498|P3|Extended Treatment Period (Part B)|Other than specified above|0
5475161|NCT01900431|18928499|P2|Extended Treatment Period (Part B)|Other than specified above|1
5475162|NCT01900431|18928500|P1|Extended Treatment Period (Part B)|Other than specified above|0
5475163|NCT01900431|18928498|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
5475164|NCT01900431|18928499|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
5475165|NCT01900431|18928500|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
5475166|NCT01900431|18928498|P3|Extended Treatment Period (Part B)|Adverse Event|0
5475167|NCT01900431|18928499|P2|Extended Treatment Period (Part B)|Adverse Event|2
5475168|NCT01900431|18928500|P1|Extended Treatment Period (Part B)|Adverse Event|0
5475169|NCT01900431|18928498|P3|Principal Treatment Period (Part A)|Other than specified above|0
5475170|NCT01900431|18928499|P2|Principal Treatment Period (Part A)|Other than specified above|1
5475171|NCT01900431|18928500|P1|Principal Treatment Period (Part A)|Other than specified above|0
5475172|NCT01900431|18928498|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
5475173|NCT01900431|18928499|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
5475174|NCT01900431|18928500|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
5475175|NCT01900431|18928498|P3|Principal Treatment Period (Part A)|Adverse Event|0
5475176|NCT01900431|18928499|P2|Principal Treatment Period (Part A)|Adverse Event|3
5475177|NCT01900431|18928500|P1|Principal Treatment Period (Part A)|Adverse Event|1
5475178|NCT01900314|18928542|P2|Overall Study|Withdrawal by Subject|3
5475179|NCT01900314|18928543|P1|Overall Study|Withdrawal by Subject|3
5475180|NCT01900314|18928542|P2|Overall Study|Protocol Violation|1
5475181|NCT01900314|18928543|P1|Overall Study|Protocol Violation|0
5475182|NCT01900314|18928542|P2|Overall Study|Lost to Follow-up|0
5475183|NCT01900314|18928543|P1|Overall Study|Lost to Follow-up|1
5475184|NCT01900054|18928573|P1|Overall Study|Withdrawal by Subject|1
5475185|NCT01900054|18928573|P1|Overall Study|Physician Decision|1
5475186|NCT01899768|18928582|P1|Part B|Withdrawal by Subject|1
5475187|NCT01899768|18928582|P1|Part B|Adverse Event|1
5475188|NCT01899768|18928582|P1|Part A|Withdrawal by Subject|1
5475189|NCT01899768|18928582|P1|Part A|Adverse Event|2
5475190|NCT01899742|18928656|P2|Overall Study|Withdrawal by Subject|5
5475191|NCT01899742|18928657|P1|Overall Study|Withdrawal by Subject|9
5475192|NCT01899742|18928656|P2|Overall Study|Protocol Violation|2
5475193|NCT01899742|18928657|P1|Overall Study|Protocol Violation|2
5475194|NCT01899742|18928656|P2|Overall Study|Lack of Efficacy|5
5475195|NCT01899742|18928657|P1|Overall Study|Lack of Efficacy|1
5475196|NCT01899742|18928656|P2|Overall Study|Adverse Event|4
5475197|NCT01899742|18928657|P1|Overall Study|Adverse Event|5
5475198|NCT01899729|18928670|P5|Overall Study|Lack of Efficacy|1
5475199|NCT01899729|18928671|P4|Overall Study|Lack of Efficacy|0
5475200|NCT01899729|18928672|P3|Overall Study|Lack of Efficacy|2
5475201|NCT01899729|18928673|P2|Overall Study|Lack of Efficacy|0
5475202|NCT01899729|18928674|P1|Overall Study|Lack of Efficacy|0
5475203|NCT01899729|18928670|P5|Overall Study|Withdrawal by Subject|0
5475204|NCT01899729|18928671|P4|Overall Study|Withdrawal by Subject|0
5475205|NCT01899729|18928672|P3|Overall Study|Withdrawal by Subject|0
5475206|NCT01899729|18928673|P2|Overall Study|Withdrawal by Subject|2
5475207|NCT01899729|18928674|P1|Overall Study|Withdrawal by Subject|1
5475208|NCT01899729|18928670|P5|Overall Study|Adverse Event|1
5475209|NCT01899729|18928671|P4|Overall Study|Adverse Event|0
5475210|NCT01899729|18928672|P3|Overall Study|Adverse Event|0
5475211|NCT01899729|18928673|P2|Overall Study|Adverse Event|0
5475212|NCT01899729|18928674|P1|Overall Study|Adverse Event|1
5475213|NCT01899144|18928721|P1|Treatment Period 5|Other|1
5475214|NCT01899144|18928721|P1|Treatment Period 3|Other|2
5475215|NCT01899144|18928721|P1|Treatment Period 2|Other|1
5475216|NCT01899053|18928757|P14|Overall Study|Symptomatic Deterioration|0
5475217|NCT01899053|18928758|P13|Overall Study|Symptomatic Deterioration|2
5475218|NCT01899053|18928759|P12|Overall Study|Symptomatic Deterioration|1
5475219|NCT01899053|18928760|P11|Overall Study|Symptomatic Deterioration|0
5475220|NCT01899053|18928761|P10|Overall Study|Symptomatic Deterioration|0
5475221|NCT01899053|18928762|P9|Overall Study|Symptomatic Deterioration|0
5475222|NCT01899053|18928763|P8|Overall Study|Symptomatic Deterioration|1
5475223|NCT01899053|18928764|P7|Overall Study|Symptomatic Deterioration|0
5475224|NCT01899053|18928765|P6|Overall Study|Symptomatic Deterioration|1
5475225|NCT01899053|18928766|P5|Overall Study|Symptomatic Deterioration|0
5475226|NCT01899053|18928767|P4|Overall Study|Symptomatic Deterioration|0
5475227|NCT01899053|18928768|P3|Overall Study|Symptomatic Deterioration|0
5475228|NCT01899053|18928769|P2|Overall Study|Symptomatic Deterioration|0
5475229|NCT01899053|18928770|P1|Overall Study|Symptomatic Deterioration|0
5475230|NCT01899053|18928757|P14|Overall Study|Unsatisfactory Therapeutic Response|0
5475231|NCT01899053|18928758|P13|Overall Study|Unsatisfactory Therapeutic Response|0
5475232|NCT01899053|18928759|P12|Overall Study|Unsatisfactory Therapeutic Response|0
5475233|NCT01899053|18928760|P11|Overall Study|Unsatisfactory Therapeutic Response|1
5475234|NCT01899053|18928761|P10|Overall Study|Unsatisfactory Therapeutic Response|0
5475235|NCT01899053|18928762|P9|Overall Study|Unsatisfactory Therapeutic Response|0
5475236|NCT01899053|18928763|P8|Overall Study|Unsatisfactory Therapeutic Response|0
5475237|NCT01899053|18928764|P7|Overall Study|Unsatisfactory Therapeutic Response|0
5475238|NCT01899053|18928765|P6|Overall Study|Unsatisfactory Therapeutic Response|0
5475239|NCT01899053|18928766|P5|Overall Study|Unsatisfactory Therapeutic Response|0
5475240|NCT01899053|18928767|P4|Overall Study|Unsatisfactory Therapeutic Response|0
5475241|NCT01899053|18928768|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5475242|NCT01899053|18928769|P2|Overall Study|Unsatisfactory Therapeutic Response|1
5475243|NCT01899053|18928770|P1|Overall Study|Unsatisfactory Therapeutic Response|1
5475244|NCT01899053|18928757|P14|Overall Study|Protocol Violation|0
5475245|NCT01899053|18928758|P13|Overall Study|Protocol Violation|0
5475246|NCT01899053|18928759|P12|Overall Study|Protocol Violation|0
5475247|NCT01899053|18928760|P11|Overall Study|Protocol Violation|0
5475248|NCT01899053|18928761|P10|Overall Study|Protocol Violation|0
5475249|NCT01899053|18928762|P9|Overall Study|Protocol Violation|0
5475250|NCT01899053|18928763|P8|Overall Study|Protocol Violation|0
5475251|NCT01899053|18928764|P7|Overall Study|Protocol Violation|0
5475252|NCT01899053|18928765|P6|Overall Study|Protocol Violation|0
5475253|NCT01899053|18928766|P5|Overall Study|Protocol Violation|0
5475254|NCT01899053|18928767|P4|Overall Study|Protocol Violation|0
5475255|NCT01899053|18928768|P3|Overall Study|Protocol Violation|1
5475256|NCT01899053|18928769|P2|Overall Study|Protocol Violation|0
5475257|NCT01899053|18928770|P1|Overall Study|Protocol Violation|0
5475258|NCT01899053|18928757|P14|Overall Study|Withdrawal by Subject|1
5475259|NCT01899053|18928758|P13|Overall Study|Withdrawal by Subject|1
5475260|NCT01899053|18928759|P12|Overall Study|Withdrawal by Subject|0
5475261|NCT01899053|18928760|P11|Overall Study|Withdrawal by Subject|0
5475262|NCT01899053|18928761|P10|Overall Study|Withdrawal by Subject|0
5475263|NCT01899053|18928762|P9|Overall Study|Withdrawal by Subject|0
5475264|NCT01899053|18928763|P8|Overall Study|Withdrawal by Subject|1
5475265|NCT01899053|18928764|P7|Overall Study|Withdrawal by Subject|0
5475266|NCT01899053|18928765|P6|Overall Study|Withdrawal by Subject|0
5475267|NCT01899053|18928766|P5|Overall Study|Withdrawal by Subject|2
5475268|NCT01899053|18928767|P4|Overall Study|Withdrawal by Subject|0
5475269|NCT01899053|18928768|P3|Overall Study|Withdrawal by Subject|2
5475270|NCT01899053|18928769|P2|Overall Study|Withdrawal by Subject|1
5475271|NCT01899053|18928770|P1|Overall Study|Withdrawal by Subject|1
5475272|NCT01899053|18928757|P14|Overall Study|Reason Not Specified|0
5475273|NCT01899053|18928758|P13|Overall Study|Reason Not Specified|1
5475274|NCT01899053|18928759|P12|Overall Study|Reason Not Specified|0
5475275|NCT01899053|18928760|P11|Overall Study|Reason Not Specified|0
5475276|NCT01899053|18928761|P10|Overall Study|Reason Not Specified|0
5475277|NCT01899053|18928762|P9|Overall Study|Reason Not Specified|0
5475278|NCT01899053|18928763|P8|Overall Study|Reason Not Specified|0
5475279|NCT01899053|18928764|P7|Overall Study|Reason Not Specified|1
5475280|NCT01899053|18928765|P6|Overall Study|Reason Not Specified|0
5475281|NCT01899053|18928766|P5|Overall Study|Reason Not Specified|0
5475282|NCT01899053|18928767|P4|Overall Study|Reason Not Specified|0
5475283|NCT01899053|18928768|P3|Overall Study|Reason Not Specified|0
5475284|NCT01899053|18928769|P2|Overall Study|Reason Not Specified|0
5475285|NCT01899053|18928770|P1|Overall Study|Reason Not Specified|0
5475286|NCT01899053|18928757|P14|Overall Study|Adverse Event|2
5475287|NCT01899053|18928758|P13|Overall Study|Adverse Event|2
5475288|NCT01899053|18928759|P12|Overall Study|Adverse Event|1
5475289|NCT01899053|18928760|P11|Overall Study|Adverse Event|3
5475290|NCT01899053|18928761|P10|Overall Study|Adverse Event|0
5475291|NCT01899053|18928762|P9|Overall Study|Adverse Event|2
5475292|NCT01899053|18928763|P8|Overall Study|Adverse Event|0
5475293|NCT01899053|18928764|P7|Overall Study|Adverse Event|1
5475294|NCT01899053|18928765|P6|Overall Study|Adverse Event|1
5475295|NCT01899053|18928766|P5|Overall Study|Adverse Event|1
5475296|NCT01899053|18928767|P4|Overall Study|Adverse Event|3
5475297|NCT01899053|18928768|P3|Overall Study|Adverse Event|1
5475298|NCT01899053|18928769|P2|Overall Study|Adverse Event|1
5475299|NCT01899053|18928770|P1|Overall Study|Adverse Event|1
5475300|NCT01899053|18928757|P14|Overall Study|Progressive Disease|17
5475301|NCT01899053|18928758|P13|Overall Study|Progressive Disease|8
5475302|NCT01899053|18928759|P12|Overall Study|Progressive Disease|5
5475303|NCT01899053|18928760|P11|Overall Study|Progressive Disease|12
5475304|NCT01899053|18928761|P10|Overall Study|Progressive Disease|3
5475305|NCT01899053|18928762|P9|Overall Study|Progressive Disease|4
5475306|NCT01899053|18928763|P8|Overall Study|Progressive Disease|1
5475307|NCT01899053|18928764|P7|Overall Study|Progressive Disease|1
5475308|NCT01899053|18928765|P6|Overall Study|Progressive Disease|1
5475309|NCT01899053|18928766|P5|Overall Study|Progressive Disease|3
5475310|NCT01899053|18928767|P4|Overall Study|Progressive Disease|0
5475311|NCT01899053|18928768|P3|Overall Study|Progressive Disease|3
5475312|NCT01899053|18928769|P2|Overall Study|Progressive Disease|0
5475313|NCT01899053|18928770|P1|Overall Study|Progressive Disease|4
5475314|NCT01898884|18929027|P9|Multiple Dose Period|Randomized Not Treated|1
5475315|NCT01898884|18929028|P8|Multiple Dose Period|Randomized Not Treated|0
5475316|NCT01898884|18929029|P7|Multiple Dose Period|Randomized Not Treated|0
5475317|NCT01898884|18929030|P6|Multiple Dose Period|Randomized Not Treated|0
5475318|NCT01898884|18929031|P5|Multiple Dose Period|Randomized Not Treated|0
5475319|NCT01898884|18929032|P4|Multiple Dose Period|Randomized Not Treated|0
5475320|NCT01898884|18929033|P3|Multiple Dose Period|Randomized Not Treated|0
5475321|NCT01898884|18929034|P2|Multiple Dose Period|Randomized Not Treated|0
5475322|NCT01898884|18929035|P1|Multiple Dose Period|Randomized Not Treated|0
5475323|NCT01898884|18929027|P9|Multiple Dose Period|Adverse Event|0
5475324|NCT01898884|18929028|P8|Multiple Dose Period|Adverse Event|0
5475325|NCT01898884|18929029|P7|Multiple Dose Period|Adverse Event|1
5475326|NCT01898884|18929030|P6|Multiple Dose Period|Adverse Event|0
5475327|NCT01898884|18929031|P5|Multiple Dose Period|Adverse Event|0
5475328|NCT01898884|18929032|P4|Multiple Dose Period|Adverse Event|0
5475329|NCT01898884|18929033|P3|Multiple Dose Period|Adverse Event|0
5475330|NCT01898884|18929034|P2|Multiple Dose Period|Adverse Event|0
5475331|NCT01898884|18929035|P1|Multiple Dose Period|Adverse Event|0
5475332|NCT01898806|18929185|P1|Overall Study|Physician Decision|1
5475333|NCT01898806|18929185|P1|Overall Study|Withdrawal by Subject|2
5475334|NCT01898598|18929215|P2|Overall Study|Other|1
5475335|NCT01898598|18929216|P1|Overall Study|Other|0
5475336|NCT01898598|18929215|P2|Overall Study|Lost to Follow-up|1
5475337|NCT01898598|18929216|P1|Overall Study|Lost to Follow-up|0
5475338|NCT01898598|18929215|P2|Overall Study|Withdrawal by Subject|0
5475339|NCT01898598|18929216|P1|Overall Study|Withdrawal by Subject|3
5475340|NCT01898598|18929215|P2|Overall Study|Adverse Event|0
5475341|NCT01898598|18929216|P1|Overall Study|Adverse Event|1
5475342|NCT01898442|18929235|P3|Overall Study|Patient vomited pills|1
5475343|NCT01898442|18929236|P2|Overall Study|Patient vomited pills|0
5475344|NCT01898442|18929237|P1|Overall Study|Patient vomited pills|0
5475345|NCT01898442|18929235|P3|Overall Study|Hemolysis/technical problems|2
5475346|NCT01898442|18929236|P2|Overall Study|Hemolysis/technical problems|2
5475347|NCT01898442|18929237|P1|Overall Study|Hemolysis/technical problems|1
5475348|NCT01898299|18929274|P2|Post Treatment (One Month)|Lost to Follow-up|4
5475349|NCT01898299|18929275|P1|Post Treatment (One Month)|Lost to Follow-up|3
5475350|NCT01898286|18929281|P1|Overall Study|Lost to Follow-up|1
5475351|NCT01898286|18929281|P1|Overall Study|Protocol Violation|1
5475352|NCT01898286|18929281|P1|Overall Study|Withdrawal by Subject|1
5475353|NCT01898208|18929291|P3|Overall Study|Lost to Follow-up|1
5475354|NCT01898208|18929292|P2|Overall Study|Lost to Follow-up|1
5475355|NCT01898208|18929293|P1|Overall Study|Lost to Follow-up|3
5475356|NCT01898208|18929291|P3|Overall Study|System/Technical Error|3
5475357|NCT01898208|18929292|P2|Overall Study|System/Technical Error|2
5475358|NCT01898208|18929293|P1|Overall Study|System/Technical Error|1
5475359|NCT01898208|18929291|P3|Overall Study|Non-Blood Specimens in Bottles|4
5475360|NCT01898208|18929292|P2|Overall Study|Non-Blood Specimens in Bottles|5
5475361|NCT01898208|18929293|P1|Overall Study|Non-Blood Specimens in Bottles|3
5475362|NCT01898208|18929291|P3|Overall Study|Negative Gram Stain|6
5475363|NCT01898208|18929292|P2|Overall Study|Negative Gram Stain|9
5475364|NCT01898208|18929293|P1|Overall Study|Negative Gram Stain|6
5475365|NCT01898208|18929291|P3|Overall Study|Death/comfort care within 24 hours|8
5475366|NCT01898208|18929292|P2|Overall Study|Death/comfort care within 24 hours|9
5475367|NCT01898208|18929293|P1|Overall Study|Death/comfort care within 24 hours|10
5475368|NCT01898208|18929291|P3|Overall Study|Positive blood culture|15
5475369|NCT01898208|18929292|P2|Overall Study|Positive blood culture|23
5475370|NCT01898208|18929293|P1|Overall Study|Positive blood culture|17
5475371|NCT01898195|18929340|P3|Smoking Abstinence|Did not have good measurements|36
5475372|NCT01898195|18929341|P2|Smoking Abstinence|Did not have good measurements|38
5475373|NCT01898195|18929342|P1|Smoking Abstinence|Did not have good measurements|35
5475374|NCT01898130|18929353|P1|Follow up Until PD or Death|Lost to Follow-up|1
5475375|NCT01898130|18929353|P1|Treatment|Progressive Disease|4
5475376|NCT01898130|18929353|P1|Treatment|Withdrawal by Subject|2
5475377|NCT01898091|18929368|P2|Overall Study|Withdrawal by Subject|5
5475378|NCT01898091|18929369|P1|Overall Study|Withdrawal by Subject|1
5475379|NCT01898091|18929368|P2|Overall Study|Lost to Follow-up|1
5475380|NCT01898091|18929369|P1|Overall Study|Lost to Follow-up|1
5475381|NCT01898078|18929377|P2|Overall Study|Reason not Specified|1
5475382|NCT01898078|18929378|P1|Overall Study|Reason not Specified|0
5475383|NCT01898078|18929377|P2|Overall Study|Symptomatic Deterioration|0
5475384|NCT01898078|18929378|P1|Overall Study|Symptomatic Deterioration|2
5475385|NCT01898078|18929377|P2|Overall Study|Withdrawal by Subject|1
5475386|NCT01898078|18929378|P1|Overall Study|Withdrawal by Subject|1
5475387|NCT01898078|18929377|P2|Overall Study|Adverse Event|1
5475388|NCT01898078|18929378|P1|Overall Study|Adverse Event|2
5475389|NCT01898078|18929377|P2|Overall Study|Progressive Disease|5
5475390|NCT01898078|18929378|P1|Overall Study|Progressive Disease|1
5475391|NCT01897896|18929415|P2|Overall Study|Other than specified|1
5475392|NCT01897896|18929416|P1|Overall Study|Other than specified|2
5475393|NCT01897896|18929415|P2|Overall Study|Caregiver can no longer participate|2
5475394|NCT01897896|18929416|P1|Overall Study|Caregiver can no longer participate|0
5475395|NCT01897896|18929415|P2|Overall Study|Withdrawal per Investigator's judgement|1
5475396|NCT01897896|18929416|P1|Overall Study|Withdrawal per Investigator's judgement|1
5475397|NCT01897896|18929415|P2|Overall Study|Protocol Violation|1
5475398|NCT01897896|18929416|P1|Overall Study|Protocol Violation|1
5475399|NCT01897896|18929415|P2|Overall Study|Require drug that interfere with study|4
5475400|NCT01897896|18929416|P1|Overall Study|Require drug that interfere with study|1
5475401|NCT01897896|18929415|P2|Overall Study|Withdrawal by Subject|1
5475402|NCT01897896|18929416|P1|Overall Study|Withdrawal by Subject|7
5475403|NCT01897896|18929415|P2|Overall Study|Non-compliance with study drug dosing|1
5475404|NCT01897896|18929416|P1|Overall Study|Non-compliance with study drug dosing|1
5475405|NCT01897896|18929415|P2|Overall Study|Lost to Follow-up|0
5475406|NCT01897896|18929416|P1|Overall Study|Lost to Follow-up|1
5475407|NCT01897896|18929415|P2|Overall Study|Adverse Event|1
5475408|NCT01897896|18929416|P1|Overall Study|Adverse Event|11
5475409|NCT01897896|18929415|P2|Overall Study|Death|0
5475410|NCT01897896|18929416|P1|Overall Study|Death|1
5475411|NCT01897727|18929548|P2|Overall Study|Exclusion: central sleep apnea|1
5475412|NCT01897727|18929549|P1|Overall Study|Exclusion: central sleep apnea|0
5475413|NCT01897714|18929561|P6|Phase II (MTD)|Other|0
5475414|NCT01897714|18929562|P5|Phase II (MTD)|Other|3
5475415|NCT01897714|18929563|P4|Phase II (MTD)|Other|0
5475416|NCT01897714|18929564|P3|Phase II (MTD)|Other|0
5475417|NCT01897714|18929565|P2|Phase II (MTD)|Other|0
5475418|NCT01897714|18929566|P1|Phase II (MTD)|Other|0
5475419|NCT01897714|18929561|P6|Phase II (MTD)|Study terminated with patient alive|0
5475420|NCT01897714|18929562|P5|Phase II (MTD)|Study terminated with patient alive|1
5475421|NCT01897714|18929563|P4|Phase II (MTD)|Study terminated with patient alive|0
5475422|NCT01897714|18929564|P3|Phase II (MTD)|Study terminated with patient alive|0
5475423|NCT01897714|18929565|P2|Phase II (MTD)|Study terminated with patient alive|0
5475424|NCT01897714|18929566|P1|Phase II (MTD)|Study terminated with patient alive|0
5475425|NCT01897714|18929561|P6|Phase II (MTD)|Death|10
5475426|NCT01897714|18929562|P5|Phase II (MTD)|Death|25
5475427|NCT01897714|18929563|P4|Phase II (MTD)|Death|0
5475428|NCT01897714|18929564|P3|Phase II (MTD)|Death|0
5475429|NCT01897714|18929565|P2|Phase II (MTD)|Death|0
5475430|NCT01897714|18929566|P1|Phase II (MTD)|Death|0
5475431|NCT01897714|18929561|P6|Phase II (MTD)|Lost to Follow-up|0
5475432|NCT01897714|18929562|P5|Phase II (MTD)|Lost to Follow-up|1
5475433|NCT01897714|18929563|P4|Phase II (MTD)|Lost to Follow-up|0
5475434|NCT01897714|18929564|P3|Phase II (MTD)|Lost to Follow-up|0
5475435|NCT01897714|18929565|P2|Phase II (MTD)|Lost to Follow-up|0
5475436|NCT01897714|18929566|P1|Phase II (MTD)|Lost to Follow-up|0
5475437|NCT01897714|18929561|P6|Phase II (MTD)|Withdrawal by Subject|1
5475438|NCT01897714|18929562|P5|Phase II (MTD)|Withdrawal by Subject|0
5475439|NCT01897714|18929563|P4|Phase II (MTD)|Withdrawal by Subject|0
5475440|NCT01897714|18929564|P3|Phase II (MTD)|Withdrawal by Subject|0
5475441|NCT01897714|18929565|P2|Phase II (MTD)|Withdrawal by Subject|0
5475442|NCT01897714|18929566|P1|Phase II (MTD)|Withdrawal by Subject|0
5475443|NCT01897714|18929561|P6|Phase I (Dose Escalation)|Other|0
5475444|NCT01897714|18929562|P5|Phase I (Dose Escalation)|Other|0
5475445|NCT01897714|18929563|P4|Phase I (Dose Escalation)|Other|0
5475446|NCT01897714|18929564|P3|Phase I (Dose Escalation)|Other|0
5475447|NCT01897714|18929565|P2|Phase I (Dose Escalation)|Other|1
5475448|NCT01897714|18929566|P1|Phase I (Dose Escalation)|Other|0
5475449|NCT01897714|18929561|P6|Phase I (Dose Escalation)|Adverse Event|0
5475450|NCT01897714|18929562|P5|Phase I (Dose Escalation)|Adverse Event|0
5475451|NCT01897714|18929563|P4|Phase I (Dose Escalation)|Adverse Event|3
5475452|NCT01897714|18929564|P3|Phase I (Dose Escalation)|Adverse Event|4
5475453|NCT01897714|18929565|P2|Phase I (Dose Escalation)|Adverse Event|1
5475454|NCT01897714|18929566|P1|Phase I (Dose Escalation)|Adverse Event|0
5475455|NCT01897714|18929561|P6|Phase I (Dose Escalation)|Disease progression|0
5475456|NCT01897714|18929562|P5|Phase I (Dose Escalation)|Disease progression|0
5475457|NCT01897714|18929563|P4|Phase I (Dose Escalation)|Disease progression|3
5475458|NCT01897714|18929564|P3|Phase I (Dose Escalation)|Disease progression|1
5475459|NCT01897714|18929565|P2|Phase I (Dose Escalation)|Disease progression|5
5475460|NCT01897714|18929566|P1|Phase I (Dose Escalation)|Disease progression|3
5475461|NCT01897532|18929612|P2|Discontinuation From Trial|Patient lost to follow-up for MACE|36
5475462|NCT01897532|18929613|P1|Discontinuation From Trial|Patient lost to follow-up for MACE|55
5475463|NCT01897532|18929612|P2|Discontinuation From Trial|Not Treated|5
5475464|NCT01897532|18929613|P1|Discontinuation From Trial|Not Treated|7
5475465|NCT01897532|18929612|P2|Discontinuation From Treatment|Adverse event/ CV outcome event|362
5475466|NCT01897532|18929613|P1|Discontinuation From Treatment|Adverse event/ CV outcome event|402
5475467|NCT01897532|18929612|P2|Discontinuation From Treatment|Non compliance|15
5475468|NCT01897532|18929613|P1|Discontinuation From Treatment|Non compliance|24
5475469|NCT01897532|18929612|P2|Discontinuation From Treatment|Withdrawal by Subject|281
5475470|NCT01897532|18929613|P1|Discontinuation From Treatment|Withdrawal by Subject|333
5475471|NCT01897532|18929612|P2|Discontinuation From Treatment|Other reason than specified|176
5475472|NCT01897532|18929613|P1|Discontinuation From Treatment|Other reason than specified|196
5475473|NCT01897532|18929612|P2|Discontinuation From Treatment|Not Treated|5
5475474|NCT01897532|18929613|P1|Discontinuation From Treatment|Not Treated|7
5475475|NCT01897493|18929621|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
5475476|NCT01897233|18929657|P1|Part B (24 Weeks)|Physician Decision|1
5475477|NCT01897233|18929657|P1|Part B (24 Weeks)|Withdrawal by Subject|2
5475478|NCT01897233|18929657|P1|Part B (24 Weeks)|Adverse Event|1
5475479|NCT01896986|18929709|P2|Overall Study|samples lost|23
5475480|NCT01896986|18929710|P1|Overall Study|samples lost|14
5475481|NCT01896934|18929716|P1|Overall Study|Withdrawal by Subject|1
5475482|NCT01896934|18929716|P1|Overall Study|Adverse Event|1
5475483|NCT01896895|18929729|P4|Double-blind MP|Lost to Follow-up|0
5475484|NCT01896895|18929730|P3|Double-blind MP|Lost to Follow-up|1
5475485|NCT01896895|18929731|P2|Double-blind MP|Lost to Follow-up|0
5475486|NCT01896895|18929732|P1|Double-blind MP|Lost to Follow-up|1
5475487|NCT01896895|18929729|P4|Double-blind MP|Withdrawal by Subject|0
5475488|NCT01896895|18929730|P3|Double-blind MP|Withdrawal by Subject|1
5475489|NCT01896895|18929731|P2|Double-blind MP|Withdrawal by Subject|2
5475490|NCT01896895|18929732|P1|Double-blind MP|Withdrawal by Subject|0
5475491|NCT01896895|18929729|P4|Double-blind MP|Physician Decision|0
5475492|NCT01896895|18929730|P3|Double-blind MP|Physician Decision|1
5475493|NCT01896895|18929731|P2|Double-blind MP|Physician Decision|0
5475494|NCT01896895|18929732|P1|Double-blind MP|Physician Decision|0
5475495|NCT01896869|18929749|P2|Overall Study|Lost to Follow-up|0
5475496|NCT01896869|18929750|P1|Overall Study|Lost to Follow-up|1
5475497|NCT01896869|18929749|P2|Overall Study|Withdrawal by Subject|6
5475498|NCT01896869|18929750|P1|Overall Study|Withdrawal by Subject|0
5475499|NCT01896856|18929775|P6|Overall Study|Transportation issues / Non-compliance|0
5475500|NCT01896856|18929776|P5|Overall Study|Transportation issues / Non-compliance|0
5475501|NCT01896856|18929777|P4|Overall Study|Transportation issues / Non-compliance|0
5475502|NCT01896856|18929778|P3|Overall Study|Transportation issues / Non-compliance|1
5475503|NCT01896856|18929779|P2|Overall Study|Transportation issues / Non-compliance|0
5475504|NCT01896856|18929780|P1|Overall Study|Transportation issues / Non-compliance|0
5475505|NCT01896726|18929799|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
5475506|NCT01896726|18929799|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
5475507|NCT01896700|18929814|P2|Overall Study|Withdrawal by Subject|1
5475508|NCT01896700|18929815|P1|Overall Study|Withdrawal by Subject|0
5475509|NCT01896700|18929814|P2|Overall Study|Adverse Event|5
5475510|NCT01896700|18929815|P1|Overall Study|Adverse Event|4
5475511|NCT01896557|18929846|P2|Clopidogrel + GI Protector|Reading error|3
5475512|NCT01896557|18929847|P1|Clopidogrel + GI Protector|Reading error|1
5475513|NCT01896557|18929846|P2|Clopidogrel + GI Protector|low adherence|1
5475514|NCT01896557|18929847|P1|Clopidogrel + GI Protector|low adherence|1
5475515|NCT01896557|18929846|P2|Clopidogrel Alone|Adverse Event|0
5475516|NCT01896557|18929847|P1|Clopidogrel Alone|Adverse Event|1
5475517|NCT01896297|18929884|P1|Overall Study|Died in post treatment phase|1
5475518|NCT01896232|18929891|P2|Overall Study|Lost to Follow-up|12
5475519|NCT01896232|18929892|P1|Overall Study|Lost to Follow-up|9
5475520|NCT01896232|18929891|P2|Overall Study|Sponsor Decision|0
5475521|NCT01896232|18929892|P1|Overall Study|Sponsor Decision|2
5475522|NCT01896232|18929891|P2|Overall Study|Withdrawal by Subject|31
5475523|NCT01896232|18929892|P1|Overall Study|Withdrawal by Subject|32
5475524|NCT01896232|18929891|P2|Overall Study|Death|10
5475525|NCT01896232|18929892|P1|Overall Study|Death|6
5475526|NCT01896193|18929920|P2|Overall Study|Withdrew Consent|0
5475527|NCT01896193|18929921|P1|Overall Study|Withdrew Consent|1
5475528|NCT01896193|18929920|P2|Overall Study|Protocol Violation|1
5475529|NCT01896193|18929921|P1|Overall Study|Protocol Violation|0
5475530|NCT01896193|18929920|P2|Overall Study|Lack of Efficacy|11
5475531|NCT01896193|18929921|P1|Overall Study|Lack of Efficacy|20
5475532|NCT01896128|18929947|P2|Overall Study|Withdrawal by Subject|3
5475533|NCT01896128|18929948|P1|Overall Study|Withdrawal by Subject|3
5475534|NCT01896050|18929990|P2|Overall Study|Death|0
5475535|NCT01896050|18929991|P1|Overall Study|Death|1
5475536|NCT01896050|18929990|P2|Overall Study|Adverse Event|2
5475537|NCT01896050|18929991|P1|Overall Study|Adverse Event|37
5475538|NCT01895777|18930035|P2|Overall Study|Non-compliance with the CTP|1
5475539|NCT01895777|18930036|P1|Overall Study|Non-compliance with the CTP|2
5475540|NCT01895777|18930035|P2|Overall Study|Other reasons|2
5475541|NCT01895777|18930036|P1|Overall Study|Other reasons|3
5475542|NCT01895777|18930035|P2|Overall Study|Not treated|0
5475543|NCT01895777|18930036|P1|Overall Study|Not treated|1
5475544|NCT01895777|18930035|P2|Overall Study|Lost to Follow-up|0
5475545|NCT01895777|18930036|P1|Overall Study|Lost to Follow-up|2
5475546|NCT01895777|18930035|P2|Overall Study|Adverse Event|2
5475547|NCT01895777|18930036|P1|Overall Study|Adverse Event|1
5475548|NCT01895608|18930092|P4|Overall Study|Withdrawal by Subject|0
5475549|NCT01895608|18930093|P3|Overall Study|Withdrawal by Subject|2
5475550|NCT01895608|18930094|P2|Overall Study|Withdrawal by Subject|0
5475551|NCT01895608|18930095|P1|Overall Study|Withdrawal by Subject|0
5475552|NCT01895608|18930092|P4|Overall Study|change in health status|0
5475553|NCT01895608|18930093|P3|Overall Study|change in health status|1
5475554|NCT01895608|18930094|P2|Overall Study|change in health status|1
5475555|NCT01895608|18930095|P1|Overall Study|change in health status|0
5475556|NCT01895543|18930125|P1|Overall Study|Other (Not fulfilling above criteria)|24
5475557|NCT01895543|18930125|P1|Overall Study|Physician Decision|2
5475558|NCT01895543|18930125|P1|Overall Study|Protocol Violation|1
5475559|NCT01895543|18930125|P1|Overall Study|Subject's substantial non-compliance|6
5475560|NCT01895543|18930125|P1|Overall Study|Adverse Event|28
5475561|NCT01895543|18930125|P1|Overall Study|Lost to Follow-up|25
5475562|NCT01895543|18930125|P1|Overall Study|Withdrawal by Subject|43
5475563|NCT01895452|18930141|P2|Overall Study|Noncompliance with study drug|1
5475564|NCT01895452|18930142|P1|Overall Study|Noncompliance with study drug|0
5475565|NCT01895452|18930141|P2|Overall Study|Underlying disease|3
5475566|NCT01895452|18930142|P1|Overall Study|Underlying disease|0
5475567|NCT01895452|18930141|P2|Overall Study|Withdrawal by Subject|14
5475568|NCT01895452|18930142|P1|Overall Study|Withdrawal by Subject|2
5475569|NCT01895452|18930141|P2|Overall Study|Pregnancy|1
5475570|NCT01895452|18930142|P1|Overall Study|Pregnancy|0
5475571|NCT01895452|18930141|P2|Overall Study|Lost to Follow-up|5
5475572|NCT01895452|18930142|P1|Overall Study|Lost to Follow-up|1
5475573|NCT01895452|18930141|P2|Overall Study|Adverse Event|4
5475574|NCT01895452|18930142|P1|Overall Study|Adverse Event|1
5475575|NCT01895361|18930155|P3|Overall Study|Reasons different from categories above|4
5475576|NCT01895361|18930156|P2|Overall Study|Reasons different from categories above|3
5475577|NCT01895361|18930157|P1|Overall Study|Reasons different from categories above|7
5475578|NCT01895361|18930155|P3|Overall Study|Lack of Efficacy|0
5475579|NCT01895361|18930156|P2|Overall Study|Lack of Efficacy|1
5475580|NCT01895361|18930157|P1|Overall Study|Lack of Efficacy|0
5475581|NCT01895361|18930155|P3|Overall Study|Withdrawal by Subject|6
5475582|NCT01895361|18930156|P2|Overall Study|Withdrawal by Subject|6
5475583|NCT01895361|18930157|P1|Overall Study|Withdrawal by Subject|7
5475584|NCT01895361|18930155|P3|Overall Study|Physician Decision|2
5475585|NCT01895361|18930156|P2|Overall Study|Physician Decision|2
5475586|NCT01895361|18930157|P1|Overall Study|Physician Decision|2
5475587|NCT01895361|18930155|P3|Overall Study|Non-compliance with study|1
5475588|NCT01895361|18930156|P2|Overall Study|Non-compliance with study|3
5475589|NCT01895361|18930157|P1|Overall Study|Non-compliance with study|1
5475590|NCT01895361|18930155|P3|Overall Study|Lost to Follow-up|6
5475591|NCT01895361|18930156|P2|Overall Study|Lost to Follow-up|4
5475592|NCT01895361|18930157|P1|Overall Study|Lost to Follow-up|4
5475593|NCT01895361|18930155|P3|Overall Study|Death|2
5475594|NCT01895361|18930156|P2|Overall Study|Death|1
5475595|NCT01895361|18930157|P1|Overall Study|Death|2
5475596|NCT01895361|18930155|P3|Overall Study|Adverse Event|3
5475597|NCT01895361|18930156|P2|Overall Study|Adverse Event|1
5475598|NCT01895361|18930157|P1|Overall Study|Adverse Event|1
5475599|NCT01895335|18930186|P1|Overall Study|Other than Specified Above|44
5475600|NCT01895335|18930186|P1|Overall Study|Included But Not treated|1
5475601|NCT01895335|18930186|P1|Overall Study|Poor Compliance to Protocol|11
5475602|NCT01895335|18930186|P1|Overall Study|Lack of Efficacy|53
5475603|NCT01895335|18930186|P1|Overall Study|Adverse Event|106
5475604|NCT01895322|18930203|P1|Overall Study|Protocol Violation|10
5475605|NCT01895322|18930203|P1|Overall Study|Withdrawal by Subject|2
5475606|NCT01895322|18930203|P1|Overall Study|Adverse Event|1
5475607|NCT01895309|18930212|P2|Overall Study|Withdrawal by Subject|18
5475608|NCT01895309|18930213|P1|Overall Study|Withdrawal by Subject|9
5475609|NCT01895309|18930212|P2|Overall Study|Physician Decision|10
5475610|NCT01895309|18930213|P1|Overall Study|Physician Decision|15
5475611|NCT01895309|18930212|P2|Overall Study|Lost to Follow-up|3
5475612|NCT01895309|18930213|P1|Overall Study|Lost to Follow-up|1
5475613|NCT01895309|18930212|P2|Overall Study|Lack of Efficacy|3
5475614|NCT01895309|18930213|P1|Overall Study|Lack of Efficacy|1
5475615|NCT01895309|18930212|P2|Overall Study|Protocol Violation|0
5475616|NCT01895309|18930213|P1|Overall Study|Protocol Violation|1
5475617|NCT01895309|18930212|P2|Overall Study|Adverse Event|17
5475618|NCT01895309|18930213|P1|Overall Study|Adverse Event|13
5475619|NCT01895270|18930227|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
5475620|NCT01895270|18930228|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
5475621|NCT01895270|18930227|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
5475622|NCT01895270|18930228|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
5475623|NCT01895270|18930227|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
5475624|NCT01895270|18930228|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
5475625|NCT01895270|18930227|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
5475626|NCT01895270|18930228|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
5475627|NCT01895270|18930227|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
5475628|NCT01895270|18930228|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
5475629|NCT01895270|18930227|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
5475630|NCT01895270|18930228|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
5475631|NCT01895270|18930227|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
5475632|NCT01895270|18930228|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
5475633|NCT01895101|18930247|P3|Overall Study|coagulation disorder|0
5475634|NCT01895101|18930248|P2|Overall Study|coagulation disorder|1
5475635|NCT01895101|18930249|P1|Overall Study|coagulation disorder|0
5475636|NCT01895101|18930247|P3|Overall Study|Death|0
5475637|NCT01895101|18930248|P2|Overall Study|Death|1
5475638|NCT01895101|18930249|P1|Overall Study|Death|0
5475639|NCT01895101|18930247|P3|Overall Study|another study, enrolled in other study|0
5475640|NCT01895101|18930248|P2|Overall Study|another study, enrolled in other study|1
5475641|NCT01895101|18930249|P1|Overall Study|another study, enrolled in other study|0
5475642|NCT01895101|18930247|P3|Overall Study|Withdrawal by Subject|2
5475643|NCT01895101|18930248|P2|Overall Study|Withdrawal by Subject|1
5475644|NCT01895101|18930249|P1|Overall Study|Withdrawal by Subject|0
5475645|NCT01895101|18930247|P3|Overall Study|OPCAB procedure|3
5475646|NCT01895101|18930248|P2|Overall Study|OPCAB procedure|1
5475647|NCT01895101|18930249|P1|Overall Study|OPCAB procedure|1
5475648|NCT01894984|18930284|P2|Overall Study|Other|175
5475649|NCT01894984|18930285|P1|Overall Study|Other|314
5475650|NCT01894919|18930314|P13|Overall Study|Lost to Follow-up|0
5475651|NCT01894919|18930315|P12|Overall Study|Lost to Follow-up|0
5475652|NCT01894919|18930316|P11|Overall Study|Lost to Follow-up|0
5475653|NCT01894919|18930317|P10|Overall Study|Lost to Follow-up|0
5475654|NCT01894919|18930318|P9|Overall Study|Lost to Follow-up|0
5475655|NCT01894919|18930319|P8|Overall Study|Lost to Follow-up|0
5475656|NCT01894919|18930320|P7|Overall Study|Lost to Follow-up|0
5475657|NCT01894919|18930321|P6|Overall Study|Lost to Follow-up|0
5475658|NCT01894919|18930322|P5|Overall Study|Lost to Follow-up|2
5475659|NCT01894919|18930323|P4|Overall Study|Lost to Follow-up|0
5475660|NCT01894919|18930324|P3|Overall Study|Lost to Follow-up|0
5475661|NCT01894919|18930325|P2|Overall Study|Lost to Follow-up|0
5475662|NCT01894919|18930326|P1|Overall Study|Lost to Follow-up|0
5475663|NCT01894919|18930314|P13|Overall Study|Other-Unspecified|0
5475664|NCT01894919|18930315|P12|Overall Study|Other-Unspecified|0
5475665|NCT01894919|18930316|P11|Overall Study|Other-Unspecified|0
5475666|NCT01894919|18930317|P10|Overall Study|Other-Unspecified|0
5475667|NCT01894919|18930318|P9|Overall Study|Other-Unspecified|0
5475668|NCT01894919|18930319|P8|Overall Study|Other-Unspecified|0
5475669|NCT01894919|18930320|P7|Overall Study|Other-Unspecified|0
5475670|NCT01894919|18930321|P6|Overall Study|Other-Unspecified|0
5475671|NCT01894919|18930322|P5|Overall Study|Other-Unspecified|0
5475672|NCT01894919|18930323|P4|Overall Study|Other-Unspecified|0
5475673|NCT01894919|18930324|P3|Overall Study|Other-Unspecified|0
5475674|NCT01894919|18930325|P2|Overall Study|Other-Unspecified|0
5475675|NCT01894919|18930326|P1|Overall Study|Other-Unspecified|1
5475676|NCT01894919|18930314|P13|Overall Study|Adverse Event|0
5475677|NCT01894919|18930315|P12|Overall Study|Adverse Event|0
5475678|NCT01894919|18930316|P11|Overall Study|Adverse Event|1
5475679|NCT01894919|18930317|P10|Overall Study|Adverse Event|0
5475680|NCT01894919|18930318|P9|Overall Study|Adverse Event|0
5475681|NCT01894919|18930319|P8|Overall Study|Adverse Event|0
5475682|NCT01894919|18930320|P7|Overall Study|Adverse Event|0
5475683|NCT01894919|18930321|P6|Overall Study|Adverse Event|0
5475684|NCT01894919|18930322|P5|Overall Study|Adverse Event|0
5475685|NCT01894919|18930323|P4|Overall Study|Adverse Event|0
5475686|NCT01894919|18930324|P3|Overall Study|Adverse Event|0
5475687|NCT01894919|18930325|P2|Overall Study|Adverse Event|0
5475688|NCT01894919|18930326|P1|Overall Study|Adverse Event|0
5475689|NCT01894919|18930314|P13|Overall Study|Withdrawal by Subject|0
5475690|NCT01894919|18930315|P12|Overall Study|Withdrawal by Subject|0
5475691|NCT01894919|18930316|P11|Overall Study|Withdrawal by Subject|1
5475692|NCT01894919|18930317|P10|Overall Study|Withdrawal by Subject|1
5475693|NCT01894919|18930318|P9|Overall Study|Withdrawal by Subject|0
5475694|NCT01894919|18930319|P8|Overall Study|Withdrawal by Subject|0
5475695|NCT01894919|18930320|P7|Overall Study|Withdrawal by Subject|0
5475696|NCT01894919|18930321|P6|Overall Study|Withdrawal by Subject|0
5475697|NCT01894919|18930322|P5|Overall Study|Withdrawal by Subject|1
5475698|NCT01894919|18930323|P4|Overall Study|Withdrawal by Subject|0
5475699|NCT01894919|18930324|P3|Overall Study|Withdrawal by Subject|0
5475700|NCT01894919|18930325|P2|Overall Study|Withdrawal by Subject|0
5475701|NCT01894919|18930326|P1|Overall Study|Withdrawal by Subject|1
5475702|NCT01894841|18930481|P2|Overall Study|Lost to Follow-up|3
5475703|NCT01894841|18930482|P1|Overall Study|Lost to Follow-up|7
5475704|NCT01894841|18930481|P2|Overall Study|Withdrawn by investigator|2
5475705|NCT01894841|18930482|P1|Overall Study|Withdrawn by investigator|2
5475706|NCT01894841|18930481|P2|Overall Study|Withdrawal by Subject|4
5475707|NCT01894841|18930482|P1|Overall Study|Withdrawal by Subject|9
5475708|NCT01894776|18930498|P1|Overall Study|Withdrawal by Subject|1
5475709|NCT01894620|18930512|P2|Overall Study|Withdrawal by Subject|1
5475710|NCT01894620|18930513|P1|Overall Study|Withdrawal by Subject|0
5475711|NCT01894607|18930521|P1|Overall Study|Ineligible|1
5475712|NCT01894581|18930528|P2|Overall Study|Screen Failure|4
5475713|NCT01894581|18930529|P1|Overall Study|Screen Failure|3
5475714|NCT01894581|18930528|P2|Overall Study|Withdrawal by Subject|3
5475715|NCT01894581|18930529|P1|Overall Study|Withdrawal by Subject|2
5475716|NCT01894568|18930537|P2|Overall Study|Lost to Follow-up|1
5475717|NCT01894568|18930538|P1|Overall Study|Lost to Follow-up|0
5475718|NCT01894568|18930537|P2|Overall Study|Physician Decision|0
5475719|NCT01894568|18930538|P1|Overall Study|Physician Decision|1
5475720|NCT01894568|18930537|P2|Overall Study|Withdrawal by Subject|5
5475721|NCT01894568|18930538|P1|Overall Study|Withdrawal by Subject|5
5475722|NCT01894568|18930537|P2|Overall Study|Protocol required discontinuation|1
5475723|NCT01894568|18930538|P1|Overall Study|Protocol required discontinuation|2
5475724|NCT01894568|18930537|P2|Overall Study|Adverse Event|3
5475725|NCT01894568|18930538|P1|Overall Study|Adverse Event|2
5475726|NCT01894516|18930586|P4|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5475727|NCT01894516|18930587|P3|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
5475728|NCT01894516|18930588|P2|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5475729|NCT01894516|18930589|P1|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5475730|NCT01894516|18930586|P4|Period 2 (Week 13 to Week 24)|Adverse Event|1
5475731|NCT01894516|18930587|P3|Period 2 (Week 13 to Week 24)|Adverse Event|3
5475732|NCT01894516|18930588|P2|Period 2 (Week 13 to Week 24)|Adverse Event|2
5475733|NCT01894516|18930589|P1|Period 2 (Week 13 to Week 24)|Adverse Event|0
5475734|NCT01894516|18930586|P4|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5475735|NCT01894516|18930587|P3|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
5475736|NCT01894516|18930588|P2|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
5475737|NCT01894516|18930589|P1|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5475738|NCT01894516|18930586|P4|Period 1 (Baseline up to Week 12)|Adverse Event|1
5475739|NCT01894516|18930587|P3|Period 1 (Baseline up to Week 12)|Adverse Event|0
5475740|NCT01894516|18930588|P2|Period 1 (Baseline up to Week 12)|Adverse Event|0
5475741|NCT01894516|18930589|P1|Period 1 (Baseline up to Week 12)|Adverse Event|2
5475742|NCT01894516|18930586|P4|Period 1 (Baseline up to Week 12)|Treatment failure|0
5475743|NCT01894516|18930587|P3|Period 1 (Baseline up to Week 12)|Treatment failure|1
5475744|NCT01894516|18930588|P2|Period 1 (Baseline up to Week 12)|Treatment failure|0
5475745|NCT01894516|18930589|P1|Period 1 (Baseline up to Week 12)|Treatment failure|0
5475746|NCT01894516|18930586|P4|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
5475747|NCT01894516|18930587|P3|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
5475748|NCT01894516|18930588|P2|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
5475749|NCT01894516|18930589|P1|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
5475750|NCT01894516|18930586|P4|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5475751|NCT01894516|18930587|P3|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5475752|NCT01894516|18930588|P2|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5475753|NCT01894516|18930589|P1|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
5475754|NCT01894516|18930586|P4|Period 1 (Baseline up to Week 12)|Other|0
5475755|NCT01894516|18930587|P3|Period 1 (Baseline up to Week 12)|Other|1
5475756|NCT01894516|18930588|P2|Period 1 (Baseline up to Week 12)|Other|1
5475757|NCT01894516|18930589|P1|Period 1 (Baseline up to Week 12)|Other|0
5475758|NCT01894477|18930645|P2|Overall Study|protocol changed due SC changed to cord|1
5475759|NCT01894477|18930646|P1|Overall Study|protocol changed due SC changed to cord|0
5475760|NCT01894477|18930645|P2|Overall Study|Protocol Violation|1
5475761|NCT01894477|18930646|P1|Overall Study|Protocol Violation|0
5475762|NCT01894256|18930657|P3|Part B|Lack of Efficacy|13
5475763|NCT01894256|18930658|P2|Part B|Lack of Efficacy|12
5475764|NCT01894256|18930659|P1|Part B|Lack of Efficacy|15
5475765|NCT01894256|18930657|P3|Part B|Withdrawal by Subject|0
5475766|NCT01894256|18930658|P2|Part B|Withdrawal by Subject|1
5475767|NCT01894256|18930659|P1|Part B|Withdrawal by Subject|0
5475768|NCT01894256|18930657|P3|Part B|Death|1
5475769|NCT01894256|18930658|P2|Part B|Death|1
5475770|NCT01894256|18930659|P1|Part B|Death|0
5475771|NCT01894256|18930657|P3|Part A|Adverse Event|0
5475772|NCT01894256|18930658|P2|Part A|Adverse Event|1
5475773|NCT01894256|18930659|P1|Part A|Adverse Event|0
5475774|NCT01894243|18930706|P3|Overall Study|Other|0
5475775|NCT01894243|18930707|P2|Overall Study|Other|0
5475776|NCT01894243|18930708|P1|Overall Study|Other|1
5475777|NCT01894243|18930706|P3|Overall Study|Subject decision|0
5475778|NCT01894243|18930707|P2|Overall Study|Subject decision|0
5475779|NCT01894243|18930708|P1|Overall Study|Subject decision|1
5475780|NCT01894243|18930706|P3|Overall Study|Condition under investigation worsened|2
5475781|NCT01894243|18930707|P2|Overall Study|Condition under investigation worsened|6
5475782|NCT01894243|18930708|P1|Overall Study|Condition under investigation worsened|8
5475783|NCT01894243|18930706|P3|Overall Study|Lack of Efficacy|1
5475784|NCT01894243|18930707|P2|Overall Study|Lack of Efficacy|3
5475785|NCT01894243|18930708|P1|Overall Study|Lack of Efficacy|3
5475786|NCT01894243|18930706|P3|Overall Study|Death|3
5475787|NCT01894243|18930707|P2|Overall Study|Death|0
5475788|NCT01894243|18930708|P1|Overall Study|Death|0
5475789|NCT01894243|18930706|P3|Overall Study|Adverse Event|2
5475790|NCT01894243|18930707|P2|Overall Study|Adverse Event|1
5475791|NCT01894243|18930708|P1|Overall Study|Adverse Event|0
5475792|NCT01894230|18930747|P2|Overall Study|Death|0
5475793|NCT01894230|18930748|P1|Overall Study|Death|1
5475794|NCT01894230|18930747|P2|Overall Study|Non-adherent|1
5475795|NCT01894230|18930748|P1|Overall Study|Non-adherent|0
5475796|NCT01894230|18930747|P2|Overall Study|Withdrawal by Subject|4
5475797|NCT01894230|18930748|P1|Overall Study|Withdrawal by Subject|4
5475798|NCT01894230|18930747|P2|Overall Study|Lost to Follow-up|2
5475799|NCT01894230|18930748|P1|Overall Study|Lost to Follow-up|2
5475800|NCT01894152|18930783|P1|Overall Study|No DMR and no Stent thrombosis|151
5475801|NCT01894100|18930826|P2|Overall Study|Withdrawal by Subject|0
5475802|NCT01894100|18930827|P1|Overall Study|Withdrawal by Subject|3
5475803|NCT01894100|18930826|P2|Overall Study|Lost to Follow-up|1
5475804|NCT01894100|18930827|P1|Overall Study|Lost to Follow-up|0
5475805|NCT01894022|18930852|P2|Overall Study|Study Closed/terminated|10
5475806|NCT01894022|18930853|P1|Overall Study|Study Closed/terminated|7
5475807|NCT01894022|18930852|P2|Overall Study|Adverse Event, non-fatal|0
5475808|NCT01894022|18930853|P1|Overall Study|Adverse Event, non-fatal|1
5475809|NCT01894022|18930852|P2|Overall Study|Death|0
5475810|NCT01894022|18930853|P1|Overall Study|Death|1
5475811|NCT01893905|18930922|P2|Overall Study|Other reason|3
5475812|NCT01893905|18930923|P1|Overall Study|Other reason|1
5475813|NCT01893905|18930922|P2|Overall Study|Lack of adherence to treatment|0
5475814|NCT01893905|18930923|P1|Overall Study|Lack of adherence to treatment|2
5475815|NCT01893905|18930922|P2|Overall Study|Protocol Violation|1
5475816|NCT01893905|18930923|P1|Overall Study|Protocol Violation|6
5475817|NCT01893905|18930922|P2|Overall Study|Lost to Follow-up|0
5475818|NCT01893905|18930923|P1|Overall Study|Lost to Follow-up|1
5475819|NCT01893905|18930922|P2|Overall Study|Lack of Efficacy|7
5475820|NCT01893905|18930923|P1|Overall Study|Lack of Efficacy|5
5475821|NCT01893905|18930922|P2|Overall Study|Adverse Event|3
5475822|NCT01893905|18930923|P1|Overall Study|Adverse Event|9
5475823|NCT01893905|18930922|P2|Overall Study|Withdrawal by Subject|0
5475824|NCT01893905|18930923|P1|Overall Study|Withdrawal by Subject|1
5475825|NCT01893827|18930940|P2|Overall Study|Lost to Follow-up|26
5475826|NCT01893827|18930941|P1|Overall Study|Lost to Follow-up|19
5475827|NCT01893411|18930971|P3|Overall Study|Lost to Follow-up|1
5475828|NCT01893411|18930972|P2|Overall Study|Lost to Follow-up|0
5475829|NCT01893411|18930973|P1|Overall Study|Lost to Follow-up|2
5475830|NCT01893411|18930971|P3|Overall Study|Withdrawal by Subject|3
5475831|NCT01893411|18930972|P2|Overall Study|Withdrawal by Subject|4
5475832|NCT01893411|18930973|P1|Overall Study|Withdrawal by Subject|7
5475833|NCT01893411|18930971|P3|Overall Study|Adverse Event|0
5475834|NCT01893411|18930972|P2|Overall Study|Adverse Event|0
5475835|NCT01893411|18930973|P1|Overall Study|Adverse Event|1
5475836|NCT01893411|18930971|P3|Overall Study|Other|3
5475837|NCT01893411|18930972|P2|Overall Study|Other|1
5475838|NCT01893411|18930973|P1|Overall Study|Other|3
5475839|NCT01893411|18930971|P3|Overall Study|Lack of Efficacy|0
5475840|NCT01893411|18930972|P2|Overall Study|Lack of Efficacy|1
5475841|NCT01893411|18930973|P1|Overall Study|Lack of Efficacy|2
5475842|NCT01893411|18930971|P3|Overall Study|Physician Decision|2
5475843|NCT01893411|18930972|P2|Overall Study|Physician Decision|1
5475844|NCT01893411|18930973|P1|Overall Study|Physician Decision|1
5475845|NCT01893411|18930971|P3|Overall Study|Protocol Violation|0
5475846|NCT01893411|18930972|P2|Overall Study|Protocol Violation|0
5475847|NCT01893411|18930973|P1|Overall Study|Protocol Violation|1
5475848|NCT01893346|18931070|P4|Overall Study|Withdrawal by Subject|0
5475849|NCT01893346|18931071|P3|Overall Study|Withdrawal by Subject|0
5475850|NCT01893346|18931072|P2|Overall Study|Withdrawal by Subject|0
5475851|NCT01893346|18931073|P1|Overall Study|Withdrawal by Subject|2
5475852|NCT01893346|18931070|P4|Overall Study|Protocol Violation|0
5475853|NCT01893346|18931071|P3|Overall Study|Protocol Violation|0
5475854|NCT01893346|18931072|P2|Overall Study|Protocol Violation|0
5475855|NCT01893346|18931073|P1|Overall Study|Protocol Violation|1
5475856|NCT01893346|18931070|P4|Overall Study|Lost to Follow-up|0
5475857|NCT01893346|18931071|P3|Overall Study|Lost to Follow-up|0
5475858|NCT01893346|18931072|P2|Overall Study|Lost to Follow-up|1
5475859|NCT01893346|18931073|P1|Overall Study|Lost to Follow-up|0
5475860|NCT01893281|18931087|P1|Overall Study|Withdrawal by Subject|1
5475861|NCT01893281|18931087|P1|Overall Study|Protocol Violation|1
5475862|NCT01893281|18931087|P1|Overall Study|Adverse Event|1
5475863|NCT01893203|18931094|P1|Overall Study|Withdrawal by Subject|1
5475864|NCT01892722|18931118|P2|Overall Study|Withdrawal by Subject|5
5475865|NCT01892722|18931119|P1|Overall Study|Withdrawal by Subject|3
5475866|NCT01892722|18931118|P2|Overall Study|Lack of Efficacy|7
5475867|NCT01892722|18931119|P1|Overall Study|Lack of Efficacy|0
5475868|NCT01892722|18931118|P2|Overall Study|Adverse Event|2
5475869|NCT01892722|18931119|P1|Overall Study|Adverse Event|3
5475870|NCT01892722|18931118|P2|Overall Study|Physician Decision|2
5475871|NCT01892722|18931119|P1|Overall Study|Physician Decision|1
5475872|NCT01892722|18931118|P2|Overall Study|Patient/guardian decision|2
5475873|NCT01892722|18931119|P1|Overall Study|Patient/guardian decision|0
5475874|NCT01892722|18931118|P2|Overall Study|Administrative problems|1
5475875|NCT01892722|18931119|P1|Overall Study|Administrative problems|0
5475876|NCT01892722|18931118|P2|Overall Study|Protocol deviation|1
5475877|NCT01892722|18931119|P1|Overall Study|Protocol deviation|0
5475878|NCT01892657|18931135|P1|Overall Study|Protocol Violation|12
5475879|NCT01892657|18931135|P1|Overall Study|Withdrawal by Subject|6
5475880|NCT01892540|18931154|P3|Overall Study|Did not fit in scanner|1
5475881|NCT01892540|18931155|P2|Overall Study|Did not fit in scanner|0
5475882|NCT01892540|18931156|P1|Overall Study|Did not fit in scanner|0
5475883|NCT01892540|18931154|P3|Overall Study|Did not complete PET/MRI|2
5475884|NCT01892540|18931155|P2|Overall Study|Did not complete PET/MRI|0
5475885|NCT01892540|18931156|P1|Overall Study|Did not complete PET/MRI|0
5475886|NCT01892436|18931177|P4|Overall Study|Adverse Event|3
5475887|NCT01892436|18931178|P3|Overall Study|Adverse Event|2
5475888|NCT01892436|18931179|P2|Overall Study|Adverse Event|6
5475889|NCT01892436|18931180|P1|Overall Study|Adverse Event|7
5475890|NCT01892436|18931177|P4|Overall Study|non-compliance with treatment|0
5475891|NCT01892436|18931178|P3|Overall Study|non-compliance with treatment|0
5475892|NCT01892436|18931179|P2|Overall Study|non-compliance with treatment|0
5475893|NCT01892436|18931180|P1|Overall Study|non-compliance with treatment|1
5475894|NCT01892436|18931177|P4|Overall Study|Lost to Follow-up|3
5475895|NCT01892436|18931178|P3|Overall Study|Lost to Follow-up|1
5475896|NCT01892436|18931179|P2|Overall Study|Lost to Follow-up|1
5475897|NCT01892436|18931180|P1|Overall Study|Lost to Follow-up|1
5475898|NCT01892436|18931177|P4|Overall Study|Lack of Efficacy|2
5475899|NCT01892436|18931178|P3|Overall Study|Lack of Efficacy|2
5475900|NCT01892436|18931179|P2|Overall Study|Lack of Efficacy|2
5475901|NCT01892436|18931180|P1|Overall Study|Lack of Efficacy|1
5475902|NCT01892436|18931177|P4|Overall Study|Technical problems|1
5475903|NCT01892436|18931178|P3|Overall Study|Technical problems|1
5475904|NCT01892436|18931179|P2|Overall Study|Technical problems|1
5475905|NCT01892436|18931180|P1|Overall Study|Technical problems|2
5475906|NCT01892436|18931177|P4|Overall Study|Pregnancy|0
5475907|NCT01892436|18931178|P3|Overall Study|Pregnancy|1
5475908|NCT01892436|18931179|P2|Overall Study|Pregnancy|2
5475909|NCT01892436|18931180|P1|Overall Study|Pregnancy|0
5475910|NCT01892436|18931177|P4|Overall Study|Physician Decision|1
5475911|NCT01892436|18931178|P3|Overall Study|Physician Decision|0
5475912|NCT01892436|18931179|P2|Overall Study|Physician Decision|1
5475913|NCT01892436|18931180|P1|Overall Study|Physician Decision|2
5475914|NCT01892436|18931177|P4|Overall Study|Death|0
5475915|NCT01892436|18931178|P3|Overall Study|Death|0
5475916|NCT01892436|18931179|P2|Overall Study|Death|1
5475917|NCT01892436|18931180|P1|Overall Study|Death|1
5475918|NCT01892436|18931177|P4|Overall Study|Withdrawal by Subject|4
5475919|NCT01892436|18931178|P3|Overall Study|Withdrawal by Subject|4
5475920|NCT01892436|18931179|P2|Overall Study|Withdrawal by Subject|15
5475921|NCT01892436|18931180|P1|Overall Study|Withdrawal by Subject|8
5475922|NCT01892345|18931220|P2|Overall Study|Withdrawal by Subject|1
5475923|NCT01892345|18931221|P1|Overall Study|Withdrawal by Subject|12
5475924|NCT01892345|18931220|P2|Overall Study|Lost to Follow-up|0
5475925|NCT01892345|18931221|P1|Overall Study|Lost to Follow-up|3
5475926|NCT01892345|18931220|P2|Overall Study|Death|0
5475927|NCT01892345|18931221|P1|Overall Study|Death|1
5475928|NCT01892345|18931220|P2|Overall Study|Adverse Event|2
5475929|NCT01892345|18931221|P1|Overall Study|Adverse Event|0
5475930|NCT01892293|18931262|P1|Overall Study|Apheresed but not treated|4
5475931|NCT01892189|18931306|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5475932|NCT01892189|18931307|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5475933|NCT01892189|18931308|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5475934|NCT01892189|18931309|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
5475935|NCT01892189|18931310|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5475936|NCT01892189|18931311|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5475937|NCT01892189|18931312|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5475938|NCT01892189|18931313|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5475939|NCT01892189|18931314|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
5475940|NCT01892189|18931306|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5475941|NCT01892189|18931307|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5475942|NCT01892189|18931308|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5475943|NCT01892189|18931309|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5475944|NCT01892189|18931310|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5475945|NCT01892189|18931311|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5475946|NCT01892189|18931312|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
5475947|NCT01892189|18931313|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5475948|NCT01892189|18931314|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5475949|NCT01892189|18931306|P9|Washout Period 1 (7 Days)|Adverse Event|1
5475950|NCT01892189|18931307|P8|Washout Period 1 (7 Days)|Adverse Event|0
5475951|NCT01892189|18931308|P7|Washout Period 1 (7 Days)|Adverse Event|0
5475952|NCT01892189|18931309|P6|Washout Period 1 (7 Days)|Adverse Event|0
5475953|NCT01892189|18931310|P5|Washout Period 1 (7 Days)|Adverse Event|0
5475954|NCT01892189|18931311|P4|Washout Period 1 (7 Days)|Adverse Event|0
5475955|NCT01892189|18931312|P3|Washout Period 1 (7 Days)|Adverse Event|0
5475956|NCT01892189|18931313|P2|Washout Period 1 (7 Days)|Adverse Event|0
5475957|NCT01892189|18931314|P1|Washout Period 1 (7 Days)|Adverse Event|0
5475958|NCT01892163|18931356|P2|Overall Study|Lost to Follow-up|0
5475959|NCT01892163|18931357|P1|Overall Study|Lost to Follow-up|1
5475960|NCT01892163|18931356|P2|Overall Study|Death|1
5475961|NCT01892163|18931357|P1|Overall Study|Death|1
5475962|NCT01892020|18931369|P2|Period 2|Protocol Violation|0
5475963|NCT01892020|18931370|P1|Period 2|Protocol Violation|1
5475964|NCT01892020|18931369|P2|Period 1|Unclassified|1
5475965|NCT01892020|18931370|P1|Period 1|Unclassified|0
5475966|NCT01892020|18931369|P2|Period 1|Protocol Violation|4
5475967|NCT01892020|18931370|P1|Period 1|Protocol Violation|2
5475968|NCT01892020|18931369|P2|Period 1|Adverse Event|1
5475969|NCT01892020|18931370|P1|Period 1|Adverse Event|1
5475970|NCT01891890|18931428|P3|Overall Study|Study ended before endpoint reached|6
5475971|NCT01891890|18931429|P2|Overall Study|Study ended before endpoint reached|3
5475972|NCT01891890|18931430|P1|Overall Study|Study ended before endpoint reached|7
5475973|NCT01891890|18931428|P3|Overall Study|Lost to Follow-up|1
5475974|NCT01891890|18931429|P2|Overall Study|Lost to Follow-up|0
5475975|NCT01891890|18931430|P1|Overall Study|Lost to Follow-up|0
5475976|NCT01891864|18931473|P6|Extension Period|Lost to Follow-up|0
5475977|NCT01891864|18931474|P5|Extension Period|Lost to Follow-up|0
5475978|NCT01891864|18931475|P4|Extension Period|Lost to Follow-up|0
5475979|NCT01891864|18931476|P3|Extension Period|Lost to Follow-up|2
5475980|NCT01891864|18931477|P2|Extension Period|Lost to Follow-up|0
5475981|NCT01891864|18931478|P1|Extension Period|Lost to Follow-up|0
5475982|NCT01891864|18931473|P6|Extension Period|Withdrawal by Subject|0
5475983|NCT01891864|18931474|P5|Extension Period|Withdrawal by Subject|4
5475984|NCT01891864|18931475|P4|Extension Period|Withdrawal by Subject|2
5475985|NCT01891864|18931476|P3|Extension Period|Withdrawal by Subject|1
5475986|NCT01891864|18931477|P2|Extension Period|Withdrawal by Subject|0
5475987|NCT01891864|18931478|P1|Extension Period|Withdrawal by Subject|0
5475988|NCT01891864|18931473|P6|Extension Period|Adverse Event|0
5475989|NCT01891864|18931474|P5|Extension Period|Adverse Event|2
5475990|NCT01891864|18931475|P4|Extension Period|Adverse Event|2
5475991|NCT01891864|18931476|P3|Extension Period|Adverse Event|4
5475992|NCT01891864|18931477|P2|Extension Period|Adverse Event|0
5475993|NCT01891864|18931478|P1|Extension Period|Adverse Event|0
5475994|NCT01891864|18931473|P6|Extension Period|Pregnancy|0
5475995|NCT01891864|18931474|P5|Extension Period|Pregnancy|0
5475996|NCT01891864|18931475|P4|Extension Period|Pregnancy|0
5475997|NCT01891864|18931476|P3|Extension Period|Pregnancy|1
5475998|NCT01891864|18931477|P2|Extension Period|Pregnancy|0
5475999|NCT01891864|18931478|P1|Extension Period|Pregnancy|0
5476000|NCT01891864|18931473|P6|Extension Period|Lack of Efficacy|0
5476001|NCT01891864|18931474|P5|Extension Period|Lack of Efficacy|1
5476002|NCT01891864|18931475|P4|Extension Period|Lack of Efficacy|1
5476003|NCT01891864|18931476|P3|Extension Period|Lack of Efficacy|0
5476004|NCT01891864|18931477|P2|Extension Period|Lack of Efficacy|0
5476005|NCT01891864|18931478|P1|Extension Period|Lack of Efficacy|0
5476006|NCT01891864|18931473|P6|Treatment Period 2|Withdrawal by Subject|1
5476007|NCT01891864|18931474|P5|Treatment Period 2|Withdrawal by Subject|1
5476008|NCT01891864|18931475|P4|Treatment Period 2|Withdrawal by Subject|4
5476009|NCT01891864|18931476|P3|Treatment Period 2|Withdrawal by Subject|3
5476010|NCT01891864|18931477|P2|Treatment Period 2|Withdrawal by Subject|0
5476011|NCT01891864|18931478|P1|Treatment Period 2|Withdrawal by Subject|0
5476012|NCT01891864|18931473|P6|Treatment Period 2|Termination of Site|0
5476013|NCT01891864|18931474|P5|Treatment Period 2|Termination of Site|2
5476014|NCT01891864|18931475|P4|Treatment Period 2|Termination of Site|0
5476015|NCT01891864|18931476|P3|Treatment Period 2|Termination of Site|0
5476016|NCT01891864|18931477|P2|Treatment Period 2|Termination of Site|0
5476017|NCT01891864|18931478|P1|Treatment Period 2|Termination of Site|0
5476018|NCT01891864|18931473|P6|Treatment Period 2|Adverse Event|4
5476019|NCT01891864|18931474|P5|Treatment Period 2|Adverse Event|0
5476020|NCT01891864|18931475|P4|Treatment Period 2|Adverse Event|2
5476021|NCT01891864|18931476|P3|Treatment Period 2|Adverse Event|1
5476022|NCT01891864|18931477|P2|Treatment Period 2|Adverse Event|0
5476023|NCT01891864|18931478|P1|Treatment Period 2|Adverse Event|0
5476024|NCT01891864|18931473|P6|Treatment Period 2|Lack of Efficacy|0
5476025|NCT01891864|18931474|P5|Treatment Period 2|Lack of Efficacy|1
5476026|NCT01891864|18931475|P4|Treatment Period 2|Lack of Efficacy|0
5476027|NCT01891864|18931476|P3|Treatment Period 2|Lack of Efficacy|1
5476028|NCT01891864|18931477|P2|Treatment Period 2|Lack of Efficacy|0
5476029|NCT01891864|18931478|P1|Treatment Period 2|Lack of Efficacy|0
5476030|NCT01891864|18931473|P6|Treatment Period 2|Site Termination|0
5476031|NCT01891864|18931474|P5|Treatment Period 2|Site Termination|0
5476032|NCT01891864|18931475|P4|Treatment Period 2|Site Termination|2
5476033|NCT01891864|18931476|P3|Treatment Period 2|Site Termination|1
5476034|NCT01891864|18931477|P2|Treatment Period 2|Site Termination|0
5476035|NCT01891864|18931478|P1|Treatment Period 2|Site Termination|0
5476036|NCT01891864|18931473|P6|Treatment Period 2|Physician Decision|0
5476037|NCT01891864|18931474|P5|Treatment Period 2|Physician Decision|0
5476038|NCT01891864|18931475|P4|Treatment Period 2|Physician Decision|0
5476039|NCT01891864|18931476|P3|Treatment Period 2|Physician Decision|1
5476040|NCT01891864|18931477|P2|Treatment Period 2|Physician Decision|0
5476041|NCT01891864|18931478|P1|Treatment Period 2|Physician Decision|0
5476042|NCT01891864|18931473|P6|Treatment Period 2|Protocol Violation|0
5476043|NCT01891864|18931474|P5|Treatment Period 2|Protocol Violation|0
5476044|NCT01891864|18931475|P4|Treatment Period 2|Protocol Violation|1
5476045|NCT01891864|18931476|P3|Treatment Period 2|Protocol Violation|0
5476046|NCT01891864|18931477|P2|Treatment Period 2|Protocol Violation|0
5476047|NCT01891864|18931478|P1|Treatment Period 2|Protocol Violation|0
5476048|NCT01891864|18931473|P6|Treatment Period 1|Lost to Follow-up|0
5476049|NCT01891864|18931474|P5|Treatment Period 1|Lost to Follow-up|0
5476050|NCT01891864|18931475|P4|Treatment Period 1|Lost to Follow-up|0
5476051|NCT01891864|18931476|P3|Treatment Period 1|Lost to Follow-up|0
5476052|NCT01891864|18931477|P2|Treatment Period 1|Lost to Follow-up|0
5476053|NCT01891864|18931478|P1|Treatment Period 1|Lost to Follow-up|1
5476054|NCT01891864|18931473|P6|Treatment Period 1|Withdrawal by Subject|0
5476055|NCT01891864|18931474|P5|Treatment Period 1|Withdrawal by Subject|0
5476056|NCT01891864|18931475|P4|Treatment Period 1|Withdrawal by Subject|0
5476057|NCT01891864|18931476|P3|Treatment Period 1|Withdrawal by Subject|0
5476058|NCT01891864|18931477|P2|Treatment Period 1|Withdrawal by Subject|5
5476059|NCT01891864|18931478|P1|Treatment Period 1|Withdrawal by Subject|2
5476060|NCT01891864|18931473|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5476061|NCT01891864|18931474|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5476062|NCT01891864|18931475|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5476063|NCT01891864|18931476|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
5476064|NCT01891864|18931477|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
5476065|NCT01891864|18931478|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
5476066|NCT01891864|18931473|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
5476067|NCT01891864|18931474|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
5476068|NCT01891864|18931475|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
5476069|NCT01891864|18931476|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
5476070|NCT01891864|18931477|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
5476071|NCT01891864|18931478|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
5476072|NCT01891864|18931473|P6|Treatment Period 1|Physician Decision|0
5476073|NCT01891864|18931474|P5|Treatment Period 1|Physician Decision|0
5476074|NCT01891864|18931475|P4|Treatment Period 1|Physician Decision|0
5476075|NCT01891864|18931476|P3|Treatment Period 1|Physician Decision|0
5476076|NCT01891864|18931477|P2|Treatment Period 1|Physician Decision|1
5476077|NCT01891864|18931478|P1|Treatment Period 1|Physician Decision|0
5476078|NCT01891864|18931473|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5476079|NCT01891864|18931474|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5476080|NCT01891864|18931475|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5476081|NCT01891864|18931476|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
5476082|NCT01891864|18931477|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
5476083|NCT01891864|18931478|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
5476084|NCT01891721|18931514|P3|Overall Study|Lost to Follow-up|1
5476085|NCT01891721|18931515|P2|Overall Study|Lost to Follow-up|5
5476086|NCT01891721|18931516|P1|Overall Study|Lost to Follow-up|10
5476087|NCT01891669|18931540|P10|Overall Study|Other|0
5476088|NCT01891669|18931541|P9|Overall Study|Other|0
5476089|NCT01891669|18931542|P8|Overall Study|Other|1
5476090|NCT01891669|18931543|P7|Overall Study|Other|0
5476091|NCT01891669|18931544|P6|Overall Study|Other|0
5476092|NCT01891669|18931545|P5|Overall Study|Other|0
5476093|NCT01891669|18931546|P4|Overall Study|Other|0
5476094|NCT01891669|18931547|P3|Overall Study|Other|0
5476095|NCT01891669|18931548|P2|Overall Study|Other|0
5476096|NCT01891669|18931549|P1|Overall Study|Other|1
5476097|NCT01891669|18931540|P10|Overall Study|Withdrawal by Subject|1
5476098|NCT01891669|18931541|P9|Overall Study|Withdrawal by Subject|1
5476099|NCT01891669|18931542|P8|Overall Study|Withdrawal by Subject|2
5476100|NCT01891669|18931543|P7|Overall Study|Withdrawal by Subject|1
5476101|NCT01891669|18931544|P6|Overall Study|Withdrawal by Subject|0
5476102|NCT01891669|18931545|P5|Overall Study|Withdrawal by Subject|0
5476103|NCT01891669|18931546|P4|Overall Study|Withdrawal by Subject|0
5476104|NCT01891669|18931547|P3|Overall Study|Withdrawal by Subject|0
5476105|NCT01891669|18931548|P2|Overall Study|Withdrawal by Subject|1
5476106|NCT01891669|18931549|P1|Overall Study|Withdrawal by Subject|1
5476107|NCT01891669|18931540|P10|Overall Study|Death|1
5476108|NCT01891669|18931541|P9|Overall Study|Death|0
5476109|NCT01891669|18931542|P8|Overall Study|Death|1
5476110|NCT01891669|18931543|P7|Overall Study|Death|0
5476111|NCT01891669|18931544|P6|Overall Study|Death|0
5476112|NCT01891669|18931545|P5|Overall Study|Death|0
5476113|NCT01891669|18931546|P4|Overall Study|Death|0
5476114|NCT01891669|18931547|P3|Overall Study|Death|0
5476115|NCT01891669|18931548|P2|Overall Study|Death|0
5476116|NCT01891669|18931549|P1|Overall Study|Death|0
5476117|NCT01891357|18931700|P1|Overall Study|Protocol Violation|3
5476118|NCT01890967|18931747|P6|Overall Study|Withdrawal by Subject|1
5476119|NCT01890967|18931748|P5|Overall Study|Withdrawal by Subject|3
5476120|NCT01890967|18931749|P4|Overall Study|Withdrawal by Subject|3
5476121|NCT01890967|18931750|P3|Overall Study|Withdrawal by Subject|2
5476122|NCT01890967|18931751|P2|Overall Study|Withdrawal by Subject|4
5476123|NCT01890967|18931752|P1|Overall Study|Withdrawal by Subject|3
5476124|NCT01890967|18931747|P6|Overall Study|Sponsor Decision|3
5476125|NCT01890967|18931748|P5|Overall Study|Sponsor Decision|2
5476126|NCT01890967|18931749|P4|Overall Study|Sponsor Decision|3
5476127|NCT01890967|18931750|P3|Overall Study|Sponsor Decision|1
5476128|NCT01890967|18931751|P2|Overall Study|Sponsor Decision|0
5476129|NCT01890967|18931752|P1|Overall Study|Sponsor Decision|2
5476130|NCT01890967|18931747|P6|Overall Study|Protocol Violation|1
5476131|NCT01890967|18931748|P5|Overall Study|Protocol Violation|4
5476132|NCT01890967|18931749|P4|Overall Study|Protocol Violation|2
5476133|NCT01890967|18931750|P3|Overall Study|Protocol Violation|3
5476134|NCT01890967|18931751|P2|Overall Study|Protocol Violation|3
5476135|NCT01890967|18931752|P1|Overall Study|Protocol Violation|0
5476136|NCT01890967|18931747|P6|Overall Study|Lost to Follow-up|1
5476137|NCT01890967|18931748|P5|Overall Study|Lost to Follow-up|0
5476138|NCT01890967|18931749|P4|Overall Study|Lost to Follow-up|1
5476139|NCT01890967|18931750|P3|Overall Study|Lost to Follow-up|1
5476140|NCT01890967|18931751|P2|Overall Study|Lost to Follow-up|1
5476141|NCT01890967|18931752|P1|Overall Study|Lost to Follow-up|1
5476142|NCT01890967|18931747|P6|Overall Study|Death|0
5476143|NCT01890967|18931748|P5|Overall Study|Death|0
5476144|NCT01890967|18931749|P4|Overall Study|Death|0
5476145|NCT01890967|18931750|P3|Overall Study|Death|0
5476146|NCT01890967|18931751|P2|Overall Study|Death|0
5476147|NCT01890967|18931752|P1|Overall Study|Death|1
5476148|NCT01890967|18931747|P6|Overall Study|Adverse Event|7
5476149|NCT01890967|18931748|P5|Overall Study|Adverse Event|1
5476150|NCT01890967|18931749|P4|Overall Study|Adverse Event|2
5476151|NCT01890967|18931750|P3|Overall Study|Adverse Event|3
5476152|NCT01890967|18931751|P2|Overall Study|Adverse Event|3
5476153|NCT01890967|18931752|P1|Overall Study|Adverse Event|3
5476154|NCT01890915|18931830|P2|Overall Study|Equipment Malfunction|1
5476155|NCT01890915|18931831|P1|Overall Study|Equipment Malfunction|0
5476156|NCT01890915|18931830|P2|Overall Study|Protocol Violation|0
5476157|NCT01890915|18931831|P1|Overall Study|Protocol Violation|2
5476158|NCT01890915|18931830|P2|Overall Study|Adverse Event|0
5476159|NCT01890915|18931831|P1|Overall Study|Adverse Event|1
5476160|NCT01890785|18931847|P6|Third Intervention|Withdrawal by Subject|0
5476161|NCT01890785|18931848|P5|Third Intervention|Withdrawal by Subject|0
5476162|NCT01890785|18931849|P4|Third Intervention|Withdrawal by Subject|0
5476163|NCT01890785|18931850|P3|Third Intervention|Withdrawal by Subject|0
5476164|NCT01890785|18931851|P2|Third Intervention|Withdrawal by Subject|1
5476165|NCT01890785|18931852|P1|Third Intervention|Withdrawal by Subject|0
5476166|NCT01890759|18931871|P2|Overall Study|Withdrawal by Subject|8
5476167|NCT01890759|18931872|P1|Overall Study|Withdrawal by Subject|2
5476168|NCT01890759|18931871|P2|Overall Study|Lost to Follow-up|2
5476169|NCT01890759|18931872|P1|Overall Study|Lost to Follow-up|0
5476170|NCT01890759|18931871|P2|Overall Study|Protocol Violation|2
5476171|NCT01890759|18931872|P1|Overall Study|Protocol Violation|0
5476172|NCT01890746|18931906|P2|Overall Study|Withdrawal by Subject|8
5476173|NCT01890746|18931907|P1|Overall Study|Withdrawal by Subject|5
5476174|NCT01890746|18931906|P2|Overall Study|Physician Decision|2
5476175|NCT01890746|18931907|P1|Overall Study|Physician Decision|3
5476176|NCT01890746|18931906|P2|Overall Study|Lost to Follow-up|1
5476177|NCT01890746|18931907|P1|Overall Study|Lost to Follow-up|4
5476178|NCT01890746|18931906|P2|Overall Study|Adverse Event|0
5476179|NCT01890746|18931907|P1|Overall Study|Adverse Event|1
5476180|NCT01890746|18931906|P2|Overall Study|Death|30
5476181|NCT01890746|18931907|P1|Overall Study|Death|39
5476182|NCT01890707|18931993|P2|Overall Study|Lost to Follow-up|1
5476183|NCT01890707|18931994|P1|Overall Study|Lost to Follow-up|1
5476184|NCT01890512|18932073|P1|Overall Study|Protocol Violation|1
5476185|NCT01890512|18932073|P1|Overall Study|Withdrawal by Subject|1
5476186|NCT01890512|18932073|P1|Overall Study|Physician Decision|1
5476187|NCT01890473|18932079|P2|Overall Study|Poor/non-compliance|0
5476188|NCT01890473|18932080|P1|Overall Study|Poor/non-compliance|1
5476189|NCT01890473|18932079|P2|Overall Study|Lost to Follow-up|0
5476190|NCT01890473|18932080|P1|Overall Study|Lost to Follow-up|1
5476191|NCT01890434|18932106|P1|Overall Study|Withdrawal by PI for ICA not performed|2
5476192|NCT01890434|18932106|P1|Overall Study|Unable to contact|1
5476193|NCT01890434|18932106|P1|Overall Study|Moved out of position|1
5476194|NCT01890434|18932106|P1|Overall Study|Uncontactable by phone|1
5476195|NCT01890434|18932106|P1|Overall Study|Participant didn't complete MRI|1
5476196|NCT01890434|18932106|P1|Overall Study|GSPECT at rest was not done|1
5476197|NCT01890434|18932106|P1|Overall Study|Decline to return for GSPECT|1
5476198|NCT01890434|18932106|P1|Overall Study|Could not get whole set of images|1
5476199|NCT01890434|18932106|P1|Overall Study|CRC didn't contact participant for FU|1
5476200|NCT01890434|18932106|P1|Overall Study|Assessment discrepancy|1
5476201|NCT01890434|18932106|P1|Overall Study|PCI at external hospital|1
5476202|NCT01890434|18932106|P1|Overall Study|Adverse Event|8
5476203|NCT01890421|18932136|P1|Overall Study|Other reason|10
5476204|NCT01890421|18932136|P1|Overall Study|Adverse Event|1
5476205|NCT01890265|18932181|P6|Overall Study|Withdrawal by Subject|0
5476206|NCT01890265|18932182|P5|Overall Study|Withdrawal by Subject|2
5476207|NCT01890265|18932183|P4|Overall Study|Withdrawal by Subject|0
5476208|NCT01890265|18932184|P3|Overall Study|Withdrawal by Subject|3
5476209|NCT01890265|18932185|P2|Overall Study|Withdrawal by Subject|2
5476210|NCT01890265|18932186|P1|Overall Study|Withdrawal by Subject|0
5476211|NCT01890265|18932181|P6|Overall Study|Death|0
5476212|NCT01890265|18932182|P5|Overall Study|Death|0
5476213|NCT01890265|18932183|P4|Overall Study|Death|0
5476214|NCT01890265|18932184|P3|Overall Study|Death|1
5476215|NCT01890265|18932185|P2|Overall Study|Death|3
5476216|NCT01890265|18932186|P1|Overall Study|Death|2
5476217|NCT01890265|18932181|P6|Overall Study|Adverse Event|0
5476218|NCT01890265|18932182|P5|Overall Study|Adverse Event|0
5476219|NCT01890265|18932183|P4|Overall Study|Adverse Event|0
5476220|NCT01890265|18932184|P3|Overall Study|Adverse Event|0
5476221|NCT01890265|18932185|P2|Overall Study|Adverse Event|1
5476222|NCT01890265|18932186|P1|Overall Study|Adverse Event|2
5476223|NCT01890265|18932181|P6|Overall Study|Progressive disease|0
5476224|NCT01890265|18932182|P5|Overall Study|Progressive disease|0
5476225|NCT01890265|18932183|P4|Overall Study|Progressive disease|0
5476226|NCT01890265|18932184|P3|Overall Study|Progressive disease|0
5476227|NCT01890265|18932185|P2|Overall Study|Progressive disease|6
5476228|NCT01890265|18932186|P1|Overall Study|Progressive disease|6
5476229|NCT01890265|18932181|P6|Overall Study|Other (Unspecified reason)|0
5476230|NCT01890265|18932182|P5|Overall Study|Other (Unspecified reason)|0
5476231|NCT01890265|18932183|P4|Overall Study|Other (Unspecified reason)|0
5476232|NCT01890265|18932184|P3|Overall Study|Other (Unspecified reason)|0
5476233|NCT01890265|18932185|P2|Overall Study|Other (Unspecified reason)|1
5476234|NCT01890265|18932186|P1|Overall Study|Other (Unspecified reason)|0
5476235|NCT01890148|18932223|P1|Overall Study|Adverse Event|1
5476236|NCT01890122|18932243|P4|Overall Study|Randomized but not Treated|0
5476237|NCT01890122|18932244|P3|Overall Study|Randomized but not Treated|0
5476238|NCT01890122|18932245|P2|Overall Study|Randomized but not Treated|1
5476239|NCT01890122|18932246|P1|Overall Study|Randomized but not Treated|1
5476240|NCT01890122|18932243|P4|Overall Study|Reason not Specified|2
5476241|NCT01890122|18932244|P3|Overall Study|Reason not Specified|1
5476242|NCT01890122|18932245|P2|Overall Study|Reason not Specified|1
5476243|NCT01890122|18932246|P1|Overall Study|Reason not Specified|0
5476244|NCT01890122|18932243|P4|Overall Study|Lack of Efficacy|41
5476245|NCT01890122|18932244|P3|Overall Study|Lack of Efficacy|7
5476246|NCT01890122|18932245|P2|Overall Study|Lack of Efficacy|24
5476247|NCT01890122|18932246|P1|Overall Study|Lack of Efficacy|14
5476248|NCT01890122|18932243|P4|Overall Study|Voluntary Withdrawal|11
5476249|NCT01890122|18932244|P3|Overall Study|Voluntary Withdrawal|2
5476250|NCT01890122|18932245|P2|Overall Study|Voluntary Withdrawal|8
5476251|NCT01890122|18932246|P1|Overall Study|Voluntary Withdrawal|8
5476252|NCT01890122|18932243|P4|Overall Study|Lost to Follow-up|2
5476253|NCT01890122|18932244|P3|Overall Study|Lost to Follow-up|2
5476254|NCT01890122|18932245|P2|Overall Study|Lost to Follow-up|1
5476255|NCT01890122|18932246|P1|Overall Study|Lost to Follow-up|0
5476256|NCT01890122|18932243|P4|Overall Study|Major Protocol Deviation|1
5476257|NCT01890122|18932244|P3|Overall Study|Major Protocol Deviation|0
5476258|NCT01890122|18932245|P2|Overall Study|Major Protocol Deviation|1
5476259|NCT01890122|18932246|P1|Overall Study|Major Protocol Deviation|3
5476260|NCT01890122|18932243|P4|Overall Study|Adverse Event|2
5476261|NCT01890122|18932244|P3|Overall Study|Adverse Event|1
5476262|NCT01890122|18932245|P2|Overall Study|Adverse Event|1
5476263|NCT01890122|18932246|P1|Overall Study|Adverse Event|1
5476264|NCT01890109|18932310|P2|Overall Study|Lost to Follow-up|2
5476265|NCT01890109|18932311|P1|Overall Study|Lost to Follow-up|1
5476266|NCT01890109|18932310|P2|Overall Study|Withdrawal by Subject|3
5476267|NCT01890109|18932311|P1|Overall Study|Withdrawal by Subject|0
5476268|NCT01889602|18932416|P3|Third Intervention|Withdrawal by Subject|0
5476269|NCT01889602|18932417|P2|Third Intervention|Withdrawal by Subject|2
5476270|NCT01889602|18932418|P1|Third Intervention|Withdrawal by Subject|2
5476271|NCT01889602|18932416|P3|Third Intervention|Protocol Violation|0
5476272|NCT01889602|18932417|P2|Third Intervention|Protocol Violation|0
5476273|NCT01889602|18932418|P1|Third Intervention|Protocol Violation|1
5476274|NCT01889602|18932416|P3|Second Intervention|Withdrawal by Subject|1
5476275|NCT01889602|18932417|P2|Second Intervention|Withdrawal by Subject|0
5476276|NCT01889602|18932418|P1|Second Intervention|Withdrawal by Subject|0
5476277|NCT01889602|18932416|P3|Second Intervention|Study ending|0
5476278|NCT01889602|18932417|P2|Second Intervention|Study ending|0
5476279|NCT01889602|18932418|P1|Second Intervention|Study ending|1
5476280|NCT01889602|18932416|P3|Second Intervention|Adverse Event|1
5476281|NCT01889602|18932417|P2|Second Intervention|Adverse Event|0
5476282|NCT01889602|18932418|P1|Second Intervention|Adverse Event|0
5476283|NCT01889602|18932416|P3|First Intervention|Study ending|0
5476284|NCT01889602|18932417|P2|First Intervention|Study ending|1
5476285|NCT01889602|18932418|P1|First Intervention|Study ending|0
5476286|NCT01889602|18932416|P3|First Intervention|Protocol Violation|1
5476287|NCT01889602|18932417|P2|First Intervention|Protocol Violation|1
5476288|NCT01889602|18932418|P1|First Intervention|Protocol Violation|0
5476289|NCT01889602|18932416|P3|First Intervention|Adverse Event|1
5476290|NCT01889602|18932417|P2|First Intervention|Adverse Event|1
5476291|NCT01889602|18932418|P1|First Intervention|Adverse Event|1
5476292|NCT01889251|18932466|P2|Overall Study|Adverse Event|0
5476293|NCT01889251|18932467|P1|Overall Study|Adverse Event|1
5476294|NCT01889238|18932473|P1|Overall Study|Treatment ongoing|9
5476295|NCT01889069|18932492|P1|Overall Study|Consent Withdrawal|3
5476296|NCT01889069|18932492|P1|Overall Study|Other|4
5476297|NCT01889069|18932492|P1|Overall Study|Lost to Follow-up|6
5476298|NCT01889069|18932492|P1|Overall Study|Progression of Disease|14
5476299|NCT01889069|18932492|P1|Overall Study|Death|18
5476300|NCT01888965|18932537|P1|Overall Study|Lack of Efficacy|4
5476301|NCT01888965|18932537|P1|Overall Study|Adverse Event|5
5476302|NCT01888900|18932549|P2|Overall Study|failed treatment|2
5476303|NCT01888900|18932550|P1|Overall Study|failed treatment|0
5476304|NCT01888874|18932577|P7|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5476305|NCT01888874|18932578|P6|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
5476306|NCT01888874|18932579|P5|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5476307|NCT01888874|18932580|P4|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5476308|NCT01888874|18932581|P3|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5476309|NCT01888874|18932582|P2|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
5476310|NCT01888874|18932583|P1|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
5476311|NCT01888874|18932577|P7|Period 2 (Week 13 to Week 24)|Adverse Event|3
5476312|NCT01888874|18932578|P6|Period 2 (Week 13 to Week 24)|Adverse Event|1
5476313|NCT01888874|18932579|P5|Period 2 (Week 13 to Week 24)|Adverse Event|1
5476314|NCT01888874|18932580|P4|Period 2 (Week 13 to Week 24)|Adverse Event|2
5476315|NCT01888874|18932581|P3|Period 2 (Week 13 to Week 24)|Adverse Event|3
5476316|NCT01888874|18932582|P2|Period 2 (Week 13 to Week 24)|Adverse Event|0
5476317|NCT01888874|18932583|P1|Period 2 (Week 13 to Week 24)|Adverse Event|2
5476318|NCT01888874|18932577|P7|Period 2 (Week 13 to Week 24)|Treatment failure|0
5476319|NCT01888874|18932578|P6|Period 2 (Week 13 to Week 24)|Treatment failure|0
5476320|NCT01888874|18932579|P5|Period 2 (Week 13 to Week 24)|Treatment failure|0
5476321|NCT01888874|18932580|P4|Period 2 (Week 13 to Week 24)|Treatment failure|0
5476322|NCT01888874|18932581|P3|Period 2 (Week 13 to Week 24)|Treatment failure|1
5476323|NCT01888874|18932582|P2|Period 2 (Week 13 to Week 24)|Treatment failure|0
5476324|NCT01888874|18932583|P1|Period 2 (Week 13 to Week 24)|Treatment failure|0
5476325|NCT01888874|18932577|P7|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5476326|NCT01888874|18932578|P6|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
5476327|NCT01888874|18932579|P5|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5476328|NCT01888874|18932580|P4|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5476329|NCT01888874|18932581|P3|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
5476330|NCT01888874|18932582|P2|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5476331|NCT01888874|18932583|P1|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
5476332|NCT01888874|18932577|P7|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5476333|NCT01888874|18932578|P6|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5476334|NCT01888874|18932579|P5|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
5476335|NCT01888874|18932580|P4|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5476336|NCT01888874|18932581|P3|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5476337|NCT01888874|18932582|P2|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5476338|NCT01888874|18932583|P1|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
5476339|NCT01888874|18932577|P7|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5476340|NCT01888874|18932578|P6|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5476341|NCT01888874|18932579|P5|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
5476342|NCT01888874|18932580|P4|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
5476343|NCT01888874|18932581|P3|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
5476344|NCT01888874|18932582|P2|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
5476345|NCT01888874|18932583|P1|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
5476346|NCT01888874|18932577|P7|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5476347|NCT01888874|18932578|P6|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
5476348|NCT01888874|18932579|P5|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5476349|NCT01888874|18932580|P4|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5476350|NCT01888874|18932581|P3|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5476351|NCT01888874|18932582|P2|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
5476352|NCT01888874|18932583|P1|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
5476353|NCT01888874|18932577|P7|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5476354|NCT01888874|18932578|P6|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5476355|NCT01888874|18932579|P5|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5476356|NCT01888874|18932580|P4|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5476357|NCT01888874|18932581|P3|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5476358|NCT01888874|18932582|P2|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
5476359|NCT01888874|18932583|P1|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
5476360|NCT01888874|18932577|P7|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5476361|NCT01888874|18932578|P6|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5476362|NCT01888874|18932579|P5|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
5476363|NCT01888874|18932580|P4|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5476364|NCT01888874|18932581|P3|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5476365|NCT01888874|18932582|P2|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5476366|NCT01888874|18932583|P1|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
5476367|NCT01888874|18932577|P7|Period 1 (Baseline up to Week 12)|Adverse Event|0
5476368|NCT01888874|18932578|P6|Period 1 (Baseline up to Week 12)|Adverse Event|1
5476369|NCT01888874|18932579|P5|Period 1 (Baseline up to Week 12)|Adverse Event|2
5476370|NCT01888874|18932580|P4|Period 1 (Baseline up to Week 12)|Adverse Event|1
5476371|NCT01888874|18932581|P3|Period 1 (Baseline up to Week 12)|Adverse Event|3
5476372|NCT01888874|18932582|P2|Period 1 (Baseline up to Week 12)|Adverse Event|2
5476373|NCT01888874|18932583|P1|Period 1 (Baseline up to Week 12)|Adverse Event|0
5476374|NCT01888874|18932577|P7|Period 1 (Baseline up to Week 12)|Physician Decision|1
5476375|NCT01888874|18932578|P6|Period 1 (Baseline up to Week 12)|Physician Decision|0
5476376|NCT01888874|18932579|P5|Period 1 (Baseline up to Week 12)|Physician Decision|0
5476377|NCT01888874|18932580|P4|Period 1 (Baseline up to Week 12)|Physician Decision|0
5476378|NCT01888874|18932581|P3|Period 1 (Baseline up to Week 12)|Physician Decision|0
5476379|NCT01888874|18932582|P2|Period 1 (Baseline up to Week 12)|Physician Decision|0
5476380|NCT01888874|18932583|P1|Period 1 (Baseline up to Week 12)|Physician Decision|0
5476381|NCT01888874|18932577|P7|Period 1 (Baseline up to Week 12)|Other|0
5476382|NCT01888874|18932578|P6|Period 1 (Baseline up to Week 12)|Other|3
5476383|NCT01888874|18932579|P5|Period 1 (Baseline up to Week 12)|Other|3
5476384|NCT01888874|18932580|P4|Period 1 (Baseline up to Week 12)|Other|1
5476385|NCT01888874|18932581|P3|Period 1 (Baseline up to Week 12)|Other|1
5476386|NCT01888874|18932582|P2|Period 1 (Baseline up to Week 12)|Other|0
5476387|NCT01888874|18932583|P1|Period 1 (Baseline up to Week 12)|Other|1
5476388|NCT01888874|18932577|P7|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
5476389|NCT01888874|18932578|P6|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
5476390|NCT01888874|18932579|P5|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
5476391|NCT01888874|18932580|P4|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
5476392|NCT01888874|18932581|P3|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
5476393|NCT01888874|18932582|P2|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5476394|NCT01888874|18932583|P1|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
5476395|NCT01888640|18932672|P3|Overall Study|Researcher Termination of Participant|1
5476396|NCT01888640|18932673|P2|Overall Study|Researcher Termination of Participant|1
5476397|NCT01888640|18932674|P1|Overall Study|Researcher Termination of Participant|0
5476398|NCT01888640|18932672|P3|Overall Study|Excluded for prior TENS|0
5476399|NCT01888640|18932673|P2|Overall Study|Excluded for prior TENS|1
5476400|NCT01888640|18932674|P1|Overall Study|Excluded for prior TENS|0
5476401|NCT01888640|18932672|P3|Overall Study|Given wrong unit (placebo)|0
5476402|NCT01888640|18932673|P2|Overall Study|Given wrong unit (placebo)|0
5476403|NCT01888640|18932674|P1|Overall Study|Given wrong unit (placebo)|1
5476404|NCT01888640|18932672|P3|Overall Study|Minimum dose not met|0
5476405|NCT01888640|18932673|P2|Overall Study|Minimum dose not met|16
5476406|NCT01888640|18932674|P1|Overall Study|Minimum dose not met|10
5476407|NCT01888640|18932672|P3|Overall Study|Withdrawal by Subject|4
5476408|NCT01888640|18932673|P2|Overall Study|Withdrawal by Subject|11
5476409|NCT01888640|18932674|P1|Overall Study|Withdrawal by Subject|15
5476410|NCT01888640|18932672|P3|Overall Study|Lost to Follow-up|0
5476411|NCT01888640|18932673|P2|Overall Study|Lost to Follow-up|2
5476412|NCT01888640|18932674|P1|Overall Study|Lost to Follow-up|1
5476413|NCT01888432|18932730|P2|36-month Analysis (Extension)|Death|0
5476414|NCT01888432|18932731|P1|36-month Analysis (Extension)|Death|1
5476415|NCT01888432|18932730|P2|24-month Analysis (FAS)|Death|4
5476416|NCT01888432|18932731|P1|24-month Analysis (FAS)|Death|8
5476417|NCT01888432|18932730|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
5476418|NCT01888432|18932731|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
5476419|NCT01888432|18932730|P2|24-month Analysis (FAS)|Physician Decision|4
5476420|NCT01888432|18932731|P1|24-month Analysis (FAS)|Physician Decision|2
5476421|NCT01888432|18932730|P2|24-month Analysis (FAS)|Lost to Follow-up|2
5476422|NCT01888432|18932731|P1|24-month Analysis (FAS)|Lost to Follow-up|0
5476423|NCT01888432|18932730|P2|24-month Analysis (FAS)|Graft loss|1
5476424|NCT01888432|18932731|P1|24-month Analysis (FAS)|Graft loss|0
5476425|NCT01888432|18932730|P2|12-month Analysis (FAS)|Death|3
5476426|NCT01888432|18932731|P1|12-month Analysis (FAS)|Death|4
5476427|NCT01888432|18932730|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
5476428|NCT01888432|18932731|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
5476429|NCT01888432|18932730|P2|12-month Analysis (FAS)|Physician Decision|1
5476430|NCT01888432|18932731|P1|12-month Analysis (FAS)|Physician Decision|1
5476431|NCT01888432|18932730|P2|12-month Analysis (FAS)|Lost to Follow-up|2
5476432|NCT01888432|18932731|P1|12-month Analysis (FAS)|Lost to Follow-up|0
5476433|NCT01888367|18932772|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
5476434|NCT01888367|18932773|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
5476435|NCT01888367|18932774|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
5476436|NCT01888367|18932772|P3|Overall Study|Protocol Violation|1
5476437|NCT01888367|18932773|P2|Overall Study|Protocol Violation|0
5476438|NCT01888367|18932774|P1|Overall Study|Protocol Violation|0
5476439|NCT01888367|18932772|P3|Overall Study|Lost to Follow-up|0
5476440|NCT01888367|18932773|P2|Overall Study|Lost to Follow-up|1
5476441|NCT01888367|18932774|P1|Overall Study|Lost to Follow-up|1
5476442|NCT01888367|18932772|P3|Overall Study|Withdrawal by Subject|1
5476443|NCT01888367|18932773|P2|Overall Study|Withdrawal by Subject|0
5476444|NCT01888367|18932774|P1|Overall Study|Withdrawal by Subject|1
5476445|NCT01888367|18932772|P3|Overall Study|Death|1
5476446|NCT01888367|18932773|P2|Overall Study|Death|0
5476447|NCT01888367|18932774|P1|Overall Study|Death|2
5476448|NCT01888367|18932772|P3|Overall Study|Physician Decision|2
5476449|NCT01888367|18932773|P2|Overall Study|Physician Decision|4
5476450|NCT01888367|18932774|P1|Overall Study|Physician Decision|3
5476451|NCT01888003|18932794|P3|Overall Study|Study Terminated|40
5476452|NCT01888003|18932795|P2|Overall Study|Study Terminated|6
5476453|NCT01888003|18932796|P1|Overall Study|Study Terminated|5
5476454|NCT01887912|18932836|P2|Overall Study|Other|58
5476455|NCT01887912|18932837|P1|Overall Study|Other|122
5476456|NCT01887912|18932836|P2|Overall Study|Withdrawal by Subject|349
5476457|NCT01887912|18932837|P1|Overall Study|Withdrawal by Subject|606
5476458|NCT01887912|18932836|P2|Overall Study|Lost to Follow-up|74
5476459|NCT01887912|18932837|P1|Overall Study|Lost to Follow-up|163
5476460|NCT01887912|18932836|P2|Overall Study|Protocol Violation|37
5476461|NCT01887912|18932837|P1|Overall Study|Protocol Violation|67
5476462|NCT01887912|18932836|P2|Overall Study|Other Adverse Event|15
5476463|NCT01887912|18932837|P1|Overall Study|Other Adverse Event|34
5476464|NCT01887912|18932836|P2|Overall Study|Serious adverse event|198
5476465|NCT01887912|18932837|P1|Overall Study|Serious adverse event|400
5476466|NCT01887717|18932865|P2|Overall Study|Administrative reasons|2
5476467|NCT01887717|18932866|P1|Overall Study|Administrative reasons|5
5476468|NCT01887717|18932865|P2|Overall Study|Physician Decision|2
5476469|NCT01887717|18932866|P1|Overall Study|Physician Decision|0
5476470|NCT01887717|18932865|P2|Overall Study|Withdrawal by Subject|7
5476471|NCT01887717|18932866|P1|Overall Study|Withdrawal by Subject|1
5476472|NCT01887678|18932888|P2|Overall Study|Specified|2
5476473|NCT01887678|18932889|P1|Overall Study|Specified|1
5476474|NCT01887678|18932888|P2|Overall Study|Non-compliance|3
5476475|NCT01887678|18932889|P1|Overall Study|Non-compliance|0
5476476|NCT01887678|18932888|P2|Overall Study|Lack of Efficacy|2
5476477|NCT01887678|18932889|P1|Overall Study|Lack of Efficacy|1
5476478|NCT01887678|18932888|P2|Overall Study|Deterioration of clinical condition|4
5476479|NCT01887678|18932889|P1|Overall Study|Deterioration of clinical condition|0
5476480|NCT01887678|18932888|P2|Overall Study|Lost to Follow-up|2
5476481|NCT01887678|18932889|P1|Overall Study|Lost to Follow-up|4
5476482|NCT01887678|18932888|P2|Overall Study|Withdrawal of consent|4
5476483|NCT01887678|18932889|P1|Overall Study|Withdrawal of consent|3
5476484|NCT01887678|18932888|P2|Overall Study|Exceeded rescue medication dosage|5
5476485|NCT01887678|18932889|P1|Overall Study|Exceeded rescue medication dosage|4
5476486|NCT01887678|18932888|P2|Overall Study|Adverse Event|6
5476487|NCT01887678|18932889|P1|Overall Study|Adverse Event|4
5476488|NCT01887600|18932933|P2|Overall Study|Progressive Disease|0
5476489|NCT01887600|18932934|P1|Overall Study|Progressive Disease|1
5476490|NCT01887600|18932933|P2|Overall Study|Miscellaneous|2
5476491|NCT01887600|18932934|P1|Overall Study|Miscellaneous|6
5476492|NCT01887600|18932933|P2|Overall Study|Non-compliance with study drug|0
5476493|NCT01887600|18932934|P1|Overall Study|Non-compliance with study drug|3
5476494|NCT01887600|18932933|P2|Overall Study|Adverse Event|9
5476495|NCT01887600|18932934|P1|Overall Study|Adverse Event|21
5476496|NCT01887600|18932933|P2|Overall Study|Withdrawal by Subject|52
5476497|NCT01887600|18932934|P1|Overall Study|Withdrawal by Subject|58
5476498|NCT01887600|18932933|P2|Overall Study|Protocol Deviation|0
5476499|NCT01887600|18932934|P1|Overall Study|Protocol Deviation|3
5476500|NCT01887600|18932933|P2|Overall Study|Physician Decision|8
5476501|NCT01887600|18932934|P1|Overall Study|Physician Decision|7
5476502|NCT01887600|18932933|P2|Overall Study|Lost to Follow-up|1
5476503|NCT01887600|18932934|P1|Overall Study|Lost to Follow-up|5
5476504|NCT01887600|18932933|P2|Overall Study|Lack of Efficacy|26
5476505|NCT01887600|18932934|P1|Overall Study|Lack of Efficacy|3
5476506|NCT01887600|18932933|P2|Overall Study|Death|16
5476507|NCT01887600|18932934|P1|Overall Study|Death|39
5476508|NCT01887418|18933075|P3|Overall Study|Travelling difficulties|1
5476509|NCT01887418|18933076|P2|Overall Study|Travelling difficulties|0
5476510|NCT01887418|18933077|P1|Overall Study|Travelling difficulties|0
5476511|NCT01887353|18933096|P2|Overall Study|Study stopped early|3
5476512|NCT01887353|18933097|P1|Overall Study|Study stopped early|4
5476513|NCT01887288|18933125|P1|Overall Study|The study was terminated and the PI has|16
5476514|NCT01887210|18933132|P2|Overall Study|Lost to Follow-up|1
5476515|NCT01887210|18933133|P1|Overall Study|Lost to Follow-up|0
5476516|NCT01887210|18933132|P2|Overall Study|Withdrawal by Subject|3
5476517|NCT01887210|18933133|P1|Overall Study|Withdrawal by Subject|1
5476518|NCT01886872|18933180|P3|Overall Study|Ineligible|12
5476519|NCT01886872|18933181|P2|Overall Study|Ineligible|4
5476520|NCT01886872|18933182|P1|Overall Study|Ineligible|7
5476521|NCT01886833|18933215|P1|Overall Study|IgA not available from both periods|204
5476522|NCT01886781|18933247|P2|Overall Study|Worsening of symptoms|1
5476523|NCT01886781|18933248|P1|Overall Study|Worsening of symptoms|1
5476524|NCT01886781|18933247|P2|Overall Study|Withdrawal by Subject|1
5476525|NCT01886781|18933248|P1|Overall Study|Withdrawal by Subject|2
5476526|NCT01886781|18933247|P2|Overall Study|Lost to Follow-up|0
5476527|NCT01886781|18933248|P1|Overall Study|Lost to Follow-up|5
5476528|NCT01886781|18933247|P2|Overall Study|Adverse Event|0
5476529|NCT01886781|18933248|P1|Overall Study|Adverse Event|1
5476530|NCT01886781|18933247|P2|Overall Study|Protocol Violation|0
5476531|NCT01886781|18933248|P1|Overall Study|Protocol Violation|5
5476532|NCT01886716|18933258|P4|Week 3|Lost to Follow-up|1
5476533|NCT01886716|18933259|P3|Week 3|Lost to Follow-up|0
5476534|NCT01886716|18933260|P2|Week 3|Lost to Follow-up|1
5476535|NCT01886716|18933261|P1|Week 3|Lost to Follow-up|1
5476536|NCT01886716|18933258|P4|Week 2|Lost to Follow-up|3
5476537|NCT01886716|18933259|P3|Week 2|Lost to Follow-up|1
5476538|NCT01886716|18933260|P2|Week 2|Lost to Follow-up|2
5476539|NCT01886716|18933261|P1|Week 2|Lost to Follow-up|3
5476540|NCT01886716|18933258|P4|Week 1|Lost to Follow-up|2
5476541|NCT01886716|18933259|P3|Week 1|Lost to Follow-up|2
5476542|NCT01886716|18933260|P2|Week 1|Lost to Follow-up|0
5476543|NCT01886716|18933261|P1|Week 1|Lost to Follow-up|0
5476544|NCT01886690|18933277|P2|Overall Study|Personal Reasons|1
5476545|NCT01886690|18933278|P1|Overall Study|Personal Reasons|0
5476546|NCT01886690|18933277|P2|Overall Study|Protocol Violation|1
5476547|NCT01886690|18933278|P1|Overall Study|Protocol Violation|0
5476548|NCT01886313|18933294|P2|Overall Study|Adverse Event|1
5476549|NCT01886313|18933295|P1|Overall Study|Adverse Event|1
5476550|NCT01886300|18933301|P1|Overall Study|Trial terminated by sponsor|16
5476551|NCT01886287|18933312|P1|Overall Study|Clinical progression due to disease|1
5476552|NCT01886287|18933312|P1|Overall Study|Radiographic disease progression|1
5476553|NCT01886105|18933328|P1|Overall Study|Lack of Efficacy|3
5476554|NCT01885936|18933335|P2|Overall Study|Withdrawal by Subject|0
5476555|NCT01885936|18933336|P1|Overall Study|Withdrawal by Subject|1
5476556|NCT01885559|18933419|P2|Overall Study|Protocol Violation|1
5476557|NCT01885559|18933420|P1|Overall Study|Protocol Violation|0
5476558|NCT01885559|18933419|P2|Overall Study|Less than full participation|19
5476559|NCT01885559|18933420|P1|Overall Study|Less than full participation|9
5476560|NCT01885559|18933419|P2|Overall Study|Lost to Follow-up|16
5476561|NCT01885559|18933420|P1|Overall Study|Lost to Follow-up|15
5476562|NCT01885208|18933442|P2|Overall Study|Unclassified|38
5476563|NCT01885208|18933443|P1|Overall Study|Unclassified|32
5476564|NCT01885182|18933461|P2|Overall Study|Lack of Efficacy|1
5476565|NCT01885182|18933462|P1|Overall Study|Lack of Efficacy|8
5476566|NCT01885182|18933461|P2|Overall Study|Lost to Follow-up|2
5476567|NCT01885182|18933462|P1|Overall Study|Lost to Follow-up|2
5476568|NCT01885182|18933461|P2|Overall Study|Withdrawal by Subject|6
5476569|NCT01885182|18933462|P1|Overall Study|Withdrawal by Subject|13
5476570|NCT01885182|18933461|P2|Overall Study|Adverse Event|13
5476571|NCT01885182|18933462|P1|Overall Study|Adverse Event|11
5476572|NCT01885104|18933509|P2|Overall Study|Physician Decision|0
5476573|NCT01885104|18933510|P1|Overall Study|Physician Decision|1
5476574|NCT01885104|18933509|P2|Overall Study|Lost to Follow-up|1
5476575|NCT01885104|18933510|P1|Overall Study|Lost to Follow-up|0
5476576|NCT01885104|18933509|P2|Overall Study|Withdrawal of Consent|0
5476577|NCT01885104|18933510|P1|Overall Study|Withdrawal of Consent|1
5476578|NCT01885000|18933520|P2|Overall Study|Protocol Violation|1
5476579|NCT01885000|18933521|P1|Overall Study|Protocol Violation|0
5476580|NCT01885000|18933520|P2|Overall Study|Withdrawal by Subject|1
5476581|NCT01885000|18933521|P1|Overall Study|Withdrawal by Subject|1
5476582|NCT01885000|18933520|P2|Overall Study|Adverse Event|0
5476583|NCT01885000|18933521|P1|Overall Study|Adverse Event|1
5476584|NCT01884688|18933542|P1|Overall Study|Screen Failure|2
5476585|NCT01884675|18933548|P2|Overall Study|Study closed/terminated|2
5476586|NCT01884675|18933549|P1|Overall Study|Study closed/terminated|3
5476587|NCT01884597|18933592|P3|Overall Study|Death|0
5476588|NCT01884597|18933593|P2|Overall Study|Death|1
5476589|NCT01884597|18933594|P1|Overall Study|Death|0
5476590|NCT01884597|18933592|P3|Overall Study|Lack of Efficacy|0
5476591|NCT01884597|18933593|P2|Overall Study|Lack of Efficacy|0
5476592|NCT01884597|18933594|P1|Overall Study|Lack of Efficacy|1
5476593|NCT01884597|18933592|P3|Overall Study|Adverse Event|1
5476594|NCT01884597|18933593|P2|Overall Study|Adverse Event|0
5476595|NCT01884597|18933594|P1|Overall Study|Adverse Event|0
5476596|NCT01884571|18933623|P1|Overall Study|Disease progression|3
5476597|NCT01884571|18933623|P1|Overall Study|Withdrawal by Subject|2
5476598|NCT01884571|18933623|P1|Overall Study|Death|2
5476599|NCT01884571|18933623|P1|Overall Study|Adverse Event|1
5476600|NCT01884545|18933638|P4|Overall Study|Non-adherence|0
5476601|NCT01884545|18933639|P3|Overall Study|Non-adherence|0
5476602|NCT01884545|18933640|P2|Overall Study|Non-adherence|2
5476603|NCT01884545|18933641|P1|Overall Study|Non-adherence|0
5476604|NCT01884545|18933638|P4|Overall Study|Patient withdrawn|5
5476605|NCT01884545|18933639|P3|Overall Study|Patient withdrawn|5
5476606|NCT01884545|18933640|P2|Overall Study|Patient withdrawn|12
5476607|NCT01884545|18933641|P1|Overall Study|Patient withdrawn|7
5476608|NCT01884545|18933638|P4|Overall Study|Lost to Follow-up|4
5476609|NCT01884545|18933639|P3|Overall Study|Lost to Follow-up|9
5476610|NCT01884545|18933640|P2|Overall Study|Lost to Follow-up|4
5476611|NCT01884545|18933641|P1|Overall Study|Lost to Follow-up|6
5476612|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
5476613|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
5476614|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
5476615|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
5476616|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
5476617|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
5476618|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
5476619|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
5476620|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
5476621|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
5476622|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
5476623|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
5476624|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
5476625|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
5476626|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
5476627|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
5476628|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
5476629|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
5476630|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
5476631|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
5476632|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
5476633|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
5476634|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
5476635|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
5476636|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
5476637|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
5476638|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
5476639|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Death|3
5476640|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Death|3
5476641|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Death|7
5476642|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
5476643|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
5476644|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
5476721|NCT01882907|18934042|P1|Overall Study|Lost to Follow-up|1
5476645|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
5476646|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
5476647|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
5476648|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
5476649|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
5476650|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
5476651|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
5476652|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
5476653|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
5476654|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
5476655|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
5476656|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
5476657|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
5476658|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
5476659|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
5476660|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
5476661|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
5476662|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
5476663|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
5476664|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
5476665|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
5476666|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
5476667|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
5476668|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
5476669|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
5476670|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
5476671|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
5476672|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Death|0
5476673|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Death|4
5476674|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Death|6
5476675|NCT01884350|18933794|P3|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
5476676|NCT01884350|18933795|P2|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
5476677|NCT01884350|18933796|P1|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
5476678|NCT01884337|18933819|P2|Follow-up Period|Lost to Follow-up|1
5476679|NCT01884337|18933820|P1|Follow-up Period|Lost to Follow-up|1
5476680|NCT01884337|18933819|P2|Treatment|Subj. request to discont. treatment|0
5476681|NCT01884337|18933820|P1|Treatment|Subj. request to discont. treatment|2
5476682|NCT01884337|18933819|P2|Treatment|Adverse Event|2
5476683|NCT01884337|18933820|P1|Treatment|Adverse Event|2
5476684|NCT01884311|18933828|P1|Overall Study|Precautionary measure|1
5476685|NCT01884311|18933828|P1|Overall Study|withdrew consent due to AEs|1
5476686|NCT01884311|18933828|P1|Overall Study|Withdrawal by Subject|3
5476687|NCT01884077|18933838|P2|Overall Study|study closed|4
5476688|NCT01884077|18933839|P1|Overall Study|study closed|6
5476689|NCT01884077|18933838|P2|Overall Study|Lost to Follow-up|4
5476690|NCT01884077|18933839|P1|Overall Study|Lost to Follow-up|0
5476691|NCT01884077|18933838|P2|Overall Study|canceled surgery|0
5476692|NCT01884077|18933839|P1|Overall Study|canceled surgery|2
5476693|NCT01884077|18933838|P2|Overall Study|screen fail|2
5476694|NCT01884077|18933839|P1|Overall Study|screen fail|0
5476695|NCT01884025|18933860|P2|Overall Study|Lost to Follow-up|4
5476696|NCT01884025|18933861|P1|Overall Study|Lost to Follow-up|3
5476697|NCT01883895|18933921|P1|Overall Study|Lost to Follow-up|2
5476698|NCT01883635|18933948|P2|Overall Study|Withdrawal by Subject|0
5476699|NCT01883635|18933949|P1|Overall Study|Withdrawal by Subject|4
5476700|NCT01883492|18933963|P2|Overall Study|bone anatomy did not meet study criteria|1
5476701|NCT01883492|18933964|P1|Overall Study|bone anatomy did not meet study criteria|1
5476702|NCT01883492|18933963|P2|Overall Study|inappropriate implant used|1
5476703|NCT01883492|18933964|P1|Overall Study|inappropriate implant used|1
5476704|NCT01883492|18933963|P2|Overall Study|Withdrawal by Subject|0
5476705|NCT01883492|18933964|P1|Overall Study|Withdrawal by Subject|1
5476706|NCT01883492|18933963|P2|Overall Study|Poor X-ray quality|4
5476707|NCT01883492|18933964|P1|Overall Study|Poor X-ray quality|7
5476708|NCT01883492|18933963|P2|Overall Study|Surgery on contra-lateral hip|1
5476709|NCT01883492|18933964|P1|Overall Study|Surgery on contra-lateral hip|0
5476710|NCT01883492|18933963|P2|Overall Study|Lost to Follow-up|4
5476711|NCT01883492|18933964|P1|Overall Study|Lost to Follow-up|3
5476712|NCT01883453|18933996|P2|Overall Study|No episode of common cold|23
5476713|NCT01883453|18933997|P1|Overall Study|No episode of common cold|25
5476714|NCT01882985|18934032|P1|Overall Study|Withdrawal by Subject|1
5476715|NCT01882985|18934032|P1|Overall Study|Lost to Follow-up|1
5476716|NCT01882907|18934041|P2|Overall Study|Withdrawal by Subject|6
5476717|NCT01882907|18934042|P1|Overall Study|Withdrawal by Subject|0
5476718|NCT01882907|18934041|P2|Overall Study|Protocol Violation|14
5476719|NCT01882907|18934042|P1|Overall Study|Protocol Violation|10
5476720|NCT01882907|18934041|P2|Overall Study|Lost to Follow-up|4
5476722|NCT01882907|18934041|P2|Overall Study|Lack of Efficacy|3
5476723|NCT01882907|18934042|P1|Overall Study|Lack of Efficacy|0
5476724|NCT01882907|18934041|P2|Overall Study|Adverse Event|1
5476725|NCT01882907|18934042|P1|Overall Study|Adverse Event|3
5476726|NCT01882829|18934088|P1|Overall Study|Withdrawal by Subject|1
5476727|NCT01882829|18934088|P1|Overall Study|Protocol Violation|1
5476728|NCT01882829|18934088|P1|Overall Study|Adverse Event|4
5476729|NCT01882803|18934102|P1|Overall Study|Withdrawal by Subject|4
5476730|NCT01882803|18934102|P1|Overall Study|Protocol Violation|1
5476731|NCT01882803|18934102|P1|Overall Study|Physician Decision|7
5476732|NCT01882803|18934102|P1|Overall Study|Death|7
5476733|NCT01882803|18934102|P1|Overall Study|Adverse Event|22
5476734|NCT01882803|18934102|P1|Overall Study|Disease Progression|53
5476735|NCT01882647|18934129|P2|Overall Study|Withdrawal by Subject|4
5476736|NCT01882647|18934130|P1|Overall Study|Withdrawal by Subject|0
5476737|NCT01882647|18934129|P2|Overall Study|Lost to Follow-up|2
5476738|NCT01882647|18934130|P1|Overall Study|Lost to Follow-up|2
5476739|NCT01882465|18934170|P7|Period 2|Protocol Violation|0
5476740|NCT01882465|18934171|P6|Period 2|Protocol Violation|0
5476741|NCT01882465|18934172|P5|Period 2|Protocol Violation|1
5476742|NCT01882465|18934173|P4|Period 2|Protocol Violation|0
5476743|NCT01882465|18934174|P3|Period 2|Protocol Violation|0
5476744|NCT01882465|18934175|P2|Period 2|Protocol Violation|0
5476745|NCT01882465|18934176|P1|Period 2|Protocol Violation|0
5476746|NCT01882465|18934170|P7|Period 1|Withdrawal by Subject|1
5476747|NCT01882465|18934171|P6|Period 1|Withdrawal by Subject|0
5476748|NCT01882465|18934172|P5|Period 1|Withdrawal by Subject|0
5476749|NCT01882465|18934173|P4|Period 1|Withdrawal by Subject|0
5476750|NCT01882465|18934174|P3|Period 1|Withdrawal by Subject|0
5476751|NCT01882465|18934175|P2|Period 1|Withdrawal by Subject|0
5476752|NCT01882465|18934176|P1|Period 1|Withdrawal by Subject|0
5476753|NCT01882465|18934170|P7|Period 1|Lens Discomfort|0
5476754|NCT01882465|18934171|P6|Period 1|Lens Discomfort|0
5476755|NCT01882465|18934172|P5|Period 1|Lens Discomfort|0
5476756|NCT01882465|18934173|P4|Period 1|Lens Discomfort|1
5476757|NCT01882465|18934174|P3|Period 1|Lens Discomfort|0
5476758|NCT01882465|18934175|P2|Period 1|Lens Discomfort|0
5476759|NCT01882465|18934176|P1|Period 1|Lens Discomfort|0
5476760|NCT01882439|18934188|P4|Overall Study|Adverse event unrelated to study drug|1
5476761|NCT01882439|18934189|P3|Overall Study|Adverse event unrelated to study drug|1
5476762|NCT01882439|18934190|P2|Overall Study|Adverse event unrelated to study drug|2
5476763|NCT01882439|18934191|P1|Overall Study|Adverse event unrelated to study drug|2
5476764|NCT01882439|18934188|P4|Overall Study|Insufficient clinical response|2
5476765|NCT01882439|18934189|P3|Overall Study|Insufficient clinical response|4
5476766|NCT01882439|18934190|P2|Overall Study|Insufficient clinical response|4
5476767|NCT01882439|18934191|P1|Overall Study|Insufficient clinical response|1
5476768|NCT01882439|18934188|P4|Overall Study|Medication error with no associated AE|0
5476769|NCT01882439|18934189|P3|Overall Study|Medication error with no associated AE|2
5476770|NCT01882439|18934190|P2|Overall Study|Medication error with no associated AE|0
5476771|NCT01882439|18934191|P1|Overall Study|Medication error with no associated AE|0
5476772|NCT01882439|18934188|P4|Overall Study|No longer willing to participate|3
5476773|NCT01882439|18934189|P3|Overall Study|No longer willing to participate|2
5476774|NCT01882439|18934190|P2|Overall Study|No longer willing to participate|4
5476775|NCT01882439|18934191|P1|Overall Study|No longer willing to participate|1
5476776|NCT01882439|18934188|P4|Overall Study|Protocol Violation|1
5476777|NCT01882439|18934189|P3|Overall Study|Protocol Violation|0
5476778|NCT01882439|18934190|P2|Overall Study|Protocol Violation|2
5476779|NCT01882439|18934191|P1|Overall Study|Protocol Violation|2
5476780|NCT01882439|18934188|P4|Overall Study|Pregnancy|0
5476781|NCT01882439|18934189|P3|Overall Study|Pregnancy|0
5476782|NCT01882439|18934190|P2|Overall Study|Pregnancy|1
5476783|NCT01882439|18934191|P1|Overall Study|Pregnancy|0
5476784|NCT01882439|18934188|P4|Overall Study|Adverse event related to study drug|2
5476785|NCT01882439|18934189|P3|Overall Study|Adverse event related to study drug|1
5476786|NCT01882439|18934190|P2|Overall Study|Adverse event related to study drug|8
5476787|NCT01882439|18934191|P1|Overall Study|Adverse event related to study drug|3
5476788|NCT01882257|18934388|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
5476789|NCT01882257|18934389|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
5476790|NCT01882257|18934390|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
5476791|NCT01882257|18934388|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
5476792|NCT01882257|18934389|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
5476793|NCT01882257|18934390|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
5476794|NCT01882088|18934397|P1|Overall Study|inadequate pH-impedance tracings|2
5476795|NCT01882088|18934397|P1|Overall Study|Protocol Violation|1
5476796|NCT01882088|18934397|P1|Overall Study|no possibility to place the catheter|1
5476797|NCT01882088|18934397|P1|Overall Study|Intolerance of esophageal manometry|1
5476798|NCT01881776|18934479|P3|Overall Study|Protocol Violation|1
5476799|NCT01881776|18934480|P2|Overall Study|Protocol Violation|2
5476800|NCT01881776|18934481|P1|Overall Study|Protocol Violation|0
5476801|NCT01881776|18934479|P3|Overall Study|Lost to Follow-up|1
5476802|NCT01881776|18934480|P2|Overall Study|Lost to Follow-up|2
5476803|NCT01881776|18934481|P1|Overall Study|Lost to Follow-up|1
5476804|NCT01881750|18934509|P2|Overall Study|Lost to Follow-up|1
5476805|NCT01881750|18934510|P1|Overall Study|Lost to Follow-up|0
5476806|NCT01881750|18934509|P2|Overall Study|Changes in concomitant therapies|3
5476807|NCT01881750|18934510|P1|Overall Study|Changes in concomitant therapies|2
5476808|NCT01881737|18934528|P1|Overall Study|Worsening of baseline behavior|1
5476809|NCT01881737|18934528|P1|Overall Study|Withdrawal by Subject|1
5476810|NCT01881737|18934528|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
5476811|NCT01881620|18934537|P1|Overall Study|Protocol Violation|4
5476812|NCT01881230|18934617|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
5476813|NCT01881230|18934618|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
5476814|NCT01881230|18934619|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
5476815|NCT01881230|18934617|P3|Overall Study|Untreated: Death|1
5476816|NCT01881230|18934618|P2|Overall Study|Untreated: Death|0
5476817|NCT01881230|18934619|P1|Overall Study|Untreated: Death|0
5476818|NCT01881230|18934617|P3|Overall Study|Untreated: Other|1
5476819|NCT01881230|18934618|P2|Overall Study|Untreated: Other|0
5476820|NCT01881230|18934619|P1|Overall Study|Untreated: Other|0
5476821|NCT01881230|18934617|P3|Overall Study|Miscellaneous|0
5476822|NCT01881230|18934618|P2|Overall Study|Miscellaneous|3
5476823|NCT01881230|18934619|P1|Overall Study|Miscellaneous|3
5476824|NCT01881230|18934617|P3|Overall Study|Protocol Violation|0
5476825|NCT01881230|18934618|P2|Overall Study|Protocol Violation|1
5476826|NCT01881230|18934619|P1|Overall Study|Protocol Violation|1
5476827|NCT01881230|18934617|P3|Overall Study|Given Commercially Available Drug|2
5476828|NCT01881230|18934618|P2|Overall Study|Given Commercially Available Drug|0
5476829|NCT01881230|18934619|P1|Overall Study|Given Commercially Available Drug|0
5476830|NCT01881230|18934617|P3|Overall Study|Non-Compliance with Study Drug|0
5476831|NCT01881230|18934618|P2|Overall Study|Non-Compliance with Study Drug|2
5476832|NCT01881230|18934619|P1|Overall Study|Non-Compliance with Study Drug|1
5476833|NCT01881230|18934617|P3|Overall Study|Physician Decision|6
5476834|NCT01881230|18934618|P2|Overall Study|Physician Decision|3
5476835|NCT01881230|18934619|P1|Overall Study|Physician Decision|4
5476836|NCT01881230|18934617|P3|Overall Study|Withdrawal by Subject|6
5476837|NCT01881230|18934618|P2|Overall Study|Withdrawal by Subject|4
5476838|NCT01881230|18934619|P1|Overall Study|Withdrawal by Subject|6
5476839|NCT01881230|18934617|P3|Overall Study|Symptomatic Deterioration|1
5476840|NCT01881230|18934618|P2|Overall Study|Symptomatic Deterioration|3
5476841|NCT01881230|18934619|P1|Overall Study|Symptomatic Deterioration|3
5476842|NCT01881230|18934617|P3|Overall Study|Progressive Disease|36
5476843|NCT01881230|18934618|P2|Overall Study|Progressive Disease|35
5476844|NCT01881230|18934619|P1|Overall Study|Progressive Disease|31
5476845|NCT01881230|18934617|P3|Overall Study|Adverse Event|12
5476846|NCT01881230|18934618|P2|Overall Study|Adverse Event|13
5476847|NCT01881230|18934619|P1|Overall Study|Adverse Event|9
5476848|NCT01881230|18934617|P3|Overall Study|Death|1
5476849|NCT01881230|18934618|P2|Overall Study|Death|0
5476850|NCT01881230|18934619|P1|Overall Study|Death|2
5476851|NCT01881126|18934647|P2|Overall Study|Adverse Event|1
5476852|NCT01881126|18934648|P1|Overall Study|Adverse Event|0
5476853|NCT01881126|18934647|P2|Overall Study|Non-compliance|1
5476854|NCT01881126|18934648|P1|Overall Study|Non-compliance|1
5476855|NCT01881009|18934729|P2|Summer Camp Session (6 Days)|Unable to wear device|1
5476856|NCT01881009|18934730|P1|Summer Camp Session (6 Days)|Unable to wear device|0
5476857|NCT01880736|18934752|P4|Overall Study|Withdrawal Criteria|5
5476858|NCT01880736|18934753|P3|Overall Study|Withdrawal Criteria|1
5476859|NCT01880736|18934754|P2|Overall Study|Withdrawal Criteria|2
5476860|NCT01880736|18934755|P1|Overall Study|Withdrawal Criteria|1
5476861|NCT01880736|18934752|P4|Overall Study|Adverse Event|1
5476862|NCT01880736|18934753|P3|Overall Study|Adverse Event|0
5476863|NCT01880736|18934754|P2|Overall Study|Adverse Event|0
5476864|NCT01880736|18934755|P1|Overall Study|Adverse Event|0
5476865|NCT01880593|18934839|P2|Overall Study|Withdrawal by Subject|1
5476866|NCT01880593|18934840|P1|Overall Study|Withdrawal by Subject|6
5476867|NCT01880593|18934839|P2|Overall Study|Lack of Efficacy|5
5476868|NCT01880593|18934840|P1|Overall Study|Lack of Efficacy|1
5476869|NCT01880593|18934839|P2|Overall Study|Adverse Event|0
5476870|NCT01880593|18934840|P1|Overall Study|Adverse Event|1
5476871|NCT01880528|18934860|P2|Overall Study|Other|1
5476872|NCT01880528|18934861|P1|Overall Study|Other|1
5476873|NCT01880515|18934877|P2|Overall Study|Disease Progression|7
5476874|NCT01880515|18934878|P1|Overall Study|Disease Progression|5
5476875|NCT01880515|18934877|P2|Overall Study|Lost to Follow-up|2
5476876|NCT01880515|18934878|P1|Overall Study|Lost to Follow-up|3
5476877|NCT01880437|18934889|P3|Overall Study|Study terminated by Sponsor|2
5476878|NCT01880437|18934890|P2|Overall Study|Study terminated by Sponsor|0
5476879|NCT01880437|18934891|P1|Overall Study|Study terminated by Sponsor|3
5476880|NCT01880437|18934889|P3|Overall Study|Death|17
5476881|NCT01880437|18934890|P2|Overall Study|Death|4
5476882|NCT01880437|18934891|P1|Overall Study|Death|12
5476883|NCT01880424|18934917|P2|Overall Study|Other|0
5476884|NCT01880424|18934918|P1|Overall Study|Other|1
5476885|NCT01880424|18934917|P2|Overall Study|Withdrawal by Subject|30
5476886|NCT01880424|18934918|P1|Overall Study|Withdrawal by Subject|10
5476887|NCT01880424|18934917|P2|Overall Study|Protocol Violation|13
5476888|NCT01880424|18934918|P1|Overall Study|Protocol Violation|11
5476889|NCT01880424|18934917|P2|Overall Study|Lost to Follow-up|2
5476890|NCT01880424|18934918|P1|Overall Study|Lost to Follow-up|3
5476891|NCT01880424|18934917|P2|Overall Study|Lack of Efficacy|4
5476892|NCT01880424|18934918|P1|Overall Study|Lack of Efficacy|1
5476893|NCT01880424|18934917|P2|Overall Study|Adverse Event|6
5476894|NCT01880424|18934918|P1|Overall Study|Adverse Event|7
5476895|NCT01880086|18934974|P2|Overall Study|Lost to Follow-up|1
5476896|NCT01880086|18934975|P1|Overall Study|Lost to Follow-up|1
5476897|NCT01879852|18935030|P2|Overall Study|Withdrawal by Subject|0
5476898|NCT01879852|18935031|P1|Overall Study|Withdrawal by Subject|2
5476899|NCT01879722|18935086|P10|Overall Study|Voluntary Withdrawal|0
5476900|NCT01879722|18935087|P9|Overall Study|Voluntary Withdrawal|1
5476901|NCT01879722|18935088|P8|Overall Study|Voluntary Withdrawal|0
5476902|NCT01879722|18935089|P7|Overall Study|Voluntary Withdrawal|0
5476903|NCT01879722|18935090|P6|Overall Study|Voluntary Withdrawal|0
5476904|NCT01879722|18935091|P5|Overall Study|Voluntary Withdrawal|0
5476905|NCT01879722|18935092|P4|Overall Study|Voluntary Withdrawal|0
5476906|NCT01879722|18935093|P3|Overall Study|Voluntary Withdrawal|0
5476907|NCT01879722|18935094|P2|Overall Study|Voluntary Withdrawal|0
5476908|NCT01879722|18935095|P1|Overall Study|Voluntary Withdrawal|0
5476909|NCT01879722|18935086|P10|Overall Study|Pretreatment Event/Adverse Event|0
5476910|NCT01879722|18935087|P9|Overall Study|Pretreatment Event/Adverse Event|1
5476911|NCT01879722|18935088|P8|Overall Study|Pretreatment Event/Adverse Event|1
5476912|NCT01879722|18935089|P7|Overall Study|Pretreatment Event/Adverse Event|0
5476913|NCT01879722|18935090|P6|Overall Study|Pretreatment Event/Adverse Event|0
5476914|NCT01879722|18935091|P5|Overall Study|Pretreatment Event/Adverse Event|1
5476915|NCT01879722|18935092|P4|Overall Study|Pretreatment Event/Adverse Event|1
5476916|NCT01879722|18935093|P3|Overall Study|Pretreatment Event/Adverse Event|0
5476917|NCT01879722|18935094|P2|Overall Study|Pretreatment Event/Adverse Event|1
5476918|NCT01879722|18935095|P1|Overall Study|Pretreatment Event/Adverse Event|0
5476919|NCT01879683|18935243|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
5476920|NCT01879618|18935250|P1|Overall Study|Adverse Event|5
5476921|NCT01879618|18935250|P1|Overall Study|Protocol Violation|6
5476922|NCT01879618|18935250|P1|Overall Study|Surgery;changed schedule; not available|8
5476923|NCT01879618|18935250|P1|Overall Study|Withdrawal by Subject|1
5476924|NCT01879618|18935250|P1|Overall Study|Does not meet entrance criteria|1
5476925|NCT01879579|18935257|P2|Overall Study|Discontinued insulin - possible allergy|1
5476926|NCT01879579|18935258|P1|Overall Study|Discontinued insulin - possible allergy|0
5476927|NCT01879579|18935257|P2|Overall Study|Phenotypic type 1 diabetes|1
5476928|NCT01879579|18935258|P1|Overall Study|Phenotypic type 1 diabetes|0
5476929|NCT01879579|18935257|P2|Overall Study|Did not initiate insulin treatment|0
5476930|NCT01879579|18935258|P1|Overall Study|Did not initiate insulin treatment|1
5476931|NCT01879579|18935257|P2|Overall Study|Did not enroll in texting platform|0
5476932|NCT01879579|18935258|P1|Overall Study|Did not enroll in texting platform|1
5476933|NCT01879579|18935257|P2|Overall Study|Phone incompatible with texting platform|0
5476934|NCT01879579|18935258|P1|Overall Study|Phone incompatible with texting platform|3
5476935|NCT01879553|18935288|P2|Overall Study|Withdrawal by Subject|0
5476936|NCT01879553|18935289|P1|Overall Study|Withdrawal by Subject|1
5476937|NCT01879410|18935323|P2|Overall Study|Randomised in Error|2
5476938|NCT01879410|18935324|P1|Overall Study|Randomised in Error|1
5476939|NCT01879410|18935323|P2|Overall Study|Withdrawal by Subject|8
5476940|NCT01879410|18935324|P1|Overall Study|Withdrawal by Subject|7
5476941|NCT01879410|18935323|P2|Overall Study|Lost to Follow-up|1
5476942|NCT01879410|18935324|P1|Overall Study|Lost to Follow-up|2
5476943|NCT01879410|18935323|P2|Overall Study|Protocol Violation|7
5476944|NCT01879410|18935324|P1|Overall Study|Protocol Violation|1
5476945|NCT01879410|18935323|P2|Overall Study|Lack of Efficacy|6
5476946|NCT01879410|18935324|P1|Overall Study|Lack of Efficacy|4
5476947|NCT01879410|18935323|P2|Overall Study|Adverse Event|14
5476948|NCT01879410|18935324|P1|Overall Study|Adverse Event|9
5476949|NCT01879319|18935391|P2|Overall Study|Lost to Follow-up|5
5476950|NCT01879319|18935392|P1|Overall Study|Lost to Follow-up|1
5476951|NCT01879319|18935391|P2|Overall Study|Withdrawal by Subject|0
5476952|NCT01879319|18935392|P1|Overall Study|Withdrawal by Subject|1
5476953|NCT01879072|18935409|P1|Overall Study|Not Transplanted|30
5476954|NCT01879072|18935409|P1|Overall Study|Withdrawal by Subject|121
5476955|NCT01878383|18935553|P2|Overall Study|Lost to Follow-up|1499
5476956|NCT01878383|18935554|P1|Overall Study|Lost to Follow-up|0
5476957|NCT01878292|18935564|P3|Double-blind Down-Taper Period|Withdrawal by Subject|4
5476958|NCT01878292|18935565|P2|Double-blind Down-Taper Period|Withdrawal by Subject|8
5476959|NCT01878292|18935566|P1|Double-blind Down-Taper Period|Withdrawal by Subject|5
5476960|NCT01878292|18935564|P3|Double-blind Treatment Period|Adverse Event|8
5476961|NCT01878292|18935565|P2|Double-blind Treatment Period|Adverse Event|9
5476962|NCT01878292|18935566|P1|Double-blind Treatment Period|Adverse Event|4
5476963|NCT01878292|18935564|P3|Double-blind Treatment Period|Lack of Efficacy|0
5476964|NCT01878292|18935565|P2|Double-blind Treatment Period|Lack of Efficacy|3
5476965|NCT01878292|18935566|P1|Double-blind Treatment Period|Lack of Efficacy|5
5476966|NCT01878292|18935564|P3|Double-blind Treatment Period|Protocol Violation|2
5476967|NCT01878292|18935565|P2|Double-blind Treatment Period|Protocol Violation|4
5476968|NCT01878292|18935566|P1|Double-blind Treatment Period|Protocol Violation|3
5476969|NCT01878292|18935564|P3|Double-blind Treatment Period|Withdrawal by Subject|8
5476970|NCT01878292|18935565|P2|Double-blind Treatment Period|Withdrawal by Subject|7
5476971|NCT01878292|18935566|P1|Double-blind Treatment Period|Withdrawal by Subject|9
5476972|NCT01878292|18935564|P3|Double-blind Treatment Period|Lost to Follow-up|1
5476973|NCT01878292|18935565|P2|Double-blind Treatment Period|Lost to Follow-up|3
5476974|NCT01878292|18935566|P1|Double-blind Treatment Period|Lost to Follow-up|6
5476975|NCT01878292|18935564|P3|Double-blind Treatment Period|Other Reasons|0
5476976|NCT01878292|18935565|P2|Double-blind Treatment Period|Other Reasons|0
5476977|NCT01878292|18935566|P1|Double-blind Treatment Period|Other Reasons|2
5476978|NCT01878292|18935564|P3|Randomized|Adverse Event|0
5476979|NCT01878292|18935565|P2|Randomized|Adverse Event|0
5476980|NCT01878292|18935566|P1|Randomized|Adverse Event|1
5476981|NCT01878292|18935564|P3|Randomized|Lost to Follow-up|0
5476982|NCT01878292|18935565|P2|Randomized|Lost to Follow-up|0
5476983|NCT01878292|18935566|P1|Randomized|Lost to Follow-up|1
5476984|NCT01878292|18935564|P3|Randomized|Protocol Violation|0
5476985|NCT01878292|18935565|P2|Randomized|Protocol Violation|0
5476986|NCT01878292|18935566|P1|Randomized|Protocol Violation|1
5476987|NCT01878253|18935577|P1|Overall Study|Completed Study w/o Follow-up Data|2
5476988|NCT01878253|18935577|P1|Overall Study|Lost to Follow-up|2
5476989|NCT01878253|18935577|P1|Overall Study|Withdrawal by Subject|1
5476990|NCT01878253|18935577|P1|Overall Study|SIdus System Removal|3
5476991|NCT01878253|18935577|P1|Overall Study|Death|1
5476992|NCT01878214|18935588|P2|Overall Study|Lost to Follow-up|36
5476993|NCT01878214|18935589|P1|Overall Study|Lost to Follow-up|35
5476994|NCT01878214|18935588|P2|Overall Study|Death|1
5476995|NCT01878214|18935589|P1|Overall Study|Death|0
5476996|NCT01878214|18935588|P2|Overall Study|Withdrawal by Subject|7
5476997|NCT01878214|18935589|P1|Overall Study|Withdrawal by Subject|18
5476998|NCT01878175|18935603|P1|Overall Study|Developed contraindicated health problem|2
5476999|NCT01878149|18935622|P2|Overall Study|Did Not Meet Eligibility Criteria|2
5477000|NCT01878149|18935623|P1|Overall Study|Did Not Meet Eligibility Criteria|2
5477001|NCT01878097|18935631|P2|Implementation Year 4|Surveys not fully completed|3007
5477002|NCT01878097|18935632|P1|Implementation Year 4|Surveys not fully completed|3604
5477003|NCT01878097|18935631|P2|Implementation Year 3|Surveys not fully completed|2980
5477004|NCT01878097|18935632|P1|Implementation Year 3|Surveys not fully completed|3494
5477005|NCT01878097|18935631|P2|Implementation Year 2|Surveys not fully completed|2841
5477006|NCT01878097|18935632|P1|Implementation Year 2|Surveys not fully completed|3281
5477007|NCT01878097|18935631|P2|Implementation Year 1|Surveys not fully completed|2549
5477008|NCT01878097|18935632|P1|Implementation Year 1|Surveys not fully completed|3202
5477009|NCT01878097|18935631|P2|Baseline|Surveys not fully completed|1800
5477010|NCT01878097|18935632|P1|Baseline|Surveys not fully completed|2497
5477011|NCT01878084|18935640|P1|Overall Study|Physician Decision|2
5477012|NCT01877915|18935674|P2|Overall Study|Other|4
5477013|NCT01877915|18935675|P1|Overall Study|Other|2
5477014|NCT01877915|18935674|P2|Overall Study|Withdrawal by Subject|55
5477015|NCT01877915|18935675|P1|Overall Study|Withdrawal by Subject|42
5477016|NCT01877915|18935674|P2|Overall Study|Lost to Follow-up|9
5477017|NCT01877915|18935675|P1|Overall Study|Lost to Follow-up|10
5477018|NCT01877720|18935697|P2|Overall Study|Adverse Event|0
5477019|NCT01877720|18935698|P1|Overall Study|Adverse Event|1
5477020|NCT01877668|18935727|P5|Overall Study|Adverse event unrelated to study drug|1
5477021|NCT01877668|18935728|P4|Overall Study|Adverse event unrelated to study drug|0
5477022|NCT01877668|18935729|P3|Overall Study|Adverse event unrelated to study drug|2
5477023|NCT01877668|18935730|P2|Overall Study|Adverse event unrelated to study drug|1
5477024|NCT01877668|18935731|P1|Overall Study|Adverse event unrelated to study drug|4
5477025|NCT01877668|18935727|P5|Overall Study|Adverse event related to study drug|1
5477026|NCT01877668|18935728|P4|Overall Study|Adverse event related to study drug|2
5477027|NCT01877668|18935729|P3|Overall Study|Adverse event related to study drug|2
5477028|NCT01877668|18935730|P2|Overall Study|Adverse event related to study drug|2
5477029|NCT01877668|18935731|P1|Overall Study|Adverse event related to study drug|2
5477030|NCT01877668|18935727|P5|Overall Study|Protocol Violation|3
5477031|NCT01877668|18935728|P4|Overall Study|Protocol Violation|0
5477032|NCT01877668|18935729|P3|Overall Study|Protocol Violation|0
5477033|NCT01877668|18935730|P2|Overall Study|Protocol Violation|1
5477034|NCT01877668|18935731|P1|Overall Study|Protocol Violation|1
5477035|NCT01877668|18935727|P5|Overall Study|Other|3
5477036|NCT01877668|18935728|P4|Overall Study|Other|1
5477037|NCT01877668|18935729|P3|Overall Study|Other|1
5477038|NCT01877668|18935730|P2|Overall Study|Other|1
5477039|NCT01877668|18935731|P1|Overall Study|Other|1
5477040|NCT01877668|18935727|P5|Overall Study|Withdrawal by Subject|2
5477041|NCT01877668|18935728|P4|Overall Study|Withdrawal by Subject|2
5477042|NCT01877668|18935729|P3|Overall Study|Withdrawal by Subject|3
5477043|NCT01877668|18935730|P2|Overall Study|Withdrawal by Subject|0
5477044|NCT01877668|18935731|P1|Overall Study|Withdrawal by Subject|2
5477045|NCT01877668|18935727|P5|Overall Study|Lost to Follow-up|0
5477046|NCT01877668|18935728|P4|Overall Study|Lost to Follow-up|0
5477047|NCT01877668|18935729|P3|Overall Study|Lost to Follow-up|1
5477048|NCT01877668|18935730|P2|Overall Study|Lost to Follow-up|2
5477049|NCT01877668|18935731|P1|Overall Study|Lost to Follow-up|0
5477050|NCT01877668|18935727|P5|Overall Study|Insufficient clinical response|0
5477051|NCT01877668|18935728|P4|Overall Study|Insufficient clinical response|2
5477052|NCT01877668|18935729|P3|Overall Study|Insufficient clinical response|2
5477053|NCT01877668|18935730|P2|Overall Study|Insufficient clinical response|1
5477054|NCT01877668|18935731|P1|Overall Study|Insufficient clinical response|0
5477055|NCT01877668|18935727|P5|Overall Study|No longer met study criteria|0
5477056|NCT01877668|18935728|P4|Overall Study|No longer met study criteria|0
5477057|NCT01877668|18935729|P3|Overall Study|No longer met study criteria|1
5477058|NCT01877668|18935730|P2|Overall Study|No longer met study criteria|0
5477059|NCT01877668|18935731|P1|Overall Study|No longer met study criteria|1
5477060|NCT01877668|18935727|P5|Overall Study|Death|0
5477061|NCT01877668|18935728|P4|Overall Study|Death|1
5477062|NCT01877668|18935729|P3|Overall Study|Death|0
5477063|NCT01877668|18935730|P2|Overall Study|Death|0
5477064|NCT01877668|18935731|P1|Overall Study|Death|0
5477065|NCT01877655|18935962|P2|Overall Study|Randomized but Never Received Drug|5
5477066|NCT01877655|18935963|P1|Overall Study|Randomized but Never Received Drug|8
5477067|NCT01877655|18935962|P2|Overall Study|Miscellaneous|4
5477068|NCT01877655|18935963|P1|Overall Study|Miscellaneous|4
5477069|NCT01877655|18935962|P2|Overall Study|Physician Decision|10
5477070|NCT01877655|18935963|P1|Overall Study|Physician Decision|11
5477071|NCT01877655|18935962|P2|Overall Study|Withdrawal by Subject|26
5477072|NCT01877655|18935963|P1|Overall Study|Withdrawal by Subject|18
5477073|NCT01877655|18935962|P2|Overall Study|Death|52
5477074|NCT01877655|18935963|P1|Overall Study|Death|57
5477075|NCT01877551|18936019|P2|Overall Study|Physician Decision|1
5477076|NCT01877551|18936020|P1|Overall Study|Physician Decision|0
5477077|NCT01877421|18936069|P18|Phase 2|Protocol Violation|0
5477078|NCT01877421|18936070|P17|Phase 2|Protocol Violation|0
5477079|NCT01877421|18936071|P16|Phase 2|Protocol Violation|0
5477080|NCT01877421|18936072|P15|Phase 2|Protocol Violation|0
5477081|NCT01877421|18936073|P14|Phase 2|Protocol Violation|0
5477082|NCT01877421|18936074|P13|Phase 2|Protocol Violation|0
5477083|NCT01877421|18936075|P12|Phase 2|Protocol Violation|0
5477084|NCT01877421|18936076|P11|Phase 2|Protocol Violation|1
5477085|NCT01877421|18936077|P10|Phase 2|Protocol Violation|0
5477086|NCT01877421|18936078|P9|Phase 2|Protocol Violation|0
5477087|NCT01877421|18936079|P8|Phase 2|Protocol Violation|0
5477088|NCT01877421|18936080|P7|Phase 2|Protocol Violation|0
5477089|NCT01877421|18936081|P6|Phase 2|Protocol Violation|0
5477090|NCT01877421|18936082|P5|Phase 2|Protocol Violation|0
5477091|NCT01877421|18936083|P4|Phase 2|Protocol Violation|0
5477092|NCT01877421|18936084|P3|Phase 2|Protocol Violation|0
5477093|NCT01877421|18936085|P2|Phase 2|Protocol Violation|0
5477094|NCT01877421|18936086|P1|Phase 2|Protocol Violation|0
5477095|NCT01877421|18936069|P18|Phase 2|Withdrawal by Subject|0
5477096|NCT01877421|18936070|P17|Phase 2|Withdrawal by Subject|0
5477097|NCT01877421|18936071|P16|Phase 2|Withdrawal by Subject|1
5477098|NCT01877421|18936072|P15|Phase 2|Withdrawal by Subject|0
5477099|NCT01877421|18936073|P14|Phase 2|Withdrawal by Subject|0
5477100|NCT01877421|18936074|P13|Phase 2|Withdrawal by Subject|1
5477101|NCT01877421|18936075|P12|Phase 2|Withdrawal by Subject|0
5477102|NCT01877421|18936076|P11|Phase 2|Withdrawal by Subject|1
5477103|NCT01877421|18936077|P10|Phase 2|Withdrawal by Subject|0
5477104|NCT01877421|18936078|P9|Phase 2|Withdrawal by Subject|1
5477105|NCT01877421|18936079|P8|Phase 2|Withdrawal by Subject|0
5477106|NCT01877421|18936080|P7|Phase 2|Withdrawal by Subject|0
5477107|NCT01877421|18936081|P6|Phase 2|Withdrawal by Subject|0
5477108|NCT01877421|18936082|P5|Phase 2|Withdrawal by Subject|0
5477109|NCT01877421|18936083|P4|Phase 2|Withdrawal by Subject|0
5477110|NCT01877421|18936084|P3|Phase 2|Withdrawal by Subject|0
5477111|NCT01877421|18936085|P2|Phase 2|Withdrawal by Subject|0
5477112|NCT01877421|18936086|P1|Phase 2|Withdrawal by Subject|0
5477113|NCT01877421|18936069|P18|Phase 2|Lost to Follow-up|0
5477114|NCT01877421|18936070|P17|Phase 2|Lost to Follow-up|0
5477115|NCT01877421|18936071|P16|Phase 2|Lost to Follow-up|0
5477116|NCT01877421|18936072|P15|Phase 2|Lost to Follow-up|0
5477117|NCT01877421|18936073|P14|Phase 2|Lost to Follow-up|0
5477118|NCT01877421|18936074|P13|Phase 2|Lost to Follow-up|0
5477119|NCT01877421|18936075|P12|Phase 2|Lost to Follow-up|0
5477120|NCT01877421|18936076|P11|Phase 2|Lost to Follow-up|0
5477121|NCT01877421|18936077|P10|Phase 2|Lost to Follow-up|0
5477122|NCT01877421|18936078|P9|Phase 2|Lost to Follow-up|0
5477123|NCT01877421|18936079|P8|Phase 2|Lost to Follow-up|0
5477124|NCT01877421|18936080|P7|Phase 2|Lost to Follow-up|1
5477125|NCT01877421|18936081|P6|Phase 2|Lost to Follow-up|0
5477126|NCT01877421|18936082|P5|Phase 2|Lost to Follow-up|0
5477127|NCT01877421|18936083|P4|Phase 2|Lost to Follow-up|0
5477128|NCT01877421|18936084|P3|Phase 2|Lost to Follow-up|0
5477129|NCT01877421|18936085|P2|Phase 2|Lost to Follow-up|0
5477130|NCT01877421|18936086|P1|Phase 2|Lost to Follow-up|0
5477131|NCT01877408|18936196|P2|Overall Study|Lost to Follow-up|2
5477132|NCT01877408|18936197|P1|Overall Study|Lost to Follow-up|0
5477133|NCT01877278|18936230|P2|Overall Study|Lost to Follow-up|3
5477134|NCT01877278|18936231|P1|Overall Study|Lost to Follow-up|3
5477135|NCT01877265|18936239|P6|Treatment Period 3|Lost to Follow-up|0
5477136|NCT01877265|18936240|P5|Treatment Period 3|Lost to Follow-up|0
5477137|NCT01877265|18936241|P4|Treatment Period 3|Lost to Follow-up|0
5477138|NCT01877265|18936242|P3|Treatment Period 3|Lost to Follow-up|0
5477139|NCT01877265|18936243|P2|Treatment Period 3|Lost to Follow-up|0
5477140|NCT01877265|18936244|P1|Treatment Period 3|Lost to Follow-up|1
5477141|NCT01877265|18936239|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
5477142|NCT01877265|18936240|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5477143|NCT01877265|18936241|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5477144|NCT01877265|18936242|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5477145|NCT01877265|18936243|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5477146|NCT01877265|18936244|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
5477147|NCT01877265|18936239|P6|Treatment Period 1|Sponsor Decision|0
5477148|NCT01877265|18936240|P5|Treatment Period 1|Sponsor Decision|0
5477149|NCT01877265|18936241|P4|Treatment Period 1|Sponsor Decision|0
5477150|NCT01877265|18936242|P3|Treatment Period 1|Sponsor Decision|1
5477151|NCT01877265|18936243|P2|Treatment Period 1|Sponsor Decision|0
5477152|NCT01877265|18936244|P1|Treatment Period 1|Sponsor Decision|0
5477153|NCT01877239|18936261|P1|Overall Study|Data not available|35
5477154|NCT01877239|18936261|P1|Overall Study|Lack of Efficacy|4
5477155|NCT01877239|18936261|P1|Overall Study|Other|2
5477156|NCT01877239|18936261|P1|Overall Study|Withdrawal by Subject|4
5477157|NCT01877239|18936261|P1|Overall Study|Disease Remission|1
5477158|NCT01877239|18936261|P1|Overall Study|Adverse Event|4
5477159|NCT01877187|18936267|P1|Overall Study|Liver transplant|2
5477160|NCT01877187|18936267|P1|Overall Study|Declining clinical status|11
5477161|NCT01877187|18936267|P1|Overall Study|Lost to Follow-up|3
5477162|NCT01877187|18936267|P1|Overall Study|Withdrawal by Subject|4
5477163|NCT01877187|18936267|P1|Overall Study|Death|2
5477164|NCT01877083|18936319|P1|Extension Phase|Adverse Event|2
5477165|NCT01877083|18936319|P1|Extension Phase|Disease Progression|3
5477166|NCT01877083|18936319|P1|Treatment Phase|Lost to Follow-up|1
5477167|NCT01877083|18936319|P1|Treatment Phase|Withdrawal by Subject|2
5477168|NCT01877083|18936319|P1|Treatment Phase|Adverse Event|6
5477169|NCT01877083|18936319|P1|Treatment Phase|Clinical Progression|1
5477170|NCT01877083|18936319|P1|Treatment Phase|Disease Progression|10
5477171|NCT01876979|18936343|P2|Overall Study|Physician Decision|3
5477172|NCT01876979|18936344|P1|Overall Study|Physician Decision|2
5477173|NCT01876823|18936350|P1|Overall Study|Patients moved|2
5477174|NCT01876823|18936350|P1|Overall Study|Physician Decision|2
5477175|NCT01876823|18936350|P1|Overall Study|Withdrawal by Subject|5
5477176|NCT01876810|18936363|P2|Overall Study|Physician Decision|1
5477177|NCT01876810|18936364|P1|Overall Study|Physician Decision|0
5477178|NCT01876784|18936376|P2|Overall Study|Ongoing|40
5477179|NCT01876784|18936377|P1|Overall Study|Ongoing|41
5477180|NCT01876784|18936376|P2|Overall Study|Other than specified above|6
5477181|NCT01876784|18936377|P1|Overall Study|Other than specified above|5
5477182|NCT01876784|18936376|P2|Overall Study|Randomized but not treated|1
5477183|NCT01876784|18936377|P1|Overall Study|Randomized but not treated|2
5477184|NCT01876784|18936376|P2|Overall Study|Death|0
5477185|NCT01876784|18936377|P1|Overall Study|Death|1
5477186|NCT01876784|18936376|P2|Overall Study|Lost to Follow-up|1
5477187|NCT01876784|18936377|P1|Overall Study|Lost to Follow-up|0
5477188|NCT01876784|18936376|P2|Overall Study|Disease progression|67
5477189|NCT01876784|18936377|P1|Overall Study|Disease progression|37
5477190|NCT01876784|18936376|P2|Overall Study|Protocol Violation|0
5477191|NCT01876784|18936377|P1|Overall Study|Protocol Violation|1
5477192|NCT01876784|18936376|P2|Overall Study|Adverse Event|2
5477193|NCT01876784|18936377|P1|Overall Study|Adverse Event|15
5477194|NCT01876784|18936376|P2|Overall Study|Withdrawal by Subject|2
5477195|NCT01876784|18936377|P1|Overall Study|Withdrawal by Subject|17
5477196|NCT01876732|18936383|P1|Overall Study|MMA was not over 800mg/dL|75
5477197|NCT01876706|18936388|P1|Overall Study|Death|3
5477198|NCT01876706|18936388|P1|Overall Study|Withdrawals|6
5477199|NCT01876706|18936388|P1|Overall Study|Lost to Follow-up|7
5477200|NCT01876706|18936388|P1|Overall Study|BPH Intervention|9
5477201|NCT01876511|18936408|P3|Overall Study|Physician Decision|1
5477202|NCT01876511|18936409|P2|Overall Study|Physician Decision|0
5477203|NCT01876511|18936410|P1|Overall Study|Physician Decision|1
5477204|NCT01876511|18936408|P3|Overall Study|Patient Decision|6
5477205|NCT01876511|18936409|P2|Overall Study|Patient Decision|0
5477206|NCT01876511|18936410|P1|Overall Study|Patient Decision|3
5477207|NCT01876511|18936408|P3|Overall Study|Drug-related Toxicity|6
5477208|NCT01876511|18936409|P2|Overall Study|Drug-related Toxicity|1
5477209|NCT01876511|18936410|P1|Overall Study|Drug-related Toxicity|5
5477210|NCT01876511|18936408|P3|Overall Study|Death (unrelated)|2
5477211|NCT01876511|18936409|P2|Overall Study|Death (unrelated)|0
5477212|NCT01876511|18936410|P1|Overall Study|Death (unrelated)|3
5477213|NCT01876511|18936408|P3|Overall Study|Disease Progression-clinical/radiologic|16
5477214|NCT01876511|18936409|P2|Overall Study|Disease Progression-clinical/radiologic|24
5477215|NCT01876511|18936410|P1|Overall Study|Disease Progression-clinical/radiologic|11
5477216|NCT01876446|18936458|P2|Overall Study|Physician Decision|3
5477217|NCT01876446|18936459|P1|Overall Study|Physician Decision|1
5477218|NCT01876446|18936458|P2|Overall Study|Withdrawal by Subject|2
5477219|NCT01876446|18936459|P1|Overall Study|Withdrawal by Subject|1
5477220|NCT01876446|18936458|P2|Overall Study|Death|1
5477221|NCT01876446|18936459|P1|Overall Study|Death|0
5477222|NCT01876420|18936475|P1|Overall Study|Missed 30 day visit|1
5477223|NCT01876381|18936487|P1|Overall Study|Withdrawal by Subject|1
5477224|NCT01876381|18936487|P1|Overall Study|Physician Decision|1
5477225|NCT01876381|18936487|P1|Overall Study|Lack of Efficacy|5
5477226|NCT01876368|18936494|P2|Overall Study|Subject/guardian decision|1
5477227|NCT01876368|18936495|P1|Overall Study|Subject/guardian decision|3
5477228|NCT01876368|18936494|P2|Overall Study|Protocol deviation|3
5477229|NCT01876368|18936495|P1|Overall Study|Protocol deviation|3
5477230|NCT01876368|18936494|P2|Overall Study|Physician Decision|2
5477231|NCT01876368|18936495|P1|Overall Study|Physician Decision|0
5477232|NCT01876368|18936494|P2|Overall Study|Non-compliance with study treatment|1
5477233|NCT01876368|18936495|P1|Overall Study|Non-compliance with study treatment|0
5477234|NCT01876368|18936494|P2|Overall Study|Lost to Follow-up|1
5477235|NCT01876368|18936495|P1|Overall Study|Lost to Follow-up|0
5477236|NCT01876368|18936494|P2|Overall Study|Lack of Efficacy|0
5477237|NCT01876368|18936495|P1|Overall Study|Lack of Efficacy|1
5477238|NCT01876368|18936494|P2|Overall Study|Adverse Event|5
5477239|NCT01876368|18936495|P1|Overall Study|Adverse Event|2
5477240|NCT01876251|18936540|P3|Overall Study|Objective progression or relapse|8
5477241|NCT01876251|18936541|P2|Overall Study|Objective progression or relapse|3
5477242|NCT01876251|18936542|P1|Overall Study|Objective progression or relapse|10
5477243|NCT01876251|18936540|P3|Overall Study|Study terminated|0
5477244|NCT01876251|18936541|P2|Overall Study|Study terminated|0
5477245|NCT01876251|18936542|P1|Overall Study|Study terminated|1
5477246|NCT01876251|18936540|P3|Overall Study|Participant refused further follow-up|1
5477247|NCT01876251|18936541|P2|Overall Study|Participant refused further follow-up|0
5477248|NCT01876251|18936542|P1|Overall Study|Participant refused further follow-up|0
5477249|NCT01876251|18936540|P3|Overall Study|Participant started new treatment|1
5477250|NCT01876251|18936541|P2|Overall Study|Participant started new treatment|0
5477251|NCT01876251|18936542|P1|Overall Study|Participant started new treatment|1
5477252|NCT01876251|18936540|P3|Overall Study|Death|1
5477253|NCT01876251|18936541|P2|Overall Study|Death|0
5477254|NCT01876251|18936542|P1|Overall Study|Death|2
5477255|NCT01876251|18936540|P3|Overall Study|Clinical progression|0
5477256|NCT01876251|18936541|P2|Overall Study|Clinical progression|0
5477257|NCT01876251|18936542|P1|Overall Study|Clinical progression|1
5477258|NCT01876043|18936646|P1|Overall Study|Withdrawal by Subject|1
5477259|NCT01876043|18936646|P1|Overall Study|Death|1
5477260|NCT01875991|18936658|P2|Overall Study|Sponsor Decision|0
5477261|NCT01875991|18936659|P1|Overall Study|Sponsor Decision|1
5477262|NCT01875991|18936658|P2|Overall Study|Withdrawal by Subject|6
5477263|NCT01875991|18936659|P1|Overall Study|Withdrawal by Subject|6
5477264|NCT01875874|18936695|P1|Overall Study|Death|3
5477265|NCT01875848|18936715|P2|Overall Study|Withdrawal by Subject|0
5477266|NCT01875848|18936716|P1|Overall Study|Withdrawal by Subject|2
5477267|NCT01875731|18936733|P2|Overall Study|Fail to obtain lab sample|0
5477268|NCT01875731|18936734|P1|Overall Study|Fail to obtain lab sample|1
5477269|NCT01875471|18936753|P2|Overall Study|Unsatisfactory Lens Fitting|0
5477270|NCT01875471|18936754|P1|Overall Study|Unsatisfactory Lens Fitting|1
5477271|NCT01875471|18936753|P2|Overall Study|Adverse Event|1
5477272|NCT01875471|18936754|P1|Overall Study|Adverse Event|0
5477273|NCT01875445|18936762|P2|Overall Study|Withdrawal by Subject|0
5477274|NCT01875445|18936763|P1|Overall Study|Withdrawal by Subject|2
5477275|NCT01875445|18936762|P2|Overall Study|Lost to Follow-up|0
5477276|NCT01875445|18936763|P1|Overall Study|Lost to Follow-up|5
5477277|NCT01875250|18936773|P2|Overall Study|Adverse Event|0
5477278|NCT01875250|18936774|P1|Overall Study|Adverse Event|2
5477279|NCT01875237|18936789|P2|Overall Study|DLI cells could not be produced|0
5477280|NCT01875237|18936790|P1|Overall Study|DLI cells could not be produced|1
5477281|NCT01875237|18936789|P2|Overall Study|GVDH before DLI|0
5477282|NCT01875237|18936790|P1|Overall Study|GVDH before DLI|1
5477283|NCT01875185|18936816|P2|Overall Study|study was terminated|48
5477284|NCT01875185|18936817|P1|Overall Study|study was terminated|52
5477285|NCT01874665|18936902|P2|Overall Study|Other|0
5477286|NCT01874665|18936903|P1|Overall Study|Other|2
5477287|NCT01874665|18936902|P2|Overall Study|Documented Progressive Disease|7
5477288|NCT01874665|18936903|P1|Overall Study|Documented Progressive Disease|11
5477289|NCT01874665|18936902|P2|Overall Study|Study Terminated by Sponsor|2
5477290|NCT01874665|18936903|P1|Overall Study|Study Terminated by Sponsor|0
5477291|NCT01874665|18936902|P2|Overall Study|Clinical Progressive Disease|3
5477292|NCT01874665|18936903|P1|Overall Study|Clinical Progressive Disease|4
5477293|NCT01874665|18936902|P2|Overall Study|Physician Decision|0
5477294|NCT01874665|18936903|P1|Overall Study|Physician Decision|3
5477295|NCT01874665|18936902|P2|Overall Study|Withdrawal by Subject|1
5477296|NCT01874665|18936903|P1|Overall Study|Withdrawal by Subject|4
5477297|NCT01874665|18936902|P2|Overall Study|Adverse Event|2
5477298|NCT01874665|18936903|P1|Overall Study|Adverse Event|6
5477299|NCT01874535|18936931|P2|Overall Study|incomplete symptom resolution|35
5477300|NCT01874535|18936932|P1|Overall Study|incomplete symptom resolution|45
5477301|NCT01874535|18936931|P2|Overall Study|Lost to Follow-up|9
5477302|NCT01874535|18936932|P1|Overall Study|Lost to Follow-up|10
5477303|NCT01874353|18936940|P2|Overall Study|Withdrawal by Subject|9
5477304|NCT01874353|18936941|P1|Overall Study|Withdrawal by Subject|7
5477305|NCT01874353|18936940|P2|Overall Study|Death|27
5477306|NCT01874353|18936941|P1|Overall Study|Death|45
5477307|NCT01874353|18936940|P2|Overall Study|Lost to Follow-up|1
5477308|NCT01874353|18936941|P1|Overall Study|Lost to Follow-up|1
5477309|NCT01874353|18936940|P2|Overall Study|Other|0
5477310|NCT01874353|18936941|P1|Overall Study|Other|2
5477311|NCT01874340|18936968|P4|Overall Study|Withdrawal by Subject|1
5477312|NCT01874340|18936969|P3|Overall Study|Withdrawal by Subject|0
5477313|NCT01874340|18936970|P2|Overall Study|Withdrawal by Subject|0
5477314|NCT01874340|18936971|P1|Overall Study|Withdrawal by Subject|0
5477315|NCT01874340|18936968|P4|Overall Study|Study terminated by Sponsor|4
5477316|NCT01874340|18936969|P3|Overall Study|Study terminated by Sponsor|8
5477317|NCT01874340|18936970|P2|Overall Study|Study terminated by Sponsor|8
5477318|NCT01874340|18936971|P1|Overall Study|Study terminated by Sponsor|6
5477319|NCT01874288|18937002|P5|Overall Study|Progressive disease|1
5477320|NCT01874288|18937003|P4|Overall Study|Progressive disease|5
5477321|NCT01874288|18937004|P3|Overall Study|Progressive disease|3
5477322|NCT01874288|18937005|P2|Overall Study|Progressive disease|0
5477323|NCT01874288|18937006|P1|Overall Study|Progressive disease|2
5477324|NCT01874288|18937002|P5|Overall Study|Physician Decision|0
5477325|NCT01874288|18937003|P4|Overall Study|Physician Decision|1
5477326|NCT01874288|18937004|P3|Overall Study|Physician Decision|0
5477327|NCT01874288|18937005|P2|Overall Study|Physician Decision|0
5477328|NCT01874288|18937006|P1|Overall Study|Physician Decision|0
5477329|NCT01874288|18937002|P5|Overall Study|Withdrawal by Subject|1
5477330|NCT01874288|18937003|P4|Overall Study|Withdrawal by Subject|1
5477331|NCT01874288|18937004|P3|Overall Study|Withdrawal by Subject|2
5477332|NCT01874288|18937005|P2|Overall Study|Withdrawal by Subject|0
5477333|NCT01874288|18937006|P1|Overall Study|Withdrawal by Subject|1
5477334|NCT01874275|18937041|P2|Overall Study|Lost to Follow-up|0
5477335|NCT01874275|18937042|P1|Overall Study|Lost to Follow-up|1
5477336|NCT01874145|18937065|P2|Extension Period|Lost to Follow-up|1
5477337|NCT01874145|18937066|P1|Extension Period|Lost to Follow-up|1
5477338|NCT01874145|18937065|P2|Extension Period|Withdrawal by Subject|1
5477339|NCT01874145|18937066|P1|Extension Period|Withdrawal by Subject|2
5477340|NCT01874145|18937065|P2|Extension Period|Adverse Event|2
5477341|NCT01874145|18937066|P1|Extension Period|Adverse Event|3
5477342|NCT01874145|18937065|P2|Core Period|Withdrawal by Subject|4
5477343|NCT01874145|18937066|P1|Core Period|Withdrawal by Subject|0
5477344|NCT01874145|18937065|P2|Core Period|Adverse Event|1
5477345|NCT01874145|18937066|P1|Core Period|Adverse Event|0
5477346|NCT01874145|18937065|P2|Core Period|Physician Decision|1
5477347|NCT01874145|18937066|P1|Core Period|Physician Decision|1
5477348|NCT01874145|18937065|P2|Core Period|Protocol Violation|1
5477349|NCT01874145|18937066|P1|Core Period|Protocol Violation|1
5477350|NCT01874145|18937065|P2|Core Period|Non-compliance|0
5477351|NCT01874145|18937066|P1|Core Period|Non-compliance|1
5477352|NCT01874054|18937125|P1|Overall Study|Death|5
5477353|NCT01874054|18937125|P1|Overall Study|Lost to Follow-up|5
5477354|NCT01874054|18937125|P1|Overall Study|Study Termination by Sponsor|42
5477355|NCT01874054|18937125|P1|Overall Study|Withdrawal by Subject|3
5477356|NCT01873950|18937147|P5|Period 5|Withdrawal by Subject|0
5477357|NCT01873950|18937148|P4|Period 5|Withdrawal by Subject|1
5477358|NCT01873950|18937149|P3|Period 5|Withdrawal by Subject|0
5477359|NCT01873950|18937150|P2|Period 5|Withdrawal by Subject|0
5477360|NCT01873950|18937151|P1|Period 5|Withdrawal by Subject|0
5477361|NCT01873859|18937188|P2|Overall Study|Withdrawal by Subject|4
5477362|NCT01873859|18937189|P1|Overall Study|Withdrawal by Subject|0
5477363|NCT01873742|18937207|P2|Overall Study|Lost to Follow-up|76
5477364|NCT01873742|18937208|P1|Overall Study|Lost to Follow-up|68
5477365|NCT01873729|18937214|P1|Overall Study|Withdrawal by Subject|1
5477366|NCT01873586|18937219|P1|Overall Study|Lost to Follow-up|3
5477367|NCT01873495|18937232|P1|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
5477368|NCT01873495|18937232|P1|Overall Study|Removed for Transplantation|1
5477369|NCT01873495|18937232|P1|Overall Study|Adverse Event|1
5477370|NCT01873495|18937232|P1|Overall Study|Physician Decision|3
5477371|NCT01873495|18937232|P1|Overall Study|Withdrawal by Subject|1
5477372|NCT01873417|18937240|P1|Overall Study|Physician Decision|3
5477373|NCT01873417|18937240|P1|Overall Study|Withdrawal by Subject|2
5477374|NCT01873417|18937240|P1|Overall Study|Lost to Follow-up|2
5477375|NCT01873417|18937240|P1|Overall Study|Adverse Event|24
5477376|NCT01873417|18937240|P1|Overall Study|Did Not Receive Any Study Drug|4
5477377|NCT01872910|18937268|P6|Overall Study|Lost to Follow-up|0
5477378|NCT01872910|18937269|P5|Overall Study|Lost to Follow-up|0
5477379|NCT01872910|18937270|P4|Overall Study|Lost to Follow-up|0
5477380|NCT01872910|18937271|P3|Overall Study|Lost to Follow-up|2
5477381|NCT01872910|18937272|P2|Overall Study|Lost to Follow-up|0
5477382|NCT01872910|18937273|P1|Overall Study|Lost to Follow-up|2
5477383|NCT01872715|18937318|P1|Overall Study|Withdrawal by Subject|2
5477384|NCT01872715|18937318|P1|Overall Study|Protocol Violation|1
5477385|NCT01872715|18937318|P1|Overall Study|Adverse Event|1
5477386|NCT01872689|18937337|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
5477387|NCT01872689|18937338|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
5477388|NCT01872689|18937339|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
5477389|NCT01872689|18937340|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
5477390|NCT01872689|18937337|P4|Open-Label Period (Only For Monotherapy)|Death|0
5477391|NCT01872689|18937338|P3|Open-Label Period (Only For Monotherapy)|Death|0
5477392|NCT01872689|18937339|P2|Open-Label Period (Only For Monotherapy)|Death|3
5477393|NCT01872689|18937340|P1|Open-Label Period (Only For Monotherapy)|Death|5
5477394|NCT01872689|18937337|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
5477395|NCT01872689|18937338|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
5477396|NCT01872689|18937339|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
5477397|NCT01872689|18937340|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
5477398|NCT01872689|18937337|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
5477399|NCT01872689|18937338|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
5477400|NCT01872689|18937339|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
5477401|NCT01872689|18937340|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
5477402|NCT01872689|18937337|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
5477403|NCT01872689|18937338|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
5477404|NCT01872689|18937339|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
5477405|NCT01872689|18937340|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
5477406|NCT01872689|18937337|P4|Open-Label Period (Only For Monotherapy)|Other|0
5477407|NCT01872689|18937338|P3|Open-Label Period (Only For Monotherapy)|Other|0
5477408|NCT01872689|18937339|P2|Open-Label Period (Only For Monotherapy)|Other|3
5477409|NCT01872689|18937340|P1|Open-Label Period (Only For Monotherapy)|Other|2
5477410|NCT01872689|18937337|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
5477411|NCT01872689|18937338|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
5477412|NCT01872689|18937339|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
5477413|NCT01872689|18937340|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
5477414|NCT01872689|18937337|P4|Double-Blind/Placebo-Controlled Period|Death|9
5477415|NCT01872689|18937338|P3|Double-Blind/Placebo-Controlled Period|Death|14
5477416|NCT01872689|18937339|P2|Double-Blind/Placebo-Controlled Period|Death|4
5477417|NCT01872689|18937340|P1|Double-Blind/Placebo-Controlled Period|Death|3
5477418|NCT01872689|18937337|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
5477419|NCT01872689|18937338|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
5477420|NCT01872689|18937339|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
5477421|NCT01872689|18937340|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
5477422|NCT01872689|18937337|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
5477423|NCT01872689|18937338|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
5477424|NCT01872689|18937339|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
5477425|NCT01872689|18937340|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
5477426|NCT01872689|18937337|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
5477427|NCT01872689|18937338|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
5477428|NCT01872689|18937339|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
5477429|NCT01872689|18937340|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
5477430|NCT01872689|18937337|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
5477431|NCT01872689|18937338|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
5477432|NCT01872689|18937339|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
5477433|NCT01872689|18937340|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
5477434|NCT01872689|18937337|P4|Double-Blind/Placebo-Controlled Period|Other|3
5477435|NCT01872689|18937338|P3|Double-Blind/Placebo-Controlled Period|Other|6
5477436|NCT01872689|18937339|P2|Double-Blind/Placebo-Controlled Period|Other|1
5477437|NCT01872689|18937340|P1|Double-Blind/Placebo-Controlled Period|Other|1
5477438|NCT01872689|18937337|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
5477439|NCT01872689|18937338|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
5477440|NCT01872689|18937339|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
5477441|NCT01872689|18937340|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
5477442|NCT01872611|18937416|P2|Overall Study|Reason not provided|6
5477443|NCT01872611|18937417|P1|Overall Study|Reason not provided|6
5477444|NCT01872611|18937416|P2|Overall Study|Withdrawal by Subject|1
5477445|NCT01872611|18937417|P1|Overall Study|Withdrawal by Subject|6
5477446|NCT01872611|18937416|P2|Overall Study|Physician Decision|0
5477447|NCT01872611|18937417|P1|Overall Study|Physician Decision|1
5477448|NCT01872611|18937416|P2|Overall Study|Lost to Follow-up|1
5477449|NCT01872611|18937417|P1|Overall Study|Lost to Follow-up|8
5477450|NCT01872611|18937416|P2|Overall Study|Death, prior to treatment|1
5477451|NCT01872611|18937417|P1|Overall Study|Death, prior to treatment|0
5477452|NCT01872611|18937416|P2|Overall Study|Death|1
5477453|NCT01872611|18937417|P1|Overall Study|Death|0
5477454|NCT01872611|18937416|P2|Overall Study|Adverse Event, prior to treatment|1
5477455|NCT01872611|18937417|P1|Overall Study|Adverse Event, prior to treatment|0
5477456|NCT01872611|18937416|P2|Overall Study|Adverse Event|1
5477457|NCT01872611|18937417|P1|Overall Study|Adverse Event|3
5477458|NCT01872078|18937469|P4|Overall Study|Patient met exclusion criterion 16.|1
5477459|NCT01872078|18937470|P3|Overall Study|Patient met exclusion criterion 16.|0
5477460|NCT01872078|18937471|P2|Overall Study|Patient met exclusion criterion 16.|0
5477461|NCT01872078|18937472|P1|Overall Study|Patient met exclusion criterion 16.|0
5477462|NCT01872078|18937469|P4|Overall Study|Withdrawal by Subject|0
5477463|NCT01872078|18937470|P3|Overall Study|Withdrawal by Subject|1
5477464|NCT01872078|18937471|P2|Overall Study|Withdrawal by Subject|0
5477465|NCT01872078|18937472|P1|Overall Study|Withdrawal by Subject|0
5477466|NCT01872078|18937469|P4|Overall Study|Protocol Violation|0
5477467|NCT01872078|18937470|P3|Overall Study|Protocol Violation|1
5477468|NCT01872078|18937471|P2|Overall Study|Protocol Violation|0
5477469|NCT01872078|18937472|P1|Overall Study|Protocol Violation|0
5477470|NCT01872078|18937469|P4|Overall Study|Dose administration non-compliance|1
5477471|NCT01872078|18937470|P3|Overall Study|Dose administration non-compliance|0
5477472|NCT01872078|18937471|P2|Overall Study|Dose administration non-compliance|0
5477473|NCT01872078|18937472|P1|Overall Study|Dose administration non-compliance|0
5477474|NCT01872078|18937469|P4|Overall Study|Adverse Event|0
5477475|NCT01872078|18937470|P3|Overall Study|Adverse Event|1
5477476|NCT01872078|18937471|P2|Overall Study|Adverse Event|0
5477477|NCT01872078|18937472|P1|Overall Study|Adverse Event|0
5477478|NCT01871870|18937482|P1|Overall Study|hyperglycemia|2
5477479|NCT01871870|18937482|P1|Overall Study|Hardware issues|7
5477480|NCT01871805|18937493|P6|Phase II|Lost to Follow-up|13
5477481|NCT01871805|18937494|P5|Phase II|Lost to Follow-up|0
5477482|NCT01871805|18937495|P4|Phase II|Lost to Follow-up|0
5477483|NCT01871805|18937496|P3|Phase II|Lost to Follow-up|0
5477484|NCT01871805|18937497|P2|Phase II|Lost to Follow-up|0
5477485|NCT01871805|18937498|P1|Phase II|Lost to Follow-up|0
5477486|NCT01871805|18937493|P6|Phase II|Alive in Survival Follow-up|29
5477487|NCT01871805|18937494|P5|Phase II|Alive in Survival Follow-up|0
5477488|NCT01871805|18937495|P4|Phase II|Alive in Survival Follow-up|0
5477489|NCT01871805|18937496|P3|Phase II|Alive in Survival Follow-up|0
5477490|NCT01871805|18937497|P2|Phase II|Alive in Survival Follow-up|0
5477491|NCT01871805|18937498|P1|Phase II|Alive in Survival Follow-up|0
5477492|NCT01871805|18937493|P6|Phase II|Death|45
5477493|NCT01871805|18937494|P5|Phase II|Death|0
5477494|NCT01871805|18937495|P4|Phase II|Death|0
5477495|NCT01871805|18937496|P3|Phase II|Death|0
5477496|NCT01871805|18937497|P2|Phase II|Death|0
5477497|NCT01871805|18937498|P1|Phase II|Death|0
5477498|NCT01871805|18937493|P6|Phase I|Lost to Follow-up|0
5477499|NCT01871805|18937494|P5|Phase I|Lost to Follow-up|0
5477500|NCT01871805|18937495|P4|Phase I|Lost to Follow-up|0
5477501|NCT01871805|18937496|P3|Phase I|Lost to Follow-up|3
5477502|NCT01871805|18937497|P2|Phase I|Lost to Follow-up|1
5477503|NCT01871805|18937498|P1|Phase I|Lost to Follow-up|0
5477504|NCT01871805|18937493|P6|Phase I|Alive in Survival Follow-up|0
5477505|NCT01871805|18937494|P5|Phase I|Alive in Survival Follow-up|4
5477506|NCT01871805|18937495|P4|Phase I|Alive in Survival Follow-up|5
5477507|NCT01871805|18937496|P3|Phase I|Alive in Survival Follow-up|4
5477508|NCT01871805|18937497|P2|Phase I|Alive in Survival Follow-up|2
5477509|NCT01871805|18937498|P1|Phase I|Alive in Survival Follow-up|0
5477510|NCT01871805|18937493|P6|Phase I|Death|0
5477511|NCT01871805|18937494|P5|Phase I|Death|9
5477512|NCT01871805|18937495|P4|Phase I|Death|2
5477513|NCT01871805|18937496|P3|Phase I|Death|6
5477514|NCT01871805|18937497|P2|Phase I|Death|4
5477515|NCT01871805|18937498|P1|Phase I|Death|7
5477516|NCT01871558|18937570|P2|Overall Study|Withdrawal by Subject|0
5477517|NCT01871558|18937571|P1|Overall Study|Withdrawal by Subject|2
5477518|NCT01871558|18937570|P2|Overall Study|antidiabetic drug prematurely stopped|1
5477519|NCT01871558|18937571|P1|Overall Study|antidiabetic drug prematurely stopped|1
5477520|NCT01871558|18937570|P2|Overall Study|Other reason|1
5477521|NCT01871558|18937571|P1|Overall Study|Other reason|0
5477522|NCT01871545|18937591|P2|Overall Study|Withdrawal by Subject|1
5477523|NCT01871545|18937592|P1|Overall Study|Withdrawal by Subject|0
5477524|NCT01871545|18937591|P2|Overall Study|Physician Decision|0
5477525|NCT01871545|18937592|P1|Overall Study|Physician Decision|4
5477526|NCT01871545|18937591|P2|Overall Study|Lack of Efficacy|2
5477527|NCT01871545|18937592|P1|Overall Study|Lack of Efficacy|11
5477528|NCT01871545|18937591|P2|Overall Study|Death|0
5477529|NCT01871545|18937592|P1|Overall Study|Death|2
5477530|NCT01871532|18937633|P2|Overall Study|Withdrawal by Subject|2
5477531|NCT01871532|18937634|P1|Overall Study|Withdrawal by Subject|1
5477532|NCT01871519|18937668|P1|Overall Study|Withdrawal by Subject|49
5477533|NCT01871519|18937668|P1|Overall Study|Lost to Follow-up|15
5477534|NCT01871519|18937668|P1|Overall Study|Death|26
5477535|NCT01871402|18937725|P2|Overall Study|Non-compliance|1
5477536|NCT01871402|18937726|P1|Overall Study|Non-compliance|0
5477537|NCT01871402|18937725|P2|Overall Study|Withdrawal by Subject|2
5477538|NCT01871402|18937726|P1|Overall Study|Withdrawal by Subject|0
5477539|NCT01871402|18937725|P2|Overall Study|Lost to Follow-up|0
5477540|NCT01871402|18937726|P1|Overall Study|Lost to Follow-up|1
5477541|NCT01871285|18937744|P4|First Intervention (1 Day)|Lost to Follow-up|0
5477542|NCT01871285|18937745|P3|First Intervention (1 Day)|Lost to Follow-up|1
5477543|NCT01871285|18937746|P2|First Intervention (1 Day)|Lost to Follow-up|1
5477544|NCT01871285|18937747|P1|First Intervention (1 Day)|Lost to Follow-up|0
5477545|NCT01871285|18937744|P4|First Intervention (1 Day)|Adverse Event|0
5477546|NCT01871285|18937745|P3|First Intervention (1 Day)|Adverse Event|0
5477547|NCT01871285|18937746|P2|First Intervention (1 Day)|Adverse Event|0
5477548|NCT01871285|18937747|P1|First Intervention (1 Day)|Adverse Event|1
5477549|NCT01871142|18937773|P1|Overall Study|Adverse Event|1
5477550|NCT01871090|18937789|P2|Overall Study|Subject Non-Compliance|1
5477551|NCT01871090|18937790|P1|Overall Study|Subject Non-Compliance|0
5477552|NCT01871090|18937789|P2|Overall Study|Interrogation not completed correctly|0
5477553|NCT01871090|18937790|P1|Overall Study|Interrogation not completed correctly|1
5477554|NCT01871090|18937789|P2|Overall Study|Interrogation not done in Emergency Room|22
5477555|NCT01871090|18937790|P1|Overall Study|Interrogation not done in Emergency Room|1
5477556|NCT01870999|18937810|P3|Overall Study|Protocol Violation|1
5477557|NCT01870999|18937811|P2|Overall Study|Protocol Violation|0
5477558|NCT01870999|18937812|P1|Overall Study|Protocol Violation|0
5477559|NCT01870999|18937810|P3|Overall Study|Withdrawal by Subject|5
5477560|NCT01870999|18937811|P2|Overall Study|Withdrawal by Subject|2
5477561|NCT01870999|18937812|P1|Overall Study|Withdrawal by Subject|0
5477562|NCT01870999|18937810|P3|Overall Study|Subject withdrawn by Investigator|0
5477563|NCT01870999|18937811|P2|Overall Study|Subject withdrawn by Investigator|0
5477564|NCT01870999|18937812|P1|Overall Study|Subject withdrawn by Investigator|1
5477565|NCT01870999|18937810|P3|Overall Study|Subject met withdrawal criteria|0
5477566|NCT01870999|18937811|P2|Overall Study|Subject met withdrawal criteria|2
5477567|NCT01870999|18937812|P1|Overall Study|Subject met withdrawal criteria|3
5477568|NCT01870999|18937810|P3|Overall Study|Adverse Event|1
5477569|NCT01870999|18937811|P2|Overall Study|Adverse Event|4
5477570|NCT01870999|18937812|P1|Overall Study|Adverse Event|0
5477571|NCT01870973|18937870|P2|Overall Study|Lost to Follow-up|3
5477572|NCT01870973|18937871|P1|Overall Study|Lost to Follow-up|10
5477573|NCT01870921|18937877|P1|Overall Study|Other|1
5477574|NCT01870921|18937877|P1|Overall Study|Subject Lost to Follow up|2
5477575|NCT01870921|18937877|P1|Overall Study|Severe non-compliance to protocol|7
5477576|NCT01870921|18937877|P1|Overall Study|Subject decision|80
5477577|NCT01870869|18937887|P4|Overall Study|Not evaluable|10
5477578|NCT01870869|18937888|P3|Overall Study|Not evaluable|42
5477579|NCT01870869|18937889|P2|Overall Study|Not evaluable|5
5477580|NCT01870869|18937890|P1|Overall Study|Not evaluable|10
5477581|NCT01870869|18937887|P4|Overall Study|Reason not Specified|4
5477582|NCT01870869|18937888|P3|Overall Study|Reason not Specified|20
5477583|NCT01870869|18937889|P2|Overall Study|Reason not Specified|2
5477584|NCT01870869|18937890|P1|Overall Study|Reason not Specified|1
5477585|NCT01870869|18937887|P4|Overall Study|Lost to Follow-up|3
5477586|NCT01870869|18937888|P3|Overall Study|Lost to Follow-up|25
5477587|NCT01870869|18937889|P2|Overall Study|Lost to Follow-up|2
5477588|NCT01870869|18937890|P1|Overall Study|Lost to Follow-up|10
5477589|NCT01870869|18937887|P4|Overall Study|Subject choice|8
5477590|NCT01870869|18937888|P3|Overall Study|Subject choice|22
5477591|NCT01870869|18937889|P2|Overall Study|Subject choice|2
5477592|NCT01870869|18937890|P1|Overall Study|Subject choice|6
5477593|NCT01870869|18937887|P4|Overall Study|Death|1
5477594|NCT01870869|18937888|P3|Overall Study|Death|7
5477595|NCT01870869|18937889|P2|Overall Study|Death|0
5477596|NCT01870869|18937890|P1|Overall Study|Death|0
5477597|NCT01870869|18937887|P4|Overall Study|Implanted with nonstudy device|4
5477598|NCT01870869|18937888|P3|Overall Study|Implanted with nonstudy device|14
5477599|NCT01870869|18937889|P2|Overall Study|Implanted with nonstudy device|3
5477600|NCT01870869|18937890|P1|Overall Study|Implanted with nonstudy device|1
5477601|NCT01870843|18937929|P1|Overall Study|Withdrawal by Subject|18
5477602|NCT01870843|18937929|P1|Overall Study|Death|1
5477603|NCT01870843|18937929|P1|Overall Study|Lost to Follow-up|24
5477604|NCT01870843|18937929|P1|Overall Study|Adverse Event|10
5477605|NCT01870778|18937944|P2|Overall Study|Lost to Follow-up|2
5477606|NCT01870778|18937945|P1|Overall Study|Lost to Follow-up|0
5477607|NCT01870778|18937944|P2|Overall Study|Withdrawal by Subject|7
5477608|NCT01870778|18937945|P1|Overall Study|Withdrawal by Subject|8
5477609|NCT01870739|18937971|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
5477610|NCT01870739|18937972|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
5477611|NCT01870739|18937971|P2|Add-on Period (40 Weeks)|Protocol deviation|1
5477612|NCT01870739|18937972|P1|Add-on Period (40 Weeks)|Protocol deviation|1
5477613|NCT01870739|18937971|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
5477614|NCT01870739|18937972|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
5477615|NCT01870739|18937971|P2|Add-on Period (40 Weeks)|Adverse Event|1
5477616|NCT01870739|18937972|P1|Add-on Period (40 Weeks)|Adverse Event|0
5477617|NCT01870739|18937971|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
5477618|NCT01870739|18937972|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
5477619|NCT01870739|18937971|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
5477620|NCT01870739|18937972|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
5477621|NCT01870739|18937971|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
5477622|NCT01870739|18937972|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
5477623|NCT01870726|18938011|P7|Overall Study|Progressive disease|10
5477624|NCT01870726|18938012|P6|Overall Study|Progressive disease|4
5477625|NCT01870726|18938013|P5|Overall Study|Progressive disease|6
5477626|NCT01870726|18938014|P4|Overall Study|Progressive disease|5
5477627|NCT01870726|18938015|P3|Overall Study|Progressive disease|4
5477628|NCT01870726|18938016|P2|Overall Study|Progressive disease|5
5477629|NCT01870726|18938017|P1|Overall Study|Progressive disease|5
5477630|NCT01870726|18938011|P7|Overall Study|Adverse Event|0
5477631|NCT01870726|18938012|P6|Overall Study|Adverse Event|1
5477632|NCT01870726|18938013|P5|Overall Study|Adverse Event|1
5477633|NCT01870726|18938014|P4|Overall Study|Adverse Event|0
5477634|NCT01870726|18938015|P3|Overall Study|Adverse Event|0
5477635|NCT01870726|18938016|P2|Overall Study|Adverse Event|0
5477636|NCT01870726|18938017|P1|Overall Study|Adverse Event|0
5477637|NCT01870726|18938011|P7|Overall Study|Withdrawal by Subject|0
5477638|NCT01870726|18938012|P6|Overall Study|Withdrawal by Subject|0
5477639|NCT01870726|18938013|P5|Overall Study|Withdrawal by Subject|0
5477640|NCT01870726|18938014|P4|Overall Study|Withdrawal by Subject|0
5477641|NCT01870726|18938015|P3|Overall Study|Withdrawal by Subject|0
5477642|NCT01870726|18938016|P2|Overall Study|Withdrawal by Subject|1
5477643|NCT01870726|18938017|P1|Overall Study|Withdrawal by Subject|0
5477644|NCT01870726|18938011|P7|Overall Study|Withdrawal of informed consent|0
5477645|NCT01870726|18938012|P6|Overall Study|Withdrawal of informed consent|0
5477646|NCT01870726|18938013|P5|Overall Study|Withdrawal of informed consent|0
5477647|NCT01870726|18938014|P4|Overall Study|Withdrawal of informed consent|1
5477648|NCT01870726|18938015|P3|Overall Study|Withdrawal of informed consent|0
5477649|NCT01870726|18938016|P2|Overall Study|Withdrawal of informed consent|0
5477650|NCT01870726|18938017|P1|Overall Study|Withdrawal of informed consent|0
5477651|NCT01870583|18938112|P3|Overall Study|Lost to Follow-up|5
5477652|NCT01870583|18938113|P2|Overall Study|Lost to Follow-up|13
5477653|NCT01870583|18938114|P1|Overall Study|Lost to Follow-up|11
5477654|NCT01870583|18938112|P3|Overall Study|Protocol Violation|3
5477655|NCT01870583|18938113|P2|Overall Study|Protocol Violation|5
5477656|NCT01870583|18938114|P1|Overall Study|Protocol Violation|0
5477657|NCT01870401|18938124|P2|Overall Study|On-going in the Study|25
5477658|NCT01870401|18938125|P1|Overall Study|On-going in the Study|35
5477659|NCT01870401|18938124|P2|Overall Study|Other|7
5477660|NCT01870401|18938125|P1|Overall Study|Other|9
5477661|NCT01870401|18938124|P2|Overall Study|Lost to Follow-up|14
5477662|NCT01870401|18938125|P1|Overall Study|Lost to Follow-up|19
5477663|NCT01870401|18938124|P2|Overall Study|Withdrawal by Subject|26
5477664|NCT01870401|18938125|P1|Overall Study|Withdrawal by Subject|39
5477665|NCT01870401|18938124|P2|Overall Study|Death|24
5477666|NCT01870401|18938125|P1|Overall Study|Death|48
5477667|NCT01870297|18938201|P7|Overall Study|Sponsor Decision|1
5477668|NCT01870297|18938202|P6|Overall Study|Sponsor Decision|0
5477669|NCT01870297|18938203|P5|Overall Study|Sponsor Decision|0
5477670|NCT01870297|18938204|P4|Overall Study|Sponsor Decision|0
5477671|NCT01870297|18938205|P3|Overall Study|Sponsor Decision|0
5477672|NCT01870297|18938206|P2|Overall Study|Sponsor Decision|6
5477673|NCT01870297|18938207|P1|Overall Study|Sponsor Decision|0
5477674|NCT01870297|18938201|P7|Overall Study|Withdrawal by Subject|1
5477675|NCT01870297|18938202|P6|Overall Study|Withdrawal by Subject|1
5477676|NCT01870297|18938203|P5|Overall Study|Withdrawal by Subject|1
5477677|NCT01870297|18938204|P4|Overall Study|Withdrawal by Subject|0
5477678|NCT01870297|18938205|P3|Overall Study|Withdrawal by Subject|0
5477679|NCT01870297|18938206|P2|Overall Study|Withdrawal by Subject|0
5477680|NCT01870297|18938207|P1|Overall Study|Withdrawal by Subject|0
5477681|NCT01870297|18938201|P7|Overall Study|Lost to Follow-up|0
5477682|NCT01870297|18938202|P6|Overall Study|Lost to Follow-up|0
5477683|NCT01870297|18938203|P5|Overall Study|Lost to Follow-up|0
5477684|NCT01870297|18938204|P4|Overall Study|Lost to Follow-up|0
5477685|NCT01870297|18938205|P3|Overall Study|Lost to Follow-up|1
5477686|NCT01870297|18938206|P2|Overall Study|Lost to Follow-up|1
5477687|NCT01870297|18938207|P1|Overall Study|Lost to Follow-up|0
5477688|NCT01870297|18938201|P7|Overall Study|Adverse Event|0
5477689|NCT01870297|18938202|P6|Overall Study|Adverse Event|0
5477690|NCT01870297|18938203|P5|Overall Study|Adverse Event|2
5477691|NCT01870297|18938204|P4|Overall Study|Adverse Event|0
5477692|NCT01870297|18938205|P3|Overall Study|Adverse Event|0
5477693|NCT01870297|18938206|P2|Overall Study|Adverse Event|0
5477694|NCT01870297|18938207|P1|Overall Study|Adverse Event|0
5477695|NCT01870076|18938251|P4|Overall Study|Withdrawal by Subject|0
5477696|NCT01870076|18938252|P3|Overall Study|Withdrawal by Subject|1
5477697|NCT01870076|18938253|P2|Overall Study|Withdrawal by Subject|0
5477698|NCT01870076|18938254|P1|Overall Study|Withdrawal by Subject|1
5477699|NCT01869959|18938272|P5|Treatment Period|Withdrawal by Subject|0
5477700|NCT01869959|18938273|P4|Treatment Period|Withdrawal by Subject|0
5477701|NCT01869959|18938274|P3|Treatment Period|Withdrawal by Subject|0
5477702|NCT01869959|18938275|P2|Treatment Period|Withdrawal by Subject|1
5477703|NCT01869959|18938276|P1|Treatment Period|Withdrawal by Subject|0
5477704|NCT01869959|18938272|P5|Treatment Period|Sponsor decision|0
5477705|NCT01869959|18938273|P4|Treatment Period|Sponsor decision|1
5477706|NCT01869959|18938274|P3|Treatment Period|Sponsor decision|0
5477707|NCT01869959|18938275|P2|Treatment Period|Sponsor decision|1
5477708|NCT01869959|18938276|P1|Treatment Period|Sponsor decision|0
5477709|NCT01869959|18938272|P5|Treatment Period|Adverse Event|0
5477710|NCT01869959|18938273|P4|Treatment Period|Adverse Event|1
5477711|NCT01869959|18938274|P3|Treatment Period|Adverse Event|3
5477712|NCT01869959|18938275|P2|Treatment Period|Adverse Event|0
5477713|NCT01869959|18938276|P1|Treatment Period|Adverse Event|1
5477714|NCT01869959|18938272|P5|Randomization Period|Physician Decision|1
5477715|NCT01869959|18938273|P4|Randomization Period|Physician Decision|0
5477716|NCT01869959|18938274|P3|Randomization Period|Physician Decision|0
5477717|NCT01869959|18938275|P2|Randomization Period|Physician Decision|0
5477718|NCT01869959|18938276|P1|Randomization Period|Physician Decision|0
5477719|NCT01869777|18938344|P1|Overall Study|Excluded from the analysis, ineligible|1
5477720|NCT01869764|18938357|P2|Overall Study|Withdrawal by Subject|2
5477721|NCT01869764|18938358|P1|Overall Study|Withdrawal by Subject|0
5477722|NCT01869699|18938376|P2|Overall Study|Withdrawal by Subject|0
5477723|NCT01869699|18938377|P1|Overall Study|Withdrawal by Subject|1
5477724|NCT01869348|18938462|P2|Overall Study|Withdrawal by Subject|1
5477725|NCT01869348|18938463|P1|Overall Study|Withdrawal by Subject|1
5477726|NCT01869192|18938471|P2|Postoperative Chemotherapy|Physician Decision|2
5477727|NCT01869192|18938472|P1|Postoperative Chemotherapy|Physician Decision|0
5477728|NCT01869192|18938471|P2|Preoperative Chemotherapy to Surgery|patient choice|1
5477729|NCT01869192|18938472|P1|Preoperative Chemotherapy to Surgery|patient choice|2
5477730|NCT01868997|18938507|P2|Overall Study|Other|1
5477731|NCT01868997|18938508|P1|Overall Study|Other|3
5477732|NCT01868997|18938507|P2|Overall Study|Lack of Efficacy|0
5477733|NCT01868997|18938508|P1|Overall Study|Lack of Efficacy|2
5477734|NCT01868997|18938507|P2|Overall Study|Adverse Event|5
5477735|NCT01868997|18938508|P1|Overall Study|Adverse Event|2
5477736|NCT01868893|18938524|P1|Overall Study|Neutropenia|1
5477737|NCT01868893|18938524|P1|Overall Study|Commercial availability of study drug|17
5477738|NCT01868893|18938524|P1|Overall Study|Adverse Event|2
5477739|NCT01868646|18938555|P2|Overall Study|Do not meet inclusion criteria|5
5477740|NCT01868646|18938556|P1|Overall Study|Do not meet inclusion criteria|3
5477741|NCT01868594|18938601|P2|Overall Study|Do not meet inclusion criteria|3
5477742|NCT01868594|18938602|P1|Overall Study|Do not meet inclusion criteria|4
5477743|NCT01868542|18938622|P2|Overall Study|Unclassified|1
5477744|NCT01868542|18938623|P1|Overall Study|Unclassified|0
5477745|NCT01868542|18938622|P2|Overall Study|Protocol Violation|1
5477746|NCT01868542|18938623|P1|Overall Study|Protocol Violation|0
5477747|NCT01868503|18938641|P1|Overall Study|Protocol Violation|1
5477748|NCT01868503|18938641|P1|Overall Study|Withdrawal by Subject|1
5477749|NCT01868477|18938651|P2|Overall Study|Withdrawal by Subject|0
5477750|NCT01868477|18938652|P1|Overall Study|Withdrawal by Subject|1
5477751|NCT01868477|18938651|P2|Overall Study|Disease progression|1
5477752|NCT01868477|18938652|P1|Overall Study|Disease progression|1
5477753|NCT01868477|18938651|P2|Overall Study|Adverse Event|4
5477754|NCT01868477|18938652|P1|Overall Study|Adverse Event|2
5477755|NCT01868243|18938756|P2|Overall Study|Death|1
5477756|NCT01868243|18938757|P1|Overall Study|Death|0
5477757|NCT01868165|18938765|P1|Overall Study|Death|4
5477758|NCT01868165|18938765|P1|Overall Study|Lost to Follow-up|3
5477759|NCT01868165|18938765|P1|Overall Study|Physician Decision|2
5477760|NCT01868165|18938765|P1|Overall Study|Withdrawal by Subject|36
5477761|NCT01868074|18938781|P2|Overall Study|Withdrawal by Subject|2
5477762|NCT01868074|18938782|P1|Overall Study|Withdrawal by Subject|4
5477763|NCT01868074|18938781|P2|Overall Study|Lost to Follow-up|2
5477764|NCT01868074|18938782|P1|Overall Study|Lost to Follow-up|3
5477765|NCT01868035|18938792|P1|Overall Study|Non-compliance|1
5477766|NCT01868035|18938792|P1|Overall Study|Progressive Disease|2
5477767|NCT01868035|18938792|P1|Overall Study|Withdrawal by Subject|1
5477768|NCT01868035|18938792|P1|Overall Study|Lost to Follow-up|3
5477769|NCT01868022|18938817|P9|Overall Study|Ongoing|0
5477770|NCT01868022|18938818|P8|Overall Study|Ongoing|3
5477771|NCT01868022|18938819|P7|Overall Study|Ongoing|0
5477772|NCT01868022|18938820|P6|Overall Study|Ongoing|0
5477773|NCT01868022|18938821|P5|Overall Study|Ongoing|0
5477774|NCT01868022|18938822|P4|Overall Study|Ongoing|0
5477775|NCT01868022|18938823|P3|Overall Study|Ongoing|0
5477776|NCT01868022|18938824|P2|Overall Study|Ongoing|0
5477777|NCT01868022|18938825|P1|Overall Study|Ongoing|0
5477778|NCT01868022|18938817|P9|Overall Study|Study closed/terminated|0
5477779|NCT01868022|18938818|P8|Overall Study|Study closed/terminated|1
5477780|NCT01868022|18938819|P7|Overall Study|Study closed/terminated|0
5477781|NCT01868022|18938820|P6|Overall Study|Study closed/terminated|0
5477782|NCT01868022|18938821|P5|Overall Study|Study closed/terminated|0
5477783|NCT01868022|18938822|P4|Overall Study|Study closed/terminated|0
5477784|NCT01868022|18938823|P3|Overall Study|Study closed/terminated|0
5477785|NCT01868022|18938824|P2|Overall Study|Study closed/terminated|0
5477786|NCT01868022|18938825|P1|Overall Study|Study closed/terminated|0
5477787|NCT01868022|18938817|P9|Overall Study|Physician Decision|0
5477788|NCT01868022|18938818|P8|Overall Study|Physician Decision|2
5477789|NCT01868022|18938819|P7|Overall Study|Physician Decision|0
5477790|NCT01868022|18938820|P6|Overall Study|Physician Decision|1
5477791|NCT01868022|18938821|P5|Overall Study|Physician Decision|0
5477792|NCT01868022|18938822|P4|Overall Study|Physician Decision|0
5477793|NCT01868022|18938823|P3|Overall Study|Physician Decision|0
5477794|NCT01868022|18938824|P2|Overall Study|Physician Decision|0
5477795|NCT01868022|18938825|P1|Overall Study|Physician Decision|0
5477796|NCT01868022|18938817|P9|Overall Study|Adverse Event|2
5477797|NCT01868022|18938818|P8|Overall Study|Adverse Event|2
5477798|NCT01868022|18938819|P7|Overall Study|Adverse Event|0
5477799|NCT01868022|18938820|P6|Overall Study|Adverse Event|0
5477800|NCT01868022|18938821|P5|Overall Study|Adverse Event|2
5477801|NCT01868022|18938822|P4|Overall Study|Adverse Event|0
5477802|NCT01868022|18938823|P3|Overall Study|Adverse Event|0
5477803|NCT01868022|18938824|P2|Overall Study|Adverse Event|0
5477804|NCT01868022|18938825|P1|Overall Study|Adverse Event|0
5477805|NCT01868022|18938817|P9|Overall Study|Withdrawal by Subject|0
5477806|NCT01868022|18938818|P8|Overall Study|Withdrawal by Subject|1
5477807|NCT01868022|18938819|P7|Overall Study|Withdrawal by Subject|0
5477808|NCT01868022|18938820|P6|Overall Study|Withdrawal by Subject|0
5477809|NCT01868022|18938821|P5|Overall Study|Withdrawal by Subject|0
5477810|NCT01868022|18938822|P4|Overall Study|Withdrawal by Subject|1
5477811|NCT01868022|18938823|P3|Overall Study|Withdrawal by Subject|1
5477812|NCT01868022|18938824|P2|Overall Study|Withdrawal by Subject|0
5477813|NCT01868022|18938825|P1|Overall Study|Withdrawal by Subject|0
5477814|NCT01868009|18939031|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
5477815|NCT01868009|18939032|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
5477816|NCT01868009|18939031|P2|Period 2 (5-9 Days)|Adverse Event|0
5477817|NCT01868009|18939032|P1|Period 2 (5-9 Days)|Adverse Event|1
5477818|NCT01868009|18939031|P2|Period 1 (5-9 Days)|Adverse Event|2
5477819|NCT01868009|18939032|P1|Period 1 (5-9 Days)|Adverse Event|0
5477820|NCT01867710|18939046|P4|Overall Study|Study medication no longer effective|0
5477821|NCT01867710|18939047|P3|Overall Study|Study medication no longer effective|0
5477822|NCT01867710|18939048|P2|Overall Study|Study medication no longer effective|1
5477823|NCT01867710|18939049|P1|Overall Study|Study medication no longer effective|0
5477824|NCT01867710|18939046|P4|Overall Study|PSA-progression|0
5477825|NCT01867710|18939047|P3|Overall Study|PSA-progression|0
5477826|NCT01867710|18939048|P2|Overall Study|PSA-progression|1
5477827|NCT01867710|18939049|P1|Overall Study|PSA-progression|0
5477828|NCT01867710|18939046|P4|Overall Study|Protocol Violation|1
5477829|NCT01867710|18939047|P3|Overall Study|Protocol Violation|0
5477830|NCT01867710|18939048|P2|Overall Study|Protocol Violation|0
5477831|NCT01867710|18939049|P1|Overall Study|Protocol Violation|0
5477832|NCT01867710|18939046|P4|Overall Study|Progressive disease|0
5477833|NCT01867710|18939047|P3|Overall Study|Progressive disease|0
5477834|NCT01867710|18939048|P2|Overall Study|Progressive disease|0
5477835|NCT01867710|18939049|P1|Overall Study|Progressive disease|1
5477836|NCT01867710|18939046|P4|Overall Study|Patient to follow subsequent treatment|0
5477837|NCT01867710|18939047|P3|Overall Study|Patient to follow subsequent treatment|0
5477838|NCT01867710|18939048|P2|Overall Study|Patient to follow subsequent treatment|1
5477839|NCT01867710|18939049|P1|Overall Study|Patient to follow subsequent treatment|0
5477840|NCT01867710|18939046|P4|Overall Study|Patient decision|1
5477841|NCT01867710|18939047|P3|Overall Study|Patient decision|0
5477842|NCT01867710|18939048|P2|Overall Study|Patient decision|0
5477843|NCT01867710|18939049|P1|Overall Study|Patient decision|0
5477844|NCT01867710|18939046|P4|Overall Study|Disease progression|0
5477845|NCT01867710|18939047|P3|Overall Study|Disease progression|0
5477846|NCT01867710|18939048|P2|Overall Study|Disease progression|0
5477847|NCT01867710|18939049|P1|Overall Study|Disease progression|1
5477848|NCT01867710|18939046|P4|Overall Study|Clinical progression|0
5477849|NCT01867710|18939047|P3|Overall Study|Clinical progression|1
5477850|NCT01867710|18939048|P2|Overall Study|Clinical progression|0
5477851|NCT01867710|18939049|P1|Overall Study|Clinical progression|0
5477852|NCT01867710|18939046|P4|Overall Study|Biochemical progression|0
5477853|NCT01867710|18939047|P3|Overall Study|Biochemical progression|0
5477854|NCT01867710|18939048|P2|Overall Study|Biochemical progression|1
5477855|NCT01867710|18939049|P1|Overall Study|Biochemical progression|0
5477856|NCT01867710|18939046|P4|Overall Study|Study Terminated by Sponsor|16
5477857|NCT01867710|18939047|P3|Overall Study|Study Terminated by Sponsor|8
5477858|NCT01867710|18939048|P2|Overall Study|Study Terminated by Sponsor|13
5477859|NCT01867710|18939049|P1|Overall Study|Study Terminated by Sponsor|9
5477860|NCT01867710|18939046|P4|Overall Study|Withdrawal of consent|2
5477861|NCT01867710|18939047|P3|Overall Study|Withdrawal of consent|1
5477862|NCT01867710|18939048|P2|Overall Study|Withdrawal of consent|5
5477863|NCT01867710|18939049|P1|Overall Study|Withdrawal of consent|2
5477864|NCT01867710|18939046|P4|Overall Study|Lost to Follow-up|2
5477865|NCT01867710|18939047|P3|Overall Study|Lost to Follow-up|3
5477866|NCT01867710|18939048|P2|Overall Study|Lost to Follow-up|4
5477867|NCT01867710|18939049|P1|Overall Study|Lost to Follow-up|3
5477868|NCT01867710|18939046|P4|Overall Study|Death|20
5477869|NCT01867710|18939047|P3|Overall Study|Death|27
5477870|NCT01867710|18939048|P2|Overall Study|Death|15
5477871|NCT01867710|18939049|P1|Overall Study|Death|25
5477872|NCT01867671|18939117|P2|Overall Study|Withdrawal by Subject|21
5477873|NCT01867671|18939118|P1|Overall Study|Withdrawal by Subject|21
5477874|NCT01867671|18939117|P2|Overall Study|Non-compliance with Study Drug|2
5477875|NCT01867671|18939118|P1|Overall Study|Non-compliance with Study Drug|1
5477876|NCT01867671|18939117|P2|Overall Study|Lost to Follow-up|1
5477877|NCT01867671|18939118|P1|Overall Study|Lost to Follow-up|0
5477878|NCT01867671|18939117|P2|Overall Study|Inability to reach 3 mg peanut/placebo|0
5477879|NCT01867671|18939118|P1|Overall Study|Inability to reach 3 mg peanut/placebo|2
5477880|NCT01867671|18939117|P2|Overall Study|Anaphylaxis|1
5477881|NCT01867671|18939118|P1|Overall Study|Anaphylaxis|0
5477882|NCT01867671|18939117|P2|Overall Study|Adverse Event|3
5477883|NCT01867671|18939118|P1|Overall Study|Adverse Event|5
5477884|NCT01867658|18939131|P1|Overall Study|Subject could not be contacted|1
5477885|NCT01867658|18939131|P1|Overall Study|Death|2
5477886|NCT01867658|18939131|P1|Overall Study|Withdrawal by Subject|6
5477887|NCT01867606|18939155|P2|Overall Study|Protocol Violation|1
5477888|NCT01867606|18939156|P1|Overall Study|Protocol Violation|0
5477889|NCT01867606|18939155|P2|Overall Study|Withdrawal by Subject|14
5477890|NCT01867606|18939156|P1|Overall Study|Withdrawal by Subject|10
5477891|NCT01867580|18939174|P2|Overall Study|Wound recurrence|1
5477892|NCT01867580|18939175|P1|Overall Study|Wound recurrence|0
5477893|NCT01867580|18939174|P2|Overall Study|Continuation of therapy|1
5477894|NCT01867580|18939175|P1|Overall Study|Continuation of therapy|0
5477895|NCT01867580|18939174|P2|Overall Study|Osteomyelitis|1
5477896|NCT01867580|18939175|P1|Overall Study|Osteomyelitis|0
5477897|NCT01867580|18939174|P2|Overall Study|Interruption to therapy|0
5477898|NCT01867580|18939175|P1|Overall Study|Interruption to therapy|3
5477899|NCT01867580|18939174|P2|Overall Study|Missed follow-up assessment|1
5477900|NCT01867580|18939175|P1|Overall Study|Missed follow-up assessment|2
5477901|NCT01867580|18939174|P2|Overall Study|Sponsor terminated study|0
5477902|NCT01867580|18939175|P1|Overall Study|Sponsor terminated study|1
5477903|NCT01867580|18939174|P2|Overall Study|Lost to Follow-up|5
5477904|NCT01867580|18939175|P1|Overall Study|Lost to Follow-up|3
5477905|NCT01867580|18939174|P2|Overall Study|Physician Decision|12
5477906|NCT01867580|18939175|P1|Overall Study|Physician Decision|17
5477907|NCT01867580|18939174|P2|Overall Study|Withdrawal by Subject|3
5477908|NCT01867580|18939175|P1|Overall Study|Withdrawal by Subject|2
5477909|NCT01867424|18939200|P2|Overall Study|Patient noncompliance|1
5477910|NCT01867424|18939201|P1|Overall Study|Patient noncompliance|2
5477911|NCT01867307|18939215|P2|Overall Study|Other Adverse Event|3
5477912|NCT01867307|18939216|P1|Overall Study|Other Adverse Event|1
5477913|NCT01867307|18939215|P2|Overall Study|Protocol Violation|0
5477914|NCT01867307|18939216|P1|Overall Study|Protocol Violation|2
5477915|NCT01867294|18939226|P4|Overall Study|Withdrawal by Subject|0
5477916|NCT01867294|18939227|P3|Overall Study|Withdrawal by Subject|0
5477917|NCT01867294|18939228|P2|Overall Study|Withdrawal by Subject|1
5477918|NCT01867294|18939229|P1|Overall Study|Withdrawal by Subject|1
5477919|NCT01867216|18939276|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
5477920|NCT01867216|18939277|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
5477921|NCT01867216|18939278|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
5477922|NCT01867216|18939279|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
5477923|NCT01867216|18939280|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
5477924|NCT01867216|18939281|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
5477925|NCT01867216|18939282|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
5477926|NCT01867216|18939276|P7|Overall Study|Physician Decision|0
5477927|NCT01867216|18939277|P6|Overall Study|Physician Decision|0
5477928|NCT01867216|18939278|P5|Overall Study|Physician Decision|0
5477929|NCT01867216|18939279|P4|Overall Study|Physician Decision|0
5477930|NCT01867216|18939280|P3|Overall Study|Physician Decision|0
5477931|NCT01867216|18939281|P2|Overall Study|Physician Decision|0
5477932|NCT01867216|18939282|P1|Overall Study|Physician Decision|1
5477933|NCT01867216|18939276|P7|Overall Study|Withdrawal by Subject|1
5477934|NCT01867216|18939277|P6|Overall Study|Withdrawal by Subject|0
5477935|NCT01867216|18939278|P5|Overall Study|Withdrawal by Subject|1
5477936|NCT01867216|18939279|P4|Overall Study|Withdrawal by Subject|0
5477937|NCT01867216|18939280|P3|Overall Study|Withdrawal by Subject|0
5477938|NCT01867216|18939281|P2|Overall Study|Withdrawal by Subject|0
5477939|NCT01867216|18939282|P1|Overall Study|Withdrawal by Subject|2
5477940|NCT01867086|18939354|P1|Overall Study|Disease Progression|1
5477941|NCT01867047|18939363|P2|Overall Study|surgery not indicated in protocol|2
5477942|NCT01867047|18939364|P1|Overall Study|surgery not indicated in protocol|1
5477943|NCT01867047|18939363|P2|Overall Study|Physician Decision|0
5477944|NCT01867047|18939364|P1|Overall Study|Physician Decision|2
5477945|NCT01867047|18939363|P2|Overall Study|Withdrawal by Subject|0
5477946|NCT01867047|18939364|P1|Overall Study|Withdrawal by Subject|2
5477947|NCT01867047|18939363|P2|Overall Study|Lost to Follow-up|3
5477948|NCT01867047|18939364|P1|Overall Study|Lost to Follow-up|3
5477949|NCT01867021|18939384|P2|Overall Study|Withdrawal by Subject|6
5477950|NCT01867021|18939385|P1|Overall Study|Withdrawal by Subject|1
5477951|NCT01867021|18939384|P2|Overall Study|Lost to Follow-up|2
5477952|NCT01867021|18939385|P1|Overall Study|Lost to Follow-up|0
5477953|NCT01867021|18939384|P2|Overall Study|Death|0
5477954|NCT01867021|18939385|P1|Overall Study|Death|1
5477955|NCT01867021|18939384|P2|Overall Study|Not Eligible|1
5477956|NCT01867021|18939385|P1|Overall Study|Not Eligible|0
5477957|NCT01867021|18939384|P2|Overall Study|Adverse Event|1
5477958|NCT01867021|18939385|P1|Overall Study|Adverse Event|0
5477959|NCT01866917|18939416|P2|Overall Study|Pharmacist stopped dispensing treatment|6
5477960|NCT01866917|18939417|P1|Overall Study|Pharmacist stopped dispensing treatment|4
5477961|NCT01866826|18939441|P2|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
5477962|NCT01866826|18939442|P1|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
5477963|NCT01866826|18939441|P2|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
5477964|NCT01866826|18939442|P1|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
5477965|NCT01866826|18939441|P2|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
5477966|NCT01866826|18939442|P1|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
5477967|NCT01866709|18939458|P2|Overall Study|Adverse Event|0
5477968|NCT01866709|18939459|P1|Overall Study|Adverse Event|1
5477969|NCT01866423|18939500|P1|Overall Study|Sponsor Decision|1
5477970|NCT01866423|18939500|P1|Overall Study|Lack of Efficacy|3
5477971|NCT01866319|18939528|P3|Overall Study|Withdrawal by Subject|12
5477972|NCT01866319|18939529|P2|Overall Study|Withdrawal by Subject|14
5477973|NCT01866319|18939530|P1|Overall Study|Withdrawal by Subject|32
5477974|NCT01866319|18939528|P3|Overall Study|Protocol Violation|1
5477975|NCT01866319|18939529|P2|Overall Study|Protocol Violation|0
5477976|NCT01866319|18939530|P1|Overall Study|Protocol Violation|0
5477977|NCT01866319|18939528|P3|Overall Study|Physician Decision|1
5477978|NCT01866319|18939529|P2|Overall Study|Physician Decision|0
5477979|NCT01866319|18939530|P1|Overall Study|Physician Decision|1
5477980|NCT01866319|18939528|P3|Overall Study|Lost to Follow-up|8
5477981|NCT01866319|18939529|P2|Overall Study|Lost to Follow-up|3
5477982|NCT01866319|18939530|P1|Overall Study|Lost to Follow-up|6
5477983|NCT01866319|18939528|P3|Overall Study|Death|147
5477984|NCT01866319|18939529|P2|Overall Study|Death|154
5477985|NCT01866319|18939530|P1|Overall Study|Death|153
5477986|NCT01866319|18939528|P3|Overall Study|Clinical progression|2
5477987|NCT01866319|18939529|P2|Overall Study|Clinical progression|2
5477988|NCT01866319|18939530|P1|Overall Study|Clinical progression|3
5477989|NCT01866319|18939528|P3|Overall Study|Adverse Event|9
5477990|NCT01866319|18939529|P2|Overall Study|Adverse Event|5
5477991|NCT01866319|18939530|P1|Overall Study|Adverse Event|12
5477992|NCT01866293|18939629|P1|Overall Study|Adverse Event|2
5477993|NCT01866098|18939674|P3|Overall Study|Death|0
5477994|NCT01866098|18939675|P2|Overall Study|Death|1
5477995|NCT01866098|18939676|P1|Overall Study|Death|0
5477996|NCT01866098|18939674|P3|Overall Study|Pregnancy|0
5477997|NCT01866098|18939675|P2|Overall Study|Pregnancy|0
5477998|NCT01866098|18939676|P1|Overall Study|Pregnancy|2
5477999|NCT01866098|18939674|P3|Overall Study|Non-compliance|1
5478000|NCT01866098|18939675|P2|Overall Study|Non-compliance|0
5478001|NCT01866098|18939676|P1|Overall Study|Non-compliance|1
5478002|NCT01866098|18939674|P3|Overall Study|Unrelated Hospitalization|1
5478003|NCT01866098|18939675|P2|Overall Study|Unrelated Hospitalization|0
5478004|NCT01866098|18939676|P1|Overall Study|Unrelated Hospitalization|2
5478005|NCT01866098|18939674|P3|Overall Study|Withdrawal by Subject|0
5478006|NCT01866098|18939675|P2|Overall Study|Withdrawal by Subject|2
5478007|NCT01866098|18939676|P1|Overall Study|Withdrawal by Subject|1
5478008|NCT01866098|18939674|P3|Overall Study|Protocol Violation|0
5478009|NCT01866098|18939675|P2|Overall Study|Protocol Violation|0
5478010|NCT01866098|18939676|P1|Overall Study|Protocol Violation|1
5478011|NCT01866098|18939674|P3|Overall Study|Adverse Event|4
5478012|NCT01866098|18939675|P2|Overall Study|Adverse Event|5
5478013|NCT01866098|18939676|P1|Overall Study|Adverse Event|1
5478014|NCT01866098|18939674|P3|Overall Study|Physician Decision|2
5478015|NCT01866098|18939675|P2|Overall Study|Physician Decision|1
5478016|NCT01866098|18939676|P1|Overall Study|Physician Decision|0
5478017|NCT01866098|18939674|P3|Overall Study|Lost to Follow-up|13
5478018|NCT01866098|18939675|P2|Overall Study|Lost to Follow-up|18
5478019|NCT01866098|18939676|P1|Overall Study|Lost to Follow-up|11
5478020|NCT01865812|18939705|P1|Overall Study|Adverse Event|2
5478021|NCT01865747|18939713|P2|Primary Intent to Treat (PITT)|Other|1
5478022|NCT01865747|18939714|P1|Primary Intent to Treat (PITT)|Other|0
5478023|NCT01865747|18939713|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
5478024|NCT01865747|18939714|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
5478025|NCT01865747|18939713|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
5478026|NCT01865747|18939714|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
5478027|NCT01865747|18939713|P2|Primary Intent to Treat (PITT)|Physician Decision|2
5478028|NCT01865747|18939714|P1|Primary Intent to Treat (PITT)|Physician Decision|4
5478029|NCT01865747|18939713|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
5478030|NCT01865747|18939714|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
5478031|NCT01865747|18939713|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
5478032|NCT01865747|18939714|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
5478033|NCT01865747|18939713|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
5478034|NCT01865747|18939714|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
5478035|NCT01865747|18939713|P2|Primary Intent to Treat (PITT)|Adverse Event|20
5478036|NCT01865747|18939714|P1|Primary Intent to Treat (PITT)|Adverse Event|21
5478037|NCT01865747|18939713|P2|Overall Study (ITT)|Reason Not Provided|1
5478038|NCT01865747|18939714|P1|Overall Study (ITT)|Reason Not Provided|0
5478039|NCT01865747|18939713|P2|Overall Study (ITT)|Progressive Disease|158
5478040|NCT01865747|18939714|P1|Overall Study (ITT)|Progressive Disease|122
5478041|NCT01865747|18939713|P2|Overall Study (ITT)|Sponsor Decision|1
5478042|NCT01865747|18939714|P1|Overall Study (ITT)|Sponsor Decision|0
5478043|NCT01865747|18939713|P2|Overall Study (ITT)|Withdrawal by Subject|11
5478044|NCT01865747|18939714|P1|Overall Study (ITT)|Withdrawal by Subject|6
5478045|NCT01865747|18939713|P2|Overall Study (ITT)|Physician Decision|2
5478046|NCT01865747|18939714|P1|Overall Study (ITT)|Physician Decision|5
5478047|NCT01865747|18939713|P2|Overall Study (ITT)|Protocol Violation|1
5478048|NCT01865747|18939714|P1|Overall Study (ITT)|Protocol Violation|1
5478049|NCT01865747|18939713|P2|Overall Study (ITT)|Lack of Efficacy|0
5478050|NCT01865747|18939714|P1|Overall Study (ITT)|Lack of Efficacy|3
5478051|NCT01865747|18939713|P2|Overall Study (ITT)|Clinical Deterioration|50
5478052|NCT01865747|18939714|P1|Overall Study (ITT)|Clinical Deterioration|29
5478053|NCT01865747|18939713|P2|Overall Study (ITT)|Adverse Event|31
5478054|NCT01865747|18939714|P1|Overall Study (ITT)|Adverse Event|32
5478055|NCT01865552|18939735|P6|Period 1|Other|0
5478056|NCT01865552|18939736|P5|Period 1|Other|1
5478057|NCT01865552|18939737|P4|Period 1|Other|0
5478058|NCT01865552|18939738|P3|Period 1|Other|0
5478059|NCT01865552|18939739|P2|Period 1|Other|0
5478060|NCT01865552|18939740|P1|Period 1|Other|0
5478061|NCT01865552|18939735|P6|Period 1|Pathological lab|0
5478062|NCT01865552|18939736|P5|Period 1|Pathological lab|1
5478063|NCT01865552|18939737|P4|Period 1|Pathological lab|0
5478064|NCT01865552|18939738|P3|Period 1|Pathological lab|0
5478065|NCT01865552|18939739|P2|Period 1|Pathological lab|0
5478066|NCT01865552|18939740|P1|Period 1|Pathological lab|0
5478067|NCT01865552|18939735|P6|Period 1|Adverse Event|1
5478068|NCT01865552|18939736|P5|Period 1|Adverse Event|1
5478069|NCT01865552|18939737|P4|Period 1|Adverse Event|1
5478070|NCT01865552|18939738|P3|Period 1|Adverse Event|0
5478071|NCT01865552|18939739|P2|Period 1|Adverse Event|0
5478072|NCT01865552|18939740|P1|Period 1|Adverse Event|1
5478073|NCT01865487|18939778|P10|Overall Study|Withdrawal by Subject|0
5478074|NCT01865487|18939779|P9|Overall Study|Withdrawal by Subject|0
5478075|NCT01865487|18939780|P8|Overall Study|Withdrawal by Subject|0
5478076|NCT01865487|18939781|P7|Overall Study|Withdrawal by Subject|0
5478077|NCT01865487|18939782|P6|Overall Study|Withdrawal by Subject|0
5478078|NCT01865487|18939783|P5|Overall Study|Withdrawal by Subject|1
5478079|NCT01865487|18939784|P4|Overall Study|Withdrawal by Subject|0
5478080|NCT01865487|18939785|P3|Overall Study|Withdrawal by Subject|0
5478081|NCT01865487|18939786|P2|Overall Study|Withdrawal by Subject|0
5478082|NCT01865487|18939787|P1|Overall Study|Withdrawal by Subject|0
5478083|NCT01865487|18939778|P10|Overall Study|Lost to Follow-up|0
5478084|NCT01865487|18939779|P9|Overall Study|Lost to Follow-up|0
5478085|NCT01865487|18939780|P8|Overall Study|Lost to Follow-up|0
5478086|NCT01865487|18939781|P7|Overall Study|Lost to Follow-up|1
5478087|NCT01865487|18939782|P6|Overall Study|Lost to Follow-up|0
5478088|NCT01865487|18939783|P5|Overall Study|Lost to Follow-up|0
5478089|NCT01865487|18939784|P4|Overall Study|Lost to Follow-up|1
5478090|NCT01865487|18939785|P3|Overall Study|Lost to Follow-up|0
5478091|NCT01865487|18939786|P2|Overall Study|Lost to Follow-up|0
5478092|NCT01865487|18939787|P1|Overall Study|Lost to Follow-up|0
5478093|NCT01865448|18939826|P2|Overall Study|dropout unrelated to study|1
5478094|NCT01865448|18939827|P1|Overall Study|dropout unrelated to study|1
5478095|NCT01865448|18939826|P2|Overall Study|Pregnancy|1
5478096|NCT01865448|18939827|P1|Overall Study|Pregnancy|0
5478097|NCT01865448|18939826|P2|Overall Study|Adverse Event|1
5478098|NCT01865448|18939827|P1|Overall Study|Adverse Event|1
5478099|NCT01865084|18939938|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
5478100|NCT01865084|18939939|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
5478101|NCT01865084|18939940|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
5478102|NCT01865084|18939938|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
5478103|NCT01865084|18939939|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
5478104|NCT01865084|18939940|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
5478105|NCT01865084|18939938|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
5478106|NCT01865084|18939939|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
5478107|NCT01865084|18939940|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
5478108|NCT01865084|18939938|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
5478109|NCT01865084|18939939|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
5478110|NCT01865084|18939940|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
5478111|NCT01865084|18939938|P3|Open Label Extension (OLE) Period|Adverse Event|1
5478112|NCT01865084|18939939|P2|Open Label Extension (OLE) Period|Adverse Event|0
5478113|NCT01865084|18939940|P1|Open Label Extension (OLE) Period|Adverse Event|0
5478114|NCT01865084|18939938|P3|Double Blind Period (DB)|Withdrawal by Subject|0
5478115|NCT01865084|18939939|P2|Double Blind Period (DB)|Withdrawal by Subject|0
5478116|NCT01865084|18939940|P1|Double Blind Period (DB)|Withdrawal by Subject|1
5478117|NCT01865084|18939938|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
5478118|NCT01865084|18939939|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
5478119|NCT01865084|18939940|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
5478120|NCT01865084|18939938|P3|Double Blind Period (DB)|Protocol Violation|1
5478121|NCT01865084|18939939|P2|Double Blind Period (DB)|Protocol Violation|0
5478122|NCT01865084|18939940|P1|Double Blind Period (DB)|Protocol Violation|0
5478123|NCT01865084|18939938|P3|Double Blind Period (DB)|Adverse Event|1
5478124|NCT01865084|18939939|P2|Double Blind Period (DB)|Adverse Event|2
5478125|NCT01865084|18939940|P1|Double Blind Period (DB)|Adverse Event|2
5478126|NCT01864564|18939968|P2|Overall Study|not reported|34
5478127|NCT01864564|18939969|P1|Overall Study|not reported|0
5478128|NCT01864564|18939968|P2|Overall Study|Protocol Violation|27
5478129|NCT01864564|18939969|P1|Overall Study|Protocol Violation|0
5478130|NCT01864564|18939968|P2|Overall Study|Withdrawal by Subject|11
5478131|NCT01864564|18939969|P1|Overall Study|Withdrawal by Subject|20
5478132|NCT01864564|18939968|P2|Overall Study|Lost to Follow-up|23
5478133|NCT01864564|18939969|P1|Overall Study|Lost to Follow-up|17
5478134|NCT01864525|18940001|P2|Overall Study|Adverse Event|0
5478135|NCT01864525|18940002|P1|Overall Study|Adverse Event|1
5478136|NCT01864291|18940023|P1|Overall Study|need for revision surgery|2
5478137|NCT01864200|18940031|P2|Overall Study|Protocol Violation|0
5478138|NCT01864200|18940032|P1|Overall Study|Protocol Violation|1
5478139|NCT01864200|18940031|P2|Overall Study|Lost to Follow-up|3
5478140|NCT01864200|18940032|P1|Overall Study|Lost to Follow-up|1
5478141|NCT01864174|18940040|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
5478142|NCT01864174|18940041|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
5478143|NCT01864174|18940040|P2|Off Treatment Follow-Up|Other|0
5478144|NCT01864174|18940041|P1|Off Treatment Follow-Up|Other|2
5478145|NCT01864174|18940040|P2|Double Blind - Compliant Randomized|Other|10
5478146|NCT01864174|18940041|P1|Double Blind - Compliant Randomized|Other|6
5478147|NCT01864174|18940040|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
5478148|NCT01864174|18940041|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
5478149|NCT01864174|18940040|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
5478150|NCT01864174|18940041|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
5478151|NCT01864174|18940040|P2|Double Blind - Compliant Randomized|Death|0
5478152|NCT01864174|18940041|P1|Double Blind - Compliant Randomized|Death|1
5478153|NCT01864174|18940040|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
5478154|NCT01864174|18940041|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
5478155|NCT01864174|18940040|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
5478156|NCT01864174|18940041|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
5478157|NCT01864174|18940040|P2|Double Blind - Compliant Randomized|Adverse Event|1
5478158|NCT01864174|18940041|P1|Double Blind - Compliant Randomized|Adverse Event|6
5478159|NCT01864174|18940040|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
5478160|NCT01864174|18940041|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
5478161|NCT01864148|18940060|P5|Overall Study|Not Dosed|0
5478162|NCT01864148|18940061|P4|Overall Study|Not Dosed|1
5478163|NCT01864148|18940062|P3|Overall Study|Not Dosed|0
5478164|NCT01864148|18940063|P2|Overall Study|Not Dosed|0
5478165|NCT01864148|18940064|P1|Overall Study|Not Dosed|0
5478166|NCT01864148|18940060|P5|Overall Study|Adverse Event|7
5478167|NCT01864148|18940061|P4|Overall Study|Adverse Event|7
5478168|NCT01864148|18940062|P3|Overall Study|Adverse Event|4
5478169|NCT01864148|18940063|P2|Overall Study|Adverse Event|2
5478170|NCT01864148|18940064|P1|Overall Study|Adverse Event|4
5478171|NCT01864148|18940060|P5|Overall Study|Lost to Follow-up|1
5478172|NCT01864148|18940061|P4|Overall Study|Lost to Follow-up|2
5478173|NCT01864148|18940062|P3|Overall Study|Lost to Follow-up|0
5478174|NCT01864148|18940063|P2|Overall Study|Lost to Follow-up|0
5478175|NCT01864148|18940064|P1|Overall Study|Lost to Follow-up|0
5478176|NCT01864148|18940060|P5|Overall Study|Withdrawal by Subject|8
5478177|NCT01864148|18940061|P4|Overall Study|Withdrawal by Subject|8
5478178|NCT01864148|18940062|P3|Overall Study|Withdrawal by Subject|6
5478179|NCT01864148|18940063|P2|Overall Study|Withdrawal by Subject|2
5478180|NCT01864148|18940064|P1|Overall Study|Withdrawal by Subject|9
5478181|NCT01864148|18940060|P5|Overall Study|Investigator Decision|6
5478182|NCT01864148|18940061|P4|Overall Study|Investigator Decision|4
5478183|NCT01864148|18940062|P3|Overall Study|Investigator Decision|0
5478184|NCT01864148|18940063|P2|Overall Study|Investigator Decision|0
5478185|NCT01864148|18940064|P1|Overall Study|Investigator Decision|5
5478186|NCT01864148|18940060|P5|Overall Study|Death|0
5478187|NCT01864148|18940061|P4|Overall Study|Death|1
5478188|NCT01864148|18940062|P3|Overall Study|Death|0
5478189|NCT01864148|18940063|P2|Overall Study|Death|0
5478190|NCT01864148|18940064|P1|Overall Study|Death|0
5478191|NCT01864148|18940060|P5|Overall Study|Other|1
5478192|NCT01864148|18940061|P4|Overall Study|Other|3
5478193|NCT01864148|18940062|P3|Overall Study|Other|1
5478194|NCT01864148|18940063|P2|Overall Study|Other|1
5478195|NCT01864148|18940064|P1|Overall Study|Other|2
5478196|NCT01864005|18940093|P2|Overall Study|Need GP IIb/IIIa|3
5478197|NCT01864005|18940094|P1|Overall Study|Need GP IIb/IIIa|1
5478198|NCT01864005|18940093|P2|Overall Study|Disease need|1
5478199|NCT01864005|18940094|P1|Overall Study|Disease need|1
5478200|NCT01864005|18940093|P2|Overall Study|Incorrect enrolment|0
5478201|NCT01864005|18940094|P1|Overall Study|Incorrect enrolment|1
5478202|NCT01864005|18940093|P2|Overall Study|Withdrawal by Subject|1
5478203|NCT01864005|18940094|P1|Overall Study|Withdrawal by Subject|0
5478204|NCT01864005|18940093|P2|Overall Study|Protocol Violation|1
5478205|NCT01864005|18940094|P1|Overall Study|Protocol Violation|0
5478206|NCT01863953|18940111|P3|Overall Study|Adverse Event|1
5478207|NCT01863953|18940112|P2|Overall Study|Adverse Event|0
5478208|NCT01863953|18940113|P1|Overall Study|Adverse Event|0
5478209|NCT01863771|18940127|P4|Maintenance Phase|Withdrawal by Subject|3
5478210|NCT01863771|18940128|P3|Maintenance Phase|Withdrawal by Subject|2
5478211|NCT01863771|18940129|P2|Maintenance Phase|Withdrawal by Subject|1
5478212|NCT01863771|18940130|P1|Maintenance Phase|Withdrawal by Subject|0
5478213|NCT01863771|18940127|P4|Maintenance Phase|Pregnancy|0
5478214|NCT01863771|18940128|P3|Maintenance Phase|Pregnancy|0
5478215|NCT01863771|18940129|P2|Maintenance Phase|Pregnancy|1
5478216|NCT01863771|18940130|P1|Maintenance Phase|Pregnancy|0
5478217|NCT01863771|18940127|P4|Maintenance Phase|Physician Decision|1
5478218|NCT01863771|18940128|P3|Maintenance Phase|Physician Decision|2
5478219|NCT01863771|18940129|P2|Maintenance Phase|Physician Decision|0
5478220|NCT01863771|18940130|P1|Maintenance Phase|Physician Decision|0
5478221|NCT01863771|18940127|P4|Maintenance Phase|Lack of Efficacy|38
5478222|NCT01863771|18940128|P3|Maintenance Phase|Lack of Efficacy|7
5478223|NCT01863771|18940129|P2|Maintenance Phase|Lack of Efficacy|3
5478224|NCT01863771|18940130|P1|Maintenance Phase|Lack of Efficacy|0
5478225|NCT01863771|18940127|P4|Maintenance Phase|Adverse Event|1
5478226|NCT01863771|18940128|P3|Maintenance Phase|Adverse Event|1
5478227|NCT01863771|18940129|P2|Maintenance Phase|Adverse Event|0
5478228|NCT01863771|18940130|P1|Maintenance Phase|Adverse Event|0
5478229|NCT01863771|18940127|P4|Induction Phase|Withdrawal by Subject|0
5478230|NCT01863771|18940128|P3|Induction Phase|Withdrawal by Subject|0
5478231|NCT01863771|18940129|P2|Induction Phase|Withdrawal by Subject|0
5478232|NCT01863771|18940130|P1|Induction Phase|Withdrawal by Subject|2
5478233|NCT01863771|18940127|P4|Induction Phase|Lack of Efficacy|0
5478234|NCT01863771|18940128|P3|Induction Phase|Lack of Efficacy|0
5478235|NCT01863771|18940129|P2|Induction Phase|Lack of Efficacy|0
5478236|NCT01863771|18940130|P1|Induction Phase|Lack of Efficacy|10
5478237|NCT01863771|18940127|P4|Induction Phase|Adverse Event|0
5478238|NCT01863771|18940128|P3|Induction Phase|Adverse Event|0
5478239|NCT01863771|18940129|P2|Induction Phase|Adverse Event|0
5478240|NCT01863771|18940130|P1|Induction Phase|Adverse Event|9
5478241|NCT01863758|18940142|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
5478242|NCT01863758|18940142|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
5478243|NCT01863732|18940154|P4|Overall Study|Death|1
5478244|NCT01863732|18940155|P3|Overall Study|Death|0
5478245|NCT01863732|18940156|P2|Overall Study|Death|0
5478246|NCT01863732|18940157|P1|Overall Study|Death|1
5478247|NCT01863732|18940154|P4|Overall Study|Subject/guardian decision|1
5478248|NCT01863732|18940155|P3|Overall Study|Subject/guardian decision|3
5478249|NCT01863732|18940156|P2|Overall Study|Subject/guardian decision|9
5478250|NCT01863732|18940157|P1|Overall Study|Subject/guardian decision|6
5478251|NCT01863732|18940154|P4|Overall Study|Technical problems|0
5478252|NCT01863732|18940155|P3|Overall Study|Technical problems|1
5478253|NCT01863732|18940156|P2|Overall Study|Technical problems|1
5478254|NCT01863732|18940157|P1|Overall Study|Technical problems|0
5478255|NCT01863732|18940154|P4|Overall Study|Pregnancy|1
5478256|NCT01863732|18940155|P3|Overall Study|Pregnancy|0
5478257|NCT01863732|18940156|P2|Overall Study|Pregnancy|0
5478258|NCT01863732|18940157|P1|Overall Study|Pregnancy|0
5478259|NCT01863732|18940154|P4|Overall Study|Physician Decision|0
5478260|NCT01863732|18940155|P3|Overall Study|Physician Decision|1
5478261|NCT01863732|18940156|P2|Overall Study|Physician Decision|0
5478262|NCT01863732|18940157|P1|Overall Study|Physician Decision|1
5478263|NCT01863732|18940154|P4|Overall Study|Lost to Follow-up|1
5478264|NCT01863732|18940155|P3|Overall Study|Lost to Follow-up|1
5478265|NCT01863732|18940156|P2|Overall Study|Lost to Follow-up|2
5478266|NCT01863732|18940157|P1|Overall Study|Lost to Follow-up|2
5478267|NCT01863732|18940154|P4|Overall Study|Lack of Efficacy|1
5478268|NCT01863732|18940155|P3|Overall Study|Lack of Efficacy|2
5478269|NCT01863732|18940156|P2|Overall Study|Lack of Efficacy|0
5478270|NCT01863732|18940157|P1|Overall Study|Lack of Efficacy|1
5478271|NCT01863732|18940154|P4|Overall Study|Adverse Event|3
5478272|NCT01863732|18940155|P3|Overall Study|Adverse Event|3
5478273|NCT01863732|18940156|P2|Overall Study|Adverse Event|0
5478274|NCT01863732|18940157|P1|Overall Study|Adverse Event|2
5478275|NCT01863680|18940170|P1|Overall Study|Other|6
5478276|NCT01863680|18940170|P1|Overall Study|Did not undergo IVF/ET|14
5478277|NCT01863680|18940170|P1|Overall Study|Withdrawal by Subject|1
5478278|NCT01863680|18940170|P1|Overall Study|Spontaneous pregnancy|2
5478279|NCT01863680|18940170|P1|Overall Study|Risk of OHSS|17
5478280|NCT01863680|18940170|P1|Overall Study|Adverse Event|17
5478281|NCT01863667|18940178|P2|Overall Study|Withdrawal by Subject|2
5478282|NCT01863667|18940179|P1|Overall Study|Withdrawal by Subject|2
5478283|NCT01863667|18940178|P2|Overall Study|Study terminated by Sponsor|30
5478284|NCT01863667|18940179|P1|Overall Study|Study terminated by Sponsor|30
5478285|NCT01863667|18940178|P2|Overall Study|Adverse Event|0
5478286|NCT01863667|18940179|P1|Overall Study|Adverse Event|1
5478287|NCT01863433|18940216|P1|Overall Study|Protocol Violation|1
5478288|NCT01863368|18940226|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
5478289|NCT01863368|18940227|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
5478290|NCT01863368|18940226|P2|Phase II, Day 35 to Day 90|Adverse Event|0
5478291|NCT01863368|18940227|P1|Phase II, Day 35 to Day 90|Adverse Event|1
5478292|NCT01863368|18940226|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
5478293|NCT01863368|18940227|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
5478294|NCT01863368|18940226|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
5478295|NCT01863368|18940227|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
5478296|NCT01863368|18940226|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
5478297|NCT01863368|18940227|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
5478298|NCT01863368|18940226|P2|Phase I, Day 0 to Day 35|Adverse Event|4
5478299|NCT01863368|18940227|P1|Phase I, Day 0 to Day 35|Adverse Event|2
5478300|NCT01862991|18940281|P3|Overall Study|Protocol Violation|0
5478301|NCT01862991|18940282|P2|Overall Study|Protocol Violation|0
5478302|NCT01862991|18940283|P1|Overall Study|Protocol Violation|1
5478303|NCT01862991|18940281|P3|Overall Study|Lost to Follow-up|1
5478304|NCT01862991|18940282|P2|Overall Study|Lost to Follow-up|1
5478305|NCT01862991|18940283|P1|Overall Study|Lost to Follow-up|2
5478306|NCT01862874|18940296|P2|Overall Study|Death|1
5478307|NCT01862874|18940297|P1|Overall Study|Death|0
5478308|NCT01862874|18940296|P2|Overall Study|Withdrawal by Subject|40
5478309|NCT01862874|18940297|P1|Overall Study|Withdrawal by Subject|46
5478310|NCT01862874|18940296|P2|Overall Study|Withdrawn by parent/guardian|1
5478311|NCT01862874|18940297|P1|Overall Study|Withdrawn by parent/guardian|1
5478312|NCT01862874|18940296|P2|Overall Study|Physician Decision|3
5478313|NCT01862874|18940297|P1|Overall Study|Physician Decision|5
5478314|NCT01862874|18940296|P2|Overall Study|Lost to Follow-up|29
5478315|NCT01862874|18940297|P1|Overall Study|Lost to Follow-up|26
5478316|NCT01862874|18940296|P2|Overall Study|Adverse Event|3
5478317|NCT01862874|18940297|P1|Overall Study|Adverse Event|0
5478318|NCT01862874|18940296|P2|Overall Study|Randomized not treated|0
5478319|NCT01862874|18940297|P1|Overall Study|Randomized not treated|1
5478320|NCT01862796|18940316|P3|Overall Study|Prohibited medications|1
5478321|NCT01862796|18940317|P2|Overall Study|Prohibited medications|0
5478322|NCT01862796|18940318|P1|Overall Study|Prohibited medications|0
5478323|NCT01862640|18940333|P4|Overall Study|Protocol Deviation|0
5478324|NCT01862640|18940334|P3|Overall Study|Protocol Deviation|1
5478325|NCT01862640|18940335|P2|Overall Study|Protocol Deviation|0
5478326|NCT01862640|18940336|P1|Overall Study|Protocol Deviation|0
5478327|NCT01862640|18940333|P4|Overall Study|Withdrawal by Subject|5
5478328|NCT01862640|18940334|P3|Overall Study|Withdrawal by Subject|8
5478329|NCT01862640|18940335|P2|Overall Study|Withdrawal by Subject|4
5478330|NCT01862640|18940336|P1|Overall Study|Withdrawal by Subject|2
5478331|NCT01862640|18940333|P4|Overall Study|Participant Withdrawn by Investigator|1
5478332|NCT01862640|18940334|P3|Overall Study|Participant Withdrawn by Investigator|1
5478333|NCT01862640|18940335|P2|Overall Study|Participant Withdrawn by Investigator|1
5478334|NCT01862640|18940336|P1|Overall Study|Participant Withdrawn by Investigator|0
5478335|NCT01862640|18940333|P4|Overall Study|Participant Met Withdrawal Criteria|1
5478336|NCT01862640|18940334|P3|Overall Study|Participant Met Withdrawal Criteria|2
5478337|NCT01862640|18940335|P2|Overall Study|Participant Met Withdrawal Criteria|1
5478338|NCT01862640|18940336|P1|Overall Study|Participant Met Withdrawal Criteria|1
5478339|NCT01862640|18940333|P4|Overall Study|Adverse Event|8
5478340|NCT01862640|18940334|P3|Overall Study|Adverse Event|6
5478341|NCT01862640|18940335|P2|Overall Study|Adverse Event|10
5478342|NCT01862640|18940336|P1|Overall Study|Adverse Event|4
5478343|NCT01862484|18940357|P2|Overall Study|Withdrawal by Subject|3
5478344|NCT01862484|18940358|P1|Overall Study|Withdrawal by Subject|0
5478345|NCT01862484|18940357|P2|Overall Study|Protocol Violation|2
5478346|NCT01862484|18940358|P1|Overall Study|Protocol Violation|0
5478347|NCT01862484|18940357|P2|Overall Study|Lost to Follow-up|2
5478348|NCT01862484|18940358|P1|Overall Study|Lost to Follow-up|1
5478349|NCT01862484|18940357|P2|Overall Study|Lack of Efficacy|1
5478350|NCT01862484|18940358|P1|Overall Study|Lack of Efficacy|1
5478351|NCT01862328|18940384|P7|Overall Study|Symptomatic Deterioration|1
5478352|NCT01862328|18940385|P6|Overall Study|Symptomatic Deterioration|0
5478353|NCT01862328|18940386|P5|Overall Study|Symptomatic Deterioration|0
5478354|NCT01862328|18940387|P4|Overall Study|Symptomatic Deterioration|0
5478355|NCT01862328|18940388|P3|Overall Study|Symptomatic Deterioration|0
5478356|NCT01862328|18940389|P2|Overall Study|Symptomatic Deterioration|0
5478357|NCT01862328|18940390|P1|Overall Study|Symptomatic Deterioration|0
5478358|NCT01862328|18940384|P7|Overall Study|Withdrawal by Subject|1
5478359|NCT01862328|18940385|P6|Overall Study|Withdrawal by Subject|1
5478360|NCT01862328|18940386|P5|Overall Study|Withdrawal by Subject|1
5478361|NCT01862328|18940387|P4|Overall Study|Withdrawal by Subject|0
5478362|NCT01862328|18940388|P3|Overall Study|Withdrawal by Subject|0
5478363|NCT01862328|18940389|P2|Overall Study|Withdrawal by Subject|1
5478364|NCT01862328|18940390|P1|Overall Study|Withdrawal by Subject|1
5478365|NCT01862328|18940384|P7|Overall Study|Other|1
5478366|NCT01862328|18940385|P6|Overall Study|Other|0
5478367|NCT01862328|18940386|P5|Overall Study|Other|4
5478368|NCT01862328|18940387|P4|Overall Study|Other|0
5478369|NCT01862328|18940388|P3|Overall Study|Other|1
5478370|NCT01862328|18940389|P2|Overall Study|Other|2
5478371|NCT01862328|18940390|P1|Overall Study|Other|0
5478372|NCT01862328|18940384|P7|Overall Study|Adverse Event|4
5478373|NCT01862328|18940385|P6|Overall Study|Adverse Event|2
5478374|NCT01862328|18940386|P5|Overall Study|Adverse Event|0
5478375|NCT01862328|18940387|P4|Overall Study|Adverse Event|1
5478376|NCT01862328|18940388|P3|Overall Study|Adverse Event|0
5478377|NCT01862328|18940389|P2|Overall Study|Adverse Event|4
5478378|NCT01862328|18940390|P1|Overall Study|Adverse Event|0
5478379|NCT01862328|18940384|P7|Overall Study|Progressive Disease|3
5478380|NCT01862328|18940385|P6|Overall Study|Progressive Disease|4
5478381|NCT01862328|18940386|P5|Overall Study|Progressive Disease|7
5478382|NCT01862328|18940387|P4|Overall Study|Progressive Disease|6
5478383|NCT01862328|18940388|P3|Overall Study|Progressive Disease|5
5478384|NCT01862328|18940389|P2|Overall Study|Progressive Disease|11
5478385|NCT01862328|18940390|P1|Overall Study|Progressive Disease|3
5478386|NCT01862250|18940442|P1|Overall Study|Adverse Event|4
5478387|NCT01862029|18940463|P1|Overall Study|Physician Decision|1
5478388|NCT01861522|18940566|P2|Overall Study|Withdrawal by Subject|0
5478389|NCT01861522|18940567|P1|Overall Study|Withdrawal by Subject|2
5478390|NCT01861522|18940566|P2|Overall Study|Adverse Event|0
5478391|NCT01861522|18940567|P1|Overall Study|Adverse Event|1
5478392|NCT01860989|18940596|P1|Overall Study|Unsatisfactory therapeutic|5
5478393|NCT01860976|18940602|P2|Long Term Extension|Ongoing treatment at time of analysis|100
5478394|NCT01860976|18940603|P1|Long Term Extension|Ongoing treatment at time of analysis|106
5478395|NCT01860976|18940602|P2|Long Term Extension|Withdrawal by Subject|0
5478396|NCT01860976|18940603|P1|Long Term Extension|Withdrawal by Subject|1
5478397|NCT01860976|18940602|P2|Long Term Extension|Subject request to discontinue treatment|0
5478398|NCT01860976|18940603|P1|Long Term Extension|Subject request to discontinue treatment|2
5478399|NCT01860976|18940602|P2|Long Term Extension|Lack of Efficacy|7
5478400|NCT01860976|18940603|P1|Long Term Extension|Lack of Efficacy|3
5478401|NCT01860976|18940602|P2|Long Term Extension|Adverse Event|0
5478402|NCT01860976|18940603|P1|Long Term Extension|Adverse Event|1
5478403|NCT01860976|18940602|P2|Open-Label|Ongoing OL treatment at time of analysis|45
5478404|NCT01860976|18940603|P1|Open-Label|Ongoing OL treatment at time of analysis|46
5478405|NCT01860976|18940602|P2|Open-Label|Other Reasons|1
5478406|NCT01860976|18940603|P1|Open-Label|Other Reasons|1
5478407|NCT01860976|18940602|P2|Open-Label|Withdrawal by Subject|1
5478408|NCT01860976|18940603|P1|Open-Label|Withdrawal by Subject|4
5478409|NCT01860976|18940602|P2|Open-Label|Subject request discontinue treatment|3
5478410|NCT01860976|18940603|P1|Open-Label|Subject request discontinue treatment|4
5478411|NCT01860976|18940602|P2|Open-Label|Lost to Follow-up|2
5478412|NCT01860976|18940603|P1|Open-Label|Lost to Follow-up|1
5478413|NCT01860976|18940602|P2|Open-Label|Lack of Efficacy|8
5478414|NCT01860976|18940603|P1|Open-Label|Lack of Efficacy|16
5478415|NCT01860976|18940602|P2|Open-Label|Adverse Event|4
5478416|NCT01860976|18940603|P1|Open-Label|Adverse Event|2
5478417|NCT01860976|18940602|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
5478418|NCT01860976|18940603|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
5478419|NCT01860976|18940602|P2|Blinded Treatment|Entered Open-Label in error|1
5478420|NCT01860976|18940603|P1|Blinded Treatment|Entered Open-Label in error|0
5478421|NCT01860976|18940602|P2|Blinded Treatment|Subject no longer met criteria|0
5478422|NCT01860976|18940603|P1|Blinded Treatment|Subject no longer met criteria|1
5478423|NCT01860976|18940602|P2|Blinded Treatment|Withdrawal by Subject|5
5478424|NCT01860976|18940603|P1|Blinded Treatment|Withdrawal by Subject|3
5478425|NCT01860976|18940602|P2|Blinded Treatment|Subject request to discontinue treatment|3
5478426|NCT01860976|18940603|P1|Blinded Treatment|Subject request to discontinue treatment|2
5478427|NCT01860976|18940602|P2|Blinded Treatment|Lack of Efficacy|12
5478428|NCT01860976|18940603|P1|Blinded Treatment|Lack of Efficacy|5
5478429|NCT01860976|18940602|P2|Blinded Treatment|Adverse Event|3
5478430|NCT01860976|18940603|P1|Blinded Treatment|Adverse Event|1
5478431|NCT01860846|18940657|P1|Overall Study|Lost to Follow-up|33
5478432|NCT01860703|18940677|P4|Overall Study|Personal reason|0
5478433|NCT01860703|18940678|P3|Overall Study|Personal reason|1
5478434|NCT01860703|18940679|P2|Overall Study|Personal reason|0
5478435|NCT01860703|18940680|P1|Overall Study|Personal reason|1
5478436|NCT01860703|18940677|P4|Overall Study|Withdrawal by Subject|0
5478437|NCT01860703|18940678|P3|Overall Study|Withdrawal by Subject|0
5478438|NCT01860703|18940679|P2|Overall Study|Withdrawal by Subject|1
5478439|NCT01860703|18940680|P1|Overall Study|Withdrawal by Subject|0
5478440|NCT01860703|18940677|P4|Overall Study|Adverse Event|2
5478441|NCT01860703|18940678|P3|Overall Study|Adverse Event|0
5478442|NCT01860703|18940679|P2|Overall Study|Adverse Event|4
5478443|NCT01860703|18940680|P1|Overall Study|Adverse Event|1
5478444|NCT01860677|18940712|P2|Second Intervention (1 Day)|Lost to Follow-up|0
5478445|NCT01860677|18940713|P1|Second Intervention (1 Day)|Lost to Follow-up|7
5478446|NCT01860534|18940770|P2|ROP #2|discharged prior to ROP #2|0
5478447|NCT01860534|18940771|P1|ROP #2|discharged prior to ROP #2|1
5478448|NCT01860534|18940770|P2|ROP #1|Needed treatment for ROP|1
5478449|NCT01860534|18940771|P1|ROP #1|Needed treatment for ROP|0
5478450|NCT01860079|18940832|P2|Overall Study|Physician Decision|22
5478451|NCT01860079|18940833|P1|Overall Study|Physician Decision|14
5478452|NCT01860040|18940841|P2|Overall Study|Withdrawal by Subject|0
5478453|NCT01860040|18940842|P1|Overall Study|Withdrawal by Subject|1
5478454|NCT01859988|18940853|P6|Overall Study|Other than specified above|3
5478455|NCT01859988|18940854|P5|Overall Study|Other than specified above|5
5478456|NCT01859988|18940855|P4|Overall Study|Other than specified above|3
5478457|NCT01859988|18940856|P3|Overall Study|Other than specified above|11
5478458|NCT01859988|18940857|P2|Overall Study|Other than specified above|2
5478459|NCT01859988|18940858|P1|Overall Study|Other than specified above|0
5478460|NCT01859988|18940853|P6|Overall Study|Protocol Violation|0
5478461|NCT01859988|18940854|P5|Overall Study|Protocol Violation|0
5478462|NCT01859988|18940855|P4|Overall Study|Protocol Violation|0
5478463|NCT01859988|18940856|P3|Overall Study|Protocol Violation|1
5478464|NCT01859988|18940857|P2|Overall Study|Protocol Violation|0
5478465|NCT01859988|18940858|P1|Overall Study|Protocol Violation|0
5478466|NCT01859988|18940853|P6|Overall Study|Lost to Follow-up|2
5478467|NCT01859988|18940854|P5|Overall Study|Lost to Follow-up|3
5478468|NCT01859988|18940855|P4|Overall Study|Lost to Follow-up|0
5478469|NCT01859988|18940856|P3|Overall Study|Lost to Follow-up|3
5478470|NCT01859988|18940857|P2|Overall Study|Lost to Follow-up|2
5478471|NCT01859988|18940858|P1|Overall Study|Lost to Follow-up|1
5478472|NCT01859988|18940853|P6|Overall Study|Adverse Event|2
5478473|NCT01859988|18940854|P5|Overall Study|Adverse Event|2
5478474|NCT01859988|18940855|P4|Overall Study|Adverse Event|1
5478475|NCT01859988|18940856|P3|Overall Study|Adverse Event|3
5478476|NCT01859988|18940857|P2|Overall Study|Adverse Event|1
5478477|NCT01859988|18940858|P1|Overall Study|Adverse Event|2
5478478|NCT01859988|18940853|P6|Overall Study|Physician Decision|1
5478479|NCT01859988|18940854|P5|Overall Study|Physician Decision|4
5478480|NCT01859988|18940855|P4|Overall Study|Physician Decision|3
5478481|NCT01859988|18940856|P3|Overall Study|Physician Decision|1
5478482|NCT01859988|18940857|P2|Overall Study|Physician Decision|3
5478483|NCT01859988|18940858|P1|Overall Study|Physician Decision|1
5478484|NCT01859988|18940853|P6|Overall Study|Lack of Efficacy|9
5478485|NCT01859988|18940854|P5|Overall Study|Lack of Efficacy|7
5478486|NCT01859988|18940855|P4|Overall Study|Lack of Efficacy|0
5478487|NCT01859988|18940856|P3|Overall Study|Lack of Efficacy|5
5478488|NCT01859988|18940857|P2|Overall Study|Lack of Efficacy|1
5478489|NCT01859988|18940858|P1|Overall Study|Lack of Efficacy|1
5478490|NCT01859988|18940853|P6|Overall Study|Withdrawal by Subject|2
5478491|NCT01859988|18940854|P5|Overall Study|Withdrawal by Subject|2
5478492|NCT01859988|18940855|P4|Overall Study|Withdrawal by Subject|3
5478493|NCT01859988|18940856|P3|Overall Study|Withdrawal by Subject|4
5478494|NCT01859988|18940857|P2|Overall Study|Withdrawal by Subject|3
5478495|NCT01859988|18940858|P1|Overall Study|Withdrawal by Subject|6
5478496|NCT01859949|18940952|P2|Overall Study|Adverse Event|1
5478497|NCT01859949|18940953|P1|Overall Study|Adverse Event|0
5478498|NCT01859949|18940952|P2|Overall Study|Protocol Violation|1
5478499|NCT01859949|18940953|P1|Overall Study|Protocol Violation|1
5478500|NCT01859949|18940952|P2|Overall Study|Withdrawal by Subject|10
5478501|NCT01859949|18940953|P1|Overall Study|Withdrawal by Subject|11
5478502|NCT01859949|18940952|P2|Overall Study|Physician Decision|4
5478503|NCT01859949|18940953|P1|Overall Study|Physician Decision|2
5478504|NCT01859949|18940952|P2|Overall Study|Family Matters|1
5478505|NCT01859949|18940953|P1|Overall Study|Family Matters|0
5478506|NCT01859923|18940973|P4|Overall Study|Adverse Event|1
5478507|NCT01859923|18940974|P3|Overall Study|Adverse Event|1
5478508|NCT01859923|18940975|P2|Overall Study|Adverse Event|0
5478509|NCT01859923|18940976|P1|Overall Study|Adverse Event|0
5478510|NCT01859793|18941030|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
5478511|NCT01859793|18941031|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
5478512|NCT01859793|18941030|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
5478513|NCT01859793|18941031|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
5478514|NCT01859793|18941030|P2|First Intervention (8 Weeks)|Adverse Event|0
5478515|NCT01859793|18941031|P1|First Intervention (8 Weeks)|Adverse Event|1
5478516|NCT01859793|18941030|P2|First Intervention (8 Weeks)|Protocol Violation|0
5478517|NCT01859793|18941031|P1|First Intervention (8 Weeks)|Protocol Violation|2
5478518|NCT01859741|18941049|P8|Overall Study|Other|0
5478519|NCT01859741|18941050|P7|Overall Study|Other|2
5478520|NCT01859741|18941051|P6|Overall Study|Other|0
5478521|NCT01859741|18941052|P5|Overall Study|Other|0
5478522|NCT01859741|18941053|P4|Overall Study|Other|0
5478523|NCT01859741|18941054|P3|Overall Study|Other|0
5478524|NCT01859741|18941055|P2|Overall Study|Other|0
5478525|NCT01859741|18941056|P1|Overall Study|Other|0
5478526|NCT01859741|18941049|P8|Overall Study|Study Terminated by Sponsor|14
5478527|NCT01859741|18941050|P7|Overall Study|Study Terminated by Sponsor|16
5478528|NCT01859741|18941051|P6|Overall Study|Study Terminated by Sponsor|0
5478529|NCT01859741|18941052|P5|Overall Study|Study Terminated by Sponsor|1
5478530|NCT01859741|18941053|P4|Overall Study|Study Terminated by Sponsor|0
5478531|NCT01859741|18941054|P3|Overall Study|Study Terminated by Sponsor|0
5478532|NCT01859741|18941055|P2|Overall Study|Study Terminated by Sponsor|0
5478533|NCT01859741|18941056|P1|Overall Study|Study Terminated by Sponsor|0
5478534|NCT01859741|18941049|P8|Overall Study|Withdrawal by Subject|1
5478535|NCT01859741|18941050|P7|Overall Study|Withdrawal by Subject|1
5478536|NCT01859741|18941051|P6|Overall Study|Withdrawal by Subject|1
5478537|NCT01859741|18941052|P5|Overall Study|Withdrawal by Subject|0
5478538|NCT01859741|18941053|P4|Overall Study|Withdrawal by Subject|0
5478539|NCT01859741|18941054|P3|Overall Study|Withdrawal by Subject|2
5478540|NCT01859741|18941055|P2|Overall Study|Withdrawal by Subject|1
5478541|NCT01859741|18941056|P1|Overall Study|Withdrawal by Subject|0
5478542|NCT01859741|18941049|P8|Overall Study|Lost to Follow-up|4
5478543|NCT01859741|18941050|P7|Overall Study|Lost to Follow-up|0
5478544|NCT01859741|18941051|P6|Overall Study|Lost to Follow-up|1
5478545|NCT01859741|18941052|P5|Overall Study|Lost to Follow-up|0
5478546|NCT01859741|18941053|P4|Overall Study|Lost to Follow-up|0
5478547|NCT01859741|18941054|P3|Overall Study|Lost to Follow-up|0
5478548|NCT01859741|18941055|P2|Overall Study|Lost to Follow-up|0
5478549|NCT01859741|18941056|P1|Overall Study|Lost to Follow-up|0
5478550|NCT01859741|18941049|P8|Overall Study|Death|51
5478551|NCT01859741|18941050|P7|Overall Study|Death|51
5478552|NCT01859741|18941051|P6|Overall Study|Death|4
5478553|NCT01859741|18941052|P5|Overall Study|Death|5
5478554|NCT01859741|18941053|P4|Overall Study|Death|3
5478555|NCT01859741|18941054|P3|Overall Study|Death|4
5478556|NCT01859741|18941055|P2|Overall Study|Death|2
5478557|NCT01859741|18941056|P1|Overall Study|Death|3
5478558|NCT01859715|18941085|P3|Overall Study|No 2nd VAS|23
5478559|NCT01859715|18941086|P2|Overall Study|No 2nd VAS|8
5478560|NCT01859715|18941087|P1|Overall Study|No 2nd VAS|16
5478561|NCT01859702|18941098|P1|Overall Study|Adverse Event|2
5478562|NCT01859702|18941098|P1|Overall Study|Protocol deviation|3
5478563|NCT01859598|18941112|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
5478564|NCT01859507|18941120|P1|Overall Study|left the country|4
5478565|NCT01859494|18941125|P1|Overall Study|Adverse Event|1
5478566|NCT01859390|18941136|P2|Overall Study|Shipment Error|1
5478567|NCT01859390|18941137|P1|Overall Study|Shipment Error|0
5478568|NCT01859390|18941136|P2|Overall Study|Tube Cracked|2
5478569|NCT01859390|18941137|P1|Overall Study|Tube Cracked|0
5478570|NCT01859390|18941136|P2|Overall Study|Sample Missing Collection Date|1
5478571|NCT01859390|18941137|P1|Overall Study|Sample Missing Collection Date|0
5478572|NCT01859390|18941136|P2|Overall Study|Insufficient Sputum Collected|3
5478573|NCT01859390|18941137|P1|Overall Study|Insufficient Sputum Collected|1
5478574|NCT01859143|18941271|P2|Overall Study|Lost to Follow-up|0
5478575|NCT01859143|18941272|P1|Overall Study|Lost to Follow-up|2
5478576|NCT01858766|18941328|P19|Overall Study|Withdrew Consent|0
5478577|NCT01858766|18941329|P18|Overall Study|Withdrew Consent|0
5478578|NCT01858766|18941330|P17|Overall Study|Withdrew Consent|0
5478579|NCT01858766|18941331|P16|Overall Study|Withdrew Consent|0
5478580|NCT01858766|18941332|P15|Overall Study|Withdrew Consent|0
5478581|NCT01858766|18941333|P14|Overall Study|Withdrew Consent|0
5478582|NCT01858766|18941334|P13|Overall Study|Withdrew Consent|0
5478583|NCT01858766|18941335|P12|Overall Study|Withdrew Consent|1
5478584|NCT01858766|18941336|P11|Overall Study|Withdrew Consent|0
5478585|NCT01858766|18941337|P10|Overall Study|Withdrew Consent|0
5478586|NCT01858766|18941338|P9|Overall Study|Withdrew Consent|0
5478587|NCT01858766|18941339|P8|Overall Study|Withdrew Consent|0
5478588|NCT01858766|18941340|P7|Overall Study|Withdrew Consent|0
5478589|NCT01858766|18941341|P6|Overall Study|Withdrew Consent|0
5478590|NCT01858766|18941342|P5|Overall Study|Withdrew Consent|0
5478591|NCT01858766|18941343|P4|Overall Study|Withdrew Consent|0
5478592|NCT01858766|18941344|P3|Overall Study|Withdrew Consent|0
5478593|NCT01858766|18941345|P2|Overall Study|Withdrew Consent|0
5478594|NCT01858766|18941346|P1|Overall Study|Withdrew Consent|0
5478595|NCT01858766|18941328|P19|Overall Study|Lost to Follow-up|1
5478596|NCT01858766|18941329|P18|Overall Study|Lost to Follow-up|0
5478597|NCT01858766|18941330|P17|Overall Study|Lost to Follow-up|1
5478598|NCT01858766|18941331|P16|Overall Study|Lost to Follow-up|1
5478599|NCT01858766|18941332|P15|Overall Study|Lost to Follow-up|3
5478600|NCT01858766|18941333|P14|Overall Study|Lost to Follow-up|0
5478601|NCT01858766|18941334|P13|Overall Study|Lost to Follow-up|0
5478602|NCT01858766|18941335|P12|Overall Study|Lost to Follow-up|1
5478603|NCT01858766|18941336|P11|Overall Study|Lost to Follow-up|0
5478604|NCT01858766|18941337|P10|Overall Study|Lost to Follow-up|0
5478605|NCT01858766|18941338|P9|Overall Study|Lost to Follow-up|0
5478606|NCT01858766|18941339|P8|Overall Study|Lost to Follow-up|2
5478607|NCT01858766|18941340|P7|Overall Study|Lost to Follow-up|0
5478608|NCT01858766|18941341|P6|Overall Study|Lost to Follow-up|1
5478609|NCT01858766|18941342|P5|Overall Study|Lost to Follow-up|0
5478610|NCT01858766|18941343|P4|Overall Study|Lost to Follow-up|0
5478611|NCT01858766|18941344|P3|Overall Study|Lost to Follow-up|0
5478612|NCT01858766|18941345|P2|Overall Study|Lost to Follow-up|0
5478613|NCT01858766|18941346|P1|Overall Study|Lost to Follow-up|0
5478614|NCT01858766|18941328|P19|Overall Study|Lack of Efficacy|3
5478615|NCT01858766|18941329|P18|Overall Study|Lack of Efficacy|3
5478616|NCT01858766|18941330|P17|Overall Study|Lack of Efficacy|2
5478617|NCT01858766|18941331|P16|Overall Study|Lack of Efficacy|5
5478618|NCT01858766|18941332|P15|Overall Study|Lack of Efficacy|5
5478619|NCT01858766|18941333|P14|Overall Study|Lack of Efficacy|3
5478620|NCT01858766|18941334|P13|Overall Study|Lack of Efficacy|5
5478621|NCT01858766|18941335|P12|Overall Study|Lack of Efficacy|3
5478622|NCT01858766|18941336|P11|Overall Study|Lack of Efficacy|0
5478623|NCT01858766|18941337|P10|Overall Study|Lack of Efficacy|0
5478624|NCT01858766|18941338|P9|Overall Study|Lack of Efficacy|0
5478625|NCT01858766|18941339|P8|Overall Study|Lack of Efficacy|0
5478626|NCT01858766|18941340|P7|Overall Study|Lack of Efficacy|0
5478627|NCT01858766|18941341|P6|Overall Study|Lack of Efficacy|2
5478628|NCT01858766|18941342|P5|Overall Study|Lack of Efficacy|1
5478629|NCT01858766|18941343|P4|Overall Study|Lack of Efficacy|0
5478630|NCT01858766|18941344|P3|Overall Study|Lack of Efficacy|0
5478631|NCT01858766|18941345|P2|Overall Study|Lack of Efficacy|0
5478632|NCT01858766|18941346|P1|Overall Study|Lack of Efficacy|1
5478633|NCT01858766|18941328|P19|Overall Study|Death|0
5478634|NCT01858766|18941329|P18|Overall Study|Death|0
5478635|NCT01858766|18941330|P17|Overall Study|Death|0
5478636|NCT01858766|18941331|P16|Overall Study|Death|0
5478637|NCT01858766|18941332|P15|Overall Study|Death|0
5478638|NCT01858766|18941333|P14|Overall Study|Death|0
5478639|NCT01858766|18941334|P13|Overall Study|Death|0
5478640|NCT01858766|18941335|P12|Overall Study|Death|0
5478641|NCT01858766|18941336|P11|Overall Study|Death|0
5478642|NCT01858766|18941337|P10|Overall Study|Death|0
5478643|NCT01858766|18941338|P9|Overall Study|Death|0
5478644|NCT01858766|18941339|P8|Overall Study|Death|0
5478645|NCT01858766|18941340|P7|Overall Study|Death|0
5478646|NCT01858766|18941341|P6|Overall Study|Death|0
5478647|NCT01858766|18941342|P5|Overall Study|Death|0
5478648|NCT01858766|18941343|P4|Overall Study|Death|0
5478649|NCT01858766|18941344|P3|Overall Study|Death|1
5478650|NCT01858766|18941345|P2|Overall Study|Death|0
5478651|NCT01858766|18941346|P1|Overall Study|Death|0
5478652|NCT01858766|18941328|P19|Overall Study|Randomized but Never Treated|0
5478653|NCT01858766|18941329|P18|Overall Study|Randomized but Never Treated|1
5478654|NCT01858766|18941330|P17|Overall Study|Randomized but Never Treated|0
5478655|NCT01858766|18941331|P16|Overall Study|Randomized but Never Treated|0
5478656|NCT01858766|18941332|P15|Overall Study|Randomized but Never Treated|0
5478657|NCT01858766|18941333|P14|Overall Study|Randomized but Never Treated|0
5478658|NCT01858766|18941334|P13|Overall Study|Randomized but Never Treated|0
5478659|NCT01858766|18941335|P12|Overall Study|Randomized but Never Treated|0
5478660|NCT01858766|18941336|P11|Overall Study|Randomized but Never Treated|0
5478661|NCT01858766|18941337|P10|Overall Study|Randomized but Never Treated|0
5478662|NCT01858766|18941338|P9|Overall Study|Randomized but Never Treated|0
5478663|NCT01858766|18941339|P8|Overall Study|Randomized but Never Treated|0
5478664|NCT01858766|18941340|P7|Overall Study|Randomized but Never Treated|0
5478665|NCT01858766|18941341|P6|Overall Study|Randomized but Never Treated|1
5478666|NCT01858766|18941342|P5|Overall Study|Randomized but Never Treated|0
5478667|NCT01858766|18941343|P4|Overall Study|Randomized but Never Treated|0
5478668|NCT01858766|18941344|P3|Overall Study|Randomized but Never Treated|0
5478669|NCT01858766|18941345|P2|Overall Study|Randomized but Never Treated|0
5478670|NCT01858766|18941346|P1|Overall Study|Randomized but Never Treated|0
5478671|NCT01858701|18941417|P2|Period 2, Second 30 Days of Wear|Comfort|1
5478672|NCT01858701|18941418|P1|Period 2, Second 30 Days of Wear|Comfort|0
5478673|NCT01858701|18941417|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
5478674|NCT01858701|18941418|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
5478675|NCT01858701|18941417|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
5478676|NCT01858701|18941418|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
5478677|NCT01858701|18941417|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
5478678|NCT01858701|18941418|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
5478679|NCT01858636|18941424|P1|Overall Study|Withdrawal by Subject|1
5478680|NCT01858636|18941424|P1|Overall Study|Lost to Follow-up|1
5478681|NCT01858636|18941424|P1|Overall Study|Death|1
5478682|NCT01858636|18941424|P1|Overall Study|Physician Decision|1
5478683|NCT01858636|18941424|P1|Overall Study|No Device Deployment Attempted|24
5478684|NCT01858558|18941431|P2|Overall Study|Failed expansion of cell product|0
5478685|NCT01858558|18941432|P1|Overall Study|Failed expansion of cell product|2
5478686|NCT01858558|18941431|P2|Overall Study|Product contamination|0
5478687|NCT01858558|18941432|P1|Overall Study|Product contamination|2
5478688|NCT01858558|18941431|P2|Overall Study|Disease progression|1
5478689|NCT01858558|18941432|P1|Overall Study|Disease progression|3
5478690|NCT01858558|18941431|P2|Overall Study|Lost to Follow-up|0
5478691|NCT01858558|18941432|P1|Overall Study|Lost to Follow-up|1
5478692|NCT01858558|18941431|P2|Overall Study|Death|1
5478693|NCT01858558|18941432|P1|Overall Study|Death|1
5478694|NCT01858532|18941454|P4|Overall Study|Other, not specified|11
5478695|NCT01858532|18941455|P3|Overall Study|Other, not specified|13
5478696|NCT01858532|18941456|P2|Overall Study|Other, not specified|15
5478697|NCT01858532|18941457|P1|Overall Study|Other, not specified|29
5478698|NCT01858532|18941454|P4|Overall Study|Investigator request|6
5478699|NCT01858532|18941455|P3|Overall Study|Investigator request|2
5478700|NCT01858532|18941456|P2|Overall Study|Investigator request|4
5478701|NCT01858532|18941457|P1|Overall Study|Investigator request|3
5478702|NCT01858532|18941454|P4|Overall Study|Deterioration of medical status|7
5478703|NCT01858532|18941455|P3|Overall Study|Deterioration of medical status|3
5478704|NCT01858532|18941456|P2|Overall Study|Deterioration of medical status|4
5478705|NCT01858532|18941457|P1|Overall Study|Deterioration of medical status|3
5478706|NCT01858532|18941454|P4|Overall Study|Lost to Follow-up|14
5478707|NCT01858532|18941455|P3|Overall Study|Lost to Follow-up|11
5478708|NCT01858532|18941456|P2|Overall Study|Lost to Follow-up|26
5478709|NCT01858532|18941457|P1|Overall Study|Lost to Follow-up|17
5478710|NCT01858532|18941454|P4|Overall Study|Withdrew consent|27
5478711|NCT01858532|18941455|P3|Overall Study|Withdrew consent|46
5478712|NCT01858532|18941456|P2|Overall Study|Withdrew consent|93
5478713|NCT01858532|18941457|P1|Overall Study|Withdrew consent|71
5478714|NCT01858532|18941454|P4|Overall Study|Adverse Event|28
5478715|NCT01858532|18941455|P3|Overall Study|Adverse Event|23
5478716|NCT01858532|18941456|P2|Overall Study|Adverse Event|50
5478717|NCT01858532|18941457|P1|Overall Study|Adverse Event|58
5478718|NCT01858389|18941511|P2|Overall Study|Did not receive treatment|3
5478719|NCT01858389|18941512|P1|Overall Study|Did not receive treatment|0
5478720|NCT01858389|18941511|P2|Overall Study|Adverse Event|1
5478721|NCT01858389|18941512|P1|Overall Study|Adverse Event|3
5478722|NCT01858389|18941511|P2|Overall Study|Other|4
5478723|NCT01858389|18941512|P1|Overall Study|Other|2
5478724|NCT01858389|18941511|P2|Overall Study|Progressive disease|11
5478725|NCT01858389|18941512|P1|Overall Study|Progressive disease|10
5478726|NCT01858389|18941511|P2|Overall Study|Withdrawal by Subject|1
5478727|NCT01858389|18941512|P1|Overall Study|Withdrawal by Subject|0
5478728|NCT01858389|18941511|P2|Overall Study|Study terminated by sponsor|2
5478729|NCT01858389|18941512|P1|Overall Study|Study terminated by sponsor|0
5478730|NCT01858389|18941511|P2|Overall Study|Death|3
5478731|NCT01858389|18941512|P1|Overall Study|Death|1
5478732|NCT01858376|18941527|P1|Overall Study|Dropped d/t lab work not fitting criter|4
5478733|NCT01858194|18941536|P2|Overall Study|Lost to Follow-up|1
5478734|NCT01858194|18941537|P1|Overall Study|Lost to Follow-up|0
5478735|NCT01858194|18941536|P2|Overall Study|Total Artificial Heart Implant|1
5478736|NCT01858194|18941537|P1|Overall Study|Total Artificial Heart Implant|0
5478737|NCT01857973|18941590|P1|Overall Study|Physician Decision|1
5478738|NCT01857973|18941590|P1|Overall Study|drop out after 3 failed attempts|1
5478739|NCT01857973|18941590|P1|Overall Study|Subject did not meet required BG range|3
5478740|NCT01857869|18941620|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5478741|NCT01857869|18941621|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5478742|NCT01857869|18941622|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5478743|NCT01857869|18941623|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5478744|NCT01857869|18941624|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5478745|NCT01857869|18941625|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5478746|NCT01857869|18941626|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
5478747|NCT01857869|18941627|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5478748|NCT01857869|18941628|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5478749|NCT01857869|18941629|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
5478750|NCT01857869|18941620|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
5478751|NCT01857869|18941621|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
5478752|NCT01857869|18941622|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
5478753|NCT01857869|18941623|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
5478754|NCT01857869|18941624|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
5478755|NCT01857869|18941625|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
5478756|NCT01857869|18941626|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
5478757|NCT01857869|18941627|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
5478758|NCT01857869|18941628|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
5478759|NCT01857869|18941629|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
5478760|NCT01857869|18941620|P10|Primary/Challenge Phase|Other|0
5478761|NCT01857869|18941621|P9|Primary/Challenge Phase|Other|0
5478762|NCT01857869|18941622|P8|Primary/Challenge Phase|Other|0
5478763|NCT01857869|18941623|P7|Primary/Challenge Phase|Other|0
5478764|NCT01857869|18941624|P6|Primary/Challenge Phase|Other|0
5478765|NCT01857869|18941625|P5|Primary/Challenge Phase|Other|0
5478766|NCT01857869|18941626|P4|Primary/Challenge Phase|Other|0
5478767|NCT01857869|18941627|P3|Primary/Challenge Phase|Other|0
5478768|NCT01857869|18941628|P2|Primary/Challenge Phase|Other|1
5478769|NCT01857869|18941629|P1|Primary/Challenge Phase|Other|1
5478770|NCT01857869|18941620|P10|Primary/Challenge Phase|Protocol Violation|0
5478771|NCT01857869|18941621|P9|Primary/Challenge Phase|Protocol Violation|0
5478772|NCT01857869|18941622|P8|Primary/Challenge Phase|Protocol Violation|0
5478773|NCT01857869|18941623|P7|Primary/Challenge Phase|Protocol Violation|0
5478774|NCT01857869|18941624|P6|Primary/Challenge Phase|Protocol Violation|0
5478775|NCT01857869|18941625|P5|Primary/Challenge Phase|Protocol Violation|0
5478776|NCT01857869|18941626|P4|Primary/Challenge Phase|Protocol Violation|0
5478777|NCT01857869|18941627|P3|Primary/Challenge Phase|Protocol Violation|0
5478778|NCT01857869|18941628|P2|Primary/Challenge Phase|Protocol Violation|0
5478779|NCT01857869|18941629|P1|Primary/Challenge Phase|Protocol Violation|1
5478780|NCT01857869|18941620|P10|Primary/Challenge Phase|Pregnancy|0
5478781|NCT01857869|18941621|P9|Primary/Challenge Phase|Pregnancy|0
5478782|NCT01857869|18941622|P8|Primary/Challenge Phase|Pregnancy|0
5478783|NCT01857869|18941623|P7|Primary/Challenge Phase|Pregnancy|0
5478784|NCT01857869|18941624|P6|Primary/Challenge Phase|Pregnancy|0
5478785|NCT01857869|18941625|P5|Primary/Challenge Phase|Pregnancy|0
5478786|NCT01857869|18941626|P4|Primary/Challenge Phase|Pregnancy|0
5478787|NCT01857869|18941627|P3|Primary/Challenge Phase|Pregnancy|0
5478788|NCT01857869|18941628|P2|Primary/Challenge Phase|Pregnancy|0
5478789|NCT01857869|18941629|P1|Primary/Challenge Phase|Pregnancy|1
5478790|NCT01857869|18941620|P10|Primary/Challenge Phase|Lost to Follow-up|0
5478791|NCT01857869|18941621|P9|Primary/Challenge Phase|Lost to Follow-up|0
5478792|NCT01857869|18941622|P8|Primary/Challenge Phase|Lost to Follow-up|0
5478793|NCT01857869|18941623|P7|Primary/Challenge Phase|Lost to Follow-up|0
5478794|NCT01857869|18941624|P6|Primary/Challenge Phase|Lost to Follow-up|0
5478795|NCT01857869|18941625|P5|Primary/Challenge Phase|Lost to Follow-up|0
5478796|NCT01857869|18941626|P4|Primary/Challenge Phase|Lost to Follow-up|0
5478797|NCT01857869|18941627|P3|Primary/Challenge Phase|Lost to Follow-up|0
5478798|NCT01857869|18941628|P2|Primary/Challenge Phase|Lost to Follow-up|0
5478799|NCT01857869|18941629|P1|Primary/Challenge Phase|Lost to Follow-up|2
5478800|NCT01857622|18941719|P3|Overall Study|Withdrawal by Subject|0
5478801|NCT01857622|18941720|P2|Overall Study|Withdrawal by Subject|0
5478802|NCT01857622|18941721|P1|Overall Study|Withdrawal by Subject|1
5478803|NCT01857622|18941719|P3|Overall Study|Protocol Violation|0
5478804|NCT01857622|18941720|P2|Overall Study|Protocol Violation|1
5478805|NCT01857622|18941721|P1|Overall Study|Protocol Violation|4
5478806|NCT01857622|18941719|P3|Overall Study|Physician Decision|0
5478807|NCT01857622|18941720|P2|Overall Study|Physician Decision|0
5478808|NCT01857622|18941721|P1|Overall Study|Physician Decision|1
5478809|NCT01857622|18941719|P3|Overall Study|Adverse Event|2
5478810|NCT01857622|18941720|P2|Overall Study|Adverse Event|0
5478811|NCT01857622|18941721|P1|Overall Study|Adverse Event|5
5478812|NCT01857583|18941733|P4|Overall Study|Withdrawal by Subject|2
5478813|NCT01857583|18941734|P3|Overall Study|Withdrawal by Subject|1
5478814|NCT01857583|18941735|P2|Overall Study|Withdrawal by Subject|0
5478815|NCT01857583|18941736|P1|Overall Study|Withdrawal by Subject|1
5478816|NCT01857583|18941733|P4|Overall Study|Physician Decision|1
5478817|NCT01857583|18941734|P3|Overall Study|Physician Decision|0
5478818|NCT01857583|18941735|P2|Overall Study|Physician Decision|0
5478819|NCT01857583|18941736|P1|Overall Study|Physician Decision|0
5478820|NCT01857583|18941733|P4|Overall Study|Death|0
5478821|NCT01857583|18941734|P3|Overall Study|Death|1
5478822|NCT01857583|18941735|P2|Overall Study|Death|1
5478823|NCT01857583|18941736|P1|Overall Study|Death|0
5478824|NCT01857583|18941733|P4|Overall Study|Adverse Event|1
5478825|NCT01857583|18941734|P3|Overall Study|Adverse Event|1
5478826|NCT01857583|18941735|P2|Overall Study|Adverse Event|0
5478827|NCT01857583|18941736|P1|Overall Study|Adverse Event|0
5478828|NCT01857531|18941746|P1|Overall Study|Withdrawal by Subject|4
5478829|NCT01857323|18941764|P1|Overall Study|Did not complete 180 doses|48
5478830|NCT01857323|18941764|P1|Overall Study|Other|4
5478831|NCT01857323|18941764|P1|Overall Study|Lost to Follow-up|1
5478832|NCT01857323|18941764|P1|Overall Study|Protocol Violation|6
5478833|NCT01857323|18941764|P1|Overall Study|Non-compliance|1
5478834|NCT01857323|18941764|P1|Overall Study|Withdrawal by Subject|3
5478835|NCT01857323|18941764|P1|Overall Study|Adverse Event|1
5478836|NCT01857310|18941775|P2|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
5478837|NCT01857310|18941776|P1|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
5478838|NCT01857271|18941871|P1|Overall Study|Lost to Follow-up|1
5478839|NCT01857206|18941924|P2|Overall Study|Withdrawal by Subject|0
5478840|NCT01857206|18941925|P1|Overall Study|Withdrawal by Subject|1
5478841|NCT01857206|18941924|P2|Overall Study|Unclassified|3
5478842|NCT01857206|18941925|P1|Overall Study|Unclassified|3
5478843|NCT01857206|18941924|P2|Overall Study|Lost to Follow-up|6
5478844|NCT01857206|18941925|P1|Overall Study|Lost to Follow-up|9
5478845|NCT01857206|18941924|P2|Overall Study|ADMINISTRATIVE REASON|1
5478846|NCT01857206|18941925|P1|Overall Study|ADMINISTRATIVE REASON|0
5478847|NCT01857102|18941943|P2|Period 2|Unsatisfactory Lens Fit|0
5478848|NCT01857102|18941944|P1|Period 2|Unsatisfactory Lens Fit|1
5478849|NCT01857102|18941943|P2|Period 2|Lens Discomfort|0
5478850|NCT01857102|18941944|P1|Period 2|Lens Discomfort|1
5478851|NCT01857102|18941943|P2|Period 1|Physician Decision|0
5478852|NCT01857102|18941944|P1|Period 1|Physician Decision|1
5478853|NCT01857102|18941943|P2|Period 1|Unsatisfactory Visual Response|0
5478854|NCT01857102|18941944|P1|Period 1|Unsatisfactory Visual Response|1
5478855|NCT01857102|18941943|P2|Period 1|Unsatisfactory Lens Fit|0
5478856|NCT01857102|18941944|P1|Period 1|Unsatisfactory Lens Fit|1
5478857|NCT01857102|18941943|P2|Period 1|Lost to Follow-up|3
5478858|NCT01857102|18941944|P1|Period 1|Lost to Follow-up|0
5478859|NCT01857102|18941943|P2|Period 1|No longer meets Eligibility Criteria|2
5478860|NCT01857102|18941944|P1|Period 1|No longer meets Eligibility Criteria|0
5478861|NCT01857063|18941954|P2|Period 2 (7 Days)|Withdrawal by Subject|0
5478862|NCT01857063|18941955|P1|Period 2 (7 Days)|Withdrawal by Subject|1
5478863|NCT01857063|18941954|P2|Period 2 (7 Days)|Physician Decision|1
5478864|NCT01857063|18941955|P1|Period 2 (7 Days)|Physician Decision|1
5478865|NCT01857063|18941954|P2|Period 2 (7 Days)|Adverse Event|1
5478866|NCT01857063|18941955|P1|Period 2 (7 Days)|Adverse Event|2
5478867|NCT01857063|18941954|P2|Period 1 (7 Days)|Withdrawal by Subject|3
5478868|NCT01857063|18941955|P1|Period 1 (7 Days)|Withdrawal by Subject|1
5478869|NCT01857063|18941954|P2|Period 1 (7 Days)|Physician Decision|0
5478870|NCT01857063|18941955|P1|Period 1 (7 Days)|Physician Decision|1
5478871|NCT01857063|18941954|P2|Period 1 (7 Days)|Adverse Event|1
5478872|NCT01857063|18941955|P1|Period 1 (7 Days)|Adverse Event|0
5478873|NCT01856907|18941989|P3|Overall Study|Withdrawal by Subject|0
5478874|NCT01856907|18941990|P2|Overall Study|Withdrawal by Subject|1
5478875|NCT01856907|18941991|P1|Overall Study|Withdrawal by Subject|0
5478876|NCT01856907|18941989|P3|Overall Study|Pregnancy|0
5478877|NCT01856907|18941990|P2|Overall Study|Pregnancy|1
5478878|NCT01856907|18941991|P1|Overall Study|Pregnancy|0
5478879|NCT01856907|18941989|P3|Overall Study|Pregnancy|0
5478880|NCT01856907|18941990|P2|Overall Study|Pregnancy|1
5478881|NCT01856907|18941991|P1|Overall Study|Pregnancy|0
5478882|NCT01856790|18942029|P1|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
5478883|NCT01856790|18942029|P1|Closed Loop Control|Withdrawal by Subject|2
5478884|NCT01856686|18942083|P2|Overall Study|Lost to Follow-up|11
5478885|NCT01856686|18942084|P1|Overall Study|Lost to Follow-up|5
5478886|NCT01856673|18942127|P3|Overall Study|Protocol Violation|1
5478887|NCT01856673|18942128|P2|Overall Study|Protocol Violation|0
5478888|NCT01856673|18942129|P1|Overall Study|Protocol Violation|1
5478889|NCT01856673|18942127|P3|Overall Study|Death|0
5478890|NCT01856673|18942128|P2|Overall Study|Death|1
5478891|NCT01856673|18942129|P1|Overall Study|Death|2
5478892|NCT01856673|18942127|P3|Overall Study|Paperwork errors|0
5478893|NCT01856673|18942128|P2|Overall Study|Paperwork errors|0
5478894|NCT01856673|18942129|P1|Overall Study|Paperwork errors|4
5478895|NCT01856673|18942127|P3|Overall Study|Psychologist decision|0
5478896|NCT01856673|18942128|P2|Overall Study|Psychologist decision|0
5478897|NCT01856673|18942129|P1|Overall Study|Psychologist decision|3
5478898|NCT01856673|18942127|P3|Overall Study|Unknown reasons|0
5478899|NCT01856673|18942128|P2|Overall Study|Unknown reasons|0
5478900|NCT01856673|18942129|P1|Overall Study|Unknown reasons|20
5478901|NCT01856673|18942127|P3|Overall Study|Lost to Follow-up|0
5478902|NCT01856673|18942128|P2|Overall Study|Lost to Follow-up|34
5478903|NCT01856673|18942129|P1|Overall Study|Lost to Follow-up|22
5478904|NCT01856673|18942127|P3|Overall Study|Withdrawal by Subject|33
5478905|NCT01856673|18942128|P2|Overall Study|Withdrawal by Subject|50
5478906|NCT01856673|18942129|P1|Overall Study|Withdrawal by Subject|46
5478907|NCT01856595|18942149|P9|Overall Study|Withdrawal by Subject|0
5478908|NCT01856595|18942150|P8|Overall Study|Withdrawal by Subject|0
5478909|NCT01856595|18942151|P7|Overall Study|Withdrawal by Subject|1
5478910|NCT01856595|18942152|P6|Overall Study|Withdrawal by Subject|0
5478911|NCT01856595|18942153|P5|Overall Study|Withdrawal by Subject|0
5478912|NCT01856595|18942154|P4|Overall Study|Withdrawal by Subject|0
5478913|NCT01856595|18942155|P3|Overall Study|Withdrawal by Subject|0
5478914|NCT01856595|18942156|P2|Overall Study|Withdrawal by Subject|1
5478915|NCT01856595|18942157|P1|Overall Study|Withdrawal by Subject|0
5478916|NCT01856582|18942390|P1|Overall Study|Died prior to Boost infusion|1
5478917|NCT01856569|18942394|P1|Overall Study|Did not met inclusion criteria|8
5478918|NCT01856569|18942394|P1|Overall Study|Lost to Follow-up|3
5478919|NCT01856569|18942394|P1|Overall Study|Changed Site/Structure|1
5478920|NCT01856569|18942394|P1|Overall Study|Other|1
5478921|NCT01856543|18942405|P2|Overall Study|Withdrawn before start|3
5478922|NCT01856543|18942406|P1|Overall Study|Withdrawn before start|7
5478923|NCT01856543|18942405|P2|Overall Study|Treatment discontinued|3
5478924|NCT01856543|18942406|P1|Overall Study|Treatment discontinued|6
5478925|NCT01856322|18942464|P3|Overall Study|off study due to lack of accrual|3
5478926|NCT01856322|18942465|P2|Overall Study|off study due to lack of accrual|0
5478927|NCT01856322|18942466|P1|Overall Study|off study due to lack of accrual|0
5478928|NCT01856309|18942477|P4|Overall Study|Noncompliance With Study Drug|1
5478929|NCT01856309|18942478|P3|Overall Study|Noncompliance With Study Drug|4
5478930|NCT01856309|18942479|P2|Overall Study|Noncompliance With Study Drug|1
5478931|NCT01856309|18942480|P1|Overall Study|Noncompliance With Study Drug|0
5478932|NCT01856309|18942477|P4|Overall Study|Physician Decision|8
5478933|NCT01856309|18942478|P3|Overall Study|Physician Decision|6
5478934|NCT01856309|18942479|P2|Overall Study|Physician Decision|1
5478935|NCT01856309|18942480|P1|Overall Study|Physician Decision|6
5478936|NCT01856309|18942477|P4|Overall Study|Pregnancy|1
5478937|NCT01856309|18942478|P3|Overall Study|Pregnancy|0
5478938|NCT01856309|18942479|P2|Overall Study|Pregnancy|0
5478939|NCT01856309|18942480|P1|Overall Study|Pregnancy|0
5478940|NCT01856309|18942477|P4|Overall Study|Adverse Event|65
5478941|NCT01856309|18942478|P3|Overall Study|Adverse Event|55
5478942|NCT01856309|18942479|P2|Overall Study|Adverse Event|31
5478943|NCT01856309|18942480|P1|Overall Study|Adverse Event|31
5478944|NCT01856309|18942477|P4|Overall Study|Lack of Efficacy|25
5478945|NCT01856309|18942478|P3|Overall Study|Lack of Efficacy|40
5478946|NCT01856309|18942479|P2|Overall Study|Lack of Efficacy|9
5478947|NCT01856309|18942480|P1|Overall Study|Lack of Efficacy|14
5478948|NCT01856309|18942477|P4|Overall Study|Other|469
5478949|NCT01856309|18942478|P3|Overall Study|Other|447
5478950|NCT01856309|18942479|P2|Overall Study|Other|225
5478951|NCT01856309|18942480|P1|Overall Study|Other|227
5478952|NCT01856309|18942477|P4|Overall Study|Withdrawal by Subject|26
5478953|NCT01856309|18942478|P3|Overall Study|Withdrawal by Subject|28
5478954|NCT01856309|18942479|P2|Overall Study|Withdrawal by Subject|13
5478955|NCT01856309|18942480|P1|Overall Study|Withdrawal by Subject|11
5478956|NCT01856309|18942477|P4|Overall Study|Lost to Follow-up|8
5478957|NCT01856309|18942478|P3|Overall Study|Lost to Follow-up|4
5478958|NCT01856309|18942479|P2|Overall Study|Lost to Follow-up|2
5478959|NCT01856309|18942480|P1|Overall Study|Lost to Follow-up|6
5478960|NCT01856309|18942477|P4|Overall Study|Death|6
5478961|NCT01856309|18942478|P3|Overall Study|Death|11
5478962|NCT01856309|18942479|P2|Overall Study|Death|6
5478963|NCT01856309|18942480|P1|Overall Study|Death|4
5478964|NCT01856257|18942604|P4|Overall Study|Donor complication|1
5478965|NCT01856257|18942605|P3|Overall Study|Donor complication|0
5478966|NCT01856257|18942606|P2|Overall Study|Donor complication|0
5478967|NCT01856257|18942607|P1|Overall Study|Donor complication|0
5478968|NCT01856257|18942604|P4|Overall Study|Withdrawal by Subject|0
5478969|NCT01856257|18942605|P3|Overall Study|Withdrawal by Subject|0
5478970|NCT01856257|18942606|P2|Overall Study|Withdrawal by Subject|1
5478971|NCT01856257|18942607|P1|Overall Study|Withdrawal by Subject|1
5478972|NCT01856257|18942604|P4|Overall Study|Physician Decision|1
5478973|NCT01856257|18942605|P3|Overall Study|Physician Decision|0
5478974|NCT01856257|18942606|P2|Overall Study|Physician Decision|0
5478975|NCT01856257|18942607|P1|Overall Study|Physician Decision|0
5478976|NCT01856257|18942604|P4|Overall Study|Death|0
5478977|NCT01856257|18942605|P3|Overall Study|Death|0
5478978|NCT01856257|18942606|P2|Overall Study|Death|0
5478979|NCT01856257|18942607|P1|Overall Study|Death|2
5478980|NCT01856114|18942722|P2|Overall Study|Adverse Event|0
5478981|NCT01856114|18942723|P1|Overall Study|Adverse Event|1
5478982|NCT01856114|18942722|P2|Overall Study|Withdrawal by Subject|0
5478983|NCT01856114|18942723|P1|Overall Study|Withdrawal by Subject|1
5478984|NCT01855958|18942788|P2|Overall Study|Withdrawal by Subject|0
5478985|NCT01855958|18942789|P1|Overall Study|Withdrawal by Subject|1
5478986|NCT01855945|18942819|P12|Overall Study|Withdrawal by Subject|1
5478987|NCT01855945|18942820|P11|Overall Study|Withdrawal by Subject|4
5478988|NCT01855945|18942821|P10|Overall Study|Withdrawal by Subject|2
5478989|NCT01855945|18942822|P9|Overall Study|Withdrawal by Subject|0
5478990|NCT01855945|18942823|P8|Overall Study|Withdrawal by Subject|0
5478991|NCT01855945|18942824|P7|Overall Study|Withdrawal by Subject|1
5478992|NCT01855945|18942825|P6|Overall Study|Withdrawal by Subject|0
5478993|NCT01855945|18942826|P5|Overall Study|Withdrawal by Subject|1
5478994|NCT01855945|18942827|P4|Overall Study|Withdrawal by Subject|1
5478995|NCT01855945|18942828|P3|Overall Study|Withdrawal by Subject|4
5478996|NCT01855945|18942829|P2|Overall Study|Withdrawal by Subject|0
5478997|NCT01855945|18942830|P1|Overall Study|Withdrawal by Subject|4
5478998|NCT01855945|18942819|P12|Overall Study|Other - Unclassified|0
5478999|NCT01855945|18942820|P11|Overall Study|Other - Unclassified|1
5479000|NCT01855945|18942821|P10|Overall Study|Other - Unclassified|0
5479001|NCT01855945|18942822|P9|Overall Study|Other - Unclassified|0
5479002|NCT01855945|18942823|P8|Overall Study|Other - Unclassified|1
5479003|NCT01855945|18942824|P7|Overall Study|Other - Unclassified|2
5479004|NCT01855945|18942825|P6|Overall Study|Other - Unclassified|0
5479005|NCT01855945|18942826|P5|Overall Study|Other - Unclassified|0
5479006|NCT01855945|18942827|P4|Overall Study|Other - Unclassified|0
5479007|NCT01855945|18942828|P3|Overall Study|Other - Unclassified|1
5479008|NCT01855945|18942829|P2|Overall Study|Other - Unclassified|1
5479009|NCT01855945|18942830|P1|Overall Study|Other - Unclassified|1
5479010|NCT01855945|18942819|P12|Overall Study|Lost to Follow-up|2
5479011|NCT01855945|18942820|P11|Overall Study|Lost to Follow-up|0
5479012|NCT01855945|18942821|P10|Overall Study|Lost to Follow-up|0
5479013|NCT01855945|18942822|P9|Overall Study|Lost to Follow-up|2
5479014|NCT01855945|18942823|P8|Overall Study|Lost to Follow-up|7
5479015|NCT01855945|18942824|P7|Overall Study|Lost to Follow-up|4
5479016|NCT01855945|18942825|P6|Overall Study|Lost to Follow-up|3
5479017|NCT01855945|18942826|P5|Overall Study|Lost to Follow-up|0
5479018|NCT01855945|18942827|P4|Overall Study|Lost to Follow-up|3
5479019|NCT01855945|18942828|P3|Overall Study|Lost to Follow-up|7
5479020|NCT01855945|18942829|P2|Overall Study|Lost to Follow-up|10
5479021|NCT01855945|18942830|P1|Overall Study|Lost to Follow-up|11
5479022|NCT01855945|18942819|P12|Overall Study|Death|0
5479023|NCT01855945|18942820|P11|Overall Study|Death|0
5479024|NCT01855945|18942821|P10|Overall Study|Death|0
5479025|NCT01855945|18942822|P9|Overall Study|Death|0
5479026|NCT01855945|18942823|P8|Overall Study|Death|0
5479027|NCT01855945|18942824|P7|Overall Study|Death|2
5479028|NCT01855945|18942825|P6|Overall Study|Death|0
5479029|NCT01855945|18942826|P5|Overall Study|Death|0
5479030|NCT01855945|18942827|P4|Overall Study|Death|0
5479031|NCT01855945|18942828|P3|Overall Study|Death|0
5479032|NCT01855945|18942829|P2|Overall Study|Death|0
5479033|NCT01855945|18942830|P1|Overall Study|Death|0
5479034|NCT01855945|18942819|P12|Overall Study|Adverse Event|0
5479035|NCT01855945|18942820|P11|Overall Study|Adverse Event|0
5479036|NCT01855945|18942821|P10|Overall Study|Adverse Event|0
5479037|NCT01855945|18942822|P9|Overall Study|Adverse Event|0
5479038|NCT01855945|18942823|P8|Overall Study|Adverse Event|0
5479039|NCT01855945|18942824|P7|Overall Study|Adverse Event|1
5479040|NCT01855945|18942825|P6|Overall Study|Adverse Event|0
5479041|NCT01855945|18942826|P5|Overall Study|Adverse Event|0
5479042|NCT01855945|18942827|P4|Overall Study|Adverse Event|0
5479043|NCT01855945|18942828|P3|Overall Study|Adverse Event|0
5479044|NCT01855945|18942829|P2|Overall Study|Adverse Event|0
5479045|NCT01855945|18942830|P1|Overall Study|Adverse Event|0
5479046|NCT01855919|18942966|P2|Overall Study|Protocol Violation|4
5479047|NCT01855919|18942967|P1|Overall Study|Protocol Violation|1
5479048|NCT01855919|18942966|P2|Overall Study|Entry Criteria Not Met|1
5479049|NCT01855919|18942967|P1|Overall Study|Entry Criteria Not Met|1
5479050|NCT01855919|18942966|P2|Overall Study|Withdrawal by Subject|10
5479051|NCT01855919|18942967|P1|Overall Study|Withdrawal by Subject|4
5479052|NCT01855919|18942966|P2|Overall Study|Lack of Efficacy|3
5479053|NCT01855919|18942967|P1|Overall Study|Lack of Efficacy|1
5479054|NCT01855919|18942966|P2|Overall Study|Adverse Event|8
5479055|NCT01855919|18942967|P1|Overall Study|Adverse Event|16
5479056|NCT01855828|18942999|P1|Overall Study|Withdrawal by Subject|1
5479057|NCT01855828|18942999|P1|Overall Study|Adverse Event|1
5479058|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Other|1
5479059|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Other|0
5479060|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Other|0
5479061|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Other|0
5479062|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Sponsor Decision|1
5479063|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Sponsor Decision|0
5479064|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Sponsor Decision|0
5479065|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Sponsor Decision|0
5479066|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
5479067|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
5479068|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
5479069|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
5479070|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Physician Decision|4
5479071|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Physician Decision|2
5479072|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Physician Decision|0
5479073|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Physician Decision|0
5479074|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
5479075|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
5479076|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
5479077|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
5479078|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Protocol Violation|1
5479079|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Protocol Violation|0
5479080|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Protocol Violation|0
5479081|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Protocol Violation|0
5479082|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
5479083|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
5479084|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
5479085|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
5479086|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
5479087|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
5479088|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
5479089|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
5479090|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
5479091|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
5479092|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
5479093|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
5479094|NCT01855789|18943009|P4|2) Week 24 up to End of Study|Adverse Event|21
5479095|NCT01855789|18943010|P3|2) Week 24 up to End of Study|Adverse Event|5
5479096|NCT01855789|18943011|P2|2) Week 24 up to End of Study|Adverse Event|4
5479097|NCT01855789|18943012|P1|2) Week 24 up to End of Study|Adverse Event|0
5479098|NCT01855789|18943009|P4|1) Baseline up to Week 24|Other|0
5479099|NCT01855789|18943010|P3|1) Baseline up to Week 24|Other|0
5479100|NCT01855789|18943011|P2|1) Baseline up to Week 24|Other|0
5479101|NCT01855789|18943012|P1|1) Baseline up to Week 24|Other|4
5479102|NCT01855789|18943009|P4|1) Baseline up to Week 24|Sponsor Decision|0
5479103|NCT01855789|18943010|P3|1) Baseline up to Week 24|Sponsor Decision|0
5479104|NCT01855789|18943011|P2|1) Baseline up to Week 24|Sponsor Decision|0
5479105|NCT01855789|18943012|P1|1) Baseline up to Week 24|Sponsor Decision|3
5479106|NCT01855789|18943009|P4|1) Baseline up to Week 24|Participant Non-compliance|0
5479107|NCT01855789|18943010|P3|1) Baseline up to Week 24|Participant Non-compliance|0
5479108|NCT01855789|18943011|P2|1) Baseline up to Week 24|Participant Non-compliance|0
5479109|NCT01855789|18943012|P1|1) Baseline up to Week 24|Participant Non-compliance|3
5479110|NCT01855789|18943009|P4|1) Baseline up to Week 24|Pregnancy|0
5479111|NCT01855789|18943010|P3|1) Baseline up to Week 24|Pregnancy|0
5479112|NCT01855789|18943011|P2|1) Baseline up to Week 24|Pregnancy|0
5479113|NCT01855789|18943012|P1|1) Baseline up to Week 24|Pregnancy|1
5479114|NCT01855789|18943009|P4|1) Baseline up to Week 24|Physician Decision|0
5479115|NCT01855789|18943010|P3|1) Baseline up to Week 24|Physician Decision|0
5479116|NCT01855789|18943011|P2|1) Baseline up to Week 24|Physician Decision|0
5479117|NCT01855789|18943012|P1|1) Baseline up to Week 24|Physician Decision|4
5479118|NCT01855789|18943009|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
5479119|NCT01855789|18943010|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
5479120|NCT01855789|18943011|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
5479121|NCT01855789|18943012|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
5479122|NCT01855789|18943009|P4|1) Baseline up to Week 24|Protocol Violation|0
5479123|NCT01855789|18943010|P3|1) Baseline up to Week 24|Protocol Violation|0
5479124|NCT01855789|18943011|P2|1) Baseline up to Week 24|Protocol Violation|0
5479125|NCT01855789|18943012|P1|1) Baseline up to Week 24|Protocol Violation|4
5479126|NCT01855789|18943009|P4|1) Baseline up to Week 24|Lost to Follow-up|0
5479127|NCT01855789|18943010|P3|1) Baseline up to Week 24|Lost to Follow-up|0
5479128|NCT01855789|18943011|P2|1) Baseline up to Week 24|Lost to Follow-up|0
5479129|NCT01855789|18943012|P1|1) Baseline up to Week 24|Lost to Follow-up|11
5479130|NCT01855789|18943009|P4|1) Baseline up to Week 24|Lack of Efficacy|0
5479131|NCT01855789|18943010|P3|1) Baseline up to Week 24|Lack of Efficacy|0
5479132|NCT01855789|18943011|P2|1) Baseline up to Week 24|Lack of Efficacy|0
5479133|NCT01855789|18943012|P1|1) Baseline up to Week 24|Lack of Efficacy|16
5479134|NCT01855789|18943009|P4|1) Baseline up to Week 24|Death|0
5479135|NCT01855789|18943010|P3|1) Baseline up to Week 24|Death|0
5479136|NCT01855789|18943011|P2|1) Baseline up to Week 24|Death|0
5479137|NCT01855789|18943012|P1|1) Baseline up to Week 24|Death|2
5479138|NCT01855789|18943009|P4|1) Baseline up to Week 24|Adverse Event|0
5479139|NCT01855789|18943010|P3|1) Baseline up to Week 24|Adverse Event|0
5479140|NCT01855789|18943011|P2|1) Baseline up to Week 24|Adverse Event|0
5479141|NCT01855789|18943012|P1|1) Baseline up to Week 24|Adverse Event|37
5479142|NCT01855750|18943036|P2|Overall Study|Sponsor ends the study|290
5479143|NCT01855750|18943037|P1|Overall Study|Sponsor ends the study|297
5479144|NCT01855750|18943036|P2|Overall Study|Withdrawal by Subject|28
5479145|NCT01855750|18943037|P1|Overall Study|Withdrawal by Subject|35
5479146|NCT01855750|18943036|P2|Overall Study|Lost to Follow-up|23
5479147|NCT01855750|18943037|P1|Overall Study|Lost to Follow-up|9
5479148|NCT01855750|18943036|P2|Overall Study|Death|78
5479149|NCT01855750|18943037|P1|Overall Study|Death|78
5479150|NCT01855425|18943053|P1|Overall Study|Physician Decision|20
5479151|NCT01855399|18943059|P2|12 Month|Lost to Follow-up|11
5479152|NCT01855399|18943060|P1|12 Month|Lost to Follow-up|7
5479153|NCT01855399|18943059|P2|6 Month|Withdrawal by Subject|6
5479154|NCT01855399|18943060|P1|6 Month|Withdrawal by Subject|8
5479155|NCT01855399|18943059|P2|6 Month|Lost to Follow-up|9
5479156|NCT01855399|18943060|P1|6 Month|Lost to Follow-up|12
5479157|NCT01855243|18943074|P3|Overall Study|develpoed diabetic ketoacidosis|0
5479158|NCT01855243|18943075|P2|Overall Study|develpoed diabetic ketoacidosis|0
5479159|NCT01855243|18943076|P1|Overall Study|develpoed diabetic ketoacidosis|1
5479160|NCT01855126|18943098|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|2
5479161|NCT01855126|18943099|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
5479162|NCT01855126|18943098|P2|First Intervention (8 Weeks)|Withdrawal by Subject|6
5479163|NCT01855126|18943099|P1|First Intervention (8 Weeks)|Withdrawal by Subject|4
5479164|NCT01855074|18943111|P1|Overall Study|Started but not treated|1
5479165|NCT01855074|18943111|P1|Overall Study|Withdrawal by Subject|8
5479166|NCT01855074|18943111|P1|Overall Study|Lost to Follow-up|4
5479167|NCT01855074|18943111|P1|Overall Study|Adverse Event|1
5479168|NCT01854944|18943123|P3|Overall Study|Withdrawal by Subject|1
5479169|NCT01854944|18943124|P2|Overall Study|Withdrawal by Subject|0
5479170|NCT01854944|18943125|P1|Overall Study|Withdrawal by Subject|0
5479171|NCT01854918|18943177|P2|All-IP Period (Years 2 and 3)|Death|16
5479172|NCT01854918|18943178|P1|All-IP Period (Years 2 and 3)|Death|5
5479173|NCT01854918|18943177|P2|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
5479174|NCT01854918|18943178|P1|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
5479175|NCT01854918|18943177|P2|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
5479176|NCT01854918|18943178|P1|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
5479177|NCT01854918|18943177|P2|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
5479178|NCT01854918|18943178|P1|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
5479179|NCT01854918|18943177|P2|SOC-controlled Period (Year 1)|Death|5
5479180|NCT01854918|18943178|P1|SOC-controlled Period (Year 1)|Death|5
5479181|NCT01854918|18943177|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|8
5479182|NCT01854918|18943178|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|3
5479183|NCT01854918|18943177|P2|SOC-controlled Period (Year 1)|Decision by Sponsor|1
5479184|NCT01854918|18943178|P1|SOC-controlled Period (Year 1)|Decision by Sponsor|2
5479185|NCT01854918|18943177|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
5479186|NCT01854918|18943178|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
5479187|NCT01854879|18943197|P1|Overall Study|incomplete data set|1
5479188|NCT01854879|18943197|P1|Overall Study|screen fail|3
5479189|NCT01854879|18943197|P1|Overall Study|Could not complete testing within the scheduled time.|1
5479190|NCT01854827|18943201|P1|Overall Study|Death|1
5479191|NCT01854710|18943213|P6|Overall Study|CRI procedural error|2
5479192|NCT01854710|18943214|P5|Overall Study|CRI procedural error|2
5479193|NCT01854710|18943215|P4|Overall Study|CRI procedural error|2
5479194|NCT01854710|18943216|P3|Overall Study|CRI procedural error|2
5479195|NCT01854710|18943217|P2|Overall Study|CRI procedural error|2
5479196|NCT01854710|18943218|P1|Overall Study|CRI procedural error|2
5479197|NCT01854710|18943213|P6|Overall Study|Withdrawal by Subject|0
5479198|NCT01854710|18943214|P5|Overall Study|Withdrawal by Subject|0
5479199|NCT01854710|18943215|P4|Overall Study|Withdrawal by Subject|0
5479200|NCT01854710|18943216|P3|Overall Study|Withdrawal by Subject|0
5479201|NCT01854710|18943217|P2|Overall Study|Withdrawal by Subject|1
5479202|NCT01854710|18943218|P1|Overall Study|Withdrawal by Subject|2
5479203|NCT01854697|18943239|P5|Overall Study|Other|0
5479204|NCT01854697|18943240|P4|Overall Study|Other|0
5479205|NCT01854697|18943241|P3|Overall Study|Other|1
5479206|NCT01854697|18943242|P2|Overall Study|Other|1
5479207|NCT01854697|18943243|P1|Overall Study|Other|0
5479208|NCT01854697|18943239|P5|Overall Study|Withdrew Consent|0
5479209|NCT01854697|18943240|P4|Overall Study|Withdrew Consent|1
5479210|NCT01854697|18943241|P3|Overall Study|Withdrew Consent|0
5479211|NCT01854697|18943242|P2|Overall Study|Withdrew Consent|1
5479212|NCT01854697|18943243|P1|Overall Study|Withdrew Consent|0
5479213|NCT01854697|18943239|P5|Overall Study|To enter another AbbVie study|1
5479214|NCT01854697|18943240|P4|Overall Study|To enter another AbbVie study|0
5479215|NCT01854697|18943241|P3|Overall Study|To enter another AbbVie study|0
5479216|NCT01854697|18943242|P2|Overall Study|To enter another AbbVie study|0
5479217|NCT01854697|18943243|P1|Overall Study|To enter another AbbVie study|1
5479218|NCT01854697|18943239|P5|Overall Study|Lost to Follow-up|0
5479219|NCT01854697|18943240|P4|Overall Study|Lost to Follow-up|2
5479220|NCT01854697|18943241|P3|Overall Study|Lost to Follow-up|1
5479221|NCT01854697|18943242|P2|Overall Study|Lost to Follow-up|1
5479222|NCT01854697|18943243|P1|Overall Study|Lost to Follow-up|4
5479223|NCT01854697|18943239|P5|Overall Study|Adverse Event|1
5479224|NCT01854697|18943240|P4|Overall Study|Adverse Event|0
5479225|NCT01854697|18943241|P3|Overall Study|Adverse Event|0
5479226|NCT01854697|18943242|P2|Overall Study|Adverse Event|0
5479227|NCT01854697|18943243|P1|Overall Study|Adverse Event|1
5479228|NCT01854658|18943287|P4|Overall Study|Administrative reasons|2
5479229|NCT01854658|18943288|P3|Overall Study|Administrative reasons|2
5479230|NCT01854658|18943289|P2|Overall Study|Administrative reasons|1
5479231|NCT01854658|18943290|P1|Overall Study|Administrative reasons|5
5479232|NCT01854658|18943287|P4|Overall Study|Adverse Event|19
5479233|NCT01854658|18943288|P3|Overall Study|Adverse Event|23
5479234|NCT01854658|18943289|P2|Overall Study|Adverse Event|14
5479235|NCT01854658|18943290|P1|Overall Study|Adverse Event|21
5479236|NCT01854658|18943287|P4|Overall Study|Lack of Efficacy|7
5479237|NCT01854658|18943288|P3|Overall Study|Lack of Efficacy|4
5479238|NCT01854658|18943289|P2|Overall Study|Lack of Efficacy|8
5479239|NCT01854658|18943290|P1|Overall Study|Lack of Efficacy|3
5479240|NCT01854658|18943287|P4|Overall Study|Protocol-specified criteria|7
5479241|NCT01854658|18943288|P3|Overall Study|Protocol-specified criteria|10
5479242|NCT01854658|18943289|P2|Overall Study|Protocol-specified criteria|15
5479243|NCT01854658|18943290|P1|Overall Study|Protocol-specified criteria|15
5479244|NCT01854658|18943287|P4|Overall Study|Withdrawal by Subject|15
5479245|NCT01854658|18943288|P3|Overall Study|Withdrawal by Subject|29
5479246|NCT01854658|18943289|P2|Overall Study|Withdrawal by Subject|21
5479247|NCT01854658|18943290|P1|Overall Study|Withdrawal by Subject|28
5479248|NCT01854658|18943287|P4|Overall Study|Lost to Follow-up|4
5479249|NCT01854658|18943288|P3|Overall Study|Lost to Follow-up|8
5479250|NCT01854658|18943289|P2|Overall Study|Lost to Follow-up|9
5479251|NCT01854658|18943290|P1|Overall Study|Lost to Follow-up|8
5479252|NCT01854658|18943287|P4|Overall Study|Physician Decision|4
5479253|NCT01854658|18943288|P3|Overall Study|Physician Decision|2
5479254|NCT01854658|18943289|P2|Overall Study|Physician Decision|5
5479255|NCT01854658|18943290|P1|Overall Study|Physician Decision|7
5479256|NCT01854658|18943287|P4|Overall Study|Protocol Violation|1
5479257|NCT01854658|18943288|P3|Overall Study|Protocol Violation|2
5479258|NCT01854658|18943289|P2|Overall Study|Protocol Violation|2
5479259|NCT01854658|18943290|P1|Overall Study|Protocol Violation|6
5479260|NCT01854645|18943325|P5|Overall Study|Adverse Event|11
5479261|NCT01854645|18943326|P4|Overall Study|Adverse Event|20
5479262|NCT01854645|18943327|P3|Overall Study|Adverse Event|19
5479263|NCT01854645|18943328|P2|Overall Study|Adverse Event|31
5479264|NCT01854645|18943329|P1|Overall Study|Adverse Event|33
5479265|NCT01854645|18943325|P5|Overall Study|Lack of Efficacy|9
5479266|NCT01854645|18943326|P4|Overall Study|Lack of Efficacy|3
5479267|NCT01854645|18943327|P3|Overall Study|Lack of Efficacy|9
5479268|NCT01854645|18943328|P2|Overall Study|Lack of Efficacy|12
5479269|NCT01854645|18943329|P1|Overall Study|Lack of Efficacy|7
5479270|NCT01854645|18943325|P5|Overall Study|Withdrawal by Subject|24
5479271|NCT01854645|18943326|P4|Overall Study|Withdrawal by Subject|21
5479272|NCT01854645|18943327|P3|Overall Study|Withdrawal by Subject|30
5479273|NCT01854645|18943328|P2|Overall Study|Withdrawal by Subject|41
5479274|NCT01854645|18943329|P1|Overall Study|Withdrawal by Subject|31
5479275|NCT01854645|18943325|P5|Overall Study|Physician Decision|7
5479276|NCT01854645|18943326|P4|Overall Study|Physician Decision|3
5479277|NCT01854645|18943327|P3|Overall Study|Physician Decision|3
5479278|NCT01854645|18943328|P2|Overall Study|Physician Decision|5
5479279|NCT01854645|18943329|P1|Overall Study|Physician Decision|1
5479280|NCT01854645|18943325|P5|Overall Study|Lost to Follow-up|0
5479281|NCT01854645|18943326|P4|Overall Study|Lost to Follow-up|5
5479282|NCT01854645|18943327|P3|Overall Study|Lost to Follow-up|8
5479283|NCT01854645|18943328|P2|Overall Study|Lost to Follow-up|7
5479284|NCT01854645|18943329|P1|Overall Study|Lost to Follow-up|10
5479285|NCT01854645|18943325|P5|Overall Study|Protocol Violation|1
5479286|NCT01854645|18943326|P4|Overall Study|Protocol Violation|4
5479287|NCT01854645|18943327|P3|Overall Study|Protocol Violation|5
5479288|NCT01854645|18943328|P2|Overall Study|Protocol Violation|0
5479289|NCT01854645|18943329|P1|Overall Study|Protocol Violation|3
5479290|NCT01854645|18943325|P5|Overall Study|Administrative Reasons / Missing|1
5479291|NCT01854645|18943326|P4|Overall Study|Administrative Reasons / Missing|1
5479292|NCT01854645|18943327|P3|Overall Study|Administrative Reasons / Missing|0
5479293|NCT01854645|18943328|P2|Overall Study|Administrative Reasons / Missing|0
5479294|NCT01854645|18943329|P1|Overall Study|Administrative Reasons / Missing|0
5479295|NCT01854645|18943325|P5|Overall Study|Protocol-Specified Criteria|7
5479296|NCT01854645|18943326|P4|Overall Study|Protocol-Specified Criteria|5
5479297|NCT01854645|18943327|P3|Overall Study|Protocol-Specified Criteria|8
5479298|NCT01854645|18943328|P2|Overall Study|Protocol-Specified Criteria|10
5479299|NCT01854645|18943329|P1|Overall Study|Protocol-Specified Criteria|13
5479300|NCT01854528|18943410|P2|Overall Study|Virologic Failure|9
5479301|NCT01854528|18943411|P1|Overall Study|Virologic Failure|0
5479302|NCT01854528|18943410|P2|Overall Study|Withdrawal by Subject|2
5479303|NCT01854528|18943411|P1|Overall Study|Withdrawal by Subject|0
5479304|NCT01854528|18943410|P2|Overall Study|Adverse Event|4
5479305|NCT01854528|18943411|P1|Overall Study|Adverse Event|0
5479306|NCT01854047|18943482|P5|Overall Study|Other than specified above|8
5479307|NCT01854047|18943483|P4|Overall Study|Other than specified above|5
5479308|NCT01854047|18943484|P3|Overall Study|Other than specified above|3
5479309|NCT01854047|18943485|P2|Overall Study|Other than specified above|3
5479310|NCT01854047|18943486|P1|Overall Study|Other than specified above|3
5479311|NCT01854047|18943482|P5|Overall Study|Randomized but not treated|4
5479312|NCT01854047|18943483|P4|Overall Study|Randomized but not treated|0
5479313|NCT01854047|18943484|P3|Overall Study|Randomized but not treated|2
5479314|NCT01854047|18943485|P2|Overall Study|Randomized but not treated|1
5479315|NCT01854047|18943486|P1|Overall Study|Randomized but not treated|0
5479316|NCT01854047|18943482|P5|Overall Study|Adverse Event|7
5479317|NCT01854047|18943483|P4|Overall Study|Adverse Event|10
5479318|NCT01854047|18943484|P3|Overall Study|Adverse Event|6
5479319|NCT01854047|18943485|P2|Overall Study|Adverse Event|4
5479320|NCT01854047|18943486|P1|Overall Study|Adverse Event|5
5479321|NCT01854047|18943482|P5|Overall Study|Poor compliance to protocol|0
5479322|NCT01854047|18943483|P4|Overall Study|Poor compliance to protocol|0
5479323|NCT01854047|18943484|P3|Overall Study|Poor compliance to protocol|2
5479324|NCT01854047|18943485|P2|Overall Study|Poor compliance to protocol|0
5479325|NCT01854047|18943486|P1|Overall Study|Poor compliance to protocol|3
5479326|NCT01854047|18943482|P5|Overall Study|Lack of Efficacy|0
5479327|NCT01854047|18943483|P4|Overall Study|Lack of Efficacy|0
5479328|NCT01854047|18943484|P3|Overall Study|Lack of Efficacy|0
5479329|NCT01854047|18943485|P2|Overall Study|Lack of Efficacy|0
5479330|NCT01854047|18943486|P1|Overall Study|Lack of Efficacy|1
5479331|NCT01853982|18943617|P2|Overall Study|Lost to Follow-up|1
5479332|NCT01853982|18943618|P1|Overall Study|Lost to Follow-up|0
5479333|NCT01853982|18943617|P2|Overall Study|Death|0
5479334|NCT01853982|18943618|P1|Overall Study|Death|1
5479335|NCT01853982|18943617|P2|Overall Study|Withdrawal by Subject|0
5479336|NCT01853982|18943618|P1|Overall Study|Withdrawal by Subject|1
5479337|NCT01853878|18943635|P2|Overall Study|Other|43
5479338|NCT01853878|18943636|P1|Overall Study|Other|55
5479339|NCT01853878|18943635|P2|Overall Study|Migrated/moved from the study area|0
5479340|NCT01853878|18943636|P1|Overall Study|Migrated/moved from the study area|1
5479341|NCT01853878|18943635|P2|Overall Study|Withdrawal by Subject|1
5479342|NCT01853878|18943636|P1|Overall Study|Withdrawal by Subject|3
5479343|NCT01853878|18943635|P2|Overall Study|Adverse Event|0
5479344|NCT01853878|18943636|P1|Overall Study|Adverse Event|2
5479345|NCT01853878|18943635|P2|Overall Study|Recurrence|0
5479346|NCT01853878|18943636|P1|Overall Study|Recurrence|2
5479347|NCT01853839|18943660|P1|Overall Study|Lost to follow-up or no valid BP measure|336
5479348|NCT01853839|18943660|P1|Overall Study|End of treatment visit too early|33
5479349|NCT01853839|18943660|P1|Overall Study|Not meet ITT population definition|58
5479350|NCT01853839|18943660|P1|Overall Study|Violated inclusion criteria|2
5479351|NCT01853696|18943693|P2|Overall Study|Lost to Follow-up|4
5479352|NCT01853696|18943694|P1|Overall Study|Lost to Follow-up|5
5479353|NCT01853696|18943693|P2|Overall Study|Withdrawal by Subject|1
5479354|NCT01853696|18943694|P1|Overall Study|Withdrawal by Subject|1
5479355|NCT01853644|18943702|P1|Follow up for 3 Years or Until Death|Still in the follow up period|3
5479356|NCT01853644|18943702|P1|Continued Treatment After First Response|Progressive Diseaes|10
5479357|NCT01853644|18943702|P1|Continued Treatment After First Response|Adverse Event|2
5479358|NCT01853644|18943702|P1|Reached First Response/Complete 2 Cycles|Progressive Disease|2
5479359|NCT01853644|18943702|P1|Reached First Response/Complete 2 Cycles|Other|1
5479360|NCT01853644|18943702|P1|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
5479361|NCT01853644|18943702|P1|Reached First Response/Complete 2 Cycles|Adverse Event|2
5479362|NCT01853644|18943702|P1|Registration and Treatment Start|Did not start treatment|1
5479363|NCT01853618|18943716|P5|Overall Study|Refused further treatment|1
5479364|NCT01853618|18943717|P4|Overall Study|Refused further treatment|0
5479365|NCT01853618|18943718|P3|Overall Study|Refused further treatment|0
5479366|NCT01853618|18943719|P2|Overall Study|Refused further treatment|0
5479367|NCT01853618|18943720|P1|Overall Study|Refused further treatment|0
5479368|NCT01853618|18943716|P5|Overall Study|Physician Decision|0
5479369|NCT01853618|18943717|P4|Overall Study|Physician Decision|0
5479370|NCT01853618|18943718|P3|Overall Study|Physician Decision|1
5479371|NCT01853618|18943719|P2|Overall Study|Physician Decision|1
5479372|NCT01853618|18943720|P1|Overall Study|Physician Decision|0
5479373|NCT01853618|18943716|P5|Overall Study|Progressive disease|2
5479374|NCT01853618|18943717|P4|Overall Study|Progressive disease|1
5479375|NCT01853618|18943718|P3|Overall Study|Progressive disease|1
5479376|NCT01853618|18943719|P2|Overall Study|Progressive disease|1
5479377|NCT01853618|18943720|P1|Overall Study|Progressive disease|1
5479378|NCT01853618|18943716|P5|Overall Study|Bile duct stent blockage/progressive dis|0
5479379|NCT01853618|18943717|P4|Overall Study|Bile duct stent blockage/progressive dis|0
5479380|NCT01853618|18943718|P3|Overall Study|Bile duct stent blockage/progressive dis|0
5479381|NCT01853618|18943719|P2|Overall Study|Bile duct stent blockage/progressive dis|0
5479382|NCT01853618|18943720|P1|Overall Study|Bile duct stent blockage/progressive dis|1
5479383|NCT01853475|18943786|P3|Overall Study|Withdrawal by Subject|0
5479384|NCT01853475|18943787|P2|Overall Study|Withdrawal by Subject|1
5479385|NCT01853475|18943788|P1|Overall Study|Withdrawal by Subject|0
5479386|NCT01853462|18943807|P2|Overall Study|Withdrawal by Subject|1
5479387|NCT01853462|18943808|P1|Overall Study|Withdrawal by Subject|1
5479388|NCT01853397|18943878|P4|Overall Study|Subject Noncompliance|1
5479389|NCT01853397|18943879|P3|Overall Study|Subject Noncompliance|0
5479390|NCT01853397|18943880|P2|Overall Study|Subject Noncompliance|0
5479391|NCT01853397|18943881|P1|Overall Study|Subject Noncompliance|0
5479392|NCT01853397|18943878|P4|Overall Study|Withdrawal by Subject|1
5479393|NCT01853397|18943879|P3|Overall Study|Withdrawal by Subject|0
5479394|NCT01853397|18943880|P2|Overall Study|Withdrawal by Subject|0
5479395|NCT01853397|18943881|P1|Overall Study|Withdrawal by Subject|0
5479396|NCT01853384|18943909|P2|Completed Follow up Visit 2|Lost to Follow-up|1
5479397|NCT01853384|18943910|P1|Completed Follow up Visit 2|Lost to Follow-up|0
5479398|NCT01853384|18943909|P2|Completed Follow up Visit 2|Death|0
5479399|NCT01853384|18943910|P1|Completed Follow up Visit 2|Death|1
5479400|NCT01853384|18943909|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
5479401|NCT01853384|18943910|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
5479402|NCT01853384|18943909|P2|Completed Follow up Visit 2|Adverse Event|0
5479403|NCT01853384|18943910|P1|Completed Follow up Visit 2|Adverse Event|1
5479404|NCT01853384|18943909|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
5479405|NCT01853384|18943910|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
5479406|NCT01853384|18943909|P2|Completed Follow up Visit 1|Early Termination|9
5479407|NCT01853384|18943910|P1|Completed Follow up Visit 1|Early Termination|13
5479408|NCT01853384|18943909|P2|Randomized|Other|3
5479409|NCT01853384|18943910|P1|Randomized|Other|3
5479410|NCT01853384|18943909|P2|Randomized|Sponsor Decision|34
5479411|NCT01853384|18943910|P1|Randomized|Sponsor Decision|47
5479412|NCT01853384|18943909|P2|Randomized|Withdrawal by Subject|3
5479413|NCT01853384|18943910|P1|Randomized|Withdrawal by Subject|5
5479414|NCT01853384|18943909|P2|Randomized|Lost to Follow-up|1
5479415|NCT01853384|18943910|P1|Randomized|Lost to Follow-up|1
5479416|NCT01853384|18943909|P2|Randomized|Death|2
5479417|NCT01853384|18943910|P1|Randomized|Death|1
5479418|NCT01853384|18943909|P2|Randomized|Adverse Event|3
5479419|NCT01853384|18943910|P1|Randomized|Adverse Event|5
5479420|NCT01853280|18943950|P2|Overall Study|Ineligible|1
5479421|NCT01853280|18943951|P1|Overall Study|Ineligible|0
5479422|NCT01853280|18943950|P2|Overall Study|Withdrawal by Subject|1
5479423|NCT01853280|18943951|P1|Overall Study|Withdrawal by Subject|0
5479424|NCT01853280|18943950|P2|Overall Study|Physician Decision|1
5479425|NCT01853280|18943951|P1|Overall Study|Physician Decision|0
5479426|NCT01853280|18943950|P2|Overall Study|Lost to Follow-up|1
5479427|NCT01853280|18943951|P1|Overall Study|Lost to Follow-up|0
5479428|NCT01853280|18943950|P2|Overall Study|Lack of Efficacy|2
5479429|NCT01853280|18943951|P1|Overall Study|Lack of Efficacy|2
5479430|NCT01853254|18943957|P1|Overall Study|Administrative/Other|16
5479431|NCT01853254|18943957|P1|Overall Study|Withdrawal of Consent|16
5479432|NCT01853254|18943957|P1|Overall Study|Other Protocol Violation|1
5479433|NCT01853254|18943957|P1|Overall Study|Refusal of Treatment|1
5479434|NCT01853254|18943957|P1|Overall Study|Insufficient Therapeutic Response|22
5479435|NCT01853254|18943957|P1|Overall Study|Failure to Return|43
5479436|NCT01853254|18943957|P1|Overall Study|Death|1
5479437|NCT01853254|18943957|P1|Overall Study|Adverse Event/Intercurrent Illness|3
5479438|NCT01853254|18943957|P1|Overall Study|Abnormal Laboratory Test|1
5479439|NCT01853228|18943961|P2|Phase 2|Lack of Efficacy|4
5479440|NCT01853228|18943962|P1|Phase 2|Lack of Efficacy|0
5479441|NCT01853228|18943961|P2|Phase 2|Proceed To Transplant|3
5479442|NCT01853228|18943962|P1|Phase 2|Proceed To Transplant|0
5479443|NCT01853228|18943961|P2|Phase 2|Physician Decision|1
5479444|NCT01853228|18943962|P1|Phase 2|Physician Decision|0
5479445|NCT01853228|18943961|P2|Phase 1|Other|0
5479446|NCT01853228|18943962|P1|Phase 1|Other|1
5479447|NCT01853228|18943961|P2|Phase 1|Lack of Efficacy|0
5479448|NCT01853228|18943962|P1|Phase 1|Lack of Efficacy|8
5479449|NCT01853176|18943992|P2|Overall Study|Study terminated|0
5479450|NCT01853176|18943993|P1|Overall Study|Study terminated|4
5479451|NCT01853137|18944001|P2|Overall Study|Lost to Follow-up|1
5479452|NCT01853137|18944002|P1|Overall Study|Lost to Follow-up|4
5479453|NCT01853072|18944023|P2|Overall Study|Reason not specified|6
5479454|NCT01853072|18944024|P1|Overall Study|Reason not specified|9
5479455|NCT01853072|18944023|P2|Overall Study|Withdrawal by Subject|2
5479456|NCT01853072|18944024|P1|Overall Study|Withdrawal by Subject|1
5479457|NCT01853072|18944023|P2|Overall Study|Physician Decision|1
5479458|NCT01853072|18944024|P1|Overall Study|Physician Decision|1
5479459|NCT01853072|18944023|P2|Overall Study|Non-compliance with study drug|1
5479460|NCT01853072|18944024|P1|Overall Study|Non-compliance with study drug|0
5479461|NCT01853072|18944023|P2|Overall Study|Lost to Follow-up|3
5479462|NCT01853072|18944024|P1|Overall Study|Lost to Follow-up|0
5479463|NCT01853072|18944023|P2|Overall Study|Death|4
5479464|NCT01853072|18944024|P1|Overall Study|Death|1
5479465|NCT01853072|18944023|P2|Overall Study|Adverse Event|3
5479466|NCT01853072|18944024|P1|Overall Study|Adverse Event|0
5479467|NCT01853072|18944023|P2|Overall Study|Adverse event prior to treatment|1
5479468|NCT01853072|18944024|P1|Overall Study|Adverse event prior to treatment|0
5479469|NCT01853046|18944044|P2|Overall Study|Disease progression|3
5479470|NCT01853046|18944045|P1|Overall Study|Disease progression|13
5479471|NCT01853046|18944044|P2|Overall Study|Adverse Event|2
5479472|NCT01853046|18944045|P1|Overall Study|Adverse Event|4
5479473|NCT01853046|18944044|P2|Overall Study|Withdrawal by Subject|1
5479474|NCT01853046|18944045|P1|Overall Study|Withdrawal by Subject|1
5479475|NCT01852942|18944112|P2|Overall Study|Lost to Follow-up|2
5479476|NCT01852942|18944113|P1|Overall Study|Lost to Follow-up|1
5479477|NCT01852942|18944112|P2|Overall Study|Withdrawal by Subject|3
5479478|NCT01852942|18944113|P1|Overall Study|Withdrawal by Subject|2
5479479|NCT01852942|18944112|P2|Overall Study|Death|1
5479480|NCT01852942|18944113|P1|Overall Study|Death|1
5479481|NCT01852942|18944112|P2|Overall Study|Physician Decision|0
5479482|NCT01852942|18944113|P1|Overall Study|Physician Decision|1
5479483|NCT01852825|18944208|P3|Overall Study|Withdrawal by Subject|0
5479484|NCT01852825|18944209|P2|Overall Study|Withdrawal by Subject|0
5479485|NCT01852825|18944210|P1|Overall Study|Withdrawal by Subject|2
5479486|NCT01852812|18944236|P3|Overall Study|Non-compliance With Study Drug|0
5479487|NCT01852812|18944237|P2|Overall Study|Non-compliance With Study Drug|1
5479488|NCT01852812|18944238|P1|Overall Study|Non-compliance With Study Drug|0
5479489|NCT01852812|18944236|P3|Overall Study|Adverse Event|1
5479490|NCT01852812|18944237|P2|Overall Study|Adverse Event|0
5479491|NCT01852812|18944238|P1|Overall Study|Adverse Event|0
5479492|NCT01852591|18944276|P1|Overall Study|Not Evaluable at Time of Analysis|1
5479493|NCT01852591|18944276|P1|Overall Study|Withdrawal by Subject|2
5479494|NCT01852292|18944330|P2|Overall Study|Progressive disease|52
5479495|NCT01852292|18944331|P1|Overall Study|Progressive disease|42
5479496|NCT01852292|18944330|P2|Overall Study|Study terminated by Sponsor|1
5479497|NCT01852292|18944331|P1|Overall Study|Study terminated by Sponsor|0
5479498|NCT01852292|18944330|P2|Overall Study|Non-compliance with study treatment|0
5479499|NCT01852292|18944331|P1|Overall Study|Non-compliance with study treatment|1
5479500|NCT01852292|18944330|P2|Overall Study|Protocol Violation|0
5479501|NCT01852292|18944331|P1|Overall Study|Protocol Violation|2
5479502|NCT01852292|18944330|P2|Overall Study|Physician Decision|2
5479503|NCT01852292|18944331|P1|Overall Study|Physician Decision|6
5479504|NCT01852292|18944330|P2|Overall Study|Adverse Event|11
5479505|NCT01852292|18944331|P1|Overall Study|Adverse Event|8
5479506|NCT01852292|18944330|P2|Overall Study|Patient/guardian decision|4
5479507|NCT01852292|18944331|P1|Overall Study|Patient/guardian decision|8
5479508|NCT01852292|18944330|P2|Overall Study|Death|8
5479509|NCT01852292|18944331|P1|Overall Study|Death|9
5479510|NCT01852292|18944330|P2|Overall Study|Untreated - did not receive study drug|1
5479511|NCT01852292|18944331|P1|Overall Study|Untreated - did not receive study drug|3
5479512|NCT01852214|18944355|P2|Washout Period|Withdrawal by Subject|1
5479513|NCT01852214|18944356|P1|Washout Period|Withdrawal by Subject|0
5479514|NCT01852214|18944355|P2|Period 1|Withdrawal by Subject|1
5479515|NCT01852214|18944356|P1|Period 1|Withdrawal by Subject|0
5479516|NCT01852214|18944355|P2|Period 1|Adverse Event|2
5479517|NCT01852214|18944356|P1|Period 1|Adverse Event|1
5479518|NCT01852162|18944408|P2|Overall Study|Withdrawal by Subject|1
5479519|NCT01852162|18944409|P1|Overall Study|Withdrawal by Subject|3
5479520|NCT01852162|18944408|P2|Overall Study|Adverse Event|0
5479521|NCT01852162|18944409|P1|Overall Study|Adverse Event|1
5479522|NCT01852110|18944425|P6|Overall Study|Withdrawal by Subject|0
5479523|NCT01852110|18944426|P5|Overall Study|Withdrawal by Subject|0
5479524|NCT01852110|18944427|P4|Overall Study|Withdrawal by Subject|0
5479525|NCT01852110|18944428|P3|Overall Study|Withdrawal by Subject|0
5479526|NCT01852110|18944429|P2|Overall Study|Withdrawal by Subject|4
5479527|NCT01852110|18944430|P1|Overall Study|Withdrawal by Subject|4
5479528|NCT01852110|18944425|P6|Overall Study|Study Terminated by Sponsor|0
5479529|NCT01852110|18944426|P5|Overall Study|Study Terminated by Sponsor|0
5479530|NCT01852110|18944427|P4|Overall Study|Study Terminated by Sponsor|0
5479531|NCT01852110|18944428|P3|Overall Study|Study Terminated by Sponsor|0
5479532|NCT01852110|18944429|P2|Overall Study|Study Terminated by Sponsor|32
5479533|NCT01852110|18944430|P1|Overall Study|Study Terminated by Sponsor|30
5479534|NCT01852110|18944425|P6|Overall Study|Protocol Violation|0
5479535|NCT01852110|18944426|P5|Overall Study|Protocol Violation|0
5479536|NCT01852110|18944427|P4|Overall Study|Protocol Violation|0
5479537|NCT01852110|18944428|P3|Overall Study|Protocol Violation|0
5479538|NCT01852110|18944429|P2|Overall Study|Protocol Violation|1
5479539|NCT01852110|18944430|P1|Overall Study|Protocol Violation|0
5479540|NCT01852110|18944425|P6|Overall Study|Physician Decision|0
5479541|NCT01852110|18944426|P5|Overall Study|Physician Decision|0
5479542|NCT01852110|18944427|P4|Overall Study|Physician Decision|0
5479543|NCT01852110|18944428|P3|Overall Study|Physician Decision|0
5479544|NCT01852110|18944429|P2|Overall Study|Physician Decision|0
5479545|NCT01852110|18944430|P1|Overall Study|Physician Decision|1
5479546|NCT01852110|18944425|P6|Overall Study|Non-compliance with Study Drug|0
5479547|NCT01852110|18944426|P5|Overall Study|Non-compliance with Study Drug|0
5479548|NCT01852110|18944427|P4|Overall Study|Non-compliance with Study Drug|0
5479549|NCT01852110|18944428|P3|Overall Study|Non-compliance with Study Drug|0
5479550|NCT01852110|18944429|P2|Overall Study|Non-compliance with Study Drug|1
5479551|NCT01852110|18944430|P1|Overall Study|Non-compliance with Study Drug|2
5479552|NCT01852110|18944425|P6|Overall Study|Lost to Follow-up|0
5479553|NCT01852110|18944426|P5|Overall Study|Lost to Follow-up|0
5479554|NCT01852110|18944427|P4|Overall Study|Lost to Follow-up|0
5479555|NCT01852110|18944428|P3|Overall Study|Lost to Follow-up|0
5479556|NCT01852110|18944429|P2|Overall Study|Lost to Follow-up|3
5479557|NCT01852110|18944430|P1|Overall Study|Lost to Follow-up|1
5479558|NCT01852110|18944425|P6|Overall Study|Adverse Event|0
5479559|NCT01852110|18944426|P5|Overall Study|Adverse Event|0
5479560|NCT01852110|18944427|P4|Overall Study|Adverse Event|0
5479561|NCT01852110|18944428|P3|Overall Study|Adverse Event|0
5479562|NCT01852110|18944429|P2|Overall Study|Adverse Event|5
5479563|NCT01852110|18944430|P1|Overall Study|Adverse Event|12
5479564|NCT01852058|18944494|P12|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479565|NCT01852058|18944495|P11|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479566|NCT01852058|18944496|P10|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479567|NCT01852058|18944497|P9|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
5479568|NCT01852058|18944498|P8|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479569|NCT01852058|18944499|P7|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479570|NCT01852058|18944500|P6|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479571|NCT01852058|18944501|P5|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479572|NCT01852058|18944502|P4|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479573|NCT01852058|18944503|P3|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479574|NCT01852058|18944504|P2|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479575|NCT01852058|18944505|P1|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
5479576|NCT01852058|18944494|P12|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479577|NCT01852058|18944495|P11|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479578|NCT01852058|18944496|P10|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479579|NCT01852058|18944497|P9|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479580|NCT01852058|18944498|P8|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
5479581|NCT01852058|18944499|P7|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479582|NCT01852058|18944500|P6|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479583|NCT01852058|18944501|P5|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479584|NCT01852058|18944502|P4|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479585|NCT01852058|18944503|P3|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479586|NCT01852058|18944504|P2|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479587|NCT01852058|18944505|P1|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
5479588|NCT01852058|18944494|P12|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479589|NCT01852058|18944495|P11|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479590|NCT01852058|18944496|P10|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479591|NCT01852058|18944497|P9|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479592|NCT01852058|18944498|P8|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479593|NCT01852058|18944499|P7|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479594|NCT01852058|18944500|P6|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
5479595|NCT01852058|18944501|P5|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
5479596|NCT01852058|18944502|P4|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479597|NCT01852058|18944503|P3|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479598|NCT01852058|18944504|P2|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479599|NCT01852058|18944505|P1|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
5479600|NCT01852058|18944494|P12|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479601|NCT01852058|18944495|P11|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479602|NCT01852058|18944496|P10|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479603|NCT01852058|18944497|P9|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479604|NCT01852058|18944498|P8|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479605|NCT01852058|18944499|P7|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479606|NCT01852058|18944500|P6|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479607|NCT01852058|18944501|P5|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479608|NCT01852058|18944502|P4|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
5479609|NCT01852058|18944503|P3|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479610|NCT01852058|18944504|P2|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479611|NCT01852058|18944505|P1|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
5479612|NCT01852058|18944494|P12|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479613|NCT01852058|18944495|P11|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479614|NCT01852058|18944496|P10|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479615|NCT01852058|18944497|P9|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479616|NCT01852058|18944498|P8|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479617|NCT01852058|18944499|P7|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479618|NCT01852058|18944500|P6|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
5479619|NCT01852058|18944501|P5|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
5479620|NCT01852058|18944502|P4|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479621|NCT01852058|18944503|P3|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479622|NCT01852058|18944504|P2|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479623|NCT01852058|18944505|P1|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
5479624|NCT01852058|18944494|P12|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479625|NCT01852058|18944495|P11|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479626|NCT01852058|18944496|P10|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479627|NCT01852058|18944497|P9|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479628|NCT01852058|18944498|P8|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479629|NCT01852058|18944499|P7|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479630|NCT01852058|18944500|P6|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479631|NCT01852058|18944501|P5|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
5479632|NCT01852058|18944502|P4|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479633|NCT01852058|18944503|P3|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479634|NCT01852058|18944504|P2|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479635|NCT01852058|18944505|P1|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
5479636|NCT01852058|18944494|P12|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479637|NCT01852058|18944495|P11|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479638|NCT01852058|18944496|P10|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479639|NCT01852058|18944497|P9|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479640|NCT01852058|18944498|P8|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479641|NCT01852058|18944499|P7|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479642|NCT01852058|18944500|P6|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
5479643|NCT01852058|18944501|P5|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
5479644|NCT01852058|18944502|P4|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479645|NCT01852058|18944503|P3|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479646|NCT01852058|18944504|P2|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479647|NCT01852058|18944505|P1|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
5479648|NCT01852058|18944494|P12|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479649|NCT01852058|18944495|P11|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479650|NCT01852058|18944496|P10|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479651|NCT01852058|18944497|P9|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479652|NCT01852058|18944498|P8|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479653|NCT01852058|18944499|P7|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479654|NCT01852058|18944500|P6|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479655|NCT01852058|18944501|P5|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
5479656|NCT01852058|18944502|P4|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479657|NCT01852058|18944503|P3|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479658|NCT01852058|18944504|P2|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479659|NCT01852058|18944505|P1|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
5479660|NCT01852058|18944494|P12|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479661|NCT01852058|18944495|P11|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479662|NCT01852058|18944496|P10|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479663|NCT01852058|18944497|P9|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479664|NCT01852058|18944498|P8|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479665|NCT01852058|18944499|P7|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479666|NCT01852058|18944500|P6|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479667|NCT01852058|18944501|P5|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479668|NCT01852058|18944502|P4|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479669|NCT01852058|18944503|P3|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479670|NCT01852058|18944504|P2|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
5479671|NCT01852058|18944505|P1|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
5479672|NCT01852045|18944585|P3|Overall Study|Other Miscellaneous Reasons|2
5479673|NCT01852045|18944586|P2|Overall Study|Other Miscellaneous Reasons|3
5479674|NCT01852045|18944587|P1|Overall Study|Other Miscellaneous Reasons|1
5479675|NCT01852045|18944585|P3|Overall Study|Withdrawal by Subject|1
5479676|NCT01852045|18944586|P2|Overall Study|Withdrawal by Subject|0
5479677|NCT01852045|18944587|P1|Overall Study|Withdrawal by Subject|1
5479678|NCT01852045|18944585|P3|Overall Study|Lost to Follow-up|1
5479679|NCT01852045|18944586|P2|Overall Study|Lost to Follow-up|1
5479680|NCT01852045|18944587|P1|Overall Study|Lost to Follow-up|0
5479681|NCT01852045|18944585|P3|Overall Study|Lack of Efficacy|0
5479682|NCT01852045|18944586|P2|Overall Study|Lack of Efficacy|0
5479683|NCT01852045|18944587|P1|Overall Study|Lack of Efficacy|3
5479684|NCT01852045|18944585|P3|Overall Study|Adverse Event|0
5479685|NCT01852045|18944586|P2|Overall Study|Adverse Event|0
5479686|NCT01852045|18944587|P1|Overall Study|Adverse Event|1
5479687|NCT01851863|18944671|P4|Overall Study|Lost to Follow-up|3
5479688|NCT01851863|18944672|P3|Overall Study|Lost to Follow-up|2
5479689|NCT01851863|18944673|P2|Overall Study|Lost to Follow-up|4
5479690|NCT01851863|18944674|P1|Overall Study|Lost to Follow-up|3
5479691|NCT01851863|18944671|P4|Overall Study|Did not receive study medication|0
5479692|NCT01851863|18944672|P3|Overall Study|Did not receive study medication|3
5479693|NCT01851863|18944673|P2|Overall Study|Did not receive study medication|5
5479694|NCT01851863|18944674|P1|Overall Study|Did not receive study medication|2
5479695|NCT01851720|18944703|P2|Overall Study|Lost to Follow-up|1
5479696|NCT01851720|18944704|P1|Overall Study|Lost to Follow-up|0
5479697|NCT01851590|18944734|P3|Overall Study|Lack of Efficacy|0
5479698|NCT01851590|18944735|P2|Overall Study|Lack of Efficacy|1
5479699|NCT01851590|18944736|P1|Overall Study|Lack of Efficacy|0
5479700|NCT01851590|18944734|P3|Overall Study|Adverse Event|2
5479701|NCT01851590|18944735|P2|Overall Study|Adverse Event|0
5479702|NCT01851590|18944736|P1|Overall Study|Adverse Event|0
5479703|NCT01851590|18944734|P3|Overall Study|Withdrawal by Subject|1
5479704|NCT01851590|18944735|P2|Overall Study|Withdrawal by Subject|0
5479705|NCT01851590|18944736|P1|Overall Study|Withdrawal by Subject|0
5479706|NCT01851330|18944759|P3|Overall Study|Investigator's Discretion|1
5479707|NCT01851330|18944760|P2|Overall Study|Investigator's Discretion|0
5479708|NCT01851330|18944761|P1|Overall Study|Investigator's Discretion|0
5479709|NCT01851330|18944759|P3|Overall Study|Withdrew Consent|0
5479710|NCT01851330|18944760|P2|Overall Study|Withdrew Consent|1
5479711|NCT01851330|18944761|P1|Overall Study|Withdrew Consent|2
5479712|NCT01851330|18944759|P3|Overall Study|Lost to Follow-up|9
5479713|NCT01851330|18944760|P2|Overall Study|Lost to Follow-up|6
5479714|NCT01851330|18944761|P1|Overall Study|Lost to Follow-up|1
5479715|NCT01851330|18944759|P3|Overall Study|Lack of Efficacy|2
5479716|NCT01851330|18944760|P2|Overall Study|Lack of Efficacy|9
5479717|NCT01851330|18944761|P1|Overall Study|Lack of Efficacy|10
5479718|NCT01850823|18944804|P3|Overall Study|Withdrawal by Subject|1
5479719|NCT01850823|18944805|P2|Overall Study|Withdrawal by Subject|0
5479720|NCT01850823|18944806|P1|Overall Study|Withdrawal by Subject|2
5479721|NCT01850823|18944804|P3|Overall Study|Significant worstening of SAR|0
5479722|NCT01850823|18944805|P2|Overall Study|Significant worstening of SAR|1
5479723|NCT01850823|18944806|P1|Overall Study|Significant worstening of SAR|0
5479724|NCT01850823|18944804|P3|Overall Study|Restricted Medication|2
5479725|NCT01850823|18944805|P2|Overall Study|Restricted Medication|0
5479726|NCT01850823|18944806|P1|Overall Study|Restricted Medication|0
5479727|NCT01850823|18944804|P3|Overall Study|Lost to Follow-up|1
5479728|NCT01850823|18944805|P2|Overall Study|Lost to Follow-up|0
5479729|NCT01850823|18944806|P1|Overall Study|Lost to Follow-up|0
5479730|NCT01850823|18944804|P3|Overall Study|Lack of Efficacy|0
5479731|NCT01850823|18944805|P2|Overall Study|Lack of Efficacy|0
5479732|NCT01850823|18944806|P1|Overall Study|Lack of Efficacy|1
5479733|NCT01850823|18944804|P3|Overall Study|Enrolled in Error|2
5479734|NCT01850823|18944805|P2|Overall Study|Enrolled in Error|1
5479735|NCT01850823|18944806|P1|Overall Study|Enrolled in Error|0
5479736|NCT01850823|18944804|P3|Overall Study|Early Visit Window|4
5479737|NCT01850823|18944805|P2|Overall Study|Early Visit Window|1
5479738|NCT01850823|18944806|P1|Overall Study|Early Visit Window|0
5479739|NCT01850641|18944829|P1|Overall Study|Increase in serum ferritin|1
5479740|NCT01850641|18944829|P1|Overall Study|Decrease in serum calcium|2
5479741|NCT01850641|18944829|P1|Overall Study|Decrease in serum phosphorus|1
5479742|NCT01850641|18944829|P1|Overall Study|Physician Decision|1
5479743|NCT01850615|18944843|P2|Overall Study|Unclassified|1
5479744|NCT01850615|18944844|P1|Overall Study|Unclassified|0
5479745|NCT01850615|18944843|P2|Overall Study|Lost to Follow-up|1
5479746|NCT01850615|18944844|P1|Overall Study|Lost to Follow-up|0
5479747|NCT01850615|18944843|P2|Overall Study|Withdrawal by Subject|1
5479748|NCT01850615|18944844|P1|Overall Study|Withdrawal by Subject|3
5479749|NCT01850615|18944843|P2|Overall Study|Adverse Event|1
5479750|NCT01850615|18944844|P1|Overall Study|Adverse Event|2
5479751|NCT01850615|18944843|P2|Overall Study|Protocol Violation|1
5479752|NCT01850615|18944844|P1|Overall Study|Protocol Violation|4
5479753|NCT01850602|18944862|P2|Overall Study|Increase in serum ferritin|0
5479754|NCT01850602|18944863|P1|Overall Study|Increase in serum ferritin|1
5479755|NCT01850602|18944862|P2|Overall Study|Decrease in serum calcium|3
5479756|NCT01850602|18944863|P1|Overall Study|Decrease in serum calcium|2
5479757|NCT01850602|18944862|P2|Overall Study|Withdrawal by Subject|4
5479758|NCT01850602|18944863|P1|Overall Study|Withdrawal by Subject|2
5479759|NCT01850602|18944862|P2|Overall Study|Physician Decision|1
5479760|NCT01850602|18944863|P1|Overall Study|Physician Decision|2
5479761|NCT01850602|18944862|P2|Overall Study|Adverse Event|10
5479762|NCT01850602|18944863|P1|Overall Study|Adverse Event|7
5479763|NCT01850589|18944877|P2|Overall Study|Withdrawal by Subject|0
5479764|NCT01850589|18944878|P1|Overall Study|Withdrawal by Subject|8
5479765|NCT01850446|18944918|P2|Overall Study|Protocol Violation|2
5479766|NCT01850446|18944919|P1|Overall Study|Protocol Violation|0
5479767|NCT01850446|18944918|P2|Overall Study|Withdrawal by Subject|0
5479768|NCT01850446|18944919|P1|Overall Study|Withdrawal by Subject|4
5479769|NCT01850446|18944918|P2|Overall Study|Lack of Efficacy|0
5479770|NCT01850446|18944919|P1|Overall Study|Lack of Efficacy|1
5479771|NCT01850030|18944978|P2|Overall Study|pregnancy not confirmed at visit 4|249
5479772|NCT01850030|18944979|P1|Overall Study|pregnancy not confirmed at visit 4|248
5479773|NCT01850030|18944978|P2|Overall Study|Protocol Violation|28
5479774|NCT01850030|18944979|P1|Overall Study|Protocol Violation|24
5479775|NCT01850030|18944978|P2|Overall Study|Withdrawal by Subject|4
5479776|NCT01850030|18944979|P1|Overall Study|Withdrawal by Subject|3
5479777|NCT01850030|18944978|P2|Overall Study|Lost to Follow-up|5
5479778|NCT01850030|18944979|P1|Overall Study|Lost to Follow-up|5
5479779|NCT01850030|18944978|P2|Overall Study|Lack of Efficacy|1
5479780|NCT01850030|18944979|P1|Overall Study|Lack of Efficacy|3
5479781|NCT01850030|18944978|P2|Overall Study|Adverse Event|82
5479782|NCT01850030|18944979|P1|Overall Study|Adverse Event|64
5479783|NCT01850004|18944991|P1|Overall Study|AE Unrelated to Study Drug|1
5479784|NCT01850004|18944991|P1|Overall Study|Subject Request to Discontinue Treatment|1
5479785|NCT01850004|18944991|P1|Overall Study|Subject Withdrew Consent|4
5479786|NCT01850004|18944991|P1|Overall Study|Poor/Non-compliance|1
5479787|NCT01850004|18944991|P1|Overall Study|Subject Moved|1
5479788|NCT01849848|18944998|P1|Overall Study|Progression of the primary disease|3
5479789|NCT01849848|18944998|P1|Overall Study|Physician Decision|1
5479790|NCT01849588|18945096|P1|Overall Study|Lack of Efficacy|3
5479791|NCT01849562|18945115|P3|Overall Study|Non-compliance with Study Drug|0
5479792|NCT01849562|18945116|P2|Overall Study|Non-compliance with Study Drug|0
5479793|NCT01849562|18945117|P1|Overall Study|Non-compliance with Study Drug|1
5479794|NCT01849562|18945115|P3|Overall Study|Lost to Follow-up|0
5479795|NCT01849562|18945116|P2|Overall Study|Lost to Follow-up|0
5479796|NCT01849562|18945117|P1|Overall Study|Lost to Follow-up|1
5479797|NCT01849497|18945130|P2|Overall Study|Lost to Follow-up|1
5479798|NCT01849497|18945131|P1|Overall Study|Lost to Follow-up|0
5479799|NCT01849497|18945130|P2|Overall Study|Sponsor Decision|1
5479800|NCT01849497|18945131|P1|Overall Study|Sponsor Decision|0
5479801|NCT01849497|18945130|P2|Overall Study|Withdrawal by Subject|2
5479802|NCT01849497|18945131|P1|Overall Study|Withdrawal by Subject|1
5479803|NCT01849458|18945139|P1|Overall Study|Lost to Follow-up|4
5479804|NCT01849289|18945178|P2|Overall Study|Unclassified|18
5479805|NCT01849289|18945179|P1|Overall Study|Unclassified|25
5479806|NCT01849289|18945178|P2|Overall Study|Withdrawal criteria|0
5479807|NCT01849289|18945179|P1|Overall Study|Withdrawal criteria|1
5479808|NCT01849289|18945178|P2|Overall Study|Protocol Violation|3
5479809|NCT01849289|18945179|P1|Overall Study|Protocol Violation|3
5479810|NCT01849289|18945178|P2|Overall Study|Adverse Event|3
5479811|NCT01849289|18945179|P1|Overall Study|Adverse Event|3
5479904|NCT01848457|18945524|P2|Overall Study|Death|0
5479812|NCT01849276|18945195|P1|Followed for Survival for 5 Years|Early termination of the study|1
5479813|NCT01849276|18945195|P1|Followed for Survival for 5 Years|Death|1
5479814|NCT01849055|18945277|P6|Overall Study|Withdrawal by Subject|0
5479815|NCT01849055|18945278|P5|Overall Study|Withdrawal by Subject|0
5479816|NCT01849055|18945279|P4|Overall Study|Withdrawal by Subject|0
5479817|NCT01849055|18945280|P3|Overall Study|Withdrawal by Subject|1
5479818|NCT01849055|18945281|P2|Overall Study|Withdrawal by Subject|0
5479819|NCT01849055|18945282|P1|Overall Study|Withdrawal by Subject|0
5479820|NCT01848990|18945317|P3|Overall Study|Other|2
5479821|NCT01848990|18945318|P2|Overall Study|Other|4
5479822|NCT01848990|18945319|P1|Overall Study|Other|1
5479823|NCT01848990|18945317|P3|Overall Study|Death|1
5479824|NCT01848990|18945318|P2|Overall Study|Death|0
5479825|NCT01848990|18945319|P1|Overall Study|Death|1
5479826|NCT01848990|18945317|P3|Overall Study|Non Compliance|0
5479827|NCT01848990|18945318|P2|Overall Study|Non Compliance|0
5479828|NCT01848990|18945319|P1|Overall Study|Non Compliance|1
5479829|NCT01848990|18945317|P3|Overall Study|Physician Decision|0
5479830|NCT01848990|18945318|P2|Overall Study|Physician Decision|1
5479831|NCT01848990|18945319|P1|Overall Study|Physician Decision|1
5479832|NCT01848990|18945317|P3|Overall Study|Withdrawal by Subject|11
5479833|NCT01848990|18945318|P2|Overall Study|Withdrawal by Subject|10
5479834|NCT01848990|18945319|P1|Overall Study|Withdrawal by Subject|29
5479835|NCT01848990|18945317|P3|Overall Study|Protocol Violation|0
5479836|NCT01848990|18945318|P2|Overall Study|Protocol Violation|1
5479837|NCT01848990|18945319|P1|Overall Study|Protocol Violation|1
5479838|NCT01848990|18945317|P3|Overall Study|Lost to Follow-up|2
5479839|NCT01848990|18945318|P2|Overall Study|Lost to Follow-up|2
5479840|NCT01848990|18945319|P1|Overall Study|Lost to Follow-up|6
5479841|NCT01848990|18945317|P3|Overall Study|Adverse Event|0
5479842|NCT01848990|18945318|P2|Overall Study|Adverse Event|2
5479843|NCT01848990|18945319|P1|Overall Study|Adverse Event|6
5479844|NCT01848938|18945389|P2|Overall Study|Lost to Follow-up|1
5479845|NCT01848938|18945390|P1|Overall Study|Lost to Follow-up|1
5479846|NCT01848834|18945439|P5|Overall Study|Not Treated|0
5479847|NCT01848834|18945440|P4|Overall Study|Not Treated|0
5479848|NCT01848834|18945441|P3|Overall Study|Not Treated|0
5479849|NCT01848834|18945442|P2|Overall Study|Not Treated|1
5479850|NCT01848834|18945443|P1|Overall Study|Not Treated|0
5479851|NCT01848834|18945439|P5|Overall Study|Withdrawal by Subject|7
5479852|NCT01848834|18945440|P4|Overall Study|Withdrawal by Subject|0
5479853|NCT01848834|18945441|P3|Overall Study|Withdrawal by Subject|3
5479854|NCT01848834|18945442|P2|Overall Study|Withdrawal by Subject|2
5479855|NCT01848834|18945443|P1|Overall Study|Withdrawal by Subject|0
5479856|NCT01848834|18945439|P5|Overall Study|Protocol Violation|2
5479857|NCT01848834|18945440|P4|Overall Study|Protocol Violation|0
5479858|NCT01848834|18945441|P3|Overall Study|Protocol Violation|1
5479859|NCT01848834|18945442|P2|Overall Study|Protocol Violation|0
5479860|NCT01848834|18945443|P1|Overall Study|Protocol Violation|0
5479861|NCT01848834|18945439|P5|Overall Study|Progressive Disease|78
5479862|NCT01848834|18945440|P4|Overall Study|Progressive Disease|36
5479863|NCT01848834|18945441|P3|Overall Study|Progressive Disease|21
5479864|NCT01848834|18945442|P2|Overall Study|Progressive Disease|41
5479865|NCT01848834|18945443|P1|Overall Study|Progressive Disease|27
5479866|NCT01848834|18945439|P5|Overall Study|Death|3
5479867|NCT01848834|18945440|P4|Overall Study|Death|0
5479868|NCT01848834|18945441|P3|Overall Study|Death|0
5479869|NCT01848834|18945442|P2|Overall Study|Death|1
5479870|NCT01848834|18945443|P1|Overall Study|Death|0
5479871|NCT01848834|18945439|P5|Overall Study|Complete Response|0
5479872|NCT01848834|18945440|P4|Overall Study|Complete Response|0
5479873|NCT01848834|18945441|P3|Overall Study|Complete Response|0
5479874|NCT01848834|18945442|P2|Overall Study|Complete Response|1
5479875|NCT01848834|18945443|P1|Overall Study|Complete Response|0
5479876|NCT01848834|18945439|P5|Overall Study|Adverse Event|15
5479877|NCT01848834|18945440|P4|Overall Study|Adverse Event|1
5479878|NCT01848834|18945441|P3|Overall Study|Adverse Event|6
5479879|NCT01848834|18945442|P2|Overall Study|Adverse Event|8
5479880|NCT01848834|18945443|P1|Overall Study|Adverse Event|3
5479881|NCT01848834|18945439|P5|Overall Study|Physician Decision|1
5479882|NCT01848834|18945440|P4|Overall Study|Physician Decision|0
5479883|NCT01848834|18945441|P3|Overall Study|Physician Decision|0
5479884|NCT01848834|18945442|P2|Overall Study|Physician Decision|0
5479885|NCT01848834|18945443|P1|Overall Study|Physician Decision|0
5479886|NCT01848834|18945439|P5|Overall Study|Ongoing in Study|26
5479887|NCT01848834|18945440|P4|Overall Study|Ongoing in Study|0
5479888|NCT01848834|18945441|P3|Overall Study|Ongoing in Study|1
5479889|NCT01848834|18945442|P2|Overall Study|Ongoing in Study|6
5479890|NCT01848834|18945443|P1|Overall Study|Ongoing in Study|0
5479891|NCT01848756|18945491|P1|Overall Study|Enrolled in Error|1
5479892|NCT01848756|18945491|P1|Overall Study|Withdrawal by Subject|1
5479893|NCT01848756|18945491|P1|Overall Study|Adverse Event|1
5479894|NCT01848483|18945503|P2|Overall Study|Incarceration|2
5479895|NCT01848483|18945504|P1|Overall Study|Incarceration|2
5479896|NCT01848483|18945503|P2|Overall Study|Withdrawal by Subject|0
5479897|NCT01848483|18945504|P1|Overall Study|Withdrawal by Subject|1
5479898|NCT01848483|18945503|P2|Overall Study|Lost to Follow-up|8
5479899|NCT01848483|18945504|P1|Overall Study|Lost to Follow-up|6
5479900|NCT01848483|18945503|P2|Overall Study|Death|1
5479901|NCT01848483|18945504|P1|Overall Study|Death|2
5479902|NCT01848457|18945522|P4|Overall Study|Death|0
5479903|NCT01848457|18945523|P3|Overall Study|Death|0
5479905|NCT01848457|18945525|P1|Overall Study|Death|1
5479906|NCT01848353|18945557|P4|Phase 3|Withdrawal by Subject|0
5479907|NCT01848353|18945558|P3|Phase 3|Withdrawal by Subject|0
5479908|NCT01848353|18945559|P2|Phase 3|Withdrawal by Subject|1
5479909|NCT01848353|18945560|P1|Phase 3|Withdrawal by Subject|1
5479910|NCT01848353|18945557|P4|Phase 2|Withdrawal by Subject|0
5479911|NCT01848353|18945558|P3|Phase 2|Withdrawal by Subject|0
5479912|NCT01848353|18945559|P2|Phase 2|Withdrawal by Subject|2
5479913|NCT01848353|18945560|P1|Phase 2|Withdrawal by Subject|3
5479914|NCT01848353|18945557|P4|Phase 1|Withdrawal by Subject|0
5479915|NCT01848353|18945558|P3|Phase 1|Withdrawal by Subject|0
5479916|NCT01848353|18945559|P2|Phase 1|Withdrawal by Subject|1
5479917|NCT01848353|18945560|P1|Phase 1|Withdrawal by Subject|3
5479918|NCT01848288|18945616|P1|Overall Study|Withdrawal by Subject|1
5479919|NCT01848288|18945616|P1|Overall Study|Protocol Violation|1
5479920|NCT01848288|18945616|P1|Overall Study|Death|1
5479921|NCT01848210|18945627|P2|Overall Study|Administrative|0
5479922|NCT01848210|18945628|P1|Overall Study|Administrative|1
5479923|NCT01848210|18945627|P2|Overall Study|Chronic Venous Insufficiency Course|2
5479924|NCT01848210|18945628|P1|Overall Study|Chronic Venous Insufficiency Course|1
5479925|NCT01848210|18945627|P2|Overall Study|Hepatic Function Alteration|0
5479926|NCT01848210|18945628|P1|Overall Study|Hepatic Function Alteration|4
5479927|NCT01848210|18945627|P2|Overall Study|Hypesensitivity|0
5479928|NCT01848210|18945628|P1|Overall Study|Hypesensitivity|1
5479929|NCT01848210|18945627|P2|Overall Study|Discontinuation Criterion|7
5479930|NCT01848210|18945628|P1|Overall Study|Discontinuation Criterion|5
5479931|NCT01848210|18945627|P2|Overall Study|Adverse Event|9
5479932|NCT01848210|18945628|P1|Overall Study|Adverse Event|7
5479933|NCT01848210|18945627|P2|Overall Study|Impedition Condition|9
5479934|NCT01848210|18945628|P1|Overall Study|Impedition Condition|5
5479935|NCT01848210|18945627|P2|Overall Study|Use of Forbidden Drugs|10
5479936|NCT01848210|18945628|P1|Overall Study|Use of Forbidden Drugs|9
5479937|NCT01848210|18945627|P2|Overall Study|Protocol Violation|5
5479938|NCT01848210|18945628|P1|Overall Study|Protocol Violation|3
5479939|NCT01848210|18945627|P2|Overall Study|Lost to Follow-up|12
5479940|NCT01848210|18945628|P1|Overall Study|Lost to Follow-up|24
5479941|NCT01848210|18945627|P2|Overall Study|Informed Consent Form Withdrawal|24
5479942|NCT01848210|18945628|P1|Overall Study|Informed Consent Form Withdrawal|28
5479943|NCT01848145|18945677|P1|Subsequent Infusions: Weeks 3-8|Death|1
5479944|NCT01848145|18945677|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
5479945|NCT01848145|18945677|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
5479946|NCT01848145|18945677|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
5479947|NCT01848145|18945677|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
5479948|NCT01848145|18945677|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
5479949|NCT01848145|18945677|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
5479950|NCT01847885|18945717|P3|Randomization|Screen Failure|0
5479951|NCT01847885|18945718|P2|Randomization|Screen Failure|3
5479952|NCT01847885|18945719|P1|Randomization|Screen Failure|0
5479953|NCT01847885|18945717|P3|Randomization|Withdrawal by Subject|2
5479954|NCT01847885|18945718|P2|Randomization|Withdrawal by Subject|0
5479955|NCT01847885|18945719|P1|Randomization|Withdrawal by Subject|0
5479956|NCT01847885|18945717|P3|Randomization|Protocol Violation|0
5479957|NCT01847885|18945718|P2|Randomization|Protocol Violation|1
5479958|NCT01847885|18945719|P1|Randomization|Protocol Violation|0
5479959|NCT01847885|18945717|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
5479960|NCT01847885|18945718|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
5479961|NCT01847885|18945719|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
5479962|NCT01847885|18945717|P3|Initial Enrollment (Consented)|Screen failure|0
5479963|NCT01847885|18945718|P2|Initial Enrollment (Consented)|Screen failure|0
5479964|NCT01847885|18945719|P1|Initial Enrollment (Consented)|Screen failure|39
5479965|NCT01847885|18945717|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
5479966|NCT01847885|18945718|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
5479967|NCT01847885|18945719|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
5479968|NCT01847885|18945717|P3|Initial Enrollment (Consented)|Protocol Violation|0
5479969|NCT01847885|18945718|P2|Initial Enrollment (Consented)|Protocol Violation|0
5479970|NCT01847885|18945719|P1|Initial Enrollment (Consented)|Protocol Violation|1
5479971|NCT01847443|18945883|P4|Washout Period Before Study Period 4|Positive alcohol test|0
5479972|NCT01847443|18945884|P3|Washout Period Before Study Period 4|Positive alcohol test|0
5479973|NCT01847443|18945885|P2|Washout Period Before Study Period 4|Positive alcohol test|0
5479974|NCT01847443|18945886|P1|Washout Period Before Study Period 4|Positive alcohol test|1
5479975|NCT01847443|18945883|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
5479976|NCT01847443|18945884|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
5479977|NCT01847443|18945885|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
5479978|NCT01847443|18945886|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
5479979|NCT01847443|18945883|P4|Washout Period Before Study Period 3|Other reason|0
5479980|NCT01847443|18945884|P3|Washout Period Before Study Period 3|Other reason|0
5479981|NCT01847443|18945885|P2|Washout Period Before Study Period 3|Other reason|0
5479982|NCT01847443|18945886|P1|Washout Period Before Study Period 3|Other reason|1
5479983|NCT01847443|18945883|P4|Washout Period Before Study Period 2|Other reason|0
5479984|NCT01847443|18945884|P3|Washout Period Before Study Period 2|Other reason|0
5479985|NCT01847443|18945885|P2|Washout Period Before Study Period 2|Other reason|0
5479986|NCT01847443|18945886|P1|Washout Period Before Study Period 2|Other reason|1
5479987|NCT01847443|18945883|P4|Washout Period Before Study Period 2|Adverse Event|0
5479988|NCT01847443|18945884|P3|Washout Period Before Study Period 2|Adverse Event|0
5479989|NCT01847443|18945885|P2|Washout Period Before Study Period 2|Adverse Event|1
5479990|NCT01847443|18945886|P1|Washout Period Before Study Period 2|Adverse Event|1
5479991|NCT01847443|18945883|P4|Study Period 1|Withdrawal by Subject|0
5479992|NCT01847443|18945884|P3|Study Period 1|Withdrawal by Subject|0
5479993|NCT01847443|18945885|P2|Study Period 1|Withdrawal by Subject|1
5479994|NCT01847443|18945886|P1|Study Period 1|Withdrawal by Subject|0
5479995|NCT01847313|18945929|P2|Overall Study|Withdrawal by Subject|1
5479996|NCT01847313|18945930|P1|Overall Study|Withdrawal by Subject|0
5479997|NCT01847313|18945929|P2|Overall Study|Death|1
5479998|NCT01847313|18945930|P1|Overall Study|Death|0
5479999|NCT01847274|18945946|P4|Overall Study|Non Compliance|0
5480000|NCT01847274|18945947|P3|Overall Study|Non Compliance|2
5480001|NCT01847274|18945948|P2|Overall Study|Non Compliance|0
5480002|NCT01847274|18945949|P1|Overall Study|Non Compliance|0
5480003|NCT01847274|18945946|P4|Overall Study|Other Reasons|3
5480004|NCT01847274|18945947|P3|Overall Study|Other Reasons|11
5480005|NCT01847274|18945948|P2|Overall Study|Other Reasons|1
5480006|NCT01847274|18945949|P1|Overall Study|Other Reasons|3
5480007|NCT01847274|18945946|P4|Overall Study|Treatment Associated Risk|0
5480008|NCT01847274|18945947|P3|Overall Study|Treatment Associated Risk|2
5480009|NCT01847274|18945948|P2|Overall Study|Treatment Associated Risk|2
5480010|NCT01847274|18945949|P1|Overall Study|Treatment Associated Risk|0
5480011|NCT01847274|18945946|P4|Overall Study|Disease Progression|98
5480012|NCT01847274|18945947|P3|Overall Study|Disease Progression|129
5480013|NCT01847274|18945948|P2|Overall Study|Disease Progression|49
5480014|NCT01847274|18945949|P1|Overall Study|Disease Progression|63
5480015|NCT01847274|18945946|P4|Overall Study|Withdrawal by Subject|1
5480016|NCT01847274|18945947|P3|Overall Study|Withdrawal by Subject|11
5480017|NCT01847274|18945948|P2|Overall Study|Withdrawal by Subject|8
5480018|NCT01847274|18945949|P1|Overall Study|Withdrawal by Subject|8
5480019|NCT01847274|18945946|P4|Overall Study|Adverse Event|2
5480020|NCT01847274|18945947|P3|Overall Study|Adverse Event|33
5480021|NCT01847274|18945948|P2|Overall Study|Adverse Event|1
5480022|NCT01847274|18945949|P1|Overall Study|Adverse Event|17
5480023|NCT01847209|18946003|P1|Overall Study|No lung nodule found on intraop CT scan|1
5480024|NCT01847209|18946003|P1|Overall Study|Withdrawal by Subject|1
5480025|NCT01847092|18946026|P2|Overall Study|Protocol Violation|2
5480026|NCT01847092|18946027|P1|Overall Study|Protocol Violation|0
5480027|NCT01847092|18946026|P2|Overall Study|Physician Decision|1
5480028|NCT01847092|18946027|P1|Overall Study|Physician Decision|1
5480029|NCT01847092|18946026|P2|Overall Study|Protocol Specified|0
5480030|NCT01847092|18946027|P1|Overall Study|Protocol Specified|8
5480031|NCT01847092|18946026|P2|Overall Study|Withdrawal by Subject|5
5480032|NCT01847092|18946027|P1|Overall Study|Withdrawal by Subject|5
5480033|NCT01847092|18946026|P2|Overall Study|Adverse Event|3
5480034|NCT01847092|18946027|P1|Overall Study|Adverse Event|12
5480035|NCT01846741|18946081|P1|Baseline Visit|Subject did not meet entry criteria|2
5480036|NCT01846624|18946237|P1|Overall Study|Died during induction, no midostaurin|1
5480037|NCT01846611|18946247|P2|Overall Study|Other|18
5480038|NCT01846611|18946248|P1|Overall Study|Other|19
5480039|NCT01846611|18946247|P2|Overall Study|Withdrawal by Subject|19
5480040|NCT01846611|18946248|P1|Overall Study|Withdrawal by Subject|15
5480041|NCT01846611|18946247|P2|Overall Study|Lost to Follow-up|6
5480042|NCT01846611|18946248|P1|Overall Study|Lost to Follow-up|4
5480043|NCT01846507|18946258|P1|Overall Study|Missing data|2
5480044|NCT01846507|18946258|P1|Overall Study|Protocol Violation|1
5480045|NCT01846507|18946258|P1|Overall Study|Lost to Follow-up|4
5480046|NCT01846442|18946356|P4|Overall Study|Left the city/Lost medication|1
5480047|NCT01846442|18946357|P3|Overall Study|Left the city/Lost medication|1
5480048|NCT01846442|18946358|P2|Overall Study|Left the city/Lost medication|0
5480049|NCT01846442|18946359|P1|Overall Study|Left the city/Lost medication|1
5480050|NCT01846442|18946356|P4|Overall Study|Withdrawal by Subject|1
5480051|NCT01846442|18946357|P3|Overall Study|Withdrawal by Subject|0
5480052|NCT01846442|18946358|P2|Overall Study|Withdrawal by Subject|2
5480053|NCT01846442|18946359|P1|Overall Study|Withdrawal by Subject|3
5480054|NCT01846442|18946356|P4|Overall Study|Lost to Follow-up|0
5480055|NCT01846442|18946357|P3|Overall Study|Lost to Follow-up|1
5480056|NCT01846442|18946358|P2|Overall Study|Lost to Follow-up|0
5480057|NCT01846442|18946359|P1|Overall Study|Lost to Follow-up|0
5480058|NCT01846442|18946356|P4|Overall Study|Adverse Event|1
5480059|NCT01846442|18946357|P3|Overall Study|Adverse Event|2
5480060|NCT01846442|18946358|P2|Overall Study|Adverse Event|4
5480061|NCT01846442|18946359|P1|Overall Study|Adverse Event|2
5480062|NCT01846416|18946400|P3|Survival Follow-up|Other|1
5480063|NCT01846416|18946401|P2|Survival Follow-up|Other|1
5480064|NCT01846416|18946402|P1|Survival Follow-up|Other|3
5480065|NCT01846416|18946400|P3|Survival Follow-up|Study Terminated by Sponsor|0
5480066|NCT01846416|18946401|P2|Survival Follow-up|Study Terminated by Sponsor|8
5480067|NCT01846416|18946402|P1|Survival Follow-up|Study Terminated by Sponsor|2
5480068|NCT01846416|18946400|P3|Survival Follow-up|Withdrawal by Subject|0
5480069|NCT01846416|18946401|P2|Survival Follow-up|Withdrawal by Subject|7
5480070|NCT01846416|18946402|P1|Survival Follow-up|Withdrawal by Subject|2
5480071|NCT01846416|18946400|P3|Survival Follow-up|Lost to Follow-up|2
5480072|NCT01846416|18946401|P2|Survival Follow-up|Lost to Follow-up|2
5480073|NCT01846416|18946402|P1|Survival Follow-up|Lost to Follow-up|0
5480074|NCT01846416|18946400|P3|Survival Follow-up|Death|9
5480075|NCT01846416|18946401|P2|Survival Follow-up|Death|62
5480076|NCT01846416|18946402|P1|Survival Follow-up|Death|21
5480077|NCT01846416|18946400|P3|Treatment Phase|Progressive Disease|9
5480078|NCT01846416|18946401|P2|Treatment Phase|Progressive Disease|63
5480079|NCT01846416|18946402|P1|Treatment Phase|Progressive Disease|21
5480080|NCT01846416|18946400|P3|Treatment Phase|Study Terminated by Sponsor|0
5480081|NCT01846416|18946401|P2|Treatment Phase|Study Terminated by Sponsor|4
5480082|NCT01846416|18946402|P1|Treatment Phase|Study Terminated by Sponsor|1
5480083|NCT01846416|18946400|P3|Treatment Phase|Non-compliance|0
5480084|NCT01846416|18946401|P2|Treatment Phase|Non-compliance|2
5480085|NCT01846416|18946402|P1|Treatment Phase|Non-compliance|0
5480086|NCT01846416|18946400|P3|Treatment Phase|Adverse Event|0
5480087|NCT01846416|18946401|P2|Treatment Phase|Adverse Event|4
5480088|NCT01846416|18946402|P1|Treatment Phase|Adverse Event|3
5480089|NCT01846416|18946400|P3|Treatment Phase|Physician Decision|0
5480090|NCT01846416|18946401|P2|Treatment Phase|Physician Decision|2
5480091|NCT01846416|18946402|P1|Treatment Phase|Physician Decision|1
5480092|NCT01846416|18946400|P3|Treatment Phase|Other|1
5480093|NCT01846416|18946401|P2|Treatment Phase|Other|5
5480094|NCT01846416|18946402|P1|Treatment Phase|Other|1
5480095|NCT01846416|18946400|P3|Treatment Phase|Withdrawal by Subject|2
5480096|NCT01846416|18946401|P2|Treatment Phase|Withdrawal by Subject|4
5480097|NCT01846416|18946402|P1|Treatment Phase|Withdrawal by Subject|2
5480098|NCT01846416|18946400|P3|Treatment Phase|Death|1
5480099|NCT01846416|18946401|P2|Treatment Phase|Death|9
5480100|NCT01846416|18946402|P1|Treatment Phase|Death|2
5480101|NCT01846299|18946447|P2|Overall Study|Adverse Event|0
5480102|NCT01846299|18946448|P1|Overall Study|Adverse Event|2
5480103|NCT01846299|18946447|P2|Overall Study|Withdrawal by Subject|6
5480104|NCT01846299|18946448|P1|Overall Study|Withdrawal by Subject|1
5480105|NCT01846299|18946447|P2|Overall Study|Lost to Follow-up|0
5480106|NCT01846299|18946448|P1|Overall Study|Lost to Follow-up|3
5480107|NCT01846299|18946447|P2|Overall Study|Death|2
5480108|NCT01846299|18946448|P1|Overall Study|Death|1
5480109|NCT01846299|18946447|P2|Overall Study|Protocol deviation|0
5480110|NCT01846299|18946448|P1|Overall Study|Protocol deviation|1
5480111|NCT01846299|18946447|P2|Overall Study|Physician Decision|2
5480112|NCT01846299|18946448|P1|Overall Study|Physician Decision|4
5480113|NCT01846273|18946487|P3|Overall Study|Physician Decision|0
5480114|NCT01846273|18946488|P2|Overall Study|Physician Decision|2
5480115|NCT01846273|18946489|P1|Overall Study|Physician Decision|1
5480116|NCT01846273|18946487|P3|Overall Study|Protocol Deviation|0
5480117|NCT01846273|18946488|P2|Overall Study|Protocol Deviation|3
5480118|NCT01846273|18946489|P1|Overall Study|Protocol Deviation|2
5480119|NCT01846273|18946487|P3|Overall Study|Disease Progression|0
5480120|NCT01846273|18946488|P2|Overall Study|Disease Progression|4
5480121|NCT01846273|18946489|P1|Overall Study|Disease Progression|0
5480122|NCT01846273|18946487|P3|Overall Study|Death|0
5480123|NCT01846273|18946488|P2|Overall Study|Death|1
5480124|NCT01846273|18946489|P1|Overall Study|Death|2
5480125|NCT01846273|18946487|P3|Overall Study|Administrative problems|0
5480126|NCT01846273|18946488|P2|Overall Study|Administrative problems|0
5480127|NCT01846273|18946489|P1|Overall Study|Administrative problems|1
5480128|NCT01846273|18946487|P3|Overall Study|Lost to Follow-up|0
5480129|NCT01846273|18946488|P2|Overall Study|Lost to Follow-up|1
5480130|NCT01846273|18946489|P1|Overall Study|Lost to Follow-up|2
5480131|NCT01846273|18946487|P3|Overall Study|Subject withdrew consent|0
5480132|NCT01846273|18946488|P2|Overall Study|Subject withdrew consent|8
5480133|NCT01846273|18946489|P1|Overall Study|Subject withdrew consent|5
5480134|NCT01846273|18946487|P3|Overall Study|Adverse Event|0
5480135|NCT01846273|18946488|P2|Overall Study|Adverse Event|7
5480136|NCT01846273|18946489|P1|Overall Study|Adverse Event|9
5480137|NCT01846221|18946545|P2|Overall Study|Age Exclusion|0
5480138|NCT01846221|18946546|P1|Overall Study|Age Exclusion|1
5480139|NCT01846221|18946545|P2|Overall Study|Catheter Failure|0
5480140|NCT01846221|18946546|P1|Overall Study|Catheter Failure|2
5480141|NCT01846208|18946563|P3|Overall Study|Refused SU OFC|1
5480142|NCT01846208|18946564|P2|Overall Study|Refused SU OFC|0
5480143|NCT01846208|18946565|P1|Overall Study|Refused SU OFC|0
5480144|NCT01846208|18946563|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
5480145|NCT01846208|18946564|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
5480146|NCT01846208|18946565|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
5480147|NCT01846208|18946563|P3|Overall Study|Non-compliance|0
5480148|NCT01846208|18946564|P2|Overall Study|Non-compliance|1
5480149|NCT01846208|18946565|P1|Overall Study|Non-compliance|1
5480150|NCT01846208|18946563|P3|Overall Study|Withdrawal by Subject|0
5480151|NCT01846208|18946564|P2|Overall Study|Withdrawal by Subject|0
5480152|NCT01846208|18946565|P1|Overall Study|Withdrawal by Subject|5
5480153|NCT01846208|18946563|P3|Overall Study|Dosing Symptoms|6
5480154|NCT01846208|18946564|P2|Overall Study|Dosing Symptoms|2
5480155|NCT01846208|18946565|P1|Overall Study|Dosing Symptoms|1
5480156|NCT01846208|18946563|P3|Overall Study|Withdrew prior to treatment|1
5480157|NCT01846208|18946564|P2|Overall Study|Withdrew prior to treatment|1
5480158|NCT01846208|18946565|P1|Overall Study|Withdrew prior to treatment|1
5480159|NCT01846104|18946585|P1|Overall Study|Withdrawal by Subject|1
5480160|NCT01846039|18946591|P1|Overall Study|Subject Withdrew Consent|1
5480161|NCT01846039|18946591|P1|Overall Study|Protocol Violation|1
5480162|NCT01845974|18946603|P2|Overall Study|screen failure|0
5480163|NCT01845974|18946604|P1|Overall Study|screen failure|1
5480164|NCT01845831|18946612|P5|Inpatient Phase|Withdrawal by Subject|0
5480165|NCT01845831|18946613|P4|Inpatient Phase|Withdrawal by Subject|0
5480166|NCT01845831|18946614|P3|Inpatient Phase|Withdrawal by Subject|0
5480167|NCT01845831|18946615|P2|Inpatient Phase|Withdrawal by Subject|1
5480168|NCT01845831|18946616|P1|Inpatient Phase|Withdrawal by Subject|1
5480169|NCT01845818|18946645|P2|Overall Study|No Follow-Up Data Available|1
5480170|NCT01845818|18946646|P1|Overall Study|No Follow-Up Data Available|4
5480171|NCT01845818|18946645|P2|Overall Study|Did Not Receive Any Dose of Adalimumab|0
5480172|NCT01845818|18946646|P1|Overall Study|Did Not Receive Any Dose of Adalimumab|5
5480173|NCT01845818|18946645|P2|Overall Study|Other|8
5480174|NCT01845818|18946646|P1|Overall Study|Other|25
5480175|NCT01845818|18946645|P2|Overall Study|Serious Adverse Event|1
5480176|NCT01845818|18946646|P1|Overall Study|Serious Adverse Event|1
5480177|NCT01845818|18946645|P2|Overall Study|Administrative Reasons|1
5480178|NCT01845818|18946646|P1|Overall Study|Administrative Reasons|3
5480179|NCT01845818|18946645|P2|Overall Study|Lost to Follow-up|5
5480180|NCT01845818|18946646|P1|Overall Study|Lost to Follow-up|7
5480181|NCT01845818|18946645|P2|Overall Study|Withdrawal by Subject|1
5480182|NCT01845818|18946646|P1|Overall Study|Withdrawal by Subject|0
5480183|NCT01845077|18946730|P6|Washout Period|Protocol Violation|0
5480184|NCT01845077|18946731|P5|Washout Period|Protocol Violation|1
5480185|NCT01845077|18946732|P4|Washout Period|Protocol Violation|1
5480186|NCT01845077|18946733|P3|Washout Period|Protocol Violation|0
5480187|NCT01845077|18946734|P2|Washout Period|Protocol Violation|0
5480188|NCT01845077|18946735|P1|Washout Period|Protocol Violation|0
5480189|NCT01845077|18946730|P6|Washout Period|elevated lab values (not clinic. sign.)|0
5480190|NCT01845077|18946731|P5|Washout Period|elevated lab values (not clinic. sign.)|0
5480191|NCT01845077|18946732|P4|Washout Period|elevated lab values (not clinic. sign.)|0
5480192|NCT01845077|18946733|P3|Washout Period|elevated lab values (not clinic. sign.)|1
5480193|NCT01845077|18946734|P2|Washout Period|elevated lab values (not clinic. sign.)|0
5480194|NCT01845077|18946735|P1|Washout Period|elevated lab values (not clinic. sign.)|0
5480195|NCT01845077|18946730|P6|Washout Period|Adverse Event|0
5480196|NCT01845077|18946731|P5|Washout Period|Adverse Event|0
5480197|NCT01845077|18946732|P4|Washout Period|Adverse Event|0
5480198|NCT01845077|18946733|P3|Washout Period|Adverse Event|0
5480199|NCT01845077|18946734|P2|Washout Period|Adverse Event|0
5480200|NCT01845077|18946735|P1|Washout Period|Adverse Event|1
5480201|NCT01845077|18946730|P6|Washout Period|Lost to Follow-up|1
5480202|NCT01845077|18946731|P5|Washout Period|Lost to Follow-up|0
5480203|NCT01845077|18946732|P4|Washout Period|Lost to Follow-up|1
5480204|NCT01845077|18946733|P3|Washout Period|Lost to Follow-up|0
5480205|NCT01845077|18946734|P2|Washout Period|Lost to Follow-up|1
5480206|NCT01845077|18946735|P1|Washout Period|Lost to Follow-up|0
5480207|NCT01845025|18946781|P2|Overall Study|Missing|1
5480208|NCT01845025|18946782|P1|Overall Study|Missing|1
5480209|NCT01845025|18946781|P2|Overall Study|Protocol deviation|6
5480210|NCT01845025|18946782|P1|Overall Study|Protocol deviation|3
5480211|NCT01845025|18946781|P2|Overall Study|Death|0
5480212|NCT01845025|18946782|P1|Overall Study|Death|2
5480213|NCT01845025|18946781|P2|Overall Study|Administrative problems|8
5480214|NCT01845025|18946782|P1|Overall Study|Administrative problems|8
5480215|NCT01845025|18946781|P2|Overall Study|Lost to Follow-up|13
5480216|NCT01845025|18946782|P1|Overall Study|Lost to Follow-up|13
5480217|NCT01845025|18946781|P2|Overall Study|Withdrawal by Subject|44
5480218|NCT01845025|18946782|P1|Overall Study|Withdrawal by Subject|48
5480219|NCT01845025|18946781|P2|Overall Study|Unsatisfactory therapeutic effect|2
5480220|NCT01845025|18946782|P1|Overall Study|Unsatisfactory therapeutic effect|4
5480221|NCT01845025|18946781|P2|Overall Study|Adverse Event|3
5480222|NCT01845025|18946782|P1|Overall Study|Adverse Event|6
5480223|NCT01844986|18946806|P2|Overall Study|Death|26
5480224|NCT01844986|18946807|P1|Overall Study|Death|55
5480225|NCT01844986|18946806|P2|Overall Study|Withdrawal by Subject|14
5480226|NCT01844986|18946807|P1|Overall Study|Withdrawal by Subject|21
5480227|NCT01844986|18946806|P2|Overall Study|Severe non-compliance to protocol|0
5480228|NCT01844986|18946807|P1|Overall Study|Severe non-compliance to protocol|1
5480229|NCT01844895|18946829|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
5480230|NCT01844895|18946829|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
5480231|NCT01844895|18946829|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
5480232|NCT01844895|18946829|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
5480233|NCT01844895|18946829|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
5480234|NCT01844895|18946829|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
5480235|NCT01844895|18946829|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
5480236|NCT01844856|18946847|P2|Overall Study|Randomized but was a Screen Failure|1
5480237|NCT01844856|18946848|P1|Overall Study|Randomized but was a Screen Failure|0
5480238|NCT01844856|18946847|P2|Overall Study|Inadvertently Not Scheduled|0
5480239|NCT01844856|18946848|P1|Overall Study|Inadvertently Not Scheduled|1
5480240|NCT01844856|18946847|P2|Overall Study|Enterococcus Resistant|1
5480241|NCT01844856|18946848|P1|Overall Study|Enterococcus Resistant|0
5480242|NCT01844856|18946847|P2|Overall Study|Noncompliance|3
5480243|NCT01844856|18946848|P1|Overall Study|Noncompliance|2
5480244|NCT01844856|18946847|P2|Overall Study|Withdrawal by Subject|2
5480245|NCT01844856|18946848|P1|Overall Study|Withdrawal by Subject|3
5480246|NCT01844856|18946847|P2|Overall Study|Adverse Event|6
5480247|NCT01844856|18946848|P1|Overall Study|Adverse Event|3
5480248|NCT01844856|18946847|P2|Overall Study|Lost to Follow-up|3
5480249|NCT01844856|18946848|P1|Overall Study|Lost to Follow-up|15
5480250|NCT01844830|18946860|P2|Overall Study|Withdrawal by Subject|0
5480251|NCT01844830|18946861|P1|Overall Study|Withdrawal by Subject|1
5480252|NCT01844817|18946891|P2|Treatment|Other|3
5480253|NCT01844817|18946892|P1|Treatment|Other|0
5480254|NCT01844817|18946891|P2|Treatment|Lost to Follow-up|1
5480255|NCT01844817|18946892|P1|Treatment|Lost to Follow-up|0
5480256|NCT01844817|18946891|P2|Treatment|Death|8
5480257|NCT01844817|18946892|P1|Treatment|Death|10
5480258|NCT01844817|18946891|P2|Treatment|Withdrawal by Subject|6
5480259|NCT01844817|18946892|P1|Treatment|Withdrawal by Subject|10
5480260|NCT01844817|18946891|P2|Treatment|Adverse Event|9
5480261|NCT01844817|18946892|P1|Treatment|Adverse Event|17
5480262|NCT01844817|18946891|P2|Treatment|Progressive Disease|36
5480263|NCT01844817|18946892|P1|Treatment|Progressive Disease|27
5480264|NCT01844817|18946891|P2|Enrolled and Randomized|Withdrawal by Subject|3
5480265|NCT01844817|18946892|P1|Enrolled and Randomized|Withdrawal by Subject|2
5480266|NCT01844778|18946905|P3|Overall Study|Adverse Event|2
5480267|NCT01844778|18946906|P2|Overall Study|Adverse Event|2
5480268|NCT01844778|18946907|P1|Overall Study|Adverse Event|0
5480269|NCT01844778|18946905|P3|Overall Study|Withdrawal by Subject|0
5480270|NCT01844778|18946906|P2|Overall Study|Withdrawal by Subject|0
5480271|NCT01844778|18946907|P1|Overall Study|Withdrawal by Subject|2
5480272|NCT01844778|18946905|P3|Overall Study|Protocol deviation|2
5480273|NCT01844778|18946906|P2|Overall Study|Protocol deviation|1
5480274|NCT01844778|18946907|P1|Overall Study|Protocol deviation|0
5480275|NCT01844765|18946933|P2|Overall Study|Untreated|0
5480276|NCT01844765|18946934|P1|Overall Study|Untreated|1
5480277|NCT01844765|18946933|P2|Overall Study|Protocol Violation|0
5480278|NCT01844765|18946934|P1|Overall Study|Protocol Violation|1
5480279|NCT01844765|18946933|P2|Overall Study|Disease progression|0
5480280|NCT01844765|18946934|P1|Overall Study|Disease progression|1
5480281|NCT01844765|18946933|P2|Overall Study|Administrative problems|1
5480282|NCT01844765|18946934|P1|Overall Study|Administrative problems|1
5480283|NCT01844765|18946933|P2|Overall Study|Withdrawal by Subject|1
5480284|NCT01844765|18946934|P1|Overall Study|Withdrawal by Subject|0
5480285|NCT01844765|18946933|P2|Overall Study|Adverse Event|4
5480286|NCT01844765|18946934|P1|Overall Study|Adverse Event|5
5480287|NCT01844700|18946954|P2|Overall Study|stopped taking meds|1
5480288|NCT01844700|18946955|P1|Overall Study|stopped taking meds|0
5480289|NCT01844700|18946954|P2|Overall Study|Withdrawal by Subject|0
5480290|NCT01844700|18946955|P1|Overall Study|Withdrawal by Subject|1
5480291|NCT01844700|18946954|P2|Overall Study|refused medication switch|0
5480292|NCT01844700|18946955|P1|Overall Study|refused medication switch|1
5480293|NCT01844700|18946954|P2|Overall Study|Lack of Efficacy|0
5480294|NCT01844700|18946955|P1|Overall Study|Lack of Efficacy|1
5480295|NCT01844687|18946967|P1|Visit 4|Withdrawal by Subject|2
5480296|NCT01844687|18946967|P1|Visit 4|Lost to Follow-up|1
5480297|NCT01844687|18946967|P1|Visit 4|Pregnancy|1
5480298|NCT01844687|18946967|P1|Visit 3|child care problems|1
5480299|NCT01844687|18946967|P1|Visit 3|Withdrawal by Subject|3
5480300|NCT01844687|18946967|P1|Visit 3|Lost to Follow-up|1
5480301|NCT01844687|18946967|P1|Visit 2|Protocol Violation|1
5480302|NCT01844687|18946967|P1|Visit 2|Withdrawal by Subject|1
5480303|NCT01844687|18946967|P1|Visit 1|Lost to Follow-up|5
5480304|NCT01844687|18946967|P1|Visit 1|Protocol Violation|3
5480305|NCT01844583|18947028|P2|Overall Study|Didn't complete dosing;PK/ECG assessment|10
5480306|NCT01844583|18947029|P1|Overall Study|Didn't complete dosing;PK/ECG assessment|8
5480307|NCT01844531|18947061|P4|Overall Study|Withdrawal by Subject|0
5480308|NCT01844531|18947062|P3|Overall Study|Withdrawal by Subject|0
5480309|NCT01844531|18947063|P2|Overall Study|Withdrawal by Subject|1
5480310|NCT01844531|18947064|P1|Overall Study|Withdrawal by Subject|0
5480311|NCT01844518|18947094|P1|Long-Term Extension|Still in On-Going Study|149
5480312|NCT01844518|18947094|P1|Long-Term Extension|No Longer Met Study Criteria|1
5480313|NCT01844518|18947094|P1|Long-Term Extension|Adverse Event|1
5480314|NCT01844518|18947094|P1|Long-Term Extension|Lack of Efficacy|6
5480315|NCT01844518|18947094|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
5480316|NCT01844518|18947094|P1|Short-Term (ST) Period|Withdrawal of Consent|2
5480317|NCT01844518|18947094|P1|Short-Term (ST) Period|Lack of Efficacy|3
5480318|NCT01844518|18947094|P1|Short-Term (ST) Period|Adverse Event|3
5480319|NCT01844505|18947111|P3|Overall Study|Not Reported|1
5480320|NCT01844505|18947112|P2|Overall Study|Not Reported|0
5480321|NCT01844505|18947113|P1|Overall Study|Not Reported|0
5480322|NCT01844505|18947111|P3|Overall Study|Other Reasons|2
5480323|NCT01844505|18947112|P2|Overall Study|Other Reasons|2
5480324|NCT01844505|18947113|P1|Overall Study|Other Reasons|4
5480325|NCT01844505|18947111|P3|Overall Study|Subject no longer meets criteria|0
5480326|NCT01844505|18947112|P2|Overall Study|Subject no longer meets criteria|1
5480327|NCT01844505|18947113|P1|Overall Study|Subject no longer meets criteria|0
5480328|NCT01844505|18947111|P3|Overall Study|Poor/non-compliance|1
5480329|NCT01844505|18947112|P2|Overall Study|Poor/non-compliance|1
5480330|NCT01844505|18947113|P1|Overall Study|Poor/non-compliance|1
5480331|NCT01844505|18947111|P3|Overall Study|Maximum clinical benefit|2
5480332|NCT01844505|18947112|P2|Overall Study|Maximum clinical benefit|11
5480333|NCT01844505|18947113|P1|Overall Study|Maximum clinical benefit|8
5480334|NCT01844505|18947111|P3|Overall Study|Lost to Follow-up|0
5480335|NCT01844505|18947112|P2|Overall Study|Lost to Follow-up|0
5480336|NCT01844505|18947113|P1|Overall Study|Lost to Follow-up|1
5480337|NCT01844505|18947111|P3|Overall Study|Withdrawal by Subject|0
5480338|NCT01844505|18947112|P2|Overall Study|Withdrawal by Subject|3
5480339|NCT01844505|18947113|P1|Overall Study|Withdrawal by Subject|0
5480340|NCT01844505|18947111|P3|Overall Study|Subject request discontinue treatment|8
5480341|NCT01844505|18947112|P2|Overall Study|Subject request discontinue treatment|14
5480342|NCT01844505|18947113|P1|Overall Study|Subject request discontinue treatment|17
5480343|NCT01844505|18947111|P3|Overall Study|Adverse event unrelated to study drug|6
5480344|NCT01844505|18947112|P2|Overall Study|Adverse event unrelated to study drug|15
5480345|NCT01844505|18947113|P1|Overall Study|Adverse event unrelated to study drug|7
5480346|NCT01844505|18947111|P3|Overall Study|Death|1
5480347|NCT01844505|18947112|P2|Overall Study|Death|3
5480348|NCT01844505|18947113|P1|Overall Study|Death|1
5480349|NCT01844505|18947111|P3|Overall Study|Study drug toxicity|50
5480350|NCT01844505|18947112|P2|Overall Study|Study drug toxicity|131
5480351|NCT01844505|18947113|P1|Overall Study|Study drug toxicity|40
5480352|NCT01844505|18947111|P3|Overall Study|Disease progression|224
5480353|NCT01844505|18947112|P2|Overall Study|Disease progression|88
5480354|NCT01844505|18947113|P1|Overall Study|Disease progression|170
5480355|NCT01844375|18947207|P2|Overall Study|Protocol Violation|1
5480356|NCT01844375|18947208|P1|Overall Study|Protocol Violation|1
5480357|NCT01844284|18947220|P2|Overall Study|Lost to Follow-up|7
5480358|NCT01844284|18947221|P1|Overall Study|Lost to Follow-up|12
5480359|NCT01844115|18947440|P2|Overall Study|Pregnancy|1
5480360|NCT01844115|18947441|P1|Overall Study|Pregnancy|0
5480361|NCT01844115|18947440|P2|Overall Study|Lost to Follow-up|10
5480362|NCT01844115|18947441|P1|Overall Study|Lost to Follow-up|11
5480363|NCT01844115|18947440|P2|Overall Study|Withdrawal by Subject|11
5480364|NCT01844115|18947441|P1|Overall Study|Withdrawal by Subject|11
5480365|NCT01844115|18947440|P2|Overall Study|Protocol Violation|10
5480366|NCT01844115|18947441|P1|Overall Study|Protocol Violation|12
5480367|NCT01844115|18947440|P2|Overall Study|Lack of Efficacy|4
5480368|NCT01844115|18947441|P1|Overall Study|Lack of Efficacy|1
5480369|NCT01844115|18947440|P2|Overall Study|Adverse Event|22
5480370|NCT01844115|18947441|P1|Overall Study|Adverse Event|4
5480371|NCT01843972|18947459|P10|Overall Study|Withdrawal by Subject|0
5480372|NCT01843972|18947460|P9|Overall Study|Withdrawal by Subject|0
5480373|NCT01843972|18947461|P8|Overall Study|Withdrawal by Subject|0
5480374|NCT01843972|18947462|P7|Overall Study|Withdrawal by Subject|0
5480375|NCT01843972|18947463|P6|Overall Study|Withdrawal by Subject|0
5480376|NCT01843972|18947464|P5|Overall Study|Withdrawal by Subject|1
5480377|NCT01843972|18947465|P4|Overall Study|Withdrawal by Subject|0
5480378|NCT01843972|18947466|P3|Overall Study|Withdrawal by Subject|0
5480379|NCT01843972|18947467|P2|Overall Study|Withdrawal by Subject|0
5480380|NCT01843972|18947468|P1|Overall Study|Withdrawal by Subject|0
5480381|NCT01843933|18947538|P2|Overall Study|Data lost|4
5480382|NCT01843933|18947539|P1|Overall Study|Data lost|6
5480383|NCT01843842|18947558|P2|Overall Study|Do not meet inclusion criteria|1
5480384|NCT01843842|18947559|P1|Overall Study|Do not meet inclusion criteria|1
5480385|NCT01843803|18947581|P2|Overall Study|not a Veteran, did not see provider|3
5480386|NCT01843803|18947582|P1|Overall Study|not a Veteran, did not see provider|1
5480387|NCT01843777|18947596|P2|Overall Study|Withdrawal by Subject|0
5480388|NCT01843777|18947597|P1|Overall Study|Withdrawal by Subject|1
5480389|NCT01843673|18947622|P1|Overall Study|Withdrawal by Subject|4
5480390|NCT01843673|18947622|P1|Overall Study|Lack of Efficacy|2
5480391|NCT01843660|18947634|P1|Overall Study|Other|30
5480392|NCT01843374|18947675|P2|Overall Study|Withdrawing due to Other reason|46
5480393|NCT01843374|18947676|P1|Overall Study|Withdrawing due to Other reason|20
5480394|NCT01843374|18947675|P2|Overall Study|Withdrawal by Subject|20
5480395|NCT01843374|18947676|P1|Overall Study|Withdrawal by Subject|14
5480396|NCT01843374|18947675|P2|Overall Study|Death|313
5480397|NCT01843374|18947676|P1|Overall Study|Death|155
5480398|NCT01843348|18947703|P3|Overall Study|Various reasons|6
5480399|NCT01843348|18947704|P2|Overall Study|Various reasons|9
5480400|NCT01843348|18947705|P1|Overall Study|Various reasons|4
5480401|NCT01843348|18947703|P3|Overall Study|Graft loss/retransplantation|11
5480402|NCT01843348|18947704|P2|Overall Study|Graft loss/retransplantation|8
5480403|NCT01843348|18947705|P1|Overall Study|Graft loss/retransplantation|5
5480404|NCT01843348|18947703|P3|Overall Study|Death|4
5480405|NCT01843348|18947704|P2|Overall Study|Death|3
5480406|NCT01843348|18947705|P1|Overall Study|Death|5
5480407|NCT01843348|18947703|P3|Overall Study|Lost to Follow-up|2
5480408|NCT01843348|18947704|P2|Overall Study|Lost to Follow-up|4
5480409|NCT01843348|18947705|P1|Overall Study|Lost to Follow-up|5
5480410|NCT01843348|18947703|P3|Overall Study|Withdrawal by Subject|18
5480411|NCT01843348|18947704|P2|Overall Study|Withdrawal by Subject|16
5480412|NCT01843348|18947705|P1|Overall Study|Withdrawal by Subject|4
5480413|NCT01843205|18947745|P2|First Treatment (11 Days)|Withdrawal by Subject|0
5480414|NCT01843205|18947746|P1|First Treatment (11 Days)|Withdrawal by Subject|1
5480415|NCT01843192|18947807|P3|Overall Study|Intra-operative exclusions per protocol|2
5480416|NCT01843192|18947808|P2|Overall Study|Intra-operative exclusions per protocol|6
5480417|NCT01843192|18947809|P1|Overall Study|Intra-operative exclusions per protocol|2
5480418|NCT01843062|18947840|P2|Overall Study|Lost to Follow-up|4
5480419|NCT01843062|18947841|P1|Overall Study|Lost to Follow-up|2
5480420|NCT01843062|18947840|P2|Overall Study|Death|2
5480421|NCT01843062|18947841|P1|Overall Study|Death|1
5480422|NCT01843062|18947840|P2|Overall Study|Withdrawal by Subject|3
5480423|NCT01843062|18947841|P1|Overall Study|Withdrawal by Subject|12
5480424|NCT01843062|18947840|P2|Overall Study|Incorrect randomisation|0
5480425|NCT01843062|18947841|P1|Overall Study|Incorrect randomisation|1
5480426|NCT01843062|18947840|P2|Overall Study|Adverse Event|0
5480427|NCT01843062|18947841|P1|Overall Study|Adverse Event|2
5480428|NCT01843062|18947840|P2|Overall Study|Pregnancy|0
5480429|NCT01843062|18947841|P1|Overall Study|Pregnancy|1
5480430|NCT01843062|18947840|P2|Overall Study|New treatment following progression|0
5480431|NCT01843062|18947841|P1|Overall Study|New treatment following progression|2
5480432|NCT01843062|18947840|P2|Overall Study|Protocol Violation|0
5480433|NCT01843062|18947841|P1|Overall Study|Protocol Violation|1
5480434|NCT01842958|18947855|P2|Overall Study|Lost to Follow-up|1
5480435|NCT01842958|18947856|P1|Overall Study|Lost to Follow-up|1
5480436|NCT01842633|18947931|P3|Overall Study|Technical issues|0
5480437|NCT01842633|18947932|P2|Overall Study|Technical issues|0
5480438|NCT01842633|18947933|P1|Overall Study|Technical issues|1
5480439|NCT01842633|18947931|P3|Overall Study|Withdrawal by Subject|0
5480440|NCT01842633|18947932|P2|Overall Study|Withdrawal by Subject|1
5480441|NCT01842633|18947933|P1|Overall Study|Withdrawal by Subject|0
5480442|NCT01842633|18947931|P3|Overall Study|Adverse Event|0
5480443|NCT01842633|18947932|P2|Overall Study|Adverse Event|1
5480444|NCT01842633|18947933|P1|Overall Study|Adverse Event|1
5480445|NCT01842633|18947931|P3|Overall Study|Screen Failure|0
5480446|NCT01842633|18947932|P2|Overall Study|Screen Failure|0
5480447|NCT01842633|18947933|P1|Overall Study|Screen Failure|1
5480448|NCT01842620|18947980|P2|Period 1|Withdrawal by Subject|0
5480449|NCT01842620|18947981|P1|Period 1|Withdrawal by Subject|1
5480450|NCT01842607|18947997|P1|Overall Study|Withdrawal by Subject|14
5480451|NCT01842607|18947997|P1|Overall Study|Physician Decision|9
5480452|NCT01842607|18947997|P1|Overall Study|Lost to Follow-up|3
5480453|NCT01842607|18947997|P1|Overall Study|Protocol defined stopping criteria|2
5480454|NCT01842607|18947997|P1|Overall Study|Protocol Violation|8
5480455|NCT01842607|18947997|P1|Overall Study|Lack of Efficacy|19
5480456|NCT01842607|18947997|P1|Overall Study|Adverse Event|11
5480457|NCT01842581|18948023|P2|Overall Study|Other than specified|1
5480458|NCT01842581|18948024|P1|Overall Study|Other than specified|3
5480459|NCT01842581|18948023|P2|Overall Study|Withdrawal by Subject|7
5480460|NCT01842581|18948024|P1|Overall Study|Withdrawal by Subject|5
5480461|NCT01842581|18948023|P2|Overall Study|Lost to Follow-up|5
5480462|NCT01842581|18948024|P1|Overall Study|Lost to Follow-up|2
5480463|NCT01842581|18948023|P2|Overall Study|Liver transplant|0
5480464|NCT01842581|18948024|P1|Overall Study|Liver transplant|2
5480465|NCT01842581|18948023|P2|Overall Study|HE breakthrough|13
5480466|NCT01842581|18948024|P1|Overall Study|HE breakthrough|26
5480467|NCT01842581|18948023|P2|Overall Study|Adverse Event|4
5480468|NCT01842581|18948024|P1|Overall Study|Adverse Event|6
5480469|NCT01842438|18948048|P2|T2: 6month Follow-up|Death|1
5480470|NCT01842438|18948049|P1|T2: 6month Follow-up|Death|0
5480471|NCT01842438|18948048|P2|T2: 6month Follow-up|Withdrawal by Subject|3
5480472|NCT01842438|18948049|P1|T2: 6month Follow-up|Withdrawal by Subject|4
5480473|NCT01842438|18948048|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
5480474|NCT01842438|18948049|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
5480475|NCT01842334|18948063|P2|Overall Study|Moved away mid-study|1
5480476|NCT01842334|18948064|P1|Overall Study|Moved away mid-study|0
5480477|NCT01842334|18948063|P2|Overall Study|Withdrawal by Subject|3
5480478|NCT01842334|18948064|P1|Overall Study|Withdrawal by Subject|3
5480479|NCT01842308|18948075|P5|Overall Study|Withdrawal by Subject|1
5480480|NCT01842308|18948076|P4|Overall Study|Withdrawal by Subject|0
5480481|NCT01842308|18948077|P3|Overall Study|Withdrawal by Subject|0
5480482|NCT01842308|18948078|P2|Overall Study|Withdrawal by Subject|0
5480483|NCT01842308|18948079|P1|Overall Study|Withdrawal by Subject|0
5480484|NCT01841970|18948098|P1|Overall Study|Lost to Follow-up|8
5480485|NCT01841970|18948098|P1|Overall Study|Physician Decision|2
5480486|NCT01841970|18948098|P1|Overall Study|Withdrawal by Subject|1
5480487|NCT01841762|18948122|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
5480488|NCT01841762|18948122|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
5480489|NCT01841762|18948122|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
5480490|NCT01841762|18948122|P1|Post-Treatment Safety Follow-Up Period|Death|1
5480491|NCT01841762|18948122|P1|Treatment Period|Other, including non-compliance|5
5480492|NCT01841762|18948122|P1|Treatment Period|Physician Decision|2
5480493|NCT01841762|18948122|P1|Treatment Period|Lost to Follow-up|1
5480494|NCT01841762|18948122|P1|Treatment Period|Withdrawal by Subject|7
5480495|NCT01841762|18948122|P1|Treatment Period|Death|1
5480496|NCT01841762|18948122|P1|Treatment Period|Adverse Event|16
5480497|NCT01841762|18948122|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
5480498|NCT01841697|18948146|P2|Overall Study|Withdrawal by Subject|16
5480499|NCT01841697|18948147|P1|Overall Study|Withdrawal by Subject|16
5480500|NCT01841697|18948146|P2|Overall Study|Lost to Follow-up|1
5480501|NCT01841697|18948147|P1|Overall Study|Lost to Follow-up|4
5480502|NCT01841697|18948146|P2|Overall Study|Death|1
5480503|NCT01841697|18948147|P1|Overall Study|Death|0
5480504|NCT01841593|18948187|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
5480505|NCT01841593|18948188|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
5480506|NCT01841593|18948187|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
5480507|NCT01841593|18948188|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
5480508|NCT01841567|18948204|P1|Overall Study|Adverse Event|3
5480509|NCT01841554|18948209|P1|Overall Study|Study exit due to secondary intervention|6
5480510|NCT01841554|18948209|P1|Overall Study|Discontinued Follow Up|5
5480511|NCT01841554|18948209|P1|Overall Study|No Implantation|1
5480512|NCT01841554|18948209|P1|Overall Study|Death|7
5480513|NCT01841073|18948258|P2|Overall Study|Lost to Follow-up|2
5480514|NCT01841073|18948259|P1|Overall Study|Lost to Follow-up|0
5480515|NCT01841073|18948258|P2|Overall Study|Physician Decision|0
5480516|NCT01841073|18948259|P1|Overall Study|Physician Decision|1
5480517|NCT01841073|18948258|P2|Overall Study|Adverse Event|1
5480518|NCT01841073|18948259|P1|Overall Study|Adverse Event|1
5480519|NCT01840943|18948281|P2|Overall Study|Lost to Follow-up|4
5480520|NCT01840943|18948282|P1|Overall Study|Lost to Follow-up|4
5480521|NCT01840943|18948281|P2|Overall Study|Physician Decision|2
5480522|NCT01840943|18948282|P1|Overall Study|Physician Decision|4
5480523|NCT01840943|18948281|P2|Overall Study|Withdrawal by Subject|6
5480524|NCT01840943|18948282|P1|Overall Study|Withdrawal by Subject|5
5480525|NCT01840605|18948331|P2|Overall Study|Physician Decision|1
5480526|NCT01840605|18948332|P1|Overall Study|Physician Decision|2
5480527|NCT01840605|18948331|P2|Overall Study|Adverse Event|1
5480528|NCT01840605|18948332|P1|Overall Study|Adverse Event|0
5480529|NCT01840410|18948346|P2|Overall Study|Adverse Event|1
5480530|NCT01840410|18948347|P1|Overall Study|Adverse Event|1
5480531|NCT01840410|18948346|P2|Overall Study|Withdrawal by Subject|1
5480532|NCT01840410|18948347|P1|Overall Study|Withdrawal by Subject|2
5480533|NCT01840410|18948346|P2|Overall Study|Lost to Follow-up|0
5480534|NCT01840410|18948347|P1|Overall Study|Lost to Follow-up|1
5480535|NCT01840410|18948346|P2|Overall Study|Protocol deviation|0
5480536|NCT01840410|18948347|P1|Overall Study|Protocol deviation|1
5480537|NCT01840410|18948346|P2|Overall Study|Pregnancy|0
5480538|NCT01840410|18948347|P1|Overall Study|Pregnancy|1
5480539|NCT01840410|18948346|P2|Overall Study|Physician Decision|2
5480540|NCT01840410|18948347|P1|Overall Study|Physician Decision|1
5480541|NCT01840228|18948396|P2|Overall Study|Lost to Follow-up|1
5480542|NCT01840228|18948397|P1|Overall Study|Lost to Follow-up|1
5480543|NCT01840163|18948425|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
5480544|NCT01840163|18948426|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
5480545|NCT01840163|18948425|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
5480546|NCT01840163|18948426|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
5480547|NCT01840163|18948425|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
5480548|NCT01840163|18948426|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
5480549|NCT01839916|18948471|P1|Overall Study|Graft Failure|1
5480550|NCT01839916|18948471|P1|Overall Study|GVHD|2
5480551|NCT01839916|18948471|P1|Overall Study|Relapse|12
5480552|NCT01839916|18948471|P1|Overall Study|Physician Decision|17
5480553|NCT01839916|18948471|P1|Overall Study|Death|9
5480554|NCT01839656|18948522|P2|Overall Study|Adverse Event|0
5480555|NCT01839656|18948523|P1|Overall Study|Adverse Event|1
5480556|NCT01839656|18948522|P2|Overall Study|Early study closure|11
5480557|NCT01839656|18948523|P1|Overall Study|Early study closure|0
5480558|NCT01839656|18948522|P2|Overall Study|Adverse event, serious fatal|4
5480559|NCT01839656|18948523|P1|Overall Study|Adverse event, serious fatal|1
5480560|NCT01839656|18948522|P2|Overall Study|Withdrawal by Subject|1
5480561|NCT01839656|18948523|P1|Overall Study|Withdrawal by Subject|1
5480562|NCT01839487|18948583|P6|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
5480563|NCT01839487|18948584|P5|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
5480564|NCT01839487|18948585|P4|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
5480565|NCT01839487|18948586|P3|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
5480566|NCT01839487|18948587|P2|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
5480567|NCT01839487|18948588|P1|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
5480568|NCT01839487|18948583|P6|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
5480569|NCT01839487|18948584|P5|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
5480570|NCT01839487|18948585|P4|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
5480571|NCT01839487|18948586|P3|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
5480572|NCT01839487|18948587|P2|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
5480573|NCT01839487|18948588|P1|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
5480574|NCT01839487|18948583|P6|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5480575|NCT01839487|18948584|P5|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
5480576|NCT01839487|18948585|P4|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5480577|NCT01839487|18948586|P3|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
5480578|NCT01839487|18948587|P2|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5480579|NCT01839487|18948588|P1|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
5480580|NCT01839487|18948583|P6|Phase 2 (Maximum Exposure:935 Days)|Death|32
5480581|NCT01839487|18948584|P5|Phase 2 (Maximum Exposure:935 Days)|Death|71
5480582|NCT01839487|18948585|P4|Phase 2 (Maximum Exposure:935 Days)|Death|49
5480583|NCT01839487|18948586|P3|Phase 2 (Maximum Exposure:935 Days)|Death|46
5480584|NCT01839487|18948587|P2|Phase 2 (Maximum Exposure:935 Days)|Death|0
5480585|NCT01839487|18948588|P1|Phase 2 (Maximum Exposure:935 Days)|Death|0
5480586|NCT01839487|18948583|P6|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
5480587|NCT01839487|18948584|P5|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
5480588|NCT01839487|18948585|P4|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
5480589|NCT01839487|18948586|P3|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
5480590|NCT01839487|18948587|P2|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
5480591|NCT01839487|18948588|P1|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
5480592|NCT01839487|18948583|P6|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5480593|NCT01839487|18948584|P5|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5480594|NCT01839487|18948585|P4|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5480595|NCT01839487|18948586|P3|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5480596|NCT01839487|18948587|P2|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
5480597|NCT01839487|18948588|P1|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
5480598|NCT01839487|18948583|P6|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5480599|NCT01839487|18948584|P5|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5480600|NCT01839487|18948585|P4|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5480601|NCT01839487|18948586|P3|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5480602|NCT01839487|18948587|P2|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
5480603|NCT01839487|18948588|P1|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
5480604|NCT01839487|18948583|P6|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5480605|NCT01839487|18948584|P5|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5480606|NCT01839487|18948585|P4|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5480607|NCT01839487|18948586|P3|Run-in Phase (Maximum Exposure:295 Days)|Death|0
5480608|NCT01839487|18948587|P2|Run-in Phase (Maximum Exposure:295 Days)|Death|6
5480609|NCT01839487|18948588|P1|Run-in Phase (Maximum Exposure:295 Days)|Death|14
5480610|NCT01839487|18948583|P6|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5480611|NCT01839487|18948584|P5|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5480612|NCT01839487|18948585|P4|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5480613|NCT01839487|18948586|P3|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5480614|NCT01839487|18948587|P2|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
5480615|NCT01839487|18948588|P1|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
5480616|NCT01839279|18948639|P3|Overall Study|Classified as 'Other'|0
5480617|NCT01839279|18948640|P2|Overall Study|Classified as 'Other'|0
5480618|NCT01839279|18948641|P1|Overall Study|Classified as 'Other'|5
5480619|NCT01839279|18948639|P3|Overall Study|Withdrawal by Subject|1
5480620|NCT01839279|18948640|P2|Overall Study|Withdrawal by Subject|1
5480621|NCT01839279|18948641|P1|Overall Study|Withdrawal by Subject|4
5480622|NCT01839279|18948639|P3|Overall Study|Adverse Event|1
5480623|NCT01839279|18948640|P2|Overall Study|Adverse Event|1
5480624|NCT01839279|18948641|P1|Overall Study|Adverse Event|4
5480625|NCT01839188|18948660|P1|Overall Study|Withdrawal by Subject|1
5480626|NCT01838941|18948732|P1|Overall Study|Withdrawal by Subject|1
5480627|NCT01838941|18948732|P1|Overall Study|Adverse Event|1
5480628|NCT01838876|18948737|P1|Overall Study|Did not meet eligibility criteria|78
5480629|NCT01838876|18948737|P1|Overall Study|Reason not Specified|7
5480630|NCT01838876|18948737|P1|Overall Study|Study or Site Terminated by Sponsor|1
5480631|NCT01838876|18948737|P1|Overall Study|Lost to Follow-up|21
5480632|NCT01838876|18948737|P1|Overall Study|Withdrawal of Consent|33
5480633|NCT01838876|18948737|P1|Overall Study|Protocol Violation|34
5480634|NCT01838876|18948737|P1|Overall Study|Insufficient Therapeutic Response|10
5480635|NCT01838876|18948737|P1|Overall Study|Adverse Event|49
5480636|NCT01838694|18948846|P2|Overall Study|Adverse Event|1
5480637|NCT01838694|18948847|P1|Overall Study|Adverse Event|0
5480638|NCT01838681|18948856|P4|Period B/A+|Administrative or other reasons|28
5480639|NCT01838681|18948857|P3|Period B/A+|Administrative or other reasons|10
5480640|NCT01838681|18948858|P2|Period B/A+|Administrative or other reasons|6
5480641|NCT01838681|18948859|P1|Period B/A+|Administrative or other reasons|0
5480642|NCT01838681|18948856|P4|Period B/A+|Withdrawal before treatment|0
5480643|NCT01838681|18948857|P3|Period B/A+|Withdrawal before treatment|0
5480644|NCT01838681|18948858|P2|Period B/A+|Withdrawal before treatment|1
5480645|NCT01838681|18948859|P1|Period B/A+|Withdrawal before treatment|0
5480646|NCT01838681|18948856|P4|Period B/A+|Lost to Follow-up|11
5480647|NCT01838681|18948857|P3|Period B/A+|Lost to Follow-up|5
5480648|NCT01838681|18948858|P2|Period B/A+|Lost to Follow-up|2
5480649|NCT01838681|18948859|P1|Period B/A+|Lost to Follow-up|0
5480650|NCT01838681|18948856|P4|Period B/A+|Non-compliance with IMP|3
5480651|NCT01838681|18948857|P3|Period B/A+|Non-compliance with IMP|3
5480652|NCT01838681|18948858|P2|Period B/A+|Non-compliance with IMP|2
5480653|NCT01838681|18948859|P1|Period B/A+|Non-compliance with IMP|0
5480654|NCT01838681|18948856|P4|Period B/A+|Protocol Violation|6
5480655|NCT01838681|18948857|P3|Period B/A+|Protocol Violation|4
5480656|NCT01838681|18948858|P2|Period B/A+|Protocol Violation|1
5480657|NCT01838681|18948859|P1|Period B/A+|Protocol Violation|0
5480658|NCT01838681|18948856|P4|Period B/A+|Withdrawal by Subject|47
5480659|NCT01838681|18948857|P3|Period B/A+|Withdrawal by Subject|35
5480660|NCT01838681|18948858|P2|Period B/A+|Withdrawal by Subject|28
5480661|NCT01838681|18948859|P1|Period B/A+|Withdrawal by Subject|0
5480662|NCT01838681|18948856|P4|Period B/A+|Lack of Efficacy|6
5480663|NCT01838681|18948857|P3|Period B/A+|Lack of Efficacy|11
5480664|NCT01838681|18948858|P2|Period B/A+|Lack of Efficacy|9
5480665|NCT01838681|18948859|P1|Period B/A+|Lack of Efficacy|0
5480666|NCT01838681|18948856|P4|Period B/A+|Adverse Event|16
5480667|NCT01838681|18948857|P3|Period B/A+|Adverse Event|27
5480668|NCT01838681|18948858|P2|Period B/A+|Adverse Event|13
5480669|NCT01838681|18948859|P1|Period B/A+|Adverse Event|0
5480670|NCT01838681|18948856|P4|Period A|Administrative or other reasons|0
5480671|NCT01838681|18948857|P3|Period A|Administrative or other reasons|0
5480672|NCT01838681|18948858|P2|Period A|Administrative or other reasons|0
5480673|NCT01838681|18948859|P1|Period A|Administrative or other reasons|17
5480674|NCT01838681|18948856|P4|Period A|Withdrawal before treatment|0
5480675|NCT01838681|18948857|P3|Period A|Withdrawal before treatment|0
5480676|NCT01838681|18948858|P2|Period A|Withdrawal before treatment|0
5480677|NCT01838681|18948859|P1|Period A|Withdrawal before treatment|4
5480678|NCT01838681|18948856|P4|Period A|Lost to Follow-up|0
5480679|NCT01838681|18948857|P3|Period A|Lost to Follow-up|0
5480680|NCT01838681|18948858|P2|Period A|Lost to Follow-up|0
5480681|NCT01838681|18948859|P1|Period A|Lost to Follow-up|4
5480682|NCT01838681|18948856|P4|Period A|Non-compliance with IMP|0
5480683|NCT01838681|18948857|P3|Period A|Non-compliance with IMP|0
5480684|NCT01838681|18948858|P2|Period A|Non-compliance with IMP|0
5480685|NCT01838681|18948859|P1|Period A|Non-compliance with IMP|6
5480686|NCT01838681|18948856|P4|Period A|Protocol Violation|0
5480687|NCT01838681|18948857|P3|Period A|Protocol Violation|0
5480688|NCT01838681|18948858|P2|Period A|Protocol Violation|0
5480689|NCT01838681|18948859|P1|Period A|Protocol Violation|16
5480690|NCT01838681|18948856|P4|Period A|Withdrawal by Subject|0
5480691|NCT01838681|18948857|P3|Period A|Withdrawal by Subject|0
5480692|NCT01838681|18948858|P2|Period A|Withdrawal by Subject|0
5480693|NCT01838681|18948859|P1|Period A|Withdrawal by Subject|70
5480694|NCT01838681|18948856|P4|Period A|Early response|0
5480695|NCT01838681|18948857|P3|Period A|Early response|0
5480696|NCT01838681|18948858|P2|Period A|Early response|0
5480697|NCT01838681|18948859|P1|Period A|Early response|148
5480698|NCT01838681|18948856|P4|Period A|Lack of Efficacy|0
5480699|NCT01838681|18948857|P3|Period A|Lack of Efficacy|0
5480700|NCT01838681|18948858|P2|Period A|Lack of Efficacy|0
5480701|NCT01838681|18948859|P1|Period A|Lack of Efficacy|21
5480702|NCT01838681|18948856|P4|Period A|Adverse Event|0
5480703|NCT01838681|18948857|P3|Period A|Adverse Event|0
5480704|NCT01838681|18948858|P2|Period A|Adverse Event|0
5480705|NCT01838681|18948859|P1|Period A|Adverse Event|39
5480706|NCT01838642|18948967|P1|Overall Study|Died on study|1
5480707|NCT01838616|18948980|P2|Pick-up Arm|Technical problems|0
5480708|NCT01838616|18948981|P1|Pick-up Arm|Technical problems|1
5480709|NCT01838616|18948980|P2|Pick-up Arm|Withdrawal by Subject|0
5480710|NCT01838616|18948981|P1|Pick-up Arm|Withdrawal by Subject|1
5480711|NCT01838616|18948980|P2|Pick-up Arm|Adverse Event|0
5480712|NCT01838616|18948981|P1|Pick-up Arm|Adverse Event|9
5480713|NCT01838616|18948980|P2|Pick-up Arm|Lack of Efficacy|0
5480714|NCT01838616|18948981|P1|Pick-up Arm|Lack of Efficacy|4
5480715|NCT01838616|18948980|P2|Continuation Period|Technical problems|1
5480716|NCT01838616|18948981|P1|Continuation Period|Technical problems|0
5480717|NCT01838616|18948980|P2|Continuation Period|Withdrawal by Subject|4
5480718|NCT01838616|18948981|P1|Continuation Period|Withdrawal by Subject|0
5480719|NCT01838616|18948980|P2|Continuation Period|Lost to Follow-up|0
5480720|NCT01838616|18948981|P1|Continuation Period|Lost to Follow-up|1
5480721|NCT01838616|18948980|P2|Continuation Period|Protocol Violation|0
5480722|NCT01838616|18948981|P1|Continuation Period|Protocol Violation|2
5480723|NCT01838616|18948980|P2|Continuation Period|Adverse Event|4
5480724|NCT01838616|18948981|P1|Continuation Period|Adverse Event|8
5480725|NCT01838616|18948980|P2|Continuation Period|Lack of Efficacy|5
5480726|NCT01838616|18948981|P1|Continuation Period|Lack of Efficacy|3
5480727|NCT01838616|18948980|P2|Titration Period|Protocol Violation|1
5480728|NCT01838616|18948981|P1|Titration Period|Protocol Violation|0
5480729|NCT01838616|18948980|P2|Titration Period|Other|0
5480730|NCT01838616|18948981|P1|Titration Period|Other|1
5480731|NCT01838616|18948980|P2|Titration Period|Technical problems|0
5480732|NCT01838616|18948981|P1|Titration Period|Technical problems|1
5480733|NCT01838616|18948980|P2|Titration Period|Withdrawal by Subject|5
5480734|NCT01838616|18948981|P1|Titration Period|Withdrawal by Subject|5
5480735|NCT01838616|18948980|P2|Titration Period|Lack of Efficacy|12
5480736|NCT01838616|18948981|P1|Titration Period|Lack of Efficacy|5
5480737|NCT01838616|18948980|P2|Titration Period|Adverse Event|48
5480738|NCT01838616|18948981|P1|Titration Period|Adverse Event|18
5480739|NCT01838590|18949052|P2|Overall Study|Lost to Follow-up|1
5480740|NCT01838590|18949053|P1|Overall Study|Lost to Follow-up|0
5480741|NCT01838590|18949052|P2|Overall Study|Lack of Efficacy|4
5480742|NCT01838590|18949053|P1|Overall Study|Lack of Efficacy|12
5480743|NCT01838499|18949077|P2|Overall Study|Withdrawal by Subject|9
5480744|NCT01838499|18949078|P1|Overall Study|Withdrawal by Subject|19
5480745|NCT01838499|18949077|P2|Overall Study|Adverse Event|1
5480746|NCT01838499|18949078|P1|Overall Study|Adverse Event|2
5480747|NCT01838499|18949077|P2|Overall Study|Lack of Efficacy|2
5480748|NCT01838499|18949078|P1|Overall Study|Lack of Efficacy|1
5480749|NCT01838499|18949077|P2|Overall Study|Lost to Follow-up|4
5480750|NCT01838499|18949078|P1|Overall Study|Lost to Follow-up|2
5480751|NCT01838499|18949077|P2|Overall Study|Protocol Violation|1
5480752|NCT01838499|18949078|P1|Overall Study|Protocol Violation|0
5480753|NCT01838447|18949090|P2|Overall Study|Withdrawal by Subject|1
5480754|NCT01838447|18949091|P1|Overall Study|Withdrawal by Subject|1
5480755|NCT01838447|18949090|P2|Overall Study|Change in surgical plan|2
5480756|NCT01838447|18949091|P1|Overall Study|Change in surgical plan|1
5480757|NCT01838213|18949139|P2|Overall Study|Ineligible|191
5480758|NCT01838213|18949140|P1|Overall Study|Ineligible|166
5480759|NCT01838200|18949148|P2|Overall Study|Progressive disease|0
5480760|NCT01838200|18949149|P1|Overall Study|Progressive disease|3
5480761|NCT01838200|18949148|P2|Overall Study|Adverse Event|2
5480762|NCT01838200|18949149|P1|Overall Study|Adverse Event|0
5480763|NCT01838044|18949161|P2|Overall Study|Lost to Follow-up|2
5480764|NCT01838044|18949162|P1|Overall Study|Lost to Follow-up|0
5480765|NCT01838044|18949161|P2|Overall Study|Medication error without associated AE|1
5480766|NCT01838044|18949162|P1|Overall Study|Medication error without associated AE|0
5480767|NCT01838044|18949161|P2|Overall Study|Insufficient clinical response|2
5480768|NCT01838044|18949162|P1|Overall Study|Insufficient clinical response|1
5480769|NCT01838044|18949161|P2|Overall Study|Withdrawal by Subject|2
5480770|NCT01838044|18949162|P1|Overall Study|Withdrawal by Subject|0
5480771|NCT01838044|18949161|P2|Overall Study|Protocol Violation|3
5480772|NCT01838044|18949162|P1|Overall Study|Protocol Violation|3
5480773|NCT01838044|18949161|P2|Overall Study|Adverse Event|6
5480774|NCT01838044|18949162|P1|Overall Study|Adverse Event|4
5480775|NCT01837966|18949195|P2|Overall Study|Withdrawal by Subject|1
5480776|NCT01837966|18949196|P1|Overall Study|Withdrawal by Subject|2
5480777|NCT01837823|18949202|P1|Overall Study|Lost to Follow-up|6
5480778|NCT01837797|18949233|P5|Period 3|Other|2
5480779|NCT01837797|18949234|P4|Period 3|Other|0
5480780|NCT01837797|18949235|P3|Period 3|Other|0
5480781|NCT01837797|18949236|P2|Period 3|Other|0
5480782|NCT01837797|18949237|P1|Period 3|Other|0
5480783|NCT01837797|18949233|P5|Period 3|Administrative reasons|20
5480784|NCT01837797|18949234|P4|Period 3|Administrative reasons|0
5480785|NCT01837797|18949235|P3|Period 3|Administrative reasons|0
5480786|NCT01837797|18949236|P2|Period 3|Administrative reasons|0
5480787|NCT01837797|18949237|P1|Period 3|Administrative reasons|0
5480788|NCT01837797|18949233|P5|Period 3|Adverse Event|1
5480789|NCT01837797|18949234|P4|Period 3|Adverse Event|0
5480790|NCT01837797|18949235|P3|Period 3|Adverse Event|0
5480791|NCT01837797|18949236|P2|Period 3|Adverse Event|0
5480792|NCT01837797|18949237|P1|Period 3|Adverse Event|0
5480793|NCT01837797|18949233|P5|Period 2|Adverse Event|0
5480794|NCT01837797|18949234|P4|Period 2|Adverse Event|1
5480795|NCT01837797|18949235|P3|Period 2|Adverse Event|0
5480796|NCT01837797|18949236|P2|Period 2|Adverse Event|0
5480797|NCT01837797|18949237|P1|Period 2|Adverse Event|0
5480798|NCT01837797|18949233|P5|Period 2|Administrative or other reasons|0
5480799|NCT01837797|18949234|P4|Period 2|Administrative or other reasons|4
5480800|NCT01837797|18949235|P3|Period 2|Administrative or other reasons|2
5480801|NCT01837797|18949236|P2|Period 2|Administrative or other reasons|5
5480802|NCT01837797|18949237|P1|Period 2|Administrative or other reasons|0
5480803|NCT01837797|18949233|P5|Period 1|Other|0
5480804|NCT01837797|18949234|P4|Period 1|Other|0
5480805|NCT01837797|18949235|P3|Period 1|Other|0
5480806|NCT01837797|18949236|P2|Period 1|Other|0
5480807|NCT01837797|18949237|P1|Period 1|Other|10
5480808|NCT01837797|18949233|P5|Period 1|Withdrawal of consent before treatment|0
5480809|NCT01837797|18949234|P4|Period 1|Withdrawal of consent before treatment|0
5480810|NCT01837797|18949235|P3|Period 1|Withdrawal of consent before treatment|0
5480811|NCT01837797|18949236|P2|Period 1|Withdrawal of consent before treatment|0
5480812|NCT01837797|18949237|P1|Period 1|Withdrawal of consent before treatment|1
5480813|NCT01837797|18949233|P5|Period 1|Administrative reasons|0
5480814|NCT01837797|18949234|P4|Period 1|Administrative reasons|0
5480815|NCT01837797|18949235|P3|Period 1|Administrative reasons|0
5480816|NCT01837797|18949236|P2|Period 1|Administrative reasons|0
5480817|NCT01837797|18949237|P1|Period 1|Administrative reasons|76
5480818|NCT01837797|18949233|P5|Period 1|Withdrawal by Subject|0
5480819|NCT01837797|18949234|P4|Period 1|Withdrawal by Subject|0
5480820|NCT01837797|18949235|P3|Period 1|Withdrawal by Subject|0
5480821|NCT01837797|18949236|P2|Period 1|Withdrawal by Subject|0
5480822|NCT01837797|18949237|P1|Period 1|Withdrawal by Subject|6
5480823|NCT01837797|18949233|P5|Period 1|Adverse Event|0
5480824|NCT01837797|18949234|P4|Period 1|Adverse Event|0
5480825|NCT01837797|18949235|P3|Period 1|Adverse Event|0
5480826|NCT01837797|18949236|P2|Period 1|Adverse Event|0
5480827|NCT01837797|18949237|P1|Period 1|Adverse Event|9
5480828|NCT01837719|18949272|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
5480829|NCT01837719|18949272|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
5480830|NCT01837680|18949341|P2|Overall Study|switched to oral hypoglycemic or diet|4
5480831|NCT01837680|18949342|P1|Overall Study|switched to oral hypoglycemic or diet|2
5480832|NCT01837680|18949341|P2|Overall Study|allergic reaction|0
5480833|NCT01837680|18949342|P1|Overall Study|allergic reaction|6
5480834|NCT01837680|18949341|P2|Overall Study|lack of insurance|2
5480835|NCT01837680|18949342|P1|Overall Study|lack of insurance|0
5480836|NCT01837680|18949341|P2|Overall Study|Lost to Follow-up|2
5480837|NCT01837680|18949342|P1|Overall Study|Lost to Follow-up|2
5480838|NCT01836549|18949476|P7|Overall Study|Patient inevaluable to start therapy|1
5480839|NCT01836549|18949477|P6|Overall Study|Patient inevaluable to start therapy|0
5480840|NCT01836549|18949478|P5|Overall Study|Patient inevaluable to start therapy|0
5480841|NCT01836549|18949479|P4|Overall Study|Patient inevaluable to start therapy|0
5480842|NCT01836549|18949480|P3|Overall Study|Patient inevaluable to start therapy|0
5480843|NCT01836549|18949481|P2|Overall Study|Patient inevaluable to start therapy|0
5480844|NCT01836549|18949482|P1|Overall Study|Patient inevaluable to start therapy|0
5480845|NCT01836549|18949476|P7|Overall Study|Patient declared ineligible|0
5480846|NCT01836549|18949477|P6|Overall Study|Patient declared ineligible|0
5480847|NCT01836549|18949478|P5|Overall Study|Patient declared ineligible|0
5480848|NCT01836549|18949479|P4|Overall Study|Patient declared ineligible|1
5480849|NCT01836549|18949480|P3|Overall Study|Patient declared ineligible|0
5480850|NCT01836549|18949481|P2|Overall Study|Patient declared ineligible|0
5480851|NCT01836549|18949482|P1|Overall Study|Patient declared ineligible|0
5480852|NCT01836549|18949476|P7|Overall Study|Did not receive study drug|0
5480853|NCT01836549|18949477|P6|Overall Study|Did not receive study drug|0
5480854|NCT01836549|18949478|P5|Overall Study|Did not receive study drug|0
5480855|NCT01836549|18949479|P4|Overall Study|Did not receive study drug|0
5480856|NCT01836549|18949480|P3|Overall Study|Did not receive study drug|1
5480857|NCT01836549|18949481|P2|Overall Study|Did not receive study drug|0
5480858|NCT01836549|18949482|P1|Overall Study|Did not receive study drug|0
5480859|NCT01836523|18949506|P4|Overall Study|Unclassified|29
5480860|NCT01836523|18949507|P3|Overall Study|Unclassified|19
5480861|NCT01836523|18949508|P2|Overall Study|Unclassified|28
5480862|NCT01836523|18949509|P1|Overall Study|Unclassified|17
5480863|NCT01836523|18949506|P4|Overall Study|Met Withdrawal Criteria|27
5480864|NCT01836523|18949507|P3|Overall Study|Met Withdrawal Criteria|21
5480865|NCT01836523|18949508|P2|Overall Study|Met Withdrawal Criteria|13
5480866|NCT01836523|18949509|P1|Overall Study|Met Withdrawal Criteria|13
5480867|NCT01836523|18949506|P4|Overall Study|Protocol Violation|4
5480868|NCT01836523|18949507|P3|Overall Study|Protocol Violation|2
5480869|NCT01836523|18949508|P2|Overall Study|Protocol Violation|3
5480870|NCT01836523|18949509|P1|Overall Study|Protocol Violation|6
5480871|NCT01836523|18949506|P4|Overall Study|Adverse Event|14
5480872|NCT01836523|18949507|P3|Overall Study|Adverse Event|49
5480873|NCT01836523|18949508|P2|Overall Study|Adverse Event|41
5480874|NCT01836523|18949509|P1|Overall Study|Adverse Event|15
5480875|NCT01836471|18949536|P5|Overall Study|Non compliance with tx|0
5480876|NCT01836471|18949537|P4|Overall Study|Non compliance with tx|0
5480877|NCT01836471|18949538|P3|Overall Study|Non compliance with tx|0
5480878|NCT01836471|18949539|P2|Overall Study|Non compliance with tx|1
5480879|NCT01836471|18949540|P1|Overall Study|Non compliance with tx|1
5480880|NCT01836471|18949536|P5|Overall Study|Adverse Event|2
5480881|NCT01836471|18949537|P4|Overall Study|Adverse Event|1
5480882|NCT01836471|18949538|P3|Overall Study|Adverse Event|1
5480883|NCT01836471|18949539|P2|Overall Study|Adverse Event|3
5480884|NCT01836471|18949540|P1|Overall Study|Adverse Event|6
5480885|NCT01836471|18949536|P5|Overall Study|Lost to Follow-up|1
5480886|NCT01836471|18949537|P4|Overall Study|Lost to Follow-up|1
5480887|NCT01836471|18949538|P3|Overall Study|Lost to Follow-up|0
5480888|NCT01836471|18949539|P2|Overall Study|Lost to Follow-up|0
5480889|NCT01836471|18949540|P1|Overall Study|Lost to Follow-up|0
5480890|NCT01836471|18949536|P5|Overall Study|Physician Decision|0
5480891|NCT01836471|18949537|P4|Overall Study|Physician Decision|0
5480892|NCT01836471|18949538|P3|Overall Study|Physician Decision|0
5480893|NCT01836471|18949539|P2|Overall Study|Physician Decision|1
5480894|NCT01836471|18949540|P1|Overall Study|Physician Decision|0
5480895|NCT01836471|18949536|P5|Overall Study|Withdrawal by Subject|2
5480896|NCT01836471|18949537|P4|Overall Study|Withdrawal by Subject|0
5480897|NCT01836471|18949538|P3|Overall Study|Withdrawal by Subject|1
5480898|NCT01836471|18949539|P2|Overall Study|Withdrawal by Subject|4
5480899|NCT01836471|18949540|P1|Overall Study|Withdrawal by Subject|3
5480900|NCT01836471|18949536|P5|Overall Study|Pregnancy|0
5480901|NCT01836471|18949537|P4|Overall Study|Pregnancy|0
5480902|NCT01836471|18949538|P3|Overall Study|Pregnancy|0
5480903|NCT01836471|18949539|P2|Overall Study|Pregnancy|0
5480904|NCT01836471|18949540|P1|Overall Study|Pregnancy|1
5480905|NCT01836458|18949569|P4|Overall Study|Unsatisfactory therapeutic effect|6
5480906|NCT01836458|18949570|P3|Overall Study|Unsatisfactory therapeutic effect|5
5480907|NCT01836458|18949571|P2|Overall Study|Unsatisfactory therapeutic effect|2
5480908|NCT01836458|18949572|P1|Overall Study|Unsatisfactory therapeutic effect|3
5480909|NCT01836276|18949657|P2|Overall Study|Lost to Follow-up|51
5480910|NCT01836276|18949658|P1|Overall Study|Lost to Follow-up|28
5480911|NCT01836198|18949666|P3|Part A, Period 2|Protocol Violation|0
5480912|NCT01836198|18949667|P2|Part A, Period 2|Protocol Violation|1
5480913|NCT01836198|18949668|P1|Part A, Period 2|Protocol Violation|0
5480914|NCT01835899|18949770|P3|Overall Study|Other than stated above|0
5480915|NCT01835899|18949771|P2|Overall Study|Other than stated above|1
5480916|NCT01835899|18949772|P1|Overall Study|Other than stated above|0
5480917|NCT01835899|18949770|P3|Overall Study|Adverse Event|1
5480918|NCT01835899|18949771|P2|Overall Study|Adverse Event|0
5480919|NCT01835899|18949772|P1|Overall Study|Adverse Event|0
5480920|NCT01835587|18949829|P4|Overall Study|Miscellaneous|0
5480921|NCT01835587|18949830|P3|Overall Study|Miscellaneous|0
5480922|NCT01835587|18949831|P2|Overall Study|Miscellaneous|1
5480923|NCT01835587|18949832|P1|Overall Study|Miscellaneous|0
5480924|NCT01835587|18949829|P4|Overall Study|Death|1
5480925|NCT01835587|18949830|P3|Overall Study|Death|0
5480926|NCT01835587|18949831|P2|Overall Study|Death|0
5480927|NCT01835587|18949832|P1|Overall Study|Death|0
5480928|NCT01835587|18949829|P4|Overall Study|Adverse Event|2
5480929|NCT01835587|18949830|P3|Overall Study|Adverse Event|2
5480930|NCT01835587|18949831|P2|Overall Study|Adverse Event|0
5480931|NCT01835587|18949832|P1|Overall Study|Adverse Event|0
5480932|NCT01835587|18949829|P4|Overall Study|Withdrawal by Subject|3
5480933|NCT01835587|18949830|P3|Overall Study|Withdrawal by Subject|0
5480934|NCT01835587|18949831|P2|Overall Study|Withdrawal by Subject|0
5480935|NCT01835587|18949832|P1|Overall Study|Withdrawal by Subject|2
5480936|NCT01835587|18949829|P4|Overall Study|Disease Recurrence or Relapse|3
5480937|NCT01835587|18949830|P3|Overall Study|Disease Recurrence or Relapse|0
5480938|NCT01835587|18949831|P2|Overall Study|Disease Recurrence or Relapse|3
5480939|NCT01835587|18949832|P1|Overall Study|Disease Recurrence or Relapse|0
5480940|NCT01835548|18949893|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
5480941|NCT01835548|18949894|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5480942|NCT01835548|18949895|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5480943|NCT01835548|18949893|P3|Double-Blind Treatment Period|Adverse Event|0
5480944|NCT01835548|18949894|P2|Double-Blind Treatment Period|Adverse Event|1
5480945|NCT01835548|18949895|P1|Double-Blind Treatment Period|Adverse Event|0
5480946|NCT01835548|18949893|P3|Dose Optimization Period|Withdrawal by Subject|1
5480947|NCT01835548|18949894|P2|Dose Optimization Period|Withdrawal by Subject|0
5480948|NCT01835548|18949895|P1|Dose Optimization Period|Withdrawal by Subject|0
5480949|NCT01835548|18949893|P3|Dose Optimization Period|Adverse Event|1
5480950|NCT01835548|18949894|P2|Dose Optimization Period|Adverse Event|0
5480951|NCT01835548|18949895|P1|Dose Optimization Period|Adverse Event|0
5480952|NCT01835470|18949924|P1|Long Term Treatment Period|Lack of Efficacy|3
5480953|NCT01835470|18949924|P1|Long Term Treatment Period|Subject Request to Discontinue|1
5480954|NCT01835431|18949936|P2|Overall Study|Protocol Violation|0
5480955|NCT01835431|18949937|P1|Overall Study|Protocol Violation|1
5480956|NCT01835431|18949936|P2|Overall Study|Withdrawal by Subject|10
5480957|NCT01835431|18949937|P1|Overall Study|Withdrawal by Subject|6
5480958|NCT01835431|18949936|P2|Overall Study|other|2
5480959|NCT01835431|18949937|P1|Overall Study|other|0
5480960|NCT01835431|18949936|P2|Overall Study|Adverse Event|0
5480961|NCT01835431|18949937|P1|Overall Study|Adverse Event|1
5480962|NCT01835223|18949977|P2|Overall Study|Became Inelligible|0
5480963|NCT01835223|18949978|P1|Overall Study|Became Inelligible|4
5480964|NCT01835223|18949977|P2|Overall Study|Disease progression|1
5480965|NCT01835223|18949978|P1|Overall Study|Disease progression|2
5480966|NCT01835223|18949977|P2|Overall Study|Withdrawal by Subject|0
5480967|NCT01835223|18949978|P1|Overall Study|Withdrawal by Subject|2
5480968|NCT01835223|18949977|P2|Overall Study|Adverse Event|0
5480969|NCT01835223|18949978|P1|Overall Study|Adverse Event|1
5480970|NCT01835158|18949998|P2|Overall Study|Withdrawal by Subject|6
5480971|NCT01835158|18949999|P1|Overall Study|Withdrawal by Subject|1
5480972|NCT01835145|18950011|P2|Overall Study|Ineligible prior to treatment|0
5480973|NCT01835145|18950012|P1|Overall Study|Ineligible prior to treatment|1
5480974|NCT01835132|18950027|P1|Initial Phase|Insufficient Therapeutic Response|2
5480975|NCT01835015|18950072|P5|Overall Study|Adverse Event|0
5480976|NCT01835015|18950073|P4|Overall Study|Adverse Event|0
5480977|NCT01835015|18950074|P3|Overall Study|Adverse Event|1
5480978|NCT01835015|18950075|P2|Overall Study|Adverse Event|0
5480979|NCT01835015|18950076|P1|Overall Study|Adverse Event|0
5480980|NCT01834729|18950153|P4|Overall Study|Adverse Event|2
5480981|NCT01834729|18950154|P3|Overall Study|Adverse Event|0
5480982|NCT01834729|18950155|P2|Overall Study|Adverse Event|0
5480983|NCT01834729|18950156|P1|Overall Study|Adverse Event|0
5480984|NCT01834729|18950153|P4|Overall Study|Withdrawal by Subject|0
5480985|NCT01834729|18950154|P3|Overall Study|Withdrawal by Subject|0
5480986|NCT01834729|18950155|P2|Overall Study|Withdrawal by Subject|1
5480987|NCT01834729|18950156|P1|Overall Study|Withdrawal by Subject|1
5480988|NCT01834729|18950153|P4|Overall Study|Did not return bowel diaries|0
5480989|NCT01834729|18950154|P3|Overall Study|Did not return bowel diaries|3
5480990|NCT01834729|18950155|P2|Overall Study|Did not return bowel diaries|0
5480991|NCT01834729|18950156|P1|Overall Study|Did not return bowel diaries|0
5480992|NCT01834586|18950189|P1|Overall Study|Adverse Event|1
5480993|NCT01834274|18950229|P2|Overall Study|Other|1
5480994|NCT01834274|18950230|P1|Overall Study|Other|2
5480995|NCT01834274|18950229|P2|Overall Study|Lost to Follow-up|1
5480996|NCT01834274|18950230|P1|Overall Study|Lost to Follow-up|3
5480997|NCT01834274|18950229|P2|Overall Study|Withdrawal by Subject|1
5480998|NCT01834274|18950230|P1|Overall Study|Withdrawal by Subject|1
5480999|NCT01834274|18950229|P2|Overall Study|Study Termination|38
5481000|NCT01834274|18950230|P1|Overall Study|Study Termination|41
5481001|NCT01834222|18950253|P1|Overall Study|Not meet inclusion/exclusion criteria|1
5481002|NCT01833897|18950348|P1|Overall Study|Lack of Efficacy|1
5481003|NCT01833832|18950360|P1|Overall Study|Pt could not be cytoreduced for HIPEC|1
5481004|NCT01833533|18950515|P2|Overall Study|Other|7
5481005|NCT01833533|18950516|P1|Overall Study|Other|2
5481006|NCT01833533|18950515|P2|Overall Study|To Enter an Extension Study|4
5481007|NCT01833533|18950516|P1|Overall Study|To Enter an Extension Study|0
5481008|NCT01833533|18950515|P2|Overall Study|Lost to Follow-up|9
5481009|NCT01833533|18950516|P1|Overall Study|Lost to Follow-up|4
5481010|NCT01833533|18950515|P2|Overall Study|Adverse Event|1
5481011|NCT01833533|18950516|P1|Overall Study|Adverse Event|0
5481012|NCT01833494|18950530|P1|Overall Study|Increase in serum ferritin|1
5481013|NCT01833494|18950530|P1|Overall Study|Decrease in serum calcium|4
5481014|NCT01833494|18950530|P1|Overall Study|Decrease in serum phosphorus|4
5481015|NCT01833494|18950530|P1|Overall Study|Withdrawal by Subject|6
5481016|NCT01833494|18950530|P1|Overall Study|Physician Decision|6
5481017|NCT01833494|18950530|P1|Overall Study|Adverse Event|24
5481018|NCT01833455|18950558|P2|Overall Study|Withdrawal by Subject|0
5481019|NCT01833455|18950559|P1|Overall Study|Withdrawal by Subject|1
5481020|NCT01833169|18950588|P1|Overall Study|Physician Decision|2
5481021|NCT01833169|18950588|P1|Overall Study|Death|3
5481022|NCT01833169|18950588|P1|Overall Study|Withdrawal by Subject|9
5481023|NCT01833169|18950588|P1|Overall Study|Adverse Event|33
5481024|NCT01833169|18950588|P1|Overall Study|Disease Progression|99
5481025|NCT01833143|18950599|P1|Overall Study|Not Treated|1
5481026|NCT01833065|18950664|P5|Overall Study|Others|4
5481027|NCT01833065|18950665|P4|Overall Study|Others|1
5481028|NCT01833065|18950666|P3|Overall Study|Others|1
5481029|NCT01833065|18950667|P2|Overall Study|Others|1
5481030|NCT01833065|18950668|P1|Overall Study|Others|2
5481031|NCT01833065|18950664|P5|Overall Study|Trial terminated by sponsor|13
5481032|NCT01833065|18950665|P4|Overall Study|Trial terminated by sponsor|3
5481033|NCT01833065|18950666|P3|Overall Study|Trial terminated by sponsor|7
5481034|NCT01833065|18950667|P2|Overall Study|Trial terminated by sponsor|8
5481035|NCT01833065|18950668|P1|Overall Study|Trial terminated by sponsor|8
5481036|NCT01833065|18950664|P5|Overall Study|Subject's substantial non-compliance|0
5481037|NCT01833065|18950665|P4|Overall Study|Subject's substantial non-compliance|0
5481038|NCT01833065|18950666|P3|Overall Study|Subject's substantial non-compliance|0
5481039|NCT01833065|18950667|P2|Overall Study|Subject's substantial non-compliance|1
5481040|NCT01833065|18950668|P1|Overall Study|Subject's substantial non-compliance|0
5481041|NCT01833065|18950664|P5|Overall Study|Withdrawal by Subject|11
5481042|NCT01833065|18950665|P4|Overall Study|Withdrawal by Subject|3
5481043|NCT01833065|18950666|P3|Overall Study|Withdrawal by Subject|4
5481044|NCT01833065|18950667|P2|Overall Study|Withdrawal by Subject|2
5481045|NCT01833065|18950668|P1|Overall Study|Withdrawal by Subject|6
5481046|NCT01833065|18950664|P5|Overall Study|Lost to Follow-up|3
5481047|NCT01833065|18950665|P4|Overall Study|Lost to Follow-up|0
5481048|NCT01833065|18950666|P3|Overall Study|Lost to Follow-up|0
5481049|NCT01833065|18950667|P2|Overall Study|Lost to Follow-up|0
5481050|NCT01833065|18950668|P1|Overall Study|Lost to Follow-up|1
5481051|NCT01833065|18950664|P5|Overall Study|Protocol Violation|2
5481052|NCT01833065|18950665|P4|Overall Study|Protocol Violation|0
5481053|NCT01833065|18950666|P3|Overall Study|Protocol Violation|0
5481054|NCT01833065|18950667|P2|Overall Study|Protocol Violation|0
5481055|NCT01833065|18950668|P1|Overall Study|Protocol Violation|1
5481056|NCT01833065|18950664|P5|Overall Study|Adverse Event|3
5481057|NCT01833065|18950665|P4|Overall Study|Adverse Event|2
5481058|NCT01833065|18950666|P3|Overall Study|Adverse Event|0
5481059|NCT01833065|18950667|P2|Overall Study|Adverse Event|1
5481060|NCT01833065|18950668|P1|Overall Study|Adverse Event|6
5481061|NCT01832818|18950737|P1|Overall Study|Lost to Follow-up|6
5481062|NCT01832766|18950746|P2|Washout|Lost to Follow-up|1
5481063|NCT01832766|18950747|P1|Washout|Lost to Follow-up|0
5481064|NCT01832727|18950783|P9|Overall Study|Study terminated by sponsor|1
5481065|NCT01832727|18950784|P8|Overall Study|Study terminated by sponsor|1
5481066|NCT01832727|18950785|P7|Overall Study|Study terminated by sponsor|0
5481067|NCT01832727|18950786|P6|Overall Study|Study terminated by sponsor|0
5481068|NCT01832727|18950787|P5|Overall Study|Study terminated by sponsor|0
5481069|NCT01832727|18950788|P4|Overall Study|Study terminated by sponsor|0
5481070|NCT01832727|18950789|P3|Overall Study|Study terminated by sponsor|0
5481071|NCT01832727|18950790|P2|Overall Study|Study terminated by sponsor|0
5481072|NCT01832727|18950791|P1|Overall Study|Study terminated by sponsor|0
5481073|NCT01832727|18950783|P9|Overall Study|Withdrawal by Subject|1
5481074|NCT01832727|18950784|P8|Overall Study|Withdrawal by Subject|2
5481075|NCT01832727|18950785|P7|Overall Study|Withdrawal by Subject|0
5481076|NCT01832727|18950786|P6|Overall Study|Withdrawal by Subject|1
5481077|NCT01832727|18950787|P5|Overall Study|Withdrawal by Subject|0
5481078|NCT01832727|18950788|P4|Overall Study|Withdrawal by Subject|1
5481079|NCT01832727|18950789|P3|Overall Study|Withdrawal by Subject|0
5481080|NCT01832727|18950790|P2|Overall Study|Withdrawal by Subject|1
5481081|NCT01832727|18950791|P1|Overall Study|Withdrawal by Subject|1
5481082|NCT01832727|18950783|P9|Overall Study|Physician Decision|0
5481083|NCT01832727|18950784|P8|Overall Study|Physician Decision|0
5481084|NCT01832727|18950785|P7|Overall Study|Physician Decision|0
5481085|NCT01832727|18950786|P6|Overall Study|Physician Decision|1
5481086|NCT01832727|18950787|P5|Overall Study|Physician Decision|0
5481087|NCT01832727|18950788|P4|Overall Study|Physician Decision|1
5481088|NCT01832727|18950789|P3|Overall Study|Physician Decision|0
5481089|NCT01832727|18950790|P2|Overall Study|Physician Decision|0
5481090|NCT01832727|18950791|P1|Overall Study|Physician Decision|1
5481091|NCT01832727|18950783|P9|Overall Study|Lost to Follow-up|0
5481092|NCT01832727|18950784|P8|Overall Study|Lost to Follow-up|0
5481093|NCT01832727|18950785|P7|Overall Study|Lost to Follow-up|0
5481094|NCT01832727|18950786|P6|Overall Study|Lost to Follow-up|0
5481095|NCT01832727|18950787|P5|Overall Study|Lost to Follow-up|0
5481096|NCT01832727|18950788|P4|Overall Study|Lost to Follow-up|1
5481097|NCT01832727|18950789|P3|Overall Study|Lost to Follow-up|0
5481098|NCT01832727|18950790|P2|Overall Study|Lost to Follow-up|0
5481099|NCT01832727|18950791|P1|Overall Study|Lost to Follow-up|0
5481100|NCT01832727|18950783|P9|Overall Study|Disease progression|7
5481101|NCT01832727|18950784|P8|Overall Study|Disease progression|2
5481102|NCT01832727|18950785|P7|Overall Study|Disease progression|6
5481103|NCT01832727|18950786|P6|Overall Study|Disease progression|3
5481104|NCT01832727|18950787|P5|Overall Study|Disease progression|3
5481105|NCT01832727|18950788|P4|Overall Study|Disease progression|1
5481106|NCT01832727|18950789|P3|Overall Study|Disease progression|2
5481107|NCT01832727|18950790|P2|Overall Study|Disease progression|0
5481108|NCT01832727|18950791|P1|Overall Study|Disease progression|3
5481109|NCT01832727|18950783|P9|Overall Study|Adverse Event|9
5481110|NCT01832727|18950784|P8|Overall Study|Adverse Event|1
5481111|NCT01832727|18950785|P7|Overall Study|Adverse Event|2
5481112|NCT01832727|18950786|P6|Overall Study|Adverse Event|1
5481113|NCT01832727|18950787|P5|Overall Study|Adverse Event|1
5481114|NCT01832727|18950788|P4|Overall Study|Adverse Event|0
5481115|NCT01832727|18950789|P3|Overall Study|Adverse Event|1
5481116|NCT01832727|18950790|P2|Overall Study|Adverse Event|6
5481117|NCT01832727|18950791|P1|Overall Study|Adverse Event|4
5481118|NCT01832532|18950904|P2|Overall Study|Withdrawal by Subject|2
5481119|NCT01832532|18950905|P1|Overall Study|Withdrawal by Subject|5
5481120|NCT01832493|18950967|P1|Overall Study|Unable to place LV lead|2
5481121|NCT01832493|18950967|P1|Overall Study|Protocol Violation|4
5481122|NCT01832493|18950967|P1|Overall Study|Physician Decision|2
5481123|NCT01832480|18950976|P2|Overall Study|post randomization ineligible|10
5481124|NCT01832480|18950977|P1|Overall Study|post randomization ineligible|8
5481125|NCT01832480|18950976|P2|Overall Study|Withdrawal by Subject|2
5481126|NCT01832480|18950977|P1|Overall Study|Withdrawal by Subject|0
5481127|NCT01832480|18950976|P2|Overall Study|Lost to Follow-up|30
5481128|NCT01832480|18950977|P1|Overall Study|Lost to Follow-up|33
5481129|NCT01832402|18950985|P2|Overall Study|Declining Performance status|1
5481130|NCT01832402|18950986|P1|Overall Study|Declining Performance status|2
5481131|NCT01832402|18950985|P2|Overall Study|Withdrawal by Subject|3
5481132|NCT01832402|18950986|P1|Overall Study|Withdrawal by Subject|3
5481133|NCT01832402|18950985|P2|Overall Study|Lost to Follow-up|0
5481134|NCT01832402|18950986|P1|Overall Study|Lost to Follow-up|2
5481135|NCT01832155|18951013|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
5481136|NCT01832155|18951014|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
5481137|NCT01832155|18951013|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
5481138|NCT01832155|18951014|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
5481139|NCT01832038|18951081|P1|Overall Study|Subject considered the efficacy was poor|1
5481140|NCT01832038|18951081|P1|Overall Study|Pregnancy and abortion in EP0008 study|1
5481141|NCT01832038|18951081|P1|Overall Study|Prohibited concomitant medication|1
5481142|NCT01832038|18951081|P1|Overall Study|Bad mood and has suicidal thought|1
5481143|NCT01832038|18951081|P1|Overall Study|Plan to pregnancy|7
5481144|NCT01832038|18951081|P1|Overall Study|Changes of implementation system|3
5481145|NCT01832038|18951081|P1|Overall Study|Not possible to visit the hospital|1
5481146|NCT01832038|18951081|P1|Overall Study|Prohibit procedure|2
5481147|NCT01832038|18951081|P1|Overall Study|Low compliance|3
5481148|NCT01832038|18951081|P1|Overall Study|Pregnancy|1
5481149|NCT01832038|18951081|P1|Overall Study|Back home|1
5481150|NCT01832038|18951081|P1|Overall Study|Participant was asked to quit|5
5481151|NCT01832038|18951081|P1|Overall Study|Not convenient to come back to site|2
5481152|NCT01832038|18951081|P1|Overall Study|Subject refused to return visit|2
5481153|NCT01832038|18951081|P1|Overall Study|Visit non-compliance|2
5481154|NCT01832038|18951081|P1|Overall Study|Withdrawal by Subject|49
5481155|NCT01832038|18951081|P1|Overall Study|Lost to Follow-up|10
5481156|NCT01832038|18951081|P1|Overall Study|Protocol Violation|7
5481157|NCT01832038|18951081|P1|Overall Study|Lack of Efficacy|81
5481158|NCT01832038|18951081|P1|Overall Study|Adverse Event|50
5481159|NCT01832038|18951081|P1|Overall Study|Death|5
5481160|NCT01831856|18951139|P2|Overall Study|Unsuccessful Electrical Cardioversion|18
5481161|NCT01831856|18951140|P1|Overall Study|Unsuccessful Electrical Cardioversion|16
5481162|NCT01831856|18951139|P2|Overall Study|Lack of Efficacy|11
5481163|NCT01831856|18951140|P1|Overall Study|Lack of Efficacy|13
5481164|NCT01831856|18951139|P2|Overall Study|Adverse Event|8
5481165|NCT01831856|18951140|P1|Overall Study|Adverse Event|5
5481166|NCT01831817|18951150|P4|Overall Study|Withdrawl of Consent|0
5481167|NCT01831817|18951151|P3|Overall Study|Withdrawl of Consent|0
5481168|NCT01831817|18951152|P2|Overall Study|Withdrawl of Consent|0
5481169|NCT01831817|18951153|P1|Overall Study|Withdrawl of Consent|3
5481170|NCT01831817|18951150|P4|Overall Study|Lost to Follow-up|0
5481171|NCT01831817|18951151|P3|Overall Study|Lost to Follow-up|0
5481172|NCT01831817|18951152|P2|Overall Study|Lost to Follow-up|0
5481173|NCT01831817|18951153|P1|Overall Study|Lost to Follow-up|1
5481174|NCT01831804|18951200|P9|Overall Study|Withdrew Consent|0
5481175|NCT01831804|18951201|P8|Overall Study|Withdrew Consent|2
5481176|NCT01831804|18951202|P7|Overall Study|Withdrew Consent|0
5481177|NCT01831804|18951203|P6|Overall Study|Withdrew Consent|0
5481178|NCT01831804|18951204|P5|Overall Study|Withdrew Consent|0
5481179|NCT01831804|18951205|P4|Overall Study|Withdrew Consent|0
5481180|NCT01831804|18951206|P3|Overall Study|Withdrew Consent|0
5481181|NCT01831804|18951207|P2|Overall Study|Withdrew Consent|1
5481182|NCT01831804|18951208|P1|Overall Study|Withdrew Consent|0
5481183|NCT01831804|18951200|P9|Overall Study|Investigator discretion|0
5481184|NCT01831804|18951201|P8|Overall Study|Investigator discretion|1
5481185|NCT01831804|18951202|P7|Overall Study|Investigator discretion|0
5481186|NCT01831804|18951203|P6|Overall Study|Investigator discretion|0
5481187|NCT01831804|18951204|P5|Overall Study|Investigator discretion|1
5481188|NCT01831804|18951205|P4|Overall Study|Investigator discretion|0
5481189|NCT01831804|18951206|P3|Overall Study|Investigator discretion|0
5481190|NCT01831804|18951207|P2|Overall Study|Investigator discretion|0
5481191|NCT01831804|18951208|P1|Overall Study|Investigator discretion|0
5481192|NCT01831804|18951200|P9|Overall Study|Lost to Follow-up|1
5481193|NCT01831804|18951201|P8|Overall Study|Lost to Follow-up|0
5481194|NCT01831804|18951202|P7|Overall Study|Lost to Follow-up|0
5481195|NCT01831804|18951203|P6|Overall Study|Lost to Follow-up|0
5481196|NCT01831804|18951204|P5|Overall Study|Lost to Follow-up|0
5481197|NCT01831804|18951205|P4|Overall Study|Lost to Follow-up|0
5481198|NCT01831804|18951206|P3|Overall Study|Lost to Follow-up|1
5481199|NCT01831804|18951207|P2|Overall Study|Lost to Follow-up|0
5481200|NCT01831804|18951208|P1|Overall Study|Lost to Follow-up|0
5481201|NCT01831804|18951200|P9|Overall Study|Protocol defined stopping criteria|0
5481202|NCT01831804|18951201|P8|Overall Study|Protocol defined stopping criteria|0
5481203|NCT01831804|18951202|P7|Overall Study|Protocol defined stopping criteria|0
5481204|NCT01831804|18951203|P6|Overall Study|Protocol defined stopping criteria|0
5481205|NCT01831804|18951204|P5|Overall Study|Protocol defined stopping criteria|1
5481206|NCT01831804|18951205|P4|Overall Study|Protocol defined stopping criteria|0
5481207|NCT01831804|18951206|P3|Overall Study|Protocol defined stopping criteria|3
5481208|NCT01831804|18951207|P2|Overall Study|Protocol defined stopping criteria|1
5481209|NCT01831804|18951208|P1|Overall Study|Protocol defined stopping criteria|1
5481210|NCT01831804|18951200|P9|Overall Study|Protocol Violation|0
5481211|NCT01831804|18951201|P8|Overall Study|Protocol Violation|0
5481212|NCT01831804|18951202|P7|Overall Study|Protocol Violation|0
5481213|NCT01831804|18951203|P6|Overall Study|Protocol Violation|0
5481214|NCT01831804|18951204|P5|Overall Study|Protocol Violation|0
5481215|NCT01831804|18951205|P4|Overall Study|Protocol Violation|0
5481216|NCT01831804|18951206|P3|Overall Study|Protocol Violation|2
5481217|NCT01831804|18951207|P2|Overall Study|Protocol Violation|0
5481218|NCT01831804|18951208|P1|Overall Study|Protocol Violation|0
5481219|NCT01831804|18951200|P9|Overall Study|Adverse Event|1
5481220|NCT01831804|18951201|P8|Overall Study|Adverse Event|0
5481221|NCT01831804|18951202|P7|Overall Study|Adverse Event|1
5481222|NCT01831804|18951203|P6|Overall Study|Adverse Event|0
5481223|NCT01831804|18951204|P5|Overall Study|Adverse Event|0
5481224|NCT01831804|18951205|P4|Overall Study|Adverse Event|0
5481225|NCT01831804|18951206|P3|Overall Study|Adverse Event|0
5481226|NCT01831804|18951207|P2|Overall Study|Adverse Event|0
5481227|NCT01831804|18951208|P1|Overall Study|Adverse Event|0
5481228|NCT01831791|18951303|P1|Overall Study|Withdrawal by Subject|10
5481229|NCT01831765|18951332|P3|Overall Study|Lost to Follow-up|3
5481230|NCT01831765|18951333|P2|Overall Study|Lost to Follow-up|3
5481231|NCT01831765|18951334|P1|Overall Study|Lost to Follow-up|2
5481232|NCT01831765|18951332|P3|Overall Study|Withdrawal criteria|16
5481233|NCT01831765|18951333|P2|Overall Study|Withdrawal criteria|10
5481234|NCT01831765|18951334|P1|Overall Study|Withdrawal criteria|12
5481235|NCT01831765|18951332|P3|Overall Study|Withdrawal by Subject|17
5481236|NCT01831765|18951333|P2|Overall Study|Withdrawal by Subject|7
5481237|NCT01831765|18951334|P1|Overall Study|Withdrawal by Subject|22
5481238|NCT01831765|18951332|P3|Overall Study|Adverse Event|3
5481239|NCT01831765|18951333|P2|Overall Study|Adverse Event|3
5481240|NCT01831765|18951334|P1|Overall Study|Adverse Event|5
5481241|NCT01831765|18951332|P3|Overall Study|Other, site closed|0
5481242|NCT01831765|18951333|P2|Overall Study|Other, site closed|1
5481243|NCT01831765|18951334|P1|Overall Study|Other, site closed|1
5481244|NCT01831765|18951332|P3|Overall Study|Death|1
5481245|NCT01831765|18951333|P2|Overall Study|Death|1
5481246|NCT01831765|18951334|P1|Overall Study|Death|0
5481247|NCT01831765|18951332|P3|Overall Study|Pregnancy|2
5481248|NCT01831765|18951333|P2|Overall Study|Pregnancy|1
5481249|NCT01831765|18951334|P1|Overall Study|Pregnancy|1
5481250|NCT01831765|18951332|P3|Overall Study|Other, sponsor withdrew subject|0
5481251|NCT01831765|18951333|P2|Overall Study|Other, sponsor withdrew subject|1
5481252|NCT01831765|18951334|P1|Overall Study|Other, sponsor withdrew subject|0
5481253|NCT01831765|18951332|P3|Overall Study|Lack of Efficacy|0
5481254|NCT01831765|18951333|P2|Overall Study|Lack of Efficacy|0
5481255|NCT01831765|18951334|P1|Overall Study|Lack of Efficacy|1
5481256|NCT01831726|18951360|P1|Overall Study|Subject/guardian decision|7
5481257|NCT01831726|18951360|P1|Overall Study|Physician Decision|1
5481258|NCT01831726|18951360|P1|Overall Study|Disease Progression|49
5481259|NCT01831726|18951360|P1|Overall Study|Death|7
5481260|NCT01831726|18951360|P1|Overall Study|Adverse Event|16
5481261|NCT01831596|18951367|P1|Overall Study|Other|8
5481262|NCT01831544|18951371|P1|Overall Study|Still on original MVAD device|2
5481263|NCT01831544|18951371|P1|Overall Study|Death|1
5481264|NCT01831466|18951400|P12|Overall Study|Adverse Event|2
5481265|NCT01831466|18951401|P11|Overall Study|Adverse Event|0
5481266|NCT01831466|18951402|P10|Overall Study|Adverse Event|1
5481267|NCT01831466|18951403|P9|Overall Study|Adverse Event|1
5481268|NCT01831466|18951404|P8|Overall Study|Adverse Event|1
5481269|NCT01831466|18951405|P7|Overall Study|Adverse Event|0
5481270|NCT01831466|18951406|P6|Overall Study|Adverse Event|7
5481271|NCT01831466|18951407|P5|Overall Study|Adverse Event|3
5481272|NCT01831466|18951408|P4|Overall Study|Adverse Event|6
5481273|NCT01831466|18951409|P3|Overall Study|Adverse Event|4
5481274|NCT01831466|18951410|P2|Overall Study|Adverse Event|0
5481275|NCT01831466|18951411|P1|Overall Study|Adverse Event|0
5481276|NCT01831466|18951400|P12|Overall Study|Lack of Efficacy|0
5481277|NCT01831466|18951401|P11|Overall Study|Lack of Efficacy|2
5481278|NCT01831466|18951402|P10|Overall Study|Lack of Efficacy|2
5481279|NCT01831466|18951403|P9|Overall Study|Lack of Efficacy|2
5481280|NCT01831466|18951404|P8|Overall Study|Lack of Efficacy|1
5481281|NCT01831466|18951405|P7|Overall Study|Lack of Efficacy|1
5481282|NCT01831466|18951406|P6|Overall Study|Lack of Efficacy|8
5481283|NCT01831466|18951407|P5|Overall Study|Lack of Efficacy|9
5481284|NCT01831466|18951408|P4|Overall Study|Lack of Efficacy|6
5481285|NCT01831466|18951409|P3|Overall Study|Lack of Efficacy|7
5481286|NCT01831466|18951410|P2|Overall Study|Lack of Efficacy|8
5481287|NCT01831466|18951411|P1|Overall Study|Lack of Efficacy|5
5481288|NCT01831466|18951400|P12|Overall Study|Lost to Follow-up|1
5481289|NCT01831466|18951401|P11|Overall Study|Lost to Follow-up|0
5481290|NCT01831466|18951402|P10|Overall Study|Lost to Follow-up|1
5481291|NCT01831466|18951403|P9|Overall Study|Lost to Follow-up|0
5481292|NCT01831466|18951404|P8|Overall Study|Lost to Follow-up|0
5481293|NCT01831466|18951405|P7|Overall Study|Lost to Follow-up|0
5481294|NCT01831466|18951406|P6|Overall Study|Lost to Follow-up|3
5481295|NCT01831466|18951407|P5|Overall Study|Lost to Follow-up|0
5481296|NCT01831466|18951408|P4|Overall Study|Lost to Follow-up|2
5481297|NCT01831466|18951409|P3|Overall Study|Lost to Follow-up|4
5481298|NCT01831466|18951410|P2|Overall Study|Lost to Follow-up|1
5481299|NCT01831466|18951411|P1|Overall Study|Lost to Follow-up|0
5481300|NCT01831466|18951400|P12|Overall Study|Withdrawal by Subject|1
5481301|NCT01831466|18951401|P11|Overall Study|Withdrawal by Subject|0
5481302|NCT01831466|18951402|P10|Overall Study|Withdrawal by Subject|1
5481303|NCT01831466|18951403|P9|Overall Study|Withdrawal by Subject|0
5481304|NCT01831466|18951404|P8|Overall Study|Withdrawal by Subject|0
5481305|NCT01831466|18951405|P7|Overall Study|Withdrawal by Subject|0
5481306|NCT01831466|18951406|P6|Overall Study|Withdrawal by Subject|5
5481307|NCT01831466|18951407|P5|Overall Study|Withdrawal by Subject|3
5481308|NCT01831466|18951408|P4|Overall Study|Withdrawal by Subject|3
5481309|NCT01831466|18951409|P3|Overall Study|Withdrawal by Subject|3
5481310|NCT01831466|18951410|P2|Overall Study|Withdrawal by Subject|3
5481311|NCT01831466|18951411|P1|Overall Study|Withdrawal by Subject|6
5481312|NCT01831466|18951400|P12|Overall Study|Death|0
5481313|NCT01831466|18951401|P11|Overall Study|Death|0
5481314|NCT01831466|18951402|P10|Overall Study|Death|0
5481315|NCT01831466|18951403|P9|Overall Study|Death|0
5481316|NCT01831466|18951404|P8|Overall Study|Death|0
5481317|NCT01831466|18951405|P7|Overall Study|Death|0
5481318|NCT01831466|18951406|P6|Overall Study|Death|0
5481319|NCT01831466|18951407|P5|Overall Study|Death|0
5481320|NCT01831466|18951408|P4|Overall Study|Death|0
5481321|NCT01831466|18951409|P3|Overall Study|Death|0
5481322|NCT01831466|18951410|P2|Overall Study|Death|1
5481323|NCT01831466|18951411|P1|Overall Study|Death|0
5481324|NCT01831466|18951400|P12|Overall Study|Non-compliance with study treatment|0
5481325|NCT01831466|18951401|P11|Overall Study|Non-compliance with study treatment|0
5481326|NCT01831466|18951402|P10|Overall Study|Non-compliance with study treatment|0
5481327|NCT01831466|18951403|P9|Overall Study|Non-compliance with study treatment|0
5481328|NCT01831466|18951404|P8|Overall Study|Non-compliance with study treatment|0
5481329|NCT01831466|18951405|P7|Overall Study|Non-compliance with study treatment|0
5481330|NCT01831466|18951406|P6|Overall Study|Non-compliance with study treatment|1
5481331|NCT01831466|18951407|P5|Overall Study|Non-compliance with study treatment|0
5481332|NCT01831466|18951408|P4|Overall Study|Non-compliance with study treatment|0
5481333|NCT01831466|18951409|P3|Overall Study|Non-compliance with study treatment|1
5481334|NCT01831466|18951410|P2|Overall Study|Non-compliance with study treatment|1
5481335|NCT01831466|18951411|P1|Overall Study|Non-compliance with study treatment|2
5481336|NCT01831466|18951400|P12|Overall Study|Other|0
5481337|NCT01831466|18951401|P11|Overall Study|Other|0
5481338|NCT01831466|18951402|P10|Overall Study|Other|0
5481339|NCT01831466|18951403|P9|Overall Study|Other|0
5481340|NCT01831466|18951404|P8|Overall Study|Other|0
5481341|NCT01831466|18951405|P7|Overall Study|Other|0
5481342|NCT01831466|18951406|P6|Overall Study|Other|1
5481343|NCT01831466|18951407|P5|Overall Study|Other|2
5481344|NCT01831466|18951408|P4|Overall Study|Other|2
5481345|NCT01831466|18951409|P3|Overall Study|Other|2
5481346|NCT01831466|18951410|P2|Overall Study|Other|3
5481347|NCT01831466|18951411|P1|Overall Study|Other|2
5481348|NCT01831466|18951400|P12|Overall Study|Protocol Violation|0
5481349|NCT01831466|18951401|P11|Overall Study|Protocol Violation|0
5481350|NCT01831466|18951402|P10|Overall Study|Protocol Violation|0
5481351|NCT01831466|18951403|P9|Overall Study|Protocol Violation|0
5481352|NCT01831466|18951404|P8|Overall Study|Protocol Violation|0
5481353|NCT01831466|18951405|P7|Overall Study|Protocol Violation|0
5481354|NCT01831466|18951406|P6|Overall Study|Protocol Violation|1
5481355|NCT01831466|18951407|P5|Overall Study|Protocol Violation|0
5481356|NCT01831466|18951408|P4|Overall Study|Protocol Violation|0
5481357|NCT01831466|18951409|P3|Overall Study|Protocol Violation|2
5481358|NCT01831466|18951410|P2|Overall Study|Protocol Violation|1
5481359|NCT01831466|18951411|P1|Overall Study|Protocol Violation|1
5481360|NCT01831258|18951533|P2|Overall Study|Lost to Follow-up|2
5481361|NCT01831258|18951534|P1|Overall Study|Lost to Follow-up|3
5481362|NCT01831258|18951533|P2|Overall Study|Withdrawal by Subject|1
5481363|NCT01831258|18951534|P1|Overall Study|Withdrawal by Subject|2
5481364|NCT01831089|18951624|P6|Cohort B: Arm B|Global end of study|1
5481365|NCT01831089|18951625|P5|Cohort B: Arm B|Global end of study|0
5481366|NCT01831089|18951626|P4|Cohort B: Arm B|Global end of study|0
5481367|NCT01831089|18951627|P3|Cohort B: Arm B|Global end of study|0
5481368|NCT01831089|18951628|P2|Cohort B: Arm B|Global end of study|0
5481369|NCT01831089|18951629|P1|Cohort B: Arm B|Global end of study|0
5481370|NCT01831089|18951624|P6|Cohort B: Arm B|Adverse Event|1
5481371|NCT01831089|18951625|P5|Cohort B: Arm B|Adverse Event|0
5481372|NCT01831089|18951626|P4|Cohort B: Arm B|Adverse Event|0
5481373|NCT01831089|18951627|P3|Cohort B: Arm B|Adverse Event|0
5481374|NCT01831089|18951628|P2|Cohort B: Arm B|Adverse Event|0
5481375|NCT01831089|18951629|P1|Cohort B: Arm B|Adverse Event|0
5481376|NCT01831089|18951624|P6|Cohort B: Arm B|Never treated|2
5481377|NCT01831089|18951625|P5|Cohort B: Arm B|Never treated|0
5481378|NCT01831089|18951626|P4|Cohort B: Arm B|Never treated|0
5481379|NCT01831089|18951627|P3|Cohort B: Arm B|Never treated|0
5481380|NCT01831089|18951628|P2|Cohort B: Arm B|Never treated|0
5481381|NCT01831089|18951629|P1|Cohort B: Arm B|Never treated|0
5481382|NCT01831089|18951624|P6|Cohort B: Arm B|Physician Decision|2
5481383|NCT01831089|18951625|P5|Cohort B: Arm B|Physician Decision|0
5481384|NCT01831089|18951626|P4|Cohort B: Arm B|Physician Decision|0
5481385|NCT01831089|18951627|P3|Cohort B: Arm B|Physician Decision|0
5481386|NCT01831089|18951628|P2|Cohort B: Arm B|Physician Decision|0
5481387|NCT01831089|18951629|P1|Cohort B: Arm B|Physician Decision|0
5481388|NCT01831089|18951624|P6|Cohort B: Arm B|Progressive disease|8
5481389|NCT01831089|18951625|P5|Cohort B: Arm B|Progressive disease|0
5481390|NCT01831089|18951626|P4|Cohort B: Arm B|Progressive disease|0
5481391|NCT01831089|18951627|P3|Cohort B: Arm B|Progressive disease|0
5481392|NCT01831089|18951628|P2|Cohort B: Arm B|Progressive disease|0
5481393|NCT01831089|18951629|P1|Cohort B: Arm B|Progressive disease|0
5481394|NCT01831089|18951624|P6|Cohort V: Dose Level 5|Lost to Follow-up|0
5481395|NCT01831089|18951625|P5|Cohort V: Dose Level 5|Lost to Follow-up|1
5481396|NCT01831089|18951626|P4|Cohort V: Dose Level 5|Lost to Follow-up|0
5481397|NCT01831089|18951627|P3|Cohort V: Dose Level 5|Lost to Follow-up|0
5481398|NCT01831089|18951628|P2|Cohort V: Dose Level 5|Lost to Follow-up|0
5481399|NCT01831089|18951629|P1|Cohort V: Dose Level 5|Lost to Follow-up|0
5481400|NCT01831089|18951624|P6|Cohort V: Dose Level 5|Global end of study|0
5481401|NCT01831089|18951625|P5|Cohort V: Dose Level 5|Global end of study|2
5481402|NCT01831089|18951626|P4|Cohort V: Dose Level 5|Global end of study|0
5481403|NCT01831089|18951627|P3|Cohort V: Dose Level 5|Global end of study|0
5481404|NCT01831089|18951628|P2|Cohort V: Dose Level 5|Global end of study|0
5481405|NCT01831089|18951629|P1|Cohort V: Dose Level 5|Global end of study|0
5481406|NCT01831089|18951624|P6|Cohort V: Dose Level 5|Death|0
5481407|NCT01831089|18951625|P5|Cohort V: Dose Level 5|Death|1
5481408|NCT01831089|18951626|P4|Cohort V: Dose Level 5|Death|0
5481409|NCT01831089|18951627|P3|Cohort V: Dose Level 5|Death|0
5481410|NCT01831089|18951628|P2|Cohort V: Dose Level 5|Death|0
5481411|NCT01831089|18951629|P1|Cohort V: Dose Level 5|Death|0
5481412|NCT01831089|18951624|P6|Cohort V: Dose Level 5|Withdrawal by Subject|0
5481413|NCT01831089|18951625|P5|Cohort V: Dose Level 5|Withdrawal by Subject|3
5481414|NCT01831089|18951626|P4|Cohort V: Dose Level 5|Withdrawal by Subject|0
5481415|NCT01831089|18951627|P3|Cohort V: Dose Level 5|Withdrawal by Subject|0
5481416|NCT01831089|18951628|P2|Cohort V: Dose Level 5|Withdrawal by Subject|0
5481417|NCT01831089|18951629|P1|Cohort V: Dose Level 5|Withdrawal by Subject|0
5481418|NCT01831089|18951624|P6|Cohort V: Dose Level 5|Progressive disease|0
5481419|NCT01831089|18951625|P5|Cohort V: Dose Level 5|Progressive disease|30
5481420|NCT01831089|18951626|P4|Cohort V: Dose Level 5|Progressive disease|0
5481421|NCT01831089|18951627|P3|Cohort V: Dose Level 5|Progressive disease|0
5481422|NCT01831089|18951628|P2|Cohort V: Dose Level 5|Progressive disease|0
5481423|NCT01831089|18951629|P1|Cohort V: Dose Level 5|Progressive disease|0
5481424|NCT01831089|18951624|P6|Cohort IV: Dose Level 4|Progressive disease|0
5481425|NCT01831089|18951625|P5|Cohort IV: Dose Level 4|Progressive disease|0
5481426|NCT01831089|18951626|P4|Cohort IV: Dose Level 4|Progressive disease|6
5481427|NCT01831089|18951627|P3|Cohort IV: Dose Level 4|Progressive disease|0
5481428|NCT01831089|18951628|P2|Cohort IV: Dose Level 4|Progressive disease|0
5481429|NCT01831089|18951629|P1|Cohort IV: Dose Level 4|Progressive disease|0
5481430|NCT01831089|18951624|P6|Cohort III: Dose Level 3|Global end of study|0
5481431|NCT01831089|18951625|P5|Cohort III: Dose Level 3|Global end of study|0
5481432|NCT01831089|18951626|P4|Cohort III: Dose Level 3|Global end of study|0
5481433|NCT01831089|18951627|P3|Cohort III: Dose Level 3|Global end of study|1
5481434|NCT01831089|18951628|P2|Cohort III: Dose Level 3|Global end of study|0
5481435|NCT01831089|18951629|P1|Cohort III: Dose Level 3|Global end of study|0
5481436|NCT01831089|18951624|P6|Cohort III: Dose Level 3|Adverse Event|0
5481437|NCT01831089|18951625|P5|Cohort III: Dose Level 3|Adverse Event|0
5481438|NCT01831089|18951626|P4|Cohort III: Dose Level 3|Adverse Event|0
5481439|NCT01831089|18951627|P3|Cohort III: Dose Level 3|Adverse Event|1
5481440|NCT01831089|18951628|P2|Cohort III: Dose Level 3|Adverse Event|0
5481441|NCT01831089|18951629|P1|Cohort III: Dose Level 3|Adverse Event|0
5481442|NCT01831089|18951624|P6|Cohort III: Dose Level 3|Withdrawal by Subject|0
5481443|NCT01831089|18951625|P5|Cohort III: Dose Level 3|Withdrawal by Subject|0
5481444|NCT01831089|18951626|P4|Cohort III: Dose Level 3|Withdrawal by Subject|0
5481445|NCT01831089|18951627|P3|Cohort III: Dose Level 3|Withdrawal by Subject|1
5481446|NCT01831089|18951628|P2|Cohort III: Dose Level 3|Withdrawal by Subject|0
5481447|NCT01831089|18951629|P1|Cohort III: Dose Level 3|Withdrawal by Subject|0
5481448|NCT01831089|18951624|P6|Cohort III: Dose Level 3|Progressive disease|0
5481449|NCT01831089|18951625|P5|Cohort III: Dose Level 3|Progressive disease|0
5481450|NCT01831089|18951626|P4|Cohort III: Dose Level 3|Progressive disease|0
5481451|NCT01831089|18951627|P3|Cohort III: Dose Level 3|Progressive disease|3
5481452|NCT01831089|18951628|P2|Cohort III: Dose Level 3|Progressive disease|0
5481453|NCT01831089|18951629|P1|Cohort III: Dose Level 3|Progressive disease|0
5481454|NCT01831089|18951624|P6|Cohort II: Dose Level 2|Clinical progressive disease|0
5481455|NCT01831089|18951625|P5|Cohort II: Dose Level 2|Clinical progressive disease|0
5481456|NCT01831089|18951626|P4|Cohort II: Dose Level 2|Clinical progressive disease|0
5481457|NCT01831089|18951627|P3|Cohort II: Dose Level 2|Clinical progressive disease|0
5481458|NCT01831089|18951628|P2|Cohort II: Dose Level 2|Clinical progressive disease|1
5481459|NCT01831089|18951629|P1|Cohort II: Dose Level 2|Clinical progressive disease|0
5481460|NCT01831089|18951624|P6|Cohort II: Dose Level 2|Progressive disease|0
5481461|NCT01831089|18951625|P5|Cohort II: Dose Level 2|Progressive disease|0
5481462|NCT01831089|18951626|P4|Cohort II: Dose Level 2|Progressive disease|0
5481463|NCT01831089|18951627|P3|Cohort II: Dose Level 2|Progressive disease|0
5481464|NCT01831089|18951628|P2|Cohort II: Dose Level 2|Progressive disease|2
5481465|NCT01831089|18951629|P1|Cohort II: Dose Level 2|Progressive disease|0
5481466|NCT01831089|18951624|P6|Cohort I: Dose Level 1|Progressive disease|0
5481467|NCT01831089|18951625|P5|Cohort I: Dose Level 1|Progressive disease|0
5481468|NCT01831089|18951626|P4|Cohort I: Dose Level 1|Progressive disease|0
5481469|NCT01831089|18951627|P3|Cohort I: Dose Level 1|Progressive disease|0
5481470|NCT01831089|18951628|P2|Cohort I: Dose Level 1|Progressive disease|0
5481471|NCT01831089|18951629|P1|Cohort I: Dose Level 1|Progressive disease|3
5481472|NCT01830972|18951680|P2|Part IV|Non-Compliance|0
5481473|NCT01830972|18951681|P1|Part IV|Non-Compliance|1
5481474|NCT01830972|18951680|P2|Part IV|Withdrawal by Subject|1
5481475|NCT01830972|18951681|P1|Part IV|Withdrawal by Subject|2
5481476|NCT01830972|18951680|P2|Part III|Noncompliance|0
5481477|NCT01830972|18951681|P1|Part III|Noncompliance|1
5481478|NCT01830972|18951680|P2|Part III|Withdrawal by Subject|0
5481479|NCT01830972|18951681|P1|Part III|Withdrawal by Subject|1
5481480|NCT01830972|18951680|P2|Part II|Withdrawal by Subject|2
5481481|NCT01830972|18951681|P1|Part II|Withdrawal by Subject|2
5481482|NCT01830920|18951725|P5|Overall Study|Other|3
5481483|NCT01830920|18951726|P4|Overall Study|Other|5
5481484|NCT01830920|18951727|P3|Overall Study|Other|1
5481485|NCT01830920|18951728|P2|Overall Study|Other|1
5481486|NCT01830920|18951729|P1|Overall Study|Other|15
5481487|NCT01830920|18951725|P5|Overall Study|Death|4
5481488|NCT01830920|18951726|P4|Overall Study|Death|4
5481489|NCT01830920|18951727|P3|Overall Study|Death|5
5481490|NCT01830920|18951728|P2|Overall Study|Death|3
5481491|NCT01830920|18951729|P1|Overall Study|Death|3
5481492|NCT01830920|18951725|P5|Overall Study|Withdrawal by Subject|1
5481493|NCT01830920|18951726|P4|Overall Study|Withdrawal by Subject|7
5481494|NCT01830920|18951727|P3|Overall Study|Withdrawal by Subject|1
5481495|NCT01830920|18951728|P2|Overall Study|Withdrawal by Subject|2
5481496|NCT01830920|18951729|P1|Overall Study|Withdrawal by Subject|2
5481497|NCT01830920|18951725|P5|Overall Study|Adverse Event|0
5481498|NCT01830920|18951726|P4|Overall Study|Adverse Event|0
5481499|NCT01830920|18951727|P3|Overall Study|Adverse Event|1
5481500|NCT01830920|18951728|P2|Overall Study|Adverse Event|0
5481501|NCT01830920|18951729|P1|Overall Study|Adverse Event|1
5481502|NCT01830881|18951768|P2|Overall Study|Changed decision to have an abortion|1
5481503|NCT01830881|18951769|P1|Overall Study|Changed decision to have an abortion|0
5481504|NCT01830855|18951817|P4|Overall Study|Lost to Follow-up|33
5481505|NCT01830855|18951818|P3|Overall Study|Lost to Follow-up|23
5481506|NCT01830855|18951819|P2|Overall Study|Lost to Follow-up|20
5481507|NCT01830855|18951820|P1|Overall Study|Lost to Follow-up|47
5481508|NCT01830855|18951817|P4|Overall Study|No longer willing to participate|17
5481509|NCT01830855|18951818|P3|Overall Study|No longer willing to participate|12
5481510|NCT01830855|18951819|P2|Overall Study|No longer willing to participate|13
5481511|NCT01830855|18951820|P1|Overall Study|No longer willing to participate|32
5481512|NCT01830855|18951817|P4|Overall Study|Withdrawal by Subject|12
5481513|NCT01830855|18951818|P3|Overall Study|Withdrawal by Subject|10
5481514|NCT01830855|18951819|P2|Overall Study|Withdrawal by Subject|14
5481515|NCT01830855|18951820|P1|Overall Study|Withdrawal by Subject|33
5481516|NCT01830855|18951817|P4|Overall Study|Protocol deviation|6
5481517|NCT01830855|18951818|P3|Overall Study|Protocol deviation|6
5481518|NCT01830855|18951819|P2|Overall Study|Protocol deviation|5
5481519|NCT01830855|18951820|P1|Overall Study|Protocol deviation|10
5481520|NCT01830855|18951817|P4|Overall Study|Adverse Event|3
5481521|NCT01830855|18951818|P3|Overall Study|Adverse Event|6
5481522|NCT01830855|18951819|P2|Overall Study|Adverse Event|5
5481523|NCT01830855|18951820|P1|Overall Study|Adverse Event|11
5481524|NCT01830855|18951817|P4|Overall Study|No longer meets eligibility criteria|5
5481525|NCT01830855|18951818|P3|Overall Study|No longer meets eligibility criteria|3
5481526|NCT01830855|18951819|P2|Overall Study|No longer meets eligibility criteria|2
5481527|NCT01830855|18951820|P1|Overall Study|No longer meets eligibility criteria|11
5481528|NCT01830855|18951817|P4|Overall Study|Pregnancy|1
5481529|NCT01830855|18951818|P3|Overall Study|Pregnancy|2
5481530|NCT01830855|18951819|P2|Overall Study|Pregnancy|1
5481531|NCT01830855|18951820|P1|Overall Study|Pregnancy|3
5481532|NCT01830855|18951817|P4|Overall Study|Medication error without associated AE|1
5481533|NCT01830855|18951818|P3|Overall Study|Medication error without associated AE|0
5481534|NCT01830855|18951819|P2|Overall Study|Medication error without associated AE|0
5481535|NCT01830855|18951820|P1|Overall Study|Medication error without associated AE|1
5481536|NCT01830855|18951817|P4|Overall Study|Other|4
5481537|NCT01830855|18951818|P3|Overall Study|Other|4
5481538|NCT01830855|18951819|P2|Overall Study|Other|1
5481539|NCT01830855|18951820|P1|Overall Study|Other|7
5481540|NCT01830816|18951936|P3|Overall Study|Reason not Specified|0
5481541|NCT01830816|18951937|P2|Overall Study|Reason not Specified|0
5481542|NCT01830816|18951938|P1|Overall Study|Reason not Specified|2
5481543|NCT01830816|18951936|P3|Overall Study|Symptomatic Deterioration|0
5481544|NCT01830816|18951937|P2|Overall Study|Symptomatic Deterioration|0
5481545|NCT01830816|18951938|P1|Overall Study|Symptomatic Deterioration|1
5481546|NCT01830816|18951936|P3|Overall Study|Lost to Follow-up|0
5481547|NCT01830816|18951937|P2|Overall Study|Lost to Follow-up|1
5481548|NCT01830816|18951938|P1|Overall Study|Lost to Follow-up|0
5481549|NCT01830816|18951936|P3|Overall Study|Withdrawal by Subject|0
5481550|NCT01830816|18951937|P2|Overall Study|Withdrawal by Subject|1
5481551|NCT01830816|18951938|P1|Overall Study|Withdrawal by Subject|1
5481552|NCT01830816|18951936|P3|Overall Study|Study Terminated by Sponsor|0
5481553|NCT01830816|18951937|P2|Overall Study|Study Terminated by Sponsor|1
5481554|NCT01830816|18951938|P1|Overall Study|Study Terminated by Sponsor|1
5481555|NCT01830816|18951936|P3|Overall Study|Adverse Event|0
5481556|NCT01830816|18951937|P2|Overall Study|Adverse Event|4
5481557|NCT01830816|18951938|P1|Overall Study|Adverse Event|3
5481558|NCT01830816|18951936|P3|Overall Study|Progressive Disease|7
5481559|NCT01830816|18951937|P2|Overall Study|Progressive Disease|7
5481560|NCT01830816|18951938|P1|Overall Study|Progressive Disease|12
5481561|NCT01830595|18952002|P2|Washout|Withdrawal by Subject|2
5481562|NCT01830595|18952003|P1|Washout|Withdrawal by Subject|2
5481563|NCT01830595|18952002|P2|First Period|Withdrawal by Subject|3
5481564|NCT01830595|18952003|P1|First Period|Withdrawal by Subject|1
5481565|NCT01830543|18952020|P3|Overall Study|Other|37
5481566|NCT01830543|18952021|P2|Overall Study|Other|17
5481567|NCT01830543|18952022|P1|Overall Study|Other|12
5481568|NCT01830543|18952020|P3|Overall Study|Withdrawal by consent|3
5481569|NCT01830543|18952021|P2|Overall Study|Withdrawal by consent|3
5481570|NCT01830543|18952022|P1|Overall Study|Withdrawal by consent|3
5481571|NCT01830543|18952020|P3|Overall Study|Physician Decision|12
5481572|NCT01830543|18952021|P2|Overall Study|Physician Decision|5
5481573|NCT01830543|18952022|P1|Overall Study|Physician Decision|11
5481574|NCT01830543|18952020|P3|Overall Study|Protocol Violation|7
5481575|NCT01830543|18952021|P2|Overall Study|Protocol Violation|7
5481576|NCT01830543|18952022|P1|Overall Study|Protocol Violation|3
5481577|NCT01830543|18952020|P3|Overall Study|Death|22
5481578|NCT01830543|18952021|P2|Overall Study|Death|22
5481579|NCT01830543|18952022|P1|Overall Study|Death|20
5481580|NCT01830543|18952020|P3|Overall Study|Adverse Event|76
5481581|NCT01830543|18952021|P2|Overall Study|Adverse Event|77
5481582|NCT01830543|18952022|P1|Overall Study|Adverse Event|91
5481583|NCT01830543|18952020|P3|Overall Study|Subject Decision|57
5481584|NCT01830543|18952021|P2|Overall Study|Subject Decision|21
5481585|NCT01830543|18952022|P1|Overall Study|Subject Decision|19
5481586|NCT01830127|18952154|P2|Overall Study|Other reason not defined above|2
5481587|NCT01830127|18952155|P1|Overall Study|Other reason not defined above|0
5481588|NCT01830127|18952154|P2|Overall Study|Withdrawal by Subject|1
5481589|NCT01830127|18952155|P1|Overall Study|Withdrawal by Subject|1
5481590|NCT01830127|18952154|P2|Overall Study|Lack of Efficacy|0
5481591|NCT01830127|18952155|P1|Overall Study|Lack of Efficacy|3
5481592|NCT01830127|18952154|P2|Overall Study|Adverse Event|6
5481593|NCT01830127|18952155|P1|Overall Study|Adverse Event|1
5481594|NCT01829711|18952188|P1|Overall Study|Due to lack of response|1
5481595|NCT01829711|18952188|P1|Overall Study|Due to progression of disease|13
5481596|NCT01829711|18952188|P1|Overall Study|Adverse Event|3
5481597|NCT01829711|18952188|P1|Overall Study|Started new therapies|17
5481598|NCT01829711|18952188|P1|Overall Study|Death|4
5481599|NCT01829711|18952188|P1|Overall Study|Withdrawal by Subject|3
5481600|NCT01829711|18952188|P1|Overall Study|Lost to Follow-up|2
5481601|NCT01829477|18952245|P2|Overall Study|Withdrawal by Subject|0
5481602|NCT01829477|18952246|P1|Overall Study|Withdrawal by Subject|1
5481603|NCT01829477|18952245|P2|Overall Study|Study Terminated by Sponsor|15
5481604|NCT01829477|18952246|P1|Overall Study|Study Terminated by Sponsor|15
5481605|NCT01829464|18952259|P3|Overall Study|Lack of Efficacy|0
5481606|NCT01829464|18952260|P2|Overall Study|Lack of Efficacy|1
5481607|NCT01829464|18952261|P1|Overall Study|Lack of Efficacy|0
5481608|NCT01829464|18952259|P3|Overall Study|Study terminated by sponsor|25
5481609|NCT01829464|18952260|P2|Overall Study|Study terminated by sponsor|28
5481610|NCT01829464|18952261|P1|Overall Study|Study terminated by sponsor|25
5481611|NCT01829464|18952259|P3|Overall Study|Withdrawal by Subject|0
5481612|NCT01829464|18952260|P2|Overall Study|Withdrawal by Subject|0
5481613|NCT01829464|18952261|P1|Overall Study|Withdrawal by Subject|2
5481614|NCT01829464|18952259|P3|Overall Study|Lost to Follow-up|1
5481615|NCT01829464|18952260|P2|Overall Study|Lost to Follow-up|0
5481616|NCT01829464|18952261|P1|Overall Study|Lost to Follow-up|0
5481617|NCT01829464|18952259|P3|Overall Study|Adverse Event|0
5481618|NCT01829464|18952260|P2|Overall Study|Adverse Event|0
5481619|NCT01829464|18952261|P1|Overall Study|Adverse Event|1
5481620|NCT01829425|18952277|P2|Overall Study|Lost to Follow-up|1
5481621|NCT01829425|18952278|P1|Overall Study|Lost to Follow-up|2
5481622|NCT01829425|18952277|P2|Overall Study|Withdrawal by Subject|3
5481623|NCT01829425|18952278|P1|Overall Study|Withdrawal by Subject|4
5481624|NCT01829360|18952321|P4|Overall Study|Protocol Violation|0
5481625|NCT01829360|18952322|P3|Overall Study|Protocol Violation|1
5481626|NCT01829360|18952323|P2|Overall Study|Protocol Violation|0
5481627|NCT01829360|18952324|P1|Overall Study|Protocol Violation|0
5481628|NCT01829347|18952344|P2|VTI-210E|Study terminated prematurely|5
5481629|NCT01829347|18952345|P1|VTI-210E|Study terminated prematurely|1
5481630|NCT01829347|18952344|P2|VTI-210E|Death|1
5481631|NCT01829347|18952345|P1|VTI-210E|Death|2
5481632|NCT01829347|18952344|P2|VTI-210|Withdrawal by Subject|0
5481633|NCT01829347|18952345|P1|VTI-210|Withdrawal by Subject|1
5481634|NCT01829347|18952344|P2|VTI-210|Death|3
5481635|NCT01829347|18952345|P1|VTI-210|Death|5
5481636|NCT01829295|18952355|P4|6-12 Months|Withdrawal by Subject|0
5481637|NCT01829295|18952356|P3|6-12 Months|Withdrawal by Subject|0
5481638|NCT01829295|18952357|P2|6-12 Months|Withdrawal by Subject|2
5481639|NCT01829295|18952358|P1|6-12 Months|Withdrawal by Subject|2
5481640|NCT01829295|18952355|P4|6-12 Months|Lost to Follow-up|0
5481641|NCT01829295|18952356|P3|6-12 Months|Lost to Follow-up|0
5481642|NCT01829295|18952357|P2|6-12 Months|Lost to Follow-up|0
5481643|NCT01829295|18952358|P1|6-12 Months|Lost to Follow-up|2
5481644|NCT01829295|18952355|P4|6-12 Months|Adverse Event|2
5481645|NCT01829295|18952356|P3|6-12 Months|Adverse Event|3
5481646|NCT01829295|18952357|P2|6-12 Months|Adverse Event|0
5481647|NCT01829295|18952358|P1|6-12 Months|Adverse Event|0
5481648|NCT01829295|18952355|P4|6-12 Months|Did not want to switch antimetabolites|11
5481649|NCT01829295|18952356|P3|6-12 Months|Did not want to switch antimetabolites|9
5481650|NCT01829295|18952357|P2|6-12 Months|Did not want to switch antimetabolites|0
5481651|NCT01829295|18952358|P1|6-12 Months|Did not want to switch antimetabolites|0
5481652|NCT01829243|18952368|P2|First Intervention|Screen Failure|2
5481653|NCT01829243|18952369|P1|First Intervention|Screen Failure|4
5481654|NCT01829230|18952383|P2|Overall Study|Lost to Follow-up|1
5481655|NCT01829230|18952384|P1|Overall Study|Lost to Follow-up|1
5481656|NCT01829230|18952383|P2|Overall Study|Withdrawal by Subject|1
5481657|NCT01829230|18952384|P1|Overall Study|Withdrawal by Subject|0
5481658|NCT01829230|18952383|P2|Overall Study|Protocol Violation|2
5481659|NCT01829230|18952384|P1|Overall Study|Protocol Violation|0
5481660|NCT01829191|18952398|P2|Overall Study|Subject was fit for ortho - k|1
5481661|NCT01829191|18952399|P1|Overall Study|Subject was fit for ortho - k|0
5481662|NCT01829191|18952398|P2|Overall Study|Lost to Follow-up|1
5481663|NCT01829191|18952399|P1|Overall Study|Lost to Follow-up|0
5481664|NCT01829191|18952398|P2|Overall Study|Withdrawal by Subject|3
5481665|NCT01829191|18952399|P1|Overall Study|Withdrawal by Subject|2
5481666|NCT01829191|18952398|P2|Overall Study|Protocol Violation|1
5481667|NCT01829191|18952399|P1|Overall Study|Protocol Violation|4
5481668|NCT01829191|18952398|P2|Overall Study|Lens handling difficulty|4
5481669|NCT01829191|18952399|P1|Overall Study|Lens handling difficulty|1
5481670|NCT01829191|18952398|P2|Overall Study|Lens discomfort|3
5481671|NCT01829191|18952399|P1|Overall Study|Lens discomfort|0
5481672|NCT01829191|18952398|P2|Overall Study|Relocation|1
5481673|NCT01829191|18952399|P1|Overall Study|Relocation|0
5481674|NCT01829165|18952408|P2|Overall Study|Did not complete intervention|0
5481675|NCT01829165|18952409|P1|Overall Study|Did not complete intervention|2
5481676|NCT01829113|18952417|P2|Overall Study|Physician Decision|1
5481677|NCT01829113|18952418|P1|Overall Study|Physician Decision|1
5481678|NCT01829113|18952417|P2|Overall Study|No Study Treatment Received|2
5481679|NCT01829113|18952418|P1|Overall Study|No Study Treatment Received|3
5481680|NCT01829113|18952417|P2|Overall Study|Sponsor Decision|1
5481681|NCT01829113|18952418|P1|Overall Study|Sponsor Decision|1
5481682|NCT01829113|18952417|P2|Overall Study|Death|6
5481683|NCT01829113|18952418|P1|Overall Study|Death|4
5481684|NCT01829113|18952417|P2|Overall Study|Withdrawal by Subject|10
5481685|NCT01829113|18952418|P1|Overall Study|Withdrawal by Subject|17
5481686|NCT01829113|18952417|P2|Overall Study|Adverse Event|10
5481687|NCT01829113|18952418|P1|Overall Study|Adverse Event|14
5481688|NCT01829113|18952417|P2|Overall Study|Disease Progression|48
5481689|NCT01829113|18952418|P1|Overall Study|Disease Progression|37
5481690|NCT01829048|18952435|P5|Overall Study|Withdrawal by Subject|0
5481691|NCT01829048|18952436|P4|Overall Study|Withdrawal by Subject|2
5481692|NCT01829048|18952437|P3|Overall Study|Withdrawal by Subject|0
5481693|NCT01829048|18952438|P2|Overall Study|Withdrawal by Subject|0
5481694|NCT01829048|18952439|P1|Overall Study|Withdrawal by Subject|0
5481695|NCT01828567|18952552|P2|Overall Study|Excluded - did not meet criteria|1
5481696|NCT01828567|18952553|P1|Overall Study|Excluded - did not meet criteria|4
5481697|NCT01828567|18952552|P2|Overall Study|Lost to Follow-up|9
5481698|NCT01828567|18952553|P1|Overall Study|Lost to Follow-up|27
5481699|NCT01828281|18952608|P2|Overall Study|Withdrawal by Subject|0
5481700|NCT01828281|18952609|P1|Overall Study|Withdrawal by Subject|1
5481701|NCT01828112|18952659|P2|Overall Study|Subject/guardian decision|8
5481702|NCT01828112|18952660|P1|Overall Study|Subject/guardian decision|6
5481703|NCT01828112|18952659|P2|Overall Study|Progressive disease|82
5481704|NCT01828112|18952660|P1|Overall Study|Progressive disease|56
5481705|NCT01828112|18952659|P2|Overall Study|Physician Decision|5
5481706|NCT01828112|18952660|P1|Overall Study|Physician Decision|5
5481707|NCT01828112|18952659|P2|Overall Study|Death|5
5481708|NCT01828112|18952660|P1|Overall Study|Death|9
5481709|NCT01828112|18952659|P2|Overall Study|Adverse Event|8
5481710|NCT01828112|18952660|P1|Overall Study|Adverse Event|6
5481711|NCT01828099|18952668|P2|Overall Study|Subject/guardian decision|23
5481712|NCT01828099|18952669|P1|Overall Study|Subject/guardian decision|7
5481713|NCT01828099|18952668|P2|Overall Study|Protocol Violation|0
5481714|NCT01828099|18952669|P1|Overall Study|Protocol Violation|1
5481715|NCT01828099|18952668|P2|Overall Study|Progressive disease|94
5481716|NCT01828099|18952669|P1|Overall Study|Progressive disease|51
5481717|NCT01828099|18952668|P2|Overall Study|Physician Decision|11
5481718|NCT01828099|18952669|P1|Overall Study|Physician Decision|7
5481719|NCT01828099|18952668|P2|Overall Study|Non-compliance with study treatment|0
5481720|NCT01828099|18952669|P1|Overall Study|Non-compliance with study treatment|2
5481721|NCT01828099|18952668|P2|Overall Study|Lost to Follow-up|0
5481722|NCT01828099|18952669|P1|Overall Study|Lost to Follow-up|2
5481723|NCT01828099|18952668|P2|Overall Study|Death|11
5481724|NCT01828099|18952669|P1|Overall Study|Death|9
5481725|NCT01828099|18952668|P2|Overall Study|Adverse Event|18
5481726|NCT01828099|18952669|P1|Overall Study|Adverse Event|15
5481727|NCT01828073|18952677|P2|Overall Study|Lost to Follow-up|2
5481728|NCT01828073|18952678|P1|Overall Study|Lost to Follow-up|1
5481729|NCT01828034|18952702|P4|Overall Study|Withdrawal by Subject|1
5481730|NCT01828034|18952703|P3|Overall Study|Withdrawal by Subject|0
5481731|NCT01828034|18952704|P2|Overall Study|Withdrawal by Subject|0
5481732|NCT01828034|18952705|P1|Overall Study|Withdrawal by Subject|0
5481733|NCT01828021|18952717|P1|Overall Study|Ileal obstruction, unrelated|1
5481734|NCT01828021|18952717|P1|Overall Study|Withdrawal by Subject|2
5481735|NCT01828021|18952717|P1|Overall Study|Lack of Efficacy|17
5481736|NCT01828021|18952717|P1|Overall Study|Adverse Event|5
5481737|NCT01827839|18952756|P1|Overall Study|Consent Withdrawal|2
5481738|NCT01827839|18952756|P1|Overall Study|Adverse Event|1
5481739|NCT01827670|18952801|P2|Overall Study|Lost to Follow-up|1
5481740|NCT01827670|18952802|P1|Overall Study|Lost to Follow-up|0
5481741|NCT01827670|18952801|P2|Overall Study|Withdrawal of Consent|2
5481742|NCT01827670|18952802|P1|Overall Study|Withdrawal of Consent|3
5481743|NCT01827592|18952821|P3|Overall Study|Others|3
5481744|NCT01827592|18952822|P2|Overall Study|Others|1
5481745|NCT01827592|18952823|P1|Overall Study|Others|0
5481746|NCT01827592|18952821|P3|Overall Study|Trial terminated by Sponsor|51
5481747|NCT01827592|18952822|P2|Overall Study|Trial terminated by Sponsor|53
5481748|NCT01827592|18952823|P1|Overall Study|Trial terminated by Sponsor|47
5481749|NCT01827592|18952821|P3|Overall Study|Patient's substantial non-compliance|6
5481750|NCT01827592|18952822|P2|Overall Study|Patient's substantial non-compliance|1
5481751|NCT01827592|18952823|P1|Overall Study|Patient's substantial non-compliance|1
5481752|NCT01827592|18952821|P3|Overall Study|Withdrawal by Subject|11
5481753|NCT01827592|18952822|P2|Overall Study|Withdrawal by Subject|11
5481754|NCT01827592|18952823|P1|Overall Study|Withdrawal by Subject|12
5481755|NCT01827592|18952821|P3|Overall Study|Lost to Follow-up|2
5481756|NCT01827592|18952822|P2|Overall Study|Lost to Follow-up|2
5481757|NCT01827592|18952823|P1|Overall Study|Lost to Follow-up|1
5481758|NCT01827592|18952821|P3|Overall Study|Protocol Violation|0
5481759|NCT01827592|18952822|P2|Overall Study|Protocol Violation|1
5481760|NCT01827592|18952823|P1|Overall Study|Protocol Violation|2
5481761|NCT01827592|18952821|P3|Overall Study|Physician Decision|1
5481762|NCT01827592|18952822|P2|Overall Study|Physician Decision|2
5481763|NCT01827592|18952823|P1|Overall Study|Physician Decision|0
5481764|NCT01827592|18952821|P3|Overall Study|Adverse Event|2
5481765|NCT01827592|18952822|P2|Overall Study|Adverse Event|9
5481766|NCT01827592|18952823|P1|Overall Study|Adverse Event|11
5481767|NCT01827371|18952888|P4|Overall Study|Temporary study halt to vaccinations|13
5481768|NCT01827371|18952889|P3|Overall Study|Temporary study halt to vaccinations|5
5481769|NCT01827371|18952890|P2|Overall Study|Temporary study halt to vaccinations|2
5481770|NCT01827371|18952891|P1|Overall Study|Temporary study halt to vaccinations|11
5481771|NCT01827371|18952888|P4|Overall Study|Physician Decision|1
5481772|NCT01827371|18952889|P3|Overall Study|Physician Decision|0
5481773|NCT01827371|18952890|P2|Overall Study|Physician Decision|1
5481774|NCT01827371|18952891|P1|Overall Study|Physician Decision|0
5481775|NCT01827371|18952888|P4|Overall Study|Withdrawal by Subject|3
5481776|NCT01827371|18952889|P3|Overall Study|Withdrawal by Subject|2
5481777|NCT01827371|18952890|P2|Overall Study|Withdrawal by Subject|2
5481778|NCT01827371|18952891|P1|Overall Study|Withdrawal by Subject|1
5481779|NCT01827371|18952888|P4|Overall Study|Protocol Violation|0
5481780|NCT01827371|18952889|P3|Overall Study|Protocol Violation|0
5481781|NCT01827371|18952890|P2|Overall Study|Protocol Violation|0
5481782|NCT01827371|18952891|P1|Overall Study|Protocol Violation|1
5481783|NCT01827371|18952888|P4|Overall Study|Lost to Follow-up|4
5481784|NCT01827371|18952889|P3|Overall Study|Lost to Follow-up|0
5481785|NCT01827371|18952890|P2|Overall Study|Lost to Follow-up|2
5481786|NCT01827371|18952891|P1|Overall Study|Lost to Follow-up|0
5481787|NCT01827371|18952888|P4|Overall Study|Adverse Event|2
5481788|NCT01827371|18952889|P3|Overall Study|Adverse Event|4
5481789|NCT01827371|18952890|P2|Overall Study|Adverse Event|0
5481790|NCT01827371|18952891|P1|Overall Study|Adverse Event|0
5481791|NCT01827332|18952950|P2|Overall Study|Lost to Follow-up|1
5481792|NCT01827332|18952951|P1|Overall Study|Lost to Follow-up|2
5481793|NCT01827319|18952959|P1|Overall Study|Lost to Follow-up|3
5481794|NCT01827267|18952982|P2|Overall Study|Still on study|2
5481795|NCT01827267|18952983|P1|Overall Study|Still on study|0
5481796|NCT01827267|18952982|P2|Overall Study|Sponsor Discontinued Study|8
5481797|NCT01827267|18952983|P1|Overall Study|Sponsor Discontinued Study|2
5481798|NCT01827267|18952982|P2|Overall Study|Disease Progression|1
5481799|NCT01827267|18952983|P1|Overall Study|Disease Progression|1
5481800|NCT01827267|18952982|P2|Overall Study|Physician Decision|0
5481801|NCT01827267|18952983|P1|Overall Study|Physician Decision|1
5481802|NCT01827267|18952982|P2|Overall Study|Did not receive study drug|1
5481803|NCT01827267|18952983|P1|Overall Study|Did not receive study drug|1
5481804|NCT01827254|18952998|P1|Overall Study|Intolerance to treatment|4
5481805|NCT01827254|18952998|P1|Overall Study|Disease progression|36
5481806|NCT01827254|18952998|P1|Overall Study|Did not complete re-challenge|1
5481807|NCT01827254|18952998|P1|Overall Study|Discontinued prior initiation: sunitinib|1
5481808|NCT01827254|18952998|P1|Overall Study|Invalidated centre|3
5481809|NCT01827254|18952998|P1|Overall Study|Case report form not completed|4
5481810|NCT01827254|18952998|P1|Overall Study|Death|10
5481811|NCT01827163|18953008|P1|Overall Study|Adverse Event|9
5481812|NCT01827163|18953008|P1|Overall Study|Hypersensitivity reaction to Paclitaxel|2
5481813|NCT01827046|18953015|P2|Overall Study|Withdrawal by Subject|4
5481814|NCT01827046|18953016|P1|Overall Study|Withdrawal by Subject|0
5481815|NCT01827046|18953015|P2|Overall Study|Lost to Follow-up|5
5481816|NCT01827046|18953016|P1|Overall Study|Lost to Follow-up|1
5481817|NCT01826981|18953071|P15|Overall Study|Enrolled/Randomized but Not Treated|0
5481818|NCT01826981|18953072|P14|Overall Study|Enrolled/Randomized but Not Treated|0
5481819|NCT01826981|18953073|P13|Overall Study|Enrolled/Randomized but Not Treated|0
5481820|NCT01826981|18953074|P12|Overall Study|Enrolled/Randomized but Not Treated|0
5481821|NCT01826981|18953075|P11|Overall Study|Enrolled/Randomized but Not Treated|0
5481822|NCT01826981|18953076|P10|Overall Study|Enrolled/Randomized but Not Treated|0
5481823|NCT01826981|18953077|P9|Overall Study|Enrolled/Randomized but Not Treated|0
5481824|NCT01826981|18953078|P8|Overall Study|Enrolled/Randomized but Not Treated|1
5481825|NCT01826981|18953079|P7|Overall Study|Enrolled/Randomized but Not Treated|0
5481826|NCT01826981|18953080|P6|Overall Study|Enrolled/Randomized but Not Treated|0
5481827|NCT01826981|18953081|P5|Overall Study|Enrolled/Randomized but Not Treated|0
5481828|NCT01826981|18953082|P4|Overall Study|Enrolled/Randomized but Not Treated|0
5481829|NCT01826981|18953083|P3|Overall Study|Enrolled/Randomized but Not Treated|0
5481830|NCT01826981|18953084|P2|Overall Study|Enrolled/Randomized but Not Treated|0
5481831|NCT01826981|18953085|P1|Overall Study|Enrolled/Randomized but Not Treated|0
5481832|NCT01826981|18953071|P15|Overall Study|Upper G-I Haemorrhage|0
5481833|NCT01826981|18953072|P14|Overall Study|Upper G-I Haemorrhage|1
5481834|NCT01826981|18953073|P13|Overall Study|Upper G-I Haemorrhage|0
5481835|NCT01826981|18953074|P12|Overall Study|Upper G-I Haemorrhage|0
5481836|NCT01826981|18953075|P11|Overall Study|Upper G-I Haemorrhage|0
5481837|NCT01826981|18953076|P10|Overall Study|Upper G-I Haemorrhage|0
5481838|NCT01826981|18953077|P9|Overall Study|Upper G-I Haemorrhage|0
5481839|NCT01826981|18953078|P8|Overall Study|Upper G-I Haemorrhage|0
5481840|NCT01826981|18953079|P7|Overall Study|Upper G-I Haemorrhage|0
5481841|NCT01826981|18953080|P6|Overall Study|Upper G-I Haemorrhage|0
5481842|NCT01826981|18953081|P5|Overall Study|Upper G-I Haemorrhage|0
5481843|NCT01826981|18953082|P4|Overall Study|Upper G-I Haemorrhage|0
5481844|NCT01826981|18953083|P3|Overall Study|Upper G-I Haemorrhage|0
5481845|NCT01826981|18953084|P2|Overall Study|Upper G-I Haemorrhage|0
5481846|NCT01826981|18953085|P1|Overall Study|Upper G-I Haemorrhage|0
5481847|NCT01826981|18953071|P15|Overall Study|Adverse Event|0
5481848|NCT01826981|18953072|P14|Overall Study|Adverse Event|0
5481849|NCT01826981|18953073|P13|Overall Study|Adverse Event|0
5481850|NCT01826981|18953074|P12|Overall Study|Adverse Event|0
5481851|NCT01826981|18953075|P11|Overall Study|Adverse Event|0
5481852|NCT01826981|18953076|P10|Overall Study|Adverse Event|0
5481853|NCT01826981|18953077|P9|Overall Study|Adverse Event|0
5481854|NCT01826981|18953078|P8|Overall Study|Adverse Event|0
5481855|NCT01826981|18953079|P7|Overall Study|Adverse Event|0
5481856|NCT01826981|18953080|P6|Overall Study|Adverse Event|0
5481857|NCT01826981|18953081|P5|Overall Study|Adverse Event|1
5481858|NCT01826981|18953082|P4|Overall Study|Adverse Event|0
5481859|NCT01826981|18953083|P3|Overall Study|Adverse Event|0
5481860|NCT01826981|18953084|P2|Overall Study|Adverse Event|0
5481861|NCT01826981|18953085|P1|Overall Study|Adverse Event|0
5481862|NCT01826981|18953071|P15|Overall Study|Withdrew Consent|0
5481863|NCT01826981|18953072|P14|Overall Study|Withdrew Consent|1
5481864|NCT01826981|18953073|P13|Overall Study|Withdrew Consent|0
5481865|NCT01826981|18953074|P12|Overall Study|Withdrew Consent|1
5481866|NCT01826981|18953075|P11|Overall Study|Withdrew Consent|0
5481867|NCT01826981|18953076|P10|Overall Study|Withdrew Consent|0
5481868|NCT01826981|18953077|P9|Overall Study|Withdrew Consent|0
5481869|NCT01826981|18953078|P8|Overall Study|Withdrew Consent|1
5481870|NCT01826981|18953079|P7|Overall Study|Withdrew Consent|1
5481871|NCT01826981|18953080|P6|Overall Study|Withdrew Consent|0
5481872|NCT01826981|18953081|P5|Overall Study|Withdrew Consent|0
5481873|NCT01826981|18953082|P4|Overall Study|Withdrew Consent|0
5481874|NCT01826981|18953083|P3|Overall Study|Withdrew Consent|0
5481875|NCT01826981|18953084|P2|Overall Study|Withdrew Consent|0
5481876|NCT01826981|18953085|P1|Overall Study|Withdrew Consent|0
5481877|NCT01826981|18953071|P15|Overall Study|Lost to Follow-up|0
5481878|NCT01826981|18953072|P14|Overall Study|Lost to Follow-up|0
5481879|NCT01826981|18953073|P13|Overall Study|Lost to Follow-up|1
5481880|NCT01826981|18953074|P12|Overall Study|Lost to Follow-up|1
5481881|NCT01826981|18953075|P11|Overall Study|Lost to Follow-up|1
5481882|NCT01826981|18953076|P10|Overall Study|Lost to Follow-up|1
5481883|NCT01826981|18953077|P9|Overall Study|Lost to Follow-up|0
5481884|NCT01826981|18953078|P8|Overall Study|Lost to Follow-up|1
5481885|NCT01826981|18953079|P7|Overall Study|Lost to Follow-up|0
5481886|NCT01826981|18953080|P6|Overall Study|Lost to Follow-up|1
5481887|NCT01826981|18953081|P5|Overall Study|Lost to Follow-up|1
5481888|NCT01826981|18953082|P4|Overall Study|Lost to Follow-up|0
5481889|NCT01826981|18953083|P3|Overall Study|Lost to Follow-up|0
5481890|NCT01826981|18953084|P2|Overall Study|Lost to Follow-up|0
5481891|NCT01826981|18953085|P1|Overall Study|Lost to Follow-up|0
5481892|NCT01826981|18953071|P15|Overall Study|Lack of Efficacy|0
5481893|NCT01826981|18953072|P14|Overall Study|Lack of Efficacy|3
5481894|NCT01826981|18953073|P13|Overall Study|Lack of Efficacy|0
5481895|NCT01826981|18953074|P12|Overall Study|Lack of Efficacy|0
5481896|NCT01826981|18953075|P11|Overall Study|Lack of Efficacy|1
5481897|NCT01826981|18953076|P10|Overall Study|Lack of Efficacy|0
5481898|NCT01826981|18953077|P9|Overall Study|Lack of Efficacy|7
5481899|NCT01826981|18953078|P8|Overall Study|Lack of Efficacy|8
5481900|NCT01826981|18953079|P7|Overall Study|Lack of Efficacy|0
5481901|NCT01826981|18953080|P6|Overall Study|Lack of Efficacy|0
5481902|NCT01826981|18953081|P5|Overall Study|Lack of Efficacy|5
5481903|NCT01826981|18953082|P4|Overall Study|Lack of Efficacy|0
5481904|NCT01826981|18953083|P3|Overall Study|Lack of Efficacy|0
5481905|NCT01826981|18953084|P2|Overall Study|Lack of Efficacy|1
5481906|NCT01826981|18953085|P1|Overall Study|Lack of Efficacy|0
5481907|NCT01826604|18953271|P2|Overall Study|Lost to Follow-up|9
5481908|NCT01826604|18953272|P1|Overall Study|Lost to Follow-up|8
5481909|NCT01826487|18953316|P2|Overall Study|Protocol Violation|1
5481910|NCT01826487|18953317|P1|Overall Study|Protocol Violation|1
5481911|NCT01826487|18953316|P2|Overall Study|Withdrawal by Subject|3
5481912|NCT01826487|18953317|P1|Overall Study|Withdrawal by Subject|1
5481913|NCT01826487|18953316|P2|Overall Study|Lost to Follow-up|0
5481914|NCT01826487|18953317|P1|Overall Study|Lost to Follow-up|1
5481915|NCT01826487|18953316|P2|Overall Study|Adverse Event|1
5481916|NCT01826487|18953317|P1|Overall Study|Adverse Event|1
5481917|NCT01826448|18953344|P2|Overall Study|2 active cancers|1
5481918|NCT01826448|18953345|P1|Overall Study|2 active cancers|0
5481919|NCT01826448|18953344|P2|Overall Study|Physician Decision|1
5481920|NCT01826448|18953345|P1|Overall Study|Physician Decision|0
5481921|NCT01826448|18953344|P2|Overall Study|Withdrawal by Subject|0
5481922|NCT01826448|18953345|P1|Overall Study|Withdrawal by Subject|1
5481923|NCT01826448|18953344|P2|Overall Study|Disease progression|4
5481924|NCT01826448|18953345|P1|Overall Study|Disease progression|2
5481925|NCT01826448|18953344|P2|Overall Study|Adverse Event|3
5481926|NCT01826448|18953345|P1|Overall Study|Adverse Event|1
5481927|NCT01826422|18953353|P2|Overall Study|Withdrawal by Subject|3
5481928|NCT01826422|18953354|P1|Overall Study|Withdrawal by Subject|1
5481929|NCT01826370|18953398|P1|Overall Study|Other reason not defined above|2
5481930|NCT01826370|18953398|P1|Overall Study|Lost to Follow-up|12
5481931|NCT01826370|18953398|P1|Overall Study|Protocol Violation|6
5481932|NCT01826214|18953410|P2|Overall Study|Subject/guardian decision|3
5481933|NCT01826214|18953411|P1|Overall Study|Subject/guardian decision|2
5481934|NCT01826214|18953410|P2|Overall Study|Study terminated by Sponsor|1
5481935|NCT01826214|18953411|P1|Overall Study|Study terminated by Sponsor|0
5481936|NCT01826214|18953410|P2|Overall Study|Progressive disease|21
5481937|NCT01826214|18953411|P1|Overall Study|Progressive disease|22
5481938|NCT01826214|18953410|P2|Overall Study|Physician Decision|2
5481939|NCT01826214|18953411|P1|Overall Study|Physician Decision|0
5481940|NCT01826214|18953410|P2|Overall Study|Lost to Follow-up|0
5481941|NCT01826214|18953411|P1|Overall Study|Lost to Follow-up|1
5481942|NCT01826214|18953410|P2|Overall Study|Death|1
5481943|NCT01826214|18953411|P1|Overall Study|Death|3
5481944|NCT01826214|18953410|P2|Overall Study|Adverse Event|6
5481945|NCT01826214|18953411|P1|Overall Study|Adverse Event|7
5481946|NCT01826201|18953429|P1|Overall Study|Non compliance with protocol|4
5481947|NCT01825941|18953437|P2|Overall Study|Lost to Follow-up|1
5481948|NCT01825941|18953438|P1|Overall Study|Lost to Follow-up|4
5481949|NCT01825876|18953457|P2|Period 2|Withdrawal by Subject|1
5481950|NCT01825876|18953458|P1|Period 2|Withdrawal by Subject|0
5481951|NCT01825837|18953479|P4|PART II|reason unspecified|0
5481952|NCT01825837|18953480|P3|PART II|reason unspecified|2
5481953|NCT01825837|18953481|P2|PART II|reason unspecified|2
5481954|NCT01825837|18953482|P1|PART II|reason unspecified|2
5481955|NCT01825837|18953479|P4|PART II|Treatment failure|0
5481956|NCT01825837|18953480|P3|PART II|Treatment failure|5
5481957|NCT01825837|18953481|P2|PART II|Treatment failure|4
5481958|NCT01825837|18953482|P1|PART II|Treatment failure|6
5481959|NCT01825837|18953479|P4|PART II|Adverse Event|0
5481960|NCT01825837|18953480|P3|PART II|Adverse Event|1
5481961|NCT01825837|18953481|P2|PART II|Adverse Event|3
5481962|NCT01825837|18953482|P1|PART II|Adverse Event|3
5481963|NCT01825837|18953479|P4|PART II|Patient non-compliance|0
5481964|NCT01825837|18953480|P3|PART II|Patient non-compliance|4
5481965|NCT01825837|18953481|P2|PART II|Patient non-compliance|2
5481966|NCT01825837|18953482|P1|PART II|Patient non-compliance|5
5481967|NCT01825837|18953479|P4|PART II|Withdrawal by Subject|0
5481968|NCT01825837|18953480|P3|PART II|Withdrawal by Subject|7
5481969|NCT01825837|18953481|P2|PART II|Withdrawal by Subject|3
5481970|NCT01825837|18953482|P1|PART II|Withdrawal by Subject|3
5481971|NCT01825837|18953479|P4|PART I|reason unspecified|3
5481972|NCT01825837|18953480|P3|PART I|reason unspecified|0
5481973|NCT01825837|18953481|P2|PART I|reason unspecified|0
5481974|NCT01825837|18953482|P1|PART I|reason unspecified|0
5481975|NCT01825837|18953479|P4|PART I|Treatment failure|7
5481976|NCT01825837|18953480|P3|PART I|Treatment failure|0
5481977|NCT01825837|18953481|P2|PART I|Treatment failure|0
5481978|NCT01825837|18953482|P1|PART I|Treatment failure|0
5481979|NCT01825837|18953479|P4|PART I|Patient non-compliance|1
5481980|NCT01825837|18953480|P3|PART I|Patient non-compliance|0
5481981|NCT01825837|18953481|P2|PART I|Patient non-compliance|0
5481982|NCT01825837|18953482|P1|PART I|Patient non-compliance|0
5481983|NCT01825837|18953479|P4|PART I|Withdrawal by Subject|6
5481984|NCT01825837|18953480|P3|PART I|Withdrawal by Subject|0
5481985|NCT01825837|18953481|P2|PART I|Withdrawal by Subject|0
5481986|NCT01825837|18953482|P1|PART I|Withdrawal by Subject|0
5481987|NCT01825798|18953492|P2|Overall Study|Lost to Follow-up|0
5481988|NCT01825798|18953493|P1|Overall Study|Lost to Follow-up|1
5481989|NCT01825798|18953492|P2|Overall Study|Adverse Event|5
5481990|NCT01825798|18953493|P1|Overall Study|Adverse Event|1
5481991|NCT01825785|18953528|P7|Overall Study|Withdrawal by Subject|0
5481992|NCT01825785|18953529|P6|Overall Study|Withdrawal by Subject|1
5481993|NCT01825785|18953530|P5|Overall Study|Withdrawal by Subject|1
5481994|NCT01825785|18953531|P4|Overall Study|Withdrawal by Subject|0
5481995|NCT01825785|18953532|P3|Overall Study|Withdrawal by Subject|0
5481996|NCT01825785|18953533|P2|Overall Study|Withdrawal by Subject|0
5481997|NCT01825785|18953534|P1|Overall Study|Withdrawal by Subject|0
5481998|NCT01825785|18953528|P7|Overall Study|Adverse Event|0
5481999|NCT01825785|18953529|P6|Overall Study|Adverse Event|0
5482000|NCT01825785|18953530|P5|Overall Study|Adverse Event|1
5482001|NCT01825785|18953531|P4|Overall Study|Adverse Event|0
5482002|NCT01825785|18953532|P3|Overall Study|Adverse Event|0
5482003|NCT01825785|18953533|P2|Overall Study|Adverse Event|0
5482004|NCT01825785|18953534|P1|Overall Study|Adverse Event|0
5482005|NCT01825577|18953687|P1|Overall Study|Lack of Efficacy|3
5482006|NCT01825577|18953687|P1|Overall Study|Withdrawn by family members|2
5482007|NCT01825577|18953687|P1|Overall Study|Withdrawal by Subject|1
5482008|NCT01825577|18953687|P1|Overall Study|Physician Decision|2
5482009|NCT01825200|18953711|P2|Overall Study|Withdrawal by Subject|1
5482010|NCT01825200|18953712|P1|Overall Study|Withdrawal by Subject|0
5482011|NCT01825200|18953711|P2|Overall Study|Lost to Follow-up|6
5482012|NCT01825200|18953712|P1|Overall Study|Lost to Follow-up|5
5482013|NCT01824979|18953735|P2|Overall Study|Protocol Violation|13
5482014|NCT01824979|18953736|P1|Overall Study|Protocol Violation|6
5482015|NCT01824979|18953735|P2|Overall Study|Physician Decision|0
5482016|NCT01824979|18953736|P1|Overall Study|Physician Decision|2
5482017|NCT01824979|18953735|P2|Overall Study|Withdrawal by Subject|0
5482018|NCT01824979|18953736|P1|Overall Study|Withdrawal by Subject|5
5482019|NCT01824823|18953753|P2|Overall Study|Off-treatment reason not submitted|0
5482020|NCT01824823|18953754|P1|Overall Study|Off-treatment reason not submitted|1
5482021|NCT01824823|18953753|P2|Overall Study|Lack of Efficacy|1
5482022|NCT01824823|18953754|P1|Overall Study|Lack of Efficacy|1
5482023|NCT01824693|18953763|P3|Overall Study|No Transplant Planned|10
5482024|NCT01824693|18953764|P2|Overall Study|No Transplant Planned|0
5482025|NCT01824693|18953765|P1|Overall Study|No Transplant Planned|0
5482026|NCT01824693|18953763|P3|Overall Study|Ineligible|3
5482027|NCT01824693|18953764|P2|Overall Study|Ineligible|0
5482028|NCT01824693|18953765|P1|Overall Study|Ineligible|0
5482029|NCT01824693|18953763|P3|Overall Study|Progressive Disease|0
5482030|NCT01824693|18953764|P2|Overall Study|Progressive Disease|5
5482031|NCT01824693|18953765|P1|Overall Study|Progressive Disease|0
5482032|NCT01824693|18953763|P3|Overall Study|Withdrawal by Subject|1
5482033|NCT01824693|18953764|P2|Overall Study|Withdrawal by Subject|0
5482034|NCT01824693|18953765|P1|Overall Study|Withdrawal by Subject|0
5482035|NCT01824693|18953763|P3|Overall Study|Physician Decision|1
5482036|NCT01824693|18953764|P2|Overall Study|Physician Decision|1
5482037|NCT01824693|18953765|P1|Overall Study|Physician Decision|1
5482038|NCT01824693|18953763|P3|Overall Study|Death|0
5482039|NCT01824693|18953764|P2|Overall Study|Death|1
5482040|NCT01824693|18953765|P1|Overall Study|Death|0
5482041|NCT01824602|18953782|P4|Overall Study|Treatment failure|1
5482042|NCT01824602|18953783|P3|Overall Study|Treatment failure|0
5482043|NCT01824602|18953784|P2|Overall Study|Treatment failure|0
5482044|NCT01824602|18953785|P1|Overall Study|Treatment failure|0
5482045|NCT01824602|18953782|P4|Overall Study|Adverse Event|2
5482046|NCT01824602|18953783|P3|Overall Study|Adverse Event|2
5482047|NCT01824602|18953784|P2|Overall Study|Adverse Event|0
5482048|NCT01824602|18953785|P1|Overall Study|Adverse Event|1
5482049|NCT01824602|18953782|P4|Overall Study|Patient non-compliance|0
5482050|NCT01824602|18953783|P3|Overall Study|Patient non-compliance|1
5482051|NCT01824602|18953784|P2|Overall Study|Patient non-compliance|0
5482052|NCT01824602|18953785|P1|Overall Study|Patient non-compliance|0
5482053|NCT01824602|18953782|P4|Overall Study|Withdrawal by Subject|2
5482054|NCT01824602|18953783|P3|Overall Study|Withdrawal by Subject|1
5482055|NCT01824602|18953784|P2|Overall Study|Withdrawal by Subject|0
5482056|NCT01824602|18953785|P1|Overall Study|Withdrawal by Subject|0
5482057|NCT01824576|18953824|P1|Overall Study|Device deficiency|2
5482058|NCT01824498|18953842|P6|Washout (8 Weeks)|Withdrawal by Subject|0
5482059|NCT01824498|18953843|P5|Washout (8 Weeks)|Withdrawal by Subject|1
5482060|NCT01824498|18953844|P4|Washout (8 Weeks)|Withdrawal by Subject|1
5482061|NCT01824498|18953845|P3|Washout (8 Weeks)|Withdrawal by Subject|2
5482062|NCT01824498|18953846|P2|Washout (8 Weeks)|Withdrawal by Subject|0
5482063|NCT01824498|18953847|P1|Washout (8 Weeks)|Withdrawal by Subject|2
5482064|NCT01824472|18953858|P3|Overall Study|Ineligible post randomization&screening|0
5482065|NCT01824472|18953859|P2|Overall Study|Ineligible post randomization&screening|2
5482066|NCT01824472|18953860|P1|Overall Study|Ineligible post randomization&screening|0
5482067|NCT01824472|18953858|P3|Overall Study|Withdrawal by Subject|3
5482068|NCT01824472|18953859|P2|Overall Study|Withdrawal by Subject|5
5482069|NCT01824472|18953860|P1|Overall Study|Withdrawal by Subject|1
5482070|NCT01824472|18953858|P3|Overall Study|Lost to Follow-up|1
5482071|NCT01824472|18953859|P2|Overall Study|Lost to Follow-up|0
5482072|NCT01824472|18953860|P1|Overall Study|Lost to Follow-up|0
5482073|NCT01824394|18953894|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
5482074|NCT01824394|18953895|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
5482075|NCT01824394|18953896|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
5482076|NCT01824394|18953894|P3|Overall Study|Discontinued Subjects|2
5482077|NCT01824394|18953895|P2|Overall Study|Discontinued Subjects|1
5482078|NCT01824394|18953896|P1|Overall Study|Discontinued Subjects|1
5482079|NCT01824394|18953894|P3|Overall Study|Death|4
5482080|NCT01824394|18953895|P2|Overall Study|Death|2
5482081|NCT01824394|18953896|P1|Overall Study|Death|3
5482082|NCT01824394|18953894|P3|Overall Study|Lost to Follow-up|3
5482083|NCT01824394|18953895|P2|Overall Study|Lost to Follow-up|9
5482084|NCT01824394|18953896|P1|Overall Study|Lost to Follow-up|0
5482085|NCT01824394|18953894|P3|Overall Study|Withdrawn due to Study Termination|41
5482086|NCT01824394|18953895|P2|Overall Study|Withdrawn due to Study Termination|83
5482087|NCT01824394|18953896|P1|Overall Study|Withdrawn due to Study Termination|91
5482088|NCT01824394|18953894|P3|Overall Study|Early Termination|3
5482089|NCT01824394|18953895|P2|Overall Study|Early Termination|1
5482090|NCT01824394|18953896|P1|Overall Study|Early Termination|1
5482091|NCT01824355|18953906|P1|Overall Study|unevaluable reference method results per|1
5482092|NCT01824355|18953906|P1|Overall Study|Adverse Event|2
5482093|NCT01824342|18953917|P2|Overall Study|Death|0
5482094|NCT01824342|18953918|P1|Overall Study|Death|2
5482095|NCT01824342|18953917|P2|Overall Study|Physician Decision|0
5482096|NCT01824342|18953918|P1|Overall Study|Physician Decision|5
5482097|NCT01824342|18953917|P2|Overall Study|Disease Progression|1
5482098|NCT01824342|18953918|P1|Overall Study|Disease Progression|1
5482099|NCT01824342|18953917|P2|Overall Study|Adverse Event|1
5482100|NCT01824342|18953918|P1|Overall Study|Adverse Event|1
5482101|NCT01824342|18953917|P2|Overall Study|Withdrawal by Subject|3
5482102|NCT01824342|18953918|P1|Overall Study|Withdrawal by Subject|0
5482103|NCT01824303|18953932|P2|Randomized Study|Other Miscellaneous Reasons|0
5482104|NCT01824303|18953933|P1|Randomized Study|Other Miscellaneous Reasons|1
5482105|NCT01824303|18953932|P2|Randomized Study|Withdrawal by Subject|1
5482106|NCT01824303|18953933|P1|Randomized Study|Withdrawal by Subject|1
5482107|NCT01824290|18953959|P2|Overall Study|Investigator Reported Clinical Worsening|1
5482108|NCT01824290|18953960|P1|Overall Study|Investigator Reported Clinical Worsening|1
5482109|NCT01824290|18953959|P2|Overall Study|Parent/Caregiver Decision|1
5482110|NCT01824290|18953960|P1|Overall Study|Parent/Caregiver Decision|1
5482111|NCT01824290|18953959|P2|Overall Study|Entry Criteria Not Met|0
5482112|NCT01824290|18953960|P1|Overall Study|Entry Criteria Not Met|1
5482113|NCT01823991|18953978|P2|Overall Study|Withdrawal by Subject|5
5482114|NCT01823991|18953979|P1|Overall Study|Withdrawal by Subject|8
5482115|NCT01823679|18954020|P1|Overall Study|Death|1
5482116|NCT01823536|18954073|P6|Overall Study|Subject moved out of the state|0
5482117|NCT01823536|18954074|P5|Overall Study|Subject moved out of the state|1
5482118|NCT01823536|18954075|P4|Overall Study|Subject moved out of the state|0
5482119|NCT01823536|18954076|P3|Overall Study|Subject moved out of the state|0
5482120|NCT01823536|18954077|P2|Overall Study|Subject moved out of the state|0
5482121|NCT01823536|18954078|P1|Overall Study|Subject moved out of the state|0
5482122|NCT01823536|18954073|P6|Overall Study|Met exclusion criterion No 6|0
5482123|NCT01823536|18954074|P5|Overall Study|Met exclusion criterion No 6|0
5482124|NCT01823536|18954075|P4|Overall Study|Met exclusion criterion No 6|1
5482125|NCT01823536|18954076|P3|Overall Study|Met exclusion criterion No 6|0
5482126|NCT01823536|18954077|P2|Overall Study|Met exclusion criterion No 6|0
5482127|NCT01823536|18954078|P1|Overall Study|Met exclusion criterion No 6|0
5482128|NCT01823536|18954073|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
5482129|NCT01823536|18954074|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
5482130|NCT01823536|18954075|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
5482131|NCT01823536|18954076|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
5482132|NCT01823536|18954077|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
5482133|NCT01823536|18954078|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
5482134|NCT01823536|18954073|P6|Overall Study|Withdrawal by Subject|0
5482135|NCT01823536|18954074|P5|Overall Study|Withdrawal by Subject|0
5482136|NCT01823536|18954075|P4|Overall Study|Withdrawal by Subject|0
5482137|NCT01823536|18954076|P3|Overall Study|Withdrawal by Subject|0
5482138|NCT01823536|18954077|P2|Overall Study|Withdrawal by Subject|1
5482139|NCT01823536|18954078|P1|Overall Study|Withdrawal by Subject|1
5482140|NCT01823536|18954073|P6|Overall Study|Protocol Violation|0
5482141|NCT01823536|18954074|P5|Overall Study|Protocol Violation|0
5482142|NCT01823536|18954075|P4|Overall Study|Protocol Violation|0
5482143|NCT01823536|18954076|P3|Overall Study|Protocol Violation|0
5482144|NCT01823536|18954077|P2|Overall Study|Protocol Violation|1
5482145|NCT01823536|18954078|P1|Overall Study|Protocol Violation|0
5482146|NCT01823536|18954073|P6|Overall Study|Lost to Follow-up|0
5482147|NCT01823536|18954074|P5|Overall Study|Lost to Follow-up|1
5482148|NCT01823536|18954075|P4|Overall Study|Lost to Follow-up|1
5482149|NCT01823536|18954076|P3|Overall Study|Lost to Follow-up|0
5482150|NCT01823536|18954077|P2|Overall Study|Lost to Follow-up|0
5482151|NCT01823536|18954078|P1|Overall Study|Lost to Follow-up|1
5482152|NCT01823341|18954140|P1|Overall Study|Adverse Event|1
5482153|NCT01823341|18954140|P1|Overall Study|Withdrawal by Subject|7
5482154|NCT01823341|18954140|P1|Overall Study|Failed run-in|7
5482155|NCT01823328|18954185|P2|Overall Study|Withdrawal by Subject|6
5482156|NCT01823328|18954186|P1|Overall Study|Withdrawal by Subject|8
5482157|NCT01823289|18954206|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
5482158|NCT01823289|18954206|P1|Overall Study|Drug affected efficacy and safety|1
5482159|NCT01823289|18954206|P1|Overall Study|Transaminase increased more than 3 times|1
5482160|NCT01823289|18954206|P1|Overall Study|Administered contraindicated medicine|1
5482161|NCT01823289|18954206|P1|Overall Study|Physician Decision|9
5482162|NCT01823289|18954206|P1|Overall Study|Lack of Efficacy|1
5482163|NCT01823289|18954206|P1|Overall Study|Adverse Event|5
5482164|NCT01823289|18954206|P1|Overall Study|Lost to Follow-up|5
5482165|NCT01823224|18954214|P2|Overall Study|Withdrawal by Subject|1
5482166|NCT01823224|18954215|P1|Overall Study|Withdrawal by Subject|0
5482167|NCT01823224|18954214|P2|Overall Study|missed med dose|1
5482168|NCT01823224|18954215|P1|Overall Study|missed med dose|0
5482169|NCT01823224|18954214|P2|Overall Study|pharmacy error|1
5482170|NCT01823224|18954215|P1|Overall Study|pharmacy error|0
5482171|NCT01823224|18954214|P2|Overall Study|didn't qualify|2
5482172|NCT01823224|18954215|P1|Overall Study|didn't qualify|1
5482173|NCT01823224|18954214|P2|Overall Study|Lost to Follow-up|6
5482174|NCT01823224|18954215|P1|Overall Study|Lost to Follow-up|5
5482175|NCT01823146|18954225|P2|Overall Study|Lost to Follow-up|1
5482176|NCT01823146|18954226|P1|Overall Study|Lost to Follow-up|2
5482177|NCT01823146|18954225|P2|Overall Study|Withdrawal by Subject|1
5482178|NCT01823146|18954226|P1|Overall Study|Withdrawal by Subject|0
5482179|NCT01823107|18954236|P1|Overall Study|Withdrawal by Subject|1
5482180|NCT01822925|18954246|P4|Overall Study|Taking prohibited medication|1
5482181|NCT01822925|18954247|P3|Overall Study|Taking prohibited medication|0
5482182|NCT01822925|18954248|P2|Overall Study|Taking prohibited medication|0
5482183|NCT01822925|18954249|P1|Overall Study|Taking prohibited medication|2
5482184|NCT01822925|18954246|P4|Overall Study|Withdrawal by Subject|2
5482185|NCT01822925|18954247|P3|Overall Study|Withdrawal by Subject|2
5482186|NCT01822925|18954248|P2|Overall Study|Withdrawal by Subject|0
5482187|NCT01822925|18954249|P1|Overall Study|Withdrawal by Subject|2
5482188|NCT01822925|18954246|P4|Overall Study|Protocol Violation|1
5482189|NCT01822925|18954247|P3|Overall Study|Protocol Violation|0
5482190|NCT01822925|18954248|P2|Overall Study|Protocol Violation|0
5482191|NCT01822925|18954249|P1|Overall Study|Protocol Violation|1
5482192|NCT01822925|18954246|P4|Overall Study|Lost to Follow-up|0
5482193|NCT01822925|18954247|P3|Overall Study|Lost to Follow-up|0
5482194|NCT01822925|18954248|P2|Overall Study|Lost to Follow-up|1
5482195|NCT01822925|18954249|P1|Overall Study|Lost to Follow-up|0
5482196|NCT01822925|18954246|P4|Overall Study|Adverse Event|1
5482197|NCT01822925|18954247|P3|Overall Study|Adverse Event|1
5482198|NCT01822925|18954248|P2|Overall Study|Adverse Event|1
5482199|NCT01822925|18954249|P1|Overall Study|Adverse Event|1
5482200|NCT01822899|18954301|P2|Overall Study|Withdrawal by Subject|7
5482201|NCT01822899|18954302|P1|Overall Study|Withdrawal by Subject|5
5482202|NCT01822899|18954301|P2|Overall Study|Lost to Follow-up|0
5482203|NCT01822899|18954302|P1|Overall Study|Lost to Follow-up|1
5482204|NCT01822899|18954301|P2|Overall Study|Protocol Violation|3
5482205|NCT01822899|18954302|P1|Overall Study|Protocol Violation|6
5482206|NCT01822899|18954301|P2|Overall Study|Lack of Efficacy|3
5482207|NCT01822899|18954302|P1|Overall Study|Lack of Efficacy|6
5482208|NCT01822899|18954301|P2|Overall Study|Adverse Event|5
5482209|NCT01822899|18954302|P1|Overall Study|Adverse Event|6
5482210|NCT01822821|18954320|P2|Overall Study|Other reasons|0
5482211|NCT01822821|18954321|P1|Overall Study|Other reasons|1
5482212|NCT01822821|18954320|P2|Overall Study|Eligible surgery cancelled|1
5482213|NCT01822821|18954321|P1|Overall Study|Eligible surgery cancelled|1
5482214|NCT01822756|18954350|P5|Overall Study|disease progression & patient preference|0
5482215|NCT01822756|18954351|P4|Overall Study|disease progression & patient preference|0
5482216|NCT01822756|18954352|P3|Overall Study|disease progression & patient preference|1
5482217|NCT01822756|18954353|P2|Overall Study|disease progression & patient preference|0
5482218|NCT01822756|18954354|P1|Overall Study|disease progression & patient preference|2
5482219|NCT01822756|18954350|P5|Overall Study|Physician Decision|0
5482220|NCT01822756|18954351|P4|Overall Study|Physician Decision|0
5482221|NCT01822756|18954352|P3|Overall Study|Physician Decision|0
5482222|NCT01822756|18954353|P2|Overall Study|Physician Decision|1
5482223|NCT01822756|18954354|P1|Overall Study|Physician Decision|0
5482224|NCT01822756|18954350|P5|Overall Study|Lost to Follow-up|1
5482225|NCT01822756|18954351|P4|Overall Study|Lost to Follow-up|0
5482226|NCT01822756|18954352|P3|Overall Study|Lost to Follow-up|1
5482227|NCT01822756|18954353|P2|Overall Study|Lost to Follow-up|0
5482228|NCT01822756|18954354|P1|Overall Study|Lost to Follow-up|1
5482229|NCT01822756|18954350|P5|Overall Study|Death|0
5482230|NCT01822756|18954351|P4|Overall Study|Death|0
5482231|NCT01822756|18954352|P3|Overall Study|Death|1
5482232|NCT01822756|18954353|P2|Overall Study|Death|2
5482233|NCT01822756|18954354|P1|Overall Study|Death|2
5482234|NCT01822756|18954350|P5|Overall Study|Disease progression|6
5482235|NCT01822756|18954351|P4|Overall Study|Disease progression|2
5482236|NCT01822756|18954352|P3|Overall Study|Disease progression|7
5482237|NCT01822756|18954353|P2|Overall Study|Disease progression|1
5482238|NCT01822756|18954354|P1|Overall Study|Disease progression|11
5482239|NCT01822756|18954350|P5|Overall Study|Adverse Event|0
5482240|NCT01822756|18954351|P4|Overall Study|Adverse Event|2
5482241|NCT01822756|18954352|P3|Overall Study|Adverse Event|0
5482242|NCT01822756|18954353|P2|Overall Study|Adverse Event|0
5482243|NCT01822756|18954354|P1|Overall Study|Adverse Event|0
5482244|NCT01822691|18954396|P1|Overall Study|Withdrawal by Subject|2
5482245|NCT01822678|18954407|P3|Overall Study|Lost to Follow-up|1
5482246|NCT01822678|18954408|P2|Overall Study|Lost to Follow-up|2
5482247|NCT01822678|18954409|P1|Overall Study|Lost to Follow-up|0
5482248|NCT01822678|18954407|P3|Overall Study|Lack of Efficacy|5
5482249|NCT01822678|18954408|P2|Overall Study|Lack of Efficacy|6
5482250|NCT01822678|18954409|P1|Overall Study|Lack of Efficacy|3
5482251|NCT01822678|18954407|P3|Overall Study|Adverse Event|1
5482252|NCT01822678|18954408|P2|Overall Study|Adverse Event|3
5482253|NCT01822678|18954409|P1|Overall Study|Adverse Event|4
5482254|NCT01822678|18954407|P3|Overall Study|Withdrawal by Subject|4
5482255|NCT01822678|18954408|P2|Overall Study|Withdrawal by Subject|4
5482256|NCT01822678|18954409|P1|Overall Study|Withdrawal by Subject|5
5482257|NCT01822665|18954417|P1|Overall Study|Other Reason|5
5482258|NCT01822665|18954417|P1|Overall Study|Adverse Event|3
5482259|NCT01822587|18954444|P3|Overall Study|Physician Decision|6
5482260|NCT01822587|18954445|P2|Overall Study|Physician Decision|6
5482261|NCT01822587|18954446|P1|Overall Study|Physician Decision|9
5482262|NCT01822587|18954444|P3|Overall Study|Lost to Follow-up|12
5482263|NCT01822587|18954445|P2|Overall Study|Lost to Follow-up|9
5482264|NCT01822587|18954446|P1|Overall Study|Lost to Follow-up|7
5482265|NCT01822561|18954485|P1|Overall Study|Withdrawal by Subject|2
5482266|NCT01822535|18954506|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
5482267|NCT01822535|18954507|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
5482268|NCT01822535|18954506|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
5482269|NCT01822535|18954507|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
5482270|NCT01822535|18954506|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
5482271|NCT01822535|18954507|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
5482272|NCT01822496|18954523|P4|Overall Study|Withdrawal by Subject|3
5482273|NCT01822496|18954524|P3|Overall Study|Withdrawal by Subject|0
5482274|NCT01822496|18954525|P2|Overall Study|Withdrawal by Subject|0
5482275|NCT01822496|18954526|P1|Overall Study|Withdrawal by Subject|0
5482276|NCT01822496|18954523|P4|Overall Study|Protocol Violation|1
5482277|NCT01822496|18954524|P3|Overall Study|Protocol Violation|0
5482278|NCT01822496|18954525|P2|Overall Study|Protocol Violation|2
5482279|NCT01822496|18954526|P1|Overall Study|Protocol Violation|2
5482280|NCT01822366|18954579|P4|Overall Study|Partial Intervention Completion|15
5482281|NCT01822366|18954580|P3|Overall Study|Partial Intervention Completion|0
5482282|NCT01822366|18954581|P2|Overall Study|Partial Intervention Completion|15
5482283|NCT01822366|18954582|P1|Overall Study|Partial Intervention Completion|0
5482284|NCT01822366|18954579|P4|Overall Study|Withdrawal by Subject|6
5482285|NCT01822366|18954580|P3|Overall Study|Withdrawal by Subject|0
5482286|NCT01822366|18954581|P2|Overall Study|Withdrawal by Subject|6
5482287|NCT01822366|18954582|P1|Overall Study|Withdrawal by Subject|0
5482288|NCT01822366|18954579|P4|Overall Study|Lost to Follow-up|1
5482289|NCT01822366|18954580|P3|Overall Study|Lost to Follow-up|5
5482290|NCT01822366|18954581|P2|Overall Study|Lost to Follow-up|1
5482291|NCT01822366|18954582|P1|Overall Study|Lost to Follow-up|5
5482292|NCT01822353|18954613|P3|Overall Study|Withdrawal by Subject|0
5482293|NCT01822353|18954614|P2|Overall Study|Withdrawal by Subject|1
5482294|NCT01822353|18954615|P1|Overall Study|Withdrawal by Subject|3
5482295|NCT01822353|18954613|P3|Overall Study|Pregnancy|0
5482296|NCT01822353|18954614|P2|Overall Study|Pregnancy|1
5482297|NCT01822353|18954615|P1|Overall Study|Pregnancy|0
5482298|NCT01822353|18954613|P3|Overall Study|Adverse Event|1
5482299|NCT01822353|18954614|P2|Overall Study|Adverse Event|3
5482300|NCT01822353|18954615|P1|Overall Study|Adverse Event|1
5482301|NCT01822223|18954635|P2|Overall Study|Death|1
5482302|NCT01822223|18954636|P1|Overall Study|Death|0
5482303|NCT01822132|18954660|P2|Overall Study|Lost to Follow-up|2
5482304|NCT01822132|18954661|P1|Overall Study|Lost to Follow-up|4
5482305|NCT01821963|18954698|P1|Overall Study|Adverse Event|1
5482306|NCT01821937|18954704|P2|Overall Study|Adverse Event|3
5482307|NCT01821937|18954705|P1|Overall Study|Adverse Event|0
5482308|NCT01821807|18954729|P2|Overall Study|Lost to Follow-up|1
5482309|NCT01821807|18954730|P1|Overall Study|Lost to Follow-up|3
5482310|NCT01821729|18954738|P1|Overall Study|Withdrawal by Subject|1
5482311|NCT01821625|18954743|P1|Overall Study|Medical contraindication|1
5482312|NCT01821625|18954743|P1|Overall Study|Adverse Event|1
5482313|NCT01821625|18954743|P1|Overall Study|Lack of Efficacy|2
5482314|NCT01821625|18954743|P1|Overall Study|Withdrawal by Subject|2
5482315|NCT01821560|18954749|P2|Overall Study|Protocol Violation|1
5482316|NCT01821560|18954750|P1|Overall Study|Protocol Violation|0
5482317|NCT01821560|18954749|P2|Overall Study|Withdrawal by Subject|1
5482318|NCT01821560|18954750|P1|Overall Study|Withdrawal by Subject|1
5482319|NCT01821560|18954749|P2|Overall Study|Lost to Follow-up|5
5482320|NCT01821560|18954750|P1|Overall Study|Lost to Follow-up|5
5482321|NCT01821391|18954778|P2|Overall Study|Adverse Event|0
5482322|NCT01821391|18954779|P1|Overall Study|Adverse Event|1
5482323|NCT01821118|18954882|P2|Overall Study|Death|1
5482324|NCT01821118|18954883|P1|Overall Study|Death|0
5482325|NCT01820637|18954930|P1|Overall Study|Withdrawal by Subject|1
5482326|NCT01820637|18954930|P1|Overall Study|Death|2
5482327|NCT01820585|18954939|P4|Overall Study|Pregnancy|0
5482328|NCT01820585|18954940|P3|Overall Study|Pregnancy|0
5482329|NCT01820585|18954941|P2|Overall Study|Pregnancy|1
5482330|NCT01820585|18954942|P1|Overall Study|Pregnancy|0
5482331|NCT01820585|18954939|P4|Overall Study|at sponsor request|0
5482332|NCT01820585|18954940|P3|Overall Study|at sponsor request|1
5482333|NCT01820585|18954941|P2|Overall Study|at sponsor request|0
5482334|NCT01820585|18954942|P1|Overall Study|at sponsor request|0
5482335|NCT01820585|18954939|P4|Overall Study|Subject non-compliance|2
5482336|NCT01820585|18954940|P3|Overall Study|Subject non-compliance|1
5482337|NCT01820585|18954941|P2|Overall Study|Subject non-compliance|0
5482338|NCT01820585|18954942|P1|Overall Study|Subject non-compliance|0
5482339|NCT01820585|18954939|P4|Overall Study|Protocol Violation|1
5482340|NCT01820585|18954940|P3|Overall Study|Protocol Violation|1
5482341|NCT01820585|18954941|P2|Overall Study|Protocol Violation|1
5482342|NCT01820585|18954942|P1|Overall Study|Protocol Violation|3
5482343|NCT01820585|18954939|P4|Overall Study|Lost to Follow-up|3
5482344|NCT01820585|18954940|P3|Overall Study|Lost to Follow-up|0
5482345|NCT01820585|18954941|P2|Overall Study|Lost to Follow-up|3
5482346|NCT01820585|18954942|P1|Overall Study|Lost to Follow-up|3
5482347|NCT01820585|18954939|P4|Overall Study|Withdrawal by Subject|8
5482348|NCT01820585|18954940|P3|Overall Study|Withdrawal by Subject|3
5482349|NCT01820585|18954941|P2|Overall Study|Withdrawal by Subject|7
5482350|NCT01820585|18954942|P1|Overall Study|Withdrawal by Subject|3
5482351|NCT01820585|18954939|P4|Overall Study|Lack of Efficacy|1
5482352|NCT01820585|18954940|P3|Overall Study|Lack of Efficacy|5
5482353|NCT01820585|18954941|P2|Overall Study|Lack of Efficacy|7
5482354|NCT01820585|18954942|P1|Overall Study|Lack of Efficacy|9
5482355|NCT01820585|18954939|P4|Overall Study|Adverse Event|34
5482356|NCT01820585|18954940|P3|Overall Study|Adverse Event|23
5482357|NCT01820585|18954941|P2|Overall Study|Adverse Event|13
5482358|NCT01820585|18954942|P1|Overall Study|Adverse Event|9
5482359|NCT01820559|18954955|P3|Overall Study|Lack of Efficacy|3
5482360|NCT01820559|18954956|P2|Overall Study|Lack of Efficacy|2
5482361|NCT01820559|18954957|P1|Overall Study|Lack of Efficacy|3
5482362|NCT01820559|18954955|P3|Overall Study|At sponsor request|1
5482363|NCT01820559|18954956|P2|Overall Study|At sponsor request|0
5482364|NCT01820559|18954957|P1|Overall Study|At sponsor request|0
5482365|NCT01820559|18954955|P3|Overall Study|Lost to Follow-up|2
5482366|NCT01820559|18954956|P2|Overall Study|Lost to Follow-up|2
5482367|NCT01820559|18954957|P1|Overall Study|Lost to Follow-up|3
5482368|NCT01820559|18954955|P3|Overall Study|Subject's non-compliance|2
5482369|NCT01820559|18954956|P2|Overall Study|Subject's non-compliance|0
5482370|NCT01820559|18954957|P1|Overall Study|Subject's non-compliance|1
5482371|NCT01820559|18954955|P3|Overall Study|Protocol Violation|3
5482372|NCT01820559|18954956|P2|Overall Study|Protocol Violation|1
5482373|NCT01820559|18954957|P1|Overall Study|Protocol Violation|2
5482374|NCT01820559|18954955|P3|Overall Study|Withdrawal by Subject|5
5482375|NCT01820559|18954956|P2|Overall Study|Withdrawal by Subject|2
5482376|NCT01820559|18954957|P1|Overall Study|Withdrawal by Subject|1
5482377|NCT01820559|18954955|P3|Overall Study|Adverse Event|13
5482378|NCT01820559|18954956|P2|Overall Study|Adverse Event|6
5482379|NCT01820559|18954957|P1|Overall Study|Adverse Event|4
5482380|NCT01820364|18954978|P2|Part II: LGX818 + MEK162|Study Termination|1
5482381|NCT01820364|18954979|P1|Part II: LGX818 + MEK162|Study Termination|0
5482382|NCT01820364|18954978|P2|Part I: LGX818|Disease Progression|0
5482383|NCT01820364|18954979|P1|Part I: LGX818|Disease Progression|4
5482384|NCT01820364|18954978|P2|Part I: LGX818|Adverse Event|0
5482385|NCT01820364|18954979|P1|Part I: LGX818|Adverse Event|6
5482386|NCT01820364|18954978|P2|Part I: LGX818|Administrative Problems|0
5482387|NCT01820364|18954979|P1|Part I: LGX818|Administrative Problems|3
5482388|NCT01820364|18954978|P2|Part I: LGX818|Death|0
5482389|NCT01820364|18954979|P1|Part I: LGX818|Death|1
5482390|NCT01819727|18955123|P2|Overall Study|Quit due to lack of health benifits|1
5482391|NCT01819727|18955124|P1|Overall Study|Quit due to lack of health benifits|0
5482392|NCT01819727|18955123|P2|Overall Study|Unable to demostrate ability self-inject|1
5482393|NCT01819727|18955124|P1|Overall Study|Unable to demostrate ability self-inject|0
5482394|NCT01819727|18955123|P2|Overall Study|Withdrawal by Subject|11
5482395|NCT01819727|18955124|P1|Overall Study|Withdrawal by Subject|6
5482396|NCT01819727|18955123|P2|Overall Study|Study Terminated by Sponsor|1
5482397|NCT01819727|18955124|P1|Overall Study|Study Terminated by Sponsor|0
5482398|NCT01819727|18955123|P2|Overall Study|Protocol Violation|2
5482399|NCT01819727|18955124|P1|Overall Study|Protocol Violation|0
5482400|NCT01819727|18955123|P2|Overall Study|Pregnancy|0
5482401|NCT01819727|18955124|P1|Overall Study|Pregnancy|1
5482402|NCT01819727|18955123|P2|Overall Study|Physician Decision|2
5482403|NCT01819727|18955124|P1|Overall Study|Physician Decision|3
5482404|NCT01819727|18955123|P2|Overall Study|Lost to Follow-up|1
5482405|NCT01819727|18955124|P1|Overall Study|Lost to Follow-up|1
5482406|NCT01819727|18955123|P2|Overall Study|Death|0
5482407|NCT01819727|18955124|P1|Overall Study|Death|1
5482408|NCT01819727|18955123|P2|Overall Study|Adverse Event|9
5482409|NCT01819727|18955124|P1|Overall Study|Adverse Event|8
5482410|NCT01819506|18955146|P2|Overall Study|Withdrawal by Subject|3
5482411|NCT01819506|18955147|P1|Overall Study|Withdrawal by Subject|3
5482412|NCT01819506|18955146|P2|Overall Study|Physician Decision|2
5482413|NCT01819506|18955147|P1|Overall Study|Physician Decision|5
5482414|NCT01819272|18955199|P6|Overall Study|Loss of Glucose Control|0
5482415|NCT01819272|18955200|P5|Overall Study|Loss of Glucose Control|2
5482416|NCT01819272|18955201|P4|Overall Study|Loss of Glucose Control|1
5482417|NCT01819272|18955202|P3|Overall Study|Loss of Glucose Control|0
5482418|NCT01819272|18955203|P2|Overall Study|Loss of Glucose Control|1
5482419|NCT01819272|18955204|P1|Overall Study|Loss of Glucose Control|2
5482420|NCT01819272|18955199|P6|Overall Study|Withdrawal of Consent|1
5482421|NCT01819272|18955200|P5|Overall Study|Withdrawal of Consent|0
5482422|NCT01819272|18955201|P4|Overall Study|Withdrawal of Consent|1
5482423|NCT01819272|18955202|P3|Overall Study|Withdrawal of Consent|2
5482424|NCT01819272|18955203|P2|Overall Study|Withdrawal of Consent|1
5482425|NCT01819272|18955204|P1|Overall Study|Withdrawal of Consent|0
5482426|NCT01819272|18955199|P6|Overall Study|Physician Decision|0
5482427|NCT01819272|18955200|P5|Overall Study|Physician Decision|0
5482428|NCT01819272|18955201|P4|Overall Study|Physician Decision|0
5482429|NCT01819272|18955202|P3|Overall Study|Physician Decision|0
5482430|NCT01819272|18955203|P2|Overall Study|Physician Decision|1
5482431|NCT01819272|18955204|P1|Overall Study|Physician Decision|0
5482432|NCT01819272|18955199|P6|Overall Study|Protocol Violation|3
5482433|NCT01819272|18955200|P5|Overall Study|Protocol Violation|2
5482434|NCT01819272|18955201|P4|Overall Study|Protocol Violation|1
5482435|NCT01819272|18955202|P3|Overall Study|Protocol Violation|0
5482436|NCT01819272|18955203|P2|Overall Study|Protocol Violation|0
5482437|NCT01819272|18955204|P1|Overall Study|Protocol Violation|0
5482438|NCT01819272|18955199|P6|Overall Study|Lost to Follow-up|3
5482439|NCT01819272|18955200|P5|Overall Study|Lost to Follow-up|0
5482440|NCT01819272|18955201|P4|Overall Study|Lost to Follow-up|0
5482441|NCT01819272|18955202|P3|Overall Study|Lost to Follow-up|1
5482442|NCT01819272|18955203|P2|Overall Study|Lost to Follow-up|0
5482443|NCT01819272|18955204|P1|Overall Study|Lost to Follow-up|3
5482444|NCT01819272|18955199|P6|Overall Study|Adverse Event|0
5482445|NCT01819272|18955200|P5|Overall Study|Adverse Event|0
5482446|NCT01819272|18955201|P4|Overall Study|Adverse Event|2
5482447|NCT01819272|18955202|P3|Overall Study|Adverse Event|0
5482448|NCT01819272|18955203|P2|Overall Study|Adverse Event|0
5482449|NCT01819272|18955204|P1|Overall Study|Adverse Event|1
5482450|NCT01819194|18955242|P1|Overall Study|Loss of study articles|2
5482451|NCT01819129|18955249|P2|Overall Study|Withdrawal Criteria|15
5482452|NCT01819129|18955250|P1|Overall Study|Withdrawal Criteria|20
5482453|NCT01819129|18955249|P2|Overall Study|Death|1
5482454|NCT01819129|18955250|P1|Overall Study|Death|1
5482455|NCT01819129|18955249|P2|Overall Study|Adverse Event|4
5482456|NCT01819129|18955250|P1|Overall Study|Adverse Event|1
5482457|NCT01819129|18955249|P2|Overall Study|Lack of Efficacy|1
5482458|NCT01819129|18955250|P1|Overall Study|Lack of Efficacy|0
5482459|NCT01819129|18955249|P2|Overall Study|Lost to Follow-up|2
5482460|NCT01819129|18955250|P1|Overall Study|Lost to Follow-up|5
5482461|NCT01819129|18955249|P2|Overall Study|Withdrawal by Subject|15
5482462|NCT01819129|18955250|P1|Overall Study|Withdrawal by Subject|15
5482463|NCT01819129|18955249|P2|Overall Study|Other, Subject moved out of the country|1
5482464|NCT01819129|18955250|P1|Overall Study|Other, Subject moved out of the country|0
5482465|NCT01819129|18955249|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
5482466|NCT01819129|18955250|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
5482467|NCT01819129|18955249|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
5482468|NCT01819129|18955250|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
5482469|NCT01818765|18955275|P1|Overall Study|Death|2
5482470|NCT01818752|18955288|P2|Overall Study|Randomized but not Dosed|4
5482471|NCT01818752|18955289|P1|Overall Study|Randomized but not Dosed|7
5482472|NCT01818752|18955288|P2|Overall Study|Continuing Treatment|4
5482473|NCT01818752|18955289|P1|Overall Study|Continuing Treatment|1
5482474|NCT01818752|18955288|P2|Overall Study|Other|8
5482475|NCT01818752|18955289|P1|Overall Study|Other|7
5482476|NCT01818752|18955288|P2|Overall Study|Disease Progression|48
5482477|NCT01818752|18955289|P1|Overall Study|Disease Progression|54
5482478|NCT01818752|18955288|P2|Overall Study|Physician Decision|8
5482479|NCT01818752|18955289|P1|Overall Study|Physician Decision|9
5482480|NCT01818752|18955288|P2|Overall Study|Withdrawal by Subject|14
5482481|NCT01818752|18955289|P1|Overall Study|Withdrawal by Subject|15
5482482|NCT01818752|18955288|P2|Overall Study|Non-compliance|20
5482483|NCT01818752|18955289|P1|Overall Study|Non-compliance|16
5482484|NCT01818752|18955288|P2|Overall Study|Death|18
5482485|NCT01818752|18955289|P1|Overall Study|Death|14
5482486|NCT01818752|18955288|P2|Overall Study|Adverse Event|74
5482487|NCT01818752|18955289|P1|Overall Study|Adverse Event|64
5482488|NCT01818726|18955309|P2|Overall Study|Decision to perform 2nd course of trtmnt|0
5482489|NCT01818726|18955310|P1|Overall Study|Decision to perform 2nd course of trtmnt|1
5482490|NCT01818726|18955309|P2|Overall Study|Withdrawal by Subject|1
5482491|NCT01818726|18955310|P1|Overall Study|Withdrawal by Subject|0
5482492|NCT01818726|18955309|P2|Overall Study|Administrative reasons|1
5482493|NCT01818726|18955310|P1|Overall Study|Administrative reasons|5
5482494|NCT01818700|18955320|P1|Overall Study|Other|1
5482495|NCT01818700|18955320|P1|Overall Study|Protocol Violation|2
5482496|NCT01818700|18955320|P1|Overall Study|Withdrawal by Subject|27
5482497|NCT01818700|18955320|P1|Overall Study|Lost to Follow-up|5
5482498|NCT01818700|18955320|P1|Overall Study|Lack of Efficacy|2
5482499|NCT01818700|18955320|P1|Overall Study|Adverse Event|67
5482500|NCT01818596|18955331|P2|Overall Study|Lost to Follow-up|0
5482501|NCT01818596|18955332|P1|Overall Study|Lost to Follow-up|7
5482502|NCT01818596|18955331|P2|Overall Study|Withdrew Consent|0
5482503|NCT01818596|18955332|P1|Overall Study|Withdrew Consent|5
5482504|NCT01818596|18955331|P2|Overall Study|Protocol Violation|0
5482505|NCT01818596|18955332|P1|Overall Study|Protocol Violation|1
5482506|NCT01818596|18955331|P2|Overall Study|Investigator's Discretion|0
5482507|NCT01818596|18955332|P1|Overall Study|Investigator's Discretion|4
5482508|NCT01818596|18955331|P2|Overall Study|Death|0
5482509|NCT01818596|18955332|P1|Overall Study|Death|3
5482510|NCT01818596|18955331|P2|Overall Study|Adverse Event|0
5482511|NCT01818596|18955332|P1|Overall Study|Adverse Event|7
5482512|NCT01818596|18955331|P2|Overall Study|Enrolled but Not Treated|0
5482513|NCT01818596|18955332|P1|Overall Study|Enrolled but Not Treated|4
5482514|NCT01818531|18955371|P2|Overall Study|Withdrawn for failure to place block|1
5482515|NCT01818531|18955372|P1|Overall Study|Withdrawn for failure to place block|0
5482516|NCT01818531|18955371|P2|Overall Study|Withdrawn for long-acting opioid patch|1
5482517|NCT01818531|18955372|P1|Overall Study|Withdrawn for long-acting opioid patch|0
5482518|NCT01818531|18955371|P2|Overall Study|Withdrawn for case delay after block|0
5482519|NCT01818531|18955372|P1|Overall Study|Withdrawn for case delay after block|1
5482520|NCT01818492|18955411|P1|Overall Study|Additional therapy when not allowed PP|4
5482521|NCT01818492|18955411|P1|Overall Study|Withdrawal by Subject|1
5482522|NCT01818492|18955411|P1|Overall Study|Death|3
5482523|NCT01818492|18955411|P1|Overall Study|Adverse Event|2
5482524|NCT01818336|18955460|P2|Overall Study|Lost to Follow-up|1
5482525|NCT01818336|18955461|P1|Overall Study|Lost to Follow-up|0
5482526|NCT01818336|18955460|P2|Overall Study|Declined retest visit|11
5482527|NCT01818336|18955461|P1|Overall Study|Declined retest visit|0
5482528|NCT01818297|18955469|P2|Open Label Phase (3-12 Months)|Early study closure|10
5482529|NCT01818297|18955470|P1|Open Label Phase (3-12 Months)|Early study closure|17
5482530|NCT01818297|18955469|P2|Open Label Phase (3-12 Months)|Physician Decision|0
5482531|NCT01818297|18955470|P1|Open Label Phase (3-12 Months)|Physician Decision|1
5482532|NCT01818297|18955469|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
5482533|NCT01818297|18955470|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
5482534|NCT01818284|18955488|P2|Overall Study|Death|2
5482535|NCT01818284|18955489|P1|Overall Study|Death|0
5482536|NCT01818284|18955488|P2|Overall Study|Not eligible due to White Blood Counts|4
5482537|NCT01818284|18955489|P1|Overall Study|Not eligible due to White Blood Counts|4
5482538|NCT01818141|18955522|P2|Overall Study|Lost to Follow-up|2
5482539|NCT01818141|18955523|P1|Overall Study|Lost to Follow-up|0
5482540|NCT01818141|18955522|P2|Overall Study|No baseline C.diff colonies|1
5482541|NCT01818141|18955523|P1|Overall Study|No baseline C.diff colonies|1
5482542|NCT01818141|18955522|P2|Overall Study|Withdrawal by Subject|0
5482543|NCT01818141|18955523|P1|Overall Study|Withdrawal by Subject|2
5482544|NCT01817959|18955546|P2|Overall Study|Patient didn't proceed to 1st Islet Inf|1
5482545|NCT01817959|18955547|P1|Overall Study|Patient didn't proceed to 1st Islet Inf|1
5482546|NCT01817959|18955546|P2|Overall Study|Adverse Event|0
5482547|NCT01817959|18955547|P1|Overall Study|Adverse Event|1
5482548|NCT01817959|18955546|P2|Overall Study|forbidden medication|1
5482549|NCT01817959|18955547|P1|Overall Study|forbidden medication|1
5482550|NCT01817959|18955546|P2|Overall Study|Graft loss|1
5482551|NCT01817959|18955547|P1|Overall Study|Graft loss|1
5482552|NCT01817790|18955639|P2|Overall Study|Other: Could not attend appointment|1
5482553|NCT01817790|18955640|P1|Overall Study|Other: Could not attend appointment|1
5482554|NCT01817790|18955639|P2|Overall Study|Withdrawal by Subject|3
5482555|NCT01817790|18955640|P1|Overall Study|Withdrawal by Subject|1
5482556|NCT01817790|18955639|P2|Overall Study|Protocol Violation|1
5482557|NCT01817790|18955640|P1|Overall Study|Protocol Violation|2
5482558|NCT01817790|18955639|P2|Overall Study|Lost to Follow-up|1
5482559|NCT01817790|18955640|P1|Overall Study|Lost to Follow-up|0
5482560|NCT01817790|18955639|P2|Overall Study|Adverse Event|2
5482561|NCT01817790|18955640|P1|Overall Study|Adverse Event|0
5482562|NCT01817777|18955684|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
5482563|NCT01817777|18955685|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
5482564|NCT01817777|18955686|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
5482565|NCT01817777|18955684|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
5482566|NCT01817777|18955685|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
5482567|NCT01817777|18955686|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
5482568|NCT01817777|18955684|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
5482569|NCT01817777|18955685|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
5482570|NCT01817777|18955686|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
5482571|NCT01817777|18955684|P3|Observational Phase (8 Weeks)|Early Study Termination|0
5482572|NCT01817777|18955685|P2|Observational Phase (8 Weeks)|Early Study Termination|0
5482573|NCT01817777|18955686|P1|Observational Phase (8 Weeks)|Early Study Termination|2
5482574|NCT01817777|18955684|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
5482575|NCT01817777|18955685|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
5482576|NCT01817777|18955686|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
5482577|NCT01817764|18955710|P2|Overall Study|Withdrawal by Subject|12
5482578|NCT01817764|18955711|P1|Overall Study|Withdrawal by Subject|10
5482579|NCT01817764|18955710|P2|Overall Study|Lost to Follow-up|4
5482580|NCT01817764|18955711|P1|Overall Study|Lost to Follow-up|1
5482581|NCT01817764|18955710|P2|Overall Study|Protocol Violation|5
5482582|NCT01817764|18955711|P1|Overall Study|Protocol Violation|7
5482583|NCT01817764|18955710|P2|Overall Study|Lack of Efficacy|7
5482584|NCT01817764|18955711|P1|Overall Study|Lack of Efficacy|9
5482585|NCT01817764|18955710|P2|Overall Study|Adverse Event|10
5482586|NCT01817764|18955711|P1|Overall Study|Adverse Event|7
5482587|NCT01817725|18955719|P1|Overall Study|Withdrawal by Subject|1
5482588|NCT01817582|18955740|P3|Overall Study|Randomized but exclusion criteria met|0
5482589|NCT01817582|18955741|P2|Overall Study|Randomized but exclusion criteria met|0
5482590|NCT01817582|18955742|P1|Overall Study|Randomized but exclusion criteria met|1
5482591|NCT01817582|18955740|P3|Overall Study|Participant revealed masked treatment|0
5482592|NCT01817582|18955741|P2|Overall Study|Participant revealed masked treatment|0
5482593|NCT01817582|18955742|P1|Overall Study|Participant revealed masked treatment|1
5482594|NCT01817582|18955740|P3|Overall Study|Withdrawal by Subject|0
5482595|NCT01817582|18955741|P2|Overall Study|Withdrawal by Subject|1
5482596|NCT01817582|18955742|P1|Overall Study|Withdrawal by Subject|0
5482597|NCT01817530|18955812|P8|Overall Study|Lost to Follow-up|4
5482598|NCT01817530|18955813|P7|Overall Study|Lost to Follow-up|8
5482599|NCT01817530|18955814|P6|Overall Study|Lost to Follow-up|2
5482600|NCT01817530|18955815|P5|Overall Study|Lost to Follow-up|3
5482601|NCT01817530|18955816|P4|Overall Study|Lost to Follow-up|1
5482602|NCT01817530|18955817|P3|Overall Study|Lost to Follow-up|2
5482603|NCT01817530|18955818|P2|Overall Study|Lost to Follow-up|4
5482604|NCT01817530|18955819|P1|Overall Study|Lost to Follow-up|1
5482605|NCT01817530|18955812|P8|Overall Study|Consent Withdrawn by Subject|10
5482606|NCT01817530|18955813|P7|Overall Study|Consent Withdrawn by Subject|3
5482607|NCT01817530|18955814|P6|Overall Study|Consent Withdrawn by Subject|3
5482608|NCT01817530|18955815|P5|Overall Study|Consent Withdrawn by Subject|5
5482609|NCT01817530|18955816|P4|Overall Study|Consent Withdrawn by Subject|3
5482610|NCT01817530|18955817|P3|Overall Study|Consent Withdrawn by Subject|7
5482611|NCT01817530|18955818|P2|Overall Study|Consent Withdrawn by Subject|4
5482612|NCT01817530|18955819|P1|Overall Study|Consent Withdrawn by Subject|3
5482613|NCT01817530|18955812|P8|Overall Study|Surgery or Invasive Intervention|0
5482614|NCT01817530|18955813|P7|Overall Study|Surgery or Invasive Intervention|1
5482615|NCT01817530|18955814|P6|Overall Study|Surgery or Invasive Intervention|1
5482616|NCT01817530|18955815|P5|Overall Study|Surgery or Invasive Intervention|1
5482617|NCT01817530|18955816|P4|Overall Study|Surgery or Invasive Intervention|0
5482618|NCT01817530|18955817|P3|Overall Study|Surgery or Invasive Intervention|0
5482619|NCT01817530|18955818|P2|Overall Study|Surgery or Invasive Intervention|0
5482620|NCT01817530|18955819|P1|Overall Study|Surgery or Invasive Intervention|1
5482621|NCT01817530|18955812|P8|Overall Study|Other|0
5482622|NCT01817530|18955813|P7|Overall Study|Other|5
5482623|NCT01817530|18955814|P6|Overall Study|Other|0
5482624|NCT01817530|18955815|P5|Overall Study|Other|1
5482625|NCT01817530|18955816|P4|Overall Study|Other|0
5482626|NCT01817530|18955817|P3|Overall Study|Other|0
5482627|NCT01817530|18955818|P2|Overall Study|Other|1
5482628|NCT01817530|18955819|P1|Overall Study|Other|0
5482629|NCT01817530|18955812|P8|Overall Study|Pregnancy|0
5482630|NCT01817530|18955813|P7|Overall Study|Pregnancy|0
5482631|NCT01817530|18955814|P6|Overall Study|Pregnancy|1
5482632|NCT01817530|18955815|P5|Overall Study|Pregnancy|0
5482633|NCT01817530|18955816|P4|Overall Study|Pregnancy|0
5482634|NCT01817530|18955817|P3|Overall Study|Pregnancy|0
5482635|NCT01817530|18955818|P2|Overall Study|Pregnancy|0
5482636|NCT01817530|18955819|P1|Overall Study|Pregnancy|0
5482637|NCT01817530|18955812|P8|Overall Study|Lack of Efficacy|1
5482638|NCT01817530|18955813|P7|Overall Study|Lack of Efficacy|0
5482639|NCT01817530|18955814|P6|Overall Study|Lack of Efficacy|1
5482640|NCT01817530|18955815|P5|Overall Study|Lack of Efficacy|0
5482641|NCT01817530|18955816|P4|Overall Study|Lack of Efficacy|0
5482642|NCT01817530|18955817|P3|Overall Study|Lack of Efficacy|0
5482643|NCT01817530|18955818|P2|Overall Study|Lack of Efficacy|0
5482644|NCT01817530|18955819|P1|Overall Study|Lack of Efficacy|1
5482645|NCT01817530|18955812|P8|Overall Study|Subject Noncompliant|1
5482646|NCT01817530|18955813|P7|Overall Study|Subject Noncompliant|1
5482647|NCT01817530|18955814|P6|Overall Study|Subject Noncompliant|1
5482648|NCT01817530|18955815|P5|Overall Study|Subject Noncompliant|0
5482649|NCT01817530|18955816|P4|Overall Study|Subject Noncompliant|4
5482650|NCT01817530|18955817|P3|Overall Study|Subject Noncompliant|0
5482651|NCT01817530|18955818|P2|Overall Study|Subject Noncompliant|1
5482652|NCT01817530|18955819|P1|Overall Study|Subject Noncompliant|3
5482653|NCT01817530|18955812|P8|Overall Study|Adverse Event|8
5482654|NCT01817530|18955813|P7|Overall Study|Adverse Event|5
5482655|NCT01817530|18955814|P6|Overall Study|Adverse Event|10
5482656|NCT01817530|18955815|P5|Overall Study|Adverse Event|0
5482657|NCT01817530|18955816|P4|Overall Study|Adverse Event|5
5482658|NCT01817530|18955817|P3|Overall Study|Adverse Event|2
5482659|NCT01817530|18955818|P2|Overall Study|Adverse Event|3
5482660|NCT01817530|18955819|P1|Overall Study|Adverse Event|6
5482661|NCT01817530|18955812|P8|Overall Study|Exclusionary Medication Received|0
5482662|NCT01817530|18955813|P7|Overall Study|Exclusionary Medication Received|0
5482663|NCT01817530|18955814|P6|Overall Study|Exclusionary Medication Received|0
5482664|NCT01817530|18955815|P5|Overall Study|Exclusionary Medication Received|1
5482665|NCT01817530|18955816|P4|Overall Study|Exclusionary Medication Received|0
5482666|NCT01817530|18955817|P3|Overall Study|Exclusionary Medication Received|0
5482667|NCT01817530|18955818|P2|Overall Study|Exclusionary Medication Received|0
5482668|NCT01817530|18955819|P1|Overall Study|Exclusionary Medication Received|0
5482669|NCT01817075|18956044|P2|Overall Study|Ineligible|2
5482670|NCT01817075|18956045|P1|Overall Study|Ineligible|0
5482671|NCT01817075|18956044|P2|Overall Study|Received Sorafenib after enrollment|1
5482672|NCT01817075|18956045|P1|Overall Study|Received Sorafenib after enrollment|0
5482673|NCT01817075|18956044|P2|Overall Study|Withdrawal by Subject|15
5482674|NCT01817075|18956045|P1|Overall Study|Withdrawal by Subject|31
5482675|NCT01817075|18956044|P2|Overall Study|Physician Decision|12
5482676|NCT01817075|18956045|P1|Overall Study|Physician Decision|9
5482677|NCT01817075|18956044|P2|Overall Study|Adverse Event|5
5482678|NCT01817075|18956045|P1|Overall Study|Adverse Event|7
5482679|NCT01816984|18956057|P1|Overall Study|declining health status|1
5482680|NCT01816906|18956070|P2|12 Months|Lost to Follow-up|1
5482681|NCT01816906|18956071|P1|12 Months|Lost to Follow-up|2
5482682|NCT01816906|18956070|P2|12 Months|Death|2
5482683|NCT01816906|18956071|P1|12 Months|Death|0
5482684|NCT01816906|18956070|P2|12 Months|Adverse Event|2
5482685|NCT01816906|18956071|P1|12 Months|Adverse Event|2
5482686|NCT01816906|18956070|P2|Six Months|Lost to Follow-up|16
5482687|NCT01816906|18956071|P1|Six Months|Lost to Follow-up|14
5482688|NCT01816906|18956070|P2|Six Months|Did Not Show Up for Baseline Measurement|6
5482689|NCT01816906|18956071|P1|Six Months|Did Not Show Up for Baseline Measurement|7
5482690|NCT01816893|18956089|P2|Washout Period|Withdrawal by Subject|0
5482691|NCT01816893|18956090|P1|Washout Period|Withdrawal by Subject|2
5482692|NCT01816763|18956126|P3|Overall Study|The main reason for an incomplete survey|11
5482693|NCT01816763|18956127|P2|Overall Study|The main reason for an incomplete survey|15
5482694|NCT01816763|18956128|P1|Overall Study|The main reason for an incomplete survey|4
5482695|NCT01816685|18956153|P2|Overall Study|Surgery Cancelled|2
5482696|NCT01816685|18956154|P1|Overall Study|Surgery Cancelled|3
5482697|NCT01816685|18956153|P2|Overall Study|Lost to Follow-up|9
5482698|NCT01816685|18956154|P1|Overall Study|Lost to Follow-up|7
5482699|NCT01816594|18956164|P2|Overall Study|Physician Decision|0
5482700|NCT01816594|18956165|P1|Overall Study|Physician Decision|1
5482701|NCT01816594|18956164|P2|Overall Study|Withdrawal by Subject|0
5482702|NCT01816594|18956165|P1|Overall Study|Withdrawal by Subject|1
5482703|NCT01816594|18956164|P2|Overall Study|Adverse Event|0
5482704|NCT01816594|18956165|P1|Overall Study|Adverse Event|9
5482705|NCT01816594|18956164|P2|Overall Study|Local Progress|2
5482706|NCT01816594|18956165|P1|Overall Study|Local Progress|0
5482707|NCT01816477|18956203|P2|Overall Study|Unable to tolerate catheter placement|0
5482708|NCT01816477|18956204|P1|Overall Study|Unable to tolerate catheter placement|3
5482709|NCT01816477|18956203|P2|Overall Study|Withdrawal by Subject|1
5482710|NCT01816477|18956204|P1|Overall Study|Withdrawal by Subject|13
5482711|NCT01816295|18956258|P2|OLE Phase|Lack of Efficacy|7
5482712|NCT01816295|18956259|P1|OLE Phase|Lack of Efficacy|3
5482713|NCT01816295|18956258|P2|OLE Phase|Withdrawal by Subject|10
5482714|NCT01816295|18956259|P1|OLE Phase|Withdrawal by Subject|10
5482715|NCT01816295|18956258|P2|OLE Phase|Sponsor Decision|9
5482716|NCT01816295|18956259|P1|OLE Phase|Sponsor Decision|7
5482717|NCT01816295|18956258|P2|OLE Phase|Protocol Violation|4
5482718|NCT01816295|18956259|P1|OLE Phase|Protocol Violation|4
5482719|NCT01816295|18956258|P2|OLE Phase|Physician Decision|1
5482720|NCT01816295|18956259|P1|OLE Phase|Physician Decision|3
5482721|NCT01816295|18956258|P2|OLE Phase|Lost to Follow-up|5
5482722|NCT01816295|18956259|P1|OLE Phase|Lost to Follow-up|5
5482723|NCT01816295|18956258|P2|OLE Phase|Entry Criteria Not Met|5
5482724|NCT01816295|18956259|P1|OLE Phase|Entry Criteria Not Met|3
5482725|NCT01816295|18956258|P2|OLE Phase|Death|0
5482726|NCT01816295|18956259|P1|OLE Phase|Death|1
5482727|NCT01816295|18956258|P2|OLE Phase|Adverse Event|15
5482728|NCT01816295|18956259|P1|OLE Phase|Adverse Event|17
5482729|NCT01816295|18956258|P2|Double Blind Phase|Withdrawal by Subject|20
5482730|NCT01816295|18956259|P1|Double Blind Phase|Withdrawal by Subject|22
5482731|NCT01816295|18956258|P2|Double Blind Phase|Sponsor Decision|8
5482732|NCT01816295|18956259|P1|Double Blind Phase|Sponsor Decision|8
5482733|NCT01816295|18956258|P2|Double Blind Phase|Protocol Violation|11
5482734|NCT01816295|18956259|P1|Double Blind Phase|Protocol Violation|17
5482735|NCT01816295|18956258|P2|Double Blind Phase|Physician Decision|2
5482736|NCT01816295|18956259|P1|Double Blind Phase|Physician Decision|2
5482737|NCT01816295|18956258|P2|Double Blind Phase|Lost to Follow-up|5
5482738|NCT01816295|18956259|P1|Double Blind Phase|Lost to Follow-up|3
5482739|NCT01816295|18956258|P2|Double Blind Phase|Entry Criteria Not Met|2
5482740|NCT01816295|18956259|P1|Double Blind Phase|Entry Criteria Not Met|0
5482741|NCT01816295|18956258|P2|Double Blind Phase|Adverse Event|8
5482742|NCT01816295|18956259|P1|Double Blind Phase|Adverse Event|11
5482743|NCT01816243|18956274|P1|Overall Study|Amputation|3
5482744|NCT01816243|18956274|P1|Overall Study|Not eligible for the study|1
5482745|NCT01816243|18956274|P1|Overall Study|Lack of Efficacy|1
5482746|NCT01816243|18956274|P1|Overall Study|Lost to Follow-up|1
5482747|NCT01816243|18956274|P1|Overall Study|Adverse Event|6
5482748|NCT01816074|18956289|P4|Phase 2|Withdrawal by Subject|0
5482749|NCT01816074|18956290|P3|Phase 2|Withdrawal by Subject|0
5482750|NCT01816074|18956291|P2|Phase 2|Withdrawal by Subject|0
5482751|NCT01816074|18956292|P1|Phase 2|Withdrawal by Subject|1
5482752|NCT01816074|18956289|P4|Phase 2|Physician Decision|1
5482753|NCT01816074|18956290|P3|Phase 2|Physician Decision|0
5482754|NCT01816074|18956291|P2|Phase 2|Physician Decision|0
5482755|NCT01816074|18956292|P1|Phase 2|Physician Decision|0
5482756|NCT01816074|18956289|P4|Phase 2|Unsatisfied with Randomization assignmen|0
5482757|NCT01816074|18956290|P3|Phase 2|Unsatisfied with Randomization assignmen|0
5482758|NCT01816074|18956291|P2|Phase 2|Unsatisfied with Randomization assignmen|0
5482759|NCT01816074|18956292|P1|Phase 2|Unsatisfied with Randomization assignmen|1
5482760|NCT01816074|18956289|P4|Phase 2|Time commitment Issues|0
5482761|NCT01816074|18956290|P3|Phase 2|Time commitment Issues|0
5482762|NCT01816074|18956291|P2|Phase 2|Time commitment Issues|2
5482763|NCT01816074|18956292|P1|Phase 2|Time commitment Issues|0
5482764|NCT01816074|18956289|P4|Phase 1|Time commitment issues|0
5482765|NCT01816074|18956290|P3|Phase 1|Time commitment issues|1
5482766|NCT01816074|18956291|P2|Phase 1|Time commitment issues|0
5482767|NCT01816074|18956292|P1|Phase 1|Time commitment issues|0
5482768|NCT01816061|18956322|P2|Overall Study|Lost to Follow-up|24
5482769|NCT01816061|18956323|P1|Overall Study|Lost to Follow-up|13
5482770|NCT01816048|18956331|P1|Overall Study|Disease Progression|3
5482771|NCT01816048|18956331|P1|Overall Study|Withdrawal by Subject|1
5482772|NCT01816048|18956331|P1|Overall Study|Death|1
5482773|NCT01816048|18956331|P1|Overall Study|Adverse Event|1
5482774|NCT01815918|18956346|P2|Overall Study|Lack of Efficacy|15
5482775|NCT01815918|18956347|P1|Overall Study|Lack of Efficacy|15
5482776|NCT01815918|18956346|P2|Overall Study|Patient samples not analyzable|4
5482777|NCT01815918|18956347|P1|Overall Study|Patient samples not analyzable|3
5482778|NCT01815840|18956363|P2|Overall Study|Sponsor Termination Treatment|0
5482779|NCT01815840|18956364|P1|Overall Study|Sponsor Termination Treatment|1
5482780|NCT01815840|18956363|P2|Overall Study|Refused Treatment|1
5482781|NCT01815840|18956364|P1|Overall Study|Refused Treatment|5
5482782|NCT01815840|18956363|P2|Overall Study|Lost to Follow-up|6
5482783|NCT01815840|18956364|P1|Overall Study|Lost to Follow-up|3
5482784|NCT01815840|18956363|P2|Overall Study|Investigators Decision|3
5482785|NCT01815840|18956364|P1|Overall Study|Investigators Decision|2
5482786|NCT01815840|18956363|P2|Overall Study|Disease progression|2
5482787|NCT01815840|18956364|P1|Overall Study|Disease progression|3
5482788|NCT01815840|18956363|P2|Overall Study|Death|2
5482789|NCT01815840|18956364|P1|Overall Study|Death|2
5482790|NCT01815840|18956363|P2|Overall Study|Adverse Event|16
5482791|NCT01815840|18956364|P1|Overall Study|Adverse Event|10
5482792|NCT01815840|18956363|P2|Overall Study|Administrative/Other|3
5482793|NCT01815840|18956364|P1|Overall Study|Administrative/Other|1
5482794|NCT01815840|18956363|P2|Overall Study|Withdrew Consent|30
5482795|NCT01815840|18956364|P1|Overall Study|Withdrew Consent|31
5482796|NCT01815840|18956363|P2|Overall Study|Missing|0
5482797|NCT01815840|18956364|P1|Overall Study|Missing|1
5482798|NCT01815736|18956394|P2|Overall Study|Still on Study|449
5482799|NCT01815736|18956395|P1|Overall Study|Still on Study|929
5482800|NCT01815736|18956394|P2|Overall Study|Lost to Follow-up|7
5482801|NCT01815736|18956395|P1|Overall Study|Lost to Follow-up|6
5482802|NCT01815736|18956394|P2|Overall Study|Withdrew Consent|15
5482803|NCT01815736|18956395|P1|Overall Study|Withdrew Consent|7
5482804|NCT01815736|18956394|P2|Overall Study|Investigator's Discretion|0
5482805|NCT01815736|18956395|P1|Overall Study|Investigator's Discretion|4
5482806|NCT01815736|18956394|P2|Overall Study|Death|0
5482807|NCT01815736|18956395|P1|Overall Study|Death|4
5482808|NCT01815736|18956394|P2|Overall Study|Adverse Event|4
5482809|NCT01815736|18956395|P1|Overall Study|Adverse Event|7
5482810|NCT01815736|18956394|P2|Overall Study|Randomized but Not Treated|3
5482811|NCT01815736|18956395|P1|Overall Study|Randomized but Not Treated|4
5482812|NCT01815424|18956464|P5|Week 16 to 52|Withdrawal by Subject|0
5482813|NCT01815424|18956465|P4|Week 16 to 52|Withdrawal by Subject|0
5482814|NCT01815424|18956466|P3|Week 16 to 52|Withdrawal by Subject|0
5482815|NCT01815424|18956467|P2|Week 16 to 52|Withdrawal by Subject|2
5482816|NCT01815424|18956468|P1|Week 16 to 52|Withdrawal by Subject|1
5482817|NCT01815424|18956464|P5|Week 16 to 52|Lost to Follow-up|1
5482818|NCT01815424|18956465|P4|Week 16 to 52|Lost to Follow-up|2
5482819|NCT01815424|18956466|P3|Week 16 to 52|Lost to Follow-up|0
5482820|NCT01815424|18956467|P2|Week 16 to 52|Lost to Follow-up|2
5482821|NCT01815424|18956468|P1|Week 16 to 52|Lost to Follow-up|0
5482822|NCT01815424|18956464|P5|Week 16 to 52|Insufficient Clinical Response|1
5482823|NCT01815424|18956465|P4|Week 16 to 52|Insufficient Clinical Response|1
5482824|NCT01815424|18956466|P3|Week 16 to 52|Insufficient Clinical Response|0
5482825|NCT01815424|18956467|P2|Week 16 to 52|Insufficient Clinical Response|0
5482826|NCT01815424|18956468|P1|Week 16 to 52|Insufficient Clinical Response|1
5482827|NCT01815424|18956464|P5|Week 16 to 52|Adverse Event|1
5482828|NCT01815424|18956465|P4|Week 16 to 52|Adverse Event|0
5482829|NCT01815424|18956466|P3|Week 16 to 52|Adverse Event|0
5482830|NCT01815424|18956467|P2|Week 16 to 52|Adverse Event|0
5482831|NCT01815424|18956468|P1|Week 16 to 52|Adverse Event|0
5482832|NCT01815424|18956464|P5|Week 16 to 52|Other|0
5482833|NCT01815424|18956465|P4|Week 16 to 52|Other|0
5482834|NCT01815424|18956466|P3|Week 16 to 52|Other|0
5482835|NCT01815424|18956467|P2|Week 16 to 52|Other|1
5482836|NCT01815424|18956468|P1|Week 16 to 52|Other|0
5482837|NCT01815424|18956464|P5|Week 0 to 16|Insufficient Clinical Response|0
5482838|NCT01815424|18956465|P4|Week 0 to 16|Insufficient Clinical Response|0
5482839|NCT01815424|18956466|P3|Week 0 to 16|Insufficient Clinical Response|4
5482840|NCT01815424|18956467|P2|Week 0 to 16|Insufficient Clinical Response|0
5482841|NCT01815424|18956468|P1|Week 0 to 16|Insufficient Clinical Response|2
5482842|NCT01815424|18956464|P5|Week 0 to 16|Protocol Violation|0
5482843|NCT01815424|18956465|P4|Week 0 to 16|Protocol Violation|0
5482844|NCT01815424|18956466|P3|Week 0 to 16|Protocol Violation|0
5482845|NCT01815424|18956467|P2|Week 0 to 16|Protocol Violation|0
5482846|NCT01815424|18956468|P1|Week 0 to 16|Protocol Violation|1
5482847|NCT01815424|18956464|P5|Week 0 to 16|Other|0
5482848|NCT01815424|18956465|P4|Week 0 to 16|Other|0
5482849|NCT01815424|18956466|P3|Week 0 to 16|Other|3
5482850|NCT01815424|18956467|P2|Week 0 to 16|Other|0
5482851|NCT01815424|18956468|P1|Week 0 to 16|Other|1
5482852|NCT01815424|18956464|P5|Week 0 to 16|Withdrawal by Subject|0
5482853|NCT01815424|18956465|P4|Week 0 to 16|Withdrawal by Subject|0
5482854|NCT01815424|18956466|P3|Week 0 to 16|Withdrawal by Subject|1
5482855|NCT01815424|18956467|P2|Week 0 to 16|Withdrawal by Subject|0
5482856|NCT01815424|18956468|P1|Week 0 to 16|Withdrawal by Subject|0
5482857|NCT01815424|18956464|P5|Week 0 to 16|Lost to Follow-up|0
5482858|NCT01815424|18956465|P4|Week 0 to 16|Lost to Follow-up|0
5482859|NCT01815424|18956466|P3|Week 0 to 16|Lost to Follow-up|0
5482860|NCT01815424|18956467|P2|Week 0 to 16|Lost to Follow-up|1
5482861|NCT01815424|18956468|P1|Week 0 to 16|Lost to Follow-up|0
5482862|NCT01815424|18956464|P5|Week 0 to 16|Does Not Meet Entrance Criteria|0
5482863|NCT01815424|18956465|P4|Week 0 to 16|Does Not Meet Entrance Criteria|0
5482864|NCT01815424|18956466|P3|Week 0 to 16|Does Not Meet Entrance Criteria|0
5482865|NCT01815424|18956467|P2|Week 0 to 16|Does Not Meet Entrance Criteria|0
5482866|NCT01815424|18956468|P1|Week 0 to 16|Does Not Meet Entrance Criteria|2
5482867|NCT01815424|18956464|P5|Week 0 to 16|Adverse Event|0
5482868|NCT01815424|18956465|P4|Week 0 to 16|Adverse Event|0
5482869|NCT01815424|18956466|P3|Week 0 to 16|Adverse Event|3
5482870|NCT01815424|18956467|P2|Week 0 to 16|Adverse Event|3
5482871|NCT01815424|18956468|P1|Week 0 to 16|Adverse Event|1
5482872|NCT01815138|18956684|P2|Overall Study|Physician Decision|5
5482873|NCT01815138|18956685|P1|Overall Study|Physician Decision|8
5482874|NCT01815138|18956684|P2|Overall Study|Withdrawal by Subject|1
5482875|NCT01815138|18956685|P1|Overall Study|Withdrawal by Subject|0
5482876|NCT01815099|18956697|P1|Overall Study|unable to attend study visits|1
5482877|NCT01815099|18956697|P1|Overall Study|Lack of Efficacy|1
5482878|NCT01814878|18956711|P2|Overall Study|Other|0
5482879|NCT01814878|18956712|P1|Overall Study|Other|2
5482880|NCT01814878|18956711|P2|Overall Study|Screening failure (drop-out)|3
5482881|NCT01814878|18956712|P1|Overall Study|Screening failure (drop-out)|0
5482882|NCT01814878|18956711|P2|Overall Study|Physician Decision|1
5482883|NCT01814878|18956712|P1|Overall Study|Physician Decision|3
5482884|NCT01814878|18956711|P2|Overall Study|Protocol Violation|5
5482885|NCT01814878|18956712|P1|Overall Study|Protocol Violation|5
5482886|NCT01814878|18956711|P2|Overall Study|Withdrawal by Subject|16
5482887|NCT01814878|18956712|P1|Overall Study|Withdrawal by Subject|20
5482888|NCT01814878|18956711|P2|Overall Study|Adverse Event|5
5482889|NCT01814878|18956712|P1|Overall Study|Adverse Event|16
5482890|NCT01814826|18956735|P3|Overall Study|Death|3
5482891|NCT01814826|18956736|P2|Overall Study|Death|24
5482892|NCT01814826|18956737|P1|Overall Study|Death|29
5482893|NCT01814826|18956735|P3|Overall Study|Other|0
5482894|NCT01814826|18956736|P2|Overall Study|Other|5
5482895|NCT01814826|18956737|P1|Overall Study|Other|3
5482896|NCT01814800|18956829|P1|Overall Study|Subject relocation|1
5482897|NCT01814800|18956829|P1|Overall Study|Sponsor decision|1
5482898|NCT01814800|18956829|P1|Overall Study|Pregnancy|1
5482899|NCT01814800|18956829|P1|Overall Study|Adverse Event|2
5482900|NCT01814761|18956889|P2|Overall Study|Lost to Follow-up|5
5482901|NCT01814761|18956890|P1|Overall Study|Lost to Follow-up|1
5482902|NCT01814761|18956889|P2|Overall Study|Ocular Adverse Event|15
5482903|NCT01814761|18956890|P1|Overall Study|Ocular Adverse Event|6
5482904|NCT01814761|18956889|P2|Overall Study|Other Reasons|10
5482905|NCT01814761|18956890|P1|Overall Study|Other Reasons|1
5482906|NCT01814748|18956904|P2|Overall Study|Withdrawal by Subject|4
5482907|NCT01814748|18956905|P1|Overall Study|Withdrawal by Subject|6
5482908|NCT01814748|18956904|P2|Overall Study|Study site terminated by sponsor|1
5482909|NCT01814748|18956905|P1|Overall Study|Study site terminated by sponsor|1
5482910|NCT01814748|18956904|P2|Overall Study|Lost to Follow-up|2
5482911|NCT01814748|18956905|P1|Overall Study|Lost to Follow-up|1
5482912|NCT01814696|18956949|P2|Overall Study|Randomized to wrong group|0
5482913|NCT01814696|18956950|P1|Overall Study|Randomized to wrong group|1
5482914|NCT01814696|18956949|P2|Overall Study|Withdrawal by Subject|0
5482915|NCT01814696|18956950|P1|Overall Study|Withdrawal by Subject|1
5482916|NCT01814670|18956968|P1|Overall Study|Protocol Violation|12
5482917|NCT01814553|18956978|P2|Overall Study|Other than stated|8
5482918|NCT01814553|18956979|P1|Overall Study|Other than stated|7
5482919|NCT01814553|18956978|P2|Overall Study|Withdrawal by Subject|1
5482920|NCT01814553|18956979|P1|Overall Study|Withdrawal by Subject|1
5482921|NCT01814553|18956978|P2|Overall Study|Other Adverse Event|5
5482922|NCT01814553|18956979|P1|Overall Study|Other Adverse Event|4
5482923|NCT01814553|18956978|P2|Overall Study|PD per clinical progression|8
5482924|NCT01814553|18956979|P1|Overall Study|PD per clinical progression|6
5482925|NCT01814397|18956993|P1|Overall Study|Withdrawal by Subject|7
5482926|NCT01814397|18956993|P1|Overall Study|Adverse Event|7
5482927|NCT01814371|18957002|P2|Overall Study|Lost to Follow-up|27
5482928|NCT01814371|18957003|P1|Overall Study|Lost to Follow-up|30
5482929|NCT01814332|18957038|P2|Overall Study|Lost to Follow-up|1
5482930|NCT01814332|18957039|P1|Overall Study|Lost to Follow-up|5
5482931|NCT01814332|18957038|P2|Overall Study|Protocol Violation|4
5482932|NCT01814332|18957039|P1|Overall Study|Protocol Violation|0
5482933|NCT01814332|18957038|P2|Overall Study|Withdrawal by Subject|8
5482934|NCT01814332|18957039|P1|Overall Study|Withdrawal by Subject|3
5482935|NCT01814332|18957038|P2|Overall Study|Adverse Event|3
5482936|NCT01814332|18957039|P1|Overall Study|Adverse Event|8
5482937|NCT01814137|18957061|P2|Overall Study|Unclassified|1
5482938|NCT01814137|18957062|P1|Overall Study|Unclassified|2
5482939|NCT01814137|18957061|P2|Overall Study|Physician Decision|1
5482940|NCT01814137|18957062|P1|Overall Study|Physician Decision|1
5482941|NCT01814137|18957061|P2|Overall Study|Withdrawal by Subject|2
5482942|NCT01814137|18957062|P1|Overall Study|Withdrawal by Subject|2
5482943|NCT01814137|18957061|P2|Overall Study|Adverse Event|1
5482944|NCT01814137|18957062|P1|Overall Study|Adverse Event|0
5482945|NCT01814046|18957078|P3|Drug Administration|Death due to complications of RSV|0
5482946|NCT01814046|18957079|P2|Drug Administration|Death due to complications of RSV|0
5482947|NCT01814046|18957080|P1|Drug Administration|Death due to complications of RSV|1
5482948|NCT01814007|18957091|P1|Overall Study|Withdrawal by Subject|1
5482949|NCT01813890|18957104|P3|Overall Study|Lack of Efficacy|2
5482950|NCT01813890|18957105|P2|Overall Study|Lack of Efficacy|1
5482951|NCT01813890|18957106|P1|Overall Study|Lack of Efficacy|9
5482952|NCT01813890|18957104|P3|Overall Study|Adverse Event|4
5482953|NCT01813890|18957105|P2|Overall Study|Adverse Event|3
5482954|NCT01813890|18957106|P1|Overall Study|Adverse Event|0
5482955|NCT01813721|18957143|P1|Overall Study|Withdrawal by Subject|1
5482956|NCT01813721|18957143|P1|Overall Study|Ineligibility determined|63
5482957|NCT01813474|18957198|P3|Overall Study|Death|1
5482958|NCT01813474|18957199|P2|Overall Study|Death|0
5482959|NCT01813474|18957200|P1|Overall Study|Death|0
5482960|NCT01813474|18957198|P3|Overall Study|Lack of Efficacy|9
5482961|NCT01813474|18957199|P2|Overall Study|Lack of Efficacy|6
5482962|NCT01813474|18957200|P1|Overall Study|Lack of Efficacy|2
5482963|NCT01813474|18957198|P3|Overall Study|Adverse Event|0
5482964|NCT01813474|18957199|P2|Overall Study|Adverse Event|1
5482965|NCT01813474|18957200|P1|Overall Study|Adverse Event|1
5482966|NCT01813474|18957198|P3|Overall Study|Withdrawal by Subject|1
5482967|NCT01813474|18957199|P2|Overall Study|Withdrawal by Subject|0
5482968|NCT01813474|18957200|P1|Overall Study|Withdrawal by Subject|0
5482969|NCT01813435|18957224|P2|Overall Study|Lost to Follow-up|237
5482970|NCT01813435|18957225|P1|Overall Study|Lost to Follow-up|268
5482971|NCT01813435|18957224|P2|Overall Study|did not finish experimental regimen|770
5482972|NCT01813435|18957225|P1|Overall Study|did not finish experimental regimen|1902
5482973|NCT01813422|18957249|P2|Overall Study|Lost to Follow-up|4
5482974|NCT01813422|18957250|P1|Overall Study|Lost to Follow-up|2
5482975|NCT01813422|18957249|P2|Overall Study|Sponsor Decision|1
5482976|NCT01813422|18957250|P1|Overall Study|Sponsor Decision|2
5482977|NCT01813422|18957249|P2|Overall Study|Death|3
5482978|NCT01813422|18957250|P1|Overall Study|Death|2
5482979|NCT01813422|18957249|P2|Overall Study|Withdrawal by Subject|8
5482980|NCT01813422|18957250|P1|Overall Study|Withdrawal by Subject|14
5482981|NCT01813357|18957264|P2|Overall Study|Lost to Follow-up|6
5482982|NCT01813357|18957265|P1|Overall Study|Lost to Follow-up|5
5482983|NCT01813071|18957306|P9|Overall Study|Met inc/exc criteria|1
5482984|NCT01813071|18957307|P8|Overall Study|Met inc/exc criteria|1
5482985|NCT01813071|18957308|P7|Overall Study|Met inc/exc criteria|0
5482986|NCT01813071|18957309|P6|Overall Study|Met inc/exc criteria|1
5482987|NCT01813071|18957310|P5|Overall Study|Met inc/exc criteria|0
5482988|NCT01813071|18957311|P4|Overall Study|Met inc/exc criteria|0
5482989|NCT01813071|18957312|P3|Overall Study|Met inc/exc criteria|0
5482990|NCT01813071|18957313|P2|Overall Study|Met inc/exc criteria|0
5482991|NCT01813071|18957314|P1|Overall Study|Met inc/exc criteria|0
5482992|NCT01813071|18957306|P9|Overall Study|Physician Decision|0
5482993|NCT01813071|18957307|P8|Overall Study|Physician Decision|0
5482994|NCT01813071|18957308|P7|Overall Study|Physician Decision|1
5482995|NCT01813071|18957309|P6|Overall Study|Physician Decision|0
5482996|NCT01813071|18957310|P5|Overall Study|Physician Decision|0
5482997|NCT01813071|18957311|P4|Overall Study|Physician Decision|0
5482998|NCT01813071|18957312|P3|Overall Study|Physician Decision|0
5482999|NCT01813071|18957313|P2|Overall Study|Physician Decision|0
5483000|NCT01813071|18957314|P1|Overall Study|Physician Decision|0
5483001|NCT01813071|18957306|P9|Overall Study|Adverse Event|0
5483002|NCT01813071|18957307|P8|Overall Study|Adverse Event|0
5483003|NCT01813071|18957308|P7|Overall Study|Adverse Event|0
5483004|NCT01813071|18957309|P6|Overall Study|Adverse Event|1
5483005|NCT01813071|18957310|P5|Overall Study|Adverse Event|0
5483006|NCT01813071|18957311|P4|Overall Study|Adverse Event|0
5483007|NCT01813071|18957312|P3|Overall Study|Adverse Event|0
5483008|NCT01813071|18957313|P2|Overall Study|Adverse Event|0
5483009|NCT01813071|18957314|P1|Overall Study|Adverse Event|0
5483010|NCT01813071|18957306|P9|Overall Study|Withdrawal by Subject|0
5483011|NCT01813071|18957307|P8|Overall Study|Withdrawal by Subject|0
5483012|NCT01813071|18957308|P7|Overall Study|Withdrawal by Subject|0
5483013|NCT01813071|18957309|P6|Overall Study|Withdrawal by Subject|1
5483014|NCT01813071|18957310|P5|Overall Study|Withdrawal by Subject|0
5483015|NCT01813071|18957311|P4|Overall Study|Withdrawal by Subject|0
5483016|NCT01813071|18957312|P3|Overall Study|Withdrawal by Subject|0
5483017|NCT01813071|18957313|P2|Overall Study|Withdrawal by Subject|0
5483018|NCT01813071|18957314|P1|Overall Study|Withdrawal by Subject|0
5483019|NCT01813071|18957306|P9|Overall Study|Protocol Violation|2
5483020|NCT01813071|18957307|P8|Overall Study|Protocol Violation|4
5483021|NCT01813071|18957308|P7|Overall Study|Protocol Violation|2
5483022|NCT01813071|18957309|P6|Overall Study|Protocol Violation|4
5483023|NCT01813071|18957310|P5|Overall Study|Protocol Violation|1
5483024|NCT01813071|18957311|P4|Overall Study|Protocol Violation|0
5483025|NCT01813071|18957312|P3|Overall Study|Protocol Violation|0
5483026|NCT01813071|18957313|P2|Overall Study|Protocol Violation|0
5483027|NCT01813071|18957314|P1|Overall Study|Protocol Violation|0
5483028|NCT01813058|18957781|P2|Overall Study|Withdrawal by Subject|4
5483029|NCT01813058|18957782|P1|Overall Study|Withdrawal by Subject|5
5483030|NCT01813019|18957790|P2|Overall Study|Protocol Deviation|1
5483031|NCT01813019|18957791|P1|Overall Study|Protocol Deviation|2
5483032|NCT01813019|18957790|P2|Overall Study|administrative problems|0
5483033|NCT01813019|18957791|P1|Overall Study|administrative problems|2
5483034|NCT01813019|18957790|P2|Overall Study|Withdrawal by Subject|2
5483035|NCT01813019|18957791|P1|Overall Study|Withdrawal by Subject|3
5483036|NCT01813019|18957790|P2|Overall Study|Adverse Event|3
5483037|NCT01813019|18957791|P1|Overall Study|Adverse Event|0
5483038|NCT01812837|18957802|P3|Overall Study|Protocol Violation|0
5483039|NCT01812837|18957803|P2|Overall Study|Protocol Violation|0
5483040|NCT01812837|18957804|P1|Overall Study|Protocol Violation|1
5483041|NCT01812837|18957802|P3|Overall Study|Lost to Follow-up|0
5483042|NCT01812837|18957803|P2|Overall Study|Lost to Follow-up|1
5483043|NCT01812837|18957804|P1|Overall Study|Lost to Follow-up|1
5483044|NCT01812759|18957815|P3|Overall Study|Physician Decision|1
5483045|NCT01812759|18957816|P2|Overall Study|Physician Decision|0
5483046|NCT01812759|18957817|P1|Overall Study|Physician Decision|0
5483047|NCT01812707|18957829|P4|Overall Study|Consent withdrawn by participant|0
5483048|NCT01812707|18957830|P3|Overall Study|Consent withdrawn by participant|0
5483049|NCT01812707|18957831|P2|Overall Study|Consent withdrawn by participant|0
5483050|NCT01812707|18957832|P1|Overall Study|Consent withdrawn by participant|1
5483051|NCT01812707|18957829|P4|Overall Study|Poor compliance to protocol|0
5483052|NCT01812707|18957830|P3|Overall Study|Poor compliance to protocol|0
5483053|NCT01812707|18957831|P2|Overall Study|Poor compliance to protocol|0
5483054|NCT01812707|18957832|P1|Overall Study|Poor compliance to protocol|1
5483055|NCT01812707|18957829|P4|Overall Study|Adverse Event|2
5483056|NCT01812707|18957830|P3|Overall Study|Adverse Event|0
5483057|NCT01812707|18957831|P2|Overall Study|Adverse Event|0
5483058|NCT01812707|18957832|P1|Overall Study|Adverse Event|0
5483059|NCT01812655|18957880|P3|Overall Study|Protocol Violation|0
5483060|NCT01812655|18957881|P2|Overall Study|Protocol Violation|1
5483061|NCT01812655|18957882|P1|Overall Study|Protocol Violation|1
5483062|NCT01812057|18957907|P2|Overall Study|Physician Decision|0
5483063|NCT01812057|18957908|P1|Overall Study|Physician Decision|1
5483064|NCT01812057|18957907|P2|Overall Study|Protocol Violation|0
5483065|NCT01812057|18957908|P1|Overall Study|Protocol Violation|1
5483066|NCT01811953|18958011|P6|Overall Study|Protocol Violation|0
5483067|NCT01811953|18958012|P5|Overall Study|Protocol Violation|1
5483068|NCT01811953|18958013|P4|Overall Study|Protocol Violation|0
5483069|NCT01811953|18958014|P3|Overall Study|Protocol Violation|0
5483070|NCT01811953|18958015|P2|Overall Study|Protocol Violation|0
5483071|NCT01811953|18958016|P1|Overall Study|Protocol Violation|0
5483072|NCT01811953|18958011|P6|Overall Study|Adverse Event|1
5483073|NCT01811953|18958012|P5|Overall Study|Adverse Event|0
5483074|NCT01811953|18958013|P4|Overall Study|Adverse Event|1
5483075|NCT01811953|18958014|P3|Overall Study|Adverse Event|0
5483076|NCT01811953|18958015|P2|Overall Study|Adverse Event|0
5483077|NCT01811953|18958016|P1|Overall Study|Adverse Event|0
5483078|NCT01811732|18958073|P2|Overall Study|Correct study drug not available on site|0
5483079|NCT01811732|18958074|P1|Overall Study|Correct study drug not available on site|1
5483080|NCT01811732|18958073|P2|Overall Study|Admitted to another facility|0
5483081|NCT01811732|18958074|P1|Overall Study|Admitted to another facility|1
5483082|NCT01811732|18958073|P2|Overall Study|Subject incarcerated|2
5483083|NCT01811732|18958074|P1|Overall Study|Subject incarcerated|1
5483084|NCT01811732|18958073|P2|Overall Study|Protocol Violation|1
5483085|NCT01811732|18958074|P1|Overall Study|Protocol Violation|0
5483086|NCT01811732|18958073|P2|Overall Study|Insufficient venous access|1
5483087|NCT01811732|18958074|P1|Overall Study|Insufficient venous access|0
5483088|NCT01811732|18958073|P2|Overall Study|Death|1
5483089|NCT01811732|18958074|P1|Overall Study|Death|1
5483090|NCT01811732|18958073|P2|Overall Study|Physician Decision|0
5483091|NCT01811732|18958074|P1|Overall Study|Physician Decision|2
5483092|NCT01811732|18958073|P2|Overall Study|Non-compliance with study drug/procedure|3
5483093|NCT01811732|18958074|P1|Overall Study|Non-compliance with study drug/procedure|3
5483094|NCT01811732|18958073|P2|Overall Study|Lack of Efficacy|1
5483095|NCT01811732|18958074|P1|Overall Study|Lack of Efficacy|3
5483096|NCT01811732|18958073|P2|Overall Study|Adverse Event|9
5483097|NCT01811732|18958074|P1|Overall Study|Adverse Event|3
5483098|NCT01811732|18958073|P2|Overall Study|Withdrawal by Subject|10
5483099|NCT01811732|18958074|P1|Overall Study|Withdrawal by Subject|16
5483100|NCT01811732|18958073|P2|Overall Study|Lost to Follow-up|30
5483101|NCT01811732|18958074|P1|Overall Study|Lost to Follow-up|24
5483102|NCT01811706|18958084|P2|First Intervention ( 4 Weeks)|Adverse Event|0
5483103|NCT01811706|18958085|P1|First Intervention ( 4 Weeks)|Adverse Event|1
5483104|NCT01811563|18958125|P2|Overall Study|Incorrect Randomization procedure|1
5483105|NCT01811563|18958126|P1|Overall Study|Incorrect Randomization procedure|0
5483106|NCT01811563|18958125|P2|Overall Study|Lost to Follow-up|2
5483107|NCT01811563|18958126|P1|Overall Study|Lost to Follow-up|5
5483108|NCT01811485|18958155|P3|Overall Study|Protocol Deviation|0
5483109|NCT01811485|18958156|P2|Overall Study|Protocol Deviation|1
5483110|NCT01811485|18958157|P1|Overall Study|Protocol Deviation|0
5483111|NCT01811485|18958155|P3|Overall Study|Administrative problems|0
5483112|NCT01811485|18958156|P2|Overall Study|Administrative problems|0
5483113|NCT01811485|18958157|P1|Overall Study|Administrative problems|1
5483114|NCT01811485|18958155|P3|Overall Study|Unsatisfactory therapeutic effect|3
5483115|NCT01811485|18958156|P2|Overall Study|Unsatisfactory therapeutic effect|0
5483116|NCT01811485|18958157|P1|Overall Study|Unsatisfactory therapeutic effect|0
5483117|NCT01811485|18958155|P3|Overall Study|Adverse Event|2
5483118|NCT01811485|18958156|P2|Overall Study|Adverse Event|3
5483119|NCT01811485|18958157|P1|Overall Study|Adverse Event|1
5483120|NCT01811472|18958177|P3|Overall Study|Subject/guardian decision|0
5483121|NCT01811472|18958178|P2|Overall Study|Subject/guardian decision|0
5483122|NCT01811472|18958179|P1|Overall Study|Subject/guardian decision|1
5483123|NCT01811472|18958177|P3|Overall Study|Lost to Follow-up|1
5483124|NCT01811472|18958178|P2|Overall Study|Lost to Follow-up|0
5483125|NCT01811472|18958179|P1|Overall Study|Lost to Follow-up|0
5483126|NCT01811472|18958177|P3|Overall Study|Adverse Event|4
5483127|NCT01811472|18958178|P2|Overall Study|Adverse Event|0
5483128|NCT01811472|18958179|P1|Overall Study|Adverse Event|1
5483129|NCT01811238|18958266|P1|Overall Study|subject refused study medication|6
5483130|NCT01811238|18958266|P1|Overall Study|Lack of Efficacy|4
5483131|NCT01811238|18958266|P1|Overall Study|Protocol Violation|4
5483132|NCT01811238|18958266|P1|Overall Study|Adverse Event|25
5483133|NCT01811238|18958266|P1|Overall Study|Withdrawal by Subject|42
5483134|NCT01811225|18958275|P2|Treatment Period 2|unable to remain smoke free overnight|4
5483135|NCT01811225|18958276|P1|Treatment Period 2|unable to remain smoke free overnight|3
5483136|NCT01811225|18958275|P2|Treatment Period 2|Lost to Follow-up|2
5483137|NCT01811225|18958276|P1|Treatment Period 2|Lost to Follow-up|1
5483138|NCT01811225|18958275|P2|Treatment Period 1|unable to remain smoke free overnight|6
5483139|NCT01811225|18958276|P1|Treatment Period 1|unable to remain smoke free overnight|10
5483140|NCT01811225|18958275|P2|Treatment Period 1|transporation|0
5483141|NCT01811225|18958276|P1|Treatment Period 1|transporation|1
5483142|NCT01811225|18958275|P2|Treatment Period 1|Lost to Follow-up|8
5483143|NCT01811225|18958276|P1|Treatment Period 1|Lost to Follow-up|12
5483144|NCT01811225|18958275|P2|Treatment Period 1|Adverse Event|3
5483145|NCT01811225|18958276|P1|Treatment Period 1|Adverse Event|2
5483146|NCT01811186|18958301|P2|Overall Study|Lost to Follow-up|2
5483147|NCT01811186|18958302|P1|Overall Study|Lost to Follow-up|4
5483148|NCT01811186|18958301|P2|Overall Study|Lack of Efficacy|6
5483149|NCT01811186|18958302|P1|Overall Study|Lack of Efficacy|3
5483150|NCT01811186|18958301|P2|Overall Study|Withdrawal by Subject|10
5483151|NCT01811186|18958302|P1|Overall Study|Withdrawal by Subject|5
5483152|NCT01811186|18958301|P2|Overall Study|Protocol Violation|6
5483153|NCT01811186|18958302|P1|Overall Study|Protocol Violation|5
5483154|NCT01811186|18958301|P2|Overall Study|Adverse Event|38
5483155|NCT01811186|18958302|P1|Overall Study|Adverse Event|54
5483156|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
5483157|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
5483158|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
5483159|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
5483160|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
5483161|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
5483162|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
5483163|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
5483164|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
5483165|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
5483166|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
5483167|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
5483168|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
5483169|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
5483170|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
5483171|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
5483172|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
5483173|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
5483174|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Death|1
5483175|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Death|0
5483176|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Death|0
5483177|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
5483178|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
5483179|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
5483180|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
5483181|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
5483182|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
5483183|NCT01810939|18958367|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
5483184|NCT01810939|18958368|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
5483185|NCT01810939|18958369|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
5483186|NCT01810939|18958367|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
5483187|NCT01810939|18958368|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
5483188|NCT01810939|18958369|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
5483189|NCT01810939|18958367|P3|Part A Treatment Period|Protocol-specified (High K+)|0
5483190|NCT01810939|18958368|P2|Part A Treatment Period|Protocol-specified (High K+)|0
5483191|NCT01810939|18958369|P1|Part A Treatment Period|Protocol-specified (High K+)|3
5483192|NCT01810939|18958367|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
5483193|NCT01810939|18958368|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
5483194|NCT01810939|18958369|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
5483195|NCT01810939|18958367|P3|Part A Treatment Period|Withdrawal by Subject|0
5483196|NCT01810939|18958368|P2|Part A Treatment Period|Withdrawal by Subject|0
5483197|NCT01810939|18958369|P1|Part A Treatment Period|Withdrawal by Subject|5
5483198|NCT01810939|18958367|P3|Part A Treatment Period|Adverse Event|0
5483199|NCT01810939|18958368|P2|Part A Treatment Period|Adverse Event|0
5483200|NCT01810939|18958369|P1|Part A Treatment Period|Adverse Event|10
5483201|NCT01810939|18958367|P3|Part A Treatment Period|Protocol Violation|0
5483202|NCT01810939|18958368|P2|Part A Treatment Period|Protocol Violation|0
5483203|NCT01810939|18958369|P1|Part A Treatment Period|Protocol Violation|2
5483204|NCT01810939|18958367|P3|Part A Treatment Period|Non-compliance with Study Drug|0
5483205|NCT01810939|18958368|P2|Part A Treatment Period|Non-compliance with Study Drug|0
5483206|NCT01810939|18958369|P1|Part A Treatment Period|Non-compliance with Study Drug|1
5483207|NCT01810783|18958382|P1|Overall Study|Enrolled, not treated|1
5483208|NCT01810783|18958382|P1|Overall Study|Adminstrative or other reason(s)|23
5483209|NCT01810783|18958382|P1|Overall Study|Non-compliance with IMP|4
5483210|NCT01810783|18958382|P1|Overall Study|Protocol Violation|5
5483211|NCT01810783|18958382|P1|Overall Study|Lost to Follow-up|10
5483212|NCT01810783|18958382|P1|Overall Study|Lack of Efficacy|12
5483213|NCT01810783|18958382|P1|Overall Study|Withdrawal by Subject|22
5483214|NCT01810783|18958382|P1|Overall Study|Adverse Event|32
5483215|NCT01810432|18958407|P2|Period 2|Lost to Follow-up|1
5483216|NCT01810432|18958408|P1|Period 2|Lost to Follow-up|1
5483217|NCT01810432|18958407|P2|Period 2|Physician Decision|0
5483218|NCT01810432|18958408|P1|Period 2|Physician Decision|1
5483219|NCT01810432|18958407|P2|Period 2|Withdrawal by Subject|1
5483220|NCT01810432|18958408|P1|Period 2|Withdrawal by Subject|2
5483221|NCT01810432|18958407|P2|Washout|Adverse Event|0
5483222|NCT01810432|18958408|P1|Washout|Adverse Event|1
5483223|NCT01810432|18958407|P2|Washout|Protocol Violation|1
5483224|NCT01810432|18958408|P1|Washout|Protocol Violation|0
5483225|NCT01810380|18958421|P3|Overall Study|Administrative or other reasons|9
5483226|NCT01810380|18958422|P2|Overall Study|Administrative or other reasons|13
5483227|NCT01810380|18958423|P1|Overall Study|Administrative or other reasons|11
5483228|NCT01810380|18958421|P3|Overall Study|Withdrawal by Subject|6
5483229|NCT01810380|18958422|P2|Overall Study|Withdrawal by Subject|0
5483230|NCT01810380|18958423|P1|Overall Study|Withdrawal by Subject|6
5483231|NCT01810380|18958421|P3|Overall Study|Protocol Violation|1
5483232|NCT01810380|18958422|P2|Overall Study|Protocol Violation|0
5483233|NCT01810380|18958423|P1|Overall Study|Protocol Violation|1
5483234|NCT01810380|18958421|P3|Overall Study|Lack of Efficacy|11
5483235|NCT01810380|18958422|P2|Overall Study|Lack of Efficacy|10
5483236|NCT01810380|18958423|P1|Overall Study|Lack of Efficacy|24
5483237|NCT01810380|18958421|P3|Overall Study|Adverse Event|4
5483238|NCT01810380|18958422|P2|Overall Study|Adverse Event|14
5483239|NCT01810380|18958423|P1|Overall Study|Adverse Event|11
5483240|NCT01810380|18958421|P3|Overall Study|Randomised not treated|1
5483241|NCT01810380|18958422|P2|Overall Study|Randomised not treated|1
5483242|NCT01810380|18958423|P1|Overall Study|Randomised not treated|2
5483243|NCT01810302|18958484|P2|Overall Study|Physician Decision|1
5483244|NCT01810302|18958485|P1|Overall Study|Physician Decision|0
5483245|NCT01810302|18958484|P2|Overall Study|Death|0
5483246|NCT01810302|18958485|P1|Overall Study|Death|1
5483247|NCT01810263|18958512|P2|Overall Study|Lost to Follow-up|7
5483248|NCT01810263|18958513|P1|Overall Study|Lost to Follow-up|8
5483249|NCT01810042|18958519|P1|Overall Study|Lost to Follow-up|10
5483250|NCT01810016|18958529|P3|Overall Study|Death|1
5483251|NCT01810016|18958530|P2|Overall Study|Death|0
5483252|NCT01810016|18958531|P1|Overall Study|Death|0
5483253|NCT01810016|18958529|P3|Overall Study|Progressive disease|0
5483254|NCT01810016|18958530|P2|Overall Study|Progressive disease|1
5483255|NCT01810016|18958531|P1|Overall Study|Progressive disease|1
5483256|NCT01809327|18958601|P5|Overall Study|Other|9
5483257|NCT01809327|18958602|P4|Overall Study|Other|4
5483258|NCT01809327|18958603|P3|Overall Study|Other|7
5483259|NCT01809327|18958604|P2|Overall Study|Other|15
5483260|NCT01809327|18958605|P1|Overall Study|Other|14
5483261|NCT01809327|18958601|P5|Overall Study|Pregnancy|0
5483262|NCT01809327|18958602|P4|Overall Study|Pregnancy|0
5483263|NCT01809327|18958603|P3|Overall Study|Pregnancy|0
5483264|NCT01809327|18958604|P2|Overall Study|Pregnancy|0
5483265|NCT01809327|18958605|P1|Overall Study|Pregnancy|1
5483266|NCT01809327|18958601|P5|Overall Study|Physician Decision|0
5483267|NCT01809327|18958602|P4|Overall Study|Physician Decision|0
5483268|NCT01809327|18958603|P3|Overall Study|Physician Decision|0
5483269|NCT01809327|18958604|P2|Overall Study|Physician Decision|1
5483270|NCT01809327|18958605|P1|Overall Study|Physician Decision|1
5483271|NCT01809327|18958601|P5|Overall Study|Protocol Violation|0
5483272|NCT01809327|18958602|P4|Overall Study|Protocol Violation|0
5483273|NCT01809327|18958603|P3|Overall Study|Protocol Violation|0
5483274|NCT01809327|18958604|P2|Overall Study|Protocol Violation|1
5483275|NCT01809327|18958605|P1|Overall Study|Protocol Violation|0
5483276|NCT01809327|18958601|P5|Overall Study|Death|0
5483277|NCT01809327|18958602|P4|Overall Study|Death|0
5483278|NCT01809327|18958603|P3|Overall Study|Death|0
5483279|NCT01809327|18958604|P2|Overall Study|Death|0
5483280|NCT01809327|18958605|P1|Overall Study|Death|1
5483281|NCT01809327|18958601|P5|Overall Study|Adverse Event|8
5483282|NCT01809327|18958602|P4|Overall Study|Adverse Event|4
5483283|NCT01809327|18958603|P3|Overall Study|Adverse Event|7
5483284|NCT01809327|18958604|P2|Overall Study|Adverse Event|3
5483285|NCT01809327|18958605|P1|Overall Study|Adverse Event|4
5483286|NCT01809327|18958601|P5|Overall Study|Withdrawal by Subject|5
5483287|NCT01809327|18958602|P4|Overall Study|Withdrawal by Subject|2
5483288|NCT01809327|18958603|P3|Overall Study|Withdrawal by Subject|4
5483289|NCT01809327|18958604|P2|Overall Study|Withdrawal by Subject|4
5483290|NCT01809327|18958605|P1|Overall Study|Withdrawal by Subject|6
5483291|NCT01809327|18958601|P5|Overall Study|Lost to Follow-up|3
5483292|NCT01809327|18958602|P4|Overall Study|Lost to Follow-up|2
5483293|NCT01809327|18958603|P3|Overall Study|Lost to Follow-up|4
5483294|NCT01809327|18958604|P2|Overall Study|Lost to Follow-up|2
5483295|NCT01809327|18958605|P1|Overall Study|Lost to Follow-up|5
5483296|NCT01809314|18958647|P1|Overall Study|Lost to Follow-up|724
5483297|NCT01809314|18958647|P1|Overall Study|Insufficient Therapeutic Response|14
5483298|NCT01809314|18958647|P1|Overall Study|Adverse Event|6
5483299|NCT01809314|18958647|P1|Overall Study|Withdrawal Prior to Treatment|1
5483300|NCT01809262|18958653|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
5483301|NCT01809262|18958654|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
5483302|NCT01809262|18958655|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
5483303|NCT01809262|18958656|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
5483304|NCT01809262|18958657|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
5483305|NCT01809262|18958658|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
5483306|NCT01809262|18958659|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
5483307|NCT01809262|18958660|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
5483308|NCT01809262|18958661|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
5483309|NCT01809262|18958662|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
5483310|NCT01809262|18958653|P10|Period 1 (First Dose + Washout)|Adverse Event|0
5483311|NCT01809262|18958654|P9|Period 1 (First Dose + Washout)|Adverse Event|0
5483312|NCT01809262|18958655|P8|Period 1 (First Dose + Washout)|Adverse Event|0
5483313|NCT01809262|18958656|P7|Period 1 (First Dose + Washout)|Adverse Event|0
5483314|NCT01809262|18958657|P6|Period 1 (First Dose + Washout)|Adverse Event|0
5483315|NCT01809262|18958658|P5|Period 1 (First Dose + Washout)|Adverse Event|1
5483316|NCT01809262|18958659|P4|Period 1 (First Dose + Washout)|Adverse Event|0
5483317|NCT01809262|18958660|P3|Period 1 (First Dose + Washout)|Adverse Event|0
5483318|NCT01809262|18958661|P2|Period 1 (First Dose + Washout)|Adverse Event|0
5483319|NCT01809262|18958662|P1|Period 1 (First Dose + Washout)|Adverse Event|0
5483320|NCT01809210|18958736|P7|Overall Study|Death|1
5483321|NCT01809210|18958737|P6|Overall Study|Death|3
5483322|NCT01809210|18958738|P5|Overall Study|Death|1
5483323|NCT01809210|18958739|P4|Overall Study|Death|0
5483324|NCT01809210|18958740|P3|Overall Study|Death|2
5483325|NCT01809210|18958741|P2|Overall Study|Death|1
5483326|NCT01809210|18958742|P1|Overall Study|Death|1
5483327|NCT01809210|18958736|P7|Overall Study|Withdrawal by Subject|4
5483328|NCT01809210|18958737|P6|Overall Study|Withdrawal by Subject|0
5483329|NCT01809210|18958738|P5|Overall Study|Withdrawal by Subject|1
5483330|NCT01809210|18958739|P4|Overall Study|Withdrawal by Subject|1
5483331|NCT01809210|18958740|P3|Overall Study|Withdrawal by Subject|1
5483332|NCT01809210|18958741|P2|Overall Study|Withdrawal by Subject|0
5483333|NCT01809210|18958742|P1|Overall Study|Withdrawal by Subject|0
5483334|NCT01809197|18958816|P2|Overall Study|Product not available|1
5483335|NCT01809197|18958817|P1|Overall Study|Product not available|0
5483336|NCT01809197|18958816|P2|Overall Study|Withdrawal by Subject|1
5483337|NCT01809197|18958817|P1|Overall Study|Withdrawal by Subject|1
5483338|NCT01809197|18958816|P2|Overall Study|Decision Unrelated to an Adverse Event|0
5483339|NCT01809197|18958817|P1|Overall Study|Decision Unrelated to an Adverse Event|1
5483340|NCT01809197|18958816|P2|Overall Study|Non-Compliance|1
5483341|NCT01809197|18958817|P1|Overall Study|Non-Compliance|1
5483342|NCT01809197|18958816|P2|Overall Study|Failed slit lamp exam|0
5483343|NCT01809197|18958817|P1|Overall Study|Failed slit lamp exam|1
5483344|NCT01809197|18958816|P2|Overall Study|Adverse Event|3
5483345|NCT01809197|18958817|P1|Overall Study|Adverse Event|2
5483346|NCT01809197|18958816|P2|Overall Study|Lost to Follow-up|2
5483347|NCT01809197|18958817|P1|Overall Study|Lost to Follow-up|4
5483348|NCT01809132|18958826|P3|Overall Study|Withdrawal by Subject|1
5483349|NCT01809132|18958827|P2|Overall Study|Withdrawal by Subject|0
5483350|NCT01809132|18958828|P1|Overall Study|Withdrawal by Subject|0
5483351|NCT01808690|18958920|P2|Overall Study|Withdrawal by Subject|2
5483352|NCT01808690|18958921|P1|Overall Study|Withdrawal by Subject|1
5483353|NCT01808651|18958940|P3|Study Period 1|Participant Decision|3
5483354|NCT01808651|18958941|P2|Study Period 1|Participant Decision|7
5483355|NCT01808651|18958942|P1|Study Period 1|Participant Decision|9
5483356|NCT01808651|18958940|P3|Study Period 1|Adverse Event|1
5483357|NCT01808651|18958941|P2|Study Period 1|Adverse Event|4
5483358|NCT01808651|18958942|P1|Study Period 1|Adverse Event|10
5483359|NCT01808651|18958940|P3|Study Period 1|Lack of Efficacy|0
5483360|NCT01808651|18958941|P2|Study Period 1|Lack of Efficacy|1
5483361|NCT01808651|18958942|P1|Study Period 1|Lack of Efficacy|2
5483362|NCT01808651|18958940|P3|Study Period 1|Physician Decision|0
5483363|NCT01808651|18958941|P2|Study Period 1|Physician Decision|2
5483364|NCT01808651|18958942|P1|Study Period 1|Physician Decision|3
5483365|NCT01808651|18958940|P3|Study Period 1|Protocol Violation|1
5483366|NCT01808651|18958941|P2|Study Period 1|Protocol Violation|0
5483367|NCT01808651|18958942|P1|Study Period 1|Protocol Violation|1
5483368|NCT01808651|18958940|P3|Study Period 1|Lost to Follow-up|0
5483369|NCT01808651|18958941|P2|Study Period 1|Lost to Follow-up|3
5483370|NCT01808651|18958942|P1|Study Period 1|Lost to Follow-up|1
5483371|NCT01808612|18958977|P3|Discontinuation Period|Lost to Follow-up|0
5483372|NCT01808612|18958978|P2|Discontinuation Period|Lost to Follow-up|1
5483373|NCT01808612|18958979|P1|Discontinuation Period|Lost to Follow-up|0
5483374|NCT01808612|18958977|P3|Discontinuation Period|Physician Decision|0
5483375|NCT01808612|18958978|P2|Discontinuation Period|Physician Decision|0
5483376|NCT01808612|18958979|P1|Discontinuation Period|Physician Decision|1
5483377|NCT01808612|18958977|P3|Discontinuation Period|Adverse Event|0
5483378|NCT01808612|18958978|P2|Discontinuation Period|Adverse Event|0
5483379|NCT01808612|18958979|P1|Discontinuation Period|Adverse Event|1
5483380|NCT01808612|18958977|P3|Treatment Period|Lack of Efficacy|2
5483381|NCT01808612|18958978|P2|Treatment Period|Lack of Efficacy|1
5483382|NCT01808612|18958979|P1|Treatment Period|Lack of Efficacy|1
5483383|NCT01808612|18958977|P3|Treatment Period|Sponsor Decision|0
5483384|NCT01808612|18958978|P2|Treatment Period|Sponsor Decision|0
5483385|NCT01808612|18958979|P1|Treatment Period|Sponsor Decision|1
5483386|NCT01808612|18958977|P3|Treatment Period|Physician Decision|4
5483387|NCT01808612|18958978|P2|Treatment Period|Physician Decision|0
5483388|NCT01808612|18958979|P1|Treatment Period|Physician Decision|1
5483389|NCT01808612|18958977|P3|Treatment Period|Withdrawal by Subject|4
5483390|NCT01808612|18958978|P2|Treatment Period|Withdrawal by Subject|0
5483391|NCT01808612|18958979|P1|Treatment Period|Withdrawal by Subject|1
5483392|NCT01808612|18958977|P3|Treatment Period|Protocol Violation|0
5483393|NCT01808612|18958978|P2|Treatment Period|Protocol Violation|0
5483394|NCT01808612|18958979|P1|Treatment Period|Protocol Violation|1
5483395|NCT01808612|18958977|P3|Treatment Period|Lost to Follow-up|1
5483396|NCT01808612|18958978|P2|Treatment Period|Lost to Follow-up|2
5483397|NCT01808612|18958979|P1|Treatment Period|Lost to Follow-up|2
5483398|NCT01808612|18958977|P3|Treatment Period|Adverse Event|3
5483399|NCT01808612|18958978|P2|Treatment Period|Adverse Event|4
5483400|NCT01808612|18958979|P1|Treatment Period|Adverse Event|8
5483401|NCT01808573|18959010|P2|Overall Study|Randomized in Error|0
5483402|NCT01808573|18959011|P1|Overall Study|Randomized in Error|1
5483403|NCT01808573|18959010|P2|Overall Study|Discontinuation of study by sponsor|64
5483404|NCT01808573|18959011|P1|Overall Study|Discontinuation of study by sponsor|79
5483405|NCT01808573|18959010|P2|Overall Study|Lost to Follow-up|0
5483406|NCT01808573|18959011|P1|Overall Study|Lost to Follow-up|3
5483407|NCT01808573|18959010|P2|Overall Study|Withdrawal by Subject|10
5483408|NCT01808573|18959011|P1|Overall Study|Withdrawal by Subject|12
5483409|NCT01808573|18959010|P2|Overall Study|Death|240
5483410|NCT01808573|18959011|P1|Overall Study|Death|212
5483411|NCT01808534|18959066|P1|Overall Study|Physician Decision|1
5483412|NCT01808534|18959066|P1|Overall Study|Disease progression|3
5483413|NCT01808508|18959077|P3|Overall Study|Lost to Follow-up|0
5483414|NCT01808508|18959078|P2|Overall Study|Lost to Follow-up|0
5483415|NCT01808508|18959079|P1|Overall Study|Lost to Follow-up|1
5483416|NCT01808339|18959096|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5483417|NCT01808339|18959097|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5483418|NCT01808339|18959098|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5483419|NCT01808339|18959099|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
5483420|NCT01808339|18959100|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5483421|NCT01808339|18959101|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
5483422|NCT01808339|18959096|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5483423|NCT01808339|18959097|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5483424|NCT01808339|18959098|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5483425|NCT01808339|18959099|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5483426|NCT01808339|18959100|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5483427|NCT01808339|18959101|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5483428|NCT01808339|18959096|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
5483429|NCT01808339|18959097|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
5483430|NCT01808339|18959098|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
5483431|NCT01808339|18959099|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
5483432|NCT01808339|18959100|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
5483433|NCT01808339|18959101|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
5483434|NCT01808313|18959145|P1|Overall Study|Physician Decision|1
5483435|NCT01808313|18959145|P1|Overall Study|Lost to Follow-up|1
5483436|NCT01808313|18959145|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
5483437|NCT01808313|18959145|P1|Overall Study|Protocol Violation|2
5483438|NCT01808313|18959145|P1|Overall Study|Adverse Event|5
5483439|NCT01808261|18959175|P2|Overall Study|Lost to Follow-up|1
5483440|NCT01808261|18959176|P1|Overall Study|Lost to Follow-up|3
5483441|NCT01808261|18959175|P2|Overall Study|Consent withdrawn by subject|7
5483442|NCT01808261|18959176|P1|Overall Study|Consent withdrawn by subject|6
5483443|NCT01808261|18959175|P2|Overall Study|Adverse event, non-fatal|0
5483444|NCT01808261|18959176|P1|Overall Study|Adverse event, non-fatal|2
5483445|NCT01808261|18959175|P2|Overall Study|Study Closed/Terminated|23
5483446|NCT01808261|18959176|P1|Overall Study|Study Closed/Terminated|25
5483447|NCT01808261|18959175|P2|Overall Study|Physician Decision|2
5483448|NCT01808261|18959176|P1|Overall Study|Physician Decision|0
5483449|NCT01808248|18959232|P1|Overall Study|Lost to Follow-up|1
5483450|NCT01808248|18959232|P1|Overall Study|Withdrawal by Subject|1
5483451|NCT01808248|18959232|P1|Overall Study|Lack of Efficacy|3
5483452|NCT01808222|18959244|P1|Overall Study|mpMR scan was not performed|1
5483453|NCT01808209|18959251|P2|Overall Study|Lost to Follow-up|1
5483454|NCT01808209|18959252|P1|Overall Study|Lost to Follow-up|0
5483455|NCT01808196|18959294|P1|Overall Study|Lost to Follow-up|1
5483456|NCT01808144|18959302|P2|Overall Study|Adverse Event|15
5483457|NCT01808144|18959303|P1|Overall Study|Adverse Event|11
5483458|NCT01808144|18959302|P2|Overall Study|Gout flare|1
5483459|NCT01808144|18959303|P1|Overall Study|Gout flare|0
5483460|NCT01808144|18959302|P2|Overall Study|Protocol Violation|6
5483461|NCT01808144|18959303|P1|Overall Study|Protocol Violation|6
5483462|NCT01808144|18959302|P2|Overall Study|Lost to Follow-up|3
5483463|NCT01808144|18959303|P1|Overall Study|Lost to Follow-up|6
5483464|NCT01808144|18959302|P2|Overall Study|Withdrawal by Subject|23
5483465|NCT01808144|18959303|P1|Overall Study|Withdrawal by Subject|16
5483466|NCT01808144|18959302|P2|Overall Study|Death|0
5483467|NCT01808144|18959303|P1|Overall Study|Death|1
5483468|NCT01808118|18959311|P3|Period 2|Switched to other therapy|0
5483469|NCT01808118|18959312|P2|Period 2|Switched to other therapy|1
5483470|NCT01808118|18959313|P1|Period 2|Switched to other therapy|0
5483471|NCT01808118|18959311|P3|Period 2|Investigator no longer conducting trials|0
5483472|NCT01808118|18959312|P2|Period 2|Investigator no longer conducting trials|1
5483473|NCT01808118|18959313|P1|Period 2|Investigator no longer conducting trials|0
5483474|NCT01808118|18959311|P3|Period 2|Lost to Follow-up|2
5483475|NCT01808118|18959312|P2|Period 2|Lost to Follow-up|0
5483476|NCT01808118|18959313|P1|Period 2|Lost to Follow-up|0
5483477|NCT01808118|18959311|P3|Period 2|Withdrew consent|6
5483478|NCT01808118|18959312|P2|Period 2|Withdrew consent|7
5483479|NCT01808118|18959313|P1|Period 2|Withdrew consent|0
5483480|NCT01808118|18959311|P3|Period 2|Adverse Event|0
5483481|NCT01808118|18959312|P2|Period 2|Adverse Event|4
5483482|NCT01808118|18959313|P1|Period 2|Adverse Event|0
5483483|NCT01808118|18959311|P3|Period 1|Lack of Efficacy|0
5483484|NCT01808118|18959312|P2|Period 1|Lack of Efficacy|0
5483485|NCT01808118|18959313|P1|Period 1|Lack of Efficacy|1
5483486|NCT01808118|18959311|P3|Period 1|Non-compliance per sponsor|0
5483487|NCT01808118|18959312|P2|Period 1|Non-compliance per sponsor|0
5483488|NCT01808118|18959313|P1|Period 1|Non-compliance per sponsor|1
5483489|NCT01808118|18959311|P3|Period 1|Investigator decision: site closure|0
5483490|NCT01808118|18959312|P2|Period 1|Investigator decision: site closure|0
5483491|NCT01808118|18959313|P1|Period 1|Investigator decision: site closure|2
5483492|NCT01808118|18959311|P3|Period 1|Non-conformance with inclusion criteria|0
5483493|NCT01808118|18959312|P2|Period 1|Non-conformance with inclusion criteria|0
5483494|NCT01808118|18959313|P1|Period 1|Non-conformance with inclusion criteria|3
5483495|NCT01808118|18959311|P3|Period 1|Did not meet inclusion criteria|0
5483496|NCT01808118|18959312|P2|Period 1|Did not meet inclusion criteria|0
5483497|NCT01808118|18959313|P1|Period 1|Did not meet inclusion criteria|3
5483498|NCT01808118|18959311|P3|Period 1|Enrolled in error|0
5483499|NCT01808118|18959312|P2|Period 1|Enrolled in error|0
5483500|NCT01808118|18959313|P1|Period 1|Enrolled in error|7
5483501|NCT01808118|18959311|P3|Period 1|Did not meet criteria for remission|0
5483502|NCT01808118|18959312|P2|Period 1|Did not meet criteria for remission|0
5483503|NCT01808118|18959313|P1|Period 1|Did not meet criteria for remission|303
5483504|NCT01808118|18959311|P3|Period 1|Lost to Follow-up|0
5483505|NCT01808118|18959312|P2|Period 1|Lost to Follow-up|0
5483506|NCT01808118|18959313|P1|Period 1|Lost to Follow-up|9
5483507|NCT01808118|18959311|P3|Period 1|Withdrew consent|0
5483508|NCT01808118|18959312|P2|Period 1|Withdrew consent|0
5483509|NCT01808118|18959313|P1|Period 1|Withdrew consent|24
5483510|NCT01808118|18959311|P3|Period 1|Adverse Event|0
5483511|NCT01808118|18959312|P2|Period 1|Adverse Event|0
5483512|NCT01808118|18959313|P1|Period 1|Adverse Event|15
5483513|NCT01808092|18959376|P2|Overall Study|Other Eligibility criteria|5
5483514|NCT01808092|18959377|P1|Overall Study|Other Eligibility criteria|3
5483515|NCT01808092|18959376|P2|Overall Study|Withdrawal by Subject|4
5483516|NCT01808092|18959377|P1|Overall Study|Withdrawal by Subject|9
5483517|NCT01808092|18959376|P2|Overall Study|Lost to Follow-up|7
5483518|NCT01808092|18959377|P1|Overall Study|Lost to Follow-up|3
5483519|NCT01808092|18959376|P2|Overall Study|Death|29
5483520|NCT01808092|18959377|P1|Overall Study|Death|39
5483521|NCT01808066|18959479|P1|Overall Study|Withdrawal by Subject|15
5483522|NCT01807949|18959490|P3|Overall Study|Randomized But Not Treated|2
5483523|NCT01807949|18959491|P2|Overall Study|Randomized But Not Treated|2
5483524|NCT01807949|18959492|P1|Overall Study|Randomized But Not Treated|0
5483525|NCT01807949|18959490|P3|Overall Study|Undefined|2
5483526|NCT01807949|18959491|P2|Overall Study|Undefined|1
5483527|NCT01807949|18959492|P1|Overall Study|Undefined|0
5483528|NCT01807949|18959490|P3|Overall Study|Non-Compliance|1
5483529|NCT01807949|18959491|P2|Overall Study|Non-Compliance|0
5483530|NCT01807949|18959492|P1|Overall Study|Non-Compliance|0
5483531|NCT01807949|18959490|P3|Overall Study|Withdrawal by Subject|2
5483532|NCT01807949|18959491|P2|Overall Study|Withdrawal by Subject|2
5483533|NCT01807949|18959492|P1|Overall Study|Withdrawal by Subject|1
5483534|NCT01807949|18959490|P3|Overall Study|Adverse Event|2
5483535|NCT01807949|18959491|P2|Overall Study|Adverse Event|2
5483536|NCT01807949|18959492|P1|Overall Study|Adverse Event|1
5483537|NCT01807923|18959544|P3|Overall Study|Randomized But Not Treated|5
5483538|NCT01807923|18959545|P2|Overall Study|Randomized But Not Treated|2
5483539|NCT01807923|18959546|P1|Overall Study|Randomized But Not Treated|3
5483540|NCT01807923|18959544|P3|Overall Study|Not Eligible (Genotype)|1
5483541|NCT01807923|18959545|P2|Overall Study|Not Eligible (Genotype)|0
5483542|NCT01807923|18959546|P1|Overall Study|Not Eligible (Genotype)|0
5483543|NCT01807923|18959544|P3|Overall Study|Physician Decision|1
5483544|NCT01807923|18959545|P2|Overall Study|Physician Decision|0
5483545|NCT01807923|18959546|P1|Overall Study|Physician Decision|0
5483546|NCT01807923|18959544|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
5483547|NCT01807923|18959545|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
5483548|NCT01807923|18959546|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
5483549|NCT01807923|18959544|P3|Overall Study|Adverse Event|2
5483550|NCT01807923|18959545|P2|Overall Study|Adverse Event|1
5483551|NCT01807923|18959546|P1|Overall Study|Adverse Event|2
5483552|NCT01807650|18959608|P1|Overall Study|Other|2
5483553|NCT01807650|18959608|P1|Overall Study|Adverse Event|5
5483554|NCT01807650|18959608|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
5483555|NCT01807598|18959694|P1|Overall Study|Other Physician Decision|1
5483556|NCT01807598|18959694|P1|Overall Study|Adverse Event|1
5483557|NCT01807598|18959694|P1|Overall Study|Withdrawal by Subject|4
5483558|NCT01807520|18959726|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
5483559|NCT01807520|18959727|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
5483560|NCT01807520|18959728|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5483561|NCT01807520|18959729|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5483562|NCT01807520|18959730|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5483563|NCT01807520|18959731|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5483564|NCT01807520|18959732|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
5483565|NCT01807520|18959726|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
5483566|NCT01807520|18959727|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
5483567|NCT01807520|18959728|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
5483568|NCT01807520|18959729|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
5483569|NCT01807520|18959730|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
5483570|NCT01807520|18959731|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
5483571|NCT01807520|18959732|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
5483572|NCT01807520|18959726|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5483573|NCT01807520|18959727|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
5483574|NCT01807520|18959728|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5483575|NCT01807520|18959729|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5483576|NCT01807520|18959730|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5483577|NCT01807520|18959731|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5483578|NCT01807520|18959732|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
5483579|NCT01807520|18959726|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
5483580|NCT01807520|18959727|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
5483581|NCT01807520|18959728|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
5483582|NCT01807520|18959729|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
5483583|NCT01807520|18959730|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
5483584|NCT01807520|18959731|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
5483585|NCT01807520|18959732|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
5483586|NCT01807520|18959726|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5483587|NCT01807520|18959727|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5483588|NCT01807520|18959728|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5483589|NCT01807520|18959729|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
5483590|NCT01807520|18959730|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
5483591|NCT01807520|18959731|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
5483592|NCT01807520|18959732|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
5483593|NCT01807520|18959726|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5483594|NCT01807520|18959727|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5483595|NCT01807520|18959728|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
5483596|NCT01807520|18959729|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5483597|NCT01807520|18959730|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
5483598|NCT01807520|18959731|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
5483599|NCT01807520|18959732|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
5483600|NCT01807520|18959726|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5483601|NCT01807520|18959727|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5483602|NCT01807520|18959728|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5483603|NCT01807520|18959729|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
5483604|NCT01807520|18959730|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5483605|NCT01807520|18959731|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
5483606|NCT01807520|18959732|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
5483607|NCT01807520|18959726|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5483608|NCT01807520|18959727|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5483609|NCT01807520|18959728|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5483610|NCT01807520|18959729|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5483611|NCT01807520|18959730|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5483612|NCT01807520|18959731|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
5483613|NCT01807520|18959732|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
5483614|NCT01807520|18959726|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5483615|NCT01807520|18959727|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5483616|NCT01807520|18959728|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5483617|NCT01807520|18959729|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5483618|NCT01807520|18959730|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5483619|NCT01807520|18959731|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
5483620|NCT01807520|18959732|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
5483621|NCT01807520|18959726|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5483622|NCT01807520|18959727|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5483623|NCT01807520|18959728|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5483624|NCT01807520|18959729|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
5483625|NCT01807520|18959730|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5483626|NCT01807520|18959731|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5483627|NCT01807520|18959732|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
5483628|NCT01807520|18959726|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5483629|NCT01807520|18959727|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5483630|NCT01807520|18959728|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
5483631|NCT01807520|18959729|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5483632|NCT01807520|18959730|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
5483633|NCT01807520|18959731|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
5483634|NCT01807520|18959732|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
5483635|NCT01807520|18959726|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5483636|NCT01807520|18959727|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5483637|NCT01807520|18959728|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5483638|NCT01807520|18959729|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5483639|NCT01807520|18959730|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5483640|NCT01807520|18959731|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
5483641|NCT01807520|18959732|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
5483642|NCT01807520|18959726|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5483643|NCT01807520|18959727|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5483644|NCT01807520|18959728|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5483645|NCT01807520|18959729|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5483646|NCT01807520|18959730|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
5483647|NCT01807520|18959731|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5483648|NCT01807520|18959732|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
5483649|NCT01807520|18959726|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5483650|NCT01807520|18959727|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5483651|NCT01807520|18959728|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5483652|NCT01807520|18959729|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5483653|NCT01807520|18959730|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5483654|NCT01807520|18959731|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
5483655|NCT01807520|18959732|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
5483656|NCT01807520|18959726|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5483657|NCT01807520|18959727|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5483658|NCT01807520|18959728|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5483659|NCT01807520|18959729|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5483660|NCT01807520|18959730|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
5483661|NCT01807520|18959731|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5483662|NCT01807520|18959732|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
5483663|NCT01807520|18959726|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5483664|NCT01807520|18959727|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5483665|NCT01807520|18959728|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5483666|NCT01807520|18959729|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5483667|NCT01807520|18959730|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
5483668|NCT01807520|18959731|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
5483669|NCT01807520|18959732|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
5483670|NCT01807520|18959726|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5483671|NCT01807520|18959727|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5483672|NCT01807520|18959728|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5483673|NCT01807520|18959729|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5483674|NCT01807520|18959730|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
5483675|NCT01807520|18959731|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
5483676|NCT01807520|18959732|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
5483677|NCT01807299|18959763|P4|Overall Study|Protocol Violation|2
5483678|NCT01807299|18959764|P3|Overall Study|Protocol Violation|0
5483679|NCT01807299|18959765|P2|Overall Study|Protocol Violation|1
5483680|NCT01807299|18959766|P1|Overall Study|Protocol Violation|3
5483681|NCT01807234|18959782|P6|Overall Study|Lack of Efficacy|1
5483682|NCT01807234|18959783|P5|Overall Study|Lack of Efficacy|1
5483683|NCT01807234|18959784|P4|Overall Study|Lack of Efficacy|0
5483684|NCT01807234|18959785|P3|Overall Study|Lack of Efficacy|0
5483685|NCT01807234|18959786|P2|Overall Study|Lack of Efficacy|0
5483686|NCT01807234|18959787|P1|Overall Study|Lack of Efficacy|0
5483687|NCT01807234|18959782|P6|Overall Study|Withdrawal by Subject|1
5483688|NCT01807234|18959783|P5|Overall Study|Withdrawal by Subject|2
5483689|NCT01807234|18959784|P4|Overall Study|Withdrawal by Subject|1
5483690|NCT01807234|18959785|P3|Overall Study|Withdrawal by Subject|1
5483691|NCT01807234|18959786|P2|Overall Study|Withdrawal by Subject|1
5483692|NCT01807234|18959787|P1|Overall Study|Withdrawal by Subject|3
5483693|NCT01807234|18959782|P6|Overall Study|Lost to Follow-up|2
5483694|NCT01807234|18959783|P5|Overall Study|Lost to Follow-up|1
5483695|NCT01807234|18959784|P4|Overall Study|Lost to Follow-up|1
5483696|NCT01807234|18959785|P3|Overall Study|Lost to Follow-up|1
5483697|NCT01807234|18959786|P2|Overall Study|Lost to Follow-up|5
5483698|NCT01807234|18959787|P1|Overall Study|Lost to Follow-up|2
5483699|NCT01807156|18959822|P1|Overall Study|Physician Decision|1
5483700|NCT01807065|18959838|P2|Overall Study|Receive no sip-T due to IV access|1
5483701|NCT01807065|18959839|P1|Overall Study|Receive no sip-T due to IV access|1
5483702|NCT01806961|18959905|P1|Overall Study|sponsor decision|16
5483703|NCT01806896|18959911|P2|Overall Study|Other|0
5483704|NCT01806896|18959912|P1|Overall Study|Other|1
5483705|NCT01806896|18959911|P2|Overall Study|Adverse Event|0
5483706|NCT01806896|18959912|P1|Overall Study|Adverse Event|2
5483707|NCT01806779|18959979|P3|Overall Study|Withdrawal by Subject|22
5483708|NCT01806779|18959980|P2|Overall Study|Withdrawal by Subject|23
5483709|NCT01806779|18959981|P1|Overall Study|Withdrawal by Subject|20
5483710|NCT01806779|18959979|P3|Overall Study|Lost to Follow-up|0
5483711|NCT01806779|18959980|P2|Overall Study|Lost to Follow-up|20
5483712|NCT01806779|18959981|P1|Overall Study|Lost to Follow-up|19
5483713|NCT01806779|18959979|P3|Overall Study|Lack of Efficacy|0
5483714|NCT01806779|18959980|P2|Overall Study|Lack of Efficacy|1
5483715|NCT01806779|18959981|P1|Overall Study|Lack of Efficacy|1
5483716|NCT01806779|18959979|P3|Overall Study|Physician Decision|1
5483717|NCT01806779|18959980|P2|Overall Study|Physician Decision|0
5483718|NCT01806779|18959981|P1|Overall Study|Physician Decision|2
5483719|NCT01806740|18959994|P1|Overall Study|Patient's refusal of treatment|1
5483720|NCT01806740|18959994|P1|Overall Study|Physician Decision|1
5483721|NCT01806740|18959994|P1|Overall Study|Withdrawal by Subject|4
5483722|NCT01806714|18960005|P2|Overall Study|No functioning phone number|170
5483723|NCT01806714|18960006|P1|Overall Study|No functioning phone number|200
5483724|NCT01806662|18960041|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
5483725|NCT01806662|18960042|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
5483726|NCT01806662|18960041|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
5483727|NCT01806662|18960042|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
5483728|NCT01806662|18960041|P2|First Intervention (Weeks 0-16)|Adverse Event|1
5483729|NCT01806662|18960042|P1|First Intervention (Weeks 0-16)|Adverse Event|0
5483730|NCT01806662|18960041|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
5483731|NCT01806662|18960042|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
5483732|NCT01806623|18960048|P1|Overall Study|Did not meet the inclusion criteria|56
5483733|NCT01806623|18960048|P1|Overall Study|Adverse Event|1
5483734|NCT01806623|18960048|P1|Overall Study|Withdrawal by Subject|1
5483735|NCT01806597|18960068|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
5483736|NCT01806597|18960069|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5483737|NCT01806597|18960070|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5483738|NCT01806597|18960071|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5483739|NCT01806597|18960072|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5483740|NCT01806597|18960073|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
5483741|NCT01806597|18960068|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
5483742|NCT01806597|18960069|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5483743|NCT01806597|18960070|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5483744|NCT01806597|18960071|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5483745|NCT01806597|18960072|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5483746|NCT01806597|18960073|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
5483747|NCT01806597|18960068|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
5483748|NCT01806597|18960069|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5483749|NCT01806597|18960070|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5483750|NCT01806597|18960071|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5483751|NCT01806597|18960072|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5483752|NCT01806597|18960073|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
5483753|NCT01806597|18960068|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
5483754|NCT01806597|18960069|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5483755|NCT01806597|18960070|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5483756|NCT01806597|18960071|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5483757|NCT01806597|18960072|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5483758|NCT01806597|18960073|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
5483759|NCT01806597|18960068|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
5483760|NCT01806597|18960069|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5483761|NCT01806597|18960070|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5483762|NCT01806597|18960071|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5483763|NCT01806597|18960072|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5483764|NCT01806597|18960073|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
5483765|NCT01806597|18960068|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
5483766|NCT01806597|18960069|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
5483767|NCT01806597|18960070|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
5483768|NCT01806597|18960071|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
5483769|NCT01806597|18960072|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
5483770|NCT01806597|18960073|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
5483771|NCT01806597|18960068|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
5483772|NCT01806597|18960069|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
5483773|NCT01806597|18960070|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
5483774|NCT01806597|18960071|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
5483775|NCT01806597|18960072|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
5483776|NCT01806597|18960073|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
5483777|NCT01806597|18960068|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
5483778|NCT01806597|18960069|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
5483779|NCT01806597|18960070|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
5483780|NCT01806597|18960071|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
5483781|NCT01806597|18960072|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
5483782|NCT01806597|18960073|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
5483783|NCT01806597|18960068|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5483784|NCT01806597|18960069|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5483785|NCT01806597|18960070|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
5483786|NCT01806597|18960071|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5483787|NCT01806597|18960072|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
5483788|NCT01806597|18960073|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
5483789|NCT01806597|18960068|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5483790|NCT01806597|18960069|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5483791|NCT01806597|18960070|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5483792|NCT01806597|18960071|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5483793|NCT01806597|18960072|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
5483794|NCT01806597|18960073|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
5483795|NCT01806597|18960068|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5483796|NCT01806597|18960069|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5483797|NCT01806597|18960070|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5483798|NCT01806597|18960071|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
5483799|NCT01806597|18960072|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
5483800|NCT01806597|18960073|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
5483801|NCT01806597|18960068|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5483802|NCT01806597|18960069|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5483803|NCT01806597|18960070|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5483804|NCT01806597|18960071|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5483805|NCT01806597|18960072|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
5483806|NCT01806597|18960073|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
5483807|NCT01806597|18960068|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
5483808|NCT01806597|18960069|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
5483809|NCT01806597|18960070|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
5483810|NCT01806597|18960071|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
5483811|NCT01806597|18960072|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
5483812|NCT01806597|18960073|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
5483813|NCT01806597|18960068|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
5483814|NCT01806597|18960069|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
5483815|NCT01806597|18960070|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
5483816|NCT01806597|18960071|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
5483817|NCT01806597|18960072|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
5483818|NCT01806597|18960073|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
5483819|NCT01806597|18960068|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
5483820|NCT01806597|18960069|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
5483821|NCT01806597|18960070|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
5483822|NCT01806597|18960071|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
5483823|NCT01806597|18960072|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
5483824|NCT01806597|18960073|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
5483825|NCT01806597|18960068|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
5483826|NCT01806597|18960069|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
5483827|NCT01806597|18960070|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
5483828|NCT01806597|18960071|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
5483829|NCT01806597|18960072|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
5483830|NCT01806597|18960073|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
5483831|NCT01806597|18960068|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
5483832|NCT01806597|18960069|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
5483833|NCT01806597|18960070|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
5483834|NCT01806597|18960071|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
5483835|NCT01806597|18960072|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
5483836|NCT01806597|18960073|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
5483837|NCT01806597|18960068|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5483838|NCT01806597|18960069|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
5483839|NCT01806597|18960070|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5483840|NCT01806597|18960071|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5483841|NCT01806597|18960072|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
5483842|NCT01806597|18960073|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
5483843|NCT01806597|18960068|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
5483844|NCT01806597|18960069|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
5483845|NCT01806597|18960070|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
5483846|NCT01806597|18960071|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
5483847|NCT01806597|18960072|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
5483848|NCT01806597|18960073|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
5483849|NCT01806584|18960109|P2|Overall Study|Other unspecified|0
5483850|NCT01806584|18960110|P1|Overall Study|Other unspecified|1
5483851|NCT01806584|18960109|P2|Overall Study|Withdrawal by Subject|1
5483852|NCT01806584|18960110|P1|Overall Study|Withdrawal by Subject|1
5483853|NCT01806584|18960109|P2|Overall Study|Study terminated by sponsor|14
5483854|NCT01806584|18960110|P1|Overall Study|Study terminated by sponsor|9
5483855|NCT01806584|18960109|P2|Overall Study|Lost to Follow-up|2
5483856|NCT01806584|18960110|P1|Overall Study|Lost to Follow-up|0
5483857|NCT01806584|18960109|P2|Overall Study|Death|0
5483858|NCT01806584|18960110|P1|Overall Study|Death|1
5483859|NCT01806584|18960109|P2|Overall Study|Adverse Event|1
5483860|NCT01806584|18960110|P1|Overall Study|Adverse Event|2
5483861|NCT01806545|18960132|P2|Overall Study|Withdrawal by Subject|2
5483862|NCT01806545|18960133|P1|Overall Study|Withdrawal by Subject|3
5483863|NCT01806545|18960132|P2|Overall Study|Lost to Follow-up|0
5483864|NCT01806545|18960133|P1|Overall Study|Lost to Follow-up|1
5483865|NCT01806545|18960132|P2|Overall Study|Adverse Event|3
5483866|NCT01806545|18960133|P1|Overall Study|Adverse Event|2
5483867|NCT01806506|18960157|P2|Overall Study|Lost to Follow-up|1
5483868|NCT01806506|18960158|P1|Overall Study|Lost to Follow-up|2
5483869|NCT01806389|18960164|P1|Overall Study|Withdrawal by Subject|4
5483870|NCT01806298|18960178|P1|Overall Study|Other|5
5483871|NCT01806298|18960178|P1|Overall Study|Withdrawal by Subject|1
5483872|NCT01806298|18960178|P1|Overall Study|Protocol Non-compliance|1
5483873|NCT01806298|18960178|P1|Overall Study|Adverse Event|3
5483874|NCT01806064|18960204|P5|Overall Study|Randomized Not Enrolled|2
5483875|NCT01806064|18960205|P4|Overall Study|Randomized Not Enrolled|1
5483876|NCT01806064|18960206|P3|Overall Study|Randomized Not Enrolled|0
5483877|NCT01806064|18960207|P2|Overall Study|Randomized Not Enrolled|0
5483878|NCT01806064|18960208|P1|Overall Study|Randomized Not Enrolled|0
5483879|NCT01806051|18960233|P1|Overall Study|Withdrawal by Subject|6
5483880|NCT01805180|18960350|P3|Lead-in Donor Phase|screen failure|0
5483881|NCT01805180|18960351|P2|Lead-in Donor Phase|screen failure|0
5483882|NCT01805180|18960352|P1|Lead-in Donor Phase|screen failure|1
5483883|NCT01804946|18960427|P2|Overall Study|Do not meet inclusion criteria|2
5483884|NCT01804946|18960428|P1|Overall Study|Do not meet inclusion criteria|1
5483885|NCT01804946|18960427|P2|Overall Study|Insufficient data available|1
5483886|NCT01804946|18960428|P1|Overall Study|Insufficient data available|0
5483887|NCT01804946|18960427|P2|Overall Study|Adverse Event|1
5483888|NCT01804946|18960428|P1|Overall Study|Adverse Event|0
5483889|NCT01804946|18960427|P2|Overall Study|Protocol Violation|0
5483890|NCT01804946|18960428|P1|Overall Study|Protocol Violation|1
5483891|NCT01804842|18960466|P3|Overall Study|Personal Reason|1
5483892|NCT01804842|18960467|P2|Overall Study|Personal Reason|0
5483893|NCT01804842|18960468|P1|Overall Study|Personal Reason|0
5483894|NCT01804842|18960466|P3|Overall Study|Non-Compliance|0
5483895|NCT01804842|18960467|P2|Overall Study|Non-Compliance|1
5483896|NCT01804842|18960468|P1|Overall Study|Non-Compliance|1
5483897|NCT01804842|18960466|P3|Overall Study|Lost to Follow-up|0
5483898|NCT01804842|18960467|P2|Overall Study|Lost to Follow-up|0
5483899|NCT01804842|18960468|P1|Overall Study|Lost to Follow-up|1
5483900|NCT01804842|18960466|P3|Overall Study|Adverse Event|0
5483901|NCT01804842|18960467|P2|Overall Study|Adverse Event|1
5483902|NCT01804842|18960468|P1|Overall Study|Adverse Event|1
5483903|NCT01804816|18960485|P1|Acupuncture (Second 5 Weeks)|Physician Decision|1
5483904|NCT01804816|18960485|P1|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
5483905|NCT01804673|18960497|P1|Overall Study|Other|4
5483906|NCT01804673|18960497|P1|Overall Study|Use of Prohibited Medication|1
5483907|NCT01804673|18960497|P1|Overall Study|No Further Therapy Required|84
5483908|NCT01804673|18960497|P1|Overall Study|Change to Oral Therapy|37
5483909|NCT01804673|18960497|P1|Overall Study|Lack of Efficacy|9
5483910|NCT01804673|18960497|P1|Overall Study|Withdrawal by Subject|1
5483911|NCT01804673|18960497|P1|Overall Study|Adverse Event|4
5483912|NCT01804582|18960515|P2|Overall Study|Physician Decision|0
5483913|NCT01804582|18960516|P1|Overall Study|Physician Decision|2
5483914|NCT01804582|18960515|P2|Overall Study|Lost to Follow-up|56
5483915|NCT01804582|18960516|P1|Overall Study|Lost to Follow-up|47
5483916|NCT01804140|18960536|P1|Overall Study|No sampling or biopsy procedures done|114
5483917|NCT01804049|18960570|P2|Overall Study|Enrollment in dual studies|1
5483918|NCT01804049|18960571|P1|Overall Study|Enrollment in dual studies|0
5483919|NCT01804049|18960570|P2|Overall Study|other MD recommended|1
5483920|NCT01804049|18960571|P1|Overall Study|other MD recommended|1
5483921|NCT01804049|18960570|P2|Overall Study|Moved out of area|7
5483922|NCT01804049|18960571|P1|Overall Study|Moved out of area|0
5483923|NCT01804049|18960570|P2|Overall Study|Other health concerns|7
5483924|NCT01804049|18960571|P1|Overall Study|Other health concerns|2
5483925|NCT01804049|18960570|P2|Overall Study|Decreased interest/personal|5
5483926|NCT01804049|18960571|P1|Overall Study|Decreased interest/personal|4
5483927|NCT01804049|18960570|P2|Overall Study|Lost to Follow-up|1
5483928|NCT01804049|18960571|P1|Overall Study|Lost to Follow-up|2
5483929|NCT01804049|18960570|P2|Overall Study|Adverse Event|10
5483930|NCT01804049|18960571|P1|Overall Study|Adverse Event|2
5483931|NCT01803880|18960619|P3|Overall Study|Incomplete data entry by sites|0
5483932|NCT01803880|18960620|P2|Overall Study|Incomplete data entry by sites|0
5483933|NCT01803880|18960621|P1|Overall Study|Incomplete data entry by sites|2
5483934|NCT01803880|18960619|P3|Overall Study|Early study termination|5
5483935|NCT01803880|18960620|P2|Overall Study|Early study termination|6
5483936|NCT01803880|18960621|P1|Overall Study|Early study termination|0
5483937|NCT01803880|18960619|P3|Overall Study|Protocol Violation|0
5483938|NCT01803880|18960620|P2|Overall Study|Protocol Violation|0
5483939|NCT01803880|18960621|P1|Overall Study|Protocol Violation|1
5483940|NCT01803880|18960619|P3|Overall Study|Lost to Follow-up|3
5483941|NCT01803880|18960620|P2|Overall Study|Lost to Follow-up|2
5483942|NCT01803880|18960621|P1|Overall Study|Lost to Follow-up|1
5483943|NCT01803880|18960619|P3|Overall Study|Unable to return for follow-up visits|2
5483944|NCT01803880|18960620|P2|Overall Study|Unable to return for follow-up visits|1
5483945|NCT01803880|18960621|P1|Overall Study|Unable to return for follow-up visits|0
5483946|NCT01803880|18960619|P3|Overall Study|Physician Decision|1
5483947|NCT01803880|18960620|P2|Overall Study|Physician Decision|0
5483948|NCT01803880|18960621|P1|Overall Study|Physician Decision|0
5483949|NCT01803880|18960619|P3|Overall Study|Withdrawal by Subject|4
5483950|NCT01803880|18960620|P2|Overall Study|Withdrawal by Subject|1
5483951|NCT01803880|18960621|P1|Overall Study|Withdrawal by Subject|1
5483952|NCT01803880|18960619|P3|Overall Study|Adverse Event|0
5483953|NCT01803880|18960620|P2|Overall Study|Adverse Event|0
5483954|NCT01803880|18960621|P1|Overall Study|Adverse Event|1
5483955|NCT01803737|18960657|P2|Overall Study|Lost to Follow-up|2
5483956|NCT01803737|18960658|P1|Overall Study|Lost to Follow-up|0
5483957|NCT01803737|18960657|P2|Overall Study|Medical Reason|1
5483958|NCT01803737|18960658|P1|Overall Study|Medical Reason|0
5483959|NCT01803737|18960657|P2|Overall Study|Lack of Time|0
5483960|NCT01803737|18960658|P1|Overall Study|Lack of Time|1
5483961|NCT01803711|18960682|P2|Overall Study|Adverse Event|1
5483962|NCT01803711|18960683|P1|Overall Study|Adverse Event|1
5483963|NCT01803646|18960701|P2|Overall Study|Lost to Follow-up|1
5483964|NCT01803646|18960702|P1|Overall Study|Lost to Follow-up|5
5483965|NCT01803646|18960701|P2|Overall Study|Randomization error|2
5483966|NCT01803646|18960702|P1|Overall Study|Randomization error|1
5483967|NCT01803646|18960701|P2|Overall Study|Withdrawal by Subject|6
5483968|NCT01803646|18960702|P1|Overall Study|Withdrawal by Subject|9
5483969|NCT01803646|18960701|P2|Overall Study|Adverse Event|1
5483970|NCT01803646|18960702|P1|Overall Study|Adverse Event|1
5483971|NCT01803646|18960701|P2|Overall Study|Protocol Violation|0
5483972|NCT01803646|18960702|P1|Overall Study|Protocol Violation|1
5483973|NCT01803607|18960714|P2|Overall Study|Withdrawal by Subject|5
5483974|NCT01803607|18960715|P1|Overall Study|Withdrawal by Subject|6
5483975|NCT01803607|18960714|P2|Overall Study|Study terminated by sponsor|56
5483976|NCT01803607|18960715|P1|Overall Study|Study terminated by sponsor|54
5483977|NCT01803607|18960714|P2|Overall Study|Protocol Violation|2
5483978|NCT01803607|18960715|P1|Overall Study|Protocol Violation|3
5483979|NCT01803607|18960714|P2|Overall Study|Lack of Efficacy|1
5483980|NCT01803607|18960715|P1|Overall Study|Lack of Efficacy|0
5483981|NCT01803607|18960714|P2|Overall Study|Adverse Event|3
5483982|NCT01803607|18960715|P1|Overall Study|Adverse Event|5
5483983|NCT01803464|18960739|P4|Overall Study|Withdrawal by Subject|0
5483984|NCT01803464|18960740|P3|Overall Study|Withdrawal by Subject|0
5483985|NCT01803464|18960741|P2|Overall Study|Withdrawal by Subject|0
5483986|NCT01803464|18960742|P1|Overall Study|Withdrawal by Subject|1
5483987|NCT01803464|18960739|P4|Overall Study|Incomplete data|0
5483988|NCT01803464|18960740|P3|Overall Study|Incomplete data|4
5483989|NCT01803464|18960741|P2|Overall Study|Incomplete data|0
5483990|NCT01803464|18960742|P1|Overall Study|Incomplete data|0
5483991|NCT01803282|18960772|P12|Overall Study|Enrolled but Never Treated|0
5483992|NCT01803282|18960773|P11|Overall Study|Enrolled but Never Treated|0
5483993|NCT01803282|18960774|P10|Overall Study|Enrolled but Never Treated|1
5483994|NCT01803282|18960775|P9|Overall Study|Enrolled but Never Treated|0
5483995|NCT01803282|18960776|P8|Overall Study|Enrolled but Never Treated|1
5483996|NCT01803282|18960777|P7|Overall Study|Enrolled but Never Treated|1
5483997|NCT01803282|18960778|P6|Overall Study|Enrolled but Never Treated|0
5483998|NCT01803282|18960779|P5|Overall Study|Enrolled but Never Treated|1
5483999|NCT01803282|18960780|P4|Overall Study|Enrolled but Never Treated|0
5484000|NCT01803282|18960781|P3|Overall Study|Enrolled but Never Treated|0
5484001|NCT01803282|18960782|P2|Overall Study|Enrolled but Never Treated|0
5484002|NCT01803282|18960783|P1|Overall Study|Enrolled but Never Treated|0
5484003|NCT01803282|18960772|P12|Overall Study|Specified Criteria for Withdrawal|0
5484004|NCT01803282|18960773|P11|Overall Study|Specified Criteria for Withdrawal|1
5484005|NCT01803282|18960774|P10|Overall Study|Specified Criteria for Withdrawal|1
5484006|NCT01803282|18960775|P9|Overall Study|Specified Criteria for Withdrawal|0
5484007|NCT01803282|18960776|P8|Overall Study|Specified Criteria for Withdrawal|0
5484008|NCT01803282|18960777|P7|Overall Study|Specified Criteria for Withdrawal|0
5484009|NCT01803282|18960778|P6|Overall Study|Specified Criteria for Withdrawal|0
5484010|NCT01803282|18960779|P5|Overall Study|Specified Criteria for Withdrawal|0
5484011|NCT01803282|18960780|P4|Overall Study|Specified Criteria for Withdrawal|0
5484012|NCT01803282|18960781|P3|Overall Study|Specified Criteria for Withdrawal|0
5484013|NCT01803282|18960782|P2|Overall Study|Specified Criteria for Withdrawal|0
5484014|NCT01803282|18960783|P1|Overall Study|Specified Criteria for Withdrawal|0
5484015|NCT01803282|18960772|P12|Overall Study|Unknown Reason|0
5484016|NCT01803282|18960773|P11|Overall Study|Unknown Reason|0
5484017|NCT01803282|18960774|P10|Overall Study|Unknown Reason|0
5484018|NCT01803282|18960775|P9|Overall Study|Unknown Reason|0
5484019|NCT01803282|18960776|P8|Overall Study|Unknown Reason|1
5484020|NCT01803282|18960777|P7|Overall Study|Unknown Reason|0
5484021|NCT01803282|18960778|P6|Overall Study|Unknown Reason|0
5484022|NCT01803282|18960779|P5|Overall Study|Unknown Reason|0
5484023|NCT01803282|18960780|P4|Overall Study|Unknown Reason|0
5484024|NCT01803282|18960781|P3|Overall Study|Unknown Reason|0
5484025|NCT01803282|18960782|P2|Overall Study|Unknown Reason|0
5484026|NCT01803282|18960783|P1|Overall Study|Unknown Reason|0
5484027|NCT01803282|18960772|P12|Overall Study|Non-Compliance with Study Drug|0
5484028|NCT01803282|18960773|P11|Overall Study|Non-Compliance with Study Drug|0
5484029|NCT01803282|18960774|P10|Overall Study|Non-Compliance with Study Drug|0
5484030|NCT01803282|18960775|P9|Overall Study|Non-Compliance with Study Drug|0
5484031|NCT01803282|18960776|P8|Overall Study|Non-Compliance with Study Drug|0
5484032|NCT01803282|18960777|P7|Overall Study|Non-Compliance with Study Drug|0
5484033|NCT01803282|18960778|P6|Overall Study|Non-Compliance with Study Drug|0
5484034|NCT01803282|18960779|P5|Overall Study|Non-Compliance with Study Drug|0
5484035|NCT01803282|18960780|P4|Overall Study|Non-Compliance with Study Drug|1
5484036|NCT01803282|18960781|P3|Overall Study|Non-Compliance with Study Drug|0
5484037|NCT01803282|18960782|P2|Overall Study|Non-Compliance with Study Drug|0
5484038|NCT01803282|18960783|P1|Overall Study|Non-Compliance with Study Drug|0
5484039|NCT01803282|18960772|P12|Overall Study|Adverse Event|3
5484040|NCT01803282|18960773|P11|Overall Study|Adverse Event|0
5484041|NCT01803282|18960774|P10|Overall Study|Adverse Event|1
5484042|NCT01803282|18960775|P9|Overall Study|Adverse Event|0
5484043|NCT01803282|18960776|P8|Overall Study|Adverse Event|2
5484044|NCT01803282|18960777|P7|Overall Study|Adverse Event|1
5484045|NCT01803282|18960778|P6|Overall Study|Adverse Event|0
5484046|NCT01803282|18960779|P5|Overall Study|Adverse Event|0
5484047|NCT01803282|18960780|P4|Overall Study|Adverse Event|0
5484048|NCT01803282|18960781|P3|Overall Study|Adverse Event|0
5484049|NCT01803282|18960782|P2|Overall Study|Adverse Event|0
5484050|NCT01803282|18960783|P1|Overall Study|Adverse Event|0
5484051|NCT01803282|18960772|P12|Overall Study|Investigator's Discretion|0
5484052|NCT01803282|18960773|P11|Overall Study|Investigator's Discretion|1
5484053|NCT01803282|18960774|P10|Overall Study|Investigator's Discretion|7
5484054|NCT01803282|18960775|P9|Overall Study|Investigator's Discretion|6
5484055|NCT01803282|18960776|P8|Overall Study|Investigator's Discretion|10
5484056|NCT01803282|18960777|P7|Overall Study|Investigator's Discretion|7
5484057|NCT01803282|18960778|P6|Overall Study|Investigator's Discretion|1
5484058|NCT01803282|18960779|P5|Overall Study|Investigator's Discretion|2
5484059|NCT01803282|18960780|P4|Overall Study|Investigator's Discretion|7
5484060|NCT01803282|18960781|P3|Overall Study|Investigator's Discretion|0
5484061|NCT01803282|18960782|P2|Overall Study|Investigator's Discretion|0
5484062|NCT01803282|18960783|P1|Overall Study|Investigator's Discretion|0
5484063|NCT01803282|18960772|P12|Overall Study|Withdrew Consent|1
5484064|NCT01803282|18960773|P11|Overall Study|Withdrew Consent|0
5484065|NCT01803282|18960774|P10|Overall Study|Withdrew Consent|5
5484066|NCT01803282|18960775|P9|Overall Study|Withdrew Consent|1
5484067|NCT01803282|18960776|P8|Overall Study|Withdrew Consent|3
5484068|NCT01803282|18960777|P7|Overall Study|Withdrew Consent|8
5484069|NCT01803282|18960778|P6|Overall Study|Withdrew Consent|0
5484070|NCT01803282|18960779|P5|Overall Study|Withdrew Consent|1
5484071|NCT01803282|18960780|P4|Overall Study|Withdrew Consent|6
5484072|NCT01803282|18960781|P3|Overall Study|Withdrew Consent|0
5484073|NCT01803282|18960782|P2|Overall Study|Withdrew Consent|0
5484074|NCT01803282|18960783|P1|Overall Study|Withdrew Consent|0
5484075|NCT01803282|18960772|P12|Overall Study|Death|0
5484076|NCT01803282|18960773|P11|Overall Study|Death|0
5484077|NCT01803282|18960774|P10|Overall Study|Death|1
5484078|NCT01803282|18960775|P9|Overall Study|Death|1
5484079|NCT01803282|18960776|P8|Overall Study|Death|5
5484080|NCT01803282|18960777|P7|Overall Study|Death|1
5484081|NCT01803282|18960778|P6|Overall Study|Death|1
5484082|NCT01803282|18960779|P5|Overall Study|Death|2
5484083|NCT01803282|18960780|P4|Overall Study|Death|0
5484084|NCT01803282|18960781|P3|Overall Study|Death|0
5484085|NCT01803282|18960782|P2|Overall Study|Death|0
5484086|NCT01803282|18960783|P1|Overall Study|Death|0
5484087|NCT01803282|18960772|P12|Overall Study|Progressive Disease|11
5484088|NCT01803282|18960773|P11|Overall Study|Progressive Disease|6
5484089|NCT01803282|18960774|P10|Overall Study|Progressive Disease|29
5484090|NCT01803282|18960775|P9|Overall Study|Progressive Disease|3
5484091|NCT01803282|18960776|P8|Overall Study|Progressive Disease|24
5484092|NCT01803282|18960777|P7|Overall Study|Progressive Disease|23
5484093|NCT01803282|18960778|P6|Overall Study|Progressive Disease|8
5484094|NCT01803282|18960779|P5|Overall Study|Progressive Disease|5
5484095|NCT01803282|18960780|P4|Overall Study|Progressive Disease|22
5484096|NCT01803282|18960781|P3|Overall Study|Progressive Disease|6
5484097|NCT01803282|18960782|P2|Overall Study|Progressive Disease|3
5484098|NCT01803282|18960783|P1|Overall Study|Progressive Disease|4
5484099|NCT01803269|18960824|P3|Overall Study|Withdrawal by Subject|0
5484100|NCT01803269|18960825|P2|Overall Study|Withdrawal by Subject|0
5484101|NCT01803269|18960826|P1|Overall Study|Withdrawal by Subject|3
5484102|NCT01802879|18961140|P1|Overall Study|Disease progression|6
5484103|NCT01802879|18961140|P1|Overall Study|Administrative problems|2
5484104|NCT01802775|18961147|P2|Overall Study|Lost to Follow-up|2
5484105|NCT01802775|18961148|P1|Overall Study|Lost to Follow-up|1
5484106|NCT01802775|18961147|P2|Overall Study|Withdrawal by Subject|5
5484107|NCT01802775|18961148|P1|Overall Study|Withdrawal by Subject|3
5484108|NCT01802775|18961147|P2|Overall Study|Adverse Event|1
5484109|NCT01802775|18961148|P1|Overall Study|Adverse Event|1
5484110|NCT01802775|18961147|P2|Overall Study|Physician Decision|0
5484111|NCT01802775|18961148|P1|Overall Study|Physician Decision|1
5484112|NCT01802775|18961147|P2|Overall Study|Reason not provided|1
5484113|NCT01802775|18961148|P1|Overall Study|Reason not provided|0
5484114|NCT01802775|18961147|P2|Overall Study|Death|3
5484115|NCT01802775|18961148|P1|Overall Study|Death|0
5484116|NCT01802632|18961183|P6|Overall Study|Other (not specified)|1
5484117|NCT01802632|18961184|P5|Overall Study|Other (not specified)|0
5484118|NCT01802632|18961185|P4|Overall Study|Other (not specified)|1
5484119|NCT01802632|18961186|P3|Overall Study|Other (not specified)|7
5484120|NCT01802632|18961187|P2|Overall Study|Other (not specified)|0
5484121|NCT01802632|18961188|P1|Overall Study|Other (not specified)|0
5484122|NCT01802632|18961183|P6|Overall Study|Ongoing Study at Data Cut-off|22
5484123|NCT01802632|18961184|P5|Overall Study|Ongoing Study at Data Cut-off|6
5484124|NCT01802632|18961185|P4|Overall Study|Ongoing Study at Data Cut-off|50
5484125|NCT01802632|18961186|P3|Overall Study|Ongoing Study at Data Cut-off|115
5484126|NCT01802632|18961187|P2|Overall Study|Ongoing Study at Data Cut-off|16
5484127|NCT01802632|18961188|P1|Overall Study|Ongoing Study at Data Cut-off|168
5484128|NCT01802632|18961183|P6|Overall Study|Objective Disease Progression|4
5484129|NCT01802632|18961184|P5|Overall Study|Objective Disease Progression|4
5484130|NCT01802632|18961185|P4|Overall Study|Objective Disease Progression|6
5484131|NCT01802632|18961186|P3|Overall Study|Objective Disease Progression|104
5484132|NCT01802632|18961187|P2|Overall Study|Objective Disease Progression|12
5484133|NCT01802632|18961188|P1|Overall Study|Objective Disease Progression|1
5484134|NCT01802632|18961183|P6|Overall Study|Withdrawal by Subject|1
5484135|NCT01802632|18961184|P5|Overall Study|Withdrawal by Subject|0
5484136|NCT01802632|18961185|P4|Overall Study|Withdrawal by Subject|3
5484137|NCT01802632|18961186|P3|Overall Study|Withdrawal by Subject|7
5484138|NCT01802632|18961187|P2|Overall Study|Withdrawal by Subject|2
5484139|NCT01802632|18961188|P1|Overall Study|Withdrawal by Subject|4
5484140|NCT01802632|18961183|P6|Overall Study|Death|0
5484141|NCT01802632|18961184|P5|Overall Study|Death|2
5484142|NCT01802632|18961185|P4|Overall Study|Death|0
5484143|NCT01802632|18961186|P3|Overall Study|Death|38
5484144|NCT01802632|18961187|P2|Overall Study|Death|1
5484145|NCT01802632|18961188|P1|Overall Study|Death|28
5484146|NCT01802580|18961204|P2|Overall Study|Lack of Efficacy|2
5484147|NCT01802580|18961205|P1|Overall Study|Lack of Efficacy|0
5484148|NCT01802580|18961204|P2|Overall Study|Other|3
5484149|NCT01802580|18961205|P1|Overall Study|Other|1
5484150|NCT01802580|18961204|P2|Overall Study|Withdrawal by Subject|6
5484151|NCT01802580|18961205|P1|Overall Study|Withdrawal by Subject|5
5484152|NCT01802580|18961204|P2|Overall Study|Protocol Violation|0
5484153|NCT01802580|18961205|P1|Overall Study|Protocol Violation|2
5484154|NCT01802580|18961204|P2|Overall Study|Physician Decision|0
5484155|NCT01802580|18961205|P1|Overall Study|Physician Decision|1
5484156|NCT01802515|18961236|P3|Overall Study|Withdrawal by Subject|0
5484157|NCT01802515|18961237|P2|Overall Study|Withdrawal by Subject|0
5484158|NCT01802515|18961238|P1|Overall Study|Withdrawal by Subject|3
5484159|NCT01802437|18961251|P2|Overall Study|Withdrawal by Subject|4
5484160|NCT01802437|18961252|P1|Overall Study|Withdrawal by Subject|3
5484161|NCT01802437|18961251|P2|Overall Study|Lost to Follow-up|0
5484162|NCT01802437|18961252|P1|Overall Study|Lost to Follow-up|1
5484163|NCT01802411|18961264|P2|Overall Study|Proc changed to video-asst thorascopic|1
5484164|NCT01802411|18961265|P1|Overall Study|Proc changed to video-asst thorascopic|0
5484165|NCT01802411|18961264|P2|Overall Study|Surgery aborted after bronchoscopy|0
5484166|NCT01802411|18961265|P1|Overall Study|Surgery aborted after bronchoscopy|1
5484167|NCT01802411|18961264|P2|Overall Study|Planned pleurodesis as part of the proc|0
5484168|NCT01802411|18961265|P1|Overall Study|Planned pleurodesis as part of the proc|1
5484169|NCT01802411|18961264|P2|Overall Study|Withdrawal by Subject|2
5484170|NCT01802411|18961265|P1|Overall Study|Withdrawal by Subject|0
5484171|NCT01802411|18961264|P2|Overall Study|Lack of Efficacy|10
5484172|NCT01802411|18961265|P1|Overall Study|Lack of Efficacy|8
5484173|NCT01802411|18961264|P2|Overall Study|Adverse Event|7
5484174|NCT01802411|18961265|P1|Overall Study|Adverse Event|2
5484175|NCT01802411|18961264|P2|Overall Study|Death|1
5484176|NCT01802411|18961265|P1|Overall Study|Death|2
5484177|NCT01802385|18961277|P2|Overall Study|Death|120
5484178|NCT01802385|18961278|P1|Overall Study|Death|106
5484179|NCT01802333|18961301|P3|Overall Study|Did not start treatment|5
5484180|NCT01802333|18961302|P2|Overall Study|Did not start treatment|2
5484181|NCT01802333|18961303|P1|Overall Study|Did not start treatment|0
5484182|NCT01802333|18961301|P3|Overall Study|Other - not protocol specified|24
5484183|NCT01802333|18961302|P2|Overall Study|Other - not protocol specified|22
5484184|NCT01802333|18961303|P1|Overall Study|Other - not protocol specified|32
5484185|NCT01802333|18961301|P3|Overall Study|Death|13
5484186|NCT01802333|18961302|P2|Overall Study|Death|14
5484187|NCT01802333|18961303|P1|Overall Study|Death|7
5484188|NCT01802333|18961301|P3|Overall Study|Progression/relapse|0
5484189|NCT01802333|18961302|P2|Overall Study|Progression/relapse|3
5484190|NCT01802333|18961303|P1|Overall Study|Progression/relapse|1
5484191|NCT01802333|18961301|P3|Overall Study|Withdrawal by Subject|5
5484192|NCT01802333|18961302|P2|Overall Study|Withdrawal by Subject|6
5484193|NCT01802333|18961303|P1|Overall Study|Withdrawal by Subject|6
5484194|NCT01802333|18961301|P3|Overall Study|Adverse Event|8
5484195|NCT01802333|18961302|P2|Overall Study|Adverse Event|8
5484196|NCT01802333|18961303|P1|Overall Study|Adverse Event|1
5484197|NCT01802333|18961301|P3|Overall Study|Ineligible|8
5484198|NCT01802333|18961302|P2|Overall Study|Ineligible|6
5484199|NCT01802333|18961303|P1|Overall Study|Ineligible|2
5484200|NCT01802320|18961330|P1|Overall Study|Withdrawal by Subject|1
5484201|NCT01802320|18961330|P1|Overall Study|Death|1
5484202|NCT01802216|18961340|P2|12 Month Visit|Participant did not show to visit|4
5484203|NCT01802216|18961341|P1|12 Month Visit|Participant did not show to visit|3
5484204|NCT01802216|18961340|P2|8 Month Visit|Participant did not show to visit|5
5484205|NCT01802216|18961341|P1|8 Month Visit|Participant did not show to visit|3
5484206|NCT01802216|18961340|P2|4 Month Visit|Participant did not show to visit|4
5484207|NCT01802216|18961341|P1|4 Month Visit|Participant did not show to visit|3
5484208|NCT01802073|18961420|P2|Overall Study|Physician Decision|7
5484209|NCT01802073|18961421|P1|Overall Study|Physician Decision|0
5484210|NCT01802073|18961420|P2|Overall Study|Withdrawal by Subject|1
5484211|NCT01802073|18961421|P1|Overall Study|Withdrawal by Subject|1
5484212|NCT01802073|18961420|P2|Overall Study|Non-compliant|2
5484213|NCT01802073|18961421|P1|Overall Study|Non-compliant|4
5484214|NCT01802073|18961420|P2|Overall Study|Lost to Follow-up|1
5484215|NCT01802073|18961421|P1|Overall Study|Lost to Follow-up|0
5484216|NCT01801982|18961437|P1|Overall Study|Lost to Follow-up|1
5484217|NCT01801917|18961451|P4|Period 1 - Randomized|Adverse Event|0
5484218|NCT01801917|18961452|P3|Period 1 - Randomized|Adverse Event|1
5484219|NCT01801917|18961453|P2|Period 1 - Randomized|Adverse Event|0
5484220|NCT01801917|18961454|P1|Period 1 - Randomized|Adverse Event|1
5484221|NCT01801865|18961474|P1|Overall Study|Physician Decision|7
5484222|NCT01801865|18961474|P1|Overall Study|Patients scanned on another MRI scanner|35
5484223|NCT01801735|18961479|P1|Overall Study|Other, including site closure|19
5484224|NCT01801735|18961479|P1|Overall Study|Death|1
5484225|NCT01801735|18961479|P1|Overall Study|Physician Decision|3
5484226|NCT01801735|18961479|P1|Overall Study|Non-compliance with Trial Drug|13
5484227|NCT01801735|18961479|P1|Overall Study|Lost to Follow-up|15
5484228|NCT01801735|18961479|P1|Overall Study|Protocol Violation|25
5484229|NCT01801735|18961479|P1|Overall Study|Withdrawal by Subject|27
5484230|NCT01801735|18961479|P1|Overall Study|Lack of Efficacy|28
5484231|NCT01801735|18961479|P1|Overall Study|Adverse Event|79
5484232|NCT01801475|18961486|P5|Overall Study|Withdrawal by Subject|1
5484233|NCT01801475|18961487|P4|Overall Study|Withdrawal by Subject|0
5484234|NCT01801475|18961488|P3|Overall Study|Withdrawal by Subject|0
5484235|NCT01801475|18961489|P2|Overall Study|Withdrawal by Subject|0
5484236|NCT01801475|18961490|P1|Overall Study|Withdrawal by Subject|0
5484237|NCT01801436|18961515|P1|Overall Study|Progressive disease|4
5484238|NCT01801436|18961515|P1|Overall Study|Adverse Event|2
5484239|NCT01801436|18961515|P1|Overall Study|Withdrawal by Subject|3
5484240|NCT01801358|18961553|P6|Overall Study|Withdrawal by Subject|2
5484241|NCT01801358|18961554|P5|Overall Study|Withdrawal by Subject|0
5484242|NCT01801358|18961555|P4|Overall Study|Withdrawal by Subject|1
5484243|NCT01801358|18961556|P3|Overall Study|Withdrawal by Subject|0
5484244|NCT01801358|18961557|P2|Overall Study|Withdrawal by Subject|0
5484245|NCT01801358|18961558|P1|Overall Study|Withdrawal by Subject|0
5484246|NCT01801358|18961553|P6|Overall Study|Progressive Disease|5
5484247|NCT01801358|18961554|P5|Overall Study|Progressive Disease|6
5484248|NCT01801358|18961555|P4|Overall Study|Progressive Disease|5
5484249|NCT01801358|18961556|P3|Overall Study|Progressive Disease|4
5484250|NCT01801358|18961557|P2|Overall Study|Progressive Disease|4
5484251|NCT01801358|18961558|P1|Overall Study|Progressive Disease|6
5484252|NCT01801358|18961553|P6|Overall Study|Physician Decision|0
5484253|NCT01801358|18961554|P5|Overall Study|Physician Decision|0
5484254|NCT01801358|18961555|P4|Overall Study|Physician Decision|0
5484255|NCT01801358|18961556|P3|Overall Study|Physician Decision|1
5484256|NCT01801358|18961557|P2|Overall Study|Physician Decision|0
5484257|NCT01801358|18961558|P1|Overall Study|Physician Decision|0
5484258|NCT01801358|18961553|P6|Overall Study|Adverse Event|1
5484259|NCT01801358|18961554|P5|Overall Study|Adverse Event|0
5484260|NCT01801358|18961555|P4|Overall Study|Adverse Event|0
5484261|NCT01801358|18961556|P3|Overall Study|Adverse Event|1
5484262|NCT01801358|18961557|P2|Overall Study|Adverse Event|2
5484263|NCT01801358|18961558|P1|Overall Study|Adverse Event|0
5484264|NCT01801280|18961680|P4|Period 4|Protocol Violation|0
5484265|NCT01801280|18961681|P3|Period 4|Protocol Violation|1
5484266|NCT01801280|18961682|P2|Period 4|Protocol Violation|0
5484267|NCT01801280|18961683|P1|Period 4|Protocol Violation|0
5484268|NCT01801280|18961680|P4|Period 2|Withdrawal by Subject|0
5484269|NCT01801280|18961681|P3|Period 2|Withdrawal by Subject|0
5484270|NCT01801280|18961682|P2|Period 2|Withdrawal by Subject|0
5484271|NCT01801280|18961683|P1|Period 2|Withdrawal by Subject|1
5484272|NCT01801280|18961680|P4|Period 1|Withdrawal by Subject|0
5484273|NCT01801280|18961681|P3|Period 1|Withdrawal by Subject|0
5484274|NCT01801280|18961682|P2|Period 1|Withdrawal by Subject|1
5484275|NCT01801280|18961683|P1|Period 1|Withdrawal by Subject|0
5484276|NCT01801111|18961698|P1|Overall Study|Progressive Disease|81
5484277|NCT01801111|18961698|P1|Overall Study|Study Terminated by Sponsor|27
5484278|NCT01801111|18961698|P1|Overall Study|Withdrawal by Subject|4
5484279|NCT01801111|18961698|P1|Overall Study|Other|1
5484280|NCT01801111|18961698|P1|Overall Study|Physician Decision|5
5484281|NCT01801111|18961698|P1|Overall Study|Death|8
5484282|NCT01801111|18961698|P1|Overall Study|Adverse Event|12
5484283|NCT01801007|18961737|P1|Overall Study|Withdrawal by Subject|5
5484284|NCT01801007|18961737|P1|Overall Study|Lost to Follow-up|4
5484285|NCT01801007|18961737|P1|Overall Study|Adverse Event|2
5484286|NCT01800968|18961750|P2|Overall Study|Physician Decision|0
5484287|NCT01800968|18961751|P1|Overall Study|Physician Decision|1
5484288|NCT01800968|18961750|P2|Overall Study|Withdrawal by Subject|9
5484289|NCT01800968|18961751|P1|Overall Study|Withdrawal by Subject|7
5484290|NCT01800968|18961750|P2|Overall Study|Lost to Follow-up|7
5484291|NCT01800968|18961751|P1|Overall Study|Lost to Follow-up|5
5484292|NCT01800968|18961750|P2|Overall Study|Death|16
5484293|NCT01800968|18961751|P1|Overall Study|Death|23
5484294|NCT01800916|18961793|P9|Test Period 1 (1 Week)|Adverse Event|0
5484295|NCT01800916|18961794|P8|Test Period 1 (1 Week)|Adverse Event|0
5484296|NCT01800916|18961795|P7|Test Period 1 (1 Week)|Adverse Event|0
5484297|NCT01800916|18961796|P6|Test Period 1 (1 Week)|Adverse Event|0
5484298|NCT01800916|18961797|P5|Test Period 1 (1 Week)|Adverse Event|1
5484299|NCT01800916|18961798|P4|Test Period 1 (1 Week)|Adverse Event|0
5484300|NCT01800916|18961799|P3|Test Period 1 (1 Week)|Adverse Event|0
5484301|NCT01800916|18961800|P2|Test Period 1 (1 Week)|Adverse Event|0
5484302|NCT01800916|18961801|P1|Test Period 1 (1 Week)|Adverse Event|0
5484303|NCT01800916|18961793|P9|Test Period 1 (1 Week)|Convex product user|0
5484304|NCT01800916|18961794|P8|Test Period 1 (1 Week)|Convex product user|0
5484305|NCT01800916|18961795|P7|Test Period 1 (1 Week)|Convex product user|0
5484306|NCT01800916|18961796|P6|Test Period 1 (1 Week)|Convex product user|0
5484307|NCT01800916|18961797|P5|Test Period 1 (1 Week)|Convex product user|0
5484308|NCT01800916|18961798|P4|Test Period 1 (1 Week)|Convex product user|1
5484309|NCT01800916|18961799|P3|Test Period 1 (1 Week)|Convex product user|0
5484310|NCT01800916|18961800|P2|Test Period 1 (1 Week)|Convex product user|0
5484311|NCT01800916|18961801|P1|Test Period 1 (1 Week)|Convex product user|0
5484312|NCT01800903|18961811|P6|Second Test Period|unable to catheterise|0
5484313|NCT01800903|18961812|P5|Second Test Period|unable to catheterise|0
5484314|NCT01800903|18961813|P4|Second Test Period|unable to catheterise|0
5484315|NCT01800903|18961814|P3|Second Test Period|unable to catheterise|0
5484316|NCT01800903|18961815|P2|Second Test Period|unable to catheterise|0
5484317|NCT01800903|18961816|P1|Second Test Period|unable to catheterise|1
5484318|NCT01800201|18961905|P2|Overall Study|PI withdrawal, cognitive concerns|1
5484319|NCT01800201|18961906|P1|Overall Study|PI withdrawal, cognitive concerns|0
5484320|NCT01800201|18961905|P2|Overall Study|did not want to use device|1
5484321|NCT01800201|18961906|P1|Overall Study|did not want to use device|0
5484322|NCT01800201|18961905|P2|Overall Study|patient privacy concerns|1
5484323|NCT01800201|18961906|P1|Overall Study|patient privacy concerns|1
5484324|NCT01800201|18961905|P2|Overall Study|Withdrawal by Subject|0
5484325|NCT01800201|18961906|P1|Overall Study|Withdrawal by Subject|2
5484326|NCT01800058|18961947|P1|Overall Study|Lost to Follow-up|1
5484327|NCT01799993|18961960|P2|Overall Study|Subject didn't return for follow-up|1
5484328|NCT01799993|18961961|P1|Overall Study|Subject didn't return for follow-up|0
5484329|NCT01799993|18961960|P2|Overall Study|Other|0
5484330|NCT01799993|18961961|P1|Overall Study|Other|1
5484331|NCT01799993|18961960|P2|Overall Study|Withdrawal by parent/guardian|1
5484332|NCT01799993|18961961|P1|Overall Study|Withdrawal by parent/guardian|0
5484333|NCT01799993|18961960|P2|Overall Study|Non-compliance with medical device|0
5484334|NCT01799993|18961961|P1|Overall Study|Non-compliance with medical device|1
5484335|NCT01799993|18961960|P2|Overall Study|Protocol deviation|0
5484336|NCT01799993|18961961|P1|Overall Study|Protocol deviation|1
5484337|NCT01799993|18961960|P2|Overall Study|Logistical difficulties|0
5484338|NCT01799993|18961961|P1|Overall Study|Logistical difficulties|1
5484339|NCT01799993|18961960|P2|Overall Study|Recovery|1
5484340|NCT01799993|18961961|P1|Overall Study|Recovery|0
5484341|NCT01799993|18961960|P2|Overall Study|Lack of Efficacy|0
5484342|NCT01799993|18961961|P1|Overall Study|Lack of Efficacy|1
5484343|NCT01799993|18961960|P2|Overall Study|Adverse Event|0
5484344|NCT01799993|18961961|P1|Overall Study|Adverse Event|1
5484345|NCT01799993|18961960|P2|Overall Study|Screen failure|1
5484346|NCT01799993|18961961|P1|Overall Study|Screen failure|0
5484347|NCT01799993|18961960|P2|Overall Study|Deterioration of general conditions|0
5484348|NCT01799993|18961961|P1|Overall Study|Deterioration of general conditions|2
5484349|NCT01799993|18961960|P2|Overall Study|Protocol Violation|1
5484350|NCT01799993|18961961|P1|Overall Study|Protocol Violation|1
5484351|NCT01799993|18961960|P2|Overall Study|Protocol driven decision point|3
5484352|NCT01799993|18961961|P1|Overall Study|Protocol driven decision point|0
5484353|NCT01799993|18961960|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
5484354|NCT01799993|18961961|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
5484355|NCT01799993|18961960|P2|Overall Study|Lost to Follow-up|8
5484356|NCT01799993|18961961|P1|Overall Study|Lost to Follow-up|5
5484357|NCT01799993|18961960|P2|Overall Study|Withdrawal by Subject|24
5484358|NCT01799993|18961961|P1|Overall Study|Withdrawal by Subject|23
5484359|NCT01799993|18961960|P2|Overall Study|Death|45
5484360|NCT01799993|18961961|P1|Overall Study|Death|61
5484361|NCT01799993|18961960|P2|Overall Study|"Didn't complete CRF page End of FU"|40
5484362|NCT01799993|18961961|P1|Overall Study|"Didn't complete CRF page End of FU"|30
5484363|NCT01799941|18961993|P1|Overall Study|Other|15
5484364|NCT01799941|18961993|P1|Overall Study|Lost to Follow-up|17
5484365|NCT01799941|18961993|P1|Overall Study|Lack of Efficacy|3
5484366|NCT01799941|18961993|P1|Overall Study|Investigator Decision|4
5484367|NCT01799941|18961993|P1|Overall Study|Death|2
5484368|NCT01799941|18961993|P1|Overall Study|Withdrawal by Subject|21
5484369|NCT01799941|18961993|P1|Overall Study|Adverse Event|34
5484370|NCT01799889|18962059|P12|Overall Study|Non-Compliance With Study Drug|0
5484371|NCT01799889|18962060|P11|Overall Study|Non-Compliance With Study Drug|0
5484372|NCT01799889|18962061|P10|Overall Study|Non-Compliance With Study Drug|0
5484373|NCT01799889|18962062|P9|Overall Study|Non-Compliance With Study Drug|0
5484374|NCT01799889|18962063|P8|Overall Study|Non-Compliance With Study Drug|0
5484375|NCT01799889|18962064|P7|Overall Study|Non-Compliance With Study Drug|0
5484376|NCT01799889|18962065|P6|Overall Study|Non-Compliance With Study Drug|1
5484377|NCT01799889|18962066|P5|Overall Study|Non-Compliance With Study Drug|0
5484378|NCT01799889|18962067|P4|Overall Study|Non-Compliance With Study Drug|0
5484379|NCT01799889|18962068|P3|Overall Study|Non-Compliance With Study Drug|0
5484380|NCT01799889|18962069|P2|Overall Study|Non-Compliance With Study Drug|0
5484381|NCT01799889|18962070|P1|Overall Study|Non-Compliance With Study Drug|0
5484382|NCT01799889|18962059|P12|Overall Study|Withdrawal by Subject|1
5484383|NCT01799889|18962060|P11|Overall Study|Withdrawal by Subject|1
5484384|NCT01799889|18962061|P10|Overall Study|Withdrawal by Subject|1
5484385|NCT01799889|18962062|P9|Overall Study|Withdrawal by Subject|2
5484386|NCT01799889|18962063|P8|Overall Study|Withdrawal by Subject|1
5484387|NCT01799889|18962064|P7|Overall Study|Withdrawal by Subject|3
5484388|NCT01799889|18962065|P6|Overall Study|Withdrawal by Subject|1
5484389|NCT01799889|18962066|P5|Overall Study|Withdrawal by Subject|5
5484390|NCT01799889|18962067|P4|Overall Study|Withdrawal by Subject|0
5484391|NCT01799889|18962068|P3|Overall Study|Withdrawal by Subject|4
5484392|NCT01799889|18962069|P2|Overall Study|Withdrawal by Subject|6
5484393|NCT01799889|18962070|P1|Overall Study|Withdrawal by Subject|1
5484394|NCT01799889|18962059|P12|Overall Study|Study Terminated By Sponsor|0
5484395|NCT01799889|18962060|P11|Overall Study|Study Terminated By Sponsor|0
5484396|NCT01799889|18962061|P10|Overall Study|Study Terminated By Sponsor|1
5484397|NCT01799889|18962062|P9|Overall Study|Study Terminated By Sponsor|1
5484398|NCT01799889|18962063|P8|Overall Study|Study Terminated By Sponsor|2
5484399|NCT01799889|18962064|P7|Overall Study|Study Terminated By Sponsor|0
5484400|NCT01799889|18962065|P6|Overall Study|Study Terminated By Sponsor|1
5484401|NCT01799889|18962066|P5|Overall Study|Study Terminated By Sponsor|2
5484402|NCT01799889|18962067|P4|Overall Study|Study Terminated By Sponsor|0
5484403|NCT01799889|18962068|P3|Overall Study|Study Terminated By Sponsor|0
5484404|NCT01799889|18962069|P2|Overall Study|Study Terminated By Sponsor|0
5484405|NCT01799889|18962070|P1|Overall Study|Study Terminated By Sponsor|1
5484406|NCT01799889|18962059|P12|Overall Study|Specified Criteria for Withdrawal|0
5484407|NCT01799889|18962060|P11|Overall Study|Specified Criteria for Withdrawal|0
5484408|NCT01799889|18962061|P10|Overall Study|Specified Criteria for Withdrawal|0
5484409|NCT01799889|18962062|P9|Overall Study|Specified Criteria for Withdrawal|0
5484410|NCT01799889|18962063|P8|Overall Study|Specified Criteria for Withdrawal|0
5484411|NCT01799889|18962064|P7|Overall Study|Specified Criteria for Withdrawal|0
5484412|NCT01799889|18962065|P6|Overall Study|Specified Criteria for Withdrawal|0
5484413|NCT01799889|18962066|P5|Overall Study|Specified Criteria for Withdrawal|0
5484414|NCT01799889|18962067|P4|Overall Study|Specified Criteria for Withdrawal|0
5484415|NCT01799889|18962068|P3|Overall Study|Specified Criteria for Withdrawal|1
5484416|NCT01799889|18962069|P2|Overall Study|Specified Criteria for Withdrawal|1
5484417|NCT01799889|18962070|P1|Overall Study|Specified Criteria for Withdrawal|0
5484418|NCT01799889|18962059|P12|Overall Study|Progressive Disease|1
5484419|NCT01799889|18962060|P11|Overall Study|Progressive Disease|3
5484420|NCT01799889|18962061|P10|Overall Study|Progressive Disease|5
5484421|NCT01799889|18962062|P9|Overall Study|Progressive Disease|18
5484422|NCT01799889|18962063|P8|Overall Study|Progressive Disease|13
5484423|NCT01799889|18962064|P7|Overall Study|Progressive Disease|8
5484424|NCT01799889|18962065|P6|Overall Study|Progressive Disease|9
5484425|NCT01799889|18962066|P5|Overall Study|Progressive Disease|23
5484426|NCT01799889|18962067|P4|Overall Study|Progressive Disease|30
5484427|NCT01799889|18962068|P3|Overall Study|Progressive Disease|25
5484428|NCT01799889|18962069|P2|Overall Study|Progressive Disease|26
5484429|NCT01799889|18962070|P1|Overall Study|Progressive Disease|30
5484430|NCT01799889|18962059|P12|Overall Study|Physician Decision|1
5484431|NCT01799889|18962060|P11|Overall Study|Physician Decision|0
5484432|NCT01799889|18962061|P10|Overall Study|Physician Decision|0
5484433|NCT01799889|18962062|P9|Overall Study|Physician Decision|6
5484434|NCT01799889|18962063|P8|Overall Study|Physician Decision|2
5484435|NCT01799889|18962064|P7|Overall Study|Physician Decision|5
5484436|NCT01799889|18962065|P6|Overall Study|Physician Decision|5
5484437|NCT01799889|18962066|P5|Overall Study|Physician Decision|5
5484438|NCT01799889|18962067|P4|Overall Study|Physician Decision|4
5484439|NCT01799889|18962068|P3|Overall Study|Physician Decision|4
5484440|NCT01799889|18962069|P2|Overall Study|Physician Decision|2
5484441|NCT01799889|18962070|P1|Overall Study|Physician Decision|3
5484442|NCT01799889|18962059|P12|Overall Study|Lost to Follow-up|0
5484443|NCT01799889|18962060|P11|Overall Study|Lost to Follow-up|0
5484444|NCT01799889|18962061|P10|Overall Study|Lost to Follow-up|0
5484445|NCT01799889|18962062|P9|Overall Study|Lost to Follow-up|0
5484446|NCT01799889|18962063|P8|Overall Study|Lost to Follow-up|0
5484447|NCT01799889|18962064|P7|Overall Study|Lost to Follow-up|0
5484448|NCT01799889|18962065|P6|Overall Study|Lost to Follow-up|0
5484449|NCT01799889|18962066|P5|Overall Study|Lost to Follow-up|0
5484450|NCT01799889|18962067|P4|Overall Study|Lost to Follow-up|0
5484451|NCT01799889|18962068|P3|Overall Study|Lost to Follow-up|0
5484452|NCT01799889|18962069|P2|Overall Study|Lost to Follow-up|1
5484453|NCT01799889|18962070|P1|Overall Study|Lost to Follow-up|0
5484454|NCT01799889|18962059|P12|Overall Study|Lack of Efficacy|0
5484455|NCT01799889|18962060|P11|Overall Study|Lack of Efficacy|1
5484456|NCT01799889|18962061|P10|Overall Study|Lack of Efficacy|0
5484457|NCT01799889|18962062|P9|Overall Study|Lack of Efficacy|2
5484458|NCT01799889|18962063|P8|Overall Study|Lack of Efficacy|0
5484459|NCT01799889|18962064|P7|Overall Study|Lack of Efficacy|0
5484460|NCT01799889|18962065|P6|Overall Study|Lack of Efficacy|2
5484461|NCT01799889|18962066|P5|Overall Study|Lack of Efficacy|2
5484462|NCT01799889|18962067|P4|Overall Study|Lack of Efficacy|1
5484463|NCT01799889|18962068|P3|Overall Study|Lack of Efficacy|0
5484464|NCT01799889|18962069|P2|Overall Study|Lack of Efficacy|1
5484465|NCT01799889|18962070|P1|Overall Study|Lack of Efficacy|1
5484466|NCT01799889|18962059|P12|Overall Study|Death|0
5484467|NCT01799889|18962060|P11|Overall Study|Death|1
5484468|NCT01799889|18962061|P10|Overall Study|Death|0
5484469|NCT01799889|18962062|P9|Overall Study|Death|1
5484470|NCT01799889|18962063|P8|Overall Study|Death|0
5484471|NCT01799889|18962064|P7|Overall Study|Death|0
5484472|NCT01799889|18962065|P6|Overall Study|Death|0
5484473|NCT01799889|18962066|P5|Overall Study|Death|1
5484474|NCT01799889|18962067|P4|Overall Study|Death|3
5484475|NCT01799889|18962068|P3|Overall Study|Death|5
5484476|NCT01799889|18962069|P2|Overall Study|Death|0
5484477|NCT01799889|18962070|P1|Overall Study|Death|1
5484478|NCT01799889|18962059|P12|Overall Study|Adverse Event|0
5484479|NCT01799889|18962060|P11|Overall Study|Adverse Event|1
5484480|NCT01799889|18962061|P10|Overall Study|Adverse Event|1
5484481|NCT01799889|18962062|P9|Overall Study|Adverse Event|3
5484482|NCT01799889|18962063|P8|Overall Study|Adverse Event|2
5484483|NCT01799889|18962064|P7|Overall Study|Adverse Event|5
5484484|NCT01799889|18962065|P6|Overall Study|Adverse Event|1
5484485|NCT01799889|18962066|P5|Overall Study|Adverse Event|11
5484486|NCT01799889|18962067|P4|Overall Study|Adverse Event|1
5484487|NCT01799889|18962068|P3|Overall Study|Adverse Event|5
5484488|NCT01799889|18962069|P2|Overall Study|Adverse Event|4
5484489|NCT01799889|18962070|P1|Overall Study|Adverse Event|4
5484490|NCT01799720|18962171|P3|Overall Study|Pregnancy|1
5484491|NCT01799720|18962172|P2|Overall Study|Pregnancy|0
5484492|NCT01799720|18962173|P1|Overall Study|Pregnancy|0
5484493|NCT01799720|18962171|P3|Overall Study|Protocol Violation|0
5484494|NCT01799720|18962172|P2|Overall Study|Protocol Violation|1
5484495|NCT01799720|18962173|P1|Overall Study|Protocol Violation|0
5484496|NCT01799720|18962171|P3|Overall Study|Withdrawal by Subject|0
5484497|NCT01799720|18962172|P2|Overall Study|Withdrawal by Subject|0
5484498|NCT01799720|18962173|P1|Overall Study|Withdrawal by Subject|3
5484499|NCT01799590|18962211|P3|Overall Study|Other|1
5484500|NCT01799590|18962212|P2|Overall Study|Other|0
5484501|NCT01799590|18962213|P1|Overall Study|Other|3
5484502|NCT01799590|18962211|P3|Overall Study|Use of prohibited concomitant drugs|0
5484503|NCT01799590|18962212|P2|Overall Study|Use of prohibited concomitant drugs|0
5484504|NCT01799590|18962213|P1|Overall Study|Use of prohibited concomitant drugs|1
5484505|NCT01799590|18962211|P3|Overall Study|Using drugs with restricted days of use|2
5484506|NCT01799590|18962212|P2|Overall Study|Using drugs with restricted days of use|3
5484507|NCT01799590|18962213|P1|Overall Study|Using drugs with restricted days of use|0
5484508|NCT01799590|18962211|P3|Overall Study|Aggravation of complications|1
5484509|NCT01799590|18962212|P2|Overall Study|Aggravation of complications|1
5484510|NCT01799590|18962213|P1|Overall Study|Aggravation of complications|0
5484511|NCT01799590|18962211|P3|Overall Study|Participants convenience|2
5484512|NCT01799590|18962212|P2|Overall Study|Participants convenience|4
5484513|NCT01799590|18962213|P1|Overall Study|Participants convenience|4
5484514|NCT01799590|18962211|P3|Overall Study|Lack of Efficacy|3
5484515|NCT01799590|18962212|P2|Overall Study|Lack of Efficacy|1
5484516|NCT01799590|18962213|P1|Overall Study|Lack of Efficacy|3
5484517|NCT01799590|18962211|P3|Overall Study|Pregnancy|0
5484518|NCT01799590|18962212|P2|Overall Study|Pregnancy|0
5484519|NCT01799590|18962213|P1|Overall Study|Pregnancy|2
5484520|NCT01799590|18962211|P3|Overall Study|Adverse Event|5
5484521|NCT01799590|18962212|P2|Overall Study|Adverse Event|7
5484522|NCT01799590|18962213|P1|Overall Study|Adverse Event|13
5484523|NCT01799239|18962256|P2|Period 2 (7 Days)|Protocol Violation|0
5484524|NCT01799239|18962257|P1|Period 2 (7 Days)|Protocol Violation|1
5484525|NCT01799239|18962256|P2|Period 2 (7 Days)|Withdrawal by Subject|1
5484526|NCT01799239|18962257|P1|Period 2 (7 Days)|Withdrawal by Subject|1
5484527|NCT01799239|18962256|P2|Period 1 (7 Days)|Protocol Violation|1
5484528|NCT01799239|18962257|P1|Period 1 (7 Days)|Protocol Violation|0
5484529|NCT01799239|18962256|P2|Period 1 (7 Days)|Withdrawal by Subject|0
5484530|NCT01799239|18962257|P1|Period 1 (7 Days)|Withdrawal by Subject|2
5484531|NCT01799239|18962256|P2|Period 1 (7 Days)|Lack of Efficacy|0
5484532|NCT01799239|18962257|P1|Period 1 (7 Days)|Lack of Efficacy|1
5484533|NCT01799226|18962265|P2|Overall Study|Disqualified at Day 14|0
5484534|NCT01799226|18962266|P1|Overall Study|Disqualified at Day 14|1
5484535|NCT01799226|18962265|P2|Overall Study|Withdrawal by Subject|0
5484536|NCT01799226|18962266|P1|Overall Study|Withdrawal by Subject|1
5484537|NCT01798992|18962297|P4|Overall Study|Insufficient biopsy tissue|0
5484538|NCT01798992|18962298|P3|Overall Study|Insufficient biopsy tissue|1
5484539|NCT01798992|18962299|P2|Overall Study|Insufficient biopsy tissue|0
5484540|NCT01798992|18962300|P1|Overall Study|Insufficient biopsy tissue|0
5484541|NCT01798992|18962297|P4|Overall Study|Lost to Follow-up|0
5484542|NCT01798992|18962298|P3|Overall Study|Lost to Follow-up|1
5484543|NCT01798992|18962299|P2|Overall Study|Lost to Follow-up|1
5484544|NCT01798992|18962300|P1|Overall Study|Lost to Follow-up|0
5484545|NCT01798992|18962297|P4|Overall Study|Administrative withdrawal|1
5484546|NCT01798992|18962298|P3|Overall Study|Administrative withdrawal|0
5484547|NCT01798992|18962299|P2|Overall Study|Administrative withdrawal|1
5484548|NCT01798992|18962300|P1|Overall Study|Administrative withdrawal|0
5484549|NCT01798927|18962320|P1|Overall Study|Withdrawal by Subject|1
5484550|NCT01798849|18962329|P3|Overall Study|Physician Decision|1
5484551|NCT01798849|18962330|P2|Overall Study|Physician Decision|0
5484552|NCT01798849|18962331|P1|Overall Study|Physician Decision|0
5484553|NCT01798706|18962521|P2|Overall Study|Other than specified above|9
5484554|NCT01798706|18962522|P1|Overall Study|Other than specified above|5
5484555|NCT01798706|18962521|P2|Overall Study|Poor compliance to protocol|0
5484556|NCT01798706|18962522|P1|Overall Study|Poor compliance to protocol|1
5484557|NCT01798706|18962521|P2|Overall Study|Lack of Efficacy|2
5484558|NCT01798706|18962522|P1|Overall Study|Lack of Efficacy|0
5484559|NCT01798706|18962521|P2|Overall Study|Adverse Event|10
5484560|NCT01798706|18962522|P1|Overall Study|Adverse Event|15
5484561|NCT01798485|18962593|P2|Overall Study|Clinical Progression|24
5484562|NCT01798485|18962594|P1|Overall Study|Clinical Progression|35
5484563|NCT01798485|18962593|P2|Overall Study|Sponsor Decision|54
5484564|NCT01798485|18962594|P1|Overall Study|Sponsor Decision|61
5484565|NCT01798485|18962593|P2|Overall Study|Death|22
5484566|NCT01798485|18962594|P1|Overall Study|Death|25
5484567|NCT01798485|18962593|P2|Overall Study|Objective Disease Progression|106
5484568|NCT01798485|18962594|P1|Overall Study|Objective Disease Progression|152
5484569|NCT01798485|18962593|P2|Overall Study|Physician Decision|10
5484570|NCT01798485|18962594|P1|Overall Study|Physician Decision|14
5484571|NCT01798485|18962593|P2|Overall Study|Lost to Follow-up|3
5484572|NCT01798485|18962594|P1|Overall Study|Lost to Follow-up|0
5484573|NCT01798485|18962593|P2|Overall Study|Withdrawal by Subject|31
5484574|NCT01798485|18962594|P1|Overall Study|Withdrawal by Subject|27
5484575|NCT01798485|18962593|P2|Overall Study|Adverse Event|40
5484576|NCT01798485|18962594|P1|Overall Study|Adverse Event|32
5484577|NCT01798134|18962731|P1|Overall Study|Liver transplant/surgery|4
5484578|NCT01798134|18962731|P1|Overall Study|Physician Decision|3
5484579|NCT01798134|18962731|P1|Overall Study|Adverse Event|3
5484580|NCT01798134|18962731|P1|Overall Study|Death|2
5484581|NCT01798134|18962731|P1|Overall Study|Withdrawal by Subject|3
5484582|NCT01798134|18962731|P1|Overall Study|Lost to Follow-up|1
5484583|NCT01798056|18962740|P2|Overall Study|Other|2
5484584|NCT01798056|18962741|P1|Overall Study|Other|0
5484585|NCT01798056|18962740|P2|Overall Study|Lost to Follow-up|1
5484586|NCT01798056|18962741|P1|Overall Study|Lost to Follow-up|1
5484587|NCT01798056|18962740|P2|Overall Study|Migrated/moved from study area|1
5484588|NCT01798056|18962741|P1|Overall Study|Migrated/moved from study area|1
5484589|NCT01798056|18962740|P2|Overall Study|Withdrawal by Subject|9
5484590|NCT01798056|18962741|P1|Overall Study|Withdrawal by Subject|12
5484591|NCT01798056|18962740|P2|Overall Study|Serious Adverse Event|12
5484592|NCT01798056|18962741|P1|Overall Study|Serious Adverse Event|13
5484593|NCT01798004|18962775|P1|Overall Study|Enrollment another COG therapeutic trial|32
5484594|NCT01798004|18962775|P1|Overall Study|Initiation of other non-protocol therapy|5
5484595|NCT01798004|18962775|P1|Overall Study|Patient/parent refusal|7
5484596|NCT01798004|18962775|P1|Overall Study|Ineligible|4
5484597|NCT01798004|18962775|P1|Overall Study|Withdrawal by Subject|4
5484598|NCT01798004|18962775|P1|Overall Study|Physician Decision|25
5484599|NCT01798004|18962775|P1|Overall Study|Lack of Efficacy|8
5484600|NCT01798004|18962775|P1|Overall Study|Death|2
5484601|NCT01797965|18962783|P4|Overall Study|Reason Not Specified|15
5484602|NCT01797965|18962784|P3|Overall Study|Reason Not Specified|0
5484603|NCT01797965|18962785|P2|Overall Study|Reason Not Specified|295
5484604|NCT01797965|18962786|P1|Overall Study|Reason Not Specified|280
5484605|NCT01797965|18962783|P4|Overall Study|Disease progression, defined by protocol|0
5484606|NCT01797965|18962784|P3|Overall Study|Disease progression, defined by protocol|0
5484607|NCT01797965|18962785|P2|Overall Study|Disease progression, defined by protocol|1
5484608|NCT01797965|18962786|P1|Overall Study|Disease progression, defined by protocol|3
5484609|NCT01797965|18962783|P4|Overall Study|Death|0
5484610|NCT01797965|18962784|P3|Overall Study|Death|0
5484611|NCT01797965|18962785|P2|Overall Study|Death|4
5484612|NCT01797965|18962786|P1|Overall Study|Death|2
5484613|NCT01797965|18962783|P4|Overall Study|Investigator decision|0
5484614|NCT01797965|18962784|P3|Overall Study|Investigator decision|0
5484615|NCT01797965|18962785|P2|Overall Study|Investigator decision|15
5484616|NCT01797965|18962786|P1|Overall Study|Investigator decision|21
5484617|NCT01797965|18962783|P4|Overall Study|Consent withdrawn|35
5484618|NCT01797965|18962784|P3|Overall Study|Consent withdrawn|3
5484619|NCT01797965|18962785|P2|Overall Study|Consent withdrawn|117
5484620|NCT01797965|18962786|P1|Overall Study|Consent withdrawn|130
5484621|NCT01797965|18962783|P4|Overall Study|Lost to Follow-up|2
5484622|NCT01797965|18962784|P3|Overall Study|Lost to Follow-up|1
5484623|NCT01797965|18962785|P2|Overall Study|Lost to Follow-up|8
5484624|NCT01797965|18962786|P1|Overall Study|Lost to Follow-up|9
5484625|NCT01797965|18962783|P4|Overall Study|Adverse Event|21
5484626|NCT01797965|18962784|P3|Overall Study|Adverse Event|4
5484627|NCT01797965|18962785|P2|Overall Study|Adverse Event|129
5484628|NCT01797965|18962786|P1|Overall Study|Adverse Event|104
5484629|NCT01797835|18962920|P2|Overall Study|Lost to Follow-up|27
5484630|NCT01797835|18962921|P1|Overall Study|Lost to Follow-up|31
5484631|NCT01797783|18962937|P2|Overall Study|Withdrawal by Subject|0
5484632|NCT01797783|18962938|P1|Overall Study|Withdrawal by Subject|1
5484633|NCT01797783|18962937|P2|Overall Study|Adverse Event|1
5484634|NCT01797783|18962938|P1|Overall Study|Adverse Event|1
5484635|NCT01797731|18962962|P2|Overall Study|Didn't have proper radiographs required|3
5484636|NCT01797731|18962963|P1|Overall Study|Didn't have proper radiographs required|3
5484637|NCT01797705|18962971|P1|Overall Study|Withdrawal by Subject|1
5484638|NCT01797705|18962971|P1|Overall Study|Equipment anomalies during sleep studies|4
5484639|NCT01797562|18963032|P1|Overall Study|Protocol Violation|5
5484640|NCT01797536|18963041|P4|Overall Study|Adverse Event|0
5484641|NCT01797536|18963042|P3|Overall Study|Adverse Event|0
5484642|NCT01797536|18963043|P2|Overall Study|Adverse Event|1
5484643|NCT01797536|18963044|P1|Overall Study|Adverse Event|0
5484644|NCT01797445|18963116|P2|Open-Label Extension Phase|Investigator's Discretion|0
5484645|NCT01797445|18963117|P1|Open-Label Extension Phase|Investigator's Discretion|1
5484646|NCT01797445|18963116|P2|Double-Blind Phase|Lost to Follow-up|26
5484647|NCT01797445|18963117|P1|Double-Blind Phase|Lost to Follow-up|34
5484648|NCT01797445|18963116|P2|Double-Blind Phase|Withdrew Consent|35
5484649|NCT01797445|18963117|P1|Double-Blind Phase|Withdrew Consent|20
5484650|NCT01797445|18963116|P2|Double-Blind Phase|Protocol Violation|1
5484651|NCT01797445|18963117|P1|Double-Blind Phase|Protocol Violation|0
5484652|NCT01797445|18963116|P2|Double-Blind Phase|Noncompliance with Study Drug|1
5484653|NCT01797445|18963117|P1|Double-Blind Phase|Noncompliance with Study Drug|5
5484654|NCT01797445|18963116|P2|Double-Blind Phase|Investigator's Discretion|17
5484655|NCT01797445|18963117|P1|Double-Blind Phase|Investigator's Discretion|15
5484656|NCT01797445|18963116|P2|Double-Blind Phase|Lack of Efficacy|2
5484657|NCT01797445|18963117|P1|Double-Blind Phase|Lack of Efficacy|1
5484658|NCT01797445|18963116|P2|Double-Blind Phase|Pregnancy|1
5484659|NCT01797445|18963117|P1|Double-Blind Phase|Pregnancy|0
5484660|NCT01797445|18963116|P2|Double-Blind Phase|Death|4
5484661|NCT01797445|18963117|P1|Double-Blind Phase|Death|5
5484662|NCT01797445|18963116|P2|Double-Blind Phase|Adverse Event|0
5484663|NCT01797445|18963117|P1|Double-Blind Phase|Adverse Event|3
5484664|NCT01797445|18963116|P2|Double-Blind Phase|Randomized but Not Treated|2
5484665|NCT01797445|18963117|P1|Double-Blind Phase|Randomized but Not Treated|4
5484666|NCT01797302|18963178|P3|Overall Study|Withdrawal by Subject|4
5484667|NCT01797302|18963179|P2|Overall Study|Withdrawal by Subject|3
5484668|NCT01797302|18963180|P1|Overall Study|Withdrawal by Subject|1
5484669|NCT01797302|18963178|P3|Overall Study|Lost to Follow-up|22
5484670|NCT01797302|18963179|P2|Overall Study|Lost to Follow-up|23
5484671|NCT01797302|18963180|P1|Overall Study|Lost to Follow-up|16
5484672|NCT01797263|18963217|P2|Overall Study|Lost to Follow-up|15
5484673|NCT01797263|18963218|P1|Overall Study|Lost to Follow-up|15
5484674|NCT01797263|18963217|P2|Overall Study|Death|0
5484675|NCT01797263|18963218|P1|Overall Study|Death|1
5484676|NCT01797263|18963217|P2|Overall Study|Withdrawal by Subject|25
5484677|NCT01797263|18963218|P1|Overall Study|Withdrawal by Subject|21
5484678|NCT01797185|18963253|P3|Overall Study|Protocol Violation|0
5484679|NCT01797185|18963254|P2|Overall Study|Protocol Violation|1
5484680|NCT01797185|18963255|P1|Overall Study|Protocol Violation|1
5484681|NCT01797185|18963253|P3|Overall Study|Physician Decision|0
5484682|NCT01797185|18963254|P2|Overall Study|Physician Decision|3
5484683|NCT01797185|18963255|P1|Overall Study|Physician Decision|1
5484684|NCT01797185|18963253|P3|Overall Study|Withdrawn per sponsor|0
5484685|NCT01797185|18963254|P2|Overall Study|Withdrawn per sponsor|0
5484686|NCT01797185|18963255|P1|Overall Study|Withdrawn per sponsor|5
5484687|NCT01797185|18963253|P3|Overall Study|Lost to Follow-up|1
5484688|NCT01797185|18963254|P2|Overall Study|Lost to Follow-up|6
5484689|NCT01797185|18963255|P1|Overall Study|Lost to Follow-up|2
5484690|NCT01797185|18963253|P3|Overall Study|Site terminated|0
5484691|NCT01797185|18963254|P2|Overall Study|Site terminated|4
5484692|NCT01797185|18963255|P1|Overall Study|Site terminated|8
5484693|NCT01797185|18963253|P3|Overall Study|Withdrawal by Subject|5
5484694|NCT01797185|18963254|P2|Overall Study|Withdrawal by Subject|9
5484695|NCT01797185|18963255|P1|Overall Study|Withdrawal by Subject|6
5484696|NCT01797185|18963253|P3|Overall Study|Adverse Event|6
5484697|NCT01797185|18963254|P2|Overall Study|Adverse Event|15
5484698|NCT01797185|18963255|P1|Overall Study|Adverse Event|5
5484699|NCT01797120|18963279|P2|Overall Study|never start protocol therapy|0
5484700|NCT01797120|18963280|P1|Overall Study|never start protocol therapy|2
5484701|NCT01797120|18963279|P2|Overall Study|still on treatment|4
5484702|NCT01797120|18963280|P1|Overall Study|still on treatment|2
5484703|NCT01797120|18963279|P2|Overall Study|Physician Decision|0
5484704|NCT01797120|18963280|P1|Overall Study|Physician Decision|3
5484705|NCT01797120|18963279|P2|Overall Study|Non-compliance|0
5484706|NCT01797120|18963280|P1|Overall Study|Non-compliance|1
5484707|NCT01797120|18963279|P2|Overall Study|Symptomatic progression|1
5484708|NCT01797120|18963280|P1|Overall Study|Symptomatic progression|2
5484709|NCT01797120|18963279|P2|Overall Study|Withdrawal by Subject|6
5484710|NCT01797120|18963280|P1|Overall Study|Withdrawal by Subject|6
5484711|NCT01797120|18963279|P2|Overall Study|Adverse Event|5
5484712|NCT01797120|18963280|P1|Overall Study|Adverse Event|13
5484713|NCT01797120|18963279|P2|Overall Study|Disesae progression|49
5484714|NCT01797120|18963280|P1|Overall Study|Disesae progression|37
5484715|NCT01797094|18963294|P2|Overall Study|Other Miscellaneous Reasons|0
5484716|NCT01797094|18963295|P1|Overall Study|Other Miscellaneous Reasons|1
5484717|NCT01797094|18963294|P2|Overall Study|Protocol Violation|1
5484718|NCT01797094|18963295|P1|Overall Study|Protocol Violation|0
5484719|NCT01797094|18963294|P2|Overall Study|Personal Reasons|0
5484720|NCT01797094|18963295|P1|Overall Study|Personal Reasons|4
5484721|NCT01797094|18963294|P2|Overall Study|Adverse Event|1
5484722|NCT01797094|18963295|P1|Overall Study|Adverse Event|1
5484723|NCT01797081|18963317|P4|Overall Study|Protocol Violation|1
5484724|NCT01797081|18963318|P3|Overall Study|Protocol Violation|0
5484725|NCT01797081|18963319|P2|Overall Study|Protocol Violation|0
5484726|NCT01797081|18963320|P1|Overall Study|Protocol Violation|0
5484727|NCT01797081|18963317|P4|Overall Study|Personal Reasons|8
5484728|NCT01797081|18963318|P3|Overall Study|Personal Reasons|4
5484729|NCT01797081|18963319|P2|Overall Study|Personal Reasons|4
5484730|NCT01797081|18963320|P1|Overall Study|Personal Reasons|12
5484731|NCT01797081|18963317|P4|Overall Study|Pregnancy|0
5484732|NCT01797081|18963318|P3|Overall Study|Pregnancy|0
5484733|NCT01797081|18963319|P2|Overall Study|Pregnancy|0
5484734|NCT01797081|18963320|P1|Overall Study|Pregnancy|1
5484735|NCT01797081|18963317|P4|Overall Study|Adverse Event|0
5484736|NCT01797081|18963318|P3|Overall Study|Adverse Event|1
5484737|NCT01797081|18963319|P2|Overall Study|Adverse Event|0
5484738|NCT01797081|18963320|P1|Overall Study|Adverse Event|1
5484739|NCT01796964|18963361|P2|Overall Study|Withdrawal by Subject|1
5484740|NCT01796964|18963362|P1|Overall Study|Withdrawal by Subject|1
5484741|NCT01796964|18963361|P2|Overall Study|Protocol Violation|1
5484742|NCT01796964|18963362|P1|Overall Study|Protocol Violation|0
5484743|NCT01796964|18963361|P2|Overall Study|Death|0
5484744|NCT01796964|18963362|P1|Overall Study|Death|1
5484745|NCT01796964|18963361|P2|Overall Study|Adverse Event|1
5484746|NCT01796964|18963362|P1|Overall Study|Adverse Event|1
5484747|NCT01796860|18963403|P1|Overall Study|Withdrawal by Subject|3
5484748|NCT01796548|18963409|P1|Overall Study|Other|2
5484749|NCT01796548|18963409|P1|Overall Study|Lost to Follow-up|1
5484750|NCT01796470|18963426|P5|Overall Study|Withdrawal by Subject|1
5484751|NCT01796470|18963427|P4|Overall Study|Withdrawal by Subject|0
5484752|NCT01796470|18963428|P3|Overall Study|Withdrawal by Subject|0
5484753|NCT01796470|18963429|P2|Overall Study|Withdrawal by Subject|0
5484754|NCT01796470|18963430|P1|Overall Study|Withdrawal by Subject|7
5484755|NCT01796470|18963426|P5|Overall Study|Protocol Criteria for Withdrawal|0
5484756|NCT01796470|18963427|P4|Overall Study|Protocol Criteria for Withdrawal|0
5484757|NCT01796470|18963428|P3|Overall Study|Protocol Criteria for Withdrawal|0
5484758|NCT01796470|18963429|P2|Overall Study|Protocol Criteria for Withdrawal|0
5484759|NCT01796470|18963430|P1|Overall Study|Protocol Criteria for Withdrawal|1
5484760|NCT01796470|18963426|P5|Overall Study|Progressive Disease|0
5484761|NCT01796470|18963427|P4|Overall Study|Progressive Disease|2
5484762|NCT01796470|18963428|P3|Overall Study|Progressive Disease|3
5484763|NCT01796470|18963429|P2|Overall Study|Progressive Disease|7
5484764|NCT01796470|18963430|P1|Overall Study|Progressive Disease|7
5484765|NCT01796470|18963426|P5|Overall Study|Physician Decision|1
5484766|NCT01796470|18963427|P4|Overall Study|Physician Decision|0
5484767|NCT01796470|18963428|P3|Overall Study|Physician Decision|1
5484768|NCT01796470|18963429|P2|Overall Study|Physician Decision|4
5484769|NCT01796470|18963430|P1|Overall Study|Physician Decision|5
5484770|NCT01796470|18963426|P5|Overall Study|Lost to Follow-up|0
5484771|NCT01796470|18963427|P4|Overall Study|Lost to Follow-up|0
5484772|NCT01796470|18963428|P3|Overall Study|Lost to Follow-up|0
5484773|NCT01796470|18963429|P2|Overall Study|Lost to Follow-up|1
5484774|NCT01796470|18963430|P1|Overall Study|Lost to Follow-up|0
5484775|NCT01796470|18963426|P5|Overall Study|Initiated New Therapy|2
5484776|NCT01796470|18963427|P4|Overall Study|Initiated New Therapy|0
5484777|NCT01796470|18963428|P3|Overall Study|Initiated New Therapy|0
5484778|NCT01796470|18963429|P2|Overall Study|Initiated New Therapy|0
5484779|NCT01796470|18963430|P1|Overall Study|Initiated New Therapy|9
5484780|NCT01796470|18963426|P5|Overall Study|Death|1
5484781|NCT01796470|18963427|P4|Overall Study|Death|0
5484782|NCT01796470|18963428|P3|Overall Study|Death|0
5484783|NCT01796470|18963429|P2|Overall Study|Death|0
5484784|NCT01796470|18963430|P1|Overall Study|Death|2
5484785|NCT01796470|18963426|P5|Overall Study|Adverse Event|3
5484786|NCT01796470|18963427|P4|Overall Study|Adverse Event|1
5484787|NCT01796470|18963428|P3|Overall Study|Adverse Event|2
5484788|NCT01796470|18963429|P2|Overall Study|Adverse Event|2
5484789|NCT01796470|18963430|P1|Overall Study|Adverse Event|4
5484790|NCT01796392|18963474|P2|Overall Study|Lost to Follow-up|0
5484791|NCT01796392|18963475|P1|Overall Study|Lost to Follow-up|1
5484792|NCT01796392|18963474|P2|Overall Study|Excluded for medical reasons|2
5484793|NCT01796392|18963475|P1|Overall Study|Excluded for medical reasons|1
5484794|NCT01796392|18963474|P2|Overall Study|Death|1
5484795|NCT01796392|18963475|P1|Overall Study|Death|5
5484796|NCT01796392|18963474|P2|Overall Study|Withdrawal by Subject|0
5484797|NCT01796392|18963475|P1|Overall Study|Withdrawal by Subject|2
5484798|NCT01796301|18963489|P2|Overall Study|Decision by Sponsor|1
5484799|NCT01796301|18963490|P1|Overall Study|Decision by Sponsor|0
5484800|NCT01796301|18963489|P2|Overall Study|Death|1
5484801|NCT01796301|18963490|P1|Overall Study|Death|0
5484802|NCT01796301|18963489|P2|Overall Study|Lost to Follow-up|3
5484803|NCT01796301|18963490|P1|Overall Study|Lost to Follow-up|3
5484804|NCT01796301|18963489|P2|Overall Study|Withdrawal by Subject|15
5484805|NCT01796301|18963490|P1|Overall Study|Withdrawal by Subject|15
5484806|NCT01795937|18963576|P3|Overall Study|Physician Decision|0
5484807|NCT01795937|18963577|P2|Overall Study|Physician Decision|1
5484808|NCT01795937|18963578|P1|Overall Study|Physician Decision|0
5484809|NCT01795937|18963576|P3|Overall Study|Withdrawal by Subject|0
5484810|NCT01795937|18963577|P2|Overall Study|Withdrawal by Subject|0
5484811|NCT01795937|18963578|P1|Overall Study|Withdrawal by Subject|1
5484812|NCT01795898|18963607|P1|Overall Study|Physician Decision|1
5484813|NCT01795898|18963607|P1|Overall Study|Withdrew consent & had adverse events|3
5484814|NCT01795898|18963607|P1|Overall Study|Death|1
5484815|NCT01795898|18963607|P1|Overall Study|No pain|1
5484816|NCT01795898|18963607|P1|Overall Study|Diagnosed with metastasis|1
5484817|NCT01795898|18963607|P1|Overall Study|Withdrawal of consent|6
5484818|NCT01795898|18963607|P1|Overall Study|Lost to Follow-up|20
5484819|NCT01795898|18963607|P1|Overall Study|Adverse Event|27
5484820|NCT01795638|18963666|P2|Overall Study|Withdrawal by Subject|0
5484821|NCT01795638|18963667|P1|Overall Study|Withdrawal by Subject|1
5484822|NCT01795638|18963666|P2|Overall Study|discharged from hospital|5
5484823|NCT01795638|18963667|P1|Overall Study|discharged from hospital|7
5484824|NCT01795638|18963666|P2|Overall Study|Protocol Violation|0
5484825|NCT01795638|18963667|P1|Overall Study|Protocol Violation|3
5484826|NCT01795638|18963666|P2|Overall Study|transferred to quaternary hospital|3
5484827|NCT01795638|18963667|P1|Overall Study|transferred to quaternary hospital|2
5484828|NCT01795638|18963666|P2|Overall Study|Death|3
5484829|NCT01795638|18963667|P1|Overall Study|Death|0
5484830|NCT01795547|18963693|P2|Overall Study|Not stated|1
5484831|NCT01795547|18963694|P1|Overall Study|Not stated|0
5484832|NCT01795547|18963693|P2|Overall Study|Others|1
5484833|NCT01795547|18963694|P1|Overall Study|Others|4
5484834|NCT01795547|18963693|P2|Overall Study|Non-compliance with IMP|1
5484835|NCT01795547|18963694|P1|Overall Study|Non-compliance with IMP|1
5484836|NCT01795547|18963693|P2|Overall Study|Not Treated|10
5484837|NCT01795547|18963694|P1|Overall Study|Not Treated|4
5484838|NCT01795547|18963693|P2|Overall Study|Withdrawal of consent|12
5484839|NCT01795547|18963694|P1|Overall Study|Withdrawal of consent|7
5484840|NCT01795547|18963693|P2|Overall Study|Lost to Follow-up|5
5484841|NCT01795547|18963694|P1|Overall Study|Lost to Follow-up|2
5484842|NCT01795547|18963693|P2|Overall Study|Protocol Violation|4
5484843|NCT01795547|18963694|P1|Overall Study|Protocol Violation|6
5484844|NCT01795547|18963693|P2|Overall Study|Lack of Efficacy|3
5484845|NCT01795547|18963694|P1|Overall Study|Lack of Efficacy|8
5484846|NCT01795547|18963693|P2|Overall Study|Adverse Event|27
5484847|NCT01795547|18963694|P1|Overall Study|Adverse Event|16
5484848|NCT01795495|18963726|P3|Overall Study|Physician Decision|1
5484849|NCT01795495|18963727|P2|Overall Study|Physician Decision|0
5484850|NCT01795495|18963728|P1|Overall Study|Physician Decision|0
5484851|NCT01795495|18963726|P3|Overall Study|Protocol Violation|1
5484852|NCT01795495|18963727|P2|Overall Study|Protocol Violation|0
5484853|NCT01795495|18963728|P1|Overall Study|Protocol Violation|1
5484854|NCT01794949|18963748|P2|Overall Study|Lost to Follow-up|0
5484855|NCT01794949|18963749|P1|Overall Study|Lost to Follow-up|1
5484856|NCT01794845|18963760|P1|Overall Study|Withdrawal by Subject|1
5484857|NCT01794780|18963788|P8|Overall Study|Other|1
5484858|NCT01794780|18963789|P7|Overall Study|Other|4
5484859|NCT01794780|18963790|P6|Overall Study|Other|24
5484860|NCT01794780|18963791|P5|Overall Study|Other|1
5484861|NCT01794780|18963792|P4|Overall Study|Other|20
5484862|NCT01794780|18963793|P3|Overall Study|Other|25
5484863|NCT01794780|18963794|P2|Overall Study|Other|12
5484864|NCT01794780|18963795|P1|Overall Study|Other|0
5484865|NCT01794780|18963788|P8|Overall Study|Withdrew informed consent|3
5484866|NCT01794780|18963789|P7|Overall Study|Withdrew informed consent|4
5484867|NCT01794780|18963790|P6|Overall Study|Withdrew informed consent|48
5484868|NCT01794780|18963791|P5|Overall Study|Withdrew informed consent|0
5484869|NCT01794780|18963792|P4|Overall Study|Withdrew informed consent|9
5484870|NCT01794780|18963793|P3|Overall Study|Withdrew informed consent|36
5484871|NCT01794780|18963794|P2|Overall Study|Withdrew informed consent|17
5484872|NCT01794780|18963795|P1|Overall Study|Withdrew informed consent|7
5484873|NCT01794780|18963788|P8|Overall Study|Lost to Follow-up|5
5484874|NCT01794780|18963789|P7|Overall Study|Lost to Follow-up|30
5484875|NCT01794780|18963790|P6|Overall Study|Lost to Follow-up|99
5484876|NCT01794780|18963791|P5|Overall Study|Lost to Follow-up|2
5484877|NCT01794780|18963792|P4|Overall Study|Lost to Follow-up|53
5484878|NCT01794780|18963793|P3|Overall Study|Lost to Follow-up|165
5484879|NCT01794780|18963794|P2|Overall Study|Lost to Follow-up|64
5484880|NCT01794780|18963795|P1|Overall Study|Lost to Follow-up|10
5484881|NCT01794780|18963788|P8|Overall Study|Death|0
5484882|NCT01794780|18963789|P7|Overall Study|Death|4
5484883|NCT01794780|18963790|P6|Overall Study|Death|9
5484884|NCT01794780|18963791|P5|Overall Study|Death|0
5484885|NCT01794780|18963792|P4|Overall Study|Death|1
5484886|NCT01794780|18963793|P3|Overall Study|Death|14
5484887|NCT01794780|18963794|P2|Overall Study|Death|2
5484888|NCT01794780|18963795|P1|Overall Study|Death|0
5484889|NCT01794780|18963788|P8|Overall Study|Adverse Event|0
5484890|NCT01794780|18963789|P7|Overall Study|Adverse Event|0
5484891|NCT01794780|18963790|P6|Overall Study|Adverse Event|0
5484892|NCT01794780|18963791|P5|Overall Study|Adverse Event|0
5484893|NCT01794780|18963792|P4|Overall Study|Adverse Event|0
5484894|NCT01794780|18963793|P3|Overall Study|Adverse Event|2
5484895|NCT01794780|18963794|P2|Overall Study|Adverse Event|1
5484896|NCT01794780|18963795|P1|Overall Study|Adverse Event|0
5484897|NCT01794689|18963871|P4|Intervention 1 (2 Nights)|Adverse Event|0
5484898|NCT01794689|18963872|P3|Intervention 1 (2 Nights)|Adverse Event|0
5484899|NCT01794689|18963873|P2|Intervention 1 (2 Nights)|Adverse Event|1
5484900|NCT01794689|18963874|P1|Intervention 1 (2 Nights)|Adverse Event|0
5484901|NCT01794689|18963871|P4|Intervention 1 (2 Nights)|Physician Decision|0
5484902|NCT01794689|18963872|P3|Intervention 1 (2 Nights)|Physician Decision|0
5484903|NCT01794689|18963873|P2|Intervention 1 (2 Nights)|Physician Decision|1
5484904|NCT01794689|18963874|P1|Intervention 1 (2 Nights)|Physician Decision|1
5484905|NCT01794689|18963871|P4|Intervention 1 (2 Nights)|Protocol Violation|0
5484906|NCT01794689|18963872|P3|Intervention 1 (2 Nights)|Protocol Violation|1
5484907|NCT01794689|18963873|P2|Intervention 1 (2 Nights)|Protocol Violation|0
5484908|NCT01794689|18963874|P1|Intervention 1 (2 Nights)|Protocol Violation|1
5484909|NCT01794689|18963871|P4|Intervention 1 (2 Nights)|Withdrawal by Subject|4
5484910|NCT01794689|18963872|P3|Intervention 1 (2 Nights)|Withdrawal by Subject|2
5484911|NCT01794689|18963873|P2|Intervention 1 (2 Nights)|Withdrawal by Subject|0
5484912|NCT01794689|18963874|P1|Intervention 1 (2 Nights)|Withdrawal by Subject|3
5484913|NCT01794000|18963943|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
5484914|NCT01794000|18963944|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
5484915|NCT01794000|18963943|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
5484916|NCT01794000|18963944|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
5484917|NCT01794000|18963943|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
5484918|NCT01794000|18963944|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
5484919|NCT01794000|18963943|P2|Double-Blind Phase (DBP)|Physician Decision|0
5484920|NCT01794000|18963944|P1|Double-Blind Phase (DBP)|Physician Decision|2
5484921|NCT01794000|18963943|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
5484922|NCT01794000|18963944|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
5484923|NCT01794000|18963943|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
5484924|NCT01794000|18963944|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
5484925|NCT01794000|18963943|P2|Double-Blind Phase (DBP)|Death|2
5484926|NCT01794000|18963944|P1|Double-Blind Phase (DBP)|Death|1
5484927|NCT01794000|18963943|P2|Double-Blind Phase (DBP)|Adverse Event|2
5484928|NCT01794000|18963944|P1|Double-Blind Phase (DBP)|Adverse Event|5
5484929|NCT01793935|18963977|P2|Overall Study|Lost to Follow-up|1
5484930|NCT01793935|18963978|P1|Overall Study|Lost to Follow-up|0
5484931|NCT01793935|18963977|P2|Overall Study|Patient did not take study medication|1
5484932|NCT01793935|18963978|P1|Overall Study|Patient did not take study medication|1
5484933|NCT01793935|18963977|P2|Overall Study|Adverse Event|0
5484934|NCT01793935|18963978|P1|Overall Study|Adverse Event|2
5484935|NCT01793935|18963977|P2|Overall Study|Protocol Violation|1
5484936|NCT01793935|18963978|P1|Overall Study|Protocol Violation|2
5484937|NCT01793935|18963977|P2|Overall Study|Pregnancy|0
5484938|NCT01793935|18963978|P1|Overall Study|Pregnancy|1
5484939|NCT01793883|18964024|P3|Overall Study|Respiratory distress during spirometry|1
5484940|NCT01793883|18964025|P2|Overall Study|Respiratory distress during spirometry|0
5484941|NCT01793883|18964026|P1|Overall Study|Respiratory distress during spirometry|0
5484942|NCT01793883|18964024|P3|Overall Study|Dosing error|0
5484943|NCT01793883|18964025|P2|Overall Study|Dosing error|1
5484944|NCT01793883|18964026|P1|Overall Study|Dosing error|0
5484945|NCT01793883|18964024|P3|Overall Study|Met exclusion criteria|0
5484946|NCT01793883|18964025|P2|Overall Study|Met exclusion criteria|0
5484947|NCT01793883|18964026|P1|Overall Study|Met exclusion criteria|1
5484948|NCT01793883|18964024|P3|Overall Study|Unable to complete measurements|0
5484949|NCT01793883|18964025|P2|Overall Study|Unable to complete measurements|0
5484950|NCT01793883|18964026|P1|Overall Study|Unable to complete measurements|1
5484951|NCT01793883|18964024|P3|Overall Study|Unable to complete spriometry|0
5484952|NCT01793883|18964025|P2|Overall Study|Unable to complete spriometry|0
5484953|NCT01793883|18964026|P1|Overall Study|Unable to complete spriometry|1
5484954|NCT01793883|18964024|P3|Overall Study|Randomized in error|0
5484955|NCT01793883|18964025|P2|Overall Study|Randomized in error|0
5484956|NCT01793883|18964026|P1|Overall Study|Randomized in error|1
5484957|NCT01793883|18964024|P3|Overall Study|Lost to Follow-up|3
5484958|NCT01793883|18964025|P2|Overall Study|Lost to Follow-up|1
5484959|NCT01793883|18964026|P1|Overall Study|Lost to Follow-up|5
5484960|NCT01793883|18964024|P3|Overall Study|Subject noncompliance|1
5484961|NCT01793883|18964025|P2|Overall Study|Subject noncompliance|1
5484962|NCT01793883|18964026|P1|Overall Study|Subject noncompliance|0
5484963|NCT01793883|18964024|P3|Overall Study|Withdrawal by Subject|3
5484964|NCT01793883|18964025|P2|Overall Study|Withdrawal by Subject|7
5484965|NCT01793883|18964026|P1|Overall Study|Withdrawal by Subject|3
5484966|NCT01793792|18964034|P1|Overall Study|Device Not Implanted|1
5484967|NCT01793792|18964034|P1|Overall Study|Withdrawal by Subject|1
5484968|NCT01793792|18964034|P1|Overall Study|Lost to Follow-up|5
5484969|NCT01793792|18964034|P1|Overall Study|Death|5
5484970|NCT01793688|18964039|P1|Overall Study|Protocol Violation|2
5484971|NCT01793610|18964049|P3|Overall Study|Withdrawal by Subject|1
5484972|NCT01793610|18964050|P2|Overall Study|Withdrawal by Subject|0
5484973|NCT01793610|18964051|P1|Overall Study|Withdrawal by Subject|1
5484974|NCT01793142|18964097|P1|Overall Study|Randomized not treated|7
5484975|NCT01792830|18964127|P11|Overall Study|Adverse Event|0
5484976|NCT01792830|18964128|P10|Overall Study|Adverse Event|0
5484977|NCT01792830|18964129|P9|Overall Study|Adverse Event|1
5484978|NCT01792830|18964130|P8|Overall Study|Adverse Event|0
5484979|NCT01792830|18964131|P7|Overall Study|Adverse Event|0
5484980|NCT01792830|18964132|P6|Overall Study|Adverse Event|0
5484981|NCT01792830|18964133|P5|Overall Study|Adverse Event|0
5484982|NCT01792830|18964134|P4|Overall Study|Adverse Event|0
5484983|NCT01792830|18964135|P3|Overall Study|Adverse Event|0
5484984|NCT01792830|18964136|P2|Overall Study|Adverse Event|0
5484985|NCT01792830|18964137|P1|Overall Study|Adverse Event|0
5484986|NCT01792830|18964127|P11|Overall Study|Death|1
5484987|NCT01792830|18964128|P10|Overall Study|Death|0
5484988|NCT01792830|18964129|P9|Overall Study|Death|1
5484989|NCT01792830|18964130|P8|Overall Study|Death|0
5484990|NCT01792830|18964131|P7|Overall Study|Death|1
5484991|NCT01792830|18964132|P6|Overall Study|Death|0
5484992|NCT01792830|18964133|P5|Overall Study|Death|0
5484993|NCT01792830|18964134|P4|Overall Study|Death|1
5484994|NCT01792830|18964135|P3|Overall Study|Death|0
5484995|NCT01792830|18964136|P2|Overall Study|Death|0
5484996|NCT01792830|18964137|P1|Overall Study|Death|3
5484997|NCT01792830|18964127|P11|Overall Study|Withdrawal by Subject|2
5484998|NCT01792830|18964128|P10|Overall Study|Withdrawal by Subject|0
5484999|NCT01792830|18964129|P9|Overall Study|Withdrawal by Subject|7
5485000|NCT01792830|18964130|P8|Overall Study|Withdrawal by Subject|1
5485001|NCT01792830|18964131|P7|Overall Study|Withdrawal by Subject|1
5485002|NCT01792830|18964132|P6|Overall Study|Withdrawal by Subject|1
5485003|NCT01792830|18964133|P5|Overall Study|Withdrawal by Subject|1
5485004|NCT01792830|18964134|P4|Overall Study|Withdrawal by Subject|2
5485005|NCT01792830|18964135|P3|Overall Study|Withdrawal by Subject|0
5485006|NCT01792830|18964136|P2|Overall Study|Withdrawal by Subject|0
5485007|NCT01792830|18964137|P1|Overall Study|Withdrawal by Subject|22
5485008|NCT01792635|18964224|P3|Part B|Study terminated|3
5485009|NCT01792635|18964225|P2|Part B|Study terminated|4
5485010|NCT01792635|18964226|P1|Part B|Study terminated|0
5485011|NCT01792635|18964224|P3|Part B|Adverse Event|1
5485012|NCT01792635|18964225|P2|Part B|Adverse Event|0
5485013|NCT01792635|18964226|P1|Part B|Adverse Event|0
5485014|NCT01792518|18964254|P2|Overall Study|Other Reason|1
5485015|NCT01792518|18964255|P1|Overall Study|Other Reason|0
5485016|NCT01792518|18964254|P2|Overall Study|Withdrawal by Subject|0
5485017|NCT01792518|18964255|P1|Overall Study|Withdrawal by Subject|2
5485018|NCT01792518|18964254|P2|Overall Study|Lost to Follow-up|1
5485019|NCT01792518|18964255|P1|Overall Study|Lost to Follow-up|3
5485020|NCT01792518|18964254|P2|Overall Study|Protocol Violation|1
5485021|NCT01792518|18964255|P1|Overall Study|Protocol Violation|0
5485022|NCT01792518|18964254|P2|Overall Study|Adverse Event|4
5485023|NCT01792518|18964255|P1|Overall Study|Adverse Event|3
5485024|NCT01792284|18964265|P3|Randomization Period 2|Withdrawal by Subject|0
5485025|NCT01792284|18964266|P2|Randomization Period 2|Withdrawal by Subject|2
5485026|NCT01792284|18964267|P1|Randomization Period 2|Withdrawal by Subject|0
5485027|NCT01792284|18964265|P3|Randomization Period 2|Protocol Violation|0
5485028|NCT01792284|18964266|P2|Randomization Period 2|Protocol Violation|1
5485029|NCT01792284|18964267|P1|Randomization Period 2|Protocol Violation|0
5485030|NCT01792284|18964265|P3|Randomization Period 1|Lost to Follow-up|1
5485031|NCT01792284|18964266|P2|Randomization Period 1|Lost to Follow-up|0
5485032|NCT01792284|18964267|P1|Randomization Period 1|Lost to Follow-up|0
5485033|NCT01792284|18964265|P3|Randomization Period 1|Adverse Event|2
5485034|NCT01792284|18964266|P2|Randomization Period 1|Adverse Event|0
5485035|NCT01792284|18964267|P1|Randomization Period 1|Adverse Event|0
5485036|NCT01792284|18964265|P3|Randomization Period 1|Physician Decision|1
5485037|NCT01792284|18964266|P2|Randomization Period 1|Physician Decision|1
5485038|NCT01792284|18964267|P1|Randomization Period 1|Physician Decision|0
5485039|NCT01792284|18964265|P3|Randomization Period 1|Withdrawal by Subject|1
5485040|NCT01792284|18964266|P2|Randomization Period 1|Withdrawal by Subject|1
5485041|NCT01792284|18964267|P1|Randomization Period 1|Withdrawal by Subject|0
5485042|NCT01792284|18964265|P3|Lead-in Period|Protocol Required Discontinuation|0
5485043|NCT01792284|18964266|P2|Lead-in Period|Protocol Required Discontinuation|0
5485044|NCT01792284|18964267|P1|Lead-in Period|Protocol Required Discontinuation|1
5485045|NCT01792284|18964265|P3|Lead-in Period|Physician Decision|0
5485046|NCT01792284|18964266|P2|Lead-in Period|Physician Decision|0
5485047|NCT01792284|18964267|P1|Lead-in Period|Physician Decision|1
5485048|NCT01792284|18964265|P3|Lead-in Period|Withdrawal by Subject|0
5485049|NCT01792284|18964266|P2|Lead-in Period|Withdrawal by Subject|0
5485050|NCT01792284|18964267|P1|Lead-in Period|Withdrawal by Subject|10
5485051|NCT01792284|18964265|P3|Lead-in Period|Protocol Violation|0
5485052|NCT01792284|18964266|P2|Lead-in Period|Protocol Violation|0
5485053|NCT01792284|18964267|P1|Lead-in Period|Protocol Violation|1
5485054|NCT01792284|18964265|P3|Lead-in Period|Lost to Follow-up|0
5485055|NCT01792284|18964266|P2|Lead-in Period|Lost to Follow-up|0
5485056|NCT01792284|18964267|P1|Lead-in Period|Lost to Follow-up|2
5485057|NCT01792284|18964265|P3|Lead-in Period|Adverse Event|0
5485058|NCT01792284|18964266|P2|Lead-in Period|Adverse Event|0
5485059|NCT01792284|18964267|P1|Lead-in Period|Adverse Event|15
5485060|NCT01792115|18964308|P3|Overall Study|Lost to Follow-up|0
5485061|NCT01792115|18964309|P2|Overall Study|Lost to Follow-up|1
5485062|NCT01792115|18964310|P1|Overall Study|Lost to Follow-up|0
5485063|NCT01791894|18964360|P1|Overall Study|Adverse Event|1
5485064|NCT01791803|18964371|P4|Overall Study|Death|2
5485065|NCT01791803|18964372|P3|Overall Study|Death|2
5485066|NCT01791803|18964373|P2|Overall Study|Death|0
5485067|NCT01791803|18964374|P1|Overall Study|Death|0
5485068|NCT01791803|18964371|P4|Overall Study|Physician Decision|1
5485069|NCT01791803|18964372|P3|Overall Study|Physician Decision|0
5485070|NCT01791803|18964373|P2|Overall Study|Physician Decision|2
5485071|NCT01791803|18964374|P1|Overall Study|Physician Decision|0
5485072|NCT01791803|18964371|P4|Overall Study|Withdrawal by Subject|2
5485073|NCT01791803|18964372|P3|Overall Study|Withdrawal by Subject|0
5485074|NCT01791803|18964373|P2|Overall Study|Withdrawal by Subject|0
5485075|NCT01791803|18964374|P1|Overall Study|Withdrawal by Subject|0
5485076|NCT01791725|18964392|P3|Overall Study|Withdrawal by Subject|0
5485077|NCT01791725|18964393|P2|Overall Study|Withdrawal by Subject|1
5485078|NCT01791725|18964394|P1|Overall Study|Withdrawal by Subject|0
5485079|NCT01791517|18964417|P12|Phase II|Pre-Existing Ocular Issue|1
5485080|NCT01791517|18964418|P11|Phase II|Pre-Existing Ocular Issue|0
5485081|NCT01791517|18964419|P10|Phase II|Pre-Existing Ocular Issue|0
5485082|NCT01791517|18964420|P9|Phase II|Pre-Existing Ocular Issue|0
5485083|NCT01791517|18964421|P8|Phase II|Pre-Existing Ocular Issue|0
5485084|NCT01791517|18964422|P7|Phase II|Pre-Existing Ocular Issue|0
5485085|NCT01791517|18964423|P6|Phase II|Pre-Existing Ocular Issue|0
5485086|NCT01791517|18964424|P5|Phase II|Pre-Existing Ocular Issue|0
5485087|NCT01791517|18964425|P4|Phase II|Pre-Existing Ocular Issue|0
5485088|NCT01791517|18964426|P3|Phase II|Pre-Existing Ocular Issue|0
5485089|NCT01791517|18964427|P2|Phase II|Pre-Existing Ocular Issue|0
5485090|NCT01791517|18964428|P1|Phase II|Pre-Existing Ocular Issue|0
5485091|NCT01791517|18964417|P12|Phase II|Unsatisfactory Lens Fitting|0
5485092|NCT01791517|18964418|P11|Phase II|Unsatisfactory Lens Fitting|0
5485093|NCT01791517|18964419|P10|Phase II|Unsatisfactory Lens Fitting|1
5485094|NCT01791517|18964420|P9|Phase II|Unsatisfactory Lens Fitting|0
5485095|NCT01791517|18964421|P8|Phase II|Unsatisfactory Lens Fitting|0
5485096|NCT01791517|18964422|P7|Phase II|Unsatisfactory Lens Fitting|0
5485097|NCT01791517|18964423|P6|Phase II|Unsatisfactory Lens Fitting|0
5485098|NCT01791517|18964424|P5|Phase II|Unsatisfactory Lens Fitting|0
5485099|NCT01791517|18964425|P4|Phase II|Unsatisfactory Lens Fitting|0
5485100|NCT01791517|18964426|P3|Phase II|Unsatisfactory Lens Fitting|0
5485101|NCT01791517|18964427|P2|Phase II|Unsatisfactory Lens Fitting|0
5485102|NCT01791517|18964428|P1|Phase II|Unsatisfactory Lens Fitting|0
5485103|NCT01791517|18964417|P12|Phase II|Lens Handling Difficulties|0
5485104|NCT01791517|18964418|P11|Phase II|Lens Handling Difficulties|0
5485105|NCT01791517|18964419|P10|Phase II|Lens Handling Difficulties|0
5485106|NCT01791517|18964420|P9|Phase II|Lens Handling Difficulties|1
5485107|NCT01791517|18964421|P8|Phase II|Lens Handling Difficulties|0
5485108|NCT01791517|18964422|P7|Phase II|Lens Handling Difficulties|0
5485109|NCT01791517|18964423|P6|Phase II|Lens Handling Difficulties|0
5485110|NCT01791517|18964424|P5|Phase II|Lens Handling Difficulties|0
5485111|NCT01791517|18964425|P4|Phase II|Lens Handling Difficulties|0
5485112|NCT01791517|18964426|P3|Phase II|Lens Handling Difficulties|0
5485113|NCT01791517|18964427|P2|Phase II|Lens Handling Difficulties|0
5485114|NCT01791517|18964428|P1|Phase II|Lens Handling Difficulties|0
5485115|NCT01791517|18964417|P12|Phase II|Adverse Event|0
5485116|NCT01791517|18964418|P11|Phase II|Adverse Event|0
5485117|NCT01791517|18964419|P10|Phase II|Adverse Event|1
5485118|NCT01791517|18964420|P9|Phase II|Adverse Event|0
5485119|NCT01791517|18964421|P8|Phase II|Adverse Event|1
5485120|NCT01791517|18964422|P7|Phase II|Adverse Event|2
5485121|NCT01791517|18964423|P6|Phase II|Adverse Event|0
5485122|NCT01791517|18964424|P5|Phase II|Adverse Event|0
5485123|NCT01791517|18964425|P4|Phase II|Adverse Event|0
5485124|NCT01791517|18964426|P3|Phase II|Adverse Event|0
5485125|NCT01791517|18964427|P2|Phase II|Adverse Event|0
5485126|NCT01791517|18964428|P1|Phase II|Adverse Event|0
5485127|NCT01791517|18964417|P12|Phase II|Lack of Efficacy|0
5485128|NCT01791517|18964418|P11|Phase II|Lack of Efficacy|0
5485129|NCT01791517|18964419|P10|Phase II|Lack of Efficacy|0
5485130|NCT01791517|18964420|P9|Phase II|Lack of Efficacy|0
5485131|NCT01791517|18964421|P8|Phase II|Lack of Efficacy|0
5485132|NCT01791517|18964422|P7|Phase II|Lack of Efficacy|0
5485133|NCT01791517|18964423|P6|Phase II|Lack of Efficacy|0
5485134|NCT01791517|18964424|P5|Phase II|Lack of Efficacy|1
5485135|NCT01791517|18964425|P4|Phase II|Lack of Efficacy|0
5485136|NCT01791517|18964426|P3|Phase II|Lack of Efficacy|0
5485137|NCT01791517|18964427|P2|Phase II|Lack of Efficacy|0
5485138|NCT01791517|18964428|P1|Phase II|Lack of Efficacy|0
5485139|NCT01791517|18964417|P12|Phase II|Withdrawal by Subject|0
5485140|NCT01791517|18964418|P11|Phase II|Withdrawal by Subject|1
5485141|NCT01791517|18964419|P10|Phase II|Withdrawal by Subject|0
5485142|NCT01791517|18964420|P9|Phase II|Withdrawal by Subject|0
5485143|NCT01791517|18964421|P8|Phase II|Withdrawal by Subject|1
5485144|NCT01791517|18964422|P7|Phase II|Withdrawal by Subject|0
5485145|NCT01791517|18964423|P6|Phase II|Withdrawal by Subject|2
5485146|NCT01791517|18964424|P5|Phase II|Withdrawal by Subject|0
5485147|NCT01791517|18964425|P4|Phase II|Withdrawal by Subject|0
5485148|NCT01791517|18964426|P3|Phase II|Withdrawal by Subject|0
5485149|NCT01791517|18964427|P2|Phase II|Withdrawal by Subject|0
5485150|NCT01791517|18964428|P1|Phase II|Withdrawal by Subject|1
5485151|NCT01791517|18964417|P12|Phase II|Lost to Follow-up|0
5485152|NCT01791517|18964418|P11|Phase II|Lost to Follow-up|0
5485153|NCT01791517|18964419|P10|Phase II|Lost to Follow-up|1
5485154|NCT01791517|18964420|P9|Phase II|Lost to Follow-up|1
5485155|NCT01791517|18964421|P8|Phase II|Lost to Follow-up|1
5485156|NCT01791517|18964422|P7|Phase II|Lost to Follow-up|0
5485157|NCT01791517|18964423|P6|Phase II|Lost to Follow-up|2
5485158|NCT01791517|18964424|P5|Phase II|Lost to Follow-up|1
5485159|NCT01791517|18964425|P4|Phase II|Lost to Follow-up|0
5485160|NCT01791517|18964426|P3|Phase II|Lost to Follow-up|1
5485161|NCT01791517|18964427|P2|Phase II|Lost to Follow-up|0
5485162|NCT01791517|18964428|P1|Phase II|Lost to Follow-up|1
5485163|NCT01791517|18964417|P12|Phase I: Period 3|Adverse Event|0
5485164|NCT01791517|18964418|P11|Phase I: Period 3|Adverse Event|0
5485165|NCT01791517|18964419|P10|Phase I: Period 3|Adverse Event|0
5485166|NCT01791517|18964420|P9|Phase I: Period 3|Adverse Event|0
5485167|NCT01791517|18964421|P8|Phase I: Period 3|Adverse Event|0
5485168|NCT01791517|18964422|P7|Phase I: Period 3|Adverse Event|0
5485169|NCT01791517|18964423|P6|Phase I: Period 3|Adverse Event|0
5485170|NCT01791517|18964424|P5|Phase I: Period 3|Adverse Event|0
5485171|NCT01791517|18964425|P4|Phase I: Period 3|Adverse Event|1
5485172|NCT01791517|18964426|P3|Phase I: Period 3|Adverse Event|0
5485173|NCT01791517|18964427|P2|Phase I: Period 3|Adverse Event|0
5485174|NCT01791517|18964428|P1|Phase I: Period 3|Adverse Event|0
5485175|NCT01791517|18964417|P12|Phase I: Period 3|Lost to Follow-up|0
5485176|NCT01791517|18964418|P11|Phase I: Period 3|Lost to Follow-up|0
5485177|NCT01791517|18964419|P10|Phase I: Period 3|Lost to Follow-up|0
5485178|NCT01791517|18964420|P9|Phase I: Period 3|Lost to Follow-up|0
5485179|NCT01791517|18964421|P8|Phase I: Period 3|Lost to Follow-up|0
5485180|NCT01791517|18964422|P7|Phase I: Period 3|Lost to Follow-up|0
5485181|NCT01791517|18964423|P6|Phase I: Period 3|Lost to Follow-up|0
5485182|NCT01791517|18964424|P5|Phase I: Period 3|Lost to Follow-up|1
5485183|NCT01791517|18964425|P4|Phase I: Period 3|Lost to Follow-up|0
5485184|NCT01791517|18964426|P3|Phase I: Period 3|Lost to Follow-up|0
5485185|NCT01791517|18964427|P2|Phase I: Period 3|Lost to Follow-up|1
5485186|NCT01791517|18964428|P1|Phase I: Period 3|Lost to Follow-up|0
5485187|NCT01791517|18964417|P12|Phase I: Period 3|Lens Discomfort|1
5485188|NCT01791517|18964418|P11|Phase I: Period 3|Lens Discomfort|0
5485189|NCT01791517|18964419|P10|Phase I: Period 3|Lens Discomfort|0
5485190|NCT01791517|18964420|P9|Phase I: Period 3|Lens Discomfort|0
5485191|NCT01791517|18964421|P8|Phase I: Period 3|Lens Discomfort|0
5485192|NCT01791517|18964422|P7|Phase I: Period 3|Lens Discomfort|0
5485193|NCT01791517|18964423|P6|Phase I: Period 3|Lens Discomfort|0
5485194|NCT01791517|18964424|P5|Phase I: Period 3|Lens Discomfort|0
5485195|NCT01791517|18964425|P4|Phase I: Period 3|Lens Discomfort|0
5485196|NCT01791517|18964426|P3|Phase I: Period 3|Lens Discomfort|0
5485197|NCT01791517|18964427|P2|Phase I: Period 3|Lens Discomfort|0
5485198|NCT01791517|18964428|P1|Phase I: Period 3|Lens Discomfort|0
5485199|NCT01791517|18964417|P12|Phase I: Period 2|Lost to Follow-up|0
5485200|NCT01791517|18964418|P11|Phase I: Period 2|Lost to Follow-up|0
5485201|NCT01791517|18964419|P10|Phase I: Period 2|Lost to Follow-up|0
5485202|NCT01791517|18964420|P9|Phase I: Period 2|Lost to Follow-up|0
5485203|NCT01791517|18964421|P8|Phase I: Period 2|Lost to Follow-up|0
5485204|NCT01791517|18964422|P7|Phase I: Period 2|Lost to Follow-up|0
5485205|NCT01791517|18964423|P6|Phase I: Period 2|Lost to Follow-up|0
5485206|NCT01791517|18964424|P5|Phase I: Period 2|Lost to Follow-up|0
5485207|NCT01791517|18964425|P4|Phase I: Period 2|Lost to Follow-up|0
5485208|NCT01791517|18964426|P3|Phase I: Period 2|Lost to Follow-up|2
5485209|NCT01791517|18964427|P2|Phase I: Period 2|Lost to Follow-up|3
5485210|NCT01791517|18964428|P1|Phase I: Period 2|Lost to Follow-up|0
5485211|NCT01791517|18964417|P12|Phase I: Period 2|Lens Discomfort|0
5485212|NCT01791517|18964418|P11|Phase I: Period 2|Lens Discomfort|0
5485213|NCT01791517|18964419|P10|Phase I: Period 2|Lens Discomfort|0
5485214|NCT01791517|18964420|P9|Phase I: Period 2|Lens Discomfort|0
5485215|NCT01791517|18964421|P8|Phase I: Period 2|Lens Discomfort|0
5485216|NCT01791517|18964422|P7|Phase I: Period 2|Lens Discomfort|0
5485217|NCT01791517|18964423|P6|Phase I: Period 2|Lens Discomfort|1
5485218|NCT01791517|18964424|P5|Phase I: Period 2|Lens Discomfort|0
5485219|NCT01791517|18964425|P4|Phase I: Period 2|Lens Discomfort|0
5485220|NCT01791517|18964426|P3|Phase I: Period 2|Lens Discomfort|0
5485221|NCT01791517|18964427|P2|Phase I: Period 2|Lens Discomfort|0
5485222|NCT01791517|18964428|P1|Phase I: Period 2|Lens Discomfort|0
5485223|NCT01791517|18964417|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
5485224|NCT01791517|18964418|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
5485225|NCT01791517|18964419|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
5485226|NCT01791517|18964420|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
5485227|NCT01791517|18964421|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
5485228|NCT01791517|18964422|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
5485229|NCT01791517|18964423|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
5485230|NCT01791517|18964424|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
5485231|NCT01791517|18964425|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
5485232|NCT01791517|18964426|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
5485233|NCT01791517|18964427|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
5485234|NCT01791517|18964428|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
5485235|NCT01791517|18964417|P12|Phase I: Period 2|Withdrawal by Subject|0
5485236|NCT01791517|18964418|P11|Phase I: Period 2|Withdrawal by Subject|1
5485237|NCT01791517|18964419|P10|Phase I: Period 2|Withdrawal by Subject|1
5485238|NCT01791517|18964420|P9|Phase I: Period 2|Withdrawal by Subject|0
5485239|NCT01791517|18964421|P8|Phase I: Period 2|Withdrawal by Subject|0
5485240|NCT01791517|18964422|P7|Phase I: Period 2|Withdrawal by Subject|0
5485241|NCT01791517|18964423|P6|Phase I: Period 2|Withdrawal by Subject|0
5485242|NCT01791517|18964424|P5|Phase I: Period 2|Withdrawal by Subject|0
5485243|NCT01791517|18964425|P4|Phase I: Period 2|Withdrawal by Subject|0
5485244|NCT01791517|18964426|P3|Phase I: Period 2|Withdrawal by Subject|0
5485245|NCT01791517|18964427|P2|Phase I: Period 2|Withdrawal by Subject|0
5485246|NCT01791517|18964428|P1|Phase I: Period 2|Withdrawal by Subject|0
5485247|NCT01791517|18964417|P12|Phase I: Period 2|Protocol Violation|0
5485248|NCT01791517|18964418|P11|Phase I: Period 2|Protocol Violation|0
5485249|NCT01791517|18964419|P10|Phase I: Period 2|Protocol Violation|0
5485250|NCT01791517|18964420|P9|Phase I: Period 2|Protocol Violation|0
5485251|NCT01791517|18964421|P8|Phase I: Period 2|Protocol Violation|0
5485252|NCT01791517|18964422|P7|Phase I: Period 2|Protocol Violation|0
5485253|NCT01791517|18964423|P6|Phase I: Period 2|Protocol Violation|0
5485254|NCT01791517|18964424|P5|Phase I: Period 2|Protocol Violation|0
5485255|NCT01791517|18964425|P4|Phase I: Period 2|Protocol Violation|1
5485256|NCT01791517|18964426|P3|Phase I: Period 2|Protocol Violation|0
5485257|NCT01791517|18964427|P2|Phase I: Period 2|Protocol Violation|0
5485258|NCT01791517|18964428|P1|Phase I: Period 2|Protocol Violation|0
5485259|NCT01791517|18964417|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485260|NCT01791517|18964418|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485261|NCT01791517|18964419|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485262|NCT01791517|18964420|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485263|NCT01791517|18964421|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485264|NCT01791517|18964422|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485265|NCT01791517|18964423|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485266|NCT01791517|18964424|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485267|NCT01791517|18964425|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485268|NCT01791517|18964426|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485269|NCT01791517|18964427|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
5485270|NCT01791517|18964428|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
5485271|NCT01791517|18964417|P12|Phase I: Period 1|Lens Handling DIfficulties|1
5485272|NCT01791517|18964418|P11|Phase I: Period 1|Lens Handling DIfficulties|0
5485273|NCT01791517|18964419|P10|Phase I: Period 1|Lens Handling DIfficulties|0
5485274|NCT01791517|18964420|P9|Phase I: Period 1|Lens Handling DIfficulties|0
5485275|NCT01791517|18964421|P8|Phase I: Period 1|Lens Handling DIfficulties|0
5485276|NCT01791517|18964422|P7|Phase I: Period 1|Lens Handling DIfficulties|0
5485277|NCT01791517|18964423|P6|Phase I: Period 1|Lens Handling DIfficulties|0
5485278|NCT01791517|18964424|P5|Phase I: Period 1|Lens Handling DIfficulties|0
5485279|NCT01791517|18964425|P4|Phase I: Period 1|Lens Handling DIfficulties|0
5485280|NCT01791517|18964426|P3|Phase I: Period 1|Lens Handling DIfficulties|0
5485281|NCT01791517|18964427|P2|Phase I: Period 1|Lens Handling DIfficulties|0
5485282|NCT01791517|18964428|P1|Phase I: Period 1|Lens Handling DIfficulties|0
5485283|NCT01791517|18964417|P12|Phase I: Period 1|Lost to Follow-up|0
5485284|NCT01791517|18964418|P11|Phase I: Period 1|Lost to Follow-up|0
5485285|NCT01791517|18964419|P10|Phase I: Period 1|Lost to Follow-up|1
5485286|NCT01791517|18964420|P9|Phase I: Period 1|Lost to Follow-up|1
5485287|NCT01791517|18964421|P8|Phase I: Period 1|Lost to Follow-up|0
5485288|NCT01791517|18964422|P7|Phase I: Period 1|Lost to Follow-up|1
5485289|NCT01791517|18964423|P6|Phase I: Period 1|Lost to Follow-up|0
5485290|NCT01791517|18964424|P5|Phase I: Period 1|Lost to Follow-up|0
5485291|NCT01791517|18964425|P4|Phase I: Period 1|Lost to Follow-up|1
5485292|NCT01791517|18964426|P3|Phase I: Period 1|Lost to Follow-up|0
5485293|NCT01791517|18964427|P2|Phase I: Period 1|Lost to Follow-up|0
5485294|NCT01791517|18964428|P1|Phase I: Period 1|Lost to Follow-up|0
5485295|NCT01791517|18964417|P12|Phase I: Period 1|Protocol Violation|0
5485296|NCT01791517|18964418|P11|Phase I: Period 1|Protocol Violation|0
5485297|NCT01791517|18964419|P10|Phase I: Period 1|Protocol Violation|0
5485298|NCT01791517|18964420|P9|Phase I: Period 1|Protocol Violation|0
5485299|NCT01791517|18964421|P8|Phase I: Period 1|Protocol Violation|0
5485300|NCT01791517|18964422|P7|Phase I: Period 1|Protocol Violation|0
5485301|NCT01791517|18964423|P6|Phase I: Period 1|Protocol Violation|0
5485302|NCT01791517|18964424|P5|Phase I: Period 1|Protocol Violation|0
5485303|NCT01791517|18964425|P4|Phase I: Period 1|Protocol Violation|0
5485304|NCT01791517|18964426|P3|Phase I: Period 1|Protocol Violation|0
5485305|NCT01791517|18964427|P2|Phase I: Period 1|Protocol Violation|1
5485306|NCT01791517|18964428|P1|Phase I: Period 1|Protocol Violation|0
5485307|NCT01791517|18964417|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485308|NCT01791517|18964418|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485309|NCT01791517|18964419|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485310|NCT01791517|18964420|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485311|NCT01791517|18964421|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485312|NCT01791517|18964422|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485313|NCT01791517|18964423|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485314|NCT01791517|18964424|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485315|NCT01791517|18964425|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485316|NCT01791517|18964426|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485317|NCT01791517|18964427|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
5485318|NCT01791517|18964428|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
5485319|NCT01791517|18964417|P12|Phase I: Period 1|Adverse Event|0
5485320|NCT01791517|18964418|P11|Phase I: Period 1|Adverse Event|0
5485321|NCT01791517|18964419|P10|Phase I: Period 1|Adverse Event|0
5485322|NCT01791517|18964420|P9|Phase I: Period 1|Adverse Event|0
5485323|NCT01791517|18964421|P8|Phase I: Period 1|Adverse Event|0
5485324|NCT01791517|18964422|P7|Phase I: Period 1|Adverse Event|0
5485325|NCT01791517|18964423|P6|Phase I: Period 1|Adverse Event|0
5485326|NCT01791517|18964424|P5|Phase I: Period 1|Adverse Event|0
5485327|NCT01791517|18964425|P4|Phase I: Period 1|Adverse Event|1
5485328|NCT01791517|18964426|P3|Phase I: Period 1|Adverse Event|1
5485329|NCT01791517|18964427|P2|Phase I: Period 1|Adverse Event|0
5485330|NCT01791517|18964428|P1|Phase I: Period 1|Adverse Event|0
5485331|NCT01791517|18964417|P12|Phase I: Period 1|Withdrawal by Subject|0
5485332|NCT01791517|18964418|P11|Phase I: Period 1|Withdrawal by Subject|0
5485333|NCT01791517|18964419|P10|Phase I: Period 1|Withdrawal by Subject|0
5485334|NCT01791517|18964420|P9|Phase I: Period 1|Withdrawal by Subject|0
5485335|NCT01791517|18964421|P8|Phase I: Period 1|Withdrawal by Subject|0
5485336|NCT01791517|18964422|P7|Phase I: Period 1|Withdrawal by Subject|0
5485337|NCT01791517|18964423|P6|Phase I: Period 1|Withdrawal by Subject|1
5485338|NCT01791517|18964424|P5|Phase I: Period 1|Withdrawal by Subject|1
5485339|NCT01791517|18964425|P4|Phase I: Period 1|Withdrawal by Subject|0
5485340|NCT01791517|18964426|P3|Phase I: Period 1|Withdrawal by Subject|1
5485341|NCT01791517|18964427|P2|Phase I: Period 1|Withdrawal by Subject|1
5485342|NCT01791517|18964428|P1|Phase I: Period 1|Withdrawal by Subject|0
5485343|NCT01791413|18964492|P2|Overall Study|Lost to Follow-up|1
5485344|NCT01791413|18964493|P1|Overall Study|Lost to Follow-up|5
5485345|NCT01791244|18964502|P2|Overall Study|Laboratory Abnormality|1
5485346|NCT01791244|18964503|P1|Overall Study|Laboratory Abnormality|0
5485347|NCT01791244|18964502|P2|Overall Study|Insufficient clinical response|10
5485348|NCT01791244|18964503|P1|Overall Study|Insufficient clinical response|10
5485349|NCT01791244|18964502|P2|Overall Study|Adverse Event|7
5485350|NCT01791244|18964503|P1|Overall Study|Adverse Event|5
5485351|NCT01791205|18964539|P2|Phase II|Physician's decision|0
5485352|NCT01791205|18964540|P1|Phase II|Physician's decision|1
5485353|NCT01791205|18964539|P2|Phase II|Remission of disease|0
5485354|NCT01791205|18964540|P1|Phase II|Remission of disease|1
5485355|NCT01791205|18964539|P2|Phase II|Lost to Follow-up|0
5485356|NCT01791205|18964540|P1|Phase II|Lost to Follow-up|1
5485357|NCT01791205|18964539|P2|Phase II|Safety|0
5485358|NCT01791205|18964540|P1|Phase II|Safety|1
5485359|NCT01791205|18964539|P2|Phase II|Adverse Event|0
5485360|NCT01791205|18964540|P1|Phase II|Adverse Event|2
5485361|NCT01791205|18964539|P2|Phase II|Lack of Efficacy|0
5485362|NCT01791205|18964540|P1|Phase II|Lack of Efficacy|6
5485363|NCT01791153|18964624|P8|Part 2: Open-label Period|Physician Decision|0
5485364|NCT01791153|18964625|P7|Part 2: Open-label Period|Physician Decision|0
5485365|NCT01791153|18964626|P6|Part 2: Open-label Period|Physician Decision|1
5485366|NCT01791153|18964627|P5|Part 2: Open-label Period|Physician Decision|1
5485367|NCT01791153|18964628|P4|Part 2: Open-label Period|Physician Decision|0
5485368|NCT01791153|18964629|P3|Part 2: Open-label Period|Physician Decision|0
5485369|NCT01791153|18964630|P2|Part 2: Open-label Period|Physician Decision|0
5485370|NCT01791153|18964631|P1|Part 2: Open-label Period|Physician Decision|0
5485371|NCT01791153|18964624|P8|Part 2: Open-label Period|Withdrawal by Subject|2
5485372|NCT01791153|18964625|P7|Part 2: Open-label Period|Withdrawal by Subject|3
5485373|NCT01791153|18964626|P6|Part 2: Open-label Period|Withdrawal by Subject|1
5485374|NCT01791153|18964627|P5|Part 2: Open-label Period|Withdrawal by Subject|1
5485375|NCT01791153|18964628|P4|Part 2: Open-label Period|Withdrawal by Subject|0
5485376|NCT01791153|18964629|P3|Part 2: Open-label Period|Withdrawal by Subject|0
5485377|NCT01791153|18964630|P2|Part 2: Open-label Period|Withdrawal by Subject|0
5485378|NCT01791153|18964631|P1|Part 2: Open-label Period|Withdrawal by Subject|0
5485379|NCT01791153|18964624|P8|Part 2: Open-label Period|Lack of Efficacy|1
5485380|NCT01791153|18964625|P7|Part 2: Open-label Period|Lack of Efficacy|0
5485381|NCT01791153|18964626|P6|Part 2: Open-label Period|Lack of Efficacy|0
5485382|NCT01791153|18964627|P5|Part 2: Open-label Period|Lack of Efficacy|0
5485383|NCT01791153|18964628|P4|Part 2: Open-label Period|Lack of Efficacy|0
5485384|NCT01791153|18964629|P3|Part 2: Open-label Period|Lack of Efficacy|0
5485385|NCT01791153|18964630|P2|Part 2: Open-label Period|Lack of Efficacy|0
5485386|NCT01791153|18964631|P1|Part 2: Open-label Period|Lack of Efficacy|0
5485387|NCT01791153|18964624|P8|Part 2: Open-label Period|Lost to Follow-up|0
5485388|NCT01791153|18964625|P7|Part 2: Open-label Period|Lost to Follow-up|1
5485389|NCT01791153|18964626|P6|Part 2: Open-label Period|Lost to Follow-up|0
5485390|NCT01791153|18964627|P5|Part 2: Open-label Period|Lost to Follow-up|0
5485391|NCT01791153|18964628|P4|Part 2: Open-label Period|Lost to Follow-up|0
5485392|NCT01791153|18964629|P3|Part 2: Open-label Period|Lost to Follow-up|0
5485393|NCT01791153|18964630|P2|Part 2: Open-label Period|Lost to Follow-up|0
5485394|NCT01791153|18964631|P1|Part 2: Open-label Period|Lost to Follow-up|0
5485395|NCT01791153|18964624|P8|Part 2: Open-label Period|Death|1
5485396|NCT01791153|18964625|P7|Part 2: Open-label Period|Death|1
5485397|NCT01791153|18964626|P6|Part 2: Open-label Period|Death|1
5485398|NCT01791153|18964627|P5|Part 2: Open-label Period|Death|0
5485399|NCT01791153|18964628|P4|Part 2: Open-label Period|Death|0
5485400|NCT01791153|18964629|P3|Part 2: Open-label Period|Death|0
5485401|NCT01791153|18964630|P2|Part 2: Open-label Period|Death|0
5485402|NCT01791153|18964631|P1|Part 2: Open-label Period|Death|0
5485403|NCT01791153|18964624|P8|Part 2: Open-label Period|Adverse Event|2
5485404|NCT01791153|18964625|P7|Part 2: Open-label Period|Adverse Event|1
5485405|NCT01791153|18964626|P6|Part 2: Open-label Period|Adverse Event|1
5485406|NCT01791153|18964627|P5|Part 2: Open-label Period|Adverse Event|0
5485407|NCT01791153|18964628|P4|Part 2: Open-label Period|Adverse Event|0
5485408|NCT01791153|18964629|P3|Part 2: Open-label Period|Adverse Event|0
5485409|NCT01791153|18964630|P2|Part 2: Open-label Period|Adverse Event|0
5485410|NCT01791153|18964631|P1|Part 2: Open-label Period|Adverse Event|0
5485411|NCT01791153|18964624|P8|Part 1: Blinded Period|Withdrawal by Subject|0
5485412|NCT01791153|18964625|P7|Part 1: Blinded Period|Withdrawal by Subject|0
5485413|NCT01791153|18964626|P6|Part 1: Blinded Period|Withdrawal by Subject|0
5485414|NCT01791153|18964627|P5|Part 1: Blinded Period|Withdrawal by Subject|0
5485415|NCT01791153|18964628|P4|Part 1: Blinded Period|Withdrawal by Subject|1
5485416|NCT01791153|18964629|P3|Part 1: Blinded Period|Withdrawal by Subject|2
5485417|NCT01791153|18964630|P2|Part 1: Blinded Period|Withdrawal by Subject|2
5485418|NCT01791153|18964631|P1|Part 1: Blinded Period|Withdrawal by Subject|6
5485419|NCT01791153|18964624|P8|Part 1: Blinded Period|Protocol Violation|0
5485420|NCT01791153|18964625|P7|Part 1: Blinded Period|Protocol Violation|0
5485421|NCT01791153|18964626|P6|Part 1: Blinded Period|Protocol Violation|0
5485422|NCT01791153|18964627|P5|Part 1: Blinded Period|Protocol Violation|0
5485423|NCT01791153|18964628|P4|Part 1: Blinded Period|Protocol Violation|1
5485424|NCT01791153|18964629|P3|Part 1: Blinded Period|Protocol Violation|0
5485425|NCT01791153|18964630|P2|Part 1: Blinded Period|Protocol Violation|0
5485426|NCT01791153|18964631|P1|Part 1: Blinded Period|Protocol Violation|0
5485427|NCT01791153|18964624|P8|Part 1: Blinded Period|Physician Decision|0
5485428|NCT01791153|18964625|P7|Part 1: Blinded Period|Physician Decision|0
5485429|NCT01791153|18964626|P6|Part 1: Blinded Period|Physician Decision|0
5485430|NCT01791153|18964627|P5|Part 1: Blinded Period|Physician Decision|0
5485431|NCT01791153|18964628|P4|Part 1: Blinded Period|Physician Decision|1
5485432|NCT01791153|18964629|P3|Part 1: Blinded Period|Physician Decision|0
5485433|NCT01791153|18964630|P2|Part 1: Blinded Period|Physician Decision|0
5485434|NCT01791153|18964631|P1|Part 1: Blinded Period|Physician Decision|0
5485435|NCT01791153|18964624|P8|Part 1: Blinded Period|Non-Compliance|0
5485436|NCT01791153|18964625|P7|Part 1: Blinded Period|Non-Compliance|0
5485437|NCT01791153|18964626|P6|Part 1: Blinded Period|Non-Compliance|0
5485438|NCT01791153|18964627|P5|Part 1: Blinded Period|Non-Compliance|0
5485439|NCT01791153|18964628|P4|Part 1: Blinded Period|Non-Compliance|0
5485440|NCT01791153|18964629|P3|Part 1: Blinded Period|Non-Compliance|0
5485441|NCT01791153|18964630|P2|Part 1: Blinded Period|Non-Compliance|0
5485442|NCT01791153|18964631|P1|Part 1: Blinded Period|Non-Compliance|1
5485443|NCT01791153|18964624|P8|Part 1: Blinded Period|Lack of Efficacy|0
5485444|NCT01791153|18964625|P7|Part 1: Blinded Period|Lack of Efficacy|0
5485445|NCT01791153|18964626|P6|Part 1: Blinded Period|Lack of Efficacy|0
5485446|NCT01791153|18964627|P5|Part 1: Blinded Period|Lack of Efficacy|0
5485447|NCT01791153|18964628|P4|Part 1: Blinded Period|Lack of Efficacy|2
5485448|NCT01791153|18964629|P3|Part 1: Blinded Period|Lack of Efficacy|2
5485449|NCT01791153|18964630|P2|Part 1: Blinded Period|Lack of Efficacy|3
5485450|NCT01791153|18964631|P1|Part 1: Blinded Period|Lack of Efficacy|1
5485451|NCT01791153|18964624|P8|Part 1: Blinded Period|Adverse Event|0
5485452|NCT01791153|18964625|P7|Part 1: Blinded Period|Adverse Event|0
5485453|NCT01791153|18964626|P6|Part 1: Blinded Period|Adverse Event|0
5485454|NCT01791153|18964627|P5|Part 1: Blinded Period|Adverse Event|0
5485455|NCT01791153|18964628|P4|Part 1: Blinded Period|Adverse Event|0
5485456|NCT01791153|18964629|P3|Part 1: Blinded Period|Adverse Event|2
5485457|NCT01791153|18964630|P2|Part 1: Blinded Period|Adverse Event|3
5485458|NCT01791153|18964631|P1|Part 1: Blinded Period|Adverse Event|7
5485459|NCT01791127|18964691|P1|Overall Study|Study terminated for EP Passion|749
5485460|NCT01791127|18964691|P1|Overall Study|Completion of 30 day safety registry|1
5485461|NCT01791127|18964691|P1|Overall Study|All Siello leads are explanted|31
5485462|NCT01791127|18964691|P1|Overall Study|Lost to Follow-up|42
5485463|NCT01791127|18964691|P1|Overall Study|Patient has withdrawn from study|293
5485464|NCT01791127|18964691|P1|Overall Study|Death|356
5485465|NCT01790932|18964715|P1|Overall Study|Withdrawal by Subject|1
5485466|NCT01790932|18964715|P1|Overall Study|Physician Decision|1
5485467|NCT01790932|18964715|P1|Overall Study|Adverse Event|7
5485468|NCT01790932|18964715|P1|Overall Study|Disease Progression|41
5485469|NCT01790828|18964721|P1|Overall Study|Other|34
5485470|NCT01790633|18964779|P2|Overall Study|RT failure and no follow-up ELISA|3
5485471|NCT01790633|18964780|P1|Overall Study|RT failure and no follow-up ELISA|0
5485472|NCT01790633|18964779|P2|Overall Study|Did not have serology performed|0
5485473|NCT01790633|18964780|P1|Overall Study|Did not have serology performed|47
5485474|NCT01790633|18964779|P2|Overall Study|Protocol Violation|2
5485475|NCT01790633|18964780|P1|Overall Study|Protocol Violation|1
5485476|NCT01790594|18964793|P3|Overall Study|Terminated prior to week 76|0
5485477|NCT01790594|18964794|P2|Overall Study|Terminated prior to week 76|2
5485478|NCT01790594|18964795|P1|Overall Study|Terminated prior to week 76|0
5485479|NCT01790594|18964793|P3|Overall Study|Transplant was not done|3
5485480|NCT01790594|18964794|P2|Overall Study|Transplant was not done|0
5485481|NCT01790594|18964795|P1|Overall Study|Transplant was not done|0
5485482|NCT01790594|18964793|P3|Overall Study|Withdrawal by Subject|0
5485483|NCT01790594|18964794|P2|Overall Study|Withdrawal by Subject|0
5485484|NCT01790594|18964795|P1|Overall Study|Withdrawal by Subject|2
5485485|NCT01790594|18964793|P3|Overall Study|Physician Decision|0
5485486|NCT01790594|18964794|P2|Overall Study|Physician Decision|1
5485487|NCT01790594|18964795|P1|Overall Study|Physician Decision|2
5485488|NCT01790594|18964793|P3|Overall Study|Death|0
5485489|NCT01790594|18964794|P2|Overall Study|Death|0
5485490|NCT01790594|18964795|P1|Overall Study|Death|1
5485491|NCT01790568|18964872|P2|Overall Study|Progression prior to transplant|1
5485492|NCT01790568|18964873|P1|Overall Study|Progression prior to transplant|0
5485493|NCT01790516|18964881|P2|Overall Study|Physician Decision|0
5485494|NCT01790516|18964882|P1|Overall Study|Physician Decision|1
5485495|NCT01790503|18964899|P11|Overall Study|Other|0
5485496|NCT01790503|18964900|P10|Overall Study|Other|2
5485497|NCT01790503|18964901|P9|Overall Study|Other|1
5485498|NCT01790503|18964902|P8|Overall Study|Other|0
5485499|NCT01790503|18964903|P7|Overall Study|Other|0
5485500|NCT01790503|18964904|P6|Overall Study|Other|0
5485501|NCT01790503|18964905|P5|Overall Study|Other|1
5485502|NCT01790503|18964906|P4|Overall Study|Other|0
5485503|NCT01790503|18964907|P3|Overall Study|Other|0
5485504|NCT01790503|18964908|P2|Overall Study|Other|0
5485505|NCT01790503|18964909|P1|Overall Study|Other|0
5485506|NCT01790503|18964899|P11|Overall Study|Non Compliance|0
5485507|NCT01790503|18964900|P10|Overall Study|Non Compliance|0
5485508|NCT01790503|18964901|P9|Overall Study|Non Compliance|0
5485509|NCT01790503|18964902|P8|Overall Study|Non Compliance|0
5485510|NCT01790503|18964903|P7|Overall Study|Non Compliance|0
5485511|NCT01790503|18964904|P6|Overall Study|Non Compliance|0
5485512|NCT01790503|18964905|P5|Overall Study|Non Compliance|1
5485513|NCT01790503|18964906|P4|Overall Study|Non Compliance|0
5485514|NCT01790503|18964907|P3|Overall Study|Non Compliance|0
5485515|NCT01790503|18964908|P2|Overall Study|Non Compliance|0
5485516|NCT01790503|18964909|P1|Overall Study|Non Compliance|0
5485517|NCT01790503|18964899|P11|Overall Study|Death|0
5485518|NCT01790503|18964900|P10|Overall Study|Death|1
5485519|NCT01790503|18964901|P9|Overall Study|Death|0
5485520|NCT01790503|18964902|P8|Overall Study|Death|0
5485521|NCT01790503|18964903|P7|Overall Study|Death|0
5485522|NCT01790503|18964904|P6|Overall Study|Death|0
5485523|NCT01790503|18964905|P5|Overall Study|Death|0
5485524|NCT01790503|18964906|P4|Overall Study|Death|0
5485525|NCT01790503|18964907|P3|Overall Study|Death|0
5485526|NCT01790503|18964908|P2|Overall Study|Death|0
5485527|NCT01790503|18964909|P1|Overall Study|Death|0
5485528|NCT01790503|18964899|P11|Overall Study|Physician Decision|1
5485529|NCT01790503|18964900|P10|Overall Study|Physician Decision|1
5485530|NCT01790503|18964901|P9|Overall Study|Physician Decision|0
5485531|NCT01790503|18964902|P8|Overall Study|Physician Decision|0
5485532|NCT01790503|18964903|P7|Overall Study|Physician Decision|0
5485533|NCT01790503|18964904|P6|Overall Study|Physician Decision|0
5485534|NCT01790503|18964905|P5|Overall Study|Physician Decision|0
5485535|NCT01790503|18964906|P4|Overall Study|Physician Decision|0
5485536|NCT01790503|18964907|P3|Overall Study|Physician Decision|0
5485537|NCT01790503|18964908|P2|Overall Study|Physician Decision|0
5485538|NCT01790503|18964909|P1|Overall Study|Physician Decision|0
5485539|NCT01790503|18964899|P11|Overall Study|Protocol Violation|0
5485540|NCT01790503|18964900|P10|Overall Study|Protocol Violation|1
5485541|NCT01790503|18964901|P9|Overall Study|Protocol Violation|0
5485542|NCT01790503|18964902|P8|Overall Study|Protocol Violation|0
5485543|NCT01790503|18964903|P7|Overall Study|Protocol Violation|0
5485544|NCT01790503|18964904|P6|Overall Study|Protocol Violation|0
5485545|NCT01790503|18964905|P5|Overall Study|Protocol Violation|0
5485546|NCT01790503|18964906|P4|Overall Study|Protocol Violation|0
5485547|NCT01790503|18964907|P3|Overall Study|Protocol Violation|0
5485548|NCT01790503|18964908|P2|Overall Study|Protocol Violation|0
5485549|NCT01790503|18964909|P1|Overall Study|Protocol Violation|0
5485550|NCT01790503|18964899|P11|Overall Study|Disease progression|7
5485551|NCT01790503|18964900|P10|Overall Study|Disease progression|17
5485552|NCT01790503|18964901|P9|Overall Study|Disease progression|0
5485553|NCT01790503|18964902|P8|Overall Study|Disease progression|1
5485554|NCT01790503|18964903|P7|Overall Study|Disease progression|0
5485555|NCT01790503|18964904|P6|Overall Study|Disease progression|1
5485556|NCT01790503|18964905|P5|Overall Study|Disease progression|2
5485557|NCT01790503|18964906|P4|Overall Study|Disease progression|1
5485558|NCT01790503|18964907|P3|Overall Study|Disease progression|0
5485559|NCT01790503|18964908|P2|Overall Study|Disease progression|1
5485560|NCT01790503|18964909|P1|Overall Study|Disease progression|2
5485561|NCT01790503|18964899|P11|Overall Study|Withdrawal by Subject|1
5485562|NCT01790503|18964900|P10|Overall Study|Withdrawal by Subject|0
5485563|NCT01790503|18964901|P9|Overall Study|Withdrawal by Subject|0
5485564|NCT01790503|18964902|P8|Overall Study|Withdrawal by Subject|0
5485565|NCT01790503|18964903|P7|Overall Study|Withdrawal by Subject|1
5485566|NCT01790503|18964904|P6|Overall Study|Withdrawal by Subject|2
5485567|NCT01790503|18964905|P5|Overall Study|Withdrawal by Subject|1
5485568|NCT01790503|18964906|P4|Overall Study|Withdrawal by Subject|1
5485569|NCT01790503|18964907|P3|Overall Study|Withdrawal by Subject|1
5485570|NCT01790503|18964908|P2|Overall Study|Withdrawal by Subject|0
5485571|NCT01790503|18964909|P1|Overall Study|Withdrawal by Subject|0
5485572|NCT01790503|18964899|P11|Overall Study|Adverse Event|7
5485573|NCT01790503|18964900|P10|Overall Study|Adverse Event|4
5485574|NCT01790503|18964901|P9|Overall Study|Adverse Event|2
5485575|NCT01790503|18964902|P8|Overall Study|Adverse Event|0
5485576|NCT01790503|18964903|P7|Overall Study|Adverse Event|0
5485577|NCT01790503|18964904|P6|Overall Study|Adverse Event|2
5485578|NCT01790503|18964905|P5|Overall Study|Adverse Event|0
5485579|NCT01790503|18964906|P4|Overall Study|Adverse Event|0
5485580|NCT01790503|18964907|P3|Overall Study|Adverse Event|0
5485581|NCT01790503|18964908|P2|Overall Study|Adverse Event|0
5485582|NCT01790503|18964909|P1|Overall Study|Adverse Event|1
5485583|NCT01790438|18964979|P2|Overall Study|Protocol Required Discontinuation|1
5485584|NCT01790438|18964980|P1|Overall Study|Protocol Required Discontinuation|7
5485585|NCT01790438|18964979|P2|Overall Study|Sponsor Decision|3
5485586|NCT01790438|18964980|P1|Overall Study|Sponsor Decision|0
5485587|NCT01790438|18964979|P2|Overall Study|Physician Decision|1
5485588|NCT01790438|18964980|P1|Overall Study|Physician Decision|3
5485589|NCT01790438|18964979|P2|Overall Study|Withdrawal by Subject|2
5485590|NCT01790438|18964980|P1|Overall Study|Withdrawal by Subject|13
5485591|NCT01790438|18964979|P2|Overall Study|Lost to Follow-up|2
5485592|NCT01790438|18964980|P1|Overall Study|Lost to Follow-up|5
5485593|NCT01790438|18964979|P2|Overall Study|Death|0
5485594|NCT01790438|18964980|P1|Overall Study|Death|4
5485595|NCT01790438|18964979|P2|Overall Study|Adverse Event|2
5485596|NCT01790438|18964980|P1|Overall Study|Adverse Event|3
5485597|NCT01790295|18965030|P1|Overall Study|Study closure|4
5485598|NCT01790295|18965030|P1|Overall Study|Lack of Efficacy|2
5485599|NCT01790295|18965030|P1|Overall Study|Death|4
5485600|NCT01790295|18965030|P1|Overall Study|Adverse Event|1
5485601|NCT01790126|18965100|P3|Overall Study|Radiographic Progression|0
5485602|NCT01790126|18965101|P2|Overall Study|Radiographic Progression|1
5485603|NCT01790126|18965102|P1|Overall Study|Radiographic Progression|3
5485604|NCT01790126|18965100|P3|Overall Study|Death|0
5485605|NCT01790126|18965101|P2|Overall Study|Death|0
5485606|NCT01790126|18965102|P1|Overall Study|Death|2
5485607|NCT01790126|18965100|P3|Overall Study|Adverse Event|0
5485608|NCT01790126|18965101|P2|Overall Study|Adverse Event|2
5485609|NCT01790126|18965102|P1|Overall Study|Adverse Event|0
5485610|NCT01790126|18965100|P3|Overall Study|Lost to Follow-up|1
5485611|NCT01790126|18965101|P2|Overall Study|Lost to Follow-up|0
5485612|NCT01790126|18965102|P1|Overall Study|Lost to Follow-up|1
5485613|NCT01790126|18965100|P3|Overall Study|Withdrawal by Subject|2
5485614|NCT01790126|18965101|P2|Overall Study|Withdrawal by Subject|1
5485615|NCT01790126|18965102|P1|Overall Study|Withdrawal by Subject|3
5485616|NCT01790126|18965100|P3|Overall Study|Withdrawal by Physician|2
5485617|NCT01790126|18965101|P2|Overall Study|Withdrawal by Physician|1
5485618|NCT01790126|18965102|P1|Overall Study|Withdrawal by Physician|1
5485619|NCT01790126|18965100|P3|Overall Study|Initiation of Non-Protocol Therapy|2
5485620|NCT01790126|18965101|P2|Overall Study|Initiation of Non-Protocol Therapy|4
5485621|NCT01790126|18965102|P1|Overall Study|Initiation of Non-Protocol Therapy|3
5485622|NCT01790126|18965100|P3|Overall Study|Other|8
5485623|NCT01790126|18965101|P2|Overall Study|Other|4
5485624|NCT01790126|18965102|P1|Overall Study|Other|5
5485625|NCT01790126|18965100|P3|Overall Study|PSA Progression|16
5485626|NCT01790126|18965101|P2|Overall Study|PSA Progression|16
5485627|NCT01790126|18965102|P1|Overall Study|PSA Progression|12
5485628|NCT01790048|18965159|P2|Overall Study|Measurement error|0
5485629|NCT01790048|18965160|P1|Overall Study|Measurement error|1
5485630|NCT01790048|18965159|P2|Overall Study|SAM at Enrollment|0
5485631|NCT01790048|18965160|P1|Overall Study|SAM at Enrollment|2
5485632|NCT01790048|18965159|P2|Overall Study|Other|2
5485633|NCT01790048|18965160|P1|Overall Study|Other|0
5485634|NCT01790048|18965159|P2|Overall Study|data entry error|1
5485635|NCT01790048|18965160|P1|Overall Study|data entry error|0
5485636|NCT01790048|18965159|P2|Overall Study|Incorrect Age|14
5485637|NCT01790048|18965160|P1|Overall Study|Incorrect Age|9
5485638|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
5485639|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
5485640|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
5485641|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Other|3
5485642|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Other|1
5485643|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Other|0
5485644|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
5485645|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
5485646|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
5485647|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
5485648|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
5485649|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
5485650|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
5485651|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
5485652|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
5485653|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
5485654|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
5485655|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
5485656|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
5485657|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
5485658|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
5485659|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
5485660|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
5485661|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5485662|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
5485663|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
5485664|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5485665|NCT01789970|18965178|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
5485666|NCT01789970|18965179|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
5485667|NCT01789970|18965180|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
5485668|NCT01789970|18965178|P3|Open-label Titration Period|Dropped out prior to dosing|0
5485669|NCT01789970|18965179|P2|Open-label Titration Period|Dropped out prior to dosing|0
5485670|NCT01789970|18965180|P1|Open-label Titration Period|Dropped out prior to dosing|2
5485671|NCT01789970|18965178|P3|Open-label Titration Period|Other|0
5485672|NCT01789970|18965179|P2|Open-label Titration Period|Other|0
5485673|NCT01789970|18965180|P1|Open-label Titration Period|Other|76
5485674|NCT01789970|18965178|P3|Open-label Titration Period|Pregnancy|0
5485675|NCT01789970|18965179|P2|Open-label Titration Period|Pregnancy|0
5485676|NCT01789970|18965180|P1|Open-label Titration Period|Pregnancy|2
5485677|NCT01789970|18965178|P3|Open-label Titration Period|Noncompliance with study procedures|0
5485678|NCT01789970|18965179|P2|Open-label Titration Period|Noncompliance with study procedures|0
5485679|NCT01789970|18965180|P1|Open-label Titration Period|Noncompliance with study procedures|8
5485680|NCT01789970|18965178|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
5485681|NCT01789970|18965179|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
5485682|NCT01789970|18965180|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
5485683|NCT01789970|18965178|P3|Open-label Titration Period|Noncompliance to study drug admin|0
5485684|NCT01789970|18965179|P2|Open-label Titration Period|Noncompliance to study drug admin|0
5485685|NCT01789970|18965180|P1|Open-label Titration Period|Noncompliance to study drug admin|11
5485686|NCT01789970|18965178|P3|Open-label Titration Period|Lost to Follow-up|0
5485687|NCT01789970|18965179|P2|Open-label Titration Period|Lost to Follow-up|0
5485688|NCT01789970|18965180|P1|Open-label Titration Period|Lost to Follow-up|5
5485689|NCT01789970|18965178|P3|Open-label Titration Period|Protocol Violation|0
5485690|NCT01789970|18965179|P2|Open-label Titration Period|Protocol Violation|0
5485691|NCT01789970|18965180|P1|Open-label Titration Period|Protocol Violation|18
5485692|NCT01789970|18965178|P3|Open-label Titration Period|Withdrawal by Subject|0
5485693|NCT01789970|18965179|P2|Open-label Titration Period|Withdrawal by Subject|0
5485694|NCT01789970|18965180|P1|Open-label Titration Period|Withdrawal by Subject|31
5485695|NCT01789970|18965178|P3|Open-label Titration Period|Lack of Efficacy|0
5485696|NCT01789970|18965179|P2|Open-label Titration Period|Lack of Efficacy|0
5485697|NCT01789970|18965180|P1|Open-label Titration Period|Lack of Efficacy|31
5485698|NCT01789970|18965178|P3|Open-label Titration Period|Adverse Event|0
5485699|NCT01789970|18965179|P2|Open-label Titration Period|Adverse Event|0
5485700|NCT01789970|18965180|P1|Open-label Titration Period|Adverse Event|68
5485701|NCT01789606|18965238|P2|Overall Study|Ineligible or not Willing to Continue|348
5485702|NCT01789606|18965239|P1|Overall Study|Ineligible or not Willing to Continue|0
5485703|NCT01789606|18965238|P2|Overall Study|Lost to Follow-up|14
5485704|NCT01789606|18965239|P1|Overall Study|Lost to Follow-up|0
5485705|NCT01789606|18965238|P2|Overall Study|Adverse Event|3
5485706|NCT01789606|18965239|P1|Overall Study|Adverse Event|0
5485707|NCT01789606|18965238|P2|Overall Study|Protocol Violation|55
5485708|NCT01789606|18965239|P1|Overall Study|Protocol Violation|0
5485709|NCT01789606|18965238|P2|Overall Study|No Study Medication Taken|1
5485710|NCT01789606|18965239|P1|Overall Study|No Study Medication Taken|0
5485711|NCT01789606|18965238|P2|Overall Study|Administrative Reasons|6
5485712|NCT01789606|18965239|P1|Overall Study|Administrative Reasons|17
5485713|NCT01789606|18965238|P2|Overall Study|Ineligible|2
5485714|NCT01789606|18965239|P1|Overall Study|Ineligible|6
5485715|NCT01789606|18965238|P2|Overall Study|Withdrawal by Subject|1
5485716|NCT01789606|18965239|P1|Overall Study|Withdrawal by Subject|0
5485717|NCT01789606|18965238|P2|Overall Study|Participant not Purchased the Product|20
5485718|NCT01789606|18965239|P1|Overall Study|Participant not Purchased the Product|0
5485719|NCT01789567|18965257|P1|Overall Study|Death|6
5485720|NCT01789476|18965266|P2|Overall Study|Unable to get IV access|0
5485721|NCT01789476|18965267|P1|Overall Study|Unable to get IV access|1
5485722|NCT01789476|18965266|P2|Overall Study|Adverse Event|0
5485723|NCT01789476|18965267|P1|Overall Study|Adverse Event|1
5485724|NCT01789476|18965266|P2|Overall Study|Lack of Efficacy|2
5485725|NCT01789476|18965267|P1|Overall Study|Lack of Efficacy|6
5485726|NCT01789203|18965289|P2|Overall Study|patient non-adherent|0
5485727|NCT01789203|18965290|P1|Overall Study|patient non-adherent|2
5485728|NCT01789203|18965289|P2|Overall Study|Other|1
5485729|NCT01789203|18965290|P1|Overall Study|Other|1
5485730|NCT01789203|18965289|P2|Overall Study|Protocol Violation|1
5485731|NCT01789203|18965290|P1|Overall Study|Protocol Violation|2
5485732|NCT01789203|18965289|P2|Overall Study|Death|0
5485733|NCT01789203|18965290|P1|Overall Study|Death|1
5485734|NCT01789203|18965289|P2|Overall Study|Withdrawal by Subject|0
5485735|NCT01789203|18965290|P1|Overall Study|Withdrawal by Subject|1
5485736|NCT01789203|18965289|P2|Overall Study|Adverse Event|2
5485737|NCT01789203|18965290|P1|Overall Study|Adverse Event|2
5485738|NCT01789047|18965331|P2|Overall Study|Withdrawal by Subject|2
5485739|NCT01789047|18965332|P1|Overall Study|Withdrawal by Subject|1
5485740|NCT01789047|18965331|P2|Overall Study|Adverse Event|2
5485741|NCT01789047|18965332|P1|Overall Study|Adverse Event|3
5485742|NCT01788943|18965340|P2|Overall Study|Withdrawal by Subject|0
5485743|NCT01788943|18965341|P1|Overall Study|Withdrawal by Subject|1
5485744|NCT01788566|18965370|P1|Overall Study|Clinical Progressive Disease|3
5485745|NCT01788566|18965370|P1|Overall Study|Adverse Event|1
5485746|NCT01788566|18965370|P1|Overall Study|Death|4
5485747|NCT01788423|18965408|P3|Overall Study|See Comments in Completed (above)|5
5485748|NCT01788423|18965409|P2|Overall Study|See Comments in Completed (above)|4
5485749|NCT01788423|18965410|P1|Overall Study|See Comments in Completed (above)|0
5485750|NCT01788358|18965421|P1|Overall Study|Adverse Event|51
5485751|NCT01788358|18965421|P1|Overall Study|Lack of Efficacy|1
5485752|NCT01788358|18965421|P1|Overall Study|Withdrawal by Subject|26
5485753|NCT01788358|18965421|P1|Overall Study|Protocol Violation|3
5485754|NCT01788358|18965421|P1|Overall Study|Lost to Follow-up|5
5485755|NCT01788358|18965421|P1|Overall Study|Logistical difficulties|1
5485756|NCT01788358|18965421|P1|Overall Study|Other|11
5485757|NCT01788228|18965435|P2|Overall Study|Migrated/moved from study area|0
5485758|NCT01788228|18965436|P1|Overall Study|Migrated/moved from study area|1
5485759|NCT01788215|18965469|P2|Overall Study|Lost to Follow-up|0
5485760|NCT01788215|18965470|P1|Overall Study|Lost to Follow-up|2
5485761|NCT01788215|18965469|P2|Overall Study|Withdrawal by Subject|1
5485762|NCT01788215|18965470|P1|Overall Study|Withdrawal by Subject|0
5485763|NCT01788163|18965499|P9|Overall Study|Withdrawal by Subject|1
5485764|NCT01788163|18965500|P8|Overall Study|Withdrawal by Subject|0
5485765|NCT01788163|18965501|P7|Overall Study|Withdrawal by Subject|0
5485766|NCT01788163|18965502|P6|Overall Study|Withdrawal by Subject|0
5485767|NCT01788163|18965503|P5|Overall Study|Withdrawal by Subject|0
5485768|NCT01788163|18965504|P4|Overall Study|Withdrawal by Subject|0
5485769|NCT01788163|18965505|P3|Overall Study|Withdrawal by Subject|0
5485770|NCT01788163|18965506|P2|Overall Study|Withdrawal by Subject|0
5485771|NCT01788163|18965507|P1|Overall Study|Withdrawal by Subject|2
5485772|NCT01788163|18965499|P9|Overall Study|Other|15
5485773|NCT01788163|18965500|P8|Overall Study|Other|48
5485774|NCT01788163|18965501|P7|Overall Study|Other|1
5485775|NCT01788163|18965502|P6|Overall Study|Other|7
5485776|NCT01788163|18965503|P5|Overall Study|Other|0
5485777|NCT01788163|18965504|P4|Overall Study|Other|0
5485778|NCT01788163|18965505|P3|Overall Study|Other|0
5485779|NCT01788163|18965506|P2|Overall Study|Other|0
5485780|NCT01788163|18965507|P1|Overall Study|Other|53
5485781|NCT01788046|18965670|P2|Overall Study|Protocol Specified Criteria|1
5485782|NCT01788046|18965671|P1|Overall Study|Protocol Specified Criteria|25
5485783|NCT01788046|18965670|P2|Overall Study|Death|5
5485784|NCT01788046|18965671|P1|Overall Study|Death|7
5485785|NCT01788046|18965670|P2|Overall Study|Lost to Follow-up|19
5485786|NCT01788046|18965671|P1|Overall Study|Lost to Follow-up|12
5485787|NCT01788046|18965670|P2|Overall Study|Withdrawal by Subject|12
5485788|NCT01788046|18965671|P1|Overall Study|Withdrawal by Subject|12
5485789|NCT01787838|18965694|P1|Overall Study|refused|1413
5485790|NCT01787825|18965698|P2|Overall Study|Data Not Analyzable|1
5485791|NCT01787825|18965699|P1|Overall Study|Data Not Analyzable|5
5485792|NCT01787825|18965698|P2|Overall Study|Subject Did Not Ingest Capsules|0
5485793|NCT01787825|18965699|P1|Overall Study|Subject Did Not Ingest Capsules|1
5485794|NCT01787760|18965717|P3|Overall Study|Near vision blur|0
5485795|NCT01787760|18965718|P2|Overall Study|Near vision blur|0
5485796|NCT01787760|18965719|P1|Overall Study|Near vision blur|1
5485797|NCT01787760|18965717|P3|Overall Study|Unsatisfactory visual response|0
5485798|NCT01787760|18965718|P2|Overall Study|Unsatisfactory visual response|1
5485799|NCT01787760|18965719|P1|Overall Study|Unsatisfactory visual response|1
5485800|NCT01787760|18965717|P3|Overall Study|Unsatisfactory physiological response|0
5485801|NCT01787760|18965718|P2|Overall Study|Unsatisfactory physiological response|4
5485802|NCT01787760|18965719|P1|Overall Study|Unsatisfactory physiological response|2
5485803|NCT01787760|18965717|P3|Overall Study|Unsatisfactory lens fitting performance|0
5485804|NCT01787760|18965718|P2|Overall Study|Unsatisfactory lens fitting performance|6
5485805|NCT01787760|18965719|P1|Overall Study|Unsatisfactory lens fitting performance|3
5485806|NCT01787760|18965717|P3|Overall Study|Stroke|0
5485807|NCT01787760|18965718|P2|Overall Study|Stroke|0
5485808|NCT01787760|18965719|P1|Overall Study|Stroke|1
5485809|NCT01787760|18965717|P3|Overall Study|Lost to Follow-up|1
5485810|NCT01787760|18965718|P2|Overall Study|Lost to Follow-up|0
5485811|NCT01787760|18965719|P1|Overall Study|Lost to Follow-up|1
5485812|NCT01787760|18965717|P3|Overall Study|Withdrawal by Subject|2
5485813|NCT01787760|18965718|P2|Overall Study|Withdrawal by Subject|1
5485814|NCT01787760|18965719|P1|Overall Study|Withdrawal by Subject|5
5485815|NCT01787760|18965717|P3|Overall Study|Protocol Violation|1
5485816|NCT01787760|18965718|P2|Overall Study|Protocol Violation|0
5485817|NCT01787760|18965719|P1|Overall Study|Protocol Violation|6
5485818|NCT01787760|18965717|P3|Overall Study|Lens handling difficulty|0
5485819|NCT01787760|18965718|P2|Overall Study|Lens handling difficulty|2
5485820|NCT01787760|18965719|P1|Overall Study|Lens handling difficulty|1
5485821|NCT01787760|18965717|P3|Overall Study|Lens discomfort|0
5485822|NCT01787760|18965718|P2|Overall Study|Lens discomfort|0
5485823|NCT01787760|18965719|P1|Overall Study|Lens discomfort|3
5485824|NCT01787760|18965717|P3|Overall Study|Relocation|0
5485825|NCT01787760|18965718|P2|Overall Study|Relocation|1
5485826|NCT01787760|18965719|P1|Overall Study|Relocation|1
5485827|NCT01787760|18965717|P3|Overall Study|Dryness|0
5485828|NCT01787760|18965718|P2|Overall Study|Dryness|1
5485829|NCT01787760|18965719|P1|Overall Study|Dryness|0
5485830|NCT01787760|18965717|P3|Overall Study|Decompensated on left exotropia|1
5485831|NCT01787760|18965718|P2|Overall Study|Decompensated on left exotropia|0
5485832|NCT01787760|18965719|P1|Overall Study|Decompensated on left exotropia|0
5485833|NCT01787760|18965717|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
5485834|NCT01787760|18965718|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
5485835|NCT01787760|18965719|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
5485836|NCT01787591|18965744|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
5485837|NCT01787591|18965745|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
5485838|NCT01787591|18965746|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
5485839|NCT01787591|18965747|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
5485840|NCT01787552|18965777|P4|Overall Study|Progressive Disease|1
5485841|NCT01787552|18965778|P3|Overall Study|Progressive Disease|1
5485842|NCT01787552|18965779|P2|Overall Study|Progressive Disease|2
5485843|NCT01787552|18965780|P1|Overall Study|Progressive Disease|2
5485844|NCT01787552|18965777|P4|Overall Study|Study terminated by Sponsor|3
5485845|NCT01787552|18965778|P3|Overall Study|Study terminated by Sponsor|1
5485846|NCT01787552|18965779|P2|Overall Study|Study terminated by Sponsor|0
5485847|NCT01787552|18965780|P1|Overall Study|Study terminated by Sponsor|0
5485848|NCT01787552|18965777|P4|Overall Study|Adverse Event|16
5485849|NCT01787552|18965778|P3|Overall Study|Adverse Event|2
5485850|NCT01787552|18965779|P2|Overall Study|Adverse Event|5
5485851|NCT01787552|18965780|P1|Overall Study|Adverse Event|2
5485852|NCT01787552|18965777|P4|Overall Study|Death|1
5485853|NCT01787552|18965778|P3|Overall Study|Death|0
5485854|NCT01787552|18965779|P2|Overall Study|Death|0
5485855|NCT01787552|18965780|P1|Overall Study|Death|0
5485856|NCT01787552|18965777|P4|Overall Study|Physician Decision|2
5485857|NCT01787552|18965778|P3|Overall Study|Physician Decision|1
5485858|NCT01787552|18965779|P2|Overall Study|Physician Decision|2
5485859|NCT01787552|18965780|P1|Overall Study|Physician Decision|2
5485860|NCT01787552|18965777|P4|Overall Study|Withdrawal by Subject|4
5485861|NCT01787552|18965778|P3|Overall Study|Withdrawal by Subject|0
5485862|NCT01787552|18965779|P2|Overall Study|Withdrawal by Subject|0
5485863|NCT01787552|18965780|P1|Overall Study|Withdrawal by Subject|2
5485864|NCT01787461|18965850|P2|Overall Study|Protocol Violation|0
5485865|NCT01787461|18965851|P1|Overall Study|Protocol Violation|3
5485866|NCT01787461|18965850|P2|Overall Study|Withdrawal by Subject|4
5485867|NCT01787461|18965851|P1|Overall Study|Withdrawal by Subject|3
5485868|NCT01787461|18965850|P2|Overall Study|No longer met eligibility criteria|0
5485869|NCT01787461|18965851|P1|Overall Study|No longer met eligibility criteria|1
5485870|NCT01787461|18965850|P2|Overall Study|Lost to Follow-up|2
5485871|NCT01787461|18965851|P1|Overall Study|Lost to Follow-up|3
5485872|NCT01787461|18965850|P2|Overall Study|Adverse Event|3
5485873|NCT01787461|18965851|P1|Overall Study|Adverse Event|4
5485874|NCT01787331|18965900|P1|Overall Study|Withdrawal by Subject|1
5485875|NCT01787331|18965900|P1|Overall Study|Physician Decision|1
5485876|NCT01787292|18965912|P2|Home Based Exercise Program|Withdrawal by Subject|1
5485877|NCT01787292|18965913|P1|Home Based Exercise Program|Withdrawal by Subject|3
5485878|NCT01787292|18965912|P2|Crossover Exercise Interventions|Withdrawal by Subject|2
5485879|NCT01787292|18965913|P1|Crossover Exercise Interventions|Withdrawal by Subject|2
5485880|NCT01787279|18965930|P1|Overall Study|Lack of Efficacy|1
5485881|NCT01787279|18965930|P1|Overall Study|Lost to Follow-up|2
5485882|NCT01787188|18965956|P3|Overall Study|Other, including patient moved|0
5485883|NCT01787188|18965957|P2|Overall Study|Other, including patient moved|3
5485884|NCT01787188|18965958|P1|Overall Study|Other, including patient moved|0
5485885|NCT01787188|18965956|P3|Overall Study|Lost to Follow-up|2
5485886|NCT01787188|18965957|P2|Overall Study|Lost to Follow-up|2
5485887|NCT01787188|18965958|P1|Overall Study|Lost to Follow-up|1
5485888|NCT01787188|18965956|P3|Overall Study|Protocol Violation|3
5485889|NCT01787188|18965957|P2|Overall Study|Protocol Violation|2
5485890|NCT01787188|18965958|P1|Overall Study|Protocol Violation|3
5485891|NCT01787188|18965956|P3|Overall Study|Withdrawal by Subject|2
5485892|NCT01787188|18965957|P2|Overall Study|Withdrawal by Subject|3
5485893|NCT01787188|18965958|P1|Overall Study|Withdrawal by Subject|4
5485894|NCT01787188|18965956|P3|Overall Study|Non-compliance with Study Drug|0
5485895|NCT01787188|18965957|P2|Overall Study|Non-compliance with Study Drug|1
5485896|NCT01787188|18965958|P1|Overall Study|Non-compliance with Study Drug|0
5485897|NCT01787188|18965956|P3|Overall Study|Lack of Efficacy|5
5485898|NCT01787188|18965957|P2|Overall Study|Lack of Efficacy|3
5485899|NCT01787188|18965958|P1|Overall Study|Lack of Efficacy|7
5485900|NCT01787188|18965956|P3|Overall Study|Adverse Event|6
5485901|NCT01787188|18965957|P2|Overall Study|Adverse Event|4
5485902|NCT01787188|18965958|P1|Overall Study|Adverse Event|2
5485903|NCT01787097|18966024|P4|Overall Study|Withdrawal by Subject|0
5485904|NCT01787097|18966025|P3|Overall Study|Withdrawal by Subject|0
5485905|NCT01787097|18966026|P2|Overall Study|Withdrawal by Subject|0
5485906|NCT01787097|18966027|P1|Overall Study|Withdrawal by Subject|1
5485907|NCT01787032|18966059|P6|Overall Study|Protocol Violation|1
5485908|NCT01787032|18966060|P5|Overall Study|Protocol Violation|1
5485909|NCT01787032|18966061|P4|Overall Study|Protocol Violation|0
5485910|NCT01787032|18966062|P3|Overall Study|Protocol Violation|0
5485911|NCT01787032|18966063|P2|Overall Study|Protocol Violation|0
5485912|NCT01787032|18966064|P1|Overall Study|Protocol Violation|0
5485913|NCT01786993|18966117|P2|Overall Study|Hospice Admission|0
5485914|NCT01786993|18966118|P1|Overall Study|Hospice Admission|1
5485915|NCT01786993|18966117|P2|Overall Study|System Explant|0
5485916|NCT01786993|18966118|P1|Overall Study|System Explant|1
5485917|NCT01786993|18966117|P2|Overall Study|Subject Non-Compliance|0
5485918|NCT01786993|18966118|P1|Overall Study|Subject Non-Compliance|1
5485919|NCT01786993|18966117|P2|Overall Study|Lost to Follow-up|1
5485920|NCT01786993|18966118|P1|Overall Study|Lost to Follow-up|0
5485921|NCT01786993|18966117|P2|Overall Study|Withdrawal by Subject|2
5485922|NCT01786993|18966118|P1|Overall Study|Withdrawal by Subject|3
5485923|NCT01786993|18966117|P2|Overall Study|Death|7
5485924|NCT01786993|18966118|P1|Overall Study|Death|6
5485925|NCT01786707|18966177|P2|Overall Study|Lost to Follow-up|1
5485926|NCT01786707|18966178|P1|Overall Study|Lost to Follow-up|1
5485927|NCT01786668|18966190|P4|Overall Study|Lost to Follow-up|0
5485928|NCT01786668|18966191|P3|Overall Study|Lost to Follow-up|1
5485929|NCT01786668|18966192|P2|Overall Study|Lost to Follow-up|0
5485930|NCT01786668|18966193|P1|Overall Study|Lost to Follow-up|1
5485931|NCT01786668|18966190|P4|Overall Study|Pregnancy|1
5485932|NCT01786668|18966191|P3|Overall Study|Pregnancy|0
5485933|NCT01786668|18966192|P2|Overall Study|Pregnancy|0
5485934|NCT01786668|18966193|P1|Overall Study|Pregnancy|0
5485935|NCT01786668|18966190|P4|Overall Study|Withdrawal by Subject|1
5485936|NCT01786668|18966191|P3|Overall Study|Withdrawal by Subject|3
5485937|NCT01786668|18966192|P2|Overall Study|Withdrawal by Subject|0
5485938|NCT01786668|18966193|P1|Overall Study|Withdrawal by Subject|0
5485939|NCT01786668|18966190|P4|Overall Study|Adverse Event|2
5485940|NCT01786668|18966191|P3|Overall Study|Adverse Event|1
5485941|NCT01786668|18966192|P2|Overall Study|Adverse Event|1
5485942|NCT01786668|18966193|P1|Overall Study|Adverse Event|0
5485943|NCT01786629|18966293|P2|Overall Study|Adverse Event|1
5485944|NCT01786629|18966294|P1|Overall Study|Adverse Event|0
5485945|NCT01786629|18966293|P2|Overall Study|Lack of Efficacy|4
5485946|NCT01786629|18966294|P1|Overall Study|Lack of Efficacy|0
5485947|NCT01786603|18966302|P2|Overall Study|Lost to Follow-up|2
5485948|NCT01786603|18966303|P1|Overall Study|Lost to Follow-up|1
5485949|NCT01786603|18966302|P2|Overall Study|Physician decision to withdraw|7
5485950|NCT01786603|18966303|P1|Overall Study|Physician decision to withdraw|6
5485951|NCT01786603|18966302|P2|Overall Study|Adverse Event|2
5485952|NCT01786603|18966303|P1|Overall Study|Adverse Event|6
5485953|NCT01786603|18966302|P2|Overall Study|Death|1
5485954|NCT01786603|18966303|P1|Overall Study|Death|5
5485955|NCT01786564|18966321|P1|Overall Study|Ineligible|17
5485956|NCT01786564|18966321|P1|Overall Study|Lost to Follow-up|47
5485957|NCT01786551|18966325|P1|Overall Study|Participant withdrew consent|2
5485958|NCT01786330|18966346|P2|Overall Study|Protocol Violation|0
5485959|NCT01786330|18966347|P1|Overall Study|Protocol Violation|1
5485960|NCT01786330|18966346|P2|Overall Study|Excluded intraoperatively|1
5485961|NCT01786330|18966347|P1|Overall Study|Excluded intraoperatively|0
5485962|NCT01786330|18966346|P2|Overall Study|Lost to Follow-up|1
5485963|NCT01786330|18966347|P1|Overall Study|Lost to Follow-up|0
5485964|NCT01786330|18966346|P2|Overall Study|Withdrawal by Subject|1
5485965|NCT01786330|18966347|P1|Overall Study|Withdrawal by Subject|0
5485966|NCT01786174|18966399|P2|Overall Study|Discontinued Study Drug|0
5485967|NCT01786174|18966400|P1|Overall Study|Discontinued Study Drug|2
5485968|NCT01786148|18966429|P2|Overall Study|Incarceration|1
5485969|NCT01786148|18966430|P1|Overall Study|Incarceration|1
5485970|NCT01786148|18966429|P2|Overall Study|Withdrawal by Subject|7
5485971|NCT01786148|18966430|P1|Overall Study|Withdrawal by Subject|0
5485972|NCT01786148|18966429|P2|Overall Study|Death|1
5485973|NCT01786148|18966430|P1|Overall Study|Death|0
5485974|NCT01786148|18966429|P2|Overall Study|Lost to Follow-up|13
5485975|NCT01786148|18966430|P1|Overall Study|Lost to Follow-up|21
5485976|NCT01786109|18966445|P3|Overall Study|adverse effects colon preparation|1
5485977|NCT01786109|18966446|P2|Overall Study|adverse effects colon preparation|0
5485978|NCT01786109|18966447|P1|Overall Study|adverse effects colon preparation|0
5485979|NCT01786109|18966445|P3|Overall Study|unrelated illness|1
5485980|NCT01786109|18966446|P2|Overall Study|unrelated illness|0
5485981|NCT01786109|18966447|P1|Overall Study|unrelated illness|0
5485982|NCT01786109|18966445|P3|Overall Study|fail manometry barostat tube placement|0
5485983|NCT01786109|18966446|P2|Overall Study|fail manometry barostat tube placement|0
5485984|NCT01786109|18966447|P1|Overall Study|fail manometry barostat tube placement|1
5485985|NCT01785875|18966476|P3|Overall Study|Missing|3
5485986|NCT01785875|18966477|P2|Overall Study|Missing|1
5485987|NCT01785875|18966478|P1|Overall Study|Missing|0
5485988|NCT01785875|18966476|P3|Overall Study|Protocol Specified Criteria|55
5485989|NCT01785875|18966477|P2|Overall Study|Protocol Specified Criteria|214
5485990|NCT01785875|18966478|P1|Overall Study|Protocol Specified Criteria|207
5485991|NCT01785875|18966476|P3|Overall Study|Sponsor Decision|0
5485992|NCT01785875|18966477|P2|Overall Study|Sponsor Decision|2
5485993|NCT01785875|18966478|P1|Overall Study|Sponsor Decision|0
5485994|NCT01785875|18966476|P3|Overall Study|Death|7
5485995|NCT01785875|18966477|P2|Overall Study|Death|16
5485996|NCT01785875|18966478|P1|Overall Study|Death|27
5485997|NCT01785875|18966476|P3|Overall Study|Lost to Follow-up|6
5485998|NCT01785875|18966477|P2|Overall Study|Lost to Follow-up|22
5485999|NCT01785875|18966478|P1|Overall Study|Lost to Follow-up|19
5486000|NCT01785875|18966476|P3|Overall Study|Withdrawal by Subject|36
5486001|NCT01785875|18966477|P2|Overall Study|Withdrawal by Subject|34
5486002|NCT01785875|18966478|P1|Overall Study|Withdrawal by Subject|41
5486003|NCT01785849|18966547|P2|Overall Study|Lost to Follow-up|11
5486004|NCT01785849|18966548|P1|Overall Study|Lost to Follow-up|10
5486005|NCT01785849|18966547|P2|Overall Study|Sponsor Decision|1
5486006|NCT01785849|18966548|P1|Overall Study|Sponsor Decision|0
5486007|NCT01785849|18966547|P2|Overall Study|Withdrawal by Subject|12
5486008|NCT01785849|18966548|P1|Overall Study|Withdrawal by Subject|15
5486009|NCT01785849|18966547|P2|Overall Study|Protocol Specified Criteria|1
5486010|NCT01785849|18966548|P1|Overall Study|Protocol Specified Criteria|29
5486011|NCT01785849|18966547|P2|Overall Study|Death|9
5486012|NCT01785849|18966548|P1|Overall Study|Death|7
5486013|NCT01785628|18966581|P2|Overall Study|Lost to Follow-up|3
5486014|NCT01785628|18966582|P1|Overall Study|Lost to Follow-up|2
5486015|NCT01785615|18966605|P4|Dietary Phase|Lost to Follow-up|24
5486016|NCT01785615|18966606|P3|Dietary Phase|Lost to Follow-up|0
5486017|NCT01785615|18966607|P2|Dietary Phase|Lost to Follow-up|0
5486018|NCT01785615|18966608|P1|Dietary Phase|Lost to Follow-up|0
5486019|NCT01785602|18966680|P2|Overall Study|Administrative problems|3
5486020|NCT01785602|18966681|P1|Overall Study|Administrative problems|7
5486021|NCT01785602|18966680|P2|Overall Study|Adverse Event|5
5486022|NCT01785602|18966681|P1|Overall Study|Adverse Event|3
5486023|NCT01785602|18966680|P2|Overall Study|Lost to Follow-up|1
5486024|NCT01785602|18966681|P1|Overall Study|Lost to Follow-up|1
5486025|NCT01785602|18966680|P2|Overall Study|Withdrawal by Subject|0
5486026|NCT01785602|18966681|P1|Overall Study|Withdrawal by Subject|2
5486027|NCT01785524|18966691|P2|Overall Study|Withdrawal by Subject|2
5486028|NCT01785524|18966692|P1|Overall Study|Withdrawal by Subject|2
5486029|NCT01785472|18966711|P3|Overall Study|Technical problems|1
5486030|NCT01785472|18966712|P2|Overall Study|Technical problems|0
5486031|NCT01785472|18966713|P1|Overall Study|Technical problems|0
5486032|NCT01785472|18966711|P3|Overall Study|Subject/guardian decision|11
5486033|NCT01785472|18966712|P2|Overall Study|Subject/guardian decision|10
5486034|NCT01785472|18966713|P1|Overall Study|Subject/guardian decision|15
5486035|NCT01785472|18966711|P3|Overall Study|Protocol deviation|2
5486036|NCT01785472|18966712|P2|Overall Study|Protocol deviation|2
5486037|NCT01785472|18966713|P1|Overall Study|Protocol deviation|0
5486038|NCT01785472|18966711|P3|Overall Study|Physician Decision|1
5486039|NCT01785472|18966712|P2|Overall Study|Physician Decision|1
5486040|NCT01785472|18966713|P1|Overall Study|Physician Decision|1
5486041|NCT01785472|18966711|P3|Overall Study|Lost to Follow-up|0
5486042|NCT01785472|18966712|P2|Overall Study|Lost to Follow-up|2
5486043|NCT01785472|18966713|P1|Overall Study|Lost to Follow-up|1
5486044|NCT01785472|18966711|P3|Overall Study|Lack of Efficacy|1
5486045|NCT01785472|18966712|P2|Overall Study|Lack of Efficacy|0
5486046|NCT01785472|18966713|P1|Overall Study|Lack of Efficacy|2
5486047|NCT01785472|18966711|P3|Overall Study|Adverse Event|6
5486048|NCT01785472|18966712|P2|Overall Study|Adverse Event|4
5486049|NCT01785472|18966713|P1|Overall Study|Adverse Event|5
5486050|NCT01785160|18966799|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
5486051|NCT01785160|18966799|P1|Treatment Period 1: Raltegravir|Not treated|1
5486052|NCT01785069|18966836|P4|Overall Study|Not evaluable|8
5486053|NCT01785069|18966837|P3|Overall Study|Not evaluable|5
5486054|NCT01785069|18966838|P2|Overall Study|Not evaluable|4
5486055|NCT01785069|18966839|P1|Overall Study|Not evaluable|7
5486056|NCT01785069|18966836|P4|Overall Study|Reason not Specified|4
5486057|NCT01785069|18966837|P3|Overall Study|Reason not Specified|1
5486058|NCT01785069|18966838|P2|Overall Study|Reason not Specified|2
5486059|NCT01785069|18966839|P1|Overall Study|Reason not Specified|1
5486060|NCT01785069|18966836|P4|Overall Study|Lost to Follow-up|1
5486061|NCT01785069|18966837|P3|Overall Study|Lost to Follow-up|4
5486062|NCT01785069|18966838|P2|Overall Study|Lost to Follow-up|2
5486063|NCT01785069|18966839|P1|Overall Study|Lost to Follow-up|1
5486064|NCT01785069|18966836|P4|Overall Study|Subject choice|1
5486065|NCT01785069|18966837|P3|Overall Study|Subject choice|0
5486066|NCT01785069|18966838|P2|Overall Study|Subject choice|2
5486067|NCT01785069|18966839|P1|Overall Study|Subject choice|2
5486068|NCT01785069|18966836|P4|Overall Study|Death|0
5486069|NCT01785069|18966837|P3|Overall Study|Death|2
5486070|NCT01785069|18966838|P2|Overall Study|Death|0
5486071|NCT01785069|18966839|P1|Overall Study|Death|0
5486072|NCT01785069|18966836|P4|Overall Study|Implanted with nonstudy device|0
5486073|NCT01785069|18966837|P3|Overall Study|Implanted with nonstudy device|1
5486074|NCT01785069|18966838|P2|Overall Study|Implanted with nonstudy device|2
5486075|NCT01785069|18966839|P1|Overall Study|Implanted with nonstudy device|1
5486076|NCT01784965|18966888|P2|Overall Study|Adverse Event|8
5486077|NCT01784965|18966889|P1|Overall Study|Adverse Event|0
5486078|NCT01784965|18966888|P2|Overall Study|Withdrawal by Subject|3
5486079|NCT01784965|18966889|P1|Overall Study|Withdrawal by Subject|6
5486080|NCT01784419|18967010|P1|Overall Study|Adverse Event|3
5486081|NCT01784211|18967018|P6|Part A (Days 1-15)|Withdrawal by Subject|0
5486082|NCT01784211|18967019|P5|Part A (Days 1-15)|Withdrawal by Subject|0
5486083|NCT01784211|18967020|P4|Part A (Days 1-15)|Withdrawal by Subject|0
5486084|NCT01784211|18967021|P3|Part A (Days 1-15)|Withdrawal by Subject|0
5486085|NCT01784211|18967022|P2|Part A (Days 1-15)|Withdrawal by Subject|1
5486086|NCT01784211|18967023|P1|Part A (Days 1-15)|Withdrawal by Subject|2
5486087|NCT01784211|18967018|P6|Part A (Days 1-15)|Adverse Event|0
5486088|NCT01784211|18967019|P5|Part A (Days 1-15)|Adverse Event|0
5486089|NCT01784211|18967020|P4|Part A (Days 1-15)|Adverse Event|0
5486090|NCT01784211|18967021|P3|Part A (Days 1-15)|Adverse Event|0
5486091|NCT01784211|18967022|P2|Part A (Days 1-15)|Adverse Event|1
5486092|NCT01784211|18967023|P1|Part A (Days 1-15)|Adverse Event|1
5486093|NCT01784029|18967048|P3|Overall Study|Lost to Follow-up|22
5486094|NCT01784029|18967049|P2|Overall Study|Lost to Follow-up|20
5486095|NCT01784029|18967050|P1|Overall Study|Lost to Follow-up|19
5486096|NCT01783938|18967079|P2|Overall Study|Other|0
5486097|NCT01783938|18967080|P1|Overall Study|Other|1
5486098|NCT01783938|18967079|P2|Overall Study|Withdrew Consent|0
5486099|NCT01783938|18967080|P1|Overall Study|Withdrew Consent|3
5486100|NCT01783938|18967079|P2|Overall Study|Request to Discontinue Study Treatment|2
5486101|NCT01783938|18967080|P1|Overall Study|Request to Discontinue Study Treatment|1
5486102|NCT01783938|18967079|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
5486103|NCT01783938|18967080|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
5486104|NCT01783938|18967079|P2|Overall Study|Study Drug Toxicity|10
5486105|NCT01783938|18967080|P1|Overall Study|Study Drug Toxicity|22
5486106|NCT01783938|18967079|P2|Overall Study|Disease Progression|39
5486107|NCT01783938|18967080|P1|Overall Study|Disease Progression|18
5486108|NCT01783886|18967108|P3|Overall Study|Adverse Event|4
5486109|NCT01783886|18967109|P2|Overall Study|Adverse Event|5
5486110|NCT01783886|18967110|P1|Overall Study|Adverse Event|4
5486111|NCT01783886|18967108|P3|Overall Study|Withdrawal of consent by participant|4
5486112|NCT01783886|18967109|P2|Overall Study|Withdrawal of consent by participant|3
5486113|NCT01783886|18967110|P1|Overall Study|Withdrawal of consent by participant|1
5486114|NCT01783886|18967108|P3|Overall Study|Protocol deviation|2
5486115|NCT01783886|18967109|P2|Overall Study|Protocol deviation|0
5486116|NCT01783886|18967110|P1|Overall Study|Protocol deviation|0
5486117|NCT01783886|18967108|P3|Overall Study|Lost to Follow-up|0
5486118|NCT01783886|18967109|P2|Overall Study|Lost to Follow-up|3
5486119|NCT01783886|18967110|P1|Overall Study|Lost to Follow-up|0
5486120|NCT01783821|18967173|P2|Overall Study|Screen Failure|1
5486121|NCT01783821|18967174|P1|Overall Study|Screen Failure|1
5486122|NCT01783743|18967192|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
5486123|NCT01783743|18967193|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
5486124|NCT01783743|18967192|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
5486125|NCT01783743|18967193|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
5486126|NCT01783743|18967192|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
5486127|NCT01783743|18967193|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
5486128|NCT01783730|18967207|P1|Overall Study|Failed to meet inclusion criteria|6
5486129|NCT01783678|18967232|P6|Overall Study|Withdrew Consent|0
5486130|NCT01783678|18967233|P5|Overall Study|Withdrew Consent|0
5486131|NCT01783678|18967234|P4|Overall Study|Withdrew Consent|2
5486132|NCT01783678|18967235|P3|Overall Study|Withdrew Consent|0
5486133|NCT01783678|18967236|P2|Overall Study|Withdrew Consent|1
5486134|NCT01783678|18967237|P1|Overall Study|Withdrew Consent|1
5486135|NCT01783678|18967232|P6|Overall Study|Lost to Follow-up|0
5486136|NCT01783678|18967233|P5|Overall Study|Lost to Follow-up|1
5486137|NCT01783678|18967234|P4|Overall Study|Lost to Follow-up|2
5486138|NCT01783678|18967235|P3|Overall Study|Lost to Follow-up|0
5486139|NCT01783678|18967236|P2|Overall Study|Lost to Follow-up|4
5486140|NCT01783678|18967237|P1|Overall Study|Lost to Follow-up|0
5486141|NCT01783678|18967232|P6|Overall Study|Lack of Efficacy|5
5486142|NCT01783678|18967233|P5|Overall Study|Lack of Efficacy|6
5486143|NCT01783678|18967234|P4|Overall Study|Lack of Efficacy|3
5486144|NCT01783678|18967235|P3|Overall Study|Lack of Efficacy|1
5486145|NCT01783678|18967236|P2|Overall Study|Lack of Efficacy|13
5486146|NCT01783678|18967237|P1|Overall Study|Lack of Efficacy|1
5486147|NCT01783678|18967232|P6|Overall Study|Randomized but Not Treated|0
5486148|NCT01783678|18967233|P5|Overall Study|Randomized but Not Treated|0
5486149|NCT01783678|18967234|P4|Overall Study|Randomized but Not Treated|1
5486150|NCT01783678|18967235|P3|Overall Study|Randomized but Not Treated|0
5486151|NCT01783678|18967236|P2|Overall Study|Randomized but Not Treated|0
5486152|NCT01783678|18967237|P1|Overall Study|Randomized but Not Treated|0
5486153|NCT01783548|18967341|P2|Overall Study|Lack of Efficacy|1
5486154|NCT01783548|18967342|P1|Overall Study|Lack of Efficacy|1
5486155|NCT01783548|18967341|P2|Overall Study|Lost to Follow-up|3
5486156|NCT01783548|18967342|P1|Overall Study|Lost to Follow-up|8
5486157|NCT01783548|18967341|P2|Overall Study|Protocol Violation|2
5486158|NCT01783548|18967342|P1|Overall Study|Protocol Violation|2
5486159|NCT01783548|18967341|P2|Overall Study|Non-compliance|0
5486160|NCT01783548|18967342|P1|Overall Study|Non-compliance|4
5486161|NCT01783548|18967341|P2|Overall Study|Withdrawal by Subject|8
5486162|NCT01783548|18967342|P1|Overall Study|Withdrawal by Subject|11
5486163|NCT01783548|18967341|P2|Overall Study|Adverse Event|4
5486164|NCT01783548|18967342|P1|Overall Study|Adverse Event|8
5486165|NCT01783496|18967375|P6|Overall Study|Withdrawal by Subject|0
5486166|NCT01783496|18967376|P5|Overall Study|Withdrawal by Subject|0
5486167|NCT01783496|18967377|P4|Overall Study|Withdrawal by Subject|0
5486168|NCT01783496|18967378|P3|Overall Study|Withdrawal by Subject|0
5486169|NCT01783496|18967379|P2|Overall Study|Withdrawal by Subject|0
5486170|NCT01783496|18967380|P1|Overall Study|Withdrawal by Subject|1
5486171|NCT01783496|18967375|P6|Overall Study|Lost to Follow-up|1
5486172|NCT01783496|18967376|P5|Overall Study|Lost to Follow-up|0
5486173|NCT01783496|18967377|P4|Overall Study|Lost to Follow-up|2
5486174|NCT01783496|18967378|P3|Overall Study|Lost to Follow-up|0
5486175|NCT01783496|18967379|P2|Overall Study|Lost to Follow-up|0
5486176|NCT01783496|18967380|P1|Overall Study|Lost to Follow-up|0
5486177|NCT01783483|18967408|P2|Overall Study|Physician Decision|1
5486178|NCT01783483|18967409|P1|Overall Study|Physician Decision|1
5486179|NCT01783483|18967408|P2|Overall Study|Withdrawal by Subject|1
5486180|NCT01783483|18967409|P1|Overall Study|Withdrawal by Subject|2
5486181|NCT01783483|18967408|P2|Overall Study|Lost to Follow-up|10
5486182|NCT01783483|18967409|P1|Overall Study|Lost to Follow-up|14
5486183|NCT01783483|18967408|P2|Overall Study|Death|3
5486184|NCT01783483|18967409|P1|Overall Study|Death|3
5486185|NCT01783418|18967447|P2|Overall Study|Withdrawal by Subject|0
5486186|NCT01783418|18967448|P1|Overall Study|Withdrawal by Subject|1
5486187|NCT01783015|18967501|P3|Open Label Treatment|Study Terminated by Sponsor|6
5486188|NCT01783015|18967502|P2|Open Label Treatment|Study Terminated by Sponsor|0
5486189|NCT01783015|18967503|P1|Open Label Treatment|Study Terminated by Sponsor|0
5486190|NCT01783015|18967501|P3|Blinded Treatment|Study Terminated by Sponsor|0
5486191|NCT01783015|18967502|P2|Blinded Treatment|Study Terminated by Sponsor|0
5486192|NCT01783015|18967503|P1|Blinded Treatment|Study Terminated by Sponsor|2
5486193|NCT01783015|18967501|P3|Blinded Treatment|Withdrawal by Subject|0
5486194|NCT01783015|18967502|P2|Blinded Treatment|Withdrawal by Subject|1
5486195|NCT01783015|18967503|P1|Blinded Treatment|Withdrawal by Subject|0
5486196|NCT01783015|18967501|P3|Blinded Treatment|Protocol Violation|0
5486197|NCT01783015|18967502|P2|Blinded Treatment|Protocol Violation|1
5486198|NCT01783015|18967503|P1|Blinded Treatment|Protocol Violation|0
5486199|NCT01783015|18967501|P3|Blinded Treatment|Adverse Event|0
5486200|NCT01783015|18967502|P2|Blinded Treatment|Adverse Event|1
5486201|NCT01783015|18967503|P1|Blinded Treatment|Adverse Event|0
5486202|NCT01782885|18967616|P2|Overall Study|Lost to Follow-up|6
5486203|NCT01782885|18967617|P1|Overall Study|Lost to Follow-up|4
5486204|NCT01782872|18967643|P4|Overall Study|Withdrawal by Subject|0
5486205|NCT01782872|18967644|P3|Overall Study|Withdrawal by Subject|0
5486206|NCT01782872|18967645|P2|Overall Study|Withdrawal by Subject|1
5486207|NCT01782872|18967646|P1|Overall Study|Withdrawal by Subject|0
5486208|NCT01782872|18967643|P4|Overall Study|Protocol Violation|1
5486209|NCT01782872|18967644|P3|Overall Study|Protocol Violation|0
5486210|NCT01782872|18967645|P2|Overall Study|Protocol Violation|0
5486211|NCT01782872|18967646|P1|Overall Study|Protocol Violation|0
5486212|NCT01782859|18967670|P2|Overall Study|Withdrawal by Subject|1
5486213|NCT01782859|18967671|P1|Overall Study|Withdrawal by Subject|0
5486214|NCT01782859|18967670|P2|Overall Study|Protocol Violation|6
5486215|NCT01782859|18967671|P1|Overall Study|Protocol Violation|6
5486216|NCT01782742|18967693|P2|Double-blind Treatment Phase|Adverse Event|0
5486217|NCT01782742|18967694|P1|Double-blind Treatment Phase|Adverse Event|1
5486218|NCT01782690|18967727|P1|Overall Study|Study completion unknown|7
5486219|NCT01782690|18967727|P1|Overall Study|Death|133
5486220|NCT01782690|18967727|P1|Overall Study|Tumor progression|74
5486221|NCT01782690|18967727|P1|Overall Study|Patient's wish|21
5486222|NCT01782690|18967727|P1|Overall Study|Physician Decision|13
5486223|NCT01782690|18967727|P1|Overall Study|Absent rash|9
5486224|NCT01782690|18967727|P1|Overall Study|Withdrawal of informed consent|2
5486225|NCT01782690|18967727|P1|Overall Study|Lost to Follow-up|31
5486226|NCT01782690|18967727|P1|Overall Study|Toxicity of erlotinib|1
5486227|NCT01782690|18967727|P1|Overall Study|Toxicity of gemcitabine|1
5486228|NCT01782690|18967727|P1|Overall Study|Not reported|7
5486229|NCT01782664|18967749|P6|Overall Study|Withdrawal by Subject|0
5486230|NCT01782664|18967750|P5|Overall Study|Withdrawal by Subject|0
5486231|NCT01782664|18967751|P4|Overall Study|Withdrawal by Subject|0
5486232|NCT01782664|18967752|P3|Overall Study|Withdrawal by Subject|0
5486233|NCT01782664|18967753|P2|Overall Study|Withdrawal by Subject|2
5486234|NCT01782664|18967754|P1|Overall Study|Withdrawal by Subject|2
5486235|NCT01782664|18967749|P6|Overall Study|Protocol Violation|0
5486236|NCT01782664|18967750|P5|Overall Study|Protocol Violation|0
5486237|NCT01782664|18967751|P4|Overall Study|Protocol Violation|1
5486238|NCT01782664|18967752|P3|Overall Study|Protocol Violation|0
5486239|NCT01782664|18967753|P2|Overall Study|Protocol Violation|1
5486240|NCT01782664|18967754|P1|Overall Study|Protocol Violation|0
5486241|NCT01782664|18967749|P6|Overall Study|Lack of Efficacy|0
5486242|NCT01782664|18967750|P5|Overall Study|Lack of Efficacy|0
5486243|NCT01782664|18967751|P4|Overall Study|Lack of Efficacy|2
5486244|NCT01782664|18967752|P3|Overall Study|Lack of Efficacy|2
5486245|NCT01782664|18967753|P2|Overall Study|Lack of Efficacy|0
5486246|NCT01782664|18967754|P1|Overall Study|Lack of Efficacy|2
5486247|NCT01782664|18967749|P6|Overall Study|Adverse Event|0
5486248|NCT01782664|18967750|P5|Overall Study|Adverse Event|0
5486249|NCT01782664|18967751|P4|Overall Study|Adverse Event|2
5486250|NCT01782664|18967752|P3|Overall Study|Adverse Event|2
5486251|NCT01782664|18967753|P2|Overall Study|Adverse Event|2
5486252|NCT01782664|18967754|P1|Overall Study|Adverse Event|2
5486253|NCT01782495|18967911|P11|Overall Study|Withdrew Consent|0
5486254|NCT01782495|18967912|P10|Overall Study|Withdrew Consent|0
5486255|NCT01782495|18967913|P9|Overall Study|Withdrew Consent|0
5486256|NCT01782495|18967914|P8|Overall Study|Withdrew Consent|1
5486257|NCT01782495|18967915|P7|Overall Study|Withdrew Consent|0
5486258|NCT01782495|18967916|P6|Overall Study|Withdrew Consent|0
5486259|NCT01782495|18967917|P5|Overall Study|Withdrew Consent|0
5486260|NCT01782495|18967918|P4|Overall Study|Withdrew Consent|0
5486261|NCT01782495|18967919|P3|Overall Study|Withdrew Consent|0
5486262|NCT01782495|18967920|P2|Overall Study|Withdrew Consent|1
5486263|NCT01782495|18967921|P1|Overall Study|Withdrew Consent|0
5486264|NCT01782495|18967911|P11|Overall Study|Adverse Event|0
5486265|NCT01782495|18967912|P10|Overall Study|Adverse Event|0
5486266|NCT01782495|18967913|P9|Overall Study|Adverse Event|0
5486267|NCT01782495|18967914|P8|Overall Study|Adverse Event|2
5486268|NCT01782495|18967915|P7|Overall Study|Adverse Event|0
5486269|NCT01782495|18967916|P6|Overall Study|Adverse Event|0
5486270|NCT01782495|18967917|P5|Overall Study|Adverse Event|0
5486271|NCT01782495|18967918|P4|Overall Study|Adverse Event|0
5486272|NCT01782495|18967919|P3|Overall Study|Adverse Event|0
5486273|NCT01782495|18967920|P2|Overall Study|Adverse Event|0
5486274|NCT01782495|18967921|P1|Overall Study|Adverse Event|0
5486275|NCT01782482|18967980|P2|Overall Study|Habitually wearing toric lens OS|1
5486276|NCT01782482|18967981|P1|Overall Study|Habitually wearing toric lens OS|0
5486277|NCT01782482|18967980|P2|Overall Study|Randomized in Error|2
5486278|NCT01782482|18967981|P1|Overall Study|Randomized in Error|2
5486279|NCT01782482|18967980|P2|Overall Study|Withdrawal by Subject|3
5486280|NCT01782482|18967981|P1|Overall Study|Withdrawal by Subject|2
5486281|NCT01782482|18967980|P2|Overall Study|Protocol Violation|0
5486282|NCT01782482|18967981|P1|Overall Study|Protocol Violation|1
5486283|NCT01782482|18967980|P2|Overall Study|Physician Decision|0
5486284|NCT01782482|18967981|P1|Overall Study|Physician Decision|1
5486285|NCT01782482|18967980|P2|Overall Study|Lost to Follow-up|3
5486286|NCT01782482|18967981|P1|Overall Study|Lost to Follow-up|2
5486287|NCT01782482|18967980|P2|Overall Study|Adverse Event|1
5486288|NCT01782482|18967981|P1|Overall Study|Adverse Event|2
5486289|NCT01782469|18967989|P1|Overall Study|Lost to Follow-up|1
5486290|NCT01782378|18967999|P2|Second Series|Did not choose to complete S2 Optional|0
5486291|NCT01782378|18968000|P1|Second Series|Did not choose to complete S2 Optional|18
5486292|NCT01782378|18967999|P2|Second Series|Lost to Follow-up|7
5486293|NCT01782378|18968000|P1|Second Series|Lost to Follow-up|8
5486294|NCT01782378|18967999|P2|Second Series|Partial Crossover Design- no Sham 2nd|25
5486295|NCT01782378|18968000|P1|Second Series|Partial Crossover Design- no Sham 2nd|0
5486296|NCT01782378|18967999|P2|First Series|Lost to Follow-up|8
5486297|NCT01782378|18968000|P1|First Series|Lost to Follow-up|7
5486298|NCT01782326|18968066|P2|Double-blind Treatment|Technical problems|5
5486299|NCT01782326|18968067|P1|Double-blind Treatment|Technical problems|0
5486300|NCT01782326|18968066|P2|Double-blind Treatment|Protocol deviation|7
5486301|NCT01782326|18968067|P1|Double-blind Treatment|Protocol deviation|8
5486302|NCT01782326|18968066|P2|Double-blind Treatment|Physician Decision|16
5486303|NCT01782326|18968067|P1|Double-blind Treatment|Physician Decision|13
5486304|NCT01782326|18968066|P2|Double-blind Treatment|Lack of Efficacy|22
5486305|NCT01782326|18968067|P1|Double-blind Treatment|Lack of Efficacy|17
5486306|NCT01782326|18968066|P2|Double-blind Treatment|Subject/guardian decision|125
5486307|NCT01782326|18968067|P1|Double-blind Treatment|Subject/guardian decision|111
5486308|NCT01782326|18968066|P2|Double-blind Treatment|Adverse Event|145
5486309|NCT01782326|18968067|P1|Double-blind Treatment|Adverse Event|129
5486310|NCT01782326|18968066|P2|Planned Treatment Epoch|Technical problems|4
5486311|NCT01782326|18968067|P1|Planned Treatment Epoch|Technical problems|0
5486312|NCT01782326|18968066|P2|Planned Treatment Epoch|Lost to Follow-up|4
5486313|NCT01782326|18968067|P1|Planned Treatment Epoch|Lost to Follow-up|4
5486314|NCT01782326|18968066|P2|Planned Treatment Epoch|Protocol deviation|3
5486315|NCT01782326|18968067|P1|Planned Treatment Epoch|Protocol deviation|2
5486316|NCT01782326|18968066|P2|Planned Treatment Epoch|Physician Decision|16
5486317|NCT01782326|18968067|P1|Planned Treatment Epoch|Physician Decision|18
5486318|NCT01782326|18968066|P2|Planned Treatment Epoch|Death|30
5486319|NCT01782326|18968067|P1|Planned Treatment Epoch|Death|29
5486320|NCT01782326|18968066|P2|Planned Treatment Epoch|Subject/guardian decision|151
5486321|NCT01782326|18968067|P1|Planned Treatment Epoch|Subject/guardian decision|149
5486322|NCT01782313|18968127|P1|Survival Follow up|Lost to Follow-up|1
5486323|NCT01782313|18968127|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
5486324|NCT01782313|18968127|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
5486325|NCT01782313|18968127|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
5486326|NCT01782313|18968127|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
5486327|NCT01782313|18968127|P1|Treated Cycle 3|Progressive Disease|21
5486328|NCT01782313|18968127|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
5486329|NCT01782313|18968127|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
5486330|NCT01782222|18968141|P3|Overall Study|Moved to other state|0
5486331|NCT01782222|18968142|P2|Overall Study|Moved to other state|1
5486332|NCT01782222|18968143|P1|Overall Study|Moved to other state|0
5486333|NCT01782222|18968141|P3|Overall Study|Withdrawal by Subject|1
5486334|NCT01782222|18968142|P2|Overall Study|Withdrawal by Subject|4
5486335|NCT01782222|18968143|P1|Overall Study|Withdrawal by Subject|1
5486336|NCT01782222|18968141|P3|Overall Study|Protocol Violation|0
5486337|NCT01782222|18968142|P2|Overall Study|Protocol Violation|0
5486338|NCT01782222|18968143|P1|Overall Study|Protocol Violation|1
5486339|NCT01782222|18968141|P3|Overall Study|Lack of Efficacy|0
5486340|NCT01782222|18968142|P2|Overall Study|Lack of Efficacy|1
5486341|NCT01782222|18968143|P1|Overall Study|Lack of Efficacy|2
5486342|NCT01782222|18968141|P3|Overall Study|Adverse Event|3
5486343|NCT01782222|18968142|P2|Overall Study|Adverse Event|5
5486344|NCT01782222|18968143|P1|Overall Study|Adverse Event|4
5486345|NCT01782131|18968181|P2|Overall Study|Reason not provided|1
5486346|NCT01782131|18968182|P1|Overall Study|Reason not provided|0
5486347|NCT01782131|18968181|P2|Overall Study|Randomized but not treated|5
5486348|NCT01782131|18968182|P1|Overall Study|Randomized but not treated|5
5486349|NCT01782131|18968181|P2|Overall Study|Withdrawal by Subject|10
5486350|NCT01782131|18968182|P1|Overall Study|Withdrawal by Subject|10
5486351|NCT01782131|18968181|P2|Overall Study|Lost to Follow-up|3
5486352|NCT01782131|18968182|P1|Overall Study|Lost to Follow-up|1
5486353|NCT01782131|18968181|P2|Overall Study|Death|96
5486354|NCT01782131|18968182|P1|Overall Study|Death|93
5486355|NCT01781975|18968219|P2|Overall Study|Withdrawal by Subject|1
5486356|NCT01781975|18968220|P1|Overall Study|Withdrawal by Subject|1
5486357|NCT01781975|18968219|P2|Overall Study|Death|0
5486358|NCT01781975|18968220|P1|Overall Study|Death|1
5486359|NCT01781962|18968236|P1|Overall Study|Other Miscellaneous Reasons|5
5486360|NCT01781832|18968242|P1|Overall Study|Withdrawal by Subject|1
5486361|NCT01781637|18968262|P2|Overall Study|Withdrawal by Subject|0
5486362|NCT01781637|18968263|P1|Overall Study|Withdrawal by Subject|1
5486363|NCT01781637|18968262|P2|Overall Study|Lack of Efficacy|6
5486364|NCT01781637|18968263|P1|Overall Study|Lack of Efficacy|2
5486365|NCT01781637|18968262|P2|Overall Study|Adverse Event|0
5486366|NCT01781637|18968263|P1|Overall Study|Adverse Event|1
5486367|NCT01781611|18968273|P2|Overall Study|Adverse Event|0
5486368|NCT01781611|18968274|P1|Overall Study|Adverse Event|4
5486369|NCT01781572|18968295|P3|MEK162 45mg LEE011 600mg|Progressive Disease|0
5486370|NCT01781572|18968296|P2|MEK162 45mg LEE011 600mg|Progressive Disease|5
5486371|NCT01781572|18968297|P1|MEK162 45mg LEE011 600mg|Progressive Disease|0
5486372|NCT01781572|18968295|P3|MEK162 45mg LEE011 600mg|Adverse Event|0
5486373|NCT01781572|18968296|P2|MEK162 45mg LEE011 600mg|Adverse Event|1
5486374|NCT01781572|18968297|P1|MEK162 45mg LEE011 600mg|Adverse Event|0
5486375|NCT01781572|18968295|P3|MEK162 45mg LEE011 450mg|Progressive Disease|0
5486376|NCT01781572|18968296|P2|MEK162 45mg LEE011 450mg|Progressive Disease|6
5486377|NCT01781572|18968297|P1|MEK162 45mg LEE011 450mg|Progressive Disease|0
5486378|NCT01781572|18968295|P3|MEK162 45mg LEE011 450mg|Physician Decision|0
5486379|NCT01781572|18968296|P2|MEK162 45mg LEE011 450mg|Physician Decision|2
5486380|NCT01781572|18968297|P1|MEK162 45mg LEE011 450mg|Physician Decision|0
5486381|NCT01781572|18968295|P3|MEK162 45mg LEE011 450mg|Adverse Event|0
5486382|NCT01781572|18968296|P2|MEK162 45mg LEE011 450mg|Adverse Event|1
5486383|NCT01781572|18968297|P1|MEK162 45mg LEE011 450mg|Adverse Event|0
5486384|NCT01781572|18968295|P3|MEK162 30mg LEE011 200mg|Progressive Disease|0
5486385|NCT01781572|18968296|P2|MEK162 30mg LEE011 200mg|Progressive Disease|5
5486386|NCT01781572|18968297|P1|MEK162 30mg LEE011 200mg|Progressive Disease|0
5486387|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 300mg|Death|0
5486388|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 300mg|Death|0
5486389|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 300mg|Death|1
5486390|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
5486391|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
5486392|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
5486393|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
5486394|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
5486395|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
5486396|NCT01781572|18968295|P3|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
5486397|NCT01781572|18968296|P2|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
5486398|NCT01781572|18968297|P1|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
5486399|NCT01781572|18968295|P3|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
5486400|NCT01781572|18968296|P2|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
5486401|NCT01781572|18968297|P1|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
5486402|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
5486403|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
5486404|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
5486405|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
5486406|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
5486407|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
5486408|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 200mg|Death|1
5486409|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 200mg|Death|0
5486410|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 200mg|Death|0
5486411|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
5486412|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
5486413|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
5486414|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
5486415|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
5486416|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
5486417|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
5486418|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
5486419|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
5486420|NCT01781572|18968295|P3|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
5486421|NCT01781572|18968296|P2|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
5486422|NCT01781572|18968297|P1|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
5486423|NCT01781429|18968638|P16|Overall Study|Enrolled, but not treated|0
5486424|NCT01781429|18968639|P15|Overall Study|Enrolled, but not treated|0
5486425|NCT01781429|18968640|P14|Overall Study|Enrolled, but not treated|0
5486426|NCT01781429|18968641|P13|Overall Study|Enrolled, but not treated|0
5486427|NCT01781429|18968642|P12|Overall Study|Enrolled, but not treated|0
5486428|NCT01781429|18968643|P11|Overall Study|Enrolled, but not treated|1
5486429|NCT01781429|18968644|P10|Overall Study|Enrolled, but not treated|0
5486430|NCT01781429|18968645|P9|Overall Study|Enrolled, but not treated|0
5486431|NCT01781429|18968646|P8|Overall Study|Enrolled, but not treated|0
5486432|NCT01781429|18968647|P7|Overall Study|Enrolled, but not treated|0
5486433|NCT01781429|18968648|P6|Overall Study|Enrolled, but not treated|0
5486434|NCT01781429|18968649|P5|Overall Study|Enrolled, but not treated|0
5486435|NCT01781429|18968650|P4|Overall Study|Enrolled, but not treated|0
5486436|NCT01781429|18968651|P3|Overall Study|Enrolled, but not treated|0
5486437|NCT01781429|18968652|P2|Overall Study|Enrolled, but not treated|0
5486438|NCT01781429|18968653|P1|Overall Study|Enrolled, but not treated|0
5486439|NCT01781429|18968638|P16|Overall Study|Other - as entered by PI in eCRF|0
5486440|NCT01781429|18968639|P15|Overall Study|Other - as entered by PI in eCRF|1
5486441|NCT01781429|18968640|P14|Overall Study|Other - as entered by PI in eCRF|1
5486442|NCT01781429|18968641|P13|Overall Study|Other - as entered by PI in eCRF|1
5486443|NCT01781429|18968642|P12|Overall Study|Other - as entered by PI in eCRF|2
5486444|NCT01781429|18968643|P11|Overall Study|Other - as entered by PI in eCRF|1
5486445|NCT01781429|18968644|P10|Overall Study|Other - as entered by PI in eCRF|1
5486446|NCT01781429|18968645|P9|Overall Study|Other - as entered by PI in eCRF|0
5486447|NCT01781429|18968646|P8|Overall Study|Other - as entered by PI in eCRF|0
5486448|NCT01781429|18968647|P7|Overall Study|Other - as entered by PI in eCRF|0
5486449|NCT01781429|18968648|P6|Overall Study|Other - as entered by PI in eCRF|0
5486450|NCT01781429|18968649|P5|Overall Study|Other - as entered by PI in eCRF|0
5486451|NCT01781429|18968650|P4|Overall Study|Other - as entered by PI in eCRF|0
5486452|NCT01781429|18968651|P3|Overall Study|Other - as entered by PI in eCRF|0
5486453|NCT01781429|18968652|P2|Overall Study|Other - as entered by PI in eCRF|1
5486454|NCT01781429|18968653|P1|Overall Study|Other - as entered by PI in eCRF|0
5486455|NCT01781429|18968638|P16|Overall Study|Patient Condition Changed|0
5486456|NCT01781429|18968639|P15|Overall Study|Patient Condition Changed|0
5486457|NCT01781429|18968640|P14|Overall Study|Patient Condition Changed|1
5486458|NCT01781429|18968641|P13|Overall Study|Patient Condition Changed|0
5486459|NCT01781429|18968642|P12|Overall Study|Patient Condition Changed|1
5486460|NCT01781429|18968643|P11|Overall Study|Patient Condition Changed|0
5486461|NCT01781429|18968644|P10|Overall Study|Patient Condition Changed|4
5486462|NCT01781429|18968645|P9|Overall Study|Patient Condition Changed|0
5486463|NCT01781429|18968646|P8|Overall Study|Patient Condition Changed|0
5486464|NCT01781429|18968647|P7|Overall Study|Patient Condition Changed|0
5486465|NCT01781429|18968648|P6|Overall Study|Patient Condition Changed|0
5486466|NCT01781429|18968649|P5|Overall Study|Patient Condition Changed|0
5486467|NCT01781429|18968650|P4|Overall Study|Patient Condition Changed|0
5486468|NCT01781429|18968651|P3|Overall Study|Patient Condition Changed|0
5486469|NCT01781429|18968652|P2|Overall Study|Patient Condition Changed|0
5486470|NCT01781429|18968653|P1|Overall Study|Patient Condition Changed|0
5486471|NCT01781429|18968638|P16|Overall Study|Unacceptable Toxicity|0
5486472|NCT01781429|18968639|P15|Overall Study|Unacceptable Toxicity|0
5486473|NCT01781429|18968640|P14|Overall Study|Unacceptable Toxicity|0
5486474|NCT01781429|18968641|P13|Overall Study|Unacceptable Toxicity|0
5486475|NCT01781429|18968642|P12|Overall Study|Unacceptable Toxicity|2
5486476|NCT01781429|18968643|P11|Overall Study|Unacceptable Toxicity|0
5486477|NCT01781429|18968644|P10|Overall Study|Unacceptable Toxicity|0
5486478|NCT01781429|18968645|P9|Overall Study|Unacceptable Toxicity|0
5486479|NCT01781429|18968646|P8|Overall Study|Unacceptable Toxicity|0
5486480|NCT01781429|18968647|P7|Overall Study|Unacceptable Toxicity|0
5486481|NCT01781429|18968648|P6|Overall Study|Unacceptable Toxicity|0
5486482|NCT01781429|18968649|P5|Overall Study|Unacceptable Toxicity|0
5486483|NCT01781429|18968650|P4|Overall Study|Unacceptable Toxicity|0
5486484|NCT01781429|18968651|P3|Overall Study|Unacceptable Toxicity|0
5486485|NCT01781429|18968652|P2|Overall Study|Unacceptable Toxicity|0
5486486|NCT01781429|18968653|P1|Overall Study|Unacceptable Toxicity|0
5486487|NCT01781429|18968638|P16|Overall Study|Disease Progression|0
5486488|NCT01781429|18968639|P15|Overall Study|Disease Progression|11
5486489|NCT01781429|18968640|P14|Overall Study|Disease Progression|4
5486490|NCT01781429|18968641|P13|Overall Study|Disease Progression|15
5486491|NCT01781429|18968642|P12|Overall Study|Disease Progression|15
5486492|NCT01781429|18968643|P11|Overall Study|Disease Progression|15
5486493|NCT01781429|18968644|P10|Overall Study|Disease Progression|15
5486494|NCT01781429|18968645|P9|Overall Study|Disease Progression|6
5486495|NCT01781429|18968646|P8|Overall Study|Disease Progression|4
5486496|NCT01781429|18968647|P7|Overall Study|Disease Progression|7
5486497|NCT01781429|18968648|P6|Overall Study|Disease Progression|4
5486498|NCT01781429|18968649|P5|Overall Study|Disease Progression|1
5486499|NCT01781429|18968650|P4|Overall Study|Disease Progression|1
5486500|NCT01781429|18968651|P3|Overall Study|Disease Progression|1
5486501|NCT01781429|18968652|P2|Overall Study|Disease Progression|0
5486502|NCT01781429|18968653|P1|Overall Study|Disease Progression|1
5486503|NCT01781429|18968638|P16|Overall Study|Withdrawal by Subject|0
5486504|NCT01781429|18968639|P15|Overall Study|Withdrawal by Subject|3
5486505|NCT01781429|18968640|P14|Overall Study|Withdrawal by Subject|2
5486506|NCT01781429|18968641|P13|Overall Study|Withdrawal by Subject|5
5486507|NCT01781429|18968642|P12|Overall Study|Withdrawal by Subject|1
5486508|NCT01781429|18968643|P11|Overall Study|Withdrawal by Subject|1
5486509|NCT01781429|18968644|P10|Overall Study|Withdrawal by Subject|3
5486510|NCT01781429|18968645|P9|Overall Study|Withdrawal by Subject|1
5486511|NCT01781429|18968646|P8|Overall Study|Withdrawal by Subject|0
5486512|NCT01781429|18968647|P7|Overall Study|Withdrawal by Subject|0
5486513|NCT01781429|18968648|P6|Overall Study|Withdrawal by Subject|0
5486514|NCT01781429|18968649|P5|Overall Study|Withdrawal by Subject|0
5486515|NCT01781429|18968650|P4|Overall Study|Withdrawal by Subject|0
5486516|NCT01781429|18968651|P3|Overall Study|Withdrawal by Subject|0
5486517|NCT01781429|18968652|P2|Overall Study|Withdrawal by Subject|0
5486518|NCT01781429|18968653|P1|Overall Study|Withdrawal by Subject|0
5486519|NCT01781429|18968638|P16|Overall Study|Death|0
5486520|NCT01781429|18968639|P15|Overall Study|Death|1
5486521|NCT01781429|18968640|P14|Overall Study|Death|0
5486522|NCT01781429|18968641|P13|Overall Study|Death|1
5486523|NCT01781429|18968642|P12|Overall Study|Death|0
5486524|NCT01781429|18968643|P11|Overall Study|Death|0
5486525|NCT01781429|18968644|P10|Overall Study|Death|1
5486526|NCT01781429|18968645|P9|Overall Study|Death|0
5486527|NCT01781429|18968646|P8|Overall Study|Death|0
5486528|NCT01781429|18968647|P7|Overall Study|Death|0
5486529|NCT01781429|18968648|P6|Overall Study|Death|0
5486530|NCT01781429|18968649|P5|Overall Study|Death|0
5486531|NCT01781429|18968650|P4|Overall Study|Death|0
5486532|NCT01781429|18968651|P3|Overall Study|Death|0
5486533|NCT01781429|18968652|P2|Overall Study|Death|0
5486534|NCT01781429|18968653|P1|Overall Study|Death|0
5486535|NCT01781299|18968730|P2|Overall Study|Withdrawal by Subject|1
5486536|NCT01781299|18968731|P1|Overall Study|Withdrawal by Subject|0
5486537|NCT01781286|18968739|P6|Overall Study|Noncompliance|0
5486538|NCT01781286|18968740|P5|Overall Study|Noncompliance|0
5486539|NCT01781286|18968741|P4|Overall Study|Noncompliance|1
5486540|NCT01781286|18968742|P3|Overall Study|Noncompliance|0
5486541|NCT01781286|18968743|P2|Overall Study|Noncompliance|0
5486542|NCT01781286|18968744|P1|Overall Study|Noncompliance|0
5486543|NCT01781286|18968739|P6|Overall Study|Time Constraints|0
5486544|NCT01781286|18968740|P5|Overall Study|Time Constraints|0
5486545|NCT01781286|18968741|P4|Overall Study|Time Constraints|0
5486546|NCT01781286|18968742|P3|Overall Study|Time Constraints|2
5486547|NCT01781286|18968743|P2|Overall Study|Time Constraints|0
5486548|NCT01781286|18968744|P1|Overall Study|Time Constraints|2
5486549|NCT01781286|18968739|P6|Overall Study|Lost to Follow-up|1
5486550|NCT01781286|18968740|P5|Overall Study|Lost to Follow-up|0
5486551|NCT01781286|18968741|P4|Overall Study|Lost to Follow-up|0
5486552|NCT01781286|18968742|P3|Overall Study|Lost to Follow-up|0
5486553|NCT01781286|18968743|P2|Overall Study|Lost to Follow-up|0
5486554|NCT01781286|18968744|P1|Overall Study|Lost to Follow-up|0
5486555|NCT01781234|18968769|P2|Overall Study|Withdrawal by Subject|3
5486556|NCT01781234|18968770|P1|Overall Study|Withdrawal by Subject|4
5486557|NCT01781234|18968769|P2|Overall Study|Protocol Violation|0
5486558|NCT01781234|18968770|P1|Overall Study|Protocol Violation|3
5486559|NCT01781234|18968769|P2|Overall Study|Adverse Event|0
5486560|NCT01781234|18968770|P1|Overall Study|Adverse Event|2
5486561|NCT01781026|18968808|P1|Overall Study|Lack of Efficacy|2
5486562|NCT01780987|18968814|P2|Overall Study|Not Receiving any Study Medication|1
5486563|NCT01780987|18968815|P1|Overall Study|Not Receiving any Study Medication|0
5486564|NCT01780987|18968814|P2|Overall Study|Changing Residence|0
5486565|NCT01780987|18968815|P1|Overall Study|Changing Residence|1
5486566|NCT01780987|18968814|P2|Overall Study|Request of Changing Hospital|1
5486567|NCT01780987|18968815|P1|Overall Study|Request of Changing Hospital|0
5486568|NCT01780987|18968814|P2|Overall Study|Withdrawal by Subject|0
5486569|NCT01780987|18968815|P1|Overall Study|Withdrawal by Subject|2
5486570|NCT01780987|18968814|P2|Overall Study|Adverse Event|4
5486571|NCT01780987|18968815|P1|Overall Study|Adverse Event|0
5486572|NCT01780974|18968833|P2|Overall Study|Adverse Event|3
5486573|NCT01780974|18968834|P1|Overall Study|Adverse Event|1
5486574|NCT01780974|18968833|P2|Overall Study|Death|0
5486575|NCT01780974|18968834|P1|Overall Study|Death|1
5486576|NCT01780935|18968844|P2|Overall Study|Patient withdrew consent|9
5486577|NCT01780935|18968845|P1|Overall Study|Patient withdrew consent|8
5486578|NCT01780935|18968844|P2|Overall Study|Protocol deviation|1
5486579|NCT01780935|18968845|P1|Overall Study|Protocol deviation|0
5486580|NCT01780935|18968844|P2|Overall Study|Physician Decision|1
5486581|NCT01780935|18968845|P1|Overall Study|Physician Decision|1
5486582|NCT01780935|18968844|P2|Overall Study|Lost to Follow-up|6
5486583|NCT01780935|18968845|P1|Overall Study|Lost to Follow-up|2
5486584|NCT01780935|18968844|P2|Overall Study|Death|6
5486585|NCT01780935|18968845|P1|Overall Study|Death|1
5486586|NCT01780935|18968844|P2|Overall Study|Adverse Event|4
5486587|NCT01780935|18968845|P1|Overall Study|Adverse Event|2
5486588|NCT01780935|18968844|P2|Overall Study|Admin problems due to early termination|309
5486589|NCT01780935|18968845|P1|Overall Study|Admin problems due to early termination|321
5486590|NCT01780831|18968950|P4|Overall Study|Lost to Follow-up|1
5486591|NCT01780831|18968951|P3|Overall Study|Lost to Follow-up|0
5486592|NCT01780831|18968952|P2|Overall Study|Lost to Follow-up|0
5486593|NCT01780831|18968953|P1|Overall Study|Lost to Follow-up|0
5486594|NCT01780831|18968950|P4|Overall Study|Withdrawal by Subject|0
5486595|NCT01780831|18968951|P3|Overall Study|Withdrawal by Subject|4
5486596|NCT01780831|18968952|P2|Overall Study|Withdrawal by Subject|0
5486597|NCT01780831|18968953|P1|Overall Study|Withdrawal by Subject|0
5486598|NCT01780662|18969021|P3|Overall Study|Ineligible|1
5486599|NCT01780662|18969022|P2|Overall Study|Ineligible|0
5486600|NCT01780662|18969023|P1|Overall Study|Ineligible|0
5486601|NCT01780662|18969021|P3|Overall Study|Protocol Violation|0
5486602|NCT01780662|18969022|P2|Overall Study|Protocol Violation|1
5486603|NCT01780662|18969023|P1|Overall Study|Protocol Violation|0
5486604|NCT01780662|18969021|P3|Overall Study|Physician Decision|7
5486605|NCT01780662|18969022|P2|Overall Study|Physician Decision|5
5486606|NCT01780662|18969023|P1|Overall Study|Physician Decision|0
5486607|NCT01780662|18969021|P3|Overall Study|Adverse Event|2
5486608|NCT01780662|18969022|P2|Overall Study|Adverse Event|0
5486609|NCT01780662|18969023|P1|Overall Study|Adverse Event|1
5486610|NCT01780584|18969040|P3|Overall Study|Protocol Violation|1
5486611|NCT01780584|18969041|P2|Overall Study|Protocol Violation|0
5486612|NCT01780584|18969042|P1|Overall Study|Protocol Violation|0
5486613|NCT01780584|18969040|P3|Overall Study|Adverse Event|0
5486614|NCT01780584|18969041|P2|Overall Study|Adverse Event|1
5486615|NCT01780584|18969042|P1|Overall Study|Adverse Event|0
5486616|NCT01780584|18969040|P3|Overall Study|Death|1
5486617|NCT01780584|18969041|P2|Overall Study|Death|0
5486618|NCT01780584|18969042|P1|Overall Study|Death|1
5486619|NCT01780545|18969064|P2|Overall Study|Lost to Follow-up|1
5486620|NCT01780545|18969065|P1|Overall Study|Lost to Follow-up|1
5486621|NCT01780545|18969064|P2|Overall Study|Withdrawal by Subject|1
5486622|NCT01780545|18969065|P1|Overall Study|Withdrawal by Subject|3
5486623|NCT01780506|18969083|P2|Open-Label Extension Phase|Enrolled but not Treated|1
5486624|NCT01780506|18969084|P1|Open-Label Extension Phase|Enrolled but not Treated|0
5486625|NCT01780506|18969083|P2|Double-Blind Phase|Lost to Follow-up|26
5486626|NCT01780506|18969084|P1|Double-Blind Phase|Lost to Follow-up|23
5486627|NCT01780506|18969083|P2|Double-Blind Phase|Withdrew Consent|24
5486628|NCT01780506|18969084|P1|Double-Blind Phase|Withdrew Consent|23
5486629|NCT01780506|18969083|P2|Double-Blind Phase|Protocol Violation|3
5486630|NCT01780506|18969084|P1|Double-Blind Phase|Protocol Violation|4
5486631|NCT01780506|18969083|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
5486632|NCT01780506|18969084|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
5486633|NCT01780506|18969083|P2|Double-Blind Phase|Investigator's Discretion|2
5486634|NCT01780506|18969084|P1|Double-Blind Phase|Investigator's Discretion|5
5486635|NCT01780506|18969083|P2|Double-Blind Phase|Lack of Efficacy|1
5486636|NCT01780506|18969084|P1|Double-Blind Phase|Lack of Efficacy|1
5486637|NCT01780506|18969083|P2|Double-Blind Phase|Pregnancy|1
5486638|NCT01780506|18969084|P1|Double-Blind Phase|Pregnancy|2
5486639|NCT01780506|18969083|P2|Double-Blind Phase|Death|2
5486640|NCT01780506|18969084|P1|Double-Blind Phase|Death|1
5486641|NCT01780506|18969083|P2|Double-Blind Phase|Adverse Event|14
5486642|NCT01780506|18969084|P1|Double-Blind Phase|Adverse Event|4
5486643|NCT01780506|18969083|P2|Double-Blind Phase|Randomized but not Treated|2
5486644|NCT01780506|18969084|P1|Double-Blind Phase|Randomized but not Treated|3
5486645|NCT01780389|18969142|P1|Overall Study|Adverse Event|1
5486646|NCT01779869|18969180|P1|Overall Study|Physician Decision|2
5486647|NCT01779700|18969186|P2|Overall Study|Withdrawal by Subject|2
5486648|NCT01779700|18969187|P1|Overall Study|Withdrawal by Subject|0
5486649|NCT01779700|18969186|P2|Overall Study|Adverse Event|3
5486650|NCT01779700|18969187|P1|Overall Study|Adverse Event|4
5486651|NCT01779648|18969227|P2|Overall Study|Protocol Violation|0
5486652|NCT01779648|18969228|P1|Overall Study|Protocol Violation|1
5486653|NCT01779440|18969258|P2|Overall Study|Withdrawal by Subject|5
5486654|NCT01779440|18969259|P1|Overall Study|Withdrawal by Subject|3
5486655|NCT01778985|18969324|P2|Overall Study|Protocol Violation|1
5486656|NCT01778985|18969325|P1|Overall Study|Protocol Violation|4
5486657|NCT01778985|18969324|P2|Overall Study|Physician Decision|2
5486658|NCT01778985|18969325|P1|Overall Study|Physician Decision|2
5486659|NCT01778985|18969324|P2|Overall Study|Lost to Follow-up|0
5486660|NCT01778985|18969325|P1|Overall Study|Lost to Follow-up|1
5486661|NCT01778855|18969371|P2|Overall Study|Death|1
5486662|NCT01778855|18969372|P1|Overall Study|Death|0
5486663|NCT01778751|18969380|P2|Overall Study|Transfered care|0
5486664|NCT01778751|18969381|P1|Overall Study|Transfered care|1
5486665|NCT01778751|18969380|P2|Overall Study|Withdrawal by Subject|2
5486666|NCT01778751|18969381|P1|Overall Study|Withdrawal by Subject|0
5486667|NCT01778751|18969380|P2|Overall Study|Lost to Follow-up|0
5486668|NCT01778751|18969381|P1|Overall Study|Lost to Follow-up|1
5486669|NCT01778556|18969438|P2|Long-term Follow-up|noncompliance with metreleptin|0
5486670|NCT01778556|18969439|P1|Long-term Follow-up|noncompliance with metreleptin|1
5486671|NCT01778556|18969438|P2|Intervention 2 (14 Days)|Protocol Violation|0
5486672|NCT01778556|18969439|P1|Intervention 2 (14 Days)|Protocol Violation|1
5486673|NCT01778556|18969438|P2|Intervention 1 (5 Days)|Withdrawal by Subject|1
5486674|NCT01778556|18969439|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
5486675|NCT01778556|18969438|P2|Intervention 1 (5 Days)|Protocol Violation|1
5486676|NCT01778556|18969439|P1|Intervention 1 (5 Days)|Protocol Violation|0
5486677|NCT01778530|18969452|P1|Overall Study|Adverse event/side effect|1
5486678|NCT01778530|18969452|P1|Overall Study|Progression on study|1
5486679|NCT01778127|18969494|P3|Overall Study|Withdrawal by Subject|4
5486680|NCT01778127|18969495|P2|Overall Study|Withdrawal by Subject|1
5486681|NCT01778127|18969496|P1|Overall Study|Withdrawal by Subject|3
5486682|NCT01778127|18969494|P3|Overall Study|Lost to Follow-up|2
5486683|NCT01778127|18969495|P2|Overall Study|Lost to Follow-up|1
5486684|NCT01778127|18969496|P1|Overall Study|Lost to Follow-up|5
5486685|NCT01778062|18969539|P2|Overall Study|major protocol deviation|3
5486686|NCT01778062|18969540|P1|Overall Study|major protocol deviation|4
5486687|NCT01778062|18969539|P2|Overall Study|Consent Withdrawal|5
5486688|NCT01778062|18969540|P1|Overall Study|Consent Withdrawal|1
5486689|NCT01778062|18969539|P2|Overall Study|Adverse Event|3
5486690|NCT01778062|18969540|P1|Overall Study|Adverse Event|1
5486691|NCT01778049|18969554|P6|Double Blind Treatment Period|Other reason not defined above|1
5486692|NCT01778049|18969555|P5|Double Blind Treatment Period|Other reason not defined above|2
5486693|NCT01778049|18969556|P4|Double Blind Treatment Period|Other reason not defined above|2
5486694|NCT01778049|18969557|P3|Double Blind Treatment Period|Other reason not defined above|4
5486695|NCT01778049|18969558|P2|Double Blind Treatment Period|Other reason not defined above|0
5486696|NCT01778049|18969559|P1|Double Blind Treatment Period|Other reason not defined above|0
5486697|NCT01778049|18969554|P6|Double Blind Treatment Period|Not treated|0
5486698|NCT01778049|18969555|P5|Double Blind Treatment Period|Not treated|2
5486699|NCT01778049|18969556|P4|Double Blind Treatment Period|Not treated|2
5486700|NCT01778049|18969557|P3|Double Blind Treatment Period|Not treated|0
5486701|NCT01778049|18969558|P2|Double Blind Treatment Period|Not treated|0
5486702|NCT01778049|18969559|P1|Double Blind Treatment Period|Not treated|0
5486703|NCT01778049|18969554|P6|Double Blind Treatment Period|Withdrawal by Subject|1
5486704|NCT01778049|18969555|P5|Double Blind Treatment Period|Withdrawal by Subject|0
5486705|NCT01778049|18969556|P4|Double Blind Treatment Period|Withdrawal by Subject|2
5486706|NCT01778049|18969557|P3|Double Blind Treatment Period|Withdrawal by Subject|1
5486707|NCT01778049|18969558|P2|Double Blind Treatment Period|Withdrawal by Subject|0
5486708|NCT01778049|18969559|P1|Double Blind Treatment Period|Withdrawal by Subject|0
5486709|NCT01778049|18969554|P6|Double Blind Treatment Period|Lost to Follow-up|2
5486710|NCT01778049|18969555|P5|Double Blind Treatment Period|Lost to Follow-up|5
5486711|NCT01778049|18969556|P4|Double Blind Treatment Period|Lost to Follow-up|1
5486712|NCT01778049|18969557|P3|Double Blind Treatment Period|Lost to Follow-up|4
5486713|NCT01778049|18969558|P2|Double Blind Treatment Period|Lost to Follow-up|0
5486714|NCT01778049|18969559|P1|Double Blind Treatment Period|Lost to Follow-up|0
5486715|NCT01778049|18969554|P6|Double Blind Treatment Period|Protocol Violation|0
5486716|NCT01778049|18969555|P5|Double Blind Treatment Period|Protocol Violation|0
5486717|NCT01778049|18969556|P4|Double Blind Treatment Period|Protocol Violation|0
5486718|NCT01778049|18969557|P3|Double Blind Treatment Period|Protocol Violation|2
5486719|NCT01778049|18969558|P2|Double Blind Treatment Period|Protocol Violation|0
5486720|NCT01778049|18969559|P1|Double Blind Treatment Period|Protocol Violation|0
5486721|NCT01778049|18969554|P6|Double Blind Treatment Period|Lack of Efficacy|1
5486722|NCT01778049|18969555|P5|Double Blind Treatment Period|Lack of Efficacy|0
5486723|NCT01778049|18969556|P4|Double Blind Treatment Period|Lack of Efficacy|0
5486724|NCT01778049|18969557|P3|Double Blind Treatment Period|Lack of Efficacy|0
5486725|NCT01778049|18969558|P2|Double Blind Treatment Period|Lack of Efficacy|0
5486726|NCT01778049|18969559|P1|Double Blind Treatment Period|Lack of Efficacy|0
5486727|NCT01778049|18969554|P6|Double Blind Treatment Period|Adverse Event|2
5486728|NCT01778049|18969555|P5|Double Blind Treatment Period|Adverse Event|3
5486729|NCT01778049|18969556|P4|Double Blind Treatment Period|Adverse Event|5
5486730|NCT01778049|18969557|P3|Double Blind Treatment Period|Adverse Event|4
5486731|NCT01778049|18969558|P2|Double Blind Treatment Period|Adverse Event|0
5486732|NCT01778049|18969559|P1|Double Blind Treatment Period|Adverse Event|0
5486733|NCT01778049|18969554|P6|Open Label Treatment Period|Other reason not defined above|0
5486734|NCT01778049|18969555|P5|Open Label Treatment Period|Other reason not defined above|0
5486735|NCT01778049|18969556|P4|Open Label Treatment Period|Other reason not defined above|0
5486736|NCT01778049|18969557|P3|Open Label Treatment Period|Other reason not defined above|0
5486737|NCT01778049|18969558|P2|Open Label Treatment Period|Other reason not defined above|94
5486738|NCT01778049|18969559|P1|Open Label Treatment Period|Other reason not defined above|77
5486739|NCT01778049|18969554|P6|Open Label Treatment Period|Not treated|0
5486740|NCT01778049|18969555|P5|Open Label Treatment Period|Not treated|0
5486741|NCT01778049|18969556|P4|Open Label Treatment Period|Not treated|0
5486742|NCT01778049|18969557|P3|Open Label Treatment Period|Not treated|0
5486743|NCT01778049|18969558|P2|Open Label Treatment Period|Not treated|1
5486744|NCT01778049|18969559|P1|Open Label Treatment Period|Not treated|2
5486745|NCT01778049|18969554|P6|Open Label Treatment Period|Withdrawal by Subject|0
5486746|NCT01778049|18969555|P5|Open Label Treatment Period|Withdrawal by Subject|0
5486747|NCT01778049|18969556|P4|Open Label Treatment Period|Withdrawal by Subject|0
5486748|NCT01778049|18969557|P3|Open Label Treatment Period|Withdrawal by Subject|0
5486749|NCT01778049|18969558|P2|Open Label Treatment Period|Withdrawal by Subject|10
5486750|NCT01778049|18969559|P1|Open Label Treatment Period|Withdrawal by Subject|4
5486751|NCT01778049|18969554|P6|Open Label Treatment Period|Lost to Follow-up|0
5486752|NCT01778049|18969555|P5|Open Label Treatment Period|Lost to Follow-up|0
5486753|NCT01778049|18969556|P4|Open Label Treatment Period|Lost to Follow-up|0
5486754|NCT01778049|18969557|P3|Open Label Treatment Period|Lost to Follow-up|0
5486755|NCT01778049|18969558|P2|Open Label Treatment Period|Lost to Follow-up|3
5486756|NCT01778049|18969559|P1|Open Label Treatment Period|Lost to Follow-up|4
5486757|NCT01778049|18969554|P6|Open Label Treatment Period|Protocol Violation|0
5486758|NCT01778049|18969555|P5|Open Label Treatment Period|Protocol Violation|0
5486759|NCT01778049|18969556|P4|Open Label Treatment Period|Protocol Violation|0
5486760|NCT01778049|18969557|P3|Open Label Treatment Period|Protocol Violation|0
5486761|NCT01778049|18969558|P2|Open Label Treatment Period|Protocol Violation|5
5486762|NCT01778049|18969559|P1|Open Label Treatment Period|Protocol Violation|5
5486763|NCT01778049|18969554|P6|Open Label Treatment Period|Lack of Efficacy|0
5486764|NCT01778049|18969555|P5|Open Label Treatment Period|Lack of Efficacy|0
5486765|NCT01778049|18969556|P4|Open Label Treatment Period|Lack of Efficacy|0
5486766|NCT01778049|18969557|P3|Open Label Treatment Period|Lack of Efficacy|0
5486767|NCT01778049|18969558|P2|Open Label Treatment Period|Lack of Efficacy|1
5486768|NCT01778049|18969559|P1|Open Label Treatment Period|Lack of Efficacy|1
5486769|NCT01778049|18969554|P6|Open Label Treatment Period|Adverse Event|0
5486770|NCT01778049|18969555|P5|Open Label Treatment Period|Adverse Event|0
5486771|NCT01778049|18969556|P4|Open Label Treatment Period|Adverse Event|0
5486772|NCT01778049|18969557|P3|Open Label Treatment Period|Adverse Event|0
5486773|NCT01778049|18969558|P2|Open Label Treatment Period|Adverse Event|15
5486774|NCT01778049|18969559|P1|Open Label Treatment Period|Adverse Event|5
5486775|NCT01778023|18969577|P2|Overall Study|Withdrawal by Subject|3
5486776|NCT01778023|18969578|P1|Overall Study|Withdrawal by Subject|0
5486777|NCT01778010|18969595|P1|Overall Study|rash while on placebo|1
5486778|NCT01778010|18969595|P1|Overall Study|Arrested|1
5486779|NCT01778010|18969595|P1|Overall Study|abnormal ECG before meds|1
5486780|NCT01778010|18969595|P1|Overall Study|Withdrawal by Subject|2
5486781|NCT01777997|18969636|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
5486782|NCT01777997|18969636|P1|Weeks 48 to 72/96 on ART|Death|1
5486783|NCT01777997|18969636|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
5486784|NCT01777997|18969636|P1|12 Week lead-in of no ART|Severe debilitation|2
5486785|NCT01777932|18969658|P1|Overall Study|Patient refused further treatment|10
5486786|NCT01777932|18969658|P1|Overall Study|Reimbursement limit|9
5486787|NCT01777932|18969658|P1|Overall Study|Investigator decision|10
5486788|NCT01777932|18969658|P1|Overall Study|Lost to Follow-up|3
5486789|NCT01777932|18969658|P1|Overall Study|Adverse Event|34
5486790|NCT01777932|18969658|P1|Overall Study|Death|3
5486791|NCT01777932|18969658|P1|Overall Study|Disease progression|136
5486792|NCT01777854|18969672|P2|Overall Study|Physician Decision|3
5486793|NCT01777854|18969673|P1|Overall Study|Physician Decision|3
5486794|NCT01777776|18969681|P4|Overall Study|Withdrawal by Subject|1
5486795|NCT01777776|18969682|P3|Overall Study|Withdrawal by Subject|0
5486796|NCT01777776|18969683|P2|Overall Study|Withdrawal by Subject|0
5486797|NCT01777776|18969684|P1|Overall Study|Withdrawal by Subject|0
5486798|NCT01777776|18969681|P4|Overall Study|Disease Progression|3
5486799|NCT01777776|18969682|P3|Overall Study|Disease Progression|6
5486800|NCT01777776|18969683|P2|Overall Study|Disease Progression|8
5486801|NCT01777776|18969684|P1|Overall Study|Disease Progression|4
5486802|NCT01777776|18969681|P4|Overall Study|Adverse Event|0
5486803|NCT01777776|18969682|P3|Overall Study|Adverse Event|0
5486804|NCT01777776|18969683|P2|Overall Study|Adverse Event|4
5486805|NCT01777776|18969684|P1|Overall Study|Adverse Event|2
5486806|NCT01777763|18969743|P2|Overall Study|Treatment Failure|6
5486807|NCT01777763|18969744|P1|Overall Study|Treatment Failure|1
5486808|NCT01777763|18969743|P2|Overall Study|Withdrawal by Subject|2
5486809|NCT01777763|18969744|P1|Overall Study|Withdrawal by Subject|0
5486810|NCT01777763|18969743|P2|Overall Study|Protocol Violation|7
5486811|NCT01777763|18969744|P1|Overall Study|Protocol Violation|1
5486812|NCT01777763|18969743|P2|Overall Study|Adverse Event|32
5486813|NCT01777763|18969744|P1|Overall Study|Adverse Event|2
5486814|NCT01777620|18969768|P2|Overall Study|Subject Withdrawal|0
5486815|NCT01777620|18969769|P1|Overall Study|Subject Withdrawal|1
5486816|NCT01777581|18969795|P2|Overall Study|Lack of Efficacy|1
5486817|NCT01777581|18969796|P1|Overall Study|Lack of Efficacy|0
5486818|NCT01777581|18969795|P2|Overall Study|Adverse Event|0
5486819|NCT01777581|18969796|P1|Overall Study|Adverse Event|2
5486820|NCT01777581|18969795|P2|Overall Study|Lost to Follow-up|1
5486821|NCT01777581|18969796|P1|Overall Study|Lost to Follow-up|1
5486822|NCT01777542|18969825|P2|Second Intervention (20 Weeks)|Adverse Event|1
5486823|NCT01777542|18969826|P1|Second Intervention (20 Weeks)|Adverse Event|0
5486824|NCT01777490|18969869|P4|Overall Study|Dyad withdrew with data use prohibition|1
5486825|NCT01777490|18969870|P3|Overall Study|Dyad withdrew with data use prohibition|1
5486826|NCT01777490|18969871|P2|Overall Study|Dyad withdrew with data use prohibition|0
5486827|NCT01777490|18969872|P1|Overall Study|Dyad withdrew with data use prohibition|0
5486828|NCT01777334|18969917|P2|Overall Study|Withdrawal by Subject|11
5486829|NCT01777334|18969918|P1|Overall Study|Withdrawal by Subject|14
5486830|NCT01777334|18969917|P2|Overall Study|Lost to Follow-up|2
5486831|NCT01777334|18969918|P1|Overall Study|Lost to Follow-up|3
5486832|NCT01777334|18969917|P2|Overall Study|Protocol Violation|7
5486833|NCT01777334|18969918|P1|Overall Study|Protocol Violation|3
5486834|NCT01777334|18969917|P2|Overall Study|Lack of Efficacy|29
5486835|NCT01777334|18969918|P1|Overall Study|Lack of Efficacy|15
5486836|NCT01777334|18969917|P2|Overall Study|Adverse Event|14
5486837|NCT01777334|18969918|P1|Overall Study|Adverse Event|18
5486838|NCT01777321|18969928|P2|Overall Study|Withdrawal by Subject|1
5486839|NCT01777321|18969929|P1|Overall Study|Withdrawal by Subject|0
5486840|NCT01777308|18969967|P2|Overall Study|Blood draw refusal at Visit 3|0
5486841|NCT01777308|18969968|P1|Overall Study|Blood draw refusal at Visit 3|1
5486842|NCT01777308|18969967|P2|Overall Study|Lost to Follow-up|2
5486843|NCT01777308|18969968|P1|Overall Study|Lost to Follow-up|7
5486844|NCT01777308|18969967|P2|Overall Study|Migrated/moved from study area|0
5486845|NCT01777308|18969968|P1|Overall Study|Migrated/moved from study area|1
5486846|NCT01777308|18969967|P2|Overall Study|Withdrawal by Subject|1
5486847|NCT01777308|18969968|P1|Overall Study|Withdrawal by Subject|5
5486848|NCT01777295|18970000|P2|Overall Study|Investigator call for AEs check|0
5486849|NCT01777295|18970001|P1|Overall Study|Investigator call for AEs check|1
5486850|NCT01777295|18970000|P2|Overall Study|Personal problem|0
5486851|NCT01777295|18970001|P1|Overall Study|Personal problem|1
5486852|NCT01777295|18970000|P2|Overall Study|Pregnancy|1
5486853|NCT01777295|18970001|P1|Overall Study|Pregnancy|0
5486854|NCT01777295|18970000|P2|Overall Study|Withdrawal by Subject|2
5486855|NCT01777295|18970001|P1|Overall Study|Withdrawal by Subject|2
5486856|NCT01777282|18970208|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
5486857|NCT01777282|18970209|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
5486858|NCT01777282|18970210|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
5486859|NCT01777282|18970211|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
5486860|NCT01777282|18970212|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
5486861|NCT01777282|18970208|P5|Overall Study|Protocol Violation|2
5486862|NCT01777282|18970209|P4|Overall Study|Protocol Violation|0
5486863|NCT01777282|18970210|P3|Overall Study|Protocol Violation|1
5486864|NCT01777282|18970211|P2|Overall Study|Protocol Violation|0
5486865|NCT01777282|18970212|P1|Overall Study|Protocol Violation|2
5486866|NCT01777282|18970208|P5|Overall Study|Withdrawal by Subject|2
5486867|NCT01777282|18970209|P4|Overall Study|Withdrawal by Subject|1
5486868|NCT01777282|18970210|P3|Overall Study|Withdrawal by Subject|0
5486869|NCT01777282|18970211|P2|Overall Study|Withdrawal by Subject|0
5486870|NCT01777282|18970212|P1|Overall Study|Withdrawal by Subject|4
5486871|NCT01777282|18970208|P5|Overall Study|Adverse Event|3
5486872|NCT01777282|18970209|P4|Overall Study|Adverse Event|1
5486873|NCT01777282|18970210|P3|Overall Study|Adverse Event|2
5486874|NCT01777282|18970211|P2|Overall Study|Adverse Event|4
5486875|NCT01777282|18970212|P1|Overall Study|Adverse Event|4
5486876|NCT01777282|18970208|P5|Overall Study|New Antidiabetic Medication|0
5486877|NCT01777282|18970209|P4|Overall Study|New Antidiabetic Medication|0
5486878|NCT01777282|18970210|P3|Overall Study|New Antidiabetic Medication|1
5486879|NCT01777282|18970211|P2|Overall Study|New Antidiabetic Medication|0
5486880|NCT01777282|18970212|P1|Overall Study|New Antidiabetic Medication|0
5486881|NCT01777282|18970208|P5|Overall Study|Persistent Hyperglycemia|0
5486882|NCT01777282|18970209|P4|Overall Study|Persistent Hyperglycemia|0
5486883|NCT01777282|18970210|P3|Overall Study|Persistent Hyperglycemia|1
5486884|NCT01777282|18970211|P2|Overall Study|Persistent Hyperglycemia|0
5486885|NCT01777282|18970212|P1|Overall Study|Persistent Hyperglycemia|0
5486886|NCT01777269|18970256|P2|Overall Study|Withdrawal by Subject|9
5486887|NCT01777269|18970257|P1|Overall Study|Withdrawal by Subject|9
5486888|NCT01777269|18970256|P2|Overall Study|Physician Decision|2
5486889|NCT01777269|18970257|P1|Overall Study|Physician Decision|5
5486890|NCT01777269|18970256|P2|Overall Study|Lost to Follow-up|0
5486891|NCT01777269|18970257|P1|Overall Study|Lost to Follow-up|4
5486892|NCT01777269|18970256|P2|Overall Study|Participants reached stopping criteria|1
5486893|NCT01777269|18970257|P1|Overall Study|Participants reached stopping criteria|1
5486894|NCT01777269|18970256|P2|Overall Study|Protocol Violation|4
5486895|NCT01777269|18970257|P1|Overall Study|Protocol Violation|4
5486896|NCT01777269|18970256|P2|Overall Study|Lack of Efficacy|10
5486897|NCT01777269|18970257|P1|Overall Study|Lack of Efficacy|8
5486898|NCT01777269|18970256|P2|Overall Study|Adverse Event|33
5486899|NCT01777269|18970257|P1|Overall Study|Adverse Event|24
5486900|NCT01777191|18970294|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
5486901|NCT01777191|18970295|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
5486902|NCT01777191|18970294|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
5486903|NCT01777191|18970295|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
5486904|NCT01777191|18970294|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
5486905|NCT01777191|18970295|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
5486906|NCT01777191|18970294|P2|Safety Extension Per (Week 12-Week 48)|Death|1
5486907|NCT01777191|18970295|P1|Safety Extension Per (Week 12-Week 48)|Death|0
5486908|NCT01777191|18970294|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
5486909|NCT01777191|18970295|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
5486910|NCT01777191|18970294|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
5486911|NCT01777191|18970295|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
5486912|NCT01777191|18970294|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
5486913|NCT01777191|18970295|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
5486914|NCT01777191|18970294|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
5486915|NCT01777191|18970295|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
5486916|NCT01777191|18970294|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
5486917|NCT01777191|18970295|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
5486918|NCT01777191|18970294|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
5486919|NCT01777191|18970295|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
5486920|NCT01777191|18970294|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
5486921|NCT01777191|18970295|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
5486922|NCT01777152|18970325|P2|Overall Study|Change of diagnosis|0
5486923|NCT01777152|18970326|P1|Overall Study|Change of diagnosis|1
5486924|NCT01777152|18970325|P2|Overall Study|Not eligible, no study drug received|0
5486925|NCT01777152|18970326|P1|Overall Study|Not eligible, no study drug received|1
5486926|NCT01777152|18970325|P2|Overall Study|Death|73
5486927|NCT01777152|18970326|P1|Overall Study|Death|51
5486928|NCT01777152|18970325|P2|Overall Study|Lost to Follow-up|4
5486929|NCT01777152|18970326|P1|Overall Study|Lost to Follow-up|0
5486930|NCT01777152|18970325|P2|Overall Study|Withdrawal by Subject|10
5486931|NCT01777152|18970326|P1|Overall Study|Withdrawal by Subject|16
5486932|NCT01777152|18970325|P2|Overall Study|In Follow Up|139
5486933|NCT01777152|18970326|P1|Overall Study|In Follow Up|157
5486934|NCT01777139|18970342|P2|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
5486935|NCT01777139|18970343|P1|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
5486936|NCT01777139|18970342|P2|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
5486937|NCT01777139|18970343|P1|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
5486938|NCT01777139|18970342|P2|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
5486939|NCT01777139|18970343|P1|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
5486940|NCT01777139|18970342|P2|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
5486941|NCT01777139|18970343|P1|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
5486942|NCT01777139|18970342|P2|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
5486943|NCT01777139|18970343|P1|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
5486944|NCT01777139|18970342|P2|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
5486945|NCT01777139|18970343|P1|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
5486946|NCT01777139|18970342|P2|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
5486947|NCT01777139|18970343|P1|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
5486948|NCT01777139|18970342|P2|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
5486949|NCT01777139|18970343|P1|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
5486950|NCT01776554|18970457|P2|Overall Study|Unclassified|1
5486951|NCT01776554|18970458|P1|Overall Study|Unclassified|4
5486952|NCT01776554|18970457|P2|Overall Study|Protocol Violation|0
5486953|NCT01776554|18970458|P1|Overall Study|Protocol Violation|1
5486954|NCT01776554|18970457|P2|Overall Study|Administrative Reason|5
5486955|NCT01776554|18970458|P1|Overall Study|Administrative Reason|2
5486956|NCT01776554|18970457|P2|Overall Study|Lost to Follow-up|9
5486957|NCT01776554|18970458|P1|Overall Study|Lost to Follow-up|6
5486958|NCT01776554|18970457|P2|Overall Study|Withdrawal by Subject|8
5486959|NCT01776554|18970458|P1|Overall Study|Withdrawal by Subject|3
5486960|NCT01776554|18970457|P2|Overall Study|Adverse Event|0
5486961|NCT01776554|18970458|P1|Overall Study|Adverse Event|1
5486962|NCT01776541|18970501|P2|Overall Study|Withdrawal by Subject|20
5486963|NCT01776541|18970502|P1|Overall Study|Withdrawal by Subject|12
5486964|NCT01776541|18970501|P2|Overall Study|Protocol Violation|1
5486965|NCT01776541|18970502|P1|Overall Study|Protocol Violation|2
5486966|NCT01776541|18970501|P2|Overall Study|Unclassified|4
5486967|NCT01776541|18970502|P1|Overall Study|Unclassified|5
5486968|NCT01776541|18970501|P2|Overall Study|Lost to Follow-up|48
5486969|NCT01776541|18970502|P1|Overall Study|Lost to Follow-up|27
5486970|NCT01776541|18970501|P2|Overall Study|Death|0
5486971|NCT01776541|18970502|P1|Overall Study|Death|4
5486972|NCT01776541|18970501|P2|Overall Study|Administrative Reason|2
5486973|NCT01776541|18970502|P1|Overall Study|Administrative Reason|6
5486974|NCT01776424|18970524|P3|Overall Study|Withdrawal by Subject|15
5486975|NCT01776424|18970525|P2|Overall Study|Withdrawal by Subject|11
5486976|NCT01776424|18970526|P1|Overall Study|Withdrawal by Subject|10
5486977|NCT01776424|18970524|P3|Overall Study|Lost to Follow-up|9
5486978|NCT01776424|18970525|P2|Overall Study|Lost to Follow-up|8
5486979|NCT01776424|18970526|P1|Overall Study|Lost to Follow-up|10
5486980|NCT01776008|18970557|P1|Overall Study|ineligible|2
5486981|NCT01775995|18970571|P2|Overall Study|Lost to Follow-up|1
5486982|NCT01775995|18970572|P1|Overall Study|Lost to Follow-up|1
5486983|NCT01775930|18970632|P1|Overall Study|Futility stopping boundary met|1
5486984|NCT01775904|18970640|P1|LY2886721 ODT (Water, Fasting)|Adverse Event|1
5486985|NCT01775904|18970640|P1|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
5486986|NCT01775787|18970706|P2|Second 7-10 Days|concerns with using IV|1
5486987|NCT01775787|18970707|P1|Second 7-10 Days|concerns with using IV|0
5486988|NCT01775787|18970706|P2|Second 7-10 Days|time commitment|1
5486989|NCT01775787|18970707|P1|Second 7-10 Days|time commitment|0
5486990|NCT01775787|18970706|P2|First 7-10 Days|concerns with using IV|2
5486991|NCT01775787|18970707|P1|First 7-10 Days|concerns with using IV|1
5486992|NCT01775787|18970706|P2|First 7-10 Days|time commitment|2
5486993|NCT01775787|18970707|P1|First 7-10 Days|time commitment|0
5486994|NCT01775787|18970706|P2|First 7-10 Days|family emergency|1
5486995|NCT01775787|18970707|P1|First 7-10 Days|family emergency|0
5486996|NCT01775787|18970706|P2|First 7-10 Days|Adverse Event|1
5486997|NCT01775787|18970707|P1|First 7-10 Days|Adverse Event|0
5486998|NCT01775670|18970763|P2|Overall Study|Lost to Follow-up|1
5486999|NCT01775670|18970764|P1|Overall Study|Lost to Follow-up|1
5487000|NCT01775553|18970790|P1|Overall Study|Disease Progression|12
5487001|NCT01775553|18970790|P1|Overall Study|Adverse Event|1
5487002|NCT01775501|18970798|P1|Overall Study|Discontinued prior to treatment|1
5487003|NCT01775189|18970822|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
5487004|NCT01775189|18970823|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
5487005|NCT01775189|18970824|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
5487006|NCT01775189|18970825|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
5487007|NCT01775189|18970826|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
5487008|NCT01775189|18970827|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
5487009|NCT01775189|18970828|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
5487010|NCT01775189|18970822|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
5487011|NCT01775189|18970823|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
5487012|NCT01775189|18970824|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
5487013|NCT01775189|18970825|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
5487014|NCT01775189|18970826|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
5487015|NCT01775189|18970827|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
5487016|NCT01775189|18970828|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
5487017|NCT01775189|18970822|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
5487018|NCT01775189|18970823|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
5487019|NCT01775189|18970824|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
5487020|NCT01775189|18970825|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
5487021|NCT01775189|18970826|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
5487022|NCT01775189|18970827|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
5487023|NCT01775189|18970828|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
5487024|NCT01775189|18970822|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5487025|NCT01775189|18970823|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5487026|NCT01775189|18970824|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5487027|NCT01775189|18970825|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5487028|NCT01775189|18970826|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
5487029|NCT01775189|18970827|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
5487030|NCT01775189|18970828|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
5487031|NCT01775189|18970822|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
5487032|NCT01775189|18970823|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
5487033|NCT01775189|18970824|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
5487034|NCT01775189|18970825|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
5487035|NCT01775189|18970826|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
5487036|NCT01775189|18970827|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
5487037|NCT01775189|18970828|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
5487038|NCT01775189|18970822|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
5487039|NCT01775189|18970823|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
5487040|NCT01775189|18970824|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
5487041|NCT01775189|18970825|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
5487042|NCT01775189|18970826|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
5487043|NCT01775189|18970827|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
5487044|NCT01775189|18970828|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
5487045|NCT01775137|18971047|P1|Overall Study|Withdrawal by participants|5
5487046|NCT01775137|18971047|P1|Overall Study|Adverse Event|1
5487047|NCT01775137|18971047|P1|Overall Study|Unsatisfactory therapeutic effect|2
5487048|NCT01775137|18971047|P1|Overall Study|Protocol deviation|2
5487049|NCT01775137|18971047|P1|Overall Study|Death|1
5487050|NCT01775124|18971074|P2|Extension Period|Withdrawal by Subject|12
5487051|NCT01775124|18971075|P1|Extension Period|Withdrawal by Subject|9
5487052|NCT01775124|18971074|P2|Extension Period|Lost to Follow-up|1
5487053|NCT01775124|18971075|P1|Extension Period|Lost to Follow-up|0
5487054|NCT01775124|18971074|P2|Extension Period|Administrative problems|1
5487055|NCT01775124|18971075|P1|Extension Period|Administrative problems|0
5487056|NCT01775124|18971074|P2|Extension Period|Physician Decision|2
5487057|NCT01775124|18971075|P1|Extension Period|Physician Decision|0
5487058|NCT01775124|18971074|P2|Extension Period|Adverse Event|2
5487059|NCT01775124|18971075|P1|Extension Period|Adverse Event|3
5487060|NCT01775124|18971074|P2|Core Period|Adverse Event|5
5487061|NCT01775124|18971075|P1|Core Period|Adverse Event|5
5487062|NCT01775124|18971074|P2|Core Period|Withdrawal by Subject|2
5487063|NCT01775124|18971075|P1|Core Period|Withdrawal by Subject|4
5487064|NCT01775124|18971074|P2|Core Period|Administrative problems|0
5487065|NCT01775124|18971075|P1|Core Period|Administrative problems|1
5487066|NCT01775124|18971074|P2|Core Period|Death|1
5487067|NCT01775124|18971075|P1|Core Period|Death|0
5487068|NCT01775124|18971074|P2|Core Period|Physician Decision|1
5487069|NCT01775124|18971075|P1|Core Period|Physician Decision|1
5487070|NCT01775124|18971074|P2|Core Period|Disease Progression|1
5487071|NCT01775124|18971075|P1|Core Period|Disease Progression|0
5487072|NCT01774981|18971110|P8|Overall Study|Death|0
5487073|NCT01774981|18971111|P7|Overall Study|Death|0
5487074|NCT01774981|18971112|P6|Overall Study|Death|0
5487075|NCT01774981|18971113|P5|Overall Study|Death|1
5487076|NCT01774981|18971114|P4|Overall Study|Death|0
5487077|NCT01774981|18971115|P3|Overall Study|Death|0
5487078|NCT01774981|18971116|P2|Overall Study|Death|0
5487079|NCT01774981|18971117|P1|Overall Study|Death|0
5487080|NCT01774981|18971110|P8|Overall Study|Withdrawal by Subject|1
5487081|NCT01774981|18971111|P7|Overall Study|Withdrawal by Subject|0
5487082|NCT01774981|18971112|P6|Overall Study|Withdrawal by Subject|0
5487083|NCT01774981|18971113|P5|Overall Study|Withdrawal by Subject|0
5487084|NCT01774981|18971114|P4|Overall Study|Withdrawal by Subject|0
5487085|NCT01774981|18971115|P3|Overall Study|Withdrawal by Subject|0
5487086|NCT01774981|18971116|P2|Overall Study|Withdrawal by Subject|0
5487087|NCT01774981|18971117|P1|Overall Study|Withdrawal by Subject|0
5487088|NCT01774981|18971110|P8|Overall Study|Adverse Event|0
5487089|NCT01774981|18971111|P7|Overall Study|Adverse Event|0
5487090|NCT01774981|18971112|P6|Overall Study|Adverse Event|1
5487091|NCT01774981|18971113|P5|Overall Study|Adverse Event|0
5487092|NCT01774981|18971114|P4|Overall Study|Adverse Event|0
5487093|NCT01774981|18971115|P3|Overall Study|Adverse Event|0
5487094|NCT01774981|18971116|P2|Overall Study|Adverse Event|0
5487095|NCT01774981|18971117|P1|Overall Study|Adverse Event|0
5487096|NCT01774968|18971149|P2|Overall Study|Withdrawal by Subject|11
5487097|NCT01774968|18971150|P1|Overall Study|Withdrawal by Subject|6
5487098|NCT01774968|18971149|P2|Overall Study|Sponsor Decision|2
5487099|NCT01774968|18971150|P1|Overall Study|Sponsor Decision|0
5487100|NCT01774968|18971149|P2|Overall Study|Protocol Violation|13
5487101|NCT01774968|18971150|P1|Overall Study|Protocol Violation|14
5487102|NCT01774968|18971149|P2|Overall Study|Physician Decision|1
5487103|NCT01774968|18971150|P1|Overall Study|Physician Decision|5
5487104|NCT01774968|18971149|P2|Overall Study|Lost to Follow-up|3
5487105|NCT01774968|18971150|P1|Overall Study|Lost to Follow-up|1
5487106|NCT01774968|18971149|P2|Overall Study|Death|1
5487107|NCT01774968|18971150|P1|Overall Study|Death|0
5487108|NCT01774968|18971149|P2|Overall Study|Adverse Event|4
5487109|NCT01774968|18971150|P1|Overall Study|Adverse Event|4
5487110|NCT01774929|18971184|P1|Overall Study|Adverse Event|3
5487111|NCT01774903|18971190|P1|Overall Study|Ineligible to continue the trial|1
5487112|NCT01774903|18971190|P1|Overall Study|Lack of Efficacy|1
5487113|NCT01774903|18971190|P1|Overall Study|Withdrawal by Subject|2
5487114|NCT01774903|18971190|P1|Overall Study|Adverse Event|7
5487115|NCT01774799|18971210|P4|Overall Study|Lost to Follow-up|0
5487116|NCT01774799|18971211|P3|Overall Study|Lost to Follow-up|0
5487117|NCT01774799|18971212|P2|Overall Study|Lost to Follow-up|1
5487118|NCT01774799|18971213|P1|Overall Study|Lost to Follow-up|1
5487119|NCT01774786|18971229|P2|Overall Study|Reason Not Specified|5
5487120|NCT01774786|18971230|P1|Overall Study|Reason Not Specified|2
5487121|NCT01774786|18971229|P2|Overall Study|Non-compliance|1
5487122|NCT01774786|18971230|P1|Overall Study|Non-compliance|0
5487123|NCT01774786|18971229|P2|Overall Study|Physician Decision|0
5487124|NCT01774786|18971230|P1|Overall Study|Physician Decision|2
5487125|NCT01774786|18971229|P2|Overall Study|Withdrawal by Subject|14
5487126|NCT01774786|18971230|P1|Overall Study|Withdrawal by Subject|18
5487127|NCT01774786|18971229|P2|Overall Study|Lost to Follow-up|7
5487128|NCT01774786|18971230|P1|Overall Study|Lost to Follow-up|6
5487129|NCT01774786|18971229|P2|Overall Study|Death|319
5487130|NCT01774786|18971230|P1|Overall Study|Death|300
5487131|NCT01774721|18971266|P2|Overall Study|Ongoing in study|120
5487132|NCT01774721|18971267|P1|Overall Study|Ongoing in study|136
5487133|NCT01774721|18971266|P2|Overall Study|Did not meet eligibility criteria|3
5487134|NCT01774721|18971267|P1|Overall Study|Did not meet eligibility criteria|0
5487135|NCT01774721|18971266|P2|Overall Study|Lost to Follow-up|1
5487136|NCT01774721|18971267|P1|Overall Study|Lost to Follow-up|1
5487137|NCT01774721|18971266|P2|Overall Study|Withdrawal by Subject|10
5487138|NCT01774721|18971267|P1|Overall Study|Withdrawal by Subject|14
5487139|NCT01774721|18971266|P2|Overall Study|Death|91
5487140|NCT01774721|18971267|P1|Overall Study|Death|76
5487141|NCT01774591|18971332|P2|Overall Study|Adverse Event|2
5487142|NCT01774591|18971333|P1|Overall Study|Adverse Event|0
5487143|NCT01774591|18971332|P2|Overall Study|Withdrawal by Subject|1
5487144|NCT01774591|18971333|P1|Overall Study|Withdrawal by Subject|0
5487145|NCT01774591|18971332|P2|Overall Study|Physician Decision|1
5487146|NCT01774591|18971333|P1|Overall Study|Physician Decision|1
5487147|NCT01774370|18971343|P1|Overall Study|Follow-up failure|34
5487148|NCT01774370|18971343|P1|Overall Study|Violated inclusion/exclusion criteria|53
5487149|NCT01774370|18971343|P1|Overall Study|Subjects of contraindications|34
5487150|NCT01774370|18971343|P1|Overall Study|Administered prior to the contract date|4
5487151|NCT01774370|18971343|P1|Overall Study|Never taken the PRADAXA during the study|4
5487152|NCT01774344|18971351|P2|Overall Study|Did not enter Survival Follow up|83
5487153|NCT01774344|18971352|P1|Overall Study|Did not enter Survival Follow up|49
5487154|NCT01774344|18971351|P2|Overall Study|Other|1
5487155|NCT01774344|18971352|P1|Overall Study|Other|0
5487156|NCT01774344|18971351|P2|Overall Study|Data collection finished|14
5487157|NCT01774344|18971352|P1|Overall Study|Data collection finished|4
5487158|NCT01774344|18971351|P2|Overall Study|End of survival follow-up not available|2
5487159|NCT01774344|18971352|P1|Overall Study|End of survival follow-up not available|2
5487160|NCT01774344|18971351|P2|Overall Study|Lost to Follow-up|10
5487161|NCT01774344|18971352|P1|Overall Study|Lost to Follow-up|4
5487162|NCT01774344|18971351|P2|Overall Study|Protocol Violation|1
5487163|NCT01774344|18971352|P1|Overall Study|Protocol Violation|0
5487164|NCT01774344|18971351|P2|Overall Study|Withdrawal by Subject|10
5487165|NCT01774344|18971352|P1|Overall Study|Withdrawal by Subject|3
5487166|NCT01774305|18971370|P2|Overall Study|Physician Decision|0
5487167|NCT01774305|18971371|P1|Overall Study|Physician Decision|1
5487168|NCT01774253|18971379|P1|Overall Study|Death|1
5487169|NCT01774253|18971379|P1|Overall Study|Withdrawal by Subject|2
5487170|NCT01774253|18971379|P1|Overall Study|Physician Decision|2
5487171|NCT01774253|18971379|P1|Overall Study|Lack of Efficacy|4
5487172|NCT01774110|18971398|P1|Overall Study|Lost to Follow-up|7
5487173|NCT01774097|18971406|P2|Overall Study|Adverse Event|1
5487174|NCT01774097|18971407|P1|Overall Study|Adverse Event|1
5487175|NCT01774097|18971406|P2|Overall Study|Withdrawal by Subject|1
5487176|NCT01774097|18971407|P1|Overall Study|Withdrawal by Subject|1
5487177|NCT01774084|18971437|P2|Overall Study|Personal reasons|0
5487178|NCT01774084|18971438|P1|Overall Study|Personal reasons|1
5487179|NCT01773993|18971463|P1|Overall Study|No Visit After Treatment|35
5487180|NCT01773967|18971482|P2|Overall Study|Lost to Follow-up|13
5487181|NCT01773967|18971483|P1|Overall Study|Lost to Follow-up|15
5487182|NCT01773889|18971498|P1|Overall Study|lack of funding|2
5487183|NCT01773473|18971504|P2|Overall Study|Lost to Follow-up|0
5487184|NCT01773473|18971505|P1|Overall Study|Lost to Follow-up|2
5487185|NCT01773473|18971504|P2|Overall Study|Withdrawal by Subject|3
5487186|NCT01773473|18971505|P1|Overall Study|Withdrawal by Subject|5
5487187|NCT01773473|18971504|P2|Overall Study|Non-Compliance with study drug|4
5487188|NCT01773473|18971505|P1|Overall Study|Non-Compliance with study drug|1
5487189|NCT01773473|18971504|P2|Overall Study|Lack of Efficacy|1
5487190|NCT01773473|18971505|P1|Overall Study|Lack of Efficacy|0
5487191|NCT01773473|18971504|P2|Overall Study|Sponsor Decision|0
5487192|NCT01773473|18971505|P1|Overall Study|Sponsor Decision|2
5487193|NCT01773473|18971504|P2|Overall Study|Physician Decision|5
5487194|NCT01773473|18971505|P1|Overall Study|Physician Decision|3
5487195|NCT01773473|18971504|P2|Overall Study|Protocol Violation|4
5487196|NCT01773473|18971505|P1|Overall Study|Protocol Violation|0
5487197|NCT01773473|18971504|P2|Overall Study|Adverse Event|2
5487198|NCT01773473|18971505|P1|Overall Study|Adverse Event|3
5487199|NCT01773421|18971527|P7|Extension Phase|Adverse Event|0
5487200|NCT01773421|18971528|P6|Extension Phase|Adverse Event|0
5487201|NCT01773421|18971529|P5|Extension Phase|Adverse Event|2
5487202|NCT01773421|18971530|P4|Extension Phase|Adverse Event|0
5487203|NCT01773421|18971531|P3|Extension Phase|Adverse Event|0
5487204|NCT01773421|18971532|P2|Extension Phase|Adverse Event|0
5487205|NCT01773421|18971533|P1|Extension Phase|Adverse Event|0
5487206|NCT01773421|18971527|P7|Extension Phase|Other|0
5487207|NCT01773421|18971528|P6|Extension Phase|Other|2
5487208|NCT01773421|18971529|P5|Extension Phase|Other|1
5487209|NCT01773421|18971530|P4|Extension Phase|Other|0
5487210|NCT01773421|18971531|P3|Extension Phase|Other|0
5487211|NCT01773421|18971532|P2|Extension Phase|Other|0
5487212|NCT01773421|18971533|P1|Extension Phase|Other|0
5487213|NCT01773421|18971527|P7|Treatment Phase|Withdrawal by Subject|0
5487214|NCT01773421|18971528|P6|Treatment Phase|Withdrawal by Subject|0
5487215|NCT01773421|18971529|P5|Treatment Phase|Withdrawal by Subject|0
5487216|NCT01773421|18971530|P4|Treatment Phase|Withdrawal by Subject|1
5487217|NCT01773421|18971531|P3|Treatment Phase|Withdrawal by Subject|1
5487218|NCT01773421|18971532|P2|Treatment Phase|Withdrawal by Subject|0
5487219|NCT01773421|18971533|P1|Treatment Phase|Withdrawal by Subject|0
5487220|NCT01773421|18971527|P7|Treatment Phase|Adverse Event|0
5487221|NCT01773421|18971528|P6|Treatment Phase|Adverse Event|0
5487222|NCT01773421|18971529|P5|Treatment Phase|Adverse Event|0
5487223|NCT01773421|18971530|P4|Treatment Phase|Adverse Event|1
5487224|NCT01773421|18971531|P3|Treatment Phase|Adverse Event|3
5487225|NCT01773421|18971532|P2|Treatment Phase|Adverse Event|0
5487226|NCT01773421|18971533|P1|Treatment Phase|Adverse Event|0
5487227|NCT01773421|18971527|P7|Treatment Phase|Other|0
5487228|NCT01773421|18971528|P6|Treatment Phase|Other|0
5487229|NCT01773421|18971529|P5|Treatment Phase|Other|0
5487230|NCT01773421|18971530|P4|Treatment Phase|Other|0
5487231|NCT01773421|18971531|P3|Treatment Phase|Other|2
5487232|NCT01773421|18971532|P2|Treatment Phase|Other|0
5487233|NCT01773421|18971533|P1|Treatment Phase|Other|0
5487234|NCT01773291|18971564|P3|Overall Study|Withdrawal by Subject|1
5487235|NCT01773291|18971565|P2|Overall Study|Withdrawal by Subject|0
5487236|NCT01773291|18971566|P1|Overall Study|Withdrawal by Subject|0
5487237|NCT01773291|18971564|P3|Overall Study|Protocol Violation|0
5487238|NCT01773291|18971565|P2|Overall Study|Protocol Violation|0
5487239|NCT01773291|18971566|P1|Overall Study|Protocol Violation|1
5487240|NCT01773226|18971577|P1|Overall Study|Withdrawal by Subject|1
5487241|NCT01773122|18971607|P4|Overall Study|Due to amended age eligibility criteria|1
5487242|NCT01773122|18971608|P3|Overall Study|Due to amended age eligibility criteria|0
5487243|NCT01773122|18971609|P2|Overall Study|Due to amended age eligibility criteria|1
5487244|NCT01773122|18971610|P1|Overall Study|Due to amended age eligibility criteria|3
5487245|NCT01773109|18971624|P1|Overall Study|Death|1
5487246|NCT01773109|18971624|P1|Overall Study|Symptomatic Progression|2
5487247|NCT01773070|18971628|P1|Overall Study|Death (unrelated to study procedures)|3
5487248|NCT01773070|18971628|P1|Overall Study|Other|15
5487249|NCT01773070|18971628|P1|Overall Study|Lost to Follow-up|39
5487250|NCT01773070|18971628|P1|Overall Study|Withdrawal by Subject|24
5487251|NCT01772823|18971638|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
5487252|NCT01772823|18971639|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
5487253|NCT01772823|18971638|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
5487254|NCT01772823|18971639|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
5487255|NCT01772823|18971638|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
5487256|NCT01772823|18971639|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
5487257|NCT01772823|18971638|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
5487258|NCT01772823|18971639|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
5487259|NCT01772823|18971638|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
5487260|NCT01772823|18971639|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
5487261|NCT01772823|18971638|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
5487262|NCT01772823|18971639|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
5487263|NCT01772823|18971638|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
5487264|NCT01772823|18971639|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
5487265|NCT01772823|18971638|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
5487266|NCT01772823|18971639|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
5487267|NCT01772823|18971638|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
5487268|NCT01772823|18971639|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
5487269|NCT01772823|18971638|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
5487270|NCT01772823|18971639|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
5487271|NCT01772823|18971638|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
5487272|NCT01772823|18971639|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
5487273|NCT01772823|18971638|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
5487274|NCT01772823|18971639|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
5487275|NCT01772823|18971638|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
5487276|NCT01772823|18971639|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
5487277|NCT01772823|18971638|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
5487278|NCT01772823|18971639|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
5487279|NCT01772823|18971638|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
5487280|NCT01772823|18971639|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
5487281|NCT01772823|18971638|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
5487282|NCT01772823|18971639|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
5487283|NCT01772719|18971752|P1|Overall Study|Lost to Follow-up|1
5487284|NCT01772719|18971752|P1|Overall Study|Protocol Violation|1
5487285|NCT01772719|18971752|P1|Overall Study|Adverse Event|2
5487286|NCT01772719|18971752|P1|Overall Study|Withdrawal by Subject|3
5487287|NCT01772693|18971765|P2|Overall Study|Alternative Treatment|0
5487288|NCT01772693|18971766|P1|Overall Study|Alternative Treatment|2
5487289|NCT01772693|18971765|P2|Overall Study|Withdrawal by Subject|0
5487290|NCT01772693|18971766|P1|Overall Study|Withdrawal by Subject|2
5487291|NCT01772693|18971765|P2|Overall Study|Health Concerns Unrelated to Study|1
5487292|NCT01772693|18971766|P1|Overall Study|Health Concerns Unrelated to Study|2
5487293|NCT01772576|18971787|P1|Overall Study|Withdrawal by Subject|6
5487294|NCT01772576|18971787|P1|Overall Study|Adverse Event|6
5487295|NCT01772576|18971787|P1|Overall Study|Study device not used|3
5487296|NCT01772576|18971787|P1|Overall Study|Lost to Follow-up|3
5487297|NCT01772576|18971787|P1|Overall Study|Protocol Violation|1
5487298|NCT01772576|18971787|P1|Overall Study|Death|15
5487299|NCT01772550|18971799|P3|Overall Study|Adverse Event|1
5487300|NCT01772550|18971800|P2|Overall Study|Adverse Event|0
5487301|NCT01772550|18971801|P1|Overall Study|Adverse Event|0
5487302|NCT01772550|18971799|P3|Overall Study|Unable to insert IV in antecubital vein|5
5487303|NCT01772550|18971800|P2|Overall Study|Unable to insert IV in antecubital vein|1
5487304|NCT01772550|18971801|P1|Overall Study|Unable to insert IV in antecubital vein|1
5487305|NCT01772537|18971842|P3|Overall Study|unsuccessful lumbar drain placement|0
5487306|NCT01772537|18971843|P2|Overall Study|unsuccessful lumbar drain placement|0
5487307|NCT01772537|18971844|P1|Overall Study|unsuccessful lumbar drain placement|1
5487308|NCT01772472|18971860|P2|Overall Study|Ongoing|635
5487309|NCT01772472|18971861|P1|Overall Study|Ongoing|597
5487310|NCT01772472|18971860|P2|Overall Study|Withdrawal by Subject|50
5487311|NCT01772472|18971861|P1|Overall Study|Withdrawal by Subject|72
5487312|NCT01772472|18971860|P2|Overall Study|Lost to Follow-up|8
5487313|NCT01772472|18971861|P1|Overall Study|Lost to Follow-up|12
5487314|NCT01772472|18971860|P2|Overall Study|Other|5
5487315|NCT01772472|18971861|P1|Overall Study|Other|5
5487316|NCT01772472|18971860|P2|Overall Study|Physician Decision|3
5487317|NCT01772472|18971861|P1|Overall Study|Physician Decision|1
5487318|NCT01772472|18971860|P2|Overall Study|Death|42
5487319|NCT01772472|18971861|P1|Overall Study|Death|56
5487320|NCT01772368|18971873|P1|Overall Study|Other|1
5487321|NCT01772368|18971873|P1|Overall Study|Protocol Violation|2
5487322|NCT01772368|18971873|P1|Overall Study|Withdrawal by Subject|3
5487323|NCT01772368|18971873|P1|Overall Study|Adverse Event|1
5487324|NCT01772316|18971919|P1|Overall Study|Withdrawn by sponsor decision|5
5487325|NCT01772316|18971919|P1|Overall Study|Inform consent withdrawn|1
5487326|NCT01772316|18971919|P1|Overall Study|Serious adverse event|1
5487327|NCT01772160|18971937|P1|Overall Study|Other|5
5487328|NCT01772160|18971937|P1|Overall Study|Lost to Follow-up|30
5487329|NCT01772160|18971937|P1|Overall Study|Migrated / moved from the study area|4
5487330|NCT01772160|18971937|P1|Overall Study|Consent withdrawal|3
5487331|NCT01772160|18971937|P1|Overall Study|Eligibility criteria not fulfilled|3
5487332|NCT01772160|18971937|P1|Overall Study|Death|3
5487333|NCT01772147|18971960|P3|Overall Study|Lack of Efficacy|6
5487334|NCT01772147|18971961|P2|Overall Study|Lack of Efficacy|6
5487335|NCT01772147|18971962|P1|Overall Study|Lack of Efficacy|8
5487336|NCT01772147|18971960|P3|Overall Study|Protocol Deviation|1
5487337|NCT01772147|18971961|P2|Overall Study|Protocol Deviation|1
5487338|NCT01772147|18971962|P1|Overall Study|Protocol Deviation|2
5487339|NCT01772147|18971960|P3|Overall Study|Lost to Follow-up|1
5487340|NCT01772147|18971961|P2|Overall Study|Lost to Follow-up|0
5487341|NCT01772147|18971962|P1|Overall Study|Lost to Follow-up|1
5487342|NCT01772147|18971960|P3|Overall Study|Withdrew Consent|4
5487343|NCT01772147|18971961|P2|Overall Study|Withdrew Consent|8
5487344|NCT01772147|18971962|P1|Overall Study|Withdrew Consent|7
5487345|NCT01772147|18971960|P3|Overall Study|Adverse Event|6
5487346|NCT01772147|18971961|P2|Overall Study|Adverse Event|10
5487347|NCT01772147|18971962|P1|Overall Study|Adverse Event|13
5487348|NCT01772134|18971982|P3|Overall Study|Randomized Study Medication Not Received|1
5487349|NCT01772134|18971983|P2|Overall Study|Randomized Study Medication Not Received|0
5487350|NCT01772134|18971984|P1|Overall Study|Randomized Study Medication Not Received|2
5487351|NCT01772134|18971982|P3|Overall Study|Protocol-defined Stopping Criteria|0
5487352|NCT01772134|18971983|P2|Overall Study|Protocol-defined Stopping Criteria|0
5487353|NCT01772134|18971984|P1|Overall Study|Protocol-defined Stopping Criteria|1
5487354|NCT01772134|18971982|P3|Overall Study|Lack of Efficacy|3
5487355|NCT01772134|18971983|P2|Overall Study|Lack of Efficacy|5
5487356|NCT01772134|18971984|P1|Overall Study|Lack of Efficacy|11
5487357|NCT01772134|18971982|P3|Overall Study|Protocol Deviation|3
5487358|NCT01772134|18971983|P2|Overall Study|Protocol Deviation|3
5487359|NCT01772134|18971984|P1|Overall Study|Protocol Deviation|4
5487360|NCT01772134|18971982|P3|Overall Study|Lost to Follow-up|0
5487361|NCT01772134|18971983|P2|Overall Study|Lost to Follow-up|0
5487362|NCT01772134|18971984|P1|Overall Study|Lost to Follow-up|2
5487363|NCT01772134|18971982|P3|Overall Study|Withdrew Consent|5
5487364|NCT01772134|18971983|P2|Overall Study|Withdrew Consent|1
5487365|NCT01772134|18971984|P1|Overall Study|Withdrew Consent|3
5487366|NCT01772134|18971982|P3|Overall Study|Adverse Event|10
5487367|NCT01772134|18971983|P2|Overall Study|Adverse Event|5
5487368|NCT01772134|18971984|P1|Overall Study|Adverse Event|6
5487369|NCT01771913|18972040|P2|Overall Study|Withdrawal by Subject|0
5487370|NCT01771913|18972041|P1|Overall Study|Withdrawal by Subject|1
5487371|NCT01771809|18972053|P2|Overall Study|Other (other)|5
5487372|NCT01771809|18972054|P1|Overall Study|Other (other)|9
5487373|NCT01771809|18972053|P2|Overall Study|Death|0
5487374|NCT01771809|18972054|P1|Overall Study|Death|1
5487375|NCT01771809|18972053|P2|Overall Study|Other (Insufficient clinical response)|20
5487376|NCT01771809|18972054|P1|Overall Study|Other (Insufficient clinical response)|22
5487377|NCT01771809|18972053|P2|Overall Study|Lost to Follow-up|3
5487378|NCT01771809|18972054|P1|Overall Study|Lost to Follow-up|1
5487379|NCT01771809|18972053|P2|Overall Study|Withdrawal by Subject|42
5487380|NCT01771809|18972054|P1|Overall Study|Withdrawal by Subject|34
5487381|NCT01771809|18972053|P2|Overall Study|Protocol Violation|1
5487382|NCT01771809|18972054|P1|Overall Study|Protocol Violation|0
5487383|NCT01771809|18972053|P2|Overall Study|Adverse Event|12
5487384|NCT01771809|18972054|P1|Overall Study|Adverse Event|4
5487385|NCT01771731|18972070|P2|Overall Study|Adverse event: Pain Crisis|1
5487386|NCT01771731|18972071|P1|Overall Study|Adverse event: Pain Crisis|1
5487387|NCT01771731|18972070|P2|Overall Study|Protocol Violation|1
5487388|NCT01771731|18972071|P1|Overall Study|Protocol Violation|0
5487389|NCT01771731|18972070|P2|Overall Study|Physician Decision|0
5487390|NCT01771731|18972071|P1|Overall Study|Physician Decision|1
5487391|NCT01771250|18972091|P2|Period 1|Met exclusion criteria|0
5487392|NCT01771250|18972092|P1|Period 1|Met exclusion criteria|1
5487393|NCT01770912|18972110|P2|Overall Study|Lost to Follow-up|0
5487394|NCT01770912|18972111|P1|Overall Study|Lost to Follow-up|2
5487395|NCT01770860|18972145|P1|Overall Study|Administrative decision made by the PI|1
5487396|NCT01770860|18972145|P1|Overall Study|Lost to Follow-up|1
5487397|NCT01770860|18972145|P1|Overall Study|Withdrawal by Subject|4
5487398|NCT01770743|18972193|P5|Overall Study|Moving Out of State|0
5487399|NCT01770743|18972194|P4|Overall Study|Moving Out of State|0
5487400|NCT01770743|18972195|P3|Overall Study|Moving Out of State|0
5487401|NCT01770743|18972196|P2|Overall Study|Moving Out of State|1
5487402|NCT01770743|18972197|P1|Overall Study|Moving Out of State|0
5487403|NCT01770743|18972193|P5|Overall Study|Sponsor Terminated Subject|0
5487404|NCT01770743|18972194|P4|Overall Study|Sponsor Terminated Subject|1
5487405|NCT01770743|18972195|P3|Overall Study|Sponsor Terminated Subject|0
5487406|NCT01770743|18972196|P2|Overall Study|Sponsor Terminated Subject|0
5487407|NCT01770743|18972197|P1|Overall Study|Sponsor Terminated Subject|1
5487408|NCT01770743|18972193|P5|Overall Study|Lost to Follow-up|1
5487409|NCT01770743|18972194|P4|Overall Study|Lost to Follow-up|0
5487410|NCT01770743|18972195|P3|Overall Study|Lost to Follow-up|0
5487411|NCT01770743|18972196|P2|Overall Study|Lost to Follow-up|2
5487412|NCT01770743|18972197|P1|Overall Study|Lost to Follow-up|0
5487413|NCT01770743|18972193|P5|Overall Study|Withdrawal by Subject|1
5487414|NCT01770743|18972194|P4|Overall Study|Withdrawal by Subject|1
5487415|NCT01770743|18972195|P3|Overall Study|Withdrawal by Subject|1
5487416|NCT01770743|18972196|P2|Overall Study|Withdrawal by Subject|0
5487417|NCT01770743|18972197|P1|Overall Study|Withdrawal by Subject|0
5487418|NCT01770743|18972193|P5|Overall Study|Adverse Event|0
5487419|NCT01770743|18972194|P4|Overall Study|Adverse Event|0
5487420|NCT01770743|18972195|P3|Overall Study|Adverse Event|0
5487421|NCT01770743|18972196|P2|Overall Study|Adverse Event|0
5487422|NCT01770743|18972197|P1|Overall Study|Adverse Event|1
5487423|NCT01770509|18972299|P2|Overall Study|Lost to Follow-up|2
5487424|NCT01770509|18972300|P1|Overall Study|Lost to Follow-up|1
5487425|NCT01770509|18972299|P2|Overall Study|Injury|1
5487426|NCT01770509|18972300|P1|Overall Study|Injury|0
5487427|NCT01770392|18972336|P1|Washout Period of at Least 14 Days|Adverse Event|1
5487428|NCT01770379|18972351|P3|Overall Study|Adverse Event|2
5487429|NCT01770379|18972352|P2|Overall Study|Adverse Event|3
5487430|NCT01770379|18972353|P1|Overall Study|Adverse Event|1
5487431|NCT01770379|18972351|P3|Overall Study|Lack of Efficacy|6
5487432|NCT01770379|18972352|P2|Overall Study|Lack of Efficacy|6
5487433|NCT01770379|18972353|P1|Overall Study|Lack of Efficacy|8
5487434|NCT01770379|18972351|P3|Overall Study|Lost to Follow-up|2
5487435|NCT01770379|18972352|P2|Overall Study|Lost to Follow-up|0
5487436|NCT01770379|18972353|P1|Overall Study|Lost to Follow-up|0
5487437|NCT01770379|18972351|P3|Overall Study|Physician Decision|2
5487438|NCT01770379|18972352|P2|Overall Study|Physician Decision|1
5487439|NCT01770379|18972353|P1|Overall Study|Physician Decision|0
5487440|NCT01770379|18972351|P3|Overall Study|Protocol Violation|1
5487441|NCT01770379|18972352|P2|Overall Study|Protocol Violation|1
5487442|NCT01770379|18972353|P1|Overall Study|Protocol Violation|0
5487443|NCT01770379|18972351|P3|Overall Study|study terminated by sponsor|22
5487444|NCT01770379|18972352|P2|Overall Study|study terminated by sponsor|23
5487445|NCT01770379|18972353|P1|Overall Study|study terminated by sponsor|22
5487446|NCT01770379|18972351|P3|Overall Study|Withdrawal by Subject|7
5487447|NCT01770379|18972352|P2|Overall Study|Withdrawal by Subject|10
5487448|NCT01770379|18972353|P1|Overall Study|Withdrawal by Subject|7
5487449|NCT01770379|18972351|P3|Overall Study|Technical issues|0
5487450|NCT01770379|18972352|P2|Overall Study|Technical issues|0
5487451|NCT01770379|18972353|P1|Overall Study|Technical issues|1
5487452|NCT01770353|18972381|P2|Overall Study|Toxicity related diarrhoea + progression|1
5487453|NCT01770353|18972382|P1|Overall Study|Toxicity related diarrhoea + progression|0
5487454|NCT01770353|18972381|P2|Overall Study|Clinical deterioration|6
5487455|NCT01770353|18972382|P1|Overall Study|Clinical deterioration|3
5487456|NCT01770353|18972381|P2|Overall Study|Physician Decision|3
5487457|NCT01770353|18972382|P1|Overall Study|Physician Decision|0
5487458|NCT01770353|18972381|P2|Overall Study|Protocol Violation|0
5487459|NCT01770353|18972382|P1|Overall Study|Protocol Violation|1
5487460|NCT01770353|18972381|P2|Overall Study|Adverse Event|1
5487461|NCT01770353|18972382|P1|Overall Study|Adverse Event|0
5487462|NCT01770353|18972381|P2|Overall Study|Progressive disease|1
5487463|NCT01770353|18972382|P1|Overall Study|Progressive disease|2
5487464|NCT01770145|18972441|P1|Treatment|Withdrawal by Subject|1
5487465|NCT01770145|18972441|P1|Treatment|Adverse Event|3
5487466|NCT01770145|18972441|P1|Baseline|Unable to define optimal dose|4
5487467|NCT01770145|18972441|P1|Baseline|Lost to Follow-up|1
5487468|NCT01770145|18972441|P1|Baseline|Withdrawal by Subject|1
5487469|NCT01770145|18972441|P1|Baseline|Adverse Event|20
5487470|NCT01769508|18972497|P1|Overall Study|Lost to Follow-up|1
5487471|NCT01769508|18972497|P1|Overall Study|Adverse Event|1
5487472|NCT01769508|18972497|P1|Overall Study|Withdrawal by Subject|1
5487473|NCT01769508|18972497|P1|Overall Study|Death|3
5487474|NCT01769469|18972506|P1|Overall Study|Subject Confirmed HIV Positive|3
5487475|NCT01769469|18972506|P1|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
5487476|NCT01769469|18972506|P1|Overall Study|Lost to Follow-up|17
5487477|NCT01769469|18972506|P1|Overall Study|Moved Out Of Area|3
5487478|NCT01769469|18972506|P1|Overall Study|Consent Withdrawn|5
5487479|NCT01769456|18972666|P1|Overall Study|Parental request to youth to withdraw|1
5487480|NCT01769456|18972666|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
5487481|NCT01769456|18972666|P1|Overall Study|Moved out of the area|3
5487482|NCT01769456|18972666|P1|Overall Study|Did not receive PCC intervention|6
5487483|NCT01769456|18972666|P1|Overall Study|Withdrawal by Subject|3
5487484|NCT01769456|18972666|P1|Overall Study|Lost to Follow-up|19
5487485|NCT01769443|18972687|P2|Overall Study|Study closure|0
5487486|NCT01769443|18972688|P1|Overall Study|Study closure|1
5487487|NCT01769404|18972730|P2|Treatment Period 2|Sponsor decision|0
5487488|NCT01769404|18972731|P1|Treatment Period 2|Sponsor decision|7
5487489|NCT01769404|18972730|P2|Treatment Period 1|Sponsor decision|0
5487490|NCT01769404|18972731|P1|Treatment Period 1|Sponsor decision|1
5487491|NCT01769404|18972730|P2|Treatment Period 1|Withdrawal by Subject|0
5487492|NCT01769404|18972731|P1|Treatment Period 1|Withdrawal by Subject|3
5487493|NCT01769404|18972730|P2|Treatment Period 1|Did not meet eligibility criteria|0
5487494|NCT01769404|18972731|P1|Treatment Period 1|Did not meet eligibility criteria|1
5487495|NCT01769391|18972753|P2|Overall Study|Investigator Decision|0
5487496|NCT01769391|18972754|P1|Overall Study|Investigator Decision|2
5487497|NCT01769391|18972753|P2|Overall Study|Withdrawal by Subject|3
5487498|NCT01769391|18972754|P1|Overall Study|Withdrawal by Subject|4
5487499|NCT01769391|18972753|P2|Overall Study|Progressive Disease|2
5487500|NCT01769391|18972754|P1|Overall Study|Progressive Disease|1
5487501|NCT01769391|18972753|P2|Overall Study|Adverse Event|3
5487502|NCT01769391|18972754|P1|Overall Study|Adverse Event|0
5487503|NCT01769391|18972753|P2|Overall Study|Death|1
5487504|NCT01769391|18972754|P1|Overall Study|Death|10
5487505|NCT01769378|18972773|P2|Overall Study|Lost to Follow-up|0
5487506|NCT01769378|18972774|P1|Overall Study|Lost to Follow-up|2
5487507|NCT01769378|18972773|P2|Overall Study|Sponsor Decision|0
5487508|NCT01769378|18972774|P1|Overall Study|Sponsor Decision|1
5487509|NCT01769378|18972773|P2|Overall Study|Withdrawal by Subject|3
5487510|NCT01769378|18972774|P1|Overall Study|Withdrawal by Subject|10
5487511|NCT01769378|18972773|P2|Overall Study|Protocol Violation|1
5487512|NCT01769378|18972774|P1|Overall Study|Protocol Violation|1
5487513|NCT01769378|18972773|P2|Overall Study|Entry criteria not met|0
5487514|NCT01769378|18972774|P1|Overall Study|Entry criteria not met|1
5487515|NCT01769378|18972773|P2|Overall Study|Adverse Event|0
5487516|NCT01769378|18972774|P1|Overall Study|Adverse Event|10
5487517|NCT01769339|18972854|P1|Overall Study|Adverse Event|1
5487518|NCT01769339|18972854|P1|Overall Study|Lost to Follow-up|42
5487519|NCT01769326|18972865|P4|Overall Study|Got sick and could not complete study|0
5487520|NCT01769326|18972866|P3|Overall Study|Got sick and could not complete study|1
5487521|NCT01769326|18972867|P2|Overall Study|Got sick and could not complete study|0
5487522|NCT01769326|18972868|P1|Overall Study|Got sick and could not complete study|0
5487523|NCT01769326|18972865|P4|Overall Study|got a job|0
5487524|NCT01769326|18972866|P3|Overall Study|got a job|0
5487525|NCT01769326|18972867|P2|Overall Study|got a job|1
5487526|NCT01769326|18972868|P1|Overall Study|got a job|0
5487527|NCT01769326|18972865|P4|Overall Study|unrelated injry|0
5487528|NCT01769326|18972866|P3|Overall Study|unrelated injry|0
5487529|NCT01769326|18972867|P2|Overall Study|unrelated injry|1
5487530|NCT01769326|18972868|P1|Overall Study|unrelated injry|1
5487531|NCT01769326|18972865|P4|Overall Study|Lost to Follow-up|0
5487532|NCT01769326|18972866|P3|Overall Study|Lost to Follow-up|0
5487533|NCT01769326|18972867|P2|Overall Study|Lost to Follow-up|2
5487534|NCT01769326|18972868|P1|Overall Study|Lost to Follow-up|1
5487535|NCT01769196|18973013|P2|Overall Study|Withdrew consent|40
5487536|NCT01769196|18973014|P1|Overall Study|Withdrew consent|36
5487537|NCT01769196|18973013|P2|Overall Study|Participant never dosed with study drug|0
5487538|NCT01769196|18973014|P1|Overall Study|Participant never dosed with study drug|1
5487539|NCT01769196|18973013|P2|Overall Study|Study terminated by sponsor|161
5487540|NCT01769196|18973014|P1|Overall Study|Study terminated by sponsor|160
5487541|NCT01769196|18973013|P2|Overall Study|Protocol Violation|3
5487542|NCT01769196|18973014|P1|Overall Study|Protocol Violation|0
5487543|NCT01769196|18973013|P2|Overall Study|Protocol defined criteria for withdrawal|11
5487544|NCT01769196|18973014|P1|Overall Study|Protocol defined criteria for withdrawal|9
5487545|NCT01769196|18973013|P2|Overall Study|Progressive disease|6
5487546|NCT01769196|18973014|P1|Overall Study|Progressive disease|11
5487547|NCT01769196|18973013|P2|Overall Study|Lack of Efficacy|2
5487548|NCT01769196|18973014|P1|Overall Study|Lack of Efficacy|3
5487549|NCT01769196|18973013|P2|Overall Study|Investigator Discretion|3
5487550|NCT01769196|18973014|P1|Overall Study|Investigator Discretion|7
5487551|NCT01769196|18973013|P2|Overall Study|Death|26
5487552|NCT01769196|18973014|P1|Overall Study|Death|21
5487553|NCT01769196|18973013|P2|Overall Study|Adverse Event|20
5487554|NCT01769196|18973014|P1|Overall Study|Adverse Event|24
5487555|NCT01769105|18973044|P2|Cross-over|Lost to Follow-up|0
5487556|NCT01769105|18973045|P1|Cross-over|Lost to Follow-up|5
5487557|NCT01769105|18973044|P2|First Intervention|Protocol Violation|2
5487558|NCT01769105|18973045|P1|First Intervention|Protocol Violation|2
5487559|NCT01768858|18973064|P1|Overall Study|Withdrawal by Subject|1
5487560|NCT01768858|18973064|P1|Overall Study|Exanthema|1
5487561|NCT01768858|18973064|P1|Overall Study|Aggravation of NY Heart Assoc 3 status|1
5487562|NCT01768858|18973064|P1|Overall Study|Participant moved to Germany|1
5487563|NCT01768858|18973064|P1|Overall Study|Serious Adverse Event|1
5487564|NCT01768858|18973064|P1|Overall Study|Lack of Efficacy|8
5487565|NCT01768858|18973064|P1|Overall Study|Lost to Follow-up|9
5487566|NCT01768676|18973115|P2|Overall Study|Withdrawal by Subject|10
5487567|NCT01768676|18973116|P1|Overall Study|Withdrawal by Subject|3
5487568|NCT01768676|18973115|P2|Overall Study|Physician Decision|1
5487569|NCT01768676|18973116|P1|Overall Study|Physician Decision|4
5487570|NCT01768676|18973115|P2|Overall Study|Protocol Violation|1
5487571|NCT01768676|18973116|P1|Overall Study|Protocol Violation|1
5487572|NCT01768676|18973115|P2|Overall Study|Lost to Follow-up|16
5487573|NCT01768676|18973116|P1|Overall Study|Lost to Follow-up|13
5487574|NCT01768676|18973115|P2|Overall Study|Adverse Event|3
5487575|NCT01768676|18973116|P1|Overall Study|Adverse Event|3
5487576|NCT01768637|18973132|P2|Overall Study|Difficult blood draw|0
5487577|NCT01768637|18973133|P1|Overall Study|Difficult blood draw|1
5487578|NCT01768637|18973132|P2|Overall Study|Lost to Follow-up|7
5487579|NCT01768637|18973133|P1|Overall Study|Lost to Follow-up|2
5487580|NCT01768572|18973146|P3|Overall Study|Other, Not due to an adverse event|1
5487581|NCT01768572|18973147|P2|Overall Study|Other, Not due to an adverse event|1
5487582|NCT01768572|18973148|P1|Overall Study|Other, Not due to an adverse event|1
5487583|NCT01768572|18973146|P3|Overall Study|Lack of Efficacy|1
5487584|NCT01768572|18973147|P2|Overall Study|Lack of Efficacy|3
5487585|NCT01768572|18973148|P1|Overall Study|Lack of Efficacy|1
5487586|NCT01768572|18973146|P3|Overall Study|Adverse Event|4
5487587|NCT01768572|18973147|P2|Overall Study|Adverse Event|8
5487588|NCT01768572|18973148|P1|Overall Study|Adverse Event|7
5487589|NCT01768559|18973159|P3|Overall Study|Other than specified|5
5487590|NCT01768559|18973160|P2|Overall Study|Other than specified|8
5487591|NCT01768559|18973161|P1|Overall Study|Other than specified|9
5487592|NCT01768559|18973159|P3|Overall Study|Poor compliance to protocol|2
5487593|NCT01768559|18973160|P2|Overall Study|Poor compliance to protocol|3
5487594|NCT01768559|18973161|P1|Overall Study|Poor compliance to protocol|0
5487595|NCT01768559|18973159|P3|Overall Study|Lack of Efficacy|0
5487596|NCT01768559|18973160|P2|Overall Study|Lack of Efficacy|4
5487597|NCT01768559|18973161|P1|Overall Study|Lack of Efficacy|6
5487598|NCT01768559|18973159|P3|Overall Study|Adverse Event|5
5487599|NCT01768559|18973160|P2|Overall Study|Adverse Event|2
5487600|NCT01768559|18973161|P1|Overall Study|Adverse Event|15
5487601|NCT01768559|18973159|P3|Overall Study|Randomized but not treated|1
5487602|NCT01768559|18973160|P2|Overall Study|Randomized but not treated|0
5487603|NCT01768559|18973161|P1|Overall Study|Randomized but not treated|0
5487604|NCT01768286|18973242|P4|Overall Study|Withdrew Consent|0
5487605|NCT01768286|18973243|P3|Overall Study|Withdrew Consent|1
5487606|NCT01768286|18973244|P2|Overall Study|Withdrew Consent|0
5487607|NCT01768286|18973245|P1|Overall Study|Withdrew Consent|0
5487608|NCT01768286|18973242|P4|Overall Study|Lack of Efficacy|1
5487609|NCT01768286|18973243|P3|Overall Study|Lack of Efficacy|0
5487610|NCT01768286|18973244|P2|Overall Study|Lack of Efficacy|4
5487611|NCT01768286|18973245|P1|Overall Study|Lack of Efficacy|7
5487612|NCT01768286|18973242|P4|Overall Study|Randomized But Not Treated|0
5487613|NCT01768286|18973243|P3|Overall Study|Randomized But Not Treated|1
5487614|NCT01768286|18973244|P2|Overall Study|Randomized But Not Treated|0
5487615|NCT01768286|18973245|P1|Overall Study|Randomized But Not Treated|0
5487616|NCT01768117|18973307|P1|Overall Study|Protocol Violation|3
5487617|NCT01768117|18973307|P1|Overall Study|Withdrawal by Subject|2
5487618|NCT01768117|18973307|P1|Overall Study|Lost to Follow-up|1
5487619|NCT01767987|18973371|P2|Overall Study|Physician Decision|1
5487620|NCT01767987|18973372|P1|Overall Study|Physician Decision|4
5487621|NCT01767909|18973404|P2|Overall Study|LP uncessessful|1
5487622|NCT01767909|18973405|P1|Overall Study|LP uncessessful|0
5487623|NCT01767909|18973404|P2|Overall Study|Lost to Follow-up|1
5487624|NCT01767909|18973405|P1|Overall Study|Lost to Follow-up|0
5487625|NCT01767909|18973404|P2|Overall Study|Investigator Recommendation|1
5487626|NCT01767909|18973405|P1|Overall Study|Investigator Recommendation|0
5487627|NCT01767909|18973404|P2|Overall Study|Perceived Lack of Efficacy|0
5487628|NCT01767909|18973405|P1|Overall Study|Perceived Lack of Efficacy|1
5487629|NCT01767909|18973404|P2|Overall Study|Non-Compliance|0
5487630|NCT01767909|18973405|P1|Overall Study|Non-Compliance|2
5487631|NCT01767909|18973404|P2|Overall Study|Withdrawal by Study Partner|1
5487632|NCT01767909|18973405|P1|Overall Study|Withdrawal by Study Partner|3
5487633|NCT01767909|18973404|P2|Overall Study|Adverse Event|1
5487634|NCT01767909|18973405|P1|Overall Study|Adverse Event|3
5487635|NCT01767909|18973404|P2|Overall Study|Withdrawal by Subject|7
5487636|NCT01767909|18973405|P1|Overall Study|Withdrawal by Subject|4
5487637|NCT01767597|18973475|P2|Overall Study|Withdrawal by Subject|0
5487638|NCT01767597|18973476|P1|Overall Study|Withdrawal by Subject|1
5487639|NCT01767597|18973475|P2|Overall Study|Incomplete intervention|1
5487640|NCT01767597|18973476|P1|Overall Study|Incomplete intervention|3
5487641|NCT01767519|18973485|P3|Overall Study|Adverse Event|1
5487642|NCT01767519|18973486|P2|Overall Study|Adverse Event|5
5487643|NCT01767519|18973487|P1|Overall Study|Adverse Event|5
5487644|NCT01767519|18973485|P3|Overall Study|Lack of Efficacy|0
5487645|NCT01767519|18973486|P2|Overall Study|Lack of Efficacy|0
5487646|NCT01767519|18973487|P1|Overall Study|Lack of Efficacy|1
5487647|NCT01767519|18973485|P3|Overall Study|Lost to Follow-up|2
5487648|NCT01767519|18973486|P2|Overall Study|Lost to Follow-up|1
5487649|NCT01767519|18973487|P1|Overall Study|Lost to Follow-up|3
5487650|NCT01767519|18973485|P3|Overall Study|Personal Reasons|0
5487651|NCT01767519|18973486|P2|Overall Study|Personal Reasons|0
5487652|NCT01767519|18973487|P1|Overall Study|Personal Reasons|1
5487653|NCT01767519|18973485|P3|Overall Study|Protocol Violation|0
5487654|NCT01767519|18973486|P2|Overall Study|Protocol Violation|3
5487655|NCT01767519|18973487|P1|Overall Study|Protocol Violation|0
5487656|NCT01767519|18973485|P3|Overall Study|Other Reasons|2
5487657|NCT01767519|18973486|P2|Overall Study|Other Reasons|4
5487658|NCT01767519|18973487|P1|Overall Study|Other Reasons|4
5487659|NCT01767467|18973528|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
5487660|NCT01767467|18973529|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
5487661|NCT01767467|18973528|P2|End of Study Phase (up to Month 13)|Physician Decision|0
5487662|NCT01767467|18973529|P1|End of Study Phase (up to Month 13)|Physician Decision|1
5487663|NCT01767467|18973528|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
5487664|NCT01767467|18973529|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
5487665|NCT01767467|18973528|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
5487666|NCT01767467|18973529|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
5487667|NCT01767467|18973528|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
5487668|NCT01767467|18973529|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
5487669|NCT01767467|18973528|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
5487670|NCT01767467|18973529|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
5487671|NCT01767467|18973528|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
5487672|NCT01767467|18973529|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
5487673|NCT01767467|18973528|P2|End of Study Phase (up to Month 13)|Adverse Event|39
5487674|NCT01767467|18973529|P1|End of Study Phase (up to Month 13)|Adverse Event|29
5487675|NCT01767467|18973528|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
5487676|NCT01767467|18973529|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
5487677|NCT01767467|18973528|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
5487678|NCT01767467|18973529|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
5487679|NCT01767467|18973528|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
5487680|NCT01767467|18973529|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
5487681|NCT01767467|18973528|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
5487682|NCT01767467|18973529|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
5487683|NCT01767467|18973528|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
5487684|NCT01767467|18973529|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
5487685|NCT01767467|18973528|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
5487686|NCT01767467|18973529|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
5487687|NCT01767376|18973585|P3|Overall Study|Withdrawal by Subject|0
5487688|NCT01767376|18973586|P2|Overall Study|Withdrawal by Subject|1
5487689|NCT01767376|18973587|P1|Overall Study|Withdrawal by Subject|1
5487690|NCT01767376|18973585|P3|Overall Study|Lost to Follow-up|0
5487691|NCT01767376|18973586|P2|Overall Study|Lost to Follow-up|2
5487692|NCT01767376|18973587|P1|Overall Study|Lost to Follow-up|3
5487693|NCT01767194|18973653|P2|Overall Study|Criteria not met on time for next cycle|1
5487694|NCT01767194|18973654|P1|Overall Study|Criteria not met on time for next cycle|0
5487695|NCT01767194|18973653|P2|Overall Study|Refusal by patient/parent|4
5487696|NCT01767194|18973654|P1|Overall Study|Refusal by patient/parent|2
5487697|NCT01767194|18973653|P2|Overall Study|Ineligible|1
5487698|NCT01767194|18973654|P1|Overall Study|Ineligible|1
5487699|NCT01767194|18973653|P2|Overall Study|Withdrawal by Subject|1
5487700|NCT01767194|18973654|P1|Overall Study|Withdrawal by Subject|0
5487701|NCT01767194|18973653|P2|Overall Study|Physician Decision|23
5487702|NCT01767194|18973654|P1|Overall Study|Physician Decision|2
5487703|NCT01767194|18973653|P2|Overall Study|Lack of Efficacy|11
5487704|NCT01767194|18973654|P1|Overall Study|Lack of Efficacy|12
5487705|NCT01767194|18973653|P2|Overall Study|Death|1
5487706|NCT01767194|18973654|P1|Overall Study|Death|0
5487707|NCT01767194|18973653|P2|Overall Study|Adverse Event|1
5487708|NCT01767194|18973654|P1|Overall Study|Adverse Event|1
5487709|NCT01767142|18973676|P1|Overall Study|Lost to Follow-up|3
5487710|NCT01767116|18973685|P2|Overall Study|Lost to Follow-up|2
5487711|NCT01767116|18973686|P1|Overall Study|Lost to Follow-up|2
5487712|NCT01766921|18973744|P2|Overall Study|Withdrawal by Subject|5
5487713|NCT01766921|18973745|P1|Overall Study|Withdrawal by Subject|14
5487714|NCT01766921|18973744|P2|Overall Study|Protocol Violation|1
5487715|NCT01766921|18973745|P1|Overall Study|Protocol Violation|1
5487716|NCT01766921|18973744|P2|Overall Study|Unclassified|2
5487717|NCT01766921|18973745|P1|Overall Study|Unclassified|2
5487718|NCT01766921|18973744|P2|Overall Study|Lost to Follow-up|3
5487719|NCT01766921|18973745|P1|Overall Study|Lost to Follow-up|1
5487720|NCT01766921|18973744|P2|Overall Study|Death|1
5487721|NCT01766921|18973745|P1|Overall Study|Death|1
5487722|NCT01766921|18973744|P2|Overall Study|Administrative Reason|5
5487723|NCT01766921|18973745|P1|Overall Study|Administrative Reason|5
5487724|NCT01766817|18973767|P3|Overall Study|Other|0
5487725|NCT01766817|18973768|P2|Overall Study|Other|0
5487726|NCT01766817|18973769|P1|Overall Study|Other|1
5487727|NCT01766817|18973767|P3|Overall Study|Physician Decision|4
5487728|NCT01766817|18973768|P2|Overall Study|Physician Decision|3
5487729|NCT01766817|18973769|P1|Overall Study|Physician Decision|3
5487730|NCT01766817|18973767|P3|Overall Study|Subject non-compliance|2
5487731|NCT01766817|18973768|P2|Overall Study|Subject non-compliance|1
5487732|NCT01766817|18973769|P1|Overall Study|Subject non-compliance|0
5487733|NCT01766817|18973767|P3|Overall Study|Withdrawal by Subject|3
5487734|NCT01766817|18973768|P2|Overall Study|Withdrawal by Subject|0
5487735|NCT01766817|18973769|P1|Overall Study|Withdrawal by Subject|2
5487736|NCT01766817|18973767|P3|Overall Study|Unable to take study drug|0
5487737|NCT01766817|18973768|P2|Overall Study|Unable to take study drug|1
5487738|NCT01766817|18973769|P1|Overall Study|Unable to take study drug|0
5487739|NCT01766817|18973767|P3|Overall Study|Death|0
5487740|NCT01766817|18973768|P2|Overall Study|Death|1
5487741|NCT01766817|18973769|P1|Overall Study|Death|1
5487742|NCT01766817|18973767|P3|Overall Study|Drug-unrelated adverse event|3
5487743|NCT01766817|18973768|P2|Overall Study|Drug-unrelated adverse event|3
5487744|NCT01766817|18973769|P1|Overall Study|Drug-unrelated adverse event|3
5487745|NCT01766817|18973767|P3|Overall Study|Drug-related adverse event|1
5487746|NCT01766817|18973768|P2|Overall Study|Drug-related adverse event|2
5487747|NCT01766817|18973769|P1|Overall Study|Drug-related adverse event|1
5487748|NCT01766778|18973820|P2|Overall Study|Withdrawal by Subject|0
5487749|NCT01766778|18973821|P1|Overall Study|Withdrawal by Subject|1
5487750|NCT01766778|18973820|P2|Overall Study|Adverse Event|4
5487751|NCT01766778|18973821|P1|Overall Study|Adverse Event|4
5487752|NCT01766401|18973875|P2|Overall Study|Pregnancy|1
5487753|NCT01766401|18973876|P1|Overall Study|Pregnancy|1
5487754|NCT01766401|18973875|P2|Overall Study|Lost to Follow-up|11
5487755|NCT01766401|18973876|P1|Overall Study|Lost to Follow-up|10
5487756|NCT01766401|18973875|P2|Overall Study|Withdrawal by Subject|12
5487757|NCT01766401|18973876|P1|Overall Study|Withdrawal by Subject|15
5487758|NCT01766401|18973875|P2|Overall Study|Protocol Violation|8
5487759|NCT01766401|18973876|P1|Overall Study|Protocol Violation|3
5487760|NCT01766401|18973875|P2|Overall Study|Lack of Efficacy|2
5487761|NCT01766401|18973876|P1|Overall Study|Lack of Efficacy|1
5487762|NCT01766401|18973875|P2|Overall Study|Adverse Event|22
5487763|NCT01766401|18973876|P1|Overall Study|Adverse Event|7
5487764|NCT01766336|18973886|P2|Overall Study|Withdrawal by Subject|15
5487765|NCT01766336|18973887|P1|Overall Study|Withdrawal by Subject|18
5487766|NCT01766336|18973886|P2|Overall Study|Sponsor Decision|43
5487767|NCT01766336|18973887|P1|Overall Study|Sponsor Decision|52
5487768|NCT01766336|18973886|P2|Overall Study|Protocol Violation|1
5487769|NCT01766336|18973887|P1|Overall Study|Protocol Violation|0
5487770|NCT01766336|18973886|P2|Overall Study|Physician Decision|2
5487771|NCT01766336|18973887|P1|Overall Study|Physician Decision|4
5487772|NCT01766336|18973886|P2|Overall Study|Lost to Follow-up|3
5487773|NCT01766336|18973887|P1|Overall Study|Lost to Follow-up|1
5487774|NCT01766336|18973886|P2|Overall Study|Death|3
5487775|NCT01766336|18973887|P1|Overall Study|Death|4
5487776|NCT01766336|18973886|P2|Overall Study|Adverse Event|8
5487777|NCT01766336|18973887|P1|Overall Study|Adverse Event|11
5487778|NCT01766310|18973895|P2|Overall Study|Lost to Follow-up|3
5487779|NCT01766310|18973896|P1|Overall Study|Lost to Follow-up|1
5487780|NCT01766206|18973926|P1|Overall Study|Withdrawal and inappropriate enrollment|1
5487781|NCT01766206|18973926|P1|Overall Study|Inappropriate enrollment|18
5487782|NCT01766206|18973926|P1|Overall Study|Lost to Follow-up|10
5487783|NCT01766206|18973926|P1|Overall Study|Withdrawal by Subject|22
5487784|NCT01766050|18973953|P1|Overall Study|Withdrawal by Subject|2
5487785|NCT01766050|18973953|P1|Overall Study|Lost to Follow-up|1
5487786|NCT01766050|18973953|P1|Overall Study|Adverse Event|1
5487787|NCT01766037|18974088|P2|Overall Study|nausea / discomfort|0
5487788|NCT01766037|18974089|P1|Overall Study|nausea / discomfort|3
5487789|NCT01766037|18974088|P2|Overall Study|medical - unrelated|2
5487790|NCT01766037|18974089|P1|Overall Study|medical - unrelated|1
5487791|NCT01766037|18974088|P2|Overall Study|Moved from area|0
5487792|NCT01766037|18974089|P1|Overall Study|Moved from area|5
5487793|NCT01766037|18974088|P2|Overall Study|Withdrawal by Subject|16
5487794|NCT01766037|18974089|P1|Overall Study|Withdrawal by Subject|18
5487795|NCT01766037|18974088|P2|Overall Study|Physician Decision|1
5487796|NCT01766037|18974089|P1|Overall Study|Physician Decision|0
5487797|NCT01766037|18974088|P2|Overall Study|Lost to Follow-up|10
5487798|NCT01766037|18974089|P1|Overall Study|Lost to Follow-up|0
5487799|NCT01766037|18974088|P2|Overall Study|Lack of Efficacy|0
5487800|NCT01766037|18974089|P1|Overall Study|Lack of Efficacy|1
5487801|NCT01766037|18974088|P2|Overall Study|Adverse Event|0
5487802|NCT01766037|18974089|P1|Overall Study|Adverse Event|1
5487803|NCT01765920|18974152|P2|Overall Study|Patient code disclosure|1
5487804|NCT01765920|18974153|P1|Overall Study|Patient code disclosure|0
5487805|NCT01765920|18974152|P2|Overall Study|Incorrect inclusion ineligible patient|5
5487806|NCT01765920|18974153|P1|Overall Study|Incorrect inclusion ineligible patient|2
5487807|NCT01765764|18974175|P3|Treatment Period|Other Miscellaneous Reasons|2
5487808|NCT01765764|18974176|P2|Treatment Period|Other Miscellaneous Reasons|2
5487809|NCT01765764|18974177|P1|Treatment Period|Other Miscellaneous Reasons|1
5487810|NCT01765764|18974175|P3|Treatment Period|Personal Reasons|1
5487811|NCT01765764|18974176|P2|Treatment Period|Personal Reasons|2
5487812|NCT01765764|18974177|P1|Treatment Period|Personal Reasons|1
5487813|NCT01765764|18974175|P3|Treatment Period|Lost to Follow-up|2
5487814|NCT01765764|18974176|P2|Treatment Period|Lost to Follow-up|3
5487815|NCT01765764|18974177|P1|Treatment Period|Lost to Follow-up|0
5487816|NCT01765764|18974175|P3|Treatment Period|Adverse Event|1
5487817|NCT01765764|18974176|P2|Treatment Period|Adverse Event|2
5487818|NCT01765764|18974177|P1|Treatment Period|Adverse Event|1
5487819|NCT01765751|18974197|P3|Overall Study|Lost to Follow-up|1
5487820|NCT01765751|18974198|P2|Overall Study|Lost to Follow-up|2
5487821|NCT01765751|18974199|P1|Overall Study|Lost to Follow-up|0
5487822|NCT01765673|18974231|P1|Overall Study|No transportation for 2nd/3rd visits|1
5487823|NCT01765582|18974264|P3|Overall Study|Withdrawal of Consent|10
5487824|NCT01765582|18974265|P2|Overall Study|Withdrawal of Consent|6
5487825|NCT01765582|18974266|P1|Overall Study|Withdrawal of Consent|11
5487826|NCT01765582|18974264|P3|Overall Study|Sponsor Decision|42
5487827|NCT01765582|18974265|P2|Overall Study|Sponsor Decision|42
5487828|NCT01765582|18974266|P1|Overall Study|Sponsor Decision|46
5487829|NCT01765582|18974264|P3|Overall Study|Death|33
5487830|NCT01765582|18974265|P2|Overall Study|Death|36
5487831|NCT01765582|18974266|P1|Overall Study|Death|31
5487832|NCT01765582|18974264|P3|Overall Study|Lost to Follow-up|1
5487833|NCT01765582|18974265|P2|Overall Study|Lost to Follow-up|2
5487834|NCT01765582|18974266|P1|Overall Study|Lost to Follow-up|2
5487835|NCT01765582|18974264|P3|Overall Study|Other|9
5487836|NCT01765582|18974265|P2|Overall Study|Other|6
5487837|NCT01765582|18974266|P1|Overall Study|Other|3
5487838|NCT01765569|18974299|P1|Period C|Death|1
5487839|NCT01765569|18974299|P1|Period B|Withdrawal by Subject|1
5487840|NCT01765543|18974320|P1|Overall Study|Withdrawal by Subject|2
5487841|NCT01765543|18974320|P1|Overall Study|Death|1
5487842|NCT01765426|18974372|P4|Overall Study|Lost to Follow-up|0
5487843|NCT01765426|18974373|P3|Overall Study|Lost to Follow-up|0
5487844|NCT01765426|18974374|P2|Overall Study|Lost to Follow-up|1
5487845|NCT01765426|18974375|P1|Overall Study|Lost to Follow-up|0
5487846|NCT01765270|18974431|P2|Overall Study|Withdrawal by Subject|1
5487847|NCT01765270|18974432|P1|Overall Study|Withdrawal by Subject|0
5487848|NCT01765270|18974431|P2|Overall Study|Physician Decision|0
5487849|NCT01765270|18974432|P1|Overall Study|Physician Decision|1
5487850|NCT01765192|18974454|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
5487851|NCT01765192|18974455|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
5487852|NCT01765192|18974454|P2|Treatment Period 2|Reason not specified|2
5487853|NCT01765192|18974455|P1|Treatment Period 2|Reason not specified|0
5487854|NCT01765192|18974454|P2|Washout Period|Reason not specified|0
5487855|NCT01765192|18974455|P1|Washout Period|Reason not specified|1
5487856|NCT01765192|18974454|P2|Washout Period|Voluntary Withdrawal|1
5487857|NCT01765192|18974455|P1|Washout Period|Voluntary Withdrawal|1
5487858|NCT01765192|18974454|P2|Treatment Period 1|Adverse Event|1
5487859|NCT01765192|18974455|P1|Treatment Period 1|Adverse Event|0
5487860|NCT01765179|18974473|P1|Overall Study|Ca elevated 10.6|1
5487861|NCT01765179|18974473|P1|Overall Study|work conflict|1
5487862|NCT01765179|18974473|P1|Overall Study|lack of venous access|1
5487863|NCT01765179|18974473|P1|Overall Study|Out of country unable to finish study|1
5487864|NCT01765179|18974473|P1|Overall Study|prohibited med|1
5487865|NCT01765179|18974473|P1|Overall Study|Hematocrit >54%|3
5487866|NCT01765179|18974473|P1|Overall Study|Withdrawal by Subject|8
5487867|NCT01765179|18974473|P1|Overall Study|Protocol Violation|1
5487868|NCT01765179|18974473|P1|Overall Study|Non-compliance with study drug|2
5487869|NCT01765179|18974473|P1|Overall Study|Lost to Follow-up|5
5487870|NCT01765179|18974473|P1|Overall Study|Adverse Event|3
5487871|NCT01765153|18974480|P2|Rest Phase 2|Lost to Follow-up|1
5487872|NCT01765153|18974481|P1|Rest Phase 2|Lost to Follow-up|2
5487873|NCT01765153|18974480|P2|Training Phase 2|Withdrawal by Subject|1
5487874|NCT01765153|18974481|P1|Training Phase 2|Withdrawal by Subject|0
5487875|NCT01765153|18974480|P2|Rest Phase 1|Withdrawal by Subject|1
5487876|NCT01765153|18974481|P1|Rest Phase 1|Withdrawal by Subject|0
5487877|NCT01765153|18974480|P2|Training Phase 1|Poor participation in intervention|1
5487878|NCT01765153|18974481|P1|Training Phase 1|Poor participation in intervention|0
5487879|NCT01765153|18974480|P2|Training Phase 1|Format of intervention differed|0
5487880|NCT01765153|18974481|P1|Training Phase 1|Format of intervention differed|1
5487881|NCT01764997|18974588|P5|Study Drug Treatment Period|Other than specified above|10
5487882|NCT01764997|18974589|P4|Study Drug Treatment Period|Other than specified above|0
5487883|NCT01764997|18974590|P3|Study Drug Treatment Period|Other than specified above|0
5487884|NCT01764997|18974591|P2|Study Drug Treatment Period|Other than specified above|0
5487885|NCT01764997|18974592|P1|Study Drug Treatment Period|Other than specified above|0
5487886|NCT01764997|18974588|P5|Study Drug Treatment Period|Lack of Efficacy|2
5487887|NCT01764997|18974589|P4|Study Drug Treatment Period|Lack of Efficacy|0
5487888|NCT01764997|18974590|P3|Study Drug Treatment Period|Lack of Efficacy|0
5487889|NCT01764997|18974591|P2|Study Drug Treatment Period|Lack of Efficacy|0
5487890|NCT01764997|18974592|P1|Study Drug Treatment Period|Lack of Efficacy|0
5487891|NCT01764997|18974588|P5|Study Drug Treatment Period|Adverse Event|24
5487892|NCT01764997|18974589|P4|Study Drug Treatment Period|Adverse Event|0
5487893|NCT01764997|18974590|P3|Study Drug Treatment Period|Adverse Event|0
5487894|NCT01764997|18974591|P2|Study Drug Treatment Period|Adverse Event|1
5487895|NCT01764997|18974592|P1|Study Drug Treatment Period|Adverse Event|0
5487896|NCT01764997|18974588|P5|Run-in Period|Other than specified above|0
5487897|NCT01764997|18974589|P4|Run-in Period|Other than specified above|0
5487898|NCT01764997|18974590|P3|Run-in Period|Other than specified above|0
5487899|NCT01764997|18974591|P2|Run-in Period|Other than specified above|0
5487900|NCT01764997|18974592|P1|Run-in Period|Other than specified above|17
5487901|NCT01764997|18974588|P5|Run-in Period|Poor compliance to protocol|0
5487902|NCT01764997|18974589|P4|Run-in Period|Poor compliance to protocol|0
5487903|NCT01764997|18974590|P3|Run-in Period|Poor compliance to protocol|0
5487904|NCT01764997|18974591|P2|Run-in Period|Poor compliance to protocol|0
5487905|NCT01764997|18974592|P1|Run-in Period|Poor compliance to protocol|1
5487906|NCT01764997|18974588|P5|Run-in Period|Lack of Efficacy|0
5487907|NCT01764997|18974589|P4|Run-in Period|Lack of Efficacy|0
5487908|NCT01764997|18974590|P3|Run-in Period|Lack of Efficacy|0
5487909|NCT01764997|18974591|P2|Run-in Period|Lack of Efficacy|0
5487910|NCT01764997|18974592|P1|Run-in Period|Lack of Efficacy|5
5487911|NCT01764997|18974588|P5|Run-in Period|Adverse Event|0
5487912|NCT01764997|18974589|P4|Run-in Period|Adverse Event|0
5487913|NCT01764997|18974590|P3|Run-in Period|Adverse Event|0
5487914|NCT01764997|18974591|P2|Run-in Period|Adverse Event|0
5487915|NCT01764997|18974592|P1|Run-in Period|Adverse Event|15
5487916|NCT01764945|18974619|P8|Overall Study|Adverse Event|0
5487917|NCT01764945|18974620|P7|Overall Study|Adverse Event|1
5487918|NCT01764945|18974621|P6|Overall Study|Adverse Event|0
5487919|NCT01764945|18974622|P5|Overall Study|Adverse Event|0
5487920|NCT01764945|18974623|P4|Overall Study|Adverse Event|0
5487921|NCT01764945|18974624|P3|Overall Study|Adverse Event|0
5487922|NCT01764945|18974625|P2|Overall Study|Adverse Event|1
5487923|NCT01764945|18974626|P1|Overall Study|Adverse Event|0
5487924|NCT01764854|18974672|P4|Overall Study|Protocol Violation|2
5487925|NCT01764854|18974673|P3|Overall Study|Protocol Violation|1
5487926|NCT01764854|18974674|P2|Overall Study|Protocol Violation|0
5487927|NCT01764854|18974675|P1|Overall Study|Protocol Violation|0
5487928|NCT01764854|18974672|P4|Overall Study|relocation|0
5487929|NCT01764854|18974673|P3|Overall Study|relocation|2
5487930|NCT01764854|18974674|P2|Overall Study|relocation|0
5487931|NCT01764854|18974675|P1|Overall Study|relocation|0
5487932|NCT01764854|18974672|P4|Overall Study|Withdrawal by Subject|0
5487933|NCT01764854|18974673|P3|Overall Study|Withdrawal by Subject|1
5487934|NCT01764854|18974674|P2|Overall Study|Withdrawal by Subject|0
5487935|NCT01764854|18974675|P1|Overall Study|Withdrawal by Subject|0
5487936|NCT01764854|18974672|P4|Overall Study|Adverse Event|0
5487937|NCT01764854|18974673|P3|Overall Study|Adverse Event|2
5487938|NCT01764854|18974674|P2|Overall Study|Adverse Event|0
5487939|NCT01764854|18974675|P1|Overall Study|Adverse Event|0
5487940|NCT01764841|18974689|P4|Overall Study|Lost to Follow-up|0
5487941|NCT01764841|18974690|P3|Overall Study|Lost to Follow-up|1
5487942|NCT01764841|18974691|P2|Overall Study|Lost to Follow-up|0
5487943|NCT01764841|18974692|P1|Overall Study|Lost to Follow-up|3
5487944|NCT01764841|18974689|P4|Overall Study|Withdrawal by Subject|15
5487945|NCT01764841|18974690|P3|Overall Study|Withdrawal by Subject|11
5487946|NCT01764841|18974691|P2|Overall Study|Withdrawal by Subject|24
5487947|NCT01764841|18974692|P1|Overall Study|Withdrawal by Subject|16
5487948|NCT01764841|18974689|P4|Overall Study|Protocol Violation|0
5487949|NCT01764841|18974690|P3|Overall Study|Protocol Violation|0
5487950|NCT01764841|18974691|P2|Overall Study|Protocol Violation|1
5487951|NCT01764841|18974692|P1|Overall Study|Protocol Violation|0
5487952|NCT01764841|18974689|P4|Overall Study|No Follow Up|0
5487953|NCT01764841|18974690|P3|Overall Study|No Follow Up|1
5487954|NCT01764841|18974691|P2|Overall Study|No Follow Up|0
5487955|NCT01764841|18974692|P1|Overall Study|No Follow Up|1
5487956|NCT01764841|18974689|P4|Overall Study|Death|4
5487957|NCT01764841|18974690|P3|Overall Study|Death|1
5487958|NCT01764841|18974691|P2|Overall Study|Death|0
5487959|NCT01764841|18974692|P1|Overall Study|Death|3
5487960|NCT01764841|18974689|P4|Overall Study|Logistical Difficulties|0
5487961|NCT01764841|18974690|P3|Overall Study|Logistical Difficulties|0
5487962|NCT01764841|18974691|P2|Overall Study|Logistical Difficulties|1
5487963|NCT01764841|18974692|P1|Overall Study|Logistical Difficulties|0
5487964|NCT01764659|18974733|P1|Overall Study|Physician Decision|1
5487965|NCT01764659|18974733|P1|Overall Study|Death|1
5487966|NCT01764633|18974747|P2|Overall Study|Lost to Follow-up|5
5487967|NCT01764633|18974748|P1|Overall Study|Lost to Follow-up|13
5487968|NCT01764633|18974747|P2|Overall Study|Withdrawal by Subject|88
5487969|NCT01764633|18974748|P1|Overall Study|Withdrawal by Subject|105
5487970|NCT01764464|18974777|P2|Second Intervention (Cross-over)|Adverse Event|0
5487971|NCT01764464|18974778|P1|Second Intervention (Cross-over)|Adverse Event|2
5487972|NCT01764464|18974777|P2|First Intervention|did not receive study drug|1
5487973|NCT01764464|18974778|P1|First Intervention|did not receive study drug|0
5487974|NCT01764464|18974777|P2|First Intervention|Adverse Event|2
5487975|NCT01764464|18974778|P1|First Intervention|Adverse Event|0
5487976|NCT01764464|18974777|P2|First Intervention|Lost to Follow-up|0
5487977|NCT01764464|18974778|P1|First Intervention|Lost to Follow-up|1
5487978|NCT01764464|18974777|P2|First Intervention|Withdrawal by Subject|0
5487979|NCT01764464|18974778|P1|First Intervention|Withdrawal by Subject|1
5487980|NCT01764386|18974796|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
5487981|NCT01764386|18974797|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
5487982|NCT01764386|18974796|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
5487983|NCT01764386|18974797|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
5487984|NCT01764386|18974796|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
5487985|NCT01764386|18974797|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
5487986|NCT01764386|18974796|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
5487987|NCT01764386|18974797|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
5487988|NCT01764386|18974796|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
5487989|NCT01764386|18974797|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
5487990|NCT01764386|18974796|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
5487991|NCT01764386|18974797|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
5487992|NCT01764386|18974796|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
5487993|NCT01764386|18974797|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
5487994|NCT01764386|18974796|P2|Controlled Treatment Period (CTP)|Adverse Event|0
5487995|NCT01764386|18974797|P1|Controlled Treatment Period (CTP)|Adverse Event|35
5487996|NCT01764256|18974842|P4|Completed Study|Lost to Follow-up|1
5487997|NCT01764256|18974843|P3|Completed Study|Lost to Follow-up|0
5487998|NCT01764256|18974844|P2|Completed Study|Lost to Follow-up|0
5487999|NCT01764256|18974845|P1|Completed Study|Lost to Follow-up|0
5488000|NCT01764256|18974842|P4|Received All Vaccinations|Lost to Follow-up|0
5488001|NCT01764256|18974843|P3|Received All Vaccinations|Lost to Follow-up|0
5488002|NCT01764256|18974844|P2|Received All Vaccinations|Lost to Follow-up|0
5488003|NCT01764256|18974845|P1|Received All Vaccinations|Lost to Follow-up|1
5488004|NCT01764256|18974842|P4|Received All Vaccinations|Did not meet inclusion criteria|0
5488005|NCT01764256|18974843|P3|Received All Vaccinations|Did not meet inclusion criteria|1
5488006|NCT01764256|18974844|P2|Received All Vaccinations|Did not meet inclusion criteria|0
5488007|NCT01764256|18974845|P1|Received All Vaccinations|Did not meet inclusion criteria|0
5488008|NCT01764256|18974842|P4|Received All Vaccinations|Adverse Event|0
5488009|NCT01764256|18974843|P3|Received All Vaccinations|Adverse Event|0
5488010|NCT01764256|18974844|P2|Received All Vaccinations|Adverse Event|1
5488011|NCT01764256|18974845|P1|Received All Vaccinations|Adverse Event|1
5488012|NCT01764022|18974888|P2|Overall Study|Protocol Violation|0
5488013|NCT01764022|18974889|P1|Overall Study|Protocol Violation|1
5488014|NCT01764022|18974888|P2|Overall Study|Lost to Follow-up|0
5488015|NCT01764022|18974889|P1|Overall Study|Lost to Follow-up|2
5488016|NCT01764022|18974888|P2|Overall Study|Physician Decision|2
5488017|NCT01764022|18974889|P1|Overall Study|Physician Decision|0
5488018|NCT01764022|18974888|P2|Overall Study|Lack of Efficacy|1
5488019|NCT01764022|18974889|P1|Overall Study|Lack of Efficacy|0
5488020|NCT01764022|18974888|P2|Overall Study|Withdrawal by Subject|6
5488021|NCT01764022|18974889|P1|Overall Study|Withdrawal by Subject|2
5488022|NCT01764022|18974888|P2|Overall Study|Death|5
5488023|NCT01764022|18974889|P1|Overall Study|Death|3
5488024|NCT01763996|18974921|P2|Treatment Period 2|Adverse Event|1
5488025|NCT01763996|18974922|P1|Treatment Period 2|Adverse Event|0
5488026|NCT01763918|18974976|P4|Overall Study|Sponsor Decision|0
5488027|NCT01763918|18974977|P3|Overall Study|Sponsor Decision|9
5488028|NCT01763918|18974978|P2|Overall Study|Sponsor Decision|0
5488029|NCT01763918|18974979|P1|Overall Study|Sponsor Decision|4
5488030|NCT01763918|18974976|P4|Overall Study|Withdrawal by Subject|2
5488031|NCT01763918|18974977|P3|Overall Study|Withdrawal by Subject|1
5488032|NCT01763918|18974978|P2|Overall Study|Withdrawal by Subject|1
5488033|NCT01763918|18974979|P1|Overall Study|Withdrawal by Subject|2
5488034|NCT01763905|18975077|P4|Overall Study|Lost to Follow-up|0
5488035|NCT01763905|18975078|P3|Overall Study|Lost to Follow-up|1
5488036|NCT01763905|18975079|P2|Overall Study|Lost to Follow-up|0
5488037|NCT01763905|18975080|P1|Overall Study|Lost to Follow-up|0
5488038|NCT01763905|18975077|P4|Overall Study|Decision by sponsor|0
5488039|NCT01763905|18975078|P3|Overall Study|Decision by sponsor|8
5488040|NCT01763905|18975079|P2|Overall Study|Decision by sponsor|0
5488041|NCT01763905|18975080|P1|Overall Study|Decision by sponsor|5
5488042|NCT01763905|18975077|P4|Overall Study|Withdrawal by Subject|1
5488043|NCT01763905|18975078|P3|Overall Study|Withdrawal by Subject|0
5488044|NCT01763905|18975079|P2|Overall Study|Withdrawal by Subject|1
5488045|NCT01763905|18975080|P1|Overall Study|Withdrawal by Subject|1
5488046|NCT01763866|18975198|P24|Overall Study|Death|0
5488047|NCT01763866|18975199|P23|Overall Study|Death|0
5488048|NCT01763866|18975200|P22|Overall Study|Death|0
5488049|NCT01763866|18975201|P21|Overall Study|Death|0
5488050|NCT01763866|18975202|P20|Overall Study|Death|0
5488051|NCT01763866|18975203|P19|Overall Study|Death|0
5488052|NCT01763866|18975204|P18|Overall Study|Death|0
5488053|NCT01763866|18975205|P17|Overall Study|Death|1
5488054|NCT01763866|18975206|P16|Overall Study|Death|0
5488055|NCT01763866|18975207|P15|Overall Study|Death|0
5488056|NCT01763866|18975208|P14|Overall Study|Death|0
5488057|NCT01763866|18975209|P13|Overall Study|Death|0
5488058|NCT01763866|18975210|P12|Overall Study|Death|0
5488059|NCT01763866|18975211|P11|Overall Study|Death|0
5488060|NCT01763866|18975212|P10|Overall Study|Death|0
5488061|NCT01763866|18975213|P9|Overall Study|Death|0
5488062|NCT01763866|18975214|P8|Overall Study|Death|0
5488063|NCT01763866|18975215|P7|Overall Study|Death|0
5488064|NCT01763866|18975216|P6|Overall Study|Death|0
5488065|NCT01763866|18975217|P5|Overall Study|Death|0
5488066|NCT01763866|18975218|P4|Overall Study|Death|0
5488067|NCT01763866|18975219|P3|Overall Study|Death|0
5488068|NCT01763866|18975220|P2|Overall Study|Death|0
5488069|NCT01763866|18975221|P1|Overall Study|Death|0
5488070|NCT01763866|18975198|P24|Overall Study|Lost to Follow-up|1
5488071|NCT01763866|18975199|P23|Overall Study|Lost to Follow-up|0
5488072|NCT01763866|18975200|P22|Overall Study|Lost to Follow-up|0
5488073|NCT01763866|18975201|P21|Overall Study|Lost to Follow-up|0
5488074|NCT01763866|18975202|P20|Overall Study|Lost to Follow-up|1
5488075|NCT01763866|18975203|P19|Overall Study|Lost to Follow-up|1
5488076|NCT01763866|18975204|P18|Overall Study|Lost to Follow-up|0
5488077|NCT01763866|18975205|P17|Overall Study|Lost to Follow-up|0
5488078|NCT01763866|18975206|P16|Overall Study|Lost to Follow-up|0
5488079|NCT01763866|18975207|P15|Overall Study|Lost to Follow-up|1
5488080|NCT01763866|18975208|P14|Overall Study|Lost to Follow-up|0
5488081|NCT01763866|18975209|P13|Overall Study|Lost to Follow-up|1
5488082|NCT01763866|18975210|P12|Overall Study|Lost to Follow-up|0
5488083|NCT01763866|18975211|P11|Overall Study|Lost to Follow-up|0
5488084|NCT01763866|18975212|P10|Overall Study|Lost to Follow-up|0
5488085|NCT01763866|18975213|P9|Overall Study|Lost to Follow-up|0
5488086|NCT01763866|18975214|P8|Overall Study|Lost to Follow-up|0
5488087|NCT01763866|18975215|P7|Overall Study|Lost to Follow-up|1
5488088|NCT01763866|18975216|P6|Overall Study|Lost to Follow-up|0
5488089|NCT01763866|18975217|P5|Overall Study|Lost to Follow-up|0
5488090|NCT01763866|18975218|P4|Overall Study|Lost to Follow-up|0
5488091|NCT01763866|18975219|P3|Overall Study|Lost to Follow-up|0
5488092|NCT01763866|18975220|P2|Overall Study|Lost to Follow-up|0
5488093|NCT01763866|18975221|P1|Overall Study|Lost to Follow-up|0
5488094|NCT01763866|18975198|P24|Overall Study|Decision by sponsor|0
5488095|NCT01763866|18975199|P23|Overall Study|Decision by sponsor|1
5488096|NCT01763866|18975200|P22|Overall Study|Decision by sponsor|0
5488097|NCT01763866|18975201|P21|Overall Study|Decision by sponsor|2
5488098|NCT01763866|18975202|P20|Overall Study|Decision by sponsor|0
5488099|NCT01763866|18975203|P19|Overall Study|Decision by sponsor|4
5488100|NCT01763866|18975204|P18|Overall Study|Decision by sponsor|0
5488101|NCT01763866|18975205|P17|Overall Study|Decision by sponsor|0
5488102|NCT01763866|18975206|P16|Overall Study|Decision by sponsor|0
5488103|NCT01763866|18975207|P15|Overall Study|Decision by sponsor|5
5488104|NCT01763866|18975208|P14|Overall Study|Decision by sponsor|0
5488105|NCT01763866|18975209|P13|Overall Study|Decision by sponsor|1
5488106|NCT01763866|18975210|P12|Overall Study|Decision by sponsor|0
5488107|NCT01763866|18975211|P11|Overall Study|Decision by sponsor|6
5488108|NCT01763866|18975212|P10|Overall Study|Decision by sponsor|0
5488109|NCT01763866|18975213|P9|Overall Study|Decision by sponsor|2
5488110|NCT01763866|18975214|P8|Overall Study|Decision by sponsor|0
5488111|NCT01763866|18975215|P7|Overall Study|Decision by sponsor|2
5488112|NCT01763866|18975216|P6|Overall Study|Decision by sponsor|0
5488113|NCT01763866|18975217|P5|Overall Study|Decision by sponsor|2
5488114|NCT01763866|18975218|P4|Overall Study|Decision by sponsor|0
5488115|NCT01763866|18975219|P3|Overall Study|Decision by sponsor|1
5488116|NCT01763866|18975220|P2|Overall Study|Decision by sponsor|0
5488117|NCT01763866|18975221|P1|Overall Study|Decision by sponsor|0
5488118|NCT01763866|18975198|P24|Overall Study|Withdrawal by Subject|1
5488119|NCT01763866|18975199|P23|Overall Study|Withdrawal by Subject|2
5488120|NCT01763866|18975200|P22|Overall Study|Withdrawal by Subject|1
5488121|NCT01763866|18975201|P21|Overall Study|Withdrawal by Subject|2
5488122|NCT01763866|18975202|P20|Overall Study|Withdrawal by Subject|1
5488123|NCT01763866|18975203|P19|Overall Study|Withdrawal by Subject|1
5488124|NCT01763866|18975204|P18|Overall Study|Withdrawal by Subject|1
5488125|NCT01763866|18975205|P17|Overall Study|Withdrawal by Subject|0
5488126|NCT01763866|18975206|P16|Overall Study|Withdrawal by Subject|3
5488127|NCT01763866|18975207|P15|Overall Study|Withdrawal by Subject|6
5488128|NCT01763866|18975208|P14|Overall Study|Withdrawal by Subject|0
5488129|NCT01763866|18975209|P13|Overall Study|Withdrawal by Subject|2
5488130|NCT01763866|18975210|P12|Overall Study|Withdrawal by Subject|2
5488131|NCT01763866|18975211|P11|Overall Study|Withdrawal by Subject|2
5488132|NCT01763866|18975212|P10|Overall Study|Withdrawal by Subject|1
5488133|NCT01763866|18975213|P9|Overall Study|Withdrawal by Subject|1
5488134|NCT01763866|18975214|P8|Overall Study|Withdrawal by Subject|0
5488135|NCT01763866|18975215|P7|Overall Study|Withdrawal by Subject|4
5488136|NCT01763866|18975216|P6|Overall Study|Withdrawal by Subject|3
5488137|NCT01763866|18975217|P5|Overall Study|Withdrawal by Subject|0
5488138|NCT01763866|18975218|P4|Overall Study|Withdrawal by Subject|0
5488139|NCT01763866|18975219|P3|Overall Study|Withdrawal by Subject|4
5488140|NCT01763866|18975220|P2|Overall Study|Withdrawal by Subject|1
5488141|NCT01763866|18975221|P1|Overall Study|Withdrawal by Subject|2
5488142|NCT01763827|18975781|P6|Overall Study|Lost to Follow-up|1
5488143|NCT01763827|18975782|P5|Overall Study|Lost to Follow-up|2
5488144|NCT01763827|18975783|P4|Overall Study|Lost to Follow-up|1
5488145|NCT01763827|18975784|P3|Overall Study|Lost to Follow-up|1
5488146|NCT01763827|18975785|P2|Overall Study|Lost to Follow-up|1
5488147|NCT01763827|18975786|P1|Overall Study|Lost to Follow-up|0
5488148|NCT01763827|18975781|P6|Overall Study|Decision by sponsor|1
5488149|NCT01763827|18975782|P5|Overall Study|Decision by sponsor|2
5488150|NCT01763827|18975783|P4|Overall Study|Decision by sponsor|0
5488151|NCT01763827|18975784|P3|Overall Study|Decision by sponsor|3
5488152|NCT01763827|18975785|P2|Overall Study|Decision by sponsor|0
5488153|NCT01763827|18975786|P1|Overall Study|Decision by sponsor|2
5488154|NCT01763827|18975781|P6|Overall Study|Withdrawal by Subject|0
5488155|NCT01763827|18975782|P5|Overall Study|Withdrawal by Subject|2
5488156|NCT01763827|18975783|P4|Overall Study|Withdrawal by Subject|0
5488157|NCT01763827|18975784|P3|Overall Study|Withdrawal by Subject|0
5488158|NCT01763827|18975785|P2|Overall Study|Withdrawal by Subject|0
5488159|NCT01763827|18975786|P1|Overall Study|Withdrawal by Subject|1
5488160|NCT01763788|18975930|P4|Overall Study|Lost to Follow-up|0
5488161|NCT01763788|18975931|P3|Overall Study|Lost to Follow-up|1
5488162|NCT01763788|18975932|P2|Overall Study|Lost to Follow-up|0
5488163|NCT01763788|18975933|P1|Overall Study|Lost to Follow-up|0
5488164|NCT01763203|18976154|P2|Overall Study|Physician Decision|1
5488165|NCT01763203|18976155|P1|Overall Study|Physician Decision|2
5488166|NCT01763203|18976154|P2|Overall Study|Moved out of study region|10
5488167|NCT01763203|18976155|P1|Overall Study|Moved out of study region|7
5488168|NCT01763203|18976154|P2|Overall Study|Withdrawal by Subject|12
5488169|NCT01763203|18976155|P1|Overall Study|Withdrawal by Subject|8
5488170|NCT01763203|18976154|P2|Overall Study|Lost to Follow-up|12
5488171|NCT01763203|18976155|P1|Overall Study|Lost to Follow-up|12
5488172|NCT01763203|18976154|P2|Overall Study|Death|7
5488173|NCT01763203|18976155|P1|Overall Study|Death|4
5488174|NCT01763047|18976201|P2|Period 2|Unsatisfactory lens Fitting|1
5488175|NCT01763047|18976202|P1|Period 2|Unsatisfactory lens Fitting|0
5488176|NCT01763047|18976201|P2|Period 2|Protocol Violation|2
5488177|NCT01763047|18976202|P1|Period 2|Protocol Violation|0
5488178|NCT01763047|18976201|P2|Period 2|Unsatisfactory Visual Response|1
5488179|NCT01763047|18976202|P1|Period 2|Unsatisfactory Visual Response|1
5488180|NCT01763047|18976201|P2|Period 2|Study Site office Closed|1
5488181|NCT01763047|18976202|P1|Period 2|Study Site office Closed|1
5488182|NCT01763047|18976201|P2|Period 2|No longer meets Eligibility Criteria|0
5488183|NCT01763047|18976202|P1|Period 2|No longer meets Eligibility Criteria|1
5488184|NCT01763047|18976201|P2|Period 2|Lens Discomfort|0
5488185|NCT01763047|18976202|P1|Period 2|Lens Discomfort|1
5488186|NCT01763047|18976201|P2|Period 1|Study Site office Closed|1
5488187|NCT01763047|18976202|P1|Period 1|Study Site office Closed|0
5488188|NCT01763047|18976201|P2|Period 1|Lens Power Not Available|1
5488189|NCT01763047|18976202|P1|Period 1|Lens Power Not Available|0
5488190|NCT01763047|18976201|P2|Period 1|Unsatisfactory Visual Response|3
5488191|NCT01763047|18976202|P1|Period 1|Unsatisfactory Visual Response|0
5488192|NCT01763047|18976201|P2|Period 1|Adverse Event|1
5488193|NCT01763047|18976202|P1|Period 1|Adverse Event|0
5488194|NCT01763047|18976201|P2|Period 1|No Longer Meets Eligibility criteria|0
5488195|NCT01763047|18976202|P1|Period 1|No Longer Meets Eligibility criteria|1
5488196|NCT01763047|18976201|P2|Period 1|Protocol Violation|4
5488197|NCT01763047|18976202|P1|Period 1|Protocol Violation|4
5488198|NCT01763047|18976201|P2|Period 1|Test Article Not Available|1
5488199|NCT01763047|18976202|P1|Period 1|Test Article Not Available|4
5488200|NCT01762943|18976241|P2|Overall Study|Withdrawal by Subject|1
5488201|NCT01762943|18976242|P1|Overall Study|Withdrawal by Subject|2
5488202|NCT01762943|18976241|P2|Overall Study|Protocol Violation|0
5488203|NCT01762943|18976242|P1|Overall Study|Protocol Violation|1
5488204|NCT01762943|18976241|P2|Overall Study|Physician Decision|1
5488205|NCT01762943|18976242|P1|Overall Study|Physician Decision|1
5488206|NCT01762800|18976259|P2|Overall Study|Withdrawal by Subject|4
5488207|NCT01762800|18976260|P1|Overall Study|Withdrawal by Subject|7
5488208|NCT01762800|18976259|P2|Overall Study|Physician Decision|1
5488209|NCT01762800|18976260|P1|Overall Study|Physician Decision|1
5488210|NCT01762800|18976259|P2|Overall Study|Study Closed/Terminated|1
5488211|NCT01762800|18976260|P1|Overall Study|Study Closed/Terminated|0
5488212|NCT01762800|18976259|P2|Overall Study|Lack of Efficacy|2
5488213|NCT01762800|18976260|P1|Overall Study|Lack of Efficacy|3
5488214|NCT01762800|18976259|P2|Overall Study|Adverse Event|13
5488215|NCT01762800|18976260|P1|Overall Study|Adverse Event|8
5488216|NCT01762761|18976334|P2|Overall Study|Withdrawal by Subject|8
5488217|NCT01762761|18976335|P1|Overall Study|Withdrawal by Subject|7
5488218|NCT01762761|18976334|P2|Overall Study|Physician Decision|6
5488219|NCT01762761|18976335|P1|Overall Study|Physician Decision|4
5488220|NCT01762761|18976334|P2|Overall Study|Lost to Follow-up|6
5488221|NCT01762761|18976335|P1|Overall Study|Lost to Follow-up|3
5488222|NCT01762761|18976334|P2|Overall Study|Study closed/terminated|2
5488223|NCT01762761|18976335|P1|Overall Study|Study closed/terminated|0
5488224|NCT01762761|18976334|P2|Overall Study|Protocol Violation|1
5488225|NCT01762761|18976335|P1|Overall Study|Protocol Violation|1
5488226|NCT01762761|18976334|P2|Overall Study|Lack of Efficacy|25
5488227|NCT01762761|18976335|P1|Overall Study|Lack of Efficacy|9
5488228|NCT01762761|18976334|P2|Overall Study|Adverse Event|17
5488229|NCT01762761|18976335|P1|Overall Study|Adverse Event|15
5488230|NCT01762345|18976434|P1|Overall Study|Protocol Violation|2
5488231|NCT01762345|18976434|P1|Overall Study|Adverse Event|5
5488232|NCT01761565|18976495|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
5488233|NCT01761292|18976507|P1|Extension 1|Withdrawal by Subject|1
5488234|NCT01761292|18976507|P1|Part 1|not receiving treatment in Part 1|1
5488235|NCT01761292|18976507|P1|Part 1|Adverse Event|1
5488236|NCT01761266|18976541|P2|Overall Study|Ongoing as of data-cut off|107
5488237|NCT01761266|18976542|P1|Overall Study|Ongoing as of data-cut off|109
5488238|NCT01761266|18976541|P2|Overall Study|Withdrawal by Subject|8
5488239|NCT01761266|18976542|P1|Overall Study|Withdrawal by Subject|13
5488240|NCT01761266|18976541|P2|Overall Study|Lost to Follow-up|11
5488241|NCT01761266|18976542|P1|Overall Study|Lost to Follow-up|5
5488242|NCT01761266|18976541|P2|Overall Study|Death|350
5488243|NCT01761266|18976542|P1|Overall Study|Death|351
5488244|NCT01761162|18976599|P1|Overall Study|Withdrawal by Subject|3
5488245|NCT01760954|18976688|P4|Post-treatment Follow-up (12 Months)|Other|6
5488246|NCT01760954|18976689|P3|Post-treatment Follow-up (12 Months)|Other|9
5488247|NCT01760954|18976690|P2|Post-treatment Follow-up (12 Months)|Other|8
5488248|NCT01760954|18976691|P1|Post-treatment Follow-up (12 Months)|Other|13
5488249|NCT01760954|18976688|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
5488250|NCT01760954|18976689|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
5488251|NCT01760954|18976690|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
5488252|NCT01760954|18976691|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
5488253|NCT01760954|18976688|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
5488254|NCT01760954|18976689|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
5488255|NCT01760954|18976690|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
5488256|NCT01760954|18976691|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
5488257|NCT01760954|18976688|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
5488336|NCT01760447|18976873|P4|Weeks 0-20|Withdrawal by Subject|0
5488258|NCT01760954|18976689|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
5488259|NCT01760954|18976690|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
5488260|NCT01760954|18976691|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
5488261|NCT01760954|18976688|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
5488262|NCT01760954|18976689|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
5488263|NCT01760954|18976690|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
5488264|NCT01760954|18976691|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
5488265|NCT01760954|18976688|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
5488266|NCT01760954|18976689|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
5488267|NCT01760954|18976690|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
5488268|NCT01760954|18976691|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
5488269|NCT01760954|18976688|P4|Treatment Period (6 Months)|Exclusionary Medication|0
5488270|NCT01760954|18976689|P3|Treatment Period (6 Months)|Exclusionary Medication|0
5488271|NCT01760954|18976690|P2|Treatment Period (6 Months)|Exclusionary Medication|0
5488272|NCT01760954|18976691|P1|Treatment Period (6 Months)|Exclusionary Medication|1
5488273|NCT01760954|18976688|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
5488274|NCT01760954|18976689|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
5488275|NCT01760954|18976690|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
5488276|NCT01760954|18976691|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
5488277|NCT01760954|18976688|P4|Treatment Period (6 Months)|Other|1
5488278|NCT01760954|18976689|P3|Treatment Period (6 Months)|Other|3
5488279|NCT01760954|18976690|P2|Treatment Period (6 Months)|Other|3
5488280|NCT01760954|18976691|P1|Treatment Period (6 Months)|Other|0
5488281|NCT01760954|18976688|P4|Treatment Period (6 Months)|Non-compliance|3
5488282|NCT01760954|18976689|P3|Treatment Period (6 Months)|Non-compliance|0
5488283|NCT01760954|18976690|P2|Treatment Period (6 Months)|Non-compliance|4
5488284|NCT01760954|18976691|P1|Treatment Period (6 Months)|Non-compliance|1
5488285|NCT01760954|18976688|P4|Treatment Period (6 Months)|Pregnancy|2
5488286|NCT01760954|18976689|P3|Treatment Period (6 Months)|Pregnancy|3
5488287|NCT01760954|18976690|P2|Treatment Period (6 Months)|Pregnancy|0
5488288|NCT01760954|18976691|P1|Treatment Period (6 Months)|Pregnancy|5
5488289|NCT01760954|18976688|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
5488290|NCT01760954|18976689|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
5488291|NCT01760954|18976690|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
5488292|NCT01760954|18976691|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
5488293|NCT01760954|18976688|P4|Treatment Period (6 Months)|Lost to Follow-up|3
5488294|NCT01760954|18976689|P3|Treatment Period (6 Months)|Lost to Follow-up|4
5488295|NCT01760954|18976690|P2|Treatment Period (6 Months)|Lost to Follow-up|1
5488296|NCT01760954|18976691|P1|Treatment Period (6 Months)|Lost to Follow-up|9
5488297|NCT01760954|18976688|P4|Treatment Period (6 Months)|Adverse Event|10
5488298|NCT01760954|18976689|P3|Treatment Period (6 Months)|Adverse Event|4
5488299|NCT01760954|18976690|P2|Treatment Period (6 Months)|Adverse Event|3
5488300|NCT01760954|18976691|P1|Treatment Period (6 Months)|Adverse Event|5
5488301|NCT01760954|18976688|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
5488302|NCT01760954|18976689|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
5488303|NCT01760954|18976690|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
5488304|NCT01760954|18976691|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
5488305|NCT01760876|18976828|P1|Overall Study|Very poor baseline OCT quality|2
5488306|NCT01760876|18976828|P1|Overall Study|Major depression|1
5488307|NCT01760876|18976828|P1|Overall Study|Impaired renal function|1
5488308|NCT01760876|18976828|P1|Overall Study|Carcinoma of prostate|1
5488309|NCT01760876|18976828|P1|Overall Study|Non-cardiac death (head injury)|1
5488310|NCT01760733|18976843|P1|Transplanted|Graft loss|7
5488311|NCT01760733|18976843|P1|Transplanted|Death|26
5488312|NCT01760733|18976843|P1|Transplanted|Not reached 10 years post transplant|184
5488313|NCT01760733|18976843|P1|Waiting List|Not received a transplant yet|13
5488314|NCT01760733|18976843|P1|Waiting List|Removed from waiting list|41
5488315|NCT01760733|18976843|P1|Waiting List|Death|18
5488316|NCT01760447|18976873|P4|Weeks 20-54|Lost to Follow-up|2
5488317|NCT01760447|18976874|P3|Weeks 20-54|Lost to Follow-up|1
5488318|NCT01760447|18976875|P2|Weeks 20-54|Lost to Follow-up|0
5488319|NCT01760447|18976876|P1|Weeks 20-54|Lost to Follow-up|0
5488320|NCT01760447|18976873|P4|Weeks 20-54|Withdrawal by Subject|2
5488321|NCT01760447|18976874|P3|Weeks 20-54|Withdrawal by Subject|1
5488322|NCT01760447|18976875|P2|Weeks 20-54|Withdrawal by Subject|1
5488323|NCT01760447|18976876|P1|Weeks 20-54|Withdrawal by Subject|2
5488324|NCT01760447|18976873|P4|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
5488325|NCT01760447|18976874|P3|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
5488326|NCT01760447|18976875|P2|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
5488327|NCT01760447|18976876|P1|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
5488328|NCT01760447|18976873|P4|Weeks 0-20|Randomized but not treated|0
5488329|NCT01760447|18976874|P3|Weeks 0-20|Randomized but not treated|2
5488330|NCT01760447|18976875|P2|Weeks 0-20|Randomized but not treated|0
5488331|NCT01760447|18976876|P1|Weeks 0-20|Randomized but not treated|0
5488332|NCT01760447|18976873|P4|Weeks 0-20|Lost to Follow-up|1
5488333|NCT01760447|18976874|P3|Weeks 0-20|Lost to Follow-up|1
5488334|NCT01760447|18976875|P2|Weeks 0-20|Lost to Follow-up|0
5488335|NCT01760447|18976876|P1|Weeks 0-20|Lost to Follow-up|1
5488337|NCT01760447|18976874|P3|Weeks 0-20|Withdrawal by Subject|1
5488338|NCT01760447|18976875|P2|Weeks 0-20|Withdrawal by Subject|0
5488339|NCT01760447|18976876|P1|Weeks 0-20|Withdrawal by Subject|2
5488340|NCT01760447|18976873|P4|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
5488341|NCT01760447|18976874|P3|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
5488342|NCT01760447|18976875|P2|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
5488343|NCT01760447|18976876|P1|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
5488344|NCT01759862|18977204|P2|Overall Study|Adverse Event|1
5488345|NCT01759862|18977205|P1|Overall Study|Adverse Event|0
5488346|NCT01759862|18977204|P2|Overall Study|Physician Decision|1
5488347|NCT01759862|18977205|P1|Overall Study|Physician Decision|3
5488348|NCT01759511|18977223|P1|Overall Study|Withdrawal by Subject|3
5488349|NCT01759511|18977223|P1|Overall Study|Study Terminated by Sponsor|13
5488350|NCT01759511|18977223|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
5488351|NCT01759511|18977223|P1|Overall Study|Progressive Disease|5
5488352|NCT01759511|18977223|P1|Overall Study|Physician Decision|1
5488353|NCT01759511|18977223|P1|Overall Study|Lack of Efficacy|2
5488354|NCT01759511|18977223|P1|Overall Study|Death|2
5488355|NCT01759511|18977223|P1|Overall Study|Adverse Event|4
5488356|NCT01759446|18977236|P5|Overall Study|Withdrawal by Subject|0
5488357|NCT01759446|18977237|P4|Overall Study|Withdrawal by Subject|1
5488358|NCT01759446|18977238|P3|Overall Study|Withdrawal by Subject|0
5488359|NCT01759446|18977239|P2|Overall Study|Withdrawal by Subject|1
5488360|NCT01759446|18977240|P1|Overall Study|Withdrawal by Subject|0
5488361|NCT01759446|18977236|P5|Overall Study|Protocol Violation|0
5488362|NCT01759446|18977237|P4|Overall Study|Protocol Violation|0
5488363|NCT01759446|18977238|P3|Overall Study|Protocol Violation|1
5488364|NCT01759446|18977239|P2|Overall Study|Protocol Violation|0
5488365|NCT01759446|18977240|P1|Overall Study|Protocol Violation|1
5488366|NCT01759420|18977252|P1|Overall Study|Inaccurate EKG machine readings|1
5488367|NCT01759420|18977252|P1|Overall Study|Screen failure|5
5488368|NCT01759407|18977259|P2|Overall Study|Protocol Violation|2
5488369|NCT01759407|18977260|P1|Overall Study|Protocol Violation|0
5488370|NCT01759381|18977272|P2|Overall Study|Death|0
5488371|NCT01759381|18977273|P1|Overall Study|Death|1
5488372|NCT01759368|18977281|P2|Overall Study|Lost to Follow-up|0
5488373|NCT01759368|18977282|P1|Overall Study|Lost to Follow-up|1
5488374|NCT01759290|18977300|P1|Overall Study|Unknown reason|4
5488375|NCT01759290|18977300|P1|Overall Study|Lost to Follow-up|53
5488376|NCT01759290|18977300|P1|Overall Study|Death|17
5488377|NCT01759290|18977300|P1|Overall Study|Physician Decision|2
5488378|NCT01759290|18977300|P1|Overall Study|Subjects withdrawn consent|5
5488379|NCT01759264|18977369|P1|Overall Study|Discontinued Humira Due to Business Trip|1
5488380|NCT01759264|18977369|P1|Overall Study|Withdrawal by Subject|3
5488381|NCT01759264|18977369|P1|Overall Study|Lost to Follow-up|2
5488382|NCT01759264|18977369|P1|Overall Study|Other|2
5488383|NCT01759264|18977369|P1|Overall Study|Adverse Event|1
5488384|NCT01759264|18977369|P1|Overall Study|Serious Adverse Events (SAEs)|1
5488385|NCT01758900|18977397|P2|Overall Study|difficulty for further intubation|8
5488386|NCT01758900|18977398|P1|Overall Study|difficulty for further intubation|7
5488387|NCT01758731|18977416|P1|Overall Study|Physician Decision|1
5488388|NCT01758523|18977435|P2|Overall Study|Withdrawal by Subject|7
5488389|NCT01758523|18977436|P1|Overall Study|Withdrawal by Subject|12
5488390|NCT01758523|18977435|P2|Overall Study|Lost to Follow-up|4
5488391|NCT01758523|18977436|P1|Overall Study|Lost to Follow-up|3
5488392|NCT01758523|18977435|P2|Overall Study|Lack of Efficacy|2
5488393|NCT01758523|18977436|P1|Overall Study|Lack of Efficacy|4
5488394|NCT01758523|18977435|P2|Overall Study|Adverse Event|1
5488395|NCT01758523|18977436|P1|Overall Study|Adverse Event|2
5488396|NCT01758289|18977539|P1|Overall Study|Adverse Event|9
5488397|NCT01758289|18977539|P1|Overall Study|Premature Study Termination|44
5488398|NCT01757847|18977565|P2|Overall Study|Withdrawal by Subject|4
5488399|NCT01757847|18977566|P1|Overall Study|Withdrawal by Subject|3
5488400|NCT01757821|18977574|P1|Overall Study|Adverse Event|1
5488401|NCT01757704|18977589|P2|Overall Study|Protocol Violation|3
5488402|NCT01757704|18977590|P1|Overall Study|Protocol Violation|1
5488403|NCT01757691|18977608|P2|Overall Study|Administrative problems|0
5488404|NCT01757691|18977609|P1|Overall Study|Administrative problems|2
5488405|NCT01757665|18977636|P2|Overall Study|Not Implanted with Device|1
5488406|NCT01757665|18977637|P1|Overall Study|Not Implanted with Device|5
5488407|NCT01757665|18977636|P2|Overall Study|Lost to Follow-up|1
5488408|NCT01757665|18977637|P1|Overall Study|Lost to Follow-up|1
5488409|NCT01757665|18977636|P2|Overall Study|Withdrawal by Subject|0
5488410|NCT01757665|18977637|P1|Overall Study|Withdrawal by Subject|10
5488411|NCT01757665|18977636|P2|Overall Study|Explant|2
5488412|NCT01757665|18977637|P1|Overall Study|Explant|1
5488413|NCT01757665|18977636|P2|Overall Study|Death|8
5488414|NCT01757665|18977637|P1|Overall Study|Death|25
5488415|NCT01757665|18977636|P2|Overall Study|Still on Study - Missed Visit|1
5488416|NCT01757665|18977637|P1|Overall Study|Still on Study - Missed Visit|14
5488417|NCT01757665|18977636|P2|Overall Study|Still on Study - Visit Pending|40
5488418|NCT01757665|18977637|P1|Overall Study|Still on Study - Visit Pending|398
5488419|NCT01757665|18977636|P2|Overall Study|Still on Study - Visit Completed|30
5488420|NCT01757665|18977637|P1|Overall Study|Still on Study - Visit Completed|240
5488421|NCT01757535|18977809|P2|Overall Study|Death|2
5488422|NCT01757535|18977810|P1|Overall Study|Death|1
5488423|NCT01757535|18977809|P2|Overall Study|Physician Decision|0
5488424|NCT01757535|18977810|P1|Overall Study|Physician Decision|6
5488425|NCT01757535|18977809|P2|Overall Study|Miscellaneous|2
5488426|NCT01757535|18977810|P1|Overall Study|Miscellaneous|5
5488427|NCT01757535|18977809|P2|Overall Study|Withdrawal by Subject|13
5488428|NCT01757535|18977810|P1|Overall Study|Withdrawal by Subject|9
5488429|NCT01757535|18977809|P2|Overall Study|Adverse Event|11
5488430|NCT01757535|18977810|P1|Overall Study|Adverse Event|29
5488431|NCT01757535|18977809|P2|Overall Study|Disease Relapse|180
5488432|NCT01757535|18977810|P1|Overall Study|Disease Relapse|143
5488433|NCT01757405|18977842|P2|Overall Study|Withdrawal by Subject|1
5488434|NCT01757405|18977843|P1|Overall Study|Withdrawal by Subject|0
5488435|NCT01757405|18977842|P2|Overall Study|Lost to Follow-up|1
5488436|NCT01757405|18977843|P1|Overall Study|Lost to Follow-up|1
5488437|NCT01757275|18977878|P2|Overall Study|Not treated|4
5488438|NCT01757275|18977879|P1|Overall Study|Not treated|3
5488439|NCT01757275|18977878|P2|Overall Study|Withdrawal by Subject|4
5488440|NCT01757275|18977879|P1|Overall Study|Withdrawal by Subject|2
5488441|NCT01757275|18977878|P2|Overall Study|Adverse Event|3
5488442|NCT01757275|18977879|P1|Overall Study|Adverse Event|3
5488443|NCT01757275|18977878|P2|Overall Study|Lost to Follow-up|2
5488444|NCT01757275|18977879|P1|Overall Study|Lost to Follow-up|1
5488445|NCT01757197|18977901|P1|Overall Study|Death|2
5488446|NCT01757184|18977910|P4|Open-label Period|Discontinued by Sponsor|2
5488447|NCT01757184|18977911|P3|Open-label Period|Discontinued by Sponsor|1
5488448|NCT01757184|18977912|P2|Open-label Period|Discontinued by Sponsor|0
5488449|NCT01757184|18977913|P1|Open-label Period|Discontinued by Sponsor|0
5488450|NCT01757184|18977910|P4|Open-label Period|Withdrawal by Subject|1
5488451|NCT01757184|18977911|P3|Open-label Period|Withdrawal by Subject|1
5488452|NCT01757184|18977912|P2|Open-label Period|Withdrawal by Subject|0
5488453|NCT01757184|18977913|P1|Open-label Period|Withdrawal by Subject|0
5488454|NCT01757184|18977910|P4|Open-label Period|Lost to Follow-up|0
5488455|NCT01757184|18977911|P3|Open-label Period|Lost to Follow-up|2
5488456|NCT01757184|18977912|P2|Open-label Period|Lost to Follow-up|0
5488457|NCT01757184|18977913|P1|Open-label Period|Lost to Follow-up|0
5488458|NCT01757184|18977910|P4|Double-blind Period|Adverse Event|0
5488459|NCT01757184|18977911|P3|Double-blind Period|Adverse Event|0
5488460|NCT01757184|18977912|P2|Double-blind Period|Adverse Event|0
5488461|NCT01757184|18977913|P1|Double-blind Period|Adverse Event|1
5488462|NCT01757171|18977957|P2|Overall Study|ECOG decline|0
5488463|NCT01757171|18977958|P1|Overall Study|ECOG decline|1
5488464|NCT01757171|18977957|P2|Overall Study|Hospitalization|0
5488465|NCT01757171|18977958|P1|Overall Study|Hospitalization|1
5488466|NCT01757171|18977957|P2|Overall Study|Disease Progression|0
5488467|NCT01757171|18977958|P1|Overall Study|Disease Progression|1
5488468|NCT01757171|18977957|P2|Overall Study|Adverse Event|1
5488469|NCT01757171|18977958|P1|Overall Study|Adverse Event|5
5488470|NCT01756846|18977994|P2|Overall Study|Withdrawal by Subject|2
5488471|NCT01756846|18977995|P1|Overall Study|Withdrawal by Subject|1
5488472|NCT01756846|18977994|P2|Overall Study|Lost to Follow-up|10
5488473|NCT01756846|18977995|P1|Overall Study|Lost to Follow-up|5
5488474|NCT01756456|18978040|P6|Follow Up Period Phase I/II|Other causes|5
5488475|NCT01756456|18978041|P5|Follow Up Period Phase I/II|Other causes|3
5488476|NCT01756456|18978042|P4|Follow Up Period Phase I/II|Other causes|1
5488477|NCT01756456|18978043|P3|Follow Up Period Phase I/II|Other causes|0
5488478|NCT01756456|18978044|P2|Follow Up Period Phase I/II|Other causes|0
5488479|NCT01756456|18978045|P1|Follow Up Period Phase I/II|Other causes|0
5488480|NCT01756456|18978040|P6|Follow Up Period Phase I/II|Lost to Follow-up|1
5488481|NCT01756456|18978041|P5|Follow Up Period Phase I/II|Lost to Follow-up|0
5488482|NCT01756456|18978042|P4|Follow Up Period Phase I/II|Lost to Follow-up|2
5488483|NCT01756456|18978043|P3|Follow Up Period Phase I/II|Lost to Follow-up|1
5488484|NCT01756456|18978044|P2|Follow Up Period Phase I/II|Lost to Follow-up|0
5488485|NCT01756456|18978045|P1|Follow Up Period Phase I/II|Lost to Follow-up|0
5488486|NCT01756456|18978040|P6|Follow Up Period Phase I/II|Adverse Event|1
5488487|NCT01756456|18978041|P5|Follow Up Period Phase I/II|Adverse Event|0
5488488|NCT01756456|18978042|P4|Follow Up Period Phase I/II|Adverse Event|5
5488489|NCT01756456|18978043|P3|Follow Up Period Phase I/II|Adverse Event|0
5488490|NCT01756456|18978044|P2|Follow Up Period Phase I/II|Adverse Event|0
5488491|NCT01756456|18978045|P1|Follow Up Period Phase I/II|Adverse Event|1
5488492|NCT01756456|18978040|P6|Follow Up Period Phase I/II|Lack of Efficacy|1
5488493|NCT01756456|18978041|P5|Follow Up Period Phase I/II|Lack of Efficacy|0
5488494|NCT01756456|18978042|P4|Follow Up Period Phase I/II|Lack of Efficacy|0
5488495|NCT01756456|18978043|P3|Follow Up Period Phase I/II|Lack of Efficacy|0
5488496|NCT01756456|18978044|P2|Follow Up Period Phase I/II|Lack of Efficacy|0
5488497|NCT01756456|18978045|P1|Follow Up Period Phase I/II|Lack of Efficacy|0
5488498|NCT01756456|18978040|P6|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5488499|NCT01756456|18978041|P5|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5488500|NCT01756456|18978042|P4|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5488501|NCT01756456|18978043|P3|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5488502|NCT01756456|18978044|P2|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
5488503|NCT01756456|18978045|P1|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
5488504|NCT01756456|18978040|P6|Follow Up Period Phase I/II|still in study after week 20|25
5488505|NCT01756456|18978041|P5|Follow Up Period Phase I/II|still in study after week 20|23
5488506|NCT01756456|18978042|P4|Follow Up Period Phase I/II|still in study after week 20|25
5488507|NCT01756456|18978043|P3|Follow Up Period Phase I/II|still in study after week 20|0
5488508|NCT01756456|18978044|P2|Follow Up Period Phase I/II|still in study after week 20|0
5488509|NCT01756456|18978045|P1|Follow Up Period Phase I/II|still in study after week 20|0
5488510|NCT01756456|18978040|P6|Treatment Period: Phase I/II|Other causes|2
5488511|NCT01756456|18978041|P5|Treatment Period: Phase I/II|Other causes|2
5488512|NCT01756456|18978042|P4|Treatment Period: Phase I/II|Other causes|1
5488513|NCT01756456|18978043|P3|Treatment Period: Phase I/II|Other causes|0
5488514|NCT01756456|18978044|P2|Treatment Period: Phase I/II|Other causes|0
5488515|NCT01756456|18978045|P1|Treatment Period: Phase I/II|Other causes|0
5488516|NCT01756456|18978040|P6|Treatment Period: Phase I/II|Adverse Event|1
5488517|NCT01756456|18978041|P5|Treatment Period: Phase I/II|Adverse Event|9
5488518|NCT01756456|18978042|P4|Treatment Period: Phase I/II|Adverse Event|3
5488519|NCT01756456|18978043|P3|Treatment Period: Phase I/II|Adverse Event|2
5488520|NCT01756456|18978044|P2|Treatment Period: Phase I/II|Adverse Event|0
5488521|NCT01756456|18978045|P1|Treatment Period: Phase I/II|Adverse Event|1
5488522|NCT01756456|18978040|P6|Treatment Period: Phase I/II|Withdrawal by Subject|0
5488523|NCT01756456|18978041|P5|Treatment Period: Phase I/II|Withdrawal by Subject|0
5488524|NCT01756456|18978042|P4|Treatment Period: Phase I/II|Withdrawal by Subject|0
5488525|NCT01756456|18978043|P3|Treatment Period: Phase I/II|Withdrawal by Subject|0
5488526|NCT01756456|18978044|P2|Treatment Period: Phase I/II|Withdrawal by Subject|1
5488527|NCT01756456|18978045|P1|Treatment Period: Phase I/II|Withdrawal by Subject|0
5488528|NCT01756456|18978040|P6|Treatment Period: Phase I/II|Lack of Efficacy|0
5488529|NCT01756456|18978041|P5|Treatment Period: Phase I/II|Lack of Efficacy|1
5488530|NCT01756456|18978042|P4|Treatment Period: Phase I/II|Lack of Efficacy|2
5488531|NCT01756456|18978043|P3|Treatment Period: Phase I/II|Lack of Efficacy|0
5488532|NCT01756456|18978044|P2|Treatment Period: Phase I/II|Lack of Efficacy|0
5488533|NCT01756456|18978045|P1|Treatment Period: Phase I/II|Lack of Efficacy|0
5488534|NCT01756456|18978040|P6|Treatment Period: Phase I/II|decision unrelated to adverse event|1
5488535|NCT01756456|18978041|P5|Treatment Period: Phase I/II|decision unrelated to adverse event|1
5488536|NCT01756456|18978042|P4|Treatment Period: Phase I/II|decision unrelated to adverse event|1
5488537|NCT01756456|18978043|P3|Treatment Period: Phase I/II|decision unrelated to adverse event|0
5488538|NCT01756456|18978044|P2|Treatment Period: Phase I/II|decision unrelated to adverse event|0
5488539|NCT01756456|18978045|P1|Treatment Period: Phase I/II|decision unrelated to adverse event|0
5488540|NCT01756352|18978147|P1|Overall Study|moved away and lost to followup|1
5488541|NCT01756300|18978152|P1|Overall Study|Withdrawal by Subject|1
5488542|NCT01756300|18978152|P1|Overall Study|Death|1
5488543|NCT01756274|18978174|P1|Overall Study|Laboratory error|1
5488544|NCT01756274|18978174|P1|Overall Study|Protocol Violation|2
5488545|NCT01756235|18978181|P1|Overall Study|Adalimumab Treatment was not Documented|2
5488546|NCT01756157|18978219|P2|First Intervention Period|Lost to Follow-up|2
5488547|NCT01756157|18978220|P1|First Intervention Period|Lost to Follow-up|0
5488548|NCT01756157|18978219|P2|First Intervention Period|Withdrawal by Subject|0
5488549|NCT01756157|18978220|P1|First Intervention Period|Withdrawal by Subject|1
5488550|NCT01756079|18978234|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
5488551|NCT01756079|18978234|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
5488552|NCT01756079|18978234|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
5488553|NCT01756079|18978234|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
5488554|NCT01756079|18978234|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
5488555|NCT01756053|18978240|P2|Period 2 (10 Days)|Protocol Violation|2
5488556|NCT01756053|18978241|P1|Period 2 (10 Days)|Protocol Violation|0
5488557|NCT01756053|18978240|P2|Period 1 (10 Days)|Protocol Violation|1
5488558|NCT01756053|18978241|P1|Period 1 (10 Days)|Protocol Violation|1
5488559|NCT01755858|18978300|P2|Overall Study|Adverse Event|1
5488560|NCT01755858|18978301|P1|Overall Study|Adverse Event|1
5488561|NCT01755767|18978327|P4|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
5488562|NCT01755767|18978328|P3|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
5488563|NCT01755767|18978329|P2|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
5488564|NCT01755767|18978330|P1|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
5488565|NCT01755767|18978327|P4|Overall Study|Other|3
5488566|NCT01755767|18978328|P3|Overall Study|Other|2
5488567|NCT01755767|18978329|P2|Overall Study|Other|0
5488568|NCT01755767|18978330|P1|Overall Study|Other|0
5488569|NCT01755767|18978327|P4|Overall Study|Withdrawal by Subject|1
5488570|NCT01755767|18978328|P3|Overall Study|Withdrawal by Subject|2
5488571|NCT01755767|18978329|P2|Overall Study|Withdrawal by Subject|0
5488572|NCT01755767|18978330|P1|Overall Study|Withdrawal by Subject|0
5488573|NCT01755767|18978327|P4|Overall Study|Subject Decision|3
5488574|NCT01755767|18978328|P3|Overall Study|Subject Decision|10
5488575|NCT01755767|18978329|P2|Overall Study|Subject Decision|0
5488576|NCT01755767|18978330|P1|Overall Study|Subject Decision|0
5488577|NCT01755767|18978327|P4|Overall Study|Death|4
5488578|NCT01755767|18978328|P3|Overall Study|Death|15
5488579|NCT01755767|18978329|P2|Overall Study|Death|2
5488580|NCT01755767|18978330|P1|Overall Study|Death|1
5488581|NCT01755767|18978327|P4|Overall Study|Adverse Event|11
5488582|NCT01755767|18978328|P3|Overall Study|Adverse Event|28
5488583|NCT01755767|18978329|P2|Overall Study|Adverse Event|0
5488584|NCT01755767|18978330|P1|Overall Study|Adverse Event|6
5488585|NCT01755767|18978327|P4|Overall Study|Radiographic Disease Progression|27
5488586|NCT01755767|18978328|P3|Overall Study|Radiographic Disease Progression|44
5488587|NCT01755767|18978329|P2|Overall Study|Radiographic Disease Progression|4
5488588|NCT01755767|18978330|P1|Overall Study|Radiographic Disease Progression|9
5488589|NCT01755767|18978327|P4|Overall Study|Clinical Disease Progression|20
5488590|NCT01755767|18978328|P3|Overall Study|Clinical Disease Progression|29
5488591|NCT01755767|18978329|P2|Overall Study|Clinical Disease Progression|2
5488592|NCT01755767|18978330|P1|Overall Study|Clinical Disease Progression|4
5488593|NCT01755767|18978327|P4|Overall Study|Progressive Disease|43
5488594|NCT01755767|18978328|P3|Overall Study|Progressive Disease|91
5488595|NCT01755767|18978329|P2|Overall Study|Progressive Disease|7
5488596|NCT01755767|18978330|P1|Overall Study|Progressive Disease|8
5488597|NCT01755702|18978346|P1|Washout Period II|Other Reason|5
5488598|NCT01755702|18978346|P1|Wash Out Period I|Other Reason|3
5488599|NCT01755689|18978393|P5|Overall Study|Pregnancy|2
5488600|NCT01755689|18978394|P4|Overall Study|Pregnancy|4
5488601|NCT01755689|18978395|P3|Overall Study|Pregnancy|2
5488602|NCT01755689|18978396|P2|Overall Study|Pregnancy|1
5488603|NCT01755689|18978397|P1|Overall Study|Pregnancy|1
5488604|NCT01755689|18978393|P5|Overall Study|Lost to Follow-up|2
5488605|NCT01755689|18978394|P4|Overall Study|Lost to Follow-up|0
5488606|NCT01755689|18978395|P3|Overall Study|Lost to Follow-up|1
5488607|NCT01755689|18978396|P2|Overall Study|Lost to Follow-up|0
5488608|NCT01755689|18978397|P1|Overall Study|Lost to Follow-up|1
5488609|NCT01755689|18978393|P5|Overall Study|Migrated/moved from study area|1
5488610|NCT01755689|18978394|P4|Overall Study|Migrated/moved from study area|1
5488611|NCT01755689|18978395|P3|Overall Study|Migrated/moved from study area|1
5488612|NCT01755689|18978396|P2|Overall Study|Migrated/moved from study area|1
5488613|NCT01755689|18978397|P1|Overall Study|Migrated/moved from study area|0
5488614|NCT01755689|18978393|P5|Overall Study|Withdrawal by Subject|1
5488615|NCT01755689|18978394|P4|Overall Study|Withdrawal by Subject|1
5488616|NCT01755689|18978395|P3|Overall Study|Withdrawal by Subject|2
5488617|NCT01755689|18978396|P2|Overall Study|Withdrawal by Subject|3
5488618|NCT01755689|18978397|P1|Overall Study|Withdrawal by Subject|1
5488619|NCT01755637|18978472|P2|Period 1|Adverse Event|1
5488620|NCT01755637|18978473|P1|Period 1|Adverse Event|0
5488621|NCT01755598|18978493|P2|Overall Study|Adverse Event|28
5488622|NCT01755598|18978494|P1|Overall Study|Adverse Event|19
5488623|NCT01755598|18978493|P2|Overall Study|Protocol Violation|7
5488624|NCT01755598|18978494|P1|Overall Study|Protocol Violation|7
5488625|NCT01755598|18978493|P2|Overall Study|Withdrawal by Subject|31
5488626|NCT01755598|18978494|P1|Overall Study|Withdrawal by Subject|22
5488627|NCT01755598|18978493|P2|Overall Study|Migrated/moved from study area|65
5488628|NCT01755598|18978494|P1|Overall Study|Migrated/moved from study area|76
5488629|NCT01755598|18978493|P2|Overall Study|Lost to Follow-up|43
5488630|NCT01755598|18978494|P1|Overall Study|Lost to Follow-up|32
5488631|NCT01755598|18978493|P2|Overall Study|Other|109
5488632|NCT01755598|18978494|P1|Overall Study|Other|109
5488633|NCT01755546|18978528|P1|Long Term Treatment|other and ongoing|41
5488634|NCT01755546|18978528|P1|Long Term Treatment|Lost to Follow-up|17
5488635|NCT01755546|18978528|P1|Long Term Treatment|Withdrawal by Subject|35
5488636|NCT01755546|18978528|P1|Long Term Treatment|Protocol Violation|10
5488637|NCT01755546|18978528|P1|Long Term Treatment|Lack of Efficacy|6
5488638|NCT01755546|18978528|P1|Long Term Treatment|Adverse Event|12
5488639|NCT01755546|18978528|P1|Titration Phase|Withdrawal by Subject|8
5488640|NCT01755546|18978528|P1|Titration Phase|Other and Continuing|22
5488641|NCT01755546|18978528|P1|Titration Phase|Lost to Follow-up|2
5488642|NCT01755546|18978528|P1|Titration Phase|Protocol Violation|9
5488643|NCT01755546|18978528|P1|Titration Phase|Lack of Efficacy|18
5488644|NCT01755546|18978528|P1|Titration Phase|Adverse Event|11
5488645|NCT01755546|18978528|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
5488646|NCT01755546|18978528|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
5488647|NCT01755546|18978528|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
5488648|NCT01755546|18978528|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
5488649|NCT01755416|18978545|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
5488650|NCT01755416|18978546|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
5488651|NCT01755234|18978554|P2|Overall Study|unblinded|0
5488652|NCT01755234|18978555|P1|Overall Study|unblinded|1
5488653|NCT01755234|18978554|P2|Overall Study|Withdrawal by Subject|1
5488654|NCT01755234|18978555|P1|Overall Study|Withdrawal by Subject|0
5488655|NCT01755234|18978554|P2|Overall Study|case cancelled|0
5488656|NCT01755234|18978555|P1|Overall Study|case cancelled|1
5488657|NCT01755234|18978554|P2|Overall Study|Change in surgical case|1
5488658|NCT01755234|18978555|P1|Overall Study|Change in surgical case|2
5488659|NCT01755234|18978554|P2|Overall Study|Lost to Follow-up|6
5488660|NCT01755234|18978555|P1|Overall Study|Lost to Follow-up|11
5488661|NCT01755156|18978586|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
5488662|NCT01755156|18978587|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
5488663|NCT01755156|18978586|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
5488664|NCT01755156|18978587|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
5488665|NCT01755156|18978586|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
5488666|NCT01755156|18978587|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
5488667|NCT01755156|18978586|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
5488668|NCT01755156|18978587|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
5488669|NCT01755156|18978586|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
5488670|NCT01755156|18978587|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
5488671|NCT01755156|18978586|P2|Phase A (Weeks 0-24)|Protocol Violation|1
5488672|NCT01755156|18978587|P1|Phase A (Weeks 0-24)|Protocol Violation|1
5488673|NCT01755156|18978586|P2|Phase A (Weeks 0-24)|Physician Decision|1
5488674|NCT01755156|18978587|P1|Phase A (Weeks 0-24)|Physician Decision|0
5488675|NCT01755156|18978586|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
5488676|NCT01755156|18978587|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
5488677|NCT01755156|18978586|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
5488678|NCT01755156|18978587|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
5488679|NCT01755156|18978586|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
5488680|NCT01755156|18978587|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
5488681|NCT01755156|18978586|P2|Phase A (Weeks 0-24)|Adverse Event|3
5488682|NCT01755156|18978587|P1|Phase A (Weeks 0-24)|Adverse Event|2
5488683|NCT01755091|18978651|P3|Overall Study|Physician Decision|2
5488684|NCT01755091|18978652|P2|Overall Study|Physician Decision|1
5488685|NCT01755091|18978653|P1|Overall Study|Physician Decision|1
5488686|NCT01755091|18978651|P3|Overall Study|Lost to Follow-up|1
5488687|NCT01755091|18978652|P2|Overall Study|Lost to Follow-up|0
5488688|NCT01755091|18978653|P1|Overall Study|Lost to Follow-up|1
5488689|NCT01755091|18978651|P3|Overall Study|Adverse Event|1
5488690|NCT01755091|18978652|P2|Overall Study|Adverse Event|1
5488691|NCT01755091|18978653|P1|Overall Study|Adverse Event|1
5488692|NCT01755091|18978651|P3|Overall Study|Withdrawal by Subject|3
5488693|NCT01755091|18978652|P2|Overall Study|Withdrawal by Subject|1
5488694|NCT01755091|18978653|P1|Overall Study|Withdrawal by Subject|6
5488695|NCT01755026|18978678|P2|Overall Study|Withdrawal by Subject|1
5488696|NCT01755026|18978679|P1|Overall Study|Withdrawal by Subject|1
5488697|NCT01755026|18978678|P2|Overall Study|Adverse Event|0
5488698|NCT01755026|18978679|P1|Overall Study|Adverse Event|1
5488699|NCT01754922|18978702|P2|Overall Study|Adverse Event|1
5488700|NCT01754922|18978703|P1|Overall Study|Adverse Event|0
5488701|NCT01754766|18978729|P3|Overall Study|Personal reasons|0
5488702|NCT01754766|18978730|P2|Overall Study|Personal reasons|1
5488703|NCT01754766|18978731|P1|Overall Study|Personal reasons|1
5488704|NCT01754727|18978745|P1|Overall Study|Adalimumab Treatment was not Documented|2
5488705|NCT01754493|18978877|P1|Overall Study|Scheduling conflict|1
5488706|NCT01754493|18978877|P1|Overall Study|Moved out of town|1
5488707|NCT01754493|18978877|P1|Overall Study|Withdrawal by Subject|1
5488708|NCT01754493|18978877|P1|Overall Study|Lost to Follow-up|3
5488709|NCT01754493|18978877|P1|Overall Study|Adverse Event|1
5488710|NCT01754467|18978902|P1|Overall Study|Lost to Follow-up|1
5488711|NCT01754402|18978912|P3|Overall Study|Lack of Efficacy|1
5488712|NCT01754402|18978913|P2|Overall Study|Lack of Efficacy|0
5488713|NCT01754402|18978914|P1|Overall Study|Lack of Efficacy|0
5488714|NCT01754402|18978912|P3|Overall Study|Withdrawal by Subject|1
5488715|NCT01754402|18978913|P2|Overall Study|Withdrawal by Subject|0
5488716|NCT01754402|18978914|P1|Overall Study|Withdrawal by Subject|0
5488717|NCT01754402|18978912|P3|Overall Study|Adverse Event|1
5488718|NCT01754402|18978913|P2|Overall Study|Adverse Event|2
5488719|NCT01754402|18978914|P1|Overall Study|Adverse Event|2
5488720|NCT01754402|18978912|P3|Overall Study|Death|1
5488721|NCT01754402|18978913|P2|Overall Study|Death|0
5488722|NCT01754402|18978914|P1|Overall Study|Death|0
5488723|NCT01754376|18978948|P1|Overall Study|Lack of Efficacy|2
5488724|NCT01754376|18978948|P1|Overall Study|Adverse Event|1
5488725|NCT01754259|18978959|P2|Overall Study|Lost to Follow-up|1
5488726|NCT01754259|18978960|P1|Overall Study|Lost to Follow-up|0
5488727|NCT01754259|18978959|P2|Overall Study|Adverse Event|1
5488728|NCT01754259|18978960|P1|Overall Study|Adverse Event|3
5488729|NCT01754259|18978959|P2|Overall Study|Withdrawal by Subject|4
5488730|NCT01754259|18978960|P1|Overall Study|Withdrawal by Subject|2
5488731|NCT01754194|18978974|P2|Overall Study|Other|8
5488732|NCT01754194|18978975|P1|Overall Study|Other|9
5488733|NCT01754194|18978974|P2|Overall Study|Withdrawal by Subject|5
5488734|NCT01754194|18978975|P1|Overall Study|Withdrawal by Subject|4
5488735|NCT01754194|18978974|P2|Overall Study|Lost to Follow-up|14
5488736|NCT01754194|18978975|P1|Overall Study|Lost to Follow-up|39
5488737|NCT01754129|18978995|P1|Overall Study|Inclusion/exclusion criteria violation|3
5488738|NCT01754129|18978995|P1|Overall Study|Withdrew consent|1
5488739|NCT01754129|18978995|P1|Overall Study|Lost to Follow-up|7
5488740|NCT01754129|18978995|P1|Overall Study|Duodopa discontinuation|9
5488741|NCT01754129|18978995|P1|Overall Study|Death|13
5488742|NCT01753999|18979018|P2|Period 2 -Cross to Alternate Arm|Physician Decision|1
5488743|NCT01753999|18979019|P1|Period 2 -Cross to Alternate Arm|Physician Decision|1
5488744|NCT01753999|18979018|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
5488745|NCT01753999|18979019|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
5488746|NCT01753999|18979018|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
5488747|NCT01753999|18979019|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
5488748|NCT01753999|18979018|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
5488749|NCT01753999|18979019|P1|Period 1 - Initial Assignment|Lost to Follow-up|18
5488750|NCT01753999|18979018|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
5488751|NCT01753999|18979019|P1|Period 1 - Initial Assignment|Withdrawal by Subject|19
5488752|NCT01753999|18979018|P2|Period 1 - Initial Assignment|Physician Decision|3
5488753|NCT01753999|18979019|P1|Period 1 - Initial Assignment|Physician Decision|2
5488754|NCT01753856|18979037|P2|Overall Study|Sponsor Decision|0
5488755|NCT01753856|18979038|P1|Overall Study|Sponsor Decision|2
5488756|NCT01753856|18979037|P2|Overall Study|Withdrawal by Subject|2
5488757|NCT01753856|18979038|P1|Overall Study|Withdrawal by Subject|0
5488758|NCT01753856|18979037|P2|Overall Study|Adverse Event|0
5488759|NCT01753856|18979038|P1|Overall Study|Adverse Event|1
5488760|NCT01753570|18979150|P3|Overall Study|Withdrawal by Subject|0
5488761|NCT01753570|18979151|P2|Overall Study|Withdrawal by Subject|4
5488762|NCT01753570|18979152|P1|Overall Study|Withdrawal by Subject|1
5488763|NCT01753570|18979150|P3|Overall Study|Physician Decision|0
5488764|NCT01753570|18979151|P2|Overall Study|Physician Decision|1
5488765|NCT01753570|18979152|P1|Overall Study|Physician Decision|0
5488766|NCT01753570|18979150|P3|Overall Study|Adverse Event|1
5488767|NCT01753570|18979151|P2|Overall Study|Adverse Event|0
5488768|NCT01753570|18979152|P1|Overall Study|Adverse Event|1
5488769|NCT01753518|18979195|P2|Postpartum Follow-up|Lost to Follow-up|15
5488770|NCT01753518|18979196|P1|Postpartum Follow-up|Lost to Follow-up|22
5488771|NCT01753518|18979195|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
5488772|NCT01753518|18979196|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
5488773|NCT01753518|18979195|P2|Intention-to-Treat Analysis|Multifetal gestation|3
5488774|NCT01753518|18979196|P1|Intention-to-Treat Analysis|Multifetal gestation|2
5488775|NCT01753518|18979195|P2|Intention-to-Treat Analysis|Missing consent form|3
5488776|NCT01753518|18979196|P1|Intention-to-Treat Analysis|Missing consent form|5
5488777|NCT01753401|18979220|P4|Open Label Period (44 Weeks)|Reason not provided|2
5488778|NCT01753401|18979221|P3|Open Label Period (44 Weeks)|Reason not provided|0
5488779|NCT01753401|18979222|P2|Open Label Period (44 Weeks)|Reason not provided|0
5488780|NCT01753401|18979223|P1|Open Label Period (44 Weeks)|Reason not provided|0
5488781|NCT01753401|18979220|P4|Open Label Period (44 Weeks)|Lack of Efficacy|1
5488782|NCT01753401|18979221|P3|Open Label Period (44 Weeks)|Lack of Efficacy|1
5488783|NCT01753401|18979222|P2|Open Label Period (44 Weeks)|Lack of Efficacy|0
5488784|NCT01753401|18979223|P1|Open Label Period (44 Weeks)|Lack of Efficacy|0
5488785|NCT01753401|18979220|P4|Open Label Period (44 Weeks)|Withdrawal by Subject|2
5488786|NCT01753401|18979221|P3|Open Label Period (44 Weeks)|Withdrawal by Subject|0
5488787|NCT01753401|18979222|P2|Open Label Period (44 Weeks)|Withdrawal by Subject|0
5488788|NCT01753401|18979223|P1|Open Label Period (44 Weeks)|Withdrawal by Subject|0
5488789|NCT01753401|18979220|P4|Open Label Period (44 Weeks)|Adverse Event|4
5488790|NCT01753401|18979221|P3|Open Label Period (44 Weeks)|Adverse Event|3
5488791|NCT01753401|18979222|P2|Open Label Period (44 Weeks)|Adverse Event|0
5488792|NCT01753401|18979223|P1|Open Label Period (44 Weeks)|Adverse Event|0
5488793|NCT01753401|18979220|P4|Double-blind Period (8 Weeks)|Protocol Violation|0
5488794|NCT01753401|18979221|P3|Double-blind Period (8 Weeks)|Protocol Violation|0
5488795|NCT01753401|18979222|P2|Double-blind Period (8 Weeks)|Protocol Violation|1
5488796|NCT01753401|18979223|P1|Double-blind Period (8 Weeks)|Protocol Violation|0
5488797|NCT01753401|18979220|P4|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
5488798|NCT01753401|18979221|P3|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
5488799|NCT01753401|18979222|P2|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
5488800|NCT01753401|18979223|P1|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
5488801|NCT01753401|18979220|P4|Double-blind Period (8 Weeks)|Adverse Event|0
5488802|NCT01753401|18979221|P3|Double-blind Period (8 Weeks)|Adverse Event|0
5488803|NCT01753401|18979222|P2|Double-blind Period (8 Weeks)|Adverse Event|2
5488804|NCT01753401|18979223|P1|Double-blind Period (8 Weeks)|Adverse Event|0
5488805|NCT01753336|18979282|P1|Overall Study|Withdrawal by Subject|1
5488806|NCT01753336|18979282|P1|Overall Study|Sponsor's decision|2
5488807|NCT01753336|18979282|P1|Overall Study|Physician Decision|2
5488808|NCT01753336|18979282|P1|Overall Study|Lost to Follow-up|3
5488809|NCT01753336|18979282|P1|Overall Study|Patient decision|12
5488810|NCT01753323|18979294|P3|Overall Study|Adverse Event|1
5488811|NCT01753323|18979295|P2|Overall Study|Adverse Event|0
5488812|NCT01753323|18979296|P1|Overall Study|Adverse Event|0
5488813|NCT01753323|18979294|P3|Overall Study|Protocol deviation|0
5488814|NCT01753323|18979295|P2|Overall Study|Protocol deviation|0
5488815|NCT01753323|18979296|P1|Overall Study|Protocol deviation|1
5488816|NCT01753323|18979294|P3|Overall Study|Lack of Efficacy|8
5488817|NCT01753323|18979295|P2|Overall Study|Lack of Efficacy|0
5488818|NCT01753323|18979296|P1|Overall Study|Lack of Efficacy|0
5488819|NCT01753310|18979334|P2|Overall Study|Withdrawal by Subject|0
5488820|NCT01753310|18979335|P1|Overall Study|Withdrawal by Subject|1
5488821|NCT01753310|18979334|P2|Overall Study|Sponsor decision|0
5488822|NCT01753310|18979335|P1|Overall Study|Sponsor decision|1
5488823|NCT01753310|18979334|P2|Overall Study|Subject decision|2
5488824|NCT01753310|18979335|P1|Overall Study|Subject decision|2
5488825|NCT01753310|18979334|P2|Overall Study|Lost to Follow-up|0
5488826|NCT01753310|18979335|P1|Overall Study|Lost to Follow-up|2
5488827|NCT01753310|18979334|P2|Overall Study|Adverse Event|0
5488828|NCT01753310|18979335|P1|Overall Study|Adverse Event|1
5488829|NCT01753310|18979334|P2|Overall Study|Entered into open label extension study|22
5488830|NCT01753310|18979335|P1|Overall Study|Entered into open label extension study|25
5488831|NCT01753297|18979357|P2|Overall Study|Did not attend end of study visit|8
5488832|NCT01753297|18979358|P1|Overall Study|Did not attend end of study visit|7
5488833|NCT01753297|18979357|P2|Overall Study|Death|2
5488834|NCT01753297|18979358|P1|Overall Study|Death|0
5488835|NCT01753297|18979357|P2|Overall Study|Adverse Event (up to Month 36)|1
5488836|NCT01753297|18979358|P1|Overall Study|Adverse Event (up to Month 36)|1
5488837|NCT01753297|18979357|P2|Overall Study|Withdrawal by Subject|23
5488838|NCT01753297|18979358|P1|Overall Study|Withdrawal by Subject|26
5488839|NCT01753297|18979357|P2|Overall Study|Lost to Follow-up|2
5488840|NCT01753297|18979358|P1|Overall Study|Lost to Follow-up|7
5488841|NCT01753193|18979390|P1|Overall Study|Other|16
5488842|NCT01753193|18979390|P1|Overall Study|Death|1
5488843|NCT01753193|18979390|P1|Overall Study|Lost to Follow-up|6
5488844|NCT01753193|18979390|P1|Overall Study|Withdrawal by Subject|23
5488845|NCT01753115|18979405|P3|Overall Study|Used excluded drug|0
5488846|NCT01753115|18979406|P2|Overall Study|Used excluded drug|1
5488847|NCT01753115|18979407|P1|Overall Study|Used excluded drug|0
5488848|NCT01753115|18979405|P3|Overall Study|Subject non-compliant|0
5488849|NCT01753115|18979406|P2|Overall Study|Subject non-compliant|3
5488850|NCT01753115|18979407|P1|Overall Study|Subject non-compliant|3
5488851|NCT01753115|18979405|P3|Overall Study|Withdrawal by Subject|6
5488852|NCT01753115|18979406|P2|Overall Study|Withdrawal by Subject|5
5488853|NCT01753115|18979407|P1|Overall Study|Withdrawal by Subject|6
5488854|NCT01753115|18979405|P3|Overall Study|Lost to Follow-up|8
5488855|NCT01753115|18979406|P2|Overall Study|Lost to Follow-up|6
5488856|NCT01753115|18979407|P1|Overall Study|Lost to Follow-up|3
5488857|NCT01753076|18979417|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
5488858|NCT01753076|18979418|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
5488859|NCT01753076|18979417|P2|Overall Study|Withdrawal by Subject|24
5488860|NCT01753076|18979418|P1|Overall Study|Withdrawal by Subject|14
5488861|NCT01753076|18979417|P2|Overall Study|Physician Decision|2
5488862|NCT01753076|18979418|P1|Overall Study|Physician Decision|4
5488863|NCT01753076|18979417|P2|Overall Study|Lost to Follow-up|1
5488864|NCT01753076|18979418|P1|Overall Study|Lost to Follow-up|2
5488865|NCT01753076|18979417|P2|Overall Study|Lack of Efficacy|1
5488866|NCT01753076|18979418|P1|Overall Study|Lack of Efficacy|3
5488867|NCT01753076|18979417|P2|Overall Study|Adverse Event|18
5488868|NCT01753076|18979418|P1|Overall Study|Adverse Event|17
5488869|NCT01752985|18979445|P3|Treatment Period|Lost to Follow-up|1
5488870|NCT01752985|18979446|P2|Treatment Period|Lost to Follow-up|0
5488871|NCT01752985|18979447|P1|Treatment Period|Lost to Follow-up|0
5488872|NCT01752985|18979445|P3|Treatment Period|Withdrawal by Subject|0
5488873|NCT01752985|18979446|P2|Treatment Period|Withdrawal by Subject|1
5488874|NCT01752985|18979447|P1|Treatment Period|Withdrawal by Subject|1
5488875|NCT01752985|18979445|P3|Treatment Period|Adverse Event|2
5488876|NCT01752985|18979446|P2|Treatment Period|Adverse Event|1
5488877|NCT01752985|18979447|P1|Treatment Period|Adverse Event|2
5488878|NCT01752985|18979445|P3|Treatment Period|Subject no longer meets study criteria|1
5488879|NCT01752985|18979446|P2|Treatment Period|Subject no longer meets study criteria|1
5488880|NCT01752985|18979447|P1|Treatment Period|Subject no longer meets study criteria|0
5488881|NCT01752985|18979445|P3|Treatment Period|Subject request to discontinue treatment|1
5488882|NCT01752985|18979446|P2|Treatment Period|Subject request to discontinue treatment|0
5488883|NCT01752985|18979447|P1|Treatment Period|Subject request to discontinue treatment|1
5488884|NCT01752933|18979475|P2|Overall Study and Follow-up|Lost to Follow-up|2
5488885|NCT01752933|18979476|P1|Overall Study and Follow-up|Lost to Follow-up|0
5488886|NCT01752933|18979475|P2|Overall Study and Follow-up|Withdrawal by Subject|3
5488887|NCT01752933|18979476|P1|Overall Study and Follow-up|Withdrawal by Subject|0
5488888|NCT01752933|18979475|P2|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
5488889|NCT01752933|18979476|P1|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
5488890|NCT01752933|18979475|P2|Overall Study and Follow-up|Death|34
5488891|NCT01752933|18979476|P1|Overall Study and Follow-up|Death|4
5488892|NCT01752933|18979475|P2|Treatment|Patient unable to travel to appointments|1
5488893|NCT01752933|18979476|P1|Treatment|Patient unable to travel to appointments|0
5488894|NCT01752933|18979475|P2|Treatment|Patient noncompliant|1
5488895|NCT01752933|18979476|P1|Treatment|Patient noncompliant|0
5488896|NCT01752933|18979475|P2|Treatment|Hepatocellular carcinoma not confirmed|1
5488897|NCT01752933|18979476|P1|Treatment|Hepatocellular carcinoma not confirmed|0
5488898|NCT01752933|18979475|P2|Treatment|Death|2
5488899|NCT01752933|18979476|P1|Treatment|Death|0
5488900|NCT01752933|18979475|P2|Treatment|Physician Decision|3
5488901|NCT01752933|18979476|P1|Treatment|Physician Decision|0
5488902|NCT01752933|18979475|P2|Treatment|Adverse Event|4
5488903|NCT01752933|18979476|P1|Treatment|Adverse Event|1
5488904|NCT01752933|18979475|P2|Treatment|Withdrawal by Subject|5
5488905|NCT01752933|18979476|P1|Treatment|Withdrawal by Subject|0
5488906|NCT01752933|18979475|P2|Treatment|Disease Progression|29
5488907|NCT01752933|18979476|P1|Treatment|Disease Progression|3
5488908|NCT01752907|18979494|P2|Overall Study|Decision by Sponsor|9
5488909|NCT01752907|18979495|P1|Overall Study|Decision by Sponsor|6
5488910|NCT01752907|18979494|P2|Overall Study|Lost to Follow-up|1
5488911|NCT01752907|18979495|P1|Overall Study|Lost to Follow-up|2
5488912|NCT01752907|18979494|P2|Overall Study|Withdrawal by Subject|10
5488913|NCT01752907|18979495|P1|Overall Study|Withdrawal by Subject|4
5488914|NCT01752855|18979515|P2|Overall Study|Lack of Efficacy|2
5488915|NCT01752855|18979516|P1|Overall Study|Lack of Efficacy|0
5488916|NCT01752855|18979515|P2|Overall Study|Withdrew Consent|2
5488917|NCT01752855|18979516|P1|Overall Study|Withdrew Consent|0
5488918|NCT01752855|18979515|P2|Overall Study|Adverse Event|0
5488919|NCT01752855|18979516|P1|Overall Study|Adverse Event|1
5488920|NCT01752842|18979532|P2|Overall Study|Withdrawal by Subject|2
5488921|NCT01752842|18979533|P1|Overall Study|Withdrawal by Subject|0
5488922|NCT01752842|18979532|P2|Overall Study|Adverse Event|0
5488923|NCT01752842|18979533|P1|Overall Study|Adverse Event|3
5488924|NCT01752634|18979568|P6|Week 24 to Week 260|Adverse Event|0
5488925|NCT01752634|18979569|P5|Week 24 to Week 260|Adverse Event|2
5488926|NCT01752634|18979570|P4|Week 24 to Week 260|Adverse Event|4
5488927|NCT01752634|18979571|P3|Week 24 to Week 260|Adverse Event|8
5488928|NCT01752634|18979572|P2|Week 24 to Week 260|Adverse Event|8
5488929|NCT01752634|18979573|P1|Week 24 to Week 260|Adverse Event|4
5488930|NCT01752634|18979568|P6|Week 24 to Week 260|Lost to Follow-up|0
5488931|NCT01752634|18979569|P5|Week 24 to Week 260|Lost to Follow-up|2
5488932|NCT01752634|18979570|P4|Week 24 to Week 260|Lost to Follow-up|0
5488933|NCT01752634|18979571|P3|Week 24 to Week 260|Lost to Follow-up|3
5488934|NCT01752634|18979572|P2|Week 24 to Week 260|Lost to Follow-up|2
5488935|NCT01752634|18979573|P1|Week 24 to Week 260|Lost to Follow-up|2
5488936|NCT01752634|18979568|P6|Week 24 to Week 260|Noncompliance with study treatment|0
5488937|NCT01752634|18979569|P5|Week 24 to Week 260|Noncompliance with study treatment|0
5488938|NCT01752634|18979570|P4|Week 24 to Week 260|Noncompliance with study treatment|0
5488939|NCT01752634|18979571|P3|Week 24 to Week 260|Noncompliance with study treatment|1
5488940|NCT01752634|18979572|P2|Week 24 to Week 260|Noncompliance with study treatment|0
5488941|NCT01752634|18979573|P1|Week 24 to Week 260|Noncompliance with study treatment|0
5488942|NCT01752634|18979568|P6|Week 24 to Week 260|Pregnancy|0
5488943|NCT01752634|18979569|P5|Week 24 to Week 260|Pregnancy|0
5488944|NCT01752634|18979570|P4|Week 24 to Week 260|Pregnancy|0
5488945|NCT01752634|18979571|P3|Week 24 to Week 260|Pregnancy|1
5488946|NCT01752634|18979572|P2|Week 24 to Week 260|Pregnancy|0
5488947|NCT01752634|18979573|P1|Week 24 to Week 260|Pregnancy|0
5488948|NCT01752634|18979568|P6|Week 24 to Week 260|Death|0
5488949|NCT01752634|18979569|P5|Week 24 to Week 260|Death|0
5488950|NCT01752634|18979570|P4|Week 24 to Week 260|Death|0
5488951|NCT01752634|18979571|P3|Week 24 to Week 260|Death|0
5488952|NCT01752634|18979572|P2|Week 24 to Week 260|Death|1
5488953|NCT01752634|18979573|P1|Week 24 to Week 260|Death|0
5488954|NCT01752634|18979568|P6|Week 24 to Week 260|Physician Decision|0
5488955|NCT01752634|18979569|P5|Week 24 to Week 260|Physician Decision|1
5488956|NCT01752634|18979570|P4|Week 24 to Week 260|Physician Decision|2
5488957|NCT01752634|18979571|P3|Week 24 to Week 260|Physician Decision|4
5488958|NCT01752634|18979572|P2|Week 24 to Week 260|Physician Decision|2
5488959|NCT01752634|18979573|P1|Week 24 to Week 260|Physician Decision|1
5488960|NCT01752634|18979568|P6|Week 24 to Week 260|Subject/guardian decision|0
5488961|NCT01752634|18979569|P5|Week 24 to Week 260|Subject/guardian decision|5
5488962|NCT01752634|18979570|P4|Week 24 to Week 260|Subject/guardian decision|5
5488963|NCT01752634|18979571|P3|Week 24 to Week 260|Subject/guardian decision|9
5488964|NCT01752634|18979572|P2|Week 24 to Week 260|Subject/guardian decision|10
5488965|NCT01752634|18979573|P1|Week 24 to Week 260|Subject/guardian decision|12
5488966|NCT01752634|18979568|P6|Week 24 to Week 260|Lack of Efficacy|0
5488967|NCT01752634|18979569|P5|Week 24 to Week 260|Lack of Efficacy|4
5488968|NCT01752634|18979570|P4|Week 24 to Week 260|Lack of Efficacy|3
5488969|NCT01752634|18979571|P3|Week 24 to Week 260|Lack of Efficacy|7
5488970|NCT01752634|18979572|P2|Week 24 to Week 260|Lack of Efficacy|7
5488971|NCT01752634|18979573|P1|Week 24 to Week 260|Lack of Efficacy|15
5488972|NCT01752634|18979568|P6|Up to Week 24 (Primary Analysis)|Adverse Event|4
5488973|NCT01752634|18979569|P5|Up to Week 24 (Primary Analysis)|Adverse Event|0
5488974|NCT01752634|18979570|P4|Up to Week 24 (Primary Analysis)|Adverse Event|0
5488975|NCT01752634|18979571|P3|Up to Week 24 (Primary Analysis)|Adverse Event|2
5488976|NCT01752634|18979572|P2|Up to Week 24 (Primary Analysis)|Adverse Event|0
5488977|NCT01752634|18979573|P1|Up to Week 24 (Primary Analysis)|Adverse Event|3
5488978|NCT01752634|18979568|P6|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
5488979|NCT01752634|18979569|P5|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
5488980|NCT01752634|18979570|P4|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
5488981|NCT01752634|18979571|P3|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
5488982|NCT01752634|18979572|P2|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
5488983|NCT01752634|18979573|P1|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
5488984|NCT01752634|18979568|P6|Up to Week 24 (Primary Analysis)|Physician Decision|0
5488985|NCT01752634|18979569|P5|Up to Week 24 (Primary Analysis)|Physician Decision|0
5488986|NCT01752634|18979570|P4|Up to Week 24 (Primary Analysis)|Physician Decision|0
5488987|NCT01752634|18979571|P3|Up to Week 24 (Primary Analysis)|Physician Decision|0
5488988|NCT01752634|18979572|P2|Up to Week 24 (Primary Analysis)|Physician Decision|1
5488989|NCT01752634|18979573|P1|Up to Week 24 (Primary Analysis)|Physician Decision|0
5488990|NCT01752634|18979568|P6|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
5488991|NCT01752634|18979569|P5|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
5488992|NCT01752634|18979570|P4|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
5488993|NCT01752634|18979571|P3|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
5488994|NCT01752634|18979572|P2|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
5488995|NCT01752634|18979573|P1|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
5488996|NCT01752036|18979631|P1|Overall Study|Death|2
5488997|NCT01752023|18979644|P2|Overall Study|Physician Decision|1
5488998|NCT01752023|18979645|P1|Overall Study|Physician Decision|2
5488999|NCT01751906|18979681|P2|Overall Study|Other|0
5489000|NCT01751906|18979682|P1|Overall Study|Other|1
5489001|NCT01751906|18979681|P2|Overall Study|Death|22
5489002|NCT01751906|18979682|P1|Overall Study|Death|38
5489003|NCT01751906|18979681|P2|Overall Study|Physician Decision|1
5489004|NCT01751906|18979682|P1|Overall Study|Physician Decision|3
5489005|NCT01751906|18979681|P2|Overall Study|Withdrawal by Subject|6
5489006|NCT01751906|18979682|P1|Overall Study|Withdrawal by Subject|14
5489007|NCT01751906|18979681|P2|Overall Study|Lost to Follow-up|18
5489008|NCT01751906|18979682|P1|Overall Study|Lost to Follow-up|28
5489009|NCT01751867|18979886|P2|Overall Study|Randomized but not treated.|1
5489010|NCT01751867|18979887|P1|Overall Study|Randomized but not treated.|2
5489011|NCT01751867|18979886|P2|Overall Study|Other|37
5489012|NCT01751867|18979887|P1|Overall Study|Other|11
5489013|NCT01751867|18979886|P2|Overall Study|Death|5
5489014|NCT01751867|18979887|P1|Overall Study|Death|0
5489015|NCT01751867|18979886|P2|Overall Study|Protocol Violation|2
5489016|NCT01751867|18979887|P1|Overall Study|Protocol Violation|0
5489017|NCT01751867|18979886|P2|Overall Study|Physician Decision|7
5489018|NCT01751867|18979887|P1|Overall Study|Physician Decision|4
5489019|NCT01751867|18979886|P2|Overall Study|Withdrawal by Subject|1
5489020|NCT01751867|18979887|P1|Overall Study|Withdrawal by Subject|3
5489021|NCT01751867|18979886|P2|Overall Study|Poor Compliance|5
5489022|NCT01751867|18979887|P1|Overall Study|Poor Compliance|0
5489023|NCT01751867|18979886|P2|Overall Study|Adverse Event|15
5489024|NCT01751867|18979887|P1|Overall Study|Adverse Event|8
5489025|NCT01751867|18979886|P2|Overall Study|Diease Progression|18
5489026|NCT01751867|18979887|P1|Overall Study|Diease Progression|4
5489027|NCT01751867|18979886|P2|Overall Study|Completed treatment,dropped in follow-up|8
5489028|NCT01751867|18979887|P1|Overall Study|Completed treatment,dropped in follow-up|4
5489029|NCT01751802|18979907|P2|Overall Study|Adverse Event|2
5489030|NCT01751802|18979908|P1|Overall Study|Adverse Event|4
5489031|NCT01751724|18979922|P2|Overall Study|withdrawn by parent|2
5489032|NCT01751724|18979923|P1|Overall Study|withdrawn by parent|0
5489033|NCT01751724|18979922|P2|Overall Study|extubated bef.start assigned treatment|0
5489034|NCT01751724|18979923|P1|Overall Study|extubated bef.start assigned treatment|1
5489035|NCT01751646|18979951|P2|Overall Study|Childcare issues|1
5489036|NCT01751646|18979952|P1|Overall Study|Childcare issues|1
5489037|NCT01751646|18979951|P2|Overall Study|Fails to comply with study requirements|1
5489038|NCT01751646|18979952|P1|Overall Study|Fails to comply with study requirements|0
5489039|NCT01751646|18979951|P2|Overall Study|Off study due to multiple obligations|1
5489040|NCT01751646|18979952|P1|Overall Study|Off study due to multiple obligations|0
5489041|NCT01751646|18979951|P2|Overall Study|Inability to attend required visits|1
5489042|NCT01751646|18979952|P1|Overall Study|Inability to attend required visits|0
5489043|NCT01751646|18979951|P2|Overall Study|Moved out of the area|5
5489044|NCT01751646|18979952|P1|Overall Study|Moved out of the area|1
5489045|NCT01751646|18979951|P2|Overall Study|Inadvertent enrollment|1
5489046|NCT01751646|18979952|P1|Overall Study|Inadvertent enrollment|1
5489047|NCT01751646|18979951|P2|Overall Study|Missed 4 or more consecutive DOT visits|3
5489048|NCT01751646|18979952|P1|Overall Study|Missed 4 or more consecutive DOT visits|2
5489049|NCT01751646|18979951|P2|Overall Study|Starting hormone therapy|0
5489050|NCT01751646|18979952|P1|Overall Study|Starting hormone therapy|1
5489051|NCT01751646|18979951|P2|Overall Study|Withdrawal by Subject|4
5489052|NCT01751646|18979952|P1|Overall Study|Withdrawal by Subject|0
5489053|NCT01751646|18979951|P2|Overall Study|Lost to Follow-up|1
5489054|NCT01751646|18979952|P1|Overall Study|Lost to Follow-up|5
5489055|NCT01751568|18980103|P3|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
5489056|NCT01751568|18980104|P2|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
5489057|NCT01751568|18980105|P1|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1
5489058|NCT01751412|18980134|P1|Overall Study|Disease Progression Before Treatment|1
5489059|NCT01751178|18980244|P3|Overall Study|Other Reason (unknown)|2
5489060|NCT01751178|18980245|P2|Overall Study|Other Reason (unknown)|0
5489061|NCT01751178|18980246|P1|Overall Study|Other Reason (unknown)|1
5489062|NCT01751178|18980244|P3|Overall Study|Adverse Event|0
5489063|NCT01751178|18980245|P2|Overall Study|Adverse Event|0
5489064|NCT01751178|18980246|P1|Overall Study|Adverse Event|2
5489065|NCT01751165|18980266|P3|Overall Study|Lost to Follow-up|1
5489066|NCT01751165|18980267|P2|Overall Study|Lost to Follow-up|1
5489067|NCT01751165|18980268|P1|Overall Study|Lost to Follow-up|1
5489068|NCT01751165|18980266|P3|Overall Study|Serious adverse event|0
5489069|NCT01751165|18980267|P2|Overall Study|Serious adverse event|2
5489070|NCT01751165|18980268|P1|Overall Study|Serious adverse event|0
5489071|NCT01751165|18980266|P3|Overall Study|Withdrawal by Subject|1
5489072|NCT01751165|18980267|P2|Overall Study|Withdrawal by Subject|0
5489073|NCT01751165|18980268|P1|Overall Study|Withdrawal by Subject|0
5489074|NCT01751165|18980266|P3|Overall Study|Adverse event, serious fatal|1
5489075|NCT01751165|18980267|P2|Overall Study|Adverse event, serious fatal|0
5489076|NCT01751165|18980268|P1|Overall Study|Adverse event, serious fatal|1
5489077|NCT01751139|18980308|P1|Overall Study|Death|31
5489078|NCT01751139|18980308|P1|Overall Study|Adverse Event|1
5489079|NCT01751139|18980308|P1|Overall Study|Withdrawal by Subject|251
5489080|NCT01751139|18980308|P1|Overall Study|Lost to Follow-up|240
5489081|NCT01751139|18980308|P1|Overall Study|Sponsor study termination|1609
5489082|NCT01751139|18980308|P1|Overall Study|Other|135
5489083|NCT01751113|18980326|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
5489084|NCT01751113|18980327|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
5489085|NCT01751113|18980328|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
5489086|NCT01751113|18980329|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
5489087|NCT01751113|18980330|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
5489088|NCT01751113|18980331|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
5489089|NCT01751113|18980326|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
5489090|NCT01751113|18980327|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
5489091|NCT01751113|18980328|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
5489092|NCT01751113|18980329|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
5489093|NCT01751113|18980330|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
5489094|NCT01751113|18980331|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
5489095|NCT01751087|18980372|P3|Overall Study|Physician Decision|1
5489096|NCT01751087|18980373|P2|Overall Study|Physician Decision|0
5489097|NCT01751087|18980374|P1|Overall Study|Physician Decision|0
5489098|NCT01751087|18980372|P3|Overall Study|Withdrawal by Subject|0
5489099|NCT01751087|18980373|P2|Overall Study|Withdrawal by Subject|0
5489100|NCT01751087|18980374|P1|Overall Study|Withdrawal by Subject|1
5489101|NCT01751061|18980408|P2|Overall Study|Physician Decision|0
5489102|NCT01751061|18980409|P1|Overall Study|Physician Decision|2
5489103|NCT01751061|18980408|P2|Overall Study|Withdrawal by Subject|1
5489104|NCT01751061|18980409|P1|Overall Study|Withdrawal by Subject|4
5489105|NCT01751061|18980408|P2|Overall Study|patient regained decisional capacity|8
5489106|NCT01751061|18980409|P1|Overall Study|patient regained decisional capacity|4
5489107|NCT01751061|18980408|P2|Overall Study|Lost to Follow-up|25
5489108|NCT01751061|18980409|P1|Overall Study|Lost to Follow-up|40
5489109|NCT01751061|18980408|P2|Overall Study|patient death|0
5489110|NCT01751061|18980409|P1|Overall Study|patient death|5
5489111|NCT01751061|18980408|P2|Overall Study|Death|0
5489112|NCT01751061|18980409|P1|Overall Study|Death|1
5489113|NCT01750840|18980483|P1|Overall Study|Lost to Follow-up|4
5489114|NCT01750697|18980488|P1|Overall Study|Withdrawal by Subject|1
5489115|NCT01750697|18980488|P1|Overall Study|Physician Decision|1
5489116|NCT01750697|18980488|P1|Overall Study|Transferred to Adult Services|5
5489117|NCT01750697|18980488|P1|Overall Study|Physician and Family Decision|1
5489118|NCT01750697|18980488|P1|Overall Study|Transferred Back to Local Hospital|1
5489119|NCT01750684|18980500|P2|Overall Study|Protocol Violation|0
5489120|NCT01750684|18980501|P1|Overall Study|Protocol Violation|1
5489121|NCT01750684|18980500|P2|Overall Study|Withdrawn by Sponsor|1
5489122|NCT01750684|18980501|P1|Overall Study|Withdrawn by Sponsor|0
5489123|NCT01750684|18980500|P2|Overall Study|Non-compliance with Study Drug|1
5489124|NCT01750684|18980501|P1|Overall Study|Non-compliance with Study Drug|0
5489125|NCT01750684|18980500|P2|Overall Study|Death|0
5489126|NCT01750684|18980501|P1|Overall Study|Death|1
5489127|NCT01750346|18980538|P3|Overall Study|Adverse Event|0
5489128|NCT01750346|18980539|P2|Overall Study|Adverse Event|0
5489129|NCT01750346|18980540|P1|Overall Study|Adverse Event|1
5489130|NCT01750294|18980566|P1|Overall Study|Safety Endpoint|1
5489131|NCT01750294|18980566|P1|Overall Study|Withdrawal by Subject|1
5489132|NCT01750281|18980573|P3|Overall Study|Did not receive treatment|0
5489133|NCT01750281|18980574|P2|Overall Study|Did not receive treatment|1
5489134|NCT01750281|18980575|P1|Overall Study|Did not receive treatment|0
5489135|NCT01750281|18980573|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
5489136|NCT01750281|18980574|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
5489137|NCT01750281|18980575|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
5489138|NCT01750281|18980573|P3|Overall Study|Discontinued Selumetinib/Placebo|75
5489139|NCT01750281|18980574|P2|Overall Study|Discontinued Selumetinib/Placebo|77
5489140|NCT01750281|18980575|P1|Overall Study|Discontinued Selumetinib/Placebo|37
5489141|NCT01750268|18980588|P2|Overall Study|Withdrawal by Subject|0
5489142|NCT01750268|18980589|P1|Overall Study|Withdrawal by Subject|2
5489143|NCT01750268|18980588|P2|Overall Study|Physician Decision|3
5489144|NCT01750268|18980589|P1|Overall Study|Physician Decision|0
5489145|NCT01750268|18980588|P2|Overall Study|Lost to Follow-up|2
5489146|NCT01750268|18980589|P1|Overall Study|Lost to Follow-up|0
5489147|NCT01750242|18980616|P1|Overall Study|Unreadable Images|3
5489148|NCT01750229|18980621|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
5489149|NCT01750229|18980621|P1|Long-term Follow-up Phase|Adverse Event|2
5489150|NCT01750229|18980621|P1|Randomized Crossover Phase|Withdrawal by Subject|1
5489151|NCT01750229|18980621|P1|Randomized Crossover Phase|Adverse Event|1
5489152|NCT01749982|18980648|P4|Overall Study|Withdrawal by Subject|1
5489153|NCT01749982|18980649|P3|Overall Study|Withdrawal by Subject|0
5489154|NCT01749982|18980650|P2|Overall Study|Withdrawal by Subject|0
5489155|NCT01749982|18980651|P1|Overall Study|Withdrawal by Subject|0
5489156|NCT01749982|18980648|P4|Overall Study|Lost to Follow-up|1
5489157|NCT01749982|18980649|P3|Overall Study|Lost to Follow-up|0
5489158|NCT01749982|18980650|P2|Overall Study|Lost to Follow-up|0
5489159|NCT01749982|18980651|P1|Overall Study|Lost to Follow-up|0
5489160|NCT01749982|18980648|P4|Overall Study|Physician Decision|1
5489161|NCT01749982|18980649|P3|Overall Study|Physician Decision|0
5489162|NCT01749982|18980650|P2|Overall Study|Physician Decision|0
5489163|NCT01749982|18980651|P1|Overall Study|Physician Decision|0
5489164|NCT01749826|18980715|P2|Overall Study|Study Terminated|0
5489165|NCT01749826|18980716|P1|Overall Study|Study Terminated|20
5489166|NCT01749800|18980731|P3|Overall Study|Withdrawal by Subject|0
5489167|NCT01749800|18980732|P2|Overall Study|Withdrawal by Subject|1
5489168|NCT01749800|18980733|P1|Overall Study|Withdrawal by Subject|0
5489169|NCT01749800|18980731|P3|Overall Study|not meeting inclusion criteria|0
5489170|NCT01749800|18980732|P2|Overall Study|not meeting inclusion criteria|0
5489171|NCT01749800|18980733|P1|Overall Study|not meeting inclusion criteria|3
5489172|NCT01749735|18980743|P2|Overall Study|Withdrawal by Subject|0
5489173|NCT01749735|18980744|P1|Overall Study|Withdrawal by Subject|1
5489174|NCT01749033|18980795|P3|Overall Study|Lost to Follow-up|1
5489175|NCT01749033|18980796|P2|Overall Study|Lost to Follow-up|2
5489176|NCT01749033|18980797|P1|Overall Study|Lost to Follow-up|0
5489177|NCT01749033|18980795|P3|Overall Study|Did not receive allocated intervention|0
5489178|NCT01749033|18980796|P2|Overall Study|Did not receive allocated intervention|3
5489179|NCT01749033|18980797|P1|Overall Study|Did not receive allocated intervention|3
5489180|NCT01748890|18980867|P1|Overall Study|Insufficient recruitment for analysis|4
5489181|NCT01748760|18980922|P2|Overall Study|Lost to Follow-up|1
5489182|NCT01748760|18980923|P1|Overall Study|Lost to Follow-up|5
5489183|NCT01748760|18980922|P2|Overall Study|Withdrawal by Subject|1
5489184|NCT01748760|18980923|P1|Overall Study|Withdrawal by Subject|1
5489185|NCT01748552|18980969|P12|Intervention Period 2 and Washout|Contingency dose not tested|0
5489186|NCT01748552|18980970|P11|Intervention Period 2 and Washout|Contingency dose not tested|0
5489187|NCT01748552|18980971|P10|Intervention Period 2 and Washout|Contingency dose not tested|0
5489188|NCT01748552|18980972|P9|Intervention Period 2 and Washout|Contingency dose not tested|3
5489189|NCT01748552|18980973|P8|Intervention Period 2 and Washout|Contingency dose not tested|3
5489190|NCT01748552|18980974|P7|Intervention Period 2 and Washout|Contingency dose not tested|3
5489191|NCT01748552|18980975|P6|Intervention Period 2 and Washout|Contingency dose not tested|0
5489192|NCT01748552|18980976|P5|Intervention Period 2 and Washout|Contingency dose not tested|0
5489193|NCT01748552|18980977|P4|Intervention Period 2 and Washout|Contingency dose not tested|0
5489194|NCT01748552|18980978|P3|Intervention Period 2 and Washout|Contingency dose not tested|0
5489195|NCT01748552|18980979|P2|Intervention Period 2 and Washout|Contingency dose not tested|0
5489196|NCT01748552|18980980|P1|Intervention Period 2 and Washout|Contingency dose not tested|0
5489197|NCT01748552|18980969|P12|Intervention Period 2 and Washout|Physician Decision|0
5489198|NCT01748552|18980970|P11|Intervention Period 2 and Washout|Physician Decision|0
5489199|NCT01748552|18980971|P10|Intervention Period 2 and Washout|Physician Decision|0
5489200|NCT01748552|18980972|P9|Intervention Period 2 and Washout|Physician Decision|0
5489201|NCT01748552|18980973|P8|Intervention Period 2 and Washout|Physician Decision|0
5489202|NCT01748552|18980974|P7|Intervention Period 2 and Washout|Physician Decision|0
5489203|NCT01748552|18980975|P6|Intervention Period 2 and Washout|Physician Decision|0
5489204|NCT01748552|18980976|P5|Intervention Period 2 and Washout|Physician Decision|0
5489205|NCT01748552|18980977|P4|Intervention Period 2 and Washout|Physician Decision|0
5489206|NCT01748552|18980978|P3|Intervention Period 2 and Washout|Physician Decision|1
5489207|NCT01748552|18980979|P2|Intervention Period 2 and Washout|Physician Decision|0
5489208|NCT01748552|18980980|P1|Intervention Period 2 and Washout|Physician Decision|0
5489209|NCT01748292|18981050|P2|Overall Study|Withdrawal by Subject|2
5489210|NCT01748292|18981051|P1|Overall Study|Withdrawal by Subject|0
5489211|NCT01748292|18981050|P2|Overall Study|Death|3
5489212|NCT01748292|18981051|P1|Overall Study|Death|0
5489213|NCT01748292|18981050|P2|Overall Study|Lost to Follow-up|3
5489214|NCT01748292|18981051|P1|Overall Study|Lost to Follow-up|0
5489215|NCT01748292|18981050|P2|Overall Study|Adverse Event|4
5489216|NCT01748292|18981051|P1|Overall Study|Adverse Event|2
5489217|NCT01748162|18981085|P2|Overall Study|reasons not available|2
5489218|NCT01748162|18981086|P1|Overall Study|reasons not available|3
5489219|NCT01748162|18981085|P2|Overall Study|participant consented but did not begin|1
5489220|NCT01748162|18981086|P1|Overall Study|participant consented but did not begin|0
5489221|NCT01748162|18981085|P2|Overall Study|no additional croup episodes to evaluate|2
5489222|NCT01748162|18981086|P1|Overall Study|no additional croup episodes to evaluate|2
5489223|NCT01748071|18981097|P3|Overall Study|Adverse Event|0
5489224|NCT01748071|18981098|P2|Overall Study|Adverse Event|2
5489225|NCT01748071|18981099|P1|Overall Study|Adverse Event|2
5489226|NCT01747915|18981362|P3|Overall Study|Pregnancy|1
5489227|NCT01747915|18981363|P2|Overall Study|Pregnancy|0
5489228|NCT01747915|18981364|P1|Overall Study|Pregnancy|0
5489229|NCT01747915|18981362|P3|Overall Study|Protocol Violation|0
5489230|NCT01747915|18981363|P2|Overall Study|Protocol Violation|0
5489231|NCT01747915|18981364|P1|Overall Study|Protocol Violation|1
5489232|NCT01747915|18981362|P3|Overall Study|Withdrawal by Subject|1
5489233|NCT01747915|18981363|P2|Overall Study|Withdrawal by Subject|4
5489234|NCT01747915|18981364|P1|Overall Study|Withdrawal by Subject|4
5489235|NCT01747915|18981362|P3|Overall Study|Lost to Follow-up|0
5489236|NCT01747915|18981363|P2|Overall Study|Lost to Follow-up|0
5489237|NCT01747915|18981364|P1|Overall Study|Lost to Follow-up|1
5489238|NCT01747915|18981362|P3|Overall Study|Lack of Efficacy|0
5489239|NCT01747915|18981363|P2|Overall Study|Lack of Efficacy|1
5489240|NCT01747915|18981364|P1|Overall Study|Lack of Efficacy|0
5489241|NCT01747915|18981362|P3|Overall Study|Death|1
5489242|NCT01747915|18981363|P2|Overall Study|Death|0
5489243|NCT01747915|18981364|P1|Overall Study|Death|0
5489244|NCT01747915|18981362|P3|Overall Study|Adverse Event|2
5489245|NCT01747915|18981363|P2|Overall Study|Adverse Event|5
5489246|NCT01747915|18981364|P1|Overall Study|Adverse Event|8
5489247|NCT01747915|18981362|P3|Overall Study|Other|1
5489248|NCT01747915|18981363|P2|Overall Study|Other|1
5489249|NCT01747915|18981364|P1|Overall Study|Other|1
5489250|NCT01747876|18981378|P3|Overall Study|Trtment duration compl. as per protocol|1
5489251|NCT01747876|18981379|P2|Overall Study|Trtment duration compl. as per protocol|1
5489252|NCT01747876|18981380|P1|Overall Study|Trtment duration compl. as per protocol|0
5489253|NCT01747876|18981378|P3|Overall Study|Disease progression|8
5489254|NCT01747876|18981379|P2|Overall Study|Disease progression|13
5489255|NCT01747876|18981380|P1|Overall Study|Disease progression|4
5489256|NCT01747876|18981378|P3|Overall Study|Withdrawal by Subject|1
5489257|NCT01747876|18981379|P2|Overall Study|Withdrawal by Subject|1
5489258|NCT01747876|18981380|P1|Overall Study|Withdrawal by Subject|0
5489259|NCT01747876|18981378|P3|Overall Study|Adverse Event|2
5489260|NCT01747876|18981379|P2|Overall Study|Adverse Event|0
5489261|NCT01747876|18981380|P1|Overall Study|Adverse Event|1
5489262|NCT01747837|18981433|P2|Overall Study|Death|4
5489263|NCT01747837|18981434|P1|Overall Study|Death|4
5489264|NCT01747837|18981433|P2|Overall Study|Lost to Follow-up|2
5489265|NCT01747837|18981434|P1|Overall Study|Lost to Follow-up|5
5489266|NCT01747811|18981464|P2|Overall Study|Lack of Efficacy|4
5489267|NCT01747811|18981465|P1|Overall Study|Lack of Efficacy|2
5489268|NCT01747772|18981481|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
5489269|NCT01747655|18981489|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
5489270|NCT01747655|18981490|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
5489271|NCT01747655|18981489|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
5489272|NCT01747655|18981490|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
5489273|NCT01747655|18981489|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
5489274|NCT01747655|18981490|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
5489275|NCT01747629|18981520|P2|Overall Study|Other|1
5489276|NCT01747629|18981521|P1|Overall Study|Other|2
5489277|NCT01747629|18981520|P2|Overall Study|Not treated|0
5489278|NCT01747629|18981521|P1|Overall Study|Not treated|1
5489279|NCT01747629|18981520|P2|Overall Study|Inclusion criteria not met|0
5489280|NCT01747629|18981521|P1|Overall Study|Inclusion criteria not met|1
5489281|NCT01747629|18981520|P2|Overall Study|Noncompliance|1
5489282|NCT01747629|18981521|P1|Overall Study|Noncompliance|1
5489283|NCT01747629|18981520|P2|Overall Study|Withdrawal by Subject|2
5489284|NCT01747629|18981521|P1|Overall Study|Withdrawal by Subject|2
5489285|NCT01747629|18981520|P2|Overall Study|Adverse Event|2
5489286|NCT01747629|18981521|P1|Overall Study|Adverse Event|1
5489287|NCT01747551|18981555|P2|Overall Study|Other|0
5489288|NCT01747551|18981556|P1|Overall Study|Other|2
5489289|NCT01747551|18981555|P2|Overall Study|Physician Decision|1
5489290|NCT01747551|18981556|P1|Overall Study|Physician Decision|2
5489291|NCT01747551|18981555|P2|Overall Study|Withdrawal by Subject|1
5489292|NCT01747551|18981556|P1|Overall Study|Withdrawal by Subject|3
5489293|NCT01747551|18981555|P2|Overall Study|Prolonged Treatment Delay|0
5489294|NCT01747551|18981556|P1|Overall Study|Prolonged Treatment Delay|2
5489295|NCT01747551|18981555|P2|Overall Study|Adverse Event|1
5489296|NCT01747551|18981556|P1|Overall Study|Adverse Event|7
5489297|NCT01747551|18981555|P2|Overall Study|Death|1
5489298|NCT01747551|18981556|P1|Overall Study|Death|3
5489299|NCT01747551|18981555|P2|Overall Study|Progressive Disease|17
5489300|NCT01747551|18981556|P1|Overall Study|Progressive Disease|24
5489301|NCT01747499|18981573|P5|Overall Study|Determined not to be eligible|1
5489302|NCT01747499|18981574|P4|Overall Study|Determined not to be eligible|0
5489303|NCT01747499|18981575|P3|Overall Study|Determined not to be eligible|0
5489304|NCT01747499|18981576|P2|Overall Study|Determined not to be eligible|0
5489305|NCT01747499|18981577|P1|Overall Study|Determined not to be eligible|0
5489306|NCT01747499|18981573|P5|Overall Study|Developed AML and death|1
5489307|NCT01747499|18981574|P4|Overall Study|Developed AML and death|0
5489308|NCT01747499|18981575|P3|Overall Study|Developed AML and death|0
5489309|NCT01747499|18981576|P2|Overall Study|Developed AML and death|0
5489310|NCT01747499|18981577|P1|Overall Study|Developed AML and death|0
5489311|NCT01747499|18981573|P5|Overall Study|Withdrawal by Subject|6
5489312|NCT01747499|18981574|P4|Overall Study|Withdrawal by Subject|0
5489313|NCT01747499|18981575|P3|Overall Study|Withdrawal by Subject|0
5489314|NCT01747499|18981576|P2|Overall Study|Withdrawal by Subject|0
5489315|NCT01747499|18981577|P1|Overall Study|Withdrawal by Subject|0
5489316|NCT01747499|18981573|P5|Overall Study|Death|1
5489317|NCT01747499|18981574|P4|Overall Study|Death|1
5489318|NCT01747499|18981575|P3|Overall Study|Death|0
5489319|NCT01747499|18981576|P2|Overall Study|Death|0
5489320|NCT01747499|18981577|P1|Overall Study|Death|0
5489321|NCT01747499|18981573|P5|Overall Study|Physician Decision|2
5489322|NCT01747499|18981574|P4|Overall Study|Physician Decision|0
5489323|NCT01747499|18981575|P3|Overall Study|Physician Decision|0
5489324|NCT01747499|18981576|P2|Overall Study|Physician Decision|1
5489325|NCT01747499|18981577|P1|Overall Study|Physician Decision|0
5489326|NCT01747499|18981573|P5|Overall Study|Steroid refractory aGvHD|4
5489327|NCT01747499|18981574|P4|Overall Study|Steroid refractory aGvHD|1
5489328|NCT01747499|18981575|P3|Overall Study|Steroid refractory aGvHD|0
5489329|NCT01747499|18981576|P2|Overall Study|Steroid refractory aGvHD|0
5489330|NCT01747499|18981577|P1|Overall Study|Steroid refractory aGvHD|1
5489331|NCT01747486|18981613|P2|Stage 2|Disease Progression|0
5489332|NCT01747486|18981614|P1|Stage 2|Disease Progression|3
5489333|NCT01747486|18981613|P2|Stage 2|New Cancer Therapy|0
5489334|NCT01747486|18981614|P1|Stage 2|New Cancer Therapy|3
5489335|NCT01747486|18981613|P2|Stage 2|Withdrawal by Subject|0
5489336|NCT01747486|18981614|P1|Stage 2|Withdrawal by Subject|1
5489337|NCT01747486|18981613|P2|Stage 2|Physician Decision|0
5489338|NCT01747486|18981614|P1|Stage 2|Physician Decision|2
5489339|NCT01747486|18981613|P2|Stage 1|Death|1
5489340|NCT01747486|18981614|P1|Stage 1|Death|1
5489341|NCT01747486|18981613|P2|Stage 1|Disease progression|9
5489342|NCT01747486|18981614|P1|Stage 1|Disease progression|4
5489343|NCT01747486|18981613|P2|Stage 1|Withdrawal by Subject|3
5489344|NCT01747486|18981614|P1|Stage 1|Withdrawal by Subject|4
5489345|NCT01747486|18981613|P2|Stage 1|Physician Decision|0
5489346|NCT01747486|18981614|P1|Stage 1|Physician Decision|3
5489347|NCT01746901|18981664|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
5489348|NCT01746901|18981665|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
5489349|NCT01746901|18981666|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
5489350|NCT01746901|18981667|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
5489351|NCT01746901|18981668|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
5489352|NCT01746901|18981669|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
5489353|NCT01746901|18981670|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
5489354|NCT01746901|18981671|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
5489355|NCT01746901|18981672|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
5489356|NCT01746901|18981664|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
5489357|NCT01746901|18981665|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
5489358|NCT01746901|18981666|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
5489359|NCT01746901|18981667|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
5489360|NCT01746901|18981668|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
5489361|NCT01746901|18981669|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
5489362|NCT01746901|18981670|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
5489363|NCT01746901|18981671|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
5489364|NCT01746901|18981672|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
5489365|NCT01746901|18981664|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5489366|NCT01746901|18981665|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5489367|NCT01746901|18981666|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5489368|NCT01746901|18981667|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5489369|NCT01746901|18981668|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5489370|NCT01746901|18981669|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
5489371|NCT01746901|18981670|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5489372|NCT01746901|18981671|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5489373|NCT01746901|18981672|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
5489374|NCT01746901|18981664|P9|Treatment Phase: Third Intervention|Protocol Violation|0
5489375|NCT01746901|18981665|P8|Treatment Phase: Third Intervention|Protocol Violation|0
5489376|NCT01746901|18981666|P7|Treatment Phase: Third Intervention|Protocol Violation|1
5489377|NCT01746901|18981667|P6|Treatment Phase: Third Intervention|Protocol Violation|1
5489378|NCT01746901|18981668|P5|Treatment Phase: Third Intervention|Protocol Violation|0
5489379|NCT01746901|18981669|P4|Treatment Phase: Third Intervention|Protocol Violation|0
5489380|NCT01746901|18981670|P3|Treatment Phase: Third Intervention|Protocol Violation|0
5489381|NCT01746901|18981671|P2|Treatment Phase: Third Intervention|Protocol Violation|0
5489382|NCT01746901|18981672|P1|Treatment Phase: Third Intervention|Protocol Violation|0
5489383|NCT01746901|18981664|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5489384|NCT01746901|18981665|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
5489385|NCT01746901|18981666|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5489386|NCT01746901|18981667|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5489387|NCT01746901|18981668|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5489388|NCT01746901|18981669|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5489389|NCT01746901|18981670|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5489390|NCT01746901|18981671|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5489391|NCT01746901|18981672|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
5489392|NCT01746901|18981664|P9|Treatment Phase: First Intervention|Protocol Violation|0
5489393|NCT01746901|18981665|P8|Treatment Phase: First Intervention|Protocol Violation|0
5489394|NCT01746901|18981666|P7|Treatment Phase: First Intervention|Protocol Violation|1
5489395|NCT01746901|18981667|P6|Treatment Phase: First Intervention|Protocol Violation|0
5489396|NCT01746901|18981668|P5|Treatment Phase: First Intervention|Protocol Violation|0
5489397|NCT01746901|18981669|P4|Treatment Phase: First Intervention|Protocol Violation|0
5489398|NCT01746901|18981670|P3|Treatment Phase: First Intervention|Protocol Violation|0
5489399|NCT01746901|18981671|P2|Treatment Phase: First Intervention|Protocol Violation|0
5489400|NCT01746901|18981672|P1|Treatment Phase: First Intervention|Protocol Violation|0
5489401|NCT01746901|18981664|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
5489402|NCT01746901|18981665|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
5489403|NCT01746901|18981666|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
5489404|NCT01746901|18981667|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
5489405|NCT01746901|18981668|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
5489406|NCT01746901|18981669|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
5489407|NCT01746901|18981670|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
5489408|NCT01746901|18981671|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
5489409|NCT01746901|18981672|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
5489410|NCT01746901|18981664|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5489411|NCT01746901|18981665|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5489412|NCT01746901|18981666|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5489413|NCT01746901|18981667|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5489414|NCT01746901|18981668|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5489415|NCT01746901|18981669|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5489416|NCT01746901|18981670|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
5489417|NCT01746901|18981671|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
5489418|NCT01746901|18981672|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
5489419|NCT01746901|18981664|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
5489420|NCT01746901|18981665|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
5489421|NCT01746901|18981666|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
5489422|NCT01746901|18981667|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
5489423|NCT01746901|18981668|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
5489424|NCT01746901|18981669|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
5489425|NCT01746901|18981670|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
5489426|NCT01746901|18981671|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
5489427|NCT01746901|18981672|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
5489428|NCT01746901|18981664|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
5489429|NCT01746901|18981665|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
5489430|NCT01746901|18981666|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
5489431|NCT01746901|18981667|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
5489432|NCT01746901|18981668|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
5489433|NCT01746901|18981669|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
5489434|NCT01746901|18981670|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
5489435|NCT01746901|18981671|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
5489436|NCT01746901|18981672|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
5489437|NCT01746901|18981664|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
5489438|NCT01746901|18981665|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
5489439|NCT01746901|18981666|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
5489440|NCT01746901|18981667|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
5489441|NCT01746901|18981668|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
5489442|NCT01746901|18981669|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
5489443|NCT01746901|18981670|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
5489444|NCT01746901|18981671|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
5489445|NCT01746901|18981672|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
5489446|NCT01746901|18981664|P9|Naloxone Challenge Phase|Adverse Event|0
5489447|NCT01746901|18981665|P8|Naloxone Challenge Phase|Adverse Event|0
5489448|NCT01746901|18981666|P7|Naloxone Challenge Phase|Adverse Event|0
5489449|NCT01746901|18981667|P6|Naloxone Challenge Phase|Adverse Event|0
5489450|NCT01746901|18981668|P5|Naloxone Challenge Phase|Adverse Event|0
5489451|NCT01746901|18981669|P4|Naloxone Challenge Phase|Adverse Event|0
5489452|NCT01746901|18981670|P3|Naloxone Challenge Phase|Adverse Event|0
5489453|NCT01746901|18981671|P2|Naloxone Challenge Phase|Adverse Event|0
5489454|NCT01746901|18981672|P1|Naloxone Challenge Phase|Adverse Event|2
5489455|NCT01746862|18981995|P2|Overall Study|Entered puberty during the study|0
5489456|NCT01746862|18981996|P1|Overall Study|Entered puberty during the study|1
5489457|NCT01746862|18981995|P2|Overall Study|Consent withdrawal by parent's guardian|2
5489458|NCT01746862|18981996|P1|Overall Study|Consent withdrawal by parent's guardian|5
5489459|NCT01746862|18981995|P2|Overall Study|Protocol Violation|0
5489460|NCT01746862|18981996|P1|Overall Study|Protocol Violation|1
5489461|NCT01746862|18981995|P2|Overall Study|Withdrawal by Subject|1
5489462|NCT01746862|18981996|P1|Overall Study|Withdrawal by Subject|1
5489463|NCT01746732|18982060|P3|Period 2|Lost to Follow-up|1
5489464|NCT01746732|18982061|P2|Period 2|Lost to Follow-up|0
5489465|NCT01746732|18982062|P1|Period 2|Lost to Follow-up|0
5489466|NCT01746732|18982060|P3|Period 2|Adverse Event|1
5489467|NCT01746732|18982061|P2|Period 2|Adverse Event|0
5489468|NCT01746732|18982062|P1|Period 2|Adverse Event|0
5489469|NCT01746732|18982060|P3|Period 2|Withdrawal by Subject|2
5489470|NCT01746732|18982061|P2|Period 2|Withdrawal by Subject|0
5489471|NCT01746732|18982062|P1|Period 2|Withdrawal by Subject|0
5489472|NCT01746732|18982060|P3|Period 1|Physician Decision|0
5489473|NCT01746732|18982061|P2|Period 1|Physician Decision|1
5489474|NCT01746732|18982062|P1|Period 1|Physician Decision|0
5489475|NCT01746732|18982060|P3|Lead-In Period|Withdrawal by Subject|0
5489476|NCT01746732|18982061|P2|Lead-In Period|Withdrawal by Subject|0
5489477|NCT01746732|18982062|P1|Lead-In Period|Withdrawal by Subject|1
5489478|NCT01746368|18982143|P2|Overall Study|Withdrawal by Subject|1
5489479|NCT01746368|18982144|P1|Overall Study|Withdrawal by Subject|0
5489480|NCT01746368|18982143|P2|Overall Study|Lost to Follow-up|0
5489481|NCT01746368|18982144|P1|Overall Study|Lost to Follow-up|2
5489482|NCT01746225|18982174|P3|Overall Study|Continuing Treatment|3
5489483|NCT01746225|18982175|P2|Overall Study|Continuing Treatment|8
5489484|NCT01746225|18982176|P1|Overall Study|Continuing Treatment|5
5489485|NCT01746225|18982174|P3|Overall Study|Adverse Event|17
5489486|NCT01746225|18982175|P2|Overall Study|Adverse Event|12
5489487|NCT01746225|18982176|P1|Overall Study|Adverse Event|15
5489488|NCT01746225|18982174|P3|Overall Study|Physician Decision|3
5489489|NCT01746225|18982175|P2|Overall Study|Physician Decision|11
5489490|NCT01746225|18982176|P1|Overall Study|Physician Decision|14
5489491|NCT01746225|18982174|P3|Overall Study|Withdrawal by Subject|19
5489492|NCT01746225|18982175|P2|Overall Study|Withdrawal by Subject|15
5489493|NCT01746225|18982176|P1|Overall Study|Withdrawal by Subject|5
5489494|NCT01746225|18982174|P3|Overall Study|Death|1
5489495|NCT01746225|18982175|P2|Overall Study|Death|0
5489496|NCT01746225|18982176|P1|Overall Study|Death|1
5489497|NCT01746173|18982199|P1|Overall Study|Disease Progression|2
5489498|NCT01746108|18982207|P3|Overall Study|Lost to Follow-up|0
5489499|NCT01746108|18982208|P2|Overall Study|Lost to Follow-up|1
5489500|NCT01746108|18982209|P1|Overall Study|Lost to Follow-up|0
5489501|NCT01746108|18982207|P3|Overall Study|Withdrawal by Subject|0
5489502|NCT01746108|18982208|P2|Overall Study|Withdrawal by Subject|1
5489503|NCT01746108|18982209|P1|Overall Study|Withdrawal by Subject|0
5489504|NCT01746108|18982207|P3|Overall Study|Adverse event, non-fatal|0
5489505|NCT01746108|18982208|P2|Overall Study|Adverse event, non-fatal|1
5489506|NCT01746108|18982209|P1|Overall Study|Adverse event, non-fatal|0
5489507|NCT01746108|18982207|P3|Overall Study|Migrated /moved from study area|0
5489508|NCT01746108|18982208|P2|Overall Study|Migrated /moved from study area|1
5489509|NCT01746108|18982209|P1|Overall Study|Migrated /moved from study area|0
5489510|NCT01746017|18982326|P11|Period 3|Withdrawal by Subject|0
5489511|NCT01746017|18982327|P10|Period 3|Withdrawal by Subject|0
5489512|NCT01746017|18982328|P9|Period 3|Withdrawal by Subject|0
5489513|NCT01746017|18982329|P8|Period 3|Withdrawal by Subject|0
5489514|NCT01746017|18982330|P7|Period 3|Withdrawal by Subject|0
5489515|NCT01746017|18982331|P6|Period 3|Withdrawal by Subject|1
5489516|NCT01746017|18982332|P5|Period 3|Withdrawal by Subject|0
5489517|NCT01746017|18982333|P4|Period 3|Withdrawal by Subject|0
5489518|NCT01746017|18982334|P3|Period 3|Withdrawal by Subject|0
5489519|NCT01746017|18982335|P2|Period 3|Withdrawal by Subject|0
5489520|NCT01746017|18982336|P1|Period 3|Withdrawal by Subject|0
5489521|NCT01746017|18982326|P11|Period 1|Withdrawal by Subject|0
5489522|NCT01746017|18982327|P10|Period 1|Withdrawal by Subject|0
5489523|NCT01746017|18982328|P9|Period 1|Withdrawal by Subject|0
5489524|NCT01746017|18982329|P8|Period 1|Withdrawal by Subject|0
5489525|NCT01746017|18982330|P7|Period 1|Withdrawal by Subject|1
5489526|NCT01746017|18982331|P6|Period 1|Withdrawal by Subject|0
5489527|NCT01746017|18982332|P5|Period 1|Withdrawal by Subject|0
5489528|NCT01746017|18982333|P4|Period 1|Withdrawal by Subject|0
5489529|NCT01746017|18982334|P3|Period 1|Withdrawal by Subject|0
5489530|NCT01746017|18982335|P2|Period 1|Withdrawal by Subject|0
5489531|NCT01746017|18982336|P1|Period 1|Withdrawal by Subject|0
5489532|NCT01745848|18982457|P1|Overall Study|Adverse Event|6
5489533|NCT01745393|18982469|P2|12-month Follow-up|Lost to Follow-up|5
5489534|NCT01745393|18982470|P1|12-month Follow-up|Lost to Follow-up|6
5489535|NCT01745393|18982469|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
5489536|NCT01745393|18982470|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
5489537|NCT01745393|18982469|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
5489538|NCT01745393|18982470|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
5489539|NCT01745380|18982482|P2|Overall Study|Lack of Efficacy|1
5489540|NCT01745380|18982483|P1|Overall Study|Lack of Efficacy|0
5489541|NCT01745380|18982482|P2|Overall Study|Lost to Follow-up|0
5489542|NCT01745380|18982483|P1|Overall Study|Lost to Follow-up|1
5489543|NCT01745367|18982521|P2|Overall Study|Other Reasons Unspecified|2
5489544|NCT01745367|18982522|P1|Overall Study|Other Reasons Unspecified|0
5489545|NCT01745367|18982521|P2|Overall Study|Termination of The Study by The Sponsor|18
5489546|NCT01745367|18982522|P1|Overall Study|Termination of The Study by The Sponsor|6
5489547|NCT01745367|18982521|P2|Overall Study|Withdrawal by Subject|2
5489548|NCT01745367|18982522|P1|Overall Study|Withdrawal by Subject|1
5489549|NCT01745367|18982521|P2|Overall Study|Death|0
5489550|NCT01745367|18982522|P1|Overall Study|Death|1
5489551|NCT01745146|18982542|P2|Overall Study|Lost to Follow-up|0
5489552|NCT01745146|18982543|P1|Overall Study|Lost to Follow-up|2
5489553|NCT01745146|18982542|P2|Overall Study|Withdrawal by Subject|3
5489554|NCT01745146|18982543|P1|Overall Study|Withdrawal by Subject|1
5489555|NCT01745120|18982565|P2|Overall Study|Investigator decision|0
5489556|NCT01745120|18982566|P1|Overall Study|Investigator decision|1
5489557|NCT01745094|18982624|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
5489558|NCT01745094|18982625|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
5489559|NCT01745094|18982626|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
5489560|NCT01745094|18982627|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
5489561|NCT01745094|18982624|P4|Overall Study|Show no Stable Solifenacin Intake|0
5489562|NCT01745094|18982625|P3|Overall Study|Show no Stable Solifenacin Intake|1
5489563|NCT01745094|18982626|P2|Overall Study|Show no Stable Solifenacin Intake|0
5489564|NCT01745094|18982627|P1|Overall Study|Show no Stable Solifenacin Intake|0
5489565|NCT01745094|18982624|P4|Overall Study|Need Further Examinations Due to Biopsy|0
5489566|NCT01745094|18982625|P3|Overall Study|Need Further Examinations Due to Biopsy|1
5489567|NCT01745094|18982626|P2|Overall Study|Need Further Examinations Due to Biopsy|0
5489568|NCT01745094|18982627|P1|Overall Study|Need Further Examinations Due to Biopsy|0
5489569|NCT01745094|18982624|P4|Overall Study|Protocol Violation|1
5489570|NCT01745094|18982625|P3|Overall Study|Protocol Violation|3
5489571|NCT01745094|18982626|P2|Overall Study|Protocol Violation|0
5489572|NCT01745094|18982627|P1|Overall Study|Protocol Violation|1
5489573|NCT01745094|18982624|P4|Overall Study|Withdrawal by Subject|2
5489574|NCT01745094|18982625|P3|Overall Study|Withdrawal by Subject|1
5489575|NCT01745094|18982626|P2|Overall Study|Withdrawal by Subject|0
5489576|NCT01745094|18982627|P1|Overall Study|Withdrawal by Subject|2
5489577|NCT01745094|18982624|P4|Overall Study|Adverse Event|0
5489578|NCT01745094|18982625|P3|Overall Study|Adverse Event|3
5489579|NCT01745094|18982626|P2|Overall Study|Adverse Event|0
5489580|NCT01745094|18982627|P1|Overall Study|Adverse Event|0
5489581|NCT01745094|18982624|P4|Overall Study|Not Meeting the Eligibility Criteria|0
5489582|NCT01745094|18982625|P3|Overall Study|Not Meeting the Eligibility Criteria|3
5489583|NCT01745094|18982626|P2|Overall Study|Not Meeting the Eligibility Criteria|0
5489584|NCT01745094|18982627|P1|Overall Study|Not Meeting the Eligibility Criteria|1
5489585|NCT01744977|18982728|P2|Overall Study|No longer meets inclusion|0
5489586|NCT01744977|18982729|P1|Overall Study|No longer meets inclusion|6
5489587|NCT01744977|18982728|P2|Overall Study|Lost to Follow-up|0
5489588|NCT01744977|18982729|P1|Overall Study|Lost to Follow-up|2
5489589|NCT01744977|18982728|P2|Overall Study|Death|3
5489590|NCT01744977|18982729|P1|Overall Study|Death|2
5489591|NCT01744977|18982728|P2|Overall Study|Withdrawal by Subject|2
5489592|NCT01744977|18982729|P1|Overall Study|Withdrawal by Subject|1
5489593|NCT01744782|18982800|P1|Overall Study|Death|1
5489594|NCT01744691|18982961|P1|Overall Study|Physician Decision|4
5489595|NCT01744691|18982961|P1|Overall Study|Withdrawal of consent for treatment|3
5489596|NCT01744691|18982961|P1|Overall Study|Unacceptable toxicity, AE or death|18
5489597|NCT01744691|18982961|P1|Overall Study|Progressive Disease|18
5489598|NCT01744665|18982966|P1|Re-initiation Phase|Withdrawal by Subject|1
5489599|NCT01744665|18982966|P1|Re-initiation Phase|No longer required treatment|1
5489600|NCT01744665|18982966|P1|Re-initiation Phase|Adverse Event|1
5489601|NCT01744665|18982966|P1|Re-initiation Phase|Administrative problems|10
5489602|NCT01744665|18982966|P1|Consolidation Phase|Administrative problems|9
5489603|NCT01744665|18982966|P1|Consolidation Phase|Withdrawal by Subject|4
5489604|NCT01744665|18982966|P1|Consolidation Phase|Unsatisfactory therapeutic effect|4
5489605|NCT01744665|18982966|P1|Consolidation Phase|Adverse Event|2
5489606|NCT01744665|18982966|P1|Monitoring Phase|Did not achieve MR4.5|1
5489607|NCT01744665|18982966|P1|Monitoring Phase|Withdrawal by Subject|5
5489608|NCT01744665|18982966|P1|Monitoring Phase|Unsatisfactory therapeutic effect|7
5489609|NCT01744665|18982966|P1|Monitoring Phase|Abnormal laboratory value(s)|1
5489610|NCT01744665|18982966|P1|Monitoring Phase|Adverse Event|4
5489611|NCT01744496|18983036|P2|Maintenance Period|Subject left town|0
5489612|NCT01744496|18983037|P1|Maintenance Period|Subject left town|1
5489613|NCT01744496|18983036|P2|Maintenance Period|Withdrawal by Subject|1
5489614|NCT01744496|18983037|P1|Maintenance Period|Withdrawal by Subject|1
5489615|NCT01744496|18983036|P2|Maintenance Period|Protocol Violation|0
5489616|NCT01744496|18983037|P1|Maintenance Period|Protocol Violation|1
5489617|NCT01744496|18983036|P2|Maintenance Period|Adverse Event|3
5489618|NCT01744496|18983037|P1|Maintenance Period|Adverse Event|1
5489619|NCT01744496|18983036|P2|Titration Period|Personal reasons|1
5489620|NCT01744496|18983037|P1|Titration Period|Personal reasons|0
5489621|NCT01744496|18983036|P2|Titration Period|Adverse Event|1
5489622|NCT01744496|18983037|P1|Titration Period|Adverse Event|2
5489623|NCT01744483|18983058|P3|Overall Study|Routed to OSH|1
5489624|NCT01744483|18983059|P2|Overall Study|Routed to OSH|0
5489625|NCT01744483|18983060|P1|Overall Study|Routed to OSH|2
5489626|NCT01744483|18983058|P3|Overall Study|No ICU Admit|2
5489627|NCT01744483|18983059|P2|Overall Study|No ICU Admit|1
5489628|NCT01744483|18983060|P1|Overall Study|No ICU Admit|5
5489629|NCT01744483|18983058|P3|Overall Study|Withdrawal by Subject|2
5489630|NCT01744483|18983059|P2|Overall Study|Withdrawal by Subject|6
5489631|NCT01744483|18983060|P1|Overall Study|Withdrawal by Subject|4
5489632|NCT01744483|18983058|P3|Overall Study|Protocol Violation|1
5489633|NCT01744483|18983059|P2|Overall Study|Protocol Violation|2
5489634|NCT01744483|18983060|P1|Overall Study|Protocol Violation|1
5489635|NCT01744483|18983058|P3|Overall Study|Lost to Follow-up|11
5489636|NCT01744483|18983059|P2|Overall Study|Lost to Follow-up|9
5489637|NCT01744483|18983060|P1|Overall Study|Lost to Follow-up|8
5489638|NCT01744483|18983058|P3|Overall Study|Death|11
5489639|NCT01744483|18983059|P2|Overall Study|Death|4
5489640|NCT01744483|18983060|P1|Overall Study|Death|9
5489641|NCT01744392|18983068|P1|Overall Study|Physician Decision|1
5489642|NCT01744197|18983108|P2|Overall Study|No patch received|2
5489643|NCT01744197|18983109|P1|Overall Study|No patch received|2
5489644|NCT01744197|18983108|P2|Overall Study|Received 1 patch|1
5489645|NCT01744197|18983109|P1|Overall Study|Received 1 patch|2
5489646|NCT01743560|18983215|P1|Overall Study|>1 dose of study drug|3
5489647|NCT01743560|18983215|P1|Overall Study|Protocol Violation|1
5489648|NCT01743560|18983215|P1|Overall Study|Withdrawal by Subject|2
5489649|NCT01743560|18983215|P1|Overall Study|Death|3
5489650|NCT01743560|18983215|P1|Overall Study|Adverse Event|8
5489651|NCT01743560|18983215|P1|Overall Study|Disease progression|26
5489652|NCT01743469|18983299|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
5489653|NCT01743469|18983300|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
5489654|NCT01743469|18983301|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
5489655|NCT01743469|18983302|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
5489656|NCT01743469|18983299|P4|Follow-up Period - Post-Treatment|Death|16
5489657|NCT01743469|18983300|P3|Follow-up Period - Post-Treatment|Death|22
5489658|NCT01743469|18983301|P2|Follow-up Period - Post-Treatment|Death|47
5489659|NCT01743469|18983302|P1|Follow-up Period - Post-Treatment|Death|43
5489660|NCT01743469|18983299|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
5489661|NCT01743469|18983300|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
5489662|NCT01743469|18983301|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
5489663|NCT01743469|18983302|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
5489664|NCT01743469|18983299|P4|Active Treatment Phase|Missing|0
5489665|NCT01743469|18983300|P3|Active Treatment Phase|Missing|0
5489666|NCT01743469|18983301|P2|Active Treatment Phase|Missing|0
5489667|NCT01743469|18983302|P1|Active Treatment Phase|Missing|1
5489668|NCT01743469|18983299|P4|Active Treatment Phase|Withdrawal by Subject|0
5489669|NCT01743469|18983300|P3|Active Treatment Phase|Withdrawal by Subject|0
5489670|NCT01743469|18983301|P2|Active Treatment Phase|Withdrawal by Subject|3
5489671|NCT01743469|18983302|P1|Active Treatment Phase|Withdrawal by Subject|2
5489672|NCT01743469|18983299|P4|Active Treatment Phase|Disease Progression|20
5489673|NCT01743469|18983300|P3|Active Treatment Phase|Disease Progression|30
5489674|NCT01743469|18983301|P2|Active Treatment Phase|Disease Progression|47
5489675|NCT01743469|18983302|P1|Active Treatment Phase|Disease Progression|40
5489676|NCT01743469|18983299|P4|Active Treatment Phase|Adverse Event|1
5489677|NCT01743469|18983300|P3|Active Treatment Phase|Adverse Event|8
5489678|NCT01743469|18983301|P2|Active Treatment Phase|Adverse Event|5
5489679|NCT01743469|18983302|P1|Active Treatment Phase|Adverse Event|10
5489680|NCT01743092|18983367|P2|Overall Study|Lost to Follow-up|15
5489681|NCT01743092|18983368|P1|Overall Study|Lost to Follow-up|14
5489682|NCT01743040|18983376|P1|Overall Study|Withdrawal by Subject|121
5489683|NCT01743040|18983376|P1|Overall Study|Protocol Violation|1
5489684|NCT01743040|18983376|P1|Overall Study|Physician Decision|40
5489685|NCT01743040|18983376|P1|Overall Study|Lost to Follow-up|66
5489686|NCT01743040|18983376|P1|Overall Study|Death|1
5489687|NCT01743027|18983384|P4|Overall Study|Withdrawal by Subject|1
5489688|NCT01743027|18983385|P3|Overall Study|Withdrawal by Subject|3
5489689|NCT01743027|18983386|P2|Overall Study|Withdrawal by Subject|0
5489690|NCT01743027|18983387|P1|Overall Study|Withdrawal by Subject|1
5489691|NCT01743027|18983384|P4|Overall Study|Protocol Violation|0
5489692|NCT01743027|18983385|P3|Overall Study|Protocol Violation|1
5489693|NCT01743027|18983386|P2|Overall Study|Protocol Violation|1
5489694|NCT01743027|18983387|P1|Overall Study|Protocol Violation|1
5489695|NCT01743027|18983384|P4|Overall Study|Progressive Disease|0
5489696|NCT01743027|18983385|P3|Overall Study|Progressive Disease|3
5489697|NCT01743027|18983386|P2|Overall Study|Progressive Disease|4
5489698|NCT01743027|18983387|P1|Overall Study|Progressive Disease|1
5489699|NCT01743027|18983384|P4|Overall Study|Lost to Follow-up|0
5489700|NCT01743027|18983385|P3|Overall Study|Lost to Follow-up|2
5489701|NCT01743027|18983386|P2|Overall Study|Lost to Follow-up|0
5489702|NCT01743027|18983387|P1|Overall Study|Lost to Follow-up|0
5489703|NCT01743027|18983384|P4|Overall Study|Adverse Event|0
5489704|NCT01743027|18983385|P3|Overall Study|Adverse Event|0
5489705|NCT01743027|18983386|P2|Overall Study|Adverse Event|0
5489706|NCT01743027|18983387|P1|Overall Study|Adverse Event|2
5489707|NCT01743001|18983427|P2|Overall Study|Death|0
5489708|NCT01743001|18983428|P1|Overall Study|Death|1
5489709|NCT01743001|18983427|P2|Overall Study|Pregnancy|0
5489710|NCT01743001|18983428|P1|Overall Study|Pregnancy|1
5489711|NCT01743001|18983427|P2|Overall Study|Physician Decision|0
5489712|NCT01743001|18983428|P1|Overall Study|Physician Decision|1
5489713|NCT01742897|18983471|P1|Overall Study|Other|1
5489714|NCT01742897|18983471|P1|Overall Study|Withdrawal by Subject|1
5489715|NCT01742897|18983471|P1|Overall Study|Adverse Event|3
5489716|NCT01742286|18983524|P7|Expansion Phase|Withdrawal by Subject|1
5489717|NCT01742286|18983525|P6|Expansion Phase|Withdrawal by Subject|0
5489718|NCT01742286|18983526|P5|Expansion Phase|Withdrawal by Subject|0
5489719|NCT01742286|18983527|P4|Expansion Phase|Withdrawal by Subject|0
5489720|NCT01742286|18983528|P3|Expansion Phase|Withdrawal by Subject|0
5489721|NCT01742286|18983529|P2|Expansion Phase|Withdrawal by Subject|0
5489722|NCT01742286|18983530|P1|Expansion Phase|Withdrawal by Subject|0
5489723|NCT01742286|18983524|P7|Expansion Phase|Disease progression|15
5489724|NCT01742286|18983525|P6|Expansion Phase|Disease progression|0
5489725|NCT01742286|18983526|P5|Expansion Phase|Disease progression|0
5489726|NCT01742286|18983527|P4|Expansion Phase|Disease progression|0
5489727|NCT01742286|18983528|P3|Expansion Phase|Disease progression|3
5489728|NCT01742286|18983529|P2|Expansion Phase|Disease progression|0
5489729|NCT01742286|18983530|P1|Expansion Phase|Disease progression|0
5489730|NCT01742286|18983524|P7|Expansion Phase|Adverse Event|6
5489731|NCT01742286|18983525|P6|Expansion Phase|Adverse Event|0
5489732|NCT01742286|18983526|P5|Expansion Phase|Adverse Event|0
5489733|NCT01742286|18983527|P4|Expansion Phase|Adverse Event|0
5489734|NCT01742286|18983528|P3|Expansion Phase|Adverse Event|0
5489735|NCT01742286|18983529|P2|Expansion Phase|Adverse Event|0
5489736|NCT01742286|18983530|P1|Expansion Phase|Adverse Event|0
5489737|NCT01742286|18983524|P7|Expansion Phase|Physician Decision|9
5489738|NCT01742286|18983525|P6|Expansion Phase|Physician Decision|0
5489739|NCT01742286|18983526|P5|Expansion Phase|Physician Decision|0
5489740|NCT01742286|18983527|P4|Expansion Phase|Physician Decision|0
5489741|NCT01742286|18983528|P3|Expansion Phase|Physician Decision|4
5489742|NCT01742286|18983529|P2|Expansion Phase|Physician Decision|0
5489743|NCT01742286|18983530|P1|Expansion Phase|Physician Decision|0
5489744|NCT01742286|18983524|P7|Expansion Phase|Administrative problems|5
5489745|NCT01742286|18983525|P6|Expansion Phase|Administrative problems|0
5489746|NCT01742286|18983526|P5|Expansion Phase|Administrative problems|0
5489747|NCT01742286|18983527|P4|Expansion Phase|Administrative problems|0
5489748|NCT01742286|18983528|P3|Expansion Phase|Administrative problems|0
5489749|NCT01742286|18983529|P2|Expansion Phase|Administrative problems|0
5489750|NCT01742286|18983530|P1|Expansion Phase|Administrative problems|0
5489751|NCT01742286|18983524|P7|Escalation Phase|Subject/guardian decision|0
5489752|NCT01742286|18983525|P6|Escalation Phase|Subject/guardian decision|0
5489753|NCT01742286|18983526|P5|Escalation Phase|Subject/guardian decision|0
5489754|NCT01742286|18983527|P4|Escalation Phase|Subject/guardian decision|0
5489755|NCT01742286|18983528|P3|Escalation Phase|Subject/guardian decision|0
5489756|NCT01742286|18983529|P2|Escalation Phase|Subject/guardian decision|0
5489757|NCT01742286|18983530|P1|Escalation Phase|Subject/guardian decision|1
5489758|NCT01742286|18983524|P7|Escalation Phase|Physician Decision|2
5489759|NCT01742286|18983525|P6|Escalation Phase|Physician Decision|0
5489760|NCT01742286|18983526|P5|Escalation Phase|Physician Decision|0
5489761|NCT01742286|18983527|P4|Escalation Phase|Physician Decision|1
5489762|NCT01742286|18983528|P3|Escalation Phase|Physician Decision|0
5489763|NCT01742286|18983529|P2|Escalation Phase|Physician Decision|3
5489764|NCT01742286|18983530|P1|Escalation Phase|Physician Decision|0
5489765|NCT01742286|18983524|P7|Escalation Phase|Death|0
5489766|NCT01742286|18983525|P6|Escalation Phase|Death|1
5489767|NCT01742286|18983526|P5|Escalation Phase|Death|0
5489768|NCT01742286|18983527|P4|Escalation Phase|Death|0
5489769|NCT01742286|18983528|P3|Escalation Phase|Death|0
5489770|NCT01742286|18983529|P2|Escalation Phase|Death|0
5489771|NCT01742286|18983530|P1|Escalation Phase|Death|0
5489772|NCT01742286|18983524|P7|Escalation Phase|Disease progression|2
5489773|NCT01742286|18983525|P6|Escalation Phase|Disease progression|3
5489774|NCT01742286|18983526|P5|Escalation Phase|Disease progression|4
5489775|NCT01742286|18983527|P4|Escalation Phase|Disease progression|1
5489776|NCT01742286|18983528|P3|Escalation Phase|Disease progression|4
5489777|NCT01742286|18983529|P2|Escalation Phase|Disease progression|7
5489778|NCT01742286|18983530|P1|Escalation Phase|Disease progression|3
5489779|NCT01742286|18983524|P7|Escalation Phase|Adverse Event|0
5489780|NCT01742286|18983525|P6|Escalation Phase|Adverse Event|1
5489781|NCT01742286|18983526|P5|Escalation Phase|Adverse Event|0
5489782|NCT01742286|18983527|P4|Escalation Phase|Adverse Event|0
5489783|NCT01742286|18983528|P3|Escalation Phase|Adverse Event|2
5489784|NCT01742286|18983529|P2|Escalation Phase|Adverse Event|1
5489785|NCT01742286|18983530|P1|Escalation Phase|Adverse Event|0
5489786|NCT01742286|18983524|P7|Escalation Phase|Administrative problems|2
5489787|NCT01742286|18983525|P6|Escalation Phase|Administrative problems|0
5489788|NCT01742286|18983526|P5|Escalation Phase|Administrative problems|0
5489789|NCT01742286|18983527|P4|Escalation Phase|Administrative problems|0
5489790|NCT01742286|18983528|P3|Escalation Phase|Administrative problems|0
5489791|NCT01742286|18983529|P2|Escalation Phase|Administrative problems|1
5489792|NCT01742286|18983530|P1|Escalation Phase|Administrative problems|1
5489793|NCT01742091|18983663|P6|Overall Study|Lost to Follow-up|1
5489794|NCT01742091|18983664|P5|Overall Study|Lost to Follow-up|0
5489795|NCT01742091|18983665|P4|Overall Study|Lost to Follow-up|0
5489796|NCT01742091|18983666|P3|Overall Study|Lost to Follow-up|0
5489797|NCT01742091|18983667|P2|Overall Study|Lost to Follow-up|0
5489798|NCT01742091|18983668|P1|Overall Study|Lost to Follow-up|0
5489799|NCT01742091|18983663|P6|Overall Study|Withdrawal by Subject|0
5489800|NCT01742091|18983664|P5|Overall Study|Withdrawal by Subject|0
5489801|NCT01742091|18983665|P4|Overall Study|Withdrawal by Subject|1
5489802|NCT01742091|18983666|P3|Overall Study|Withdrawal by Subject|0
5489803|NCT01742091|18983667|P2|Overall Study|Withdrawal by Subject|0
5489804|NCT01742091|18983668|P1|Overall Study|Withdrawal by Subject|0
5489805|NCT01742091|18983663|P6|Overall Study|Physician Decision|1
5489806|NCT01742091|18983664|P5|Overall Study|Physician Decision|0
5489807|NCT01742091|18983665|P4|Overall Study|Physician Decision|0
5489808|NCT01742091|18983666|P3|Overall Study|Physician Decision|0
5489809|NCT01742091|18983667|P2|Overall Study|Physician Decision|0
5489810|NCT01742091|18983668|P1|Overall Study|Physician Decision|0
5489811|NCT01742091|18983663|P6|Overall Study|Adverse Event|0
5489812|NCT01742091|18983664|P5|Overall Study|Adverse Event|1
5489813|NCT01742091|18983665|P4|Overall Study|Adverse Event|0
5489814|NCT01742091|18983666|P3|Overall Study|Adverse Event|0
5489815|NCT01742091|18983667|P2|Overall Study|Adverse Event|0
5489816|NCT01742091|18983668|P1|Overall Study|Adverse Event|0
5489817|NCT01742078|18983714|P9|Overall Study|Withdrawal by Subject|0
5489818|NCT01742078|18983715|P8|Overall Study|Withdrawal by Subject|0
5489819|NCT01742078|18983716|P7|Overall Study|Withdrawal by Subject|0
5489820|NCT01742078|18983717|P6|Overall Study|Withdrawal by Subject|0
5489821|NCT01742078|18983718|P5|Overall Study|Withdrawal by Subject|0
5489822|NCT01742078|18983719|P4|Overall Study|Withdrawal by Subject|1
5489823|NCT01742078|18983720|P3|Overall Study|Withdrawal by Subject|0
5489824|NCT01742078|18983721|P2|Overall Study|Withdrawal by Subject|0
5489825|NCT01742078|18983722|P1|Overall Study|Withdrawal by Subject|0
5489826|NCT01741792|18983791|P3|Overall Study|Death|12
5489827|NCT01741792|18983792|P2|Overall Study|Death|1
5489828|NCT01741792|18983793|P1|Overall Study|Death|6
5489829|NCT01741701|18983860|P2|Overall Study|Withdrawal by Subject|1
5489830|NCT01741701|18983861|P1|Overall Study|Withdrawal by Subject|0
5489831|NCT01741701|18983860|P2|Overall Study|Adverse Event|1
5489832|NCT01741701|18983861|P1|Overall Study|Adverse Event|5
5489833|NCT01741688|18983877|P1|Overall Study|Withdrawal by Subject|1
5489834|NCT01741688|18983877|P1|Overall Study|Lack of insurance coverage|2
5489835|NCT01741545|18983896|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
5489836|NCT01741545|18983897|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
5489837|NCT01741545|18983896|P2|Follow-up Period (24 Weeks)|Other than specified|1
5489838|NCT01741545|18983897|P1|Follow-up Period (24 Weeks)|Other than specified|0
5489839|NCT01741545|18983896|P2|Treatment Period|Adverse event, non-fatal|3
5489840|NCT01741545|18983897|P1|Treatment Period|Adverse event, non-fatal|1
5489841|NCT01741545|18983896|P2|Treatment Period|Lack of Efficacy|1
5489842|NCT01741545|18983897|P1|Treatment Period|Lack of Efficacy|0
5489843|NCT01741532|18983921|P2|Overall Study|Medical event|0
5489844|NCT01741532|18983922|P1|Overall Study|Medical event|1
5489845|NCT01741532|18983921|P2|Overall Study|Sponsor decision|0
5489846|NCT01741532|18983922|P1|Overall Study|Sponsor decision|1
5489847|NCT01741532|18983921|P2|Overall Study|Worsening of the disease|1
5489848|NCT01741532|18983922|P1|Overall Study|Worsening of the disease|3
5489849|NCT01741532|18983921|P2|Overall Study|Protocol Violation|1
5489850|NCT01741532|18983922|P1|Overall Study|Protocol Violation|0
5489851|NCT01741532|18983921|P2|Overall Study|Withdrawal by Subject|1
5489852|NCT01741532|18983922|P1|Overall Study|Withdrawal by Subject|1
5489853|NCT01741532|18983921|P2|Overall Study|Adverse Event|0
5489854|NCT01741532|18983922|P1|Overall Study|Adverse Event|4
5489855|NCT01741259|18984136|P2|Overall Study|Withdrawal by Subject|2
5489856|NCT01741259|18984137|P1|Overall Study|Withdrawal by Subject|0
5489857|NCT01741259|18984136|P2|Overall Study|Protocol Violation|4
5489858|NCT01741259|18984137|P1|Overall Study|Protocol Violation|6
5489859|NCT01741012|18984191|P1|Overall Study|Withdrawal by Subject|2
5489860|NCT01741012|18984191|P1|Overall Study|Lost to Follow-up|1
5489861|NCT01740791|18984215|P6|Overall Study|Adverse Event|1
5489862|NCT01740791|18984216|P5|Overall Study|Adverse Event|0
5489863|NCT01740791|18984217|P4|Overall Study|Adverse Event|0
5489864|NCT01740791|18984218|P3|Overall Study|Adverse Event|0
5489865|NCT01740791|18984219|P2|Overall Study|Adverse Event|0
5489866|NCT01740791|18984220|P1|Overall Study|Adverse Event|0
5489867|NCT01740791|18984215|P6|Overall Study|Investigator's discretion|1
5489868|NCT01740791|18984216|P5|Overall Study|Investigator's discretion|0
5489869|NCT01740791|18984217|P4|Overall Study|Investigator's discretion|0
5489870|NCT01740791|18984218|P3|Overall Study|Investigator's discretion|1
5489871|NCT01740791|18984219|P2|Overall Study|Investigator's discretion|0
5489872|NCT01740791|18984220|P1|Overall Study|Investigator's discretion|1
5489873|NCT01740791|18984215|P6|Overall Study|Withdrew Consent|3
5489874|NCT01740791|18984216|P5|Overall Study|Withdrew Consent|0
5489875|NCT01740791|18984217|P4|Overall Study|Withdrew Consent|2
5489876|NCT01740791|18984218|P3|Overall Study|Withdrew Consent|1
5489877|NCT01740791|18984219|P2|Overall Study|Withdrew Consent|0
5489878|NCT01740791|18984220|P1|Overall Study|Withdrew Consent|4
5489879|NCT01740791|18984215|P6|Overall Study|Lost to Follow-up|3
5489880|NCT01740791|18984216|P5|Overall Study|Lost to Follow-up|2
5489881|NCT01740791|18984217|P4|Overall Study|Lost to Follow-up|3
5489882|NCT01740791|18984218|P3|Overall Study|Lost to Follow-up|2
5489883|NCT01740791|18984219|P2|Overall Study|Lost to Follow-up|0
5489884|NCT01740791|18984220|P1|Overall Study|Lost to Follow-up|2
5489885|NCT01740791|18984215|P6|Overall Study|Randomized but never treated|3
5489886|NCT01740791|18984216|P5|Overall Study|Randomized but never treated|1
5489887|NCT01740791|18984217|P4|Overall Study|Randomized but never treated|2
5489888|NCT01740791|18984218|P3|Overall Study|Randomized but never treated|2
5489889|NCT01740791|18984219|P2|Overall Study|Randomized but never treated|3
5489890|NCT01740791|18984220|P1|Overall Study|Randomized but never treated|5
5489891|NCT01740440|18984403|P1|Overall Study|Lost to Follow-up|3
5489892|NCT01740427|18984411|P2|Overall Study|Study terminated by Sponsor|0
5489893|NCT01740427|18984412|P1|Overall Study|Study terminated by Sponsor|1
5489894|NCT01740427|18984411|P2|Overall Study|Lost to Follow-up|0
5489895|NCT01740427|18984412|P1|Overall Study|Lost to Follow-up|1
5489896|NCT01740427|18984411|P2|Overall Study|Protocol Violation|3
5489897|NCT01740427|18984412|P1|Overall Study|Protocol Violation|5
5489898|NCT01740427|18984411|P2|Overall Study|Death|2
5489899|NCT01740427|18984412|P1|Overall Study|Death|6
5489900|NCT01740427|18984411|P2|Overall Study|Unspecified reasons|4
5489901|NCT01740427|18984412|P1|Overall Study|Unspecified reasons|6
5489902|NCT01740427|18984411|P2|Overall Study|Subject refused continued treatment|9
5489903|NCT01740427|18984412|P1|Overall Study|Subject refused continued treatment|12
5489904|NCT01740427|18984411|P2|Overall Study|Global deterioration of health status|9
5489905|NCT01740427|18984412|P1|Overall Study|Global deterioration of health status|16
5489906|NCT01740427|18984411|P2|Overall Study|Adverse Event|9
5489907|NCT01740427|18984412|P1|Overall Study|Adverse Event|20
5489908|NCT01740427|18984411|P2|Overall Study|Objective progression or relapse|125
5489909|NCT01740427|18984412|P1|Overall Study|Objective progression or relapse|172
5489910|NCT01740427|18984411|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
5489911|NCT01740427|18984412|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
5489912|NCT01740401|18984464|P1|Overall Study|Did not reach primary endpoint|2
5489913|NCT01740401|18984464|P1|Overall Study|Adverse Event|2
5489914|NCT01740401|18984464|P1|Overall Study|Progression of disease|6
5489915|NCT01740388|18984473|P2|Overall Study|Subjects missing data, completed|36
5489916|NCT01740388|18984474|P1|Overall Study|Subjects missing data, completed|41
5489917|NCT01740388|18984473|P2|Overall Study|Physician Decision|6
5489918|NCT01740388|18984474|P1|Overall Study|Physician Decision|2
5489919|NCT01740388|18984473|P2|Overall Study|Lost to Follow-up|0
5489920|NCT01740388|18984474|P1|Overall Study|Lost to Follow-up|2
5489921|NCT01740388|18984473|P2|Overall Study|Withdrawal by Subject|2
5489922|NCT01740388|18984474|P1|Overall Study|Withdrawal by Subject|1
5489923|NCT01740323|18984525|P2|Overall Study|Randomized but did not take study drug|0
5489924|NCT01740323|18984526|P1|Overall Study|Randomized but did not take study drug|1
5489925|NCT01740323|18984525|P2|Overall Study|Adverse Event|0
5489926|NCT01740323|18984526|P1|Overall Study|Adverse Event|1
5489927|NCT01740297|18984547|P3|Overall Study|Sponsor Decision|0
5489928|NCT01740297|18984548|P2|Overall Study|Sponsor Decision|1
5489929|NCT01740297|18984549|P1|Overall Study|Sponsor Decision|0
5489930|NCT01740297|18984547|P3|Overall Study|Death|19
5489931|NCT01740297|18984548|P2|Overall Study|Death|23
5489932|NCT01740297|18984549|P1|Overall Study|Death|8
5489933|NCT01740297|18984547|P3|Overall Study|Withdrawal by Subject|11
5489934|NCT01740297|18984548|P2|Overall Study|Withdrawal by Subject|9
5489935|NCT01740297|18984549|P1|Overall Study|Withdrawal by Subject|1
5489936|NCT01740297|18984547|P3|Overall Study|Continuing Study|68
5489937|NCT01740297|18984548|P2|Overall Study|Continuing Study|67
5489938|NCT01740297|18984549|P1|Overall Study|Continuing Study|10
5489939|NCT01740154|18984604|P1|Overall Study|Adverse Event|1
5489940|NCT01740128|18984612|P2|Overall Study|Insufficient protocol compliance|2
5489941|NCT01740128|18984613|P1|Overall Study|Insufficient protocol compliance|2
5489942|NCT01740128|18984612|P2|Overall Study|Withdrawal by Subject|0
5489943|NCT01740128|18984613|P1|Overall Study|Withdrawal by Subject|1
5489944|NCT01740128|18984612|P2|Overall Study|Lost to Follow-up|2
5489945|NCT01740128|18984613|P1|Overall Study|Lost to Follow-up|2
5489946|NCT01740128|18984612|P2|Overall Study|Protocol Violation|2
5489947|NCT01740128|18984613|P1|Overall Study|Protocol Violation|1
5489948|NCT01740128|18984612|P2|Overall Study|Pregnancy|1
5489949|NCT01740128|18984613|P1|Overall Study|Pregnancy|0
5489950|NCT01740089|18984642|P3|After 12 Weeks|Withdrawal by Subject|1
5489951|NCT01740089|18984643|P2|After 12 Weeks|Withdrawal by Subject|1
5489952|NCT01740089|18984644|P1|After 12 Weeks|Withdrawal by Subject|1
5489953|NCT01740089|18984642|P3|After 12 Weeks|Protocol Violation|1
5489954|NCT01740089|18984643|P2|After 12 Weeks|Protocol Violation|1
5489955|NCT01740089|18984644|P1|After 12 Weeks|Protocol Violation|1
5489956|NCT01740089|18984642|P3|After 12 Weeks|Adverse Event|5
5489957|NCT01740089|18984643|P2|After 12 Weeks|Adverse Event|0
5489958|NCT01740089|18984644|P1|After 12 Weeks|Adverse Event|2
5489959|NCT01740089|18984642|P3|After 12 Weeks|Lack of Efficacy|4
5489960|NCT01740089|18984643|P2|After 12 Weeks|Lack of Efficacy|1
5489961|NCT01740089|18984644|P1|After 12 Weeks|Lack of Efficacy|3
5489962|NCT01740089|18984642|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
5489963|NCT01740089|18984643|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
5489964|NCT01740089|18984644|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
5489965|NCT01740089|18984642|P3|First 12 Weeks of Treatment|Adverse Event|2
5489966|NCT01740089|18984643|P2|First 12 Weeks of Treatment|Adverse Event|1
5489967|NCT01740089|18984644|P1|First 12 Weeks of Treatment|Adverse Event|0
5489968|NCT01739803|18984662|P2|Overall Study|Lost to Follow-up|6
5489969|NCT01739803|18984663|P1|Overall Study|Lost to Follow-up|9
5489970|NCT01739790|18984675|P2|Overall Study|Early Trial Termination|4
5489971|NCT01739790|18984676|P1|Overall Study|Early Trial Termination|2
5489972|NCT01739764|18984685|P3|Overall Study|Withdrawal by Subject|27
5489973|NCT01739764|18984686|P2|Overall Study|Withdrawal by Subject|5
5489974|NCT01739764|18984687|P1|Overall Study|Withdrawal by Subject|6
5489975|NCT01739764|18984685|P3|Overall Study|Study Terminated by Sponsor|26
5489976|NCT01739764|18984686|P2|Overall Study|Study Terminated by Sponsor|13
5489977|NCT01739764|18984687|P1|Overall Study|Study Terminated by Sponsor|8
5489978|NCT01739764|18984685|P3|Overall Study|Protocol Violation|2
5489979|NCT01739764|18984686|P2|Overall Study|Protocol Violation|0
5489980|NCT01739764|18984687|P1|Overall Study|Protocol Violation|0
5489981|NCT01739764|18984685|P3|Overall Study|Progressive Disease|16
5489982|NCT01739764|18984686|P2|Overall Study|Progressive Disease|5
5489983|NCT01739764|18984687|P1|Overall Study|Progressive Disease|3
5489984|NCT01739764|18984685|P3|Overall Study|Physician Decision|4
5489985|NCT01739764|18984686|P2|Overall Study|Physician Decision|2
5489986|NCT01739764|18984687|P1|Overall Study|Physician Decision|2
5489987|NCT01739764|18984685|P3|Overall Study|Multiple Reasons|3
5489988|NCT01739764|18984686|P2|Overall Study|Multiple Reasons|2
5489989|NCT01739764|18984687|P1|Overall Study|Multiple Reasons|3
5489990|NCT01739764|18984685|P3|Overall Study|Non-Compliance|1
5489991|NCT01739764|18984686|P2|Overall Study|Non-Compliance|0
5489992|NCT01739764|18984687|P1|Overall Study|Non-Compliance|0
5489993|NCT01739764|18984685|P3|Overall Study|Lost to Follow-up|5
5489994|NCT01739764|18984686|P2|Overall Study|Lost to Follow-up|0
5489995|NCT01739764|18984687|P1|Overall Study|Lost to Follow-up|0
5489996|NCT01739764|18984685|P3|Overall Study|Death|38
5489997|NCT01739764|18984686|P2|Overall Study|Death|6
5489998|NCT01739764|18984687|P1|Overall Study|Death|4
5489999|NCT01739764|18984685|P3|Overall Study|Adverse Event|4
5490000|NCT01739764|18984686|P2|Overall Study|Adverse Event|3
5490001|NCT01739764|18984687|P1|Overall Study|Adverse Event|0
5490002|NCT01739595|18984701|P3|Overall Study|Drug discrepancy|0
5490003|NCT01739595|18984702|P2|Overall Study|Drug discrepancy|0
5490004|NCT01739595|18984703|P1|Overall Study|Drug discrepancy|1
5490005|NCT01739595|18984701|P3|Overall Study|Lab assessment|0
5490006|NCT01739595|18984702|P2|Overall Study|Lab assessment|0
5490007|NCT01739595|18984703|P1|Overall Study|Lab assessment|1
5490008|NCT01739595|18984701|P3|Overall Study|Protocol Violation|0
5490009|NCT01739595|18984702|P2|Overall Study|Protocol Violation|0
5490010|NCT01739595|18984703|P1|Overall Study|Protocol Violation|1
5490011|NCT01739595|18984701|P3|Overall Study|Eligibility issue|0
5490012|NCT01739595|18984702|P2|Overall Study|Eligibility issue|0
5490013|NCT01739595|18984703|P1|Overall Study|Eligibility issue|3
5490014|NCT01739595|18984701|P3|Overall Study|Withdrawal by Subject|2
5490015|NCT01739595|18984702|P2|Overall Study|Withdrawal by Subject|1
5490016|NCT01739595|18984703|P1|Overall Study|Withdrawal by Subject|2
5490017|NCT01739595|18984701|P3|Overall Study|Lost to Follow-up|0
5490018|NCT01739595|18984702|P2|Overall Study|Lost to Follow-up|0
5490019|NCT01739595|18984703|P1|Overall Study|Lost to Follow-up|2
5490020|NCT01739595|18984701|P3|Overall Study|Adverse Event|0
5490021|NCT01739595|18984702|P2|Overall Study|Adverse Event|0
5490022|NCT01739595|18984703|P1|Overall Study|Adverse Event|3
5490023|NCT01739400|18984713|P2|Overall Study|Withdrawal by Subject|7
5490024|NCT01739400|18984714|P1|Overall Study|Withdrawal by Subject|7
5490025|NCT01739400|18984713|P2|Overall Study|Death|2
5490026|NCT01739400|18984714|P1|Overall Study|Death|5
5490027|NCT01739400|18984713|P2|Overall Study|Lost to Follow-up|0
5490028|NCT01739400|18984714|P1|Overall Study|Lost to Follow-up|2
5490029|NCT01739400|18984713|P2|Overall Study|Physician Decision|0
5490030|NCT01739400|18984714|P1|Overall Study|Physician Decision|3
5490031|NCT01739348|18984742|P4|Part II (Extension Study)|Withdrawal by Subject|7
5490032|NCT01739348|18984743|P3|Part II (Extension Study)|Withdrawal by Subject|4
5490033|NCT01739348|18984744|P2|Part II (Extension Study)|Withdrawal by Subject|2
5490034|NCT01739348|18984745|P1|Part II (Extension Study)|Withdrawal by Subject|5
5490035|NCT01739348|18984742|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
5490036|NCT01739348|18984743|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
5490037|NCT01739348|18984744|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
5490038|NCT01739348|18984745|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
5490039|NCT01739348|18984742|P4|Part II (Extension Study)|Participant Moved|3
5490040|NCT01739348|18984743|P3|Part II (Extension Study)|Participant Moved|0
5490041|NCT01739348|18984744|P2|Part II (Extension Study)|Participant Moved|3
5490042|NCT01739348|18984745|P1|Part II (Extension Study)|Participant Moved|3
5490043|NCT01739348|18984742|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
5490044|NCT01739348|18984743|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
5490045|NCT01739348|18984744|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
5490046|NCT01739348|18984745|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
5490047|NCT01739348|18984742|P4|Part II (Extension Study)|Physician Decision|12
5490048|NCT01739348|18984743|P3|Part II (Extension Study)|Physician Decision|6
5490049|NCT01739348|18984744|P2|Part II (Extension Study)|Physician Decision|11
5490050|NCT01739348|18984745|P1|Part II (Extension Study)|Physician Decision|7
5490051|NCT01739348|18984742|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
5490052|NCT01739348|18984743|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
5490053|NCT01739348|18984744|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
5490054|NCT01739348|18984745|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
5490055|NCT01739348|18984742|P4|Part II (Extension Study)|Lost to Follow-up|1
5490056|NCT01739348|18984743|P3|Part II (Extension Study)|Lost to Follow-up|0
5490057|NCT01739348|18984744|P2|Part II (Extension Study)|Lost to Follow-up|4
5490058|NCT01739348|18984745|P1|Part II (Extension Study)|Lost to Follow-up|3
5490059|NCT01739348|18984742|P4|Part II (Extension Study)|Lack of Efficacy|1
5490060|NCT01739348|18984743|P3|Part II (Extension Study)|Lack of Efficacy|0
5490061|NCT01739348|18984744|P2|Part II (Extension Study)|Lack of Efficacy|5
5490062|NCT01739348|18984745|P1|Part II (Extension Study)|Lack of Efficacy|1
5490063|NCT01739348|18984742|P4|Part II (Extension Study)|Death|6
5490064|NCT01739348|18984743|P3|Part II (Extension Study)|Death|2
5490065|NCT01739348|18984744|P2|Part II (Extension Study)|Death|3
5490066|NCT01739348|18984745|P1|Part II (Extension Study)|Death|3
5490067|NCT01739348|18984742|P4|Part II (Extension Study)|Adverse Event|26
5490068|NCT01739348|18984743|P3|Part II (Extension Study)|Adverse Event|7
5490069|NCT01739348|18984744|P2|Part II (Extension Study)|Adverse Event|11
5490070|NCT01739348|18984745|P1|Part II (Extension Study)|Adverse Event|10
5490071|NCT01739348|18984742|P4|Part I (Base Study)|Withdrawal by Subject|20
5490072|NCT01739348|18984743|P3|Part I (Base Study)|Withdrawal by Subject|7
5490073|NCT01739348|18984744|P2|Part I (Base Study)|Withdrawal by Subject|21
5490074|NCT01739348|18984745|P1|Part I (Base Study)|Withdrawal by Subject|23
5490075|NCT01739348|18984742|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
5490076|NCT01739348|18984743|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
5490077|NCT01739348|18984744|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
5490078|NCT01739348|18984745|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
5490079|NCT01739348|18984742|P4|Part I (Base Study)|Participant Moved|7
5490080|NCT01739348|18984743|P3|Part I (Base Study)|Participant Moved|1
5490081|NCT01739348|18984744|P2|Part I (Base Study)|Participant Moved|3
5490082|NCT01739348|18984745|P1|Part I (Base Study)|Participant Moved|4
5490083|NCT01739348|18984742|P4|Part I (Base Study)|Study Terminated by Sponsor|86
5490084|NCT01739348|18984743|P3|Part I (Base Study)|Study Terminated by Sponsor|0
5490085|NCT01739348|18984744|P2|Part I (Base Study)|Study Terminated by Sponsor|73
5490086|NCT01739348|18984745|P1|Part I (Base Study)|Study Terminated by Sponsor|72
5490087|NCT01739348|18984742|P4|Part I (Base Study)|Site Discontinued Study Participation|0
5490088|NCT01739348|18984743|P3|Part I (Base Study)|Site Discontinued Study Participation|0
5490089|NCT01739348|18984744|P2|Part I (Base Study)|Site Discontinued Study Participation|3
5490090|NCT01739348|18984745|P1|Part I (Base Study)|Site Discontinued Study Participation|1
5490091|NCT01739348|18984742|P4|Part I (Base Study)|Screen Failure|0
5490092|NCT01739348|18984743|P3|Part I (Base Study)|Screen Failure|0
5490093|NCT01739348|18984744|P2|Part I (Base Study)|Screen Failure|0
5490094|NCT01739348|18984745|P1|Part I (Base Study)|Screen Failure|2
5490095|NCT01739348|18984742|P4|Part I (Base Study)|Protocol Violation|2
5490096|NCT01739348|18984743|P3|Part I (Base Study)|Protocol Violation|1
5490097|NCT01739348|18984744|P2|Part I (Base Study)|Protocol Violation|0
5490098|NCT01739348|18984745|P1|Part I (Base Study)|Protocol Violation|2
5490099|NCT01739348|18984742|P4|Part I (Base Study)|Physician Decision|4
5490100|NCT01739348|18984743|P3|Part I (Base Study)|Physician Decision|1
5490101|NCT01739348|18984744|P2|Part I (Base Study)|Physician Decision|7
5490102|NCT01739348|18984745|P1|Part I (Base Study)|Physician Decision|10
5490103|NCT01739348|18984742|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
5490104|NCT01739348|18984743|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
5490105|NCT01739348|18984744|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
5490106|NCT01739348|18984745|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
5490107|NCT01739348|18984742|P4|Part I (Base Study)|Lost to Follow-up|4
5490108|NCT01739348|18984743|P3|Part I (Base Study)|Lost to Follow-up|4
5490109|NCT01739348|18984744|P2|Part I (Base Study)|Lost to Follow-up|2
5490110|NCT01739348|18984745|P1|Part I (Base Study)|Lost to Follow-up|4
5490111|NCT01739348|18984742|P4|Part I (Base Study)|Lack of Efficacy|7
5490112|NCT01739348|18984743|P3|Part I (Base Study)|Lack of Efficacy|0
5490113|NCT01739348|18984744|P2|Part I (Base Study)|Lack of Efficacy|8
5490114|NCT01739348|18984745|P1|Part I (Base Study)|Lack of Efficacy|3
5490115|NCT01739348|18984742|P4|Part I (Base Study)|Death|8
5490116|NCT01739348|18984743|P3|Part I (Base Study)|Death|2
5490117|NCT01739348|18984744|P2|Part I (Base Study)|Death|7
5490118|NCT01739348|18984745|P1|Part I (Base Study)|Death|10
5490119|NCT01739348|18984742|P4|Part I (Base Study)|Adverse Event|33
5490120|NCT01739348|18984743|P3|Part I (Base Study)|Adverse Event|8
5490121|NCT01739348|18984744|P2|Part I (Base Study)|Adverse Event|52
5490122|NCT01739348|18984745|P1|Part I (Base Study)|Adverse Event|41
5490123|NCT01739335|18984817|P2|Overall Study|Ineligible patient randomized|1
5490124|NCT01739335|18984818|P1|Overall Study|Ineligible patient randomized|0
5490125|NCT01739335|18984817|P2|Overall Study|Lost to Follow-up|4
5490126|NCT01739335|18984818|P1|Overall Study|Lost to Follow-up|7
5490127|NCT01739309|18984850|P1|Overall Study|On study treatment|3
5490128|NCT01738984|18985045|P2|Overall Study|Lost to Follow-up|39
5490129|NCT01738984|18985046|P1|Overall Study|Lost to Follow-up|59
5490130|NCT01738984|18985045|P2|Overall Study|Withdrawal by Subject|0
5490131|NCT01738984|18985046|P1|Overall Study|Withdrawal by Subject|1
5490132|NCT01738984|18985045|P2|Overall Study|Pregnancy|0
5490133|NCT01738984|18985046|P1|Overall Study|Pregnancy|4
5490134|NCT01738971|18985059|P3|Overall Study|Lost to Follow-up|17
5490135|NCT01738971|18985060|P2|Overall Study|Lost to Follow-up|30
5490136|NCT01738971|18985061|P1|Overall Study|Lost to Follow-up|19
5490137|NCT01738919|18985077|P2|Overall Study|Not treated in accordance to guidelines|1
5490138|NCT01738919|18985078|P1|Overall Study|Not treated in accordance to guidelines|0
5490139|NCT01738919|18985077|P2|Overall Study|Withdrawal by Subject|1
5490140|NCT01738919|18985078|P1|Overall Study|Withdrawal by Subject|0
5490141|NCT01738919|18985077|P2|Overall Study|Immigrated|1
5490142|NCT01738919|18985078|P1|Overall Study|Immigrated|0
5490143|NCT01738919|18985077|P2|Overall Study|Lost to Follow-up|0
5490144|NCT01738919|18985078|P1|Overall Study|Lost to Follow-up|1
5490145|NCT01738646|18985228|P1|Overall Study|Still Receiving Treatment|2
5490146|NCT01738594|18985239|P8|Follow up for 1 Year|Other|0
5490147|NCT01738594|18985240|P7|Follow up for 1 Year|Other|0
5490148|NCT01738594|18985241|P6|Follow up for 1 Year|Other|2
5490149|NCT01738594|18985242|P5|Follow up for 1 Year|Other|0
5490150|NCT01738594|18985243|P4|Follow up for 1 Year|Other|0
5490151|NCT01738594|18985244|P3|Follow up for 1 Year|Other|0
5490152|NCT01738594|18985245|P2|Follow up for 1 Year|Other|0
5490153|NCT01738594|18985246|P1|Follow up for 1 Year|Other|0
5490154|NCT01738594|18985239|P8|Follow up for 1 Year|Death|0
5490155|NCT01738594|18985240|P7|Follow up for 1 Year|Death|0
5490156|NCT01738594|18985241|P6|Follow up for 1 Year|Death|1
5490157|NCT01738594|18985242|P5|Follow up for 1 Year|Death|0
5490158|NCT01738594|18985243|P4|Follow up for 1 Year|Death|0
5490159|NCT01738594|18985244|P3|Follow up for 1 Year|Death|0
5490160|NCT01738594|18985245|P2|Follow up for 1 Year|Death|0
5490161|NCT01738594|18985246|P1|Follow up for 1 Year|Death|0
5490162|NCT01738594|18985239|P8|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5490163|NCT01738594|18985240|P7|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5490164|NCT01738594|18985241|P6|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5490165|NCT01738594|18985242|P5|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
5490166|NCT01738594|18985243|P4|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5490167|NCT01738594|18985244|P3|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5490168|NCT01738594|18985245|P2|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5490169|NCT01738594|18985246|P1|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
5490170|NCT01738594|18985239|P8|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5490171|NCT01738594|18985240|P7|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5490172|NCT01738594|18985241|P6|Went on to Continue Treatment Cycle 5|Progressive Disease|1
5490173|NCT01738594|18985242|P5|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5490174|NCT01738594|18985243|P4|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5490175|NCT01738594|18985244|P3|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5490176|NCT01738594|18985245|P2|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5490177|NCT01738594|18985246|P1|Went on to Continue Treatment Cycle 5|Progressive Disease|0
5490178|NCT01738594|18985239|P8|Completed 4 Cycles of Treatment|No response/patient benefit|0
5490179|NCT01738594|18985240|P7|Completed 4 Cycles of Treatment|No response/patient benefit|0
5490180|NCT01738594|18985241|P6|Completed 4 Cycles of Treatment|No response/patient benefit|1
5490181|NCT01738594|18985242|P5|Completed 4 Cycles of Treatment|No response/patient benefit|0
5490182|NCT01738594|18985243|P4|Completed 4 Cycles of Treatment|No response/patient benefit|0
5490183|NCT01738594|18985244|P3|Completed 4 Cycles of Treatment|No response/patient benefit|0
5490184|NCT01738594|18985245|P2|Completed 4 Cycles of Treatment|No response/patient benefit|0
5490185|NCT01738594|18985246|P1|Completed 4 Cycles of Treatment|No response/patient benefit|0
5490186|NCT01738594|18985239|P8|Completed 4 Cycles of Treatment|Progressive disease|0
5490187|NCT01738594|18985240|P7|Completed 4 Cycles of Treatment|Progressive disease|0
5490188|NCT01738594|18985241|P6|Completed 4 Cycles of Treatment|Progressive disease|0
5490189|NCT01738594|18985242|P5|Completed 4 Cycles of Treatment|Progressive disease|0
5490190|NCT01738594|18985243|P4|Completed 4 Cycles of Treatment|Progressive disease|0
5490191|NCT01738594|18985244|P3|Completed 4 Cycles of Treatment|Progressive disease|0
5490192|NCT01738594|18985245|P2|Completed 4 Cycles of Treatment|Progressive disease|2
5490193|NCT01738594|18985246|P1|Completed 4 Cycles of Treatment|Progressive disease|0
5490194|NCT01738594|18985239|P8|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5490195|NCT01738594|18985240|P7|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5490196|NCT01738594|18985241|P6|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
5490197|NCT01738594|18985242|P5|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5490198|NCT01738594|18985243|P4|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5490199|NCT01738594|18985244|P3|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5490200|NCT01738594|18985245|P2|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5490201|NCT01738594|18985246|P1|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
5490202|NCT01738594|18985239|P8|Registration and Treatment Start|Adverse Event|0
5490203|NCT01738594|18985240|P7|Registration and Treatment Start|Adverse Event|0
5490204|NCT01738594|18985241|P6|Registration and Treatment Start|Adverse Event|0
5490205|NCT01738594|18985242|P5|Registration and Treatment Start|Adverse Event|0
5490206|NCT01738594|18985243|P4|Registration and Treatment Start|Adverse Event|0
5490207|NCT01738594|18985244|P3|Registration and Treatment Start|Adverse Event|0
5490208|NCT01738594|18985245|P2|Registration and Treatment Start|Adverse Event|1
5490209|NCT01738594|18985246|P1|Registration and Treatment Start|Adverse Event|0
5490210|NCT01738581|18985264|P2|Overall Study|Lost to Follow-up|0
5490211|NCT01738581|18985265|P1|Overall Study|Lost to Follow-up|1
5490212|NCT01738503|18985289|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
5490213|NCT01738503|18985290|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
5490214|NCT01738503|18985291|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5490215|NCT01738503|18985292|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5490216|NCT01738503|18985293|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5490217|NCT01738503|18985294|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5490218|NCT01738503|18985295|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
5490219|NCT01738503|18985289|P7|PET Imaging Sub-study|Adverse Event|0
5490220|NCT01738503|18985290|P6|PET Imaging Sub-study|Adverse Event|1
5490221|NCT01738503|18985291|P5|PET Imaging Sub-study|Adverse Event|0
5490222|NCT01738503|18985292|P4|PET Imaging Sub-study|Adverse Event|0
5490223|NCT01738503|18985293|P3|PET Imaging Sub-study|Adverse Event|0
5490224|NCT01738503|18985294|P2|PET Imaging Sub-study|Adverse Event|0
5490225|NCT01738503|18985295|P1|PET Imaging Sub-study|Adverse Event|0
5490226|NCT01738503|18985289|P7|Treatment Period|Other|0
5490227|NCT01738503|18985290|P6|Treatment Period|Other|0
5490228|NCT01738503|18985291|P5|Treatment Period|Other|0
5490229|NCT01738503|18985292|P4|Treatment Period|Other|0
5490230|NCT01738503|18985293|P3|Treatment Period|Other|1
5490231|NCT01738503|18985294|P2|Treatment Period|Other|0
5490232|NCT01738503|18985295|P1|Treatment Period|Other|0
5490233|NCT01738503|18985289|P7|Treatment Period|Protocol Violation|0
5490234|NCT01738503|18985290|P6|Treatment Period|Protocol Violation|2
5490235|NCT01738503|18985291|P5|Treatment Period|Protocol Violation|4
5490236|NCT01738503|18985292|P4|Treatment Period|Protocol Violation|0
5490237|NCT01738503|18985293|P3|Treatment Period|Protocol Violation|1
5490238|NCT01738503|18985294|P2|Treatment Period|Protocol Violation|3
5490239|NCT01738503|18985295|P1|Treatment Period|Protocol Violation|0
5490240|NCT01738503|18985289|P7|Treatment Period|Withdrawal by Subject|1
5490241|NCT01738503|18985290|P6|Treatment Period|Withdrawal by Subject|1
5490242|NCT01738503|18985291|P5|Treatment Period|Withdrawal by Subject|1
5490243|NCT01738503|18985292|P4|Treatment Period|Withdrawal by Subject|1
5490244|NCT01738503|18985293|P3|Treatment Period|Withdrawal by Subject|0
5490245|NCT01738503|18985294|P2|Treatment Period|Withdrawal by Subject|1
5490246|NCT01738503|18985295|P1|Treatment Period|Withdrawal by Subject|0
5490247|NCT01738503|18985289|P7|Treatment Period|Lost to Follow-up|5
5490248|NCT01738503|18985290|P6|Treatment Period|Lost to Follow-up|1
5490249|NCT01738503|18985291|P5|Treatment Period|Lost to Follow-up|1
5490250|NCT01738503|18985292|P4|Treatment Period|Lost to Follow-up|4
5490251|NCT01738503|18985293|P3|Treatment Period|Lost to Follow-up|3
5490252|NCT01738503|18985294|P2|Treatment Period|Lost to Follow-up|0
5490253|NCT01738503|18985295|P1|Treatment Period|Lost to Follow-up|0
5490254|NCT01738503|18985289|P7|Treatment Period|Adverse Event|2
5490255|NCT01738503|18985290|P6|Treatment Period|Adverse Event|2
5490256|NCT01738503|18985291|P5|Treatment Period|Adverse Event|2
5490257|NCT01738503|18985292|P4|Treatment Period|Adverse Event|1
5490258|NCT01738503|18985293|P3|Treatment Period|Adverse Event|0
5490259|NCT01738503|18985294|P2|Treatment Period|Adverse Event|1
5490260|NCT01738503|18985295|P1|Treatment Period|Adverse Event|0
5490261|NCT01738503|18985289|P7|Induction/Stabilization (Days -14 to -1)|Other|0
5490262|NCT01738503|18985290|P6|Induction/Stabilization (Days -14 to -1)|Other|0
5490263|NCT01738503|18985291|P5|Induction/Stabilization (Days -14 to -1)|Other|0
5490264|NCT01738503|18985292|P4|Induction/Stabilization (Days -14 to -1)|Other|0
5490265|NCT01738503|18985293|P3|Induction/Stabilization (Days -14 to -1)|Other|0
5490266|NCT01738503|18985294|P2|Induction/Stabilization (Days -14 to -1)|Other|0
5490267|NCT01738503|18985295|P1|Induction/Stabilization (Days -14 to -1)|Other|35
5490268|NCT01738477|18985493|P2|Overall Study|Lost to Follow-up|4
5490269|NCT01738477|18985494|P1|Overall Study|Lost to Follow-up|1
5490270|NCT01738438|18985522|P1|Overall Study|Adverse Event|3
5490271|NCT01738438|18985522|P1|Overall Study|Disease Progression|32
5490272|NCT01738191|18985539|P2|Overall Study|Withdrawal by Subject|1
5490273|NCT01738191|18985540|P1|Overall Study|Withdrawal by Subject|4
5490274|NCT01737996|18985563|P3|Overall Study|Withdrawal by Subject|1
5490275|NCT01737996|18985564|P2|Overall Study|Withdrawal by Subject|0
5490276|NCT01737996|18985565|P1|Overall Study|Withdrawal by Subject|0
5490277|NCT01737996|18985563|P3|Overall Study|Adverse Event|1
5490278|NCT01737996|18985564|P2|Overall Study|Adverse Event|1
5490279|NCT01737996|18985565|P1|Overall Study|Adverse Event|0
5490280|NCT01737931|18985627|P3|Overall Study|Physician Decision|0
5490281|NCT01737931|18985628|P2|Overall Study|Physician Decision|1
5490282|NCT01737931|18985629|P1|Overall Study|Physician Decision|0
5490283|NCT01737931|18985627|P3|Overall Study|Withdrawal by Subject|1
5490284|NCT01737931|18985628|P2|Overall Study|Withdrawal by Subject|1
5490285|NCT01737931|18985629|P1|Overall Study|Withdrawal by Subject|0
5490286|NCT01737879|18985644|P1|Overall Study|Sponsor decision|40
5490287|NCT01737879|18985644|P1|Overall Study|Death|1
5490288|NCT01737840|18985653|P2|Overall Study|Diagnosed with an other pathology|2
5490289|NCT01737840|18985654|P1|Overall Study|Diagnosed with an other pathology|2
5490290|NCT01737762|18985664|P2|Overall Study|Trial termination|9
5490291|NCT01737762|18985665|P1|Overall Study|Trial termination|11
5490292|NCT01737762|18985664|P2|Overall Study|Moved from area|1
5490293|NCT01737762|18985665|P1|Overall Study|Moved from area|2
5490294|NCT01737762|18985664|P2|Overall Study|Physician Decision|1
5490295|NCT01737762|18985665|P1|Overall Study|Physician Decision|1
5490296|NCT01737762|18985664|P2|Overall Study|Progressive disease|2
5490297|NCT01737762|18985665|P1|Overall Study|Progressive disease|1
5490298|NCT01737762|18985664|P2|Overall Study|Withdrawal by Subject|2
5490299|NCT01737762|18985665|P1|Overall Study|Withdrawal by Subject|2
5490300|NCT01737762|18985664|P2|Overall Study|Lost to Follow-up|0
5490301|NCT01737762|18985665|P1|Overall Study|Lost to Follow-up|1
5490302|NCT01737762|18985664|P2|Overall Study|Adverse Event|2
5490303|NCT01737762|18985665|P1|Overall Study|Adverse Event|2
5490304|NCT01737710|18985678|P5|Overall Study|Vaccinated in Error/Ineligible|0
5490305|NCT01737710|18985679|P4|Overall Study|Vaccinated in Error/Ineligible|0
5490306|NCT01737710|18985680|P3|Overall Study|Vaccinated in Error/Ineligible|0
5490307|NCT01737710|18985681|P2|Overall Study|Vaccinated in Error/Ineligible|1
5490308|NCT01737710|18985682|P1|Overall Study|Vaccinated in Error/Ineligible|1
5490309|NCT01737710|18985678|P5|Overall Study|Withdrawal by Subject|0
5490310|NCT01737710|18985679|P4|Overall Study|Withdrawal by Subject|0
5490311|NCT01737710|18985680|P3|Overall Study|Withdrawal by Subject|1
5490312|NCT01737710|18985681|P2|Overall Study|Withdrawal by Subject|1
5490313|NCT01737710|18985682|P1|Overall Study|Withdrawal by Subject|1
5490314|NCT01737710|18985678|P5|Overall Study|Lost to Follow-up|0
5490315|NCT01737710|18985679|P4|Overall Study|Lost to Follow-up|0
5490316|NCT01737710|18985680|P3|Overall Study|Lost to Follow-up|2
5490317|NCT01737710|18985681|P2|Overall Study|Lost to Follow-up|2
5490318|NCT01737710|18985682|P1|Overall Study|Lost to Follow-up|0
5490319|NCT01737697|18985724|P15|Subacute Phase|Death|0
5490320|NCT01737697|18985725|P14|Subacute Phase|Death|0
5490321|NCT01737697|18985726|P13|Subacute Phase|Death|0
5490322|NCT01737697|18985727|P12|Subacute Phase|Death|0
5490323|NCT01737697|18985728|P11|Subacute Phase|Death|1
5490324|NCT01737697|18985729|P10|Subacute Phase|Death|0
5490325|NCT01737697|18985730|P9|Subacute Phase|Death|0
5490326|NCT01737697|18985731|P8|Subacute Phase|Death|0
5490327|NCT01737697|18985732|P7|Subacute Phase|Death|0
5490328|NCT01737697|18985733|P6|Subacute Phase|Death|0
5490329|NCT01737697|18985734|P5|Subacute Phase|Death|0
5490330|NCT01737697|18985735|P4|Subacute Phase|Death|0
5490331|NCT01737697|18985736|P3|Subacute Phase|Death|0
5490332|NCT01737697|18985737|P2|Subacute Phase|Death|0
5490333|NCT01737697|18985738|P1|Subacute Phase|Death|0
5490334|NCT01737697|18985724|P15|Subacute Phase|Physician Decision|0
5490335|NCT01737697|18985725|P14|Subacute Phase|Physician Decision|0
5490336|NCT01737697|18985726|P13|Subacute Phase|Physician Decision|0
5490337|NCT01737697|18985727|P12|Subacute Phase|Physician Decision|0
5490338|NCT01737697|18985728|P11|Subacute Phase|Physician Decision|0
5490339|NCT01737697|18985729|P10|Subacute Phase|Physician Decision|0
5490340|NCT01737697|18985730|P9|Subacute Phase|Physician Decision|1
5490341|NCT01737697|18985731|P8|Subacute Phase|Physician Decision|0
5490342|NCT01737697|18985732|P7|Subacute Phase|Physician Decision|0
5490343|NCT01737697|18985733|P6|Subacute Phase|Physician Decision|0
5490344|NCT01737697|18985734|P5|Subacute Phase|Physician Decision|0
5490345|NCT01737697|18985735|P4|Subacute Phase|Physician Decision|0
5490346|NCT01737697|18985736|P3|Subacute Phase|Physician Decision|0
5490347|NCT01737697|18985737|P2|Subacute Phase|Physician Decision|0
5490348|NCT01737697|18985738|P1|Subacute Phase|Physician Decision|0
5490349|NCT01737697|18985724|P15|Subacute Phase|Protocol Violation|0
5490350|NCT01737697|18985725|P14|Subacute Phase|Protocol Violation|0
5490351|NCT01737697|18985726|P13|Subacute Phase|Protocol Violation|0
5490352|NCT01737697|18985727|P12|Subacute Phase|Protocol Violation|0
5490353|NCT01737697|18985728|P11|Subacute Phase|Protocol Violation|1
5490354|NCT01737697|18985729|P10|Subacute Phase|Protocol Violation|0
5490355|NCT01737697|18985730|P9|Subacute Phase|Protocol Violation|0
5490356|NCT01737697|18985731|P8|Subacute Phase|Protocol Violation|0
5490357|NCT01737697|18985732|P7|Subacute Phase|Protocol Violation|0
5490358|NCT01737697|18985733|P6|Subacute Phase|Protocol Violation|1
5490359|NCT01737697|18985734|P5|Subacute Phase|Protocol Violation|0
5490360|NCT01737697|18985735|P4|Subacute Phase|Protocol Violation|0
5490361|NCT01737697|18985736|P3|Subacute Phase|Protocol Violation|0
5490362|NCT01737697|18985737|P2|Subacute Phase|Protocol Violation|0
5490363|NCT01737697|18985738|P1|Subacute Phase|Protocol Violation|0
5490364|NCT01737697|18985724|P15|Subacute Phase|Hypo-or hyperkalemia|0
5490365|NCT01737697|18985725|P14|Subacute Phase|Hypo-or hyperkalemia|1
5490366|NCT01737697|18985726|P13|Subacute Phase|Hypo-or hyperkalemia|0
5490367|NCT01737697|18985727|P12|Subacute Phase|Hypo-or hyperkalemia|1
5490368|NCT01737697|18985728|P11|Subacute Phase|Hypo-or hyperkalemia|0
5490369|NCT01737697|18985729|P10|Subacute Phase|Hypo-or hyperkalemia|0
5490370|NCT01737697|18985730|P9|Subacute Phase|Hypo-or hyperkalemia|0
5490371|NCT01737697|18985731|P8|Subacute Phase|Hypo-or hyperkalemia|0
5490372|NCT01737697|18985732|P7|Subacute Phase|Hypo-or hyperkalemia|0
5490373|NCT01737697|18985733|P6|Subacute Phase|Hypo-or hyperkalemia|0
5490374|NCT01737697|18985734|P5|Subacute Phase|Hypo-or hyperkalemia|0
5490375|NCT01737697|18985735|P4|Subacute Phase|Hypo-or hyperkalemia|0
5490376|NCT01737697|18985736|P3|Subacute Phase|Hypo-or hyperkalemia|0
5490377|NCT01737697|18985737|P2|Subacute Phase|Hypo-or hyperkalemia|0
5490378|NCT01737697|18985738|P1|Subacute Phase|Hypo-or hyperkalemia|0
5490379|NCT01737697|18985724|P15|Subacute Phase|Lost to Follow-up|1
5490380|NCT01737697|18985725|P14|Subacute Phase|Lost to Follow-up|0
5490381|NCT01737697|18985726|P13|Subacute Phase|Lost to Follow-up|0
5490382|NCT01737697|18985727|P12|Subacute Phase|Lost to Follow-up|0
5490383|NCT01737697|18985728|P11|Subacute Phase|Lost to Follow-up|0
5490384|NCT01737697|18985729|P10|Subacute Phase|Lost to Follow-up|0
5490385|NCT01737697|18985730|P9|Subacute Phase|Lost to Follow-up|0
5490386|NCT01737697|18985731|P8|Subacute Phase|Lost to Follow-up|0
5490387|NCT01737697|18985732|P7|Subacute Phase|Lost to Follow-up|0
5490388|NCT01737697|18985733|P6|Subacute Phase|Lost to Follow-up|0
5490389|NCT01737697|18985734|P5|Subacute Phase|Lost to Follow-up|0
5490390|NCT01737697|18985735|P4|Subacute Phase|Lost to Follow-up|0
5490391|NCT01737697|18985736|P3|Subacute Phase|Lost to Follow-up|0
5490392|NCT01737697|18985737|P2|Subacute Phase|Lost to Follow-up|0
5490393|NCT01737697|18985738|P1|Subacute Phase|Lost to Follow-up|0
5490394|NCT01737697|18985724|P15|Subacute Phase|Withdrawal by Subject|0
5490395|NCT01737697|18985725|P14|Subacute Phase|Withdrawal by Subject|1
5490396|NCT01737697|18985726|P13|Subacute Phase|Withdrawal by Subject|1
5490397|NCT01737697|18985727|P12|Subacute Phase|Withdrawal by Subject|1
5490398|NCT01737697|18985728|P11|Subacute Phase|Withdrawal by Subject|0
5490399|NCT01737697|18985729|P10|Subacute Phase|Withdrawal by Subject|1
5490400|NCT01737697|18985730|P9|Subacute Phase|Withdrawal by Subject|0
5490401|NCT01737697|18985731|P8|Subacute Phase|Withdrawal by Subject|2
5490402|NCT01737697|18985732|P7|Subacute Phase|Withdrawal by Subject|0
5490403|NCT01737697|18985733|P6|Subacute Phase|Withdrawal by Subject|1
5490404|NCT01737697|18985734|P5|Subacute Phase|Withdrawal by Subject|0
5490405|NCT01737697|18985735|P4|Subacute Phase|Withdrawal by Subject|0
5490406|NCT01737697|18985736|P3|Subacute Phase|Withdrawal by Subject|0
5490407|NCT01737697|18985737|P2|Subacute Phase|Withdrawal by Subject|0
5490408|NCT01737697|18985738|P1|Subacute Phase|Withdrawal by Subject|0
5490409|NCT01737697|18985724|P15|Subacute Phase|Adverse Event|0
5490410|NCT01737697|18985725|P14|Subacute Phase|Adverse Event|0
5490411|NCT01737697|18985726|P13|Subacute Phase|Adverse Event|1
5490412|NCT01737697|18985727|P12|Subacute Phase|Adverse Event|1
5490413|NCT01737697|18985728|P11|Subacute Phase|Adverse Event|4
5490414|NCT01737697|18985729|P10|Subacute Phase|Adverse Event|1
5490415|NCT01737697|18985730|P9|Subacute Phase|Adverse Event|1
5490416|NCT01737697|18985731|P8|Subacute Phase|Adverse Event|1
5490417|NCT01737697|18985732|P7|Subacute Phase|Adverse Event|1
5490418|NCT01737697|18985733|P6|Subacute Phase|Adverse Event|1
5490419|NCT01737697|18985734|P5|Subacute Phase|Adverse Event|0
5490420|NCT01737697|18985735|P4|Subacute Phase|Adverse Event|0
5490421|NCT01737697|18985736|P3|Subacute Phase|Adverse Event|0
5490422|NCT01737697|18985737|P2|Subacute Phase|Adverse Event|0
5490423|NCT01737697|18985738|P1|Subacute Phase|Adverse Event|0
5490424|NCT01737697|18985724|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490425|NCT01737697|18985725|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490426|NCT01737697|18985726|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490427|NCT01737697|18985727|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490428|NCT01737697|18985728|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490429|NCT01737697|18985729|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490430|NCT01737697|18985730|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490431|NCT01737697|18985731|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490432|NCT01737697|18985732|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490433|NCT01737697|18985733|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490434|NCT01737697|18985734|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
5490435|NCT01737697|18985735|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
5490436|NCT01737697|18985736|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
5490437|NCT01737697|18985737|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
5490438|NCT01737697|18985738|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
5490439|NCT01737697|18985724|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490440|NCT01737697|18985725|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490441|NCT01737697|18985726|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490442|NCT01737697|18985727|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490443|NCT01737697|18985728|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490444|NCT01737697|18985729|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490445|NCT01737697|18985730|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490446|NCT01737697|18985731|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490447|NCT01737697|18985732|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490448|NCT01737697|18985733|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490449|NCT01737697|18985734|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
5490450|NCT01737697|18985735|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490451|NCT01737697|18985736|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490452|NCT01737697|18985737|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490453|NCT01737697|18985738|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
5490454|NCT01737697|18985724|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490455|NCT01737697|18985725|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490456|NCT01737697|18985726|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490457|NCT01737697|18985727|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490458|NCT01737697|18985728|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490459|NCT01737697|18985729|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490460|NCT01737697|18985730|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490461|NCT01737697|18985731|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490462|NCT01737697|18985732|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490463|NCT01737697|18985733|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490464|NCT01737697|18985734|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490465|NCT01737697|18985735|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490466|NCT01737697|18985736|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490467|NCT01737697|18985737|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
5490468|NCT01737697|18985738|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
5490469|NCT01737697|18985724|P15|Acute Phase-Initial 48 Hours|Family emergency|0
5490470|NCT01737697|18985725|P14|Acute Phase-Initial 48 Hours|Family emergency|0
5490471|NCT01737697|18985726|P13|Acute Phase-Initial 48 Hours|Family emergency|0
5490472|NCT01737697|18985727|P12|Acute Phase-Initial 48 Hours|Family emergency|0
5490473|NCT01737697|18985728|P11|Acute Phase-Initial 48 Hours|Family emergency|0
5490474|NCT01737697|18985729|P10|Acute Phase-Initial 48 Hours|Family emergency|0
5490475|NCT01737697|18985730|P9|Acute Phase-Initial 48 Hours|Family emergency|0
5490476|NCT01737697|18985731|P8|Acute Phase-Initial 48 Hours|Family emergency|0
5490477|NCT01737697|18985732|P7|Acute Phase-Initial 48 Hours|Family emergency|0
5490478|NCT01737697|18985733|P6|Acute Phase-Initial 48 Hours|Family emergency|0
5490479|NCT01737697|18985734|P5|Acute Phase-Initial 48 Hours|Family emergency|0
5490480|NCT01737697|18985735|P4|Acute Phase-Initial 48 Hours|Family emergency|1
5490481|NCT01737697|18985736|P3|Acute Phase-Initial 48 Hours|Family emergency|0
5490482|NCT01737697|18985737|P2|Acute Phase-Initial 48 Hours|Family emergency|0
5490483|NCT01737697|18985738|P1|Acute Phase-Initial 48 Hours|Family emergency|0
5490484|NCT01737697|18985724|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490485|NCT01737697|18985725|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490486|NCT01737697|18985726|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490487|NCT01737697|18985727|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490488|NCT01737697|18985728|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490489|NCT01737697|18985729|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490490|NCT01737697|18985730|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490491|NCT01737697|18985731|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490492|NCT01737697|18985732|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490493|NCT01737697|18985733|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490494|NCT01737697|18985734|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490495|NCT01737697|18985735|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
5490496|NCT01737697|18985736|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
5490497|NCT01737697|18985737|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
5490498|NCT01737697|18985738|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
5490499|NCT01737697|18985724|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
5490500|NCT01737697|18985725|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
5490501|NCT01737697|18985726|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
5490502|NCT01737697|18985727|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
5490503|NCT01737697|18985728|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
5490504|NCT01737697|18985729|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
5490505|NCT01737697|18985730|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
5490506|NCT01737697|18985731|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
5490507|NCT01737697|18985732|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
5490508|NCT01737697|18985733|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
5490509|NCT01737697|18985734|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
5490510|NCT01737697|18985735|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
5490511|NCT01737697|18985736|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
5490512|NCT01737697|18985737|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
5490513|NCT01737697|18985738|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
5490514|NCT01737398|18985881|P2|Overall Study|Sponsor's decision|0
5490515|NCT01737398|18985882|P1|Overall Study|Sponsor's decision|2
5490516|NCT01737398|18985881|P2|Overall Study|Disease progression|3
5490517|NCT01737398|18985882|P1|Overall Study|Disease progression|2
5490518|NCT01737398|18985881|P2|Overall Study|Liver transplant|0
5490519|NCT01737398|18985882|P1|Overall Study|Liver transplant|1
5490520|NCT01737398|18985881|P2|Overall Study|Ineligibility|0
5490521|NCT01737398|18985882|P1|Overall Study|Ineligibility|1
5490522|NCT01737398|18985881|P2|Overall Study|Voluntary withdrawal|3
5490523|NCT01737398|18985882|P1|Overall Study|Voluntary withdrawal|2
5490524|NCT01737398|18985881|P2|Overall Study|Stopping rule met|1
5490525|NCT01737398|18985882|P1|Overall Study|Stopping rule met|2
5490526|NCT01737398|18985881|P2|Overall Study|Adverse event or SAE|1
5490527|NCT01737398|18985882|P1|Overall Study|Adverse event or SAE|16
5490528|NCT01737268|18985935|P1|Overall Study|In consideration of the patient's safety|1
5490529|NCT01737268|18985935|P1|Overall Study|Worsening of Target Disease|2
5490530|NCT01737268|18985935|P1|Overall Study|Adverse Event|6
5490531|NCT01737021|18985949|P2|Overall Study|Lost to Follow-up|3
5490532|NCT01737021|18985950|P1|Overall Study|Lost to Follow-up|5
5490533|NCT01736917|18985996|P1|Overall Study|Protocol Violation|10
5490534|NCT01736917|18985996|P1|Overall Study|Adverse Event|1
5490535|NCT01736696|18986036|P7|Overall Study|Withdrawal by Subject|0
5490536|NCT01736696|18986037|P6|Overall Study|Withdrawal by Subject|0
5490537|NCT01736696|18986038|P5|Overall Study|Withdrawal by Subject|0
5490538|NCT01736696|18986039|P4|Overall Study|Withdrawal by Subject|0
5490539|NCT01736696|18986040|P3|Overall Study|Withdrawal by Subject|1
5490540|NCT01736696|18986041|P2|Overall Study|Withdrawal by Subject|0
5490541|NCT01736696|18986042|P1|Overall Study|Withdrawal by Subject|0
5490542|NCT01736683|18986364|P5|Overall Study|Other|1
5490543|NCT01736683|18986365|P4|Overall Study|Other|9
5490544|NCT01736683|18986366|P3|Overall Study|Other|1
5490545|NCT01736683|18986367|P2|Overall Study|Other|0
5490546|NCT01736683|18986368|P1|Overall Study|Other|0
5490547|NCT01736683|18986364|P5|Overall Study|Progressive Disease|0
5490548|NCT01736683|18986365|P4|Overall Study|Progressive Disease|1
5490549|NCT01736683|18986366|P3|Overall Study|Progressive Disease|0
5490550|NCT01736683|18986367|P2|Overall Study|Progressive Disease|0
5490551|NCT01736683|18986368|P1|Overall Study|Progressive Disease|0
5490552|NCT01736683|18986364|P5|Overall Study|Lack of Therapeutic Effect|1
5490553|NCT01736683|18986365|P4|Overall Study|Lack of Therapeutic Effect|20
5490554|NCT01736683|18986366|P3|Overall Study|Lack of Therapeutic Effect|13
5490555|NCT01736683|18986367|P2|Overall Study|Lack of Therapeutic Effect|4
5490556|NCT01736683|18986368|P1|Overall Study|Lack of Therapeutic Effect|7
5490557|NCT01736683|18986364|P5|Overall Study|Withdrawal by Subject|1
5490558|NCT01736683|18986365|P4|Overall Study|Withdrawal by Subject|1
5490559|NCT01736683|18986366|P3|Overall Study|Withdrawal by Subject|3
5490560|NCT01736683|18986367|P2|Overall Study|Withdrawal by Subject|0
5490561|NCT01736683|18986368|P1|Overall Study|Withdrawal by Subject|0
5490562|NCT01736683|18986364|P5|Overall Study|Adverse Event|2
5490563|NCT01736683|18986365|P4|Overall Study|Adverse Event|3
5490564|NCT01736683|18986366|P3|Overall Study|Adverse Event|2
5490565|NCT01736683|18986367|P2|Overall Study|Adverse Event|2
5490566|NCT01736683|18986368|P1|Overall Study|Adverse Event|0
5490567|NCT01736683|18986364|P5|Overall Study|Disease Relapse|0
5490568|NCT01736683|18986365|P4|Overall Study|Disease Relapse|1
5490569|NCT01736683|18986366|P3|Overall Study|Disease Relapse|2
5490570|NCT01736683|18986367|P2|Overall Study|Disease Relapse|0
5490571|NCT01736683|18986368|P1|Overall Study|Disease Relapse|0
5490572|NCT01736657|18986430|P1|Overall Study|insufficient vascular access|1
5490573|NCT01736579|18986439|P2|Overall Study|Termination of Study by Sponsor|2
5490574|NCT01736579|18986440|P1|Overall Study|Termination of Study by Sponsor|2
5490575|NCT01736566|18986479|P5|Long Term Follow-up|Still collecting data|1
5490576|NCT01736566|18986480|P4|Long Term Follow-up|Still collecting data|0
5490577|NCT01736566|18986481|P3|Long Term Follow-up|Still collecting data|49
5490578|NCT01736566|18986482|P2|Long Term Follow-up|Still collecting data|0
5490579|NCT01736566|18986483|P1|Long Term Follow-up|Still collecting data|42
5490580|NCT01736553|18986568|P2|Overall Study|Lost to Follow-up|2
5490581|NCT01736553|18986569|P1|Overall Study|Lost to Follow-up|2
5490582|NCT01736553|18986568|P2|Overall Study|Withdrawal by Subject|2
5490583|NCT01736553|18986569|P1|Overall Study|Withdrawal by Subject|5
5490584|NCT01736553|18986568|P2|Overall Study|Death|0
5490585|NCT01736553|18986569|P1|Overall Study|Death|12
5490586|NCT01736540|18986620|P1|Overall Study|Unable to make MRI appointment|3
5490587|NCT01736540|18986620|P1|Overall Study|No show for MRI appointment|1
5490588|NCT01736540|18986620|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
5490589|NCT01736540|18986620|P1|Overall Study|Protocol Violation|1
5490590|NCT01736540|18986620|P1|Overall Study|Withdrawal by Subject|5
5490591|NCT01736540|18986620|P1|Overall Study|Abnormal test procedure|1
5490592|NCT01736540|18986620|P1|Overall Study|Death|1
5490593|NCT01736540|18986620|P1|Overall Study|Did not complete scan within 45 days|2
5490594|NCT01736475|18986686|P2|Overall Study|Other - Surgical procedure|0
5490595|NCT01736475|18986687|P1|Overall Study|Other - Surgical procedure|1
5490596|NCT01736475|18986686|P2|Overall Study|Other - Screen failure|0
5490597|NCT01736475|18986687|P1|Overall Study|Other - Screen failure|1
5490598|NCT01736475|18986686|P2|Overall Study|Protocol Violation|0
5490599|NCT01736475|18986687|P1|Overall Study|Protocol Violation|4
5490600|NCT01736475|18986686|P2|Overall Study|Withdrawal by Subject|0
5490601|NCT01736475|18986687|P1|Overall Study|Withdrawal by Subject|2
5490602|NCT01736475|18986686|P2|Overall Study|Adverse Event|0
5490603|NCT01736475|18986687|P1|Overall Study|Adverse Event|4
5490604|NCT01736397|18986742|P2|Overall Study|Not stated|4
5490605|NCT01736397|18986743|P1|Overall Study|Not stated|1
5490606|NCT01736397|18986742|P2|Overall Study|Adverse Event|3
5490607|NCT01736397|18986743|P1|Overall Study|Adverse Event|6
5490608|NCT01736397|18986742|P2|Overall Study|Lost to Follow-up|1
5490609|NCT01736397|18986743|P1|Overall Study|Lost to Follow-up|0
5490610|NCT01736397|18986742|P2|Overall Study|Withdrawal by Subject|5
5490611|NCT01736397|18986743|P1|Overall Study|Withdrawal by Subject|6
5490612|NCT01736397|18986742|P2|Overall Study|Lack of Efficacy|11
5490613|NCT01736397|18986743|P1|Overall Study|Lack of Efficacy|1
5490614|NCT01736254|18986776|P1|Period 3 (Days 13 to 23)|Adverse Event|1
5490615|NCT01736254|18986776|P1|Period 2 (Days 2 to 12)|Adverse Event|3
5490616|NCT01736215|18986841|P1|Overall Study|Insufficient data to perform analysis|8
5490617|NCT01736215|18986841|P1|Overall Study|Progressive disease stop chemotherapy|1
5490618|NCT01736215|18986841|P1|Overall Study|Adverse Event|4
5490619|NCT01736215|18986841|P1|Overall Study|Early termination of erythropoietin use|1
5490620|NCT01736189|18986853|P1|Overall Study|Criteria and protocol violations|1
5490621|NCT01736189|18986853|P1|Overall Study|Protocol Violation|4
5490622|NCT01736189|18986853|P1|Overall Study|Violation of registration criteria|41
5490623|NCT01736176|18986862|P1|Overall Study|Unable to Complete PEG Placement|1
5490624|NCT01736176|18986862|P1|Overall Study|Lack of Efficacy|3
5490625|NCT01736176|18986862|P1|Overall Study|Withdrawal by Subject|4
5490626|NCT01736176|18986862|P1|Overall Study|Adverse Event|3
5490627|NCT01735994|18986933|P2|Overall Study|Lost to Follow-up|62
5490628|NCT01735994|18986934|P1|Overall Study|Lost to Follow-up|50
5490629|NCT01735994|18986933|P2|Overall Study|Kicked off team|0
5490630|NCT01735994|18986934|P1|Overall Study|Kicked off team|5
5490631|NCT01735994|18986933|P2|Overall Study|Injury|0
5490632|NCT01735994|18986934|P1|Overall Study|Injury|2
5490633|NCT01735994|18986933|P2|Overall Study|Withdrawal by Subject|4
5490634|NCT01735994|18986934|P1|Overall Study|Withdrawal by Subject|6
5490635|NCT01735916|18986949|P3|Overall Study|Withdrawal by Subject|0
5490636|NCT01735916|18986950|P2|Overall Study|Withdrawal by Subject|0
5490637|NCT01735916|18986951|P1|Overall Study|Withdrawal by Subject|3
5490638|NCT01735916|18986949|P3|Overall Study|Early termination of study by sponsor|7
5490639|NCT01735916|18986950|P2|Overall Study|Early termination of study by sponsor|19
5490640|NCT01735916|18986951|P1|Overall Study|Early termination of study by sponsor|4
5490641|NCT01735916|18986949|P3|Overall Study|Subject not eligible to be randomized|0
5490642|NCT01735916|18986950|P2|Overall Study|Subject not eligible to be randomized|0
5490643|NCT01735916|18986951|P1|Overall Study|Subject not eligible to be randomized|11
5490644|NCT01735630|18986989|P2|Overall Study|Withdrawal by Subject|9
5490645|NCT01735630|18986990|P1|Overall Study|Withdrawal by Subject|7
5490646|NCT01735630|18986989|P2|Overall Study|Sponsor Decision|1
5490647|NCT01735630|18986990|P1|Overall Study|Sponsor Decision|2
5490648|NCT01735630|18986989|P2|Overall Study|Physician Decision|1
5490649|NCT01735630|18986990|P1|Overall Study|Physician Decision|0
5490650|NCT01735630|18986989|P2|Overall Study|Lost to Follow-up|0
5490651|NCT01735630|18986990|P1|Overall Study|Lost to Follow-up|1
5490652|NCT01735630|18986989|P2|Overall Study|Adverse Event|7
5490653|NCT01735630|18986990|P1|Overall Study|Adverse Event|8
5490654|NCT01735396|18987017|P1|Overall Study|not evaluable|1
5490655|NCT01735279|18987028|P2|Overall Study|Lost to Follow-up|8
5490656|NCT01735279|18987029|P1|Overall Study|Lost to Follow-up|11
5490657|NCT01735201|18987061|P8|Overall Study|Other Miscellaneous Reasons|1
5490658|NCT01735201|18987062|P7|Overall Study|Other Miscellaneous Reasons|1
5490659|NCT01735201|18987063|P6|Overall Study|Other Miscellaneous Reasons|2
5490660|NCT01735201|18987064|P5|Overall Study|Other Miscellaneous Reasons|0
5490661|NCT01735201|18987065|P4|Overall Study|Other Miscellaneous Reasons|1
5490662|NCT01735201|18987066|P3|Overall Study|Other Miscellaneous Reasons|0
5490663|NCT01735201|18987067|P2|Overall Study|Other Miscellaneous Reasons|0
5490664|NCT01735201|18987068|P1|Overall Study|Other Miscellaneous Reasons|0
5490665|NCT01735201|18987061|P8|Overall Study|Protocol Violation|0
5490666|NCT01735201|18987062|P7|Overall Study|Protocol Violation|0
5490667|NCT01735201|18987063|P6|Overall Study|Protocol Violation|0
5490668|NCT01735201|18987064|P5|Overall Study|Protocol Violation|0
5490669|NCT01735201|18987065|P4|Overall Study|Protocol Violation|0
5490670|NCT01735201|18987066|P3|Overall Study|Protocol Violation|0
5490671|NCT01735201|18987067|P2|Overall Study|Protocol Violation|0
5490672|NCT01735201|18987068|P1|Overall Study|Protocol Violation|1
5490673|NCT01735201|18987061|P8|Overall Study|Personal Reasons|0
5490674|NCT01735201|18987062|P7|Overall Study|Personal Reasons|0
5490675|NCT01735201|18987063|P6|Overall Study|Personal Reasons|0
5490676|NCT01735201|18987064|P5|Overall Study|Personal Reasons|0
5490677|NCT01735201|18987065|P4|Overall Study|Personal Reasons|0
5490678|NCT01735201|18987066|P3|Overall Study|Personal Reasons|0
5490679|NCT01735201|18987067|P2|Overall Study|Personal Reasons|0
5490680|NCT01735201|18987068|P1|Overall Study|Personal Reasons|1
5490681|NCT01735201|18987061|P8|Overall Study|Adverse Event|1
5490682|NCT01735201|18987062|P7|Overall Study|Adverse Event|2
5490683|NCT01735201|18987063|P6|Overall Study|Adverse Event|3
5490684|NCT01735201|18987064|P5|Overall Study|Adverse Event|1
5490685|NCT01735201|18987065|P4|Overall Study|Adverse Event|1
5490686|NCT01735201|18987066|P3|Overall Study|Adverse Event|0
5490687|NCT01735201|18987067|P2|Overall Study|Adverse Event|1
5490688|NCT01735201|18987068|P1|Overall Study|Adverse Event|1
5490689|NCT01735175|18987104|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
5490690|NCT01735175|18987105|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
5490691|NCT01735175|18987104|P2|Overall Study|Death|2
5490692|NCT01735175|18987105|P1|Overall Study|Death|3
5490693|NCT01735175|18987104|P2|Overall Study|Lost to Follow-up|2
5490694|NCT01735175|18987105|P1|Overall Study|Lost to Follow-up|4
5490695|NCT01735175|18987104|P2|Overall Study|Withdrawal by Subject|2
5490696|NCT01735175|18987105|P1|Overall Study|Withdrawal by Subject|9
5490697|NCT01734993|18987125|P1|Overall Study|Lack of Efficacy|1
5490698|NCT01734993|18987125|P1|Overall Study|Adverse Event|1
5490699|NCT01734902|18987153|P2|Overall Study|Other than listed|2
5490700|NCT01734902|18987154|P1|Overall Study|Other than listed|0
5490701|NCT01734850|18987175|P3|Overall Study|Not infused due to manufacturing failure|1
5490702|NCT01734850|18987176|P2|Overall Study|Not infused due to manufacturing failure|0
5490703|NCT01734850|18987177|P1|Overall Study|Not infused due to manufacturing failure|0
5490704|NCT01734850|18987175|P3|Overall Study|Continued to Week 48 but recommenced ART|3
5490705|NCT01734850|18987176|P2|Overall Study|Continued to Week 48 but recommenced ART|2
5490706|NCT01734850|18987177|P1|Overall Study|Continued to Week 48 but recommenced ART|3
5490707|NCT01734811|18987234|P2|Overall Study|Withdrawal by Subject|0
5490708|NCT01734811|18987235|P1|Overall Study|Withdrawal by Subject|2
5490709|NCT01734811|18987234|P2|Overall Study|Lost to Follow-up|3
5490710|NCT01734811|18987235|P1|Overall Study|Lost to Follow-up|2
5490711|NCT01734785|18987262|P4|Double-Blind Period|Not treated|0
5490712|NCT01734785|18987263|P3|Double-Blind Period|Not treated|0
5490713|NCT01734785|18987264|P2|Double-Blind Period|Not treated|0
5490714|NCT01734785|18987265|P1|Double-Blind Period|Not treated|1
5490715|NCT01734785|18987262|P4|Double-Blind Period|Withdrawal by Subject|0
5490716|NCT01734785|18987263|P3|Double-Blind Period|Withdrawal by Subject|0
5490717|NCT01734785|18987264|P2|Double-Blind Period|Withdrawal by Subject|0
5490718|NCT01734785|18987265|P1|Double-Blind Period|Withdrawal by Subject|2
5490719|NCT01734785|18987262|P4|Double-Blind Period|Lost to Follow-up|0
5490720|NCT01734785|18987263|P3|Double-Blind Period|Lost to Follow-up|2
5490721|NCT01734785|18987264|P2|Double-Blind Period|Lost to Follow-up|4
5490722|NCT01734785|18987265|P1|Double-Blind Period|Lost to Follow-up|2
5490723|NCT01734785|18987262|P4|Double-Blind Period|Protocol Violation|0
5490724|NCT01734785|18987263|P3|Double-Blind Period|Protocol Violation|1
5490725|NCT01734785|18987264|P2|Double-Blind Period|Protocol Violation|1
5490726|NCT01734785|18987265|P1|Double-Blind Period|Protocol Violation|0
5490727|NCT01734785|18987262|P4|Double-Blind Period|Lack of Efficacy|0
5490728|NCT01734785|18987263|P3|Double-Blind Period|Lack of Efficacy|0
5490729|NCT01734785|18987264|P2|Double-Blind Period|Lack of Efficacy|1
5490730|NCT01734785|18987265|P1|Double-Blind Period|Lack of Efficacy|0
5490731|NCT01734785|18987262|P4|Double-Blind Period|Adverse Event|0
5490732|NCT01734785|18987263|P3|Double-Blind Period|Adverse Event|2
5490733|NCT01734785|18987264|P2|Double-Blind Period|Adverse Event|3
5490734|NCT01734785|18987265|P1|Double-Blind Period|Adverse Event|0
5490735|NCT01734785|18987262|P4|Open-Label Period|Other Reasons|224
5490736|NCT01734785|18987263|P3|Open-Label Period|Other Reasons|0
5490737|NCT01734785|18987264|P2|Open-Label Period|Other Reasons|0
5490738|NCT01734785|18987265|P1|Open-Label Period|Other Reasons|0
5490739|NCT01734785|18987262|P4|Open-Label Period|Withdrawal by Subject|12
5490740|NCT01734785|18987263|P3|Open-Label Period|Withdrawal by Subject|0
5490741|NCT01734785|18987264|P2|Open-Label Period|Withdrawal by Subject|0
5490742|NCT01734785|18987265|P1|Open-Label Period|Withdrawal by Subject|0
5490743|NCT01734785|18987262|P4|Open-Label Period|Lost to Follow-up|14
5490744|NCT01734785|18987263|P3|Open-Label Period|Lost to Follow-up|0
5490745|NCT01734785|18987264|P2|Open-Label Period|Lost to Follow-up|0
5490746|NCT01734785|18987265|P1|Open-Label Period|Lost to Follow-up|0
5490747|NCT01734785|18987262|P4|Open-Label Period|Protocol Violation|13
5490748|NCT01734785|18987263|P3|Open-Label Period|Protocol Violation|0
5490749|NCT01734785|18987264|P2|Open-Label Period|Protocol Violation|0
5490750|NCT01734785|18987265|P1|Open-Label Period|Protocol Violation|0
5490751|NCT01734785|18987262|P4|Open-Label Period|Lack of Efficacy|1
5490752|NCT01734785|18987263|P3|Open-Label Period|Lack of Efficacy|0
5490753|NCT01734785|18987264|P2|Open-Label Period|Lack of Efficacy|0
5490754|NCT01734785|18987265|P1|Open-Label Period|Lack of Efficacy|0
5490755|NCT01734785|18987262|P4|Open-Label Period|Adverse Event|9
5490756|NCT01734785|18987263|P3|Open-Label Period|Adverse Event|0
5490757|NCT01734785|18987264|P2|Open-Label Period|Adverse Event|0
5490758|NCT01734785|18987265|P1|Open-Label Period|Adverse Event|0
5490759|NCT01734772|18987282|P2|Overall Study|Withdrawal by Subject|1
5490760|NCT01734772|18987283|P1|Overall Study|Withdrawal by Subject|0
5490761|NCT01734772|18987282|P2|Overall Study|Adverse Event|2
5490762|NCT01734772|18987283|P1|Overall Study|Adverse Event|1
5490763|NCT01734434|18987338|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
5490764|NCT01734434|18987339|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
5490765|NCT01734434|18987340|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
5490766|NCT01734434|18987341|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
5490767|NCT01734434|18987338|P4|Overall Study|Wrong Version of Consent Form Signed|0
5490768|NCT01734434|18987339|P3|Overall Study|Wrong Version of Consent Form Signed|1
5490769|NCT01734434|18987340|P2|Overall Study|Wrong Version of Consent Form Signed|0
5490770|NCT01734434|18987341|P1|Overall Study|Wrong Version of Consent Form Signed|0
5490771|NCT01734434|18987338|P4|Overall Study|Treatment Defaulter|0
5490772|NCT01734434|18987339|P3|Overall Study|Treatment Defaulter|1
5490773|NCT01734434|18987340|P2|Overall Study|Treatment Defaulter|0
5490774|NCT01734434|18987341|P1|Overall Study|Treatment Defaulter|0
5490775|NCT01734434|18987338|P4|Overall Study|Subject Not Reachable|0
5490776|NCT01734434|18987339|P3|Overall Study|Subject Not Reachable|1
5490777|NCT01734434|18987340|P2|Overall Study|Subject Not Reachable|0
5490778|NCT01734434|18987341|P1|Overall Study|Subject Not Reachable|0
5490779|NCT01734434|18987338|P4|Overall Study|Signed Adult Version of Consent Form|0
5490780|NCT01734434|18987339|P3|Overall Study|Signed Adult Version of Consent Form|1
5490781|NCT01734434|18987340|P2|Overall Study|Signed Adult Version of Consent Form|0
5490782|NCT01734434|18987341|P1|Overall Study|Signed Adult Version of Consent Form|0
5490783|NCT01734434|18987338|P4|Overall Study|Withdrawal by Subject|1
5490784|NCT01734434|18987339|P3|Overall Study|Withdrawal by Subject|8
5490785|NCT01734434|18987340|P2|Overall Study|Withdrawal by Subject|0
5490786|NCT01734434|18987341|P1|Overall Study|Withdrawal by Subject|4
5490787|NCT01734434|18987338|P4|Overall Study|No Live Birth|6
5490788|NCT01734434|18987339|P3|Overall Study|No Live Birth|32
5490789|NCT01734434|18987340|P2|Overall Study|No Live Birth|2
5490790|NCT01734434|18987341|P1|Overall Study|No Live Birth|1
5490791|NCT01734434|18987338|P4|Overall Study|Lost to Follow-up|11
5490792|NCT01734434|18987339|P3|Overall Study|Lost to Follow-up|67
5490793|NCT01734434|18987340|P2|Overall Study|Lost to Follow-up|9
5490794|NCT01734434|18987341|P1|Overall Study|Lost to Follow-up|2
5490795|NCT01734434|18987338|P4|Overall Study|Death Infant|5
5490796|NCT01734434|18987339|P3|Overall Study|Death Infant|17
5490797|NCT01734434|18987340|P2|Overall Study|Death Infant|1
5490798|NCT01734434|18987341|P1|Overall Study|Death Infant|3
5490799|NCT01734395|18987363|P1|Overall Study|Missing the reasons for not completed|3
5490800|NCT01734395|18987363|P1|Overall Study|Withdrawal by Subject|10
5490801|NCT01734395|18987363|P1|Overall Study|Adverse Event|40
5490802|NCT01734395|18987363|P1|Overall Study|Lack of Efficacy|5
5490803|NCT01734395|18987363|P1|Overall Study|Lost to Follow-up|287
5490804|NCT01734395|18987363|P1|Overall Study|Other|65
5490805|NCT01734382|18987372|P3|Part 2|Withdrawal by Subject|1
5490806|NCT01734382|18987373|P2|Part 2|Withdrawal by Subject|0
5490807|NCT01734382|18987374|P1|Part 2|Withdrawal by Subject|0
5490808|NCT01734382|18987372|P3|Part 2|Protocol Violation|0
5490809|NCT01734382|18987373|P2|Part 2|Protocol Violation|1
5490810|NCT01734382|18987374|P1|Part 2|Protocol Violation|0
5490811|NCT01734382|18987372|P3|Part 2|Physician Decision|3
5490812|NCT01734382|18987373|P2|Part 2|Physician Decision|0
5490813|NCT01734382|18987374|P1|Part 2|Physician Decision|0
5490814|NCT01734382|18987372|P3|Part 2|Other|1
5490815|NCT01734382|18987373|P2|Part 2|Other|0
5490816|NCT01734382|18987374|P1|Part 2|Other|0
5490817|NCT01734382|18987372|P3|Part 2|Lack of Efficacy|1
5490818|NCT01734382|18987373|P2|Part 2|Lack of Efficacy|1
5490819|NCT01734382|18987374|P1|Part 2|Lack of Efficacy|0
5490820|NCT01734382|18987372|P3|Part 2|Adverse Event|1
5490821|NCT01734382|18987373|P2|Part 2|Adverse Event|0
5490822|NCT01734382|18987374|P1|Part 2|Adverse Event|0
5490823|NCT01734382|18987372|P3|Part 1|Adverse Event|0
5490824|NCT01734382|18987373|P2|Part 1|Adverse Event|0
5490825|NCT01734382|18987374|P1|Part 1|Adverse Event|2
5490826|NCT01733758|18987487|P4|Overall Study|Inv Decision, HbA1c not controlled|1
5490827|NCT01733758|18987488|P3|Overall Study|Inv Decision, HbA1c not controlled|0
5490828|NCT01733758|18987489|P2|Overall Study|Inv Decision, HbA1c not controlled|1
5490829|NCT01733758|18987490|P1|Overall Study|Inv Decision, HbA1c not controlled|1
5490830|NCT01733758|18987487|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
5490831|NCT01733758|18987488|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
5490832|NCT01733758|18987489|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
5490833|NCT01733758|18987490|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
5490834|NCT01733758|18987487|P4|Overall Study|Non-compliance|0
5490835|NCT01733758|18987488|P3|Overall Study|Non-compliance|0
5490836|NCT01733758|18987489|P2|Overall Study|Non-compliance|0
5490837|NCT01733758|18987490|P1|Overall Study|Non-compliance|1
5490838|NCT01733758|18987487|P4|Overall Study|Protocol Violation|2
5490839|NCT01733758|18987488|P3|Overall Study|Protocol Violation|2
5490840|NCT01733758|18987489|P2|Overall Study|Protocol Violation|1
5490841|NCT01733758|18987490|P1|Overall Study|Protocol Violation|0
5490842|NCT01733758|18987487|P4|Overall Study|Persistent Hyperglycemia|0
5490843|NCT01733758|18987488|P3|Overall Study|Persistent Hyperglycemia|0
5490844|NCT01733758|18987489|P2|Overall Study|Persistent Hyperglycemia|2
5490845|NCT01733758|18987490|P1|Overall Study|Persistent Hyperglycemia|3
5490846|NCT01733758|18987487|P4|Overall Study|Withdrawal by Subject|3
5490847|NCT01733758|18987488|P3|Overall Study|Withdrawal by Subject|5
5490848|NCT01733758|18987489|P2|Overall Study|Withdrawal by Subject|1
5490849|NCT01733758|18987490|P1|Overall Study|Withdrawal by Subject|1
5490850|NCT01733758|18987487|P4|Overall Study|Adverse Event|1
5490851|NCT01733758|18987488|P3|Overall Study|Adverse Event|8
5490852|NCT01733758|18987489|P2|Overall Study|Adverse Event|7
5490853|NCT01733758|18987490|P1|Overall Study|Adverse Event|5
5490854|NCT01733732|18987556|P2|Overall Study|Did not attend all study visits|0
5490855|NCT01733732|18987557|P1|Overall Study|Did not attend all study visits|1
5490856|NCT01733732|18987556|P2|Overall Study|Adverse Event|0
5490857|NCT01733732|18987557|P1|Overall Study|Adverse Event|1
5490858|NCT01733680|18987593|P2|Overall Study|Withdrawal by Subject|1
5490859|NCT01733680|18987594|P1|Overall Study|Withdrawal by Subject|0
5490860|NCT01733329|18987653|P2|Overall Study|Uterine artery injury|0
5490861|NCT01733329|18987654|P1|Overall Study|Uterine artery injury|1
5490862|NCT01733329|18987653|P2|Overall Study|Protocol Violation|1
5490863|NCT01733329|18987654|P1|Overall Study|Protocol Violation|1
5490864|NCT01733316|18987666|P1|Long Term Extension Phase|Sponsor Decision|2
5490865|NCT01733316|18987666|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
5490866|NCT01733316|18987666|P1|Long Term Extension Phase|Adverse Event|1
5490867|NCT01733316|18987666|P1|RP103 Phase|Non-compliance|1
5490868|NCT01733121|18987709|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
5490869|NCT01733121|18987710|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
5490870|NCT01733121|18987709|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
5490871|NCT01733121|18987710|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
5490872|NCT01733121|18987709|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
5490873|NCT01733121|18987710|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
5490874|NCT01733121|18987709|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
5490875|NCT01733121|18987710|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
5490876|NCT01732926|18987752|P2|Overall Study|Blind Broken by Subject or Study Site|1
5490877|NCT01732926|18987753|P1|Overall Study|Blind Broken by Subject or Study Site|1
5490878|NCT01732926|18987752|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
5490879|NCT01732926|18987753|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
5490880|NCT01732926|18987752|P2|Overall Study|Other Reason|4
5490881|NCT01732926|18987753|P1|Overall Study|Other Reason|21
5490882|NCT01732926|18987752|P2|Overall Study|Physician Decision|11
5490883|NCT01732926|18987753|P1|Overall Study|Physician Decision|24
5490884|NCT01732926|18987752|P2|Overall Study|Withdrawal by Subject|8
5490885|NCT01732926|18987753|P1|Overall Study|Withdrawal by Subject|46
5490886|NCT01732926|18987752|P2|Overall Study|Study Terminated by Sponsor|80
5490887|NCT01732926|18987753|P1|Overall Study|Study Terminated by Sponsor|168
5490888|NCT01732913|18987769|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
5490889|NCT01732913|18987770|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
5490890|NCT01732913|18987769|P2|Overall Study|Other|1
5490891|NCT01732913|18987770|P1|Overall Study|Other|7
5490892|NCT01732913|18987769|P2|Overall Study|Physician Decision|7
5490893|NCT01732913|18987770|P1|Overall Study|Physician Decision|14
5490894|NCT01732913|18987769|P2|Overall Study|Withdrawal by Subject|4
5490895|NCT01732913|18987770|P1|Overall Study|Withdrawal by Subject|27
5490896|NCT01732913|18987769|P2|Overall Study|Study Terminated by Sponsor|55
5490897|NCT01732913|18987770|P1|Overall Study|Study Terminated by Sponsor|105
5490898|NCT01732835|18987784|P1|2-year Extended Follow-up|Death|1
5490899|NCT01732835|18987784|P1|2-year Extended Follow-up|Adverse Event|3
5490900|NCT01732835|18987784|P1|2-year Extended Follow-up|Withdrawal by Subject|1
5490901|NCT01732835|18987784|P1|6-month Primary Endpoint|Adverse Event|3
5490902|NCT01732835|18987784|P1|6-month Primary Endpoint|Withdrawal by Subject|2
5490903|NCT01732835|18987784|P1|6-month Primary Endpoint|Did not receive device|19
5490904|NCT01732822|18987817|P2|Overall Study|Withdrawal by Subject|113
5490905|NCT01732822|18987818|P1|Overall Study|Withdrawal by Subject|123
5490906|NCT01732796|18987910|P3|Overall Study|Other reason not defined above|2
5490907|NCT01732796|18987911|P2|Overall Study|Other reason not defined above|0
5490908|NCT01732796|18987912|P1|Overall Study|Other reason not defined above|1
5490909|NCT01732796|18987910|P3|Overall Study|Withdrawal by Subject|2
5490910|NCT01732796|18987911|P2|Overall Study|Withdrawal by Subject|8
5490911|NCT01732796|18987912|P1|Overall Study|Withdrawal by Subject|6
5490912|NCT01732796|18987910|P3|Overall Study|Lost to Follow-up|0
5490913|NCT01732796|18987911|P2|Overall Study|Lost to Follow-up|0
5490914|NCT01732796|18987912|P1|Overall Study|Lost to Follow-up|2
5490915|NCT01732796|18987910|P3|Overall Study|Lack of Efficacy|5
5490916|NCT01732796|18987911|P2|Overall Study|Lack of Efficacy|18
5490917|NCT01732796|18987912|P1|Overall Study|Lack of Efficacy|21
5490918|NCT01732796|18987910|P3|Overall Study|Adverse Event|4
5490919|NCT01732796|18987911|P2|Overall Study|Adverse Event|16
5490920|NCT01732796|18987912|P1|Overall Study|Adverse Event|16
5490921|NCT01732783|18987931|P3|Overall Study|Withdrawal by Subject|0
5490922|NCT01732783|18987932|P2|Overall Study|Withdrawal by Subject|0
5490923|NCT01732783|18987933|P1|Overall Study|Withdrawal by Subject|1
5490924|NCT01732783|18987931|P3|Overall Study|Administrative Decision|1
5490925|NCT01732783|18987932|P2|Overall Study|Administrative Decision|2
5490926|NCT01732783|18987933|P1|Overall Study|Administrative Decision|8
5490927|NCT01732783|18987931|P3|Overall Study|Lost to Follow-up|1
5490928|NCT01732783|18987932|P2|Overall Study|Lost to Follow-up|1
5490929|NCT01732783|18987933|P1|Overall Study|Lost to Follow-up|7
5490930|NCT01732783|18987931|P3|Overall Study|Death|1
5490931|NCT01732783|18987932|P2|Overall Study|Death|4
5490932|NCT01732783|18987933|P1|Overall Study|Death|13
5490933|NCT01732783|18987931|P3|Overall Study|Discontinued Panitumumab Treatment|7
5490934|NCT01732783|18987932|P2|Overall Study|Discontinued Panitumumab Treatment|25
5490935|NCT01732783|18987933|P1|Overall Study|Discontinued Panitumumab Treatment|106
5490936|NCT01732770|18987997|P2|Overall Study|Death|0
5490937|NCT01732770|18987998|P1|Overall Study|Death|1
5490938|NCT01732770|18987997|P2|Overall Study|Decision by Sponsor|2
5490939|NCT01732770|18987998|P1|Overall Study|Decision by Sponsor|2
5490940|NCT01732770|18987997|P2|Overall Study|Withdrawal by Subject|3
5490941|NCT01732770|18987998|P1|Overall Study|Withdrawal by Subject|5
5490942|NCT01732770|18987997|P2|Overall Study|Lost to Follow-up|3
5490943|NCT01732770|18987998|P1|Overall Study|Lost to Follow-up|2
5490944|NCT01732757|18988013|P3|Overall Study|Lost to Follow-up|0
5490945|NCT01732757|18988014|P2|Overall Study|Lost to Follow-up|0
5490946|NCT01732757|18988015|P1|Overall Study|Lost to Follow-up|1
5490947|NCT01732692|18988092|P2|Overall Study|Adverse Event|1
5490948|NCT01732692|18988093|P1|Overall Study|Adverse Event|0
5490949|NCT01732640|18988107|P2|Overall Study|Death|1
5490950|NCT01732640|18988108|P1|Overall Study|Death|0
5490951|NCT01732640|18988107|P2|Overall Study|Adverse Event|1
5490952|NCT01732640|18988108|P1|Overall Study|Adverse Event|0
5490953|NCT01732627|18988125|P2|Overall Study|Withdrawal by Subject|0
5490954|NCT01732627|18988126|P1|Overall Study|Withdrawal by Subject|1
5490955|NCT01732588|18988159|P3|First Intervention (7 Days)|Adverse Event|0
5490956|NCT01732588|18988160|P2|First Intervention (7 Days)|Adverse Event|1
5490957|NCT01732588|18988161|P1|First Intervention (7 Days)|Adverse Event|0
5490958|NCT01732549|18988177|P2|Overall Study|Other|14
5490959|NCT01732549|18988178|P1|Overall Study|Other|8
5490960|NCT01732549|18988177|P2|Overall Study|Disease progression|50
5490961|NCT01732549|18988178|P1|Overall Study|Disease progression|37
5490962|NCT01732549|18988177|P2|Overall Study|Consent withdrawn|6
5490963|NCT01732549|18988178|P1|Overall Study|Consent withdrawn|13
5490964|NCT01732549|18988177|P2|Overall Study|Adverse Event|3
5490965|NCT01732549|18988178|P1|Overall Study|Adverse Event|13
5490966|NCT01732536|18988200|P2|Overall Study|Withdrawal by Subject|1
5490967|NCT01732536|18988201|P1|Overall Study|Withdrawal by Subject|1
5490968|NCT01732510|18988224|P7|Overall Study|Study Terminated By Sponsor|6
5490969|NCT01732510|18988225|P6|Overall Study|Study Terminated By Sponsor|12
5490970|NCT01732510|18988226|P5|Overall Study|Study Terminated By Sponsor|0
5490971|NCT01732510|18988227|P4|Overall Study|Study Terminated By Sponsor|1
5490972|NCT01732510|18988228|P3|Overall Study|Study Terminated By Sponsor|0
5490973|NCT01732510|18988229|P2|Overall Study|Study Terminated By Sponsor|0
5490974|NCT01732510|18988230|P1|Overall Study|Study Terminated By Sponsor|0
5490975|NCT01732510|18988224|P7|Overall Study|Pregnancy|0
5490976|NCT01732510|18988225|P6|Overall Study|Pregnancy|0
5490977|NCT01732510|18988226|P5|Overall Study|Pregnancy|0
5490978|NCT01732510|18988227|P4|Overall Study|Pregnancy|1
5490979|NCT01732510|18988228|P3|Overall Study|Pregnancy|0
5490980|NCT01732510|18988229|P2|Overall Study|Pregnancy|0
5490981|NCT01732510|18988230|P1|Overall Study|Pregnancy|0
5490982|NCT01732510|18988224|P7|Overall Study|Physician Decision|0
5490983|NCT01732510|18988225|P6|Overall Study|Physician Decision|0
5490984|NCT01732510|18988226|P5|Overall Study|Physician Decision|0
5490985|NCT01732510|18988227|P4|Overall Study|Physician Decision|0
5490986|NCT01732510|18988228|P3|Overall Study|Physician Decision|0
5490987|NCT01732510|18988229|P2|Overall Study|Physician Decision|1
5490988|NCT01732510|18988230|P1|Overall Study|Physician Decision|0
5490989|NCT01732510|18988224|P7|Overall Study|Lost to Follow-up|0
5490990|NCT01732510|18988225|P6|Overall Study|Lost to Follow-up|1
5490991|NCT01732510|18988226|P5|Overall Study|Lost to Follow-up|0
5490992|NCT01732510|18988227|P4|Overall Study|Lost to Follow-up|1
5490993|NCT01732510|18988228|P3|Overall Study|Lost to Follow-up|1
5490994|NCT01732510|18988229|P2|Overall Study|Lost to Follow-up|0
5490995|NCT01732510|18988230|P1|Overall Study|Lost to Follow-up|0
5490996|NCT01732510|18988224|P7|Overall Study|Withdrawal by Subject|1
5490997|NCT01732510|18988225|P6|Overall Study|Withdrawal by Subject|0
5490998|NCT01732510|18988226|P5|Overall Study|Withdrawal by Subject|5
5490999|NCT01732510|18988227|P4|Overall Study|Withdrawal by Subject|1
5491000|NCT01732510|18988228|P3|Overall Study|Withdrawal by Subject|2
5491001|NCT01732510|18988229|P2|Overall Study|Withdrawal by Subject|3
5491002|NCT01732510|18988230|P1|Overall Study|Withdrawal by Subject|1
5491003|NCT01732510|18988224|P7|Overall Study|Protocol Violation|0
5491004|NCT01732510|18988225|P6|Overall Study|Protocol Violation|0
5491005|NCT01732510|18988226|P5|Overall Study|Protocol Violation|0
5491006|NCT01732510|18988227|P4|Overall Study|Protocol Violation|1
5491007|NCT01732510|18988228|P3|Overall Study|Protocol Violation|0
5491008|NCT01732510|18988229|P2|Overall Study|Protocol Violation|0
5491009|NCT01732510|18988230|P1|Overall Study|Protocol Violation|0
5491010|NCT01732510|18988224|P7|Overall Study|Adverse Event|1
5491011|NCT01732510|18988225|P6|Overall Study|Adverse Event|0
5491012|NCT01732510|18988226|P5|Overall Study|Adverse Event|0
5491013|NCT01732510|18988227|P4|Overall Study|Adverse Event|0
5491014|NCT01732510|18988228|P3|Overall Study|Adverse Event|1
5491015|NCT01732510|18988229|P2|Overall Study|Adverse Event|1
5491016|NCT01732510|18988230|P1|Overall Study|Adverse Event|0
5491017|NCT01732484|18988309|P1|Overall Study|chronical illness|5
5491018|NCT01732484|18988309|P1|Overall Study|Lost to Follow-up|14
5491019|NCT01732484|18988309|P1|Overall Study|Death|7
5491020|NCT01732471|18988317|P1|Overall Study|Withdrawal by Subject|1
5491021|NCT01732458|18988328|P4|Overall Study|Screen Failure|0
5491022|NCT01732458|18988329|P3|Overall Study|Screen Failure|0
5491023|NCT01732458|18988330|P2|Overall Study|Screen Failure|1
5491024|NCT01732458|18988331|P1|Overall Study|Screen Failure|0
5491025|NCT01732458|18988328|P4|Overall Study|Protocol Violation|2
5491026|NCT01732458|18988329|P3|Overall Study|Protocol Violation|0
5491027|NCT01732458|18988330|P2|Overall Study|Protocol Violation|0
5491028|NCT01732458|18988331|P1|Overall Study|Protocol Violation|2
5491029|NCT01732458|18988328|P4|Overall Study|Physician Decision|0
5491030|NCT01732458|18988329|P3|Overall Study|Physician Decision|2
5491031|NCT01732458|18988330|P2|Overall Study|Physician Decision|2
5491032|NCT01732458|18988331|P1|Overall Study|Physician Decision|1
5491033|NCT01732458|18988328|P4|Overall Study|Non-Compliance With Study Drug|0
5491034|NCT01732458|18988329|P3|Overall Study|Non-Compliance With Study Drug|1
5491035|NCT01732458|18988330|P2|Overall Study|Non-Compliance With Study Drug|0
5491036|NCT01732458|18988331|P1|Overall Study|Non-Compliance With Study Drug|0
5491037|NCT01732458|18988328|P4|Overall Study|Lost to Follow-up|0
5491038|NCT01732458|18988329|P3|Overall Study|Lost to Follow-up|0
5491039|NCT01732458|18988330|P2|Overall Study|Lost to Follow-up|2
5491040|NCT01732458|18988331|P1|Overall Study|Lost to Follow-up|0
5491041|NCT01732107|18988493|P1|Overall Study|Withdrawal by Subject|2
5491042|NCT01732107|18988493|P1|Overall Study|Physician Decision|1
5491043|NCT01732107|18988493|P1|Overall Study|Disease Progression|8
5491044|NCT01732107|18988493|P1|Overall Study|Adverse Event|2
5491045|NCT01731990|18988510|P2|Overall Study|Death|0
5491046|NCT01731990|18988511|P1|Overall Study|Death|1
5491047|NCT01731990|18988510|P2|Overall Study|Protocol deviation|2
5491048|NCT01731990|18988511|P1|Overall Study|Protocol deviation|1
5491049|NCT01731990|18988510|P2|Overall Study|Withdrawal by Subject|1
5491050|NCT01731990|18988511|P1|Overall Study|Withdrawal by Subject|1
5491051|NCT01731990|18988510|P2|Overall Study|Adverse Event|5
5491052|NCT01731990|18988511|P1|Overall Study|Adverse Event|1
5491053|NCT01731938|18988527|P2|Primary Part II|Missed Week 6 visit|3
5491054|NCT01731938|18988528|P1|Primary Part II|Missed Week 6 visit|2
5491055|NCT01731938|18988527|P2|Primary Part II|Death|1
5491056|NCT01731938|18988528|P1|Primary Part II|Death|2
5491057|NCT01731938|18988527|P2|Primary Part II|Lost to Follow-up|5
5491058|NCT01731938|18988528|P1|Primary Part II|Lost to Follow-up|4
5491059|NCT01731938|18988527|P2|Primary Part II|Withdrawal by Subject|4
5491060|NCT01731938|18988528|P1|Primary Part II|Withdrawal by Subject|5
5491061|NCT01731938|18988527|P2|Preliminary Part I|Missed Week 6 visit|3
5491062|NCT01731938|18988528|P1|Preliminary Part I|Missed Week 6 visit|0
5491063|NCT01731938|18988527|P2|Preliminary Part I|Lost to Follow-up|3
5491064|NCT01731938|18988528|P1|Preliminary Part I|Lost to Follow-up|0
5491065|NCT01731938|18988527|P2|Preliminary Part I|Physician Decision|0
5491066|NCT01731938|18988528|P1|Preliminary Part I|Physician Decision|1
5491067|NCT01731938|18988527|P2|Preliminary Part I|Withdrawal by Subject|2
5491068|NCT01731938|18988528|P1|Preliminary Part I|Withdrawal by Subject|2
5491069|NCT01731912|18988540|P1|Overall Study|noncompliance|2
5491070|NCT01731886|18988547|P2|Overall Study|Non-compliant|0
5491071|NCT01731886|18988548|P1|Overall Study|Non-compliant|1
5491072|NCT01731886|18988547|P2|Overall Study|Never started treatment|1
5491073|NCT01731886|18988548|P1|Overall Study|Never started treatment|0
5491074|NCT01731886|18988547|P2|Overall Study|Death|0
5491075|NCT01731886|18988548|P1|Overall Study|Death|1
5491076|NCT01731678|18988593|P1|Overall Study|RMT too high, making TMS difficult|3
5491077|NCT01731678|18988593|P1|Overall Study|Did not meet inclusion criteria|1
5491078|NCT01731678|18988593|P1|Overall Study|Withdrawal by Subject|3
5491079|NCT01731600|18988599|P2|Overall Study|Other reasons|0
5491080|NCT01731600|18988600|P1|Overall Study|Other reasons|3
5491081|NCT01731600|18988599|P2|Overall Study|Withdrawal criteria|0
5491082|NCT01731600|18988600|P1|Overall Study|Withdrawal criteria|1
5491083|NCT01731600|18988599|P2|Overall Study|Adverse Event|0
5491084|NCT01731600|18988600|P1|Overall Study|Adverse Event|2
5491085|NCT01731470|18988654|P1|Overall Study|Did not meet study criteria|1
5491086|NCT01731470|18988654|P1|Overall Study|Withdrawal by Subject|1
5491087|NCT01731171|18988661|P2|Overall Study|Terminated for Safety Reasons|1
5491088|NCT01731171|18988662|P1|Overall Study|Terminated for Safety Reasons|0
5491089|NCT01731171|18988661|P2|Overall Study|Terminated for Lack of Adherence|1
5491090|NCT01731171|18988662|P1|Overall Study|Terminated for Lack of Adherence|0
5491091|NCT01731171|18988661|P2|Overall Study|Moved out of Area|2
5491092|NCT01731171|18988662|P1|Overall Study|Moved out of Area|0
5491093|NCT01731171|18988661|P2|Overall Study|Lost to Follow-up|2
5491094|NCT01731171|18988662|P1|Overall Study|Lost to Follow-up|3
5491095|NCT01731171|18988661|P2|Overall Study|Withdrawal by Subject|1
5491096|NCT01731171|18988662|P1|Overall Study|Withdrawal by Subject|4
5491097|NCT01731002|18988696|P3|Overall Study|Inappropriate use of study medications|1
5491098|NCT01731002|18988697|P2|Overall Study|Inappropriate use of study medications|0
5491099|NCT01731002|18988698|P1|Overall Study|Inappropriate use of study medications|0
5491100|NCT01731002|18988696|P3|Overall Study|Elevated IOP|0
5491101|NCT01731002|18988697|P2|Overall Study|Elevated IOP|0
5491102|NCT01731002|18988698|P1|Overall Study|Elevated IOP|1
5491103|NCT01731002|18988696|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
5491104|NCT01731002|18988697|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
5491105|NCT01731002|18988698|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
5491106|NCT01731002|18988696|P3|Overall Study|Test Agent Discontinuation|0
5491107|NCT01731002|18988697|P2|Overall Study|Test Agent Discontinuation|1
5491108|NCT01731002|18988698|P1|Overall Study|Test Agent Discontinuation|0
5491109|NCT01731002|18988696|P3|Overall Study|Lost to Follow-up|0
5491110|NCT01731002|18988697|P2|Overall Study|Lost to Follow-up|0
5491111|NCT01731002|18988698|P1|Overall Study|Lost to Follow-up|1
5491112|NCT01731002|18988696|P3|Overall Study|Non-Compliant|0
5491113|NCT01731002|18988697|P2|Overall Study|Non-Compliant|1
5491114|NCT01731002|18988698|P1|Overall Study|Non-Compliant|0
5491115|NCT01731002|18988696|P3|Overall Study|Adverse Event|2
5491116|NCT01731002|18988697|P2|Overall Study|Adverse Event|2
5491117|NCT01731002|18988698|P1|Overall Study|Adverse Event|0
5491118|NCT01730950|18988711|P2|Overall Study|Protocol Violation|6
5491119|NCT01730950|18988712|P1|Overall Study|Protocol Violation|6
5491120|NCT01730729|18988758|P1|Overall Study|Progressive Disease|12
5491121|NCT01730729|18988758|P1|Overall Study|Death|1
5491122|NCT01730729|18988758|P1|Overall Study|Adverse Event|1
5491123|NCT01730586|18988772|P1|Overall Study|Hospice|1
5491124|NCT01730586|18988772|P1|Overall Study|Adverse Event|2
5491125|NCT01730586|18988772|P1|Overall Study|Inadequate Trial|8
5491126|NCT01730586|18988772|P1|Overall Study|Progressive Disease|2
5491127|NCT01730534|18988781|P2|Overall Study|Lost to Follow-up|18
5491128|NCT01730534|18988782|P1|Overall Study|Lost to Follow-up|12
5491129|NCT01730534|18988781|P2|Overall Study|Withdrawal by Subject|127
5491130|NCT01730534|18988782|P1|Overall Study|Withdrawal by Subject|97
5491131|NCT01730378|18988796|P2|Overall Study|Lost to Follow-up|0
5491132|NCT01730378|18988797|P1|Overall Study|Lost to Follow-up|1
5491133|NCT01730339|18988828|P2|Overall Study|Un-specified|0
5491134|NCT01730339|18988829|P1|Overall Study|Un-specified|1
5491135|NCT01730339|18988828|P2|Overall Study|Lost to Follow-up|1
5491136|NCT01730339|18988829|P1|Overall Study|Lost to Follow-up|1
5491137|NCT01730339|18988828|P2|Overall Study|Withdrawal by Subject|2
5491138|NCT01730339|18988829|P1|Overall Study|Withdrawal by Subject|3
5491139|NCT01730053|18988869|P6|Overall Study|Other than specified|9
5491140|NCT01730053|18988870|P5|Overall Study|Other than specified|7
5491141|NCT01730053|18988871|P4|Overall Study|Other than specified|4
5491142|NCT01730053|18988872|P3|Overall Study|Other than specified|5
5491143|NCT01730053|18988873|P2|Overall Study|Other than specified|6
5491144|NCT01730053|18988874|P1|Overall Study|Other than specified|2
5491145|NCT01730053|18988869|P6|Overall Study|Poor compliance to protocol|2
5491146|NCT01730053|18988870|P5|Overall Study|Poor compliance to protocol|0
5491147|NCT01730053|18988871|P4|Overall Study|Poor compliance to protocol|0
5491148|NCT01730053|18988872|P3|Overall Study|Poor compliance to protocol|2
5491149|NCT01730053|18988873|P2|Overall Study|Poor compliance to protocol|2
5491150|NCT01730053|18988874|P1|Overall Study|Poor compliance to protocol|1
5491151|NCT01730053|18988869|P6|Overall Study|Adverse Event|2
5491152|NCT01730053|18988870|P5|Overall Study|Adverse Event|2
5491153|NCT01730053|18988871|P4|Overall Study|Adverse Event|3
5491154|NCT01730053|18988872|P3|Overall Study|Adverse Event|3
5491155|NCT01730053|18988873|P2|Overall Study|Adverse Event|6
5491156|NCT01730053|18988874|P1|Overall Study|Adverse Event|2
5491157|NCT01730053|18988869|P6|Overall Study|Physician Decision|0
5491158|NCT01730053|18988870|P5|Overall Study|Physician Decision|0
5491159|NCT01730053|18988871|P4|Overall Study|Physician Decision|1
5491160|NCT01730053|18988872|P3|Overall Study|Physician Decision|0
5491161|NCT01730053|18988873|P2|Overall Study|Physician Decision|0
5491162|NCT01730053|18988874|P1|Overall Study|Physician Decision|0
5491163|NCT01730053|18988869|P6|Overall Study|Participant moved|0
5491164|NCT01730053|18988870|P5|Overall Study|Participant moved|0
5491165|NCT01730053|18988871|P4|Overall Study|Participant moved|0
5491166|NCT01730053|18988872|P3|Overall Study|Participant moved|1
5491167|NCT01730053|18988873|P2|Overall Study|Participant moved|0
5491168|NCT01730053|18988874|P1|Overall Study|Participant moved|0
5491169|NCT01730040|18989033|P7|Overall Study|Poor compliance to protocol|1
5491170|NCT01730040|18989034|P6|Overall Study|Poor compliance to protocol|0
5491171|NCT01730040|18989035|P5|Overall Study|Poor compliance to protocol|0
5491172|NCT01730040|18989036|P4|Overall Study|Poor compliance to protocol|0
5491173|NCT01730040|18989037|P3|Overall Study|Poor compliance to protocol|0
5491174|NCT01730040|18989038|P2|Overall Study|Poor compliance to protocol|4
5491175|NCT01730040|18989039|P1|Overall Study|Poor compliance to protocol|2
5491176|NCT01730040|18989033|P7|Overall Study|Adverse Event|2
5491177|NCT01730040|18989034|P6|Overall Study|Adverse Event|1
5491178|NCT01730040|18989035|P5|Overall Study|Adverse Event|1
5491179|NCT01730040|18989036|P4|Overall Study|Adverse Event|3
5491180|NCT01730040|18989037|P3|Overall Study|Adverse Event|5
5491181|NCT01730040|18989038|P2|Overall Study|Adverse Event|3
5491182|NCT01730040|18989039|P1|Overall Study|Adverse Event|4
5491183|NCT01730040|18989033|P7|Overall Study|Other than specified|4
5491184|NCT01730040|18989034|P6|Overall Study|Other than specified|4
5491185|NCT01730040|18989035|P5|Overall Study|Other than specified|5
5491186|NCT01730040|18989036|P4|Overall Study|Other than specified|5
5491187|NCT01730040|18989037|P3|Overall Study|Other than specified|5
5491188|NCT01730040|18989038|P2|Overall Study|Other than specified|8
5491189|NCT01730040|18989039|P1|Overall Study|Other than specified|7
5491190|NCT01730040|18989033|P7|Overall Study|Physician Decision|1
5491191|NCT01730040|18989034|P6|Overall Study|Physician Decision|1
5491192|NCT01730040|18989035|P5|Overall Study|Physician Decision|0
5491193|NCT01730040|18989036|P4|Overall Study|Physician Decision|0
5491194|NCT01730040|18989037|P3|Overall Study|Physician Decision|0
5491195|NCT01730040|18989038|P2|Overall Study|Physician Decision|0
5491196|NCT01730040|18989039|P1|Overall Study|Physician Decision|0
5491197|NCT01730040|18989033|P7|Overall Study|Subject moved|1
5491198|NCT01730040|18989034|P6|Overall Study|Subject moved|0
5491199|NCT01730040|18989035|P5|Overall Study|Subject moved|0
5491200|NCT01730040|18989036|P4|Overall Study|Subject moved|0
5491201|NCT01730040|18989037|P3|Overall Study|Subject moved|1
5491202|NCT01730040|18989038|P2|Overall Study|Subject moved|0
5491203|NCT01730040|18989039|P1|Overall Study|Subject moved|0
5491204|NCT01730040|18989033|P7|Overall Study|Randomized but not treated|0
5491205|NCT01730040|18989034|P6|Overall Study|Randomized but not treated|1
5491206|NCT01730040|18989035|P5|Overall Study|Randomized but not treated|0
5491207|NCT01730040|18989036|P4|Overall Study|Randomized but not treated|0
5491208|NCT01730040|18989037|P3|Overall Study|Randomized but not treated|0
5491209|NCT01730040|18989038|P2|Overall Study|Randomized but not treated|0
5491210|NCT01730040|18989039|P1|Overall Study|Randomized but not treated|0
5491211|NCT01729871|18989228|P2|Overall Study|Other|9
5491212|NCT01729871|18989229|P1|Overall Study|Other|4
5491213|NCT01729871|18989228|P2|Overall Study|Withdrawal by Subject|3
5491214|NCT01729871|18989229|P1|Overall Study|Withdrawal by Subject|0
5491215|NCT01729871|18989228|P2|Overall Study|Protocol Violation|0
5491216|NCT01729871|18989229|P1|Overall Study|Protocol Violation|1
5491217|NCT01729871|18989228|P2|Overall Study|Physician Decision|2
5491218|NCT01729871|18989229|P1|Overall Study|Physician Decision|0
5491219|NCT01729871|18989228|P2|Overall Study|Lack of Efficacy|1
5491220|NCT01729871|18989229|P1|Overall Study|Lack of Efficacy|0
5491221|NCT01729871|18989228|P2|Overall Study|Death|1
5491222|NCT01729871|18989229|P1|Overall Study|Death|0
5491223|NCT01729871|18989228|P2|Overall Study|Adverse Event|7
5491224|NCT01729871|18989229|P1|Overall Study|Adverse Event|7
5491225|NCT01729819|18989263|P2|Overall Study|Withdrawal by Subject|2
5491226|NCT01729819|18989264|P1|Overall Study|Withdrawal by Subject|0
5491227|NCT01729819|18989263|P2|Overall Study|Protocol Violation|1
5491228|NCT01729819|18989264|P1|Overall Study|Protocol Violation|0
5491229|NCT01729819|18989263|P2|Overall Study|Other reason|0
5491230|NCT01729819|18989264|P1|Overall Study|Other reason|1
5491231|NCT01729819|18989263|P2|Overall Study|Lost to Follow-up|0
5491232|NCT01729819|18989264|P1|Overall Study|Lost to Follow-up|2
5491233|NCT01729819|18989263|P2|Overall Study|Lack of Efficacy|0
5491234|NCT01729819|18989264|P1|Overall Study|Lack of Efficacy|1
5491235|NCT01729819|18989263|P2|Overall Study|Adverse Event|4
5491236|NCT01729819|18989264|P1|Overall Study|Adverse Event|2
5491237|NCT01729754|18989283|P10|Part 3|Other Protocol Specified Criteria|0
5491238|NCT01729754|18989284|P9|Part 3|Other Protocol Specified Criteria|0
5491239|NCT01729754|18989285|P8|Part 3|Other Protocol Specified Criteria|1
5491240|NCT01729754|18989286|P7|Part 3|Other Protocol Specified Criteria|0
5491241|NCT01729754|18989287|P6|Part 3|Other Protocol Specified Criteria|2
5491242|NCT01729754|18989288|P5|Part 3|Other Protocol Specified Criteria|0
5491243|NCT01729754|18989289|P4|Part 3|Other Protocol Specified Criteria|0
5491244|NCT01729754|18989290|P3|Part 3|Other Protocol Specified Criteria|0
5491245|NCT01729754|18989291|P2|Part 3|Other Protocol Specified Criteria|0
5491246|NCT01729754|18989292|P1|Part 3|Other Protocol Specified Criteria|0
5491247|NCT01729754|18989283|P10|Part 3|Withdrawal by Subject|0
5491248|NCT01729754|18989284|P9|Part 3|Withdrawal by Subject|0
5491249|NCT01729754|18989285|P8|Part 3|Withdrawal by Subject|2
5491250|NCT01729754|18989286|P7|Part 3|Withdrawal by Subject|0
5491251|NCT01729754|18989287|P6|Part 3|Withdrawal by Subject|1
5491252|NCT01729754|18989288|P5|Part 3|Withdrawal by Subject|2
5491253|NCT01729754|18989289|P4|Part 3|Withdrawal by Subject|0
5491254|NCT01729754|18989290|P3|Part 3|Withdrawal by Subject|1
5491255|NCT01729754|18989291|P2|Part 3|Withdrawal by Subject|4
5491256|NCT01729754|18989292|P1|Part 3|Withdrawal by Subject|0
5491257|NCT01729754|18989283|P10|Part 3|Physician Decision|0
5491258|NCT01729754|18989284|P9|Part 3|Physician Decision|0
5491259|NCT01729754|18989285|P8|Part 3|Physician Decision|0
5491260|NCT01729754|18989286|P7|Part 3|Physician Decision|0
5491261|NCT01729754|18989287|P6|Part 3|Physician Decision|0
5491262|NCT01729754|18989288|P5|Part 3|Physician Decision|0
5491263|NCT01729754|18989289|P4|Part 3|Physician Decision|0
5491264|NCT01729754|18989290|P3|Part 3|Physician Decision|1
5491265|NCT01729754|18989291|P2|Part 3|Physician Decision|0
5491266|NCT01729754|18989292|P1|Part 3|Physician Decision|0
5491267|NCT01729754|18989283|P10|Part 3|Lost to Follow-up|0
5491268|NCT01729754|18989284|P9|Part 3|Lost to Follow-up|1
5491269|NCT01729754|18989285|P8|Part 3|Lost to Follow-up|0
5491270|NCT01729754|18989286|P7|Part 3|Lost to Follow-up|0
5491271|NCT01729754|18989287|P6|Part 3|Lost to Follow-up|3
5491272|NCT01729754|18989288|P5|Part 3|Lost to Follow-up|0
5491273|NCT01729754|18989289|P4|Part 3|Lost to Follow-up|0
5491274|NCT01729754|18989290|P3|Part 3|Lost to Follow-up|2
5491275|NCT01729754|18989291|P2|Part 3|Lost to Follow-up|1
5491276|NCT01729754|18989292|P1|Part 3|Lost to Follow-up|0
5491277|NCT01729754|18989283|P10|Part 3|Lack of Efficacy|4
5491278|NCT01729754|18989284|P9|Part 3|Lack of Efficacy|0
5491279|NCT01729754|18989285|P8|Part 3|Lack of Efficacy|0
5491280|NCT01729754|18989286|P7|Part 3|Lack of Efficacy|0
5491281|NCT01729754|18989287|P6|Part 3|Lack of Efficacy|0
5491282|NCT01729754|18989288|P5|Part 3|Lack of Efficacy|2
5491283|NCT01729754|18989289|P4|Part 3|Lack of Efficacy|0
5491284|NCT01729754|18989290|P3|Part 3|Lack of Efficacy|0
5491285|NCT01729754|18989291|P2|Part 3|Lack of Efficacy|0
5491286|NCT01729754|18989292|P1|Part 3|Lack of Efficacy|0
5491287|NCT01729754|18989283|P10|Part 3|Death|0
5491288|NCT01729754|18989284|P9|Part 3|Death|0
5491289|NCT01729754|18989285|P8|Part 3|Death|0
5491290|NCT01729754|18989286|P7|Part 3|Death|0
5491291|NCT01729754|18989287|P6|Part 3|Death|2
5491292|NCT01729754|18989288|P5|Part 3|Death|0
5491293|NCT01729754|18989289|P4|Part 3|Death|0
5491294|NCT01729754|18989290|P3|Part 3|Death|0
5491295|NCT01729754|18989291|P2|Part 3|Death|0
5491296|NCT01729754|18989292|P1|Part 3|Death|0
5491297|NCT01729754|18989283|P10|Part 3|Adverse Event|3
5491298|NCT01729754|18989284|P9|Part 3|Adverse Event|0
5491299|NCT01729754|18989285|P8|Part 3|Adverse Event|0
5491300|NCT01729754|18989286|P7|Part 3|Adverse Event|0
5491301|NCT01729754|18989287|P6|Part 3|Adverse Event|5
5491302|NCT01729754|18989288|P5|Part 3|Adverse Event|0
5491303|NCT01729754|18989289|P4|Part 3|Adverse Event|0
5491304|NCT01729754|18989290|P3|Part 3|Adverse Event|1
5491305|NCT01729754|18989291|P2|Part 3|Adverse Event|0
5491306|NCT01729754|18989292|P1|Part 3|Adverse Event|0
5491307|NCT01729754|18989283|P10|Part 2|Other Protocol Specified Criteria|0
5491308|NCT01729754|18989284|P9|Part 2|Other Protocol Specified Criteria|0
5491309|NCT01729754|18989285|P8|Part 2|Other Protocol Specified Criteria|1
5491310|NCT01729754|18989286|P7|Part 2|Other Protocol Specified Criteria|0
5491311|NCT01729754|18989287|P6|Part 2|Other Protocol Specified Criteria|0
5491312|NCT01729754|18989288|P5|Part 2|Other Protocol Specified Criteria|0
5491313|NCT01729754|18989289|P4|Part 2|Other Protocol Specified Criteria|0
5491314|NCT01729754|18989290|P3|Part 2|Other Protocol Specified Criteria|0
5491315|NCT01729754|18989291|P2|Part 2|Other Protocol Specified Criteria|0
5491316|NCT01729754|18989292|P1|Part 2|Other Protocol Specified Criteria|1
5491317|NCT01729754|18989283|P10|Part 2|Withdrawal by Subject|4
5491318|NCT01729754|18989284|P9|Part 2|Withdrawal by Subject|1
5491319|NCT01729754|18989285|P8|Part 2|Withdrawal by Subject|1
5491320|NCT01729754|18989286|P7|Part 2|Withdrawal by Subject|0
5491321|NCT01729754|18989287|P6|Part 2|Withdrawal by Subject|0
5491322|NCT01729754|18989288|P5|Part 2|Withdrawal by Subject|0
5491323|NCT01729754|18989289|P4|Part 2|Withdrawal by Subject|2
5491324|NCT01729754|18989290|P3|Part 2|Withdrawal by Subject|0
5491325|NCT01729754|18989291|P2|Part 2|Withdrawal by Subject|0
5491326|NCT01729754|18989292|P1|Part 2|Withdrawal by Subject|3
5491327|NCT01729754|18989283|P10|Part 2|Pregnancy|1
5491328|NCT01729754|18989284|P9|Part 2|Pregnancy|0
5491329|NCT01729754|18989285|P8|Part 2|Pregnancy|0
5491330|NCT01729754|18989286|P7|Part 2|Pregnancy|0
5491331|NCT01729754|18989287|P6|Part 2|Pregnancy|0
5491332|NCT01729754|18989288|P5|Part 2|Pregnancy|0
5491333|NCT01729754|18989289|P4|Part 2|Pregnancy|1
5491334|NCT01729754|18989290|P3|Part 2|Pregnancy|0
5491335|NCT01729754|18989291|P2|Part 2|Pregnancy|0
5491336|NCT01729754|18989292|P1|Part 2|Pregnancy|0
5491337|NCT01729754|18989283|P10|Part 2|Non-Compliance with Study Drug|1
5491338|NCT01729754|18989284|P9|Part 2|Non-Compliance with Study Drug|0
5491339|NCT01729754|18989285|P8|Part 2|Non-Compliance with Study Drug|0
5491340|NCT01729754|18989286|P7|Part 2|Non-Compliance with Study Drug|0
5491341|NCT01729754|18989287|P6|Part 2|Non-Compliance with Study Drug|0
5491342|NCT01729754|18989288|P5|Part 2|Non-Compliance with Study Drug|0
5491343|NCT01729754|18989289|P4|Part 2|Non-Compliance with Study Drug|0
5491344|NCT01729754|18989290|P3|Part 2|Non-Compliance with Study Drug|0
5491345|NCT01729754|18989291|P2|Part 2|Non-Compliance with Study Drug|0
5491346|NCT01729754|18989292|P1|Part 2|Non-Compliance with Study Drug|0
5491347|NCT01729754|18989283|P10|Part 2|Lost to Follow-up|2
5491348|NCT01729754|18989284|P9|Part 2|Lost to Follow-up|0
5491349|NCT01729754|18989285|P8|Part 2|Lost to Follow-up|1
5491350|NCT01729754|18989286|P7|Part 2|Lost to Follow-up|0
5491351|NCT01729754|18989287|P6|Part 2|Lost to Follow-up|0
5491352|NCT01729754|18989288|P5|Part 2|Lost to Follow-up|0
5491353|NCT01729754|18989289|P4|Part 2|Lost to Follow-up|2
5491354|NCT01729754|18989290|P3|Part 2|Lost to Follow-up|0
5491355|NCT01729754|18989291|P2|Part 2|Lost to Follow-up|0
5491356|NCT01729754|18989292|P1|Part 2|Lost to Follow-up|0
5491357|NCT01729754|18989283|P10|Part 2|Lack of Efficacy|2
5491358|NCT01729754|18989284|P9|Part 2|Lack of Efficacy|2
5491359|NCT01729754|18989285|P8|Part 2|Lack of Efficacy|0
5491360|NCT01729754|18989286|P7|Part 2|Lack of Efficacy|0
5491361|NCT01729754|18989287|P6|Part 2|Lack of Efficacy|0
5491362|NCT01729754|18989288|P5|Part 2|Lack of Efficacy|0
5491363|NCT01729754|18989289|P4|Part 2|Lack of Efficacy|0
5491364|NCT01729754|18989290|P3|Part 2|Lack of Efficacy|0
5491365|NCT01729754|18989291|P2|Part 2|Lack of Efficacy|0
5491366|NCT01729754|18989292|P1|Part 2|Lack of Efficacy|0
5491367|NCT01729754|18989283|P10|Part 2|Adverse Event|2
5491368|NCT01729754|18989284|P9|Part 2|Adverse Event|1
5491369|NCT01729754|18989285|P8|Part 2|Adverse Event|0
5491370|NCT01729754|18989286|P7|Part 2|Adverse Event|0
5491371|NCT01729754|18989287|P6|Part 2|Adverse Event|0
5491372|NCT01729754|18989288|P5|Part 2|Adverse Event|0
5491373|NCT01729754|18989289|P4|Part 2|Adverse Event|0
5491374|NCT01729754|18989290|P3|Part 2|Adverse Event|0
5491375|NCT01729754|18989291|P2|Part 2|Adverse Event|0
5491376|NCT01729754|18989292|P1|Part 2|Adverse Event|2
5491377|NCT01729754|18989283|P10|Part 1|Other Protocol Specified Criteria|4
5491378|NCT01729754|18989284|P9|Part 1|Other Protocol Specified Criteria|0
5491379|NCT01729754|18989285|P8|Part 1|Other Protocol Specified Criteria|0
5491380|NCT01729754|18989286|P7|Part 1|Other Protocol Specified Criteria|1
5491381|NCT01729754|18989287|P6|Part 1|Other Protocol Specified Criteria|0
5491382|NCT01729754|18989288|P5|Part 1|Other Protocol Specified Criteria|0
5491383|NCT01729754|18989289|P4|Part 1|Other Protocol Specified Criteria|0
5491384|NCT01729754|18989290|P3|Part 1|Other Protocol Specified Criteria|0
5491385|NCT01729754|18989291|P2|Part 1|Other Protocol Specified Criteria|0
5491386|NCT01729754|18989292|P1|Part 1|Other Protocol Specified Criteria|2
5491387|NCT01729754|18989283|P10|Part 1|Withdrawal by Subject|6
5491388|NCT01729754|18989284|P9|Part 1|Withdrawal by Subject|0
5491389|NCT01729754|18989285|P8|Part 1|Withdrawal by Subject|0
5491390|NCT01729754|18989286|P7|Part 1|Withdrawal by Subject|5
5491391|NCT01729754|18989287|P6|Part 1|Withdrawal by Subject|0
5491392|NCT01729754|18989288|P5|Part 1|Withdrawal by Subject|0
5491393|NCT01729754|18989289|P4|Part 1|Withdrawal by Subject|7
5491394|NCT01729754|18989290|P3|Part 1|Withdrawal by Subject|0
5491395|NCT01729754|18989291|P2|Part 1|Withdrawal by Subject|0
5491396|NCT01729754|18989292|P1|Part 1|Withdrawal by Subject|5
5491397|NCT01729754|18989283|P10|Part 1|Protocol Violation|0
5491398|NCT01729754|18989284|P9|Part 1|Protocol Violation|0
5491399|NCT01729754|18989285|P8|Part 1|Protocol Violation|0
5491400|NCT01729754|18989286|P7|Part 1|Protocol Violation|1
5491401|NCT01729754|18989287|P6|Part 1|Protocol Violation|0
5491402|NCT01729754|18989288|P5|Part 1|Protocol Violation|0
5491403|NCT01729754|18989289|P4|Part 1|Protocol Violation|1
5491404|NCT01729754|18989290|P3|Part 1|Protocol Violation|0
5491405|NCT01729754|18989291|P2|Part 1|Protocol Violation|0
5491406|NCT01729754|18989292|P1|Part 1|Protocol Violation|2
5491407|NCT01729754|18989283|P10|Part 1|Progressive Disease|1
5491408|NCT01729754|18989284|P9|Part 1|Progressive Disease|0
5491409|NCT01729754|18989285|P8|Part 1|Progressive Disease|0
5491410|NCT01729754|18989286|P7|Part 1|Progressive Disease|0
5491411|NCT01729754|18989287|P6|Part 1|Progressive Disease|0
5491412|NCT01729754|18989288|P5|Part 1|Progressive Disease|0
5491413|NCT01729754|18989289|P4|Part 1|Progressive Disease|0
5491414|NCT01729754|18989290|P3|Part 1|Progressive Disease|0
5491415|NCT01729754|18989291|P2|Part 1|Progressive Disease|0
5491416|NCT01729754|18989292|P1|Part 1|Progressive Disease|0
5491417|NCT01729754|18989283|P10|Part 1|Pregnancy|1
5491418|NCT01729754|18989284|P9|Part 1|Pregnancy|0
5491419|NCT01729754|18989285|P8|Part 1|Pregnancy|0
5491420|NCT01729754|18989286|P7|Part 1|Pregnancy|0
5491421|NCT01729754|18989287|P6|Part 1|Pregnancy|0
5491422|NCT01729754|18989288|P5|Part 1|Pregnancy|0
5491423|NCT01729754|18989289|P4|Part 1|Pregnancy|1
5491424|NCT01729754|18989290|P3|Part 1|Pregnancy|0
5491425|NCT01729754|18989291|P2|Part 1|Pregnancy|0
5491426|NCT01729754|18989292|P1|Part 1|Pregnancy|0
5491427|NCT01729754|18989283|P10|Part 1|Physician Decision|4
5491428|NCT01729754|18989284|P9|Part 1|Physician Decision|0
5491429|NCT01729754|18989285|P8|Part 1|Physician Decision|0
5491430|NCT01729754|18989286|P7|Part 1|Physician Decision|0
5491431|NCT01729754|18989287|P6|Part 1|Physician Decision|0
5491432|NCT01729754|18989288|P5|Part 1|Physician Decision|0
5491433|NCT01729754|18989289|P4|Part 1|Physician Decision|0
5491434|NCT01729754|18989290|P3|Part 1|Physician Decision|0
5491435|NCT01729754|18989291|P2|Part 1|Physician Decision|0
5491436|NCT01729754|18989292|P1|Part 1|Physician Decision|0
5491437|NCT01729754|18989283|P10|Part 1|Non-compliance with Study Drug|0
5491438|NCT01729754|18989284|P9|Part 1|Non-compliance with Study Drug|0
5491439|NCT01729754|18989285|P8|Part 1|Non-compliance with Study Drug|0
5491440|NCT01729754|18989286|P7|Part 1|Non-compliance with Study Drug|0
5491441|NCT01729754|18989287|P6|Part 1|Non-compliance with Study Drug|0
5491442|NCT01729754|18989288|P5|Part 1|Non-compliance with Study Drug|0
5491443|NCT01729754|18989289|P4|Part 1|Non-compliance with Study Drug|0
5491444|NCT01729754|18989290|P3|Part 1|Non-compliance with Study Drug|0
5491445|NCT01729754|18989291|P2|Part 1|Non-compliance with Study Drug|0
5491446|NCT01729754|18989292|P1|Part 1|Non-compliance with Study Drug|1
5491447|NCT01729754|18989283|P10|Part 1|Lost to Follow-up|3
5491448|NCT01729754|18989284|P9|Part 1|Lost to Follow-up|0
5491449|NCT01729754|18989285|P8|Part 1|Lost to Follow-up|0
5491450|NCT01729754|18989286|P7|Part 1|Lost to Follow-up|3
5491451|NCT01729754|18989287|P6|Part 1|Lost to Follow-up|0
5491452|NCT01729754|18989288|P5|Part 1|Lost to Follow-up|0
5491453|NCT01729754|18989289|P4|Part 1|Lost to Follow-up|2
5491454|NCT01729754|18989290|P3|Part 1|Lost to Follow-up|0
5491455|NCT01729754|18989291|P2|Part 1|Lost to Follow-up|0
5491456|NCT01729754|18989292|P1|Part 1|Lost to Follow-up|1
5491457|NCT01729754|18989283|P10|Part 1|Lack of Efficacy|0
5491458|NCT01729754|18989284|P9|Part 1|Lack of Efficacy|0
5491459|NCT01729754|18989285|P8|Part 1|Lack of Efficacy|0
5491460|NCT01729754|18989286|P7|Part 1|Lack of Efficacy|2
5491461|NCT01729754|18989287|P6|Part 1|Lack of Efficacy|0
5491462|NCT01729754|18989288|P5|Part 1|Lack of Efficacy|0
5491463|NCT01729754|18989289|P4|Part 1|Lack of Efficacy|0
5491464|NCT01729754|18989290|P3|Part 1|Lack of Efficacy|0
5491465|NCT01729754|18989291|P2|Part 1|Lack of Efficacy|0
5491466|NCT01729754|18989292|P1|Part 1|Lack of Efficacy|1
5491467|NCT01729754|18989283|P10|Part 1|Adverse Event|5
5491468|NCT01729754|18989284|P9|Part 1|Adverse Event|0
5491469|NCT01729754|18989285|P8|Part 1|Adverse Event|0
5491470|NCT01729754|18989286|P7|Part 1|Adverse Event|2
5491471|NCT01729754|18989287|P6|Part 1|Adverse Event|0
5491472|NCT01729754|18989288|P5|Part 1|Adverse Event|0
5491473|NCT01729754|18989289|P4|Part 1|Adverse Event|1
5491474|NCT01729754|18989290|P3|Part 1|Adverse Event|0
5491475|NCT01729754|18989291|P2|Part 1|Adverse Event|0
5491476|NCT01729754|18989292|P1|Part 1|Adverse Event|2
5491477|NCT01729728|18989499|P3|Overall Study|Protocol Violation|1
5491478|NCT01729728|18989500|P2|Overall Study|Protocol Violation|0
5491479|NCT01729728|18989501|P1|Overall Study|Protocol Violation|1
5491480|NCT01729728|18989499|P3|Overall Study|Adverse Event|0
5491481|NCT01729728|18989500|P2|Overall Study|Adverse Event|6
5491482|NCT01729728|18989501|P1|Overall Study|Adverse Event|0
5491483|NCT01729559|18989651|P2|Overall Study|Protocol Violation|28
5491484|NCT01729559|18989652|P1|Overall Study|Protocol Violation|31
5491485|NCT01729208|18989695|P2|36 Months Follow-up|Withdrawal by Subject|4
5491486|NCT01729208|18989696|P1|36 Months Follow-up|Withdrawal by Subject|2
5491487|NCT01729208|18989695|P2|36 Months Follow-up|Physician Decision|0
5491488|NCT01729208|18989696|P1|36 Months Follow-up|Physician Decision|1
5491489|NCT01729208|18989695|P2|24 Months Follow-up|Lost to Follow-up|0
5491490|NCT01729208|18989696|P1|24 Months Follow-up|Lost to Follow-up|3
5491491|NCT01729208|18989695|P2|12 Months Follow-up|Lost to Follow-up|3
5491492|NCT01729208|18989696|P1|12 Months Follow-up|Lost to Follow-up|3
5491493|NCT01729208|18989695|P2|12 Months Follow-up|Withdrawal by Subject|7
5491494|NCT01729208|18989696|P1|12 Months Follow-up|Withdrawal by Subject|4
5491495|NCT01729208|18989695|P2|Baseline|Physician Decision|4
5491496|NCT01729208|18989696|P1|Baseline|Physician Decision|5
5491497|NCT01729156|18989729|P3|Overall Study|Withdrawal by Subject|0
5491498|NCT01729156|18989730|P2|Overall Study|Withdrawal by Subject|0
5491499|NCT01729156|18989731|P1|Overall Study|Withdrawal by Subject|1
5491500|NCT01729039|18989759|P2|Overall Study|Withdrawal by Subject|7
5491501|NCT01729039|18989760|P1|Overall Study|Withdrawal by Subject|8
5491502|NCT01729039|18989759|P2|Overall Study|disqualified|5
5491503|NCT01729039|18989760|P1|Overall Study|disqualified|2
5491504|NCT01729026|18989776|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
5491505|NCT01729026|18989777|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
5491506|NCT01729026|18989776|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
5491507|NCT01729026|18989777|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
5491508|NCT01728792|18989880|P5|Overall Study|Lost to Follow-up|0
5491509|NCT01728792|18989881|P4|Overall Study|Lost to Follow-up|2
5491510|NCT01728792|18989882|P3|Overall Study|Lost to Follow-up|4
5491511|NCT01728792|18989883|P2|Overall Study|Lost to Follow-up|1
5491512|NCT01728792|18989884|P1|Overall Study|Lost to Follow-up|2
5491513|NCT01728792|18989880|P5|Overall Study|Withdrawal of Consent|0
5491514|NCT01728792|18989881|P4|Overall Study|Withdrawal of Consent|1
5491515|NCT01728792|18989882|P3|Overall Study|Withdrawal of Consent|0
5491516|NCT01728792|18989883|P2|Overall Study|Withdrawal of Consent|1
5491517|NCT01728792|18989884|P1|Overall Study|Withdrawal of Consent|1
5491518|NCT01728623|18989934|P1|Overall Study|Withdrawal by Subject|1
5491519|NCT01728623|18989934|P1|Overall Study|Adverse Event|1
5491520|NCT01728623|18989934|P1|Overall Study|Disease progression|26
5491521|NCT01728584|18989960|P4|Overall Study|Other reason (not specified)|1
5491522|NCT01728584|18989961|P3|Overall Study|Other reason (not specified)|0
5491523|NCT01728584|18989962|P2|Overall Study|Other reason (not specified)|0
5491524|NCT01728584|18989963|P1|Overall Study|Other reason (not specified)|1
5491525|NCT01728584|18989960|P4|Overall Study|Screen failure|0
5491526|NCT01728584|18989961|P3|Overall Study|Screen failure|0
5491527|NCT01728584|18989962|P2|Overall Study|Screen failure|0
5491528|NCT01728584|18989963|P1|Overall Study|Screen failure|1
5491529|NCT01728584|18989960|P4|Overall Study|Withdrawal by Subject|0
5491530|NCT01728584|18989961|P3|Overall Study|Withdrawal by Subject|0
5491531|NCT01728584|18989962|P2|Overall Study|Withdrawal by Subject|0
5491532|NCT01728584|18989963|P1|Overall Study|Withdrawal by Subject|1
5491533|NCT01728584|18989960|P4|Overall Study|Physician Decision|0
5491534|NCT01728584|18989961|P3|Overall Study|Physician Decision|1
5491535|NCT01728584|18989962|P2|Overall Study|Physician Decision|0
5491536|NCT01728584|18989963|P1|Overall Study|Physician Decision|4
5491537|NCT01728584|18989960|P4|Overall Study|Adverse Event|0
5491538|NCT01728584|18989961|P3|Overall Study|Adverse Event|0
5491539|NCT01728584|18989962|P2|Overall Study|Adverse Event|0
5491540|NCT01728584|18989963|P1|Overall Study|Adverse Event|1
5491541|NCT01728454|18990018|P3|Stage 3|Withdrew due to Adverse Events/Toxicity|0
5491542|NCT01728454|18990019|P2|Stage 3|Withdrew due to Adverse Events/Toxicity|0
5491543|NCT01728454|18990020|P1|Stage 3|Withdrew due to Adverse Events/Toxicity|1
5491544|NCT01728454|18990018|P3|Stage 3|Lost to Follow-up|1
5491545|NCT01728454|18990019|P2|Stage 3|Lost to Follow-up|3
5491546|NCT01728454|18990020|P1|Stage 3|Lost to Follow-up|0
5491547|NCT01728454|18990018|P3|Stage 3|Non-compliance with Protocol|1
5491548|NCT01728454|18990019|P2|Stage 3|Non-compliance with Protocol|0
5491549|NCT01728454|18990020|P1|Stage 3|Non-compliance with Protocol|0
5491550|NCT01728454|18990018|P3|Stage 3|Withdrew Consent|1
5491551|NCT01728454|18990019|P2|Stage 3|Withdrew Consent|0
5491552|NCT01728454|18990020|P1|Stage 3|Withdrew Consent|1
5491553|NCT01728454|18990018|P3|Stage 3|Pregnancy|0
5491554|NCT01728454|18990019|P2|Stage 3|Pregnancy|0
5491555|NCT01728454|18990020|P1|Stage 3|Pregnancy|1
5491556|NCT01728454|18990018|P3|Stage 3|Subject Required Other Treatment|0
5491557|NCT01728454|18990019|P2|Stage 3|Subject Required Other Treatment|1
5491558|NCT01728454|18990020|P1|Stage 3|Subject Required Other Treatment|0
5491559|NCT01728454|18990018|P3|Stage 3|Reason Missing|1
5491560|NCT01728454|18990019|P2|Stage 3|Reason Missing|0
5491561|NCT01728454|18990020|P1|Stage 3|Reason Missing|0
5491562|NCT01728454|18990018|P3|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
5491563|NCT01728454|18990019|P2|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
5491564|NCT01728454|18990020|P1|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
5491565|NCT01728454|18990018|P3|Stage 1 and 2|Lost to Follow-up|0
5491566|NCT01728454|18990019|P2|Stage 1 and 2|Lost to Follow-up|1
5491567|NCT01728454|18990020|P1|Stage 1 and 2|Lost to Follow-up|1
5491568|NCT01728454|18990018|P3|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
5491569|NCT01728454|18990019|P2|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
5491570|NCT01728454|18990020|P1|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
5491571|NCT01728454|18990018|P3|Stage 1 and 2|Non-compliance with Protocol|1
5491572|NCT01728454|18990019|P2|Stage 1 and 2|Non-compliance with Protocol|0
5491573|NCT01728454|18990020|P1|Stage 1 and 2|Non-compliance with Protocol|0
5491574|NCT01728454|18990018|P3|Stage 1 and 2|Pregnancy|0
5491575|NCT01728454|18990019|P2|Stage 1 and 2|Pregnancy|0
5491576|NCT01728454|18990020|P1|Stage 1 and 2|Pregnancy|1
5491577|NCT01728376|18990070|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
5491578|NCT01728376|18990071|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
5491579|NCT01728376|18990072|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
5491580|NCT01728376|18990073|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
5491581|NCT01728376|18990074|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
5491582|NCT01728376|18990075|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
5491583|NCT01728376|18990070|P6|Overall Study|Did not receive treatment|0
5491584|NCT01728376|18990071|P5|Overall Study|Did not receive treatment|0
5491585|NCT01728376|18990072|P4|Overall Study|Did not receive treatment|0
5491586|NCT01728376|18990073|P3|Overall Study|Did not receive treatment|0
5491587|NCT01728376|18990074|P2|Overall Study|Did not receive treatment|1
5491588|NCT01728376|18990075|P1|Overall Study|Did not receive treatment|0
5491589|NCT01728376|18990070|P6|Overall Study|No relevant bacteria|1
5491590|NCT01728376|18990071|P5|Overall Study|No relevant bacteria|1
5491591|NCT01728376|18990072|P4|Overall Study|No relevant bacteria|0
5491592|NCT01728376|18990073|P3|Overall Study|No relevant bacteria|0
5491593|NCT01728376|18990074|P2|Overall Study|No relevant bacteria|0
5491594|NCT01728376|18990075|P1|Overall Study|No relevant bacteria|2
5491595|NCT01728376|18990070|P6|Overall Study|Persistent Positive Blood Cultures|0
5491596|NCT01728376|18990071|P5|Overall Study|Persistent Positive Blood Cultures|0
5491597|NCT01728376|18990072|P4|Overall Study|Persistent Positive Blood Cultures|0
5491598|NCT01728376|18990073|P3|Overall Study|Persistent Positive Blood Cultures|1
5491599|NCT01728376|18990074|P2|Overall Study|Persistent Positive Blood Cultures|0
5491600|NCT01728376|18990075|P1|Overall Study|Persistent Positive Blood Cultures|1
5491601|NCT01728376|18990070|P6|Overall Study|Adverse Event|0
5491602|NCT01728376|18990071|P5|Overall Study|Adverse Event|1
5491603|NCT01728376|18990072|P4|Overall Study|Adverse Event|1
5491604|NCT01728376|18990073|P3|Overall Study|Adverse Event|1
5491605|NCT01728376|18990074|P2|Overall Study|Adverse Event|1
5491606|NCT01728376|18990075|P1|Overall Study|Adverse Event|1
5491607|NCT01728324|18990148|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
5491608|NCT01728324|18990149|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
5491609|NCT01728324|18990150|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
5491610|NCT01728324|18990148|P3|Termination of RBV|Adverse Event (Placebo Period)|0
5491611|NCT01728324|18990149|P2|Termination of RBV|Adverse Event (Placebo Period)|1
5491612|NCT01728324|18990150|P1|Termination of RBV|Adverse Event (Placebo Period)|0
5491613|NCT01728324|18990148|P3|Termination of RBV|Other than stated|1
5491614|NCT01728324|18990149|P2|Termination of RBV|Other than stated|3
5491615|NCT01728324|18990150|P1|Termination of RBV|Other than stated|1
5491616|NCT01728324|18990148|P3|Termination of RBV|Withdrawal by Subject|2
5491617|NCT01728324|18990149|P2|Termination of RBV|Withdrawal by Subject|5
5491618|NCT01728324|18990150|P1|Termination of RBV|Withdrawal by Subject|9
5491619|NCT01728324|18990148|P3|Termination of RBV|Lack of Efficacy|7
5491620|NCT01728324|18990149|P2|Termination of RBV|Lack of Efficacy|11
5491621|NCT01728324|18990150|P1|Termination of RBV|Lack of Efficacy|14
5491622|NCT01728324|18990148|P3|Termination of RBV|Adverse Event|5
5491623|NCT01728324|18990149|P2|Termination of RBV|Adverse Event|16
5491624|NCT01728324|18990150|P1|Termination of RBV|Adverse Event|15
5491625|NCT01728324|18990148|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
5491626|NCT01728324|18990149|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
5491627|NCT01728324|18990150|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
5491628|NCT01728324|18990148|P3|Termination of FDV|Adverse Event (Placebo Period)|0
5491629|NCT01728324|18990149|P2|Termination of FDV|Adverse Event (Placebo Period)|1
5491630|NCT01728324|18990150|P1|Termination of FDV|Adverse Event (Placebo Period)|0
5491631|NCT01728324|18990148|P3|Termination of FDV|Other than stated|0
5491632|NCT01728324|18990149|P2|Termination of FDV|Other than stated|3
5491633|NCT01728324|18990150|P1|Termination of FDV|Other than stated|1
5491634|NCT01728324|18990148|P3|Termination of FDV|Withdrawal by Subject|2
5491635|NCT01728324|18990149|P2|Termination of FDV|Withdrawal by Subject|6
5491636|NCT01728324|18990150|P1|Termination of FDV|Withdrawal by Subject|9
5491637|NCT01728324|18990148|P3|Termination of FDV|Lack of Efficacy|8
5491638|NCT01728324|18990149|P2|Termination of FDV|Lack of Efficacy|12
5491639|NCT01728324|18990150|P1|Termination of FDV|Lack of Efficacy|14
5491640|NCT01728324|18990148|P3|Termination of FDV|Adverse Event|4
5491641|NCT01728324|18990149|P2|Termination of FDV|Adverse Event|13
5491642|NCT01728324|18990150|P1|Termination of FDV|Adverse Event|14
5491643|NCT01728324|18990148|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
5491644|NCT01728324|18990149|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
5491645|NCT01728324|18990150|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
5491646|NCT01728324|18990148|P3|Termination of DBV|Adverse Event (Placebo Period)|0
5491647|NCT01728324|18990149|P2|Termination of DBV|Adverse Event (Placebo Period)|1
5491648|NCT01728324|18990150|P1|Termination of DBV|Adverse Event (Placebo Period)|0
5491649|NCT01728324|18990148|P3|Termination of DBV|Other than stated|0
5491650|NCT01728324|18990149|P2|Termination of DBV|Other than stated|3
5491651|NCT01728324|18990150|P1|Termination of DBV|Other than stated|1
5491652|NCT01728324|18990148|P3|Termination of DBV|Withdrawal by Subject|2
5491653|NCT01728324|18990149|P2|Termination of DBV|Withdrawal by Subject|6
5491654|NCT01728324|18990150|P1|Termination of DBV|Withdrawal by Subject|9
5491655|NCT01728324|18990148|P3|Termination of DBV|Lack of Efficacy|8
5491656|NCT01728324|18990149|P2|Termination of DBV|Lack of Efficacy|12
5491657|NCT01728324|18990150|P1|Termination of DBV|Lack of Efficacy|14
5491658|NCT01728324|18990148|P3|Termination of DBV|Adverse Event|4
5491659|NCT01728324|18990149|P2|Termination of DBV|Adverse Event|13
5491660|NCT01728324|18990150|P1|Termination of DBV|Adverse Event|14
5491661|NCT01728246|18990171|P2|Overall Study|Adverse Event|5
5491662|NCT01728246|18990172|P1|Overall Study|Adverse Event|8
5491663|NCT01728246|18990171|P2|Overall Study|Lack of Efficacy|1
5491664|NCT01728246|18990172|P1|Overall Study|Lack of Efficacy|1
5491665|NCT01728246|18990171|P2|Overall Study|Lost to Follow-up|22
5491666|NCT01728246|18990172|P1|Overall Study|Lost to Follow-up|23
5491667|NCT01728246|18990171|P2|Overall Study|Withdrawal by Subject|3
5491668|NCT01728246|18990172|P1|Overall Study|Withdrawal by Subject|2
5491669|NCT01728246|18990171|P2|Overall Study|Protocol Violation|0
5491670|NCT01728246|18990172|P1|Overall Study|Protocol Violation|1
5491671|NCT01728246|18990171|P2|Overall Study|Participant needed rescue medication|5
5491672|NCT01728246|18990172|P1|Overall Study|Participant needed rescue medication|1
5491673|NCT01728194|18990190|P2|Overall Study|Family Member Request|0
5491674|NCT01728194|18990191|P1|Overall Study|Family Member Request|1
5491675|NCT01728194|18990190|P2|Overall Study|Perceived Medication Side Effects|0
5491676|NCT01728194|18990191|P1|Overall Study|Perceived Medication Side Effects|4
5491677|NCT01728194|18990190|P2|Overall Study|Withdrawal by Subject|3
5491678|NCT01728194|18990191|P1|Overall Study|Withdrawal by Subject|7
5491679|NCT01728194|18990190|P2|Overall Study|Physician Decision|0
5491680|NCT01728194|18990191|P1|Overall Study|Physician Decision|4
5491681|NCT01728194|18990190|P2|Overall Study|Lost to Follow-up|3
5491682|NCT01728194|18990191|P1|Overall Study|Lost to Follow-up|4
5491683|NCT01728116|18990201|P2|Overall Study|various not noted previously|0
5491684|NCT01728116|18990202|P1|Overall Study|various not noted previously|5
5491685|NCT01728116|18990201|P2|Overall Study|Incorrectly enrolled in Study|1
5491686|NCT01728116|18990202|P1|Overall Study|Incorrectly enrolled in Study|0
5491687|NCT01728116|18990201|P2|Overall Study|Inter-current finding at procedure|0
5491688|NCT01728116|18990202|P1|Overall Study|Inter-current finding at procedure|1
5491689|NCT01728116|18990201|P2|Overall Study|Subject Non-Compliance|0
5491690|NCT01728116|18990202|P1|Overall Study|Subject Non-Compliance|2
5491691|NCT01728116|18990201|P2|Overall Study|Physician Decision|0
5491692|NCT01728116|18990202|P1|Overall Study|Physician Decision|2
5491693|NCT01728116|18990201|P2|Overall Study|Lost to Follow-up|2
5491694|NCT01728116|18990202|P1|Overall Study|Lost to Follow-up|9
5491695|NCT01728116|18990201|P2|Overall Study|Procedure/device failure|0
5491696|NCT01728116|18990202|P1|Overall Study|Procedure/device failure|7
5491697|NCT01728116|18990201|P2|Overall Study|Adverse Event|0
5491698|NCT01728116|18990202|P1|Overall Study|Adverse Event|13
5491699|NCT01728116|18990201|P2|Overall Study|Withdrawal by Subject|9
5491700|NCT01728116|18990202|P1|Overall Study|Withdrawal by Subject|16
5491701|NCT01728116|18990201|P2|Overall Study|Sponsor Terminated Study|35
5491702|NCT01728116|18990202|P1|Overall Study|Sponsor Terminated Study|106
5491703|NCT01728077|18990227|P2|Overall Study|Non compliance|0
5491704|NCT01728077|18990228|P1|Overall Study|Non compliance|1
5491705|NCT01728077|18990227|P2|Overall Study|Patient moving|0
5491706|NCT01728077|18990228|P1|Overall Study|Patient moving|1
5491707|NCT01728077|18990227|P2|Overall Study|Death|1
5491708|NCT01728077|18990228|P1|Overall Study|Death|0
5491709|NCT01728077|18990227|P2|Overall Study|Subject choice|3
5491710|NCT01728077|18990228|P1|Overall Study|Subject choice|2
5491711|NCT01728077|18990227|P2|Overall Study|Lost to Follow-up|0
5491712|NCT01728077|18990228|P1|Overall Study|Lost to Follow-up|1
5491713|NCT01728077|18990227|P2|Overall Study|Lack of Efficacy|1
5491714|NCT01728077|18990228|P1|Overall Study|Lack of Efficacy|3
5491715|NCT01727713|18990326|P1|Overall Study|Protocol Deviation|2
5491716|NCT01727713|18990326|P1|Overall Study|Withdrawal by Subject|13
5491717|NCT01727713|18990326|P1|Overall Study|Participant Met Withdrawal Criteria|5
5491718|NCT01727713|18990326|P1|Overall Study|Adverse Event|10
5491719|NCT01727713|18990326|P1|Overall Study|Lost to Follow-up|5
5491720|NCT01727700|18990353|P3|Overall Study|Protocol Violation|0
5491721|NCT01727700|18990354|P2|Overall Study|Protocol Violation|0
5491722|NCT01727700|18990355|P1|Overall Study|Protocol Violation|2
5491723|NCT01727700|18990353|P3|Overall Study|Particpant withdrew consent|1
5491724|NCT01727700|18990354|P2|Overall Study|Particpant withdrew consent|3
5491725|NCT01727700|18990355|P1|Overall Study|Particpant withdrew consent|0
5491726|NCT01727700|18990353|P3|Overall Study|Adverse Event|1
5491727|NCT01727700|18990354|P2|Overall Study|Adverse Event|7
5491728|NCT01727700|18990355|P1|Overall Study|Adverse Event|0
5491729|NCT01727505|18990378|P2|Second 24 Hours|Missing data|1
5491730|NCT01727505|18990379|P1|Second 24 Hours|Missing data|0
5491731|NCT01727505|18990378|P2|First 24 Hours|Adverse Event|1
5491732|NCT01727505|18990379|P1|First 24 Hours|Adverse Event|0
5491733|NCT01727297|18990404|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
5491734|NCT01727297|18990405|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
5491735|NCT01727297|18990404|P2|Overall Study|Physician Decision|5
5491736|NCT01727297|18990405|P1|Overall Study|Physician Decision|19
5491737|NCT01727297|18990404|P2|Overall Study|Withdrawal by Subject|27
5491738|NCT01727297|18990405|P1|Overall Study|Withdrawal by Subject|26
5491739|NCT01727297|18990404|P2|Overall Study|Lost to Follow-up|0
5491740|NCT01727297|18990405|P1|Overall Study|Lost to Follow-up|11
5491741|NCT01727297|18990404|P2|Overall Study|Adverse Event|1
5491742|NCT01727297|18990405|P1|Overall Study|Adverse Event|3
5491743|NCT01727297|18990404|P2|Overall Study|Protocol Violation|10
5491744|NCT01727297|18990405|P1|Overall Study|Protocol Violation|1
5491745|NCT01727297|18990404|P2|Overall Study|Death|0
5491746|NCT01727297|18990405|P1|Overall Study|Death|13
5491747|NCT01727258|18990421|P3|Overall Study|Lost to Follow-up|0
5491748|NCT01727258|18990422|P2|Overall Study|Lost to Follow-up|0
5491749|NCT01727258|18990423|P1|Overall Study|Lost to Follow-up|1
5491750|NCT01727258|18990421|P3|Overall Study|Withdrawal by Subject|0
5491751|NCT01727258|18990422|P2|Overall Study|Withdrawal by Subject|1
5491752|NCT01727258|18990423|P1|Overall Study|Withdrawal by Subject|1
5491753|NCT01727258|18990421|P3|Overall Study|Noncompliance with Study Drug|1
5491754|NCT01727258|18990422|P2|Overall Study|Noncompliance with Study Drug|0
5491755|NCT01727258|18990423|P1|Overall Study|Noncompliance with Study Drug|0
5491756|NCT01727258|18990421|P3|Overall Study|Adverse Event|0
5491757|NCT01727258|18990422|P2|Overall Study|Adverse Event|2
5491758|NCT01727258|18990423|P1|Overall Study|Adverse Event|0
5491759|NCT01727154|18990461|P1|Overall Study|No Discontinuation Documentation|4
5491760|NCT01727154|18990461|P1|Overall Study|Study Terminated|6
5491761|NCT01727154|18990461|P1|Overall Study|Subject Withdrew Consent|18
5491762|NCT01727154|18990461|P1|Overall Study|Withdrawal by Subject|14
5491763|NCT01727154|18990461|P1|Overall Study|Death|17
5491764|NCT01727141|18990469|P4|Overall Study|Withdrawal by Subject|11
5491765|NCT01727141|18990470|P3|Overall Study|Withdrawal by Subject|2
5491766|NCT01727141|18990471|P2|Overall Study|Withdrawal by Subject|4
5491767|NCT01727141|18990472|P1|Overall Study|Withdrawal by Subject|4
5491768|NCT01727141|18990469|P4|Overall Study|Protocol deviation|1
5491769|NCT01727141|18990470|P3|Overall Study|Protocol deviation|0
5491770|NCT01727141|18990471|P2|Overall Study|Protocol deviation|1
5491771|NCT01727141|18990472|P1|Overall Study|Protocol deviation|1
5491772|NCT01727141|18990469|P4|Overall Study|Death|1
5491773|NCT01727141|18990470|P3|Overall Study|Death|1
5491774|NCT01727141|18990471|P2|Overall Study|Death|1
5491775|NCT01727141|18990472|P1|Overall Study|Death|0
5491776|NCT01727141|18990469|P4|Overall Study|Lost to Follow-up|0
5491777|NCT01727141|18990470|P3|Overall Study|Lost to Follow-up|0
5491778|NCT01727141|18990471|P2|Overall Study|Lost to Follow-up|2
5491779|NCT01727141|18990472|P1|Overall Study|Lost to Follow-up|0
5491780|NCT01727141|18990469|P4|Overall Study|Physician Decision|2
5491781|NCT01727141|18990470|P3|Overall Study|Physician Decision|0
5491782|NCT01727141|18990471|P2|Overall Study|Physician Decision|1
5491783|NCT01727141|18990472|P1|Overall Study|Physician Decision|0
5491784|NCT01727024|18990537|P2|Period 1|Withdrawal by Subject|3
5491785|NCT01727024|18990538|P1|Period 1|Withdrawal by Subject|2
5491786|NCT01727024|18990537|P2|Period 1|Lost to Follow-up|1
5491787|NCT01727024|18990538|P1|Period 1|Lost to Follow-up|1
5491788|NCT01726803|18990553|P2|Overall Study|Withdrawal by Subject|0
5491789|NCT01726803|18990554|P1|Overall Study|Withdrawal by Subject|1
5491790|NCT01726803|18990553|P2|Overall Study|Lost to Follow-up|1
5491791|NCT01726803|18990554|P1|Overall Study|Lost to Follow-up|6
5491792|NCT01726517|18990606|P5|Overall Study|Withdrawal by Subject|0
5491793|NCT01726517|18990607|P4|Overall Study|Withdrawal by Subject|0
5491794|NCT01726517|18990608|P3|Overall Study|Withdrawal by Subject|1
5491795|NCT01726517|18990609|P2|Overall Study|Withdrawal by Subject|0
5491796|NCT01726517|18990610|P1|Overall Study|Withdrawal by Subject|0
5491797|NCT01726335|18990666|P1|Overall Study|Exacerbation of psychotic symptoms|1
5491798|NCT01726335|18990666|P1|Overall Study|Lost to Follow-up|2
5491799|NCT01726335|18990666|P1|Overall Study|Adverse Event|4
5491800|NCT01726335|18990666|P1|Overall Study|Withdrawal by Subject|15
5491801|NCT01726335|18990666|P1|Overall Study|Lost to Follow-up|2
5491802|NCT01726270|18990682|P1|Part 2, Actual-Use Phase|Other than reason specified above|7
5491803|NCT01726270|18990682|P1|Part 2, Actual-Use Phase|Lost to Follow-up|5
5491804|NCT01726270|18990682|P1|Part 2, Actual-Use Phase|Adverse Event|6
5491805|NCT01726270|18990682|P1|Part 2, Actual-Use Phase|Withdrawal by Subject|21
5491806|NCT01726270|18990682|P1|Eligibility for Part 2|Eligible but did not enter Part 2|20
5491807|NCT01726270|18990682|P1|Part 1, Self-Selection Phase|Withdrawal by Subject|10
5491808|NCT01726049|18990695|P2|Overall Study|refused second HC|2
5491809|NCT01726049|18990696|P1|Overall Study|refused second HC|0
5491810|NCT01726049|18990695|P2|Overall Study|Adverse Event|1
5491811|NCT01726049|18990696|P1|Overall Study|Adverse Event|4
5491812|NCT01726049|18990695|P2|Overall Study|Death|1
5491813|NCT01726049|18990696|P1|Overall Study|Death|1
5491814|NCT01726023|18990721|P2|Overall Study|Withdrawal by Subject|8
5491815|NCT01726023|18990722|P1|Overall Study|Withdrawal by Subject|16
5491816|NCT01726023|18990721|P2|Overall Study|Other Eligibility criteria|7
5491817|NCT01726023|18990722|P1|Overall Study|Other Eligibility criteria|7
5491818|NCT01726023|18990721|P2|Overall Study|Lost to Follow-up|10
5491819|NCT01726023|18990722|P1|Overall Study|Lost to Follow-up|5
5491820|NCT01726023|18990721|P2|Overall Study|Death|1
5491821|NCT01726023|18990722|P1|Overall Study|Death|1
5491822|NCT01725750|18990856|P2|Overall Study|Withdrawal by Subject|9
5491823|NCT01725750|18990857|P1|Overall Study|Withdrawal by Subject|0
5491824|NCT01725750|18990856|P2|Overall Study|Lost to Follow-up|1
5491825|NCT01725750|18990857|P1|Overall Study|Lost to Follow-up|1
5491826|NCT01725750|18990856|P2|Overall Study|Adverse Event|0
5491827|NCT01725750|18990857|P1|Overall Study|Adverse Event|1
5491828|NCT01725529|18990890|P3|Overall Study|Withdrawal by Subject|8
5491829|NCT01725529|18990891|P2|Overall Study|Withdrawal by Subject|14
5491830|NCT01725529|18990892|P1|Overall Study|Withdrawal by Subject|12
5491831|NCT01725529|18990890|P3|Overall Study|Protocol Violation|1
5491832|NCT01725529|18990891|P2|Overall Study|Protocol Violation|1
5491833|NCT01725529|18990892|P1|Overall Study|Protocol Violation|0
5491834|NCT01725529|18990890|P3|Overall Study|Lost to Follow-up|1
5491835|NCT01725529|18990891|P2|Overall Study|Lost to Follow-up|1
5491836|NCT01725529|18990892|P1|Overall Study|Lost to Follow-up|2
5491837|NCT01725529|18990890|P3|Overall Study|Adverse Event|0
5491838|NCT01725529|18990891|P2|Overall Study|Adverse Event|0
5491839|NCT01725529|18990892|P1|Overall Study|Adverse Event|1
5491840|NCT01725451|18990918|P4|Period 4|Adverse Event|0
5491841|NCT01725451|18990919|P3|Period 4|Adverse Event|1
5491842|NCT01725451|18990920|P2|Period 4|Adverse Event|0
5491843|NCT01725451|18990921|P1|Period 4|Adverse Event|0
5491844|NCT01725451|18990918|P4|Washout From Period 3|Adverse Event|0
5491845|NCT01725451|18990919|P3|Washout From Period 3|Adverse Event|0
5491846|NCT01725451|18990920|P2|Washout From Period 3|Adverse Event|1
5491847|NCT01725451|18990921|P1|Washout From Period 3|Adverse Event|0
5491848|NCT01725451|18990918|P4|Washout From Period 3|Protocol Violation|0
5491849|NCT01725451|18990919|P3|Washout From Period 3|Protocol Violation|1
5491850|NCT01725451|18990920|P2|Washout From Period 3|Protocol Violation|0
5491851|NCT01725451|18990921|P1|Washout From Period 3|Protocol Violation|0
5491852|NCT01725451|18990918|P4|Period 1|Withdrawal by Subject|0
5491853|NCT01725451|18990919|P3|Period 1|Withdrawal by Subject|0
5491854|NCT01725451|18990920|P2|Period 1|Withdrawal by Subject|0
5491855|NCT01725451|18990921|P1|Period 1|Withdrawal by Subject|1
5491856|NCT01725386|18990943|P2|Overall Study|Withdrawal by Subject|0
5491857|NCT01725386|18990944|P1|Overall Study|Withdrawal by Subject|10
5491858|NCT01725386|18990943|P2|Overall Study|Lost to Follow-up|6
5491859|NCT01725386|18990944|P1|Overall Study|Lost to Follow-up|81
5491860|NCT01725386|18990943|P2|Overall Study|Death|40
5491861|NCT01725386|18990944|P1|Overall Study|Death|84
5491862|NCT01725308|18990963|P3|Treatment Period II|Miscellaneous|7
5491863|NCT01725308|18990964|P2|Treatment Period II|Miscellaneous|3
5491864|NCT01725308|18990965|P1|Treatment Period II|Miscellaneous|5
5491865|NCT01725308|18990963|P3|Treatment Period II|Protocol Deviations|1
5491866|NCT01725308|18990964|P2|Treatment Period II|Protocol Deviations|0
5491867|NCT01725308|18990965|P1|Treatment Period II|Protocol Deviations|0
5491868|NCT01725308|18990963|P3|Treatment Period II|Lost to Follow-up|3
5491869|NCT01725308|18990964|P2|Treatment Period II|Lost to Follow-up|5
5491870|NCT01725308|18990965|P1|Treatment Period II|Lost to Follow-up|1
5491871|NCT01725308|18990963|P3|Treatment Period II|Withdrawal of Consent|16
5491872|NCT01725308|18990964|P2|Treatment Period II|Withdrawal of Consent|2
5491873|NCT01725308|18990965|P1|Treatment Period II|Withdrawal of Consent|28
5491874|NCT01725308|18990963|P3|Treatment Period II|Changes in the Episodes|5
5491875|NCT01725308|18990964|P2|Treatment Period II|Changes in the Episodes|0
5491876|NCT01725308|18990965|P1|Treatment Period II|Changes in the Episodes|1
5491877|NCT01725308|18990963|P3|Treatment Period II|Worsening of the Target Disease|2
5491878|NCT01725308|18990964|P2|Treatment Period II|Worsening of the Target Disease|4
5491879|NCT01725308|18990965|P1|Treatment Period II|Worsening of the Target Disease|1
5491880|NCT01725308|18990963|P3|Treatment Period II|Insufficient Response|6
5491881|NCT01725308|18990964|P2|Treatment Period II|Insufficient Response|4
5491882|NCT01725308|18990965|P1|Treatment Period II|Insufficient Response|2
5491883|NCT01725308|18990963|P3|Treatment Period II|Adverse Event|20
5491884|NCT01725308|18990964|P2|Treatment Period II|Adverse Event|8
5491885|NCT01725308|18990965|P1|Treatment Period II|Adverse Event|13
5491886|NCT01725308|18990963|P3|Treatment Period II|Did Not Receive Drug|0
5491887|NCT01725308|18990964|P2|Treatment Period II|Did Not Receive Drug|0
5491888|NCT01725308|18990965|P1|Treatment Period II|Did Not Receive Drug|4
5491889|NCT01725308|18990963|P3|Treatment Period II|Did Not Meet Transition Criteria|4
5491890|NCT01725308|18990964|P2|Treatment Period II|Did Not Meet Transition Criteria|3
5491891|NCT01725308|18990965|P1|Treatment Period II|Did Not Meet Transition Criteria|0
5491892|NCT01725308|18990963|P3|Treatment Period I|Miscellaneous|3
5491893|NCT01725308|18990964|P2|Treatment Period I|Miscellaneous|0
5491894|NCT01725308|18990965|P1|Treatment Period I|Miscellaneous|2
5491895|NCT01725308|18990963|P3|Treatment Period I|Protocol Deviations|1
5491896|NCT01725308|18990964|P2|Treatment Period I|Protocol Deviations|1
5491897|NCT01725308|18990965|P1|Treatment Period I|Protocol Deviations|3
5491898|NCT01725308|18990963|P3|Treatment Period I|Lost to Follow-up|2
5491899|NCT01725308|18990964|P2|Treatment Period I|Lost to Follow-up|2
5491900|NCT01725308|18990965|P1|Treatment Period I|Lost to Follow-up|3
5491901|NCT01725308|18990963|P3|Treatment Period I|Withdrawal of Consent|5
5491902|NCT01725308|18990964|P2|Treatment Period I|Withdrawal of Consent|7
5491903|NCT01725308|18990965|P1|Treatment Period I|Withdrawal of Consent|12
5491904|NCT01725308|18990963|P3|Treatment Period I|Changes in the Episodes|2
5491905|NCT01725308|18990964|P2|Treatment Period I|Changes in the Episodes|0
5491906|NCT01725308|18990965|P1|Treatment Period I|Changes in the Episodes|3
5491907|NCT01725308|18990963|P3|Treatment Period I|Worsening of the Target Disease|2
5491908|NCT01725308|18990964|P2|Treatment Period I|Worsening of the Target Disease|0
5491909|NCT01725308|18990965|P1|Treatment Period I|Worsening of the Target Disease|8
5491910|NCT01725308|18990963|P3|Treatment Period I|Insufficient Response|5
5491911|NCT01725308|18990964|P2|Treatment Period I|Insufficient Response|0
5491912|NCT01725308|18990965|P1|Treatment Period I|Insufficient Response|7
5491913|NCT01725308|18990963|P3|Treatment Period I|Adverse Event|21
5491914|NCT01725308|18990964|P2|Treatment Period I|Adverse Event|4
5491915|NCT01725308|18990965|P1|Treatment Period I|Adverse Event|5
5491916|NCT01725308|18990963|P3|Treatment Period I|Did Not Receive Drug|0
5491917|NCT01725308|18990964|P2|Treatment Period I|Did Not Receive Drug|0
5491918|NCT01725308|18990965|P1|Treatment Period I|Did Not Receive Drug|1
5491919|NCT01725282|18991112|P4|Overall Study|Lack of Efficacy|1
5491920|NCT01725282|18991113|P3|Overall Study|Lack of Efficacy|0
5491921|NCT01725282|18991114|P2|Overall Study|Lack of Efficacy|1
5491922|NCT01725282|18991115|P1|Overall Study|Lack of Efficacy|0
5491923|NCT01725282|18991112|P4|Overall Study|Withdrawal by Subject|1
5491924|NCT01725282|18991113|P3|Overall Study|Withdrawal by Subject|1
5491925|NCT01725282|18991114|P2|Overall Study|Withdrawal by Subject|0
5491926|NCT01725282|18991115|P1|Overall Study|Withdrawal by Subject|0
5491927|NCT01725282|18991112|P4|Overall Study|Study Site Withdrawal|0
5491928|NCT01725282|18991113|P3|Overall Study|Study Site Withdrawal|0
5491929|NCT01725282|18991114|P2|Overall Study|Study Site Withdrawal|1
5491930|NCT01725282|18991115|P1|Overall Study|Study Site Withdrawal|0
5491931|NCT01725282|18991112|P4|Overall Study|Met Exclusion Criteria|0
5491932|NCT01725282|18991113|P3|Overall Study|Met Exclusion Criteria|1
5491933|NCT01725282|18991114|P2|Overall Study|Met Exclusion Criteria|0
5491934|NCT01725282|18991115|P1|Overall Study|Met Exclusion Criteria|0
5491935|NCT01725282|18991112|P4|Overall Study|Exacerbation of Target Disease|1
5491936|NCT01725282|18991113|P3|Overall Study|Exacerbation of Target Disease|0
5491937|NCT01725282|18991114|P2|Overall Study|Exacerbation of Target Disease|0
5491938|NCT01725282|18991115|P1|Overall Study|Exacerbation of Target Disease|1
5491939|NCT01725282|18991112|P4|Overall Study|Adverse Event|4
5491940|NCT01725282|18991113|P3|Overall Study|Adverse Event|6
5491941|NCT01725282|18991114|P2|Overall Study|Adverse Event|3
5491942|NCT01725282|18991115|P1|Overall Study|Adverse Event|1
5491943|NCT01725217|18991148|P3|Overall Study|Withdrawal by Subject|0
5491944|NCT01725217|18991149|P2|Overall Study|Withdrawal by Subject|0
5491945|NCT01725217|18991150|P1|Overall Study|Withdrawal by Subject|1
5491946|NCT01725126|18991184|P6|Overall Study|Withdrawal by Subject|0
5491947|NCT01725126|18991185|P5|Overall Study|Withdrawal by Subject|0
5491948|NCT01725126|18991186|P4|Overall Study|Withdrawal by Subject|1
5491949|NCT01725126|18991187|P3|Overall Study|Withdrawal by Subject|0
5491950|NCT01725126|18991188|P2|Overall Study|Withdrawal by Subject|0
5491951|NCT01725126|18991189|P1|Overall Study|Withdrawal by Subject|0
5491952|NCT01725126|18991184|P6|Overall Study|Protocol Violation|0
5491953|NCT01725126|18991185|P5|Overall Study|Protocol Violation|0
5491954|NCT01725126|18991186|P4|Overall Study|Protocol Violation|0
5491955|NCT01725126|18991187|P3|Overall Study|Protocol Violation|0
5491956|NCT01725126|18991188|P2|Overall Study|Protocol Violation|1
5491957|NCT01725126|18991189|P1|Overall Study|Protocol Violation|0
5491958|NCT01724528|18991387|P2|Overall Study|Patient refused to attend last visit|0
5491959|NCT01724528|18991388|P1|Overall Study|Patient refused to attend last visit|1
5491960|NCT01724528|18991387|P2|Overall Study|Protocol Violation|1
5491961|NCT01724528|18991388|P1|Overall Study|Protocol Violation|0
5491962|NCT01724528|18991387|P2|Overall Study|Withdrawal by Subject|2
5491963|NCT01724528|18991388|P1|Overall Study|Withdrawal by Subject|0
5491964|NCT01724528|18991387|P2|Overall Study|Death|0
5491965|NCT01724528|18991388|P1|Overall Study|Death|3
5491966|NCT01724489|18991404|P2|Overall Study|Withdrawal by Subject|6
5491967|NCT01724489|18991405|P1|Overall Study|Withdrawal by Subject|6
5491968|NCT01724489|18991404|P2|Overall Study|Lost to Follow-up|2
5491969|NCT01724489|18991405|P1|Overall Study|Lost to Follow-up|1
5491970|NCT01724489|18991404|P2|Overall Study|Surgery, medication|1
5491971|NCT01724489|18991405|P1|Overall Study|Surgery, medication|1
5491972|NCT01724489|18991404|P2|Overall Study|Adverse Event|3
5491973|NCT01724489|18991405|P1|Overall Study|Adverse Event|8
5491974|NCT01724359|18991411|P1|Overall Study|Other|20
5491975|NCT01724359|18991411|P1|Overall Study|Death|1
5491976|NCT01724359|18991411|P1|Overall Study|Adverse Event|10
5491977|NCT01724216|18991424|P1|Overall Study|Scan was not completed|1
5491978|NCT01724177|18991428|P1|Overall Study|Serious Adverse Event Related|1
5491979|NCT01724177|18991428|P1|Overall Study|Nervous participant|1
5491980|NCT01724177|18991428|P1|Overall Study|Progressive disease or Relapsed Disease|16
5491981|NCT01724177|18991428|P1|Overall Study|Adverse Event|8
5491982|NCT01724021|18991474|P2|Overall Study|Missing|1
5491983|NCT01724021|18991475|P1|Overall Study|Missing|1
5491984|NCT01724021|18991474|P2|Overall Study|Reason Not Specified|39
5491985|NCT01724021|18991475|P1|Overall Study|Reason Not Specified|36
5491986|NCT01724021|18991474|P2|Overall Study|Lost to Follow-up|15
5491987|NCT01724021|18991475|P1|Overall Study|Lost to Follow-up|15
5491988|NCT01724021|18991474|P2|Overall Study|Participant request/ Withdrew consent|14
5491989|NCT01724021|18991475|P1|Overall Study|Participant request/ Withdrew consent|18
5491990|NCT01724021|18991474|P2|Overall Study|Death|58
5491991|NCT01724021|18991475|P1|Overall Study|Death|46
5491992|NCT01724021|18991474|P2|Overall Study|Adverse Event|6
5491993|NCT01724021|18991475|P1|Overall Study|Adverse Event|11
5491994|NCT01723904|18991507|P1|Overall Study|Unable to follow protocol/ judged by inv|3
5491995|NCT01723904|18991507|P1|Overall Study|Adverse Event|5
5491996|NCT01723904|18991507|P1|Overall Study|Noncompliant|3
5491997|NCT01723826|18991521|P4|Overall Study|Withdrawal by Subject|48
5491998|NCT01723826|18991522|P3|Overall Study|Withdrawal by Subject|27
5491999|NCT01723826|18991523|P2|Overall Study|Withdrawal by Subject|17
5492000|NCT01723826|18991524|P1|Overall Study|Withdrawal by Subject|10
5492001|NCT01723826|18991521|P4|Overall Study|Protocol Violation|1
5492002|NCT01723826|18991522|P3|Overall Study|Protocol Violation|3
5492003|NCT01723826|18991523|P2|Overall Study|Protocol Violation|1
5492004|NCT01723826|18991524|P1|Overall Study|Protocol Violation|1
5492005|NCT01723826|18991521|P4|Overall Study|Physician Decision|11
5492006|NCT01723826|18991522|P3|Overall Study|Physician Decision|4
5492007|NCT01723826|18991523|P2|Overall Study|Physician Decision|3
5492008|NCT01723826|18991524|P1|Overall Study|Physician Decision|1
5492009|NCT01723826|18991521|P4|Overall Study|Other Reason|14
5492010|NCT01723826|18991522|P3|Overall Study|Other Reason|12
5492011|NCT01723826|18991523|P2|Overall Study|Other Reason|6
5492012|NCT01723826|18991524|P1|Overall Study|Other Reason|8
5492013|NCT01723826|18991521|P4|Overall Study|Non-compliance With Study Drug|0
5492014|NCT01723826|18991522|P3|Overall Study|Non-compliance With Study Drug|0
5492015|NCT01723826|18991523|P2|Overall Study|Non-compliance With Study Drug|1
5492016|NCT01723826|18991524|P1|Overall Study|Non-compliance With Study Drug|0
5492017|NCT01723826|18991521|P4|Overall Study|Non-compliance|3
5492018|NCT01723826|18991522|P3|Overall Study|Non-compliance|3
5492019|NCT01723826|18991523|P2|Overall Study|Non-compliance|1
5492020|NCT01723826|18991524|P1|Overall Study|Non-compliance|0
5492021|NCT01723826|18991521|P4|Overall Study|Lost to Follow-up|1
5492022|NCT01723826|18991522|P3|Overall Study|Lost to Follow-up|1
5492023|NCT01723826|18991523|P2|Overall Study|Lost to Follow-up|3
5492024|NCT01723826|18991524|P1|Overall Study|Lost to Follow-up|1
5492025|NCT01723826|18991521|P4|Overall Study|Death according to AE eCRF|7
5492026|NCT01723826|18991522|P3|Overall Study|Death according to AE eCRF|3
5492027|NCT01723826|18991523|P2|Overall Study|Death according to AE eCRF|3
5492028|NCT01723826|18991524|P1|Overall Study|Death according to AE eCRF|2
5492029|NCT01723826|18991521|P4|Overall Study|Adverse Event|5
5492030|NCT01723826|18991522|P3|Overall Study|Adverse Event|4
5492031|NCT01723826|18991523|P2|Overall Study|Adverse Event|1
5492032|NCT01723826|18991524|P1|Overall Study|Adverse Event|4
5492033|NCT01723397|18991669|P2|Study Period 2|Protocol Violation|1
5492034|NCT01723397|18991670|P1|Study Period 2|Protocol Violation|0
5492035|NCT01723397|18991669|P2|Study Period 1|Protocol Violation|1
5492036|NCT01723397|18991670|P1|Study Period 1|Protocol Violation|0
5492037|NCT01723254|18991697|P8|Overall Study|Withdrawal by Subject|2
5492038|NCT01723254|18991698|P7|Overall Study|Withdrawal by Subject|1
5492039|NCT01723254|18991699|P6|Overall Study|Withdrawal by Subject|1
5492040|NCT01723254|18991700|P5|Overall Study|Withdrawal by Subject|1
5492041|NCT01723254|18991701|P4|Overall Study|Withdrawal by Subject|0
5492042|NCT01723254|18991702|P3|Overall Study|Withdrawal by Subject|1
5492043|NCT01723254|18991703|P2|Overall Study|Withdrawal by Subject|2
5492044|NCT01723254|18991704|P1|Overall Study|Withdrawal by Subject|1
5492045|NCT01723254|18991697|P8|Overall Study|Protocol Violation|0
5492046|NCT01723254|18991698|P7|Overall Study|Protocol Violation|0
5492047|NCT01723254|18991699|P6|Overall Study|Protocol Violation|0
5492048|NCT01723254|18991700|P5|Overall Study|Protocol Violation|0
5492049|NCT01723254|18991701|P4|Overall Study|Protocol Violation|0
5492050|NCT01723254|18991702|P3|Overall Study|Protocol Violation|0
5492051|NCT01723254|18991703|P2|Overall Study|Protocol Violation|1
5492052|NCT01723254|18991704|P1|Overall Study|Protocol Violation|0
5492053|NCT01723254|18991697|P8|Overall Study|Move/Left to another country/city|0
5492054|NCT01723254|18991698|P7|Overall Study|Move/Left to another country/city|0
5492055|NCT01723254|18991699|P6|Overall Study|Move/Left to another country/city|0
5492056|NCT01723254|18991700|P5|Overall Study|Move/Left to another country/city|1
5492057|NCT01723254|18991701|P4|Overall Study|Move/Left to another country/city|1
5492058|NCT01723254|18991702|P3|Overall Study|Move/Left to another country/city|2
5492059|NCT01723254|18991703|P2|Overall Study|Move/Left to another country/city|0
5492060|NCT01723254|18991704|P1|Overall Study|Move/Left to another country/city|0
5492061|NCT01723254|18991697|P8|Overall Study|No longer have time to participate|0
5492062|NCT01723254|18991698|P7|Overall Study|No longer have time to participate|0
5492063|NCT01723254|18991699|P6|Overall Study|No longer have time to participate|0
5492064|NCT01723254|18991700|P5|Overall Study|No longer have time to participate|0
5492065|NCT01723254|18991701|P4|Overall Study|No longer have time to participate|1
5492066|NCT01723254|18991702|P3|Overall Study|No longer have time to participate|0
5492067|NCT01723254|18991703|P2|Overall Study|No longer have time to participate|0
5492068|NCT01723254|18991704|P1|Overall Study|No longer have time to participate|0
5492069|NCT01723254|18991697|P8|Overall Study|Personal issues|0
5492070|NCT01723254|18991698|P7|Overall Study|Personal issues|0
5492071|NCT01723254|18991699|P6|Overall Study|Personal issues|1
5492072|NCT01723254|18991700|P5|Overall Study|Personal issues|0
5492073|NCT01723254|18991701|P4|Overall Study|Personal issues|0
5492074|NCT01723254|18991702|P3|Overall Study|Personal issues|0
5492075|NCT01723254|18991703|P2|Overall Study|Personal issues|0
5492076|NCT01723254|18991704|P1|Overall Study|Personal issues|0
5492077|NCT01723254|18991697|P8|Overall Study|Conflict with work schedule|1
5492078|NCT01723254|18991698|P7|Overall Study|Conflict with work schedule|0
5492079|NCT01723254|18991699|P6|Overall Study|Conflict with work schedule|0
5492080|NCT01723254|18991700|P5|Overall Study|Conflict with work schedule|0
5492081|NCT01723254|18991701|P4|Overall Study|Conflict with work schedule|0
5492082|NCT01723254|18991702|P3|Overall Study|Conflict with work schedule|0
5492083|NCT01723254|18991703|P2|Overall Study|Conflict with work schedule|0
5492084|NCT01723254|18991704|P1|Overall Study|Conflict with work schedule|0
5492085|NCT01723228|18991756|P2|Overall Study|Other|1
5492086|NCT01723228|18991757|P1|Overall Study|Other|2
5492087|NCT01723228|18991756|P2|Overall Study|Lost to Follow-up|1
5492088|NCT01723228|18991757|P1|Overall Study|Lost to Follow-up|2
5492089|NCT01723228|18991756|P2|Overall Study|Protocol Violation|2
5492090|NCT01723228|18991757|P1|Overall Study|Protocol Violation|0
5492091|NCT01723228|18991756|P2|Overall Study|Withdrawal by Subject|1
5492092|NCT01723228|18991757|P1|Overall Study|Withdrawal by Subject|2
5492093|NCT01723228|18991756|P2|Overall Study|Adverse Event|6
5492094|NCT01723228|18991757|P1|Overall Study|Adverse Event|2
5492095|NCT01723163|18991775|P2|12-Month Follow-up|Unable to Contact|28
5492096|NCT01723163|18991776|P1|12-Month Follow-up|Unable to Contact|23
5492097|NCT01723163|18991775|P2|12-Month Follow-up|Death|0
5492098|NCT01723163|18991776|P1|12-Month Follow-up|Death|1
5492099|NCT01723163|18991775|P2|6-Month Follow-up|Unable to Contact|15
5492100|NCT01723163|18991776|P1|6-Month Follow-up|Unable to Contact|17
5492101|NCT01723163|18991775|P2|6-Month Follow-up|Death|0
5492102|NCT01723163|18991776|P1|6-Month Follow-up|Death|1
5492103|NCT01723163|18991775|P2|3-Month Follow-up|Unable to Contact|19
5492104|NCT01723163|18991776|P1|3-Month Follow-up|Unable to Contact|12
5492105|NCT01723163|18991775|P2|3-Month Follow-up|Withdrawal by Subject|0
5492106|NCT01723163|18991776|P1|3-Month Follow-up|Withdrawal by Subject|1
5492107|NCT01723163|18991775|P2|Treatment Phase|Withdrawal by PI|1
5492108|NCT01723163|18991776|P1|Treatment Phase|Withdrawal by PI|5
5492109|NCT01723163|18991775|P2|Treatment Phase|Withdrawal by Subject|6
5492110|NCT01723163|18991776|P1|Treatment Phase|Withdrawal by Subject|14
5492111|NCT01723072|18991784|P2|Overall Study|Other|3
5492112|NCT01723072|18991785|P1|Overall Study|Other|4
5492113|NCT01723072|18991784|P2|Overall Study|Discon for rescue medication after wk 24|5
5492114|NCT01723072|18991785|P1|Overall Study|Discon for rescue medication after wk 24|0
5492115|NCT01723072|18991784|P2|Overall Study|Withdrawal by Subject|13
5492116|NCT01723072|18991785|P1|Overall Study|Withdrawal by Subject|7
5492117|NCT01722994|18991823|P2|Overall Study|Missing data|17
5492118|NCT01722994|18991824|P1|Overall Study|Missing data|25
5492119|NCT01722877|18991843|P1|Overall Study|Lost to Follow-up|1
5492120|NCT01722877|18991843|P1|Overall Study|Death|1
5492121|NCT01722669|18991869|P6|Overall Study|Withdrawal by Subject|2
5492122|NCT01722669|18991870|P5|Overall Study|Withdrawal by Subject|0
5492123|NCT01722669|18991871|P4|Overall Study|Withdrawal by Subject|0
5492124|NCT01722669|18991872|P3|Overall Study|Withdrawal by Subject|0
5492125|NCT01722669|18991873|P2|Overall Study|Withdrawal by Subject|0
5492126|NCT01722669|18991874|P1|Overall Study|Withdrawal by Subject|0
5492127|NCT01722331|18991945|P7|Part 3|Other Protocol Specified Criteria|0
5492128|NCT01722331|18991946|P6|Part 3|Other Protocol Specified Criteria|0
5492129|NCT01722331|18991947|P5|Part 3|Other Protocol Specified Criteria|0
5492130|NCT01722331|18991948|P4|Part 3|Other Protocol Specified Criteria|0
5492131|NCT01722331|18991949|P3|Part 3|Other Protocol Specified Criteria|0
5492132|NCT01722331|18991950|P2|Part 3|Other Protocol Specified Criteria|1
5492133|NCT01722331|18991951|P1|Part 3|Other Protocol Specified Criteria|1
5492134|NCT01722331|18991945|P7|Part 3|Withdrawal by Subject|1
5492135|NCT01722331|18991946|P6|Part 3|Withdrawal by Subject|2
5492136|NCT01722331|18991947|P5|Part 3|Withdrawal by Subject|0
5492137|NCT01722331|18991948|P4|Part 3|Withdrawal by Subject|0
5492138|NCT01722331|18991949|P3|Part 3|Withdrawal by Subject|0
5492139|NCT01722331|18991950|P2|Part 3|Withdrawal by Subject|7
5492140|NCT01722331|18991951|P1|Part 3|Withdrawal by Subject|4
5492141|NCT01722331|18991945|P7|Part 3|Protocol Violation|0
5492142|NCT01722331|18991946|P6|Part 3|Protocol Violation|0
5492143|NCT01722331|18991947|P5|Part 3|Protocol Violation|0
5492144|NCT01722331|18991948|P4|Part 3|Protocol Violation|0
5492145|NCT01722331|18991949|P3|Part 3|Protocol Violation|0
5492146|NCT01722331|18991950|P2|Part 3|Protocol Violation|1
5492147|NCT01722331|18991951|P1|Part 3|Protocol Violation|2
5492148|NCT01722331|18991945|P7|Part 3|Physician Decision|1
5492149|NCT01722331|18991946|P6|Part 3|Physician Decision|0
5492150|NCT01722331|18991947|P5|Part 3|Physician Decision|0
5492151|NCT01722331|18991948|P4|Part 3|Physician Decision|0
5492152|NCT01722331|18991949|P3|Part 3|Physician Decision|0
5492153|NCT01722331|18991950|P2|Part 3|Physician Decision|1
5492154|NCT01722331|18991951|P1|Part 3|Physician Decision|1
5492155|NCT01722331|18991945|P7|Part 3|Non-Compliance with Study Drug|0
5492156|NCT01722331|18991946|P6|Part 3|Non-Compliance with Study Drug|0
5492157|NCT01722331|18991947|P5|Part 3|Non-Compliance with Study Drug|0
5492158|NCT01722331|18991948|P4|Part 3|Non-Compliance with Study Drug|0
5492159|NCT01722331|18991949|P3|Part 3|Non-Compliance with Study Drug|0
5492160|NCT01722331|18991950|P2|Part 3|Non-Compliance with Study Drug|1
5492161|NCT01722331|18991951|P1|Part 3|Non-Compliance with Study Drug|0
5492162|NCT01722331|18991945|P7|Part 3|Lost to Follow-up|0
5492163|NCT01722331|18991946|P6|Part 3|Lost to Follow-up|1
5492164|NCT01722331|18991947|P5|Part 3|Lost to Follow-up|0
5492165|NCT01722331|18991948|P4|Part 3|Lost to Follow-up|0
5492166|NCT01722331|18991949|P3|Part 3|Lost to Follow-up|0
5492167|NCT01722331|18991950|P2|Part 3|Lost to Follow-up|4
5492168|NCT01722331|18991951|P1|Part 3|Lost to Follow-up|3
5492169|NCT01722331|18991945|P7|Part 3|Lack of Efficacy|0
5492170|NCT01722331|18991946|P6|Part 3|Lack of Efficacy|0
5492171|NCT01722331|18991947|P5|Part 3|Lack of Efficacy|0
5492172|NCT01722331|18991948|P4|Part 3|Lack of Efficacy|0
5492173|NCT01722331|18991949|P3|Part 3|Lack of Efficacy|0
5492174|NCT01722331|18991950|P2|Part 3|Lack of Efficacy|0
5492175|NCT01722331|18991951|P1|Part 3|Lack of Efficacy|1
5492176|NCT01722331|18991945|P7|Part 3|Death|0
5492177|NCT01722331|18991946|P6|Part 3|Death|0
5492178|NCT01722331|18991947|P5|Part 3|Death|0
5492179|NCT01722331|18991948|P4|Part 3|Death|0
5492180|NCT01722331|18991949|P3|Part 3|Death|0
5492181|NCT01722331|18991950|P2|Part 3|Death|0
5492182|NCT01722331|18991951|P1|Part 3|Death|1
5492183|NCT01722331|18991945|P7|Part 3|Adverse Event|0
5492184|NCT01722331|18991946|P6|Part 3|Adverse Event|0
5492185|NCT01722331|18991947|P5|Part 3|Adverse Event|0
5492186|NCT01722331|18991948|P4|Part 3|Adverse Event|1
5492187|NCT01722331|18991949|P3|Part 3|Adverse Event|0
5492188|NCT01722331|18991950|P2|Part 3|Adverse Event|2
5492189|NCT01722331|18991951|P1|Part 3|Adverse Event|2
5492190|NCT01722331|18991945|P7|Part 2|Other Protocol Specified Criteria|1
5492191|NCT01722331|18991946|P6|Part 2|Other Protocol Specified Criteria|2
5492192|NCT01722331|18991947|P5|Part 2|Other Protocol Specified Criteria|0
5492193|NCT01722331|18991948|P4|Part 2|Other Protocol Specified Criteria|0
5492194|NCT01722331|18991949|P3|Part 2|Other Protocol Specified Criteria|10
5492195|NCT01722331|18991950|P2|Part 2|Other Protocol Specified Criteria|0
5492196|NCT01722331|18991951|P1|Part 2|Other Protocol Specified Criteria|6
5492197|NCT01722331|18991945|P7|Part 2|Withdrawal by Subject|2
5492198|NCT01722331|18991946|P6|Part 2|Withdrawal by Subject|2
5492199|NCT01722331|18991947|P5|Part 2|Withdrawal by Subject|0
5492200|NCT01722331|18991948|P4|Part 2|Withdrawal by Subject|0
5492201|NCT01722331|18991949|P3|Part 2|Withdrawal by Subject|3
5492202|NCT01722331|18991950|P2|Part 2|Withdrawal by Subject|0
5492203|NCT01722331|18991951|P1|Part 2|Withdrawal by Subject|5
5492204|NCT01722331|18991945|P7|Part 2|Protocol Violation|0
5492205|NCT01722331|18991946|P6|Part 2|Protocol Violation|0
5492206|NCT01722331|18991947|P5|Part 2|Protocol Violation|0
5492207|NCT01722331|18991948|P4|Part 2|Protocol Violation|0
5492208|NCT01722331|18991949|P3|Part 2|Protocol Violation|0
5492209|NCT01722331|18991950|P2|Part 2|Protocol Violation|0
5492210|NCT01722331|18991951|P1|Part 2|Protocol Violation|1
5492211|NCT01722331|18991945|P7|Part 2|Progressive Disease|0
5492212|NCT01722331|18991946|P6|Part 2|Progressive Disease|0
5492213|NCT01722331|18991947|P5|Part 2|Progressive Disease|0
5492214|NCT01722331|18991948|P4|Part 2|Progressive Disease|0
5492215|NCT01722331|18991949|P3|Part 2|Progressive Disease|1
5492216|NCT01722331|18991950|P2|Part 2|Progressive Disease|0
5492217|NCT01722331|18991951|P1|Part 2|Progressive Disease|0
5492218|NCT01722331|18991945|P7|Part 2|Pregnancy|0
5492219|NCT01722331|18991946|P6|Part 2|Pregnancy|1
5492220|NCT01722331|18991947|P5|Part 2|Pregnancy|0
5492221|NCT01722331|18991948|P4|Part 2|Pregnancy|0
5492222|NCT01722331|18991949|P3|Part 2|Pregnancy|0
5492223|NCT01722331|18991950|P2|Part 2|Pregnancy|0
5492224|NCT01722331|18991951|P1|Part 2|Pregnancy|0
5492225|NCT01722331|18991945|P7|Part 2|Physician Decision|0
5492226|NCT01722331|18991946|P6|Part 2|Physician Decision|0
5492227|NCT01722331|18991947|P5|Part 2|Physician Decision|0
5492228|NCT01722331|18991948|P4|Part 2|Physician Decision|0
5492229|NCT01722331|18991949|P3|Part 2|Physician Decision|2
5492230|NCT01722331|18991950|P2|Part 2|Physician Decision|0
5492231|NCT01722331|18991951|P1|Part 2|Physician Decision|0
5492232|NCT01722331|18991945|P7|Part 2|Non-Compliance with Study Drug|0
5492233|NCT01722331|18991946|P6|Part 2|Non-Compliance with Study Drug|0
5492234|NCT01722331|18991947|P5|Part 2|Non-Compliance with Study Drug|0
5492235|NCT01722331|18991948|P4|Part 2|Non-Compliance with Study Drug|0
5492236|NCT01722331|18991949|P3|Part 2|Non-Compliance with Study Drug|1
5492237|NCT01722331|18991950|P2|Part 2|Non-Compliance with Study Drug|0
5492238|NCT01722331|18991951|P1|Part 2|Non-Compliance with Study Drug|1
5492239|NCT01722331|18991945|P7|Part 2|Lost to Follow-up|1
5492240|NCT01722331|18991946|P6|Part 2|Lost to Follow-up|1
5492241|NCT01722331|18991947|P5|Part 2|Lost to Follow-up|0
5492242|NCT01722331|18991948|P4|Part 2|Lost to Follow-up|0
5492243|NCT01722331|18991949|P3|Part 2|Lost to Follow-up|3
5492244|NCT01722331|18991950|P2|Part 2|Lost to Follow-up|0
5492245|NCT01722331|18991951|P1|Part 2|Lost to Follow-up|0
5492246|NCT01722331|18991945|P7|Part 2|Lack of Efficacy|3
5492247|NCT01722331|18991946|P6|Part 2|Lack of Efficacy|3
5492248|NCT01722331|18991947|P5|Part 2|Lack of Efficacy|0
5492249|NCT01722331|18991948|P4|Part 2|Lack of Efficacy|0
5492250|NCT01722331|18991949|P3|Part 2|Lack of Efficacy|11
5492251|NCT01722331|18991950|P2|Part 2|Lack of Efficacy|0
5492252|NCT01722331|18991951|P1|Part 2|Lack of Efficacy|3
5492253|NCT01722331|18991945|P7|Part 2|Adverse Event|0
5492254|NCT01722331|18991946|P6|Part 2|Adverse Event|1
5492255|NCT01722331|18991947|P5|Part 2|Adverse Event|0
5492256|NCT01722331|18991948|P4|Part 2|Adverse Event|0
5492257|NCT01722331|18991949|P3|Part 2|Adverse Event|0
5492258|NCT01722331|18991950|P2|Part 2|Adverse Event|0
5492259|NCT01722331|18991951|P1|Part 2|Adverse Event|3
5492260|NCT01722331|18991945|P7|Part 1|Withdrawal by Subject|0
5492261|NCT01722331|18991946|P6|Part 1|Withdrawal by Subject|0
5492262|NCT01722331|18991947|P5|Part 1|Withdrawal by Subject|3
5492263|NCT01722331|18991948|P4|Part 1|Withdrawal by Subject|0
5492264|NCT01722331|18991949|P3|Part 1|Withdrawal by Subject|3
5492265|NCT01722331|18991950|P2|Part 1|Withdrawal by Subject|0
5492266|NCT01722331|18991951|P1|Part 1|Withdrawal by Subject|2
5492267|NCT01722331|18991945|P7|Part 1|Protocol Violation|0
5492268|NCT01722331|18991946|P6|Part 1|Protocol Violation|0
5492269|NCT01722331|18991947|P5|Part 1|Protocol Violation|1
5492270|NCT01722331|18991948|P4|Part 1|Protocol Violation|0
5492271|NCT01722331|18991949|P3|Part 1|Protocol Violation|0
5492272|NCT01722331|18991950|P2|Part 1|Protocol Violation|0
5492273|NCT01722331|18991951|P1|Part 1|Protocol Violation|1
5492274|NCT01722331|18991945|P7|Part 1|Progressive Disease|0
5492275|NCT01722331|18991946|P6|Part 1|Progressive Disease|0
5492276|NCT01722331|18991947|P5|Part 1|Progressive Disease|1
5492277|NCT01722331|18991948|P4|Part 1|Progressive Disease|0
5492278|NCT01722331|18991949|P3|Part 1|Progressive Disease|0
5492279|NCT01722331|18991950|P2|Part 1|Progressive Disease|0
5492280|NCT01722331|18991951|P1|Part 1|Progressive Disease|0
5492281|NCT01722331|18991945|P7|Part 1|Pregnancy|0
5492282|NCT01722331|18991946|P6|Part 1|Pregnancy|0
5492283|NCT01722331|18991947|P5|Part 1|Pregnancy|0
5492284|NCT01722331|18991948|P4|Part 1|Pregnancy|0
5492285|NCT01722331|18991949|P3|Part 1|Pregnancy|0
5492286|NCT01722331|18991950|P2|Part 1|Pregnancy|0
5492287|NCT01722331|18991951|P1|Part 1|Pregnancy|1
5492288|NCT01722331|18991945|P7|Part 1|Physician Decision|0
5492289|NCT01722331|18991946|P6|Part 1|Physician Decision|0
5492290|NCT01722331|18991947|P5|Part 1|Physician Decision|1
5492291|NCT01722331|18991948|P4|Part 1|Physician Decision|0
5492292|NCT01722331|18991949|P3|Part 1|Physician Decision|3
5492293|NCT01722331|18991950|P2|Part 1|Physician Decision|0
5492294|NCT01722331|18991951|P1|Part 1|Physician Decision|0
5492295|NCT01722331|18991945|P7|Part 1|Lost to Follow-up|0
5492296|NCT01722331|18991946|P6|Part 1|Lost to Follow-up|0
5492297|NCT01722331|18991947|P5|Part 1|Lost to Follow-up|1
5492298|NCT01722331|18991948|P4|Part 1|Lost to Follow-up|0
5492299|NCT01722331|18991949|P3|Part 1|Lost to Follow-up|2
5492300|NCT01722331|18991950|P2|Part 1|Lost to Follow-up|0
5492301|NCT01722331|18991951|P1|Part 1|Lost to Follow-up|1
5492302|NCT01722331|18991945|P7|Part 1|Lack of Efficacy|0
5492303|NCT01722331|18991946|P6|Part 1|Lack of Efficacy|0
5492304|NCT01722331|18991947|P5|Part 1|Lack of Efficacy|2
5492305|NCT01722331|18991948|P4|Part 1|Lack of Efficacy|0
5492306|NCT01722331|18991949|P3|Part 1|Lack of Efficacy|1
5492307|NCT01722331|18991950|P2|Part 1|Lack of Efficacy|0
5492308|NCT01722331|18991951|P1|Part 1|Lack of Efficacy|0
5492309|NCT01722331|18991945|P7|Part 1|Adverse Event|0
5492310|NCT01722331|18991946|P6|Part 1|Adverse Event|0
5492311|NCT01722331|18991947|P5|Part 1|Adverse Event|0
5492312|NCT01722331|18991948|P4|Part 1|Adverse Event|0
5492313|NCT01722331|18991949|P3|Part 1|Adverse Event|0
5492314|NCT01722331|18991950|P2|Part 1|Adverse Event|0
5492315|NCT01722331|18991951|P1|Part 1|Adverse Event|5
5492316|NCT01722266|18992067|P4|Overall Study|Dropped out due to Nausea|0
5492317|NCT01722266|18992068|P3|Overall Study|Dropped out due to Nausea|2
5492318|NCT01722266|18992069|P2|Overall Study|Dropped out due to Nausea|0
5492319|NCT01722266|18992070|P1|Overall Study|Dropped out due to Nausea|0
5492320|NCT01722266|18992067|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
5492321|NCT01722266|18992068|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
5492322|NCT01722266|18992069|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
5492323|NCT01722266|18992070|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
5492324|NCT01722266|18992067|P4|Overall Study|Withdrawal by Subject|0
5492325|NCT01722266|18992068|P3|Overall Study|Withdrawal by Subject|0
5492326|NCT01722266|18992069|P2|Overall Study|Withdrawal by Subject|2
5492327|NCT01722266|18992070|P1|Overall Study|Withdrawal by Subject|1
5492328|NCT01722162|18992098|P2|Overall Study|Noncompliance|1
5492329|NCT01722162|18992099|P1|Overall Study|Noncompliance|0
5492330|NCT01722162|18992098|P2|Overall Study|Insurance denial post enrollment|1
5492331|NCT01722162|18992099|P1|Overall Study|Insurance denial post enrollment|0
5492332|NCT01722162|18992098|P2|Overall Study|Adverse Event|1
5492333|NCT01722162|18992099|P1|Overall Study|Adverse Event|1
5492334|NCT01722162|18992098|P2|Overall Study|Unrelated to study adverse event|2
5492335|NCT01722162|18992099|P1|Overall Study|Unrelated to study adverse event|2
5492336|NCT01722162|18992098|P2|Overall Study|Found ineligible|0
5492337|NCT01722162|18992099|P1|Overall Study|Found ineligible|1
5492338|NCT01722162|18992098|P2|Overall Study|Withdrawal by Subject|1
5492339|NCT01722162|18992099|P1|Overall Study|Withdrawal by Subject|1
5492340|NCT01722097|18992109|P2|Overall Study|Patient sheets not returned|5
5492341|NCT01722097|18992110|P1|Overall Study|Patient sheets not returned|6
5492342|NCT01722071|18992118|P2|Overall Study|Protocol Violation|0
5492343|NCT01722071|18992119|P1|Overall Study|Protocol Violation|1
5492344|NCT01722045|18992125|P1|Overall Study|Relocation (did not wish to transfer)|1
5492345|NCT01722045|18992125|P1|Overall Study|Physician Decision|3
5492346|NCT01722045|18992125|P1|Overall Study|Protocol Deviation|1
5492347|NCT01722045|18992125|P1|Overall Study|Lost to Follow-up|4
5492348|NCT01722045|18992125|P1|Overall Study|Withdrawal by Subject|8
5492349|NCT01722045|18992125|P1|Overall Study|Death|3
5492350|NCT01722045|18992125|P1|Overall Study|Adverse Event|8
5492351|NCT01721954|18992146|P2|Overall Study|Lost to Follow-up|1
5492352|NCT01721954|18992147|P1|Overall Study|Lost to Follow-up|2
5492353|NCT01721954|18992146|P2|Overall Study|Adverse Event|0
5492354|NCT01721954|18992147|P1|Overall Study|Adverse Event|2
5492355|NCT01721954|18992146|P2|Overall Study|Withdrawal by Subject|4
5492356|NCT01721954|18992147|P1|Overall Study|Withdrawal by Subject|8
5492357|NCT01721954|18992146|P2|Overall Study|Death|64
5492358|NCT01721954|18992147|P1|Overall Study|Death|58
5492359|NCT01721772|18992161|P2|Overall Study|Other|1
5492360|NCT01721772|18992162|P1|Overall Study|Other|0
5492361|NCT01721772|18992161|P2|Overall Study|Maximum clinical benefit|1
5492362|NCT01721772|18992162|P1|Overall Study|Maximum clinical benefit|1
5492363|NCT01721772|18992161|P2|Overall Study|Withdrawal by Subject|5
5492364|NCT01721772|18992162|P1|Overall Study|Withdrawal by Subject|7
5492365|NCT01721772|18992161|P2|Overall Study|Unrelated adverse event|3
5492366|NCT01721772|18992162|P1|Overall Study|Unrelated adverse event|2
5492367|NCT01721772|18992161|P2|Overall Study|Study drug toxicity|7
5492368|NCT01721772|18992162|P1|Overall Study|Study drug toxicity|5
5492369|NCT01721772|18992161|P2|Overall Study|Disease progression|175
5492370|NCT01721772|18992162|P1|Overall Study|Disease progression|96
5492371|NCT01721759|18992182|P1|Overall Study|Withdrawal by Subject|1
5492372|NCT01721759|18992182|P1|Overall Study|Adverse event unrelated to study drug|9
5492373|NCT01721759|18992182|P1|Overall Study|Study drug toxicity|14
5492374|NCT01721759|18992182|P1|Overall Study|Disease progression|78
5492375|NCT01721746|18992190|P3|Treatment Period|Other|1
5492376|NCT01721746|18992191|P2|Treatment Period|Other|1
5492377|NCT01721746|18992192|P1|Treatment Period|Other|2
5492378|NCT01721746|18992190|P3|Treatment Period|Subject No Longer Met Study Criteria|0
5492379|NCT01721746|18992191|P2|Treatment Period|Subject No Longer Met Study Criteria|0
5492380|NCT01721746|18992192|P1|Treatment Period|Subject No Longer Met Study Criteria|4
5492381|NCT01721746|18992190|P3|Treatment Period|Poor/Non-compliance|0
5492382|NCT01721746|18992191|P2|Treatment Period|Poor/Non-compliance|0
5492383|NCT01721746|18992192|P1|Treatment Period|Poor/Non-compliance|1
5492384|NCT01721746|18992190|P3|Treatment Period|Maximum Clinical Benefit|3
5492385|NCT01721746|18992191|P2|Treatment Period|Maximum Clinical Benefit|0
5492386|NCT01721746|18992192|P1|Treatment Period|Maximum Clinical Benefit|1
5492387|NCT01721746|18992190|P3|Treatment Period|Subject Withdrew Consent|2
5492388|NCT01721746|18992191|P2|Treatment Period|Subject Withdrew Consent|0
5492389|NCT01721746|18992192|P1|Treatment Period|Subject Withdrew Consent|3
5492390|NCT01721746|18992190|P3|Treatment Period|Subject Request to Discontinue Treatment|6
5492391|NCT01721746|18992191|P2|Treatment Period|Subject Request to Discontinue Treatment|1
5492392|NCT01721746|18992192|P1|Treatment Period|Subject Request to Discontinue Treatment|19
5492393|NCT01721746|18992190|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
5492394|NCT01721746|18992191|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
5492395|NCT01721746|18992192|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
5492396|NCT01721746|18992190|P3|Treatment Period|Study Drug Toxicity|9
5492397|NCT01721746|18992191|P2|Treatment Period|Study Drug Toxicity|2
5492398|NCT01721746|18992192|P1|Treatment Period|Study Drug Toxicity|15
5492399|NCT01721746|18992190|P3|Treatment Period|Disease Progression|34
5492400|NCT01721746|18992191|P2|Treatment Period|Disease Progression|40
5492401|NCT01721746|18992192|P1|Treatment Period|Disease Progression|182
5492402|NCT01721486|18992232|P2|Overall Study|Physician Decision|1
5492403|NCT01721486|18992233|P1|Overall Study|Physician Decision|0
5492404|NCT01721486|18992232|P2|Overall Study|Protocol Violation|0
5492405|NCT01721486|18992233|P1|Overall Study|Protocol Violation|1
5492406|NCT01721408|18992281|P2|Overall Study|Does not meet entrance criteria|0
5492407|NCT01721408|18992282|P1|Overall Study|Does not meet entrance criteria|1
5492408|NCT01721408|18992281|P2|Overall Study|Lost to Follow-up|2
5492409|NCT01721408|18992282|P1|Overall Study|Lost to Follow-up|1
5492410|NCT01721408|18992281|P2|Overall Study|Other|3
5492411|NCT01721408|18992282|P1|Overall Study|Other|3
5492412|NCT01721408|18992281|P2|Overall Study|Protocol Violation|2
5492413|NCT01721408|18992282|P1|Overall Study|Protocol Violation|0
5492414|NCT01721408|18992281|P2|Overall Study|No longer willing to participate study|10
5492415|NCT01721408|18992282|P1|Overall Study|No longer willing to participate study|9
5492416|NCT01721408|18992281|P2|Overall Study|Insufficient clinical response|6
5492417|NCT01721408|18992282|P1|Overall Study|Insufficient clinical response|15
5492418|NCT01721408|18992281|P2|Overall Study|Death|0
5492419|NCT01721408|18992282|P1|Overall Study|Death|1
5492420|NCT01721408|18992281|P2|Overall Study|Adverse Event|1
5492421|NCT01721408|18992282|P1|Overall Study|Adverse Event|6
5492422|NCT01721369|18992296|P1|Overall Study|Not initial etiological diagnosis|12
5492423|NCT01721330|18992302|P2|Overall Study|Withdrawal by Subject|1
5492424|NCT01721330|18992303|P1|Overall Study|Withdrawal by Subject|0
5492425|NCT01721317|18992311|P2|Overall Study|Withdrawal by Subject|1
5492426|NCT01721317|18992312|P1|Overall Study|Withdrawal by Subject|0
5492427|NCT01721317|18992311|P2|Overall Study|Physician Decision|1
5492428|NCT01721317|18992312|P1|Overall Study|Physician Decision|0
5492429|NCT01721317|18992311|P2|Overall Study|Study Closed / Terminated|2
5492430|NCT01721317|18992312|P1|Overall Study|Study Closed / Terminated|2
5492431|NCT01721200|18992391|P2|Overall Study|Lost to Follow-up|5
5492432|NCT01721200|18992392|P1|Overall Study|Lost to Follow-up|3
5492433|NCT01721161|18992417|P2|Overall Study|Other|1
5492434|NCT01721161|18992418|P1|Overall Study|Other|0
5492435|NCT01721161|18992417|P2|Overall Study|Withdrawal by Subject|1
5492436|NCT01721161|18992418|P1|Overall Study|Withdrawal by Subject|1
5492437|NCT01721161|18992417|P2|Overall Study|Lost to Follow-up|2
5492438|NCT01721161|18992418|P1|Overall Study|Lost to Follow-up|1
5492439|NCT01721161|18992417|P2|Overall Study|Adverse Event|3
5492440|NCT01721161|18992418|P1|Overall Study|Adverse Event|2
5492441|NCT01721109|18992441|P1|Overall Study|Lost to Follow-up|2
5492442|NCT01721109|18992441|P1|Overall Study|Withdrew Consent|1
5492443|NCT01721109|18992441|P1|Overall Study|Non- Compliance with Study Drug|3
5492444|NCT01721109|18992441|P1|Overall Study|Lack of Efficacy|1
5492445|NCT01721070|18992636|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
5492446|NCT01721057|18992647|P7|Rescue Period|Lack of Efficacy|0
5492447|NCT01721057|18992648|P6|Rescue Period|Lack of Efficacy|0
5492448|NCT01721057|18992649|P5|Rescue Period|Lack of Efficacy|0
5492449|NCT01721057|18992650|P4|Rescue Period|Lack of Efficacy|2
5492450|NCT01721057|18992651|P3|Rescue Period|Lack of Efficacy|0
5492451|NCT01721057|18992652|P2|Rescue Period|Lack of Efficacy|0
5492452|NCT01721057|18992653|P1|Rescue Period|Lack of Efficacy|0
5492453|NCT01721057|18992647|P7|Rescue Period|Adverse Event|0
5492454|NCT01721057|18992648|P6|Rescue Period|Adverse Event|0
5492455|NCT01721057|18992649|P5|Rescue Period|Adverse Event|0
5492456|NCT01721057|18992650|P4|Rescue Period|Adverse Event|1
5492457|NCT01721057|18992651|P3|Rescue Period|Adverse Event|0
5492458|NCT01721057|18992652|P2|Rescue Period|Adverse Event|0
5492459|NCT01721057|18992653|P1|Rescue Period|Adverse Event|0
5492460|NCT01721057|18992647|P7|Treatment Period|Death|0
5492461|NCT01721057|18992648|P6|Treatment Period|Death|0
5492462|NCT01721057|18992649|P5|Treatment Period|Death|0
5492463|NCT01721057|18992650|P4|Treatment Period|Death|0
5492464|NCT01721057|18992651|P3|Treatment Period|Death|0
5492465|NCT01721057|18992652|P2|Treatment Period|Death|0
5492466|NCT01721057|18992653|P1|Treatment Period|Death|2
5492467|NCT01721057|18992647|P7|Treatment Period|Physician Decision|0
5492468|NCT01721057|18992648|P6|Treatment Period|Physician Decision|0
5492469|NCT01721057|18992649|P5|Treatment Period|Physician Decision|0
5492470|NCT01721057|18992650|P4|Treatment Period|Physician Decision|0
5492471|NCT01721057|18992651|P3|Treatment Period|Physician Decision|3
5492472|NCT01721057|18992652|P2|Treatment Period|Physician Decision|1
5492473|NCT01721057|18992653|P1|Treatment Period|Physician Decision|0
5492474|NCT01721057|18992647|P7|Treatment Period|Lost to Follow-up|0
5492475|NCT01721057|18992648|P6|Treatment Period|Lost to Follow-up|0
5492476|NCT01721057|18992649|P5|Treatment Period|Lost to Follow-up|0
5492477|NCT01721057|18992650|P4|Treatment Period|Lost to Follow-up|0
5492478|NCT01721057|18992651|P3|Treatment Period|Lost to Follow-up|0
5492479|NCT01721057|18992652|P2|Treatment Period|Lost to Follow-up|0
5492480|NCT01721057|18992653|P1|Treatment Period|Lost to Follow-up|1
5492481|NCT01721057|18992647|P7|Treatment Period|Lack of Efficacy|0
5492482|NCT01721057|18992648|P6|Treatment Period|Lack of Efficacy|0
5492483|NCT01721057|18992649|P5|Treatment Period|Lack of Efficacy|0
5492484|NCT01721057|18992650|P4|Treatment Period|Lack of Efficacy|0
5492485|NCT01721057|18992651|P3|Treatment Period|Lack of Efficacy|0
5492486|NCT01721057|18992652|P2|Treatment Period|Lack of Efficacy|3
5492487|NCT01721057|18992653|P1|Treatment Period|Lack of Efficacy|7
5492488|NCT01721057|18992647|P7|Treatment Period|Adverse Event|0
5492489|NCT01721057|18992648|P6|Treatment Period|Adverse Event|0
5492490|NCT01721057|18992649|P5|Treatment Period|Adverse Event|0
5492491|NCT01721057|18992650|P4|Treatment Period|Adverse Event|0
5492492|NCT01721057|18992651|P3|Treatment Period|Adverse Event|12
5492493|NCT01721057|18992652|P2|Treatment Period|Adverse Event|10
5492494|NCT01721057|18992653|P1|Treatment Period|Adverse Event|7
5492495|NCT01721057|18992647|P7|Treatment Period|Withdrawal by Subject|0
5492496|NCT01721057|18992648|P6|Treatment Period|Withdrawal by Subject|0
5492497|NCT01721057|18992649|P5|Treatment Period|Withdrawal by Subject|0
5492498|NCT01721057|18992650|P4|Treatment Period|Withdrawal by Subject|0
5492499|NCT01721057|18992651|P3|Treatment Period|Withdrawal by Subject|8
5492500|NCT01721057|18992652|P2|Treatment Period|Withdrawal by Subject|5
5492501|NCT01721057|18992653|P1|Treatment Period|Withdrawal by Subject|11
5492502|NCT01721044|18992726|P3|Treatment Period|Withdrawal by Subject|1
5492503|NCT01721044|18992727|P2|Treatment Period|Withdrawal by Subject|6
5492504|NCT01721044|18992728|P1|Treatment Period|Withdrawal by Subject|7
5492505|NCT01721044|18992726|P3|Treatment Period|Protocol Violation|0
5492506|NCT01721044|18992727|P2|Treatment Period|Protocol Violation|0
5492507|NCT01721044|18992728|P1|Treatment Period|Protocol Violation|1
5492508|NCT01721044|18992726|P3|Treatment Period|Physician Decision|2
5492509|NCT01721044|18992727|P2|Treatment Period|Physician Decision|0
5492510|NCT01721044|18992728|P1|Treatment Period|Physician Decision|1
5492511|NCT01721044|18992726|P3|Treatment Period|Lost to Follow-up|1
5492512|NCT01721044|18992727|P2|Treatment Period|Lost to Follow-up|0
5492513|NCT01721044|18992728|P1|Treatment Period|Lost to Follow-up|0
5492514|NCT01721044|18992726|P3|Treatment Period|Lack of Efficacy|4
5492515|NCT01721044|18992727|P2|Treatment Period|Lack of Efficacy|4
5492516|NCT01721044|18992728|P1|Treatment Period|Lack of Efficacy|16
5492517|NCT01721044|18992726|P3|Treatment Period|Death|1
5492518|NCT01721044|18992727|P2|Treatment Period|Death|0
5492519|NCT01721044|18992728|P1|Treatment Period|Death|0
5492520|NCT01721044|18992726|P3|Treatment Period|Adverse Event|10
5492521|NCT01721044|18992727|P2|Treatment Period|Adverse Event|7
5492522|NCT01721044|18992728|P1|Treatment Period|Adverse Event|7
5492523|NCT01720797|18992801|P2|Overall Study|Withdrawal by Subject|0
5492524|NCT01720797|18992802|P1|Overall Study|Withdrawal by Subject|3
5492525|NCT01720667|18992810|P2|Overall Study|Withdrawal by Subject|0
5492526|NCT01720667|18992811|P1|Overall Study|Withdrawal by Subject|3
5492527|NCT01720667|18992810|P2|Overall Study|Adverse Event|1
5492528|NCT01720667|18992811|P1|Overall Study|Adverse Event|1
5492529|NCT01720602|18992825|P1|Overall Study|Progressive disease on therapy|2
5492530|NCT01720602|18992825|P1|Overall Study|Adverse Event|3
5492531|NCT01720524|18992835|P2|Part B|Death|2
5492532|NCT01720524|18992836|P1|Part B|Death|0
5492533|NCT01720524|18992835|P2|Part B|Lost to Follow-up|3
5492534|NCT01720524|18992836|P1|Part B|Lost to Follow-up|1
5492535|NCT01720524|18992835|P2|Part B|Other|0
5492536|NCT01720524|18992836|P1|Part B|Other|2
5492537|NCT01720524|18992835|P2|Part B|Withdrawal by Subject|4
5492538|NCT01720524|18992836|P1|Part B|Withdrawal by Subject|1
5492539|NCT01720524|18992835|P2|Part B|Ongoing|5
5492540|NCT01720524|18992836|P1|Part B|Ongoing|3
5492541|NCT01720524|18992835|P2|Part A|Lost to Follow-up|1
5492542|NCT01720524|18992836|P1|Part A|Lost to Follow-up|0
5492543|NCT01720524|18992835|P2|Part A|Other|1
5492544|NCT01720524|18992836|P1|Part A|Other|0
5492545|NCT01720524|18992835|P2|Part A|Withdrawal by Subject|1
5492546|NCT01720524|18992836|P1|Part A|Withdrawal by Subject|0
5492547|NCT01720524|18992835|P2|Part A|Missed 28 day follow-up visit|1
5492548|NCT01720524|18992836|P1|Part A|Missed 28 day follow-up visit|1
5492549|NCT01720524|18992835|P2|Part A|Lost to Follow-up|1
5492550|NCT01720524|18992836|P1|Part A|Lost to Follow-up|0
5492551|NCT01720524|18992835|P2|Part A|Death|1
5492552|NCT01720524|18992836|P1|Part A|Death|2
5492553|NCT01720524|18992835|P2|Part A|Adverse Event|2
5492554|NCT01720524|18992836|P1|Part A|Adverse Event|2
5492555|NCT01720524|18992835|P2|Part A|Insufficient Clinical Response|4
5492556|NCT01720524|18992836|P1|Part A|Insufficient Clinical Response|2
5492557|NCT01720446|18992869|P4|Overall Study|Withdrawal by Subject|4
5492558|NCT01720446|18992870|P3|Overall Study|Withdrawal by Subject|4
5492559|NCT01720446|18992871|P2|Overall Study|Withdrawal by Subject|5
5492560|NCT01720446|18992872|P1|Overall Study|Withdrawal by Subject|2
5492561|NCT01720446|18992869|P4|Overall Study|Lost to Follow-up|16
5492562|NCT01720446|18992870|P3|Overall Study|Lost to Follow-up|16
5492563|NCT01720446|18992871|P2|Overall Study|Lost to Follow-up|6
5492564|NCT01720446|18992872|P1|Overall Study|Lost to Follow-up|12
5492565|NCT01720264|18992993|P1|Post-transplant (Day 16) to 1 Year|Disease Progression|4
5492566|NCT01720264|18992993|P1|Post-transplant (Day 16) to 1 Year|Death|8
5492567|NCT01720264|18992993|P1|Transplant With Sitagliptin for 15 Days|Adverse Event|1
5492568|NCT01720225|18993015|P2|Overall Study|Did not complete 2 cycles of therapy|0
5492569|NCT01720225|18993016|P1|Overall Study|Did not complete 2 cycles of therapy|3
5492570|NCT01720225|18993015|P2|Overall Study|Withdrawal by Subject|1
5492571|NCT01720225|18993016|P1|Overall Study|Withdrawal by Subject|0
5492572|NCT01720069|18993035|P3|Overall Study|Lost to Follow-up|1
5492573|NCT01720069|18993036|P2|Overall Study|Lost to Follow-up|0
5492574|NCT01720069|18993037|P1|Overall Study|Lost to Follow-up|0
5492575|NCT01720069|18993035|P3|Overall Study|Non-compliance on using e-diary|1
5492576|NCT01720069|18993036|P2|Overall Study|Non-compliance on using e-diary|0
5492577|NCT01720069|18993037|P1|Overall Study|Non-compliance on using e-diary|0
5492578|NCT01720069|18993035|P3|Overall Study|OCS bursts occured, discontinued in line|0
5492579|NCT01720069|18993036|P2|Overall Study|OCS bursts occured, discontinued in line|0
5492580|NCT01720069|18993037|P1|Overall Study|OCS bursts occured, discontinued in line|1
5492581|NCT01720069|18993035|P3|Overall Study|Withdrawal by Subject|1
5492582|NCT01720069|18993036|P2|Overall Study|Withdrawal by Subject|2
5492583|NCT01720069|18993037|P1|Overall Study|Withdrawal by Subject|0
5492584|NCT01720069|18993035|P3|Overall Study|Treatment period withdrawal criteria met|9
5492585|NCT01720069|18993036|P2|Overall Study|Treatment period withdrawal criteria met|8
5492586|NCT01720069|18993037|P1|Overall Study|Treatment period withdrawal criteria met|4
5492587|NCT01720069|18993035|P3|Overall Study|Lack of Efficacy|0
5492588|NCT01720069|18993036|P2|Overall Study|Lack of Efficacy|4
5492589|NCT01720069|18993037|P1|Overall Study|Lack of Efficacy|0
5492590|NCT01720069|18993035|P3|Overall Study|Adverse Event|1
5492591|NCT01720069|18993036|P2|Overall Study|Adverse Event|0
5492592|NCT01720069|18993037|P1|Overall Study|Adverse Event|0
5492593|NCT01720069|18993035|P3|Overall Study|Randomised without baseline values|1
5492594|NCT01720069|18993036|P2|Overall Study|Randomised without baseline values|0
5492595|NCT01720069|18993037|P1|Overall Study|Randomised without baseline values|0
5492596|NCT01720069|18993035|P3|Overall Study|Could not use e-diary correctly|1
5492597|NCT01720069|18993036|P2|Overall Study|Could not use e-diary correctly|1
5492598|NCT01720069|18993037|P1|Overall Study|Could not use e-diary correctly|0
5492599|NCT01720043|18993063|P1|Overall Study|Withdrawal by Subject|1
5492600|NCT01719861|18993092|P1|Cycle 2|Death|1
5492601|NCT01719861|18993092|P1|Cycle 1|Death|4
5492602|NCT01719783|18993102|P2|Dose 2|Physician Decision|0
5492603|NCT01719783|18993103|P1|Dose 2|Physician Decision|1
5492604|NCT01719757|18993189|P1|Overall Study|well controlled pain|27
5492605|NCT01719757|18993189|P1|Overall Study|Protocol Violation|1
5492606|NCT01719757|18993189|P1|Overall Study|Lost to Follow-up|20
5492607|NCT01719757|18993189|P1|Overall Study|Withdrawal by Subject|15
5492608|NCT01719757|18993189|P1|Overall Study|Adverse Event|38
5492609|NCT01719224|18993243|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
5492610|NCT01719224|18993244|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
5492611|NCT01719172|18993253|P1|Overall Study|Death|1
5492612|NCT01719172|18993253|P1|Overall Study|Lost to Follow-up|1
5492613|NCT01719003|18993267|P9|Overall Study|Lack of Efficacy|0
5492614|NCT01719003|18993268|P8|Overall Study|Lack of Efficacy|0
5492615|NCT01719003|18993269|P7|Overall Study|Lack of Efficacy|1
5492616|NCT01719003|18993270|P6|Overall Study|Lack of Efficacy|0
5492617|NCT01719003|18993271|P5|Overall Study|Lack of Efficacy|0
5492618|NCT01719003|18993272|P4|Overall Study|Lack of Efficacy|0
5492619|NCT01719003|18993273|P3|Overall Study|Lack of Efficacy|0
5492620|NCT01719003|18993274|P2|Overall Study|Lack of Efficacy|0
5492621|NCT01719003|18993275|P1|Overall Study|Lack of Efficacy|0
5492622|NCT01719003|18993267|P9|Overall Study|Reason other than those specified|1
5492623|NCT01719003|18993268|P8|Overall Study|Reason other than those specified|3
5492624|NCT01719003|18993269|P7|Overall Study|Reason other than those specified|0
5492625|NCT01719003|18993270|P6|Overall Study|Reason other than those specified|1
5492626|NCT01719003|18993271|P5|Overall Study|Reason other than those specified|4
5492627|NCT01719003|18993272|P4|Overall Study|Reason other than those specified|3
5492628|NCT01719003|18993273|P3|Overall Study|Reason other than those specified|2
5492629|NCT01719003|18993274|P2|Overall Study|Reason other than those specified|0
5492630|NCT01719003|18993275|P1|Overall Study|Reason other than those specified|0
5492631|NCT01719003|18993267|P9|Overall Study|Refusal to continue, not due to AE|1
5492632|NCT01719003|18993268|P8|Overall Study|Refusal to continue, not due to AE|7
5492633|NCT01719003|18993269|P7|Overall Study|Refusal to continue, not due to AE|8
5492634|NCT01719003|18993270|P6|Overall Study|Refusal to continue, not due to AE|3
5492635|NCT01719003|18993271|P5|Overall Study|Refusal to continue, not due to AE|4
5492636|NCT01719003|18993272|P4|Overall Study|Refusal to continue, not due to AE|4
5492637|NCT01719003|18993273|P3|Overall Study|Refusal to continue, not due to AE|4
5492638|NCT01719003|18993274|P2|Overall Study|Refusal to continue, not due to AE|5
5492639|NCT01719003|18993275|P1|Overall Study|Refusal to continue, not due to AE|2
5492640|NCT01719003|18993267|P9|Overall Study|Lost to Follow-up|2
5492641|NCT01719003|18993268|P8|Overall Study|Lost to Follow-up|2
5492642|NCT01719003|18993269|P7|Overall Study|Lost to Follow-up|3
5492643|NCT01719003|18993270|P6|Overall Study|Lost to Follow-up|4
5492644|NCT01719003|18993271|P5|Overall Study|Lost to Follow-up|3
5492645|NCT01719003|18993272|P4|Overall Study|Lost to Follow-up|2
5492646|NCT01719003|18993273|P3|Overall Study|Lost to Follow-up|7
5492647|NCT01719003|18993274|P2|Overall Study|Lost to Follow-up|6
5492648|NCT01719003|18993275|P1|Overall Study|Lost to Follow-up|0
5492649|NCT01719003|18993267|P9|Overall Study|Adverse Event|0
5492650|NCT01719003|18993268|P8|Overall Study|Adverse Event|5
5492651|NCT01719003|18993269|P7|Overall Study|Adverse Event|6
5492652|NCT01719003|18993270|P6|Overall Study|Adverse Event|3
5492653|NCT01719003|18993271|P5|Overall Study|Adverse Event|4
5492654|NCT01719003|18993272|P4|Overall Study|Adverse Event|3
5492655|NCT01719003|18993273|P3|Overall Study|Adverse Event|4
5492656|NCT01719003|18993274|P2|Overall Study|Adverse Event|5
5492657|NCT01719003|18993275|P1|Overall Study|Adverse Event|6
5492658|NCT01719003|18993267|P9|Overall Study|Non compliant with protocol|0
5492659|NCT01719003|18993268|P8|Overall Study|Non compliant with protocol|3
5492660|NCT01719003|18993269|P7|Overall Study|Non compliant with protocol|2
5492661|NCT01719003|18993270|P6|Overall Study|Non compliant with protocol|1
5492662|NCT01719003|18993271|P5|Overall Study|Non compliant with protocol|2
5492663|NCT01719003|18993272|P4|Overall Study|Non compliant with protocol|1
5492664|NCT01719003|18993273|P3|Overall Study|Non compliant with protocol|0
5492665|NCT01719003|18993274|P2|Overall Study|Non compliant with protocol|1
5492666|NCT01719003|18993275|P1|Overall Study|Non compliant with protocol|1
5492667|NCT01718535|18993356|P10|Overall Study|Bidirectional Sequencing not possible|0
5492668|NCT01718535|18993357|P9|Overall Study|Bidirectional Sequencing not possible|0
5492669|NCT01718535|18993358|P8|Overall Study|Bidirectional Sequencing not possible|0
5492670|NCT01718535|18993359|P7|Overall Study|Bidirectional Sequencing not possible|0
5492671|NCT01718535|18993360|P6|Overall Study|Bidirectional Sequencing not possible|0
5492672|NCT01718535|18993361|P5|Overall Study|Bidirectional Sequencing not possible|0
5492673|NCT01718535|18993362|P4|Overall Study|Bidirectional Sequencing not possible|1
5492674|NCT01718535|18993363|P3|Overall Study|Bidirectional Sequencing not possible|0
5492675|NCT01718535|18993364|P2|Overall Study|Bidirectional Sequencing not possible|0
5492676|NCT01718535|18993365|P1|Overall Study|Bidirectional Sequencing not possible|1
5492677|NCT01718509|18993403|P2|Overall Study|Lack of Efficacy|0
5492678|NCT01718509|18993404|P1|Overall Study|Lack of Efficacy|1
5492679|NCT01718509|18993403|P2|Overall Study|Protocol Violation|2
5492680|NCT01718509|18993404|P1|Overall Study|Protocol Violation|4
5492681|NCT01718509|18993403|P2|Overall Study|Other|11
5492682|NCT01718509|18993404|P1|Overall Study|Other|13
5492683|NCT01718509|18993403|P2|Overall Study|Adverse Event|7
5492684|NCT01718509|18993404|P1|Overall Study|Adverse Event|5
5492685|NCT01718509|18993403|P2|Overall Study|Withdrawal by Subject|13
5492686|NCT01718509|18993404|P1|Overall Study|Withdrawal by Subject|7
5492687|NCT01718509|18993403|P2|Overall Study|Lost to Follow-up|15
5492688|NCT01718509|18993404|P1|Overall Study|Lost to Follow-up|18
5492689|NCT01718483|18993450|P2|Overall Study|Lack of Efficacy|0
5492690|NCT01718483|18993451|P1|Overall Study|Lack of Efficacy|1
5492691|NCT01718483|18993450|P2|Overall Study|Pregnancy|1
5492692|NCT01718483|18993451|P1|Overall Study|Pregnancy|1
5492693|NCT01718483|18993450|P2|Overall Study|Other|4
5492694|NCT01718483|18993451|P1|Overall Study|Other|1
5492695|NCT01718483|18993450|P2|Overall Study|Protocol Violation|2
5492696|NCT01718483|18993451|P1|Overall Study|Protocol Violation|4
5492697|NCT01718483|18993450|P2|Overall Study|Lost to Follow-up|3
5492698|NCT01718483|18993451|P1|Overall Study|Lost to Follow-up|8
5492699|NCT01718483|18993450|P2|Overall Study|Adverse Event|12
5492700|NCT01718483|18993451|P1|Overall Study|Adverse Event|5
5492701|NCT01718483|18993450|P2|Overall Study|Withdrawal by Subject|12
5492702|NCT01718483|18993451|P1|Overall Study|Withdrawal by Subject|14
5492703|NCT01718353|18993506|P2|Overall Study|Randomized but not treated|0
5492704|NCT01718353|18993507|P1|Overall Study|Randomized but not treated|2
5492705|NCT01718353|18993506|P2|Overall Study|Principal Investigator's Decision|4
5492706|NCT01718353|18993507|P1|Overall Study|Principal Investigator's Decision|10
5492707|NCT01718353|18993506|P2|Overall Study|Lost to Follow-up|1
5492708|NCT01718353|18993507|P1|Overall Study|Lost to Follow-up|0
5492709|NCT01717989|18993538|P1|Overall Study|Other|40
5492710|NCT01717989|18993538|P1|Overall Study|Protocol-specified criteria|551
5492711|NCT01717989|18993538|P1|Overall Study|Death|439
5492712|NCT01717989|18993538|P1|Overall Study|Lost to Follow-up|11
5492713|NCT01717989|18993538|P1|Overall Study|Physician Decision|2
5492714|NCT01717989|18993538|P1|Overall Study|Withdrawal by Subject|11
5492715|NCT01717989|18993538|P1|Overall Study|Protocol deviation|6
5492716|NCT01717989|18993538|P1|Overall Study|Ineligibility determined|6
5492717|NCT01717976|18993606|P2|Overall Study|Protocol Violation|1
5492718|NCT01717976|18993607|P1|Overall Study|Protocol Violation|0
5492719|NCT01717859|18993662|P1|Overall Study|Withdrawal by Subject|2
5492720|NCT01717859|18993662|P1|Overall Study|Lost to Follow-up|1
5492721|NCT01717859|18993662|P1|Overall Study|Patient concerned about mental health|1
5492722|NCT01717859|18993662|P1|Overall Study|Moved out of state|1
5492723|NCT01717859|18993662|P1|Overall Study|Adverse Event|5
5492724|NCT01717768|18993683|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492725|NCT01717768|18993684|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492726|NCT01717768|18993685|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
5492727|NCT01717768|18993686|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492728|NCT01717768|18993687|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492729|NCT01717768|18993688|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492730|NCT01717768|18993689|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492731|NCT01717768|18993690|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492732|NCT01717768|18993691|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492733|NCT01717768|18993692|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492734|NCT01717768|18993693|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492735|NCT01717768|18993694|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
5492736|NCT01717768|18993683|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492737|NCT01717768|18993684|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492738|NCT01717768|18993685|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492739|NCT01717768|18993686|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492740|NCT01717768|18993687|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
5492741|NCT01717768|18993688|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492742|NCT01717768|18993689|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492743|NCT01717768|18993690|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492744|NCT01717768|18993691|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492745|NCT01717768|18993692|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492746|NCT01717768|18993693|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492747|NCT01717768|18993694|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
5492748|NCT01717768|18993683|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
5492749|NCT01717768|18993684|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492750|NCT01717768|18993685|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492751|NCT01717768|18993686|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492752|NCT01717768|18993687|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492753|NCT01717768|18993688|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492754|NCT01717768|18993689|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492755|NCT01717768|18993690|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492756|NCT01717768|18993691|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492757|NCT01717768|18993692|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492758|NCT01717768|18993693|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492759|NCT01717768|18993694|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
5492760|NCT01717768|18993683|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492761|NCT01717768|18993684|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492762|NCT01717768|18993685|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492763|NCT01717768|18993686|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492764|NCT01717768|18993687|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492765|NCT01717768|18993688|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492766|NCT01717768|18993689|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492767|NCT01717768|18993690|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492768|NCT01717768|18993691|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492769|NCT01717768|18993692|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492770|NCT01717768|18993693|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
5492771|NCT01717768|18993694|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
5492772|NCT01717638|18993774|P13|Overall Study|Withdrawal by Subject|18
5492773|NCT01717638|18993775|P12|Overall Study|Withdrawal by Subject|0
5492774|NCT01717638|18993776|P11|Overall Study|Withdrawal by Subject|0
5492775|NCT01717638|18993777|P10|Overall Study|Withdrawal by Subject|1
5492776|NCT01717638|18993778|P9|Overall Study|Withdrawal by Subject|2
5492777|NCT01717638|18993779|P8|Overall Study|Withdrawal by Subject|1
5492778|NCT01717638|18993780|P7|Overall Study|Withdrawal by Subject|2
5492779|NCT01717638|18993781|P6|Overall Study|Withdrawal by Subject|0
5492780|NCT01717638|18993782|P5|Overall Study|Withdrawal by Subject|1
5492781|NCT01717638|18993783|P4|Overall Study|Withdrawal by Subject|0
5492782|NCT01717638|18993784|P3|Overall Study|Withdrawal by Subject|1
5492783|NCT01717638|18993785|P2|Overall Study|Withdrawal by Subject|1
5492784|NCT01717638|18993786|P1|Overall Study|Withdrawal by Subject|0
5492785|NCT01717638|18993774|P13|Overall Study|Father in hospital|1
5492786|NCT01717638|18993775|P12|Overall Study|Father in hospital|0
5492787|NCT01717638|18993776|P11|Overall Study|Father in hospital|0
5492788|NCT01717638|18993777|P10|Overall Study|Father in hospital|0
5492789|NCT01717638|18993778|P9|Overall Study|Father in hospital|0
5492790|NCT01717638|18993779|P8|Overall Study|Father in hospital|0
5492791|NCT01717638|18993780|P7|Overall Study|Father in hospital|0
5492792|NCT01717638|18993781|P6|Overall Study|Father in hospital|0
5492793|NCT01717638|18993782|P5|Overall Study|Father in hospital|0
5492794|NCT01717638|18993783|P4|Overall Study|Father in hospital|0
5492795|NCT01717638|18993784|P3|Overall Study|Father in hospital|0
5492796|NCT01717638|18993785|P2|Overall Study|Father in hospital|0
5492797|NCT01717638|18993786|P1|Overall Study|Father in hospital|0
5492798|NCT01717638|18993774|P13|Overall Study|Lost to Follow-up|0
5492799|NCT01717638|18993775|P12|Overall Study|Lost to Follow-up|0
5492800|NCT01717638|18993776|P11|Overall Study|Lost to Follow-up|0
5492801|NCT01717638|18993777|P10|Overall Study|Lost to Follow-up|0
5492802|NCT01717638|18993778|P9|Overall Study|Lost to Follow-up|0
5492803|NCT01717638|18993779|P8|Overall Study|Lost to Follow-up|0
5492804|NCT01717638|18993780|P7|Overall Study|Lost to Follow-up|0
5492805|NCT01717638|18993781|P6|Overall Study|Lost to Follow-up|1
5492806|NCT01717638|18993782|P5|Overall Study|Lost to Follow-up|0
5492807|NCT01717638|18993783|P4|Overall Study|Lost to Follow-up|0
5492808|NCT01717638|18993784|P3|Overall Study|Lost to Follow-up|0
5492809|NCT01717638|18993785|P2|Overall Study|Lost to Follow-up|0
5492810|NCT01717638|18993786|P1|Overall Study|Lost to Follow-up|0
5492811|NCT01717456|18993962|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
5492812|NCT01717456|18993963|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
5492813|NCT01717456|18993962|P2|End of Treatment|Lost to Follow-up|1
5492814|NCT01717456|18993963|P1|End of Treatment|Lost to Follow-up|0
5492815|NCT01717456|18993962|P2|End of Treatment|Physician Decision|1
5492816|NCT01717456|18993963|P1|End of Treatment|Physician Decision|0
5492817|NCT01717391|18994031|P1|Overall Study|FLT technical failure|3
5492818|NCT01717391|18994031|P1|Overall Study|Physician Decision|1
5492819|NCT01717391|18994031|P1|Overall Study|Withdrawal by Subject|5
5492820|NCT01717326|18994060|P20|Overall Study|Withdrawal by Subject|3
5492821|NCT01717326|18994061|P19|Overall Study|Withdrawal by Subject|2
5492822|NCT01717326|18994062|P18|Overall Study|Withdrawal by Subject|0
5492823|NCT01717326|18994063|P17|Overall Study|Withdrawal by Subject|0
5492824|NCT01717326|18994064|P16|Overall Study|Withdrawal by Subject|1
5492825|NCT01717326|18994065|P15|Overall Study|Withdrawal by Subject|0
5492826|NCT01717326|18994066|P14|Overall Study|Withdrawal by Subject|0
5492827|NCT01717326|18994067|P13|Overall Study|Withdrawal by Subject|1
5492828|NCT01717326|18994068|P12|Overall Study|Withdrawal by Subject|0
5492829|NCT01717326|18994069|P11|Overall Study|Withdrawal by Subject|0
5492830|NCT01717326|18994070|P10|Overall Study|Withdrawal by Subject|1
5492831|NCT01717326|18994071|P9|Overall Study|Withdrawal by Subject|0
5492832|NCT01717326|18994072|P8|Overall Study|Withdrawal by Subject|0
5492833|NCT01717326|18994073|P7|Overall Study|Withdrawal by Subject|0
5492834|NCT01717326|18994074|P6|Overall Study|Withdrawal by Subject|0
5492835|NCT01717326|18994075|P5|Overall Study|Withdrawal by Subject|0
5492836|NCT01717326|18994076|P4|Overall Study|Withdrawal by Subject|0
5492837|NCT01717326|18994077|P3|Overall Study|Withdrawal by Subject|0
5492838|NCT01717326|18994078|P2|Overall Study|Withdrawal by Subject|1
5492839|NCT01717326|18994079|P1|Overall Study|Withdrawal by Subject|0
5492840|NCT01717326|18994060|P20|Overall Study|Protocol Violation|0
5492841|NCT01717326|18994061|P19|Overall Study|Protocol Violation|0
5492842|NCT01717326|18994062|P18|Overall Study|Protocol Violation|0
5492843|NCT01717326|18994063|P17|Overall Study|Protocol Violation|0
5492844|NCT01717326|18994064|P16|Overall Study|Protocol Violation|0
5492845|NCT01717326|18994065|P15|Overall Study|Protocol Violation|0
5492846|NCT01717326|18994066|P14|Overall Study|Protocol Violation|0
5492847|NCT01717326|18994067|P13|Overall Study|Protocol Violation|0
5492848|NCT01717326|18994068|P12|Overall Study|Protocol Violation|0
5492849|NCT01717326|18994069|P11|Overall Study|Protocol Violation|0
5492850|NCT01717326|18994070|P10|Overall Study|Protocol Violation|0
5492851|NCT01717326|18994071|P9|Overall Study|Protocol Violation|0
5492852|NCT01717326|18994072|P8|Overall Study|Protocol Violation|0
5492853|NCT01717326|18994073|P7|Overall Study|Protocol Violation|0
5492854|NCT01717326|18994074|P6|Overall Study|Protocol Violation|0
5492855|NCT01717326|18994075|P5|Overall Study|Protocol Violation|1
5492856|NCT01717326|18994076|P4|Overall Study|Protocol Violation|0
5492857|NCT01717326|18994077|P3|Overall Study|Protocol Violation|0
5492858|NCT01717326|18994078|P2|Overall Study|Protocol Violation|0
5492859|NCT01717326|18994079|P1|Overall Study|Protocol Violation|0
5492860|NCT01717326|18994060|P20|Overall Study|Physician Decision|0
5492861|NCT01717326|18994061|P19|Overall Study|Physician Decision|0
5492862|NCT01717326|18994062|P18|Overall Study|Physician Decision|0
5492863|NCT01717326|18994063|P17|Overall Study|Physician Decision|0
5492864|NCT01717326|18994064|P16|Overall Study|Physician Decision|0
5492865|NCT01717326|18994065|P15|Overall Study|Physician Decision|0
5492866|NCT01717326|18994066|P14|Overall Study|Physician Decision|0
5492867|NCT01717326|18994067|P13|Overall Study|Physician Decision|0
5492868|NCT01717326|18994068|P12|Overall Study|Physician Decision|0
5492869|NCT01717326|18994069|P11|Overall Study|Physician Decision|0
5492870|NCT01717326|18994070|P10|Overall Study|Physician Decision|1
5492871|NCT01717326|18994071|P9|Overall Study|Physician Decision|0
5492872|NCT01717326|18994072|P8|Overall Study|Physician Decision|0
5492873|NCT01717326|18994073|P7|Overall Study|Physician Decision|0
5492874|NCT01717326|18994074|P6|Overall Study|Physician Decision|0
5492875|NCT01717326|18994075|P5|Overall Study|Physician Decision|0
5492876|NCT01717326|18994076|P4|Overall Study|Physician Decision|0
5492877|NCT01717326|18994077|P3|Overall Study|Physician Decision|0
5492878|NCT01717326|18994078|P2|Overall Study|Physician Decision|0
5492879|NCT01717326|18994079|P1|Overall Study|Physician Decision|0
5492880|NCT01717326|18994060|P20|Overall Study|Lost to Follow-up|3
5492881|NCT01717326|18994061|P19|Overall Study|Lost to Follow-up|2
5492882|NCT01717326|18994062|P18|Overall Study|Lost to Follow-up|0
5492883|NCT01717326|18994063|P17|Overall Study|Lost to Follow-up|1
5492884|NCT01717326|18994064|P16|Overall Study|Lost to Follow-up|2
5492885|NCT01717326|18994065|P15|Overall Study|Lost to Follow-up|0
5492886|NCT01717326|18994066|P14|Overall Study|Lost to Follow-up|0
5492887|NCT01717326|18994067|P13|Overall Study|Lost to Follow-up|0
5492888|NCT01717326|18994068|P12|Overall Study|Lost to Follow-up|0
5492889|NCT01717326|18994069|P11|Overall Study|Lost to Follow-up|1
5492890|NCT01717326|18994070|P10|Overall Study|Lost to Follow-up|0
5492891|NCT01717326|18994071|P9|Overall Study|Lost to Follow-up|0
5492892|NCT01717326|18994072|P8|Overall Study|Lost to Follow-up|0
5492893|NCT01717326|18994073|P7|Overall Study|Lost to Follow-up|1
5492894|NCT01717326|18994074|P6|Overall Study|Lost to Follow-up|0
5492895|NCT01717326|18994075|P5|Overall Study|Lost to Follow-up|1
5492896|NCT01717326|18994076|P4|Overall Study|Lost to Follow-up|2
5492897|NCT01717326|18994077|P3|Overall Study|Lost to Follow-up|0
5492898|NCT01717326|18994078|P2|Overall Study|Lost to Follow-up|0
5492899|NCT01717326|18994079|P1|Overall Study|Lost to Follow-up|3
5492900|NCT01717326|18994060|P20|Overall Study|Death|0
5492901|NCT01717326|18994061|P19|Overall Study|Death|0
5492902|NCT01717326|18994062|P18|Overall Study|Death|0
5492903|NCT01717326|18994063|P17|Overall Study|Death|0
5492904|NCT01717326|18994064|P16|Overall Study|Death|0
5492905|NCT01717326|18994065|P15|Overall Study|Death|0
5492906|NCT01717326|18994066|P14|Overall Study|Death|0
5492907|NCT01717326|18994067|P13|Overall Study|Death|0
5492908|NCT01717326|18994068|P12|Overall Study|Death|0
5492909|NCT01717326|18994069|P11|Overall Study|Death|1
5492910|NCT01717326|18994070|P10|Overall Study|Death|0
5492911|NCT01717326|18994071|P9|Overall Study|Death|0
5492912|NCT01717326|18994072|P8|Overall Study|Death|0
5492913|NCT01717326|18994073|P7|Overall Study|Death|0
5492914|NCT01717326|18994074|P6|Overall Study|Death|0
5492915|NCT01717326|18994075|P5|Overall Study|Death|0
5492916|NCT01717326|18994076|P4|Overall Study|Death|0
5492917|NCT01717326|18994077|P3|Overall Study|Death|0
5492918|NCT01717326|18994078|P2|Overall Study|Death|0
5492919|NCT01717326|18994079|P1|Overall Study|Death|0
5492920|NCT01717313|18994343|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
5492921|NCT01717313|18994344|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
5492922|NCT01717313|18994343|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
5492923|NCT01717313|18994344|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
5492924|NCT01717313|18994343|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
5492925|NCT01717313|18994344|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
5492926|NCT01717313|18994343|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
5492927|NCT01717313|18994344|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
5492928|NCT01717313|18994343|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
5492929|NCT01717313|18994344|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
5492930|NCT01717313|18994343|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
5492931|NCT01717313|18994344|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
5492932|NCT01717313|18994343|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
5492933|NCT01717313|18994344|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
5492934|NCT01717313|18994343|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
5492935|NCT01717313|18994344|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
5492936|NCT01717313|18994343|P2|Phase A (Weeks 0 to 24)|Death|1
5492937|NCT01717313|18994344|P1|Phase A (Weeks 0 to 24)|Death|0
5492938|NCT01717287|18994382|P2|Overall Study|Protocol Violation|1
5492939|NCT01717287|18994383|P1|Overall Study|Protocol Violation|0
5492940|NCT01717287|18994382|P2|Overall Study|Lost to Follow-up|2
5492941|NCT01717287|18994383|P1|Overall Study|Lost to Follow-up|0
5492942|NCT01717040|18994423|P2|Overall Study|New Substance Use Disorder|0
5492943|NCT01717040|18994424|P1|Overall Study|New Substance Use Disorder|1
5492944|NCT01717040|18994423|P2|Overall Study|Required Medication Change|1
5492945|NCT01717040|18994424|P1|Overall Study|Required Medication Change|0
5492946|NCT01717040|18994423|P2|Overall Study|Adverse Event|0
5492947|NCT01717040|18994424|P1|Overall Study|Adverse Event|1
5492948|NCT01717040|18994423|P2|Overall Study|Lack of Efficacy|1
5492949|NCT01717040|18994424|P1|Overall Study|Lack of Efficacy|1
5492950|NCT01717040|18994423|P2|Overall Study|Lost to Follow-up|3
5492951|NCT01717040|18994424|P1|Overall Study|Lost to Follow-up|2
5492952|NCT01716754|18994451|P4|Overall Study|Withdrawal by Subject|3
5492953|NCT01716754|18994452|P3|Overall Study|Withdrawal by Subject|4
5492954|NCT01716754|18994453|P2|Overall Study|Withdrawal by Subject|0
5492955|NCT01716754|18994454|P1|Overall Study|Withdrawal by Subject|5
5492956|NCT01716754|18994451|P4|Overall Study|Adverse Event|1
5492957|NCT01716754|18994452|P3|Overall Study|Adverse Event|2
5492958|NCT01716754|18994453|P2|Overall Study|Adverse Event|2
5492959|NCT01716754|18994454|P1|Overall Study|Adverse Event|4
5492960|NCT01716754|18994451|P4|Overall Study|Lost to Follow-up|1
5492961|NCT01716754|18994452|P3|Overall Study|Lost to Follow-up|0
5492962|NCT01716754|18994453|P2|Overall Study|Lost to Follow-up|0
5492963|NCT01716754|18994454|P1|Overall Study|Lost to Follow-up|1
5492964|NCT01716754|18994451|P4|Overall Study|Physician Decision|0
5492965|NCT01716754|18994452|P3|Overall Study|Physician Decision|0
5492966|NCT01716754|18994453|P2|Overall Study|Physician Decision|0
5492967|NCT01716754|18994454|P1|Overall Study|Physician Decision|1
5492968|NCT01716754|18994451|P4|Overall Study|Non-compliance with study treatment|0
5492969|NCT01716754|18994452|P3|Overall Study|Non-compliance with study treatment|1
5492970|NCT01716754|18994453|P2|Overall Study|Non-compliance with study treatment|0
5492971|NCT01716754|18994454|P1|Overall Study|Non-compliance with study treatment|0
5492972|NCT01716754|18994451|P4|Overall Study|Protocol deviation|2
5492973|NCT01716754|18994452|P3|Overall Study|Protocol deviation|7
5492974|NCT01716754|18994453|P2|Overall Study|Protocol deviation|2
5492975|NCT01716754|18994454|P1|Overall Study|Protocol deviation|0
5492976|NCT01716754|18994451|P4|Overall Study|Death|1
5492977|NCT01716754|18994452|P3|Overall Study|Death|0
5492978|NCT01716754|18994453|P2|Overall Study|Death|0
5492979|NCT01716754|18994454|P1|Overall Study|Death|0
5492980|NCT01716715|18994477|P2|Overall Study|Never Treated|4
5492981|NCT01716715|18994478|P1|Overall Study|Never Treated|2
5492982|NCT01716663|18994494|P1|Overall Study|Treated with non-study catheter|2
5492983|NCT01716663|18994494|P1|Overall Study|Withdrawn prior to procedure|4
5492984|NCT01716585|18994504|P2|Open-label Treatment|Withdrawal by Subject|3
5492985|NCT01716585|18994505|P1|Open-label Treatment|Withdrawal by Subject|0
5492986|NCT01716585|18994504|P2|Open-label Treatment|Virologic Failure|2
5492987|NCT01716585|18994505|P1|Open-label Treatment|Virologic Failure|0
5492988|NCT01716585|18994504|P2|Open-label Treatment|Adverse Event|2
5492989|NCT01716585|18994505|P1|Open-label Treatment|Adverse Event|0
5492990|NCT01716585|18994504|P2|Double-blind Treatment|Other|0
5492991|NCT01716585|18994505|P1|Double-blind Treatment|Other|1
5492992|NCT01716585|18994504|P2|Double-blind Treatment|Subject Noncompliant|0
5492993|NCT01716585|18994505|P1|Double-blind Treatment|Subject Noncompliant|1
5492994|NCT01716585|18994504|P2|Double-blind Treatment|Lost to Follow-up|0
5492995|NCT01716585|18994505|P1|Double-blind Treatment|Lost to Follow-up|2
5492996|NCT01716585|18994504|P2|Double-blind Treatment|Withdrawal by Subject|0
5492997|NCT01716585|18994505|P1|Double-blind Treatment|Withdrawal by Subject|3
5492998|NCT01716585|18994504|P2|Double-blind Treatment|Adverse Event|1
5492999|NCT01716585|18994505|P1|Double-blind Treatment|Adverse Event|2
5493000|NCT01716585|18994504|P2|Double-blind Treatment|Did Not Receive Study Drug|1
5493001|NCT01716585|18994505|P1|Double-blind Treatment|Did Not Receive Study Drug|4
5493002|NCT01716559|18994517|P1|Overall Study|Other withdrawal reason|75
5493003|NCT01716559|18994517|P1|Overall Study|Withdrawal by Subject|4
5493004|NCT01716559|18994517|P1|Overall Study|Death|21
5493005|NCT01716559|18994517|P1|Overall Study|Adverse Event|11
5493006|NCT01716533|18994529|P4|Overall Study|Immunosuppressants>14days past 6months|1
5493007|NCT01716533|18994530|P3|Overall Study|Immunosuppressants>14days past 6months|0
5493008|NCT01716533|18994531|P2|Overall Study|Immunosuppressants>14days past 6months|0
5493009|NCT01716533|18994532|P1|Overall Study|Immunosuppressants>14days past 6months|0
5493010|NCT01716533|18994529|P4|Overall Study|Death|2
5493011|NCT01716533|18994530|P3|Overall Study|Death|0
5493012|NCT01716533|18994531|P2|Overall Study|Death|0
5493013|NCT01716533|18994532|P1|Overall Study|Death|0
5493014|NCT01716533|18994529|P4|Overall Study|Withdrawal by Subject|5
5493015|NCT01716533|18994530|P3|Overall Study|Withdrawal by Subject|0
5493016|NCT01716533|18994531|P2|Overall Study|Withdrawal by Subject|0
5493017|NCT01716533|18994532|P1|Overall Study|Withdrawal by Subject|0
5493018|NCT01716533|18994529|P4|Overall Study|Failure of antibiotic treatment to treat|0
5493019|NCT01716533|18994530|P3|Overall Study|Failure of antibiotic treatment to treat|5
5493020|NCT01716533|18994531|P2|Overall Study|Failure of antibiotic treatment to treat|0
5493021|NCT01716533|18994532|P1|Overall Study|Failure of antibiotic treatment to treat|0
5493022|NCT01716520|18994586|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5493023|NCT01716520|18994587|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5493024|NCT01716520|18994588|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5493025|NCT01716520|18994589|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
5493026|NCT01716520|18994590|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5493027|NCT01716520|18994591|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5493028|NCT01716520|18994586|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
5493029|NCT01716520|18994587|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5493030|NCT01716520|18994588|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5493031|NCT01716520|18994589|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5493032|NCT01716520|18994590|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5493033|NCT01716520|18994591|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5493034|NCT01716520|18994586|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5493035|NCT01716520|18994587|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5493036|NCT01716520|18994588|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5493037|NCT01716520|18994589|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5493038|NCT01716520|18994590|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
5493039|NCT01716520|18994591|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
5493040|NCT01716520|18994586|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
5493041|NCT01716520|18994587|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5493042|NCT01716520|18994588|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5493043|NCT01716520|18994589|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5493044|NCT01716520|18994590|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5493045|NCT01716520|18994591|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
5493046|NCT01716520|18994586|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5493047|NCT01716520|18994587|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5493048|NCT01716520|18994588|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5493049|NCT01716520|18994589|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5493050|NCT01716520|18994590|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
5493051|NCT01716520|18994591|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
5493052|NCT01716520|18994586|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
5493053|NCT01716520|18994587|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
5493054|NCT01716520|18994588|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
5493055|NCT01716520|18994589|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
5493056|NCT01716520|18994590|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
5493057|NCT01716520|18994591|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
5493058|NCT01716520|18994586|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5493059|NCT01716520|18994587|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5493060|NCT01716520|18994588|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
5493061|NCT01716520|18994589|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5493062|NCT01716520|18994590|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5493063|NCT01716520|18994591|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
5493064|NCT01716520|18994586|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
5493065|NCT01716520|18994587|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
5493066|NCT01716520|18994588|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
5493067|NCT01716520|18994589|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
5493068|NCT01716520|18994590|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
5493069|NCT01716520|18994591|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
5493070|NCT01716520|18994586|P6|Treatment Period 2 (14 Days)|Adverse Event|0
5493071|NCT01716520|18994587|P5|Treatment Period 2 (14 Days)|Adverse Event|1
5493072|NCT01716520|18994588|P4|Treatment Period 2 (14 Days)|Adverse Event|0
5493073|NCT01716520|18994589|P3|Treatment Period 2 (14 Days)|Adverse Event|0
5493074|NCT01716520|18994590|P2|Treatment Period 2 (14 Days)|Adverse Event|0
5493075|NCT01716520|18994591|P1|Treatment Period 2 (14 Days)|Adverse Event|0
5493076|NCT01716520|18994586|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
5493077|NCT01716520|18994587|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5493078|NCT01716520|18994588|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5493079|NCT01716520|18994589|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
5493080|NCT01716520|18994590|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5493081|NCT01716520|18994591|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
5493082|NCT01716520|18994586|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
5493083|NCT01716520|18994587|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5493084|NCT01716520|18994588|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5493085|NCT01716520|18994589|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5493086|NCT01716520|18994590|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5493087|NCT01716520|18994591|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5493088|NCT01716520|18994586|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5493089|NCT01716520|18994587|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5493090|NCT01716520|18994588|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5493091|NCT01716520|18994589|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5493092|NCT01716520|18994590|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
5493093|NCT01716520|18994591|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
5493094|NCT01716520|18994586|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5493095|NCT01716520|18994587|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5493096|NCT01716520|18994588|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5493097|NCT01716520|18994589|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5493098|NCT01716520|18994590|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5493099|NCT01716520|18994591|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5493100|NCT01716520|18994586|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
5493101|NCT01716520|18994587|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
5493102|NCT01716520|18994588|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
5493103|NCT01716520|18994589|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
5493104|NCT01716520|18994590|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
5493105|NCT01716520|18994591|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
5493106|NCT01716520|18994586|P6|Treatment Period 1 (14 Days)|Adverse Event|0
5493107|NCT01716520|18994587|P5|Treatment Period 1 (14 Days)|Adverse Event|0
5493108|NCT01716520|18994588|P4|Treatment Period 1 (14 Days)|Adverse Event|0
5493109|NCT01716520|18994589|P3|Treatment Period 1 (14 Days)|Adverse Event|0
5493110|NCT01716520|18994590|P2|Treatment Period 1 (14 Days)|Adverse Event|0
5493111|NCT01716520|18994591|P1|Treatment Period 1 (14 Days)|Adverse Event|1
5493112|NCT01716234|18994646|P7|Overall Study|Withdrawal by Subject|0
5493113|NCT01716234|18994647|P6|Overall Study|Withdrawal by Subject|3
5493114|NCT01716234|18994648|P5|Overall Study|Withdrawal by Subject|1
5493115|NCT01716234|18994649|P4|Overall Study|Withdrawal by Subject|2
5493116|NCT01716234|18994650|P3|Overall Study|Withdrawal by Subject|2
5493117|NCT01716234|18994651|P2|Overall Study|Withdrawal by Subject|0
5493118|NCT01716234|18994652|P1|Overall Study|Withdrawal by Subject|3
5493119|NCT01716234|18994646|P7|Overall Study|Adverse Event|0
5493120|NCT01716234|18994647|P6|Overall Study|Adverse Event|6
5493121|NCT01716234|18994648|P5|Overall Study|Adverse Event|3
5493122|NCT01716234|18994649|P4|Overall Study|Adverse Event|8
5493123|NCT01716234|18994650|P3|Overall Study|Adverse Event|2
5493124|NCT01716234|18994651|P2|Overall Study|Adverse Event|10
5493125|NCT01716234|18994652|P1|Overall Study|Adverse Event|7
5493126|NCT01716234|18994646|P7|Overall Study|Did not meet protocol eligibility|0
5493127|NCT01716234|18994647|P6|Overall Study|Did not meet protocol eligibility|4
5493128|NCT01716234|18994648|P5|Overall Study|Did not meet protocol eligibility|0
5493129|NCT01716234|18994649|P4|Overall Study|Did not meet protocol eligibility|0
5493130|NCT01716234|18994650|P3|Overall Study|Did not meet protocol eligibility|1
5493131|NCT01716234|18994651|P2|Overall Study|Did not meet protocol eligibility|0
5493132|NCT01716234|18994652|P1|Overall Study|Did not meet protocol eligibility|0
5493133|NCT01716234|18994646|P7|Overall Study|Lack of Efficacy|0
5493134|NCT01716234|18994647|P6|Overall Study|Lack of Efficacy|0
5493135|NCT01716234|18994648|P5|Overall Study|Lack of Efficacy|0
5493136|NCT01716234|18994649|P4|Overall Study|Lack of Efficacy|1
5493137|NCT01716234|18994650|P3|Overall Study|Lack of Efficacy|0
5493138|NCT01716234|18994651|P2|Overall Study|Lack of Efficacy|0
5493139|NCT01716234|18994652|P1|Overall Study|Lack of Efficacy|0
5493140|NCT01716234|18994646|P7|Overall Study|Protocol Violation|0
5493141|NCT01716234|18994647|P6|Overall Study|Protocol Violation|1
5493142|NCT01716234|18994648|P5|Overall Study|Protocol Violation|1
5493143|NCT01716234|18994649|P4|Overall Study|Protocol Violation|1
5493144|NCT01716234|18994650|P3|Overall Study|Protocol Violation|0
5493145|NCT01716234|18994651|P2|Overall Study|Protocol Violation|0
5493146|NCT01716234|18994652|P1|Overall Study|Protocol Violation|0
5493147|NCT01716169|18994715|P1|Overall Study|inconsistent dressing application|1
5493148|NCT01716169|18994715|P1|Overall Study|Withdrawal by Subject|1
5493149|NCT01716169|18994715|P1|Overall Study|Lost to Follow-up|1
5493150|NCT01716169|18994715|P1|Overall Study|Adverse Event|1
5493151|NCT01716156|18994724|P3|Overall Study|Lost to Follow-up|0
5493152|NCT01716156|18994725|P2|Overall Study|Lost to Follow-up|0
5493153|NCT01716156|18994726|P1|Overall Study|Lost to Follow-up|1
5493154|NCT01716156|18994724|P3|Overall Study|Withdrawal by Subject|2
5493155|NCT01716156|18994725|P2|Overall Study|Withdrawal by Subject|1
5493156|NCT01716156|18994726|P1|Overall Study|Withdrawal by Subject|0
5493157|NCT01716156|18994724|P3|Overall Study|Protocol Violation|0
5493158|NCT01716156|18994725|P2|Overall Study|Protocol Violation|0
5493159|NCT01716156|18994726|P1|Overall Study|Protocol Violation|1
5493160|NCT01716117|18994752|P2|Overall Study|Withdrawal by Subject|0
5493161|NCT01716117|18994753|P1|Overall Study|Withdrawal by Subject|2
5493162|NCT01716117|18994752|P2|Overall Study|Death|2
5493163|NCT01716117|18994753|P1|Overall Study|Death|5
5493164|NCT01716104|18994772|P2|Overall Study|Do not meet inclusion criteria|7
5493165|NCT01716104|18994773|P1|Overall Study|Do not meet inclusion criteria|6
5493166|NCT01716052|18994799|P2|Overall Study|Withdrawal of funding|1
5493167|NCT01716052|18994800|P1|Overall Study|Withdrawal of funding|1
5493168|NCT01715896|18994842|P2|Overall Study|Other|5
5493169|NCT01715896|18994843|P1|Overall Study|Other|2
5493170|NCT01715896|18994842|P2|Overall Study|Withdrawal by Subject|4
5493171|NCT01715896|18994843|P1|Overall Study|Withdrawal by Subject|1
5493172|NCT01715896|18994842|P2|Overall Study|Lost to Follow-up|2
5493173|NCT01715896|18994843|P1|Overall Study|Lost to Follow-up|0
5493174|NCT01715857|18994916|P1|Overall Study|Did Not Meet Eligibility Criteria|96
5493175|NCT01715831|18994926|P1|Overall Study|Adverse Event|1
5493176|NCT01715805|18994942|P4|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
5493177|NCT01715805|18994943|P3|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
5493178|NCT01715805|18994944|P2|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
5493179|NCT01715805|18994945|P1|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
5493180|NCT01715805|18994942|P4|Double-Blind or Continued Treatment|Other Reason Not Specified|3
5493181|NCT01715805|18994943|P3|Double-Blind or Continued Treatment|Other Reason Not Specified|0
5493182|NCT01715805|18994944|P2|Double-Blind or Continued Treatment|Other Reason Not Specified|1
5493183|NCT01715805|18994945|P1|Double-Blind or Continued Treatment|Other Reason Not Specified|0
5493184|NCT01715805|18994942|P4|Double-Blind or Continued Treatment|Lost to Follow-up|10
5493185|NCT01715805|18994943|P3|Double-Blind or Continued Treatment|Lost to Follow-up|10
5493186|NCT01715805|18994944|P2|Double-Blind or Continued Treatment|Lost to Follow-up|7
5493187|NCT01715805|18994945|P1|Double-Blind or Continued Treatment|Lost to Follow-up|0
5493188|NCT01715805|18994942|P4|Double-Blind or Continued Treatment|Withdrawal of consent|13
5493189|NCT01715805|18994943|P3|Double-Blind or Continued Treatment|Withdrawal of consent|11
5493190|NCT01715805|18994944|P2|Double-Blind or Continued Treatment|Withdrawal of consent|11
5493191|NCT01715805|18994945|P1|Double-Blind or Continued Treatment|Withdrawal of consent|0
5493192|NCT01715805|18994942|P4|Double-Blind or Continued Treatment|Protocol Violation|19
5493193|NCT01715805|18994943|P3|Double-Blind or Continued Treatment|Protocol Violation|12
5493194|NCT01715805|18994944|P2|Double-Blind or Continued Treatment|Protocol Violation|14
5493195|NCT01715805|18994945|P1|Double-Blind or Continued Treatment|Protocol Violation|0
5493196|NCT01715805|18994942|P4|Double-Blind or Continued Treatment|Adverse Event|2
5493197|NCT01715805|18994943|P3|Double-Blind or Continued Treatment|Adverse Event|23
5493198|NCT01715805|18994944|P2|Double-Blind or Continued Treatment|Adverse Event|3
5493199|NCT01715805|18994945|P1|Double-Blind or Continued Treatment|Adverse Event|0
5493200|NCT01715805|18994942|P4|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
5493201|NCT01715805|18994943|P3|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
5493202|NCT01715805|18994944|P2|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
5493203|NCT01715805|18994945|P1|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
5493204|NCT01715805|18994942|P4|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
5493205|NCT01715805|18994943|P3|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
5493206|NCT01715805|18994944|P2|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
5493207|NCT01715805|18994945|P1|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
5493208|NCT01715805|18994942|P4|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
5493209|NCT01715805|18994943|P3|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
5493210|NCT01715805|18994944|P2|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
5493211|NCT01715805|18994945|P1|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
5493212|NCT01715805|18994942|P4|Placebo + ADT Lead-in Period|Lost to Follow-up|0
5493213|NCT01715805|18994943|P3|Placebo + ADT Lead-in Period|Lost to Follow-up|0
5493214|NCT01715805|18994944|P2|Placebo + ADT Lead-in Period|Lost to Follow-up|0
5493215|NCT01715805|18994945|P1|Placebo + ADT Lead-in Period|Lost to Follow-up|34
5493216|NCT01715805|18994942|P4|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
5493217|NCT01715805|18994943|P3|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
5493218|NCT01715805|18994944|P2|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
5493219|NCT01715805|18994945|P1|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
5493220|NCT01715805|18994942|P4|Placebo + ADT Lead-in Period|Protocol Violation|0
5493221|NCT01715805|18994943|P3|Placebo + ADT Lead-in Period|Protocol Violation|0
5493222|NCT01715805|18994944|P2|Placebo + ADT Lead-in Period|Protocol Violation|0
5493223|NCT01715805|18994945|P1|Placebo + ADT Lead-in Period|Protocol Violation|74
5493224|NCT01715805|18994942|P4|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
5493225|NCT01715805|18994943|P3|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
5493226|NCT01715805|18994944|P2|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
5493227|NCT01715805|18994945|P1|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
5493228|NCT01715805|18994942|P4|Placebo + ADT Lead-in Period|Adverse Event|0
5493229|NCT01715805|18994943|P3|Placebo + ADT Lead-in Period|Adverse Event|0
5493230|NCT01715805|18994944|P2|Placebo + ADT Lead-in Period|Adverse Event|0
5493231|NCT01715805|18994945|P1|Placebo + ADT Lead-in Period|Adverse Event|41
5493232|NCT01715415|18994959|P2|Open-label Treatment|Subject Noncompliant|1
5493233|NCT01715415|18994960|P1|Open-label Treatment|Subject Noncompliant|0
5493234|NCT01715415|18994959|P2|Open-label Treatment|Adverse Event|1
5493235|NCT01715415|18994960|P1|Open-label Treatment|Adverse Event|0
5493236|NCT01715415|18994959|P2|Double-blind Treatment|Other|0
5493237|NCT01715415|18994960|P1|Double-blind Treatment|Other|1
5493238|NCT01715415|18994959|P2|Double-blind Treatment|Withdrawal by Subject|1
5493239|NCT01715415|18994960|P1|Double-blind Treatment|Withdrawal by Subject|1
5493240|NCT01715415|18994959|P2|Double-blind Treatment|Adverse Event|0
5493241|NCT01715415|18994960|P1|Double-blind Treatment|Adverse Event|3
5493242|NCT01715415|18994959|P2|Double-blind Treatment|Did Not Receive Study Drug|1
5493243|NCT01715415|18994960|P1|Double-blind Treatment|Did Not Receive Study Drug|0
5493244|NCT01715298|18994974|P2|Overall Study|Patient/guardian decision|9
5493245|NCT01715298|18994975|P1|Overall Study|Patient/guardian decision|7
5493246|NCT01715298|18994974|P2|Overall Study|Lost to Follow-up|2
5493247|NCT01715298|18994975|P1|Overall Study|Lost to Follow-up|0
5493248|NCT01715285|18995013|P3|Open-label (OL) Extension Phase|Ongoing|72
5493249|NCT01715285|18995014|P2|Open-label (OL) Extension Phase|Ongoing|0
5493250|NCT01715285|18995015|P1|Open-label (OL) Extension Phase|Ongoing|157
5493251|NCT01715285|18995013|P3|Treatment Period|Placebo Cross-over|0
5493252|NCT01715285|18995014|P2|Treatment Period|Placebo Cross-over|72
5493253|NCT01715285|18995015|P1|Treatment Period|Placebo Cross-over|0
5493254|NCT01715285|18995013|P3|Treatment Period|Other|0
5493255|NCT01715285|18995014|P2|Treatment Period|Other|12
5493256|NCT01715285|18995015|P1|Treatment Period|Other|10
5493257|NCT01715285|18995013|P3|Treatment Period|Ongoing|0
5493258|NCT01715285|18995014|P2|Treatment Period|Ongoing|0
5493259|NCT01715285|18995015|P1|Treatment Period|Ongoing|157
5493260|NCT01715285|18995013|P3|Treatment Period|Physician Decision|0
5493261|NCT01715285|18995014|P2|Treatment Period|Physician Decision|23
5493262|NCT01715285|18995015|P1|Treatment Period|Physician Decision|21
5493263|NCT01715285|18995013|P3|Treatment Period|Withdrawal Of Consent|0
5493264|NCT01715285|18995014|P2|Treatment Period|Withdrawal Of Consent|47
5493265|NCT01715285|18995015|P1|Treatment Period|Withdrawal Of Consent|52
5493266|NCT01715285|18995013|P3|Treatment Period|Progressive Disease|0
5493267|NCT01715285|18995014|P2|Treatment Period|Progressive Disease|388
5493268|NCT01715285|18995015|P1|Treatment Period|Progressive Disease|254
5493269|NCT01715285|18995013|P3|Treatment Period|Noncompliance With Study Drug|0
5493270|NCT01715285|18995014|P2|Treatment Period|Noncompliance With Study Drug|2
5493271|NCT01715285|18995015|P1|Treatment Period|Noncompliance With Study Drug|4
5493272|NCT01715285|18995013|P3|Treatment Period|Death|0
5493273|NCT01715285|18995014|P2|Treatment Period|Death|23
5493274|NCT01715285|18995015|P1|Treatment Period|Death|36
5493275|NCT01715285|18995013|P3|Treatment Period|Lost to Follow-up|0
5493276|NCT01715285|18995014|P2|Treatment Period|Lost to Follow-up|2
5493277|NCT01715285|18995015|P1|Treatment Period|Lost to Follow-up|3
5493278|NCT01715285|18995013|P3|Treatment Period|Adverse Event|0
5493279|NCT01715285|18995014|P2|Treatment Period|Adverse Event|33
5493280|NCT01715285|18995015|P1|Treatment Period|Adverse Event|60
5493281|NCT01715129|18995051|P1|Overall Study|Other|1
5493282|NCT01715129|18995051|P1|Overall Study|Lost to Follow-up|1
5493283|NCT01715129|18995051|P1|Overall Study|Consent Withdrawn|2
5493284|NCT01715129|18995051|P1|Overall Study|Protocol Violation|1
5493285|NCT01715129|18995051|P1|Overall Study|Lack of Efficacy|3
5493286|NCT01715129|18995051|P1|Overall Study|Adverse Event, fatal|1
5493287|NCT01714947|18995077|P1|Part B|Progressive Disease|3
5493288|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Study was terminated|1
5493289|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Study was terminated|0
5493290|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Investigator decision, study termination|1
5493291|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Investigator decision, study termination|0
5493292|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Absence of renal response|1
5493293|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Absence of renal response|0
5493294|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38
5493295|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33
5493296|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0
5493297|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1
5493298|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Study drug toxicity|0
5493299|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Study drug toxicity|1
5493300|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Pregnancy|0
5493301|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Pregnancy|1
5493302|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Lost to Follow-up|1
5493303|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Lost to Follow-up|0
5493304|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0
5493305|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1
5493306|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Participant withdrew consent|1
5493307|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Participant withdrew consent|1
5493308|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
5493309|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
5493310|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Not effective|1
5493311|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Not effective|0
5493312|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Disease progression|4
5493313|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Disease progression|1
5493314|NCT01714817|18995118|P2|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21
5493315|NCT01714817|18995119|P1|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27
5493316|NCT01714817|18995118|P2|Year 2 Period|Given cyclophosphamide, corticosteroids|1
5493317|NCT01714817|18995119|P1|Year 2 Period|Given cyclophosphamide, corticosteroids|0
5493318|NCT01714817|18995118|P2|Year 2 Period|Completed Year 1, did not enter Year 2|1
5493319|NCT01714817|18995119|P1|Year 2 Period|Completed Year 1, did not enter Year 2|2
5493320|NCT01714817|18995118|P2|Year 2 Period|Pregnancy|1
5493321|NCT01714817|18995119|P1|Year 2 Period|Pregnancy|1
5493322|NCT01714817|18995118|P2|Year 2 Period|Participant went to US stopped treatment|1
5493323|NCT01714817|18995119|P1|Year 2 Period|Participant went to US stopped treatment|0
5493324|NCT01714817|18995118|P2|Year 2 Period|Lost to Follow-up|0
5493325|NCT01714817|18995119|P1|Year 2 Period|Lost to Follow-up|2
5493326|NCT01714817|18995118|P2|Year 2 Period|Participant no longer meets criteria|4
5493327|NCT01714817|18995119|P1|Year 2 Period|Participant no longer meets criteria|1
5493328|NCT01714817|18995118|P2|Year 2 Period|Participant withdrew consent|5
5493329|NCT01714817|18995119|P1|Year 2 Period|Participant withdrew consent|1
5493330|NCT01714817|18995118|P2|Year 2 Period|Administrative reason by Sponsor|3
5493331|NCT01714817|18995119|P1|Year 2 Period|Administrative reason by Sponsor|4
5493332|NCT01714817|18995118|P2|Year 2 Period|Participant request to stop treatment|4
5493333|NCT01714817|18995119|P1|Year 2 Period|Participant request to stop treatment|4
5493334|NCT01714817|18995118|P2|Year 2 Period|Adverse Event|6
5493335|NCT01714817|18995119|P1|Year 2 Period|Adverse Event|7
5493336|NCT01714817|18995118|P2|Year 2 Period|Lack of Efficacy|12
5493337|NCT01714817|18995119|P1|Year 2 Period|Lack of Efficacy|4
5493338|NCT01714817|18995118|P2|Year 1 Period|Hypersensitivity to the medication|1
5493339|NCT01714817|18995119|P1|Year 1 Period|Hypersensitivity to the medication|0
5493340|NCT01714817|18995118|P2|Year 1 Period|Antiproteinuric changed/dose increased|1
5493341|NCT01714817|18995119|P1|Year 1 Period|Antiproteinuric changed/dose increased|0
5493342|NCT01714817|18995118|P2|Year 1 Period|Need of use of Prohibited Medications|0
5493343|NCT01714817|18995119|P1|Year 1 Period|Need of use of Prohibited Medications|1
5493344|NCT01714817|18995118|P2|Year 1 Period|Change in Concomitant Medication|1
5493345|NCT01714817|18995119|P1|Year 1 Period|Change in Concomitant Medication|0
5493346|NCT01714817|18995118|P2|Year 1 Period|Not treated- received ACE inhibition|0
5493347|NCT01714817|18995119|P1|Year 1 Period|Not treated- received ACE inhibition|1
5493348|NCT01714817|18995118|P2|Year 1 Period|Participant no longer meets criteria|2
5493349|NCT01714817|18995119|P1|Year 1 Period|Participant no longer meets criteria|6
5493350|NCT01714817|18995118|P2|Year 1 Period|Pregnancy|0
5493351|NCT01714817|18995119|P1|Year 1 Period|Pregnancy|2
5493352|NCT01714817|18995118|P2|Year 1 Period|Poor / non-compliance|1
5493353|NCT01714817|18995119|P1|Year 1 Period|Poor / non-compliance|0
5493354|NCT01714817|18995118|P2|Year 1 Period|Lost to Follow-up|2
5493355|NCT01714817|18995119|P1|Year 1 Period|Lost to Follow-up|0
5493356|NCT01714817|18995118|P2|Year 1 Period|Death|1
5493357|NCT01714817|18995119|P1|Year 1 Period|Death|1
5493358|NCT01714817|18995118|P2|Year 1 Period|Withdrawal by Subject|7
5493359|NCT01714817|18995119|P1|Year 1 Period|Withdrawal by Subject|6
5493360|NCT01714817|18995118|P2|Year 1 Period|Adverse Event|17
5493361|NCT01714817|18995119|P1|Year 1 Period|Adverse Event|20
5493362|NCT01714817|18995118|P2|Year 1 Period|Lack of Efficacy|9
5493363|NCT01714817|18995119|P1|Year 1 Period|Lack of Efficacy|11
5493364|NCT01714726|18995226|P4|Open-Label Period|Lost to Follow-up|4
5493365|NCT01714726|18995227|P3|Open-Label Period|Lost to Follow-up|3
5493366|NCT01714726|18995228|P2|Open-Label Period|Lost to Follow-up|0
5493367|NCT01714726|18995229|P1|Open-Label Period|Lost to Follow-up|0
5493368|NCT01714726|18995226|P4|Open-Label Period|Developed specific withdrawal criteria|2
5493369|NCT01714726|18995227|P3|Open-Label Period|Developed specific withdrawal criteria|5
5493370|NCT01714726|18995228|P2|Open-Label Period|Developed specific withdrawal criteria|0
5493371|NCT01714726|18995229|P1|Open-Label Period|Developed specific withdrawal criteria|0
5493372|NCT01714726|18995226|P4|Open-Label Period|Withdrawal by Subject|19
5493373|NCT01714726|18995227|P3|Open-Label Period|Withdrawal by Subject|9
5493374|NCT01714726|18995228|P2|Open-Label Period|Withdrawal by Subject|0
5493375|NCT01714726|18995229|P1|Open-Label Period|Withdrawal by Subject|0
5493376|NCT01714726|18995226|P4|Open-Label Period|Adverse Event|0
5493377|NCT01714726|18995227|P3|Open-Label Period|Adverse Event|1
5493378|NCT01714726|18995228|P2|Open-Label Period|Adverse Event|0
5493379|NCT01714726|18995229|P1|Open-Label Period|Adverse Event|0
5493380|NCT01714726|18995226|P4|Open-Label Period|Other|3
5493381|NCT01714726|18995227|P3|Open-Label Period|Other|1
5493382|NCT01714726|18995228|P2|Open-Label Period|Other|0
5493383|NCT01714726|18995229|P1|Open-Label Period|Other|0
5493384|NCT01714726|18995226|P4|Double-Blinded Induction Period|Lost to Follow-up|0
5493385|NCT01714726|18995227|P3|Double-Blinded Induction Period|Lost to Follow-up|0
5493386|NCT01714726|18995228|P2|Double-Blinded Induction Period|Lost to Follow-up|2
5493387|NCT01714726|18995229|P1|Double-Blinded Induction Period|Lost to Follow-up|0
5493388|NCT01714726|18995226|P4|Double-Blinded Induction Period|Withdrawal by Subject|0
5493389|NCT01714726|18995227|P3|Double-Blinded Induction Period|Withdrawal by Subject|0
5493390|NCT01714726|18995228|P2|Double-Blinded Induction Period|Withdrawal by Subject|3
5493391|NCT01714726|18995229|P1|Double-Blinded Induction Period|Withdrawal by Subject|5
5493392|NCT01714726|18995226|P4|Double-Blinded Induction Period|Adverse Event|0
5493393|NCT01714726|18995227|P3|Double-Blinded Induction Period|Adverse Event|0
5493394|NCT01714726|18995228|P2|Double-Blinded Induction Period|Adverse Event|1
5493395|NCT01714726|18995229|P1|Double-Blinded Induction Period|Adverse Event|0
5493396|NCT01714726|18995226|P4|Double-Blinded Induction Period|Subject not in open label period|0
5493397|NCT01714726|18995227|P3|Double-Blinded Induction Period|Subject not in open label period|0
5493398|NCT01714726|18995228|P2|Double-Blinded Induction Period|Subject not in open label period|1
5493399|NCT01714726|18995229|P1|Double-Blinded Induction Period|Subject not in open label period|3
5493400|NCT01714687|18995309|P2|Overall Study|Lost to Follow-up|4
5493401|NCT01714687|18995310|P1|Overall Study|Lost to Follow-up|2
5493402|NCT01714687|18995309|P2|Overall Study|Withdrawal by Subject|0
5493403|NCT01714687|18995310|P1|Overall Study|Withdrawal by Subject|1
5493404|NCT01714635|18995334|P3|Overall Study|Missed 6-month exam|0
5493405|NCT01714635|18995335|P2|Overall Study|Missed 6-month exam|0
5493406|NCT01714635|18995336|P1|Overall Study|Missed 6-month exam|1
5493407|NCT01714635|18995334|P3|Overall Study|Discontinued|2
5493408|NCT01714635|18995335|P2|Overall Study|Discontinued|0
5493409|NCT01714635|18995336|P1|Overall Study|Discontinued|1
5493410|NCT01714609|18995352|P2|Overall Study|Protocol Violation|0
5493411|NCT01714609|18995353|P1|Overall Study|Protocol Violation|1
5493412|NCT01714544|18995359|P1|Overall Study|Withdrawal by Subject|1
5493413|NCT01714544|18995359|P1|Overall Study|Physician Decision|1
5493414|NCT01714544|18995359|P1|Overall Study|Lost to Follow-up|1
5493415|NCT01714310|18995430|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
5493416|NCT01714310|18995431|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
5493417|NCT01714310|18995432|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
5493418|NCT01714310|18995430|P3|Double Blind Adjunctive Treatment|Adverse Event|0
5493419|NCT01714310|18995431|P2|Double Blind Adjunctive Treatment|Adverse Event|1
5493420|NCT01714310|18995432|P1|Double Blind Adjunctive Treatment|Adverse Event|1
5493421|NCT01714310|18995430|P3|Open Lisdexamfetamine Titration|Adverse Event|3
5493422|NCT01714310|18995431|P2|Open Lisdexamfetamine Titration|Adverse Event|0
5493423|NCT01714310|18995432|P1|Open Lisdexamfetamine Titration|Adverse Event|0
5493424|NCT01714310|18995430|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
5493425|NCT01714310|18995431|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
5493426|NCT01714310|18995432|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
5493427|NCT01714063|18995485|P1|Overall Study|Equipment malfunction|2
5493428|NCT01713998|18995522|P3|Overall Study|Withdrawal by Subject|0
5493429|NCT01713998|18995523|P2|Overall Study|Withdrawal by Subject|0
5493430|NCT01713998|18995524|P1|Overall Study|Withdrawal by Subject|1
5493431|NCT01713998|18995522|P3|Overall Study|Lost to Follow-up|2
5493432|NCT01713998|18995523|P2|Overall Study|Lost to Follow-up|0
5493433|NCT01713998|18995524|P1|Overall Study|Lost to Follow-up|2
5493434|NCT01713946|18995545|P3|Overall Study|Patients never switched to everolimus|5
5493435|NCT01713946|18995546|P2|Overall Study|Patients never switched to everolimus|0
5493436|NCT01713946|18995547|P1|Overall Study|Patients never switched to everolimus|0
5493437|NCT01713946|18995545|P3|Overall Study|Did not continue in Post-Ext. Phase|0
5493438|NCT01713946|18995546|P2|Overall Study|Did not continue in Post-Ext. Phase|2
5493439|NCT01713946|18995547|P1|Overall Study|Did not continue in Post-Ext. Phase|1
5493440|NCT01713946|18995545|P3|Overall Study|Did not continue in Ext|0
5493441|NCT01713946|18995546|P2|Overall Study|Did not continue in Ext|3
5493442|NCT01713946|18995547|P1|Overall Study|Did not continue in Ext|0
5493443|NCT01713946|18995545|P3|Overall Study|Administrative problems|0
5493444|NCT01713946|18995546|P2|Overall Study|Administrative problems|0
5493445|NCT01713946|18995547|P1|Overall Study|Administrative problems|1
5493446|NCT01713946|18995545|P3|Overall Study|Lost to Follow-up|1
5493447|NCT01713946|18995546|P2|Overall Study|Lost to Follow-up|0
5493448|NCT01713946|18995547|P1|Overall Study|Lost to Follow-up|0
5493449|NCT01713946|18995545|P3|Overall Study|Protocol Violation|1
5493450|NCT01713946|18995546|P2|Overall Study|Protocol Violation|4
5493451|NCT01713946|18995547|P1|Overall Study|Protocol Violation|2
5493452|NCT01713946|18995545|P3|Overall Study|Lack of Efficacy|14
5493453|NCT01713946|18995546|P2|Overall Study|Lack of Efficacy|8
5493454|NCT01713946|18995547|P1|Overall Study|Lack of Efficacy|8
5493455|NCT01713946|18995545|P3|Overall Study|Withdrawal by Subject|8
5493456|NCT01713946|18995546|P2|Overall Study|Withdrawal by Subject|12
5493457|NCT01713946|18995547|P1|Overall Study|Withdrawal by Subject|12
5493458|NCT01713946|18995545|P3|Overall Study|Adverse Event|13
5493459|NCT01713946|18995546|P2|Overall Study|Adverse Event|14
5493460|NCT01713946|18995547|P1|Overall Study|Adverse Event|19
5493461|NCT01713946|18995545|P3|Overall Study|Death|2
5493462|NCT01713946|18995546|P2|Overall Study|Death|2
5493463|NCT01713946|18995547|P1|Overall Study|Death|0
5493464|NCT01713933|18995638|P1|Overall Study|Excluded from analysis as a BMI outlier|1
5493465|NCT01713933|18995638|P1|Overall Study|Withdrawal by Subject|3
5493466|NCT01713933|18995638|P1|Overall Study|Lost to Follow-up|2
5493467|NCT01713686|18995687|P1|Overall Study|Withdrawal by Subject|6
5493468|NCT01713686|18995687|P1|Overall Study|Lost to Follow-up|9
5493469|NCT01713582|18995757|P21|Overall Study|Disease progression and adverse event|0
5493470|NCT01713582|18995758|P20|Overall Study|Disease progression and adverse event|0
5493471|NCT01713582|18995759|P19|Overall Study|Disease progression and adverse event|0
5493472|NCT01713582|18995760|P18|Overall Study|Disease progression and adverse event|0
5493473|NCT01713582|18995761|P17|Overall Study|Disease progression and adverse event|1
5493474|NCT01713582|18995762|P16|Overall Study|Disease progression and adverse event|0
5493475|NCT01713582|18995763|P15|Overall Study|Disease progression and adverse event|0
5493476|NCT01713582|18995764|P14|Overall Study|Disease progression and adverse event|0
5493477|NCT01713582|18995765|P13|Overall Study|Disease progression and adverse event|0
5493478|NCT01713582|18995766|P12|Overall Study|Disease progression and adverse event|0
5493479|NCT01713582|18995767|P11|Overall Study|Disease progression and adverse event|0
5493480|NCT01713582|18995768|P10|Overall Study|Disease progression and adverse event|0
5493481|NCT01713582|18995769|P9|Overall Study|Disease progression and adverse event|0
5493482|NCT01713582|18995770|P8|Overall Study|Disease progression and adverse event|0
5493483|NCT01713582|18995771|P7|Overall Study|Disease progression and adverse event|0
5493484|NCT01713582|18995772|P6|Overall Study|Disease progression and adverse event|0
5493485|NCT01713582|18995773|P5|Overall Study|Disease progression and adverse event|0
5493486|NCT01713582|18995774|P4|Overall Study|Disease progression and adverse event|0
5493487|NCT01713582|18995775|P3|Overall Study|Disease progression and adverse event|0
5493488|NCT01713582|18995776|P2|Overall Study|Disease progression and adverse event|0
5493489|NCT01713582|18995777|P1|Overall Study|Disease progression and adverse event|0
5493490|NCT01713582|18995757|P21|Overall Study|Stopped to receive bone marrow graft|0
5493491|NCT01713582|18995758|P20|Overall Study|Stopped to receive bone marrow graft|0
5493492|NCT01713582|18995759|P19|Overall Study|Stopped to receive bone marrow graft|0
5493493|NCT01713582|18995760|P18|Overall Study|Stopped to receive bone marrow graft|0
5493494|NCT01713582|18995761|P17|Overall Study|Stopped to receive bone marrow graft|1
5493495|NCT01713582|18995762|P16|Overall Study|Stopped to receive bone marrow graft|0
5493496|NCT01713582|18995763|P15|Overall Study|Stopped to receive bone marrow graft|0
5493497|NCT01713582|18995764|P14|Overall Study|Stopped to receive bone marrow graft|0
5493498|NCT01713582|18995765|P13|Overall Study|Stopped to receive bone marrow graft|0
5493499|NCT01713582|18995766|P12|Overall Study|Stopped to receive bone marrow graft|0
5493500|NCT01713582|18995767|P11|Overall Study|Stopped to receive bone marrow graft|0
5493501|NCT01713582|18995768|P10|Overall Study|Stopped to receive bone marrow graft|0
5493502|NCT01713582|18995769|P9|Overall Study|Stopped to receive bone marrow graft|0
5493503|NCT01713582|18995770|P8|Overall Study|Stopped to receive bone marrow graft|0
5493504|NCT01713582|18995771|P7|Overall Study|Stopped to receive bone marrow graft|0
5493505|NCT01713582|18995772|P6|Overall Study|Stopped to receive bone marrow graft|0
5493506|NCT01713582|18995773|P5|Overall Study|Stopped to receive bone marrow graft|0
5493507|NCT01713582|18995774|P4|Overall Study|Stopped to receive bone marrow graft|0
5493508|NCT01713582|18995775|P3|Overall Study|Stopped to receive bone marrow graft|0
5493509|NCT01713582|18995776|P2|Overall Study|Stopped to receive bone marrow graft|0
5493510|NCT01713582|18995777|P1|Overall Study|Stopped to receive bone marrow graft|0
5493511|NCT01713582|18995757|P21|Overall Study|Withdrawal by Subject|0
5493512|NCT01713582|18995758|P20|Overall Study|Withdrawal by Subject|0
5493513|NCT01713582|18995759|P19|Overall Study|Withdrawal by Subject|0
5493514|NCT01713582|18995760|P18|Overall Study|Withdrawal by Subject|1
5493515|NCT01713582|18995761|P17|Overall Study|Withdrawal by Subject|0
5493516|NCT01713582|18995762|P16|Overall Study|Withdrawal by Subject|0
5493517|NCT01713582|18995763|P15|Overall Study|Withdrawal by Subject|0
5493518|NCT01713582|18995764|P14|Overall Study|Withdrawal by Subject|0
5493519|NCT01713582|18995765|P13|Overall Study|Withdrawal by Subject|0
5493520|NCT01713582|18995766|P12|Overall Study|Withdrawal by Subject|0
5493521|NCT01713582|18995767|P11|Overall Study|Withdrawal by Subject|0
5493522|NCT01713582|18995768|P10|Overall Study|Withdrawal by Subject|0
5493523|NCT01713582|18995769|P9|Overall Study|Withdrawal by Subject|0
5493524|NCT01713582|18995770|P8|Overall Study|Withdrawal by Subject|0
5493525|NCT01713582|18995771|P7|Overall Study|Withdrawal by Subject|0
5493526|NCT01713582|18995772|P6|Overall Study|Withdrawal by Subject|0
5493527|NCT01713582|18995773|P5|Overall Study|Withdrawal by Subject|0
5493528|NCT01713582|18995774|P4|Overall Study|Withdrawal by Subject|0
5493529|NCT01713582|18995775|P3|Overall Study|Withdrawal by Subject|0
5493530|NCT01713582|18995776|P2|Overall Study|Withdrawal by Subject|0
5493531|NCT01713582|18995777|P1|Overall Study|Withdrawal by Subject|0
5493532|NCT01713582|18995757|P21|Overall Study|Lack of Efficacy|0
5493533|NCT01713582|18995758|P20|Overall Study|Lack of Efficacy|0
5493534|NCT01713582|18995759|P19|Overall Study|Lack of Efficacy|0
5493535|NCT01713582|18995760|P18|Overall Study|Lack of Efficacy|0
5493536|NCT01713582|18995761|P17|Overall Study|Lack of Efficacy|0
5493537|NCT01713582|18995762|P16|Overall Study|Lack of Efficacy|0
5493538|NCT01713582|18995763|P15|Overall Study|Lack of Efficacy|0
5493539|NCT01713582|18995764|P14|Overall Study|Lack of Efficacy|0
5493540|NCT01713582|18995765|P13|Overall Study|Lack of Efficacy|0
5493541|NCT01713582|18995766|P12|Overall Study|Lack of Efficacy|0
5493542|NCT01713582|18995767|P11|Overall Study|Lack of Efficacy|2
5493543|NCT01713582|18995768|P10|Overall Study|Lack of Efficacy|1
5493544|NCT01713582|18995769|P9|Overall Study|Lack of Efficacy|0
5493545|NCT01713582|18995770|P8|Overall Study|Lack of Efficacy|0
5493546|NCT01713582|18995771|P7|Overall Study|Lack of Efficacy|0
5493547|NCT01713582|18995772|P6|Overall Study|Lack of Efficacy|0
5493548|NCT01713582|18995773|P5|Overall Study|Lack of Efficacy|0
5493549|NCT01713582|18995774|P4|Overall Study|Lack of Efficacy|0
5493550|NCT01713582|18995775|P3|Overall Study|Lack of Efficacy|0
5493551|NCT01713582|18995776|P2|Overall Study|Lack of Efficacy|0
5493552|NCT01713582|18995777|P1|Overall Study|Lack of Efficacy|0
5493553|NCT01713582|18995757|P21|Overall Study|Withdrawal of consent|0
5493554|NCT01713582|18995758|P20|Overall Study|Withdrawal of consent|0
5493555|NCT01713582|18995759|P19|Overall Study|Withdrawal of consent|1
5493556|NCT01713582|18995760|P18|Overall Study|Withdrawal of consent|0
5493557|NCT01713582|18995761|P17|Overall Study|Withdrawal of consent|0
5493558|NCT01713582|18995762|P16|Overall Study|Withdrawal of consent|0
5493559|NCT01713582|18995763|P15|Overall Study|Withdrawal of consent|0
5493560|NCT01713582|18995764|P14|Overall Study|Withdrawal of consent|0
5493561|NCT01713582|18995765|P13|Overall Study|Withdrawal of consent|0
5493562|NCT01713582|18995766|P12|Overall Study|Withdrawal of consent|0
5493563|NCT01713582|18995767|P11|Overall Study|Withdrawal of consent|0
5493564|NCT01713582|18995768|P10|Overall Study|Withdrawal of consent|1
5493565|NCT01713582|18995769|P9|Overall Study|Withdrawal of consent|0
5493566|NCT01713582|18995770|P8|Overall Study|Withdrawal of consent|0
5493567|NCT01713582|18995771|P7|Overall Study|Withdrawal of consent|0
5493568|NCT01713582|18995772|P6|Overall Study|Withdrawal of consent|1
5493569|NCT01713582|18995773|P5|Overall Study|Withdrawal of consent|0
5493570|NCT01713582|18995774|P4|Overall Study|Withdrawal of consent|0
5493571|NCT01713582|18995775|P3|Overall Study|Withdrawal of consent|1
5493572|NCT01713582|18995776|P2|Overall Study|Withdrawal of consent|0
5493573|NCT01713582|18995777|P1|Overall Study|Withdrawal of consent|0
5493574|NCT01713582|18995757|P21|Overall Study|Adverse event-unrelated|0
5493575|NCT01713582|18995758|P20|Overall Study|Adverse event-unrelated|0
5493576|NCT01713582|18995759|P19|Overall Study|Adverse event-unrelated|0
5493577|NCT01713582|18995760|P18|Overall Study|Adverse event-unrelated|0
5493578|NCT01713582|18995761|P17|Overall Study|Adverse event-unrelated|0
5493579|NCT01713582|18995762|P16|Overall Study|Adverse event-unrelated|0
5493580|NCT01713582|18995763|P15|Overall Study|Adverse event-unrelated|1
5493581|NCT01713582|18995764|P14|Overall Study|Adverse event-unrelated|1
5493582|NCT01713582|18995765|P13|Overall Study|Adverse event-unrelated|0
5493583|NCT01713582|18995766|P12|Overall Study|Adverse event-unrelated|0
5493584|NCT01713582|18995767|P11|Overall Study|Adverse event-unrelated|0
5493585|NCT01713582|18995768|P10|Overall Study|Adverse event-unrelated|0
5493586|NCT01713582|18995769|P9|Overall Study|Adverse event-unrelated|0
5493587|NCT01713582|18995770|P8|Overall Study|Adverse event-unrelated|1
5493588|NCT01713582|18995771|P7|Overall Study|Adverse event-unrelated|1
5493589|NCT01713582|18995772|P6|Overall Study|Adverse event-unrelated|1
5493590|NCT01713582|18995773|P5|Overall Study|Adverse event-unrelated|0
5493591|NCT01713582|18995774|P4|Overall Study|Adverse event-unrelated|0
5493592|NCT01713582|18995775|P3|Overall Study|Adverse event-unrelated|0
5493593|NCT01713582|18995776|P2|Overall Study|Adverse event-unrelated|0
5493594|NCT01713582|18995777|P1|Overall Study|Adverse event-unrelated|0
5493595|NCT01713582|18995757|P21|Overall Study|Adverse event-related|0
5493596|NCT01713582|18995758|P20|Overall Study|Adverse event-related|0
5493597|NCT01713582|18995759|P19|Overall Study|Adverse event-related|1
5493598|NCT01713582|18995760|P18|Overall Study|Adverse event-related|0
5493599|NCT01713582|18995761|P17|Overall Study|Adverse event-related|0
5493600|NCT01713582|18995762|P16|Overall Study|Adverse event-related|0
5493601|NCT01713582|18995763|P15|Overall Study|Adverse event-related|0
5493602|NCT01713582|18995764|P14|Overall Study|Adverse event-related|0
5493603|NCT01713582|18995765|P13|Overall Study|Adverse event-related|0
5493604|NCT01713582|18995766|P12|Overall Study|Adverse event-related|0
5493605|NCT01713582|18995767|P11|Overall Study|Adverse event-related|1
5493606|NCT01713582|18995768|P10|Overall Study|Adverse event-related|1
5493607|NCT01713582|18995769|P9|Overall Study|Adverse event-related|0
5493608|NCT01713582|18995770|P8|Overall Study|Adverse event-related|0
5493609|NCT01713582|18995771|P7|Overall Study|Adverse event-related|0
5493610|NCT01713582|18995772|P6|Overall Study|Adverse event-related|0
5493611|NCT01713582|18995773|P5|Overall Study|Adverse event-related|0
5493612|NCT01713582|18995774|P4|Overall Study|Adverse event-related|0
5493613|NCT01713582|18995775|P3|Overall Study|Adverse event-related|0
5493614|NCT01713582|18995776|P2|Overall Study|Adverse event-related|0
5493615|NCT01713582|18995777|P1|Overall Study|Adverse event-related|0
5493616|NCT01713582|18995757|P21|Overall Study|Death|0
5493617|NCT01713582|18995758|P20|Overall Study|Death|0
5493618|NCT01713582|18995759|P19|Overall Study|Death|0
5493619|NCT01713582|18995760|P18|Overall Study|Death|0
5493620|NCT01713582|18995761|P17|Overall Study|Death|0
5493621|NCT01713582|18995762|P16|Overall Study|Death|0
5493622|NCT01713582|18995763|P15|Overall Study|Death|0
5493623|NCT01713582|18995764|P14|Overall Study|Death|0
5493624|NCT01713582|18995765|P13|Overall Study|Death|0
5493625|NCT01713582|18995766|P12|Overall Study|Death|0
5493626|NCT01713582|18995767|P11|Overall Study|Death|3
5493627|NCT01713582|18995768|P10|Overall Study|Death|4
5493628|NCT01713582|18995769|P9|Overall Study|Death|3
5493629|NCT01713582|18995770|P8|Overall Study|Death|2
5493630|NCT01713582|18995771|P7|Overall Study|Death|3
5493631|NCT01713582|18995772|P6|Overall Study|Death|3
5493632|NCT01713582|18995773|P5|Overall Study|Death|1
5493633|NCT01713582|18995774|P4|Overall Study|Death|1
5493634|NCT01713582|18995775|P3|Overall Study|Death|0
5493635|NCT01713582|18995776|P2|Overall Study|Death|0
5493636|NCT01713582|18995777|P1|Overall Study|Death|0
5493637|NCT01713582|18995757|P21|Overall Study|Disease progression|15
5493638|NCT01713582|18995758|P20|Overall Study|Disease progression|5
5493639|NCT01713582|18995759|P19|Overall Study|Disease progression|3
5493640|NCT01713582|18995760|P18|Overall Study|Disease progression|2
5493641|NCT01713582|18995761|P17|Overall Study|Disease progression|5
5493642|NCT01713582|18995762|P16|Overall Study|Disease progression|6
5493643|NCT01713582|18995763|P15|Overall Study|Disease progression|6
5493644|NCT01713582|18995764|P14|Overall Study|Disease progression|3
5493645|NCT01713582|18995765|P13|Overall Study|Disease progression|3
5493646|NCT01713582|18995766|P12|Overall Study|Disease progression|5
5493647|NCT01713582|18995767|P11|Overall Study|Disease progression|10
5493648|NCT01713582|18995768|P10|Overall Study|Disease progression|11
5493649|NCT01713582|18995769|P9|Overall Study|Disease progression|3
5493650|NCT01713582|18995770|P8|Overall Study|Disease progression|3
5493651|NCT01713582|18995771|P7|Overall Study|Disease progression|3
5493652|NCT01713582|18995772|P6|Overall Study|Disease progression|3
5493653|NCT01713582|18995773|P5|Overall Study|Disease progression|3
5493654|NCT01713582|18995774|P4|Overall Study|Disease progression|2
5493655|NCT01713582|18995775|P3|Overall Study|Disease progression|3
5493656|NCT01713582|18995776|P2|Overall Study|Disease progression|3
5493657|NCT01713582|18995777|P1|Overall Study|Disease progression|3
5493658|NCT01713530|18995940|P2|Overall Study|Unclassified|2
5493659|NCT01713530|18995941|P1|Overall Study|Unclassified|4
5493660|NCT01713530|18995940|P2|Overall Study|Withdrawal criteria|12
5493661|NCT01713530|18995941|P1|Overall Study|Withdrawal criteria|21
5493662|NCT01713530|18995940|P2|Overall Study|Adverse Event|5
5493663|NCT01713530|18995941|P1|Overall Study|Adverse Event|0
5493664|NCT01713348|18995972|P4|Overall Study|Lost to Follow-up|0
5493665|NCT01713348|18995973|P3|Overall Study|Lost to Follow-up|0
5493666|NCT01713348|18995974|P2|Overall Study|Lost to Follow-up|0
5493667|NCT01713348|18995975|P1|Overall Study|Lost to Follow-up|1
5493668|NCT01713348|18995972|P4|Overall Study|Withdrawal by Subject|0
5493669|NCT01713348|18995973|P3|Overall Study|Withdrawal by Subject|2
5493670|NCT01713348|18995974|P2|Overall Study|Withdrawal by Subject|2
5493671|NCT01713348|18995975|P1|Overall Study|Withdrawal by Subject|3
5493672|NCT01713283|18996005|P2|Overall Study|Lost to Follow-up|1
5493673|NCT01713283|18996006|P1|Overall Study|Lost to Follow-up|1
5493674|NCT01713283|18996005|P2|Overall Study|Lack of Efficacy|2
5493675|NCT01713283|18996006|P1|Overall Study|Lack of Efficacy|10
5493676|NCT01713036|18996028|P1|Overall Study|Death|1
5493677|NCT01712984|18996068|P3|Overall Study|Withdrawal by Subject|7
5493678|NCT01712984|18996069|P2|Overall Study|Withdrawal by Subject|6
5493679|NCT01712984|18996070|P1|Overall Study|Withdrawal by Subject|6
5493680|NCT01712984|18996068|P3|Overall Study|Lost to Follow-up|1
5493681|NCT01712984|18996069|P2|Overall Study|Lost to Follow-up|10
5493682|NCT01712984|18996070|P1|Overall Study|Lost to Follow-up|8
5493683|NCT01712984|18996068|P3|Overall Study|Protocol Violation|1
5493684|NCT01712984|18996069|P2|Overall Study|Protocol Violation|0
5493685|NCT01712984|18996070|P1|Overall Study|Protocol Violation|2
5493686|NCT01712984|18996068|P3|Overall Study|Adverse Event|1
5493687|NCT01712984|18996069|P2|Overall Study|Adverse Event|0
5493688|NCT01712984|18996070|P1|Overall Study|Adverse Event|0
5493689|NCT01712854|18996090|P1|Overall Study|Physician Decision|1
5493690|NCT01712685|18996113|P1|Overall Study|pt declined to participate before trmt|1
5493691|NCT01712516|18996129|P4|Overall Study|Withdrawal by Subject|9
5493692|NCT01712516|18996130|P3|Overall Study|Withdrawal by Subject|3
5493693|NCT01712516|18996131|P2|Overall Study|Withdrawal by Subject|9
5493694|NCT01712516|18996132|P1|Overall Study|Withdrawal by Subject|3
5493695|NCT01712516|18996129|P4|Overall Study|Physician Decision|1
5493696|NCT01712516|18996130|P3|Overall Study|Physician Decision|0
5493697|NCT01712516|18996131|P2|Overall Study|Physician Decision|0
5493698|NCT01712516|18996132|P1|Overall Study|Physician Decision|2
5493699|NCT01712516|18996129|P4|Overall Study|Protocol deviation|0
5493700|NCT01712516|18996130|P3|Overall Study|Protocol deviation|1
5493701|NCT01712516|18996131|P2|Overall Study|Protocol deviation|0
5493702|NCT01712516|18996132|P1|Overall Study|Protocol deviation|1
5493703|NCT01712516|18996129|P4|Overall Study|Death|0
5493704|NCT01712516|18996130|P3|Overall Study|Death|0
5493705|NCT01712516|18996131|P2|Overall Study|Death|1
5493706|NCT01712516|18996132|P1|Overall Study|Death|0
5493707|NCT01712516|18996129|P4|Overall Study|Lost to Follow-up|1
5493708|NCT01712516|18996130|P3|Overall Study|Lost to Follow-up|2
5493709|NCT01712516|18996131|P2|Overall Study|Lost to Follow-up|0
5493710|NCT01712516|18996132|P1|Overall Study|Lost to Follow-up|0
5493711|NCT01712516|18996129|P4|Overall Study|Technical problems|2
5493712|NCT01712516|18996130|P3|Overall Study|Technical problems|0
5493713|NCT01712516|18996131|P2|Overall Study|Technical problems|0
5493714|NCT01712516|18996132|P1|Overall Study|Technical problems|0
5493715|NCT01712490|18996184|P2|Overall Study|Lost to Follow-up|29
5493716|NCT01712490|18996185|P1|Overall Study|Lost to Follow-up|16
5493717|NCT01712490|18996184|P2|Overall Study|Withdrawal by Subject|44
5493718|NCT01712490|18996185|P1|Overall Study|Withdrawal by Subject|36
5493719|NCT01712490|18996184|P2|Overall Study|Other|11
5493720|NCT01712490|18996185|P1|Overall Study|Other|11
5493721|NCT01712490|18996184|P2|Overall Study|Ongoing|586
5493722|NCT01712490|18996185|P1|Overall Study|Ongoing|601
5493723|NCT01712438|18996222|P1|Overall Study|Prematurely Discontinued|25
5493724|NCT01712438|18996222|P1|Overall Study|Violated inclusion & exclusion criteria|4
5493725|NCT01712438|18996222|P1|Overall Study|Ongoing ITI treatment|6
5493726|NCT01712438|18996222|P1|Overall Study|Not treated with Human-cl rhFVIII|2
5493727|NCT01712399|18996232|P1|Overall Study|Study closure|345
5493728|NCT01712399|18996232|P1|Overall Study|Adverse Event|11
5493729|NCT01712399|18996232|P1|Overall Study|Death|1
5493730|NCT01712399|18996232|P1|Overall Study|Withdrawal by Subject|39
5493731|NCT01712399|18996232|P1|Overall Study|Lost to Follow-up|1
5493732|NCT01712334|18996278|P2|Treatment Period 1|Randomized in Error|2
5493733|NCT01712334|18996279|P1|Treatment Period 1|Randomized in Error|0
5493734|NCT01712256|18996287|P1|Overall Study|Lost to Follow-up|1
5493735|NCT01712204|18996317|P2|Overall Study|Protocol Violation|1
5493736|NCT01712204|18996318|P1|Overall Study|Protocol Violation|1
5493737|NCT01712204|18996317|P2|Overall Study|Lost to Follow-up|0
5493738|NCT01712204|18996318|P1|Overall Study|Lost to Follow-up|1
5493739|NCT01712204|18996317|P2|Overall Study|Withdrawal by Subject|3
5493740|NCT01712204|18996318|P1|Overall Study|Withdrawal by Subject|3
5493741|NCT01712204|18996317|P2|Overall Study|Adverse Event|1
5493742|NCT01712204|18996318|P1|Overall Study|Adverse Event|3
5493743|NCT01712178|18996326|P2|Overall Study|Lost to Follow-up|1
5493744|NCT01712178|18996327|P1|Overall Study|Lost to Follow-up|0
5493745|NCT01712178|18996326|P2|Overall Study|Serious adverse event/withdrew consent|1
5493746|NCT01712178|18996327|P1|Overall Study|Serious adverse event/withdrew consent|0
5493747|NCT01712178|18996326|P2|Overall Study|Withdrew consent due to an adverse event|1
5493748|NCT01712178|18996327|P1|Overall Study|Withdrew consent due to an adverse event|1
5493749|NCT01712074|18996352|P3|Double Blind Period|No longer met eligibility criteria|0
5493750|NCT01712074|18996353|P2|Double Blind Period|No longer met eligibility criteria|3
5493751|NCT01712074|18996354|P1|Double Blind Period|No longer met eligibility criteria|0
5493752|NCT01712074|18996352|P3|Double Blind Period|Protocol Violation|1
5493753|NCT01712074|18996353|P2|Double Blind Period|Protocol Violation|0
5493754|NCT01712074|18996354|P1|Double Blind Period|Protocol Violation|0
5493755|NCT01712074|18996352|P3|Double Blind Period|Other|1
5493756|NCT01712074|18996353|P2|Double Blind Period|Other|4
5493757|NCT01712074|18996354|P1|Double Blind Period|Other|0
5493758|NCT01712074|18996352|P3|Double Blind Period|Lost to Follow-up|1
5493759|NCT01712074|18996353|P2|Double Blind Period|Lost to Follow-up|2
5493760|NCT01712074|18996354|P1|Double Blind Period|Lost to Follow-up|0
5493761|NCT01712074|18996352|P3|Double Blind Period|Death|0
5493762|NCT01712074|18996353|P2|Double Blind Period|Death|1
5493763|NCT01712074|18996354|P1|Double Blind Period|Death|0
5493764|NCT01712074|18996352|P3|Double Blind Period|No longer willing to participate|4
5493765|NCT01712074|18996353|P2|Double Blind Period|No longer willing to participate|2
5493766|NCT01712074|18996354|P1|Double Blind Period|No longer willing to participate|0
5493767|NCT01712074|18996352|P3|Double Blind Period|Adverse Event|1
5493768|NCT01712074|18996353|P2|Double Blind Period|Adverse Event|2
5493769|NCT01712074|18996354|P1|Double Blind Period|Adverse Event|0
5493770|NCT01712074|18996352|P3|Placebo Run-in Period|No longer willing to participate|0
5493771|NCT01712074|18996353|P2|Placebo Run-in Period|No longer willing to participate|0
5493772|NCT01712074|18996354|P1|Placebo Run-in Period|No longer willing to participate|1
5493773|NCT01712074|18996352|P3|Placebo Run-in Period|Other|0
5493774|NCT01712074|18996353|P2|Placebo Run-in Period|Other|0
5493775|NCT01712074|18996354|P1|Placebo Run-in Period|Other|1
5493776|NCT01712074|18996352|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
5493777|NCT01712074|18996353|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
5493778|NCT01712074|18996354|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
5493779|NCT01712074|18996352|P3|Placebo Run-in Period|Lost to Follow-up|0
5493780|NCT01712074|18996353|P2|Placebo Run-in Period|Lost to Follow-up|0
5493781|NCT01712074|18996354|P1|Placebo Run-in Period|Lost to Follow-up|1
5493782|NCT01712074|18996352|P3|Placebo Run-in Period|Adverse Event|0
5493783|NCT01712074|18996353|P2|Placebo Run-in Period|Adverse Event|0
5493784|NCT01712074|18996354|P1|Placebo Run-in Period|Adverse Event|2
5493785|NCT01712061|18996410|P3|Overall Study|Other|0
5493786|NCT01712061|18996411|P2|Overall Study|Other|3
5493787|NCT01712061|18996412|P1|Overall Study|Other|0
5493788|NCT01712061|18996410|P3|Overall Study|Withdrawal by Subject|1
5493789|NCT01712061|18996411|P2|Overall Study|Withdrawal by Subject|7
5493790|NCT01712061|18996412|P1|Overall Study|Withdrawal by Subject|1
5493791|NCT01712061|18996410|P3|Overall Study|Medication Error Without Associated AE|0
5493792|NCT01712061|18996411|P2|Overall Study|Medication Error Without Associated AE|1
5493793|NCT01712061|18996412|P1|Overall Study|Medication Error Without Associated AE|0
5493794|NCT01712061|18996410|P3|Overall Study|Did Not Meet Entrance Criteria|3
5493795|NCT01712061|18996411|P2|Overall Study|Did Not Meet Entrance Criteria|6
5493796|NCT01712061|18996412|P1|Overall Study|Did Not Meet Entrance Criteria|4
5493797|NCT01712061|18996410|P3|Overall Study|Lost to Follow-up|1
5493798|NCT01712061|18996411|P2|Overall Study|Lost to Follow-up|0
5493799|NCT01712061|18996412|P1|Overall Study|Lost to Follow-up|1
5493800|NCT01712061|18996410|P3|Overall Study|Death|1
5493801|NCT01712061|18996411|P2|Overall Study|Death|0
5493802|NCT01712061|18996412|P1|Overall Study|Death|0
5493803|NCT01712061|18996410|P3|Overall Study|Adverse Event|5
5493804|NCT01712061|18996411|P2|Overall Study|Adverse Event|9
5493805|NCT01712061|18996412|P1|Overall Study|Adverse Event|4
5493806|NCT01712009|18996452|P3|Overall Study|Decision by Sponsor|12
5493807|NCT01712009|18996453|P2|Overall Study|Decision by Sponsor|14
5493808|NCT01712009|18996454|P1|Overall Study|Decision by Sponsor|12
5493809|NCT01712009|18996452|P3|Overall Study|Lost to Follow-up|1
5493810|NCT01712009|18996453|P2|Overall Study|Lost to Follow-up|0
5493811|NCT01712009|18996454|P1|Overall Study|Lost to Follow-up|2
5493812|NCT01712009|18996452|P3|Overall Study|Withdrawal by Subject|8
5493813|NCT01712009|18996453|P2|Overall Study|Withdrawal by Subject|15
5493814|NCT01712009|18996454|P1|Overall Study|Withdrawal by Subject|24
5493815|NCT01711983|18996480|P1|36-Month Closure Evaluation|Missed Echocardiograph|62
5493816|NCT01711983|18996480|P1|36-Month Closure Evaluation|Test Device Removal|2
5493817|NCT01711983|18996480|P1|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
5493818|NCT01711983|18996480|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
5493819|NCT01711866|18996498|P1|Overall Study|Adverse Event|2
5493820|NCT01711866|18996498|P1|Overall Study|Withdrawal by Subject|3
5493821|NCT01711866|18996498|P1|Overall Study|Noncompliant|3
5493822|NCT01711853|18996503|P1|Overall Study|Not treated|3
5493823|NCT01711736|18996510|P2|Overall Study|Migrated/moved from study area|1
5493824|NCT01711736|18996511|P1|Overall Study|Migrated/moved from study area|2
5493825|NCT01711736|18996510|P2|Overall Study|Withdrawal by Subject|6
5493826|NCT01711736|18996511|P1|Overall Study|Withdrawal by Subject|6
5493827|NCT01711736|18996510|P2|Overall Study|Lost to Follow-up|1
5493828|NCT01711736|18996511|P1|Overall Study|Lost to Follow-up|4
5493829|NCT01711645|18996539|P1|Overall Study|Physician Decision|5
5493830|NCT01711645|18996539|P1|Overall Study|Lost to Follow-up|6
5493831|NCT01711645|18996539|P1|Overall Study|Withdrawal by Subject|8
5493832|NCT01711619|18996576|P2|Overall Study|Lost to Follow-up|0
5493833|NCT01711619|18996577|P1|Overall Study|Lost to Follow-up|1
5493834|NCT01711619|18996576|P2|Overall Study|Adverse Event|0
5493835|NCT01711619|18996577|P1|Overall Study|Adverse Event|2
5493836|NCT01711619|18996576|P2|Overall Study|Protocol Violation|3
5493837|NCT01711619|18996577|P1|Overall Study|Protocol Violation|2
5493838|NCT01711619|18996576|P2|Overall Study|Withdrawal by Subject|7
5493839|NCT01711619|18996577|P1|Overall Study|Withdrawal by Subject|3
5493840|NCT01711619|18996576|P2|Overall Study|Early study termination|14
5493841|NCT01711619|18996577|P1|Overall Study|Early study termination|10
5493842|NCT01711541|18996594|P5|Overall Study|Ineligible|0
5493843|NCT01711541|18996595|P4|Overall Study|Ineligible|0
5493844|NCT01711541|18996596|P3|Overall Study|Ineligible|0
5493845|NCT01711541|18996597|P2|Overall Study|Ineligible|1
5493846|NCT01711541|18996598|P1|Overall Study|Ineligible|0
5493847|NCT01711541|18996594|P5|Overall Study|Cancel prior to treatment|0
5493848|NCT01711541|18996595|P4|Overall Study|Cancel prior to treatment|1
5493849|NCT01711541|18996596|P3|Overall Study|Cancel prior to treatment|0
5493850|NCT01711541|18996597|P2|Overall Study|Cancel prior to treatment|0
5493851|NCT01711541|18996598|P1|Overall Study|Cancel prior to treatment|0
5493852|NCT01711359|18996647|P3|Treatment Period|Randomized, Not Treated|0
5493853|NCT01711359|18996648|P2|Treatment Period|Randomized, Not Treated|1
5493854|NCT01711359|18996649|P1|Treatment Period|Randomized, Not Treated|3
5493855|NCT01711359|18996647|P3|Treatment Period|Lost to Follow-up|1
5493856|NCT01711359|18996648|P2|Treatment Period|Lost to Follow-up|1
5493857|NCT01711359|18996649|P1|Treatment Period|Lost to Follow-up|1
5493858|NCT01711359|18996647|P3|Treatment Period|Sponsor Decision|0
5493859|NCT01711359|18996648|P2|Treatment Period|Sponsor Decision|0
5493860|NCT01711359|18996649|P1|Treatment Period|Sponsor Decision|1
5493861|NCT01711359|18996647|P3|Treatment Period|Entry Criteria Not Met|0
5493862|NCT01711359|18996648|P2|Treatment Period|Entry Criteria Not Met|0
5493863|NCT01711359|18996649|P1|Treatment Period|Entry Criteria Not Met|1
5493864|NCT01711359|18996647|P3|Treatment Period|Death|0
5493865|NCT01711359|18996648|P2|Treatment Period|Death|0
5493866|NCT01711359|18996649|P1|Treatment Period|Death|3
5493867|NCT01711359|18996647|P3|Treatment Period|Physician Decision|2
5493868|NCT01711359|18996648|P2|Treatment Period|Physician Decision|3
5493869|NCT01711359|18996649|P1|Treatment Period|Physician Decision|4
5493870|NCT01711359|18996647|P3|Treatment Period|Adverse Event|24
5493871|NCT01711359|18996648|P2|Treatment Period|Adverse Event|10
5493872|NCT01711359|18996649|P1|Treatment Period|Adverse Event|8
5493873|NCT01711359|18996647|P3|Treatment Period|Lack of Efficacy|2
5493874|NCT01711359|18996648|P2|Treatment Period|Lack of Efficacy|2
5493875|NCT01711359|18996649|P1|Treatment Period|Lack of Efficacy|13
5493876|NCT01711359|18996647|P3|Treatment Period|Withdrawal by Subject|13
5493877|NCT01711359|18996648|P2|Treatment Period|Withdrawal by Subject|7
5493878|NCT01711359|18996649|P1|Treatment Period|Withdrawal by Subject|18
5493879|NCT01711216|18996733|P1|Overall Study|no reason specified|22
5493880|NCT01711216|18996733|P1|Overall Study|variety of other minor reasons|83
5493881|NCT01711216|18996733|P1|Overall Study|Lost to Follow-up|46
5493882|NCT01711216|18996733|P1|Overall Study|Withdrawal by Subject|6
5493883|NCT01711216|18996733|P1|Overall Study|Pregnancy|56
5493884|NCT01711216|18996733|P1|Overall Study|Adverse Event|4
5493885|NCT01710800|18996811|P1|Overall Study|Protocol Violation|1
5493886|NCT01710800|18996811|P1|Overall Study|Withdrawal by Subject|21
5493887|NCT01710709|18996875|P1|Overall Study|Lack of Efficacy|3
5493888|NCT01710709|18996875|P1|Overall Study|Protocol Violation|5
5493889|NCT01710709|18996875|P1|Overall Study|Withdrawal by Subject|53
5493890|NCT01710709|18996875|P1|Overall Study|Participant withdrawn by investigator|2
5493891|NCT01710709|18996875|P1|Overall Study|Participant met withdrawal criteria|33
5493892|NCT01710709|18996875|P1|Overall Study|Adverse Event|48
5493893|NCT01710709|18996875|P1|Overall Study|Lost to Follow-up|29
5493894|NCT01710657|18996890|P3|Overall Study|Lack of Efficacy|1
5493895|NCT01710657|18996891|P2|Overall Study|Lack of Efficacy|1
5493896|NCT01710657|18996892|P1|Overall Study|Lack of Efficacy|0
5493897|NCT01710657|18996890|P3|Overall Study|Withdrawal by Subject|2
5493898|NCT01710657|18996891|P2|Overall Study|Withdrawal by Subject|1
5493899|NCT01710657|18996892|P1|Overall Study|Withdrawal by Subject|0
5493900|NCT01710657|18996890|P3|Overall Study|Adverse Event|28
5493901|NCT01710657|18996891|P2|Overall Study|Adverse Event|8
5493902|NCT01710657|18996892|P1|Overall Study|Adverse Event|14
5493903|NCT01710657|18996890|P3|Overall Study|Protocol Violation|0
5493904|NCT01710657|18996891|P2|Overall Study|Protocol Violation|2
5493905|NCT01710657|18996892|P1|Overall Study|Protocol Violation|2
5493906|NCT01710657|18996890|P3|Overall Study|Lost to Follow-up|1
5493907|NCT01710657|18996891|P2|Overall Study|Lost to Follow-up|0
5493908|NCT01710657|18996892|P1|Overall Study|Lost to Follow-up|2
5493909|NCT01710527|18996909|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
5493910|NCT01710527|18996910|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
5493911|NCT01710514|18996936|P2|Overall Study|Withdrawal by Subject|0
5493912|NCT01710514|18996937|P1|Overall Study|Withdrawal by Subject|1
5493913|NCT01710514|18996936|P2|Overall Study|Adverse Event|7
5493914|NCT01710514|18996937|P1|Overall Study|Adverse Event|6
5493915|NCT01710501|18996958|P3|Overall Study|Lost to Follow-up|0
5493916|NCT01710501|18996959|P2|Overall Study|Lost to Follow-up|0
5493917|NCT01710501|18996960|P1|Overall Study|Lost to Follow-up|2
5493918|NCT01710358|18996992|P3|Rescue Period|Withdrawal by Subject|0
5493919|NCT01710358|18996993|P2|Rescue Period|Withdrawal by Subject|8
5493920|NCT01710358|18996994|P1|Rescue Period|Withdrawal by Subject|0
5493921|NCT01710358|18996992|P3|Rescue Period|Lack of Efficacy|0
5493922|NCT01710358|18996993|P2|Rescue Period|Lack of Efficacy|7
5493923|NCT01710358|18996994|P1|Rescue Period|Lack of Efficacy|0
5493924|NCT01710358|18996992|P3|Rescue Period|Death|0
5493925|NCT01710358|18996993|P2|Rescue Period|Death|1
5493926|NCT01710358|18996994|P1|Rescue Period|Death|0
5493927|NCT01710358|18996992|P3|Rescue Period|Adverse Event|0
5493928|NCT01710358|18996993|P2|Rescue Period|Adverse Event|15
5493929|NCT01710358|18996994|P1|Rescue Period|Adverse Event|0
5493930|NCT01710358|18996992|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
5493931|NCT01710358|18996993|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
5493932|NCT01710358|18996994|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
5493933|NCT01710358|18996992|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
5493934|NCT01710358|18996993|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
5493935|NCT01710358|18996994|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
5493936|NCT01710358|18996992|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
5493937|NCT01710358|18996993|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
5493938|NCT01710358|18996994|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
5493939|NCT01710358|18996992|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
5493940|NCT01710358|18996993|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
5493941|NCT01710358|18996994|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
5493942|NCT01710358|18996992|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
5493943|NCT01710358|18996993|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
5493944|NCT01710358|18996994|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
5493945|NCT01710358|18996992|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
5493946|NCT01710358|18996993|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
5493947|NCT01710358|18996994|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
5493948|NCT01710358|18996992|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
5493949|NCT01710358|18996993|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
5493950|NCT01710358|18996994|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
5493951|NCT01710358|18996992|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
5493952|NCT01710358|18996993|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
5493953|NCT01710358|18996994|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
5493954|NCT01710358|18996992|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
5493955|NCT01710358|18996993|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
5493956|NCT01710358|18996994|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
5493957|NCT01710358|18996992|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
5493958|NCT01710358|18996993|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
5493959|NCT01710358|18996994|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
5493960|NCT01710358|18996992|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
5493961|NCT01710358|18996993|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
5493962|NCT01710358|18996994|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
5493963|NCT01710358|18996992|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
5493964|NCT01710358|18996993|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
5493965|NCT01710358|18996994|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
5493966|NCT01710358|18996992|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
5493967|NCT01710358|18996993|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
5493968|NCT01710358|18996994|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
5493969|NCT01710358|18996992|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
5493970|NCT01710358|18996993|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
5493971|NCT01710358|18996994|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
5493972|NCT01710358|18996992|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
5493973|NCT01710358|18996993|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
5493974|NCT01710358|18996994|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
5493975|NCT01710358|18996992|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
5493976|NCT01710358|18996993|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
5493977|NCT01710358|18996994|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
5493978|NCT01710345|18997065|P3|Overall Study|Drug Dosing Error|0
5493979|NCT01710345|18997066|P2|Overall Study|Drug Dosing Error|0
5493980|NCT01710345|18997067|P1|Overall Study|Drug Dosing Error|1
5493981|NCT01710345|18997065|P3|Overall Study|Lack of Efficacy|1
5493982|NCT01710345|18997066|P2|Overall Study|Lack of Efficacy|3
5493983|NCT01710345|18997067|P1|Overall Study|Lack of Efficacy|2
5493984|NCT01710345|18997065|P3|Overall Study|Adverse Event|0
5493985|NCT01710345|18997066|P2|Overall Study|Adverse Event|2
5493986|NCT01710345|18997067|P1|Overall Study|Adverse Event|0
5493987|NCT01710046|18997126|P2|Overall Study|Lost to Follow-up|0
5493988|NCT01710046|18997127|P1|Overall Study|Lost to Follow-up|1
5493989|NCT01710033|18997167|P5|Stage 2|Adverse Event|1
5493990|NCT01710033|18997168|P4|Stage 2|Adverse Event|0
5493991|NCT01710033|18997169|P3|Stage 2|Adverse Event|0
5493992|NCT01710033|18997170|P2|Stage 2|Adverse Event|0
5493993|NCT01710033|18997171|P1|Stage 2|Adverse Event|0
5493994|NCT01710020|18997252|P1|Period 1|Protocol Violation|1
5493995|NCT01709903|18997288|P2|Overall Study|Adverse Event|18
5493996|NCT01709903|18997289|P1|Overall Study|Adverse Event|11
5493997|NCT01709903|18997288|P2|Overall Study|Withdrawal by Subject|6
5493998|NCT01709903|18997289|P1|Overall Study|Withdrawal by Subject|6
5493999|NCT01709903|18997288|P2|Overall Study|Lack of Efficacy|3
5494000|NCT01709903|18997289|P1|Overall Study|Lack of Efficacy|3
5494001|NCT01709903|18997288|P2|Overall Study|Protocol Violation|2
5494002|NCT01709903|18997289|P1|Overall Study|Protocol Violation|3
5494003|NCT01709903|18997288|P2|Overall Study|Death|0
5494004|NCT01709903|18997289|P1|Overall Study|Death|2
5494005|NCT01709903|18997288|P2|Overall Study|Lost to Follow-up|2
5494006|NCT01709903|18997289|P1|Overall Study|Lost to Follow-up|0
5494007|NCT01709903|18997288|P2|Overall Study|no longer needed study drug|1
5494008|NCT01709903|18997289|P1|Overall Study|no longer needed study drug|0
5494009|NCT01709903|18997288|P2|Overall Study|In ability to use device|1
5494010|NCT01709903|18997289|P1|Overall Study|In ability to use device|1
5494011|NCT01709903|18997288|P2|Overall Study|Abnormal test procedure results|0
5494012|NCT01709903|18997289|P1|Overall Study|Abnormal test procedure results|1
5494013|NCT01709903|18997288|P2|Overall Study|administrative problems|6
5494014|NCT01709903|18997289|P1|Overall Study|administrative problems|2
5494015|NCT01709864|18997313|P2|Overall Study|Death|1
5494016|NCT01709864|18997314|P1|Overall Study|Death|0
5494017|NCT01709864|18997313|P2|Overall Study|Adverse Event|2
5494018|NCT01709864|18997314|P1|Overall Study|Adverse Event|0
5494019|NCT01709864|18997313|P2|Overall Study|non-compliance with study treatment|1
5494020|NCT01709864|18997314|P1|Overall Study|non-compliance with study treatment|1
5494021|NCT01709864|18997313|P2|Overall Study|Lost to Follow-up|0
5494022|NCT01709864|18997314|P1|Overall Study|Lost to Follow-up|1
5494023|NCT01709864|18997313|P2|Overall Study|subject/guardian decision|6
5494024|NCT01709864|18997314|P1|Overall Study|subject/guardian decision|5
5494025|NCT01709864|18997313|P2|Overall Study|Physician Decision|1
5494026|NCT01709864|18997314|P1|Overall Study|Physician Decision|0
5494027|NCT01709838|18997348|P1|Overall Study|Protocol Violation|1
5494028|NCT01709838|18997348|P1|Overall Study|Death|3
5494029|NCT01709838|18997348|P1|Overall Study|Physician Decision|4
5494030|NCT01709838|18997348|P1|Overall Study|Adverse Event|4
5494031|NCT01709838|18997348|P1|Overall Study|Subject/guardian decision|8
5494032|NCT01709838|18997348|P1|Overall Study|Pregnancy|10
5494033|NCT01709838|18997348|P1|Overall Study|Lost to Follow-up|16
5494034|NCT01709838|18997348|P1|Overall Study|Withdrawal by Subject|21
5494035|NCT01709708|18997405|P2|Overall Study|Protocol Violation|2
5494036|NCT01709708|18997406|P1|Overall Study|Protocol Violation|1
5494037|NCT01709695|18997430|P2|Overall Study|Withdrawal by Subject|1
5494038|NCT01709695|18997431|P1|Overall Study|Withdrawal by Subject|1
5494039|NCT01709578|18997456|P3|Overall Study|Other, not related to safety or efficacy|5
5494040|NCT01709578|18997457|P2|Overall Study|Other, not related to safety or efficacy|7
5494041|NCT01709578|18997458|P1|Overall Study|Other, not related to safety or efficacy|2
5494042|NCT01709578|18997456|P3|Overall Study|Poor compliance to protocol|1
5494043|NCT01709578|18997457|P2|Overall Study|Poor compliance to protocol|2
5494044|NCT01709578|18997458|P1|Overall Study|Poor compliance to protocol|1
5494045|NCT01709578|18997456|P3|Overall Study|Lack of Efficacy|2
5494046|NCT01709578|18997457|P2|Overall Study|Lack of Efficacy|4
5494047|NCT01709578|18997458|P1|Overall Study|Lack of Efficacy|5
5494048|NCT01709578|18997456|P3|Overall Study|Adverse Event|17
5494049|NCT01709578|18997457|P2|Overall Study|Adverse Event|18
5494050|NCT01709578|18997458|P1|Overall Study|Adverse Event|9
5494051|NCT01709578|18997456|P3|Overall Study|Rescued and entered in long term safety|26
5494052|NCT01709578|18997457|P2|Overall Study|Rescued and entered in long term safety|25
5494053|NCT01709578|18997458|P1|Overall Study|Rescued and entered in long term safety|63
5494054|NCT01709513|18997589|P3|Overall Study|Other|7
5494055|NCT01709513|18997590|P2|Overall Study|Other|11
5494056|NCT01709513|18997591|P1|Overall Study|Other|3
5494057|NCT01709513|18997589|P3|Overall Study|Poor compliance to protocol|0
5494058|NCT01709513|18997590|P2|Overall Study|Poor compliance to protocol|0
5494059|NCT01709513|18997591|P1|Overall Study|Poor compliance to protocol|2
5494060|NCT01709513|18997589|P3|Overall Study|Adverse Event|23
5494061|NCT01709513|18997590|P2|Overall Study|Adverse Event|31
5494062|NCT01709513|18997591|P1|Overall Study|Adverse Event|16
5494063|NCT01709513|18997589|P3|Overall Study|Randomized but not treated|0
5494064|NCT01709513|18997590|P2|Overall Study|Randomized but not treated|1
5494065|NCT01709513|18997591|P1|Overall Study|Randomized but not treated|0
5494066|NCT01709500|18997652|P2|Overall Study|Treatment ongoing|78
5494067|NCT01709500|18997653|P1|Overall Study|Treatment ongoing|156
5494068|NCT01709500|18997652|P2|Overall Study|Related to IMP administration|0
5494069|NCT01709500|18997653|P1|Overall Study|Related to IMP administration|1
5494070|NCT01709500|18997652|P2|Overall Study|Other|1
5494071|NCT01709500|18997653|P1|Overall Study|Other|3
5494072|NCT01709500|18997652|P2|Overall Study|Poor compliance to protocol|1
5494073|NCT01709500|18997653|P1|Overall Study|Poor compliance to protocol|2
5494074|NCT01709500|18997652|P2|Overall Study|Adverse Event|1
5494075|NCT01709500|18997653|P1|Overall Study|Adverse Event|5
5494076|NCT01709500|18997652|P2|Overall Study|Randomized but not treated|1
5494077|NCT01709500|18997653|P1|Overall Study|Randomized but not treated|0
5494078|NCT01709409|18997731|P2|Overall Study|Protocol Violation|0
5494079|NCT01709409|18997732|P1|Overall Study|Protocol Violation|1
5494080|NCT01709383|18997740|P2|Overall Study|Lost to Follow-up|0
5494081|NCT01709383|18997741|P1|Overall Study|Lost to Follow-up|1
5494082|NCT01709331|18997759|P1|Overall Study|Adverse Event|1
5494083|NCT01709318|18997772|P7|Overall Study|Other Protocol Specified Criteria|0
5494084|NCT01709318|18997773|P6|Overall Study|Other Protocol Specified Criteria|0
5494085|NCT01709318|18997774|P5|Overall Study|Other Protocol Specified Criteria|0
5494086|NCT01709318|18997775|P4|Overall Study|Other Protocol Specified Criteria|0
5494087|NCT01709318|18997776|P3|Overall Study|Other Protocol Specified Criteria|0
5494088|NCT01709318|18997777|P2|Overall Study|Other Protocol Specified Criteria|1
5494089|NCT01709318|18997778|P1|Overall Study|Other Protocol Specified Criteria|0
5494090|NCT01709318|18997772|P7|Overall Study|Withdrawal by Subject|4
5494091|NCT01709318|18997773|P6|Overall Study|Withdrawal by Subject|2
5494092|NCT01709318|18997774|P5|Overall Study|Withdrawal by Subject|0
5494093|NCT01709318|18997775|P4|Overall Study|Withdrawal by Subject|3
5494094|NCT01709318|18997776|P3|Overall Study|Withdrawal by Subject|3
5494095|NCT01709318|18997777|P2|Overall Study|Withdrawal by Subject|0
5494096|NCT01709318|18997778|P1|Overall Study|Withdrawal by Subject|3
5494097|NCT01709318|18997772|P7|Overall Study|Technical Problems|0
5494098|NCT01709318|18997773|P6|Overall Study|Technical Problems|0
5494099|NCT01709318|18997774|P5|Overall Study|Technical Problems|0
5494100|NCT01709318|18997775|P4|Overall Study|Technical Problems|0
5494101|NCT01709318|18997776|P3|Overall Study|Technical Problems|0
5494102|NCT01709318|18997777|P2|Overall Study|Technical Problems|0
5494103|NCT01709318|18997778|P1|Overall Study|Technical Problems|1
5494104|NCT01709318|18997772|P7|Overall Study|Protocol Violation|1
5494105|NCT01709318|18997773|P6|Overall Study|Protocol Violation|0
5494106|NCT01709318|18997774|P5|Overall Study|Protocol Violation|2
5494107|NCT01709318|18997775|P4|Overall Study|Protocol Violation|0
5494108|NCT01709318|18997776|P3|Overall Study|Protocol Violation|0
5494109|NCT01709318|18997777|P2|Overall Study|Protocol Violation|0
5494110|NCT01709318|18997778|P1|Overall Study|Protocol Violation|0
5494111|NCT01709318|18997772|P7|Overall Study|Pregnancy|0
5494112|NCT01709318|18997773|P6|Overall Study|Pregnancy|0
5494113|NCT01709318|18997774|P5|Overall Study|Pregnancy|1
5494114|NCT01709318|18997775|P4|Overall Study|Pregnancy|0
5494115|NCT01709318|18997776|P3|Overall Study|Pregnancy|0
5494116|NCT01709318|18997777|P2|Overall Study|Pregnancy|0
5494117|NCT01709318|18997778|P1|Overall Study|Pregnancy|0
5494118|NCT01709318|18997772|P7|Overall Study|Physician Decision|1
5494119|NCT01709318|18997773|P6|Overall Study|Physician Decision|0
5494120|NCT01709318|18997774|P5|Overall Study|Physician Decision|0
5494121|NCT01709318|18997775|P4|Overall Study|Physician Decision|0
5494122|NCT01709318|18997776|P3|Overall Study|Physician Decision|0
5494123|NCT01709318|18997777|P2|Overall Study|Physician Decision|0
5494124|NCT01709318|18997778|P1|Overall Study|Physician Decision|0
5494125|NCT01709318|18997772|P7|Overall Study|Non-compliance with Study Drug|2
5494126|NCT01709318|18997773|P6|Overall Study|Non-compliance with Study Drug|0
5494127|NCT01709318|18997774|P5|Overall Study|Non-compliance with Study Drug|0
5494128|NCT01709318|18997775|P4|Overall Study|Non-compliance with Study Drug|1
5494129|NCT01709318|18997776|P3|Overall Study|Non-compliance with Study Drug|1
5494130|NCT01709318|18997777|P2|Overall Study|Non-compliance with Study Drug|2
5494131|NCT01709318|18997778|P1|Overall Study|Non-compliance with Study Drug|0
5494132|NCT01709318|18997772|P7|Overall Study|Lost to Follow-up|1
5494133|NCT01709318|18997773|P6|Overall Study|Lost to Follow-up|1
5494134|NCT01709318|18997774|P5|Overall Study|Lost to Follow-up|1
5494135|NCT01709318|18997775|P4|Overall Study|Lost to Follow-up|0
5494136|NCT01709318|18997776|P3|Overall Study|Lost to Follow-up|0
5494137|NCT01709318|18997777|P2|Overall Study|Lost to Follow-up|0
5494138|NCT01709318|18997778|P1|Overall Study|Lost to Follow-up|2
5494139|NCT01709318|18997772|P7|Overall Study|Adverse Event|2
5494140|NCT01709318|18997773|P6|Overall Study|Adverse Event|1
5494141|NCT01709318|18997774|P5|Overall Study|Adverse Event|0
5494142|NCT01709318|18997775|P4|Overall Study|Adverse Event|2
5494143|NCT01709318|18997776|P3|Overall Study|Adverse Event|2
5494144|NCT01709318|18997777|P2|Overall Study|Adverse Event|4
5494145|NCT01709318|18997778|P1|Overall Study|Adverse Event|3
5494146|NCT01709305|18997871|P5|Phase 2|Withdrawal by Subject|12
5494147|NCT01709305|18997872|P4|Phase 2|Withdrawal by Subject|15
5494148|NCT01709305|18997873|P3|Phase 2|Withdrawal by Subject|6
5494149|NCT01709305|18997874|P2|Phase 2|Withdrawal by Subject|8
5494150|NCT01709305|18997875|P1|Phase 2|Withdrawal by Subject|0
5494151|NCT01709305|18997871|P5|Phase 2|Protocol Violation|9
5494152|NCT01709305|18997872|P4|Phase 2|Protocol Violation|13
5494153|NCT01709305|18997873|P3|Phase 2|Protocol Violation|19
5494154|NCT01709305|18997874|P2|Phase 2|Protocol Violation|19
5494155|NCT01709305|18997875|P1|Phase 2|Protocol Violation|0
5494156|NCT01709305|18997871|P5|Phase 2|Physician Decision|2
5494157|NCT01709305|18997872|P4|Phase 2|Physician Decision|1
5494158|NCT01709305|18997873|P3|Phase 2|Physician Decision|0
5494159|NCT01709305|18997874|P2|Phase 2|Physician Decision|2
5494160|NCT01709305|18997875|P1|Phase 2|Physician Decision|0
5494161|NCT01709305|18997871|P5|Phase 2|Travel, moving, etc.|5
5494162|NCT01709305|18997872|P4|Phase 2|Travel, moving, etc.|3
5494163|NCT01709305|18997873|P3|Phase 2|Travel, moving, etc.|3
5494164|NCT01709305|18997874|P2|Phase 2|Travel, moving, etc.|2
5494165|NCT01709305|18997875|P1|Phase 2|Travel, moving, etc.|0
5494166|NCT01709305|18997871|P5|Phase 2|Lost to Follow-up|5
5494167|NCT01709305|18997872|P4|Phase 2|Lost to Follow-up|9
5494168|NCT01709305|18997873|P3|Phase 2|Lost to Follow-up|6
5494169|NCT01709305|18997874|P2|Phase 2|Lost to Follow-up|10
5494170|NCT01709305|18997875|P1|Phase 2|Lost to Follow-up|0
5494171|NCT01709305|18997871|P5|Phase 2|Laboratory Adverse Event|1
5494172|NCT01709305|18997872|P4|Phase 2|Laboratory Adverse Event|1
5494173|NCT01709305|18997873|P3|Phase 2|Laboratory Adverse Event|0
5494174|NCT01709305|18997874|P2|Phase 2|Laboratory Adverse Event|1
5494175|NCT01709305|18997875|P1|Phase 2|Laboratory Adverse Event|0
5494176|NCT01709305|18997871|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
5494177|NCT01709305|18997872|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
5494178|NCT01709305|18997873|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
5494179|NCT01709305|18997874|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
5494180|NCT01709305|18997875|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
5494181|NCT01709305|18997871|P5|Phase 2|Death|0
5494182|NCT01709305|18997872|P4|Phase 2|Death|0
5494183|NCT01709305|18997873|P3|Phase 2|Death|1
5494184|NCT01709305|18997874|P2|Phase 2|Death|0
5494185|NCT01709305|18997875|P1|Phase 2|Death|0
5494186|NCT01709305|18997871|P5|Phase 2|Clinical Adverse Event|11
5494187|NCT01709305|18997872|P4|Phase 2|Clinical Adverse Event|6
5494188|NCT01709305|18997873|P3|Phase 2|Clinical Adverse Event|10
5494189|NCT01709305|18997874|P2|Phase 2|Clinical Adverse Event|10
5494190|NCT01709305|18997875|P1|Phase 2|Clinical Adverse Event|0
5494191|NCT01709305|18997871|P5|Phase 1|Withdrawal by Subject|0
5494192|NCT01709305|18997872|P4|Phase 1|Withdrawal by Subject|0
5494193|NCT01709305|18997873|P3|Phase 1|Withdrawal by Subject|0
5494194|NCT01709305|18997874|P2|Phase 1|Withdrawal by Subject|0
5494195|NCT01709305|18997875|P1|Phase 1|Withdrawal by Subject|218
5494196|NCT01709305|18997871|P5|Phase 1|Protocol Violation|0
5494197|NCT01709305|18997872|P4|Phase 1|Protocol Violation|0
5494198|NCT01709305|18997873|P3|Phase 1|Protocol Violation|0
5494199|NCT01709305|18997874|P2|Phase 1|Protocol Violation|0
5494200|NCT01709305|18997875|P1|Phase 1|Protocol Violation|118
5494201|NCT01709305|18997871|P5|Phase 1|Physician Decision|0
5494202|NCT01709305|18997872|P4|Phase 1|Physician Decision|0
5494203|NCT01709305|18997873|P3|Phase 1|Physician Decision|0
5494204|NCT01709305|18997874|P2|Phase 1|Physician Decision|0
5494205|NCT01709305|18997875|P1|Phase 1|Physician Decision|13
5494206|NCT01709305|18997871|P5|Phase 1|Travel, moving, etc.|0
5494207|NCT01709305|18997872|P4|Phase 1|Travel, moving, etc.|0
5494208|NCT01709305|18997873|P3|Phase 1|Travel, moving, etc.|0
5494209|NCT01709305|18997874|P2|Phase 1|Travel, moving, etc.|0
5494210|NCT01709305|18997875|P1|Phase 1|Travel, moving, etc.|30
5494211|NCT01709305|18997871|P5|Phase 1|Lost to Follow-up|0
5494212|NCT01709305|18997872|P4|Phase 1|Lost to Follow-up|0
5494213|NCT01709305|18997873|P3|Phase 1|Lost to Follow-up|0
5494214|NCT01709305|18997874|P2|Phase 1|Lost to Follow-up|0
5494215|NCT01709305|18997875|P1|Phase 1|Lost to Follow-up|147
5494216|NCT01709305|18997871|P5|Phase 1|Laboratory Adverse Event|0
5494217|NCT01709305|18997872|P4|Phase 1|Laboratory Adverse Event|0
5494218|NCT01709305|18997873|P3|Phase 1|Laboratory Adverse Event|0
5494219|NCT01709305|18997874|P2|Phase 1|Laboratory Adverse Event|0
5494220|NCT01709305|18997875|P1|Phase 1|Laboratory Adverse Event|16
5494221|NCT01709305|18997871|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
5494222|NCT01709305|18997872|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
5494223|NCT01709305|18997873|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
5494224|NCT01709305|18997874|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
5494225|NCT01709305|18997875|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
5494226|NCT01709305|18997871|P5|Phase 1|Death|0
5494227|NCT01709305|18997872|P4|Phase 1|Death|0
5494228|NCT01709305|18997873|P3|Phase 1|Death|0
5494229|NCT01709305|18997874|P2|Phase 1|Death|0
5494230|NCT01709305|18997875|P1|Phase 1|Death|2
5494231|NCT01709305|18997871|P5|Phase 1|Clinical Adverse Event|0
5494232|NCT01709305|18997872|P4|Phase 1|Clinical Adverse Event|0
5494233|NCT01709305|18997873|P3|Phase 1|Clinical Adverse Event|0
5494234|NCT01709305|18997874|P2|Phase 1|Clinical Adverse Event|0
5494235|NCT01709305|18997875|P1|Phase 1|Clinical Adverse Event|80
5494236|NCT01709227|18997912|P2|Overall Study|Pleural Peritoneal communication|9
5494237|NCT01709227|18997913|P1|Overall Study|Pleural Peritoneal communication|0
5494238|NCT01709227|18997912|P2|Overall Study|Physician Decision|0
5494239|NCT01709227|18997913|P1|Overall Study|Physician Decision|1
5494240|NCT01709162|18997939|P2|Overall Study|Withdrawal by Subject|1
5494241|NCT01709162|18997940|P1|Overall Study|Withdrawal by Subject|0
5494242|NCT01709162|18997939|P2|Overall Study|Other|0
5494243|NCT01709162|18997940|P1|Overall Study|Other|1
5494244|NCT01709162|18997939|P2|Overall Study|Administrative reason by sponsor|1
5494245|NCT01709162|18997940|P1|Overall Study|Administrative reason by sponsor|0
5494246|NCT01709162|18997939|P2|Overall Study|Study drug toxicity|0
5494247|NCT01709162|18997940|P1|Overall Study|Study drug toxicity|2
5494248|NCT01709162|18997939|P2|Overall Study|Disease progression|3
5494249|NCT01709162|18997940|P1|Overall Study|Disease progression|3
5494250|NCT01709149|18997955|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5494251|NCT01709149|18997956|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
5494252|NCT01709149|18997957|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5494253|NCT01709149|18997955|P3|Double-blind, Placebo-controlled Phase|not defined|2
5494254|NCT01709149|18997956|P2|Double-blind, Placebo-controlled Phase|not defined|1
5494255|NCT01709149|18997957|P1|Double-blind, Placebo-controlled Phase|not defined|0
5494256|NCT01709149|18997955|P3|Double-blind, Placebo-controlled Phase|Death|0
5494257|NCT01709149|18997956|P2|Double-blind, Placebo-controlled Phase|Death|2
5494258|NCT01709149|18997957|P1|Double-blind, Placebo-controlled Phase|Death|0
5494259|NCT01709149|18997955|P3|Double-blind, Placebo-controlled Phase|Physician Decision|5
5494260|NCT01709149|18997956|P2|Double-blind, Placebo-controlled Phase|Physician Decision|2
5494261|NCT01709149|18997957|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
5494262|NCT01709149|18997955|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
5494263|NCT01709149|18997956|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
5494264|NCT01709149|18997957|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5494265|NCT01709149|18997955|P3|Double-blind, Placebo-controlled Phase|Adverse Event|78
5494266|NCT01709149|18997956|P2|Double-blind, Placebo-controlled Phase|Adverse Event|12
5494267|NCT01709149|18997957|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
5494268|NCT01709149|18997955|P3|Open-label Lead-in Phase|Protocol Violation|0
5494269|NCT01709149|18997956|P2|Open-label Lead-in Phase|Protocol Violation|0
5494270|NCT01709149|18997957|P1|Open-label Lead-in Phase|Protocol Violation|3
5494271|NCT01709149|18997955|P3|Open-label Lead-in Phase|Death|0
5494272|NCT01709149|18997956|P2|Open-label Lead-in Phase|Death|0
5494273|NCT01709149|18997957|P1|Open-label Lead-in Phase|Death|1
5494274|NCT01709149|18997955|P3|Open-label Lead-in Phase|Withdrawal by Subject|0
5494275|NCT01709149|18997956|P2|Open-label Lead-in Phase|Withdrawal by Subject|0
5494276|NCT01709149|18997957|P1|Open-label Lead-in Phase|Withdrawal by Subject|2
5494277|NCT01709149|18997955|P3|Open-label Lead-in Phase|Adverse Event|0
5494278|NCT01709149|18997956|P2|Open-label Lead-in Phase|Adverse Event|0
5494279|NCT01709149|18997957|P1|Open-label Lead-in Phase|Adverse Event|109
5494280|NCT01709110|18997985|P2|Overall Study|Caregiver Decision|1
5494281|NCT01709110|18997986|P1|Overall Study|Caregiver Decision|1
5494282|NCT01709110|18997985|P2|Overall Study|Lack of Efficacy|1
5494283|NCT01709110|18997986|P1|Overall Study|Lack of Efficacy|1
5494284|NCT01709110|18997985|P2|Overall Study|Sponsor Decision|2
5494285|NCT01709110|18997986|P1|Overall Study|Sponsor Decision|2
5494286|NCT01709110|18997985|P2|Overall Study|Physician Decision|10
5494287|NCT01709110|18997986|P1|Overall Study|Physician Decision|4
5494288|NCT01709110|18997985|P2|Overall Study|Withdrawal by Subject|89
5494289|NCT01709110|18997986|P1|Overall Study|Withdrawal by Subject|96
5494290|NCT01709110|18997985|P2|Overall Study|Protocol Violation|6
5494291|NCT01709110|18997986|P1|Overall Study|Protocol Violation|4
5494292|NCT01709110|18997985|P2|Overall Study|Lost to Follow-up|5
5494293|NCT01709110|18997986|P1|Overall Study|Lost to Follow-up|7
5494294|NCT01709110|18997985|P2|Overall Study|Death|6
5494295|NCT01709110|18997986|P1|Overall Study|Death|14
5494296|NCT01709110|18997985|P2|Overall Study|Adverse Event|48
5494297|NCT01709110|18997986|P1|Overall Study|Adverse Event|56
5494298|NCT01709084|18998016|P2|Overall Study|Not Treated|2
5494299|NCT01709084|18998017|P1|Overall Study|Not Treated|0
5494300|NCT01709084|18998016|P2|Overall Study|Participant Reached a Virologic Endpoint|1
5494301|NCT01709084|18998017|P1|Overall Study|Participant Reached a Virologic Endpoint|0
5494302|NCT01709084|18998016|P2|Overall Study|Other|3
5494303|NCT01709084|18998017|P1|Overall Study|Other|5
5494304|NCT01709084|18998016|P2|Overall Study|Adverse Event|0
5494305|NCT01709084|18998017|P1|Overall Study|Adverse Event|5
5494306|NCT01709084|18998016|P2|Overall Study|Withdrawal by Subject|2
5494307|NCT01709084|18998017|P1|Overall Study|Withdrawal by Subject|2
5494308|NCT01709084|18998016|P2|Overall Study|Lost to Follow-up|7
5494309|NCT01709084|18998017|P1|Overall Study|Lost to Follow-up|4
5494310|NCT01708954|18998050|P3|Step 2|Withdrawal by Subject|0
5494311|NCT01708954|18998051|P2|Step 2|Withdrawal by Subject|1
5494312|NCT01708954|18998052|P1|Step 2|Withdrawal by Subject|1
5494313|NCT01708954|18998050|P3|Step 2|Adverse Event|0
5494314|NCT01708954|18998051|P2|Step 2|Adverse Event|2
5494315|NCT01708954|18998052|P1|Step 2|Adverse Event|3
5494316|NCT01708954|18998050|P3|Step 2|Disease progression|0
5494317|NCT01708954|18998051|P2|Step 2|Disease progression|4
5494318|NCT01708954|18998052|P1|Step 2|Disease progression|9
5494319|NCT01708954|18998050|P3|Step 1|Ineligible or never received treatment|8
5494320|NCT01708954|18998051|P2|Step 1|Ineligible or never received treatment|2
5494321|NCT01708954|18998052|P1|Step 1|Ineligible or never received treatment|4
5494322|NCT01708954|18998050|P3|Step 1|Off-treatment reason not submitted|1
5494323|NCT01708954|18998051|P2|Step 1|Off-treatment reason not submitted|1
5494324|NCT01708954|18998052|P1|Step 1|Off-treatment reason not submitted|1
5494325|NCT01708954|18998050|P3|Step 1|Symptomatic deterioration|1
5494326|NCT01708954|18998051|P2|Step 1|Symptomatic deterioration|0
5494327|NCT01708954|18998052|P1|Step 1|Symptomatic deterioration|1
5494328|NCT01708954|18998050|P3|Step 1|Crossed over to Step 2|0
5494329|NCT01708954|18998051|P2|Step 1|Crossed over to Step 2|0
5494330|NCT01708954|18998052|P1|Step 1|Crossed over to Step 2|2
5494331|NCT01708954|18998050|P3|Step 1|Other complicating disease|0
5494332|NCT01708954|18998051|P2|Step 1|Other complicating disease|2
5494333|NCT01708954|18998052|P1|Step 1|Other complicating disease|0
5494334|NCT01708954|18998050|P3|Step 1|Withdrawal by Subject|3
5494335|NCT01708954|18998051|P2|Step 1|Withdrawal by Subject|5
5494336|NCT01708954|18998052|P1|Step 1|Withdrawal by Subject|2
5494337|NCT01708954|18998050|P3|Step 1|Death|3
5494338|NCT01708954|18998051|P2|Step 1|Death|2
5494339|NCT01708954|18998052|P1|Step 1|Death|3
5494340|NCT01708954|18998050|P3|Step 1|Adverse Event|13
5494341|NCT01708954|18998051|P2|Step 1|Adverse Event|11
5494342|NCT01708954|18998052|P1|Step 1|Adverse Event|3
5494343|NCT01708954|18998050|P3|Step 1|Disease progression|14
5494344|NCT01708954|18998051|P2|Step 1|Disease progression|17
5494345|NCT01708954|18998052|P1|Step 1|Disease progression|26
5494346|NCT01708941|18998077|P4|Overall Study|Ineligible|0
5494347|NCT01708941|18998078|P3|Overall Study|Ineligible|2
5494348|NCT01708941|18998079|P2|Overall Study|Ineligible|0
5494349|NCT01708941|18998080|P1|Overall Study|Ineligible|0
5494350|NCT01708941|18998077|P4|Overall Study|Never started treatment|0
5494351|NCT01708941|18998078|P3|Overall Study|Never started treatment|0
5494352|NCT01708941|18998079|P2|Overall Study|Never started treatment|1
5494353|NCT01708941|18998080|P1|Overall Study|Never started treatment|2
5494354|NCT01708941|18998077|P4|Overall Study|Ineligible and never started treatment|0
5494355|NCT01708941|18998078|P3|Overall Study|Ineligible and never started treatment|1
5494356|NCT01708941|18998079|P2|Overall Study|Ineligible and never started treatment|0
5494357|NCT01708941|18998080|P1|Overall Study|Ineligible and never started treatment|1
5494358|NCT01708941|18998077|P4|Overall Study|Alternative therapy|0
5494359|NCT01708941|18998078|P3|Overall Study|Alternative therapy|2
5494360|NCT01708941|18998079|P2|Overall Study|Alternative therapy|0
5494361|NCT01708941|18998080|P1|Overall Study|Alternative therapy|0
5494362|NCT01708941|18998077|P4|Overall Study|Disease progression|0
5494363|NCT01708941|18998078|P3|Overall Study|Disease progression|8
5494364|NCT01708941|18998079|P2|Overall Study|Disease progression|10
5494365|NCT01708941|18998080|P1|Overall Study|Disease progression|9
5494366|NCT01708941|18998077|P4|Overall Study|Withdrawal by Subject|4
5494367|NCT01708941|18998078|P3|Overall Study|Withdrawal by Subject|3
5494368|NCT01708941|18998079|P2|Overall Study|Withdrawal by Subject|0
5494369|NCT01708941|18998080|P1|Overall Study|Withdrawal by Subject|1
5494370|NCT01708941|18998077|P4|Overall Study|Death|14
5494371|NCT01708941|18998078|P3|Overall Study|Death|2
5494372|NCT01708941|18998079|P2|Overall Study|Death|1
5494373|NCT01708941|18998080|P1|Overall Study|Death|1
5494374|NCT01708941|18998077|P4|Overall Study|Adverse Event|0
5494375|NCT01708941|18998078|P3|Overall Study|Adverse Event|1
5494376|NCT01708941|18998079|P2|Overall Study|Adverse Event|6
5494377|NCT01708941|18998080|P1|Overall Study|Adverse Event|4
5494378|NCT01708915|18998098|P4|Overall Study|Other reasons than stated above|2
5494379|NCT01708915|18998099|P3|Overall Study|Other reasons than stated above|0
5494380|NCT01708915|18998100|P2|Overall Study|Other reasons than stated above|1
5494381|NCT01708915|18998101|P1|Overall Study|Other reasons than stated above|1
5494382|NCT01708915|18998098|P4|Overall Study|Withdrawal by Subject|2
5494383|NCT01708915|18998099|P3|Overall Study|Withdrawal by Subject|2
5494384|NCT01708915|18998100|P2|Overall Study|Withdrawal by Subject|1
5494385|NCT01708915|18998101|P1|Overall Study|Withdrawal by Subject|0
5494386|NCT01708915|18998098|P4|Overall Study|Protocol Violation|1
5494387|NCT01708915|18998099|P3|Overall Study|Protocol Violation|0
5494388|NCT01708915|18998100|P2|Overall Study|Protocol Violation|0
5494389|NCT01708915|18998101|P1|Overall Study|Protocol Violation|0
5494390|NCT01708915|18998098|P4|Overall Study|Lack of Efficacy|15
5494391|NCT01708915|18998099|P3|Overall Study|Lack of Efficacy|35
5494392|NCT01708915|18998100|P2|Overall Study|Lack of Efficacy|60
5494393|NCT01708915|18998101|P1|Overall Study|Lack of Efficacy|84
5494394|NCT01708915|18998098|P4|Overall Study|Adverse Event|13
5494395|NCT01708915|18998099|P3|Overall Study|Adverse Event|9
5494396|NCT01708915|18998100|P2|Overall Study|Adverse Event|0
5494397|NCT01708915|18998101|P1|Overall Study|Adverse Event|1
5494398|NCT01708902|18998130|P7|Overall Study|Other Reason|0
5494399|NCT01708902|18998131|P6|Overall Study|Other Reason|2
5494400|NCT01708902|18998132|P5|Overall Study|Other Reason|1
5494401|NCT01708902|18998133|P4|Overall Study|Other Reason|1
5494402|NCT01708902|18998134|P3|Overall Study|Other Reason|1
5494403|NCT01708902|18998135|P2|Overall Study|Other Reason|0
5494404|NCT01708902|18998136|P1|Overall Study|Other Reason|1
5494405|NCT01708902|18998130|P7|Overall Study|Refused to continue trial medication|1
5494406|NCT01708902|18998131|P6|Overall Study|Refused to continue trial medication|1
5494407|NCT01708902|18998132|P5|Overall Study|Refused to continue trial medication|8
5494408|NCT01708902|18998133|P4|Overall Study|Refused to continue trial medication|2
5494409|NCT01708902|18998134|P3|Overall Study|Refused to continue trial medication|4
5494410|NCT01708902|18998135|P2|Overall Study|Refused to continue trial medication|0
5494411|NCT01708902|18998136|P1|Overall Study|Refused to continue trial medication|8
5494412|NCT01708902|18998130|P7|Overall Study|Lost to Follow-up|1
5494413|NCT01708902|18998131|P6|Overall Study|Lost to Follow-up|0
5494414|NCT01708902|18998132|P5|Overall Study|Lost to Follow-up|0
5494415|NCT01708902|18998133|P4|Overall Study|Lost to Follow-up|2
5494416|NCT01708902|18998134|P3|Overall Study|Lost to Follow-up|2
5494417|NCT01708902|18998135|P2|Overall Study|Lost to Follow-up|1
5494418|NCT01708902|18998136|P1|Overall Study|Lost to Follow-up|2
5494419|NCT01708902|18998130|P7|Overall Study|Non compliance with protocol|0
5494420|NCT01708902|18998131|P6|Overall Study|Non compliance with protocol|0
5494421|NCT01708902|18998132|P5|Overall Study|Non compliance with protocol|0
5494422|NCT01708902|18998133|P4|Overall Study|Non compliance with protocol|3
5494423|NCT01708902|18998134|P3|Overall Study|Non compliance with protocol|1
5494424|NCT01708902|18998135|P2|Overall Study|Non compliance with protocol|2
5494425|NCT01708902|18998136|P1|Overall Study|Non compliance with protocol|0
5494426|NCT01708902|18998130|P7|Overall Study|Lack of Efficacy|0
5494427|NCT01708902|18998131|P6|Overall Study|Lack of Efficacy|1
5494428|NCT01708902|18998132|P5|Overall Study|Lack of Efficacy|0
5494429|NCT01708902|18998133|P4|Overall Study|Lack of Efficacy|0
5494430|NCT01708902|18998134|P3|Overall Study|Lack of Efficacy|0
5494431|NCT01708902|18998135|P2|Overall Study|Lack of Efficacy|1
5494432|NCT01708902|18998136|P1|Overall Study|Lack of Efficacy|3
5494433|NCT01708902|18998130|P7|Overall Study|Adverse Event|5
5494434|NCT01708902|18998131|P6|Overall Study|Adverse Event|3
5494435|NCT01708902|18998132|P5|Overall Study|Adverse Event|7
5494436|NCT01708902|18998133|P4|Overall Study|Adverse Event|2
5494437|NCT01708902|18998134|P3|Overall Study|Adverse Event|9
5494438|NCT01708902|18998135|P2|Overall Study|Adverse Event|4
5494439|NCT01708902|18998136|P1|Overall Study|Adverse Event|3
5494440|NCT01708291|18998278|P2|Overall Study|fighting|1
5494441|NCT01708291|18998279|P1|Overall Study|fighting|2
5494442|NCT01708187|18998318|P2|Overall Study|Lost to Follow-up|1
5494443|NCT01708187|18998319|P1|Overall Study|Lost to Follow-up|0
5494444|NCT01708174|18998328|P3|Treatment Period|Adverse Event|0
5494445|NCT01708174|18998329|P2|Treatment Period|Adverse Event|1
5494446|NCT01708174|18998330|P1|Treatment Period|Adverse Event|0
5494447|NCT01708174|18998328|P3|Treatment Period|Death|1
5494448|NCT01708174|18998329|P2|Treatment Period|Death|0
5494449|NCT01708174|18998330|P1|Treatment Period|Death|0
5494450|NCT01708174|18998328|P3|Treatment Period|Progressive disease|0
5494451|NCT01708174|18998329|P2|Treatment Period|Progressive disease|1
5494452|NCT01708174|18998330|P1|Treatment Period|Progressive disease|0
5494453|NCT01708174|18998328|P3|Treatment Period|Withdrawal by Subject|0
5494454|NCT01708174|18998329|P2|Treatment Period|Withdrawal by Subject|0
5494455|NCT01708174|18998330|P1|Treatment Period|Withdrawal by Subject|1
5494456|NCT01708161|18998362|P6|Overall Study|Disease progression|0
5494457|NCT01708161|18998363|P5|Overall Study|Disease progression|3
5494458|NCT01708161|18998364|P4|Overall Study|Disease progression|13
5494459|NCT01708161|18998365|P3|Overall Study|Disease progression|5
5494460|NCT01708161|18998366|P2|Overall Study|Disease progression|5
5494461|NCT01708161|18998367|P1|Overall Study|Disease progression|3
5494462|NCT01708161|18998362|P6|Overall Study|Administrative problems|0
5494463|NCT01708161|18998363|P5|Overall Study|Administrative problems|0
5494464|NCT01708161|18998364|P4|Overall Study|Administrative problems|0
5494465|NCT01708161|18998365|P3|Overall Study|Administrative problems|0
5494466|NCT01708161|18998366|P2|Overall Study|Administrative problems|1
5494467|NCT01708161|18998367|P1|Overall Study|Administrative problems|0
5494468|NCT01708161|18998362|P6|Overall Study|Withdrawal by Subject|0
5494469|NCT01708161|18998363|P5|Overall Study|Withdrawal by Subject|0
5494470|NCT01708161|18998364|P4|Overall Study|Withdrawal by Subject|0
5494471|NCT01708161|18998365|P3|Overall Study|Withdrawal by Subject|1
5494472|NCT01708161|18998366|P2|Overall Study|Withdrawal by Subject|1
5494473|NCT01708161|18998367|P1|Overall Study|Withdrawal by Subject|0
5494474|NCT01708161|18998362|P6|Overall Study|Death|1
5494475|NCT01708161|18998363|P5|Overall Study|Death|0
5494476|NCT01708161|18998364|P4|Overall Study|Death|1
5494477|NCT01708161|18998365|P3|Overall Study|Death|0
5494478|NCT01708161|18998366|P2|Overall Study|Death|0
5494479|NCT01708161|18998367|P1|Overall Study|Death|0
5494480|NCT01708161|18998362|P6|Overall Study|Adverse Event|0
5494481|NCT01708161|18998363|P5|Overall Study|Adverse Event|3
5494482|NCT01708161|18998364|P4|Overall Study|Adverse Event|2
5494483|NCT01708161|18998365|P3|Overall Study|Adverse Event|4
5494484|NCT01708161|18998366|P2|Overall Study|Adverse Event|3
5494485|NCT01708161|18998367|P1|Overall Study|Adverse Event|1
5494486|NCT01708057|18998418|P3|Overall Study|Withdrawal due to study termination.|1
5494487|NCT01708057|18998419|P2|Overall Study|Withdrawal due to study termination.|1
5494488|NCT01708057|18998420|P1|Overall Study|Withdrawal due to study termination.|1
5494489|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5494490|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
5494491|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5494492|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5494493|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5494494|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
5494495|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
5494496|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
5494497|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
5494498|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
5494499|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
5494500|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
5494501|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Noncompliance|2
5494502|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Noncompliance|4
5494503|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Noncompliance|0
5494504|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Noncompliance|0
5494505|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Noncompliance|0
5494506|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Noncompliance|0
5494507|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Other than specified|2
5494508|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Other than specified|5
5494509|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Other than specified|1
5494510|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Other than specified|0
5494511|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Other than specified|0
5494512|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Other than specified|0
5494513|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Death|0
5494514|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Death|0
5494515|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Death|2
5494516|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Death|0
5494517|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Death|0
5494518|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Death|0
5494519|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Lost to Follow-up|1
5494520|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Lost to Follow-up|11
5494521|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Lost to Follow-up|5
5494522|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Lost to Follow-up|0
5494523|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Lost to Follow-up|0
5494524|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Lost to Follow-up|0
5494525|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Pregnancy|2
5494526|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Pregnancy|5
5494527|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Pregnancy|2
5494528|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Pregnancy|0
5494529|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Pregnancy|0
5494530|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Pregnancy|0
5494531|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
5494532|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
5494533|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
5494534|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
5494535|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
5494536|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
5494537|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Lack of Efficacy|2
5494538|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Lack of Efficacy|1
5494539|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Lack of Efficacy|3
5494540|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Lack of Efficacy|0
5494541|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Lack of Efficacy|0
5494542|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Lack of Efficacy|0
5494543|NCT01707992|18998479|P6|Active Treatment Phase (24 Months)|Adverse Event|0
5494544|NCT01707992|18998480|P5|Active Treatment Phase (24 Months)|Adverse Event|1
5494545|NCT01707992|18998481|P4|Active Treatment Phase (24 Months)|Adverse Event|4
5494546|NCT01707992|18998482|P3|Active Treatment Phase (24 Months)|Adverse Event|0
5494547|NCT01707992|18998483|P2|Active Treatment Phase (24 Months)|Adverse Event|0
5494548|NCT01707992|18998484|P1|Active Treatment Phase (24 Months)|Adverse Event|0
5494549|NCT01707992|18998479|P6|Placebo-Controlled Phase (24 Months)|Other than specified|0
5494550|NCT01707992|18998480|P5|Placebo-Controlled Phase (24 Months)|Other than specified|0
5494551|NCT01707992|18998481|P4|Placebo-Controlled Phase (24 Months)|Other than specified|0
5494552|NCT01707992|18998482|P3|Placebo-Controlled Phase (24 Months)|Other than specified|10
5494553|NCT01707992|18998483|P2|Placebo-Controlled Phase (24 Months)|Other than specified|9
5494554|NCT01707992|18998484|P1|Placebo-Controlled Phase (24 Months)|Other than specified|11
5494555|NCT01707992|18998479|P6|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
5494556|NCT01707992|18998480|P5|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
5494557|NCT01707992|18998481|P4|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
5494558|NCT01707992|18998482|P3|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
5494559|NCT01707992|18998483|P2|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
5494560|NCT01707992|18998484|P1|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
5494561|NCT01707992|18998479|P6|Placebo-Controlled Phase (24 Months)|Death|0
5494562|NCT01707992|18998480|P5|Placebo-Controlled Phase (24 Months)|Death|0
5494563|NCT01707992|18998481|P4|Placebo-Controlled Phase (24 Months)|Death|0
5494564|NCT01707992|18998482|P3|Placebo-Controlled Phase (24 Months)|Death|1
5494565|NCT01707992|18998483|P2|Placebo-Controlled Phase (24 Months)|Death|1
5494566|NCT01707992|18998484|P1|Placebo-Controlled Phase (24 Months)|Death|2
5494567|NCT01707992|18998479|P6|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
5494568|NCT01707992|18998480|P5|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
5494569|NCT01707992|18998481|P4|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
5494570|NCT01707992|18998482|P3|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
5494571|NCT01707992|18998483|P2|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
5494572|NCT01707992|18998484|P1|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
5494573|NCT01707992|18998479|P6|Placebo-Controlled Phase (24 Months)|Pregnancy|0
5494574|NCT01707992|18998480|P5|Placebo-Controlled Phase (24 Months)|Pregnancy|0
5494575|NCT01707992|18998481|P4|Placebo-Controlled Phase (24 Months)|Pregnancy|0
5494576|NCT01707992|18998482|P3|Placebo-Controlled Phase (24 Months)|Pregnancy|9
5494577|NCT01707992|18998483|P2|Placebo-Controlled Phase (24 Months)|Pregnancy|5
5494578|NCT01707992|18998484|P1|Placebo-Controlled Phase (24 Months)|Pregnancy|12
5494579|NCT01707992|18998479|P6|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5494580|NCT01707992|18998480|P5|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5494581|NCT01707992|18998481|P4|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5494582|NCT01707992|18998482|P3|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5494583|NCT01707992|18998483|P2|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
5494584|NCT01707992|18998484|P1|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
5494585|NCT01707992|18998479|P6|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
5494586|NCT01707992|18998480|P5|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
5494587|NCT01707992|18998481|P4|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
5494588|NCT01707992|18998482|P3|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
5494589|NCT01707992|18998483|P2|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
5494590|NCT01707992|18998484|P1|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
5494591|NCT01707992|18998479|P6|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
5494592|NCT01707992|18998480|P5|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
5494593|NCT01707992|18998481|P4|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
5494594|NCT01707992|18998482|P3|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
5494595|NCT01707992|18998483|P2|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
5494596|NCT01707992|18998484|P1|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
5494597|NCT01707992|18998479|P6|Placebo-Controlled Phase (24 Months)|Adverse Event|0
5494598|NCT01707992|18998480|P5|Placebo-Controlled Phase (24 Months)|Adverse Event|0
5494599|NCT01707992|18998481|P4|Placebo-Controlled Phase (24 Months)|Adverse Event|0
5494600|NCT01707992|18998482|P3|Placebo-Controlled Phase (24 Months)|Adverse Event|9
5494601|NCT01707992|18998483|P2|Placebo-Controlled Phase (24 Months)|Adverse Event|13
5494602|NCT01707992|18998484|P1|Placebo-Controlled Phase (24 Months)|Adverse Event|8
5494603|NCT01707693|18998536|P2|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
5494604|NCT01707693|18998537|P1|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
5494605|NCT01707693|18998536|P2|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
5494606|NCT01707693|18998537|P1|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
5494607|NCT01707693|18998536|P2|Overall Study Allocation|Protocol Violation|3
5494608|NCT01707693|18998537|P1|Overall Study Allocation|Protocol Violation|4
5494609|NCT01707693|18998536|P2|Overall Study Allocation|Withdrawal by Subject|5
5494610|NCT01707693|18998537|P1|Overall Study Allocation|Withdrawal by Subject|9
5494611|NCT01707667|18998551|P2|Period 1|expulsion of colonic sensor catheter|0
5494612|NCT01707667|18998552|P1|Period 1|expulsion of colonic sensor catheter|1
5494613|NCT01707290|18998622|P2|Overall Study|Other unspecified|0
5494614|NCT01707290|18998623|P1|Overall Study|Other unspecified|17
5494615|NCT01707290|18998622|P2|Overall Study|Commercial drug available|1
5494616|NCT01707290|18998623|P1|Overall Study|Commercial drug available|60
5494617|NCT01707290|18998622|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
5494618|NCT01707290|18998623|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
5494619|NCT01707290|18998622|P2|Overall Study|Lost to Follow-up|0
5494620|NCT01707290|18998623|P1|Overall Study|Lost to Follow-up|3
5494621|NCT01707290|18998622|P2|Overall Study|Physician Decision|0
5494622|NCT01707290|18998623|P1|Overall Study|Physician Decision|1
5494623|NCT01707290|18998622|P2|Overall Study|Adverse event (AE)|0
5494624|NCT01707290|18998623|P1|Overall Study|Adverse event (AE)|1
5494625|NCT01707147|18998668|P1|Overall Study|Violated inclusion/exclusion criteria|77
5494626|NCT01707147|18998668|P1|Overall Study|Follow-up failure|17
5494627|NCT01707147|18998668|P1|Overall Study|Patients who have not taken Trajenta|1
5494628|NCT01707147|18998668|P1|Overall Study|Administered Trajenta prior to contract|5
5494629|NCT01707030|18998700|P2|Overall Study|Lost to Follow-up|13
5494630|NCT01707030|18998701|P1|Overall Study|Lost to Follow-up|8
5494631|NCT01707030|18998700|P2|Overall Study|Withdrawal by Subject|3
5494632|NCT01707030|18998701|P1|Overall Study|Withdrawal by Subject|2
5494633|NCT01707030|18998700|P2|Overall Study|Death|1
5494634|NCT01707030|18998701|P1|Overall Study|Death|1
5494635|NCT01707004|18998719|P1|Overall Study|Physician Decision|3
5494636|NCT01706926|18998773|P4|Overall Study|Other|3
5494637|NCT01706926|18998774|P3|Overall Study|Other|4
5494638|NCT01706926|18998775|P2|Overall Study|Other|4
5494639|NCT01706926|18998776|P1|Overall Study|Other|4
5494640|NCT01706926|18998773|P4|Overall Study|Withdrawal by Subject|2
5494641|NCT01706926|18998774|P3|Overall Study|Withdrawal by Subject|1
5494642|NCT01706926|18998775|P2|Overall Study|Withdrawal by Subject|0
5494643|NCT01706926|18998776|P1|Overall Study|Withdrawal by Subject|2
5494644|NCT01706926|18998773|P4|Overall Study|Lost to Follow-up|0
5494645|NCT01706926|18998774|P3|Overall Study|Lost to Follow-up|1
5494646|NCT01706926|18998775|P2|Overall Study|Lost to Follow-up|0
5494647|NCT01706926|18998776|P1|Overall Study|Lost to Follow-up|0
5494648|NCT01706770|18998895|P2|Overall Study|Physician Decision|0
5494649|NCT01706770|18998896|P1|Overall Study|Physician Decision|1
5494650|NCT01706770|18998895|P2|Overall Study|Lost to Follow-up|0
5494651|NCT01706770|18998896|P1|Overall Study|Lost to Follow-up|1
5494652|NCT01706575|18998944|P1|Overall Study|Started but not Treated|6
5494653|NCT01706575|18998944|P1|Overall Study|Lost to Follow-up|2
5494654|NCT01706575|18998944|P1|Overall Study|Participant Withdrew Consent|4
5494655|NCT01706536|18998965|P5|Overall Study|non compliance|0
5494656|NCT01706536|18998966|P4|Overall Study|non compliance|0
5494657|NCT01706536|18998967|P3|Overall Study|non compliance|0
5494658|NCT01706536|18998968|P2|Overall Study|non compliance|1
5494659|NCT01706536|18998969|P1|Overall Study|non compliance|0
5494660|NCT01706536|18998965|P5|Overall Study|Lack of Efficacy|0
5494661|NCT01706536|18998966|P4|Overall Study|Lack of Efficacy|1
5494662|NCT01706536|18998967|P3|Overall Study|Lack of Efficacy|0
5494663|NCT01706536|18998968|P2|Overall Study|Lack of Efficacy|0
5494664|NCT01706536|18998969|P1|Overall Study|Lack of Efficacy|1
5494665|NCT01706536|18998965|P5|Overall Study|Adverse Event|2
5494666|NCT01706536|18998966|P4|Overall Study|Adverse Event|3
5494667|NCT01706536|18998967|P3|Overall Study|Adverse Event|4
5494668|NCT01706536|18998968|P2|Overall Study|Adverse Event|3
5494669|NCT01706536|18998969|P1|Overall Study|Adverse Event|2
5494670|NCT01706536|18998965|P5|Overall Study|Withdrawal by Subject|0
5494671|NCT01706536|18998966|P4|Overall Study|Withdrawal by Subject|0
5494672|NCT01706536|18998967|P3|Overall Study|Withdrawal by Subject|1
5494673|NCT01706536|18998968|P2|Overall Study|Withdrawal by Subject|0
5494674|NCT01706536|18998969|P1|Overall Study|Withdrawal by Subject|1
5494675|NCT01706458|18999036|P2|Overall Study|Physician Decision|4
5494676|NCT01706458|18999037|P1|Overall Study|Physician Decision|3
5494677|NCT01706328|18999061|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
5494678|NCT01706328|18999062|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
5494679|NCT01706328|18999063|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
5494680|NCT01706328|18999061|P3|12-week Double-blind Treatment Period|Physician Decision|2
5494681|NCT01706328|18999062|P2|12-week Double-blind Treatment Period|Physician Decision|2
5494682|NCT01706328|18999063|P1|12-week Double-blind Treatment Period|Physician Decision|0
5494683|NCT01706328|18999061|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
5494684|NCT01706328|18999062|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
5494685|NCT01706328|18999063|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
5494686|NCT01706328|18999061|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
5494687|NCT01706328|18999062|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
5494688|NCT01706328|18999063|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
5494689|NCT01706328|18999061|P3|12-week Double-blind Treatment Period|Protocol Violation|2
5494690|NCT01706328|18999062|P2|12-week Double-blind Treatment Period|Protocol Violation|4
5494691|NCT01706328|18999063|P1|12-week Double-blind Treatment Period|Protocol Violation|0
5494692|NCT01706328|18999061|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
5494693|NCT01706328|18999062|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
5494694|NCT01706328|18999063|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
5494695|NCT01706328|18999061|P3|12-week Double-blind Treatment Period|Adverse Event|16
5494696|NCT01706328|18999062|P2|12-week Double-blind Treatment Period|Adverse Event|14
5494697|NCT01706328|18999063|P1|12-week Double-blind Treatment Period|Adverse Event|0
5494698|NCT01706328|18999061|P3|2-week Run-in Period|Lost to Follow-up|0
5494699|NCT01706328|18999062|P2|2-week Run-in Period|Lost to Follow-up|0
5494700|NCT01706328|18999063|P1|2-week Run-in Period|Lost to Follow-up|2
5494701|NCT01706328|18999061|P3|2-week Run-in Period|Adverse Event|0
5494702|NCT01706328|18999062|P2|2-week Run-in Period|Adverse Event|0
5494703|NCT01706328|18999063|P1|2-week Run-in Period|Adverse Event|4
5494704|NCT01706328|18999061|P3|2-week Run-in Period|Physician Decision|0
5494705|NCT01706328|18999062|P2|2-week Run-in Period|Physician Decision|0
5494706|NCT01706328|18999063|P1|2-week Run-in Period|Physician Decision|4
5494707|NCT01706328|18999061|P3|2-week Run-in Period|Withdrawal by Subject|0
5494708|NCT01706328|18999062|P2|2-week Run-in Period|Withdrawal by Subject|0
5494709|NCT01706328|18999063|P1|2-week Run-in Period|Withdrawal by Subject|15
5494710|NCT01706328|18999061|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5494711|NCT01706328|18999062|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5494712|NCT01706328|18999063|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
5494713|NCT01706250|18999082|P1|Overall Study|Lost to Follow-up|2
5494714|NCT01706198|18999113|P2|Overall Study|Withdrawal by Subject|31
5494715|NCT01706198|18999114|P1|Overall Study|Withdrawal by Subject|23
5494716|NCT01706198|18999113|P2|Overall Study|Physician Decision|37
5494717|NCT01706198|18999114|P1|Overall Study|Physician Decision|23
5494718|NCT01706198|18999113|P2|Overall Study|Lost to Follow-up|93
5494719|NCT01706198|18999114|P1|Overall Study|Lost to Follow-up|97
5494720|NCT01706198|18999113|P2|Overall Study|Other: Subject reached stopping criteria|13
5494721|NCT01706198|18999114|P1|Overall Study|Other: Subject reached stopping criteria|11
5494722|NCT01706198|18999113|P2|Overall Study|Protocol Violation|5
5494723|NCT01706198|18999114|P1|Overall Study|Protocol Violation|7
5494724|NCT01706198|18999113|P2|Overall Study|Adverse Event|15
5494725|NCT01706198|18999114|P1|Overall Study|Adverse Event|12
5494726|NCT01706159|18999166|P2|Overall Study|Unclassified|1
5494727|NCT01706159|18999167|P1|Overall Study|Unclassified|6
5494728|NCT01706159|18999166|P2|Overall Study|Withdrawal Criteria|1
5494729|NCT01706159|18999167|P1|Overall Study|Withdrawal Criteria|2
5494730|NCT01706146|18999181|P1|Overall Study|Developed AF and need for antiplatelets|2
5494731|NCT01706146|18999181|P1|Overall Study|Adverse Event|3
5494732|NCT01706146|18999181|P1|Overall Study|Withdrawal by Subject|1
5494733|NCT01706003|18999201|P2|Overall Study|Lost to Follow-up|4
5494734|NCT01706003|18999202|P1|Overall Study|Lost to Follow-up|6
5494735|NCT01706003|18999201|P2|Overall Study|Not scheduled|0
5494736|NCT01706003|18999202|P1|Overall Study|Not scheduled|3
5494737|NCT01706003|18999201|P2|Overall Study|Withdrawal by Subject|0
5494738|NCT01706003|18999202|P1|Overall Study|Withdrawal by Subject|2
5494739|NCT01705977|18999210|P2|Overall Study|Missing study conclusion form|2
5494740|NCT01705977|18999211|P1|Overall Study|Missing study conclusion form|2
5494741|NCT01705977|18999210|P2|Overall Study|Physician Decision|38
5494742|NCT01705977|18999211|P1|Overall Study|Physician Decision|48
5494743|NCT01705977|18999210|P2|Overall Study|Lost to Follow-up|37
5494744|NCT01705977|18999211|P1|Overall Study|Lost to Follow-up|33
5494745|NCT01705977|18999210|P2|Overall Study|Site closure|2
5494746|NCT01705977|18999211|P1|Overall Study|Site closure|3
5494747|NCT01705977|18999210|P2|Overall Study|Protocol Violation|4
5494748|NCT01705977|18999211|P1|Overall Study|Protocol Violation|2
5494749|NCT01705977|18999210|P2|Overall Study|Adverse Event|49
5494750|NCT01705977|18999211|P1|Overall Study|Adverse Event|57
5494751|NCT01705977|18999210|P2|Overall Study|Withdrawal by Subject|128
5494752|NCT01705977|18999211|P1|Overall Study|Withdrawal by Subject|128
5494753|NCT01705730|18999229|P1|Overall Study|Reason not Specified|4
5494754|NCT01705730|18999229|P1|Overall Study|Lost to Follow-up|1
5494755|NCT01705730|18999229|P1|Overall Study|Adverse Event|3
5494756|NCT01705730|18999229|P1|Overall Study|Lack of Efficacy|1
5494757|NCT01705717|18999269|P2|Overall Study|Other|2
5494758|NCT01705717|18999270|P1|Overall Study|Other|0
5494759|NCT01705717|18999269|P2|Overall Study|Lack of Efficacy|1
5494760|NCT01705717|18999270|P1|Overall Study|Lack of Efficacy|0
5494761|NCT01705717|18999269|P2|Overall Study|Adverse Event|2
5494762|NCT01705717|18999270|P1|Overall Study|Adverse Event|2
5494763|NCT01705691|18999287|P2|Overall Study|Other|1
5494764|NCT01705691|18999288|P1|Overall Study|Other|0
5494765|NCT01705691|18999287|P2|Overall Study|Lost to Follow-up|1
5494766|NCT01705691|18999288|P1|Overall Study|Lost to Follow-up|1
5494767|NCT01705691|18999287|P2|Overall Study|Withdrawal by Subject|2
5494768|NCT01705691|18999288|P1|Overall Study|Withdrawal by Subject|1
5494769|NCT01705691|18999287|P2|Overall Study|Death|2
5494770|NCT01705691|18999288|P1|Overall Study|Death|1
5494771|NCT01705652|18999308|P2|Overall Study|non-compliance|1
5494772|NCT01705652|18999309|P1|Overall Study|non-compliance|1
5494773|NCT01705652|18999308|P2|Overall Study|Withdrawal by Subject|2
5494774|NCT01705652|18999309|P1|Overall Study|Withdrawal by Subject|1
5494775|NCT01705652|18999308|P2|Overall Study|Adverse Event|0
5494776|NCT01705652|18999309|P1|Overall Study|Adverse Event|1
5494777|NCT01705587|18999317|P2|Overall Study|Withdrawal by Subject|1
5494778|NCT01705587|18999318|P1|Overall Study|Withdrawal by Subject|0
5494779|NCT01705574|18999336|P4|Open-Label Extension Phase|Pregnancy|1
5494780|NCT01705574|18999337|P3|Open-Label Extension Phase|Pregnancy|1
5494781|NCT01705574|18999338|P2|Open-Label Extension Phase|Pregnancy|0
5494782|NCT01705574|18999339|P1|Open-Label Extension Phase|Pregnancy|0
5494783|NCT01705574|18999336|P4|Open-Label Extension Phase|Physician Decision|0
5494784|NCT01705574|18999337|P3|Open-Label Extension Phase|Physician Decision|2
5494785|NCT01705574|18999338|P2|Open-Label Extension Phase|Physician Decision|0
5494786|NCT01705574|18999339|P1|Open-Label Extension Phase|Physician Decision|0
5494787|NCT01705574|18999336|P4|Open-Label Extension Phase|Non-Compliance with Study Drug|0
5494788|NCT01705574|18999337|P3|Open-Label Extension Phase|Non-Compliance with Study Drug|1
5494789|NCT01705574|18999338|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
5494790|NCT01705574|18999339|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|0
5494791|NCT01705574|18999336|P4|Open-Label Extension Phase|Death|0
5494792|NCT01705574|18999337|P3|Open-Label Extension Phase|Death|1
5494793|NCT01705574|18999338|P2|Open-Label Extension Phase|Death|0
5494794|NCT01705574|18999339|P1|Open-Label Extension Phase|Death|2
5494795|NCT01705574|18999336|P4|Open-Label Extension Phase|Adverse Event|1
5494796|NCT01705574|18999337|P3|Open-Label Extension Phase|Adverse Event|0
5494797|NCT01705574|18999338|P2|Open-Label Extension Phase|Adverse Event|0
5494798|NCT01705574|18999339|P1|Open-Label Extension Phase|Adverse Event|3
5494799|NCT01705574|18999336|P4|Open-Label Extension Phase|Withdrew Consent|1
5494800|NCT01705574|18999337|P3|Open-Label Extension Phase|Withdrew Consent|4
5494801|NCT01705574|18999338|P2|Open-Label Extension Phase|Withdrew Consent|0
5494802|NCT01705574|18999339|P1|Open-Label Extension Phase|Withdrew Consent|4
5494803|NCT01705574|18999336|P4|Open-Label Extension Phase|Lost to Follow-up|2
5494804|NCT01705574|18999337|P3|Open-Label Extension Phase|Lost to Follow-up|2
5494805|NCT01705574|18999338|P2|Open-Label Extension Phase|Lost to Follow-up|0
5494806|NCT01705574|18999339|P1|Open-Label Extension Phase|Lost to Follow-up|6
5494807|NCT01705574|18999336|P4|Double-Blind Phase|Randomized but Not Treated|0
5494808|NCT01705574|18999337|P3|Double-Blind Phase|Randomized but Not Treated|0
5494809|NCT01705574|18999338|P2|Double-Blind Phase|Randomized but Not Treated|4
5494810|NCT01705574|18999339|P1|Double-Blind Phase|Randomized but Not Treated|4
5494811|NCT01705574|18999336|P4|Double-Blind Phase|Protocol Violation|0
5494812|NCT01705574|18999337|P3|Double-Blind Phase|Protocol Violation|0
5494813|NCT01705574|18999338|P2|Double-Blind Phase|Protocol Violation|0
5494814|NCT01705574|18999339|P1|Double-Blind Phase|Protocol Violation|1
5494815|NCT01705574|18999336|P4|Double-Blind Phase|Pregnancy|0
5494816|NCT01705574|18999337|P3|Double-Blind Phase|Pregnancy|0
5494817|NCT01705574|18999338|P2|Double-Blind Phase|Pregnancy|1
5494818|NCT01705574|18999339|P1|Double-Blind Phase|Pregnancy|1
5494819|NCT01705574|18999336|P4|Double-Blind Phase|Non-Compliance with Study Drug|0
5494820|NCT01705574|18999337|P3|Double-Blind Phase|Non-Compliance with Study Drug|0
5494821|NCT01705574|18999338|P2|Double-Blind Phase|Non-Compliance with Study Drug|5
5494822|NCT01705574|18999339|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
5494823|NCT01705574|18999336|P4|Double-Blind Phase|Withdrew Consent|0
5494824|NCT01705574|18999337|P3|Double-Blind Phase|Withdrew Consent|0
5494825|NCT01705574|18999338|P2|Double-Blind Phase|Withdrew Consent|5
5494826|NCT01705574|18999339|P1|Double-Blind Phase|Withdrew Consent|8
5494827|NCT01705574|18999336|P4|Double-Blind Phase|Adverse Event|0
5494828|NCT01705574|18999337|P3|Double-Blind Phase|Adverse Event|0
5494829|NCT01705574|18999338|P2|Double-Blind Phase|Adverse Event|10
5494830|NCT01705574|18999339|P1|Double-Blind Phase|Adverse Event|3
5494831|NCT01705574|18999336|P4|Double-Blind Phase|Lost to Follow-up|0
5494832|NCT01705574|18999337|P3|Double-Blind Phase|Lost to Follow-up|0
5494833|NCT01705574|18999338|P2|Double-Blind Phase|Lost to Follow-up|16
5494834|NCT01705574|18999339|P1|Double-Blind Phase|Lost to Follow-up|12
5494835|NCT01705509|18999356|P1|CPET w/ Ranexa|Screen Failure|2
5494836|NCT01705509|18999356|P1|Inclusion CPET|Withdrawal by Subject|2
5494837|NCT01705509|18999356|P1|Inclusion CPET|Screen Failure|5
5494838|NCT01705236|18999383|P1|Overall Study|Adverse Event|5
5494839|NCT01705236|18999383|P1|Overall Study|Withdrawal by Subject|5
5494840|NCT01705236|18999383|P1|Overall Study|Abnormal laboratory value(s)|4
5494841|NCT01705236|18999383|P1|Overall Study|Abnormal test procedure result(s)|4
5494842|NCT01705236|18999383|P1|Overall Study|Protocol Violation|3
5494843|NCT01705236|18999383|P1|Overall Study|Unsatisfactory therapeutic effect|3
5494844|NCT01705236|18999383|P1|Overall Study|Administrative problems|2
5494845|NCT01705236|18999383|P1|Overall Study|Lost to Follow-up|1
5494846|NCT01705145|18999392|P1|Part B|Adverse Event|1
5494847|NCT01705080|18999432|P4|Overall Study|Missed 6 Month Visit|0
5494848|NCT01705080|18999433|P3|Overall Study|Missed 6 Month Visit|1
5494849|NCT01705080|18999434|P2|Overall Study|Missed 6 Month Visit|1
5494850|NCT01705080|18999435|P1|Overall Study|Missed 6 Month Visit|3
5494851|NCT01705080|18999432|P4|Overall Study|Protocol Violation|0
5494852|NCT01705080|18999433|P3|Overall Study|Protocol Violation|0
5494853|NCT01705080|18999434|P2|Overall Study|Protocol Violation|0
5494854|NCT01705080|18999435|P1|Overall Study|Protocol Violation|2
5494855|NCT01705080|18999432|P4|Overall Study|Lost to Follow-up|2
5494856|NCT01705080|18999433|P3|Overall Study|Lost to Follow-up|0
5494857|NCT01705080|18999434|P2|Overall Study|Lost to Follow-up|0
5494858|NCT01705080|18999435|P1|Overall Study|Lost to Follow-up|0
5494859|NCT01705080|18999432|P4|Overall Study|Physician Decision|8
5494860|NCT01705080|18999433|P3|Overall Study|Physician Decision|1
5494861|NCT01705080|18999434|P2|Overall Study|Physician Decision|2
5494862|NCT01705080|18999435|P1|Overall Study|Physician Decision|1
5494863|NCT01705080|18999432|P4|Overall Study|Withdrawal by Subject|12
5494864|NCT01705080|18999433|P3|Overall Study|Withdrawal by Subject|0
5494865|NCT01705080|18999434|P2|Overall Study|Withdrawal by Subject|1
5494866|NCT01705080|18999435|P1|Overall Study|Withdrawal by Subject|1
5494867|NCT01705080|18999432|P4|Overall Study|Death|0
5494868|NCT01705080|18999433|P3|Overall Study|Death|0
5494869|NCT01705080|18999434|P2|Overall Study|Death|1
5494870|NCT01705080|18999435|P1|Overall Study|Death|0
5494871|NCT01705080|18999432|P4|Overall Study|Failed Procedure|0
5494872|NCT01705080|18999433|P3|Overall Study|Failed Procedure|0
5494873|NCT01705080|18999434|P2|Overall Study|Failed Procedure|2
5494874|NCT01705080|18999435|P1|Overall Study|Failed Procedure|0
5494875|NCT01705080|18999432|P4|Overall Study|Screen Failure Post Consent|20
5494876|NCT01705080|18999433|P3|Overall Study|Screen Failure Post Consent|3
5494877|NCT01705080|18999434|P2|Overall Study|Screen Failure Post Consent|9
5494878|NCT01705080|18999435|P1|Overall Study|Screen Failure Post Consent|8
5494879|NCT01704846|18999564|P2|Treatment Period 2|Withdrawal by Subject|1
5494880|NCT01704846|18999565|P1|Treatment Period 2|Withdrawal by Subject|0
5494881|NCT01704755|18999620|P2|Overall Study|Withdrew consent and personal issues|0
5494882|NCT01704755|18999621|P1|Overall Study|Withdrew consent and personal issues|1
5494883|NCT01704755|18999620|P2|Overall Study|Other (not specified)|1
5494884|NCT01704755|18999621|P1|Overall Study|Other (not specified)|3
5494885|NCT01704755|18999620|P2|Overall Study|Withdrew consent|1
5494886|NCT01704755|18999621|P1|Overall Study|Withdrew consent|1
5494887|NCT01704755|18999620|P2|Overall Study|Lost to Follow-up|4
5494888|NCT01704755|18999621|P1|Overall Study|Lost to Follow-up|3
5494889|NCT01704755|18999620|P2|Overall Study|Adverse Event|1
5494890|NCT01704755|18999621|P1|Overall Study|Adverse Event|4
5494891|NCT01704651|18999635|P2|Overall Study|Post-op did not have laparotomy|1
5494892|NCT01704651|18999636|P1|Overall Study|Post-op did not have laparotomy|2
5494893|NCT01704651|18999635|P2|Overall Study|Nasogastric tube placement in surgery|1
5494894|NCT01704651|18999636|P1|Overall Study|Nasogastric tube placement in surgery|1
5494895|NCT01704651|18999635|P2|Overall Study|Pre-op change in treatment plan|4
5494896|NCT01704651|18999636|P1|Overall Study|Pre-op change in treatment plan|1
5494897|NCT01704651|18999635|P2|Overall Study|Pre-op withdrawal by subject|1
5494898|NCT01704651|18999636|P1|Overall Study|Pre-op withdrawal by subject|1
5494899|NCT01704599|18999644|P1|Overall Study|Adverse Event|1
5494900|NCT01704495|18999684|P4|Optional Safety Extension|Withdrawal by Subject|2
5494901|NCT01704495|18999685|P3|Optional Safety Extension|Withdrawal by Subject|1
5494902|NCT01704495|18999686|P2|Optional Safety Extension|Withdrawal by Subject|0
5494903|NCT01704495|18999687|P1|Optional Safety Extension|Withdrawal by Subject|2
5494904|NCT01704495|18999684|P4|Optional Safety Extension|Other reason|28
5494905|NCT01704495|18999685|P3|Optional Safety Extension|Other reason|30
5494906|NCT01704495|18999686|P2|Optional Safety Extension|Other reason|29
5494907|NCT01704495|18999687|P1|Optional Safety Extension|Other reason|27
5494908|NCT01704495|18999684|P4|Optional Safety Extension|Adverse Event|1
5494909|NCT01704495|18999685|P3|Optional Safety Extension|Adverse Event|0
5494910|NCT01704495|18999686|P2|Optional Safety Extension|Adverse Event|4
5494911|NCT01704495|18999687|P1|Optional Safety Extension|Adverse Event|0
5494912|NCT01704495|18999684|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
5494913|NCT01704495|18999685|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
5494914|NCT01704495|18999686|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
5494915|NCT01704495|18999687|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
5494916|NCT01704495|18999684|P4|Subjects Randomized|Protocol Violation|0
5494917|NCT01704495|18999685|P3|Subjects Randomized|Protocol Violation|2
5494918|NCT01704495|18999686|P2|Subjects Randomized|Protocol Violation|1
5494919|NCT01704495|18999687|P1|Subjects Randomized|Protocol Violation|1
5494920|NCT01704495|18999684|P4|Subjects Randomized|Withdrawal by Subject|5
5494921|NCT01704495|18999685|P3|Subjects Randomized|Withdrawal by Subject|5
5494922|NCT01704495|18999686|P2|Subjects Randomized|Withdrawal by Subject|5
5494923|NCT01704495|18999687|P1|Subjects Randomized|Withdrawal by Subject|5
5494924|NCT01704495|18999684|P4|Subjects Randomized|Adverse Event|7
5494925|NCT01704495|18999685|P3|Subjects Randomized|Adverse Event|0
5494926|NCT01704495|18999686|P2|Subjects Randomized|Adverse Event|2
5494927|NCT01704495|18999687|P1|Subjects Randomized|Adverse Event|8
5494928|NCT01704495|18999684|P4|Subjects Randomized|Discontinuation criteria met|0
5494929|NCT01704495|18999685|P3|Subjects Randomized|Discontinuation criteria met|2
5494930|NCT01704495|18999686|P2|Subjects Randomized|Discontinuation criteria met|2
5494931|NCT01704495|18999687|P1|Subjects Randomized|Discontinuation criteria met|4
5494932|NCT01704495|18999684|P4|Subjects Randomized|Other Reason|2
5494933|NCT01704495|18999685|P3|Subjects Randomized|Other Reason|3
5494934|NCT01704495|18999686|P2|Subjects Randomized|Other Reason|2
5494935|NCT01704495|18999687|P1|Subjects Randomized|Other Reason|3
5494936|NCT01704456|18999863|P2|Overall Study|Lost to Follow-up|14
5494937|NCT01704456|18999864|P1|Overall Study|Lost to Follow-up|8
5494938|NCT01704287|18999926|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5494939|NCT01704287|18999927|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
5494940|NCT01704287|18999928|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5494941|NCT01704287|18999929|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5494942|NCT01704287|18999930|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
5494943|NCT01704287|18999926|P5|Switch to Pembrolizumab Treatment Period|Death|37
5494944|NCT01704287|18999927|P4|Switch to Pembrolizumab Treatment Period|Death|35
5494945|NCT01704287|18999928|P3|Switch to Pembrolizumab Treatment Period|Death|0
5494946|NCT01704287|18999929|P2|Switch to Pembrolizumab Treatment Period|Death|0
5494947|NCT01704287|18999930|P1|Switch to Pembrolizumab Treatment Period|Death|0
5494948|NCT01704287|18999926|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
5494949|NCT01704287|18999927|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
5494950|NCT01704287|18999928|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
5494951|NCT01704287|18999929|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
5494952|NCT01704287|18999930|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
5494953|NCT01704287|18999926|P5|Initial Treatment Period|Switched to Pembrolizumab|0
5494954|NCT01704287|18999927|P4|Initial Treatment Period|Switched to Pembrolizumab|0
5494955|NCT01704287|18999928|P3|Initial Treatment Period|Switched to Pembrolizumab|98
5494956|NCT01704287|18999929|P2|Initial Treatment Period|Switched to Pembrolizumab|0
5494957|NCT01704287|18999930|P1|Initial Treatment Period|Switched to Pembrolizumab|0
5494958|NCT01704287|18999926|P5|Initial Treatment Period|Lost to Follow-up|0
5494959|NCT01704287|18999927|P4|Initial Treatment Period|Lost to Follow-up|0
5494960|NCT01704287|18999928|P3|Initial Treatment Period|Lost to Follow-up|0
5494961|NCT01704287|18999929|P2|Initial Treatment Period|Lost to Follow-up|3
5494962|NCT01704287|18999930|P1|Initial Treatment Period|Lost to Follow-up|5
5494963|NCT01704287|18999926|P5|Initial Treatment Period|Withdrawal by Subject|0
5494964|NCT01704287|18999927|P4|Initial Treatment Period|Withdrawal by Subject|0
5494965|NCT01704287|18999928|P3|Initial Treatment Period|Withdrawal by Subject|4
5494966|NCT01704287|18999929|P2|Initial Treatment Period|Withdrawal by Subject|2
5494967|NCT01704287|18999930|P1|Initial Treatment Period|Withdrawal by Subject|3
5494968|NCT01704287|18999926|P5|Initial Treatment Period|Death|0
5494969|NCT01704287|18999927|P4|Initial Treatment Period|Death|0
5494970|NCT01704287|18999928|P3|Initial Treatment Period|Death|71
5494971|NCT01704287|18999929|P2|Initial Treatment Period|Death|129
5494972|NCT01704287|18999930|P1|Initial Treatment Period|Death|139
5494973|NCT01704261|18999978|P2|Overall Study|Lost to Follow-up|0
5494974|NCT01704261|18999979|P1|Overall Study|Lost to Follow-up|1
5494975|NCT01704261|18999978|P2|Overall Study|Withdrawal by Subject|15
5494976|NCT01704261|18999979|P1|Overall Study|Withdrawal by Subject|12
5494977|NCT01704079|19000006|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
5494978|NCT01704079|19000007|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
5494979|NCT01704079|19000006|P2|Overall Study|Subject noncompliance|3
5494980|NCT01704079|19000007|P1|Overall Study|Subject noncompliance|2
5494981|NCT01704079|19000006|P2|Overall Study|Protocol Violation|0
5494982|NCT01704079|19000007|P1|Overall Study|Protocol Violation|1
5494983|NCT01704079|19000006|P2|Overall Study|Adverse Event|7
5494984|NCT01704079|19000007|P1|Overall Study|Adverse Event|4
5494985|NCT01704079|19000006|P2|Overall Study|Lost to Follow-up|5
5494986|NCT01704079|19000007|P1|Overall Study|Lost to Follow-up|2
5494987|NCT01704079|19000006|P2|Overall Study|Withdrawal by Subject|7
5494988|NCT01704079|19000007|P1|Overall Study|Withdrawal by Subject|5
5494989|NCT01703988|19000023|P4|Overall Study|Investigator Judgment|1
5494990|NCT01703988|19000024|P3|Overall Study|Investigator Judgment|0
5494991|NCT01703988|19000025|P2|Overall Study|Investigator Judgment|0
5494992|NCT01703988|19000026|P1|Overall Study|Investigator Judgment|0
5494993|NCT01703858|19000056|P3|Overall Study|Withdrawal by Subject|0
5494994|NCT01703858|19000057|P2|Overall Study|Withdrawal by Subject|1
5494995|NCT01703858|19000058|P1|Overall Study|Withdrawal by Subject|0
5494996|NCT01703845|19000083|P2|Overall Study|other than stated above|0
5494997|NCT01703845|19000084|P1|Overall Study|other than stated above|1
5494998|NCT01703845|19000083|P2|Overall Study|Protocol Violation|0
5494999|NCT01703845|19000084|P1|Overall Study|Protocol Violation|1
5495000|NCT01703845|19000083|P2|Overall Study|Adverse Event|0
5495001|NCT01703845|19000084|P1|Overall Study|Adverse Event|1
5495002|NCT01703832|19000121|P2|Overall Study|Withdrawal by Subject|0
5495003|NCT01703832|19000122|P1|Overall Study|Withdrawal by Subject|1
5495004|NCT01703819|19000154|P2|Overall Study|Withdrawal by Subject|1
5495005|NCT01703819|19000155|P1|Overall Study|Withdrawal by Subject|0
5495006|NCT01703819|19000154|P2|Overall Study|Adverse Event|1
5495007|NCT01703819|19000155|P1|Overall Study|Adverse Event|0
5495008|NCT01703741|19000185|P1|Overall Study|Subject started testosterone injections|1
5495009|NCT01703741|19000185|P1|Overall Study|Subject cannot comply with study visits|1
5495010|NCT01703741|19000185|P1|Overall Study|Subject did not want to continue|2
5495011|NCT01703741|19000185|P1|Overall Study|Lost to Follow-up|3
5495012|NCT01703741|19000185|P1|Overall Study|Protocol Violation|1
5495013|NCT01703741|19000185|P1|Overall Study|Physician Decision|2
5495014|NCT01703741|19000185|P1|Overall Study|Adverse Event|2
5495015|NCT01703741|19000185|P1|Overall Study|Withdrawal by Subject|6
5495016|NCT01703286|19000251|P6|Period 2 Including Washout|Adverse Event|0
5495017|NCT01703286|19000252|P5|Period 2 Including Washout|Adverse Event|0
5495018|NCT01703286|19000253|P4|Period 2 Including Washout|Adverse Event|1
5495019|NCT01703286|19000254|P3|Period 2 Including Washout|Adverse Event|0
5495020|NCT01703286|19000255|P2|Period 2 Including Washout|Adverse Event|0
5495021|NCT01703286|19000256|P1|Period 2 Including Washout|Adverse Event|0
5495022|NCT01703286|19000251|P6|Period 1 Including Washout|Withdrawal by Subject|1
5495023|NCT01703286|19000252|P5|Period 1 Including Washout|Withdrawal by Subject|0
5495024|NCT01703286|19000253|P4|Period 1 Including Washout|Withdrawal by Subject|1
5495025|NCT01703286|19000254|P3|Period 1 Including Washout|Withdrawal by Subject|0
5495026|NCT01703286|19000255|P2|Period 1 Including Washout|Withdrawal by Subject|0
5495027|NCT01703286|19000256|P1|Period 1 Including Washout|Withdrawal by Subject|0
5495028|NCT01703260|19000279|P3|Overall Study|Study Termination|0
5495029|NCT01703260|19000280|P2|Overall Study|Study Termination|2
5495030|NCT01703260|19000281|P1|Overall Study|Study Termination|1
5495031|NCT01703260|19000279|P3|Overall Study|Withdrawal by Subject|1
5495032|NCT01703260|19000280|P2|Overall Study|Withdrawal by Subject|0
5495033|NCT01703260|19000281|P1|Overall Study|Withdrawal by Subject|0
5495034|NCT01703260|19000279|P3|Overall Study|Lost to Follow-up|0
5495035|NCT01703260|19000280|P2|Overall Study|Lost to Follow-up|0
5495036|NCT01703260|19000281|P1|Overall Study|Lost to Follow-up|1
5495037|NCT01703260|19000279|P3|Overall Study|Adverse Event|2
5495038|NCT01703260|19000280|P2|Overall Study|Adverse Event|2
5495039|NCT01703260|19000281|P1|Overall Study|Adverse Event|1
5495040|NCT01703221|19000307|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
5495041|NCT01703221|19000308|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
5495042|NCT01703221|19000309|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
5495043|NCT01703221|19000307|P3|Phase B - (Week 25 to 52)|Adverse Event|2
5495044|NCT01703221|19000308|P2|Phase B - (Week 25 to 52)|Adverse Event|3
5495045|NCT01703221|19000309|P1|Phase B - (Week 25 to 52)|Adverse Event|2
5495046|NCT01703221|19000307|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
5495047|NCT01703221|19000308|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
5495048|NCT01703221|19000309|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
5495049|NCT01703221|19000307|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
5495050|NCT01703221|19000308|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495051|NCT01703221|19000309|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495052|NCT01703221|19000307|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5495053|NCT01703221|19000308|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5495054|NCT01703221|19000309|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
5495055|NCT01703221|19000307|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
5495056|NCT01703221|19000308|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
5495057|NCT01703221|19000309|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
5495058|NCT01703221|19000307|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
5495059|NCT01703221|19000308|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
5495060|NCT01703221|19000309|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
5495061|NCT01703221|19000307|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
5495062|NCT01703221|19000308|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
5495063|NCT01703221|19000309|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
5495064|NCT01703208|19000340|P2|Overall Study|Protocol Deviation|0
5495065|NCT01703208|19000341|P1|Overall Study|Protocol Deviation|2
5495066|NCT01703208|19000340|P2|Overall Study|Technical Problems|1
5495067|NCT01703208|19000341|P1|Overall Study|Technical Problems|0
5495068|NCT01703208|19000340|P2|Overall Study|Adverse Event|19
5495069|NCT01703208|19000341|P1|Overall Study|Adverse Event|14
5495070|NCT01703208|19000340|P2|Overall Study|Withdrawal by Subject|209
5495071|NCT01703208|19000341|P1|Overall Study|Withdrawal by Subject|205
5495072|NCT01703208|19000340|P2|Overall Study|Study Terminated by Sponsor|1716
5495073|NCT01703208|19000341|P1|Overall Study|Study Terminated by Sponsor|1710
5495074|NCT01703208|19000340|P2|Overall Study|Protocol Violation|1
5495075|NCT01703208|19000341|P1|Overall Study|Protocol Violation|1
5495076|NCT01703208|19000340|P2|Overall Study|Progressive disease|2
5495077|NCT01703208|19000341|P1|Overall Study|Progressive disease|2
5495078|NCT01703208|19000340|P2|Overall Study|Physician Decision|13
5495079|NCT01703208|19000341|P1|Overall Study|Physician Decision|11
5495080|NCT01703208|19000340|P2|Overall Study|Site Discontinued Study Participation|27
5495081|NCT01703208|19000341|P1|Overall Study|Site Discontinued Study Participation|23
5495082|NCT01703208|19000340|P2|Overall Study|Excluded Medication|2
5495083|NCT01703208|19000341|P1|Overall Study|Excluded Medication|1
5495084|NCT01703208|19000340|P2|Overall Study|Non-Compliance with Study Drug|0
5495085|NCT01703208|19000341|P1|Overall Study|Non-Compliance with Study Drug|1
5495086|NCT01703208|19000340|P2|Overall Study|Lost to Follow-up|62
5495087|NCT01703208|19000341|P1|Overall Study|Lost to Follow-up|68
5495088|NCT01703208|19000340|P2|Overall Study|Lack of Efficacy|2
5495089|NCT01703208|19000341|P1|Overall Study|Lack of Efficacy|1
5495090|NCT01703208|19000340|P2|Overall Study|Death|48
5495091|NCT01703208|19000341|P1|Overall Study|Death|61
5495092|NCT01703091|19000405|P2|Overall Study|Sponsor Decision|0
5495093|NCT01703091|19000406|P1|Overall Study|Sponsor Decision|1
5495094|NCT01703091|19000405|P2|Overall Study|Withdrawal by Subject|0
5495095|NCT01703091|19000406|P1|Overall Study|Withdrawal by Subject|1
5495096|NCT01703091|19000405|P2|Overall Study|Physician Decision|1
5495097|NCT01703091|19000406|P1|Overall Study|Physician Decision|2
5495098|NCT01703091|19000405|P2|Overall Study|Adverse Event|3
5495099|NCT01703091|19000406|P1|Overall Study|Adverse Event|5
5495100|NCT01703065|19000424|P2|Overall Study|Lack of Efficacy|0
5495101|NCT01703065|19000425|P1|Overall Study|Lack of Efficacy|1
5495102|NCT01703000|19000455|P1|Overall Study|Death|1
5495103|NCT01702987|19000488|P2|Overall Study|Withdrawal by Subject|0
5495104|NCT01702987|19000489|P1|Overall Study|Withdrawal by Subject|1
5495105|NCT01702961|19000495|P1|Overall Study|Ongoing|11
5495106|NCT01702961|19000495|P1|Overall Study|Lost to Follow-up|2
5495107|NCT01702961|19000495|P1|Overall Study|Death|6
5495108|NCT01702961|19000495|P1|Overall Study|Relapse|20
5495109|NCT01702961|19000495|P1|Overall Study|Progressive disease|5
5495110|NCT01702961|19000495|P1|Overall Study|Additional treatment|3
5495111|NCT01702844|19000513|P1|Overall Study|Physician Decision|6
5495112|NCT01702844|19000513|P1|Overall Study|Withdrawal by Subject|3
5495113|NCT01702844|19000513|P1|Overall Study|Death|1
5495114|NCT01702844|19000513|P1|Overall Study|Adverse Event|9
5495115|NCT01702558|19000525|P5|Overall Study|Other|17
5495116|NCT01702558|19000526|P4|Overall Study|Other|16
5495117|NCT01702558|19000527|P3|Overall Study|Other|0
5495118|NCT01702558|19000528|P2|Overall Study|Other|0
5495119|NCT01702558|19000529|P1|Overall Study|Other|0
5495120|NCT01702558|19000525|P5|Overall Study|Study Terminated by Sponsor|1
5495121|NCT01702558|19000526|P4|Overall Study|Study Terminated by Sponsor|0
5495122|NCT01702558|19000527|P3|Overall Study|Study Terminated by Sponsor|0
5495123|NCT01702558|19000528|P2|Overall Study|Study Terminated by Sponsor|1
5495124|NCT01702558|19000529|P1|Overall Study|Study Terminated by Sponsor|0
5495125|NCT01702558|19000525|P5|Overall Study|Safety Follow-Up less than 3 Months|0
5495126|NCT01702558|19000526|P4|Overall Study|Safety Follow-Up less than 3 Months|0
5495127|NCT01702558|19000527|P3|Overall Study|Safety Follow-Up less than 3 Months|2
5495128|NCT01702558|19000528|P2|Overall Study|Safety Follow-Up less than 3 Months|0
5495129|NCT01702558|19000529|P1|Overall Study|Safety Follow-Up less than 3 Months|0
5495130|NCT01702558|19000525|P5|Overall Study|Death|20
5495131|NCT01702558|19000526|P4|Overall Study|Death|16
5495132|NCT01702558|19000527|P3|Overall Study|Death|3
5495133|NCT01702558|19000528|P2|Overall Study|Death|3
5495134|NCT01702558|19000529|P1|Overall Study|Death|4
5495135|NCT01702558|19000525|P5|Overall Study|Lost to Follow-up|0
5495136|NCT01702558|19000526|P4|Overall Study|Lost to Follow-up|3
5495137|NCT01702558|19000527|P3|Overall Study|Lost to Follow-up|0
5495138|NCT01702558|19000528|P2|Overall Study|Lost to Follow-up|0
5495139|NCT01702558|19000529|P1|Overall Study|Lost to Follow-up|0
5495140|NCT01702558|19000525|P5|Overall Study|Withdrawal by Subject|4
5495141|NCT01702558|19000526|P4|Overall Study|Withdrawal by Subject|12
5495142|NCT01702558|19000527|P3|Overall Study|Withdrawal by Subject|0
5495143|NCT01702558|19000528|P2|Overall Study|Withdrawal by Subject|0
5495144|NCT01702558|19000529|P1|Overall Study|Withdrawal by Subject|0
5495145|NCT01702532|19000594|P2|Overall Study|Adverse Event|1
5495146|NCT01702532|19000595|P1|Overall Study|Adverse Event|0
5495147|NCT01702519|19000605|P2|Washout Period|Withdrawal by Subject|2
5495148|NCT01702519|19000606|P1|Washout Period|Withdrawal by Subject|0
5495149|NCT01702519|19000605|P2|Washout Period|Lost to Follow-up|0
5495150|NCT01702519|19000606|P1|Washout Period|Lost to Follow-up|1
5495151|NCT01702454|19000624|P2|Overall Study|Lost to Follow-up|6
5495152|NCT01702454|19000625|P1|Overall Study|Lost to Follow-up|3
5495153|NCT01702454|19000624|P2|Overall Study|Migrated/moved from study area|1
5495154|NCT01702454|19000625|P1|Overall Study|Migrated/moved from study area|0
5495155|NCT01702454|19000624|P2|Overall Study|Consent withdrawal|1
5495156|NCT01702454|19000625|P1|Overall Study|Consent withdrawal|0
5495157|NCT01702428|19000707|P4|Overall Study|Withdrawal by Subject|10
5495158|NCT01702428|19000708|P3|Overall Study|Withdrawal by Subject|14
5495159|NCT01702428|19000709|P2|Overall Study|Withdrawal by Subject|23
5495160|NCT01702428|19000710|P1|Overall Study|Withdrawal by Subject|21
5495161|NCT01702428|19000707|P4|Overall Study|Protocol Violation|0
5495162|NCT01702428|19000708|P3|Overall Study|Protocol Violation|1
5495163|NCT01702428|19000709|P2|Overall Study|Protocol Violation|0
5495164|NCT01702428|19000710|P1|Overall Study|Protocol Violation|3
5495165|NCT01702428|19000707|P4|Overall Study|Parents too busy|0
5495166|NCT01702428|19000708|P3|Overall Study|Parents too busy|0
5495167|NCT01702428|19000709|P2|Overall Study|Parents too busy|0
5495168|NCT01702428|19000710|P1|Overall Study|Parents too busy|1
5495169|NCT01702428|19000707|P4|Overall Study|Mother transferred care|0
5495170|NCT01702428|19000708|P3|Overall Study|Mother transferred care|0
5495171|NCT01702428|19000709|P2|Overall Study|Mother transferred care|1
5495172|NCT01702428|19000710|P1|Overall Study|Mother transferred care|0
5495173|NCT01702428|19000707|P4|Overall Study|Lost Health Plan|2
5495174|NCT01702428|19000708|P3|Overall Study|Lost Health Plan|0
5495175|NCT01702428|19000709|P2|Overall Study|Lost Health Plan|5
5495176|NCT01702428|19000710|P1|Overall Study|Lost Health Plan|3
5495177|NCT01702428|19000707|P4|Overall Study|Lost Coverage|1
5495178|NCT01702428|19000708|P3|Overall Study|Lost Coverage|0
5495179|NCT01702428|19000709|P2|Overall Study|Lost Coverage|0
5495180|NCT01702428|19000710|P1|Overall Study|Lost Coverage|0
5495181|NCT01702428|19000707|P4|Overall Study|Parents cannot assist to site|0
5495182|NCT01702428|19000708|P3|Overall Study|Parents cannot assist to site|1
5495183|NCT01702428|19000709|P2|Overall Study|Parents cannot assist to site|0
5495184|NCT01702428|19000710|P1|Overall Study|Parents cannot assist to site|1
5495185|NCT01702428|19000707|P4|Overall Study|Lost to Follow-up|44
5495186|NCT01702428|19000708|P3|Overall Study|Lost to Follow-up|37
5495187|NCT01702428|19000709|P2|Overall Study|Lost to Follow-up|41
5495188|NCT01702428|19000710|P1|Overall Study|Lost to Follow-up|33
5495189|NCT01702428|19000707|P4|Overall Study|Adverse Event|0
5495190|NCT01702428|19000708|P3|Overall Study|Adverse Event|0
5495191|NCT01702428|19000709|P2|Overall Study|Adverse Event|0
5495192|NCT01702428|19000710|P1|Overall Study|Adverse Event|2
5495193|NCT01702363|19000797|P1|Overall Study|Withdrawal by Subject|2
5495194|NCT01702363|19000797|P1|Overall Study|Lack of Efficacy|4
5495195|NCT01702363|19000797|P1|Overall Study|Adverse Event|14
5495196|NCT01702311|19000814|P2|Overall Study|Physician Decision|4
5495197|NCT01702311|19000815|P1|Overall Study|Physician Decision|3
5495198|NCT01702311|19000814|P2|Overall Study|Discharge less than 24 hours|7
5495199|NCT01702311|19000815|P1|Overall Study|Discharge less than 24 hours|10
5495200|NCT01702311|19000814|P2|Overall Study|Withdrawal by Subject|2
5495201|NCT01702311|19000815|P1|Overall Study|Withdrawal by Subject|3
5495202|NCT01702298|19000845|P1|Overall Study|Withdrawal by Subject|1
5495203|NCT01702246|19000873|P1|Overall Study|Physician Decision|1
5495204|NCT01702246|19000873|P1|Overall Study|Withdrawal by Subject|2
5495205|NCT01702246|19000873|P1|Overall Study|Lost to Follow-up|2
5495206|NCT01702025|19000927|P4|Overall Study|Adverse Event|0
5495207|NCT01702025|19000928|P3|Overall Study|Adverse Event|1
5495208|NCT01702025|19000929|P2|Overall Study|Adverse Event|1
5495209|NCT01702025|19000930|P1|Overall Study|Adverse Event|1
5495210|NCT01702025|19000927|P4|Overall Study|Equipment failure|0
5495211|NCT01702025|19000928|P3|Overall Study|Equipment failure|0
5495212|NCT01702025|19000929|P2|Overall Study|Equipment failure|0
5495213|NCT01702025|19000930|P1|Overall Study|Equipment failure|1
5495214|NCT01701973|19000959|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
5495215|NCT01701973|19000960|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
5495216|NCT01701973|19000961|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
5495217|NCT01701973|19000962|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
5495218|NCT01701973|19000963|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
5495219|NCT01701973|19000964|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
5495220|NCT01701973|19000965|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
5495221|NCT01701973|19000966|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
5495222|NCT01701674|19001013|P1|Overall Study|Unable to safely complete treatment|1
5495223|NCT01701583|19001027|P2|Overall Study|Withdrawal by Subject|0
5495224|NCT01701583|19001028|P1|Overall Study|Withdrawal by Subject|2
5495225|NCT01701401|19001111|P4|Overall Study|Protocol Violation|0
5495226|NCT01701401|19001112|P3|Overall Study|Protocol Violation|1
5495227|NCT01701401|19001113|P2|Overall Study|Protocol Violation|0
5495228|NCT01701401|19001114|P1|Overall Study|Protocol Violation|0
5495229|NCT01701401|19001111|P4|Overall Study|Adverse Event|0
5495230|NCT01701401|19001112|P3|Overall Study|Adverse Event|0
5495231|NCT01701401|19001113|P2|Overall Study|Adverse Event|0
5495232|NCT01701401|19001114|P1|Overall Study|Adverse Event|1
5495233|NCT01701401|19001111|P4|Overall Study|Lack of Efficacy|0
5495234|NCT01701401|19001112|P3|Overall Study|Lack of Efficacy|2
5495235|NCT01701401|19001113|P2|Overall Study|Lack of Efficacy|0
5495236|NCT01701401|19001114|P1|Overall Study|Lack of Efficacy|1
5495237|NCT01701401|19001111|P4|Overall Study|Withdrew Consent|2
5495238|NCT01701401|19001112|P3|Overall Study|Withdrew Consent|1
5495239|NCT01701401|19001113|P2|Overall Study|Withdrew Consent|3
5495240|NCT01701401|19001114|P1|Overall Study|Withdrew Consent|0
5495241|NCT01701401|19001111|P4|Overall Study|Lost to Follow-up|3
5495242|NCT01701401|19001112|P3|Overall Study|Lost to Follow-up|1
5495243|NCT01701401|19001113|P2|Overall Study|Lost to Follow-up|5
5495244|NCT01701401|19001114|P1|Overall Study|Lost to Follow-up|5
5495245|NCT01701401|19001111|P4|Overall Study|Randomized But Not Treated|1
5495246|NCT01701401|19001112|P3|Overall Study|Randomized But Not Treated|0
5495247|NCT01701401|19001113|P2|Overall Study|Randomized But Not Treated|1
5495248|NCT01701401|19001114|P1|Overall Study|Randomized But Not Treated|3
5495249|NCT01701362|19001166|P2|Overall Study|Reasons other than those mentioned above|5
5495250|NCT01701362|19001167|P1|Overall Study|Reasons other than those mentioned above|3
5495251|NCT01701362|19001166|P2|Overall Study|Randomized but not treated|2
5495252|NCT01701362|19001167|P1|Overall Study|Randomized but not treated|1
5495253|NCT01701362|19001166|P2|Overall Study|Death|1
5495254|NCT01701362|19001167|P1|Overall Study|Death|0
5495255|NCT01701362|19001166|P2|Overall Study|Insufficient clinical response|6
5495256|NCT01701362|19001167|P1|Overall Study|Insufficient clinical response|6
5495257|NCT01701362|19001166|P2|Overall Study|Lost to Follow-up|9
5495258|NCT01701362|19001167|P1|Overall Study|Lost to Follow-up|6
5495259|NCT01701362|19001166|P2|Overall Study|No longer willing to participate|14
5495260|NCT01701362|19001167|P1|Overall Study|No longer willing to participate|8
5495261|NCT01701362|19001166|P2|Overall Study|Protocol Violation|3
5495262|NCT01701362|19001167|P1|Overall Study|Protocol Violation|5
5495263|NCT01701362|19001166|P2|Overall Study|Adverse events related to study drug|10
5495264|NCT01701362|19001167|P1|Overall Study|Adverse events related to study drug|12
5495265|NCT01701362|19001166|P2|Overall Study|Adverse events not related to study drug|6
5495266|NCT01701362|19001167|P1|Overall Study|Adverse events not related to study drug|1
5495267|NCT01701258|19001205|P13|Assessment and Scheduling|Investigator Terminated|0
5495268|NCT01701258|19001206|P12|Assessment and Scheduling|Investigator Terminated|0
5495269|NCT01701258|19001207|P11|Assessment and Scheduling|Investigator Terminated|0
5495270|NCT01701258|19001208|P10|Assessment and Scheduling|Investigator Terminated|0
5495271|NCT01701258|19001209|P9|Assessment and Scheduling|Investigator Terminated|0
5495272|NCT01701258|19001210|P8|Assessment and Scheduling|Investigator Terminated|0
5495273|NCT01701258|19001211|P7|Assessment and Scheduling|Investigator Terminated|0
5495274|NCT01701258|19001212|P6|Assessment and Scheduling|Investigator Terminated|0
5495275|NCT01701258|19001213|P5|Assessment and Scheduling|Investigator Terminated|0
5495276|NCT01701258|19001214|P4|Assessment and Scheduling|Investigator Terminated|0
5495277|NCT01701258|19001215|P3|Assessment and Scheduling|Investigator Terminated|0
5495278|NCT01701258|19001216|P2|Assessment and Scheduling|Investigator Terminated|0
5495279|NCT01701258|19001217|P1|Assessment and Scheduling|Investigator Terminated|2
5495280|NCT01701258|19001205|P13|Assessment and Scheduling|Withdrawal by Subject|0
5495281|NCT01701258|19001206|P12|Assessment and Scheduling|Withdrawal by Subject|0
5495282|NCT01701258|19001207|P11|Assessment and Scheduling|Withdrawal by Subject|0
5495283|NCT01701258|19001208|P10|Assessment and Scheduling|Withdrawal by Subject|0
5495284|NCT01701258|19001209|P9|Assessment and Scheduling|Withdrawal by Subject|0
5495285|NCT01701258|19001210|P8|Assessment and Scheduling|Withdrawal by Subject|0
5495286|NCT01701258|19001211|P7|Assessment and Scheduling|Withdrawal by Subject|0
5495287|NCT01701258|19001212|P6|Assessment and Scheduling|Withdrawal by Subject|0
5495288|NCT01701258|19001213|P5|Assessment and Scheduling|Withdrawal by Subject|0
5495289|NCT01701258|19001214|P4|Assessment and Scheduling|Withdrawal by Subject|0
5495290|NCT01701258|19001215|P3|Assessment and Scheduling|Withdrawal by Subject|0
5495291|NCT01701258|19001216|P2|Assessment and Scheduling|Withdrawal by Subject|0
5495292|NCT01701258|19001217|P1|Assessment and Scheduling|Withdrawal by Subject|14
5495293|NCT01701258|19001205|P13|Assessment and Scheduling|Lost to Follow-up|0
5495294|NCT01701258|19001206|P12|Assessment and Scheduling|Lost to Follow-up|0
5495295|NCT01701258|19001207|P11|Assessment and Scheduling|Lost to Follow-up|0
5495296|NCT01701258|19001208|P10|Assessment and Scheduling|Lost to Follow-up|0
5495297|NCT01701258|19001209|P9|Assessment and Scheduling|Lost to Follow-up|0
5495298|NCT01701258|19001210|P8|Assessment and Scheduling|Lost to Follow-up|0
5495299|NCT01701258|19001211|P7|Assessment and Scheduling|Lost to Follow-up|0
5495300|NCT01701258|19001212|P6|Assessment and Scheduling|Lost to Follow-up|0
5495301|NCT01701258|19001213|P5|Assessment and Scheduling|Lost to Follow-up|0
5495302|NCT01701258|19001214|P4|Assessment and Scheduling|Lost to Follow-up|0
5495303|NCT01701258|19001215|P3|Assessment and Scheduling|Lost to Follow-up|0
5495304|NCT01701258|19001216|P2|Assessment and Scheduling|Lost to Follow-up|0
5495305|NCT01701258|19001217|P1|Assessment and Scheduling|Lost to Follow-up|10
5495306|NCT01701258|19001205|P13|Assessment and Scheduling|Found to be Ineligible|0
5495307|NCT01701258|19001206|P12|Assessment and Scheduling|Found to be Ineligible|0
5495308|NCT01701258|19001207|P11|Assessment and Scheduling|Found to be Ineligible|0
5495309|NCT01701258|19001208|P10|Assessment and Scheduling|Found to be Ineligible|0
5495310|NCT01701258|19001209|P9|Assessment and Scheduling|Found to be Ineligible|0
5495311|NCT01701258|19001210|P8|Assessment and Scheduling|Found to be Ineligible|0
5495312|NCT01701258|19001211|P7|Assessment and Scheduling|Found to be Ineligible|0
5495313|NCT01701258|19001212|P6|Assessment and Scheduling|Found to be Ineligible|0
5495314|NCT01701258|19001213|P5|Assessment and Scheduling|Found to be Ineligible|0
5495315|NCT01701258|19001214|P4|Assessment and Scheduling|Found to be Ineligible|0
5495316|NCT01701258|19001215|P3|Assessment and Scheduling|Found to be Ineligible|0
5495317|NCT01701258|19001216|P2|Assessment and Scheduling|Found to be Ineligible|0
5495318|NCT01701258|19001217|P1|Assessment and Scheduling|Found to be Ineligible|57
5495319|NCT01701245|19001271|P2|Overall Study|Did not complete the open label period|12
5495320|NCT01701245|19001272|P1|Overall Study|Did not complete the open label period|11
5495321|NCT01701245|19001271|P2|Overall Study|Protocol Violation|3
5495322|NCT01701245|19001272|P1|Overall Study|Protocol Violation|1
5495323|NCT01701063|19001319|P3|Overall Study|Other|1
5495324|NCT01701063|19001320|P2|Overall Study|Other|0
5495325|NCT01701063|19001321|P1|Overall Study|Other|0
5495326|NCT01701063|19001319|P3|Overall Study|Withdrawal by Subject|1
5495327|NCT01701063|19001320|P2|Overall Study|Withdrawal by Subject|0
5495328|NCT01701063|19001321|P1|Overall Study|Withdrawal by Subject|0
5495329|NCT01701063|19001319|P3|Overall Study|Lost to Follow-up|0
5495330|NCT01701063|19001320|P2|Overall Study|Lost to Follow-up|1
5495331|NCT01701063|19001321|P1|Overall Study|Lost to Follow-up|0
5495332|NCT01700985|19001405|P2|Overall Study|Incarcerated|1
5495333|NCT01700985|19001406|P1|Overall Study|Incarcerated|0
5495334|NCT01700959|19001428|P6|Overall Study|Side effects|1
5495335|NCT01700959|19001429|P5|Overall Study|Side effects|4
5495336|NCT01700959|19001430|P4|Overall Study|Side effects|4
5495337|NCT01700959|19001431|P3|Overall Study|Side effects|8
5495338|NCT01700959|19001432|P2|Overall Study|Side effects|4
5495339|NCT01700959|19001433|P1|Overall Study|Side effects|1
5495340|NCT01700959|19001428|P6|Overall Study|Noncompliant|9
5495341|NCT01700959|19001429|P5|Overall Study|Noncompliant|15
5495342|NCT01700959|19001430|P4|Overall Study|Noncompliant|18
5495343|NCT01700959|19001431|P3|Overall Study|Noncompliant|17
5495344|NCT01700959|19001432|P2|Overall Study|Noncompliant|9
5495345|NCT01700959|19001433|P1|Overall Study|Noncompliant|9
5495346|NCT01700959|19001428|P6|Overall Study|Ineligible|1
5495347|NCT01700959|19001429|P5|Overall Study|Ineligible|0
5495348|NCT01700959|19001430|P4|Overall Study|Ineligible|0
5495349|NCT01700959|19001431|P3|Overall Study|Ineligible|2
5495350|NCT01700959|19001432|P2|Overall Study|Ineligible|1
5495351|NCT01700959|19001433|P1|Overall Study|Ineligible|2
5495352|NCT01700959|19001428|P6|Overall Study|Withdrawal by Subject|12
5495353|NCT01700959|19001429|P5|Overall Study|Withdrawal by Subject|8
5495354|NCT01700959|19001430|P4|Overall Study|Withdrawal by Subject|11
5495355|NCT01700959|19001431|P3|Overall Study|Withdrawal by Subject|12
5495356|NCT01700959|19001432|P2|Overall Study|Withdrawal by Subject|9
5495357|NCT01700959|19001433|P1|Overall Study|Withdrawal by Subject|15
5495358|NCT01700959|19001428|P6|Overall Study|Adverse Event|2
5495359|NCT01700959|19001429|P5|Overall Study|Adverse Event|0
5495360|NCT01700959|19001430|P4|Overall Study|Adverse Event|2
5495361|NCT01700959|19001431|P3|Overall Study|Adverse Event|1
5495362|NCT01700959|19001432|P2|Overall Study|Adverse Event|1
5495363|NCT01700959|19001433|P1|Overall Study|Adverse Event|0
5495364|NCT01700829|19001474|P2|Overall Study|Withdrawal by Subject|1
5495365|NCT01700829|19001475|P1|Overall Study|Withdrawal by Subject|1
5495366|NCT01700621|19001535|P2|Analyzed for Immunogenicity|Baseline measles measure high|2
5495367|NCT01700621|19001536|P1|Analyzed for Immunogenicity|Baseline measles measure high|1
5495368|NCT01700621|19001535|P2|Analyzed for Immunogenicity|Protocol Violation|1
5495369|NCT01700621|19001536|P1|Analyzed for Immunogenicity|Protocol Violation|5
5495370|NCT01700621|19001535|P2|Analyzed for Immunogenicity|Lost to Follow-up|4
5495371|NCT01700621|19001536|P1|Analyzed for Immunogenicity|Lost to Follow-up|7
5495372|NCT01700530|19001574|P3|Overall Study|Withdrawal by Subject|1
5495373|NCT01700530|19001575|P2|Overall Study|Withdrawal by Subject|3
5495374|NCT01700530|19001576|P1|Overall Study|Withdrawal by Subject|0
5495375|NCT01700387|19001625|P2|Overall Study|Lost to Follow-up|1
5495376|NCT01700387|19001626|P1|Overall Study|Lost to Follow-up|2
5495377|NCT01700387|19001625|P2|Overall Study|Adverse Event|1
5495378|NCT01700387|19001626|P1|Overall Study|Adverse Event|1
5495379|NCT01700387|19001625|P2|Overall Study|Withdrawal by Subject|2
5495380|NCT01700387|19001626|P1|Overall Study|Withdrawal by Subject|1
5495381|NCT01700348|19001656|P1|Overall Study|Lost to Follow-up|1
5495382|NCT01700348|19001656|P1|Overall Study|Withdrawal by Subject|22
5495383|NCT01700205|19001679|P2|Overall Study|Protocol Violation|2
5495384|NCT01700205|19001680|P1|Overall Study|Protocol Violation|2
5495385|NCT01700205|19001679|P2|Overall Study|Withdrawal by Subject|13
5495386|NCT01700205|19001680|P1|Overall Study|Withdrawal by Subject|13
5495387|NCT01700192|19001702|P2|Overall Study|Never received study drug|0
5495388|NCT01700192|19001703|P1|Overall Study|Never received study drug|1
5495389|NCT01700192|19001702|P2|Overall Study|Withdrawal by Subject|64
5495390|NCT01700192|19001703|P1|Overall Study|Withdrawal by Subject|56
5495391|NCT01700192|19001702|P2|Overall Study|Technical problems|1
5495392|NCT01700192|19001703|P1|Overall Study|Technical problems|0
5495393|NCT01700192|19001702|P2|Overall Study|Protocol Violation|4
5495394|NCT01700192|19001703|P1|Overall Study|Protocol Violation|3
5495395|NCT01700192|19001702|P2|Overall Study|Progressive disease|0
5495396|NCT01700192|19001703|P1|Overall Study|Progressive disease|1
5495397|NCT01700192|19001702|P2|Overall Study|Pregnancy|4
5495398|NCT01700192|19001703|P1|Overall Study|Pregnancy|1
5495399|NCT01700192|19001702|P2|Overall Study|Physician Decision|3
5495400|NCT01700192|19001703|P1|Overall Study|Physician Decision|2
5495401|NCT01700192|19001702|P2|Overall Study|Noncompliance with study drug|5
5495402|NCT01700192|19001703|P1|Overall Study|Noncompliance with study drug|0
5495403|NCT01700192|19001702|P2|Overall Study|Lost to Follow-up|29
5495404|NCT01700192|19001703|P1|Overall Study|Lost to Follow-up|42
5495405|NCT01700192|19001702|P2|Overall Study|Lack of Efficacy|0
5495406|NCT01700192|19001703|P1|Overall Study|Lack of Efficacy|1
5495407|NCT01700192|19001702|P2|Overall Study|Adverse Event|18
5495408|NCT01700192|19001703|P1|Overall Study|Adverse Event|73
5495409|NCT01700179|19001721|P1|Overall Study|Physician Decision|2
5495410|NCT01700140|19001728|P3|Overall Study|Inclusion/exclusion criteria deviation|0
5495411|NCT01700140|19001729|P2|Overall Study|Inclusion/exclusion criteria deviation|4
5495412|NCT01700140|19001730|P1|Overall Study|Inclusion/exclusion criteria deviation|1
5495413|NCT01700140|19001728|P3|Overall Study|Adverse Event|0
5495414|NCT01700140|19001729|P2|Overall Study|Adverse Event|1
5495415|NCT01700140|19001730|P1|Overall Study|Adverse Event|0
5495416|NCT01700140|19001728|P3|Overall Study|Aggravation of symptoms|0
5495417|NCT01700140|19001729|P2|Overall Study|Aggravation of symptoms|0
5495418|NCT01700140|19001730|P1|Overall Study|Aggravation of symptoms|1
5495419|NCT01700140|19001728|P3|Overall Study|Use of chemotherapy or surgical therapy|0
5495420|NCT01700140|19001729|P2|Overall Study|Use of chemotherapy or surgical therapy|1
5495421|NCT01700140|19001730|P1|Overall Study|Use of chemotherapy or surgical therapy|0
5495422|NCT01700140|19001728|P3|Overall Study|Discontinuation of radiotherapy|0
5495423|NCT01700140|19001729|P2|Overall Study|Discontinuation of radiotherapy|0
5495424|NCT01700140|19001730|P1|Overall Study|Discontinuation of radiotherapy|1
5495425|NCT01700140|19001728|P3|Overall Study|Use of rescue drugs|1
5495426|NCT01700140|19001729|P2|Overall Study|Use of rescue drugs|3
5495427|NCT01700140|19001730|P1|Overall Study|Use of rescue drugs|3
5495428|NCT01700049|19001762|P1|Overall Study|Withdrawal by Subject|1
5495429|NCT01699867|19001777|P1|Overall Study|Screening Failure|3
5495430|NCT01699815|19001784|P2|Overall Study|Adverse Event|1
5495431|NCT01699815|19001785|P1|Overall Study|Adverse Event|0
5495432|NCT01699815|19001784|P2|Overall Study|record could not be located|0
5495433|NCT01699815|19001785|P1|Overall Study|record could not be located|1
5495434|NCT01699815|19001784|P2|Overall Study|Protocol Violation|7
5495435|NCT01699815|19001785|P1|Overall Study|Protocol Violation|4
5495436|NCT01699789|19001797|P2|Overall Study|Lost to Follow-up|101
5495437|NCT01699789|19001798|P1|Overall Study|Lost to Follow-up|83
5495438|NCT01699789|19001797|P2|Overall Study|Death|2
5495439|NCT01699789|19001798|P1|Overall Study|Death|1
5495440|NCT01699789|19001797|P2|Overall Study|Withdrawal by Subject|23
5495441|NCT01699789|19001798|P1|Overall Study|Withdrawal by Subject|18
5495442|NCT01699750|19001868|P2|Overall Study|Other|2
5495443|NCT01699750|19001869|P1|Overall Study|Other|0
5495444|NCT01699750|19001868|P2|Overall Study|Withdrew Consent|1
5495445|NCT01699750|19001869|P1|Overall Study|Withdrew Consent|0
5495446|NCT01699685|19001904|P2|Period 2|Lost to Follow-up|0
5495447|NCT01699685|19001905|P1|Period 2|Lost to Follow-up|1
5495448|NCT01699685|19001904|P2|Period 1|Patient request|1
5495449|NCT01699685|19001905|P1|Period 1|Patient request|0
5495450|NCT01699685|19001904|P2|Period 1|Other|1
5495451|NCT01699685|19001905|P1|Period 1|Other|0
5495452|NCT01699685|19001904|P2|Period 1|Medical or ethical, noncompliance|0
5495453|NCT01699685|19001905|P1|Period 1|Medical or ethical, noncompliance|2
5495454|NCT01699685|19001904|P2|Period 1|Adverse Event|1
5495455|NCT01699685|19001905|P1|Period 1|Adverse Event|1
5495456|NCT01699503|19001931|P2|Overall Study|Excluded due to quality|791
5495457|NCT01699503|19001932|P1|Overall Study|Excluded due to quality|783
5495458|NCT01699503|19001931|P2|Overall Study|Lost to Follow-up|117
5495459|NCT01699503|19001932|P1|Overall Study|Lost to Follow-up|121
5495460|NCT01699503|19001931|P2|Overall Study|Withdrawal by Subject|57
5495461|NCT01699503|19001932|P1|Overall Study|Withdrawal by Subject|65
5495462|NCT01699503|19001931|P2|Overall Study|Death|40
5495463|NCT01699503|19001932|P1|Overall Study|Death|31
5495464|NCT01699178|19001957|P2|Overall Study|ineligible/noncompliant/ subject reason|4
5495465|NCT01699178|19001958|P1|Overall Study|ineligible/noncompliant/ subject reason|4
5495466|NCT01699178|19001957|P2|Overall Study|PSA increase of >1.4 ng/mL|3
5495467|NCT01699178|19001958|P1|Overall Study|PSA increase of >1.4 ng/mL|4
5495468|NCT01699178|19001957|P2|Overall Study|Hematocrit >54%|1
5495469|NCT01699178|19001958|P1|Overall Study|Hematocrit >54%|1
5495470|NCT01699178|19001957|P2|Overall Study|Withdrawal by Subject|12
5495471|NCT01699178|19001958|P1|Overall Study|Withdrawal by Subject|4
5495472|NCT01699178|19001957|P2|Overall Study|Physician Decision|0
5495473|NCT01699178|19001958|P1|Overall Study|Physician Decision|1
5495474|NCT01699178|19001957|P2|Overall Study|Non-compliance with Study Drug|1
5495475|NCT01699178|19001958|P1|Overall Study|Non-compliance with Study Drug|3
5495476|NCT01699178|19001957|P2|Overall Study|Lost to Follow-up|6
5495477|NCT01699178|19001958|P1|Overall Study|Lost to Follow-up|1
5495478|NCT01699178|19001957|P2|Overall Study|Adverse Event|5
5495479|NCT01699178|19001958|P1|Overall Study|Adverse Event|1
5495480|NCT01699087|19001974|P1|Overall Study|Unable to make future visits|2
5495481|NCT01699087|19001974|P1|Overall Study|Screen failure (prior to treatment)|15
5495482|NCT01699087|19001974|P1|Overall Study|Lost to Follow-up|7
5495483|NCT01699022|19001988|P1|Overall Study|Early discontinuation from the study|3
5495484|NCT01698814|19002003|P2|Overall Study|Randomized in error|0
5495485|NCT01698814|19002004|P1|Overall Study|Randomized in error|1
5495486|NCT01698814|19002003|P2|Overall Study|Pregnancy|0
5495487|NCT01698814|19002004|P1|Overall Study|Pregnancy|1
5495488|NCT01698814|19002003|P2|Overall Study|Lost to Follow-up|1
5495489|NCT01698814|19002004|P1|Overall Study|Lost to Follow-up|0
5495490|NCT01698814|19002003|P2|Overall Study|Adverse Event|2
5495491|NCT01698814|19002004|P1|Overall Study|Adverse Event|0
5495492|NCT01698801|19002010|P1|Follow Up Phase|Death|4
5495493|NCT01698801|19002010|P1|Follow Up Phase|Withdrawal by Subject|1
5495494|NCT01698801|19002010|P1|Treatment Phase|Disease progression|1
5495495|NCT01698801|19002010|P1|Treatment Phase|Withdrawal by Subject|1
5495496|NCT01698801|19002010|P1|Treatment Phase|Other|4
5495497|NCT01698801|19002010|P1|Treatment Phase|Protocol Violation|1
5495498|NCT01698801|19002010|P1|Treatment Phase|Adverse Event|4
5495499|NCT01698775|19002021|P2|Phase B|Withdrawal by Subject|2
5495500|NCT01698775|19002022|P1|Phase B|Withdrawal by Subject|6
5495501|NCT01698775|19002021|P2|Phase B|Protocol Violation|1
5495502|NCT01698775|19002022|P1|Phase B|Protocol Violation|1
5495503|NCT01698775|19002021|P2|Phase B|Physician Decision|1
5495504|NCT01698775|19002022|P1|Phase B|Physician Decision|1
5495505|NCT01698775|19002021|P2|Phase B|Lost to Follow-up|1
5495506|NCT01698775|19002022|P1|Phase B|Lost to Follow-up|0
5495507|NCT01698775|19002021|P2|Phase B|Lack of Efficacy|1
5495508|NCT01698775|19002022|P1|Phase B|Lack of Efficacy|0
5495509|NCT01698775|19002021|P2|Phase B|Death|1
5495510|NCT01698775|19002022|P1|Phase B|Death|0
5495511|NCT01698775|19002021|P2|Phase B|Adverse Event|3
5495512|NCT01698775|19002022|P1|Phase B|Adverse Event|6
5495513|NCT01698775|19002021|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
5495514|NCT01698775|19002022|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
5495515|NCT01698775|19002021|P2|Phase A|Kidney [transplant]|1
5495516|NCT01698775|19002022|P1|Phase A|Kidney [transplant]|0
5495517|NCT01698775|19002021|P2|Phase A|Withdrawal by Subject|4
5495518|NCT01698775|19002022|P1|Phase A|Withdrawal by Subject|3
5495519|NCT01698775|19002021|P2|Phase A|Protocol Violation|0
5495520|NCT01698775|19002022|P1|Phase A|Protocol Violation|1
5495521|NCT01698775|19002021|P2|Phase A|Lost to Follow-up|2
5495522|NCT01698775|19002022|P1|Phase A|Lost to Follow-up|1
5495523|NCT01698775|19002021|P2|Phase A|Lack of Efficacy|0
5495524|NCT01698775|19002022|P1|Phase A|Lack of Efficacy|1
5495525|NCT01698775|19002021|P2|Phase A|Death|1
5495526|NCT01698775|19002022|P1|Phase A|Death|1
5495527|NCT01698775|19002021|P2|Phase A|Adverse Event|1
5495528|NCT01698775|19002022|P1|Phase A|Adverse Event|2
5495529|NCT01698554|19002071|P4|Overall Study|Other Miscellaneous Reasons|0
5495530|NCT01698554|19002072|P3|Overall Study|Other Miscellaneous Reasons|0
5495531|NCT01698554|19002073|P2|Overall Study|Other Miscellaneous Reasons|0
5495532|NCT01698554|19002074|P1|Overall Study|Other Miscellaneous Reasons|1
5495533|NCT01698554|19002071|P4|Overall Study|Protocol Violation|0
5495534|NCT01698554|19002072|P3|Overall Study|Protocol Violation|1
5495535|NCT01698554|19002073|P2|Overall Study|Protocol Violation|0
5495536|NCT01698554|19002074|P1|Overall Study|Protocol Violation|2
5495537|NCT01698554|19002071|P4|Overall Study|Personal Reasons|1
5495538|NCT01698554|19002072|P3|Overall Study|Personal Reasons|1
5495539|NCT01698554|19002073|P2|Overall Study|Personal Reasons|5
5495540|NCT01698554|19002074|P1|Overall Study|Personal Reasons|0
5495541|NCT01698554|19002071|P4|Overall Study|Lost to Follow-up|0
5495542|NCT01698554|19002072|P3|Overall Study|Lost to Follow-up|0
5495543|NCT01698554|19002073|P2|Overall Study|Lost to Follow-up|0
5495544|NCT01698554|19002074|P1|Overall Study|Lost to Follow-up|1
5495545|NCT01698554|19002071|P4|Overall Study|Adverse Event|1
5495546|NCT01698554|19002072|P3|Overall Study|Adverse Event|0
5495547|NCT01698554|19002073|P2|Overall Study|Adverse Event|5
5495548|NCT01698554|19002074|P1|Overall Study|Adverse Event|2
5495549|NCT01698320|19002144|P3|40-Week Open-Label Period|Lost to Follow-up|0
5495550|NCT01698320|19002145|P2|40-Week Open-Label Period|Lost to Follow-up|2
5495551|NCT01698320|19002146|P1|40-Week Open-Label Period|Lost to Follow-up|0
5495552|NCT01698320|19002144|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
5495553|NCT01698320|19002145|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
5495554|NCT01698320|19002146|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
5495555|NCT01698320|19002144|P3|40-Week Open-Label Period|Pregnancy|1
5495556|NCT01698320|19002145|P2|40-Week Open-Label Period|Pregnancy|2
5495557|NCT01698320|19002146|P1|40-Week Open-Label Period|Pregnancy|0
5495558|NCT01698320|19002144|P3|40-Week Open-Label Period|Withdrawal by Subject|7
5495559|NCT01698320|19002145|P2|40-Week Open-Label Period|Withdrawal by Subject|11
5495560|NCT01698320|19002146|P1|40-Week Open-Label Period|Withdrawal by Subject|0
5495561|NCT01698320|19002144|P3|40-Week Open-Label Period|Adverse Event|2
5495562|NCT01698320|19002145|P2|40-Week Open-Label Period|Adverse Event|3
5495563|NCT01698320|19002146|P1|40-Week Open-Label Period|Adverse Event|0
5495564|NCT01698320|19002144|P3|12-Week Double-Blind Period|Lost to Follow-up|4
5495565|NCT01698320|19002145|P2|12-Week Double-Blind Period|Lost to Follow-up|0
5495566|NCT01698320|19002146|P1|12-Week Double-Blind Period|Lost to Follow-up|0
5495567|NCT01698320|19002144|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
5495568|NCT01698320|19002145|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
5495569|NCT01698320|19002146|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
5495570|NCT01698320|19002144|P3|12-Week Double-Blind Period|Pregnancy|1
5495571|NCT01698320|19002145|P2|12-Week Double-Blind Period|Pregnancy|1
5495572|NCT01698320|19002146|P1|12-Week Double-Blind Period|Pregnancy|0
5495573|NCT01698320|19002144|P3|12-Week Double-Blind Period|Protocol Violation|2
5495574|NCT01698320|19002145|P2|12-Week Double-Blind Period|Protocol Violation|0
5495575|NCT01698320|19002146|P1|12-Week Double-Blind Period|Protocol Violation|0
5495576|NCT01698320|19002144|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
5495577|NCT01698320|19002145|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
5495578|NCT01698320|19002146|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
5495579|NCT01698320|19002144|P3|12-Week Double-Blind Period|Adverse Event|1
5495580|NCT01698320|19002145|P2|12-Week Double-Blind Period|Adverse Event|1
5495581|NCT01698320|19002146|P1|12-Week Double-Blind Period|Adverse Event|0
5495582|NCT01698320|19002144|P3|Run-In Period (Week -1 to Day 0)|Other|0
5495583|NCT01698320|19002145|P2|Run-In Period (Week -1 to Day 0)|Other|0
5495584|NCT01698320|19002146|P1|Run-In Period (Week -1 to Day 0)|Other|1
5495585|NCT01698320|19002144|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
5495586|NCT01698320|19002145|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
5495587|NCT01698320|19002146|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
5495588|NCT01698320|19002144|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
5495589|NCT01698320|19002145|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
5495590|NCT01698320|19002146|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
5495591|NCT01698320|19002144|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
5495592|NCT01698320|19002145|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
5495593|NCT01698320|19002146|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
5495594|NCT01698268|19002166|P2|Overall Study|Physician Decision|1
5495595|NCT01698268|19002167|P1|Overall Study|Physician Decision|2
5495596|NCT01698008|19002175|P2|Overall Study|Withdrawal by Subject|2
5495597|NCT01698008|19002176|P1|Overall Study|Withdrawal by Subject|1
5495598|NCT01697969|19002182|P1|Overall Study|Did not meet inc/exc criteria|3
5495599|NCT01697956|19002189|P2|Overall Study|Protocol Violation|1
5495600|NCT01697956|19002190|P1|Overall Study|Protocol Violation|1
5495601|NCT01697800|19002220|P2|Overall Study|Death|1
5495602|NCT01697800|19002221|P1|Overall Study|Death|0
5495603|NCT01697748|19002229|P2|Overall Study|Lost to Follow-up|65
5495604|NCT01697748|19002230|P1|Overall Study|Lost to Follow-up|53
5495605|NCT01697748|19002229|P2|Overall Study|ineligible uterine incision|1
5495606|NCT01697748|19002230|P1|Overall Study|ineligible uterine incision|4
5495607|NCT01697748|19002229|P2|Overall Study|ineligible skin incision|2
5495608|NCT01697748|19002230|P1|Overall Study|ineligible skin incision|1
5495609|NCT01697696|19002259|P2|Overall Study|Subject/guardian decision|35
5495610|NCT01697696|19002260|P1|Overall Study|Subject/guardian decision|31
5495611|NCT01697696|19002259|P2|Overall Study|Lost to Follow-up|7
5495612|NCT01697696|19002260|P1|Overall Study|Lost to Follow-up|10
5495613|NCT01697696|19002259|P2|Overall Study|Death|2
5495614|NCT01697696|19002260|P1|Overall Study|Death|4
5495615|NCT01697696|19002259|P2|Overall Study|Physician Decision|0
5495616|NCT01697696|19002260|P1|Overall Study|Physician Decision|1
5495617|NCT01697696|19002259|P2|Overall Study|Protocol deviation|0
5495618|NCT01697696|19002260|P1|Overall Study|Protocol deviation|1
5495619|NCT01697696|19002259|P2|Overall Study|Study terminated by sponsor|3
5495620|NCT01697696|19002260|P1|Overall Study|Study terminated by sponsor|0
5495621|NCT01697592|19002292|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
5495622|NCT01697592|19002293|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
5495623|NCT01697592|19002294|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
5495624|NCT01697592|19002295|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
5495625|NCT01697592|19002296|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
5495626|NCT01697592|19002297|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
5495627|NCT01697592|19002298|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
5495628|NCT01697592|19002299|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
5495629|NCT01697592|19002300|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
5495630|NCT01697592|19002301|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
5495631|NCT01697592|19002292|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5495632|NCT01697592|19002293|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5495633|NCT01697592|19002294|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
5495634|NCT01697592|19002295|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5495635|NCT01697592|19002296|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
5495636|NCT01697592|19002297|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5495637|NCT01697592|19002298|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5495638|NCT01697592|19002299|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5495639|NCT01697592|19002300|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
5495640|NCT01697592|19002301|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
5495641|NCT01697592|19002292|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
5495642|NCT01697592|19002293|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
5495643|NCT01697592|19002294|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
5495644|NCT01697592|19002295|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
5495645|NCT01697592|19002296|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
5495646|NCT01697592|19002297|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
5495647|NCT01697592|19002298|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
5495648|NCT01697592|19002299|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
5495649|NCT01697592|19002300|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
5495650|NCT01697592|19002301|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
5495651|NCT01697592|19002292|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
5495652|NCT01697592|19002293|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
5495653|NCT01697592|19002294|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
5495654|NCT01697592|19002295|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
5495655|NCT01697592|19002296|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
5495656|NCT01697592|19002297|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
5495657|NCT01697592|19002298|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
5495658|NCT01697592|19002299|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
5495659|NCT01697592|19002300|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
5495660|NCT01697592|19002301|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
5495661|NCT01697592|19002292|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5495662|NCT01697592|19002293|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5495663|NCT01697592|19002294|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5495664|NCT01697592|19002295|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5495665|NCT01697592|19002296|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5495666|NCT01697592|19002297|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5495667|NCT01697592|19002298|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5495668|NCT01697592|19002299|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
5495669|NCT01697592|19002300|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5495670|NCT01697592|19002301|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
5495671|NCT01697592|19002292|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495672|NCT01697592|19002293|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495673|NCT01697592|19002294|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495674|NCT01697592|19002295|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495675|NCT01697592|19002296|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495676|NCT01697592|19002297|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495677|NCT01697592|19002298|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495678|NCT01697592|19002299|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495679|NCT01697592|19002300|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
5495680|NCT01697592|19002301|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
5495681|NCT01697592|19002292|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
5495682|NCT01697592|19002293|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
5495683|NCT01697592|19002294|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
5495684|NCT01697592|19002295|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
5495685|NCT01697592|19002296|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
5495686|NCT01697592|19002297|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
5495687|NCT01697592|19002298|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
5495688|NCT01697592|19002299|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
5495689|NCT01697592|19002300|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
5495690|NCT01697592|19002301|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
5495691|NCT01697592|19002292|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5495692|NCT01697592|19002293|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5495693|NCT01697592|19002294|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5495694|NCT01697592|19002295|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5495695|NCT01697592|19002296|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5495696|NCT01697592|19002297|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5495697|NCT01697592|19002298|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5495698|NCT01697592|19002299|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5495699|NCT01697592|19002300|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
5495700|NCT01697592|19002301|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
5495701|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
5495702|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5495703|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5495704|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5495705|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5495706|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5495707|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
5495708|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
5495709|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
5495710|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5495711|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5495712|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5495713|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5495714|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
5495715|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Participant Moved|2
5495716|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Participant Moved|0
5495717|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Participant Moved|0
5495718|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Participant Moved|0
5495719|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Participant Moved|0
5495720|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Participant Moved|0
5495721|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Participant Moved|0
5495722|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Technical Problems|1
5495723|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Technical Problems|0
5495724|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Technical Problems|0
5495725|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Technical Problems|0
5495726|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Technical Problems|0
5495727|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Technical Problems|0
5495728|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Technical Problems|0
5495729|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
5495730|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5495731|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5495732|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5495733|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5495734|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5495735|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
5495736|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
5495737|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
5495738|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5495739|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5495740|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5495741|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5495742|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
5495743|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
5495744|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
5495745|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5495746|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5495747|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5495748|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5495749|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
5495750|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5495751|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
5495752|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5495753|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5495754|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5495755|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5495756|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
5495757|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
5495758|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
5495759|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
5495760|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
5495761|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
5495762|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
5495763|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
5495764|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
5495765|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
5495766|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
5495767|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
5495768|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
5495769|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
5495770|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
5495771|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Physician Decision|11
5495772|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Physician Decision|7
5495773|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Physician Decision|0
5495774|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Physician Decision|0
5495775|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Physician Decision|0
5495776|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Physician Decision|0
5495777|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Physician Decision|0
5495778|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
5495779|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
5495780|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5495781|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5495782|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5495783|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5495784|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
5495785|NCT01697579|19002370|P7|Optional Extension-Cycles 2-6|Death|2
5495786|NCT01697579|19002371|P6|Optional Extension-Cycles 2-6|Death|0
5495787|NCT01697579|19002372|P5|Optional Extension-Cycles 2-6|Death|0
5495788|NCT01697579|19002373|P4|Optional Extension-Cycles 2-6|Death|0
5495789|NCT01697579|19002374|P3|Optional Extension-Cycles 2-6|Death|0
5495790|NCT01697579|19002375|P2|Optional Extension-Cycles 2-6|Death|0
5495791|NCT01697579|19002376|P1|Optional Extension-Cycles 2-6|Death|0
5495792|NCT01697579|19002370|P7|Base Study-Cycle 1|Technical Problems|0
5495793|NCT01697579|19002371|P6|Base Study-Cycle 1|Technical Problems|0
5495794|NCT01697579|19002372|P5|Base Study-Cycle 1|Technical Problems|0
5495795|NCT01697579|19002373|P4|Base Study-Cycle 1|Technical Problems|1
5495796|NCT01697579|19002374|P3|Base Study-Cycle 1|Technical Problems|1
5495797|NCT01697579|19002375|P2|Base Study-Cycle 1|Technical Problems|0
5495798|NCT01697579|19002376|P1|Base Study-Cycle 1|Technical Problems|0
5495799|NCT01697579|19002370|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5495800|NCT01697579|19002371|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5495801|NCT01697579|19002372|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5495802|NCT01697579|19002373|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5495803|NCT01697579|19002374|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5495804|NCT01697579|19002375|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
5495805|NCT01697579|19002376|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
5495806|NCT01697579|19002370|P7|Base Study-Cycle 1|Protocol Violation|0
5495807|NCT01697579|19002371|P6|Base Study-Cycle 1|Protocol Violation|0
5495808|NCT01697579|19002372|P5|Base Study-Cycle 1|Protocol Violation|3
5495809|NCT01697579|19002373|P4|Base Study-Cycle 1|Protocol Violation|0
5495810|NCT01697579|19002374|P3|Base Study-Cycle 1|Protocol Violation|0
5495811|NCT01697579|19002375|P2|Base Study-Cycle 1|Protocol Violation|0
5495812|NCT01697579|19002376|P1|Base Study-Cycle 1|Protocol Violation|0
5495813|NCT01697579|19002370|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5495814|NCT01697579|19002371|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5495815|NCT01697579|19002372|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5495816|NCT01697579|19002373|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5495817|NCT01697579|19002374|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5495818|NCT01697579|19002375|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
5495819|NCT01697579|19002376|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
5495820|NCT01697579|19002370|P7|Base Study-Cycle 1|Adverse Event|0
5495821|NCT01697579|19002371|P6|Base Study-Cycle 1|Adverse Event|0
5495822|NCT01697579|19002372|P5|Base Study-Cycle 1|Adverse Event|0
5495823|NCT01697579|19002373|P4|Base Study-Cycle 1|Adverse Event|0
5495824|NCT01697579|19002374|P3|Base Study-Cycle 1|Adverse Event|0
5495825|NCT01697579|19002375|P2|Base Study-Cycle 1|Adverse Event|0
5495826|NCT01697579|19002376|P1|Base Study-Cycle 1|Adverse Event|1
5495827|NCT01697501|19002488|P1|Overall Study|Protocol Violation|2
5495828|NCT01697462|19002531|P1|Overall Study|Missing|5
5495829|NCT01697462|19002531|P1|Overall Study|Other|10
5495830|NCT01697462|19002531|P1|Overall Study|Death|1
5495831|NCT01697462|19002531|P1|Overall Study|Investigator Decision|21
5495832|NCT01697462|19002531|P1|Overall Study|Withdrawal by Subject|12
5495833|NCT01697462|19002531|P1|Overall Study|Lost to Follow-up|21
5495834|NCT01697462|19002531|P1|Overall Study|Adverse Event|6
5495835|NCT01697462|19002531|P1|Overall Study|Disease Progression|1
5495836|NCT01697449|19002538|P1|Overall Study|Missing|25
5495837|NCT01697449|19002538|P1|Overall Study|Other|1
5495838|NCT01697449|19002538|P1|Overall Study|Death|2
5495839|NCT01697449|19002538|P1|Overall Study|Physician Decision|1
5495840|NCT01697449|19002538|P1|Overall Study|Withdrawal by Subject|2
5495841|NCT01697449|19002538|P1|Overall Study|Lost to Follow-up|5
5495842|NCT01697449|19002538|P1|Overall Study|Adverse Event|7
5495843|NCT01697449|19002538|P1|Overall Study|Disease progression|47
5495844|NCT01697358|19002549|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
5495845|NCT01697358|19002550|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
5495846|NCT01697358|19002549|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
5495847|NCT01697358|19002550|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
5495848|NCT01697358|19002549|P2|Period II: 6-24M Long-term Follow-up|Death|1
5495849|NCT01697358|19002550|P1|Period II: 6-24M Long-term Follow-up|Death|1
5495850|NCT01697358|19002549|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
5495851|NCT01697358|19002550|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
5495852|NCT01697358|19002549|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
5495853|NCT01697358|19002550|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
5495854|NCT01697358|19002549|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
5495855|NCT01697358|19002550|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
5495856|NCT01697358|19002549|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
5495857|NCT01697358|19002550|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
5495858|NCT01697358|19002549|P2|Period I: Randomization to 6 Months|Adverse Event|1
5495859|NCT01697358|19002550|P1|Period I: Randomization to 6 Months|Adverse Event|1
5495860|NCT01697358|19002549|P2|Period I: Randomization to 6 Months|Physician Decision|0
5495861|NCT01697358|19002550|P1|Period I: Randomization to 6 Months|Physician Decision|4
5495862|NCT01697358|19002549|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
5495863|NCT01697358|19002550|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
5495864|NCT01697345|19002566|P1|Overall Study|Withdrawal by Subject|1
5495865|NCT01697319|19002591|P1|Extension Phase|Terminated by Sponsor|15
5495866|NCT01697319|19002591|P1|Primary Phase|Withdrawal by Subject|1
5495867|NCT01696994|19002600|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
5495868|NCT01696994|19002601|P1|Overall Study|Refused Screen (Ovarian Screening)|0
5495869|NCT01696994|19002600|P2|Overall Study|Refused ASU (Control)|0
5495870|NCT01696994|19002601|P1|Overall Study|Refused ASU (Control)|311
5495871|NCT01696994|19002600|P2|Overall Study|No Ovaries at Baseline|4851
5495872|NCT01696994|19002601|P1|Overall Study|No Ovaries at Baseline|4807
5495873|NCT01696994|19002600|P2|Overall Study|Died Before ASU (Control)|0
5495874|NCT01696994|19002601|P1|Overall Study|Died Before ASU (Control)|73
5495875|NCT01696994|19002600|P2|Overall Study|Died Before Randomization|2
5495876|NCT01696994|19002601|P1|Overall Study|Died Before Randomization|1
5495877|NCT01696994|19002600|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
5495878|NCT01696994|19002601|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
5495879|NCT01696981|19002629|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
5495880|NCT01696981|19002630|P1|Overall Study|Refused Screen (Colorectal Screening)|0
5495881|NCT01696981|19002629|P2|Overall Study|Refused ASU (Control)|0
5495882|NCT01696981|19002630|P1|Overall Study|Refused ASU (Control)|920
5495883|NCT01696981|19002629|P2|Overall Study|Died Before ASU (Control)|0
5495884|NCT01696981|19002630|P1|Overall Study|Died Before ASU (Control)|278
5495885|NCT01696981|19002629|P2|Overall Study|Died Before Randomization|8
5495886|NCT01696981|19002630|P1|Overall Study|Died Before Randomization|3
5495887|NCT01696981|19002629|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
5495888|NCT01696981|19002630|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
5495889|NCT01696968|19002650|P2|Overall Study|Refused Screen (Lung Screening)|6796
5495890|NCT01696968|19002651|P1|Overall Study|Refused Screen (Lung Screening)|0
5495891|NCT01696968|19002650|P2|Overall Study|Refused ASU (Control)|0
5495892|NCT01696968|19002651|P1|Overall Study|Refused ASU (Control)|920
5495893|NCT01696968|19002650|P2|Overall Study|Died Before ASU (Control)|0
5495894|NCT01696968|19002651|P1|Overall Study|Died Before ASU (Control)|278
5495895|NCT01696968|19002650|P2|Overall Study|Died Before Randomization|8
5495896|NCT01696968|19002651|P1|Overall Study|Died Before Randomization|3
5495897|NCT01696968|19002650|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
5495898|NCT01696968|19002651|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
5495899|NCT01696955|19002673|P2|Main Study|Withdrawal by Subject|1
5495900|NCT01696955|19002674|P1|Main Study|Withdrawal by Subject|1
5495901|NCT01696955|19002673|P2|Main Study|Protocol Violation|0
5495902|NCT01696955|19002674|P1|Main Study|Protocol Violation|1
5495903|NCT01696942|19002699|P2|Overall Study|screen failure|1
5495904|NCT01696942|19002700|P1|Overall Study|screen failure|0
5495905|NCT01696942|19002699|P2|Overall Study|Protocol Violation|2
5495906|NCT01696942|19002700|P1|Overall Study|Protocol Violation|1
5495907|NCT01696942|19002699|P2|Overall Study|Withdrawal by Subject|0
5495908|NCT01696942|19002700|P1|Overall Study|Withdrawal by Subject|1
5495909|NCT01696929|19002708|P1|Overall Study|Physician Decision|1
5495910|NCT01696877|19002715|P2|Overall Study|Adverse Event|1
5495911|NCT01696877|19002716|P1|Overall Study|Adverse Event|0
5495912|NCT01696773|19002738|P2|Days 15-27, Washout|Adverse Event|0
5495913|NCT01696773|19002739|P1|Days 15-27, Washout|Adverse Event|1
5495914|NCT01696695|19002766|P1|Overall Study|Major Protocol Violation|192
5495915|NCT01696695|19002766|P1|Overall Study|Other|74
5495916|NCT01696695|19002766|P1|Overall Study|Lost to Follow-up|48
5495917|NCT01696695|19002766|P1|Overall Study|Withdrawal by Subject|92
5495918|NCT01696695|19002766|P1|Overall Study|Adverse Event|74
5495919|NCT01696695|19002766|P1|Overall Study|Death|29
5495920|NCT01696695|19002766|P1|Overall Study|Disease progression|373
5495921|NCT01696643|19002778|P2|Overall Study|Participant Did Not Receive Study Drug|2
5495922|NCT01696643|19002779|P1|Overall Study|Participant Did Not Receive Study Drug|2
5495923|NCT01696643|19002778|P2|Overall Study|Medical Monitor Decision|2
5495924|NCT01696643|19002779|P1|Overall Study|Medical Monitor Decision|0
5495925|NCT01696643|19002778|P2|Overall Study|Participant Incarcerated|1
5495926|NCT01696643|19002779|P1|Overall Study|Participant Incarcerated|0
5495927|NCT01696643|19002778|P2|Overall Study|Site Error|1
5495928|NCT01696643|19002779|P1|Overall Study|Site Error|2
5495929|NCT01696643|19002778|P2|Overall Study|Participant on Restricted Bed Rest|0
5495930|NCT01696643|19002779|P1|Overall Study|Participant on Restricted Bed Rest|1
5495931|NCT01696643|19002778|P2|Overall Study|Withdrawal by Subject|149
5495932|NCT01696643|19002779|P1|Overall Study|Withdrawal by Subject|142
5495933|NCT01696643|19002778|P2|Overall Study|Study Terminated by Sponsor|294
5495934|NCT01696643|19002779|P1|Overall Study|Study Terminated by Sponsor|286
5495935|NCT01696643|19002778|P2|Overall Study|Protocol Violation|7
5495936|NCT01696643|19002779|P1|Overall Study|Protocol Violation|7
5495937|NCT01696643|19002778|P2|Overall Study|Pregnancy|1
5495938|NCT01696643|19002779|P1|Overall Study|Pregnancy|0
5495939|NCT01696643|19002778|P2|Overall Study|Physician Decision|2
5495940|NCT01696643|19002779|P1|Overall Study|Physician Decision|3
5495941|NCT01696643|19002778|P2|Overall Study|Lost to Follow-up|67
5495942|NCT01696643|19002779|P1|Overall Study|Lost to Follow-up|67
5495943|NCT01696643|19002778|P2|Overall Study|Lack of Efficacy|0
5495944|NCT01696643|19002779|P1|Overall Study|Lack of Efficacy|3
5495945|NCT01696643|19002778|P2|Overall Study|Death|2
5495946|NCT01696643|19002779|P1|Overall Study|Death|1
5495947|NCT01696643|19002778|P2|Overall Study|Adverse Event|7
5495948|NCT01696643|19002779|P1|Overall Study|Adverse Event|15
5495949|NCT01696396|19002798|P4|Overall Study|Death|0
5495950|NCT01696396|19002799|P3|Overall Study|Death|1
5495951|NCT01696396|19002800|P2|Overall Study|Death|0
5495952|NCT01696396|19002801|P1|Overall Study|Death|0
5495953|NCT01696396|19002798|P4|Overall Study|Lost to Follow-up|1
5495954|NCT01696396|19002799|P3|Overall Study|Lost to Follow-up|4
5495955|NCT01696396|19002800|P2|Overall Study|Lost to Follow-up|1
5495956|NCT01696396|19002801|P1|Overall Study|Lost to Follow-up|9
5495957|NCT01696396|19002798|P4|Overall Study|Decision by Sponsor|2
5495958|NCT01696396|19002799|P3|Overall Study|Decision by Sponsor|2
5495959|NCT01696396|19002800|P2|Overall Study|Decision by Sponsor|1
5495960|NCT01696396|19002801|P1|Overall Study|Decision by Sponsor|3
5495961|NCT01696396|19002798|P4|Overall Study|Withdrawal by Subject|11
5495962|NCT01696396|19002799|P3|Overall Study|Withdrawal by Subject|19
5495963|NCT01696396|19002800|P2|Overall Study|Withdrawal by Subject|5
5495964|NCT01696396|19002801|P1|Overall Study|Withdrawal by Subject|19
5495965|NCT01696279|19002852|P4|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
5495966|NCT01696279|19002853|P3|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
5495967|NCT01696279|19002854|P2|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
5495968|NCT01696279|19002855|P1|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
5495969|NCT01696279|19002852|P4|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
5495970|NCT01696279|19002853|P3|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
5495971|NCT01696279|19002854|P2|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
5495972|NCT01696279|19002855|P1|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
5495973|NCT01696279|19002852|P4|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
5495974|NCT01696279|19002853|P3|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
5495975|NCT01696279|19002854|P2|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
5495976|NCT01696279|19002855|P1|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
5495977|NCT01696279|19002852|P4|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
5495978|NCT01696279|19002853|P3|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
5495979|NCT01696279|19002854|P2|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
5495980|NCT01696279|19002855|P1|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
5495981|NCT01696279|19002852|P4|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
5495982|NCT01696279|19002853|P3|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
5495983|NCT01696279|19002854|P2|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
5495984|NCT01696279|19002855|P1|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
5495985|NCT01696279|19002852|P4|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
5495986|NCT01696279|19002853|P3|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
5495987|NCT01696279|19002854|P2|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
5495988|NCT01696279|19002855|P1|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
5495989|NCT01696279|19002852|P4|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
5495990|NCT01696279|19002853|P3|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
5495991|NCT01696279|19002854|P2|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
5495992|NCT01696279|19002855|P1|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
5495993|NCT01696279|19002852|P4|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
5495994|NCT01696279|19002853|P3|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
5495995|NCT01696279|19002854|P2|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
5495996|NCT01696279|19002855|P1|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
5495997|NCT01696279|19002852|P4|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
5495998|NCT01696279|19002853|P3|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
5495999|NCT01696279|19002854|P2|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
5496000|NCT01696279|19002855|P1|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
5496001|NCT01696279|19002852|P4|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
5496002|NCT01696279|19002853|P3|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
5496003|NCT01696279|19002854|P2|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
5496004|NCT01696279|19002855|P1|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
5496005|NCT01696279|19002852|P4|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
5496006|NCT01696279|19002853|P3|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
5496007|NCT01696279|19002854|P2|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
5496008|NCT01696279|19002855|P1|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
5496009|NCT01696214|19002893|P4|Overall Study|Lost to Follow-up|0
5496010|NCT01696214|19002894|P3|Overall Study|Lost to Follow-up|0
5496011|NCT01696214|19002895|P2|Overall Study|Lost to Follow-up|0
5496012|NCT01696214|19002896|P1|Overall Study|Lost to Follow-up|1
5496013|NCT01696188|19002916|P2|Overall Study|Protocol Violation|1
5496014|NCT01696188|19002917|P1|Overall Study|Protocol Violation|1
5496015|NCT01696071|19002948|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
5496016|NCT01696071|19002949|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
5496017|NCT01696058|19002977|P2|Overall Study|Other reason prematurely discontinued|3
5496018|NCT01696058|19002978|P1|Overall Study|Other reason prematurely discontinued|5
5496019|NCT01696058|19002977|P2|Overall Study|Withdrawal by Subject|6
5496020|NCT01696058|19002978|P1|Overall Study|Withdrawal by Subject|4
5496021|NCT01696058|19002977|P2|Overall Study|Lost to Follow-up|5
5496022|NCT01696058|19002978|P1|Overall Study|Lost to Follow-up|2
5496023|NCT01696058|19002977|P2|Overall Study|Protocol Violation|3
5496024|NCT01696058|19002978|P1|Overall Study|Protocol Violation|9
5496025|NCT01696058|19002977|P2|Overall Study|Lack of Efficacy|3
5496026|NCT01696058|19002978|P1|Overall Study|Lack of Efficacy|2
5496027|NCT01696058|19002977|P2|Overall Study|Adverse Event|11
5496028|NCT01696058|19002978|P1|Overall Study|Adverse Event|21
5496029|NCT01696045|19003006|P2|Overall Study|Disease progression|2
5496030|NCT01696045|19003007|P1|Overall Study|Disease progression|2
5496031|NCT01696045|19003006|P2|Overall Study|Study drug toxicity|5
5496032|NCT01696045|19003007|P1|Overall Study|Study drug toxicity|1
5496033|NCT01695993|19003026|P3|Overall Study|Changed Medical Facility|1
5496034|NCT01695993|19003027|P2|Overall Study|Changed Medical Facility|0
5496035|NCT01695993|19003028|P1|Overall Study|Changed Medical Facility|0
5496036|NCT01695993|19003026|P3|Overall Study|To ill to continue|0
5496037|NCT01695993|19003027|P2|Overall Study|To ill to continue|2
5496038|NCT01695993|19003028|P1|Overall Study|To ill to continue|1
5496039|NCT01695993|19003026|P3|Overall Study|Withdrawal by Subject|2
5496040|NCT01695993|19003027|P2|Overall Study|Withdrawal by Subject|2
5496041|NCT01695993|19003028|P1|Overall Study|Withdrawal by Subject|2
5496042|NCT01695993|19003026|P3|Overall Study|Lost to Follow-up|3
5496043|NCT01695993|19003027|P2|Overall Study|Lost to Follow-up|1
5496044|NCT01695993|19003028|P1|Overall Study|Lost to Follow-up|2
5496045|NCT01695954|19003038|P2|Overall Study|Adverse Event|2
5496046|NCT01695954|19003039|P1|Overall Study|Adverse Event|0
5496047|NCT01695954|19003038|P2|Overall Study|Withdrawal by Subject|0
5496048|NCT01695954|19003039|P1|Overall Study|Withdrawal by Subject|4
5496049|NCT01695772|19003049|P1|Overall Study|Unspecified Reason|1
5496050|NCT01695772|19003049|P1|Overall Study|Protocol Violation|2
5496051|NCT01695772|19003049|P1|Overall Study|Lost to Follow-up|4
5496052|NCT01695772|19003049|P1|Overall Study|Investigator Decision|5
5496053|NCT01695772|19003049|P1|Overall Study|Progressive Disease|8
5496054|NCT01695772|19003049|P1|Overall Study|Withdrawal by Subject|18
5496055|NCT01695746|19003061|P1|Overall Study|Participant not willing to participate|3
5496056|NCT01695746|19003061|P1|Overall Study|Protocol Violation|5
5496057|NCT01695746|19003061|P1|Overall Study|Non-compliance by the participant|3
5496058|NCT01695746|19003061|P1|Overall Study|Adverse Event|1
5496059|NCT01695239|19003121|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
5496060|NCT01695239|19003122|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
5496061|NCT01695239|19003123|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
5496062|NCT01695239|19003124|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
5496063|NCT01695239|19003125|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
5496064|NCT01695239|19003126|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
5496065|NCT01695239|19003127|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
5496066|NCT01695239|19003128|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
5496067|NCT01695239|19003129|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
5496068|NCT01695239|19003130|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
5496069|NCT01695239|19003131|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
5496070|NCT01695239|19003132|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
5496071|NCT01695239|19003133|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
5496072|NCT01695239|19003134|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
5496073|NCT01695239|19003121|P14|Post-Treatment Follow-Up Period|Physician Decision|0
5496074|NCT01695239|19003122|P13|Post-Treatment Follow-Up Period|Physician Decision|2
5496075|NCT01695239|19003123|P12|Post-Treatment Follow-Up Period|Physician Decision|0
5496076|NCT01695239|19003124|P11|Post-Treatment Follow-Up Period|Physician Decision|0
5496077|NCT01695239|19003125|P10|Post-Treatment Follow-Up Period|Physician Decision|0
5496078|NCT01695239|19003126|P9|Post-Treatment Follow-Up Period|Physician Decision|0
5496079|NCT01695239|19003127|P8|Post-Treatment Follow-Up Period|Physician Decision|0
5496080|NCT01695239|19003128|P7|Post-Treatment Follow-Up Period|Physician Decision|0
5496081|NCT01695239|19003129|P6|Post-Treatment Follow-Up Period|Physician Decision|0
5496082|NCT01695239|19003130|P5|Post-Treatment Follow-Up Period|Physician Decision|0
5496083|NCT01695239|19003131|P4|Post-Treatment Follow-Up Period|Physician Decision|0
5496084|NCT01695239|19003132|P3|Post-Treatment Follow-Up Period|Physician Decision|0
5496085|NCT01695239|19003133|P2|Post-Treatment Follow-Up Period|Physician Decision|0
5496086|NCT01695239|19003134|P1|Post-Treatment Follow-Up Period|Physician Decision|0
5496087|NCT01695239|19003121|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
5496088|NCT01695239|19003122|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|1
5496089|NCT01695239|19003123|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496090|NCT01695239|19003124|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496091|NCT01695239|19003125|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496092|NCT01695239|19003126|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496093|NCT01695239|19003127|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496094|NCT01695239|19003128|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496095|NCT01695239|19003129|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496096|NCT01695239|19003130|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496097|NCT01695239|19003131|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496098|NCT01695239|19003132|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496099|NCT01695239|19003133|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496100|NCT01695239|19003134|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
5496101|NCT01695239|19003121|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
5496102|NCT01695239|19003122|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
5496103|NCT01695239|19003123|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
5496104|NCT01695239|19003124|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496105|NCT01695239|19003125|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496106|NCT01695239|19003126|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496107|NCT01695239|19003127|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496108|NCT01695239|19003128|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496109|NCT01695239|19003129|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496110|NCT01695239|19003130|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496111|NCT01695239|19003131|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496112|NCT01695239|19003132|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496113|NCT01695239|19003133|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496114|NCT01695239|19003134|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
5496115|NCT01695239|19003121|P14|Extension Long-Term Extension Periods|Death|0
5496116|NCT01695239|19003122|P13|Extension Long-Term Extension Periods|Death|0
5496117|NCT01695239|19003123|P12|Extension Long-Term Extension Periods|Death|0
5496118|NCT01695239|19003124|P11|Extension Long-Term Extension Periods|Death|0
5496119|NCT01695239|19003125|P10|Extension Long-Term Extension Periods|Death|0
5496120|NCT01695239|19003126|P9|Extension Long-Term Extension Periods|Death|1
5496121|NCT01695239|19003127|P8|Extension Long-Term Extension Periods|Death|0
5496122|NCT01695239|19003128|P7|Extension Long-Term Extension Periods|Death|0
5496123|NCT01695239|19003129|P6|Extension Long-Term Extension Periods|Death|0
5496124|NCT01695239|19003130|P5|Extension Long-Term Extension Periods|Death|0
5496125|NCT01695239|19003131|P4|Extension Long-Term Extension Periods|Death|0
5496126|NCT01695239|19003132|P3|Extension Long-Term Extension Periods|Death|0
5496127|NCT01695239|19003133|P2|Extension Long-Term Extension Periods|Death|0
5496128|NCT01695239|19003134|P1|Extension Long-Term Extension Periods|Death|0
5496129|NCT01695239|19003121|P14|Extension Long-Term Extension Periods|Sponsor Decision|0
5496419|NCT01694771|19003327|P2|Overall Study|Adverse Event|16
5496130|NCT01695239|19003122|P13|Extension Long-Term Extension Periods|Sponsor Decision|0
5496131|NCT01695239|19003123|P12|Extension Long-Term Extension Periods|Sponsor Decision|0
5496132|NCT01695239|19003124|P11|Extension Long-Term Extension Periods|Sponsor Decision|0
5496133|NCT01695239|19003125|P10|Extension Long-Term Extension Periods|Sponsor Decision|1
5496134|NCT01695239|19003126|P9|Extension Long-Term Extension Periods|Sponsor Decision|2
5496135|NCT01695239|19003127|P8|Extension Long-Term Extension Periods|Sponsor Decision|0
5496136|NCT01695239|19003128|P7|Extension Long-Term Extension Periods|Sponsor Decision|0
5496137|NCT01695239|19003129|P6|Extension Long-Term Extension Periods|Sponsor Decision|0
5496138|NCT01695239|19003130|P5|Extension Long-Term Extension Periods|Sponsor Decision|0
5496139|NCT01695239|19003131|P4|Extension Long-Term Extension Periods|Sponsor Decision|0
5496140|NCT01695239|19003132|P3|Extension Long-Term Extension Periods|Sponsor Decision|0
5496141|NCT01695239|19003133|P2|Extension Long-Term Extension Periods|Sponsor Decision|0
5496142|NCT01695239|19003134|P1|Extension Long-Term Extension Periods|Sponsor Decision|0
5496143|NCT01695239|19003121|P14|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496144|NCT01695239|19003122|P13|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496145|NCT01695239|19003123|P12|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496146|NCT01695239|19003124|P11|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496147|NCT01695239|19003125|P10|Extension Long-Term Extension Periods|Lost to Follow-up|1
5496148|NCT01695239|19003126|P9|Extension Long-Term Extension Periods|Lost to Follow-up|2
5496149|NCT01695239|19003127|P8|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496150|NCT01695239|19003128|P7|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496151|NCT01695239|19003129|P6|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496152|NCT01695239|19003130|P5|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496153|NCT01695239|19003131|P4|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496154|NCT01695239|19003132|P3|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496155|NCT01695239|19003133|P2|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496156|NCT01695239|19003134|P1|Extension Long-Term Extension Periods|Lost to Follow-up|0
5496157|NCT01695239|19003121|P14|Extension Long-Term Extension Periods|Physician Decision|0
5496158|NCT01695239|19003122|P13|Extension Long-Term Extension Periods|Physician Decision|0
5496159|NCT01695239|19003123|P12|Extension Long-Term Extension Periods|Physician Decision|0
5496160|NCT01695239|19003124|P11|Extension Long-Term Extension Periods|Physician Decision|0
5496161|NCT01695239|19003125|P10|Extension Long-Term Extension Periods|Physician Decision|0
5496162|NCT01695239|19003126|P9|Extension Long-Term Extension Periods|Physician Decision|3
5496163|NCT01695239|19003127|P8|Extension Long-Term Extension Periods|Physician Decision|0
5496164|NCT01695239|19003128|P7|Extension Long-Term Extension Periods|Physician Decision|0
5496165|NCT01695239|19003129|P6|Extension Long-Term Extension Periods|Physician Decision|0
5496166|NCT01695239|19003130|P5|Extension Long-Term Extension Periods|Physician Decision|0
5496167|NCT01695239|19003131|P4|Extension Long-Term Extension Periods|Physician Decision|0
5496168|NCT01695239|19003132|P3|Extension Long-Term Extension Periods|Physician Decision|0
5496169|NCT01695239|19003133|P2|Extension Long-Term Extension Periods|Physician Decision|0
5496170|NCT01695239|19003134|P1|Extension Long-Term Extension Periods|Physician Decision|0
5496171|NCT01695239|19003121|P14|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496172|NCT01695239|19003122|P13|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496173|NCT01695239|19003123|P12|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496174|NCT01695239|19003124|P11|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496175|NCT01695239|19003125|P10|Extension Long-Term Extension Periods|Withdrawal by Subject|7
5496176|NCT01695239|19003126|P9|Extension Long-Term Extension Periods|Withdrawal by Subject|6
5496177|NCT01695239|19003127|P8|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496178|NCT01695239|19003128|P7|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496179|NCT01695239|19003129|P6|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496180|NCT01695239|19003130|P5|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496181|NCT01695239|19003131|P4|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496182|NCT01695239|19003132|P3|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496183|NCT01695239|19003133|P2|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496184|NCT01695239|19003134|P1|Extension Long-Term Extension Periods|Withdrawal by Subject|0
5496185|NCT01695239|19003121|P14|Extension Long-Term Extension Periods|Adverse Event|0
5496186|NCT01695239|19003122|P13|Extension Long-Term Extension Periods|Adverse Event|0
5496187|NCT01695239|19003123|P12|Extension Long-Term Extension Periods|Adverse Event|0
5496188|NCT01695239|19003124|P11|Extension Long-Term Extension Periods|Adverse Event|0
5496189|NCT01695239|19003125|P10|Extension Long-Term Extension Periods|Adverse Event|21
5496190|NCT01695239|19003126|P9|Extension Long-Term Extension Periods|Adverse Event|15
5496191|NCT01695239|19003127|P8|Extension Long-Term Extension Periods|Adverse Event|0
5496192|NCT01695239|19003128|P7|Extension Long-Term Extension Periods|Adverse Event|0
5496193|NCT01695239|19003129|P6|Extension Long-Term Extension Periods|Adverse Event|0
5496194|NCT01695239|19003130|P5|Extension Long-Term Extension Periods|Adverse Event|0
5496195|NCT01695239|19003131|P4|Extension Long-Term Extension Periods|Adverse Event|0
5496196|NCT01695239|19003132|P3|Extension Long-Term Extension Periods|Adverse Event|0
5496197|NCT01695239|19003133|P2|Extension Long-Term Extension Periods|Adverse Event|0
5496198|NCT01695239|19003134|P1|Extension Long-Term Extension Periods|Adverse Event|0
5496199|NCT01695239|19003121|P14|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496200|NCT01695239|19003122|P13|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496201|NCT01695239|19003123|P12|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496202|NCT01695239|19003124|P11|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496203|NCT01695239|19003125|P10|Extension Long-Term Extension Periods|Lack of Efficacy|31
5496204|NCT01695239|19003126|P9|Extension Long-Term Extension Periods|Lack of Efficacy|37
5496205|NCT01695239|19003127|P8|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496206|NCT01695239|19003128|P7|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496207|NCT01695239|19003129|P6|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496208|NCT01695239|19003130|P5|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496209|NCT01695239|19003131|P4|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496210|NCT01695239|19003132|P3|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496211|NCT01695239|19003133|P2|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496212|NCT01695239|19003134|P1|Extension Long-Term Extension Periods|Lack of Efficacy|0
5496213|NCT01695239|19003121|P14|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496214|NCT01695239|19003122|P13|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496215|NCT01695239|19003123|P12|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496216|NCT01695239|19003124|P11|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496217|NCT01695239|19003125|P10|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496218|NCT01695239|19003126|P9|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496219|NCT01695239|19003127|P8|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
5496220|NCT01695239|19003128|P7|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496221|NCT01695239|19003129|P6|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496222|NCT01695239|19003130|P5|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496223|NCT01695239|19003131|P4|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496224|NCT01695239|19003132|P3|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496225|NCT01695239|19003133|P2|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496226|NCT01695239|19003134|P1|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
5496227|NCT01695239|19003121|P14|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496228|NCT01695239|19003122|P13|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496229|NCT01695239|19003123|P12|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496230|NCT01695239|19003124|P11|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496231|NCT01695239|19003125|P10|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496232|NCT01695239|19003126|P9|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496233|NCT01695239|19003127|P8|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
5496234|NCT01695239|19003128|P7|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496235|NCT01695239|19003129|P6|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496236|NCT01695239|19003130|P5|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496237|NCT01695239|19003131|P4|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496238|NCT01695239|19003132|P3|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496239|NCT01695239|19003133|P2|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496240|NCT01695239|19003134|P1|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
5496241|NCT01695239|19003121|P14|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496242|NCT01695239|19003122|P13|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496243|NCT01695239|19003123|P12|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496244|NCT01695239|19003124|P11|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496245|NCT01695239|19003125|P10|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496246|NCT01695239|19003126|P9|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496247|NCT01695239|19003127|P8|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
5496248|NCT01695239|19003128|P7|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496249|NCT01695239|19003129|P6|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496250|NCT01695239|19003130|P5|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496251|NCT01695239|19003131|P4|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496252|NCT01695239|19003132|P3|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496253|NCT01695239|19003133|P2|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496254|NCT01695239|19003134|P1|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
5496255|NCT01695239|19003121|P14|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496256|NCT01695239|19003122|P13|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496257|NCT01695239|19003123|P12|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496258|NCT01695239|19003124|P11|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496259|NCT01695239|19003125|P10|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496260|NCT01695239|19003126|P9|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496261|NCT01695239|19003127|P8|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496262|NCT01695239|19003128|P7|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496263|NCT01695239|19003129|P6|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496264|NCT01695239|19003130|P5|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496265|NCT01695239|19003131|P4|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496266|NCT01695239|19003132|P3|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496267|NCT01695239|19003133|P2|Double-Blind (DB) Treatment Period|Protocol Violation|0
5496268|NCT01695239|19003134|P1|Double-Blind (DB) Treatment Period|Protocol Violation|1
5496269|NCT01695239|19003121|P14|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496270|NCT01695239|19003122|P13|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496271|NCT01695239|19003123|P12|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496272|NCT01695239|19003124|P11|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496273|NCT01695239|19003125|P10|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496274|NCT01695239|19003126|P9|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496275|NCT01695239|19003127|P8|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496276|NCT01695239|19003128|P7|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496277|NCT01695239|19003129|P6|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496278|NCT01695239|19003130|P5|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496279|NCT01695239|19003131|P4|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496280|NCT01695239|19003132|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5496281|NCT01695239|19003133|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5496282|NCT01695239|19003134|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5496283|NCT01695239|19003121|P14|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496284|NCT01695239|19003122|P13|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496285|NCT01695239|19003123|P12|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496286|NCT01695239|19003124|P11|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496287|NCT01695239|19003125|P10|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496288|NCT01695239|19003126|P9|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496289|NCT01695239|19003127|P8|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496290|NCT01695239|19003128|P7|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496291|NCT01695239|19003129|P6|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496292|NCT01695239|19003130|P5|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496293|NCT01695239|19003131|P4|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496294|NCT01695239|19003132|P3|Double-Blind (DB) Treatment Period|Sponsor Decision|1
5496295|NCT01695239|19003133|P2|Double-Blind (DB) Treatment Period|Sponsor Decision|0
5496296|NCT01695239|19003134|P1|Double-Blind (DB) Treatment Period|Sponsor Decision|3
5496297|NCT01695239|19003121|P14|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496298|NCT01695239|19003122|P13|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496299|NCT01695239|19003123|P12|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496300|NCT01695239|19003124|P11|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496301|NCT01695239|19003125|P10|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496302|NCT01695239|19003126|P9|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496303|NCT01695239|19003127|P8|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496304|NCT01695239|19003128|P7|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496305|NCT01695239|19003129|P6|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496306|NCT01695239|19003130|P5|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496307|NCT01695239|19003131|P4|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5496308|NCT01695239|19003132|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
5496309|NCT01695239|19003133|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
5496310|NCT01695239|19003134|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
5496311|NCT01695239|19003121|P14|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496312|NCT01695239|19003122|P13|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496313|NCT01695239|19003123|P12|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496314|NCT01695239|19003124|P11|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496315|NCT01695239|19003125|P10|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496316|NCT01695239|19003126|P9|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496317|NCT01695239|19003127|P8|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496318|NCT01695239|19003128|P7|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496319|NCT01695239|19003129|P6|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496320|NCT01695239|19003130|P5|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496321|NCT01695239|19003131|P4|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496322|NCT01695239|19003132|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
5496323|NCT01695239|19003133|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5496324|NCT01695239|19003134|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
5496325|NCT01695239|19003121|P14|Double-Blind (DB) Treatment Period|Adverse Event|0
5496326|NCT01695239|19003122|P13|Double-Blind (DB) Treatment Period|Adverse Event|0
5496327|NCT01695239|19003123|P12|Double-Blind (DB) Treatment Period|Adverse Event|0
5496328|NCT01695239|19003124|P11|Double-Blind (DB) Treatment Period|Adverse Event|0
5496329|NCT01695239|19003125|P10|Double-Blind (DB) Treatment Period|Adverse Event|0
5496330|NCT01695239|19003126|P9|Double-Blind (DB) Treatment Period|Adverse Event|0
5496331|NCT01695239|19003127|P8|Double-Blind (DB) Treatment Period|Adverse Event|0
5496332|NCT01695239|19003128|P7|Double-Blind (DB) Treatment Period|Adverse Event|0
5496333|NCT01695239|19003129|P6|Double-Blind (DB) Treatment Period|Adverse Event|0
5496334|NCT01695239|19003130|P5|Double-Blind (DB) Treatment Period|Adverse Event|0
5496335|NCT01695239|19003131|P4|Double-Blind (DB) Treatment Period|Adverse Event|3
5496336|NCT01695239|19003132|P3|Double-Blind (DB) Treatment Period|Adverse Event|2
5496337|NCT01695239|19003133|P2|Double-Blind (DB) Treatment Period|Adverse Event|2
5496338|NCT01695239|19003134|P1|Double-Blind (DB) Treatment Period|Adverse Event|2
5496339|NCT01695239|19003121|P14|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496340|NCT01695239|19003122|P13|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496341|NCT01695239|19003123|P12|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496342|NCT01695239|19003124|P11|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496420|NCT01694771|19003328|P1|Overall Study|Adverse Event|18
5496343|NCT01695239|19003125|P10|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496344|NCT01695239|19003126|P9|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496345|NCT01695239|19003127|P8|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496346|NCT01695239|19003128|P7|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496347|NCT01695239|19003129|P6|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496348|NCT01695239|19003130|P5|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
5496349|NCT01695239|19003131|P4|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
5496350|NCT01695239|19003132|P3|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
5496351|NCT01695239|19003133|P2|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
5496352|NCT01695239|19003134|P1|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
5496353|NCT01695135|19003275|P4|Open Label Extension Treatment Phase|Noncompliance with study drug|1
5496354|NCT01695135|19003276|P3|Open Label Extension Treatment Phase|Noncompliance with study drug|0
5496355|NCT01695135|19003277|P2|Open Label Extension Treatment Phase|Noncompliance with study drug|0
5496356|NCT01695135|19003278|P1|Open Label Extension Treatment Phase|Noncompliance with study drug|0
5496357|NCT01695135|19003275|P4|Open Label Extension Treatment Phase|Death|7
5496358|NCT01695135|19003276|P3|Open Label Extension Treatment Phase|Death|2
5496359|NCT01695135|19003277|P2|Open Label Extension Treatment Phase|Death|0
5496360|NCT01695135|19003278|P1|Open Label Extension Treatment Phase|Death|0
5496361|NCT01695135|19003275|P4|Open Label Extension Treatment Phase|Physician Decision|1
5496362|NCT01695135|19003276|P3|Open Label Extension Treatment Phase|Physician Decision|4
5496363|NCT01695135|19003277|P2|Open Label Extension Treatment Phase|Physician Decision|0
5496364|NCT01695135|19003278|P1|Open Label Extension Treatment Phase|Physician Decision|0
5496365|NCT01695135|19003275|P4|Open Label Extension Treatment Phase|Other|7
5496366|NCT01695135|19003276|P3|Open Label Extension Treatment Phase|Other|4
5496367|NCT01695135|19003277|P2|Open Label Extension Treatment Phase|Other|0
5496368|NCT01695135|19003278|P1|Open Label Extension Treatment Phase|Other|0
5496369|NCT01695135|19003275|P4|Open Label Extension Treatment Phase|Adverse Event|16
5496370|NCT01695135|19003276|P3|Open Label Extension Treatment Phase|Adverse Event|11
5496371|NCT01695135|19003277|P2|Open Label Extension Treatment Phase|Adverse Event|0
5496372|NCT01695135|19003278|P1|Open Label Extension Treatment Phase|Adverse Event|0
5496373|NCT01695135|19003275|P4|Open Label Extension Treatment Phase|Withdrawal by Subject|16
5496374|NCT01695135|19003276|P3|Open Label Extension Treatment Phase|Withdrawal by Subject|6
5496375|NCT01695135|19003277|P2|Open Label Extension Treatment Phase|Withdrawal by Subject|0
5496376|NCT01695135|19003278|P1|Open Label Extension Treatment Phase|Withdrawal by Subject|0
5496377|NCT01695135|19003275|P4|Open Label Extension Treatment Phase|Progressive disease|22
5496378|NCT01695135|19003276|P3|Open Label Extension Treatment Phase|Progressive disease|13
5496379|NCT01695135|19003277|P2|Open Label Extension Treatment Phase|Progressive disease|0
5496380|NCT01695135|19003278|P1|Open Label Extension Treatment Phase|Progressive disease|0
5496381|NCT01695135|19003275|P4|Double-blind Treatment Phase|Noncompliance with study drug|0
5496382|NCT01695135|19003276|P3|Double-blind Treatment Phase|Noncompliance with study drug|0
5496383|NCT01695135|19003277|P2|Double-blind Treatment Phase|Noncompliance with study drug|1
5496384|NCT01695135|19003278|P1|Double-blind Treatment Phase|Noncompliance with study drug|0
5496385|NCT01695135|19003275|P4|Double-blind Treatment Phase|Death|0
5496386|NCT01695135|19003276|P3|Double-blind Treatment Phase|Death|0
5496387|NCT01695135|19003277|P2|Double-blind Treatment Phase|Death|1
5496388|NCT01695135|19003278|P1|Double-blind Treatment Phase|Death|1
5496389|NCT01695135|19003275|P4|Double-blind Treatment Phase|Physician Decision|0
5496390|NCT01695135|19003276|P3|Double-blind Treatment Phase|Physician Decision|0
5496391|NCT01695135|19003277|P2|Double-blind Treatment Phase|Physician Decision|3
5496392|NCT01695135|19003278|P1|Double-blind Treatment Phase|Physician Decision|6
5496393|NCT01695135|19003275|P4|Double-blind Treatment Phase|Other|0
5496394|NCT01695135|19003276|P3|Double-blind Treatment Phase|Other|0
5496395|NCT01695135|19003277|P2|Double-blind Treatment Phase|Other|3
5496396|NCT01695135|19003278|P1|Double-blind Treatment Phase|Other|1
5496397|NCT01695135|19003275|P4|Double-blind Treatment Phase|Adverse Event|0
5496398|NCT01695135|19003276|P3|Double-blind Treatment Phase|Adverse Event|0
5496399|NCT01695135|19003277|P2|Double-blind Treatment Phase|Adverse Event|7
5496400|NCT01695135|19003278|P1|Double-blind Treatment Phase|Adverse Event|7
5496401|NCT01695135|19003275|P4|Double-blind Treatment Phase|Withdrawal by Subject|0
5496402|NCT01695135|19003276|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
5496403|NCT01695135|19003277|P2|Double-blind Treatment Phase|Withdrawal by Subject|14
5496404|NCT01695135|19003278|P1|Double-blind Treatment Phase|Withdrawal by Subject|6
5496405|NCT01695135|19003275|P4|Double-blind Treatment Phase|Progressive disease|0
5496406|NCT01695135|19003276|P3|Double-blind Treatment Phase|Progressive disease|0
5496407|NCT01695135|19003277|P2|Double-blind Treatment Phase|Progressive disease|110
5496408|NCT01695135|19003278|P1|Double-blind Treatment Phase|Progressive disease|50
5496409|NCT01694771|19003327|P2|Overall Study|Other reasons|6
5496410|NCT01694771|19003328|P1|Overall Study|Other reasons|5
5496411|NCT01694771|19003327|P2|Overall Study|Consent withdrawn|9
5496412|NCT01694771|19003328|P1|Overall Study|Consent withdrawn|7
5496413|NCT01694771|19003327|P2|Overall Study|Lost to Follow-up|3
5496414|NCT01694771|19003328|P1|Overall Study|Lost to Follow-up|2
5496415|NCT01694771|19003327|P2|Overall Study|Non compliance protocol|6
5496416|NCT01694771|19003328|P1|Overall Study|Non compliance protocol|7
5496417|NCT01694771|19003327|P2|Overall Study|Lack of Efficacy|0
5496418|NCT01694771|19003328|P1|Overall Study|Lack of Efficacy|1
5499306|NCT01667900|19014183|P5|Part B|Death|0
5496421|NCT01694706|19003352|P3|Overall Study|other reason not defined above|0
5496422|NCT01694706|19003353|P2|Overall Study|other reason not defined above|0
5496423|NCT01694706|19003354|P1|Overall Study|other reason not defined above|1
5496424|NCT01694706|19003352|P3|Overall Study|Adverse Event|0
5496425|NCT01694706|19003353|P2|Overall Study|Adverse Event|1
5496426|NCT01694706|19003354|P1|Overall Study|Adverse Event|0
5496427|NCT01694485|19003413|P5|Overall Study|Death|0
5496428|NCT01694485|19003414|P4|Overall Study|Death|1
5496429|NCT01694485|19003415|P3|Overall Study|Death|0
5496430|NCT01694485|19003416|P2|Overall Study|Death|0
5496431|NCT01694485|19003417|P1|Overall Study|Death|1
5496432|NCT01694485|19003413|P5|Overall Study|Lost to Follow-up|7
5496433|NCT01694485|19003414|P4|Overall Study|Lost to Follow-up|10
5496434|NCT01694485|19003415|P3|Overall Study|Lost to Follow-up|6
5496435|NCT01694485|19003416|P2|Overall Study|Lost to Follow-up|1
5496436|NCT01694485|19003417|P1|Overall Study|Lost to Follow-up|9
5496437|NCT01694485|19003413|P5|Overall Study|Sponsor Decision|0
5496438|NCT01694485|19003414|P4|Overall Study|Sponsor Decision|2
5496439|NCT01694485|19003415|P3|Overall Study|Sponsor Decision|0
5496440|NCT01694485|19003416|P2|Overall Study|Sponsor Decision|0
5496441|NCT01694485|19003417|P1|Overall Study|Sponsor Decision|3
5496442|NCT01694485|19003413|P5|Overall Study|Withdrawal by Subject|18
5496443|NCT01694485|19003414|P4|Overall Study|Withdrawal by Subject|25
5496444|NCT01694485|19003415|P3|Overall Study|Withdrawal by Subject|7
5496445|NCT01694485|19003416|P2|Overall Study|Withdrawal by Subject|6
5496446|NCT01694485|19003417|P1|Overall Study|Withdrawal by Subject|20
5496447|NCT01694433|19003451|P2|Overall Study|Withdrawal by Subject|4
5496448|NCT01694433|19003452|P1|Overall Study|Withdrawal by Subject|3
5496449|NCT01694433|19003451|P2|Overall Study|Physician Decision|0
5496450|NCT01694433|19003452|P1|Overall Study|Physician Decision|1
5496451|NCT01694433|19003451|P2|Overall Study|Adverse Event|0
5496452|NCT01694433|19003452|P1|Overall Study|Adverse Event|7
5496453|NCT01694420|19003460|P1|Overall Study|Lost to Follow-up|3
5496454|NCT01694121|19003497|P2|Overall Study|Participant used false ID, was withdrawn|0
5496455|NCT01694121|19003498|P1|Overall Study|Participant used false ID, was withdrawn|1
5496456|NCT01693614|19003612|P3|Overall Study|Withdrawal by Subject|5
5496457|NCT01693614|19003613|P2|Overall Study|Withdrawal by Subject|0
5496458|NCT01693614|19003614|P1|Overall Study|Withdrawal by Subject|1
5496459|NCT01693614|19003612|P3|Overall Study|Withdrawal by subject/guardian|2
5496460|NCT01693614|19003613|P2|Overall Study|Withdrawal by subject/guardian|0
5496461|NCT01693614|19003614|P1|Overall Study|Withdrawal by subject/guardian|0
5496462|NCT01693614|19003612|P3|Overall Study|Physician Decision|4
5496463|NCT01693614|19003613|P2|Overall Study|Physician Decision|1
5496464|NCT01693614|19003614|P1|Overall Study|Physician Decision|1
5496465|NCT01693614|19003612|P3|Overall Study|Death|0
5496466|NCT01693614|19003613|P2|Overall Study|Death|0
5496467|NCT01693614|19003614|P1|Overall Study|Death|1
5496468|NCT01693614|19003612|P3|Overall Study|Protocol Violation|1
5496469|NCT01693614|19003613|P2|Overall Study|Protocol Violation|2
5496470|NCT01693614|19003614|P1|Overall Study|Protocol Violation|5
5496471|NCT01693614|19003612|P3|Overall Study|Disease progression|7
5496472|NCT01693614|19003613|P2|Overall Study|Disease progression|8
5496473|NCT01693614|19003614|P1|Overall Study|Disease progression|11
5496474|NCT01693614|19003612|P3|Overall Study|Adverse Event|5
5496475|NCT01693614|19003613|P2|Overall Study|Adverse Event|11
5496476|NCT01693614|19003614|P1|Overall Study|Adverse Event|7
5496477|NCT01693523|19003639|P3|Overall Study|Chemotherapy was held|0
5496478|NCT01693523|19003640|P2|Overall Study|Chemotherapy was held|2
5496479|NCT01693523|19003641|P1|Overall Study|Chemotherapy was held|1
5496480|NCT01693523|19003639|P3|Overall Study|Lack of compliance study medication|0
5496481|NCT01693523|19003640|P2|Overall Study|Lack of compliance study medication|2
5496482|NCT01693523|19003641|P1|Overall Study|Lack of compliance study medication|1
5496483|NCT01693523|19003639|P3|Overall Study|Withdrawal by Subject|2
5496484|NCT01693523|19003640|P2|Overall Study|Withdrawal by Subject|2
5496485|NCT01693523|19003641|P1|Overall Study|Withdrawal by Subject|1
5496486|NCT01693523|19003639|P3|Overall Study|Physician Decision|1
5496487|NCT01693523|19003640|P2|Overall Study|Physician Decision|0
5496488|NCT01693523|19003641|P1|Overall Study|Physician Decision|0
5496489|NCT01693523|19003639|P3|Overall Study|Lost to Follow-up|4
5496490|NCT01693523|19003640|P2|Overall Study|Lost to Follow-up|0
5496491|NCT01693523|19003641|P1|Overall Study|Lost to Follow-up|0
5496492|NCT01693523|19003639|P3|Overall Study|Death|1
5496493|NCT01693523|19003640|P2|Overall Study|Death|1
5496494|NCT01693523|19003641|P1|Overall Study|Death|0
5496495|NCT01693523|19003639|P3|Overall Study|Adverse Event|0
5496496|NCT01693523|19003640|P2|Overall Study|Adverse Event|1
5496497|NCT01693523|19003641|P1|Overall Study|Adverse Event|2
5496498|NCT01693367|19003657|P2|Overall Study|Physician Decision|1
5496499|NCT01693367|19003658|P1|Overall Study|Physician Decision|0
5496500|NCT01693367|19003657|P2|Overall Study|Withdrawal by Subject|1
5496501|NCT01693367|19003658|P1|Overall Study|Withdrawal by Subject|1
5496502|NCT01693250|19003676|P2|Overall Study|Lost to Follow-up|2
5496503|NCT01693250|19003677|P1|Overall Study|Lost to Follow-up|2
5496504|NCT01693185|19003687|P2|Overall Study|diagnostic procedure after colonoscopy|6
5496505|NCT01693185|19003688|P1|Overall Study|diagnostic procedure after colonoscopy|0
5496506|NCT01693120|19003704|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
5496507|NCT01693120|19003704|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
5496508|NCT01693120|19003704|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
5499307|NCT01667900|19014184|P4|Part B|Death|0
5496509|NCT01693120|19003704|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
5496510|NCT01693120|19003704|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
5496511|NCT01693120|19003704|P1|Enrollment|Other|1
5496512|NCT01693120|19003704|P1|Enrollment|Study closed|8
5496513|NCT01693120|19003704|P1|Enrollment|Adverse Event|1
5496514|NCT01693120|19003704|P1|Enrollment|Physician Decision|3
5496515|NCT01693120|19003704|P1|Enrollment|Protocol Violation|46
5496516|NCT01693120|19003704|P1|Enrollment|Withdrawal by Subject|10
5496517|NCT01693120|19003704|P1|Enrollment|Lost to Follow-up|1
5496518|NCT01693068|19003713|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
5496519|NCT01693068|19003714|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
5496520|NCT01693068|19003715|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
5496521|NCT01693068|19003713|P3|Randomization Period|On-study|0
5496522|NCT01693068|19003714|P2|Randomization Period|On-study|5
5496523|NCT01693068|19003715|P1|Randomization Period|On-study|2
5496524|NCT01693029|19003747|P2|Overall Study|Non-compliance|1
5496525|NCT01693029|19003748|P1|Overall Study|Non-compliance|2
5496526|NCT01693029|19003747|P2|Overall Study|Death|8
5496527|NCT01693029|19003748|P1|Overall Study|Death|5
5496528|NCT01693029|19003747|P2|Overall Study|Adverse Event|6
5496529|NCT01693029|19003748|P1|Overall Study|Adverse Event|1
5496530|NCT01693029|19003747|P2|Overall Study|Lost to Follow-up|1
5496531|NCT01693029|19003748|P1|Overall Study|Lost to Follow-up|0
5496532|NCT01693029|19003747|P2|Overall Study|Physician Decision|2
5496533|NCT01693029|19003748|P1|Overall Study|Physician Decision|0
5496534|NCT01693029|19003747|P2|Overall Study|Change in dialysis modality|1
5496535|NCT01693029|19003748|P1|Overall Study|Change in dialysis modality|2
5496536|NCT01693029|19003747|P2|Overall Study|Protocol Violation|7
5496537|NCT01693029|19003748|P1|Overall Study|Protocol Violation|6
5496538|NCT01693029|19003747|P2|Overall Study|Bindinging anti-EPO antibodies|2
5496539|NCT01693029|19003748|P1|Overall Study|Bindinging anti-EPO antibodies|6
5496540|NCT01693029|19003747|P2|Overall Study|Kidney transplantation|7
5496541|NCT01693029|19003748|P1|Overall Study|Kidney transplantation|7
5496542|NCT01693029|19003747|P2|Overall Study|Withdrawal by Subject|22
5496543|NCT01693029|19003748|P1|Overall Study|Withdrawal by Subject|15
5496544|NCT01692938|19003784|P2|Overall Study|Study completed prior to site completion|3
5496545|NCT01692938|19003785|P1|Overall Study|Study completed prior to site completion|3
5496546|NCT01692938|19003784|P2|Overall Study|Protocol Deviation|1
5496547|NCT01692938|19003785|P1|Overall Study|Protocol Deviation|1
5496548|NCT01692782|19003796|P3|Overall Study|Withdrawal by Subject|3
5496549|NCT01692782|19003797|P2|Overall Study|Withdrawal by Subject|10
5496550|NCT01692782|19003798|P1|Overall Study|Withdrawal by Subject|3
5496551|NCT01692782|19003796|P3|Overall Study|SAE not related to study drug|0
5496552|NCT01692782|19003797|P2|Overall Study|SAE not related to study drug|1
5496553|NCT01692782|19003798|P1|Overall Study|SAE not related to study drug|0
5496554|NCT01692782|19003796|P3|Overall Study|Non-compliant with study visits|1
5496555|NCT01692782|19003797|P2|Overall Study|Non-compliant with study visits|0
5496556|NCT01692782|19003798|P1|Overall Study|Non-compliant with study visits|0
5496557|NCT01692782|19003796|P3|Overall Study|Non-complance with study drug|1
5496558|NCT01692782|19003797|P2|Overall Study|Non-complance with study drug|4
5496559|NCT01692782|19003798|P1|Overall Study|Non-complance with study drug|0
5496560|NCT01692782|19003796|P3|Overall Study|Protocol Violation|2
5496561|NCT01692782|19003797|P2|Overall Study|Protocol Violation|0
5496562|NCT01692782|19003798|P1|Overall Study|Protocol Violation|1
5496563|NCT01692782|19003796|P3|Overall Study|Pregnancy|0
5496564|NCT01692782|19003797|P2|Overall Study|Pregnancy|0
5496565|NCT01692782|19003798|P1|Overall Study|Pregnancy|1
5496566|NCT01692782|19003796|P3|Overall Study|Lost to Follow-up|1
5496567|NCT01692782|19003797|P2|Overall Study|Lost to Follow-up|7
5496568|NCT01692782|19003798|P1|Overall Study|Lost to Follow-up|2
5496569|NCT01692782|19003796|P3|Overall Study|Lack of Efficacy|0
5496570|NCT01692782|19003797|P2|Overall Study|Lack of Efficacy|2
5496571|NCT01692782|19003798|P1|Overall Study|Lack of Efficacy|1
5496572|NCT01692782|19003796|P3|Overall Study|Adverse Event|2
5496573|NCT01692782|19003797|P2|Overall Study|Adverse Event|32
5496574|NCT01692782|19003798|P1|Overall Study|Adverse Event|12
5496575|NCT01692730|19003907|P2|Overall Study|Lost to Follow-up|227
5496576|NCT01692730|19003908|P1|Overall Study|Lost to Follow-up|225
5496577|NCT01692626|19003922|P2|Overall Study|Withdrawal by Subject|0
5496578|NCT01692626|19003923|P1|Overall Study|Withdrawal by Subject|1
5496579|NCT01692626|19003922|P2|Overall Study|Protocol Violation|2
5496580|NCT01692626|19003923|P1|Overall Study|Protocol Violation|1
5496581|NCT01692626|19003922|P2|Overall Study|Adverse Event|3
5496582|NCT01692626|19003923|P1|Overall Study|Adverse Event|2
5496583|NCT01692626|19003922|P2|Overall Study|Death|1
5496584|NCT01692626|19003923|P1|Overall Study|Death|0
5496585|NCT01692301|19003958|P2|Overall Study|Lost to Follow-up|1
5496586|NCT01692301|19003959|P1|Overall Study|Lost to Follow-up|1
5496587|NCT01692301|19003958|P2|Overall Study|Physician Decision|2
5496588|NCT01692301|19003959|P1|Overall Study|Physician Decision|2
5496589|NCT01692301|19003958|P2|Overall Study|Technical problems|1
5496590|NCT01692301|19003959|P1|Overall Study|Technical problems|0
5496591|NCT01692301|19003958|P2|Overall Study|Patient/guardian decision|15
5496592|NCT01692301|19003959|P1|Overall Study|Patient/guardian decision|16
5496593|NCT01692301|19003958|P2|Overall Study|Protocol deviation|2
5496594|NCT01692301|19003959|P1|Overall Study|Protocol deviation|9
5496595|NCT01692301|19003958|P2|Overall Study|Non-compliance with study treatment|2
5496596|NCT01692301|19003959|P1|Overall Study|Non-compliance with study treatment|1
5496597|NCT01692301|19003958|P2|Overall Study|Lack of Efficacy|5
5496598|NCT01692301|19003959|P1|Overall Study|Lack of Efficacy|0
5496599|NCT01692301|19003958|P2|Overall Study|Death|2
5496600|NCT01692301|19003959|P1|Overall Study|Death|1
5496601|NCT01692301|19003958|P2|Overall Study|Adverse Event|12
5496602|NCT01692301|19003959|P1|Overall Study|Adverse Event|15
5496603|NCT01692275|19003991|P2|Overall Study|Withdrawal by Subject|11
5496604|NCT01692275|19003992|P1|Overall Study|Withdrawal by Subject|9
5496605|NCT01692275|19003991|P2|Overall Study|Lost to Follow-up|48
5496606|NCT01692275|19003992|P1|Overall Study|Lost to Follow-up|57
5496607|NCT01692197|19004052|P1|Overall Study|Failed Screening|3
5496608|NCT01691898|19004074|P6|Overall Study|Non-Compliance|0
5496609|NCT01691898|19004075|P5|Overall Study|Non-Compliance|1
5496610|NCT01691898|19004076|P4|Overall Study|Non-Compliance|0
5496611|NCT01691898|19004077|P3|Overall Study|Non-Compliance|0
5496612|NCT01691898|19004078|P2|Overall Study|Non-Compliance|0
5496613|NCT01691898|19004079|P1|Overall Study|Non-Compliance|0
5496614|NCT01691898|19004074|P6|Overall Study|Withdrawal by Subject|3
5496615|NCT01691898|19004075|P5|Overall Study|Withdrawal by Subject|3
5496616|NCT01691898|19004076|P4|Overall Study|Withdrawal by Subject|1
5496617|NCT01691898|19004077|P3|Overall Study|Withdrawal by Subject|2
5496618|NCT01691898|19004078|P2|Overall Study|Withdrawal by Subject|8
5496619|NCT01691898|19004079|P1|Overall Study|Withdrawal by Subject|9
5496620|NCT01691898|19004074|P6|Overall Study|Lost to Follow-up|0
5496621|NCT01691898|19004075|P5|Overall Study|Lost to Follow-up|1
5496622|NCT01691898|19004076|P4|Overall Study|Lost to Follow-up|0
5496623|NCT01691898|19004077|P3|Overall Study|Lost to Follow-up|0
5496624|NCT01691898|19004078|P2|Overall Study|Lost to Follow-up|1
5496625|NCT01691898|19004079|P1|Overall Study|Lost to Follow-up|3
5496626|NCT01691898|19004074|P6|Overall Study|Progression of Disease|1
5496627|NCT01691898|19004075|P5|Overall Study|Progression of Disease|0
5496628|NCT01691898|19004076|P4|Overall Study|Progression of Disease|0
5496629|NCT01691898|19004077|P3|Overall Study|Progression of Disease|1
5496630|NCT01691898|19004078|P2|Overall Study|Progression of Disease|2
5496631|NCT01691898|19004079|P1|Overall Study|Progression of Disease|1
5496632|NCT01691898|19004074|P6|Overall Study|Adverse Event|0
5496633|NCT01691898|19004075|P5|Overall Study|Adverse Event|1
5496634|NCT01691898|19004076|P4|Overall Study|Adverse Event|1
5496635|NCT01691898|19004077|P3|Overall Study|Adverse Event|0
5496636|NCT01691898|19004078|P2|Overall Study|Adverse Event|1
5496637|NCT01691898|19004079|P1|Overall Study|Adverse Event|0
5496638|NCT01691898|19004074|P6|Overall Study|Death|31
5496639|NCT01691898|19004075|P5|Overall Study|Death|8
5496640|NCT01691898|19004076|P4|Overall Study|Death|3
5496641|NCT01691898|19004077|P3|Overall Study|Death|6
5496642|NCT01691898|19004078|P2|Overall Study|Death|32
5496643|NCT01691898|19004079|P1|Overall Study|Death|34
5496644|NCT01691885|19004233|P2|Washout Period (7-9 Days)|Adverse Event|1
5496645|NCT01691885|19004234|P1|Washout Period (7-9 Days)|Adverse Event|0
5496646|NCT01691885|19004233|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
5496647|NCT01691885|19004234|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
5496648|NCT01691859|19004240|P1|Overall Study|Withdrawal by Subject|31
5496649|NCT01691859|19004240|P1|Overall Study|Physician Decision|6
5496650|NCT01691859|19004240|P1|Overall Study|Lost to Follow-up|5
5496651|NCT01691859|19004240|P1|Overall Study|Study closed/terminated|50
5496652|NCT01691859|19004240|P1|Overall Study|Product commercially available|221
5496653|NCT01691859|19004240|P1|Overall Study|Protocol Violation|4
5496654|NCT01691859|19004240|P1|Overall Study|Lack of Efficacy|11
5496655|NCT01691859|19004240|P1|Overall Study|Adverse Event|19
5496656|NCT01691820|19004287|P3|Overall Study|Other (unspecified)|1
5496657|NCT01691820|19004288|P2|Overall Study|Other (unspecified)|0
5496658|NCT01691820|19004289|P1|Overall Study|Other (unspecified)|5
5496659|NCT01691820|19004287|P3|Overall Study|Lost to Follow-up|0
5496660|NCT01691820|19004288|P2|Overall Study|Lost to Follow-up|15
5496661|NCT01691820|19004289|P1|Overall Study|Lost to Follow-up|8
5496662|NCT01691820|19004287|P3|Overall Study|Migrated/moved from study area|0
5496663|NCT01691820|19004288|P2|Overall Study|Migrated/moved from study area|4
5496664|NCT01691820|19004289|P1|Overall Study|Migrated/moved from study area|7
5496665|NCT01691820|19004287|P3|Overall Study|Consent withdrawal (not due to an AE)|0
5496666|NCT01691820|19004288|P2|Overall Study|Consent withdrawal (not due to an AE)|15
5496667|NCT01691820|19004289|P1|Overall Study|Consent withdrawal (not due to an AE)|9
5496668|NCT01691794|19004327|P3|Overall Study|Did not complete first 24 weeks of study|3
5496669|NCT01691794|19004328|P2|Overall Study|Did not complete first 24 weeks of study|3
5496670|NCT01691794|19004329|P1|Overall Study|Did not complete first 24 weeks of study|0
5496671|NCT01691794|19004327|P3|Overall Study|Completed Only first 24 weeks of study|3
5496672|NCT01691794|19004328|P2|Overall Study|Completed Only first 24 weeks of study|2
5496673|NCT01691794|19004329|P1|Overall Study|Completed Only first 24 weeks of study|0
5496674|NCT01691794|19004327|P3|Overall Study|Adverse Event|1
5496675|NCT01691794|19004328|P2|Overall Study|Adverse Event|1
5496676|NCT01691794|19004329|P1|Overall Study|Adverse Event|0
5496677|NCT01691794|19004327|P3|Overall Study|Participant request to discontinue|0
5496678|NCT01691794|19004328|P2|Overall Study|Participant request to discontinue|1
5496679|NCT01691794|19004329|P1|Overall Study|Participant request to discontinue|0
5496680|NCT01691794|19004327|P3|Overall Study|Lack of Efficacy|1
5496681|NCT01691794|19004328|P2|Overall Study|Lack of Efficacy|7
5496682|NCT01691794|19004329|P1|Overall Study|Lack of Efficacy|0
5496683|NCT01691794|19004327|P3|Overall Study|Death|1
5496684|NCT01691794|19004328|P2|Overall Study|Death|0
5496685|NCT01691794|19004329|P1|Overall Study|Death|0
5496686|NCT01691794|19004327|P3|Overall Study|Poor/Non-Compliance|1
5496687|NCT01691794|19004328|P2|Overall Study|Poor/Non-Compliance|4
5496688|NCT01691794|19004329|P1|Overall Study|Poor/Non-Compliance|1
5496689|NCT01691781|19004345|P2|Overall Study|Adverse Event|1
5496690|NCT01691781|19004346|P1|Overall Study|Adverse Event|0
5496691|NCT01691781|19004345|P2|Overall Study|Protocol Violation|2
5496692|NCT01691781|19004346|P1|Overall Study|Protocol Violation|2
5496693|NCT01691781|19004345|P2|Overall Study|Physician Decision|1
5496694|NCT01691781|19004346|P1|Overall Study|Physician Decision|1
5496695|NCT01691781|19004345|P2|Overall Study|Withdrawal by Subject|3
5496696|NCT01691781|19004346|P1|Overall Study|Withdrawal by Subject|4
5496697|NCT01691768|19004358|P2|Overall Study|Investigator decision|1
5496698|NCT01691768|19004359|P1|Overall Study|Investigator decision|1
5496699|NCT01691768|19004358|P2|Overall Study|Relocated|1
5496700|NCT01691768|19004359|P1|Overall Study|Relocated|0
5496701|NCT01691768|19004358|P2|Overall Study|Withdrawal by Subject|9
5496702|NCT01691768|19004359|P1|Overall Study|Withdrawal by Subject|10
5496703|NCT01691768|19004358|P2|Overall Study|Lost to Follow-up|3
5496704|NCT01691768|19004359|P1|Overall Study|Lost to Follow-up|4
5496705|NCT01691768|19004358|P2|Overall Study|Death|2
5496706|NCT01691768|19004359|P1|Overall Study|Death|0
5496707|NCT01691612|19004394|P1|Overall Study|Adverse Event|1
5496708|NCT01691612|19004394|P1|Overall Study|deemed ineligible after 1st visit|6
5496709|NCT01691521|19004505|P3|Overall Study|Withdrawal by Subject|4
5496710|NCT01691521|19004506|P2|Overall Study|Withdrawal by Subject|9
5496711|NCT01691521|19004507|P1|Overall Study|Withdrawal by Subject|5
5496712|NCT01691521|19004505|P3|Overall Study|Physician Decision|0
5496713|NCT01691521|19004506|P2|Overall Study|Physician Decision|1
5496714|NCT01691521|19004507|P1|Overall Study|Physician Decision|2
5496715|NCT01691521|19004505|P3|Overall Study|Lost to Follow-up|2
5496716|NCT01691521|19004506|P2|Overall Study|Lost to Follow-up|2
5496717|NCT01691521|19004507|P1|Overall Study|Lost to Follow-up|0
5496718|NCT01691521|19004505|P3|Overall Study|Protocol Violation|0
5496719|NCT01691521|19004506|P2|Overall Study|Protocol Violation|3
5496720|NCT01691521|19004507|P1|Overall Study|Protocol Violation|0
5496721|NCT01691521|19004505|P3|Overall Study|Lack of Efficacy|2
5496722|NCT01691521|19004506|P2|Overall Study|Lack of Efficacy|1
5496723|NCT01691521|19004507|P1|Overall Study|Lack of Efficacy|1
5496724|NCT01691521|19004505|P3|Overall Study|Adverse Event|1
5496725|NCT01691521|19004506|P2|Overall Study|Adverse Event|0
5496726|NCT01691521|19004507|P1|Overall Study|Adverse Event|4
5496727|NCT01691508|19004529|P2|Overall Study|Withdrawal by Subject|0
5496728|NCT01691508|19004530|P1|Overall Study|Withdrawal by Subject|1
5496729|NCT01691508|19004529|P2|Overall Study|Adverse Event|3
5496730|NCT01691508|19004530|P1|Overall Study|Adverse Event|3
5496731|NCT01691482|19004544|P2|Treatment Period 2|Protocol Violation|1
5496732|NCT01691482|19004545|P1|Treatment Period 2|Protocol Violation|1
5496733|NCT01691482|19004544|P2|Treatment Period 2|Adverse Event|1
5496734|NCT01691482|19004545|P1|Treatment Period 2|Adverse Event|0
5496735|NCT01691430|19004563|P2|Overall Study|Lost to Follow-up|3
5496736|NCT01691430|19004564|P1|Overall Study|Lost to Follow-up|0
5496737|NCT01691430|19004563|P2|Overall Study|Withdrawal by Subject|1
5496738|NCT01691430|19004564|P1|Overall Study|Withdrawal by Subject|5
5496739|NCT01691430|19004563|P2|Overall Study|Death|16
5496740|NCT01691430|19004564|P1|Overall Study|Death|17
5496741|NCT01691378|19004590|P2|Overall Study|Lost to Follow-up|2
5496742|NCT01691378|19004591|P1|Overall Study|Lost to Follow-up|5
5496743|NCT01691378|19004590|P2|Overall Study|Withdrawal by Subject|0
5496744|NCT01691378|19004591|P1|Overall Study|Withdrawal by Subject|2
5496745|NCT01691248|19004674|P2|Overall Study|Not Treated|7
5496746|NCT01691248|19004675|P1|Overall Study|Not Treated|4
5496747|NCT01691248|19004674|P2|Overall Study|Reason not provided|4
5496748|NCT01691248|19004675|P1|Overall Study|Reason not provided|4
5496749|NCT01691248|19004674|P2|Overall Study|Lost to Follow-up|5
5496750|NCT01691248|19004675|P1|Overall Study|Lost to Follow-up|2
5496751|NCT01691248|19004674|P2|Overall Study|Confirmed CDAD|31
5496752|NCT01691248|19004675|P1|Overall Study|Confirmed CDAD|14
5496753|NCT01691248|19004674|P2|Overall Study|Withdrawal by Subject|18
5496754|NCT01691248|19004675|P1|Overall Study|Withdrawal by Subject|20
5496755|NCT01691248|19004674|P2|Overall Study|Adverse Event|22
5496756|NCT01691248|19004675|P1|Overall Study|Adverse Event|24
5496757|NCT01691248|19004674|P2|Overall Study|Protocol Violation|27
5496758|NCT01691248|19004675|P1|Overall Study|Protocol Violation|43
5496759|NCT01691105|19004687|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
5496760|NCT01691105|19004688|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
5496761|NCT01691105|19004687|P2|12 Month Biochemical Verification|Lost to Follow-up|71
5496762|NCT01691105|19004688|P1|12 Month Biochemical Verification|Lost to Follow-up|50
5496763|NCT01691105|19004687|P2|12 Month Biochemical Verification|Death|30
5496764|NCT01691105|19004688|P1|12 Month Biochemical Verification|Death|22
5496765|NCT01691105|19004687|P2|12 Month Follow-up|Death|30
5496766|NCT01691105|19004688|P1|12 Month Follow-up|Death|22
5496767|NCT01691105|19004687|P2|12 Month Follow-up|Lost to Follow-up|71
5496768|NCT01691105|19004688|P1|12 Month Follow-up|Lost to Follow-up|50
5496769|NCT01691105|19004687|P2|6 Month Follow-up|Death|13
5496770|NCT01691105|19004688|P1|6 Month Follow-up|Death|13
5496771|NCT01691105|19004687|P2|6 Month Follow-up|Lost to Follow-up|58
5496772|NCT01691105|19004688|P1|6 Month Follow-up|Lost to Follow-up|39
5499308|NCT01667900|19014185|P3|Part B|Death|0
5496773|NCT01691105|19004687|P2|1 Month Follow-up|Death|3
5496774|NCT01691105|19004688|P1|1 Month Follow-up|Death|2
5496775|NCT01691105|19004687|P2|1 Month Follow-up|Lost to Follow-up|38
5496776|NCT01691105|19004688|P1|1 Month Follow-up|Lost to Follow-up|41
5496777|NCT01691092|19004708|P1|Overall Study|screen fail|19
5496778|NCT01691092|19004708|P1|Overall Study|used for different study|2
5496779|NCT01691092|19004708|P1|Overall Study|non-compliance|3
5496780|NCT01691092|19004708|P1|Overall Study|Withdrawal by Subject|3
5496781|NCT01691092|19004708|P1|Overall Study|Physician Decision|4
5496782|NCT01691092|19004708|P1|Overall Study|Lost to Follow-up|10
5496783|NCT01691014|19004732|P4|Overall Study|Lack of Efficacy|0
5496784|NCT01691014|19004733|P3|Overall Study|Lack of Efficacy|7
5496785|NCT01691014|19004734|P2|Overall Study|Lack of Efficacy|3
5496786|NCT01691014|19004735|P1|Overall Study|Lack of Efficacy|2
5496787|NCT01691014|19004732|P4|Overall Study|Adverse Event|1
5496788|NCT01691014|19004733|P3|Overall Study|Adverse Event|1
5496789|NCT01691014|19004734|P2|Overall Study|Adverse Event|5
5496790|NCT01691014|19004735|P1|Overall Study|Adverse Event|0
5496791|NCT01691014|19004732|P4|Overall Study|Withdrawal by Subject|1
5496792|NCT01691014|19004733|P3|Overall Study|Withdrawal by Subject|1
5496793|NCT01691014|19004734|P2|Overall Study|Withdrawal by Subject|1
5496794|NCT01691014|19004735|P1|Overall Study|Withdrawal by Subject|0
5496795|NCT01691014|19004732|P4|Overall Study|Other|0
5496796|NCT01691014|19004733|P3|Overall Study|Other|2
5496797|NCT01691014|19004734|P2|Overall Study|Other|0
5496798|NCT01691014|19004735|P1|Overall Study|Other|0
5496799|NCT01691014|19004732|P4|Overall Study|Premature Termination|3
5496800|NCT01691014|19004733|P3|Overall Study|Premature Termination|0
5496801|NCT01691014|19004734|P2|Overall Study|Premature Termination|6
5496802|NCT01691014|19004735|P1|Overall Study|Premature Termination|1
5496803|NCT01690988|19004780|P3|Overall Study|Sedated|2
5496804|NCT01690988|19004781|P2|Overall Study|Sedated|1
5496805|NCT01690988|19004782|P1|Overall Study|Sedated|1
5496806|NCT01690988|19004780|P3|Overall Study|Death|1
5496807|NCT01690988|19004781|P2|Overall Study|Death|1
5496808|NCT01690988|19004782|P1|Overall Study|Death|1
5496809|NCT01690988|19004780|P3|Overall Study|Determined ineligible|0
5496810|NCT01690988|19004781|P2|Overall Study|Determined ineligible|0
5496811|NCT01690988|19004782|P1|Overall Study|Determined ineligible|1
5496812|NCT01690988|19004780|P3|Overall Study|Operation Cancelled|0
5496813|NCT01690988|19004781|P2|Overall Study|Operation Cancelled|1
5496814|NCT01690988|19004782|P1|Overall Study|Operation Cancelled|1
5496815|NCT01690988|19004780|P3|Overall Study|Physician Decision|1
5496816|NCT01690988|19004781|P2|Overall Study|Physician Decision|0
5496817|NCT01690988|19004782|P1|Overall Study|Physician Decision|0
5496818|NCT01690988|19004780|P3|Overall Study|Withdrawal by Subject|3
5496819|NCT01690988|19004781|P2|Overall Study|Withdrawal by Subject|2
5496820|NCT01690988|19004782|P1|Overall Study|Withdrawal by Subject|2
5496821|NCT01690299|19004850|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
5496822|NCT01690299|19004851|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5496823|NCT01690299|19004852|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5496824|NCT01690299|19004853|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5496825|NCT01690299|19004854|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5496826|NCT01690299|19004855|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
5496827|NCT01690299|19004850|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
5496828|NCT01690299|19004851|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
5496829|NCT01690299|19004852|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
5496830|NCT01690299|19004853|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
5496831|NCT01690299|19004854|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
5496832|NCT01690299|19004855|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
5496833|NCT01690299|19004850|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
5496834|NCT01690299|19004851|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
5496835|NCT01690299|19004852|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
5496836|NCT01690299|19004853|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
5496837|NCT01690299|19004854|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
5496838|NCT01690299|19004855|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
5496839|NCT01690299|19004850|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
5496840|NCT01690299|19004851|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
5496841|NCT01690299|19004852|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5496842|NCT01690299|19004853|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5496843|NCT01690299|19004854|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5496844|NCT01690299|19004855|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
5496845|NCT01690299|19004850|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
5496846|NCT01690299|19004851|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
5496847|NCT01690299|19004852|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
5496848|NCT01690299|19004853|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
5496849|NCT01690299|19004854|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
5496850|NCT01690299|19004855|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
5496851|NCT01690299|19004850|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
5496852|NCT01690299|19004851|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
5499309|NCT01667900|19014186|P2|Part B|Death|0
5496853|NCT01690299|19004852|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
5496854|NCT01690299|19004853|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
5496855|NCT01690299|19004854|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
5496856|NCT01690299|19004855|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
5496857|NCT01690299|19004850|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
5496858|NCT01690299|19004851|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
5496859|NCT01690299|19004852|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
5496860|NCT01690299|19004853|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
5496861|NCT01690299|19004854|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
5496862|NCT01690299|19004855|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
5496863|NCT01690299|19004850|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5496864|NCT01690299|19004851|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5496865|NCT01690299|19004852|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5496866|NCT01690299|19004853|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5496867|NCT01690299|19004854|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
5496868|NCT01690299|19004855|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
5496869|NCT01690299|19004850|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5496870|NCT01690299|19004851|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5496871|NCT01690299|19004852|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5496872|NCT01690299|19004853|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5496873|NCT01690299|19004854|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5496874|NCT01690299|19004855|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
5496875|NCT01690299|19004850|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
5496876|NCT01690299|19004851|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
5496877|NCT01690299|19004852|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
5496878|NCT01690299|19004853|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
5496879|NCT01690299|19004854|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
5496880|NCT01690299|19004855|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
5496881|NCT01690143|19004952|P1|Overall Study|Withdrawal by Subject|1
5496882|NCT01690130|19004962|P2|Overall Study|Subject have cancelled visit.|0
5496883|NCT01690130|19004963|P1|Overall Study|Subject have cancelled visit.|1
5496884|NCT01690052|19005010|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
5496885|NCT01690052|19005011|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
5496886|NCT01689974|19005028|P2|Overall Study|Termination of Study|5
5496887|NCT01689974|19005029|P1|Overall Study|Termination of Study|5
5496888|NCT01689857|19005060|P2|Overall Study|Lost to Follow-up|2
5496889|NCT01689857|19005061|P1|Overall Study|Lost to Follow-up|5
5496890|NCT01689649|19005154|P1|Overall Study|Lost to Follow-up|5
5496891|NCT01689649|19005154|P1|Overall Study|Protocol Violation|3
5496892|NCT01689649|19005154|P1|Overall Study|Non-compliance|11
5496893|NCT01689649|19005154|P1|Overall Study|Lack of Efficacy|3
5496894|NCT01689532|19005166|P2|Overall Study|Physician Decision|0
5496895|NCT01689532|19005167|P1|Overall Study|Physician Decision|2
5496896|NCT01689532|19005166|P2|Overall Study|Withdrawal by Subject|2
5496897|NCT01689532|19005167|P1|Overall Study|Withdrawal by Subject|1
5496898|NCT01689532|19005166|P2|Overall Study|Lack of Efficacy|2
5496899|NCT01689532|19005167|P1|Overall Study|Lack of Efficacy|2
5496900|NCT01689532|19005166|P2|Overall Study|Adverse Event|5
5496901|NCT01689532|19005167|P1|Overall Study|Adverse Event|9
5496902|NCT01689519|19005231|P2|Safety Population|Withdrawal by Subject|20
5496903|NCT01689519|19005232|P1|Safety Population|Withdrawal by Subject|20
5496904|NCT01689519|19005231|P2|Safety Population|Study Terminated By Sponsor|47
5496905|NCT01689519|19005232|P1|Safety Population|Study Terminated By Sponsor|60
5496906|NCT01689519|19005231|P2|Safety Population|Physician Decision|1
5496907|NCT01689519|19005232|P1|Safety Population|Physician Decision|4
5496908|NCT01689519|19005231|P2|Safety Population|Other|4
5496909|NCT01689519|19005232|P1|Safety Population|Other|2
5496910|NCT01689519|19005231|P2|Safety Population|Lost to Follow-up|8
5496911|NCT01689519|19005232|P1|Safety Population|Lost to Follow-up|4
5496912|NCT01689519|19005231|P2|Safety Population|Death|165
5496913|NCT01689519|19005232|P1|Safety Population|Death|158
5496914|NCT01689519|19005231|P2|Intent to Treat|Withdrawal by Subject|20
5496915|NCT01689519|19005232|P1|Intent to Treat|Withdrawal by Subject|21
5496916|NCT01689519|19005231|P2|Intent to Treat|Study terminated by Spon6sor|48
5496917|NCT01689519|19005232|P1|Intent to Treat|Study terminated by Spon6sor|59
5496918|NCT01689519|19005231|P2|Intent to Treat|Physician Decision|1
5496919|NCT01689519|19005232|P1|Intent to Treat|Physician Decision|4
5496920|NCT01689519|19005231|P2|Intent to Treat|Other|4
5496921|NCT01689519|19005232|P1|Intent to Treat|Other|2
5496922|NCT01689519|19005231|P2|Intent to Treat|Lost to Follow-up|8
5496923|NCT01689519|19005232|P1|Intent to Treat|Lost to Follow-up|4
5496924|NCT01689519|19005231|P2|Intent to Treat|Death|167
5496925|NCT01689519|19005232|P1|Intent to Treat|Death|157
5496926|NCT01689363|19005257|P8|Overall Study|Protocol Violation|0
5496927|NCT01689363|19005258|P7|Overall Study|Protocol Violation|0
5496928|NCT01689363|19005259|P6|Overall Study|Protocol Violation|0
5496929|NCT01689363|19005260|P5|Overall Study|Protocol Violation|0
5496930|NCT01689363|19005261|P4|Overall Study|Protocol Violation|0
5496931|NCT01689363|19005262|P3|Overall Study|Protocol Violation|0
5496932|NCT01689363|19005263|P2|Overall Study|Protocol Violation|1
5496933|NCT01689363|19005264|P1|Overall Study|Protocol Violation|0
5496934|NCT01689337|19005319|P1|Overall Study|Study Discontinuation|1
5496935|NCT01689207|19005358|P11|Overall Study|Adverse Event|0
5496936|NCT01689207|19005359|P10|Overall Study|Adverse Event|0
5496937|NCT01689207|19005360|P9|Overall Study|Adverse Event|1
5496938|NCT01689207|19005361|P8|Overall Study|Adverse Event|0
5496939|NCT01689207|19005362|P7|Overall Study|Adverse Event|0
5496940|NCT01689207|19005363|P6|Overall Study|Adverse Event|1
5496941|NCT01689207|19005364|P5|Overall Study|Adverse Event|2
5496942|NCT01689207|19005365|P4|Overall Study|Adverse Event|0
5496943|NCT01689207|19005366|P3|Overall Study|Adverse Event|0
5496944|NCT01689207|19005367|P2|Overall Study|Adverse Event|1
5496945|NCT01689207|19005368|P1|Overall Study|Adverse Event|0
5496946|NCT01688999|19005476|P3|Overall Study|Ineligible/Not treated|0
5496947|NCT01688999|19005477|P2|Overall Study|Ineligible/Not treated|0
5496948|NCT01688999|19005478|P1|Overall Study|Ineligible/Not treated|1
5496949|NCT01688999|19005476|P3|Overall Study|Adverse Event|2
5496950|NCT01688999|19005477|P2|Overall Study|Adverse Event|0
5496951|NCT01688999|19005478|P1|Overall Study|Adverse Event|2
5496952|NCT01688999|19005476|P3|Overall Study|Withdrawal by Subject|1
5496953|NCT01688999|19005477|P2|Overall Study|Withdrawal by Subject|1
5496954|NCT01688999|19005478|P1|Overall Study|Withdrawal by Subject|5
5496955|NCT01688973|19005494|P2|Overall Study|Ineligible|3
5496956|NCT01688973|19005495|P1|Overall Study|Ineligible|2
5496957|NCT01688921|19005509|P2|Overall Study|informed consent|0
5496958|NCT01688921|19005510|P1|Overall Study|informed consent|3
5496959|NCT01688921|19005509|P2|Overall Study|Protocol Violation|1
5496960|NCT01688921|19005510|P1|Overall Study|Protocol Violation|0
5496961|NCT01688921|19005509|P2|Overall Study|Physician Decision|1
5496962|NCT01688921|19005510|P1|Overall Study|Physician Decision|6
5496963|NCT01688921|19005509|P2|Overall Study|Lost to Follow-up|13
5496964|NCT01688921|19005510|P1|Overall Study|Lost to Follow-up|7
5496965|NCT01688882|19005542|P2|Overall Study|Administrative problems|0
5496966|NCT01688882|19005543|P1|Overall Study|Administrative problems|1
5496967|NCT01688882|19005542|P2|Overall Study|Unsatisfactory therapeutic effect|1
5496968|NCT01688882|19005543|P1|Overall Study|Unsatisfactory therapeutic effect|1
5496969|NCT01688882|19005542|P2|Overall Study|Adverse Event|0
5496970|NCT01688882|19005543|P1|Overall Study|Adverse Event|1
5496971|NCT01688830|19005614|P21|Overall Study|Lost to Follow-up|0
5496972|NCT01688830|19005615|P20|Overall Study|Lost to Follow-up|0
5496973|NCT01688830|19005616|P19|Overall Study|Lost to Follow-up|0
5496974|NCT01688830|19005617|P18|Overall Study|Lost to Follow-up|0
5496975|NCT01688830|19005618|P17|Overall Study|Lost to Follow-up|0
5496976|NCT01688830|19005619|P16|Overall Study|Lost to Follow-up|0
5496977|NCT01688830|19005620|P15|Overall Study|Lost to Follow-up|0
5496978|NCT01688830|19005621|P14|Overall Study|Lost to Follow-up|0
5496979|NCT01688830|19005622|P13|Overall Study|Lost to Follow-up|0
5496980|NCT01688830|19005623|P12|Overall Study|Lost to Follow-up|0
5496981|NCT01688830|19005624|P11|Overall Study|Lost to Follow-up|1
5496982|NCT01688830|19005625|P10|Overall Study|Lost to Follow-up|0
5496983|NCT01688830|19005626|P9|Overall Study|Lost to Follow-up|0
5496984|NCT01688830|19005627|P8|Overall Study|Lost to Follow-up|0
5496985|NCT01688830|19005628|P7|Overall Study|Lost to Follow-up|0
5496986|NCT01688830|19005629|P6|Overall Study|Lost to Follow-up|0
5496987|NCT01688830|19005630|P5|Overall Study|Lost to Follow-up|0
5496988|NCT01688830|19005631|P4|Overall Study|Lost to Follow-up|0
5496989|NCT01688830|19005632|P3|Overall Study|Lost to Follow-up|0
5496990|NCT01688830|19005633|P2|Overall Study|Lost to Follow-up|0
5496991|NCT01688830|19005634|P1|Overall Study|Lost to Follow-up|0
5496992|NCT01688739|19005788|P10|Overall Study|Administrative Decision|0
5496993|NCT01688739|19005789|P9|Overall Study|Administrative Decision|0
5496994|NCT01688739|19005790|P8|Overall Study|Administrative Decision|0
5496995|NCT01688739|19005791|P7|Overall Study|Administrative Decision|0
5496996|NCT01688739|19005792|P6|Overall Study|Administrative Decision|0
5496997|NCT01688739|19005793|P5|Overall Study|Administrative Decision|0
5496998|NCT01688739|19005794|P4|Overall Study|Administrative Decision|0
5496999|NCT01688739|19005795|P3|Overall Study|Administrative Decision|0
5497000|NCT01688739|19005796|P2|Overall Study|Administrative Decision|0
5497001|NCT01688739|19005797|P1|Overall Study|Administrative Decision|1
5497002|NCT01688726|19005873|P2|Overall Study|Relocated abroad|1
5497003|NCT01688726|19005874|P1|Overall Study|Relocated abroad|0
5497004|NCT01688726|19005873|P2|Overall Study|Adverse Event|0
5497005|NCT01688726|19005874|P1|Overall Study|Adverse Event|1
5497006|NCT01688635|19005886|P2|Washout 3|Withdrawal by Subject|0
5497007|NCT01688635|19005887|P1|Washout 3|Withdrawal by Subject|1
5497008|NCT01688635|19005886|P2|Washout 2|Sponsor Decision|2
5497009|NCT01688635|19005887|P1|Washout 2|Sponsor Decision|1
5497010|NCT01688635|19005886|P2|Washout 2|Withdrawal by Subject|0
5497011|NCT01688635|19005887|P1|Washout 2|Withdrawal by Subject|1
5497012|NCT01688635|19005886|P2|Washout 2|Physician Decision|0
5497013|NCT01688635|19005887|P1|Washout 2|Physician Decision|1
5497014|NCT01688635|19005886|P2|Washout 1|Physician Decision|1
5497015|NCT01688635|19005887|P1|Washout 1|Physician Decision|0
5497016|NCT01688635|19005886|P2|Washout 1|Adverse Event|1
5497017|NCT01688635|19005887|P1|Washout 1|Adverse Event|0
5497018|NCT01688635|19005886|P2|Washout 1|Withdrawal by Subject|0
5497019|NCT01688635|19005887|P1|Washout 1|Withdrawal by Subject|1
5497020|NCT01688466|19005934|P2|Overall Study|Not evaluable|1
5497021|NCT01688466|19005935|P1|Overall Study|Not evaluable|0
5497022|NCT01688466|19005934|P2|Overall Study|Adverse Event|4
5497023|NCT01688466|19005935|P1|Overall Study|Adverse Event|0
5497024|NCT01688466|19005934|P2|Overall Study|Death|1
5497025|NCT01688466|19005935|P1|Overall Study|Death|0
5497026|NCT01688466|19005934|P2|Overall Study|Withdrawal by Subject|1
5497027|NCT01688466|19005935|P1|Overall Study|Withdrawal by Subject|2
5497028|NCT01688050|19006026|P1|Overall Study|Withdrawal by Subject|10
5497029|NCT01688050|19006026|P1|Overall Study|Lost to Follow-up|13
5497030|NCT01688050|19006026|P1|Overall Study|Conversion to open repair|1
5497031|NCT01688050|19006026|P1|Overall Study|Death|7
5497032|NCT01688037|19006035|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
5497033|NCT01688037|19006036|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
5497034|NCT01688037|19006037|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
5497035|NCT01688037|19006035|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
5497036|NCT01688037|19006036|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
5497037|NCT01688037|19006037|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
5497038|NCT01688037|19006035|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
5497039|NCT01688037|19006036|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
5497040|NCT01688037|19006037|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
5497041|NCT01688037|19006035|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
5497042|NCT01688037|19006036|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
5497043|NCT01688037|19006037|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
5497044|NCT01688037|19006035|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
5497045|NCT01688037|19006036|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
5497046|NCT01688037|19006037|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
5497047|NCT01688037|19006035|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
5497048|NCT01688037|19006036|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
5497049|NCT01688037|19006037|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
5497050|NCT01688037|19006035|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
5497051|NCT01688037|19006036|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
5497052|NCT01688037|19006037|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
5497053|NCT01688037|19006035|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
5497054|NCT01688037|19006036|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
5497055|NCT01688037|19006037|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
5497056|NCT01688037|19006035|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
5497057|NCT01688037|19006036|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
5497058|NCT01688037|19006037|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
5497059|NCT01688037|19006035|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
5497060|NCT01688037|19006036|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
5497061|NCT01688037|19006037|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
5497062|NCT01687998|19006053|P2|Overall Study|Lost to Follow-up|7
5497063|NCT01687998|19006054|P1|Overall Study|Lost to Follow-up|9
5497064|NCT01687998|19006053|P2|Overall Study|Known to be Alive at Study End|62
5497065|NCT01687998|19006054|P1|Overall Study|Known to be Alive at Study End|54
5497066|NCT01687998|19006053|P2|Overall Study|Withdrawal by Subject|51
5497067|NCT01687998|19006054|P1|Overall Study|Withdrawal by Subject|49
5497068|NCT01687712|19006090|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
5497069|NCT01687712|19006091|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
5497070|NCT01687712|19006090|P2|Cycle 3|Ectopic Pregnancy|0
5497071|NCT01687712|19006091|P1|Cycle 3|Ectopic Pregnancy|1
5497072|NCT01687712|19006090|P2|Cycle 3|Early Pregnancy Loss|2
5497073|NCT01687712|19006091|P1|Cycle 3|Early Pregnancy Loss|1
5497074|NCT01687712|19006090|P2|Cycle 3|Not Biochemically Pregnant|22
5497075|NCT01687712|19006091|P1|Cycle 3|Not Biochemically Pregnant|21
5497076|NCT01687712|19006090|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
5497077|NCT01687712|19006091|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
5497078|NCT01687712|19006090|P2|Cycle 2|Still Birth|0
5497079|NCT01687712|19006091|P1|Cycle 2|Still Birth|1
5497080|NCT01687712|19006090|P2|Cycle 2|Ectopic Pregnancy|1
5497081|NCT01687712|19006091|P1|Cycle 2|Ectopic Pregnancy|0
5497082|NCT01687712|19006090|P2|Cycle 2|Early Pregnancy Loss|16
5497083|NCT01687712|19006091|P1|Cycle 2|Early Pregnancy Loss|18
5497084|NCT01687712|19006090|P2|Cycle 2|Not Biochemically Pregnant|77
5497085|NCT01687712|19006091|P1|Cycle 2|Not Biochemically Pregnant|74
5497086|NCT01687712|19006090|P2|Cycle 1|Lost to Follow-up|1
5497087|NCT01687712|19006091|P1|Cycle 1|Lost to Follow-up|1
5497088|NCT01687712|19006090|P2|Cycle 1|Intrauterine Fetal Death|1
5497089|NCT01687712|19006091|P1|Cycle 1|Intrauterine Fetal Death|0
5497090|NCT01687712|19006090|P2|Cycle 1|Abortion|0
5497091|NCT01687712|19006091|P1|Cycle 1|Abortion|3
5497092|NCT01687712|19006090|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
5497093|NCT01687712|19006091|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
5497094|NCT01687712|19006090|P2|Cycle 1|Heterotropic Pregnancy|0
5497095|NCT01687712|19006091|P1|Cycle 1|Heterotropic Pregnancy|1
5497096|NCT01687712|19006090|P2|Cycle 1|Ectopic Pregnancy|5
5497097|NCT01687712|19006091|P1|Cycle 1|Ectopic Pregnancy|5
5497098|NCT01687712|19006090|P2|Cycle 1|Early Pregnancy Loss|60
5497099|NCT01687712|19006091|P1|Cycle 1|Early Pregnancy Loss|43
5497100|NCT01687712|19006090|P2|Cycle 1|Not Biochemically Pregnant|348
5497101|NCT01687712|19006091|P1|Cycle 1|Not Biochemically Pregnant|386
5497102|NCT01687673|19006129|P1|Overall Study|Physician Decision|1
5497103|NCT01687478|19006143|P2|Overall Study|Entry Criteria Not Met|2
5497104|NCT01687478|19006144|P1|Overall Study|Entry Criteria Not Met|6
5497105|NCT01687478|19006143|P2|Overall Study|Physician Decision|3
5497106|NCT01687478|19006144|P1|Overall Study|Physician Decision|1
5497107|NCT01687478|19006143|P2|Overall Study|Withdrawal by Subject|19
5497108|NCT01687478|19006144|P1|Overall Study|Withdrawal by Subject|21
5497109|NCT01687478|19006143|P2|Overall Study|Protocol Violation|2
5497110|NCT01687478|19006144|P1|Overall Study|Protocol Violation|0
5497111|NCT01687478|19006143|P2|Overall Study|Lost to Follow-up|3
5497112|NCT01687478|19006144|P1|Overall Study|Lost to Follow-up|1
5497113|NCT01687478|19006143|P2|Overall Study|Adverse Event|10
5497114|NCT01687478|19006144|P1|Overall Study|Adverse Event|3
5497115|NCT01687413|19006168|P2|Overall Study|Patient withdrew before completing all radiotherapy|0
5497116|NCT01687413|19006169|P1|Overall Study|Patient withdrew before completing all radiotherapy|1
5497117|NCT01687413|19006168|P2|Overall Study|Not eligible|2
5497118|NCT01687413|19006169|P1|Overall Study|Not eligible|0
5497119|NCT01687413|19006168|P2|Overall Study|Withdrawal by Subject|2
5497120|NCT01687413|19006169|P1|Overall Study|Withdrawal by Subject|0
5497121|NCT01687296|19006274|P2|Overall Study|Withdrawal by Subject|3
5497122|NCT01687296|19006275|P1|Overall Study|Withdrawal by Subject|6
5497123|NCT01687296|19006274|P2|Overall Study|Protocol Violation|1
5497124|NCT01687296|19006275|P1|Overall Study|Protocol Violation|0
5497125|NCT01687296|19006274|P2|Overall Study|Lack of Efficacy|1
5497126|NCT01687296|19006275|P1|Overall Study|Lack of Efficacy|1
5497127|NCT01687283|19006297|P2|Overall Study|Withdrawal by Subject|8
5497128|NCT01687283|19006298|P1|Overall Study|Withdrawal by Subject|9
5497129|NCT01687283|19006297|P2|Overall Study|Investigator discretion|0
5497130|NCT01687283|19006298|P1|Overall Study|Investigator discretion|2
5497131|NCT01687283|19006297|P2|Overall Study|Lost to Follow-up|1
5497132|NCT01687283|19006298|P1|Overall Study|Lost to Follow-up|1
5497133|NCT01687283|19006297|P2|Overall Study|protocol defined stopping criteria|10
5497134|NCT01687283|19006298|P1|Overall Study|protocol defined stopping criteria|8
5497135|NCT01687283|19006297|P2|Overall Study|Protocol Violation|3
5497136|NCT01687283|19006298|P1|Overall Study|Protocol Violation|1
5497137|NCT01687283|19006297|P2|Overall Study|Lack of Efficacy|1
5497138|NCT01687283|19006298|P1|Overall Study|Lack of Efficacy|3
5497139|NCT01687283|19006297|P2|Overall Study|Adverse Event|4
5497140|NCT01687283|19006298|P1|Overall Study|Adverse Event|11
5497141|NCT01687270|19006321|P1|Overall Study|Lost to Follow-up|1
5497142|NCT01687270|19006321|P1|Overall Study|Lack of Efficacy|11
5497143|NCT01687257|19006332|P3|Overall Study|Investigator's Discretion|0
5497144|NCT01687257|19006333|P2|Overall Study|Investigator's Discretion|3
5497145|NCT01687257|19006334|P1|Overall Study|Investigator's Discretion|0
5497146|NCT01687257|19006332|P3|Overall Study|Adverse Event|0
5497147|NCT01687257|19006333|P2|Overall Study|Adverse Event|0
5497148|NCT01687257|19006334|P1|Overall Study|Adverse Event|1
5497149|NCT01687257|19006332|P3|Overall Study|Subject Withdrew Consent|1
5497150|NCT01687257|19006333|P2|Overall Study|Subject Withdrew Consent|1
5497151|NCT01687257|19006334|P1|Overall Study|Subject Withdrew Consent|1
5497152|NCT01687257|19006332|P3|Overall Study|Efficacy Failure|5
5497153|NCT01687257|19006333|P2|Overall Study|Efficacy Failure|0
5497154|NCT01687257|19006334|P1|Overall Study|Efficacy Failure|6
5497155|NCT01687218|19006399|P6|Overall Study|Relocated, no follow-up planned|0
5497156|NCT01687218|19006400|P5|Overall Study|Relocated, no follow-up planned|0
5497157|NCT01687218|19006401|P4|Overall Study|Relocated, no follow-up planned|1
5497158|NCT01687218|19006402|P3|Overall Study|Relocated, no follow-up planned|1
5497159|NCT01687218|19006403|P2|Overall Study|Relocated, no follow-up planned|0
5497160|NCT01687218|19006404|P1|Overall Study|Relocated, no follow-up planned|1
5497161|NCT01687218|19006399|P6|Overall Study|Withdrawal by Subject|0
5497162|NCT01687218|19006400|P5|Overall Study|Withdrawal by Subject|1
5497163|NCT01687218|19006401|P4|Overall Study|Withdrawal by Subject|1
5497164|NCT01687218|19006402|P3|Overall Study|Withdrawal by Subject|0
5497165|NCT01687218|19006403|P2|Overall Study|Withdrawal by Subject|3
5497166|NCT01687218|19006404|P1|Overall Study|Withdrawal by Subject|2
5497167|NCT01687166|19006456|P4|Overall Study|Insurance|1
5497168|NCT01687166|19006457|P3|Overall Study|Insurance|1
5497169|NCT01687166|19006458|P2|Overall Study|Insurance|0
5497170|NCT01687166|19006459|P1|Overall Study|Insurance|0
5497171|NCT01687166|19006456|P4|Overall Study|Physician choice to use different device|0
5497172|NCT01687166|19006457|P3|Overall Study|Physician choice to use different device|4
5497173|NCT01687166|19006458|P2|Overall Study|Physician choice to use different device|2
5497174|NCT01687166|19006459|P1|Overall Study|Physician choice to use different device|1
5497175|NCT01687166|19006456|P4|Overall Study|Patient unable to be compliant|0
5497176|NCT01687166|19006457|P3|Overall Study|Patient unable to be compliant|0
5497177|NCT01687166|19006458|P2|Overall Study|Patient unable to be compliant|0
5497178|NCT01687166|19006459|P1|Overall Study|Patient unable to be compliant|1
5497179|NCT01687166|19006456|P4|Overall Study|Subject moved out of state|0
5497180|NCT01687166|19006457|P3|Overall Study|Subject moved out of state|0
5497181|NCT01687166|19006458|P2|Overall Study|Subject moved out of state|1
5497182|NCT01687166|19006459|P1|Overall Study|Subject moved out of state|0
5497183|NCT01687166|19006456|P4|Overall Study|Protocol Violation|0
5497184|NCT01687166|19006457|P3|Overall Study|Protocol Violation|1
5497185|NCT01687166|19006458|P2|Overall Study|Protocol Violation|1
5497186|NCT01687166|19006459|P1|Overall Study|Protocol Violation|1
5497187|NCT01687166|19006456|P4|Overall Study|Death|0
5497188|NCT01687166|19006457|P3|Overall Study|Death|0
5497189|NCT01687166|19006458|P2|Overall Study|Death|1
5497190|NCT01687166|19006459|P1|Overall Study|Death|1
5497191|NCT01687166|19006456|P4|Overall Study|Equipment/Device Availability|0
5497192|NCT01687166|19006457|P3|Overall Study|Equipment/Device Availability|0
5497193|NCT01687166|19006458|P2|Overall Study|Equipment/Device Availability|1
5499310|NCT01667900|19014187|P1|Part B|Death|0
5497194|NCT01687166|19006459|P1|Overall Study|Equipment/Device Availability|0
5497195|NCT01687166|19006456|P4|Overall Study|Lost to Follow-up|0
5497196|NCT01687166|19006457|P3|Overall Study|Lost to Follow-up|1
5497197|NCT01687166|19006458|P2|Overall Study|Lost to Follow-up|5
5497198|NCT01687166|19006459|P1|Overall Study|Lost to Follow-up|2
5497199|NCT01687166|19006456|P4|Overall Study|Withdrawal by Subject|0
5497200|NCT01687166|19006457|P3|Overall Study|Withdrawal by Subject|3
5497201|NCT01687166|19006458|P2|Overall Study|Withdrawal by Subject|4
5497202|NCT01687166|19006459|P1|Overall Study|Withdrawal by Subject|11
5497203|NCT01687166|19006456|P4|Overall Study|Physician Decision|0
5497204|NCT01687166|19006457|P3|Overall Study|Physician Decision|1
5497205|NCT01687166|19006458|P2|Overall Study|Physician Decision|2
5497206|NCT01687166|19006459|P1|Overall Study|Physician Decision|3
5497207|NCT01687166|19006456|P4|Overall Study|Adverse Event|0
5497208|NCT01687166|19006457|P3|Overall Study|Adverse Event|0
5497209|NCT01687166|19006458|P2|Overall Study|Adverse Event|1
5497210|NCT01687166|19006459|P1|Overall Study|Adverse Event|2
5497211|NCT01687166|19006456|P4|Overall Study|Did not meet eligibility criteria|1
5497212|NCT01687166|19006457|P3|Overall Study|Did not meet eligibility criteria|1
5497213|NCT01687166|19006458|P2|Overall Study|Did not meet eligibility criteria|6
5497214|NCT01687166|19006459|P1|Overall Study|Did not meet eligibility criteria|4
5497215|NCT01687166|19006456|P4|Overall Study|Attempt subject|0
5497216|NCT01687166|19006457|P3|Overall Study|Attempt subject|2
5497217|NCT01687166|19006458|P2|Overall Study|Attempt subject|3
5497218|NCT01687166|19006459|P1|Overall Study|Attempt subject|2
5497219|NCT01687101|19006475|P1|Overall Study|Lost to Follow-up|7
5497220|NCT01686958|19006500|P1|Overall Study|Withdrawal by Subject|1
5497221|NCT01686932|19006513|P2|Period 1|Adverse Event|1
5497222|NCT01686932|19006514|P1|Period 1|Adverse Event|1
5497223|NCT01686828|19006544|P4|Overall Study|Weight Loss|0
5497224|NCT01686828|19006545|P3|Overall Study|Weight Loss|1
5497225|NCT01686828|19006546|P2|Overall Study|Weight Loss|0
5497226|NCT01686828|19006547|P1|Overall Study|Weight Loss|0
5497227|NCT01686828|19006544|P4|Overall Study|New Job|0
5497228|NCT01686828|19006545|P3|Overall Study|New Job|0
5497229|NCT01686828|19006546|P2|Overall Study|New Job|1
5497230|NCT01686828|19006547|P1|Overall Study|New Job|0
5497231|NCT01686828|19006544|P4|Overall Study|Physician Decision|0
5497232|NCT01686828|19006545|P3|Overall Study|Physician Decision|0
5497233|NCT01686828|19006546|P2|Overall Study|Physician Decision|0
5497234|NCT01686828|19006547|P1|Overall Study|Physician Decision|1
5497235|NCT01686633|19006660|P3|Overall Study|Lost to Follow-up|1
5497236|NCT01686633|19006661|P2|Overall Study|Lost to Follow-up|1
5497237|NCT01686633|19006662|P1|Overall Study|Lost to Follow-up|0
5497238|NCT01686633|19006660|P3|Overall Study|Protocol-defined Stopping Criteria|1
5497239|NCT01686633|19006661|P2|Overall Study|Protocol-defined Stopping Criteria|0
5497240|NCT01686633|19006662|P1|Overall Study|Protocol-defined Stopping Criteria|1
5497241|NCT01686633|19006660|P3|Overall Study|Protocol Violation|0
5497242|NCT01686633|19006661|P2|Overall Study|Protocol Violation|3
5497243|NCT01686633|19006662|P1|Overall Study|Protocol Violation|2
5497244|NCT01686633|19006660|P3|Overall Study|Adverse Event|3
5497245|NCT01686633|19006661|P2|Overall Study|Adverse Event|3
5497246|NCT01686633|19006662|P1|Overall Study|Adverse Event|4
5497247|NCT01686633|19006660|P3|Overall Study|Physician Decision|4
5497248|NCT01686633|19006661|P2|Overall Study|Physician Decision|4
5497249|NCT01686633|19006662|P1|Overall Study|Physician Decision|3
5497250|NCT01686633|19006660|P3|Overall Study|Withdrawal by Subject|5
5497251|NCT01686633|19006661|P2|Overall Study|Withdrawal by Subject|8
5497252|NCT01686633|19006662|P1|Overall Study|Withdrawal by Subject|8
5497253|NCT01686633|19006660|P3|Overall Study|Lack of Efficacy|11
5497254|NCT01686633|19006661|P2|Overall Study|Lack of Efficacy|13
5497255|NCT01686633|19006662|P1|Overall Study|Lack of Efficacy|33
5497256|NCT01686581|19006685|P1|Overall Study|Reason Missing|1
5497257|NCT01686581|19006685|P1|Overall Study|Other Miscellaneous Reasons|36
5497258|NCT01686581|19006685|P1|Overall Study|Thinks it is Inconvenient|17
5497259|NCT01686581|19006685|P1|Overall Study|Trying to get Pregnant or Nursing|2
5497260|NCT01686581|19006685|P1|Overall Study|Thinks Injections Take Too Much Time|2
5497261|NCT01686581|19006685|P1|Overall Study|Thinks Injections Too Painful|8
5497262|NCT01686581|19006685|P1|Overall Study|Participant Concerned about Risks|6
5497263|NCT01686581|19006685|P1|Overall Study|Lack of Efficacy|90
5497264|NCT01686581|19006685|P1|Overall Study|Side-effects or Health Problems|15
5497265|NCT01686568|19006698|P2|Sub-Study|Not consented for sub-study|2
5497266|NCT01686568|19006699|P1|Sub-Study|Not consented for sub-study|2
5497267|NCT01686568|19006698|P2|Main Study|Liver enzymes above range of exclusion|0
5497268|NCT01686568|19006699|P1|Main Study|Liver enzymes above range of exclusion|1
5497269|NCT01686568|19006698|P2|Main Study|Noncompliance with protocol|1
5497270|NCT01686568|19006699|P1|Main Study|Noncompliance with protocol|0
5497271|NCT01686568|19006698|P2|Main Study|Withdrawal by Subject|3
5497272|NCT01686568|19006699|P1|Main Study|Withdrawal by Subject|1
5497273|NCT01686438|19006776|P3|Overall Study|Withdrawal by Subject|1
5497274|NCT01686438|19006777|P2|Overall Study|Withdrawal by Subject|0
5497275|NCT01686438|19006778|P1|Overall Study|Withdrawal by Subject|0
5497276|NCT01686438|19006776|P3|Overall Study|Protocol Violation|1
5497277|NCT01686438|19006777|P2|Overall Study|Protocol Violation|0
5497278|NCT01686438|19006778|P1|Overall Study|Protocol Violation|0
5497279|NCT01686438|19006776|P3|Overall Study|Adverse Event|1
5497280|NCT01686438|19006777|P2|Overall Study|Adverse Event|0
5497281|NCT01686438|19006778|P1|Overall Study|Adverse Event|0
5497282|NCT01686438|19006776|P3|Overall Study|Lost to Follow-up|10
5497283|NCT01686438|19006777|P2|Overall Study|Lost to Follow-up|9
5497284|NCT01686438|19006778|P1|Overall Study|Lost to Follow-up|8
5497285|NCT01686373|19006826|P2|Overall Study|Adverse Event|1
5497286|NCT01686373|19006827|P1|Overall Study|Adverse Event|0
5497287|NCT01686373|19006826|P2|Overall Study|Withdrawal by Subject|1
5497288|NCT01686373|19006827|P1|Overall Study|Withdrawal by Subject|0
5497289|NCT01686373|19006826|P2|Overall Study|Lost to Follow-up|0
5497290|NCT01686373|19006827|P1|Overall Study|Lost to Follow-up|3
5497291|NCT01686152|19006843|P3|Overall Study|Lost to Follow-up|5
5497292|NCT01686152|19006844|P2|Overall Study|Lost to Follow-up|6
5497293|NCT01686152|19006845|P1|Overall Study|Lost to Follow-up|7
5497294|NCT01686152|19006843|P3|Overall Study|IP Non-compliance|0
5497295|NCT01686152|19006844|P2|Overall Study|IP Non-compliance|5
5497296|NCT01686152|19006845|P1|Overall Study|IP Non-compliance|5
5497297|NCT01686152|19006843|P3|Overall Study|Lack of Efficacy|1
5497298|NCT01686152|19006844|P2|Overall Study|Lack of Efficacy|0
5497299|NCT01686152|19006845|P1|Overall Study|Lack of Efficacy|0
5497300|NCT01686152|19006843|P3|Overall Study|Adverse Event|0
5497301|NCT01686152|19006844|P2|Overall Study|Adverse Event|11
5497302|NCT01686152|19006845|P1|Overall Study|Adverse Event|12
5497303|NCT01686152|19006843|P3|Overall Study|Protocol Violation|0
5497304|NCT01686152|19006844|P2|Overall Study|Protocol Violation|1
5497305|NCT01686152|19006845|P1|Overall Study|Protocol Violation|6
5497306|NCT01686152|19006843|P3|Overall Study|Drug Code Unblinded|0
5497307|NCT01686152|19006844|P2|Overall Study|Drug Code Unblinded|1
5497308|NCT01686152|19006845|P1|Overall Study|Drug Code Unblinded|0
5497309|NCT01686152|19006843|P3|Overall Study|Withdrawal by Subject|3
5497310|NCT01686152|19006844|P2|Overall Study|Withdrawal by Subject|11
5497311|NCT01686152|19006845|P1|Overall Study|Withdrawal by Subject|11
5497312|NCT01685983|19006864|P1|Overall Study|Noncompliance with Study Drug|1
5497313|NCT01685983|19006864|P1|Overall Study|Progressive Disease|32
5497314|NCT01685983|19006864|P1|Overall Study|Other|7
5497315|NCT01685983|19006864|P1|Overall Study|Physician Decision|13
5497316|NCT01685983|19006864|P1|Overall Study|Protocol Violation|2
5497317|NCT01685983|19006864|P1|Overall Study|Withdrawal by Subject|19
5497318|NCT01685983|19006864|P1|Overall Study|Death|1
5497319|NCT01685983|19006864|P1|Overall Study|Adverse Event|7
5497320|NCT01685840|19006876|P2|Overall Study|Had VAD, Dialysis or Transplant|17
5497321|NCT01685840|19006877|P1|Overall Study|Had VAD, Dialysis or Transplant|11
5497322|NCT01685840|19006876|P2|Overall Study|Futility|200
5497323|NCT01685840|19006877|P1|Overall Study|Futility|197
5497324|NCT01685840|19006876|P2|Overall Study|Withdrawal by Subject|17
5497325|NCT01685840|19006877|P1|Overall Study|Withdrawal by Subject|14
5497326|NCT01685840|19006876|P2|Overall Study|Physician Decision|7
5497327|NCT01685840|19006877|P1|Overall Study|Physician Decision|3
5497328|NCT01685840|19006876|P2|Overall Study|Lost to Follow-up|25
5497329|NCT01685840|19006877|P1|Overall Study|Lost to Follow-up|27
5497330|NCT01685840|19006876|P2|Overall Study|Death|66
5497331|NCT01685840|19006877|P1|Overall Study|Death|77
5497332|NCT01685801|19006921|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
5497333|NCT01685801|19006922|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
5497334|NCT01685801|19006923|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
5497335|NCT01685801|19006924|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
5497336|NCT01685801|19006921|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
5497337|NCT01685801|19006922|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
5497338|NCT01685801|19006923|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
5497339|NCT01685801|19006924|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
5497340|NCT01685697|19006946|P2|Overall Study|Protocol Violation|3
5497341|NCT01685697|19006947|P1|Overall Study|Protocol Violation|3
5497342|NCT01685606|19006981|P1|Overall Study|Withdrawal by Subject|1
5497343|NCT01685437|19007009|P1|Overall Study|Unable to make visits due to work|1
5497344|NCT01685437|19007009|P1|Overall Study|Protocol Violation|4
5497345|NCT01685437|19007009|P1|Overall Study|Adverse Event|1
5497346|NCT01685437|19007009|P1|Overall Study|Lost to Follow-up|3
5497347|NCT01685437|19007009|P1|Overall Study|Withdrawal by Subject|22
5497348|NCT01685372|19007023|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
5497349|NCT01685372|19007024|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
5497350|NCT01685229|19007114|P2|Overall Study|Death|0
5497351|NCT01685229|19007115|P1|Overall Study|Death|1
5497352|NCT01685229|19007114|P2|Overall Study|Withdrawal by Subject|5
5497353|NCT01685229|19007115|P1|Overall Study|Withdrawal by Subject|6
5497354|NCT01685229|19007114|P2|Overall Study|Lost to Follow-up|10
5497355|NCT01685229|19007115|P1|Overall Study|Lost to Follow-up|16
5497356|NCT01685229|19007114|P2|Overall Study|Subjects missing Study Exit form|1
5497357|NCT01685229|19007115|P1|Overall Study|Subjects missing Study Exit form|3
5497358|NCT01685216|19007141|P1|Overall Study|Did not receive study drug|1
5497359|NCT01685203|19007158|P7|Overall Study|Patient's decision|0
5497360|NCT01685203|19007159|P6|Overall Study|Patient's decision|1
5497361|NCT01685203|19007160|P5|Overall Study|Patient's decision|0
5497362|NCT01685203|19007161|P4|Overall Study|Patient's decision|0
5497363|NCT01685203|19007162|P3|Overall Study|Patient's decision|0
5497364|NCT01685203|19007163|P2|Overall Study|Patient's decision|0
5497365|NCT01685203|19007164|P1|Overall Study|Patient's decision|0
5497366|NCT01685203|19007158|P7|Overall Study|Adverse event and withdrew consent|0
5497367|NCT01685203|19007159|P6|Overall Study|Adverse event and withdrew consent|0
5497368|NCT01685203|19007160|P5|Overall Study|Adverse event and withdrew consent|0
5497369|NCT01685203|19007161|P4|Overall Study|Adverse event and withdrew consent|0
5497370|NCT01685203|19007162|P3|Overall Study|Adverse event and withdrew consent|0
5497371|NCT01685203|19007163|P2|Overall Study|Adverse event and withdrew consent|0
5497372|NCT01685203|19007164|P1|Overall Study|Adverse event and withdrew consent|1
5497373|NCT01685203|19007158|P7|Overall Study|Adverse Event|0
5497374|NCT01685203|19007159|P6|Overall Study|Adverse Event|2
5497375|NCT01685203|19007160|P5|Overall Study|Adverse Event|0
5497376|NCT01685203|19007161|P4|Overall Study|Adverse Event|0
5497377|NCT01685203|19007162|P3|Overall Study|Adverse Event|0
5497378|NCT01685203|19007163|P2|Overall Study|Adverse Event|0
5497379|NCT01685203|19007164|P1|Overall Study|Adverse Event|0
5497380|NCT01685203|19007158|P7|Overall Study|Lost to Follow-up|0
5497381|NCT01685203|19007159|P6|Overall Study|Lost to Follow-up|0
5497382|NCT01685203|19007160|P5|Overall Study|Lost to Follow-up|0
5497383|NCT01685203|19007161|P4|Overall Study|Lost to Follow-up|1
5497384|NCT01685203|19007162|P3|Overall Study|Lost to Follow-up|0
5497385|NCT01685203|19007163|P2|Overall Study|Lost to Follow-up|3
5497386|NCT01685203|19007164|P1|Overall Study|Lost to Follow-up|3
5497387|NCT01685138|19007208|P1|Overall Study|Progressive disease|53
5497388|NCT01685138|19007208|P1|Overall Study|Adverse Event|18
5497389|NCT01685138|19007208|P1|Overall Study|Death|10
5497390|NCT01685138|19007208|P1|Overall Study|Physician Decision|6
5497391|NCT01685138|19007208|P1|Overall Study|Subject/guardian decision|2
5497392|NCT01685138|19007208|P1|Overall Study|No longer requires treatment|1
5497393|NCT01685138|19007208|P1|Overall Study|Protocol Violation|1
5497394|NCT01685138|19007208|P1|Overall Study|Lost to Follow-up|1
5497395|NCT01685073|19007224|P2|Overall Study|Withdrawal by Subject|24
5497396|NCT01685073|19007225|P1|Overall Study|Withdrawal by Subject|24
5497397|NCT01685073|19007224|P2|Overall Study|Lost to Follow-up|8
5497398|NCT01685073|19007225|P1|Overall Study|Lost to Follow-up|6
5497399|NCT01685060|19007233|P1|Overall Study|Death|8
5497400|NCT01685060|19007233|P1|Overall Study|Lost to Follow-up|1
5497401|NCT01685060|19007233|P1|Overall Study|Subject/guardian decision|20
5497402|NCT01685060|19007233|P1|Overall Study|Physician Decision|14
5497403|NCT01685060|19007233|P1|Overall Study|Progressive disease|69
5497404|NCT01685060|19007233|P1|Overall Study|Adverse Event|12
5497405|NCT01685060|19007233|P1|Overall Study|Rollover patients|16
5497406|NCT01685047|19007248|P1|Overall Study|patient withdrawn by sponsor|1
5497407|NCT01685047|19007248|P1|Overall Study|Adverse Event|5
5497408|NCT01685047|19007248|P1|Overall Study|Physician Decision|25
5497409|NCT01685047|19007248|P1|Overall Study|Lost to Follow-up|8
5497410|NCT01685047|19007248|P1|Overall Study|Death|26
5497411|NCT01685047|19007248|P1|Overall Study|Withdrawal by Subject|20
5497412|NCT01684943|19007264|P3|Overall Study|Planning Pregnancy|0
5497413|NCT01684943|19007265|P2|Overall Study|Planning Pregnancy|0
5497414|NCT01684943|19007266|P1|Overall Study|Planning Pregnancy|1
5497415|NCT01684943|19007264|P3|Overall Study|Lost to Follow-up|0
5497416|NCT01684943|19007265|P2|Overall Study|Lost to Follow-up|0
5497417|NCT01684943|19007266|P1|Overall Study|Lost to Follow-up|3
5497418|NCT01684943|19007264|P3|Overall Study|Excluded from Analysis|1
5497419|NCT01684943|19007265|P2|Overall Study|Excluded from Analysis|1
5497420|NCT01684943|19007266|P1|Overall Study|Excluded from Analysis|1
5497421|NCT01684943|19007264|P3|Overall Study|Principal Investigator Determination|0
5497422|NCT01684943|19007265|P2|Overall Study|Principal Investigator Determination|0
5497423|NCT01684943|19007266|P1|Overall Study|Principal Investigator Determination|1
5497424|NCT01684943|19007264|P3|Overall Study|Inadequate Venous Access|0
5497425|NCT01684943|19007265|P2|Overall Study|Inadequate Venous Access|0
5497426|NCT01684943|19007266|P1|Overall Study|Inadequate Venous Access|3
5497427|NCT01684930|19007285|P2|Overall Study|Withdrawal by Subject|1
5497428|NCT01684930|19007286|P1|Overall Study|Withdrawal by Subject|3
5497429|NCT01684878|19007343|P4|Part 2: Randomized Phase|Participant noncompliance|1
5497430|NCT01684878|19007344|P3|Part 2: Randomized Phase|Participant noncompliance|0
5497431|NCT01684878|19007345|P2|Part 2: Randomized Phase|Participant noncompliance|0
5497432|NCT01684878|19007346|P1|Part 2: Randomized Phase|Participant noncompliance|0
5497433|NCT01684878|19007343|P4|Part 2: Randomized Phase|Alive at data-cut|7
5497434|NCT01684878|19007344|P3|Part 2: Randomized Phase|Alive at data-cut|13
5497435|NCT01684878|19007345|P2|Part 2: Randomized Phase|Alive at data-cut|0
5497436|NCT01684878|19007346|P1|Part 2: Randomized Phase|Alive at data-cut|0
5497437|NCT01684878|19007343|P4|Part 2: Randomized Phase|Death|68
5497438|NCT01684878|19007344|P3|Part 2: Randomized Phase|Death|62
5497439|NCT01684878|19007345|P2|Part 2: Randomized Phase|Death|0
5497440|NCT01684878|19007346|P1|Part 2: Randomized Phase|Death|0
5497441|NCT01684878|19007343|P4|Part 2: Randomized Phase|Lost to Follow-up|0
5497442|NCT01684878|19007344|P3|Part 2: Randomized Phase|Lost to Follow-up|2
5497443|NCT01684878|19007345|P2|Part 2: Randomized Phase|Lost to Follow-up|0
5497444|NCT01684878|19007346|P1|Part 2: Randomized Phase|Lost to Follow-up|0
5497445|NCT01684878|19007343|P4|Part 2: Randomized Phase|Participant withdrew consent|2
5497446|NCT01684878|19007344|P3|Part 2: Randomized Phase|Participant withdrew consent|1
5497447|NCT01684878|19007345|P2|Part 2: Randomized Phase|Participant withdrew consent|0
5497448|NCT01684878|19007346|P1|Part 2: Randomized Phase|Participant withdrew consent|0
5497449|NCT01684878|19007343|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
5497450|NCT01684878|19007344|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
5497451|NCT01684878|19007345|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
5497452|NCT01684878|19007346|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
5497453|NCT01684878|19007343|P4|Part 1: Safety Run in Phase|Death|0
5497454|NCT01684878|19007344|P3|Part 1: Safety Run in Phase|Death|0
5497455|NCT01684878|19007345|P2|Part 1: Safety Run in Phase|Death|20
5497456|NCT01684878|19007346|P1|Part 1: Safety Run in Phase|Death|15
5497457|NCT01684878|19007343|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
5497458|NCT01684878|19007344|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
5497459|NCT01684878|19007345|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
5497460|NCT01684878|19007346|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
5497461|NCT01684722|19007394|P4|Overall Study|Death|21
5497462|NCT01684722|19007395|P3|Overall Study|Death|19
5497463|NCT01684722|19007396|P2|Overall Study|Death|21
5497464|NCT01684722|19007397|P1|Overall Study|Death|19
5497465|NCT01684722|19007394|P4|Overall Study|Lost to Follow-up|89
5497466|NCT01684722|19007395|P3|Overall Study|Lost to Follow-up|75
5497467|NCT01684722|19007396|P2|Overall Study|Lost to Follow-up|56
5497468|NCT01684722|19007397|P1|Overall Study|Lost to Follow-up|78
5497469|NCT01684423|19007471|P5|Overall Study|Withdrawal by Subject|0
5497470|NCT01684423|19007472|P4|Overall Study|Withdrawal by Subject|0
5497471|NCT01684423|19007473|P3|Overall Study|Withdrawal by Subject|1
5497472|NCT01684423|19007474|P2|Overall Study|Withdrawal by Subject|0
5497473|NCT01684423|19007475|P1|Overall Study|Withdrawal by Subject|0
5497474|NCT01684215|19007532|P4|Phase 2|Lost to Follow-up|4
5497475|NCT01684215|19007533|P3|Phase 2|Lost to Follow-up|0
5497476|NCT01684215|19007534|P2|Phase 2|Lost to Follow-up|0
5497477|NCT01684215|19007535|P1|Phase 2|Lost to Follow-up|0
5497478|NCT01684215|19007532|P4|Phase 2|Enrolled but not treated|1
5497479|NCT01684215|19007533|P3|Phase 2|Enrolled but not treated|0
5497480|NCT01684215|19007534|P2|Phase 2|Enrolled but not treated|0
5497481|NCT01684215|19007535|P1|Phase 2|Enrolled but not treated|0
5497482|NCT01684215|19007532|P4|Phase 2|Study terminated by sponsor|30
5497483|NCT01684215|19007533|P3|Phase 2|Study terminated by sponsor|0
5497484|NCT01684215|19007534|P2|Phase 2|Study terminated by sponsor|0
5497485|NCT01684215|19007535|P1|Phase 2|Study terminated by sponsor|0
5497486|NCT01684215|19007532|P4|Phase 2|Death|8
5497487|NCT01684215|19007533|P3|Phase 2|Death|0
5497488|NCT01684215|19007534|P2|Phase 2|Death|0
5497489|NCT01684215|19007535|P1|Phase 2|Death|0
5497490|NCT01684215|19007532|P4|Phase 1, Part 2|Withdrawal by Subject|0
5497491|NCT01684215|19007533|P3|Phase 1, Part 2|Withdrawal by Subject|1
5497492|NCT01684215|19007534|P2|Phase 1, Part 2|Withdrawal by Subject|0
5497493|NCT01684215|19007535|P1|Phase 1, Part 2|Withdrawal by Subject|0
5497494|NCT01684215|19007532|P4|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
5497495|NCT01684215|19007533|P3|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
5497496|NCT01684215|19007534|P2|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
5497497|NCT01684215|19007535|P1|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
5497498|NCT01684215|19007532|P4|Phase 1, Part 2|Adverse Event|0
5497499|NCT01684215|19007533|P3|Phase 1, Part 2|Adverse Event|1
5497500|NCT01684215|19007534|P2|Phase 1, Part 2|Adverse Event|0
5497501|NCT01684215|19007535|P1|Phase 1, Part 2|Adverse Event|0
5497502|NCT01684215|19007532|P4|Phase 1, Part 1|Objective progression or relapse|0
5497503|NCT01684215|19007533|P3|Phase 1, Part 1|Objective progression or relapse|0
5497504|NCT01684215|19007534|P2|Phase 1, Part 1|Objective progression or relapse|6
5497505|NCT01684215|19007535|P1|Phase 1, Part 1|Objective progression or relapse|5
5497506|NCT01684215|19007532|P4|Phase 1, Part 1|Adverse Event|0
5497507|NCT01684215|19007533|P3|Phase 1, Part 1|Adverse Event|0
5497508|NCT01684215|19007534|P2|Phase 1, Part 1|Adverse Event|0
5497509|NCT01684215|19007535|P1|Phase 1, Part 1|Adverse Event|1
5497510|NCT01684046|19007609|P2|Period 1, First 30 Days|Adverse Event|2
5497511|NCT01684046|19007610|P1|Period 1, First 30 Days|Adverse Event|0
5497512|NCT01684033|19007616|P2|Period 2, Second 30 Days|Adverse Event|0
5497513|NCT01684033|19007617|P1|Period 2, Second 30 Days|Adverse Event|1
5497514|NCT01684033|19007616|P2|Period 1, First 30 Days|Lost to Follow-up|0
5497515|NCT01684033|19007617|P1|Period 1, First 30 Days|Lost to Follow-up|1
5497516|NCT01684033|19007616|P2|Period 1, First 30 Days|Withdrawal by Subject|0
5497517|NCT01684033|19007617|P1|Period 1, First 30 Days|Withdrawal by Subject|1
5497518|NCT01684033|19007616|P2|Period 1, First 30 Days|Noncompliance|0
5497519|NCT01684033|19007617|P1|Period 1, First 30 Days|Noncompliance|1
5497520|NCT01684033|19007616|P2|Period 1, First 30 Days|Adverse Event|1
5497521|NCT01684033|19007617|P1|Period 1, First 30 Days|Adverse Event|1
5497522|NCT01683994|19007666|P5|Overall Study|Intercurrent illness|1
5497523|NCT01683994|19007667|P4|Overall Study|Intercurrent illness|2
5497524|NCT01683994|19007668|P3|Overall Study|Intercurrent illness|0
5497525|NCT01683994|19007669|P2|Overall Study|Intercurrent illness|0
5497526|NCT01683994|19007670|P1|Overall Study|Intercurrent illness|0
5497527|NCT01683994|19007666|P5|Overall Study|Withdrawal by Subject|0
5497528|NCT01683994|19007667|P4|Overall Study|Withdrawal by Subject|1
5497529|NCT01683994|19007668|P3|Overall Study|Withdrawal by Subject|0
5497530|NCT01683994|19007669|P2|Overall Study|Withdrawal by Subject|0
5497531|NCT01683994|19007670|P1|Overall Study|Withdrawal by Subject|1
5497532|NCT01683838|19007711|P2|Overall Study|Other|3
5497533|NCT01683838|19007712|P1|Overall Study|Other|4
5497534|NCT01683838|19007711|P2|Overall Study|Lost to Follow-up|1
5497535|NCT01683838|19007712|P1|Overall Study|Lost to Follow-up|1
5497536|NCT01683838|19007711|P2|Overall Study|Withdrawal by Subject|5
5497537|NCT01683838|19007712|P1|Overall Study|Withdrawal by Subject|6
5497538|NCT01683838|19007711|P2|Overall Study|Protocol Violation|1
5497539|NCT01683838|19007712|P1|Overall Study|Protocol Violation|3
5497540|NCT01683838|19007711|P2|Overall Study|Adverse Event|2
5497541|NCT01683838|19007712|P1|Overall Study|Adverse Event|12
5497542|NCT01683604|19007752|P1|Overall Study|Other|2
5497543|NCT01683604|19007752|P1|Overall Study|Lack of Efficacy|1
5497544|NCT01683604|19007752|P1|Overall Study|Adverse Event|2
5497545|NCT01683565|19007917|P2|Overall Study|Discontinued Intervention|1
5497546|NCT01683565|19007918|P1|Overall Study|Discontinued Intervention|1
5497547|NCT01683565|19007917|P2|Overall Study|Lost to Follow-up|0
5497548|NCT01683565|19007918|P1|Overall Study|Lost to Follow-up|2
5497549|NCT01683409|19007952|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5497550|NCT01683409|19007953|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5497551|NCT01683409|19007954|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
5497552|NCT01683409|19007955|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5497553|NCT01683409|19007956|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
5497554|NCT01683409|19007952|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
5497555|NCT01683409|19007953|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5497556|NCT01683409|19007954|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5497557|NCT01683409|19007955|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5497558|NCT01683409|19007956|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
5497559|NCT01683409|19007952|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
5497560|NCT01683409|19007953|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
5497561|NCT01683409|19007954|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
5497562|NCT01683409|19007955|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
5497563|NCT01683409|19007956|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
5497564|NCT01683409|19007952|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5497565|NCT01683409|19007953|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5497566|NCT01683409|19007954|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5497567|NCT01683409|19007955|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
5497568|NCT01683409|19007956|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
5497569|NCT01683409|19007952|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
5497570|NCT01683409|19007953|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
5497571|NCT01683409|19007954|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
5497572|NCT01683409|19007955|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
5497573|NCT01683409|19007956|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
5497574|NCT01683409|19007952|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
5497575|NCT01683409|19007953|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
5497576|NCT01683409|19007954|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
5497577|NCT01683409|19007955|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
5497578|NCT01683409|19007956|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
5497579|NCT01683409|19007952|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5497580|NCT01683409|19007953|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5497581|NCT01683409|19007954|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
5497582|NCT01683409|19007955|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5497583|NCT01683409|19007956|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
5497584|NCT01683409|19007952|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
5497585|NCT01683409|19007953|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
5497586|NCT01683409|19007954|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
5497587|NCT01683409|19007955|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
5497588|NCT01683409|19007956|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
5497589|NCT01683409|19007952|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5497590|NCT01683409|19007953|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5497591|NCT01683409|19007954|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5497592|NCT01683409|19007955|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
5497593|NCT01683409|19007956|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
5497594|NCT01683409|19007952|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
5497595|NCT01683409|19007953|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
5497596|NCT01683409|19007954|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
5497597|NCT01683409|19007955|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
5497598|NCT01683409|19007956|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
5497599|NCT01683409|19007952|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5497600|NCT01683409|19007953|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5497601|NCT01683409|19007954|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
5497602|NCT01683409|19007955|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5497603|NCT01683409|19007956|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
5497604|NCT01683383|19007999|P2|Overall Study|Infant was not transported|0
5497605|NCT01683383|19008000|P1|Overall Study|Infant was not transported|1
5497606|NCT01683266|19008027|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
5497607|NCT01683266|19008028|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
5497608|NCT01683266|19008027|P2|Overall Study|Possibly Hypoglycemia|0
5497609|NCT01683266|19008028|P1|Overall Study|Possibly Hypoglycemia|1
5497610|NCT01683266|19008027|P2|Overall Study|Perceived Lack of Efficacy|1
5497611|NCT01683266|19008028|P1|Overall Study|Perceived Lack of Efficacy|1
5497612|NCT01683266|19008027|P2|Overall Study|Nonserious Hypoglycemia|3
5497613|NCT01683266|19008028|P1|Overall Study|Nonserious Hypoglycemia|0
5497614|NCT01683266|19008027|P2|Overall Study|Site Closure / Site Withdrawal|3
5497615|NCT01683266|19008028|P1|Overall Study|Site Closure / Site Withdrawal|1
5497616|NCT01683266|19008027|P2|Overall Study|Lost to Follow-up|0
5497617|NCT01683266|19008028|P1|Overall Study|Lost to Follow-up|5
5497618|NCT01683266|19008027|P2|Overall Study|Selection Criterion / Protocol Violation|5
5497619|NCT01683266|19008028|P1|Overall Study|Selection Criterion / Protocol Violation|7
5497620|NCT01683266|19008027|P2|Overall Study|Personal Reason|25
5497621|NCT01683266|19008028|P1|Overall Study|Personal Reason|17
5497622|NCT01683266|19008027|P2|Overall Study|Protocol Violation|6
5497623|NCT01683266|19008028|P1|Overall Study|Protocol Violation|13
5497624|NCT01683266|19008027|P2|Overall Study|Lack of Efficacy|2
5497625|NCT01683266|19008028|P1|Overall Study|Lack of Efficacy|5
5497626|NCT01683266|19008027|P2|Overall Study|Adverse Event|4
5497627|NCT01683266|19008028|P1|Overall Study|Adverse Event|5
5497628|NCT01683071|19008062|P6|Part 2|Withdrawal by investigator decision|2
5497629|NCT01683071|19008063|P5|Part 2|Withdrawal by investigator decision|1
5497630|NCT01683071|19008064|P4|Part 2|Withdrawal by investigator decision|0
5497631|NCT01683071|19008065|P3|Part 2|Withdrawal by investigator decision|0
5497632|NCT01683071|19008066|P2|Part 2|Withdrawal by investigator decision|0
5497633|NCT01683071|19008067|P1|Part 2|Withdrawal by investigator decision|0
5497634|NCT01683071|19008062|P6|Part 2|Protocol deviation|2
5497635|NCT01683071|19008063|P5|Part 2|Protocol deviation|1
5497636|NCT01683071|19008064|P4|Part 2|Protocol deviation|0
5497637|NCT01683071|19008065|P3|Part 2|Protocol deviation|0
5497638|NCT01683071|19008066|P2|Part 2|Protocol deviation|0
5497639|NCT01683071|19008067|P1|Part 2|Protocol deviation|0
5497640|NCT01683071|19008062|P6|Part 2|Met exclusion criterion|1
5497641|NCT01683071|19008063|P5|Part 2|Met exclusion criterion|1
5497642|NCT01683071|19008064|P4|Part 2|Met exclusion criterion|0
5497643|NCT01683071|19008065|P3|Part 2|Met exclusion criterion|0
5497644|NCT01683071|19008066|P2|Part 2|Met exclusion criterion|0
5497645|NCT01683071|19008067|P1|Part 2|Met exclusion criterion|0
5497646|NCT01683071|19008062|P6|Part 2|Did not receive study drug|1
5497647|NCT01683071|19008063|P5|Part 2|Did not receive study drug|2
5497648|NCT01683071|19008064|P4|Part 2|Did not receive study drug|0
5497649|NCT01683071|19008065|P3|Part 2|Did not receive study drug|0
5497650|NCT01683071|19008066|P2|Part 2|Did not receive study drug|0
5497651|NCT01683071|19008067|P1|Part 2|Did not receive study drug|0
5497652|NCT01683071|19008062|P6|Part 2|Surgery cancelled|2
5497653|NCT01683071|19008063|P5|Part 2|Surgery cancelled|4
5497654|NCT01683071|19008064|P4|Part 2|Surgery cancelled|0
5497655|NCT01683071|19008065|P3|Part 2|Surgery cancelled|0
5497656|NCT01683071|19008066|P2|Part 2|Surgery cancelled|0
5497657|NCT01683071|19008067|P1|Part 2|Surgery cancelled|0
5497658|NCT01683071|19008062|P6|Part 2|Withdrawal by Subject|3
5497659|NCT01683071|19008063|P5|Part 2|Withdrawal by Subject|3
5497660|NCT01683071|19008064|P4|Part 2|Withdrawal by Subject|0
5497661|NCT01683071|19008065|P3|Part 2|Withdrawal by Subject|0
5497662|NCT01683071|19008066|P2|Part 2|Withdrawal by Subject|0
5497663|NCT01683071|19008067|P1|Part 2|Withdrawal by Subject|0
5497664|NCT01683071|19008062|P6|Part 2|Lost to Follow-up|0
5497665|NCT01683071|19008063|P5|Part 2|Lost to Follow-up|2
5497666|NCT01683071|19008064|P4|Part 2|Lost to Follow-up|0
5497667|NCT01683071|19008065|P3|Part 2|Lost to Follow-up|0
5497668|NCT01683071|19008066|P2|Part 2|Lost to Follow-up|0
5497669|NCT01683071|19008067|P1|Part 2|Lost to Follow-up|0
5497670|NCT01683071|19008062|P6|Part 2|Lack of Efficacy|4
5497671|NCT01683071|19008063|P5|Part 2|Lack of Efficacy|3
5497672|NCT01683071|19008064|P4|Part 2|Lack of Efficacy|0
5497673|NCT01683071|19008065|P3|Part 2|Lack of Efficacy|0
5497674|NCT01683071|19008066|P2|Part 2|Lack of Efficacy|0
5497675|NCT01683071|19008067|P1|Part 2|Lack of Efficacy|0
5497676|NCT01683071|19008062|P6|Part 1|Early termination; met exclusion criteria|0
5497677|NCT01683071|19008063|P5|Part 1|Early termination; met exclusion criteria|0
5497678|NCT01683071|19008064|P4|Part 1|Early termination; met exclusion criteria|0
5497679|NCT01683071|19008065|P3|Part 1|Early termination; met exclusion criteria|1
5497680|NCT01683071|19008066|P2|Part 1|Early termination; met exclusion criteria|2
5497681|NCT01683071|19008067|P1|Part 1|Early termination; met exclusion criteria|0
5497682|NCT01683071|19008062|P6|Part 1|Did not receive study drug|0
5497683|NCT01683071|19008063|P5|Part 1|Did not receive study drug|0
5497684|NCT01683071|19008064|P4|Part 1|Did not receive study drug|1
5497685|NCT01683071|19008065|P3|Part 1|Did not receive study drug|0
5497686|NCT01683071|19008066|P2|Part 1|Did not receive study drug|0
5497687|NCT01683071|19008067|P1|Part 1|Did not receive study drug|1
5497688|NCT01683071|19008062|P6|Part 1|Surgery Cancelled|0
5497689|NCT01683071|19008063|P5|Part 1|Surgery Cancelled|0
5497690|NCT01683071|19008064|P4|Part 1|Surgery Cancelled|0
5497691|NCT01683071|19008065|P3|Part 1|Surgery Cancelled|0
5497692|NCT01683071|19008066|P2|Part 1|Surgery Cancelled|0
5497693|NCT01683071|19008067|P1|Part 1|Surgery Cancelled|1
5497694|NCT01683071|19008062|P6|Part 1|Withdrawal by Subject|0
5497695|NCT01683071|19008063|P5|Part 1|Withdrawal by Subject|0
5497696|NCT01683071|19008064|P4|Part 1|Withdrawal by Subject|1
5497697|NCT01683071|19008065|P3|Part 1|Withdrawal by Subject|2
5497698|NCT01683071|19008066|P2|Part 1|Withdrawal by Subject|2
5497699|NCT01683071|19008067|P1|Part 1|Withdrawal by Subject|1
5497700|NCT01683071|19008062|P6|Part 1|Lack of Efficacy|0
5497701|NCT01683071|19008063|P5|Part 1|Lack of Efficacy|0
5497702|NCT01683071|19008064|P4|Part 1|Lack of Efficacy|3
5497703|NCT01683071|19008065|P3|Part 1|Lack of Efficacy|0
5497704|NCT01683071|19008066|P2|Part 1|Lack of Efficacy|0
5497705|NCT01683071|19008067|P1|Part 1|Lack of Efficacy|1
5497706|NCT01683058|19008093|P1|Overall Study|Lack of Efficacy|2
5497707|NCT01683058|19008093|P1|Overall Study|Withdrawal by Subject|7
5497708|NCT01683058|19008093|P1|Overall Study|Subject Met Withdrawal Criteria|5
5497709|NCT01683058|19008093|P1|Overall Study|Adverse Event|6
5497710|NCT01683058|19008093|P1|Overall Study|Lost to Follow-up|9
5497711|NCT01683019|19008124|P3|Overall Study|Withdrawal by Subject|4
5497712|NCT01683019|19008125|P2|Overall Study|Withdrawal by Subject|1
5497713|NCT01683019|19008126|P1|Overall Study|Withdrawal by Subject|2
5497714|NCT01682876|19008160|P4|Overall Study|Other|1
5497715|NCT01682876|19008161|P3|Overall Study|Other|1
5497716|NCT01682876|19008162|P2|Overall Study|Other|0
5497717|NCT01682876|19008163|P1|Overall Study|Other|1
5497718|NCT01682876|19008160|P4|Overall Study|Withdrawal by Subject|2
5497719|NCT01682876|19008161|P3|Overall Study|Withdrawal by Subject|0
5497720|NCT01682876|19008162|P2|Overall Study|Withdrawal by Subject|0
5497721|NCT01682876|19008163|P1|Overall Study|Withdrawal by Subject|4
5497722|NCT01682876|19008160|P4|Overall Study|Protocol Violation|1
5497723|NCT01682876|19008161|P3|Overall Study|Protocol Violation|1
5497724|NCT01682876|19008162|P2|Overall Study|Protocol Violation|1
5497725|NCT01682876|19008163|P1|Overall Study|Protocol Violation|1
5497726|NCT01682876|19008160|P4|Overall Study|Lost to Follow-up|11
5497727|NCT01682876|19008161|P3|Overall Study|Lost to Follow-up|9
5497728|NCT01682876|19008162|P2|Overall Study|Lost to Follow-up|15
5497729|NCT01682876|19008163|P1|Overall Study|Lost to Follow-up|11
5497730|NCT01682876|19008160|P4|Overall Study|Adverse Event|1
5497731|NCT01682876|19008161|P3|Overall Study|Adverse Event|0
5497732|NCT01682876|19008162|P2|Overall Study|Adverse Event|0
5497733|NCT01682876|19008163|P1|Overall Study|Adverse Event|0
5497734|NCT01682876|19008160|P4|Overall Study|Administrative reason|3
5497735|NCT01682876|19008161|P3|Overall Study|Administrative reason|0
5497736|NCT01682876|19008162|P2|Overall Study|Administrative reason|4
5497737|NCT01682876|19008163|P1|Overall Study|Administrative reason|4
5497738|NCT01682863|19008209|P3|Overall Study|Physician Decision|1
5497739|NCT01682863|19008210|P2|Overall Study|Physician Decision|0
5497740|NCT01682863|19008211|P1|Overall Study|Physician Decision|0
5497741|NCT01682863|19008209|P3|Overall Study|Adverse Event|2
5497742|NCT01682863|19008210|P2|Overall Study|Adverse Event|1
5497743|NCT01682863|19008211|P1|Overall Study|Adverse Event|0
5497744|NCT01682863|19008209|P3|Overall Study|Technical problems|0
5497745|NCT01682863|19008210|P2|Overall Study|Technical problems|0
5497746|NCT01682863|19008211|P1|Overall Study|Technical problems|1
5497747|NCT01682863|19008209|P3|Overall Study|Protocol deviation|1
5497748|NCT01682863|19008210|P2|Overall Study|Protocol deviation|0
5497749|NCT01682863|19008211|P1|Overall Study|Protocol deviation|1
5497750|NCT01682863|19008209|P3|Overall Study|Death|4
5497751|NCT01682863|19008210|P2|Overall Study|Death|3
5497752|NCT01682863|19008211|P1|Overall Study|Death|1
5497753|NCT01682863|19008209|P3|Overall Study|Lost to Follow-up|6
5497754|NCT01682863|19008210|P2|Overall Study|Lost to Follow-up|1
5497755|NCT01682863|19008211|P1|Overall Study|Lost to Follow-up|5
5497756|NCT01682863|19008209|P3|Overall Study|Subject/guardian decision|10
5497757|NCT01682863|19008210|P2|Overall Study|Subject/guardian decision|12
5497758|NCT01682863|19008211|P1|Overall Study|Subject/guardian decision|19
5497759|NCT01682837|19008240|P1|Baseline|Withdrawal by Subject|5
5497760|NCT01682759|19008284|P2|Overall Study|Withdrawal by Subject|55
5497761|NCT01682759|19008285|P1|Overall Study|Withdrawal by Subject|56
5497762|NCT01682759|19008284|P2|Overall Study|Physician Decision|1
5497763|NCT01682759|19008285|P1|Overall Study|Physician Decision|1
5497764|NCT01682759|19008284|P2|Overall Study|Lost to Follow-up|13
5497765|NCT01682759|19008285|P1|Overall Study|Lost to Follow-up|10
5497766|NCT01682759|19008284|P2|Overall Study|Death|1
5497767|NCT01682759|19008285|P1|Overall Study|Death|2
5497768|NCT01682720|19008309|P4|Overall Study|Adverse Event|1
5497769|NCT01682720|19008310|P3|Overall Study|Adverse Event|1
5497770|NCT01682720|19008311|P2|Overall Study|Adverse Event|0
5497771|NCT01682720|19008312|P1|Overall Study|Adverse Event|1
5497772|NCT01682720|19008309|P4|Overall Study|Subject Withdrew Consent|2
5497773|NCT01682720|19008310|P3|Overall Study|Subject Withdrew Consent|2
5497774|NCT01682720|19008311|P2|Overall Study|Subject Withdrew Consent|0
5497775|NCT01682720|19008312|P1|Overall Study|Subject Withdrew Consent|0
5497776|NCT01682720|19008309|P4|Overall Study|Lost to Follow-up|6
5497777|NCT01682720|19008310|P3|Overall Study|Lost to Follow-up|0
5497778|NCT01682720|19008311|P2|Overall Study|Lost to Follow-up|1
5497779|NCT01682720|19008312|P1|Overall Study|Lost to Follow-up|1
5497780|NCT01682720|19008309|P4|Overall Study|Efficacy Failure|30
5497781|NCT01682720|19008310|P3|Overall Study|Efficacy Failure|3
5497782|NCT01682720|19008311|P2|Overall Study|Efficacy Failure|3
5497783|NCT01682720|19008312|P1|Overall Study|Efficacy Failure|0
5497784|NCT01682720|19008309|P4|Overall Study|Terminated by Sponsor|0
5497785|NCT01682720|19008310|P3|Overall Study|Terminated by Sponsor|0
5497786|NCT01682720|19008311|P2|Overall Study|Terminated by Sponsor|0
5497787|NCT01682720|19008312|P1|Overall Study|Terminated by Sponsor|83
5497788|NCT01682720|19008309|P4|Overall Study|Randomized but Not Treated|0
5497789|NCT01682720|19008310|P3|Overall Study|Randomized but Not Treated|1
5497790|NCT01682720|19008311|P2|Overall Study|Randomized but Not Treated|1
5497791|NCT01682720|19008312|P1|Overall Study|Randomized but Not Treated|0
5497792|NCT01682681|19008329|P1|Overall Study|Low compliance|13
5497793|NCT01682681|19008329|P1|Overall Study|Other|21
5497794|NCT01682681|19008329|P1|Overall Study|tapering of topiramate|5
5497795|NCT01682681|19008329|P1|Overall Study|Adverse Event|46
5497796|NCT01682681|19008329|P1|Overall Study|Lost to Follow-up|174
5497797|NCT01682681|19008329|P1|Overall Study|Moved to other hospital|10
5497798|NCT01682681|19008329|P1|Overall Study|Withdrawal by Subject|1
5497799|NCT01682681|19008329|P1|Overall Study|Lack of Efficacy|62
5497800|NCT01682603|19008358|P1|Overall Study|Lost to Follow-up|3
5497801|NCT01682512|19008403|P3|Overall Study|Other than stated above|2
5497802|NCT01682512|19008404|P2|Overall Study|Other than stated above|4
5497803|NCT01682512|19008405|P1|Overall Study|Other than stated above|2
5497804|NCT01682512|19008403|P3|Overall Study|Secondary lack of efficacy|0
5497805|NCT01682512|19008404|P2|Overall Study|Secondary lack of efficacy|1
5497806|NCT01682512|19008405|P1|Overall Study|Secondary lack of efficacy|1
5497807|NCT01682512|19008403|P3|Overall Study|Primary lack of efficacy|7
5497808|NCT01682512|19008404|P2|Overall Study|Primary lack of efficacy|7
5497809|NCT01682512|19008405|P1|Overall Study|Primary lack of efficacy|10
5497810|NCT01682512|19008403|P3|Overall Study|Protocol Violation|2
5497811|NCT01682512|19008404|P2|Overall Study|Protocol Violation|3
5497812|NCT01682512|19008405|P1|Overall Study|Protocol Violation|2
5497813|NCT01682512|19008403|P3|Overall Study|Lost to Follow-up|2
5497814|NCT01682512|19008404|P2|Overall Study|Lost to Follow-up|0
5497815|NCT01682512|19008405|P1|Overall Study|Lost to Follow-up|3
5497816|NCT01682512|19008403|P3|Overall Study|Study terminated by sponsor|0
5497817|NCT01682512|19008404|P2|Overall Study|Study terminated by sponsor|43
5497818|NCT01682512|19008405|P1|Overall Study|Study terminated by sponsor|46
5497819|NCT01682512|19008403|P3|Overall Study|Physician Decision|0
5497820|NCT01682512|19008404|P2|Overall Study|Physician Decision|2
5497821|NCT01682512|19008405|P1|Overall Study|Physician Decision|0
5497822|NCT01682512|19008403|P3|Overall Study|Withdrawal by Subject|3
5497823|NCT01682512|19008404|P2|Overall Study|Withdrawal by Subject|6
5497824|NCT01682512|19008405|P1|Overall Study|Withdrawal by Subject|2
5497825|NCT01682512|19008403|P3|Overall Study|Adverse Event|2
5497826|NCT01682512|19008404|P2|Overall Study|Adverse Event|5
5497827|NCT01682512|19008405|P1|Overall Study|Adverse Event|6
5497828|NCT01682460|19008430|P1|Overall Study|Did not meet inclusion criteria|2
5497829|NCT01682460|19008430|P1|Overall Study|Withdrawal by Subject|2
5497830|NCT01682213|19008445|P1|Overall Study|Withdrawal by Subject|2
5497831|NCT01682148|19008453|P2|Overall Study|Protocol Violation|1
5497832|NCT01682148|19008454|P1|Overall Study|Protocol Violation|1
5497833|NCT01682148|19008453|P2|Overall Study|Lost to Follow-up|2
5497834|NCT01682148|19008454|P1|Overall Study|Lost to Follow-up|1
5497835|NCT01682148|19008453|P2|Overall Study|Withdrawal by Subject|0
5497836|NCT01682148|19008454|P1|Overall Study|Withdrawal by Subject|2
5497837|NCT01682083|19008514|P2|Overall Study|Physician Decision|4
5497838|NCT01682083|19008515|P1|Overall Study|Physician Decision|5
5497839|NCT01682083|19008514|P2|Overall Study|Death|93
5497840|NCT01682083|19008515|P1|Overall Study|Death|60
5497841|NCT01682083|19008514|P2|Overall Study|Withdrawal by Subject|40
5497842|NCT01682083|19008515|P1|Overall Study|Withdrawal by Subject|31
5497843|NCT01682083|19008514|P2|Overall Study|Lost to Follow-up|18
5497844|NCT01682083|19008515|P1|Overall Study|Lost to Follow-up|11
5497845|NCT01682044|19008527|P1|Overall Study|Progression|3
5497846|NCT01682044|19008527|P1|Overall Study|Death|1
5497847|NCT01682031|19008539|P2|Overall Study|Patient stopped selenium on his own|1
5497848|NCT01682031|19008540|P1|Overall Study|Patient stopped selenium on his own|0
5497849|NCT01682031|19008539|P2|Overall Study|Patient could not swallow tablets|0
5497850|NCT01682031|19008540|P1|Overall Study|Patient could not swallow tablets|1
5497851|NCT01682031|19008539|P2|Overall Study|MRI results indicate increased nodul|1
5497852|NCT01682031|19008540|P1|Overall Study|MRI results indicate increased nodul|0
5497853|NCT01682031|19008539|P2|Overall Study|Adverse Event|2
5497854|NCT01682031|19008540|P1|Overall Study|Adverse Event|0
5497855|NCT01682031|19008539|P2|Overall Study|Withdrawal by Subject|1
5497856|NCT01682031|19008540|P1|Overall Study|Withdrawal by Subject|0
5497857|NCT01681992|19008563|P3|Overall Study|Withdrawal by Subject|25
5497858|NCT01681992|19008564|P2|Overall Study|Withdrawal by Subject|30
5497859|NCT01681992|19008565|P1|Overall Study|Withdrawal by Subject|27
5497860|NCT01681992|19008563|P3|Overall Study|Protocol Violation|1
5497861|NCT01681992|19008564|P2|Overall Study|Protocol Violation|0
5497862|NCT01681992|19008565|P1|Overall Study|Protocol Violation|0
5497863|NCT01681992|19008563|P3|Overall Study|As Per Sponsor Decision|1
5497864|NCT01681992|19008564|P2|Overall Study|As Per Sponsor Decision|0
5497865|NCT01681992|19008565|P1|Overall Study|As Per Sponsor Decision|0
5497866|NCT01681992|19008563|P3|Overall Study|Lost to Follow-up|53
5497867|NCT01681992|19008564|P2|Overall Study|Lost to Follow-up|38
5497868|NCT01681992|19008565|P1|Overall Study|Lost to Follow-up|36
5497869|NCT01681992|19008563|P3|Overall Study|Adverse Event|3
5497870|NCT01681992|19008564|P2|Overall Study|Adverse Event|2
5497871|NCT01681992|19008565|P1|Overall Study|Adverse Event|3
5497872|NCT01681849|19008654|P3|Overall Study|Lost to Follow-up|6
5497873|NCT01681849|19008655|P2|Overall Study|Lost to Follow-up|2
5497874|NCT01681849|19008656|P1|Overall Study|Lost to Follow-up|3
5497875|NCT01681849|19008654|P3|Overall Study|Withdrawal by Subject|33
5497876|NCT01681849|19008655|P2|Overall Study|Withdrawal by Subject|5
5497877|NCT01681849|19008656|P1|Overall Study|Withdrawal by Subject|3
5497878|NCT01681849|19008654|P3|Overall Study|Protocol Violation|0
5497879|NCT01681849|19008655|P2|Overall Study|Protocol Violation|0
5497880|NCT01681849|19008656|P1|Overall Study|Protocol Violation|2
5497881|NCT01681836|19008665|P2|Second Intervention|Withdrawal by Subject|1
5497882|NCT01681836|19008666|P1|Second Intervention|Withdrawal by Subject|0
5497883|NCT01681771|19008700|P2|Overall Study|Lost to Follow-up|2
5497884|NCT01681771|19008701|P1|Overall Study|Lost to Follow-up|4
5497885|NCT01681628|19008709|P2|19 Months Follow-up|Lost to Follow-up|43
5497886|NCT01681628|19008710|P1|19 Months Follow-up|Lost to Follow-up|61
5497887|NCT01681628|19008709|P2|19 Months Follow-up|Death|0
5497888|NCT01681628|19008710|P1|19 Months Follow-up|Death|1
5497889|NCT01681628|19008709|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
5497890|NCT01681628|19008710|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
5497891|NCT01681628|19008709|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
5497892|NCT01681628|19008710|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
5497893|NCT01681576|19008739|P2|Period 2|Non-compliance with study treatment|0
5497894|NCT01681576|19008740|P1|Period 2|Non-compliance with study treatment|1
5497895|NCT01681576|19008739|P2|Period 2|subject/guardian decision|1
5497896|NCT01681576|19008740|P1|Period 2|subject/guardian decision|3
5497897|NCT01681576|19008739|P2|Period 1|Protocol Deviation|0
5497898|NCT01681576|19008740|P1|Period 1|Protocol Deviation|1
5497899|NCT01681576|19008739|P2|Period 1|Adverse Event|0
5497900|NCT01681576|19008740|P1|Period 1|Adverse Event|1
5497901|NCT01681511|19008756|P2|Overall Study|No post-catheter sample collected|4
5497902|NCT01681511|19008757|P1|Overall Study|No post-catheter sample collected|11
5497903|NCT01681511|19008756|P2|Overall Study|No Daily Urine Sample Collected|1
5497904|NCT01681511|19008757|P1|Overall Study|No Daily Urine Sample Collected|0
5497905|NCT01681511|19008756|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
5497906|NCT01681511|19008757|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
5497907|NCT01681511|19008756|P2|Overall Study|Failed Inclusion/Exclusion|0
5497908|NCT01681511|19008757|P1|Overall Study|Failed Inclusion/Exclusion|3
5497909|NCT01681511|19008756|P2|Overall Study|No Treatment Received|3
5497910|NCT01681511|19008757|P1|Overall Study|No Treatment Received|1
5497911|NCT01681472|19008775|P4|Overall Study|Adverse Event|0
5497912|NCT01681472|19008776|P3|Overall Study|Adverse Event|0
5497913|NCT01681472|19008777|P2|Overall Study|Adverse Event|1
5497914|NCT01681472|19008778|P1|Overall Study|Adverse Event|0
5497915|NCT01681433|19008958|P2|Overall Study|Lost to Follow-up|1
5497916|NCT01681433|19008959|P1|Overall Study|Lost to Follow-up|0
5497917|NCT01681433|19008958|P2|Overall Study|Adverse Event|4
5497918|NCT01681433|19008959|P1|Overall Study|Adverse Event|2
5497919|NCT01681433|19008958|P2|Overall Study|Protocol Violation|0
5497920|NCT01681433|19008959|P1|Overall Study|Protocol Violation|2
5497921|NCT01681433|19008958|P2|Overall Study|Withdrawal by Subject|5
5497922|NCT01681433|19008959|P1|Overall Study|Withdrawal by Subject|5
5497923|NCT01681433|19008958|P2|Overall Study|Lack of Efficacy|23
5497924|NCT01681433|19008959|P1|Overall Study|Lack of Efficacy|23
5497925|NCT01681368|19008977|P1|Overall Study|Refused further follow up|1
5497926|NCT01681368|19008977|P1|Overall Study|Refused further treatment|1
5497927|NCT01681277|19008994|P5|Overall Study|Adverse Event|0
5497928|NCT01681277|19008995|P4|Overall Study|Adverse Event|0
5497929|NCT01681277|19008996|P3|Overall Study|Adverse Event|0
5497930|NCT01681277|19008997|P2|Overall Study|Adverse Event|0
5497931|NCT01681277|19008998|P1|Overall Study|Adverse Event|1
5497932|NCT01681212|19009039|P1|Overall Study|Administrative reason by sponsor|1
5497933|NCT01681212|19009039|P1|Overall Study|No longer met study criteria|5
5497934|NCT01681186|19009053|P8|Fourth Intervention|Protocol Violation|1
5497935|NCT01681186|19009054|P7|Fourth Intervention|Protocol Violation|0
5497936|NCT01681186|19009055|P6|Fourth Intervention|Protocol Violation|0
5497937|NCT01681186|19009056|P5|Fourth Intervention|Protocol Violation|0
5497938|NCT01681186|19009057|P4|Fourth Intervention|Protocol Violation|0
5497939|NCT01681186|19009058|P3|Fourth Intervention|Protocol Violation|0
5497940|NCT01681186|19009059|P2|Fourth Intervention|Protocol Violation|0
5497941|NCT01681186|19009060|P1|Fourth Intervention|Protocol Violation|0
5497942|NCT01681186|19009053|P8|Washout Period From Third Intervention|Lost to Follow-up|0
5497943|NCT01681186|19009054|P7|Washout Period From Third Intervention|Lost to Follow-up|1
5497944|NCT01681186|19009055|P6|Washout Period From Third Intervention|Lost to Follow-up|0
5497945|NCT01681186|19009056|P5|Washout Period From Third Intervention|Lost to Follow-up|0
5497946|NCT01681186|19009057|P4|Washout Period From Third Intervention|Lost to Follow-up|0
5497947|NCT01681186|19009058|P3|Washout Period From Third Intervention|Lost to Follow-up|0
5497948|NCT01681186|19009059|P2|Washout Period From Third Intervention|Lost to Follow-up|0
5497949|NCT01681186|19009060|P1|Washout Period From Third Intervention|Lost to Follow-up|0
5497950|NCT01681186|19009053|P8|Washout Period From Second Intervention|Protocol Violation|1
5497951|NCT01681186|19009054|P7|Washout Period From Second Intervention|Protocol Violation|0
5497952|NCT01681186|19009055|P6|Washout Period From Second Intervention|Protocol Violation|0
5497953|NCT01681186|19009056|P5|Washout Period From Second Intervention|Protocol Violation|0
5497954|NCT01681186|19009057|P4|Washout Period From Second Intervention|Protocol Violation|0
5497955|NCT01681186|19009058|P3|Washout Period From Second Intervention|Protocol Violation|0
5497956|NCT01681186|19009059|P2|Washout Period From Second Intervention|Protocol Violation|0
5497957|NCT01681186|19009060|P1|Washout Period From Second Intervention|Protocol Violation|0
5497958|NCT01681186|19009053|P8|Washout Period From Second Intervention|Adverse Event|0
5497959|NCT01681186|19009054|P7|Washout Period From Second Intervention|Adverse Event|1
5497960|NCT01681186|19009055|P6|Washout Period From Second Intervention|Adverse Event|0
5497961|NCT01681186|19009056|P5|Washout Period From Second Intervention|Adverse Event|0
5497962|NCT01681186|19009057|P4|Washout Period From Second Intervention|Adverse Event|0
5497963|NCT01681186|19009058|P3|Washout Period From Second Intervention|Adverse Event|0
5497964|NCT01681186|19009059|P2|Washout Period From Second Intervention|Adverse Event|0
5497965|NCT01681186|19009060|P1|Washout Period From Second Intervention|Adverse Event|0
5497966|NCT01681069|19009163|P2|Overall Study|Adverse Event|1
5497967|NCT01681069|19009164|P1|Overall Study|Adverse Event|0
5497968|NCT01681069|19009163|P2|Overall Study|Protocol Violation|1
5497969|NCT01681069|19009164|P1|Overall Study|Protocol Violation|1
5497970|NCT01681069|19009163|P2|Overall Study|Withdrawal by Subject|5
5497971|NCT01681069|19009164|P1|Overall Study|Withdrawal by Subject|4
5497972|NCT01681004|19009201|P2|Study Completion|Death|1
5497973|NCT01681004|19009202|P1|Study Completion|Death|1
5497974|NCT01681004|19009201|P2|Study Completion|Site Termination|1
5497975|NCT01681004|19009202|P1|Study Completion|Site Termination|2
5497976|NCT01681004|19009201|P2|Study Completion|Physician Decision|3
5497977|NCT01681004|19009202|P1|Study Completion|Physician Decision|1
5497978|NCT01681004|19009201|P2|Study Completion|Lost to Follow-up|3
5497979|NCT01681004|19009202|P1|Study Completion|Lost to Follow-up|8
5497980|NCT01681004|19009201|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
5497981|NCT01681004|19009202|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
5497982|NCT01680991|19009259|P3|Overall Study|PD confirmed in other hospital|0
5497983|NCT01680991|19009260|P2|Overall Study|PD confirmed in other hospital|0
5497984|NCT01680991|19009261|P1|Overall Study|PD confirmed in other hospital|1
5497985|NCT01680991|19009259|P3|Overall Study|Bad physical condition|1
5497986|NCT01680991|19009260|P2|Overall Study|Bad physical condition|0
5497987|NCT01680991|19009261|P1|Overall Study|Bad physical condition|0
5497988|NCT01680991|19009259|P3|Overall Study|Physician Decision|2
5497989|NCT01680991|19009260|P2|Overall Study|Physician Decision|7
5497990|NCT01680991|19009261|P1|Overall Study|Physician Decision|0
5497991|NCT01680991|19009259|P3|Overall Study|Progressive disease (PD)|0
5497992|NCT01680991|19009260|P2|Overall Study|Progressive disease (PD)|10
5497993|NCT01680991|19009261|P1|Overall Study|Progressive disease (PD)|0
5497994|NCT01680991|19009259|P3|Overall Study|Withdrawal by Subject|0
5497995|NCT01680991|19009260|P2|Overall Study|Withdrawal by Subject|1
5497996|NCT01680991|19009261|P1|Overall Study|Withdrawal by Subject|5
5497997|NCT01680991|19009259|P3|Overall Study|Protocol Violation|0
5497998|NCT01680991|19009260|P2|Overall Study|Protocol Violation|1
5497999|NCT01680991|19009261|P1|Overall Study|Protocol Violation|0
5498000|NCT01680991|19009259|P3|Overall Study|Death|1
5498001|NCT01680991|19009260|P2|Overall Study|Death|0
5498002|NCT01680991|19009261|P1|Overall Study|Death|1
5498003|NCT01680991|19009259|P3|Overall Study|Adverse Event|0
5498004|NCT01680991|19009260|P2|Overall Study|Adverse Event|0
5498005|NCT01680991|19009261|P1|Overall Study|Adverse Event|1
5498006|NCT01680965|19009324|P4|Overall Study|Death|6
5498007|NCT01680965|19009325|P3|Overall Study|Death|0
5498008|NCT01680965|19009326|P2|Overall Study|Death|0
5498009|NCT01680965|19009327|P1|Overall Study|Death|0
5498010|NCT01680861|19009368|P2|Early Post-transplant Period|Protocol Violation|1
5498011|NCT01680861|19009369|P1|Early Post-transplant Period|Protocol Violation|1
5498012|NCT01680497|19009466|P1|Overall Study|Lost to Follow-up|2
5498013|NCT01680458|19009476|P1|Overall Study|Protocol Violation|3
5498014|NCT01680341|19009487|P2|Overall Study|Unclassified|15
5498015|NCT01680341|19009488|P1|Overall Study|Unclassified|18
5498016|NCT01680341|19009487|P2|Overall Study|Adverse Event|2
5498017|NCT01680341|19009488|P1|Overall Study|Adverse Event|3
5498018|NCT01680159|19009559|P1|Increased Dose Period|Withdrawal by Subject|2
5498019|NCT01680159|19009559|P1|Increased Dose Period|Adverse Event|6
5498020|NCT01680159|19009559|P1|Screening Period|Not meet criteria for dose-up period|7
5498021|NCT01680016|19009586|P4|Overall Study|Withdrawal by Subject|1
5498022|NCT01680016|19009587|P3|Overall Study|Withdrawal by Subject|1
5498023|NCT01680016|19009588|P2|Overall Study|Withdrawal by Subject|7
5498024|NCT01680016|19009589|P1|Overall Study|Withdrawal by Subject|5
5498025|NCT01680016|19009586|P4|Overall Study|Protocol Violation|0
5498026|NCT01680016|19009587|P3|Overall Study|Protocol Violation|0
5498027|NCT01680016|19009588|P2|Overall Study|Protocol Violation|1
5498028|NCT01680016|19009589|P1|Overall Study|Protocol Violation|0
5498029|NCT01680016|19009586|P4|Overall Study|The Subject went out of The Trial|0
5498030|NCT01680016|19009587|P3|Overall Study|The Subject went out of The Trial|3
5498031|NCT01680016|19009588|P2|Overall Study|The Subject went out of The Trial|0
5498032|NCT01680016|19009589|P1|Overall Study|The Subject went out of The Trial|1
5498033|NCT01680016|19009586|P4|Overall Study|Adverse Event|4
5498034|NCT01680016|19009587|P3|Overall Study|Adverse Event|1
5498035|NCT01680016|19009588|P2|Overall Study|Adverse Event|0
5498036|NCT01680016|19009589|P1|Overall Study|Adverse Event|0
5498037|NCT01679613|19009651|P4|Overall Study|other than stated above|2
5498038|NCT01679613|19009652|P3|Overall Study|other than stated above|2
5498039|NCT01679613|19009653|P2|Overall Study|other than stated above|1
5498040|NCT01679613|19009654|P1|Overall Study|other than stated above|0
5498041|NCT01679405|19009676|P2|Overall Study|Death|5
5498042|NCT01679405|19009677|P1|Overall Study|Death|2
5498043|NCT01679301|19009712|P3|Screening Period|screen failure|0
5498044|NCT01679301|19009713|P2|Screening Period|screen failure|0
5498045|NCT01679301|19009714|P1|Screening Period|screen failure|3
5498046|NCT01679236|19009722|P2|Overall Study|Lost to Follow-up|15
5498047|NCT01679236|19009723|P1|Overall Study|Lost to Follow-up|15
5498048|NCT01679002|19009770|P3|Overall Study|Adverse Event|0
5498049|NCT01679002|19009771|P2|Overall Study|Adverse Event|1
5498050|NCT01679002|19009772|P1|Overall Study|Adverse Event|1
5498051|NCT01678924|19009803|P4|Overall Study|Unable to attend scheduled visits|1
5498052|NCT01678924|19009804|P3|Overall Study|Unable to attend scheduled visits|0
5498053|NCT01678924|19009805|P2|Overall Study|Unable to attend scheduled visits|0
5498054|NCT01678924|19009806|P1|Overall Study|Unable to attend scheduled visits|0
5498055|NCT01678924|19009803|P4|Overall Study|Withdrawal by Subject|2
5498056|NCT01678924|19009804|P3|Overall Study|Withdrawal by Subject|0
5498057|NCT01678924|19009805|P2|Overall Study|Withdrawal by Subject|3
5498058|NCT01678924|19009806|P1|Overall Study|Withdrawal by Subject|0
5498059|NCT01678924|19009803|P4|Overall Study|Personal Reasons|7
5498060|NCT01678924|19009804|P3|Overall Study|Personal Reasons|2
5498061|NCT01678924|19009805|P2|Overall Study|Personal Reasons|2
5498062|NCT01678924|19009806|P1|Overall Study|Personal Reasons|2
5498063|NCT01678924|19009803|P4|Overall Study|Lost to Follow-up|2
5498064|NCT01678924|19009804|P3|Overall Study|Lost to Follow-up|0
5498065|NCT01678924|19009805|P2|Overall Study|Lost to Follow-up|4
5498066|NCT01678924|19009806|P1|Overall Study|Lost to Follow-up|0
5498067|NCT01678924|19009803|P4|Overall Study|Lack of Efficacy|5
5498068|NCT01678924|19009804|P3|Overall Study|Lack of Efficacy|0
5498069|NCT01678924|19009805|P2|Overall Study|Lack of Efficacy|2
5498070|NCT01678924|19009806|P1|Overall Study|Lack of Efficacy|7
5498071|NCT01678924|19009803|P4|Overall Study|Adverse Event|1
5498072|NCT01678924|19009804|P3|Overall Study|Adverse Event|0
5498073|NCT01678924|19009805|P2|Overall Study|Adverse Event|1
5498074|NCT01678924|19009806|P1|Overall Study|Adverse Event|1
5498075|NCT01678911|19009937|P2|Second Intervention|Lost to Follow-up|0
5498076|NCT01678911|19009938|P1|Second Intervention|Lost to Follow-up|2
5498077|NCT01678898|19009955|P3|PB-102-F01|Physician Decision|0
5498078|NCT01678898|19009956|P2|PB-102-F01|Physician Decision|1
5498079|NCT01678898|19009957|P1|PB-102-F01|Physician Decision|0
5498080|NCT01678898|19009955|P3|PB-102-F01|Adverse Event|0
5498081|NCT01678898|19009956|P2|PB-102-F01|Adverse Event|1
5498082|NCT01678898|19009957|P1|PB-102-F01|Adverse Event|0
5498083|NCT01678820|19010067|P3|Overall Study|Not treated with double-blind study drug|2
5498084|NCT01678820|19010068|P2|Overall Study|Not treated with double-blind study drug|2
5498085|NCT01678820|19010069|P1|Overall Study|Not treated with double-blind study drug|0
5498086|NCT01678820|19010067|P3|Overall Study|Protocol Violation|4
5498087|NCT01678820|19010068|P2|Overall Study|Protocol Violation|5
5498088|NCT01678820|19010069|P1|Overall Study|Protocol Violation|4
5498089|NCT01678820|19010067|P3|Overall Study|Physician Decision|1
5498090|NCT01678820|19010068|P2|Overall Study|Physician Decision|0
5498091|NCT01678820|19010069|P1|Overall Study|Physician Decision|0
5498092|NCT01678820|19010067|P3|Overall Study|Non-compliance with study drug|0
5498093|NCT01678820|19010068|P2|Overall Study|Non-compliance with study drug|1
5498094|NCT01678820|19010069|P1|Overall Study|Non-compliance with study drug|0
5498095|NCT01678820|19010067|P3|Overall Study|Lost to Follow-up|2
5498096|NCT01678820|19010068|P2|Overall Study|Lost to Follow-up|2
5498097|NCT01678820|19010069|P1|Overall Study|Lost to Follow-up|7
5498098|NCT01678820|19010067|P3|Overall Study|Adverse Event|2
5498099|NCT01678820|19010068|P2|Overall Study|Adverse Event|2
5498100|NCT01678820|19010069|P1|Overall Study|Adverse Event|2
5498101|NCT01678820|19010067|P3|Overall Study|Protocol Specified Criteria|1
5498102|NCT01678820|19010068|P2|Overall Study|Protocol Specified Criteria|3
5498103|NCT01678820|19010069|P1|Overall Study|Protocol Specified Criteria|2
5498104|NCT01678820|19010067|P3|Overall Study|Withdrawal by Subject|2
5498105|NCT01678820|19010068|P2|Overall Study|Withdrawal by Subject|5
5498106|NCT01678820|19010069|P1|Overall Study|Withdrawal by Subject|2
5498107|NCT01678820|19010067|P3|Overall Study|Study Terminated by Sponsor|43
5498108|NCT01678820|19010068|P2|Overall Study|Study Terminated by Sponsor|43
5498109|NCT01678820|19010069|P1|Overall Study|Study Terminated by Sponsor|45
5498110|NCT01678807|19010114|P3|Overall Study|Withdrawn by Parent/Guardian|0
5498111|NCT01678807|19010115|P2|Overall Study|Withdrawn by Parent/Guardian|1
5498112|NCT01678807|19010116|P1|Overall Study|Withdrawn by Parent/Guardian|0
5498113|NCT01678807|19010114|P3|Overall Study|Adverse Event|0
5498114|NCT01678807|19010115|P2|Overall Study|Adverse Event|4
5498115|NCT01678807|19010116|P1|Overall Study|Adverse Event|4
5498116|NCT01678560|19010129|P2|Overall Study|Withdrawal by Subject|1
5498117|NCT01678560|19010130|P1|Overall Study|Withdrawal by Subject|0
5498118|NCT01678560|19010129|P2|Overall Study|Death|1
5498119|NCT01678560|19010130|P1|Overall Study|Death|0
5498120|NCT01678560|19010129|P2|Overall Study|Physician Decision|4
5498121|NCT01678560|19010130|P1|Overall Study|Physician Decision|4
5498122|NCT01678313|19010151|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
5498123|NCT01678313|19010152|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
5498124|NCT01678313|19010151|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
5498125|NCT01678313|19010152|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
5498126|NCT01678313|19010151|P2|Completed the 3-month Therapy|Physician Decision|4
5498127|NCT01678313|19010152|P1|Completed the 3-month Therapy|Physician Decision|3
5498128|NCT01678313|19010151|P2|Completed the 3-month Therapy|Lost to Follow-up|8
5498129|NCT01678313|19010152|P1|Completed the 3-month Therapy|Lost to Follow-up|3
5498130|NCT01678209|19010171|P3|Overall Study|screen fail|16
5498131|NCT01678209|19010172|P2|Overall Study|screen fail|17
5498132|NCT01678209|19010173|P1|Overall Study|screen fail|16
5498133|NCT01678209|19010171|P3|Overall Study|scheduling conflicts|1
5498134|NCT01678209|19010172|P2|Overall Study|scheduling conflicts|0
5498135|NCT01678209|19010173|P1|Overall Study|scheduling conflicts|0
5498136|NCT01678209|19010171|P3|Overall Study|could not scan twice|1
5498137|NCT01678209|19010172|P2|Overall Study|could not scan twice|1
5498138|NCT01678209|19010173|P1|Overall Study|could not scan twice|1
5498139|NCT01678144|19010214|P1|Stage 1: MAR Classic|Adverse Event|1
5498140|NCT01678131|19010233|P3|Overall Study|Withdrawal by Subject|2
5498141|NCT01678131|19010234|P2|Overall Study|Withdrawal by Subject|0
5498142|NCT01678131|19010235|P1|Overall Study|Withdrawal by Subject|0
5498143|NCT01678131|19010233|P3|Overall Study|Adverse Event|0
5498144|NCT01678131|19010234|P2|Overall Study|Adverse Event|1
5498145|NCT01678131|19010235|P1|Overall Study|Adverse Event|0
5498146|NCT01677988|19010243|P1|Overall Study|Lack of Efficacy|2
5498147|NCT01677936|19010256|P2|Overall Study|Protocol Violation|4
5498148|NCT01677936|19010257|P1|Overall Study|Protocol Violation|0
5498149|NCT01677936|19010256|P2|Overall Study|Lost to Follow-up|0
5498150|NCT01677936|19010257|P1|Overall Study|Lost to Follow-up|1
5498151|NCT01677936|19010256|P2|Overall Study|Adverse Event|0
5498152|NCT01677936|19010257|P1|Overall Study|Adverse Event|1
5498153|NCT01677936|19010256|P2|Overall Study|Protocol Violation|0
5498154|NCT01677936|19010257|P1|Overall Study|Protocol Violation|3
5498155|NCT01677936|19010256|P2|Overall Study|Lost to Follow-up|1
5498156|NCT01677936|19010257|P1|Overall Study|Lost to Follow-up|4
5498157|NCT01677910|19010268|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
5498158|NCT01677910|19010269|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
5498159|NCT01677910|19010270|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
5498160|NCT01677910|19010271|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
5498161|NCT01677910|19010268|P4|Open-Label Extension Period (OLE)|Adverse Event|15
5498162|NCT01677910|19010269|P3|Open-Label Extension Period (OLE)|Adverse Event|0
5498163|NCT01677910|19010270|P2|Open-Label Extension Period (OLE)|Adverse Event|0
5498164|NCT01677910|19010271|P1|Open-Label Extension Period (OLE)|Adverse Event|0
5498165|NCT01677910|19010268|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
5498166|NCT01677910|19010269|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5498167|NCT01677910|19010270|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5498168|NCT01677910|19010271|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
5498169|NCT01677910|19010268|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
5498170|NCT01677910|19010269|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5498171|NCT01677910|19010270|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5498172|NCT01677910|19010271|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
5498173|NCT01677910|19010268|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
5498174|NCT01677910|19010269|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
5498175|NCT01677910|19010270|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
5498176|NCT01677910|19010271|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
5498177|NCT01677910|19010268|P4|Open-Label Extension Period (OLE)|Physician Decision|4
5498178|NCT01677910|19010269|P3|Open-Label Extension Period (OLE)|Physician Decision|0
5498179|NCT01677910|19010270|P2|Open-Label Extension Period (OLE)|Physician Decision|0
5498180|NCT01677910|19010271|P1|Open-Label Extension Period (OLE)|Physician Decision|0
5498181|NCT01677910|19010268|P4|Double-Blind Treatment Period|Reason Not Specified|0
5498182|NCT01677910|19010269|P3|Double-Blind Treatment Period|Reason Not Specified|0
5498183|NCT01677910|19010270|P2|Double-Blind Treatment Period|Reason Not Specified|1
5498184|NCT01677910|19010271|P1|Double-Blind Treatment Period|Reason Not Specified|0
5498185|NCT01677910|19010268|P4|Double-Blind Treatment Period|Withdrawal of consent|0
5498186|NCT01677910|19010269|P3|Double-Blind Treatment Period|Withdrawal of consent|3
5498187|NCT01677910|19010270|P2|Double-Blind Treatment Period|Withdrawal of consent|0
5498188|NCT01677910|19010271|P1|Double-Blind Treatment Period|Withdrawal of consent|1
5498189|NCT01677910|19010268|P4|Double-Blind Treatment Period|Physician Decision|0
5498190|NCT01677910|19010269|P3|Double-Blind Treatment Period|Physician Decision|1
5498191|NCT01677910|19010270|P2|Double-Blind Treatment Period|Physician Decision|0
5498192|NCT01677910|19010271|P1|Double-Blind Treatment Period|Physician Decision|0
5498193|NCT01677910|19010268|P4|Double-Blind Treatment Period|Adverse Event|0
5498194|NCT01677910|19010269|P3|Double-Blind Treatment Period|Adverse Event|3
5498195|NCT01677910|19010270|P2|Double-Blind Treatment Period|Adverse Event|2
5498196|NCT01677910|19010271|P1|Double-Blind Treatment Period|Adverse Event|6
5498197|NCT01677858|19010298|P5|Overall Study|Lost to Follow-up|1
5498198|NCT01677858|19010299|P4|Overall Study|Lost to Follow-up|0
5498199|NCT01677858|19010300|P3|Overall Study|Lost to Follow-up|0
5498200|NCT01677858|19010301|P2|Overall Study|Lost to Follow-up|0
5498201|NCT01677858|19010302|P1|Overall Study|Lost to Follow-up|0
5498202|NCT01677858|19010298|P5|Overall Study|Withdrawal by Subject|15
5498203|NCT01677858|19010299|P4|Overall Study|Withdrawal by Subject|0
5498204|NCT01677858|19010300|P3|Overall Study|Withdrawal by Subject|1
5498205|NCT01677858|19010301|P2|Overall Study|Withdrawal by Subject|1
5498206|NCT01677858|19010302|P1|Overall Study|Withdrawal by Subject|0
5498207|NCT01677858|19010298|P5|Overall Study|Progressive Disease|43
5498208|NCT01677858|19010299|P4|Overall Study|Progressive Disease|3
5498209|NCT01677858|19010300|P3|Overall Study|Progressive Disease|9
5498210|NCT01677858|19010301|P2|Overall Study|Progressive Disease|1
5498211|NCT01677858|19010302|P1|Overall Study|Progressive Disease|2
5498212|NCT01677858|19010298|P5|Overall Study|Physician Decision|12
5498213|NCT01677858|19010299|P4|Overall Study|Physician Decision|0
5498214|NCT01677858|19010300|P3|Overall Study|Physician Decision|2
5498215|NCT01677858|19010301|P2|Overall Study|Physician Decision|0
5498216|NCT01677858|19010302|P1|Overall Study|Physician Decision|1
5498217|NCT01677858|19010298|P5|Overall Study|Death|1
5498218|NCT01677858|19010299|P4|Overall Study|Death|0
5498219|NCT01677858|19010300|P3|Overall Study|Death|0
5498220|NCT01677858|19010301|P2|Overall Study|Death|0
5498221|NCT01677858|19010302|P1|Overall Study|Death|0
5498222|NCT01677858|19010298|P5|Overall Study|Adverse Event|13
5498223|NCT01677858|19010299|P4|Overall Study|Adverse Event|3
5498224|NCT01677858|19010300|P3|Overall Study|Adverse Event|2
5498225|NCT01677858|19010301|P2|Overall Study|Adverse Event|0
5498226|NCT01677858|19010302|P1|Overall Study|Adverse Event|0
5498227|NCT01677767|19010375|P1|Overall Study|Non-compliance by the participants|3
5498228|NCT01677767|19010375|P1|Overall Study|Withdrawal by Subject|10
5498229|NCT01677767|19010375|P1|Overall Study|Protocol Violation|4
5498230|NCT01677767|19010375|P1|Overall Study|Death|4
5498231|NCT01677767|19010375|P1|Overall Study|Adverse Event|1
5498232|NCT01677624|19010389|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
5498233|NCT01677507|19010394|P2|Second Assigment|Adverse Event|3
5498234|NCT01677507|19010395|P1|Second Assigment|Adverse Event|1
5498235|NCT01677507|19010394|P2|Second Assigment|Withdrawal by Subject|2
5498236|NCT01677507|19010395|P1|Second Assigment|Withdrawal by Subject|2
5498237|NCT01677507|19010394|P2|Initial Assignment|Protocol Violation|1
5498238|NCT01677507|19010395|P1|Initial Assignment|Protocol Violation|0
5498239|NCT01677507|19010394|P2|Initial Assignment|Adverse Event|1
5498240|NCT01677507|19010395|P1|Initial Assignment|Adverse Event|0
5498241|NCT01677377|19010408|P3|Overall Study|Pregnancy|1
5498242|NCT01677377|19010409|P2|Overall Study|Pregnancy|0
5498243|NCT01677377|19010410|P1|Overall Study|Pregnancy|0
5498244|NCT01677377|19010408|P3|Overall Study|Lack of Efficacy|1
5498245|NCT01677377|19010409|P2|Overall Study|Lack of Efficacy|0
5498246|NCT01677377|19010410|P1|Overall Study|Lack of Efficacy|0
5498247|NCT01677377|19010408|P3|Overall Study|Withdrawal by Subject|3
5498248|NCT01677377|19010409|P2|Overall Study|Withdrawal by Subject|0
5498249|NCT01677377|19010410|P1|Overall Study|Withdrawal by Subject|0
5498250|NCT01677377|19010408|P3|Overall Study|Lost to Follow-up|1
5498251|NCT01677377|19010409|P2|Overall Study|Lost to Follow-up|1
5498252|NCT01677377|19010410|P1|Overall Study|Lost to Follow-up|0
5498253|NCT01677377|19010408|P3|Overall Study|Protocol Violation|0
5498254|NCT01677377|19010409|P2|Overall Study|Protocol Violation|0
5498255|NCT01677377|19010410|P1|Overall Study|Protocol Violation|1
5498256|NCT01677299|19010626|P4|Overall Study|Withdrawal by Subject|1
5498257|NCT01677299|19010627|P3|Overall Study|Withdrawal by Subject|0
5498258|NCT01677299|19010628|P2|Overall Study|Withdrawal by Subject|1
5498259|NCT01677299|19010629|P1|Overall Study|Withdrawal by Subject|0
5498260|NCT01677299|19010626|P4|Overall Study|Adverse Event|0
5498261|NCT01677299|19010627|P3|Overall Study|Adverse Event|1
5498262|NCT01677299|19010628|P2|Overall Study|Adverse Event|2
5498263|NCT01677299|19010629|P1|Overall Study|Adverse Event|0
5498264|NCT01677195|19010661|P3|Overall Study|Protocol Violation|4
5498265|NCT01677195|19010662|P2|Overall Study|Protocol Violation|3
5498266|NCT01677195|19010663|P1|Overall Study|Protocol Violation|7
5498267|NCT01677195|19010661|P3|Overall Study|Pregnancy|0
5498268|NCT01677195|19010662|P2|Overall Study|Pregnancy|1
5498269|NCT01677195|19010663|P1|Overall Study|Pregnancy|0
5498270|NCT01677195|19010661|P3|Overall Study|Physician Decision|2
5498271|NCT01677195|19010662|P2|Overall Study|Physician Decision|2
5498272|NCT01677195|19010663|P1|Overall Study|Physician Decision|1
5498273|NCT01677195|19010661|P3|Overall Study|Adverse Event|1
5498274|NCT01677195|19010662|P2|Overall Study|Adverse Event|4
5498275|NCT01677195|19010663|P1|Overall Study|Adverse Event|6
5498276|NCT01677195|19010661|P3|Overall Study|Withdrawal by Subject|1
5498277|NCT01677195|19010662|P2|Overall Study|Withdrawal by Subject|0
5498278|NCT01677195|19010663|P1|Overall Study|Withdrawal by Subject|1
5498279|NCT01677195|19010661|P3|Overall Study|Lost to Follow-up|22
5498280|NCT01677195|19010662|P2|Overall Study|Lost to Follow-up|22
5498281|NCT01677195|19010663|P1|Overall Study|Lost to Follow-up|14
5498282|NCT01677182|19010674|P3|Overall Study|Other reasons|2
5498283|NCT01677182|19010675|P2|Overall Study|Other reasons|5
5498284|NCT01677182|19010676|P1|Overall Study|Other reasons|1
5498285|NCT01677182|19010674|P3|Overall Study|Lack of Efficacy|1
5498286|NCT01677182|19010675|P2|Overall Study|Lack of Efficacy|0
5498287|NCT01677182|19010676|P1|Overall Study|Lack of Efficacy|3
5498288|NCT01677182|19010674|P3|Overall Study|Study termination|11
5498289|NCT01677182|19010675|P2|Overall Study|Study termination|9
5498290|NCT01677182|19010676|P1|Overall Study|Study termination|12
5498291|NCT01677182|19010674|P3|Overall Study|Withdrawal by Subject|10
5498292|NCT01677182|19010675|P2|Overall Study|Withdrawal by Subject|12
5498293|NCT01677182|19010676|P1|Overall Study|Withdrawal by Subject|7
5498294|NCT01677182|19010674|P3|Overall Study|Lost to Follow-up|3
5498295|NCT01677182|19010675|P2|Overall Study|Lost to Follow-up|0
5498296|NCT01677182|19010676|P1|Overall Study|Lost to Follow-up|4
5498297|NCT01677182|19010674|P3|Overall Study|Protocol Violation|4
5498298|NCT01677182|19010675|P2|Overall Study|Protocol Violation|1
5498299|NCT01677182|19010676|P1|Overall Study|Protocol Violation|5
5498300|NCT01677182|19010674|P3|Overall Study|Adverse Event|8
5498301|NCT01677182|19010675|P2|Overall Study|Adverse Event|1
5498302|NCT01677182|19010676|P1|Overall Study|Adverse Event|2
5498303|NCT01676961|19010708|P1|Overall Study|Withdrawal by Subject|1
5498304|NCT01676961|19010708|P1|Overall Study|Lost to Follow-up|1
5498305|NCT01676961|19010708|P1|Overall Study|Death|3
5498306|NCT01676909|19010715|P2|Overall Study|Lost to Follow-up|9
5498307|NCT01676909|19010716|P1|Overall Study|Lost to Follow-up|15
5498308|NCT01676909|19010715|P2|Overall Study|Withdrawal by Subject|5
5498309|NCT01676909|19010716|P1|Overall Study|Withdrawal by Subject|3
5498310|NCT01676896|19010781|P3|Overall Study|Withdrawal by Subject|19
5498311|NCT01676896|19010782|P2|Overall Study|Withdrawal by Subject|7
5498312|NCT01676896|19010783|P1|Overall Study|Withdrawal by Subject|12
5498313|NCT01676727|19010891|P1|Overall Study|Valve explanted|1
5498314|NCT01676727|19010891|P1|Overall Study|Not willing to attend 1-year visit|2
5498315|NCT01676727|19010891|P1|Overall Study|Screening failure|5
5498316|NCT01676727|19010891|P1|Overall Study|Withdrawal by Subject|6
5498317|NCT01676727|19010891|P1|Overall Study|Death|18
5498318|NCT01676701|19010905|P2|Overall Study|Sponsor Decision|4
5498319|NCT01676701|19010906|P1|Overall Study|Sponsor Decision|3
5498320|NCT01676701|19010905|P2|Overall Study|Protocol Violation|0
5498321|NCT01676701|19010906|P1|Overall Study|Protocol Violation|1
5498322|NCT01676220|19011008|P2|Overall Study|No More Need of Insulin|0
5498323|NCT01676220|19011009|P1|Overall Study|No More Need of Insulin|1
5498324|NCT01676220|19011008|P2|Overall Study|Non Serious Hypoglycemia|0
5498325|NCT01676220|19011009|P1|Overall Study|Non Serious Hypoglycemia|2
5498326|NCT01676220|19011008|P2|Overall Study|Perceived Lack of Efficacy|1
5498327|NCT01676220|19011009|P1|Overall Study|Perceived Lack of Efficacy|3
5498328|NCT01676220|19011008|P2|Overall Study|Site Closure/Site Withdrawal|4
5498329|NCT01676220|19011009|P1|Overall Study|Site Closure/Site Withdrawal|1
5498330|NCT01676220|19011008|P2|Overall Study|Selection Criterion/Protocol Violation|9
5498331|NCT01676220|19011009|P1|Overall Study|Selection Criterion/Protocol Violation|9
5498332|NCT01676220|19011008|P2|Overall Study|Lost to Follow-up|18
5498333|NCT01676220|19011009|P1|Overall Study|Lost to Follow-up|11
5498334|NCT01676220|19011008|P2|Overall Study|Personal Reason|45
5498335|NCT01676220|19011009|P1|Overall Study|Personal Reason|34
5498336|NCT01676220|19011008|P2|Overall Study|Received Rescue Therapy|22
5498337|NCT01676220|19011009|P1|Overall Study|Received Rescue Therapy|14
5498338|NCT01676220|19011008|P2|Overall Study|Protocol Violation|12
5498339|NCT01676220|19011009|P1|Overall Study|Protocol Violation|11
5498340|NCT01676220|19011008|P2|Overall Study|Lack of Efficacy|5
5498341|NCT01676220|19011009|P1|Overall Study|Lack of Efficacy|2
5498342|NCT01676220|19011008|P2|Overall Study|Adverse Event|8
5498343|NCT01676220|19011009|P1|Overall Study|Adverse Event|10
5498344|NCT01676220|19011008|P2|Overall Study|Randomized But Not Treated|1
5498345|NCT01676220|19011009|P1|Overall Study|Randomized But Not Treated|4
5498346|NCT01676116|19011041|P2|Overall Study|Protocol Violation|3
5498347|NCT01676116|19011042|P1|Overall Study|Protocol Violation|9
5498348|NCT01676116|19011041|P2|Overall Study|Unclassified|10
5498349|NCT01676116|19011042|P1|Overall Study|Unclassified|4
5498350|NCT01676116|19011041|P2|Overall Study|Adverse Event|2
5498351|NCT01676116|19011042|P1|Overall Study|Adverse Event|1
5498352|NCT01676116|19011041|P2|Overall Study|Withdrawal criteria|14
5498353|NCT01676116|19011042|P1|Overall Study|Withdrawal criteria|2
5498354|NCT01676012|19011064|P1|Overall Study|incomplete set of videos|1
5498355|NCT01676012|19011064|P1|Overall Study|Adverse Event|2
5498356|NCT01675765|19011108|P2|Overall Study|Clinical progression|2
5498357|NCT01675765|19011109|P1|Overall Study|Clinical progression|3
5498358|NCT01675765|19011108|P2|Overall Study|Death|0
5498359|NCT01675765|19011109|P1|Overall Study|Death|1
5498360|NCT01675765|19011108|P2|Overall Study|Withdrawal by Subject|0
5498361|NCT01675765|19011109|P1|Overall Study|Withdrawal by Subject|2
5498362|NCT01675765|19011108|P2|Overall Study|Adverse Event|2
5498363|NCT01675765|19011109|P1|Overall Study|Adverse Event|1
5498364|NCT01675765|19011108|P2|Overall Study|Progressive disease|4
5498365|NCT01675765|19011109|P1|Overall Study|Progressive disease|4
5498366|NCT01675661|19011125|P2|Overall Study|Other reason|2
5498367|NCT01675661|19011126|P1|Overall Study|Other reason|1
5498368|NCT01675661|19011125|P2|Overall Study|Death|1
5498369|NCT01675661|19011126|P1|Overall Study|Death|0
5498370|NCT01675661|19011125|P2|Overall Study|Physician Decision|2
5498371|NCT01675661|19011126|P1|Overall Study|Physician Decision|0
5498372|NCT01675661|19011125|P2|Overall Study|Withdrawal by Subject|7
5498373|NCT01675661|19011126|P1|Overall Study|Withdrawal by Subject|3
5498374|NCT01675661|19011125|P2|Overall Study|Moved away|6
5498375|NCT01675661|19011126|P1|Overall Study|Moved away|5
5498376|NCT01675661|19011125|P2|Overall Study|Practical problems|5
5498377|NCT01675661|19011126|P1|Overall Study|Practical problems|9
5498378|NCT01675661|19011125|P2|Overall Study|Lost to Follow-up|23
5498379|NCT01675661|19011126|P1|Overall Study|Lost to Follow-up|22
5498380|NCT01675622|19011155|P2|Overall Study|Other|4
5498381|NCT01675622|19011156|P1|Overall Study|Other|5
5498382|NCT01675622|19011155|P2|Overall Study|Lost to Follow-up|3
5498383|NCT01675622|19011156|P1|Overall Study|Lost to Follow-up|1
5498384|NCT01675622|19011155|P2|Overall Study|Lack of Efficacy|4
5498385|NCT01675622|19011156|P1|Overall Study|Lack of Efficacy|2
5498386|NCT01675622|19011155|P2|Overall Study|Protocol Violation|1
5498387|NCT01675622|19011156|P1|Overall Study|Protocol Violation|4
5498388|NCT01675622|19011155|P2|Overall Study|Adverse Event|10
5498389|NCT01675622|19011156|P1|Overall Study|Adverse Event|12
5498390|NCT01675622|19011155|P2|Overall Study|Withdrawal by Subject|2
5498391|NCT01675622|19011156|P1|Overall Study|Withdrawal by Subject|2
5498392|NCT01675596|19011180|P1|Overall Study|Missed Visit|1
5498393|NCT01675596|19011180|P1|Overall Study|Exit with other reason|1
5498394|NCT01675596|19011180|P1|Overall Study|Death|6
5498395|NCT01675544|19011186|P1|Overall Study|Withdrawal by Subject|2
5498396|NCT01675531|19011191|P1|Overall Study|Protocol Violation|8
5498397|NCT01675531|19011191|P1|Overall Study|Lack of Efficacy|1
5498398|NCT01675531|19011191|P1|Overall Study|Withdrawal by Subject|7
5498399|NCT01675531|19011191|P1|Overall Study|Adverse Event|9
5498400|NCT01675492|19011198|P1|Overall Study|study completed early - product approval|42
5498401|NCT01675479|19011203|P1|Overall Study|Lost to Follow-up|11
5498402|NCT01675427|19011217|P1|Overall Study|Other|2
5498403|NCT01675427|19011217|P1|Overall Study|Lost to Follow-up|5
5498404|NCT01675427|19011217|P1|Overall Study|Sample not Collected by Mistake|2
5498405|NCT01675427|19011217|P1|Overall Study|Participant Refused Sample Collection|18
5498406|NCT01675427|19011217|P1|Overall Study|Withdrawal by Subject|7
5498407|NCT01675167|19011517|P3|Double-blind Treatment Phase|Other|5
5498408|NCT01675167|19011518|P2|Double-blind Treatment Phase|Other|7
5498409|NCT01675167|19011519|P1|Double-blind Treatment Phase|Other|0
5498410|NCT01675167|19011517|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
5498411|NCT01675167|19011518|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
5498412|NCT01675167|19011519|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
5498413|NCT01675167|19011517|P3|Double-blind Treatment Phase|Lost to Follow-up|5
5498414|NCT01675167|19011518|P2|Double-blind Treatment Phase|Lost to Follow-up|1
5498415|NCT01675167|19011519|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5498416|NCT01675167|19011517|P3|Double-blind Treatment Phase|Protocol Violation|11
5498417|NCT01675167|19011518|P2|Double-blind Treatment Phase|Protocol Violation|4
5498418|NCT01675167|19011519|P1|Double-blind Treatment Phase|Protocol Violation|0
5498419|NCT01675167|19011517|P3|Double-blind Treatment Phase|Adverse Event|13
5498420|NCT01675167|19011518|P2|Double-blind Treatment Phase|Adverse Event|5
5498421|NCT01675167|19011519|P1|Double-blind Treatment Phase|Adverse Event|0
5498422|NCT01675167|19011517|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
5498423|NCT01675167|19011518|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
5498424|NCT01675167|19011519|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
5498425|NCT01675167|19011517|P3|Double-blind Treatment Phase|Lack of Efficacy|61
5498426|NCT01675167|19011518|P2|Double-blind Treatment Phase|Lack of Efficacy|19
5498427|NCT01675167|19011519|P1|Double-blind Treatment Phase|Lack of Efficacy|0
5498428|NCT01675167|19011517|P3|Open-label Titration Phase|Other|0
5498429|NCT01675167|19011518|P2|Open-label Titration Phase|Other|0
5498430|NCT01675167|19011519|P1|Open-label Titration Phase|Other|55
5498431|NCT01675167|19011517|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
5498432|NCT01675167|19011518|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
5498433|NCT01675167|19011519|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
5498434|NCT01675167|19011517|P3|Open-label Titration Phase|Lost to Follow-up|0
5498435|NCT01675167|19011518|P2|Open-label Titration Phase|Lost to Follow-up|0
5498436|NCT01675167|19011519|P1|Open-label Titration Phase|Lost to Follow-up|15
5498437|NCT01675167|19011517|P3|Open-label Titration Phase|Protocol Violation|0
5498438|NCT01675167|19011518|P2|Open-label Titration Phase|Protocol Violation|0
5498439|NCT01675167|19011519|P1|Open-label Titration Phase|Protocol Violation|43
5498440|NCT01675167|19011517|P3|Open-label Titration Phase|Withdrawal by Subject|0
5498441|NCT01675167|19011518|P2|Open-label Titration Phase|Withdrawal by Subject|0
5498442|NCT01675167|19011519|P1|Open-label Titration Phase|Withdrawal by Subject|46
5498443|NCT01675167|19011517|P3|Open-label Titration Phase|Lack of Efficacy|0
5498444|NCT01675167|19011518|P2|Open-label Titration Phase|Lack of Efficacy|0
5498445|NCT01675167|19011519|P1|Open-label Titration Phase|Lack of Efficacy|63
5498446|NCT01675167|19011517|P3|Open-label Titration Phase|Adverse Event|0
5498447|NCT01675167|19011518|P2|Open-label Titration Phase|Adverse Event|0
5498448|NCT01675167|19011519|P1|Open-label Titration Phase|Adverse Event|81
5498449|NCT01675141|19011541|P1|Overall Study|No treatment, per protocol|1
5498450|NCT01675141|19011541|P1|Overall Study|Physician Decision|4
5498451|NCT01675141|19011541|P1|Overall Study|Withdrawal by Subject|3
5498452|NCT01675141|19011541|P1|Overall Study|Lenalidomide outside NIH|3
5498453|NCT01675128|19011554|P3|Overall Study|Pulmonary complication; off study|0
5498454|NCT01675128|19011555|P2|Overall Study|Pulmonary complication; off study|1
5498455|NCT01675128|19011556|P1|Overall Study|Pulmonary complication; off study|0
5498456|NCT01675128|19011554|P3|Overall Study|Refused further treatment|0
5498457|NCT01675128|19011555|P2|Overall Study|Refused further treatment|0
5498458|NCT01675128|19011556|P1|Overall Study|Refused further treatment|1
5498459|NCT01675128|19011554|P3|Overall Study|Disease progression on study|1
5498460|NCT01675128|19011555|P2|Overall Study|Disease progression on study|1
5498461|NCT01675128|19011556|P1|Overall Study|Disease progression on study|1
5498462|NCT01675050|19011584|P2|Period One Treatment|Withdrawal by Subject|0
5498463|NCT01675050|19011585|P1|Period One Treatment|Withdrawal by Subject|1
5498464|NCT01675011|19011595|P2|Overall Study|Trial terminated by Sponsor|1
5498465|NCT01675011|19011596|P1|Overall Study|Trial terminated by Sponsor|3
5498466|NCT01674725|19011604|P2|Overall Study|Lost to Follow-up|1
5498467|NCT01674725|19011605|P1|Overall Study|Lost to Follow-up|0
5498468|NCT01674725|19011604|P2|Overall Study|Withdrawal by Subject|0
5498469|NCT01674725|19011605|P1|Overall Study|Withdrawal by Subject|1
5498470|NCT01674725|19011604|P2|Overall Study|Did not receive study drug|0
5498471|NCT01674725|19011605|P1|Overall Study|Did not receive study drug|1
5498472|NCT01674725|19011604|P2|Overall Study|Adverse Event|0
5498473|NCT01674725|19011605|P1|Overall Study|Adverse Event|1
5498474|NCT01674712|19011624|P5|Overall Study|Lack of Efficacy|1
5498475|NCT01674712|19011625|P4|Overall Study|Lack of Efficacy|0
5498476|NCT01674712|19011626|P3|Overall Study|Lack of Efficacy|1
5498477|NCT01674712|19011627|P2|Overall Study|Lack of Efficacy|0
5498478|NCT01674712|19011628|P1|Overall Study|Lack of Efficacy|0
5498479|NCT01674712|19011624|P5|Overall Study|Administrative|1
5498480|NCT01674712|19011625|P4|Overall Study|Administrative|0
5498481|NCT01674712|19011626|P3|Overall Study|Administrative|0
5498482|NCT01674712|19011627|P2|Overall Study|Administrative|1
5498483|NCT01674712|19011628|P1|Overall Study|Administrative|0
5498484|NCT01674712|19011624|P5|Overall Study|Withdrawal by Subject|3
5498485|NCT01674712|19011625|P4|Overall Study|Withdrawal by Subject|4
5498486|NCT01674712|19011626|P3|Overall Study|Withdrawal by Subject|5
5498487|NCT01674712|19011627|P2|Overall Study|Withdrawal by Subject|2
5498488|NCT01674712|19011628|P1|Overall Study|Withdrawal by Subject|2
5498489|NCT01674712|19011624|P5|Overall Study|Protocol Violation|0
5498490|NCT01674712|19011625|P4|Overall Study|Protocol Violation|0
5498491|NCT01674712|19011626|P3|Overall Study|Protocol Violation|0
5498492|NCT01674712|19011627|P2|Overall Study|Protocol Violation|0
5498493|NCT01674712|19011628|P1|Overall Study|Protocol Violation|2
5498494|NCT01674712|19011624|P5|Overall Study|Lost to Follow-up|0
5498495|NCT01674712|19011625|P4|Overall Study|Lost to Follow-up|0
5498496|NCT01674712|19011626|P3|Overall Study|Lost to Follow-up|0
5498497|NCT01674712|19011627|P2|Overall Study|Lost to Follow-up|0
5498498|NCT01674712|19011628|P1|Overall Study|Lost to Follow-up|1
5498499|NCT01674712|19011624|P5|Overall Study|Adverse Event|6
5498500|NCT01674712|19011625|P4|Overall Study|Adverse Event|4
5498501|NCT01674712|19011626|P3|Overall Study|Adverse Event|3
5498502|NCT01674712|19011627|P2|Overall Study|Adverse Event|6
5498503|NCT01674712|19011628|P1|Overall Study|Adverse Event|5
5498504|NCT01674647|19011652|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
5498505|NCT01674647|19011653|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
5498506|NCT01674647|19011652|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
5498507|NCT01674647|19011653|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
5498508|NCT01674647|19011652|P2|30-day Safety Follow-up Period|Logistical difficulties|3
5498509|NCT01674647|19011653|P1|30-day Safety Follow-up Period|Logistical difficulties|1
5498510|NCT01674647|19011652|P2|30-day Safety Follow-up Period|Protocol Violation|22
5498511|NCT01674647|19011653|P1|30-day Safety Follow-up Period|Protocol Violation|39
5498512|NCT01674647|19011652|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
5498513|NCT01674647|19011653|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
5498514|NCT01674647|19011652|P2|30-day Safety Follow-up Period|Death|2
5498515|NCT01674647|19011653|P1|30-day Safety Follow-up Period|Death|3
5498516|NCT01674647|19011652|P2|Treatment Period|Protocol Violation|36
5498517|NCT01674647|19011653|P1|Treatment Period|Protocol Violation|56
5498518|NCT01674647|19011652|P2|Treatment Period|Treatment failure|14
5498519|NCT01674647|19011653|P1|Treatment Period|Treatment failure|0
5498520|NCT01674647|19011652|P2|Treatment Period|Logistical difficulties|8
5498521|NCT01674647|19011653|P1|Treatment Period|Logistical difficulties|5
5498522|NCT01674647|19011652|P2|Treatment Period|Switching to other therapy|2
5498523|NCT01674647|19011653|P1|Treatment Period|Switching to other therapy|5
5498524|NCT01674647|19011652|P2|Treatment Period|Withdrawal by Subject|16
5498525|NCT01674647|19011653|P1|Treatment Period|Withdrawal by Subject|19
5498526|NCT01674647|19011652|P2|Treatment Period|Lost to Follow-up|1
5498527|NCT01674647|19011653|P1|Treatment Period|Lost to Follow-up|1
5498528|NCT01674647|19011652|P2|Treatment Period|Non-compliance with study drug|0
5498529|NCT01674647|19011653|P1|Treatment Period|Non-compliance with study drug|3
5498530|NCT01674647|19011652|P2|Treatment Period|Adverse Event|22
5498531|NCT01674647|19011653|P1|Treatment Period|Adverse Event|60
5498532|NCT01674647|19011652|P2|Treatment Period|Physician Decision|1
5498533|NCT01674647|19011653|P1|Treatment Period|Physician Decision|3
5498534|NCT01674647|19011652|P2|Treatment Period|Efficacy outcome reached|1
5498535|NCT01674647|19011653|P1|Treatment Period|Efficacy outcome reached|0
5498536|NCT01674647|19011652|P2|Treatment Period|Death|1
5498537|NCT01674647|19011653|P1|Treatment Period|Death|4
5498538|NCT01674634|19011679|P1|Overall Study|Lost to Follow-up|3
5498539|NCT01674634|19011679|P1|Overall Study|Withdrawal by Subject|3
5498540|NCT01674621|19011699|P5|Overall Study|Other than specified|2
5498541|NCT01674621|19011700|P4|Overall Study|Other than specified|0
5498542|NCT01674621|19011701|P3|Overall Study|Other than specified|0
5498543|NCT01674621|19011702|P2|Overall Study|Other than specified|1
5498544|NCT01674621|19011703|P1|Overall Study|Other than specified|0
5498545|NCT01674621|19011699|P5|Overall Study|Withdrawal by Subject|1
5498546|NCT01674621|19011700|P4|Overall Study|Withdrawal by Subject|0
5498547|NCT01674621|19011701|P3|Overall Study|Withdrawal by Subject|2
5498548|NCT01674621|19011702|P2|Overall Study|Withdrawal by Subject|5
5498549|NCT01674621|19011703|P1|Overall Study|Withdrawal by Subject|2
5498550|NCT01674621|19011699|P5|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5498551|NCT01674621|19011700|P4|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
5498552|NCT01674621|19011701|P3|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5498553|NCT01674621|19011702|P2|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5498554|NCT01674621|19011703|P1|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
5498555|NCT01674621|19011699|P5|Overall Study|Inability to Complete Study Procedures|2
5498556|NCT01674621|19011700|P4|Overall Study|Inability to Complete Study Procedures|0
5498557|NCT01674621|19011701|P3|Overall Study|Inability to Complete Study Procedures|0
5498558|NCT01674621|19011702|P2|Overall Study|Inability to Complete Study Procedures|0
5498559|NCT01674621|19011703|P1|Overall Study|Inability to Complete Study Procedures|0
5498560|NCT01674621|19011699|P5|Overall Study|Adverse Event|1
5498561|NCT01674621|19011700|P4|Overall Study|Adverse Event|5
5498562|NCT01674621|19011701|P3|Overall Study|Adverse Event|5
5498563|NCT01674621|19011702|P2|Overall Study|Adverse Event|2
5498564|NCT01674621|19011703|P1|Overall Study|Adverse Event|3
5498565|NCT01674569|19011780|P6|Overall Study|Withdrawal by Subject|0
5498566|NCT01674569|19011781|P5|Overall Study|Withdrawal by Subject|0
5498567|NCT01674569|19011782|P4|Overall Study|Withdrawal by Subject|0
5498568|NCT01674569|19011783|P3|Overall Study|Withdrawal by Subject|1
5498569|NCT01674569|19011784|P2|Overall Study|Withdrawal by Subject|0
5498570|NCT01674569|19011785|P1|Overall Study|Withdrawal by Subject|0
5498571|NCT01674569|19011780|P6|Overall Study|Protocol Violation|0
5498572|NCT01674569|19011781|P5|Overall Study|Protocol Violation|0
5498573|NCT01674569|19011782|P4|Overall Study|Protocol Violation|0
5498574|NCT01674569|19011783|P3|Overall Study|Protocol Violation|1
5498575|NCT01674569|19011784|P2|Overall Study|Protocol Violation|1
5498576|NCT01674569|19011785|P1|Overall Study|Protocol Violation|0
5498577|NCT01674569|19011780|P6|Overall Study|Adverse Event|2
5498578|NCT01674569|19011781|P5|Overall Study|Adverse Event|2
5498579|NCT01674569|19011782|P4|Overall Study|Adverse Event|1
5498580|NCT01674569|19011783|P3|Overall Study|Adverse Event|0
5498581|NCT01674569|19011784|P2|Overall Study|Adverse Event|2
5498582|NCT01674569|19011785|P1|Overall Study|Adverse Event|0
5498583|NCT01674062|19011806|P2|Overall Study|Programming Error|0
5498584|NCT01674062|19011807|P1|Overall Study|Programming Error|1
5498585|NCT01674062|19011806|P2|Overall Study|Death|1
5498586|NCT01674062|19011807|P1|Overall Study|Death|0
5498587|NCT01674062|19011806|P2|Overall Study|Adverse Event|1
5498588|NCT01674062|19011807|P1|Overall Study|Adverse Event|1
5498589|NCT01674062|19011806|P2|Overall Study|Other|1
5498590|NCT01674062|19011807|P1|Overall Study|Other|8
5498591|NCT01674062|19011806|P2|Overall Study|Insufficient Therapeutic Response|26
5498592|NCT01674062|19011807|P1|Overall Study|Insufficient Therapeutic Response|56
5498593|NCT01674010|19011822|P3|Randomization Phase 2|Withdrawal by Subject|7
5498594|NCT01674010|19011823|P2|Randomization Phase 2|Withdrawal by Subject|8
5498595|NCT01674010|19011824|P1|Randomization Phase 2|Withdrawal by Subject|0
5498596|NCT01674010|19011822|P3|Randomization Phase 2|Sponsor Decision|45
5498597|NCT01674010|19011823|P2|Randomization Phase 2|Sponsor Decision|42
5498598|NCT01674010|19011824|P1|Randomization Phase 2|Sponsor Decision|0
5498599|NCT01674010|19011822|P3|Randomization Phase 2|Protocol Violation|1
5498600|NCT01674010|19011823|P2|Randomization Phase 2|Protocol Violation|1
5498601|NCT01674010|19011824|P1|Randomization Phase 2|Protocol Violation|0
5498602|NCT01674010|19011822|P3|Randomization Phase 2|Pregnancy|1
5498603|NCT01674010|19011823|P2|Randomization Phase 2|Pregnancy|1
5498604|NCT01674010|19011824|P1|Randomization Phase 2|Pregnancy|0
5498605|NCT01674010|19011822|P3|Randomization Phase 2|Physician Decision|2
5498606|NCT01674010|19011823|P2|Randomization Phase 2|Physician Decision|0
5498607|NCT01674010|19011824|P1|Randomization Phase 2|Physician Decision|0
5498608|NCT01674010|19011822|P3|Randomization Phase 2|Mood episode recurrence|2
5498609|NCT01674010|19011823|P2|Randomization Phase 2|Mood episode recurrence|8
5498610|NCT01674010|19011824|P1|Randomization Phase 2|Mood episode recurrence|0
5498611|NCT01674010|19011822|P3|Randomization Phase 2|Lost to Follow-up|2
5498612|NCT01674010|19011823|P2|Randomization Phase 2|Lost to Follow-up|1
5498613|NCT01674010|19011824|P1|Randomization Phase 2|Lost to Follow-up|0
5498614|NCT01674010|19011822|P3|Randomization Phase 2|Adverse Event|1
5498615|NCT01674010|19011823|P2|Randomization Phase 2|Adverse Event|1
5498616|NCT01674010|19011824|P1|Randomization Phase 2|Adverse Event|0
5498617|NCT01674010|19011822|P3|Open Treatment Phase 1|Withdrawal by Subject|0
5498618|NCT01674010|19011823|P2|Open Treatment Phase 1|Withdrawal by Subject|0
5498619|NCT01674010|19011824|P1|Open Treatment Phase 1|Withdrawal by Subject|25
5498620|NCT01674010|19011822|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
5498621|NCT01674010|19011823|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
5498622|NCT01674010|19011824|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
5498623|NCT01674010|19011822|P3|Open Treatment Phase 1|Sponsor Decision|0
5498624|NCT01674010|19011823|P2|Open Treatment Phase 1|Sponsor Decision|0
5498625|NCT01674010|19011824|P1|Open Treatment Phase 1|Sponsor Decision|79
5498626|NCT01674010|19011822|P3|Open Treatment Phase 1|Protocol Violation|0
5498627|NCT01674010|19011823|P2|Open Treatment Phase 1|Protocol Violation|0
5498628|NCT01674010|19011824|P1|Open Treatment Phase 1|Protocol Violation|7
5498629|NCT01674010|19011822|P3|Open Treatment Phase 1|Physician Decision|0
5498630|NCT01674010|19011823|P2|Open Treatment Phase 1|Physician Decision|0
5498631|NCT01674010|19011824|P1|Open Treatment Phase 1|Physician Decision|9
5498632|NCT01674010|19011822|P3|Open Treatment Phase 1|Lost to Follow-up|0
5498633|NCT01674010|19011823|P2|Open Treatment Phase 1|Lost to Follow-up|0
5498634|NCT01674010|19011824|P1|Open Treatment Phase 1|Lost to Follow-up|19
5498635|NCT01674010|19011822|P3|Open Treatment Phase 1|Death|0
5498636|NCT01674010|19011823|P2|Open Treatment Phase 1|Death|0
5498637|NCT01674010|19011824|P1|Open Treatment Phase 1|Death|1
5498638|NCT01674010|19011822|P3|Open Treatment Phase 1|Adverse Event|0
5498639|NCT01674010|19011823|P2|Open Treatment Phase 1|Adverse Event|0
5498640|NCT01674010|19011824|P1|Open Treatment Phase 1|Adverse Event|10
5498641|NCT01673984|19011843|P2|Overall Study|Study termination|6
5498642|NCT01673984|19011844|P1|Overall Study|Study termination|9
5498643|NCT01673984|19011843|P2|Overall Study|Adverse Event|0
5498644|NCT01673984|19011844|P1|Overall Study|Adverse Event|1
5498645|NCT01673867|19011894|P2|Treatment|Physician Decision|1
5498646|NCT01673867|19011895|P1|Treatment|Physician Decision|0
5498647|NCT01673867|19011894|P2|Treatment|Symptomatic deterioration|1
5498648|NCT01673867|19011895|P1|Treatment|Symptomatic deterioration|0
5498649|NCT01673867|19011894|P2|Treatment|Required prolonged hospitalization|1
5498650|NCT01673867|19011895|P1|Treatment|Required prolonged hospitalization|0
5498651|NCT01673867|19011894|P2|Treatment|Health status not improved|0
5498652|NCT01673867|19011895|P1|Treatment|Health status not improved|1
5498653|NCT01673867|19011894|P2|Treatment|Required steroid therapy|0
5498654|NCT01673867|19011895|P1|Treatment|Required steroid therapy|1
5498655|NCT01673867|19011894|P2|Treatment|No longer meets criteria|0
5498656|NCT01673867|19011895|P1|Treatment|No longer meets criteria|2
5498657|NCT01673867|19011894|P2|Treatment|Maximum clinical benefit|10
5498658|NCT01673867|19011895|P1|Treatment|Maximum clinical benefit|0
5498659|NCT01673867|19011894|P2|Treatment|Withdrawal by Subject|6
5498660|NCT01673867|19011895|P1|Treatment|Withdrawal by Subject|4
5498661|NCT01673867|19011894|P2|Treatment|Requested treatment discontinuation|16
5498662|NCT01673867|19011895|P1|Treatment|Requested treatment discontinuation|5
5498663|NCT01673867|19011894|P2|Treatment|AE unrelated to study drug|11
5498664|NCT01673867|19011895|P1|Treatment|AE unrelated to study drug|19
5498665|NCT01673867|19011894|P2|Treatment|Death|1
5498666|NCT01673867|19011895|P1|Treatment|Death|1
5498667|NCT01673867|19011894|P2|Treatment|Study Drug Toxicity|42
5498668|NCT01673867|19011895|P1|Treatment|Study Drug Toxicity|17
5498669|NCT01673867|19011894|P2|Treatment|Disease Progression|179
5498670|NCT01673867|19011895|P1|Treatment|Disease Progression|194
5498671|NCT01673867|19011894|P2|Randomization|No longer meets criteria|5
5498672|NCT01673867|19011895|P1|Randomization|No longer meets criteria|4
5498673|NCT01673867|19011894|P2|Randomization|Lost to Follow-up|1
5498674|NCT01673867|19011895|P1|Randomization|Lost to Follow-up|0
5498675|NCT01673867|19011894|P2|Randomization|Withdrawal by Subject|12
5498676|NCT01673867|19011895|P1|Randomization|Withdrawal by Subject|0
5498677|NCT01673867|19011894|P2|Randomization|Requested treatment discontinuation|4
5498678|NCT01673867|19011895|P1|Randomization|Requested treatment discontinuation|0
5498679|NCT01673867|19011894|P2|Randomization|AE unrelated to study drug|0
5498680|NCT01673867|19011895|P1|Randomization|AE unrelated to study drug|1
5498681|NCT01673854|19011921|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
5498682|NCT01673854|19011921|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
5498683|NCT01673854|19011921|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
5498684|NCT01673854|19011921|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
5498685|NCT01673854|19011921|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
5498686|NCT01673854|19011921|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
5498687|NCT01673854|19011921|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
5498688|NCT01673854|19011921|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
5498689|NCT01673854|19011921|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
5498690|NCT01673854|19011921|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
5498691|NCT01673854|19011921|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
5498692|NCT01673854|19011921|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
5498693|NCT01673698|19011944|P2|Overall Study|Lost to Follow-up|13
5498694|NCT01673698|19011945|P1|Overall Study|Lost to Follow-up|51
5498695|NCT01673646|19011956|P3|Overall Study|Completed Core/did not enter Ext.|1
5498696|NCT01673646|19011957|P2|Overall Study|Completed Core/did not enter Ext.|1
5498697|NCT01673646|19011958|P1|Overall Study|Completed Core/did not enter Ext.|2
5498698|NCT01673646|19011956|P3|Overall Study|Withdrawal by Subject|2
5498699|NCT01673646|19011957|P2|Overall Study|Withdrawal by Subject|2
5498700|NCT01673646|19011958|P1|Overall Study|Withdrawal by Subject|0
5498701|NCT01673646|19011956|P3|Overall Study|Condition no longer requires study drug|0
5498702|NCT01673646|19011957|P2|Overall Study|Condition no longer requires study drug|1
5498703|NCT01673646|19011958|P1|Overall Study|Condition no longer requires study drug|0
5498704|NCT01673646|19011956|P3|Overall Study|Unsatisfactory therapeutic effect|0
5498705|NCT01673646|19011957|P2|Overall Study|Unsatisfactory therapeutic effect|2
5498706|NCT01673646|19011958|P1|Overall Study|Unsatisfactory therapeutic effect|0
5498707|NCT01673646|19011956|P3|Overall Study|Adverse Event|1
5498708|NCT01673646|19011957|P2|Overall Study|Adverse Event|1
5498709|NCT01673646|19011958|P1|Overall Study|Adverse Event|2
5498710|NCT01673620|19011997|P2|Overall Study|Adverse Event|0
5498711|NCT01673620|19011998|P1|Overall Study|Adverse Event|1
5498712|NCT01673594|19012008|P2|Overall Study|Withdrawal by Subject|1
5498713|NCT01673594|19012009|P1|Overall Study|Withdrawal by Subject|0
5498714|NCT01673594|19012008|P2|Overall Study|Physician Decision|4
5498715|NCT01673594|19012009|P1|Overall Study|Physician Decision|2
5498716|NCT01673594|19012008|P2|Overall Study|Lost to Follow-up|0
5498717|NCT01673594|19012009|P1|Overall Study|Lost to Follow-up|1
5498718|NCT01673594|19012008|P2|Overall Study|Adverse Event|1
5498719|NCT01673594|19012009|P1|Overall Study|Adverse Event|3
5498720|NCT01673490|19012028|P1|Overall Study|Withdrawal by Subject|3
5498721|NCT01673490|19012028|P1|Overall Study|Adverse Event|3
5498722|NCT01673490|19012028|P1|Overall Study|Lost to Follow-up|1
5498723|NCT01673386|19012045|P2|Overall Study|Withdrawal by Subject|2
5498724|NCT01673386|19012046|P1|Overall Study|Withdrawal by Subject|0
5498725|NCT01673386|19012045|P2|Overall Study|Progressive disease|1
5498726|NCT01673386|19012046|P1|Overall Study|Progressive disease|4
5498727|NCT01673386|19012045|P2|Overall Study|Adverse Event|2
5498728|NCT01673386|19012046|P1|Overall Study|Adverse Event|5
5498729|NCT01673386|19012045|P2|Overall Study|Study terminated by sponsor|22
5498730|NCT01673386|19012046|P1|Overall Study|Study terminated by sponsor|16
5498731|NCT01673373|19012076|P1|Overall Study|Death|2
5498732|NCT01673347|19012092|P1|Overall Study|failure of allograft|7
5498733|NCT01673282|19012101|P2|Overall Study|Other|6
5498734|NCT01673282|19012102|P1|Overall Study|Other|1
5498735|NCT01673282|19012101|P2|Overall Study|Withdrawal by Subject|3
5498736|NCT01673282|19012102|P1|Overall Study|Withdrawal by Subject|3
5498737|NCT01673282|19012101|P2|Overall Study|Lost to Follow-up|10
5498738|NCT01673282|19012102|P1|Overall Study|Lost to Follow-up|11
5498739|NCT01673282|19012101|P2|Overall Study|Lack of Efficacy|2
5498740|NCT01673282|19012102|P1|Overall Study|Lack of Efficacy|9
5498741|NCT01673282|19012101|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
5498742|NCT01673282|19012102|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
5498743|NCT01673178|19012138|P5|Overall Study|Other|0
5498744|NCT01673178|19012139|P4|Overall Study|Other|1
5498745|NCT01673178|19012140|P3|Overall Study|Other|2
5498746|NCT01673178|19012141|P2|Overall Study|Other|0
5498747|NCT01673178|19012142|P1|Overall Study|Other|1
5498748|NCT01673178|19012138|P5|Overall Study|Adverse Event|0
5498749|NCT01673178|19012139|P4|Overall Study|Adverse Event|2
5498750|NCT01673178|19012140|P3|Overall Study|Adverse Event|0
5498751|NCT01673178|19012141|P2|Overall Study|Adverse Event|0
5498752|NCT01673178|19012142|P1|Overall Study|Adverse Event|1
5498753|NCT01673178|19012138|P5|Overall Study|Protocol Violation|0
5498754|NCT01673178|19012139|P4|Overall Study|Protocol Violation|1
5498755|NCT01673178|19012140|P3|Overall Study|Protocol Violation|0
5498756|NCT01673178|19012141|P2|Overall Study|Protocol Violation|1
5498757|NCT01673178|19012142|P1|Overall Study|Protocol Violation|1
5498758|NCT01673178|19012138|P5|Overall Study|Withdrawal by Subject|2
5498759|NCT01673178|19012139|P4|Overall Study|Withdrawal by Subject|4
5498760|NCT01673178|19012140|P3|Overall Study|Withdrawal by Subject|1
5498761|NCT01673178|19012141|P2|Overall Study|Withdrawal by Subject|0
5498762|NCT01673178|19012142|P1|Overall Study|Withdrawal by Subject|0
5498763|NCT01673178|19012138|P5|Overall Study|Lost to Follow-up|0
5498764|NCT01673178|19012139|P4|Overall Study|Lost to Follow-up|0
5498765|NCT01673178|19012140|P3|Overall Study|Lost to Follow-up|0
5498766|NCT01673178|19012141|P2|Overall Study|Lost to Follow-up|1
5498767|NCT01673178|19012142|P1|Overall Study|Lost to Follow-up|0
5498768|NCT01673126|19012381|P2|Overall Study|change of diagnosis|3
5498769|NCT01673126|19012382|P1|Overall Study|change of diagnosis|4
5498770|NCT01673009|19012421|P1|Overall Study|Withdrawal by Subject|8
5498771|NCT01673009|19012421|P1|Overall Study|Physician Decision|5
5498772|NCT01672970|19012506|P1|Overall Study|Enrolled but not treated|1
5498773|NCT01672970|19012506|P1|Overall Study|Other|9
5498774|NCT01672970|19012506|P1|Overall Study|Lost to Follow-up|5
5498775|NCT01672970|19012506|P1|Overall Study|Withdrawal by Subject|2
5498776|NCT01672970|19012506|P1|Overall Study|Adverse Event|18
5498777|NCT01672970|19012506|P1|Overall Study|Lack of Efficacy|12
5498778|NCT01672957|19012542|P1|Overall Study|ICF Signed After Transplantation|5
5498779|NCT01672957|19012542|P1|Overall Study|Death|2
5498780|NCT01672957|19012542|P1|Overall Study|Protocol Violation|48
5498781|NCT01672892|19012557|P2|Overall Study|Protocol Violation|3
5498782|NCT01672892|19012558|P1|Overall Study|Protocol Violation|7
5498783|NCT01672879|19012587|P3|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
5498784|NCT01672879|19012588|P2|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
5498785|NCT01672879|19012589|P1|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
5498786|NCT01672879|19012587|P3|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
5498787|NCT01672879|19012588|P2|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
5498788|NCT01672879|19012589|P1|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
5498789|NCT01672879|19012587|P3|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
5498790|NCT01672879|19012588|P2|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
5498791|NCT01672879|19012589|P1|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
5498792|NCT01672879|19012587|P3|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
5498793|NCT01672879|19012588|P2|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
5498794|NCT01672879|19012589|P1|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
5498795|NCT01672879|19012587|P3|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
5498796|NCT01672879|19012588|P2|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
5498797|NCT01672879|19012589|P1|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
5498798|NCT01672879|19012587|P3|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
5498799|NCT01672879|19012588|P2|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
5498800|NCT01672879|19012589|P1|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
5498801|NCT01672879|19012587|P3|Blinded Phase (Up to 240 Weeks)|Missing|0
5498802|NCT01672879|19012588|P2|Blinded Phase (Up to 240 Weeks)|Missing|0
5498803|NCT01672879|19012589|P1|Blinded Phase (Up to 240 Weeks)|Missing|1
5498804|NCT01672879|19012587|P3|Blinded Phase (Up to 240 Weeks)|Death|0
5498805|NCT01672879|19012588|P2|Blinded Phase (Up to 240 Weeks)|Death|2
5498806|NCT01672879|19012589|P1|Blinded Phase (Up to 240 Weeks)|Death|0
5498807|NCT01672879|19012587|P3|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
5498808|NCT01672879|19012588|P2|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
5498809|NCT01672879|19012589|P1|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
5498810|NCT01672879|19012587|P3|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
5498811|NCT01672879|19012588|P2|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
5498812|NCT01672879|19012589|P1|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
5498813|NCT01672879|19012587|P3|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
5498814|NCT01672879|19012588|P2|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
5498815|NCT01672879|19012589|P1|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
5498816|NCT01672879|19012587|P3|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
5498817|NCT01672879|19012588|P2|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
5498818|NCT01672879|19012589|P1|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
5498819|NCT01672879|19012587|P3|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
5498820|NCT01672879|19012588|P2|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
5498821|NCT01672879|19012589|P1|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
5498822|NCT01672866|19012604|P3|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
5498823|NCT01672866|19012605|P2|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
5498824|NCT01672866|19012606|P1|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
5498825|NCT01672866|19012604|P3|Open-Label Phase (up to 240 Weeks)|Death|0
5498826|NCT01672866|19012605|P2|Open-Label Phase (up to 240 Weeks)|Death|0
5498827|NCT01672866|19012606|P1|Open-Label Phase (up to 240 Weeks)|Death|1
5498828|NCT01672866|19012604|P3|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
5498829|NCT01672866|19012605|P2|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
5498830|NCT01672866|19012606|P1|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
5498831|NCT01672866|19012604|P3|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
5498832|NCT01672866|19012605|P2|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
5498833|NCT01672866|19012606|P1|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
5498834|NCT01672866|19012604|P3|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
5498835|NCT01672866|19012605|P2|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
5498836|NCT01672866|19012606|P1|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
5498837|NCT01672866|19012604|P3|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
5498838|NCT01672866|19012605|P2|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
5498839|NCT01672866|19012606|P1|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
5498840|NCT01672866|19012604|P3|Blinded Phase (up to 240 Weeks)|Death|1
5498841|NCT01672866|19012605|P2|Blinded Phase (up to 240 Weeks)|Death|0
5498842|NCT01672866|19012606|P1|Blinded Phase (up to 240 Weeks)|Death|0
5498843|NCT01672866|19012604|P3|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
5498844|NCT01672866|19012605|P2|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
5498845|NCT01672866|19012606|P1|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
5498846|NCT01672866|19012604|P3|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
5498847|NCT01672866|19012605|P2|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
5498848|NCT01672866|19012606|P1|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
5498849|NCT01672866|19012604|P3|Blinded Phase (up to 240 Weeks)|Adverse Event|3
5498850|NCT01672866|19012605|P2|Blinded Phase (up to 240 Weeks)|Adverse Event|3
5498851|NCT01672866|19012606|P1|Blinded Phase (up to 240 Weeks)|Adverse Event|3
5498852|NCT01672866|19012604|P3|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
5498853|NCT01672866|19012605|P2|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
5498854|NCT01672866|19012606|P1|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
5498855|NCT01672866|19012604|P3|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
5498856|NCT01672866|19012605|P2|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
5498857|NCT01672866|19012606|P1|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
5498858|NCT01672866|19012604|P3|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
5498859|NCT01672866|19012605|P2|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
5498860|NCT01672866|19012606|P1|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
5498861|NCT01672853|19012621|P3|Overall Study|Randomized but Never Treated|1
5498862|NCT01672853|19012622|P2|Overall Study|Randomized but Never Treated|0
5498863|NCT01672853|19012623|P1|Overall Study|Randomized but Never Treated|0
5498864|NCT01672853|19012621|P3|Overall Study|Lost to Follow-up|0
5498865|NCT01672853|19012622|P2|Overall Study|Lost to Follow-up|1
5498866|NCT01672853|19012623|P1|Overall Study|Lost to Follow-up|0
5498867|NCT01672853|19012621|P3|Overall Study|Adverse Event|8
5498868|NCT01672853|19012622|P2|Overall Study|Adverse Event|6
5498869|NCT01672853|19012623|P1|Overall Study|Adverse Event|4
5498870|NCT01672853|19012621|P3|Overall Study|Withdrew Consent|5
5498871|NCT01672853|19012622|P2|Overall Study|Withdrew Consent|5
5498872|NCT01672853|19012623|P1|Overall Study|Withdrew Consent|5
5498873|NCT01672853|19012621|P3|Overall Study|Investigator's Discretion|0
5498874|NCT01672853|19012622|P2|Overall Study|Investigator's Discretion|0
5498875|NCT01672853|19012623|P1|Overall Study|Investigator's Discretion|1
5498876|NCT01672853|19012621|P3|Overall Study|Pregnancy|0
5498877|NCT01672853|19012622|P2|Overall Study|Pregnancy|1
5498878|NCT01672853|19012623|P1|Overall Study|Pregnancy|0
5498879|NCT01672853|19012621|P3|Overall Study|Protocol Specified Criteria for Withdraw|0
5498880|NCT01672853|19012622|P2|Overall Study|Protocol Specified Criteria for Withdraw|4
5498881|NCT01672853|19012623|P1|Overall Study|Protocol Specified Criteria for Withdraw|0
5498882|NCT01672801|19012648|P2|Overall Study|Screen Failure|1
5498883|NCT01672801|19012649|P1|Overall Study|Screen Failure|0
5498884|NCT01672788|19012657|P4|Washout Period 2 (7 Days)|Adverse Event|1
5498885|NCT01672788|19012658|P3|Washout Period 2 (7 Days)|Adverse Event|0
5498886|NCT01672788|19012659|P2|Washout Period 2 (7 Days)|Adverse Event|0
5498887|NCT01672788|19012660|P1|Washout Period 2 (7 Days)|Adverse Event|0
5498888|NCT01672736|19012690|P1|Overall Study|Available drug expired on 31 May 16|3
5498889|NCT01672723|19012694|P2|First Intervention|Adverse Event|0
5498890|NCT01672723|19012695|P1|First Intervention|Adverse Event|3
5498891|NCT01672710|19012707|P2|3 Month Follow up|follow up due after termination date|1
5498892|NCT01672710|19012708|P1|3 Month Follow up|follow up due after termination date|4
5498893|NCT01672710|19012707|P2|3 Month Follow up|Lost to Follow-up|3
5498894|NCT01672710|19012708|P1|3 Month Follow up|Lost to Follow-up|2
5498895|NCT01672710|19012707|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
5498896|NCT01672710|19012708|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
5498897|NCT01672294|19012743|P4|Overall Study|Lost to Follow-up|9
5498898|NCT01672294|19012744|P3|Overall Study|Lost to Follow-up|7
5498899|NCT01672294|19012745|P2|Overall Study|Lost to Follow-up|16
5498900|NCT01672294|19012746|P1|Overall Study|Lost to Follow-up|1
5498901|NCT01672294|19012743|P4|Overall Study|Excluded by study|0
5498902|NCT01672294|19012744|P3|Overall Study|Excluded by study|0
5498903|NCT01672294|19012745|P2|Overall Study|Excluded by study|1
5498904|NCT01672294|19012746|P1|Overall Study|Excluded by study|1
5498905|NCT01672294|19012743|P4|Overall Study|Withdrawal by Subject|4
5498906|NCT01672294|19012744|P3|Overall Study|Withdrawal by Subject|4
5498907|NCT01672294|19012745|P2|Overall Study|Withdrawal by Subject|4
5498908|NCT01672294|19012746|P1|Overall Study|Withdrawal by Subject|4
5498909|NCT01671748|19012791|P2|4 Week run-in Phase|Not eligible|0
5498910|NCT01671748|19012792|P1|4 Week run-in Phase|Not eligible|9
5498911|NCT01671748|19012791|P2|4 Week run-in Phase|Adverse Event|0
5498912|NCT01671748|19012792|P1|4 Week run-in Phase|Adverse Event|1
5498913|NCT01671748|19012791|P2|4 Week run-in Phase|Withdrawal by Subject|0
5498914|NCT01671748|19012792|P1|4 Week run-in Phase|Withdrawal by Subject|1
5498915|NCT01671488|19012819|P1|Overall Study|Withdrawal by Subject|1
5498916|NCT01671345|19012827|P2|Overall Study|visit with non-participating physician|3
5498917|NCT01671345|19012828|P1|Overall Study|visit with non-participating physician|3
5498918|NCT01671345|19012827|P2|Overall Study|Lost to Follow-up|6
5498919|NCT01671345|19012828|P1|Overall Study|Lost to Follow-up|10
5498920|NCT01671332|19012842|P2|Overall Study|Withdrawal by Subject|1
5498921|NCT01671332|19012843|P1|Overall Study|Withdrawal by Subject|1
5498922|NCT01671319|19012857|P1|Overall Study|Withdrawal by Subject|1
5498923|NCT01671280|19012872|P1|Overall Study|Withdrawal by Subject|2
5498924|NCT01671111|19012883|P1|Overall Study|Other|24
5498925|NCT01671111|19012883|P1|Overall Study|Physician Decision|1
5498926|NCT01671111|19012883|P1|Overall Study|Withdrawal by Subject|2
5498927|NCT01671111|19012883|P1|Overall Study|Lack of Efficacy|1
5498928|NCT01671111|19012883|P1|Overall Study|Adverse Event|2
5498929|NCT01671085|19012895|P2|Overall Study|Withdrawal by Subject|0
5498930|NCT01671085|19012896|P1|Overall Study|Withdrawal by Subject|1
5498931|NCT01671059|19012907|P1|Overall Study|Lack of Efficacy|1
5498932|NCT01671059|19012907|P1|Overall Study|Adverse Event|4
5498933|NCT01671007|19012939|P9|Overall Study|Not eligible|0
5498934|NCT01671007|19012940|P8|Overall Study|Not eligible|19
5498935|NCT01671007|19012941|P7|Overall Study|Not eligible|1
5498936|NCT01671007|19012942|P6|Overall Study|Not eligible|6
5498937|NCT01671007|19012943|P5|Overall Study|Not eligible|0
5498938|NCT01671007|19012944|P4|Overall Study|Not eligible|17
5498939|NCT01671007|19012945|P3|Overall Study|Not eligible|25
5498940|NCT01671007|19012946|P2|Overall Study|Not eligible|76
5498941|NCT01671007|19012947|P1|Overall Study|Not eligible|23
5498942|NCT01671007|19012939|P9|Overall Study|No end of study case report form|0
5498943|NCT01671007|19012940|P8|Overall Study|No end of study case report form|0
5498944|NCT01671007|19012941|P7|Overall Study|No end of study case report form|0
5498945|NCT01671007|19012942|P6|Overall Study|No end of study case report form|0
5498946|NCT01671007|19012943|P5|Overall Study|No end of study case report form|0
5498947|NCT01671007|19012944|P4|Overall Study|No end of study case report form|2
5498948|NCT01671007|19012945|P3|Overall Study|No end of study case report form|0
5498949|NCT01671007|19012946|P2|Overall Study|No end of study case report form|1
5498950|NCT01671007|19012947|P1|Overall Study|No end of study case report form|3
5498951|NCT01671007|19012939|P9|Overall Study|Lost to Follow-up|0
5498952|NCT01671007|19012940|P8|Overall Study|Lost to Follow-up|28
5498953|NCT01671007|19012941|P7|Overall Study|Lost to Follow-up|2
5498954|NCT01671007|19012942|P6|Overall Study|Lost to Follow-up|20
5498955|NCT01671007|19012943|P5|Overall Study|Lost to Follow-up|7
5498956|NCT01671007|19012944|P4|Overall Study|Lost to Follow-up|63
5498957|NCT01671007|19012945|P3|Overall Study|Lost to Follow-up|91
5498958|NCT01671007|19012946|P2|Overall Study|Lost to Follow-up|142
5498959|NCT01671007|19012947|P1|Overall Study|Lost to Follow-up|93
5498960|NCT01671007|19012939|P9|Overall Study|Withdrawal by Subject|0
5498961|NCT01671007|19012940|P8|Overall Study|Withdrawal by Subject|19
5498962|NCT01671007|19012941|P7|Overall Study|Withdrawal by Subject|1
5498963|NCT01671007|19012942|P6|Overall Study|Withdrawal by Subject|15
5498964|NCT01671007|19012943|P5|Overall Study|Withdrawal by Subject|4
5498965|NCT01671007|19012944|P4|Overall Study|Withdrawal by Subject|58
5498966|NCT01671007|19012945|P3|Overall Study|Withdrawal by Subject|53
5498967|NCT01671007|19012946|P2|Overall Study|Withdrawal by Subject|59
5498968|NCT01671007|19012947|P1|Overall Study|Withdrawal by Subject|36
5498969|NCT01671007|19012939|P9|Overall Study|Other reasons than listed|0
5498970|NCT01671007|19012940|P8|Overall Study|Other reasons than listed|66
5498971|NCT01671007|19012941|P7|Overall Study|Other reasons than listed|17
5498972|NCT01671007|19012942|P6|Overall Study|Other reasons than listed|71
5498973|NCT01671007|19012943|P5|Overall Study|Other reasons than listed|14
5498974|NCT01671007|19012944|P4|Overall Study|Other reasons than listed|228
5498975|NCT01671007|19012945|P3|Overall Study|Other reasons than listed|197
5498976|NCT01671007|19012946|P2|Overall Study|Other reasons than listed|373
5498977|NCT01671007|19012947|P1|Overall Study|Other reasons than listed|166
5498978|NCT01670721|19013053|P1|Overall Study|Other than specified above|38
5498979|NCT01670721|19013053|P1|Overall Study|Participant's decision|15
5498980|NCT01670656|19013065|P5|Overall Study|Subject moved|0
5498981|NCT01670656|19013066|P4|Overall Study|Subject moved|1
5498982|NCT01670656|19013067|P3|Overall Study|Subject moved|0
5498983|NCT01670656|19013068|P2|Overall Study|Subject moved|0
5498984|NCT01670656|19013069|P1|Overall Study|Subject moved|0
5498985|NCT01670656|19013065|P5|Overall Study|Lost to Follow-up|3
5498986|NCT01670656|19013066|P4|Overall Study|Lost to Follow-up|0
5498987|NCT01670656|19013067|P3|Overall Study|Lost to Follow-up|0
5498988|NCT01670656|19013068|P2|Overall Study|Lost to Follow-up|0
5498989|NCT01670656|19013069|P1|Overall Study|Lost to Follow-up|0
5498990|NCT01670656|19013065|P5|Overall Study|Subject withdrew consent|1
5498991|NCT01670656|19013066|P4|Overall Study|Subject withdrew consent|1
5498992|NCT01670656|19013067|P3|Overall Study|Subject withdrew consent|2
5498993|NCT01670656|19013068|P2|Overall Study|Subject withdrew consent|1
5498994|NCT01670656|19013069|P1|Overall Study|Subject withdrew consent|0
5498995|NCT01670656|19013065|P5|Overall Study|Adverse Event|3
5498996|NCT01670656|19013066|P4|Overall Study|Adverse Event|3
5498997|NCT01670656|19013067|P3|Overall Study|Adverse Event|2
5498998|NCT01670656|19013068|P2|Overall Study|Adverse Event|2
5498999|NCT01670656|19013069|P1|Overall Study|Adverse Event|2
5499000|NCT01670656|19013065|P5|Overall Study|Non-compliance with protocol|2
5499001|NCT01670656|19013066|P4|Overall Study|Non-compliance with protocol|1
5499002|NCT01670656|19013067|P3|Overall Study|Non-compliance with protocol|1
5499003|NCT01670656|19013068|P2|Overall Study|Non-compliance with protocol|3
5499004|NCT01670656|19013069|P1|Overall Study|Non-compliance with protocol|0
5499005|NCT01670656|19013065|P5|Overall Study|Withdrawal by Subject|0
5499006|NCT01670656|19013066|P4|Overall Study|Withdrawal by Subject|0
5499007|NCT01670656|19013067|P3|Overall Study|Withdrawal by Subject|0
5499008|NCT01670656|19013068|P2|Overall Study|Withdrawal by Subject|1
5499009|NCT01670656|19013069|P1|Overall Study|Withdrawal by Subject|1
5499010|NCT01670656|19013065|P5|Overall Study|Pregnancy|1
5499011|NCT01670656|19013066|P4|Overall Study|Pregnancy|0
5499012|NCT01670656|19013067|P3|Overall Study|Pregnancy|0
5499013|NCT01670656|19013068|P2|Overall Study|Pregnancy|0
5499014|NCT01670656|19013069|P1|Overall Study|Pregnancy|0
5499015|NCT01670656|19013065|P5|Overall Study|Non-compliance with study drug|1
5499016|NCT01670656|19013066|P4|Overall Study|Non-compliance with study drug|0
5499017|NCT01670656|19013067|P3|Overall Study|Non-compliance with study drug|3
5499018|NCT01670656|19013068|P2|Overall Study|Non-compliance with study drug|0
5499019|NCT01670656|19013069|P1|Overall Study|Non-compliance with study drug|0
5499020|NCT01670526|19013098|P2|Overall Study|Lost to Follow-up|5
5499021|NCT01670526|19013099|P1|Overall Study|Lost to Follow-up|9
5499022|NCT01670526|19013098|P2|Overall Study|Withdrawal by Subject|1
5499023|NCT01670526|19013099|P1|Overall Study|Withdrawal by Subject|3
5499024|NCT01670500|19013113|P2|Overall Study|Withdrawal by Subject|0
5499025|NCT01670500|19013114|P1|Overall Study|Withdrawal by Subject|1
5499026|NCT01670292|19013137|P1|Overall Study|Lost to Follow-up|14
5499027|NCT01670279|19013178|P4|Overall Study|Participant met withdrawal criteria|1
5499028|NCT01670279|19013179|P3|Overall Study|Participant met withdrawal criteria|0
5499029|NCT01670279|19013180|P2|Overall Study|Participant met withdrawal criteria|0
5499030|NCT01670279|19013181|P1|Overall Study|Participant met withdrawal criteria|0
5499031|NCT01670279|19013178|P4|Overall Study|Physician Decision|0
5499032|NCT01670279|19013179|P3|Overall Study|Physician Decision|0
5499033|NCT01670279|19013180|P2|Overall Study|Physician Decision|1
5499034|NCT01670279|19013181|P1|Overall Study|Physician Decision|0
5499035|NCT01670279|19013178|P4|Overall Study|Adverse Event|0
5499036|NCT01670279|19013179|P3|Overall Study|Adverse Event|0
5499037|NCT01670279|19013180|P2|Overall Study|Adverse Event|1
5499038|NCT01670279|19013181|P1|Overall Study|Adverse Event|0
5499039|NCT01670188|19013223|P2|Overall Study|Death|1
5499040|NCT01670188|19013224|P1|Overall Study|Death|0
5499041|NCT01670045|19013253|P1|Overall Study|Lost to Follow-up|11
5499042|NCT01670045|19013253|P1|Overall Study|Death|1
5499043|NCT01670045|19013253|P1|Overall Study|Adverse Event|1
5499044|NCT01670045|19013253|P1|Overall Study|Withdrawal by Subject|3
5499045|NCT01670019|19013271|P2|Overall Study|Withdrawal by Subject|0
5499046|NCT01670019|19013272|P1|Overall Study|Withdrawal by Subject|6
5499047|NCT01670019|19013271|P2|Overall Study|Adverse Event|0
5499048|NCT01670019|19013272|P1|Overall Study|Adverse Event|3
5499049|NCT01669902|19013286|P1|Overall Study|Other|8
5499050|NCT01669902|19013286|P1|Overall Study|Lack of Efficacy|10
5499051|NCT01669902|19013286|P1|Overall Study|Adverse Event|11
5499052|NCT01669811|19013321|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
5499053|NCT01669811|19013322|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
5499054|NCT01669811|19013321|P2|Overall Study|Adverse Event|6
5499055|NCT01669811|19013322|P1|Overall Study|Adverse Event|2
5499056|NCT01669811|19013321|P2|Overall Study|Withdrawal by Subject|2
5499057|NCT01669811|19013322|P1|Overall Study|Withdrawal by Subject|1
5499058|NCT01669811|19013321|P2|Overall Study|Investigator decision|1
5499059|NCT01669811|19013322|P1|Overall Study|Investigator decision|0
5499060|NCT01669798|19013340|P1|Overall Study|Physician Decision|5
5499061|NCT01669629|19013446|P2|Period 1|protocol deviation|2
5499062|NCT01669629|19013447|P1|Period 1|protocol deviation|1
5499063|NCT01669577|19013470|P1|Overall Study|Physician Decision|34
5499064|NCT01669577|19013470|P1|Overall Study|Lost to Follow-up|78
5499065|NCT01669577|19013470|P1|Overall Study|Death|22
5499066|NCT01669421|19013508|P1|Phase 1: Standard Dose Therapy|Physician Decision|1
5499067|NCT01669421|19013508|P1|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
5499068|NCT01669174|19013527|P2|Overall Study|Administrative problems|2
5499069|NCT01669174|19013528|P1|Overall Study|Administrative problems|1
5499070|NCT01669174|19013527|P2|Overall Study|Adverse Event|2
5499071|NCT01669174|19013528|P1|Overall Study|Adverse Event|2
5499072|NCT01669174|19013527|P2|Overall Study|Lost to Follow-up|0
5499073|NCT01669174|19013528|P1|Overall Study|Lost to Follow-up|1
5499074|NCT01669174|19013527|P2|Overall Study|Subject withdrew consent|2
5499075|NCT01669174|19013528|P1|Overall Study|Subject withdrew consent|2
5499076|NCT01669122|19013544|P1|Washout Period II|Protocol Violation|2
5499077|NCT01669122|19013544|P1|Period I|Lost to Follow-up|1
5499078|NCT01668966|19013611|P1|Overall Study|Not treated|2
5499079|NCT01668966|19013611|P1|Overall Study|Death|1
5499080|NCT01668966|19013611|P1|Overall Study|Withdrawal by Subject|1
5499081|NCT01668797|19013707|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
5499082|NCT01668797|19013708|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
5499083|NCT01668797|19013709|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
5499084|NCT01668797|19013710|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
5499085|NCT01668797|19013707|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
5499086|NCT01668797|19013708|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
5499087|NCT01668797|19013709|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
5499088|NCT01668797|19013710|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
5499089|NCT01668797|19013707|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
5499090|NCT01668797|19013708|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
5499091|NCT01668797|19013709|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
5499092|NCT01668797|19013710|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
5499093|NCT01668797|19013707|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
5499094|NCT01668797|19013708|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
5499095|NCT01668797|19013709|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
5499096|NCT01668797|19013710|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
5499097|NCT01668797|19013707|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
5499098|NCT01668797|19013708|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
5499099|NCT01668797|19013709|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
5499100|NCT01668797|19013710|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
5499101|NCT01668797|19013707|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
5499102|NCT01668797|19013708|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
5499103|NCT01668797|19013709|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
5499104|NCT01668797|19013710|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
5499105|NCT01668797|19013707|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
5499106|NCT01668797|19013708|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
5499107|NCT01668797|19013709|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
5499108|NCT01668797|19013710|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
5499109|NCT01668797|19013707|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
5499110|NCT01668797|19013708|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
5499111|NCT01668797|19013709|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
5499112|NCT01668797|19013710|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
5499113|NCT01668797|19013707|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
5499114|NCT01668797|19013708|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
5499115|NCT01668797|19013709|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
5499116|NCT01668797|19013710|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
5499117|NCT01668797|19013707|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
5499118|NCT01668797|19013708|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
5499119|NCT01668797|19013709|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
5499120|NCT01668797|19013710|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
5499121|NCT01668797|19013707|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
5499122|NCT01668797|19013708|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
5499123|NCT01668797|19013709|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
5499124|NCT01668797|19013710|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
5499125|NCT01668797|19013707|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
5499126|NCT01668797|19013708|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
5499127|NCT01668797|19013709|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
5499128|NCT01668797|19013710|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
5499129|NCT01668797|19013707|P4|Phase B (Stabilization Phase)|Protocol Violation|0
5499130|NCT01668797|19013708|P3|Phase B (Stabilization Phase)|Protocol Violation|0
5499131|NCT01668797|19013709|P2|Phase B (Stabilization Phase)|Protocol Violation|3
5499132|NCT01668797|19013710|P1|Phase B (Stabilization Phase)|Protocol Violation|0
5499133|NCT01668797|19013707|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
5499134|NCT01668797|19013708|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
5499135|NCT01668797|19013709|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
5499136|NCT01668797|19013710|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
5499137|NCT01668797|19013707|P4|Phase B (Stabilization Phase)|Physician Decision|0
5499138|NCT01668797|19013708|P3|Phase B (Stabilization Phase)|Physician Decision|0
5499139|NCT01668797|19013709|P2|Phase B (Stabilization Phase)|Physician Decision|11
5499140|NCT01668797|19013710|P1|Phase B (Stabilization Phase)|Physician Decision|0
5499141|NCT01668797|19013707|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
5499142|NCT01668797|19013708|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
5499143|NCT01668797|19013709|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
5499144|NCT01668797|19013710|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
5499145|NCT01668797|19013707|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
5499146|NCT01668797|19013708|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
5499147|NCT01668797|19013709|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
5499148|NCT01668797|19013710|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
5499149|NCT01668797|19013707|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
5499150|NCT01668797|19013708|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
5499151|NCT01668797|19013709|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
5499152|NCT01668797|19013710|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
5499153|NCT01668797|19013707|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
5499154|NCT01668797|19013708|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
5499155|NCT01668797|19013709|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
5499156|NCT01668797|19013710|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
5499157|NCT01668797|19013707|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
5499158|NCT01668797|19013708|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
5499159|NCT01668797|19013709|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
5499160|NCT01668797|19013710|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
5499161|NCT01668797|19013707|P4|Phase A (Conversion Phase)|Protocol Violation|0
5499162|NCT01668797|19013708|P3|Phase A (Conversion Phase)|Protocol Violation|0
5499163|NCT01668797|19013709|P2|Phase A (Conversion Phase)|Protocol Violation|0
5499164|NCT01668797|19013710|P1|Phase A (Conversion Phase)|Protocol Violation|2
5499165|NCT01668797|19013707|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
5499166|NCT01668797|19013708|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
5499167|NCT01668797|19013709|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
5499168|NCT01668797|19013710|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
5499169|NCT01668797|19013707|P4|Phase A (Conversion Phase)|Physician Decision|0
5499170|NCT01668797|19013708|P3|Phase A (Conversion Phase)|Physician Decision|0
5499171|NCT01668797|19013709|P2|Phase A (Conversion Phase)|Physician Decision|0
5499172|NCT01668797|19013710|P1|Phase A (Conversion Phase)|Physician Decision|2
5499173|NCT01668797|19013707|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
5499174|NCT01668797|19013708|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
5499175|NCT01668797|19013709|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
5499176|NCT01668797|19013710|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
5499177|NCT01668797|19013707|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
5499178|NCT01668797|19013708|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
5499179|NCT01668797|19013709|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
5499180|NCT01668797|19013710|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
5499181|NCT01668784|19013775|P2|Treated (Overall)|Other|4
5499182|NCT01668784|19013776|P1|Treated (Overall)|Other|0
5499183|NCT01668784|19013775|P2|Treated (Overall)|Maximal Clinical Benefit|3
5499184|NCT01668784|19013776|P1|Treated (Overall)|Maximal Clinical Benefit|2
5499185|NCT01668784|19013775|P2|Treated (Overall)|Withdrawal by Subject|3
5499186|NCT01668784|19013776|P1|Treated (Overall)|Withdrawal by Subject|2
5499187|NCT01668784|19013775|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
5499188|NCT01668784|19013776|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
5499189|NCT01668784|19013775|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
5499190|NCT01668784|19013776|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
5499191|NCT01668784|19013775|P2|Treated (Overall)|Death|1
5499192|NCT01668784|19013776|P1|Treated (Overall)|Death|1
5499193|NCT01668784|19013775|P2|Treated (Overall)|Study Drug Toxicity|53
5499194|NCT01668784|19013776|P1|Treated (Overall)|Study Drug Toxicity|35
5499195|NCT01668784|19013775|P2|Treated (Overall)|Disease Progression|273
5499196|NCT01668784|19013776|P1|Treated (Overall)|Disease Progression|285
5499197|NCT01668784|19013775|P2|Randomized (Pre-treatment)|Other|1
5499198|NCT01668784|19013776|P1|Randomized (Pre-treatment)|Other|0
5499199|NCT01668784|19013775|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
5499200|NCT01668784|19013776|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
5499201|NCT01668784|19013775|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
5499202|NCT01668784|19013776|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
5499203|NCT01668784|19013775|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
5499204|NCT01668784|19013776|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
5499205|NCT01668784|19013775|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
5499206|NCT01668784|19013776|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
5499207|NCT01668784|19013775|P2|Randomized (Pre-treatment)|Disease Progression|1
5499208|NCT01668784|19013776|P1|Randomized (Pre-treatment)|Disease Progression|0
5499209|NCT01668667|19013804|P4|Overall Study|Withdrawal by Subject|5
5499210|NCT01668667|19013805|P3|Overall Study|Withdrawal by Subject|5
5499211|NCT01668667|19013806|P2|Overall Study|Withdrawal by Subject|4
5499212|NCT01668667|19013807|P1|Overall Study|Withdrawal by Subject|7
5499213|NCT01668667|19013804|P4|Overall Study|Physician Decision|0
5499214|NCT01668667|19013805|P3|Overall Study|Physician Decision|1
5499215|NCT01668667|19013806|P2|Overall Study|Physician Decision|0
5499216|NCT01668667|19013807|P1|Overall Study|Physician Decision|3
5499217|NCT01668667|19013804|P4|Overall Study|Lost to Follow-up|6
5499218|NCT01668667|19013805|P3|Overall Study|Lost to Follow-up|7
5499219|NCT01668667|19013806|P2|Overall Study|Lost to Follow-up|4
5499220|NCT01668667|19013807|P1|Overall Study|Lost to Follow-up|9
5499221|NCT01668667|19013804|P4|Overall Study|Protocol Violation|5
5499222|NCT01668667|19013805|P3|Overall Study|Protocol Violation|12
5499223|NCT01668667|19013806|P2|Overall Study|Protocol Violation|10
5499224|NCT01668667|19013807|P1|Overall Study|Protocol Violation|6
5499225|NCT01668667|19013804|P4|Overall Study|Lack of Efficacy|3
5499226|NCT01668667|19013805|P3|Overall Study|Lack of Efficacy|2
5499227|NCT01668667|19013806|P2|Overall Study|Lack of Efficacy|2
5499228|NCT01668667|19013807|P1|Overall Study|Lack of Efficacy|3
5499229|NCT01668667|19013804|P4|Overall Study|Adverse Event|4
5499230|NCT01668667|19013805|P3|Overall Study|Adverse Event|4
5499231|NCT01668667|19013806|P2|Overall Study|Adverse Event|6
5499232|NCT01668667|19013807|P1|Overall Study|Adverse Event|3
5499233|NCT01668654|19013829|P1|Overall Study|Withdrawal by Subject|1
5499234|NCT01668654|19013829|P1|Overall Study|Study Closed/Terminated|3
5499235|NCT01668589|19013890|P4|Overall Study|Other|15
5499236|NCT01668589|19013891|P3|Overall Study|Other|7
5499237|NCT01668589|19013892|P2|Overall Study|Other|10
5499238|NCT01668589|19013893|P1|Overall Study|Other|44
5499239|NCT01668589|19013890|P4|Overall Study|Death|11
5499240|NCT01668589|19013891|P3|Overall Study|Death|2
5499241|NCT01668589|19013892|P2|Overall Study|Death|3
5499242|NCT01668589|19013893|P1|Overall Study|Death|12
5499243|NCT01668589|19013890|P4|Overall Study|Full Consent/Agreement Withdrawn|4
5499244|NCT01668589|19013891|P3|Overall Study|Full Consent/Agreement Withdrawn|11
5499245|NCT01668589|19013892|P2|Overall Study|Full Consent/Agreement Withdrawn|8
5499246|NCT01668589|19013893|P1|Overall Study|Full Consent/Agreement Withdrawn|54
5499247|NCT01668589|19013890|P4|Overall Study|Lost to Follow-up|5
5499248|NCT01668589|19013891|P3|Overall Study|Lost to Follow-up|15
5499249|NCT01668589|19013892|P2|Overall Study|Lost to Follow-up|37
5499250|NCT01668589|19013893|P1|Overall Study|Lost to Follow-up|29
5499251|NCT01668537|19013933|P2|Overall Study|Other|3
5499252|NCT01668537|19013934|P1|Overall Study|Other|2
5499253|NCT01668537|19013933|P2|Overall Study|Lost to Follow-up|6
5499254|NCT01668537|19013934|P1|Overall Study|Lost to Follow-up|13
5499255|NCT01668537|19013933|P2|Overall Study|Reason Precludes Participation|0
5499256|NCT01668537|19013934|P1|Overall Study|Reason Precludes Participation|1
5499257|NCT01668537|19013933|P2|Overall Study|Subject unwilling/unable to comply|0
5499258|NCT01668537|19013934|P1|Overall Study|Subject unwilling/unable to comply|5
5499259|NCT01668537|19013933|P2|Overall Study|Request to Discontinue Prematurely|1
5499260|NCT01668537|19013934|P1|Overall Study|Request to Discontinue Prematurely|1
5499261|NCT01668355|19013976|P2|Overall Study|Withdrawal by Subject|1
5499262|NCT01668355|19013977|P1|Overall Study|Withdrawal by Subject|6
5499263|NCT01668355|19013976|P2|Overall Study|Death|1
5499264|NCT01668355|19013977|P1|Overall Study|Death|3
5499265|NCT01668173|19013997|P1|Overall Study|Trial suspension|4
5499266|NCT01668173|19013997|P1|Overall Study|Adverse Event|3
5499267|NCT01668147|19014001|P1|Overall Study|Withdrawal by Subject|6
5499268|NCT01668004|19014131|P1|Overall Study|Non-compliance with treatment|2
5499269|NCT01668004|19014131|P1|Overall Study|Lack of Efficacy|9
5499270|NCT01668004|19014131|P1|Overall Study|Lost to Follow-up|5
5499271|NCT01668004|19014131|P1|Overall Study|Withdrawal by Subject|2
5499272|NCT01668004|19014131|P1|Overall Study|Adverse Event|7
5499273|NCT01667926|19014153|P3|Overall Study|Side effects|0
5499274|NCT01667926|19014154|P2|Overall Study|Side effects|0
5499275|NCT01667926|19014155|P1|Overall Study|Side effects|3
5499276|NCT01667926|19014153|P3|Overall Study|Lost to Follow-up|1
5499277|NCT01667926|19014154|P2|Overall Study|Lost to Follow-up|2
5499278|NCT01667926|19014155|P1|Overall Study|Lost to Follow-up|1
5499279|NCT01667926|19014153|P3|Overall Study|Inclusion/Exclusion Criteria|5
5499280|NCT01667926|19014154|P2|Overall Study|Inclusion/Exclusion Criteria|0
5499281|NCT01667926|19014155|P1|Overall Study|Inclusion/Exclusion Criteria|0
5499282|NCT01667926|19014153|P3|Overall Study|Time committment|2
5499283|NCT01667926|19014154|P2|Overall Study|Time committment|0
5499284|NCT01667926|19014155|P1|Overall Study|Time committment|0
5499285|NCT01667926|19014153|P3|Overall Study|Physician Decision|1
5499286|NCT01667926|19014154|P2|Overall Study|Physician Decision|0
5499287|NCT01667926|19014155|P1|Overall Study|Physician Decision|0
5499288|NCT01667926|19014153|P3|Overall Study|Withdrawal by Subject|2
5499289|NCT01667926|19014154|P2|Overall Study|Withdrawal by Subject|2
5499290|NCT01667926|19014155|P1|Overall Study|Withdrawal by Subject|1
5499291|NCT01667900|19014168|P20|Part B|Death|0
5499292|NCT01667900|19014169|P19|Part B|Death|0
5499293|NCT01667900|19014170|P18|Part B|Death|0
5499294|NCT01667900|19014171|P17|Part B|Death|1
5499295|NCT01667900|19014172|P16|Part B|Death|0
5499296|NCT01667900|19014173|P15|Part B|Death|0
5499297|NCT01667900|19014174|P14|Part B|Death|0
5499298|NCT01667900|19014175|P13|Part B|Death|0
5499299|NCT01667900|19014176|P12|Part B|Death|0
5499300|NCT01667900|19014177|P11|Part B|Death|0
5499301|NCT01667900|19014178|P10|Part B|Death|0
5499302|NCT01667900|19014179|P9|Part B|Death|0
5499303|NCT01667900|19014180|P8|Part B|Death|0
5499304|NCT01667900|19014181|P7|Part B|Death|0
5499305|NCT01667900|19014182|P6|Part B|Death|0
5499311|NCT01667731|19014257|P5|Overall Study|Death|0
5499312|NCT01667731|19014258|P4|Overall Study|Death|0
5499313|NCT01667731|19014259|P3|Overall Study|Death|0
5499314|NCT01667731|19014260|P2|Overall Study|Death|1
5499315|NCT01667731|19014261|P1|Overall Study|Death|0
5499316|NCT01667731|19014257|P5|Overall Study|Subject Withdrew Consent|1
5499317|NCT01667731|19014258|P4|Overall Study|Subject Withdrew Consent|0
5499318|NCT01667731|19014259|P3|Overall Study|Subject Withdrew Consent|1
5499319|NCT01667731|19014260|P2|Overall Study|Subject Withdrew Consent|0
5499320|NCT01667731|19014261|P1|Overall Study|Subject Withdrew Consent|2
5499321|NCT01667731|19014257|P5|Overall Study|Lost to Follow-up|2
5499322|NCT01667731|19014258|P4|Overall Study|Lost to Follow-up|1
5499323|NCT01667731|19014259|P3|Overall Study|Lost to Follow-up|1
5499324|NCT01667731|19014260|P2|Overall Study|Lost to Follow-up|3
5499325|NCT01667731|19014261|P1|Overall Study|Lost to Follow-up|2
5499326|NCT01667731|19014257|P5|Overall Study|Efficacy Failure|24
5499327|NCT01667731|19014258|P4|Overall Study|Efficacy Failure|1
5499328|NCT01667731|19014259|P3|Overall Study|Efficacy Failure|0
5499329|NCT01667731|19014260|P2|Overall Study|Efficacy Failure|12
5499330|NCT01667731|19014261|P1|Overall Study|Efficacy Failure|1
5499331|NCT01667731|19014257|P5|Overall Study|Enrolled but not treated|1
5499332|NCT01667731|19014258|P4|Overall Study|Enrolled but not treated|0
5499333|NCT01667731|19014259|P3|Overall Study|Enrolled but not treated|0
5499334|NCT01667731|19014260|P2|Overall Study|Enrolled but not treated|0
5499335|NCT01667731|19014261|P1|Overall Study|Enrolled but not treated|0
5499336|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
5499337|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
5499338|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
5499339|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
5499340|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
5499341|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
5499342|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
5499343|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
5499344|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
5499345|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
5499346|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
5499347|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
5499348|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
5499349|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
5499350|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
5499351|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
5499352|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
5499353|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
5499354|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
5499355|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
5499356|NCT01667679|19014316|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
5499357|NCT01667679|19014317|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
5499358|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
5499359|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
5499360|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
5499361|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
5499362|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
5499363|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
5499364|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
5499365|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
5499366|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
5499367|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
5499368|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
5499369|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
5499370|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
5499371|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
5499372|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
5499373|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
5499374|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
5499375|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
5499376|NCT01667679|19014316|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
5499377|NCT01667679|19014317|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
5499378|NCT01667562|19014375|P2|Erlotinib Phase|Switch to Commercial Drug|1
5499379|NCT01667562|19014376|P1|Erlotinib Phase|Switch to Commercial Drug|0
5499380|NCT01667562|19014375|P2|Erlotinib Phase|Adverse Event|1
5499381|NCT01667562|19014376|P1|Erlotinib Phase|Adverse Event|0
5499382|NCT01667562|19014375|P2|Erlotinib Phase|Lost to Follow-up|1
5499383|NCT01667562|19014376|P1|Erlotinib Phase|Lost to Follow-up|0
5499384|NCT01667562|19014375|P2|Diagnostic Phase|Started Erlotinib in Treatment Period|0
5499385|NCT01667562|19014376|P1|Diagnostic Phase|Started Erlotinib in Treatment Period|30
5499386|NCT01667549|19014390|P5|Overall Study|Withdrawal by Subject|1
5499387|NCT01667549|19014391|P4|Overall Study|Withdrawal by Subject|6
5499388|NCT01667549|19014392|P3|Overall Study|Withdrawal by Subject|7
5499389|NCT01667549|19014393|P2|Overall Study|Withdrawal by Subject|5
5499390|NCT01667549|19014394|P1|Overall Study|Withdrawal by Subject|3
5499391|NCT01667432|19014453|P1|Overall Study|Missing Information|4
5499392|NCT01667432|19014453|P1|Overall Study|Reason Not Specified|2
5499393|NCT01667432|19014453|P1|Overall Study|Principal Investigator Decision|1
5499394|NCT01667432|19014453|P1|Overall Study|Protocol Deviation|2
5499395|NCT01667432|19014453|P1|Overall Study|Adverse Event|1
5499396|NCT01667432|19014453|P1|Overall Study|Insufficient Therapeutic Response|4
5499397|NCT01667432|19014453|P1|Overall Study|Refused Treatment/Withdrew Consent|1
5499398|NCT01667432|19014453|P1|Overall Study|Lost to Follow-up|3
5499399|NCT01667432|19014453|P1|Overall Study|Moved to Another Center|3
5499400|NCT01667432|19014453|P1|Overall Study|Failure to Return|10
5499401|NCT01667432|19014453|P1|Overall Study|Premature Study Termination|26
5499402|NCT01667419|19014462|P4|Overall Study|Death|26
5499403|NCT01667419|19014463|P3|Overall Study|Death|25
5499404|NCT01667419|19014464|P2|Overall Study|Death|33
5499405|NCT01667419|19014465|P1|Overall Study|Death|18
5499406|NCT01667419|19014462|P4|Overall Study|Lost to Follow-up|4
5499407|NCT01667419|19014463|P3|Overall Study|Lost to Follow-up|2
5499408|NCT01667419|19014464|P2|Overall Study|Lost to Follow-up|6
5499409|NCT01667419|19014465|P1|Overall Study|Lost to Follow-up|7
5499410|NCT01667419|19014462|P4|Overall Study|Protocol Violation|0
5499411|NCT01667419|19014463|P3|Overall Study|Protocol Violation|0
5499412|NCT01667419|19014464|P2|Overall Study|Protocol Violation|0
5499413|NCT01667419|19014465|P1|Overall Study|Protocol Violation|1
5499414|NCT01667419|19014462|P4|Overall Study|Non-compliance|1
5499415|NCT01667419|19014463|P3|Overall Study|Non-compliance|0
5499416|NCT01667419|19014464|P2|Overall Study|Non-compliance|0
5499417|NCT01667419|19014465|P1|Overall Study|Non-compliance|0
5499418|NCT01667419|19014462|P4|Overall Study|Withdrawal by Subject|8
5499419|NCT01667419|19014463|P3|Overall Study|Withdrawal by Subject|9
5499420|NCT01667419|19014464|P2|Overall Study|Withdrawal by Subject|8
5499421|NCT01667419|19014465|P1|Overall Study|Withdrawal by Subject|16
5499422|NCT01667419|19014462|P4|Overall Study|Reason Not Specified|0
5499423|NCT01667419|19014463|P3|Overall Study|Reason Not Specified|0
5499424|NCT01667419|19014464|P2|Overall Study|Reason Not Specified|0
5499425|NCT01667419|19014465|P1|Overall Study|Reason Not Specified|1
5499426|NCT01667224|19014513|P2|Overall Study|Protocol Violation|1
5499427|NCT01667224|19014514|P1|Overall Study|Protocol Violation|1
5499428|NCT01667224|19014513|P2|Overall Study|Withdrawal by Subject|1
5499429|NCT01667224|19014514|P1|Overall Study|Withdrawal by Subject|3
5499430|NCT01667107|19014528|P2|Overall Study|Lack of Efficacy|1
5499431|NCT01667107|19014529|P1|Overall Study|Lack of Efficacy|0
5499432|NCT01667107|19014528|P2|Overall Study|Protocol Violation|1
5499433|NCT01667107|19014529|P1|Overall Study|Protocol Violation|0
5499434|NCT01667107|19014528|P2|Overall Study|Tolerability issues|2
5499435|NCT01667107|19014529|P1|Overall Study|Tolerability issues|0
5499436|NCT01667107|19014528|P2|Overall Study|Adverse Event|3
5499437|NCT01667107|19014529|P1|Overall Study|Adverse Event|4
5499438|NCT01666951|19014588|P2|Overall Study|Not dosed|1
5499439|NCT01666951|19014589|P1|Overall Study|Not dosed|1
5499440|NCT01666782|19014640|P2|Overall Study|Enrolled both years; year 1 data used|0
5499441|NCT01666782|19014641|P1|Overall Study|Enrolled both years; year 1 data used|4
5499442|NCT01666782|19014640|P2|Overall Study|Received 2 doses of vaccine|1
5499443|NCT01666782|19014641|P1|Overall Study|Received 2 doses of vaccine|0
5499444|NCT01666652|19014662|P5|Overall Study|Lost to Follow-up|0
5499445|NCT01666652|19014663|P4|Overall Study|Lost to Follow-up|1
5499446|NCT01666652|19014664|P3|Overall Study|Lost to Follow-up|1
5499447|NCT01666652|19014665|P2|Overall Study|Lost to Follow-up|1
5499448|NCT01666652|19014666|P1|Overall Study|Lost to Follow-up|1
5499449|NCT01666652|19014662|P5|Overall Study|Moved from study area|0
5499450|NCT01666652|19014663|P4|Overall Study|Moved from study area|2
5499451|NCT01666652|19014664|P3|Overall Study|Moved from study area|0
5499452|NCT01666652|19014665|P2|Overall Study|Moved from study area|0
5499453|NCT01666652|19014666|P1|Overall Study|Moved from study area|1
5499454|NCT01666652|19014662|P5|Overall Study|Withdrawal by Subject|1
5499455|NCT01666652|19014663|P4|Overall Study|Withdrawal by Subject|0
5499456|NCT01666652|19014664|P3|Overall Study|Withdrawal by Subject|0
5499457|NCT01666652|19014665|P2|Overall Study|Withdrawal by Subject|0
5499458|NCT01666652|19014666|P1|Overall Study|Withdrawal by Subject|0
5499459|NCT01666652|19014662|P5|Overall Study|Serious Adverse Event|0
5499460|NCT01666652|19014663|P4|Overall Study|Serious Adverse Event|1
5499461|NCT01666652|19014664|P3|Overall Study|Serious Adverse Event|0
5499462|NCT01666652|19014665|P2|Overall Study|Serious Adverse Event|0
5499463|NCT01666652|19014666|P1|Overall Study|Serious Adverse Event|0
5499464|NCT01666444|19014715|P2|Overall Study|Did not initiate treatment|1
5499465|NCT01666444|19014716|P1|Overall Study|Did not initiate treatment|2
5499466|NCT01666314|19014734|P4|Overall Study|Reason not Specified|5
5499467|NCT01666314|19014735|P3|Overall Study|Reason not Specified|5
5499468|NCT01666314|19014736|P2|Overall Study|Reason not Specified|7
5499469|NCT01666314|19014737|P1|Overall Study|Reason not Specified|10
5499470|NCT01666314|19014734|P4|Overall Study|Withdrawal by Subject|3
5499471|NCT01666314|19014735|P3|Overall Study|Withdrawal by Subject|2
5499472|NCT01666314|19014736|P2|Overall Study|Withdrawal by Subject|1
5499473|NCT01666314|19014737|P1|Overall Study|Withdrawal by Subject|1
5499474|NCT01666314|19014734|P4|Overall Study|Unsatisfactory Therapeutic Response|1
5499475|NCT01666314|19014735|P3|Overall Study|Unsatisfactory Therapeutic Response|1
5499476|NCT01666314|19014736|P2|Overall Study|Unsatisfactory Therapeutic Response|2
5499477|NCT01666314|19014737|P1|Overall Study|Unsatisfactory Therapeutic Response|7
5499478|NCT01666314|19014734|P4|Overall Study|Symptomatic Deterioration|0
5499479|NCT01666314|19014735|P3|Overall Study|Symptomatic Deterioration|2
5499480|NCT01666314|19014736|P2|Overall Study|Symptomatic Deterioration|0
5499481|NCT01666314|19014737|P1|Overall Study|Symptomatic Deterioration|1
5499482|NCT01666314|19014734|P4|Overall Study|Progressive Disease|20
5499483|NCT01666314|19014735|P3|Overall Study|Progressive Disease|19
5499484|NCT01666314|19014736|P2|Overall Study|Progressive Disease|9
5499485|NCT01666314|19014737|P1|Overall Study|Progressive Disease|11
5499486|NCT01666314|19014734|P4|Overall Study|Adverse Event|7
5499487|NCT01666314|19014735|P3|Overall Study|Adverse Event|7
5499488|NCT01666314|19014736|P2|Overall Study|Adverse Event|13
5499489|NCT01666314|19014737|P1|Overall Study|Adverse Event|3
5499490|NCT01666119|19014873|P1|Overall Study|Subject experiencing withdrawal symptoms|5
5499491|NCT01666119|19014873|P1|Overall Study|non compliance with study medication, pa|18
5499492|NCT01666119|19014873|P1|Overall Study|Lost to Follow-up|7
5499493|NCT01666119|19014873|P1|Overall Study|Withdrawal by Subject|16
5499494|NCT01666119|19014873|P1|Overall Study|Adverse Event|6
5499495|NCT01666002|19014880|P2|Overall Study|Lost to Follow-up|0
5499496|NCT01666002|19014881|P1|Overall Study|Lost to Follow-up|5
5499497|NCT01665911|19014902|P1|Overall Study|Adverse Event|1
5499498|NCT01665911|19014902|P1|Overall Study|Withdrawal by Subject|1
5499499|NCT01665911|19014902|P1|Overall Study|Protocol Violation|4
5499500|NCT01665807|19014928|P3|Overall Study|Withdrawal by Subject|1
5499501|NCT01665807|19014929|P2|Overall Study|Withdrawal by Subject|0
5499502|NCT01665807|19014930|P1|Overall Study|Withdrawal by Subject|2
5499503|NCT01665768|19014941|P1|Overall Study|Withdrawal by Subject|1
5499504|NCT01665768|19014941|P1|Overall Study|Lack of Efficacy|19
5499505|NCT01665768|19014941|P1|Overall Study|Adverse Event|3
5499506|NCT01665599|19014946|P1|Overall Study|Could Not Continue Due to Time Constrain|1
5499507|NCT01665599|19014946|P1|Overall Study|Participant Left for More Than 3 Months|1
5499508|NCT01665599|19014946|P1|Overall Study|Lost to Follow-up|2
5499509|NCT01665599|19014946|P1|Overall Study|Death|1
5499510|NCT01665599|19014946|P1|Overall Study|Investigator/Sponsor decision|1
5499511|NCT01665599|19014946|P1|Overall Study|Consent Withdrawn|1
5499512|NCT01665599|19014946|P1|Overall Study|Adverse Event|1
5499513|NCT01665430|19014982|P1|Overall Study|Other Unspecified|2
5499514|NCT01665430|19014982|P1|Overall Study|Withdrawal by Subject|6
5499515|NCT01665430|19014982|P1|Overall Study|Adverse Event|1
5499516|NCT01665144|19015080|P2|Overall Study|Withdrawal by Subject|77
5499517|NCT01665144|19015081|P1|Overall Study|Withdrawal by Subject|96
5499518|NCT01665144|19015080|P2|Overall Study|Adverse Event|18
5499519|NCT01665144|19015081|P1|Overall Study|Adverse Event|45
5499520|NCT01665144|19015080|P2|Overall Study|Lack of Efficacy|11
5499521|NCT01665144|19015081|P1|Overall Study|Lack of Efficacy|16
5499522|NCT01665144|19015080|P2|Overall Study|Physician Decision|1
5499523|NCT01665144|19015081|P1|Overall Study|Physician Decision|13
5499524|NCT01665144|19015080|P2|Overall Study|Lost to Follow-up|8
5499525|NCT01665144|19015081|P1|Overall Study|Lost to Follow-up|9
5499526|NCT01665144|19015080|P2|Overall Study|Progressive disease|4
5499527|NCT01665144|19015081|P1|Overall Study|Progressive disease|8
5499528|NCT01665144|19015080|P2|Overall Study|Non-compliance w/study treatment|0
5499529|NCT01665144|19015081|P1|Overall Study|Non-compliance w/study treatment|5
5499530|NCT01665144|19015080|P2|Overall Study|Protocol deviation|1
5499531|NCT01665144|19015081|P1|Overall Study|Protocol deviation|3
5499532|NCT01665144|19015080|P2|Overall Study|Death|1
5499533|NCT01665144|19015081|P1|Overall Study|Death|3
5499534|NCT01665144|19015080|P2|Overall Study|Technical problems|0
5499535|NCT01665144|19015081|P1|Overall Study|Technical problems|2
5499536|NCT01665144|19015080|P2|Overall Study|New therapy for study indication|1
5499537|NCT01665144|19015081|P1|Overall Study|New therapy for study indication|2
5499538|NCT01664949|19015161|P2|Overall Study|Other Miscellaneous Reasons|1
5499539|NCT01664949|19015162|P1|Overall Study|Other Miscellaneous Reasons|3
5499540|NCT01664949|19015161|P2|Overall Study|Protocol Violation|5
5499541|NCT01664949|19015162|P1|Overall Study|Protocol Violation|5
5499542|NCT01664949|19015161|P2|Overall Study|Personal Reasons|4
5499543|NCT01664949|19015162|P1|Overall Study|Personal Reasons|3
5499544|NCT01664949|19015161|P2|Overall Study|Lost to Follow-up|2
5499545|NCT01664949|19015162|P1|Overall Study|Lost to Follow-up|1
5499546|NCT01664949|19015161|P2|Overall Study|Lack of Efficacy|1
5499547|NCT01664949|19015162|P1|Overall Study|Lack of Efficacy|1
5499548|NCT01664949|19015161|P2|Overall Study|Adverse Event|12
5499549|NCT01664949|19015162|P1|Overall Study|Adverse Event|11
5499550|NCT01664923|19015178|P2|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
5499551|NCT01664923|19015179|P1|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
5499552|NCT01664923|19015178|P2|Period 2: Open-label Phase-36 Months|Adverse Event|7
5499553|NCT01664923|19015179|P1|Period 2: Open-label Phase-36 Months|Adverse Event|4
5499554|NCT01664923|19015178|P2|Period 2: Open-label Phase-36 Months|Other|1
5499555|NCT01664923|19015179|P1|Period 2: Open-label Phase-36 Months|Other|3
5499556|NCT01664923|19015178|P2|Period 2: Open-label Phase-36 Months|Disease progression|9
5499557|NCT01664923|19015179|P1|Period 2: Open-label Phase-36 Months|Disease progression|28
5499558|NCT01664923|19015178|P2|Period 2: Open-label Phase-36 Months|On Treatment|1
5499559|NCT01664923|19015179|P1|Period 2: Open-label Phase-36 Months|On Treatment|1
5499560|NCT01664923|19015178|P2|Period 2: Open-label Phase-36 Months|Death|1
5499561|NCT01664923|19015179|P1|Period 2: Open-label Phase-36 Months|Death|3
5499562|NCT01664923|19015178|P2|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
5499563|NCT01664923|19015179|P1|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
5499564|NCT01664923|19015178|P2|Period1:Double Blind Phase-29 Months|Other|4
5499565|NCT01664923|19015179|P1|Period1:Double Blind Phase-29 Months|Other|3
5499566|NCT01664923|19015178|P2|Period1:Double Blind Phase-29 Months|Adverse Event|9
5499567|NCT01664923|19015179|P1|Period1:Double Blind Phase-29 Months|Adverse Event|14
5499568|NCT01664923|19015178|P2|Period1:Double Blind Phase-29 Months|Disease Progression|132
5499569|NCT01664923|19015179|P1|Period1:Double Blind Phase-29 Months|Disease Progression|65
5499570|NCT01664923|19015178|P2|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
5499571|NCT01664923|19015179|P1|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
5499572|NCT01664923|19015178|P2|Period1:Double Blind Phase-29 Months|Protocol Violation|0
5499573|NCT01664923|19015179|P1|Period1:Double Blind Phase-29 Months|Protocol Violation|2
5499574|NCT01664923|19015178|P2|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
5499575|NCT01664923|19015179|P1|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
5499576|NCT01664923|19015178|P2|Period1:Double Blind Phase-29 Months|Death|6
5499577|NCT01664923|19015179|P1|Period1:Double Blind Phase-29 Months|Death|8
5499578|NCT01664624|19015270|P4|Overall Study|Adverse Event|0
5499579|NCT01664624|19015271|P3|Overall Study|Adverse Event|0
5499580|NCT01664624|19015272|P2|Overall Study|Adverse Event|1
5499581|NCT01664624|19015273|P1|Overall Study|Adverse Event|0
5499582|NCT01664533|19015320|P1|Overall Study|Protocol Violation|3
5499583|NCT01664533|19015320|P1|Overall Study|Study termination|9
5499584|NCT01664533|19015320|P1|Overall Study|Lost to Follow-up|3
5499585|NCT01664533|19015320|P1|Overall Study|Death|42
5499586|NCT01664494|19015328|P1|Overall Study|Lost to Follow-up|99
5499587|NCT01664494|19015328|P1|Overall Study|Other|49
5499588|NCT01664494|19015328|P1|Overall Study|Death|18
5499589|NCT01664494|19015328|P1|Overall Study|Withdrawal by Subject|27
5499590|NCT01664247|19015335|P2|Overall Study|Unclassified|29
5499591|NCT01664247|19015336|P1|Overall Study|Unclassified|5
5499592|NCT01664247|19015335|P2|Overall Study|Withdrawal Criteria|4
5499593|NCT01664247|19015336|P1|Overall Study|Withdrawal Criteria|1
5499594|NCT01664247|19015335|P2|Overall Study|Protocol Violation|5
5499595|NCT01664247|19015336|P1|Overall Study|Protocol Violation|3
5499596|NCT01664247|19015335|P2|Overall Study|Adverse Event|3
5499597|NCT01664247|19015336|P1|Overall Study|Adverse Event|5
5499598|NCT01664130|19015358|P1|Overall Study|competing secondary disease|2
5499599|NCT01664104|19015436|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
5499600|NCT01664104|19015436|P1|Overall Study|Other|1
5499601|NCT01664104|19015436|P1|Overall Study|Lost to Follow-up|4
5499602|NCT01664104|19015436|P1|Overall Study|Withdrawal by Subject|1
5499603|NCT01664104|19015436|P1|Overall Study|Lack of Efficacy|2
5499604|NCT01664104|19015436|P1|Overall Study|Adverse Event|6
5499605|NCT01664091|19015503|P1|Overall Study|Withdrawal by Subject|1
5499606|NCT01664091|19015503|P1|Overall Study|Lost to Follow-up|2
5499607|NCT01664091|19015503|P1|Overall Study|Disease Progression|2
5499608|NCT01664091|19015503|P1|Overall Study|Death|1
5499609|NCT01664078|19015511|P1|Overall Study|Other|53
5499610|NCT01664078|19015511|P1|Overall Study|missed 5 year visit|1
5499611|NCT01664078|19015511|P1|Overall Study|Lost to Follow-up|2
5499612|NCT01664078|19015511|P1|Overall Study|Withdrawal by Subject|4
5499613|NCT01664078|19015511|P1|Overall Study|Death|9
5499614|NCT01664052|19015564|P2|Phase 2|No device placement|4
5499615|NCT01664052|19015565|P1|Phase 2|No device placement|0
5499616|NCT01664052|19015564|P2|Phase 1|No HSG 1 hr post placement|0
5499617|NCT01664052|19015565|P1|Phase 1|No HSG 1 hr post placement|1
5499618|NCT01664052|19015564|P2|Phase 1|No device placement|0
5499619|NCT01664052|19015565|P1|Phase 1|No device placement|6
5499620|NCT01664039|19015583|P2|Overall Study|Noncompliance|1
5499621|NCT01664039|19015584|P1|Overall Study|Noncompliance|1
5499622|NCT01664039|19015583|P2|Overall Study|Withdrawal by Subject|3
5499623|NCT01664039|19015584|P1|Overall Study|Withdrawal by Subject|1
5499624|NCT01664039|19015583|P2|Overall Study|Lost to Follow-up|1
5499625|NCT01664039|19015584|P1|Overall Study|Lost to Follow-up|1
5499626|NCT01664039|19015583|P2|Overall Study|Adverse Event|4
5499627|NCT01664039|19015584|P1|Overall Study|Adverse Event|3
5499628|NCT01663987|19015606|P2|Overall Study|Other reason not defined above|0
5499629|NCT01663987|19015607|P1|Overall Study|Other reason not defined above|3
5499630|NCT01663987|19015606|P2|Overall Study|Withdrawal by Subject|3
5499631|NCT01663987|19015607|P1|Overall Study|Withdrawal by Subject|2
5499632|NCT01663987|19015606|P2|Overall Study|Lost to Follow-up|1
5499633|NCT01663987|19015607|P1|Overall Study|Lost to Follow-up|1
5499634|NCT01663987|19015606|P2|Overall Study|Adverse Event|2
5499635|NCT01663987|19015607|P1|Overall Study|Adverse Event|7
5499636|NCT01663896|19015646|P1|Overall Study|Various reasons|43
5499637|NCT01663857|19015657|P4|Overall Study|Lost to Follow-up|1
5499638|NCT01663857|19015658|P3|Overall Study|Lost to Follow-up|3
5499639|NCT01663857|19015659|P2|Overall Study|Lost to Follow-up|0
5499640|NCT01663857|19015660|P1|Overall Study|Lost to Follow-up|0
5499641|NCT01663857|19015657|P4|Overall Study|Withdrew Consent to Study Participation|3
5499642|NCT01663857|19015658|P3|Overall Study|Withdrew Consent to Study Participation|7
5499643|NCT01663857|19015659|P2|Overall Study|Withdrew Consent to Study Participation|1
5499644|NCT01663857|19015660|P1|Overall Study|Withdrew Consent to Study Participation|0
5499645|NCT01663740|19015688|P2|Overall Study|No end of study status|0
5499646|NCT01663740|19015689|P1|Overall Study|No end of study status|3
5499647|NCT01663740|19015688|P2|Overall Study|Withdrawal by Subject|1
5499648|NCT01663740|19015689|P1|Overall Study|Withdrawal by Subject|2
5499649|NCT01663740|19015688|P2|Overall Study|Death|1
5499650|NCT01663740|19015689|P1|Overall Study|Death|0
5499651|NCT01663740|19015688|P2|Overall Study|Inclusion/Exclusion not met|0
5499652|NCT01663740|19015689|P1|Overall Study|Inclusion/Exclusion not met|1
5499653|NCT01663740|19015688|P2|Overall Study|Other|2
5499654|NCT01663740|19015689|P1|Overall Study|Other|9
5499655|NCT01663740|19015688|P2|Overall Study|Lost to Follow-up|4
5499656|NCT01663740|19015689|P1|Overall Study|Lost to Follow-up|1
5499657|NCT01663727|19015749|P2|Overall Study|Withdrawal prior to dosing.|0
5499658|NCT01663727|19015750|P1|Overall Study|Withdrawal prior to dosing.|1
5499659|NCT01663727|19015749|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
5499660|NCT01663727|19015750|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
5499661|NCT01663727|19015749|P2|Overall Study|Study Terminated|50
5499662|NCT01663727|19015750|P1|Overall Study|Study Terminated|51
5499663|NCT01663727|19015749|P2|Overall Study|Withdrawal by Subject|25
5499664|NCT01663727|19015750|P1|Overall Study|Withdrawal by Subject|18
5499665|NCT01663727|19015749|P2|Overall Study|Lost to Follow-up|8
5499666|NCT01663727|19015750|P1|Overall Study|Lost to Follow-up|10
5499667|NCT01663727|19015749|P2|Overall Study|Death|155
5499668|NCT01663727|19015750|P1|Overall Study|Death|161
5499669|NCT01663714|19015782|P1|Long-Term Follow-Up|Non-compliance|1
5499670|NCT01663714|19015782|P1|Long-Term Follow-Up|Death|4
5499671|NCT01663714|19015782|P1|Long-Term Follow-Up|Lost to Follow-up|1
5499672|NCT01663714|19015782|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
5499673|NCT01663714|19015782|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
5499674|NCT01663714|19015782|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
5499675|NCT01663636|19015811|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
5499676|NCT01663636|19015812|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
5499677|NCT01663623|19015820|P2|Overall Study|Withdrawal by Subject|1
5499678|NCT01663623|19015821|P1|Overall Study|Withdrawal by Subject|2
5499679|NCT01663623|19015820|P2|Overall Study|Physician Decision|4
5499680|NCT01663623|19015821|P1|Overall Study|Physician Decision|1
5499681|NCT01663623|19015820|P2|Overall Study|Other-Study closed/terminated|1
5499682|NCT01663623|19015821|P1|Overall Study|Other-Study closed/terminated|1
5499683|NCT01663623|19015820|P2|Overall Study|Protocol Violation|1
5499684|NCT01663623|19015821|P1|Overall Study|Protocol Violation|0
5499685|NCT01663623|19015820|P2|Overall Study|Lack of Efficacy|6
5499686|NCT01663623|19015821|P1|Overall Study|Lack of Efficacy|5
5499687|NCT01663623|19015820|P2|Overall Study|Adverse Event|7
5499688|NCT01663623|19015821|P1|Overall Study|Adverse Event|3
5499689|NCT01663532|19015831|P2|Overall Study|Lack of Efficacy|60
5499690|NCT01663532|19015832|P1|Overall Study|Lack of Efficacy|15
5499691|NCT01663532|19015831|P2|Overall Study|Withdrawal by Subject|17
5499692|NCT01663532|19015832|P1|Overall Study|Withdrawal by Subject|35
5499693|NCT01663532|19015831|P2|Overall Study|Physician Decision|1
5499694|NCT01663532|19015832|P1|Overall Study|Physician Decision|1
5499695|NCT01663532|19015831|P2|Overall Study|Met Withdrawal Criteria|6
5499696|NCT01663532|19015832|P1|Overall Study|Met Withdrawal Criteria|7
5499697|NCT01663532|19015831|P2|Overall Study|Adverse Event|13
5499698|NCT01663532|19015832|P1|Overall Study|Adverse Event|7
5499699|NCT01663532|19015831|P2|Overall Study|Lost to Follow-up|10
5499700|NCT01663532|19015832|P1|Overall Study|Lost to Follow-up|9
5499701|NCT01663506|19015850|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
5499702|NCT01663506|19015850|P1|Overall Study|Adverse Event|1
5499703|NCT01663506|19015850|P1|Overall Study|Lost to Follow-up|1
5499704|NCT01663506|19015850|P1|Overall Study|Consent Withdrawal by Subject|1
5499705|NCT01663506|19015850|P1|Overall Study|Lack of Efficacy|3
5499706|NCT01663402|19015881|P2|Overall Study|Other than specified above|147
5499707|NCT01663402|19015882|P1|Overall Study|Other than specified above|172
5499708|NCT01663402|19015881|P2|Overall Study|Lost to Follow-up|15
5499709|NCT01663402|19015882|P1|Overall Study|Lost to Follow-up|17
5499710|NCT01663402|19015881|P2|Overall Study|Related to study drug administration|105
5499711|NCT01663402|19015882|P1|Overall Study|Related to study drug administration|96
5499712|NCT01663402|19015881|P2|Overall Study|Withdrawal by Subject|91
5499713|NCT01663402|19015882|P1|Overall Study|Withdrawal by Subject|118
5499714|NCT01663402|19015881|P2|Overall Study|Participant moved|104
5499715|NCT01663402|19015882|P1|Overall Study|Participant moved|139
5499716|NCT01663402|19015881|P2|Overall Study|Site terminated by sponsor|3
5499717|NCT01663402|19015882|P1|Overall Study|Site terminated by sponsor|1
5499718|NCT01663402|19015881|P2|Overall Study|Physician Decision|62
5499719|NCT01663402|19015882|P1|Overall Study|Physician Decision|77
5499720|NCT01663402|19015881|P2|Overall Study|Poor compliance to protocol|454
5499721|NCT01663402|19015882|P1|Overall Study|Poor compliance to protocol|529
5499722|NCT01663402|19015881|P2|Overall Study|Two consecutive LDL-C <15 mg/dL|730
5499723|NCT01663402|19015882|P1|Overall Study|Two consecutive LDL-C <15 mg/dL|0
5499724|NCT01663402|19015881|P2|Overall Study|Adverse Event|362
5499725|NCT01663402|19015882|P1|Overall Study|Adverse Event|347
5499726|NCT01663402|19015881|P2|Overall Study|Randomized but not treated|11
5499727|NCT01663402|19015882|P1|Overall Study|Randomized but not treated|19
5499728|NCT01663233|19015945|P2|Overall Study|Lost to Follow-up|1
5499729|NCT01663233|19015946|P1|Overall Study|Lost to Follow-up|0
5499730|NCT01663233|19015945|P2|Overall Study|Protocol Deviation|4
5499731|NCT01663233|19015946|P1|Overall Study|Protocol Deviation|1
5499732|NCT01663233|19015945|P2|Overall Study|Withdrawal by Subject|2
5499733|NCT01663233|19015946|P1|Overall Study|Withdrawal by Subject|3
5499734|NCT01663103|19015970|P2|Overall Study|dog bite|0
5499735|NCT01663103|19015971|P1|Overall Study|dog bite|1
5499736|NCT01663103|19015970|P2|Overall Study|Adverse Event|0
5499737|NCT01663103|19015971|P1|Overall Study|Adverse Event|1
5499738|NCT01663103|19015970|P2|Overall Study|Withdrawal by Subject|2
5499739|NCT01663103|19015971|P1|Overall Study|Withdrawal by Subject|1
5499740|NCT01662999|19015999|P6|Period 3|Withdrawal by Subject|0
5499741|NCT01662999|19016000|P5|Period 3|Withdrawal by Subject|0
5499742|NCT01662999|19016001|P4|Period 3|Withdrawal by Subject|0
5499743|NCT01662999|19016002|P3|Period 3|Withdrawal by Subject|0
5499744|NCT01662999|19016003|P2|Period 3|Withdrawal by Subject|1
5499745|NCT01662999|19016004|P1|Period 3|Withdrawal by Subject|0
5499746|NCT01662986|19016075|P2|Overall Study|Other than stated above|0
5499747|NCT01662986|19016076|P1|Overall Study|Other than stated above|3
5499748|NCT01662986|19016075|P2|Overall Study|Not Treated|0
5499749|NCT01662986|19016076|P1|Overall Study|Not Treated|1
5499750|NCT01662986|19016075|P2|Overall Study|Withdrawal by Subject|2
5499751|NCT01662986|19016076|P1|Overall Study|Withdrawal by Subject|2
5499752|NCT01662986|19016075|P2|Overall Study|Lost to Follow-up|4
5499753|NCT01662986|19016076|P1|Overall Study|Lost to Follow-up|5
5499754|NCT01662986|19016075|P2|Overall Study|Protocol Violation|3
5499755|NCT01662986|19016076|P1|Overall Study|Protocol Violation|2
5499756|NCT01662986|19016075|P2|Overall Study|Adverse Event|4
5499757|NCT01662986|19016076|P1|Overall Study|Adverse Event|5
5499758|NCT01662895|19016164|P2|Overall Study|Lost to Follow-up|1
5499759|NCT01662895|19016165|P1|Overall Study|Lost to Follow-up|0
5499760|NCT01662648|19016289|P2|Overall Study|LOE and Participant non-compliant|1
5499761|NCT01662648|19016290|P1|Overall Study|LOE and Participant non-compliant|0
5499762|NCT01662648|19016289|P2|Overall Study|LOE and other reason unspecified|0
5499763|NCT01662648|19016290|P1|Overall Study|LOE and other reason unspecified|1
5499764|NCT01662648|19016289|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
5499765|NCT01662648|19016290|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
5499766|NCT01662648|19016289|P2|Overall Study|Other|11
5499767|NCT01662648|19016290|P1|Overall Study|Other|8
5499768|NCT01662648|19016289|P2|Overall Study|Participant non-compliant|20
5499769|NCT01662648|19016290|P1|Overall Study|Participant non-compliant|16
5499770|NCT01662648|19016289|P2|Overall Study|Withdrawal by Subject|53
5499771|NCT01662648|19016290|P1|Overall Study|Withdrawal by Subject|36
5499772|NCT01662648|19016289|P2|Overall Study|Lost to Follow-up|36
5499773|NCT01662648|19016290|P1|Overall Study|Lost to Follow-up|24
5499774|NCT01662648|19016289|P2|Overall Study|Participant ineligible to continue trial|1
5499775|NCT01662648|19016290|P1|Overall Study|Participant ineligible to continue trial|1
5499776|NCT01662648|19016289|P2|Overall Study|Lack of Efficacy|16
5499777|NCT01662648|19016290|P1|Overall Study|Lack of Efficacy|17
5499778|NCT01662648|19016289|P2|Overall Study|Adverse Event|37
5499779|NCT01662648|19016290|P1|Overall Study|Adverse Event|40
5499780|NCT01662648|19016289|P2|Overall Study|Death|3
5499781|NCT01662648|19016290|P1|Overall Study|Death|1
5499782|NCT01662635|19016312|P1|Overall Study|scarce samples for evaluation|30
5499783|NCT01662505|19016363|P3|Overall Study|Not specified above|2
5499784|NCT01662505|19016364|P2|Overall Study|Not specified above|3
5499785|NCT01662505|19016365|P1|Overall Study|Not specified above|1
5499786|NCT01662505|19016363|P3|Overall Study|Refused cont. medication|1
5499787|NCT01662505|19016364|P2|Overall Study|Refused cont. medication|0
5499788|NCT01662505|19016365|P1|Overall Study|Refused cont. medication|0
5499789|NCT01662505|19016363|P3|Overall Study|Progressive disease|5
5499790|NCT01662505|19016364|P2|Overall Study|Progressive disease|1
5499791|NCT01662505|19016365|P1|Overall Study|Progressive disease|6
5499792|NCT01662492|19016389|P3|Overall Study|Lack of Efficacy|2
5499793|NCT01662492|19016390|P2|Overall Study|Lack of Efficacy|1
5499794|NCT01662492|19016391|P1|Overall Study|Lack of Efficacy|1
5499795|NCT01662492|19016389|P3|Overall Study|Lost to Follow-up|2
5499796|NCT01662492|19016390|P2|Overall Study|Lost to Follow-up|0
5499797|NCT01662492|19016391|P1|Overall Study|Lost to Follow-up|0
5499798|NCT01662492|19016389|P3|Overall Study|Protocol Violation|0
5499799|NCT01662492|19016390|P2|Overall Study|Protocol Violation|0
5499800|NCT01662492|19016391|P1|Overall Study|Protocol Violation|1
5499801|NCT01662492|19016389|P3|Overall Study|Withdrawal by Subject|1
5499802|NCT01662492|19016390|P2|Overall Study|Withdrawal by Subject|0
5499803|NCT01662492|19016391|P1|Overall Study|Withdrawal by Subject|0
5499804|NCT01662492|19016389|P3|Overall Study|Other miscellaneous reasons.|1
5499805|NCT01662492|19016390|P2|Overall Study|Other miscellaneous reasons.|0
5499806|NCT01662492|19016391|P1|Overall Study|Other miscellaneous reasons.|1
5499807|NCT01662440|19016415|P4|Overall Study|Withdrawal by Subject|2
5499808|NCT01662440|19016416|P3|Overall Study|Withdrawal by Subject|2
5499809|NCT01662440|19016417|P2|Overall Study|Withdrawal by Subject|2
5499810|NCT01662440|19016418|P1|Overall Study|Withdrawal by Subject|5
5499811|NCT01662440|19016415|P4|Overall Study|Protocol Violation|0
5499812|NCT01662440|19016416|P3|Overall Study|Protocol Violation|0
5499813|NCT01662440|19016417|P2|Overall Study|Protocol Violation|0
5499814|NCT01662440|19016418|P1|Overall Study|Protocol Violation|1
5499815|NCT01662440|19016415|P4|Overall Study|Subject moved to another country.|0
5499816|NCT01662440|19016416|P3|Overall Study|Subject moved to another country.|0
5499817|NCT01662440|19016417|P2|Overall Study|Subject moved to another country.|1
5499818|NCT01662440|19016418|P1|Overall Study|Subject moved to another country.|0
5499819|NCT01662440|19016415|P4|Overall Study|Lost to Follow-up|1
5499820|NCT01662440|19016416|P3|Overall Study|Lost to Follow-up|4
5499821|NCT01662440|19016417|P2|Overall Study|Lost to Follow-up|2
5499822|NCT01662440|19016418|P1|Overall Study|Lost to Follow-up|2
5499823|NCT01662440|19016415|P4|Overall Study|Death|0
5499824|NCT01662440|19016416|P3|Overall Study|Death|0
5499825|NCT01662440|19016417|P2|Overall Study|Death|1
5499826|NCT01662440|19016418|P1|Overall Study|Death|0
5499827|NCT01662440|19016415|P4|Overall Study|Adverse Event|1
5499828|NCT01662440|19016416|P3|Overall Study|Adverse Event|0
5499829|NCT01662440|19016417|P2|Overall Study|Adverse Event|0
5499830|NCT01662440|19016418|P1|Overall Study|Adverse Event|1
5499831|NCT01662362|19016466|P1|Overall Study|Lost to Follow-up|38
5499832|NCT01662336|19016471|P1|Overall Study|Withdrawal by Subject|6
5499833|NCT01662336|19016471|P1|Overall Study|Other|29
5499834|NCT01662336|19016471|P1|Overall Study|No longer on LPV/r|30
5499835|NCT01662336|19016471|P1|Overall Study|Adverse Event|1
5499836|NCT01662310|19016497|P5|Open-Label Extension Phase|Withdrawal by Subject|7
5499837|NCT01662310|19016498|P4|Open-Label Extension Phase|Withdrawal by Subject|2
5499838|NCT01662310|19016499|P3|Open-Label Extension Phase|Withdrawal by Subject|0
5499839|NCT01662310|19016500|P2|Open-Label Extension Phase|Withdrawal by Subject|0
5499840|NCT01662310|19016501|P1|Open-Label Extension Phase|Withdrawal by Subject|0
5499841|NCT01662310|19016497|P5|Open-Label Extension Phase|Pregnancy|0
5499842|NCT01662310|19016498|P4|Open-Label Extension Phase|Pregnancy|1
5499843|NCT01662310|19016499|P3|Open-Label Extension Phase|Pregnancy|0
5499844|NCT01662310|19016500|P2|Open-Label Extension Phase|Pregnancy|0
5499845|NCT01662310|19016501|P1|Open-Label Extension Phase|Pregnancy|0
5499846|NCT01662310|19016497|P5|Open-Label Extension Phase|Lost to Follow-up|1
5499847|NCT01662310|19016498|P4|Open-Label Extension Phase|Lost to Follow-up|2
5499848|NCT01662310|19016499|P3|Open-Label Extension Phase|Lost to Follow-up|0
5499849|NCT01662310|19016500|P2|Open-Label Extension Phase|Lost to Follow-up|0
5499850|NCT01662310|19016501|P1|Open-Label Extension Phase|Lost to Follow-up|0
5499851|NCT01662310|19016497|P5|Open-Label Extension Phase|Lack of Efficacy|2
5499852|NCT01662310|19016498|P4|Open-Label Extension Phase|Lack of Efficacy|2
5499853|NCT01662310|19016499|P3|Open-Label Extension Phase|Lack of Efficacy|0
5499854|NCT01662310|19016500|P2|Open-Label Extension Phase|Lack of Efficacy|0
5499855|NCT01662310|19016501|P1|Open-Label Extension Phase|Lack of Efficacy|0
5499856|NCT01662310|19016497|P5|Open-Label Extension Phase|Death|0
5499857|NCT01662310|19016498|P4|Open-Label Extension Phase|Death|1
5499858|NCT01662310|19016499|P3|Open-Label Extension Phase|Death|0
5499859|NCT01662310|19016500|P2|Open-Label Extension Phase|Death|0
5499860|NCT01662310|19016501|P1|Open-Label Extension Phase|Death|0
5499861|NCT01662310|19016497|P5|Open-Label Extension Phase|Adverse Event|0
5499862|NCT01662310|19016498|P4|Open-Label Extension Phase|Adverse Event|3
5499863|NCT01662310|19016499|P3|Open-Label Extension Phase|Adverse Event|0
5499864|NCT01662310|19016500|P2|Open-Label Extension Phase|Adverse Event|0
5499865|NCT01662310|19016501|P1|Open-Label Extension Phase|Adverse Event|0
5499866|NCT01662310|19016497|P5|Double-Blind Phase|Randomized but not treated|0
5499867|NCT01662310|19016498|P4|Double-Blind Phase|Randomized but not treated|0
5499868|NCT01662310|19016499|P3|Double-Blind Phase|Randomized but not treated|0
5499869|NCT01662310|19016500|P2|Double-Blind Phase|Randomized but not treated|1
5499870|NCT01662310|19016501|P1|Double-Blind Phase|Randomized but not treated|0
5499871|NCT01662310|19016497|P5|Double-Blind Phase|Other|0
5499872|NCT01662310|19016498|P4|Double-Blind Phase|Other|0
5499873|NCT01662310|19016499|P3|Double-Blind Phase|Other|1
5499874|NCT01662310|19016500|P2|Double-Blind Phase|Other|0
5499875|NCT01662310|19016501|P1|Double-Blind Phase|Other|0
5499876|NCT01662310|19016497|P5|Double-Blind Phase|Withdrawal by Subject|0
5499877|NCT01662310|19016498|P4|Double-Blind Phase|Withdrawal by Subject|0
5499878|NCT01662310|19016499|P3|Double-Blind Phase|Withdrawal by Subject|3
5499879|NCT01662310|19016500|P2|Double-Blind Phase|Withdrawal by Subject|9
5499880|NCT01662310|19016501|P1|Double-Blind Phase|Withdrawal by Subject|0
5499881|NCT01662310|19016497|P5|Double-Blind Phase|Pregnancy|0
5499882|NCT01662310|19016498|P4|Double-Blind Phase|Pregnancy|0
5499883|NCT01662310|19016499|P3|Double-Blind Phase|Pregnancy|0
5499884|NCT01662310|19016500|P2|Double-Blind Phase|Pregnancy|2
5499885|NCT01662310|19016501|P1|Double-Blind Phase|Pregnancy|0
5499886|NCT01662310|19016497|P5|Double-Blind Phase|Lost to Follow-up|0
5499887|NCT01662310|19016498|P4|Double-Blind Phase|Lost to Follow-up|0
5499888|NCT01662310|19016499|P3|Double-Blind Phase|Lost to Follow-up|0
5499889|NCT01662310|19016500|P2|Double-Blind Phase|Lost to Follow-up|3
5499890|NCT01662310|19016501|P1|Double-Blind Phase|Lost to Follow-up|0
5499891|NCT01662310|19016497|P5|Double-Blind Phase|Adverse Event|0
5499892|NCT01662310|19016498|P4|Double-Blind Phase|Adverse Event|0
5499893|NCT01662310|19016499|P3|Double-Blind Phase|Adverse Event|1
5499894|NCT01662310|19016500|P2|Double-Blind Phase|Adverse Event|0
5499895|NCT01662310|19016501|P1|Double-Blind Phase|Adverse Event|0
5499896|NCT01662310|19016497|P5|Run-In or Stabilization Phase|Other|0
5499897|NCT01662310|19016498|P4|Run-In or Stabilization Phase|Other|0
5499898|NCT01662310|19016499|P3|Run-In or Stabilization Phase|Other|0
5499899|NCT01662310|19016500|P2|Run-In or Stabilization Phase|Other|0
5499900|NCT01662310|19016501|P1|Run-In or Stabilization Phase|Other|1
5499901|NCT01662310|19016497|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
5499902|NCT01662310|19016498|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
5499903|NCT01662310|19016499|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
5499904|NCT01662310|19016500|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
5499905|NCT01662310|19016501|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
5499906|NCT01662310|19016497|P5|Run-In or Stabilization Phase|Protocol Violation|0
5499907|NCT01662310|19016498|P4|Run-In or Stabilization Phase|Protocol Violation|0
5499908|NCT01662310|19016499|P3|Run-In or Stabilization Phase|Protocol Violation|0
5499909|NCT01662310|19016500|P2|Run-In or Stabilization Phase|Protocol Violation|0
5499910|NCT01662310|19016501|P1|Run-In or Stabilization Phase|Protocol Violation|15
5499911|NCT01662310|19016497|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
5499912|NCT01662310|19016498|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
5499913|NCT01662310|19016499|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
5499914|NCT01662310|19016500|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
5499915|NCT01662310|19016501|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
5499916|NCT01662310|19016497|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
5499917|NCT01662310|19016498|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
5499918|NCT01662310|19016499|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
5499919|NCT01662310|19016500|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
5499920|NCT01662310|19016501|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
5499921|NCT01662310|19016497|P5|Run-In or Stabilization Phase|Adverse Event|0
5499922|NCT01662310|19016498|P4|Run-In or Stabilization Phase|Adverse Event|0
5499923|NCT01662310|19016499|P3|Run-In or Stabilization Phase|Adverse Event|0
5499924|NCT01662310|19016500|P2|Run-In or Stabilization Phase|Adverse Event|0
5499925|NCT01662310|19016501|P1|Run-In or Stabilization Phase|Adverse Event|11
5499926|NCT01662102|19016582|P2|Overall Study|Sponsor's decision|0
5499927|NCT01662102|19016583|P1|Overall Study|Sponsor's decision|1
5499928|NCT01662063|19016591|P3|Overall Study|Other|0
5499929|NCT01662063|19016592|P2|Overall Study|Other|1
5499930|NCT01662063|19016593|P1|Overall Study|Other|0
5499931|NCT01662063|19016591|P3|Overall Study|Physician Decision|0
5499932|NCT01662063|19016592|P2|Overall Study|Physician Decision|2
5499933|NCT01662063|19016593|P1|Overall Study|Physician Decision|0
5499934|NCT01662063|19016591|P3|Overall Study|Withdrawal by Subject|1
5499935|NCT01662063|19016592|P2|Overall Study|Withdrawal by Subject|4
5499936|NCT01662063|19016593|P1|Overall Study|Withdrawal by Subject|2
5499937|NCT01662063|19016591|P3|Overall Study|Protocol Violation|0
5499938|NCT01662063|19016592|P2|Overall Study|Protocol Violation|0
5499939|NCT01662063|19016593|P1|Overall Study|Protocol Violation|1
5499940|NCT01662063|19016591|P3|Overall Study|Lost to Follow-up|0
5499941|NCT01662063|19016592|P2|Overall Study|Lost to Follow-up|4
5499942|NCT01662063|19016593|P1|Overall Study|Lost to Follow-up|0
5499943|NCT01662063|19016591|P3|Overall Study|Lack of Efficacy|0
5499944|NCT01662063|19016592|P2|Overall Study|Lack of Efficacy|6
5499945|NCT01662063|19016593|P1|Overall Study|Lack of Efficacy|1
5499946|NCT01662063|19016591|P3|Overall Study|Adverse Event or Intercurrent Illness|0
5499947|NCT01662063|19016592|P2|Overall Study|Adverse Event or Intercurrent Illness|12
5499948|NCT01662063|19016593|P1|Overall Study|Adverse Event or Intercurrent Illness|1
5499949|NCT01662024|19016672|P1|Overall Study|Withdrawal by Subject|3
5499950|NCT01662024|19016672|P1|Overall Study|Pregnancy|2
5499951|NCT01661972|19016684|P2|Overall Study|Withdrawal by Subject|1
5499952|NCT01661972|19016685|P1|Overall Study|Withdrawal by Subject|0
5499953|NCT01661972|19016684|P2|Overall Study|Death during Treatment period|1
5499954|NCT01661972|19016685|P1|Overall Study|Death during Treatment period|1
5499955|NCT01661972|19016684|P2|Overall Study|Adverse Event|2
5499956|NCT01661972|19016685|P1|Overall Study|Adverse Event|1
5499957|NCT01661933|19016704|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
5499958|NCT01661933|19016704|P1|Low-dose Gluten Challenge|Physician Decision|2
5499959|NCT01661881|19016711|P1|Overall Study|Disease Progression|1
5499960|NCT01661790|19016719|P2|Overall Study|Lost to Follow-up|2
5499961|NCT01661790|19016720|P1|Overall Study|Lost to Follow-up|0
5499962|NCT01661686|19016820|P2|Overall Study|did not receive allocated intervention|1
5499963|NCT01661686|19016821|P1|Overall Study|did not receive allocated intervention|0
5499964|NCT01661686|19016820|P2|Overall Study|Lost to Follow-up|1
5499965|NCT01661686|19016821|P1|Overall Study|Lost to Follow-up|2
5499966|NCT01661595|19016862|P4|Phase 2: Week 5-8.|Protocol Violation|0
5499967|NCT01661595|19016863|P3|Phase 2: Week 5-8.|Protocol Violation|1
5499968|NCT01661595|19016864|P2|Phase 2: Week 5-8.|Protocol Violation|0
5499969|NCT01661595|19016865|P1|Phase 2: Week 5-8.|Protocol Violation|0
5499970|NCT01661595|19016862|P4|Phase 1: Week 0-4|Adverse Event|0
5499971|NCT01661595|19016863|P3|Phase 1: Week 0-4|Adverse Event|0
5499972|NCT01661595|19016864|P2|Phase 1: Week 0-4|Adverse Event|0
5499973|NCT01661595|19016865|P1|Phase 1: Week 0-4|Adverse Event|1
5499974|NCT01661205|19016993|P1|Overall Study|Physician Decision|2
5499975|NCT01661179|19017004|P1|Overall Study|Other Eligibility criteria|4
5499976|NCT01661179|19017004|P1|Overall Study|Withdrawal by Subject|1
5499977|NCT01661179|19017004|P1|Overall Study|Death|1
5499978|NCT01661140|19017008|P3|Double-Blind Period|Administrative/Other|6
5499979|NCT01661140|19017009|P2|Double-Blind Period|Administrative/Other|7
5499980|NCT01661140|19017010|P1|Double-Blind Period|Administrative/Other|0
5499981|NCT01661140|19017008|P3|Double-Blind Period|Sponsor Termination|17
5499982|NCT01661140|19017009|P2|Double-Blind Period|Sponsor Termination|14
5499983|NCT01661140|19017010|P1|Double-Blind Period|Sponsor Termination|0
5499984|NCT01661140|19017008|P3|Double-Blind Period|Investigator's Decision|2
5499985|NCT01661140|19017009|P2|Double-Blind Period|Investigator's Decision|1
5499986|NCT01661140|19017010|P1|Double-Blind Period|Investigator's Decision|0
5499987|NCT01661140|19017008|P3|Double-Blind Period|Withdrawal by Subject|3
5499988|NCT01661140|19017009|P2|Double-Blind Period|Withdrawal by Subject|1
5499989|NCT01661140|19017010|P1|Double-Blind Period|Withdrawal by Subject|0
5499990|NCT01661140|19017008|P3|Double-Blind Period|Protocol Violation|3
5499991|NCT01661140|19017009|P2|Double-Blind Period|Protocol Violation|2
5499992|NCT01661140|19017010|P1|Double-Blind Period|Protocol Violation|0
5499993|NCT01661140|19017008|P3|Double-Blind Period|Adverse Event|18
5499994|NCT01661140|19017009|P2|Double-Blind Period|Adverse Event|16
5499995|NCT01661140|19017010|P1|Double-Blind Period|Adverse Event|0
5499996|NCT01661140|19017008|P3|Double-Blind Period|Refused Treatment|1
5499997|NCT01661140|19017009|P2|Double-Blind Period|Refused Treatment|0
5499998|NCT01661140|19017010|P1|Double-Blind Period|Refused Treatment|0
5499999|NCT01661140|19017008|P3|Open-Label Period|Lost to Follow-up|0
5500000|NCT01661140|19017009|P2|Open-Label Period|Lost to Follow-up|0
5500001|NCT01661140|19017010|P1|Open-Label Period|Lost to Follow-up|2
5500002|NCT01661140|19017008|P3|Open-Label Period|Did not meet EULAR criteria|0
5500003|NCT01661140|19017009|P2|Open-Label Period|Did not meet EULAR criteria|0
5500004|NCT01661140|19017010|P1|Open-Label Period|Did not meet EULAR criteria|1
5500005|NCT01661140|19017008|P3|Open-Label Period|Sponsor termination|0
5500006|NCT01661140|19017009|P2|Open-Label Period|Sponsor termination|0
5500007|NCT01661140|19017010|P1|Open-Label Period|Sponsor termination|16
5500008|NCT01661140|19017008|P3|Open-Label Period|Administrative/Other|0
5500009|NCT01661140|19017009|P2|Open-Label Period|Administrative/Other|0
5500010|NCT01661140|19017010|P1|Open-Label Period|Administrative/Other|1
5500011|NCT01661140|19017008|P3|Open-Label Period|Death|0
5500012|NCT01661140|19017009|P2|Open-Label Period|Death|0
5500013|NCT01661140|19017010|P1|Open-Label Period|Death|1
5500014|NCT01661140|19017008|P3|Open-Label Period|Investigator Decision|0
5500015|NCT01661140|19017009|P2|Open-Label Period|Investigator Decision|0
5500016|NCT01661140|19017010|P1|Open-Label Period|Investigator Decision|3
5500017|NCT01661140|19017008|P3|Open-Label Period|Withdrawal by Subject|0
5500018|NCT01661140|19017009|P2|Open-Label Period|Withdrawal by Subject|0
5500019|NCT01661140|19017010|P1|Open-Label Period|Withdrawal by Subject|5
5500020|NCT01661140|19017008|P3|Open-Label Period|Protocol Violation|0
5500021|NCT01661140|19017009|P2|Open-Label Period|Protocol Violation|0
5500022|NCT01661140|19017010|P1|Open-Label Period|Protocol Violation|3
5500023|NCT01661140|19017008|P3|Open-Label Period|Adverse Event|0
5500024|NCT01661140|19017009|P2|Open-Label Period|Adverse Event|0
5500025|NCT01661140|19017010|P1|Open-Label Period|Adverse Event|44
5500026|NCT01661062|19017062|P1|Overall Study|Withdrawal by Subject|2
5500027|NCT01661062|19017062|P1|Overall Study|Completed Treatment Off Study|3
5500028|NCT01660906|19017067|P1|Overall Study|Discontinued due to study drug toxicity|3
5500029|NCT01660763|19017150|P2|Overall Study|Patient ready for early discharge|4
5500030|NCT01660763|19017151|P1|Overall Study|Patient ready for early discharge|28
5500031|NCT01660763|19017150|P2|Overall Study|Withdrawal by Subject|0
5500032|NCT01660763|19017151|P1|Overall Study|Withdrawal by Subject|4
5500033|NCT01660763|19017150|P2|Overall Study|Protocol Violation|0
5500034|NCT01660763|19017151|P1|Overall Study|Protocol Violation|1
5500035|NCT01660763|19017150|P2|Overall Study|Adverse Event|7
5500036|NCT01660763|19017151|P1|Overall Study|Adverse Event|22
5500037|NCT01660763|19017150|P2|Overall Study|Lack of Efficacy|50
5500038|NCT01660763|19017151|P1|Overall Study|Lack of Efficacy|45
5500039|NCT01660451|19017199|P3|Overall Study|Ongoing with treatment|46
5500040|NCT01660451|19017200|P2|Overall Study|Ongoing with treatment|3
5500041|NCT01660451|19017201|P1|Overall Study|Ongoing with treatment|3
5500042|NCT01660451|19017199|P3|Overall Study|Withdrawal by Subject|16
5500043|NCT01660451|19017200|P2|Overall Study|Withdrawal by Subject|0
5500044|NCT01660451|19017201|P1|Overall Study|Withdrawal by Subject|1
5500045|NCT01660451|19017199|P3|Overall Study|Physician Decision|5
5500046|NCT01660451|19017200|P2|Overall Study|Physician Decision|2
5500047|NCT01660451|19017201|P1|Overall Study|Physician Decision|1
5500048|NCT01660451|19017199|P3|Overall Study|Protocol Deviation|1
5500049|NCT01660451|19017200|P2|Overall Study|Protocol Deviation|0
5500050|NCT01660451|19017201|P1|Overall Study|Protocol Deviation|0
5500051|NCT01660451|19017199|P3|Overall Study|Sponsor Decision|1
5500052|NCT01660451|19017200|P2|Overall Study|Sponsor Decision|0
5500053|NCT01660451|19017201|P1|Overall Study|Sponsor Decision|0
5500054|NCT01660451|19017199|P3|Overall Study|AE with Clinical PD|9
5500055|NCT01660451|19017200|P2|Overall Study|AE with Clinical PD|3
5500056|NCT01660451|19017201|P1|Overall Study|AE with Clinical PD|1
5500057|NCT01660451|19017199|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
5500058|NCT01660451|19017200|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
5500059|NCT01660451|19017201|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
5500060|NCT01660451|19017199|P3|Overall Study|Protocol Violation|1
5500061|NCT01660451|19017200|P2|Overall Study|Protocol Violation|1
5500062|NCT01660451|19017201|P1|Overall Study|Protocol Violation|0
5500063|NCT01660412|19017229|P2|Overall Study|Protocol Violation|3
5500064|NCT01660412|19017230|P1|Overall Study|Protocol Violation|0
5500065|NCT01660334|19017236|P1|Overall Study|Lost to Follow-up|1
5500066|NCT01660022|19017479|P6|First Sequence (7 Days)|Protocol Violation|1
5500067|NCT01660022|19017480|P5|First Sequence (7 Days)|Protocol Violation|0
5500068|NCT01660022|19017481|P4|First Sequence (7 Days)|Protocol Violation|0
5500069|NCT01660022|19017482|P3|First Sequence (7 Days)|Protocol Violation|0
5500070|NCT01660022|19017483|P2|First Sequence (7 Days)|Protocol Violation|0
5500071|NCT01660022|19017484|P1|First Sequence (7 Days)|Protocol Violation|0
5500072|NCT01660022|19017479|P6|First Sequence (7 Days)|Adverse Event|3
5500073|NCT01660022|19017480|P5|First Sequence (7 Days)|Adverse Event|1
5500074|NCT01660022|19017481|P4|First Sequence (7 Days)|Adverse Event|0
5500075|NCT01660022|19017482|P3|First Sequence (7 Days)|Adverse Event|0
5500076|NCT01660022|19017483|P2|First Sequence (7 Days)|Adverse Event|0
5500077|NCT01660022|19017484|P1|First Sequence (7 Days)|Adverse Event|0
5500078|NCT01660022|19017479|P6|First Sequence (7 Days)|Withdrawal by Subject|0
5500079|NCT01660022|19017480|P5|First Sequence (7 Days)|Withdrawal by Subject|0
5500080|NCT01660022|19017481|P4|First Sequence (7 Days)|Withdrawal by Subject|1
5500081|NCT01660022|19017482|P3|First Sequence (7 Days)|Withdrawal by Subject|0
5500082|NCT01660022|19017483|P2|First Sequence (7 Days)|Withdrawal by Subject|1
5500083|NCT01660022|19017484|P1|First Sequence (7 Days)|Withdrawal by Subject|0
5500084|NCT01659996|19017543|P3|Overall Study|Withdrawal by Subject|5
5500085|NCT01659996|19017544|P2|Overall Study|Withdrawal by Subject|1
5500086|NCT01659996|19017545|P1|Overall Study|Withdrawal by Subject|4
5500087|NCT01659996|19017543|P3|Overall Study|Adverse Event|1
5500088|NCT01659996|19017544|P2|Overall Study|Adverse Event|0
5500089|NCT01659996|19017545|P1|Overall Study|Adverse Event|0
5500090|NCT01659996|19017543|P3|Overall Study|Lost to Follow-up|2
5500091|NCT01659996|19017544|P2|Overall Study|Lost to Follow-up|3
5500092|NCT01659996|19017545|P1|Overall Study|Lost to Follow-up|1
5500093|NCT01659996|19017543|P3|Overall Study|Protocol Violation|3
5500094|NCT01659996|19017544|P2|Overall Study|Protocol Violation|3
5500095|NCT01659996|19017545|P1|Overall Study|Protocol Violation|3
5500096|NCT01659853|19017586|P2|Washout , 3 to 7 Days|Protocol Violation|0
5500097|NCT01659853|19017587|P1|Washout , 3 to 7 Days|Protocol Violation|1
5500098|NCT01659853|19017586|P2|Washout , 3 to 7 Days|Adverse Event|0
5500099|NCT01659853|19017587|P1|Washout , 3 to 7 Days|Adverse Event|1
5500100|NCT01659736|19017597|P2|3-month Follow-up|Lost to Follow-up|1
5500101|NCT01659736|19017598|P1|3-month Follow-up|Lost to Follow-up|0
5500102|NCT01659736|19017597|P2|Treatment Period|Withdrawal by Subject|0
5500103|NCT01659736|19017598|P1|Treatment Period|Withdrawal by Subject|1
5500104|NCT01659736|19017597|P2|Treatment Period|Protocol Violation|1
5500105|NCT01659736|19017598|P1|Treatment Period|Protocol Violation|3
5500106|NCT01659736|19017597|P2|Treatment Period|Adverse Event|1
5500107|NCT01659736|19017598|P1|Treatment Period|Adverse Event|1
5500108|NCT01659567|19017612|P1|Overall Study|Other|13
5500109|NCT01659567|19017612|P1|Overall Study|Progression of the main disease|1
5500110|NCT01659567|19017612|P1|Overall Study|Withdrawal by Subject|64
5500111|NCT01659567|19017612|P1|Overall Study|Good result at early stage of treatment|5
5500112|NCT01659567|19017612|P1|Overall Study|Adverse Event|12
5500113|NCT01659567|19017612|P1|Overall Study|Switched to Pegferon|6
5500114|NCT01659567|19017612|P1|Overall Study|Lack of Efficacy|22
5500115|NCT01659554|19017629|P1|Overall Study|Study Termination|4
5500116|NCT01659320|19017636|P1|Overall Study|Physician Decision|1
5500117|NCT01659320|19017636|P1|Overall Study|Withdrawal by Subject|2
5500118|NCT01659125|19017655|P1|Overall Study|Failed to Start Treatment|2
5500119|NCT01659125|19017655|P1|Overall Study|Time Constraints|2
5500120|NCT01659125|19017655|P1|Overall Study|Technical Problem|1
5500121|NCT01659125|19017655|P1|Overall Study|Lost to Follow-up|7
5500122|NCT01659125|19017655|P1|Overall Study|Withdrawal by Subject|2
5500123|NCT01659021|19017662|P2|Long-Term Follow Up|Withdrawal by Subject|1
5500124|NCT01659021|19017663|P1|Long-Term Follow Up|Withdrawal by Subject|2
5500125|NCT01659021|19017662|P2|Long-Term Follow Up|Lost to Follow-up|3
5500126|NCT01659021|19017663|P1|Long-Term Follow Up|Lost to Follow-up|3
5500127|NCT01659021|19017662|P2|Main Study|Study Terminated by Sponsor|1
5500128|NCT01659021|19017663|P1|Main Study|Study Terminated by Sponsor|16
5500129|NCT01659021|19017662|P2|Main Study|Withdrawal by Subject|16
5500130|NCT01659021|19017663|P1|Main Study|Withdrawal by Subject|19
5500131|NCT01659021|19017662|P2|Main Study|Physician Decision|16
5500132|NCT01659021|19017663|P1|Main Study|Physician Decision|34
5500133|NCT01659021|19017662|P2|Main Study|Unknown Reasons|1
5500134|NCT01659021|19017663|P1|Main Study|Unknown Reasons|2
5500135|NCT01659021|19017662|P2|Main Study|Lost to Follow-up|0
5500136|NCT01659021|19017663|P1|Main Study|Lost to Follow-up|1
5500137|NCT01659021|19017662|P2|Main Study|Adverse Event|3
5500138|NCT01659021|19017663|P1|Main Study|Adverse Event|2
5500139|NCT01658943|19017681|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
5500140|NCT01658943|19017682|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
5500141|NCT01658943|19017681|P2|Overall Study|Not eligible|9
5500142|NCT01658943|19017682|P1|Overall Study|Not eligible|7
5500143|NCT01658943|19017681|P2|Overall Study|not protocol specified|1
5500144|NCT01658943|19017682|P1|Overall Study|not protocol specified|4
5500145|NCT01658943|19017681|P2|Overall Study|Death|2
5500146|NCT01658943|19017682|P1|Overall Study|Death|4
5500147|NCT01658943|19017681|P2|Overall Study|Progression/Relapse|40
5500148|NCT01658943|19017682|P1|Overall Study|Progression/Relapse|39
5500149|NCT01658943|19017681|P2|Overall Study|Withdrawal by Subject|2
5500150|NCT01658943|19017682|P1|Overall Study|Withdrawal by Subject|9
5500151|NCT01658943|19017681|P2|Overall Study|Adverse Event|13
5500152|NCT01658943|19017682|P1|Overall Study|Adverse Event|6
5500153|NCT01658904|19017697|P3|Overall Study|Principal Investigator discretion|0
5500154|NCT01658904|19017698|P2|Overall Study|Principal Investigator discretion|0
5500155|NCT01658904|19017699|P1|Overall Study|Principal Investigator discretion|2
5500156|NCT01658813|19017725|P1|Overall Study|Disease progression|3
5500157|NCT01658735|19017736|P3|Overall Study|Withdrawal by Subject|3
5500158|NCT01658735|19017737|P2|Overall Study|Withdrawal by Subject|5
5500159|NCT01658735|19017738|P1|Overall Study|Withdrawal by Subject|3
5500160|NCT01658735|19017736|P3|Overall Study|Protocol Violation|0
5500161|NCT01658735|19017737|P2|Overall Study|Protocol Violation|1
5500162|NCT01658735|19017738|P1|Overall Study|Protocol Violation|0
5500163|NCT01658735|19017736|P3|Overall Study|Lost to Follow-up|0
5500164|NCT01658735|19017737|P2|Overall Study|Lost to Follow-up|1
5500165|NCT01658735|19017738|P1|Overall Study|Lost to Follow-up|1
5500166|NCT01658735|19017736|P3|Overall Study|Lack of Efficacy|1
5500167|NCT01658735|19017737|P2|Overall Study|Lack of Efficacy|0
5500168|NCT01658735|19017738|P1|Overall Study|Lack of Efficacy|1
5500169|NCT01658579|19017780|P4|Treatment Period B|Other|1
5500170|NCT01658579|19017781|P3|Treatment Period B|Other|0
5500171|NCT01658579|19017782|P2|Treatment Period B|Other|0
5500172|NCT01658579|19017783|P1|Treatment Period B|Other|0
5500173|NCT01658579|19017780|P4|Treatment Period A|Adverse Event|0
5500174|NCT01658579|19017781|P3|Treatment Period A|Adverse Event|0
5500175|NCT01658579|19017782|P2|Treatment Period A|Adverse Event|0
5500176|NCT01658579|19017783|P1|Treatment Period A|Adverse Event|1
5500177|NCT01658579|19017780|P4|Treatment Period A|Other|1
5500178|NCT01658579|19017781|P3|Treatment Period A|Other|1
5500179|NCT01658579|19017782|P2|Treatment Period A|Other|0
5500180|NCT01658579|19017783|P1|Treatment Period A|Other|0
5500181|NCT01658514|19017811|P3|Overall Study|Protocol Violation|2
5500182|NCT01658514|19017812|P2|Overall Study|Protocol Violation|0
5500183|NCT01658514|19017813|P1|Overall Study|Protocol Violation|1
5500184|NCT01658436|19017824|P2|Overall Study|Death|0
5500185|NCT01658436|19017825|P1|Overall Study|Death|1
5500186|NCT01658436|19017824|P2|Overall Study|Subject/guardian decision|1
5500187|NCT01658436|19017825|P1|Overall Study|Subject/guardian decision|0
5500188|NCT01658436|19017824|P2|Overall Study|Study terminated by sponsor|1
5500189|NCT01658436|19017825|P1|Overall Study|Study terminated by sponsor|0
5500190|NCT01658436|19017824|P2|Overall Study|Progressive disease|4
5500191|NCT01658436|19017825|P1|Overall Study|Progressive disease|12
5500192|NCT01658436|19017824|P2|Overall Study|Physician Decision|0
5500193|NCT01658436|19017825|P1|Overall Study|Physician Decision|1
5500194|NCT01658436|19017824|P2|Overall Study|Adverse Event|5
5500195|NCT01658436|19017825|P1|Overall Study|Adverse Event|6
5500196|NCT01658150|19017845|P1|Overall Study|Withdrawal by Subject|1
5500197|NCT01658072|19017867|P2|Overall Study|Protocol Violation|2
5500198|NCT01658072|19017868|P1|Overall Study|Protocol Violation|4
5500199|NCT01658020|19017883|P2|Overall Study|Protocol Violation|1
5500200|NCT01658020|19017884|P1|Overall Study|Protocol Violation|0
5500201|NCT01658020|19017883|P2|Overall Study|Withdrawal by Subject|5
5500202|NCT01658020|19017884|P1|Overall Study|Withdrawal by Subject|4
5500203|NCT01658020|19017883|P2|Overall Study|Lost to Follow-up|0
5500204|NCT01658020|19017884|P1|Overall Study|Lost to Follow-up|1
5500205|NCT01658020|19017883|P2|Overall Study|Adverse Event|3
5500206|NCT01658020|19017884|P1|Overall Study|Adverse Event|3
5500207|NCT01657903|19017900|P1|Overall Study|Withdrawal by Subject|1
5500208|NCT01657903|19017900|P1|Overall Study|Lost to Follow-up|1
5500209|NCT01657877|19017922|P1|Overall Study|Other Reason|2
5500210|NCT01657877|19017922|P1|Overall Study|Adverse Event|2
5500211|NCT01657877|19017922|P1|Overall Study|Protocol Violation|6
5500212|NCT01657877|19017922|P1|Overall Study|Withdrawal by Subject|4
5500213|NCT01657799|19017942|P3|Overall Study|Other|49
5500214|NCT01657799|19017943|P2|Overall Study|Other|62
5500215|NCT01657799|19017944|P1|Overall Study|Other|52
5500216|NCT01657799|19017942|P3|Overall Study|Radiographic & Clinical Progression|15
5500217|NCT01657799|19017943|P2|Overall Study|Radiographic & Clinical Progression|11
5500218|NCT01657799|19017944|P1|Overall Study|Radiographic & Clinical Progression|16
5500219|NCT01657799|19017942|P3|Overall Study|Progressive Disease Clinical|7
5500220|NCT01657799|19017943|P2|Overall Study|Progressive Disease Clinical|4
5500221|NCT01657799|19017944|P1|Overall Study|Progressive Disease Clinical|7
5500222|NCT01657799|19017942|P3|Overall Study|Disease Progression|4
5500223|NCT01657799|19017943|P2|Overall Study|Disease Progression|4
5500224|NCT01657799|19017944|P1|Overall Study|Disease Progression|2
5500225|NCT01657799|19017942|P3|Overall Study|Lost to Follow-up|1
5500226|NCT01657799|19017943|P2|Overall Study|Lost to Follow-up|0
5500227|NCT01657799|19017944|P1|Overall Study|Lost to Follow-up|1
5500228|NCT01657799|19017942|P3|Overall Study|Withdrawal by Subject|10
5500229|NCT01657799|19017943|P2|Overall Study|Withdrawal by Subject|10
5500230|NCT01657799|19017944|P1|Overall Study|Withdrawal by Subject|13
5500231|NCT01657799|19017942|P3|Overall Study|Adverse Event Not Related to Progression|4
5500232|NCT01657799|19017943|P2|Overall Study|Adverse Event Not Related to Progression|4
5500233|NCT01657799|19017944|P1|Overall Study|Adverse Event Not Related to Progression|5
5500234|NCT01657799|19017942|P3|Overall Study|Adverse Event Related to progression|12
5500235|NCT01657799|19017943|P2|Overall Study|Adverse Event Related to progression|8
5500236|NCT01657799|19017944|P1|Overall Study|Adverse Event Related to progression|6
5500237|NCT01657760|19017963|P4|Overall Study|Physician Decision|2
5500238|NCT01657760|19017964|P3|Overall Study|Physician Decision|1
5500239|NCT01657760|19017965|P2|Overall Study|Physician Decision|1
5500240|NCT01657760|19017966|P1|Overall Study|Physician Decision|1
5500241|NCT01657760|19017963|P4|Overall Study|Withdrawal by Subject|1
5500242|NCT01657760|19017964|P3|Overall Study|Withdrawal by Subject|0
5500243|NCT01657760|19017965|P2|Overall Study|Withdrawal by Subject|0
5500244|NCT01657760|19017966|P1|Overall Study|Withdrawal by Subject|0
5500245|NCT01657461|19017985|P2|Overall Study|Withdrawal by Subject|3
5500246|NCT01657461|19017986|P1|Overall Study|Withdrawal by Subject|1
5500247|NCT01657461|19017985|P2|Overall Study|Physician Decision|2
5500248|NCT01657461|19017986|P1|Overall Study|Physician Decision|0
5500249|NCT01657461|19017985|P2|Overall Study|Lost to Follow-up|3
5500250|NCT01657461|19017986|P1|Overall Study|Lost to Follow-up|0
5500251|NCT01657461|19017985|P2|Overall Study|Death|12
5500252|NCT01657461|19017986|P1|Overall Study|Death|9
5500253|NCT01657370|19018016|P6|Overall Study|Lost to Follow-up|1
5500254|NCT01657370|19018017|P5|Overall Study|Lost to Follow-up|0
5500255|NCT01657370|19018018|P4|Overall Study|Lost to Follow-up|0
5500256|NCT01657370|19018019|P3|Overall Study|Lost to Follow-up|1
5500257|NCT01657370|19018020|P2|Overall Study|Lost to Follow-up|0
5500258|NCT01657370|19018021|P1|Overall Study|Lost to Follow-up|2
5500259|NCT01657370|19018016|P6|Overall Study|Protocol Violation|0
5500260|NCT01657370|19018017|P5|Overall Study|Protocol Violation|0
5500261|NCT01657370|19018018|P4|Overall Study|Protocol Violation|1
5500262|NCT01657370|19018019|P3|Overall Study|Protocol Violation|1
5500263|NCT01657370|19018020|P2|Overall Study|Protocol Violation|1
5500264|NCT01657370|19018021|P1|Overall Study|Protocol Violation|1
5500265|NCT01657370|19018016|P6|Overall Study|Adverse Event|0
5500266|NCT01657370|19018017|P5|Overall Study|Adverse Event|1
5500267|NCT01657370|19018018|P4|Overall Study|Adverse Event|0
5500268|NCT01657370|19018019|P3|Overall Study|Adverse Event|0
5500269|NCT01657370|19018020|P2|Overall Study|Adverse Event|0
5500270|NCT01657370|19018021|P1|Overall Study|Adverse Event|0
5500271|NCT01657370|19018016|P6|Overall Study|Lack of Qualifying Event|2
5500272|NCT01657370|19018017|P5|Overall Study|Lack of Qualifying Event|1
5500273|NCT01657370|19018018|P4|Overall Study|Lack of Qualifying Event|2
5500274|NCT01657370|19018019|P3|Overall Study|Lack of Qualifying Event|3
5500275|NCT01657370|19018020|P2|Overall Study|Lack of Qualifying Event|0
5500276|NCT01657370|19018021|P1|Overall Study|Lack of Qualifying Event|1
5500277|NCT01657370|19018016|P6|Overall Study|Physician Decision|0
5500278|NCT01657370|19018017|P5|Overall Study|Physician Decision|5
5500279|NCT01657370|19018018|P4|Overall Study|Physician Decision|2
5500280|NCT01657370|19018019|P3|Overall Study|Physician Decision|1
5500281|NCT01657370|19018020|P2|Overall Study|Physician Decision|3
5500282|NCT01657370|19018021|P1|Overall Study|Physician Decision|2
5500283|NCT01657370|19018016|P6|Overall Study|Withdrawal by Subject|1
5500284|NCT01657370|19018017|P5|Overall Study|Withdrawal by Subject|0
5500285|NCT01657370|19018018|P4|Overall Study|Withdrawal by Subject|0
5500286|NCT01657370|19018019|P3|Overall Study|Withdrawal by Subject|1
5500287|NCT01657370|19018020|P2|Overall Study|Withdrawal by Subject|0
5500288|NCT01657370|19018021|P1|Overall Study|Withdrawal by Subject|0
5500289|NCT01657305|19018119|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
5500290|NCT01657305|19018119|P1|Overall Study|Lost to Follow-up|1
5500291|NCT01657305|19018119|P1|Overall Study|Adverse Event|1
5500292|NCT01657305|19018119|P1|Overall Study|Withdrawal by Subject|4
5500293|NCT01657305|19018119|P1|Overall Study|Lack of Wound Closure at Day 28|15
5500294|NCT01657292|19018169|P1|Overall Study|Change of therapy|1
5500295|NCT01657292|19018169|P1|Overall Study|Violation of eligibility criteria|1
5500296|NCT01657292|19018169|P1|Overall Study|Withdrawal by Subject|2
5500297|NCT01657292|19018169|P1|Overall Study|Adverse Event|6
5500298|NCT01657266|19018178|P2|Overall Study|Adverse Event|3
5500299|NCT01657266|19018179|P1|Overall Study|Adverse Event|2
5500300|NCT01657266|19018178|P2|Overall Study|Lost to Follow-up|2
5500301|NCT01657266|19018179|P1|Overall Study|Lost to Follow-up|2
5500302|NCT01657253|19018201|P2|Overall Study|Adverse Event|1
5500303|NCT01657253|19018202|P1|Overall Study|Adverse Event|0
5500304|NCT01657253|19018201|P2|Overall Study|Withdrawal by Subject|12
5500305|NCT01657253|19018202|P1|Overall Study|Withdrawal by Subject|11
5500306|NCT01657253|19018201|P2|Overall Study|Lost to Follow-up|5
5500307|NCT01657253|19018202|P1|Overall Study|Lost to Follow-up|6
5500308|NCT01657162|19018214|P2|Overall Study|Other than Specified|2
5500309|NCT01657162|19018215|P1|Overall Study|Other than Specified|0
5500310|NCT01657162|19018214|P2|Overall Study|Hypersensitivity to Alendronate|1
5500311|NCT01657162|19018215|P1|Overall Study|Hypersensitivity to Alendronate|0
5500312|NCT01657162|19018214|P2|Overall Study|Protocol Violation|0
5500313|NCT01657162|19018215|P1|Overall Study|Protocol Violation|1
5500314|NCT01657162|19018214|P2|Overall Study|Inability to Complete Study Procedures|7
5500315|NCT01657162|19018215|P1|Overall Study|Inability to Complete Study Procedures|1
5500316|NCT01657162|19018214|P2|Overall Study|Death|3
5500317|NCT01657162|19018215|P1|Overall Study|Death|2
5500318|NCT01657162|19018214|P2|Overall Study|Lost to Follow-up|4
5500319|NCT01657162|19018215|P1|Overall Study|Lost to Follow-up|3
5500320|NCT01657162|19018214|P2|Overall Study|Refusal of Treatment|6
5500321|NCT01657162|19018215|P1|Overall Study|Refusal of Treatment|4
5500322|NCT01657162|19018214|P2|Overall Study|Continuing Significant Deterioration|3
5500323|NCT01657162|19018215|P1|Overall Study|Continuing Significant Deterioration|9
5500324|NCT01657162|19018214|P2|Overall Study|Withdrawal by Subject|13
5500325|NCT01657162|19018215|P1|Overall Study|Withdrawal by Subject|13
5500326|NCT01657162|19018214|P2|Overall Study|Adverse Event|36
5500327|NCT01657162|19018215|P1|Overall Study|Adverse Event|26
5500328|NCT01657032|19018243|P2|Overall Study|Lost to Follow-up|7
5500329|NCT01657032|19018244|P1|Overall Study|Lost to Follow-up|0
5500330|NCT01657019|19018270|P1|Overall Study|Other|58
5500331|NCT01657019|19018270|P1|Overall Study|Lack of Efficacy|3
5500332|NCT01657019|19018270|P1|Overall Study|Protocol Violation|6
5500333|NCT01657019|19018270|P1|Overall Study|Lost to Follow-up|48
5500334|NCT01657019|19018270|P1|Overall Study|Adverse Event|55
5500335|NCT01657019|19018270|P1|Overall Study|Withdrawal by Subject|65
5500336|NCT01656967|19018284|P2|Overall Study|unsuccessful ETT insertion|2
5500337|NCT01656967|19018285|P1|Overall Study|unsuccessful ETT insertion|3
5500338|NCT01656967|19018284|P2|Overall Study|faulty monitor|0
5500339|NCT01656967|19018285|P1|Overall Study|faulty monitor|1
5500340|NCT01656889|19018311|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
5500341|NCT01656889|19018312|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
5500342|NCT01656889|19018311|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
5500343|NCT01656889|19018312|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
5500344|NCT01656889|19018311|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
5500345|NCT01656889|19018312|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
5500346|NCT01656889|19018311|P2|Post Treatment Follow-Up, 3 Months|Death|5
5500347|NCT01656889|19018312|P1|Post Treatment Follow-Up, 3 Months|Death|1
5500348|NCT01656889|19018311|P2|Treatment Period, 12 Weeks|Moved out of the area|2
5500349|NCT01656889|19018312|P1|Treatment Period, 12 Weeks|Moved out of the area|0
5500350|NCT01656889|19018311|P2|Treatment Period, 12 Weeks|Protocol Violation|1
5500351|NCT01656889|19018312|P1|Treatment Period, 12 Weeks|Protocol Violation|0
5500352|NCT01656889|19018311|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
5500353|NCT01656889|19018312|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
5500354|NCT01656889|19018311|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
5500355|NCT01656889|19018312|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
5500356|NCT01656889|19018311|P2|Treatment Period, 12 Weeks|Death|1
5500357|NCT01656889|19018312|P1|Treatment Period, 12 Weeks|Death|0
5500358|NCT01656889|19018311|P2|Treatment Period, 12 Weeks|Adverse Event|4
5500359|NCT01656889|19018312|P1|Treatment Period, 12 Weeks|Adverse Event|10
5500360|NCT01656850|19018332|P2|First Intervention (3 Months)|Withdrawal by Subject|4
5500361|NCT01656850|19018333|P1|First Intervention (3 Months)|Withdrawal by Subject|3
5500362|NCT01656759|19018424|P2|Overall Study|Protocol Violation|3
5500363|NCT01656759|19018425|P1|Overall Study|Protocol Violation|2
5500364|NCT01656733|19018439|P2|Overall Study|Spontaneous abortion|1
5500365|NCT01656733|19018440|P1|Overall Study|Spontaneous abortion|0
5500366|NCT01656733|19018439|P2|Overall Study|Delivery at another hospital|2
5500367|NCT01656733|19018440|P1|Overall Study|Delivery at another hospital|0
5500368|NCT01656733|19018439|P2|Overall Study|No permission to collect birth outcomes|1
5500369|NCT01656733|19018440|P1|Overall Study|No permission to collect birth outcomes|0
5500370|NCT01656434|19018490|P2|Overall Study|Withdrawal by Subject|7
5500371|NCT01656434|19018491|P1|Overall Study|Withdrawal by Subject|64
5500372|NCT01656434|19018490|P2|Overall Study|Participant withdrew consent|9
5500373|NCT01656434|19018491|P1|Overall Study|Participant withdrew consent|28
5500374|NCT01656434|19018490|P2|Overall Study|Participant moved|12
5500375|NCT01656434|19018491|P1|Overall Study|Participant moved|40
5500376|NCT01656434|19018490|P2|Overall Study|Non-compliance with protocol|15
5500377|NCT01656434|19018491|P1|Overall Study|Non-compliance with protocol|39
5500378|NCT01656434|19018490|P2|Overall Study|Part. discontinued; unrelated to drug|10
5500379|NCT01656434|19018491|P1|Overall Study|Part. discontinued; unrelated to drug|55
5500380|NCT01656434|19018490|P2|Overall Study|Participant discontinued; drug related|4
5500381|NCT01656434|19018491|P1|Overall Study|Participant discontinued; drug related|13
5500382|NCT01656434|19018490|P2|Overall Study|Study terminated by sponsor|348
5500383|NCT01656434|19018491|P1|Overall Study|Study terminated by sponsor|1501
5500384|NCT01656434|19018490|P2|Overall Study|Non-compliance with study drug|9
5500385|NCT01656434|19018491|P1|Overall Study|Non-compliance with study drug|48
5500386|NCT01656434|19018490|P2|Overall Study|Physician Decision|2
5500387|NCT01656434|19018491|P1|Overall Study|Physician Decision|7
5500388|NCT01656434|19018490|P2|Overall Study|Pregnancy|10
5500389|NCT01656434|19018491|P1|Overall Study|Pregnancy|45
5500390|NCT01656434|19018490|P2|Overall Study|Pregnancy wish|6
5500391|NCT01656434|19018491|P1|Overall Study|Pregnancy wish|18
5500392|NCT01656434|19018490|P2|Overall Study|Protocol Violation|0
5500393|NCT01656434|19018491|P1|Overall Study|Protocol Violation|7
5500394|NCT01656434|19018490|P2|Overall Study|Screen failure|0
5500395|NCT01656434|19018491|P1|Overall Study|Screen failure|2
5500396|NCT01656434|19018490|P2|Overall Study|Site discontinued study participation|9
5500397|NCT01656434|19018491|P1|Overall Study|Site discontinued study participation|24
5500398|NCT01656434|19018490|P2|Overall Study|Lost to Follow-up|76
5500399|NCT01656434|19018491|P1|Overall Study|Lost to Follow-up|309
5500400|NCT01656434|19018490|P2|Overall Study|Enrollment terminated at trial site|0
5500401|NCT01656434|19018491|P1|Overall Study|Enrollment terminated at trial site|2
5500402|NCT01656434|19018490|P2|Overall Study|Adverse Event|63
5500403|NCT01656434|19018491|P1|Overall Study|Adverse Event|199
5500404|NCT01656408|19018517|P10|Overall Study|Physician Decision|3
5500405|NCT01656408|19018518|P9|Overall Study|Physician Decision|1
5500406|NCT01656408|19018519|P8|Overall Study|Physician Decision|1
5500407|NCT01656408|19018520|P7|Overall Study|Physician Decision|0
5500408|NCT01656408|19018521|P6|Overall Study|Physician Decision|1
5500409|NCT01656408|19018522|P5|Overall Study|Physician Decision|1
5500410|NCT01656408|19018523|P4|Overall Study|Physician Decision|0
5500411|NCT01656408|19018524|P3|Overall Study|Physician Decision|1
5500412|NCT01656408|19018525|P2|Overall Study|Physician Decision|0
5500413|NCT01656408|19018526|P1|Overall Study|Physician Decision|1
5500414|NCT01656408|19018517|P10|Overall Study|Adverse Event|0
5500415|NCT01656408|19018518|P9|Overall Study|Adverse Event|1
5500416|NCT01656408|19018519|P8|Overall Study|Adverse Event|0
5500417|NCT01656408|19018520|P7|Overall Study|Adverse Event|1
5500418|NCT01656408|19018521|P6|Overall Study|Adverse Event|1
5500419|NCT01656408|19018522|P5|Overall Study|Adverse Event|0
5500420|NCT01656408|19018523|P4|Overall Study|Adverse Event|0
5500421|NCT01656408|19018524|P3|Overall Study|Adverse Event|1
5500422|NCT01656408|19018525|P2|Overall Study|Adverse Event|0
5500423|NCT01656408|19018526|P1|Overall Study|Adverse Event|0
5500424|NCT01656395|19018721|P8|Overall Study|Withdrawal by Subject|0
5500425|NCT01656395|19018722|P7|Overall Study|Withdrawal by Subject|0
5500426|NCT01656395|19018723|P6|Overall Study|Withdrawal by Subject|3
5500427|NCT01656395|19018724|P5|Overall Study|Withdrawal by Subject|0
5500428|NCT01656395|19018725|P4|Overall Study|Withdrawal by Subject|2
5500429|NCT01656395|19018726|P3|Overall Study|Withdrawal by Subject|4
5500430|NCT01656395|19018727|P2|Overall Study|Withdrawal by Subject|1
5500431|NCT01656395|19018728|P1|Overall Study|Withdrawal by Subject|3
5500432|NCT01656395|19018721|P8|Overall Study|Screen Failure|0
5500433|NCT01656395|19018722|P7|Overall Study|Screen Failure|0
5500434|NCT01656395|19018723|P6|Overall Study|Screen Failure|8
5500435|NCT01656395|19018724|P5|Overall Study|Screen Failure|0
5500436|NCT01656395|19018725|P4|Overall Study|Screen Failure|1
5500437|NCT01656395|19018726|P3|Overall Study|Screen Failure|7
5500438|NCT01656395|19018727|P2|Overall Study|Screen Failure|1
5500439|NCT01656395|19018728|P1|Overall Study|Screen Failure|2
5500440|NCT01656395|19018721|P8|Overall Study|Protocol Violation|0
5500441|NCT01656395|19018722|P7|Overall Study|Protocol Violation|0
5500442|NCT01656395|19018723|P6|Overall Study|Protocol Violation|10
5500443|NCT01656395|19018724|P5|Overall Study|Protocol Violation|4
5500444|NCT01656395|19018725|P4|Overall Study|Protocol Violation|2
5500445|NCT01656395|19018726|P3|Overall Study|Protocol Violation|9
5500446|NCT01656395|19018727|P2|Overall Study|Protocol Violation|6
5500447|NCT01656395|19018728|P1|Overall Study|Protocol Violation|6
5500448|NCT01656395|19018721|P8|Overall Study|Progressive Disease|0
5500449|NCT01656395|19018722|P7|Overall Study|Progressive Disease|0
5500450|NCT01656395|19018723|P6|Overall Study|Progressive Disease|1
5500451|NCT01656395|19018724|P5|Overall Study|Progressive Disease|0
5500452|NCT01656395|19018725|P4|Overall Study|Progressive Disease|0
5500453|NCT01656395|19018726|P3|Overall Study|Progressive Disease|0
5500454|NCT01656395|19018727|P2|Overall Study|Progressive Disease|0
5500455|NCT01656395|19018728|P1|Overall Study|Progressive Disease|0
5500456|NCT01656395|19018721|P8|Overall Study|Pregnancy|0
5500457|NCT01656395|19018722|P7|Overall Study|Pregnancy|0
5500458|NCT01656395|19018723|P6|Overall Study|Pregnancy|0
5500459|NCT01656395|19018724|P5|Overall Study|Pregnancy|0
5500460|NCT01656395|19018725|P4|Overall Study|Pregnancy|0
5500461|NCT01656395|19018726|P3|Overall Study|Pregnancy|1
5500462|NCT01656395|19018727|P2|Overall Study|Pregnancy|0
5500463|NCT01656395|19018728|P1|Overall Study|Pregnancy|0
5500464|NCT01656395|19018721|P8|Overall Study|Physician Decision|0
5500465|NCT01656395|19018722|P7|Overall Study|Physician Decision|0
5500466|NCT01656395|19018723|P6|Overall Study|Physician Decision|3
5500467|NCT01656395|19018724|P5|Overall Study|Physician Decision|3
5500468|NCT01656395|19018725|P4|Overall Study|Physician Decision|2
5500469|NCT01656395|19018726|P3|Overall Study|Physician Decision|3
5500470|NCT01656395|19018727|P2|Overall Study|Physician Decision|3
5500471|NCT01656395|19018728|P1|Overall Study|Physician Decision|2
5500472|NCT01656395|19018721|P8|Overall Study|Other|0
5500473|NCT01656395|19018722|P7|Overall Study|Other|0
5500474|NCT01656395|19018723|P6|Overall Study|Other|1
5500475|NCT01656395|19018724|P5|Overall Study|Other|0
5500476|NCT01656395|19018725|P4|Overall Study|Other|0
5500477|NCT01656395|19018726|P3|Overall Study|Other|1
5500478|NCT01656395|19018727|P2|Overall Study|Other|0
5500479|NCT01656395|19018728|P1|Overall Study|Other|0
5500480|NCT01656395|19018721|P8|Overall Study|Non-Compliance with Study Drug|0
5500481|NCT01656395|19018722|P7|Overall Study|Non-Compliance with Study Drug|0
5500482|NCT01656395|19018723|P6|Overall Study|Non-Compliance with Study Drug|1
5500483|NCT01656395|19018724|P5|Overall Study|Non-Compliance with Study Drug|1
5500484|NCT01656395|19018725|P4|Overall Study|Non-Compliance with Study Drug|0
5500485|NCT01656395|19018726|P3|Overall Study|Non-Compliance with Study Drug|0
5500486|NCT01656395|19018727|P2|Overall Study|Non-Compliance with Study Drug|1
5500487|NCT01656395|19018728|P1|Overall Study|Non-Compliance with Study Drug|1
5500488|NCT01656395|19018721|P8|Overall Study|Lost to Follow-up|0
5500489|NCT01656395|19018722|P7|Overall Study|Lost to Follow-up|0
5500490|NCT01656395|19018723|P6|Overall Study|Lost to Follow-up|0
5500491|NCT01656395|19018724|P5|Overall Study|Lost to Follow-up|0
5500492|NCT01656395|19018725|P4|Overall Study|Lost to Follow-up|0
5500493|NCT01656395|19018726|P3|Overall Study|Lost to Follow-up|0
5500494|NCT01656395|19018727|P2|Overall Study|Lost to Follow-up|0
5500495|NCT01656395|19018728|P1|Overall Study|Lost to Follow-up|1
5500496|NCT01656395|19018721|P8|Overall Study|Lack of Efficacy|0
5500497|NCT01656395|19018722|P7|Overall Study|Lack of Efficacy|0
5500498|NCT01656395|19018723|P6|Overall Study|Lack of Efficacy|6
5500499|NCT01656395|19018724|P5|Overall Study|Lack of Efficacy|1
5500500|NCT01656395|19018725|P4|Overall Study|Lack of Efficacy|1
5500501|NCT01656395|19018726|P3|Overall Study|Lack of Efficacy|6
5500502|NCT01656395|19018727|P2|Overall Study|Lack of Efficacy|8
5500503|NCT01656395|19018728|P1|Overall Study|Lack of Efficacy|1
5500504|NCT01656395|19018721|P8|Overall Study|Adverse Event|0
5500505|NCT01656395|19018722|P7|Overall Study|Adverse Event|0
5500506|NCT01656395|19018723|P6|Overall Study|Adverse Event|7
5500507|NCT01656395|19018724|P5|Overall Study|Adverse Event|5
5500508|NCT01656395|19018725|P4|Overall Study|Adverse Event|4
5500509|NCT01656395|19018726|P3|Overall Study|Adverse Event|5
5500510|NCT01656395|19018727|P2|Overall Study|Adverse Event|14
5500511|NCT01656395|19018728|P1|Overall Study|Adverse Event|1
5500512|NCT01656304|19018814|P1|Overall Study|Ineligible, uncontrolled hypertension|1
5500513|NCT01656200|19018855|P1|Overall Study|Withdrawal by Subject|1
5500514|NCT01656161|19018870|P1|Overall Study|Withdrawal by Subject|1
5500515|NCT01656161|19018870|P1|Overall Study|Protocol Violation|1
5500516|NCT01656161|19018870|P1|Overall Study|Adverse Event|2
5500517|NCT01656161|19018870|P1|Overall Study|Death|3
5500518|NCT01655901|19018888|P6|Third Intervention (Hour 3)|Lost to Follow-up|0
5500519|NCT01655901|19018889|P5|Third Intervention (Hour 3)|Lost to Follow-up|1
5500520|NCT01655901|19018890|P4|Third Intervention (Hour 3)|Lost to Follow-up|0
5500521|NCT01655901|19018891|P3|Third Intervention (Hour 3)|Lost to Follow-up|1
5500522|NCT01655901|19018892|P2|Third Intervention (Hour 3)|Lost to Follow-up|1
5500523|NCT01655901|19018893|P1|Third Intervention (Hour 3)|Lost to Follow-up|1
5500524|NCT01655823|19018907|P5|Overall Study|Withdrawal by Subject|0
5500525|NCT01655823|19018908|P4|Overall Study|Withdrawal by Subject|1
5500526|NCT01655823|19018909|P3|Overall Study|Withdrawal by Subject|0
5500527|NCT01655823|19018910|P2|Overall Study|Withdrawal by Subject|1
5500528|NCT01655823|19018911|P1|Overall Study|Withdrawal by Subject|0
5500529|NCT01655823|19018907|P5|Overall Study|Lost to Follow-up|1
5500530|NCT01655823|19018908|P4|Overall Study|Lost to Follow-up|0
5500531|NCT01655823|19018909|P3|Overall Study|Lost to Follow-up|0
5500532|NCT01655823|19018910|P2|Overall Study|Lost to Follow-up|1
5500533|NCT01655823|19018911|P1|Overall Study|Lost to Follow-up|0
5500534|NCT01655498|19018942|P1|Overall Study|Withdrawal by Subject|1
5500535|NCT01655498|19018942|P1|Overall Study|Protocol Violation|2
5500536|NCT01655498|19018942|P1|Overall Study|Unrelated health issue|2
5500537|NCT01655381|19018949|P1|Overall Study|Insufficient Treatment Response|1
5500538|NCT01655381|19018949|P1|Overall Study|Moved to Another City|1
5500539|NCT01655381|19018949|P1|Overall Study|Investigator Decision|1
5500540|NCT01655069|19018989|P4|Overall Study|Withdrawal by Subject|0
5500541|NCT01655069|19018990|P3|Overall Study|Withdrawal by Subject|0
5500542|NCT01655069|19018991|P2|Overall Study|Withdrawal by Subject|3
5500543|NCT01655069|19018992|P1|Overall Study|Withdrawal by Subject|2
5500544|NCT01655069|19018989|P4|Overall Study|No Treatment Needed|0
5500545|NCT01655069|19018990|P3|Overall Study|No Treatment Needed|0
5500546|NCT01655069|19018991|P2|Overall Study|No Treatment Needed|1
5500547|NCT01655069|19018992|P1|Overall Study|No Treatment Needed|0
5500548|NCT01655069|19018989|P4|Overall Study|Lack of Efficacy|0
5500549|NCT01655069|19018990|P3|Overall Study|Lack of Efficacy|0
5500550|NCT01655069|19018991|P2|Overall Study|Lack of Efficacy|1
5500551|NCT01655069|19018992|P1|Overall Study|Lack of Efficacy|0
5500552|NCT01655069|19018989|P4|Overall Study|Adverse Event|3
5500553|NCT01655069|19018990|P3|Overall Study|Adverse Event|2
5500554|NCT01655069|19018991|P2|Overall Study|Adverse Event|7
5500555|NCT01655069|19018992|P1|Overall Study|Adverse Event|6
5500556|NCT01655069|19018989|P4|Overall Study|Physician Decision|1
5500557|NCT01655069|19018990|P3|Overall Study|Physician Decision|0
5500558|NCT01655069|19018991|P2|Overall Study|Physician Decision|0
5500559|NCT01655069|19018992|P1|Overall Study|Physician Decision|0
5500560|NCT01654666|19019052|P3|Overall Study|Withdrawal by Subject|1
5500561|NCT01654666|19019053|P2|Overall Study|Withdrawal by Subject|4
5500562|NCT01654666|19019054|P1|Overall Study|Withdrawal by Subject|4
5500563|NCT01654666|19019052|P3|Overall Study|Lost to Follow-up|5
5500564|NCT01654666|19019053|P2|Overall Study|Lost to Follow-up|5
5500565|NCT01654666|19019054|P1|Overall Study|Lost to Follow-up|4
5500566|NCT01654666|19019052|P3|Overall Study|Protocol Violation|8
5500567|NCT01654666|19019053|P2|Overall Study|Protocol Violation|4
5500568|NCT01654666|19019054|P1|Overall Study|Protocol Violation|7
5500569|NCT01654601|19019079|P2|2nd Administration|Protocol Violation|1
5500570|NCT01654601|19019080|P1|2nd Administration|Protocol Violation|0
5500571|NCT01654601|19019079|P2|2nd Administration|Adverse Event|0
5500572|NCT01654601|19019080|P1|2nd Administration|Adverse Event|1
5500573|NCT01654601|19019079|P2|1st Administration|Protocol Violation|2
5500574|NCT01654601|19019080|P1|1st Administration|Protocol Violation|0
5500575|NCT01654601|19019079|P2|1st Administration|Withdrawal by Subject|0
5500576|NCT01654601|19019080|P1|1st Administration|Withdrawal by Subject|2
5500577|NCT01654549|19019094|P2|Overall Study|H.pylori eradication not successful|1
5500578|NCT01654549|19019095|P1|Overall Study|H.pylori eradication not successful|0
5500579|NCT01654536|19019107|P2|Overall Study|Withdrawal by Subject|25
5500580|NCT01654536|19019108|P1|Overall Study|Withdrawal by Subject|27
5500581|NCT01654536|19019107|P2|Overall Study|Physician Decision|8
5500582|NCT01654536|19019108|P1|Overall Study|Physician Decision|12
5500583|NCT01654536|19019107|P2|Overall Study|Lost to Follow-up|5
5500584|NCT01654536|19019108|P1|Overall Study|Lost to Follow-up|5
5500585|NCT01654523|19019144|P1|Overall Study|Withdrawal by Subject|1
5500586|NCT01654380|19019163|P4|Part B, Period 1|Physician Decision|0
5500587|NCT01654380|19019164|P3|Part B, Period 1|Physician Decision|1
5500588|NCT01654380|19019165|P2|Part B, Period 1|Physician Decision|0
5500589|NCT01654380|19019166|P1|Part B, Period 1|Physician Decision|0
5500590|NCT01654302|19019209|P2|Second Intervention (Day 7)|Lost to Follow-up|1
5500591|NCT01654302|19019210|P1|Second Intervention (Day 7)|Lost to Follow-up|1
5500592|NCT01654289|19019219|P3|Overall Study|Withdrew from intervention only|0
5500593|NCT01654289|19019220|P2|Overall Study|Withdrew from intervention only|20
5500594|NCT01654289|19019221|P1|Overall Study|Withdrew from intervention only|17
5500595|NCT01654289|19019219|P3|Overall Study|Withdrawal by Subject|5
5500596|NCT01654289|19019220|P2|Overall Study|Withdrawal by Subject|8
5500597|NCT01654289|19019221|P1|Overall Study|Withdrawal by Subject|10
5500598|NCT01654276|19019259|P1|Overall Study|Withdrawal by Subject|1
5500599|NCT01654276|19019259|P1|Overall Study|Lost to Follow-up|4
5500600|NCT01654276|19019259|P1|Overall Study|Lack of Efficacy|1
5500601|NCT01654250|19019313|P2|Overall Study|Lost to Follow-up|0
5500602|NCT01654250|19019314|P1|Overall Study|Lost to Follow-up|1
5500603|NCT01654224|19019331|P2|Overall Study|Insufficient blood sample|2
5500604|NCT01654224|19019332|P1|Overall Study|Insufficient blood sample|3
5500605|NCT01654224|19019331|P2|Overall Study|Did not receive allocation|8
5500606|NCT01654224|19019332|P1|Overall Study|Did not receive allocation|1
5500607|NCT01654224|19019331|P2|Overall Study|Lost to Follow-up|2
5500608|NCT01654224|19019332|P1|Overall Study|Lost to Follow-up|2
5500609|NCT01653912|19019363|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
5500610|NCT01653912|19019364|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5500611|NCT01653912|19019365|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5500612|NCT01653912|19019366|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5500613|NCT01653912|19019367|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5500614|NCT01653912|19019368|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
5500615|NCT01653912|19019363|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
5500616|NCT01653912|19019364|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5500617|NCT01653912|19019365|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5500618|NCT01653912|19019366|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5500619|NCT01653912|19019367|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5500620|NCT01653912|19019368|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
5500621|NCT01653912|19019363|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
5500622|NCT01653912|19019364|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
5500623|NCT01653912|19019365|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
5500624|NCT01653912|19019366|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
5500625|NCT01653912|19019367|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
5500626|NCT01653912|19019368|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
5500627|NCT01653912|19019363|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5500628|NCT01653912|19019364|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5500629|NCT01653912|19019365|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
5500630|NCT01653912|19019366|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5500631|NCT01653912|19019367|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5500632|NCT01653912|19019368|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
5500633|NCT01653912|19019363|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5500634|NCT01653912|19019364|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5500635|NCT01653912|19019365|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
5500636|NCT01653912|19019366|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5500637|NCT01653912|19019367|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5500638|NCT01653912|19019368|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
5500639|NCT01653912|19019363|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5500640|NCT01653912|19019364|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5500641|NCT01653912|19019365|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5500642|NCT01653912|19019366|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
5500643|NCT01653912|19019367|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5500644|NCT01653912|19019368|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
5500645|NCT01653912|19019363|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5500646|NCT01653912|19019364|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5500647|NCT01653912|19019365|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5500648|NCT01653912|19019366|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5500649|NCT01653912|19019367|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
5500650|NCT01653912|19019368|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
5500651|NCT01653782|19019386|P3|Overall Study|Lost to Follow-up|2
5500652|NCT01653782|19019387|P2|Overall Study|Lost to Follow-up|3
5500653|NCT01653782|19019388|P1|Overall Study|Lost to Follow-up|7
5500654|NCT01653782|19019386|P3|Overall Study|Withdrawal by Subject|4
5500655|NCT01653782|19019387|P2|Overall Study|Withdrawal by Subject|15
5500656|NCT01653782|19019388|P1|Overall Study|Withdrawal by Subject|9
5500657|NCT01653743|19019398|P2|Overall Study|Investigator discretion|0
5500658|NCT01653743|19019399|P1|Overall Study|Investigator discretion|3
5500659|NCT01653743|19019398|P2|Overall Study|Withdrawal by Subject|0
5500660|NCT01653743|19019399|P1|Overall Study|Withdrawal by Subject|1
5500661|NCT01653704|19019415|P2|Overall Study|Performance not reflective of training|0
5500662|NCT01653704|19019416|P1|Overall Study|Performance not reflective of training|1
5500663|NCT01653704|19019415|P2|Overall Study|Technical failure during recording|1
5500664|NCT01653704|19019416|P1|Overall Study|Technical failure during recording|1
5500665|NCT01653327|19019485|P1|Overall Study|Withdrawal by Subject|1
5500666|NCT01653262|19019510|P1|Overall Study|AE, non-serious non-fatal|1
5500667|NCT01653262|19019510|P1|Overall Study|SAE, non-fatal|1
5500668|NCT01653262|19019510|P1|Overall Study|Lack of Efficacy|1
5500669|NCT01653158|19019528|P8|Overall Study|Withdrawal by Subject|0
5500670|NCT01653158|19019529|P7|Overall Study|Withdrawal by Subject|0
5500671|NCT01653158|19019530|P6|Overall Study|Withdrawal by Subject|0
5500672|NCT01653158|19019531|P5|Overall Study|Withdrawal by Subject|0
5500673|NCT01653158|19019532|P4|Overall Study|Withdrawal by Subject|0
5500674|NCT01653158|19019533|P3|Overall Study|Withdrawal by Subject|0
5500675|NCT01653158|19019534|P2|Overall Study|Withdrawal by Subject|0
5500676|NCT01653158|19019535|P1|Overall Study|Withdrawal by Subject|1
5500677|NCT01653158|19019528|P8|Overall Study|Progressive disease|9
5500678|NCT01653158|19019529|P7|Overall Study|Progressive disease|2
5500679|NCT01653158|19019530|P6|Overall Study|Progressive disease|1
5500680|NCT01653158|19019531|P5|Overall Study|Progressive disease|1
5500681|NCT01653158|19019532|P4|Overall Study|Progressive disease|0
5500682|NCT01653158|19019533|P3|Overall Study|Progressive disease|0
5500683|NCT01653158|19019534|P2|Overall Study|Progressive disease|0
5500684|NCT01653158|19019535|P1|Overall Study|Progressive disease|0
5500685|NCT01653158|19019528|P8|Overall Study|Other|1
5500686|NCT01653158|19019529|P7|Overall Study|Other|0
5500687|NCT01653158|19019530|P6|Overall Study|Other|0
5500688|NCT01653158|19019531|P5|Overall Study|Other|0
5500689|NCT01653158|19019532|P4|Overall Study|Other|0
5500690|NCT01653158|19019533|P3|Overall Study|Other|0
5500691|NCT01653158|19019534|P2|Overall Study|Other|0
5500692|NCT01653158|19019535|P1|Overall Study|Other|0
5500693|NCT01653158|19019528|P8|Overall Study|Adverse Event|3
5500694|NCT01653158|19019529|P7|Overall Study|Adverse Event|0
5500695|NCT01653158|19019530|P6|Overall Study|Adverse Event|0
5500696|NCT01653158|19019531|P5|Overall Study|Adverse Event|0
5500697|NCT01653158|19019532|P4|Overall Study|Adverse Event|1
5500698|NCT01653158|19019533|P3|Overall Study|Adverse Event|0
5500699|NCT01653158|19019534|P2|Overall Study|Adverse Event|0
5500700|NCT01653158|19019535|P1|Overall Study|Adverse Event|0
5500701|NCT01653158|19019528|P8|Overall Study|Death|2
5500702|NCT01653158|19019529|P7|Overall Study|Death|0
5500703|NCT01653158|19019530|P6|Overall Study|Death|0
5500704|NCT01653158|19019531|P5|Overall Study|Death|0
5500705|NCT01653158|19019532|P4|Overall Study|Death|1
5500706|NCT01653158|19019533|P3|Overall Study|Death|0
5500707|NCT01653158|19019534|P2|Overall Study|Death|0
5500708|NCT01653158|19019535|P1|Overall Study|Death|0
5500709|NCT01653132|19019807|P2|First Intervention|Protocol Violation|0
5500710|NCT01653132|19019808|P1|First Intervention|Protocol Violation|1
5500711|NCT01652885|19019872|P1|Overall Study|Adverse Event|1
5500712|NCT01652872|19019899|P2|Overall Study|Withdrawal by Subject|84
5500713|NCT01652872|19019900|P1|Overall Study|Withdrawal by Subject|76
5500714|NCT01652872|19019899|P2|Overall Study|Decision by sponsor|7
5500715|NCT01652872|19019900|P1|Overall Study|Decision by sponsor|5
5500716|NCT01652872|19019899|P2|Overall Study|Lost to Follow-up|23
5500717|NCT01652872|19019900|P1|Overall Study|Lost to Follow-up|28
5500718|NCT01652872|19019899|P2|Overall Study|Death|39
5500719|NCT01652872|19019900|P1|Overall Study|Death|36
5500720|NCT01652729|19019917|P3|Overall Study|Administrative|0
5500721|NCT01652729|19019918|P2|Overall Study|Administrative|0
5500722|NCT01652729|19019919|P1|Overall Study|Administrative|1
5500723|NCT01652729|19019917|P3|Overall Study|Lost to Follow-up|3
5500724|NCT01652729|19019918|P2|Overall Study|Lost to Follow-up|6
5500725|NCT01652729|19019919|P1|Overall Study|Lost to Follow-up|6
5500726|NCT01652729|19019917|P3|Overall Study|Protocol Violation|0
5500727|NCT01652729|19019918|P2|Overall Study|Protocol Violation|0
5500728|NCT01652729|19019919|P1|Overall Study|Protocol Violation|1
5500729|NCT01652729|19019917|P3|Overall Study|Physician Decision|1
5500730|NCT01652729|19019918|P2|Overall Study|Physician Decision|0
5500731|NCT01652729|19019919|P1|Overall Study|Physician Decision|1
5500732|NCT01652729|19019917|P3|Overall Study|Adverse Event|3
5500733|NCT01652729|19019918|P2|Overall Study|Adverse Event|0
5500734|NCT01652729|19019919|P1|Overall Study|Adverse Event|4
5500735|NCT01652729|19019917|P3|Overall Study|Withdrawal by Subject|7
5500736|NCT01652729|19019918|P2|Overall Study|Withdrawal by Subject|7
5500737|NCT01652729|19019919|P1|Overall Study|Withdrawal by Subject|14
5500738|NCT01652716|19019941|P2|Overall Study|Withdrawal by Subject|18
5500739|NCT01652716|19019942|P1|Overall Study|Withdrawal by Subject|33
5500740|NCT01652716|19019941|P2|Overall Study|Adverse Event|10
5500741|NCT01652716|19019942|P1|Overall Study|Adverse Event|7
5500742|NCT01652716|19019941|P2|Overall Study|Protocol Violation|1
5500743|NCT01652716|19019942|P1|Overall Study|Protocol Violation|2
5500744|NCT01652716|19019941|P2|Overall Study|Lost to Follow-up|11
5500745|NCT01652716|19019942|P1|Overall Study|Lost to Follow-up|12
5500746|NCT01652716|19019941|P2|Overall Study|Investigator decision|4
5500747|NCT01652716|19019942|P1|Overall Study|Investigator decision|1
5500748|NCT01652716|19019941|P2|Overall Study|Administrative|2
5500749|NCT01652716|19019942|P1|Overall Study|Administrative|0
5500750|NCT01652716|19019941|P2|Overall Study|Loss of glucose control|0
5500751|NCT01652716|19019942|P1|Overall Study|Loss of glucose control|1
5500752|NCT01652703|19019962|P6|Overall Study|Other|1
5500753|NCT01652703|19019963|P5|Overall Study|Other|1
5500754|NCT01652703|19019964|P4|Overall Study|Other|1
5500755|NCT01652703|19019965|P3|Overall Study|Other|0
5500756|NCT01652703|19019966|P2|Overall Study|Other|0
5500757|NCT01652703|19019967|P1|Overall Study|Other|0
5500758|NCT01652703|19019962|P6|Overall Study|Withdrawal by Subject|1
5500759|NCT01652703|19019963|P5|Overall Study|Withdrawal by Subject|0
5500760|NCT01652703|19019964|P4|Overall Study|Withdrawal by Subject|1
5500761|NCT01652703|19019965|P3|Overall Study|Withdrawal by Subject|3
5500762|NCT01652703|19019966|P2|Overall Study|Withdrawal by Subject|1
5500763|NCT01652703|19019967|P1|Overall Study|Withdrawal by Subject|0
5500764|NCT01652690|19020025|P2|Overall Study|Death|2
5500765|NCT01652690|19020026|P1|Overall Study|Death|5
5500766|NCT01652690|19020025|P2|Overall Study|Lost to Follow-up|6
5500767|NCT01652690|19020026|P1|Overall Study|Lost to Follow-up|6
5500768|NCT01652690|19020025|P2|Overall Study|Other|9
5500769|NCT01652690|19020026|P1|Overall Study|Other|8
5500770|NCT01652690|19020025|P2|Overall Study|Withdrawal by Subject|4
5500771|NCT01652690|19020026|P1|Overall Study|Withdrawal by Subject|16
5500772|NCT01652664|19020060|P2|Overall Study|Inadequate IOP control|0
5500773|NCT01652664|19020061|P1|Overall Study|Inadequate IOP control|1
5500774|NCT01652664|19020060|P2|Overall Study|Treatment Failure|1
5500775|NCT01652664|19020061|P1|Overall Study|Treatment Failure|5
5500776|NCT01652573|19020070|P2|Overall Study|Adverse Event|1
5500777|NCT01652573|19020071|P1|Overall Study|Adverse Event|0
5500778|NCT01652534|19020113|P2|Overall Study|Lack of Efficacy|0
5500779|NCT01652534|19020114|P1|Overall Study|Lack of Efficacy|1
5500780|NCT01652469|19020155|P2|Overall Study|Lost to Follow-up|2
5500781|NCT01652469|19020156|P1|Overall Study|Lost to Follow-up|0
5500782|NCT01652469|19020155|P2|Overall Study|Withdrawal by Subject|4
5500783|NCT01652469|19020156|P1|Overall Study|Withdrawal by Subject|1
5500784|NCT01652287|19020172|P2|Overall Study|Withdrawal by Subject|0
5500785|NCT01652287|19020173|P1|Overall Study|Withdrawal by Subject|2
5500786|NCT01651949|19020204|P3|Overall Study|Withdrawal by Subject|9
5500787|NCT01651949|19020205|P2|Overall Study|Withdrawal by Subject|18
5500788|NCT01651949|19020206|P1|Overall Study|Withdrawal by Subject|17
5500789|NCT01651949|19020204|P3|Overall Study|Screen failure|0
5500790|NCT01651949|19020205|P2|Overall Study|Screen failure|2
5500791|NCT01651949|19020206|P1|Overall Study|Screen failure|2
5500792|NCT01651949|19020204|P3|Overall Study|Adverse Event|1
5500793|NCT01651949|19020205|P2|Overall Study|Adverse Event|2
5500794|NCT01651949|19020206|P1|Overall Study|Adverse Event|0
5500795|NCT01651949|19020204|P3|Overall Study|Physician Decision|0
5500796|NCT01651949|19020205|P2|Overall Study|Physician Decision|2
5500797|NCT01651949|19020206|P1|Overall Study|Physician Decision|0
5500798|NCT01651949|19020204|P3|Overall Study|Protocol Violation|1
5500799|NCT01651949|19020205|P2|Overall Study|Protocol Violation|2
5500800|NCT01651949|19020206|P1|Overall Study|Protocol Violation|0
5500801|NCT01651949|19020204|P3|Overall Study|Lost to Follow-up|20
5500802|NCT01651949|19020205|P2|Overall Study|Lost to Follow-up|56
5500803|NCT01651949|19020206|P1|Overall Study|Lost to Follow-up|30
5500804|NCT01651949|19020204|P3|Overall Study|Unknown status|0
5500805|NCT01651949|19020205|P2|Overall Study|Unknown status|4
5500806|NCT01651949|19020206|P1|Overall Study|Unknown status|4
5500807|NCT01651936|19020226|P3|Extension Study|Study terminated by sponsor|13
5500808|NCT01651936|19020227|P2|Extension Study|Study terminated by sponsor|0
5500809|NCT01651936|19020228|P1|Extension Study|Study terminated by sponsor|0
5500810|NCT01651936|19020226|P3|Extension Study|Lack of Efficacy|1
5500811|NCT01651936|19020227|P2|Extension Study|Lack of Efficacy|0
5500812|NCT01651936|19020228|P1|Extension Study|Lack of Efficacy|0
5500813|NCT01651936|19020226|P3|Base Study|Study terminated by sponsor|0
5500814|NCT01651936|19020227|P2|Base Study|Study terminated by sponsor|16
5500815|NCT01651936|19020228|P1|Base Study|Study terminated by sponsor|21
5500816|NCT01651936|19020226|P3|Base Study|Early Escape|0
5500817|NCT01651936|19020227|P2|Base Study|Early Escape|8
5500818|NCT01651936|19020228|P1|Base Study|Early Escape|2
5500819|NCT01651936|19020226|P3|Base Study|Withdrawal by Subject|0
5500820|NCT01651936|19020227|P2|Base Study|Withdrawal by Subject|1
5500821|NCT01651936|19020228|P1|Base Study|Withdrawal by Subject|1
5500822|NCT01651936|19020226|P3|Base Study|Adverse Event|0
5500823|NCT01651936|19020227|P2|Base Study|Adverse Event|0
5500824|NCT01651936|19020228|P1|Base Study|Adverse Event|3
5500825|NCT01651780|19020298|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
5500826|NCT01651780|19020299|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
5500827|NCT01651780|19020298|P2|Overall Study|Lost to Follow-up|2
5500828|NCT01651780|19020299|P1|Overall Study|Lost to Follow-up|1
5500829|NCT01651780|19020298|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5500830|NCT01651780|19020299|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
5500831|NCT01651780|19020298|P2|Overall Study|Withdrawal by Subject|0
5500832|NCT01651780|19020299|P1|Overall Study|Withdrawal by Subject|2
5500833|NCT01651780|19020298|P2|Overall Study|Reason Not Specified: No 30-day visit|2
5500834|NCT01651780|19020299|P1|Overall Study|Reason Not Specified: No 30-day visit|2
5500835|NCT01651780|19020298|P2|Overall Study|Physician decision: No 30-day visit|1
5500836|NCT01651780|19020299|P1|Overall Study|Physician decision: No 30-day visit|2
5500837|NCT01651403|19020350|P2|Open-Label Phase (Weeks 49/73-120/144)|Withdrew consent/assent|2
5500838|NCT01651403|19020351|P1|Open-Label Phase (Weeks 49/73-120/144)|Withdrew consent/assent|1
5500839|NCT01651403|19020350|P2|Open-Label Phase (Weeks 49/73-120/144)|Investigator decision|1
5500840|NCT01651403|19020351|P1|Open-Label Phase (Weeks 49/73-120/144)|Investigator decision|1
5500841|NCT01651403|19020350|P2|Open-Label Phase (Weeks 49/73-120/144)|Continuing Study|13
5500842|NCT01651403|19020351|P1|Open-Label Phase (Weeks 49/73-120/144)|Continuing Study|25
5500843|NCT01651403|19020350|P2|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|1
5500844|NCT01651403|19020351|P1|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|0
5500845|NCT01651403|19020350|P2|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
5500846|NCT01651403|19020351|P1|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
5500847|NCT01651403|19020350|P2|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|0
5500848|NCT01651403|19020351|P1|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
5500849|NCT01651260|19020401|P1|Overall Study|unable to apply product|3
5500850|NCT01651208|19020408|P2|Overall Study|Lost to Follow-up|16
5500851|NCT01651208|19020409|P1|Overall Study|Lost to Follow-up|14
5500852|NCT01651117|19020421|P4|Overall Study|Death|2
5500853|NCT01651117|19020422|P3|Overall Study|Death|2
5500854|NCT01651117|19020423|P2|Overall Study|Death|3
5500855|NCT01651117|19020424|P1|Overall Study|Death|2
5500856|NCT01651052|19020504|P1|Overall Study|Lost to Follow-up|3
5500857|NCT01651052|19020504|P1|Overall Study|Withdrawal by Subject|1
5500858|NCT01651052|19020504|P1|Overall Study|Explant|1
5500859|NCT01651052|19020504|P1|Overall Study|Death|21
5500860|NCT01651039|19020524|P1|Overall Study|Progressive Disease|22
5500861|NCT01651039|19020524|P1|Overall Study|Withdrawal by Subject|1
5500862|NCT01651039|19020524|P1|Overall Study|Physician Decision|2
5500863|NCT01651039|19020524|P1|Overall Study|Non-evaluables|5
5500864|NCT01651000|19020537|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
5500865|NCT01651000|19020538|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
5500866|NCT01651000|19020537|P2|Overall Study|Administrative reason|0
5500867|NCT01651000|19020538|P1|Overall Study|Administrative reason|1
5500868|NCT01651000|19020537|P2|Overall Study|Physician Decision|0
5500869|NCT01651000|19020538|P1|Overall Study|Physician Decision|1
5500870|NCT01651000|19020537|P2|Overall Study|Lack of Efficacy|1
5500871|NCT01651000|19020538|P1|Overall Study|Lack of Efficacy|1
5500872|NCT01651000|19020537|P2|Overall Study|Subject noncompliance|3
5500873|NCT01651000|19020538|P1|Overall Study|Subject noncompliance|0
5500874|NCT01651000|19020537|P2|Overall Study|Withdrawal by Subject|10
5500875|NCT01651000|19020538|P1|Overall Study|Withdrawal by Subject|2
5500876|NCT01651000|19020537|P2|Overall Study|Protocol Violation|3
5500877|NCT01651000|19020538|P1|Overall Study|Protocol Violation|0
5500878|NCT01651000|19020537|P2|Overall Study|Lost to Follow-up|2
5500879|NCT01651000|19020538|P1|Overall Study|Lost to Follow-up|3
5500880|NCT01651000|19020537|P2|Overall Study|Adverse Event|8
5500881|NCT01651000|19020538|P1|Overall Study|Adverse Event|2
5500882|NCT01650831|19020559|P1|Overall Study|Screen failure|1
5500883|NCT01650805|19020569|P2|Overall Study|Withdrawal by Subject|0
5500884|NCT01650805|19020570|P1|Overall Study|Withdrawal by Subject|1
5500885|NCT01650779|19020580|P1|Overall Study|Withdrawal by Subject|1
5500886|NCT01650636|19020589|P2|Washout up to 9 Months|Lost to Follow-up|1
5500887|NCT01650636|19020590|P1|Washout up to 9 Months|Lost to Follow-up|2
5500888|NCT01650636|19020589|P2|Washout up to 9 Months|Withdrawal by Subject|2
5500889|NCT01650636|19020590|P1|Washout up to 9 Months|Withdrawal by Subject|4
5500890|NCT01650636|19020589|P2|Washout up to 5 Months|Lost to Follow-up|8
5500891|NCT01650636|19020590|P1|Washout up to 5 Months|Lost to Follow-up|2
5500892|NCT01650636|19020589|P2|Washout up to 5 Months|Death|0
5500893|NCT01650636|19020590|P1|Washout up to 5 Months|Death|1
5500894|NCT01650636|19020589|P2|Washout up to 5 Months|Physician Decision|2
5500895|NCT01650636|19020590|P1|Washout up to 5 Months|Physician Decision|2
5500896|NCT01650636|19020589|P2|Washout up to 5 Months|Withdrawal by Subject|8
5500897|NCT01650636|19020590|P1|Washout up to 5 Months|Withdrawal by Subject|4
5500898|NCT01650519|19020630|P2|Overall Study|Withdrawal by Subject|0
5500899|NCT01650519|19020631|P1|Overall Study|Withdrawal by Subject|1
5500900|NCT01650285|19020713|P1|Overall Study|Adverse Event|1
5500901|NCT01650259|19020720|P2|Overall Study|Other than listed|146
5500902|NCT01650259|19020721|P1|Overall Study|Other than listed|64
5500903|NCT01650259|19020720|P2|Overall Study|Not treated|7
5500904|NCT01650259|19020721|P1|Overall Study|Not treated|1
5500905|NCT01650259|19020720|P2|Overall Study|CRF not collected|82
5500906|NCT01650259|19020721|P1|Overall Study|CRF not collected|98
5500907|NCT01650259|19020720|P2|Overall Study|Patients had no visit after entry|0
5500908|NCT01650259|19020721|P1|Overall Study|Patients had no visit after entry|70
5500909|NCT01650259|19020720|P2|Overall Study|Lost to Follow-up|0
5500910|NCT01650259|19020721|P1|Overall Study|Lost to Follow-up|435
5500911|NCT01650259|19020720|P2|Overall Study|Lack of Efficacy|0
5500912|NCT01650259|19020721|P1|Overall Study|Lack of Efficacy|143
5500913|NCT01650259|19020720|P2|Overall Study|Adverse Event|0
5500914|NCT01650259|19020721|P1|Overall Study|Adverse Event|127
5500915|NCT01650259|19020720|P2|Overall Study|Improvement|0
5500916|NCT01650259|19020721|P1|Overall Study|Improvement|105
5500917|NCT01650246|19020726|P1|Overall Study|Lack of Efficacy|30
5500918|NCT01650246|19020726|P1|Overall Study|Death|1
5500919|NCT01650246|19020726|P1|Overall Study|Withdrawal by Subject|26
5500920|NCT01650246|19020726|P1|Overall Study|Lost to Follow-up|5
5500921|NCT01650246|19020726|P1|Overall Study|Sponsor terminated study|53
5500922|NCT01650246|19020726|P1|Overall Study|Protocol Violation|5
5500923|NCT01650246|19020726|P1|Overall Study|Adverse Event|23
5500924|NCT01650194|19020731|P1|Overall Study|Miscellaneous|10
5500925|NCT01650194|19020731|P1|Overall Study|Withdrawal by Subject|2
5500926|NCT01650194|19020731|P1|Overall Study|Progressive Disease (PD)|35
5500927|NCT01649856|19020767|P2|Overall Study|Other|5
5500928|NCT01649856|19020768|P1|Overall Study|Other|20
5500929|NCT01649856|19020767|P2|Overall Study|Lack of Compliance|1
5500930|NCT01649856|19020768|P1|Overall Study|Lack of Compliance|6
5500931|NCT01649856|19020767|P2|Overall Study|Lost to Follow-up|16
5500932|NCT01649856|19020768|P1|Overall Study|Lost to Follow-up|20
5500933|NCT01649856|19020767|P2|Overall Study|Stable or Progressed Disease|3
5500934|NCT01649856|19020768|P1|Overall Study|Stable or Progressed Disease|5
5500935|NCT01649856|19020767|P2|Overall Study|Death|34
5500936|NCT01649856|19020768|P1|Overall Study|Death|69
5500937|NCT01649856|19020767|P2|Overall Study|Treatment Failure|1
5500938|NCT01649856|19020768|P1|Overall Study|Treatment Failure|1
5500939|NCT01649856|19020767|P2|Overall Study|Protocol Violation|4
5500940|NCT01649856|19020768|P1|Overall Study|Protocol Violation|4
5500941|NCT01649856|19020767|P2|Overall Study|Withdrawal by Subject|14
5500942|NCT01649856|19020768|P1|Overall Study|Withdrawal by Subject|14
5500943|NCT01649804|19020800|P1|Overall Study|Administrative/Other|8
5500944|NCT01649791|19020812|P1|Overall Study|Adverse Event|1
5500945|NCT01649791|19020812|P1|Overall Study|Disease Progression|2
5500946|NCT01649765|19020821|P2|Overall Study|Withdrawal by Subject|1
5500947|NCT01649765|19020822|P1|Overall Study|Withdrawal by Subject|2
5500948|NCT01649765|19020821|P2|Overall Study|Protocol Violation|0
5500949|NCT01649765|19020822|P1|Overall Study|Protocol Violation|1
5500950|NCT01649765|19020821|P2|Overall Study|Physician Decision|3
5500951|NCT01649765|19020822|P1|Overall Study|Physician Decision|0
5500952|NCT01649765|19020821|P2|Overall Study|Lack of Efficacy|1
5500953|NCT01649765|19020822|P1|Overall Study|Lack of Efficacy|1
5500954|NCT01649765|19020821|P2|Overall Study|Adverse Event|3
5500955|NCT01649765|19020822|P1|Overall Study|Adverse Event|5
5500956|NCT01649557|19020873|P3|Overall Study|Lack of Efficacy|0
5500957|NCT01649557|19020874|P2|Overall Study|Lack of Efficacy|0
5500958|NCT01649557|19020875|P1|Overall Study|Lack of Efficacy|5
5500959|NCT01649557|19020873|P3|Overall Study|Protocol deviation|0
5500960|NCT01649557|19020874|P2|Overall Study|Protocol deviation|2
5500961|NCT01649557|19020875|P1|Overall Study|Protocol deviation|0
5500962|NCT01649557|19020873|P3|Overall Study|Withdrawal by Subject|4
5500963|NCT01649557|19020874|P2|Overall Study|Withdrawal by Subject|5
5500964|NCT01649557|19020875|P1|Overall Study|Withdrawal by Subject|15
5500965|NCT01649557|19020873|P3|Overall Study|Physician Decision|1
5500966|NCT01649557|19020874|P2|Overall Study|Physician Decision|2
5500967|NCT01649557|19020875|P1|Overall Study|Physician Decision|8
5500968|NCT01649557|19020873|P3|Overall Study|Met withdrawal criteria|0
5500969|NCT01649557|19020874|P2|Overall Study|Met withdrawal criteria|0
5500970|NCT01649557|19020875|P1|Overall Study|Met withdrawal criteria|4
5500971|NCT01649557|19020873|P3|Overall Study|Adverse Event|1
5500972|NCT01649557|19020874|P2|Overall Study|Adverse Event|5
5500973|NCT01649557|19020875|P1|Overall Study|Adverse Event|7
5500974|NCT01649557|19020873|P3|Overall Study|Lost to Follow-up|3
5500975|NCT01649557|19020874|P2|Overall Study|Lost to Follow-up|0
5500976|NCT01649557|19020875|P1|Overall Study|Lost to Follow-up|5
5500977|NCT01649427|19020921|P2|Overall Study|Surgical problems during nephrectomy|2
5500978|NCT01649427|19020922|P1|Overall Study|Surgical problems during nephrectomy|2
5500979|NCT01649427|19020921|P2|Overall Study|Graft loss|1
5500980|NCT01649427|19020922|P1|Overall Study|Graft loss|0
5500981|NCT01649427|19020921|P2|Overall Study|Lost to Follow-up|1
5500982|NCT01649427|19020922|P1|Overall Study|Lost to Follow-up|0
5500983|NCT01649427|19020921|P2|Overall Study|Withdrawal by Subject|7
5500984|NCT01649427|19020922|P1|Overall Study|Withdrawal by Subject|8
5500985|NCT01649427|19020921|P2|Overall Study|Adverse Event|1
5500986|NCT01649427|19020922|P1|Overall Study|Adverse Event|1
5500987|NCT01649375|19020941|P5|Week 16 up to Week 260|Adverse Event|2
5500988|NCT01649375|19020942|P4|Week 16 up to Week 260|Adverse Event|3
5500989|NCT01649375|19020943|P3|Week 16 up to Week 260|Adverse Event|0
5500990|NCT01649375|19020944|P2|Week 16 up to Week 260|Adverse Event|2
5500991|NCT01649375|19020945|P1|Week 16 up to Week 260|Adverse Event|5
5500992|NCT01649375|19020941|P5|Week 16 up to Week 260|Death|0
5500993|NCT01649375|19020942|P4|Week 16 up to Week 260|Death|0
5500994|NCT01649375|19020943|P3|Week 16 up to Week 260|Death|0
5500995|NCT01649375|19020944|P2|Week 16 up to Week 260|Death|1
5500996|NCT01649375|19020945|P1|Week 16 up to Week 260|Death|1
5500997|NCT01649375|19020941|P5|Week 16 up to Week 260|Withdrawal by Subject|1
5500998|NCT01649375|19020942|P4|Week 16 up to Week 260|Withdrawal by Subject|3
5500999|NCT01649375|19020943|P3|Week 16 up to Week 260|Withdrawal by Subject|0
5501000|NCT01649375|19020944|P2|Week 16 up to Week 260|Withdrawal by Subject|2
5501001|NCT01649375|19020945|P1|Week 16 up to Week 260|Withdrawal by Subject|7
5501002|NCT01649375|19020941|P5|Week 16 up to Week 260|Technical issues|0
5501003|NCT01649375|19020942|P4|Week 16 up to Week 260|Technical issues|1
5501004|NCT01649375|19020943|P3|Week 16 up to Week 260|Technical issues|0
5501005|NCT01649375|19020944|P2|Week 16 up to Week 260|Technical issues|1
5501006|NCT01649375|19020945|P1|Week 16 up to Week 260|Technical issues|0
5501007|NCT01649375|19020941|P5|Week 16 up to Week 260|Physician Decision|0
5501008|NCT01649375|19020942|P4|Week 16 up to Week 260|Physician Decision|0
5501009|NCT01649375|19020943|P3|Week 16 up to Week 260|Physician Decision|0
5501010|NCT01649375|19020944|P2|Week 16 up to Week 260|Physician Decision|2
5501011|NCT01649375|19020945|P1|Week 16 up to Week 260|Physician Decision|0
5501012|NCT01649375|19020941|P5|Week 16 up to Week 260|Non-compliance|0
5501013|NCT01649375|19020942|P4|Week 16 up to Week 260|Non-compliance|1
5501014|NCT01649375|19020943|P3|Week 16 up to Week 260|Non-compliance|0
5501015|NCT01649375|19020944|P2|Week 16 up to Week 260|Non-compliance|1
5501016|NCT01649375|19020945|P1|Week 16 up to Week 260|Non-compliance|0
5501017|NCT01649375|19020941|P5|Week 16 up to Week 260|Lack of Efficacy|2
5501018|NCT01649375|19020942|P4|Week 16 up to Week 260|Lack of Efficacy|4
5501019|NCT01649375|19020943|P3|Week 16 up to Week 260|Lack of Efficacy|0
5501020|NCT01649375|19020944|P2|Week 16 up to Week 260|Lack of Efficacy|4
5501021|NCT01649375|19020945|P1|Week 16 up to Week 260|Lack of Efficacy|7
5501022|NCT01649375|19020941|P5|Up to Week 16|Death|0
5501023|NCT01649375|19020942|P4|Up to Week 16|Death|0
5501024|NCT01649375|19020943|P3|Up to Week 16|Death|0
5501025|NCT01649375|19020944|P2|Up to Week 16|Death|0
5501026|NCT01649375|19020945|P1|Up to Week 16|Death|1
5501027|NCT01649375|19020941|P5|Up to Week 16|Withdrawal by Subject|0
5501028|NCT01649375|19020942|P4|Up to Week 16|Withdrawal by Subject|0
5501029|NCT01649375|19020943|P3|Up to Week 16|Withdrawal by Subject|2
5501030|NCT01649375|19020944|P2|Up to Week 16|Withdrawal by Subject|1
5501031|NCT01649375|19020945|P1|Up to Week 16|Withdrawal by Subject|2
5501032|NCT01649375|19020941|P5|Up to Week 16|Physician Decision|0
5501033|NCT01649375|19020942|P4|Up to Week 16|Physician Decision|0
5501034|NCT01649375|19020943|P3|Up to Week 16|Physician Decision|1
5501035|NCT01649375|19020944|P2|Up to Week 16|Physician Decision|0
5501036|NCT01649375|19020945|P1|Up to Week 16|Physician Decision|0
5501037|NCT01649375|19020941|P5|Up to Week 16|Lack of Efficacy|0
5501038|NCT01649375|19020942|P4|Up to Week 16|Lack of Efficacy|0
5501039|NCT01649375|19020943|P3|Up to Week 16|Lack of Efficacy|1
5501040|NCT01649375|19020944|P2|Up to Week 16|Lack of Efficacy|0
5501041|NCT01649375|19020945|P1|Up to Week 16|Lack of Efficacy|0
5501042|NCT01649375|19020941|P5|Up to Week 16|Adverse Event|0
5501043|NCT01649375|19020942|P4|Up to Week 16|Adverse Event|0
5501044|NCT01649375|19020943|P3|Up to Week 16|Adverse Event|4
5501045|NCT01649375|19020944|P2|Up to Week 16|Adverse Event|5
5501046|NCT01649375|19020945|P1|Up to Week 16|Adverse Event|2
5501047|NCT01649297|19020992|P5|Overall Study|For other reason|0
5501048|NCT01649297|19020993|P4|Overall Study|For other reason|0
5501049|NCT01649297|19020994|P3|Overall Study|For other reason|2
5501050|NCT01649297|19020995|P2|Overall Study|For other reason|1
5501051|NCT01649297|19020996|P1|Overall Study|For other reason|4
5501052|NCT01649297|19020992|P5|Overall Study|Patient withdrawal (not due to AE)|1
5501053|NCT01649297|19020993|P4|Overall Study|Patient withdrawal (not due to AE)|1
5501054|NCT01649297|19020994|P3|Overall Study|Patient withdrawal (not due to AE)|4
5501055|NCT01649297|19020995|P2|Overall Study|Patient withdrawal (not due to AE)|6
5501056|NCT01649297|19020996|P1|Overall Study|Patient withdrawal (not due to AE)|3
5501057|NCT01649297|19020992|P5|Overall Study|Lost to Follow-up|0
5501058|NCT01649297|19020993|P4|Overall Study|Lost to Follow-up|3
5501059|NCT01649297|19020994|P3|Overall Study|Lost to Follow-up|4
5501060|NCT01649297|19020995|P2|Overall Study|Lost to Follow-up|1
5501061|NCT01649297|19020996|P1|Overall Study|Lost to Follow-up|1
5501062|NCT01649297|19020992|P5|Overall Study|Non compliant with Protocol|1
5501063|NCT01649297|19020993|P4|Overall Study|Non compliant with Protocol|2
5501064|NCT01649297|19020994|P3|Overall Study|Non compliant with Protocol|3
5501065|NCT01649297|19020995|P2|Overall Study|Non compliant with Protocol|0
5501066|NCT01649297|19020996|P1|Overall Study|Non compliant with Protocol|1
5501067|NCT01649297|19020992|P5|Overall Study|Lack of Efficacy|1
5501068|NCT01649297|19020993|P4|Overall Study|Lack of Efficacy|0
5501069|NCT01649297|19020994|P3|Overall Study|Lack of Efficacy|0
5501070|NCT01649297|19020995|P2|Overall Study|Lack of Efficacy|0
5501071|NCT01649297|19020996|P1|Overall Study|Lack of Efficacy|0
5501072|NCT01649297|19020992|P5|Overall Study|Adverse Event|1
5501073|NCT01649297|19020993|P4|Overall Study|Adverse Event|13
5501074|NCT01649297|19020994|P3|Overall Study|Adverse Event|4
5501075|NCT01649297|19020995|P2|Overall Study|Adverse Event|5
5501076|NCT01649297|19020996|P1|Overall Study|Adverse Event|5
5501077|NCT01649271|19021015|P2|Overall Study|Other than stated above|0
5501078|NCT01649271|19021016|P1|Overall Study|Other than stated above|1
5501079|NCT01649271|19021015|P2|Overall Study|Withdrawal by Subject|0
5501080|NCT01649271|19021016|P1|Overall Study|Withdrawal by Subject|1
5501081|NCT01649271|19021015|P2|Overall Study|Other Adverse Event|2
5501082|NCT01649271|19021016|P1|Overall Study|Other Adverse Event|0
5501083|NCT01649271|19021015|P2|Overall Study|Progressive disease|5
5501084|NCT01649271|19021016|P1|Overall Study|Progressive disease|4
5501085|NCT01649232|19021031|P2|Overall Study|Physician Decision|0
5501086|NCT01649232|19021032|P1|Overall Study|Physician Decision|2
5501087|NCT01648790|19021088|P5|Treatment 3|Withdrawal by Subject|0
5501088|NCT01648790|19021089|P4|Treatment 3|Withdrawal by Subject|1
5501089|NCT01648790|19021090|P3|Treatment 3|Withdrawal by Subject|0
5501090|NCT01648790|19021091|P2|Treatment 3|Withdrawal by Subject|0
5501091|NCT01648790|19021092|P1|Treatment 3|Withdrawal by Subject|0
5501092|NCT01648764|19021127|P14|Overall Study|Investigator Decision|0
5501093|NCT01648764|19021128|P13|Overall Study|Investigator Decision|0
5501094|NCT01648764|19021129|P12|Overall Study|Investigator Decision|1
5501095|NCT01648764|19021130|P11|Overall Study|Investigator Decision|0
5501096|NCT01648764|19021131|P10|Overall Study|Investigator Decision|0
5501097|NCT01648764|19021132|P9|Overall Study|Investigator Decision|0
5501098|NCT01648764|19021133|P8|Overall Study|Investigator Decision|0
5501099|NCT01648764|19021134|P7|Overall Study|Investigator Decision|1
5501100|NCT01648764|19021135|P6|Overall Study|Investigator Decision|0
5501101|NCT01648764|19021136|P5|Overall Study|Investigator Decision|0
5501102|NCT01648764|19021137|P4|Overall Study|Investigator Decision|0
5501103|NCT01648764|19021138|P3|Overall Study|Investigator Decision|0
5501104|NCT01648764|19021139|P2|Overall Study|Investigator Decision|0
5501105|NCT01648764|19021140|P1|Overall Study|Investigator Decision|0
5501106|NCT01648764|19021127|P14|Overall Study|Withdrawal by Subject|0
5501107|NCT01648764|19021128|P13|Overall Study|Withdrawal by Subject|1
5501108|NCT01648764|19021129|P12|Overall Study|Withdrawal by Subject|0
5501109|NCT01648764|19021130|P11|Overall Study|Withdrawal by Subject|0
5501110|NCT01648764|19021131|P10|Overall Study|Withdrawal by Subject|0
5501111|NCT01648764|19021132|P9|Overall Study|Withdrawal by Subject|0
5501112|NCT01648764|19021133|P8|Overall Study|Withdrawal by Subject|0
5501113|NCT01648764|19021134|P7|Overall Study|Withdrawal by Subject|2
5501114|NCT01648764|19021135|P6|Overall Study|Withdrawal by Subject|0
5501115|NCT01648764|19021136|P5|Overall Study|Withdrawal by Subject|0
5501116|NCT01648764|19021137|P4|Overall Study|Withdrawal by Subject|0
5501117|NCT01648764|19021138|P3|Overall Study|Withdrawal by Subject|0
5501118|NCT01648764|19021139|P2|Overall Study|Withdrawal by Subject|0
5501119|NCT01648764|19021140|P1|Overall Study|Withdrawal by Subject|0
5501120|NCT01648764|19021127|P14|Overall Study|Death|1
5501121|NCT01648764|19021128|P13|Overall Study|Death|0
5501122|NCT01648764|19021129|P12|Overall Study|Death|0
5501123|NCT01648764|19021130|P11|Overall Study|Death|0
5501124|NCT01648764|19021131|P10|Overall Study|Death|0
5501125|NCT01648764|19021132|P9|Overall Study|Death|0
5501126|NCT01648764|19021133|P8|Overall Study|Death|0
5501127|NCT01648764|19021134|P7|Overall Study|Death|1
5501128|NCT01648764|19021135|P6|Overall Study|Death|0
5501129|NCT01648764|19021136|P5|Overall Study|Death|0
5501130|NCT01648764|19021137|P4|Overall Study|Death|0
5501131|NCT01648764|19021138|P3|Overall Study|Death|0
5501132|NCT01648764|19021139|P2|Overall Study|Death|0
5501133|NCT01648764|19021140|P1|Overall Study|Death|0
5501134|NCT01648764|19021127|P14|Overall Study|Adverse Event|1
5501135|NCT01648764|19021128|P13|Overall Study|Adverse Event|1
5501136|NCT01648764|19021129|P12|Overall Study|Adverse Event|3
5501137|NCT01648764|19021130|P11|Overall Study|Adverse Event|0
5501138|NCT01648764|19021131|P10|Overall Study|Adverse Event|1
5501139|NCT01648764|19021132|P9|Overall Study|Adverse Event|0
5501140|NCT01648764|19021133|P8|Overall Study|Adverse Event|0
5501141|NCT01648764|19021134|P7|Overall Study|Adverse Event|0
5501142|NCT01648764|19021135|P6|Overall Study|Adverse Event|1
5501143|NCT01648764|19021136|P5|Overall Study|Adverse Event|0
5501144|NCT01648764|19021137|P4|Overall Study|Adverse Event|0
5501145|NCT01648764|19021138|P3|Overall Study|Adverse Event|0
5501146|NCT01648764|19021139|P2|Overall Study|Adverse Event|0
5501147|NCT01648764|19021140|P1|Overall Study|Adverse Event|0
5501148|NCT01648764|19021127|P14|Overall Study|Progressive Disease|1
5501149|NCT01648764|19021128|P13|Overall Study|Progressive Disease|2
5501150|NCT01648764|19021129|P12|Overall Study|Progressive Disease|1
5501151|NCT01648764|19021130|P11|Overall Study|Progressive Disease|0
5501152|NCT01648764|19021131|P10|Overall Study|Progressive Disease|2
5501153|NCT01648764|19021132|P9|Overall Study|Progressive Disease|0
5501154|NCT01648764|19021133|P8|Overall Study|Progressive Disease|0
5501155|NCT01648764|19021134|P7|Overall Study|Progressive Disease|1
5501156|NCT01648764|19021135|P6|Overall Study|Progressive Disease|1
5501157|NCT01648764|19021136|P5|Overall Study|Progressive Disease|0
5501158|NCT01648764|19021137|P4|Overall Study|Progressive Disease|0
5501159|NCT01648764|19021138|P3|Overall Study|Progressive Disease|0
5501160|NCT01648764|19021139|P2|Overall Study|Progressive Disease|1
5501161|NCT01648764|19021140|P1|Overall Study|Progressive Disease|0
5501162|NCT01648699|19021292|P1|Overall Study|Unspecified/unable to complete 4 visits|2
5501163|NCT01648699|19021292|P1|Overall Study|Lost to Follow-up|2
5501164|NCT01648699|19021292|P1|Overall Study|Death|1
5501165|NCT01648582|19021321|P3|Overall Study|Sponsor Decision|1
5501166|NCT01648582|19021322|P2|Overall Study|Sponsor Decision|1
5501167|NCT01648582|19021323|P1|Overall Study|Sponsor Decision|0
5501168|NCT01648582|19021321|P3|Overall Study|Death|0
5501169|NCT01648582|19021322|P2|Overall Study|Death|0
5501170|NCT01648582|19021323|P1|Overall Study|Death|1
5501171|NCT01648582|19021321|P3|Overall Study|Physician Decision|3
5501172|NCT01648582|19021322|P2|Overall Study|Physician Decision|1
5501173|NCT01648582|19021323|P1|Overall Study|Physician Decision|0
5501174|NCT01648582|19021321|P3|Overall Study|Withdrawal by Subject|17
5501175|NCT01648582|19021322|P2|Overall Study|Withdrawal by Subject|17
5501176|NCT01648582|19021323|P1|Overall Study|Withdrawal by Subject|15
5501177|NCT01648582|19021321|P3|Overall Study|Protocol Violation|1
5501178|NCT01648582|19021322|P2|Overall Study|Protocol Violation|2
5501179|NCT01648582|19021323|P1|Overall Study|Protocol Violation|1
5501180|NCT01648582|19021321|P3|Overall Study|Lost to Follow-up|8
5501181|NCT01648582|19021322|P2|Overall Study|Lost to Follow-up|6
5501182|NCT01648582|19021323|P1|Overall Study|Lost to Follow-up|9
5501183|NCT01648582|19021321|P3|Overall Study|Adverse Event|2
5501184|NCT01648582|19021322|P2|Overall Study|Adverse Event|11
5501185|NCT01648582|19021323|P1|Overall Study|Adverse Event|6
5501186|NCT01648348|19021426|P6|Overall Study|Replaced for MTD analysis|0
5501187|NCT01648348|19021427|P5|Overall Study|Replaced for MTD analysis|0
5501188|NCT01648348|19021428|P4|Overall Study|Replaced for MTD analysis|0
5501189|NCT01648348|19021429|P3|Overall Study|Replaced for MTD analysis|1
5501190|NCT01648348|19021430|P2|Overall Study|Replaced for MTD analysis|0
5501191|NCT01648348|19021431|P1|Overall Study|Replaced for MTD analysis|1
5501192|NCT01648348|19021426|P6|Overall Study|Cancel|6
5501193|NCT01648348|19021427|P5|Overall Study|Cancel|3
5501194|NCT01648348|19021428|P4|Overall Study|Cancel|0
5501195|NCT01648348|19021429|P3|Overall Study|Cancel|0
5501196|NCT01648348|19021430|P2|Overall Study|Cancel|0
5501197|NCT01648348|19021431|P1|Overall Study|Cancel|1
5501198|NCT01648283|19021518|P1|Overall Study|Withdrawal by Subject|14
5501199|NCT01648270|19021524|P1|Intravenous Buprenorphine|Withdrawal by Subject|12
5501200|NCT01648166|19021536|P2|Overall Study|inadequate toenail samples|100
5501201|NCT01648166|19021537|P1|Overall Study|inadequate toenail samples|53
5501202|NCT01648140|19021547|P4|Overall Study|Lost to Follow-up|0
5501203|NCT01648140|19021548|P3|Overall Study|Lost to Follow-up|2
5501204|NCT01648140|19021549|P2|Overall Study|Lost to Follow-up|1
5501205|NCT01648140|19021550|P1|Overall Study|Lost to Follow-up|2
5501206|NCT01648140|19021547|P4|Overall Study|Withdrawal by Subject|2
5501207|NCT01648140|19021548|P3|Overall Study|Withdrawal by Subject|3
5501208|NCT01648140|19021549|P2|Overall Study|Withdrawal by Subject|3
5501209|NCT01648140|19021550|P1|Overall Study|Withdrawal by Subject|2
5501210|NCT01648140|19021547|P4|Overall Study|Adverse Event|0
5501211|NCT01648140|19021548|P3|Overall Study|Adverse Event|2
5501212|NCT01648140|19021549|P2|Overall Study|Adverse Event|1
5501213|NCT01648140|19021550|P1|Overall Study|Adverse Event|3
5501214|NCT01648140|19021547|P4|Overall Study|Lack of Efficacy|0
5501215|NCT01648140|19021548|P3|Overall Study|Lack of Efficacy|1
5501216|NCT01648140|19021549|P2|Overall Study|Lack of Efficacy|7
5501217|NCT01648140|19021550|P1|Overall Study|Lack of Efficacy|4
5501218|NCT01648140|19021547|P4|Overall Study|Physician Decision|0
5501219|NCT01648140|19021548|P3|Overall Study|Physician Decision|0
5501220|NCT01648140|19021549|P2|Overall Study|Physician Decision|0
5501221|NCT01648140|19021550|P1|Overall Study|Physician Decision|1
5501222|NCT01648101|19021715|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
5501223|NCT01648101|19021716|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
5501224|NCT01648101|19021717|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
5501225|NCT01648101|19021715|P3|Transition Phase (4 Weeks)|Study Terminated|0
5501226|NCT01648101|19021716|P2|Transition Phase (4 Weeks)|Study Terminated|0
5501227|NCT01648101|19021717|P1|Transition Phase (4 Weeks)|Study Terminated|1
5501228|NCT01648101|19021715|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
5501229|NCT01648101|19021716|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
5501230|NCT01648101|19021717|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
5501231|NCT01648101|19021715|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
5501232|NCT01648101|19021716|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
5501233|NCT01648101|19021717|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
5501234|NCT01648101|19021715|P3|Transition Phase (4 Weeks)|Adverse Event|2
5501235|NCT01648101|19021716|P2|Transition Phase (4 Weeks)|Adverse Event|3
5501236|NCT01648101|19021717|P1|Transition Phase (4 Weeks)|Adverse Event|4
5501237|NCT01648101|19021715|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
5501238|NCT01648101|19021716|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
5501239|NCT01648101|19021717|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
5501240|NCT01648101|19021715|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
5501241|NCT01648101|19021716|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
5501242|NCT01648101|19021717|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
5501243|NCT01648101|19021715|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
5501244|NCT01648101|19021716|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
5501245|NCT01648101|19021717|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
5501246|NCT01648101|19021715|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
5501247|NCT01648101|19021716|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
5501248|NCT01648101|19021717|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
5501249|NCT01648101|19021715|P3|Titration Phase (4 Weeks)|Adverse Event|3
5501250|NCT01648101|19021716|P2|Titration Phase (4 Weeks)|Adverse Event|2
5501251|NCT01648101|19021717|P1|Titration Phase (4 Weeks)|Adverse Event|0
5501252|NCT01648101|19021715|P3|Titration Phase (4 Weeks)|Protocol Violation|2
5501253|NCT01648101|19021716|P2|Titration Phase (4 Weeks)|Protocol Violation|1
5501254|NCT01648101|19021717|P1|Titration Phase (4 Weeks)|Protocol Violation|2
5501255|NCT01647958|19021767|P2|Extended Follow-up Phase|Lost to Follow-up|0
5501256|NCT01647958|19021768|P1|Extended Follow-up Phase|Lost to Follow-up|8
5501257|NCT01647958|19021767|P2|Continuation Phase|treatment received during Overall Study|0
5501258|NCT01647958|19021768|P1|Continuation Phase|treatment received during Overall Study|39
5501259|NCT01647958|19021767|P2|Initial Study|Lost to Follow-up|3
5501260|NCT01647958|19021768|P1|Initial Study|Lost to Follow-up|2
5501261|NCT01647711|19021855|P5|Overall Study|Other reason not defined|0
5501262|NCT01647711|19021856|P4|Overall Study|Other reason not defined|1
5501263|NCT01647711|19021857|P3|Overall Study|Other reason not defined|1
5501264|NCT01647711|19021858|P2|Overall Study|Other reason not defined|1
5501265|NCT01647711|19021859|P1|Overall Study|Other reason not defined|0
5501266|NCT01647711|19021855|P5|Overall Study|Refused to continue taking medication|1
5501267|NCT01647711|19021856|P4|Overall Study|Refused to continue taking medication|2
5501268|NCT01647711|19021857|P3|Overall Study|Refused to continue taking medication|0
5501269|NCT01647711|19021858|P2|Overall Study|Refused to continue taking medication|0
5501270|NCT01647711|19021859|P1|Overall Study|Refused to continue taking medication|0
5501271|NCT01647711|19021855|P5|Overall Study|Protocol Violation|1
5501272|NCT01647711|19021856|P4|Overall Study|Protocol Violation|0
5501273|NCT01647711|19021857|P3|Overall Study|Protocol Violation|0
5501274|NCT01647711|19021858|P2|Overall Study|Protocol Violation|0
5501275|NCT01647711|19021859|P1|Overall Study|Protocol Violation|0
5501276|NCT01647711|19021855|P5|Overall Study|Other adverse event|2
5501277|NCT01647711|19021856|P4|Overall Study|Other adverse event|0
5501278|NCT01647711|19021857|P3|Overall Study|Other adverse event|2
5501279|NCT01647711|19021858|P2|Overall Study|Other adverse event|0
5501280|NCT01647711|19021859|P1|Overall Study|Other adverse event|0
5501281|NCT01647711|19021855|P5|Overall Study|Progressive disease|2
5501282|NCT01647711|19021856|P4|Overall Study|Progressive disease|8
5501283|NCT01647711|19021857|P3|Overall Study|Progressive disease|6
5501284|NCT01647711|19021858|P2|Overall Study|Progressive disease|2
5501285|NCT01647711|19021859|P1|Overall Study|Progressive disease|6
5501286|NCT01647542|19021896|P3|Overall Study|Death|1
5501287|NCT01647542|19021897|P2|Overall Study|Death|0
5501288|NCT01647542|19021898|P1|Overall Study|Death|0
5501289|NCT01647542|19021896|P3|Overall Study|Lack of Efficacy|0
5501290|NCT01647542|19021897|P2|Overall Study|Lack of Efficacy|1
5501291|NCT01647542|19021898|P1|Overall Study|Lack of Efficacy|1
5501292|NCT01647542|19021896|P3|Overall Study|Study Termination|65
5501293|NCT01647542|19021897|P2|Overall Study|Study Termination|61
5501294|NCT01647542|19021898|P1|Overall Study|Study Termination|64
5501295|NCT01647542|19021896|P3|Overall Study|Withdrawal by Subject|0
5501296|NCT01647542|19021897|P2|Overall Study|Withdrawal by Subject|4
5501297|NCT01647542|19021898|P1|Overall Study|Withdrawal by Subject|6
5501298|NCT01647542|19021896|P3|Overall Study|Lost to Follow-up|2
5501299|NCT01647542|19021897|P2|Overall Study|Lost to Follow-up|2
5501300|NCT01647542|19021898|P1|Overall Study|Lost to Follow-up|0
5501301|NCT01647542|19021896|P3|Overall Study|Adverse Event|4
5501302|NCT01647542|19021897|P2|Overall Study|Adverse Event|5
5501303|NCT01647542|19021898|P1|Overall Study|Adverse Event|4
5501304|NCT01647542|19021896|P3|Overall Study|Major Protocol Deviation|0
5501305|NCT01647542|19021897|P2|Overall Study|Major Protocol Deviation|0
5501306|NCT01647542|19021898|P1|Overall Study|Major Protocol Deviation|1
5501307|NCT01647516|19021918|P6|Open-Label Period|No completion / discontinuation visit|1
5501308|NCT01647516|19021919|P5|Open-Label Period|No completion / discontinuation visit|2
5501309|NCT01647516|19021920|P4|Open-Label Period|No completion / discontinuation visit|0
5501310|NCT01647516|19021921|P3|Open-Label Period|No completion / discontinuation visit|0
5501311|NCT01647516|19021922|P2|Open-Label Period|No completion / discontinuation visit|0
5501312|NCT01647516|19021923|P1|Open-Label Period|No completion / discontinuation visit|0
5501313|NCT01647516|19021918|P6|Open-Label Period|Participant Choice to Stop Study Drug|10
5501314|NCT01647516|19021919|P5|Open-Label Period|Participant Choice to Stop Study Drug|9
5501315|NCT01647516|19021920|P4|Open-Label Period|Participant Choice to Stop Study Drug|7
5501316|NCT01647516|19021921|P3|Open-Label Period|Participant Choice to Stop Study Drug|0
5501317|NCT01647516|19021922|P2|Open-Label Period|Participant Choice to Stop Study Drug|0
5501318|NCT01647516|19021923|P1|Open-Label Period|Participant Choice to Stop Study Drug|0
5501319|NCT01647516|19021918|P6|Open-Label Period|Lack of Efficacy|10
5501320|NCT01647516|19021919|P5|Open-Label Period|Lack of Efficacy|9
5501321|NCT01647516|19021920|P4|Open-Label Period|Lack of Efficacy|7
5501322|NCT01647516|19021921|P3|Open-Label Period|Lack of Efficacy|0
5501323|NCT01647516|19021922|P2|Open-Label Period|Lack of Efficacy|0
5501324|NCT01647516|19021923|P1|Open-Label Period|Lack of Efficacy|0
5501325|NCT01647516|19021918|P6|Open-Label Period|Sponsor Termination; moved to 3102 study|23
5501326|NCT01647516|19021919|P5|Open-Label Period|Sponsor Termination; moved to 3102 study|13
5501327|NCT01647516|19021920|P4|Open-Label Period|Sponsor Termination; moved to 3102 study|18
5501328|NCT01647516|19021921|P3|Open-Label Period|Sponsor Termination; moved to 3102 study|0
5501329|NCT01647516|19021922|P2|Open-Label Period|Sponsor Termination; moved to 3102 study|0
5501330|NCT01647516|19021923|P1|Open-Label Period|Sponsor Termination; moved to 3102 study|0
5501331|NCT01647516|19021918|P6|Open-Label Period|Lost to Follow-up|1
5501332|NCT01647516|19021919|P5|Open-Label Period|Lost to Follow-up|0
5501333|NCT01647516|19021920|P4|Open-Label Period|Lost to Follow-up|1
5501334|NCT01647516|19021921|P3|Open-Label Period|Lost to Follow-up|0
5501335|NCT01647516|19021922|P2|Open-Label Period|Lost to Follow-up|0
5501336|NCT01647516|19021923|P1|Open-Label Period|Lost to Follow-up|0
5501337|NCT01647516|19021918|P6|Open-Label Period|Withdrawal by Subject|6
5501338|NCT01647516|19021919|P5|Open-Label Period|Withdrawal by Subject|11
5501339|NCT01647516|19021920|P4|Open-Label Period|Withdrawal by Subject|9
5501340|NCT01647516|19021921|P3|Open-Label Period|Withdrawal by Subject|0
5501341|NCT01647516|19021922|P2|Open-Label Period|Withdrawal by Subject|0
5501342|NCT01647516|19021923|P1|Open-Label Period|Withdrawal by Subject|0
5501343|NCT01647516|19021918|P6|Open-Label Period|Physician Decision|0
5501344|NCT01647516|19021919|P5|Open-Label Period|Physician Decision|1
5501345|NCT01647516|19021920|P4|Open-Label Period|Physician Decision|1
5501346|NCT01647516|19021921|P3|Open-Label Period|Physician Decision|0
5501347|NCT01647516|19021922|P2|Open-Label Period|Physician Decision|0
5501348|NCT01647516|19021923|P1|Open-Label Period|Physician Decision|0
5501349|NCT01647516|19021918|P6|Open-Label Period|Non-compliance|1
5501350|NCT01647516|19021919|P5|Open-Label Period|Non-compliance|0
5501351|NCT01647516|19021920|P4|Open-Label Period|Non-compliance|1
5501352|NCT01647516|19021921|P3|Open-Label Period|Non-compliance|0
5501353|NCT01647516|19021922|P2|Open-Label Period|Non-compliance|0
5501354|NCT01647516|19021923|P1|Open-Label Period|Non-compliance|0
5501355|NCT01647516|19021918|P6|Open-Label Period|Pregnancy|1
5501356|NCT01647516|19021919|P5|Open-Label Period|Pregnancy|0
5501357|NCT01647516|19021920|P4|Open-Label Period|Pregnancy|0
5501358|NCT01647516|19021921|P3|Open-Label Period|Pregnancy|0
5501359|NCT01647516|19021922|P2|Open-Label Period|Pregnancy|0
5501360|NCT01647516|19021923|P1|Open-Label Period|Pregnancy|0
5501361|NCT01647516|19021918|P6|Open-Label Period|Adverse Event|3
5501362|NCT01647516|19021919|P5|Open-Label Period|Adverse Event|6
5501363|NCT01647516|19021920|P4|Open-Label Period|Adverse Event|5
5501364|NCT01647516|19021921|P3|Open-Label Period|Adverse Event|0
5501365|NCT01647516|19021922|P2|Open-Label Period|Adverse Event|0
5501366|NCT01647516|19021923|P1|Open-Label Period|Adverse Event|0
5501367|NCT01647516|19021918|P6|Maintenance Period (MP)|Lack of Efficacy|0
5501368|NCT01647516|19021919|P5|Maintenance Period (MP)|Lack of Efficacy|0
5501369|NCT01647516|19021920|P4|Maintenance Period (MP)|Lack of Efficacy|0
5501370|NCT01647516|19021921|P3|Maintenance Period (MP)|Lack of Efficacy|1
5501371|NCT01647516|19021922|P2|Maintenance Period (MP)|Lack of Efficacy|4
5501372|NCT01647516|19021923|P1|Maintenance Period (MP)|Lack of Efficacy|1
5501373|NCT01647516|19021918|P6|Maintenance Period (MP)|Withdrawal by Subject|0
5501374|NCT01647516|19021919|P5|Maintenance Period (MP)|Withdrawal by Subject|0
5501375|NCT01647516|19021920|P4|Maintenance Period (MP)|Withdrawal by Subject|0
5501376|NCT01647516|19021921|P3|Maintenance Period (MP)|Withdrawal by Subject|1
5501377|NCT01647516|19021922|P2|Maintenance Period (MP)|Withdrawal by Subject|1
5501378|NCT01647516|19021923|P1|Maintenance Period (MP)|Withdrawal by Subject|0
5501379|NCT01647516|19021918|P6|Maintenance Period (MP)|Non-compliance|0
5501380|NCT01647516|19021919|P5|Maintenance Period (MP)|Non-compliance|0
5501381|NCT01647516|19021920|P4|Maintenance Period (MP)|Non-compliance|0
5501382|NCT01647516|19021921|P3|Maintenance Period (MP)|Non-compliance|0
5501383|NCT01647516|19021922|P2|Maintenance Period (MP)|Non-compliance|0
5501384|NCT01647516|19021923|P1|Maintenance Period (MP)|Non-compliance|1
5501385|NCT01647516|19021918|P6|Maintenance Period (MP)|Adverse Event|0
5501386|NCT01647516|19021919|P5|Maintenance Period (MP)|Adverse Event|0
5501387|NCT01647516|19021920|P4|Maintenance Period (MP)|Adverse Event|0
5501388|NCT01647516|19021921|P3|Maintenance Period (MP)|Adverse Event|0
5501389|NCT01647516|19021922|P2|Maintenance Period (MP)|Adverse Event|1
5501390|NCT01647516|19021923|P1|Maintenance Period (MP)|Adverse Event|2
5501391|NCT01647516|19021918|P6|Induction Period (IP)|No study drug received|0
5501392|NCT01647516|19021919|P5|Induction Period (IP)|No study drug received|0
5501393|NCT01647516|19021920|P4|Induction Period (IP)|No study drug received|0
5501394|NCT01647516|19021921|P3|Induction Period (IP)|No study drug received|0
5501395|NCT01647516|19021922|P2|Induction Period (IP)|No study drug received|1
5501396|NCT01647516|19021923|P1|Induction Period (IP)|No study drug received|1
5501397|NCT01647516|19021918|P6|Induction Period (IP)|Lack of Efficacy|0
5501398|NCT01647516|19021919|P5|Induction Period (IP)|Lack of Efficacy|0
5501399|NCT01647516|19021920|P4|Induction Period (IP)|Lack of Efficacy|0
5501400|NCT01647516|19021921|P3|Induction Period (IP)|Lack of Efficacy|0
5501401|NCT01647516|19021922|P2|Induction Period (IP)|Lack of Efficacy|0
5501402|NCT01647516|19021923|P1|Induction Period (IP)|Lack of Efficacy|1
5501403|NCT01647516|19021918|P6|Induction Period (IP)|Participant Choice|0
5501404|NCT01647516|19021919|P5|Induction Period (IP)|Participant Choice|0
5501405|NCT01647516|19021920|P4|Induction Period (IP)|Participant Choice|0
5501406|NCT01647516|19021921|P3|Induction Period (IP)|Participant Choice|1
5501407|NCT01647516|19021922|P2|Induction Period (IP)|Participant Choice|0
5501408|NCT01647516|19021923|P1|Induction Period (IP)|Participant Choice|0
5501409|NCT01647516|19021918|P6|Induction Period (IP)|Withdrawal by Subject|0
5501410|NCT01647516|19021919|P5|Induction Period (IP)|Withdrawal by Subject|0
5501411|NCT01647516|19021920|P4|Induction Period (IP)|Withdrawal by Subject|0
5501412|NCT01647516|19021921|P3|Induction Period (IP)|Withdrawal by Subject|3
5501413|NCT01647516|19021922|P2|Induction Period (IP)|Withdrawal by Subject|0
5501414|NCT01647516|19021923|P1|Induction Period (IP)|Withdrawal by Subject|1
5501415|NCT01647516|19021918|P6|Induction Period (IP)|Adverse Event|0
5501416|NCT01647516|19021919|P5|Induction Period (IP)|Adverse Event|0
5501417|NCT01647516|19021920|P4|Induction Period (IP)|Adverse Event|0
5501418|NCT01647516|19021921|P3|Induction Period (IP)|Adverse Event|0
5501419|NCT01647516|19021922|P2|Induction Period (IP)|Adverse Event|2
5501420|NCT01647516|19021923|P1|Induction Period (IP)|Adverse Event|1
5501421|NCT01647516|19021918|P6|Induction Period (IP)|Physician Decision|0
5501422|NCT01647516|19021919|P5|Induction Period (IP)|Physician Decision|0
5501423|NCT01647516|19021920|P4|Induction Period (IP)|Physician Decision|0
5501424|NCT01647516|19021921|P3|Induction Period (IP)|Physician Decision|0
5501425|NCT01647516|19021922|P2|Induction Period (IP)|Physician Decision|0
5501426|NCT01647516|19021923|P1|Induction Period (IP)|Physician Decision|2
5501427|NCT01647282|19021979|P2|Overall Study|Physician Decision|5
5501428|NCT01647282|19021980|P1|Overall Study|Physician Decision|7
5501429|NCT01646827|19022001|P2|Overall Study|Withdrawal by Subject|0
5501430|NCT01646827|19022002|P1|Overall Study|Withdrawal by Subject|1
5501431|NCT01646827|19022001|P2|Overall Study|Physician Decision|2
5501432|NCT01646827|19022002|P1|Overall Study|Physician Decision|1
5501433|NCT01646827|19022001|P2|Overall Study|Lost to Follow-up|3
5501434|NCT01646827|19022002|P1|Overall Study|Lost to Follow-up|0
5501435|NCT01646645|19022087|P1|Overall Study|Inevaluable Donor|29
5501436|NCT01646645|19022087|P1|Overall Study|No Treated|1
5501437|NCT01646398|19022094|P2|Overall Study|Withdrawal by Subject|0
5501438|NCT01646398|19022095|P1|Overall Study|Withdrawal by Subject|1
5501439|NCT01646385|19022111|P2|Overall Study|Switched to alternate biologic|649
5501440|NCT01646385|19022112|P1|Overall Study|Switched to alternate biologic|636
5501441|NCT01646385|19022111|P2|Overall Study|Death|222
5501442|NCT01646385|19022112|P1|Overall Study|Death|202
5501443|NCT01646320|19022155|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
5501444|NCT01646320|19022156|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
5501445|NCT01646320|19022155|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
5501446|NCT01646320|19022156|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
5501447|NCT01646320|19022155|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
5501448|NCT01646320|19022156|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
5501449|NCT01646320|19022155|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
5501450|NCT01646320|19022156|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
5501451|NCT01646320|19022155|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
5501452|NCT01646320|19022156|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
5501453|NCT01646320|19022155|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
5501454|NCT01646320|19022156|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
5501455|NCT01646320|19022155|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5501456|NCT01646320|19022156|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5501457|NCT01646320|19022155|P2|Short-term Period (Day 1 to Week 24)|Other|0
5501458|NCT01646320|19022156|P1|Short-term Period (Day 1 to Week 24)|Other|1
5501459|NCT01646320|19022155|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
5501460|NCT01646320|19022156|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
5501461|NCT01646320|19022155|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
5501462|NCT01646320|19022156|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
5501463|NCT01646320|19022155|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
5501464|NCT01646320|19022156|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
5501465|NCT01646268|19022172|P2|Overall Study|Other|0
5501466|NCT01646268|19022173|P1|Overall Study|Other|2
5501467|NCT01646268|19022172|P2|Overall Study|Withdrawal by Subject|5
5501468|NCT01646268|19022173|P1|Overall Study|Withdrawal by Subject|2
5501469|NCT01646268|19022172|P2|Overall Study|Protocol Violation|1
5501470|NCT01646268|19022173|P1|Overall Study|Protocol Violation|0
5501471|NCT01646268|19022172|P2|Overall Study|Lack of Efficacy|3
5501472|NCT01646268|19022173|P1|Overall Study|Lack of Efficacy|1
5501473|NCT01646268|19022172|P2|Overall Study|Adverse Event|7
5501474|NCT01646268|19022173|P1|Overall Study|Adverse Event|6
5501475|NCT01646255|19022187|P2|Overall Study|Inclusion Criteria Deviation|0
5501476|NCT01646255|19022188|P1|Overall Study|Inclusion Criteria Deviation|1
5501477|NCT01646255|19022187|P2|Overall Study|Compliance is not well|0
5501478|NCT01646255|19022188|P1|Overall Study|Compliance is not well|1
5501479|NCT01646255|19022187|P2|Overall Study|Withdrawal by Subject|6
5501480|NCT01646255|19022188|P1|Overall Study|Withdrawal by Subject|10
5501481|NCT01646255|19022187|P2|Overall Study|Lack of Efficacy|0
5501482|NCT01646255|19022188|P1|Overall Study|Lack of Efficacy|2
5501483|NCT01646255|19022187|P2|Overall Study|Adverse Event|8
5501484|NCT01646255|19022188|P1|Overall Study|Adverse Event|7
5501485|NCT01646216|19022220|P2|Overall Study|Investigator decision|1
5501486|NCT01646216|19022221|P1|Overall Study|Investigator decision|1
5501487|NCT01646216|19022220|P2|Overall Study|Did not complete training|2
5501488|NCT01646216|19022221|P1|Overall Study|Did not complete training|0
5501489|NCT01646216|19022220|P2|Overall Study|Baseline step length difference (<5cm)|10
5501490|NCT01646216|19022221|P1|Overall Study|Baseline step length difference (<5cm)|10
5501491|NCT01646203|19022243|P3|Overall Study|Physician's Decision|0
5501492|NCT01646203|19022244|P2|Overall Study|Physician's Decision|1
5501493|NCT01646203|19022245|P1|Overall Study|Physician's Decision|0
5501494|NCT01646203|19022243|P3|Overall Study|Withdrawal by Subject|0
5501495|NCT01646203|19022244|P2|Overall Study|Withdrawal by Subject|1
5501496|NCT01646203|19022245|P1|Overall Study|Withdrawal by Subject|0
5501497|NCT01646203|19022243|P3|Overall Study|Adverse Event|1
5501498|NCT01646203|19022244|P2|Overall Study|Adverse Event|0
5501499|NCT01646203|19022245|P1|Overall Study|Adverse Event|2
5501500|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
5501501|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
5501502|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501503|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501504|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501505|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501506|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501507|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501508|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501509|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501510|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501511|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
5501512|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Death|1
5501513|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Death|1
5501514|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5501515|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Death|1
5501516|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5501517|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5501518|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5501519|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5501520|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5501521|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5501522|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5501523|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Death|0
5501524|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
5501525|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
5501526|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
5501527|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5501528|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5501529|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5501530|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5501531|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5501532|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5501533|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5501534|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5501900|NCT01645280|19022575|P1|Overall Study|Withdrawal by Subject|4
5501535|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
5501536|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
5501537|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
5501538|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
5501539|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5501540|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5501541|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5501542|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5501543|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5501544|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5501545|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5501546|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5501547|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
5501548|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
5501549|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
5501550|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
5501551|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
5501552|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5501553|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5501554|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5501555|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5501556|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5501557|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5501558|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5501559|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
5501560|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
5501561|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
5501562|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
5501563|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
5501564|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5501565|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5501566|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5501567|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5501568|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5501569|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5501570|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5501571|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
5501572|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
5501573|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
5501574|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
5501575|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
5501576|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5501577|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5501578|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5501579|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5501580|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5501581|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5501582|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5501583|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
5501584|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
5501585|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
5501586|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
5501587|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
5501588|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5501589|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5501590|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5501591|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5501592|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5501593|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5501594|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5501595|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
5501596|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
5501597|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
5501598|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
5501599|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
5501600|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5501601|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5501602|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5501603|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5501604|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5501605|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5501606|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5501607|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
5501608|NCT01646177|19022274|P12|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
5501609|NCT01646177|19022275|P11|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
5501610|NCT01646177|19022276|P10|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
5501611|NCT01646177|19022277|P9|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
5501612|NCT01646177|19022278|P8|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5501613|NCT01646177|19022279|P7|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5501614|NCT01646177|19022280|P6|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5501615|NCT01646177|19022281|P5|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5501616|NCT01646177|19022282|P4|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5501617|NCT01646177|19022283|P3|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5501618|NCT01646177|19022284|P2|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5501619|NCT01646177|19022285|P1|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
5501620|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5501621|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5501622|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5501623|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5501624|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
5501625|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
5501626|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
5501627|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5501628|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5501629|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5501630|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5501631|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
5501632|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501633|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501634|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501635|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501636|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
5501637|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501638|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501639|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501640|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501641|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501642|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501643|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
5501644|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5501645|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5501646|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5501647|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5501648|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
5501649|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
5501650|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
5501651|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
5501652|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5501653|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5501654|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5501655|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
5501656|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Death|0
5501657|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Death|0
5501658|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Death|0
5501659|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Death|0
5501660|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Death|3
5501661|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Death|1
5501662|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Death|3
5501663|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Death|1
5501664|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Death|0
5501665|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Death|0
5501666|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Death|0
5501667|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Death|0
5501668|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5501669|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5501670|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5501671|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5501672|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
5501673|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
5501674|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
5501675|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
5501676|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5501677|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5501678|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5501679|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
5501680|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5501681|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5501682|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5501683|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5501684|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
5501685|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5501686|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
5501687|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
5501688|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5501689|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5501690|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5501691|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
5501692|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5501693|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5501694|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5501695|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5501696|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Physician Decision|5
5501697|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Physician Decision|5
5501698|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Physician Decision|5
5501699|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Physician Decision|3
5501700|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5501701|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5501702|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5501703|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Physician Decision|0
5501704|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5501705|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5501706|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5501707|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5501708|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
5501709|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
5501710|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
5501711|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
5501712|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5501713|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5501714|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5501715|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
5501716|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5501717|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5501718|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5501719|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5501720|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
5501721|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
5501722|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
5501723|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
5501724|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5501725|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5501726|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5501727|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
5501728|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5501729|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5501730|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5501731|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5501732|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
5501733|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
5501734|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
5501735|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
5501736|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5501737|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5501738|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5501739|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
5501740|NCT01646177|19022274|P12|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5501741|NCT01646177|19022275|P11|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5501742|NCT01646177|19022276|P10|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5501743|NCT01646177|19022277|P9|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5501744|NCT01646177|19022278|P8|Long-Term Extension Period (Week 12-264)|Adverse Event|30
5501745|NCT01646177|19022279|P7|Long-Term Extension Period (Week 12-264)|Adverse Event|43
5501746|NCT01646177|19022280|P6|Long-Term Extension Period (Week 12-264)|Adverse Event|34
5501747|NCT01646177|19022281|P5|Long-Term Extension Period (Week 12-264)|Adverse Event|16
5501748|NCT01646177|19022282|P4|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5501749|NCT01646177|19022283|P3|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5501750|NCT01646177|19022284|P2|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5501751|NCT01646177|19022285|P1|Long-Term Extension Period (Week 12-264)|Adverse Event|0
5501752|NCT01646177|19022274|P12|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5501753|NCT01646177|19022275|P11|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5501754|NCT01646177|19022276|P10|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5501755|NCT01646177|19022277|P9|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5501756|NCT01646177|19022278|P8|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5501757|NCT01646177|19022279|P7|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5501758|NCT01646177|19022280|P6|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5501759|NCT01646177|19022281|P5|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5501760|NCT01646177|19022282|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
5501761|NCT01646177|19022283|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
5501762|NCT01646177|19022284|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
5501763|NCT01646177|19022285|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
5501764|NCT01646177|19022274|P12|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501765|NCT01646177|19022275|P11|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501766|NCT01646177|19022276|P10|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501767|NCT01646177|19022277|P9|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501768|NCT01646177|19022278|P8|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501769|NCT01646177|19022279|P7|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501770|NCT01646177|19022280|P6|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501771|NCT01646177|19022281|P5|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501772|NCT01646177|19022282|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
5501773|NCT01646177|19022283|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
5501774|NCT01646177|19022284|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501775|NCT01646177|19022285|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
5501776|NCT01646177|19022274|P12|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5501777|NCT01646177|19022275|P11|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5501778|NCT01646177|19022276|P10|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5501779|NCT01646177|19022277|P9|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5501780|NCT01646177|19022278|P8|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5501781|NCT01646177|19022279|P7|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5501782|NCT01646177|19022280|P6|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5501783|NCT01646177|19022281|P5|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
5501784|NCT01646177|19022282|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
5501785|NCT01646177|19022283|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
5501786|NCT01646177|19022284|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
5501787|NCT01646177|19022285|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
5501788|NCT01646177|19022274|P12|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5501789|NCT01646177|19022275|P11|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5501790|NCT01646177|19022276|P10|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5501791|NCT01646177|19022277|P9|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5501792|NCT01646177|19022278|P8|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5501793|NCT01646177|19022279|P7|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5501794|NCT01646177|19022280|P6|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5501795|NCT01646177|19022281|P5|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
5501796|NCT01646177|19022282|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
5501797|NCT01646177|19022283|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
5501798|NCT01646177|19022284|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
5501799|NCT01646177|19022285|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
5501800|NCT01646177|19022274|P12|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5501801|NCT01646177|19022275|P11|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5501802|NCT01646177|19022276|P10|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5501803|NCT01646177|19022277|P9|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5501804|NCT01646177|19022278|P8|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5501805|NCT01646177|19022279|P7|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5501806|NCT01646177|19022280|P6|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5501807|NCT01646177|19022281|P5|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
5501808|NCT01646177|19022282|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
5501809|NCT01646177|19022283|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
5501810|NCT01646177|19022284|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
5501811|NCT01646177|19022285|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
5501812|NCT01646177|19022274|P12|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5501813|NCT01646177|19022275|P11|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5501814|NCT01646177|19022276|P10|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5501815|NCT01646177|19022277|P9|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5501816|NCT01646177|19022278|P8|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5501817|NCT01646177|19022279|P7|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5501818|NCT01646177|19022280|P6|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5501819|NCT01646177|19022281|P5|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
5501820|NCT01646177|19022282|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
5501821|NCT01646177|19022283|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
5501822|NCT01646177|19022284|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
5501823|NCT01646177|19022285|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
5501824|NCT01646138|19022387|P5|Overall Study|Lost to Follow-up|2
5501825|NCT01646138|19022388|P4|Overall Study|Lost to Follow-up|0
5501826|NCT01646138|19022389|P3|Overall Study|Lost to Follow-up|0
5501827|NCT01646138|19022390|P2|Overall Study|Lost to Follow-up|0
5501828|NCT01646138|19022391|P1|Overall Study|Lost to Follow-up|0
5501829|NCT01646125|19022405|P2|Overall Study|Subject/Guardian decision|1
5501830|NCT01646125|19022406|P1|Overall Study|Subject/Guardian decision|1
5501831|NCT01646125|19022405|P2|Overall Study|Study terminated by sponsor|1
5501832|NCT01646125|19022406|P1|Overall Study|Study terminated by sponsor|2
5501833|NCT01646125|19022405|P2|Overall Study|Progressive disease|16
5501834|NCT01646125|19022406|P1|Overall Study|Progressive disease|22
5501835|NCT01646125|19022405|P2|Overall Study|Physician Decision|3
5501836|NCT01646125|19022406|P1|Overall Study|Physician Decision|1
5501837|NCT01646125|19022405|P2|Overall Study|Death|1
5501838|NCT01646125|19022406|P1|Overall Study|Death|1
5501839|NCT01646125|19022405|P2|Overall Study|Adverse Event|1
5501840|NCT01646125|19022406|P1|Overall Study|Adverse Event|2
5501841|NCT01646125|19022405|P2|Overall Study|Untreated|5
5501842|NCT01646125|19022406|P1|Overall Study|Untreated|2
5501843|NCT01646073|19022431|P2|Period B (12 Weeks)|Lost to Follow-up|1
5501844|NCT01646073|19022432|P1|Period B (12 Weeks)|Lost to Follow-up|0
5501845|NCT01646073|19022431|P2|Period B (12 Weeks)|Withdrawal by Subject|5
5501846|NCT01646073|19022432|P1|Period B (12 Weeks)|Withdrawal by Subject|1
5501847|NCT01646073|19022431|P2|Period B (12 Weeks)|Adverse Event|7
5501848|NCT01646073|19022432|P1|Period B (12 Weeks)|Adverse Event|0
5501849|NCT01646073|19022431|P2|Period A (12 Weeks)|Other|1
5501850|NCT01646073|19022432|P1|Period A (12 Weeks)|Other|0
5501851|NCT01646073|19022431|P2|Period A (12 Weeks)|Protocol Violation|1
5501852|NCT01646073|19022432|P1|Period A (12 Weeks)|Protocol Violation|0
5501853|NCT01646073|19022431|P2|Period A (12 Weeks)|Lack of Efficacy|0
5501854|NCT01646073|19022432|P1|Period A (12 Weeks)|Lack of Efficacy|1
5501855|NCT01646073|19022431|P2|Period A (12 Weeks)|Withdrawal by Subject|1
5501856|NCT01646073|19022432|P1|Period A (12 Weeks)|Withdrawal by Subject|1
5501857|NCT01646073|19022431|P2|Period A (12 Weeks)|Adverse Event|2
5501858|NCT01646073|19022432|P1|Period A (12 Weeks)|Adverse Event|0
5501859|NCT01646021|19022473|P2|Overall Study|Withdrawal by Subject|15
5501860|NCT01646021|19022474|P1|Overall Study|Withdrawal by Subject|10
5501861|NCT01646021|19022473|P2|Overall Study|Lost to Follow-up|2
5501862|NCT01646021|19022474|P1|Overall Study|Lost to Follow-up|2
5501863|NCT01646021|19022473|P2|Overall Study|Study Terminated by Sponsor|41
5501864|NCT01646021|19022474|P1|Overall Study|Study Terminated by Sponsor|50
5501865|NCT01646021|19022473|P2|Overall Study|Death|83
5501866|NCT01646021|19022474|P1|Overall Study|Death|77
5501867|NCT01645930|19022511|P1|Overall Study|Reason not Defined|1
5501868|NCT01645930|19022511|P1|Overall Study|Withdrawal by Participant|2
5501869|NCT01645930|19022511|P1|Overall Study|Unsatisfactory Therapeutic Response|2
5501870|NCT01645930|19022511|P1|Overall Study|Adverse Event|4
5501871|NCT01645930|19022511|P1|Overall Study|Progressive Disease|12
5501872|NCT01645930|19022511|P1|Overall Study|Participants Ongoing on Study Treatment|22
5501873|NCT01645735|19022528|P2|Overall Study|Adverse Event|1
5501874|NCT01645735|19022529|P1|Overall Study|Adverse Event|0
5501875|NCT01645735|19022528|P2|Overall Study|Protocol Violation|0
5501876|NCT01645735|19022529|P1|Overall Study|Protocol Violation|1
5501877|NCT01645735|19022528|P2|Overall Study|Withdrawal by Subject|0
5501878|NCT01645735|19022529|P1|Overall Study|Withdrawal by Subject|1
5501879|NCT01645735|19022528|P2|Overall Study|Physician Decision|0
5501880|NCT01645735|19022529|P1|Overall Study|Physician Decision|2
5501881|NCT01645280|19022571|P5|Overall Study|Treatment not completed/Completed f/u|2
5501882|NCT01645280|19022572|P4|Overall Study|Treatment not completed/Completed f/u|0
5501883|NCT01645280|19022573|P3|Overall Study|Treatment not completed/Completed f/u|2
5501884|NCT01645280|19022574|P2|Overall Study|Treatment not completed/Completed f/u|1
5501885|NCT01645280|19022575|P1|Overall Study|Treatment not completed/Completed f/u|1
5501886|NCT01645280|19022571|P5|Overall Study|Other|0
5501887|NCT01645280|19022572|P4|Overall Study|Other|0
5501888|NCT01645280|19022573|P3|Overall Study|Other|2
5501889|NCT01645280|19022574|P2|Overall Study|Other|1
5501890|NCT01645280|19022575|P1|Overall Study|Other|1
5501891|NCT01645280|19022571|P5|Overall Study|Lost to Follow-up|1
5501892|NCT01645280|19022572|P4|Overall Study|Lost to Follow-up|2
5501893|NCT01645280|19022573|P3|Overall Study|Lost to Follow-up|0
5501894|NCT01645280|19022574|P2|Overall Study|Lost to Follow-up|0
5501895|NCT01645280|19022575|P1|Overall Study|Lost to Follow-up|0
5501896|NCT01645280|19022571|P5|Overall Study|Withdrawal by Subject|5
5501897|NCT01645280|19022572|P4|Overall Study|Withdrawal by Subject|4
5501898|NCT01645280|19022573|P3|Overall Study|Withdrawal by Subject|2
5501899|NCT01645280|19022574|P2|Overall Study|Withdrawal by Subject|0
5501901|NCT01645280|19022571|P5|Overall Study|Death|0
5501902|NCT01645280|19022572|P4|Overall Study|Death|0
5501903|NCT01645280|19022573|P3|Overall Study|Death|0
5501904|NCT01645280|19022574|P2|Overall Study|Death|1
5501905|NCT01645280|19022575|P1|Overall Study|Death|0
5501906|NCT01645176|19022603|P1|Overall Study|did not complete final MRI|1
5501907|NCT01645176|19022603|P1|Overall Study|Lack of Efficacy|4
5501908|NCT01645111|19022607|P1|Overall Study|Did not require Clevidipine|15
5501909|NCT01644890|19022648|P2|Overall Study|Other|9
5501910|NCT01644890|19022649|P1|Overall Study|Other|8
5501911|NCT01644890|19022648|P2|Overall Study|> 28 days since last dose of study drug|3
5501912|NCT01644890|19022649|P1|Overall Study|> 28 days since last dose of study drug|6
5501913|NCT01644890|19022648|P2|Overall Study|Clinical Progression|6
5501914|NCT01644890|19022649|P1|Overall Study|Clinical Progression|6
5501915|NCT01644890|19022648|P2|Overall Study|Progression Disease|131
5501916|NCT01644890|19022649|P1|Overall Study|Progression Disease|160
5501917|NCT01644890|19022648|P2|Overall Study|Withdrawal by Subject|27
5501918|NCT01644890|19022649|P1|Overall Study|Withdrawal by Subject|19
5501919|NCT01644890|19022648|P2|Overall Study|Protocol Violation|7
5501920|NCT01644890|19022649|P1|Overall Study|Protocol Violation|6
5501921|NCT01644890|19022648|P2|Overall Study|Physician Decision|9
5501922|NCT01644890|19022649|P1|Overall Study|Physician Decision|3
5501923|NCT01644890|19022648|P2|Overall Study|Death|3
5501924|NCT01644890|19022649|P1|Overall Study|Death|1
5501925|NCT01644890|19022648|P2|Overall Study|Adverse Event|20
5501926|NCT01644890|19022649|P1|Overall Study|Adverse Event|7
5501927|NCT01644734|19022659|P1|Overall Study|Missing documentation|238
5501928|NCT01644734|19022659|P1|Overall Study|Reasons other than stated above|7
5501929|NCT01644734|19022659|P1|Overall Study|Lost to Follow-up|17
5501930|NCT01644734|19022659|P1|Overall Study|Adverse Event|4
5501931|NCT01644643|19022673|P4|Overall Study|Other Eligibility criteria|2
5501932|NCT01644643|19022674|P3|Overall Study|Other Eligibility criteria|0
5501933|NCT01644643|19022675|P2|Overall Study|Other Eligibility criteria|0
5501934|NCT01644643|19022676|P1|Overall Study|Other Eligibility criteria|0
5501935|NCT01644643|19022673|P4|Overall Study|Withdrawal by Subject|1
5501936|NCT01644643|19022674|P3|Overall Study|Withdrawal by Subject|2
5501937|NCT01644643|19022675|P2|Overall Study|Withdrawal by Subject|0
5501938|NCT01644643|19022676|P1|Overall Study|Withdrawal by Subject|1
5501939|NCT01644643|19022673|P4|Overall Study|Lost to Follow-up|4
5501940|NCT01644643|19022674|P3|Overall Study|Lost to Follow-up|0
5501941|NCT01644643|19022675|P2|Overall Study|Lost to Follow-up|0
5501942|NCT01644643|19022676|P1|Overall Study|Lost to Follow-up|0
5501943|NCT01644643|19022673|P4|Overall Study|Death|3
5501944|NCT01644643|19022674|P3|Overall Study|Death|3
5501945|NCT01644643|19022675|P2|Overall Study|Death|0
5501946|NCT01644643|19022676|P1|Overall Study|Death|1
5501947|NCT01644617|19022841|P3|Overall Study|Adverse Event|6
5501948|NCT01644617|19022842|P2|Overall Study|Adverse Event|0
5501949|NCT01644617|19022843|P1|Overall Study|Adverse Event|3
5501950|NCT01644617|19022841|P3|Overall Study|Lost to Follow-up|0
5501951|NCT01644617|19022842|P2|Overall Study|Lost to Follow-up|1
5501952|NCT01644617|19022843|P1|Overall Study|Lost to Follow-up|0
5501953|NCT01644617|19022841|P3|Overall Study|Withdrawal by Subject|1
5501954|NCT01644617|19022842|P2|Overall Study|Withdrawal by Subject|4
5501955|NCT01644617|19022843|P1|Overall Study|Withdrawal by Subject|3
5501956|NCT01644565|19022893|P9|Overall Study|Relocation|1
5501957|NCT01644565|19022894|P8|Overall Study|Relocation|0
5501958|NCT01644565|19022895|P7|Overall Study|Relocation|0
5501959|NCT01644565|19022896|P6|Overall Study|Relocation|0
5501960|NCT01644565|19022897|P5|Overall Study|Relocation|0
5501961|NCT01644565|19022898|P4|Overall Study|Relocation|0
5501962|NCT01644565|19022899|P3|Overall Study|Relocation|0
5501963|NCT01644565|19022900|P2|Overall Study|Relocation|0
5501964|NCT01644565|19022901|P1|Overall Study|Relocation|0
5501965|NCT01644565|19022893|P9|Overall Study|Family emergency|0
5501966|NCT01644565|19022894|P8|Overall Study|Family emergency|0
5501967|NCT01644565|19022895|P7|Overall Study|Family emergency|0
5501968|NCT01644565|19022896|P6|Overall Study|Family emergency|0
5501969|NCT01644565|19022897|P5|Overall Study|Family emergency|1
5501970|NCT01644565|19022898|P4|Overall Study|Family emergency|0
5501971|NCT01644565|19022899|P3|Overall Study|Family emergency|0
5501972|NCT01644565|19022900|P2|Overall Study|Family emergency|0
5501973|NCT01644565|19022901|P1|Overall Study|Family emergency|0
5501974|NCT01644565|19022893|P9|Overall Study|Lost to Follow-up|0
5501975|NCT01644565|19022894|P8|Overall Study|Lost to Follow-up|2
5501976|NCT01644565|19022895|P7|Overall Study|Lost to Follow-up|0
5501977|NCT01644565|19022896|P6|Overall Study|Lost to Follow-up|0
5501978|NCT01644565|19022897|P5|Overall Study|Lost to Follow-up|0
5501979|NCT01644565|19022898|P4|Overall Study|Lost to Follow-up|1
5501980|NCT01644565|19022899|P3|Overall Study|Lost to Follow-up|0
5501981|NCT01644565|19022900|P2|Overall Study|Lost to Follow-up|0
5501982|NCT01644565|19022901|P1|Overall Study|Lost to Follow-up|0
5501983|NCT01644565|19022893|P9|Overall Study|Undisclosed Medical History|0
5501984|NCT01644565|19022894|P8|Overall Study|Undisclosed Medical History|0
5501985|NCT01644565|19022895|P7|Overall Study|Undisclosed Medical History|0
5501986|NCT01644565|19022896|P6|Overall Study|Undisclosed Medical History|0
5501987|NCT01644565|19022897|P5|Overall Study|Undisclosed Medical History|0
5501988|NCT01644565|19022898|P4|Overall Study|Undisclosed Medical History|0
5501989|NCT01644565|19022899|P3|Overall Study|Undisclosed Medical History|0
5501990|NCT01644565|19022900|P2|Overall Study|Undisclosed Medical History|0
5501991|NCT01644565|19022901|P1|Overall Study|Undisclosed Medical History|1
5501992|NCT01644500|19022942|P3|Overall Study|Physician Decision|1
5501993|NCT01644500|19022943|P2|Overall Study|Physician Decision|1
5501994|NCT01644500|19022944|P1|Overall Study|Physician Decision|1
5501995|NCT01644500|19022942|P3|Overall Study|Withdrawal by Subject|12
5501996|NCT01644500|19022943|P2|Overall Study|Withdrawal by Subject|12
5501997|NCT01644500|19022944|P1|Overall Study|Withdrawal by Subject|11
5501998|NCT01644500|19022942|P3|Overall Study|Protocol Violation|0
5501999|NCT01644500|19022943|P2|Overall Study|Protocol Violation|1
5502000|NCT01644500|19022944|P1|Overall Study|Protocol Violation|1
5502001|NCT01644500|19022942|P3|Overall Study|Lost to Follow-up|0
5502002|NCT01644500|19022943|P2|Overall Study|Lost to Follow-up|8
5502003|NCT01644500|19022944|P1|Overall Study|Lost to Follow-up|3
5502004|NCT01644500|19022942|P3|Overall Study|Death|0
5502005|NCT01644500|19022943|P2|Overall Study|Death|1
5502006|NCT01644500|19022944|P1|Overall Study|Death|0
5502007|NCT01644500|19022942|P3|Overall Study|Adverse Event|2
5502008|NCT01644500|19022943|P2|Overall Study|Adverse Event|1
5502009|NCT01644500|19022944|P1|Overall Study|Adverse Event|6
5502010|NCT01644474|19023014|P2|Overall Study|Protocol Violation|0
5502011|NCT01644474|19023015|P1|Overall Study|Protocol Violation|1
5502012|NCT01644474|19023014|P2|Overall Study|Site scheduling error|1
5502013|NCT01644474|19023015|P1|Overall Study|Site scheduling error|1
5502014|NCT01644474|19023014|P2|Overall Study|Adverse Event|5
5502015|NCT01644474|19023015|P1|Overall Study|Adverse Event|4
5502016|NCT01644474|19023014|P2|Overall Study|Participant moved|1
5502017|NCT01644474|19023015|P1|Overall Study|Participant moved|0
5502018|NCT01644474|19023014|P2|Overall Study|Consent withdrawn by participant|1
5502019|NCT01644474|19023015|P1|Overall Study|Consent withdrawn by participant|0
5502020|NCT01644474|19023014|P2|Overall Study|Poor compliance to protocol|0
5502021|NCT01644474|19023015|P1|Overall Study|Poor compliance to protocol|1
5502022|NCT01644188|19023199|P2|Overall Study|Other than specified above|7
5502023|NCT01644188|19023200|P1|Overall Study|Other than specified above|6
5502024|NCT01644188|19023199|P2|Overall Study|Site closure|1
5502025|NCT01644188|19023200|P1|Overall Study|Site closure|1
5502026|NCT01644188|19023199|P2|Overall Study|Last visit outside protocol visit window|16
5502027|NCT01644188|19023200|P1|Overall Study|Last visit outside protocol visit window|14
5502028|NCT01644188|19023199|P2|Overall Study|Death|3
5502029|NCT01644188|19023200|P1|Overall Study|Death|4
5502030|NCT01644188|19023199|P2|Overall Study|Lost to Follow-up|0
5502031|NCT01644188|19023200|P1|Overall Study|Lost to Follow-up|1
5502032|NCT01644188|19023199|P2|Overall Study|Selection criteria finally not met|0
5502033|NCT01644188|19023200|P1|Overall Study|Selection criteria finally not met|2
5502034|NCT01644188|19023199|P2|Overall Study|Consent withdrawn by participant|7
5502035|NCT01644188|19023200|P1|Overall Study|Consent withdrawn by participant|14
5502036|NCT01644188|19023199|P2|Overall Study|Related to auto-injector administration|2
5502037|NCT01644188|19023200|P1|Overall Study|Related to auto-injector administration|2
5502038|NCT01644188|19023199|P2|Overall Study|Participant moved|2
5502039|NCT01644188|19023200|P1|Overall Study|Participant moved|7
5502040|NCT01644188|19023199|P2|Overall Study|Physician Decision|3
5502041|NCT01644188|19023200|P1|Overall Study|Physician Decision|1
5502042|NCT01644188|19023199|P2|Overall Study|Poor compliance to protocol|14
5502043|NCT01644188|19023200|P1|Overall Study|Poor compliance to protocol|26
5502044|NCT01644188|19023199|P2|Overall Study|Adverse Event|20
5502045|NCT01644188|19023200|P1|Overall Study|Adverse Event|44
5502046|NCT01644175|19023258|P2|Overall Study|Other than specified above|3
5502047|NCT01644175|19023259|P1|Overall Study|Other than specified above|0
5502048|NCT01644175|19023258|P2|Overall Study|Lost to Follow-up|0
5502049|NCT01644175|19023259|P1|Overall Study|Lost to Follow-up|1
5502050|NCT01644175|19023258|P2|Overall Study|Site closure|2
5502051|NCT01644175|19023259|P1|Overall Study|Site closure|2
5502052|NCT01644175|19023258|P2|Overall Study|Selection criteria finally not met|1
5502053|NCT01644175|19023259|P1|Overall Study|Selection criteria finally not met|0
5502054|NCT01644175|19023258|P2|Overall Study|Last visit outside protocol visit window|11
5502055|NCT01644175|19023259|P1|Overall Study|Last visit outside protocol visit window|4
5502056|NCT01644175|19023258|P2|Overall Study|Related to Autoinjector Administration|1
5502057|NCT01644175|19023259|P1|Overall Study|Related to Autoinjector Administration|2
5502058|NCT01644175|19023258|P2|Overall Study|Consent withdrawn by participant|4
5502059|NCT01644175|19023259|P1|Overall Study|Consent withdrawn by participant|3
5502060|NCT01644175|19023258|P2|Overall Study|Participant Moved|2
5502061|NCT01644175|19023259|P1|Overall Study|Participant Moved|1
5502062|NCT01644175|19023258|P2|Overall Study|Physician Decision|2
5502063|NCT01644175|19023259|P1|Overall Study|Physician Decision|1
5502064|NCT01644175|19023258|P2|Overall Study|Poor compliance to protocol|10
5502065|NCT01644175|19023259|P1|Overall Study|Poor compliance to protocol|9
5502066|NCT01644175|19023258|P2|Overall Study|Death|2
5502067|NCT01644175|19023259|P1|Overall Study|Death|1
5502068|NCT01644175|19023258|P2|Overall Study|Adverse Event|13
5502069|NCT01644175|19023259|P1|Overall Study|Adverse Event|8
5502070|NCT01644175|19023258|P2|Overall Study|Randomized But Not Treated|2
5502071|NCT01644175|19023259|P1|Overall Study|Randomized But Not Treated|0
5502072|NCT01644149|19023311|P2|Overall Study|Lost to Follow-up|1
5502073|NCT01644149|19023312|P1|Overall Study|Lost to Follow-up|3
5502074|NCT01644149|19023311|P2|Overall Study|Withdrawal by Subject|0
5502075|NCT01644149|19023312|P1|Overall Study|Withdrawal by Subject|1
5502076|NCT01643928|19023332|P5|Overall Study|Adverse Event|2
5502077|NCT01643928|19023333|P4|Overall Study|Adverse Event|1
5502078|NCT01643928|19023334|P3|Overall Study|Adverse Event|0
5502079|NCT01643928|19023335|P2|Overall Study|Adverse Event|1
5502080|NCT01643928|19023336|P1|Overall Study|Adverse Event|2
5502081|NCT01643928|19023332|P5|Overall Study|Other|0
5502082|NCT01643928|19023333|P4|Overall Study|Other|0
5502083|NCT01643928|19023334|P3|Overall Study|Other|1
5502084|NCT01643928|19023335|P2|Overall Study|Other|1
5502085|NCT01643928|19023336|P1|Overall Study|Other|5
5502086|NCT01643928|19023332|P5|Overall Study|Pregnancy|0
5502087|NCT01643928|19023333|P4|Overall Study|Pregnancy|1
5502088|NCT01643928|19023334|P3|Overall Study|Pregnancy|0
5502089|NCT01643928|19023335|P2|Overall Study|Pregnancy|0
5502090|NCT01643928|19023336|P1|Overall Study|Pregnancy|0
5502091|NCT01643928|19023332|P5|Overall Study|Withdrawal by Subject|0
5502092|NCT01643928|19023333|P4|Overall Study|Withdrawal by Subject|1
5502093|NCT01643928|19023334|P3|Overall Study|Withdrawal by Subject|0
5502094|NCT01643928|19023335|P2|Overall Study|Withdrawal by Subject|0
5502095|NCT01643928|19023336|P1|Overall Study|Withdrawal by Subject|2
5502096|NCT01643928|19023332|P5|Overall Study|Lost to Follow-up|0
5502097|NCT01643928|19023333|P4|Overall Study|Lost to Follow-up|0
5502098|NCT01643928|19023334|P3|Overall Study|Lost to Follow-up|2
5502099|NCT01643928|19023335|P2|Overall Study|Lost to Follow-up|0
5502100|NCT01643928|19023336|P1|Overall Study|Lost to Follow-up|1
5502101|NCT01643850|19023640|P9|Overall Study|Administrative Problems|0
5502102|NCT01643850|19023641|P8|Overall Study|Administrative Problems|0
5502103|NCT01643850|19023642|P7|Overall Study|Administrative Problems|0
5502104|NCT01643850|19023643|P6|Overall Study|Administrative Problems|0
5502105|NCT01643850|19023644|P5|Overall Study|Administrative Problems|1
5502106|NCT01643850|19023645|P4|Overall Study|Administrative Problems|0
5502107|NCT01643850|19023646|P3|Overall Study|Administrative Problems|1
5502108|NCT01643850|19023647|P2|Overall Study|Administrative Problems|0
5502109|NCT01643850|19023648|P1|Overall Study|Administrative Problems|0
5502110|NCT01643850|19023640|P9|Overall Study|Adverse Event|0
5502111|NCT01643850|19023641|P8|Overall Study|Adverse Event|0
5502112|NCT01643850|19023642|P7|Overall Study|Adverse Event|0
5502113|NCT01643850|19023643|P6|Overall Study|Adverse Event|0
5502114|NCT01643850|19023644|P5|Overall Study|Adverse Event|1
5502115|NCT01643850|19023645|P4|Overall Study|Adverse Event|0
5502116|NCT01643850|19023646|P3|Overall Study|Adverse Event|0
5502117|NCT01643850|19023647|P2|Overall Study|Adverse Event|0
5502118|NCT01643850|19023648|P1|Overall Study|Adverse Event|0
5502119|NCT01643850|19023640|P9|Overall Study|Lost to Follow-up|1
5502120|NCT01643850|19023641|P8|Overall Study|Lost to Follow-up|0
5502121|NCT01643850|19023642|P7|Overall Study|Lost to Follow-up|1
5502122|NCT01643850|19023643|P6|Overall Study|Lost to Follow-up|0
5502123|NCT01643850|19023644|P5|Overall Study|Lost to Follow-up|0
5502124|NCT01643850|19023645|P4|Overall Study|Lost to Follow-up|0
5502125|NCT01643850|19023646|P3|Overall Study|Lost to Follow-up|0
5502126|NCT01643850|19023647|P2|Overall Study|Lost to Follow-up|0
5502127|NCT01643850|19023648|P1|Overall Study|Lost to Follow-up|0
5502128|NCT01643850|19023640|P9|Overall Study|Withdrawal by Subject|0
5502129|NCT01643850|19023641|P8|Overall Study|Withdrawal by Subject|0
5502130|NCT01643850|19023642|P7|Overall Study|Withdrawal by Subject|0
5502131|NCT01643850|19023643|P6|Overall Study|Withdrawal by Subject|0
5502132|NCT01643850|19023644|P5|Overall Study|Withdrawal by Subject|1
5502133|NCT01643850|19023645|P4|Overall Study|Withdrawal by Subject|0
5502134|NCT01643850|19023646|P3|Overall Study|Withdrawal by Subject|0
5502135|NCT01643850|19023647|P2|Overall Study|Withdrawal by Subject|0
5502136|NCT01643850|19023648|P1|Overall Study|Withdrawal by Subject|0
5502137|NCT01643798|19023787|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
5502138|NCT01643798|19023788|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
5502139|NCT01643772|19023803|P4|Overall Study|Adverse Event|1
5502140|NCT01643772|19023804|P3|Overall Study|Adverse Event|0
5502141|NCT01643772|19023805|P2|Overall Study|Adverse Event|0
5502142|NCT01643772|19023806|P1|Overall Study|Adverse Event|0
5502143|NCT01643772|19023803|P4|Overall Study|Protocol Violation|1
5502144|NCT01643772|19023804|P3|Overall Study|Protocol Violation|0
5502145|NCT01643772|19023805|P2|Overall Study|Protocol Violation|0
5502146|NCT01643772|19023806|P1|Overall Study|Protocol Violation|0
5502147|NCT01643668|19023846|P1|Overall Study|Death|1
5502148|NCT01643473|19023877|P2|Overall Study|Lost to Follow-up|0
5502149|NCT01643473|19023878|P1|Overall Study|Lost to Follow-up|1
5502150|NCT01643044|19023910|P2|Overall Study|Delivered outside of hospital|2
5502151|NCT01643044|19023911|P1|Overall Study|Delivered outside of hospital|1
5502152|NCT01643044|19023910|P2|Overall Study|Miscarried baby|2
5502153|NCT01643044|19023911|P1|Overall Study|Miscarried baby|2
5502154|NCT01643044|19023910|P2|Overall Study|Lost to Follow-up|1
5502155|NCT01643044|19023911|P1|Overall Study|Lost to Follow-up|1
5502156|NCT01642914|19023920|P3|Overall Study|Other Reason|0
5502157|NCT01642914|19023921|P2|Overall Study|Other Reason|0
5502158|NCT01642914|19023922|P1|Overall Study|Other Reason|1
5502159|NCT01642914|19023920|P3|Overall Study|Lost to Follow-up|7
5502160|NCT01642914|19023921|P2|Overall Study|Lost to Follow-up|3
5502161|NCT01642914|19023922|P1|Overall Study|Lost to Follow-up|5
5502162|NCT01642914|19023920|P3|Overall Study|Withdrawal by Subject|10
5502163|NCT01642914|19023921|P2|Overall Study|Withdrawal by Subject|5
5502164|NCT01642914|19023922|P1|Overall Study|Withdrawal by Subject|5
5502165|NCT01642914|19023920|P3|Overall Study|Protocol Violation|6
5502166|NCT01642914|19023921|P2|Overall Study|Protocol Violation|13
5502167|NCT01642914|19023922|P1|Overall Study|Protocol Violation|15
5502168|NCT01642914|19023920|P3|Overall Study|Lack of Efficacy|2
5502169|NCT01642914|19023921|P2|Overall Study|Lack of Efficacy|4
5502170|NCT01642914|19023922|P1|Overall Study|Lack of Efficacy|9
5502171|NCT01642914|19023920|P3|Overall Study|Adverse Event|15
5502172|NCT01642914|19023921|P2|Overall Study|Adverse Event|7
5502173|NCT01642914|19023922|P1|Overall Study|Adverse Event|11
5502174|NCT01642732|19023997|P1|Overall Study|Withdrawal by Subject|1
5502175|NCT01642615|19024002|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
5502176|NCT01642615|19024003|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
5502177|NCT01642615|19024004|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
5502178|NCT01642615|19024002|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
5502179|NCT01642615|19024003|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
5502180|NCT01642615|19024004|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
5502181|NCT01642615|19024002|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
5502182|NCT01642615|19024003|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
5502183|NCT01642615|19024004|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
5502184|NCT01642615|19024002|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
5502185|NCT01642615|19024003|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
5502186|NCT01642615|19024004|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
5502187|NCT01642615|19024002|P3|Open Label Maintenance Phase|Did not receive treatment|0
5502188|NCT01642615|19024003|P2|Open Label Maintenance Phase|Did not receive treatment|0
5502189|NCT01642615|19024004|P1|Open Label Maintenance Phase|Did not receive treatment|1
5502190|NCT01642615|19024002|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
5502191|NCT01642615|19024003|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
5502192|NCT01642615|19024004|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
5502193|NCT01642615|19024002|P3|Open Label Maintenance Phase|Lost to Follow-up|0
5502194|NCT01642615|19024003|P2|Open Label Maintenance Phase|Lost to Follow-up|0
5502195|NCT01642615|19024004|P1|Open Label Maintenance Phase|Lost to Follow-up|1
5502196|NCT01642615|19024002|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
5502197|NCT01642615|19024003|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
5502198|NCT01642615|19024004|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
5502199|NCT01642615|19024002|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
5502200|NCT01642615|19024003|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
5502201|NCT01642615|19024004|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
5502202|NCT01642602|19024018|P1|Overall Study|Adverse Event|2
5502203|NCT01642589|19024025|P2|Overall Study|Withdrawal by Subject|1
5502204|NCT01642589|19024026|P1|Overall Study|Withdrawal by Subject|1
5502205|NCT01642407|19024065|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
5502206|NCT01642407|19024065|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
5502207|NCT01642407|19024065|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
5502208|NCT01642277|19024112|P2|Overall Study|Withdrawal by Subject|0
5502209|NCT01642277|19024113|P1|Overall Study|Withdrawal by Subject|11
5502210|NCT01642277|19024112|P2|Overall Study|Protocol Violation|0
5502211|NCT01642277|19024113|P1|Overall Study|Protocol Violation|1
5502212|NCT01642277|19024112|P2|Overall Study|Physician Decision|0
5502213|NCT01642277|19024113|P1|Overall Study|Physician Decision|2
5502214|NCT01642277|19024112|P2|Overall Study|Adverse Event|0
5502215|NCT01642277|19024113|P1|Overall Study|Adverse Event|10
5502216|NCT01642251|19024125|P4|Overall Study|Ineligible/never start protocol therapy|8
5502217|NCT01642251|19024126|P3|Overall Study|Ineligible/never start protocol therapy|11
5502218|NCT01642251|19024127|P2|Overall Study|Ineligible/never start protocol therapy|0
5502219|NCT01642251|19024128|P1|Overall Study|Ineligible/never start protocol therapy|0
5502220|NCT01642251|19024125|P4|Overall Study|Other complicating disease|0
5502221|NCT01642251|19024126|P3|Overall Study|Other complicating disease|1
5502222|NCT01642251|19024127|P2|Overall Study|Other complicating disease|0
5502223|NCT01642251|19024128|P1|Overall Study|Other complicating disease|0
5502224|NCT01642251|19024125|P4|Overall Study|Alternative therapy|2
5502225|NCT01642251|19024126|P3|Overall Study|Alternative therapy|0
5502226|NCT01642251|19024127|P2|Overall Study|Alternative therapy|0
5502227|NCT01642251|19024128|P1|Overall Study|Alternative therapy|0
5502228|NCT01642251|19024125|P4|Overall Study|Withdrawal by Subject|3
5502229|NCT01642251|19024126|P3|Overall Study|Withdrawal by Subject|1
5502230|NCT01642251|19024127|P2|Overall Study|Withdrawal by Subject|0
5502231|NCT01642251|19024128|P1|Overall Study|Withdrawal by Subject|0
5502232|NCT01642251|19024125|P4|Overall Study|Death|3
5502233|NCT01642251|19024126|P3|Overall Study|Death|1
5502234|NCT01642251|19024127|P2|Overall Study|Death|0
5502235|NCT01642251|19024128|P1|Overall Study|Death|0
5502236|NCT01642251|19024125|P4|Overall Study|Adverse Event|4
5502237|NCT01642251|19024126|P3|Overall Study|Adverse Event|5
5502238|NCT01642251|19024127|P2|Overall Study|Adverse Event|0
5502239|NCT01642251|19024128|P1|Overall Study|Adverse Event|0
5502240|NCT01642251|19024125|P4|Overall Study|Progressive disease|3
5502241|NCT01642251|19024126|P3|Overall Study|Progressive disease|3
5502242|NCT01642251|19024127|P2|Overall Study|Progressive disease|0
5502243|NCT01642251|19024128|P1|Overall Study|Progressive disease|0
5502244|NCT01642212|19024166|P5|Open-label Extension|Other|1
5502245|NCT01642212|19024167|P4|Open-label Extension|Other|0
5502246|NCT01642212|19024168|P3|Open-label Extension|Other|0
5502247|NCT01642212|19024169|P2|Open-label Extension|Other|0
5502248|NCT01642212|19024170|P1|Open-label Extension|Other|0
5502249|NCT01642212|19024166|P5|Open-label Extension|Lost to Follow-up|1
5502250|NCT01642212|19024167|P4|Open-label Extension|Lost to Follow-up|0
5502251|NCT01642212|19024168|P3|Open-label Extension|Lost to Follow-up|0
5502252|NCT01642212|19024169|P2|Open-label Extension|Lost to Follow-up|0
5502253|NCT01642212|19024170|P1|Open-label Extension|Lost to Follow-up|0
5502254|NCT01642212|19024166|P5|Open-label Extension|Consent Withdrawn|2
5502255|NCT01642212|19024167|P4|Open-label Extension|Consent Withdrawn|0
5502256|NCT01642212|19024168|P3|Open-label Extension|Consent Withdrawn|0
5502257|NCT01642212|19024169|P2|Open-label Extension|Consent Withdrawn|0
5502258|NCT01642212|19024170|P1|Open-label Extension|Consent Withdrawn|0
5502259|NCT01642212|19024166|P5|Open-label Extension|Sponsor Decision|4
5502260|NCT01642212|19024167|P4|Open-label Extension|Sponsor Decision|7
5502261|NCT01642212|19024168|P3|Open-label Extension|Sponsor Decision|0
5502262|NCT01642212|19024169|P2|Open-label Extension|Sponsor Decision|0
5502263|NCT01642212|19024170|P1|Open-label Extension|Sponsor Decision|0
5502264|NCT01642212|19024166|P5|Open-label Extension|Adverse Event|0
5502265|NCT01642212|19024167|P4|Open-label Extension|Adverse Event|3
5502266|NCT01642212|19024168|P3|Open-label Extension|Adverse Event|0
5502267|NCT01642212|19024169|P2|Open-label Extension|Adverse Event|0
5502268|NCT01642212|19024170|P1|Open-label Extension|Adverse Event|0
5502269|NCT01642212|19024166|P5|Double-blind Treatment|Adverse Event|0
5502270|NCT01642212|19024167|P4|Double-blind Treatment|Adverse Event|0
5502271|NCT01642212|19024168|P3|Double-blind Treatment|Adverse Event|1
5502272|NCT01642212|19024169|P2|Double-blind Treatment|Adverse Event|0
5502273|NCT01642212|19024170|P1|Double-blind Treatment|Adverse Event|0
5502274|NCT01642212|19024166|P5|Double-blind Treatment|Non-compliance|0
5502275|NCT01642212|19024167|P4|Double-blind Treatment|Non-compliance|0
5502276|NCT01642212|19024168|P3|Double-blind Treatment|Non-compliance|0
5502277|NCT01642212|19024169|P2|Double-blind Treatment|Non-compliance|1
5502278|NCT01642212|19024170|P1|Double-blind Treatment|Non-compliance|0
5502279|NCT01642212|19024166|P5|Double-blind Treatment|Other|0
5502280|NCT01642212|19024167|P4|Double-blind Treatment|Other|0
5502281|NCT01642212|19024168|P3|Double-blind Treatment|Other|1
5502282|NCT01642212|19024169|P2|Double-blind Treatment|Other|2
5502283|NCT01642212|19024170|P1|Double-blind Treatment|Other|0
5502284|NCT01642212|19024166|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5502285|NCT01642212|19024167|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5502286|NCT01642212|19024168|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5502287|NCT01642212|19024169|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
5502288|NCT01642212|19024170|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
5502289|NCT01642004|19024265|P2|Treatment|Missing from data|1
5502290|NCT01642004|19024266|P1|Treatment|Missing from data|0
5502291|NCT01642004|19024265|P2|Treatment|Other|2
5502292|NCT01642004|19024266|P1|Treatment|Other|1
5502293|NCT01642004|19024265|P2|Treatment|No longer meets study criteria|2
5502294|NCT01642004|19024266|P1|Treatment|No longer meets study criteria|1
5502295|NCT01642004|19024265|P2|Treatment|Poor/non-compliance|0
5502296|NCT01642004|19024266|P1|Treatment|Poor/non-compliance|1
5502297|NCT01642004|19024265|P2|Treatment|Maximum clinical benefit|7
5502298|NCT01642004|19024266|P1|Treatment|Maximum clinical benefit|2
5502299|NCT01642004|19024265|P2|Treatment|Withdrawal by Subject|9
5502300|NCT01642004|19024266|P1|Treatment|Withdrawal by Subject|5
5502301|NCT01642004|19024265|P2|Treatment|Adverse event unrelated to study drug|13
5502302|NCT01642004|19024266|P1|Treatment|Adverse event unrelated to study drug|6
5502303|NCT01642004|19024265|P2|Treatment|Death|0
5502304|NCT01642004|19024266|P1|Treatment|Death|1
5502305|NCT01642004|19024265|P2|Treatment|Study drug toxicity|13
5502306|NCT01642004|19024266|P1|Treatment|Study drug toxicity|5
5502307|NCT01642004|19024265|P2|Treatment|Disease progression|80
5502308|NCT01642004|19024266|P1|Treatment|Disease progression|88
5502309|NCT01642004|19024265|P2|Randomization|No longer meets study criteria|2
5502310|NCT01642004|19024266|P1|Randomization|No longer meets study criteria|2
5502311|NCT01642004|19024265|P2|Randomization|Withdrawal by Subject|6
5502312|NCT01642004|19024266|P1|Randomization|Withdrawal by Subject|1
5502313|NCT01642004|19024265|P2|Randomization|Adverse Event unrelated to study drug|0
5502314|NCT01642004|19024266|P1|Randomization|Adverse Event unrelated to study drug|1
5502315|NCT01641991|19024300|P4|Overall Study|no longer eligible|4
5502316|NCT01641991|19024301|P3|Overall Study|no longer eligible|0
5502317|NCT01641991|19024302|P2|Overall Study|no longer eligible|1
5502318|NCT01641991|19024303|P1|Overall Study|no longer eligible|2
5502319|NCT01641991|19024300|P4|Overall Study|Pregnancy|0
5502320|NCT01641991|19024301|P3|Overall Study|Pregnancy|1
5502321|NCT01641991|19024302|P2|Overall Study|Pregnancy|0
5502322|NCT01641991|19024303|P1|Overall Study|Pregnancy|0
5502323|NCT01641991|19024300|P4|Overall Study|Protocol Violation|0
5502324|NCT01641991|19024301|P3|Overall Study|Protocol Violation|3
5502325|NCT01641991|19024302|P2|Overall Study|Protocol Violation|1
5502326|NCT01641991|19024303|P1|Overall Study|Protocol Violation|1
5502327|NCT01641991|19024300|P4|Overall Study|Lost to Follow-up|1
5502328|NCT01641991|19024301|P3|Overall Study|Lost to Follow-up|3
5502329|NCT01641991|19024302|P2|Overall Study|Lost to Follow-up|2
5502330|NCT01641991|19024303|P1|Overall Study|Lost to Follow-up|0
5502331|NCT01641991|19024300|P4|Overall Study|Adverse Event|1
5502332|NCT01641991|19024301|P3|Overall Study|Adverse Event|2
5502333|NCT01641991|19024302|P2|Overall Study|Adverse Event|1
5502334|NCT01641991|19024303|P1|Overall Study|Adverse Event|2
5502335|NCT01641991|19024300|P4|Overall Study|Withdrawal by Subject|5
5502336|NCT01641991|19024301|P3|Overall Study|Withdrawal by Subject|1
5502337|NCT01641991|19024302|P2|Overall Study|Withdrawal by Subject|2
5502338|NCT01641991|19024303|P1|Overall Study|Withdrawal by Subject|4
5502339|NCT01641991|19024300|P4|Overall Study|Physician Decision|5
5502340|NCT01641991|19024301|P3|Overall Study|Physician Decision|7
5502341|NCT01641991|19024302|P2|Overall Study|Physician Decision|1
5502342|NCT01641991|19024303|P1|Overall Study|Physician Decision|0
5502343|NCT01641952|19024387|P1|Overall Study|Adverse Event|6
5502344|NCT01641952|19024387|P1|Overall Study|Lost to Follow-up|28
5502345|NCT01641939|19024403|P3|Overall Study|Study Terminated by Sponsor|3
5502346|NCT01641939|19024404|P2|Overall Study|Study Terminated by Sponsor|28
5502347|NCT01641939|19024405|P1|Overall Study|Study Terminated by Sponsor|10
5502348|NCT01641939|19024403|P3|Overall Study|Withdrawal by Subject|5
5502349|NCT01641939|19024404|P2|Overall Study|Withdrawal by Subject|11
5502350|NCT01641939|19024405|P1|Overall Study|Withdrawal by Subject|14
5502351|NCT01641939|19024403|P3|Overall Study|Lost to Follow-up|1
5502352|NCT01641939|19024404|P2|Overall Study|Lost to Follow-up|2
5502353|NCT01641939|19024405|P1|Overall Study|Lost to Follow-up|3
5502354|NCT01641939|19024403|P3|Overall Study|Death|61
5502355|NCT01641939|19024404|P2|Overall Study|Death|187
5502356|NCT01641939|19024405|P1|Overall Study|Death|90
5502357|NCT01641926|19024448|P4|Overall Study|Not Treated|0
5502358|NCT01641926|19024449|P3|Overall Study|Not Treated|1
5502359|NCT01641926|19024450|P2|Overall Study|Not Treated|1
5502360|NCT01641926|19024451|P1|Overall Study|Not Treated|1
5502361|NCT01641926|19024448|P4|Overall Study|Withdrawal by Subject|1
5502362|NCT01641926|19024449|P3|Overall Study|Withdrawal by Subject|6
5502363|NCT01641926|19024450|P2|Overall Study|Withdrawal by Subject|5
5502364|NCT01641926|19024451|P1|Overall Study|Withdrawal by Subject|13
5502365|NCT01641926|19024448|P4|Overall Study|Protocol Violation|1
5502366|NCT01641926|19024449|P3|Overall Study|Protocol Violation|0
5502367|NCT01641926|19024450|P2|Overall Study|Protocol Violation|0
5502368|NCT01641926|19024451|P1|Overall Study|Protocol Violation|1
5502369|NCT01641926|19024448|P4|Overall Study|Physician Decision|1
5502370|NCT01641926|19024449|P3|Overall Study|Physician Decision|0
5502371|NCT01641926|19024450|P2|Overall Study|Physician Decision|5
5502372|NCT01641926|19024451|P1|Overall Study|Physician Decision|6
5502373|NCT01641926|19024448|P4|Overall Study|Lost to Follow-up|0
5502374|NCT01641926|19024449|P3|Overall Study|Lost to Follow-up|1
5502375|NCT01641926|19024450|P2|Overall Study|Lost to Follow-up|2
5502376|NCT01641926|19024451|P1|Overall Study|Lost to Follow-up|2
5502377|NCT01641926|19024448|P4|Overall Study|Adverse Event|1
5502378|NCT01641926|19024449|P3|Overall Study|Adverse Event|3
5502379|NCT01641926|19024450|P2|Overall Study|Adverse Event|2
5502380|NCT01641926|19024451|P1|Overall Study|Adverse Event|5
5502381|NCT01641900|19024479|P2|Overall Study|Withdrawal by Subject|2
5502382|NCT01641900|19024480|P1|Overall Study|Withdrawal by Subject|2
5502383|NCT01641861|19024492|P2|Overall Study|Died due to drowning|1
5502384|NCT01641861|19024493|P1|Overall Study|Died due to drowning|0
5502385|NCT01641861|19024492|P2|Overall Study|Lost the tooth due to normal exfoliation|8
5502386|NCT01641861|19024493|P1|Overall Study|Lost the tooth due to normal exfoliation|14
5502387|NCT01641861|19024492|P2|Overall Study|Lost to Follow-up|16
5502388|NCT01641861|19024493|P1|Overall Study|Lost to Follow-up|21
5502389|NCT01641822|19024514|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
5502390|NCT01641822|19024515|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
5502391|NCT01641822|19024516|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
5502392|NCT01641822|19024514|P3|Comparative Phase|Withdrew consent|7
5502393|NCT01641822|19024515|P2|Comparative Phase|Withdrew consent|3
5502394|NCT01641822|19024516|P1|Comparative Phase|Withdrew consent|0
5502395|NCT01641822|19024514|P3|Comparative Phase|Adverse event, serious fatal|0
5502396|NCT01641822|19024515|P2|Comparative Phase|Adverse event, serious fatal|1
5502397|NCT01641822|19024516|P1|Comparative Phase|Adverse event, serious fatal|0
5502398|NCT01641822|19024514|P3|Comparative Phase|Pregnancy|1
5502399|NCT01641822|19024515|P2|Comparative Phase|Pregnancy|0
5502400|NCT01641822|19024516|P1|Comparative Phase|Pregnancy|0
5502401|NCT01641822|19024514|P3|Comparative Phase|Investigator's discretion|1
5502402|NCT01641822|19024515|P2|Comparative Phase|Investigator's discretion|0
5502403|NCT01641822|19024516|P1|Comparative Phase|Investigator's discretion|0
5502404|NCT01641822|19024514|P3|Comparative Phase|Noncompliance with study drug|0
5502405|NCT01641822|19024515|P2|Comparative Phase|Noncompliance with study drug|1
5502406|NCT01641822|19024516|P1|Comparative Phase|Noncompliance with study drug|0
5502407|NCT01641822|19024514|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
5502408|NCT01641822|19024515|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
5502409|NCT01641822|19024516|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
5502410|NCT01641822|19024514|P3|Run-in Phase|Withdrew consent|0
5502411|NCT01641822|19024515|P2|Run-in Phase|Withdrew consent|0
5502412|NCT01641822|19024516|P1|Run-in Phase|Withdrew consent|1
5502413|NCT01641822|19024514|P3|Run-in Phase|Adverse Event|0
5502414|NCT01641822|19024515|P2|Run-in Phase|Adverse Event|0
5502415|NCT01641822|19024516|P1|Run-in Phase|Adverse Event|3
5502416|NCT01641822|19024514|P3|Run-in Phase|Noncompliance with study drug|0
5502417|NCT01641822|19024515|P2|Run-in Phase|Noncompliance with study drug|0
5502418|NCT01641822|19024516|P1|Run-in Phase|Noncompliance with study drug|1
5502419|NCT01641809|19024537|P4|Open-label (Week 96 to Week 324)|Adverse Event|0
5502420|NCT01641809|19024538|P3|Open-label (Week 96 to Week 324)|Adverse Event|1
5502421|NCT01641809|19024539|P2|Open-label (Week 96 to Week 324)|Adverse Event|2
5502422|NCT01641809|19024540|P1|Open-label (Week 96 to Week 324)|Adverse Event|3
5502423|NCT01641809|19024537|P4|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
5502424|NCT01641809|19024538|P3|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
5502425|NCT01641809|19024539|P2|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
5502426|NCT01641809|19024540|P1|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
5502427|NCT01641809|19024537|P4|Open-label (Week 96 to Week 324)|Protocol Violation|0
5502428|NCT01641809|19024538|P3|Open-label (Week 96 to Week 324)|Protocol Violation|0
5502429|NCT01641809|19024539|P2|Open-label (Week 96 to Week 324)|Protocol Violation|1
5502430|NCT01641809|19024540|P1|Open-label (Week 96 to Week 324)|Protocol Violation|1
5502431|NCT01641809|19024537|P4|Open-label (Week 96 to Week 324)|Site closed|0
5502432|NCT01641809|19024538|P3|Open-label (Week 96 to Week 324)|Site closed|0
5502433|NCT01641809|19024539|P2|Open-label (Week 96 to Week 324)|Site closed|0
5502434|NCT01641809|19024540|P1|Open-label (Week 96 to Week 324)|Site closed|1
5502435|NCT01641809|19024537|P4|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
5502436|NCT01641809|19024538|P3|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
5502437|NCT01641809|19024539|P2|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
5502438|NCT01641809|19024540|P1|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
5502439|NCT01641809|19024537|P4|Open-label (Week 96 to Week 324)|Physician Decision|0
5502440|NCT01641809|19024538|P3|Open-label (Week 96 to Week 324)|Physician Decision|1
5502441|NCT01641809|19024539|P2|Open-label (Week 96 to Week 324)|Physician Decision|1
5502442|NCT01641809|19024540|P1|Open-label (Week 96 to Week 324)|Physician Decision|0
5502443|NCT01641809|19024537|P4|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
5502444|NCT01641809|19024538|P3|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
5502445|NCT01641809|19024539|P2|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
5502446|NCT01641809|19024540|P1|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
5502447|NCT01641809|19024537|P4|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
5502448|NCT01641809|19024538|P3|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
5502449|NCT01641809|19024539|P2|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
5502450|NCT01641809|19024540|P1|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
5502451|NCT01641809|19024537|P4|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
5502452|NCT01641809|19024538|P3|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
5502453|NCT01641809|19024539|P2|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
5502454|NCT01641809|19024540|P1|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
5502455|NCT01641809|19024537|P4|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
5502456|NCT01641809|19024538|P3|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
5502457|NCT01641809|19024539|P2|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
5502458|NCT01641809|19024540|P1|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
5502459|NCT01641809|19024537|P4|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
5502460|NCT01641809|19024538|P3|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
5502461|NCT01641809|19024539|P2|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
5502462|NCT01641809|19024540|P1|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
5502463|NCT01641809|19024537|P4|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
5502464|NCT01641809|19024538|P3|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
5502465|NCT01641809|19024539|P2|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
5502466|NCT01641809|19024540|P1|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
5502467|NCT01641809|19024537|P4|Induction Phase (Day 1 to Week 24)|Adverse Event|7
5502468|NCT01641809|19024538|P3|Induction Phase (Day 1 to Week 24)|Adverse Event|3
5502469|NCT01641809|19024539|P2|Induction Phase (Day 1 to Week 24)|Adverse Event|1
5502470|NCT01641809|19024540|P1|Induction Phase (Day 1 to Week 24)|Adverse Event|0
5502471|NCT01641809|19024537|P4|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
5502472|NCT01641809|19024538|P3|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
5502473|NCT01641809|19024539|P2|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
5502474|NCT01641809|19024540|P1|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
5502475|NCT01641809|19024537|P4|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
5502476|NCT01641809|19024538|P3|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
5502477|NCT01641809|19024539|P2|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
5502478|NCT01641809|19024540|P1|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
5502479|NCT01641809|19024537|P4|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
5502480|NCT01641809|19024538|P3|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
5502481|NCT01641809|19024539|P2|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
5502482|NCT01641809|19024540|P1|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
5502483|NCT01641809|19024537|P4|Induction Phase (Day 1 to Week 24)|Physician Decision|1
5502484|NCT01641809|19024538|P3|Induction Phase (Day 1 to Week 24)|Physician Decision|0
5502485|NCT01641809|19024539|P2|Induction Phase (Day 1 to Week 24)|Physician Decision|1
5502486|NCT01641809|19024540|P1|Induction Phase (Day 1 to Week 24)|Physician Decision|0
5502487|NCT01641809|19024537|P4|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
5502488|NCT01641809|19024538|P3|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
5502489|NCT01641809|19024539|P2|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
5502490|NCT01641809|19024540|P1|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
5502491|NCT01641692|19024724|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
5502492|NCT01641692|19024725|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5502493|NCT01641692|19024726|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5502494|NCT01641692|19024727|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
5502495|NCT01641692|19024728|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5502496|NCT01641692|19024729|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5502497|NCT01641692|19024730|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
5502498|NCT01641692|19024731|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
5502499|NCT01641692|19024724|P8|Washout Period 3 or Follow-up|Protocol Violation|0
5502500|NCT01641692|19024725|P7|Washout Period 3 or Follow-up|Protocol Violation|0
5502501|NCT01641692|19024726|P6|Washout Period 3 or Follow-up|Protocol Violation|1
5502502|NCT01641692|19024727|P5|Washout Period 3 or Follow-up|Protocol Violation|0
5502503|NCT01641692|19024728|P4|Washout Period 3 or Follow-up|Protocol Violation|0
5502504|NCT01641692|19024729|P3|Washout Period 3 or Follow-up|Protocol Violation|0
5502505|NCT01641692|19024730|P2|Washout Period 3 or Follow-up|Protocol Violation|0
5502506|NCT01641692|19024731|P1|Washout Period 3 or Follow-up|Protocol Violation|0
5502507|NCT01641692|19024724|P8|Treatment Period 3|Lost to Follow-up|0
5502508|NCT01641692|19024725|P7|Treatment Period 3|Lost to Follow-up|0
5502509|NCT01641692|19024726|P6|Treatment Period 3|Lost to Follow-up|0
5502510|NCT01641692|19024727|P5|Treatment Period 3|Lost to Follow-up|0
5502511|NCT01641692|19024728|P4|Treatment Period 3|Lost to Follow-up|0
5502512|NCT01641692|19024729|P3|Treatment Period 3|Lost to Follow-up|0
5502513|NCT01641692|19024730|P2|Treatment Period 3|Lost to Follow-up|1
5502514|NCT01641692|19024731|P1|Treatment Period 3|Lost to Follow-up|0
5502515|NCT01641692|19024724|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
5502516|NCT01641692|19024725|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
5502517|NCT01641692|19024726|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
5502518|NCT01641692|19024727|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
5502519|NCT01641692|19024728|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
5502520|NCT01641692|19024729|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
5502521|NCT01641692|19024730|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
5502522|NCT01641692|19024731|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
5502523|NCT01641692|19024724|P8|Treatment Period 3|Protocol Violation|0
5502524|NCT01641692|19024725|P7|Treatment Period 3|Protocol Violation|0
5502525|NCT01641692|19024726|P6|Treatment Period 3|Protocol Violation|0
5502526|NCT01641692|19024727|P5|Treatment Period 3|Protocol Violation|0
5502527|NCT01641692|19024728|P4|Treatment Period 3|Protocol Violation|0
5502528|NCT01641692|19024729|P3|Treatment Period 3|Protocol Violation|1
5502529|NCT01641692|19024730|P2|Treatment Period 3|Protocol Violation|0
5502530|NCT01641692|19024731|P1|Treatment Period 3|Protocol Violation|0
5502531|NCT01641692|19024724|P8|Treatment Period 3|Adverse Event|0
5502532|NCT01641692|19024725|P7|Treatment Period 3|Adverse Event|1
5502533|NCT01641692|19024726|P6|Treatment Period 3|Adverse Event|0
5502534|NCT01641692|19024727|P5|Treatment Period 3|Adverse Event|0
5502535|NCT01641692|19024728|P4|Treatment Period 3|Adverse Event|0
5502536|NCT01641692|19024729|P3|Treatment Period 3|Adverse Event|0
5502537|NCT01641692|19024730|P2|Treatment Period 3|Adverse Event|0
5502538|NCT01641692|19024731|P1|Treatment Period 3|Adverse Event|0
5502539|NCT01641692|19024724|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5502540|NCT01641692|19024725|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5502541|NCT01641692|19024726|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5502542|NCT01641692|19024727|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5502543|NCT01641692|19024728|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5502544|NCT01641692|19024729|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5502545|NCT01641692|19024730|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5502546|NCT01641692|19024731|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5502547|NCT01641692|19024724|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5502548|NCT01641692|19024725|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
5502549|NCT01641692|19024726|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5502550|NCT01641692|19024727|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
5502551|NCT01641692|19024728|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5502552|NCT01641692|19024729|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5502553|NCT01641692|19024730|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5502554|NCT01641692|19024731|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
5502555|NCT01641692|19024724|P8|Treatment Period 2|Withdrawal by Subject|1
5502556|NCT01641692|19024725|P7|Treatment Period 2|Withdrawal by Subject|0
5502557|NCT01641692|19024726|P6|Treatment Period 2|Withdrawal by Subject|1
5502558|NCT01641692|19024727|P5|Treatment Period 2|Withdrawal by Subject|0
5502559|NCT01641692|19024728|P4|Treatment Period 2|Withdrawal by Subject|0
5502560|NCT01641692|19024729|P3|Treatment Period 2|Withdrawal by Subject|0
5502561|NCT01641692|19024730|P2|Treatment Period 2|Withdrawal by Subject|0
5502562|NCT01641692|19024731|P1|Treatment Period 2|Withdrawal by Subject|1
5502563|NCT01641692|19024724|P8|Treatment Period 2|Lost to Follow-up|0
5502564|NCT01641692|19024725|P7|Treatment Period 2|Lost to Follow-up|0
5502565|NCT01641692|19024726|P6|Treatment Period 2|Lost to Follow-up|1
5502566|NCT01641692|19024727|P5|Treatment Period 2|Lost to Follow-up|0
5502567|NCT01641692|19024728|P4|Treatment Period 2|Lost to Follow-up|0
5502568|NCT01641692|19024729|P3|Treatment Period 2|Lost to Follow-up|0
5502569|NCT01641692|19024730|P2|Treatment Period 2|Lost to Follow-up|0
5502570|NCT01641692|19024731|P1|Treatment Period 2|Lost to Follow-up|0
5502571|NCT01641692|19024724|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
5502572|NCT01641692|19024725|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
5502573|NCT01641692|19024726|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
5502574|NCT01641692|19024727|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
5502575|NCT01641692|19024728|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
5502576|NCT01641692|19024729|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
5502577|NCT01641692|19024730|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
5502578|NCT01641692|19024731|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
5502579|NCT01641692|19024724|P8|Treatment Period 2|Lack of Efficacy|0
5502580|NCT01641692|19024725|P7|Treatment Period 2|Lack of Efficacy|0
5502581|NCT01641692|19024726|P6|Treatment Period 2|Lack of Efficacy|0
5502582|NCT01641692|19024727|P5|Treatment Period 2|Lack of Efficacy|0
5502583|NCT01641692|19024728|P4|Treatment Period 2|Lack of Efficacy|0
5502584|NCT01641692|19024729|P3|Treatment Period 2|Lack of Efficacy|0
5502585|NCT01641692|19024730|P2|Treatment Period 2|Lack of Efficacy|0
5502586|NCT01641692|19024731|P1|Treatment Period 2|Lack of Efficacy|1
5502587|NCT01641692|19024724|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5502588|NCT01641692|19024725|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5502589|NCT01641692|19024726|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5502590|NCT01641692|19024727|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5502591|NCT01641692|19024728|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5502592|NCT01641692|19024729|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5502593|NCT01641692|19024730|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5502594|NCT01641692|19024731|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5502595|NCT01641692|19024724|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
5502596|NCT01641692|19024725|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
5502597|NCT01641692|19024726|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
5502598|NCT01641692|19024727|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
5502599|NCT01641692|19024728|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
5502600|NCT01641692|19024729|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
5502601|NCT01641692|19024730|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
5502602|NCT01641692|19024731|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
5502603|NCT01641692|19024724|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
5502604|NCT01641692|19024725|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
5502605|NCT01641692|19024726|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
5502606|NCT01641692|19024727|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
5502607|NCT01641692|19024728|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
5502608|NCT01641692|19024729|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
5502609|NCT01641692|19024730|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
5502610|NCT01641692|19024731|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
5502611|NCT01641692|19024724|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
5502612|NCT01641692|19024725|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
5502613|NCT01641692|19024726|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
5502614|NCT01641692|19024727|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
5502615|NCT01641692|19024728|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
5502616|NCT01641692|19024729|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
5502617|NCT01641692|19024730|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
5502618|NCT01641692|19024731|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
5502619|NCT01641692|19024724|P8|Treatment Period 1|Withdrawal by Subject|1
5502620|NCT01641692|19024725|P7|Treatment Period 1|Withdrawal by Subject|0
5502621|NCT01641692|19024726|P6|Treatment Period 1|Withdrawal by Subject|2
5502622|NCT01641692|19024727|P5|Treatment Period 1|Withdrawal by Subject|0
5502623|NCT01641692|19024728|P4|Treatment Period 1|Withdrawal by Subject|0
5502624|NCT01641692|19024729|P3|Treatment Period 1|Withdrawal by Subject|0
5502625|NCT01641692|19024730|P2|Treatment Period 1|Withdrawal by Subject|0
5502626|NCT01641692|19024731|P1|Treatment Period 1|Withdrawal by Subject|0
5502627|NCT01641692|19024724|P8|Treatment Period 1|Physician Decision|0
5502628|NCT01641692|19024725|P7|Treatment Period 1|Physician Decision|0
5502629|NCT01641692|19024726|P6|Treatment Period 1|Physician Decision|0
5502630|NCT01641692|19024727|P5|Treatment Period 1|Physician Decision|1
5502631|NCT01641692|19024728|P4|Treatment Period 1|Physician Decision|0
5502632|NCT01641692|19024729|P3|Treatment Period 1|Physician Decision|0
5502633|NCT01641692|19024730|P2|Treatment Period 1|Physician Decision|0
5502634|NCT01641692|19024731|P1|Treatment Period 1|Physician Decision|0
5502635|NCT01641692|19024724|P8|Treatment Period 1|Lost to Follow-up|0
5502636|NCT01641692|19024725|P7|Treatment Period 1|Lost to Follow-up|0
5502637|NCT01641692|19024726|P6|Treatment Period 1|Lost to Follow-up|0
5502638|NCT01641692|19024727|P5|Treatment Period 1|Lost to Follow-up|0
5502639|NCT01641692|19024728|P4|Treatment Period 1|Lost to Follow-up|0
5502640|NCT01641692|19024729|P3|Treatment Period 1|Lost to Follow-up|1
5502641|NCT01641692|19024730|P2|Treatment Period 1|Lost to Follow-up|0
5502642|NCT01641692|19024731|P1|Treatment Period 1|Lost to Follow-up|0
5502643|NCT01641692|19024724|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
5502644|NCT01641692|19024725|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
5502645|NCT01641692|19024726|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
5502646|NCT01641692|19024727|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
5502647|NCT01641692|19024728|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
5502648|NCT01641692|19024729|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
5502649|NCT01641692|19024730|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
5502650|NCT01641692|19024731|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
5502651|NCT01641692|19024724|P8|Treatment Period 1|Protocol Violation|0
5502652|NCT01641692|19024725|P7|Treatment Period 1|Protocol Violation|0
5502653|NCT01641692|19024726|P6|Treatment Period 1|Protocol Violation|0
5502654|NCT01641692|19024727|P5|Treatment Period 1|Protocol Violation|2
5502655|NCT01641692|19024728|P4|Treatment Period 1|Protocol Violation|0
5502656|NCT01641692|19024729|P3|Treatment Period 1|Protocol Violation|0
5502657|NCT01641692|19024730|P2|Treatment Period 1|Protocol Violation|0
5502658|NCT01641692|19024731|P1|Treatment Period 1|Protocol Violation|1
5502659|NCT01641692|19024724|P8|Treatment Period 1|Lack of Efficacy|1
5502660|NCT01641692|19024725|P7|Treatment Period 1|Lack of Efficacy|0
5502661|NCT01641692|19024726|P6|Treatment Period 1|Lack of Efficacy|0
5502662|NCT01641692|19024727|P5|Treatment Period 1|Lack of Efficacy|0
5502663|NCT01641692|19024728|P4|Treatment Period 1|Lack of Efficacy|0
5502664|NCT01641692|19024729|P3|Treatment Period 1|Lack of Efficacy|0
5502665|NCT01641692|19024730|P2|Treatment Period 1|Lack of Efficacy|0
5502666|NCT01641692|19024731|P1|Treatment Period 1|Lack of Efficacy|0
5502667|NCT01641692|19024724|P8|Treatment Period 1|Adverse Event|0
5502668|NCT01641692|19024725|P7|Treatment Period 1|Adverse Event|0
5502669|NCT01641692|19024726|P6|Treatment Period 1|Adverse Event|0
5502670|NCT01641692|19024727|P5|Treatment Period 1|Adverse Event|0
5502671|NCT01641692|19024728|P4|Treatment Period 1|Adverse Event|0
5502672|NCT01641692|19024729|P3|Treatment Period 1|Adverse Event|0
5502673|NCT01641692|19024730|P2|Treatment Period 1|Adverse Event|0
5502674|NCT01641692|19024731|P1|Treatment Period 1|Adverse Event|1
5502675|NCT01641640|19024931|P1|Overall Study|Adverse Event|1
5502676|NCT01641640|19024931|P1|Overall Study|Withdrawal by Subject|2
5502677|NCT01641640|19024931|P1|Overall Study|Lost to Follow-up|3
5502678|NCT01641640|19024931|P1|Overall Study|Efficacy failure|29
5502679|NCT01641640|19024931|P1|Overall Study|Enrolled but not treated|1
5502680|NCT01641601|19024942|P2|Overall Study|Study discontinued.|5
5502681|NCT01641601|19024943|P1|Overall Study|Study discontinued.|3
5502682|NCT01641471|19024953|P2|Overall Study|Protocol Violation|4
5502683|NCT01641471|19024954|P1|Overall Study|Protocol Violation|2
5502684|NCT01641471|19024953|P2|Overall Study|Lost to Follow-up|4
5502685|NCT01641471|19024954|P1|Overall Study|Lost to Follow-up|2
5502686|NCT01641471|19024953|P2|Overall Study|Withdrawal by Subject|19
5502687|NCT01641471|19024954|P1|Overall Study|Withdrawal by Subject|19
5502688|NCT01641367|19025001|P8|Randomized Adherence Intervention|Lost to Follow-up|12
5502689|NCT01641367|19025002|P7|Randomized Adherence Intervention|Lost to Follow-up|8
5502690|NCT01641367|19025003|P6|Randomized Adherence Intervention|Lost to Follow-up|0
5502691|NCT01641367|19025004|P5|Randomized Adherence Intervention|Lost to Follow-up|0
5502692|NCT01641367|19025005|P4|Randomized Adherence Intervention|Lost to Follow-up|0
5502693|NCT01641367|19025006|P3|Randomized Adherence Intervention|Lost to Follow-up|0
5502694|NCT01641367|19025007|P2|Randomized Adherence Intervention|Lost to Follow-up|0
5502695|NCT01641367|19025008|P1|Randomized Adherence Intervention|Lost to Follow-up|0
5502696|NCT01641367|19025001|P8|Randomized Adherence Intervention|Death|12
5502697|NCT01641367|19025002|P7|Randomized Adherence Intervention|Death|11
5502698|NCT01641367|19025003|P6|Randomized Adherence Intervention|Death|0
5502699|NCT01641367|19025004|P5|Randomized Adherence Intervention|Death|0
5502700|NCT01641367|19025005|P4|Randomized Adherence Intervention|Death|0
5502701|NCT01641367|19025006|P3|Randomized Adherence Intervention|Death|0
5502702|NCT01641367|19025007|P2|Randomized Adherence Intervention|Death|0
5502703|NCT01641367|19025008|P1|Randomized Adherence Intervention|Death|0
5502704|NCT01641367|19025001|P8|Cohorts|Lost to Follow-up|0
5502705|NCT01641367|19025002|P7|Cohorts|Lost to Follow-up|0
5502706|NCT01641367|19025003|P6|Cohorts|Lost to Follow-up|0
5502707|NCT01641367|19025004|P5|Cohorts|Lost to Follow-up|2
5502708|NCT01641367|19025005|P4|Cohorts|Lost to Follow-up|0
5502709|NCT01641367|19025006|P3|Cohorts|Lost to Follow-up|2
5502710|NCT01641367|19025007|P2|Cohorts|Lost to Follow-up|0
5502711|NCT01641367|19025008|P1|Cohorts|Lost to Follow-up|16
5502712|NCT01641367|19025001|P8|Cohorts|Death|0
5502713|NCT01641367|19025002|P7|Cohorts|Death|0
5502714|NCT01641367|19025003|P6|Cohorts|Death|1
5502715|NCT01641367|19025004|P5|Cohorts|Death|1
5502716|NCT01641367|19025005|P4|Cohorts|Death|0
5502717|NCT01641367|19025006|P3|Cohorts|Death|2
5502718|NCT01641367|19025007|P2|Cohorts|Death|1
5502719|NCT01641367|19025008|P1|Cohorts|Death|18
5502720|NCT01641237|19025259|P4|Period III|Lost to Follow-up|0
5502721|NCT01641237|19025260|P3|Period III|Lost to Follow-up|0
5502722|NCT01641237|19025261|P2|Period III|Lost to Follow-up|0
5502723|NCT01641237|19025262|P1|Period III|Lost to Follow-up|1
5502724|NCT01641237|19025259|P4|Period II|Withdrawal by Subject|0
5502725|NCT01641237|19025260|P3|Period II|Withdrawal by Subject|0
5502726|NCT01641237|19025261|P2|Period II|Withdrawal by Subject|0
5502727|NCT01641237|19025262|P1|Period II|Withdrawal by Subject|1
5502728|NCT01641198|19025287|P3|At 15-20 Years of Function|Death|1
5502729|NCT01641198|19025288|P2|At 15-20 Years of Function|Death|0
5502730|NCT01641198|19025289|P1|At 15-20 Years of Function|Death|1
5502731|NCT01641198|19025287|P3|At 15-20 Years of Function|Lost to Follow-up|1
5502732|NCT01641198|19025288|P2|At 15-20 Years of Function|Lost to Follow-up|1
5502733|NCT01641198|19025289|P1|At 15-20 Years of Function|Lost to Follow-up|5
5502734|NCT01641198|19025287|P3|After 24 Months of Function|Lost to Follow-up|6
5502735|NCT01641198|19025288|P2|After 24 Months of Function|Lost to Follow-up|9
5502736|NCT01641198|19025289|P1|After 24 Months of Function|Lost to Follow-up|4
5502737|NCT01641198|19025287|P3|After 12 Months of Function|Adverse Event|0
5502738|NCT01641198|19025288|P2|After 12 Months of Function|Adverse Event|1
5502739|NCT01641198|19025289|P1|After 12 Months of Function|Adverse Event|0
5502740|NCT01641198|19025287|P3|After 12 Months of Function|Protocol Violation|0
5502741|NCT01641198|19025288|P2|After 12 Months of Function|Protocol Violation|0
5502742|NCT01641198|19025289|P1|After 12 Months of Function|Protocol Violation|1
5502743|NCT01641198|19025287|P3|After 12 Months of Function|Lost to Follow-up|2
5502744|NCT01641198|19025288|P2|After 12 Months of Function|Lost to Follow-up|2
5502745|NCT01641198|19025289|P1|After 12 Months of Function|Lost to Follow-up|3
5502746|NCT01641159|19025305|P2|Overall Study|Withdrawal by Subject|1
5502747|NCT01641159|19025306|P1|Overall Study|Withdrawal by Subject|0
5502748|NCT01641159|19025305|P2|Overall Study|Lost to Follow-up|1
5502749|NCT01641159|19025306|P1|Overall Study|Lost to Follow-up|2
5502750|NCT01641133|19025317|P3|Overall Study|Lost to Follow-up|2
5502751|NCT01641133|19025318|P2|Overall Study|Lost to Follow-up|2
5502752|NCT01641133|19025319|P1|Overall Study|Lost to Follow-up|0
5502753|NCT01641133|19025317|P3|Overall Study|Withdrawal by Subject|3
5502754|NCT01641133|19025318|P2|Overall Study|Withdrawal by Subject|3
5502755|NCT01641133|19025319|P1|Overall Study|Withdrawal by Subject|5
5502756|NCT01641133|19025317|P3|Overall Study|Adverse Event|1
5502757|NCT01641133|19025318|P2|Overall Study|Adverse Event|0
5502758|NCT01641133|19025319|P1|Overall Study|Adverse Event|0
5502759|NCT01641133|19025317|P3|Overall Study|Migrated/moved from study area|1
5502760|NCT01641133|19025318|P2|Overall Study|Migrated/moved from study area|3
5502761|NCT01641133|19025319|P1|Overall Study|Migrated/moved from study area|5
5502762|NCT01641133|19025317|P3|Overall Study|Protocol Violation|1
5502763|NCT01641133|19025318|P2|Overall Study|Protocol Violation|1
5502764|NCT01641133|19025319|P1|Overall Study|Protocol Violation|0
5502765|NCT01641081|19025372|P10|Period 5|Adverse Event|0
5502766|NCT01641081|19025373|P9|Period 5|Adverse Event|0
5502767|NCT01641081|19025374|P8|Period 5|Adverse Event|0
5502768|NCT01641081|19025375|P7|Period 5|Adverse Event|0
5502769|NCT01641081|19025376|P6|Period 5|Adverse Event|0
5502770|NCT01641081|19025377|P5|Period 5|Adverse Event|0
5502771|NCT01641081|19025378|P4|Period 5|Adverse Event|0
5502772|NCT01641081|19025379|P3|Period 5|Adverse Event|2
5502773|NCT01641081|19025380|P2|Period 5|Adverse Event|0
5502774|NCT01641081|19025381|P1|Period 5|Adverse Event|0
5502775|NCT01641081|19025372|P10|Period 4|Adverse Event|0
5502776|NCT01641081|19025373|P9|Period 4|Adverse Event|0
5502777|NCT01641081|19025374|P8|Period 4|Adverse Event|0
5502778|NCT01641081|19025375|P7|Period 4|Adverse Event|0
5502779|NCT01641081|19025376|P6|Period 4|Adverse Event|0
5502780|NCT01641081|19025377|P5|Period 4|Adverse Event|0
5502781|NCT01641081|19025378|P4|Period 4|Adverse Event|1
5502782|NCT01641081|19025379|P3|Period 4|Adverse Event|0
5502783|NCT01641081|19025380|P2|Period 4|Adverse Event|1
5502784|NCT01641081|19025381|P1|Period 4|Adverse Event|0
5502785|NCT01641081|19025372|P10|Period 3|Withdrawal by Subject|0
5502786|NCT01641081|19025373|P9|Period 3|Withdrawal by Subject|1
5502787|NCT01641081|19025374|P8|Period 3|Withdrawal by Subject|0
5502788|NCT01641081|19025375|P7|Period 3|Withdrawal by Subject|0
5502789|NCT01641081|19025376|P6|Period 3|Withdrawal by Subject|0
5502790|NCT01641081|19025377|P5|Period 3|Withdrawal by Subject|0
5502791|NCT01641081|19025378|P4|Period 3|Withdrawal by Subject|0
5502792|NCT01641081|19025379|P3|Period 3|Withdrawal by Subject|0
5502793|NCT01641081|19025380|P2|Period 3|Withdrawal by Subject|0
5502794|NCT01641081|19025381|P1|Period 3|Withdrawal by Subject|0
5502795|NCT01641081|19025372|P10|Period 3|Adverse Event|0
5502796|NCT01641081|19025373|P9|Period 3|Adverse Event|0
5502797|NCT01641081|19025374|P8|Period 3|Adverse Event|0
5502798|NCT01641081|19025375|P7|Period 3|Adverse Event|0
5502799|NCT01641081|19025376|P6|Period 3|Adverse Event|0
5502800|NCT01641081|19025377|P5|Period 3|Adverse Event|0
5502801|NCT01641081|19025378|P4|Period 3|Adverse Event|0
5502802|NCT01641081|19025379|P3|Period 3|Adverse Event|1
5502803|NCT01641081|19025380|P2|Period 3|Adverse Event|0
5502804|NCT01641081|19025381|P1|Period 3|Adverse Event|0
5502805|NCT01641081|19025372|P10|Period 2|Protocol Violation|0
5502806|NCT01641081|19025373|P9|Period 2|Protocol Violation|0
5502807|NCT01641081|19025374|P8|Period 2|Protocol Violation|0
5502808|NCT01641081|19025375|P7|Period 2|Protocol Violation|0
5502809|NCT01641081|19025376|P6|Period 2|Protocol Violation|0
5502810|NCT01641081|19025377|P5|Period 2|Protocol Violation|0
5502811|NCT01641081|19025378|P4|Period 2|Protocol Violation|0
5502812|NCT01641081|19025379|P3|Period 2|Protocol Violation|0
5502813|NCT01641081|19025380|P2|Period 2|Protocol Violation|0
5502814|NCT01641081|19025381|P1|Period 2|Protocol Violation|1
5502815|NCT01641081|19025372|P10|Period 2|Withdrawal by Subject|0
5502816|NCT01641081|19025373|P9|Period 2|Withdrawal by Subject|0
5502817|NCT01641081|19025374|P8|Period 2|Withdrawal by Subject|0
5502818|NCT01641081|19025375|P7|Period 2|Withdrawal by Subject|2
5502819|NCT01641081|19025376|P6|Period 2|Withdrawal by Subject|0
5502820|NCT01641081|19025377|P5|Period 2|Withdrawal by Subject|0
5502821|NCT01641081|19025378|P4|Period 2|Withdrawal by Subject|1
5502822|NCT01641081|19025379|P3|Period 2|Withdrawal by Subject|0
5502823|NCT01641081|19025380|P2|Period 2|Withdrawal by Subject|0
5502824|NCT01641081|19025381|P1|Period 2|Withdrawal by Subject|0
5502825|NCT01641081|19025372|P10|Period 2|Adverse Event|0
5502826|NCT01641081|19025373|P9|Period 2|Adverse Event|0
5502827|NCT01641081|19025374|P8|Period 2|Adverse Event|0
5502828|NCT01641081|19025375|P7|Period 2|Adverse Event|0
5502829|NCT01641081|19025376|P6|Period 2|Adverse Event|1
5502830|NCT01641081|19025377|P5|Period 2|Adverse Event|0
5502831|NCT01641081|19025378|P4|Period 2|Adverse Event|0
5502832|NCT01641081|19025379|P3|Period 2|Adverse Event|0
5502833|NCT01641081|19025380|P2|Period 2|Adverse Event|0
5502834|NCT01641081|19025381|P1|Period 2|Adverse Event|0
5502835|NCT01641081|19025372|P10|Period 1|Adverse Event|0
5502836|NCT01641081|19025373|P9|Period 1|Adverse Event|0
5502837|NCT01641081|19025374|P8|Period 1|Adverse Event|2
5502838|NCT01641081|19025375|P7|Period 1|Adverse Event|0
5502839|NCT01641081|19025376|P6|Period 1|Adverse Event|0
5502840|NCT01641081|19025377|P5|Period 1|Adverse Event|0
5502841|NCT01641081|19025378|P4|Period 1|Adverse Event|0
5502842|NCT01641081|19025379|P3|Period 1|Adverse Event|0
5502843|NCT01641081|19025380|P2|Period 1|Adverse Event|0
5502844|NCT01641081|19025381|P1|Period 1|Adverse Event|1
5502845|NCT01641081|19025372|P10|Period 1|Protocol Violation|0
5502846|NCT01641081|19025373|P9|Period 1|Protocol Violation|0
5502847|NCT01641081|19025374|P8|Period 1|Protocol Violation|1
5502848|NCT01641081|19025375|P7|Period 1|Protocol Violation|0
5502849|NCT01641081|19025376|P6|Period 1|Protocol Violation|0
5502850|NCT01641081|19025377|P5|Period 1|Protocol Violation|1
5502851|NCT01641081|19025378|P4|Period 1|Protocol Violation|0
5502852|NCT01641081|19025379|P3|Period 1|Protocol Violation|0
5502853|NCT01641081|19025380|P2|Period 1|Protocol Violation|0
5502854|NCT01641081|19025381|P1|Period 1|Protocol Violation|0
5502855|NCT01641081|19025372|P10|Period 1|Sponsor request (potential unblinding)|0
5502856|NCT01641081|19025373|P9|Period 1|Sponsor request (potential unblinding)|0
5502857|NCT01641081|19025374|P8|Period 1|Sponsor request (potential unblinding)|0
5502858|NCT01641081|19025375|P7|Period 1|Sponsor request (potential unblinding)|1
5502859|NCT01641081|19025376|P6|Period 1|Sponsor request (potential unblinding)|0
5502860|NCT01641081|19025377|P5|Period 1|Sponsor request (potential unblinding)|0
5502861|NCT01641081|19025378|P4|Period 1|Sponsor request (potential unblinding)|0
5502862|NCT01641081|19025379|P3|Period 1|Sponsor request (potential unblinding)|0
5502863|NCT01641081|19025380|P2|Period 1|Sponsor request (potential unblinding)|0
5502864|NCT01641081|19025381|P1|Period 1|Sponsor request (potential unblinding)|0
5502865|NCT01640964|19025450|P3|Overall Study|Protocol Deviation|2
5502866|NCT01640964|19025451|P2|Overall Study|Protocol Deviation|1
5502867|NCT01640964|19025452|P1|Overall Study|Protocol Deviation|1
5502868|NCT01640964|19025450|P3|Overall Study|Lost to Follow-up|1
5502869|NCT01640964|19025451|P2|Overall Study|Lost to Follow-up|0
5502870|NCT01640964|19025452|P1|Overall Study|Lost to Follow-up|0
5502871|NCT01640951|19025475|P8|Overall Study|Death|2
5502872|NCT01640951|19025476|P7|Overall Study|Death|0
5502873|NCT01640951|19025477|P6|Overall Study|Death|0
5502874|NCT01640951|19025478|P5|Overall Study|Death|0
5502875|NCT01640951|19025479|P4|Overall Study|Death|0
5502876|NCT01640951|19025480|P3|Overall Study|Death|1
5502877|NCT01640951|19025481|P2|Overall Study|Death|1
5502878|NCT01640951|19025482|P1|Overall Study|Death|0
5502879|NCT01640951|19025475|P8|Overall Study|Subject/Guardian decision|4
5502880|NCT01640951|19025476|P7|Overall Study|Subject/Guardian decision|5
5502881|NCT01640951|19025477|P6|Overall Study|Subject/Guardian decision|19
5502882|NCT01640951|19025478|P5|Overall Study|Subject/Guardian decision|7
5502883|NCT01640951|19025479|P4|Overall Study|Subject/Guardian decision|15
5502884|NCT01640951|19025480|P3|Overall Study|Subject/Guardian decision|13
5502885|NCT01640951|19025481|P2|Overall Study|Subject/Guardian decision|4
5502886|NCT01640951|19025482|P1|Overall Study|Subject/Guardian decision|12
5502887|NCT01640951|19025475|P8|Overall Study|Protocol Deviation|0
5502888|NCT01640951|19025476|P7|Overall Study|Protocol Deviation|0
5502889|NCT01640951|19025477|P6|Overall Study|Protocol Deviation|1
5502890|NCT01640951|19025478|P5|Overall Study|Protocol Deviation|0
5502891|NCT01640951|19025479|P4|Overall Study|Protocol Deviation|1
5502892|NCT01640951|19025480|P3|Overall Study|Protocol Deviation|2
5502893|NCT01640951|19025481|P2|Overall Study|Protocol Deviation|1
5502894|NCT01640951|19025482|P1|Overall Study|Protocol Deviation|0
5502895|NCT01640951|19025475|P8|Overall Study|Pregnancy|0
5502896|NCT01640951|19025476|P7|Overall Study|Pregnancy|2
5502897|NCT01640951|19025477|P6|Overall Study|Pregnancy|0
5502898|NCT01640951|19025478|P5|Overall Study|Pregnancy|0
5502899|NCT01640951|19025479|P4|Overall Study|Pregnancy|4
5502900|NCT01640951|19025480|P3|Overall Study|Pregnancy|0
5502901|NCT01640951|19025481|P2|Overall Study|Pregnancy|0
5502902|NCT01640951|19025482|P1|Overall Study|Pregnancy|3
5502903|NCT01640951|19025475|P8|Overall Study|Physician Decision|0
5502904|NCT01640951|19025476|P7|Overall Study|Physician Decision|3
5502905|NCT01640951|19025477|P6|Overall Study|Physician Decision|3
5502906|NCT01640951|19025478|P5|Overall Study|Physician Decision|2
5502907|NCT01640951|19025479|P4|Overall Study|Physician Decision|2
5502908|NCT01640951|19025480|P3|Overall Study|Physician Decision|2
5502909|NCT01640951|19025481|P2|Overall Study|Physician Decision|5
5502910|NCT01640951|19025482|P1|Overall Study|Physician Decision|2
5502911|NCT01640951|19025475|P8|Overall Study|Non-compliance with study treatment|0
5502912|NCT01640951|19025476|P7|Overall Study|Non-compliance with study treatment|1
5502913|NCT01640951|19025477|P6|Overall Study|Non-compliance with study treatment|4
5502914|NCT01640951|19025478|P5|Overall Study|Non-compliance with study treatment|1
5502915|NCT01640951|19025479|P4|Overall Study|Non-compliance with study treatment|1
5502916|NCT01640951|19025480|P3|Overall Study|Non-compliance with study treatment|1
5502917|NCT01640951|19025481|P2|Overall Study|Non-compliance with study treatment|0
5502918|NCT01640951|19025482|P1|Overall Study|Non-compliance with study treatment|0
5502919|NCT01640951|19025475|P8|Overall Study|Lost to Follow-up|1
5502920|NCT01640951|19025476|P7|Overall Study|Lost to Follow-up|1
5502921|NCT01640951|19025477|P6|Overall Study|Lost to Follow-up|3
5502922|NCT01640951|19025478|P5|Overall Study|Lost to Follow-up|2
5502923|NCT01640951|19025479|P4|Overall Study|Lost to Follow-up|2
5502924|NCT01640951|19025480|P3|Overall Study|Lost to Follow-up|6
5502925|NCT01640951|19025481|P2|Overall Study|Lost to Follow-up|0
5502926|NCT01640951|19025482|P1|Overall Study|Lost to Follow-up|1
5502927|NCT01640951|19025475|P8|Overall Study|Lack of Efficacy|6
5502928|NCT01640951|19025476|P7|Overall Study|Lack of Efficacy|5
5502929|NCT01640951|19025477|P6|Overall Study|Lack of Efficacy|6
5502930|NCT01640951|19025478|P5|Overall Study|Lack of Efficacy|0
5502931|NCT01640951|19025479|P4|Overall Study|Lack of Efficacy|14
5502932|NCT01640951|19025480|P3|Overall Study|Lack of Efficacy|7
5502933|NCT01640951|19025481|P2|Overall Study|Lack of Efficacy|1
5502934|NCT01640951|19025482|P1|Overall Study|Lack of Efficacy|20
5502935|NCT01640951|19025475|P8|Overall Study|Adverse Event|3
5502936|NCT01640951|19025476|P7|Overall Study|Adverse Event|1
5502937|NCT01640951|19025477|P6|Overall Study|Adverse Event|11
5502938|NCT01640951|19025478|P5|Overall Study|Adverse Event|1
5502939|NCT01640951|19025479|P4|Overall Study|Adverse Event|6
5502940|NCT01640951|19025480|P3|Overall Study|Adverse Event|10
5502941|NCT01640951|19025481|P2|Overall Study|Adverse Event|3
5502942|NCT01640951|19025482|P1|Overall Study|Adverse Event|8
5502943|NCT01640925|19025584|P2|Overall Study|Previously enrolled in this trial|11
5502944|NCT01640925|19025585|P1|Overall Study|Previously enrolled in this trial|13
5502945|NCT01640925|19025584|P2|Overall Study|Withdrawal by Subject|0
5502946|NCT01640925|19025585|P1|Overall Study|Withdrawal by Subject|1
5502947|NCT01640873|19025599|P2|Overall Study|Protocol Violation|1
5502948|NCT01640873|19025600|P1|Overall Study|Protocol Violation|2
5502949|NCT01640808|19025650|P2|Overall Study|Randomized but not treated|2
5502950|NCT01640808|19025651|P1|Overall Study|Randomized but not treated|4
5502951|NCT01640808|19025650|P2|Overall Study|Physician Decision|5
5502952|NCT01640808|19025651|P1|Overall Study|Physician Decision|19
5502953|NCT01640808|19025650|P2|Overall Study|Administration of anticancer drugs|1
5502954|NCT01640808|19025651|P1|Overall Study|Administration of anticancer drugs|2
5502955|NCT01640808|19025650|P2|Overall Study|Start an antiviral therapy using IFN|0
5502956|NCT01640808|19025651|P1|Overall Study|Start an antiviral therapy using IFN|3
5502957|NCT01640808|19025650|P2|Overall Study|Lost to Follow-up|0
5502958|NCT01640808|19025651|P1|Overall Study|Lost to Follow-up|4
5502959|NCT01640808|19025650|P2|Overall Study|Withdrawal by Subject|4
5502960|NCT01640808|19025651|P1|Overall Study|Withdrawal by Subject|12
5502961|NCT01640808|19025650|P2|Overall Study|Unable to continue dynamic CT|4
5502962|NCT01640808|19025651|P1|Overall Study|Unable to continue dynamic CT|14
5502963|NCT01640366|19025686|P1|Overall Study|Lost to Follow-up|5
5502964|NCT01640366|19025686|P1|Overall Study|Protocol Violation|16
5502965|NCT01640366|19025686|P1|Overall Study|Withdrawal by Subject|1
5502966|NCT01640353|19025699|P1|Overall Study|Physician Decision|1
5502967|NCT01640353|19025699|P1|Overall Study|Lost to Follow-up|12
5502968|NCT01640353|19025699|P1|Overall Study|Early site termination|3
5502969|NCT01640353|19025699|P1|Overall Study|Death|2
5502970|NCT01640353|19025699|P1|Overall Study|Withdrawal by Subject|5
5502971|NCT01640353|19025699|P1|Overall Study|Withdrawn from analysis at term site|12
5502972|NCT01640353|19025699|P1|Overall Study|Withdrew prior to treatment|10
5502973|NCT01640314|19025747|P2|Overall Study|Protocol Violation|1
5502974|NCT01640314|19025748|P1|Overall Study|Protocol Violation|0
5502975|NCT01640288|19025764|P2|Overall Study|Withdrawal by Subject|0
5502976|NCT01640288|19025765|P1|Overall Study|Withdrawal by Subject|1
5502977|NCT01640288|19025764|P2|Overall Study|Withdrawn by PI|0
5502978|NCT01640288|19025765|P1|Overall Study|Withdrawn by PI|5
5502979|NCT01640288|19025764|P2|Overall Study|Screen Failure|18
5502980|NCT01640288|19025765|P1|Overall Study|Screen Failure|20
5502981|NCT01640288|19025764|P2|Overall Study|Equipment Failure or Poor Image Quality|5
5502982|NCT01640288|19025765|P1|Overall Study|Equipment Failure or Poor Image Quality|4
5502983|NCT01640249|19025782|P7|Period 1|Withdrawal by Subject|0
5502984|NCT01640249|19025783|P6|Period 1|Withdrawal by Subject|1
5502985|NCT01640249|19025784|P5|Period 1|Withdrawal by Subject|0
5502986|NCT01640249|19025785|P4|Period 1|Withdrawal by Subject|0
5502987|NCT01640249|19025786|P3|Period 1|Withdrawal by Subject|0
5502988|NCT01640249|19025787|P2|Period 1|Withdrawal by Subject|0
5502989|NCT01640249|19025788|P1|Period 1|Withdrawal by Subject|1
5502990|NCT01640184|19025836|P3|Overall Study|Protocol Violation|1
5502991|NCT01640184|19025837|P2|Overall Study|Protocol Violation|0
5502992|NCT01640184|19025838|P1|Overall Study|Protocol Violation|0
5502993|NCT01640184|19025836|P3|Overall Study|Withdrawal by Subject|1
5502994|NCT01640184|19025837|P2|Overall Study|Withdrawal by Subject|1
5502995|NCT01640184|19025838|P1|Overall Study|Withdrawal by Subject|0
5502996|NCT01640184|19025836|P3|Overall Study|Physician Decision|0
5502997|NCT01640184|19025837|P2|Overall Study|Physician Decision|0
5502998|NCT01640184|19025838|P1|Overall Study|Physician Decision|3
5502999|NCT01640184|19025836|P3|Overall Study|Lost to Follow-up|0
5503000|NCT01640184|19025837|P2|Overall Study|Lost to Follow-up|1
5503001|NCT01640184|19025838|P1|Overall Study|Lost to Follow-up|4
5503002|NCT01640184|19025836|P3|Overall Study|Death|0
5503003|NCT01640184|19025837|P2|Overall Study|Death|0
5503004|NCT01640184|19025838|P1|Overall Study|Death|1
5503005|NCT01640054|19025867|P1|Overall Study|Adverse Event|2
5503006|NCT01640054|19025867|P1|Overall Study|Lack of Efficacy|3
5503007|NCT01640054|19025867|P1|Overall Study|Study-specific disc criteria|1
5503008|NCT01639833|19025888|P2|Overall Study|Withdrawal by Subject|2
5503009|NCT01639833|19025889|P1|Overall Study|Withdrawal by Subject|2
5503010|NCT01639833|19025888|P2|Overall Study|Death|2
5503011|NCT01639833|19025889|P1|Overall Study|Death|4
5503012|NCT01639755|19025897|P1|Overall Study|Patient had device explantation|4
5503013|NCT01639755|19025897|P1|Overall Study|Study Ongoing|15
5503014|NCT01639742|19025905|P1|Overall Study|Lost to Follow-up|1
5503015|NCT01639742|19025905|P1|Overall Study|Study Ongoing|17
5503016|NCT01639729|19025913|P6|Overall Study|Withdrawal by Subject|0
5503017|NCT01639729|19025914|P5|Overall Study|Withdrawal by Subject|0
5503018|NCT01639729|19025915|P4|Overall Study|Withdrawal by Subject|1
5503019|NCT01639729|19025916|P3|Overall Study|Withdrawal by Subject|1
5503020|NCT01639729|19025917|P2|Overall Study|Withdrawal by Subject|0
5503021|NCT01639729|19025918|P1|Overall Study|Withdrawal by Subject|1
5503022|NCT01639703|19025940|P1|Overall Study|Other reason|7
5503023|NCT01639703|19025940|P1|Overall Study|Withdrawal by Subject|5
5503024|NCT01639560|19026005|P2|Overall Study|Adverse Event|2
5503025|NCT01639560|19026006|P1|Overall Study|Adverse Event|0
5503026|NCT01639560|19026005|P2|Overall Study|Lost to Follow-up|11
5503027|NCT01639560|19026006|P1|Overall Study|Lost to Follow-up|9
5503028|NCT01639560|19026005|P2|Overall Study|Lack of Efficacy|2
5503029|NCT01639560|19026006|P1|Overall Study|Lack of Efficacy|1
5503030|NCT01639560|19026005|P2|Overall Study|Withdrawal by Subject|14
5503031|NCT01639560|19026006|P1|Overall Study|Withdrawal by Subject|9
5503032|NCT01639495|19026018|P1|Overall Study|No radiofrequency energy applied|2
5503033|NCT01639495|19026018|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
5503034|NCT01639495|19026018|P1|Overall Study|Consented but didn't have study catheter|4
5503035|NCT01639495|19026018|P1|Overall Study|Lost to Follow-up|6
5503036|NCT01639469|19026028|P2|Overall Study|Lost to Follow-up|1
5503037|NCT01639469|19026029|P1|Overall Study|Lost to Follow-up|1
5503038|NCT01639469|19026028|P2|Overall Study|Death|2
5503039|NCT01639469|19026029|P1|Overall Study|Death|4
5503040|NCT01639339|19026065|P2|Overall Study|Adverse Event|7
5503041|NCT01639339|19026066|P1|Overall Study|Adverse Event|10
5503042|NCT01639339|19026065|P2|Overall Study|Lack of Efficacy|1
5503043|NCT01639339|19026066|P1|Overall Study|Lack of Efficacy|2
5503044|NCT01639339|19026065|P2|Overall Study|Protocol Violation|2
5503045|NCT01639339|19026066|P1|Overall Study|Protocol Violation|0
5503046|NCT01639339|19026065|P2|Overall Study|Lost to Follow-up|4
5503047|NCT01639339|19026066|P1|Overall Study|Lost to Follow-up|5
5503048|NCT01639339|19026065|P2|Overall Study|Physician Decision|5
5503049|NCT01639339|19026066|P1|Overall Study|Physician Decision|11
5503050|NCT01639339|19026065|P2|Overall Study|Withdrawal by Subject|19
5503051|NCT01639339|19026066|P1|Overall Study|Withdrawal by Subject|26
5503052|NCT01639144|19026155|P2|Overall Study|Met postoperative exclusion criteria|3
5503053|NCT01639144|19026156|P1|Overall Study|Met postoperative exclusion criteria|4
5503054|NCT01639144|19026155|P2|Overall Study|Physician Decision|0
5503055|NCT01639144|19026156|P1|Overall Study|Physician Decision|2
5503056|NCT01639144|19026155|P2|Overall Study|Withdrawal by Subject|2
5503057|NCT01639144|19026156|P1|Overall Study|Withdrawal by Subject|4
5503058|NCT01639040|19026164|P2|Overall Study|Adverse Event|0
5503059|NCT01639040|19026165|P1|Overall Study|Adverse Event|1
5503060|NCT01639001|19026183|P2|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2
5503061|NCT01639001|19026184|P1|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1
5503062|NCT01639001|19026183|P2|Overall Study|Randomized but not treated|2
5503063|NCT01639001|19026184|P1|Overall Study|Randomized but not treated|0
5503064|NCT01639001|19026183|P2|Overall Study|Death|61
5503065|NCT01639001|19026184|P1|Overall Study|Death|62
5503066|NCT01639001|19026183|P2|Overall Study|Lost to Follow-up|0
5503067|NCT01639001|19026184|P1|Overall Study|Lost to Follow-up|3
5503068|NCT01639001|19026183|P2|Overall Study|Refused further follow-up|12
5503069|NCT01639001|19026184|P1|Overall Study|Refused further follow-up|9
5503070|NCT01638819|19026230|P2|Overall Study|Lost to Follow-up|0
5503071|NCT01638819|19026231|P1|Overall Study|Lost to Follow-up|1
5503072|NCT01638559|19026240|P1|Overall Study|Subject declined to travel for biopsy|1
5503073|NCT01638559|19026240|P1|Overall Study|Withdrawal by Subject|1
5503074|NCT01638559|19026240|P1|Overall Study|Lost to Follow-up|1
5503075|NCT01638546|19026258|P2|Overall Study|Adverse Event|3
5503076|NCT01638546|19026259|P1|Overall Study|Adverse Event|1
5503077|NCT01638429|19026298|P1|Overall Study|Withdrawal by Subject|1
5503078|NCT01638390|19026349|P1|Overall Study|screening failures|21
5503079|NCT01638013|19026373|P3|Overall Study|Not met inclusion or exclusion criteria|1
5503080|NCT01638013|19026374|P2|Overall Study|Not met inclusion or exclusion criteria|0
5503081|NCT01638013|19026375|P1|Overall Study|Not met inclusion or exclusion criteria|0
5503082|NCT01638013|19026373|P3|Overall Study|Withdrawal of Consent|16
5503083|NCT01638013|19026374|P2|Overall Study|Withdrawal of Consent|12
5503084|NCT01638013|19026375|P1|Overall Study|Withdrawal of Consent|16
5503085|NCT01638013|19026373|P3|Overall Study|Miscellaneous|23
5503086|NCT01638013|19026374|P2|Overall Study|Miscellaneous|19
5503087|NCT01638013|19026375|P1|Overall Study|Miscellaneous|25
5503088|NCT01638013|19026373|P3|Overall Study|Subject Lost to Follow up|1
5503089|NCT01638013|19026374|P2|Overall Study|Subject Lost to Follow up|0
5503090|NCT01638013|19026375|P1|Overall Study|Subject Lost to Follow up|1
5503091|NCT01638013|19026373|P3|Overall Study|Met discontinuation criteria|7
5503092|NCT01638013|19026374|P2|Overall Study|Met discontinuation criteria|0
5503093|NCT01638013|19026375|P1|Overall Study|Met discontinuation criteria|4
5503094|NCT01638013|19026373|P3|Overall Study|Protocol Violation|11
5503095|NCT01638013|19026374|P2|Overall Study|Protocol Violation|7
5503096|NCT01638013|19026375|P1|Overall Study|Protocol Violation|10
5503097|NCT01638013|19026373|P3|Overall Study|Lack of Efficacy|14
5503098|NCT01638013|19026374|P2|Overall Study|Lack of Efficacy|11
5503099|NCT01638013|19026375|P1|Overall Study|Lack of Efficacy|39
5503100|NCT01638013|19026373|P3|Overall Study|Adverse Event|48
5503101|NCT01638013|19026374|P2|Overall Study|Adverse Event|29
5503102|NCT01638013|19026375|P1|Overall Study|Adverse Event|36
5503103|NCT01638000|19026508|P2|Overall Study|Miscellaneous|2
5503104|NCT01638000|19026509|P1|Overall Study|Miscellaneous|2
5503105|NCT01638000|19026508|P2|Overall Study|Withdrawal by Subject|24
5503106|NCT01638000|19026509|P1|Overall Study|Withdrawal by Subject|21
5503107|NCT01638000|19026508|P2|Overall Study|Protocol Violation|13
5503108|NCT01638000|19026509|P1|Overall Study|Protocol Violation|11
5503109|NCT01638000|19026508|P2|Overall Study|Lack of Efficacy|6
5503110|NCT01638000|19026509|P1|Overall Study|Lack of Efficacy|5
5503111|NCT01638000|19026508|P2|Overall Study|Adverse Event|16
5503112|NCT01638000|19026509|P1|Overall Study|Adverse Event|14
5503113|NCT01638000|19026508|P2|Overall Study|Randomized but Never Received Drug|10
5503114|NCT01638000|19026509|P1|Overall Study|Randomized but Never Received Drug|7
5503115|NCT01637961|19026607|P1|Overall Study|Ineligible: inadequate pathology|1
5503116|NCT01637961|19026607|P1|Overall Study|Ineligible: wrong primary|1
5503117|NCT01637922|19026639|P2|Overall Study|Lost to Follow-up|0
5503118|NCT01637922|19026640|P1|Overall Study|Lost to Follow-up|2
5503119|NCT01637922|19026639|P2|Overall Study|Withdrawal by Subject|3
5503120|NCT01637922|19026640|P1|Overall Study|Withdrawal by Subject|0
5503121|NCT01637922|19026639|P2|Overall Study|Protocol Violation|1
5503122|NCT01637922|19026640|P1|Overall Study|Protocol Violation|0
5503123|NCT01637922|19026639|P2|Overall Study|Adverse Event|1
5503124|NCT01637922|19026640|P1|Overall Study|Adverse Event|0
5503125|NCT01637623|19026670|P3|Overall Study|Physician Decision|1
5503126|NCT01637623|19026671|P2|Overall Study|Physician Decision|0
5503127|NCT01637623|19026672|P1|Overall Study|Physician Decision|1
5503128|NCT01637623|19026670|P3|Overall Study|Lost to Follow-up|2
5503129|NCT01637623|19026671|P2|Overall Study|Lost to Follow-up|0
5503130|NCT01637623|19026672|P1|Overall Study|Lost to Follow-up|0
5503131|NCT01637584|19026712|P2|Overall Study|Withdrawal by Subject|3
5503132|NCT01637584|19026713|P1|Overall Study|Withdrawal by Subject|1
5503133|NCT01637402|19026720|P2|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
5503134|NCT01637402|19026721|P1|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
5503135|NCT01637402|19026720|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
5503136|NCT01637402|19026721|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|4
5503137|NCT01637402|19026720|P2|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
5503138|NCT01637402|19026721|P1|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
5503139|NCT01637402|19026720|P2|Week 12 Evaluation|Lack of Efficacy|0
5503140|NCT01637402|19026721|P1|Week 12 Evaluation|Lack of Efficacy|6
5503141|NCT01637402|19026720|P2|Standard Dose Regimen|Adverse Event|0
5503142|NCT01637402|19026721|P1|Standard Dose Regimen|Adverse Event|1
5503143|NCT01637402|19026720|P2|Standard Dose Regimen|Lack of Efficacy|0
5503144|NCT01637402|19026721|P1|Standard Dose Regimen|Lack of Efficacy|2
5503145|NCT01637272|19026752|P1|Overall Study|Protocol Violation|2
5503146|NCT01637272|19026752|P1|Overall Study|Administrative problems|1
5503147|NCT01637272|19026752|P1|Overall Study|completed core, did not enter ext. phase|4
5503148|NCT01637272|19026752|P1|Overall Study|Lost to Follow-up|2
5503149|NCT01637272|19026752|P1|Overall Study|Withdrawal by Subject|3
5503150|NCT01637272|19026752|P1|Overall Study|Unsatisfactory therapeutic effect|2
5503151|NCT01637272|19026752|P1|Overall Study|Adverse Event|6
5503152|NCT01637077|19026832|P2|Overall Study|No cycle 1 questionnaire data|0
5503153|NCT01637077|19026833|P1|Overall Study|No cycle 1 questionnaire data|2
5503154|NCT01637077|19026832|P2|Overall Study|Withdrawal by Subject|0
5503155|NCT01637077|19026833|P1|Overall Study|Withdrawal by Subject|1
5503156|NCT01637077|19026832|P2|Overall Study|Cancel|1
5503157|NCT01637077|19026833|P1|Overall Study|Cancel|1
5503158|NCT01636986|19026861|P2|Overall Study|Corneal Staining|1
5503159|NCT01636986|19026862|P1|Overall Study|Corneal Staining|0
5503160|NCT01636986|19026861|P2|Overall Study|Withdrawal by Subject|1
5503161|NCT01636986|19026862|P1|Overall Study|Withdrawal by Subject|0
5503162|NCT01636960|19026868|P1|Maintenance Phase|Progressive disease|1
5503163|NCT01636960|19026868|P1|Maintenance Phase|Adverse Event|3
5503164|NCT01636960|19026868|P1|Maintenance Phase|Continued drug after regulatory approval|3
5503165|NCT01636960|19026868|P1|Induction Phase|Adverse Event|2
5503166|NCT01636947|19026876|P2|Overall Study|Did Not Meet Eligibility Criteria|4
5503167|NCT01636947|19026877|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5503168|NCT01636947|19026876|P2|Overall Study|Adverse Event|1
5503169|NCT01636947|19026877|P1|Overall Study|Adverse Event|1
5503170|NCT01636947|19026876|P2|Overall Study|Withdrawal by Subject|3
5503171|NCT01636947|19026877|P1|Overall Study|Withdrawal by Subject|3
5503172|NCT01636947|19026876|P2|Overall Study|Protocol Violation|1
5503173|NCT01636947|19026877|P1|Overall Study|Protocol Violation|1
5503174|NCT01636947|19026876|P2|Overall Study|Lost to Follow-up|0
5503175|NCT01636947|19026877|P1|Overall Study|Lost to Follow-up|4
5503176|NCT01636947|19026876|P2|Overall Study|Not Treated|2
5503177|NCT01636947|19026877|P1|Overall Study|Not Treated|2
5503178|NCT01636934|19026899|P2|Overall Study|Never started study medication|1
5503179|NCT01636934|19026900|P1|Overall Study|Never started study medication|1
5503180|NCT01636934|19026899|P2|Overall Study|Too ill to continue|0
5503181|NCT01636934|19026900|P1|Overall Study|Too ill to continue|1
5503182|NCT01636934|19026899|P2|Overall Study|Chemo cancel|0
5503183|NCT01636934|19026900|P1|Overall Study|Chemo cancel|1
5503184|NCT01636934|19026899|P2|Overall Study|Withdrawal by Subject|2
5503185|NCT01636934|19026900|P1|Overall Study|Withdrawal by Subject|3
5503186|NCT01636778|19026912|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
5503187|NCT01636778|19026913|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
5503188|NCT01636778|19026914|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
5503189|NCT01636778|19026912|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
5503190|NCT01636778|19026913|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
5503191|NCT01636778|19026914|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
5503192|NCT01636778|19026912|P3|Follow-up Period After Part 2|Other|1
5503193|NCT01636778|19026913|P2|Follow-up Period After Part 2|Other|0
5503194|NCT01636778|19026914|P1|Follow-up Period After Part 2|Other|0
5503195|NCT01636778|19026912|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
5503196|NCT01636778|19026913|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
5503197|NCT01636778|19026914|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
5503198|NCT01636778|19026912|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
5503199|NCT01636778|19026913|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
5503200|NCT01636778|19026914|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
5503201|NCT01636778|19026912|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
5503202|NCT01636778|19026913|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
5503203|NCT01636778|19026914|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
5503204|NCT01636778|19026912|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
5503205|NCT01636778|19026913|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
5503206|NCT01636778|19026914|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
5503207|NCT01636778|19026912|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
5503208|NCT01636778|19026913|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
5503209|NCT01636778|19026914|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
5503210|NCT01636713|19026985|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
5503211|NCT01636713|19026986|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
5503212|NCT01636713|19026987|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
5503213|NCT01636713|19026985|P3|Overall Study|Withdrawal by Subject|8
5503214|NCT01636713|19026986|P2|Overall Study|Withdrawal by Subject|4
5503215|NCT01636713|19026987|P1|Overall Study|Withdrawal by Subject|5
5503216|NCT01636713|19026985|P3|Overall Study|Lost to Follow-up|1
5503217|NCT01636713|19026986|P2|Overall Study|Lost to Follow-up|0
5503218|NCT01636713|19026987|P1|Overall Study|Lost to Follow-up|0
5503219|NCT01636713|19026985|P3|Overall Study|Protocol Violation|1
5503220|NCT01636713|19026986|P2|Overall Study|Protocol Violation|0
5503221|NCT01636713|19026987|P1|Overall Study|Protocol Violation|3
5503222|NCT01636713|19026985|P3|Overall Study|Lack of Efficacy|2
5503223|NCT01636713|19026986|P2|Overall Study|Lack of Efficacy|6
5503224|NCT01636713|19026987|P1|Overall Study|Lack of Efficacy|6
5503225|NCT01636713|19026985|P3|Overall Study|Adverse Event|7
5503226|NCT01636713|19026986|P2|Overall Study|Adverse Event|16
5503227|NCT01636713|19026987|P1|Overall Study|Adverse Event|16
5503228|NCT01636687|19027004|P5|Follow-up Period|Withdrawal by Subject|1
5503229|NCT01636687|19027005|P4|Follow-up Period|Withdrawal by Subject|0
5503230|NCT01636687|19027006|P3|Follow-up Period|Withdrawal by Subject|0
5503231|NCT01636687|19027007|P2|Follow-up Period|Withdrawal by Subject|0
5503232|NCT01636687|19027008|P1|Follow-up Period|Withdrawal by Subject|1
5503233|NCT01636687|19027004|P5|Extension Period|Withdrawal by Subject|0
5503234|NCT01636687|19027005|P4|Extension Period|Withdrawal by Subject|1
5503235|NCT01636687|19027006|P3|Extension Period|Withdrawal by Subject|1
5503236|NCT01636687|19027007|P2|Extension Period|Withdrawal by Subject|0
5503237|NCT01636687|19027008|P1|Extension Period|Withdrawal by Subject|1
5503238|NCT01636687|19027004|P5|Extension Period|study terminated by sponsor|0
5503239|NCT01636687|19027005|P4|Extension Period|study terminated by sponsor|23
5503240|NCT01636687|19027006|P3|Extension Period|study terminated by sponsor|17
5503241|NCT01636687|19027007|P2|Extension Period|study terminated by sponsor|50
5503242|NCT01636687|19027008|P1|Extension Period|study terminated by sponsor|33
5503243|NCT01636687|19027004|P5|Extension Period|Physician Decision|0
5503244|NCT01636687|19027005|P4|Extension Period|Physician Decision|1
5503245|NCT01636687|19027006|P3|Extension Period|Physician Decision|0
5503246|NCT01636687|19027007|P2|Extension Period|Physician Decision|0
5503247|NCT01636687|19027008|P1|Extension Period|Physician Decision|1
5503248|NCT01636687|19027004|P5|Extension Period|Lost to Follow-up|0
5503249|NCT01636687|19027005|P4|Extension Period|Lost to Follow-up|0
5503250|NCT01636687|19027006|P3|Extension Period|Lost to Follow-up|1
5503251|NCT01636687|19027007|P2|Extension Period|Lost to Follow-up|0
5503252|NCT01636687|19027008|P1|Extension Period|Lost to Follow-up|1
5503253|NCT01636687|19027004|P5|Extension Period|Lack of Efficacy|0
5503254|NCT01636687|19027005|P4|Extension Period|Lack of Efficacy|1
5503255|NCT01636687|19027006|P3|Extension Period|Lack of Efficacy|2
5503256|NCT01636687|19027007|P2|Extension Period|Lack of Efficacy|0
5503257|NCT01636687|19027008|P1|Extension Period|Lack of Efficacy|7
5503258|NCT01636687|19027004|P5|Extension Period|Adverse Event|0
5503259|NCT01636687|19027005|P4|Extension Period|Adverse Event|1
5503260|NCT01636687|19027006|P3|Extension Period|Adverse Event|2
5503261|NCT01636687|19027007|P2|Extension Period|Adverse Event|3
5503262|NCT01636687|19027008|P1|Extension Period|Adverse Event|4
5503263|NCT01636687|19027004|P5|Extension Period|technical problems|0
5503264|NCT01636687|19027005|P4|Extension Period|technical problems|1
5503265|NCT01636687|19027006|P3|Extension Period|technical problems|2
5503266|NCT01636687|19027007|P2|Extension Period|technical problems|1
5503267|NCT01636687|19027008|P1|Extension Period|technical problems|0
5503268|NCT01636687|19027004|P5|Maintenance Period|Physician Decision|1
5503269|NCT01636687|19027005|P4|Maintenance Period|Physician Decision|0
5503270|NCT01636687|19027006|P3|Maintenance Period|Physician Decision|0
5503271|NCT01636687|19027007|P2|Maintenance Period|Physician Decision|0
5503272|NCT01636687|19027008|P1|Maintenance Period|Physician Decision|0
5503273|NCT01636687|19027004|P5|Maintenance Period|Lost to Follow-up|1
5503274|NCT01636687|19027005|P4|Maintenance Period|Lost to Follow-up|0
5503275|NCT01636687|19027006|P3|Maintenance Period|Lost to Follow-up|0
5503276|NCT01636687|19027007|P2|Maintenance Period|Lost to Follow-up|1
5503277|NCT01636687|19027008|P1|Maintenance Period|Lost to Follow-up|1
5503278|NCT01636687|19027004|P5|Maintenance Period|Lack of Efficacy|0
5503279|NCT01636687|19027005|P4|Maintenance Period|Lack of Efficacy|0
5503280|NCT01636687|19027006|P3|Maintenance Period|Lack of Efficacy|0
5503281|NCT01636687|19027007|P2|Maintenance Period|Lack of Efficacy|1
5503282|NCT01636687|19027008|P1|Maintenance Period|Lack of Efficacy|4
5503283|NCT01636687|19027004|P5|Maintenance Period|Adverse Event|0
5503284|NCT01636687|19027005|P4|Maintenance Period|Adverse Event|0
5503285|NCT01636687|19027006|P3|Maintenance Period|Adverse Event|0
5503286|NCT01636687|19027007|P2|Maintenance Period|Adverse Event|0
5503287|NCT01636687|19027008|P1|Maintenance Period|Adverse Event|1
5503288|NCT01636687|19027004|P5|Maintenance Period|Withdrawal by Subject|0
5503289|NCT01636687|19027005|P4|Maintenance Period|Withdrawal by Subject|0
5503290|NCT01636687|19027006|P3|Maintenance Period|Withdrawal by Subject|2
5503291|NCT01636687|19027007|P2|Maintenance Period|Withdrawal by Subject|0
5503292|NCT01636687|19027008|P1|Maintenance Period|Withdrawal by Subject|2
5503293|NCT01636687|19027004|P5|Induction Period|Physician Decision|0
5503294|NCT01636687|19027005|P4|Induction Period|Physician Decision|0
5503295|NCT01636687|19027006|P3|Induction Period|Physician Decision|0
5503296|NCT01636687|19027007|P2|Induction Period|Physician Decision|0
5503297|NCT01636687|19027008|P1|Induction Period|Physician Decision|1
5503298|NCT01636687|19027004|P5|Induction Period|Lack of Efficacy|1
5503299|NCT01636687|19027005|P4|Induction Period|Lack of Efficacy|0
5503300|NCT01636687|19027006|P3|Induction Period|Lack of Efficacy|0
5503301|NCT01636687|19027007|P2|Induction Period|Lack of Efficacy|0
5503302|NCT01636687|19027008|P1|Induction Period|Lack of Efficacy|0
5503303|NCT01636687|19027004|P5|Induction Period|Adverse Event|1
5503304|NCT01636687|19027005|P4|Induction Period|Adverse Event|0
5503305|NCT01636687|19027006|P3|Induction Period|Adverse Event|0
5503306|NCT01636687|19027007|P2|Induction Period|Adverse Event|0
5503307|NCT01636687|19027008|P1|Induction Period|Adverse Event|1
5503308|NCT01636687|19027004|P5|Induction Period|Withdrawal by Subject|0
5503309|NCT01636687|19027005|P4|Induction Period|Withdrawal by Subject|0
5503310|NCT01636687|19027006|P3|Induction Period|Withdrawal by Subject|0
5503311|NCT01636687|19027007|P2|Induction Period|Withdrawal by Subject|0
5503312|NCT01636687|19027008|P1|Induction Period|Withdrawal by Subject|1
5503313|NCT01636362|19027149|P1|Overall Study|Withdrawal by Subject|1
5503314|NCT01636362|19027149|P1|Overall Study|Subject healed, not returning|1
5503315|NCT01636362|19027149|P1|Overall Study|Physician Decision|6
5503316|NCT01636258|19027180|P2|Overall Study|Lost to Follow-up|0
5503317|NCT01636258|19027181|P1|Overall Study|Lost to Follow-up|1
5503318|NCT01636076|19027221|P2|Overall Study|Withdrawal by Subject|10
5503319|NCT01636076|19027222|P1|Overall Study|Withdrawal by Subject|7
5503320|NCT01636076|19027221|P2|Overall Study|Adverse Event|11
5503321|NCT01636076|19027222|P1|Overall Study|Adverse Event|6
5503322|NCT01636076|19027221|P2|Overall Study|Non-compliance with study treatment|1
5503323|NCT01636076|19027222|P1|Overall Study|Non-compliance with study treatment|1
5503324|NCT01636076|19027221|P2|Overall Study|Physician Decision|1
5503325|NCT01636076|19027222|P1|Overall Study|Physician Decision|1
5503326|NCT01636076|19027221|P2|Overall Study|Lost to Follow-up|0
5503327|NCT01636076|19027222|P1|Overall Study|Lost to Follow-up|1
5503328|NCT01636076|19027221|P2|Overall Study|Lack of Efficacy|1
5503329|NCT01636076|19027222|P1|Overall Study|Lack of Efficacy|0
5503330|NCT01636076|19027221|P2|Overall Study|Terminated by sponsor|1
5503331|NCT01636076|19027222|P1|Overall Study|Terminated by sponsor|1
5503332|NCT01635998|19027293|P2|Overall Study|Withdrawal by Subject|5
5503333|NCT01635998|19027294|P1|Overall Study|Withdrawal by Subject|1
5503334|NCT01635998|19027293|P2|Overall Study|Lost to Follow-up|1
5503335|NCT01635998|19027294|P1|Overall Study|Lost to Follow-up|2
5503336|NCT01635998|19027293|P2|Overall Study|Death|1
5503337|NCT01635998|19027294|P1|Overall Study|Death|1
5503338|NCT01635933|19027322|P2|Overall Study|No longer had transportation|1
5503339|NCT01635933|19027323|P1|Overall Study|No longer had transportation|0
5503340|NCT01635933|19027322|P2|Overall Study|Noncompliance|1
5503341|NCT01635933|19027323|P1|Overall Study|Noncompliance|0
5503342|NCT01635933|19027322|P2|Overall Study|Subject decision|1
5503343|NCT01635933|19027323|P1|Overall Study|Subject decision|1
5503344|NCT01635933|19027322|P2|Overall Study|Lost to Follow-up|5
5503345|NCT01635933|19027323|P1|Overall Study|Lost to Follow-up|0
5503346|NCT01635933|19027322|P2|Overall Study|Adverse Event|0
5503347|NCT01635933|19027323|P1|Overall Study|Adverse Event|1
5503348|NCT01635920|19027335|P2|Overall Study|Subject decision|0
5503349|NCT01635920|19027336|P1|Overall Study|Subject decision|2
5503350|NCT01635920|19027335|P2|Overall Study|Lost to Follow-up|1
5503351|NCT01635920|19027336|P1|Overall Study|Lost to Follow-up|0
5503352|NCT01635920|19027335|P2|Overall Study|Adverse Event|0
5503353|NCT01635920|19027336|P1|Overall Study|Adverse Event|1
5503354|NCT01635855|19027349|P1|Overall Study|Withdrawal by Subject|4
5503355|NCT01635764|19027358|P1|Overall Study|Other|28
5503356|NCT01635764|19027358|P1|Overall Study|Lost to Follow-up|53
5503357|NCT01635764|19027358|P1|Overall Study|Withdrew Consent|67
5503358|NCT01635764|19027358|P1|Overall Study|Protocol Deviation|1
5503359|NCT01635764|19027358|P1|Overall Study|Exceed Protocol-specified Interventions|2
5503360|NCT01635764|19027358|P1|Overall Study|Lack of Efficacy|76
5503361|NCT01635764|19027358|P1|Overall Study|Adverse Event|46
5503362|NCT01635283|19027408|P1|Overall Study|Lost to Follow-up|1
5503363|NCT01635283|19027408|P1|Overall Study|Tumor Progression|3
5503364|NCT01635218|19027432|P3|Overall Study|Lost to Follow-up|6
5503365|NCT01635218|19027433|P2|Overall Study|Lost to Follow-up|7
5503366|NCT01635218|19027434|P1|Overall Study|Lost to Follow-up|3
5503367|NCT01635153|19027456|P2|Overall Study|Lost to Follow-up|43
5503368|NCT01635153|19027457|P1|Overall Study|Lost to Follow-up|40
5503369|NCT01634854|19027510|P2|Overall Study|Cesarean delivery|7
5503370|NCT01634854|19027511|P1|Overall Study|Cesarean delivery|2
5503371|NCT01634659|19027531|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
5503372|NCT01634659|19027532|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
5503373|NCT01634659|19027531|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
5503374|NCT01634659|19027532|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
5503375|NCT01634555|19027562|P1|Overall Study|Physician Decision|1
5503376|NCT01634555|19027562|P1|Overall Study|Adverse Event|3
5503377|NCT01634360|19027573|P2|Overall Study|Study termination by sponsor|44
5503378|NCT01634360|19027574|P1|Overall Study|Study termination by sponsor|18
5503379|NCT01634360|19027573|P2|Overall Study|Other|20
5503380|NCT01634360|19027574|P1|Overall Study|Other|3
5503381|NCT01634360|19027573|P2|Overall Study|Lack of Efficacy|14
5503382|NCT01634360|19027574|P1|Overall Study|Lack of Efficacy|4
5503383|NCT01634360|19027573|P2|Overall Study|Protocol Violation|1
5503384|NCT01634360|19027574|P1|Overall Study|Protocol Violation|1
5503385|NCT01634360|19027573|P2|Overall Study|subject withdrew consent|23
5503386|NCT01634360|19027574|P1|Overall Study|subject withdrew consent|13
5503387|NCT01634360|19027573|P2|Overall Study|Adverse Event|34
5503388|NCT01634360|19027574|P1|Overall Study|Adverse Event|10
5503389|NCT01634243|19027648|P2|Overall Study|Lack of Efficacy|0
5503390|NCT01634243|19027649|P1|Overall Study|Lack of Efficacy|1
5503391|NCT01634243|19027648|P2|Overall Study|Adverse Event|5
5503392|NCT01634243|19027649|P1|Overall Study|Adverse Event|5
5503393|NCT01634165|19027675|P4|Period 2|Adverse Event|0
5503394|NCT01634165|19027676|P3|Period 2|Adverse Event|0
5503395|NCT01634165|19027677|P2|Period 2|Adverse Event|1
5503396|NCT01634165|19027678|P1|Period 2|Adverse Event|0
5503397|NCT01634152|19027711|P3|Overall Study|Other reason not defined above|1
5503398|NCT01634152|19027712|P2|Overall Study|Other reason not defined above|0
5503399|NCT01634152|19027713|P1|Overall Study|Other reason not defined above|1
5503400|NCT01634152|19027711|P3|Overall Study|Not treated|0
5503401|NCT01634152|19027712|P2|Overall Study|Not treated|1
5503402|NCT01634152|19027713|P1|Overall Study|Not treated|0
5503403|NCT01634152|19027711|P3|Overall Study|Consent withdrawn not due to AE|1
5503404|NCT01634152|19027712|P2|Overall Study|Consent withdrawn not due to AE|0
5503405|NCT01634152|19027713|P1|Overall Study|Consent withdrawn not due to AE|1
5503406|NCT01634152|19027711|P3|Overall Study|Adverse Event|2
5503407|NCT01634152|19027712|P2|Overall Study|Adverse Event|0
5503408|NCT01634152|19027713|P1|Overall Study|Adverse Event|2
5503409|NCT01634139|19027796|P3|Overall Study|Not treated|0
5503410|NCT01634139|19027797|P2|Overall Study|Not treated|1
5503411|NCT01634139|19027798|P1|Overall Study|Not treated|1
5503412|NCT01634139|19027796|P3|Overall Study|Lost to Follow-up|0
5503413|NCT01634139|19027797|P2|Overall Study|Lost to Follow-up|2
5503414|NCT01634139|19027798|P1|Overall Study|Lost to Follow-up|0
5503415|NCT01634139|19027796|P3|Overall Study|Other|3
5503416|NCT01634139|19027797|P2|Overall Study|Other|0
5503417|NCT01634139|19027798|P1|Overall Study|Other|4
5503418|NCT01634139|19027796|P3|Overall Study|Consent withdrawn not due to AE|2
5503419|NCT01634139|19027797|P2|Overall Study|Consent withdrawn not due to AE|3
5503420|NCT01634139|19027798|P1|Overall Study|Consent withdrawn not due to AE|4
5503421|NCT01634139|19027796|P3|Overall Study|Non compliant with protocol|0
5503422|NCT01634139|19027797|P2|Overall Study|Non compliant with protocol|0
5503423|NCT01634139|19027798|P1|Overall Study|Non compliant with protocol|1
5503424|NCT01634113|19027899|P3|Overall Study|Not treated|1
5503425|NCT01634113|19027900|P2|Overall Study|Not treated|0
5503426|NCT01634113|19027901|P1|Overall Study|Not treated|0
5503427|NCT01634100|19027945|P6|Overall Study|Withdrawal by Subject|0
5503428|NCT01634100|19027946|P5|Overall Study|Withdrawal by Subject|0
5503429|NCT01634100|19027947|P4|Overall Study|Withdrawal by Subject|0
5503430|NCT01634100|19027948|P3|Overall Study|Withdrawal by Subject|1
5503431|NCT01634100|19027949|P2|Overall Study|Withdrawal by Subject|0
5503432|NCT01634100|19027950|P1|Overall Study|Withdrawal by Subject|1
5503433|NCT01633944|19027966|P3|Double-blind Treatment Phase|Other|0
5503434|NCT01633944|19027967|P2|Double-blind Treatment Phase|Other|7
5503435|NCT01633944|19027968|P1|Double-blind Treatment Phase|Other|0
5503436|NCT01633944|19027966|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
5503437|NCT01633944|19027967|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
5503438|NCT01633944|19027968|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
5503439|NCT01633944|19027966|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
5503440|NCT01633944|19027967|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
5503441|NCT01633944|19027968|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
5503442|NCT01633944|19027966|P3|Double-blind Treatment Phase|Lost to Follow-up|9
5503443|NCT01633944|19027967|P2|Double-blind Treatment Phase|Lost to Follow-up|4
5503444|NCT01633944|19027968|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5503445|NCT01633944|19027966|P3|Double-blind Treatment Phase|Protocol Violation|10
5503446|NCT01633944|19027967|P2|Double-blind Treatment Phase|Protocol Violation|7
5503447|NCT01633944|19027968|P1|Double-blind Treatment Phase|Protocol Violation|0
5503448|NCT01633944|19027966|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
5503449|NCT01633944|19027967|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
5503450|NCT01633944|19027968|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
5503451|NCT01633944|19027966|P3|Double-blind Treatment Phase|Lack of Efficacy|23
5503452|NCT01633944|19027967|P2|Double-blind Treatment Phase|Lack of Efficacy|8
5503453|NCT01633944|19027968|P1|Double-blind Treatment Phase|Lack of Efficacy|0
5503454|NCT01633944|19027966|P3|Double-blind Treatment Phase|Adverse Event|7
5503455|NCT01633944|19027967|P2|Double-blind Treatment Phase|Adverse Event|13
5503456|NCT01633944|19027968|P1|Double-blind Treatment Phase|Adverse Event|0
5503457|NCT01633944|19027966|P3|Open-label Titration Phase|Other|0
5503458|NCT01633944|19027967|P2|Open-label Titration Phase|Other|0
5503459|NCT01633944|19027968|P1|Open-label Titration Phase|Other|68
5503460|NCT01633944|19027966|P3|Open-label Titration Phase|Lost to Follow-up|0
5503461|NCT01633944|19027967|P2|Open-label Titration Phase|Lost to Follow-up|0
5503462|NCT01633944|19027968|P1|Open-label Titration Phase|Lost to Follow-up|22
5503463|NCT01633944|19027966|P3|Open-label Titration Phase|Protocol Violation|0
5503464|NCT01633944|19027967|P2|Open-label Titration Phase|Protocol Violation|0
5503465|NCT01633944|19027968|P1|Open-label Titration Phase|Protocol Violation|24
5503466|NCT01633944|19027966|P3|Open-label Titration Phase|Withdrawal by Subject|0
5503467|NCT01633944|19027967|P2|Open-label Titration Phase|Withdrawal by Subject|0
5503468|NCT01633944|19027968|P1|Open-label Titration Phase|Withdrawal by Subject|34
5503469|NCT01633944|19027966|P3|Open-label Titration Phase|Lack of Efficacy|0
5503470|NCT01633944|19027967|P2|Open-label Titration Phase|Lack of Efficacy|0
5503471|NCT01633944|19027968|P1|Open-label Titration Phase|Lack of Efficacy|33
5503472|NCT01633944|19027966|P3|Open-label Titration Phase|Adverse Event|0
5503473|NCT01633944|19027967|P2|Open-label Titration Phase|Adverse Event|0
5503474|NCT01633944|19027968|P1|Open-label Titration Phase|Adverse Event|109
5503475|NCT01633788|19028036|P4|Overall Study|Other Reasons|7
5503476|NCT01633788|19028037|P3|Overall Study|Other Reasons|3
5503477|NCT01633788|19028038|P2|Overall Study|Other Reasons|2
5503478|NCT01633788|19028039|P1|Overall Study|Other Reasons|0
5503479|NCT01633788|19028036|P4|Overall Study|Protocol Violation|0
5503480|NCT01633788|19028037|P3|Overall Study|Protocol Violation|1
5503481|NCT01633788|19028038|P2|Overall Study|Protocol Violation|0
5503482|NCT01633788|19028039|P1|Overall Study|Protocol Violation|1
5503483|NCT01633788|19028036|P4|Overall Study|Personal Reasons|3
5503484|NCT01633788|19028037|P3|Overall Study|Personal Reasons|1
5503485|NCT01633788|19028038|P2|Overall Study|Personal Reasons|1
5503486|NCT01633788|19028039|P1|Overall Study|Personal Reasons|3
5503487|NCT01633788|19028036|P4|Overall Study|Lost to Follow-up|0
5503488|NCT01633788|19028037|P3|Overall Study|Lost to Follow-up|2
5503489|NCT01633788|19028038|P2|Overall Study|Lost to Follow-up|2
5503490|NCT01633788|19028039|P1|Overall Study|Lost to Follow-up|2
5503491|NCT01633788|19028036|P4|Overall Study|Adverse Event|3
5503492|NCT01633788|19028037|P3|Overall Study|Adverse Event|3
5503493|NCT01633788|19028038|P2|Overall Study|Adverse Event|3
5503494|NCT01633788|19028039|P1|Overall Study|Adverse Event|1
5503495|NCT01633112|19028071|P3|Overall Study|missing Study Completion CRF|4
5503496|NCT01633112|19028072|P2|Overall Study|missing Study Completion CRF|1
5503497|NCT01633112|19028073|P1|Overall Study|missing Study Completion CRF|1
5503498|NCT01633112|19028071|P3|Overall Study|Withdrawal by Subject|41
5503499|NCT01633112|19028072|P2|Overall Study|Withdrawal by Subject|12
5503500|NCT01633112|19028073|P1|Overall Study|Withdrawal by Subject|20
5503501|NCT01633112|19028071|P3|Overall Study|Subject no longer requires study drug|1
5503502|NCT01633112|19028072|P2|Overall Study|Subject no longer requires study drug|0
5503503|NCT01633112|19028073|P1|Overall Study|Subject no longer requires study drug|0
5503504|NCT01633112|19028071|P3|Overall Study|Protocol Violation|2
5503505|NCT01633112|19028072|P2|Overall Study|Protocol Violation|0
5503506|NCT01633112|19028073|P1|Overall Study|Protocol Violation|4
5503507|NCT01633112|19028071|P3|Overall Study|Lost to Follow-up|6
5503508|NCT01633112|19028072|P2|Overall Study|Lost to Follow-up|19
5503509|NCT01633112|19028073|P1|Overall Study|Lost to Follow-up|7
5503510|NCT01633112|19028071|P3|Overall Study|Adverse Event|20
5503511|NCT01633112|19028072|P2|Overall Study|Adverse Event|18
5503512|NCT01633112|19028073|P1|Overall Study|Adverse Event|16
5503513|NCT01633112|19028071|P3|Overall Study|Administrative problems|5
5503514|NCT01633112|19028072|P2|Overall Study|Administrative problems|2
5503515|NCT01633112|19028073|P1|Overall Study|Administrative problems|1
5503516|NCT01633112|19028071|P3|Overall Study|Abnormal test procedure result(s)|0
5503517|NCT01633112|19028072|P2|Overall Study|Abnormal test procedure result(s)|1
5503518|NCT01633112|19028073|P1|Overall Study|Abnormal test procedure result(s)|0
5503519|NCT01633112|19028071|P3|Overall Study|Abnormal laboratory value(s)|0
5503520|NCT01633112|19028072|P2|Overall Study|Abnormal laboratory value(s)|1
5503521|NCT01633112|19028073|P1|Overall Study|Abnormal laboratory value(s)|3
5503522|NCT01633112|19028071|P3|Overall Study|Lack of Efficacy|13
5503523|NCT01633112|19028072|P2|Overall Study|Lack of Efficacy|6
5503524|NCT01633112|19028073|P1|Overall Study|Lack of Efficacy|1
5503525|NCT01633060|19028108|P2|Post-Treatment Efficacy Follow-Up Phase|Death|0
5503526|NCT01633060|19028109|P1|Post-Treatment Efficacy Follow-Up Phase|Death|1
5503527|NCT01633060|19028108|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
5503528|NCT01633060|19028109|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
5503529|NCT01633060|19028108|P2|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
5503530|NCT01633060|19028109|P1|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
5503531|NCT01633060|19028108|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
5503532|NCT01633060|19028109|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
5503533|NCT01633060|19028108|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
5503534|NCT01633060|19028109|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
5503535|NCT01633060|19028108|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5503536|NCT01633060|19028109|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
5503537|NCT01633060|19028108|P2|Treatment Phase|Death|3
5503538|NCT01633060|19028109|P1|Treatment Phase|Death|4
5503539|NCT01633060|19028108|P2|Treatment Phase|Subject/guardian decision|4
5503540|NCT01633060|19028109|P1|Treatment Phase|Subject/guardian decision|25
5503541|NCT01633060|19028108|P2|Treatment Phase|Study Terminated by sponsor|3
5503542|NCT01633060|19028109|P1|Treatment Phase|Study Terminated by sponsor|7
5503543|NCT01633060|19028108|P2|Treatment Phase|Protocol Deviation|0
5503544|NCT01633060|19028109|P1|Treatment Phase|Protocol Deviation|1
5503545|NCT01633060|19028108|P2|Treatment Phase|Progressive Disease|120
5503546|NCT01633060|19028109|P1|Treatment Phase|Progressive Disease|210
5503547|NCT01633060|19028108|P2|Treatment Phase|Physician Decision|7
5503548|NCT01633060|19028109|P1|Treatment Phase|Physician Decision|16
5503549|NCT01633060|19028108|P2|Treatment Phase|Lost to Follow-up|0
5503550|NCT01633060|19028109|P1|Treatment Phase|Lost to Follow-up|1
5503551|NCT01633060|19028108|P2|Treatment Phase|Adverse Event|3
5503552|NCT01633060|19028109|P1|Treatment Phase|Adverse Event|24
5503553|NCT01633060|19028108|P2|Randomization Phase|Technical problem|1
5503554|NCT01633060|19028109|P1|Randomization Phase|Technical problem|0
5503555|NCT01633060|19028108|P2|Randomization Phase|Protocol deviation|2
5503556|NCT01633060|19028109|P1|Randomization Phase|Protocol deviation|1
5503557|NCT01632904|19028149|P2|Overall Study|Reason for discontinuation not available|1
5503558|NCT01632904|19028150|P1|Overall Study|Reason for discontinuation not available|0
5503559|NCT01632904|19028149|P2|Overall Study|Disease Progression|1
5503560|NCT01632904|19028150|P1|Overall Study|Disease Progression|0
5503561|NCT01632904|19028149|P2|Overall Study|Subject decision|2
5503562|NCT01632904|19028150|P1|Overall Study|Subject decision|3
5503563|NCT01632904|19028149|P2|Overall Study|Physician Decision|1
5503564|NCT01632904|19028150|P1|Overall Study|Physician Decision|0
5503565|NCT01632904|19028149|P2|Overall Study|Adverse Event|1
5503566|NCT01632904|19028150|P1|Overall Study|Adverse Event|4
5503567|NCT01632891|19028161|P2|Overall Study|Withdrawal by Subject|0
5503568|NCT01632891|19028162|P1|Overall Study|Withdrawal by Subject|1
5503569|NCT01632891|19028161|P2|Overall Study|Lost to Follow-up|1
5503570|NCT01632891|19028162|P1|Overall Study|Lost to Follow-up|0
5503571|NCT01632878|19028186|P1|Treatment|no information on study completion|43
5503572|NCT01632878|19028186|P1|Treatment|missing information|4
5503573|NCT01632878|19028186|P1|Treatment|Physician Decision|34
5503574|NCT01632878|19028186|P1|Treatment|Withdrawal by Subject|36
5503575|NCT01632878|19028186|P1|Treatment|Lost to Follow-up|41
5503576|NCT01632878|19028186|P1|Screening|Physician Decision|268
5503577|NCT01632800|19028190|P1|Overall Study|Subject did not fit in apparatus|1
5503578|NCT01632579|19028257|P9|Period 2 (Second Intervention)|Adverse Event|0
5503579|NCT01632579|19028258|P8|Period 2 (Second Intervention)|Adverse Event|0
5503580|NCT01632579|19028259|P7|Period 2 (Second Intervention)|Adverse Event|0
5503581|NCT01632579|19028260|P6|Period 2 (Second Intervention)|Adverse Event|0
5503582|NCT01632579|19028261|P5|Period 2 (Second Intervention)|Adverse Event|0
5503583|NCT01632579|19028262|P4|Period 2 (Second Intervention)|Adverse Event|0
5503584|NCT01632579|19028263|P3|Period 2 (Second Intervention)|Adverse Event|0
5503585|NCT01632579|19028264|P2|Period 2 (Second Intervention)|Adverse Event|0
5503586|NCT01632579|19028265|P1|Period 2 (Second Intervention)|Adverse Event|1
5503587|NCT01632579|19028257|P9|Washout Period|Adverse Event|0
5503588|NCT01632579|19028258|P8|Washout Period|Adverse Event|0
5503589|NCT01632579|19028259|P7|Washout Period|Adverse Event|0
5503590|NCT01632579|19028260|P6|Washout Period|Adverse Event|0
5503591|NCT01632579|19028261|P5|Washout Period|Adverse Event|0
5503592|NCT01632579|19028262|P4|Washout Period|Adverse Event|0
5503593|NCT01632579|19028263|P3|Washout Period|Adverse Event|0
5503594|NCT01632579|19028264|P2|Washout Period|Adverse Event|0
5503595|NCT01632579|19028265|P1|Washout Period|Adverse Event|1
5503596|NCT01632566|19028332|P5|Overall Study|Sponsor Decision|2
5503597|NCT01632566|19028333|P4|Overall Study|Sponsor Decision|2
5503598|NCT01632566|19028334|P3|Overall Study|Sponsor Decision|9
5503599|NCT01632566|19028335|P2|Overall Study|Sponsor Decision|2
5503600|NCT01632566|19028336|P1|Overall Study|Sponsor Decision|0
5503601|NCT01632566|19028332|P5|Overall Study|Withdrawal by Subject|0
5503602|NCT01632566|19028333|P4|Overall Study|Withdrawal by Subject|0
5503603|NCT01632566|19028334|P3|Overall Study|Withdrawal by Subject|0
5503604|NCT01632566|19028335|P2|Overall Study|Withdrawal by Subject|1
5503605|NCT01632566|19028336|P1|Overall Study|Withdrawal by Subject|0
5503606|NCT01632345|19028387|P7|Treatment: Part II|Withdrawal by Subject|2
5503607|NCT01632345|19028388|P6|Treatment: Part II|Withdrawal by Subject|2
5503608|NCT01632345|19028389|P5|Treatment: Part II|Withdrawal by Subject|0
5503609|NCT01632345|19028390|P4|Treatment: Part II|Withdrawal by Subject|0
5503610|NCT01632345|19028391|P3|Treatment: Part II|Withdrawal by Subject|0
5503611|NCT01632345|19028392|P2|Treatment: Part II|Withdrawal by Subject|0
5503612|NCT01632345|19028393|P1|Treatment: Part II|Withdrawal by Subject|0
5503613|NCT01632345|19028387|P7|Treatment: Part II|Non-Compliance with Study Drug|0
5503614|NCT01632345|19028388|P6|Treatment: Part II|Non-Compliance with Study Drug|3
5503615|NCT01632345|19028389|P5|Treatment: Part II|Non-Compliance with Study Drug|0
5503616|NCT01632345|19028390|P4|Treatment: Part II|Non-Compliance with Study Drug|0
5503617|NCT01632345|19028391|P3|Treatment: Part II|Non-Compliance with Study Drug|0
5503618|NCT01632345|19028392|P2|Treatment: Part II|Non-Compliance with Study Drug|0
5503619|NCT01632345|19028393|P1|Treatment: Part II|Non-Compliance with Study Drug|0
5503620|NCT01632345|19028387|P7|Treatment: Part II|Lost to Follow-up|1
5503621|NCT01632345|19028388|P6|Treatment: Part II|Lost to Follow-up|3
5503622|NCT01632345|19028389|P5|Treatment: Part II|Lost to Follow-up|0
5503623|NCT01632345|19028390|P4|Treatment: Part II|Lost to Follow-up|0
5503624|NCT01632345|19028391|P3|Treatment: Part II|Lost to Follow-up|0
5503625|NCT01632345|19028392|P2|Treatment: Part II|Lost to Follow-up|0
5503626|NCT01632345|19028393|P1|Treatment: Part II|Lost to Follow-up|0
5503627|NCT01632345|19028387|P7|Treatment: Part II|Adverse Event|8
5503628|NCT01632345|19028388|P6|Treatment: Part II|Adverse Event|3
5503629|NCT01632345|19028389|P5|Treatment: Part II|Adverse Event|0
5503630|NCT01632345|19028390|P4|Treatment: Part II|Adverse Event|0
5503631|NCT01632345|19028391|P3|Treatment: Part II|Adverse Event|0
5503632|NCT01632345|19028392|P2|Treatment: Part II|Adverse Event|0
5503633|NCT01632345|19028393|P1|Treatment: Part II|Adverse Event|0
5503634|NCT01632345|19028387|P7|Treatment: Part I|Withdrawal by Subject|0
5503635|NCT01632345|19028388|P6|Treatment: Part I|Withdrawal by Subject|0
5503636|NCT01632345|19028389|P5|Treatment: Part I|Withdrawal by Subject|4
5503637|NCT01632345|19028390|P4|Treatment: Part I|Withdrawal by Subject|1
5503638|NCT01632345|19028391|P3|Treatment: Part I|Withdrawal by Subject|4
5503639|NCT01632345|19028392|P2|Treatment: Part I|Withdrawal by Subject|4
5503640|NCT01632345|19028393|P1|Treatment: Part I|Withdrawal by Subject|3
5503641|NCT01632345|19028387|P7|Treatment: Part I|Protocol Deviation|0
5503642|NCT01632345|19028388|P6|Treatment: Part I|Protocol Deviation|0
5503643|NCT01632345|19028389|P5|Treatment: Part I|Protocol Deviation|0
5503644|NCT01632345|19028390|P4|Treatment: Part I|Protocol Deviation|1
5503645|NCT01632345|19028391|P3|Treatment: Part I|Protocol Deviation|1
5503646|NCT01632345|19028392|P2|Treatment: Part I|Protocol Deviation|0
5503647|NCT01632345|19028393|P1|Treatment: Part I|Protocol Deviation|0
5503648|NCT01632345|19028387|P7|Treatment: Part I|Pregnancy|0
5503649|NCT01632345|19028388|P6|Treatment: Part I|Pregnancy|0
5503650|NCT01632345|19028389|P5|Treatment: Part I|Pregnancy|0
5503651|NCT01632345|19028390|P4|Treatment: Part I|Pregnancy|0
5503652|NCT01632345|19028391|P3|Treatment: Part I|Pregnancy|0
5503653|NCT01632345|19028392|P2|Treatment: Part I|Pregnancy|1
5503654|NCT01632345|19028393|P1|Treatment: Part I|Pregnancy|0
5503655|NCT01632345|19028387|P7|Treatment: Part I|Physician Decision|0
5503656|NCT01632345|19028388|P6|Treatment: Part I|Physician Decision|0
5503657|NCT01632345|19028389|P5|Treatment: Part I|Physician Decision|1
5503658|NCT01632345|19028390|P4|Treatment: Part I|Physician Decision|0
5503659|NCT01632345|19028391|P3|Treatment: Part I|Physician Decision|0
5503660|NCT01632345|19028392|P2|Treatment: Part I|Physician Decision|1
5503661|NCT01632345|19028393|P1|Treatment: Part I|Physician Decision|2
5503662|NCT01632345|19028387|P7|Treatment: Part I|Non-Compliance with Study Drug|0
5503663|NCT01632345|19028388|P6|Treatment: Part I|Non-Compliance with Study Drug|0
5503664|NCT01632345|19028389|P5|Treatment: Part I|Non-Compliance with Study Drug|0
5503665|NCT01632345|19028390|P4|Treatment: Part I|Non-Compliance with Study Drug|1
5503666|NCT01632345|19028391|P3|Treatment: Part I|Non-Compliance with Study Drug|2
5503667|NCT01632345|19028392|P2|Treatment: Part I|Non-Compliance with Study Drug|2
5503668|NCT01632345|19028393|P1|Treatment: Part I|Non-Compliance with Study Drug|3
5503669|NCT01632345|19028387|P7|Treatment: Part I|Lost to Follow-up|0
5503670|NCT01632345|19028388|P6|Treatment: Part I|Lost to Follow-up|0
5503671|NCT01632345|19028389|P5|Treatment: Part I|Lost to Follow-up|4
5503672|NCT01632345|19028390|P4|Treatment: Part I|Lost to Follow-up|3
5503673|NCT01632345|19028391|P3|Treatment: Part I|Lost to Follow-up|1
5503674|NCT01632345|19028392|P2|Treatment: Part I|Lost to Follow-up|2
5503675|NCT01632345|19028393|P1|Treatment: Part I|Lost to Follow-up|3
5503676|NCT01632345|19028387|P7|Treatment: Part I|Lack of Efficacy|0
5503677|NCT01632345|19028388|P6|Treatment: Part I|Lack of Efficacy|0
5503678|NCT01632345|19028389|P5|Treatment: Part I|Lack of Efficacy|1
5503679|NCT01632345|19028390|P4|Treatment: Part I|Lack of Efficacy|1
5503680|NCT01632345|19028391|P3|Treatment: Part I|Lack of Efficacy|0
5503681|NCT01632345|19028392|P2|Treatment: Part I|Lack of Efficacy|1
5503682|NCT01632345|19028393|P1|Treatment: Part I|Lack of Efficacy|0
5503683|NCT01632345|19028387|P7|Treatment: Part I|Adverse Event|0
5503684|NCT01632345|19028388|P6|Treatment: Part I|Adverse Event|0
5503685|NCT01632345|19028389|P5|Treatment: Part I|Adverse Event|3
5503686|NCT01632345|19028390|P4|Treatment: Part I|Adverse Event|1
5503687|NCT01632345|19028391|P3|Treatment: Part I|Adverse Event|2
5503688|NCT01632345|19028392|P2|Treatment: Part I|Adverse Event|4
5503689|NCT01632345|19028393|P1|Treatment: Part I|Adverse Event|1
5503690|NCT01632306|19028455|P3|Overall Study|Protocol Violation|0
5503691|NCT01632306|19028456|P2|Overall Study|Protocol Violation|0
5503692|NCT01632306|19028457|P1|Overall Study|Protocol Violation|1
5503693|NCT01632280|19028473|P2|Overall Study|Withdrawal by Subject|0
5503694|NCT01632280|19028474|P1|Overall Study|Withdrawal by Subject|1
5503695|NCT01632241|19028490|P2|Open-label (Week 52 to Week 76)|Adverse Event|0
5503696|NCT01632241|19028491|P1|Open-label (Week 52 to Week 76)|Adverse Event|1
5503697|NCT01632241|19028490|P2|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
5503698|NCT01632241|19028491|P1|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
5503699|NCT01632241|19028490|P2|Open-label (Week 52 to Week 76)|Protocol Violation|2
5503700|NCT01632241|19028491|P1|Open-label (Week 52 to Week 76)|Protocol Violation|0
5503701|NCT01632241|19028490|P2|Open-label (Week 52 to Week 76)|Site Closed|8
5503702|NCT01632241|19028491|P1|Open-label (Week 52 to Week 76)|Site Closed|2
5503703|NCT01632241|19028490|P2|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
5503704|NCT01632241|19028491|P1|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
5503705|NCT01632241|19028490|P2|Open-label (Week 52 to Week 76)|Physician Decision|4
5503706|NCT01632241|19028491|P1|Open-label (Week 52 to Week 76)|Physician Decision|1
5503707|NCT01632241|19028490|P2|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
5503708|NCT01632241|19028491|P1|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
5503709|NCT01632241|19028490|P2|Double-blinded (Up to Week 52)|Adverse Event|19
5503710|NCT01632241|19028491|P1|Double-blinded (Up to Week 52)|Adverse Event|10
5503711|NCT01632241|19028490|P2|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
5503712|NCT01632241|19028491|P1|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
5503713|NCT01632241|19028490|P2|Double-blinded (Up to Week 52)|Lack of Efficacy|15
5503714|NCT01632241|19028491|P1|Double-blinded (Up to Week 52)|Lack of Efficacy|9
5503715|NCT01632241|19028490|P2|Double-blinded (Up to Week 52)|Physician Decision|12
5503716|NCT01632241|19028491|P1|Double-blinded (Up to Week 52)|Physician Decision|9
5503717|NCT01632241|19028490|P2|Double-blinded (Up to Week 52)|Lost to Follow-up|8
5503718|NCT01632241|19028491|P1|Double-blinded (Up to Week 52)|Lost to Follow-up|1
5503719|NCT01632241|19028490|P2|Double-blinded (Up to Week 52)|Protocol Violation|6
5503720|NCT01632241|19028491|P1|Double-blinded (Up to Week 52)|Protocol Violation|2
5503721|NCT01632241|19028490|P2|Double-blinded (Up to Week 52)|Site Closed|5
5503722|NCT01632241|19028491|P1|Double-blinded (Up to Week 52)|Site Closed|3
5503723|NCT01632150|19028561|P1|Overall Study|Moved to compassionate program|2
5503724|NCT01632150|19028561|P1|Overall Study|Patient underwent autologous transplant|1
5503725|NCT01632150|19028561|P1|Overall Study|Withdrawal by Subject|2
5503726|NCT01632150|19028561|P1|Overall Study|Unrelated adverse event|7
5503727|NCT01632150|19028561|P1|Overall Study|Study drug toxicity|1
5503728|NCT01632150|19028561|P1|Overall Study|Disease progression|27
5503729|NCT01632020|19028570|P2|Overall Study|Adverse Event|0
5503730|NCT01632020|19028571|P1|Overall Study|Adverse Event|1
5503731|NCT01632020|19028570|P2|Overall Study|Withdrawal by Subject|0
5503732|NCT01632020|19028571|P1|Overall Study|Withdrawal by Subject|1
5503733|NCT01631864|19028590|P2|Overall Study|Adverse Event|3
5503734|NCT01631864|19028591|P1|Overall Study|Adverse Event|2
5503735|NCT01631864|19028590|P2|Overall Study|Withdrawal by Subject|1
5503736|NCT01631864|19028591|P1|Overall Study|Withdrawal by Subject|0
5503737|NCT01631825|19028603|P1|Overall Study|Physician Decision|2
5503738|NCT01631825|19028603|P1|Overall Study|Discontinuation criteria|1
5503739|NCT01631825|19028603|P1|Overall Study|Protocol Violation|4
5503740|NCT01631825|19028603|P1|Overall Study|Withdrawal by Subject|9
5503741|NCT01631825|19028603|P1|Overall Study|Lack of Efficacy|7
5503742|NCT01631825|19028603|P1|Overall Study|Adverse Event|42
5503743|NCT01631812|19028623|P1|Overall Study|Physician Decision|3
5503744|NCT01631812|19028623|P1|Overall Study|Withdrawal by Subject|4
5503745|NCT01631812|19028623|P1|Overall Study|Lack of Efficacy|5
5503746|NCT01631812|19028623|P1|Overall Study|Adverse Event|25
5503747|NCT01631747|19028633|P2|One Year Infant Outcomes|Patient Refused|9
5503748|NCT01631747|19028634|P1|One Year Infant Outcomes|Patient Refused|13
5503749|NCT01631747|19028633|P2|Live Birth|Stillbirth|1
5503750|NCT01631747|19028634|P1|Live Birth|Stillbirth|1
5503751|NCT01631747|19028633|P2|Live Birth|MIscarriage|0
5503752|NCT01631747|19028634|P1|Live Birth|MIscarriage|2
5503753|NCT01631747|19028633|P2|Live Birth|Pregnancy Termination|0
5503754|NCT01631747|19028634|P1|Live Birth|Pregnancy Termination|1
5503755|NCT01631747|19028633|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
5503756|NCT01631747|19028634|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
5503757|NCT01631474|19028816|P5|Overall Study|Adverse Event|0
5503758|NCT01631474|19028817|P4|Overall Study|Adverse Event|0
5503759|NCT01631474|19028818|P3|Overall Study|Adverse Event|0
5503760|NCT01631474|19028819|P2|Overall Study|Adverse Event|1
5503761|NCT01631474|19028820|P1|Overall Study|Adverse Event|0
5503762|NCT01631474|19028816|P5|Overall Study|Noncompliance with Study Drug|1
5503763|NCT01631474|19028817|P4|Overall Study|Noncompliance with Study Drug|0
5503764|NCT01631474|19028818|P3|Overall Study|Noncompliance with Study Drug|0
5503765|NCT01631474|19028819|P2|Overall Study|Noncompliance with Study Drug|0
5503766|NCT01631474|19028820|P1|Overall Study|Noncompliance with Study Drug|0
5503767|NCT01631474|19028816|P5|Overall Study|Lack of Efficacy|2
5503768|NCT01631474|19028817|P4|Overall Study|Lack of Efficacy|0
5503769|NCT01631474|19028818|P3|Overall Study|Lack of Efficacy|0
5503770|NCT01631474|19028819|P2|Overall Study|Lack of Efficacy|2
5503771|NCT01631474|19028820|P1|Overall Study|Lack of Efficacy|2
5503772|NCT01631474|19028816|P5|Overall Study|Withdrawal by Subject|5
5503773|NCT01631474|19028817|P4|Overall Study|Withdrawal by Subject|6
5503774|NCT01631474|19028818|P3|Overall Study|Withdrawal by Subject|2
5503775|NCT01631474|19028819|P2|Overall Study|Withdrawal by Subject|4
5503776|NCT01631474|19028820|P1|Overall Study|Withdrawal by Subject|4
5503777|NCT01631474|19028816|P5|Overall Study|Lost to Follow-up|5
5503778|NCT01631474|19028817|P4|Overall Study|Lost to Follow-up|5
5503779|NCT01631474|19028818|P3|Overall Study|Lost to Follow-up|7
5503780|NCT01631474|19028819|P2|Overall Study|Lost to Follow-up|5
5503781|NCT01631474|19028820|P1|Overall Study|Lost to Follow-up|8
5503782|NCT01631435|19028857|P1|Overall Study|incomplete study procedure|5
5503783|NCT01631435|19028857|P1|Overall Study|Withdrawal by Subject|2
5503784|NCT01631435|19028857|P1|Overall Study|Adverse Event|2
5503785|NCT01631227|19028871|P2|Overall Study|administrative|1
5503786|NCT01631227|19028872|P1|Overall Study|administrative|2
5503787|NCT01631227|19028871|P2|Overall Study|Adverse Event|0
5503788|NCT01631227|19028872|P1|Overall Study|Adverse Event|1
5503789|NCT01631227|19028871|P2|Overall Study|withdrawn consent|21
5503790|NCT01631227|19028872|P1|Overall Study|withdrawn consent|27
5503791|NCT01631214|19028880|P2|Overall Study|Administrative Decision|0
5503792|NCT01631214|19028881|P1|Overall Study|Administrative Decision|1
5503793|NCT01631214|19028880|P2|Overall Study|Ineligibility determined|2
5503794|NCT01631214|19028881|P1|Overall Study|Ineligibility determined|5
5503795|NCT01631214|19028880|P2|Overall Study|Protocol Deviation|3
5503796|NCT01631214|19028881|P1|Overall Study|Protocol Deviation|4
5503797|NCT01631214|19028880|P2|Overall Study|Requirement for Alternative Therapy|3
5503798|NCT01631214|19028881|P1|Overall Study|Requirement for Alternative Therapy|8
5503799|NCT01631214|19028880|P2|Overall Study|Noncompliance|15
5503800|NCT01631214|19028881|P1|Overall Study|Noncompliance|16
5503801|NCT01631214|19028880|P2|Overall Study|Other|19
5503802|NCT01631214|19028881|P1|Overall Study|Other|22
5503803|NCT01631214|19028880|P2|Overall Study|Adverse Event|45
5503804|NCT01631214|19028881|P1|Overall Study|Adverse Event|45
5503805|NCT01631214|19028880|P2|Overall Study|Lost to Follow-up|40
5503806|NCT01631214|19028881|P1|Overall Study|Lost to Follow-up|54
5503807|NCT01631214|19028880|P2|Overall Study|Death|106
5503808|NCT01631214|19028881|P1|Overall Study|Death|113
5503809|NCT01631214|19028880|P2|Overall Study|Withdrawal by Subject|290
5503810|NCT01631214|19028881|P1|Overall Study|Withdrawal by Subject|276
5503811|NCT01630811|19028990|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
5503812|NCT01630811|19028991|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
5503813|NCT01630616|19029018|P6|Overall Study|Withdrawal by Subject|0
5503814|NCT01630616|19029019|P5|Overall Study|Withdrawal by Subject|0
5503815|NCT01630616|19029020|P4|Overall Study|Withdrawal by Subject|2
5503816|NCT01630616|19029021|P3|Overall Study|Withdrawal by Subject|0
5503817|NCT01630616|19029022|P2|Overall Study|Withdrawal by Subject|0
5503818|NCT01630616|19029023|P1|Overall Study|Withdrawal by Subject|0
5503819|NCT01630616|19029018|P6|Overall Study|Adverse Event|0
5503820|NCT01630616|19029019|P5|Overall Study|Adverse Event|0
5503821|NCT01630616|19029020|P4|Overall Study|Adverse Event|1
5503822|NCT01630616|19029021|P3|Overall Study|Adverse Event|0
5503823|NCT01630616|19029022|P2|Overall Study|Adverse Event|0
5503824|NCT01630616|19029023|P1|Overall Study|Adverse Event|0
5503825|NCT01630135|19029123|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
5503826|NCT01630135|19029124|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
5503827|NCT01629966|19029188|P3|Overall Study|Adverse Event|30
5503828|NCT01629966|19029189|P2|Overall Study|Adverse Event|18
5503829|NCT01629966|19029190|P1|Overall Study|Adverse Event|11
5503830|NCT01629966|19029188|P3|Overall Study|Lack of Efficacy|4
5503831|NCT01629966|19029189|P2|Overall Study|Lack of Efficacy|2
5503832|NCT01629966|19029190|P1|Overall Study|Lack of Efficacy|5
5503833|NCT01629966|19029188|P3|Overall Study|Protocol Violation|7
5503834|NCT01629966|19029189|P2|Overall Study|Protocol Violation|9
5503835|NCT01629966|19029190|P1|Overall Study|Protocol Violation|7
5503836|NCT01629966|19029188|P3|Overall Study|Withdrawal by Subject|16
5503837|NCT01629966|19029189|P2|Overall Study|Withdrawal by Subject|9
5503838|NCT01629966|19029190|P1|Overall Study|Withdrawal by Subject|8
5503839|NCT01629966|19029188|P3|Overall Study|Lost to Follow-up|9
5503840|NCT01629966|19029189|P2|Overall Study|Lost to Follow-up|13
5503841|NCT01629966|19029190|P1|Overall Study|Lost to Follow-up|10
5503842|NCT01629966|19029188|P3|Overall Study|Pregnancy|0
5503843|NCT01629966|19029189|P2|Overall Study|Pregnancy|1
5503844|NCT01629966|19029190|P1|Overall Study|Pregnancy|0
5503845|NCT01629953|19029203|P2|Overall Study|Lost to Follow-up|14
5503846|NCT01629953|19029204|P1|Overall Study|Lost to Follow-up|10
5503847|NCT01629953|19029203|P2|Overall Study|Death|1
5503848|NCT01629953|19029204|P1|Overall Study|Death|3
5503849|NCT01629823|19029224|P3|Washout Period|Protocol Violation|0
5503850|NCT01629823|19029225|P2|Washout Period|Protocol Violation|1
5503851|NCT01629823|19029226|P1|Washout Period|Protocol Violation|0
5503852|NCT01629823|19029224|P3|Washout Period|Pregnancy|0
5503853|NCT01629823|19029225|P2|Washout Period|Pregnancy|0
5503854|NCT01629823|19029226|P1|Washout Period|Pregnancy|1
5503855|NCT01629823|19029224|P3|Washout Period|Safety|0
5503856|NCT01629823|19029225|P2|Washout Period|Safety|5
5503857|NCT01629823|19029226|P1|Washout Period|Safety|2
5503858|NCT01629823|19029224|P3|Trial Period|Failed to hold medication|1
5503859|NCT01629823|19029225|P2|Trial Period|Failed to hold medication|0
5503860|NCT01629823|19029226|P1|Trial Period|Failed to hold medication|0
5503861|NCT01629823|19029224|P3|Trial Period|Out-of-window visit|0
5503862|NCT01629823|19029225|P2|Trial Period|Out-of-window visit|2
5503863|NCT01629823|19029226|P1|Trial Period|Out-of-window visit|0
5503864|NCT01629823|19029224|P3|Trial Period|Adverse Event|0
5503865|NCT01629823|19029225|P2|Trial Period|Adverse Event|1
5503866|NCT01629823|19029226|P1|Trial Period|Adverse Event|0
5503867|NCT01629823|19029224|P3|Trial Period|Pregnancy|0
5503868|NCT01629823|19029225|P2|Trial Period|Pregnancy|0
5503869|NCT01629823|19029226|P1|Trial Period|Pregnancy|1
5503870|NCT01629823|19029224|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
5503871|NCT01629823|19029225|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
5503872|NCT01629823|19029226|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
5503873|NCT01629823|19029224|P3|Trial Period|Missed visit|8
5503874|NCT01629823|19029225|P2|Trial Period|Missed visit|9
5503875|NCT01629823|19029226|P1|Trial Period|Missed visit|11
5503876|NCT01629706|19029261|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
5503877|NCT01629706|19029261|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
5503878|NCT01629706|19029261|P1|Phase 2 Habitual|Relocation prior to Dispense|1
5503879|NCT01629706|19029261|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
5503880|NCT01629706|19029261|P1|Phase 2 Habitual|Screen Failure|6
5503881|NCT01629706|19029261|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
5503882|NCT01629706|19029261|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
5503883|NCT01629706|19029261|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
5503884|NCT01629706|19029261|P1|Phase 1 PureVision|Screen Failure|4
5503885|NCT01629693|19029289|P2|Overall Study|Subject decision unrelated to AE|1
5503886|NCT01629693|19029290|P1|Overall Study|Subject decision unrelated to AE|0
5503887|NCT01629693|19029289|P2|Overall Study|Poor comfort of study lenses|2
5503888|NCT01629693|19029290|P1|Overall Study|Poor comfort of study lenses|0
5503889|NCT01629693|19029289|P2|Overall Study|Investigator decision|1
5503890|NCT01629693|19029290|P1|Overall Study|Investigator decision|0
5503891|NCT01629693|19029289|P2|Overall Study|Adverse Event|0
5503892|NCT01629693|19029290|P1|Overall Study|Adverse Event|1
5503893|NCT01629693|19029289|P2|Overall Study|Withdrawal by Subject|2
5503894|NCT01629693|19029290|P1|Overall Study|Withdrawal by Subject|2
5503895|NCT01629693|19029289|P2|Overall Study|Lost to Follow-up|4
5503896|NCT01629693|19029290|P1|Overall Study|Lost to Follow-up|2
5503897|NCT01629667|19029299|P3|Overall Study|Code break|0
5503898|NCT01629667|19029300|P2|Overall Study|Code break|0
5503899|NCT01629667|19029301|P1|Overall Study|Code break|1
5503900|NCT01629667|19029299|P3|Overall Study|Enrolled in another clinical study|0
5503901|NCT01629667|19029300|P2|Overall Study|Enrolled in another clinical study|1
5503902|NCT01629667|19029301|P1|Overall Study|Enrolled in another clinical study|0
5503903|NCT01629667|19029299|P3|Overall Study|Site error in safety follow-up|1
5503904|NCT01629667|19029300|P2|Overall Study|Site error in safety follow-up|0
5503905|NCT01629667|19029301|P1|Overall Study|Site error in safety follow-up|0
5503906|NCT01629667|19029299|P3|Overall Study|Started other medicine|1
5503907|NCT01629667|19029300|P2|Overall Study|Started other medicine|0
5503908|NCT01629667|19029301|P1|Overall Study|Started other medicine|1
5503909|NCT01629667|19029299|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
5503910|NCT01629667|19029300|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
5503911|NCT01629667|19029301|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
5503912|NCT01629667|19029299|P3|Overall Study|Requiring lung transplant|3
5503913|NCT01629667|19029300|P2|Overall Study|Requiring lung transplant|1
5503914|NCT01629667|19029301|P1|Overall Study|Requiring lung transplant|2
5503915|NCT01629667|19029299|P3|Overall Study|Ongoing AE worsening right heart failure|0
5503916|NCT01629667|19029300|P2|Overall Study|Ongoing AE worsening right heart failure|1
5503917|NCT01629667|19029301|P1|Overall Study|Ongoing AE worsening right heart failure|0
5503918|NCT01629667|19029299|P3|Overall Study|Randomized, not treated|0
5503919|NCT01629667|19029300|P2|Overall Study|Randomized, not treated|1
5503920|NCT01629667|19029301|P1|Overall Study|Randomized, not treated|2
5503921|NCT01629667|19029299|P3|Overall Study|Death|3
5503922|NCT01629667|19029300|P2|Overall Study|Death|5
5503923|NCT01629667|19029301|P1|Overall Study|Death|1
5503924|NCT01629667|19029299|P3|Overall Study|Withdrawal by Subject|28
5503925|NCT01629667|19029300|P2|Overall Study|Withdrawal by Subject|20
5503926|NCT01629667|19029301|P1|Overall Study|Withdrawal by Subject|31
5503927|NCT01629667|19029299|P3|Overall Study|Lost to Follow-up|1
5503928|NCT01629667|19029300|P2|Overall Study|Lost to Follow-up|1
5503929|NCT01629667|19029301|P1|Overall Study|Lost to Follow-up|0
5503930|NCT01629589|19029392|P2|Overall Study|Did not receive study vaccine|1
5503931|NCT01629589|19029393|P1|Overall Study|Did not receive study vaccine|0
5503932|NCT01629589|19029392|P2|Overall Study|Withdrawal by Subject|3
5503933|NCT01629589|19029393|P1|Overall Study|Withdrawal by Subject|2
5503934|NCT01629589|19029392|P2|Overall Study|Lost to Follow-up|1
5503935|NCT01629589|19029393|P1|Overall Study|Lost to Follow-up|2
5503936|NCT01629589|19029392|P2|Overall Study|Protocol Violation|2
5503937|NCT01629589|19029393|P1|Overall Study|Protocol Violation|4
5503938|NCT01629563|19029411|P2|Overall Study|Protocol Violation|1
5503939|NCT01629563|19029412|P1|Overall Study|Protocol Violation|0
5503940|NCT01629563|19029411|P2|Overall Study|Lack of return of menses|7
5503941|NCT01629563|19029412|P1|Overall Study|Lack of return of menses|12
5503942|NCT01629563|19029411|P2|Overall Study|surgery|3
5503943|NCT01629563|19029412|P1|Overall Study|surgery|0
5503944|NCT01629563|19029411|P2|Overall Study|Withdrawal by Subject|20
5503945|NCT01629563|19029412|P1|Overall Study|Withdrawal by Subject|27
5503946|NCT01629563|19029411|P2|Overall Study|Protocol Violation|1
5503947|NCT01629563|19029412|P1|Overall Study|Protocol Violation|0
5503948|NCT01629563|19029411|P2|Overall Study|Pregnancy|2
5503949|NCT01629563|19029412|P1|Overall Study|Pregnancy|1
5503950|NCT01629563|19029411|P2|Overall Study|Lost to Follow-up|0
5503951|NCT01629563|19029412|P1|Overall Study|Lost to Follow-up|1
5503952|NCT01629563|19029411|P2|Overall Study|Lack of Efficacy|3
5503953|NCT01629563|19029412|P1|Overall Study|Lack of Efficacy|2
5503954|NCT01629563|19029411|P2|Overall Study|Death|0
5503955|NCT01629563|19029412|P1|Overall Study|Death|2
5503956|NCT01629563|19029411|P2|Overall Study|Adverse Event|16
5503957|NCT01629563|19029412|P1|Overall Study|Adverse Event|16
5503958|NCT01628965|19029501|P1|Overall Study|Discontinuation criteria|8
5503959|NCT01628965|19029501|P1|Overall Study|Lost to Follow-up|1
5503960|NCT01628965|19029501|P1|Overall Study|Withdrawal by Subject|3
5503961|NCT01628965|19029501|P1|Overall Study|Lack of Efficacy|7
5503962|NCT01628965|19029501|P1|Overall Study|Adverse Event|30
5503963|NCT01628926|19029510|P3|Overall Study|Physician Decision|1
5503964|NCT01628926|19029511|P2|Overall Study|Physician Decision|2
5503965|NCT01628926|19029512|P1|Overall Study|Physician Decision|2
5503966|NCT01628926|19029510|P3|Overall Study|Discontinuation criteria|0
5503967|NCT01628926|19029511|P2|Overall Study|Discontinuation criteria|4
5503968|NCT01628926|19029512|P1|Overall Study|Discontinuation criteria|3
5503969|NCT01628926|19029510|P3|Overall Study|Protocol Violation|0
5503970|NCT01628926|19029511|P2|Overall Study|Protocol Violation|1
5503971|NCT01628926|19029512|P1|Overall Study|Protocol Violation|0
5503972|NCT01628926|19029510|P3|Overall Study|Withdrawal by Subject|2
5503973|NCT01628926|19029511|P2|Overall Study|Withdrawal by Subject|4
5503974|NCT01628926|19029512|P1|Overall Study|Withdrawal by Subject|6
5503975|NCT01628926|19029510|P3|Overall Study|Lack of Efficacy|5
5503976|NCT01628926|19029511|P2|Overall Study|Lack of Efficacy|1
5503977|NCT01628926|19029512|P1|Overall Study|Lack of Efficacy|2
5503978|NCT01628926|19029510|P3|Overall Study|Adverse Event|9
5503979|NCT01628926|19029511|P2|Overall Study|Adverse Event|11
5503980|NCT01628926|19029512|P1|Overall Study|Adverse Event|13
5503981|NCT01628913|19029561|P2|Overall Study|Physician Decision|3
5503982|NCT01628913|19029562|P1|Overall Study|Physician Decision|1
5503983|NCT01628913|19029561|P2|Overall Study|Withdrawal by Subject|0
5503984|NCT01628913|19029562|P1|Overall Study|Withdrawal by Subject|1
5503985|NCT01628913|19029561|P2|Overall Study|study terminated by Sponsor|9
5503986|NCT01628913|19029562|P1|Overall Study|study terminated by Sponsor|4
5503987|NCT01628913|19029561|P2|Overall Study|Death|0
5503988|NCT01628913|19029562|P1|Overall Study|Death|1
5503989|NCT01628913|19029561|P2|Overall Study|Protocol Violation|0
5503990|NCT01628913|19029562|P1|Overall Study|Protocol Violation|1
5503991|NCT01628913|19029561|P2|Overall Study|Disease Progression|14
5503992|NCT01628913|19029562|P1|Overall Study|Disease Progression|11
5503993|NCT01628913|19029561|P2|Overall Study|Adverse Event|5
5503994|NCT01628913|19029562|P1|Overall Study|Adverse Event|12
5503995|NCT01628874|19029576|P2|Overall Study|Age >4 months|2
5503996|NCT01628874|19029577|P1|Overall Study|Age >4 months|4
5503997|NCT01628874|19029576|P2|Overall Study|Physician Decision|1
5503998|NCT01628874|19029577|P1|Overall Study|Physician Decision|1
5503999|NCT01628848|19029593|P2|Overall Study|Physician Decision|1
5504000|NCT01628848|19029594|P1|Overall Study|Physician Decision|3
5504001|NCT01628848|19029593|P2|Overall Study|Withdrawal by Subject|2
5504002|NCT01628848|19029594|P1|Overall Study|Withdrawal by Subject|0
5504003|NCT01628848|19029593|P2|Overall Study|Lack of Efficacy|4
5504004|NCT01628848|19029594|P1|Overall Study|Lack of Efficacy|0
5504005|NCT01628848|19029593|P2|Overall Study|Adverse Event|7
5504006|NCT01628848|19029594|P1|Overall Study|Adverse Event|9
5504007|NCT01628692|19029637|P6|Overall Study|Completed 12 Week only|1
5504008|NCT01628692|19029638|P5|Overall Study|Completed 12 Week only|0
5504009|NCT01628692|19029639|P4|Overall Study|Completed 12 Week only|0
5504010|NCT01628692|19029640|P3|Overall Study|Completed 12 Week only|0
5504011|NCT01628692|19029641|P2|Overall Study|Completed 12 Week only|0
5504012|NCT01628692|19029642|P1|Overall Study|Completed 12 Week only|0
5504013|NCT01628692|19029637|P6|Overall Study|Administrative reason by sponsor|1
5504014|NCT01628692|19029638|P5|Overall Study|Administrative reason by sponsor|0
5504015|NCT01628692|19029639|P4|Overall Study|Administrative reason by sponsor|0
5504016|NCT01628692|19029640|P3|Overall Study|Administrative reason by sponsor|0
5504017|NCT01628692|19029641|P2|Overall Study|Administrative reason by sponsor|0
5504018|NCT01628692|19029642|P1|Overall Study|Administrative reason by sponsor|0
5504019|NCT01628692|19029637|P6|Overall Study|Poor compliance/noncompliance|0
5504020|NCT01628692|19029638|P5|Overall Study|Poor compliance/noncompliance|0
5504021|NCT01628692|19029639|P4|Overall Study|Poor compliance/noncompliance|0
5504022|NCT01628692|19029640|P3|Overall Study|Poor compliance/noncompliance|0
5504023|NCT01628692|19029641|P2|Overall Study|Poor compliance/noncompliance|0
5504024|NCT01628692|19029642|P1|Overall Study|Poor compliance/noncompliance|1
5504025|NCT01628692|19029637|P6|Overall Study|Death|0
5504026|NCT01628692|19029638|P5|Overall Study|Death|0
5504027|NCT01628692|19029639|P4|Overall Study|Death|0
5504028|NCT01628692|19029640|P3|Overall Study|Death|0
5504029|NCT01628692|19029641|P2|Overall Study|Death|1
5504030|NCT01628692|19029642|P1|Overall Study|Death|0
5504031|NCT01628692|19029637|P6|Overall Study|Withdrawal by Subject|0
5504032|NCT01628692|19029638|P5|Overall Study|Withdrawal by Subject|0
5504033|NCT01628692|19029639|P4|Overall Study|Withdrawal by Subject|0
5504034|NCT01628692|19029640|P3|Overall Study|Withdrawal by Subject|1
5504035|NCT01628692|19029641|P2|Overall Study|Withdrawal by Subject|1
5504036|NCT01628692|19029642|P1|Overall Study|Withdrawal by Subject|0
5504037|NCT01628692|19029637|P6|Overall Study|Adverse Event|0
5504038|NCT01628692|19029638|P5|Overall Study|Adverse Event|0
5504039|NCT01628692|19029639|P4|Overall Study|Adverse Event|0
5504040|NCT01628692|19029640|P3|Overall Study|Adverse Event|2
5504041|NCT01628692|19029641|P2|Overall Study|Adverse Event|0
5504042|NCT01628692|19029642|P1|Overall Study|Adverse Event|2
5504043|NCT01628692|19029637|P6|Overall Study|Lack of Efficacy|7
5504044|NCT01628692|19029638|P5|Overall Study|Lack of Efficacy|4
5504045|NCT01628692|19029639|P4|Overall Study|Lack of Efficacy|1
5504046|NCT01628692|19029640|P3|Overall Study|Lack of Efficacy|5
5504047|NCT01628692|19029641|P2|Overall Study|Lack of Efficacy|4
5504048|NCT01628692|19029642|P1|Overall Study|Lack of Efficacy|4
5504049|NCT01628549|19029712|P4|Overall Study|positive pregnancy test|1
5504050|NCT01628549|19029713|P3|Overall Study|positive pregnancy test|0
5504051|NCT01628549|19029714|P2|Overall Study|positive pregnancy test|0
5504052|NCT01628549|19029715|P1|Overall Study|positive pregnancy test|0
5504053|NCT01628549|19029712|P4|Overall Study|abnormal laboratory test results|0
5504054|NCT01628549|19029713|P3|Overall Study|abnormal laboratory test results|1
5504055|NCT01628549|19029714|P2|Overall Study|abnormal laboratory test results|0
5504056|NCT01628549|19029715|P1|Overall Study|abnormal laboratory test results|0
5504057|NCT01628549|19029712|P4|Overall Study|withdrawn for noncompliance|0
5504058|NCT01628549|19029713|P3|Overall Study|withdrawn for noncompliance|1
5504059|NCT01628549|19029714|P2|Overall Study|withdrawn for noncompliance|2
5504060|NCT01628549|19029715|P1|Overall Study|withdrawn for noncompliance|0
5504061|NCT01628549|19029712|P4|Overall Study|Protocol Violation|0
5504062|NCT01628549|19029713|P3|Overall Study|Protocol Violation|1
5504063|NCT01628549|19029714|P2|Overall Study|Protocol Violation|1
5504064|NCT01628549|19029715|P1|Overall Study|Protocol Violation|2
5504065|NCT01628549|19029712|P4|Overall Study|Withdrawal by Subject|1
5504066|NCT01628549|19029713|P3|Overall Study|Withdrawal by Subject|4
5504067|NCT01628549|19029714|P2|Overall Study|Withdrawal by Subject|4
5504068|NCT01628549|19029715|P1|Overall Study|Withdrawal by Subject|3
5504069|NCT01628549|19029712|P4|Overall Study|Lost to Follow-up|3
5504070|NCT01628549|19029713|P3|Overall Study|Lost to Follow-up|3
5504071|NCT01628549|19029714|P2|Overall Study|Lost to Follow-up|4
5504072|NCT01628549|19029715|P1|Overall Study|Lost to Follow-up|3
5504073|NCT01628549|19029712|P4|Overall Study|Adverse Event|4
5504074|NCT01628549|19029713|P3|Overall Study|Adverse Event|0
5504075|NCT01628549|19029714|P2|Overall Study|Adverse Event|1
5504076|NCT01628549|19029715|P1|Overall Study|Adverse Event|1
5504077|NCT01628510|19029756|P2|Overall Study|Death|1
5504078|NCT01628510|19029757|P1|Overall Study|Death|3
5504079|NCT01628510|19029756|P2|Overall Study|Withdrawal by Subject|4
5504080|NCT01628510|19029757|P1|Overall Study|Withdrawal by Subject|0
5504081|NCT01628367|19029767|P2|Overall Study|Adverse Event|0
5504082|NCT01628367|19029768|P1|Overall Study|Adverse Event|1
5504083|NCT01628198|19029787|P1|Overall Study|Screen failure|1
5504084|NCT01628198|19029787|P1|Overall Study|Withdrawal by Subject|10
5504085|NCT01628198|19029787|P1|Overall Study|Lost to Follow-up|7
5504086|NCT01628120|19029814|P1|Overall Study|Use of Standard of Care|1
5504087|NCT01628120|19029814|P1|Overall Study|Kidney Transplant|2
5504088|NCT01628120|19029814|P1|Overall Study|Moved or Relocated|5
5504089|NCT01628120|19029814|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
5504090|NCT01628120|19029814|P1|Overall Study|Switched Dialysis Method|2
5504091|NCT01628120|19029814|P1|Overall Study|Sponsor Decision|5
5504092|NCT01628120|19029814|P1|Overall Study|Not Treated|3
5504093|NCT01628120|19029814|P1|Overall Study|Non-compliant with Study Procedures|1
5504094|NCT01628120|19029814|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
5504095|NCT01628120|19029814|P1|Overall Study|Lost to Follow-up|1
5504096|NCT01628120|19029814|P1|Overall Study|Adverse Event|12
5504097|NCT01628120|19029814|P1|Overall Study|Withdrawal by Subject|7
5504098|NCT01628107|19029839|P1|Overall Study|Use of Standard of Care|9
5504099|NCT01628107|19029839|P1|Overall Study|Kidney Transplant|9
5504100|NCT01628107|19029839|P1|Overall Study|Relocated|8
5504101|NCT01628107|19029839|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
5504102|NCT01628107|19029839|P1|Overall Study|Sponsor Decision|11
5504103|NCT01628107|19029839|P1|Overall Study|Not Treated|8
5504104|NCT01628107|19029839|P1|Overall Study|Non-compliant with Study Procedures|10
5504105|NCT01628107|19029839|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
5504106|NCT01628107|19029839|P1|Overall Study|Physician Decision|2
5504107|NCT01628107|19029839|P1|Overall Study|Adverse Event|33
5504108|NCT01628107|19029839|P1|Overall Study|Lost to Follow-up|4
5504109|NCT01628107|19029839|P1|Overall Study|Withdrawal by Subject|17
5504110|NCT01627899|19029905|P1|Overall Study|Study terminated early by sponsor.|5
5504111|NCT01627860|19029915|P2|Overall Study|Protocol Violation|0
5504112|NCT01627860|19029916|P1|Overall Study|Protocol Violation|1
5504113|NCT01627860|19029915|P2|Overall Study|Seizure frequency doubled|1
5504114|NCT01627860|19029916|P1|Overall Study|Seizure frequency doubled|0
5504115|NCT01627860|19029915|P2|Overall Study|Withdrawal by Subject|1
5504116|NCT01627860|19029916|P1|Overall Study|Withdrawal by Subject|2
5504117|NCT01627860|19029915|P2|Overall Study|Adverse Event|4
5504118|NCT01627860|19029916|P1|Overall Study|Adverse Event|9
5504119|NCT01627782|19029930|P4|Overall Study|Randomized But Not Treated|0
5504120|NCT01627782|19029931|P3|Overall Study|Randomized But Not Treated|0
5504121|NCT01627782|19029932|P2|Overall Study|Randomized But Not Treated|0
5504122|NCT01627782|19029933|P1|Overall Study|Randomized But Not Treated|1
5504123|NCT01627782|19029930|P4|Overall Study|Other|3
5504124|NCT01627782|19029931|P3|Overall Study|Other|0
5504125|NCT01627782|19029932|P2|Overall Study|Other|2
5504126|NCT01627782|19029933|P1|Overall Study|Other|0
5504127|NCT01627782|19029930|P4|Overall Study|Withdrawal by Subject|0
5504128|NCT01627782|19029931|P3|Overall Study|Withdrawal by Subject|0
5504129|NCT01627782|19029932|P2|Overall Study|Withdrawal by Subject|1
5504130|NCT01627782|19029933|P1|Overall Study|Withdrawal by Subject|2
5504131|NCT01627782|19029930|P4|Overall Study|Protocol Violation|0
5504132|NCT01627782|19029931|P3|Overall Study|Protocol Violation|0
5504133|NCT01627782|19029932|P2|Overall Study|Protocol Violation|0
5504134|NCT01627782|19029933|P1|Overall Study|Protocol Violation|1
5504135|NCT01627782|19029930|P4|Overall Study|Lack of Efficacy|2
5504136|NCT01627782|19029931|P3|Overall Study|Lack of Efficacy|15
5504137|NCT01627782|19029932|P2|Overall Study|Lack of Efficacy|1
5504138|NCT01627782|19029933|P1|Overall Study|Lack of Efficacy|11
5504139|NCT01627782|19029930|P4|Overall Study|Adverse Event|1
5504140|NCT01627782|19029931|P3|Overall Study|Adverse Event|0
5504141|NCT01627782|19029932|P2|Overall Study|Adverse Event|2
5504142|NCT01627782|19029933|P1|Overall Study|Adverse Event|1
5504143|NCT01627691|19029989|P1|Overall Study|Missed the visit|3
5504144|NCT01627691|19029989|P1|Overall Study|Withdrawal by Subject|1
5504145|NCT01627691|19029989|P1|Overall Study|Lost to Follow-up|3
5504146|NCT01627691|19029989|P1|Overall Study|Death|11
5504147|NCT01627574|19030002|P2|Overall Study|Lost to Follow-up|13
5504148|NCT01627574|19030003|P1|Overall Study|Lost to Follow-up|13
5504149|NCT01627574|19030002|P2|Overall Study|Withdrawal by Subject|5
5504150|NCT01627574|19030003|P1|Overall Study|Withdrawal by Subject|8
5504151|NCT01627561|19030017|P2|Overall Study|Migrated/moved from study area|2
5504152|NCT01627561|19030018|P1|Overall Study|Migrated/moved from study area|0
5504153|NCT01627561|19030017|P2|Overall Study|Withdrawal by Subject|1
5504154|NCT01627561|19030018|P1|Overall Study|Withdrawal by Subject|0
5504155|NCT01627561|19030017|P2|Overall Study|Lost to Follow-up|0
5504156|NCT01627561|19030018|P1|Overall Study|Lost to Follow-up|1
5504157|NCT01627340|19030084|P2|Overall Study|Withdrawal by Subject|0
5504158|NCT01627340|19030085|P1|Overall Study|Withdrawal by Subject|2
5504159|NCT01627340|19030084|P2|Overall Study|Pregnancy|0
5504160|NCT01627340|19030085|P1|Overall Study|Pregnancy|1
5504161|NCT01627340|19030084|P2|Overall Study|Lost to Follow-up|4
5504162|NCT01627340|19030085|P1|Overall Study|Lost to Follow-up|8
5504163|NCT01627340|19030084|P2|Overall Study|Adverse Event|0
5504164|NCT01627340|19030085|P1|Overall Study|Adverse Event|1
5504165|NCT01627327|19030103|P2|Overall Study|Withdrawal by Subject|3
5504166|NCT01627327|19030104|P1|Overall Study|Withdrawal by Subject|3
5504167|NCT01627327|19030103|P2|Overall Study|Physician Decision|0
5504168|NCT01627327|19030104|P1|Overall Study|Physician Decision|1
5504169|NCT01627327|19030103|P2|Overall Study|Lost to Follow-up|3
5504170|NCT01627327|19030104|P1|Overall Study|Lost to Follow-up|1
5504171|NCT01627327|19030103|P2|Overall Study|Protocol Violation|10
5504172|NCT01627327|19030104|P1|Overall Study|Protocol Violation|4
5504173|NCT01627327|19030103|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
5504174|NCT01627327|19030104|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
5504175|NCT01627327|19030103|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
5504176|NCT01627327|19030104|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
5504177|NCT01627327|19030103|P2|Overall Study|Adverse Event|12
5504178|NCT01627327|19030104|P1|Overall Study|Adverse Event|6
5504179|NCT01627249|19030154|P3|Overall Study|Missed Visit|0
5504180|NCT01627249|19030155|P2|Overall Study|Missed Visit|1
5504181|NCT01627249|19030156|P1|Overall Study|Missed Visit|1
5504182|NCT01627249|19030154|P3|Overall Study|Withdrawal by Subject|9
5504183|NCT01627249|19030155|P2|Overall Study|Withdrawal by Subject|6
5504184|NCT01627249|19030156|P1|Overall Study|Withdrawal by Subject|12
5504185|NCT01627249|19030154|P3|Overall Study|Death|3
5504186|NCT01627249|19030155|P2|Overall Study|Death|5
5504187|NCT01627249|19030156|P1|Overall Study|Death|3
5504188|NCT01627067|19030191|P1|Overall Study|Screen Failure|1
5504189|NCT01626989|19030260|P3|Screening Period|Withdrawal by Subject|0
5504190|NCT01626989|19030261|P2|Screening Period|Withdrawal by Subject|0
5504191|NCT01626989|19030262|P1|Screening Period|Withdrawal by Subject|2
5504192|NCT01626989|19030260|P3|Screening Period|Screen Failure|0
5504193|NCT01626989|19030261|P2|Screening Period|Screen Failure|0
5504194|NCT01626989|19030262|P1|Screening Period|Screen Failure|15
5504195|NCT01626690|19030334|P2|Overall Study|Adverse Event|0
5504196|NCT01626690|19030335|P1|Overall Study|Adverse Event|1
5504197|NCT01626690|19030334|P2|Overall Study|Protocol Violation|0
5504198|NCT01626690|19030335|P1|Overall Study|Protocol Violation|1
5504199|NCT01626495|19030372|P1|Overall Study|Manufacturing failure|1
5504200|NCT01626495|19030372|P1|Overall Study|New cancer therapy|16
5504201|NCT01626495|19030372|P1|Overall Study|Physician Decision|1
5504202|NCT01626495|19030372|P1|Overall Study|Death|2
5504203|NCT01626495|19030372|P1|Overall Study|Administrative problem|1
5504204|NCT01626495|19030372|P1|Overall Study|Withdrawal by Subject|1
5504205|NCT01626495|19030372|P1|Overall Study|Disease progression|27
5504206|NCT01626495|19030372|P1|Overall Study|Adverse Event|3
5504207|NCT01626456|19030381|P2|Overall Study|Incarceration|2
5504208|NCT01626456|19030382|P1|Overall Study|Incarceration|0
5504209|NCT01626456|19030381|P2|Overall Study|Site Closure|3
5504210|NCT01626456|19030382|P1|Overall Study|Site Closure|2
5504211|NCT01626456|19030381|P2|Overall Study|Protocol Violation|1
5504212|NCT01626456|19030382|P1|Overall Study|Protocol Violation|1
5504213|NCT01626456|19030381|P2|Overall Study|Physician Decision|4
5504214|NCT01626456|19030382|P1|Overall Study|Physician Decision|1
5504215|NCT01626456|19030381|P2|Overall Study|Lack of Efficacy|7
5504216|NCT01626456|19030382|P1|Overall Study|Lack of Efficacy|6
5504217|NCT01626456|19030381|P2|Overall Study|Lost to Follow-up|27
5504218|NCT01626456|19030382|P1|Overall Study|Lost to Follow-up|2
5504219|NCT01626456|19030381|P2|Overall Study|Adverse Event|27
5504220|NCT01626456|19030382|P1|Overall Study|Adverse Event|2
5504221|NCT01626456|19030381|P2|Overall Study|Withdrawal by Subject|46
5504222|NCT01626456|19030382|P1|Overall Study|Withdrawal by Subject|21
5504223|NCT01626391|19030412|P2|Overall Study|Withdrawal by Subject|0
5504224|NCT01626391|19030413|P1|Overall Study|Withdrawal by Subject|1
5504225|NCT01626391|19030412|P2|Overall Study|Physician Decision|0
5504226|NCT01626391|19030413|P1|Overall Study|Physician Decision|1
5504227|NCT01626352|19030419|P1|Overall Study|Never Treated|1
5504228|NCT01626352|19030419|P1|Overall Study|Non-Compliance|1
5504229|NCT01626352|19030419|P1|Overall Study|Withdrawal by Subject|1
5504230|NCT01626352|19030419|P1|Overall Study|Death|2
5504231|NCT01626352|19030419|P1|Overall Study|Intercurrent Illness|2
5504232|NCT01626352|19030419|P1|Overall Study|Disease Progression|3
5504233|NCT01626118|19030433|P4|Overall Study|Investigator Decision|0
5504234|NCT01626118|19030434|P3|Overall Study|Investigator Decision|0
5504235|NCT01626118|19030435|P2|Overall Study|Investigator Decision|1
5504236|NCT01626118|19030436|P1|Overall Study|Investigator Decision|0
5504237|NCT01626118|19030433|P4|Overall Study|Adverse Event|0
5504238|NCT01626118|19030434|P3|Overall Study|Adverse Event|1
5504239|NCT01626118|19030435|P2|Overall Study|Adverse Event|1
5504240|NCT01626118|19030436|P1|Overall Study|Adverse Event|0
5504241|NCT01626118|19030433|P4|Overall Study|Lost to Follow-up|0
5504242|NCT01626118|19030434|P3|Overall Study|Lost to Follow-up|0
5504243|NCT01626118|19030435|P2|Overall Study|Lost to Follow-up|0
5504244|NCT01626118|19030436|P1|Overall Study|Lost to Follow-up|1
5504245|NCT01626118|19030433|P4|Overall Study|Lack of Efficacy|3
5504246|NCT01626118|19030434|P3|Overall Study|Lack of Efficacy|1
5504247|NCT01626118|19030435|P2|Overall Study|Lack of Efficacy|0
5504248|NCT01626118|19030436|P1|Overall Study|Lack of Efficacy|1
5504249|NCT01626079|19030482|P2|Overall Study|Visits Expected or Not Due|69
5504250|NCT01626079|19030483|P1|Overall Study|Visits Expected or Not Due|74
5504251|NCT01626079|19030482|P2|Overall Study|Lost to Follow-up|3
5504252|NCT01626079|19030483|P1|Overall Study|Lost to Follow-up|3
5504253|NCT01626079|19030482|P2|Overall Study|Withdrawal by Subject|29
5504254|NCT01626079|19030483|P1|Overall Study|Withdrawal by Subject|12
5504255|NCT01626079|19030482|P2|Overall Study|Death|115
5504256|NCT01626079|19030483|P1|Overall Study|Death|78
5504257|NCT01625988|19030856|P2|Overall Study|Protocol Violation|2
5504258|NCT01625988|19030857|P1|Overall Study|Protocol Violation|0
5504259|NCT01625988|19030856|P2|Overall Study|Randomized Inappropriately|0
5504260|NCT01625988|19030857|P1|Overall Study|Randomized Inappropriately|1
5504261|NCT01625988|19030856|P2|Overall Study|Lack of Efficacy|1
5504262|NCT01625988|19030857|P1|Overall Study|Lack of Efficacy|0
5504263|NCT01625988|19030856|P2|Overall Study|Adverse Event|1
5504264|NCT01625988|19030857|P1|Overall Study|Adverse Event|0
5504265|NCT01625988|19030856|P2|Overall Study|Withdrawal by Subject|3
5504266|NCT01625988|19030857|P1|Overall Study|Withdrawal by Subject|8
5504267|NCT01625988|19030856|P2|Overall Study|Lost to Follow-up|6
5504268|NCT01625988|19030857|P1|Overall Study|Lost to Follow-up|5
5504269|NCT01625910|19030881|P2|Overall Study|Lost to Follow-up|4
5504270|NCT01625910|19030882|P1|Overall Study|Lost to Follow-up|3
5504271|NCT01625845|19030892|P2|Overall Study|Withdrawal by Subject|0
5504272|NCT01625845|19030893|P1|Overall Study|Withdrawal by Subject|2
5504273|NCT01625845|19030892|P2|Overall Study|Lost to Follow-up|1
5504274|NCT01625845|19030893|P1|Overall Study|Lost to Follow-up|2
5504275|NCT01625845|19030892|P2|Overall Study|Adverse Event|2
5504276|NCT01625845|19030893|P1|Overall Study|Adverse Event|1
5504277|NCT01625689|19030913|P2|Overall Study|Migration|1
5504278|NCT01625689|19030914|P1|Overall Study|Migration|2
5504279|NCT01625377|19030969|P2|Overall Study|Abnormal laboratory values|0
5504280|NCT01625377|19030970|P1|Overall Study|Abnormal laboratory values|1
5504281|NCT01625377|19030969|P2|Overall Study|Unsatisfactory therapeutic effect|1
5504282|NCT01625377|19030970|P1|Overall Study|Unsatisfactory therapeutic effect|0
5504283|NCT01625377|19030969|P2|Overall Study|Graft loss|0
5504284|NCT01625377|19030970|P1|Overall Study|Graft loss|1
5504285|NCT01625377|19030969|P2|Overall Study|Adverse Event|16
5504286|NCT01625377|19030970|P1|Overall Study|Adverse Event|3
5504287|NCT01625377|19030969|P2|Overall Study|Protocol Violation|3
5504288|NCT01625377|19030970|P1|Overall Study|Protocol Violation|0
5504289|NCT01625377|19030969|P2|Overall Study|Administrative Problem|1
5504290|NCT01625377|19030970|P1|Overall Study|Administrative Problem|1
5504291|NCT01625377|19030969|P2|Overall Study|Death|1
5504292|NCT01625377|19030970|P1|Overall Study|Death|1
5504293|NCT01625338|19031003|P3|Overall Study|Study Discontinued by Sponsor|1
5504294|NCT01625338|19031004|P2|Overall Study|Study Discontinued by Sponsor|0
5504295|NCT01625338|19031005|P1|Overall Study|Study Discontinued by Sponsor|0
5504296|NCT01625338|19031003|P3|Overall Study|Adverse Event|1
5504297|NCT01625338|19031004|P2|Overall Study|Adverse Event|0
5504298|NCT01625338|19031005|P1|Overall Study|Adverse Event|1
5504299|NCT01625338|19031003|P3|Overall Study|Subject Withdrew Consent|2
5504300|NCT01625338|19031004|P2|Overall Study|Subject Withdrew Consent|0
5504301|NCT01625338|19031005|P1|Overall Study|Subject Withdrew Consent|1
5504302|NCT01625338|19031003|P3|Overall Study|Investigator Decision|1
5504303|NCT01625338|19031004|P2|Overall Study|Investigator Decision|2
5504304|NCT01625338|19031005|P1|Overall Study|Investigator Decision|0
5504305|NCT01625338|19031003|P3|Overall Study|Lost to Follow-up|2
5504306|NCT01625338|19031004|P2|Overall Study|Lost to Follow-up|3
5504307|NCT01625338|19031005|P1|Overall Study|Lost to Follow-up|3
5504308|NCT01625338|19031003|P3|Overall Study|Efficacy Failure|31
5504309|NCT01625338|19031004|P2|Overall Study|Efficacy Failure|39
5504310|NCT01625338|19031005|P1|Overall Study|Efficacy Failure|27
5504311|NCT01625338|19031003|P3|Overall Study|Enrolled but not Treated|1
5504312|NCT01625338|19031004|P2|Overall Study|Enrolled but not Treated|0
5504313|NCT01625338|19031005|P1|Overall Study|Enrolled but not Treated|0
5504314|NCT01625286|19031032|P7|Overall Study|Ongoing on-treatment at DCO|6
5504315|NCT01625286|19031033|P6|Overall Study|Ongoing on-treatment at DCO|8
5504316|NCT01625286|19031034|P5|Overall Study|Ongoing on-treatment at DCO|0
5504317|NCT01625286|19031035|P4|Overall Study|Ongoing on-treatment at DCO|0
5504318|NCT01625286|19031036|P3|Overall Study|Ongoing on-treatment at DCO|0
5504319|NCT01625286|19031037|P2|Overall Study|Ongoing on-treatment at DCO|4
5504320|NCT01625286|19031038|P1|Overall Study|Ongoing on-treatment at DCO|6
5504321|NCT01625286|19031032|P7|Overall Study|Ongoing off-treatment at DCO|31
5504322|NCT01625286|19031033|P6|Overall Study|Ongoing off-treatment at DCO|32
5504323|NCT01625286|19031034|P5|Overall Study|Ongoing off-treatment at DCO|0
5504324|NCT01625286|19031035|P4|Overall Study|Ongoing off-treatment at DCO|0
5504325|NCT01625286|19031036|P3|Overall Study|Ongoing off-treatment at DCO|0
5504326|NCT01625286|19031037|P2|Overall Study|Ongoing off-treatment at DCO|0
5504327|NCT01625286|19031038|P1|Overall Study|Ongoing off-treatment at DCO|0
5504328|NCT01625286|19031032|P7|Overall Study|Lost to Follow-up|1
5504329|NCT01625286|19031033|P6|Overall Study|Lost to Follow-up|0
5504330|NCT01625286|19031034|P5|Overall Study|Lost to Follow-up|0
5504331|NCT01625286|19031035|P4|Overall Study|Lost to Follow-up|0
5504332|NCT01625286|19031036|P3|Overall Study|Lost to Follow-up|0
5504333|NCT01625286|19031037|P2|Overall Study|Lost to Follow-up|0
5504334|NCT01625286|19031038|P1|Overall Study|Lost to Follow-up|0
5504335|NCT01625286|19031032|P7|Overall Study|Progressive disease|0
5504336|NCT01625286|19031033|P6|Overall Study|Progressive disease|0
5504337|NCT01625286|19031034|P5|Overall Study|Progressive disease|5
5504338|NCT01625286|19031035|P4|Overall Study|Progressive disease|5
5504339|NCT01625286|19031036|P3|Overall Study|Progressive disease|4
5504340|NCT01625286|19031037|P2|Overall Study|Progressive disease|3
5504341|NCT01625286|19031038|P1|Overall Study|Progressive disease|6
5504342|NCT01625286|19031032|P7|Overall Study|Any reason not specifically recorded|0
5504343|NCT01625286|19031033|P6|Overall Study|Any reason not specifically recorded|1
5504344|NCT01625286|19031034|P5|Overall Study|Any reason not specifically recorded|0
5504345|NCT01625286|19031035|P4|Overall Study|Any reason not specifically recorded|0
5504346|NCT01625286|19031036|P3|Overall Study|Any reason not specifically recorded|0
5504347|NCT01625286|19031037|P2|Overall Study|Any reason not specifically recorded|0
5504348|NCT01625286|19031038|P1|Overall Study|Any reason not specifically recorded|0
5504349|NCT01625286|19031032|P7|Overall Study|Withdrawal by Subject|1
5504350|NCT01625286|19031033|P6|Overall Study|Withdrawal by Subject|0
5504351|NCT01625286|19031034|P5|Overall Study|Withdrawal by Subject|0
5504352|NCT01625286|19031035|P4|Overall Study|Withdrawal by Subject|1
5504353|NCT01625286|19031036|P3|Overall Study|Withdrawal by Subject|0
5504354|NCT01625286|19031037|P2|Overall Study|Withdrawal by Subject|1
5504355|NCT01625286|19031038|P1|Overall Study|Withdrawal by Subject|0
5504356|NCT01625286|19031032|P7|Overall Study|Death|16
5504357|NCT01625286|19031033|P6|Overall Study|Death|11
5504358|NCT01625286|19031034|P5|Overall Study|Death|0
5504359|NCT01625286|19031035|P4|Overall Study|Death|1
5504360|NCT01625286|19031036|P3|Overall Study|Death|1
5504361|NCT01625286|19031037|P2|Overall Study|Death|0
5504362|NCT01625286|19031038|P1|Overall Study|Death|0
5504363|NCT01625286|19031032|P7|Overall Study|Adverse Event|1
5504364|NCT01625286|19031033|P6|Overall Study|Adverse Event|2
5504365|NCT01625286|19031034|P5|Overall Study|Adverse Event|1
5504366|NCT01625286|19031035|P4|Overall Study|Adverse Event|0
5504367|NCT01625286|19031036|P3|Overall Study|Adverse Event|0
5504368|NCT01625286|19031037|P2|Overall Study|Adverse Event|0
5504369|NCT01625286|19031038|P1|Overall Study|Adverse Event|0
5504370|NCT01625182|19031124|P2|Overall Study|Lack of Efficacy|8
5504371|NCT01625182|19031125|P1|Overall Study|Lack of Efficacy|12
5504372|NCT01625182|19031124|P2|Overall Study|Withdrawal by Subject|1
5504373|NCT01625182|19031125|P1|Overall Study|Withdrawal by Subject|5
5504374|NCT01625182|19031124|P2|Overall Study|Adverse Event|0
5504375|NCT01625182|19031125|P1|Overall Study|Adverse Event|2
5504376|NCT01625182|19031124|P2|Overall Study|Protocol deviation|2
5504377|NCT01625182|19031125|P1|Overall Study|Protocol deviation|0
5504378|NCT01625182|19031124|P2|Overall Study|Administrative problems|0
5504379|NCT01625182|19031125|P1|Overall Study|Administrative problems|1
5504380|NCT01625091|19031162|P2|Post-intervention|Study termination|1
5504381|NCT01625091|19031163|P1|Post-intervention|Study termination|2
5504382|NCT01625091|19031162|P2|Post-intervention|Lost to Follow-up|0
5504383|NCT01625091|19031163|P1|Post-intervention|Lost to Follow-up|2
5504384|NCT01625091|19031162|P2|Post-intervention|Death|1
5504385|NCT01625091|19031163|P1|Post-intervention|Death|0
5504386|NCT01625091|19031162|P2|Intervention|Study termination|3
5504387|NCT01625091|19031163|P1|Intervention|Study termination|2
5504388|NCT01625091|19031162|P2|Intervention|Lost to Follow-up|4
5504389|NCT01625091|19031163|P1|Intervention|Lost to Follow-up|4
5504390|NCT01625091|19031162|P2|Intervention|Adverse Event|2
5504391|NCT01625091|19031163|P1|Intervention|Adverse Event|0
5504392|NCT01625091|19031162|P2|Intervention|Withdrawal by Subject|1
5504393|NCT01625091|19031163|P1|Intervention|Withdrawal by Subject|4
5504394|NCT01625091|19031162|P2|Intervention|Death|1
5504395|NCT01625091|19031163|P1|Intervention|Death|1
5504396|NCT01624974|19031181|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
5504397|NCT01624974|19031182|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
5504398|NCT01624974|19031181|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
5504399|NCT01624974|19031182|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
5504400|NCT01624974|19031181|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
5504401|NCT01624974|19031182|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
5504402|NCT01624974|19031181|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
5504403|NCT01624974|19031182|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
5504404|NCT01624974|19031181|P2|Period IV Washout (4 Weeks)|Adverse Event|0
5504405|NCT01624974|19031182|P1|Period IV Washout (4 Weeks)|Adverse Event|2
5504406|NCT01624974|19031181|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
5504407|NCT01624974|19031182|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
5504408|NCT01624974|19031181|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
5504409|NCT01624974|19031182|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
5504410|NCT01624974|19031181|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
5504411|NCT01624974|19031182|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
5504412|NCT01624974|19031181|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
5504413|NCT01624974|19031182|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
5504414|NCT01624974|19031181|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
5504415|NCT01624974|19031182|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
5504416|NCT01624974|19031181|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
5504417|NCT01624974|19031182|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
5504418|NCT01624974|19031181|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
5504419|NCT01624974|19031182|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
5504420|NCT01624870|19031223|P1|Overall Study|Lost to follow up|1
5504421|NCT01624870|19031223|P1|Overall Study|CoreValve not implanted|6
5504422|NCT01624870|19031223|P1|Overall Study|Withdrawal by Subject|1
5504423|NCT01624870|19031223|P1|Overall Study|Death|19
5504424|NCT01624662|19031243|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5504425|NCT01624662|19031244|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
5504426|NCT01624662|19031245|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5504427|NCT01624662|19031246|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5504428|NCT01624662|19031243|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5504429|NCT01624662|19031244|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5504430|NCT01624662|19031245|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
5504431|NCT01624662|19031246|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5504432|NCT01624662|19031243|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5504433|NCT01624662|19031244|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
5504434|NCT01624662|19031245|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5504435|NCT01624662|19031246|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5504436|NCT01624662|19031243|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
5504437|NCT01624662|19031244|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
5504438|NCT01624662|19031245|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
5504439|NCT01624662|19031246|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
5504440|NCT01624662|19031243|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5504441|NCT01624662|19031244|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5504442|NCT01624662|19031245|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
5504443|NCT01624662|19031246|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5504444|NCT01624662|19031243|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
5504445|NCT01624662|19031244|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
5504446|NCT01624662|19031245|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
5504447|NCT01624662|19031246|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
5504448|NCT01624662|19031243|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
5504449|NCT01624662|19031244|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
5504450|NCT01624662|19031245|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
5504451|NCT01624662|19031246|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
5504452|NCT01624467|19031317|P1|Overall Study|Subject Withdrew from Treatment|1
5504453|NCT01624467|19031317|P1|Overall Study|Per Sponsor Requirement|1
5504454|NCT01624467|19031317|P1|Overall Study|Progressive Disease|19
5504455|NCT01624467|19031317|P1|Overall Study|Adverse Event|7
5504456|NCT01624467|19031317|P1|Overall Study|Lost to Follow-up|1
5504457|NCT01624467|19031317|P1|Overall Study|Withdrawal by Subject|2
5504458|NCT01624259|19031356|P2|Overall Study|Abnormal laboratory measure|0
5504459|NCT01624259|19031357|P1|Overall Study|Abnormal laboratory measure|3
5504460|NCT01624259|19031356|P2|Overall Study|Lost to Follow-up|3
5504461|NCT01624259|19031357|P1|Overall Study|Lost to Follow-up|2
5504462|NCT01624259|19031356|P2|Overall Study|Physician Decision|1
5504463|NCT01624259|19031357|P1|Overall Study|Physician Decision|1
5504464|NCT01624259|19031356|P2|Overall Study|Withdrawal by Subject|7
5504465|NCT01624259|19031357|P1|Overall Study|Withdrawal by Subject|5
5504466|NCT01624259|19031356|P2|Overall Study|Protocol Violation|2
5504467|NCT01624259|19031357|P1|Overall Study|Protocol Violation|1
5504468|NCT01624259|19031356|P2|Overall Study|Adverse Event|18
5504469|NCT01624259|19031357|P1|Overall Study|Adverse Event|18
5504470|NCT01624233|19031406|P1|Period 6: Follow-up|Withdrawal by Subject|3
5504471|NCT01624233|19031406|P1|Period 6: Follow-up|Physician Decision|1
5504472|NCT01624233|19031406|P1|Period 6: Follow-up|Lack of Efficacy|2
5504473|NCT01624233|19031406|P1|Period 6: Follow-up|Adverse Event|3
5504474|NCT01624233|19031406|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
5504475|NCT01624233|19031406|P1|Period 5 - Retreatment Period|Physician Decision|1
5504476|NCT01624233|19031406|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
5504477|NCT01624233|19031406|P1|Period 5 - Retreatment Period|Adverse Event|5
5504478|NCT01624233|19031406|P1|Period 4 - Drug Free Period|Relapsed|61
5504479|NCT01624233|19031406|P1|Period 3 - Maintenance|Withdrawal by Subject|2
5504480|NCT01624233|19031406|P1|Period 3 - Maintenance|Physician Decision|2
5504481|NCT01624233|19031406|P1|Period 3 - Maintenance|Lack of Efficacy|1
5504482|NCT01624233|19031406|P1|Period 3 - Maintenance|Adverse Event|2
5504483|NCT01624233|19031406|P1|Period 2 - Induction|Adverse Event|1
5504484|NCT01624194|19031438|P2|Overall Study|Withdrawal by Subject|0
5504485|NCT01624194|19031439|P1|Overall Study|Withdrawal by Subject|1
5504486|NCT01624194|19031438|P2|Overall Study|Lost to Follow-up|0
5504487|NCT01624194|19031439|P1|Overall Study|Lost to Follow-up|1
5504488|NCT01624142|19031507|P2|Overall Study|Other|0
5504489|NCT01624142|19031508|P1|Overall Study|Other|1
5504490|NCT01624142|19031507|P2|Overall Study|Lost to Follow-up|0
5504491|NCT01624142|19031508|P1|Overall Study|Lost to Follow-up|2
5504492|NCT01624142|19031507|P2|Overall Study|Study Closure|6
5504493|NCT01624142|19031508|P1|Overall Study|Study Closure|12
5504494|NCT01624142|19031507|P2|Overall Study|Death|6
5504495|NCT01624142|19031508|P1|Overall Study|Death|3
5504496|NCT01624142|19031507|P2|Overall Study|Withdrawal by Subject|4
5504497|NCT01624142|19031508|P1|Overall Study|Withdrawal by Subject|14
5504498|NCT01624090|19031533|P4|Overall Study|Dose escalated|0
5504499|NCT01624090|19031534|P3|Overall Study|Dose escalated|3
5504500|NCT01624090|19031535|P2|Overall Study|Dose escalated|0
5504501|NCT01624090|19031536|P1|Overall Study|Dose escalated|0
5504502|NCT01624090|19031533|P4|Overall Study|Did not complete 1 crse of therapy|0
5504503|NCT01624090|19031534|P3|Overall Study|Did not complete 1 crse of therapy|2
5504504|NCT01624090|19031535|P2|Overall Study|Did not complete 1 crse of therapy|0
5504505|NCT01624090|19031536|P1|Overall Study|Did not complete 1 crse of therapy|0
5504506|NCT01624090|19031533|P4|Overall Study|Died on study|0
5504507|NCT01624090|19031534|P3|Overall Study|Died on study|2
5504508|NCT01624090|19031535|P2|Overall Study|Died on study|0
5504509|NCT01624090|19031536|P1|Overall Study|Died on study|0
5504510|NCT01624090|19031533|P4|Overall Study|Withdrew prior to treatment|0
5504511|NCT01624090|19031534|P3|Overall Study|Withdrew prior to treatment|0
5504512|NCT01624090|19031535|P2|Overall Study|Withdrew prior to treatment|1
5504513|NCT01624090|19031536|P1|Overall Study|Withdrew prior to treatment|0
5504514|NCT01624090|19031533|P4|Overall Study|DLT, taken off therapy|0
5504515|NCT01624090|19031534|P3|Overall Study|DLT, taken off therapy|0
5504516|NCT01624090|19031535|P2|Overall Study|DLT, taken off therapy|1
5504517|NCT01624090|19031536|P1|Overall Study|DLT, taken off therapy|0
5504518|NCT01623830|19031558|P2|Overall Study|Exclusion from Study|2
5504519|NCT01623830|19031559|P1|Overall Study|Exclusion from Study|1
5504520|NCT01623830|19031558|P2|Overall Study|Withdrawal by Subject|7
5504521|NCT01623830|19031559|P1|Overall Study|Withdrawal by Subject|6
5504522|NCT01623752|19031576|P3|Phase 2 (78 Weeks)|Adverse Event|0
5504523|NCT01623752|19031577|P2|Phase 2 (78 Weeks)|Adverse Event|4
5504524|NCT01623752|19031578|P1|Phase 2 (78 Weeks)|Adverse Event|4
5504525|NCT01623752|19031576|P3|Phase 2 (78 Weeks)|No Data|0
5504526|NCT01623752|19031577|P2|Phase 2 (78 Weeks)|No Data|11
5504527|NCT01623752|19031578|P1|Phase 2 (78 Weeks)|No Data|43
5504528|NCT01623752|19031576|P3|Phase 2 (78 Weeks)|Other|0
5504529|NCT01623752|19031577|P2|Phase 2 (78 Weeks)|Other|1
5504530|NCT01623752|19031578|P1|Phase 2 (78 Weeks)|Other|5
5504531|NCT01623752|19031576|P3|Phase 2 (78 Weeks)|Lack of Efficacy|0
5504532|NCT01623752|19031577|P2|Phase 2 (78 Weeks)|Lack of Efficacy|2
5504533|NCT01623752|19031578|P1|Phase 2 (78 Weeks)|Lack of Efficacy|14
5504534|NCT01623752|19031576|P3|Phase 1 (78 Weeks)|Lack of Efficacy|0
5504535|NCT01623752|19031577|P2|Phase 1 (78 Weeks)|Lack of Efficacy|82
5504536|NCT01623752|19031578|P1|Phase 1 (78 Weeks)|Lack of Efficacy|227
5504537|NCT01623752|19031576|P3|Phase 1 (78 Weeks)|Adverse Event|0
5504538|NCT01623752|19031577|P2|Phase 1 (78 Weeks)|Adverse Event|39
5504539|NCT01623752|19031578|P1|Phase 1 (78 Weeks)|Adverse Event|122
5504540|NCT01623752|19031576|P3|Phase 1 (78 Weeks)|Other|0
5504541|NCT01623752|19031577|P2|Phase 1 (78 Weeks)|Other|20
5504542|NCT01623752|19031578|P1|Phase 1 (78 Weeks)|Other|33
5504543|NCT01623752|19031576|P3|Phase 1 (78 Weeks)|No Data|2
5504544|NCT01623752|19031577|P2|Phase 1 (78 Weeks)|No Data|66
5504545|NCT01623752|19031578|P1|Phase 1 (78 Weeks)|No Data|249
5504546|NCT01623596|19031681|P2|Overall Study|Lack of Efficacy|3
5504547|NCT01623596|19031682|P1|Overall Study|Lack of Efficacy|5
5504548|NCT01623596|19031681|P2|Overall Study|Protocol Violation|6
5504549|NCT01623596|19031682|P1|Overall Study|Protocol Violation|0
5504550|NCT01623596|19031681|P2|Overall Study|Patient no longer requires study drug|0
5504551|NCT01623596|19031682|P1|Overall Study|Patient no longer requires study drug|1
5504552|NCT01623596|19031681|P2|Overall Study|Withdrawal by Subject|31
5504553|NCT01623596|19031682|P1|Overall Study|Withdrawal by Subject|13
5504554|NCT01623596|19031681|P2|Overall Study|Lost to Follow-up|16
5504555|NCT01623596|19031682|P1|Overall Study|Lost to Follow-up|12
5504556|NCT01623596|19031681|P2|Overall Study|Death|2
5504557|NCT01623596|19031682|P1|Overall Study|Death|0
5504558|NCT01623596|19031681|P2|Overall Study|Adverse Event|29
5504559|NCT01623596|19031682|P1|Overall Study|Adverse Event|20
5504560|NCT01623596|19031681|P2|Overall Study|Administrative problems|13
5504561|NCT01623596|19031682|P1|Overall Study|Administrative problems|9
5504562|NCT01623596|19031681|P2|Overall Study|Abnormal laboratory values|0
5504563|NCT01623596|19031682|P1|Overall Study|Abnormal laboratory values|2
5504564|NCT01623531|19031700|P2|Overall Study|Missing data at primary outcome time poi|1
5504565|NCT01623531|19031701|P1|Overall Study|Missing data at primary outcome time poi|1
5504566|NCT01623531|19031700|P2|Overall Study|Protocol Violation|1
5504567|NCT01623531|19031701|P1|Overall Study|Protocol Violation|2
5504568|NCT01623531|19031700|P2|Overall Study|Death|0
5504569|NCT01623531|19031701|P1|Overall Study|Death|1
5504570|NCT01623310|19031768|P1|Overall Study|Investigators Discretion-Noncompliant|1
5504571|NCT01623310|19031768|P1|Overall Study|Diagnoses of bilateral cateracts|1
5504572|NCT01623310|19031768|P1|Overall Study|Became potentially child-bearing|1
5504573|NCT01623310|19031768|P1|Overall Study|Withdrawal by Subject|25
5504574|NCT01623310|19031768|P1|Overall Study|Protocol Violation|6
5504575|NCT01623310|19031768|P1|Overall Study|Lack of Efficacy|6
5504576|NCT01623310|19031768|P1|Overall Study|Lost to Follow-up|18
5504577|NCT01623310|19031768|P1|Overall Study|Adverse Event|21
5504578|NCT01623271|19031777|P1|Overall Study|Withdrawal by Subject|2
5504579|NCT01623154|19031794|P1|Overall Study|Did not drink Pranactin Citric|4
5504580|NCT01623115|19031802|P2|Overall Study|Other than specified above|3
5504581|NCT01623115|19031803|P1|Overall Study|Other than specified above|0
5504582|NCT01623115|19031802|P2|Overall Study|Death|4
5504583|NCT01623115|19031803|P1|Overall Study|Death|0
5504584|NCT01623115|19031802|P2|Overall Study|Site closure|7
5504585|NCT01623115|19031803|P1|Overall Study|Site closure|1
5504586|NCT01623115|19031802|P2|Overall Study|Last visit outside protocol visit window|26
5504587|NCT01623115|19031803|P1|Overall Study|Last visit outside protocol visit window|14
5504588|NCT01623115|19031802|P2|Overall Study|Related to study drug administration|2
5504589|NCT01623115|19031803|P1|Overall Study|Related to study drug administration|0
5504590|NCT01623115|19031802|P2|Overall Study|Consent withdrawn by participant|6
5504591|NCT01623115|19031803|P1|Overall Study|Consent withdrawn by participant|2
5504592|NCT01623115|19031802|P2|Overall Study|Poor compliance to protocol|10
5504593|NCT01623115|19031803|P1|Overall Study|Poor compliance to protocol|4
5504594|NCT01623115|19031802|P2|Overall Study|Adverse Event|13
5504595|NCT01623115|19031803|P1|Overall Study|Adverse Event|10
5504596|NCT01623115|19031802|P2|Overall Study|Participants moved|5
5504597|NCT01623115|19031803|P1|Overall Study|Participants moved|1
5504598|NCT01623115|19031802|P2|Overall Study|Physician Decision|0
5504599|NCT01623115|19031803|P1|Overall Study|Physician Decision|1
5504600|NCT01623115|19031802|P2|Overall Study|Randomized but not treated|1
5504601|NCT01623115|19031803|P1|Overall Study|Randomized but not treated|0
5504602|NCT01623050|19031863|P1|Overall Study|Lost to Follow-up|9
5504603|NCT01622673|19031901|P6|Treatment Period 3|Protocol Violation|0
5504604|NCT01622673|19031902|P5|Treatment Period 3|Protocol Violation|0
5504605|NCT01622673|19031903|P4|Treatment Period 3|Protocol Violation|0
5504606|NCT01622673|19031904|P3|Treatment Period 3|Protocol Violation|0
5504607|NCT01622673|19031905|P2|Treatment Period 3|Protocol Violation|1
5504608|NCT01622673|19031906|P1|Treatment Period 3|Protocol Violation|0
5504609|NCT01622673|19031901|P6|Treatment Period 2|Withdrawal by Subject|0
5504610|NCT01622673|19031902|P5|Treatment Period 2|Withdrawal by Subject|0
5504611|NCT01622673|19031903|P4|Treatment Period 2|Withdrawal by Subject|1
5504612|NCT01622673|19031904|P3|Treatment Period 2|Withdrawal by Subject|0
5504613|NCT01622673|19031905|P2|Treatment Period 2|Withdrawal by Subject|0
5504614|NCT01622673|19031906|P1|Treatment Period 2|Withdrawal by Subject|0
5504615|NCT01622673|19031901|P6|Treatment Period 1|Protocol Violation|0
5504616|NCT01622673|19031902|P5|Treatment Period 1|Protocol Violation|0
5504617|NCT01622673|19031903|P4|Treatment Period 1|Protocol Violation|0
5504618|NCT01622673|19031904|P3|Treatment Period 1|Protocol Violation|0
5504619|NCT01622673|19031905|P2|Treatment Period 1|Protocol Violation|1
5504620|NCT01622673|19031906|P1|Treatment Period 1|Protocol Violation|0
5504621|NCT01622673|19031901|P6|Treatment Period 1|Withdrawal by Subject|0
5504622|NCT01622673|19031902|P5|Treatment Period 1|Withdrawal by Subject|0
5504623|NCT01622673|19031903|P4|Treatment Period 1|Withdrawal by Subject|1
5504624|NCT01622673|19031904|P3|Treatment Period 1|Withdrawal by Subject|0
5504625|NCT01622673|19031905|P2|Treatment Period 1|Withdrawal by Subject|0
5504626|NCT01622673|19031906|P1|Treatment Period 1|Withdrawal by Subject|0
5504627|NCT01622660|19031941|P1|Overall Study|Adverse Event|1
5504628|NCT01622569|19031949|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
5504629|NCT01622569|19031950|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5504630|NCT01622569|19031951|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5504631|NCT01622569|19031952|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
5504632|NCT01622569|19031949|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
5504633|NCT01622569|19031950|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
5504634|NCT01622569|19031951|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
5504635|NCT01622569|19031952|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
5504636|NCT01622569|19031949|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
5504637|NCT01622569|19031950|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
5504638|NCT01622569|19031951|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
5504639|NCT01622569|19031952|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
5504640|NCT01622569|19031949|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
5504641|NCT01622569|19031950|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
5504642|NCT01622569|19031951|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
5504643|NCT01622569|19031952|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
5504644|NCT01622569|19031949|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
5504645|NCT01622569|19031950|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5504646|NCT01622569|19031951|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
5504647|NCT01622569|19031952|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
5504648|NCT01622569|19031949|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
5504649|NCT01622569|19031950|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
5504650|NCT01622569|19031951|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
5504651|NCT01622569|19031952|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
5504652|NCT01622569|19031949|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
5504653|NCT01622569|19031950|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
5504654|NCT01622569|19031951|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
5504655|NCT01622569|19031952|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
5504656|NCT01622569|19031949|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
5504657|NCT01622569|19031950|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
5504658|NCT01622569|19031951|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
5504659|NCT01622569|19031952|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
5504660|NCT01622348|19032037|P3|Overall Study|Withdrawal by Subject|1
5504661|NCT01622348|19032038|P2|Overall Study|Withdrawal by Subject|0
5504662|NCT01622348|19032039|P1|Overall Study|Withdrawal by Subject|1
5504663|NCT01622231|19032078|P1|Overall Study|Withdrawal by Subject|1
5504664|NCT01622231|19032078|P1|Overall Study|Physician Decision|1
5504665|NCT01621880|19032108|P2|Overall Study|Withdrawal by Subject|4
5504666|NCT01621880|19032109|P1|Overall Study|Withdrawal by Subject|5
5504667|NCT01621880|19032108|P2|Overall Study|Adverse Event|1
5504668|NCT01621880|19032109|P1|Overall Study|Adverse Event|5
5504669|NCT01621802|19032123|P6|Overall Study|Lost to Follow-up|11
5504670|NCT01621802|19032124|P5|Overall Study|Lost to Follow-up|31
5504671|NCT01621802|19032125|P4|Overall Study|Lost to Follow-up|7
5504672|NCT01621802|19032126|P3|Overall Study|Lost to Follow-up|24
5504673|NCT01621802|19032127|P2|Overall Study|Lost to Follow-up|16
5504674|NCT01621802|19032128|P1|Overall Study|Lost to Follow-up|36
5504675|NCT01621802|19032123|P6|Overall Study|Others|0
5504676|NCT01621802|19032124|P5|Overall Study|Others|1
5504677|NCT01621802|19032125|P4|Overall Study|Others|2
5504678|NCT01621802|19032126|P3|Overall Study|Others|3
5504679|NCT01621802|19032127|P2|Overall Study|Others|3
5504680|NCT01621802|19032128|P1|Overall Study|Others|3
5504681|NCT01621802|19032123|P6|Overall Study|Migrated/moved from study area|0
5504682|NCT01621802|19032124|P5|Overall Study|Migrated/moved from study area|1
5504683|NCT01621802|19032125|P4|Overall Study|Migrated/moved from study area|0
5504684|NCT01621802|19032126|P3|Overall Study|Migrated/moved from study area|2
5504685|NCT01621802|19032127|P2|Overall Study|Migrated/moved from study area|0
5504686|NCT01621802|19032128|P1|Overall Study|Migrated/moved from study area|0
5504687|NCT01621802|19032123|P6|Overall Study|Withdrawal by Subject|0
5504688|NCT01621802|19032124|P5|Overall Study|Withdrawal by Subject|2
5504689|NCT01621802|19032125|P4|Overall Study|Withdrawal by Subject|2
5504690|NCT01621802|19032126|P3|Overall Study|Withdrawal by Subject|4
5504691|NCT01621802|19032127|P2|Overall Study|Withdrawal by Subject|4
5504692|NCT01621802|19032128|P1|Overall Study|Withdrawal by Subject|8
5504693|NCT01621802|19032123|P6|Overall Study|Protocol Violation|1
5504694|NCT01621802|19032124|P5|Overall Study|Protocol Violation|0
5504695|NCT01621802|19032125|P4|Overall Study|Protocol Violation|0
5504696|NCT01621802|19032126|P3|Overall Study|Protocol Violation|0
5504697|NCT01621802|19032127|P2|Overall Study|Protocol Violation|0
5504698|NCT01621802|19032128|P1|Overall Study|Protocol Violation|0
5504699|NCT01621542|19032313|P6|Overall Study|study stopped by sponsor|0
5504700|NCT01621542|19032314|P5|Overall Study|study stopped by sponsor|0
5504701|NCT01621542|19032315|P4|Overall Study|study stopped by sponsor|1
5504702|NCT01621542|19032316|P3|Overall Study|study stopped by sponsor|0
5504703|NCT01621542|19032317|P2|Overall Study|study stopped by sponsor|0
5504704|NCT01621542|19032318|P1|Overall Study|study stopped by sponsor|0
5504705|NCT01621542|19032313|P6|Overall Study|Protocol Violation|0
5504706|NCT01621542|19032314|P5|Overall Study|Protocol Violation|0
5504707|NCT01621542|19032315|P4|Overall Study|Protocol Violation|1
5504708|NCT01621542|19032316|P3|Overall Study|Protocol Violation|0
5504709|NCT01621542|19032317|P2|Overall Study|Protocol Violation|0
5504710|NCT01621542|19032318|P1|Overall Study|Protocol Violation|0
5504711|NCT01621542|19032313|P6|Overall Study|progression/treatment failure|5
5504712|NCT01621542|19032314|P5|Overall Study|progression/treatment failure|3
5504713|NCT01621542|19032315|P4|Overall Study|progression/treatment failure|7
5504714|NCT01621542|19032316|P3|Overall Study|progression/treatment failure|3
5504715|NCT01621542|19032317|P2|Overall Study|progression/treatment failure|4
5504716|NCT01621542|19032318|P1|Overall Study|progression/treatment failure|2
5504717|NCT01621542|19032313|P6|Overall Study|Withdrawal by Subject|3
5504718|NCT01621542|19032314|P5|Overall Study|Withdrawal by Subject|3
5504719|NCT01621542|19032315|P4|Overall Study|Withdrawal by Subject|3
5504720|NCT01621542|19032316|P3|Overall Study|Withdrawal by Subject|1
5504721|NCT01621542|19032317|P2|Overall Study|Withdrawal by Subject|0
5504722|NCT01621542|19032318|P1|Overall Study|Withdrawal by Subject|2
5504723|NCT01621542|19032313|P6|Overall Study|Physician Decision|1
5504724|NCT01621542|19032314|P5|Overall Study|Physician Decision|3
5504725|NCT01621542|19032315|P4|Overall Study|Physician Decision|13
5504726|NCT01621542|19032316|P3|Overall Study|Physician Decision|1
5504727|NCT01621542|19032317|P2|Overall Study|Physician Decision|0
5504728|NCT01621542|19032318|P1|Overall Study|Physician Decision|1
5504729|NCT01621542|19032313|P6|Overall Study|Death|0
5504730|NCT01621542|19032314|P5|Overall Study|Death|0
5504731|NCT01621542|19032315|P4|Overall Study|Death|0
5504732|NCT01621542|19032316|P3|Overall Study|Death|0
5504733|NCT01621542|19032317|P2|Overall Study|Death|1
5504734|NCT01621542|19032318|P1|Overall Study|Death|0
5504735|NCT01621542|19032313|P6|Overall Study|Adverse Event|0
5504736|NCT01621542|19032314|P5|Overall Study|Adverse Event|0
5504737|NCT01621542|19032315|P4|Overall Study|Adverse Event|3
5504738|NCT01621542|19032316|P3|Overall Study|Adverse Event|1
5504739|NCT01621542|19032317|P2|Overall Study|Adverse Event|0
5504740|NCT01621542|19032318|P1|Overall Study|Adverse Event|0
5504741|NCT01621490|19032359|P9|Overall Study|Patient delayed due to toxicity|0
5504742|NCT01621490|19032360|P8|Overall Study|Patient delayed due to toxicity|0
5504743|NCT01621490|19032361|P7|Overall Study|Patient delayed due to toxicity|0
5504744|NCT01621490|19032362|P6|Overall Study|Patient delayed due to toxicity|1
5504745|NCT01621490|19032363|P5|Overall Study|Patient delayed due to toxicity|0
5504746|NCT01621490|19032364|P4|Overall Study|Patient delayed due to toxicity|0
5504747|NCT01621490|19032365|P3|Overall Study|Patient delayed due to toxicity|0
5504748|NCT01621490|19032366|P2|Overall Study|Patient delayed due to toxicity|0
5504749|NCT01621490|19032367|P1|Overall Study|Patient delayed due to toxicity|0
5504750|NCT01621490|19032359|P9|Overall Study|Complete response|1
5504751|NCT01621490|19032360|P8|Overall Study|Complete response|0
5504752|NCT01621490|19032361|P7|Overall Study|Complete response|0
5504753|NCT01621490|19032362|P6|Overall Study|Complete response|0
5504754|NCT01621490|19032363|P5|Overall Study|Complete response|0
5504755|NCT01621490|19032364|P4|Overall Study|Complete response|0
5504756|NCT01621490|19032365|P3|Overall Study|Complete response|0
5504757|NCT01621490|19032366|P2|Overall Study|Complete response|0
5504758|NCT01621490|19032367|P1|Overall Study|Complete response|0
5504759|NCT01621490|19032359|P9|Overall Study|Clinical deterioration|0
5504760|NCT01621490|19032360|P8|Overall Study|Clinical deterioration|0
5504761|NCT01621490|19032361|P7|Overall Study|Clinical deterioration|0
5504762|NCT01621490|19032362|P6|Overall Study|Clinical deterioration|0
5504763|NCT01621490|19032363|P5|Overall Study|Clinical deterioration|0
5504764|NCT01621490|19032364|P4|Overall Study|Clinical deterioration|0
5504765|NCT01621490|19032365|P3|Overall Study|Clinical deterioration|0
5504766|NCT01621490|19032366|P2|Overall Study|Clinical deterioration|1
5504767|NCT01621490|19032367|P1|Overall Study|Clinical deterioration|0
5504768|NCT01621490|19032359|P9|Overall Study|Patient reached treatment 2 yr limit|0
5504769|NCT01621490|19032360|P8|Overall Study|Patient reached treatment 2 yr limit|0
5504770|NCT01621490|19032361|P7|Overall Study|Patient reached treatment 2 yr limit|0
5504771|NCT01621490|19032362|P6|Overall Study|Patient reached treatment 2 yr limit|0
5504772|NCT01621490|19032363|P5|Overall Study|Patient reached treatment 2 yr limit|0
5504773|NCT01621490|19032364|P4|Overall Study|Patient reached treatment 2 yr limit|0
5504774|NCT01621490|19032365|P3|Overall Study|Patient reached treatment 2 yr limit|0
5504775|NCT01621490|19032366|P2|Overall Study|Patient reached treatment 2 yr limit|1
5504776|NCT01621490|19032367|P1|Overall Study|Patient reached treatment 2 yr limit|0
5504777|NCT01621490|19032359|P9|Overall Study|Documented disease progression|0
5504778|NCT01621490|19032360|P8|Overall Study|Documented disease progression|0
5504779|NCT01621490|19032361|P7|Overall Study|Documented disease progression|0
5504780|NCT01621490|19032362|P6|Overall Study|Documented disease progression|0
5504781|NCT01621490|19032363|P5|Overall Study|Documented disease progression|0
5504782|NCT01621490|19032364|P4|Overall Study|Documented disease progression|0
5504783|NCT01621490|19032365|P3|Overall Study|Documented disease progression|1
5504784|NCT01621490|19032366|P2|Overall Study|Documented disease progression|0
5504785|NCT01621490|19032367|P1|Overall Study|Documented disease progression|0
5504786|NCT01621490|19032359|P9|Overall Study|Investigator decision|0
5504787|NCT01621490|19032360|P8|Overall Study|Investigator decision|0
5504788|NCT01621490|19032361|P7|Overall Study|Investigator decision|1
5504789|NCT01621490|19032362|P6|Overall Study|Investigator decision|0
5504790|NCT01621490|19032363|P5|Overall Study|Investigator decision|1
5504791|NCT01621490|19032364|P4|Overall Study|Investigator decision|0
5504792|NCT01621490|19032365|P3|Overall Study|Investigator decision|1
5504793|NCT01621490|19032366|P2|Overall Study|Investigator decision|0
5504794|NCT01621490|19032367|P1|Overall Study|Investigator decision|0
5504795|NCT01621490|19032359|P9|Overall Study|BMS informed of patient status|0
5504796|NCT01621490|19032360|P8|Overall Study|BMS informed of patient status|0
5504797|NCT01621490|19032361|P7|Overall Study|BMS informed of patient status|0
5504798|NCT01621490|19032362|P6|Overall Study|BMS informed of patient status|0
5504799|NCT01621490|19032363|P5|Overall Study|BMS informed of patient status|0
5504800|NCT01621490|19032364|P4|Overall Study|BMS informed of patient status|0
5504801|NCT01621490|19032365|P3|Overall Study|BMS informed of patient status|1
5504802|NCT01621490|19032366|P2|Overall Study|BMS informed of patient status|0
5504803|NCT01621490|19032367|P1|Overall Study|BMS informed of patient status|0
5504804|NCT01621490|19032359|P9|Overall Study|Grade 4 Lipase elevation|0
5504805|NCT01621490|19032360|P8|Overall Study|Grade 4 Lipase elevation|0
5504806|NCT01621490|19032361|P7|Overall Study|Grade 4 Lipase elevation|0
5504807|NCT01621490|19032362|P6|Overall Study|Grade 4 Lipase elevation|0
5504808|NCT01621490|19032363|P5|Overall Study|Grade 4 Lipase elevation|0
5504809|NCT01621490|19032364|P4|Overall Study|Grade 4 Lipase elevation|0
5504810|NCT01621490|19032365|P3|Overall Study|Grade 4 Lipase elevation|0
5504811|NCT01621490|19032366|P2|Overall Study|Grade 4 Lipase elevation|0
5504812|NCT01621490|19032367|P1|Overall Study|Grade 4 Lipase elevation|1
5504813|NCT01621490|19032359|P9|Overall Study|Death|0
5504814|NCT01621490|19032360|P8|Overall Study|Death|1
5504815|NCT01621490|19032361|P7|Overall Study|Death|0
5504816|NCT01621490|19032362|P6|Overall Study|Death|0
5504817|NCT01621490|19032363|P5|Overall Study|Death|0
5504818|NCT01621490|19032364|P4|Overall Study|Death|0
5504819|NCT01621490|19032365|P3|Overall Study|Death|0
5504820|NCT01621490|19032366|P2|Overall Study|Death|0
5504821|NCT01621490|19032367|P1|Overall Study|Death|0
5504822|NCT01621490|19032359|P9|Overall Study|Study drug toxicity|1
5504823|NCT01621490|19032360|P8|Overall Study|Study drug toxicity|4
5504824|NCT01621490|19032361|P7|Overall Study|Study drug toxicity|1
5504825|NCT01621490|19032362|P6|Overall Study|Study drug toxicity|10
5504826|NCT01621490|19032363|P5|Overall Study|Study drug toxicity|1
5504827|NCT01621490|19032364|P4|Overall Study|Study drug toxicity|3
5504828|NCT01621490|19032365|P3|Overall Study|Study drug toxicity|5
5504829|NCT01621490|19032366|P2|Overall Study|Study drug toxicity|4
5504830|NCT01621490|19032367|P1|Overall Study|Study drug toxicity|1
5504831|NCT01621490|19032359|P9|Overall Study|Disease progression|4
5504832|NCT01621490|19032360|P8|Overall Study|Disease progression|0
5504833|NCT01621490|19032361|P7|Overall Study|Disease progression|7
5504834|NCT01621490|19032362|P6|Overall Study|Disease progression|8
5504835|NCT01621490|19032363|P5|Overall Study|Disease progression|3
5504836|NCT01621490|19032364|P4|Overall Study|Disease progression|5
5504837|NCT01621490|19032365|P3|Overall Study|Disease progression|1
5504838|NCT01621490|19032366|P2|Overall Study|Disease progression|28
5504839|NCT01621490|19032367|P1|Overall Study|Disease progression|27
5504840|NCT01621490|19032359|P9|Overall Study|Adverse event unrelated to study drug|1
5504841|NCT01621490|19032360|P8|Overall Study|Adverse event unrelated to study drug|2
5504842|NCT01621490|19032361|P7|Overall Study|Adverse event unrelated to study drug|0
5504843|NCT01621490|19032362|P6|Overall Study|Adverse event unrelated to study drug|0
5504844|NCT01621490|19032363|P5|Overall Study|Adverse event unrelated to study drug|0
5504845|NCT01621490|19032364|P4|Overall Study|Adverse event unrelated to study drug|0
5504846|NCT01621490|19032365|P3|Overall Study|Adverse event unrelated to study drug|0
5504847|NCT01621490|19032366|P2|Overall Study|Adverse event unrelated to study drug|1
5504848|NCT01621490|19032367|P1|Overall Study|Adverse event unrelated to study drug|2
5504849|NCT01621490|19032359|P9|Overall Study|Subject request to discontinue study|1
5504850|NCT01621490|19032360|P8|Overall Study|Subject request to discontinue study|0
5504851|NCT01621490|19032361|P7|Overall Study|Subject request to discontinue study|1
5504852|NCT01621490|19032362|P6|Overall Study|Subject request to discontinue study|2
5504853|NCT01621490|19032363|P5|Overall Study|Subject request to discontinue study|0
5504854|NCT01621490|19032364|P4|Overall Study|Subject request to discontinue study|1
5504855|NCT01621490|19032365|P3|Overall Study|Subject request to discontinue study|1
5504856|NCT01621490|19032366|P2|Overall Study|Subject request to discontinue study|3
5504857|NCT01621490|19032367|P1|Overall Study|Subject request to discontinue study|1
5504858|NCT01621490|19032359|P9|Overall Study|Withdrawal by Subject|0
5504859|NCT01621490|19032360|P8|Overall Study|Withdrawal by Subject|0
5504860|NCT01621490|19032361|P7|Overall Study|Withdrawal by Subject|0
5504861|NCT01621490|19032362|P6|Overall Study|Withdrawal by Subject|3
5504862|NCT01621490|19032363|P5|Overall Study|Withdrawal by Subject|0
5504863|NCT01621490|19032364|P4|Overall Study|Withdrawal by Subject|0
5504864|NCT01621490|19032365|P3|Overall Study|Withdrawal by Subject|0
5504865|NCT01621490|19032366|P2|Overall Study|Withdrawal by Subject|0
5504866|NCT01621490|19032367|P1|Overall Study|Withdrawal by Subject|1
5504867|NCT01621490|19032359|P9|Overall Study|Maximum clinical benefit|0
5504868|NCT01621490|19032360|P8|Overall Study|Maximum clinical benefit|2
5504869|NCT01621490|19032361|P7|Overall Study|Maximum clinical benefit|1
5504870|NCT01621490|19032362|P6|Overall Study|Maximum clinical benefit|0
5504871|NCT01621490|19032363|P5|Overall Study|Maximum clinical benefit|0
5504872|NCT01621490|19032364|P4|Overall Study|Maximum clinical benefit|0
5504873|NCT01621490|19032365|P3|Overall Study|Maximum clinical benefit|0
5504874|NCT01621490|19032366|P2|Overall Study|Maximum clinical benefit|2
5504875|NCT01621490|19032367|P1|Overall Study|Maximum clinical benefit|3
5504876|NCT01621490|19032359|P9|Overall Study|Subject no longer meets study criteria|0
5504877|NCT01621490|19032360|P8|Overall Study|Subject no longer meets study criteria|0
5504878|NCT01621490|19032361|P7|Overall Study|Subject no longer meets study criteria|0
5504879|NCT01621490|19032362|P6|Overall Study|Subject no longer meets study criteria|0
5504880|NCT01621490|19032363|P5|Overall Study|Subject no longer meets study criteria|1
5504881|NCT01621490|19032364|P4|Overall Study|Subject no longer meets study criteria|0
5504882|NCT01621490|19032365|P3|Overall Study|Subject no longer meets study criteria|0
5504883|NCT01621490|19032366|P2|Overall Study|Subject no longer meets study criteria|0
5504884|NCT01621490|19032367|P1|Overall Study|Subject no longer meets study criteria|0
5504885|NCT01621490|19032359|P9|Overall Study|Patient could not travel|0
5504886|NCT01621490|19032360|P8|Overall Study|Patient could not travel|0
5504887|NCT01621490|19032361|P7|Overall Study|Patient could not travel|0
5504888|NCT01621490|19032362|P6|Overall Study|Patient could not travel|0
5504889|NCT01621490|19032363|P5|Overall Study|Patient could not travel|0
5504890|NCT01621490|19032364|P4|Overall Study|Patient could not travel|0
5504891|NCT01621490|19032365|P3|Overall Study|Patient could not travel|0
5504892|NCT01621490|19032366|P2|Overall Study|Patient could not travel|0
5504893|NCT01621490|19032367|P1|Overall Study|Patient could not travel|1
5504894|NCT01621490|19032359|P9|Overall Study|Participant completed treatment|0
5504895|NCT01621490|19032360|P8|Overall Study|Participant completed treatment|1
5504896|NCT01621490|19032361|P7|Overall Study|Participant completed treatment|0
5504897|NCT01621490|19032362|P6|Overall Study|Participant completed treatment|0
5504898|NCT01621490|19032363|P5|Overall Study|Participant completed treatment|0
5504899|NCT01621490|19032364|P4|Overall Study|Participant completed treatment|0
5504900|NCT01621490|19032365|P3|Overall Study|Participant completed treatment|1
5504901|NCT01621490|19032366|P2|Overall Study|Participant completed treatment|4
5504902|NCT01621490|19032367|P1|Overall Study|Participant completed treatment|4
5504903|NCT01621191|19032619|P1|Overall Study|Site Removed From Study|1
5504904|NCT01621191|19032619|P1|Overall Study|Lost to Follow-up|1
5504905|NCT01621191|19032619|P1|Overall Study|Lack of Efficacy|6
5504906|NCT01621191|19032619|P1|Overall Study|Withdrawal by Subject|8
5504907|NCT01621191|19032619|P1|Overall Study|Adverse Event|9
5504908|NCT01621178|19032633|P3|Overall Study|Physician Decision|7
5504909|NCT01621178|19032634|P2|Overall Study|Physician Decision|2
5504910|NCT01621178|19032635|P1|Overall Study|Physician Decision|5
5504911|NCT01621178|19032633|P3|Overall Study|Withdrawal by Subject|18
5504912|NCT01621178|19032634|P2|Overall Study|Withdrawal by Subject|17
5504913|NCT01621178|19032635|P1|Overall Study|Withdrawal by Subject|14
5504914|NCT01621178|19032633|P3|Overall Study|Lost to Follow-up|1
5504915|NCT01621178|19032634|P2|Overall Study|Lost to Follow-up|2
5504916|NCT01621178|19032635|P1|Overall Study|Lost to Follow-up|1
5504917|NCT01621178|19032633|P3|Overall Study|Death|2
5504918|NCT01621178|19032634|P2|Overall Study|Death|7
5504919|NCT01621178|19032635|P1|Overall Study|Death|6
5504920|NCT01621178|19032633|P3|Overall Study|Adverse Event|8
5504921|NCT01621178|19032634|P2|Overall Study|Adverse Event|2
5504922|NCT01621178|19032635|P1|Overall Study|Adverse Event|5
5504923|NCT01621126|19032727|P1|Overall Study|Physician Decision|6
5504924|NCT01620983|19032749|P3|Overall Study|Physician Decision|5
5504925|NCT01620983|19032750|P2|Overall Study|Physician Decision|10
5504926|NCT01620983|19032751|P1|Overall Study|Physician Decision|3
5504927|NCT01620983|19032749|P3|Overall Study|Death|0
5504928|NCT01620983|19032750|P2|Overall Study|Death|0
5504929|NCT01620983|19032751|P1|Overall Study|Death|2
5504930|NCT01620983|19032749|P3|Overall Study|Withdrawal by Subject|1
5504931|NCT01620983|19032750|P2|Overall Study|Withdrawal by Subject|8
5504932|NCT01620983|19032751|P1|Overall Study|Withdrawal by Subject|6
5504933|NCT01620983|19032749|P3|Overall Study|Lost to Follow-up|9
5504934|NCT01620983|19032750|P2|Overall Study|Lost to Follow-up|4
5504935|NCT01620983|19032751|P1|Overall Study|Lost to Follow-up|8
5504936|NCT01620762|19032780|P3|Overall Study|Use of prohibted therapies|1
5504937|NCT01620762|19032781|P2|Overall Study|Use of prohibted therapies|1
5504938|NCT01620762|19032782|P1|Overall Study|Use of prohibted therapies|0
5504939|NCT01620762|19032780|P3|Overall Study|Non-specified|5
5504940|NCT01620762|19032781|P2|Overall Study|Non-specified|6
5504941|NCT01620762|19032782|P1|Overall Study|Non-specified|3
5504942|NCT01620762|19032780|P3|Overall Study|Subject deterioration|1
5504943|NCT01620762|19032781|P2|Overall Study|Subject deterioration|1
5504944|NCT01620762|19032782|P1|Overall Study|Subject deterioration|0
5504945|NCT01620762|19032780|P3|Overall Study|Protocol deviation|6
5504946|NCT01620762|19032781|P2|Overall Study|Protocol deviation|1
5504947|NCT01620762|19032782|P1|Overall Study|Protocol deviation|1
5504948|NCT01620762|19032780|P3|Overall Study|Lost to Follow-up|10
5504949|NCT01620762|19032781|P2|Overall Study|Lost to Follow-up|17
5504950|NCT01620762|19032782|P1|Overall Study|Lost to Follow-up|11
5504951|NCT01620762|19032780|P3|Overall Study|Withdrawal by Subject|27
5504952|NCT01620762|19032781|P2|Overall Study|Withdrawal by Subject|26
5504953|NCT01620762|19032782|P1|Overall Study|Withdrawal by Subject|23
5504954|NCT01620762|19032780|P3|Overall Study|Adverse Event|2
5504955|NCT01620762|19032781|P2|Overall Study|Adverse Event|5
5504956|NCT01620762|19032782|P1|Overall Study|Adverse Event|9
5504957|NCT01620762|19032780|P3|Overall Study|Protocol Violation|1
5504958|NCT01620762|19032781|P2|Overall Study|Protocol Violation|1
5504959|NCT01620762|19032782|P1|Overall Study|Protocol Violation|1
5504960|NCT01620528|19032843|P3|Post-Treatment Follow-Up Period|Other|2
5504961|NCT01620528|19032844|P2|Post-Treatment Follow-Up Period|Other|4
5504962|NCT01620528|19032845|P1|Post-Treatment Follow-Up Period|Other|6
5504963|NCT01620528|19032843|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
5504964|NCT01620528|19032844|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
5505048|NCT01620086|19033324|P1|Overall Study|Physician Decision|1
5504965|NCT01620528|19032845|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
5504966|NCT01620528|19032843|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
5504967|NCT01620528|19032844|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
5504968|NCT01620528|19032845|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
5504969|NCT01620528|19032843|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
5504970|NCT01620528|19032844|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
5504971|NCT01620528|19032845|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
5504972|NCT01620528|19032843|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
5504973|NCT01620528|19032844|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
5504974|NCT01620528|19032845|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
5504975|NCT01620528|19032843|P3|Treatment Period|Exclusionary Medication Received|0
5504976|NCT01620528|19032844|P2|Treatment Period|Exclusionary Medication Received|1
5504977|NCT01620528|19032845|P1|Treatment Period|Exclusionary Medication Received|0
5504978|NCT01620528|19032843|P3|Treatment Period|Surgery/Invasive Intervention|3
5504979|NCT01620528|19032844|P2|Treatment Period|Surgery/Invasive Intervention|1
5504980|NCT01620528|19032845|P1|Treatment Period|Surgery/Invasive Intervention|5
5504981|NCT01620528|19032843|P3|Treatment Period|Pregnancy|2
5504982|NCT01620528|19032844|P2|Treatment Period|Pregnancy|2
5504983|NCT01620528|19032845|P1|Treatment Period|Pregnancy|7
5504984|NCT01620528|19032843|P3|Treatment Period|Subject Noncompliant|2
5504985|NCT01620528|19032844|P2|Treatment Period|Subject Noncompliant|2
5504986|NCT01620528|19032845|P1|Treatment Period|Subject Noncompliant|11
5504987|NCT01620528|19032843|P3|Treatment Period|Other|7
5504988|NCT01620528|19032844|P2|Treatment Period|Other|5
5504989|NCT01620528|19032845|P1|Treatment Period|Other|9
5504990|NCT01620528|19032843|P3|Treatment Period|Lost to Follow-up|14
5504991|NCT01620528|19032844|P2|Treatment Period|Lost to Follow-up|8
5504992|NCT01620528|19032845|P1|Treatment Period|Lost to Follow-up|16
5504993|NCT01620528|19032843|P3|Treatment Period|Adverse Event|21
5504994|NCT01620528|19032844|P2|Treatment Period|Adverse Event|13
5504995|NCT01620528|19032845|P1|Treatment Period|Adverse Event|17
5504996|NCT01620528|19032843|P3|Treatment Period|Withdrawal by Subject|16
5504997|NCT01620528|19032844|P2|Treatment Period|Withdrawal by Subject|21
5504998|NCT01620528|19032845|P1|Treatment Period|Withdrawal by Subject|35
5504999|NCT01620528|19032843|P3|Treatment Period|Did Not Receive Study Drug|1
5505000|NCT01620528|19032844|P2|Treatment Period|Did Not Receive Study Drug|0
5505001|NCT01620528|19032845|P1|Treatment Period|Did Not Receive Study Drug|0
5505002|NCT01620489|19033185|P2|Overall Study|Unclassified|2
5505003|NCT01620489|19033186|P1|Overall Study|Unclassified|1
5505004|NCT01620489|19033185|P2|Overall Study|Withdrawal Criteria|25
5505005|NCT01620489|19033186|P1|Overall Study|Withdrawal Criteria|17
5505006|NCT01620489|19033185|P2|Overall Study|Protocol Violation|3
5505007|NCT01620489|19033186|P1|Overall Study|Protocol Violation|0
5505008|NCT01620489|19033185|P2|Overall Study|Adverse Event|4
5505009|NCT01620489|19033186|P1|Overall Study|Adverse Event|17
5505010|NCT01620255|19033207|P5|Overall Study|Withdrawn at discretion of investigator|1
5505011|NCT01620255|19033208|P4|Overall Study|Withdrawn at discretion of investigator|0
5505012|NCT01620255|19033209|P3|Overall Study|Withdrawn at discretion of investigator|0
5505013|NCT01620255|19033210|P2|Overall Study|Withdrawn at discretion of investigator|0
5505014|NCT01620255|19033211|P1|Overall Study|Withdrawn at discretion of investigator|0
5505015|NCT01620255|19033207|P5|Overall Study|Adverse Event|1
5505016|NCT01620255|19033208|P4|Overall Study|Adverse Event|1
5505017|NCT01620255|19033209|P3|Overall Study|Adverse Event|0
5505018|NCT01620255|19033210|P2|Overall Study|Adverse Event|4
5505019|NCT01620255|19033211|P1|Overall Study|Adverse Event|0
5505020|NCT01620255|19033207|P5|Overall Study|Non-compliance|0
5505021|NCT01620255|19033208|P4|Overall Study|Non-compliance|0
5505022|NCT01620255|19033209|P3|Overall Study|Non-compliance|0
5505023|NCT01620255|19033210|P2|Overall Study|Non-compliance|1
5505024|NCT01620255|19033211|P1|Overall Study|Non-compliance|0
5505025|NCT01620255|19033207|P5|Overall Study|Participant underwent fecal transplant|0
5505026|NCT01620255|19033208|P4|Overall Study|Participant underwent fecal transplant|0
5505027|NCT01620255|19033209|P3|Overall Study|Participant underwent fecal transplant|1
5505028|NCT01620255|19033210|P2|Overall Study|Participant underwent fecal transplant|0
5505029|NCT01620255|19033211|P1|Overall Study|Participant underwent fecal transplant|0
5505030|NCT01620255|19033207|P5|Overall Study|Withdrawal by Subject|4
5505031|NCT01620255|19033208|P4|Overall Study|Withdrawal by Subject|2
5505032|NCT01620255|19033209|P3|Overall Study|Withdrawal by Subject|1
5505033|NCT01620255|19033210|P2|Overall Study|Withdrawal by Subject|1
5505034|NCT01620255|19033211|P1|Overall Study|Withdrawal by Subject|4
5505035|NCT01620177|19033288|P1|Overall Study|Randomized, Not Active due to Scheduling|1
5505036|NCT01620177|19033288|P1|Overall Study|Physician Decision|2
5505037|NCT01620177|19033288|P1|Overall Study|Lost to Follow-up|7
5505038|NCT01620177|19033288|P1|Overall Study|Withdrawal by Subject|26
5505039|NCT01620177|19033288|P1|Overall Study|Failure at Screening Visit|43
5505040|NCT01620138|19033313|P2|Overall Study|Adverse Event|0
5505041|NCT01620138|19033314|P1|Overall Study|Adverse Event|2
5505042|NCT01620138|19033313|P2|Overall Study|Lack of Efficacy|0
5505043|NCT01620138|19033314|P1|Overall Study|Lack of Efficacy|1
5505044|NCT01620138|19033313|P2|Overall Study|Withdrawal by Subject|0
5505045|NCT01620138|19033314|P1|Overall Study|Withdrawal by Subject|3
5505046|NCT01620086|19033322|P3|Overall Study|Physician Decision|0
5505047|NCT01620086|19033323|P2|Overall Study|Physician Decision|0
5505049|NCT01620086|19033322|P3|Overall Study|failed study criteria|0
5505050|NCT01620086|19033323|P2|Overall Study|failed study criteria|4
5505051|NCT01620086|19033324|P1|Overall Study|failed study criteria|1
5505052|NCT01620086|19033322|P3|Overall Study|Withdrawal by Subject|0
5505053|NCT01620086|19033323|P2|Overall Study|Withdrawal by Subject|3
5505054|NCT01620086|19033324|P1|Overall Study|Withdrawal by Subject|3
5505055|NCT01620060|19033343|P1|Overall Study|Per Sponsor Decision|2
5505056|NCT01620060|19033343|P1|Overall Study|Family emergency|1
5505057|NCT01620060|19033343|P1|Overall Study|Did not comply with Study Produre|1
5505058|NCT01620060|19033343|P1|Overall Study|Withdrawal by Subject|1
5505059|NCT01620060|19033343|P1|Overall Study|Protocol Violation|1
5505060|NCT01620060|19033343|P1|Overall Study|Adverse Event|9
5505061|NCT01619878|19033381|P1|Follow-up at 12 Months of Age|Death|2
5505062|NCT01619878|19033381|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
5505063|NCT01619878|19033381|P1|6 Week Follow-up Phase|Adverse Event|1
5505064|NCT01619852|19033395|P2|3 Month Follow up|Lost to Follow-up|34
5505065|NCT01619852|19033396|P1|3 Month Follow up|Lost to Follow-up|31
5505066|NCT01619852|19033395|P2|24 Hour Assessment|Withdrawal by Subject|1
5505067|NCT01619852|19033396|P1|24 Hour Assessment|Withdrawal by Subject|1
5505068|NCT01619800|19033412|P2|Overall Study|study terminated|0
5505069|NCT01619800|19033413|P1|Overall Study|study terminated|2
5505070|NCT01619787|19033421|P1|Overall Study|Lost to Follow-up|5
5505071|NCT01619579|19033438|P2|Overall Study|Withdrawal by Subject|3
5505072|NCT01619579|19033439|P1|Overall Study|Withdrawal by Subject|0
5505073|NCT01619423|19033453|P4|Part 1 (Dose Escalation)|High basal Mn|0
5505074|NCT01619423|19033454|P3|Part 1 (Dose Escalation)|High basal Mn|0
5505075|NCT01619423|19033455|P2|Part 1 (Dose Escalation)|High basal Mn|2
5505076|NCT01619423|19033456|P1|Part 1 (Dose Escalation)|High basal Mn|0
5505077|NCT01619410|19033469|P2|Overall Study|Lost to Follow-up|4
5505078|NCT01619410|19033470|P1|Overall Study|Lost to Follow-up|7
5505079|NCT01619085|19033482|P1|Overall Study|Ongoing on trial|27
5505080|NCT01619085|19033482|P1|Overall Study|Not treated|1
5505081|NCT01619085|19033482|P1|Overall Study|Other than specified|94
5505082|NCT01619085|19033482|P1|Overall Study|Withdrawal by Subject|15
5505083|NCT01619085|19033482|P1|Overall Study|Lost to Follow-up|10
5505084|NCT01619085|19033482|P1|Overall Study|Protocol Violation|10
5505085|NCT01619085|19033482|P1|Overall Study|Adverse Event|212
5505086|NCT01619059|19033488|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
5505087|NCT01619059|19033489|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
5505088|NCT01619059|19033488|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
5505089|NCT01619059|19033489|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
5505090|NCT01619059|19033488|P2|Long-Term (LT) Treatment Period|Death|0
5505091|NCT01619059|19033489|P1|Long-Term (LT) Treatment Period|Death|1
5505092|NCT01619059|19033488|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
5505093|NCT01619059|19033489|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
5505094|NCT01619059|19033488|P2|Long-Term (LT) Treatment Period|Adverse Event|3
5505095|NCT01619059|19033489|P1|Long-Term (LT) Treatment Period|Adverse Event|2
5505096|NCT01619059|19033488|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
5505097|NCT01619059|19033489|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
5505098|NCT01619059|19033488|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
5505099|NCT01619059|19033489|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
5505100|NCT01619059|19033488|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
5505101|NCT01619059|19033489|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
5505102|NCT01619059|19033488|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
5505103|NCT01619059|19033489|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
5505104|NCT01619059|19033488|P2|Short-Term (ST) Treatment Period|Adverse Event|0
5505105|NCT01619059|19033489|P1|Short-Term (ST) Treatment Period|Adverse Event|1
5505106|NCT01618968|19033505|P4|Overall Study|Death|1
5505107|NCT01618968|19033506|P3|Overall Study|Death|0
5505108|NCT01618968|19033507|P2|Overall Study|Death|0
5505109|NCT01618968|19033508|P1|Overall Study|Death|0
5505110|NCT01618968|19033505|P4|Overall Study|Adverse Event|0
5505111|NCT01618968|19033506|P3|Overall Study|Adverse Event|0
5505112|NCT01618968|19033507|P2|Overall Study|Adverse Event|0
5505113|NCT01618968|19033508|P1|Overall Study|Adverse Event|1
5505114|NCT01618916|19033581|P6|Overall Study|Lost to Follow-up|0
5505115|NCT01618916|19033582|P5|Overall Study|Lost to Follow-up|0
5505116|NCT01618916|19033583|P4|Overall Study|Lost to Follow-up|2
5505117|NCT01618916|19033584|P3|Overall Study|Lost to Follow-up|0
5505118|NCT01618916|19033585|P2|Overall Study|Lost to Follow-up|0
5505119|NCT01618916|19033586|P1|Overall Study|Lost to Follow-up|1
5505120|NCT01618916|19033581|P6|Overall Study|Withdrawal by Subject|0
5505121|NCT01618916|19033582|P5|Overall Study|Withdrawal by Subject|1
5505122|NCT01618916|19033583|P4|Overall Study|Withdrawal by Subject|0
5505123|NCT01618916|19033584|P3|Overall Study|Withdrawal by Subject|1
5505124|NCT01618916|19033585|P2|Overall Study|Withdrawal by Subject|1
5505125|NCT01618916|19033586|P1|Overall Study|Withdrawal by Subject|0
5505126|NCT01618916|19033581|P6|Overall Study|Adverse Event|0
5505127|NCT01618916|19033582|P5|Overall Study|Adverse Event|0
5505128|NCT01618916|19033583|P4|Overall Study|Adverse Event|0
5505129|NCT01618916|19033584|P3|Overall Study|Adverse Event|0
5505130|NCT01618916|19033585|P2|Overall Study|Adverse Event|0
5505131|NCT01618916|19033586|P1|Overall Study|Adverse Event|1
5505132|NCT01618864|19033616|P1|Overall Study|Lost to Follow-up|2
5505133|NCT01618864|19033616|P1|Overall Study|Withdrawal by Subject|2
5505134|NCT01618838|19033625|P1|Overall Study|slow accrual, trial closed prematurely.|4
5505135|NCT01618708|19033633|P2|Overall Study|Randomized but not treated|2
5505136|NCT01618708|19033634|P1|Overall Study|Randomized but not treated|3
5505137|NCT01618708|19033633|P2|Overall Study|Other than specified above|1
5505138|NCT01618708|19033634|P1|Overall Study|Other than specified above|1
5505139|NCT01618708|19033633|P2|Overall Study|Technical problems|0
5505140|NCT01618708|19033634|P1|Overall Study|Technical problems|2
5505141|NCT01618708|19033633|P2|Overall Study|Lack of Efficacy|8
5505142|NCT01618708|19033634|P1|Overall Study|Lack of Efficacy|8
5505143|NCT01618708|19033633|P2|Overall Study|Withdrawal by Subject|22
5505144|NCT01618708|19033634|P1|Overall Study|Withdrawal by Subject|17
5505145|NCT01618708|19033633|P2|Overall Study|Lost to Follow-up|3
5505146|NCT01618708|19033634|P1|Overall Study|Lost to Follow-up|3
5505147|NCT01618708|19033633|P2|Overall Study|Adverse Event|10
5505148|NCT01618708|19033634|P1|Overall Study|Adverse Event|10
5505149|NCT01618695|19033650|P4|Overall Study|Not treated|0
5505150|NCT01618695|19033651|P3|Overall Study|Not treated|2
5505151|NCT01618695|19033652|P2|Overall Study|Not treated|0
5505152|NCT01618695|19033653|P1|Overall Study|Not treated|1
5505153|NCT01618695|19033650|P4|Overall Study|Other than specified|2
5505154|NCT01618695|19033651|P3|Overall Study|Other than specified|2
5505155|NCT01618695|19033652|P2|Overall Study|Other than specified|2
5505156|NCT01618695|19033653|P1|Overall Study|Other than specified|1
5505157|NCT01618695|19033650|P4|Overall Study|Lack of Efficacy|1
5505158|NCT01618695|19033651|P3|Overall Study|Lack of Efficacy|1
5505159|NCT01618695|19033652|P2|Overall Study|Lack of Efficacy|2
5505160|NCT01618695|19033653|P1|Overall Study|Lack of Efficacy|1
5505161|NCT01618695|19033650|P4|Overall Study|Pregnancy|0
5505162|NCT01618695|19033651|P3|Overall Study|Pregnancy|0
5505163|NCT01618695|19033652|P2|Overall Study|Pregnancy|0
5505164|NCT01618695|19033653|P1|Overall Study|Pregnancy|2
5505165|NCT01618695|19033650|P4|Overall Study|Withdrawal by Subject|13
5505166|NCT01618695|19033651|P3|Overall Study|Withdrawal by Subject|9
5505167|NCT01618695|19033652|P2|Overall Study|Withdrawal by Subject|11
5505168|NCT01618695|19033653|P1|Overall Study|Withdrawal by Subject|16
5505169|NCT01618695|19033650|P4|Overall Study|Lost to Follow-up|0
5505170|NCT01618695|19033651|P3|Overall Study|Lost to Follow-up|1
5505171|NCT01618695|19033652|P2|Overall Study|Lost to Follow-up|0
5505172|NCT01618695|19033653|P1|Overall Study|Lost to Follow-up|0
5505173|NCT01618695|19033650|P4|Overall Study|Adverse Event|20
5505174|NCT01618695|19033651|P3|Overall Study|Adverse Event|15
5505175|NCT01618695|19033652|P2|Overall Study|Adverse Event|5
5505176|NCT01618695|19033653|P1|Overall Study|Adverse Event|4
5505177|NCT01618669|19033677|P2|Overall Study|Miscellaneous Reason|1
5505178|NCT01618669|19033678|P1|Overall Study|Miscellaneous Reason|0
5505179|NCT01618669|19033677|P2|Overall Study|Withdrawal by Subject|9
5505180|NCT01618669|19033678|P1|Overall Study|Withdrawal by Subject|9
5505181|NCT01618669|19033677|P2|Overall Study|Protocol Violation|3
5505182|NCT01618669|19033678|P1|Overall Study|Protocol Violation|5
5505183|NCT01618669|19033677|P2|Overall Study|Adverse Event|7
5505184|NCT01618669|19033678|P1|Overall Study|Adverse Event|16
5505185|NCT01618669|19033677|P2|Overall Study|Randomized but Never Received Study Drug|2
5505186|NCT01618669|19033678|P1|Overall Study|Randomized but Never Received Study Drug|3
5505187|NCT01618669|19033677|P2|Overall Study|Lost to Follow-up|1
5505188|NCT01618669|19033678|P1|Overall Study|Lost to Follow-up|1
5505189|NCT01618305|19033737|P2|Overall Study|Withdrawal by Subject|2
5505190|NCT01618305|19033738|P1|Overall Study|Withdrawal by Subject|3
5505191|NCT01618305|19033737|P2|Overall Study|Protocol Violation|0
5505192|NCT01618305|19033738|P1|Overall Study|Protocol Violation|1
5505193|NCT01618305|19033737|P2|Overall Study|Lost to Follow-up|7
5505194|NCT01618305|19033738|P1|Overall Study|Lost to Follow-up|11
5505195|NCT01618305|19033737|P2|Overall Study|Death|1
5505196|NCT01618305|19033738|P1|Overall Study|Death|0
5505197|NCT01618266|19033780|P1|Overall Study|Protocol Violation|43
5505198|NCT01618266|19033780|P1|Overall Study|Lack of Efficacy|23
5505199|NCT01618266|19033780|P1|Overall Study|Other reasons|11
5505200|NCT01618266|19033780|P1|Overall Study|Treatment satisfaction|10
5505201|NCT01618266|19033780|P1|Overall Study|Lost to Follow-up|9
5505202|NCT01618214|19033817|P2|Overall Study|Unclassified|5
5505203|NCT01618214|19033818|P1|Overall Study|Unclassified|4
5505204|NCT01618214|19033817|P2|Overall Study|Withdrawal Criteria|2
5505205|NCT01618214|19033818|P1|Overall Study|Withdrawal Criteria|1
5505206|NCT01618214|19033817|P2|Overall Study|Protocol Violation|4
5505207|NCT01618214|19033818|P1|Overall Study|Protocol Violation|1
5505208|NCT01618214|19033817|P2|Overall Study|Lack of Efficacy|1
5505209|NCT01618214|19033818|P1|Overall Study|Lack of Efficacy|1
5505210|NCT01618214|19033817|P2|Overall Study|Adverse Event|1
5505211|NCT01618214|19033818|P1|Overall Study|Adverse Event|3
5505212|NCT01618162|19033834|P2|Overall Study|Unclassified|13
5505213|NCT01618162|19033835|P1|Overall Study|Unclassified|14
5505214|NCT01618162|19033834|P2|Overall Study|Withdrawal Criteria|10
5505215|NCT01618162|19033835|P1|Overall Study|Withdrawal Criteria|2
5505216|NCT01618162|19033834|P2|Overall Study|Adverse Event|2
5505217|NCT01618162|19033835|P1|Overall Study|Adverse Event|9
5505218|NCT01618162|19033834|P2|Overall Study|Protocol Violation|10
5505219|NCT01618162|19033835|P1|Overall Study|Protocol Violation|13
5505220|NCT01618019|19033855|P2|Overall Study|Withdrawal by Subject|14
5505221|NCT01618019|19033856|P1|Overall Study|Withdrawal by Subject|14
5505222|NCT01617967|19033882|P6|Overall Study|Dosing Suspended by Sponsor|0
5505223|NCT01617967|19033883|P5|Overall Study|Dosing Suspended by Sponsor|0
5505224|NCT01617967|19033884|P4|Overall Study|Dosing Suspended by Sponsor|0
5505225|NCT01617967|19033885|P3|Overall Study|Dosing Suspended by Sponsor|0
5505226|NCT01617967|19033886|P2|Overall Study|Dosing Suspended by Sponsor|0
5505227|NCT01617967|19033887|P1|Overall Study|Dosing Suspended by Sponsor|1
5505228|NCT01617967|19033882|P6|Overall Study|Withdrawal by Subject|1
5505229|NCT01617967|19033883|P5|Overall Study|Withdrawal by Subject|0
5505230|NCT01617967|19033884|P4|Overall Study|Withdrawal by Subject|0
5505231|NCT01617967|19033885|P3|Overall Study|Withdrawal by Subject|0
5505232|NCT01617967|19033886|P2|Overall Study|Withdrawal by Subject|0
5505233|NCT01617967|19033887|P1|Overall Study|Withdrawal by Subject|0
5505234|NCT01617967|19033882|P6|Overall Study|Protocol Violation|0
5505235|NCT01617967|19033883|P5|Overall Study|Protocol Violation|0
5505236|NCT01617967|19033884|P4|Overall Study|Protocol Violation|1
5505237|NCT01617967|19033885|P3|Overall Study|Protocol Violation|0
5505238|NCT01617967|19033886|P2|Overall Study|Protocol Violation|0
5505239|NCT01617967|19033887|P1|Overall Study|Protocol Violation|0
5505240|NCT01617681|19033941|P5|Period 2 Open Label|Withdrawal by Subject|3
5505241|NCT01617681|19033942|P4|Period 2 Open Label|Withdrawal by Subject|0
5505242|NCT01617681|19033943|P3|Period 2 Open Label|Withdrawal by Subject|0
5505243|NCT01617681|19033944|P2|Period 2 Open Label|Withdrawal by Subject|0
5505244|NCT01617681|19033945|P1|Period 2 Open Label|Withdrawal by Subject|0
5505245|NCT01617681|19033941|P5|Period 2 Open Label|Adverse Event|3
5505246|NCT01617681|19033942|P4|Period 2 Open Label|Adverse Event|0
5505247|NCT01617681|19033943|P3|Period 2 Open Label|Adverse Event|0
5505248|NCT01617681|19033944|P2|Period 2 Open Label|Adverse Event|0
5505249|NCT01617681|19033945|P1|Period 2 Open Label|Adverse Event|0
5505250|NCT01617681|19033941|P5|Period 1 Double Blind|Withdrawal by Subject|0
5505251|NCT01617681|19033942|P4|Period 1 Double Blind|Withdrawal by Subject|0
5505252|NCT01617681|19033943|P3|Period 1 Double Blind|Withdrawal by Subject|1
5505253|NCT01617681|19033944|P2|Period 1 Double Blind|Withdrawal by Subject|1
5505254|NCT01617681|19033945|P1|Period 1 Double Blind|Withdrawal by Subject|1
5505255|NCT01617681|19033941|P5|Period 1 Double Blind|Adverse Event|0
5505256|NCT01617681|19033942|P4|Period 1 Double Blind|Adverse Event|2
5505257|NCT01617681|19033943|P3|Period 1 Double Blind|Adverse Event|0
5505258|NCT01617681|19033944|P2|Period 1 Double Blind|Adverse Event|0
5505259|NCT01617681|19033945|P1|Period 1 Double Blind|Adverse Event|2
5505260|NCT01617668|19033966|P4|Overall Study|Subject/guardian decision|1
5505261|NCT01617668|19033967|P3|Overall Study|Subject/guardian decision|2
5505262|NCT01617668|19033968|P2|Overall Study|Subject/guardian decision|3
5505263|NCT01617668|19033969|P1|Overall Study|Subject/guardian decision|1
5505264|NCT01617668|19033966|P4|Overall Study|Progressive Disease|9
5505265|NCT01617668|19033967|P3|Overall Study|Progressive Disease|6
5505266|NCT01617668|19033968|P2|Overall Study|Progressive Disease|4
5505267|NCT01617668|19033969|P1|Overall Study|Progressive Disease|4
5505268|NCT01617668|19033966|P4|Overall Study|Physician Decision|0
5505269|NCT01617668|19033967|P3|Overall Study|Physician Decision|3
5505270|NCT01617668|19033968|P2|Overall Study|Physician Decision|2
5505271|NCT01617668|19033969|P1|Overall Study|Physician Decision|1
5505272|NCT01617668|19033966|P4|Overall Study|Adverse Event|5
5505273|NCT01617668|19033967|P3|Overall Study|Adverse Event|12
5505274|NCT01617668|19033968|P2|Overall Study|Adverse Event|0
5505275|NCT01617668|19033969|P1|Overall Study|Adverse Event|7
5505276|NCT01617655|19034010|P2|Overall Study|Other than specified above|2
5505277|NCT01617655|19034011|P1|Overall Study|Other than specified above|1
5505278|NCT01617655|19034010|P2|Overall Study|Site closure|5
5505279|NCT01617655|19034011|P1|Overall Study|Site closure|3
5505280|NCT01617655|19034010|P2|Overall Study|Last visit outside protocol visit window|10
5505281|NCT01617655|19034011|P1|Overall Study|Last visit outside protocol visit window|1
5505282|NCT01617655|19034010|P2|Overall Study|Consent withdrawn by participant|1
5505283|NCT01617655|19034011|P1|Overall Study|Consent withdrawn by participant|1
5505284|NCT01617655|19034010|P2|Overall Study|Participants moved|4
5505285|NCT01617655|19034011|P1|Overall Study|Participants moved|0
5505286|NCT01617655|19034010|P2|Overall Study|Poor compliance to protocol|4
5505287|NCT01617655|19034011|P1|Overall Study|Poor compliance to protocol|1
5505288|NCT01617655|19034010|P2|Overall Study|Adverse Event|3
5505289|NCT01617655|19034011|P1|Overall Study|Adverse Event|2
5505290|NCT01617629|19034071|P1|Overall Study|Participant Withdrew Consent|2
5505291|NCT01617629|19034071|P1|Overall Study|Reason Not Specified|1
5505292|NCT01617629|19034071|P1|Overall Study|Investigator's Clinical Judgement|1
5505293|NCT01617629|19034071|P1|Overall Study|Death|2
5505294|NCT01617460|19034099|P1|Overall Study|Withdrawal by Subject|9
5505295|NCT01617460|19034099|P1|Overall Study|Protocol Violation|5
5505296|NCT01617460|19034099|P1|Overall Study|Physician Decision|16
5505297|NCT01617460|19034099|P1|Overall Study|Adverse Event|10
5505298|NCT01617447|19034105|P2|Overall Study|Physician Decision|2
5505299|NCT01617447|19034106|P1|Overall Study|Physician Decision|0
5505300|NCT01617447|19034105|P2|Overall Study|Adverse Event|1
5505301|NCT01617447|19034106|P1|Overall Study|Adverse Event|0
5505302|NCT01617434|19034114|P2|Overall Study|Unclassified|4
5505303|NCT01617434|19034115|P1|Overall Study|Unclassified|3
5505304|NCT01617434|19034114|P2|Overall Study|Withdrawal Criteria|37
5505305|NCT01617434|19034115|P1|Overall Study|Withdrawal Criteria|12
5505306|NCT01617434|19034114|P2|Overall Study|Protocol Violation|7
5505307|NCT01617434|19034115|P1|Overall Study|Protocol Violation|8
5505308|NCT01617434|19034114|P2|Overall Study|Adverse Event|3
5505309|NCT01617434|19034115|P1|Overall Study|Adverse Event|12
5505388|NCT01616173|19034478|P1|Overall Study|Lost to Follow-up|0
5505310|NCT01617187|19034154|P4|Treatment Through Study Completion|Protocol Violation|1
5505311|NCT01617187|19034155|P3|Treatment Through Study Completion|Protocol Violation|0
5505312|NCT01617187|19034156|P2|Treatment Through Study Completion|Protocol Violation|0
5505313|NCT01617187|19034157|P1|Treatment Through Study Completion|Protocol Violation|1
5505314|NCT01617187|19034154|P4|Treatment Through Study Completion|Withdrawal by Subject|6
5505315|NCT01617187|19034155|P3|Treatment Through Study Completion|Withdrawal by Subject|3
5505316|NCT01617187|19034156|P2|Treatment Through Study Completion|Withdrawal by Subject|8
5505317|NCT01617187|19034157|P1|Treatment Through Study Completion|Withdrawal by Subject|5
5505318|NCT01617187|19034154|P4|Treatment Through Study Completion|Lost to Follow-up|2
5505319|NCT01617187|19034155|P3|Treatment Through Study Completion|Lost to Follow-up|2
5505320|NCT01617187|19034156|P2|Treatment Through Study Completion|Lost to Follow-up|2
5505321|NCT01617187|19034157|P1|Treatment Through Study Completion|Lost to Follow-up|4
5505322|NCT01617187|19034154|P4|Treatment Through Study Completion|Adverse Event|1
5505323|NCT01617187|19034155|P3|Treatment Through Study Completion|Adverse Event|0
5505324|NCT01617187|19034156|P2|Treatment Through Study Completion|Adverse Event|1
5505325|NCT01617187|19034157|P1|Treatment Through Study Completion|Adverse Event|1
5505326|NCT01617187|19034154|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
5505327|NCT01617187|19034155|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
5505328|NCT01617187|19034156|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
5505329|NCT01617187|19034157|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
5505330|NCT01617187|19034154|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
5505331|NCT01617187|19034155|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
5505332|NCT01617187|19034156|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
5505333|NCT01617187|19034157|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
5505334|NCT01617187|19034154|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
5505335|NCT01617187|19034155|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
5505336|NCT01617187|19034156|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
5505337|NCT01617187|19034157|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
5505338|NCT01617070|19034254|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
5505339|NCT01617005|19034272|P1|Overall Study|Lack of motivation for treatment|1
5505340|NCT01617005|19034272|P1|Overall Study|Pregnancy|1
5505341|NCT01616953|19034281|P2|Overall Study|lack of bone and soft tissue|0
5505342|NCT01616953|19034282|P1|Overall Study|lack of bone and soft tissue|1
5505343|NCT01616953|19034281|P2|Overall Study|Lost to Follow-up|0
5505344|NCT01616953|19034282|P1|Overall Study|Lost to Follow-up|1
5505345|NCT01616771|19034290|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
5505346|NCT01616693|19034303|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
5505347|NCT01616693|19034304|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
5505348|NCT01616693|19034305|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
5505349|NCT01616693|19034306|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
5505350|NCT01616693|19034303|P4|Received Both Vaccines|Lost to Follow-up|4
5505351|NCT01616693|19034304|P3|Received Both Vaccines|Lost to Follow-up|4
5505352|NCT01616693|19034305|P2|Received Both Vaccines|Lost to Follow-up|3
5505353|NCT01616693|19034306|P1|Received Both Vaccines|Lost to Follow-up|4
5505354|NCT01616693|19034303|P4|Received Both Vaccines|Withdrawal by Subject|15
5505355|NCT01616693|19034304|P3|Received Both Vaccines|Withdrawal by Subject|8
5505356|NCT01616693|19034305|P2|Received Both Vaccines|Withdrawal by Subject|7
5505357|NCT01616693|19034306|P1|Received Both Vaccines|Withdrawal by Subject|7
5505358|NCT01616693|19034303|P4|Received Both Vaccines|Adverse Event|0
5505359|NCT01616693|19034304|P3|Received Both Vaccines|Adverse Event|0
5505360|NCT01616693|19034305|P2|Received Both Vaccines|Adverse Event|0
5505361|NCT01616693|19034306|P1|Received Both Vaccines|Adverse Event|2
5505362|NCT01616693|19034303|P4|Evaluated for Safety|Physician Decision|0
5505363|NCT01616693|19034304|P3|Evaluated for Safety|Physician Decision|1
5505364|NCT01616693|19034305|P2|Evaluated for Safety|Physician Decision|0
5505365|NCT01616693|19034306|P1|Evaluated for Safety|Physician Decision|1
5505366|NCT01616459|19034372|P4|Overall Study|Other reason|0
5505367|NCT01616459|19034373|P3|Overall Study|Other reason|1
5505368|NCT01616459|19034374|P2|Overall Study|Other reason|1
5505369|NCT01616459|19034375|P1|Overall Study|Other reason|0
5505370|NCT01616459|19034372|P4|Overall Study|Withdrawal by Subject|4
5505371|NCT01616459|19034373|P3|Overall Study|Withdrawal by Subject|4
5505372|NCT01616459|19034374|P2|Overall Study|Withdrawal by Subject|4
5505373|NCT01616459|19034375|P1|Overall Study|Withdrawal by Subject|2
5505374|NCT01616459|19034372|P4|Overall Study|Protocol Violation|2
5505375|NCT01616459|19034373|P3|Overall Study|Protocol Violation|0
5505376|NCT01616459|19034374|P2|Overall Study|Protocol Violation|0
5505377|NCT01616459|19034375|P1|Overall Study|Protocol Violation|0
5505378|NCT01616459|19034372|P4|Overall Study|Lost to Follow-up|2
5505379|NCT01616459|19034373|P3|Overall Study|Lost to Follow-up|3
5505380|NCT01616459|19034374|P2|Overall Study|Lost to Follow-up|11
5505381|NCT01616459|19034375|P1|Overall Study|Lost to Follow-up|1
5505382|NCT01616459|19034372|P4|Overall Study|Adverse Event|0
5505383|NCT01616459|19034373|P3|Overall Study|Adverse Event|2
5505384|NCT01616459|19034374|P2|Overall Study|Adverse Event|1
5505385|NCT01616459|19034375|P1|Overall Study|Adverse Event|1
5505386|NCT01616173|19034476|P3|Overall Study|Lost to Follow-up|0
5505387|NCT01616173|19034477|P2|Overall Study|Lost to Follow-up|2
5505389|NCT01615939|19034524|P2|Overall Study|Lost to Follow-up|0
5505390|NCT01615939|19034525|P1|Overall Study|Lost to Follow-up|5
5505391|NCT01615822|19034538|P3|Period 2|Lost to Follow-up|2
5505392|NCT01615822|19034539|P2|Period 2|Lost to Follow-up|1
5505393|NCT01615822|19034540|P1|Period 2|Lost to Follow-up|0
5505394|NCT01615822|19034538|P3|Period 1|Adverse Event|0
5505395|NCT01615822|19034539|P2|Period 1|Adverse Event|1
5505396|NCT01615822|19034540|P1|Period 1|Adverse Event|1
5505397|NCT01615822|19034538|P3|Period 1|Withdrawal by Subject|0
5505398|NCT01615822|19034539|P2|Period 1|Withdrawal by Subject|1
5505399|NCT01615822|19034540|P1|Period 1|Withdrawal by Subject|0
5505400|NCT01615328|19034628|P2|Overall Study|Lost to Follow-up|5
5505401|NCT01615328|19034629|P1|Overall Study|Lost to Follow-up|3
5505402|NCT01615263|19034641|P2|Overall Study|Post-randomization exclusion|2
5505403|NCT01615263|19034642|P1|Overall Study|Post-randomization exclusion|0
5505404|NCT01615198|19034656|P2|Overall Study|Adverse Event|5
5505405|NCT01615198|19034657|P1|Overall Study|Adverse Event|11
5505406|NCT01615198|19034656|P2|Overall Study|Lack of Efficacy|6
5505407|NCT01615198|19034657|P1|Overall Study|Lack of Efficacy|1
5505408|NCT01615198|19034656|P2|Overall Study|Lost to Follow-up|1
5505409|NCT01615198|19034657|P1|Overall Study|Lost to Follow-up|1
5505410|NCT01615198|19034656|P2|Overall Study|Physician Decision|1
5505411|NCT01615198|19034657|P1|Overall Study|Physician Decision|5
5505412|NCT01615198|19034656|P2|Overall Study|Protocol deviation|1
5505413|NCT01615198|19034657|P1|Overall Study|Protocol deviation|1
5505414|NCT01615198|19034656|P2|Overall Study|Withdrawal by Subject|5
5505415|NCT01615198|19034657|P1|Overall Study|Withdrawal by Subject|5
5505416|NCT01615029|19034690|P5|Overall Study|Ongoing|23
5505417|NCT01615029|19034691|P4|Overall Study|Ongoing|2
5505418|NCT01615029|19034692|P3|Overall Study|Ongoing|3
5505419|NCT01615029|19034693|P2|Overall Study|Ongoing|2
5505420|NCT01615029|19034694|P1|Overall Study|Ongoing|1
5505421|NCT01615029|19034690|P5|Overall Study|Physician Decision|1
5505422|NCT01615029|19034691|P4|Overall Study|Physician Decision|0
5505423|NCT01615029|19034692|P3|Overall Study|Physician Decision|0
5505424|NCT01615029|19034693|P2|Overall Study|Physician Decision|0
5505425|NCT01615029|19034694|P1|Overall Study|Physician Decision|0
5505426|NCT01615029|19034690|P5|Overall Study|Progressive disease|5
5505427|NCT01615029|19034691|P4|Overall Study|Progressive disease|1
5505428|NCT01615029|19034692|P3|Overall Study|Progressive disease|1
5505429|NCT01615029|19034693|P2|Overall Study|Progressive disease|1
5505430|NCT01615029|19034694|P1|Overall Study|Progressive disease|2
5505431|NCT01615029|19034690|P5|Overall Study|Lost to Follow-up|1
5505432|NCT01615029|19034691|P4|Overall Study|Lost to Follow-up|0
5505433|NCT01615029|19034692|P3|Overall Study|Lost to Follow-up|0
5505434|NCT01615029|19034693|P2|Overall Study|Lost to Follow-up|0
5505435|NCT01615029|19034694|P1|Overall Study|Lost to Follow-up|0
5505436|NCT01615029|19034690|P5|Overall Study|Death|1
5505437|NCT01615029|19034691|P4|Overall Study|Death|0
5505438|NCT01615029|19034692|P3|Overall Study|Death|0
5505439|NCT01615029|19034693|P2|Overall Study|Death|0
5505440|NCT01615029|19034694|P1|Overall Study|Death|0
5505441|NCT01615029|19034690|P5|Overall Study|Adverse Event|1
5505442|NCT01615029|19034691|P4|Overall Study|Adverse Event|0
5505443|NCT01615029|19034692|P3|Overall Study|Adverse Event|0
5505444|NCT01615029|19034693|P2|Overall Study|Adverse Event|0
5505445|NCT01615029|19034694|P1|Overall Study|Adverse Event|0
5505446|NCT01614886|19034762|P2|Overall Study|Protocol deviation|2
5505447|NCT01614886|19034763|P1|Overall Study|Protocol deviation|0
5505448|NCT01614886|19034762|P2|Overall Study|Death|0
5505449|NCT01614886|19034763|P1|Overall Study|Death|1
5505450|NCT01614886|19034762|P2|Overall Study|Withdrawal by Subject|4
5505451|NCT01614886|19034763|P1|Overall Study|Withdrawal by Subject|4
5505452|NCT01614886|19034762|P2|Overall Study|Adverse Event|20
5505453|NCT01614886|19034763|P1|Overall Study|Adverse Event|15
5505454|NCT01614795|19034804|P4|Overall Study|Ineligible|0
5505455|NCT01614795|19034805|P3|Overall Study|Ineligible|0
5505456|NCT01614795|19034806|P2|Overall Study|Ineligible|1
5505457|NCT01614795|19034807|P1|Overall Study|Ineligible|0
5505458|NCT01614795|19034804|P4|Overall Study|Withdrawal by Subject|2
5505459|NCT01614795|19034805|P3|Overall Study|Withdrawal by Subject|0
5505460|NCT01614795|19034806|P2|Overall Study|Withdrawal by Subject|1
5505461|NCT01614795|19034807|P1|Overall Study|Withdrawal by Subject|0
5505462|NCT01614795|19034804|P4|Overall Study|Physician Decision|1
5505463|NCT01614795|19034805|P3|Overall Study|Physician Decision|1
5505464|NCT01614795|19034806|P2|Overall Study|Physician Decision|0
5505465|NCT01614795|19034807|P1|Overall Study|Physician Decision|1
5505466|NCT01614795|19034804|P4|Overall Study|Lack of Efficacy|8
5505467|NCT01614795|19034805|P3|Overall Study|Lack of Efficacy|9
5505468|NCT01614795|19034806|P2|Overall Study|Lack of Efficacy|10
5505469|NCT01614795|19034807|P1|Overall Study|Lack of Efficacy|10
5505470|NCT01614795|19034804|P4|Overall Study|Adverse Event|1
5505471|NCT01614795|19034805|P3|Overall Study|Adverse Event|1
5505472|NCT01614795|19034806|P2|Overall Study|Adverse Event|0
5505473|NCT01614795|19034807|P1|Overall Study|Adverse Event|0
5505474|NCT01614769|19034827|P6|Period 3|Withdrawal by Subject|0
5505475|NCT01614769|19034828|P5|Period 3|Withdrawal by Subject|0
5505476|NCT01614769|19034829|P4|Period 3|Withdrawal by Subject|0
5505477|NCT01614769|19034830|P3|Period 3|Withdrawal by Subject|1
5505478|NCT01614769|19034831|P2|Period 3|Withdrawal by Subject|0
5505479|NCT01614769|19034832|P1|Period 3|Withdrawal by Subject|0
5505480|NCT01614769|19034827|P6|Period 1|Withdrawal by Subject|0
5505481|NCT01614769|19034828|P5|Period 1|Withdrawal by Subject|0
5505482|NCT01614769|19034829|P4|Period 1|Withdrawal by Subject|0
5505483|NCT01614769|19034830|P3|Period 1|Withdrawal by Subject|0
5505484|NCT01614769|19034831|P2|Period 1|Withdrawal by Subject|0
5505485|NCT01614769|19034832|P1|Period 1|Withdrawal by Subject|1
5505486|NCT01614769|19034827|P6|Period 1|Protocol Violation|0
5505487|NCT01614769|19034828|P5|Period 1|Protocol Violation|0
5505488|NCT01614769|19034829|P4|Period 1|Protocol Violation|1
5505489|NCT01614769|19034830|P3|Period 1|Protocol Violation|0
5505490|NCT01614769|19034831|P2|Period 1|Protocol Violation|0
5505491|NCT01614769|19034832|P1|Period 1|Protocol Violation|0
5505492|NCT01614769|19034827|P6|Period 1|Discontinued due to Hypoglycemia|1
5505493|NCT01614769|19034828|P5|Period 1|Discontinued due to Hypoglycemia|0
5505494|NCT01614769|19034829|P4|Period 1|Discontinued due to Hypoglycemia|1
5505495|NCT01614769|19034830|P3|Period 1|Discontinued due to Hypoglycemia|0
5505496|NCT01614769|19034831|P2|Period 1|Discontinued due to Hypoglycemia|0
5505497|NCT01614769|19034832|P1|Period 1|Discontinued due to Hypoglycemia|0
5505498|NCT01614600|19034869|P1|Overall Study|Protocol deviation|1
5505499|NCT01614600|19034869|P1|Overall Study|Unable to remove lens at the end of day|1
5505500|NCT01614600|19034869|P1|Overall Study|Discomfort|1
5505501|NCT01614600|19034869|P1|Overall Study|Unacceptable fit|1
5505502|NCT01614470|19034900|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
5505503|NCT01614470|19034901|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
5505504|NCT01614470|19034902|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
5505505|NCT01614470|19034900|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5505506|NCT01614470|19034901|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
5505507|NCT01614470|19034902|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
5505508|NCT01614457|19034924|P2|Overall Study|Pregnancy (Self or Partner)|0
5505509|NCT01614457|19034925|P1|Overall Study|Pregnancy (Self or Partner)|1
5505510|NCT01614457|19034924|P2|Overall Study|Non-Compliance|0
5505511|NCT01614457|19034925|P1|Overall Study|Non-Compliance|1
5505512|NCT01614249|19034952|P2|Overall Study|Lost to Follow-up|23
5505513|NCT01614249|19034953|P1|Overall Study|Lost to Follow-up|11
5505514|NCT01614093|19034967|P1|Overall Study|Withdrawal by Subject|1
5505515|NCT01613716|19034980|P1|Overall Study|Lost to Follow-up|4
5505516|NCT01613716|19034980|P1|Overall Study|screen failures|3
5505517|NCT01613599|19034985|P1|Overall Study|Reason not specified|3
5505518|NCT01613599|19034985|P1|Overall Study|Withdrawal by Subject|8
5505519|NCT01613599|19034985|P1|Overall Study|Lost to Follow-up|5
5505520|NCT01613599|19034985|P1|Overall Study|Death|9
5505521|NCT01613417|19035000|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
5505522|NCT01613417|19035001|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
5505523|NCT01613378|19035038|P1|Overall Study|Other Reason|4
5505524|NCT01613378|19035038|P1|Overall Study|Lost to Follow-up|1
5505525|NCT01613378|19035038|P1|Overall Study|Death|2
5505526|NCT01613378|19035038|P1|Overall Study|Withdrawal by Subject|8
5505527|NCT01613378|19035038|P1|Overall Study|Adverse Event|11
5505528|NCT01613378|19035038|P1|Overall Study|Lack of Efficacy|13
5505529|NCT01613326|19035068|P2|Overall Study|Protocol Violation|1
5505530|NCT01613326|19035069|P1|Overall Study|Protocol Violation|0
5505531|NCT01613326|19035068|P2|Overall Study|Administrative|2
5505532|NCT01613326|19035069|P1|Overall Study|Administrative|0
5505533|NCT01613326|19035068|P2|Overall Study|Lost to Follow-up|1
5505534|NCT01613326|19035069|P1|Overall Study|Lost to Follow-up|0
5505535|NCT01613326|19035068|P2|Overall Study|Lack of Efficacy|1
5505536|NCT01613326|19035069|P1|Overall Study|Lack of Efficacy|0
5505537|NCT01613326|19035068|P2|Overall Study|inability to use device|0
5505538|NCT01613326|19035069|P1|Overall Study|inability to use device|1
5505539|NCT01613326|19035068|P2|Overall Study|Abnormal test procedure result(s)|0
5505540|NCT01613326|19035069|P1|Overall Study|Abnormal test procedure result(s)|2
5505541|NCT01613326|19035068|P2|Overall Study|Withdrawal by Subject|4
5505542|NCT01613326|19035069|P1|Overall Study|Withdrawal by Subject|3
5505543|NCT01613326|19035068|P2|Overall Study|Adverse Event|5
5505544|NCT01613326|19035069|P1|Overall Study|Adverse Event|7
5505545|NCT01613248|19035126|P6|Overall Study|Pregnancy|0
5505546|NCT01613248|19035127|P5|Overall Study|Pregnancy|0
5505547|NCT01613248|19035128|P4|Overall Study|Pregnancy|1
5505548|NCT01613248|19035129|P3|Overall Study|Pregnancy|0
5505549|NCT01613248|19035130|P2|Overall Study|Pregnancy|0
5505550|NCT01613248|19035131|P1|Overall Study|Pregnancy|0
5505551|NCT01613248|19035126|P6|Overall Study|Lack of Qualifying Event|18
5505552|NCT01613248|19035127|P5|Overall Study|Lack of Qualifying Event|15
5505553|NCT01613248|19035128|P4|Overall Study|Lack of Qualifying Event|11
5505554|NCT01613248|19035129|P3|Overall Study|Lack of Qualifying Event|10
5505555|NCT01613248|19035130|P2|Overall Study|Lack of Qualifying Event|11
5505556|NCT01613248|19035131|P1|Overall Study|Lack of Qualifying Event|9
5505557|NCT01613248|19035126|P6|Overall Study|Physician Decision|6
5505558|NCT01613248|19035127|P5|Overall Study|Physician Decision|7
5505559|NCT01613248|19035128|P4|Overall Study|Physician Decision|4
5505560|NCT01613248|19035129|P3|Overall Study|Physician Decision|9
5505561|NCT01613248|19035130|P2|Overall Study|Physician Decision|8
5505562|NCT01613248|19035131|P1|Overall Study|Physician Decision|8
5505563|NCT01613248|19035126|P6|Overall Study|Study Terminated by Sponsor|11
5505564|NCT01613248|19035127|P5|Overall Study|Study Terminated by Sponsor|9
5505565|NCT01613248|19035128|P4|Overall Study|Study Terminated by Sponsor|8
5505566|NCT01613248|19035129|P3|Overall Study|Study Terminated by Sponsor|8
5505567|NCT01613248|19035130|P2|Overall Study|Study Terminated by Sponsor|6
5505568|NCT01613248|19035131|P1|Overall Study|Study Terminated by Sponsor|4
5505569|NCT01613248|19035126|P6|Overall Study|Lost to Follow-up|2
5505570|NCT01613248|19035127|P5|Overall Study|Lost to Follow-up|4
5505571|NCT01613248|19035128|P4|Overall Study|Lost to Follow-up|8
5505572|NCT01613248|19035129|P3|Overall Study|Lost to Follow-up|4
5505573|NCT01613248|19035130|P2|Overall Study|Lost to Follow-up|7
5505574|NCT01613248|19035131|P1|Overall Study|Lost to Follow-up|5
5505575|NCT01613248|19035126|P6|Overall Study|Withdrawal by Subject|1
5505576|NCT01613248|19035127|P5|Overall Study|Withdrawal by Subject|0
5505577|NCT01613248|19035128|P4|Overall Study|Withdrawal by Subject|5
5505578|NCT01613248|19035129|P3|Overall Study|Withdrawal by Subject|2
5505579|NCT01613248|19035130|P2|Overall Study|Withdrawal by Subject|2
5505580|NCT01613248|19035131|P1|Overall Study|Withdrawal by Subject|3
5505581|NCT01613248|19035126|P6|Overall Study|Adverse Event|0
5505582|NCT01613248|19035127|P5|Overall Study|Adverse Event|0
5505583|NCT01613248|19035128|P4|Overall Study|Adverse Event|1
5505584|NCT01613248|19035129|P3|Overall Study|Adverse Event|0
5505585|NCT01613248|19035130|P2|Overall Study|Adverse Event|0
5505586|NCT01613248|19035131|P1|Overall Study|Adverse Event|0
5505587|NCT01613222|19035229|P1|Overall Study|Reused disposable sensors|10
5505588|NCT01613222|19035229|P1|Overall Study|Unable to place arterial line|1
5505589|NCT01613222|19035229|P1|Overall Study|Physician Decision|1
5505590|NCT01613131|19035244|P2|Overall Study|Withdrawal by Subject|5
5505591|NCT01613131|19035245|P1|Overall Study|Withdrawal by Subject|3
5505592|NCT01613027|19035273|P1|Overall Study|Patient's Decision Due to Adverse Event|1
5505593|NCT01613027|19035273|P1|Overall Study|Lack of Efficacy|1
5505594|NCT01613027|19035273|P1|Overall Study|Switched Physician|1
5505595|NCT01613027|19035273|P1|Overall Study|Lost to Follow-up|5
5505596|NCT01612858|19035316|P2|Overall Study|Withdrawal by Subject|1
5505597|NCT01612858|19035317|P1|Overall Study|Withdrawal by Subject|5
5505598|NCT01612780|19035334|P1|Overall Study|Withdrawal by Subject|5
5505599|NCT01612780|19035334|P1|Overall Study|Treatment not completed|1
5505600|NCT01612702|19035396|P2|Overall Study|Protocol Violation|11
5505601|NCT01612702|19035397|P1|Overall Study|Protocol Violation|11
5505602|NCT01612676|19035411|P4|Overall Study|Protocol Violation|0
5505603|NCT01612676|19035412|P3|Overall Study|Protocol Violation|0
5505604|NCT01612676|19035413|P2|Overall Study|Protocol Violation|1
5505605|NCT01612676|19035414|P1|Overall Study|Protocol Violation|0
5505606|NCT01612676|19035411|P4|Overall Study|Adverse Event|3
5505607|NCT01612676|19035412|P3|Overall Study|Adverse Event|1
5505608|NCT01612676|19035413|P2|Overall Study|Adverse Event|3
5505609|NCT01612676|19035414|P1|Overall Study|Adverse Event|2
5505610|NCT01612156|19035512|P2|Overall Study|Protocol Violation|0
5505611|NCT01612156|19035513|P1|Overall Study|Protocol Violation|2
5505612|NCT01612000|19035525|P4|Overall Study|Withdrawal by Subject|2
5505613|NCT01612000|19035526|P3|Overall Study|Withdrawal by Subject|2
5505614|NCT01612000|19035527|P2|Overall Study|Withdrawal by Subject|1
5505615|NCT01612000|19035528|P1|Overall Study|Withdrawal by Subject|3
5505616|NCT01612000|19035525|P4|Overall Study|Physician Decision|0
5505617|NCT01612000|19035526|P3|Overall Study|Physician Decision|1
5505618|NCT01612000|19035527|P2|Overall Study|Physician Decision|0
5505619|NCT01612000|19035528|P1|Overall Study|Physician Decision|0
5505620|NCT01612000|19035525|P4|Overall Study|Lost to Follow-up|8
5505621|NCT01612000|19035526|P3|Overall Study|Lost to Follow-up|4
5505622|NCT01612000|19035527|P2|Overall Study|Lost to Follow-up|4
5505623|NCT01612000|19035528|P1|Overall Study|Lost to Follow-up|6
5505624|NCT01611974|19035553|P3|Overall Study|Withdrawal by Subject|4
5505625|NCT01611974|19035554|P2|Overall Study|Withdrawal by Subject|1
5505626|NCT01611974|19035555|P1|Overall Study|Withdrawal by Subject|0
5505627|NCT01611974|19035553|P3|Overall Study|Physician Decision|2
5505628|NCT01611974|19035554|P2|Overall Study|Physician Decision|1
5505629|NCT01611974|19035555|P1|Overall Study|Physician Decision|5
5505630|NCT01611974|19035553|P3|Overall Study|Lost to Follow-up|0
5505631|NCT01611974|19035554|P2|Overall Study|Lost to Follow-up|1
5505632|NCT01611974|19035555|P1|Overall Study|Lost to Follow-up|0
5505633|NCT01611974|19035553|P3|Overall Study|Death|10
5505634|NCT01611974|19035554|P2|Overall Study|Death|12
5505635|NCT01611974|19035555|P1|Overall Study|Death|10
5505636|NCT01611935|19035601|P2|Overall Study|Family Declined Participation|0
5505637|NCT01611935|19035602|P1|Overall Study|Family Declined Participation|1
5505638|NCT01611883|19035614|P2|Overall Study|Adverse Event|1
5505639|NCT01611883|19035615|P1|Overall Study|Adverse Event|1
5505640|NCT01611857|19035641|P2|Overall Study|Withdrawal by Subject|2
5505641|NCT01611857|19035642|P1|Overall Study|Withdrawal by Subject|0
5505642|NCT01611792|19035654|P2|Followup: at 6 Months|Lost to Follow-up|13
5505643|NCT01611792|19035655|P1|Followup: at 6 Months|Lost to Follow-up|6
5505644|NCT01611792|19035654|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
5505645|NCT01611792|19035655|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
5505646|NCT01611558|19035709|P1|Maintenance Phase|Elevated Uric acid|1
5505647|NCT01611558|19035709|P1|Maintenance Phase|Withdrawal by Subject|1
5505648|NCT01611558|19035709|P1|Induction Phase|Death|1
5505649|NCT01611558|19035709|P1|Induction Phase|Adverse event unrelated to study drug|3
5505650|NCT01611558|19035709|P1|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
5505651|NCT01611558|19035709|P1|Induction Phase|Disease progression|18
5505652|NCT01611558|19035709|P1|Induction Phase|Study drug toxicity|15
5505653|NCT01611298|19035715|P1|Overall Study|Relapsed|2
5505654|NCT01611259|19035720|P1|Overall Study|Withdrawal by Subject|7
5505655|NCT01611259|19035720|P1|Overall Study|Adverse Event|4
5505656|NCT01611259|19035720|P1|Overall Study|Lack of Efficacy|2
5505657|NCT01611259|19035720|P1|Overall Study|Physician Decision|1
5505658|NCT01611194|19035726|P2|Overall Study|drug use|1
5505659|NCT01611194|19035727|P1|Overall Study|drug use|0
5505660|NCT01611194|19035726|P2|Overall Study|Withdrawal by Subject|1
5505661|NCT01611194|19035727|P1|Overall Study|Withdrawal by Subject|0
5505662|NCT01611194|19035726|P2|Overall Study|Lost to Follow-up|1
5505663|NCT01611194|19035727|P1|Overall Study|Lost to Follow-up|0
5505664|NCT01611155|19035765|P2|Overall Study|Ineligible patient|1
5505665|NCT01611155|19035766|P1|Overall Study|Ineligible patient|0
5505666|NCT01611155|19035765|P2|Overall Study|Alternative treatment|1
5505667|NCT01611155|19035766|P1|Overall Study|Alternative treatment|0
5505668|NCT01611155|19035765|P2|Overall Study|Withdrawal by Subject|0
5505669|NCT01611155|19035766|P1|Overall Study|Withdrawal by Subject|1
5505670|NCT01611155|19035765|P2|Overall Study|Disease progression|0
5505671|NCT01611155|19035766|P1|Overall Study|Disease progression|1
5505672|NCT01611155|19035765|P2|Overall Study|Refused further treatment|4
5505673|NCT01611155|19035766|P1|Overall Study|Refused further treatment|6
5505674|NCT01611155|19035765|P2|Overall Study|Adverse Event|1
5505675|NCT01611155|19035766|P1|Overall Study|Adverse Event|1
5505676|NCT01611090|19035776|P3|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
5505677|NCT01611090|19035777|P2|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
5505678|NCT01611090|19035778|P1|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
5505679|NCT01611090|19035776|P3|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
5505680|NCT01611090|19035777|P2|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
5505681|NCT01611090|19035778|P1|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
5505682|NCT01611090|19035776|P3|Randomized Period|Withdrawal by Subject|0
5505683|NCT01611090|19035777|P2|Randomized Period|Withdrawal by Subject|26
5505684|NCT01611090|19035778|P1|Randomized Period|Withdrawal by Subject|22
5505685|NCT01611090|19035776|P3|Randomized Period|Lost to Follow-up|0
5505686|NCT01611090|19035777|P2|Randomized Period|Lost to Follow-up|3
5505687|NCT01611090|19035778|P1|Randomized Period|Lost to Follow-up|8
5505688|NCT01610791|19035811|P1|Overall Study|Not determined|5
5505689|NCT01610791|19035811|P1|Overall Study|Death|1
5505690|NCT01610791|19035811|P1|Overall Study|Adverse event and Investigator decision|1
5505691|NCT01610791|19035811|P1|Overall Study|Physician Decision|1
5505692|NCT01610791|19035811|P1|Overall Study|Adverse Event|6
5505693|NCT01610791|19035811|P1|Overall Study|Lost to Follow-up|7
5505694|NCT01610752|19035835|P3|Overall Study|Miscarriage/Pregnancy loss|4
5505695|NCT01610752|19035836|P2|Overall Study|Miscarriage/Pregnancy loss|0
5505696|NCT01610752|19035837|P1|Overall Study|Miscarriage/Pregnancy loss|0
5505697|NCT01610713|19035859|P2|Overall Study|Lost to Follow-up|1
5505698|NCT01610713|19035860|P1|Overall Study|Lost to Follow-up|0
5505699|NCT01610713|19035859|P2|Overall Study|adv. to use original dose/amitriptyline|0
5505700|NCT01610713|19035860|P1|Overall Study|adv. to use original dose/amitriptyline|1
5505701|NCT01610713|19035859|P2|Overall Study|low mood and poor motivation|0
5505702|NCT01610713|19035860|P1|Overall Study|low mood and poor motivation|1
5505703|NCT01610713|19035859|P2|Overall Study|Lack of Efficacy|0
5505704|NCT01610713|19035860|P1|Overall Study|Lack of Efficacy|1
5505705|NCT01610713|19035859|P2|Overall Study|Adverse Event|0
5505706|NCT01610713|19035860|P1|Overall Study|Adverse Event|3
5505707|NCT01610700|19035918|P2|Overall Study|subject took one dose of street cannabis|1
5505708|NCT01610700|19035919|P1|Overall Study|subject took one dose of street cannabis|0
5505709|NCT01610700|19035918|P2|Overall Study|Withdrawal by Subject|1
5505710|NCT01610700|19035919|P1|Overall Study|Withdrawal by Subject|0
5505711|NCT01610700|19035918|P2|Overall Study|Adverse Event|1
5505712|NCT01610700|19035919|P1|Overall Study|Adverse Event|3
5505713|NCT01610687|19035973|P1|Overall Study|Felt more alter without study medication|1
5505714|NCT01610687|19035973|P1|Overall Study|Cannabis affecting job|1
5505715|NCT01610687|19035973|P1|Overall Study|Death|1
5505716|NCT01610687|19035973|P1|Overall Study|Unable to make journey|1
5505717|NCT01610687|19035973|P1|Overall Study|Symptom control without study medication|2
5505718|NCT01610687|19035973|P1|Overall Study|Lost to Follow-up|4
5505719|NCT01610687|19035973|P1|Overall Study|Withdrawal by Subject|7
5505720|NCT01610687|19035973|P1|Overall Study|Moved out of area|6
5505721|NCT01610687|19035973|P1|Overall Study|Adverse Event|18
5505722|NCT01610687|19035973|P1|Overall Study|Lack of Efficacy|26
5505723|NCT01610596|19035986|P2|Overall Study|Lost to Follow-up|1
5505724|NCT01610596|19035987|P1|Overall Study|Lost to Follow-up|0
5505725|NCT01610557|19036045|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
5505726|NCT01610557|19036046|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
5505727|NCT01610557|19036047|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
5505728|NCT01610557|19036048|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
5505729|NCT01610557|19036049|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
5505730|NCT01610557|19036045|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5505731|NCT01610557|19036046|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5505732|NCT01610557|19036047|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5505733|NCT01610557|19036048|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
5505734|NCT01610557|19036049|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
5505735|NCT01610492|19036062|P1|Overall Study|Other:Treatment stopped due to remission|1
5505736|NCT01610492|19036062|P1|Overall Study|Other: Reached stopping criteria|1
5505737|NCT01610492|19036062|P1|Overall Study|Lack of Efficacy|3
5505738|NCT01610492|19036062|P1|Overall Study|Adverse Event|1
5505739|NCT01610414|19036128|P2|After Month 25|Study end not reached|53
5505740|NCT01610414|19036129|P1|After Month 25|Study end not reached|48
5505741|NCT01610414|19036128|P2|Month 13 - Month 25|Other reasons for withdrawal|7
5505742|NCT01610414|19036129|P1|Month 13 - Month 25|Other reasons for withdrawal|6
5505743|NCT01610414|19036128|P2|Month 13 - Month 25|Lost to Follow-up|9
5505744|NCT01610414|19036129|P1|Month 13 - Month 25|Lost to Follow-up|5
5505745|NCT01610414|19036128|P2|Month 13 - Month 25|Protocol Violation|2
5505746|NCT01610414|19036129|P1|Month 13 - Month 25|Protocol Violation|0
5505747|NCT01610414|19036128|P2|Month 13 - Month 25|Migrated/moved from study area|2
5505748|NCT01610414|19036129|P1|Month 13 - Month 25|Migrated/moved from study area|4
5505749|NCT01610414|19036128|P2|Month 13 - Month 25|Withdrawal by Subject|8
5505750|NCT01610414|19036129|P1|Month 13 - Month 25|Withdrawal by Subject|7
5505751|NCT01610414|19036128|P2|Month 13 - Month 25|Adverse Event|4
5505752|NCT01610414|19036129|P1|Month 13 - Month 25|Adverse Event|8
5505753|NCT01610414|19036128|P2|Month 13 - Month 25|Serious Adverse Event|38
5505754|NCT01610414|19036129|P1|Month 13 - Month 25|Serious Adverse Event|35
5505755|NCT01610414|19036128|P2|Study Start - Month 13|Other reasons for withdrawal|4
5505756|NCT01610414|19036129|P1|Study Start - Month 13|Other reasons for withdrawal|3
5505757|NCT01610414|19036128|P2|Study Start - Month 13|Suspected HZ episode|3
5505758|NCT01610414|19036129|P1|Study Start - Month 13|Suspected HZ episode|1
5505759|NCT01610414|19036128|P2|Study Start - Month 13|Lost to Follow-up|6
5505760|NCT01610414|19036129|P1|Study Start - Month 13|Lost to Follow-up|4
5505761|NCT01610414|19036128|P2|Study Start - Month 13|Migrated/moved from study area|4
5505762|NCT01610414|19036129|P1|Study Start - Month 13|Migrated/moved from study area|2
5505763|NCT01610414|19036128|P2|Study Start - Month 13|Withdrawal by Subject|30
5505764|NCT01610414|19036129|P1|Study Start - Month 13|Withdrawal by Subject|23
5505765|NCT01610414|19036128|P2|Study Start - Month 13|Protocol Violation|1
5505766|NCT01610414|19036129|P1|Study Start - Month 13|Protocol Violation|3
5505767|NCT01610414|19036128|P2|Study Start - Month 13|Adverse Event|14
5505768|NCT01610414|19036129|P1|Study Start - Month 13|Adverse Event|14
5505769|NCT01610414|19036128|P2|Study Start - Month 13|Serious Adverse Event|67
5505770|NCT01610414|19036129|P1|Study Start - Month 13|Serious Adverse Event|65
5505771|NCT01610297|19036158|P1|Overall Study|Lost to Follow-up|1
5505772|NCT01610284|19036168|P2|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
5505773|NCT01610284|19036169|P1|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
5505774|NCT01610284|19036168|P2|Post-Treatment Efficacy Follow-Up Phase|Death|4
5505775|NCT01610284|19036169|P1|Post-Treatment Efficacy Follow-Up Phase|Death|4
5505776|NCT01610284|19036168|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
5505777|NCT01610284|19036169|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
5505778|NCT01610284|19036168|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
5505779|NCT01610284|19036169|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
5505780|NCT01610284|19036168|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
5505781|NCT01610284|19036169|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
5505782|NCT01610284|19036168|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
5505783|NCT01610284|19036169|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
5505784|NCT01610284|19036168|P2|Treatment Phase|Death|5
5505785|NCT01610284|19036169|P1|Treatment Phase|Death|6
5505786|NCT01610284|19036168|P2|Treatment Phase|Subject/Guardian Decision|23
5505787|NCT01610284|19036169|P1|Treatment Phase|Subject/Guardian Decision|55
5505788|NCT01610284|19036168|P2|Treatment Phase|Study terminated by Sponsor|15
5505789|NCT01610284|19036169|P1|Treatment Phase|Study terminated by Sponsor|18
5505790|NCT01610284|19036168|P2|Treatment Phase|Protocol Deviation|3
5505791|NCT01610284|19036169|P1|Treatment Phase|Protocol Deviation|2
5505792|NCT01610284|19036168|P2|Treatment Phase|Progressive Disease|486
5505793|NCT01610284|19036169|P1|Treatment Phase|Progressive Disease|377
5505794|NCT01610284|19036168|P2|Treatment Phase|Physician Decision|24
5505795|NCT01610284|19036169|P1|Treatment Phase|Physician Decision|27
5505796|NCT01610284|19036168|P2|Treatment Phase|Non-compliance with Study Treatment|1
5505797|NCT01610284|19036169|P1|Treatment Phase|Non-compliance with Study Treatment|8
5505798|NCT01610284|19036168|P2|Treatment Phase|Lost to Follow-up|0
5505799|NCT01610284|19036169|P1|Treatment Phase|Lost to Follow-up|1
5505800|NCT01610284|19036168|P2|Treatment Phase|Adverse Event|12
5505801|NCT01610284|19036169|P1|Treatment Phase|Adverse Event|80
5505802|NCT01610284|19036168|P2|Randomization Phase|Death|1
5505803|NCT01610284|19036169|P1|Randomization Phase|Death|0
5505804|NCT01610284|19036168|P2|Randomization Phase|Physician Decision|1
5505805|NCT01610284|19036169|P1|Randomization Phase|Physician Decision|1
5505806|NCT01610284|19036168|P2|Randomization Phase|Adverse Event|0
5505807|NCT01610284|19036169|P1|Randomization Phase|Adverse Event|1
5505808|NCT01610271|19036191|P2|Overall Study|Prosthesis not implanted|3
5505809|NCT01610271|19036192|P1|Overall Study|Prosthesis not implanted|2
5505810|NCT01610271|19036191|P2|Overall Study|Surgery not complete|1
5505811|NCT01610271|19036192|P1|Overall Study|Surgery not complete|0
5505812|NCT01610167|19036207|P3|Overall Study|Scheduling conflict.|2
5505813|NCT01610167|19036208|P2|Overall Study|Scheduling conflict.|0
5505814|NCT01610167|19036209|P1|Overall Study|Scheduling conflict.|0
5505815|NCT01610076|19036246|P2|Overall Study|Lost to Follow-up|4
5505816|NCT01610076|19036247|P1|Overall Study|Lost to Follow-up|3
5505817|NCT01610076|19036246|P2|Overall Study|Technical issue with video|1
5505818|NCT01610076|19036247|P1|Overall Study|Technical issue with video|0
5505819|NCT01610063|19036258|P2|Overall Study|Lost to Follow-up|20
5505820|NCT01610063|19036259|P1|Overall Study|Lost to Follow-up|42
5505821|NCT01610037|19036282|P3|Treatment and Follow up Period|Lost to Follow-up|4
5505822|NCT01610037|19036283|P2|Treatment and Follow up Period|Lost to Follow-up|6
5505823|NCT01610037|19036284|P1|Treatment and Follow up Period|Lost to Follow-up|1
5505824|NCT01610037|19036282|P3|Treatment and Follow up Period|Administrative problems|2
5505825|NCT01610037|19036283|P2|Treatment and Follow up Period|Administrative problems|3
5505826|NCT01610037|19036284|P1|Treatment and Follow up Period|Administrative problems|1
5505827|NCT01610037|19036282|P3|Treatment and Follow up Period|Death|4
5505828|NCT01610037|19036283|P2|Treatment and Follow up Period|Death|5
5505829|NCT01610037|19036284|P1|Treatment and Follow up Period|Death|10
5505830|NCT01610037|19036282|P3|Treatment and Follow up Period|Subject withdrew consent|16
5505831|NCT01610037|19036283|P2|Treatment and Follow up Period|Subject withdrew consent|14
5505832|NCT01610037|19036284|P1|Treatment and Follow up Period|Subject withdrew consent|13
5505833|NCT01610037|19036282|P3|All Patients|Abnormal test procedure result(s)|3
5505834|NCT01610037|19036283|P2|All Patients|Abnormal test procedure result(s)|1
5505835|NCT01610037|19036284|P1|All Patients|Abnormal test procedure result(s)|0
5505836|NCT01610037|19036282|P3|All Patients|Lost to Follow-up|0
5505837|NCT01610037|19036283|P2|All Patients|Lost to Follow-up|0
5505838|NCT01610037|19036284|P1|All Patients|Lost to Follow-up|1
5505839|NCT01610037|19036282|P3|All Patients|Administrative problems|4
5505840|NCT01610037|19036283|P2|All Patients|Administrative problems|4
5505841|NCT01610037|19036284|P1|All Patients|Administrative problems|1
5505842|NCT01610037|19036282|P3|All Patients|Abnormal laboratory value|0
5505843|NCT01610037|19036283|P2|All Patients|Abnormal laboratory value|1
5505844|NCT01610037|19036284|P1|All Patients|Abnormal laboratory value|1
5505845|NCT01610037|19036282|P3|All Patients|Protocol deviation|3
5505846|NCT01610037|19036283|P2|All Patients|Protocol deviation|3
5505847|NCT01610037|19036284|P1|All Patients|Protocol deviation|4
5505848|NCT01610037|19036282|P3|All Patients|Death|1
5505849|NCT01610037|19036283|P2|All Patients|Death|2
5505850|NCT01610037|19036284|P1|All Patients|Death|4
5505851|NCT01610037|19036282|P3|All Patients|Unsatisfactory therapeutic effect|27
5505852|NCT01610037|19036283|P2|All Patients|Unsatisfactory therapeutic effect|8
5505853|NCT01610037|19036284|P1|All Patients|Unsatisfactory therapeutic effect|9
5505854|NCT01610037|19036282|P3|All Patients|Withdrawal by Subject|20
5505855|NCT01610037|19036283|P2|All Patients|Withdrawal by Subject|10
5505856|NCT01610037|19036284|P1|All Patients|Withdrawal by Subject|12
5505857|NCT01610037|19036282|P3|All Patients|Adverse Event|26
5505858|NCT01610037|19036283|P2|All Patients|Adverse Event|22
5505859|NCT01610037|19036284|P1|All Patients|Adverse Event|27
5505860|NCT01609933|19036334|P1|Overall Study|Withdrawal by Subject|3
5505861|NCT01609933|19036334|P1|Overall Study|Adverse Event|1
5505862|NCT01609842|19036345|P2|Concurrent Intervention Control|pharmacy data not available|0
5505863|NCT01609842|19036346|P1|Concurrent Intervention Control|pharmacy data not available|2
5505864|NCT01609790|19036373|P3|Overall Study|Protocol Violation|8
5505865|NCT01609790|19036374|P2|Overall Study|Protocol Violation|7
5505866|NCT01609790|19036375|P1|Overall Study|Protocol Violation|1
5505867|NCT01609582|19036394|P2|Overall Study|Randomized, but not treated|3
5505868|NCT01609582|19036395|P1|Overall Study|Randomized, but not treated|0
5505869|NCT01609582|19036394|P2|Overall Study|Other|10
5505870|NCT01609582|19036395|P1|Overall Study|Other|9
5505871|NCT01609582|19036394|P2|Overall Study|Study Terminated by Sponsor|1548
5505872|NCT01609582|19036395|P1|Overall Study|Study Terminated by Sponsor|1543
5505873|NCT01609582|19036394|P2|Overall Study|Withdrawal by Subject|15
5505874|NCT01609582|19036395|P1|Overall Study|Withdrawal by Subject|21
5505875|NCT01609582|19036394|P2|Overall Study|Lost to Follow-up|10
5505876|NCT01609582|19036395|P1|Overall Study|Lost to Follow-up|10
5505877|NCT01609582|19036394|P2|Overall Study|Adverse Event|18
5505878|NCT01609582|19036395|P1|Overall Study|Adverse Event|20
5505879|NCT01609543|19036403|P1|Overall Study|Death|7
5505880|NCT01609543|19036403|P1|Overall Study|Protocol Violation|1
5505881|NCT01609543|19036403|P1|Overall Study|Withdrawal by Subject|1
5505882|NCT01609543|19036403|P1|Overall Study|Adverse Event|5
5505883|NCT01609543|19036403|P1|Overall Study|Disease Progression|28
5505884|NCT01609478|19036412|P3|Overall Study|Withdrawal by Subject|2
5505885|NCT01609478|19036413|P2|Overall Study|Withdrawal by Subject|0
5505886|NCT01609478|19036414|P1|Overall Study|Withdrawal by Subject|2
5505887|NCT01609478|19036412|P3|Overall Study|Physician Decision|1
5505888|NCT01609478|19036413|P2|Overall Study|Physician Decision|0
5505889|NCT01609478|19036414|P1|Overall Study|Physician Decision|1
5505890|NCT01609478|19036412|P3|Overall Study|Non-Compliance with study treatment|0
5505891|NCT01609478|19036413|P2|Overall Study|Non-Compliance with study treatment|0
5505892|NCT01609478|19036414|P1|Overall Study|Non-Compliance with study treatment|1
5505893|NCT01609478|19036412|P3|Overall Study|Protocol Deviation|1
5505894|NCT01609478|19036413|P2|Overall Study|Protocol Deviation|1
5505895|NCT01609478|19036414|P1|Overall Study|Protocol Deviation|0
5505896|NCT01609478|19036412|P3|Overall Study|Adverse Event|5
5505897|NCT01609478|19036413|P2|Overall Study|Adverse Event|1
5505898|NCT01609478|19036414|P1|Overall Study|Adverse Event|3
5505899|NCT01609296|19036487|P1|Overall Study|Withdrawal by Subject|71
5505900|NCT01609296|19036487|P1|Overall Study|Death|49
5505901|NCT01609257|19036500|P2|Overall Study|Non-compliance/Protocol deviation|6
5505902|NCT01609257|19036501|P1|Overall Study|Non-compliance/Protocol deviation|4
5505903|NCT01609257|19036500|P2|Overall Study|Voluntary Withdrawal by Subject|1
5505904|NCT01609257|19036501|P1|Overall Study|Voluntary Withdrawal by Subject|0
5505905|NCT01609257|19036500|P2|Overall Study|Lost to Follow-up|1
5505906|NCT01609257|19036501|P1|Overall Study|Lost to Follow-up|2
5505907|NCT01609231|19036573|P2|Overall Study|Withdrawal by Subject|0
5505908|NCT01609231|19036574|P1|Overall Study|Withdrawal by Subject|1
5505909|NCT01609231|19036573|P2|Overall Study|Physician Decision|0
5505910|NCT01609231|19036574|P1|Overall Study|Physician Decision|1
5505911|NCT01609231|19036573|P2|Overall Study|Adverse Event|3
5505912|NCT01609231|19036574|P1|Overall Study|Adverse Event|1
5505913|NCT01609062|19036584|P2|Extension Phase|Anticipated surgery & transition to EAP|1
5505914|NCT01609062|19036585|P1|Extension Phase|Anticipated surgery & transition to EAP|0
5505915|NCT01609062|19036584|P2|Extension Phase|Discontinued drug and then was pregnant|0
5505916|NCT01609062|19036585|P1|Extension Phase|Discontinued drug and then was pregnant|1
5505917|NCT01609062|19036584|P2|Extension Phase|Terminated by Sponsor|9
5505918|NCT01609062|19036585|P1|Extension Phase|Terminated by Sponsor|14
5505919|NCT01609023|19036628|P1|Overall Study|Personal reasons|1
5505920|NCT01609023|19036628|P1|Overall Study|Death|2
5505921|NCT01609023|19036628|P1|Overall Study|Physician Decision|2
5505922|NCT01609023|19036628|P1|Overall Study|Disease progression|10
5505923|NCT01609023|19036628|P1|Overall Study|Toxicity|3
5505924|NCT01609023|19036628|P1|Overall Study|Lost to Follow-up|8
5505925|NCT01609023|19036628|P1|Overall Study|Withdrawal by Subject|4
5505926|NCT01609023|19036628|P1|Overall Study|Lack of Efficacy|3
5505927|NCT01609010|19036640|P2|Overall Study|Lost to Follow-up|1
5505928|NCT01609010|19036641|P1|Overall Study|Lost to Follow-up|1
5505929|NCT01609010|19036640|P2|Overall Study|New cancer|0
5505930|NCT01609010|19036641|P1|Overall Study|New cancer|1
5505931|NCT01609010|19036640|P2|Overall Study|Protocol Violation|1
5505932|NCT01609010|19036641|P1|Overall Study|Protocol Violation|1
5505933|NCT01609010|19036640|P2|Overall Study|Pathology review|1
5505934|NCT01609010|19036641|P1|Overall Study|Pathology review|2
5505935|NCT01609010|19036640|P2|Overall Study|Other malignancy|0
5505936|NCT01609010|19036641|P1|Overall Study|Other malignancy|1
5505937|NCT01609010|19036640|P2|Overall Study|Other|0
5505938|NCT01609010|19036641|P1|Overall Study|Other|2
5505939|NCT01609010|19036640|P2|Overall Study|Withdrawal by Subject|2
5505940|NCT01609010|19036641|P1|Overall Study|Withdrawal by Subject|2
5505941|NCT01609010|19036640|P2|Overall Study|Adverse Event|6
5505942|NCT01609010|19036641|P1|Overall Study|Adverse Event|3
5505943|NCT01609010|19036640|P2|Overall Study|Progressive disease (PD)|10
5505944|NCT01609010|19036641|P1|Overall Study|Progressive disease (PD)|8
5505945|NCT01609010|19036640|P2|Overall Study|Stable disease (SD)|16
5505946|NCT01609010|19036641|P1|Overall Study|Stable disease (SD)|22
5505947|NCT01608724|19036702|P1|Overall Study|Safety reasons|1
5505948|NCT01608724|19036702|P1|Overall Study|bood sugar too high, etc.|3
5505949|NCT01608724|19036702|P1|Overall Study|Protocol Violation|6
5505950|NCT01608724|19036702|P1|Overall Study|Adverse Event|29
5505951|NCT01608724|19036702|P1|Overall Study|Study-specific discontinuation criteria|32
5505952|NCT01608724|19036702|P1|Overall Study|Lost to Follow-up|41
5505953|NCT01608724|19036702|P1|Overall Study|Withdrawal by Subject|131
5505954|NCT01608321|19036744|P2|Overall Study|Withdrawal by Subject|0
5505955|NCT01608321|19036745|P1|Overall Study|Withdrawal by Subject|1
5505956|NCT01608308|19036753|P2|Overall Study|pretreatment medical and billing reasons|2
5505957|NCT01608308|19036754|P1|Overall Study|pretreatment medical and billing reasons|0
5505958|NCT01608087|19036817|P3|Overall Study|Other Reason|0
5505959|NCT01608087|19036818|P2|Overall Study|Other Reason|1
5505960|NCT01608087|19036819|P1|Overall Study|Other Reason|0
5505961|NCT01608087|19036817|P3|Overall Study|Lost to Follow-up|0
5505962|NCT01608087|19036818|P2|Overall Study|Lost to Follow-up|1
5505963|NCT01608087|19036819|P1|Overall Study|Lost to Follow-up|0
5505964|NCT01607957|19036849|P2|Overall Study|Participant refusal|0
5505965|NCT01607957|19036850|P1|Overall Study|Participant refusal|1
5505966|NCT01607957|19036849|P2|Overall Study|Lost to Follow-up|3
5505967|NCT01607957|19036850|P1|Overall Study|Lost to Follow-up|3
5505968|NCT01607957|19036849|P2|Overall Study|Death|211
5505969|NCT01607957|19036850|P1|Overall Study|Death|367
5505970|NCT01607957|19036849|P2|Overall Study|Not treated|1
5505971|NCT01607957|19036850|P1|Overall Study|Not treated|1
5505972|NCT01607593|19037029|P1|Overall Study|Other|4
5505973|NCT01607593|19037029|P1|Overall Study|Continuation|33
5505974|NCT01607593|19037029|P1|Overall Study|Lost to Follow-up|25
5505975|NCT01607593|19037029|P1|Overall Study|Lack of Efficacy|16
5505976|NCT01607593|19037029|P1|Overall Study|Adverse Event|15
5505977|NCT01607554|19037035|P1|Overall Study|Disease progression|2
5505978|NCT01607476|19037048|P3|Overall Study|Lost to Follow-up|2
5505979|NCT01607476|19037049|P2|Overall Study|Lost to Follow-up|0
5505980|NCT01607476|19037050|P1|Overall Study|Lost to Follow-up|0
5505981|NCT01607476|19037048|P3|Overall Study|Withdrawal by Subject|1
5505982|NCT01607476|19037049|P2|Overall Study|Withdrawal by Subject|0
5505983|NCT01607476|19037050|P1|Overall Study|Withdrawal by Subject|1
5505984|NCT01607398|19037144|P2|Overall Study|Severe COPD|0
5505985|NCT01607398|19037145|P1|Overall Study|Severe COPD|2
5505986|NCT01607398|19037144|P2|Overall Study|Adverse Event|2
5505987|NCT01607398|19037145|P1|Overall Study|Adverse Event|0
5505988|NCT01607346|19037189|P1|Overall Study|Adverse Event|3
5505989|NCT01606800|19037287|P2|Overall Study|Missing completion status|0
5505990|NCT01606800|19037288|P1|Overall Study|Missing completion status|2
5505991|NCT01606800|19037287|P2|Overall Study|Participant withdrew consent|1
5505992|NCT01606800|19037288|P1|Overall Study|Participant withdrew consent|0
5505993|NCT01606800|19037287|P2|Overall Study|Adverse Event|1
5505994|NCT01606800|19037288|P1|Overall Study|Adverse Event|3
5505995|NCT01606787|19037296|P2|Overall Study|Surgery canceled|2
5505996|NCT01606787|19037297|P1|Overall Study|Surgery canceled|0
5505997|NCT01606787|19037296|P2|Overall Study|Withdrawal by Subject|5
5505998|NCT01606787|19037297|P1|Overall Study|Withdrawal by Subject|4
5505999|NCT01606761|19037308|P5|Safety Follow-up Period (Week 52-68)|Other|3
5506000|NCT01606761|19037309|P4|Safety Follow-up Period (Week 52-68)|Other|1
5506001|NCT01606761|19037310|P3|Safety Follow-up Period (Week 52-68)|Other|9
5506002|NCT01606761|19037311|P2|Safety Follow-up Period (Week 52-68)|Other|3
5506003|NCT01606761|19037312|P1|Safety Follow-up Period (Week 52-68)|Other|0
5506004|NCT01606761|19037308|P5|Safety Follow-up Period (Week 52-68)|Death|1
5506005|NCT01606761|19037309|P4|Safety Follow-up Period (Week 52-68)|Death|0
5506006|NCT01606761|19037310|P3|Safety Follow-up Period (Week 52-68)|Death|0
5506007|NCT01606761|19037311|P2|Safety Follow-up Period (Week 52-68)|Death|0
5506008|NCT01606761|19037312|P1|Safety Follow-up Period (Week 52-68)|Death|0
5506009|NCT01606761|19037308|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
5506010|NCT01606761|19037309|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
5506011|NCT01606761|19037310|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
5506012|NCT01606761|19037311|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
5506013|NCT01606761|19037312|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
5506014|NCT01606761|19037308|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
5506015|NCT01606761|19037309|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
5506016|NCT01606761|19037310|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
5506017|NCT01606761|19037311|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
5506018|NCT01606761|19037312|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
5506019|NCT01606761|19037308|P5|Week 24 to Week 52|Other|2
5506020|NCT01606761|19037309|P4|Week 24 to Week 52|Other|2
5506021|NCT01606761|19037310|P3|Week 24 to Week 52|Other|5
5506022|NCT01606761|19037311|P2|Week 24 to Week 52|Other|1
5506023|NCT01606761|19037312|P1|Week 24 to Week 52|Other|0
5506024|NCT01606761|19037308|P5|Week 24 to Week 52|Physician Decision|0
5506025|NCT01606761|19037309|P4|Week 24 to Week 52|Physician Decision|0
5506026|NCT01606761|19037310|P3|Week 24 to Week 52|Physician Decision|1
5506027|NCT01606761|19037311|P2|Week 24 to Week 52|Physician Decision|1
5506028|NCT01606761|19037312|P1|Week 24 to Week 52|Physician Decision|0
5506029|NCT01606761|19037308|P5|Week 24 to Week 52|Lack of Efficacy|3
5506030|NCT01606761|19037309|P4|Week 24 to Week 52|Lack of Efficacy|10
5506031|NCT01606761|19037310|P3|Week 24 to Week 52|Lack of Efficacy|7
5506032|NCT01606761|19037311|P2|Week 24 to Week 52|Lack of Efficacy|13
5506033|NCT01606761|19037312|P1|Week 24 to Week 52|Lack of Efficacy|0
5506034|NCT01606761|19037308|P5|Week 24 to Week 52|Death|0
5506035|NCT01606761|19037309|P4|Week 24 to Week 52|Death|1
5506036|NCT01606761|19037310|P3|Week 24 to Week 52|Death|2
5506037|NCT01606761|19037311|P2|Week 24 to Week 52|Death|0
5506038|NCT01606761|19037312|P1|Week 24 to Week 52|Death|0
5506039|NCT01606761|19037308|P5|Week 24 to Week 52|Adverse Event|15
5506040|NCT01606761|19037309|P4|Week 24 to Week 52|Adverse Event|3
5506041|NCT01606761|19037310|P3|Week 24 to Week 52|Adverse Event|14
5506042|NCT01606761|19037311|P2|Week 24 to Week 52|Adverse Event|11
5506043|NCT01606761|19037312|P1|Week 24 to Week 52|Adverse Event|0
5506044|NCT01606761|19037308|P5|Week 24 to Week 52|Withdrawal by Subject|0
5506045|NCT01606761|19037309|P4|Week 24 to Week 52|Withdrawal by Subject|0
5506046|NCT01606761|19037310|P3|Week 24 to Week 52|Withdrawal by Subject|3
5506047|NCT01606761|19037311|P2|Week 24 to Week 52|Withdrawal by Subject|6
5506048|NCT01606761|19037312|P1|Week 24 to Week 52|Withdrawal by Subject|0
5506049|NCT01606761|19037308|P5|Week 24 to Week 52|Lost to Follow-up|0
5506050|NCT01606761|19037309|P4|Week 24 to Week 52|Lost to Follow-up|1
5506051|NCT01606761|19037310|P3|Week 24 to Week 52|Lost to Follow-up|1
5506052|NCT01606761|19037311|P2|Week 24 to Week 52|Lost to Follow-up|1
5506053|NCT01606761|19037312|P1|Week 24 to Week 52|Lost to Follow-up|0
5506054|NCT01606761|19037308|P5|Prior to Week 24|Other|0
5506055|NCT01606761|19037309|P4|Prior to Week 24|Other|0
5506056|NCT01606761|19037310|P3|Prior to Week 24|Other|5
5506057|NCT01606761|19037311|P2|Prior to Week 24|Other|7
5506058|NCT01606761|19037312|P1|Prior to Week 24|Other|4
5506059|NCT01606761|19037308|P5|Prior to Week 24|Physician Decision|0
5506060|NCT01606761|19037309|P4|Prior to Week 24|Physician Decision|0
5506061|NCT01606761|19037310|P3|Prior to Week 24|Physician Decision|1
5506062|NCT01606761|19037311|P2|Prior to Week 24|Physician Decision|3
5506063|NCT01606761|19037312|P1|Prior to Week 24|Physician Decision|0
5506064|NCT01606761|19037308|P5|Prior to Week 24|Lack of Efficacy|0
5506065|NCT01606761|19037309|P4|Prior to Week 24|Lack of Efficacy|0
5506066|NCT01606761|19037310|P3|Prior to Week 24|Lack of Efficacy|8
5506067|NCT01606761|19037311|P2|Prior to Week 24|Lack of Efficacy|14
5506068|NCT01606761|19037312|P1|Prior to Week 24|Lack of Efficacy|15
5506069|NCT01606761|19037308|P5|Prior to Week 24|Adverse Event|0
5506070|NCT01606761|19037309|P4|Prior to Week 24|Adverse Event|0
5506071|NCT01606761|19037310|P3|Prior to Week 24|Adverse Event|22
5506072|NCT01606761|19037311|P2|Prior to Week 24|Adverse Event|18
5506073|NCT01606761|19037312|P1|Prior to Week 24|Adverse Event|11
5506074|NCT01606761|19037308|P5|Prior to Week 24|Withdrawal by Subject|0
5506075|NCT01606761|19037309|P4|Prior to Week 24|Withdrawal by Subject|0
5506076|NCT01606761|19037310|P3|Prior to Week 24|Withdrawal by Subject|9
5506077|NCT01606761|19037311|P2|Prior to Week 24|Withdrawal by Subject|10
5506078|NCT01606761|19037312|P1|Prior to Week 24|Withdrawal by Subject|12
5506079|NCT01606761|19037308|P5|Prior to Week 24|Lost to Follow-up|0
5506080|NCT01606761|19037309|P4|Prior to Week 24|Lost to Follow-up|0
5506081|NCT01606761|19037310|P3|Prior to Week 24|Lost to Follow-up|2
5506082|NCT01606761|19037311|P2|Prior to Week 24|Lost to Follow-up|3
5506083|NCT01606761|19037312|P1|Prior to Week 24|Lost to Follow-up|0
5506084|NCT01606748|19037338|P2|Overall Study|Withdrawal by Subject|0
5506085|NCT01606748|19037339|P1|Overall Study|Withdrawal by Subject|1
5506086|NCT01606748|19037338|P2|Overall Study|Progressive Disease|0
5506087|NCT01606748|19037339|P1|Overall Study|Progressive Disease|1
5506088|NCT01606748|19037338|P2|Overall Study|Adverse Event|0
5506089|NCT01606748|19037339|P1|Overall Study|Adverse Event|1
5506090|NCT01606670|19037391|P1|Overall Study|Other Reason|2
5506091|NCT01606670|19037391|P1|Overall Study|Withdrawal by Subject|3
5506092|NCT01606670|19037391|P1|Overall Study|Lost to Follow-up|3
5506093|NCT01606670|19037391|P1|Overall Study|Lack of Efficacy|2
5506094|NCT01606670|19037391|P1|Overall Study|Adverse Event|6
5506095|NCT01606319|19037401|P2|Overall Study|Adverse Event|4
5506096|NCT01606319|19037402|P1|Overall Study|Adverse Event|1
5506097|NCT01606319|19037401|P2|Overall Study|Lack of Efficacy|8
5506098|NCT01606319|19037402|P1|Overall Study|Lack of Efficacy|6
5506099|NCT01606319|19037401|P2|Overall Study|Physician Decision|2
5506100|NCT01606319|19037402|P1|Overall Study|Physician Decision|1
5506101|NCT01606319|19037401|P2|Overall Study|Withdrawal by Subject|12
5506102|NCT01606319|19037402|P1|Overall Study|Withdrawal by Subject|9
5506103|NCT01606319|19037401|P2|Overall Study|Lost to Follow-up|14
5506104|NCT01606319|19037402|P1|Overall Study|Lost to Follow-up|17
5506105|NCT01606306|19037420|P6|Overall Study|Physician Decision|0
5506106|NCT01606306|19037421|P5|Overall Study|Physician Decision|0
5506107|NCT01606306|19037422|P4|Overall Study|Physician Decision|0
5506108|NCT01606306|19037423|P3|Overall Study|Physician Decision|0
5506109|NCT01606306|19037424|P2|Overall Study|Physician Decision|2
5506110|NCT01606306|19037425|P1|Overall Study|Physician Decision|1
5506111|NCT01606306|19037420|P6|Overall Study|Withdrawal by Subject|4
5506112|NCT01606306|19037421|P5|Overall Study|Withdrawal by Subject|5
5506113|NCT01606306|19037422|P4|Overall Study|Withdrawal by Subject|4
5506114|NCT01606306|19037423|P3|Overall Study|Withdrawal by Subject|4
5506115|NCT01606306|19037424|P2|Overall Study|Withdrawal by Subject|3
5506116|NCT01606306|19037425|P1|Overall Study|Withdrawal by Subject|4
5506117|NCT01606306|19037420|P6|Overall Study|Lost to Follow-up|5
5506118|NCT01606306|19037421|P5|Overall Study|Lost to Follow-up|3
5506119|NCT01606306|19037422|P4|Overall Study|Lost to Follow-up|4
5506120|NCT01606306|19037423|P3|Overall Study|Lost to Follow-up|5
5506121|NCT01606306|19037424|P2|Overall Study|Lost to Follow-up|4
5506122|NCT01606306|19037425|P1|Overall Study|Lost to Follow-up|7
5506123|NCT01606306|19037420|P6|Overall Study|Adverse Event|0
5506124|NCT01606306|19037421|P5|Overall Study|Adverse Event|2
5506125|NCT01606306|19037422|P4|Overall Study|Adverse Event|1
5506126|NCT01606306|19037423|P3|Overall Study|Adverse Event|1
5506127|NCT01606306|19037424|P2|Overall Study|Adverse Event|0
5506128|NCT01606306|19037425|P1|Overall Study|Adverse Event|1
5506129|NCT01606306|19037420|P6|Overall Study|Lack of Efficacy|2
5506130|NCT01606306|19037421|P5|Overall Study|Lack of Efficacy|1
5506131|NCT01606306|19037422|P4|Overall Study|Lack of Efficacy|4
5506132|NCT01606306|19037423|P3|Overall Study|Lack of Efficacy|4
5506133|NCT01606306|19037424|P2|Overall Study|Lack of Efficacy|1
5506134|NCT01606306|19037425|P1|Overall Study|Lack of Efficacy|2
5506135|NCT01606254|19037435|P4|Overall Study|Adverse Event|1
5506136|NCT01606254|19037436|P3|Overall Study|Adverse Event|0
5506137|NCT01606254|19037437|P2|Overall Study|Adverse Event|1
5506138|NCT01606254|19037438|P1|Overall Study|Adverse Event|1
5506139|NCT01606254|19037435|P4|Overall Study|Withdrawal by Subject|2
5506140|NCT01606254|19037436|P3|Overall Study|Withdrawal by Subject|0
5506141|NCT01606254|19037437|P2|Overall Study|Withdrawal by Subject|3
5506142|NCT01606254|19037438|P1|Overall Study|Withdrawal by Subject|1
5506143|NCT01606228|19037520|P1|Overall Study|Adverse Event|1
5506144|NCT01606228|19037520|P1|Overall Study|Lack of Efficacy|2
5506145|NCT01606228|19037520|P1|Overall Study|Non-compliant|3
5506146|NCT01606228|19037520|P1|Overall Study|Withdrawal by Subject|3
5506147|NCT01606228|19037520|P1|Overall Study|Lost to Follow-up|20
5506148|NCT01606202|19037537|P2|Overall Study|Problems with administration|1
5506149|NCT01606202|19037538|P1|Overall Study|Problems with administration|0
5506150|NCT01606202|19037537|P2|Overall Study|Personal problems|1
5506151|NCT01606202|19037538|P1|Overall Study|Personal problems|0
5506152|NCT01606202|19037537|P2|Overall Study|Withdrawal by Subject|1
5506153|NCT01606202|19037538|P1|Overall Study|Withdrawal by Subject|2
5506154|NCT01606202|19037537|P2|Overall Study|Adverse Event|0
5506155|NCT01606202|19037538|P1|Overall Study|Adverse Event|5
5506156|NCT01606189|19037570|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
5506157|NCT01606189|19037571|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5506158|NCT01606189|19037572|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5506159|NCT01606189|19037573|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5506160|NCT01606189|19037574|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5506161|NCT01606189|19037575|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
5506162|NCT01606189|19037570|P6|Second Intenvention (14-20 Days)|Adverse Event|1
5506163|NCT01606189|19037571|P5|Second Intenvention (14-20 Days)|Adverse Event|0
5506164|NCT01606189|19037572|P4|Second Intenvention (14-20 Days)|Adverse Event|0
5506165|NCT01606189|19037573|P3|Second Intenvention (14-20 Days)|Adverse Event|0
5506166|NCT01606189|19037574|P2|Second Intenvention (14-20 Days)|Adverse Event|0
5506167|NCT01606189|19037575|P1|Second Intenvention (14-20 Days)|Adverse Event|0
5506168|NCT01606176|19037609|P2|Overall Study|Withdrawal by Subject|0
5506169|NCT01606176|19037610|P1|Overall Study|Withdrawal by Subject|1
5506170|NCT01606176|19037609|P2|Overall Study|Disease progression|0
5506171|NCT01606176|19037610|P1|Overall Study|Disease progression|1
5506172|NCT01606176|19037609|P2|Overall Study|Adverse Event|3
5506173|NCT01606176|19037610|P1|Overall Study|Adverse Event|2
5506174|NCT01606137|19037655|P1|Overall Study|Unable to collect consistent data|1
5506175|NCT01606137|19037655|P1|Overall Study|Patient moving|1
5506176|NCT01606137|19037655|P1|Overall Study|Unable to tolerate study med. taste|1
5506177|NCT01606137|19037655|P1|Overall Study|Personal reasons|1
5506178|NCT01606137|19037655|P1|Overall Study|Patient leaving country|1
5506179|NCT01606137|19037655|P1|Overall Study|Wanted to try another treatment|1
5506180|NCT01606137|19037655|P1|Overall Study|Not enough improvement|4
5506181|NCT01606137|19037655|P1|Overall Study|Spray causes nausea|1
5506182|NCT01606137|19037655|P1|Overall Study|Increased bilirubin|1
5506183|NCT01606137|19037655|P1|Overall Study|multiple sclerosis less stable|1
5506184|NCT01606137|19037655|P1|Overall Study|Issues with driving|4
5506185|NCT01606137|19037655|P1|Overall Study|Decreased/no pain|4
5506186|NCT01606137|19037655|P1|Overall Study|Death|1
5506187|NCT01606137|19037655|P1|Overall Study|Patient non-compliance|9
5506188|NCT01606137|19037655|P1|Overall Study|Protocol Violation|1
5506189|NCT01606137|19037655|P1|Overall Study|Lost to Follow-up|15
5506190|NCT01606137|19037655|P1|Overall Study|Lack of Efficacy|56
5506191|NCT01606137|19037655|P1|Overall Study|Withdrawal by Subject|74
5506192|NCT01606137|19037655|P1|Overall Study|Adverse Event|85
5506193|NCT01606007|19037689|P3|Overall Study|Poor/Non-compliance|0
5506194|NCT01606007|19037690|P2|Overall Study|Poor/Non-compliance|0
5506195|NCT01606007|19037691|P1|Overall Study|Poor/Non-compliance|1
5506196|NCT01606007|19037689|P3|Overall Study|Lost to Follow-up|5
5506197|NCT01606007|19037690|P2|Overall Study|Lost to Follow-up|8
5506198|NCT01606007|19037691|P1|Overall Study|Lost to Follow-up|6
5506199|NCT01606007|19037689|P3|Overall Study|discontinue study treatment|1
5506200|NCT01606007|19037690|P2|Overall Study|discontinue study treatment|2
5506201|NCT01606007|19037691|P1|Overall Study|discontinue study treatment|0
5506202|NCT01606007|19037689|P3|Overall Study|Adverse Event|1
5506203|NCT01606007|19037690|P2|Overall Study|Adverse Event|1
5506204|NCT01606007|19037691|P1|Overall Study|Adverse Event|0
5506205|NCT01606007|19037689|P3|Overall Study|Withdrawal by Subject|1
5506206|NCT01606007|19037690|P2|Overall Study|Withdrawal by Subject|6
5506207|NCT01606007|19037691|P1|Overall Study|Withdrawal by Subject|8
5506208|NCT01606007|19037689|P3|Overall Study|Pregnancy|1
5506209|NCT01606007|19037690|P2|Overall Study|Pregnancy|1
5506210|NCT01606007|19037691|P1|Overall Study|Pregnancy|0
5506211|NCT01606007|19037689|P3|Overall Study|Reason 'Other' in the protocol|1
5506212|NCT01606007|19037690|P2|Overall Study|Reason 'Other' in the protocol|1
5506213|NCT01606007|19037691|P1|Overall Study|Reason 'Other' in the protocol|0
5506214|NCT01605916|19037726|P5|Overall Study|Withdrawal by Subject|2
5506215|NCT01605916|19037727|P4|Overall Study|Withdrawal by Subject|0
5506216|NCT01605916|19037728|P3|Overall Study|Withdrawal by Subject|0
5506217|NCT01605916|19037729|P2|Overall Study|Withdrawal by Subject|1
5506218|NCT01605916|19037730|P1|Overall Study|Withdrawal by Subject|1
5506219|NCT01605916|19037726|P5|Overall Study|Lack of Efficacy|4
5506220|NCT01605916|19037727|P4|Overall Study|Lack of Efficacy|5
5506221|NCT01605916|19037728|P3|Overall Study|Lack of Efficacy|3
5506222|NCT01605916|19037729|P2|Overall Study|Lack of Efficacy|3
5506223|NCT01605916|19037730|P1|Overall Study|Lack of Efficacy|2
5506224|NCT01605916|19037726|P5|Overall Study|Adverse Event|0
5506225|NCT01605916|19037727|P4|Overall Study|Adverse Event|1
5506226|NCT01605916|19037728|P3|Overall Study|Adverse Event|0
5506227|NCT01605916|19037729|P2|Overall Study|Adverse Event|0
5506228|NCT01605916|19037730|P1|Overall Study|Adverse Event|1
5506229|NCT01605877|19037827|P1|Overall Study|Withdrawal by Subject|1
5506230|NCT01605825|19037891|P2|Overall Study|Non-Compliance with Protocol|0
5506231|NCT01605825|19037892|P1|Overall Study|Non-Compliance with Protocol|3
5506232|NCT01605825|19037891|P2|Overall Study|Non-Compliance -Investigational Drug|0
5506233|NCT01605825|19037892|P1|Overall Study|Non-Compliance -Investigational Drug|3
5506234|NCT01605825|19037891|P2|Overall Study|Withdrawal by Subject|1
5506235|NCT01605825|19037892|P1|Overall Study|Withdrawal by Subject|0
5506236|NCT01605825|19037891|P2|Overall Study|Adverse Event|2
5506237|NCT01605825|19037892|P1|Overall Study|Adverse Event|4
5506238|NCT01605799|19037900|P2|Overall Study|Withdrawal by Subject|1
5506239|NCT01605799|19037901|P1|Overall Study|Withdrawal by Subject|2
5506240|NCT01605617|19037916|P2|Washout Period of 4 Weeks|Study Terminated|1
5506241|NCT01605617|19037917|P1|Washout Period of 4 Weeks|Study Terminated|2
5506242|NCT01605617|19037916|P2|First Intervention|Adverse Event|1
5506243|NCT01605617|19037917|P1|First Intervention|Adverse Event|0
5506244|NCT01605461|19037976|P1|Overall Study|Withdrawal by Subject|1
5506245|NCT01605461|19037976|P1|Overall Study|Lost to Follow-up|3
5506246|NCT01605396|19038035|P2|Overall Study|Transfer Off Study|5
5506247|NCT01605396|19038036|P1|Overall Study|Transfer Off Study|4
5506248|NCT01605396|19038035|P2|Overall Study|Withdrawal by Subject|2
5506249|NCT01605396|19038036|P1|Overall Study|Withdrawal by Subject|4
5506250|NCT01605396|19038035|P2|Overall Study|Progressive Disease|27
5506251|NCT01605396|19038036|P1|Overall Study|Progressive Disease|23
5506252|NCT01605396|19038035|P2|Overall Study|Physician Decision|2
5506253|NCT01605396|19038036|P1|Overall Study|Physician Decision|2
5506254|NCT01605396|19038035|P2|Overall Study|Non-Compliance With Study Drug|1
5506255|NCT01605396|19038036|P1|Overall Study|Non-Compliance With Study Drug|1
5506256|NCT01605396|19038035|P2|Overall Study|Lost to Follow-up|0
5506257|NCT01605396|19038036|P1|Overall Study|Lost to Follow-up|1
5506258|NCT01605396|19038035|P2|Overall Study|Adverse Event|3
5506259|NCT01605396|19038036|P1|Overall Study|Adverse Event|5
5506260|NCT01605370|19038050|P2|Overall Study|Adverse Event|0
5506261|NCT01605370|19038051|P1|Overall Study|Adverse Event|1
5506262|NCT01605227|19038086|P2|Overall Study|Dose Held >6 weeks|1
5506263|NCT01605227|19038087|P1|Overall Study|Dose Held >6 weeks|0
5506264|NCT01605227|19038086|P2|Overall Study|Subject Decision|1
5506265|NCT01605227|19038087|P1|Overall Study|Subject Decision|0
5506266|NCT01605227|19038086|P2|Overall Study|Started New Therapy|0
5506267|NCT01605227|19038087|P1|Overall Study|Started New Therapy|1
5506268|NCT01605227|19038086|P2|Overall Study|Sponsor Decision|0
5506269|NCT01605227|19038087|P1|Overall Study|Sponsor Decision|2
5506270|NCT01605227|19038086|P2|Overall Study|Withdrawal by Subject|14
5506271|NCT01605227|19038087|P1|Overall Study|Withdrawal by Subject|18
5506272|NCT01605227|19038086|P2|Overall Study|Physician Decision|7
5506273|NCT01605227|19038087|P1|Overall Study|Physician Decision|9
5506274|NCT01605227|19038086|P2|Overall Study|Protocol Violation|0
5506275|NCT01605227|19038087|P1|Overall Study|Protocol Violation|1
5506276|NCT01605227|19038086|P2|Overall Study|Lost to Follow-up|0
5506277|NCT01605227|19038087|P1|Overall Study|Lost to Follow-up|1
5506278|NCT01605227|19038086|P2|Overall Study|Clinical Deterioration|133
5506279|NCT01605227|19038087|P1|Overall Study|Clinical Deterioration|227
5506280|NCT01605227|19038086|P2|Overall Study|Progressive Disease|128
5506281|NCT01605227|19038087|P1|Overall Study|Progressive Disease|132
5506282|NCT01605227|19038086|P2|Overall Study|Adverse Event|42
5506283|NCT01605227|19038087|P1|Overall Study|Adverse Event|228
5506284|NCT01605227|19038086|P2|Overall Study|Did not receive study treatment|3
5506285|NCT01605227|19038087|P1|Overall Study|Did not receive study treatment|2
5506286|NCT01605136|19038099|P2|Safety Follow-Up Period|Withdrawal by Subject|2
5506287|NCT01605136|19038100|P1|Safety Follow-Up Period|Withdrawal by Subject|1
5506288|NCT01605136|19038099|P2|Study Period|Lost to Follow-up|2
5506289|NCT01605136|19038100|P1|Study Period|Lost to Follow-up|0
5506290|NCT01605136|19038099|P2|Study Period|Physician Decision|1
5506291|NCT01605136|19038100|P1|Study Period|Physician Decision|1
5506292|NCT01605136|19038099|P2|Study Period|Withdrawal by Subject|0
5506293|NCT01605136|19038100|P1|Study Period|Withdrawal by Subject|2
5506294|NCT01605019|19038129|P2|Overall Study|pt did not meet transplant endpoint|0
5506295|NCT01605019|19038130|P1|Overall Study|pt did not meet transplant endpoint|3
5506296|NCT01604941|19038140|P6|Overall Study|Early Study Termination|0
5506297|NCT01604941|19038141|P5|Overall Study|Early Study Termination|0
5506298|NCT01604941|19038142|P4|Overall Study|Early Study Termination|3
5506299|NCT01604941|19038143|P3|Overall Study|Early Study Termination|3
5506300|NCT01604941|19038144|P2|Overall Study|Early Study Termination|2
5506301|NCT01604941|19038145|P1|Overall Study|Early Study Termination|9
5506302|NCT01604941|19038140|P6|Overall Study|Participant Decision|2
5506303|NCT01604941|19038141|P5|Overall Study|Participant Decision|0
5506304|NCT01604941|19038142|P4|Overall Study|Participant Decision|0
5506305|NCT01604941|19038143|P3|Overall Study|Participant Decision|0
5506306|NCT01604941|19038144|P2|Overall Study|Participant Decision|0
5506307|NCT01604941|19038145|P1|Overall Study|Participant Decision|0
5506308|NCT01604941|19038140|P6|Overall Study|Non-compliance|0
5506309|NCT01604941|19038141|P5|Overall Study|Non-compliance|0
5506310|NCT01604941|19038142|P4|Overall Study|Non-compliance|0
5506311|NCT01604941|19038143|P3|Overall Study|Non-compliance|0
5506312|NCT01604941|19038144|P2|Overall Study|Non-compliance|0
5506313|NCT01604941|19038145|P1|Overall Study|Non-compliance|1
5506314|NCT01604941|19038140|P6|Overall Study|Adverse Event|5
5506315|NCT01604941|19038141|P5|Overall Study|Adverse Event|1
5506316|NCT01604941|19038142|P4|Overall Study|Adverse Event|0
5506317|NCT01604941|19038143|P3|Overall Study|Adverse Event|0
5506318|NCT01604941|19038144|P2|Overall Study|Adverse Event|2
5506319|NCT01604941|19038145|P1|Overall Study|Adverse Event|1
5506320|NCT01604850|19038173|P2|Overall Study|Subject withdrew consent|0
5506321|NCT01604850|19038174|P1|Overall Study|Subject withdrew consent|1
5506322|NCT01604850|19038173|P2|Overall Study|Lost to Follow-up|0
5506323|NCT01604850|19038174|P1|Overall Study|Lost to Follow-up|1
5506324|NCT01604850|19038173|P2|Overall Study|Efficacy Failure|29
5506325|NCT01604850|19038174|P1|Overall Study|Efficacy Failure|50
5506326|NCT01604850|19038173|P2|Overall Study|Enrolled but never treated|1
5506327|NCT01604850|19038174|P1|Overall Study|Enrolled but never treated|0
5506328|NCT01604824|19038194|P6|Open-label Extension (OLE) Period|Refused to come into office|0
5506329|NCT01604824|19038195|P5|Open-label Extension (OLE) Period|Refused to come into office|1
5506330|NCT01604824|19038196|P4|Open-label Extension (OLE) Period|Refused to come into office|0
5506331|NCT01604824|19038197|P3|Open-label Extension (OLE) Period|Refused to come into office|0
5506332|NCT01604824|19038198|P2|Open-label Extension (OLE) Period|Refused to come into office|0
5506333|NCT01604824|19038199|P1|Open-label Extension (OLE) Period|Refused to come into office|0
5506334|NCT01604824|19038194|P6|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5506335|NCT01604824|19038195|P5|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
5506336|NCT01604824|19038196|P4|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5506420|NCT01604343|19038269|P1|Week 52 to Week 104|Adverse Event|0
5506337|NCT01604824|19038197|P3|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5506338|NCT01604824|19038198|P2|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5506339|NCT01604824|19038199|P1|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
5506340|NCT01604785|19038229|P2|Overall Study|Repeat Visits Not Included in Analysis|1
5506341|NCT01604785|19038230|P1|Overall Study|Repeat Visits Not Included in Analysis|7
5506342|NCT01604408|19038249|P2|Observation Period|Withdrawal by Subject|2
5506343|NCT01604408|19038250|P1|Observation Period|Withdrawal by Subject|0
5506344|NCT01604408|19038249|P2|Observation Period|Adverse Event|1
5506345|NCT01604408|19038250|P1|Observation Period|Adverse Event|1
5506346|NCT01604408|19038249|P2|Treatment Period 6|Sponsor decision|1
5506347|NCT01604408|19038250|P1|Treatment Period 6|Sponsor decision|0
5506348|NCT01604408|19038249|P2|Treatment Period 6|Adverse Event|0
5506349|NCT01604408|19038250|P1|Treatment Period 6|Adverse Event|2
5506350|NCT01604408|19038249|P2|Treatment Period 6|Lost to Follow-up|1
5506351|NCT01604408|19038250|P1|Treatment Period 6|Lost to Follow-up|0
5506352|NCT01604408|19038249|P2|Treatment Period 5|Adverse Event|0
5506353|NCT01604408|19038250|P1|Treatment Period 5|Adverse Event|4
5506354|NCT01604408|19038249|P2|Treatment Period 4|Adverse Event|1
5506355|NCT01604408|19038250|P1|Treatment Period 4|Adverse Event|0
5506356|NCT01604408|19038249|P2|Treatment Period 4|Withdrawal by Subject|1
5506357|NCT01604408|19038250|P1|Treatment Period 4|Withdrawal by Subject|2
5506358|NCT01604408|19038249|P2|Treatment Period 4|Death|0
5506359|NCT01604408|19038250|P1|Treatment Period 4|Death|1
5506360|NCT01604408|19038249|P2|Treatment Period 3|Sponsor Decision|0
5506361|NCT01604408|19038250|P1|Treatment Period 3|Sponsor Decision|1
5506362|NCT01604408|19038249|P2|Treatment Period 3|Withdrawal by Subject|1
5506363|NCT01604408|19038250|P1|Treatment Period 3|Withdrawal by Subject|3
5506364|NCT01604408|19038249|P2|Treatment Period 3|Adverse Event|3
5506365|NCT01604408|19038250|P1|Treatment Period 3|Adverse Event|0
5506366|NCT01604408|19038249|P2|Treatment Period 3|Protocol Violation|1
5506367|NCT01604408|19038250|P1|Treatment Period 3|Protocol Violation|1
5506368|NCT01604408|19038249|P2|Treatment Period 2|Adverse Event|1
5506369|NCT01604408|19038250|P1|Treatment Period 2|Adverse Event|0
5506370|NCT01604408|19038249|P2|Treatment Period 2|Protocol Violation|0
5506371|NCT01604408|19038250|P1|Treatment Period 2|Protocol Violation|1
5506372|NCT01604408|19038249|P2|Treatment Period 2|Withdrawal by Subject|1
5506373|NCT01604408|19038250|P1|Treatment Period 2|Withdrawal by Subject|1
5506374|NCT01604408|19038249|P2|Treatment Period 1|Protocol Violation|1
5506375|NCT01604408|19038250|P1|Treatment Period 1|Protocol Violation|0
5506376|NCT01604343|19038265|P5|Safety Follow-up Period (Week 104-120)|Other|14
5506377|NCT01604343|19038266|P4|Safety Follow-up Period (Week 104-120)|Other|6
5506378|NCT01604343|19038267|P3|Safety Follow-up Period (Week 104-120)|Other|20
5506379|NCT01604343|19038268|P2|Safety Follow-up Period (Week 104-120)|Other|2
5506380|NCT01604343|19038269|P1|Safety Follow-up Period (Week 104-120)|Other|15
5506381|NCT01604343|19038265|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
5506382|NCT01604343|19038266|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
5506383|NCT01604343|19038267|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
5506384|NCT01604343|19038268|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
5506385|NCT01604343|19038269|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
5506386|NCT01604343|19038265|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
5506387|NCT01604343|19038266|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
5506388|NCT01604343|19038267|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
5506389|NCT01604343|19038268|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
5506390|NCT01604343|19038269|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
5506391|NCT01604343|19038265|P5|Week 52 to Week 104|Other|3
5506392|NCT01604343|19038266|P4|Week 52 to Week 104|Other|6
5506393|NCT01604343|19038267|P3|Week 52 to Week 104|Other|11
5506394|NCT01604343|19038268|P2|Week 52 to Week 104|Other|11
5506395|NCT01604343|19038269|P1|Week 52 to Week 104|Other|0
5506396|NCT01604343|19038265|P5|Week 52 to Week 104|Pregnancy|1
5506397|NCT01604343|19038266|P4|Week 52 to Week 104|Pregnancy|2
5506398|NCT01604343|19038267|P3|Week 52 to Week 104|Pregnancy|1
5506399|NCT01604343|19038268|P2|Week 52 to Week 104|Pregnancy|0
5506400|NCT01604343|19038269|P1|Week 52 to Week 104|Pregnancy|0
5506401|NCT01604343|19038265|P5|Week 52 to Week 104|Physician Decision|2
5506402|NCT01604343|19038266|P4|Week 52 to Week 104|Physician Decision|0
5506403|NCT01604343|19038267|P3|Week 52 to Week 104|Physician Decision|0
5506404|NCT01604343|19038268|P2|Week 52 to Week 104|Physician Decision|1
5506405|NCT01604343|19038269|P1|Week 52 to Week 104|Physician Decision|0
5506406|NCT01604343|19038265|P5|Week 52 to Week 104|Lack of Efficacy|3
5506407|NCT01604343|19038266|P4|Week 52 to Week 104|Lack of Efficacy|2
5506408|NCT01604343|19038267|P3|Week 52 to Week 104|Lack of Efficacy|11
5506409|NCT01604343|19038268|P2|Week 52 to Week 104|Lack of Efficacy|6
5506410|NCT01604343|19038269|P1|Week 52 to Week 104|Lack of Efficacy|0
5506411|NCT01604343|19038265|P5|Week 52 to Week 104|Death|0
5506412|NCT01604343|19038266|P4|Week 52 to Week 104|Death|5
5506413|NCT01604343|19038267|P3|Week 52 to Week 104|Death|2
5506414|NCT01604343|19038268|P2|Week 52 to Week 104|Death|4
5506415|NCT01604343|19038269|P1|Week 52 to Week 104|Death|0
5506416|NCT01604343|19038265|P5|Week 52 to Week 104|Adverse Event|27
5506417|NCT01604343|19038266|P4|Week 52 to Week 104|Adverse Event|21
5506418|NCT01604343|19038267|P3|Week 52 to Week 104|Adverse Event|26
5506419|NCT01604343|19038268|P2|Week 52 to Week 104|Adverse Event|12
5506421|NCT01604343|19038265|P5|Week 52 to Week 104|Withdrawal by Subject|4
5506422|NCT01604343|19038266|P4|Week 52 to Week 104|Withdrawal by Subject|8
5506423|NCT01604343|19038267|P3|Week 52 to Week 104|Withdrawal by Subject|12
5506424|NCT01604343|19038268|P2|Week 52 to Week 104|Withdrawal by Subject|7
5506425|NCT01604343|19038269|P1|Week 52 to Week 104|Withdrawal by Subject|0
5506426|NCT01604343|19038265|P5|Week 52 to Week 104|Lost to Follow-up|1
5506427|NCT01604343|19038266|P4|Week 52 to Week 104|Lost to Follow-up|2
5506428|NCT01604343|19038267|P3|Week 52 to Week 104|Lost to Follow-up|4
5506429|NCT01604343|19038268|P2|Week 52 to Week 104|Lost to Follow-up|2
5506430|NCT01604343|19038269|P1|Week 52 to Week 104|Lost to Follow-up|0
5506431|NCT01604343|19038265|P5|Prior to W52 Administration(Through W52)|Other|6
5506432|NCT01604343|19038266|P4|Prior to W52 Administration(Through W52)|Other|0
5506433|NCT01604343|19038267|P3|Prior to W52 Administration(Through W52)|Other|10
5506434|NCT01604343|19038268|P2|Prior to W52 Administration(Through W52)|Other|0
5506435|NCT01604343|19038269|P1|Prior to W52 Administration(Through W52)|Other|15
5506436|NCT01604343|19038265|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
5506437|NCT01604343|19038266|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
5506438|NCT01604343|19038267|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
5506439|NCT01604343|19038268|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
5506440|NCT01604343|19038269|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
5506441|NCT01604343|19038265|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
5506442|NCT01604343|19038266|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
5506443|NCT01604343|19038267|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
5506444|NCT01604343|19038268|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
5506445|NCT01604343|19038269|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
5506446|NCT01604343|19038265|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
5506447|NCT01604343|19038266|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
5506448|NCT01604343|19038267|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
5506449|NCT01604343|19038268|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
5506450|NCT01604343|19038269|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
5506451|NCT01604343|19038265|P5|Prior to W52 Administration(Through W52)|Death|4
5506452|NCT01604343|19038266|P4|Prior to W52 Administration(Through W52)|Death|0
5506453|NCT01604343|19038267|P3|Prior to W52 Administration(Through W52)|Death|2
5506454|NCT01604343|19038268|P2|Prior to W52 Administration(Through W52)|Death|0
5506455|NCT01604343|19038269|P1|Prior to W52 Administration(Through W52)|Death|5
5506456|NCT01604343|19038265|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
5506457|NCT01604343|19038266|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
5506458|NCT01604343|19038267|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
5506459|NCT01604343|19038268|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
5506460|NCT01604343|19038269|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
5506461|NCT01604343|19038265|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
5506462|NCT01604343|19038266|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
5506463|NCT01604343|19038267|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
5506464|NCT01604343|19038268|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
5506465|NCT01604343|19038269|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
5506466|NCT01604343|19038265|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
5506467|NCT01604343|19038266|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
5506468|NCT01604343|19038267|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
5506469|NCT01604343|19038268|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
5506470|NCT01604343|19038269|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
5506471|NCT01604278|19038434|P2|Overall Study|Protocol Deviation|3
5506472|NCT01604278|19038435|P1|Overall Study|Protocol Deviation|5
5506473|NCT01604278|19038434|P2|Overall Study|Adverse Event|5
5506474|NCT01604278|19038435|P1|Overall Study|Adverse Event|3
5506475|NCT01604278|19038434|P2|Overall Study|Withdrawal by Subject|3
5506476|NCT01604278|19038435|P1|Overall Study|Withdrawal by Subject|3
5506477|NCT01604278|19038434|P2|Overall Study|Administrative problems|1
5506478|NCT01604278|19038435|P1|Overall Study|Administrative problems|2
5506479|NCT01604278|19038434|P2|Overall Study|Lost to Follow-up|0
5506480|NCT01604278|19038435|P1|Overall Study|Lost to Follow-up|1
5506481|NCT01604278|19038434|P2|Overall Study|Lack of Efficacy|1
5506482|NCT01604278|19038435|P1|Overall Study|Lack of Efficacy|0
5506483|NCT01604265|19038461|P2|Overall Study|Withdrawal by Subject|0
5506484|NCT01604265|19038462|P1|Overall Study|Withdrawal by Subject|1
5506485|NCT01604265|19038461|P2|Overall Study|Adverse Event|0
5506486|NCT01604265|19038462|P1|Overall Study|Adverse Event|1
5506487|NCT01603875|19038573|P3|Overall Study|Protocol Violation|0
5506488|NCT01603875|19038574|P2|Overall Study|Protocol Violation|1
5506489|NCT01603875|19038575|P1|Overall Study|Protocol Violation|0
5506490|NCT01603875|19038573|P3|Overall Study|Lost to Follow-up|6
5506491|NCT01603875|19038574|P2|Overall Study|Lost to Follow-up|3
5506492|NCT01603875|19038575|P1|Overall Study|Lost to Follow-up|4
5506493|NCT01603875|19038573|P3|Overall Study|Preexisting rabies antibody|3
5506494|NCT01603875|19038574|P2|Overall Study|Preexisting rabies antibody|4
5506495|NCT01603875|19038575|P1|Overall Study|Preexisting rabies antibody|3
5506496|NCT01603641|19038595|P1|Overall Study|Other Miscellaneous Reasons|6
5506497|NCT01603641|19038595|P1|Overall Study|Personal Reasons|18
5506498|NCT01603641|19038595|P1|Overall Study|Lost to Follow-up|6
5506499|NCT01603641|19038595|P1|Overall Study|Lack of Efficacy|1
5506500|NCT01603641|19038595|P1|Overall Study|Adverse Event|1
5506501|NCT01603641|19038595|P1|Overall Study|Did not Receive Treatment|3
5506502|NCT01603628|19038602|P3|Overall Study|Other Miscellaneous Reason|0
5506503|NCT01603628|19038603|P2|Overall Study|Other Miscellaneous Reason|0
5506504|NCT01603628|19038604|P1|Overall Study|Other Miscellaneous Reason|1
5506505|NCT01603628|19038602|P3|Overall Study|Lost to Follow-up|0
5506506|NCT01603628|19038603|P2|Overall Study|Lost to Follow-up|1
5506507|NCT01603628|19038604|P1|Overall Study|Lost to Follow-up|0
5506508|NCT01603628|19038602|P3|Overall Study|Protocol Violation|0
5506509|NCT01603628|19038603|P2|Overall Study|Protocol Violation|1
5506510|NCT01603628|19038604|P1|Overall Study|Protocol Violation|1
5506511|NCT01603628|19038602|P3|Overall Study|Personal Reasons|2
5506512|NCT01603628|19038603|P2|Overall Study|Personal Reasons|1
5506513|NCT01603628|19038604|P1|Overall Study|Personal Reasons|1
5506514|NCT01603615|19038621|P1|Overall Study|Other Miscellaneous|1
5506515|NCT01603615|19038621|P1|Overall Study|Personal Reasons|17
5506516|NCT01603615|19038621|P1|Overall Study|Lost to Follow-up|9
5506517|NCT01603615|19038621|P1|Overall Study|Did not Receive Treatment|7
5506518|NCT01603602|19038628|P3|Overall Study|Personal Reasons|1
5506519|NCT01603602|19038629|P2|Overall Study|Personal Reasons|0
5506520|NCT01603602|19038630|P1|Overall Study|Personal Reasons|1
5506521|NCT01603602|19038628|P3|Overall Study|Adverse Event|0
5506522|NCT01603602|19038629|P2|Overall Study|Adverse Event|0
5506523|NCT01603602|19038630|P1|Overall Study|Adverse Event|1
5506524|NCT01603459|19038650|P1|Overall Study|Administrative reason|1
5506525|NCT01603459|19038650|P1|Overall Study|Non-compliance|1
5506526|NCT01603459|19038650|P1|Overall Study|Predefined discontinuation criteria|3
5506527|NCT01603459|19038650|P1|Overall Study|Lost to Follow-up|3
5506528|NCT01603459|19038650|P1|Overall Study|Withdrawal by Subject|5
5506529|NCT01603459|19038650|P1|Overall Study|Adverse Event|5
5506530|NCT01603394|19038801|P1|Overall Study|Adverse Event|1
5506531|NCT01603355|19038855|P1|Overall Study|Lack of Efficacy|2
5506532|NCT01603277|19038861|P2|Overall Study|Non-Compliance|1
5506533|NCT01603277|19038862|P1|Overall Study|Non-Compliance|2
5506534|NCT01603277|19038861|P2|Overall Study|Withdrawal by Subject|4
5506535|NCT01603277|19038862|P1|Overall Study|Withdrawal by Subject|5
5506536|NCT01603277|19038861|P2|Overall Study|Protocol Violation|10
5506537|NCT01603277|19038862|P1|Overall Study|Protocol Violation|6
5506538|NCT01603277|19038861|P2|Overall Study|Physician Decision|1
5506539|NCT01603277|19038862|P1|Overall Study|Physician Decision|0
5506540|NCT01603277|19038861|P2|Overall Study|Adverse Event|2
5506541|NCT01603277|19038862|P1|Overall Study|Adverse Event|1
5506542|NCT01603121|19038868|P2|Second Intervention, 10 Hours|Adverse Event|0
5506543|NCT01603121|19038869|P1|Second Intervention, 10 Hours|Adverse Event|1
5506544|NCT01603082|19038881|P2|Overall Study|Failed inclusion criterion after dosed|0
5506545|NCT01603082|19038882|P1|Overall Study|Failed inclusion criterion after dosed|1
5506546|NCT01603082|19038881|P2|Overall Study|Withdrawal by Subject|0
5506547|NCT01603082|19038882|P1|Overall Study|Withdrawal by Subject|1
5506548|NCT01603082|19038881|P2|Overall Study|Adverse Event|1
5506549|NCT01603082|19038882|P1|Overall Study|Adverse Event|0
5506550|NCT01603043|19038923|P2|Overall Study|Study Futility|3
5506551|NCT01603043|19038924|P1|Overall Study|Study Futility|7
5506552|NCT01602965|19038936|P2|Overall Study|Lost to Follow-up|2
5506553|NCT01602965|19038937|P1|Overall Study|Lost to Follow-up|4
5506554|NCT01602744|19038945|P2|Overall Study|Lost to Follow-up|8
5506555|NCT01602744|19038946|P1|Overall Study|Lost to Follow-up|13
5506556|NCT01602744|19038945|P2|Overall Study|Death|15
5506557|NCT01602744|19038946|P1|Overall Study|Death|17
5506558|NCT01602666|19039004|P2|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9
5506559|NCT01602666|19039005|P1|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0
5506560|NCT01602666|19039004|P2|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14
5506561|NCT01602666|19039005|P1|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0
5506562|NCT01602666|19039004|P2|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0
5506563|NCT01602666|19039005|P1|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4
5506564|NCT01602666|19039004|P2|Radiation Therapy on Protocol|Withdrawal by Subject|3
5506565|NCT01602666|19039005|P1|Radiation Therapy on Protocol|Withdrawal by Subject|2
5506566|NCT01602666|19039004|P2|Radiation Therapy on Protocol|Lost to Follow-up|5
5506567|NCT01602666|19039005|P1|Radiation Therapy on Protocol|Lost to Follow-up|4
5506568|NCT01602666|19039004|P2|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3
5506569|NCT01602666|19039005|P1|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2
5506570|NCT01602666|19039004|P2|Induction Chemotherapy|Refusal of further protocol therapy|6
5506571|NCT01602666|19039005|P1|Induction Chemotherapy|Refusal of further protocol therapy|5
5506572|NCT01602666|19039004|P2|Induction Chemotherapy|Withdrawal by Subject|2
5506573|NCT01602666|19039005|P1|Induction Chemotherapy|Withdrawal by Subject|0
5506574|NCT01602666|19039004|P2|Induction Chemotherapy|Physician Decision|5
5506575|NCT01602666|19039005|P1|Induction Chemotherapy|Physician Decision|12
5506576|NCT01602666|19039004|P2|Induction Chemotherapy|Lack of Efficacy|7
5506577|NCT01602666|19039005|P1|Induction Chemotherapy|Lack of Efficacy|16
5506578|NCT01602666|19039004|P2|Induction Chemotherapy|Death|1
5506579|NCT01602666|19039005|P1|Induction Chemotherapy|Death|2
5506580|NCT01602562|19039092|P2|Overall Study|Withdrawal by Subject|1
5506581|NCT01602562|19039093|P1|Overall Study|Withdrawal by Subject|1
5506582|NCT01602562|19039092|P2|Overall Study|Physician Decision|1
5506583|NCT01602562|19039093|P1|Overall Study|Physician Decision|1
5506584|NCT01602562|19039092|P2|Overall Study|Adverse Event|1
5506585|NCT01602562|19039093|P1|Overall Study|Adverse Event|3
5506586|NCT01602549|19039129|P2|Overall Study|Withdrawal by Subject|0
5506587|NCT01602549|19039130|P1|Overall Study|Withdrawal by Subject|1
5506588|NCT01602549|19039129|P2|Overall Study|Protocol Violation|1
5506589|NCT01602549|19039130|P1|Overall Study|Protocol Violation|0
5506590|NCT01602510|19039209|P3|Randomized Phase|Withdrawal by Subject|7
5506591|NCT01602510|19039210|P2|Randomized Phase|Withdrawal by Subject|6
5506592|NCT01602510|19039211|P1|Randomized Phase|Withdrawal by Subject|0
5506593|NCT01602510|19039209|P3|Randomized Phase|Physician Decision|2
5506594|NCT01602510|19039210|P2|Randomized Phase|Physician Decision|0
5506595|NCT01602510|19039211|P1|Randomized Phase|Physician Decision|0
5506596|NCT01602510|19039209|P3|Randomized Phase|Lost to Follow-up|3
5506597|NCT01602510|19039210|P2|Randomized Phase|Lost to Follow-up|1
5506598|NCT01602510|19039211|P1|Randomized Phase|Lost to Follow-up|0
5506599|NCT01602510|19039209|P3|Randomized Phase|Met protocol-defined stopping criteria|48
5506600|NCT01602510|19039210|P2|Randomized Phase|Met protocol-defined stopping criteria|58
5506601|NCT01602510|19039211|P1|Randomized Phase|Met protocol-defined stopping criteria|0
5506602|NCT01602510|19039209|P3|Randomized Phase|Protocol Violation|3
5506603|NCT01602510|19039210|P2|Randomized Phase|Protocol Violation|3
5506604|NCT01602510|19039211|P1|Randomized Phase|Protocol Violation|0
5506605|NCT01602510|19039209|P3|Randomized Phase|Lack of Efficacy|4
5506606|NCT01602510|19039210|P2|Randomized Phase|Lack of Efficacy|4
5506607|NCT01602510|19039211|P1|Randomized Phase|Lack of Efficacy|0
5506608|NCT01602510|19039209|P3|Randomized Phase|Adverse Event|6
5506609|NCT01602510|19039210|P2|Randomized Phase|Adverse Event|2
5506610|NCT01602510|19039211|P1|Randomized Phase|Adverse Event|0
5506611|NCT01602510|19039209|P3|Open Label Phase|Withdrawal by Subject|0
5506612|NCT01602510|19039210|P2|Open Label Phase|Withdrawal by Subject|0
5506613|NCT01602510|19039211|P1|Open Label Phase|Withdrawal by Subject|57
5506614|NCT01602510|19039209|P3|Open Label Phase|Physician Decision|0
5506615|NCT01602510|19039210|P2|Open Label Phase|Physician Decision|0
5506616|NCT01602510|19039211|P1|Open Label Phase|Physician Decision|19
5506617|NCT01602510|19039209|P3|Open Label Phase|Lost to Follow-up|0
5506618|NCT01602510|19039210|P2|Open Label Phase|Lost to Follow-up|0
5506619|NCT01602510|19039211|P1|Open Label Phase|Lost to Follow-up|22
5506620|NCT01602510|19039209|P3|Open Label Phase|Met protocol-defined stopping criteria|0
5506621|NCT01602510|19039210|P2|Open Label Phase|Met protocol-defined stopping criteria|0
5506622|NCT01602510|19039211|P1|Open Label Phase|Met protocol-defined stopping criteria|122
5506623|NCT01602510|19039209|P3|Open Label Phase|Protocol Violation|0
5506624|NCT01602510|19039210|P2|Open Label Phase|Protocol Violation|0
5506625|NCT01602510|19039211|P1|Open Label Phase|Protocol Violation|15
5506626|NCT01602510|19039209|P3|Open Label Phase|Lack of Efficacy|0
5506627|NCT01602510|19039210|P2|Open Label Phase|Lack of Efficacy|0
5506628|NCT01602510|19039211|P1|Open Label Phase|Lack of Efficacy|22
5506629|NCT01602510|19039209|P3|Open Label Phase|Adverse Event|0
5506630|NCT01602510|19039210|P2|Open Label Phase|Adverse Event|0
5506631|NCT01602510|19039211|P1|Open Label Phase|Adverse Event|46
5506632|NCT01602484|19039237|P2|Overall Study|Airway issues unrelated to study|1
5506633|NCT01602484|19039238|P1|Overall Study|Airway issues unrelated to study|0
5506634|NCT01602419|19039254|P1|Overall Study|Lost to Follow-up|6
5506635|NCT01602419|19039254|P1|Overall Study|Withdrawal by Subject|5
5506636|NCT01602419|19039254|P1|Overall Study|Treatment centre closed|1
5506637|NCT01602419|19039254|P1|Overall Study|Changed treatment centre|1
5506638|NCT01602419|19039254|P1|Overall Study|Insurance issues|3
5506639|NCT01602419|19039254|P1|Overall Study|Adverse Drug Reaction|4
5506640|NCT01602419|19039254|P1|Overall Study|Not treated with Wilate|9
5506641|NCT01602380|19039309|P2|Overall Study|Eligibility criteria not fulfilled|3
5506642|NCT01602380|19039310|P1|Overall Study|Eligibility criteria not fulfilled|2
5506643|NCT01602380|19039309|P2|Overall Study|Lost to Follow-up|1
5506644|NCT01602380|19039310|P1|Overall Study|Lost to Follow-up|6
5506645|NCT01602380|19039309|P2|Overall Study|Withdrawal by Subject|29
5506646|NCT01602380|19039310|P1|Overall Study|Withdrawal by Subject|22
5506647|NCT01602380|19039309|P2|Overall Study|Death|68
5506648|NCT01602380|19039310|P1|Overall Study|Death|63
5506649|NCT01602341|19039334|P2|Overall Study|Adverse Event|1
5506650|NCT01602341|19039335|P1|Overall Study|Adverse Event|0
5506651|NCT01602315|19039376|P7|Overall Study|Cross-over patients to combo treatment|0
5506652|NCT01602315|19039377|P6|Overall Study|Cross-over patients to combo treatment|16
5506653|NCT01602315|19039378|P5|Overall Study|Cross-over patients to combo treatment|0
5506654|NCT01602315|19039379|P4|Overall Study|Cross-over patients to combo treatment|0
5506655|NCT01602315|19039380|P3|Overall Study|Cross-over patients to combo treatment|0
5506656|NCT01602315|19039381|P2|Overall Study|Cross-over patients to combo treatment|0
5506657|NCT01602315|19039382|P1|Overall Study|Cross-over patients to combo treatment|0
5506658|NCT01602315|19039376|P7|Overall Study|Subject/guardian decision|1
5506659|NCT01602315|19039377|P6|Overall Study|Subject/guardian decision|0
5506660|NCT01602315|19039378|P5|Overall Study|Subject/guardian decision|0
5506661|NCT01602315|19039379|P4|Overall Study|Subject/guardian decision|0
5506662|NCT01602315|19039380|P3|Overall Study|Subject/guardian decision|0
5506663|NCT01602315|19039381|P2|Overall Study|Subject/guardian decision|0
5506664|NCT01602315|19039382|P1|Overall Study|Subject/guardian decision|0
5506665|NCT01602315|19039376|P7|Overall Study|Adverse Event|9
5506666|NCT01602315|19039377|P6|Overall Study|Adverse Event|3
5506667|NCT01602315|19039378|P5|Overall Study|Adverse Event|15
5506668|NCT01602315|19039379|P4|Overall Study|Adverse Event|4
5506669|NCT01602315|19039380|P3|Overall Study|Adverse Event|5
5506670|NCT01602315|19039381|P2|Overall Study|Adverse Event|1
5506671|NCT01602315|19039382|P1|Overall Study|Adverse Event|5
5506672|NCT01602315|19039376|P7|Overall Study|Withdrawal by Subject|1
5506673|NCT01602315|19039377|P6|Overall Study|Withdrawal by Subject|0
5506674|NCT01602315|19039378|P5|Overall Study|Withdrawal by Subject|6
5506675|NCT01602315|19039379|P4|Overall Study|Withdrawal by Subject|0
5506676|NCT01602315|19039380|P3|Overall Study|Withdrawal by Subject|2
5506677|NCT01602315|19039381|P2|Overall Study|Withdrawal by Subject|0
5506678|NCT01602315|19039382|P1|Overall Study|Withdrawal by Subject|2
5506679|NCT01602315|19039376|P7|Overall Study|Death|2
5506680|NCT01602315|19039377|P6|Overall Study|Death|2
5506681|NCT01602315|19039378|P5|Overall Study|Death|7
5506682|NCT01602315|19039379|P4|Overall Study|Death|1
5506683|NCT01602315|19039380|P3|Overall Study|Death|1
5506684|NCT01602315|19039381|P2|Overall Study|Death|1
5506685|NCT01602315|19039382|P1|Overall Study|Death|1
5506686|NCT01602315|19039376|P7|Overall Study|Disease progression|15
5506687|NCT01602315|19039377|P6|Overall Study|Disease progression|12
5506688|NCT01602315|19039378|P5|Overall Study|Disease progression|41
5506689|NCT01602315|19039379|P4|Overall Study|Disease progression|1
5506690|NCT01602315|19039380|P3|Overall Study|Disease progression|10
5506691|NCT01602315|19039381|P2|Overall Study|Disease progression|3
5506692|NCT01602315|19039382|P1|Overall Study|Disease progression|6
5506693|NCT01602315|19039376|P7|Overall Study|Physician Decision|1
5506694|NCT01602315|19039377|P6|Overall Study|Physician Decision|1
5506695|NCT01602315|19039378|P5|Overall Study|Physician Decision|2
5506696|NCT01602315|19039379|P4|Overall Study|Physician Decision|0
5506697|NCT01602315|19039380|P3|Overall Study|Physician Decision|0
5506698|NCT01602315|19039381|P2|Overall Study|Physician Decision|0
5506699|NCT01602315|19039382|P1|Overall Study|Physician Decision|2
5506700|NCT01602315|19039376|P7|Overall Study|Protocol Violation|0
5506701|NCT01602315|19039377|P6|Overall Study|Protocol Violation|1
5506702|NCT01602315|19039378|P5|Overall Study|Protocol Violation|0
5506703|NCT01602315|19039379|P4|Overall Study|Protocol Violation|0
5506704|NCT01602315|19039380|P3|Overall Study|Protocol Violation|0
5506705|NCT01602315|19039381|P2|Overall Study|Protocol Violation|0
5506706|NCT01602315|19039382|P1|Overall Study|Protocol Violation|0
5506707|NCT01602224|19039471|P3|Overall Study|Withdrawal by Subject|3
5506708|NCT01602224|19039472|P2|Overall Study|Withdrawal by Subject|3
5506709|NCT01602224|19039473|P1|Overall Study|Withdrawal by Subject|5
5506710|NCT01602224|19039471|P3|Overall Study|Sponsor Decision|2
5506711|NCT01602224|19039472|P2|Overall Study|Sponsor Decision|3
5506712|NCT01602224|19039473|P1|Overall Study|Sponsor Decision|2
5506713|NCT01602224|19039471|P3|Overall Study|Protocol Violation|0
5506714|NCT01602224|19039472|P2|Overall Study|Protocol Violation|1
5506715|NCT01602224|19039473|P1|Overall Study|Protocol Violation|0
5506716|NCT01602224|19039471|P3|Overall Study|Lost to Follow-up|1
5506717|NCT01602224|19039472|P2|Overall Study|Lost to Follow-up|0
5506718|NCT01602224|19039473|P1|Overall Study|Lost to Follow-up|0
5506719|NCT01602224|19039471|P3|Overall Study|Investigator Decison|0
5506720|NCT01602224|19039472|P2|Overall Study|Investigator Decison|0
5506721|NCT01602224|19039473|P1|Overall Study|Investigator Decison|1
5506722|NCT01602224|19039471|P3|Overall Study|Adverse Event|0
5506723|NCT01602224|19039472|P2|Overall Study|Adverse Event|1
5506724|NCT01602224|19039473|P1|Overall Study|Adverse Event|0
5506725|NCT01602120|19039558|P4|Overall Study|Unspecified Reason|2
5506726|NCT01602120|19039559|P3|Overall Study|Unspecified Reason|0
5506727|NCT01602120|19039560|P2|Overall Study|Unspecified Reason|1
5506728|NCT01602120|19039561|P1|Overall Study|Unspecified Reason|3
5506729|NCT01602120|19039558|P4|Overall Study|Physician Decision|0
5506730|NCT01602120|19039559|P3|Overall Study|Physician Decision|0
5506731|NCT01602120|19039560|P2|Overall Study|Physician Decision|3
5506732|NCT01602120|19039561|P1|Overall Study|Physician Decision|2
5506733|NCT01602120|19039558|P4|Overall Study|Study Terminated by Sponsor|44
5506734|NCT01602120|19039559|P3|Overall Study|Study Terminated by Sponsor|17
5506735|NCT01602120|19039560|P2|Overall Study|Study Terminated by Sponsor|24
5506736|NCT01602120|19039561|P1|Overall Study|Study Terminated by Sponsor|12
5506737|NCT01602120|19039558|P4|Overall Study|Withdrawal by Subject|3
5506738|NCT01602120|19039559|P3|Overall Study|Withdrawal by Subject|0
5506739|NCT01602120|19039560|P2|Overall Study|Withdrawal by Subject|17
5506740|NCT01602120|19039561|P1|Overall Study|Withdrawal by Subject|8
5506741|NCT01602120|19039558|P4|Overall Study|Non-compliance|1
5506742|NCT01602120|19039559|P3|Overall Study|Non-compliance|0
5506743|NCT01602120|19039560|P2|Overall Study|Non-compliance|3
5506744|NCT01602120|19039561|P1|Overall Study|Non-compliance|0
5506745|NCT01602120|19039558|P4|Overall Study|Protocol Violation|0
5506746|NCT01602120|19039559|P3|Overall Study|Protocol Violation|0
5506747|NCT01602120|19039560|P2|Overall Study|Protocol Violation|1
5506748|NCT01602120|19039561|P1|Overall Study|Protocol Violation|1
5506749|NCT01602120|19039558|P4|Overall Study|Lost to Follow-up|1
5506750|NCT01602120|19039559|P3|Overall Study|Lost to Follow-up|0
5506751|NCT01602120|19039560|P2|Overall Study|Lost to Follow-up|1
5506752|NCT01602120|19039561|P1|Overall Study|Lost to Follow-up|0
5506753|NCT01602120|19039558|P4|Overall Study|Death|0
5506754|NCT01602120|19039559|P3|Overall Study|Death|0
5506755|NCT01602120|19039560|P2|Overall Study|Death|4
5506756|NCT01602120|19039561|P1|Overall Study|Death|0
5506757|NCT01602120|19039558|P4|Overall Study|Adverse Event|2
5506758|NCT01602120|19039559|P3|Overall Study|Adverse Event|0
5506759|NCT01602120|19039560|P2|Overall Study|Adverse Event|6
5506760|NCT01602120|19039561|P1|Overall Study|Adverse Event|3
5506761|NCT01601873|19039609|P2|Overall Study|Lost to Follow-up|3
5506762|NCT01601873|19039610|P1|Overall Study|Lost to Follow-up|2
5506763|NCT01601847|19039636|P2|Overall Study|Lost to Follow-up|3
5506764|NCT01601847|19039637|P1|Overall Study|Lost to Follow-up|1
5506765|NCT01601847|19039636|P2|Overall Study|Withdrawal by Subject|7
5506766|NCT01601847|19039637|P1|Overall Study|Withdrawal by Subject|11
5506767|NCT01601847|19039636|P2|Overall Study|Death|0
5506768|NCT01601847|19039637|P1|Overall Study|Death|1
5506769|NCT01601821|19039649|P2|Overall Study|Other|1
5506770|NCT01601821|19039650|P1|Overall Study|Other|5
5506771|NCT01601821|19039649|P2|Overall Study|Study Events|1
5506772|NCT01601821|19039650|P1|Overall Study|Study Events|7
5506773|NCT01601821|19039649|P2|Overall Study|Graft Loss|6
5506774|NCT01601821|19039650|P1|Overall Study|Graft Loss|6
5506775|NCT01601821|19039649|P2|Overall Study|Withdrawal by Subject|0
5506776|NCT01601821|19039650|P1|Overall Study|Withdrawal by Subject|1
5506777|NCT01601821|19039649|P2|Overall Study|Lost to Follow-up|14
5506778|NCT01601821|19039650|P1|Overall Study|Lost to Follow-up|6
5506779|NCT01601821|19039649|P2|Overall Study|Protocol Violation|2
5506780|NCT01601821|19039650|P1|Overall Study|Protocol Violation|2
5506781|NCT01601821|19039649|P2|Overall Study|Death|5
5506782|NCT01601821|19039650|P1|Overall Study|Death|2
5506783|NCT01601704|19039686|P2|Overall Study|Randomized but not dispensed study med|4
5506784|NCT01601704|19039687|P1|Overall Study|Randomized but not dispensed study med|1
5506785|NCT01601626|19039708|P3|Overall Study|Not Willing to Adhere to Requirements|0
5506786|NCT01601626|19039709|P2|Overall Study|Not Willing to Adhere to Requirements|0
5506787|NCT01601626|19039710|P1|Overall Study|Not Willing to Adhere to Requirements|1
5506788|NCT01601626|19039708|P3|Overall Study|Withdrawal by Subject|1
5506789|NCT01601626|19039709|P2|Overall Study|Withdrawal by Subject|1
5506790|NCT01601626|19039710|P1|Overall Study|Withdrawal by Subject|0
5506791|NCT01601626|19039708|P3|Overall Study|Unable to Get to Clinic|0
5506792|NCT01601626|19039709|P2|Overall Study|Unable to Get to Clinic|1
5506793|NCT01601626|19039710|P1|Overall Study|Unable to Get to Clinic|0
5506794|NCT01601626|19039708|P3|Overall Study|Lost to Follow-up|0
5506795|NCT01601626|19039709|P2|Overall Study|Lost to Follow-up|2
5506796|NCT01601626|19039710|P1|Overall Study|Lost to Follow-up|1
5506797|NCT01601626|19039708|P3|Overall Study|Death|1
5506798|NCT01601626|19039709|P2|Overall Study|Death|1
5506799|NCT01601626|19039710|P1|Overall Study|Death|1
5506800|NCT01601535|19039799|P6|Phase 2|Started Another Treatment|2
5506801|NCT01601535|19039800|P5|Phase 2|Started Another Treatment|1
5506802|NCT01601535|19039801|P4|Phase 2|Started Another Treatment|0
5506803|NCT01601535|19039802|P3|Phase 2|Started Another Treatment|0
5506804|NCT01601535|19039803|P2|Phase 2|Started Another Treatment|0
5506805|NCT01601535|19039804|P1|Phase 2|Started Another Treatment|0
5506806|NCT01601535|19039799|P6|Phase 2|Progressive Disease|7
5506807|NCT01601535|19039800|P5|Phase 2|Progressive Disease|5
5506808|NCT01601535|19039801|P4|Phase 2|Progressive Disease|0
5506809|NCT01601535|19039802|P3|Phase 2|Progressive Disease|0
5506810|NCT01601535|19039803|P2|Phase 2|Progressive Disease|0
5506811|NCT01601535|19039804|P1|Phase 2|Progressive Disease|0
5506812|NCT01601535|19039799|P6|Phase 2|Withdrawal by Subject|2
5506813|NCT01601535|19039800|P5|Phase 2|Withdrawal by Subject|8
5506814|NCT01601535|19039801|P4|Phase 2|Withdrawal by Subject|0
5506815|NCT01601535|19039802|P3|Phase 2|Withdrawal by Subject|0
5506816|NCT01601535|19039803|P2|Phase 2|Withdrawal by Subject|0
5506817|NCT01601535|19039804|P1|Phase 2|Withdrawal by Subject|0
5506818|NCT01601535|19039799|P6|Phase 2|Adverse Event|1
5506819|NCT01601535|19039800|P5|Phase 2|Adverse Event|5
5506820|NCT01601535|19039801|P4|Phase 2|Adverse Event|0
5506821|NCT01601535|19039802|P3|Phase 2|Adverse Event|0
5506822|NCT01601535|19039803|P2|Phase 2|Adverse Event|0
5506823|NCT01601535|19039804|P1|Phase 2|Adverse Event|0
5506824|NCT01601535|19039799|P6|Phase 1|Started Another Treatment|0
5506825|NCT01601535|19039800|P5|Phase 1|Started Another Treatment|0
5506826|NCT01601535|19039801|P4|Phase 1|Started Another Treatment|0
5506827|NCT01601535|19039802|P3|Phase 1|Started Another Treatment|0
5506828|NCT01601535|19039803|P2|Phase 1|Started Another Treatment|2
5506829|NCT01601535|19039804|P1|Phase 1|Started Another Treatment|1
5506830|NCT01601535|19039799|P6|Phase 1|Progressive Disease|0
5506831|NCT01601535|19039800|P5|Phase 1|Progressive Disease|0
5506832|NCT01601535|19039801|P4|Phase 1|Progressive Disease|1
5506833|NCT01601535|19039802|P3|Phase 1|Progressive Disease|2
5506834|NCT01601535|19039803|P2|Phase 1|Progressive Disease|3
5506835|NCT01601535|19039804|P1|Phase 1|Progressive Disease|2
5506836|NCT01601535|19039799|P6|Phase 1|Withdrawal by Subject|0
5506837|NCT01601535|19039800|P5|Phase 1|Withdrawal by Subject|0
5506838|NCT01601535|19039801|P4|Phase 1|Withdrawal by Subject|2
5506839|NCT01601535|19039802|P3|Phase 1|Withdrawal by Subject|1
5506840|NCT01601535|19039803|P2|Phase 1|Withdrawal by Subject|1
5506841|NCT01601535|19039804|P1|Phase 1|Withdrawal by Subject|2
5506842|NCT01601535|19039799|P6|Phase 1|Adverse Event|0
5506843|NCT01601535|19039800|P5|Phase 1|Adverse Event|0
5506844|NCT01601535|19039801|P4|Phase 1|Adverse Event|1
5506845|NCT01601535|19039802|P3|Phase 1|Adverse Event|2
5506846|NCT01601535|19039803|P2|Phase 1|Adverse Event|0
5506847|NCT01601535|19039804|P1|Phase 1|Adverse Event|1
5506848|NCT01601496|19039860|P1|Overall Study|Other: patient refusal to continue|3
5506849|NCT01601496|19039860|P1|Overall Study|Death|4
5506850|NCT01601496|19039860|P1|Overall Study|Lost to Follow-up|6
5506851|NCT01601496|19039860|P1|Overall Study|Withdrawal by Subject|1
5506852|NCT01601496|19039860|P1|Overall Study|Physician Decision|1
5506853|NCT01601470|19039868|P1|Period 2 - LCZ696|Physician Decision|1
5506854|NCT01601132|19039939|P1|Overall Study|Protocol deviation|1
5506855|NCT01601132|19039939|P1|Overall Study|Patient withdrew consent|1
5506856|NCT01600885|19039984|P2|First Period|moved out of area|0
5506857|NCT01600885|19039985|P1|First Period|moved out of area|1
5506858|NCT01600885|19039984|P2|First Period|Adverse Event|1
5506859|NCT01600885|19039985|P1|First Period|Adverse Event|1
5506860|NCT01600716|19040002|P2|Overall Study|Adverse Event|1
5506861|NCT01600716|19040003|P1|Overall Study|Adverse Event|1
5506862|NCT01600716|19040002|P2|Overall Study|Lack of Efficacy|1
5506863|NCT01600716|19040003|P1|Overall Study|Lack of Efficacy|2
5506864|NCT01600716|19040002|P2|Overall Study|Pregnancy|0
5506865|NCT01600716|19040003|P1|Overall Study|Pregnancy|1
5506866|NCT01600716|19040002|P2|Overall Study|Lost to Follow-up|2
5506867|NCT01600716|19040003|P1|Overall Study|Lost to Follow-up|0
5506868|NCT01600716|19040002|P2|Overall Study|Personal Reasons|2
5506869|NCT01600716|19040003|P1|Overall Study|Personal Reasons|0
5506870|NCT01600716|19040002|P2|Overall Study|Other Reasons|1
5506871|NCT01600716|19040003|P1|Overall Study|Other Reasons|3
5506872|NCT01600586|19040051|P2|Overall Study|Physician Decision|3
5506873|NCT01600586|19040052|P1|Overall Study|Physician Decision|3
5506874|NCT01600326|19040104|P2|Overall Study|Lost to Follow-up|1
5506875|NCT01600326|19040105|P1|Overall Study|Lost to Follow-up|1
5506876|NCT01600105|19040206|P2|Sub Study V|Poor Image Quality|0
5506877|NCT01600105|19040207|P1|Sub Study V|Poor Image Quality|2
5506878|NCT01600105|19040206|P2|Sub Study III|Insufficient image quality|0
5506879|NCT01600105|19040207|P1|Sub Study III|Insufficient image quality|5
5506880|NCT01600105|19040206|P2|Sub Study II|Insufficient image quality|0
5506881|NCT01600105|19040207|P1|Sub Study II|Insufficient image quality|3
5506882|NCT01600105|19040206|P2|Sub Study II|No images in PACS|0
5506883|NCT01600105|19040207|P1|Sub Study II|No images in PACS|1
5506884|NCT01600105|19040206|P2|Sub Study II|Withdrawal by Subject|0
5506885|NCT01600105|19040207|P1|Sub Study II|Withdrawal by Subject|1
5506886|NCT01600105|19040206|P2|Sub Study I|Insufficient image quality|10
5506887|NCT01600105|19040207|P1|Sub Study I|Insufficient image quality|0
5506888|NCT01600105|19040206|P2|Total Participants|Insufficient image quality|10
5506889|NCT01600105|19040207|P1|Total Participants|Insufficient image quality|30
5506890|NCT01600105|19040206|P2|Total Participants|No images in PACS|0
5506891|NCT01600105|19040207|P1|Total Participants|No images in PACS|10
5506892|NCT01600105|19040206|P2|Total Participants|Withdrawal by Subject|0
5506893|NCT01600105|19040207|P1|Total Participants|Withdrawal by Subject|1
5506894|NCT01600092|19040235|P2|Overall Study|Randomized but not vaccinated|3
5506895|NCT01600092|19040236|P1|Overall Study|Randomized but not vaccinated|3
5506896|NCT01600092|19040235|P2|Overall Study|Physician Decision|1
5506897|NCT01600092|19040236|P1|Overall Study|Physician Decision|1
5506898|NCT01600092|19040235|P2|Overall Study|Withdrawal by parent/guardian|6
5506899|NCT01600092|19040236|P1|Overall Study|Withdrawal by parent/guardian|8
5506900|NCT01600092|19040235|P2|Overall Study|Lost to Follow-up|6
5506901|NCT01600092|19040236|P1|Overall Study|Lost to Follow-up|4
5506902|NCT01600092|19040235|P2|Overall Study|Adverse Event|0
5506903|NCT01600092|19040236|P1|Overall Study|Adverse Event|2
5506904|NCT01600053|19040250|P1|Overall Study|trial will not meet the interim endpoint|9
5506905|NCT01600053|19040250|P1|Overall Study|Adverse Event|2
5506906|NCT01600014|19040255|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
5506907|NCT01600014|19040256|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
5506908|NCT01600014|19040255|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
5506909|NCT01600014|19040256|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
5506910|NCT01600014|19040255|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
5506911|NCT01600014|19040256|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
5506912|NCT01600014|19040255|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
5506913|NCT01600014|19040256|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
5506914|NCT01600014|19040255|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
5506915|NCT01600014|19040256|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
5506916|NCT01600014|19040255|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
5506917|NCT01600014|19040256|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
5506918|NCT01600014|19040255|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
5506919|NCT01600014|19040256|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
5506920|NCT01600014|19040255|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
5506921|NCT01600014|19040256|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
5506922|NCT01600014|19040255|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
5506923|NCT01600014|19040256|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
5506924|NCT01600014|19040255|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
5506925|NCT01600014|19040256|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
5506926|NCT01600014|19040255|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
5506927|NCT01600014|19040256|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
5506928|NCT01600014|19040255|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
5506929|NCT01600014|19040256|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
5506930|NCT01600014|19040255|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
5506931|NCT01600014|19040256|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
5506932|NCT01600014|19040255|P2|1. Cycle & Observation Period D1 to W52|Other|0
5506933|NCT01600014|19040256|P1|1. Cycle & Observation Period D1 to W52|Other|27
5506934|NCT01600014|19040255|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
5506935|NCT01600014|19040256|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
5506936|NCT01600014|19040255|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
5506937|NCT01600014|19040256|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
5506938|NCT01600014|19040255|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
5506939|NCT01600014|19040256|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
5506940|NCT01599806|19040284|P2|Overall Study|Other Eligibility criteria|9
5506941|NCT01599806|19040285|P1|Overall Study|Other Eligibility criteria|11
5506942|NCT01599806|19040284|P2|Overall Study|Withdrawal by Subject|12
5506943|NCT01599806|19040285|P1|Overall Study|Withdrawal by Subject|12
5506944|NCT01599806|19040284|P2|Overall Study|Lost to Follow-up|20
5506945|NCT01599806|19040285|P1|Overall Study|Lost to Follow-up|20
5506946|NCT01599793|19040409|P1|Overall Study|Adverse Event|2
5506947|NCT01599754|19040421|P2|Overall Study|Study terminated by sponsor|285
5506948|NCT01599754|19040422|P1|Overall Study|Study terminated by sponsor|282
5506949|NCT01599754|19040421|P2|Overall Study|Withdrawal by Subject|25
5506950|NCT01599754|19040422|P1|Overall Study|Withdrawal by Subject|24
5506951|NCT01599754|19040421|P2|Overall Study|Investigator decision|3
5506952|NCT01599754|19040422|P1|Overall Study|Investigator decision|1
5506953|NCT01599754|19040421|P2|Overall Study|Adverse Event|2
5506954|NCT01599754|19040422|P1|Overall Study|Adverse Event|3
5506955|NCT01599754|19040421|P2|Overall Study|Death|33
5506956|NCT01599754|19040422|P1|Overall Study|Death|31
5506957|NCT01599754|19040421|P2|Overall Study|Lost to Follow-up|6
5506958|NCT01599754|19040422|P1|Overall Study|Lost to Follow-up|13
5506959|NCT01599754|19040421|P2|Overall Study|Participant noncompliance|4
5506960|NCT01599754|19040422|P1|Overall Study|Participant noncompliance|4
5506961|NCT01599754|19040421|P2|Overall Study|Anticancer therapy need not in protocol|2
5506962|NCT01599754|19040422|P1|Overall Study|Anticancer therapy need not in protocol|5
5506963|NCT01599650|19040453|P3|Overall Study|Adverse Event|4
5506964|NCT01599650|19040454|P2|Overall Study|Adverse Event|8
5506965|NCT01599650|19040455|P1|Overall Study|Adverse Event|3
5506966|NCT01599650|19040453|P3|Overall Study|Withdrawal by Subject|10
5506967|NCT01599650|19040454|P2|Overall Study|Withdrawal by Subject|11
5506968|NCT01599650|19040455|P1|Overall Study|Withdrawal by Subject|11
5506969|NCT01599650|19040453|P3|Overall Study|Lost to Follow-up|3
5506970|NCT01599650|19040454|P2|Overall Study|Lost to Follow-up|3
5506971|NCT01599650|19040455|P1|Overall Study|Lost to Follow-up|3
5506972|NCT01599650|19040453|P3|Overall Study|Death|2
5506973|NCT01599650|19040454|P2|Overall Study|Death|1
5506974|NCT01599650|19040455|P1|Overall Study|Death|2
5506975|NCT01599650|19040453|P3|Overall Study|Protocol Violation|0
5506976|NCT01599650|19040454|P2|Overall Study|Protocol Violation|3
5506977|NCT01599650|19040455|P1|Overall Study|Protocol Violation|0
5506978|NCT01599650|19040453|P3|Overall Study|Physician Decision|7
5506979|NCT01599650|19040454|P2|Overall Study|Physician Decision|0
5506980|NCT01599650|19040455|P1|Overall Study|Physician Decision|2
5506981|NCT01599650|19040453|P3|Overall Study|Administrative issue|1
5506982|NCT01599650|19040454|P2|Overall Study|Administrative issue|0
5506983|NCT01599650|19040455|P1|Overall Study|Administrative issue|1
5506984|NCT01599637|19040494|P3|Overall Study|Adverse Event|0
5506985|NCT01599637|19040495|P2|Overall Study|Adverse Event|0
5506986|NCT01599637|19040496|P1|Overall Study|Adverse Event|1
5506987|NCT01599637|19040494|P3|Overall Study|administrative problems|0
5506988|NCT01599637|19040495|P2|Overall Study|administrative problems|2
5506989|NCT01599637|19040496|P1|Overall Study|administrative problems|0
5506990|NCT01599585|19040543|P2|Overall Study|randomized did not start treatment|3
5506991|NCT01599585|19040544|P1|Overall Study|randomized did not start treatment|3
5506992|NCT01599585|19040543|P2|Overall Study|Lost to Follow-up|5
5506993|NCT01599585|19040544|P1|Overall Study|Lost to Follow-up|3
5506994|NCT01599585|19040543|P2|Overall Study|Withdrawal by Subject|9
5506995|NCT01599585|19040544|P1|Overall Study|Withdrawal by Subject|16
5506996|NCT01599325|19040582|P1|Extension Phase|Withdrawal by Subject|8
5506997|NCT01599325|19040582|P1|Extension Phase|Disease Progression|1
5506998|NCT01599325|19040582|P1|Extension Phase|Lack of Therapeutic Effect|4
5506999|NCT01599325|19040582|P1|Extension Phase|Stopped to Receive Stem Cell Transplant|1
5507000|NCT01599325|19040582|P1|Extension Phase|Study Closure|1
5507001|NCT01599325|19040582|P1|Primary Parent Phase|Other|2
5507002|NCT01599325|19040582|P1|Primary Parent Phase|Lack of Therapeutic Effect|9
5507003|NCT01599325|19040582|P1|Primary Parent Phase|Protocol Violation|1
5507004|NCT01599325|19040582|P1|Primary Parent Phase|Death|13
5507005|NCT01599325|19040582|P1|Primary Parent Phase|Withdrawal by Subject|20
5507006|NCT01599325|19040582|P1|Primary Parent Phase|Disease Progression|7
5507007|NCT01599325|19040582|P1|Primary Parent Phase|Adverse Event|5
5507008|NCT01599234|19040606|P2|Overall Study|Pregnancy|1
5507009|NCT01599234|19040607|P1|Overall Study|Pregnancy|0
5507010|NCT01599234|19040606|P2|Overall Study|Contra-indication discovered|1
5507011|NCT01599234|19040607|P1|Overall Study|Contra-indication discovered|0
5507012|NCT01599234|19040606|P2|Overall Study|Patient would not stop driving|0
5507013|NCT01599234|19040607|P1|Overall Study|Patient would not stop driving|1
5507014|NCT01599234|19040606|P2|Overall Study|Death|0
5507015|NCT01599234|19040607|P1|Overall Study|Death|1
5507016|NCT01599234|19040606|P2|Overall Study|Sponsor request as creatinine levels <50|1
5507017|NCT01599234|19040607|P1|Overall Study|Sponsor request as creatinine levels <50|0
5507018|NCT01599234|19040606|P2|Overall Study|Unable to operate spray|0
5507019|NCT01599234|19040607|P1|Overall Study|Unable to operate spray|1
5507020|NCT01599234|19040606|P2|Overall Study|Lack of Efficacy|4
5507021|NCT01599234|19040607|P1|Overall Study|Lack of Efficacy|2
5507022|NCT01599234|19040606|P2|Overall Study|Lost to Follow-up|2
5507023|NCT01599234|19040607|P1|Overall Study|Lost to Follow-up|1
5507024|NCT01599234|19040606|P2|Overall Study|Withdrawal by Subject|1
5507025|NCT01599234|19040607|P1|Overall Study|Withdrawal by Subject|2
5507026|NCT01599234|19040606|P2|Overall Study|Adverse Event|5
5507027|NCT01599234|19040607|P1|Overall Study|Adverse Event|9
5507028|NCT01599104|19040632|P3|Overall Study|Adverse Event|12
5507029|NCT01599104|19040633|P2|Overall Study|Adverse Event|6
5507030|NCT01599104|19040634|P1|Overall Study|Adverse Event|7
5507031|NCT01599104|19040632|P3|Overall Study|Lack of Efficacy|10
5507032|NCT01599104|19040633|P2|Overall Study|Lack of Efficacy|4
5507033|NCT01599104|19040634|P1|Overall Study|Lack of Efficacy|4
5507034|NCT01599104|19040632|P3|Overall Study|Non-compliance with study treatment|0
5507035|NCT01599104|19040633|P2|Overall Study|Non-compliance with study treatment|1
5507036|NCT01599104|19040634|P1|Overall Study|Non-compliance with study treatment|0
5507037|NCT01599104|19040632|P3|Overall Study|Physician Decision|2
5507038|NCT01599104|19040633|P2|Overall Study|Physician Decision|2
5507039|NCT01599104|19040634|P1|Overall Study|Physician Decision|3
5507040|NCT01599104|19040632|P3|Overall Study|Technical Problems|0
5507041|NCT01599104|19040633|P2|Overall Study|Technical Problems|0
5507042|NCT01599104|19040634|P1|Overall Study|Technical Problems|1
5507043|NCT01599104|19040632|P3|Overall Study|Withdrawal by Subject|2
5507044|NCT01599104|19040633|P2|Overall Study|Withdrawal by Subject|1
5507045|NCT01599104|19040634|P1|Overall Study|Withdrawal by Subject|1
5507046|NCT01598987|19040672|P1|Baseline to 24 Month|Lost to Follow-up|1
5507047|NCT01598987|19040672|P1|Baseline to 24 Month|Administrative problems|2
5507048|NCT01598987|19040672|P1|Baseline to 24 Month|Withdrawal by Subject|5
5507049|NCT01598987|19040672|P1|Baseline to Month 12|Withdrawal by Subject|4
5507050|NCT01598987|19040672|P1|Baseline to Month 12|Administrative problems|2
5507051|NCT01598896|19040731|P2|Overall Study|Lack of Efficacy|1
5507052|NCT01598896|19040732|P1|Overall Study|Lack of Efficacy|0
5507053|NCT01598896|19040731|P2|Overall Study|Withdrawal by Subject|1
5507054|NCT01598896|19040732|P1|Overall Study|Withdrawal by Subject|0
5507055|NCT01598753|19040771|P4|Overall Study|Withdrawal by Subject|1
5507056|NCT01598753|19040772|P3|Overall Study|Withdrawal by Subject|0
5507057|NCT01598753|19040773|P2|Overall Study|Withdrawal by Subject|2
5507058|NCT01598753|19040774|P1|Overall Study|Withdrawal by Subject|7
5507059|NCT01598753|19040771|P4|Overall Study|Physician Decision|2
5507060|NCT01598753|19040772|P3|Overall Study|Physician Decision|0
5507061|NCT01598753|19040773|P2|Overall Study|Physician Decision|1
5507062|NCT01598753|19040774|P1|Overall Study|Physician Decision|0
5507063|NCT01598753|19040771|P4|Overall Study|Lost to Follow-up|5
5507064|NCT01598753|19040772|P3|Overall Study|Lost to Follow-up|7
5507065|NCT01598753|19040773|P2|Overall Study|Lost to Follow-up|3
5507066|NCT01598753|19040774|P1|Overall Study|Lost to Follow-up|4
5507067|NCT01598753|19040771|P4|Overall Study|Adverse Event|7
5507068|NCT01598753|19040772|P3|Overall Study|Adverse Event|1
5507069|NCT01598753|19040773|P2|Overall Study|Adverse Event|9
5507070|NCT01598753|19040774|P1|Overall Study|Adverse Event|1
5507071|NCT01598662|19040814|P2|Overall Study|IUD expelled before month 6|2
5507072|NCT01598662|19040815|P1|Overall Study|IUD expelled before month 6|0
5507073|NCT01598662|19040814|P2|Overall Study|Physician Decision|2
5507074|NCT01598662|19040815|P1|Overall Study|Physician Decision|1
5507075|NCT01598662|19040814|P2|Overall Study|Lost to Follow-up|17
5507076|NCT01598662|19040815|P1|Overall Study|Lost to Follow-up|10
5507077|NCT01598610|19040821|P1|Overall Study|Adverse Event|1
5507078|NCT01598532|19040838|P1|Overall Study|Did not meet inclusion criteria|8
5507079|NCT01598532|19040838|P1|Overall Study|Lost to Follow-up|3
5507080|NCT01598506|19040847|P1|Overall Study|Withdrawal by Subject|2
5507081|NCT01598311|19040867|P2|Overall Study|Assigned to CB but received vancomycin|0
5507082|NCT01598311|19040868|P1|Overall Study|Assigned to CB but received vancomycin|1
5507083|NCT01598311|19040867|P2|Overall Study|Treated but no confirmed CDAD|8
5507084|NCT01598311|19040868|P1|Overall Study|Treated but no confirmed CDAD|9
5507085|NCT01598311|19040867|P2|Overall Study|Randomized but never treated|5
5507086|NCT01598311|19040868|P1|Overall Study|Randomized but never treated|8
5507087|NCT01598311|19040867|P2|Overall Study|No reason provided.|5
5507088|NCT01598311|19040868|P1|Overall Study|No reason provided.|0
5507089|NCT01598311|19040867|P2|Overall Study|Withdrawal by Subject|13
5507090|NCT01598311|19040868|P1|Overall Study|Withdrawal by Subject|9
5507091|NCT01598311|19040867|P2|Overall Study|Lost to Follow-up|12
5507092|NCT01598311|19040868|P1|Overall Study|Lost to Follow-up|7
5507093|NCT01598311|19040867|P2|Overall Study|Adverse Event|13
5507094|NCT01598311|19040868|P1|Overall Study|Adverse Event|9
5507095|NCT01598311|19040867|P2|Overall Study|Physician Decision|5
5507096|NCT01598311|19040868|P1|Overall Study|Physician Decision|4
5507097|NCT01598298|19040884|P2|Overall Study|Other reason (not protocol specified)|0
5507098|NCT01598298|19040885|P1|Overall Study|Other reason (not protocol specified)|4
5507099|NCT01598298|19040884|P2|Overall Study|Withdrawal by Subject|15
5507100|NCT01598298|19040885|P1|Overall Study|Withdrawal by Subject|10
5507101|NCT01598298|19040884|P2|Overall Study|Progression/relapse|2
5507102|NCT01598298|19040885|P1|Overall Study|Progression/relapse|0
5507103|NCT01598298|19040884|P2|Overall Study|Adverse Event|19
5507104|NCT01598298|19040885|P1|Overall Study|Adverse Event|21
5507105|NCT01598298|19040884|P2|Overall Study|Not eligible|5
5507106|NCT01598298|19040885|P1|Overall Study|Not eligible|5
5507107|NCT01598129|19040929|P1|Overall Study|Withdrawal by Subject|1
5507108|NCT01598129|19040929|P1|Overall Study|Deterioration of WHO status to WHO 4|2
5507109|NCT01598129|19040929|P1|Overall Study|Disease progression|6
5507110|NCT01598090|19040941|P3|Follow-up Period|Lost to Follow-up|12
5507111|NCT01598090|19040942|P2|Follow-up Period|Lost to Follow-up|10
5507112|NCT01598090|19040943|P1|Follow-up Period|Lost to Follow-up|2
5507113|NCT01598090|19040941|P3|Follow-up Period|Other reasons|8
5507114|NCT01598090|19040942|P2|Follow-up Period|Other reasons|8
5507115|NCT01598090|19040943|P1|Follow-up Period|Other reasons|2
5507116|NCT01598090|19040941|P3|Follow-up Period|Withdrawal by Subject|2
5507117|NCT01598090|19040942|P2|Follow-up Period|Withdrawal by Subject|3
5507118|NCT01598090|19040943|P1|Follow-up Period|Withdrawal by Subject|0
5507119|NCT01598090|19040941|P3|Follow-up Period|Not reported|4
5507120|NCT01598090|19040942|P2|Follow-up Period|Not reported|10
5507121|NCT01598090|19040943|P1|Follow-up Period|Not reported|0
5507122|NCT01598090|19040941|P3|Follow-up Period|No longer required per protocol|2
5507123|NCT01598090|19040942|P2|Follow-up Period|No longer required per protocol|3
5507124|NCT01598090|19040943|P1|Follow-up Period|No longer required per protocol|1
5507125|NCT01598090|19040941|P3|Follow-up Period|Death|0
5507126|NCT01598090|19040942|P2|Follow-up Period|Death|1
5507127|NCT01598090|19040943|P1|Follow-up Period|Death|0
5507128|NCT01598090|19040941|P3|Treatment Period|Lost to Follow-up|1
5507129|NCT01598090|19040942|P2|Treatment Period|Lost to Follow-up|5
5507130|NCT01598090|19040943|P1|Treatment Period|Lost to Follow-up|1
5507131|NCT01598090|19040941|P3|Treatment Period|Withdrawal by Subject|10
5507132|NCT01598090|19040942|P2|Treatment Period|Withdrawal by Subject|13
5507133|NCT01598090|19040943|P1|Treatment Period|Withdrawal by Subject|3
5507134|NCT01598090|19040941|P3|Treatment Period|Other reasons|1
5507135|NCT01598090|19040942|P2|Treatment Period|Other reasons|4
5507136|NCT01598090|19040943|P1|Treatment Period|Other reasons|0
5507137|NCT01598090|19040941|P3|Treatment Period|Adverse Event|17
5507138|NCT01598090|19040942|P2|Treatment Period|Adverse Event|33
5507139|NCT01598090|19040943|P1|Treatment Period|Adverse Event|2
5507140|NCT01598090|19040941|P3|Treatment Period|Lack of Efficacy|6
5507141|NCT01598090|19040942|P2|Treatment Period|Lack of Efficacy|14
5507142|NCT01598090|19040943|P1|Treatment Period|Lack of Efficacy|5
5507143|NCT01598090|19040941|P3|Treatment Period|No longer meet study criteria|0
5507144|NCT01598090|19040942|P2|Treatment Period|No longer meet study criteria|1
5507145|NCT01598090|19040943|P1|Treatment Period|No longer meet study criteria|0
5507146|NCT01598090|19040941|P3|Treatment Period|Poor/non-compliance|0
5507147|NCT01598090|19040942|P2|Treatment Period|Poor/non-compliance|2
5507148|NCT01598090|19040943|P1|Treatment Period|Poor/non-compliance|0
5507149|NCT01597908|19040990|P2|Overall Study|Ongoing|202
5507150|NCT01597908|19040991|P1|Overall Study|Ongoing|236
5507151|NCT01597908|19040990|P2|Overall Study|Withdrawal by Subject|18
5507152|NCT01597908|19040991|P1|Overall Study|Withdrawal by Subject|10
5507153|NCT01597908|19040990|P2|Overall Study|Physician Decision|1
5507154|NCT01597908|19040991|P1|Overall Study|Physician Decision|2
5507155|NCT01597908|19040990|P2|Overall Study|Lost to Follow-up|9
5507156|NCT01597908|19040991|P1|Overall Study|Lost to Follow-up|4
5507157|NCT01597908|19040990|P2|Overall Study|Death|122
5507158|NCT01597908|19040991|P1|Overall Study|Death|100
5507159|NCT01597791|19041037|P2|Overall Study|Protocol Violation|1
5507160|NCT01597791|19041038|P1|Overall Study|Protocol Violation|0
5507161|NCT01597791|19041037|P2|Overall Study|Subject withdrawal|1
5507162|NCT01597791|19041038|P1|Overall Study|Subject withdrawal|0
5507163|NCT01597791|19041037|P2|Overall Study|Cesarean Section|7
5507164|NCT01597791|19041038|P1|Overall Study|Cesarean Section|6
5507165|NCT01597791|19041037|P2|Overall Study|Physician Decision|1
5507166|NCT01597791|19041038|P1|Overall Study|Physician Decision|2
5507167|NCT01597635|19041125|P3|Part B|Withdrawal by Subject|0
5507168|NCT01597635|19041126|P2|Part B|Withdrawal by Subject|1
5507169|NCT01597635|19041127|P1|Part B|Withdrawal by Subject|0
5507170|NCT01597635|19041125|P3|Part B|Protocol-defined stopping criteria|3
5507171|NCT01597635|19041126|P2|Part B|Protocol-defined stopping criteria|4
5507172|NCT01597635|19041127|P1|Part B|Protocol-defined stopping criteria|0
5507173|NCT01597635|19041125|P3|Part B|Protocol Violation|0
5507174|NCT01597635|19041126|P2|Part B|Protocol Violation|1
5507175|NCT01597635|19041127|P1|Part B|Protocol Violation|0
5507176|NCT01597635|19041125|P3|Part B|Adverse Event|1
5507177|NCT01597635|19041126|P2|Part B|Adverse Event|0
5507178|NCT01597635|19041127|P1|Part B|Adverse Event|0
5507179|NCT01597635|19041125|P3|Part A|Adverse Event|0
5507180|NCT01597635|19041126|P2|Part A|Adverse Event|0
5507181|NCT01597635|19041127|P1|Part A|Adverse Event|3
5507182|NCT01597622|19041190|P1|Overall Study|Death|1
5507183|NCT01597622|19041190|P1|Overall Study|Withdrawal by Subject|20
5507184|NCT01597622|19041190|P1|Overall Study|Investigator Discretion|5
5507185|NCT01597622|19041190|P1|Overall Study|Lost to Follow-up|1
5507186|NCT01597622|19041190|P1|Overall Study|Protocol Violation|1
5507187|NCT01597622|19041190|P1|Overall Study|Lack of Efficacy|3
5507188|NCT01597622|19041190|P1|Overall Study|Adverse Event|7
5507189|NCT01597596|19041197|P2|Overall Study|Physician Decision|1
5507190|NCT01597596|19041198|P1|Overall Study|Physician Decision|0
5507191|NCT01597596|19041197|P2|Overall Study|Study terminated by sponsor|0
5507192|NCT01597596|19041198|P1|Overall Study|Study terminated by sponsor|1
5507193|NCT01597557|19041212|P2|Overall Study|Did not undergo cardioversion procedure|3
5507194|NCT01597557|19041213|P1|Overall Study|Did not undergo cardioversion procedure|4
5507195|NCT01597505|19041225|P2|Overall Study|Missing|0
5507196|NCT01597505|19041226|P1|Overall Study|Missing|1
5507197|NCT01597505|19041225|P2|Overall Study|Other|6
5507198|NCT01597505|19041226|P1|Overall Study|Other|5
5507199|NCT01597505|19041225|P2|Overall Study|Withdrawal by Subject|18
5507200|NCT01597505|19041226|P1|Overall Study|Withdrawal by Subject|10
5507201|NCT01597505|19041225|P2|Overall Study|Lost to Follow-up|2
5507202|NCT01597505|19041226|P1|Overall Study|Lost to Follow-up|4
5507203|NCT01597505|19041225|P2|Overall Study|Adverse Event|7
5507204|NCT01597505|19041226|P1|Overall Study|Adverse Event|19
5507205|NCT01597505|19041225|P2|Overall Study|Physician Decision|0
5507206|NCT01597505|19041226|P1|Overall Study|Physician Decision|5
5507207|NCT01597492|19041260|P2|Overall Study|Other Reason|0
5507208|NCT01597492|19041261|P1|Overall Study|Other Reason|2
5507209|NCT01597492|19041260|P2|Overall Study|Lost to Follow-up|2
5507210|NCT01597492|19041261|P1|Overall Study|Lost to Follow-up|0
5507211|NCT01597492|19041260|P2|Overall Study|Adverse Event|0
5507212|NCT01597492|19041261|P1|Overall Study|Adverse Event|3
5507213|NCT01597492|19041260|P2|Overall Study|Withdrawal by Subject|2
5507214|NCT01597492|19041261|P1|Overall Study|Withdrawal by Subject|1
5507215|NCT01597479|19041269|P2|Overall Study|Lost to Follow-up|0
5507216|NCT01597479|19041270|P1|Overall Study|Lost to Follow-up|1
5507217|NCT01597479|19041269|P2|Overall Study|Protocol Violation|0
5507218|NCT01597479|19041270|P1|Overall Study|Protocol Violation|1
5507219|NCT01597375|19041556|P2|Second Intervention|Failed to react at both Aspirin|1
5507220|NCT01597375|19041557|P1|Second Intervention|Failed to react at both Aspirin|1
5507221|NCT01597375|19041556|P2|Washout (2 Weeks)|Adverse Event|0
5507222|NCT01597375|19041557|P1|Washout (2 Weeks)|Adverse Event|1
5507223|NCT01597375|19041556|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
5507224|NCT01597375|19041557|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
5507225|NCT01597375|19041556|P2|First Intervention (4 Weeks)|Needed surgery|0
5507226|NCT01597375|19041557|P1|First Intervention (4 Weeks)|Needed surgery|1
5507227|NCT01597375|19041556|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
5507228|NCT01597375|19041557|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
5507229|NCT01597258|19041574|P1|Overall Study|No Drug Administration|1
5507230|NCT01597245|19041583|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507231|NCT01597245|19041584|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
5507232|NCT01597245|19041585|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507233|NCT01597245|19041586|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507234|NCT01597245|19041587|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507235|NCT01597245|19041588|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507236|NCT01597245|19041589|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507237|NCT01597245|19041590|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507238|NCT01597245|19041591|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507239|NCT01597245|19041592|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507240|NCT01597245|19041593|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507241|NCT01597245|19041594|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507242|NCT01597245|19041595|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507243|NCT01597245|19041596|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507244|NCT01597245|19041597|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507245|NCT01597245|19041598|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507246|NCT01597245|19041599|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507247|NCT01597245|19041600|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507248|NCT01597245|19041601|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507249|NCT01597245|19041602|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507250|NCT01597245|19041603|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
5507251|NCT01597245|19041583|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507252|NCT01597245|19041584|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
5507253|NCT01597245|19041585|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507254|NCT01597245|19041586|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507255|NCT01597245|19041587|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
5507256|NCT01597245|19041588|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507257|NCT01597245|19041589|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507258|NCT01597245|19041590|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507259|NCT01597245|19041591|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507260|NCT01597245|19041592|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507261|NCT01597245|19041593|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507262|NCT01597245|19041594|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507263|NCT01597245|19041595|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507264|NCT01597245|19041596|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507265|NCT01597245|19041597|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507266|NCT01597245|19041598|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507267|NCT01597245|19041599|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507268|NCT01597245|19041600|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507269|NCT01597245|19041601|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507270|NCT01597245|19041602|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507271|NCT01597245|19041603|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
5507272|NCT01597245|19041583|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507273|NCT01597245|19041584|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
5507274|NCT01597245|19041585|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507275|NCT01597245|19041586|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507276|NCT01597245|19041587|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
5507277|NCT01597245|19041588|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507278|NCT01597245|19041589|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507279|NCT01597245|19041590|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507280|NCT01597245|19041591|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507281|NCT01597245|19041592|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507282|NCT01597245|19041593|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507283|NCT01597245|19041594|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507284|NCT01597245|19041595|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507285|NCT01597245|19041596|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507286|NCT01597245|19041597|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507287|NCT01597245|19041598|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507288|NCT01597245|19041599|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507289|NCT01597245|19041600|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507290|NCT01597245|19041601|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507291|NCT01597245|19041602|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507292|NCT01597245|19041603|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
5507293|NCT01597245|19041583|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
5507294|NCT01597245|19041584|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
5507295|NCT01597245|19041585|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507296|NCT01597245|19041586|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507297|NCT01597245|19041587|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
5507298|NCT01597245|19041588|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507299|NCT01597245|19041589|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507300|NCT01597245|19041590|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507301|NCT01597245|19041591|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507302|NCT01597245|19041592|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507303|NCT01597245|19041593|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507304|NCT01597245|19041594|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507305|NCT01597245|19041595|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507306|NCT01597245|19041596|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507307|NCT01597245|19041597|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507308|NCT01597245|19041598|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507309|NCT01597245|19041599|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507310|NCT01597245|19041600|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507311|NCT01597245|19041601|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507312|NCT01597245|19041602|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507313|NCT01597245|19041603|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
5507314|NCT01597245|19041583|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
5507315|NCT01597245|19041584|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
5507316|NCT01597245|19041585|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507317|NCT01597245|19041586|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507318|NCT01597245|19041587|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
5507319|NCT01597245|19041588|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507320|NCT01597245|19041589|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507321|NCT01597245|19041590|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507322|NCT01597245|19041591|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507323|NCT01597245|19041592|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507324|NCT01597245|19041593|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507325|NCT01597245|19041594|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507326|NCT01597245|19041595|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507327|NCT01597245|19041596|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507328|NCT01597245|19041597|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507329|NCT01597245|19041598|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507330|NCT01597245|19041599|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507331|NCT01597245|19041600|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507332|NCT01597245|19041601|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507333|NCT01597245|19041602|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507334|NCT01597245|19041603|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
5507335|NCT01597245|19041583|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
5508046|NCT01595009|19042368|P4|Extension|Administrative problems|1
5507336|NCT01597245|19041584|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
5507337|NCT01597245|19041585|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
5507338|NCT01597245|19041586|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507339|NCT01597245|19041587|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507340|NCT01597245|19041588|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507341|NCT01597245|19041589|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507342|NCT01597245|19041590|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507343|NCT01597245|19041591|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507344|NCT01597245|19041592|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507345|NCT01597245|19041593|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507346|NCT01597245|19041594|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507347|NCT01597245|19041595|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507348|NCT01597245|19041596|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507349|NCT01597245|19041597|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507350|NCT01597245|19041598|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507351|NCT01597245|19041599|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507352|NCT01597245|19041600|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507353|NCT01597245|19041601|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507354|NCT01597245|19041602|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507355|NCT01597245|19041603|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
5507356|NCT01597245|19041583|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
5507357|NCT01597245|19041584|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
5507358|NCT01597245|19041585|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507359|NCT01597245|19041586|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507360|NCT01597245|19041587|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
5507361|NCT01597245|19041588|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507362|NCT01597245|19041589|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507363|NCT01597245|19041590|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507364|NCT01597245|19041591|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507365|NCT01597245|19041592|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507366|NCT01597245|19041593|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507367|NCT01597245|19041594|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507368|NCT01597245|19041595|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507369|NCT01597245|19041596|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507370|NCT01597245|19041597|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507371|NCT01597245|19041598|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507372|NCT01597245|19041599|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507373|NCT01597245|19041600|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507374|NCT01597245|19041601|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507375|NCT01597245|19041602|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507376|NCT01597245|19041603|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
5507377|NCT01597245|19041583|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
5507378|NCT01597245|19041584|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
5507379|NCT01597245|19041585|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
5507380|NCT01597245|19041586|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
5507381|NCT01597245|19041587|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507382|NCT01597245|19041588|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507383|NCT01597245|19041589|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507384|NCT01597245|19041590|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507385|NCT01597245|19041591|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507386|NCT01597245|19041592|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507387|NCT01597245|19041593|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507388|NCT01597245|19041594|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507389|NCT01597245|19041595|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507390|NCT01597245|19041596|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507391|NCT01597245|19041597|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507392|NCT01597245|19041598|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507393|NCT01597245|19041599|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507394|NCT01597245|19041600|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507395|NCT01597245|19041601|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507396|NCT01597245|19041602|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507397|NCT01597245|19041603|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
5507398|NCT01597245|19041583|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
5507399|NCT01597245|19041584|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
5507400|NCT01597245|19041585|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
5507401|NCT01597245|19041586|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
5507402|NCT01597245|19041587|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
5507403|NCT01597245|19041588|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5508047|NCT01595009|19042369|P3|Extension|Administrative problems|0
5507404|NCT01597245|19041589|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507405|NCT01597245|19041590|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507406|NCT01597245|19041591|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507407|NCT01597245|19041592|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507408|NCT01597245|19041593|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507409|NCT01597245|19041594|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507410|NCT01597245|19041595|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507411|NCT01597245|19041596|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507412|NCT01597245|19041597|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507413|NCT01597245|19041598|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507414|NCT01597245|19041599|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507415|NCT01597245|19041600|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507416|NCT01597245|19041601|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507417|NCT01597245|19041602|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507418|NCT01597245|19041603|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
5507419|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507420|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507421|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507422|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507423|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507424|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507425|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507426|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
5507427|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507428|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507429|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507430|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507431|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507432|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507433|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507434|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507435|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507436|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507437|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507438|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507439|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
5507440|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507441|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507442|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507443|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507444|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507445|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
5507446|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
5507447|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507448|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507449|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507450|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507451|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507452|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507453|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507454|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507455|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507456|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507457|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507458|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507459|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507460|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
5507461|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507462|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507463|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507464|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507465|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507466|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
5507467|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
5507468|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507469|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507470|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507471|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5508048|NCT01595009|19042370|P2|Extension|Administrative problems|0
5507472|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507473|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507474|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507475|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507476|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507477|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507478|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507479|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507480|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507481|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
5507482|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507483|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507484|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507485|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507486|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507487|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
5507488|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
5507489|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507490|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507491|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507492|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507493|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507494|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507495|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507496|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507497|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507498|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507499|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507500|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507501|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507502|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
5507503|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Death|0
5507504|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Death|0
5507505|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Death|0
5507506|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Death|0
5507507|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Death|0
5507508|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Death|8
5507509|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Death|8
5507510|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Death|0
5507511|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Death|0
5507512|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Death|0
5507513|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Death|0
5507514|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Death|0
5507515|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Death|0
5507516|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Death|0
5507517|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Death|0
5507518|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Death|0
5507519|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Death|0
5507520|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Death|0
5507521|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Death|0
5507522|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Death|0
5507523|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Death|0
5507524|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507525|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507526|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507527|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507528|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507529|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
5507530|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
5507531|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
5507532|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507533|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507534|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507535|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507536|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507537|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507538|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507539|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507540|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507541|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507542|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5508049|NCT01595009|19042371|P1|Extension|Administrative problems|0
5507543|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507544|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
5507545|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507546|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507547|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507548|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507549|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507550|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
5507551|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
5507552|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507553|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507554|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507555|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507556|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507557|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507558|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507559|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507560|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507561|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507562|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507563|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507564|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507565|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
5507566|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507567|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507568|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507569|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507570|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507571|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
5507572|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
5507573|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507574|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507575|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507576|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507577|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507578|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507579|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507580|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507581|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507582|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507583|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507584|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507585|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507586|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
5507587|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507588|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507589|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507590|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507591|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507592|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
5507593|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
5507594|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
5507595|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507596|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507597|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507598|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507599|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507600|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507601|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507602|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507603|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507604|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507605|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507606|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507607|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
5507608|NCT01597245|19041583|P21|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507609|NCT01597245|19041584|P20|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507610|NCT01597245|19041585|P19|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5508050|NCT01595009|19042368|P4|Core|Administrative problems|0
5507611|NCT01597245|19041586|P18|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507612|NCT01597245|19041587|P17|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507613|NCT01597245|19041588|P16|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
5507614|NCT01597245|19041589|P15|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
5507615|NCT01597245|19041590|P14|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
5507616|NCT01597245|19041591|P13|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507617|NCT01597245|19041592|P12|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507618|NCT01597245|19041593|P11|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507619|NCT01597245|19041594|P10|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507620|NCT01597245|19041595|P9|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507621|NCT01597245|19041596|P8|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507622|NCT01597245|19041597|P7|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507623|NCT01597245|19041598|P6|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507624|NCT01597245|19041599|P5|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507625|NCT01597245|19041600|P4|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507626|NCT01597245|19041601|P3|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507627|NCT01597245|19041602|P2|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507628|NCT01597245|19041603|P1|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
5507629|NCT01597245|19041583|P21|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507630|NCT01597245|19041584|P20|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507631|NCT01597245|19041585|P19|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507632|NCT01597245|19041586|P18|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507633|NCT01597245|19041587|P17|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507634|NCT01597245|19041588|P16|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507635|NCT01597245|19041589|P15|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507636|NCT01597245|19041590|P14|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507637|NCT01597245|19041591|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507638|NCT01597245|19041592|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507639|NCT01597245|19041593|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
5507640|NCT01597245|19041594|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507641|NCT01597245|19041595|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507642|NCT01597245|19041596|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507643|NCT01597245|19041597|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507644|NCT01597245|19041598|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507645|NCT01597245|19041599|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507646|NCT01597245|19041600|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507647|NCT01597245|19041601|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507648|NCT01597245|19041602|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507649|NCT01597245|19041603|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
5507650|NCT01597245|19041583|P21|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507651|NCT01597245|19041584|P20|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507652|NCT01597245|19041585|P19|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507653|NCT01597245|19041586|P18|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507654|NCT01597245|19041587|P17|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507655|NCT01597245|19041588|P16|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507656|NCT01597245|19041589|P15|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507657|NCT01597245|19041590|P14|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507658|NCT01597245|19041591|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507659|NCT01597245|19041592|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5507660|NCT01597245|19041593|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5507661|NCT01597245|19041594|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5507662|NCT01597245|19041595|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5507663|NCT01597245|19041596|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507664|NCT01597245|19041597|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507665|NCT01597245|19041598|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
5507666|NCT01597245|19041599|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507667|NCT01597245|19041600|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507668|NCT01597245|19041601|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507669|NCT01597245|19041602|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507670|NCT01597245|19041603|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
5507671|NCT01597245|19041583|P21|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507672|NCT01597245|19041584|P20|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507673|NCT01597245|19041585|P19|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507674|NCT01597245|19041586|P18|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507675|NCT01597245|19041587|P17|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507676|NCT01597245|19041588|P16|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507677|NCT01597245|19041589|P15|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507678|NCT01597245|19041590|P14|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507679|NCT01597245|19041591|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
5507680|NCT01597245|19041592|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
5507681|NCT01597245|19041593|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
5507682|NCT01597245|19041594|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
5507683|NCT01597245|19041595|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
5507684|NCT01597245|19041596|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507685|NCT01597245|19041597|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
5507686|NCT01597245|19041598|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
5507687|NCT01597245|19041599|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
5507688|NCT01597245|19041600|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507689|NCT01597245|19041601|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507690|NCT01597245|19041602|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507691|NCT01597245|19041603|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
5507692|NCT01597245|19041583|P21|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507693|NCT01597245|19041584|P20|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507694|NCT01597245|19041585|P19|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507695|NCT01597245|19041586|P18|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507696|NCT01597245|19041587|P17|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507697|NCT01597245|19041588|P16|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507698|NCT01597245|19041589|P15|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507699|NCT01597245|19041590|P14|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507700|NCT01597245|19041591|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
5507701|NCT01597245|19041592|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507702|NCT01597245|19041593|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
5507703|NCT01597245|19041594|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
5507704|NCT01597245|19041595|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
5507705|NCT01597245|19041596|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507706|NCT01597245|19041597|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507707|NCT01597245|19041598|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507708|NCT01597245|19041599|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
5507709|NCT01597245|19041600|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507710|NCT01597245|19041601|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507711|NCT01597245|19041602|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507712|NCT01597245|19041603|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
5507713|NCT01597245|19041583|P21|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507714|NCT01597245|19041584|P20|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507715|NCT01597245|19041585|P19|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507716|NCT01597245|19041586|P18|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507717|NCT01597245|19041587|P17|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507718|NCT01597245|19041588|P16|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507719|NCT01597245|19041589|P15|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507720|NCT01597245|19041590|P14|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507721|NCT01597245|19041591|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
5507722|NCT01597245|19041592|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
5507723|NCT01597245|19041593|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
5507724|NCT01597245|19041594|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
5507725|NCT01597245|19041595|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
5507726|NCT01597245|19041596|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507727|NCT01597245|19041597|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
5507728|NCT01597245|19041598|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
5507729|NCT01597245|19041599|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
5507730|NCT01597245|19041600|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507731|NCT01597245|19041601|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507732|NCT01597245|19041602|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507733|NCT01597245|19041603|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
5507734|NCT01597245|19041583|P21|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507735|NCT01597245|19041584|P20|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507736|NCT01597245|19041585|P19|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507737|NCT01597245|19041586|P18|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507738|NCT01597245|19041587|P17|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507739|NCT01597245|19041588|P16|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507740|NCT01597245|19041589|P15|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507741|NCT01597245|19041590|P14|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507742|NCT01597245|19041591|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
5507743|NCT01597245|19041592|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
5507744|NCT01597245|19041593|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
5507745|NCT01597245|19041594|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
5507746|NCT01597245|19041595|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
5507747|NCT01597245|19041596|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
5507748|NCT01597245|19041597|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
5508051|NCT01595009|19042369|P3|Core|Administrative problems|0
5507749|NCT01597245|19041598|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
5507750|NCT01597245|19041599|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
5507751|NCT01597245|19041600|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507752|NCT01597245|19041601|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507753|NCT01597245|19041602|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507754|NCT01597245|19041603|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
5507755|NCT01597245|19041583|P21|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507756|NCT01597245|19041584|P20|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507757|NCT01597245|19041585|P19|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507758|NCT01597245|19041586|P18|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507759|NCT01597245|19041587|P17|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507760|NCT01597245|19041588|P16|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507761|NCT01597245|19041589|P15|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507762|NCT01597245|19041590|P14|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507763|NCT01597245|19041591|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
5507764|NCT01597245|19041592|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
5507765|NCT01597245|19041593|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
5507766|NCT01597245|19041594|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507767|NCT01597245|19041595|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
5507768|NCT01597245|19041596|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507769|NCT01597245|19041597|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507770|NCT01597245|19041598|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
5507771|NCT01597245|19041599|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507772|NCT01597245|19041600|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507773|NCT01597245|19041601|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507774|NCT01597245|19041602|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507775|NCT01597245|19041603|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
5507776|NCT01597245|19041583|P21|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507777|NCT01597245|19041584|P20|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507778|NCT01597245|19041585|P19|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507779|NCT01597245|19041586|P18|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507780|NCT01597245|19041587|P17|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507781|NCT01597245|19041588|P16|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507782|NCT01597245|19041589|P15|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507783|NCT01597245|19041590|P14|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507784|NCT01597245|19041591|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507785|NCT01597245|19041592|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507786|NCT01597245|19041593|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507787|NCT01597245|19041594|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|114
5507788|NCT01597245|19041595|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507789|NCT01597245|19041596|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
5507790|NCT01597245|19041597|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|80
5507791|NCT01597245|19041598|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|22
5507792|NCT01597245|19041599|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|150
5507793|NCT01597245|19041600|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507794|NCT01597245|19041601|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507795|NCT01597245|19041602|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507796|NCT01597245|19041603|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
5507797|NCT01597245|19041583|P21|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507798|NCT01597245|19041584|P20|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507799|NCT01597245|19041585|P19|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507800|NCT01597245|19041586|P18|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507801|NCT01597245|19041587|P17|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507802|NCT01597245|19041588|P16|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507803|NCT01597245|19041589|P15|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507804|NCT01597245|19041590|P14|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507805|NCT01597245|19041591|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507806|NCT01597245|19041592|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507807|NCT01597245|19041593|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507808|NCT01597245|19041594|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507809|NCT01597245|19041595|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507810|NCT01597245|19041596|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507811|NCT01597245|19041597|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
5507812|NCT01597245|19041598|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
5507813|NCT01597245|19041599|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507814|NCT01597245|19041600|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507815|NCT01597245|19041601|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507816|NCT01597245|19041602|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507817|NCT01597245|19041603|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
5507818|NCT01597245|19041583|P21|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507819|NCT01597245|19041584|P20|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5508052|NCT01595009|19042370|P2|Core|Administrative problems|1
5507820|NCT01597245|19041585|P19|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507821|NCT01597245|19041586|P18|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507822|NCT01597245|19041587|P17|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507823|NCT01597245|19041588|P16|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507824|NCT01597245|19041589|P15|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507825|NCT01597245|19041590|P14|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507826|NCT01597245|19041591|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507827|NCT01597245|19041592|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507828|NCT01597245|19041593|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507829|NCT01597245|19041594|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507830|NCT01597245|19041595|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507831|NCT01597245|19041596|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507832|NCT01597245|19041597|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507833|NCT01597245|19041598|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507834|NCT01597245|19041599|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507835|NCT01597245|19041600|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
5507836|NCT01597245|19041601|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
5507837|NCT01597245|19041602|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
5507838|NCT01597245|19041603|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
5507839|NCT01597245|19041583|P21|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507840|NCT01597245|19041584|P20|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507841|NCT01597245|19041585|P19|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507842|NCT01597245|19041586|P18|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507843|NCT01597245|19041587|P17|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507844|NCT01597245|19041588|P16|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507845|NCT01597245|19041589|P15|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507846|NCT01597245|19041590|P14|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507847|NCT01597245|19041591|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507848|NCT01597245|19041592|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507849|NCT01597245|19041593|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507850|NCT01597245|19041594|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507851|NCT01597245|19041595|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507852|NCT01597245|19041596|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507853|NCT01597245|19041597|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507854|NCT01597245|19041598|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507855|NCT01597245|19041599|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507856|NCT01597245|19041600|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
5507857|NCT01597245|19041601|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507858|NCT01597245|19041602|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
5507859|NCT01597245|19041603|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
5507860|NCT01597245|19041583|P21|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507861|NCT01597245|19041584|P20|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507862|NCT01597245|19041585|P19|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507863|NCT01597245|19041586|P18|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507864|NCT01597245|19041587|P17|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507865|NCT01597245|19041588|P16|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507866|NCT01597245|19041589|P15|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507867|NCT01597245|19041590|P14|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507868|NCT01597245|19041591|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507869|NCT01597245|19041592|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507870|NCT01597245|19041593|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507871|NCT01597245|19041594|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507872|NCT01597245|19041595|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507873|NCT01597245|19041596|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507874|NCT01597245|19041597|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507875|NCT01597245|19041598|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507876|NCT01597245|19041599|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507877|NCT01597245|19041600|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
5507878|NCT01597245|19041601|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
5507879|NCT01597245|19041602|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
5507880|NCT01597245|19041603|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
5507881|NCT01597245|19041583|P21|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507882|NCT01597245|19041584|P20|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507883|NCT01597245|19041585|P19|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507884|NCT01597245|19041586|P18|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507885|NCT01597245|19041587|P17|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507886|NCT01597245|19041588|P16|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507887|NCT01597245|19041589|P15|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507888|NCT01597245|19041590|P14|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507889|NCT01597245|19041591|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507890|NCT01597245|19041592|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507891|NCT01597245|19041593|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507892|NCT01597245|19041594|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507893|NCT01597245|19041595|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507894|NCT01597245|19041596|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507895|NCT01597245|19041597|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507896|NCT01597245|19041598|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507897|NCT01597245|19041599|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
5507898|NCT01597245|19041600|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
5507899|NCT01597245|19041601|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
5507900|NCT01597245|19041602|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
5507901|NCT01597245|19041603|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
5507902|NCT01597245|19041583|P21|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507903|NCT01597245|19041584|P20|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507904|NCT01597245|19041585|P19|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507905|NCT01597245|19041586|P18|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507906|NCT01597245|19041587|P17|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507907|NCT01597245|19041588|P16|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507908|NCT01597245|19041589|P15|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507909|NCT01597245|19041590|P14|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507910|NCT01597245|19041591|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507911|NCT01597245|19041592|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507912|NCT01597245|19041593|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507913|NCT01597245|19041594|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507914|NCT01597245|19041595|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507915|NCT01597245|19041596|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507916|NCT01597245|19041597|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507917|NCT01597245|19041598|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507918|NCT01597245|19041599|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
5507919|NCT01597245|19041600|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
5507920|NCT01597245|19041601|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
5507921|NCT01597245|19041602|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
5507922|NCT01597245|19041603|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
5507923|NCT01597245|19041583|P21|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507924|NCT01597245|19041584|P20|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507925|NCT01597245|19041585|P19|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507926|NCT01597245|19041586|P18|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507927|NCT01597245|19041587|P17|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507928|NCT01597245|19041588|P16|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507929|NCT01597245|19041589|P15|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507930|NCT01597245|19041590|P14|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507931|NCT01597245|19041591|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507932|NCT01597245|19041592|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507933|NCT01597245|19041593|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507934|NCT01597245|19041594|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507935|NCT01597245|19041595|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507936|NCT01597245|19041596|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507937|NCT01597245|19041597|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507938|NCT01597245|19041598|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507939|NCT01597245|19041599|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
5507940|NCT01597245|19041600|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
5507941|NCT01597245|19041601|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
5507942|NCT01597245|19041602|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
5507943|NCT01597245|19041603|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
5507944|NCT01597193|19041701|P7|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5507945|NCT01597193|19041702|P6|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
5507946|NCT01597193|19041703|P5|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5507947|NCT01597193|19041704|P4|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
5507948|NCT01597193|19041705|P3|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5507949|NCT01597193|19041706|P2|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5507950|NCT01597193|19041707|P1|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
5507951|NCT01597193|19041701|P7|Stage 2: Dose Expansion (1067 Days)|Other|0
5507952|NCT01597193|19041702|P6|Stage 2: Dose Expansion (1067 Days)|Other|1
5507953|NCT01597193|19041703|P5|Stage 2: Dose Expansion (1067 Days)|Other|0
5507954|NCT01597193|19041704|P4|Stage 2: Dose Expansion (1067 Days)|Other|0
5507955|NCT01597193|19041705|P3|Stage 2: Dose Expansion (1067 Days)|Other|0
5507956|NCT01597193|19041706|P2|Stage 2: Dose Expansion (1067 Days)|Other|0
5507957|NCT01597193|19041707|P1|Stage 2: Dose Expansion (1067 Days)|Other|0
5507958|NCT01597193|19041701|P7|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
5507959|NCT01597193|19041702|P6|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
5507960|NCT01597193|19041703|P5|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
5507961|NCT01597193|19041704|P4|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
5507962|NCT01597193|19041705|P3|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
5507963|NCT01597193|19041706|P2|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
5507964|NCT01597193|19041707|P1|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
5507965|NCT01597193|19041701|P7|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5507966|NCT01597193|19041702|P6|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
5507967|NCT01597193|19041703|P5|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
5507968|NCT01597193|19041704|P4|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
5507969|NCT01597193|19041705|P3|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5507970|NCT01597193|19041706|P2|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5507971|NCT01597193|19041707|P1|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
5507972|NCT01597193|19041701|P7|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5507973|NCT01597193|19041702|P6|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5507974|NCT01597193|19041703|P5|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5507975|NCT01597193|19041704|P4|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5507976|NCT01597193|19041705|P3|Stage 1: Dose Escalation (141 Days)|Disease progression|0
5507977|NCT01597193|19041706|P2|Stage 1: Dose Escalation (141 Days)|Disease progression|8
5507978|NCT01597193|19041707|P1|Stage 1: Dose Escalation (141 Days)|Disease progression|7
5507979|NCT01597050|19041826|P2|Overall Study|Withdrawal by Subject|0
5507980|NCT01597050|19041827|P1|Overall Study|Withdrawal by Subject|1
5507981|NCT01596972|19041835|P2|Overall Study|Withdrawal by Subject|1
5507982|NCT01596972|19041836|P1|Overall Study|Withdrawal by Subject|0
5507983|NCT01596972|19041835|P2|Overall Study|Lost to Follow-up|4
5507984|NCT01596972|19041836|P1|Overall Study|Lost to Follow-up|0
5507985|NCT01596972|19041835|P2|Overall Study|Physician Decision|9
5507986|NCT01596972|19041836|P1|Overall Study|Physician Decision|1
5507987|NCT01596582|19041908|P2|Overall Study|Missing all outcome data|1
5507988|NCT01596582|19041909|P1|Overall Study|Missing all outcome data|1
5507989|NCT01596582|19041908|P2|Overall Study|Deemed ineligible after study visit|6
5507990|NCT01596582|19041909|P1|Overall Study|Deemed ineligible after study visit|3
5507991|NCT01596504|19041936|P3|Overall Study|Withdrawal by Subject|0
5507992|NCT01596504|19041937|P2|Overall Study|Withdrawal by Subject|0
5507993|NCT01596504|19041938|P1|Overall Study|Withdrawal by Subject|1
5507994|NCT01596504|19041936|P3|Overall Study|Adverse Event|1
5507995|NCT01596504|19041937|P2|Overall Study|Adverse Event|2
5507996|NCT01596504|19041938|P1|Overall Study|Adverse Event|1
5507997|NCT01596504|19041936|P3|Overall Study|Participant's Private Reason|0
5507998|NCT01596504|19041937|P2|Overall Study|Participant's Private Reason|1
5507999|NCT01596504|19041938|P1|Overall Study|Participant's Private Reason|0
5508000|NCT01596335|19041996|P2|Overall Study|exacerbation of primary disease|9
5508001|NCT01596335|19041997|P1|Overall Study|exacerbation of primary disease|5
5508002|NCT01596127|19042033|P1|Overall Study|Patient Ineligible|1
5508003|NCT01596062|19042045|P3|Overall Study|Lack of Efficacy|1
5508004|NCT01596062|19042046|P2|Overall Study|Lack of Efficacy|0
5508005|NCT01596062|19042047|P1|Overall Study|Lack of Efficacy|0
5508006|NCT01596062|19042045|P3|Overall Study|Adverse Event|2
5508007|NCT01596062|19042046|P2|Overall Study|Adverse Event|0
5508008|NCT01596062|19042047|P1|Overall Study|Adverse Event|1
5508009|NCT01595646|19042111|P3|Overall Study|Withdrawal by Subject|0
5508010|NCT01595646|19042112|P2|Overall Study|Withdrawal by Subject|0
5508011|NCT01595646|19042113|P1|Overall Study|Withdrawal by Subject|1
5508012|NCT01595529|19042135|P2|Overall Study|Entry Failure/Screening Failure|1
5508013|NCT01595529|19042136|P1|Overall Study|Entry Failure/Screening Failure|6
5508014|NCT01595529|19042135|P2|Overall Study|Administrative Decision|0
5508015|NCT01595529|19042136|P1|Overall Study|Administrative Decision|1
5508016|NCT01595529|19042135|P2|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
5508017|NCT01595529|19042136|P1|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
5508018|NCT01595529|19042135|P2|Overall Study|Physician Decision|0
5508019|NCT01595529|19042136|P1|Overall Study|Physician Decision|1
5508020|NCT01595529|19042135|P2|Overall Study|Protocol Violation|2
5508021|NCT01595529|19042136|P1|Overall Study|Protocol Violation|1
5508022|NCT01595529|19042135|P2|Overall Study|Lost to Follow-up|14
5508023|NCT01595529|19042136|P1|Overall Study|Lost to Follow-up|8
5508024|NCT01595529|19042135|P2|Overall Study|Subject Non-Compliant|0
5508025|NCT01595529|19042136|P1|Overall Study|Subject Non-Compliant|2
5508026|NCT01595529|19042135|P2|Overall Study|Adverse Event|0
5508027|NCT01595529|19042136|P1|Overall Study|Adverse Event|2
5508028|NCT01595438|19042199|P2|Overall Study|Other Eligibility criteria|9
5508029|NCT01595438|19042200|P1|Overall Study|Other Eligibility criteria|11
5508030|NCT01595438|19042199|P2|Overall Study|Withdrawal by Subject|12
5508031|NCT01595438|19042200|P1|Overall Study|Withdrawal by Subject|12
5508032|NCT01595438|19042199|P2|Overall Study|Lost to Follow-up|20
5508033|NCT01595438|19042200|P1|Overall Study|Lost to Follow-up|20
5508034|NCT01595009|19042368|P4|Extension|Adverse Event|1
5508035|NCT01595009|19042369|P3|Extension|Adverse Event|0
5508036|NCT01595009|19042370|P2|Extension|Adverse Event|0
5508037|NCT01595009|19042371|P1|Extension|Adverse Event|0
5508038|NCT01595009|19042368|P4|Extension|Disease progression|7
5508039|NCT01595009|19042369|P3|Extension|Disease progression|4
5508040|NCT01595009|19042370|P2|Extension|Disease progression|0
5508041|NCT01595009|19042371|P1|Extension|Disease progression|0
5508042|NCT01595009|19042368|P4|Extension|Patients completed per protocol|2
5508043|NCT01595009|19042369|P3|Extension|Patients completed per protocol|0
5508044|NCT01595009|19042370|P2|Extension|Patients completed per protocol|0
5508045|NCT01595009|19042371|P1|Extension|Patients completed per protocol|0
5508053|NCT01595009|19042371|P1|Core|Administrative problems|0
5508054|NCT01595009|19042368|P4|Core|Protocol deviation|0
5508055|NCT01595009|19042369|P3|Core|Protocol deviation|0
5508056|NCT01595009|19042370|P2|Core|Protocol deviation|1
5508057|NCT01595009|19042371|P1|Core|Protocol deviation|0
5508058|NCT01595009|19042368|P4|Core|Lost to Follow-up|0
5508059|NCT01595009|19042369|P3|Core|Lost to Follow-up|0
5508060|NCT01595009|19042370|P2|Core|Lost to Follow-up|2
5508061|NCT01595009|19042371|P1|Core|Lost to Follow-up|1
5508062|NCT01595009|19042368|P4|Core|Death|0
5508063|NCT01595009|19042369|P3|Core|Death|0
5508064|NCT01595009|19042370|P2|Core|Death|6
5508065|NCT01595009|19042371|P1|Core|Death|3
5508066|NCT01595009|19042368|P4|Core|Withdrawal by Subject|0
5508067|NCT01595009|19042369|P3|Core|Withdrawal by Subject|0
5508068|NCT01595009|19042370|P2|Core|Withdrawal by Subject|17
5508069|NCT01595009|19042371|P1|Core|Withdrawal by Subject|4
5508070|NCT01595009|19042368|P4|Core|Disease progression|0
5508071|NCT01595009|19042369|P3|Core|Disease progression|0
5508072|NCT01595009|19042370|P2|Core|Disease progression|26
5508073|NCT01595009|19042371|P1|Core|Disease progression|14
5508074|NCT01595009|19042368|P4|Core|Adverse Event|0
5508075|NCT01595009|19042369|P3|Core|Adverse Event|0
5508076|NCT01595009|19042370|P2|Core|Adverse Event|23
5508077|NCT01595009|19042371|P1|Core|Adverse Event|19
5508078|NCT01595009|19042368|P4|Core|Patients completed per protocol|0
5508079|NCT01595009|19042369|P3|Core|Patients completed per protocol|0
5508080|NCT01595009|19042370|P2|Core|Patients completed per protocol|44
5508081|NCT01595009|19042371|P1|Core|Patients completed per protocol|85
5508082|NCT01594970|19042406|P3|Overall Study|Lost to Follow-up|37
5508083|NCT01594970|19042407|P2|Overall Study|Lost to Follow-up|54
5508084|NCT01594970|19042408|P1|Overall Study|Lost to Follow-up|54
5508085|NCT01594970|19042406|P3|Overall Study|Adverse Event|23
5508086|NCT01594970|19042407|P2|Overall Study|Adverse Event|23
5508087|NCT01594970|19042408|P1|Overall Study|Adverse Event|17
5508088|NCT01594970|19042406|P3|Overall Study|Non-Adverse Event Related|6
5508089|NCT01594970|19042407|P2|Overall Study|Non-Adverse Event Related|5
5508090|NCT01594970|19042408|P1|Overall Study|Non-Adverse Event Related|4
5508091|NCT01594853|19042427|P2|Overall Study|noncompliance with exercise|1
5508092|NCT01594853|19042428|P1|Overall Study|noncompliance with exercise|0
5508093|NCT01594853|19042427|P2|Overall Study|Lost to Follow-up|1
5508094|NCT01594853|19042428|P1|Overall Study|Lost to Follow-up|1
5508095|NCT01594853|19042427|P2|Overall Study|Withdrawal by Subject|1
5508096|NCT01594853|19042428|P1|Overall Study|Withdrawal by Subject|1
5508097|NCT01594827|19042436|P2|Overall Study|Physician Decision|0
5508098|NCT01594827|19042437|P1|Overall Study|Physician Decision|3
5508099|NCT01594827|19042436|P2|Overall Study|Adverse Event|0
5508100|NCT01594827|19042437|P1|Overall Study|Adverse Event|1
5508101|NCT01594762|19042461|P2|Overall Study|Lost to Follow-up|10
5508102|NCT01594762|19042462|P1|Overall Study|Lost to Follow-up|10
5508103|NCT01594762|19042461|P2|Overall Study|Withdrawal by Subject|0
5508104|NCT01594762|19042462|P1|Overall Study|Withdrawal by Subject|1
5508105|NCT01594749|19042474|P2|Overall Study|Lost Source Documentation|0
5508106|NCT01594749|19042475|P1|Overall Study|Lost Source Documentation|1
5508107|NCT01594749|19042474|P2|Overall Study|Not Treated|10
5508108|NCT01594749|19042475|P1|Overall Study|Not Treated|4
5508109|NCT01594749|19042474|P2|Overall Study|Death|3
5508110|NCT01594749|19042475|P1|Overall Study|Death|9
5508111|NCT01594749|19042474|P2|Overall Study|Lost to Follow-up|0
5508112|NCT01594749|19042475|P1|Overall Study|Lost to Follow-up|1
5508113|NCT01594749|19042474|P2|Overall Study|Non-compliance with Protocol|1
5508114|NCT01594749|19042475|P1|Overall Study|Non-compliance with Protocol|0
5508115|NCT01594749|19042474|P2|Overall Study|Physician Decision|1
5508116|NCT01594749|19042475|P1|Overall Study|Physician Decision|1
5508117|NCT01594749|19042474|P2|Overall Study|Protocol Violation|0
5508118|NCT01594749|19042475|P1|Overall Study|Protocol Violation|2
5508119|NCT01594749|19042474|P2|Overall Study|Withdrawal by Subject|2
5508120|NCT01594749|19042475|P1|Overall Study|Withdrawal by Subject|2
5508121|NCT01594749|19042474|P2|Overall Study|Adverse Event|1
5508122|NCT01594749|19042475|P1|Overall Study|Adverse Event|2
5508123|NCT01594476|19042613|P2|Overall Study|Protocol Violation|3
5508124|NCT01594476|19042614|P1|Overall Study|Protocol Violation|1
5508125|NCT01594411|19042636|P1|Overall Study|Lost to Follow-up|2
5508126|NCT01594333|19042670|P2|Overall Study|Withdrawal by Subject|63
5508127|NCT01594333|19042671|P1|Overall Study|Withdrawal by Subject|60
5508128|NCT01594333|19042670|P2|Overall Study|Lost to Follow-up|5
5508129|NCT01594333|19042671|P1|Overall Study|Lost to Follow-up|5
5508130|NCT01594333|19042670|P2|Overall Study|Death|83
5508131|NCT01594333|19042671|P1|Overall Study|Death|96
5508132|NCT01594281|19042717|P3|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
5508133|NCT01594281|19042718|P2|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
5508134|NCT01594281|19042719|P1|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
5508135|NCT01594281|19042717|P3|Non-Interventional Follow Up Phase|Administrative Problems|1
5508136|NCT01594281|19042718|P2|Non-Interventional Follow Up Phase|Administrative Problems|0
5508137|NCT01594281|19042719|P1|Non-Interventional Follow Up Phase|Administrative Problems|0
5508138|NCT01594281|19042717|P3|Non-Interventional Follow Up Phase|Lost to Follow-up|0
5508139|NCT01594281|19042718|P2|Non-Interventional Follow Up Phase|Lost to Follow-up|2
5508140|NCT01594281|19042719|P1|Non-Interventional Follow Up Phase|Lost to Follow-up|2
5508141|NCT01594281|19042717|P3|Interventional Core Phase|Adverse Event|4
5508142|NCT01594281|19042718|P2|Interventional Core Phase|Adverse Event|4
5508143|NCT01594281|19042719|P1|Interventional Core Phase|Adverse Event|4
5508144|NCT01594281|19042717|P3|Interventional Core Phase|Lost to Follow-up|1
5508145|NCT01594281|19042718|P2|Interventional Core Phase|Lost to Follow-up|4
5508146|NCT01594281|19042719|P1|Interventional Core Phase|Lost to Follow-up|1
5508147|NCT01594281|19042717|P3|Interventional Core Phase|Death|2
5508148|NCT01594281|19042718|P2|Interventional Core Phase|Death|1
5508149|NCT01594281|19042719|P1|Interventional Core Phase|Death|1
5508150|NCT01594281|19042717|P3|Interventional Core Phase|Subject Withdrew Consent|1
5508151|NCT01594281|19042718|P2|Interventional Core Phase|Subject Withdrew Consent|1
5508152|NCT01594281|19042719|P1|Interventional Core Phase|Subject Withdrew Consent|0
5508153|NCT01594281|19042717|P3|Interventional Core Phase|Protocol Deviation|0
5508154|NCT01594281|19042718|P2|Interventional Core Phase|Protocol Deviation|0
5508155|NCT01594281|19042719|P1|Interventional Core Phase|Protocol Deviation|1
5508156|NCT01594125|19042759|P5|Overall Study|Progressive Disease|7
5508157|NCT01594125|19042760|P4|Overall Study|Progressive Disease|3
5508158|NCT01594125|19042761|P3|Overall Study|Progressive Disease|3
5508159|NCT01594125|19042762|P2|Overall Study|Progressive Disease|12
5508160|NCT01594125|19042763|P1|Overall Study|Progressive Disease|3
5508161|NCT01594125|19042759|P5|Overall Study|Withdrawal by Subject|0
5508162|NCT01594125|19042760|P4|Overall Study|Withdrawal by Subject|1
5508163|NCT01594125|19042761|P3|Overall Study|Withdrawal by Subject|0
5508164|NCT01594125|19042762|P2|Overall Study|Withdrawal by Subject|0
5508165|NCT01594125|19042763|P1|Overall Study|Withdrawal by Subject|1
5508166|NCT01593787|19042823|P3|Overall Study|Adverse Event|0
5508167|NCT01593787|19042824|P2|Overall Study|Adverse Event|0
5508168|NCT01593787|19042825|P1|Overall Study|Adverse Event|1
5508169|NCT01593696|19042901|P4|Dose Expansion|Fungal infection|0
5508170|NCT01593696|19042902|P3|Dose Expansion|Fungal infection|1
5508171|NCT01593696|19042903|P2|Dose Expansion|Fungal infection|0
5508172|NCT01593696|19042904|P1|Dose Expansion|Fungal infection|0
5508173|NCT01593696|19042901|P4|Dose Escalation|Progressive Disease|0
5508174|NCT01593696|19042902|P3|Dose Escalation|Progressive Disease|0
5508175|NCT01593696|19042903|P2|Dose Escalation|Progressive Disease|0
5508176|NCT01593696|19042904|P1|Dose Escalation|Progressive Disease|2
5508177|NCT01593254|19042961|P2|Follow-Up Period|Study Drug Side Effects|1
5508178|NCT01593254|19042962|P1|Follow-Up Period|Study Drug Side Effects|0
5508179|NCT01593254|19042961|P2|Follow-Up Period|Disease Progression|1
5508180|NCT01593254|19042962|P1|Follow-Up Period|Disease Progression|0
5508181|NCT01593254|19042961|P2|Follow-Up Period|Fundus Hemorrhage|1
5508182|NCT01593254|19042962|P1|Follow-Up Period|Fundus Hemorrhage|0
5508183|NCT01593254|19042961|P2|Follow-Up Period|Patient refused to return|1
5508184|NCT01593254|19042962|P1|Follow-Up Period|Patient refused to return|0
5508185|NCT01593254|19042961|P2|Follow-Up Period|Study Drug Toxicity|1
5508186|NCT01593254|19042962|P1|Follow-Up Period|Study Drug Toxicity|0
5508187|NCT01593254|19042961|P2|Follow-Up Period|Pregnancy|1
5508188|NCT01593254|19042962|P1|Follow-Up Period|Pregnancy|0
5508189|NCT01593254|19042961|P2|Follow-Up Period|Subject request to Discontinue|1
5508190|NCT01593254|19042962|P1|Follow-Up Period|Subject request to Discontinue|0
5508191|NCT01593254|19042961|P2|Follow-Up Period|Death|2
5508192|NCT01593254|19042962|P1|Follow-Up Period|Death|2
5508193|NCT01593254|19042961|P2|Follow-Up Period|Non-Compliance|0
5508194|NCT01593254|19042962|P1|Follow-Up Period|Non-Compliance|1
5508195|NCT01593254|19042961|P2|Follow-Up Period|Withdrawal by Subject|2
5508196|NCT01593254|19042962|P1|Follow-Up Period|Withdrawal by Subject|0
5508197|NCT01593254|19042961|P2|Treatment Period|Investigator Decision|1
5508198|NCT01593254|19042962|P1|Treatment Period|Investigator Decision|2
5508199|NCT01593254|19042961|P2|Treatment Period|T315I MUTATION|1
5508200|NCT01593254|19042962|P1|Treatment Period|T315I MUTATION|0
5508201|NCT01593254|19042961|P2|Treatment Period|No Response|0
5508202|NCT01593254|19042962|P1|Treatment Period|No Response|1
5508203|NCT01593254|19042961|P2|Treatment Period|Patient Refused to Return|1
5508204|NCT01593254|19042962|P1|Treatment Period|Patient Refused to Return|0
5508205|NCT01593254|19042961|P2|Treatment Period|Did Not Achieve RCC|1
5508206|NCT01593254|19042962|P1|Treatment Period|Did Not Achieve RCC|0
5508207|NCT01593254|19042961|P2|Treatment Period|Disease Progression|6
5508208|NCT01593254|19042962|P1|Treatment Period|Disease Progression|1
5508209|NCT01593254|19042961|P2|Treatment Period|Study Drug Toxicity|9
5508210|NCT01593254|19042962|P1|Treatment Period|Study Drug Toxicity|3
5508211|NCT01593254|19042961|P2|Treatment Period|Death|1
5508212|NCT01593254|19042962|P1|Treatment Period|Death|2
5508213|NCT01593254|19042961|P2|Treatment Period|AE unrelated to Study Drug|1
5508214|NCT01593254|19042962|P1|Treatment Period|AE unrelated to Study Drug|0
5508215|NCT01593254|19042961|P2|Treatment Period|Subject Request to Discontinue|1
5508216|NCT01593254|19042962|P1|Treatment Period|Subject Request to Discontinue|1
5508217|NCT01593254|19042961|P2|Treatment Period|Subject withdrew consent|5
5508218|NCT01593254|19042962|P1|Treatment Period|Subject withdrew consent|0
5508219|NCT01593254|19042961|P2|Treatment Period|Maximum clinical benefit|0
5508220|NCT01593254|19042962|P1|Treatment Period|Maximum clinical benefit|1
5508221|NCT01593254|19042961|P2|Treatment Period|Poor/Non-Compliance|1
5508222|NCT01593254|19042962|P1|Treatment Period|Poor/Non-Compliance|2
5508223|NCT01593254|19042961|P2|Treatment Period|Pregnancy|1
5508224|NCT01593254|19042962|P1|Treatment Period|Pregnancy|0
5508225|NCT01593254|19042961|P2|Treatment Period|Treatment Failure|2
5508226|NCT01593254|19042962|P1|Treatment Period|Treatment Failure|1
5508227|NCT01592864|19042980|P2|Overall Study|Withdrawal by Subject|1
5508228|NCT01592864|19042981|P1|Overall Study|Withdrawal by Subject|0
5508229|NCT01592786|19043042|P1|Overall Study|Other|3
5508230|NCT01592786|19043042|P1|Overall Study|Lost to Follow-up|19
5508231|NCT01592786|19043042|P1|Overall Study|Withdrawal by Subject|23
5508232|NCT01592786|19043042|P1|Overall Study|Protocol Violation|14
5508233|NCT01592786|19043042|P1|Overall Study|Lack of Efficacy|19
5508234|NCT01592786|19043042|P1|Overall Study|Adverse Event|60
5508235|NCT01592773|19043046|P1|Overall Study|Other Reason|1
5508236|NCT01592773|19043046|P1|Overall Study|Inclusion/exclusion not meet|1
5508237|NCT01592773|19043046|P1|Overall Study|Protocol Violation|2
5508238|NCT01592773|19043046|P1|Overall Study|Lack of Efficacy|9
5508239|NCT01592773|19043046|P1|Overall Study|Adverse Event|17
5508240|NCT01592773|19043046|P1|Overall Study|Lost to Follow-up|19
5508241|NCT01592773|19043046|P1|Overall Study|Withdrawal by Subject|35
5508242|NCT01592773|19043046|P1|Overall Study|Study Terminated by Sponsor|582
5508243|NCT01592760|19043053|P3|24-hour Follow-Up|Lost to Follow-up|2
5508244|NCT01592760|19043054|P2|24-hour Follow-Up|Lost to Follow-up|3
5508245|NCT01592760|19043055|P1|24-hour Follow-Up|Lost to Follow-up|4
5508246|NCT01592747|19043099|P3|Overall Study|Other Reasons|0
5508247|NCT01592747|19043100|P2|Overall Study|Other Reasons|1
5508248|NCT01592747|19043101|P1|Overall Study|Other Reasons|1
5508249|NCT01592747|19043099|P3|Overall Study|Lost to Follow-up|1
5508250|NCT01592747|19043100|P2|Overall Study|Lost to Follow-up|0
5508251|NCT01592747|19043101|P1|Overall Study|Lost to Follow-up|1
5508252|NCT01592747|19043099|P3|Overall Study|Withdrawal by Subject|2
5508253|NCT01592747|19043100|P2|Overall Study|Withdrawal by Subject|0
5508254|NCT01592747|19043101|P1|Overall Study|Withdrawal by Subject|2
5508255|NCT01592747|19043099|P3|Overall Study|Lack of Efficacy|0
5508256|NCT01592747|19043100|P2|Overall Study|Lack of Efficacy|1
5508257|NCT01592747|19043101|P1|Overall Study|Lack of Efficacy|0
5508258|NCT01592747|19043099|P3|Overall Study|Protocol Violation|4
5508259|NCT01592747|19043100|P2|Overall Study|Protocol Violation|0
5508260|NCT01592747|19043101|P1|Overall Study|Protocol Violation|4
5508261|NCT01592747|19043099|P3|Overall Study|Adverse Event|0
5508262|NCT01592747|19043100|P2|Overall Study|Adverse Event|0
5508263|NCT01592747|19043101|P1|Overall Study|Adverse Event|1
5508264|NCT01592747|19043099|P3|Overall Study|Inclusion/Exclusion criteria not met|1
5508265|NCT01592747|19043100|P2|Overall Study|Inclusion/Exclusion criteria not met|1
5508266|NCT01592747|19043101|P1|Overall Study|Inclusion/Exclusion criteria not met|0
5508267|NCT01592747|19043099|P3|Overall Study|Loss of Therapeutic Response|100
5508268|NCT01592747|19043100|P2|Overall Study|Loss of Therapeutic Response|108
5508269|NCT01592747|19043101|P1|Overall Study|Loss of Therapeutic Response|107
5508270|NCT01592708|19043144|P2|Overall Study|Protocol Violation|0
5508271|NCT01592708|19043145|P1|Overall Study|Protocol Violation|3
5508272|NCT01592695|19043161|P2|Overall Study|Lost to Follow-up|4
5508273|NCT01592695|19043162|P1|Overall Study|Lost to Follow-up|8
5508274|NCT01592409|19043217|P2|Overall Study|Withdrawal by Subject|1
5508275|NCT01592409|19043218|P1|Overall Study|Withdrawal by Subject|0
5508276|NCT01592383|19043242|P1|Overall Study|Adverse Event|1
5508277|NCT01592344|19043253|P2|Overall Study|not available at primary outcome visit|4
5508278|NCT01592344|19043254|P1|Overall Study|not available at primary outcome visit|2
5508279|NCT01592344|19043253|P2|Overall Study|Lack of Efficacy|0
5508280|NCT01592344|19043254|P1|Overall Study|Lack of Efficacy|1
5508281|NCT01592344|19043253|P2|Overall Study|Adverse Event|1
5508282|NCT01592344|19043254|P1|Overall Study|Adverse Event|1
5508283|NCT01592292|19043268|P4|Overall Study|Other|1
5508284|NCT01592292|19043269|P3|Overall Study|Other|2
5508285|NCT01592292|19043270|P2|Overall Study|Other|1
5508286|NCT01592292|19043271|P1|Overall Study|Other|1
5508287|NCT01592292|19043268|P4|Overall Study|Withdrew consent|0
5508288|NCT01592292|19043269|P3|Overall Study|Withdrew consent|0
5508289|NCT01592292|19043270|P2|Overall Study|Withdrew consent|1
5508290|NCT01592292|19043271|P1|Overall Study|Withdrew consent|2
5508291|NCT01592292|19043268|P4|Overall Study|Follow-up loss|0
5508292|NCT01592292|19043269|P3|Overall Study|Follow-up loss|1
5508293|NCT01592292|19043270|P2|Overall Study|Follow-up loss|3
5508294|NCT01592292|19043271|P1|Overall Study|Follow-up loss|3
5508295|NCT01592240|19043310|P7|Overall Study|Did Not Meet Entrance Criteria|0
5508296|NCT01592240|19043311|P6|Overall Study|Did Not Meet Entrance Criteria|0
5508297|NCT01592240|19043312|P5|Overall Study|Did Not Meet Entrance Criteria|0
5508298|NCT01592240|19043313|P4|Overall Study|Did Not Meet Entrance Criteria|0
5508299|NCT01592240|19043314|P3|Overall Study|Did Not Meet Entrance Criteria|1
5508300|NCT01592240|19043315|P2|Overall Study|Did Not Meet Entrance Criteria|0
5508301|NCT01592240|19043316|P1|Overall Study|Did Not Meet Entrance Criteria|1
5508302|NCT01592240|19043310|P7|Overall Study|Other|1
5508303|NCT01592240|19043311|P6|Overall Study|Other|0
5508304|NCT01592240|19043312|P5|Overall Study|Other|0
5508305|NCT01592240|19043313|P4|Overall Study|Other|1
5508306|NCT01592240|19043314|P3|Overall Study|Other|1
5508307|NCT01592240|19043315|P2|Overall Study|Other|3
5508308|NCT01592240|19043316|P1|Overall Study|Other|0
5508309|NCT01592240|19043310|P7|Overall Study|Withdrawal by Subject|2
5508310|NCT01592240|19043311|P6|Overall Study|Withdrawal by Subject|0
5508311|NCT01592240|19043312|P5|Overall Study|Withdrawal by Subject|3
5508312|NCT01592240|19043313|P4|Overall Study|Withdrawal by Subject|1
5508313|NCT01592240|19043314|P3|Overall Study|Withdrawal by Subject|4
5508314|NCT01592240|19043315|P2|Overall Study|Withdrawal by Subject|4
5508315|NCT01592240|19043316|P1|Overall Study|Withdrawal by Subject|0
5508316|NCT01592240|19043310|P7|Overall Study|Protocol Violation|0
5508317|NCT01592240|19043311|P6|Overall Study|Protocol Violation|1
5508318|NCT01592240|19043312|P5|Overall Study|Protocol Violation|0
5508319|NCT01592240|19043313|P4|Overall Study|Protocol Violation|0
5508320|NCT01592240|19043314|P3|Overall Study|Protocol Violation|0
5508321|NCT01592240|19043315|P2|Overall Study|Protocol Violation|0
5508322|NCT01592240|19043316|P1|Overall Study|Protocol Violation|0
5508323|NCT01592240|19043310|P7|Overall Study|Lost to Follow-up|0
5508324|NCT01592240|19043311|P6|Overall Study|Lost to Follow-up|2
5508325|NCT01592240|19043312|P5|Overall Study|Lost to Follow-up|3
5508326|NCT01592240|19043313|P4|Overall Study|Lost to Follow-up|0
5508327|NCT01592240|19043314|P3|Overall Study|Lost to Follow-up|1
5508328|NCT01592240|19043315|P2|Overall Study|Lost to Follow-up|3
5508329|NCT01592240|19043316|P1|Overall Study|Lost to Follow-up|1
5508330|NCT01592240|19043310|P7|Overall Study|Death|0
5508331|NCT01592240|19043311|P6|Overall Study|Death|0
5508332|NCT01592240|19043312|P5|Overall Study|Death|0
5508333|NCT01592240|19043313|P4|Overall Study|Death|0
5508334|NCT01592240|19043314|P3|Overall Study|Death|0
5508335|NCT01592240|19043315|P2|Overall Study|Death|1
5508336|NCT01592240|19043316|P1|Overall Study|Death|0
5508337|NCT01592240|19043310|P7|Overall Study|Adverse Event|0
5508338|NCT01592240|19043311|P6|Overall Study|Adverse Event|0
5508339|NCT01592240|19043312|P5|Overall Study|Adverse Event|1
5508340|NCT01592240|19043313|P4|Overall Study|Adverse Event|1
5508341|NCT01592240|19043314|P3|Overall Study|Adverse Event|0
5508342|NCT01592240|19043315|P2|Overall Study|Adverse Event|0
5508343|NCT01592240|19043316|P1|Overall Study|Adverse Event|1
5508344|NCT01592045|19043509|P2|Overall Study|Moved out of country|0
5508345|NCT01592045|19043510|P1|Overall Study|Moved out of country|2
5508346|NCT01592045|19043509|P2|Overall Study|Withdrawal by Subject|0
5508347|NCT01592045|19043510|P1|Overall Study|Withdrawal by Subject|1
5508348|NCT01592045|19043509|P2|Overall Study|Adverse Event|1
5508349|NCT01592045|19043510|P1|Overall Study|Adverse Event|1
5508350|NCT01592045|19043509|P2|Overall Study|Disease Progression|1
5508351|NCT01592045|19043510|P1|Overall Study|Disease Progression|1
5508352|NCT01591863|19043528|P1|Overall Study|Lack of Efficacy|1
5508353|NCT01591863|19043528|P1|Overall Study|recurrence|9
5508354|NCT01591863|19043528|P1|Overall Study|Withdrawal by Subject|1
5508355|NCT01591863|19043528|P1|Overall Study|Adverse Event|3
5508356|NCT01591785|19043557|P2|Overall Study|Lost to Follow-up|0
5508357|NCT01591785|19043558|P1|Overall Study|Lost to Follow-up|1
5508358|NCT01591785|19043557|P2|Overall Study|Protocol Violation|0
5508359|NCT01591785|19043558|P1|Overall Study|Protocol Violation|2
5508360|NCT01591785|19043557|P2|Overall Study|worsening condition|2
5508361|NCT01591785|19043558|P1|Overall Study|worsening condition|1
5508362|NCT01591681|19043600|P1|Overall Study|Failed to use system during run-in|1
5508363|NCT01591681|19043600|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
5508364|NCT01591616|19043647|P1|Overall Study|Withdrawal by Subject|1
5508365|NCT01591499|19043788|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
5508366|NCT01591499|19043789|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
5508367|NCT01591499|19043790|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
5508368|NCT01591499|19043791|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
5508369|NCT01591499|19043788|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
5508370|NCT01591499|19043789|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
5508371|NCT01591499|19043790|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
5508372|NCT01591499|19043791|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
5508373|NCT01591499|19043788|P4|Baseline Visit|Withdrawal by Subject|2
5508374|NCT01591499|19043789|P3|Baseline Visit|Withdrawal by Subject|0
5508375|NCT01591499|19043790|P2|Baseline Visit|Withdrawal by Subject|2
5508376|NCT01591499|19043791|P1|Baseline Visit|Withdrawal by Subject|0
5508377|NCT01591460|19043857|P1|Overall Study|Protocol Violation|1
5508378|NCT01591460|19043857|P1|Overall Study|Withdrawal by Subject|1
5508379|NCT01591460|19043857|P1|Overall Study|Participant Refusal|3
5508380|NCT01591460|19043857|P1|Overall Study|Noncompliance|1
5508381|NCT01591460|19043857|P1|Overall Study|Lost to Follow-up|1
5508382|NCT01591460|19043857|P1|Overall Study|Treatment Discontinued by Error|1
5508383|NCT01591460|19043857|P1|Overall Study|Rebound or Breakthrough|3
5508384|NCT01591460|19043857|P1|Overall Study|Futility Rule (Week 24)|3
5508385|NCT01591460|19043857|P1|Overall Study|Futility Rule (Week 12)|7
5508386|NCT01591460|19043857|P1|Overall Study|Adverse Event or Intercurrent Illness|5
5508387|NCT01591382|19043948|P2|Overall Study|Participant Opted for Morphine PCA|1
5508388|NCT01591382|19043949|P1|Overall Study|Participant Opted for Morphine PCA|1
5508389|NCT01591382|19043948|P2|Overall Study|Discharged Prior to Study Completion|1
5508390|NCT01591382|19043949|P1|Overall Study|Discharged Prior to Study Completion|2
5508391|NCT01591096|19044017|P1|Overall Study|Adverse Event|1
5508392|NCT01590888|19044102|P3|Overall Study|Lost to Follow-up|0
5508393|NCT01590888|19044103|P2|Overall Study|Lost to Follow-up|0
5508394|NCT01590888|19044104|P1|Overall Study|Lost to Follow-up|1
5508395|NCT01590888|19044102|P3|Overall Study|Adverse Event|1
5508396|NCT01590888|19044103|P2|Overall Study|Adverse Event|0
5508397|NCT01590888|19044104|P1|Overall Study|Adverse Event|3
5508398|NCT01590810|19044164|P5|Overall Study|Physician Decision|0
5508399|NCT01590810|19044165|P4|Overall Study|Physician Decision|0
5508400|NCT01590810|19044166|P3|Overall Study|Physician Decision|1
5508401|NCT01590810|19044167|P2|Overall Study|Physician Decision|1
5508402|NCT01590810|19044168|P1|Overall Study|Physician Decision|0
5508403|NCT01590797|19044313|P2|Overall Study|Other Protocol Specified Criteria|4
5508404|NCT01590797|19044314|P1|Overall Study|Other Protocol Specified Criteria|2
5508405|NCT01590797|19044313|P2|Overall Study|Withdrawal by Subject|5
5508406|NCT01590797|19044314|P1|Overall Study|Withdrawal by Subject|7
5508407|NCT01590797|19044313|P2|Overall Study|Protocol Violation|1
5508408|NCT01590797|19044314|P1|Overall Study|Protocol Violation|4
5508409|NCT01590797|19044313|P2|Overall Study|Lost to Follow-up|1
5508410|NCT01590797|19044314|P1|Overall Study|Lost to Follow-up|0
5508411|NCT01590797|19044313|P2|Overall Study|Lack of Efficacy|2
5508412|NCT01590797|19044314|P1|Overall Study|Lack of Efficacy|0
5508413|NCT01590797|19044313|P2|Overall Study|Adverse Event|3
5508414|NCT01590797|19044314|P1|Overall Study|Adverse Event|4
5508415|NCT01590771|19044330|P2|Overall Study|Adverse Event|7
5508416|NCT01590771|19044331|P1|Overall Study|Adverse Event|3
5508417|NCT01590771|19044330|P2|Overall Study|Lack of Efficacy|0
5508418|NCT01590771|19044331|P1|Overall Study|Lack of Efficacy|1
5508419|NCT01590771|19044330|P2|Overall Study|Lost to Follow-up|1
5508420|NCT01590771|19044331|P1|Overall Study|Lost to Follow-up|1
5508421|NCT01590771|19044330|P2|Overall Study|Protocol Violation|2
5508422|NCT01590771|19044331|P1|Overall Study|Protocol Violation|1
5508423|NCT01590771|19044330|P2|Overall Study|Withdrawal by Subject|15
5508424|NCT01590771|19044331|P1|Overall Study|Withdrawal by Subject|8
5508425|NCT01590771|19044330|P2|Overall Study|Other Protocol Specified Criteria|14
5508426|NCT01590771|19044331|P1|Overall Study|Other Protocol Specified Criteria|5
5508427|NCT01590758|19044359|P2|Overall Study|Lost to Follow-up|2
5508428|NCT01590758|19044360|P1|Overall Study|Lost to Follow-up|4
5508429|NCT01590758|19044359|P2|Overall Study|Physician Decision|2
5508430|NCT01590758|19044360|P1|Overall Study|Physician Decision|1
5508431|NCT01590758|19044359|P2|Overall Study|Withdrawal by Subject|3
5508432|NCT01590758|19044360|P1|Overall Study|Withdrawal by Subject|0
5508433|NCT01590563|19044370|P1|Overall Study|simple uterine hyperplasia - not related|1
5508434|NCT01590433|19044384|P2|Overall Study|Adverse Event|3
5508435|NCT01590433|19044385|P1|Overall Study|Adverse Event|11
5508436|NCT01590433|19044384|P2|Overall Study|Withdrawal by Subject|11
5508437|NCT01590433|19044385|P1|Overall Study|Withdrawal by Subject|21
5508438|NCT01590433|19044384|P2|Overall Study|Lost to Follow-up|8
5508439|NCT01590433|19044385|P1|Overall Study|Lost to Follow-up|20
5508440|NCT01590212|19044407|P3|Overall Study|Lost to Follow-up|3
5508441|NCT01590212|19044408|P2|Overall Study|Lost to Follow-up|2
5508442|NCT01590212|19044409|P1|Overall Study|Lost to Follow-up|1
5508443|NCT01590212|19044407|P3|Overall Study|Withdrawal by Subject|2
5508444|NCT01590212|19044408|P2|Overall Study|Withdrawal by Subject|2
5508445|NCT01590212|19044409|P1|Overall Study|Withdrawal by Subject|2
5508446|NCT01590082|19044428|P2|Overall Study|Ineligible|0
5508447|NCT01590082|19044429|P1|Overall Study|Ineligible|1
5508448|NCT01590082|19044428|P2|Overall Study|Withdrawal by Subject|0
5508449|NCT01590082|19044429|P1|Overall Study|Withdrawal by Subject|1
5508450|NCT01590017|19044435|P1|Overall Study|Physician Decision|1
5508451|NCT01590017|19044435|P1|Overall Study|Lack of Efficacy|1
5508452|NCT01590017|19044435|P1|Overall Study|Withdrawal by Subject|1
5508453|NCT01590017|19044435|P1|Overall Study|Adverse Event|1
5508454|NCT01589822|19044488|P3|Overall Study|Missed 90 day visit|1
5508455|NCT01589822|19044489|P2|Overall Study|Missed 90 day visit|1
5508456|NCT01589822|19044490|P1|Overall Study|Missed 90 day visit|2
5508457|NCT01589822|19044488|P3|Overall Study|Death|0
5508458|NCT01589822|19044489|P2|Overall Study|Death|0
5508459|NCT01589822|19044490|P1|Overall Study|Death|1
5508460|NCT01589822|19044488|P3|Overall Study|Withdrawal by Subject|0
5508461|NCT01589822|19044489|P2|Overall Study|Withdrawal by Subject|2
5508462|NCT01589822|19044490|P1|Overall Study|Withdrawal by Subject|1
5508463|NCT01589770|19044509|P2|Overall Study|claustrophobic when entering cardiac MRI|1
5508464|NCT01589770|19044510|P1|Overall Study|claustrophobic when entering cardiac MRI|2
5508465|NCT01589770|19044509|P2|Overall Study|EGFR <60ml/min|4
5508466|NCT01589770|19044510|P1|Overall Study|EGFR <60ml/min|6
5508467|NCT01589653|19044520|P2|Overall Study|Unclassified|3
5508468|NCT01589653|19044521|P1|Overall Study|Unclassified|0
5508469|NCT01589653|19044520|P2|Overall Study|Withdrawal criteria|7
5508470|NCT01589653|19044521|P1|Overall Study|Withdrawal criteria|4
5508471|NCT01589653|19044520|P2|Overall Study|Protocol Violation|1
5508472|NCT01589653|19044521|P1|Overall Study|Protocol Violation|3
5508473|NCT01589497|19044571|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
5508474|NCT01589497|19044572|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
5508475|NCT01589497|19044573|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
5508476|NCT01589497|19044574|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
5508477|NCT01589497|19044571|P4|Overall Study|Death|0
5508478|NCT01589497|19044572|P3|Overall Study|Death|0
5508479|NCT01589497|19044573|P2|Overall Study|Death|0
5508480|NCT01589497|19044574|P1|Overall Study|Death|1
5508481|NCT01589497|19044571|P4|Overall Study|Withdrawal by Subject|1
5508482|NCT01589497|19044572|P3|Overall Study|Withdrawal by Subject|0
5508483|NCT01589497|19044573|P2|Overall Study|Withdrawal by Subject|1
5508484|NCT01589497|19044574|P1|Overall Study|Withdrawal by Subject|0
5508485|NCT01589445|19044680|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
5508486|NCT01589445|19044680|P1|002 (Metformin)-3 Months|Adverse Event|2
5508487|NCT01589445|19044680|P1|002 (Metformin)-3 Months|Protocol Violation|2
5508488|NCT01589445|19044680|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
5508489|NCT01589445|19044680|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
5508490|NCT01589445|19044680|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
5508491|NCT01589445|19044680|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
5508492|NCT01589445|19044680|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
5508493|NCT01589445|19044680|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
5508494|NCT01589445|19044680|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
5508495|NCT01589237|19044723|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
5508496|NCT01589237|19044724|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
5508497|NCT01589237|19044725|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
5508498|NCT01589237|19044726|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
5508499|NCT01589237|19044723|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
5508500|NCT01589237|19044724|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
5508501|NCT01589237|19044725|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
5508502|NCT01589237|19044726|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
5508503|NCT01589237|19044723|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
5508504|NCT01589237|19044724|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
5508505|NCT01589237|19044725|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
5508506|NCT01589237|19044726|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
5508507|NCT01589237|19044723|P4|Part A (52 Weeks)|Subject/guardian decision|0
5508508|NCT01589237|19044724|P3|Part A (52 Weeks)|Subject/guardian decision|2
5508509|NCT01589237|19044725|P2|Part A (52 Weeks)|Subject/guardian decision|3
5508510|NCT01589237|19044726|P1|Part A (52 Weeks)|Subject/guardian decision|2
5508511|NCT01589185|19044777|P5|Overall Study|Lost to Follow-up|0
5508512|NCT01589185|19044778|P4|Overall Study|Lost to Follow-up|3
5508513|NCT01589185|19044779|P3|Overall Study|Lost to Follow-up|2
5508514|NCT01589185|19044780|P2|Overall Study|Lost to Follow-up|0
5508515|NCT01589185|19044781|P1|Overall Study|Lost to Follow-up|1
5508516|NCT01589185|19044777|P5|Overall Study|Death|1
5508517|NCT01589185|19044778|P4|Overall Study|Death|0
5508518|NCT01589185|19044779|P3|Overall Study|Death|2
5508519|NCT01589185|19044780|P2|Overall Study|Death|2
5508520|NCT01589185|19044781|P1|Overall Study|Death|1
5508521|NCT01589094|19044814|P1|Overall Study|Did not receive treatment|2
5508522|NCT01588990|19044821|P1|Phase B|Other|2
5508523|NCT01588990|19044821|P1|Phase B|Physician Decision|4
5508524|NCT01588990|19044821|P1|Phase B|Withdrawal by Subject|3
5508525|NCT01588990|19044821|P1|Phase B|Still on therapy at end of study|5
5508526|NCT01588990|19044821|P1|Phase B|Adverse Event|2
5508527|NCT01588990|19044821|P1|Phase A|Still on therapy at end of study|6
5508528|NCT01588990|19044821|P1|Phase A|Adverse Event|28
5508529|NCT01588990|19044821|P1|Phase A|Death|5
5508530|NCT01588990|19044821|P1|Phase A|Lost to Follow-up|1
5508531|NCT01588990|19044821|P1|Phase A|Other|14
5508532|NCT01588990|19044821|P1|Phase A|Physician Decision|11
5508533|NCT01588990|19044821|P1|Phase A|Withdrawal by Subject|5
5508534|NCT01588951|19044849|P3|Overall Study|Ineligible in retrospect|1
5508535|NCT01588951|19044850|P2|Overall Study|Ineligible in retrospect|0
5508536|NCT01588951|19044851|P1|Overall Study|Ineligible in retrospect|0
5508537|NCT01588548|19044887|P6|Overall Study|Condition Under Investigation Worsened|3
5508538|NCT01588548|19044888|P5|Overall Study|Condition Under Investigation Worsened|3
5508539|NCT01588548|19044889|P4|Overall Study|Condition Under Investigation Worsened|4
5508540|NCT01588548|19044890|P3|Overall Study|Condition Under Investigation Worsened|4
5508541|NCT01588548|19044891|P2|Overall Study|Condition Under Investigation Worsened|6
5508542|NCT01588548|19044892|P1|Overall Study|Condition Under Investigation Worsened|3
5508543|NCT01588548|19044887|P6|Overall Study|Adverse Event|0
5508544|NCT01588548|19044888|P5|Overall Study|Adverse Event|1
5508545|NCT01588548|19044889|P4|Overall Study|Adverse Event|2
5508546|NCT01588548|19044890|P3|Overall Study|Adverse Event|1
5508547|NCT01588548|19044891|P2|Overall Study|Adverse Event|0
5508548|NCT01588548|19044892|P1|Overall Study|Adverse Event|0
5508549|NCT01588548|19044887|P6|Overall Study|Withdrawal by Subject|3
5508550|NCT01588548|19044888|P5|Overall Study|Withdrawal by Subject|2
5508551|NCT01588548|19044889|P4|Overall Study|Withdrawal by Subject|1
5508552|NCT01588548|19044890|P3|Overall Study|Withdrawal by Subject|1
5508553|NCT01588548|19044891|P2|Overall Study|Withdrawal by Subject|1
5508554|NCT01588548|19044892|P1|Overall Study|Withdrawal by Subject|0
5508555|NCT01588509|19044908|P2|Overall Study|Lost to Follow-up|0
5508556|NCT01588509|19044909|P1|Overall Study|Lost to Follow-up|1
5508557|NCT01588496|19044932|P3|Overall Study|Withdrawal by Subject|0
5508558|NCT01588496|19044933|P2|Overall Study|Withdrawal by Subject|1
5508559|NCT01588496|19044934|P1|Overall Study|Withdrawal by Subject|0
5508560|NCT01588405|19045009|P1|Overall Study|Clinical Worsening|1
5508561|NCT01588405|19045009|P1|Overall Study|Adverse Event|1
5508562|NCT01588366|19045038|P6|Overall Study|Adverse Event|2
5508563|NCT01588366|19045039|P5|Overall Study|Adverse Event|0
5508564|NCT01588366|19045040|P4|Overall Study|Adverse Event|1
5508565|NCT01588366|19045041|P3|Overall Study|Adverse Event|0
5508566|NCT01588366|19045042|P2|Overall Study|Adverse Event|1
5508567|NCT01588366|19045043|P1|Overall Study|Adverse Event|0
5508568|NCT01588353|19045071|P3|Step3|Adverse Event|2
5508569|NCT01588353|19045072|P2|Step3|Adverse Event|0
5508570|NCT01588353|19045073|P1|Step3|Adverse Event|0
5508571|NCT01588353|19045071|P3|Step2|Withdrawal by Subject|0
5508572|NCT01588353|19045072|P2|Step2|Withdrawal by Subject|1
5508573|NCT01588353|19045073|P1|Step2|Withdrawal by Subject|0
5508574|NCT01588197|19045122|P2|Overall Study|No MRI|0
5508575|NCT01588197|19045123|P1|Overall Study|No MRI|1
5508576|NCT01588197|19045122|P2|Overall Study|Lack of Efficacy|1
5508577|NCT01588197|19045123|P1|Overall Study|Lack of Efficacy|0
5508578|NCT01588184|19045139|P6|Overall Study|multiple reasons|0
5508579|NCT01588184|19045140|P5|Overall Study|multiple reasons|0
5508580|NCT01588184|19045141|P4|Overall Study|multiple reasons|1
5508581|NCT01588184|19045142|P3|Overall Study|multiple reasons|0
5508582|NCT01588184|19045143|P2|Overall Study|multiple reasons|3
5508583|NCT01588184|19045144|P1|Overall Study|multiple reasons|0
5508584|NCT01588184|19045139|P6|Overall Study|Bevacizumab treatment provision changed|3
5508585|NCT01588184|19045140|P5|Overall Study|Bevacizumab treatment provision changed|1
5508586|NCT01588184|19045141|P4|Overall Study|Bevacizumab treatment provision changed|0
5508587|NCT01588184|19045142|P3|Overall Study|Bevacizumab treatment provision changed|2
5508588|NCT01588184|19045143|P2|Overall Study|Bevacizumab treatment provision changed|6
5508589|NCT01588184|19045144|P1|Overall Study|Bevacizumab treatment provision changed|0
5508590|NCT01588184|19045139|P6|Overall Study|Withdrawal by Subject|0
5508591|NCT01588184|19045140|P5|Overall Study|Withdrawal by Subject|0
5508592|NCT01588184|19045141|P4|Overall Study|Withdrawal by Subject|1
5508593|NCT01588184|19045142|P3|Overall Study|Withdrawal by Subject|0
5508594|NCT01588184|19045143|P2|Overall Study|Withdrawal by Subject|4
5508595|NCT01588184|19045144|P1|Overall Study|Withdrawal by Subject|2
5508596|NCT01588184|19045139|P6|Overall Study|Death|1
5508597|NCT01588184|19045140|P5|Overall Study|Death|1
5508598|NCT01588184|19045141|P4|Overall Study|Death|1
5508599|NCT01588184|19045142|P3|Overall Study|Death|0
5508600|NCT01588184|19045143|P2|Overall Study|Death|0
5508601|NCT01588184|19045144|P1|Overall Study|Death|1
5508602|NCT01588106|19045197|P2|Overall Study|Withdrawal by Subject|4
5508603|NCT01588106|19045198|P1|Overall Study|Withdrawal by Subject|5
5508604|NCT01587989|19045206|P3|Randomized Study Treatment|Physician Decision|1
5508605|NCT01587989|19045207|P2|Randomized Study Treatment|Physician Decision|0
5508606|NCT01587989|19045208|P1|Randomized Study Treatment|Physician Decision|0
5508607|NCT01587989|19045206|P3|Randomized Study Treatment|Screening failure|0
5508608|NCT01587989|19045207|P2|Randomized Study Treatment|Screening failure|1
5508609|NCT01587989|19045208|P1|Randomized Study Treatment|Screening failure|0
5508610|NCT01587989|19045206|P3|Randomized Study Treatment|Withdrawal by Subject|0
5508611|NCT01587989|19045207|P2|Randomized Study Treatment|Withdrawal by Subject|1
5508612|NCT01587989|19045208|P1|Randomized Study Treatment|Withdrawal by Subject|0
5508613|NCT01587989|19045206|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
5508614|NCT01587989|19045207|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
5508615|NCT01587989|19045208|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
5508616|NCT01587989|19045206|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
5508617|NCT01587989|19045207|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
5508618|NCT01587989|19045208|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
5508619|NCT01587989|19045206|P3|12-Week Open-Label Run-In Period|Physician Decision|0
5508620|NCT01587989|19045207|P2|12-Week Open-Label Run-In Period|Physician Decision|0
5508621|NCT01587989|19045208|P1|12-Week Open-Label Run-In Period|Physician Decision|7
5508622|NCT01587924|19045273|P4|Overall Study|Withdrawal by Subject|0
5508623|NCT01587924|19045274|P3|Overall Study|Withdrawal by Subject|1
5508624|NCT01587924|19045275|P2|Overall Study|Withdrawal by Subject|1
5508625|NCT01587924|19045276|P1|Overall Study|Withdrawal by Subject|0
5508626|NCT01587924|19045273|P4|Overall Study|Met Hemoglobin stopping criteria|0
5508627|NCT01587924|19045274|P3|Overall Study|Met Hemoglobin stopping criteria|1
5508628|NCT01587924|19045275|P2|Overall Study|Met Hemoglobin stopping criteria|0
5508629|NCT01587924|19045276|P1|Overall Study|Met Hemoglobin stopping criteria|2
5508630|NCT01587924|19045273|P4|Overall Study|Protocol Violation|1
5508631|NCT01587924|19045274|P3|Overall Study|Protocol Violation|2
5508632|NCT01587924|19045275|P2|Overall Study|Protocol Violation|1
5508633|NCT01587924|19045276|P1|Overall Study|Protocol Violation|2
5508634|NCT01587924|19045273|P4|Overall Study|Adverse Event|0
5508635|NCT01587924|19045274|P3|Overall Study|Adverse Event|0
5508636|NCT01587924|19045275|P2|Overall Study|Adverse Event|2
5508637|NCT01587924|19045276|P1|Overall Study|Adverse Event|0
5508638|NCT01587898|19045377|P4|Overall Study|Met haemoglobin stopping criteria|0
5508639|NCT01587898|19045378|P3|Overall Study|Met haemoglobin stopping criteria|1
5508640|NCT01587898|19045379|P2|Overall Study|Met haemoglobin stopping criteria|1
5508641|NCT01587898|19045380|P1|Overall Study|Met haemoglobin stopping criteria|1
5508642|NCT01587898|19045377|P4|Overall Study|Withdrawal by Subject|0
5508643|NCT01587898|19045378|P3|Overall Study|Withdrawal by Subject|0
5508644|NCT01587898|19045379|P2|Overall Study|Withdrawal by Subject|1
5508645|NCT01587898|19045380|P1|Overall Study|Withdrawal by Subject|2
5508646|NCT01587898|19045377|P4|Overall Study|Lost to Follow-up|1
5508647|NCT01587898|19045378|P3|Overall Study|Lost to Follow-up|0
5508648|NCT01587898|19045379|P2|Overall Study|Lost to Follow-up|0
5508649|NCT01587898|19045380|P1|Overall Study|Lost to Follow-up|0
5508650|NCT01587898|19045377|P4|Overall Study|Protocol Violation|1
5508651|NCT01587898|19045378|P3|Overall Study|Protocol Violation|1
5508652|NCT01587898|19045379|P2|Overall Study|Protocol Violation|2
5508653|NCT01587898|19045380|P1|Overall Study|Protocol Violation|0
5508654|NCT01587898|19045377|P4|Overall Study|Adverse Event|0
5508655|NCT01587898|19045378|P3|Overall Study|Adverse Event|0
5508656|NCT01587898|19045379|P2|Overall Study|Adverse Event|1
5508657|NCT01587898|19045380|P1|Overall Study|Adverse Event|1
5508658|NCT01587885|19045556|P2|Treatment Period 1|Protocol Violation|2
5508659|NCT01587885|19045557|P1|Treatment Period 1|Protocol Violation|0
5508660|NCT01587885|19045556|P2|Treatment Period 1|Failure to Return|1
5508661|NCT01587885|19045557|P1|Treatment Period 1|Failure to Return|0
5508662|NCT01587703|19045588|P19|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508663|NCT01587703|19045589|P18|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508664|NCT01587703|19045590|P17|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508665|NCT01587703|19045591|P16|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508666|NCT01587703|19045592|P15|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508667|NCT01587703|19045593|P14|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508668|NCT01587703|19045594|P13|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508669|NCT01587703|19045595|P12|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
5508670|NCT01587703|19045596|P11|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508671|NCT01587703|19045597|P10|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508672|NCT01587703|19045598|P9|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508673|NCT01587703|19045599|P8|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508674|NCT01587703|19045600|P7|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508675|NCT01587703|19045601|P6|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508676|NCT01587703|19045602|P5|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508677|NCT01587703|19045603|P4|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508678|NCT01587703|19045604|P3|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508679|NCT01587703|19045605|P2|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508680|NCT01587703|19045606|P1|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
5508681|NCT01587703|19045588|P19|Part2(Median Exposure of 1.41 Months)|Death|0
5508682|NCT01587703|19045589|P18|Part2(Median Exposure of 1.41 Months)|Death|0
5508683|NCT01587703|19045590|P17|Part2(Median Exposure of 1.41 Months)|Death|5
5508684|NCT01587703|19045591|P16|Part2(Median Exposure of 1.41 Months)|Death|17
5508685|NCT01587703|19045592|P15|Part2(Median Exposure of 1.41 Months)|Death|16
5508686|NCT01587703|19045593|P14|Part2(Median Exposure of 1.41 Months)|Death|21
5508687|NCT01587703|19045594|P13|Part2(Median Exposure of 1.41 Months)|Death|12
5508688|NCT01587703|19045595|P12|Part2(Median Exposure of 1.41 Months)|Death|8
5508689|NCT01587703|19045596|P11|Part2(Median Exposure of 1.41 Months)|Death|0
5508690|NCT01587703|19045597|P10|Part2(Median Exposure of 1.41 Months)|Death|0
5508691|NCT01587703|19045598|P9|Part2(Median Exposure of 1.41 Months)|Death|0
5508692|NCT01587703|19045599|P8|Part2(Median Exposure of 1.41 Months)|Death|0
5508693|NCT01587703|19045600|P7|Part2(Median Exposure of 1.41 Months)|Death|0
5508694|NCT01587703|19045601|P6|Part2(Median Exposure of 1.41 Months)|Death|0
5508695|NCT01587703|19045602|P5|Part2(Median Exposure of 1.41 Months)|Death|0
5508696|NCT01587703|19045603|P4|Part2(Median Exposure of 1.41 Months)|Death|0
5508697|NCT01587703|19045604|P3|Part2(Median Exposure of 1.41 Months)|Death|0
5508698|NCT01587703|19045605|P2|Part2(Median Exposure of 1.41 Months)|Death|0
5508699|NCT01587703|19045606|P1|Part2(Median Exposure of 1.41 Months)|Death|0
5508700|NCT01587703|19045588|P19|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508701|NCT01587703|19045589|P18|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508702|NCT01587703|19045590|P17|Part2(Median Exposure of 1.41 Months)|Site closed|8
5508703|NCT01587703|19045591|P16|Part2(Median Exposure of 1.41 Months)|Site closed|3
5508704|NCT01587703|19045592|P15|Part2(Median Exposure of 1.41 Months)|Site closed|1
5508705|NCT01587703|19045593|P14|Part2(Median Exposure of 1.41 Months)|Site closed|1
5508706|NCT01587703|19045594|P13|Part2(Median Exposure of 1.41 Months)|Site closed|2
5508707|NCT01587703|19045595|P12|Part2(Median Exposure of 1.41 Months)|Site closed|2
5508708|NCT01587703|19045596|P11|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508709|NCT01587703|19045597|P10|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508710|NCT01587703|19045598|P9|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508711|NCT01587703|19045599|P8|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508712|NCT01587703|19045600|P7|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508713|NCT01587703|19045601|P6|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508714|NCT01587703|19045602|P5|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508715|NCT01587703|19045603|P4|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508716|NCT01587703|19045604|P3|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508717|NCT01587703|19045605|P2|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508718|NCT01587703|19045606|P1|Part2(Median Exposure of 1.41 Months)|Site closed|0
5508719|NCT01587703|19045588|P19|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508720|NCT01587703|19045589|P18|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508721|NCT01587703|19045590|P17|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508722|NCT01587703|19045591|P16|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508723|NCT01587703|19045592|P15|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
5508724|NCT01587703|19045593|P14|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508725|NCT01587703|19045594|P13|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508726|NCT01587703|19045595|P12|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
5508727|NCT01587703|19045596|P11|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508728|NCT01587703|19045597|P10|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508729|NCT01587703|19045598|P9|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508730|NCT01587703|19045599|P8|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508731|NCT01587703|19045600|P7|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508732|NCT01587703|19045601|P6|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508733|NCT01587703|19045602|P5|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508734|NCT01587703|19045603|P4|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508735|NCT01587703|19045604|P3|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508736|NCT01587703|19045605|P2|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508737|NCT01587703|19045606|P1|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
5508738|NCT01587703|19045588|P19|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508739|NCT01587703|19045589|P18|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508740|NCT01587703|19045590|P17|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508741|NCT01587703|19045591|P16|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
5508742|NCT01587703|19045592|P15|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508743|NCT01587703|19045593|P14|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508744|NCT01587703|19045594|P13|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508745|NCT01587703|19045595|P12|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508746|NCT01587703|19045596|P11|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508747|NCT01587703|19045597|P10|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508748|NCT01587703|19045598|P9|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508749|NCT01587703|19045599|P8|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508750|NCT01587703|19045600|P7|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508751|NCT01587703|19045601|P6|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508752|NCT01587703|19045602|P5|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508753|NCT01587703|19045603|P4|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508754|NCT01587703|19045604|P3|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508755|NCT01587703|19045605|P2|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508756|NCT01587703|19045606|P1|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
5508757|NCT01587703|19045588|P19|Substudy-P4,Maximum Exposure of 5.5month|Death|4
5508758|NCT01587703|19045589|P18|Substudy-P4,Maximum Exposure of 5.5month|Death|5
5508759|NCT01587703|19045590|P17|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508760|NCT01587703|19045591|P16|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508761|NCT01587703|19045592|P15|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508762|NCT01587703|19045593|P14|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508763|NCT01587703|19045594|P13|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508764|NCT01587703|19045595|P12|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508765|NCT01587703|19045596|P11|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508766|NCT01587703|19045597|P10|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508767|NCT01587703|19045598|P9|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508768|NCT01587703|19045599|P8|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508769|NCT01587703|19045600|P7|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508770|NCT01587703|19045601|P6|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508771|NCT01587703|19045602|P5|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508772|NCT01587703|19045603|P4|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508773|NCT01587703|19045604|P3|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508774|NCT01587703|19045605|P2|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508775|NCT01587703|19045606|P1|Substudy-P4,Maximum Exposure of 5.5month|Death|0
5508776|NCT01587703|19045588|P19|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
5508777|NCT01587703|19045589|P18|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508778|NCT01587703|19045590|P17|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508779|NCT01587703|19045591|P16|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508780|NCT01587703|19045592|P15|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508781|NCT01587703|19045593|P14|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508782|NCT01587703|19045594|P13|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508783|NCT01587703|19045595|P12|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508784|NCT01587703|19045596|P11|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508785|NCT01587703|19045597|P10|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508786|NCT01587703|19045598|P9|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508787|NCT01587703|19045599|P8|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508788|NCT01587703|19045600|P7|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508789|NCT01587703|19045601|P6|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508790|NCT01587703|19045602|P5|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508791|NCT01587703|19045603|P4|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508792|NCT01587703|19045604|P3|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508793|NCT01587703|19045605|P2|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508794|NCT01587703|19045606|P1|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
5508795|NCT01587703|19045588|P19|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508796|NCT01587703|19045589|P18|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508797|NCT01587703|19045590|P17|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508798|NCT01587703|19045591|P16|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508799|NCT01587703|19045592|P15|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508800|NCT01587703|19045593|P14|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508801|NCT01587703|19045594|P13|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508802|NCT01587703|19045595|P12|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508803|NCT01587703|19045596|P11|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508804|NCT01587703|19045597|P10|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508805|NCT01587703|19045598|P9|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
5508806|NCT01587703|19045599|P8|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508807|NCT01587703|19045600|P7|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508808|NCT01587703|19045601|P6|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508809|NCT01587703|19045602|P5|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508810|NCT01587703|19045603|P4|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508811|NCT01587703|19045604|P3|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508812|NCT01587703|19045605|P2|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508813|NCT01587703|19045606|P1|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
5508814|NCT01587703|19045588|P19|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508815|NCT01587703|19045589|P18|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508816|NCT01587703|19045590|P17|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508817|NCT01587703|19045591|P16|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508818|NCT01587703|19045592|P15|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508819|NCT01587703|19045593|P14|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508820|NCT01587703|19045594|P13|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508821|NCT01587703|19045595|P12|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508822|NCT01587703|19045596|P11|Part1 BID(Median Exposure of 1.41months)|Site closed|1
5508823|NCT01587703|19045597|P10|Part1 BID(Median Exposure of 1.41months)|Site closed|1
5508824|NCT01587703|19045598|P9|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508825|NCT01587703|19045599|P8|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508826|NCT01587703|19045600|P7|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508827|NCT01587703|19045601|P6|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508828|NCT01587703|19045602|P5|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508829|NCT01587703|19045603|P4|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508830|NCT01587703|19045604|P3|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508831|NCT01587703|19045605|P2|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508832|NCT01587703|19045606|P1|Part1 BID(Median Exposure of 1.41months)|Site closed|0
5508833|NCT01587703|19045588|P19|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508834|NCT01587703|19045589|P18|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508835|NCT01587703|19045590|P17|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508836|NCT01587703|19045591|P16|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508837|NCT01587703|19045592|P15|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508838|NCT01587703|19045593|P14|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508839|NCT01587703|19045594|P13|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508840|NCT01587703|19045595|P12|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508841|NCT01587703|19045596|P11|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
5508842|NCT01587703|19045597|P10|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508843|NCT01587703|19045598|P9|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
5508844|NCT01587703|19045599|P8|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508845|NCT01587703|19045600|P7|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508846|NCT01587703|19045601|P6|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508847|NCT01587703|19045602|P5|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508848|NCT01587703|19045603|P4|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508849|NCT01587703|19045604|P3|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508850|NCT01587703|19045605|P2|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508851|NCT01587703|19045606|P1|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
5508852|NCT01587703|19045588|P19|Part1 BID(Median Exposure of 1.41months)|Death|0
5508853|NCT01587703|19045589|P18|Part1 BID(Median Exposure of 1.41months)|Death|0
5508854|NCT01587703|19045590|P17|Part1 BID(Median Exposure of 1.41months)|Death|0
5508855|NCT01587703|19045591|P16|Part1 BID(Median Exposure of 1.41months)|Death|0
5508856|NCT01587703|19045592|P15|Part1 BID(Median Exposure of 1.41months)|Death|0
5508857|NCT01587703|19045593|P14|Part1 BID(Median Exposure of 1.41months)|Death|0
5508858|NCT01587703|19045594|P13|Part1 BID(Median Exposure of 1.41months)|Death|0
5508859|NCT01587703|19045595|P12|Part1 BID(Median Exposure of 1.41months)|Death|0
5508860|NCT01587703|19045596|P11|Part1 BID(Median Exposure of 1.41months)|Death|3
5508861|NCT01587703|19045597|P10|Part1 BID(Median Exposure of 1.41months)|Death|9
5508862|NCT01587703|19045598|P9|Part1 BID(Median Exposure of 1.41months)|Death|1
5508863|NCT01587703|19045599|P8|Part1 BID(Median Exposure of 1.41months)|Death|0
5508864|NCT01587703|19045600|P7|Part1 BID(Median Exposure of 1.41months)|Death|0
5508865|NCT01587703|19045601|P6|Part1 BID(Median Exposure of 1.41months)|Death|0
5508866|NCT01587703|19045602|P5|Part1 BID(Median Exposure of 1.41months)|Death|0
5508867|NCT01587703|19045603|P4|Part1 BID(Median Exposure of 1.41months)|Death|0
5508868|NCT01587703|19045604|P3|Part1 BID(Median Exposure of 1.41months)|Death|0
5508869|NCT01587703|19045605|P2|Part1 BID(Median Exposure of 1.41months)|Death|0
5508870|NCT01587703|19045606|P1|Part1 BID(Median Exposure of 1.41months)|Death|0
5508871|NCT01587703|19045588|P19|Part1 QD(Median Exposure of 1.38months)|Death|0
5508872|NCT01587703|19045589|P18|Part1 QD(Median Exposure of 1.38months)|Death|0
5508873|NCT01587703|19045590|P17|Part1 QD(Median Exposure of 1.38months)|Death|0
5508874|NCT01587703|19045591|P16|Part1 QD(Median Exposure of 1.38months)|Death|0
5508875|NCT01587703|19045592|P15|Part1 QD(Median Exposure of 1.38months)|Death|0
5508876|NCT01587703|19045593|P14|Part1 QD(Median Exposure of 1.38months)|Death|0
5508877|NCT01587703|19045594|P13|Part1 QD(Median Exposure of 1.38months)|Death|0
5508878|NCT01587703|19045595|P12|Part1 QD(Median Exposure of 1.38months)|Death|0
5508879|NCT01587703|19045596|P11|Part1 QD(Median Exposure of 1.38months)|Death|0
5508880|NCT01587703|19045597|P10|Part1 QD(Median Exposure of 1.38months)|Death|0
5508881|NCT01587703|19045598|P9|Part1 QD(Median Exposure of 1.38months)|Death|0
5508882|NCT01587703|19045599|P8|Part1 QD(Median Exposure of 1.38months)|Death|7
5508883|NCT01587703|19045600|P7|Part1 QD(Median Exposure of 1.38months)|Death|30
5508884|NCT01587703|19045601|P6|Part1 QD(Median Exposure of 1.38months)|Death|7
5508885|NCT01587703|19045602|P5|Part1 QD(Median Exposure of 1.38months)|Death|4
5508886|NCT01587703|19045603|P4|Part1 QD(Median Exposure of 1.38months)|Death|3
5508887|NCT01587703|19045604|P3|Part1 QD(Median Exposure of 1.38months)|Death|1
5508888|NCT01587703|19045605|P2|Part1 QD(Median Exposure of 1.38months)|Death|4
5508889|NCT01587703|19045606|P1|Part1 QD(Median Exposure of 1.38months)|Death|2
5508890|NCT01587703|19045588|P19|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508891|NCT01587703|19045589|P18|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508892|NCT01587703|19045590|P17|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508893|NCT01587703|19045591|P16|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508894|NCT01587703|19045592|P15|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508895|NCT01587703|19045593|P14|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508896|NCT01587703|19045594|P13|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508897|NCT01587703|19045595|P12|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508898|NCT01587703|19045596|P11|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508899|NCT01587703|19045597|P10|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508900|NCT01587703|19045598|P9|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508901|NCT01587703|19045599|P8|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508902|NCT01587703|19045600|P7|Part1 QD(Median Exposure of 1.38months)|Site closed|2
5508903|NCT01587703|19045601|P6|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508904|NCT01587703|19045602|P5|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508905|NCT01587703|19045603|P4|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508906|NCT01587703|19045604|P3|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508907|NCT01587703|19045605|P2|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508908|NCT01587703|19045606|P1|Part1 QD(Median Exposure of 1.38months)|Site closed|0
5508909|NCT01587703|19045588|P19|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508910|NCT01587703|19045589|P18|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508911|NCT01587703|19045590|P17|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508912|NCT01587703|19045591|P16|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508913|NCT01587703|19045592|P15|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508914|NCT01587703|19045593|P14|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508915|NCT01587703|19045594|P13|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508916|NCT01587703|19045595|P12|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508917|NCT01587703|19045596|P11|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508918|NCT01587703|19045597|P10|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508919|NCT01587703|19045598|P9|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508920|NCT01587703|19045599|P8|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
5508921|NCT01587703|19045600|P7|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508922|NCT01587703|19045601|P6|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
5508923|NCT01587703|19045602|P5|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508924|NCT01587703|19045603|P4|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508925|NCT01587703|19045604|P3|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508926|NCT01587703|19045605|P2|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508927|NCT01587703|19045606|P1|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
5508928|NCT01587703|19045588|P19|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508929|NCT01587703|19045589|P18|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508930|NCT01587703|19045590|P17|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508931|NCT01587703|19045591|P16|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508932|NCT01587703|19045592|P15|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508933|NCT01587703|19045593|P14|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508934|NCT01587703|19045594|P13|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508935|NCT01587703|19045595|P12|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508936|NCT01587703|19045596|P11|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508937|NCT01587703|19045597|P10|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508938|NCT01587703|19045598|P9|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508939|NCT01587703|19045599|P8|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508940|NCT01587703|19045600|P7|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508941|NCT01587703|19045601|P6|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508942|NCT01587703|19045602|P5|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508943|NCT01587703|19045603|P4|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508944|NCT01587703|19045604|P3|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508945|NCT01587703|19045605|P2|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
5508946|NCT01587703|19045606|P1|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
5508947|NCT01587651|19046013|P3|Overall Study|Withdrawal by Subject|0
5508948|NCT01587651|19046014|P2|Overall Study|Withdrawal by Subject|1
5508949|NCT01587651|19046015|P1|Overall Study|Withdrawal by Subject|0
5508950|NCT01587651|19046013|P3|Overall Study|Protocol Violation|1
5508951|NCT01587651|19046014|P2|Overall Study|Protocol Violation|1
5508952|NCT01587651|19046015|P1|Overall Study|Protocol Violation|0
5508953|NCT01587651|19046013|P3|Overall Study|Adverse Event|0
5508954|NCT01587651|19046014|P2|Overall Study|Adverse Event|1
5508955|NCT01587651|19046015|P1|Overall Study|Adverse Event|0
5508956|NCT01587274|19046045|P3|Overall Study|Lost to Follow-up|3
5508957|NCT01587274|19046046|P2|Overall Study|Lost to Follow-up|5
5508958|NCT01587274|19046047|P1|Overall Study|Lost to Follow-up|4
5508959|NCT01587118|19046055|P1|Overall Study|nonresponse|1
5508960|NCT01587118|19046055|P1|Overall Study|Relocation|1
5508961|NCT01587118|19046055|P1|Overall Study|Lost to Follow-up|2
5508962|NCT01587118|19046055|P1|Overall Study|Adverse Event|3
5508963|NCT01587079|19046079|P1|Overall Study|Adverse Event|14
5508964|NCT01587079|19046079|P1|Overall Study|Withdrawal by Subject|7
5508965|NCT01587079|19046079|P1|Overall Study|Physician Decision|2
5508966|NCT01587079|19046079|P1|Overall Study|Lost to Follow-up|2
5508967|NCT01587079|19046079|P1|Overall Study|Protocol Violation|5
5508968|NCT01587079|19046079|P1|Overall Study|Protocol-specified criteria|9
5508969|NCT01587040|19046205|P4|Overall Study|Other than specified|1
5508970|NCT01587040|19046206|P3|Overall Study|Other than specified|11
5508971|NCT01587040|19046207|P2|Overall Study|Other than specified|1
5508972|NCT01587040|19046208|P1|Overall Study|Other than specified|5
5508973|NCT01587040|19046205|P4|Overall Study|Disease progression|3
5508974|NCT01587040|19046206|P3|Overall Study|Disease progression|15
5508975|NCT01587040|19046207|P2|Overall Study|Disease progression|1
5508976|NCT01587040|19046208|P1|Overall Study|Disease progression|12
5508977|NCT01587040|19046205|P4|Overall Study|Adverse Event|0
5508978|NCT01587040|19046206|P3|Overall Study|Adverse Event|10
5508979|NCT01587040|19046207|P2|Overall Study|Adverse Event|1
5508980|NCT01587040|19046208|P1|Overall Study|Adverse Event|0
5508981|NCT01587040|19046205|P4|Overall Study|Protocol Violation|0
5508982|NCT01587040|19046206|P3|Overall Study|Protocol Violation|1
5508983|NCT01587040|19046207|P2|Overall Study|Protocol Violation|0
5508984|NCT01587040|19046208|P1|Overall Study|Protocol Violation|0
5508985|NCT01587014|19046235|P1|Overall Study|Death|2
5508986|NCT01587001|19046242|P2|Overall Study|Insufficient samples to complete testing|1
5508987|NCT01587001|19046243|P1|Overall Study|Insufficient samples to complete testing|4
5508988|NCT01587001|19046242|P2|Overall Study|Lost to Follow-up|0
5508989|NCT01587001|19046243|P1|Overall Study|Lost to Follow-up|2
5508990|NCT01586910|19046272|P2|Overall Study|Physician withdrew Subject|24
5508991|NCT01586910|19046273|P1|Overall Study|Physician withdrew Subject|5
5508992|NCT01586910|19046272|P2|Overall Study|Withdrawal by Subject|43
5508993|NCT01586910|19046273|P1|Overall Study|Withdrawal by Subject|6
5508994|NCT01586910|19046272|P2|Overall Study|Death|4
5508995|NCT01586910|19046273|P1|Overall Study|Death|4
5508996|NCT01586819|19046347|P2|Overall Study|Withdrawal by Subject|0
5508997|NCT01586819|19046348|P1|Overall Study|Withdrawal by Subject|1
5508998|NCT01586806|19046359|P3|Overall Study|Lost to Follow-up|2
5508999|NCT01586806|19046360|P2|Overall Study|Lost to Follow-up|3
5509000|NCT01586806|19046361|P1|Overall Study|Lost to Follow-up|2
5509001|NCT01586806|19046359|P3|Overall Study|Withdrawal by Subject|0
5509002|NCT01586806|19046360|P2|Overall Study|Withdrawal by Subject|0
5509003|NCT01586806|19046361|P1|Overall Study|Withdrawal by Subject|1
5509004|NCT01586806|19046359|P3|Overall Study|Protocol Violation|0
5509005|NCT01586806|19046360|P2|Overall Study|Protocol Violation|1
5509006|NCT01586806|19046361|P1|Overall Study|Protocol Violation|0
5509007|NCT01586364|19046394|P1|Overall Study|Other-Not specified|1
5509008|NCT01586364|19046394|P1|Overall Study|Other-PI discretion, site closing|2
5509009|NCT01586364|19046394|P1|Overall Study|Other-Site closure due to PI illness|1
5509010|NCT01586364|19046394|P1|Overall Study|Other-Subject wasn't getting much relief|1
5509011|NCT01586364|19046394|P1|Overall Study|Other-Did not feel better post-treatment|1
5509012|NCT01586364|19046394|P1|Overall Study|Lack of Efficacy|1
5509013|NCT01586364|19046394|P1|Overall Study|Protocol Violation|16
5509014|NCT01586364|19046394|P1|Overall Study|Lost to Follow-up|17
5509015|NCT01586364|19046394|P1|Overall Study|Adverse Event|37
5509016|NCT01586364|19046394|P1|Overall Study|Withdrawal by Subject|40
5509017|NCT01586338|19046447|P1|Overall Study|Other|1
5509018|NCT01586338|19046447|P1|Overall Study|Withdrawal by participant|3
5509019|NCT01586338|19046447|P1|Overall Study|Lost to Follow-up|1
5509020|NCT01586338|19046447|P1|Overall Study|Adverse Event|3
5509021|NCT01586195|19046470|P1|Overall Study|Reason not specified|9
5509022|NCT01586195|19046470|P1|Overall Study|Started new anti-melanoma therapy|1
5509023|NCT01586195|19046470|P1|Overall Study|Withdrawal of Consent|5
5509024|NCT01586195|19046470|P1|Overall Study|Death|11
5509025|NCT01586156|19046484|P3|Overall Study|Pregnancy|0
5509026|NCT01586156|19046485|P2|Overall Study|Pregnancy|1
5509027|NCT01586156|19046486|P1|Overall Study|Pregnancy|0
5509028|NCT01585987|19046543|P2|Treated|Poor/Non-Compliance|1
5509029|NCT01585987|19046544|P1|Treated|Poor/Non-Compliance|0
5509030|NCT01585987|19046543|P2|Treated|Subject Request|1
5509031|NCT01585987|19046544|P1|Treated|Subject Request|0
5509032|NCT01585987|19046543|P2|Treated|Non-Specified|2
5509033|NCT01585987|19046544|P1|Treated|Non-Specified|1
5509034|NCT01585987|19046543|P2|Treated|Maximum Clinical Benefit|1
5509035|NCT01585987|19046544|P1|Treated|Maximum Clinical Benefit|0
5509036|NCT01585987|19046543|P2|Treated|Lost to Follow-up|1
5509037|NCT01585987|19046544|P1|Treated|Lost to Follow-up|0
5509038|NCT01585987|19046543|P2|Treated|Death|0
5509039|NCT01585987|19046544|P1|Treated|Death|1
5509040|NCT01585987|19046543|P2|Treated|Withdrawal by Subject|2
5509041|NCT01585987|19046544|P1|Treated|Withdrawal by Subject|1
5509042|NCT01585987|19046543|P2|Treated|Adverse Event|0
5509043|NCT01585987|19046544|P1|Treated|Adverse Event|3
5509044|NCT01585987|19046543|P2|Treated|Study Drug Toxicity|5
5509045|NCT01585987|19046544|P1|Treated|Study Drug Toxicity|9
5509046|NCT01585987|19046543|P2|Treated|Disease Progression|36
5509047|NCT01585987|19046544|P1|Treated|Disease Progression|39
5509048|NCT01585987|19046543|P2|Randomized|No longer met criteria|2
5509049|NCT01585987|19046544|P1|Randomized|No longer met criteria|0
5509050|NCT01585987|19046543|P2|Randomized|Withdrawal by Subject|4
5509051|NCT01585987|19046544|P1|Randomized|Withdrawal by Subject|0
5509052|NCT01585961|19046559|P1|Overall Study|Ablation cancelled for slow-heal wound|1
5509053|NCT01585961|19046559|P1|Overall Study|Lost to Follow-up|23
5509054|NCT01585961|19046559|P1|Overall Study|Withdrawal by Subject|1
5509055|NCT01585961|19046559|P1|Overall Study|Decision to use non-study catheter|1
5509056|NCT01585961|19046559|P1|Overall Study|Physician Decision|1
5509057|NCT01585961|19046559|P1|Overall Study|Death|6
5509058|NCT01585766|19046637|P6|Overall Study|Physician Decision|0
5509059|NCT01585766|19046638|P5|Overall Study|Physician Decision|0
5509060|NCT01585766|19046639|P4|Overall Study|Physician Decision|0
5509061|NCT01585766|19046640|P3|Overall Study|Physician Decision|1
5509062|NCT01585766|19046641|P2|Overall Study|Physician Decision|0
5509063|NCT01585766|19046642|P1|Overall Study|Physician Decision|0
5509064|NCT01585766|19046637|P6|Overall Study|Death|0
5509065|NCT01585766|19046638|P5|Overall Study|Death|0
5509066|NCT01585766|19046639|P4|Overall Study|Death|0
5509067|NCT01585766|19046640|P3|Overall Study|Death|0
5509068|NCT01585766|19046641|P2|Overall Study|Death|1
5509069|NCT01585766|19046642|P1|Overall Study|Death|0
5509070|NCT01585766|19046637|P6|Overall Study|Withdrawal by Subject|0
5509071|NCT01585766|19046638|P5|Overall Study|Withdrawal by Subject|0
5509072|NCT01585766|19046639|P4|Overall Study|Withdrawal by Subject|0
5509073|NCT01585766|19046640|P3|Overall Study|Withdrawal by Subject|1
5509074|NCT01585766|19046641|P2|Overall Study|Withdrawal by Subject|1
5509075|NCT01585766|19046642|P1|Overall Study|Withdrawal by Subject|0
5509076|NCT01585584|19046746|P1|Overall Study|Physician Decision|2
5509077|NCT01585584|19046746|P1|Overall Study|Withdrawal by Subject|1
5509078|NCT01585584|19046746|P1|Overall Study|Lack of Efficacy|1
5509079|NCT01585558|19046753|P3|Overall Study|Lack of Efficacy|1
5509080|NCT01585558|19046754|P2|Overall Study|Lack of Efficacy|0
5509081|NCT01585558|19046755|P1|Overall Study|Lack of Efficacy|0
5509082|NCT01585558|19046753|P3|Overall Study|Protocol Violation|2
5509083|NCT01585558|19046754|P2|Overall Study|Protocol Violation|3
5509084|NCT01585558|19046755|P1|Overall Study|Protocol Violation|4
5509085|NCT01585558|19046753|P3|Overall Study|Adverse Event|1
5509086|NCT01585558|19046754|P2|Overall Study|Adverse Event|4
5509087|NCT01585558|19046755|P1|Overall Study|Adverse Event|3
5509088|NCT01585558|19046753|P3|Overall Study|Lost to Follow-up|3
5509089|NCT01585558|19046754|P2|Overall Study|Lost to Follow-up|0
5509090|NCT01585558|19046755|P1|Overall Study|Lost to Follow-up|2
5509091|NCT01585558|19046753|P3|Overall Study|Withdrawal by Subject|8
5509092|NCT01585558|19046754|P2|Overall Study|Withdrawal by Subject|5
5509093|NCT01585558|19046755|P1|Overall Study|Withdrawal by Subject|4
5509094|NCT01585428|19046989|P2|Overall Study|Death during treatment|0
5509095|NCT01585428|19046990|P1|Overall Study|Death during treatment|1
5509096|NCT01585298|19047014|P1|Overall Study|Adverse Event|24
5509097|NCT01585298|19047014|P1|Overall Study|Abnormal test procedure results|1
5509098|NCT01585298|19047014|P1|Overall Study|Withdrawal by Subject|4
5509099|NCT01585298|19047014|P1|Overall Study|Lost to Follow-up|2
5509100|NCT01585298|19047014|P1|Overall Study|Administrative problems|4
5509101|NCT01585298|19047014|P1|Overall Study|Protocol deviation|1
5509102|NCT01585298|19047014|P1|Overall Study|Study completion was not documented.|1
5509103|NCT01585272|19047022|P1|Overall Study|Withdrawal by Subject|10
5509104|NCT01585272|19047022|P1|Overall Study|Protocol Violation|7
5509105|NCT01585272|19047022|P1|Overall Study|Adverse Event|22
5509106|NCT01585246|19047035|P5|Overall Study|Other|0
5509107|NCT01585246|19047036|P4|Overall Study|Other|1
5509108|NCT01585246|19047037|P3|Overall Study|Other|1
5509109|NCT01585246|19047038|P2|Overall Study|Other|1
5509110|NCT01585246|19047039|P1|Overall Study|Other|0
5509111|NCT01585246|19047035|P5|Overall Study|Withdrawal by Subject|1
5509112|NCT01585246|19047036|P4|Overall Study|Withdrawal by Subject|2
5509113|NCT01585246|19047037|P3|Overall Study|Withdrawal by Subject|1
5509114|NCT01585246|19047038|P2|Overall Study|Withdrawal by Subject|0
5509115|NCT01585246|19047039|P1|Overall Study|Withdrawal by Subject|0
5509116|NCT01585246|19047035|P5|Overall Study|Protocol Violation|1
5509117|NCT01585246|19047036|P4|Overall Study|Protocol Violation|0
5509118|NCT01585246|19047037|P3|Overall Study|Protocol Violation|0
5509119|NCT01585246|19047038|P2|Overall Study|Protocol Violation|0
5509120|NCT01585246|19047039|P1|Overall Study|Protocol Violation|0
5509121|NCT01585246|19047035|P5|Overall Study|Lost to Follow-up|0
5509122|NCT01585246|19047036|P4|Overall Study|Lost to Follow-up|1
5509123|NCT01585246|19047037|P3|Overall Study|Lost to Follow-up|2
5509124|NCT01585246|19047038|P2|Overall Study|Lost to Follow-up|0
5509125|NCT01585246|19047039|P1|Overall Study|Lost to Follow-up|0
5509126|NCT01585194|19047058|P1|Overall Study|Lack of insurance|1
5509127|NCT01585194|19047058|P1|Overall Study|Physician Decision|2
5509128|NCT01585194|19047058|P1|Overall Study|Withdrawal by Subject|1
5509129|NCT01585168|19047067|P4|Overall Study|Lost to Follow-up|1
5509130|NCT01585168|19047068|P3|Overall Study|Lost to Follow-up|1
5509131|NCT01585168|19047069|P2|Overall Study|Lost to Follow-up|1
5509132|NCT01585168|19047070|P1|Overall Study|Lost to Follow-up|3
5509133|NCT01585155|19047090|P1|Overall Study|Worsening ulcerative colitis|2
5509134|NCT01585155|19047090|P1|Overall Study|Lack of Efficacy|2
5509135|NCT01585155|19047090|P1|Overall Study|Adverse Event|1
5509136|NCT01585038|19047112|P2|Overall Study|Adverse Event|2
5509137|NCT01585038|19047113|P1|Overall Study|Adverse Event|2
5509138|NCT01585025|19047128|P3|Overall Study|Withdrawal by Subject|4
5509139|NCT01585025|19047129|P2|Overall Study|Withdrawal by Subject|3
5509140|NCT01585025|19047130|P1|Overall Study|Withdrawal by Subject|0
5509141|NCT01584843|19047160|P6|Second Treatment Period|Withdrawal by Subject|1
5509142|NCT01584843|19047161|P5|Second Treatment Period|Withdrawal by Subject|0
5509143|NCT01584843|19047162|P4|Second Treatment Period|Withdrawal by Subject|0
5509144|NCT01584843|19047163|P3|Second Treatment Period|Withdrawal by Subject|0
5509145|NCT01584843|19047164|P2|Second Treatment Period|Withdrawal by Subject|0
5509146|NCT01584843|19047165|P1|Second Treatment Period|Withdrawal by Subject|0
5509147|NCT01584843|19047160|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
5509148|NCT01584843|19047161|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5509149|NCT01584843|19047162|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5509150|NCT01584843|19047163|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5509151|NCT01584843|19047164|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5509152|NCT01584843|19047165|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
5509153|NCT01584843|19047160|P6|First Treatment Period|Protocol Violation|1
5509154|NCT01584843|19047161|P5|First Treatment Period|Protocol Violation|0
5509155|NCT01584843|19047162|P4|First Treatment Period|Protocol Violation|0
5509156|NCT01584843|19047163|P3|First Treatment Period|Protocol Violation|0
5509157|NCT01584843|19047164|P2|First Treatment Period|Protocol Violation|0
5509158|NCT01584843|19047165|P1|First Treatment Period|Protocol Violation|0
5509159|NCT01584843|19047160|P6|First Treatment Period|Adverse Event|0
5509160|NCT01584843|19047161|P5|First Treatment Period|Adverse Event|0
5509161|NCT01584843|19047162|P4|First Treatment Period|Adverse Event|0
5509162|NCT01584843|19047163|P3|First Treatment Period|Adverse Event|1
5509163|NCT01584843|19047164|P2|First Treatment Period|Adverse Event|0
5509164|NCT01584843|19047165|P1|First Treatment Period|Adverse Event|0
5509165|NCT01584648|19047276|P2|Overall Study|Ongoing|147
5509166|NCT01584648|19047277|P1|Overall Study|Ongoing|154
5509167|NCT01584648|19047276|P2|Overall Study|Death|55
5509168|NCT01584648|19047277|P1|Overall Study|Death|40
5509169|NCT01584648|19047276|P2|Overall Study|Withdrawal by Subject|5
5509170|NCT01584648|19047277|P1|Overall Study|Withdrawal by Subject|11
5509171|NCT01584648|19047276|P2|Overall Study|Physician Decision|2
5509172|NCT01584648|19047277|P1|Overall Study|Physician Decision|2
5509173|NCT01584648|19047276|P2|Overall Study|Lost to Follow-up|3
5509174|NCT01584648|19047277|P1|Overall Study|Lost to Follow-up|4
5509175|NCT01584232|19047405|P2|Overall Study|Lost to Follow-up|0
5509176|NCT01584232|19047406|P1|Overall Study|Lost to Follow-up|1
5509177|NCT01584232|19047405|P2|Overall Study|Physician Decision|1
5509178|NCT01584232|19047406|P1|Overall Study|Physician Decision|2
5509179|NCT01584232|19047405|P2|Overall Study|Withdrawal by Subject|1
5509180|NCT01584232|19047406|P1|Overall Study|Withdrawal by Subject|2
5509181|NCT01584232|19047405|P2|Overall Study|Adverse Event|1
5509182|NCT01584232|19047406|P1|Overall Study|Adverse Event|3
5509183|NCT01584024|19047422|P1|Overall Study|Withdrawal by Subject|3
5509184|NCT01584024|19047422|P1|Overall Study|Lost to Follow-up|10
5509185|NCT01583530|19047519|P6|Overall Study|Lack of compliance|0
5509186|NCT01583530|19047520|P5|Overall Study|Lack of compliance|1
5509187|NCT01583530|19047521|P4|Overall Study|Lack of compliance|0
5509188|NCT01583530|19047522|P3|Overall Study|Lack of compliance|0
5509189|NCT01583530|19047523|P2|Overall Study|Lack of compliance|0
5509190|NCT01583530|19047524|P1|Overall Study|Lack of compliance|0
5509191|NCT01583530|19047519|P6|Overall Study|Lost to Follow-up|0
5509192|NCT01583530|19047520|P5|Overall Study|Lost to Follow-up|3
5509193|NCT01583530|19047521|P4|Overall Study|Lost to Follow-up|0
5509194|NCT01583530|19047522|P3|Overall Study|Lost to Follow-up|0
5509195|NCT01583530|19047523|P2|Overall Study|Lost to Follow-up|0
5509196|NCT01583530|19047524|P1|Overall Study|Lost to Follow-up|0
5509197|NCT01583530|19047519|P6|Overall Study|Withdrawal by Subject|2
5509198|NCT01583530|19047520|P5|Overall Study|Withdrawal by Subject|1
5509199|NCT01583530|19047521|P4|Overall Study|Withdrawal by Subject|1
5509200|NCT01583530|19047522|P3|Overall Study|Withdrawal by Subject|0
5509201|NCT01583530|19047523|P2|Overall Study|Withdrawal by Subject|3
5509202|NCT01583530|19047524|P1|Overall Study|Withdrawal by Subject|0
5509203|NCT01583530|19047519|P6|Overall Study|Adverse Event|1
5509204|NCT01583530|19047520|P5|Overall Study|Adverse Event|0
5509205|NCT01583530|19047521|P4|Overall Study|Adverse Event|0
5509206|NCT01583530|19047522|P3|Overall Study|Adverse Event|0
5509207|NCT01583530|19047523|P2|Overall Study|Adverse Event|0
5509208|NCT01583530|19047524|P1|Overall Study|Adverse Event|0
5509209|NCT01583374|19047586|P9|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
5509210|NCT01583374|19047587|P8|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
5509211|NCT01583374|19047588|P7|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
5509212|NCT01583374|19047589|P6|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
5509213|NCT01583374|19047590|P5|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
5509214|NCT01583374|19047591|P4|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
5509215|NCT01583374|19047592|P3|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
5509216|NCT01583374|19047593|P2|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
5509217|NCT01583374|19047594|P1|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
5509218|NCT01583374|19047586|P9|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5509219|NCT01583374|19047587|P8|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5509220|NCT01583374|19047588|P7|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5509221|NCT01583374|19047589|P6|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5509222|NCT01583374|19047590|P5|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5509223|NCT01583374|19047591|P4|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5509224|NCT01583374|19047592|P3|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5509225|NCT01583374|19047593|P2|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
5509226|NCT01583374|19047594|P1|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
5509227|NCT01583374|19047586|P9|Long-Term Extension Phase Weeks 52-260|Death|0
5509228|NCT01583374|19047587|P8|Long-Term Extension Phase Weeks 52-260|Death|0
5509229|NCT01583374|19047588|P7|Long-Term Extension Phase Weeks 52-260|Death|1
5509230|NCT01583374|19047589|P6|Long-Term Extension Phase Weeks 52-260|Death|0
5509231|NCT01583374|19047590|P5|Long-Term Extension Phase Weeks 52-260|Death|1
5509232|NCT01583374|19047591|P4|Long-Term Extension Phase Weeks 52-260|Death|0
5509233|NCT01583374|19047592|P3|Long-Term Extension Phase Weeks 52-260|Death|0
5509234|NCT01583374|19047593|P2|Long-Term Extension Phase Weeks 52-260|Death|0
5509235|NCT01583374|19047594|P1|Long-Term Extension Phase Weeks 52-260|Death|0
5509236|NCT01583374|19047586|P9|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
5509237|NCT01583374|19047587|P8|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
5509238|NCT01583374|19047588|P7|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
5509239|NCT01583374|19047589|P6|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
5509240|NCT01583374|19047590|P5|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
5509241|NCT01583374|19047591|P4|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
5509242|NCT01583374|19047592|P3|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
5509243|NCT01583374|19047593|P2|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
5509244|NCT01583374|19047594|P1|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
5509245|NCT01583374|19047586|P9|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
5509246|NCT01583374|19047587|P8|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
5509247|NCT01583374|19047588|P7|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5509248|NCT01583374|19047589|P6|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5509249|NCT01583374|19047590|P5|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
5509250|NCT01583374|19047591|P4|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5509251|NCT01583374|19047592|P3|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5509252|NCT01583374|19047593|P2|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5509253|NCT01583374|19047594|P1|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
5509254|NCT01583374|19047586|P9|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
5509255|NCT01583374|19047587|P8|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
5509256|NCT01583374|19047588|P7|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
5509257|NCT01583374|19047589|P6|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
5509258|NCT01583374|19047590|P5|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
5509259|NCT01583374|19047591|P4|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
5509260|NCT01583374|19047592|P3|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
5509261|NCT01583374|19047593|P2|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
5509262|NCT01583374|19047594|P1|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
5509263|NCT01583374|19047586|P9|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
5509264|NCT01583374|19047587|P8|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
5509265|NCT01583374|19047588|P7|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5509266|NCT01583374|19047589|P6|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5509267|NCT01583374|19047590|P5|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
5509268|NCT01583374|19047591|P4|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5509269|NCT01583374|19047592|P3|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
5509270|NCT01583374|19047593|P2|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
5509271|NCT01583374|19047594|P1|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
5509272|NCT01583374|19047586|P9|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5509273|NCT01583374|19047587|P8|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5509274|NCT01583374|19047588|P7|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5509275|NCT01583374|19047589|P6|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
5509276|NCT01583374|19047590|P5|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
5509277|NCT01583374|19047591|P4|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5509278|NCT01583374|19047592|P3|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
5509279|NCT01583374|19047593|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5509280|NCT01583374|19047594|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5509281|NCT01583374|19047586|P9|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5509282|NCT01583374|19047587|P8|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5509283|NCT01583374|19047588|P7|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5509284|NCT01583374|19047589|P6|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5509285|NCT01583374|19047590|P5|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
5509286|NCT01583374|19047591|P4|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5509287|NCT01583374|19047592|P3|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
5509288|NCT01583374|19047593|P2|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
5509289|NCT01583374|19047594|P1|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
5509290|NCT01583374|19047586|P9|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
5509291|NCT01583374|19047587|P8|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
5509292|NCT01583374|19047588|P7|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
5509293|NCT01583374|19047589|P6|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
5509294|NCT01583374|19047590|P5|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
5509295|NCT01583374|19047591|P4|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
5509296|NCT01583374|19047592|P3|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
5509297|NCT01583374|19047593|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
5509298|NCT01583374|19047594|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
5509299|NCT01583374|19047586|P9|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5509300|NCT01583374|19047587|P8|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5509301|NCT01583374|19047588|P7|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5509302|NCT01583374|19047589|P6|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5509303|NCT01583374|19047590|P5|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5509304|NCT01583374|19047591|P4|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5509305|NCT01583374|19047592|P3|Extension Phase (Weeks 24 to 52)|Adverse Event|2
5509306|NCT01583374|19047593|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5509307|NCT01583374|19047594|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|0
5509308|NCT01583374|19047586|P9|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5509309|NCT01583374|19047587|P8|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
5509310|NCT01583374|19047588|P7|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5509311|NCT01583374|19047589|P6|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5509312|NCT01583374|19047590|P5|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5509313|NCT01583374|19047591|P4|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5509314|NCT01583374|19047592|P3|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5509315|NCT01583374|19047593|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5509316|NCT01583374|19047594|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5509317|NCT01583374|19047586|P9|Placebo-controlled Phase (Week 0-24)|Other|0
5509318|NCT01583374|19047587|P8|Placebo-controlled Phase (Week 0-24)|Other|0
5509319|NCT01583374|19047588|P7|Placebo-controlled Phase (Week 0-24)|Other|0
5509320|NCT01583374|19047589|P6|Placebo-controlled Phase (Week 0-24)|Other|0
5509321|NCT01583374|19047590|P5|Placebo-controlled Phase (Week 0-24)|Other|0
5509322|NCT01583374|19047591|P4|Placebo-controlled Phase (Week 0-24)|Other|0
5509323|NCT01583374|19047592|P3|Placebo-controlled Phase (Week 0-24)|Other|0
5509324|NCT01583374|19047593|P2|Placebo-controlled Phase (Week 0-24)|Other|1
5509325|NCT01583374|19047594|P1|Placebo-controlled Phase (Week 0-24)|Other|0
5509326|NCT01583374|19047586|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5509327|NCT01583374|19047587|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5509328|NCT01583374|19047588|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5509329|NCT01583374|19047589|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5509330|NCT01583374|19047590|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5509331|NCT01583374|19047591|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5509332|NCT01583374|19047592|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
5509333|NCT01583374|19047593|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5509334|NCT01583374|19047594|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5509335|NCT01583374|19047586|P9|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5509336|NCT01583374|19047587|P8|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5509337|NCT01583374|19047588|P7|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5509338|NCT01583374|19047589|P6|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5509339|NCT01583374|19047590|P5|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5509340|NCT01583374|19047591|P4|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5509341|NCT01583374|19047592|P3|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
5509342|NCT01583374|19047593|P2|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
5509343|NCT01583374|19047594|P1|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
5509344|NCT01583374|19047586|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5509345|NCT01583374|19047587|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5509346|NCT01583374|19047588|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5509347|NCT01583374|19047589|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5509348|NCT01583374|19047590|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5509349|NCT01583374|19047591|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5509350|NCT01583374|19047592|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
5509351|NCT01583374|19047593|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
5509352|NCT01583374|19047594|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
5509353|NCT01583374|19047586|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5509354|NCT01583374|19047587|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5509355|NCT01583374|19047588|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5509356|NCT01583374|19047589|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5509357|NCT01583374|19047590|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5509358|NCT01583374|19047591|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5509359|NCT01583374|19047592|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5509440|NCT01582854|19047725|P2|Overall Study|Adverse Event|3
5509360|NCT01583374|19047593|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
5509361|NCT01583374|19047594|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
5509362|NCT01583374|19047586|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5509363|NCT01583374|19047587|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5509364|NCT01583374|19047588|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5509365|NCT01583374|19047589|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5509366|NCT01583374|19047590|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5509367|NCT01583374|19047591|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5509368|NCT01583374|19047592|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
5509369|NCT01583374|19047593|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
5509370|NCT01583374|19047594|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
5509371|NCT01583374|19047586|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5509372|NCT01583374|19047587|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5509373|NCT01583374|19047588|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5509374|NCT01583374|19047589|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5509375|NCT01583374|19047590|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5509376|NCT01583374|19047591|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5509377|NCT01583374|19047592|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
5509378|NCT01583374|19047593|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
5509379|NCT01583374|19047594|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
5509380|NCT01583218|19047636|P2|Overall Study|Withdraw of consent on day of random|0
5509381|NCT01583218|19047637|P1|Overall Study|Withdraw of consent on day of random|1
5509382|NCT01583218|19047636|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
5509383|NCT01583218|19047637|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
5509384|NCT01583218|19047636|P2|Overall Study|Patient was randomized due to mistake|0
5509385|NCT01583218|19047637|P1|Overall Study|Patient was randomized due to mistake|1
5509386|NCT01583218|19047636|P2|Overall Study|Patient was early terminated from study|1
5509387|NCT01583218|19047637|P1|Overall Study|Patient was early terminated from study|0
5509388|NCT01583218|19047636|P2|Overall Study|Patient deemed ineligible after random|0
5509389|NCT01583218|19047637|P1|Overall Study|Patient deemed ineligible after random|2
5509390|NCT01583218|19047636|P2|Overall Study|Patient was assessed via phone in person|0
5509391|NCT01583218|19047637|P1|Overall Study|Patient was assessed via phone in person|1
5509392|NCT01583218|19047636|P2|Overall Study|Patient randomized but not dosed|16
5509393|NCT01583218|19047637|P1|Overall Study|Patient randomized but not dosed|17
5509394|NCT01583218|19047636|P2|Overall Study|Patient did not wish to attend visits|1
5509395|NCT01583218|19047637|P1|Overall Study|Patient did not wish to attend visits|0
5509396|NCT01583218|19047636|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
5509397|NCT01583218|19047637|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
5509398|NCT01583218|19047636|P2|Overall Study|Cannot contact patient directly|2
5509399|NCT01583218|19047637|P1|Overall Study|Cannot contact patient directly|1
5509400|NCT01583218|19047636|P2|Overall Study|Patient /Family decision|0
5509401|NCT01583218|19047637|P1|Overall Study|Patient /Family decision|3
5509402|NCT01583218|19047636|P2|Overall Study|Adverse event or serious adverse event|3
5509403|NCT01583218|19047637|P1|Overall Study|Adverse event or serious adverse event|3
5509404|NCT01583218|19047636|P2|Overall Study|Lost to Follow-up|17
5509405|NCT01583218|19047637|P1|Overall Study|Lost to Follow-up|11
5509406|NCT01583218|19047636|P2|Overall Study|Death|211
5509407|NCT01583218|19047637|P1|Overall Study|Death|206
5509408|NCT01583218|19047636|P2|Overall Study|Withdrawal by Subject|29
5509409|NCT01583218|19047637|P1|Overall Study|Withdrawal by Subject|43
5509410|NCT01583179|19047657|P2|Overall Study|Screen failure|2
5509411|NCT01583179|19047658|P1|Overall Study|Screen failure|1
5509412|NCT01583166|19047668|P2|Overall Study|Withdrawal by Subject|6
5509413|NCT01583166|19047669|P1|Overall Study|Withdrawal by Subject|4
5509414|NCT01582971|19047692|P2|Overall Study|Other|13
5509415|NCT01582971|19047693|P1|Overall Study|Other|15
5509416|NCT01582971|19047692|P2|Overall Study|Withdrawal by Subject|2
5509417|NCT01582971|19047693|P1|Overall Study|Withdrawal by Subject|4
5509418|NCT01582971|19047692|P2|Overall Study|Lost to Follow-up|21
5509419|NCT01582971|19047693|P1|Overall Study|Lost to Follow-up|18
5509420|NCT01582971|19047692|P2|Overall Study|Death|1
5509421|NCT01582971|19047693|P1|Overall Study|Death|2
5509422|NCT01582945|19047711|P1|Overall Study|Scheduling conflicts|1
5509423|NCT01582945|19047711|P1|Overall Study|Intolerable side-effects|1
5509424|NCT01582854|19047725|P2|Overall Study|Other Miscellaneous Reason|0
5509425|NCT01582854|19047726|P1|Overall Study|Other Miscellaneous Reason|1
5509426|NCT01582854|19047725|P2|Overall Study|General Anaesthesia|1
5509427|NCT01582854|19047726|P1|Overall Study|General Anaesthesia|0
5509428|NCT01582854|19047725|P2|Overall Study|Carotid or Neurosurgery|1
5509429|NCT01582854|19047726|P1|Overall Study|Carotid or Neurosurgery|0
5509430|NCT01582854|19047725|P2|Overall Study|Disallowed Concomitant Medication|2
5509431|NCT01582854|19047726|P1|Overall Study|Disallowed Concomitant Medication|3
5509432|NCT01582854|19047725|P2|Overall Study|Recurrent Stroke|8
5509433|NCT01582854|19047726|P1|Overall Study|Recurrent Stroke|13
5509434|NCT01582854|19047725|P2|Overall Study|Physician Decision|1
5509435|NCT01582854|19047726|P1|Overall Study|Physician Decision|0
5509436|NCT01582854|19047725|P2|Overall Study|Lost to Follow-up|2
5509437|NCT01582854|19047726|P1|Overall Study|Lost to Follow-up|1
5509438|NCT01582854|19047725|P2|Overall Study|Withdrawal by Participant|11
5509439|NCT01582854|19047726|P1|Overall Study|Withdrawal by Participant|8
5509441|NCT01582854|19047726|P1|Overall Study|Adverse Event|2
5509442|NCT01582854|19047725|P2|Overall Study|Death|5
5509443|NCT01582854|19047726|P1|Overall Study|Death|8
5509444|NCT01582789|19047754|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
5509445|NCT01582789|19047755|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
5509446|NCT01582451|19047815|P2|Overall Study|Sponsor Decision|0
5509447|NCT01582451|19047816|P1|Overall Study|Sponsor Decision|1
5509448|NCT01582451|19047815|P2|Overall Study|Physician Decision|0
5509449|NCT01582451|19047816|P1|Overall Study|Physician Decision|3
5509450|NCT01582451|19047815|P2|Overall Study|Withdrawal by Subject|9
5509451|NCT01582451|19047816|P1|Overall Study|Withdrawal by Subject|13
5509452|NCT01582451|19047815|P2|Overall Study|Protocol Violation|3
5509453|NCT01582451|19047816|P1|Overall Study|Protocol Violation|11
5509454|NCT01582451|19047815|P2|Overall Study|Lost to Follow-up|2
5509455|NCT01582451|19047816|P1|Overall Study|Lost to Follow-up|0
5509456|NCT01582451|19047815|P2|Overall Study|Death|3
5509457|NCT01582451|19047816|P1|Overall Study|Death|3
5509458|NCT01582451|19047815|P2|Overall Study|Adverse Event|3
5509459|NCT01582451|19047816|P1|Overall Study|Adverse Event|1
5509460|NCT01582308|19047858|P10|Period 4|Physician Decision|1
5509461|NCT01582308|19047859|P9|Period 4|Physician Decision|0
5509462|NCT01582308|19047860|P8|Period 4|Physician Decision|0
5509463|NCT01582308|19047861|P7|Period 4|Physician Decision|0
5509464|NCT01582308|19047862|P6|Period 4|Physician Decision|1
5509465|NCT01582308|19047863|P5|Period 4|Physician Decision|0
5509466|NCT01582308|19047864|P4|Period 4|Physician Decision|0
5509467|NCT01582308|19047865|P3|Period 4|Physician Decision|0
5509468|NCT01582308|19047866|P2|Period 4|Physician Decision|0
5509469|NCT01582308|19047867|P1|Period 4|Physician Decision|1
5509470|NCT01582308|19047858|P10|10-day Washout Following Period 1|Physician Decision|0
5509471|NCT01582308|19047859|P9|10-day Washout Following Period 1|Physician Decision|0
5509472|NCT01582308|19047860|P8|10-day Washout Following Period 1|Physician Decision|0
5509473|NCT01582308|19047861|P7|10-day Washout Following Period 1|Physician Decision|0
5509474|NCT01582308|19047862|P6|10-day Washout Following Period 1|Physician Decision|0
5509475|NCT01582308|19047863|P5|10-day Washout Following Period 1|Physician Decision|1
5509476|NCT01582308|19047864|P4|10-day Washout Following Period 1|Physician Decision|0
5509477|NCT01582308|19047865|P3|10-day Washout Following Period 1|Physician Decision|0
5509478|NCT01582308|19047866|P2|10-day Washout Following Period 1|Physician Decision|0
5509479|NCT01582308|19047867|P1|10-day Washout Following Period 1|Physician Decision|0
5509480|NCT01582308|19047858|P10|Period 1|Withdrawal by Subject|0
5509481|NCT01582308|19047859|P9|Period 1|Withdrawal by Subject|0
5509482|NCT01582308|19047860|P8|Period 1|Withdrawal by Subject|0
5509483|NCT01582308|19047861|P7|Period 1|Withdrawal by Subject|1
5509484|NCT01582308|19047862|P6|Period 1|Withdrawal by Subject|0
5509485|NCT01582308|19047863|P5|Period 1|Withdrawal by Subject|0
5509486|NCT01582308|19047864|P4|Period 1|Withdrawal by Subject|0
5509487|NCT01582308|19047865|P3|Period 1|Withdrawal by Subject|0
5509488|NCT01582308|19047866|P2|Period 1|Withdrawal by Subject|0
5509489|NCT01582308|19047867|P1|Period 1|Withdrawal by Subject|0
5509490|NCT01582282|19047895|P3|Overall Study|fasting blood glucose outside Protocol|0
5509491|NCT01582282|19047896|P2|Overall Study|fasting blood glucose outside Protocol|1
5509492|NCT01582282|19047897|P1|Overall Study|fasting blood glucose outside Protocol|0
5509493|NCT01582282|19047895|P3|Overall Study|Lost to Follow-up|0
5509494|NCT01582282|19047896|P2|Overall Study|Lost to Follow-up|0
5509495|NCT01582282|19047897|P1|Overall Study|Lost to Follow-up|1
5509496|NCT01582282|19047895|P3|Overall Study|Adverse Event|0
5509497|NCT01582282|19047896|P2|Overall Study|Adverse Event|1
5509498|NCT01582282|19047897|P1|Overall Study|Adverse Event|1
5509499|NCT01582243|19047920|P1|Overall Study|Lost to Follow-up|1
5509500|NCT01582243|19047920|P1|Overall Study|Adverse Event|1
5509501|NCT01582243|19047920|P1|Overall Study|Withdrawal by Subject|1
5509502|NCT01582178|19047931|P2|Overall Study|Physician Decision|5
5509503|NCT01582178|19047932|P1|Overall Study|Physician Decision|6
5509504|NCT01582152|19047940|P2|Overall Study|Adverse Event|1
5509505|NCT01582152|19047941|P1|Overall Study|Adverse Event|2
5509506|NCT01582152|19047940|P2|Overall Study|Disease Progression|5
5509507|NCT01582152|19047941|P1|Overall Study|Disease Progression|4
5509508|NCT01582100|19047964|P1|Overall Study|Withdrawal by Subject|1
5509509|NCT01582100|19047964|P1|Overall Study|Adverse Event|1
5509510|NCT01582061|19047970|P2|Overall Study|Lost to Follow-up|0
5509511|NCT01582061|19047971|P1|Overall Study|Lost to Follow-up|1
5509512|NCT01582061|19047970|P2|Overall Study|condition no longer requires study drug|0
5509513|NCT01582061|19047971|P1|Overall Study|condition no longer requires study drug|1
5509514|NCT01582061|19047970|P2|Overall Study|Death|1
5509515|NCT01582061|19047971|P1|Overall Study|Death|0
5509516|NCT01582061|19047970|P2|Overall Study|Abnormal laboratory value(s)|0
5509517|NCT01582061|19047971|P1|Overall Study|Abnormal laboratory value(s)|1
5509518|NCT01582061|19047970|P2|Overall Study|Withdrawal by Subject|4
5509519|NCT01582061|19047971|P1|Overall Study|Withdrawal by Subject|10
5509520|NCT01582061|19047970|P2|Overall Study|Adverse Event|8
5509521|NCT01582061|19047971|P1|Overall Study|Adverse Event|12
5509522|NCT01582061|19047970|P2|Overall Study|Lack of Efficacy|23
5509523|NCT01582061|19047971|P1|Overall Study|Lack of Efficacy|3
5509524|NCT01582009|19048021|P1|Overall Study|Physician Decision|1
5509525|NCT01582009|19048021|P1|Overall Study|Withdrawal by Subject|1
5509526|NCT01581931|19048038|P2|Washout|Adverse Event|1
5509527|NCT01581931|19048039|P1|Washout|Adverse Event|0
5509528|NCT01581684|19048092|P10|Overall Study|Other reason not defined|0
5509529|NCT01581684|19048093|P9|Overall Study|Other reason not defined|1
5509530|NCT01581684|19048094|P8|Overall Study|Other reason not defined|0
5509531|NCT01581684|19048095|P7|Overall Study|Other reason not defined|0
5509532|NCT01581684|19048096|P6|Overall Study|Other reason not defined|0
5509533|NCT01581684|19048097|P5|Overall Study|Other reason not defined|0
5509534|NCT01581684|19048098|P4|Overall Study|Other reason not defined|0
5509535|NCT01581684|19048099|P3|Overall Study|Other reason not defined|0
5509536|NCT01581684|19048100|P2|Overall Study|Other reason not defined|0
5509537|NCT01581684|19048101|P1|Overall Study|Other reason not defined|0
5509538|NCT01581619|19048197|P1|Overall Study|Lost to Follow-up|1
5509539|NCT01581619|19048197|P1|Overall Study|Withdrawal by Subject|1
5509540|NCT01581307|19048350|P1|Overall Study|Withdrawal by Subject|1
5509541|NCT01581281|19048359|P3|Overall Study|Early Study Closure|12
5509542|NCT01581281|19048360|P2|Overall Study|Early Study Closure|6
5509543|NCT01581281|19048361|P1|Overall Study|Early Study Closure|15
5509544|NCT01581021|19048383|P2|Overall Study|Lack of Efficacy|1
5509545|NCT01581021|19048384|P1|Overall Study|Lack of Efficacy|0
5509546|NCT01581021|19048383|P2|Overall Study|Lenke 6 Classification|1
5509547|NCT01581021|19048384|P1|Overall Study|Lenke 6 Classification|0
5509548|NCT01581021|19048383|P2|Overall Study|Not Randomized|2
5509549|NCT01581021|19048384|P1|Overall Study|Not Randomized|1
5509550|NCT01581021|19048383|P2|Overall Study|Neuromuscular|1
5509551|NCT01581021|19048384|P1|Overall Study|Neuromuscular|2
5509552|NCT01581021|19048383|P2|Overall Study|More than 2 hooks in thoracic|0
5509553|NCT01581021|19048384|P1|Overall Study|More than 2 hooks in thoracic|3
5509554|NCT01581021|19048383|P2|Overall Study|Lost to Follow-up|6
5509555|NCT01581021|19048384|P1|Overall Study|Lost to Follow-up|4
5509556|NCT01580995|19048411|P2|Overall Study|Lost to Follow-up|2
5509557|NCT01580995|19048412|P1|Overall Study|Lost to Follow-up|2
5509558|NCT01580969|19048421|P3|Overall Study|Physician Decision|0
5509559|NCT01580969|19048422|P2|Overall Study|Physician Decision|0
5509560|NCT01580969|19048423|P1|Overall Study|Physician Decision|3
5509561|NCT01580670|19048470|P1|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
5509562|NCT01580670|19048470|P1|Maintenance Period (Week 14 to 54)|Adverse Event|1
5509563|NCT01580488|19048511|P1|Overall Study|Withdrawal by Subject|1
5509564|NCT01580293|19048617|P3|Part B|Other reason|1
5509565|NCT01580293|19048618|P2|Part B|Other reason|0
5509566|NCT01580293|19048619|P1|Part B|Other reason|0
5509567|NCT01580293|19048617|P3|Part B|Withdrawal by Subject|1
5509568|NCT01580293|19048618|P2|Part B|Withdrawal by Subject|0
5509569|NCT01580293|19048619|P1|Part B|Withdrawal by Subject|0
5509570|NCT01580293|19048617|P3|Part A_Extension|Completed Japan only|0
5509571|NCT01580293|19048618|P2|Part A_Extension|Completed Japan only|5
5509572|NCT01580293|19048619|P1|Part A_Extension|Completed Japan only|0
5509573|NCT01580293|19048617|P3|Part A_Extension|Other Reason|0
5509574|NCT01580293|19048618|P2|Part A_Extension|Other Reason|1
5509575|NCT01580293|19048619|P1|Part A_Extension|Other Reason|0
5509576|NCT01580293|19048617|P3|Part A_Extension|Lost to Follow-up|0
5509577|NCT01580293|19048618|P2|Part A_Extension|Lost to Follow-up|1
5509578|NCT01580293|19048619|P1|Part A_Extension|Lost to Follow-up|0
5509579|NCT01580293|19048617|P3|Part A_Extension|Withdrawal by Subject|0
5509580|NCT01580293|19048618|P2|Part A_Extension|Withdrawal by Subject|3
5509581|NCT01580293|19048619|P1|Part A_Extension|Withdrawal by Subject|0
5509582|NCT01580293|19048617|P3|Part A_Extension|Adverse Event|0
5509583|NCT01580293|19048618|P2|Part A_Extension|Adverse Event|2
5509584|NCT01580293|19048619|P1|Part A_Extension|Adverse Event|0
5509585|NCT01580293|19048617|P3|Part A_Main Trial|Non-adherence to the protocol|0
5509586|NCT01580293|19048618|P2|Part A_Main Trial|Non-adherence to the protocol|0
5509587|NCT01580293|19048619|P1|Part A_Main Trial|Non-adherence to the protocol|1
5509588|NCT01580293|19048617|P3|Part A_Main Trial|Withdrawal by Subject|0
5509589|NCT01580293|19048618|P2|Part A_Main Trial|Withdrawal by Subject|4
5509590|NCT01580293|19048619|P1|Part A_Main Trial|Withdrawal by Subject|1
5509591|NCT01580293|19048617|P3|Part A_Main Trial|Adverse Event|0
5509592|NCT01580293|19048618|P2|Part A_Main Trial|Adverse Event|2
5509593|NCT01580293|19048619|P1|Part A_Main Trial|Adverse Event|0
5509594|NCT01580020|19048759|P4|Overall Study|Lost to Follow-up|0
5509595|NCT01580020|19048760|P3|Overall Study|Lost to Follow-up|1
5509596|NCT01580020|19048761|P2|Overall Study|Lost to Follow-up|0
5509597|NCT01580020|19048762|P1|Overall Study|Lost to Follow-up|0
5509598|NCT01580020|19048759|P4|Overall Study|Administrative Problems|0
5509599|NCT01580020|19048760|P3|Overall Study|Administrative Problems|1
5509600|NCT01580020|19048761|P2|Overall Study|Administrative Problems|0
5509601|NCT01580020|19048762|P1|Overall Study|Administrative Problems|0
5509602|NCT01580020|19048759|P4|Overall Study|Adverse Event|1
5509603|NCT01580020|19048760|P3|Overall Study|Adverse Event|1
5509604|NCT01580020|19048761|P2|Overall Study|Adverse Event|1
5509605|NCT01580020|19048762|P1|Overall Study|Adverse Event|1
5509606|NCT01580020|19048759|P4|Overall Study|Withdrawal by Subject|0
5509607|NCT01580020|19048760|P3|Overall Study|Withdrawal by Subject|1
5509608|NCT01580020|19048761|P2|Overall Study|Withdrawal by Subject|1
5509609|NCT01580020|19048762|P1|Overall Study|Withdrawal by Subject|0
5509610|NCT01580020|19048759|P4|Overall Study|Lack of Efficacy|1
5509611|NCT01580020|19048760|P3|Overall Study|Lack of Efficacy|0
5509612|NCT01580020|19048761|P2|Overall Study|Lack of Efficacy|5
5509613|NCT01580020|19048762|P1|Overall Study|Lack of Efficacy|0
5509614|NCT01579916|19048806|P2|Overall Study|Death|0
5509615|NCT01579916|19048807|P1|Overall Study|Death|1
5509616|NCT01579916|19048806|P2|Overall Study|Withdrawal by Subject|1
5509617|NCT01579916|19048807|P1|Overall Study|Withdrawal by Subject|1
5509618|NCT01579916|19048806|P2|Overall Study|Lost to Follow-up|1
5509619|NCT01579916|19048807|P1|Overall Study|Lost to Follow-up|6
5509620|NCT01579812|19048833|P1|Overall Study|Withdrawal by Subject|6
5509621|NCT01579812|19048833|P1|Overall Study|Noncompliance|3
5509622|NCT01579812|19048833|P1|Overall Study|Patient choice|3
5509623|NCT01579812|19048833|P1|Overall Study|Ineligible after treatment start|40
5509624|NCT01579578|19048867|P2|Overall Study|Ongoing|0
5509625|NCT01579578|19048868|P1|Overall Study|Ongoing|3
5509626|NCT01579578|19048867|P2|Overall Study|Eligibility criteria|9
5509627|NCT01579578|19048868|P1|Overall Study|Eligibility criteria|3
5509628|NCT01579578|19048867|P2|Overall Study|Withdrawal by Subject|1
5509629|NCT01579578|19048868|P1|Overall Study|Withdrawal by Subject|2
5509630|NCT01579578|19048867|P2|Overall Study|Lost to Follow-up|1
5509631|NCT01579578|19048868|P1|Overall Study|Lost to Follow-up|1
5509632|NCT01579578|19048867|P2|Overall Study|Death|1
5509633|NCT01579578|19048868|P1|Overall Study|Death|4
5509634|NCT01579565|19048880|P2|Treated|declined to return for final visit|1
5509635|NCT01579565|19048881|P1|Treated|declined to return for final visit|0
5509636|NCT01579565|19048880|P2|Treated|Lost to Follow-up|1
5509637|NCT01579565|19048881|P1|Treated|Lost to Follow-up|2
5509638|NCT01579565|19048880|P2|Treated|Physician Decision|1
5509639|NCT01579565|19048881|P1|Treated|Physician Decision|0
5509640|NCT01579565|19048880|P2|Randomized|prohibited preoperative medication|1
5509641|NCT01579565|19048881|P1|Randomized|prohibited preoperative medication|0
5509642|NCT01579565|19048880|P2|Randomized|prohibited preoperative eating|0
5509643|NCT01579565|19048881|P1|Randomized|prohibited preoperative eating|1
5509644|NCT01579565|19048880|P2|Randomized|inadequate preoperative pupil dilation|1
5509645|NCT01579565|19048881|P1|Randomized|inadequate preoperative pupil dilation|0
5509646|NCT01579565|19048880|P2|Randomized|Withdrawal by Subject|0
5509647|NCT01579565|19048881|P1|Randomized|Withdrawal by Subject|3
5509648|NCT01579565|19048880|P2|Randomized|Adverse Event|3
5509649|NCT01579565|19048881|P1|Randomized|Adverse Event|1
5509650|NCT01579474|19048932|P6|Overall Study|Withdrawal by Subject|0
5509651|NCT01579474|19048933|P5|Overall Study|Withdrawal by Subject|0
5509652|NCT01579474|19048934|P4|Overall Study|Withdrawal by Subject|0
5509653|NCT01579474|19048935|P3|Overall Study|Withdrawal by Subject|0
5509654|NCT01579474|19048936|P2|Overall Study|Withdrawal by Subject|0
5509655|NCT01579474|19048937|P1|Overall Study|Withdrawal by Subject|1
5509656|NCT01579474|19048932|P6|Overall Study|Lack of Efficacy|0
5509657|NCT01579474|19048933|P5|Overall Study|Lack of Efficacy|1
5509658|NCT01579474|19048934|P4|Overall Study|Lack of Efficacy|0
5509659|NCT01579474|19048935|P3|Overall Study|Lack of Efficacy|0
5509660|NCT01579474|19048936|P2|Overall Study|Lack of Efficacy|0
5509661|NCT01579474|19048937|P1|Overall Study|Lack of Efficacy|1
5509662|NCT01579474|19048932|P6|Overall Study|Adverse Event|1
5509663|NCT01579474|19048933|P5|Overall Study|Adverse Event|0
5509664|NCT01579474|19048934|P4|Overall Study|Adverse Event|0
5509665|NCT01579474|19048935|P3|Overall Study|Adverse Event|2
5509666|NCT01579474|19048936|P2|Overall Study|Adverse Event|13
5509667|NCT01579474|19048937|P1|Overall Study|Adverse Event|1
5509668|NCT01579318|19049011|P1|Overall Study|Disease Progression|1
5509669|NCT01579006|19049106|P1|Overall Study|Scheduled surgery|1
5509670|NCT01579006|19049106|P1|Overall Study|Due to participant's health fund|1
5509671|NCT01579006|19049106|P1|Overall Study|Non-compliance|3
5509672|NCT01579006|19049106|P1|Overall Study|Withdrawal by Subject|5
5509673|NCT01579006|19049106|P1|Overall Study|Adverse Event|13
5509674|NCT01579006|19049106|P1|Overall Study|Lack of Efficacy|10
5509675|NCT01578850|19049174|P3|Period 2|Unspecified Reasons|0
5509676|NCT01578850|19049175|P2|Period 2|Unspecified Reasons|1
5509677|NCT01578850|19049176|P1|Period 2|Unspecified Reasons|0
5509678|NCT01578850|19049174|P3|Period 2|Study Terminated by Sponsor|4
5509679|NCT01578850|19049175|P2|Period 2|Study Terminated by Sponsor|5
5509680|NCT01578850|19049176|P1|Period 2|Study Terminated by Sponsor|0
5509681|NCT01578850|19049174|P3|Period 2|Withdrawal by Subject|2
5509682|NCT01578850|19049175|P2|Period 2|Withdrawal by Subject|2
5509683|NCT01578850|19049176|P1|Period 2|Withdrawal by Subject|0
5509684|NCT01578850|19049174|P3|Period 2|Lost to Follow-up|2
5509685|NCT01578850|19049175|P2|Period 2|Lost to Follow-up|1
5509686|NCT01578850|19049176|P1|Period 2|Lost to Follow-up|0
5509687|NCT01578850|19049174|P3|Period 2|Adverse Event|6
5509688|NCT01578850|19049175|P2|Period 2|Adverse Event|3
5509689|NCT01578850|19049176|P1|Period 2|Adverse Event|0
5509690|NCT01578850|19049174|P3|Period 2|Insufficient Clinical Response|0
5509691|NCT01578850|19049175|P2|Period 2|Insufficient Clinical Response|1
5509692|NCT01578850|19049176|P1|Period 2|Insufficient Clinical Response|0
5509693|NCT01578850|19049174|P3|Period 1|Study Terminated by Sponsor|0
5509694|NCT01578850|19049175|P2|Period 1|Study Terminated by Sponsor|0
5509695|NCT01578850|19049176|P1|Period 1|Study Terminated by Sponsor|3
5509696|NCT01578850|19049174|P3|Period 1|Withdrawal by Subject|0
5509697|NCT01578850|19049175|P2|Period 1|Withdrawal by Subject|0
5509698|NCT01578850|19049176|P1|Period 1|Withdrawal by Subject|9
5509699|NCT01578850|19049174|P3|Period 1|Does Not Meet Entrance Criteria|0
5509700|NCT01578850|19049175|P2|Period 1|Does Not Meet Entrance Criteria|0
5509701|NCT01578850|19049176|P1|Period 1|Does Not Meet Entrance Criteria|12
5509702|NCT01578850|19049174|P3|Period 1|Death|0
5509703|NCT01578850|19049175|P2|Period 1|Death|0
5509704|NCT01578850|19049176|P1|Period 1|Death|1
5509705|NCT01578850|19049174|P3|Period 1|Adverse Event|0
5509706|NCT01578850|19049175|P2|Period 1|Adverse Event|0
5509707|NCT01578850|19049176|P1|Period 1|Adverse Event|11
5509708|NCT01578850|19049174|P3|Period 1|Insufficient Clinical Response|0
5509709|NCT01578850|19049175|P2|Period 1|Insufficient Clinical Response|0
5509710|NCT01578850|19049176|P1|Period 1|Insufficient Clinical Response|1
5509711|NCT01578785|19049228|P2|Overall Study|Study terminated by sponsor|118
5509712|NCT01578785|19049229|P1|Overall Study|Study terminated by sponsor|59
5509713|NCT01578785|19049228|P2|Overall Study|Withdrawal by Subject|1
5509714|NCT01578785|19049229|P1|Overall Study|Withdrawal by Subject|0
5509715|NCT01578551|19049294|P2|Overall Study|Adverse Event|0
5509716|NCT01578551|19049295|P1|Overall Study|Adverse Event|1
5509717|NCT01578499|19049307|P2|Overall Study|Died and End of Study Page not Completed|0
5509718|NCT01578499|19049308|P1|Overall Study|Died and End of Study Page not Completed|2
5509719|NCT01578499|19049307|P2|Overall Study|Death|25
5509720|NCT01578499|19049308|P1|Overall Study|Death|20
5509721|NCT01578499|19049307|P2|Overall Study|Withdrawal by Subject|16
5509722|NCT01578499|19049308|P1|Overall Study|Withdrawal by Subject|10
5509723|NCT01578499|19049307|P2|Overall Study|Lost to Follow-up|1
5509724|NCT01578499|19049308|P1|Overall Study|Lost to Follow-up|2
5509725|NCT01578499|19049307|P2|Overall Study|Reason not Specified|1
5509726|NCT01578499|19049308|P1|Overall Study|Reason not Specified|0
5509727|NCT01578486|19049342|P1|Overall Study|Withdrawal by Subject|2
5509728|NCT01578486|19049342|P1|Overall Study|Physician Decision|3
5509729|NCT01578330|19049353|P1|Overall Study|Protocol Violation|5
5509730|NCT01578330|19049353|P1|Overall Study|Adverse Event|2
5509731|NCT01578187|19049395|P1|Usability Phase|Withdrawal by Subject|1
5509732|NCT01577758|19049437|P8|mCRC Expansion Phase|Progression Disease|19
5509733|NCT01577758|19049438|P7|mCRC Expansion Phase|Progression Disease|0
5509734|NCT01577758|19049439|P6|mCRC Expansion Phase|Progression Disease|0
5509735|NCT01577758|19049440|P5|mCRC Expansion Phase|Progression Disease|0
5509736|NCT01577758|19049441|P4|mCRC Expansion Phase|Progression Disease|0
5509737|NCT01577758|19049442|P3|mCRC Expansion Phase|Progression Disease|0
5509738|NCT01577758|19049443|P2|mCRC Expansion Phase|Progression Disease|0
5509739|NCT01577758|19049444|P1|mCRC Expansion Phase|Progression Disease|0
5509740|NCT01577758|19049437|P8|mCRC Expansion Phase|Withdrawal by Subject|2
5509741|NCT01577758|19049438|P7|mCRC Expansion Phase|Withdrawal by Subject|0
5509742|NCT01577758|19049439|P6|mCRC Expansion Phase|Withdrawal by Subject|0
5509743|NCT01577758|19049440|P5|mCRC Expansion Phase|Withdrawal by Subject|0
5509744|NCT01577758|19049441|P4|mCRC Expansion Phase|Withdrawal by Subject|0
5509745|NCT01577758|19049442|P3|mCRC Expansion Phase|Withdrawal by Subject|0
5509746|NCT01577758|19049443|P2|mCRC Expansion Phase|Withdrawal by Subject|0
5509747|NCT01577758|19049444|P1|mCRC Expansion Phase|Withdrawal by Subject|0
5509748|NCT01577758|19049437|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
5509749|NCT01577758|19049438|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
5509750|NCT01577758|19049439|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
5509751|NCT01577758|19049440|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
5509752|NCT01577758|19049441|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
5509753|NCT01577758|19049442|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
5509754|NCT01577758|19049443|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
5509755|NCT01577758|19049444|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
5509756|NCT01577758|19049437|P8|Dose Escalation Phase|Progression Disease|0
5509757|NCT01577758|19049438|P7|Dose Escalation Phase|Progression Disease|0
5509758|NCT01577758|19049439|P6|Dose Escalation Phase|Progression Disease|0
5509759|NCT01577758|19049440|P5|Dose Escalation Phase|Progression Disease|5
5509760|NCT01577758|19049441|P4|Dose Escalation Phase|Progression Disease|2
5509761|NCT01577758|19049442|P3|Dose Escalation Phase|Progression Disease|1
5509762|NCT01577758|19049443|P2|Dose Escalation Phase|Progression Disease|2
5509763|NCT01577758|19049444|P1|Dose Escalation Phase|Progression Disease|2
5509764|NCT01577758|19049437|P8|Dose Escalation Phase|Withdrawal by Subject|0
5509765|NCT01577758|19049438|P7|Dose Escalation Phase|Withdrawal by Subject|0
5509766|NCT01577758|19049439|P6|Dose Escalation Phase|Withdrawal by Subject|1
5509767|NCT01577758|19049440|P5|Dose Escalation Phase|Withdrawal by Subject|0
5509768|NCT01577758|19049441|P4|Dose Escalation Phase|Withdrawal by Subject|0
5509769|NCT01577758|19049442|P3|Dose Escalation Phase|Withdrawal by Subject|0
5509770|NCT01577758|19049443|P2|Dose Escalation Phase|Withdrawal by Subject|0
5509771|NCT01577758|19049444|P1|Dose Escalation Phase|Withdrawal by Subject|0
5509772|NCT01577758|19049437|P8|Dose Escalation Phase|Symptomatic Deterioration|0
5509773|NCT01577758|19049438|P7|Dose Escalation Phase|Symptomatic Deterioration|0
5509774|NCT01577758|19049439|P6|Dose Escalation Phase|Symptomatic Deterioration|1
5509775|NCT01577758|19049440|P5|Dose Escalation Phase|Symptomatic Deterioration|1
5509776|NCT01577758|19049441|P4|Dose Escalation Phase|Symptomatic Deterioration|0
5509777|NCT01577758|19049442|P3|Dose Escalation Phase|Symptomatic Deterioration|1
5509778|NCT01577758|19049443|P2|Dose Escalation Phase|Symptomatic Deterioration|0
5509779|NCT01577758|19049444|P1|Dose Escalation Phase|Symptomatic Deterioration|0
5509780|NCT01577758|19049437|P8|Dose Escalation Phase|Adverse Event|0
5509781|NCT01577758|19049438|P7|Dose Escalation Phase|Adverse Event|1
5509782|NCT01577758|19049439|P6|Dose Escalation Phase|Adverse Event|2
5509783|NCT01577758|19049440|P5|Dose Escalation Phase|Adverse Event|0
5509784|NCT01577758|19049441|P4|Dose Escalation Phase|Adverse Event|0
5509785|NCT01577758|19049442|P3|Dose Escalation Phase|Adverse Event|0
5509786|NCT01577758|19049443|P2|Dose Escalation Phase|Adverse Event|0
5509787|NCT01577758|19049444|P1|Dose Escalation Phase|Adverse Event|0
5509788|NCT01577745|19049483|P6|Overall Study|Alternative Therapy|0
5509789|NCT01577745|19049484|P5|Overall Study|Alternative Therapy|1
5509790|NCT01577745|19049485|P4|Overall Study|Alternative Therapy|1
5509791|NCT01577745|19049486|P3|Overall Study|Alternative Therapy|0
5509792|NCT01577745|19049487|P2|Overall Study|Alternative Therapy|0
5509793|NCT01577745|19049488|P1|Overall Study|Alternative Therapy|0
5509794|NCT01577745|19049483|P6|Overall Study|Lost to Follow-up|1
5509795|NCT01577745|19049484|P5|Overall Study|Lost to Follow-up|0
5509796|NCT01577745|19049485|P4|Overall Study|Lost to Follow-up|0
5509797|NCT01577745|19049486|P3|Overall Study|Lost to Follow-up|0
5509798|NCT01577745|19049487|P2|Overall Study|Lost to Follow-up|0
5509799|NCT01577745|19049488|P1|Overall Study|Lost to Follow-up|0
5509800|NCT01577745|19049483|P6|Overall Study|Physician Decision|0
5509801|NCT01577745|19049484|P5|Overall Study|Physician Decision|1
5509802|NCT01577745|19049485|P4|Overall Study|Physician Decision|1
5509803|NCT01577745|19049486|P3|Overall Study|Physician Decision|0
5509804|NCT01577745|19049487|P2|Overall Study|Physician Decision|0
5509805|NCT01577745|19049488|P1|Overall Study|Physician Decision|0
5509806|NCT01577745|19049483|P6|Overall Study|Death|3
5509807|NCT01577745|19049484|P5|Overall Study|Death|1
5509808|NCT01577745|19049485|P4|Overall Study|Death|1
5509809|NCT01577745|19049486|P3|Overall Study|Death|2
5509810|NCT01577745|19049487|P2|Overall Study|Death|2
5509811|NCT01577745|19049488|P1|Overall Study|Death|3
5509812|NCT01577745|19049483|P6|Overall Study|Withdrawal by Subject|0
5509813|NCT01577745|19049484|P5|Overall Study|Withdrawal by Subject|2
5509814|NCT01577745|19049485|P4|Overall Study|Withdrawal by Subject|3
5509815|NCT01577745|19049486|P3|Overall Study|Withdrawal by Subject|0
5509816|NCT01577745|19049487|P2|Overall Study|Withdrawal by Subject|1
5509817|NCT01577745|19049488|P1|Overall Study|Withdrawal by Subject|0
5509818|NCT01577381|19049689|P4|Overall Study|Ongoing at Date of Cut-Off|0
5509819|NCT01577381|19049690|P3|Overall Study|Ongoing at Date of Cut-Off|1
5509820|NCT01577381|19049691|P2|Overall Study|Ongoing at Date of Cut-Off|2
5509821|NCT01577381|19049692|P1|Overall Study|Ongoing at Date of Cut-Off|0
5509822|NCT01577381|19049689|P4|Overall Study|Discontinued|2
5509823|NCT01577381|19049690|P3|Overall Study|Discontinued|2
5509824|NCT01577381|19049691|P2|Overall Study|Discontinued|1
5509825|NCT01577381|19049692|P1|Overall Study|Discontinued|2
5509826|NCT01577186|19049847|P1|Overall Study|Other|2
5509827|NCT01577186|19049847|P1|Overall Study|Non-Compliant|8
5509828|NCT01577186|19049847|P1|Overall Study|Ineligible to Continue|15
5509829|NCT01577186|19049847|P1|Overall Study|Insufficient Response|18
5509830|NCT01577186|19049847|P1|Overall Study|Withdrawal by Subject|35
5509831|NCT01577186|19049847|P1|Overall Study|Lost to Follow-up|28
5509832|NCT01577186|19049847|P1|Overall Study|Death|1
5509833|NCT01577186|19049847|P1|Overall Study|Adverse Event|23
5509834|NCT01577160|19049855|P1|Overall Study|Other|9
5509835|NCT01577160|19049855|P1|Overall Study|Subject Uncooperative|7
5509836|NCT01577160|19049855|P1|Overall Study|Withdrawal by Subject|18
5509837|NCT01577160|19049855|P1|Overall Study|Lost to Follow-up|40
5509838|NCT01577160|19049855|P1|Overall Study|Lack of Efficacy|15
5509839|NCT01577160|19049855|P1|Overall Study|Adverse Event|9
5509840|NCT01576783|19049910|P2|Overall Study|Withdrawal by Subject|1
5509841|NCT01576783|19049911|P1|Overall Study|Withdrawal by Subject|5
5509842|NCT01576783|19049910|P2|Overall Study|Lost to Follow-up|16
5509843|NCT01576783|19049911|P1|Overall Study|Lost to Follow-up|14
5509844|NCT01576783|19049910|P2|Overall Study|Change in Medical Care|0
5509845|NCT01576783|19049911|P1|Overall Study|Change in Medical Care|1
5509846|NCT01576718|19049937|P7|Treatment Period|Noncompliance to study medication|1
5509847|NCT01576718|19049938|P6|Treatment Period|Noncompliance to study medication|1
5509848|NCT01576718|19049939|P5|Treatment Period|Noncompliance to study medication|0
5509849|NCT01576718|19049940|P4|Treatment Period|Noncompliance to study medication|0
5509850|NCT01576718|19049941|P3|Treatment Period|Noncompliance to study medication|0
5509851|NCT01576718|19049942|P2|Treatment Period|Noncompliance to study medication|0
5509852|NCT01576718|19049943|P1|Treatment Period|Noncompliance to study medication|0
5509853|NCT01576718|19049937|P7|Treatment Period|Lost to Follow-up|0
5509854|NCT01576718|19049938|P6|Treatment Period|Lost to Follow-up|0
5509855|NCT01576718|19049939|P5|Treatment Period|Lost to Follow-up|1
5509856|NCT01576718|19049940|P4|Treatment Period|Lost to Follow-up|0
5509857|NCT01576718|19049941|P3|Treatment Period|Lost to Follow-up|0
5509858|NCT01576718|19049942|P2|Treatment Period|Lost to Follow-up|0
5509859|NCT01576718|19049943|P1|Treatment Period|Lost to Follow-up|0
5509860|NCT01576718|19049937|P7|Treatment Period|Met stopping criteria|15
5509861|NCT01576718|19049938|P6|Treatment Period|Met stopping criteria|33
5509862|NCT01576718|19049939|P5|Treatment Period|Met stopping criteria|16
5509863|NCT01576718|19049940|P4|Treatment Period|Met stopping criteria|19
5509864|NCT01576718|19049941|P3|Treatment Period|Met stopping criteria|13
5509865|NCT01576718|19049942|P2|Treatment Period|Met stopping criteria|16
5509866|NCT01576718|19049943|P1|Treatment Period|Met stopping criteria|0
5509867|NCT01576718|19049937|P7|Treatment Period|Sponsor request|0
5509868|NCT01576718|19049938|P6|Treatment Period|Sponsor request|1
5509869|NCT01576718|19049939|P5|Treatment Period|Sponsor request|0
5509870|NCT01576718|19049940|P4|Treatment Period|Sponsor request|0
5509871|NCT01576718|19049941|P3|Treatment Period|Sponsor request|0
5509872|NCT01576718|19049942|P2|Treatment Period|Sponsor request|1
5509873|NCT01576718|19049943|P1|Treatment Period|Sponsor request|0
5509874|NCT01576718|19049937|P7|Treatment Period|Protocol Violation|12
5509875|NCT01576718|19049938|P6|Treatment Period|Protocol Violation|8
5509876|NCT01576718|19049939|P5|Treatment Period|Protocol Violation|6
5509877|NCT01576718|19049940|P4|Treatment Period|Protocol Violation|10
5509878|NCT01576718|19049941|P3|Treatment Period|Protocol Violation|4
5509879|NCT01576718|19049942|P2|Treatment Period|Protocol Violation|5
5509880|NCT01576718|19049943|P1|Treatment Period|Protocol Violation|0
5509881|NCT01576718|19049937|P7|Treatment Period|Physician Decision|0
5509882|NCT01576718|19049938|P6|Treatment Period|Physician Decision|0
5509883|NCT01576718|19049939|P5|Treatment Period|Physician Decision|1
5509884|NCT01576718|19049940|P4|Treatment Period|Physician Decision|1
5509885|NCT01576718|19049941|P3|Treatment Period|Physician Decision|1
5509886|NCT01576718|19049942|P2|Treatment Period|Physician Decision|1
5509887|NCT01576718|19049943|P1|Treatment Period|Physician Decision|0
5509888|NCT01576718|19049937|P7|Treatment Period|Withdrawal by Subject|2
5509889|NCT01576718|19049938|P6|Treatment Period|Withdrawal by Subject|4
5509890|NCT01576718|19049939|P5|Treatment Period|Withdrawal by Subject|2
5509891|NCT01576718|19049940|P4|Treatment Period|Withdrawal by Subject|0
5509892|NCT01576718|19049941|P3|Treatment Period|Withdrawal by Subject|1
5509893|NCT01576718|19049942|P2|Treatment Period|Withdrawal by Subject|1
5509894|NCT01576718|19049943|P1|Treatment Period|Withdrawal by Subject|0
5509895|NCT01576718|19049937|P7|Treatment Period|Adverse Event|0
5509896|NCT01576718|19049938|P6|Treatment Period|Adverse Event|1
5509897|NCT01576718|19049939|P5|Treatment Period|Adverse Event|1
5509898|NCT01576718|19049940|P4|Treatment Period|Adverse Event|1
5509899|NCT01576718|19049941|P3|Treatment Period|Adverse Event|1
5509900|NCT01576718|19049942|P2|Treatment Period|Adverse Event|1
5509901|NCT01576718|19049943|P1|Treatment Period|Adverse Event|0
5509902|NCT01576718|19049937|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
5509903|NCT01576718|19049938|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
5509904|NCT01576718|19049939|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
5509905|NCT01576718|19049940|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
5509906|NCT01576718|19049941|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
5509907|NCT01576718|19049942|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
5509908|NCT01576718|19049943|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
5509909|NCT01576718|19049937|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5509910|NCT01576718|19049938|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5509911|NCT01576718|19049939|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5509912|NCT01576718|19049940|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5509913|NCT01576718|19049941|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5509914|NCT01576718|19049942|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5509915|NCT01576718|19049943|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
5509916|NCT01576718|19049937|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5509917|NCT01576718|19049938|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5509918|NCT01576718|19049939|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5509919|NCT01576718|19049940|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5509920|NCT01576718|19049941|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5509921|NCT01576718|19049942|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5509922|NCT01576718|19049943|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
5509923|NCT01576718|19049937|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5509924|NCT01576718|19049938|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5509925|NCT01576718|19049939|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5509926|NCT01576718|19049940|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5509927|NCT01576718|19049941|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5509928|NCT01576718|19049942|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5509929|NCT01576718|19049943|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
5509930|NCT01576718|19049937|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5509931|NCT01576718|19049938|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5509932|NCT01576718|19049939|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5509933|NCT01576718|19049940|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5509934|NCT01576718|19049941|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5509935|NCT01576718|19049942|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5509936|NCT01576718|19049943|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
5509937|NCT01576705|19050039|P4|Overall Study|invalid ICF|0
5509938|NCT01576705|19050040|P3|Overall Study|invalid ICF|0
5509939|NCT01576705|19050041|P2|Overall Study|invalid ICF|1
5509940|NCT01576705|19050042|P1|Overall Study|invalid ICF|0
5509941|NCT01576705|19050039|P4|Overall Study|TSH > 7 mIU/L at baseline|3
5509942|NCT01576705|19050040|P3|Overall Study|TSH > 7 mIU/L at baseline|5
5509943|NCT01576705|19050041|P2|Overall Study|TSH > 7 mIU/L at baseline|7
5509944|NCT01576705|19050042|P1|Overall Study|TSH > 7 mIU/L at baseline|3
5509945|NCT01576575|19050063|P1|Buprenorphine + Grapefruit|Withdrawal by Subject|1
5509946|NCT01576575|19050063|P1|Buprenorphine + Rifampin|Withdrawal by Subject|3
5509947|NCT01576575|19050063|P1|Buprenorphine Control|Withdrawal by Subject|3
5509948|NCT01576549|19050073|P1|Overall Study|Sponsor Decision|2
5509949|NCT01576484|19050089|P2|Overall Study|Other|5
5509950|NCT01576484|19050090|P1|Overall Study|Other|2
5509951|NCT01576484|19050089|P2|Overall Study|Withdrawal by Subject|3
5509952|NCT01576484|19050090|P1|Overall Study|Withdrawal by Subject|0
5509953|NCT01576484|19050089|P2|Overall Study|Sponsor Decision|8
5509954|NCT01576484|19050090|P1|Overall Study|Sponsor Decision|2
5509955|NCT01576484|19050089|P2|Overall Study|Protocol Violation|2
5509956|NCT01576484|19050090|P1|Overall Study|Protocol Violation|0
5509957|NCT01576484|19050089|P2|Overall Study|Adverse Event|1
5509958|NCT01576484|19050090|P1|Overall Study|Adverse Event|1
5509959|NCT01576406|19050169|P6|Overall Study|Other|0
5509960|NCT01576406|19050170|P5|Overall Study|Other|0
5509961|NCT01576406|19050171|P4|Overall Study|Other|2
5509962|NCT01576406|19050172|P3|Overall Study|Other|2
5509963|NCT01576406|19050173|P2|Overall Study|Other|0
5509964|NCT01576406|19050174|P1|Overall Study|Other|0
5509965|NCT01576406|19050169|P6|Overall Study|Withdrawal the consent|3
5509966|NCT01576406|19050170|P5|Overall Study|Withdrawal the consent|1
5509967|NCT01576406|19050171|P4|Overall Study|Withdrawal the consent|1
5509968|NCT01576406|19050172|P3|Overall Study|Withdrawal the consent|5
5509969|NCT01576406|19050173|P2|Overall Study|Withdrawal the consent|2
5509970|NCT01576406|19050174|P1|Overall Study|Withdrawal the consent|2
5509971|NCT01576406|19050169|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
5509972|NCT01576406|19050170|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
5509973|NCT01576406|19050171|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
5509974|NCT01576406|19050172|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
5509975|NCT01576406|19050173|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
5509976|NCT01576406|19050174|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
5509977|NCT01576406|19050169|P6|Overall Study|Death|9
5509978|NCT01576406|19050170|P5|Overall Study|Death|7
5509979|NCT01576406|19050171|P4|Overall Study|Death|5
5509980|NCT01576406|19050172|P3|Overall Study|Death|8
5509981|NCT01576406|19050173|P2|Overall Study|Death|4
5509982|NCT01576406|19050174|P1|Overall Study|Death|3
5509983|NCT01576406|19050169|P6|Overall Study|Lost to Follow-up|0
5509984|NCT01576406|19050170|P5|Overall Study|Lost to Follow-up|0
5509985|NCT01576406|19050171|P4|Overall Study|Lost to Follow-up|0
5509986|NCT01576406|19050172|P3|Overall Study|Lost to Follow-up|0
5509987|NCT01576406|19050173|P2|Overall Study|Lost to Follow-up|2
5509988|NCT01576406|19050174|P1|Overall Study|Lost to Follow-up|1
5509989|NCT01576367|19050422|P1|Overall Study|Moved to commercial use after 6 months|1
5509990|NCT01576367|19050422|P1|Overall Study|Unsatisfactory therapeutic effect|2
5509991|NCT01576341|19050430|P1|Overall Study|Other|12
5509992|NCT01576341|19050430|P1|Overall Study|Protocol Violation|12
5509993|NCT01576341|19050430|P1|Overall Study|Kidney transplantation|10
5509994|NCT01576341|19050430|P1|Overall Study|Lost to Follow-up|2
5509995|NCT01576341|19050430|P1|Overall Study|Physician Decision|2
5509996|NCT01576341|19050430|P1|Overall Study|Death|21
5509997|NCT01576341|19050430|P1|Overall Study|Adverse Event|10
5509998|NCT01576341|19050430|P1|Overall Study|Withdrawal by Subject|24
5509999|NCT01576172|19050449|P2|Overall Study|Insurance issue|0
5510000|NCT01576172|19050450|P1|Overall Study|Insurance issue|1
5510001|NCT01576172|19050449|P2|Overall Study|Withdrawal by Subject|0
5510002|NCT01576172|19050450|P1|Overall Study|Withdrawal by Subject|2
5510003|NCT01576172|19050449|P2|Overall Study|Ineligible|1
5510004|NCT01576172|19050450|P1|Overall Study|Ineligible|2
5510005|NCT01576159|19050468|P4|Overall Study|Protocol Violation|0
5510006|NCT01576159|19050469|P3|Overall Study|Protocol Violation|0
5510007|NCT01576159|19050470|P2|Overall Study|Protocol Violation|0
5510008|NCT01576159|19050471|P1|Overall Study|Protocol Violation|1
5510009|NCT01576159|19050468|P4|Overall Study|Lost to Follow-up|1
5510010|NCT01576159|19050469|P3|Overall Study|Lost to Follow-up|0
5510011|NCT01576159|19050470|P2|Overall Study|Lost to Follow-up|0
5510012|NCT01576159|19050471|P1|Overall Study|Lost to Follow-up|0
5510013|NCT01576159|19050468|P4|Overall Study|Physician Decision|0
5510014|NCT01576159|19050469|P3|Overall Study|Physician Decision|1
5510015|NCT01576159|19050470|P2|Overall Study|Physician Decision|0
5510016|NCT01576159|19050471|P1|Overall Study|Physician Decision|0
5510017|NCT01576159|19050468|P4|Overall Study|Withdrawal by Subject|0
5510018|NCT01576159|19050469|P3|Overall Study|Withdrawal by Subject|0
5510019|NCT01576159|19050470|P2|Overall Study|Withdrawal by Subject|1
5510020|NCT01576159|19050471|P1|Overall Study|Withdrawal by Subject|0
5510021|NCT01576146|19050489|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
5510022|NCT01576146|19050489|P1|Extension Period 2|Renal Transplant|1
5510023|NCT01576146|19050489|P1|Extension Period 2|Adverse Event|1
5510024|NCT01576146|19050489|P1|Extension Period 2|Death|1
5510025|NCT01576146|19050489|P1|Extension Period 2|Sponsor Decision|13
5510026|NCT01576146|19050489|P1|Extension Period 1|Renal Transplant|1
5510027|NCT01576146|19050489|P1|Extension Period 1|Parathyroidectomy|1
5510028|NCT01576146|19050489|P1|Extension Period 1|Lost to Follow-up|1
5510029|NCT01576146|19050489|P1|Extension Period 1|Withdrawal by Subject|1
5510030|NCT01576146|19050489|P1|Extension Period 1|Physician Decision|2
5510031|NCT01576146|19050489|P1|Extension Period 1|Death|2
5510032|NCT01576146|19050489|P1|Extension Period 1|Adverse Event|2
5510033|NCT01576042|19050522|P2|Overall Study|Physician Decision|0
5510034|NCT01576042|19050523|P1|Overall Study|Physician Decision|2
5510035|NCT01576016|19050545|P2|MRI Safety|MRI scan not performed at MRI visit|3
5510036|NCT01576016|19050546|P1|MRI Safety|MRI scan not performed at MRI visit|0
5510037|NCT01576016|19050545|P2|MRI Safety|Has not yet completed MRI scan|56
5510038|NCT01576016|19050546|P1|MRI Safety|Has not yet completed MRI scan|0
5510039|NCT01576016|19050545|P2|MRI Safety|Non-MRI Compatible Device or Material|5
5510040|NCT01576016|19050546|P1|MRI Safety|Non-MRI Compatible Device or Material|0
5510041|NCT01576016|19050545|P2|MRI Safety|Withdrawal by Subject|10
5510042|NCT01576016|19050546|P1|MRI Safety|Withdrawal by Subject|0
5510043|NCT01576016|19050545|P2|Lead Safety|Patient no longer followed by study PI|0
5510044|NCT01576016|19050546|P1|Lead Safety|Patient no longer followed by study PI|1
5510045|NCT01576016|19050545|P2|Lead Safety|System deactivated|0
5510046|NCT01576016|19050546|P1|Lead Safety|System deactivated|1
5510047|NCT01576016|19050545|P2|Lead Safety|Too far from study site|0
5510048|NCT01576016|19050546|P1|Lead Safety|Too far from study site|1
5510049|NCT01576016|19050545|P2|Lead Safety|Patient noncompliance|0
5510050|NCT01576016|19050546|P1|Lead Safety|Patient noncompliance|1
5510051|NCT01576016|19050545|P2|Lead Safety|Patient on Palliative Care|0
5510052|NCT01576016|19050546|P1|Lead Safety|Patient on Palliative Care|1
5510053|NCT01576016|19050545|P2|Lead Safety|Device replaced with CRT-D|0
5510054|NCT01576016|19050546|P1|Lead Safety|Device replaced with CRT-D|1
5510055|NCT01576016|19050545|P2|Lead Safety|Sponsor request|0
5510056|NCT01576016|19050546|P1|Lead Safety|Sponsor request|1
5510057|NCT01576016|19050545|P2|Lead Safety|Unsuccessful implant|0
5510058|NCT01576016|19050546|P1|Lead Safety|Unsuccessful implant|2
5510059|NCT01576016|19050545|P2|Lead Safety|Lost to Follow-up|0
5510060|NCT01576016|19050546|P1|Lead Safety|Lost to Follow-up|13
5510061|NCT01576016|19050545|P2|Lead Safety|Physician Decision|0
5510062|NCT01576016|19050546|P1|Lead Safety|Physician Decision|14
5510063|NCT01576016|19050545|P2|Lead Safety|System Explanted without Replacement|0
5510064|NCT01576016|19050546|P1|Lead Safety|System Explanted without Replacement|24
5510065|NCT01576016|19050545|P2|Lead Safety|Withdrawal by Subject|0
5510066|NCT01576016|19050546|P1|Lead Safety|Withdrawal by Subject|81
5510067|NCT01576016|19050545|P2|Lead Safety|Death|0
5510068|NCT01576016|19050546|P1|Lead Safety|Death|132
5510069|NCT01575899|19050598|P3|Overall Study|Protocol Violation|0
5510070|NCT01575899|19050599|P2|Overall Study|Protocol Violation|1
5510071|NCT01575899|19050600|P1|Overall Study|Protocol Violation|2
5510072|NCT01575899|19050598|P3|Overall Study|Lost to Follow-up|2
5510073|NCT01575899|19050599|P2|Overall Study|Lost to Follow-up|4
5510074|NCT01575899|19050600|P1|Overall Study|Lost to Follow-up|3
5510075|NCT01575873|19050614|P4|Overall Study|Other|2
5510076|NCT01575873|19050615|P3|Overall Study|Other|4
5510077|NCT01575873|19050616|P2|Overall Study|Other|0
5510078|NCT01575873|19050617|P1|Overall Study|Other|0
5510079|NCT01575873|19050614|P4|Overall Study|Requirement for Alternative Therapy|1
5510080|NCT01575873|19050615|P3|Overall Study|Requirement for Alternative Therapy|1
5510081|NCT01575873|19050616|P2|Overall Study|Requirement for Alternative Therapy|0
5510082|NCT01575873|19050617|P1|Overall Study|Requirement for Alternative Therapy|0
5510083|NCT01575873|19050614|P4|Overall Study|Protocol deviation|1
5510084|NCT01575873|19050615|P3|Overall Study|Protocol deviation|0
5510085|NCT01575873|19050616|P2|Overall Study|Protocol deviation|1
5510086|NCT01575873|19050617|P1|Overall Study|Protocol deviation|0
5510087|NCT01575873|19050614|P4|Overall Study|Administrative decision|0
5510088|NCT01575873|19050615|P3|Overall Study|Administrative decision|1
5510089|NCT01575873|19050616|P2|Overall Study|Administrative decision|1
5510090|NCT01575873|19050617|P1|Overall Study|Administrative decision|1
5510091|NCT01575873|19050614|P4|Overall Study|Noncompliance|3
5510092|NCT01575873|19050615|P3|Overall Study|Noncompliance|4
5510093|NCT01575873|19050616|P2|Overall Study|Noncompliance|2
5510094|NCT01575873|19050617|P1|Overall Study|Noncompliance|1
5510095|NCT01575873|19050614|P4|Overall Study|Death|9
5510096|NCT01575873|19050615|P3|Overall Study|Death|8
5510097|NCT01575873|19050616|P2|Overall Study|Death|2
5510098|NCT01575873|19050617|P1|Overall Study|Death|3
5510099|NCT01575873|19050614|P4|Overall Study|Lost to Follow-up|5
5510100|NCT01575873|19050615|P3|Overall Study|Lost to Follow-up|13
5510101|NCT01575873|19050616|P2|Overall Study|Lost to Follow-up|3
5510102|NCT01575873|19050617|P1|Overall Study|Lost to Follow-up|1
5510103|NCT01575873|19050614|P4|Overall Study|Adverse Event|12
5510104|NCT01575873|19050615|P3|Overall Study|Adverse Event|9
5510105|NCT01575873|19050616|P2|Overall Study|Adverse Event|7
5510106|NCT01575873|19050617|P1|Overall Study|Adverse Event|7
5510107|NCT01575873|19050614|P4|Overall Study|Withdrawal by Subject|34
5510108|NCT01575873|19050615|P3|Overall Study|Withdrawal by Subject|34
5510109|NCT01575873|19050616|P2|Overall Study|Withdrawal by Subject|20
5510110|NCT01575873|19050617|P1|Overall Study|Withdrawal by Subject|15
5510111|NCT01575860|19050641|P1|Overall Study|Progression Prior to Lenalidomide Maint.|1
5510112|NCT01575860|19050641|P1|Overall Study|Withdrawal by Subject|1
5510113|NCT01575834|19050649|P2|Overall Study|Requirement for Alternative Therapy|4
5510114|NCT01575834|19050650|P1|Overall Study|Requirement for Alternative Therapy|2
5510115|NCT01575834|19050649|P2|Overall Study|Protocol Deviation|3
5510116|NCT01575834|19050650|P1|Overall Study|Protocol Deviation|4
5510117|NCT01575834|19050649|P2|Overall Study|Ineligibility Determined|8
5510118|NCT01575834|19050650|P1|Overall Study|Ineligibility Determined|5
5510119|NCT01575834|19050649|P2|Overall Study|Administrative decision|33
5510120|NCT01575834|19050650|P1|Overall Study|Administrative decision|15
5510121|NCT01575834|19050649|P2|Overall Study|Noncompliance|27
5510122|NCT01575834|19050650|P1|Overall Study|Noncompliance|52
5510123|NCT01575834|19050649|P2|Overall Study|Lost to Follow-up|68
5510124|NCT01575834|19050650|P1|Overall Study|Lost to Follow-up|55
5510125|NCT01575834|19050649|P2|Overall Study|Adverse Event|61
5510126|NCT01575834|19050650|P1|Overall Study|Adverse Event|63
5510127|NCT01575834|19050649|P2|Overall Study|Other|70
5510128|NCT01575834|19050650|P1|Overall Study|Other|70
5510129|NCT01575834|19050649|P2|Overall Study|Death|74
5510130|NCT01575834|19050650|P1|Overall Study|Death|81
5510131|NCT01575834|19050649|P2|Overall Study|Withdrawal by Subject|390
5510132|NCT01575834|19050650|P1|Overall Study|Withdrawal by Subject|352
5510133|NCT01575808|19050702|P2|Overall Study|Withdrawal by Subject|0
5510134|NCT01575808|19050703|P1|Overall Study|Withdrawal by Subject|1
5510135|NCT01575808|19050702|P2|Overall Study|Death|0
5510136|NCT01575808|19050703|P1|Overall Study|Death|2
5510137|NCT01575769|19050750|P1|Overall Study|Study terminated by sponsor|40
5510138|NCT01575769|19050750|P1|Overall Study|Adverse Event|1
5510139|NCT01575561|19050808|P1|Overall Study|administration|1
5510140|NCT01575561|19050808|P1|Overall Study|Withdrawal by Subject|11
5510141|NCT01575561|19050808|P1|Overall Study|Protocol Violation|4
5510142|NCT01575561|19050808|P1|Overall Study|Lost to Follow-up|6
5510143|NCT01575561|19050808|P1|Overall Study|Lack of Efficacy|8
5510144|NCT01575561|19050808|P1|Overall Study|Adverse Event|9
5510145|NCT01575197|19050838|P3|Overall Study|Protocol Violation|1
5510146|NCT01575197|19050839|P2|Overall Study|Protocol Violation|1
5510147|NCT01575197|19050840|P1|Overall Study|Protocol Violation|2
5510148|NCT01575197|19050838|P3|Overall Study|Withdrawal by Subject|1
5510149|NCT01575197|19050839|P2|Overall Study|Withdrawal by Subject|1
5510150|NCT01575197|19050840|P1|Overall Study|Withdrawal by Subject|0
5510151|NCT01575197|19050838|P3|Overall Study|Lost to Follow-up|0
5510152|NCT01575197|19050839|P2|Overall Study|Lost to Follow-up|1
5510153|NCT01575197|19050840|P1|Overall Study|Lost to Follow-up|0
5510154|NCT01575197|19050838|P3|Overall Study|SAE|0
5510155|NCT01575197|19050839|P2|Overall Study|SAE|1
5510156|NCT01575197|19050840|P1|Overall Study|SAE|0
5510157|NCT01575197|19050838|P3|Overall Study|Migration out of study area|4
5510158|NCT01575197|19050839|P2|Overall Study|Migration out of study area|5
5510159|NCT01575197|19050840|P1|Overall Study|Migration out of study area|1
5510160|NCT01575054|19050868|P2|Overall Study|Adverse Event|8
5510161|NCT01575054|19050869|P1|Overall Study|Adverse Event|9
5510162|NCT01575054|19050868|P2|Overall Study|Lost to Follow-up|3
5510163|NCT01575054|19050869|P1|Overall Study|Lost to Follow-up|3
5510164|NCT01575054|19050868|P2|Overall Study|Personal Reasons|11
5510165|NCT01575054|19050869|P1|Overall Study|Personal Reasons|10
5510166|NCT01575054|19050868|P2|Overall Study|Protocol Violation|1
5510167|NCT01575054|19050869|P1|Overall Study|Protocol Violation|2
5510168|NCT01575054|19050868|P2|Overall Study|Other Reasons|3
5510169|NCT01575054|19050869|P1|Overall Study|Other Reasons|5
5510170|NCT01575028|19050885|P2|Overall Study|Physician Decision|1
5510171|NCT01575028|19050886|P1|Overall Study|Physician Decision|0
5510172|NCT01574716|19050903|P5|Part 2|Lost to Follow-up|0
5510173|NCT01574716|19050904|P4|Part 2|Lost to Follow-up|3
5510174|NCT01574716|19050905|P3|Part 2|Lost to Follow-up|0
5510175|NCT01574716|19050906|P2|Part 2|Lost to Follow-up|0
5510176|NCT01574716|19050907|P1|Part 2|Lost to Follow-up|0
5510177|NCT01574716|19050903|P5|Part 2|Brain metastases|0
5510178|NCT01574716|19050904|P4|Part 2|Brain metastases|1
5510179|NCT01574716|19050905|P3|Part 2|Brain metastases|0
5510180|NCT01574716|19050906|P2|Part 2|Brain metastases|0
5510181|NCT01574716|19050907|P1|Part 2|Brain metastases|0
5510182|NCT01574716|19050903|P5|Part 2|Withdrawal by Subject|4
5510183|NCT01574716|19050904|P4|Part 2|Withdrawal by Subject|5
5510184|NCT01574716|19050905|P3|Part 2|Withdrawal by Subject|0
5510185|NCT01574716|19050906|P2|Part 2|Withdrawal by Subject|0
5510186|NCT01574716|19050907|P1|Part 2|Withdrawal by Subject|0
5510187|NCT01574716|19050903|P5|Part 2|Discontinuation of study by sponsor|31
5510188|NCT01574716|19050904|P4|Part 2|Discontinuation of study by sponsor|51
5510189|NCT01574716|19050905|P3|Part 2|Discontinuation of study by sponsor|0
5510190|NCT01574716|19050906|P2|Part 2|Discontinuation of study by sponsor|0
5510191|NCT01574716|19050907|P1|Part 2|Discontinuation of study by sponsor|0
5510192|NCT01574716|19050903|P5|Part 2|Death|35
5510193|NCT01574716|19050904|P4|Part 2|Death|76
5510194|NCT01574716|19050905|P3|Part 2|Death|0
5510195|NCT01574716|19050906|P2|Part 2|Death|0
5510196|NCT01574716|19050907|P1|Part 2|Death|0
5510197|NCT01574716|19050903|P5|Part 2|Progressive disease|0
5510198|NCT01574716|19050904|P4|Part 2|Progressive disease|1
5510199|NCT01574716|19050905|P3|Part 2|Progressive disease|0
5510200|NCT01574716|19050906|P2|Part 2|Progressive disease|0
5510201|NCT01574716|19050907|P1|Part 2|Progressive disease|0
5510202|NCT01574716|19050903|P5|Part 1|Lost to Follow-up|0
5510203|NCT01574716|19050904|P4|Part 1|Lost to Follow-up|0
5510204|NCT01574716|19050905|P3|Part 1|Lost to Follow-up|0
5510205|NCT01574716|19050906|P2|Part 1|Lost to Follow-up|1
5510206|NCT01574716|19050907|P1|Part 1|Lost to Follow-up|0
5510207|NCT01574716|19050903|P5|Part 1|Withdrawal by Subject|0
5510208|NCT01574716|19050904|P4|Part 1|Withdrawal by Subject|0
5510209|NCT01574716|19050905|P3|Part 1|Withdrawal by Subject|0
5510210|NCT01574716|19050906|P2|Part 1|Withdrawal by Subject|2
5510211|NCT01574716|19050907|P1|Part 1|Withdrawal by Subject|0
5510212|NCT01574716|19050903|P5|Part 1|Discontinuation of study by sponsor|0
5510213|NCT01574716|19050904|P4|Part 1|Discontinuation of study by sponsor|0
5510214|NCT01574716|19050905|P3|Part 1|Discontinuation of study by sponsor|1
5510215|NCT01574716|19050906|P2|Part 1|Discontinuation of study by sponsor|0
5510216|NCT01574716|19050907|P1|Part 1|Discontinuation of study by sponsor|0
5510217|NCT01574716|19050903|P5|Part 1|Death|0
5510218|NCT01574716|19050904|P4|Part 1|Death|0
5510219|NCT01574716|19050905|P3|Part 1|Death|8
5510220|NCT01574716|19050906|P2|Part 1|Death|1
5510221|NCT01574716|19050907|P1|Part 1|Death|3
5510222|NCT01574703|19050930|P4|Overall Study|Death|0
5510223|NCT01574703|19050931|P3|Overall Study|Death|1
5510224|NCT01574703|19050932|P2|Overall Study|Death|1
5510225|NCT01574703|19050933|P1|Overall Study|Death|2
5510226|NCT01574703|19050930|P4|Overall Study|Lost to Follow-up|35
5510227|NCT01574703|19050931|P3|Overall Study|Lost to Follow-up|46
5510228|NCT01574703|19050932|P2|Overall Study|Lost to Follow-up|41
5510229|NCT01574703|19050933|P1|Overall Study|Lost to Follow-up|43
5510230|NCT01574703|19050930|P4|Overall Study|Met Withdrawal Criteria|0
5510231|NCT01574703|19050931|P3|Overall Study|Met Withdrawal Criteria|1
5510232|NCT01574703|19050932|P2|Overall Study|Met Withdrawal Criteria|1
5510233|NCT01574703|19050933|P1|Overall Study|Met Withdrawal Criteria|0
5510234|NCT01574703|19050930|P4|Overall Study|Withdrawal by Subject|61
5510235|NCT01574703|19050931|P3|Overall Study|Withdrawal by Subject|36
5510236|NCT01574703|19050932|P2|Overall Study|Withdrawal by Subject|52
5510237|NCT01574703|19050933|P1|Overall Study|Withdrawal by Subject|53
5510238|NCT01574703|19050930|P4|Overall Study|Unspecified Reason|16
5510239|NCT01574703|19050931|P3|Overall Study|Unspecified Reason|20
5510240|NCT01574703|19050932|P2|Overall Study|Unspecified Reason|15
5510241|NCT01574703|19050933|P1|Overall Study|Unspecified Reason|27
5510242|NCT01574703|19050930|P4|Overall Study|Protocol Violation|1
5510243|NCT01574703|19050931|P3|Overall Study|Protocol Violation|0
5510244|NCT01574703|19050932|P2|Overall Study|Protocol Violation|0
5510245|NCT01574703|19050933|P1|Overall Study|Protocol Violation|0
5510246|NCT01574703|19050930|P4|Overall Study|Adverse Event|1
5510247|NCT01574703|19050931|P3|Overall Study|Adverse Event|1
5510248|NCT01574703|19050932|P2|Overall Study|Adverse Event|2
5510249|NCT01574703|19050933|P1|Overall Study|Adverse Event|0
5510250|NCT01574651|19050977|P2|Overall Study|Withdrawal by Subject|10
5510251|NCT01574651|19050978|P1|Overall Study|Withdrawal by Subject|9
5510252|NCT01574651|19050977|P2|Overall Study|Protocol Violation|5
5510253|NCT01574651|19050978|P1|Overall Study|Protocol Violation|3
5510254|NCT01574651|19050977|P2|Overall Study|Unsatisfactory therapeutic effect|0
5510255|NCT01574651|19050978|P1|Overall Study|Unsatisfactory therapeutic effect|6
5510256|NCT01574651|19050977|P2|Overall Study|Abnormal test procedure result(s)|1
5510257|NCT01574651|19050978|P1|Overall Study|Abnormal test procedure result(s)|1
5510258|NCT01574651|19050977|P2|Overall Study|Abnormal laboratory value(s)|0
5510259|NCT01574651|19050978|P1|Overall Study|Abnormal laboratory value(s)|1
5510260|NCT01574651|19050977|P2|Overall Study|Adverse Event|27
5510261|NCT01574651|19050978|P1|Overall Study|Adverse Event|36
5510262|NCT01574651|19050977|P2|Overall Study|Patient's inability to use the device|1
5510263|NCT01574651|19050978|P1|Overall Study|Patient's inability to use the device|0
5510264|NCT01574651|19050977|P2|Overall Study|Death|3
5510265|NCT01574651|19050978|P1|Overall Study|Death|3
5510266|NCT01574651|19050977|P2|Overall Study|Administrative problems|1
5510267|NCT01574651|19050978|P1|Overall Study|Administrative problems|0
5510268|NCT01574651|19050977|P2|Overall Study|Lost to Follow-up|4
5510269|NCT01574651|19050978|P1|Overall Study|Lost to Follow-up|2
5510270|NCT01574612|19051000|P1|Overall Study|Lost to Follow-up|2
5510271|NCT01574612|19051000|P1|Overall Study|Withdrawal by Subject|1
5510272|NCT01574612|19051000|P1|Overall Study|non compliant with drug|2
5510273|NCT01574612|19051000|P1|Overall Study|Adverse Event|3
5510274|NCT01574352|19051006|P2|Overall Study|Injury in non-camp related sport|0
5510275|NCT01574352|19051007|P1|Overall Study|Injury in non-camp related sport|1
5510276|NCT01574352|19051006|P2|Overall Study|Withdrawal by Subject|13
5510277|NCT01574352|19051007|P1|Overall Study|Withdrawal by Subject|6
5510278|NCT01574326|19051019|P2|Overall Study|Other: Mainly kidney transplant|8
5510279|NCT01574326|19051020|P1|Overall Study|Other: Mainly kidney transplant|8
5510280|NCT01574326|19051019|P2|Overall Study|Adverse Event|3
5510281|NCT01574326|19051020|P1|Overall Study|Adverse Event|1
5510282|NCT01574326|19051019|P2|Overall Study|Physician Decision|3
5510283|NCT01574326|19051020|P1|Overall Study|Physician Decision|5
5510284|NCT01574326|19051019|P2|Overall Study|Withdrawal by Participant|4
5510285|NCT01574326|19051020|P1|Overall Study|Withdrawal by Participant|2
5510286|NCT01574326|19051019|P2|Overall Study|Randomized but not treated|1
5510287|NCT01574326|19051020|P1|Overall Study|Randomized but not treated|0
5510288|NCT01574248|19051038|P2|Overall Study|Missing primary endpoint data|0
5510289|NCT01574248|19051039|P1|Overall Study|Missing primary endpoint data|1
5510290|NCT01574248|19051038|P2|Overall Study|Withdrawal by Subject|0
5510291|NCT01574248|19051039|P1|Overall Study|Withdrawal by Subject|2
5510292|NCT01574157|19051072|P2|Overall Study|Lost to Follow-up|3
5510293|NCT01574157|19051073|P1|Overall Study|Lost to Follow-up|0
5510294|NCT01574157|19051072|P2|Overall Study|Withdrawal by Subject|5
5510295|NCT01574157|19051073|P1|Overall Study|Withdrawal by Subject|4
5510296|NCT01574079|19051107|P2|Overall Study|Lost to Follow-up|0
5510297|NCT01574079|19051108|P1|Overall Study|Lost to Follow-up|1
5510298|NCT01574079|19051107|P2|Overall Study|Physician Decision|2
5510299|NCT01574079|19051108|P1|Overall Study|Physician Decision|0
5510300|NCT01573910|19051127|P2|Overall Study|Patient decision unrelated to Advs Event|11
5510301|NCT01573910|19051128|P1|Overall Study|Patient decision unrelated to Advs Event|11
5510302|NCT01573910|19051127|P2|Overall Study|Protocol Violation|0
5510303|NCT01573910|19051128|P1|Overall Study|Protocol Violation|3
5510304|NCT01573910|19051127|P2|Overall Study|Withdrawal by Subject|1
5510305|NCT01573910|19051128|P1|Overall Study|Withdrawal by Subject|0
5510306|NCT01573910|19051127|P2|Overall Study|Lost to Follow-up|1
5510307|NCT01573910|19051128|P1|Overall Study|Lost to Follow-up|2
5510308|NCT01573910|19051127|P2|Overall Study|Adverse Event|4
5510309|NCT01573910|19051128|P1|Overall Study|Adverse Event|4
5510310|NCT01573767|19051140|P4|Overall Study|Withdrawal by Subject|0
5510311|NCT01573767|19051141|P3|Overall Study|Withdrawal by Subject|0
5510312|NCT01573767|19051142|P2|Overall Study|Withdrawal by Subject|1
5510313|NCT01573767|19051143|P1|Overall Study|Withdrawal by Subject|0
5510314|NCT01573767|19051140|P4|Overall Study|Physician Decision|2
5510315|NCT01573767|19051141|P3|Overall Study|Physician Decision|0
5510316|NCT01573767|19051142|P2|Overall Study|Physician Decision|2
5510317|NCT01573767|19051143|P1|Overall Study|Physician Decision|1
5510318|NCT01573767|19051140|P4|Overall Study|Lost to Follow-up|1
5510319|NCT01573767|19051141|P3|Overall Study|Lost to Follow-up|1
5510320|NCT01573767|19051142|P2|Overall Study|Lost to Follow-up|1
5510321|NCT01573767|19051143|P1|Overall Study|Lost to Follow-up|0
5510322|NCT01573767|19051140|P4|Overall Study|Protocol Violation|3
5510323|NCT01573767|19051141|P3|Overall Study|Protocol Violation|1
5510324|NCT01573767|19051142|P2|Overall Study|Protocol Violation|1
5510325|NCT01573767|19051143|P1|Overall Study|Protocol Violation|3
5510326|NCT01573767|19051140|P4|Overall Study|Lack of Efficacy|17
5510327|NCT01573767|19051141|P3|Overall Study|Lack of Efficacy|12
5510328|NCT01573767|19051142|P2|Overall Study|Lack of Efficacy|15
5510329|NCT01573767|19051143|P1|Overall Study|Lack of Efficacy|18
5510330|NCT01573767|19051140|P4|Overall Study|Adverse Event|1
5510331|NCT01573767|19051141|P3|Overall Study|Adverse Event|0
5510332|NCT01573767|19051142|P2|Overall Study|Adverse Event|1
5510333|NCT01573767|19051143|P1|Overall Study|Adverse Event|0
5510334|NCT01573624|19051177|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5510335|NCT01573624|19051178|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5510336|NCT01573624|19051179|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5510337|NCT01573624|19051180|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5510338|NCT01573624|19051181|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5510339|NCT01573624|19051182|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
5510340|NCT01573624|19051183|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
5510341|NCT01573624|19051177|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5510342|NCT01573624|19051178|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
5510343|NCT01573624|19051179|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
5510344|NCT01573624|19051180|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5510345|NCT01573624|19051181|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5510346|NCT01573624|19051182|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5510347|NCT01573624|19051183|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
5510348|NCT01573624|19051177|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5510349|NCT01573624|19051178|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5510350|NCT01573624|19051179|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5510351|NCT01573624|19051180|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5510352|NCT01573624|19051181|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5510353|NCT01573624|19051182|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
5510354|NCT01573624|19051183|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
5510355|NCT01573624|19051177|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5510356|NCT01573624|19051178|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
5510357|NCT01573624|19051179|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5510358|NCT01573624|19051180|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5510359|NCT01573624|19051181|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5510360|NCT01573624|19051182|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
5510361|NCT01573624|19051183|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
5510362|NCT01573624|19051177|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
5510363|NCT01573624|19051178|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
5510364|NCT01573624|19051179|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
5510365|NCT01573624|19051180|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
5510366|NCT01573624|19051181|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
5510367|NCT01573624|19051182|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
5510368|NCT01573624|19051183|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
5510369|NCT01573624|19051177|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
5510370|NCT01573624|19051178|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5510371|NCT01573624|19051179|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
5510372|NCT01573624|19051180|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5510373|NCT01573624|19051181|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5510374|NCT01573624|19051182|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
5510375|NCT01573624|19051183|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
5510376|NCT01573624|19051177|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5510377|NCT01573624|19051178|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
5510378|NCT01573624|19051179|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5510379|NCT01573624|19051180|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5510380|NCT01573624|19051181|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5510381|NCT01573624|19051182|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5510382|NCT01573624|19051183|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
5510383|NCT01573624|19051177|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5510384|NCT01573624|19051178|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5510385|NCT01573624|19051179|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5510386|NCT01573624|19051180|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5510387|NCT01573624|19051181|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5510388|NCT01573624|19051182|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
5510389|NCT01573624|19051183|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
5510390|NCT01573624|19051177|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5510391|NCT01573624|19051178|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5510392|NCT01573624|19051179|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5510393|NCT01573624|19051180|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5510394|NCT01573624|19051181|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5510395|NCT01573624|19051182|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
5510396|NCT01573624|19051183|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
5510397|NCT01573624|19051177|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5510398|NCT01573624|19051178|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
5510399|NCT01573624|19051179|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5510400|NCT01573624|19051180|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5510401|NCT01573624|19051181|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5510402|NCT01573624|19051182|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
5510403|NCT01573624|19051183|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
5510404|NCT01573624|19051177|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
5510405|NCT01573624|19051178|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5510406|NCT01573624|19051179|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5510407|NCT01573624|19051180|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5510408|NCT01573624|19051181|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5510409|NCT01573624|19051182|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
5510410|NCT01573624|19051183|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
5510411|NCT01573624|19051177|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5510412|NCT01573624|19051178|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5510413|NCT01573624|19051179|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5510414|NCT01573624|19051180|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5510415|NCT01573624|19051181|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5510416|NCT01573624|19051182|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
5510417|NCT01573624|19051183|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
5510418|NCT01573624|19051177|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5510419|NCT01573624|19051178|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5510420|NCT01573624|19051179|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5510421|NCT01573624|19051180|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5510422|NCT01573624|19051181|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5510423|NCT01573624|19051182|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5510424|NCT01573624|19051183|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5510425|NCT01573624|19051177|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5510426|NCT01573624|19051178|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5510427|NCT01573624|19051179|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5510428|NCT01573624|19051180|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5510429|NCT01573624|19051181|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5510430|NCT01573624|19051182|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
5510431|NCT01573624|19051183|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
5510432|NCT01573624|19051177|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5510433|NCT01573624|19051178|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
5510434|NCT01573624|19051179|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5510435|NCT01573624|19051180|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5510436|NCT01573624|19051181|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5510437|NCT01573624|19051182|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
5510438|NCT01573624|19051183|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
5510439|NCT01573624|19051177|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
5510440|NCT01573624|19051178|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
5510441|NCT01573624|19051179|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
5510442|NCT01573624|19051180|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
5510443|NCT01573624|19051181|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
5510444|NCT01573624|19051182|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
5510445|NCT01573624|19051183|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
5510446|NCT01573624|19051177|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5510447|NCT01573624|19051178|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
5510448|NCT01573624|19051179|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5510449|NCT01573624|19051180|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
5510450|NCT01573624|19051181|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
5510451|NCT01573624|19051182|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5510452|NCT01573624|19051183|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
5510453|NCT01573624|19051177|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
5510454|NCT01573624|19051178|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5510455|NCT01573624|19051179|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5510456|NCT01573624|19051180|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
5510457|NCT01573624|19051181|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5510458|NCT01573624|19051182|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5510459|NCT01573624|19051183|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
5510460|NCT01573624|19051177|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5510461|NCT01573624|19051178|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
5510462|NCT01573624|19051179|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5510463|NCT01573624|19051180|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5510464|NCT01573624|19051181|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5510465|NCT01573624|19051182|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5510466|NCT01573624|19051183|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
5510467|NCT01573624|19051177|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5510468|NCT01573624|19051178|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5510469|NCT01573624|19051179|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5510470|NCT01573624|19051180|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
5510471|NCT01573624|19051181|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
5510472|NCT01573624|19051182|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
5510473|NCT01573624|19051183|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
5510474|NCT01573624|19051177|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
5510475|NCT01573624|19051178|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5510476|NCT01573624|19051179|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5510477|NCT01573624|19051180|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
5510478|NCT01573624|19051181|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5510479|NCT01573624|19051182|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
5510480|NCT01573624|19051183|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
5510481|NCT01573624|19051177|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5510482|NCT01573624|19051178|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
5510483|NCT01573624|19051179|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5510484|NCT01573624|19051180|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5510485|NCT01573624|19051181|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5510486|NCT01573624|19051182|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5510487|NCT01573624|19051183|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
5510488|NCT01573624|19051177|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5510489|NCT01573624|19051178|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5510490|NCT01573624|19051179|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
5510491|NCT01573624|19051180|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5510492|NCT01573624|19051181|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
5510493|NCT01573624|19051182|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
5510494|NCT01573624|19051183|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
5510495|NCT01573624|19051177|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5510496|NCT01573624|19051178|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
5510497|NCT01573624|19051179|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5510498|NCT01573624|19051180|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5510499|NCT01573624|19051181|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5510500|NCT01573624|19051182|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5510501|NCT01573624|19051183|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5510502|NCT01573624|19051177|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5510503|NCT01573624|19051178|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5510504|NCT01573624|19051179|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5510505|NCT01573624|19051180|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5510506|NCT01573624|19051181|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5510507|NCT01573624|19051182|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
5510508|NCT01573624|19051183|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
5510509|NCT01573624|19051177|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
5510510|NCT01573624|19051178|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
5510511|NCT01573624|19051179|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
5510512|NCT01573624|19051180|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
5510513|NCT01573624|19051181|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
5510514|NCT01573624|19051182|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
5510515|NCT01573624|19051183|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
5510516|NCT01573624|19051177|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5510517|NCT01573624|19051178|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
5510518|NCT01573624|19051179|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5510519|NCT01573624|19051180|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5510520|NCT01573624|19051181|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
5510521|NCT01573624|19051182|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5510522|NCT01573624|19051183|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
5510523|NCT01573442|19051243|P2|Overall Study|Cancels|10
5510524|NCT01573442|19051244|P1|Overall Study|Cancels|9
5510525|NCT01573000|19051388|P2|Long-Term Follow-Up|Lost to Follow-up|1
5510526|NCT01573000|19051389|P1|Long-Term Follow-Up|Lost to Follow-up|0
5510527|NCT01573000|19051388|P2|Long-Term Follow-Up|Death|0
5510528|NCT01573000|19051389|P1|Long-Term Follow-Up|Death|3
5510529|NCT01573000|19051388|P2|Crossover Phase|Death|3
5510530|NCT01573000|19051389|P1|Crossover Phase|Death|0
5510531|NCT01573000|19051388|P2|Crossover Phase|Lost to Follow-up|2
5510532|NCT01573000|19051389|P1|Crossover Phase|Lost to Follow-up|0
5510533|NCT01573000|19051388|P2|Crossover Phase|Lack of Efficacy|13
5510534|NCT01573000|19051389|P1|Crossover Phase|Lack of Efficacy|0
5510535|NCT01573000|19051388|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
5510536|NCT01573000|19051389|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
5510537|NCT01573000|19051388|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
5510538|NCT01573000|19051389|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
5510539|NCT01573000|19051388|P2|Dosimetric and Therapeutic Treatment|Death|1
5510540|NCT01573000|19051389|P1|Dosimetric and Therapeutic Treatment|Death|0
5510541|NCT01573000|19051388|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
5510542|NCT01573000|19051389|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
5510543|NCT01573000|19051388|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
5510544|NCT01573000|19051389|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
5510545|NCT01572948|19051485|P2|Overall Study|unable to contact|1
5510546|NCT01572948|19051486|P1|Overall Study|unable to contact|0
5510547|NCT01572948|19051485|P2|Overall Study|Lost to Follow-up|0
5510548|NCT01572948|19051486|P1|Overall Study|Lost to Follow-up|1
5510549|NCT01572922|19051502|P1|Overall Study|Death|1
5510550|NCT01572922|19051502|P1|Overall Study|Protocol Violation|1
5510551|NCT01572922|19051502|P1|Overall Study|Adverse Event|1
5510552|NCT01572909|19051514|P2|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
5510553|NCT01572909|19051515|P1|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
5510554|NCT01572909|19051514|P2|Overall Study|Withdrawal by Subject|11
5510555|NCT01572909|19051515|P1|Overall Study|Withdrawal by Subject|12
5510556|NCT01572909|19051514|P2|Overall Study|Technical Issues|0
5510557|NCT01572909|19051515|P1|Overall Study|Technical Issues|1
5510558|NCT01572909|19051514|P2|Overall Study|Physician Decision|1
5510559|NCT01572909|19051515|P1|Overall Study|Physician Decision|1
5510560|NCT01572909|19051514|P2|Overall Study|Lost to Follow-up|7
5510561|NCT01572909|19051515|P1|Overall Study|Lost to Follow-up|8
5510562|NCT01572909|19051514|P2|Overall Study|Death|1
5510563|NCT01572909|19051515|P1|Overall Study|Death|3
5510564|NCT01572909|19051514|P2|Overall Study|Adverse Event|2
5510565|NCT01572909|19051515|P1|Overall Study|Adverse Event|7
5510566|NCT01572844|19051559|P2|Overall Study|Physician Decision|1
5510567|NCT01572844|19051560|P1|Overall Study|Physician Decision|1
5510568|NCT01572792|19051578|P5|Extension Study|Site termination/COPD exacerbation/other|6
5510569|NCT01572792|19051579|P4|Extension Study|Site termination/COPD exacerbation/other|6
5510570|NCT01572792|19051580|P3|Extension Study|Site termination/COPD exacerbation/other|4
5510571|NCT01572792|19051581|P2|Extension Study|Site termination/COPD exacerbation/other|8
5510572|NCT01572792|19051582|P1|Extension Study|Site termination/COPD exacerbation/other|3
5510573|NCT01572792|19051578|P5|Extension Study|Adverse Event|4
5510574|NCT01572792|19051579|P4|Extension Study|Adverse Event|6
5510575|NCT01572792|19051580|P3|Extension Study|Adverse Event|5
5510576|NCT01572792|19051581|P2|Extension Study|Adverse Event|6
5510577|NCT01572792|19051582|P1|Extension Study|Adverse Event|7
5510578|NCT01572792|19051578|P5|Extension Study|Lack of Efficacy|2
5510579|NCT01572792|19051579|P4|Extension Study|Lack of Efficacy|2
5510580|NCT01572792|19051580|P3|Extension Study|Lack of Efficacy|3
5510581|NCT01572792|19051581|P2|Extension Study|Lack of Efficacy|3
5510582|NCT01572792|19051582|P1|Extension Study|Lack of Efficacy|2
5510583|NCT01572792|19051578|P5|Extension Study|Protocol Violation|3
5510584|NCT01572792|19051579|P4|Extension Study|Protocol Violation|4
5510585|NCT01572792|19051580|P3|Extension Study|Protocol Violation|3
5510586|NCT01572792|19051581|P2|Extension Study|Protocol Violation|4
5510587|NCT01572792|19051582|P1|Extension Study|Protocol Violation|0
5510588|NCT01572792|19051578|P5|Extension Study|Withdrawal by Subject|14
5510589|NCT01572792|19051579|P4|Extension Study|Withdrawal by Subject|8
5510590|NCT01572792|19051580|P3|Extension Study|Withdrawal by Subject|11
5510591|NCT01572792|19051581|P2|Extension Study|Withdrawal by Subject|6
5510592|NCT01572792|19051582|P1|Extension Study|Withdrawal by Subject|7
5510593|NCT01572792|19051578|P5|Extension Study|Lost to Follow-up|3
5510594|NCT01572792|19051579|P4|Extension Study|Lost to Follow-up|3
5510595|NCT01572792|19051580|P3|Extension Study|Lost to Follow-up|0
5510596|NCT01572792|19051581|P2|Extension Study|Lost to Follow-up|2
5510597|NCT01572792|19051582|P1|Extension Study|Lost to Follow-up|6
5510598|NCT01572792|19051578|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
5510599|NCT01572792|19051579|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
5510600|NCT01572792|19051580|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
5510601|NCT01572792|19051581|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
5510602|NCT01572792|19051582|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
5510603|NCT01572792|19051578|P5|Lead-in Study|Adverse Event|14
5510604|NCT01572792|19051579|P4|Lead-in Study|Adverse Event|16
5510605|NCT01572792|19051580|P3|Lead-in Study|Adverse Event|22
5510606|NCT01572792|19051581|P2|Lead-in Study|Adverse Event|21
5510607|NCT01572792|19051582|P1|Lead-in Study|Adverse Event|21
5510608|NCT01572792|19051578|P5|Lead-in Study|Lack of Efficacy|10
5510609|NCT01572792|19051579|P4|Lead-in Study|Lack of Efficacy|8
5510610|NCT01572792|19051580|P3|Lead-in Study|Lack of Efficacy|4
5510611|NCT01572792|19051581|P2|Lead-in Study|Lack of Efficacy|5
5510612|NCT01572792|19051582|P1|Lead-in Study|Lack of Efficacy|20
5510613|NCT01572792|19051578|P5|Lead-in Study|Protocol Violation|21
5510614|NCT01572792|19051579|P4|Lead-in Study|Protocol Violation|13
5510615|NCT01572792|19051580|P3|Lead-in Study|Protocol Violation|12
5510616|NCT01572792|19051581|P2|Lead-in Study|Protocol Violation|10
5510617|NCT01572792|19051582|P1|Lead-in Study|Protocol Violation|19
5510618|NCT01572792|19051578|P5|Lead-in Study|Withdrawal by Subject|11
5510619|NCT01572792|19051579|P4|Lead-in Study|Withdrawal by Subject|24
5510620|NCT01572792|19051580|P3|Lead-in Study|Withdrawal by Subject|12
5510621|NCT01572792|19051581|P2|Lead-in Study|Withdrawal by Subject|11
5510622|NCT01572792|19051582|P1|Lead-in Study|Withdrawal by Subject|22
5510623|NCT01572792|19051578|P5|Lead-in Study|Lost to Follow-up|4
5510624|NCT01572792|19051579|P4|Lead-in Study|Lost to Follow-up|2
5510625|NCT01572792|19051580|P3|Lead-in Study|Lost to Follow-up|4
5510626|NCT01572792|19051581|P2|Lead-in Study|Lost to Follow-up|9
5510627|NCT01572792|19051582|P1|Lead-in Study|Lost to Follow-up|5
5510628|NCT01572740|19051631|P2|Overall Study|unclassified|3
5510629|NCT01572740|19051632|P1|Overall Study|unclassified|4
5510630|NCT01572740|19051631|P2|Overall Study|Withdrawal by Subject|1
5510631|NCT01572740|19051632|P1|Overall Study|Withdrawal by Subject|1
5510632|NCT01572740|19051631|P2|Overall Study|Adverse Event|1
5510633|NCT01572740|19051632|P1|Overall Study|Adverse Event|1
5510634|NCT01572727|19051662|P2|Overall Study|Untreated|7
5510635|NCT01572727|19051663|P1|Overall Study|Untreated|4
5510636|NCT01572727|19051662|P2|Overall Study|Death|2
5510637|NCT01572727|19051663|P1|Overall Study|Death|2
5510638|NCT01572727|19051662|P2|Overall Study|Parent/guardian decision|9
5510639|NCT01572727|19051663|P1|Overall Study|Parent/guardian decision|14
5510640|NCT01572727|19051662|P2|Overall Study|Study terminated by sponsor|83
5510641|NCT01572727|19051663|P1|Overall Study|Study terminated by sponsor|61
5510642|NCT01572727|19051662|P2|Overall Study|Protocol Violation|1
5510643|NCT01572727|19051663|P1|Overall Study|Protocol Violation|0
5510644|NCT01572727|19051662|P2|Overall Study|Progressive disease|82
5510645|NCT01572727|19051663|P1|Overall Study|Progressive disease|59
5510646|NCT01572727|19051662|P2|Overall Study|Physician Decision|9
5510647|NCT01572727|19051663|P1|Overall Study|Physician Decision|23
5510648|NCT01572727|19051662|P2|Overall Study|Lost to Follow-up|1
5510649|NCT01572727|19051663|P1|Overall Study|Lost to Follow-up|1
5510650|NCT01572727|19051662|P2|Overall Study|Adverse Event|15
5510651|NCT01572727|19051663|P1|Overall Study|Adverse Event|43
5510652|NCT01572675|19051685|P2|Overall Study|Lost to Follow-up|27
5510653|NCT01572675|19051686|P1|Overall Study|Lost to Follow-up|22
5510654|NCT01572675|19051685|P2|Overall Study|Missing data|4
5510655|NCT01572675|19051686|P1|Overall Study|Missing data|1
5510656|NCT01572675|19051685|P2|Overall Study|Rheumatologist new evaluation|1
5510657|NCT01572675|19051686|P1|Overall Study|Rheumatologist new evaluation|0
5510658|NCT01572675|19051685|P2|Overall Study|Unknown reason|1
5510659|NCT01572675|19051686|P1|Overall Study|Unknown reason|1
5510660|NCT01572675|19051685|P2|Overall Study|Other disease detected|1
5510661|NCT01572675|19051686|P1|Overall Study|Other disease detected|1
5510662|NCT01572675|19051685|P2|Overall Study|Death unrelated to coxibs|1
5510663|NCT01572675|19051686|P1|Overall Study|Death unrelated to coxibs|1
5510664|NCT01572675|19051685|P2|Overall Study|Physician Decision|2
5510665|NCT01572675|19051686|P1|Overall Study|Physician Decision|2
5510666|NCT01572675|19051685|P2|Overall Study|Withdrawal by Subject|1
5510667|NCT01572675|19051686|P1|Overall Study|Withdrawal by Subject|5
5510668|NCT01572675|19051685|P2|Overall Study|Surgical intervention|6
5510669|NCT01572675|19051686|P1|Overall Study|Surgical intervention|3
5510670|NCT01572675|19051685|P2|Overall Study|Improved symptoms|2
5510671|NCT01572675|19051686|P1|Overall Study|Improved symptoms|8
5510672|NCT01572675|19051685|P2|Overall Study|Intolerance|5
5510673|NCT01572675|19051686|P1|Overall Study|Intolerance|6
5510674|NCT01572675|19051685|P2|Overall Study|Lack of Efficacy|31
5510675|NCT01572675|19051686|P1|Overall Study|Lack of Efficacy|31
5510676|NCT01572675|19051685|P2|Overall Study|Recovery|23
5510677|NCT01572675|19051686|P1|Overall Study|Recovery|16
5510678|NCT01572675|19051685|P2|Overall Study|End of prescribed treatment|118
5510679|NCT01572675|19051686|P1|Overall Study|End of prescribed treatment|140
5510680|NCT01572389|19051804|P2|Overall Study|Only A1C or Assessment was Collected|2
5510681|NCT01572389|19051805|P1|Overall Study|Only A1C or Assessment was Collected|6
5510682|NCT01572389|19051804|P2|Overall Study|Lost to Follow-up|14
5510683|NCT01572389|19051805|P1|Overall Study|Lost to Follow-up|25
5510684|NCT01572389|19051804|P2|Overall Study|Withdrawal by Subject|2
5510685|NCT01572389|19051805|P1|Overall Study|Withdrawal by Subject|14
5510686|NCT01572389|19051804|P2|Overall Study|Death|3
5510687|NCT01572389|19051805|P1|Overall Study|Death|1
5510688|NCT01572038|19051837|P1|Overall Study|Sponsor Decision|1
5510689|NCT01572038|19051837|P1|Overall Study|Patient Deterioration|1
5510690|NCT01572038|19051837|P1|Overall Study|Termination by Sponsor|2
5510691|NCT01572038|19051837|P1|Overall Study|Participated in Another Trial|3
5510692|NCT01572038|19051837|P1|Overall Study|Enrolled into Another Trial|3
5510693|NCT01572038|19051837|P1|Overall Study|Site Closed Before Completing Form|6
5510694|NCT01572038|19051837|P1|Overall Study|Progressive Disease|8
5510695|NCT01572038|19051837|P1|Overall Study|Patient Decision|14
5510696|NCT01572038|19051837|P1|Overall Study|Physician Decision|20
5510697|NCT01572038|19051837|P1|Overall Study|Lost to Follow-up|81
5510698|NCT01572038|19051837|P1|Overall Study|Withdrawal by Subject|204
5510699|NCT01572038|19051837|P1|Overall Study|Death|648
5510700|NCT01571453|19051952|P2|Overall Study|Administrative or other reason(s)|3
5510701|NCT01571453|19051953|P1|Overall Study|Administrative or other reason(s)|4
5510702|NCT01571453|19051952|P2|Overall Study|Lost to Follow-up|2
5510703|NCT01571453|19051953|P1|Overall Study|Lost to Follow-up|4
5510704|NCT01571453|19051952|P2|Overall Study|Withdrawal of consent|13
5510705|NCT01571453|19051953|P1|Overall Study|Withdrawal of consent|5
5510706|NCT01571453|19051952|P2|Overall Study|Protocol Violation|5
5510707|NCT01571453|19051953|P1|Overall Study|Protocol Violation|1
5510708|NCT01571453|19051952|P2|Overall Study|Non-compliance|4
5510709|NCT01571453|19051953|P1|Overall Study|Non-compliance|2
5510710|NCT01571453|19051952|P2|Overall Study|Lack of Efficacy|3
5510711|NCT01571453|19051953|P1|Overall Study|Lack of Efficacy|8
5510712|NCT01571453|19051952|P2|Overall Study|Adverse Event|32
5510713|NCT01571453|19051953|P1|Overall Study|Adverse Event|14
5510714|NCT01571362|19052000|P3|Double-Blind Treatment Period|Other - unspecified|1
5510715|NCT01571362|19052001|P2|Double-Blind Treatment Period|Other - unspecified|6
5510716|NCT01571362|19052002|P1|Double-Blind Treatment Period|Other - unspecified|0
5510717|NCT01571362|19052000|P3|Double-Blind Treatment Period|Insufficient clinical response|4
5510718|NCT01571362|19052001|P2|Double-Blind Treatment Period|Insufficient clinical response|16
5510719|NCT01571362|19052002|P1|Double-Blind Treatment Period|Insufficient clinical response|0
5510720|NCT01571362|19052000|P3|Double-Blind Treatment Period|Lost to Follow-up|6
5510721|NCT01571362|19052001|P2|Double-Blind Treatment Period|Lost to Follow-up|3
5510722|NCT01571362|19052002|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5510723|NCT01571362|19052000|P3|Double-Blind Treatment Period|Adverse Event|14
5510724|NCT01571362|19052001|P2|Double-Blind Treatment Period|Adverse Event|9
5510725|NCT01571362|19052002|P1|Double-Blind Treatment Period|Adverse Event|0
5510726|NCT01571362|19052000|P3|Double-Blind Treatment Period|Protocol Violation|9
5510727|NCT01571362|19052001|P2|Double-Blind Treatment Period|Protocol Violation|8
5510728|NCT01571362|19052002|P1|Double-Blind Treatment Period|Protocol Violation|0
5510729|NCT01571362|19052000|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
5510730|NCT01571362|19052001|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
5510731|NCT01571362|19052002|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5510732|NCT01571362|19052000|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
5510733|NCT01571362|19052001|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
5510734|NCT01571362|19052002|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
5510735|NCT01571362|19052000|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
5510736|NCT01571362|19052001|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
5510737|NCT01571362|19052002|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
5510738|NCT01571362|19052000|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
5510739|NCT01571362|19052001|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
5510740|NCT01571362|19052002|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
5510741|NCT01571362|19052000|P3|Open-Label Conversion + Titration Period|Adverse Event|0
5510742|NCT01571362|19052001|P2|Open-Label Conversion + Titration Period|Adverse Event|0
5510743|NCT01571362|19052002|P1|Open-Label Conversion + Titration Period|Adverse Event|57
5510744|NCT01571362|19052000|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
5510745|NCT01571362|19052001|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
5510746|NCT01571362|19052002|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
5510747|NCT01571362|19052000|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
5510748|NCT01571362|19052001|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
5510749|NCT01571362|19052002|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
5510750|NCT01571284|19052172|P1|Overall Study|Other than specified above|80
5510751|NCT01571284|19052172|P1|Overall Study|Enrolled but not treated|2
5510752|NCT01571284|19052172|P1|Overall Study|Lost to Follow-up|3
5510753|NCT01571284|19052172|P1|Overall Study|Participant's decision|84
5510754|NCT01571232|19052195|P2|Overall Study|Withdrawal by Subject|0
5510755|NCT01571232|19052196|P1|Overall Study|Withdrawal by Subject|1
5510756|NCT01571232|19052195|P2|Overall Study|Lost to Follow-up|1
5510757|NCT01571232|19052196|P1|Overall Study|Lost to Follow-up|0
5510758|NCT01570868|19052208|P2|Overall Study|Withdrawal by Subject|0
5510759|NCT01570868|19052209|P1|Overall Study|Withdrawal by Subject|1
5510760|NCT01570868|19052208|P2|Overall Study|Lost to Follow-up|0
5510761|NCT01570868|19052209|P1|Overall Study|Lost to Follow-up|1
5510762|NCT01570868|19052208|P2|Overall Study|Physician Decision|4
5510763|NCT01570868|19052209|P1|Overall Study|Physician Decision|10
5510764|NCT01570868|19052208|P2|Overall Study|FDA Recommendation|3
5510765|NCT01570868|19052209|P1|Overall Study|FDA Recommendation|23
5510766|NCT01570868|19052208|P2|Overall Study|Adverse Event|1
5510767|NCT01570868|19052209|P1|Overall Study|Adverse Event|8
5510768|NCT01570751|19052221|P2|Period B (16 Weeks)|Protocol Violation|1
5510769|NCT01570751|19052222|P1|Period B (16 Weeks)|Protocol Violation|0
5510770|NCT01570751|19052221|P2|Period B (16 Weeks)|Adverse Event|0
5510771|NCT01570751|19052222|P1|Period B (16 Weeks)|Adverse Event|1
5510772|NCT01570751|19052221|P2|Period A (16 Weeks)|Unclassified|3
5510773|NCT01570751|19052222|P1|Period A (16 Weeks)|Unclassified|2
5510774|NCT01570751|19052221|P2|Period A (16 Weeks)|Withdrawal criteria|1
5510775|NCT01570751|19052222|P1|Period A (16 Weeks)|Withdrawal criteria|0
5510776|NCT01570751|19052221|P2|Period A (16 Weeks)|Protocol Violation|1
5510777|NCT01570751|19052222|P1|Period A (16 Weeks)|Protocol Violation|1
5510778|NCT01570686|19052240|P2|Overall Study|Unsatisfactory therapeutic effect|1
5510779|NCT01570686|19052241|P1|Overall Study|Unsatisfactory therapeutic effect|2
5510780|NCT01570686|19052240|P2|Overall Study|Withdrawal by Subject|4
5510781|NCT01570686|19052241|P1|Overall Study|Withdrawal by Subject|4
5510782|NCT01570686|19052240|P2|Overall Study|Protocol Deviation|0
5510783|NCT01570686|19052241|P1|Overall Study|Protocol Deviation|3
5510784|NCT01570686|19052240|P2|Overall Study|Lost to Follow-up|3
5510785|NCT01570686|19052241|P1|Overall Study|Lost to Follow-up|4
5510786|NCT01570686|19052240|P2|Overall Study|Adverse Event|6
5510787|NCT01570686|19052241|P1|Overall Study|Adverse Event|8
5510788|NCT01570686|19052240|P2|Overall Study|Administrative problems|1
5510789|NCT01570686|19052241|P1|Overall Study|Administrative problems|0
5510790|NCT01570686|19052240|P2|Overall Study|Abnormal test procedure result(s)|1
5510791|NCT01570686|19052241|P1|Overall Study|Abnormal test procedure result(s)|1
5510792|NCT01570491|19052277|P2|Overall Study|treatment: not given or discontinued|0
5510793|NCT01570491|19052278|P1|Overall Study|treatment: not given or discontinued|2
5510794|NCT01570491|19052277|P2|Overall Study|Lost to Follow-up|1
5510795|NCT01570491|19052278|P1|Overall Study|Lost to Follow-up|3
5510796|NCT01570387|19052294|P4|Overall Study|Withdrawal by Subject|1
5510797|NCT01570387|19052295|P3|Overall Study|Withdrawal by Subject|0
5510798|NCT01570387|19052296|P2|Overall Study|Withdrawal by Subject|0
5510799|NCT01570387|19052297|P1|Overall Study|Withdrawal by Subject|0
5510800|NCT01570387|19052294|P4|Overall Study|Death|1
5510801|NCT01570387|19052295|P3|Overall Study|Death|0
5510802|NCT01570387|19052296|P2|Overall Study|Death|0
5510803|NCT01570387|19052297|P1|Overall Study|Death|0
5510804|NCT01570387|19052294|P4|Overall Study|Adverse Event|0
5510805|NCT01570387|19052295|P3|Overall Study|Adverse Event|0
5510806|NCT01570387|19052296|P2|Overall Study|Adverse Event|0
5510807|NCT01570387|19052297|P1|Overall Study|Adverse Event|1
5510808|NCT01570361|19052309|P2|Overall Study|Other|2
5510809|NCT01570361|19052310|P1|Overall Study|Other|0
5510810|NCT01570361|19052309|P2|Overall Study|Death|4
5510811|NCT01570361|19052310|P1|Overall Study|Death|5
5510812|NCT01570361|19052309|P2|Overall Study|Lost to Follow-up|4
5510813|NCT01570361|19052310|P1|Overall Study|Lost to Follow-up|4
5510814|NCT01570361|19052309|P2|Overall Study|Adverse Event|1
5510815|NCT01570361|19052310|P1|Overall Study|Adverse Event|2
5510816|NCT01570361|19052309|P2|Overall Study|Subject withdrew consent|9
5510817|NCT01570361|19052310|P1|Overall Study|Subject withdrew consent|14
5510818|NCT01570361|19052309|P2|Overall Study|Subject excluded|3
5510819|NCT01570361|19052310|P1|Overall Study|Subject excluded|5
5510820|NCT01570361|19052309|P2|Overall Study|Sponsor closing the study|50
5510821|NCT01570361|19052310|P1|Overall Study|Sponsor closing the study|51
5510822|NCT01570361|19052309|P2|Overall Study|Subject discontinued|2
5510823|NCT01570361|19052310|P1|Overall Study|Subject discontinued|1
5510824|NCT01570309|19052353|P2|Overall Study|Withdrawal by Subject|3
5510825|NCT01570309|19052354|P1|Overall Study|Withdrawal by Subject|3
5510826|NCT01570283|19052371|P6|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
5510827|NCT01570283|19052372|P5|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5510828|NCT01570283|19052373|P4|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5510829|NCT01570283|19052374|P3|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5510830|NCT01570283|19052375|P2|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5510831|NCT01570283|19052376|P1|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
5510832|NCT01570283|19052371|P6|Cohort 3: Dose Level 3|Death|1
5510833|NCT01570283|19052372|P5|Cohort 3: Dose Level 3|Death|0
5510834|NCT01570283|19052373|P4|Cohort 3: Dose Level 3|Death|0
5510835|NCT01570283|19052374|P3|Cohort 3: Dose Level 3|Death|0
5510836|NCT01570283|19052375|P2|Cohort 3: Dose Level 3|Death|0
5510837|NCT01570283|19052376|P1|Cohort 3: Dose Level 3|Death|0
5510838|NCT01570283|19052371|P6|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5510839|NCT01570283|19052372|P5|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5510840|NCT01570283|19052373|P4|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
5510841|NCT01570283|19052374|P3|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5510842|NCT01570283|19052375|P2|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5510843|NCT01570283|19052376|P1|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
5510844|NCT01570283|19052371|P6|Cohort 2: Dose Level 2|Death|0
5510845|NCT01570283|19052372|P5|Cohort 2: Dose Level 2|Death|0
5510846|NCT01570283|19052373|P4|Cohort 2: Dose Level 2|Death|0
5510847|NCT01570283|19052374|P3|Cohort 2: Dose Level 2|Death|1
5510848|NCT01570283|19052375|P2|Cohort 2: Dose Level 2|Death|0
5510849|NCT01570283|19052376|P1|Cohort 2: Dose Level 2|Death|0
5510850|NCT01570283|19052371|P6|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5510851|NCT01570283|19052372|P5|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5510852|NCT01570283|19052373|P4|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5510853|NCT01570283|19052374|P3|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5510854|NCT01570283|19052375|P2|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
5510855|NCT01570283|19052376|P1|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
5510856|NCT01570283|19052371|P6|Cohort 1: Dose Level 1|Death|0
5510857|NCT01570283|19052372|P5|Cohort 1: Dose Level 1|Death|0
5510858|NCT01570283|19052373|P4|Cohort 1: Dose Level 1|Death|0
5510859|NCT01570283|19052374|P3|Cohort 1: Dose Level 1|Death|0
5510860|NCT01570283|19052375|P2|Cohort 1: Dose Level 1|Death|1
5510861|NCT01570283|19052376|P1|Cohort 1: Dose Level 1|Death|0
5510862|NCT01570244|19052393|P1|Microgynon+Faldaprevir|Adverse Event|1
5510863|NCT01570192|19052415|P2|Overall Study|Physician Decision|1
5510864|NCT01570192|19052416|P1|Overall Study|Physician Decision|0
5510865|NCT01570192|19052415|P2|Overall Study|changed to palliative care|0
5510866|NCT01570192|19052416|P1|Overall Study|changed to palliative care|1
5510867|NCT01570192|19052415|P2|Overall Study|no qualifying organism|12
5510868|NCT01570192|19052416|P1|Overall Study|no qualifying organism|6
5510869|NCT01569841|19052469|P2|Period A (6 Weeks)|Withdrawal by Subject|1
5510870|NCT01569841|19052470|P1|Period A (6 Weeks)|Withdrawal by Subject|0
5510871|NCT01569763|19052559|P2|Overall Study|Adverse Event|0
5510872|NCT01569763|19052560|P1|Overall Study|Adverse Event|1
5510873|NCT01569763|19052559|P2|Overall Study|Lack of Efficacy|7
5510874|NCT01569763|19052560|P1|Overall Study|Lack of Efficacy|2
5510875|NCT01569594|19052599|P1|Overall Study|No ECM used|9
5510876|NCT01569594|19052599|P1|Overall Study|Other|4
5510877|NCT01569594|19052599|P1|Overall Study|Withdrawal by Subject|13
5510878|NCT01569594|19052599|P1|Overall Study|Adverse Event|2
5510879|NCT01569594|19052599|P1|Overall Study|Lost to Follow-up|22
5510880|NCT01569594|19052599|P1|Overall Study|Death|13
5510881|NCT01569594|19052599|P1|Overall Study|Physician Decision|4
5510882|NCT01569568|19052605|P2|Overall Study|Physician Decision|2
5510883|NCT01569568|19052606|P1|Overall Study|Physician Decision|0
5510884|NCT01569464|19052629|P2|Overall Study|Other|1
5510885|NCT01569464|19052630|P1|Overall Study|Other|1
5510886|NCT01569464|19052629|P2|Overall Study|Withdrawal by Subject|1
5510887|NCT01569464|19052630|P1|Overall Study|Withdrawal by Subject|1
5510888|NCT01569464|19052629|P2|Overall Study|Lost to Follow-up|3
5510889|NCT01569464|19052630|P1|Overall Study|Lost to Follow-up|2
5510890|NCT01569464|19052629|P2|Overall Study|Protocol Violation|0
5510891|NCT01569464|19052630|P1|Overall Study|Protocol Violation|1
5510892|NCT01569464|19052629|P2|Overall Study|Lack of Efficacy|0
5510893|NCT01569464|19052630|P1|Overall Study|Lack of Efficacy|1
5510894|NCT01569464|19052629|P2|Overall Study|Adverse Event|0
5510895|NCT01569464|19052630|P1|Overall Study|Adverse Event|4
5510896|NCT01569438|19052697|P2|Overall Study|Unable to adhere to study schedule|1
5510897|NCT01569438|19052698|P1|Overall Study|Unable to adhere to study schedule|0
5510898|NCT01569438|19052697|P2|Overall Study|Sponsor/Physician decision|1
5510899|NCT01569438|19052698|P1|Overall Study|Sponsor/Physician decision|1
5510900|NCT01569438|19052697|P2|Overall Study|Decrease of GFR greater than 30 ml/min|0
5510901|NCT01569438|19052698|P1|Overall Study|Decrease of GFR greater than 30 ml/min|1
5510902|NCT01569438|19052697|P2|Overall Study|Protocol Violation|0
5510903|NCT01569438|19052698|P1|Overall Study|Protocol Violation|2
5510904|NCT01569438|19052697|P2|Overall Study|Adverse Event|15
5510905|NCT01569438|19052698|P1|Overall Study|Adverse Event|2
5510906|NCT01569438|19052697|P2|Overall Study|Withdrawal by Subject|3
5510907|NCT01569438|19052698|P1|Overall Study|Withdrawal by Subject|0
5510908|NCT01569438|19052697|P2|Overall Study|Lack of Efficacy|2
5510909|NCT01569438|19052698|P1|Overall Study|Lack of Efficacy|1
5510910|NCT01569295|19052712|P2|Overall Study|Lost to Follow-up|1
5510911|NCT01569295|19052713|P1|Overall Study|Lost to Follow-up|1
5510912|NCT01569295|19052712|P2|Overall Study|Other Anticancer/Experimental Therapy|2
5510913|NCT01569295|19052713|P1|Overall Study|Other Anticancer/Experimental Therapy|2
5510914|NCT01569295|19052712|P2|Overall Study|Non-Compliance with Study Drug|1
5510915|NCT01569295|19052713|P1|Overall Study|Non-Compliance with Study Drug|6
5510916|NCT01569295|19052712|P2|Overall Study|Other Reason not Specified|5
5510917|NCT01569295|19052713|P1|Overall Study|Other Reason not Specified|3
5510918|NCT01569295|19052712|P2|Overall Study|Study Terminated by Sponsor|2
5510919|NCT01569295|19052713|P1|Overall Study|Study Terminated by Sponsor|24
5510920|NCT01569295|19052712|P2|Overall Study|Physician Decision|18
5510921|NCT01569295|19052713|P1|Overall Study|Physician Decision|13
5510922|NCT01569295|19052712|P2|Overall Study|Death|15
5510923|NCT01569295|19052713|P1|Overall Study|Death|19
5510924|NCT01569295|19052712|P2|Overall Study|Withdrawal by Subject|12
5510925|NCT01569295|19052713|P1|Overall Study|Withdrawal by Subject|25
5510926|NCT01569295|19052712|P2|Overall Study|Adverse Event|14
5510927|NCT01569295|19052713|P1|Overall Study|Adverse Event|39
5510928|NCT01569295|19052712|P2|Overall Study|Progressive Disease|139
5510929|NCT01569295|19052713|P1|Overall Study|Progressive Disease|75
5510930|NCT01569152|19052750|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
5510931|NCT01569152|19052751|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
5510932|NCT01569152|19052752|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
5510933|NCT01569152|19052750|P3|Safety Extension, Period 3|Physician Decision|2
5510934|NCT01569152|19052751|P2|Safety Extension, Period 3|Physician Decision|0
5510935|NCT01569152|19052752|P1|Safety Extension, Period 3|Physician Decision|0
5510936|NCT01569152|19052750|P3|Safety Extension, Period 3|Withdrawal by Subject|2
5510937|NCT01569152|19052751|P2|Safety Extension, Period 3|Withdrawal by Subject|0
5510938|NCT01569152|19052752|P1|Safety Extension, Period 3|Withdrawal by Subject|0
5510939|NCT01569152|19052750|P3|Safety Extension, Period 3|Adverse Event|4
5510940|NCT01569152|19052751|P2|Safety Extension, Period 3|Adverse Event|0
5510941|NCT01569152|19052752|P1|Safety Extension, Period 3|Adverse Event|0
5510942|NCT01569152|19052750|P3|Phase IIa, Period 1|Withdrawal by Subject|0
5510943|NCT01569152|19052751|P2|Phase IIa, Period 1|Withdrawal by Subject|1
5510944|NCT01569152|19052752|P1|Phase IIa, Period 1|Withdrawal by Subject|2
5510945|NCT01569152|19052750|P3|Phase IIa, Period 1|Protocol Violation|0
5510946|NCT01569152|19052751|P2|Phase IIa, Period 1|Protocol Violation|1
5510947|NCT01569152|19052752|P1|Phase IIa, Period 1|Protocol Violation|0
5510948|NCT01569152|19052750|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
5510949|NCT01569152|19052751|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
5510950|NCT01569152|19052752|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
5510951|NCT01569152|19052750|P3|Phase IIa, Period 1|Lost to Follow-up|0
5510952|NCT01569152|19052751|P2|Phase IIa, Period 1|Lost to Follow-up|0
5510953|NCT01569152|19052752|P1|Phase IIa, Period 1|Lost to Follow-up|1
5510954|NCT01569152|19052750|P3|Phase IIa, Period 1|Adverse Event|0
5510955|NCT01569152|19052751|P2|Phase IIa, Period 1|Adverse Event|0
5510956|NCT01569152|19052752|P1|Phase IIa, Period 1|Adverse Event|4
5510957|NCT01569152|19052750|P3|Phase IIa, Period 1|Early Escape|0
5510958|NCT01569152|19052751|P2|Phase IIa, Period 1|Early Escape|22
5510959|NCT01569152|19052752|P1|Phase IIa, Period 1|Early Escape|5
5510960|NCT01569074|19052888|P5|Overall Study|Adverse Event|0
5510961|NCT01569074|19052889|P4|Overall Study|Adverse Event|0
5510962|NCT01569074|19052890|P3|Overall Study|Adverse Event|3
5510963|NCT01569074|19052891|P2|Overall Study|Adverse Event|0
5510964|NCT01569074|19052892|P1|Overall Study|Adverse Event|1
5510965|NCT01569074|19052888|P5|Overall Study|eg change in circumstances|1
5510966|NCT01569074|19052889|P4|Overall Study|eg change in circumstances|1
5510967|NCT01569074|19052890|P3|Overall Study|eg change in circumstances|0
5510968|NCT01569074|19052891|P2|Overall Study|eg change in circumstances|2
5510969|NCT01569074|19052892|P1|Overall Study|eg change in circumstances|0
5510970|NCT01569074|19052888|P5|Overall Study|Severe non-compliance to protocol|0
5510971|NCT01569074|19052889|P4|Overall Study|Severe non-compliance to protocol|0
5510972|NCT01569074|19052890|P3|Overall Study|Severe non-compliance to protocol|1
5510973|NCT01569074|19052891|P2|Overall Study|Severe non-compliance to protocol|0
5510974|NCT01569074|19052892|P1|Overall Study|Severe non-compliance to protocol|0
5510975|NCT01569074|19052888|P5|Overall Study|Study-specific discontinuation criteria|0
5510976|NCT01569074|19052889|P4|Overall Study|Study-specific discontinuation criteria|0
5510977|NCT01569074|19052890|P3|Overall Study|Study-specific discontinuation criteria|0
5510978|NCT01569074|19052891|P2|Overall Study|Study-specific discontinuation criteria|1
5510979|NCT01569074|19052892|P1|Overall Study|Study-specific discontinuation criteria|0
5510980|NCT01569074|19052888|P5|Overall Study|Study stopped|7
5510981|NCT01569074|19052889|P4|Overall Study|Study stopped|7
5510982|NCT01569074|19052890|P3|Overall Study|Study stopped|8
5510983|NCT01569074|19052891|P2|Overall Study|Study stopped|6
5510984|NCT01569074|19052892|P1|Overall Study|Study stopped|6
5510985|NCT01569022|19052948|P2|Second Intervention|Lost to Follow-up|2
5510986|NCT01569022|19052949|P1|Second Intervention|Lost to Follow-up|2
5510987|NCT01569022|19052948|P2|First Intervention|Lost to Follow-up|1
5510988|NCT01569022|19052949|P1|First Intervention|Lost to Follow-up|2
5510989|NCT01568892|19053004|P2|Open-label Phase|Lost to Follow-up|1
5510990|NCT01568892|19053005|P1|Open-label Phase|Lost to Follow-up|0
5510991|NCT01568892|19053004|P2|Open-label Phase|Lack of Efficacy|2
5510992|NCT01568892|19053005|P1|Open-label Phase|Lack of Efficacy|4
5510993|NCT01568892|19053004|P2|Open-label Phase|Adverse Event|0
5510994|NCT01568892|19053005|P1|Open-label Phase|Adverse Event|2
5510995|NCT01568866|19053075|P2|Overall Study|Randomized but Not Dosed|1
5510996|NCT01568866|19053076|P1|Overall Study|Randomized but Not Dosed|9
5510997|NCT01568866|19053075|P2|Overall Study|Lost to Follow-up|0
5510998|NCT01568866|19053076|P1|Overall Study|Lost to Follow-up|1
5510999|NCT01568866|19053075|P2|Overall Study|Protocol Non-compliance|4
5511000|NCT01568866|19053076|P1|Overall Study|Protocol Non-compliance|2
5511001|NCT01568866|19053075|P2|Overall Study|Death|18
5511002|NCT01568866|19053076|P1|Overall Study|Death|10
5511003|NCT01568866|19053075|P2|Overall Study|Withdrawal by Subject|11
5511004|NCT01568866|19053076|P1|Overall Study|Withdrawal by Subject|19
5511005|NCT01568866|19053075|P2|Overall Study|Physician Decision|32
5511006|NCT01568866|19053076|P1|Overall Study|Physician Decision|40
5511007|NCT01568866|19053075|P2|Overall Study|Patient Request|71
5511008|NCT01568866|19053076|P1|Overall Study|Patient Request|55
5511009|NCT01568866|19053075|P2|Overall Study|Adverse Event|96
5511010|NCT01568866|19053076|P1|Overall Study|Adverse Event|94
5511011|NCT01568866|19053075|P2|Overall Study|Disease Progression|183
5511012|NCT01568866|19053076|P1|Overall Study|Disease Progression|208
5511013|NCT01568593|19053111|P2|Overall Study|Adverse Event|2
5511014|NCT01568593|19053112|P1|Overall Study|Adverse Event|3
5511015|NCT01568593|19053111|P2|Overall Study|Lack of Efficacy|1
5511016|NCT01568593|19053112|P1|Overall Study|Lack of Efficacy|4
5511017|NCT01568112|19053157|P4|Overall Study|Withdrawal by Physician|1
5511018|NCT01568112|19053158|P3|Overall Study|Withdrawal by Physician|1
5511019|NCT01568112|19053159|P2|Overall Study|Withdrawal by Physician|0
5511020|NCT01568112|19053160|P1|Overall Study|Withdrawal by Physician|1
5511021|NCT01568112|19053157|P4|Overall Study|Withdrawal by Subject|7
5511022|NCT01568112|19053158|P3|Overall Study|Withdrawal by Subject|0
5511023|NCT01568112|19053159|P2|Overall Study|Withdrawal by Subject|3
5511024|NCT01568112|19053160|P1|Overall Study|Withdrawal by Subject|2
5511025|NCT01568112|19053157|P4|Overall Study|Lost to Follow-up|1
5511026|NCT01568112|19053158|P3|Overall Study|Lost to Follow-up|0
5511027|NCT01568112|19053159|P2|Overall Study|Lost to Follow-up|0
5511028|NCT01568112|19053160|P1|Overall Study|Lost to Follow-up|0
5511029|NCT01568112|19053157|P4|Overall Study|Withdrew due to Adverse Event|3
5511030|NCT01568112|19053158|P3|Overall Study|Withdrew due to Adverse Event|6
5511031|NCT01568112|19053159|P2|Overall Study|Withdrew due to Adverse Event|4
5511032|NCT01568112|19053160|P1|Overall Study|Withdrew due to Adverse Event|2
5511033|NCT01568112|19053157|P4|Overall Study|Randomized But Not Treated|0
5511034|NCT01568112|19053158|P3|Overall Study|Randomized But Not Treated|0
5511035|NCT01568112|19053159|P2|Overall Study|Randomized But Not Treated|1
5511036|NCT01568112|19053160|P1|Overall Study|Randomized But Not Treated|0
5511037|NCT01568047|19053318|P4|Overall Study|Adverse Event|1
5511038|NCT01568047|19053319|P3|Overall Study|Adverse Event|1
5511039|NCT01568047|19053320|P2|Overall Study|Adverse Event|0
5511040|NCT01568047|19053321|P1|Overall Study|Adverse Event|0
5511041|NCT01568047|19053318|P4|Overall Study|Withdrawal by Subject|0
5511042|NCT01568047|19053319|P3|Overall Study|Withdrawal by Subject|0
5511043|NCT01568047|19053320|P2|Overall Study|Withdrawal by Subject|1
5511044|NCT01568047|19053321|P1|Overall Study|Withdrawal by Subject|0
5511045|NCT01568047|19053318|P4|Overall Study|Ineligibility|0
5511046|NCT01568047|19053319|P3|Overall Study|Ineligibility|0
5511047|NCT01568047|19053320|P2|Overall Study|Ineligibility|0
5511048|NCT01568047|19053321|P1|Overall Study|Ineligibility|1
5511049|NCT01568034|19053339|P4|Overall Study|Withdrawal by Subject|0
5511050|NCT01568034|19053340|P3|Overall Study|Withdrawal by Subject|0
5511051|NCT01568034|19053341|P2|Overall Study|Withdrawal by Subject|0
5511052|NCT01568034|19053342|P1|Overall Study|Withdrawal by Subject|1
5511053|NCT01567865|19053405|P4|Evaluated for Immunogenicity|Missing blood sample|28
5511054|NCT01567865|19053406|P3|Evaluated for Immunogenicity|Missing blood sample|16
5511055|NCT01567865|19053407|P2|Evaluated for Immunogenicity|Missing blood sample|24
5511056|NCT01567865|19053408|P1|Evaluated for Immunogenicity|Missing blood sample|17
5511057|NCT01567865|19053405|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
5511058|NCT01567865|19053406|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
5511059|NCT01567865|19053407|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
5511060|NCT01567865|19053408|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
5511061|NCT01567852|19053438|P2|Overall Study|ECT discontinued|1
5511062|NCT01567852|19053439|P1|Overall Study|ECT discontinued|1
5511063|NCT01567852|19053438|P2|Overall Study|Withdrawal by Subject|6
5511064|NCT01567852|19053439|P1|Overall Study|Withdrawal by Subject|3
5511065|NCT01567826|19053457|P2|Overall Study|Lost to Follow-up|2
5511066|NCT01567826|19053458|P1|Overall Study|Lost to Follow-up|3
5511067|NCT01567527|19053484|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
5511068|NCT01567527|19053485|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
5511069|NCT01567527|19053486|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5511070|NCT01567527|19053487|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5511071|NCT01567527|19053488|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
5511072|NCT01567527|19053484|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
5511073|NCT01567527|19053485|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
5511074|NCT01567527|19053486|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
5511075|NCT01567527|19053487|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
5511076|NCT01567527|19053488|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
5511077|NCT01567527|19053484|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
5511078|NCT01567527|19053485|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
5511079|NCT01567527|19053486|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
5511080|NCT01567527|19053487|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
5511081|NCT01567527|19053488|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
5511082|NCT01567527|19053484|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
5511083|NCT01567527|19053485|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
5511084|NCT01567527|19053486|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5511085|NCT01567527|19053487|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5511086|NCT01567527|19053488|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
5511087|NCT01567527|19053484|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
5511088|NCT01567527|19053485|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
5511089|NCT01567527|19053486|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
5511090|NCT01567527|19053487|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
5511091|NCT01567527|19053488|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
5511092|NCT01567527|19053484|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
5511093|NCT01567527|19053485|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
5511094|NCT01567527|19053486|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
5511095|NCT01567527|19053487|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
5511096|NCT01567527|19053488|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
5511097|NCT01567527|19053484|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
5511098|NCT01567527|19053485|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
5511099|NCT01567527|19053486|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
5511100|NCT01567527|19053487|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
5511101|NCT01567527|19053488|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
5511102|NCT01567527|19053484|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
5511103|NCT01567527|19053485|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
5511104|NCT01567527|19053486|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
5511105|NCT01567527|19053487|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
5511106|NCT01567527|19053488|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
5511107|NCT01567527|19053484|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
5511108|NCT01567527|19053485|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
5511109|NCT01567527|19053486|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
5511110|NCT01567527|19053487|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
5511111|NCT01567527|19053488|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
5511112|NCT01567527|19053484|P5|IM Depot Stabilization.|Adverse Event|0
5511113|NCT01567527|19053485|P4|IM Depot Stabilization.|Adverse Event|0
5511114|NCT01567527|19053486|P3|IM Depot Stabilization.|Adverse Event|37
5511115|NCT01567527|19053487|P2|IM Depot Stabilization.|Adverse Event|0
5511116|NCT01567527|19053488|P1|IM Depot Stabilization.|Adverse Event|0
5511117|NCT01567527|19053484|P5|IM Depot Stabilization.|Lack of Efficacy|0
5511118|NCT01567527|19053485|P4|IM Depot Stabilization.|Lack of Efficacy|0
5511119|NCT01567527|19053486|P3|IM Depot Stabilization.|Lack of Efficacy|7
5511120|NCT01567527|19053487|P2|IM Depot Stabilization.|Lack of Efficacy|0
5511121|NCT01567527|19053488|P1|IM Depot Stabilization.|Lack of Efficacy|0
5511122|NCT01567527|19053484|P5|IM Depot Stabilization.|Lost to Follow-up|0
5511123|NCT01567527|19053485|P4|IM Depot Stabilization.|Lost to Follow-up|0
5511124|NCT01567527|19053486|P3|IM Depot Stabilization.|Lost to Follow-up|21
5511125|NCT01567527|19053487|P2|IM Depot Stabilization.|Lost to Follow-up|0
5511126|NCT01567527|19053488|P1|IM Depot Stabilization.|Lost to Follow-up|0
5511127|NCT01567527|19053484|P5|IM Depot Stabilization.|Sponsor discontinued study|0
5511128|NCT01567527|19053485|P4|IM Depot Stabilization.|Sponsor discontinued study|0
5511129|NCT01567527|19053486|P3|IM Depot Stabilization.|Sponsor discontinued study|1
5511130|NCT01567527|19053487|P2|IM Depot Stabilization.|Sponsor discontinued study|0
5511131|NCT01567527|19053488|P1|IM Depot Stabilization.|Sponsor discontinued study|0
5511132|NCT01567527|19053484|P5|IM Depot Stabilization.|Withdrawal by Subject|0
5511133|NCT01567527|19053485|P4|IM Depot Stabilization.|Withdrawal by Subject|0
5511134|NCT01567527|19053486|P3|IM Depot Stabilization.|Withdrawal by Subject|56
5511135|NCT01567527|19053487|P2|IM Depot Stabilization.|Withdrawal by Subject|0
5511136|NCT01567527|19053488|P1|IM Depot Stabilization.|Withdrawal by Subject|0
5511137|NCT01567527|19053484|P5|IM Depot Stabilization.|Met withdrawal criteria|0
5511138|NCT01567527|19053485|P4|IM Depot Stabilization.|Met withdrawal criteria|0
5511139|NCT01567527|19053486|P3|IM Depot Stabilization.|Met withdrawal criteria|26
5511140|NCT01567527|19053487|P2|IM Depot Stabilization.|Met withdrawal criteria|0
5511141|NCT01567527|19053488|P1|IM Depot Stabilization.|Met withdrawal criteria|0
5511142|NCT01567527|19053484|P5|IM Depot Stabilization.|Protocol deviation|0
5511143|NCT01567527|19053485|P4|IM Depot Stabilization.|Protocol deviation|0
5511144|NCT01567527|19053486|P3|IM Depot Stabilization.|Protocol deviation|5
5511145|NCT01567527|19053487|P2|IM Depot Stabilization.|Protocol deviation|0
5511146|NCT01567527|19053488|P1|IM Depot Stabilization.|Protocol deviation|0
5511147|NCT01567527|19053484|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5511148|NCT01567527|19053485|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5511149|NCT01567527|19053486|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5511150|NCT01567527|19053487|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
5511151|NCT01567527|19053488|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
5511152|NCT01567527|19053484|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5511153|NCT01567527|19053485|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5511154|NCT01567527|19053486|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5511155|NCT01567527|19053487|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
5511156|NCT01567527|19053488|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
5511157|NCT01567527|19053484|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5511158|NCT01567527|19053485|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5511159|NCT01567527|19053486|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5511160|NCT01567527|19053487|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
5511161|NCT01567527|19053488|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
5511162|NCT01567527|19053484|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5511163|NCT01567527|19053485|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5511164|NCT01567527|19053486|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5511165|NCT01567527|19053487|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
5511166|NCT01567527|19053488|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
5511167|NCT01567527|19053484|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5511168|NCT01567527|19053485|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5511169|NCT01567527|19053486|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5511170|NCT01567527|19053487|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
5511171|NCT01567527|19053488|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
5511172|NCT01567527|19053484|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5511173|NCT01567527|19053485|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5511174|NCT01567527|19053486|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5511261|NCT01566721|19053845|P2|Overall Study|Withdrew Prior to Treatment|1
5511175|NCT01567527|19053487|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
5511176|NCT01567527|19053488|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
5511177|NCT01567527|19053484|P5|Conversion Phase.|Withdrawn by the investigator|0
5511178|NCT01567527|19053485|P4|Conversion Phase.|Withdrawn by the investigator|0
5511179|NCT01567527|19053486|P3|Conversion Phase.|Withdrawn by the investigator|0
5511180|NCT01567527|19053487|P2|Conversion Phase.|Withdrawn by the investigator|0
5511181|NCT01567527|19053488|P1|Conversion Phase.|Withdrawn by the investigator|3
5511182|NCT01567527|19053484|P5|Conversion Phase.|Adverse Event|0
5511183|NCT01567527|19053485|P4|Conversion Phase.|Adverse Event|0
5511184|NCT01567527|19053486|P3|Conversion Phase.|Adverse Event|0
5511185|NCT01567527|19053487|P2|Conversion Phase.|Adverse Event|0
5511186|NCT01567527|19053488|P1|Conversion Phase.|Adverse Event|33
5511187|NCT01567527|19053484|P5|Conversion Phase.|Lack of Efficacy|0
5511188|NCT01567527|19053485|P4|Conversion Phase.|Lack of Efficacy|0
5511189|NCT01567527|19053486|P3|Conversion Phase.|Lack of Efficacy|0
5511190|NCT01567527|19053487|P2|Conversion Phase.|Lack of Efficacy|0
5511191|NCT01567527|19053488|P1|Conversion Phase.|Lack of Efficacy|2
5511192|NCT01567527|19053484|P5|Conversion Phase.|Lost to Follow-up|0
5511193|NCT01567527|19053485|P4|Conversion Phase.|Lost to Follow-up|0
5511194|NCT01567527|19053486|P3|Conversion Phase.|Lost to Follow-up|0
5511195|NCT01567527|19053487|P2|Conversion Phase.|Lost to Follow-up|0
5511196|NCT01567527|19053488|P1|Conversion Phase.|Lost to Follow-up|16
5511197|NCT01567527|19053484|P5|Conversion Phase.|Withdrawal by Subject|0
5511198|NCT01567527|19053485|P4|Conversion Phase.|Withdrawal by Subject|0
5511199|NCT01567527|19053486|P3|Conversion Phase.|Withdrawal by Subject|0
5511200|NCT01567527|19053487|P2|Conversion Phase.|Withdrawal by Subject|0
5511201|NCT01567527|19053488|P1|Conversion Phase.|Withdrawal by Subject|32
5511202|NCT01567527|19053484|P5|Conversion Phase.|Met withdrawal criteria|0
5511203|NCT01567527|19053485|P4|Conversion Phase.|Met withdrawal criteria|0
5511204|NCT01567527|19053486|P3|Conversion Phase.|Met withdrawal criteria|0
5511205|NCT01567527|19053487|P2|Conversion Phase.|Met withdrawal criteria|0
5511206|NCT01567527|19053488|P1|Conversion Phase.|Met withdrawal criteria|10
5511207|NCT01567527|19053484|P5|Conversion Phase.|Protocol deviation|0
5511208|NCT01567527|19053485|P4|Conversion Phase.|Protocol deviation|0
5511209|NCT01567527|19053486|P3|Conversion Phase.|Protocol deviation|0
5511210|NCT01567527|19053487|P2|Conversion Phase.|Protocol deviation|0
5511211|NCT01567527|19053488|P1|Conversion Phase.|Protocol deviation|3
5511212|NCT01567462|19053505|P2|Overall Study|Withdrawal by Subject|7
5511213|NCT01567462|19053506|P1|Overall Study|Withdrawal by Subject|4
5511214|NCT01567306|19053529|P6|Overall Study|Withdrawal by Subject|1
5511215|NCT01567306|19053530|P5|Overall Study|Withdrawal by Subject|0
5511216|NCT01567306|19053531|P4|Overall Study|Withdrawal by Subject|0
5511217|NCT01567306|19053532|P3|Overall Study|Withdrawal by Subject|0
5511218|NCT01567306|19053533|P2|Overall Study|Withdrawal by Subject|0
5511219|NCT01567306|19053534|P1|Overall Study|Withdrawal by Subject|0
5511220|NCT01567306|19053529|P6|Overall Study|Lost to Follow-up|0
5511221|NCT01567306|19053530|P5|Overall Study|Lost to Follow-up|2
5511222|NCT01567306|19053531|P4|Overall Study|Lost to Follow-up|0
5511223|NCT01567306|19053532|P3|Overall Study|Lost to Follow-up|0
5511224|NCT01567306|19053533|P2|Overall Study|Lost to Follow-up|0
5511225|NCT01567306|19053534|P1|Overall Study|Lost to Follow-up|0
5511226|NCT01567306|19053529|P6|Overall Study|Adverse Event|1
5511227|NCT01567306|19053530|P5|Overall Study|Adverse Event|4
5511228|NCT01567306|19053531|P4|Overall Study|Adverse Event|2
5511229|NCT01567306|19053532|P3|Overall Study|Adverse Event|0
5511230|NCT01567306|19053533|P2|Overall Study|Adverse Event|0
5511231|NCT01567306|19053534|P1|Overall Study|Adverse Event|0
5511232|NCT01567306|19053529|P6|Overall Study|Change site living|0
5511233|NCT01567306|19053530|P5|Overall Study|Change site living|0
5511234|NCT01567306|19053531|P4|Overall Study|Change site living|0
5511235|NCT01567306|19053532|P3|Overall Study|Change site living|0
5511236|NCT01567306|19053533|P2|Overall Study|Change site living|0
5511237|NCT01567306|19053534|P1|Overall Study|Change site living|1
5511238|NCT01567306|19053529|P6|Overall Study|Protocol Violation|1
5511239|NCT01567306|19053530|P5|Overall Study|Protocol Violation|1
5511240|NCT01567306|19053531|P4|Overall Study|Protocol Violation|3
5511241|NCT01567306|19053532|P3|Overall Study|Protocol Violation|0
5511242|NCT01567306|19053533|P2|Overall Study|Protocol Violation|2
5511243|NCT01567306|19053534|P1|Overall Study|Protocol Violation|2
5511244|NCT01567163|19053548|P1|Overall Study|Lost to Follow-up|2
5511245|NCT01567163|19053548|P1|Overall Study|Progressive Disease|2
5511246|NCT01567085|19053569|P1|Overall Study|Terminal chronic kidney dysfunction|1
5511247|NCT01567085|19053569|P1|Overall Study|Returned to chronic dialysis|1
5511248|NCT01567085|19053569|P1|Overall Study|Renal transplantectomy|1
5511249|NCT01567085|19053569|P1|Overall Study|Graft loss|2
5511250|NCT01567085|19053569|P1|Overall Study|Lost to Follow-up|3
5511251|NCT01567085|19053569|P1|Overall Study|Adverse Event|6
5511252|NCT01567085|19053569|P1|Overall Study|Death|6
5511253|NCT01566981|19053606|P2|Overall Study|Lost to Follow-up|8
5511254|NCT01566981|19053607|P1|Overall Study|Lost to Follow-up|5
5511255|NCT01566773|19053636|P1|Overall Study|Physician Decision|2
5511256|NCT01566773|19053636|P1|Overall Study|Adverse Event|10
5511257|NCT01566773|19053636|P1|Overall Study|Administrative reason|1
5511258|NCT01566773|19053636|P1|Overall Study|Withdrawal by Subject|9
5511259|NCT01566773|19053636|P1|Overall Study|Protocol Violation|4
5511260|NCT01566773|19053636|P1|Overall Study|Protocol specified criteria|4
5511262|NCT01566721|19053846|P1|Overall Study|Withdrew Prior to Treatment|3
5511263|NCT01566721|19053845|P2|Overall Study|Other|4
5511264|NCT01566721|19053846|P1|Overall Study|Other|10
5511265|NCT01566721|19053845|P2|Overall Study|Death|3
5511266|NCT01566721|19053846|P1|Overall Study|Death|6
5511267|NCT01566721|19053845|P2|Overall Study|Lost to Follow-up|0
5511268|NCT01566721|19053846|P1|Overall Study|Lost to Follow-up|18
5511269|NCT01566721|19053845|P2|Overall Study|Disease Progression/Recurrence|28
5511270|NCT01566721|19053846|P1|Overall Study|Disease Progression/Recurrence|123
5511271|NCT01566721|19053845|P2|Overall Study|Withdrawal by Subject|15
5511272|NCT01566721|19053846|P1|Overall Study|Withdrawal by Subject|58
5511273|NCT01566721|19053845|P2|Overall Study|Ongoing Study|659
5511274|NCT01566721|19053846|P1|Overall Study|Ongoing Study|1649
5511275|NCT01566695|19053871|P2|Overall Study|Miscellaneous|6
5511276|NCT01566695|19053872|P1|Overall Study|Miscellaneous|4
5511277|NCT01566695|19053871|P2|Overall Study|Progressive Disease|6
5511278|NCT01566695|19053872|P1|Overall Study|Progressive Disease|11
5511279|NCT01566695|19053871|P2|Overall Study|Withdrawal by Subject|7
5511280|NCT01566695|19053872|P1|Overall Study|Withdrawal by Subject|14
5511281|NCT01566695|19053871|P2|Overall Study|Death|8
5511282|NCT01566695|19053872|P1|Overall Study|Death|20
5511283|NCT01566695|19053871|P2|Overall Study|Adverse Event|27
5511284|NCT01566695|19053872|P1|Overall Study|Adverse Event|28
5511285|NCT01566695|19053871|P2|Overall Study|Lack of Efficacy|45
5511286|NCT01566695|19053872|P1|Overall Study|Lack of Efficacy|18
5511287|NCT01566604|19054037|P2|Overall Study|Withdrawal by Subject|6
5511288|NCT01566604|19054038|P1|Overall Study|Withdrawal by Subject|9
5511289|NCT01566604|19054037|P2|Overall Study|Adverse Event|2
5511290|NCT01566604|19054038|P1|Overall Study|Adverse Event|4
5511291|NCT01566604|19054037|P2|Overall Study|Death|1
5511292|NCT01566604|19054038|P1|Overall Study|Death|4
5511293|NCT01566604|19054037|P2|Overall Study|Abnormal laboratory value|0
5511294|NCT01566604|19054038|P1|Overall Study|Abnormal laboratory value|2
5511295|NCT01566604|19054037|P2|Overall Study|Protocol deviation|0
5511296|NCT01566604|19054038|P1|Overall Study|Protocol deviation|2
5511297|NCT01566604|19054037|P2|Overall Study|Lack of Efficacy|2
5511298|NCT01566604|19054038|P1|Overall Study|Lack of Efficacy|1
5511299|NCT01566604|19054037|P2|Overall Study|Administrative problems|0
5511300|NCT01566604|19054038|P1|Overall Study|Administrative problems|1
5511301|NCT01566604|19054037|P2|Overall Study|Patient's inability to use the device|0
5511302|NCT01566604|19054038|P1|Overall Study|Patient's inability to use the device|1
5511303|NCT01566435|19054194|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
5511304|NCT01566214|19054260|P2|Overall Study|Lost to Follow-up|0
5511305|NCT01566214|19054261|P1|Overall Study|Lost to Follow-up|3
5511306|NCT01566149|19054305|P2|Overall Study|Withdrawal by Subject|0
5511307|NCT01566149|19054306|P1|Overall Study|Withdrawal by Subject|1
5511308|NCT01566149|19054305|P2|Overall Study|Protocol Violation|1
5511309|NCT01566149|19054306|P1|Overall Study|Protocol Violation|0
5511310|NCT01566149|19054305|P2|Overall Study|Non-compliance with study medication|0
5511311|NCT01566149|19054306|P1|Overall Study|Non-compliance with study medication|2
5511312|NCT01566149|19054305|P2|Overall Study|Adverse Event|1
5511313|NCT01566149|19054306|P1|Overall Study|Adverse Event|0
5511314|NCT01565993|19054339|P2|Overall Study|Physician Decision|3
5511315|NCT01565993|19054340|P1|Overall Study|Physician Decision|0
5511316|NCT01565980|19054348|P2|Overall Study|Withdrawal by Subject|3
5511317|NCT01565980|19054349|P1|Overall Study|Withdrawal by Subject|0
5511318|NCT01565980|19054348|P2|Overall Study|stopped medical treatment|0
5511319|NCT01565980|19054349|P1|Overall Study|stopped medical treatment|1
5511320|NCT01565980|19054348|P2|Overall Study|health complications|1
5511321|NCT01565980|19054349|P1|Overall Study|health complications|1
5511322|NCT01565980|19054348|P2|Overall Study|Lost to Follow-up|0
5511323|NCT01565980|19054349|P1|Overall Study|Lost to Follow-up|1
5511324|NCT01565980|19054348|P2|Overall Study|Death|0
5511325|NCT01565980|19054349|P1|Overall Study|Death|1
5511326|NCT01565941|19054369|P2|Overall Study|Randomized; did not receive intevention|2
5511327|NCT01565941|19054370|P1|Overall Study|Randomized; did not receive intevention|8
5511328|NCT01565941|19054369|P2|Overall Study|Withdrawn by parent/guardian|2
5511329|NCT01565941|19054370|P1|Overall Study|Withdrawn by parent/guardian|3
5511330|NCT01565928|19054412|P1|Overall Study|Death|2
5511331|NCT01565928|19054412|P1|Overall Study|Withdrawal by Subject|1
5511332|NCT01565928|19054412|P1|Overall Study|Progressive Disease|13
5511333|NCT01565928|19054412|P1|Overall Study|Other|3
5511334|NCT01565928|19054412|P1|Overall Study|Adverse Event|3
5511335|NCT01565889|19054466|P6|Part B|Lost to Follow-up|1
5511336|NCT01565889|19054467|P5|Part B|Lost to Follow-up|0
5511337|NCT01565889|19054468|P4|Part B|Lost to Follow-up|0
5511338|NCT01565889|19054469|P3|Part B|Lost to Follow-up|0
5511339|NCT01565889|19054470|P2|Part B|Lost to Follow-up|0
5511340|NCT01565889|19054471|P1|Part B|Lost to Follow-up|0
5511341|NCT01565889|19054466|P6|Part B|Lack of Efficacy|2
5511342|NCT01565889|19054467|P5|Part B|Lack of Efficacy|0
5511343|NCT01565889|19054468|P4|Part B|Lack of Efficacy|0
5511344|NCT01565889|19054469|P3|Part B|Lack of Efficacy|0
5511345|NCT01565889|19054470|P2|Part B|Lack of Efficacy|0
5511346|NCT01565889|19054471|P1|Part B|Lack of Efficacy|0
5511347|NCT01565889|19054466|P6|Part B|Withdrawal by Subject|1
5511348|NCT01565889|19054467|P5|Part B|Withdrawal by Subject|0
5511349|NCT01565889|19054468|P4|Part B|Withdrawal by Subject|0
5511350|NCT01565889|19054469|P3|Part B|Withdrawal by Subject|0
5511351|NCT01565889|19054470|P2|Part B|Withdrawal by Subject|0
5511352|NCT01565889|19054471|P1|Part B|Withdrawal by Subject|0
5511353|NCT01565889|19054466|P6|Part A|Withdrawal by Subject|0
5511354|NCT01565889|19054467|P5|Part A|Withdrawal by Subject|0
5511355|NCT01565889|19054468|P4|Part A|Withdrawal by Subject|0
5511356|NCT01565889|19054469|P3|Part A|Withdrawal by Subject|0
5511357|NCT01565889|19054470|P2|Part A|Withdrawal by Subject|0
5511358|NCT01565889|19054471|P1|Part A|Withdrawal by Subject|1
5511359|NCT01565850|19054502|P2|Overall Study|Withdrew Consent|2
5511360|NCT01565850|19054503|P1|Overall Study|Withdrew Consent|4
5511361|NCT01565850|19054502|P2|Overall Study|Participant noncompliance|0
5511362|NCT01565850|19054503|P1|Overall Study|Participant noncompliance|2
5511363|NCT01565850|19054502|P2|Overall Study|Investigator's Discretion|1
5511364|NCT01565850|19054503|P1|Overall Study|Investigator's Discretion|2
5511365|NCT01565850|19054502|P2|Overall Study|Lost to Follow-up|4
5511366|NCT01565850|19054503|P1|Overall Study|Lost to Follow-up|12
5511367|NCT01565850|19054502|P2|Overall Study|Adverse Event|1
5511368|NCT01565850|19054503|P1|Overall Study|Adverse Event|0
5511369|NCT01565707|19054523|P4|Overall Study|Miscellaneous|2
5511370|NCT01565707|19054524|P3|Overall Study|Miscellaneous|0
5511371|NCT01565707|19054525|P2|Overall Study|Miscellaneous|1
5511372|NCT01565707|19054526|P1|Overall Study|Miscellaneous|1
5511373|NCT01565707|19054523|P4|Overall Study|Randomized but not evaluable|0
5511374|NCT01565707|19054524|P3|Overall Study|Randomized but not evaluable|0
5511375|NCT01565707|19054525|P2|Overall Study|Randomized but not evaluable|0
5511376|NCT01565707|19054526|P1|Overall Study|Randomized but not evaluable|2
5511377|NCT01565707|19054523|P4|Overall Study|Withdrawal by Subject|1
5511378|NCT01565707|19054524|P3|Overall Study|Withdrawal by Subject|1
5511379|NCT01565707|19054525|P2|Overall Study|Withdrawal by Subject|1
5511380|NCT01565707|19054526|P1|Overall Study|Withdrawal by Subject|3
5511381|NCT01565707|19054523|P4|Overall Study|Protocol Violation|1
5511382|NCT01565707|19054524|P3|Overall Study|Protocol Violation|0
5511383|NCT01565707|19054525|P2|Overall Study|Protocol Violation|0
5511384|NCT01565707|19054526|P1|Overall Study|Protocol Violation|1
5511385|NCT01565707|19054523|P4|Overall Study|Lost to Follow-up|0
5511386|NCT01565707|19054524|P3|Overall Study|Lost to Follow-up|0
5511387|NCT01565707|19054525|P2|Overall Study|Lost to Follow-up|0
5511388|NCT01565707|19054526|P1|Overall Study|Lost to Follow-up|1
5511389|NCT01565707|19054523|P4|Overall Study|Adverse Event|1
5511390|NCT01565707|19054524|P3|Overall Study|Adverse Event|2
5511391|NCT01565707|19054525|P2|Overall Study|Adverse Event|6
5511392|NCT01565707|19054526|P1|Overall Study|Adverse Event|1
5511393|NCT01565694|19054617|P1|Fixed-Dose Assessment Period|Withdrawal by Subject|4
5511394|NCT01565694|19054617|P1|Dose-Titration Period|Protocol Violation|10
5511395|NCT01565694|19054617|P1|Dose-Titration Period|Adverse Event|4
5511396|NCT01565668|19054638|P2|Overall Study|HSCT Transplant|15
5511397|NCT01565668|19054639|P1|Overall Study|HSCT Transplant|11
5511398|NCT01565668|19054638|P2|Overall Study|Withdrawal by Subject|3
5511399|NCT01565668|19054639|P1|Overall Study|Withdrawal by Subject|1
5511400|NCT01565668|19054638|P2|Overall Study|Progressive disease|14
5511401|NCT01565668|19054639|P1|Overall Study|Progressive disease|13
5511402|NCT01565668|19054638|P2|Overall Study|Randomized, but never received drug|2
5511403|NCT01565668|19054639|P1|Overall Study|Randomized, but never received drug|0
5511404|NCT01565668|19054638|P2|Overall Study|Adverse Event|1
5511405|NCT01565668|19054639|P1|Overall Study|Adverse Event|6
5511406|NCT01565668|19054638|P2|Overall Study|Participant went on Hospice Care|0
5511407|NCT01565668|19054639|P1|Overall Study|Participant went on Hospice Care|1
5511408|NCT01565668|19054638|P2|Overall Study|Lack of Efficacy|2
5511409|NCT01565668|19054639|P1|Overall Study|Lack of Efficacy|4
5511410|NCT01565668|19054638|P2|Overall Study|Death|1
5511411|NCT01565668|19054639|P1|Overall Study|Death|2
5511412|NCT01565642|19054663|P2|Overall Study|Withdrawal by Subject|1
5511413|NCT01565642|19054664|P1|Overall Study|Withdrawal by Subject|2
5511414|NCT01565564|19054699|P2|Overall Study|Lost to Follow-up|1
5511415|NCT01565564|19054700|P1|Overall Study|Lost to Follow-up|5
5511416|NCT01565499|19054730|P1|Overall Study|Withdrawal by Subject|2
5511417|NCT01565499|19054730|P1|Overall Study|Adverse Event|5
5511418|NCT01565499|19054730|P1|Overall Study|Physician Decision|1
5511419|NCT01565343|19054764|P3|Overall Study|Administrative decision/technical issues|0
5511420|NCT01565343|19054765|P2|Overall Study|Administrative decision/technical issues|0
5511421|NCT01565343|19054766|P1|Overall Study|Administrative decision/technical issues|1
5511422|NCT01565291|19054796|P2|Overall Study|Withdrawal by Subject|0
5511423|NCT01565291|19054797|P1|Overall Study|Withdrawal by Subject|1
5511424|NCT01565148|19054809|P4|Overall Study|Physician Decision|0
5511425|NCT01565148|19054810|P3|Overall Study|Physician Decision|0
5511426|NCT01565148|19054811|P2|Overall Study|Physician Decision|5
5511427|NCT01565148|19054812|P1|Overall Study|Physician Decision|2
5511428|NCT01565148|19054809|P4|Overall Study|Death|0
5511429|NCT01565148|19054810|P3|Overall Study|Death|1
5511430|NCT01565148|19054811|P2|Overall Study|Death|0
5511431|NCT01565148|19054812|P1|Overall Study|Death|0
5511432|NCT01565148|19054809|P4|Overall Study|Rescue Therapy|8
5511433|NCT01565148|19054810|P3|Overall Study|Rescue Therapy|5
5511434|NCT01565148|19054811|P2|Overall Study|Rescue Therapy|5
5511435|NCT01565148|19054812|P1|Overall Study|Rescue Therapy|8
5511436|NCT01565148|19054809|P4|Overall Study|Lost to Follow-up|3
5511437|NCT01565148|19054810|P3|Overall Study|Lost to Follow-up|0
5511438|NCT01565148|19054811|P2|Overall Study|Lost to Follow-up|4
5511439|NCT01565148|19054812|P1|Overall Study|Lost to Follow-up|4
5511440|NCT01565148|19054809|P4|Overall Study|Withdrawal by Subject|2
5511441|NCT01565148|19054810|P3|Overall Study|Withdrawal by Subject|1
5511442|NCT01565148|19054811|P2|Overall Study|Withdrawal by Subject|1
5511443|NCT01565148|19054812|P1|Overall Study|Withdrawal by Subject|1
5511444|NCT01565083|19054848|P2|Overall Study|Other|5
5511445|NCT01565083|19054849|P1|Overall Study|Other|3
5511446|NCT01565083|19054848|P2|Overall Study|Death|23
5511447|NCT01565083|19054849|P1|Overall Study|Death|22
5511448|NCT01565083|19054848|P2|Overall Study|Lost to Follow-up|7
5511449|NCT01565083|19054849|P1|Overall Study|Lost to Follow-up|2
5511450|NCT01565083|19054848|P2|Overall Study|Withdrawal by Subject|4
5511451|NCT01565083|19054849|P1|Overall Study|Withdrawal by Subject|6
5511452|NCT01564862|19054900|P3|Overall Study|Other reason(s)|0
5511453|NCT01564862|19054901|P2|Overall Study|Other reason(s)|0
5511454|NCT01564862|19054902|P1|Overall Study|Other reason(s)|1
5511455|NCT01564862|19054900|P3|Overall Study|Lack of Efficacy|6
5511456|NCT01564862|19054901|P2|Overall Study|Lack of Efficacy|5
5511457|NCT01564862|19054902|P1|Overall Study|Lack of Efficacy|1
5511458|NCT01564862|19054900|P3|Overall Study|Voluntary Withdrawal|8
5511459|NCT01564862|19054901|P2|Overall Study|Voluntary Withdrawal|6
5511460|NCT01564862|19054902|P1|Overall Study|Voluntary Withdrawal|9
5511461|NCT01564862|19054900|P3|Overall Study|Lost to Follow-up|6
5511462|NCT01564862|19054901|P2|Overall Study|Lost to Follow-up|8
5511463|NCT01564862|19054902|P1|Overall Study|Lost to Follow-up|10
5511464|NCT01564862|19054900|P3|Overall Study|Major Protocol Deviation|4
5511465|NCT01564862|19054901|P2|Overall Study|Major Protocol Deviation|3
5511466|NCT01564862|19054902|P1|Overall Study|Major Protocol Deviation|3
5511467|NCT01564862|19054900|P3|Overall Study|Pretreatment Event or Adverse Event|6
5511468|NCT01564862|19054901|P2|Overall Study|Pretreatment Event or Adverse Event|12
5511469|NCT01564862|19054902|P1|Overall Study|Pretreatment Event or Adverse Event|6
5511470|NCT01564784|19054953|P2|Overall Study|Death|126
5511471|NCT01564784|19054954|P1|Overall Study|Death|131
5511472|NCT01564784|19054953|P2|Overall Study|Lost to Follow-up|1
5511473|NCT01564784|19054954|P1|Overall Study|Lost to Follow-up|1
5511474|NCT01564784|19054953|P2|Overall Study|Subject refused further follow-up|6
5511475|NCT01564784|19054954|P1|Overall Study|Subject refused further follow-up|1
5511476|NCT01564784|19054953|P2|Overall Study|Other|0
5511477|NCT01564784|19054954|P1|Overall Study|Other|1
5511478|NCT01564758|19054981|P1|Overall Study|Other|3
5511479|NCT01564758|19054981|P1|Overall Study|Adverse Event|3
5511480|NCT01564758|19054981|P1|Overall Study|Death|8
5511481|NCT01564732|19054988|P2|Overall Study|Early termination by the study sponsor|5
5511482|NCT01564732|19054989|P1|Overall Study|Early termination by the study sponsor|6
5511483|NCT01564537|19055030|P2|Overall Study|Other Miscellaneous Reasons|2
5511484|NCT01564537|19055031|P1|Overall Study|Other Miscellaneous Reasons|1
5511485|NCT01564537|19055030|P2|Overall Study|Lost to Follow-up|0
5511486|NCT01564537|19055031|P1|Overall Study|Lost to Follow-up|1
5511487|NCT01564537|19055030|P2|Overall Study|Withdrawal by Participant|4
5511488|NCT01564537|19055031|P1|Overall Study|Withdrawal by Participant|4
5511489|NCT01564459|19055054|P3|Double-blind Treatment|Adverse Event|1
5511490|NCT01564459|19055055|P2|Double-blind Treatment|Adverse Event|0
5511491|NCT01564459|19055056|P1|Double-blind Treatment|Adverse Event|0
5511492|NCT01564459|19055054|P3|Run-In|Withdrawal by Subject|0
5511493|NCT01564459|19055055|P2|Run-In|Withdrawal by Subject|0
5511494|NCT01564459|19055056|P1|Run-In|Withdrawal by Subject|1
5511495|NCT01564459|19055054|P3|Run-In|Protocol Violation|0
5511496|NCT01564459|19055055|P2|Run-In|Protocol Violation|0
5511497|NCT01564459|19055056|P1|Run-In|Protocol Violation|1
5511498|NCT01564459|19055054|P3|Run-In|Non-compliance with study drug|0
5511499|NCT01564459|19055055|P2|Run-In|Non-compliance with study drug|0
5511500|NCT01564459|19055056|P1|Run-In|Non-compliance with study drug|2
5511501|NCT01564459|19055054|P3|Run-In|Lost to Follow-up|0
5511502|NCT01564459|19055055|P2|Run-In|Lost to Follow-up|0
5511503|NCT01564459|19055056|P1|Run-In|Lost to Follow-up|1
5511504|NCT01564459|19055054|P3|Run-In|Adverse Event|0
5511505|NCT01564459|19055055|P2|Run-In|Adverse Event|0
5511506|NCT01564459|19055056|P1|Run-In|Adverse Event|7
5511507|NCT01564407|19055080|P5|Overall Study|funding lost, study ended|0
5511508|NCT01564407|19055081|P4|Overall Study|funding lost, study ended|1
5511509|NCT01564407|19055082|P3|Overall Study|funding lost, study ended|0
5511510|NCT01564407|19055083|P2|Overall Study|funding lost, study ended|0
5511511|NCT01564407|19055084|P1|Overall Study|funding lost, study ended|0
5511512|NCT01564407|19055080|P5|Overall Study|Withdrawal by Subject|0
5511513|NCT01564407|19055081|P4|Overall Study|Withdrawal by Subject|0
5511514|NCT01564407|19055082|P3|Overall Study|Withdrawal by Subject|0
5511515|NCT01564407|19055083|P2|Overall Study|Withdrawal by Subject|1
5511516|NCT01564407|19055084|P1|Overall Study|Withdrawal by Subject|0
5511517|NCT01564407|19055080|P5|Overall Study|Lost to Follow-up|0
5511518|NCT01564407|19055081|P4|Overall Study|Lost to Follow-up|0
5511519|NCT01564407|19055082|P3|Overall Study|Lost to Follow-up|0
5511520|NCT01564407|19055083|P2|Overall Study|Lost to Follow-up|1
5511521|NCT01564407|19055084|P1|Overall Study|Lost to Follow-up|0
5511522|NCT01564394|19055125|P2|Overall Study|Withdrawal by Subject|10
5511523|NCT01564394|19055126|P1|Overall Study|Withdrawal by Subject|6
5511524|NCT01564277|19055140|P2|Overall Study|Physician Decision|0
5511525|NCT01564277|19055141|P1|Overall Study|Physician Decision|1
5511526|NCT01564277|19055140|P2|Overall Study|Protocol Violation|1
5511527|NCT01564277|19055141|P1|Overall Study|Protocol Violation|0
5511528|NCT01563978|19055159|P2|Overall Study|Adverse Event|2
5511529|NCT01563978|19055160|P1|Overall Study|Adverse Event|1
5511530|NCT01563978|19055159|P2|Overall Study|Dev. of study specific discont. criteria|0
5511531|NCT01563978|19055160|P1|Overall Study|Dev. of study specific discont. criteria|1
5511532|NCT01563978|19055159|P2|Overall Study|Lost to Follow-up|0
5511533|NCT01563978|19055160|P1|Overall Study|Lost to Follow-up|1
5511534|NCT01563978|19055159|P2|Overall Study|Physician Decision|0
5511535|NCT01563978|19055160|P1|Overall Study|Physician Decision|1
5511536|NCT01563913|19055186|P2|Overall Study|Spouse Passed Away|0
5511537|NCT01563913|19055187|P1|Overall Study|Spouse Passed Away|1
5511538|NCT01563913|19055186|P2|Overall Study|Physician Decision|0
5511539|NCT01563913|19055187|P1|Overall Study|Physician Decision|1
5511540|NCT01563536|19055199|P2|Overall Study|Lost to Follow-up|0
5511541|NCT01563536|19055200|P1|Overall Study|Lost to Follow-up|1
5511542|NCT01563536|19055199|P2|Overall Study|Withdrawal by Subject|2
5511543|NCT01563536|19055200|P1|Overall Study|Withdrawal by Subject|0
5511544|NCT01563185|19055259|P1|Overall Study|Non-Compliance with study drug|1
5511545|NCT01563185|19055259|P1|Overall Study|Withdrawal by Subject|1
5511546|NCT01563172|19055273|P1|Overall Study|Other (Not specified)|1
5511547|NCT01563172|19055273|P1|Overall Study|Other (Protocol deviation)|5
5511548|NCT01563172|19055273|P1|Overall Study|Lost to Follow-up|2
5511549|NCT01563172|19055273|P1|Overall Study|Adverse Event|5
5511550|NCT01563029|19055379|P5|Overall Study|Withdrawal by Subject|3
5511551|NCT01563029|19055380|P4|Overall Study|Withdrawal by Subject|4
5511552|NCT01563029|19055381|P3|Overall Study|Withdrawal by Subject|3
5511553|NCT01563029|19055382|P2|Overall Study|Withdrawal by Subject|1
5511554|NCT01563029|19055383|P1|Overall Study|Withdrawal by Subject|4
5511555|NCT01563029|19055379|P5|Overall Study|Physician Decision|2
5511556|NCT01563029|19055380|P4|Overall Study|Physician Decision|4
5511557|NCT01563029|19055381|P3|Overall Study|Physician Decision|2
5511558|NCT01563029|19055382|P2|Overall Study|Physician Decision|5
5511559|NCT01563029|19055383|P1|Overall Study|Physician Decision|3
5511560|NCT01563029|19055379|P5|Overall Study|Lost to Follow-up|1
5511561|NCT01563029|19055380|P4|Overall Study|Lost to Follow-up|1
5511562|NCT01563029|19055381|P3|Overall Study|Lost to Follow-up|1
5511563|NCT01563029|19055382|P2|Overall Study|Lost to Follow-up|0
5511564|NCT01563029|19055383|P1|Overall Study|Lost to Follow-up|1
5511565|NCT01563029|19055379|P5|Overall Study|Protocol defined stopping criteria|0
5511566|NCT01563029|19055380|P4|Overall Study|Protocol defined stopping criteria|0
5511567|NCT01563029|19055381|P3|Overall Study|Protocol defined stopping criteria|0
5511568|NCT01563029|19055382|P2|Overall Study|Protocol defined stopping criteria|0
5511569|NCT01563029|19055383|P1|Overall Study|Protocol defined stopping criteria|1
5511570|NCT01563029|19055379|P5|Overall Study|Protocol Violation|3
5511571|NCT01563029|19055380|P4|Overall Study|Protocol Violation|1
5511572|NCT01563029|19055381|P3|Overall Study|Protocol Violation|3
5511573|NCT01563029|19055382|P2|Overall Study|Protocol Violation|2
5511574|NCT01563029|19055383|P1|Overall Study|Protocol Violation|1
5511575|NCT01563029|19055379|P5|Overall Study|Lack of Efficacy|19
5511576|NCT01563029|19055380|P4|Overall Study|Lack of Efficacy|21
5511577|NCT01563029|19055381|P3|Overall Study|Lack of Efficacy|23
5511578|NCT01563029|19055382|P2|Overall Study|Lack of Efficacy|16
5511579|NCT01563029|19055383|P1|Overall Study|Lack of Efficacy|42
5511580|NCT01563029|19055379|P5|Overall Study|Adverse Event|1
5511581|NCT01563029|19055380|P4|Overall Study|Adverse Event|2
5511582|NCT01563029|19055381|P3|Overall Study|Adverse Event|1
5511583|NCT01563029|19055382|P2|Overall Study|Adverse Event|0
5511584|NCT01563029|19055383|P1|Overall Study|Adverse Event|1
5511585|NCT01562873|19055449|P2|Overall Study|Clinical PD and adverse event|0
5511586|NCT01562873|19055450|P1|Overall Study|Clinical PD and adverse event|1
5511587|NCT01562873|19055449|P2|Overall Study|Clinical Disease Progression|0
5511588|NCT01562873|19055450|P1|Overall Study|Clinical Disease Progression|9
5511589|NCT01562873|19055449|P2|Overall Study|Adverse Event|0
5511590|NCT01562873|19055450|P1|Overall Study|Adverse Event|1
5511591|NCT01562873|19055449|P2|Overall Study|Disease Progression per RECIST|0
5511592|NCT01562873|19055450|P1|Overall Study|Disease Progression per RECIST|10
5511593|NCT01562782|19055459|P2|Overall Study|screen failure|2
5511594|NCT01562782|19055460|P1|Overall Study|screen failure|1
5511595|NCT01562782|19055459|P2|Overall Study|Withdrawal by Subject|3
5511596|NCT01562782|19055460|P1|Overall Study|Withdrawal by Subject|3
5511597|NCT01562743|19055489|P1|Overall Study|Physician Decision|2
5511598|NCT01562743|19055489|P1|Overall Study|Lost to Follow-up|2
5511599|NCT01562743|19055489|P1|Overall Study|Discontinuation criteria|2
5511600|NCT01562743|19055489|P1|Overall Study|Protocol Violation|1
5511601|NCT01562743|19055489|P1|Overall Study|Withdrawal by Subject|13
5511602|NCT01562743|19055489|P1|Overall Study|Lack of Efficacy|3
5511603|NCT01562743|19055489|P1|Overall Study|Adverse Event|29
5511604|NCT01562613|19055508|P1|Overall Study|Withdrawal by Subject|2
5511605|NCT01562613|19055508|P1|Overall Study|Lost to Follow-up|2
5511606|NCT01562548|19055518|P4|Overall Study|Lost to Follow-up|0
5511607|NCT01562548|19055519|P3|Overall Study|Lost to Follow-up|1
5511608|NCT01562548|19055520|P2|Overall Study|Lost to Follow-up|0
5511609|NCT01562548|19055521|P1|Overall Study|Lost to Follow-up|0
5511610|NCT01562444|19055574|P3|Overall Study|Protocol forbidden medication|0
5511611|NCT01562444|19055575|P2|Overall Study|Protocol forbidden medication|0
5511612|NCT01562444|19055576|P1|Overall Study|Protocol forbidden medication|1
5511613|NCT01562444|19055574|P3|Overall Study|Protocol forbidden concomitant vaccine|1
5511614|NCT01562444|19055575|P2|Overall Study|Protocol forbidden concomitant vaccine|0
5511615|NCT01562444|19055576|P1|Overall Study|Protocol forbidden concomitant vaccine|1
5511616|NCT01562444|19055574|P3|Overall Study|Unavailable serological results|2
5511617|NCT01562444|19055575|P2|Overall Study|Unavailable serological results|2
5511618|NCT01562444|19055576|P1|Overall Study|Unavailable serological results|0
5511619|NCT01562444|19055574|P3|Overall Study|Did not comply with blood draw schedule|1
5511620|NCT01562444|19055575|P2|Overall Study|Did not comply with blood draw schedule|0
5511621|NCT01562444|19055576|P1|Overall Study|Did not comply with blood draw schedule|1
5511622|NCT01562444|19055574|P3|Overall Study|Did not meet entry criteria|3
5511623|NCT01562444|19055575|P2|Overall Study|Did not meet entry criteria|0
5511624|NCT01562444|19055576|P1|Overall Study|Did not meet entry criteria|2
5511625|NCT01562327|19055842|P1|Overall Study|Infusion not received at 6 month window|4
5511626|NCT01562327|19055842|P1|Overall Study|Participant drop-out|1
5511627|NCT01562327|19055842|P1|Overall Study|Lack of Efficacy|1
5511628|NCT01562327|19055842|P1|Overall Study|Adverse Event|2
5511629|NCT01562314|19055872|P2|Overall Study|Withdrawal by Subject|1
5511630|NCT01562314|19055873|P1|Overall Study|Withdrawal by Subject|0
5511631|NCT01562314|19055872|P2|Overall Study|Met Withdrawal Criteria|2
5511632|NCT01562314|19055873|P1|Overall Study|Met Withdrawal Criteria|3
5511633|NCT01562314|19055872|P2|Overall Study|Adverse Event|5
5511634|NCT01562314|19055873|P1|Overall Study|Adverse Event|10
5511635|NCT01562275|19055930|P13|Stage 2|Progression of Disease|4
5511636|NCT01562275|19055931|P12|Stage 2|Progression of Disease|12
5511637|NCT01562275|19055932|P11|Stage 2|Progression of Disease|0
5511638|NCT01562275|19055933|P10|Stage 2|Progression of Disease|0
5511639|NCT01562275|19055934|P9|Stage 2|Progression of Disease|0
5511640|NCT01562275|19055935|P8|Stage 2|Progression of Disease|0
5511641|NCT01562275|19055936|P7|Stage 2|Progression of Disease|0
5511642|NCT01562275|19055937|P6|Stage 2|Progression of Disease|0
5511643|NCT01562275|19055938|P5|Stage 2|Progression of Disease|0
5511644|NCT01562275|19055939|P4|Stage 2|Progression of Disease|0
5511645|NCT01562275|19055940|P3|Stage 2|Progression of Disease|0
5511646|NCT01562275|19055941|P2|Stage 2|Progression of Disease|0
5511647|NCT01562275|19055942|P1|Stage 2|Progression of Disease|0
5511648|NCT01562275|19055930|P13|Stage 2|Death|1
5511649|NCT01562275|19055931|P12|Stage 2|Death|2
5511650|NCT01562275|19055932|P11|Stage 2|Death|0
5511651|NCT01562275|19055933|P10|Stage 2|Death|0
5511652|NCT01562275|19055934|P9|Stage 2|Death|0
5511653|NCT01562275|19055935|P8|Stage 2|Death|0
5511654|NCT01562275|19055936|P7|Stage 2|Death|0
5511655|NCT01562275|19055937|P6|Stage 2|Death|0
5511656|NCT01562275|19055938|P5|Stage 2|Death|0
5511657|NCT01562275|19055939|P4|Stage 2|Death|0
5511658|NCT01562275|19055940|P3|Stage 2|Death|0
5511659|NCT01562275|19055941|P2|Stage 2|Death|0
5511660|NCT01562275|19055942|P1|Stage 2|Death|0
5511661|NCT01562275|19055930|P13|Stage 1|Withdrawal by Subject|0
5511662|NCT01562275|19055931|P12|Stage 1|Withdrawal by Subject|0
5511663|NCT01562275|19055932|P11|Stage 1|Withdrawal by Subject|0
5511664|NCT01562275|19055933|P10|Stage 1|Withdrawal by Subject|1
5511665|NCT01562275|19055934|P9|Stage 1|Withdrawal by Subject|0
5511666|NCT01562275|19055935|P8|Stage 1|Withdrawal by Subject|0
5511667|NCT01562275|19055936|P7|Stage 1|Withdrawal by Subject|1
5511668|NCT01562275|19055937|P6|Stage 1|Withdrawal by Subject|0
5511669|NCT01562275|19055938|P5|Stage 1|Withdrawal by Subject|0
5511670|NCT01562275|19055939|P4|Stage 1|Withdrawal by Subject|2
5511671|NCT01562275|19055940|P3|Stage 1|Withdrawal by Subject|0
5511672|NCT01562275|19055941|P2|Stage 1|Withdrawal by Subject|1
5511673|NCT01562275|19055942|P1|Stage 1|Withdrawal by Subject|0
5511674|NCT01562275|19055930|P13|Stage 1|Progression of Disease|0
5511675|NCT01562275|19055931|P12|Stage 1|Progression of Disease|0
5511676|NCT01562275|19055932|P11|Stage 1|Progression of Disease|3
5511677|NCT01562275|19055933|P10|Stage 1|Progression of Disease|5
5511678|NCT01562275|19055934|P9|Stage 1|Progression of Disease|2
5511679|NCT01562275|19055935|P8|Stage 1|Progression of Disease|7
5511680|NCT01562275|19055936|P7|Stage 1|Progression of Disease|1
5511681|NCT01562275|19055937|P6|Stage 1|Progression of Disease|4
5511682|NCT01562275|19055938|P5|Stage 1|Progression of Disease|2
5511683|NCT01562275|19055939|P4|Stage 1|Progression of Disease|1
5511684|NCT01562275|19055940|P3|Stage 1|Progression of Disease|2
5511685|NCT01562275|19055941|P2|Stage 1|Progression of Disease|6
5511686|NCT01562275|19055942|P1|Stage 1|Progression of Disease|2
5511687|NCT01562275|19055930|P13|Stage 1|Physician Decision|0
5511688|NCT01562275|19055931|P12|Stage 1|Physician Decision|0
5511689|NCT01562275|19055932|P11|Stage 1|Physician Decision|0
5511690|NCT01562275|19055933|P10|Stage 1|Physician Decision|0
5511691|NCT01562275|19055934|P9|Stage 1|Physician Decision|1
5511692|NCT01562275|19055935|P8|Stage 1|Physician Decision|0
5511693|NCT01562275|19055936|P7|Stage 1|Physician Decision|1
5511694|NCT01562275|19055937|P6|Stage 1|Physician Decision|0
5511695|NCT01562275|19055938|P5|Stage 1|Physician Decision|1
5511696|NCT01562275|19055939|P4|Stage 1|Physician Decision|0
5511697|NCT01562275|19055940|P3|Stage 1|Physician Decision|0
5511698|NCT01562275|19055941|P2|Stage 1|Physician Decision|0
5511699|NCT01562275|19055942|P1|Stage 1|Physician Decision|0
5511700|NCT01562275|19055930|P13|Stage 1|Non Compliance|0
5511701|NCT01562275|19055931|P12|Stage 1|Non Compliance|0
5511702|NCT01562275|19055932|P11|Stage 1|Non Compliance|0
5511703|NCT01562275|19055933|P10|Stage 1|Non Compliance|0
5511704|NCT01562275|19055934|P9|Stage 1|Non Compliance|0
5511705|NCT01562275|19055935|P8|Stage 1|Non Compliance|0
5511706|NCT01562275|19055936|P7|Stage 1|Non Compliance|0
5511707|NCT01562275|19055937|P6|Stage 1|Non Compliance|0
5511708|NCT01562275|19055938|P5|Stage 1|Non Compliance|0
5511709|NCT01562275|19055939|P4|Stage 1|Non Compliance|0
5511710|NCT01562275|19055940|P3|Stage 1|Non Compliance|1
5511711|NCT01562275|19055941|P2|Stage 1|Non Compliance|0
5511712|NCT01562275|19055942|P1|Stage 1|Non Compliance|0
5511713|NCT01562275|19055930|P13|Stage 1|Death|0
5511714|NCT01562275|19055931|P12|Stage 1|Death|0
5511715|NCT01562275|19055932|P11|Stage 1|Death|0
5511716|NCT01562275|19055933|P10|Stage 1|Death|0
5511717|NCT01562275|19055934|P9|Stage 1|Death|0
5511718|NCT01562275|19055935|P8|Stage 1|Death|0
5511719|NCT01562275|19055936|P7|Stage 1|Death|0
5511720|NCT01562275|19055937|P6|Stage 1|Death|0
5511721|NCT01562275|19055938|P5|Stage 1|Death|0
5511722|NCT01562275|19055939|P4|Stage 1|Death|0
5511723|NCT01562275|19055940|P3|Stage 1|Death|0
5511724|NCT01562275|19055941|P2|Stage 1|Death|0
5511725|NCT01562275|19055942|P1|Stage 1|Death|1
5511726|NCT01562275|19055930|P13|Stage 1|Adverse Event|0
5511727|NCT01562275|19055931|P12|Stage 1|Adverse Event|0
5511728|NCT01562275|19055932|P11|Stage 1|Adverse Event|0
5511729|NCT01562275|19055933|P10|Stage 1|Adverse Event|1
5511730|NCT01562275|19055934|P9|Stage 1|Adverse Event|0
5511731|NCT01562275|19055935|P8|Stage 1|Adverse Event|0
5511732|NCT01562275|19055936|P7|Stage 1|Adverse Event|0
5511733|NCT01562275|19055937|P6|Stage 1|Adverse Event|0
5511734|NCT01562275|19055938|P5|Stage 1|Adverse Event|1
5511735|NCT01562275|19055939|P4|Stage 1|Adverse Event|1
5511736|NCT01562275|19055940|P3|Stage 1|Adverse Event|0
5511737|NCT01562275|19055941|P2|Stage 1|Adverse Event|0
5511738|NCT01562275|19055942|P1|Stage 1|Adverse Event|0
5511739|NCT01562028|19056083|P2|Overall Study|Lost to Follow-up|1
5511740|NCT01562028|19056084|P1|Overall Study|Lost to Follow-up|2
5511741|NCT01562028|19056083|P2|Overall Study|Withdrawal by Subject|1
5511742|NCT01562028|19056084|P1|Overall Study|Withdrawal by Subject|1
5511743|NCT01561989|19056104|P2|Overall Study|accural target not met.|6
5511744|NCT01561989|19056105|P1|Overall Study|accural target not met.|5
5511745|NCT01561976|19056127|P6|Washout Period 2 (7 Days)|Non-compliance|0
5511746|NCT01561976|19056128|P5|Washout Period 2 (7 Days)|Non-compliance|0
5511747|NCT01561976|19056129|P4|Washout Period 2 (7 Days)|Non-compliance|0
5511748|NCT01561976|19056130|P3|Washout Period 2 (7 Days)|Non-compliance|1
5511749|NCT01561976|19056131|P2|Washout Period 2 (7 Days)|Non-compliance|0
5511750|NCT01561976|19056132|P1|Washout Period 2 (7 Days)|Non-compliance|1
5511751|NCT01561976|19056127|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5511752|NCT01561976|19056128|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5511753|NCT01561976|19056129|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5511754|NCT01561976|19056130|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5511755|NCT01561976|19056131|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5511756|NCT01561976|19056132|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5511757|NCT01561976|19056127|P6|Washout Period 1 (7 Days)|Adverse Event|0
5511758|NCT01561976|19056128|P5|Washout Period 1 (7 Days)|Adverse Event|0
5511759|NCT01561976|19056129|P4|Washout Period 1 (7 Days)|Adverse Event|1
5511760|NCT01561976|19056130|P3|Washout Period 1 (7 Days)|Adverse Event|0
5511761|NCT01561976|19056131|P2|Washout Period 1 (7 Days)|Adverse Event|0
5511762|NCT01561976|19056132|P1|Washout Period 1 (7 Days)|Adverse Event|0
5511763|NCT01561976|19056127|P6|Period 1|Adverse Event|0
5511764|NCT01561976|19056128|P5|Period 1|Adverse Event|0
5511765|NCT01561976|19056129|P4|Period 1|Adverse Event|0
5511766|NCT01561976|19056130|P3|Period 1|Adverse Event|1
5511767|NCT01561976|19056131|P2|Period 1|Adverse Event|0
5511768|NCT01561976|19056132|P1|Period 1|Adverse Event|0
5511769|NCT01561898|19056165|P4|Overall Study|Physician Decision|1
5511770|NCT01561898|19056166|P3|Overall Study|Physician Decision|7
5511771|NCT01561898|19056167|P2|Overall Study|Physician Decision|5
5511772|NCT01561898|19056168|P1|Overall Study|Physician Decision|1
5511773|NCT01561898|19056165|P4|Overall Study|Adverse Event|9
5511774|NCT01561898|19056166|P3|Overall Study|Adverse Event|14
5511775|NCT01561898|19056167|P2|Overall Study|Adverse Event|19
5511776|NCT01561898|19056168|P1|Overall Study|Adverse Event|1
5511777|NCT01561898|19056165|P4|Overall Study|Lost to Follow-up|0
5511778|NCT01561898|19056166|P3|Overall Study|Lost to Follow-up|1
5511779|NCT01561898|19056167|P2|Overall Study|Lost to Follow-up|0
5511780|NCT01561898|19056168|P1|Overall Study|Lost to Follow-up|0
5511781|NCT01561898|19056165|P4|Overall Study|Worsening of complications|0
5511782|NCT01561898|19056166|P3|Overall Study|Worsening of complications|0
5511783|NCT01561898|19056167|P2|Overall Study|Worsening of complications|1
5511784|NCT01561898|19056168|P1|Overall Study|Worsening of complications|0
5511785|NCT01561898|19056165|P4|Overall Study|Lack of Efficacy|5
5511786|NCT01561898|19056166|P3|Overall Study|Lack of Efficacy|10
5511787|NCT01561898|19056167|P2|Overall Study|Lack of Efficacy|8
5511788|NCT01561898|19056168|P1|Overall Study|Lack of Efficacy|0
5511789|NCT01561898|19056165|P4|Overall Study|Withdrawal by Subject|5
5511790|NCT01561898|19056166|P3|Overall Study|Withdrawal by Subject|12
5511791|NCT01561898|19056167|P2|Overall Study|Withdrawal by Subject|8
5511792|NCT01561898|19056168|P1|Overall Study|Withdrawal by Subject|0
5511793|NCT01561755|19056186|P2|Overall Study|Lost to Follow-up|1
5511794|NCT01561755|19056187|P1|Overall Study|Lost to Follow-up|0
5511795|NCT01561560|19056239|P2|Second Two Weeks of Wear|Adverse Event|1
5511796|NCT01561560|19056240|P1|Second Two Weeks of Wear|Adverse Event|0
5511797|NCT01561560|19056239|P2|First Two Weeks of Wear|Adverse Event|1
5511798|NCT01561560|19056240|P1|First Two Weeks of Wear|Adverse Event|0
5511799|NCT01561560|19056239|P2|First Two Weeks of Wear|Time/job conflict|1
5511800|NCT01561560|19056240|P1|First Two Weeks of Wear|Time/job conflict|0
5511801|NCT01561430|19056275|P4|Overall Study|Sponsor Decision|12
5511802|NCT01561430|19056276|P3|Overall Study|Sponsor Decision|13
5511803|NCT01561430|19056277|P2|Overall Study|Sponsor Decision|14
5511804|NCT01561430|19056278|P1|Overall Study|Sponsor Decision|1
5511805|NCT01561430|19056275|P4|Overall Study|Physician Decision|0
5511806|NCT01561430|19056276|P3|Overall Study|Physician Decision|0
5511807|NCT01561430|19056277|P2|Overall Study|Physician Decision|1
5511808|NCT01561430|19056278|P1|Overall Study|Physician Decision|0
5511809|NCT01561430|19056275|P4|Overall Study|Withdrawal by Subject|0
5511810|NCT01561430|19056276|P3|Overall Study|Withdrawal by Subject|1
5511811|NCT01561430|19056277|P2|Overall Study|Withdrawal by Subject|0
5511812|NCT01561430|19056278|P1|Overall Study|Withdrawal by Subject|0
5511813|NCT01561430|19056275|P4|Overall Study|Adverse Event|1
5511814|NCT01561430|19056276|P3|Overall Study|Adverse Event|3
5511815|NCT01561430|19056277|P2|Overall Study|Adverse Event|0
5511816|NCT01561430|19056278|P1|Overall Study|Adverse Event|0
5511817|NCT01561313|19056341|P2|Overall Study|Adverse event and withdrawal by subject|0
5511818|NCT01561313|19056342|P1|Overall Study|Adverse event and withdrawal by subject|1
5511819|NCT01561313|19056341|P2|Overall Study|Withdrawal by Subject|0
5511820|NCT01561313|19056342|P1|Overall Study|Withdrawal by Subject|1
5511821|NCT01561300|19056360|P2|Run in on Placebo|Adverse Event|0
5511822|NCT01561300|19056361|P1|Run in on Placebo|Adverse Event|1
5511823|NCT01561079|19056372|P1|Overall Study|Protocol Violation|2
5511824|NCT01561079|19056372|P1|Overall Study|Withdrawal by Subject|59
5511825|NCT01561079|19056372|P1|Overall Study|Physician Decision|17
5511826|NCT01560988|19056458|P2|Washout (Six Weeks)|Lost to Follow-up|2
5511827|NCT01560988|19056459|P1|Washout (Six Weeks)|Lost to Follow-up|2
5511828|NCT01560988|19056458|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
5511829|NCT01560988|19056459|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
5511830|NCT01560988|19056458|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
5511831|NCT01560988|19056459|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
5511832|NCT01560949|19056495|P1|Surgery Phase|Physician Decision|3
5511833|NCT01560949|19056495|P1|Systemic Phase: mFOLFIRINOX|Adverse Event|6
5511834|NCT01560871|19056529|P2|Overall Study|Lost to Follow-up|0
5511835|NCT01560871|19056530|P1|Overall Study|Lost to Follow-up|1
5511836|NCT01560871|19056529|P2|Overall Study|readmission to a hospital|1
5511837|NCT01560871|19056530|P1|Overall Study|readmission to a hospital|2
5511838|NCT01560871|19056529|P2|Overall Study|relocation|0
5511839|NCT01560871|19056530|P1|Overall Study|relocation|1
5511840|NCT01560871|19056529|P2|Overall Study|transportation issues|1
5511841|NCT01560871|19056530|P1|Overall Study|transportation issues|2
5511842|NCT01560819|19056546|P2|Overall Study|Physician Decision|0
5511843|NCT01560819|19056547|P1|Overall Study|Physician Decision|1
5511844|NCT01560780|19056553|P2|Overall Study|Patient Preference|11
5511845|NCT01560780|19056554|P1|Overall Study|Patient Preference|11
5511846|NCT01560780|19056553|P2|Overall Study|Death|1
5511847|NCT01560780|19056554|P1|Overall Study|Death|2
5511848|NCT01560507|19056590|P3|Overall Study|Withdrawal by Subject|0
5511849|NCT01560507|19056591|P2|Overall Study|Withdrawal by Subject|1
5511850|NCT01560507|19056592|P1|Overall Study|Withdrawal by Subject|1
5511851|NCT01560507|19056590|P3|Overall Study|Lost to Follow-up|2
5511852|NCT01560507|19056591|P2|Overall Study|Lost to Follow-up|1
5511853|NCT01560507|19056592|P1|Overall Study|Lost to Follow-up|3
5511854|NCT01560429|19056605|P2|Overall Study|Protocol Violation|6
5511855|NCT01560429|19056606|P1|Overall Study|Protocol Violation|3
5511856|NCT01560416|19056616|P2|Randomized Phase|Crossover Participants|0
5511857|NCT01560416|19056617|P1|Randomized Phase|Crossover Participants|7
5511858|NCT01560403|19056635|P2|Overall Study|Lost to Follow-up|1
5511859|NCT01560403|19056636|P1|Overall Study|Lost to Follow-up|0
5511860|NCT01560234|19056684|P8|Overall Study|Lost to Follow-up|2
5511861|NCT01560234|19056685|P7|Overall Study|Lost to Follow-up|0
5511862|NCT01560234|19056686|P6|Overall Study|Lost to Follow-up|2
5511863|NCT01560234|19056687|P5|Overall Study|Lost to Follow-up|0
5511864|NCT01560234|19056688|P4|Overall Study|Lost to Follow-up|0
5511865|NCT01560234|19056689|P3|Overall Study|Lost to Follow-up|1
5511866|NCT01560234|19056690|P2|Overall Study|Lost to Follow-up|0
5511867|NCT01560234|19056691|P1|Overall Study|Lost to Follow-up|3
5511868|NCT01559935|19056786|P1|Maintenance Phase|Non-compliance|2
5511869|NCT01559935|19056786|P1|Maintenance Phase|Withdrawal by Subject|5
5511870|NCT01559935|19056786|P1|Maintenance Phase|Lack of Efficacy|18
5511871|NCT01559935|19056786|P1|Maintenance Phase|Toxicity|1
5511872|NCT01559935|19056786|P1|Maintenance Phase|Remains on study|28
5511873|NCT01559935|19056786|P1|BiRD Phase|Withdrawal by Subject|2
5511874|NCT01559935|19056786|P1|BiRD Phase|Lack of Efficacy|1
5511875|NCT01559935|19056786|P1|BiRD Phase|Toxicity|1
5511876|NCT01559935|19056786|P1|Car Phase|non-compliance|1
5511877|NCT01559935|19056786|P1|Car Phase|Insurance|1
5511878|NCT01559935|19056786|P1|Car Phase|Per protocol|1
5511879|NCT01559935|19056786|P1|Car Phase|Withdrawal by Subject|2
5511880|NCT01559935|19056786|P1|Car Phase|Physician Decision|1
5511881|NCT01559935|19056786|P1|Car Phase|Lost to Follow-up|1
5511882|NCT01559935|19056786|P1|Car Phase|Lack of Efficacy|2
5511883|NCT01559935|19056786|P1|Car Phase|Death|1
5511884|NCT01559935|19056786|P1|Car Phase|Toxicity|4
5511885|NCT01559844|19056822|P1|Overall Study|No Longer A Transplant Candidate|3
5511886|NCT01559844|19056822|P1|Overall Study|Efficacy Failure|10
5511887|NCT01559844|19056822|P1|Overall Study|Death|5
5511888|NCT01559844|19056822|P1|Overall Study|Consent Withdrawn|7
5511889|NCT01559675|19056835|P2|Overall Study|2nd operation on same patient excluded|12
5511890|NCT01559675|19056836|P1|Overall Study|2nd operation on same patient excluded|14
5511891|NCT01559675|19056835|P2|Overall Study|Protocol Violation|2
5511892|NCT01559675|19056836|P1|Overall Study|Protocol Violation|1
5511893|NCT01559454|19056867|P2|Overall Study|Lack of Efficacy|1
5511894|NCT01559454|19056868|P1|Overall Study|Lack of Efficacy|0
5511895|NCT01559454|19056867|P2|Overall Study|Protocol Violation|1
5511896|NCT01559454|19056868|P1|Overall Study|Protocol Violation|0
5511897|NCT01559454|19056867|P2|Overall Study|Physician Decision|1
5511898|NCT01559454|19056868|P1|Overall Study|Physician Decision|0
5511899|NCT01559454|19056867|P2|Overall Study|Withdrawal by Subject|1
5511900|NCT01559454|19056868|P1|Overall Study|Withdrawal by Subject|0
5511901|NCT01559454|19056867|P2|Overall Study|Lost to Follow-up|2
5511902|NCT01559454|19056868|P1|Overall Study|Lost to Follow-up|3
5511903|NCT01559389|19056886|P2|Overall Study|Withdrawal by Subject|20
5511904|NCT01559389|19056887|P1|Overall Study|Withdrawal by Subject|20
5511905|NCT01559311|19056900|P3|Overall Study|Adverse Event|1
5511906|NCT01559311|19056901|P2|Overall Study|Adverse Event|0
5511907|NCT01559311|19056902|P1|Overall Study|Adverse Event|0
5511908|NCT01559311|19056900|P3|Overall Study|Lost to Follow-up|2
5511909|NCT01559311|19056901|P2|Overall Study|Lost to Follow-up|3
5511910|NCT01559311|19056902|P1|Overall Study|Lost to Follow-up|0
5511911|NCT01559311|19056900|P3|Overall Study|Death|3
5511912|NCT01559311|19056901|P2|Overall Study|Death|2
5511913|NCT01559311|19056902|P1|Overall Study|Death|0
5511914|NCT01559311|19056900|P3|Overall Study|Withdrawal by Subject|0
5511915|NCT01559311|19056901|P2|Overall Study|Withdrawal by Subject|1
5511916|NCT01559311|19056902|P1|Overall Study|Withdrawal by Subject|2
5511917|NCT01559311|19056900|P3|Overall Study|Difficulty in cannulating the lateral ve|0
5511918|NCT01559311|19056901|P2|Overall Study|Difficulty in cannulating the lateral ve|0
5511919|NCT01559311|19056902|P1|Overall Study|Difficulty in cannulating the lateral ve|1
5511920|NCT01559311|19056900|P3|Overall Study|Protocol Violation|2
5511921|NCT01559311|19056901|P2|Overall Study|Protocol Violation|0
5511922|NCT01559311|19056902|P1|Overall Study|Protocol Violation|0
5511923|NCT01559259|19056918|P5|Overall Study|Adverse Event|0
5511924|NCT01559259|19056919|P4|Overall Study|Adverse Event|0
5511925|NCT01559259|19056920|P3|Overall Study|Adverse Event|1
5511926|NCT01559259|19056921|P2|Overall Study|Adverse Event|1
5511927|NCT01559259|19056922|P1|Overall Study|Adverse Event|0
5511928|NCT01559259|19056918|P5|Overall Study|Withdrawal by Subject|0
5511929|NCT01559259|19056919|P4|Overall Study|Withdrawal by Subject|1
5511930|NCT01559259|19056920|P3|Overall Study|Withdrawal by Subject|0
5511931|NCT01559259|19056921|P2|Overall Study|Withdrawal by Subject|0
5511932|NCT01559259|19056922|P1|Overall Study|Withdrawal by Subject|0
5511933|NCT01559129|19057011|P2|Open-label Extension Period|Study Terminated by Sponsor|2
5511934|NCT01559129|19057012|P1|Open-label Extension Period|Study Terminated by Sponsor|5
5511935|NCT01559129|19057011|P2|Open-label Extension Period|Adverse Event|0
5511936|NCT01559129|19057012|P1|Open-label Extension Period|Adverse Event|1
5511937|NCT01559129|19057011|P2|Treatment Phase|Did Not Receive Study Drug|1
5511938|NCT01559129|19057012|P1|Treatment Phase|Did Not Receive Study Drug|0
5511939|NCT01559129|19057011|P2|Treatment Phase|Protocol Exclusion Criteria|0
5511940|NCT01559129|19057012|P1|Treatment Phase|Protocol Exclusion Criteria|1
5511941|NCT01559129|19057011|P2|Treatment Phase|Study Terminated by Sponsor|2
5511942|NCT01559129|19057012|P1|Treatment Phase|Study Terminated by Sponsor|3
5511943|NCT01559129|19057011|P2|Treatment Phase|Lack of Efficacy|1
5511944|NCT01559129|19057012|P1|Treatment Phase|Lack of Efficacy|0
5511945|NCT01559129|19057011|P2|Treatment Phase|Progressive Disease|1
5511946|NCT01559129|19057012|P1|Treatment Phase|Progressive Disease|1
5511947|NCT01559129|19057011|P2|Treatment Phase|Adverse Event|2
5511948|NCT01559129|19057012|P1|Treatment Phase|Adverse Event|0
5511949|NCT01559116|19057088|P1|Overall Study|other than stated above|9
5511950|NCT01559116|19057088|P1|Overall Study|Withdrawal by Subject|4
5511951|NCT01559116|19057088|P1|Overall Study|Protocol Violation|1
5511952|NCT01559116|19057088|P1|Overall Study|Lost to Follow-up|1
5511953|NCT01559116|19057088|P1|Overall Study|Lack of Efficacy|1
5511954|NCT01559116|19057088|P1|Overall Study|Adverse Event|10
5511955|NCT01559090|19057159|P3|Stage II|Withdrawal by Subject|0
5511956|NCT01559090|19057160|P2|Stage II|Withdrawal by Subject|0
5511957|NCT01559090|19057161|P1|Stage II|Withdrawal by Subject|1
5511958|NCT01559090|19057159|P3|Stage I|Withdrawal by Subject|3
5511959|NCT01559090|19057160|P2|Stage I|Withdrawal by Subject|2
5511960|NCT01559090|19057161|P1|Stage I|Withdrawal by Subject|2
5511961|NCT01559012|19057193|P2|Overall Study|Withdrawal by Subject|1
5511962|NCT01559012|19057194|P1|Overall Study|Withdrawal by Subject|0
5511963|NCT01558752|19057234|P2|Overall Study|Physician Decision|0
5511964|NCT01558752|19057235|P1|Overall Study|Physician Decision|2
5511965|NCT01558739|19057241|P1|Overall Study|Protocol Violation|1
5511966|NCT01558739|19057241|P1|Overall Study|Disease Progression|4
5511967|NCT01558739|19057241|P1|Overall Study|Death|3
5511968|NCT01558739|19057241|P1|Overall Study|Withdrawal by Subject|2
5511969|NCT01558739|19057241|P1|Overall Study|Adverse Event|7
5511970|NCT01558674|19057266|P2|Part 1|Withdrawal by Subject|0
5511971|NCT01558674|19057267|P1|Part 1|Withdrawal by Subject|1
5511972|NCT01558674|19057266|P2|Part 1|Study Terminated by Sponsor|0
5511973|NCT01558674|19057267|P1|Part 1|Study Terminated by Sponsor|10
5511974|NCT01558635|19057318|P1|Overall Study|Reveal XT was explanted|1
5511975|NCT01558635|19057318|P1|Overall Study|Subject received other treatment|1
5511976|NCT01558635|19057318|P1|Overall Study|Physician Decision|1
5511977|NCT01558635|19057318|P1|Overall Study|Withdrawal by Subject|2
5511978|NCT01558635|19057318|P1|Overall Study|Death|1
5511979|NCT01558596|19057335|P2|Overall Study|Protocol Violation|0
5511980|NCT01558596|19057336|P1|Overall Study|Protocol Violation|1
5511981|NCT01558596|19057335|P2|Overall Study|surgery elsewhere or cancelled|1
5511982|NCT01558596|19057336|P1|Overall Study|surgery elsewhere or cancelled|1
5511983|NCT01558596|19057335|P2|Overall Study|Withdrawal by Subject|0
5511984|NCT01558596|19057336|P1|Overall Study|Withdrawal by Subject|1
5511985|NCT01558297|19057351|P3|Overall Study|Withdrawal by Subject|1
5511986|NCT01558297|19057352|P2|Overall Study|Withdrawal by Subject|2
5511987|NCT01558297|19057353|P1|Overall Study|Withdrawal by Subject|2
5511988|NCT01558271|19057370|P3|Overall Study|Physician Decision|1
5511989|NCT01558271|19057371|P2|Overall Study|Physician Decision|2
5511990|NCT01558271|19057372|P1|Overall Study|Physician Decision|0
5511991|NCT01558271|19057370|P3|Overall Study|Withdrawal by Subject|12
5511992|NCT01558271|19057371|P2|Overall Study|Withdrawal by Subject|6
5511993|NCT01558271|19057372|P1|Overall Study|Withdrawal by Subject|10
5511994|NCT01558271|19057370|P3|Overall Study|Protocol Violation|0
5511995|NCT01558271|19057371|P2|Overall Study|Protocol Violation|0
5511996|NCT01558271|19057372|P1|Overall Study|Protocol Violation|1
5511997|NCT01558271|19057370|P3|Overall Study|Lost to Follow-up|0
5511998|NCT01558271|19057371|P2|Overall Study|Lost to Follow-up|0
5511999|NCT01558271|19057372|P1|Overall Study|Lost to Follow-up|1
5512000|NCT01558271|19057370|P3|Overall Study|Adverse Event|4
5512001|NCT01558271|19057371|P2|Overall Study|Adverse Event|3
5512002|NCT01558271|19057372|P1|Overall Study|Adverse Event|6
5512003|NCT01558089|19057438|P1|Overall Study|Withdrawal by Subject|6
5512004|NCT01558089|19057438|P1|Overall Study|Lost to Follow-up|5
5512005|NCT01558089|19057438|P1|Overall Study|Lack of Efficacy|1
5512006|NCT01558089|19057438|P1|Overall Study|Adverse Event|1
5512007|NCT01557946|19057491|P2|Overall Study|Adverse Event|0
5512008|NCT01557946|19057492|P1|Overall Study|Adverse Event|3
5512009|NCT01557920|19057498|P2|Overall Study|Lack of Efficacy|0
5512010|NCT01557920|19057499|P1|Overall Study|Lack of Efficacy|1
5512011|NCT01557920|19057498|P2|Overall Study|Withdrawal by Subject|3
5512012|NCT01557920|19057499|P1|Overall Study|Withdrawal by Subject|2
5512013|NCT01557842|19057568|P2|Overall Study|Not Ablated|0
5512014|NCT01557842|19057569|P1|Overall Study|Not Ablated|2
5512015|NCT01557842|19057568|P2|Overall Study|Study Terminated by Sponsor|4
5512016|NCT01557842|19057569|P1|Overall Study|Study Terminated by Sponsor|3
5512017|NCT01557842|19057568|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
5512018|NCT01557842|19057569|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
5512019|NCT01557842|19057568|P2|Overall Study|Lack of Efficacy|1
5512020|NCT01557842|19057569|P1|Overall Study|Lack of Efficacy|0
5512021|NCT01557842|19057568|P2|Overall Study|Death|0
5512022|NCT01557842|19057569|P1|Overall Study|Death|1
5512023|NCT01557842|19057568|P2|Overall Study|Lost to Follow-up|1
5512024|NCT01557842|19057569|P1|Overall Study|Lost to Follow-up|0
5512025|NCT01557751|19057581|P1|Overall Study|Physician Decision|3
5512026|NCT01557582|19057626|P1|Overall Study|Operator error|2
5512027|NCT01557582|19057626|P1|Overall Study|Protocol Violation|4
5512028|NCT01557569|19057634|P2|Overall Study|noncompliance with rules of residential|1
5512029|NCT01557569|19057635|P1|Overall Study|noncompliance with rules of residential|0
5512030|NCT01557569|19057634|P2|Overall Study|Withdrawal by Subject|5
5512031|NCT01557569|19057635|P1|Overall Study|Withdrawal by Subject|3
5512032|NCT01557569|19057634|P2|Overall Study|high blood pressure|1
5512033|NCT01557569|19057635|P1|Overall Study|high blood pressure|0
5512034|NCT01557569|19057634|P2|Overall Study|Adverse Event|0
5512035|NCT01557569|19057635|P1|Overall Study|Adverse Event|2
5512036|NCT01557517|19057643|P2|Overall Study|Pt declined before treatment started|0
5512037|NCT01557517|19057644|P1|Overall Study|Pt declined before treatment started|1
5512038|NCT01557517|19057643|P2|Overall Study|Adverse Event|2
5512039|NCT01557517|19057644|P1|Overall Study|Adverse Event|0
5512040|NCT01557517|19057643|P2|Overall Study|Refused further treatment|2
5512041|NCT01557517|19057644|P1|Overall Study|Refused further treatment|0
5512042|NCT01557517|19057643|P2|Overall Study|Death|0
5512043|NCT01557517|19057644|P1|Overall Study|Death|1
5512044|NCT01557504|19057670|P2|Overall Study|Physician Decision|0
5512045|NCT01557504|19057671|P1|Overall Study|Physician Decision|1
5512046|NCT01557400|19057694|P1|Overall Study|Withdrawal by Subject|9
5512047|NCT01557400|19057694|P1|Overall Study|Lost to Follow-up|5
5512048|NCT01557400|19057694|P1|Overall Study|Adverse Event|3
5512049|NCT01557400|19057694|P1|Overall Study|Transitioned to Commercial Drug Product|40
5512050|NCT01557348|19057706|P2|Overall Study|Administrative|11
5512051|NCT01557348|19057707|P1|Overall Study|Administrative|18
5512052|NCT01557348|19057706|P2|Overall Study|Lost to Follow-up|22
5512053|NCT01557348|19057707|P1|Overall Study|Lost to Follow-up|26
5512054|NCT01557348|19057706|P2|Overall Study|Withdrawal by Subject|4
5512055|NCT01557348|19057707|P1|Overall Study|Withdrawal by Subject|5
5512056|NCT01557348|19057706|P2|Overall Study|Insufficient Therapeutic Response|28
5512057|NCT01557348|19057707|P1|Overall Study|Insufficient Therapeutic Response|13
5512058|NCT01557348|19057706|P2|Overall Study|Death|4
5512059|NCT01557348|19057707|P1|Overall Study|Death|7
5512060|NCT01557348|19057706|P2|Overall Study|Infusion reaction event|5
5512061|NCT01557348|19057707|P1|Overall Study|Infusion reaction event|5
5512062|NCT01557348|19057706|P2|Overall Study|Adverse Event|16
5512063|NCT01557348|19057707|P1|Overall Study|Adverse Event|6
5512064|NCT01557283|19057824|P1|Overall Study|Other|6
5512065|NCT01557283|19057824|P1|Overall Study|Worsening of psoriasis|1
5512066|NCT01557283|19057824|P1|Overall Study|Participant's weight too high for dose|1
5512067|NCT01557283|19057824|P1|Overall Study|Withdrawal by Subject|1
5512068|NCT01557283|19057824|P1|Overall Study|Non-compliance|1
5512069|NCT01557283|19057824|P1|Overall Study|Lack of Efficacy|1
5512070|NCT01557283|19057824|P1|Overall Study|Adverse Event|7
5512071|NCT01557283|19057824|P1|Overall Study|Non-responder|19
5512072|NCT01557283|19057824|P1|Overall Study|Lost to Follow-up|7
5512073|NCT01557166|19057836|P2|Overall Study|Unclassified|5
5512074|NCT01557166|19057837|P1|Overall Study|Unclassified|2
5512075|NCT01557166|19057836|P2|Overall Study|Psychiatric disorder|0
5512076|NCT01557166|19057837|P1|Overall Study|Psychiatric disorder|1
5512077|NCT01557166|19057836|P2|Overall Study|Target dose not tolerated|0
5512078|NCT01557166|19057837|P1|Overall Study|Target dose not tolerated|1
5512079|NCT01557166|19057836|P2|Overall Study|Withdrawn consent|20
5512080|NCT01557166|19057837|P1|Overall Study|Withdrawn consent|12
5512081|NCT01557166|19057836|P2|Overall Study|Protocol Violation|5
5512082|NCT01557166|19057837|P1|Overall Study|Protocol Violation|8
5512083|NCT01557166|19057836|P2|Overall Study|Lack of Efficacy|1
5512084|NCT01557166|19057837|P1|Overall Study|Lack of Efficacy|2
5512085|NCT01557166|19057836|P2|Overall Study|Adverse Event|6
5512086|NCT01557166|19057837|P1|Overall Study|Adverse Event|20
5512087|NCT01556997|19057852|P3|Overall Study|Other|7
5512088|NCT01556997|19057853|P2|Overall Study|Other|3
5512089|NCT01556997|19057854|P1|Overall Study|Other|2
5512090|NCT01556997|19057852|P3|Overall Study|Withdrawal by Subject|8
5512091|NCT01556997|19057853|P2|Overall Study|Withdrawal by Subject|6
5512092|NCT01556997|19057854|P1|Overall Study|Withdrawal by Subject|7
5512093|NCT01556997|19057852|P3|Overall Study|Physician Decision|1
5512094|NCT01556997|19057853|P2|Overall Study|Physician Decision|1
5512095|NCT01556997|19057854|P1|Overall Study|Physician Decision|1
5512096|NCT01556997|19057852|P3|Overall Study|Lost to Follow-up|4
5512097|NCT01556997|19057853|P2|Overall Study|Lost to Follow-up|6
5512098|NCT01556997|19057854|P1|Overall Study|Lost to Follow-up|6
5512099|NCT01556997|19057852|P3|Overall Study|Adverse Event|12
5512100|NCT01556997|19057853|P2|Overall Study|Adverse Event|12
5512101|NCT01556997|19057854|P1|Overall Study|Adverse Event|10
5512102|NCT01556932|19057865|P2|Time Point 60 Minutes|Withdrawal by Subject|1
5512103|NCT01556932|19057866|P1|Time Point 60 Minutes|Withdrawal by Subject|1
5512104|NCT01556763|19057892|P3|Overall Study|Withdrawal by Subject|0
5512105|NCT01556763|19057893|P2|Overall Study|Withdrawal by Subject|1
5512106|NCT01556763|19057894|P1|Overall Study|Withdrawal by Subject|0
5512107|NCT01556438|19058033|P2|Overall Study|Death|1
5512108|NCT01556438|19058034|P1|Overall Study|Death|0
5512109|NCT01556438|19058033|P2|Overall Study|Progressive Disease|6
5512110|NCT01556438|19058034|P1|Overall Study|Progressive Disease|0
5512111|NCT01556438|19058033|P2|Overall Study|Sponsor Decision|2
5512112|NCT01556438|19058034|P1|Overall Study|Sponsor Decision|0
5512113|NCT01556438|19058033|P2|Overall Study|Adverse Event|2
5512114|NCT01556438|19058034|P1|Overall Study|Adverse Event|4
5512115|NCT01556165|19058121|P2|Overall Study|Withdrawal of Consent|1
5512116|NCT01556165|19058122|P1|Overall Study|Withdrawal of Consent|7
5512117|NCT01556165|19058121|P2|Overall Study|Protocol Violation|3
5512118|NCT01556165|19058122|P1|Overall Study|Protocol Violation|0
5512119|NCT01556165|19058121|P2|Overall Study|Adverse Event|3
5512120|NCT01556165|19058122|P1|Overall Study|Adverse Event|5
5512121|NCT01555983|19058163|P6|Overall Study|Withdrawal by Subject|1
5512122|NCT01555983|19058164|P5|Overall Study|Withdrawal by Subject|1
5512123|NCT01555983|19058165|P4|Overall Study|Withdrawal by Subject|0
5512124|NCT01555983|19058166|P3|Overall Study|Withdrawal by Subject|0
5512125|NCT01555983|19058167|P2|Overall Study|Withdrawal by Subject|0
5512126|NCT01555983|19058168|P1|Overall Study|Withdrawal by Subject|1
5512127|NCT01555931|19058189|P2|Overall Study|Lost to Follow-up|5
5512128|NCT01555931|19058190|P1|Overall Study|Lost to Follow-up|2
5512129|NCT01555762|19058198|P1|Overall Study|Death linked to an adverse event|14
5512130|NCT01555762|19058198|P1|Overall Study|Missing data|1
5512131|NCT01555762|19058198|P1|Overall Study|Participant not wishing to continue|5
5512132|NCT01555762|19058198|P1|Overall Study|Investigator's decision|10
5512133|NCT01555762|19058198|P1|Overall Study|Lost follow-up/moved house/changed team|35
5512134|NCT01555762|19058198|P1|Overall Study|Death linked to progression of disease|165
5512135|NCT01555762|19058198|P1|Overall Study|Treatment with Bevacizumab ticked No|24
5512136|NCT01555762|19058198|P1|Overall Study|75 years old or more ticked No|1
5512137|NCT01555762|19058198|P1|Overall Study|Missing start date of infusion|8
5512138|NCT01555762|19058198|P1|Overall Study|No information on Bevacizumab intake|11
5512139|NCT01555463|19058278|P2|Follow up|Other reason|3
5512140|NCT01555463|19058279|P1|Follow up|Other reason|3
5512141|NCT01555463|19058278|P2|Follow up|Protocol Violation|4
5512142|NCT01555463|19058279|P1|Follow up|Protocol Violation|2
5512143|NCT01555463|19058278|P2|Follow up|Lost to Follow-up|10
5512144|NCT01555463|19058279|P1|Follow up|Lost to Follow-up|9
5512145|NCT01555463|19058278|P2|Follow up|Withdrawal by Subject|22
5512146|NCT01555463|19058279|P1|Follow up|Withdrawal by Subject|22
5512147|NCT01555463|19058278|P2|Follow up|Death|1
5512148|NCT01555463|19058279|P1|Follow up|Death|0
5512149|NCT01555463|19058278|P2|Follow up|Adverse Event|5
5512150|NCT01555463|19058279|P1|Follow up|Adverse Event|2
5512151|NCT01555463|19058278|P2|Treatment|Other reason|3
5512152|NCT01555463|19058279|P1|Treatment|Other reason|2
5512153|NCT01555463|19058278|P2|Treatment|Protocol Violation|5
5512154|NCT01555463|19058279|P1|Treatment|Protocol Violation|4
5512155|NCT01555463|19058278|P2|Treatment|Lost to Follow-up|23
5512156|NCT01555463|19058279|P1|Treatment|Lost to Follow-up|28
5512157|NCT01555463|19058278|P2|Treatment|Withdrawal by Subject|36
5512158|NCT01555463|19058279|P1|Treatment|Withdrawal by Subject|24
5512159|NCT01555463|19058278|P2|Treatment|Adverse Event|12
5512160|NCT01555463|19058279|P1|Treatment|Adverse Event|6
5512161|NCT01555164|19058321|P2|Overall Study|Subject Withdrew Consent|11
5512162|NCT01555164|19058322|P1|Overall Study|Subject Withdrew Consent|6
5512163|NCT01555164|19058321|P2|Overall Study|Subject Non-compliance|6
5512164|NCT01555164|19058322|P1|Overall Study|Subject Non-compliance|14
5512165|NCT01555164|19058321|P2|Overall Study|Protocol Violation|5
5512166|NCT01555164|19058322|P1|Overall Study|Protocol Violation|9
5512167|NCT01555164|19058321|P2|Overall Study|Lost to Follow-up|3
5512168|NCT01555164|19058322|P1|Overall Study|Lost to Follow-up|4
5512169|NCT01555164|19058321|P2|Overall Study|Investigator's Discretion|2
5512170|NCT01555164|19058322|P1|Overall Study|Investigator's Discretion|2
5512171|NCT01555164|19058321|P2|Overall Study|Hyperglycemia|1
5512172|NCT01555164|19058322|P1|Overall Study|Hyperglycemia|0
5512173|NCT01555164|19058321|P2|Overall Study|Adverse Event|7
5512174|NCT01555164|19058322|P1|Overall Study|Adverse Event|5
5512175|NCT01555151|19058336|P4|Overall Study|Lost to Follow-up|1
5512176|NCT01555151|19058337|P3|Overall Study|Lost to Follow-up|0
5512177|NCT01555151|19058338|P2|Overall Study|Lost to Follow-up|0
5512178|NCT01555151|19058339|P1|Overall Study|Lost to Follow-up|0
5512179|NCT01555151|19058336|P4|Overall Study|Adverse Event|2
5512180|NCT01555151|19058337|P3|Overall Study|Adverse Event|1
5512181|NCT01555151|19058338|P2|Overall Study|Adverse Event|2
5512182|NCT01555151|19058339|P1|Overall Study|Adverse Event|1
5512183|NCT01555151|19058336|P4|Overall Study|Protocol Violation|5
5512184|NCT01555151|19058337|P3|Overall Study|Protocol Violation|3
5512185|NCT01555151|19058338|P2|Overall Study|Protocol Violation|3
5512186|NCT01555151|19058339|P1|Overall Study|Protocol Violation|3
5512187|NCT01555151|19058336|P4|Overall Study|Administrative|0
5512188|NCT01555151|19058337|P3|Overall Study|Administrative|2
5512189|NCT01555151|19058338|P2|Overall Study|Administrative|1
5512190|NCT01555151|19058339|P1|Overall Study|Administrative|3
5512191|NCT01555151|19058336|P4|Overall Study|Withdrawal by Subject|2
5512192|NCT01555151|19058337|P3|Overall Study|Withdrawal by Subject|0
5512193|NCT01555151|19058338|P2|Overall Study|Withdrawal by Subject|2
5512194|NCT01555151|19058339|P1|Overall Study|Withdrawal by Subject|6
5512195|NCT01555138|19058392|P2|Overall Study|Adverse Event|14
5512196|NCT01555138|19058393|P1|Overall Study|Adverse Event|14
5512197|NCT01555138|19058392|P2|Overall Study|Withdrawal by Subject|15
5512198|NCT01555138|19058393|P1|Overall Study|Withdrawal by Subject|16
5512199|NCT01555138|19058392|P2|Overall Study|Administrative problems|0
5512200|NCT01555138|19058393|P1|Overall Study|Administrative problems|8
5512201|NCT01555138|19058392|P2|Overall Study|Protocol Violation|3
5512202|NCT01555138|19058393|P1|Overall Study|Protocol Violation|5
5512203|NCT01555138|19058392|P2|Overall Study|Lack of Efficacy|2
5512204|NCT01555138|19058393|P1|Overall Study|Lack of Efficacy|2
5512205|NCT01555138|19058392|P2|Overall Study|Abnormal Lab reults|3
5512206|NCT01555138|19058393|P1|Overall Study|Abnormal Lab reults|1
5512207|NCT01555138|19058392|P2|Overall Study|Lost to Follow-up|0
5512208|NCT01555138|19058393|P1|Overall Study|Lost to Follow-up|1
5512209|NCT01555138|19058392|P2|Overall Study|Death|1
5512210|NCT01555138|19058393|P1|Overall Study|Death|0
5512211|NCT01555125|19058422|P5|Follow-Up Period|Subject / guardian decision|0
5512212|NCT01555125|19058423|P4|Follow-Up Period|Subject / guardian decision|1
5512213|NCT01555125|19058424|P3|Follow-Up Period|Subject / guardian decision|1
5512214|NCT01555125|19058425|P2|Follow-Up Period|Subject / guardian decision|1
5512215|NCT01555125|19058426|P1|Follow-Up Period|Subject / guardian decision|3
5512216|NCT01555125|19058422|P5|Follow-Up Period|Lost to Follow-up|0
5512217|NCT01555125|19058423|P4|Follow-Up Period|Lost to Follow-up|0
5512218|NCT01555125|19058424|P3|Follow-Up Period|Lost to Follow-up|0
5512219|NCT01555125|19058425|P2|Follow-Up Period|Lost to Follow-up|0
5512220|NCT01555125|19058426|P1|Follow-Up Period|Lost to Follow-up|1
5512221|NCT01555125|19058422|P5|Extension|Technical Problems|0
5512222|NCT01555125|19058423|P4|Extension|Technical Problems|1
5512223|NCT01555125|19058424|P3|Extension|Technical Problems|0
5512224|NCT01555125|19058425|P2|Extension|Technical Problems|0
5512225|NCT01555125|19058426|P1|Extension|Technical Problems|1
5512226|NCT01555125|19058422|P5|Extension|Subject/guardian decision|0
5512227|NCT01555125|19058423|P4|Extension|Subject/guardian decision|0
5512228|NCT01555125|19058424|P3|Extension|Subject/guardian decision|1
5512229|NCT01555125|19058425|P2|Extension|Subject/guardian decision|9
5512230|NCT01555125|19058426|P1|Extension|Subject/guardian decision|1
5512231|NCT01555125|19058422|P5|Extension|Study terminated by sponsor|0
5512232|NCT01555125|19058423|P4|Extension|Study terminated by sponsor|20
5512233|NCT01555125|19058424|P3|Extension|Study terminated by sponsor|16
5512234|NCT01555125|19058425|P2|Extension|Study terminated by sponsor|33
5512235|NCT01555125|19058426|P1|Extension|Study terminated by sponsor|32
5512236|NCT01555125|19058422|P5|Extension|Lost to Follow-up|0
5512237|NCT01555125|19058423|P4|Extension|Lost to Follow-up|0
5512238|NCT01555125|19058424|P3|Extension|Lost to Follow-up|2
5512239|NCT01555125|19058425|P2|Extension|Lost to Follow-up|1
5512240|NCT01555125|19058426|P1|Extension|Lost to Follow-up|2
5512241|NCT01555125|19058422|P5|Extension|Lack of Efficacy|0
5512242|NCT01555125|19058423|P4|Extension|Lack of Efficacy|0
5512243|NCT01555125|19058424|P3|Extension|Lack of Efficacy|3
5512244|NCT01555125|19058425|P2|Extension|Lack of Efficacy|6
5512245|NCT01555125|19058426|P1|Extension|Lack of Efficacy|7
5512246|NCT01555125|19058422|P5|Extension|Protocol deviation|0
5512247|NCT01555125|19058423|P4|Extension|Protocol deviation|0
5512248|NCT01555125|19058424|P3|Extension|Protocol deviation|0
5512249|NCT01555125|19058425|P2|Extension|Protocol deviation|0
5512250|NCT01555125|19058426|P1|Extension|Protocol deviation|1
5512251|NCT01555125|19058422|P5|Extension|Adverse Event|0
5512252|NCT01555125|19058423|P4|Extension|Adverse Event|1
5512253|NCT01555125|19058424|P3|Extension|Adverse Event|1
5512254|NCT01555125|19058425|P2|Extension|Adverse Event|2
5512255|NCT01555125|19058426|P1|Extension|Adverse Event|1
5512256|NCT01555125|19058422|P5|Maintenance Period|Death|0
5512257|NCT01555125|19058423|P4|Maintenance Period|Death|1
5512258|NCT01555125|19058424|P3|Maintenance Period|Death|0
5512259|NCT01555125|19058425|P2|Maintenance Period|Death|0
5512260|NCT01555125|19058426|P1|Maintenance Period|Death|0
5512261|NCT01555125|19058422|P5|Maintenance Period|Physician Decision|0
5512262|NCT01555125|19058423|P4|Maintenance Period|Physician Decision|0
5512263|NCT01555125|19058424|P3|Maintenance Period|Physician Decision|1
5512264|NCT01555125|19058425|P2|Maintenance Period|Physician Decision|0
5512265|NCT01555125|19058426|P1|Maintenance Period|Physician Decision|0
5512266|NCT01555125|19058422|P5|Maintenance Period|Lack of Efficacy|0
5512267|NCT01555125|19058423|P4|Maintenance Period|Lack of Efficacy|0
5512268|NCT01555125|19058424|P3|Maintenance Period|Lack of Efficacy|3
5512269|NCT01555125|19058425|P2|Maintenance Period|Lack of Efficacy|1
5512270|NCT01555125|19058426|P1|Maintenance Period|Lack of Efficacy|6
5512271|NCT01555125|19058422|P5|Maintenance Period|Lost to Follow-up|0
5512272|NCT01555125|19058423|P4|Maintenance Period|Lost to Follow-up|1
5512273|NCT01555125|19058424|P3|Maintenance Period|Lost to Follow-up|0
5512274|NCT01555125|19058425|P2|Maintenance Period|Lost to Follow-up|0
5512275|NCT01555125|19058426|P1|Maintenance Period|Lost to Follow-up|2
5512276|NCT01555125|19058422|P5|Maintenance Period|Subject / guardian decision|0
5512277|NCT01555125|19058423|P4|Maintenance Period|Subject / guardian decision|0
5512278|NCT01555125|19058424|P3|Maintenance Period|Subject / guardian decision|0
5512279|NCT01555125|19058425|P2|Maintenance Period|Subject / guardian decision|2
5512280|NCT01555125|19058426|P1|Maintenance Period|Subject / guardian decision|1
5512281|NCT01555125|19058422|P5|Maintenance Period|Adverse Event|0
5512282|NCT01555125|19058423|P4|Maintenance Period|Adverse Event|0
5512283|NCT01555125|19058424|P3|Maintenance Period|Adverse Event|0
5512284|NCT01555125|19058425|P2|Maintenance Period|Adverse Event|1
5512285|NCT01555125|19058426|P1|Maintenance Period|Adverse Event|1
5512286|NCT01555125|19058422|P5|Induction Period|Death|0
5512287|NCT01555125|19058423|P4|Induction Period|Death|0
5512288|NCT01555125|19058424|P3|Induction Period|Death|0
5512289|NCT01555125|19058425|P2|Induction Period|Death|0
5512290|NCT01555125|19058426|P1|Induction Period|Death|1
5512291|NCT01555125|19058422|P5|Induction Period|Subject / guardian decision|2
5512292|NCT01555125|19058423|P4|Induction Period|Subject / guardian decision|0
5512293|NCT01555125|19058424|P3|Induction Period|Subject / guardian decision|0
5512294|NCT01555125|19058425|P2|Induction Period|Subject / guardian decision|0
5512295|NCT01555125|19058426|P1|Induction Period|Subject / guardian decision|0
5512296|NCT01555125|19058422|P5|Induction Period|Adverse Event|1
5512297|NCT01555125|19058423|P4|Induction Period|Adverse Event|0
5512298|NCT01555125|19058424|P3|Induction Period|Adverse Event|0
5512299|NCT01555125|19058425|P2|Induction Period|Adverse Event|1
5512300|NCT01555125|19058426|P1|Induction Period|Adverse Event|0
5512301|NCT01555125|19058422|P5|Induction Period|Lost to Follow-up|0
5512302|NCT01555125|19058423|P4|Induction Period|Lost to Follow-up|0
5512303|NCT01555125|19058424|P3|Induction Period|Lost to Follow-up|0
5512304|NCT01555125|19058425|P2|Induction Period|Lost to Follow-up|2
5512305|NCT01555125|19058426|P1|Induction Period|Lost to Follow-up|0
5512306|NCT01555073|19058519|P4|Overall Study|Lost to Follow-up|5
5512307|NCT01555073|19058520|P3|Overall Study|Lost to Follow-up|0
5512308|NCT01555073|19058521|P2|Overall Study|Lost to Follow-up|2
5512309|NCT01555073|19058522|P1|Overall Study|Lost to Follow-up|1
5512310|NCT01555021|19058538|P2|Overall Study|Lost to Follow-up|2
5512311|NCT01555021|19058539|P1|Overall Study|Lost to Follow-up|1
5512312|NCT01554904|19058564|P1|Overall Study|Had sleep apnea on Home Study 1|1
5512313|NCT01554904|19058564|P1|Overall Study|Withdrawal by Subject|3
5512314|NCT01554618|19058609|P2|Open-Label Extension Period|Lost to Follow-up|1
5512315|NCT01554618|19058610|P1|Open-Label Extension Period|Lost to Follow-up|1
5512316|NCT01554618|19058609|P2|Open-Label Extension Period|Physician Decision|1
5512317|NCT01554618|19058610|P1|Open-Label Extension Period|Physician Decision|0
5512318|NCT01554618|19058609|P2|Open-Label Extension Period|Withdrawal by Subject|3
5512319|NCT01554618|19058610|P1|Open-Label Extension Period|Withdrawal by Subject|2
5512320|NCT01554618|19058609|P2|Controlled Assessment Period|Withdrawal by Subject|0
5512321|NCT01554618|19058610|P1|Controlled Assessment Period|Withdrawal by Subject|6
5512322|NCT01554618|19058609|P2|Controlled Assessment Period|Lost to Follow-up|1
5512323|NCT01554618|19058610|P1|Controlled Assessment Period|Lost to Follow-up|2
5512324|NCT01554618|19058609|P2|Randomized Through Start of Treatment|Adverse Event|0
5512325|NCT01554618|19058610|P1|Randomized Through Start of Treatment|Adverse Event|1
5512326|NCT01554579|19058662|P2|Overall Study|Withdrawal by Subject|1
5512327|NCT01554579|19058663|P1|Overall Study|Withdrawal by Subject|2
5512328|NCT01554579|19058662|P2|Overall Study|Lack of Efficacy|1
5512329|NCT01554579|19058663|P1|Overall Study|Lack of Efficacy|2
5512330|NCT01554579|19058662|P2|Overall Study|Adverse Event|25
5512331|NCT01554579|19058663|P1|Overall Study|Adverse Event|6
5512332|NCT01554527|19058676|P3|Overall Study|Physician Decision|1
5512333|NCT01554527|19058677|P2|Overall Study|Physician Decision|0
5512334|NCT01554527|19058678|P1|Overall Study|Physician Decision|0
5512335|NCT01554527|19058676|P3|Overall Study|Lost to Follow-up|4
5512336|NCT01554527|19058677|P2|Overall Study|Lost to Follow-up|0
5512337|NCT01554527|19058678|P1|Overall Study|Lost to Follow-up|0
5512338|NCT01554527|19058676|P3|Overall Study|Withdrawal by Subject|3
5512339|NCT01554527|19058677|P2|Overall Study|Withdrawal by Subject|0
5512340|NCT01554527|19058678|P1|Overall Study|Withdrawal by Subject|1
5512341|NCT01554241|19058734|P4|Overall Study|Withdrawal by Subject|0
5512342|NCT01554241|19058735|P3|Overall Study|Withdrawal by Subject|2
5512343|NCT01554241|19058736|P2|Overall Study|Withdrawal by Subject|0
5512344|NCT01554241|19058737|P1|Overall Study|Withdrawal by Subject|0
5512345|NCT01554241|19058734|P4|Overall Study|protocol specified change in eGFR|0
5512346|NCT01554241|19058735|P3|Overall Study|protocol specified change in eGFR|1
5512347|NCT01554241|19058736|P2|Overall Study|protocol specified change in eGFR|0
5512348|NCT01554241|19058737|P1|Overall Study|protocol specified change in eGFR|0
5512349|NCT01554241|19058734|P4|Overall Study|protocol specified renal stone|1
5512350|NCT01554241|19058735|P3|Overall Study|protocol specified renal stone|0
5512351|NCT01554241|19058736|P2|Overall Study|protocol specified renal stone|0
5512352|NCT01554241|19058737|P1|Overall Study|protocol specified renal stone|0
5512353|NCT01554241|19058734|P4|Overall Study|Death|0
5512354|NCT01554241|19058735|P3|Overall Study|Death|1
5512355|NCT01554241|19058736|P2|Overall Study|Death|1
5512356|NCT01554241|19058737|P1|Overall Study|Death|3
5512357|NCT01554176|19058753|P5|Run-out Phase|Protocol Violation|0
5512358|NCT01554176|19058754|P4|Run-out Phase|Protocol Violation|1
5512359|NCT01554176|19058755|P3|Run-out Phase|Protocol Violation|0
5512360|NCT01554176|19058756|P2|Run-out Phase|Protocol Violation|0
5512361|NCT01554176|19058757|P1|Run-out Phase|Protocol Violation|0
5512362|NCT01554176|19058753|P5|Treatment Phase|Lost to Follow-up|0
5512363|NCT01554176|19058754|P4|Treatment Phase|Lost to Follow-up|0
5512364|NCT01554176|19058755|P3|Treatment Phase|Lost to Follow-up|0
5512365|NCT01554176|19058756|P2|Treatment Phase|Lost to Follow-up|0
5512366|NCT01554176|19058757|P1|Treatment Phase|Lost to Follow-up|3
5512367|NCT01554176|19058753|P5|Treatment Phase|Withdrawal by Subject|0
5512368|NCT01554176|19058754|P4|Treatment Phase|Withdrawal by Subject|0
5512369|NCT01554176|19058755|P3|Treatment Phase|Withdrawal by Subject|0
5512370|NCT01554176|19058756|P2|Treatment Phase|Withdrawal by Subject|0
5512371|NCT01554176|19058757|P1|Treatment Phase|Withdrawal by Subject|1
5512372|NCT01554176|19058753|P5|Treatment Phase|Non-compliance with study drug|0
5512373|NCT01554176|19058754|P4|Treatment Phase|Non-compliance with study drug|0
5512374|NCT01554176|19058755|P3|Treatment Phase|Non-compliance with study drug|0
5512375|NCT01554176|19058756|P2|Treatment Phase|Non-compliance with study drug|0
5512376|NCT01554176|19058757|P1|Treatment Phase|Non-compliance with study drug|1
5512377|NCT01554176|19058753|P5|Treatment Phase|Adverse event, non-fatal|0
5512378|NCT01554176|19058754|P4|Treatment Phase|Adverse event, non-fatal|0
5512379|NCT01554176|19058755|P3|Treatment Phase|Adverse event, non-fatal|0
5512380|NCT01554176|19058756|P2|Treatment Phase|Adverse event, non-fatal|1
5512381|NCT01554176|19058757|P1|Treatment Phase|Adverse event, non-fatal|1
5512382|NCT01554176|19058753|P5|Treatment Phase|Lack of Efficacy|0
5512383|NCT01554176|19058754|P4|Treatment Phase|Lack of Efficacy|0
5512384|NCT01554176|19058755|P3|Treatment Phase|Lack of Efficacy|0
5512385|NCT01554176|19058756|P2|Treatment Phase|Lack of Efficacy|1
5512386|NCT01554176|19058757|P1|Treatment Phase|Lack of Efficacy|0
5512387|NCT01554176|19058753|P5|Treatment Phase|Physician Decision|0
5512388|NCT01554176|19058754|P4|Treatment Phase|Physician Decision|0
5512389|NCT01554176|19058755|P3|Treatment Phase|Physician Decision|0
5512390|NCT01554176|19058756|P2|Treatment Phase|Physician Decision|1
5512391|NCT01554176|19058757|P1|Treatment Phase|Physician Decision|1
5512392|NCT01554176|19058753|P5|Treatment Phase|Protocol Violation|0
5512393|NCT01554176|19058754|P4|Treatment Phase|Protocol Violation|0
5512394|NCT01554176|19058755|P3|Treatment Phase|Protocol Violation|0
5512395|NCT01554176|19058756|P2|Treatment Phase|Protocol Violation|2
5512396|NCT01554176|19058757|P1|Treatment Phase|Protocol Violation|1
5512397|NCT01554163|19058784|P2|Overall Study|Not Treated|0
5512398|NCT01554163|19058785|P1|Overall Study|Not Treated|1
5512399|NCT01554163|19058784|P2|Overall Study|Withdrawal by Subject|5
5512400|NCT01554163|19058785|P1|Overall Study|Withdrawal by Subject|1
5512401|NCT01554163|19058784|P2|Overall Study|Protocol Violation|4
5512402|NCT01554163|19058785|P1|Overall Study|Protocol Violation|0
5512403|NCT01554163|19058784|P2|Overall Study|Non-Compliance With Study Drug|1
5512404|NCT01554163|19058785|P1|Overall Study|Non-Compliance With Study Drug|1
5512405|NCT01554163|19058784|P2|Overall Study|Lost to Follow-up|0
5512406|NCT01554163|19058785|P1|Overall Study|Lost to Follow-up|1
5512407|NCT01554163|19058784|P2|Overall Study|Lack of Efficacy|0
5512408|NCT01554163|19058785|P1|Overall Study|Lack of Efficacy|1
5512409|NCT01554163|19058784|P2|Overall Study|Adverse Event|0
5512410|NCT01554163|19058785|P1|Overall Study|Adverse Event|3
5512411|NCT01553916|19058803|P1|Overall Study|Pre-treatment MRI metastatic disease|1
5512412|NCT01553916|19058803|P1|Overall Study|Withdrawal by Subject|2
5512413|NCT01553851|19058820|P1|Overall Study|constipation|1
5512414|NCT01553851|19058820|P1|Overall Study|Adverse Event|2
5512415|NCT01553747|19058835|P3|Overall Study|Physician decision: lack of efficacy|3
5512416|NCT01553747|19058836|P2|Overall Study|Physician decision: lack of efficacy|5
5512417|NCT01553747|19058837|P1|Overall Study|Physician decision: lack of efficacy|1
5512418|NCT01553747|19058835|P3|Overall Study|Sponsor decision, specify|0
5512419|NCT01553747|19058836|P2|Overall Study|Sponsor decision, specify|5
5512420|NCT01553747|19058837|P1|Overall Study|Sponsor decision, specify|7
5512421|NCT01553747|19058835|P3|Overall Study|Lost to Follow-up|6
5512422|NCT01553747|19058836|P2|Overall Study|Lost to Follow-up|5
5512423|NCT01553747|19058837|P1|Overall Study|Lost to Follow-up|11
5512424|NCT01553747|19058835|P3|Overall Study|Physician decision: other|7
5512425|NCT01553747|19058836|P2|Overall Study|Physician decision: other|8
5512426|NCT01553747|19058837|P1|Overall Study|Physician decision: other|10
5512427|NCT01553747|19058835|P3|Overall Study|Adverse event or SAE|19
5512428|NCT01553747|19058836|P2|Overall Study|Adverse event or SAE|28
5512429|NCT01553747|19058837|P1|Overall Study|Adverse event or SAE|32
5512430|NCT01553747|19058835|P3|Overall Study|Voluntarily withdrew|74
5512431|NCT01553747|19058836|P2|Overall Study|Voluntarily withdrew|66
5512432|NCT01553747|19058837|P1|Overall Study|Voluntarily withdrew|70
5512433|NCT01553747|19058835|P3|Overall Study|Protocol Violation|0
5512434|NCT01553747|19058836|P2|Overall Study|Protocol Violation|2
5512435|NCT01553747|19058837|P1|Overall Study|Protocol Violation|0
5512436|NCT01553591|19058899|P3|Overall Study|Randomized and never dispensed drug|0
5512437|NCT01553591|19058900|P2|Overall Study|Randomized and never dispensed drug|1
5512438|NCT01553591|19058901|P1|Overall Study|Randomized and never dispensed drug|0
5512439|NCT01553591|19058899|P3|Overall Study|Sponsor decision|3
5512440|NCT01553591|19058900|P2|Overall Study|Sponsor decision|0
5512441|NCT01553591|19058901|P1|Overall Study|Sponsor decision|1
5512442|NCT01553591|19058899|P3|Overall Study|Protocol Violation|4
5512443|NCT01553591|19058900|P2|Overall Study|Protocol Violation|4
5512444|NCT01553591|19058901|P1|Overall Study|Protocol Violation|3
5512445|NCT01553591|19058899|P3|Overall Study|Physician decision: lack of efficacy|7
5512446|NCT01553591|19058900|P2|Overall Study|Physician decision: lack of efficacy|3
5512447|NCT01553591|19058901|P1|Overall Study|Physician decision: lack of efficacy|2
5512448|NCT01553591|19058899|P3|Overall Study|Physician decision: other|16
5512449|NCT01553591|19058900|P2|Overall Study|Physician decision: other|14
5512450|NCT01553591|19058901|P1|Overall Study|Physician decision: other|11
5512451|NCT01553591|19058899|P3|Overall Study|Lost to Follow-up|16
5512452|NCT01553591|19058900|P2|Overall Study|Lost to Follow-up|23
5512453|NCT01553591|19058901|P1|Overall Study|Lost to Follow-up|25
5512454|NCT01553591|19058899|P3|Overall Study|Adverse Event|16
5512455|NCT01553591|19058900|P2|Overall Study|Adverse Event|45
5512456|NCT01553591|19058901|P1|Overall Study|Adverse Event|36
5512457|NCT01553591|19058899|P3|Overall Study|Voluntarily withdrew|96
5512458|NCT01553591|19058900|P2|Overall Study|Voluntarily withdrew|79
5512459|NCT01553591|19058901|P1|Overall Study|Voluntarily withdrew|94
5512460|NCT01553318|19058961|P2|Overall Study|Protocol Violation|2
5512461|NCT01553318|19058962|P1|Overall Study|Protocol Violation|3
5512462|NCT01553279|19058992|P2|Period 2: Toddler Vaccinations|Lost to Follow-up|2
5512463|NCT01553279|19058993|P1|Period 2: Toddler Vaccinations|Lost to Follow-up|3
5512464|NCT01553279|19058992|P2|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
5512465|NCT01553279|19058993|P1|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
5512466|NCT01553279|19058992|P2|Interim Period|Lost to Follow-up|0
5512467|NCT01553279|19058993|P1|Interim Period|Lost to Follow-up|1
5512468|NCT01553279|19058992|P2|Interim Period|Withdrawal by Subject|2
5512469|NCT01553279|19058993|P1|Interim Period|Withdrawal by Subject|2
5512470|NCT01553279|19058992|P2|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
5512471|NCT01553279|19058993|P1|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
5512472|NCT01553279|19058992|P2|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
5512473|NCT01553279|19058993|P1|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
5512474|NCT01553188|19059068|P4|Overall Study|Intercurrent illness and adverse event|0
5512475|NCT01553188|19059069|P3|Overall Study|Intercurrent illness and adverse event|2
5512476|NCT01553188|19059070|P2|Overall Study|Intercurrent illness and adverse event|1
5512477|NCT01553188|19059071|P1|Overall Study|Intercurrent illness and adverse event|0
5512478|NCT01553188|19059068|P4|Overall Study|Patient choice|0
5512479|NCT01553188|19059069|P3|Overall Study|Patient choice|0
5512480|NCT01553188|19059070|P2|Overall Study|Patient choice|0
5512481|NCT01553188|19059071|P1|Overall Study|Patient choice|1
5512482|NCT01553136|19059098|P2|Overall Study|Scheduling Difficulties|4
5512483|NCT01553136|19059099|P1|Overall Study|Scheduling Difficulties|5
5512484|NCT01553136|19059098|P2|Overall Study|Physician Decision|3
5512485|NCT01553136|19059099|P1|Overall Study|Physician Decision|2
5512486|NCT01553136|19059098|P2|Overall Study|Lost to Follow-up|10
5512487|NCT01553136|19059099|P1|Overall Study|Lost to Follow-up|4
5512488|NCT01553136|19059098|P2|Overall Study|Withdrawal by Subject|3
5512489|NCT01553136|19059099|P1|Overall Study|Withdrawal by Subject|2
5512490|NCT01553136|19059098|P2|Overall Study|Adverse Event|2
5512491|NCT01553136|19059099|P1|Overall Study|Adverse Event|3
5512492|NCT01553084|19059116|P3|Overall Study|Withdrawal by Subject|35
5512493|NCT01553084|19059117|P2|Overall Study|Withdrawal by Subject|13
5512494|NCT01553084|19059118|P1|Overall Study|Withdrawal by Subject|15
5512495|NCT01552954|19059200|P2|Overall Study|diagnosed DM|0
5512496|NCT01552954|19059201|P1|Overall Study|diagnosed DM|1
5512497|NCT01552954|19059200|P2|Overall Study|Protocol Violation|2
5512498|NCT01552954|19059201|P1|Overall Study|Protocol Violation|1
5512499|NCT01552954|19059200|P2|Overall Study|Withdrawal by Subject|1
5512500|NCT01552954|19059201|P1|Overall Study|Withdrawal by Subject|1
5512501|NCT01552954|19059200|P2|Overall Study|Lost to Follow-up|1
5512502|NCT01552954|19059201|P1|Overall Study|Lost to Follow-up|1
5512503|NCT01552954|19059200|P2|Overall Study|Adverse Event|2
5512504|NCT01552954|19059201|P1|Overall Study|Adverse Event|1
5512505|NCT01552928|19059217|P4|Period 3|Adverse Event|0
5512506|NCT01552928|19059218|P3|Period 3|Adverse Event|1
5512507|NCT01552928|19059219|P2|Period 3|Adverse Event|0
5512508|NCT01552928|19059220|P1|Period 3|Adverse Event|0
5512509|NCT01552915|19059267|P3|Overall Study|Other|6
5512510|NCT01552915|19059268|P2|Overall Study|Other|0
5512511|NCT01552915|19059269|P1|Overall Study|Other|2
5512512|NCT01552915|19059267|P3|Overall Study|Lack of Efficacy|4
5512513|NCT01552915|19059268|P2|Overall Study|Lack of Efficacy|1
5512514|NCT01552915|19059269|P1|Overall Study|Lack of Efficacy|8
5512515|NCT01552915|19059267|P3|Overall Study|Protocol Violation|4
5512516|NCT01552915|19059268|P2|Overall Study|Protocol Violation|4
5512517|NCT01552915|19059269|P1|Overall Study|Protocol Violation|0
5512518|NCT01552915|19059267|P3|Overall Study|Withdrawal by Subject|5
5512519|NCT01552915|19059268|P2|Overall Study|Withdrawal by Subject|4
5512520|NCT01552915|19059269|P1|Overall Study|Withdrawal by Subject|6
5512521|NCT01552915|19059267|P3|Overall Study|Lost to Follow-up|5
5512522|NCT01552915|19059268|P2|Overall Study|Lost to Follow-up|6
5512523|NCT01552915|19059269|P1|Overall Study|Lost to Follow-up|4
5512524|NCT01552915|19059267|P3|Overall Study|Adverse Event|3
5512525|NCT01552915|19059268|P2|Overall Study|Adverse Event|14
5512526|NCT01552915|19059269|P1|Overall Study|Adverse Event|3
5512527|NCT01552902|19059292|P3|Overall Study|Other|3
5512528|NCT01552902|19059293|P2|Overall Study|Other|4
5512529|NCT01552902|19059294|P1|Overall Study|Other|3
5512530|NCT01552902|19059292|P3|Overall Study|Lost to Follow-up|6
5512531|NCT01552902|19059293|P2|Overall Study|Lost to Follow-up|3
5512532|NCT01552902|19059294|P1|Overall Study|Lost to Follow-up|1
5512533|NCT01552902|19059292|P3|Overall Study|Withdrawal by Subject|6
5512534|NCT01552902|19059293|P2|Overall Study|Withdrawal by Subject|9
5512535|NCT01552902|19059294|P1|Overall Study|Withdrawal by Subject|1
5512536|NCT01552902|19059292|P3|Overall Study|Lack of Efficacy|1
5512537|NCT01552902|19059293|P2|Overall Study|Lack of Efficacy|3
5512538|NCT01552902|19059294|P1|Overall Study|Lack of Efficacy|4
5512539|NCT01552902|19059292|P3|Overall Study|Protocol Violation|3
5512540|NCT01552902|19059293|P2|Overall Study|Protocol Violation|3
5512541|NCT01552902|19059294|P1|Overall Study|Protocol Violation|3
5512542|NCT01552902|19059292|P3|Overall Study|Adverse Event|14
5512543|NCT01552902|19059293|P2|Overall Study|Adverse Event|15
5512544|NCT01552902|19059294|P1|Overall Study|Adverse Event|1
5512545|NCT01552772|19059344|P1|Overall Study|Protocol Deviation|1
5512546|NCT01552772|19059344|P1|Overall Study|Adverse Event|1
5512547|NCT01552772|19059344|P1|Overall Study|Lost to Follow-up|2
5512548|NCT01552694|19059360|P2|Overall Study|Protocol Violation|1
5512549|NCT01552694|19059361|P1|Overall Study|Protocol Violation|0
5512550|NCT01552694|19059360|P2|Overall Study|Lost to Follow-up|1
5512551|NCT01552694|19059361|P1|Overall Study|Lost to Follow-up|0
5512552|NCT01552681|19059377|P2|Overall Study|Subject moved away|1
5512553|NCT01552681|19059378|P1|Overall Study|Subject moved away|0
5512554|NCT01552681|19059377|P2|Overall Study|Physician Decision|0
5512555|NCT01552681|19059378|P1|Overall Study|Physician Decision|1
5512556|NCT01552681|19059377|P2|Overall Study|Withdrawal by Subject|0
5512557|NCT01552681|19059378|P1|Overall Study|Withdrawal by Subject|4
5512558|NCT01552603|19059426|P1|Overall Study|Physician Decision|1
5512559|NCT01552408|19059433|P2|Overall Study|Withdrawal by Subject|1
5512560|NCT01552408|19059434|P1|Overall Study|Withdrawal by Subject|2
5512561|NCT01552408|19059433|P2|Overall Study|Relocation|1
5512562|NCT01552408|19059434|P1|Overall Study|Relocation|0
5512563|NCT01552408|19059433|P2|Overall Study|Lost to Follow-up|0
5512564|NCT01552408|19059434|P1|Overall Study|Lost to Follow-up|2
5512565|NCT01552369|19059456|P2|Overall Study|Did not consent to extended follow up|9
5512566|NCT01552369|19059457|P1|Overall Study|Did not consent to extended follow up|8
5512567|NCT01552057|19059546|P2|Overall Study|Physician Decision|0
5512568|NCT01552057|19059547|P1|Overall Study|Physician Decision|1
5512569|NCT01552057|19059546|P2|Overall Study|Entry Criteria Not Met|2
5512570|NCT01552057|19059547|P1|Overall Study|Entry Criteria Not Met|2
5512571|NCT01552057|19059546|P2|Overall Study|Withdrawal by Subject|8
5512572|NCT01552057|19059547|P1|Overall Study|Withdrawal by Subject|5
5512573|NCT01552057|19059546|P2|Overall Study|Lack of Efficacy|23
5512574|NCT01552057|19059547|P1|Overall Study|Lack of Efficacy|8
5512575|NCT01552057|19059546|P2|Overall Study|Adverse Event|15
5512576|NCT01552057|19059547|P1|Overall Study|Adverse Event|14
5512577|NCT01551758|19059613|P2|Overall Study|Withdrawal by Subject|17
5512578|NCT01551758|19059614|P1|Overall Study|Withdrawal by Subject|14
5512579|NCT01551758|19059613|P2|Overall Study|Physician Decision|3
5512580|NCT01551758|19059614|P1|Overall Study|Physician Decision|9
5512581|NCT01551758|19059613|P2|Overall Study|Lost to Follow-up|25
5512582|NCT01551758|19059614|P1|Overall Study|Lost to Follow-up|29
5512583|NCT01551758|19059613|P2|Overall Study|Met Protocol-defined stopping criteria|10
5512584|NCT01551758|19059614|P1|Overall Study|Met Protocol-defined stopping criteria|8
5512585|NCT01551758|19059613|P2|Overall Study|Protocol Violation|6
5512586|NCT01551758|19059614|P1|Overall Study|Protocol Violation|5
5512587|NCT01551758|19059613|P2|Overall Study|Lack of Efficacy|1
5512588|NCT01551758|19059614|P1|Overall Study|Lack of Efficacy|0
5512589|NCT01551758|19059613|P2|Overall Study|Adverse Event|43
5512590|NCT01551758|19059614|P1|Overall Study|Adverse Event|29
5512591|NCT01551745|19059652|P1|Overall Study|Disease Progression|2
5512592|NCT01551745|19059652|P1|Overall Study|Withdrawal by Subject|1
5512593|NCT01551693|19059661|P2|Overall Study|Withdrawal by Subject|1
5512594|NCT01551693|19059662|P1|Overall Study|Withdrawal by Subject|0
5512595|NCT01551693|19059661|P2|Overall Study|Adverse Event|1
5512596|NCT01551693|19059662|P1|Overall Study|Adverse Event|0
5512597|NCT01551693|19059661|P2|Overall Study|Disease Progression|0
5512598|NCT01551693|19059662|P1|Overall Study|Disease Progression|1
5512599|NCT01551420|19059683|P2|Home Use (Part B)|Withdrawal by staff|1
5512600|NCT01551420|19059684|P1|Home Use (Part B)|Withdrawal by staff|0
5512601|NCT01551420|19059683|P2|Home Use (Part B)|Withdrawal by Subject|0
5512602|NCT01551420|19059684|P1|Home Use (Part B)|Withdrawal by Subject|6
5512603|NCT01551420|19059683|P2|Screened for Part B Eligibility|Deemed ineligible by staff|2
5512604|NCT01551420|19059684|P1|Screened for Part B Eligibility|Deemed ineligible by staff|1
5512605|NCT01551420|19059683|P2|Screened for Part B Eligibility|Declined participation|1
5512606|NCT01551420|19059684|P1|Screened for Part B Eligibility|Declined participation|8
5512607|NCT01551420|19059683|P2|In-laboratory (Part A)|Scheduling conflict|1
5512608|NCT01551420|19059684|P1|In-laboratory (Part A)|Scheduling conflict|2
5512609|NCT01551420|19059683|P2|In-laboratory (Part A)|Withdrawal by Subject|0
5512610|NCT01551420|19059684|P1|In-laboratory (Part A)|Withdrawal by Subject|2
5512611|NCT01551420|19059683|P2|In-laboratory (Part A)|Lost to Follow-up|1
5512612|NCT01551420|19059684|P1|In-laboratory (Part A)|Lost to Follow-up|2
5512613|NCT01551355|19059714|P6|Overall Study|Lost to Follow-up|6
5512614|NCT01551355|19059715|P5|Overall Study|Lost to Follow-up|9
5512615|NCT01551355|19059716|P4|Overall Study|Lost to Follow-up|24
5512616|NCT01551355|19059717|P3|Overall Study|Lost to Follow-up|34
5512617|NCT01551355|19059718|P2|Overall Study|Lost to Follow-up|49
5512618|NCT01551355|19059719|P1|Overall Study|Lost to Follow-up|51
5512619|NCT01551303|19059733|P2|Overall Study|failed awareness check on vision test|7
5512620|NCT01551303|19059734|P1|Overall Study|failed awareness check on vision test|4
5512621|NCT01551212|19059742|P2|Overall Study|Never Received Study Treatment|4
5512622|NCT01551212|19059743|P1|Overall Study|Never Received Study Treatment|2
5512623|NCT01551212|19059742|P2|Overall Study|Death|4
5512624|NCT01551212|19059743|P1|Overall Study|Death|2
5512625|NCT01551212|19059742|P2|Overall Study|Withdrawal by Subject|7
5512626|NCT01551212|19059743|P1|Overall Study|Withdrawal by Subject|0
5512627|NCT01551212|19059742|P2|Overall Study|Protocol Violation|1
5512628|NCT01551212|19059743|P1|Overall Study|Protocol Violation|0
5512629|NCT01551212|19059742|P2|Overall Study|Lost to Follow-up|1
5512630|NCT01551212|19059743|P1|Overall Study|Lost to Follow-up|0
5512631|NCT01551212|19059742|P2|Overall Study|Administrative problems|2
5512632|NCT01551212|19059743|P1|Overall Study|Administrative problems|1
5512633|NCT01551212|19059742|P2|Overall Study|Graft loss/Retransplantation|1
5512634|NCT01551212|19059743|P1|Overall Study|Graft loss/Retransplantation|0
5512635|NCT01551173|19059778|P2|Overall Study|Other|3
5512636|NCT01551173|19059779|P1|Overall Study|Other|5
5512637|NCT01551173|19059778|P2|Overall Study|Lost to Follow-up|7
5512638|NCT01551173|19059779|P1|Overall Study|Lost to Follow-up|5
5512639|NCT01551173|19059778|P2|Overall Study|Adverse Event|6
5512640|NCT01551173|19059779|P1|Overall Study|Adverse Event|7
5512641|NCT01551173|19059778|P2|Overall Study|Withdrawal by Subject|16
5512642|NCT01551173|19059779|P1|Overall Study|Withdrawal by Subject|11
5512643|NCT01550965|19059856|P1|Overall Study|Other|13
5512644|NCT01550965|19059856|P1|Overall Study|Lack of Efficacy|59
5512645|NCT01550965|19059856|P1|Overall Study|Lost to Follow-up|2
5512646|NCT01550965|19059856|P1|Overall Study|Withdrawal by Subject|10
5512647|NCT01550965|19059856|P1|Overall Study|Adverse Event|26
5512648|NCT01550757|19059900|P4|Overall Study|Withdrawal by Subject|1
5512649|NCT01550757|19059901|P3|Overall Study|Withdrawal by Subject|3
5512650|NCT01550757|19059902|P2|Overall Study|Withdrawal by Subject|0
5512651|NCT01550757|19059903|P1|Overall Study|Withdrawal by Subject|2
5512652|NCT01550757|19059900|P4|Overall Study|Lost to Follow-up|53
5512653|NCT01550757|19059901|P3|Overall Study|Lost to Follow-up|42
5512654|NCT01550757|19059902|P2|Overall Study|Lost to Follow-up|14
5512655|NCT01550757|19059903|P1|Overall Study|Lost to Follow-up|21
5512656|NCT01550744|19059913|P3|Double-Blind|Other|10
5512657|NCT01550744|19059914|P2|Double-Blind|Other|2
5512658|NCT01550744|19059915|P1|Double-Blind|Other|0
5512659|NCT01550744|19059913|P3|Double-Blind|Pregnancy|3
5512660|NCT01550744|19059914|P2|Double-Blind|Pregnancy|0
5512661|NCT01550744|19059915|P1|Double-Blind|Pregnancy|0
5512662|NCT01550744|19059913|P3|Double-Blind|Protocol Violation|4
5512663|NCT01550744|19059914|P2|Double-Blind|Protocol Violation|0
5512664|NCT01550744|19059915|P1|Double-Blind|Protocol Violation|0
5512665|NCT01550744|19059913|P3|Double-Blind|Lack of Efficacy|8
5512666|NCT01550744|19059914|P2|Double-Blind|Lack of Efficacy|2
5512667|NCT01550744|19059915|P1|Double-Blind|Lack of Efficacy|0
5512668|NCT01550744|19059913|P3|Double-Blind|Death|0
5512669|NCT01550744|19059914|P2|Double-Blind|Death|1
5512670|NCT01550744|19059915|P1|Double-Blind|Death|0
5512671|NCT01550744|19059913|P3|Double-Blind|Adverse Event|15
5512672|NCT01550744|19059914|P2|Double-Blind|Adverse Event|4
5512673|NCT01550744|19059915|P1|Double-Blind|Adverse Event|0
5512674|NCT01550744|19059913|P3|Double-Blind|Withdrawal by Subject|15
5512675|NCT01550744|19059914|P2|Double-Blind|Withdrawal by Subject|2
5512676|NCT01550744|19059915|P1|Double-Blind|Withdrawal by Subject|0
5512677|NCT01550744|19059913|P3|Double-Blind|Lost to Follow-up|12
5512678|NCT01550744|19059914|P2|Double-Blind|Lost to Follow-up|6
5512679|NCT01550744|19059915|P1|Double-Blind|Lost to Follow-up|0
5512680|NCT01550744|19059913|P3|Open-Label|Other|0
5512681|NCT01550744|19059914|P2|Open-Label|Other|0
5512682|NCT01550744|19059915|P1|Open-Label|Other|1
5512683|NCT01550744|19059913|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
5512684|NCT01550744|19059914|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
5512685|NCT01550744|19059915|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
5512686|NCT01550744|19059913|P3|Open-Label|Not all 3 study drug injections received|0
5512687|NCT01550744|19059914|P2|Open-Label|Not all 3 study drug injections received|0
5512688|NCT01550744|19059915|P1|Open-Label|Not all 3 study drug injections received|2
5512689|NCT01550744|19059913|P3|Open-Label|Protocol Violation|0
5512690|NCT01550744|19059914|P2|Open-Label|Protocol Violation|0
5512691|NCT01550744|19059915|P1|Open-Label|Protocol Violation|4
5512692|NCT01550744|19059913|P3|Open-Label|Lack of Efficacy|0
5512693|NCT01550744|19059914|P2|Open-Label|Lack of Efficacy|0
5512694|NCT01550744|19059915|P1|Open-Label|Lack of Efficacy|4
5512695|NCT01550744|19059913|P3|Open-Label|Adverse Event|0
5512696|NCT01550744|19059914|P2|Open-Label|Adverse Event|0
5512697|NCT01550744|19059915|P1|Open-Label|Adverse Event|11
5512698|NCT01550744|19059913|P3|Open-Label|Withdrawal by Subject|0
5512699|NCT01550744|19059914|P2|Open-Label|Withdrawal by Subject|0
5512700|NCT01550744|19059915|P1|Open-Label|Withdrawal by Subject|13
5512701|NCT01550744|19059913|P3|Open-Label|Lost to Follow-up|0
5512702|NCT01550744|19059914|P2|Open-Label|Lost to Follow-up|0
5512703|NCT01550744|19059915|P1|Open-Label|Lost to Follow-up|7
5512704|NCT01550289|19060064|P2|Overall Study|Withdrawal by Subject|3
5512705|NCT01550289|19060065|P1|Overall Study|Withdrawal by Subject|11
5512706|NCT01550289|19060064|P2|Overall Study|Lost to Follow-up|1
5512707|NCT01550289|19060065|P1|Overall Study|Lost to Follow-up|1
5512708|NCT01550289|19060064|P2|Overall Study|Protocol Violation|0
5512709|NCT01550289|19060065|P1|Overall Study|Protocol Violation|1
5512710|NCT01549964|19060141|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
5512711|NCT01549964|19060142|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
5512712|NCT01549964|19060143|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
5512713|NCT01549964|19060144|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
5512714|NCT01549964|19060141|P4|80-Week Extension Period|Lost to Follow-up|1
5512715|NCT01549964|19060142|P3|80-Week Extension Period|Lost to Follow-up|2
5512716|NCT01549964|19060143|P2|80-Week Extension Period|Lost to Follow-up|0
5512717|NCT01549964|19060144|P1|80-Week Extension Period|Lost to Follow-up|1
5512718|NCT01549964|19060141|P4|80-Week Extension Period|Voluntary Withdrawal|2
5512719|NCT01549964|19060142|P3|80-Week Extension Period|Voluntary Withdrawal|4
5512720|NCT01549964|19060143|P2|80-Week Extension Period|Voluntary Withdrawal|1
5512721|NCT01549964|19060144|P1|80-Week Extension Period|Voluntary Withdrawal|0
5512722|NCT01549964|19060141|P4|80-Week Extension Period|Study Terminated by Sponsor|132
5512723|NCT01549964|19060142|P3|80-Week Extension Period|Study Terminated by Sponsor|132
5512724|NCT01549964|19060143|P2|80-Week Extension Period|Study Terminated by Sponsor|137
5512725|NCT01549964|19060144|P1|80-Week Extension Period|Study Terminated by Sponsor|65
5512726|NCT01549964|19060141|P4|80-Week Extension Period|Pregnancy|0
5512727|NCT01549964|19060142|P3|80-Week Extension Period|Pregnancy|1
5512728|NCT01549964|19060143|P2|80-Week Extension Period|Pregnancy|0
5512729|NCT01549964|19060144|P1|80-Week Extension Period|Pregnancy|0
5512730|NCT01549964|19060141|P4|24-Week Treatment Period|Completion Status Unknown|0
5512731|NCT01549964|19060142|P3|24-Week Treatment Period|Completion Status Unknown|1
5512732|NCT01549964|19060143|P2|24-Week Treatment Period|Completion Status Unknown|0
5512733|NCT01549964|19060144|P1|24-Week Treatment Period|Completion Status Unknown|1
5512734|NCT01549964|19060141|P4|24-Week Treatment Period|Randomized but Not Treated|1
5512735|NCT01549964|19060142|P3|24-Week Treatment Period|Randomized but Not Treated|0
5512736|NCT01549964|19060143|P2|24-Week Treatment Period|Randomized but Not Treated|0
5512737|NCT01549964|19060144|P1|24-Week Treatment Period|Randomized but Not Treated|0
5512738|NCT01549964|19060141|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
5512739|NCT01549964|19060142|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
5512740|NCT01549964|19060143|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
5512741|NCT01549964|19060144|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
5512742|NCT01549964|19060141|P4|24-Week Treatment Period|Other|0
5512743|NCT01549964|19060142|P3|24-Week Treatment Period|Other|1
5512744|NCT01549964|19060143|P2|24-Week Treatment Period|Other|0
5512745|NCT01549964|19060144|P1|24-Week Treatment Period|Other|1
5512746|NCT01549964|19060141|P4|24-Week Treatment Period|Lack of Efficacy|1
5512747|NCT01549964|19060142|P3|24-Week Treatment Period|Lack of Efficacy|1
5512748|NCT01549964|19060143|P2|24-Week Treatment Period|Lack of Efficacy|0
5512749|NCT01549964|19060144|P1|24-Week Treatment Period|Lack of Efficacy|1
5512750|NCT01549964|19060141|P4|24-Week Treatment Period|Lost to Follow-up|2
5512751|NCT01549964|19060142|P3|24-Week Treatment Period|Lost to Follow-up|1
5512752|NCT01549964|19060143|P2|24-Week Treatment Period|Lost to Follow-up|0
5512753|NCT01549964|19060144|P1|24-Week Treatment Period|Lost to Follow-up|1
5512754|NCT01549964|19060141|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
5512755|NCT01549964|19060142|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
5512756|NCT01549964|19060143|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
5512757|NCT01549964|19060144|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
5512758|NCT01549964|19060141|P4|24-Week Treatment Period|Voluntary Withdrawal|8
5512759|NCT01549964|19060142|P3|24-Week Treatment Period|Voluntary Withdrawal|3
5512760|NCT01549964|19060143|P2|24-Week Treatment Period|Voluntary Withdrawal|3
5512761|NCT01549964|19060144|P1|24-Week Treatment Period|Voluntary Withdrawal|6
5512762|NCT01549964|19060141|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
5512763|NCT01549964|19060142|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
5512764|NCT01549964|19060143|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
5512765|NCT01549964|19060144|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
5512766|NCT01549951|19060162|P1|Overall Study|Other|2
5512767|NCT01549951|19060162|P1|Overall Study|Symptomatic deterioration|1
5512768|NCT01549951|19060162|P1|Overall Study|Progressive disease|29
5512769|NCT01549951|19060162|P1|Overall Study|Unsatisfactory therapeutic response|1
5512770|NCT01549951|19060162|P1|Overall Study|Withdrawal by Subject|2
5512771|NCT01549951|19060162|P1|Overall Study|Adverse Event|15
5512772|NCT01549873|19060189|P2|Overall Study|Physician Decision|1
5512773|NCT01549873|19060190|P1|Overall Study|Physician Decision|0
5512774|NCT01549860|19060202|P2|Overall Study|Physician Decision|1
5512775|NCT01549860|19060203|P1|Overall Study|Physician Decision|1
5512776|NCT01549860|19060202|P2|Overall Study|Withdrawal by Subject|0
5512777|NCT01549860|19060203|P1|Overall Study|Withdrawal by Subject|1
5512778|NCT01549652|19060216|P4|Overall Study|Withdrawal by Subject|3
5512779|NCT01549652|19060217|P3|Overall Study|Withdrawal by Subject|5
5512780|NCT01549652|19060218|P2|Overall Study|Withdrawal by Subject|0
5512781|NCT01549652|19060219|P1|Overall Study|Withdrawal by Subject|0
5512782|NCT01549652|19060216|P4|Overall Study|Titration Side Effects|3
5512783|NCT01549652|19060217|P3|Overall Study|Titration Side Effects|6
5512784|NCT01549652|19060218|P2|Overall Study|Titration Side Effects|0
5512785|NCT01549652|19060219|P1|Overall Study|Titration Side Effects|0
5512786|NCT01549652|19060216|P4|Overall Study|Titration Non-Compliance|5
5512787|NCT01549652|19060217|P3|Overall Study|Titration Non-Compliance|4
5512788|NCT01549652|19060218|P2|Overall Study|Titration Non-Compliance|3
5512789|NCT01549652|19060219|P1|Overall Study|Titration Non-Compliance|1
5512790|NCT01549652|19060216|P4|Overall Study|Problem with Infusion|0
5512791|NCT01549652|19060217|P3|Overall Study|Problem with Infusion|0
5512792|NCT01549652|19060218|P2|Overall Study|Problem with Infusion|0
5512793|NCT01549652|19060219|P1|Overall Study|Problem with Infusion|1
5512794|NCT01549652|19060216|P4|Overall Study|Did Not Return Due to Withdrawal Effect|0
5512795|NCT01549652|19060217|P3|Overall Study|Did Not Return Due to Withdrawal Effect|0
5512796|NCT01549652|19060218|P2|Overall Study|Did Not Return Due to Withdrawal Effect|1
5512797|NCT01549652|19060219|P1|Overall Study|Did Not Return Due to Withdrawal Effect|5
5512798|NCT01549652|19060216|P4|Overall Study|Withdrawal Effect|0
5512799|NCT01549652|19060217|P3|Overall Study|Withdrawal Effect|0
5512800|NCT01549652|19060218|P2|Overall Study|Withdrawal Effect|2
5512801|NCT01549652|19060219|P1|Overall Study|Withdrawal Effect|0
5512802|NCT01549652|19060216|P4|Overall Study|Study Drug Titration Failure|0
5512803|NCT01549652|19060217|P3|Overall Study|Study Drug Titration Failure|0
5512804|NCT01549652|19060218|P2|Overall Study|Study Drug Titration Failure|6
5512805|NCT01549652|19060219|P1|Overall Study|Study Drug Titration Failure|5
5512806|NCT01549652|19060216|P4|Overall Study|Did Not Receive Allocated Intervention|0
5512807|NCT01549652|19060217|P3|Overall Study|Did Not Receive Allocated Intervention|2
5512808|NCT01549652|19060218|P2|Overall Study|Did Not Receive Allocated Intervention|0
5512809|NCT01549652|19060219|P1|Overall Study|Did Not Receive Allocated Intervention|0
5512810|NCT01549613|19060237|P2|Overall Study|Lost to Follow-up|11
5512811|NCT01549613|19060238|P1|Overall Study|Lost to Follow-up|11
5512812|NCT01549392|19060276|P2|Overall Study|Withdrawal by Subject|0
5512813|NCT01549392|19060277|P1|Overall Study|Withdrawal by Subject|1
5512814|NCT01549275|19060315|P2|Overall Study|Lost to Follow-up|0
5512815|NCT01549275|19060316|P1|Overall Study|Lost to Follow-up|1
5512816|NCT01549041|19060339|P2|Overall Study|Adverse Event|4
5512817|NCT01549041|19060340|P1|Overall Study|Adverse Event|0
5512818|NCT01549041|19060339|P2|Overall Study|Lack of Efficacy|4
5512819|NCT01549041|19060340|P1|Overall Study|Lack of Efficacy|2
5512820|NCT01549002|19060350|P2|Overall Study|Moderate sedation required|2
5512821|NCT01549002|19060351|P1|Overall Study|Moderate sedation required|0
5512822|NCT01549002|19060350|P2|Overall Study|Excessive pain|2
5512823|NCT01549002|19060351|P1|Overall Study|Excessive pain|0
5512824|NCT01548768|19060378|P4|Overall Study|Non-Compliance|3
5512825|NCT01548768|19060379|P3|Overall Study|Non-Compliance|0
5512826|NCT01548768|19060380|P2|Overall Study|Non-Compliance|0
5512827|NCT01548768|19060381|P1|Overall Study|Non-Compliance|0
5512828|NCT01548768|19060378|P4|Overall Study|Adverse Event|1
5512829|NCT01548768|19060379|P3|Overall Study|Adverse Event|0
5512830|NCT01548768|19060380|P2|Overall Study|Adverse Event|0
5512831|NCT01548768|19060381|P1|Overall Study|Adverse Event|0
5512832|NCT01548768|19060378|P4|Overall Study|Physician Decision|0
5512833|NCT01548768|19060379|P3|Overall Study|Physician Decision|0
5512834|NCT01548768|19060380|P2|Overall Study|Physician Decision|0
5512835|NCT01548768|19060381|P1|Overall Study|Physician Decision|1
5512836|NCT01548768|19060378|P4|Overall Study|Withdrawal by Subject|0
5512837|NCT01548768|19060379|P3|Overall Study|Withdrawal by Subject|1
5512838|NCT01548768|19060380|P2|Overall Study|Withdrawal by Subject|2
5512839|NCT01548768|19060381|P1|Overall Study|Withdrawal by Subject|0
5512840|NCT01548638|19060459|P1|Overall Study|Withdrawal by Subject|1
5512841|NCT01548638|19060459|P1|Overall Study|Protocol Violation|3
5512842|NCT01548599|19060471|P2|Overall Study|Death|1
5512843|NCT01548599|19060472|P1|Overall Study|Death|2
5512844|NCT01548599|19060471|P2|Overall Study|Withdrawal by Subject|0
5512845|NCT01548599|19060472|P1|Overall Study|Withdrawal by Subject|4
5512846|NCT01548599|19060471|P2|Overall Study|Lost to Follow-up|1
5512847|NCT01548599|19060472|P1|Overall Study|Lost to Follow-up|0
5512848|NCT01548573|19060488|P1|Overall Study|Withdrawal by Subject|2
5512849|NCT01548573|19060488|P1|Overall Study|Death|3
5512850|NCT01548417|19060497|P2|Overall Study|Withdrawal by Subject|2
5512851|NCT01548417|19060498|P1|Overall Study|Withdrawal by Subject|0
5512852|NCT01548404|19060508|P2|Overall Study|Other than specified above|2
5512853|NCT01548404|19060509|P1|Overall Study|Other than specified above|0
5512854|NCT01548404|19060508|P2|Overall Study|Withdrawal by Subject|3
5512855|NCT01548404|19060509|P1|Overall Study|Withdrawal by Subject|0
5512856|NCT01548404|19060508|P2|Overall Study|Lost to Follow-up|0
5512857|NCT01548404|19060509|P1|Overall Study|Lost to Follow-up|2
5512858|NCT01548404|19060508|P2|Overall Study|Inadequate response to study treatment|7
5512859|NCT01548404|19060509|P1|Overall Study|Inadequate response to study treatment|23
5512860|NCT01548404|19060508|P2|Overall Study|Physician Decision|1
5512861|NCT01548404|19060509|P1|Overall Study|Physician Decision|2
5512862|NCT01548404|19060508|P2|Overall Study|Adverse Event|1
5512863|NCT01548404|19060509|P1|Overall Study|Adverse Event|3
5512864|NCT01548287|19060548|P5|Randomized Period|Adverse Event|0
5512865|NCT01548287|19060549|P4|Randomized Period|Adverse Event|0
5512866|NCT01548287|19060550|P3|Randomized Period|Adverse Event|5
5512867|NCT01548287|19060551|P2|Randomized Period|Adverse Event|2
5512868|NCT01548287|19060552|P1|Randomized Period|Adverse Event|0
5512869|NCT01548287|19060548|P5|Randomized Period|Did not meet inclusion criteria|0
5512870|NCT01548287|19060549|P4|Randomized Period|Did not meet inclusion criteria|0
5512871|NCT01548287|19060550|P3|Randomized Period|Did not meet inclusion criteria|2
5512872|NCT01548287|19060551|P2|Randomized Period|Did not meet inclusion criteria|0
5512873|NCT01548287|19060552|P1|Randomized Period|Did not meet inclusion criteria|0
5512874|NCT01548287|19060548|P5|Screening|Did not meet eligibility criteria|74
5512875|NCT01548287|19060549|P4|Screening|Did not meet eligibility criteria|0
5512876|NCT01548287|19060550|P3|Screening|Did not meet eligibility criteria|0
5512877|NCT01548287|19060551|P2|Screening|Did not meet eligibility criteria|0
5512878|NCT01548287|19060552|P1|Screening|Did not meet eligibility criteria|0
5512879|NCT01548287|19060548|P5|Screening|No reason provided|9
5512880|NCT01548287|19060549|P4|Screening|No reason provided|0
5512881|NCT01548287|19060550|P3|Screening|No reason provided|0
5512882|NCT01548287|19060551|P2|Screening|No reason provided|0
5512883|NCT01548287|19060552|P1|Screening|No reason provided|0
5512884|NCT01547728|19060609|P1|Overall Study|Screen failure|39
5512885|NCT01547728|19060609|P1|Overall Study|Drug not ready for subject|1
5512886|NCT01547728|19060609|P1|Overall Study|Change in procedure and equipment|1
5512887|NCT01547598|19060718|P2|Overall Study|Other Miscellaneous Reasons|1
5512888|NCT01547598|19060719|P1|Overall Study|Other Miscellaneous Reasons|2
5512889|NCT01547598|19060718|P2|Overall Study|Protocol Violation|1
5512890|NCT01547598|19060719|P1|Overall Study|Protocol Violation|1
5512891|NCT01547598|19060718|P2|Overall Study|Adverse Event|1
5512892|NCT01547598|19060719|P1|Overall Study|Adverse Event|1
5512893|NCT01547598|19060718|P2|Overall Study|Lost to Follow-up|1
5512894|NCT01547598|19060719|P1|Overall Study|Lost to Follow-up|1
5512895|NCT01547598|19060718|P2|Overall Study|Withdrew consent|1
5512896|NCT01547598|19060719|P1|Overall Study|Withdrew consent|1
5512897|NCT01547390|19060736|P2|Overall Study|Adverse Event|0
5512898|NCT01547390|19060737|P1|Overall Study|Adverse Event|3
5512899|NCT01547390|19060736|P2|Overall Study|Lost to Follow-up|2
5512900|NCT01547390|19060737|P1|Overall Study|Lost to Follow-up|0
5512901|NCT01547390|19060736|P2|Overall Study|termination of pregnancy|1
5512902|NCT01547390|19060737|P1|Overall Study|termination of pregnancy|0
5512903|NCT01547390|19060736|P2|Overall Study|Withdrawal by Subject|7
5512904|NCT01547390|19060737|P1|Overall Study|Withdrawal by Subject|10
5512905|NCT01547299|19060747|P2|Overall Study|Withdrawal by Subject|2
5512906|NCT01547299|19060748|P1|Overall Study|Withdrawal by Subject|2
5512907|NCT01547286|19060814|P1|Overall Study|Physician Decision|1
5512908|NCT01547286|19060814|P1|Overall Study|Did not meet all eligibility criteria|1
5512909|NCT01547130|19060834|P2|Overall Study|Lost to Follow-up|5
5512910|NCT01547130|19060835|P1|Overall Study|Lost to Follow-up|9
5512911|NCT01546922|19060858|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
5512912|NCT01546922|19060859|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
5512913|NCT01546922|19060858|P2|Second Period of 10 Weeks|Protocol Violation|1
5512914|NCT01546922|19060859|P1|Second Period of 10 Weeks|Protocol Violation|3
5512915|NCT01546922|19060858|P2|First Period of 10 Weeks|Investigator's judgment|0
5512916|NCT01546922|19060859|P1|First Period of 10 Weeks|Investigator's judgment|1
5512917|NCT01546922|19060858|P2|First Period of 10 Weeks|Withdrawal by Subject|1
5512918|NCT01546922|19060859|P1|First Period of 10 Weeks|Withdrawal by Subject|1
5512919|NCT01546922|19060858|P2|First Period of 10 Weeks|Protocol Violation|1
5512920|NCT01546922|19060859|P1|First Period of 10 Weeks|Protocol Violation|3
5512921|NCT01546883|19060865|P1|Overall Study|other unrelated illness|1
5512922|NCT01546883|19060865|P1|Overall Study|early closure of study|2
5512923|NCT01546883|19060865|P1|Overall Study|Lost to Follow-up|2
5512924|NCT01546883|19060865|P1|Overall Study|Adverse Event|4
5512925|NCT01546883|19060865|P1|Overall Study|Withdrawal by Subject|3
5512926|NCT01546688|19060871|P2|Overall Study|Lack of Efficacy|0
5512927|NCT01546688|19060872|P1|Overall Study|Lack of Efficacy|1
5512928|NCT01546688|19060871|P2|Overall Study|Withdrawal by Subject|1
5512929|NCT01546688|19060872|P1|Overall Study|Withdrawal by Subject|2
5512930|NCT01546688|19060871|P2|Overall Study|Adverse Event|4
5512931|NCT01546688|19060872|P1|Overall Study|Adverse Event|0
5512932|NCT01546649|19060904|P2|Overall Study|Withdrawal by Subject|2
5512933|NCT01546649|19060905|P1|Overall Study|Withdrawal by Subject|1
5512934|NCT01546649|19060904|P2|Overall Study|Discovery of secondary cancer|1
5512935|NCT01546649|19060905|P1|Overall Study|Discovery of secondary cancer|0
5512936|NCT01546649|19060904|P2|Overall Study|Recurrence|1
5512937|NCT01546649|19060905|P1|Overall Study|Recurrence|1
5512938|NCT01546649|19060904|P2|Overall Study|Lack of Efficacy|0
5512939|NCT01546649|19060905|P1|Overall Study|Lack of Efficacy|1
5512940|NCT01546649|19060904|P2|Overall Study|Protocol Violation|0
5512941|NCT01546649|19060905|P1|Overall Study|Protocol Violation|1
5512942|NCT01546649|19060904|P2|Overall Study|Adverse Event|5
5512943|NCT01546649|19060905|P1|Overall Study|Adverse Event|4
5512944|NCT01546623|19060940|P2|Overall Study|Did Not Receive Study Drug|1
5512945|NCT01546623|19060941|P1|Overall Study|Did Not Receive Study Drug|1
5512946|NCT01546623|19060940|P2|Overall Study|High Prostate specific antigen|1
5512947|NCT01546623|19060941|P1|Overall Study|High Prostate specific antigen|2
5512948|NCT01546623|19060940|P2|Overall Study|Major Protocol Deviation|1
5512949|NCT01546623|19060941|P1|Overall Study|Major Protocol Deviation|1
5512950|NCT01546623|19060940|P2|Overall Study|Adverse Event|3
5512951|NCT01546623|19060941|P1|Overall Study|Adverse Event|2
5512952|NCT01546519|19060971|P4|Overall Study|Withdrawal by Subject|0
5512953|NCT01546519|19060972|P3|Overall Study|Withdrawal by Subject|0
5512954|NCT01546519|19060973|P2|Overall Study|Withdrawal by Subject|0
5512955|NCT01546519|19060974|P1|Overall Study|Withdrawal by Subject|1
5512956|NCT01546519|19060971|P4|Overall Study|Physician Decision|3
5512957|NCT01546519|19060972|P3|Overall Study|Physician Decision|2
5512958|NCT01546519|19060973|P2|Overall Study|Physician Decision|5
5512959|NCT01546519|19060974|P1|Overall Study|Physician Decision|6
5512960|NCT01546519|19060971|P4|Overall Study|related to disease progression|1
5512961|NCT01546519|19060972|P3|Overall Study|related to disease progression|2
5512962|NCT01546519|19060973|P2|Overall Study|related to disease progression|2
5512963|NCT01546519|19060974|P1|Overall Study|related to disease progression|2
5512964|NCT01546519|19060971|P4|Overall Study|Death|1
5512965|NCT01546519|19060972|P3|Overall Study|Death|3
5512966|NCT01546519|19060973|P2|Overall Study|Death|1
5512967|NCT01546519|19060974|P1|Overall Study|Death|0
5512968|NCT01546519|19060971|P4|Overall Study|Adverse Event|1
5512969|NCT01546519|19060972|P3|Overall Study|Adverse Event|1
5512970|NCT01546519|19060973|P2|Overall Study|Adverse Event|0
5512971|NCT01546519|19060974|P1|Overall Study|Adverse Event|0
5512972|NCT01546207|19061039|P1|Overall Study|Death|1
5512973|NCT01546168|19061054|P2|Overall Study|ineligible after signing consent|0
5512974|NCT01546168|19061055|P1|Overall Study|ineligible after signing consent|2
5512975|NCT01546168|19061054|P2|Overall Study|Withdrawal by Subject|0
5512976|NCT01546168|19061055|P1|Overall Study|Withdrawal by Subject|1
5512977|NCT01546168|19061054|P2|Overall Study|Lost to Follow-up|0
5512978|NCT01546168|19061055|P1|Overall Study|Lost to Follow-up|1
5512979|NCT01546155|19061067|P1|Overall Study|could not tolerate long scan duration|3
5512980|NCT01546142|19061073|P2|Overall Study|Subject Randomized but Not Treated|0
5512981|NCT01546142|19061074|P1|Overall Study|Subject Randomized but Not Treated|1
5512982|NCT01546142|19061073|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
5512983|NCT01546142|19061074|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
5512984|NCT01546142|19061073|P2|Overall Study|Lost to Follow-up|15
5512985|NCT01546142|19061074|P1|Overall Study|Lost to Follow-up|20
5512986|NCT01546142|19061073|P2|Overall Study|Adverse Event|3
5512987|NCT01546142|19061074|P1|Overall Study|Adverse Event|6
5512988|NCT01546142|19061073|P2|Overall Study|Subject Noncompliance|1
5512989|NCT01546142|19061074|P1|Overall Study|Subject Noncompliance|1
5512990|NCT01546142|19061073|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
5512991|NCT01546142|19061074|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
5512992|NCT01546038|19061092|P9|Overall Study|: Randomized, not treated|3
5512993|NCT01546038|19061093|P8|Overall Study|: Randomized, not treated|4
5512994|NCT01546038|19061094|P7|Overall Study|: Randomized, not treated|2
5512995|NCT01546038|19061095|P6|Overall Study|: Randomized, not treated|0
5512996|NCT01546038|19061096|P5|Overall Study|: Randomized, not treated|0
5512997|NCT01546038|19061097|P4|Overall Study|: Randomized, not treated|0
5512998|NCT01546038|19061098|P3|Overall Study|: Randomized, not treated|0
5512999|NCT01546038|19061099|P2|Overall Study|: Randomized, not treated|0
5513000|NCT01546038|19061100|P1|Overall Study|: Randomized, not treated|0
5513001|NCT01546038|19061092|P9|Overall Study|Withdrawal by Subject|1
5513002|NCT01546038|19061093|P8|Overall Study|Withdrawal by Subject|3
5513003|NCT01546038|19061094|P7|Overall Study|Withdrawal by Subject|3
5513004|NCT01546038|19061095|P6|Overall Study|Withdrawal by Subject|1
5513005|NCT01546038|19061096|P5|Overall Study|Withdrawal by Subject|0
5513006|NCT01546038|19061097|P4|Overall Study|Withdrawal by Subject|1
5513007|NCT01546038|19061098|P3|Overall Study|Withdrawal by Subject|0
5513008|NCT01546038|19061099|P2|Overall Study|Withdrawal by Subject|0
5513009|NCT01546038|19061100|P1|Overall Study|Withdrawal by Subject|1
5513010|NCT01546038|19061092|P9|Overall Study|Lost to Follow-up|0
5513011|NCT01546038|19061093|P8|Overall Study|Lost to Follow-up|1
5513012|NCT01546038|19061094|P7|Overall Study|Lost to Follow-up|2
5513013|NCT01546038|19061095|P6|Overall Study|Lost to Follow-up|0
5513014|NCT01546038|19061096|P5|Overall Study|Lost to Follow-up|1
5513015|NCT01546038|19061097|P4|Overall Study|Lost to Follow-up|0
5513016|NCT01546038|19061098|P3|Overall Study|Lost to Follow-up|0
5513017|NCT01546038|19061099|P2|Overall Study|Lost to Follow-up|0
5513018|NCT01546038|19061100|P1|Overall Study|Lost to Follow-up|0
5513019|NCT01546038|19061092|P9|Overall Study|Death|39
5513020|NCT01546038|19061093|P8|Overall Study|Death|76
5513021|NCT01546038|19061094|P7|Overall Study|Death|46
5513022|NCT01546038|19061095|P6|Overall Study|Death|3
5513023|NCT01546038|19061096|P5|Overall Study|Death|9
5513024|NCT01546038|19061097|P4|Overall Study|Death|2
5513025|NCT01546038|19061098|P3|Overall Study|Death|4
5513026|NCT01546038|19061099|P2|Overall Study|Death|6
5513027|NCT01546038|19061100|P1|Overall Study|Death|15
5513028|NCT01545817|19061294|P2|Everolimus|Adverse Event|6
5513029|NCT01545817|19061295|P1|Everolimus|Adverse Event|0
5513030|NCT01545817|19061294|P2|Everolimus|Disease progression|25
5513031|NCT01545817|19061295|P1|Everolimus|Disease progression|0
5513032|NCT01545817|19061294|P2|Everolimus|Other reason|7
5513033|NCT01545817|19061295|P1|Everolimus|Other reason|0
5513034|NCT01545817|19061294|P2|Pazopanib|Other reason|0
5513035|NCT01545817|19061295|P1|Pazopanib|Other reason|4
5513036|NCT01545817|19061294|P2|Pazopanib|Adverse Event|0
5513037|NCT01545817|19061295|P1|Pazopanib|Adverse Event|19
5513038|NCT01545817|19061294|P2|Pazopanib|Disease progression|0
5513039|NCT01545817|19061295|P1|Pazopanib|Disease progression|51
5513040|NCT01545388|19061444|P3|Overall Study|Other|0
5513041|NCT01545388|19061445|P2|Overall Study|Other|1
5513042|NCT01545388|19061446|P1|Overall Study|Other|1
5513043|NCT01545388|19061444|P3|Overall Study|Withdrawal by Subject|2
5513044|NCT01545388|19061445|P2|Overall Study|Withdrawal by Subject|4
5513045|NCT01545388|19061446|P1|Overall Study|Withdrawal by Subject|1
5513046|NCT01545388|19061444|P3|Overall Study|Participant moved or relocated|0
5513047|NCT01545388|19061445|P2|Overall Study|Participant moved or relocated|0
5513048|NCT01545388|19061446|P1|Overall Study|Participant moved or relocated|1
5513049|NCT01545388|19061444|P3|Overall Study|Lack of Efficacy|5
5513050|NCT01545388|19061445|P2|Overall Study|Lack of Efficacy|2
5513051|NCT01545388|19061446|P1|Overall Study|Lack of Efficacy|3
5513052|NCT01545388|19061444|P3|Overall Study|Adverse Event|1
5513053|NCT01545388|19061445|P2|Overall Study|Adverse Event|4
5513054|NCT01545388|19061446|P1|Overall Study|Adverse Event|2
5513055|NCT01545375|19061465|P2|Overall Study|Withdrawal by Subject|55
5513056|NCT01545375|19061466|P1|Overall Study|Withdrawal by Subject|58
5513057|NCT01545375|19061465|P2|Overall Study|Protocol Violation|3
5513058|NCT01545375|19061466|P1|Overall Study|Protocol Violation|3
5513059|NCT01545375|19061465|P2|Overall Study|Lost to Follow-up|31
5513060|NCT01545375|19061466|P1|Overall Study|Lost to Follow-up|34
5513061|NCT01545375|19061465|P2|Overall Study|Adverse Event|1
5513062|NCT01545375|19061466|P1|Overall Study|Adverse Event|2
5513063|NCT01545076|19061598|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
5513064|NCT01545076|19061599|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
5513065|NCT01545076|19061600|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
5513066|NCT01545076|19061601|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
5513067|NCT01545076|19061602|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
5513068|NCT01545076|19061598|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
5513069|NCT01545076|19061599|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
5513070|NCT01545076|19061600|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
5513071|NCT01545076|19061601|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
5513072|NCT01545076|19061602|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
5513073|NCT01545076|19061598|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
5513074|NCT01545076|19061599|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
5513075|NCT01545076|19061600|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
5513076|NCT01545076|19061601|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
5513077|NCT01545076|19061602|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
5513078|NCT01545076|19061598|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5513079|NCT01545076|19061599|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
5513080|NCT01545076|19061600|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5513081|NCT01545076|19061601|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5513082|NCT01545076|19061602|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
5513083|NCT01545076|19061598|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
5513084|NCT01545076|19061599|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
5513085|NCT01545076|19061600|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
5513086|NCT01545076|19061601|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
5513087|NCT01545076|19061602|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
5513088|NCT01545076|19061598|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5513089|NCT01545076|19061599|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5513090|NCT01545076|19061600|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5513091|NCT01545076|19061601|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
5513092|NCT01545076|19061602|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
5513093|NCT01545076|19061598|P5|IgPro10 Restabilization Period|Protocol Violation|0
5513094|NCT01545076|19061599|P4|IgPro10 Restabilization Period|Protocol Violation|0
5513095|NCT01545076|19061600|P3|IgPro10 Restabilization Period|Protocol Violation|0
5513096|NCT01545076|19061601|P2|IgPro10 Restabilization Period|Protocol Violation|0
5513097|NCT01545076|19061602|P1|IgPro10 Restabilization Period|Protocol Violation|1
5513098|NCT01545076|19061598|P5|IgPro10 Restabilization Period|Physician Decision|0
5513099|NCT01545076|19061599|P4|IgPro10 Restabilization Period|Physician Decision|0
5513100|NCT01545076|19061600|P3|IgPro10 Restabilization Period|Physician Decision|0
5513101|NCT01545076|19061601|P2|IgPro10 Restabilization Period|Physician Decision|0
5513102|NCT01545076|19061602|P1|IgPro10 Restabilization Period|Physician Decision|2
5513103|NCT01545076|19061598|P5|IgPro10 Restabilization Period|Adverse Event|0
5513104|NCT01545076|19061599|P4|IgPro10 Restabilization Period|Adverse Event|0
5513105|NCT01545076|19061600|P3|IgPro10 Restabilization Period|Adverse Event|0
5513106|NCT01545076|19061601|P2|IgPro10 Restabilization Period|Adverse Event|0
5513107|NCT01545076|19061602|P1|IgPro10 Restabilization Period|Adverse Event|4
5513108|NCT01544920|19061673|P2|Overall Study|Withdrawal by Subject|4
5513109|NCT01544920|19061674|P1|Overall Study|Withdrawal by Subject|4
5513110|NCT01544920|19061673|P2|Overall Study|Physician Decision|1
5513111|NCT01544920|19061674|P1|Overall Study|Physician Decision|4
5513112|NCT01544920|19061673|P2|Overall Study|Protocol Violation|2
5513113|NCT01544920|19061674|P1|Overall Study|Protocol Violation|0
5513114|NCT01544920|19061673|P2|Overall Study|Lost to Follow-up|12
5513115|NCT01544920|19061674|P1|Overall Study|Lost to Follow-up|11
5513116|NCT01544920|19061673|P2|Overall Study|Death|1
5513117|NCT01544920|19061674|P1|Overall Study|Death|0
5513118|NCT01544920|19061673|P2|Overall Study|Adverse Event|3
5513119|NCT01544920|19061674|P1|Overall Study|Adverse Event|0
5513120|NCT01544595|19061688|P6|Status at Week 156|Lack of Efficacy|5
5513121|NCT01544595|19061689|P5|Status at Week 156|Lack of Efficacy|10
5513122|NCT01544595|19061690|P4|Status at Week 156|Lack of Efficacy|4
5513123|NCT01544595|19061691|P3|Status at Week 156|Lack of Efficacy|1
5513124|NCT01544595|19061692|P2|Status at Week 156|Lack of Efficacy|0
5513125|NCT01544595|19061693|P1|Status at Week 156|Lack of Efficacy|1
5513126|NCT01544595|19061688|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
5513127|NCT01544595|19061689|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
5513128|NCT01544595|19061690|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
5513129|NCT01544595|19061691|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
5513130|NCT01544595|19061692|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
5513131|NCT01544595|19061693|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
5513132|NCT01544595|19061688|P6|Status at Week 156|Technical problems|0
5513133|NCT01544595|19061689|P5|Status at Week 156|Technical problems|0
5513134|NCT01544595|19061690|P4|Status at Week 156|Technical problems|1
5513135|NCT01544595|19061691|P3|Status at Week 156|Technical problems|0
5513136|NCT01544595|19061692|P2|Status at Week 156|Technical problems|1
5513137|NCT01544595|19061693|P1|Status at Week 156|Technical problems|3
5513138|NCT01544595|19061688|P6|Status at Week 156|Protocol Violation|0
5513139|NCT01544595|19061689|P5|Status at Week 156|Protocol Violation|0
5513140|NCT01544595|19061690|P4|Status at Week 156|Protocol Violation|2
5513141|NCT01544595|19061691|P3|Status at Week 156|Protocol Violation|2
5513142|NCT01544595|19061692|P2|Status at Week 156|Protocol Violation|1
5513143|NCT01544595|19061693|P1|Status at Week 156|Protocol Violation|3
5513144|NCT01544595|19061688|P6|Status at Week 156|Pregnancy|0
5513145|NCT01544595|19061689|P5|Status at Week 156|Pregnancy|0
5513146|NCT01544595|19061690|P4|Status at Week 156|Pregnancy|0
5513147|NCT01544595|19061691|P3|Status at Week 156|Pregnancy|0
5513148|NCT01544595|19061692|P2|Status at Week 156|Pregnancy|3
5513149|NCT01544595|19061693|P1|Status at Week 156|Pregnancy|2
5513150|NCT01544595|19061688|P6|Status at Week 156|Physician Decision|0
5513151|NCT01544595|19061689|P5|Status at Week 156|Physician Decision|0
5513152|NCT01544595|19061690|P4|Status at Week 156|Physician Decision|0
5513153|NCT01544595|19061691|P3|Status at Week 156|Physician Decision|1
5513154|NCT01544595|19061692|P2|Status at Week 156|Physician Decision|3
5513155|NCT01544595|19061693|P1|Status at Week 156|Physician Decision|0
5513156|NCT01544595|19061688|P6|Status at Week 156|Non-compliance with study treatement|1
5513157|NCT01544595|19061689|P5|Status at Week 156|Non-compliance with study treatement|0
5513158|NCT01544595|19061690|P4|Status at Week 156|Non-compliance with study treatement|1
5513159|NCT01544595|19061691|P3|Status at Week 156|Non-compliance with study treatement|0
5513160|NCT01544595|19061692|P2|Status at Week 156|Non-compliance with study treatement|1
5513161|NCT01544595|19061693|P1|Status at Week 156|Non-compliance with study treatement|0
5513162|NCT01544595|19061688|P6|Status at Week 156|Lost to Follow-up|1
5513163|NCT01544595|19061689|P5|Status at Week 156|Lost to Follow-up|4
5513164|NCT01544595|19061690|P4|Status at Week 156|Lost to Follow-up|1
5513165|NCT01544595|19061691|P3|Status at Week 156|Lost to Follow-up|0
5513166|NCT01544595|19061692|P2|Status at Week 156|Lost to Follow-up|4
5513167|NCT01544595|19061693|P1|Status at Week 156|Lost to Follow-up|4
5513168|NCT01544595|19061688|P6|Status at Week 156|Adverse Event|2
5513169|NCT01544595|19061689|P5|Status at Week 156|Adverse Event|4
5513170|NCT01544595|19061690|P4|Status at Week 156|Adverse Event|3
5513171|NCT01544595|19061691|P3|Status at Week 156|Adverse Event|1
5513172|NCT01544595|19061692|P2|Status at Week 156|Adverse Event|11
5513173|NCT01544595|19061693|P1|Status at Week 156|Adverse Event|9
5513174|NCT01544595|19061688|P6|Status at Week 156|Withdrawal by Subject|6
5513175|NCT01544595|19061689|P5|Status at Week 156|Withdrawal by Subject|20
5513176|NCT01544595|19061690|P4|Status at Week 156|Withdrawal by Subject|9
5513177|NCT01544595|19061691|P3|Status at Week 156|Withdrawal by Subject|4
5513178|NCT01544595|19061692|P2|Status at Week 156|Withdrawal by Subject|10
5513179|NCT01544595|19061693|P1|Status at Week 156|Withdrawal by Subject|9
5513180|NCT01544595|19061688|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
5513345|NCT01544179|19061991|P1|Overall Study|Withdrawal by Subject|12
5513181|NCT01544595|19061689|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
5513182|NCT01544595|19061690|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
5513183|NCT01544595|19061691|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
5513184|NCT01544595|19061692|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
5513185|NCT01544595|19061693|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
5513186|NCT01544595|19061688|P6|Status at Week 68|Withdrawal by Subject|0
5513187|NCT01544595|19061689|P5|Status at Week 68|Withdrawal by Subject|0
5513188|NCT01544595|19061690|P4|Status at Week 68|Withdrawal by Subject|2
5513189|NCT01544595|19061691|P3|Status at Week 68|Withdrawal by Subject|1
5513190|NCT01544595|19061692|P2|Status at Week 68|Withdrawal by Subject|1
5513191|NCT01544595|19061693|P1|Status at Week 68|Withdrawal by Subject|0
5513192|NCT01544595|19061688|P6|Status at Week 68|Technical problems|0
5513193|NCT01544595|19061689|P5|Status at Week 68|Technical problems|0
5513194|NCT01544595|19061690|P4|Status at Week 68|Technical problems|1
5513195|NCT01544595|19061691|P3|Status at Week 68|Technical problems|0
5513196|NCT01544595|19061692|P2|Status at Week 68|Technical problems|0
5513197|NCT01544595|19061693|P1|Status at Week 68|Technical problems|1
5513198|NCT01544595|19061688|P6|Status at Week 68|Protocol Violation|0
5513199|NCT01544595|19061689|P5|Status at Week 68|Protocol Violation|0
5513200|NCT01544595|19061690|P4|Status at Week 68|Protocol Violation|1
5513201|NCT01544595|19061691|P3|Status at Week 68|Protocol Violation|1
5513202|NCT01544595|19061692|P2|Status at Week 68|Protocol Violation|0
5513203|NCT01544595|19061693|P1|Status at Week 68|Protocol Violation|2
5513204|NCT01544595|19061688|P6|Status at Week 68|Non-compliance with study treatment|0
5513205|NCT01544595|19061689|P5|Status at Week 68|Non-compliance with study treatment|0
5513206|NCT01544595|19061690|P4|Status at Week 68|Non-compliance with study treatment|1
5513207|NCT01544595|19061691|P3|Status at Week 68|Non-compliance with study treatment|0
5513208|NCT01544595|19061692|P2|Status at Week 68|Non-compliance with study treatment|0
5513209|NCT01544595|19061693|P1|Status at Week 68|Non-compliance with study treatment|1
5513210|NCT01544595|19061688|P6|Status at Week 68|Lost to Follow-up|0
5513211|NCT01544595|19061689|P5|Status at Week 68|Lost to Follow-up|0
5513212|NCT01544595|19061690|P4|Status at Week 68|Lost to Follow-up|0
5513213|NCT01544595|19061691|P3|Status at Week 68|Lost to Follow-up|0
5513214|NCT01544595|19061692|P2|Status at Week 68|Lost to Follow-up|1
5513215|NCT01544595|19061693|P1|Status at Week 68|Lost to Follow-up|1
5513216|NCT01544595|19061688|P6|Status at Week 68|Lack of Efficacy|0
5513217|NCT01544595|19061689|P5|Status at Week 68|Lack of Efficacy|0
5513218|NCT01544595|19061690|P4|Status at Week 68|Lack of Efficacy|0
5513219|NCT01544595|19061691|P3|Status at Week 68|Lack of Efficacy|0
5513220|NCT01544595|19061692|P2|Status at Week 68|Lack of Efficacy|0
5513221|NCT01544595|19061693|P1|Status at Week 68|Lack of Efficacy|1
5513222|NCT01544595|19061688|P6|Status at Week 68|Adverse Event|0
5513223|NCT01544595|19061689|P5|Status at Week 68|Adverse Event|0
5513224|NCT01544595|19061690|P4|Status at Week 68|Adverse Event|0
5513225|NCT01544595|19061691|P3|Status at Week 68|Adverse Event|1
5513226|NCT01544595|19061692|P2|Status at Week 68|Adverse Event|2
5513227|NCT01544595|19061693|P1|Status at Week 68|Adverse Event|3
5513228|NCT01544582|19061769|P4|Analysis Population|Participant in Jail|0
5513229|NCT01544582|19061770|P3|Analysis Population|Participant in Jail|1
5513230|NCT01544582|19061771|P2|Analysis Population|Participant in Jail|0
5513231|NCT01544582|19061772|P1|Analysis Population|Participant in Jail|0
5513232|NCT01544582|19061769|P4|Analysis Population|Programmed Surgery|0
5513233|NCT01544582|19061770|P3|Analysis Population|Programmed Surgery|0
5513234|NCT01544582|19061771|P2|Analysis Population|Programmed Surgery|1
5513235|NCT01544582|19061772|P1|Analysis Population|Programmed Surgery|0
5513236|NCT01544582|19061769|P4|Analysis Population|Poor Participant Compliance|0
5513237|NCT01544582|19061770|P3|Analysis Population|Poor Participant Compliance|0
5513238|NCT01544582|19061771|P2|Analysis Population|Poor Participant Compliance|1
5513239|NCT01544582|19061772|P1|Analysis Population|Poor Participant Compliance|0
5513240|NCT01544582|19061769|P4|Analysis Population|Poor Adherence|0
5513241|NCT01544582|19061770|P3|Analysis Population|Poor Adherence|1
5513242|NCT01544582|19061771|P2|Analysis Population|Poor Adherence|0
5513243|NCT01544582|19061772|P1|Analysis Population|Poor Adherence|0
5513244|NCT01544582|19061769|P4|Analysis Population|No Social Insurance|0
5513245|NCT01544582|19061770|P3|Analysis Population|No Social Insurance|1
5513246|NCT01544582|19061771|P2|Analysis Population|No Social Insurance|0
5513247|NCT01544582|19061772|P1|Analysis Population|No Social Insurance|0
5513248|NCT01544582|19061769|P4|Analysis Population|Liver Transplantation|0
5513249|NCT01544582|19061770|P3|Analysis Population|Liver Transplantation|1
5513250|NCT01544582|19061771|P2|Analysis Population|Liver Transplantation|0
5513251|NCT01544582|19061772|P1|Analysis Population|Liver Transplantation|0
5513252|NCT01544582|19061769|P4|Analysis Population|Intolerance|0
5513253|NCT01544582|19061770|P3|Analysis Population|Intolerance|0
5513254|NCT01544582|19061771|P2|Analysis Population|Intolerance|1
5513255|NCT01544582|19061772|P1|Analysis Population|Intolerance|0
5513256|NCT01544582|19061769|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
5513257|NCT01544582|19061770|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
5513258|NCT01544582|19061771|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
5513259|NCT01544582|19061772|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
5513260|NCT01544582|19061769|P4|Analysis Population|Bad Tolerance to Treatment|0
5513261|NCT01544582|19061770|P3|Analysis Population|Bad Tolerance to Treatment|2
5513262|NCT01544582|19061771|P2|Analysis Population|Bad Tolerance to Treatment|0
5513263|NCT01544582|19061772|P1|Analysis Population|Bad Tolerance to Treatment|0
5513264|NCT01544582|19061769|P4|Analysis Population|Lost to Follow-up|5
5513265|NCT01544582|19061770|P3|Analysis Population|Lost to Follow-up|6
5513266|NCT01544582|19061771|P2|Analysis Population|Lost to Follow-up|6
5513267|NCT01544582|19061772|P1|Analysis Population|Lost to Follow-up|0
5513268|NCT01544582|19061769|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
5513269|NCT01544582|19061770|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
5513270|NCT01544582|19061771|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
5513271|NCT01544582|19061772|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
5513272|NCT01544582|19061769|P4|Analysis Population|Effectiveness Reason|12
5513273|NCT01544582|19061770|P3|Analysis Population|Effectiveness Reason|29
5513274|NCT01544582|19061771|P2|Analysis Population|Effectiveness Reason|48
5513275|NCT01544582|19061772|P1|Analysis Population|Effectiveness Reason|0
5513276|NCT01544582|19061769|P4|Analysis Population|Safety Reason|8
5513277|NCT01544582|19061770|P3|Analysis Population|Safety Reason|31
5513278|NCT01544582|19061771|P2|Analysis Population|Safety Reason|33
5513279|NCT01544582|19061772|P1|Analysis Population|Safety Reason|0
5513280|NCT01544582|19061769|P4|Analysis Population|Physician Decision|9
5513281|NCT01544582|19061770|P3|Analysis Population|Physician Decision|10
5513282|NCT01544582|19061771|P2|Analysis Population|Physician Decision|13
5513283|NCT01544582|19061772|P1|Analysis Population|Physician Decision|0
5513284|NCT01544582|19061769|P4|Analysis Population|Participant Refuses to Continue Study|4
5513285|NCT01544582|19061770|P3|Analysis Population|Participant Refuses to Continue Study|17
5513286|NCT01544582|19061771|P2|Analysis Population|Participant Refuses to Continue Study|15
5513287|NCT01544582|19061772|P1|Analysis Population|Participant Refuses to Continue Study|0
5513288|NCT01544582|19061769|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
5513289|NCT01544582|19061770|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
5513290|NCT01544582|19061771|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
5513291|NCT01544582|19061772|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
5513292|NCT01544582|19061769|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
5513293|NCT01544582|19061770|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
5513294|NCT01544582|19061771|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
5513295|NCT01544582|19061772|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
5513296|NCT01544491|19061832|P2|Overall Study|administrative problems|0
5513297|NCT01544491|19061833|P1|Overall Study|administrative problems|2
5513298|NCT01544491|19061832|P2|Overall Study|Lost to Follow-up|1
5513299|NCT01544491|19061833|P1|Overall Study|Lost to Follow-up|0
5513300|NCT01544491|19061832|P2|Overall Study|Withdrawal by Subject|2
5513301|NCT01544491|19061833|P1|Overall Study|Withdrawal by Subject|3
5513302|NCT01544478|19061859|P1|Overall Study|Withdrawal by Subject|52
5513303|NCT01544478|19061859|P1|Overall Study|Pregnancy|1
5513304|NCT01544478|19061859|P1|Overall Study|Physician Decision|15
5513305|NCT01544478|19061859|P1|Overall Study|Lost to Follow-up|48
5513306|NCT01544478|19061859|P1|Overall Study|Death|1
5513307|NCT01544478|19061859|P1|Overall Study|Adverse Event|1
5513308|NCT01544348|19061902|P8|Overall Study|Physician Decision|0
5513309|NCT01544348|19061903|P7|Overall Study|Physician Decision|0
5513310|NCT01544348|19061904|P6|Overall Study|Physician Decision|1
5513311|NCT01544348|19061905|P5|Overall Study|Physician Decision|0
5513312|NCT01544348|19061906|P4|Overall Study|Physician Decision|0
5513313|NCT01544348|19061907|P3|Overall Study|Physician Decision|0
5513314|NCT01544348|19061908|P2|Overall Study|Physician Decision|0
5513315|NCT01544348|19061909|P1|Overall Study|Physician Decision|0
5513316|NCT01544348|19061902|P8|Overall Study|Withdrawal by Subject|0
5513317|NCT01544348|19061903|P7|Overall Study|Withdrawal by Subject|1
5513318|NCT01544348|19061904|P6|Overall Study|Withdrawal by Subject|2
5513319|NCT01544348|19061905|P5|Overall Study|Withdrawal by Subject|1
5513320|NCT01544348|19061906|P4|Overall Study|Withdrawal by Subject|0
5513321|NCT01544348|19061907|P3|Overall Study|Withdrawal by Subject|0
5513322|NCT01544348|19061908|P2|Overall Study|Withdrawal by Subject|0
5513323|NCT01544348|19061909|P1|Overall Study|Withdrawal by Subject|1
5513324|NCT01544348|19061902|P8|Overall Study|Lost to Follow-up|0
5513325|NCT01544348|19061903|P7|Overall Study|Lost to Follow-up|1
5513326|NCT01544348|19061904|P6|Overall Study|Lost to Follow-up|0
5513327|NCT01544348|19061905|P5|Overall Study|Lost to Follow-up|0
5513328|NCT01544348|19061906|P4|Overall Study|Lost to Follow-up|0
5513329|NCT01544348|19061907|P3|Overall Study|Lost to Follow-up|0
5513330|NCT01544348|19061908|P2|Overall Study|Lost to Follow-up|0
5513331|NCT01544348|19061909|P1|Overall Study|Lost to Follow-up|1
5513332|NCT01544309|19061951|P2|Overall Study|Administered prohibit prior medication|0
5513333|NCT01544309|19061952|P1|Overall Study|Administered prohibit prior medication|1
5513334|NCT01544309|19061951|P2|Overall Study|Not performed pre-dose examination|2
5513335|NCT01544309|19061952|P1|Overall Study|Not performed pre-dose examination|1
5513336|NCT01544309|19061951|P2|Overall Study|Physician Decision|1
5513337|NCT01544309|19061952|P1|Overall Study|Physician Decision|4
5513338|NCT01544309|19061951|P2|Overall Study|Protocol Violation|1
5513339|NCT01544309|19061952|P1|Overall Study|Protocol Violation|2
5513340|NCT01544309|19061951|P2|Overall Study|Withdrawal by Subject|7
5513341|NCT01544309|19061952|P1|Overall Study|Withdrawal by Subject|12
5513342|NCT01544179|19061990|P2|Overall Study|Eligibility criteria not fulfilled|0
5513343|NCT01544179|19061991|P1|Overall Study|Eligibility criteria not fulfilled|1
5513344|NCT01544179|19061990|P2|Overall Study|Withdrawal by Subject|7
5513346|NCT01544179|19061990|P2|Overall Study|Adverse Event|1
5513347|NCT01544179|19061991|P1|Overall Study|Adverse Event|0
5513348|NCT01544179|19061990|P2|Overall Study|Lost to Follow-up|1
5513349|NCT01544179|19061991|P1|Overall Study|Lost to Follow-up|0
5513350|NCT01544179|19061990|P2|Overall Study|Death|37
5513351|NCT01544179|19061991|P1|Overall Study|Death|50
5513352|NCT01544153|19062084|P4|Overall Study|Non-smoker|0
5513353|NCT01544153|19062085|P3|Overall Study|Non-smoker|1
5513354|NCT01544153|19062086|P2|Overall Study|Non-smoker|0
5513355|NCT01544153|19062087|P1|Overall Study|Non-smoker|0
5513356|NCT01544153|19062084|P4|Overall Study|Under 18|0
5513357|NCT01544153|19062085|P3|Overall Study|Under 18|0
5513358|NCT01544153|19062086|P2|Overall Study|Under 18|1
5513359|NCT01544153|19062087|P1|Overall Study|Under 18|0
5513360|NCT01544127|19062104|P3|Overall Study|Went active duty|1
5513361|NCT01544127|19062105|P2|Overall Study|Went active duty|0
5513362|NCT01544127|19062106|P1|Overall Study|Went active duty|0
5513363|NCT01544127|19062104|P3|Overall Study|Researcher withdrew|0
5513364|NCT01544127|19062105|P2|Overall Study|Researcher withdrew|0
5513365|NCT01544127|19062106|P1|Overall Study|Researcher withdrew|1
5513366|NCT01544127|19062104|P3|Overall Study|Became Psychotic|0
5513367|NCT01544127|19062105|P2|Overall Study|Became Psychotic|0
5513368|NCT01544127|19062106|P1|Overall Study|Became Psychotic|1
5513369|NCT01544127|19062104|P3|Overall Study|Jail or Prison|2
5513370|NCT01544127|19062105|P2|Overall Study|Jail or Prison|1
5513371|NCT01544127|19062106|P1|Overall Study|Jail or Prison|1
5513372|NCT01544127|19062104|P3|Overall Study|Death|0
5513373|NCT01544127|19062105|P2|Overall Study|Death|0
5513374|NCT01544127|19062106|P1|Overall Study|Death|1
5513375|NCT01544127|19062104|P3|Overall Study|Discharged out of catchment area|1
5513376|NCT01544127|19062105|P2|Overall Study|Discharged out of catchment area|1
5513377|NCT01544127|19062106|P1|Overall Study|Discharged out of catchment area|1
5513378|NCT01544127|19062104|P3|Overall Study|Withdrawal by Subject|1
5513379|NCT01544127|19062105|P2|Overall Study|Withdrawal by Subject|2
5513380|NCT01544127|19062106|P1|Overall Study|Withdrawal by Subject|2
5513381|NCT01544127|19062104|P3|Overall Study|Lost to Follow-up|9
5513382|NCT01544127|19062105|P2|Overall Study|Lost to Follow-up|2
5513383|NCT01544127|19062106|P1|Overall Study|Lost to Follow-up|4
5513384|NCT01544114|19062126|P3|Overall Study|Protocol Violation|0
5513385|NCT01544114|19062127|P2|Overall Study|Protocol Violation|1
5513386|NCT01544114|19062128|P1|Overall Study|Protocol Violation|0
5513387|NCT01544114|19062126|P3|Overall Study|Adverse Event|2
5513388|NCT01544114|19062127|P2|Overall Study|Adverse Event|1
5513389|NCT01544114|19062128|P1|Overall Study|Adverse Event|1
5513390|NCT01544114|19062126|P3|Overall Study|Lost to Follow-up|0
5513391|NCT01544114|19062127|P2|Overall Study|Lost to Follow-up|2
5513392|NCT01544114|19062128|P1|Overall Study|Lost to Follow-up|0
5513393|NCT01544114|19062126|P3|Overall Study|Withdrawal by Subject|3
5513394|NCT01544114|19062127|P2|Overall Study|Withdrawal by Subject|0
5513395|NCT01544114|19062128|P1|Overall Study|Withdrawal by Subject|0
5513396|NCT01543958|19062226|P1|Overall Study|ART initiation|1
5513397|NCT01543958|19062226|P1|Overall Study|Loss to follow-up|3
5513398|NCT01543828|19062281|P2|Treatment 2|Lost to Follow-up|0
5513399|NCT01543828|19062282|P1|Treatment 2|Lost to Follow-up|1
5513400|NCT01543776|19062292|P2|Overall Study|Withdrawal by Subject|2
5513401|NCT01543776|19062293|P1|Overall Study|Withdrawal by Subject|2
5513402|NCT01543685|19062312|P5|Overall Study|Adverse Event|2
5513403|NCT01543685|19062313|P4|Overall Study|Adverse Event|0
5513404|NCT01543685|19062314|P3|Overall Study|Adverse Event|0
5513405|NCT01543685|19062315|P2|Overall Study|Adverse Event|1
5513406|NCT01543685|19062316|P1|Overall Study|Adverse Event|2
5513407|NCT01543685|19062312|P5|Overall Study|Lack of Efficacy|2
5513408|NCT01543685|19062313|P4|Overall Study|Lack of Efficacy|0
5513409|NCT01543685|19062314|P3|Overall Study|Lack of Efficacy|2
5513410|NCT01543685|19062315|P2|Overall Study|Lack of Efficacy|2
5513411|NCT01543685|19062316|P1|Overall Study|Lack of Efficacy|1
5513412|NCT01543503|19062388|P2|Overall Study|Screen failure|0
5513413|NCT01543503|19062389|P1|Overall Study|Screen failure|1
5513414|NCT01543503|19062388|P2|Overall Study|Participant went to United States|0
5513415|NCT01543503|19062389|P1|Overall Study|Participant went to United States|1
5513416|NCT01543503|19062388|P2|Overall Study|Participant consented to another study|2
5513417|NCT01543503|19062389|P1|Overall Study|Participant consented to another study|0
5513418|NCT01543503|19062388|P2|Overall Study|Moved to other rheumatologic site|1
5513419|NCT01543503|19062389|P1|Overall Study|Moved to other rheumatologic site|0
5513420|NCT01543503|19062388|P2|Overall Study|Participant did not attend a visit|0
5513421|NCT01543503|19062389|P1|Overall Study|Participant did not attend a visit|1
5513422|NCT01543503|19062388|P2|Overall Study|Site stopped participation|1
5513423|NCT01543503|19062389|P1|Overall Study|Site stopped participation|5
5513424|NCT01543503|19062388|P2|Overall Study|Participant recruited after closing date|1
5513425|NCT01543503|19062389|P1|Overall Study|Participant recruited after closing date|0
5513426|NCT01543503|19062388|P2|Overall Study|Investigator did not wish to participate|1
5513427|NCT01543503|19062389|P1|Overall Study|Investigator did not wish to participate|1
5513428|NCT01543503|19062388|P2|Overall Study|Participant decision to stop treatment|0
5513429|NCT01543503|19062389|P1|Overall Study|Participant decision to stop treatment|1
5513430|NCT01543503|19062388|P2|Overall Study|Participant moved to Scotland|0
5513431|NCT01543503|19062389|P1|Overall Study|Participant moved to Scotland|1
5513432|NCT01543503|19062388|P2|Overall Study|Participant transferred to another city|0
5513433|NCT01543503|19062389|P1|Overall Study|Participant transferred to another city|1
5513434|NCT01543503|19062388|P2|Overall Study|Participant will not return for visits|2
5513435|NCT01543503|19062389|P1|Overall Study|Participant will not return for visits|0
5513436|NCT01543503|19062388|P2|Overall Study|Participant moved to another city|0
5513437|NCT01543503|19062389|P1|Overall Study|Participant moved to another city|2
5513438|NCT01543503|19062388|P2|Overall Study|Incorrect medication received|0
5513439|NCT01543503|19062389|P1|Overall Study|Incorrect medication received|1
5513440|NCT01543503|19062388|P2|Overall Study|Refused to continue treatment|0
5513441|NCT01543503|19062389|P1|Overall Study|Refused to continue treatment|7
5513442|NCT01543503|19062388|P2|Overall Study|Participant did not complete last visit|2
5513443|NCT01543503|19062389|P1|Overall Study|Participant did not complete last visit|0
5513444|NCT01543503|19062388|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
5513445|NCT01543503|19062389|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
5513446|NCT01543503|19062388|P2|Overall Study|Intolerance to the biologic treatment|1
5513447|NCT01543503|19062389|P1|Overall Study|Intolerance to the biologic treatment|0
5513448|NCT01543503|19062388|P2|Overall Study|Change of jobs|1
5513449|NCT01543503|19062389|P1|Overall Study|Change of jobs|0
5513450|NCT01543503|19062388|P2|Overall Study|Participant withdrew informed consent|10
5513451|NCT01543503|19062389|P1|Overall Study|Participant withdrew informed consent|8
5513452|NCT01543503|19062388|P2|Overall Study|Lack of Efficacy|16
5513453|NCT01543503|19062389|P1|Overall Study|Lack of Efficacy|4
5513454|NCT01543503|19062388|P2|Overall Study|Adverse Event|13
5513455|NCT01543503|19062389|P1|Overall Study|Adverse Event|9
5513456|NCT01543503|19062388|P2|Overall Study|Lost to Follow-up|36
5513457|NCT01543503|19062389|P1|Overall Study|Lost to Follow-up|32
5513458|NCT01543204|19062433|P1|Overall Study|Lost to Follow-up|1
5513459|NCT01543204|19062433|P1|Overall Study|Requirement for Alternative Therapy|1
5513460|NCT01543204|19062433|P1|Overall Study|Withdrawal by Subject|4
5513461|NCT01543204|19062433|P1|Overall Study|Adverse Event|1
5513462|NCT01543204|19062433|P1|Overall Study|Non-compliance|1
5513463|NCT01543087|19062495|P6|Booster Stage (26 Months)|Lost to Follow-up|0
5513464|NCT01543087|19062496|P5|Booster Stage (26 Months)|Lost to Follow-up|0
5513465|NCT01543087|19062497|P4|Booster Stage (26 Months)|Lost to Follow-up|0
5513466|NCT01543087|19062498|P3|Booster Stage (26 Months)|Lost to Follow-up|1
5513467|NCT01543087|19062499|P2|Booster Stage (26 Months)|Lost to Follow-up|0
5513468|NCT01543087|19062500|P1|Booster Stage (26 Months)|Lost to Follow-up|0
5513469|NCT01543087|19062495|P6|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5513470|NCT01543087|19062496|P5|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
5513471|NCT01543087|19062497|P4|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5513472|NCT01543087|19062498|P3|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5513473|NCT01543087|19062499|P2|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
5513474|NCT01543087|19062500|P1|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
5513475|NCT01543087|19062495|P6|Stage 1 (48 Months)|Protocol Violation|0
5513476|NCT01543087|19062496|P5|Stage 1 (48 Months)|Protocol Violation|0
5513477|NCT01543087|19062497|P4|Stage 1 (48 Months)|Protocol Violation|0
5513478|NCT01543087|19062498|P3|Stage 1 (48 Months)|Protocol Violation|0
5513479|NCT01543087|19062499|P2|Stage 1 (48 Months)|Protocol Violation|3
5513480|NCT01543087|19062500|P1|Stage 1 (48 Months)|Protocol Violation|0
5513481|NCT01543087|19062495|P6|Stage 1 (48 Months)|Other than specified|0
5513482|NCT01543087|19062496|P5|Stage 1 (48 Months)|Other than specified|0
5513483|NCT01543087|19062497|P4|Stage 1 (48 Months)|Other than specified|0
5513484|NCT01543087|19062498|P3|Stage 1 (48 Months)|Other than specified|9
5513485|NCT01543087|19062499|P2|Stage 1 (48 Months)|Other than specified|0
5513486|NCT01543087|19062500|P1|Stage 1 (48 Months)|Other than specified|5
5513487|NCT01543087|19062495|P6|Stage 1 (48 Months)|No longer willing to participate|0
5513488|NCT01543087|19062496|P5|Stage 1 (48 Months)|No longer willing to participate|3
5513489|NCT01543087|19062497|P4|Stage 1 (48 Months)|No longer willing to participate|6
5513490|NCT01543087|19062498|P3|Stage 1 (48 Months)|No longer willing to participate|18
5513491|NCT01543087|19062499|P2|Stage 1 (48 Months)|No longer willing to participate|3
5513492|NCT01543087|19062500|P1|Stage 1 (48 Months)|No longer willing to participate|5
5513493|NCT01543087|19062495|P6|Stage 1 (48 Months)|No longer met eligibility criteria|0
5513494|NCT01543087|19062496|P5|Stage 1 (48 Months)|No longer met eligibility criteria|0
5513495|NCT01543087|19062497|P4|Stage 1 (48 Months)|No longer met eligibility criteria|2
5513496|NCT01543087|19062498|P3|Stage 1 (48 Months)|No longer met eligibility criteria|1
5513497|NCT01543087|19062499|P2|Stage 1 (48 Months)|No longer met eligibility criteria|0
5513498|NCT01543087|19062500|P1|Stage 1 (48 Months)|No longer met eligibility criteria|1
5513499|NCT01543087|19062495|P6|Stage 1 (48 Months)|Lost to Follow-up|0
5513500|NCT01543087|19062496|P5|Stage 1 (48 Months)|Lost to Follow-up|0
5513501|NCT01543087|19062497|P4|Stage 1 (48 Months)|Lost to Follow-up|0
5513502|NCT01543087|19062498|P3|Stage 1 (48 Months)|Lost to Follow-up|12
5513503|NCT01543087|19062499|P2|Stage 1 (48 Months)|Lost to Follow-up|4
5513504|NCT01543087|19062500|P1|Stage 1 (48 Months)|Lost to Follow-up|3
5513505|NCT01542788|19062677|P2|Overall Study|Withdrawal by Subject|0
5513506|NCT01542788|19062678|P1|Overall Study|Withdrawal by Subject|1
5513507|NCT01542788|19062677|P2|Overall Study|Physician Decision|0
5513508|NCT01542788|19062678|P1|Overall Study|Physician Decision|1
5513509|NCT01542788|19062677|P2|Overall Study|Protocol Violation|0
5513510|NCT01542788|19062678|P1|Overall Study|Protocol Violation|2
5513511|NCT01542788|19062677|P2|Overall Study|Death|0
5513512|NCT01542788|19062678|P1|Overall Study|Death|3
5513513|NCT01542788|19062677|P2|Overall Study|Lost to Follow-up|0
5513514|NCT01542788|19062678|P1|Overall Study|Lost to Follow-up|5
5513515|NCT01542788|19062677|P2|Overall Study|Lack of Efficacy|71
5513516|NCT01542788|19062678|P1|Overall Study|Lack of Efficacy|41
5513517|NCT01542788|19062677|P2|Overall Study|Randomized but Not Treated|0
5513518|NCT01542788|19062678|P1|Overall Study|Randomized but Not Treated|2
5513519|NCT01542632|19062725|P6|Overall Study|Sponsor/Investigator Decision|0
5513520|NCT01542632|19062726|P5|Overall Study|Sponsor/Investigator Decision|1
5513521|NCT01542632|19062727|P4|Overall Study|Sponsor/Investigator Decision|0
5513522|NCT01542632|19062728|P3|Overall Study|Sponsor/Investigator Decision|0
5513523|NCT01542632|19062729|P2|Overall Study|Sponsor/Investigator Decision|0
5513524|NCT01542632|19062730|P1|Overall Study|Sponsor/Investigator Decision|0
5513525|NCT01542632|19062725|P6|Overall Study|Lost to Follow-up|0
5513526|NCT01542632|19062726|P5|Overall Study|Lost to Follow-up|0
5513527|NCT01542632|19062727|P4|Overall Study|Lost to Follow-up|0
5513528|NCT01542632|19062728|P3|Overall Study|Lost to Follow-up|0
5513529|NCT01542632|19062729|P2|Overall Study|Lost to Follow-up|1
5513530|NCT01542632|19062730|P1|Overall Study|Lost to Follow-up|0
5513531|NCT01542632|19062725|P6|Overall Study|Adverse Event|0
5513532|NCT01542632|19062726|P5|Overall Study|Adverse Event|0
5513533|NCT01542632|19062727|P4|Overall Study|Adverse Event|0
5513534|NCT01542632|19062728|P3|Overall Study|Adverse Event|1
5513535|NCT01542632|19062729|P2|Overall Study|Adverse Event|0
5513536|NCT01542632|19062730|P1|Overall Study|Adverse Event|0
5513537|NCT01542632|19062725|P6|Overall Study|Withdrawal of Consent|0
5513538|NCT01542632|19062726|P5|Overall Study|Withdrawal of Consent|3
5513539|NCT01542632|19062727|P4|Overall Study|Withdrawal of Consent|2
5513540|NCT01542632|19062728|P3|Overall Study|Withdrawal of Consent|0
5513541|NCT01542632|19062729|P2|Overall Study|Withdrawal of Consent|0
5513542|NCT01542632|19062730|P1|Overall Study|Withdrawal of Consent|0
5513543|NCT01542528|19062787|P2|Overall Study|Withdrawal by Subject|6
5513544|NCT01542528|19062788|P1|Overall Study|Withdrawal by Subject|9
5513545|NCT01542528|19062787|P2|Overall Study|Physician Decision|0
5513546|NCT01542528|19062788|P1|Overall Study|Physician Decision|1
5513547|NCT01542528|19062787|P2|Overall Study|Lost to Follow-up|1
5513548|NCT01542528|19062788|P1|Overall Study|Lost to Follow-up|2
5513549|NCT01542034|19062896|P2|Overall Study|Lost to Follow-up|6
5513550|NCT01542034|19062897|P1|Overall Study|Lost to Follow-up|7
5513551|NCT01542034|19062896|P2|Overall Study|Adverse Event|2
5513552|NCT01542034|19062897|P1|Overall Study|Adverse Event|2
5513553|NCT01542034|19062896|P2|Overall Study|Subject Noncompliance|0
5513554|NCT01542034|19062897|P1|Overall Study|Subject Noncompliance|1
5513555|NCT01542034|19062896|P2|Overall Study|Administrative decision|3
5513556|NCT01542034|19062897|P1|Overall Study|Administrative decision|0
5513557|NCT01542034|19062896|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
5513558|NCT01542034|19062897|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
5513559|NCT01541969|19062911|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
5513560|NCT01541969|19062912|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
5513561|NCT01541969|19062911|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
5513562|NCT01541969|19062912|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
5513563|NCT01541969|19062911|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
5513564|NCT01541969|19062912|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
5513565|NCT01541969|19062911|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
5513566|NCT01541969|19062912|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
5513567|NCT01541969|19062911|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
5513568|NCT01541969|19062912|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
5513569|NCT01541969|19062911|P2|Double-blind (0-12 Weeks)|Adverse Event|0
5513570|NCT01541969|19062912|P1|Double-blind (0-12 Weeks)|Adverse Event|2
5513571|NCT01541969|19062911|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
5513572|NCT01541969|19062912|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
5513573|NCT01541969|19062911|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
5513574|NCT01541969|19062912|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
5513575|NCT01541969|19062911|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
5513576|NCT01541969|19062912|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
5513577|NCT01541969|19062911|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
5513578|NCT01541969|19062912|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
5513579|NCT01541930|19062928|P1|Overall Study|Withdrawal by Subject|1
5513580|NCT01541917|19062950|P2|Overall Study|Withdrawal by Subject|7
5513581|NCT01541917|19062951|P1|Overall Study|Withdrawal by Subject|13
5513582|NCT01541917|19062950|P2|Overall Study|Lost to Follow-up|2
5513583|NCT01541917|19062951|P1|Overall Study|Lost to Follow-up|2
5513584|NCT01541865|19062980|P1|Overall Study|Protocol Violation|1
5513585|NCT01541865|19062980|P1|Overall Study|Adverse Event|1
5513586|NCT01541865|19062980|P1|Overall Study|Withdrawal by Subject|9
5513587|NCT01541865|19062980|P1|Overall Study|Lost to Follow-up|11
5513588|NCT01541826|19062998|P3|Overall Study|Withdrawal by Subject|0
5513589|NCT01541826|19062999|P2|Overall Study|Withdrawal by Subject|0
5513590|NCT01541826|19063000|P1|Overall Study|Withdrawal by Subject|2
5513591|NCT01541826|19062998|P3|Overall Study|Lost to Follow-up|0
5513592|NCT01541826|19062999|P2|Overall Study|Lost to Follow-up|3
5513593|NCT01541826|19063000|P1|Overall Study|Lost to Follow-up|2
5513594|NCT01541748|19063067|P1|Overall Study|Did not receive study device|1
5513595|NCT01541748|19063067|P1|Overall Study|Screen failure|5
5513596|NCT01541748|19063067|P1|Overall Study|Withdrawal by Subject|7
5513597|NCT01541748|19063067|P1|Overall Study|Moved out of state|1
5513598|NCT01541748|19063067|P1|Overall Study|Lost to Follow-up|17
5513599|NCT01541644|19063103|P1|Overall Study|Withdrawal by Subject|3
5513600|NCT01541397|19063122|P2|Overall Study|Study ended prior to data collection|2
5513601|NCT01541397|19063123|P1|Overall Study|Study ended prior to data collection|4
5513602|NCT01541371|19063148|P1|Overall Study|Other|6
5513603|NCT01541371|19063148|P1|Overall Study|Study medication non-compliance|3
5513604|NCT01541371|19063148|P1|Overall Study|Protocol Violation|6
5513605|NCT01541371|19063148|P1|Overall Study|Lack of Efficacy|12
5513606|NCT01541371|19063148|P1|Overall Study|Adverse Event|15
5513607|NCT01541371|19063148|P1|Overall Study|Lost to Follow-up|21
5513608|NCT01541371|19063148|P1|Overall Study|Withdrawal by Subject|14
5513609|NCT01541254|19063177|P1|Overall Study|alternate stent used|1
5513610|NCT01541254|19063177|P1|Overall Study|stent not required|1
5513611|NCT01541254|19063177|P1|Overall Study|GI bleed prior to procedure|1
5513612|NCT01541254|19063177|P1|Overall Study|enrolled after study closed|1
5513613|NCT01541254|19063177|P1|Overall Study|excluded - metal allergy|1
5513614|NCT01541254|19063177|P1|Overall Study|Withdrawal by Subject|1
5513615|NCT01541215|19063184|P2|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
5513616|NCT01541215|19063185|P1|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
5513617|NCT01541215|19063184|P2|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
5513618|NCT01541215|19063185|P1|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
5513619|NCT01541215|19063184|P2|Treatment Period (52 Weeks)|Unclassified|3
5513620|NCT01541215|19063185|P1|Treatment Period (52 Weeks)|Unclassified|0
5513621|NCT01541215|19063184|P2|Treatment Period (52 Weeks)|Adverse Event|1
5513622|NCT01541215|19063185|P1|Treatment Period (52 Weeks)|Adverse Event|0
5513623|NCT01541215|19063184|P2|Treatment Period (52 Weeks)|Non-compliance|4
5513624|NCT01541215|19063185|P1|Treatment Period (52 Weeks)|Non-compliance|4
5513625|NCT01541215|19063184|P2|Treatment Period (52 Weeks)|Withdrawal criteria|8
5513626|NCT01541215|19063185|P1|Treatment Period (52 Weeks)|Withdrawal criteria|6
5513627|NCT01540981|19063331|P2|Overall Study|Withdrawal by Subject|0
5513628|NCT01540981|19063332|P1|Overall Study|Withdrawal by Subject|1
5513629|NCT01540851|19063342|P2|Overall Study|Withdrawal by Subject|3
5513630|NCT01540851|19063343|P1|Overall Study|Withdrawal by Subject|7
5513631|NCT01540851|19063342|P2|Overall Study|Lost to Follow-up|15
5513632|NCT01540851|19063343|P1|Overall Study|Lost to Follow-up|14
5513633|NCT01540838|19063355|P2|Overall Study|Not BM. Other treatment|1
5513634|NCT01540838|19063356|P1|Overall Study|Not BM. Other treatment|3
5513635|NCT01540838|19063355|P2|Overall Study|Died before treatment initiation|1
5513636|NCT01540838|19063356|P1|Overall Study|Died before treatment initiation|1
5513637|NCT01540838|19063355|P2|Overall Study|Additional antibiotic treatment|2
5513638|NCT01540838|19063356|P1|Overall Study|Additional antibiotic treatment|1
5513639|NCT01540838|19063355|P2|Overall Study|Treatment doses missing|12
5513640|NCT01540838|19063356|P1|Overall Study|Treatment doses missing|8
5513641|NCT01540838|19063355|P2|Overall Study|Open nasogastric tube|7
5513642|NCT01540838|19063356|P1|Overall Study|Open nasogastric tube|9
5513643|NCT01540565|19063506|P1|Overall Study|Ineligible|2
5513644|NCT01540487|19063525|P2|Overall Study|Protocol Violation|0
5513645|NCT01540487|19063526|P1|Overall Study|Protocol Violation|1
5513646|NCT01539837|19063665|P3|Overall Study|bad compliance|1
5513647|NCT01539837|19063666|P2|Overall Study|bad compliance|0
5513648|NCT01539837|19063667|P1|Overall Study|bad compliance|0
5513649|NCT01539837|19063665|P3|Overall Study|reduce neutrophil level|1
5513650|NCT01539837|19063666|P2|Overall Study|reduce neutrophil level|1
5513651|NCT01539837|19063667|P1|Overall Study|reduce neutrophil level|0
5513652|NCT01539759|19063689|P2|Overall Study|Lost to Follow-up|8
5513653|NCT01539759|19063690|P1|Overall Study|Lost to Follow-up|6
5513654|NCT01539642|19063711|P2|Overall Study|Withdrawal by Subject|2
5513655|NCT01539642|19063712|P1|Overall Study|Withdrawal by Subject|2
5513656|NCT01539642|19063711|P2|Overall Study|Adverse Event|4
5513657|NCT01539642|19063712|P1|Overall Study|Adverse Event|6
5513658|NCT01539642|19063711|P2|Overall Study|Patient ready for early discharge|7
5513659|NCT01539642|19063712|P1|Overall Study|Patient ready for early discharge|8
5513660|NCT01539642|19063711|P2|Overall Study|Lack of Efficacy|18
5513661|NCT01539642|19063712|P1|Overall Study|Lack of Efficacy|20
5513662|NCT01539538|19063729|P2|Overall Study|PCA no longer required or PCA problem|7
5513663|NCT01539538|19063730|P1|Overall Study|PCA no longer required or PCA problem|3
5513664|NCT01539538|19063729|P2|Overall Study|Withdrawal by Subject|3
5513665|NCT01539538|19063730|P1|Overall Study|Withdrawal by Subject|2
5513666|NCT01539538|19063729|P2|Overall Study|Lack of Efficacy|16
5513667|NCT01539538|19063730|P1|Overall Study|Lack of Efficacy|13
5513668|NCT01539538|19063729|P2|Overall Study|Adverse Event|18
5513669|NCT01539538|19063730|P1|Overall Study|Adverse Event|13
5513670|NCT01539525|19063739|P3|Overall Study|Protocol Violation|4
5513671|NCT01539525|19063740|P2|Overall Study|Protocol Violation|1
5513672|NCT01539525|19063741|P1|Overall Study|Protocol Violation|1
5513673|NCT01539525|19063739|P3|Overall Study|Withdrawal by Subject|2
5513674|NCT01539525|19063740|P2|Overall Study|Withdrawal by Subject|3
5513675|NCT01539525|19063741|P1|Overall Study|Withdrawal by Subject|0
5513676|NCT01539525|19063739|P3|Overall Study|Lost to Follow-up|11
5513677|NCT01539525|19063740|P2|Overall Study|Lost to Follow-up|12
5513678|NCT01539525|19063741|P1|Overall Study|Lost to Follow-up|19
5513679|NCT01539512|19063760|P2|Overall Study|Richter's Transformation|0
5513680|NCT01539512|19063761|P1|Overall Study|Richter's Transformation|1
5513681|NCT01539512|19063760|P2|Overall Study|Withdrawal by Subject|5
5513682|NCT01539512|19063761|P1|Overall Study|Withdrawal by Subject|12
5513683|NCT01539512|19063760|P2|Overall Study|Physician Decision|1
5513684|NCT01539512|19063761|P1|Overall Study|Physician Decision|1
5513685|NCT01539512|19063760|P2|Overall Study|Adverse Event|7
5513686|NCT01539512|19063761|P1|Overall Study|Adverse Event|9
5513687|NCT01539317|19063777|P2|Overall Study|Screening Error. Deleted from analysis.|0
5513688|NCT01539317|19063778|P1|Overall Study|Screening Error. Deleted from analysis.|1
5513689|NCT01539291|19063796|P4|Study GS-US-312-0117|Other|1
5513690|NCT01539291|19063797|P3|Study GS-US-312-0117|Other|1
5513691|NCT01539291|19063798|P2|Study GS-US-312-0117|Other|1
5513692|NCT01539291|19063799|P1|Study GS-US-312-0117|Other|2
5513693|NCT01539291|19063796|P4|Study GS-US-312-0117|Study Terminated by Sponsor|5
5513694|NCT01539291|19063797|P3|Study GS-US-312-0117|Study Terminated by Sponsor|0
5513695|NCT01539291|19063798|P2|Study GS-US-312-0117|Study Terminated by Sponsor|0
5513696|NCT01539291|19063799|P1|Study GS-US-312-0117|Study Terminated by Sponsor|3
5513697|NCT01539291|19063796|P4|Study GS-US-312-0117|Withdrawal by Subject|4
5513698|NCT01539291|19063797|P3|Study GS-US-312-0117|Withdrawal by Subject|6
5513699|NCT01539291|19063798|P2|Study GS-US-312-0117|Withdrawal by Subject|0
5513700|NCT01539291|19063799|P1|Study GS-US-312-0117|Withdrawal by Subject|5
5513701|NCT01539291|19063796|P4|Study GS-US-312-0117|Physician Decision|4
5513702|NCT01539291|19063797|P3|Study GS-US-312-0117|Physician Decision|6
5513703|NCT01539291|19063798|P2|Study GS-US-312-0117|Physician Decision|0
5513704|NCT01539291|19063799|P1|Study GS-US-312-0117|Physician Decision|9
5513705|NCT01539291|19063796|P4|Study GS-US-312-0117|Adverse Event|12
5513706|NCT01539291|19063797|P3|Study GS-US-312-0117|Adverse Event|9
5513707|NCT01539291|19063798|P2|Study GS-US-312-0117|Adverse Event|1
5513708|NCT01539291|19063799|P1|Study GS-US-312-0117|Adverse Event|22
5513709|NCT01539291|19063796|P4|Study GS-US-312-0116|Other|0
5513710|NCT01539291|19063797|P3|Study GS-US-312-0116|Other|0
5513711|NCT01539291|19063798|P2|Study GS-US-312-0116|Other|0
5513712|NCT01539291|19063799|P1|Study GS-US-312-0116|Other|1
5513713|NCT01539291|19063796|P4|Study GS-US-312-0116|Study Terminated by Sponsor|0
5513714|NCT01539291|19063797|P3|Study GS-US-312-0116|Study Terminated by Sponsor|0
5513715|NCT01539291|19063798|P2|Study GS-US-312-0116|Study Terminated by Sponsor|0
5513716|NCT01539291|19063799|P1|Study GS-US-312-0116|Study Terminated by Sponsor|2
5513717|NCT01539291|19063796|P4|Study GS-US-312-0116|Withdrawal by Subject|0
5513718|NCT01539291|19063797|P3|Study GS-US-312-0116|Withdrawal by Subject|0
5513719|NCT01539291|19063798|P2|Study GS-US-312-0116|Withdrawal by Subject|0
5513720|NCT01539291|19063799|P1|Study GS-US-312-0116|Withdrawal by Subject|12
5513721|NCT01539291|19063796|P4|Study GS-US-312-0116|Physician Decision|0
5513722|NCT01539291|19063797|P3|Study GS-US-312-0116|Physician Decision|0
5513723|NCT01539291|19063798|P2|Study GS-US-312-0116|Physician Decision|0
5513724|NCT01539291|19063799|P1|Study GS-US-312-0116|Physician Decision|1
5513725|NCT01539291|19063796|P4|Study GS-US-312-0116|Adverse Event|0
5513726|NCT01539291|19063797|P3|Study GS-US-312-0116|Adverse Event|0
5513727|NCT01539291|19063798|P2|Study GS-US-312-0116|Adverse Event|0
5513728|NCT01539291|19063799|P1|Study GS-US-312-0116|Adverse Event|9
5513729|NCT01539239|19063871|P2|Overall Study|Lost to Follow-up|12
5513730|NCT01539239|19063872|P1|Overall Study|Lost to Follow-up|7
5513731|NCT01539239|19063871|P2|Overall Study|Death|5
5513732|NCT01539239|19063872|P1|Overall Study|Death|5
5513733|NCT01539083|19063895|P3|After Randomization (TP and VTP)|Death|11
5513734|NCT01539083|19063896|P2|After Randomization (TP and VTP)|Death|6
5513735|NCT01539083|19063897|P1|After Randomization (TP and VTP)|Death|0
5513736|NCT01539083|19063895|P3|After Randomization (TP and VTP)|Progressive Disease|3
5513737|NCT01539083|19063896|P2|After Randomization (TP and VTP)|Progressive Disease|6
5513738|NCT01539083|19063897|P1|After Randomization (TP and VTP)|Progressive Disease|0
5513739|NCT01539083|19063895|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
5513740|NCT01539083|19063896|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
5513741|NCT01539083|19063897|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
5513742|NCT01539083|19063895|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
5513743|NCT01539083|19063896|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
5513744|NCT01539083|19063897|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
5513745|NCT01539083|19063895|P3|After Randomization (TP and VTP)|Adverse Event|1
5513746|NCT01539083|19063896|P2|After Randomization (TP and VTP)|Adverse Event|1
5513747|NCT01539083|19063897|P1|After Randomization (TP and VTP)|Adverse Event|0
5513748|NCT01539083|19063895|P3|After Randomization (TP and VTP)|Other|1
5513749|NCT01539083|19063896|P2|After Randomization (TP and VTP)|Other|1
5513750|NCT01539083|19063897|P1|After Randomization (TP and VTP)|Other|0
5513751|NCT01539083|19063895|P3|After Randomization (TP and VTP)|Physician Decision|1
5513752|NCT01539083|19063896|P2|After Randomization (TP and VTP)|Physician Decision|0
5513753|NCT01539083|19063897|P1|After Randomization (TP and VTP)|Physician Decision|0
5513754|NCT01539083|19063895|P3|Before Randomization (VCD Induction)|Other|0
5513755|NCT01539083|19063896|P2|Before Randomization (VCD Induction)|Other|0
5513756|NCT01539083|19063897|P1|Before Randomization (VCD Induction)|Other|5
5513757|NCT01539083|19063895|P3|Before Randomization (VCD Induction)|Progressive Disease|0
5513758|NCT01539083|19063896|P2|Before Randomization (VCD Induction)|Progressive Disease|0
5513759|NCT01539083|19063897|P1|Before Randomization (VCD Induction)|Progressive Disease|8
5513760|NCT01539083|19063895|P3|Before Randomization (VCD Induction)|Physician Decision|0
5513761|NCT01539083|19063896|P2|Before Randomization (VCD Induction)|Physician Decision|0
5513762|NCT01539083|19063897|P1|Before Randomization (VCD Induction)|Physician Decision|14
5513763|NCT01539083|19063895|P3|Before Randomization (VCD Induction)|Protocol Violation|0
5513764|NCT01539083|19063896|P2|Before Randomization (VCD Induction)|Protocol Violation|0
5513765|NCT01539083|19063897|P1|Before Randomization (VCD Induction)|Protocol Violation|2
5513766|NCT01539083|19063895|P3|Before Randomization (VCD Induction)|Death|0
5513767|NCT01539083|19063896|P2|Before Randomization (VCD Induction)|Death|0
5513768|NCT01539083|19063897|P1|Before Randomization (VCD Induction)|Death|6
5513769|NCT01539083|19063895|P3|Before Randomization (VCD Induction)|Adverse Event|0
5513770|NCT01539083|19063896|P2|Before Randomization (VCD Induction)|Adverse Event|0
5513771|NCT01539083|19063897|P1|Before Randomization (VCD Induction)|Adverse Event|14
5513772|NCT01539083|19063895|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
5513773|NCT01539083|19063896|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
5513774|NCT01539083|19063897|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
5513775|NCT01538719|19063941|P2|Overall Study|Lost to Follow-up|0
5513776|NCT01538719|19063942|P1|Overall Study|Lost to Follow-up|2
5513777|NCT01538472|19063965|P1|Overall Study|Death|1
5513778|NCT01538472|19063965|P1|Overall Study|Disease Progression|3
5513779|NCT01538199|19063976|P4|Overall Study|Lack of Efficacy|0
5513780|NCT01538199|19063977|P3|Overall Study|Lack of Efficacy|0
5513781|NCT01538199|19063978|P2|Overall Study|Lack of Efficacy|1
5513782|NCT01538199|19063979|P1|Overall Study|Lack of Efficacy|0
5513783|NCT01538199|19063976|P4|Overall Study|participant did not have time|2
5513784|NCT01538199|19063977|P3|Overall Study|participant did not have time|0
5513785|NCT01538199|19063978|P2|Overall Study|participant did not have time|0
5513786|NCT01538199|19063979|P1|Overall Study|participant did not have time|1
5513787|NCT01538199|19063976|P4|Overall Study|Lost to Follow-up|0
5513788|NCT01538199|19063977|P3|Overall Study|Lost to Follow-up|1
5513789|NCT01538199|19063978|P2|Overall Study|Lost to Follow-up|2
5513790|NCT01538199|19063979|P1|Overall Study|Lost to Follow-up|1
5513791|NCT01537887|19064013|P6|Period 3|Withdrawal by Subject|0
5513792|NCT01537887|19064014|P5|Period 3|Withdrawal by Subject|0
5513793|NCT01537887|19064015|P4|Period 3|Withdrawal by Subject|0
5513794|NCT01537887|19064016|P3|Period 3|Withdrawal by Subject|0
5513795|NCT01537887|19064017|P2|Period 3|Withdrawal by Subject|1
5513796|NCT01537887|19064018|P1|Period 3|Withdrawal by Subject|0
5513797|NCT01537887|19064013|P6|Period 3|Adverse Event|0
5513798|NCT01537887|19064014|P5|Period 3|Adverse Event|0
5513799|NCT01537887|19064015|P4|Period 3|Adverse Event|0
5513800|NCT01537887|19064016|P3|Period 3|Adverse Event|1
5513801|NCT01537887|19064017|P2|Period 3|Adverse Event|0
5513802|NCT01537887|19064018|P1|Period 3|Adverse Event|0
5513803|NCT01537887|19064013|P6|Period 2|Withdrawal by Subject|0
5513804|NCT01537887|19064014|P5|Period 2|Withdrawal by Subject|0
5513805|NCT01537887|19064015|P4|Period 2|Withdrawal by Subject|0
5513806|NCT01537887|19064016|P3|Period 2|Withdrawal by Subject|0
5513807|NCT01537887|19064017|P2|Period 2|Withdrawal by Subject|1
5513808|NCT01537887|19064018|P1|Period 2|Withdrawal by Subject|0
5513809|NCT01537887|19064013|P6|Period 1|Did not receive treatment|0
5513810|NCT01537887|19064014|P5|Period 1|Did not receive treatment|0
5513811|NCT01537887|19064015|P4|Period 1|Did not receive treatment|0
5513812|NCT01537887|19064016|P3|Period 1|Did not receive treatment|1
5513813|NCT01537887|19064017|P2|Period 1|Did not receive treatment|0
5513814|NCT01537887|19064018|P1|Period 1|Did not receive treatment|0
5513815|NCT01537887|19064013|P6|Period 1|Physician Decision|1
5513816|NCT01537887|19064014|P5|Period 1|Physician Decision|1
5513817|NCT01537887|19064015|P4|Period 1|Physician Decision|0
5513818|NCT01537887|19064016|P3|Period 1|Physician Decision|0
5513819|NCT01537887|19064017|P2|Period 1|Physician Decision|0
5513820|NCT01537887|19064018|P1|Period 1|Physician Decision|0
5513821|NCT01537783|19064047|P2|Overall Study|Lost to Follow-up|2
5513822|NCT01537783|19064048|P1|Overall Study|Lost to Follow-up|11
5513823|NCT01537549|19064099|P1|Overall Study|Withdrawal by Subject|2
5513824|NCT01537549|19064099|P1|Overall Study|Lost to Follow-up|1
5513825|NCT01537432|19064107|P2|Overall Study|Unsatisfactory therapeutic effect|0
5513826|NCT01537432|19064108|P1|Overall Study|Unsatisfactory therapeutic effect|1
5513827|NCT01537432|19064107|P2|Overall Study|Adverse Event|0
5513828|NCT01537432|19064108|P1|Overall Study|Adverse Event|1
5513829|NCT01537432|19064107|P2|Overall Study|Administrative problems|0
5513830|NCT01537432|19064108|P1|Overall Study|Administrative problems|1
5513831|NCT01537432|19064107|P2|Overall Study|Withdrawal by Subject|1
5513832|NCT01537432|19064108|P1|Overall Study|Withdrawal by Subject|0
5513833|NCT01537432|19064107|P2|Overall Study|Lost to Follow-up|1
5513834|NCT01537432|19064108|P1|Overall Study|Lost to Follow-up|3
5513835|NCT01537393|19064131|P2|Overall Study|Censored (severe event unrelated to PT)|1
5513836|NCT01537393|19064132|P1|Overall Study|Censored (severe event unrelated to PT)|1
5513837|NCT01537393|19064131|P2|Overall Study|Failure - Not regrafted|6
5513838|NCT01537393|19064132|P1|Overall Study|Failure - Not regrafted|2
5513839|NCT01537393|19064131|P2|Overall Study|Failure - Regrafted|43
5513840|NCT01537393|19064132|P1|Overall Study|Failure - Regrafted|28
5513841|NCT01537393|19064131|P2|Overall Study|Lost to Follow-up|48
5513842|NCT01537393|19064132|P1|Overall Study|Lost to Follow-up|53
5513843|NCT01537393|19064131|P2|Overall Study|Withdrawal by Subject|17
5513844|NCT01537393|19064132|P1|Overall Study|Withdrawal by Subject|18
5513845|NCT01537393|19064131|P2|Overall Study|Death|32
5513846|NCT01537393|19064132|P1|Overall Study|Death|20
5513847|NCT01537393|19064131|P2|Overall Study|Exclude prior to study|44
5513848|NCT01537393|19064132|P1|Overall Study|Exclude prior to study|32
5513849|NCT01537302|19064168|P1|Overall Study|Withdrawal by Subject|1
5513850|NCT01537302|19064168|P1|Overall Study|Lost to Follow-up|1
5513851|NCT01537211|19064177|P2|Overall Study|Lost to Follow-up|1
5513852|NCT01537211|19064178|P1|Overall Study|Lost to Follow-up|0
5513853|NCT01537198|19064212|P1|Overall Study|Other|111
5513854|NCT01537198|19064212|P1|Overall Study|No Further Visits to the Clinic|37
5513855|NCT01537198|19064212|P1|Overall Study|Adverse Event|4
5513856|NCT01537198|19064212|P1|Overall Study|RSV infection|2
5513857|NCT01537133|19064241|P4|Overall Study|Lost to Follow-up|0
5513858|NCT01537133|19064242|P3|Overall Study|Lost to Follow-up|0
5513859|NCT01537133|19064243|P2|Overall Study|Lost to Follow-up|0
5513860|NCT01537133|19064244|P1|Overall Study|Lost to Follow-up|1
5513861|NCT01537133|19064241|P4|Overall Study|Withdrawal by Subject|0
5513862|NCT01537133|19064242|P3|Overall Study|Withdrawal by Subject|0
5513863|NCT01537133|19064243|P2|Overall Study|Withdrawal by Subject|0
5513864|NCT01537133|19064244|P1|Overall Study|Withdrawal by Subject|2
5513865|NCT01537120|19064260|P1|3 Weeks Placebo|Withdrawal by Subject|1
5513866|NCT01537120|19064260|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
5513867|NCT01537081|19064273|P3|Overall Study|Assigned but never dosed|0
5513868|NCT01537081|19064274|P2|Overall Study|Assigned but never dosed|0
5513869|NCT01537081|19064275|P1|Overall Study|Assigned but never dosed|1
5513870|NCT01537081|19064273|P3|Overall Study|Sponsor decision|0
5513871|NCT01537081|19064274|P2|Overall Study|Sponsor decision|1
5513872|NCT01537081|19064275|P1|Overall Study|Sponsor decision|0
5513873|NCT01537081|19064273|P3|Overall Study|Physician Decision|0
5513874|NCT01537081|19064274|P2|Overall Study|Physician Decision|6
5513875|NCT01537081|19064275|P1|Overall Study|Physician Decision|5
5513876|NCT01537081|19064273|P3|Overall Study|Withdrawal by Subject|3
5513877|NCT01537081|19064274|P2|Overall Study|Withdrawal by Subject|11
5513878|NCT01537081|19064275|P1|Overall Study|Withdrawal by Subject|6
5513879|NCT01537081|19064273|P3|Overall Study|Protocol Violation|2
5513880|NCT01537081|19064274|P2|Overall Study|Protocol Violation|2
5513881|NCT01537081|19064275|P1|Overall Study|Protocol Violation|3
5513882|NCT01537081|19064273|P3|Overall Study|Lost to Follow-up|9
5513883|NCT01537081|19064274|P2|Overall Study|Lost to Follow-up|15
5513884|NCT01537081|19064275|P1|Overall Study|Lost to Follow-up|17
5513885|NCT01537081|19064273|P3|Overall Study|Lack of Efficacy|0
5513886|NCT01537081|19064274|P2|Overall Study|Lack of Efficacy|1
5513887|NCT01537081|19064275|P1|Overall Study|Lack of Efficacy|2
5513888|NCT01537081|19064273|P3|Overall Study|Adverse Event|2
5513889|NCT01537081|19064274|P2|Overall Study|Adverse Event|2
5513890|NCT01537081|19064275|P1|Overall Study|Adverse Event|5
5513891|NCT01537068|19064288|P2|Overall Study|Lack of Efficacy|0
5513892|NCT01537068|19064289|P1|Overall Study|Lack of Efficacy|1
5513893|NCT01537068|19064288|P2|Overall Study|Withdrawal by Subject|1
5513894|NCT01537068|19064289|P1|Overall Study|Withdrawal by Subject|1
5513895|NCT01537068|19064288|P2|Overall Study|Adverse Event|1
5513896|NCT01537068|19064289|P1|Overall Study|Adverse Event|0
5513897|NCT01537068|19064288|P2|Overall Study|Lost to Follow-up|1
5513898|NCT01537068|19064289|P1|Overall Study|Lost to Follow-up|2
5513899|NCT01537042|19064301|P2|Overall Study|Other|1
5513900|NCT01537042|19064302|P1|Overall Study|Other|0
5513901|NCT01537042|19064301|P2|Overall Study|Protocol Violation|1
5513902|NCT01537042|19064302|P1|Overall Study|Protocol Violation|0
5513903|NCT01537042|19064301|P2|Overall Study|Lack of Efficacy|1
5513904|NCT01537042|19064302|P1|Overall Study|Lack of Efficacy|0
5513905|NCT01537042|19064301|P2|Overall Study|Adverse Event|2
5513906|NCT01537042|19064302|P1|Overall Study|Adverse Event|0
5513907|NCT01536951|19064344|P9|Second Intervention and Washout Period 2|Adverse Event|0
5513908|NCT01536951|19064345|P8|Second Intervention and Washout Period 2|Adverse Event|1
5513909|NCT01536951|19064346|P7|Second Intervention and Washout Period 2|Adverse Event|0
5513910|NCT01536951|19064347|P6|Second Intervention and Washout Period 2|Adverse Event|0
5513911|NCT01536951|19064348|P5|Second Intervention and Washout Period 2|Adverse Event|0
5513912|NCT01536951|19064349|P4|Second Intervention and Washout Period 2|Adverse Event|0
5513913|NCT01536951|19064350|P3|Second Intervention and Washout Period 2|Adverse Event|0
5513914|NCT01536951|19064351|P2|Second Intervention and Washout Period 2|Adverse Event|0
5513915|NCT01536951|19064352|P1|Second Intervention and Washout Period 2|Adverse Event|0
5513916|NCT01536951|19064344|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
5513917|NCT01536951|19064345|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
5513918|NCT01536951|19064346|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
5513919|NCT01536951|19064347|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
5513920|NCT01536951|19064348|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
5513921|NCT01536951|19064349|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
5513922|NCT01536951|19064350|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
5513923|NCT01536951|19064351|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
5513924|NCT01536951|19064352|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
5513925|NCT01536860|19064409|P3|Washout Period (3 Days)|Lost to Follow-up|0
5513926|NCT01536860|19064410|P2|Washout Period (3 Days)|Lost to Follow-up|0
5513927|NCT01536860|19064411|P1|Washout Period (3 Days)|Lost to Follow-up|1
5513928|NCT01536704|19064419|P4|Washout Period 3|Adverse Event|0
5513929|NCT01536704|19064420|P3|Washout Period 3|Adverse Event|1
5513930|NCT01536704|19064421|P2|Washout Period 3|Adverse Event|0
5513931|NCT01536704|19064422|P1|Washout Period 3|Adverse Event|0
5513932|NCT01536704|19064419|P4|Period 3|Adverse Event|1
5513933|NCT01536704|19064420|P3|Period 3|Adverse Event|0
5513934|NCT01536704|19064421|P2|Period 3|Adverse Event|0
5513935|NCT01536704|19064422|P1|Period 3|Adverse Event|0
5513936|NCT01536704|19064419|P4|Washout Period 2|Withdrawal by Subject|1
5513937|NCT01536704|19064420|P3|Washout Period 2|Withdrawal by Subject|0
5513938|NCT01536704|19064421|P2|Washout Period 2|Withdrawal by Subject|0
5513939|NCT01536704|19064422|P1|Washout Period 2|Withdrawal by Subject|0
5513940|NCT01536704|19064419|P4|Washout Period 2|Adverse Event|0
5513941|NCT01536704|19064420|P3|Washout Period 2|Adverse Event|0
5513942|NCT01536704|19064421|P2|Washout Period 2|Adverse Event|0
5513943|NCT01536704|19064422|P1|Washout Period 2|Adverse Event|1
5513944|NCT01536704|19064419|P4|Washout Period 1|Withdrawal by Subject|0
5513945|NCT01536704|19064420|P3|Washout Period 1|Withdrawal by Subject|0
5513946|NCT01536704|19064421|P2|Washout Period 1|Withdrawal by Subject|2
5513947|NCT01536704|19064422|P1|Washout Period 1|Withdrawal by Subject|1
5513948|NCT01536587|19064452|P1|Overall Study|Adverse Event|2
5513949|NCT01536574|19064491|P2|Overall Study|Lack of Efficacy|0
5513950|NCT01536574|19064492|P1|Overall Study|Lack of Efficacy|1
5513951|NCT01536574|19064491|P2|Overall Study|Withdrawal by Subject|2
5513952|NCT01536574|19064492|P1|Overall Study|Withdrawal by Subject|1
5513953|NCT01536574|19064491|P2|Overall Study|Adverse Event|5
5513954|NCT01536574|19064492|P1|Overall Study|Adverse Event|4
5513955|NCT01536561|19064510|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
5513956|NCT01536561|19064510|P1|Dosimetric and Therapeutic Treatment|Death|2
5513957|NCT01536561|19064510|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
5513958|NCT01536561|19064510|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
5513959|NCT01536561|19064510|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
5513960|NCT01536561|19064510|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
5513961|NCT01536535|19064550|P2|Overall Study|Participant moved|1
5513962|NCT01536535|19064551|P1|Overall Study|Participant moved|0
5513963|NCT01536535|19064550|P2|Overall Study|Physician Decision|1
5513964|NCT01536535|19064551|P1|Overall Study|Physician Decision|1
5513965|NCT01536535|19064550|P2|Overall Study|Lost to Follow-up|6
5513966|NCT01536535|19064551|P1|Overall Study|Lost to Follow-up|4
5513967|NCT01536535|19064550|P2|Overall Study|Withdrawal by Subject|5
5513968|NCT01536535|19064551|P1|Overall Study|Withdrawal by Subject|10
5513969|NCT01536418|19064600|P2|Overall Study|Withdrawal by Subject|3
5513970|NCT01536418|19064601|P1|Overall Study|Withdrawal by Subject|5
5513971|NCT01536418|19064600|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
5513972|NCT01536418|19064601|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
5513973|NCT01536418|19064600|P2|Overall Study|Adverse Event|4
5513974|NCT01536418|19064601|P1|Overall Study|Adverse Event|9
5513975|NCT01536418|19064600|P2|Overall Study|Lack of Efficacy|16
5513976|NCT01536418|19064601|P1|Overall Study|Lack of Efficacy|10
5513977|NCT01536418|19064600|P2|Overall Study|Study closed/terminated|37
5513978|NCT01536418|19064601|P1|Overall Study|Study closed/terminated|41
5513979|NCT01536418|19064600|P2|Overall Study|Physician Decision|3
5513980|NCT01536418|19064601|P1|Overall Study|Physician Decision|1
5513981|NCT01536418|19064600|P2|Overall Study|Protocol Violation|3
5513982|NCT01536418|19064601|P1|Overall Study|Protocol Violation|2
5513983|NCT01536405|19064621|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
5513984|NCT01536405|19064622|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
5513985|NCT01536405|19064621|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
5513986|NCT01536405|19064622|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
5513987|NCT01536405|19064621|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
5513988|NCT01536405|19064622|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
5513989|NCT01536405|19064621|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
5513990|NCT01536405|19064622|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
5513991|NCT01536405|19064621|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
5513992|NCT01536405|19064622|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
5513993|NCT01536405|19064621|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
5513994|NCT01536405|19064622|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
5513995|NCT01536405|19064621|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
5513996|NCT01536405|19064622|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
5513997|NCT01536405|19064621|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
5513998|NCT01536405|19064622|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
5513999|NCT01536405|19064621|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
5514000|NCT01536405|19064622|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
5514001|NCT01536405|19064621|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
5514002|NCT01536405|19064622|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
5514003|NCT01536405|19064621|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
5514004|NCT01536405|19064622|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
5514005|NCT01536405|19064621|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
5514006|NCT01536405|19064622|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
5514007|NCT01536405|19064621|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
5514008|NCT01536405|19064622|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
5514009|NCT01536379|19064660|P2|Overall Study|Withdrawal by Subject|1
5514010|NCT01536379|19064661|P1|Overall Study|Withdrawal by Subject|1
5514011|NCT01536379|19064660|P2|Overall Study|Adverse Event|2
5514012|NCT01536379|19064661|P1|Overall Study|Adverse Event|1
5514013|NCT01536262|19064753|P3|Overall Study|Other than stated above|0
5514014|NCT01536262|19064754|P2|Overall Study|Other than stated above|0
5514015|NCT01536262|19064755|P1|Overall Study|Other than stated above|1
5514016|NCT01536262|19064753|P3|Overall Study|Withdrawal by Subject|0
5514017|NCT01536262|19064754|P2|Overall Study|Withdrawal by Subject|1
5514018|NCT01536262|19064755|P1|Overall Study|Withdrawal by Subject|1
5514019|NCT01536262|19064753|P3|Overall Study|Adverse Event|2
5514020|NCT01536262|19064754|P2|Overall Study|Adverse Event|1
5514021|NCT01536262|19064755|P1|Overall Study|Adverse Event|6
5514022|NCT01536171|19064797|P1|Overall Study|Withdrawal by Subject|1
5514023|NCT01536145|19064802|P11|Overall Study|Adverse Event|3
5514024|NCT01536145|19064803|P10|Overall Study|Adverse Event|0
5514025|NCT01536145|19064804|P9|Overall Study|Adverse Event|0
5514026|NCT01536145|19064805|P8|Overall Study|Adverse Event|2
5514027|NCT01536145|19064806|P7|Overall Study|Adverse Event|0
5514028|NCT01536145|19064807|P6|Overall Study|Adverse Event|0
5514029|NCT01536145|19064808|P5|Overall Study|Adverse Event|0
5514030|NCT01536145|19064809|P4|Overall Study|Adverse Event|0
5514031|NCT01536145|19064810|P3|Overall Study|Adverse Event|0
5514032|NCT01536145|19064811|P2|Overall Study|Adverse Event|0
5514033|NCT01536145|19064812|P1|Overall Study|Adverse Event|0
5514034|NCT01536145|19064802|P11|Overall Study|Death|0
5514035|NCT01536145|19064803|P10|Overall Study|Death|0
5514036|NCT01536145|19064804|P9|Overall Study|Death|0
5514037|NCT01536145|19064805|P8|Overall Study|Death|0
5514038|NCT01536145|19064806|P7|Overall Study|Death|1
5514039|NCT01536145|19064807|P6|Overall Study|Death|0
5514040|NCT01536145|19064808|P5|Overall Study|Death|0
5514041|NCT01536145|19064809|P4|Overall Study|Death|0
5514042|NCT01536145|19064810|P3|Overall Study|Death|0
5514043|NCT01536145|19064811|P2|Overall Study|Death|0
5514044|NCT01536145|19064812|P1|Overall Study|Death|0
5514045|NCT01536145|19064802|P11|Overall Study|Other|2
5514046|NCT01536145|19064803|P10|Overall Study|Other|3
5514047|NCT01536145|19064804|P9|Overall Study|Other|0
5514048|NCT01536145|19064805|P8|Overall Study|Other|0
5514049|NCT01536145|19064806|P7|Overall Study|Other|0
5514050|NCT01536145|19064807|P6|Overall Study|Other|0
5514051|NCT01536145|19064808|P5|Overall Study|Other|1
5514052|NCT01536145|19064809|P4|Overall Study|Other|0
5514053|NCT01536145|19064810|P3|Overall Study|Other|0
5514054|NCT01536145|19064811|P2|Overall Study|Other|0
5514055|NCT01536145|19064812|P1|Overall Study|Other|0
5514056|NCT01536145|19064802|P11|Overall Study|Withdrawal by Subject|2
5514057|NCT01536145|19064803|P10|Overall Study|Withdrawal by Subject|0
5514058|NCT01536145|19064804|P9|Overall Study|Withdrawal by Subject|2
5514059|NCT01536145|19064805|P8|Overall Study|Withdrawal by Subject|0
5514060|NCT01536145|19064806|P7|Overall Study|Withdrawal by Subject|0
5514061|NCT01536145|19064807|P6|Overall Study|Withdrawal by Subject|1
5514062|NCT01536145|19064808|P5|Overall Study|Withdrawal by Subject|0
5514063|NCT01536145|19064809|P4|Overall Study|Withdrawal by Subject|0
5514064|NCT01536145|19064810|P3|Overall Study|Withdrawal by Subject|1
5514065|NCT01536145|19064811|P2|Overall Study|Withdrawal by Subject|0
5514066|NCT01536145|19064812|P1|Overall Study|Withdrawal by Subject|0
5514067|NCT01536145|19064802|P11|Overall Study|Progressive disease|3
5514068|NCT01536145|19064803|P10|Overall Study|Progressive disease|3
5514069|NCT01536145|19064804|P9|Overall Study|Progressive disease|1
5514070|NCT01536145|19064805|P8|Overall Study|Progressive disease|2
5514071|NCT01536145|19064806|P7|Overall Study|Progressive disease|1
5514072|NCT01536145|19064807|P6|Overall Study|Progressive disease|2
5514073|NCT01536145|19064808|P5|Overall Study|Progressive disease|1
5514074|NCT01536145|19064809|P4|Overall Study|Progressive disease|2
5514075|NCT01536145|19064810|P3|Overall Study|Progressive disease|1
5514076|NCT01536145|19064811|P2|Overall Study|Progressive disease|4
5514077|NCT01536145|19064812|P1|Overall Study|Progressive disease|3
5514078|NCT01536119|19064919|P2|Overall Study|Lost to Follow-up|14
5514079|NCT01536119|19064920|P1|Overall Study|Lost to Follow-up|17
5514080|NCT01536093|19064946|P2|Overall Study|Withdrawal by Subject|1
5514081|NCT01536093|19064947|P1|Overall Study|Withdrawal by Subject|0
5514082|NCT01536093|19064946|P2|Overall Study|absence of maternal colostrum|0
5514083|NCT01536093|19064947|P1|Overall Study|absence of maternal colostrum|2
5514084|NCT01536093|19064946|P2|Overall Study|Death|2
5514085|NCT01536093|19064947|P1|Overall Study|Death|1
5514086|NCT01536067|19064963|P1|Overall Study|Disease Progression|1
5514087|NCT01536015|19064976|P2|Overall Study|Study closure|5
5514088|NCT01536015|19064977|P1|Overall Study|Study closure|5
5514089|NCT01536015|19064976|P2|Overall Study|Inclusion Criterion not met|0
5514090|NCT01536015|19064977|P1|Overall Study|Inclusion Criterion not met|2
5514091|NCT01536015|19064976|P2|Overall Study|Lost to Follow-up|1
5514092|NCT01536015|19064977|P1|Overall Study|Lost to Follow-up|0
5514093|NCT01536015|19064976|P2|Overall Study|Adverse Event|4
5514094|NCT01536015|19064977|P1|Overall Study|Adverse Event|1
5514095|NCT01535807|19065015|P2|Overall Study|Data collection error|1
5514096|NCT01535807|19065016|P1|Overall Study|Data collection error|1
5514097|NCT01535807|19065015|P2|Overall Study|Withdrawal by Subject|1
5514098|NCT01535807|19065016|P1|Overall Study|Withdrawal by Subject|1
5514099|NCT01535729|19065022|P1|Overall Study|No participant record available|5
5514100|NCT01535729|19065022|P1|Overall Study|Not treated|9
5514101|NCT01535729|19065022|P1|Overall Study|Screening failure|1
5514102|NCT01535729|19065022|P1|Overall Study|Protocol Violation|11
5514103|NCT01535729|19065022|P1|Overall Study|NSCLC grade IV histology not confirmed|20
5514104|NCT01535729|19065022|P1|Overall Study|No previous chemotherapy|33
5514105|NCT01535729|19065022|P1|Overall Study|Did not sign informed consent|1
5514106|NCT01535729|19065022|P1|Overall Study|Other|19
5514107|NCT01535729|19065022|P1|Overall Study|Death|52
5514108|NCT01535729|19065022|P1|Overall Study|Lost to Follow-up|8
5514109|NCT01535729|19065022|P1|Overall Study|Discontinued treatment|25
5514110|NCT01535729|19065022|P1|Overall Study|Disease progression|230
5514111|NCT01535729|19065022|P1|Overall Study|Withdrawal by Subject|2
5514112|NCT01535638|19065063|P6|Treatment 3 (Single Dose)|Protocol Violation|0
5514113|NCT01535638|19065064|P5|Treatment 3 (Single Dose)|Protocol Violation|0
5514114|NCT01535638|19065065|P4|Treatment 3 (Single Dose)|Protocol Violation|1
5514115|NCT01535638|19065066|P3|Treatment 3 (Single Dose)|Protocol Violation|0
5514116|NCT01535638|19065067|P2|Treatment 3 (Single Dose)|Protocol Violation|0
5514117|NCT01535638|19065068|P1|Treatment 3 (Single Dose)|Protocol Violation|0
5514118|NCT01535638|19065063|P6|Treatment 1 (Single Dose)|Protocol Violation|1
5514119|NCT01535638|19065064|P5|Treatment 1 (Single Dose)|Protocol Violation|0
5514120|NCT01535638|19065065|P4|Treatment 1 (Single Dose)|Protocol Violation|0
5514121|NCT01535638|19065066|P3|Treatment 1 (Single Dose)|Protocol Violation|0
5514122|NCT01535638|19065067|P2|Treatment 1 (Single Dose)|Protocol Violation|0
5514123|NCT01535638|19065068|P1|Treatment 1 (Single Dose)|Protocol Violation|0
5514124|NCT01535599|19065082|P2|Overall Study|Noncompliance|1
5514125|NCT01535599|19065083|P1|Overall Study|Noncompliance|0
5514126|NCT01535599|19065082|P2|Overall Study|Stopped medication|1
5514127|NCT01535599|19065083|P1|Overall Study|Stopped medication|0
5514128|NCT01535599|19065082|P2|Overall Study|Other|0
5514129|NCT01535599|19065083|P1|Overall Study|Other|1
5514130|NCT01535599|19065082|P2|Overall Study|Did not use product|0
5514131|NCT01535599|19065083|P1|Overall Study|Did not use product|1
5514132|NCT01535599|19065082|P2|Overall Study|Randomized in Error|4
5514133|NCT01535599|19065083|P1|Overall Study|Randomized in Error|2
5514134|NCT01535599|19065082|P2|Overall Study|BL Culture + for Yeast//Fungi|1
5514135|NCT01535599|19065083|P1|Overall Study|BL Culture + for Yeast//Fungi|0
5514136|NCT01535599|19065082|P2|Overall Study|BL Culture + for Group A Strep|1
5514137|NCT01535599|19065083|P1|Overall Study|BL Culture + for Group A Strep|0
5514138|NCT01535599|19065082|P2|Overall Study|Treatment Failure|66
5514139|NCT01535599|19065083|P1|Overall Study|Treatment Failure|33
5514140|NCT01535599|19065082|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
5514141|NCT01535599|19065083|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
5514142|NCT01535599|19065082|P2|Overall Study|Lost to Follow-up|4
5514143|NCT01535599|19065083|P1|Overall Study|Lost to Follow-up|3
5514144|NCT01535599|19065082|P2|Overall Study|Adverse Event|15
5514145|NCT01535599|19065083|P1|Overall Study|Adverse Event|6
5514146|NCT01535560|19065117|P2|Overall Study|Randomized in Error|1
5514147|NCT01535560|19065118|P1|Overall Study|Randomized in Error|0
5514148|NCT01535560|19065117|P2|Overall Study|Other|1
5514149|NCT01535560|19065118|P1|Overall Study|Other|0
5514150|NCT01535560|19065117|P2|Overall Study|Treatment Failure|83
5514151|NCT01535560|19065118|P1|Overall Study|Treatment Failure|21
5514152|NCT01535560|19065117|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
5514153|NCT01535560|19065118|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
5514154|NCT01535560|19065117|P2|Overall Study|Lost to Follow-up|3
5514155|NCT01535560|19065118|P1|Overall Study|Lost to Follow-up|1
5514156|NCT01535560|19065117|P2|Overall Study|Adverse Event|7
5514157|NCT01535560|19065118|P1|Overall Study|Adverse Event|12
5514158|NCT01535443|19065128|P1|Overall Study|Physician Decision|3
5514159|NCT01535287|19065178|P2|Overall Study|drug not prepared in time|6
5514160|NCT01535287|19065179|P1|Overall Study|drug not prepared in time|5
5514161|NCT01535261|19065195|P1|Overall Study|Adverse Event|12
5514162|NCT01535261|19065195|P1|Overall Study|Withdrawal by Subject|14
5514163|NCT01535261|19065195|P1|Overall Study|Lost to Follow-up|8
5514164|NCT01535261|19065195|P1|Overall Study|Death|5
5514165|NCT01535261|19065195|P1|Overall Study|Protocol Violation|3
5514166|NCT01535261|19065195|P1|Overall Study|Physician Decision|8
5514167|NCT01535235|19065208|P2|Overall Study|Adverse Event|0
5514168|NCT01535235|19065209|P1|Overall Study|Adverse Event|1
5514169|NCT01535222|19065223|P6|Overall Study|Inclusion/exclusion|0
5514170|NCT01535222|19065224|P5|Overall Study|Inclusion/exclusion|0
5514171|NCT01535222|19065225|P4|Overall Study|Inclusion/exclusion|0
5514172|NCT01535222|19065226|P3|Overall Study|Inclusion/exclusion|1
5514173|NCT01535222|19065227|P2|Overall Study|Inclusion/exclusion|0
5514174|NCT01535222|19065228|P1|Overall Study|Inclusion/exclusion|0
5514175|NCT01535053|19065259|P2|Overall Study|Ineligible|2
5514176|NCT01535053|19065260|P1|Overall Study|Ineligible|1
5514177|NCT01535040|19065278|P2|Overall Study|Multiple Reasons|1
5514178|NCT01535040|19065279|P1|Overall Study|Multiple Reasons|1
5514179|NCT01535040|19065278|P2|Overall Study|Toxicity|5
5514180|NCT01535040|19065279|P1|Overall Study|Toxicity|7
5514181|NCT01535040|19065278|P2|Overall Study|Never Started|4
5514182|NCT01535040|19065279|P1|Overall Study|Never Started|9
5514183|NCT01535040|19065278|P2|Overall Study|Withdrawal by Subject|10
5514184|NCT01535040|19065279|P1|Overall Study|Withdrawal by Subject|13
5514185|NCT01535040|19065278|P2|Overall Study|Physician Decision|1
5514186|NCT01535040|19065279|P1|Overall Study|Physician Decision|0
5514187|NCT01534962|19065376|P4|Overall Study|Discontinued at AF recurrence|31
5514188|NCT01534962|19065377|P3|Overall Study|Discontinued at AF recurrence|24
5514189|NCT01534962|19065378|P2|Overall Study|Discontinued at AF recurrence|26
5514190|NCT01534962|19065379|P1|Overall Study|Discontinued at AF recurrence|35
5514191|NCT01534962|19065376|P4|Overall Study|Randomized but did not start treatment|1
5514192|NCT01534962|19065377|P3|Overall Study|Randomized but did not start treatment|0
5514193|NCT01534962|19065378|P2|Overall Study|Randomized but did not start treatment|0
5514194|NCT01534962|19065379|P1|Overall Study|Randomized but did not start treatment|2
5514195|NCT01534676|19065436|P2|Overall Study|Study closed due to poor enrollment|1
5514196|NCT01534676|19065437|P1|Overall Study|Study closed due to poor enrollment|2
5514197|NCT01534663|19065445|P2|Overall Study|Adverse Event|1
5514198|NCT01534663|19065446|P1|Overall Study|Adverse Event|2
5514199|NCT01534663|19065445|P2|Overall Study|Lost to Follow-up|2
5514200|NCT01534663|19065446|P1|Overall Study|Lost to Follow-up|0
5514201|NCT01534637|19065480|P1|Overall Study|Liver Mets before treatment|1
5514202|NCT01534637|19065480|P1|Overall Study|Adverse Event|1
5514203|NCT01534637|19065480|P1|Overall Study|Withdrawal by Subject|1
5514204|NCT01534637|19065480|P1|Overall Study|Lack of Efficacy|3
5514205|NCT01534637|19065480|P1|Overall Study|Physician Decision|3
5514206|NCT01534533|19065490|P4|Overall Study|Withdrawal by Subject|1
5514207|NCT01534533|19065491|P3|Overall Study|Withdrawal by Subject|4
5514208|NCT01534533|19065492|P2|Overall Study|Withdrawal by Subject|3
5514209|NCT01534533|19065493|P1|Overall Study|Withdrawal by Subject|5
5514210|NCT01534533|19065490|P4|Overall Study|Lost to Follow-up|3
5514211|NCT01534533|19065491|P3|Overall Study|Lost to Follow-up|4
5514212|NCT01534533|19065492|P2|Overall Study|Lost to Follow-up|0
5514213|NCT01534533|19065493|P1|Overall Study|Lost to Follow-up|3
5514214|NCT01534520|19065521|P2|Overall Study|Adverse Event|1
5514215|NCT01534520|19065522|P1|Overall Study|Adverse Event|0
5514216|NCT01534351|19065556|P3|Overall Study|Study Terminated Early|0
5514217|NCT01534351|19065557|P2|Overall Study|Study Terminated Early|0
5514218|NCT01534351|19065558|P1|Overall Study|Study Terminated Early|1
5514219|NCT01534273|19065579|P7|Period 1|Physician Decision|0
5514220|NCT01534273|19065580|P6|Period 1|Physician Decision|0
5514221|NCT01534273|19065581|P5|Period 1|Physician Decision|0
5514222|NCT01534273|19065582|P4|Period 1|Physician Decision|1
5514223|NCT01534273|19065583|P3|Period 1|Physician Decision|0
5514224|NCT01534273|19065584|P2|Period 1|Physician Decision|0
5514225|NCT01534273|19065585|P1|Period 1|Physician Decision|0
5514226|NCT01534260|19065612|P2|Overall Study|No treatment, per protocol|1
5514227|NCT01534260|19065613|P1|Overall Study|No treatment, per protocol|0
5514228|NCT01534260|19065612|P2|Overall Study|Physician Decision|1
5514229|NCT01534260|19065613|P1|Overall Study|Physician Decision|3
5514230|NCT01534260|19065612|P2|Overall Study|Disease Progression|6
5514231|NCT01534260|19065613|P1|Overall Study|Disease Progression|8
5514232|NCT01534260|19065612|P2|Overall Study|Withdrawal by Subject|3
5514233|NCT01534260|19065613|P1|Overall Study|Withdrawal by Subject|1
5514234|NCT01534260|19065612|P2|Overall Study|Lack of Efficacy|1
5514235|NCT01534260|19065613|P1|Overall Study|Lack of Efficacy|1
5514236|NCT01534260|19065612|P2|Overall Study|Death|0
5514237|NCT01534260|19065613|P1|Overall Study|Death|2
5514238|NCT01534260|19065612|P2|Overall Study|Adverse Event|8
5514239|NCT01534260|19065613|P1|Overall Study|Adverse Event|1
5514240|NCT01534208|19065623|P2|Overall Study|Needed prohibited meds|0
5514241|NCT01534208|19065624|P1|Overall Study|Needed prohibited meds|1
5514242|NCT01534208|19065623|P2|Overall Study|PCP decision|0
5514243|NCT01534208|19065624|P1|Overall Study|PCP decision|1
5514244|NCT01534208|19065623|P2|Overall Study|Eligibility error|0
5514245|NCT01534208|19065624|P1|Overall Study|Eligibility error|3
5514246|NCT01534208|19065623|P2|Overall Study|Lab assessment|1
5514247|NCT01534208|19065624|P1|Overall Study|Lab assessment|2
5514248|NCT01534208|19065623|P2|Overall Study|Subject relocation|0
5514249|NCT01534208|19065624|P1|Overall Study|Subject relocation|2
5514250|NCT01534208|19065623|P2|Overall Study|Sponsor decision|1
5514251|NCT01534208|19065624|P1|Overall Study|Sponsor decision|4
5514252|NCT01534208|19065623|P2|Overall Study|Protocol Violation|2
5514253|NCT01534208|19065624|P1|Overall Study|Protocol Violation|2
5514254|NCT01534208|19065623|P2|Overall Study|Lack of Efficacy|3
5514255|NCT01534208|19065624|P1|Overall Study|Lack of Efficacy|0
5514256|NCT01534208|19065623|P2|Overall Study|Physician Decision|0
5514257|NCT01534208|19065624|P1|Overall Study|Physician Decision|2
5514258|NCT01534208|19065623|P2|Overall Study|Adverse Event|8
5514259|NCT01534208|19065624|P1|Overall Study|Adverse Event|15
5514260|NCT01534208|19065623|P2|Overall Study|Withdrawal by Subject|20
5514261|NCT01534208|19065624|P1|Overall Study|Withdrawal by Subject|6
5514262|NCT01534208|19065623|P2|Overall Study|Lost to Follow-up|14
5514263|NCT01534208|19065624|P1|Overall Study|Lost to Follow-up|19
5514264|NCT01534195|19065642|P2|Overall Study|Withdrawal by Subject|1
5514265|NCT01534195|19065643|P1|Overall Study|Withdrawal by Subject|1
5514266|NCT01534182|19065657|P2|Overall Study|Adverse Event|3
5514267|NCT01534182|19065658|P1|Overall Study|Adverse Event|7
5514268|NCT01534182|19065657|P2|Overall Study|Withdrawal by Subject|7
5514269|NCT01534182|19065658|P1|Overall Study|Withdrawal by Subject|4
5514270|NCT01534182|19065657|P2|Overall Study|Administrative problems|0
5514271|NCT01534182|19065658|P1|Overall Study|Administrative problems|1
5514272|NCT01534078|19065689|P1|Overall Study|Withdrawal by Subject|1
5514273|NCT01534078|19065689|P1|Overall Study|Death|1
5514274|NCT01533935|19065726|P5|Overall Study|Other reason not defined above|1
5514275|NCT01533935|19065727|P4|Overall Study|Other reason not defined above|0
5514276|NCT01533935|19065728|P3|Overall Study|Other reason not defined above|1
5514277|NCT01533935|19065729|P2|Overall Study|Other reason not defined above|0
5514278|NCT01533935|19065730|P1|Overall Study|Other reason not defined above|1
5514279|NCT01533935|19065726|P5|Overall Study|Withdrawal by Subject|4
5514280|NCT01533935|19065727|P4|Overall Study|Withdrawal by Subject|2
5514281|NCT01533935|19065728|P3|Overall Study|Withdrawal by Subject|5
5514282|NCT01533935|19065729|P2|Overall Study|Withdrawal by Subject|4
5514283|NCT01533935|19065730|P1|Overall Study|Withdrawal by Subject|0
5514284|NCT01533935|19065726|P5|Overall Study|Lost to Follow-up|0
5514285|NCT01533935|19065727|P4|Overall Study|Lost to Follow-up|0
5514286|NCT01533935|19065728|P3|Overall Study|Lost to Follow-up|1
5514287|NCT01533935|19065729|P2|Overall Study|Lost to Follow-up|0
5514288|NCT01533935|19065730|P1|Overall Study|Lost to Follow-up|0
5514289|NCT01533935|19065726|P5|Overall Study|Protocol Violation|0
5514290|NCT01533935|19065727|P4|Overall Study|Protocol Violation|0
5514291|NCT01533935|19065728|P3|Overall Study|Protocol Violation|0
5514292|NCT01533935|19065729|P2|Overall Study|Protocol Violation|2
5514293|NCT01533935|19065730|P1|Overall Study|Protocol Violation|0
5514294|NCT01533935|19065726|P5|Overall Study|Adverse Event|3
5514295|NCT01533935|19065727|P4|Overall Study|Adverse Event|5
5514296|NCT01533935|19065728|P3|Overall Study|Adverse Event|1
5514297|NCT01533935|19065729|P2|Overall Study|Adverse Event|7
5514298|NCT01533935|19065730|P1|Overall Study|Adverse Event|5
5514299|NCT01533922|19065757|P5|Overall Study|Other reason not defined above|0
5514300|NCT01533922|19065758|P4|Overall Study|Other reason not defined above|0
5514301|NCT01533922|19065759|P3|Overall Study|Other reason not defined above|1
5514302|NCT01533922|19065760|P2|Overall Study|Other reason not defined above|0
5514303|NCT01533922|19065761|P1|Overall Study|Other reason not defined above|2
5514304|NCT01533922|19065757|P5|Overall Study|Withdrawal by Subject|1
5514305|NCT01533922|19065758|P4|Overall Study|Withdrawal by Subject|2
5514306|NCT01533922|19065759|P3|Overall Study|Withdrawal by Subject|2
5514307|NCT01533922|19065760|P2|Overall Study|Withdrawal by Subject|1
5514308|NCT01533922|19065761|P1|Overall Study|Withdrawal by Subject|3
5514309|NCT01533922|19065757|P5|Overall Study|Protocol Violation|1
5514310|NCT01533922|19065758|P4|Overall Study|Protocol Violation|0
5514311|NCT01533922|19065759|P3|Overall Study|Protocol Violation|0
5514312|NCT01533922|19065760|P2|Overall Study|Protocol Violation|3
5514313|NCT01533922|19065761|P1|Overall Study|Protocol Violation|0
5514314|NCT01533922|19065757|P5|Overall Study|Lack of Efficacy|0
5514315|NCT01533922|19065758|P4|Overall Study|Lack of Efficacy|0
5514316|NCT01533922|19065759|P3|Overall Study|Lack of Efficacy|1
5514317|NCT01533922|19065760|P2|Overall Study|Lack of Efficacy|0
5514318|NCT01533922|19065761|P1|Overall Study|Lack of Efficacy|0
5514319|NCT01533922|19065757|P5|Overall Study|Adverse Event|4
5514320|NCT01533922|19065758|P4|Overall Study|Adverse Event|3
5514321|NCT01533922|19065759|P3|Overall Study|Adverse Event|6
5514322|NCT01533922|19065760|P2|Overall Study|Adverse Event|8
5514323|NCT01533922|19065761|P1|Overall Study|Adverse Event|5
5514324|NCT01533688|19065806|P3|Overall Study|Had colonoscopy at outside hospital|2
5514325|NCT01533688|19065807|P2|Overall Study|Had colonoscopy at outside hospital|3
5514326|NCT01533688|19065808|P1|Overall Study|Had colonoscopy at outside hospital|2
5514327|NCT01533688|19065806|P3|Overall Study|Medically unstable|3
5514328|NCT01533688|19065807|P2|Overall Study|Medically unstable|3
5514329|NCT01533688|19065808|P1|Overall Study|Medically unstable|1
5514330|NCT01533688|19065806|P3|Overall Study|Withdrawal by Subject|3
5514331|NCT01533688|19065807|P2|Overall Study|Withdrawal by Subject|4
5514332|NCT01533688|19065808|P1|Overall Study|Withdrawal by Subject|5
5514333|NCT01533493|19065840|P2|Overall Study|Lost to Follow-up|0
5514334|NCT01533493|19065841|P1|Overall Study|Lost to Follow-up|2
5514335|NCT01533493|19065840|P2|Overall Study|Withdrawal by Subject|2
5514336|NCT01533493|19065841|P1|Overall Study|Withdrawal by Subject|1
5514337|NCT01533493|19065840|P2|Overall Study|Adverse Event|1
5514338|NCT01533493|19065841|P1|Overall Study|Adverse Event|2
5514339|NCT01533428|19065849|P2|Overall Study|Withdrawal by Subject|6
5514340|NCT01533428|19065850|P1|Overall Study|Withdrawal by Subject|7
5514341|NCT01533428|19065849|P2|Overall Study|Lost to Follow-up|1
5514342|NCT01533428|19065850|P1|Overall Study|Lost to Follow-up|2
5514343|NCT01533428|19065849|P2|Overall Study|Adverse Event|1
5514344|NCT01533428|19065850|P1|Overall Study|Adverse Event|0
5514345|NCT01533246|19065896|P1|Overall Study|Withdrawal by Subject|1
5514346|NCT01533246|19065896|P1|Overall Study|Adverse Event|1
5514347|NCT01533181|19065920|P2|Overall Study|Patient withdrawal pre-active treatment|0
5514348|NCT01533181|19065921|P1|Overall Study|Patient withdrawal pre-active treatment|1
5514349|NCT01533181|19065920|P2|Overall Study|Disease progression pre-active treatment|1
5514350|NCT01533181|19065921|P1|Overall Study|Disease progression pre-active treatment|0
5514351|NCT01532999|19066038|P2|Overall Study|New job|2
5514352|NCT01532999|19066039|P1|Overall Study|New job|0
5514353|NCT01532999|19066038|P2|Overall Study|incarcerated|1
5514354|NCT01532999|19066039|P1|Overall Study|incarcerated|0
5514355|NCT01532999|19066038|P2|Overall Study|Adverse Event|1
5514356|NCT01532999|19066039|P1|Overall Study|Adverse Event|0
5514357|NCT01532999|19066038|P2|Overall Study|no show for week 9 assessments|4
5514358|NCT01532999|19066039|P1|Overall Study|no show for week 9 assessments|6
5514359|NCT01532999|19066038|P2|Overall Study|substantial noncompliance|0
5514360|NCT01532999|19066039|P1|Overall Study|substantial noncompliance|2
5514361|NCT01532999|19066038|P2|Overall Study|should not have been randomized|0
5514362|NCT01532999|19066039|P1|Overall Study|should not have been randomized|1
5514363|NCT01532999|19066038|P2|Overall Study|Relocated|0
5514364|NCT01532999|19066039|P1|Overall Study|Relocated|2
5514365|NCT01532999|19066038|P2|Overall Study|Withdrawal by Subject|0
5514366|NCT01532999|19066039|P1|Overall Study|Withdrawal by Subject|5
5514367|NCT01532999|19066038|P2|Overall Study|Physician Decision|2
5514368|NCT01532999|19066039|P1|Overall Study|Physician Decision|1
5514369|NCT01532999|19066038|P2|Overall Study|Lost to Follow-up|8
5514370|NCT01532999|19066039|P1|Overall Study|Lost to Follow-up|14
5514371|NCT01532986|19066063|P2|Overall Study|Physician Decision|5
5514372|NCT01532986|19066064|P1|Overall Study|Physician Decision|7
5514373|NCT01532986|19066063|P2|Overall Study|Withdrawal by Subject|10
5514374|NCT01532986|19066064|P1|Overall Study|Withdrawal by Subject|7
5514375|NCT01532986|19066063|P2|Overall Study|Death|9
5514376|NCT01532986|19066064|P1|Overall Study|Death|9
5514377|NCT01532934|19066148|P2|Overall Study|In controlled environment|2
5514378|NCT01532934|19066149|P1|Overall Study|In controlled environment|3
5514379|NCT01532934|19066148|P2|Overall Study|Lost to Follow-up|11
5514380|NCT01532934|19066149|P1|Overall Study|Lost to Follow-up|11
5514381|NCT01532921|19066159|P1|Overall Study|Device was explanted during procedure|1
5514382|NCT01532921|19066159|P1|Overall Study|Physician Decision|7
5514383|NCT01532921|19066159|P1|Overall Study|Lost to Follow-up|3
5514384|NCT01532921|19066159|P1|Overall Study|Withdrawal by Subject|2
5514385|NCT01532921|19066159|P1|Overall Study|Death|3
5514386|NCT01532869|19066181|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
5514387|NCT01532869|19066182|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
5514388|NCT01532869|19066181|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
5514389|NCT01532869|19066182|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
5514390|NCT01532869|19066181|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
5514391|NCT01532869|19066182|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
5514392|NCT01532869|19066181|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
5514393|NCT01532869|19066182|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
5514394|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
5514395|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
5514396|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
5514397|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
5514398|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
5514399|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
5514400|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
5514401|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
5514402|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
5514403|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
5514404|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
5514405|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
5514406|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
5514407|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
5514408|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
5514409|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
5514410|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
5514411|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
5514412|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
5514413|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
5514414|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
5514415|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
5514416|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
5514417|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
5514418|NCT01532869|19066181|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
5514419|NCT01532869|19066182|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
5514420|NCT01532648|19066241|P2|Overall Study|Withdrawal by Subject|2
5514421|NCT01532648|19066242|P1|Overall Study|Withdrawal by Subject|16
5514422|NCT01532648|19066241|P2|Overall Study|Adverse Event|9
5514423|NCT01532648|19066242|P1|Overall Study|Adverse Event|12
5514424|NCT01532648|19066241|P2|Overall Study|Protocol Violation|1
5514425|NCT01532648|19066242|P1|Overall Study|Protocol Violation|1
5514426|NCT01532648|19066241|P2|Overall Study|Lack of Efficacy|1
5514427|NCT01532648|19066242|P1|Overall Study|Lack of Efficacy|4
5514428|NCT01532648|19066241|P2|Overall Study|Lost to Follow-up|4
5514429|NCT01532648|19066242|P1|Overall Study|Lost to Follow-up|3
5514430|NCT01532570|19066276|P4|Overall Study|Withdrawal by Subject|0
5514431|NCT01532570|19066277|P3|Overall Study|Withdrawal by Subject|0
5514432|NCT01532570|19066278|P2|Overall Study|Withdrawal by Subject|1
5514433|NCT01532570|19066279|P1|Overall Study|Withdrawal by Subject|0
5514434|NCT01532570|19066276|P4|Overall Study|Lack of Efficacy|0
5514435|NCT01532570|19066277|P3|Overall Study|Lack of Efficacy|0
5514436|NCT01532570|19066278|P2|Overall Study|Lack of Efficacy|0
5514437|NCT01532570|19066279|P1|Overall Study|Lack of Efficacy|1
5514438|NCT01532414|19066324|P3|Overall Study|Withdrawn by sponsor|0
5514439|NCT01532414|19066325|P2|Overall Study|Withdrawn by sponsor|0
5514440|NCT01532414|19066326|P1|Overall Study|Withdrawn by sponsor|1
5514441|NCT01532414|19066324|P3|Overall Study|Unable to complete 24 hour PK|1
5514442|NCT01532414|19066325|P2|Overall Study|Unable to complete 24 hour PK|0
5514443|NCT01532414|19066326|P1|Overall Study|Unable to complete 24 hour PK|0
5514444|NCT01532414|19066324|P3|Overall Study|Adverse Event|1
5514445|NCT01532414|19066325|P2|Overall Study|Adverse Event|1
5514446|NCT01532414|19066326|P1|Overall Study|Adverse Event|0
5514447|NCT01532414|19066324|P3|Overall Study|No V6 semen sample|0
5514448|NCT01532414|19066325|P2|Overall Study|No V6 semen sample|1
5514449|NCT01532414|19066326|P1|Overall Study|No V6 semen sample|0
5514450|NCT01532414|19066324|P3|Overall Study|Withdrawal by Subject|0
5514451|NCT01532414|19066325|P2|Overall Study|Withdrawal by Subject|0
5514452|NCT01532414|19066326|P1|Overall Study|Withdrawal by Subject|3
5514453|NCT01532414|19066324|P3|Overall Study|Lost to Follow-up|1
5514454|NCT01532414|19066325|P2|Overall Study|Lost to Follow-up|0
5514455|NCT01532414|19066326|P1|Overall Study|Lost to Follow-up|3
5514456|NCT01532388|19066336|P2|12-month Follow-up|Lost to Follow-up|67
5514457|NCT01532388|19066337|P1|12-month Follow-up|Lost to Follow-up|69
5514458|NCT01532388|19066336|P2|6-month Follow-up|Lost to Follow-up|66
5514459|NCT01532388|19066337|P1|6-month Follow-up|Lost to Follow-up|74
5514460|NCT01532388|19066336|P2|3-month Follow-up|Lost to Follow-up|68
5514461|NCT01532388|19066337|P1|3-month Follow-up|Lost to Follow-up|68
5514462|NCT01531998|19066442|P1|Overall Study|Withdrawal by Subject|3
5514463|NCT01531894|19066464|P1|Overall Study|Death|1
5514464|NCT01531894|19066464|P1|Overall Study|Physician Decision|8
5514465|NCT01531725|19066481|P1|Overall Study|Protocol Violation|5
5514466|NCT01531673|19066499|P13|Overall Study|Other|0
5514467|NCT01531673|19066500|P12|Overall Study|Other|0
5514468|NCT01531673|19066501|P11|Overall Study|Other|0
5514469|NCT01531673|19066502|P10|Overall Study|Other|1
5514470|NCT01531673|19066503|P9|Overall Study|Other|0
5514471|NCT01531673|19066504|P8|Overall Study|Other|0
5514472|NCT01531673|19066505|P7|Overall Study|Other|0
5514473|NCT01531673|19066506|P6|Overall Study|Other|0
5514474|NCT01531673|19066507|P5|Overall Study|Other|0
5514475|NCT01531673|19066508|P4|Overall Study|Other|1
5514476|NCT01531673|19066509|P3|Overall Study|Other|0
5514477|NCT01531673|19066510|P2|Overall Study|Other|0
5514478|NCT01531673|19066511|P1|Overall Study|Other|0
5514479|NCT01531673|19066499|P13|Overall Study|Lost to Follow-up|0
5514480|NCT01531673|19066500|P12|Overall Study|Lost to Follow-up|0
5514481|NCT01531673|19066501|P11|Overall Study|Lost to Follow-up|0
5514482|NCT01531673|19066502|P10|Overall Study|Lost to Follow-up|0
5514483|NCT01531673|19066503|P9|Overall Study|Lost to Follow-up|0
5514484|NCT01531673|19066504|P8|Overall Study|Lost to Follow-up|0
5514485|NCT01531673|19066505|P7|Overall Study|Lost to Follow-up|0
5514486|NCT01531673|19066506|P6|Overall Study|Lost to Follow-up|0
5514487|NCT01531673|19066507|P5|Overall Study|Lost to Follow-up|1
5514488|NCT01531673|19066508|P4|Overall Study|Lost to Follow-up|0
5514489|NCT01531673|19066509|P3|Overall Study|Lost to Follow-up|0
5514490|NCT01531673|19066510|P2|Overall Study|Lost to Follow-up|0
5514491|NCT01531673|19066511|P1|Overall Study|Lost to Follow-up|0
5514492|NCT01531673|19066499|P13|Overall Study|Adverse Event|0
5514493|NCT01531673|19066500|P12|Overall Study|Adverse Event|0
5514494|NCT01531673|19066501|P11|Overall Study|Adverse Event|0
5514495|NCT01531673|19066502|P10|Overall Study|Adverse Event|0
5514496|NCT01531673|19066503|P9|Overall Study|Adverse Event|0
5514497|NCT01531673|19066504|P8|Overall Study|Adverse Event|0
5514498|NCT01531673|19066505|P7|Overall Study|Adverse Event|0
5514499|NCT01531673|19066506|P6|Overall Study|Adverse Event|0
5514500|NCT01531673|19066507|P5|Overall Study|Adverse Event|0
5514501|NCT01531673|19066508|P4|Overall Study|Adverse Event|0
5514502|NCT01531673|19066509|P3|Overall Study|Adverse Event|0
5514503|NCT01531673|19066510|P2|Overall Study|Adverse Event|1
5514504|NCT01531673|19066511|P1|Overall Study|Adverse Event|0
5514505|NCT01531673|19066499|P13|Overall Study|Non-Compliance|0
5514506|NCT01531673|19066500|P12|Overall Study|Non-Compliance|0
5514507|NCT01531673|19066501|P11|Overall Study|Non-Compliance|0
5514508|NCT01531673|19066502|P10|Overall Study|Non-Compliance|0
5514509|NCT01531673|19066503|P9|Overall Study|Non-Compliance|0
5514510|NCT01531673|19066504|P8|Overall Study|Non-Compliance|0
5514511|NCT01531673|19066505|P7|Overall Study|Non-Compliance|0
5514512|NCT01531673|19066506|P6|Overall Study|Non-Compliance|1
5514513|NCT01531673|19066507|P5|Overall Study|Non-Compliance|0
5514514|NCT01531673|19066508|P4|Overall Study|Non-Compliance|0
5514515|NCT01531673|19066509|P3|Overall Study|Non-Compliance|0
5514516|NCT01531673|19066510|P2|Overall Study|Non-Compliance|0
5514517|NCT01531673|19066511|P1|Overall Study|Non-Compliance|0
5514518|NCT01531387|19066637|P2|Overall Study|Early termination of study|11
5514519|NCT01531387|19066638|P1|Overall Study|Early termination of study|11
5514520|NCT01531205|19066730|P1|Overall Study|Did not proceed to surgery|1
5514521|NCT01531153|19066742|P3|Overall Study|Withdrawal by Subject|15
5514522|NCT01531153|19066743|P2|Overall Study|Withdrawal by Subject|9
5514523|NCT01531153|19066744|P1|Overall Study|Withdrawal by Subject|10
5514524|NCT01530997|19066800|P1|Overall Study|Withdrawal by Subject|1
5514525|NCT01530997|19066800|P1|Overall Study|Physician Decision|1
5514526|NCT01530464|19066844|P2|Washout (24h)|Withdrawal by Subject|1
5514527|NCT01530464|19066845|P1|Washout (24h)|Withdrawal by Subject|0
5514528|NCT01530464|19066844|P2|Washout (24h)|Withdrawal by Subject|0
5514529|NCT01530464|19066845|P1|Washout (24h)|Withdrawal by Subject|1
5514530|NCT01530334|19066897|P1|Overall Study|Progressive disease|47
5514531|NCT01530334|19066897|P1|Overall Study|unknown reason|1
5514532|NCT01530334|19066897|P1|Overall Study|Adverse Event|3
5514533|NCT01530087|19066944|P1|Overall Study|Physician Decision|2
5514534|NCT01529749|19066960|P4|Overall Study|Protocol Violation|1
5514535|NCT01529749|19066961|P3|Overall Study|Protocol Violation|0
5514536|NCT01529749|19066962|P2|Overall Study|Protocol Violation|0
5514537|NCT01529749|19066963|P1|Overall Study|Protocol Violation|0
5514538|NCT01529749|19066960|P4|Overall Study|Withdrawal by Subject|0
5514539|NCT01529749|19066961|P3|Overall Study|Withdrawal by Subject|1
5514540|NCT01529749|19066962|P2|Overall Study|Withdrawal by Subject|1
5514541|NCT01529749|19066963|P1|Overall Study|Withdrawal by Subject|0
5514542|NCT01529749|19066960|P4|Overall Study|Physician Decision|1
5514543|NCT01529749|19066961|P3|Overall Study|Physician Decision|0
5514544|NCT01529749|19066962|P2|Overall Study|Physician Decision|0
5514545|NCT01529749|19066963|P1|Overall Study|Physician Decision|0
5514546|NCT01529749|19066960|P4|Overall Study|Lost to Follow-up|0
5514547|NCT01529749|19066961|P3|Overall Study|Lost to Follow-up|1
5514548|NCT01529749|19066962|P2|Overall Study|Lost to Follow-up|1
5514549|NCT01529749|19066963|P1|Overall Study|Lost to Follow-up|0
5514550|NCT01529645|19067047|P10|Overall Study|Withdrawal by Subject|0
5514551|NCT01529645|19067048|P9|Overall Study|Withdrawal by Subject|0
5514552|NCT01529645|19067049|P8|Overall Study|Withdrawal by Subject|0
5514553|NCT01529645|19067050|P7|Overall Study|Withdrawal by Subject|0
5514554|NCT01529645|19067051|P6|Overall Study|Withdrawal by Subject|1
5514555|NCT01529645|19067052|P5|Overall Study|Withdrawal by Subject|1
5514556|NCT01529645|19067053|P4|Overall Study|Withdrawal by Subject|1
5514557|NCT01529645|19067054|P3|Overall Study|Withdrawal by Subject|0
5514558|NCT01529645|19067055|P2|Overall Study|Withdrawal by Subject|0
5514559|NCT01529645|19067056|P1|Overall Study|Withdrawal by Subject|2
5514560|NCT01529645|19067047|P10|Overall Study|SAE - Premature contractions|0
5514561|NCT01529645|19067048|P9|Overall Study|SAE - Premature contractions|0
5514562|NCT01529645|19067049|P8|Overall Study|SAE - Premature contractions|0
5514563|NCT01529645|19067050|P7|Overall Study|SAE - Premature contractions|0
5514564|NCT01529645|19067051|P6|Overall Study|SAE - Premature contractions|0
5514565|NCT01529645|19067052|P5|Overall Study|SAE - Premature contractions|0
5514566|NCT01529645|19067053|P4|Overall Study|SAE - Premature contractions|0
5514567|NCT01529645|19067054|P3|Overall Study|SAE - Premature contractions|1
5514568|NCT01529645|19067055|P2|Overall Study|SAE - Premature contractions|0
5514569|NCT01529645|19067056|P1|Overall Study|SAE - Premature contractions|0
5514570|NCT01529645|19067047|P10|Overall Study|Lost to Follow-up|0
5514571|NCT01529645|19067048|P9|Overall Study|Lost to Follow-up|1
5514572|NCT01529645|19067049|P8|Overall Study|Lost to Follow-up|0
5514573|NCT01529645|19067050|P7|Overall Study|Lost to Follow-up|2
5514574|NCT01529645|19067051|P6|Overall Study|Lost to Follow-up|0
5514575|NCT01529645|19067052|P5|Overall Study|Lost to Follow-up|1
5514576|NCT01529645|19067053|P4|Overall Study|Lost to Follow-up|1
5514577|NCT01529645|19067054|P3|Overall Study|Lost to Follow-up|1
5514578|NCT01529645|19067055|P2|Overall Study|Lost to Follow-up|1
5514579|NCT01529645|19067056|P1|Overall Study|Lost to Follow-up|0
5514580|NCT01529632|19067154|P2|Overall Study|Adverse Event|1
5514581|NCT01529632|19067155|P1|Overall Study|Adverse Event|1
5514582|NCT01529632|19067154|P2|Overall Study|Protocol Violation|1
5514583|NCT01529632|19067155|P1|Overall Study|Protocol Violation|0
5514584|NCT01529632|19067154|P2|Overall Study|Administrative problem|1
5514585|NCT01529632|19067155|P1|Overall Study|Administrative problem|2
5514586|NCT01529606|19067175|P2|Overall Study|Lost to Follow-up|18
5514587|NCT01529606|19067176|P1|Overall Study|Lost to Follow-up|21
5514588|NCT01529515|19067188|P4|DOUBLE BLIND PHASE|Other|2
5514589|NCT01529515|19067189|P3|DOUBLE BLIND PHASE|Other|9
5514590|NCT01529515|19067190|P2|DOUBLE BLIND PHASE|Other|0
5514591|NCT01529515|19067191|P1|DOUBLE BLIND PHASE|Other|0
5514592|NCT01529515|19067188|P4|DOUBLE BLIND PHASE|Protocol Violation|0
5514593|NCT01529515|19067189|P3|DOUBLE BLIND PHASE|Protocol Violation|1
5514594|NCT01529515|19067190|P2|DOUBLE BLIND PHASE|Protocol Violation|0
5514595|NCT01529515|19067191|P1|DOUBLE BLIND PHASE|Protocol Violation|0
5514596|NCT01529515|19067188|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
5514597|NCT01529515|19067189|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
5514598|NCT01529515|19067190|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
5514599|NCT01529515|19067191|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
5514600|NCT01529515|19067188|P4|DOUBLE BLIND PHASE|Pregnancy|0
5514601|NCT01529515|19067189|P3|DOUBLE BLIND PHASE|Pregnancy|1
5514602|NCT01529515|19067190|P2|DOUBLE BLIND PHASE|Pregnancy|0
5514603|NCT01529515|19067191|P1|DOUBLE BLIND PHASE|Pregnancy|0
5514604|NCT01529515|19067188|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
5514605|NCT01529515|19067189|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
5514606|NCT01529515|19067190|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
5514607|NCT01529515|19067191|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
5514608|NCT01529515|19067188|P4|DOUBLE BLIND PHASE|Adverse Event|0
5514609|NCT01529515|19067189|P3|DOUBLE BLIND PHASE|Adverse Event|1
5514610|NCT01529515|19067190|P2|DOUBLE BLIND PHASE|Adverse Event|0
5514611|NCT01529515|19067191|P1|DOUBLE BLIND PHASE|Adverse Event|0
5514612|NCT01529515|19067188|P4|MAINTENANCE PHASE|Other|0
5514613|NCT01529515|19067189|P3|MAINTENANCE PHASE|Other|0
5514614|NCT01529515|19067190|P2|MAINTENANCE PHASE|Other|10
5514615|NCT01529515|19067191|P1|MAINTENANCE PHASE|Other|0
5514616|NCT01529515|19067188|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
5514617|NCT01529515|19067189|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
5514618|NCT01529515|19067190|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
5514619|NCT01529515|19067191|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
5514620|NCT01529515|19067188|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
5514621|NCT01529515|19067189|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
5514622|NCT01529515|19067190|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
5514623|NCT01529515|19067191|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
5514624|NCT01529515|19067188|P4|MAINTENANCE PHASE|Protocol Violation|0
5514625|NCT01529515|19067189|P3|MAINTENANCE PHASE|Protocol Violation|0
5514626|NCT01529515|19067190|P2|MAINTENANCE PHASE|Protocol Violation|12
5514627|NCT01529515|19067191|P1|MAINTENANCE PHASE|Protocol Violation|0
5514628|NCT01529515|19067188|P4|MAINTENANCE PHASE|Lost to Follow-up|0
5514629|NCT01529515|19067189|P3|MAINTENANCE PHASE|Lost to Follow-up|0
5514630|NCT01529515|19067190|P2|MAINTENANCE PHASE|Lost to Follow-up|5
5514631|NCT01529515|19067191|P1|MAINTENANCE PHASE|Lost to Follow-up|0
5514632|NCT01529515|19067188|P4|MAINTENANCE PHASE|Lack of Efficacy|0
5514633|NCT01529515|19067189|P3|MAINTENANCE PHASE|Lack of Efficacy|0
5514634|NCT01529515|19067190|P2|MAINTENANCE PHASE|Lack of Efficacy|9
5514635|NCT01529515|19067191|P1|MAINTENANCE PHASE|Lack of Efficacy|0
5514636|NCT01529515|19067188|P4|MAINTENANCE PHASE|Adverse Event|0
5514637|NCT01529515|19067189|P3|MAINTENANCE PHASE|Adverse Event|0
5514638|NCT01529515|19067190|P2|MAINTENANCE PHASE|Adverse Event|10
5514639|NCT01529515|19067191|P1|MAINTENANCE PHASE|Adverse Event|0
5514640|NCT01529515|19067188|P4|TRANSITION PHASE|Other|0
5514641|NCT01529515|19067189|P3|TRANSITION PHASE|Other|0
5514642|NCT01529515|19067190|P2|TRANSITION PHASE|Other|0
5514643|NCT01529515|19067191|P1|TRANSITION PHASE|Other|9
5514644|NCT01529515|19067188|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
5514645|NCT01529515|19067189|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
5514646|NCT01529515|19067190|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
5514647|NCT01529515|19067191|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
5514648|NCT01529515|19067188|P4|TRANSITION PHASE|Withdrawal by Subject|0
5514649|NCT01529515|19067189|P3|TRANSITION PHASE|Withdrawal by Subject|0
5514650|NCT01529515|19067190|P2|TRANSITION PHASE|Withdrawal by Subject|0
5514651|NCT01529515|19067191|P1|TRANSITION PHASE|Withdrawal by Subject|51
5514652|NCT01529515|19067188|P4|TRANSITION PHASE|Protocol Violation|0
5514653|NCT01529515|19067189|P3|TRANSITION PHASE|Protocol Violation|0
5514654|NCT01529515|19067190|P2|TRANSITION PHASE|Protocol Violation|0
5514655|NCT01529515|19067191|P1|TRANSITION PHASE|Protocol Violation|4
5514656|NCT01529515|19067188|P4|TRANSITION PHASE|Lost to Follow-up|0
5514657|NCT01529515|19067189|P3|TRANSITION PHASE|Lost to Follow-up|0
5514658|NCT01529515|19067190|P2|TRANSITION PHASE|Lost to Follow-up|0
5514659|NCT01529515|19067191|P1|TRANSITION PHASE|Lost to Follow-up|19
5514660|NCT01529515|19067188|P4|TRANSITION PHASE|Lack of Efficacy|0
5514661|NCT01529515|19067189|P3|TRANSITION PHASE|Lack of Efficacy|0
5514662|NCT01529515|19067190|P2|TRANSITION PHASE|Lack of Efficacy|0
5514663|NCT01529515|19067191|P1|TRANSITION PHASE|Lack of Efficacy|19
5514664|NCT01529515|19067188|P4|TRANSITION PHASE|Death|0
5514665|NCT01529515|19067189|P3|TRANSITION PHASE|Death|0
5514666|NCT01529515|19067190|P2|TRANSITION PHASE|Death|0
5514667|NCT01529515|19067191|P1|TRANSITION PHASE|Death|1
5514668|NCT01529515|19067188|P4|TRANSITION PHASE|Adverse Event|0
5514669|NCT01529515|19067189|P3|TRANSITION PHASE|Adverse Event|0
5514670|NCT01529515|19067190|P2|TRANSITION PHASE|Adverse Event|0
5514671|NCT01529515|19067191|P1|TRANSITION PHASE|Adverse Event|16
5514672|NCT01529385|19067238|P2|Overall Study|Lost to Follow-up|1
5514673|NCT01529385|19067239|P1|Overall Study|Lost to Follow-up|2
5514674|NCT01529346|19067268|P5|Overall Study|Other|0
5514675|NCT01529346|19067269|P4|Overall Study|Other|0
5514676|NCT01529346|19067270|P3|Overall Study|Other|1
5514677|NCT01529346|19067271|P2|Overall Study|Other|1
5514678|NCT01529346|19067272|P1|Overall Study|Other|0
5514679|NCT01529346|19067268|P5|Overall Study|Lost to Follow-up|0
5514680|NCT01529346|19067269|P4|Overall Study|Lost to Follow-up|0
5514681|NCT01529346|19067270|P3|Overall Study|Lost to Follow-up|1
5514682|NCT01529346|19067271|P2|Overall Study|Lost to Follow-up|0
5514683|NCT01529346|19067272|P1|Overall Study|Lost to Follow-up|2
5514684|NCT01529268|19067360|P2|Overall Study|Moved|0
5514685|NCT01529268|19067361|P1|Overall Study|Moved|3
5514686|NCT01529268|19067360|P2|Overall Study|Lost to Follow-up|3
5514687|NCT01529268|19067361|P1|Overall Study|Lost to Follow-up|9
5514688|NCT01529112|19067423|P2|Overall Study|Withdrawal by Subject|3
5514689|NCT01529112|19067424|P1|Overall Study|Withdrawal by Subject|7
5514690|NCT01529112|19067423|P2|Overall Study|Protocol Violation|0
5514691|NCT01529112|19067424|P1|Overall Study|Protocol Violation|1
5514692|NCT01529112|19067423|P2|Overall Study|Death|38
5514693|NCT01529112|19067424|P1|Overall Study|Death|59
5514694|NCT01529112|19067423|P2|Overall Study|Adverse Event|0
5514695|NCT01529112|19067424|P1|Overall Study|Adverse Event|2
5514696|NCT01529034|19067460|P1|Overall Study|Study drug not available|2
5514697|NCT01529034|19067460|P1|Overall Study|Investigator no longer available|2
5514698|NCT01529034|19067460|P1|Overall Study|Lack of Efficacy|4
5514699|NCT01529034|19067460|P1|Overall Study|Protocol Violation|4
5514700|NCT01529034|19067460|P1|Overall Study|Adverse Event|4
5514701|NCT01529034|19067460|P1|Overall Study|Caregiver no longer available|7
5514702|NCT01529034|19067460|P1|Overall Study|Noncompliance|8
5514703|NCT01529034|19067460|P1|Overall Study|No treated SCs within protocol window|13
5514704|NCT01529034|19067460|P1|Overall Study|Withdrawal by Subject|25
5514705|NCT01529034|19067460|P1|Overall Study|Study termination|29
5514706|NCT01529034|19067460|P1|Overall Study|Site closure|62
5514707|NCT01529034|19067460|P1|Overall Study|Discontinued prior to study treatment|14
5514708|NCT01528969|19067475|P2|Overall Study|absent from the school at baseline|0
5514709|NCT01528969|19067476|P1|Overall Study|absent from the school at baseline|2
5514710|NCT01528787|19067509|P4|Overall Study|Family Emergency|0
5514711|NCT01528787|19067510|P3|Overall Study|Family Emergency|1
5514712|NCT01528787|19067511|P2|Overall Study|Family Emergency|0
5514713|NCT01528787|19067512|P1|Overall Study|Family Emergency|0
5514714|NCT01528787|19067509|P4|Overall Study|Withdrawal by Subject|1
5514715|NCT01528787|19067510|P3|Overall Study|Withdrawal by Subject|0
5514716|NCT01528787|19067511|P2|Overall Study|Withdrawal by Subject|0
5514717|NCT01528787|19067512|P1|Overall Study|Withdrawal by Subject|0
5514718|NCT01528735|19067524|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
5514719|NCT01528735|19067525|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
5514720|NCT01528735|19067524|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
5514721|NCT01528735|19067525|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
5514722|NCT01528709|19067627|P2|Overall Study|allergy|0
5514723|NCT01528709|19067628|P1|Overall Study|allergy|1
5514724|NCT01528709|19067627|P2|Overall Study|Withdrawal by Subject|15
5514725|NCT01528709|19067628|P1|Overall Study|Withdrawal by Subject|10
5514726|NCT01528709|19067627|P2|Overall Study|Death|0
5514727|NCT01528709|19067628|P1|Overall Study|Death|2
5514728|NCT01528696|19067638|P2|Overall Study|See detailed description|19
5514729|NCT01528696|19067639|P1|Overall Study|See detailed description|18
5514730|NCT01528605|19067655|P6|Overall Study|Death|0
5514731|NCT01528605|19067656|P5|Overall Study|Death|0
5514732|NCT01528605|19067657|P4|Overall Study|Death|0
5514733|NCT01528605|19067658|P3|Overall Study|Death|0
5514734|NCT01528605|19067659|P2|Overall Study|Death|0
5514735|NCT01528605|19067660|P1|Overall Study|Death|1
5514736|NCT01528605|19067655|P6|Overall Study|Lost to Follow-up|0
5514737|NCT01528605|19067656|P5|Overall Study|Lost to Follow-up|0
5514738|NCT01528605|19067657|P4|Overall Study|Lost to Follow-up|1
5514739|NCT01528605|19067658|P3|Overall Study|Lost to Follow-up|1
5514740|NCT01528605|19067659|P2|Overall Study|Lost to Follow-up|0
5514741|NCT01528605|19067660|P1|Overall Study|Lost to Follow-up|1
5514742|NCT01528345|19067690|P2|Overall Study|Subject/Guardian Decision|0
5514743|NCT01528345|19067691|P1|Overall Study|Subject/Guardian Decision|5
5514744|NCT01528345|19067690|P2|Overall Study|Study Terminated by Sponsor|8
5514745|NCT01528345|19067691|P1|Overall Study|Study Terminated by Sponsor|4
5514746|NCT01528345|19067690|P2|Overall Study|Progressive Disease|40
5514747|NCT01528345|19067691|P1|Overall Study|Progressive Disease|26
5514748|NCT01528345|19067690|P2|Overall Study|Non-compliance with study treatment|0
5514749|NCT01528345|19067691|P1|Overall Study|Non-compliance with study treatment|1
5514750|NCT01528345|19067690|P2|Overall Study|Death|1
5514751|NCT01528345|19067691|P1|Overall Study|Death|1
5514752|NCT01528345|19067690|P2|Overall Study|Adverse Event|1
5514753|NCT01528345|19067691|P1|Overall Study|Adverse Event|10
5514754|NCT01528254|19067742|P2|Overall Study|No longer requires study drug|1
5514755|NCT01528254|19067743|P1|Overall Study|No longer requires study drug|1
5514756|NCT01528254|19067742|P2|Overall Study|Abnormal test procedure result(s)|0
5514757|NCT01528254|19067743|P1|Overall Study|Abnormal test procedure result(s)|1
5514758|NCT01528254|19067742|P2|Overall Study|Abnormal laboratory value(s)|7
5514759|NCT01528254|19067743|P1|Overall Study|Abnormal laboratory value(s)|3
5514760|NCT01528254|19067742|P2|Overall Study|Withdrawal by Subject|4
5514761|NCT01528254|19067743|P1|Overall Study|Withdrawal by Subject|5
5514762|NCT01528254|19067742|P2|Overall Study|Unsatisfactory therapeutic effect|8
5514763|NCT01528254|19067743|P1|Overall Study|Unsatisfactory therapeutic effect|6
5514764|NCT01528254|19067742|P2|Overall Study|New therapy for study indication|6
5514765|NCT01528254|19067743|P1|Overall Study|New therapy for study indication|8
5514766|NCT01528254|19067742|P2|Overall Study|Protocol deviation|19
5514767|NCT01528254|19067743|P1|Overall Study|Protocol deviation|9
5514768|NCT01528254|19067742|P2|Overall Study|Death|9
5514769|NCT01528254|19067743|P1|Overall Study|Death|13
5514770|NCT01528254|19067742|P2|Overall Study|Lost to Follow-up|24
5514771|NCT01528254|19067743|P1|Overall Study|Lost to Follow-up|17
5514772|NCT01528254|19067742|P2|Overall Study|Adverse Event|44
5514773|NCT01528254|19067743|P1|Overall Study|Adverse Event|28
5514774|NCT01528254|19067742|P2|Overall Study|Administrative problems|94
5514775|NCT01528254|19067743|P1|Overall Study|Administrative problems|96
5514776|NCT01528215|19067775|P2|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
5514777|NCT01528215|19067776|P1|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
5514778|NCT01528215|19067775|P2|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
5514779|NCT01528215|19067776|P1|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
5514780|NCT01528215|19067775|P2|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
5514781|NCT01528215|19067776|P1|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
5514782|NCT01528215|19067775|P2|Enrollment to 1 Year Follow-up|Adverse Event|1
5514783|NCT01528215|19067776|P1|Enrollment to 1 Year Follow-up|Adverse Event|4
5514784|NCT01528072|19067835|P1|Overall Study|Early Termination of Study|52
5514785|NCT01528072|19067835|P1|Overall Study|Death|2
5514786|NCT01528072|19067835|P1|Overall Study|Site Closure|4
5514787|NCT01528072|19067835|P1|Overall Study|Explanted|2
5514788|NCT01528072|19067835|P1|Overall Study|Lost to Follow-up|5
5514789|NCT01528072|19067835|P1|Overall Study|Missed Visit|2
5514790|NCT01528072|19067835|P1|Overall Study|Determined not eligible by AEAC|1
5514791|NCT01528072|19067835|P1|Overall Study|Physician Decision|1
5514792|NCT01528072|19067835|P1|Overall Study|Withdrawal by Subject|5
5514793|NCT01528033|19067841|P2|Follow Up|No data available|44
5514794|NCT01528033|19067842|P1|Follow Up|No data available|46
5514795|NCT01528033|19067841|P2|Primary Endpoint Assessment ITT|No post baseline documentation|2
5514796|NCT01528033|19067842|P1|Primary Endpoint Assessment ITT|No post baseline documentation|2
5514797|NCT01528033|19067841|P2|Primary Endpoint Assessment ITT|Physician Decision|1
5514798|NCT01528033|19067842|P1|Primary Endpoint Assessment ITT|Physician Decision|2
5514799|NCT01528033|19067841|P2|Primary Endpoint Assessment ITT|Death|2
5514800|NCT01528033|19067842|P1|Primary Endpoint Assessment ITT|Death|2
5514801|NCT01528033|19067841|P2|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
5514894|NCT01526928|19068164|P3|Overall Study|Protocol Deviation|0
5514802|NCT01528033|19067842|P1|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
5514803|NCT01528033|19067841|P2|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
5514804|NCT01528033|19067842|P1|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
5514805|NCT01527682|19067865|P1|Overall Study|Protocol Violation|8
5514806|NCT01527500|19067888|P2|Part B|Adverse Event|0
5514807|NCT01527500|19067889|P1|Part B|Adverse Event|1
5514808|NCT01527500|19067888|P2|Part A|Withdrawal by Subject|0
5514809|NCT01527500|19067889|P1|Part A|Withdrawal by Subject|2
5514810|NCT01527500|19067888|P2|Part A|Protocol Deviation|2
5514811|NCT01527500|19067889|P1|Part A|Protocol Deviation|9
5514812|NCT01527500|19067888|P2|Part A|Lost to Follow-up|1
5514813|NCT01527500|19067889|P1|Part A|Lost to Follow-up|0
5514814|NCT01527500|19067888|P2|Part A|Death|1
5514815|NCT01527500|19067889|P1|Part A|Death|4
5514816|NCT01527500|19067888|P2|Part A|Adverse Event|2
5514817|NCT01527500|19067889|P1|Part A|Adverse Event|4
5514818|NCT01527500|19067888|P2|Part A|Administrative|7
5514819|NCT01527500|19067889|P1|Part A|Administrative|11
5514820|NCT01527487|19067919|P2|Overall Study|Death|1
5514821|NCT01527487|19067920|P1|Overall Study|Death|0
5514822|NCT01527487|19067919|P2|Overall Study|Adverse Event|1
5514823|NCT01527487|19067920|P1|Overall Study|Adverse Event|1
5514824|NCT01527487|19067919|P2|Overall Study|Disease Progression|1
5514825|NCT01527487|19067920|P1|Overall Study|Disease Progression|4
5514826|NCT01527487|19067919|P2|Overall Study|MD Discretion/Lack of Efficacy|4
5514827|NCT01527487|19067920|P1|Overall Study|MD Discretion/Lack of Efficacy|3
5514828|NCT01527383|19067934|P2|Overall Study|Withdrawal by Subject|3
5514829|NCT01527383|19067935|P1|Overall Study|Withdrawal by Subject|2
5514830|NCT01527383|19067934|P2|Overall Study|Participant moved|1
5514831|NCT01527383|19067935|P1|Overall Study|Participant moved|0
5514832|NCT01527383|19067934|P2|Overall Study|Screen failure|0
5514833|NCT01527383|19067935|P1|Overall Study|Screen failure|1
5514834|NCT01527383|19067934|P2|Overall Study|Protocol Violation|0
5514835|NCT01527383|19067935|P1|Overall Study|Protocol Violation|1
5514836|NCT01527383|19067934|P2|Overall Study|Pregnancy|0
5514837|NCT01527383|19067935|P1|Overall Study|Pregnancy|1
5514838|NCT01527383|19067934|P2|Overall Study|Physician Decision|0
5514839|NCT01527383|19067935|P1|Overall Study|Physician Decision|2
5514840|NCT01527383|19067934|P2|Overall Study|Lost to Follow-up|0
5514841|NCT01527383|19067935|P1|Overall Study|Lost to Follow-up|3
5514842|NCT01527383|19067934|P2|Overall Study|Adverse Event|0
5514843|NCT01527383|19067935|P1|Overall Study|Adverse Event|5
5514844|NCT01527370|19067949|P1|Overall Study|Death|1
5514845|NCT01527370|19067949|P1|Overall Study|Physician Decision|1
5514846|NCT01527370|19067949|P1|Overall Study|Withdrawal by Subject|4
5514847|NCT01527357|19067957|P2|Overall Study|Did Not Receive Treatment|0
5514848|NCT01527357|19067958|P1|Overall Study|Did Not Receive Treatment|2
5514849|NCT01527357|19067957|P2|Overall Study|No Day 29 Visit|1
5514850|NCT01527357|19067958|P1|Overall Study|No Day 29 Visit|0
5514851|NCT01527357|19067957|P2|Overall Study|Non-compliance|1
5514852|NCT01527357|19067958|P1|Overall Study|Non-compliance|0
5514853|NCT01527357|19067957|P2|Overall Study|Withdrew Consent|1
5514854|NCT01527357|19067958|P1|Overall Study|Withdrew Consent|1
5514855|NCT01527357|19067957|P2|Overall Study|Lost to Follow-up|4
5514856|NCT01527357|19067958|P1|Overall Study|Lost to Follow-up|6
5514857|NCT01527357|19067957|P2|Overall Study|Death|2
5514858|NCT01527357|19067958|P1|Overall Study|Death|8
5514859|NCT01527292|19067980|P2|Overall Study|Physician Decision|3
5514860|NCT01527292|19067981|P1|Overall Study|Physician Decision|0
5514861|NCT01527149|19068008|P1|Overall Study|Death|2
5514862|NCT01527110|19068023|P1|Overall Study|Adverse Event|1
5514863|NCT01527006|19068104|P2|Extension Phase|Other|3
5514864|NCT01527006|19068105|P1|Extension Phase|Other|0
5514865|NCT01527006|19068104|P2|Extension Phase|Inadequate therapeutic effect|1
5514866|NCT01527006|19068105|P1|Extension Phase|Inadequate therapeutic effect|1
5514867|NCT01527006|19068104|P2|Extension Phase|Subject Choice|1
5514868|NCT01527006|19068105|P1|Extension Phase|Subject Choice|1
5514869|NCT01527006|19068104|P2|Extension Phase|Lost to Follow-up|1
5514870|NCT01527006|19068105|P1|Extension Phase|Lost to Follow-up|0
5514871|NCT01527006|19068104|P2|Extension Phase|Adverse Event|2
5514872|NCT01527006|19068105|P1|Extension Phase|Adverse Event|4
5514873|NCT01527006|19068104|P2|Core Study|Other|2
5514874|NCT01527006|19068105|P1|Core Study|Other|0
5514875|NCT01527006|19068104|P2|Core Study|Withdrawal by Subject|1
5514876|NCT01527006|19068105|P1|Core Study|Withdrawal by Subject|0
5514877|NCT01527006|19068104|P2|Core Study|Inadequate Therapeutic Effect|0
5514878|NCT01527006|19068105|P1|Core Study|Inadequate Therapeutic Effect|1
5514879|NCT01527006|19068104|P2|Core Study|Subject Choice|0
5514880|NCT01527006|19068105|P1|Core Study|Subject Choice|1
5514881|NCT01527006|19068104|P2|Core Study|Lost to Follow-up|1
5514882|NCT01527006|19068105|P1|Core Study|Lost to Follow-up|0
5514883|NCT01527006|19068104|P2|Core Study|Adverse Event|2
5514884|NCT01527006|19068105|P1|Core Study|Adverse Event|0
5514885|NCT01526928|19068161|P6|Overall Study|Missing|0
5514886|NCT01526928|19068162|P5|Overall Study|Missing|2
5514887|NCT01526928|19068163|P4|Overall Study|Missing|0
5514888|NCT01526928|19068164|P3|Overall Study|Missing|1
5514889|NCT01526928|19068165|P2|Overall Study|Missing|0
5514890|NCT01526928|19068166|P1|Overall Study|Missing|0
5514891|NCT01526928|19068161|P6|Overall Study|Protocol Deviation|0
5514892|NCT01526928|19068162|P5|Overall Study|Protocol Deviation|0
5514893|NCT01526928|19068163|P4|Overall Study|Protocol Deviation|2
5514895|NCT01526928|19068165|P2|Overall Study|Protocol Deviation|0
5514896|NCT01526928|19068166|P1|Overall Study|Protocol Deviation|0
5514897|NCT01526928|19068161|P6|Overall Study|Lost to Follow-up|0
5514898|NCT01526928|19068162|P5|Overall Study|Lost to Follow-up|0
5514899|NCT01526928|19068163|P4|Overall Study|Lost to Follow-up|1
5514900|NCT01526928|19068164|P3|Overall Study|Lost to Follow-up|0
5514901|NCT01526928|19068165|P2|Overall Study|Lost to Follow-up|0
5514902|NCT01526928|19068166|P1|Overall Study|Lost to Follow-up|0
5514903|NCT01526928|19068161|P6|Overall Study|Other Reason|0
5514904|NCT01526928|19068162|P5|Overall Study|Other Reason|1
5514905|NCT01526928|19068163|P4|Overall Study|Other Reason|4
5514906|NCT01526928|19068164|P3|Overall Study|Other Reason|11
5514907|NCT01526928|19068165|P2|Overall Study|Other Reason|1
5514908|NCT01526928|19068166|P1|Overall Study|Other Reason|0
5514909|NCT01526928|19068161|P6|Overall Study|Physician Decision|0
5514910|NCT01526928|19068162|P5|Overall Study|Physician Decision|0
5514911|NCT01526928|19068163|P4|Overall Study|Physician Decision|5
5514912|NCT01526928|19068164|P3|Overall Study|Physician Decision|2
5514913|NCT01526928|19068165|P2|Overall Study|Physician Decision|0
5514914|NCT01526928|19068166|P1|Overall Study|Physician Decision|0
5514915|NCT01526928|19068161|P6|Overall Study|Withdrawal by Subject|0
5514916|NCT01526928|19068162|P5|Overall Study|Withdrawal by Subject|3
5514917|NCT01526928|19068163|P4|Overall Study|Withdrawal by Subject|11
5514918|NCT01526928|19068164|P3|Overall Study|Withdrawal by Subject|13
5514919|NCT01526928|19068165|P2|Overall Study|Withdrawal by Subject|0
5514920|NCT01526928|19068166|P1|Overall Study|Withdrawal by Subject|1
5514921|NCT01526928|19068161|P6|Overall Study|Death|0
5514922|NCT01526928|19068162|P5|Overall Study|Death|0
5514923|NCT01526928|19068163|P4|Overall Study|Death|0
5514924|NCT01526928|19068164|P3|Overall Study|Death|3
5514925|NCT01526928|19068165|P2|Overall Study|Death|0
5514926|NCT01526928|19068166|P1|Overall Study|Death|0
5514927|NCT01526928|19068161|P6|Overall Study|Adverse Event|2
5514928|NCT01526928|19068162|P5|Overall Study|Adverse Event|13
5514929|NCT01526928|19068163|P4|Overall Study|Adverse Event|40
5514930|NCT01526928|19068164|P3|Overall Study|Adverse Event|29
5514931|NCT01526928|19068165|P2|Overall Study|Adverse Event|1
5514932|NCT01526928|19068166|P1|Overall Study|Adverse Event|2
5514933|NCT01526928|19068161|P6|Overall Study|Progressive Disease|4
5514934|NCT01526928|19068162|P5|Overall Study|Progressive Disease|76
5514935|NCT01526928|19068163|P4|Overall Study|Progressive Disease|182
5514936|NCT01526928|19068164|P3|Overall Study|Progressive Disease|150
5514937|NCT01526928|19068165|P2|Overall Study|Progressive Disease|17
5514938|NCT01526928|19068166|P1|Overall Study|Progressive Disease|35
5514939|NCT01526889|19068304|P2|Treatment Extension Period|Administrative problems|0
5514940|NCT01526889|19068305|P1|Treatment Extension Period|Administrative problems|1
5514941|NCT01526889|19068304|P2|Treatment Period|Adverse Event|0
5514942|NCT01526889|19068305|P1|Treatment Period|Adverse Event|2
5514943|NCT01526785|19068326|P1|Overall Study|Withdrawal by Subject|2
5514944|NCT01526785|19068326|P1|Overall Study|Physician Decision|1
5514945|NCT01526785|19068326|P1|Overall Study|Death|2
5514946|NCT01526785|19068326|P1|Overall Study|Study Terminated by Sponsor|8
5514947|NCT01526733|19068336|P2|Phase 1|Withdrawal by Subject|1
5514948|NCT01526733|19068337|P1|Phase 1|Withdrawal by Subject|1
5514949|NCT01526733|19068336|P2|Phase 1|Protocol Violation|0
5514950|NCT01526733|19068337|P1|Phase 1|Protocol Violation|1
5514951|NCT01526551|19068376|P1|Overall Study|Lack of returned parental consent form|424
5514952|NCT01526148|19068454|P2|Overall Study|Incarcerated|2
5514953|NCT01526148|19068455|P1|Overall Study|Incarcerated|0
5514954|NCT01526148|19068454|P2|Overall Study|Moved out of state|0
5514955|NCT01526148|19068455|P1|Overall Study|Moved out of state|1
5514956|NCT01526148|19068454|P2|Overall Study|Unable to discontinue concomitant med|0
5514957|NCT01526148|19068455|P1|Overall Study|Unable to discontinue concomitant med|1
5514958|NCT01526148|19068454|P2|Overall Study|Unstable Medical Condition|0
5514959|NCT01526148|19068455|P1|Overall Study|Unstable Medical Condition|1
5514960|NCT01526148|19068454|P2|Overall Study|Withdrawal by Subject|0
5514961|NCT01526148|19068455|P1|Overall Study|Withdrawal by Subject|2
5514962|NCT01526148|19068454|P2|Overall Study|Lost to Follow-up|6
5514963|NCT01526148|19068455|P1|Overall Study|Lost to Follow-up|3
5514964|NCT01526148|19068454|P2|Overall Study|Adverse Event|5
5514965|NCT01526148|19068455|P1|Overall Study|Adverse Event|6
5514966|NCT01526057|19068466|P3|Overall Study|Protocol Violation|1
5514967|NCT01526057|19068467|P2|Overall Study|Protocol Violation|0
5514968|NCT01526057|19068468|P1|Overall Study|Protocol Violation|0
5514969|NCT01526057|19068466|P3|Overall Study|Other|1
5514970|NCT01526057|19068467|P2|Overall Study|Other|0
5514971|NCT01526057|19068468|P1|Overall Study|Other|1
5514972|NCT01526057|19068466|P3|Overall Study|Lost to Follow-up|1
5514973|NCT01526057|19068467|P2|Overall Study|Lost to Follow-up|0
5514974|NCT01526057|19068468|P1|Overall Study|Lost to Follow-up|1
5514975|NCT01526057|19068466|P3|Overall Study|Death|0
5514976|NCT01526057|19068467|P2|Overall Study|Death|0
5514977|NCT01526057|19068468|P1|Overall Study|Death|1
5514978|NCT01526057|19068466|P3|Overall Study|Adverse Event|1
5514979|NCT01526057|19068467|P2|Overall Study|Adverse Event|1
5514980|NCT01526057|19068468|P1|Overall Study|Adverse Event|3
5514981|NCT01526057|19068466|P3|Overall Study|Withdrawal by Subject|2
5514982|NCT01526057|19068467|P2|Overall Study|Withdrawal by Subject|2
5514983|NCT01526057|19068468|P1|Overall Study|Withdrawal by Subject|3
5514984|NCT01525875|19068567|P2|Open-label Period|Lost to Follow-up|2
5514985|NCT01525875|19068568|P1|Open-label Period|Lost to Follow-up|0
5514986|NCT01525875|19068567|P2|Placebo-controlled Period|Withdrawal by Subject|2
5514987|NCT01525875|19068568|P1|Placebo-controlled Period|Withdrawal by Subject|1
5514988|NCT01525849|19068591|P2|Overall Study|Anatomic exclusion criteria identified|3
5514989|NCT01525849|19068592|P1|Overall Study|Anatomic exclusion criteria identified|0
5514990|NCT01525849|19068591|P2|Overall Study|Unrelated medical issue (not treated)|2
5514991|NCT01525849|19068592|P1|Overall Study|Unrelated medical issue (not treated)|1
5514992|NCT01525849|19068591|P2|Overall Study|Withdrawal by Subject|9
5514993|NCT01525849|19068592|P1|Overall Study|Withdrawal by Subject|1
5514994|NCT01525849|19068591|P2|Overall Study|Lost to Follow-up|2
5514995|NCT01525849|19068592|P1|Overall Study|Lost to Follow-up|3
5514996|NCT01525641|19068648|P1|Overall Study|Other than stated above|7
5514997|NCT01525641|19068648|P1|Overall Study|Lost to follow-up (Changing hospital)|19
5514998|NCT01525641|19068648|P1|Overall Study|Lost to follow-up (Unknown reason)|10
5514999|NCT01525641|19068648|P1|Overall Study|Lost to follow-up (relocation)|1
5515000|NCT01525641|19068648|P1|Overall Study|Improvement|5
5515001|NCT01525641|19068648|P1|Overall Study|Lack of Efficacy|24
5515002|NCT01525641|19068648|P1|Overall Study|Adverse Event|73
5515003|NCT01525641|19068648|P1|Overall Study|No visit since the first visit|16
5515004|NCT01525641|19068648|P1|Overall Study|Case report form not collected|25
5515005|NCT01525628|19068662|P5|Overall Study|Other reason not defined above|0
5515006|NCT01525628|19068663|P4|Overall Study|Other reason not defined above|3
5515007|NCT01525628|19068664|P3|Overall Study|Other reason not defined above|0
5515008|NCT01525628|19068665|P2|Overall Study|Other reason not defined above|0
5515009|NCT01525628|19068666|P1|Overall Study|Other reason not defined above|0
5515010|NCT01525628|19068662|P5|Overall Study|Withdrawal by Subject|0
5515011|NCT01525628|19068663|P4|Overall Study|Withdrawal by Subject|0
5515012|NCT01525628|19068664|P3|Overall Study|Withdrawal by Subject|0
5515013|NCT01525628|19068665|P2|Overall Study|Withdrawal by Subject|1
5515014|NCT01525628|19068666|P1|Overall Study|Withdrawal by Subject|0
5515015|NCT01525628|19068662|P5|Overall Study|Lost to Follow-up|0
5515016|NCT01525628|19068663|P4|Overall Study|Lost to Follow-up|0
5515017|NCT01525628|19068664|P3|Overall Study|Lost to Follow-up|0
5515018|NCT01525628|19068665|P2|Overall Study|Lost to Follow-up|1
5515019|NCT01525628|19068666|P1|Overall Study|Lost to Follow-up|1
5515020|NCT01525628|19068662|P5|Overall Study|Protocol Violation|0
5515021|NCT01525628|19068663|P4|Overall Study|Protocol Violation|0
5515022|NCT01525628|19068664|P3|Overall Study|Protocol Violation|1
5515023|NCT01525628|19068665|P2|Overall Study|Protocol Violation|0
5515024|NCT01525628|19068666|P1|Overall Study|Protocol Violation|0
5515025|NCT01525628|19068662|P5|Overall Study|Lack of Efficacy|2
5515026|NCT01525628|19068663|P4|Overall Study|Lack of Efficacy|1
5515027|NCT01525628|19068664|P3|Overall Study|Lack of Efficacy|2
5515028|NCT01525628|19068665|P2|Overall Study|Lack of Efficacy|2
5515029|NCT01525628|19068666|P1|Overall Study|Lack of Efficacy|0
5515030|NCT01525628|19068662|P5|Overall Study|Adverse Event|1
5515031|NCT01525628|19068663|P4|Overall Study|Adverse Event|0
5515032|NCT01525628|19068664|P3|Overall Study|Adverse Event|2
5515033|NCT01525628|19068665|P2|Overall Study|Adverse Event|1
5515034|NCT01525628|19068666|P1|Overall Study|Adverse Event|1
5515035|NCT01525615|19068733|P3|Overall Study|Other reason not described above|1
5515036|NCT01525615|19068734|P2|Overall Study|Other reason not described above|0
5515037|NCT01525615|19068735|P1|Overall Study|Other reason not described above|1
5515038|NCT01525615|19068733|P3|Overall Study|Withdrawal by Subject|0
5515039|NCT01525615|19068734|P2|Overall Study|Withdrawal by Subject|0
5515040|NCT01525615|19068735|P1|Overall Study|Withdrawal by Subject|1
5515041|NCT01525615|19068733|P3|Overall Study|Lost to Follow-up|0
5515042|NCT01525615|19068734|P2|Overall Study|Lost to Follow-up|0
5515043|NCT01525615|19068735|P1|Overall Study|Lost to Follow-up|1
5515044|NCT01525615|19068733|P3|Overall Study|Adverse Event|5
5515045|NCT01525615|19068734|P2|Overall Study|Adverse Event|7
5515046|NCT01525615|19068735|P1|Overall Study|Adverse Event|11
5515047|NCT01525602|19068787|P8|Overall Study|Unqualified based on biopsy; not dosed|1
5515048|NCT01525602|19068788|P7|Overall Study|Unqualified based on biopsy; not dosed|1
5515049|NCT01525602|19068789|P6|Overall Study|Unqualified based on biopsy; not dosed|0
5515050|NCT01525602|19068790|P5|Overall Study|Unqualified based on biopsy; not dosed|0
5515051|NCT01525602|19068791|P4|Overall Study|Unqualified based on biopsy; not dosed|0
5515052|NCT01525602|19068792|P3|Overall Study|Unqualified based on biopsy; not dosed|0
5515053|NCT01525602|19068793|P2|Overall Study|Unqualified based on biopsy; not dosed|0
5515054|NCT01525602|19068794|P1|Overall Study|Unqualified based on biopsy; not dosed|0
5515055|NCT01525602|19068787|P8|Overall Study|Death|0
5515056|NCT01525602|19068788|P7|Overall Study|Death|0
5515057|NCT01525602|19068789|P6|Overall Study|Death|1
5515058|NCT01525602|19068790|P5|Overall Study|Death|1
5515059|NCT01525602|19068791|P4|Overall Study|Death|0
5515060|NCT01525602|19068792|P3|Overall Study|Death|0
5515061|NCT01525602|19068793|P2|Overall Study|Death|0
5515062|NCT01525602|19068794|P1|Overall Study|Death|0
5515063|NCT01525602|19068787|P8|Overall Study|Physician Decision|0
5515064|NCT01525602|19068788|P7|Overall Study|Physician Decision|1
5515065|NCT01525602|19068789|P6|Overall Study|Physician Decision|0
5515066|NCT01525602|19068790|P5|Overall Study|Physician Decision|3
5515067|NCT01525602|19068791|P4|Overall Study|Physician Decision|0
5515068|NCT01525602|19068792|P3|Overall Study|Physician Decision|0
5515069|NCT01525602|19068793|P2|Overall Study|Physician Decision|0
5515070|NCT01525602|19068794|P1|Overall Study|Physician Decision|0
5515071|NCT01525602|19068787|P8|Overall Study|Withdrawal by Subject|1
5515072|NCT01525602|19068788|P7|Overall Study|Withdrawal by Subject|0
5515073|NCT01525602|19068789|P6|Overall Study|Withdrawal by Subject|1
5515074|NCT01525602|19068790|P5|Overall Study|Withdrawal by Subject|3
5515075|NCT01525602|19068791|P4|Overall Study|Withdrawal by Subject|0
5515076|NCT01525602|19068792|P3|Overall Study|Withdrawal by Subject|0
5515077|NCT01525602|19068793|P2|Overall Study|Withdrawal by Subject|0
5515078|NCT01525602|19068794|P1|Overall Study|Withdrawal by Subject|0
5515079|NCT01525602|19068787|P8|Overall Study|Non-compliance|0
5515080|NCT01525602|19068788|P7|Overall Study|Non-compliance|0
5515081|NCT01525602|19068789|P6|Overall Study|Non-compliance|0
5515082|NCT01525602|19068790|P5|Overall Study|Non-compliance|1
5515083|NCT01525602|19068791|P4|Overall Study|Non-compliance|0
5515084|NCT01525602|19068792|P3|Overall Study|Non-compliance|0
5515085|NCT01525602|19068793|P2|Overall Study|Non-compliance|0
5515086|NCT01525602|19068794|P1|Overall Study|Non-compliance|0
5515087|NCT01525602|19068787|P8|Overall Study|Clinical progression|1
5515088|NCT01525602|19068788|P7|Overall Study|Clinical progression|1
5515089|NCT01525602|19068789|P6|Overall Study|Clinical progression|0
5515090|NCT01525602|19068790|P5|Overall Study|Clinical progression|0
5515091|NCT01525602|19068791|P4|Overall Study|Clinical progression|0
5515092|NCT01525602|19068792|P3|Overall Study|Clinical progression|0
5515093|NCT01525602|19068793|P2|Overall Study|Clinical progression|0
5515094|NCT01525602|19068794|P1|Overall Study|Clinical progression|2
5515095|NCT01525602|19068787|P8|Overall Study|Disease progression|3
5515096|NCT01525602|19068788|P7|Overall Study|Disease progression|3
5515097|NCT01525602|19068789|P6|Overall Study|Disease progression|2
5515098|NCT01525602|19068790|P5|Overall Study|Disease progression|22
5515099|NCT01525602|19068791|P4|Overall Study|Disease progression|5
5515100|NCT01525602|19068792|P3|Overall Study|Disease progression|2
5515101|NCT01525602|19068793|P2|Overall Study|Disease progression|3
5515102|NCT01525602|19068794|P1|Overall Study|Disease progression|6
5515103|NCT01525602|19068787|P8|Overall Study|Adverse Event|1
5515104|NCT01525602|19068788|P7|Overall Study|Adverse Event|0
5515105|NCT01525602|19068789|P6|Overall Study|Adverse Event|3
5515106|NCT01525602|19068790|P5|Overall Study|Adverse Event|3
5515107|NCT01525602|19068791|P4|Overall Study|Adverse Event|1
5515108|NCT01525602|19068792|P3|Overall Study|Adverse Event|1
5515109|NCT01525602|19068793|P2|Overall Study|Adverse Event|0
5515110|NCT01525602|19068794|P1|Overall Study|Adverse Event|1
5515111|NCT01525589|19068865|P3|Overall Study|Withdrawal by Subject|0
5515112|NCT01525589|19068866|P2|Overall Study|Withdrawal by Subject|1
5515113|NCT01525589|19068867|P1|Overall Study|Withdrawal by Subject|0
5515114|NCT01525589|19068865|P3|Overall Study|Other reasons|0
5515115|NCT01525589|19068866|P2|Overall Study|Other reasons|1
5515116|NCT01525589|19068867|P1|Overall Study|Other reasons|0
5515117|NCT01525589|19068865|P3|Overall Study|Treatment-related AE|2
5515118|NCT01525589|19068866|P2|Overall Study|Treatment-related AE|1
5515119|NCT01525589|19068867|P1|Overall Study|Treatment-related AE|1
5515120|NCT01525589|19068865|P3|Overall Study|Death|2
5515121|NCT01525589|19068866|P2|Overall Study|Death|0
5515122|NCT01525589|19068867|P1|Overall Study|Death|0
5515123|NCT01525589|19068865|P3|Overall Study|Physician Decision|2
5515124|NCT01525589|19068866|P2|Overall Study|Physician Decision|2
5515125|NCT01525589|19068867|P1|Overall Study|Physician Decision|4
5515126|NCT01525589|19068865|P3|Overall Study|Never treated|0
5515127|NCT01525589|19068866|P2|Overall Study|Never treated|0
5515128|NCT01525589|19068867|P1|Overall Study|Never treated|2
5515129|NCT01525589|19068865|P3|Overall Study|Progressive disease|29
5515130|NCT01525589|19068866|P2|Overall Study|Progressive disease|15
5515131|NCT01525589|19068867|P1|Overall Study|Progressive disease|48
5515132|NCT01525589|19068865|P3|Overall Study|Non-treatment-related AE|0
5515133|NCT01525589|19068866|P2|Overall Study|Non-treatment-related AE|0
5515134|NCT01525589|19068867|P1|Overall Study|Non-treatment-related AE|1
5515135|NCT01525550|19068923|P2|Overall Study|Withdrawal by Subject|0
5515136|NCT01525550|19068924|P1|Overall Study|Withdrawal by Subject|4
5515137|NCT01525550|19068923|P2|Overall Study|Sponsor's Decision|11
5515138|NCT01525550|19068924|P1|Overall Study|Sponsor's Decision|30
5515139|NCT01525550|19068923|P2|Overall Study|Other|4
5515140|NCT01525550|19068924|P1|Overall Study|Other|0
5515141|NCT01525550|19068923|P2|Overall Study|Death|28
5515142|NCT01525550|19068924|P1|Overall Study|Death|19
5515143|NCT01525550|19068923|P2|Overall Study|Lost to Follow-up|2
5515144|NCT01525550|19068924|P1|Overall Study|Lost to Follow-up|8
5515145|NCT01525407|19068995|P2|Overall Study|Delay in Transplant|0
5515146|NCT01525407|19068996|P1|Overall Study|Delay in Transplant|1
5515147|NCT01525407|19068995|P2|Overall Study|Transplant was delayed|1
5515148|NCT01525407|19068996|P1|Overall Study|Transplant was delayed|0
5515149|NCT01525407|19068995|P2|Overall Study|Withdrawal by Subject|1
5515150|NCT01525407|19068996|P1|Overall Study|Withdrawal by Subject|0
5515151|NCT01525407|19068995|P2|Overall Study|Change in recipient treatment plan|2
5515152|NCT01525407|19068996|P1|Overall Study|Change in recipient treatment plan|2
5515153|NCT01525238|19069030|P3|Overall Study|Withdrawal by Subject|0
5515154|NCT01525238|19069031|P2|Overall Study|Withdrawal by Subject|0
5515155|NCT01525238|19069032|P1|Overall Study|Withdrawal by Subject|1
5515156|NCT01525225|19069097|P1|Enrollment|Other|1
5515157|NCT01525225|19069097|P1|Enrollment|No longer met study criteria|1
5515158|NCT01525082|19069111|P1|Overall Study|Death|1
5515159|NCT01524991|19069122|P1|Overall Study|Symptomatic Deterioration|1
5515160|NCT01524991|19069122|P1|Overall Study|Withdrawal by Subject|2
5515161|NCT01524991|19069122|P1|Overall Study|Other complicating disease|1
5515162|NCT01524991|19069122|P1|Overall Study|Disease ProgressionDu|17
5515163|NCT01524991|19069122|P1|Overall Study|Death|1
5515164|NCT01524991|19069122|P1|Overall Study|Adverse Event|12
5515165|NCT01524978|19069140|P11|Overall Study|Death|17
5515166|NCT01524978|19069141|P10|Overall Study|Death|6
5515167|NCT01524978|19069142|P9|Overall Study|Death|5
5515168|NCT01524978|19069143|P8|Overall Study|Death|9
5515169|NCT01524978|19069144|P7|Overall Study|Death|1
5515170|NCT01524978|19069145|P6|Overall Study|Death|4
5515171|NCT01524978|19069146|P5|Overall Study|Death|4
5515172|NCT01524978|19069147|P4|Overall Study|Death|24
5515173|NCT01524978|19069148|P3|Overall Study|Death|5
5515174|NCT01524978|19069149|P2|Overall Study|Death|2
5515175|NCT01524978|19069150|P1|Overall Study|Death|34
5515176|NCT01524978|19069140|P11|Overall Study|Lost to Follow-up|1
5515177|NCT01524978|19069141|P10|Overall Study|Lost to Follow-up|1
5515178|NCT01524978|19069142|P9|Overall Study|Lost to Follow-up|1
5515179|NCT01524978|19069143|P8|Overall Study|Lost to Follow-up|0
5515180|NCT01524978|19069144|P7|Overall Study|Lost to Follow-up|2
5515181|NCT01524978|19069145|P6|Overall Study|Lost to Follow-up|1
5515182|NCT01524978|19069146|P5|Overall Study|Lost to Follow-up|1
5515183|NCT01524978|19069147|P4|Overall Study|Lost to Follow-up|0
5515184|NCT01524978|19069148|P3|Overall Study|Lost to Follow-up|3
5515185|NCT01524978|19069149|P2|Overall Study|Lost to Follow-up|0
5515186|NCT01524978|19069150|P1|Overall Study|Lost to Follow-up|0
5515187|NCT01524978|19069140|P11|Overall Study|Withdrawal by Subject|5
5515188|NCT01524978|19069141|P10|Overall Study|Withdrawal by Subject|0
5515189|NCT01524978|19069142|P9|Overall Study|Withdrawal by Subject|4
5515190|NCT01524978|19069143|P8|Overall Study|Withdrawal by Subject|2
5515191|NCT01524978|19069144|P7|Overall Study|Withdrawal by Subject|6
5515192|NCT01524978|19069145|P6|Overall Study|Withdrawal by Subject|1
5515193|NCT01524978|19069146|P5|Overall Study|Withdrawal by Subject|3
5515194|NCT01524978|19069147|P4|Overall Study|Withdrawal by Subject|1
5515195|NCT01524978|19069148|P3|Overall Study|Withdrawal by Subject|1
5515196|NCT01524978|19069149|P2|Overall Study|Withdrawal by Subject|0
5515197|NCT01524978|19069150|P1|Overall Study|Withdrawal by Subject|12
5515198|NCT01524978|19069140|P11|Overall Study|Other|5
5515199|NCT01524978|19069141|P10|Overall Study|Other|2
5515200|NCT01524978|19069142|P9|Overall Study|Other|2
5515201|NCT01524978|19069143|P8|Overall Study|Other|1
5515202|NCT01524978|19069144|P7|Overall Study|Other|17
5515203|NCT01524978|19069145|P6|Overall Study|Other|3
5515204|NCT01524978|19069146|P5|Overall Study|Other|1
5515205|NCT01524978|19069147|P4|Overall Study|Other|2
5515206|NCT01524978|19069148|P3|Overall Study|Other|1
5515207|NCT01524978|19069149|P2|Overall Study|Other|2
5515208|NCT01524978|19069150|P1|Overall Study|Other|16
5515209|NCT01524913|19069278|P3|Overall Study|Lost to Follow-up|0
5515210|NCT01524913|19069279|P2|Overall Study|Lost to Follow-up|0
5515211|NCT01524913|19069280|P1|Overall Study|Lost to Follow-up|4
5515212|NCT01524900|19069302|P5|Overall Study|No reason documented|0
5515213|NCT01524900|19069303|P4|Overall Study|No reason documented|1
5515214|NCT01524900|19069304|P3|Overall Study|No reason documented|0
5515215|NCT01524900|19069305|P2|Overall Study|No reason documented|1
5515216|NCT01524900|19069306|P1|Overall Study|No reason documented|2
5515217|NCT01524900|19069302|P5|Overall Study|Other reason than stated above|0
5515218|NCT01524900|19069303|P4|Overall Study|Other reason than stated above|0
5515219|NCT01524900|19069304|P3|Overall Study|Other reason than stated above|0
5515220|NCT01524900|19069305|P2|Overall Study|Other reason than stated above|1
5515221|NCT01524900|19069306|P1|Overall Study|Other reason than stated above|1
5515222|NCT01524900|19069302|P5|Overall Study|Lost to Follow-up|0
5515223|NCT01524900|19069303|P4|Overall Study|Lost to Follow-up|0
5515224|NCT01524900|19069304|P3|Overall Study|Lost to Follow-up|1
5515225|NCT01524900|19069305|P2|Overall Study|Lost to Follow-up|12
5515226|NCT01524900|19069306|P1|Overall Study|Lost to Follow-up|3
5515227|NCT01524887|19069351|P3|Overall Study|Use of prohibited medication|0
5515228|NCT01524887|19069352|P2|Overall Study|Use of prohibited medication|0
5515229|NCT01524887|19069353|P1|Overall Study|Use of prohibited medication|1
5515230|NCT01524887|19069351|P3|Overall Study|Withdrawal by Caregiver|2
5515231|NCT01524887|19069352|P2|Overall Study|Withdrawal by Caregiver|0
5515232|NCT01524887|19069353|P1|Overall Study|Withdrawal by Caregiver|0
5515233|NCT01524887|19069351|P3|Overall Study|Study termination|79
5515234|NCT01524887|19069352|P2|Overall Study|Study termination|87
5515235|NCT01524887|19069353|P1|Overall Study|Study termination|73
5515236|NCT01524887|19069351|P3|Overall Study|Protocol Violation|1
5515237|NCT01524887|19069352|P2|Overall Study|Protocol Violation|0
5515238|NCT01524887|19069353|P1|Overall Study|Protocol Violation|0
5515239|NCT01524887|19069351|P3|Overall Study|Adverse Event|1
5515240|NCT01524887|19069352|P2|Overall Study|Adverse Event|1
5515241|NCT01524887|19069353|P1|Overall Study|Adverse Event|5
5515242|NCT01524887|19069351|P3|Overall Study|Withdrawal by Subject|3
5515243|NCT01524887|19069352|P2|Overall Study|Withdrawal by Subject|2
5515244|NCT01524887|19069353|P1|Overall Study|Withdrawal by Subject|6
5515245|NCT01524796|19069397|P1|Overall Study|Adverse Event and Lack of Efficacy|1
5515246|NCT01524796|19069397|P1|Overall Study|Switch to carbamazapine|1
5515247|NCT01524796|19069397|P1|Overall Study|Nervous about confidentiality|1
5515248|NCT01524796|19069397|P1|Overall Study|Gall stone surgery|1
5515249|NCT01524796|19069397|P1|Overall Study|Deterioration of pains|1
5515250|NCT01524796|19069397|P1|Overall Study|Move|1
5515251|NCT01524796|19069397|P1|Overall Study|Withdrawal by Subject|4
5515252|NCT01524796|19069397|P1|Overall Study|The price|1
5515253|NCT01524796|19069397|P1|Overall Study|Lost to Follow-up|1
5515254|NCT01524796|19069397|P1|Overall Study|Lack of Efficacy|3
5515255|NCT01524796|19069397|P1|Overall Study|Adverse Event|13
5515256|NCT01524783|19069412|P2|Randomized and Treated|Death|1
5515257|NCT01524783|19069413|P1|Randomized and Treated|Death|4
5515258|NCT01524783|19069412|P2|Randomized and Treated|Protocol Violation|1
5515259|NCT01524783|19069413|P1|Randomized and Treated|Protocol Violation|1
5515260|NCT01524783|19069412|P2|Randomized and Treated|Withdrawal by Subject|5
5515261|NCT01524783|19069413|P1|Randomized and Treated|Withdrawal by Subject|15
5515262|NCT01524783|19069412|P2|Randomized and Treated|Disease Progression|70
5515263|NCT01524783|19069413|P1|Randomized and Treated|Disease Progression|76
5515264|NCT01524783|19069412|P2|Randomized and Treated|Adverse Event|7
5515265|NCT01524783|19069413|P1|Randomized and Treated|Adverse Event|59
5515266|NCT01524783|19069412|P2|Randomized But Not Treated|Randomized, did not receive drug|0
5515267|NCT01524783|19069413|P1|Randomized But Not Treated|Randomized, did not receive drug|2
5515268|NCT01524770|19069421|P2|First Intervention|Protocol Violation|0
5515269|NCT01524770|19069422|P1|First Intervention|Protocol Violation|1
5515270|NCT01524770|19069421|P2|First Intervention|Adverse Event|1
5515271|NCT01524770|19069422|P1|First Intervention|Adverse Event|1
5515272|NCT01524770|19069421|P2|First Intervention|Withdrawal by Subject|0
5515273|NCT01524770|19069422|P1|First Intervention|Withdrawal by Subject|1
5515274|NCT01524692|19069432|P1|Overall Study|Withdrawal by Subject|3
5515275|NCT01524679|19069442|P2|Overall Study|e.g.wish for children, relocation|1
5515276|NCT01524679|19069443|P1|Overall Study|e.g.wish for children, relocation|6
5515277|NCT01524679|19069442|P2|Overall Study|Lack of Efficacy|0
5515278|NCT01524679|19069443|P1|Overall Study|Lack of Efficacy|2
5515279|NCT01524679|19069442|P2|Overall Study|Protocol Violation|0
5515280|NCT01524679|19069443|P1|Overall Study|Protocol Violation|1
5515281|NCT01524679|19069442|P2|Overall Study|Adverse Event|0
5515282|NCT01524679|19069443|P1|Overall Study|Adverse Event|9
5515283|NCT01524679|19069442|P2|Overall Study|Withdrawal by Subject|4
5515284|NCT01524679|19069443|P1|Overall Study|Withdrawal by Subject|4
5515285|NCT01524679|19069442|P2|Overall Study|Lost to Follow-up|4
5515286|NCT01524679|19069443|P1|Overall Study|Lost to Follow-up|1
5515287|NCT01524627|19069455|P2|Overall Study|Lost to Follow-up|1
5515288|NCT01524627|19069456|P1|Overall Study|Lost to Follow-up|1
5515289|NCT01524627|19069455|P2|Overall Study|Physician Decision|1
5515290|NCT01524627|19069456|P1|Overall Study|Physician Decision|0
5515291|NCT01524289|19069483|P2|Overall Study|Did not take study medication|0
5515292|NCT01524289|19069484|P1|Overall Study|Did not take study medication|1
5515293|NCT01524289|19069483|P2|Overall Study|Adverse Event|5
5515294|NCT01524289|19069484|P1|Overall Study|Adverse Event|12
5515295|NCT01524289|19069483|P2|Overall Study|Withdrawal by Subject|7
5515296|NCT01524289|19069484|P1|Overall Study|Withdrawal by Subject|11
5515297|NCT01524289|19069483|P2|Overall Study|Protocol Violation|1
5515298|NCT01524289|19069484|P1|Overall Study|Protocol Violation|5
5515299|NCT01524289|19069483|P2|Overall Study|Physician Decision|0
5515300|NCT01524289|19069484|P1|Overall Study|Physician Decision|1
5515301|NCT01524289|19069483|P2|Overall Study|Lost to Follow-up|1
5515302|NCT01524289|19069484|P1|Overall Study|Lost to Follow-up|0
5515303|NCT01524224|19069542|P8|Overall Study|Sponsor Decision|0
5515304|NCT01524224|19069543|P7|Overall Study|Sponsor Decision|0
5515305|NCT01524224|19069544|P6|Overall Study|Sponsor Decision|0
5515306|NCT01524224|19069545|P5|Overall Study|Sponsor Decision|1
5515307|NCT01524224|19069546|P4|Overall Study|Sponsor Decision|0
5515308|NCT01524224|19069547|P3|Overall Study|Sponsor Decision|0
5515309|NCT01524224|19069548|P2|Overall Study|Sponsor Decision|0
5515310|NCT01524224|19069549|P1|Overall Study|Sponsor Decision|0
5515311|NCT01524224|19069542|P8|Overall Study|Physician Decision|1
5515312|NCT01524224|19069543|P7|Overall Study|Physician Decision|0
5515313|NCT01524224|19069544|P6|Overall Study|Physician Decision|0
5515314|NCT01524224|19069545|P5|Overall Study|Physician Decision|1
5515315|NCT01524224|19069546|P4|Overall Study|Physician Decision|1
5515316|NCT01524224|19069547|P3|Overall Study|Physician Decision|0
5515317|NCT01524224|19069548|P2|Overall Study|Physician Decision|0
5515318|NCT01524224|19069549|P1|Overall Study|Physician Decision|0
5515319|NCT01524224|19069542|P8|Overall Study|Adverse Event|0
5515320|NCT01524224|19069543|P7|Overall Study|Adverse Event|0
5515321|NCT01524224|19069544|P6|Overall Study|Adverse Event|1
5515322|NCT01524224|19069545|P5|Overall Study|Adverse Event|0
5515323|NCT01524224|19069546|P4|Overall Study|Adverse Event|0
5515324|NCT01524224|19069547|P3|Overall Study|Adverse Event|0
5515325|NCT01524224|19069548|P2|Overall Study|Adverse Event|1
5515326|NCT01524224|19069549|P1|Overall Study|Adverse Event|0
5515327|NCT01524224|19069542|P8|Overall Study|Withdrawal by Subject|0
5515328|NCT01524224|19069543|P7|Overall Study|Withdrawal by Subject|2
5515329|NCT01524224|19069544|P6|Overall Study|Withdrawal by Subject|0
5515330|NCT01524224|19069545|P5|Overall Study|Withdrawal by Subject|0
5515331|NCT01524224|19069546|P4|Overall Study|Withdrawal by Subject|0
5515332|NCT01524224|19069547|P3|Overall Study|Withdrawal by Subject|0
5515333|NCT01524224|19069548|P2|Overall Study|Withdrawal by Subject|0
5515334|NCT01524224|19069549|P1|Overall Study|Withdrawal by Subject|2
5515335|NCT01524224|19069542|P8|Overall Study|Progressive Disease|5
5515336|NCT01524224|19069543|P7|Overall Study|Progressive Disease|1
5515337|NCT01524224|19069544|P6|Overall Study|Progressive Disease|1
5515338|NCT01524224|19069545|P5|Overall Study|Progressive Disease|2
5515339|NCT01524224|19069546|P4|Overall Study|Progressive Disease|1
5515340|NCT01524224|19069547|P3|Overall Study|Progressive Disease|2
5515341|NCT01524224|19069548|P2|Overall Study|Progressive Disease|0
5515342|NCT01524224|19069549|P1|Overall Study|Progressive Disease|1
5515343|NCT01524198|19069585|P2|Overall Study|Withdrawal by Subject|10
5515344|NCT01524198|19069586|P1|Overall Study|Withdrawal by Subject|15
5515345|NCT01524198|19069585|P2|Overall Study|Protocol Violation|6
5515346|NCT01524198|19069586|P1|Overall Study|Protocol Violation|8
5515347|NCT01524133|19069597|P3|Overall Study 52 Weeks|Lost to Follow-up|15
5515348|NCT01524133|19069598|P2|Overall Study 52 Weeks|Lost to Follow-up|15
5515349|NCT01524133|19069599|P1|Overall Study 52 Weeks|Lost to Follow-up|16
5515350|NCT01524133|19069597|P3|Overall Study 52 Weeks|Physician Decision|2
5515351|NCT01524133|19069598|P2|Overall Study 52 Weeks|Physician Decision|0
5515352|NCT01524133|19069599|P1|Overall Study 52 Weeks|Physician Decision|1
5515353|NCT01524133|19069597|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
5515354|NCT01524133|19069598|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
5515355|NCT01524133|19069599|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
5515356|NCT01524133|19069597|P3|Treatment Phase|Lost to Follow-up|2
5515357|NCT01524133|19069598|P2|Treatment Phase|Lost to Follow-up|1
5515358|NCT01524133|19069599|P1|Treatment Phase|Lost to Follow-up|0
5515359|NCT01524133|19069597|P3|Treatment Phase|Physician Decision|3
5515360|NCT01524133|19069598|P2|Treatment Phase|Physician Decision|3
5515361|NCT01524133|19069599|P1|Treatment Phase|Physician Decision|6
5515362|NCT01524133|19069597|P3|Treatment Phase|Withdrawal by Subject|31
5515363|NCT01524133|19069598|P2|Treatment Phase|Withdrawal by Subject|28
5515364|NCT01524133|19069599|P1|Treatment Phase|Withdrawal by Subject|13
5515365|NCT01523886|19069642|P2|Overall Study|surgery cancelled|1
5515366|NCT01523886|19069643|P1|Overall Study|surgery cancelled|0
5515367|NCT01523873|19069649|P1|Overall Study|Protocol Violation|422
5515368|NCT01523756|19069744|P2|Test Period 2|Withdrawal by Subject|1
5515369|NCT01523756|19069745|P1|Test Period 2|Withdrawal by Subject|0
5515370|NCT01523756|19069744|P2|Test Period 1|Adverse Event|0
5515371|NCT01523756|19069745|P1|Test Period 1|Adverse Event|1
5515372|NCT01523756|19069744|P2|Baseline Period|Adverse Event|1
5515373|NCT01523756|19069745|P1|Baseline Period|Adverse Event|0
5515374|NCT01523743|19069753|P2|Period 2|Adverse Event|0
5515375|NCT01523743|19069754|P1|Period 2|Adverse Event|1
5515376|NCT01523743|19069753|P2|Period 2|Withdrawal by Subject|2
5515377|NCT01523743|19069754|P1|Period 2|Withdrawal by Subject|0
5515378|NCT01523743|19069753|P2|Period 1|Felt unable to empty bladder|0
5515379|NCT01523743|19069754|P1|Period 1|Felt unable to empty bladder|1
5515380|NCT01523743|19069753|P2|Period 1|Lack of Efficacy|0
5515381|NCT01523743|19069754|P1|Period 1|Lack of Efficacy|1
5515382|NCT01523743|19069753|P2|Period 1|Lost to Follow-up|0
5515383|NCT01523743|19069754|P1|Period 1|Lost to Follow-up|1
5515384|NCT01523743|19069753|P2|Period 1|Withdrawal by Subject|2
5515385|NCT01523743|19069754|P1|Period 1|Withdrawal by Subject|6
5515386|NCT01523743|19069753|P2|Period 1|Adverse Event|0
5515387|NCT01523743|19069754|P1|Period 1|Adverse Event|1
5515388|NCT01523587|19069777|P2|Overall Study|Randomised but bot treated|2
5515389|NCT01523587|19069778|P1|Overall Study|Randomised but bot treated|6
5515390|NCT01523587|19069777|P2|Overall Study|Withdrew due to Progressive disease|279
5515391|NCT01523587|19069778|P1|Overall Study|Withdrew due to Progressive disease|265
5515392|NCT01523587|19069777|P2|Overall Study|Withdrawal by Subject|20
5515393|NCT01523587|19069778|P1|Overall Study|Withdrawal by Subject|28
5515394|NCT01523587|19069777|P2|Overall Study|Lost to Follow-up|2
5515395|NCT01523587|19069778|P1|Overall Study|Lost to Follow-up|2
5515396|NCT01523587|19069777|P2|Overall Study|Protocol Violation|3
5515397|NCT01523587|19069778|P1|Overall Study|Protocol Violation|5
5515398|NCT01523587|19069777|P2|Overall Study|Adverse Event|52
5515399|NCT01523587|19069778|P1|Overall Study|Adverse Event|68
5515400|NCT01523587|19069777|P2|Overall Study|Worsening of underlying cancer disease|34
5515401|NCT01523587|19069778|P1|Overall Study|Worsening of underlying cancer disease|19
5515402|NCT01523587|19069777|P2|Overall Study|Other than listed|5
5515403|NCT01523587|19069778|P1|Overall Study|Other than listed|5
5515404|NCT01523457|19069821|P2|Overall Study|Withdrawal by Subject|2
5515405|NCT01523457|19069822|P1|Overall Study|Withdrawal by Subject|7
5515406|NCT01523392|19069840|P2|Washout Period - 10 to 14 Days|Adverse Event|0
5515407|NCT01523392|19069841|P1|Washout Period - 10 to 14 Days|Adverse Event|1
5515408|NCT01523392|19069840|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
5515409|NCT01523392|19069841|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
5515410|NCT01523392|19069840|P2|Treatment Period 1|Withdrawal by Subject|0
5515411|NCT01523392|19069841|P1|Treatment Period 1|Withdrawal by Subject|2
5515412|NCT01523366|19069857|P2|Treatment Period 2|Not completed at least 7 days treatment|0
5515413|NCT01523366|19069858|P1|Treatment Period 2|Not completed at least 7 days treatment|1
5515414|NCT01523366|19069857|P2|Treatment Period 1|Withdrawal by Subject|0
5515415|NCT01523366|19069858|P1|Treatment Period 1|Withdrawal by Subject|1
5515416|NCT01523301|19069874|P2|Overall Study|Other Reason|2
5515417|NCT01523301|19069875|P1|Overall Study|Other Reason|0
5515418|NCT01523301|19069874|P2|Overall Study|Withdrawal by Subject|8
5515419|NCT01523301|19069875|P1|Overall Study|Withdrawal by Subject|6
5515420|NCT01523301|19069874|P2|Overall Study|Lost to Follow-up|0
5515421|NCT01523301|19069875|P1|Overall Study|Lost to Follow-up|1
5515422|NCT01523301|19069874|P2|Overall Study|Protocol Violation|4
5515423|NCT01523301|19069875|P1|Overall Study|Protocol Violation|3
5515424|NCT01523301|19069874|P2|Overall Study|Lack of Efficacy|2
5515425|NCT01523301|19069875|P1|Overall Study|Lack of Efficacy|0
5515426|NCT01523301|19069874|P2|Overall Study|Adverse Event|16
5515427|NCT01523301|19069875|P1|Overall Study|Adverse Event|25
5515428|NCT01523275|19069895|P2|Overall Study|Withdrawal by Subject|0
5515429|NCT01523275|19069896|P1|Overall Study|Withdrawal by Subject|1
5515430|NCT01523275|19069895|P2|Overall Study|Lost to Follow-up|2
5515431|NCT01523275|19069896|P1|Overall Study|Lost to Follow-up|1
5515432|NCT01522976|19069909|P3|Overall Study|Not protocol specified|27
5515433|NCT01522976|19069910|P2|Overall Study|Not protocol specified|27
5515434|NCT01522976|19069911|P1|Overall Study|Not protocol specified|22
5515435|NCT01522976|19069909|P3|Overall Study|Refusal unrelated to adverse event|14
5515436|NCT01522976|19069910|P2|Overall Study|Refusal unrelated to adverse event|13
5515437|NCT01522976|19069911|P1|Overall Study|Refusal unrelated to adverse event|10
5515438|NCT01522976|19069909|P3|Overall Study|Adverse Event|18
5515439|NCT01522976|19069910|P2|Overall Study|Adverse Event|7
5515440|NCT01522976|19069911|P1|Overall Study|Adverse Event|17
5515441|NCT01522976|19069909|P3|Overall Study|Disease progression|25
5515442|NCT01522976|19069910|P2|Overall Study|Disease progression|30
5515443|NCT01522976|19069911|P1|Overall Study|Disease progression|28
5515444|NCT01522976|19069909|P3|Overall Study|Still on treatment|6
5515445|NCT01522976|19069910|P2|Overall Study|Still on treatment|9
5515446|NCT01522976|19069911|P1|Overall Study|Still on treatment|9
5515447|NCT01522976|19069909|P3|Overall Study|Death|2
5515448|NCT01522976|19069910|P2|Overall Study|Death|6
5515449|NCT01522976|19069911|P1|Overall Study|Death|7
5515450|NCT01522976|19069909|P3|Overall Study|Ineligible|1
5515451|NCT01522976|19069910|P2|Overall Study|Ineligible|0
5515452|NCT01522976|19069911|P1|Overall Study|Ineligible|4
5515453|NCT01522950|19069956|P3|Overall Study|Study Medication Sensitivity|0
5515454|NCT01522950|19069957|P2|Overall Study|Study Medication Sensitivity|1
5515455|NCT01522950|19069958|P1|Overall Study|Study Medication Sensitivity|0
5515456|NCT01522950|19069956|P3|Overall Study|Death|1
5515457|NCT01522950|19069957|P2|Overall Study|Death|1
5515458|NCT01522950|19069958|P1|Overall Study|Death|0
5515459|NCT01522950|19069956|P3|Overall Study|Protocol Violation|2
5515460|NCT01522950|19069957|P2|Overall Study|Protocol Violation|0
5515461|NCT01522950|19069958|P1|Overall Study|Protocol Violation|0
5515462|NCT01522950|19069956|P3|Overall Study|Adverse Event|1
5515463|NCT01522950|19069957|P2|Overall Study|Adverse Event|1
5515464|NCT01522950|19069958|P1|Overall Study|Adverse Event|3
5515465|NCT01522950|19069956|P3|Overall Study|Withdrawal by Subject|1
5515466|NCT01522950|19069957|P2|Overall Study|Withdrawal by Subject|2
5515467|NCT01522950|19069958|P1|Overall Study|Withdrawal by Subject|3
5515468|NCT01522651|19070026|P5|Overall Study|Randomized but Never Treated|1
5515469|NCT01522651|19070027|P4|Overall Study|Randomized but Never Treated|1
5515470|NCT01522651|19070028|P3|Overall Study|Randomized but Never Treated|0
5515471|NCT01522651|19070029|P2|Overall Study|Randomized but Never Treated|1
5515472|NCT01522651|19070030|P1|Overall Study|Randomized but Never Treated|0
5515473|NCT01522651|19070026|P5|Overall Study|Withdrew Consent|1
5515474|NCT01522651|19070027|P4|Overall Study|Withdrew Consent|1
5515475|NCT01522651|19070028|P3|Overall Study|Withdrew Consent|0
5515476|NCT01522651|19070029|P2|Overall Study|Withdrew Consent|1
5515477|NCT01522651|19070030|P1|Overall Study|Withdrew Consent|1
5515478|NCT01522651|19070026|P5|Overall Study|Participant Non-Compliance|0
5515479|NCT01522651|19070027|P4|Overall Study|Participant Non-Compliance|0
5515480|NCT01522651|19070028|P3|Overall Study|Participant Non-Compliance|0
5515481|NCT01522651|19070029|P2|Overall Study|Participant Non-Compliance|0
5515482|NCT01522651|19070030|P1|Overall Study|Participant Non-Compliance|1
5515483|NCT01522651|19070026|P5|Overall Study|Reason Not Specified|0
5515484|NCT01522651|19070027|P4|Overall Study|Reason Not Specified|1
5515485|NCT01522651|19070028|P3|Overall Study|Reason Not Specified|0
5515486|NCT01522651|19070029|P2|Overall Study|Reason Not Specified|0
5515487|NCT01522651|19070030|P1|Overall Study|Reason Not Specified|0
5515488|NCT01522651|19070026|P5|Overall Study|Protocol Violation|0
5515489|NCT01522651|19070027|P4|Overall Study|Protocol Violation|0
5515490|NCT01522651|19070028|P3|Overall Study|Protocol Violation|0
5515491|NCT01522651|19070029|P2|Overall Study|Protocol Violation|0
5515492|NCT01522651|19070030|P1|Overall Study|Protocol Violation|3
5515493|NCT01522651|19070026|P5|Overall Study|Investigator's Discretion|0
5515494|NCT01522651|19070027|P4|Overall Study|Investigator's Discretion|0
5515495|NCT01522651|19070028|P3|Overall Study|Investigator's Discretion|0
5515496|NCT01522651|19070029|P2|Overall Study|Investigator's Discretion|1
5515497|NCT01522651|19070030|P1|Overall Study|Investigator's Discretion|0
5515498|NCT01522651|19070026|P5|Overall Study|Device Malfunction|0
5515499|NCT01522651|19070027|P4|Overall Study|Device Malfunction|0
5515500|NCT01522651|19070028|P3|Overall Study|Device Malfunction|0
5515501|NCT01522651|19070029|P2|Overall Study|Device Malfunction|1
5515502|NCT01522651|19070030|P1|Overall Study|Device Malfunction|0
5515503|NCT01522651|19070026|P5|Overall Study|Cardioversion|0
5515504|NCT01522651|19070027|P4|Overall Study|Cardioversion|0
5515505|NCT01522651|19070028|P3|Overall Study|Cardioversion|0
5515506|NCT01522651|19070029|P2|Overall Study|Cardioversion|0
5515507|NCT01522651|19070030|P1|Overall Study|Cardioversion|1
5515508|NCT01522651|19070026|P5|Overall Study|Adverse Event|4
5515509|NCT01522651|19070027|P4|Overall Study|Adverse Event|5
5515510|NCT01522651|19070028|P3|Overall Study|Adverse Event|4
5515511|NCT01522651|19070029|P2|Overall Study|Adverse Event|4
5515512|NCT01522651|19070030|P1|Overall Study|Adverse Event|3
5515513|NCT01522456|19070057|P1|Overall Study|Tolerability Assessment|1
5515514|NCT01522456|19070057|P1|Overall Study|Pregnancy|1
5515515|NCT01522456|19070057|P1|Overall Study|Withdrawal by Subject|2
5515516|NCT01522456|19070057|P1|Overall Study|Lost to Follow-up|2
5515517|NCT01522456|19070057|P1|Overall Study|Adverse Event|2
5515518|NCT01522443|19070120|P2|Overall Study|Other|3
5515519|NCT01522443|19070121|P1|Overall Study|Other|1
5515520|NCT01522443|19070120|P2|Overall Study|No study treatment given|1
5515521|NCT01522443|19070121|P1|Overall Study|No study treatment given|1
5515522|NCT01522443|19070120|P2|Overall Study|Withdrawal by Subject|8
5515523|NCT01522443|19070121|P1|Overall Study|Withdrawal by Subject|5
5515524|NCT01522443|19070120|P2|Overall Study|Adverse Event|15
5515525|NCT01522443|19070121|P1|Overall Study|Adverse Event|10
5515526|NCT01522443|19070120|P2|Overall Study|No longer receiving clinical benefit|28
5515527|NCT01522443|19070121|P1|Overall Study|No longer receiving clinical benefit|36
5515528|NCT01522404|19070133|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
5515529|NCT01522404|19070134|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
5515530|NCT01522404|19070133|P2|First Intervention (up to Week 29)|Adverse Event|0
5515531|NCT01522404|19070134|P1|First Intervention (up to Week 29)|Adverse Event|1
5515532|NCT01522404|19070133|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
5515533|NCT01522404|19070134|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
5515534|NCT01522248|19070220|P2|Overall Study|Lost to Follow-up|0
5515535|NCT01522248|19070221|P1|Overall Study|Lost to Follow-up|1
5515536|NCT01522235|19070236|P2|Overall Study|Physician Decision|1
5515537|NCT01522235|19070237|P1|Overall Study|Physician Decision|1
5515538|NCT01521923|19070273|P4|Overall Study|AE, captured in Period 1|1
5515539|NCT01521923|19070274|P3|Overall Study|AE, captured in Period 1|0
5515540|NCT01521923|19070275|P2|Overall Study|AE, captured in Period 1|1
5515541|NCT01521923|19070276|P1|Overall Study|AE, captured in Period 1|0
5515542|NCT01521923|19070273|P4|Overall Study|Other|6
5515543|NCT01521923|19070274|P3|Overall Study|Other|3
5515544|NCT01521923|19070275|P2|Overall Study|Other|1
5515545|NCT01521923|19070276|P1|Overall Study|Other|2
5515546|NCT01521923|19070273|P4|Overall Study|Withdrawal by Subject|2
5515547|NCT01521923|19070274|P3|Overall Study|Withdrawal by Subject|1
5515548|NCT01521923|19070275|P2|Overall Study|Withdrawal by Subject|1
5515549|NCT01521923|19070276|P1|Overall Study|Withdrawal by Subject|1
5515550|NCT01521923|19070273|P4|Overall Study|Lost to Follow-up|1
5515551|NCT01521923|19070274|P3|Overall Study|Lost to Follow-up|2
5515552|NCT01521923|19070275|P2|Overall Study|Lost to Follow-up|0
5515553|NCT01521923|19070276|P1|Overall Study|Lost to Follow-up|1
5515554|NCT01521923|19070273|P4|Overall Study|Protocol Violation|0
5515555|NCT01521923|19070274|P3|Overall Study|Protocol Violation|1
5515556|NCT01521923|19070275|P2|Overall Study|Protocol Violation|0
5515557|NCT01521923|19070276|P1|Overall Study|Protocol Violation|0
5515558|NCT01521923|19070273|P4|Overall Study|Lack of Efficacy|0
5515559|NCT01521923|19070274|P3|Overall Study|Lack of Efficacy|0
5515560|NCT01521923|19070275|P2|Overall Study|Lack of Efficacy|1
5515561|NCT01521923|19070276|P1|Overall Study|Lack of Efficacy|1
5515562|NCT01521923|19070273|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
5515563|NCT01521923|19070274|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
5515564|NCT01521923|19070275|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
5515565|NCT01521923|19070276|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
5515566|NCT01521923|19070273|P4|Overall Study|AE, non-serious, non-fatal|2
5515567|NCT01521923|19070274|P3|Overall Study|AE, non-serious, non-fatal|6
5515568|NCT01521923|19070275|P2|Overall Study|AE, non-serious, non-fatal|3
5515569|NCT01521923|19070276|P1|Overall Study|AE, non-serious, non-fatal|1
5515570|NCT01521923|19070273|P4|Overall Study|SAE, non-fatal|0
5515571|NCT01521923|19070274|P3|Overall Study|SAE, non-fatal|2
5515572|NCT01521923|19070275|P2|Overall Study|SAE, non-fatal|2
5515573|NCT01521923|19070276|P1|Overall Study|SAE, non-fatal|0
5515574|NCT01521923|19070273|P4|Overall Study|AE, serious fatal|0
5515575|NCT01521923|19070274|P3|Overall Study|AE, serious fatal|0
5515576|NCT01521923|19070275|P2|Overall Study|AE, serious fatal|0
5515577|NCT01521923|19070276|P1|Overall Study|AE, serious fatal|1
5515578|NCT01521897|19070396|P1|Overall Study|Lost to Follow-up|5
5515579|NCT01521897|19070396|P1|Overall Study|Protocol Violation|18
5515580|NCT01521884|19070408|P1|Overall Study|Lost to Follow-up|4
5515581|NCT01521884|19070408|P1|Overall Study|Participant non-eligible|1
5515582|NCT01521884|19070408|P1|Overall Study|Protocol Violation|3
5515583|NCT01521884|19070408|P1|Overall Study|Physician Decision|2
5515584|NCT01521884|19070408|P1|Overall Study|Withdrawal by Subject|1
5515585|NCT01521884|19070408|P1|Overall Study|Pregnancy|1
5515586|NCT01521884|19070408|P1|Overall Study|Adverse Event|5
5515587|NCT01521884|19070408|P1|Overall Study|Non Responders|10
5515588|NCT01521559|19070505|P2|Overall Study|Other|2
5515589|NCT01521559|19070506|P1|Overall Study|Other|1
5515590|NCT01521559|19070505|P2|Overall Study|Protocol Violation|0
5515591|NCT01521559|19070506|P1|Overall Study|Protocol Violation|1
5515592|NCT01521559|19070505|P2|Overall Study|Lost to Follow-up|1
5515593|NCT01521559|19070506|P1|Overall Study|Lost to Follow-up|3
5515594|NCT01521559|19070505|P2|Overall Study|Withdrawal by Subject|11
5515595|NCT01521559|19070506|P1|Overall Study|Withdrawal by Subject|9
5515596|NCT01521559|19070505|P2|Overall Study|Death|0
5515597|NCT01521559|19070506|P1|Overall Study|Death|1
5515598|NCT01521559|19070505|P2|Overall Study|Adverse Event|4
5515599|NCT01521559|19070506|P1|Overall Study|Adverse Event|0
5515600|NCT01521507|19070529|P2|Stage 2: Observational Design|Physician Decision|0
5515601|NCT01521507|19070530|P1|Stage 2: Observational Design|Physician Decision|1
5515602|NCT01521507|19070529|P2|Stage 2: Observational Design|Withdrawal by Subject|1
5515603|NCT01521507|19070530|P1|Stage 2: Observational Design|Withdrawal by Subject|3
5515604|NCT01521507|19070529|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
5515605|NCT01521507|19070530|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
5515606|NCT01521507|19070529|P2|Stage 1: Randomized Design|Lost to Follow-up|2
5515607|NCT01521507|19070530|P1|Stage 1: Randomized Design|Lost to Follow-up|0
5515608|NCT01521507|19070529|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
5515609|NCT01521507|19070530|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
5515610|NCT01521507|19070529|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
5515611|NCT01521507|19070530|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
5515612|NCT01521494|19070552|P5|Overall Study|Physician Decision|2
5515613|NCT01521494|19070553|P4|Overall Study|Physician Decision|0
5515614|NCT01521494|19070554|P3|Overall Study|Physician Decision|0
5515615|NCT01521494|19070555|P2|Overall Study|Physician Decision|0
5515616|NCT01521494|19070556|P1|Overall Study|Physician Decision|0
5515617|NCT01521494|19070552|P5|Overall Study|Decrease in serum calcium|1
5515618|NCT01521494|19070553|P4|Overall Study|Decrease in serum calcium|1
5515619|NCT01521494|19070554|P3|Overall Study|Decrease in serum calcium|0
5515620|NCT01521494|19070555|P2|Overall Study|Decrease in serum calcium|0
5515621|NCT01521494|19070556|P1|Overall Study|Decrease in serum calcium|0
5515622|NCT01521494|19070552|P5|Overall Study|Decrease in serum phosphate|0
5515623|NCT01521494|19070553|P4|Overall Study|Decrease in serum phosphate|12
5515624|NCT01521494|19070554|P3|Overall Study|Decrease in serum phosphate|3
5515625|NCT01521494|19070555|P2|Overall Study|Decrease in serum phosphate|2
5515626|NCT01521494|19070556|P1|Overall Study|Decrease in serum phosphate|0
5515627|NCT01521494|19070552|P5|Overall Study|Withdrawal by Subject|0
5515628|NCT01521494|19070553|P4|Overall Study|Withdrawal by Subject|2
5515629|NCT01521494|19070554|P3|Overall Study|Withdrawal by Subject|0
5515630|NCT01521494|19070555|P2|Overall Study|Withdrawal by Subject|1
5515631|NCT01521494|19070556|P1|Overall Study|Withdrawal by Subject|1
5515632|NCT01521494|19070552|P5|Overall Study|Lack of Efficacy|2
5515633|NCT01521494|19070553|P4|Overall Study|Lack of Efficacy|0
5515634|NCT01521494|19070554|P3|Overall Study|Lack of Efficacy|0
5515635|NCT01521494|19070555|P2|Overall Study|Lack of Efficacy|0
5515636|NCT01521494|19070556|P1|Overall Study|Lack of Efficacy|0
5515637|NCT01521494|19070552|P5|Overall Study|Adverse Event|2
5515638|NCT01521494|19070553|P4|Overall Study|Adverse Event|6
5515639|NCT01521494|19070554|P3|Overall Study|Adverse Event|9
5515640|NCT01521494|19070555|P2|Overall Study|Adverse Event|2
5515641|NCT01521494|19070556|P1|Overall Study|Adverse Event|1
5515642|NCT01521364|19070578|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
5515643|NCT01521364|19070578|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
5515644|NCT01520987|19070654|P8|Overall Study|Withdrawal by Subject|0
5515645|NCT01520987|19070655|P7|Overall Study|Withdrawal by Subject|0
5515646|NCT01520987|19070656|P6|Overall Study|Withdrawal by Subject|1
5515647|NCT01520987|19070657|P5|Overall Study|Withdrawal by Subject|0
5515648|NCT01520987|19070658|P4|Overall Study|Withdrawal by Subject|0
5515649|NCT01520987|19070659|P3|Overall Study|Withdrawal by Subject|0
5515650|NCT01520987|19070660|P2|Overall Study|Withdrawal by Subject|0
5515651|NCT01520987|19070661|P1|Overall Study|Withdrawal by Subject|1
5515652|NCT01520922|19070721|P2|Survival Follow-up|Withdrawal by Subject|0
5515653|NCT01520922|19070722|P1|Survival Follow-up|Withdrawal by Subject|1
5515654|NCT01520922|19070721|P2|Follow up|Lost to Follow-up|1
5515655|NCT01520922|19070722|P1|Follow up|Lost to Follow-up|0
5515656|NCT01520922|19070721|P2|Treatment Phase|Adverse Event|5
5515657|NCT01520922|19070722|P1|Treatment Phase|Adverse Event|3
5515658|NCT01520922|19070721|P2|Treatment Phase|Progression|2
5515659|NCT01520922|19070722|P1|Treatment Phase|Progression|0
5515660|NCT01520922|19070721|P2|Treatment Phase|Physician Decision|1
5515661|NCT01520922|19070722|P1|Treatment Phase|Physician Decision|2
5515662|NCT01520909|19070784|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
5515663|NCT01520909|19070785|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
5515664|NCT01520909|19070786|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
5515665|NCT01520909|19070784|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
5515666|NCT01520909|19070785|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
5515667|NCT01520909|19070786|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
5515668|NCT01520909|19070784|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
5515669|NCT01520909|19070785|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
5515670|NCT01520909|19070786|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
5515671|NCT01520909|19070784|P3|Part 1 (Randomized Period)|Adverse Event|0
5515672|NCT01520909|19070785|P2|Part 1 (Randomized Period)|Adverse Event|2
5515673|NCT01520909|19070786|P1|Part 1 (Randomized Period)|Adverse Event|1
5515674|NCT01520714|19070903|P2|Overall Study|Lack of Efficacy|1
5515675|NCT01520714|19070904|P1|Overall Study|Lack of Efficacy|0
5515676|NCT01520714|19070903|P2|Overall Study|Adverse Event|2
5515677|NCT01520714|19070904|P1|Overall Study|Adverse Event|0
5515678|NCT01520714|19070903|P2|Overall Study|Protocol Violation|3
5515679|NCT01520714|19070904|P1|Overall Study|Protocol Violation|0
5515680|NCT01520506|19070949|P1|Overall Study|Withdrawal by Subject|1
5515681|NCT01520506|19070949|P1|Overall Study|Lost to Follow-up|1
5515682|NCT01520506|19070949|P1|Overall Study|Missed Visit|4
5515683|NCT01520402|19071004|P1|Overall Study|Physician Decision|3
5515684|NCT01520402|19071004|P1|Overall Study|Withdrawal by Subject|2
5515685|NCT01520363|19071017|P2|Overall Study|Withdrawal by Subject|0
5515686|NCT01520363|19071018|P1|Overall Study|Withdrawal by Subject|2
5515687|NCT01520324|19071092|P1|Overall Study|Subject discontinued (moderate illness)|1
5515688|NCT01519960|19071121|P3|Overall Study|Lost to Follow-up|0
5515689|NCT01519960|19071122|P2|Overall Study|Lost to Follow-up|1
5515690|NCT01519960|19071123|P1|Overall Study|Lost to Follow-up|0
5515691|NCT01519960|19071121|P3|Overall Study|Withdrawal by Subject|0
5515692|NCT01519960|19071122|P2|Overall Study|Withdrawal by Subject|4
5515693|NCT01519960|19071123|P1|Overall Study|Withdrawal by Subject|0
5515694|NCT01519960|19071121|P3|Overall Study|Adverse Event|0
5515695|NCT01519960|19071122|P2|Overall Study|Adverse Event|1
5515696|NCT01519960|19071123|P1|Overall Study|Adverse Event|0
5515697|NCT01519960|19071121|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
5515698|NCT01519960|19071122|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
5515699|NCT01519960|19071123|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
5515700|NCT01519960|19071121|P3|Overall Study|Ongoing in Follow-Up|10
5515701|NCT01519960|19071122|P2|Overall Study|Ongoing in Follow-Up|11
5515702|NCT01519960|19071123|P1|Overall Study|Ongoing in Follow-Up|101
5515703|NCT01519947|19071233|P4|Overall Study|Adverse Event|1
5515704|NCT01519947|19071234|P3|Overall Study|Adverse Event|1
5515705|NCT01519947|19071235|P2|Overall Study|Adverse Event|0
5515706|NCT01519947|19071236|P1|Overall Study|Adverse Event|1
5515707|NCT01519947|19071233|P4|Overall Study|Poor Response|1
5515708|NCT01519947|19071234|P3|Overall Study|Poor Response|0
5515709|NCT01519947|19071235|P2|Overall Study|Poor Response|0
5515710|NCT01519947|19071236|P1|Overall Study|Poor Response|1
5515711|NCT01519947|19071233|P4|Overall Study|Lost to Follow-up|2
5515712|NCT01519947|19071234|P3|Overall Study|Lost to Follow-up|3
5515713|NCT01519947|19071235|P2|Overall Study|Lost to Follow-up|0
5515714|NCT01519947|19071236|P1|Overall Study|Lost to Follow-up|0
5515715|NCT01519947|19071233|P4|Overall Study|Withdrawal by Subject|1
5515716|NCT01519947|19071234|P3|Overall Study|Withdrawal by Subject|0
5515717|NCT01519947|19071235|P2|Overall Study|Withdrawal by Subject|1
5515718|NCT01519947|19071236|P1|Overall Study|Withdrawal by Subject|0
5515719|NCT01519947|19071233|P4|Overall Study|Blood Transfusion|0
5515720|NCT01519947|19071234|P3|Overall Study|Blood Transfusion|1
5515721|NCT01519947|19071235|P2|Overall Study|Blood Transfusion|1
5515722|NCT01519947|19071236|P1|Overall Study|Blood Transfusion|0
5515723|NCT01519947|19071233|P4|Overall Study|Development of Anemia|1
5515724|NCT01519947|19071234|P3|Overall Study|Development of Anemia|0
5515725|NCT01519947|19071235|P2|Overall Study|Development of Anemia|1
5515726|NCT01519947|19071236|P1|Overall Study|Development of Anemia|0
5515727|NCT01519947|19071233|P4|Overall Study|Peritoneal Dialysis Needed|0
5515728|NCT01519947|19071234|P3|Overall Study|Peritoneal Dialysis Needed|0
5515729|NCT01519947|19071235|P2|Overall Study|Peritoneal Dialysis Needed|1
5515730|NCT01519947|19071236|P1|Overall Study|Peritoneal Dialysis Needed|0
5515731|NCT01519947|19071233|P4|Overall Study|Protocol Violation|1
5515732|NCT01519947|19071234|P3|Overall Study|Protocol Violation|2
5515733|NCT01519947|19071235|P2|Overall Study|Protocol Violation|0
5515734|NCT01519947|19071236|P1|Overall Study|Protocol Violation|0
5515735|NCT01519947|19071233|P4|Overall Study|Death|1
5515736|NCT01519947|19071234|P3|Overall Study|Death|0
5515737|NCT01519947|19071235|P2|Overall Study|Death|0
5515738|NCT01519947|19071236|P1|Overall Study|Death|0
5515739|NCT01519934|19071266|P1|Overall Study|Lost to Follow-up|3
5515740|NCT01519921|19071275|P2|Overall Study|High alanine aminotransferase (ALT)|1
5515741|NCT01519921|19071276|P1|Overall Study|High alanine aminotransferase (ALT)|0
5515742|NCT01519921|19071275|P2|Overall Study|Treatment refusal|1
5515743|NCT01519921|19071276|P1|Overall Study|Treatment refusal|2
5515744|NCT01519921|19071275|P2|Overall Study|Lost to Follow-up|1
5515745|NCT01519921|19071276|P1|Overall Study|Lost to Follow-up|2
5515746|NCT01519921|19071275|P2|Overall Study|Withdrawal by Subject|0
5515747|NCT01519921|19071276|P1|Overall Study|Withdrawal by Subject|3
5515748|NCT01519921|19071275|P2|Overall Study|Lack of Efficacy|3
5515749|NCT01519921|19071276|P1|Overall Study|Lack of Efficacy|4
5515750|NCT01519921|19071275|P2|Overall Study|Adverse Event|9
5515751|NCT01519921|19071276|P1|Overall Study|Adverse Event|10
5515752|NCT01519869|19071325|P1|Overall Study|Lost to Follow-up|1
5515753|NCT01519817|19071329|P4|Overall Study|Off study due to infection|1
5515754|NCT01519817|19071330|P3|Overall Study|Off study due to infection|0
5515755|NCT01519817|19071331|P2|Overall Study|Off study due to infection|0
5515756|NCT01519817|19071332|P1|Overall Study|Off study due to infection|0
5515757|NCT01519817|19071329|P4|Overall Study|Withdrawal by Subject|0
5515758|NCT01519817|19071330|P3|Overall Study|Withdrawal by Subject|0
5515759|NCT01519817|19071331|P2|Overall Study|Withdrawal by Subject|0
5515760|NCT01519817|19071332|P1|Overall Study|Withdrawal by Subject|1
5515761|NCT01519791|19071372|P2|Overall Study|Lost to Follow-up|14
5515762|NCT01519791|19071373|P1|Overall Study|Lost to Follow-up|6
5515763|NCT01519791|19071372|P2|Overall Study|Withdrawal by Subject|37
5515764|NCT01519791|19071373|P1|Overall Study|Withdrawal by Subject|15
5515765|NCT01519791|19071372|P2|Overall Study|AE, non-serious non-fatal|31
5515766|NCT01519791|19071373|P1|Overall Study|AE, non-serious non-fatal|12
5515767|NCT01519791|19071372|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
5515768|NCT01519791|19071373|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
5515769|NCT01519791|19071372|P2|Overall Study|AE, serious fatal|1
5515770|NCT01519791|19071373|P1|Overall Study|AE, serious fatal|0
5515771|NCT01519791|19071372|P2|Overall Study|SAE, non-fatal|22
5515772|NCT01519791|19071373|P1|Overall Study|SAE, non-fatal|6
5515773|NCT01519791|19071372|P2|Overall Study|Lack of Efficacy|20
5515774|NCT01519791|19071373|P1|Overall Study|Lack of Efficacy|16
5515775|NCT01519791|19071372|P2|Overall Study|subjects randomized in error|0
5515776|NCT01519791|19071373|P1|Overall Study|subjects randomized in error|2
5515777|NCT01519791|19071372|P2|Overall Study|Other Reason|222
5515778|NCT01519791|19071373|P1|Overall Study|Other Reason|87
5515779|NCT01519791|19071372|P2|Overall Study|Protocol Violation|19
5515780|NCT01519791|19071373|P1|Overall Study|Protocol Violation|6
5515781|NCT01519791|19071372|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
5515782|NCT01519791|19071373|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
5515783|NCT01519778|19071437|P1|Overall Study|Physician Decision|1
5515784|NCT01519778|19071437|P1|Overall Study|Lost to Follow-up|10
5515785|NCT01519778|19071437|P1|Overall Study|Withdrawal by Subject|3
5515786|NCT01519765|19071443|P2|Overall Study|Withdrawal by Subject|1
5515787|NCT01519765|19071444|P1|Overall Study|Withdrawal by Subject|0
5515788|NCT01519765|19071443|P2|Overall Study|Protocol Violation|0
5515789|NCT01519765|19071444|P1|Overall Study|Protocol Violation|1
5515790|NCT01519765|19071443|P2|Overall Study|Lack of Efficacy|0
5515791|NCT01519765|19071444|P1|Overall Study|Lack of Efficacy|2
5515792|NCT01519765|19071443|P2|Overall Study|Adverse Event|1
5515793|NCT01519765|19071444|P1|Overall Study|Adverse Event|0
5515794|NCT01519700|19071522|P4|Overall Study|Other Reason|4
5515795|NCT01519700|19071523|P3|Overall Study|Other Reason|0
5515796|NCT01519700|19071524|P2|Overall Study|Other Reason|2
5515797|NCT01519700|19071525|P1|Overall Study|Other Reason|2
5515798|NCT01519700|19071522|P4|Overall Study|Withdrawal by Subject|2
5515799|NCT01519700|19071523|P3|Overall Study|Withdrawal by Subject|3
5515800|NCT01519700|19071524|P2|Overall Study|Withdrawal by Subject|3
5515801|NCT01519700|19071525|P1|Overall Study|Withdrawal by Subject|5
5515802|NCT01519700|19071522|P4|Overall Study|Physician Decision|0
5515803|NCT01519700|19071523|P3|Overall Study|Physician Decision|3
5515804|NCT01519700|19071524|P2|Overall Study|Physician Decision|1
5515805|NCT01519700|19071525|P1|Overall Study|Physician Decision|1
5515806|NCT01519700|19071522|P4|Overall Study|Lost to Follow-up|1
5515807|NCT01519700|19071523|P3|Overall Study|Lost to Follow-up|1
5515808|NCT01519700|19071524|P2|Overall Study|Lost to Follow-up|0
5515809|NCT01519700|19071525|P1|Overall Study|Lost to Follow-up|0
5515810|NCT01519700|19071522|P4|Overall Study|Death|0
5515811|NCT01519700|19071523|P3|Overall Study|Death|0
5515812|NCT01519700|19071524|P2|Overall Study|Death|0
5515813|NCT01519700|19071525|P1|Overall Study|Death|1
5515814|NCT01519674|19071560|P3|Overall Study|Unsclassified|3
5515815|NCT01519674|19071561|P2|Overall Study|Unsclassified|4
5515816|NCT01519674|19071562|P1|Overall Study|Unsclassified|10
5515817|NCT01519674|19071560|P3|Overall Study|Withdrawal Criteria|7
5515818|NCT01519674|19071561|P2|Overall Study|Withdrawal Criteria|2
5515819|NCT01519674|19071562|P1|Overall Study|Withdrawal Criteria|7
5515820|NCT01519674|19071560|P3|Overall Study|Protocol Violation|1
5515821|NCT01519674|19071561|P2|Overall Study|Protocol Violation|3
5515822|NCT01519674|19071562|P1|Overall Study|Protocol Violation|0
5515823|NCT01519674|19071560|P3|Overall Study|Lack of Efficacy|1
5515824|NCT01519674|19071561|P2|Overall Study|Lack of Efficacy|1
5515825|NCT01519674|19071562|P1|Overall Study|Lack of Efficacy|1
5515826|NCT01519674|19071560|P3|Overall Study|Adverse Event|0
5515827|NCT01519674|19071561|P2|Overall Study|Adverse Event|3
5515828|NCT01519674|19071562|P1|Overall Study|Adverse Event|3
5515829|NCT01519661|19071600|P1|Overall Study|Adverse Event|29
5515830|NCT01519661|19071600|P1|Overall Study|Lack of Efficacy|6
5515831|NCT01519661|19071600|P1|Overall Study|Withdrawal by Subject|17
5515832|NCT01519661|19071600|P1|Overall Study|Lost to Follow-up|3
5515833|NCT01519661|19071600|P1|Overall Study|Protocol deviation|6
5515834|NCT01519635|19071626|P2|Overall Study|No possibility to put a catheter|2
5515835|NCT01519635|19071627|P1|Overall Study|No possibility to put a catheter|1
5515836|NCT01519635|19071626|P2|Overall Study|Withdrawal by Subject|1
5515837|NCT01519635|19071627|P1|Overall Study|Withdrawal by Subject|0
5515838|NCT01519518|19071644|P2|Overall Study|Consent not available|10
5515839|NCT01519518|19071645|P1|Overall Study|Consent not available|7
5515840|NCT01519427|19071670|P1|Overall Study|disease progression|2
5515841|NCT01519323|19071702|P2|Overall Study|Study terminated by sponsor|1
5515842|NCT01519323|19071703|P1|Overall Study|Study terminated by sponsor|0
5515843|NCT01519323|19071702|P2|Overall Study|Death|2
5515844|NCT01519323|19071703|P1|Overall Study|Death|3
5515845|NCT01519245|19071763|P2|Overall Study|Met exclusion criteria, not analysed|2
5515846|NCT01519245|19071764|P1|Overall Study|Met exclusion criteria, not analysed|1
5515847|NCT01519206|19071776|P1|Overall Study|Missed Visit|2
5515848|NCT01519206|19071776|P1|Overall Study|Lost to Follow-up|3
5515849|NCT01519167|19071790|P2|Overall Study|Physician Decision|1
5515850|NCT01519167|19071791|P1|Overall Study|Physician Decision|0
5515851|NCT01519167|19071790|P2|Overall Study|Medical condition changes&deep sedation|2
5515852|NCT01519167|19071791|P1|Overall Study|Medical condition changes&deep sedation|0
5515853|NCT01519167|19071790|P2|Overall Study|Lack of Efficacy|1
5515854|NCT01519167|19071791|P1|Overall Study|Lack of Efficacy|0
5515855|NCT01519167|19071790|P2|Overall Study|Adverse Event|1
5515856|NCT01519167|19071791|P1|Overall Study|Adverse Event|0
5515857|NCT01519167|19071790|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
5515858|NCT01519167|19071791|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
5515859|NCT01519089|19071817|P2|Overall Study|Not received study drug|1
5515860|NCT01519089|19071818|P1|Overall Study|Not received study drug|0
5515861|NCT01519089|19071817|P2|Overall Study|Other|6
5515862|NCT01519089|19071818|P1|Overall Study|Other|2
5515863|NCT01519089|19071817|P2|Overall Study|Withdrawal by Subject|2
5515864|NCT01519089|19071818|P1|Overall Study|Withdrawal by Subject|0
5515865|NCT01519089|19071817|P2|Overall Study|Lost to Follow-up|0
5515866|NCT01519089|19071818|P1|Overall Study|Lost to Follow-up|1
5515867|NCT01519089|19071817|P2|Overall Study|Lack of Efficacy|2
5515868|NCT01519089|19071818|P1|Overall Study|Lack of Efficacy|0
5515869|NCT01519089|19071817|P2|Overall Study|Adverse Event|4
5515870|NCT01519089|19071818|P1|Overall Study|Adverse Event|4
5515871|NCT01518972|19071960|P2|Overall Study|Declined medication starting on day 12|1
5515872|NCT01518972|19071961|P1|Overall Study|Declined medication starting on day 12|0
5515873|NCT01518972|19071960|P2|Overall Study|Exclusionary medication|1
5515874|NCT01518972|19071961|P1|Overall Study|Exclusionary medication|0
5515875|NCT01518972|19071960|P2|Overall Study|Missed safety visits|1
5515876|NCT01518972|19071961|P1|Overall Study|Missed safety visits|0
5515877|NCT01518972|19071960|P2|Overall Study|Exclusionary medical condition|0
5515878|NCT01518972|19071961|P1|Overall Study|Exclusionary medical condition|1
5515879|NCT01518972|19071960|P2|Overall Study|Transportation problems|0
5515880|NCT01518972|19071961|P1|Overall Study|Transportation problems|1
5515881|NCT01518972|19071960|P2|Overall Study|Moved from area|0
5515882|NCT01518972|19071961|P1|Overall Study|Moved from area|1
5515883|NCT01518972|19071960|P2|Overall Study|Withdrawal by Subject|0
5515884|NCT01518972|19071961|P1|Overall Study|Withdrawal by Subject|1
5515885|NCT01518972|19071960|P2|Overall Study|Lost to Follow-up|1
5515886|NCT01518972|19071961|P1|Overall Study|Lost to Follow-up|2
5515887|NCT01518946|19071975|P3|Randomized Phase (First Intervention)|Other|0
5515888|NCT01518946|19071976|P2|Randomized Phase (First Intervention)|Other|1
5515889|NCT01518946|19071977|P1|Randomized Phase (First Intervention)|Other|0
5515890|NCT01518946|19071975|P3|Open-label Phase|Other|0
5515891|NCT01518946|19071976|P2|Open-label Phase|Other|0
5515892|NCT01518946|19071977|P1|Open-label Phase|Other|4
5515893|NCT01518374|19071997|P1|Overall Study|Lost to Follow-up|2
5515894|NCT01518374|19071997|P1|Overall Study|Protocol Violation|3
5515895|NCT01518374|19071997|P1|Overall Study|Withdrawal by Subject|2
5515896|NCT01518322|19072001|P1|Overall Study|FeNO measurement was missing|13
5515897|NCT01518309|19072014|P1|Overall Study|Not in Predefined Categories|9
5515898|NCT01518309|19072014|P1|Overall Study|Sponsor Decision|2
5515899|NCT01518309|19072014|P1|Overall Study|Physician Decision|3
5515900|NCT01518309|19072014|P1|Overall Study|Withdrawal by Subject|6
5515901|NCT01518309|19072014|P1|Overall Study|Lack of Efficacy|7
5515902|NCT01518309|19072014|P1|Overall Study|Death|6
5515903|NCT01518309|19072014|P1|Overall Study|Adverse Event|6
5515904|NCT01518257|19072026|P2|Overall Study|Other Miscellaneous Reason|0
5515905|NCT01518257|19072027|P1|Overall Study|Other Miscellaneous Reason|1
5515906|NCT01518257|19072026|P2|Overall Study|Lost to Follow-up|0
5515907|NCT01518257|19072027|P1|Overall Study|Lost to Follow-up|1
5515908|NCT01518244|19072049|P1|Overall Study|Adverse Event|3
5515909|NCT01518192|19072057|P3|Overall Study|Lost to Follow-up|35
5515910|NCT01518192|19072058|P2|Overall Study|Lost to Follow-up|26
5515911|NCT01518192|19072059|P1|Overall Study|Lost to Follow-up|29
5515912|NCT01518153|19072080|P3|Donor Lymphocyte Infusion|Death|1
5515913|NCT01518153|19072081|P2|Donor Lymphocyte Infusion|Death|2
5515914|NCT01518153|19072082|P1|Donor Lymphocyte Infusion|Death|0
5515915|NCT01518153|19072080|P3|Stem Cell Transplant|Adverse Event|0
5515916|NCT01518153|19072081|P2|Stem Cell Transplant|Adverse Event|0
5515917|NCT01518153|19072082|P1|Stem Cell Transplant|Adverse Event|1
5515918|NCT01518153|19072080|P3|Stem Cell Transplant|Secondary graft failure|0
5515919|NCT01518153|19072081|P2|Stem Cell Transplant|Secondary graft failure|0
5515920|NCT01518153|19072082|P1|Stem Cell Transplant|Secondary graft failure|1
5515921|NCT01518153|19072080|P3|Stem Cell Transplant|Death|0
5515922|NCT01518153|19072081|P2|Stem Cell Transplant|Death|0
5515923|NCT01518153|19072082|P1|Stem Cell Transplant|Death|2
5515924|NCT01518153|19072080|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
5515925|NCT01518153|19072081|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
5515926|NCT01518153|19072082|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
5515927|NCT01517984|19072093|P4|Overall Study|Ineligible for randomization|0
5515928|NCT01517984|19072094|P3|Overall Study|Ineligible for randomization|0
5515929|NCT01517984|19072095|P2|Overall Study|Ineligible for randomization|14
5515930|NCT01517984|19072096|P1|Overall Study|Ineligible for randomization|0
5515931|NCT01517984|19072093|P4|Overall Study|Screen Failure|0
5515932|NCT01517984|19072094|P3|Overall Study|Screen Failure|0
5515933|NCT01517984|19072095|P2|Overall Study|Screen Failure|0
5515934|NCT01517984|19072096|P1|Overall Study|Screen Failure|4
5515935|NCT01517984|19072093|P4|Overall Study|Withdrawal by Subject|1
5515936|NCT01517984|19072094|P3|Overall Study|Withdrawal by Subject|4
5515937|NCT01517984|19072095|P2|Overall Study|Withdrawal by Subject|8
5515938|NCT01517984|19072096|P1|Overall Study|Withdrawal by Subject|1
5515939|NCT01517984|19072093|P4|Overall Study|Lost to Follow-up|0
5515940|NCT01517984|19072094|P3|Overall Study|Lost to Follow-up|0
5515941|NCT01517984|19072095|P2|Overall Study|Lost to Follow-up|1
5515942|NCT01517984|19072096|P1|Overall Study|Lost to Follow-up|0
5515943|NCT01517893|19072122|P2|Overall Study|Withdrawal by Subject|0
5515944|NCT01517893|19072123|P1|Overall Study|Withdrawal by Subject|3
5515945|NCT01517867|19072145|P2|Overall Study|Still in treatment at study end|3
5515946|NCT01517867|19072146|P1|Overall Study|Still in treatment at study end|0
5515947|NCT01517867|19072145|P2|Overall Study|Withdrawal by Subject|30
5515948|NCT01517867|19072146|P1|Overall Study|Withdrawal by Subject|34
5515949|NCT01517867|19072145|P2|Overall Study|never started treatment|32
5515950|NCT01517867|19072146|P1|Overall Study|never started treatment|29
5515951|NCT01517750|19072174|P4|Overall Study|Lost to Follow-up|1
5515952|NCT01517750|19072175|P3|Overall Study|Lost to Follow-up|4
5515953|NCT01517750|19072176|P2|Overall Study|Lost to Follow-up|2
5515954|NCT01517750|19072177|P1|Overall Study|Lost to Follow-up|1
5515955|NCT01517412|19072221|P2|Overall Study|Other than specified above|5
5515956|NCT01517412|19072222|P1|Overall Study|Other than specified above|8
5515957|NCT01517412|19072221|P2|Overall Study|Poor compliance to protocol|3
5515958|NCT01517412|19072222|P1|Overall Study|Poor compliance to protocol|8
5515959|NCT01517412|19072221|P2|Overall Study|Lack of Efficacy|5
5515960|NCT01517412|19072222|P1|Overall Study|Lack of Efficacy|10
5515961|NCT01517412|19072221|P2|Overall Study|Adverse Event|11
5515962|NCT01517412|19072222|P1|Overall Study|Adverse Event|10
5515963|NCT01517373|19072251|P6|Treatment Period|Medication error without AEs|2
5515964|NCT01517373|19072252|P5|Treatment Period|Medication error without AEs|0
5515965|NCT01517373|19072253|P4|Treatment Period|Medication error without AEs|1
5515966|NCT01517373|19072254|P3|Treatment Period|Medication error without AEs|2
5515967|NCT01517373|19072255|P2|Treatment Period|Medication error without AEs|0
5515968|NCT01517373|19072256|P1|Treatment Period|Medication error without AEs|0
5515969|NCT01517373|19072251|P6|Treatment Period|Lack of Efficacy|0
5515970|NCT01517373|19072252|P5|Treatment Period|Lack of Efficacy|2
5515971|NCT01517373|19072253|P4|Treatment Period|Lack of Efficacy|3
5515972|NCT01517373|19072254|P3|Treatment Period|Lack of Efficacy|1
5515973|NCT01517373|19072255|P2|Treatment Period|Lack of Efficacy|1
5515974|NCT01517373|19072256|P1|Treatment Period|Lack of Efficacy|0
5515975|NCT01517373|19072251|P6|Treatment Period|Protocol Violation|0
5515976|NCT01517373|19072252|P5|Treatment Period|Protocol Violation|1
5515977|NCT01517373|19072253|P4|Treatment Period|Protocol Violation|0
5515978|NCT01517373|19072254|P3|Treatment Period|Protocol Violation|0
5515979|NCT01517373|19072255|P2|Treatment Period|Protocol Violation|0
5515980|NCT01517373|19072256|P1|Treatment Period|Protocol Violation|0
5515981|NCT01517373|19072251|P6|Treatment Period|Other|0
5515982|NCT01517373|19072252|P5|Treatment Period|Other|1
5515983|NCT01517373|19072253|P4|Treatment Period|Other|0
5515984|NCT01517373|19072254|P3|Treatment Period|Other|0
5515985|NCT01517373|19072255|P2|Treatment Period|Other|0
5515986|NCT01517373|19072256|P1|Treatment Period|Other|0
5515987|NCT01517373|19072251|P6|Treatment Period|Withdrawal by Subject|3
5515988|NCT01517373|19072252|P5|Treatment Period|Withdrawal by Subject|2
5515989|NCT01517373|19072253|P4|Treatment Period|Withdrawal by Subject|2
5515990|NCT01517373|19072254|P3|Treatment Period|Withdrawal by Subject|2
5515991|NCT01517373|19072255|P2|Treatment Period|Withdrawal by Subject|3
5515992|NCT01517373|19072256|P1|Treatment Period|Withdrawal by Subject|0
5515993|NCT01517373|19072251|P6|Treatment Period|Lost to Follow-up|0
5515994|NCT01517373|19072252|P5|Treatment Period|Lost to Follow-up|0
5515995|NCT01517373|19072253|P4|Treatment Period|Lost to Follow-up|1
5515996|NCT01517373|19072254|P3|Treatment Period|Lost to Follow-up|1
5515997|NCT01517373|19072255|P2|Treatment Period|Lost to Follow-up|0
5515998|NCT01517373|19072256|P1|Treatment Period|Lost to Follow-up|0
5515999|NCT01517373|19072251|P6|Treatment Period|Adverse Event|2
5516000|NCT01517373|19072252|P5|Treatment Period|Adverse Event|0
5516001|NCT01517373|19072253|P4|Treatment Period|Adverse Event|0
5516002|NCT01517373|19072254|P3|Treatment Period|Adverse Event|0
5516003|NCT01517373|19072255|P2|Treatment Period|Adverse Event|0
5516004|NCT01517373|19072256|P1|Treatment Period|Adverse Event|0
5516005|NCT01517373|19072251|P6|Run-in Period|Other|0
5516006|NCT01517373|19072252|P5|Run-in Period|Other|0
5516007|NCT01517373|19072253|P4|Run-in Period|Other|0
5516008|NCT01517373|19072254|P3|Run-in Period|Other|0
5516009|NCT01517373|19072255|P2|Run-in Period|Other|0
5516010|NCT01517373|19072256|P1|Run-in Period|Other|1
5516011|NCT01517373|19072251|P6|Run-in Period|Sponsor Decision|0
5516012|NCT01517373|19072252|P5|Run-in Period|Sponsor Decision|0
5516013|NCT01517373|19072253|P4|Run-in Period|Sponsor Decision|0
5516014|NCT01517373|19072254|P3|Run-in Period|Sponsor Decision|0
5516015|NCT01517373|19072255|P2|Run-in Period|Sponsor Decision|0
5516016|NCT01517373|19072256|P1|Run-in Period|Sponsor Decision|3
5516017|NCT01517373|19072251|P6|Run-in Period|Withdrawal by Subject|0
5516018|NCT01517373|19072252|P5|Run-in Period|Withdrawal by Subject|0
5516019|NCT01517373|19072253|P4|Run-in Period|Withdrawal by Subject|0
5516020|NCT01517373|19072254|P3|Run-in Period|Withdrawal by Subject|0
5516021|NCT01517373|19072255|P2|Run-in Period|Withdrawal by Subject|0
5516022|NCT01517373|19072256|P1|Run-in Period|Withdrawal by Subject|12
5516023|NCT01517373|19072251|P6|Run-in Period|Lost to Follow-up|0
5516024|NCT01517373|19072252|P5|Run-in Period|Lost to Follow-up|0
5516025|NCT01517373|19072253|P4|Run-in Period|Lost to Follow-up|0
5516026|NCT01517373|19072254|P3|Run-in Period|Lost to Follow-up|0
5516027|NCT01517373|19072255|P2|Run-in Period|Lost to Follow-up|0
5516028|NCT01517373|19072256|P1|Run-in Period|Lost to Follow-up|1
5516029|NCT01517373|19072251|P6|Run-in Period|Did not meet eligibility criteria|0
5516030|NCT01517373|19072252|P5|Run-in Period|Did not meet eligibility criteria|0
5516031|NCT01517373|19072253|P4|Run-in Period|Did not meet eligibility criteria|0
5516032|NCT01517373|19072254|P3|Run-in Period|Did not meet eligibility criteria|0
5516033|NCT01517373|19072255|P2|Run-in Period|Did not meet eligibility criteria|0
5516034|NCT01517373|19072256|P1|Run-in Period|Did not meet eligibility criteria|34
5516035|NCT01517373|19072251|P6|Run-in Period|Adverse Event|0
5516036|NCT01517373|19072252|P5|Run-in Period|Adverse Event|0
5516037|NCT01517373|19072253|P4|Run-in Period|Adverse Event|0
5516038|NCT01517373|19072254|P3|Run-in Period|Adverse Event|0
5516039|NCT01517373|19072255|P2|Run-in Period|Adverse Event|0
5516040|NCT01517373|19072256|P1|Run-in Period|Adverse Event|5
5516041|NCT01517373|19072251|P6|Run-in Period|Death|0
5516042|NCT01517373|19072252|P5|Run-in Period|Death|0
5516043|NCT01517373|19072253|P4|Run-in Period|Death|0
5516044|NCT01517373|19072254|P3|Run-in Period|Death|0
5516045|NCT01517373|19072255|P2|Run-in Period|Death|0
5516046|NCT01517373|19072256|P1|Run-in Period|Death|1
5516047|NCT01517295|19072326|P2|Overall Study|Physician Decision|0
5516048|NCT01517295|19072327|P1|Overall Study|Physician Decision|1
5516049|NCT01517282|19072341|P4|Overall Study|Physician Decision|0
5516050|NCT01517282|19072342|P3|Overall Study|Physician Decision|0
5516051|NCT01517282|19072343|P2|Overall Study|Physician Decision|0
5516052|NCT01517282|19072344|P1|Overall Study|Physician Decision|1
5516053|NCT01517282|19072341|P4|Overall Study|Consent withdrawn|1
5516054|NCT01517282|19072342|P3|Overall Study|Consent withdrawn|1
5516055|NCT01517282|19072343|P2|Overall Study|Consent withdrawn|1
5516056|NCT01517282|19072344|P1|Overall Study|Consent withdrawn|0
5516057|NCT01517178|19072378|P2|Period 2|E.g. study termination|2
5516058|NCT01517178|19072379|P1|Period 2|E.g. study termination|2
5516059|NCT01517178|19072378|P2|Period 2|Withdrawal by Subject|0
5516060|NCT01517178|19072379|P1|Period 2|Withdrawal by Subject|3
5516061|NCT01517178|19072378|P2|Period 2|Adverse Event|0
5516062|NCT01517178|19072379|P1|Period 2|Adverse Event|1
5516063|NCT01517178|19072378|P2|Period 1|Withdrawal by Subject|1
5516064|NCT01517178|19072379|P1|Period 1|Withdrawal by Subject|0
5516065|NCT01517178|19072378|P2|Period 1|E.g. study termination|1
5516066|NCT01517178|19072379|P1|Period 1|E.g. study termination|3
5516067|NCT01517178|19072378|P2|Period 1|Lack of Efficacy|1
5516068|NCT01517178|19072379|P1|Period 1|Lack of Efficacy|0
5516069|NCT01517178|19072378|P2|Period 1|Adverse Event|2
5516070|NCT01517178|19072379|P1|Period 1|Adverse Event|1
5516071|NCT01516970|19072407|P2|Overall Study|Other|7
5516072|NCT01516970|19072408|P1|Overall Study|Other|9
5516073|NCT01516970|19072407|P2|Overall Study|Withdrawal by Subject|1
5516074|NCT01516970|19072408|P1|Overall Study|Withdrawal by Subject|1
5516075|NCT01516970|19072407|P2|Overall Study|Adverse Event|5
5516076|NCT01516970|19072408|P1|Overall Study|Adverse Event|1
5516077|NCT01516970|19072407|P2|Overall Study|Lost to Follow-up|8
5516078|NCT01516970|19072408|P1|Overall Study|Lost to Follow-up|7
5516079|NCT01516892|19072447|P1|Overall Study|Missing|1
5516080|NCT01516892|19072447|P1|Overall Study|Other Miscellaneous Reasons|43
5516081|NCT01516892|19072447|P1|Overall Study|Protocol Violation|60
5516082|NCT01516892|19072447|P1|Overall Study|Subject Withdrew Consent|92
5516083|NCT01516892|19072447|P1|Overall Study|Lost to Follow-up|82
5516084|NCT01516892|19072447|P1|Overall Study|Pregnancy|5
5516085|NCT01516892|19072447|P1|Overall Study|Lack of Efficacy|35
5516086|NCT01516892|19072447|P1|Overall Study|Adverse Event|25
5516087|NCT01516879|19072455|P2|Overall Study|Other|10
5516088|NCT01516879|19072456|P1|Overall Study|Other|5
5516089|NCT01516879|19072455|P2|Overall Study|Lost to Follow-up|11
5516090|NCT01516879|19072456|P1|Overall Study|Lost to Follow-up|2
5516091|NCT01516879|19072455|P2|Overall Study|Death|2
5516092|NCT01516879|19072456|P1|Overall Study|Death|0
5516093|NCT01516879|19072455|P2|Overall Study|Withdrawal by Subject|11
5516094|NCT01516879|19072456|P1|Overall Study|Withdrawal by Subject|9
5516095|NCT01516749|19072490|P1|Follow-up Off Therapy|Lost to Follow-up|1
5516096|NCT01516749|19072490|P1|Active Therapy|Lost to Follow-up|1
5516097|NCT01516736|19072499|P2|Overall Study|Other (not specified)|1
5516098|NCT01516736|19072500|P1|Overall Study|Other (not specified)|0
5516099|NCT01516736|19072499|P2|Overall Study|Protocol Violation|1
5516100|NCT01516736|19072500|P1|Overall Study|Protocol Violation|0
5516101|NCT01516736|19072499|P2|Overall Study|Lack of Efficacy|0
5516102|NCT01516736|19072500|P1|Overall Study|Lack of Efficacy|1
5516103|NCT01516736|19072499|P2|Overall Study|Physician Decision|1
5516104|NCT01516736|19072500|P1|Overall Study|Physician Decision|2
5516105|NCT01516736|19072499|P2|Overall Study|Death|1
5516106|NCT01516736|19072500|P1|Overall Study|Death|3
5516107|NCT01516736|19072499|P2|Overall Study|Adverse Event|5
5516108|NCT01516736|19072500|P1|Overall Study|Adverse Event|4
5516109|NCT01516736|19072499|P2|Overall Study|Withdrawal by Subject|4
5516110|NCT01516736|19072500|P1|Overall Study|Withdrawal by Subject|10
5516111|NCT01516437|19072554|P4|Overall Study|Reason not specified|1
5516112|NCT01516437|19072555|P3|Overall Study|Reason not specified|1
5516113|NCT01516437|19072556|P2|Overall Study|Reason not specified|0
5516114|NCT01516437|19072557|P1|Overall Study|Reason not specified|0
5516115|NCT01516034|19072629|P1|Overall Study|Lack of Efficacy|7
5516116|NCT01516034|19072629|P1|Overall Study|Physician Decision|1
5516117|NCT01516008|19072636|P3|Overall Study|Reason not specified|1
5516118|NCT01516008|19072637|P2|Overall Study|Reason not specified|0
5516119|NCT01516008|19072638|P1|Overall Study|Reason not specified|0
5516120|NCT01516008|19072636|P3|Overall Study|Protocol Violation|0
5516121|NCT01516008|19072637|P2|Overall Study|Protocol Violation|0
5516122|NCT01516008|19072638|P1|Overall Study|Protocol Violation|1
5516123|NCT01516008|19072636|P3|Overall Study|Lack of Efficacy|10
5516124|NCT01516008|19072637|P2|Overall Study|Lack of Efficacy|14
5516125|NCT01516008|19072638|P1|Overall Study|Lack of Efficacy|44
5516126|NCT01516008|19072636|P3|Overall Study|Adverse Event|7
5516127|NCT01516008|19072637|P2|Overall Study|Adverse Event|2
5516128|NCT01516008|19072638|P1|Overall Study|Adverse Event|0
5516129|NCT01515865|19072743|P3|Part B (Open-label)|Other|0
5516130|NCT01515865|19072744|P2|Part B (Open-label)|Other|0
5516131|NCT01515865|19072745|P1|Part B (Open-label)|Other|1
5516132|NCT01515865|19072743|P3|Part B (Open-label)|Withdrawal by Subject|0
5516133|NCT01515865|19072744|P2|Part B (Open-label)|Withdrawal by Subject|0
5516134|NCT01515865|19072745|P1|Part B (Open-label)|Withdrawal by Subject|1
5516135|NCT01515865|19072743|P3|Part A (Open-label)|Other|0
5516136|NCT01515865|19072744|P2|Part A (Open-label)|Other|0
5516137|NCT01515865|19072745|P1|Part A (Open-label)|Other|3
5516138|NCT01515748|19072755|P2|Overall Study|Ongoing|90
5516139|NCT01515748|19072756|P1|Overall Study|Ongoing|86
5516140|NCT01515748|19072755|P2|Overall Study|Lost to Follow-up|4
5516141|NCT01515748|19072756|P1|Overall Study|Lost to Follow-up|2
5516142|NCT01515748|19072755|P2|Overall Study|Withdrawal by Subject|41
5516143|NCT01515748|19072756|P1|Overall Study|Withdrawal by Subject|32
5516144|NCT01515475|19072839|P4|Overall Study|Lost to Follow-up|12
5516145|NCT01515475|19072840|P3|Overall Study|Lost to Follow-up|12
5516146|NCT01515475|19072841|P2|Overall Study|Lost to Follow-up|15
5516147|NCT01515475|19072842|P1|Overall Study|Lost to Follow-up|20
5516148|NCT01515423|19072916|P3|DOUBLE BLIND|Blind broken by investigator|0
5516149|NCT01515423|19072917|P2|DOUBLE BLIND|Blind broken by investigator|1
5516150|NCT01515423|19072918|P1|DOUBLE BLIND|Blind broken by investigator|0
5516151|NCT01515423|19072916|P3|DOUBLE BLIND|Other|12
5516152|NCT01515423|19072917|P2|DOUBLE BLIND|Other|6
5516153|NCT01515423|19072918|P1|DOUBLE BLIND|Other|0
5516154|NCT01515423|19072916|P3|DOUBLE BLIND|Withdrawal by Subject|53
5516155|NCT01515423|19072917|P2|DOUBLE BLIND|Withdrawal by Subject|50
5516156|NCT01515423|19072918|P1|DOUBLE BLIND|Withdrawal by Subject|0
5516157|NCT01515423|19072916|P3|DOUBLE BLIND|Pregnancy|0
5516158|NCT01515423|19072917|P2|DOUBLE BLIND|Pregnancy|2
5516159|NCT01515423|19072918|P1|DOUBLE BLIND|Pregnancy|0
5516160|NCT01515423|19072916|P3|DOUBLE BLIND|Lost to Follow-up|12
5516161|NCT01515423|19072917|P2|DOUBLE BLIND|Lost to Follow-up|7
5516162|NCT01515423|19072918|P1|DOUBLE BLIND|Lost to Follow-up|0
5516163|NCT01515423|19072916|P3|DOUBLE BLIND|Death|2
5516164|NCT01515423|19072917|P2|DOUBLE BLIND|Death|1
5516165|NCT01515423|19072918|P1|DOUBLE BLIND|Death|0
5516166|NCT01515423|19072916|P3|DOUBLE BLIND|Adverse Event|13
5516167|NCT01515423|19072917|P2|DOUBLE BLIND|Adverse Event|15
5516168|NCT01515423|19072918|P1|DOUBLE BLIND|Adverse Event|0
5516169|NCT01515423|19072916|P3|Open Label Phase|Other|0
5516170|NCT01515423|19072917|P2|Open Label Phase|Other|0
5516171|NCT01515423|19072918|P1|Open Label Phase|Other|28
5516172|NCT01515423|19072916|P3|Open Label Phase|excluded from DB Phase|0
5516173|NCT01515423|19072917|P2|Open Label Phase|excluded from DB Phase|0
5516174|NCT01515423|19072918|P1|Open Label Phase|excluded from DB Phase|70
5516175|NCT01515423|19072916|P3|Open Label Phase|Withdrawal by Subject|0
5516176|NCT01515423|19072917|P2|Open Label Phase|Withdrawal by Subject|0
5516177|NCT01515423|19072918|P1|Open Label Phase|Withdrawal by Subject|118
5516178|NCT01515423|19072916|P3|Open Label Phase|Lost to Follow-up|0
5516179|NCT01515423|19072917|P2|Open Label Phase|Lost to Follow-up|0
5516180|NCT01515423|19072918|P1|Open Label Phase|Lost to Follow-up|21
5516181|NCT01515423|19072916|P3|Open Label Phase|Lack of Efficacy|0
5516182|NCT01515423|19072917|P2|Open Label Phase|Lack of Efficacy|0
5516183|NCT01515423|19072918|P1|Open Label Phase|Lack of Efficacy|117
5516184|NCT01515423|19072916|P3|Open Label Phase|Death|0
5516185|NCT01515423|19072917|P2|Open Label Phase|Death|0
5516186|NCT01515423|19072918|P1|Open Label Phase|Death|2
5516187|NCT01515423|19072916|P3|Open Label Phase|Adverse Event|0
5516188|NCT01515423|19072917|P2|Open Label Phase|Adverse Event|0
5516189|NCT01515423|19072918|P1|Open Label Phase|Adverse Event|57
5516190|NCT01515306|19072959|P2|Overall Study|Ongoing receiving treatment|14
5516191|NCT01515306|19072960|P1|Overall Study|Ongoing receiving treatment|9
5516192|NCT01515306|19072959|P2|Overall Study|Progressive Disease|0
5516193|NCT01515306|19072960|P1|Overall Study|Progressive Disease|1
5516194|NCT01515306|19072959|P2|Overall Study|Adverse Event|0
5516195|NCT01515306|19072960|P1|Overall Study|Adverse Event|2
5516196|NCT01515189|19072973|P2|First Re-Induction Phase|Other|0
5516197|NCT01515189|19072974|P1|First Re-Induction Phase|Other|1
5516198|NCT01515189|19072973|P2|First Re-Induction Phase|No longer meets study criteria|0
5516199|NCT01515189|19072974|P1|First Re-Induction Phase|No longer meets study criteria|1
5516200|NCT01515189|19072973|P2|First Re-Induction Phase|Withdrawal by Subject|1
5516201|NCT01515189|19072974|P1|First Re-Induction Phase|Withdrawal by Subject|1
5516202|NCT01515189|19072973|P2|First Re-Induction Phase|Study drug toxicity|0
5516203|NCT01515189|19072974|P1|First Re-Induction Phase|Study drug toxicity|5
5516204|NCT01515189|19072973|P2|First Re-Induction Phase|Disease progression|14
5516205|NCT01515189|19072974|P1|First Re-Induction Phase|Disease progression|6
5516206|NCT01515189|19072973|P2|Induction|Other|4
5516207|NCT01515189|19072974|P1|Induction|Other|0
5516208|NCT01515189|19072973|P2|Induction|Lost to Follow-up|0
5516209|NCT01515189|19072974|P1|Induction|Lost to Follow-up|1
5516210|NCT01515189|19072973|P2|Induction|No longer meets study criteria|2
5516211|NCT01515189|19072974|P1|Induction|No longer meets study criteria|0
5516212|NCT01515189|19072973|P2|Induction|Withdrawal by Subject|9
5516213|NCT01515189|19072974|P1|Induction|Withdrawal by Subject|3
5516214|NCT01515189|19072973|P2|Induction|Adverse Event|9
5516215|NCT01515189|19072974|P1|Induction|Adverse Event|14
5516216|NCT01515189|19072973|P2|Induction|Death|17
5516217|NCT01515189|19072974|P1|Induction|Death|24
5516218|NCT01515189|19072973|P2|Induction|Study drug toxicity|36
5516219|NCT01515189|19072974|P1|Induction|Study drug toxicity|86
5516220|NCT01515189|19072973|P2|Induction|Disease Progression|155
5516221|NCT01515189|19072974|P1|Induction|Disease Progression|109
5516222|NCT01514864|19073062|P2|Overall Study|Study drug toxicity|0
5516223|NCT01514864|19073063|P1|Overall Study|Study drug toxicity|2
5516224|NCT01514864|19073062|P2|Overall Study|Disease progression|5
5516225|NCT01514864|19073063|P1|Overall Study|Disease progression|7
5516226|NCT01514760|19073088|P1|Overall Study|Lost to Follow-up|2
5516227|NCT01514682|19073101|P2|Overall Study|Physician Decision|3
5516228|NCT01514682|19073102|P1|Overall Study|Physician Decision|4
5516229|NCT01514682|19073101|P2|Overall Study|Withdrawal by Subject|3
5516230|NCT01514682|19073102|P1|Overall Study|Withdrawal by Subject|2
5516231|NCT01514461|19073136|P3|Overall Study|Death|0
5516232|NCT01514461|19073137|P2|Overall Study|Death|0
5516233|NCT01514461|19073138|P1|Overall Study|Death|1
5516234|NCT01514461|19073136|P3|Overall Study|Patient/guardian decision|1
5516235|NCT01514461|19073137|P2|Overall Study|Patient/guardian decision|1
5516236|NCT01514461|19073138|P1|Overall Study|Patient/guardian decision|1
5516237|NCT01514461|19073136|P3|Overall Study|Physician Decision|0
5516238|NCT01514461|19073137|P2|Overall Study|Physician Decision|1
5516239|NCT01514461|19073138|P1|Overall Study|Physician Decision|1
5516240|NCT01514461|19073136|P3|Overall Study|Adverse Event|3
5516241|NCT01514461|19073137|P2|Overall Study|Adverse Event|1
5516242|NCT01514461|19073138|P1|Overall Study|Adverse Event|2
5516243|NCT01514448|19073177|P2|Overall Study|New Cancer Therapy|0
5516244|NCT01514448|19073178|P1|Overall Study|New Cancer Therapy|1
5516245|NCT01514448|19073177|P2|Overall Study|Lost to Follow-up|0
5516246|NCT01514448|19073178|P1|Overall Study|Lost to Follow-up|2
5516247|NCT01514448|19073177|P2|Overall Study|Withdrawal by Subject|0
5516248|NCT01514448|19073178|P1|Overall Study|Withdrawal by Subject|2
5516249|NCT01514448|19073177|P2|Overall Study|Death|8
5516250|NCT01514448|19073178|P1|Overall Study|Death|7
5516251|NCT01514422|19073193|P1|Overall Study|Lost to Follow-up|1
5516252|NCT01514370|19073211|P2|Overall Study|Other|7
5516253|NCT01514370|19073212|P1|Overall Study|Other|6
5516254|NCT01514370|19073211|P2|Overall Study|Adverse Event|3
5516255|NCT01514370|19073212|P1|Overall Study|Adverse Event|1
5516256|NCT01514370|19073211|P2|Overall Study|Withdrawal by Subject|1
5516257|NCT01514370|19073212|P1|Overall Study|Withdrawal by Subject|2
5516258|NCT01514370|19073211|P2|Overall Study|Lost to Follow-up|2
5516259|NCT01514370|19073212|P1|Overall Study|Lost to Follow-up|0
5516260|NCT01514370|19073211|P2|Overall Study|Protocol Violation|3
5516261|NCT01514370|19073212|P1|Overall Study|Protocol Violation|2
5516262|NCT01514357|19073258|P2|Overall Study|Withdrawal by Subject|0
5516263|NCT01514357|19073259|P1|Overall Study|Withdrawal by Subject|2
5516264|NCT01514357|19073258|P2|Overall Study|Screen failure|0
5516265|NCT01514357|19073259|P1|Overall Study|Screen failure|2
5516266|NCT01514240|19073344|P2|Overall Study|Subject Decision|7
5516267|NCT01514240|19073345|P1|Overall Study|Subject Decision|2
5516268|NCT01514240|19073344|P2|Overall Study|Adverse Event|4
5516269|NCT01514240|19073345|P1|Overall Study|Adverse Event|4
5516270|NCT01514201|19073423|P4|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
5516271|NCT01514201|19073424|P3|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5516272|NCT01514201|19073425|P2|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5516273|NCT01514201|19073426|P1|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5516274|NCT01514201|19073423|P4|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
5516275|NCT01514201|19073424|P3|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5516276|NCT01514201|19073425|P2|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5516277|NCT01514201|19073426|P1|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5516278|NCT01514201|19073423|P4|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
5516279|NCT01514201|19073424|P3|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
5516280|NCT01514201|19073425|P2|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
5516281|NCT01514201|19073426|P1|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
5516282|NCT01514201|19073423|P4|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
5516283|NCT01514201|19073424|P3|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
5516284|NCT01514201|19073425|P2|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
5516285|NCT01514201|19073426|P1|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
5516286|NCT01514201|19073423|P4|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
5516287|NCT01514201|19073424|P3|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
5516288|NCT01514201|19073425|P2|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
5516289|NCT01514201|19073426|P1|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
5516290|NCT01514201|19073423|P4|PHASE II: Veliparib + Radiation Therapy|Death|1
5516291|NCT01514201|19073424|P3|PHASE II: Veliparib + Radiation Therapy|Death|0
5516292|NCT01514201|19073425|P2|PHASE II: Veliparib + Radiation Therapy|Death|0
5516293|NCT01514201|19073426|P1|PHASE II: Veliparib + Radiation Therapy|Death|0
5516294|NCT01514201|19073423|P4|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
5516295|NCT01514201|19073424|P3|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
5516296|NCT01514201|19073425|P2|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
5516297|NCT01514201|19073426|P1|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
5516298|NCT01514201|19073423|P4|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
5516299|NCT01514201|19073424|P3|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
5516300|NCT01514201|19073425|P2|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
5516301|NCT01514201|19073426|P1|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
5516302|NCT01514201|19073423|P4|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5516303|NCT01514201|19073424|P3|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
5516304|NCT01514201|19073425|P2|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
5516305|NCT01514201|19073426|P1|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
5516306|NCT01514201|19073423|P4|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
5516307|NCT01514201|19073424|P3|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
5516308|NCT01514201|19073425|P2|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
5516309|NCT01514201|19073426|P1|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
5516310|NCT01514201|19073423|P4|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
5516311|NCT01514201|19073424|P3|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
5516312|NCT01514201|19073425|P2|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
5516313|NCT01514201|19073426|P1|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
5516314|NCT01514201|19073423|P4|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
5516315|NCT01514201|19073424|P3|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
5516316|NCT01514201|19073425|P2|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
5516317|NCT01514201|19073426|P1|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
5516318|NCT01514136|19073524|P8|Test Period 2; Test C*|Protocol Violation|0
5516319|NCT01514136|19073525|P7|Test Period 2; Test C*|Protocol Violation|1
5516320|NCT01514136|19073526|P6|Test Period 2; Test C*|Protocol Violation|0
5516321|NCT01514136|19073527|P5|Test Period 2; Test C*|Protocol Violation|0
5516322|NCT01514136|19073528|P4|Test Period 2; Test C*|Protocol Violation|0
5516323|NCT01514136|19073529|P3|Test Period 2; Test C*|Protocol Violation|0
5516324|NCT01514136|19073530|P2|Test Period 2; Test C*|Protocol Violation|0
5516325|NCT01514136|19073531|P1|Test Period 2; Test C*|Protocol Violation|0
5516326|NCT01514136|19073524|P8|Test Period 2; Test C*|holiday|0
5516327|NCT01514136|19073525|P7|Test Period 2; Test C*|holiday|1
5516328|NCT01514136|19073526|P6|Test Period 2; Test C*|holiday|0
5516329|NCT01514136|19073527|P5|Test Period 2; Test C*|holiday|0
5516330|NCT01514136|19073528|P4|Test Period 2; Test C*|holiday|0
5516331|NCT01514136|19073529|P3|Test Period 2; Test C*|holiday|0
5516332|NCT01514136|19073530|P2|Test Period 2; Test C*|holiday|0
5516333|NCT01514136|19073531|P1|Test Period 2; Test C*|holiday|0
5516334|NCT01514136|19073524|P8|Test Period 2; Test C*|Withdrawal by Subject|0
5516335|NCT01514136|19073525|P7|Test Period 2; Test C*|Withdrawal by Subject|1
5516336|NCT01514136|19073526|P6|Test Period 2; Test C*|Withdrawal by Subject|0
5516337|NCT01514136|19073527|P5|Test Period 2; Test C*|Withdrawal by Subject|0
5516338|NCT01514136|19073528|P4|Test Period 2; Test C*|Withdrawal by Subject|0
5516339|NCT01514136|19073529|P3|Test Period 2; Test C*|Withdrawal by Subject|0
5516340|NCT01514136|19073530|P2|Test Period 2; Test C*|Withdrawal by Subject|0
5516341|NCT01514136|19073531|P1|Test Period 2; Test C*|Withdrawal by Subject|0
5516342|NCT01514136|19073524|P8|Test Period 2; Test B*|Withdrawal by Subject|0
5516343|NCT01514136|19073525|P7|Test Period 2; Test B*|Withdrawal by Subject|0
5516344|NCT01514136|19073526|P6|Test Period 2; Test B*|Withdrawal by Subject|2
5516345|NCT01514136|19073527|P5|Test Period 2; Test B*|Withdrawal by Subject|0
5516346|NCT01514136|19073528|P4|Test Period 2; Test B*|Withdrawal by Subject|0
5516347|NCT01514136|19073529|P3|Test Period 2; Test B*|Withdrawal by Subject|0
5516348|NCT01514136|19073530|P2|Test Period 2; Test B*|Withdrawal by Subject|0
5516349|NCT01514136|19073531|P1|Test Period 2; Test B*|Withdrawal by Subject|0
5516350|NCT01514136|19073524|P8|Test Period 2; Test A*|Holiday|0
5516351|NCT01514136|19073525|P7|Test Period 2; Test A*|Holiday|0
5516352|NCT01514136|19073526|P6|Test Period 2; Test A*|Holiday|0
5516353|NCT01514136|19073527|P5|Test Period 2; Test A*|Holiday|1
5516354|NCT01514136|19073528|P4|Test Period 2; Test A*|Holiday|0
5516355|NCT01514136|19073529|P3|Test Period 2; Test A*|Holiday|0
5516356|NCT01514136|19073530|P2|Test Period 2; Test A*|Holiday|0
5516357|NCT01514136|19073531|P1|Test Period 2; Test A*|Holiday|0
5516358|NCT01514136|19073524|P8|Test Period 2; Test A*|Adverse Event|0
5516359|NCT01514136|19073525|P7|Test Period 2; Test A*|Adverse Event|0
5516360|NCT01514136|19073526|P6|Test Period 2; Test A*|Adverse Event|0
5516361|NCT01514136|19073527|P5|Test Period 2; Test A*|Adverse Event|1
5516362|NCT01514136|19073528|P4|Test Period 2; Test A*|Adverse Event|0
5516363|NCT01514136|19073529|P3|Test Period 2; Test A*|Adverse Event|0
5516364|NCT01514136|19073530|P2|Test Period 2; Test A*|Adverse Event|0
5516365|NCT01514136|19073531|P1|Test Period 2; Test A*|Adverse Event|0
5516366|NCT01514136|19073524|P8|Test Period 1; Test D|Subject took a break due to holiday|0
5516367|NCT01514136|19073525|P7|Test Period 1; Test D|Subject took a break due to holiday|0
5516368|NCT01514136|19073526|P6|Test Period 1; Test D|Subject took a break due to holiday|0
5516369|NCT01514136|19073527|P5|Test Period 1; Test D|Subject took a break due to holiday|0
5516370|NCT01514136|19073528|P4|Test Period 1; Test D|Subject took a break due to holiday|2
5516371|NCT01514136|19073529|P3|Test Period 1; Test D|Subject took a break due to holiday|0
5516372|NCT01514136|19073530|P2|Test Period 1; Test D|Subject took a break due to holiday|0
5516373|NCT01514136|19073531|P1|Test Period 1; Test D|Subject took a break due to holiday|0
5516374|NCT01514136|19073524|P8|Test Period 1; Test B|Withdrawal by Subject|0
5516375|NCT01514136|19073525|P7|Test Period 1; Test B|Withdrawal by Subject|0
5516376|NCT01514136|19073526|P6|Test Period 1; Test B|Withdrawal by Subject|0
5516377|NCT01514136|19073527|P5|Test Period 1; Test B|Withdrawal by Subject|0
5516378|NCT01514136|19073528|P4|Test Period 1; Test B|Withdrawal by Subject|0
5516379|NCT01514136|19073529|P3|Test Period 1; Test B|Withdrawal by Subject|0
5516380|NCT01514136|19073530|P2|Test Period 1; Test B|Withdrawal by Subject|1
5516381|NCT01514136|19073531|P1|Test Period 1; Test B|Withdrawal by Subject|0
5516382|NCT01514136|19073524|P8|Test Period 1; Test A|Break from study holiday|0
5516383|NCT01514136|19073525|P7|Test Period 1; Test A|Break from study holiday|0
5516384|NCT01514136|19073526|P6|Test Period 1; Test A|Break from study holiday|0
5516385|NCT01514136|19073527|P5|Test Period 1; Test A|Break from study holiday|0
5516386|NCT01514136|19073528|P4|Test Period 1; Test A|Break from study holiday|0
5516387|NCT01514136|19073529|P3|Test Period 1; Test A|Break from study holiday|0
5516388|NCT01514136|19073530|P2|Test Period 1; Test A|Break from study holiday|0
5516389|NCT01514136|19073531|P1|Test Period 1; Test A|Break from study holiday|2
5516390|NCT01514136|19073524|P8|Test Period 1; Test A|Protocol Violation|0
5516391|NCT01514136|19073525|P7|Test Period 1; Test A|Protocol Violation|0
5516392|NCT01514136|19073526|P6|Test Period 1; Test A|Protocol Violation|0
5516393|NCT01514136|19073527|P5|Test Period 1; Test A|Protocol Violation|0
5516394|NCT01514136|19073528|P4|Test Period 1; Test A|Protocol Violation|0
5516395|NCT01514136|19073529|P3|Test Period 1; Test A|Protocol Violation|0
5516396|NCT01514136|19073530|P2|Test Period 1; Test A|Protocol Violation|0
5516397|NCT01514136|19073531|P1|Test Period 1; Test A|Protocol Violation|1
5516398|NCT01513967|19073565|P8|Overall Study|Physician Decision|0
5516399|NCT01513967|19073566|P7|Overall Study|Physician Decision|0
5516400|NCT01513967|19073567|P6|Overall Study|Physician Decision|1
5516401|NCT01513967|19073568|P5|Overall Study|Physician Decision|0
5516402|NCT01513967|19073569|P4|Overall Study|Physician Decision|0
5516403|NCT01513967|19073570|P3|Overall Study|Physician Decision|0
5516404|NCT01513967|19073571|P2|Overall Study|Physician Decision|0
5516405|NCT01513967|19073572|P1|Overall Study|Physician Decision|0
5516406|NCT01513967|19073565|P8|Overall Study|excluded due to positive drug screen|2
5516407|NCT01513967|19073566|P7|Overall Study|excluded due to positive drug screen|0
5516408|NCT01513967|19073567|P6|Overall Study|excluded due to positive drug screen|0
5516409|NCT01513967|19073568|P5|Overall Study|excluded due to positive drug screen|0
5516410|NCT01513967|19073569|P4|Overall Study|excluded due to positive drug screen|0
5516411|NCT01513967|19073570|P3|Overall Study|excluded due to positive drug screen|0
5516412|NCT01513967|19073571|P2|Overall Study|excluded due to positive drug screen|0
5516413|NCT01513967|19073572|P1|Overall Study|excluded due to positive drug screen|0
5516414|NCT01513967|19073565|P8|Overall Study|missed a study visit|0
5516415|NCT01513967|19073566|P7|Overall Study|missed a study visit|1
5516416|NCT01513967|19073567|P6|Overall Study|missed a study visit|0
5516417|NCT01513967|19073568|P5|Overall Study|missed a study visit|0
5516418|NCT01513967|19073569|P4|Overall Study|missed a study visit|0
5516419|NCT01513967|19073570|P3|Overall Study|missed a study visit|0
5516420|NCT01513967|19073571|P2|Overall Study|missed a study visit|0
5516421|NCT01513967|19073572|P1|Overall Study|missed a study visit|0
5516422|NCT01513967|19073565|P8|Overall Study|Pregnancy|0
5516423|NCT01513967|19073566|P7|Overall Study|Pregnancy|1
5516424|NCT01513967|19073567|P6|Overall Study|Pregnancy|0
5516425|NCT01513967|19073568|P5|Overall Study|Pregnancy|0
5516426|NCT01513967|19073569|P4|Overall Study|Pregnancy|0
5516427|NCT01513967|19073570|P3|Overall Study|Pregnancy|0
5516428|NCT01513967|19073571|P2|Overall Study|Pregnancy|0
5516429|NCT01513967|19073572|P1|Overall Study|Pregnancy|0
5516430|NCT01513759|19073630|P1|Overall Study|Death during catheter placement|1
5516431|NCT01513759|19073630|P1|Overall Study|Protocol Violation|4
5516432|NCT01513590|19073641|P2|Overall Study|Unclassified|10
5516433|NCT01513590|19073642|P1|Overall Study|Unclassified|5
5516434|NCT01513590|19073641|P2|Overall Study|Withdrawal Criteria|0
5516435|NCT01513590|19073642|P1|Overall Study|Withdrawal Criteria|3
5516436|NCT01513590|19073641|P2|Overall Study|Adverse Event|3
5516437|NCT01513590|19073642|P1|Overall Study|Adverse Event|2
5516438|NCT01513551|19073663|P3|Overall Study|Randomized but not vaccinated|1
5516439|NCT01513551|19073664|P2|Overall Study|Randomized but not vaccinated|0
5516440|NCT01513551|19073665|P1|Overall Study|Randomized but not vaccinated|0
5516441|NCT01513551|19073663|P3|Overall Study|Withdrawal by Subject|2
5516442|NCT01513551|19073664|P2|Overall Study|Withdrawal by Subject|0
5516443|NCT01513551|19073665|P1|Overall Study|Withdrawal by Subject|1
5516444|NCT01513551|19073663|P3|Overall Study|Lost to Follow-up|2
5516445|NCT01513551|19073664|P2|Overall Study|Lost to Follow-up|5
5516446|NCT01513551|19073665|P1|Overall Study|Lost to Follow-up|3
5516447|NCT01513551|19073663|P3|Overall Study|Death|0
5516448|NCT01513551|19073664|P2|Overall Study|Death|1
5516449|NCT01513551|19073665|P1|Overall Study|Death|0
5516450|NCT01513473|19073697|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
5516451|NCT01513473|19073698|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
5516452|NCT01513473|19073697|P2|Extension Trial (26 Weeks)|Adverse Event|1
5516453|NCT01513473|19073698|P1|Extension Trial (26 Weeks)|Adverse Event|0
5516454|NCT01513473|19073697|P2|Main Trial (26 Weeks)|Unclassified|2
5516455|NCT01513473|19073698|P1|Main Trial (26 Weeks)|Unclassified|0
5516456|NCT01513473|19073697|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
5516457|NCT01513473|19073698|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
5516458|NCT01513473|19073697|P2|Main Trial (26 Weeks)|Adverse Event|2
5516459|NCT01513473|19073698|P1|Main Trial (26 Weeks)|Adverse Event|0
5516460|NCT01513460|19073725|P3|Overall Study|Abnormal test procedure|0
5516461|NCT01513460|19073726|P2|Overall Study|Abnormal test procedure|0
5516462|NCT01513460|19073727|P1|Overall Study|Abnormal test procedure|1
5516463|NCT01513460|19073725|P3|Overall Study|Adverse Event|23
5516464|NCT01513460|19073726|P2|Overall Study|Adverse Event|18
5516465|NCT01513460|19073727|P1|Overall Study|Adverse Event|16
5516466|NCT01513460|19073725|P3|Overall Study|Withdrawal by Subject|21
5516467|NCT01513460|19073726|P2|Overall Study|Withdrawal by Subject|8
5516468|NCT01513460|19073727|P1|Overall Study|Withdrawal by Subject|7
5516469|NCT01513460|19073725|P3|Overall Study|Protocol deviations|3
5516470|NCT01513460|19073726|P2|Overall Study|Protocol deviations|4
5516471|NCT01513460|19073727|P1|Overall Study|Protocol deviations|3
5516472|NCT01513460|19073725|P3|Overall Study|Lack of Efficacy|5
5516473|NCT01513460|19073726|P2|Overall Study|Lack of Efficacy|2
5516474|NCT01513460|19073727|P1|Overall Study|Lack of Efficacy|1
5516475|NCT01513460|19073725|P3|Overall Study|Abnormal laboratory value|1
5516476|NCT01513460|19073726|P2|Overall Study|Abnormal laboratory value|0
5516477|NCT01513460|19073727|P1|Overall Study|Abnormal laboratory value|1
5516478|NCT01513460|19073725|P3|Overall Study|Lost to Follow-up|2
5516479|NCT01513460|19073726|P2|Overall Study|Lost to Follow-up|0
5516480|NCT01513460|19073727|P1|Overall Study|Lost to Follow-up|0
5516481|NCT01513460|19073725|P3|Overall Study|Death|1
5516482|NCT01513460|19073726|P2|Overall Study|Death|0
5516483|NCT01513460|19073727|P1|Overall Study|Death|0
5516484|NCT01513330|19073762|P2|Standard Care First,|Other|0
5516485|NCT01513330|19073763|P1|Standard Care First,|Other|1
5516486|NCT01513330|19073762|P2|Standard Care First,|Withdrawal by Subject|2
5516487|NCT01513330|19073763|P1|Standard Care First,|Withdrawal by Subject|1
5516488|NCT01513330|19073762|P2|Standard Care First,|Lack of Efficacy|2
5516489|NCT01513330|19073763|P1|Standard Care First,|Lack of Efficacy|2
5516490|NCT01513330|19073762|P2|SenSura Mio First,|Other|0
5516491|NCT01513330|19073763|P1|SenSura Mio First,|Other|1
5516492|NCT01513330|19073762|P2|SenSura Mio First,|Withdrawal by Subject|1
5516493|NCT01513330|19073763|P1|SenSura Mio First,|Withdrawal by Subject|1
5516494|NCT01513330|19073762|P2|SenSura Mio First,|Lack of Efficacy|1
5516495|NCT01513330|19073763|P1|SenSura Mio First,|Lack of Efficacy|0
5516496|NCT01513330|19073762|P2|SenSura Mio First,|Adverse Event|0
5516497|NCT01513330|19073763|P1|SenSura Mio First,|Adverse Event|2
5516498|NCT01513317|19073771|P2|Overall Study|Other|1
5516499|NCT01513317|19073772|P1|Overall Study|Other|0
5516500|NCT01513317|19073771|P2|Overall Study|Study terminated by sponsor|18
5516501|NCT01513317|19073772|P1|Overall Study|Study terminated by sponsor|18
5516502|NCT01513317|19073771|P2|Overall Study|Death|1
5516503|NCT01513317|19073772|P1|Overall Study|Death|1
5516504|NCT01513317|19073771|P2|Overall Study|Withdrawal by Subject|4
5516505|NCT01513317|19073772|P1|Overall Study|Withdrawal by Subject|15
5516506|NCT01513291|19073790|P5|Run-out Period|Withdrawal by Subject|0
5516507|NCT01513291|19073791|P4|Run-out Period|Withdrawal by Subject|1
5516508|NCT01513291|19073792|P3|Run-out Period|Withdrawal by Subject|0
5516509|NCT01513291|19073793|P2|Run-out Period|Withdrawal by Subject|0
5516510|NCT01513291|19073794|P1|Run-out Period|Withdrawal by Subject|0
5516511|NCT01513291|19073790|P5|Run-out Period|Lost to Follow-up|0
5516512|NCT01513291|19073791|P4|Run-out Period|Lost to Follow-up|1
5516513|NCT01513291|19073792|P3|Run-out Period|Lost to Follow-up|0
5516514|NCT01513291|19073793|P2|Run-out Period|Lost to Follow-up|0
5516515|NCT01513291|19073794|P1|Run-out Period|Lost to Follow-up|0
5516516|NCT01513291|19073790|P5|Treatment Period|Randomized not treated|0
5516517|NCT01513291|19073791|P4|Treatment Period|Randomized not treated|0
5516518|NCT01513291|19073792|P3|Treatment Period|Randomized not treated|0
5516519|NCT01513291|19073793|P2|Treatment Period|Randomized not treated|2
5516520|NCT01513291|19073794|P1|Treatment Period|Randomized not treated|0
5516521|NCT01513291|19073790|P5|Treatment Period|Withdrawal by Subject|0
5516522|NCT01513291|19073791|P4|Treatment Period|Withdrawal by Subject|0
5516523|NCT01513291|19073792|P3|Treatment Period|Withdrawal by Subject|0
5516524|NCT01513291|19073793|P2|Treatment Period|Withdrawal by Subject|5
5516525|NCT01513291|19073794|P1|Treatment Period|Withdrawal by Subject|8
5516526|NCT01513291|19073790|P5|Treatment Period|Protocol Violation|0
5516527|NCT01513291|19073791|P4|Treatment Period|Protocol Violation|0
5516528|NCT01513291|19073792|P3|Treatment Period|Protocol Violation|0
5516529|NCT01513291|19073793|P2|Treatment Period|Protocol Violation|2
5516530|NCT01513291|19073794|P1|Treatment Period|Protocol Violation|1
5516531|NCT01513291|19073790|P5|Treatment Period|Physician Decision|0
5516532|NCT01513291|19073791|P4|Treatment Period|Physician Decision|0
5516533|NCT01513291|19073792|P3|Treatment Period|Physician Decision|0
5516534|NCT01513291|19073793|P2|Treatment Period|Physician Decision|0
5516535|NCT01513291|19073794|P1|Treatment Period|Physician Decision|1
5516536|NCT01513291|19073790|P5|Treatment Period|Lost to Follow-up|0
5516537|NCT01513291|19073791|P4|Treatment Period|Lost to Follow-up|0
5516538|NCT01513291|19073792|P3|Treatment Period|Lost to Follow-up|0
5516539|NCT01513291|19073793|P2|Treatment Period|Lost to Follow-up|3
5516540|NCT01513291|19073794|P1|Treatment Period|Lost to Follow-up|2
5516541|NCT01513291|19073790|P5|Treatment Period|Lack of Efficacy|0
5516542|NCT01513291|19073791|P4|Treatment Period|Lack of Efficacy|0
5516543|NCT01513291|19073792|P3|Treatment Period|Lack of Efficacy|0
5516544|NCT01513291|19073793|P2|Treatment Period|Lack of Efficacy|0
5516545|NCT01513291|19073794|P1|Treatment Period|Lack of Efficacy|3
5516546|NCT01513291|19073790|P5|Treatment Period|Adverse Event|0
5516547|NCT01513291|19073791|P4|Treatment Period|Adverse Event|0
5516548|NCT01513291|19073792|P3|Treatment Period|Adverse Event|0
5516549|NCT01513291|19073793|P2|Treatment Period|Adverse Event|4
5516550|NCT01513291|19073794|P1|Treatment Period|Adverse Event|8
5516551|NCT01513239|19073822|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
5516552|NCT01513239|19073823|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
5516553|NCT01513239|19073824|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
5516554|NCT01513239|19073825|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
5516555|NCT01513239|19073826|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
5516556|NCT01513239|19073827|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
5516557|NCT01513239|19073822|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
5516558|NCT01513239|19073823|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
5516559|NCT01513239|19073824|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
5516560|NCT01513239|19073825|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
5516561|NCT01513239|19073826|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
5516562|NCT01513239|19073827|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
5516563|NCT01513239|19073822|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5516564|NCT01513239|19073823|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
5516565|NCT01513239|19073824|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
5516566|NCT01513239|19073825|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5516567|NCT01513239|19073826|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5516568|NCT01513239|19073827|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
5516569|NCT01513239|19073822|P6|Period 2: 9 Month Extension Phase|Death|2
5516570|NCT01513239|19073823|P5|Period 2: 9 Month Extension Phase|Death|5
5516571|NCT01513239|19073824|P4|Period 2: 9 Month Extension Phase|Death|2
5516572|NCT01513239|19073825|P3|Period 2: 9 Month Extension Phase|Death|0
5516573|NCT01513239|19073826|P2|Period 2: 9 Month Extension Phase|Death|0
5516574|NCT01513239|19073827|P1|Period 2: 9 Month Extension Phase|Death|0
5516575|NCT01513239|19073822|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
5516576|NCT01513239|19073823|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
5516577|NCT01513239|19073824|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
5516578|NCT01513239|19073825|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
5516579|NCT01513239|19073826|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
5516580|NCT01513239|19073827|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
5516581|NCT01513239|19073822|P6|Period 1: Main Phase|Withdrawal by Subject|0
5516582|NCT01513239|19073823|P5|Period 1: Main Phase|Withdrawal by Subject|0
5516583|NCT01513239|19073824|P4|Period 1: Main Phase|Withdrawal by Subject|0
5516584|NCT01513239|19073825|P3|Period 1: Main Phase|Withdrawal by Subject|42
5516585|NCT01513239|19073826|P2|Period 1: Main Phase|Withdrawal by Subject|29
5516586|NCT01513239|19073827|P1|Period 1: Main Phase|Withdrawal by Subject|27
5516587|NCT01513239|19073822|P6|Period 1: Main Phase|Technical Problems|0
5516588|NCT01513239|19073823|P5|Period 1: Main Phase|Technical Problems|0
5516589|NCT01513239|19073824|P4|Period 1: Main Phase|Technical Problems|0
5516590|NCT01513239|19073825|P3|Period 1: Main Phase|Technical Problems|0
5516591|NCT01513239|19073826|P2|Period 1: Main Phase|Technical Problems|2
5516592|NCT01513239|19073827|P1|Period 1: Main Phase|Technical Problems|1
5516593|NCT01513239|19073822|P6|Period 1: Main Phase|Protocol Violation|0
5516594|NCT01513239|19073823|P5|Period 1: Main Phase|Protocol Violation|0
5516595|NCT01513239|19073824|P4|Period 1: Main Phase|Protocol Violation|0
5516596|NCT01513239|19073825|P3|Period 1: Main Phase|Protocol Violation|2
5516597|NCT01513239|19073826|P2|Period 1: Main Phase|Protocol Violation|2
5516598|NCT01513239|19073827|P1|Period 1: Main Phase|Protocol Violation|2
5516599|NCT01513239|19073822|P6|Period 1: Main Phase|Physician Decision|0
5516600|NCT01513239|19073823|P5|Period 1: Main Phase|Physician Decision|0
5516601|NCT01513239|19073824|P4|Period 1: Main Phase|Physician Decision|0
5516602|NCT01513239|19073825|P3|Period 1: Main Phase|Physician Decision|4
5516603|NCT01513239|19073826|P2|Period 1: Main Phase|Physician Decision|4
5516604|NCT01513239|19073827|P1|Period 1: Main Phase|Physician Decision|4
5516605|NCT01513239|19073822|P6|Period 1: Main Phase|Lost to Follow-up|0
5516606|NCT01513239|19073823|P5|Period 1: Main Phase|Lost to Follow-up|0
5516607|NCT01513239|19073824|P4|Period 1: Main Phase|Lost to Follow-up|0
5516608|NCT01513239|19073825|P3|Period 1: Main Phase|Lost to Follow-up|6
5516609|NCT01513239|19073826|P2|Period 1: Main Phase|Lost to Follow-up|10
5516610|NCT01513239|19073827|P1|Period 1: Main Phase|Lost to Follow-up|11
5516611|NCT01513239|19073822|P6|Period 1: Main Phase|Death|0
5516612|NCT01513239|19073823|P5|Period 1: Main Phase|Death|0
5516613|NCT01513239|19073824|P4|Period 1: Main Phase|Death|0
5516614|NCT01513239|19073825|P3|Period 1: Main Phase|Death|32
5516615|NCT01513239|19073826|P2|Period 1: Main Phase|Death|22
5516616|NCT01513239|19073827|P1|Period 1: Main Phase|Death|29
5516617|NCT01513239|19073822|P6|Period 1: Main Phase|Adverse Event|0
5516618|NCT01513239|19073823|P5|Period 1: Main Phase|Adverse Event|0
5516619|NCT01513239|19073824|P4|Period 1: Main Phase|Adverse Event|0
5516620|NCT01513239|19073825|P3|Period 1: Main Phase|Adverse Event|2
5516621|NCT01513239|19073826|P2|Period 1: Main Phase|Adverse Event|1
5516622|NCT01513239|19073827|P1|Period 1: Main Phase|Adverse Event|1
5516623|NCT01513148|19073880|P2|Overall Study|Protocol Violation|2
5516624|NCT01513148|19073881|P1|Overall Study|Protocol Violation|2
5516625|NCT01512979|19073948|P2|Overall Study|Reason other than stated above|9
5516626|NCT01512979|19073949|P1|Overall Study|Reason other than stated above|13
5516627|NCT01512979|19073948|P2|Overall Study|Withdrawal by Subject|2
5516628|NCT01512979|19073949|P1|Overall Study|Withdrawal by Subject|1
5516629|NCT01512979|19073948|P2|Overall Study|Lost to Follow-up|5
5516630|NCT01512979|19073949|P1|Overall Study|Lost to Follow-up|2
5516631|NCT01512979|19073948|P2|Overall Study|Protocol Violation|4
5516632|NCT01512979|19073949|P1|Overall Study|Protocol Violation|1
5516633|NCT01512979|19073948|P2|Overall Study|Adverse Event|2
5516634|NCT01512979|19073949|P1|Overall Study|Adverse Event|2
5516635|NCT01512745|19074049|P2|Overall Study|Protocol Violation|0
5516636|NCT01512745|19074050|P1|Overall Study|Protocol Violation|1
5516637|NCT01512745|19074049|P2|Overall Study|Lack of Efficacy|2
5516638|NCT01512745|19074050|P1|Overall Study|Lack of Efficacy|2
5516639|NCT01512745|19074049|P2|Overall Study|Lost to Follow-up|0
5516640|NCT01512745|19074050|P1|Overall Study|Lost to Follow-up|4
5516641|NCT01512745|19074049|P2|Overall Study|Withdrawal by Subject|2
5516642|NCT01512745|19074050|P1|Overall Study|Withdrawal by Subject|2
5516643|NCT01512745|19074049|P2|Overall Study|Death|13
5516644|NCT01512745|19074050|P1|Overall Study|Death|9
5516645|NCT01512745|19074049|P2|Overall Study|Adverse Event|3
5516646|NCT01512745|19074050|P1|Overall Study|Adverse Event|22
5516647|NCT01512693|19074066|P2|Overall Study|Withdrawal by Subject|1
5516648|NCT01512693|19074067|P1|Overall Study|Withdrawal by Subject|0
5516649|NCT01512368|19074107|P1|Overall Study|Protocol Violation|3
5516650|NCT01512264|19074120|P4|Overall Study|Lost to Follow-up|1
5516651|NCT01512264|19074121|P3|Overall Study|Lost to Follow-up|0
5516652|NCT01512264|19074122|P2|Overall Study|Lost to Follow-up|0
5516653|NCT01512264|19074123|P1|Overall Study|Lost to Follow-up|0
5516654|NCT01512160|19074262|P4|Overall Study|Withdrawal by Subject|1
5516655|NCT01512160|19074263|P3|Overall Study|Withdrawal by Subject|0
5516656|NCT01512160|19074264|P2|Overall Study|Withdrawal by Subject|0
5516657|NCT01512160|19074265|P1|Overall Study|Withdrawal by Subject|1
5516658|NCT01512160|19074262|P4|Overall Study|Lost to Follow-up|0
5516659|NCT01512160|19074263|P3|Overall Study|Lost to Follow-up|0
5516660|NCT01512160|19074264|P2|Overall Study|Lost to Follow-up|0
5516661|NCT01512160|19074265|P1|Overall Study|Lost to Follow-up|1
5516662|NCT01512108|19074357|P2|Overall Study|Unclassified|3
5516663|NCT01512108|19074358|P1|Overall Study|Unclassified|11
5516664|NCT01512108|19074357|P2|Overall Study|Withdrawal Criteria|0
5516665|NCT01512108|19074358|P1|Overall Study|Withdrawal Criteria|1
5516666|NCT01512108|19074357|P2|Overall Study|Protocol Violation|2
5516667|NCT01512108|19074358|P1|Overall Study|Protocol Violation|1
5516668|NCT01512108|19074357|P2|Overall Study|Adverse Event|4
5516669|NCT01512108|19074358|P1|Overall Study|Adverse Event|9
5516670|NCT01511939|19074384|P3|Overall Study|Withdrawal by Subject|0
5516671|NCT01511939|19074385|P2|Overall Study|Withdrawal by Subject|1
5516672|NCT01511939|19074386|P1|Overall Study|Withdrawal by Subject|2
5516673|NCT01511536|19074415|P3|Phase 2|Other|9
5516674|NCT01511536|19074416|P2|Phase 2|Other|0
5516675|NCT01511536|19074417|P1|Phase 2|Other|0
5516676|NCT01511536|19074415|P3|Phase 1|Other|0
5516677|NCT01511536|19074416|P2|Phase 1|Other|1
5516678|NCT01511536|19074417|P1|Phase 1|Other|0
5516679|NCT01511445|19074439|P2|Overall Study|Protocol Violation|0
5516680|NCT01511445|19074440|P1|Overall Study|Protocol Violation|1
5516681|NCT01511445|19074439|P2|Overall Study|Protocol Violation|3
5516682|NCT01511445|19074440|P1|Overall Study|Protocol Violation|1
5516683|NCT01511445|19074439|P2|Overall Study|Lost to Follow-up|1
5516684|NCT01511445|19074440|P1|Overall Study|Lost to Follow-up|3
5516685|NCT01511419|19074450|P2|Dose 2|Physician Decision|0
5516686|NCT01511419|19074451|P1|Dose 2|Physician Decision|1
5516687|NCT01511250|19074563|P10|Overall Study|Protocol Violation|0
5516688|NCT01511250|19074564|P9|Overall Study|Protocol Violation|0
5516689|NCT01511250|19074565|P8|Overall Study|Protocol Violation|0
5516690|NCT01511250|19074566|P7|Overall Study|Protocol Violation|0
5516691|NCT01511250|19074567|P6|Overall Study|Protocol Violation|0
5516692|NCT01511250|19074568|P5|Overall Study|Protocol Violation|0
5516693|NCT01511250|19074569|P4|Overall Study|Protocol Violation|0
5516694|NCT01511250|19074570|P3|Overall Study|Protocol Violation|1
5516695|NCT01511250|19074571|P2|Overall Study|Protocol Violation|2
5516696|NCT01511250|19074572|P1|Overall Study|Protocol Violation|0
5516697|NCT01511250|19074563|P10|Overall Study|Lost to Follow-up|5
5516698|NCT01511250|19074564|P9|Overall Study|Lost to Follow-up|13
5516699|NCT01511250|19074565|P8|Overall Study|Lost to Follow-up|3
5516700|NCT01511250|19074566|P7|Overall Study|Lost to Follow-up|2
5516701|NCT01511250|19074567|P6|Overall Study|Lost to Follow-up|0
5516702|NCT01511250|19074568|P5|Overall Study|Lost to Follow-up|0
5516703|NCT01511250|19074569|P4|Overall Study|Lost to Follow-up|3
5516704|NCT01511250|19074570|P3|Overall Study|Lost to Follow-up|3
5516705|NCT01511250|19074571|P2|Overall Study|Lost to Follow-up|3
5516706|NCT01511250|19074572|P1|Overall Study|Lost to Follow-up|7
5516707|NCT01511250|19074563|P10|Overall Study|Sponsor/Investigator Decision|0
5516708|NCT01511250|19074564|P9|Overall Study|Sponsor/Investigator Decision|0
5516709|NCT01511250|19074565|P8|Overall Study|Sponsor/Investigator Decision|0
5516710|NCT01511250|19074566|P7|Overall Study|Sponsor/Investigator Decision|0
5516711|NCT01511250|19074567|P6|Overall Study|Sponsor/Investigator Decision|0
5516712|NCT01511250|19074568|P5|Overall Study|Sponsor/Investigator Decision|0
5516713|NCT01511250|19074569|P4|Overall Study|Sponsor/Investigator Decision|0
5516714|NCT01511250|19074570|P3|Overall Study|Sponsor/Investigator Decision|0
5516715|NCT01511250|19074571|P2|Overall Study|Sponsor/Investigator Decision|0
5516716|NCT01511250|19074572|P1|Overall Study|Sponsor/Investigator Decision|1
5516717|NCT01511250|19074563|P10|Overall Study|Withdrawal of Consent|0
5516718|NCT01511250|19074564|P9|Overall Study|Withdrawal of Consent|1
5516719|NCT01511250|19074565|P8|Overall Study|Withdrawal of Consent|1
5516720|NCT01511250|19074566|P7|Overall Study|Withdrawal of Consent|0
5516721|NCT01511250|19074567|P6|Overall Study|Withdrawal of Consent|0
5516722|NCT01511250|19074568|P5|Overall Study|Withdrawal of Consent|0
5516723|NCT01511250|19074569|P4|Overall Study|Withdrawal of Consent|0
5516724|NCT01511250|19074570|P3|Overall Study|Withdrawal of Consent|0
5516725|NCT01511250|19074571|P2|Overall Study|Withdrawal of Consent|0
5516726|NCT01511250|19074572|P1|Overall Study|Withdrawal of Consent|1
5516727|NCT01511107|19074720|P2|Overall Study|Withdrawal by Subject|20
5516728|NCT01511107|19074721|P1|Overall Study|Withdrawal by Subject|9
5516729|NCT01511107|19074720|P2|Overall Study|Lost to Follow-up|19
5516730|NCT01511107|19074721|P1|Overall Study|Lost to Follow-up|10
5516731|NCT01511107|19074720|P2|Overall Study|Ineligible|2
5516732|NCT01511107|19074721|P1|Overall Study|Ineligible|3
5516733|NCT01511055|19074793|P1|Overall Study|Withdrawal by Subject|6
5516734|NCT01510912|19074817|P1|Overall Study|Other, including joint replacement|5
5516735|NCT01510912|19074817|P1|Overall Study|Lost to Follow-up|26
5516736|NCT01510912|19074817|P1|Overall Study|Protocol Violation|27
5516737|NCT01510912|19074817|P1|Overall Study|Physician Decision|1
5516738|NCT01510912|19074817|P1|Overall Study|Withdrawal by Subject|49
5516739|NCT01510912|19074817|P1|Overall Study|Non-compliance with trial drug|23
5516740|NCT01510912|19074817|P1|Overall Study|Lack of Efficacy|12
5516741|NCT01510912|19074817|P1|Overall Study|Adverse Event|99
5516742|NCT01510769|19074833|P3|Overall Study|Death|0
5516743|NCT01510769|19074834|P2|Overall Study|Death|1
5516744|NCT01510769|19074835|P1|Overall Study|Death|1
5516745|NCT01510769|19074833|P3|Overall Study|Withdrawal by Subject|3
5516746|NCT01510769|19074834|P2|Overall Study|Withdrawal by Subject|4
5516747|NCT01510769|19074835|P1|Overall Study|Withdrawal by Subject|3
5516748|NCT01510769|19074833|P3|Overall Study|Lost to Follow-up|5
5516749|NCT01510769|19074834|P2|Overall Study|Lost to Follow-up|1
5516750|NCT01510769|19074835|P1|Overall Study|Lost to Follow-up|5
5516751|NCT01510769|19074833|P3|Overall Study|Protocol Violation|9
5516752|NCT01510769|19074834|P2|Overall Study|Protocol Violation|10
5516753|NCT01510769|19074835|P1|Overall Study|Protocol Violation|11
5516754|NCT01510769|19074833|P3|Overall Study|Gout Flare|1
5516755|NCT01510769|19074834|P2|Overall Study|Gout Flare|3
5516756|NCT01510769|19074835|P1|Overall Study|Gout Flare|0
5516757|NCT01510769|19074833|P3|Overall Study|Adverse Event|4
5516758|NCT01510769|19074834|P2|Overall Study|Adverse Event|6
5516759|NCT01510769|19074835|P1|Overall Study|Adverse Event|7
5516760|NCT01510756|19074852|P1|Overall Study|Physician Decision|1
5516761|NCT01510756|19074852|P1|Overall Study|Lack of Efficacy|2
5516762|NCT01510756|19074852|P1|Overall Study|Death|1
5516763|NCT01510717|19074860|P2|Overall Study|Withdrawal by Subject|2
5516764|NCT01510717|19074861|P1|Overall Study|Withdrawal by Subject|0
5516765|NCT01510717|19074860|P2|Overall Study|Lost to Follow-up|1
5516766|NCT01510717|19074861|P1|Overall Study|Lost to Follow-up|0
5516767|NCT01510717|19074860|P2|Overall Study|Death|0
5516768|NCT01510717|19074861|P1|Overall Study|Death|1
5516769|NCT01510717|19074860|P2|Overall Study|Adverse Event|2
5516770|NCT01510717|19074861|P1|Overall Study|Adverse Event|1
5516771|NCT01510158|19074981|P3|Overall Study|Death|0
5516772|NCT01510158|19074982|P2|Overall Study|Death|0
5516773|NCT01510158|19074983|P1|Overall Study|Death|1
5516774|NCT01510158|19074981|P3|Overall Study|Withdrawal by Subject|10
5516775|NCT01510158|19074982|P2|Overall Study|Withdrawal by Subject|13
5516776|NCT01510158|19074983|P1|Overall Study|Withdrawal by Subject|10
5516777|NCT01510158|19074981|P3|Overall Study|Lost to Follow-up|9
5516778|NCT01510158|19074982|P2|Overall Study|Lost to Follow-up|16
5516779|NCT01510158|19074983|P1|Overall Study|Lost to Follow-up|13
5516780|NCT01510158|19074981|P3|Overall Study|Sponsor terminated study.|2
5516781|NCT01510158|19074982|P2|Overall Study|Sponsor terminated study.|0
5516782|NCT01510158|19074983|P1|Overall Study|Sponsor terminated study.|2
5516783|NCT01510158|19074981|P3|Overall Study|Protocol Violation|24
5516784|NCT01510158|19074982|P2|Overall Study|Protocol Violation|16
5516785|NCT01510158|19074983|P1|Overall Study|Protocol Violation|17
5516786|NCT01510158|19074981|P3|Overall Study|Gout flare|0
5516787|NCT01510158|19074982|P2|Overall Study|Gout flare|0
5516788|NCT01510158|19074983|P1|Overall Study|Gout flare|1
5516789|NCT01510158|19074981|P3|Overall Study|Adverse Event|5
5516790|NCT01510158|19074982|P2|Overall Study|Adverse Event|8
5516791|NCT01510158|19074983|P1|Overall Study|Adverse Event|7
5516792|NCT01510145|19074997|P1|Overall Study|Relative reported subject withdrew|1
5516793|NCT01510145|19074997|P1|Overall Study|Withdrawal by Subject|6
5516794|NCT01510145|19074997|P1|Overall Study|Lost to Follow-up|5
5516795|NCT01510145|19074997|P1|Overall Study|Adverse Event|6
5516796|NCT01510028|19075006|P4|Overall Study|Lack of Efficacy|0
5516797|NCT01510028|19075007|P3|Overall Study|Lack of Efficacy|0
5516798|NCT01510028|19075008|P2|Overall Study|Lack of Efficacy|0
5516799|NCT01510028|19075009|P1|Overall Study|Lack of Efficacy|1
5516800|NCT01509664|19075270|P2|Overall Study|Lost to Follow-up|21
5516801|NCT01509664|19075271|P1|Overall Study|Lost to Follow-up|15
5516802|NCT01509547|19075347|P2|Overall Study|Physician Decision|1
5516803|NCT01509547|19075348|P1|Overall Study|Physician Decision|0
5516804|NCT01509547|19075347|P2|Overall Study|Withdrawal by Subject|24
5516805|NCT01509547|19075348|P1|Overall Study|Withdrawal by Subject|11
5516806|NCT01509547|19075347|P2|Overall Study|Lost to Follow-up|14
5516807|NCT01509547|19075348|P1|Overall Study|Lost to Follow-up|24
5516808|NCT01509079|19075415|P2|Overall Study|started an excluded medication|1
5516809|NCT01509079|19075416|P1|Overall Study|started an excluded medication|0
5516810|NCT01509079|19075415|P2|Overall Study|Lack of Efficacy|2
5516811|NCT01509079|19075416|P1|Overall Study|Lack of Efficacy|0
5516812|NCT01509053|19075436|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
5516813|NCT01509053|19075436|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
5516814|NCT01509053|19075436|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
5516815|NCT01509053|19075436|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
5516816|NCT01509053|19075436|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
5516817|NCT01509053|19075436|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
5516818|NCT01508936|19075498|P2|Overall Study|Data from 2 sites deemed invalid|11
5516819|NCT01508936|19075499|P1|Overall Study|Data from 2 sites deemed invalid|4
5516820|NCT01508936|19075498|P2|Overall Study|Other|5
5516821|NCT01508936|19075499|P1|Overall Study|Other|0
5516822|NCT01508936|19075498|P2|Overall Study|Lost to Follow-up|9
5516823|NCT01508936|19075499|P1|Overall Study|Lost to Follow-up|2
5516824|NCT01508936|19075498|P2|Overall Study|Protocol Violation|3
5516825|NCT01508936|19075499|P1|Overall Study|Protocol Violation|2
5516826|NCT01508936|19075498|P2|Overall Study|Withdrawal by Subject|18
5516827|NCT01508936|19075499|P1|Overall Study|Withdrawal by Subject|4
5516828|NCT01508936|19075498|P2|Overall Study|Lack of Efficacy|1
5516829|NCT01508936|19075499|P1|Overall Study|Lack of Efficacy|0
5516830|NCT01508936|19075498|P2|Overall Study|Adverse Event|32
5516831|NCT01508936|19075499|P1|Overall Study|Adverse Event|11
5516832|NCT01508910|19075538|P4|Treatment|Sponsor Decision|1
5516833|NCT01508910|19075539|P3|Treatment|Sponsor Decision|0
5516834|NCT01508910|19075540|P2|Treatment|Sponsor Decision|0
5516835|NCT01508910|19075541|P1|Treatment|Sponsor Decision|0
5516836|NCT01508910|19075538|P4|Treatment|Withdrawal by Subject|1
5516837|NCT01508910|19075539|P3|Treatment|Withdrawal by Subject|6
5516838|NCT01508910|19075540|P2|Treatment|Withdrawal by Subject|1
5516839|NCT01508910|19075541|P1|Treatment|Withdrawal by Subject|0
5516840|NCT01508910|19075538|P4|Treatment|Lost to Follow-up|1
5516841|NCT01508910|19075539|P3|Treatment|Lost to Follow-up|2
5516842|NCT01508910|19075540|P2|Treatment|Lost to Follow-up|0
5516843|NCT01508910|19075541|P1|Treatment|Lost to Follow-up|0
5516844|NCT01508910|19075538|P4|Treatment|Death|0
5516845|NCT01508910|19075539|P3|Treatment|Death|2
5516846|NCT01508910|19075540|P2|Treatment|Death|3
5516847|NCT01508910|19075541|P1|Treatment|Death|2
5516848|NCT01508702|19075574|P2|Overall Study|Withdrawal by Subject|7
5516849|NCT01508702|19075575|P1|Overall Study|Withdrawal by Subject|11
5516850|NCT01508702|19075574|P2|Overall Study|Lost to Follow-up|2
5516851|NCT01508702|19075575|P1|Overall Study|Lost to Follow-up|1
5516852|NCT01508702|19075574|P2|Overall Study|Protocol Violation|1
5516853|NCT01508702|19075575|P1|Overall Study|Protocol Violation|2
5516854|NCT01508702|19075574|P2|Overall Study|Gout flare|0
5516855|NCT01508702|19075575|P1|Overall Study|Gout flare|2
5516856|NCT01508702|19075574|P2|Overall Study|Adverse Event|3
5516857|NCT01508702|19075575|P1|Overall Study|Adverse Event|7
5516858|NCT01508676|19075583|P2|Phase II (2 Weeks)|Medication Exclusion|0
5516859|NCT01508676|19075584|P1|Phase II (2 Weeks)|Medication Exclusion|1
5516860|NCT01508676|19075583|P2|Phase II (2 Weeks)|Skin Sensitivity|1
5516861|NCT01508676|19075584|P1|Phase II (2 Weeks)|Skin Sensitivity|0
5516862|NCT01508676|19075583|P2|Phase I (2 Weeks)|Positive Drug Screen|2
5516863|NCT01508676|19075584|P1|Phase I (2 Weeks)|Positive Drug Screen|0
5516864|NCT01508676|19075583|P2|Phase I (2 Weeks)|Wrong Pain Type|0
5516865|NCT01508676|19075584|P1|Phase I (2 Weeks)|Wrong Pain Type|1
5516866|NCT01508676|19075583|P2|Phase I (2 Weeks)|Medication Exclusion|1
5516867|NCT01508676|19075584|P1|Phase I (2 Weeks)|Medication Exclusion|1
5516868|NCT01508650|19075596|P2|Overall Study|Lost to Follow-up|3
5516869|NCT01508650|19075597|P1|Overall Study|Lost to Follow-up|0
5516870|NCT01508325|19075616|P2|Overall Study|Other|2
5516871|NCT01508325|19075617|P1|Overall Study|Other|2
5516872|NCT01508325|19075616|P2|Overall Study|Lost to Follow-up|6
5516873|NCT01508325|19075617|P1|Overall Study|Lost to Follow-up|5
5516874|NCT01508325|19075616|P2|Overall Study|Adverse Event|0
5516875|NCT01508325|19075617|P1|Overall Study|Adverse Event|1
5516876|NCT01508325|19075616|P2|Overall Study|Physician Decision|1
5516877|NCT01508325|19075617|P1|Overall Study|Physician Decision|2
5516878|NCT01508325|19075616|P2|Overall Study|Protocol Violation|3
5516879|NCT01508325|19075617|P1|Overall Study|Protocol Violation|0
5516880|NCT01508325|19075616|P2|Overall Study|Withdrawal by Subject|9
5516881|NCT01508325|19075617|P1|Overall Study|Withdrawal by Subject|8
5516882|NCT01508169|19075647|P2|Overall Study|Lost to Follow-up|2
5516883|NCT01508169|19075648|P1|Overall Study|Lost to Follow-up|1
5516884|NCT01508169|19075647|P2|Overall Study|Withdrawal by Subject|0
5516885|NCT01508169|19075648|P1|Overall Study|Withdrawal by Subject|1
5516886|NCT01508169|19075647|P2|Overall Study|Adverse Event|0
5516887|NCT01508169|19075648|P1|Overall Study|Adverse Event|1
5516888|NCT01508130|19075662|P2|Overall Study|Administrative|3
5516889|NCT01508130|19075663|P1|Overall Study|Administrative|14
5516890|NCT01508130|19075662|P2|Overall Study|Insufficient therapeutic response|23
5516891|NCT01508130|19075663|P1|Overall Study|Insufficient therapeutic response|74
5516892|NCT01508130|19075662|P2|Overall Study|Subject's substantial non-compliance|9
5516893|NCT01508130|19075663|P1|Overall Study|Subject's substantial non-compliance|25
5516894|NCT01508130|19075662|P2|Overall Study|Withdrawal by Subject|3
5516895|NCT01508130|19075663|P1|Overall Study|Withdrawal by Subject|3
5516896|NCT01508130|19075662|P2|Overall Study|Lost to Follow-up|2
5516897|NCT01508130|19075663|P1|Overall Study|Lost to Follow-up|25
5516898|NCT01508130|19075662|P2|Overall Study|Protocol Violation|0
5516899|NCT01508130|19075663|P1|Overall Study|Protocol Violation|2
5516900|NCT01508130|19075662|P2|Overall Study|Death|1
5516901|NCT01508130|19075663|P1|Overall Study|Death|3
5516902|NCT01508130|19075662|P2|Overall Study|Adverse Event|28
5516903|NCT01508130|19075663|P1|Overall Study|Adverse Event|81
5516904|NCT01507896|19075731|P1|Overall Study|The surgery was denied by the sponsor.|1
5516905|NCT01507896|19075731|P1|Overall Study|Withdrawal by Subject|1
5516906|NCT01507831|19075774|P2|Overall Study|Other|6
5516907|NCT01507831|19075775|P1|Overall Study|Other|3
5516908|NCT01507831|19075774|P2|Overall Study|Potential lost to follow-up|0
5516909|NCT01507831|19075775|P1|Overall Study|Potential lost to follow-up|3
5516910|NCT01507831|19075774|P2|Overall Study|Site closure|3
5516911|NCT01507831|19075775|P1|Overall Study|Site closure|0
5516912|NCT01507831|19075774|P2|Overall Study|Selection criteria finally not met|1
5516913|NCT01507831|19075775|P1|Overall Study|Selection criteria finally not met|0
5516914|NCT01507831|19075774|P2|Overall Study|Last visit outside protocol visit window|143
5516915|NCT01507831|19075775|P1|Overall Study|Last visit outside protocol visit window|51
5516916|NCT01507831|19075774|P2|Overall Study|Related to study drug administration|14
5516917|NCT01507831|19075775|P1|Overall Study|Related to study drug administration|5
5516918|NCT01507831|19075774|P2|Overall Study|Consent withdrawn by participant|72
5516919|NCT01507831|19075775|P1|Overall Study|Consent withdrawn by participant|34
5516920|NCT01507831|19075774|P2|Overall Study|Participant moved|19
5516921|NCT01507831|19075775|P1|Overall Study|Participant moved|5
5516922|NCT01507831|19075774|P2|Overall Study|Physician Decision|4
5516923|NCT01507831|19075775|P1|Overall Study|Physician Decision|0
5516924|NCT01507831|19075774|P2|Overall Study|Poor compliance to protocol|60
5516925|NCT01507831|19075775|P1|Overall Study|Poor compliance to protocol|38
5516926|NCT01507831|19075774|P2|Overall Study|Death|2
5516927|NCT01507831|19075775|P1|Overall Study|Death|6
5516928|NCT01507831|19075774|P2|Overall Study|Adverse Event|113
5516929|NCT01507831|19075775|P1|Overall Study|Adverse Event|48
5516930|NCT01507831|19075774|P2|Overall Study|Randomized but not treated|3
5516931|NCT01507831|19075775|P1|Overall Study|Randomized but not treated|0
5516932|NCT01507662|19075895|P2|Overall Study|Proxy interview done|3
5516933|NCT01507662|19075896|P1|Overall Study|Proxy interview done|2
5516934|NCT01507662|19075895|P2|Overall Study|Lost to Follow-up|523
5516935|NCT01507662|19075896|P1|Overall Study|Lost to Follow-up|498
5516936|NCT01507662|19075895|P2|Overall Study|Withdrawal by Subject|287
5516937|NCT01507662|19075896|P1|Overall Study|Withdrawal by Subject|290
5516938|NCT01507662|19075895|P2|Overall Study|Death|18
5516939|NCT01507662|19075896|P1|Overall Study|Death|26
5516940|NCT01507298|19075931|P2|Overall Study|Protocol Violation|6
5516941|NCT01507298|19075932|P1|Overall Study|Protocol Violation|0
5516942|NCT01507246|19075942|P2|Overall Study|Required different surgical procedures|1
5516943|NCT01507246|19075943|P1|Overall Study|Required different surgical procedures|2
5516944|NCT01507090|19076041|P1|Overall Study|incomplete dataset|18
5516945|NCT01507051|19076080|P4|Overall Study|Adverse Event|0
5516946|NCT01507051|19076081|P3|Overall Study|Adverse Event|0
5516947|NCT01507051|19076082|P2|Overall Study|Adverse Event|0
5516948|NCT01507051|19076083|P1|Overall Study|Adverse Event|1
5516949|NCT01507051|19076080|P4|Overall Study|Physician Decision|1
5516950|NCT01507051|19076081|P3|Overall Study|Physician Decision|0
5516951|NCT01507051|19076082|P2|Overall Study|Physician Decision|0
5516952|NCT01507051|19076083|P1|Overall Study|Physician Decision|0
5516953|NCT01507051|19076080|P4|Overall Study|Withdrawal by Subject|6
5516954|NCT01507051|19076081|P3|Overall Study|Withdrawal by Subject|1
5516955|NCT01507051|19076082|P2|Overall Study|Withdrawal by Subject|3
5516956|NCT01507051|19076083|P1|Overall Study|Withdrawal by Subject|1
5516957|NCT01506960|19076201|P1|Overall Study|Did not meet angiographic criteria|47
5516958|NCT01506947|19076207|P1|Overall Study|Did Not Meet Eligibility Criteria|3
5516959|NCT01506947|19076207|P1|Overall Study|Death|1
5516960|NCT01506947|19076207|P1|Overall Study|Adverse Event|5
5516961|NCT01506947|19076207|P1|Overall Study|Lost to Follow-up|7
5516962|NCT01506908|19076225|P2|Overall Study|Adverse Event|0
5516963|NCT01506908|19076226|P1|Overall Study|Adverse Event|1
5516964|NCT01506882|19076244|P2|Overall Study|Other Reason|0
5516965|NCT01506882|19076245|P1|Overall Study|Other Reason|2
5516966|NCT01506882|19076244|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5516967|NCT01506882|19076245|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
5516968|NCT01506882|19076244|P2|Overall Study|AE, non-serious non-fatal|1
5516969|NCT01506882|19076245|P1|Overall Study|AE, non-serious non-fatal|3
5516970|NCT01506882|19076244|P2|Overall Study|SAE, non-fatal|0
5516971|NCT01506882|19076245|P1|Overall Study|SAE, non-fatal|2
5516972|NCT01506882|19076244|P2|Overall Study|Withdrawal by Subject|3
5516973|NCT01506882|19076245|P1|Overall Study|Withdrawal by Subject|9
5516974|NCT01506882|19076244|P2|Overall Study|Lost to Follow-up|0
5516975|NCT01506882|19076245|P1|Overall Study|Lost to Follow-up|1
5516976|NCT01506882|19076244|P2|Overall Study|Lack of Efficacy|3
5516977|NCT01506882|19076245|P1|Overall Study|Lack of Efficacy|4
5516978|NCT01506726|19076259|P2|Overall Study|Adverse Event|2
5516979|NCT01506726|19076260|P1|Overall Study|Adverse Event|1
5516980|NCT01506596|19076300|P1|Overall Study|ineligible pathology|1
5516981|NCT01506479|19076311|P3|Overall Study|Adverse Event|0
5516982|NCT01506479|19076312|P2|Overall Study|Adverse Event|1
5516983|NCT01506479|19076313|P1|Overall Study|Adverse Event|0
5516984|NCT01506479|19076311|P3|Overall Study|Missing assessment|0
5516985|NCT01506479|19076312|P2|Overall Study|Missing assessment|0
5516986|NCT01506479|19076313|P1|Overall Study|Missing assessment|1
5516987|NCT01506479|19076311|P3|Overall Study|Withdrawal by Subject|1
5516988|NCT01506479|19076312|P2|Overall Study|Withdrawal by Subject|2
5516989|NCT01506479|19076313|P1|Overall Study|Withdrawal by Subject|1
5516990|NCT01506479|19076311|P3|Overall Study|Lost to Follow-up|2
5516991|NCT01506479|19076312|P2|Overall Study|Lost to Follow-up|2
5516992|NCT01506479|19076313|P1|Overall Study|Lost to Follow-up|1
5516993|NCT01506453|19076327|P2|Overall Study|Withdrawal prior to treatment|2
5516994|NCT01506453|19076328|P1|Overall Study|Withdrawal prior to treatment|0
5516995|NCT01506323|19076344|P2|Overall Study|Started another treatment|0
5516996|NCT01506323|19076345|P1|Overall Study|Started another treatment|1
5516997|NCT01506323|19076344|P2|Overall Study|Schedule or Transportation conflict|0
5516998|NCT01506323|19076345|P1|Overall Study|Schedule or Transportation conflict|8
5516999|NCT01506323|19076344|P2|Overall Study|Moved out of area|2
5517000|NCT01506323|19076345|P1|Overall Study|Moved out of area|5
5517001|NCT01506323|19076344|P2|Overall Study|Lack of Efficacy|3
5517002|NCT01506323|19076345|P1|Overall Study|Lack of Efficacy|1
5517003|NCT01506323|19076344|P2|Overall Study|Withdrawal by Subject|4
5517004|NCT01506323|19076345|P1|Overall Study|Withdrawal by Subject|4
5517005|NCT01506323|19076344|P2|Overall Study|Lost to Follow-up|4
5517006|NCT01506323|19076345|P1|Overall Study|Lost to Follow-up|5
5517007|NCT01506271|19076374|P3|Overall Study|Lost to Follow-up|2
5517008|NCT01506271|19076375|P2|Overall Study|Lost to Follow-up|1
5517009|NCT01506271|19076376|P1|Overall Study|Lost to Follow-up|0
5517010|NCT01506271|19076374|P3|Overall Study|Withdrawal by Subject|1
5517011|NCT01506271|19076375|P2|Overall Study|Withdrawal by Subject|1
5517012|NCT01506271|19076376|P1|Overall Study|Withdrawal by Subject|0
5517013|NCT01506271|19076374|P3|Overall Study|Insufficient supply of study drug|0
5517014|NCT01506271|19076375|P2|Overall Study|Insufficient supply of study drug|0
5517015|NCT01506271|19076376|P1|Overall Study|Insufficient supply of study drug|1
5517016|NCT01506271|19076374|P3|Overall Study|Adverse Event|0
5517017|NCT01506271|19076375|P2|Overall Study|Adverse Event|2
5517018|NCT01506271|19076376|P1|Overall Study|Adverse Event|0
5517019|NCT01506271|19076374|P3|Overall Study|Death|0
5517020|NCT01506271|19076375|P2|Overall Study|Death|1
5517021|NCT01506271|19076376|P1|Overall Study|Death|0
5517022|NCT01506271|19076374|P3|Overall Study|Protocol Violation|0
5517023|NCT01506271|19076375|P2|Overall Study|Protocol Violation|1
5517024|NCT01506271|19076376|P1|Overall Study|Protocol Violation|3
5517025|NCT01506271|19076374|P3|Overall Study|Progressive disease|0
5517026|NCT01506271|19076375|P2|Overall Study|Progressive disease|1
5517027|NCT01506271|19076376|P1|Overall Study|Progressive disease|0
5517028|NCT01506193|19076438|P3|Overall Study|Lost to Follow-up|3
5517029|NCT01506193|19076439|P2|Overall Study|Lost to Follow-up|3
5517030|NCT01506193|19076440|P1|Overall Study|Lost to Follow-up|8
5517031|NCT01506193|19076438|P3|Overall Study|Withdrawal by Subject|8
5517032|NCT01506193|19076439|P2|Overall Study|Withdrawal by Subject|1
5517033|NCT01506193|19076440|P1|Overall Study|Withdrawal by Subject|5
5517034|NCT01506193|19076438|P3|Overall Study|Adverse event, non-fatal|1
5517035|NCT01506193|19076439|P2|Overall Study|Adverse event, non-fatal|0
5517036|NCT01506193|19076440|P1|Overall Study|Adverse event, non-fatal|0
5517037|NCT01506193|19076438|P3|Overall Study|Migrated/moved from study area|1
5517038|NCT01506193|19076439|P2|Overall Study|Migrated/moved from study area|0
5517039|NCT01506193|19076440|P1|Overall Study|Migrated/moved from study area|0
5517040|NCT01506193|19076438|P3|Overall Study|Protocol Violation|1
5517041|NCT01506193|19076439|P2|Overall Study|Protocol Violation|0
5517042|NCT01506193|19076440|P1|Overall Study|Protocol Violation|1
5517043|NCT01505881|19076486|P2|Overall Study|Withdrawal by Subject|0
5517044|NCT01505881|19076487|P1|Overall Study|Withdrawal by Subject|2
5517045|NCT01505881|19076486|P2|Overall Study|Lost to Follow-up|0
5517046|NCT01505881|19076487|P1|Overall Study|Lost to Follow-up|2
5517047|NCT01505881|19076486|P2|Overall Study|Adverse Event|1
5517048|NCT01505881|19076487|P1|Overall Study|Adverse Event|0
5517049|NCT01505647|19076593|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
5517050|NCT01505647|19076594|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
5517051|NCT01505647|19076593|P2|Day 43 Through Day 182 Follow-up|Death|1
5517052|NCT01505647|19076594|P1|Day 43 Through Day 182 Follow-up|Death|0
5517053|NCT01505647|19076593|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
5517054|NCT01505647|19076594|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
5517055|NCT01505647|19076593|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
5517056|NCT01505647|19076594|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
5517057|NCT01505647|19076593|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
5517058|NCT01505647|19076594|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
5517059|NCT01505634|19076611|P3|Overall Study|In a conflict zone|1
5517060|NCT01505634|19076612|P2|Overall Study|In a conflict zone|0
5517061|NCT01505634|19076613|P1|Overall Study|In a conflict zone|0
5517062|NCT01505634|19076611|P3|Overall Study|Death|0
5517063|NCT01505634|19076612|P2|Overall Study|Death|0
5517064|NCT01505634|19076613|P1|Overall Study|Death|1
5517065|NCT01505634|19076611|P3|Overall Study|Lost to Follow-up|4
5517066|NCT01505634|19076612|P2|Overall Study|Lost to Follow-up|4
5517067|NCT01505634|19076613|P1|Overall Study|Lost to Follow-up|1
5517068|NCT01505634|19076611|P3|Overall Study|Protocol Violation|0
5517069|NCT01505634|19076612|P2|Overall Study|Protocol Violation|0
5517070|NCT01505634|19076613|P1|Overall Study|Protocol Violation|2
5517071|NCT01505634|19076611|P3|Overall Study|Insufficient supply of drug at site|0
5517072|NCT01505634|19076612|P2|Overall Study|Insufficient supply of drug at site|0
5517073|NCT01505634|19076613|P1|Overall Study|Insufficient supply of drug at site|1
5517074|NCT01505634|19076611|P3|Overall Study|Adverse Event|0
5517075|NCT01505634|19076612|P2|Overall Study|Adverse Event|0
5517076|NCT01505634|19076613|P1|Overall Study|Adverse Event|1
5517077|NCT01505634|19076611|P3|Overall Study|Physician Decision|0
5517078|NCT01505634|19076612|P2|Overall Study|Physician Decision|1
5517079|NCT01505634|19076613|P1|Overall Study|Physician Decision|1
5517080|NCT01505634|19076611|P3|Overall Study|Withdrawal by Subject|1
5517081|NCT01505634|19076612|P2|Overall Study|Withdrawal by Subject|5
5517082|NCT01505634|19076613|P1|Overall Study|Withdrawal by Subject|2
5517083|NCT01505608|19076668|P2|Phase II|Protocol Violation|1
5517084|NCT01505608|19076669|P1|Phase II|Protocol Violation|0
5517085|NCT01505608|19076668|P2|Phase II|Lack of Efficacy|1
5517086|NCT01505608|19076669|P1|Phase II|Lack of Efficacy|2
5517087|NCT01505608|19076668|P2|Phase I|Withdrawal by Subject|1
5517088|NCT01505608|19076669|P1|Phase I|Withdrawal by Subject|0
5517089|NCT01505608|19076668|P2|Phase I|Adverse Event|1
5517090|NCT01505608|19076669|P1|Phase I|Adverse Event|0
5517091|NCT01505608|19076668|P2|Phase I|Lack of Efficacy|4
5517092|NCT01505608|19076669|P1|Phase I|Lack of Efficacy|0
5517093|NCT01505530|19076688|P3|Overall Study|entry criteria not met|0
5517094|NCT01505530|19076689|P2|Overall Study|entry criteria not met|1
5517095|NCT01505530|19076690|P1|Overall Study|entry criteria not met|0
5517096|NCT01505530|19076688|P3|Overall Study|Death|5
5517097|NCT01505530|19076689|P2|Overall Study|Death|6
5517098|NCT01505530|19076690|P1|Overall Study|Death|7
5517099|NCT01505530|19076688|P3|Overall Study|Sponsor Decision|7
5517100|NCT01505530|19076689|P2|Overall Study|Sponsor Decision|8
5517101|NCT01505530|19076690|P1|Overall Study|Sponsor Decision|1
5517102|NCT01505530|19076688|P3|Overall Study|Physician Decision|5
5517103|NCT01505530|19076689|P2|Overall Study|Physician Decision|2
5517104|NCT01505530|19076690|P1|Overall Study|Physician Decision|6
5517105|NCT01505530|19076688|P3|Overall Study|Withdrawal by Subject|6
5517106|NCT01505530|19076689|P2|Overall Study|Withdrawal by Subject|8
5517107|NCT01505530|19076690|P1|Overall Study|Withdrawal by Subject|7
5517108|NCT01505530|19076688|P3|Overall Study|Adverse Event|0
5517109|NCT01505530|19076689|P2|Overall Study|Adverse Event|1
5517110|NCT01505530|19076690|P1|Overall Study|Adverse Event|1
5517111|NCT01505530|19076688|P3|Overall Study|Progressive Disease|18
5517112|NCT01505530|19076689|P2|Overall Study|Progressive Disease|17
5517113|NCT01505530|19076690|P1|Overall Study|Progressive Disease|19
5517114|NCT01505491|19076734|P3|Overall Study|Lost to Follow-up|1
5517115|NCT01505491|19076735|P2|Overall Study|Lost to Follow-up|0
5517116|NCT01505491|19076736|P1|Overall Study|Lost to Follow-up|0
5517117|NCT01505491|19076734|P3|Overall Study|Withdrawal by Subject|4
5517118|NCT01505491|19076735|P2|Overall Study|Withdrawal by Subject|1
5517119|NCT01505491|19076736|P1|Overall Study|Withdrawal by Subject|1
5517120|NCT01505491|19076734|P3|Overall Study|Other reason not listed|0
5517121|NCT01505491|19076735|P2|Overall Study|Other reason not listed|0
5517122|NCT01505491|19076736|P1|Overall Study|Other reason not listed|1
5517123|NCT01505387|19076775|P2|Overall Study|Withdrawal by Subject|1
5517124|NCT01505387|19076776|P1|Overall Study|Withdrawal by Subject|1
5517125|NCT01505387|19076775|P2|Overall Study|Protocol Violation|0
5517126|NCT01505387|19076776|P1|Overall Study|Protocol Violation|1
5517127|NCT01505374|19076782|P2|Overall Study|Lost to Follow-up|0
5517128|NCT01505374|19076783|P1|Overall Study|Lost to Follow-up|1
5517129|NCT01505114|19076833|P4|Overall Study|investigator decision|0
5517130|NCT01505114|19076834|P3|Overall Study|investigator decision|1
5517131|NCT01505114|19076835|P2|Overall Study|investigator decision|0
5517132|NCT01505114|19076836|P1|Overall Study|investigator decision|1
5517133|NCT01505114|19076833|P4|Overall Study|staff safety concerns|1
5517134|NCT01505114|19076834|P3|Overall Study|staff safety concerns|0
5517135|NCT01505114|19076835|P2|Overall Study|staff safety concerns|0
5517136|NCT01505114|19076836|P1|Overall Study|staff safety concerns|0
5517137|NCT01505114|19076833|P4|Overall Study|inadvertent enrollment due to peanut all|1
5517138|NCT01505114|19076834|P3|Overall Study|inadvertent enrollment due to peanut all|0
5517139|NCT01505114|19076835|P2|Overall Study|inadvertent enrollment due to peanut all|0
5517140|NCT01505114|19076836|P1|Overall Study|inadvertent enrollment due to peanut all|0
5517141|NCT01505114|19076833|P4|Overall Study|relocated|3
5517142|NCT01505114|19076834|P3|Overall Study|relocated|2
5517143|NCT01505114|19076835|P2|Overall Study|relocated|2
5517144|NCT01505114|19076836|P1|Overall Study|relocated|4
5517145|NCT01505114|19076833|P4|Overall Study|Lost to Follow-up|7
5517146|NCT01505114|19076834|P3|Overall Study|Lost to Follow-up|8
5517147|NCT01505114|19076835|P2|Overall Study|Lost to Follow-up|5
5517148|NCT01505114|19076836|P1|Overall Study|Lost to Follow-up|11
5517149|NCT01505114|19076833|P4|Overall Study|unable to adhere to visit schedule|3
5517150|NCT01505114|19076834|P3|Overall Study|unable to adhere to visit schedule|3
5517151|NCT01505114|19076835|P2|Overall Study|unable to adhere to visit schedule|2
5517152|NCT01505114|19076836|P1|Overall Study|unable to adhere to visit schedule|3
5517153|NCT01505114|19076833|P4|Overall Study|Death|1
5517154|NCT01505114|19076834|P3|Overall Study|Death|0
5517155|NCT01505114|19076835|P2|Overall Study|Death|0
5517156|NCT01505114|19076836|P1|Overall Study|Death|1
5517157|NCT01505114|19076833|P4|Overall Study|Withdrawal by Subject|7
5517158|NCT01505114|19076834|P3|Overall Study|Withdrawal by Subject|4
5517159|NCT01505114|19076835|P2|Overall Study|Withdrawal by Subject|4
5517160|NCT01505114|19076836|P1|Overall Study|Withdrawal by Subject|5
5517161|NCT01505010|19076864|P2|Overall Study|Lost to Follow-up|1
5517162|NCT01505010|19076865|P1|Overall Study|Lost to Follow-up|0
5517163|NCT01505010|19076864|P2|Overall Study|Protocol Violation|1
5517164|NCT01505010|19076865|P1|Overall Study|Protocol Violation|0
5517165|NCT01504971|19076879|P1|Overall Study|Physician Decision|13
5517166|NCT01504867|19076908|P2|Overall Study|Consent revoked|1
5517167|NCT01504867|19076909|P1|Overall Study|Consent revoked|5
5517168|NCT01504867|19076908|P2|Overall Study|Inclusion criteria not met|2
5517169|NCT01504867|19076909|P1|Overall Study|Inclusion criteria not met|2
5517170|NCT01504841|19076947|P3|Overall Study|On study due to Long-term Follow-up|0
5517171|NCT01504841|19076948|P2|Overall Study|On study due to Long-term Follow-up|3
5517172|NCT01504841|19076949|P1|Overall Study|On study due to Long-term Follow-up|15
5517173|NCT01504841|19076947|P3|Overall Study|Withdrawal by Subject|0
5517174|NCT01504841|19076948|P2|Overall Study|Withdrawal by Subject|1
5517175|NCT01504841|19076949|P1|Overall Study|Withdrawal by Subject|1
5517176|NCT01504412|19077002|P5|Overall Study|Death|0
5517177|NCT01504412|19077003|P4|Overall Study|Death|1
5517178|NCT01504412|19077004|P3|Overall Study|Death|0
5517179|NCT01504412|19077005|P2|Overall Study|Death|0
5517180|NCT01504412|19077006|P1|Overall Study|Death|0
5517181|NCT01504412|19077002|P5|Overall Study|Lack of Efficacy|1
5517182|NCT01504412|19077003|P4|Overall Study|Lack of Efficacy|0
5517183|NCT01504412|19077004|P3|Overall Study|Lack of Efficacy|1
5517184|NCT01504412|19077005|P2|Overall Study|Lack of Efficacy|0
5517185|NCT01504412|19077006|P1|Overall Study|Lack of Efficacy|0
5517186|NCT01504412|19077002|P5|Overall Study|Lost to Follow-up|0
5517187|NCT01504412|19077003|P4|Overall Study|Lost to Follow-up|0
5517188|NCT01504412|19077004|P3|Overall Study|Lost to Follow-up|0
5517189|NCT01504412|19077005|P2|Overall Study|Lost to Follow-up|2
5517190|NCT01504412|19077006|P1|Overall Study|Lost to Follow-up|0
5517191|NCT01504412|19077002|P5|Overall Study|Other|1
5517192|NCT01504412|19077003|P4|Overall Study|Other|6
5517193|NCT01504412|19077004|P3|Overall Study|Other|1
5517194|NCT01504412|19077005|P2|Overall Study|Other|1
5517195|NCT01504412|19077006|P1|Overall Study|Other|2
5517196|NCT01504412|19077002|P5|Overall Study|Withdrawal by Subject|1
5517197|NCT01504412|19077003|P4|Overall Study|Withdrawal by Subject|5
5517198|NCT01504412|19077004|P3|Overall Study|Withdrawal by Subject|1
5517199|NCT01504412|19077005|P2|Overall Study|Withdrawal by Subject|1
5517200|NCT01504412|19077006|P1|Overall Study|Withdrawal by Subject|2
5517201|NCT01504412|19077002|P5|Overall Study|Adverse Event|10
5517202|NCT01504412|19077003|P4|Overall Study|Adverse Event|7
5517203|NCT01504412|19077004|P3|Overall Study|Adverse Event|1
5517204|NCT01504412|19077005|P2|Overall Study|Adverse Event|8
5517205|NCT01504412|19077006|P1|Overall Study|Adverse Event|1
5517206|NCT01504204|19077025|P2|Overall Study|Lost to Follow-up|1
5517207|NCT01504204|19077026|P1|Overall Study|Lost to Follow-up|1
5517208|NCT01503164|19077083|P2|Overall Study|Withdrawal by Subject|1
5517209|NCT01503164|19077084|P1|Overall Study|Withdrawal by Subject|2
5517210|NCT01503021|19077114|P2|Overall Study|Moved, received transplant, etc.|7
5517211|NCT01503021|19077115|P1|Overall Study|Moved, received transplant, etc.|5
5517212|NCT01503021|19077114|P2|Overall Study|Withdrawal by Subject|8
5517213|NCT01503021|19077115|P1|Overall Study|Withdrawal by Subject|9
5517214|NCT01503021|19077114|P2|Overall Study|Protocol Violation|3
5517215|NCT01503021|19077115|P1|Overall Study|Protocol Violation|1
5517216|NCT01503021|19077114|P2|Overall Study|Physician Decision|0
5517217|NCT01503021|19077115|P1|Overall Study|Physician Decision|3
5517218|NCT01503021|19077114|P2|Overall Study|Lost to Follow-up|0
5517219|NCT01503021|19077115|P1|Overall Study|Lost to Follow-up|2
5517220|NCT01503021|19077114|P2|Overall Study|Death|2
5517221|NCT01503021|19077115|P1|Overall Study|Death|0
5517222|NCT01503021|19077114|P2|Overall Study|Adverse Event|6
5517223|NCT01503021|19077115|P1|Overall Study|Adverse Event|7
5517224|NCT01502956|19077164|P2|Overall Study|Withdrawal by Subject|10
5517225|NCT01502956|19077165|P1|Overall Study|Withdrawal by Subject|8
5517226|NCT01502956|19077164|P2|Overall Study|Physician Decision|3
5517227|NCT01502956|19077165|P1|Overall Study|Physician Decision|2
5517228|NCT01502956|19077164|P2|Overall Study|Lost to Follow-up|11
5517229|NCT01502956|19077165|P1|Overall Study|Lost to Follow-up|14
5517230|NCT01502956|19077164|P2|Overall Study|Death|2
5517231|NCT01502956|19077165|P1|Overall Study|Death|0
5517232|NCT01502709|19077223|P2|Overall Study|Lost to Follow-up|0
5517233|NCT01502709|19077224|P1|Overall Study|Lost to Follow-up|4
5517234|NCT01502644|19077237|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
5517235|NCT01502644|19077238|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
5517236|NCT01502644|19077239|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
5517237|NCT01502644|19077240|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
5517238|NCT01502644|19077237|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
5517239|NCT01502644|19077238|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
5517240|NCT01502644|19077239|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
5517241|NCT01502644|19077240|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
5517242|NCT01502644|19077237|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
5517243|NCT01502644|19077238|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
5517244|NCT01502644|19077239|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
5517245|NCT01502644|19077240|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
5517246|NCT01502644|19077237|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
5517247|NCT01502644|19077238|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
5517248|NCT01502644|19077239|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
5517249|NCT01502644|19077240|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
5517250|NCT01502644|19077237|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
5517251|NCT01502644|19077238|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
5517252|NCT01502644|19077239|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
5517253|NCT01502644|19077240|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
5517254|NCT01502423|19077250|P2|Overall Study|Withdrawal by Subject|1
5517255|NCT01502423|19077251|P1|Overall Study|Withdrawal by Subject|0
5517256|NCT01502410|19077273|P4|Overall Study|Withdrawal by Subject|0
5517257|NCT01502410|19077274|P3|Overall Study|Withdrawal by Subject|0
5517258|NCT01502410|19077275|P2|Overall Study|Withdrawal by Subject|0
5517259|NCT01502410|19077276|P1|Overall Study|Withdrawal by Subject|2
5517260|NCT01502410|19077273|P4|Overall Study|Physician Decision|0
5517261|NCT01502410|19077274|P3|Overall Study|Physician Decision|0
5517262|NCT01502410|19077275|P2|Overall Study|Physician Decision|1
5517263|NCT01502410|19077276|P1|Overall Study|Physician Decision|0
5517264|NCT01502410|19077273|P4|Overall Study|Lack of Efficacy|0
5517265|NCT01502410|19077274|P3|Overall Study|Lack of Efficacy|0
5517266|NCT01502410|19077275|P2|Overall Study|Lack of Efficacy|7
5517267|NCT01502410|19077276|P1|Overall Study|Lack of Efficacy|7
5517268|NCT01502410|19077273|P4|Overall Study|Adverse Event|0
5517269|NCT01502410|19077274|P3|Overall Study|Adverse Event|0
5517270|NCT01502410|19077275|P2|Overall Study|Adverse Event|2
5517271|NCT01502410|19077276|P1|Overall Study|Adverse Event|1
5517272|NCT01502371|19077294|P5|Overall Study|Excluded Medication|1
5517273|NCT01502371|19077295|P4|Overall Study|Excluded Medication|0
5517274|NCT01502371|19077296|P3|Overall Study|Excluded Medication|1
5517275|NCT01502371|19077297|P2|Overall Study|Excluded Medication|1
5517276|NCT01502371|19077298|P1|Overall Study|Excluded Medication|0
5517277|NCT01502371|19077294|P5|Overall Study|Protocol Violation|10
5517278|NCT01502371|19077295|P4|Overall Study|Protocol Violation|5
5517279|NCT01502371|19077296|P3|Overall Study|Protocol Violation|6
5517280|NCT01502371|19077297|P2|Overall Study|Protocol Violation|5
5517281|NCT01502371|19077298|P1|Overall Study|Protocol Violation|9
5517282|NCT01502371|19077294|P5|Overall Study|Technical Problems|1
5517283|NCT01502371|19077295|P4|Overall Study|Technical Problems|4
5517284|NCT01502371|19077296|P3|Overall Study|Technical Problems|2
5517285|NCT01502371|19077297|P2|Overall Study|Technical Problems|0
5517286|NCT01502371|19077298|P1|Overall Study|Technical Problems|1
5517287|NCT01502371|19077294|P5|Overall Study|Noncompliance with Study Drug|1
5517288|NCT01502371|19077295|P4|Overall Study|Noncompliance with Study Drug|2
5517289|NCT01502371|19077296|P3|Overall Study|Noncompliance with Study Drug|1
5517290|NCT01502371|19077297|P2|Overall Study|Noncompliance with Study Drug|0
5517291|NCT01502371|19077298|P1|Overall Study|Noncompliance with Study Drug|0
5517292|NCT01502371|19077294|P5|Overall Study|Physician Decision|1
5517293|NCT01502371|19077295|P4|Overall Study|Physician Decision|0
5517294|NCT01502371|19077296|P3|Overall Study|Physician Decision|0
5517295|NCT01502371|19077297|P2|Overall Study|Physician Decision|0
5517296|NCT01502371|19077298|P1|Overall Study|Physician Decision|3
5517297|NCT01502371|19077294|P5|Overall Study|Lack of Efficacy|4
5517298|NCT01502371|19077295|P4|Overall Study|Lack of Efficacy|2
5517299|NCT01502371|19077296|P3|Overall Study|Lack of Efficacy|2
5517300|NCT01502371|19077297|P2|Overall Study|Lack of Efficacy|3
5517301|NCT01502371|19077298|P1|Overall Study|Lack of Efficacy|3
5517302|NCT01502371|19077294|P5|Overall Study|Treatment Failure|30
5517303|NCT01502371|19077295|P4|Overall Study|Treatment Failure|19
5517304|NCT01502371|19077296|P3|Overall Study|Treatment Failure|12
5517305|NCT01502371|19077297|P2|Overall Study|Treatment Failure|20
5517306|NCT01502371|19077298|P1|Overall Study|Treatment Failure|22
5517307|NCT01502371|19077294|P5|Overall Study|Adverse Event|3
5517308|NCT01502371|19077295|P4|Overall Study|Adverse Event|4
5517309|NCT01502371|19077296|P3|Overall Study|Adverse Event|0
5517310|NCT01502371|19077297|P2|Overall Study|Adverse Event|1
5517311|NCT01502371|19077298|P1|Overall Study|Adverse Event|2
5517312|NCT01502371|19077294|P5|Overall Study|Withdrawal by Subject|1
5517313|NCT01502371|19077295|P4|Overall Study|Withdrawal by Subject|1
5517314|NCT01502371|19077296|P3|Overall Study|Withdrawal by Subject|1
5517315|NCT01502371|19077297|P2|Overall Study|Withdrawal by Subject|2
5517316|NCT01502371|19077298|P1|Overall Study|Withdrawal by Subject|1
5517317|NCT01502293|19077363|P3|Overall Study|Physician Decision|1
5517318|NCT01502293|19077364|P2|Overall Study|Physician Decision|0
5517319|NCT01502293|19077365|P1|Overall Study|Physician Decision|0
5517320|NCT01502293|19077363|P3|Overall Study|Reason Not Specified|0
5517321|NCT01502293|19077364|P2|Overall Study|Reason Not Specified|0
5517322|NCT01502293|19077365|P1|Overall Study|Reason Not Specified|2
5517323|NCT01502293|19077363|P3|Overall Study|Adverse Event|0
5517324|NCT01502293|19077364|P2|Overall Study|Adverse Event|2
5517325|NCT01502293|19077365|P1|Overall Study|Adverse Event|0
5517326|NCT01502293|19077363|P3|Overall Study|Withdrawal by Subject|1
5517327|NCT01502293|19077364|P2|Overall Study|Withdrawal by Subject|3
5517328|NCT01502293|19077365|P1|Overall Study|Withdrawal by Subject|3
5517329|NCT01502293|19077363|P3|Overall Study|Progressive Disease|2
5517330|NCT01502293|19077364|P2|Overall Study|Progressive Disease|12
5517331|NCT01502293|19077365|P1|Overall Study|Progressive Disease|20
5517332|NCT01502228|19077394|P1|Overall Study|Death|1
5517333|NCT01502033|19077399|P1|Overall Study|1 participant went back to school|1
5517334|NCT01502033|19077399|P1|Overall Study|1 participant had worsening depression|1
5517335|NCT01502033|19077399|P1|Overall Study|1 participant had scalp discomfort|1
5517336|NCT01501955|19077407|P2|Overall Study|Adverse Event|3
5517337|NCT01501955|19077408|P1|Overall Study|Adverse Event|1
5517338|NCT01501955|19077407|P2|Overall Study|Withdrawal by Subject|0
5517339|NCT01501955|19077408|P1|Overall Study|Withdrawal by Subject|1
5517340|NCT01501110|19077472|P2|Overall Study|Death|1
5517341|NCT01501110|19077473|P1|Overall Study|Death|0
5517342|NCT01500720|19077558|P2|Overall Study|Other|8
5517343|NCT01500720|19077559|P1|Overall Study|Other|4
5517344|NCT01500720|19077558|P2|Overall Study|Randomized But Not Treated|1
5517345|NCT01500720|19077559|P1|Overall Study|Randomized But Not Treated|1
5517346|NCT01500694|19077573|P2|Overall Study|Other|3
5517347|NCT01500694|19077574|P1|Overall Study|Other|9
5517348|NCT01500694|19077573|P2|Overall Study|Lack of Efficacy|5
5517349|NCT01500694|19077574|P1|Overall Study|Lack of Efficacy|14
5517350|NCT01500694|19077573|P2|Overall Study|Lost to Follow-up|3
5517351|NCT01500694|19077574|P1|Overall Study|Lost to Follow-up|2
5517352|NCT01500694|19077573|P2|Overall Study|Withdrawal by Subject|14
5517353|NCT01500694|19077574|P1|Overall Study|Withdrawal by Subject|23
5517354|NCT01500694|19077573|P2|Overall Study|Protocol Violation|1
5517355|NCT01500694|19077574|P1|Overall Study|Protocol Violation|0
5517356|NCT01500694|19077573|P2|Overall Study|Adverse Event|3
5517357|NCT01500694|19077574|P1|Overall Study|Adverse Event|4
5517358|NCT01500629|19077600|P2|Washout Period of 14 to 30 Days|Pregnancy|0
5517359|NCT01500629|19077601|P1|Washout Period of 14 to 30 Days|Pregnancy|1
5517360|NCT01500434|19077685|P1|Overall Study|Missed 12-month follow-up|5
5517361|NCT01500434|19077685|P1|Overall Study|Withdrawal by Subject|1
5517362|NCT01500434|19077685|P1|Overall Study|Death|1
5517363|NCT01500382|19077718|P4|Washout Period|Study site went out of business|0
5517364|NCT01500382|19077719|P3|Washout Period|Study site went out of business|1
5517365|NCT01500382|19077720|P2|Washout Period|Study site went out of business|0
5517366|NCT01500382|19077721|P1|Washout Period|Study site went out of business|0
5517367|NCT01500317|19077746|P3|Overall Study|Withdrawal by Subject|0
5517368|NCT01500317|19077747|P2|Overall Study|Withdrawal by Subject|2
5517369|NCT01500317|19077748|P1|Overall Study|Withdrawal by Subject|3
5517370|NCT01500278|19077770|P2|Week 13 - Week 104|Adverse Event|54
5517371|NCT01500278|19077771|P1|Week 13 - Week 104|Adverse Event|54
5517372|NCT01500278|19077770|P2|Week 13 - Week 104|Death|4
5517373|NCT01500278|19077771|P1|Week 13 - Week 104|Death|2
5517374|NCT01500278|19077770|P2|Week 13 - Week 104|Not completed|1
5517375|NCT01500278|19077771|P1|Week 13 - Week 104|Not completed|0
5517376|NCT01500278|19077770|P2|Week 13 - Week 104|Personal reason|1
5517377|NCT01500278|19077771|P1|Week 13 - Week 104|Personal reason|0
5517378|NCT01500278|19077770|P2|Week 13 - Week 104|Medical monitor decision|2
5517379|NCT01500278|19077771|P1|Week 13 - Week 104|Medical monitor decision|0
5517380|NCT01500278|19077770|P2|Week 13 - Week 104|Sponsor decision|2
5517381|NCT01500278|19077771|P1|Week 13 - Week 104|Sponsor decision|0
5517382|NCT01500278|19077770|P2|Week 13 - Week 104|Relocation|1
5517383|NCT01500278|19077771|P1|Week 13 - Week 104|Relocation|0
5517384|NCT01500278|19077770|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
5517385|NCT01500278|19077771|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
5517386|NCT01500278|19077770|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
5517387|NCT01500278|19077771|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
5517388|NCT01500278|19077770|P2|Week 13 - Week 104|Principal investigator retiring|0
5517389|NCT01500278|19077771|P1|Week 13 - Week 104|Principal investigator retiring|1
5517390|NCT01500278|19077770|P2|Week 13 - Week 104|Protocol deviation|0
5517391|NCT01500278|19077771|P1|Week 13 - Week 104|Protocol deviation|1
5517392|NCT01500278|19077770|P2|Week 13 - Week 104|Exclusion criteria not met|0
5517393|NCT01500278|19077771|P1|Week 13 - Week 104|Exclusion criteria not met|1
5517394|NCT01500278|19077770|P2|Week 13 - Week 104|Withdrawn in error|0
5517395|NCT01500278|19077771|P1|Week 13 - Week 104|Withdrawn in error|1
5517396|NCT01500278|19077770|P2|Week 13 - Week 104|Sponsor request|0
5517397|NCT01500278|19077771|P1|Week 13 - Week 104|Sponsor request|4
5517398|NCT01500278|19077770|P2|Week 13 - Week 104|False positive test|2
5517399|NCT01500278|19077771|P1|Week 13 - Week 104|False positive test|1
5517400|NCT01500278|19077770|P2|Week 13 - Week 104|Recurrent infections|0
5517401|NCT01500278|19077771|P1|Week 13 - Week 104|Recurrent infections|1
5517402|NCT01500278|19077770|P2|Week 13 - Week 104|Non/bad compliance|5
5517403|NCT01500278|19077771|P1|Week 13 - Week 104|Non/bad compliance|7
5517404|NCT01500278|19077770|P2|Week 13 - Week 104|Week 24 Non-Responder|16
5517405|NCT01500278|19077771|P1|Week 13 - Week 104|Week 24 Non-Responder|20
5517406|NCT01500278|19077770|P2|Week 13 - Week 104|Withdrawal by Subject|13
5517407|NCT01500278|19077771|P1|Week 13 - Week 104|Withdrawal by Subject|22
5517408|NCT01500278|19077770|P2|Week 13 - Week 104|Lost to Follow-up|5
5517409|NCT01500278|19077771|P1|Week 13 - Week 104|Lost to Follow-up|6
5517410|NCT01500278|19077770|P2|Week 13 - Week 104|Protocol Violation|6
5517411|NCT01500278|19077771|P1|Week 13 - Week 104|Protocol Violation|6
5517412|NCT01500278|19077770|P2|Week 13 - Week 104|Lack of Efficacy|12
5517413|NCT01500278|19077771|P1|Week 13 - Week 104|Lack of Efficacy|11
5517414|NCT01500278|19077770|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
5517415|NCT01500278|19077771|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
5517416|NCT01500278|19077770|P2|Week 0 - Week 12|Other serious disease|1
5517417|NCT01500278|19077771|P1|Week 0 - Week 12|Other serious disease|0
5517418|NCT01500278|19077770|P2|Week 0 - Week 12|Personal reason|1
5517419|NCT01500278|19077771|P1|Week 0 - Week 12|Personal reason|0
5517420|NCT01500278|19077770|P2|Week 0 - Week 12|Sponsor decision|0
5517421|NCT01500278|19077771|P1|Week 0 - Week 12|Sponsor decision|1
5517422|NCT01500278|19077770|P2|Week 0 - Week 12|Prior history of serious disease|0
5517423|NCT01500278|19077771|P1|Week 0 - Week 12|Prior history of serious disease|1
5517424|NCT01500278|19077770|P2|Week 0 - Week 12|Investigator decision|0
5517425|NCT01500278|19077771|P1|Week 0 - Week 12|Investigator decision|1
5517426|NCT01500278|19077770|P2|Week 0 - Week 12|Exclusion criteria not met|0
5517427|NCT01500278|19077771|P1|Week 0 - Week 12|Exclusion criteria not met|1
5517428|NCT01500278|19077770|P2|Week 0 - Week 12|Patient decision|0
5517429|NCT01500278|19077771|P1|Week 0 - Week 12|Patient decision|1
5517430|NCT01500278|19077770|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
5517431|NCT01500278|19077771|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
5517432|NCT01500278|19077770|P2|Week 0 - Week 12|Withdrawal by Subject|2
5517433|NCT01500278|19077771|P1|Week 0 - Week 12|Withdrawal by Subject|7
5517434|NCT01500278|19077770|P2|Week 0 - Week 12|Lost to Follow-up|1
5517435|NCT01500278|19077771|P1|Week 0 - Week 12|Lost to Follow-up|1
5517436|NCT01500278|19077770|P2|Week 0 - Week 12|Protocol Violation|16
5517437|NCT01500278|19077771|P1|Week 0 - Week 12|Protocol Violation|10
5517438|NCT01500278|19077770|P2|Week 0 - Week 12|Lack of Efficacy|1
5517439|NCT01500278|19077771|P1|Week 0 - Week 12|Lack of Efficacy|0
5517440|NCT01500252|19077795|P2|Overall Study|Lost to Follow-up|4
5517441|NCT01500252|19077796|P1|Overall Study|Lost to Follow-up|5
5517442|NCT01500252|19077795|P2|Overall Study|Death|2
5517443|NCT01500252|19077796|P1|Overall Study|Death|4
5517444|NCT01500226|19077822|P2|Overall Study|Other Reasons|16
5517445|NCT01500226|19077823|P1|Overall Study|Other Reasons|19
5517446|NCT01500226|19077822|P2|Overall Study|Lost to Follow-up|5
5517447|NCT01500226|19077823|P1|Overall Study|Lost to Follow-up|9
5517448|NCT01500226|19077822|P2|Overall Study|Lack of Efficacy|30
5517449|NCT01500226|19077823|P1|Overall Study|Lack of Efficacy|14
5517450|NCT01500226|19077822|P2|Overall Study|Physician Decision|15
5517451|NCT01500226|19077823|P1|Overall Study|Physician Decision|17
5517452|NCT01500226|19077822|P2|Overall Study|Protocol Violation|39
5517453|NCT01500226|19077823|P1|Overall Study|Protocol Violation|53
5517454|NCT01500226|19077822|P2|Overall Study|Disease Progression|14
5517455|NCT01500226|19077823|P1|Overall Study|Disease Progression|16
5517456|NCT01500226|19077822|P2|Overall Study|Death|4
5517457|NCT01500226|19077823|P1|Overall Study|Death|12
5517458|NCT01500226|19077822|P2|Overall Study|Withdrawal by Subject|96
5517459|NCT01500226|19077823|P1|Overall Study|Withdrawal by Subject|93
5517460|NCT01500226|19077822|P2|Overall Study|Chemo Completed or Change in Therapy|237
5517461|NCT01500226|19077823|P1|Overall Study|Chemo Completed or Change in Therapy|235
5517462|NCT01500226|19077822|P2|Overall Study|Adverse Event|38
5517463|NCT01500226|19077823|P1|Overall Study|Adverse Event|31
5517464|NCT01500213|19077835|P2|Overall Study|Other Reasons|5
5517465|NCT01500213|19077836|P1|Overall Study|Other Reasons|7
5517466|NCT01500213|19077835|P2|Overall Study|Lost to Follow-up|6
5517467|NCT01500213|19077836|P1|Overall Study|Lost to Follow-up|3
5517468|NCT01500213|19077835|P2|Overall Study|Lack of Efficacy|7
5517469|NCT01500213|19077836|P1|Overall Study|Lack of Efficacy|9
5517470|NCT01500213|19077835|P2|Overall Study|Physician Decision|10
5517471|NCT01500213|19077836|P1|Overall Study|Physician Decision|12
5517472|NCT01500213|19077835|P2|Overall Study|Protocol Violation|19
5517473|NCT01500213|19077836|P1|Overall Study|Protocol Violation|19
5517474|NCT01500213|19077835|P2|Overall Study|Disease Progression|21
5517475|NCT01500213|19077836|P1|Overall Study|Disease Progression|13
5517476|NCT01500213|19077835|P2|Overall Study|Death|3
5517477|NCT01500213|19077836|P1|Overall Study|Death|7
5517478|NCT01500213|19077835|P2|Overall Study|Withdrawal by Subject|37
5517479|NCT01500213|19077836|P1|Overall Study|Withdrawal by Subject|28
5517480|NCT01500213|19077835|P2|Overall Study|Chemo Completed or Change in Therapy|81
5517481|NCT01500213|19077836|P1|Overall Study|Chemo Completed or Change in Therapy|84
5517482|NCT01500213|19077835|P2|Overall Study|Adverse Event|35
5517483|NCT01500213|19077836|P1|Overall Study|Adverse Event|35
5517484|NCT01500200|19077849|P6|Stage 2|Adverse Event|4
5517485|NCT01500200|19077850|P5|Stage 2|Adverse Event|5
5517486|NCT01500200|19077851|P4|Stage 2|Adverse Event|0
5517487|NCT01500200|19077852|P3|Stage 2|Adverse Event|0
5517488|NCT01500200|19077853|P2|Stage 2|Adverse Event|0
5517489|NCT01500200|19077854|P1|Stage 2|Adverse Event|0
5517490|NCT01500200|19077849|P6|Stage 1|Physician Decision|0
5517491|NCT01500200|19077850|P5|Stage 1|Physician Decision|0
5517492|NCT01500200|19077851|P4|Stage 1|Physician Decision|0
5517493|NCT01500200|19077852|P3|Stage 1|Physician Decision|0
5517494|NCT01500200|19077853|P2|Stage 1|Physician Decision|0
5517495|NCT01500200|19077854|P1|Stage 1|Physician Decision|1
5517496|NCT01500200|19077849|P6|Stage 1|Noncompliance with Study Drug|0
5517497|NCT01500200|19077850|P5|Stage 1|Noncompliance with Study Drug|0
5517498|NCT01500200|19077851|P4|Stage 1|Noncompliance with Study Drug|0
5517499|NCT01500200|19077852|P3|Stage 1|Noncompliance with Study Drug|0
5517500|NCT01500200|19077853|P2|Stage 1|Noncompliance with Study Drug|0
5517501|NCT01500200|19077854|P1|Stage 1|Noncompliance with Study Drug|1
5517502|NCT01500200|19077849|P6|Stage 1|Withdrawal by Subject|0
5517503|NCT01500200|19077850|P5|Stage 1|Withdrawal by Subject|0
5517504|NCT01500200|19077851|P4|Stage 1|Withdrawal by Subject|0
5517505|NCT01500200|19077852|P3|Stage 1|Withdrawal by Subject|0
5517506|NCT01500200|19077853|P2|Stage 1|Withdrawal by Subject|0
5517507|NCT01500200|19077854|P1|Stage 1|Withdrawal by Subject|3
5517508|NCT01500200|19077849|P6|Stage 1|Lost to Follow-up|0
5517509|NCT01500200|19077850|P5|Stage 1|Lost to Follow-up|0
5517510|NCT01500200|19077851|P4|Stage 1|Lost to Follow-up|0
5517511|NCT01500200|19077852|P3|Stage 1|Lost to Follow-up|1
5517512|NCT01500200|19077853|P2|Stage 1|Lost to Follow-up|2
5517513|NCT01500200|19077854|P1|Stage 1|Lost to Follow-up|2
5517514|NCT01500200|19077849|P6|Stage 1|Adverse Event|0
5517515|NCT01500200|19077850|P5|Stage 1|Adverse Event|0
5517516|NCT01500200|19077851|P4|Stage 1|Adverse Event|0
5517517|NCT01500200|19077852|P3|Stage 1|Adverse Event|5
5517518|NCT01500200|19077853|P2|Stage 1|Adverse Event|4
5517519|NCT01500200|19077854|P1|Stage 1|Adverse Event|1
5517520|NCT01500187|19077888|P2|Overall Study|Lost to Follow-up|0
5517521|NCT01500187|19077889|P1|Overall Study|Lost to Follow-up|6
5517522|NCT01500135|19077897|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
5517523|NCT01500135|19077898|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
5517524|NCT01500135|19077897|P2|Overall Study|Participant was a Safety Concern|0
5517525|NCT01500135|19077898|P1|Overall Study|Participant was a Safety Concern|1
5517526|NCT01500135|19077897|P2|Overall Study|Patient Missed Scheduled Appointments|1
5517527|NCT01500135|19077898|P1|Overall Study|Patient Missed Scheduled Appointments|0
5517528|NCT01500135|19077897|P2|Overall Study|Principal Investigator (PI) Discretion|0
5517529|NCT01500135|19077898|P1|Overall Study|Principal Investigator (PI) Discretion|1
5517530|NCT01500135|19077897|P2|Overall Study|Fatal Adverse Event (AE)|5
5517531|NCT01500135|19077898|P1|Overall Study|Fatal Adverse Event (AE)|5
5517532|NCT01500135|19077897|P2|Overall Study|Lost to Follow-up|4
5517533|NCT01500135|19077898|P1|Overall Study|Lost to Follow-up|6
5517534|NCT01500135|19077897|P2|Overall Study|Withdrawal of Consent|0
5517535|NCT01500135|19077898|P1|Overall Study|Withdrawal of Consent|4
5517536|NCT01500096|19077925|P4|Overall Study|Lost to Follow-up|2
5517537|NCT01500096|19077926|P3|Overall Study|Lost to Follow-up|0
5517538|NCT01500096|19077927|P2|Overall Study|Lost to Follow-up|0
5517539|NCT01500096|19077928|P1|Overall Study|Lost to Follow-up|1
5517540|NCT01500083|19077984|P2|Overall Study|Other Reasons|5
5517541|NCT01500083|19077985|P1|Overall Study|Other Reasons|2
5517542|NCT01500083|19077984|P2|Overall Study|Investigator Discretion|8
5517543|NCT01500083|19077985|P1|Overall Study|Investigator Discretion|3
5517544|NCT01500083|19077984|P2|Overall Study|Disease Progression|10
5517545|NCT01500083|19077985|P1|Overall Study|Disease Progression|2
5517546|NCT01500083|19077984|P2|Overall Study|Withdrawal of Consent|1
5517547|NCT01500083|19077985|P1|Overall Study|Withdrawal of Consent|0
5517548|NCT01500083|19077984|P2|Overall Study|Lost to Follow-up|0
5517549|NCT01500083|19077985|P1|Overall Study|Lost to Follow-up|1
5517550|NCT01500083|19077984|P2|Overall Study|Death|2
5517551|NCT01500083|19077985|P1|Overall Study|Death|0
5517552|NCT01500083|19077984|P2|Overall Study|Adverse Event|17
5517553|NCT01500083|19077985|P1|Overall Study|Adverse Event|4
5517554|NCT01500057|19077993|P2|Overall Study|Lost to Follow-up|4
5517555|NCT01500057|19077994|P1|Overall Study|Lost to Follow-up|6
5517556|NCT01500031|19078004|P1|Overall Study|Withdrawal by Subject|4
5517557|NCT01500031|19078004|P1|Overall Study|Death|1
5517558|NCT01499849|19078039|P2|Overall Study|Other Reasons|30
5517559|NCT01499849|19078040|P1|Overall Study|Other Reasons|27
5517560|NCT01499849|19078039|P2|Overall Study|Lost to Follow-up|3
5517561|NCT01499849|19078040|P1|Overall Study|Lost to Follow-up|6
5517562|NCT01499849|19078039|P2|Overall Study|Lack of Efficacy|4
5517563|NCT01499849|19078040|P1|Overall Study|Lack of Efficacy|3
5517564|NCT01499849|19078039|P2|Overall Study|Physician Decision|19
5517565|NCT01499849|19078040|P1|Overall Study|Physician Decision|20
5517566|NCT01499849|19078039|P2|Overall Study|Protocol Violation|11
5517567|NCT01499849|19078040|P1|Overall Study|Protocol Violation|11
5517568|NCT01499849|19078039|P2|Overall Study|Disease Progression|10
5517569|NCT01499849|19078040|P1|Overall Study|Disease Progression|11
5517570|NCT01499849|19078039|P2|Overall Study|Death|7
5517571|NCT01499849|19078040|P1|Overall Study|Death|5
5517572|NCT01499849|19078039|P2|Overall Study|Withdrawal by Subject|43
5517573|NCT01499849|19078040|P1|Overall Study|Withdrawal by Subject|43
5517574|NCT01499849|19078039|P2|Overall Study|Chemo completed or Change in Therapy|67
5517575|NCT01499849|19078040|P1|Overall Study|Chemo completed or Change in Therapy|70
5517576|NCT01499849|19078039|P2|Overall Study|Adverse Event|32
5517577|NCT01499849|19078040|P1|Overall Study|Adverse Event|28
5517578|NCT01499810|19078050|P1|Overall Study|Withdrawal by Subject|1
5517579|NCT01499810|19078050|P1|Overall Study|Protocol Violation|1
5517580|NCT01499810|19078050|P1|Overall Study|Lost to Follow-up|10
5517581|NCT01499667|19078100|P3|Overall Study|Lack of Efficacy|0
5517582|NCT01499667|19078101|P2|Overall Study|Lack of Efficacy|0
5517583|NCT01499667|19078102|P1|Overall Study|Lack of Efficacy|2
5517584|NCT01499667|19078100|P3|Overall Study|Withdrawal by Subject|1
5517585|NCT01499667|19078101|P2|Overall Study|Withdrawal by Subject|1
5517586|NCT01499667|19078102|P1|Overall Study|Withdrawal by Subject|2
5517587|NCT01499667|19078100|P3|Overall Study|Adverse Event|2
5517588|NCT01499667|19078101|P2|Overall Study|Adverse Event|2
5517589|NCT01499667|19078102|P1|Overall Study|Adverse Event|0
5517590|NCT01499667|19078100|P3|Overall Study|Protocol Violation|2
5517591|NCT01499667|19078101|P2|Overall Study|Protocol Violation|3
5517592|NCT01499667|19078102|P1|Overall Study|Protocol Violation|1
5517593|NCT01499667|19078100|P3|Overall Study|administrative problems|5
5517594|NCT01499667|19078101|P2|Overall Study|administrative problems|5
5517595|NCT01499667|19078102|P1|Overall Study|administrative problems|4
5517596|NCT01499576|19078150|P1|Overall Study|Withdrawal by Subject|9
5517597|NCT01499576|19078150|P1|Overall Study|Physician Decision|12
5517598|NCT01499511|19078158|P2|Overall Study|Death|0
5517599|NCT01499511|19078159|P1|Overall Study|Death|1
5517600|NCT01499368|19078187|P3|Overall Study|Error of Prescriptions|1
5517601|NCT01499368|19078188|P2|Overall Study|Error of Prescriptions|0
5517602|NCT01499368|19078189|P1|Overall Study|Error of Prescriptions|0
5517603|NCT01499368|19078187|P3|Overall Study|Deviation from visit window|1
5517604|NCT01499368|19078188|P2|Overall Study|Deviation from visit window|0
5517605|NCT01499368|19078189|P1|Overall Study|Deviation from visit window|0
5517606|NCT01499368|19078187|P3|Overall Study|Physician Decision|0
5517607|NCT01499368|19078188|P2|Overall Study|Physician Decision|1
5517608|NCT01499368|19078189|P1|Overall Study|Physician Decision|0
5517609|NCT01499368|19078187|P3|Overall Study|Adverse Event|2
5517610|NCT01499368|19078188|P2|Overall Study|Adverse Event|0
5517611|NCT01499368|19078189|P1|Overall Study|Adverse Event|4
5517612|NCT01499368|19078187|P3|Overall Study|Lost to Follow-up|5
5517613|NCT01499368|19078188|P2|Overall Study|Lost to Follow-up|2
5517614|NCT01499368|19078189|P1|Overall Study|Lost to Follow-up|3
5517615|NCT01499368|19078187|P3|Overall Study|Withdrawal by Subject|8
5517616|NCT01499368|19078188|P2|Overall Study|Withdrawal by Subject|10
5517617|NCT01499368|19078189|P1|Overall Study|Withdrawal by Subject|11
5517618|NCT01499368|19078187|P3|Overall Study|Prohibited Concomitant medication|0
5517619|NCT01499368|19078188|P2|Overall Study|Prohibited Concomitant medication|1
5517620|NCT01499368|19078189|P1|Overall Study|Prohibited Concomitant medication|1
5517621|NCT01499368|19078187|P3|Overall Study|Did not meet I/E criteria|4
5517622|NCT01499368|19078188|P2|Overall Study|Did not meet I/E criteria|4
5517623|NCT01499368|19078189|P1|Overall Study|Did not meet I/E criteria|8
5517624|NCT01499355|19078206|P4|Double-Blind Period|Lost to Follow-up|0
5517625|NCT01499355|19078207|P3|Double-Blind Period|Lost to Follow-up|0
5517626|NCT01499355|19078208|P2|Double-Blind Period|Lost to Follow-up|1
5517627|NCT01499355|19078209|P1|Double-Blind Period|Lost to Follow-up|0
5517628|NCT01499355|19078206|P4|Double-Blind Period|Consent Withdrawn|2
5517629|NCT01499355|19078207|P3|Double-Blind Period|Consent Withdrawn|1
5517630|NCT01499355|19078208|P2|Double-Blind Period|Consent Withdrawn|0
5517631|NCT01499355|19078209|P1|Double-Blind Period|Consent Withdrawn|0
5517632|NCT01499355|19078206|P4|Double-Blind Period|Investigator Decision|3
5517633|NCT01499355|19078207|P3|Double-Blind Period|Investigator Decision|3
5517634|NCT01499355|19078208|P2|Double-Blind Period|Investigator Decision|0
5517635|NCT01499355|19078209|P1|Double-Blind Period|Investigator Decision|0
5517636|NCT01499355|19078206|P4|Double-Blind Period|Death|0
5517637|NCT01499355|19078207|P3|Double-Blind Period|Death|0
5517638|NCT01499355|19078208|P2|Double-Blind Period|Death|1
5517639|NCT01499355|19078209|P1|Double-Blind Period|Death|0
5517640|NCT01499355|19078206|P4|Double-Blind Period|Other|2
5517641|NCT01499355|19078207|P3|Double-Blind Period|Other|2
5517642|NCT01499355|19078208|P2|Double-Blind Period|Other|1
5517643|NCT01499355|19078209|P1|Double-Blind Period|Other|0
5517644|NCT01499355|19078206|P4|Double-Blind Period|Study Termination|14
5517645|NCT01499355|19078207|P3|Double-Blind Period|Study Termination|16
5517646|NCT01499355|19078208|P2|Double-Blind Period|Study Termination|18
5517647|NCT01499355|19078209|P1|Double-Blind Period|Study Termination|0
5517648|NCT01499355|19078206|P4|Double-Blind Period|Adverse Event|2
5517649|NCT01499355|19078207|P3|Double-Blind Period|Adverse Event|3
5517650|NCT01499355|19078208|P2|Double-Blind Period|Adverse Event|2
5517651|NCT01499355|19078209|P1|Double-Blind Period|Adverse Event|0
5517652|NCT01499355|19078206|P4|Run-In Period|Adverse Event|0
5517653|NCT01499355|19078207|P3|Run-In Period|Adverse Event|0
5517654|NCT01499355|19078208|P2|Run-In Period|Adverse Event|0
5517655|NCT01499355|19078209|P1|Run-In Period|Adverse Event|8
5517656|NCT01499355|19078206|P4|Run-In Period|Consent Withdrawn|0
5517657|NCT01499355|19078207|P3|Run-In Period|Consent Withdrawn|0
5517658|NCT01499355|19078208|P2|Run-In Period|Consent Withdrawn|0
5517659|NCT01499355|19078209|P1|Run-In Period|Consent Withdrawn|1
5517660|NCT01499355|19078206|P4|Run-In Period|Investigator Decision|0
5517661|NCT01499355|19078207|P3|Run-In Period|Investigator Decision|0
5517662|NCT01499355|19078208|P2|Run-In Period|Investigator Decision|0
5517663|NCT01499355|19078209|P1|Run-In Period|Investigator Decision|2
5517664|NCT01499355|19078206|P4|Run-In Period|Death|0
5517665|NCT01499355|19078207|P3|Run-In Period|Death|0
5517666|NCT01499355|19078208|P2|Run-In Period|Death|0
5517667|NCT01499355|19078209|P1|Run-In Period|Death|2
5517668|NCT01499355|19078206|P4|Run-In Period|Other|0
5517669|NCT01499355|19078207|P3|Run-In Period|Other|0
5517670|NCT01499355|19078208|P2|Run-In Period|Other|0
5517671|NCT01499355|19078209|P1|Run-In Period|Other|3
5517672|NCT01499355|19078206|P4|Run-In Period|Study Termination|0
5517673|NCT01499355|19078207|P3|Run-In Period|Study Termination|0
5517674|NCT01499355|19078208|P2|Run-In Period|Study Termination|0
5517675|NCT01499355|19078209|P1|Run-In Period|Study Termination|15
5517676|NCT01499303|19078242|P2|Overall Study|Other|1
5517677|NCT01499303|19078243|P1|Overall Study|Other|0
5517678|NCT01499303|19078242|P2|Overall Study|Adverse Event|4
5517679|NCT01499303|19078243|P1|Overall Study|Adverse Event|1
5517680|NCT01499303|19078242|P2|Overall Study|Withdrawal by Subject|1
5517681|NCT01499303|19078243|P1|Overall Study|Withdrawal by Subject|0
5517682|NCT01499303|19078242|P2|Overall Study|Ongoing|1
5517683|NCT01499303|19078243|P1|Overall Study|Ongoing|2
5517684|NCT01499290|19078251|P2|Overall Study|Adverse Event|7
5517685|NCT01499290|19078252|P1|Overall Study|Adverse Event|14
5517686|NCT01499290|19078251|P2|Overall Study|Lack of Efficacy|8
5517687|NCT01499290|19078252|P1|Overall Study|Lack of Efficacy|7
5517688|NCT01499290|19078251|P2|Overall Study|Condition improved/subject recovered|0
5517689|NCT01499290|19078252|P1|Overall Study|Condition improved/subject recovered|1
5517690|NCT01499290|19078251|P2|Overall Study|Not specified in study report|5
5517691|NCT01499290|19078252|P1|Overall Study|Not specified in study report|11
5517692|NCT01499290|19078251|P2|Overall Study|Withdrawal by Subject|15
5517693|NCT01499290|19078252|P1|Overall Study|Withdrawal by Subject|22
5517694|NCT01499277|19078302|P2|Overall Study|Lack of therapeutic response and other|7
5517695|NCT01499277|19078303|P1|Overall Study|Lack of therapeutic response and other|8
5517696|NCT01499277|19078302|P2|Overall Study|Withdrawal by Subject|6
5517697|NCT01499277|19078303|P1|Overall Study|Withdrawal by Subject|16
5517698|NCT01499277|19078302|P2|Overall Study|Protocol Violation|3
5517699|NCT01499277|19078303|P1|Overall Study|Protocol Violation|2
5517700|NCT01499277|19078302|P2|Overall Study|Lost to Follow-up|8
5517701|NCT01499277|19078303|P1|Overall Study|Lost to Follow-up|15
5517702|NCT01499277|19078302|P2|Overall Study|Death|2
5517703|NCT01499277|19078303|P1|Overall Study|Death|3
5517704|NCT01499277|19078302|P2|Overall Study|Adverse Event|6
5517705|NCT01499277|19078303|P1|Overall Study|Adverse Event|3
5517706|NCT01499199|19078325|P1|Overall Study|Lack of Efficacy|1
5517707|NCT01499199|19078325|P1|Overall Study|Adverse Event|1
5517708|NCT01499160|19078354|P1|Overall Study|Withdrawal by Subject|1
5517709|NCT01499160|19078354|P1|Overall Study|Adverse Event|1
5517710|NCT01499134|19078377|P2|Overall Study|Withdrawal by Subject|1
5517711|NCT01499134|19078378|P1|Overall Study|Withdrawal by Subject|0
5517712|NCT01499095|19078400|P2|Overall Study|Perceived Lack of Efficacy|1
5517713|NCT01499095|19078401|P1|Overall Study|Perceived Lack of Efficacy|1
5517714|NCT01499095|19078400|P2|Overall Study|Change in Injection Schedule|0
5517715|NCT01499095|19078401|P1|Overall Study|Change in Injection Schedule|2
5517716|NCT01499095|19078400|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
5517717|NCT01499095|19078401|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
5517718|NCT01499095|19078400|P2|Overall Study|Hypoglycemia|1
5517719|NCT01499095|19078401|P1|Overall Study|Hypoglycemia|3
5517720|NCT01499095|19078400|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
5517721|NCT01499095|19078401|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
5517722|NCT01499095|19078400|P2|Overall Study|Lost to Follow-up|4
5517723|NCT01499095|19078401|P1|Overall Study|Lost to Follow-up|6
5517724|NCT01499095|19078400|P2|Overall Study|Diverse Reasons|25
5517725|NCT01499095|19078401|P1|Overall Study|Diverse Reasons|22
5517726|NCT01499095|19078400|P2|Overall Study|Received Rescue Therapy|40
5517727|NCT01499095|19078401|P1|Overall Study|Received Rescue Therapy|32
5517728|NCT01499095|19078400|P2|Overall Study|Protocol Violation|7
5517729|NCT01499095|19078401|P1|Overall Study|Protocol Violation|6
5517730|NCT01499095|19078400|P2|Overall Study|Lack of Efficacy|1
5517731|NCT01499095|19078401|P1|Overall Study|Lack of Efficacy|2
5517732|NCT01499095|19078400|P2|Overall Study|Adverse Event|7
5517733|NCT01499095|19078401|P1|Overall Study|Adverse Event|12
5517734|NCT01499095|19078400|P2|Overall Study|Randomized But Not Treated|1
5517735|NCT01499095|19078401|P1|Overall Study|Randomized But Not Treated|1
5517736|NCT01499082|19078431|P2|Overall Study|Lost to Follow-up|3
5517737|NCT01499082|19078432|P1|Overall Study|Lost to Follow-up|1
5517738|NCT01499082|19078431|P2|Overall Study|Hypoglycemia|3
5517739|NCT01499082|19078432|P1|Overall Study|Hypoglycemia|2
5517740|NCT01499082|19078431|P2|Overall Study|Site Closure for Noncompliance|2
5517741|NCT01499082|19078432|P1|Overall Study|Site Closure for Noncompliance|5
5517742|NCT01499082|19078431|P2|Overall Study|Diverse Reasons|14
5517743|NCT01499082|19078432|P1|Overall Study|Diverse Reasons|18
5517744|NCT01499082|19078431|P2|Overall Study|Protocol Violation|8
5517745|NCT01499082|19078432|P1|Overall Study|Protocol Violation|6
5517746|NCT01499082|19078431|P2|Overall Study|Lack of Efficacy|1
5517747|NCT01499082|19078432|P1|Overall Study|Lack of Efficacy|1
5517748|NCT01499082|19078431|P2|Overall Study|Adverse Event|16
5517749|NCT01499082|19078432|P1|Overall Study|Adverse Event|12
5517750|NCT01499082|19078431|P2|Overall Study|Randomized but not Treated|1
5517751|NCT01499082|19078432|P1|Overall Study|Randomized but not Treated|0
5517752|NCT01499043|19078460|P1|Overall Study|Adverse Event|1
5517753|NCT01499043|19078460|P1|Overall Study|Withdrawal by Subject|2
5517754|NCT01499043|19078460|P1|Overall Study|Progressive disease (clinical)|1
5517755|NCT01499043|19078460|P1|Overall Study|Progressive disease (radiographic)|2
5517756|NCT01498952|19078503|P5|Overall Study|Death|0
5517757|NCT01498952|19078504|P4|Overall Study|Death|0
5517758|NCT01498952|19078505|P3|Overall Study|Death|0
5517759|NCT01498952|19078506|P2|Overall Study|Death|2
5517760|NCT01498952|19078507|P1|Overall Study|Death|2
5517761|NCT01498887|19078549|P2|Overall Study|Adverse Event|1
5517762|NCT01498887|19078550|P1|Overall Study|Adverse Event|4
5517763|NCT01498887|19078549|P2|Overall Study|Abnormal laboratory value|2
5517764|NCT01498887|19078550|P1|Overall Study|Abnormal laboratory value|2
5517765|NCT01498887|19078549|P2|Overall Study|Abnormal result from test procedure|1
5517766|NCT01498887|19078550|P1|Overall Study|Abnormal result from test procedure|1
5517767|NCT01498887|19078549|P2|Overall Study|Lack of Efficacy|3
5517768|NCT01498887|19078550|P1|Overall Study|Lack of Efficacy|5
5517769|NCT01498887|19078549|P2|Overall Study|Protocol Violation|3
5517770|NCT01498887|19078550|P1|Overall Study|Protocol Violation|1
5517771|NCT01498887|19078549|P2|Overall Study|Withdrawal by Subject|0
5517772|NCT01498887|19078550|P1|Overall Study|Withdrawal by Subject|1
5517773|NCT01498887|19078549|P2|Overall Study|Lost to Follow-up|1
5517774|NCT01498887|19078550|P1|Overall Study|Lost to Follow-up|1
5517775|NCT01498887|19078549|P2|Overall Study|Administrative problems|0
5517776|NCT01498887|19078550|P1|Overall Study|Administrative problems|1
5517777|NCT01498822|19078571|P2|Overall Study|Lost to Follow-up|3
5517778|NCT01498822|19078572|P1|Overall Study|Lost to Follow-up|8
5517779|NCT01498822|19078571|P2|Overall Study|Withdrawal by Subject|25
5517780|NCT01498822|19078572|P1|Overall Study|Withdrawal by Subject|15
5517781|NCT01498822|19078571|P2|Overall Study|Adverse Event, serious fatal|1
5517782|NCT01498822|19078572|P1|Overall Study|Adverse Event, serious fatal|1
5517783|NCT01498822|19078571|P2|Overall Study|SAE, non-fatal|2
5517784|NCT01498822|19078572|P1|Overall Study|SAE, non-fatal|2
5517785|NCT01498822|19078571|P2|Overall Study|AE, non-serious non-fatal|17
5517786|NCT01498822|19078572|P1|Overall Study|AE, non-serious non-fatal|8
5517787|NCT01498822|19078571|P2|Overall Study|Lack of Efficacy|2
5517788|NCT01498822|19078572|P1|Overall Study|Lack of Efficacy|7
5517789|NCT01498822|19078571|P2|Overall Study|Other Reason|2
5517790|NCT01498822|19078572|P1|Overall Study|Other Reason|5
5517791|NCT01498822|19078571|P2|Overall Study|Protocol Violation|4
5517792|NCT01498822|19078572|P1|Overall Study|Protocol Violation|8
5517793|NCT01498692|19078599|P1|Overall Study|Missed 12-month visit|3
5517794|NCT01498692|19078599|P1|Overall Study|Withdrawal by Subject|1
5517795|NCT01498692|19078599|P1|Overall Study|Death|4
5517796|NCT01498679|19078630|P2|Overall Study|Withdrawal by Subject|4
5517797|NCT01498679|19078631|P1|Overall Study|Withdrawal by Subject|12
5517798|NCT01498679|19078630|P2|Overall Study|Physician Decision|2
5517799|NCT01498679|19078631|P1|Overall Study|Physician Decision|0
5517800|NCT01498679|19078630|P2|Overall Study|Protocol Violation|0
5517801|NCT01498679|19078631|P1|Overall Study|Protocol Violation|4
5517802|NCT01498679|19078630|P2|Overall Study|Lack of Efficacy|12
5517803|NCT01498679|19078631|P1|Overall Study|Lack of Efficacy|72
5517804|NCT01498679|19078630|P2|Overall Study|Adverse Event|4
5517805|NCT01498679|19078631|P1|Overall Study|Adverse Event|1
5517806|NCT01498653|19078647|P2|Overall Study|Withdrawal by Subject|3
5517807|NCT01498653|19078648|P1|Overall Study|Withdrawal by Subject|2
5517808|NCT01498653|19078647|P2|Overall Study|Physician Decision|0
5517809|NCT01498653|19078648|P1|Overall Study|Physician Decision|2
5517810|NCT01498653|19078647|P2|Overall Study|Lost to Follow-up|0
5517811|NCT01498653|19078648|P1|Overall Study|Lost to Follow-up|1
5517812|NCT01498653|19078647|P2|Overall Study|Protocol Violation|4
5517813|NCT01498653|19078648|P1|Overall Study|Protocol Violation|0
5517814|NCT01498653|19078647|P2|Overall Study|Lack of Efficacy|26
5517815|NCT01498653|19078648|P1|Overall Study|Lack of Efficacy|12
5517816|NCT01498653|19078647|P2|Overall Study|Adverse Event|2
5517817|NCT01498653|19078648|P1|Overall Study|Adverse Event|2
5517818|NCT01498640|19078662|P1|Overall Study|Other|3
5517819|NCT01498640|19078662|P1|Overall Study|Death|1
5517820|NCT01498640|19078662|P1|Overall Study|Lost to Follow-up|1
5517821|NCT01498575|19078692|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
5517822|NCT01498575|19078693|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
5517823|NCT01498575|19078692|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
5517824|NCT01498575|19078693|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
5517825|NCT01498575|19078692|P2|Overall Sample|Withdrawal by Subject|14
5517826|NCT01498575|19078693|P1|Overall Sample|Withdrawal by Subject|60
5517827|NCT01498458|19078710|P1|Overall Study|Physician Decision|3
5517828|NCT01498458|19078710|P1|Overall Study|Adverse Event|4
5517829|NCT01498445|19078725|P6|Overall Study|Screen Failure|1
5517830|NCT01498445|19078726|P5|Overall Study|Screen Failure|1
5517831|NCT01498445|19078727|P4|Overall Study|Screen Failure|0
5517832|NCT01498445|19078728|P3|Overall Study|Screen Failure|0
5517833|NCT01498445|19078729|P2|Overall Study|Screen Failure|0
5517834|NCT01498445|19078730|P1|Overall Study|Screen Failure|0
5517835|NCT01498445|19078725|P6|Overall Study|Lack of Efficacy|0
5517836|NCT01498445|19078726|P5|Overall Study|Lack of Efficacy|0
5517837|NCT01498445|19078727|P4|Overall Study|Lack of Efficacy|2
5517838|NCT01498445|19078728|P3|Overall Study|Lack of Efficacy|1
5517839|NCT01498445|19078729|P2|Overall Study|Lack of Efficacy|0
5517840|NCT01498445|19078730|P1|Overall Study|Lack of Efficacy|0
5517841|NCT01498289|19078805|P2|Overall Study|Reason under review|1
5517842|NCT01498289|19078806|P1|Overall Study|Reason under review|0
5517843|NCT01498289|19078805|P2|Overall Study|Not protocol specified|2
5517844|NCT01498289|19078806|P1|Overall Study|Not protocol specified|7
5517845|NCT01498289|19078805|P2|Overall Study|Progression/relapse|59
5517846|NCT01498289|19078806|P1|Overall Study|Progression/relapse|53
5517847|NCT01498289|19078805|P2|Overall Study|Withdrawal unrelated to AE|16
5517848|NCT01498289|19078806|P1|Overall Study|Withdrawal unrelated to AE|16
5517849|NCT01498289|19078805|P2|Overall Study|Death|8
5517850|NCT01498289|19078806|P1|Overall Study|Death|6
5517851|NCT01498289|19078805|P2|Overall Study|Adverse Event|18
5517852|NCT01498289|19078806|P1|Overall Study|Adverse Event|16
5517853|NCT01498185|19078827|P5|Overall Study|No longer met criteria, etc|2
5517854|NCT01498185|19078828|P4|Overall Study|No longer met criteria, etc|0
5517855|NCT01498185|19078829|P3|Overall Study|No longer met criteria, etc|0
5517856|NCT01498185|19078830|P2|Overall Study|No longer met criteria, etc|0
5517857|NCT01498185|19078831|P1|Overall Study|No longer met criteria, etc|0
5517858|NCT01498185|19078827|P5|Overall Study|Withdrawal by Subject|1
5517859|NCT01498185|19078828|P4|Overall Study|Withdrawal by Subject|2
5517860|NCT01498185|19078829|P3|Overall Study|Withdrawal by Subject|0
5517861|NCT01498185|19078830|P2|Overall Study|Withdrawal by Subject|1
5517862|NCT01498185|19078831|P1|Overall Study|Withdrawal by Subject|1
5517863|NCT01498185|19078827|P5|Overall Study|Adverse Event|0
5517864|NCT01498185|19078828|P4|Overall Study|Adverse Event|1
5517865|NCT01498185|19078829|P3|Overall Study|Adverse Event|0
5517866|NCT01498185|19078830|P2|Overall Study|Adverse Event|0
5517867|NCT01498185|19078831|P1|Overall Study|Adverse Event|0
5517868|NCT01498120|19078871|P1|Overall Study|Other|4
5517869|NCT01498120|19078871|P1|Overall Study|AE, non-serious non-fatal|3
5517870|NCT01498120|19078871|P1|Overall Study|Withdrawal by Subject|5
5517871|NCT01498120|19078871|P1|Overall Study|Lost to Follow-up|1
5517872|NCT01498068|19078878|P2|Overall Study|Withdrawal by Subject|1
5517873|NCT01498068|19078879|P1|Overall Study|Withdrawal by Subject|1
5517874|NCT01497938|19078897|P2|Overall Study|Device Violation|0
5517875|NCT01497938|19078898|P1|Overall Study|Device Violation|1
5517876|NCT01497938|19078897|P2|Overall Study|Withdrawal by Subject|0
5517877|NCT01497938|19078898|P1|Overall Study|Withdrawal by Subject|4
5517878|NCT01497938|19078897|P2|Overall Study|Physician Decision|1
5517879|NCT01497938|19078898|P1|Overall Study|Physician Decision|0
5517880|NCT01497938|19078897|P2|Overall Study|Adverse Event|1
5517881|NCT01497938|19078898|P1|Overall Study|Adverse Event|0
5517882|NCT01497899|19078910|P4|Open-Label Extension Phase|Lost to Follow-up|5
5517883|NCT01497899|19078911|P3|Open-Label Extension Phase|Lost to Follow-up|5
5517884|NCT01497899|19078912|P2|Open-Label Extension Phase|Lost to Follow-up|3
5517885|NCT01497899|19078913|P1|Open-Label Extension Phase|Lost to Follow-up|9
5517886|NCT01497899|19078910|P4|Open-Label Extension Phase|Protocol Violation|0
5517887|NCT01497899|19078911|P3|Open-Label Extension Phase|Protocol Violation|1
5517888|NCT01497899|19078912|P2|Open-Label Extension Phase|Protocol Violation|0
5517889|NCT01497899|19078913|P1|Open-Label Extension Phase|Protocol Violation|0
5517890|NCT01497899|19078910|P4|Open-Label Extension Phase|Pregnancy|0
5517891|NCT01497899|19078911|P3|Open-Label Extension Phase|Pregnancy|1
5517892|NCT01497899|19078912|P2|Open-Label Extension Phase|Pregnancy|1
5517893|NCT01497899|19078913|P1|Open-Label Extension Phase|Pregnancy|0
5517894|NCT01497899|19078910|P4|Open-Label Extension Phase|Withdrew Consent|0
5517895|NCT01497899|19078911|P3|Open-Label Extension Phase|Withdrew Consent|2
5517896|NCT01497899|19078912|P2|Open-Label Extension Phase|Withdrew Consent|3
5517897|NCT01497899|19078913|P1|Open-Label Extension Phase|Withdrew Consent|8
5517898|NCT01497899|19078910|P4|Open-Label Extension Phase|Death|0
5517899|NCT01497899|19078911|P3|Open-Label Extension Phase|Death|0
5517900|NCT01497899|19078912|P2|Open-Label Extension Phase|Death|0
5517901|NCT01497899|19078913|P1|Open-Label Extension Phase|Death|1
5517902|NCT01497899|19078910|P4|Open-Label Extension Phase|Adverse Event|0
5517903|NCT01497899|19078911|P3|Open-Label Extension Phase|Adverse Event|0
5517904|NCT01497899|19078912|P2|Open-Label Extension Phase|Adverse Event|0
5517905|NCT01497899|19078913|P1|Open-Label Extension Phase|Adverse Event|1
5517906|NCT01497899|19078910|P4|Double-Blind Phase|Subject Non-Compliance|0
5517907|NCT01497899|19078911|P3|Double-Blind Phase|Subject Non-Compliance|0
5517908|NCT01497899|19078912|P2|Double-Blind Phase|Subject Non-Compliance|1
5517909|NCT01497899|19078913|P1|Double-Blind Phase|Subject Non-Compliance|0
5517910|NCT01497899|19078910|P4|Double-Blind Phase|Lost to Follow-up|0
5517911|NCT01497899|19078911|P3|Double-Blind Phase|Lost to Follow-up|0
5517912|NCT01497899|19078912|P2|Double-Blind Phase|Lost to Follow-up|2
5517913|NCT01497899|19078913|P1|Double-Blind Phase|Lost to Follow-up|3
5517914|NCT01497899|19078910|P4|Double-Blind Phase|Withdrew Consent|0
5517915|NCT01497899|19078911|P3|Double-Blind Phase|Withdrew Consent|0
5517916|NCT01497899|19078912|P2|Double-Blind Phase|Withdrew Consent|1
5517917|NCT01497899|19078913|P1|Double-Blind Phase|Withdrew Consent|0
5517918|NCT01497899|19078910|P4|Double-Blind Phase|Investigator's Discretion|0
5517919|NCT01497899|19078911|P3|Double-Blind Phase|Investigator's Discretion|0
5517920|NCT01497899|19078912|P2|Double-Blind Phase|Investigator's Discretion|0
5517921|NCT01497899|19078913|P1|Double-Blind Phase|Investigator's Discretion|1
5517922|NCT01497899|19078910|P4|Double-Blind Phase|Lack of Efficacy|0
5517923|NCT01497899|19078911|P3|Double-Blind Phase|Lack of Efficacy|0
5517924|NCT01497899|19078912|P2|Double-Blind Phase|Lack of Efficacy|1
5517925|NCT01497899|19078913|P1|Double-Blind Phase|Lack of Efficacy|0
5517926|NCT01497899|19078910|P4|Double-Blind Phase|Adverse Event|0
5517927|NCT01497899|19078911|P3|Double-Blind Phase|Adverse Event|0
5517928|NCT01497899|19078912|P2|Double-Blind Phase|Adverse Event|0
5517929|NCT01497899|19078913|P1|Double-Blind Phase|Adverse Event|1
5517930|NCT01497899|19078910|P4|Double-Blind Phase|Randomized but not Treated|0
5517931|NCT01497899|19078911|P3|Double-Blind Phase|Randomized but not Treated|0
5517932|NCT01497899|19078912|P2|Double-Blind Phase|Randomized but not Treated|0
5517933|NCT01497899|19078913|P1|Double-Blind Phase|Randomized but not Treated|1
5517934|NCT01497366|19078990|P2|Overall Study|Randomized but not treated|21
5517935|NCT01497366|19078991|P1|Overall Study|Randomized but not treated|7
5517936|NCT01497366|19078990|P2|Overall Study|Death|1
5517937|NCT01497366|19078991|P1|Overall Study|Death|1
5517938|NCT01497366|19078990|P2|Overall Study|Other|0
5517939|NCT01497366|19078991|P1|Overall Study|Other|5
5517940|NCT01497366|19078990|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
5517941|NCT01497366|19078991|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
5517942|NCT01497366|19078990|P2|Overall Study|Withdrawal by Subject|6
5517943|NCT01497366|19078991|P1|Overall Study|Withdrawal by Subject|6
5517944|NCT01497366|19078990|P2|Overall Study|Lost to Follow-up|10
5517945|NCT01497366|19078991|P1|Overall Study|Lost to Follow-up|11
5517946|NCT01497366|19078990|P2|Overall Study|Virologic failure|50
5517947|NCT01497366|19078991|P1|Overall Study|Virologic failure|2
5517948|NCT01497275|19079009|P1|Overall Study|Adverse Event|1
5517949|NCT01497275|19079009|P1|Overall Study|Death|1
5517950|NCT01497262|19079016|P1|Overall Study|Protocol Violation|1
5517951|NCT01497262|19079016|P1|Overall Study|Adverse Event|2
5517952|NCT01497262|19079016|P1|Overall Study|Withdrawal by Subject|2
5517953|NCT01497262|19079016|P1|Overall Study|Physician Decision|1
5517954|NCT01497262|19079016|P1|Overall Study|Abnormal Test Procedure Result|1
5517955|NCT01497262|19079016|P1|Overall Study|Abnormal Lab Values|4
5517956|NCT01497197|19079023|P2|Overall Study|Other|1
5517957|NCT01497197|19079024|P1|Overall Study|Other|3
5517958|NCT01497197|19079023|P2|Overall Study|All embryos discarded|3
5517959|NCT01497197|19079024|P1|Overall Study|All embryos discarded|0
5517960|NCT01497197|19079023|P2|Overall Study|Intention to freeze all embryos|1
5517961|NCT01497197|19079024|P1|Overall Study|Intention to freeze all embryos|0
5517962|NCT01497197|19079023|P2|Overall Study|No fertilisation|5
5517963|NCT01497197|19079024|P1|Overall Study|No fertilisation|6
5517964|NCT01497197|19079023|P2|Overall Study|No oocytes retrieved|2
5517965|NCT01497197|19079024|P1|Overall Study|No oocytes retrieved|3
5517966|NCT01497197|19079023|P2|Overall Study|Risk of OHSS|0
5517967|NCT01497197|19079024|P1|Overall Study|Risk of OHSS|1
5517968|NCT01497197|19079023|P2|Overall Study|Excessive/lack of response to treatment|0
5517969|NCT01497197|19079024|P1|Overall Study|Excessive/lack of response to treatment|1
5517970|NCT01497197|19079023|P2|Overall Study|Withdrawal by Subject|1
5517971|NCT01497197|19079024|P1|Overall Study|Withdrawal by Subject|2
5517972|NCT01497197|19079023|P2|Overall Study|Protocol Violation|2
5517973|NCT01497197|19079024|P1|Overall Study|Protocol Violation|0
5517974|NCT01497197|19079023|P2|Overall Study|Lost to Follow-up|0
5517975|NCT01497197|19079024|P1|Overall Study|Lost to Follow-up|1
5517976|NCT01497067|19079059|P1|Overall Study|Other|13
5517977|NCT01497067|19079059|P1|Overall Study|Patient decision unrel to Adverse Event|10
5517978|NCT01497067|19079059|P1|Overall Study|Adverse Event|3
5517979|NCT01497067|19079059|P1|Overall Study|Lost to Follow-up|56
5517980|NCT01496846|19079070|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5517981|NCT01496846|19079071|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5517982|NCT01496846|19079072|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5517983|NCT01496846|19079073|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
5517984|NCT01496846|19079074|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
5517985|NCT01496846|19079075|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
5517986|NCT01496807|19079086|P1|Overall Study|Change in diagnosis|1
5517987|NCT01496807|19079086|P1|Overall Study|Participant preference/toxicity|8
5517988|NCT01496807|19079086|P1|Overall Study|Progressive Disease|21
5517989|NCT01496469|19079098|P2|Overall Study|Other|1
5517990|NCT01496469|19079099|P1|Overall Study|Other|1
5517991|NCT01496469|19079098|P2|Overall Study|BP exceeds protocol limits|2
5517992|NCT01496469|19079099|P1|Overall Study|BP exceeds protocol limits|1
5517993|NCT01496469|19079098|P2|Overall Study|Withdrawal by Subject|4
5517994|NCT01496469|19079099|P1|Overall Study|Withdrawal by Subject|4
5517995|NCT01496469|19079098|P2|Overall Study|Lost to Follow-up|1
5517996|NCT01496469|19079099|P1|Overall Study|Lost to Follow-up|1
5517997|NCT01496469|19079098|P2|Overall Study|Protocol Violation|0
5517998|NCT01496469|19079099|P1|Overall Study|Protocol Violation|2
5517999|NCT01496469|19079098|P2|Overall Study|Adverse Event|0
5518000|NCT01496469|19079099|P1|Overall Study|Adverse Event|1
5518001|NCT01496456|19079109|P1|Overall Study|Lost to Follow-up|7
5518002|NCT01496456|19079109|P1|Overall Study|Protocol Violation|1
5518003|NCT01496430|19079122|P3|Overall Study|Other|0
5518004|NCT01496430|19079123|P2|Overall Study|Other|0
5518005|NCT01496430|19079124|P1|Overall Study|Other|2
5518006|NCT01496430|19079122|P3|Overall Study|Principal Investigator Discretion|1
5518007|NCT01496430|19079123|P2|Overall Study|Principal Investigator Discretion|1
5518008|NCT01496430|19079124|P1|Overall Study|Principal Investigator Discretion|0
5518009|NCT01496430|19079122|P3|Overall Study|Voluntary Withdrawal|6
5518010|NCT01496430|19079123|P2|Overall Study|Voluntary Withdrawal|1
5518011|NCT01496430|19079124|P1|Overall Study|Voluntary Withdrawal|2
5518012|NCT01496430|19079122|P3|Overall Study|Lost to Follow-up|1
5518013|NCT01496430|19079123|P2|Overall Study|Lost to Follow-up|3
5518014|NCT01496430|19079124|P1|Overall Study|Lost to Follow-up|2
5518015|NCT01496430|19079122|P3|Overall Study|Major Protocol Deviation|1
5518016|NCT01496430|19079123|P2|Overall Study|Major Protocol Deviation|0
5518017|NCT01496430|19079124|P1|Overall Study|Major Protocol Deviation|0
5518018|NCT01496430|19079122|P3|Overall Study|Adverse Event|1
5518019|NCT01496430|19079123|P2|Overall Study|Adverse Event|0
5518020|NCT01496430|19079124|P1|Overall Study|Adverse Event|0
5518021|NCT01496287|19079236|P1|Overall Study|Incomplete anesthesia|5
5518022|NCT01496287|19079236|P1|Overall Study|Lost to Follow-up|1
5518023|NCT01496274|19079246|P2|Overall Study|Lost to Follow-up|3
5518024|NCT01496274|19079247|P1|Overall Study|Lost to Follow-up|0
5518025|NCT01496274|19079246|P2|Overall Study|Withdrawal by Subject|0
5518026|NCT01496274|19079247|P1|Overall Study|Withdrawal by Subject|2
5518027|NCT01496274|19079246|P2|Overall Study|Adverse Event|1
5518028|NCT01496274|19079247|P1|Overall Study|Adverse Event|1
5518029|NCT01496274|19079246|P2|Overall Study|Protocol Violation|1
5518030|NCT01496274|19079247|P1|Overall Study|Protocol Violation|0
5518031|NCT01496183|19079292|P2|Overall Study|Withdrawal by Subject|1
5518032|NCT01496183|19079293|P1|Overall Study|Withdrawal by Subject|0
5518033|NCT01496183|19079292|P2|Overall Study|Physician Decision|1
5518034|NCT01496183|19079293|P1|Overall Study|Physician Decision|3
5518035|NCT01496066|19079345|P2|Overall Study|Death|4
5518036|NCT01496066|19079346|P1|Overall Study|Death|1
5518037|NCT01496066|19079345|P2|Overall Study|Explant|0
5518038|NCT01496066|19079346|P1|Overall Study|Explant|3
5518039|NCT01496066|19079345|P2|Overall Study|Lost to Follow-up|5
5518040|NCT01496066|19079346|P1|Overall Study|Lost to Follow-up|8
5518041|NCT01495975|19079408|P2|Overall Study|Lost to Follow-up|0
5518042|NCT01495975|19079409|P1|Overall Study|Lost to Follow-up|1
5518043|NCT01495793|19079533|P1|Overall Study|Violation of inclusion criteria|1
5518044|NCT01495793|19079533|P1|Overall Study|Lost to Follow-up|1
5518045|NCT01495702|19079546|P2|Randomized Phase|Protocol Violation|1
5518046|NCT01495702|19079547|P1|Randomized Phase|Protocol Violation|3
5518047|NCT01495702|19079546|P2|Randomized Phase|Participant Noncompliance|0
5518048|NCT01495702|19079547|P1|Randomized Phase|Participant Noncompliance|1
5518049|NCT01495702|19079546|P2|Randomized Phase|Lost to Follow-up|3
5518050|NCT01495702|19079547|P1|Randomized Phase|Lost to Follow-up|4
5518051|NCT01495702|19079546|P2|Randomized Phase|Withdrew Consent|18
5518052|NCT01495702|19079547|P1|Randomized Phase|Withdrew Consent|10
5518053|NCT01495702|19079546|P2|Randomized Phase|Investigators Discretion|0
5518054|NCT01495702|19079547|P1|Randomized Phase|Investigators Discretion|2
5518055|NCT01495702|19079546|P2|Randomized Phase|Lack of Efficacy|0
5518056|NCT01495702|19079547|P1|Randomized Phase|Lack of Efficacy|2
5518057|NCT01495702|19079546|P2|Randomized Phase|Death|0
5518058|NCT01495702|19079547|P1|Randomized Phase|Death|1
5518059|NCT01495702|19079546|P2|Randomized Phase|Adverse Event|2
5518060|NCT01495702|19079547|P1|Randomized Phase|Adverse Event|2
5518061|NCT01495702|19079546|P2|Randomized Phase|Randomized But Not Treated|4
5518062|NCT01495702|19079547|P1|Randomized Phase|Randomized But Not Treated|1
5518063|NCT01495000|19079625|P2|Overall Study|Withdrawal by Subject|10
5518064|NCT01495000|19079626|P1|Overall Study|Withdrawal by Subject|10
5518065|NCT01495000|19079625|P2|Overall Study|Protocol Violation|0
5518066|NCT01495000|19079626|P1|Overall Study|Protocol Violation|1
5518067|NCT01495000|19079625|P2|Overall Study|Lost to Follow-up|2
5518068|NCT01495000|19079626|P1|Overall Study|Lost to Follow-up|2
5518069|NCT01494987|19079668|P2|Overall Study|Subject Withdrew Consent|3
5518070|NCT01494987|19079669|P1|Overall Study|Subject Withdrew Consent|2
5518071|NCT01494987|19079668|P2|Overall Study|Subject Non-Compliance|10
5518072|NCT01494987|19079669|P1|Overall Study|Subject Non-Compliance|9
5518073|NCT01494987|19079668|P2|Overall Study|Protocol Violation|3
5518074|NCT01494987|19079669|P1|Overall Study|Protocol Violation|3
5518075|NCT01494987|19079668|P2|Overall Study|Lost to Follow-up|1
5518076|NCT01494987|19079669|P1|Overall Study|Lost to Follow-up|1
5518077|NCT01494987|19079668|P2|Overall Study|Investigator's Discretion|2
5518078|NCT01494987|19079669|P1|Overall Study|Investigator's Discretion|1
5518079|NCT01494987|19079668|P2|Overall Study|Hyperglycemia|4
5518080|NCT01494987|19079669|P1|Overall Study|Hyperglycemia|6
5518081|NCT01494987|19079668|P2|Overall Study|Adverse Event|5
5518082|NCT01494987|19079669|P1|Overall Study|Adverse Event|6
5518083|NCT01494818|19079683|P2|Overall Study|Lost to Follow-up|0
5518084|NCT01494818|19079684|P1|Overall Study|Lost to Follow-up|1
5518085|NCT01494818|19079683|P2|Overall Study|Relocation|2
5518086|NCT01494818|19079684|P1|Overall Study|Relocation|1
5518087|NCT01494649|19079715|P2|Overall Study|Lost to Follow-up|1
5518088|NCT01494649|19079716|P1|Overall Study|Lost to Follow-up|0
5518089|NCT01494610|19079732|P2|Period 4|Protocol Violation|0
5518090|NCT01494610|19079733|P1|Period 4|Protocol Violation|1
5518091|NCT01494610|19079732|P2|Period 3|Withdrawal by Subject|0
5518092|NCT01494610|19079733|P1|Period 3|Withdrawal by Subject|1
5518093|NCT01494610|19079732|P2|Period 3|Adverse Event|0
5518094|NCT01494610|19079733|P1|Period 3|Adverse Event|1
5518095|NCT01494610|19079732|P2|Period 1|Withdrawal by Subject|1
5518096|NCT01494610|19079733|P1|Period 1|Withdrawal by Subject|1
5518097|NCT01494584|19079801|P1|Overall Study|Study Closed/Terminated|1
5518098|NCT01494532|19079933|P6|Overall Study|Withdrawal by Subject|0
5518099|NCT01494532|19079934|P5|Overall Study|Withdrawal by Subject|2
5518100|NCT01494532|19079935|P4|Overall Study|Withdrawal by Subject|3
5518101|NCT01494532|19079936|P3|Overall Study|Withdrawal by Subject|4
5518102|NCT01494532|19079937|P2|Overall Study|Withdrawal by Subject|1
5518103|NCT01494532|19079938|P1|Overall Study|Withdrawal by Subject|3
5518104|NCT01494532|19079933|P6|Overall Study|Physician Decision|0
5518105|NCT01494532|19079934|P5|Overall Study|Physician Decision|0
5518106|NCT01494532|19079935|P4|Overall Study|Physician Decision|2
5518107|NCT01494532|19079936|P3|Overall Study|Physician Decision|1
5518108|NCT01494532|19079937|P2|Overall Study|Physician Decision|1
5518109|NCT01494532|19079938|P1|Overall Study|Physician Decision|0
5518110|NCT01494532|19079933|P6|Overall Study|Lost to Follow-up|0
5518111|NCT01494532|19079934|P5|Overall Study|Lost to Follow-up|0
5518112|NCT01494532|19079935|P4|Overall Study|Lost to Follow-up|2
5518113|NCT01494532|19079936|P3|Overall Study|Lost to Follow-up|0
5518114|NCT01494532|19079937|P2|Overall Study|Lost to Follow-up|0
5518115|NCT01494532|19079938|P1|Overall Study|Lost to Follow-up|1
5518116|NCT01494532|19079933|P6|Overall Study|Protocol-defined stopping criteria|0
5518117|NCT01494532|19079934|P5|Overall Study|Protocol-defined stopping criteria|0
5518118|NCT01494532|19079935|P4|Overall Study|Protocol-defined stopping criteria|0
5518119|NCT01494532|19079936|P3|Overall Study|Protocol-defined stopping criteria|1
5518120|NCT01494532|19079937|P2|Overall Study|Protocol-defined stopping criteria|0
5518121|NCT01494532|19079938|P1|Overall Study|Protocol-defined stopping criteria|0
5518122|NCT01494532|19079933|P6|Overall Study|Protocol deviation|0
5518123|NCT01494532|19079934|P5|Overall Study|Protocol deviation|3
5518124|NCT01494532|19079935|P4|Overall Study|Protocol deviation|2
5518125|NCT01494532|19079936|P3|Overall Study|Protocol deviation|3
5518126|NCT01494532|19079937|P2|Overall Study|Protocol deviation|1
5518127|NCT01494532|19079938|P1|Overall Study|Protocol deviation|2
5518128|NCT01494532|19079933|P6|Overall Study|Lack of Efficacy|0
5518129|NCT01494532|19079934|P5|Overall Study|Lack of Efficacy|2
5518130|NCT01494532|19079935|P4|Overall Study|Lack of Efficacy|0
5518131|NCT01494532|19079936|P3|Overall Study|Lack of Efficacy|0
5518132|NCT01494532|19079937|P2|Overall Study|Lack of Efficacy|0
5518133|NCT01494532|19079938|P1|Overall Study|Lack of Efficacy|0
5518134|NCT01494532|19079933|P6|Overall Study|Adverse Event|0
5518135|NCT01494532|19079934|P5|Overall Study|Adverse Event|5
5518136|NCT01494532|19079935|P4|Overall Study|Adverse Event|6
5518137|NCT01494532|19079936|P3|Overall Study|Adverse Event|8
5518138|NCT01494532|19079937|P2|Overall Study|Adverse Event|1
5518139|NCT01494532|19079938|P1|Overall Study|Adverse Event|4
5518140|NCT01494506|19080093|P3|Overall Study|Other|1
5518141|NCT01494506|19080094|P2|Overall Study|Other|3
5518142|NCT01494506|19080095|P1|Overall Study|Other|0
5518143|NCT01494506|19080093|P3|Overall Study|Sponsor Decision|1
5518144|NCT01494506|19080094|P2|Overall Study|Sponsor Decision|0
5518145|NCT01494506|19080095|P1|Overall Study|Sponsor Decision|0
5518146|NCT01494506|19080093|P3|Overall Study|Clinical Deterioration|13
5518147|NCT01494506|19080094|P2|Overall Study|Clinical Deterioration|17
5518148|NCT01494506|19080095|P1|Overall Study|Clinical Deterioration|21
5518149|NCT01494506|19080093|P3|Overall Study|Withdrawal by Subject|14
5518150|NCT01494506|19080094|P2|Overall Study|Withdrawal by Subject|20
5518151|NCT01494506|19080095|P1|Overall Study|Withdrawal by Subject|17
5518152|NCT01494506|19080093|P3|Overall Study|Physician Decision|4
5518153|NCT01494506|19080094|P2|Overall Study|Physician Decision|5
5518154|NCT01494506|19080095|P1|Overall Study|Physician Decision|7
5518155|NCT01494506|19080093|P3|Overall Study|Death|2
5518156|NCT01494506|19080094|P2|Overall Study|Death|5
5518157|NCT01494506|19080095|P1|Overall Study|Death|9
5518158|NCT01494506|19080093|P3|Overall Study|Adverse Event|11
5518159|NCT01494506|19080094|P2|Overall Study|Adverse Event|10
5518160|NCT01494506|19080095|P1|Overall Study|Adverse Event|17
5518161|NCT01494506|19080093|P3|Overall Study|Lack of Efficacy|57
5518162|NCT01494506|19080094|P2|Overall Study|Lack of Efficacy|83
5518163|NCT01494506|19080095|P1|Overall Study|Lack of Efficacy|77
5518164|NCT01494467|19080132|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
5518165|NCT01494467|19080133|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
5518166|NCT01494467|19080132|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
5518167|NCT01494467|19080133|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
5518168|NCT01494467|19080132|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
5518169|NCT01494467|19080133|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
5518170|NCT01494467|19080132|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
5518171|NCT01494467|19080133|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
5518172|NCT01494467|19080132|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
5518173|NCT01494467|19080133|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
5518174|NCT01494467|19080132|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
5518175|NCT01494467|19080133|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
5518176|NCT01494467|19080132|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
5518177|NCT01494467|19080133|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
5518178|NCT01494467|19080132|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
5518179|NCT01494467|19080133|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
5518180|NCT01494467|19080132|P2|Part A Vehicle Control (12 Weeks)|Other|1
5518181|NCT01494467|19080133|P1|Part A Vehicle Control (12 Weeks)|Other|1
5518182|NCT01494467|19080132|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
5518183|NCT01494467|19080133|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
5518184|NCT01494467|19080132|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
5518185|NCT01494467|19080133|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
5518186|NCT01494467|19080132|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
5518187|NCT01494467|19080133|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
5518188|NCT01494467|19080132|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
5518189|NCT01494467|19080133|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
5518190|NCT01494467|19080132|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
5518191|NCT01494467|19080133|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
5518192|NCT01494350|19080149|P1|Overall Study|Worsening of lesion|1
5518193|NCT01494298|19080159|P2|Overall Study|Protocol Violation|8
5518194|NCT01494298|19080160|P1|Overall Study|Protocol Violation|2
5518195|NCT01494038|19080183|P2|Overall Study|Death|4
5518196|NCT01494038|19080184|P1|Overall Study|Death|2
5518197|NCT01494038|19080183|P2|Overall Study|Not willing to adhere to reqs|9
5518198|NCT01494038|19080184|P1|Overall Study|Not willing to adhere to reqs|2
5518199|NCT01494038|19080183|P2|Overall Study|Not able to get to clinic|15
5518200|NCT01494038|19080184|P1|Overall Study|Not able to get to clinic|21
5518201|NCT01494038|19080183|P2|Overall Study|Withdrawal by Subject|34
5518202|NCT01494038|19080184|P1|Overall Study|Withdrawal by Subject|44
5518203|NCT01494038|19080183|P2|Overall Study|Lost to Follow-up|20
5518204|NCT01494038|19080184|P1|Overall Study|Lost to Follow-up|18
5518205|NCT01494038|19080183|P2|Overall Study|Protocol Violation|1
5518206|NCT01494038|19080184|P1|Overall Study|Protocol Violation|1
5518207|NCT01493960|19080272|P2|Overall Study|Non-specified|4
5518208|NCT01493960|19080273|P1|Overall Study|Non-specified|4
5518209|NCT01493960|19080272|P2|Overall Study|Withdrawal by Subject|4
5518210|NCT01493960|19080273|P1|Overall Study|Withdrawal by Subject|10
5518211|NCT01493960|19080272|P2|Overall Study|Protocol Violation|0
5518212|NCT01493960|19080273|P1|Overall Study|Protocol Violation|3
5518213|NCT01493960|19080272|P2|Overall Study|Lack of Efficacy|9
5518214|NCT01493960|19080273|P1|Overall Study|Lack of Efficacy|15
5518215|NCT01493960|19080272|P2|Overall Study|Adverse Event|1
5518216|NCT01493960|19080273|P1|Overall Study|Adverse Event|0
5518217|NCT01493778|19080304|P1|Overall Study|Withdrawal by Subject|8
5518218|NCT01493687|19080366|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
5518219|NCT01493687|19080367|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
5518220|NCT01493687|19080366|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
5518221|NCT01493687|19080367|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
5518222|NCT01493687|19080366|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
5518223|NCT01493687|19080367|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
5518224|NCT01493687|19080366|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
5518225|NCT01493687|19080367|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
5518226|NCT01493687|19080366|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
5518227|NCT01493687|19080367|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
5518228|NCT01493687|19080366|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
5518229|NCT01493687|19080367|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
5518230|NCT01493687|19080366|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
5518231|NCT01493687|19080367|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
5518232|NCT01493687|19080366|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
5518233|NCT01493687|19080367|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
5518234|NCT01493687|19080366|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
5518235|NCT01493687|19080367|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
5518236|NCT01493687|19080366|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
5518237|NCT01493687|19080367|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
5518238|NCT01493687|19080366|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
5518239|NCT01493687|19080367|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
5518240|NCT01493687|19080366|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
5518241|NCT01493687|19080367|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
5518242|NCT01493687|19080366|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
5518243|NCT01493687|19080367|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
5518244|NCT01493687|19080366|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
5518245|NCT01493687|19080367|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
5518246|NCT01493687|19080366|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
5518247|NCT01493687|19080367|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
5518248|NCT01493557|19080386|P3|Adding the Second Strategy|Withdrawal by Subject|0
5518249|NCT01493557|19080387|P2|Adding the Second Strategy|Withdrawal by Subject|1
5518250|NCT01493557|19080388|P1|Adding the Second Strategy|Withdrawal by Subject|0
5518251|NCT01493557|19080386|P3|Adding the Second Strategy|Other adverse event|0
5518252|NCT01493557|19080387|P2|Adding the Second Strategy|Other adverse event|2
5518253|NCT01493557|19080388|P1|Adding the Second Strategy|Other adverse event|1
5518254|NCT01493557|19080386|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
5518255|NCT01493557|19080387|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
5518256|NCT01493557|19080388|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
5518257|NCT01493557|19080386|P3|Randomized to Management Strategies|Other than stated above|0
5518258|NCT01493557|19080387|P2|Randomized to Management Strategies|Other than stated above|3
5518259|NCT01493557|19080388|P1|Randomized to Management Strategies|Other than stated above|1
5518260|NCT01493557|19080386|P3|Randomized to Management Strategies|Withdrawal by Subject|0
5518261|NCT01493557|19080387|P2|Randomized to Management Strategies|Withdrawal by Subject|1
5518262|NCT01493557|19080388|P1|Randomized to Management Strategies|Withdrawal by Subject|0
5518263|NCT01493557|19080386|P3|Randomized to Management Strategies|Protocol Violation|0
5518264|NCT01493557|19080387|P2|Randomized to Management Strategies|Protocol Violation|0
5518265|NCT01493557|19080388|P1|Randomized to Management Strategies|Protocol Violation|3
5518266|NCT01493557|19080386|P3|Randomized to Management Strategies|Other adverse event|0
5518267|NCT01493557|19080387|P2|Randomized to Management Strategies|Other adverse event|5
5518268|NCT01493557|19080388|P1|Randomized to Management Strategies|Other adverse event|8
5518269|NCT01493557|19080386|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
5518270|NCT01493557|19080387|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
5518271|NCT01493557|19080388|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
5518272|NCT01493557|19080386|P3|Not Randomized to Management Strategies|Other than stated above|21
5518273|NCT01493557|19080387|P2|Not Randomized to Management Strategies|Other than stated above|0
5518274|NCT01493557|19080388|P1|Not Randomized to Management Strategies|Other than stated above|0
5518275|NCT01493557|19080386|P3|Not Randomized to Management Strategies|Early termination|34
5518276|NCT01493557|19080387|P2|Not Randomized to Management Strategies|Early termination|0
5518277|NCT01493557|19080388|P1|Not Randomized to Management Strategies|Early termination|0
5518278|NCT01493557|19080386|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
5518279|NCT01493557|19080387|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
5518363|NCT01492426|19080680|P1|Follow-Up|Death|1
5518280|NCT01493557|19080388|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
5518281|NCT01493557|19080386|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
5518282|NCT01493557|19080387|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
5518283|NCT01493557|19080388|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
5518284|NCT01493557|19080386|P3|Not Randomized to Management Strategies|Protocol Violation|1
5518285|NCT01493557|19080387|P2|Not Randomized to Management Strategies|Protocol Violation|0
5518286|NCT01493557|19080388|P1|Not Randomized to Management Strategies|Protocol Violation|0
5518287|NCT01493557|19080386|P3|Not Randomized to Management Strategies|Other adverse event|54
5518288|NCT01493557|19080387|P2|Not Randomized to Management Strategies|Other adverse event|0
5518289|NCT01493557|19080388|P1|Not Randomized to Management Strategies|Other adverse event|0
5518290|NCT01493557|19080386|P3|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
5518291|NCT01493557|19080387|P2|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
5518292|NCT01493557|19080388|P1|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
5518293|NCT01493557|19080386|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
5518294|NCT01493557|19080387|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
5518295|NCT01493557|19080388|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
5518296|NCT01493531|19080416|P3|Overall Study|Death|0
5518297|NCT01493531|19080417|P2|Overall Study|Death|1
5518298|NCT01493531|19080418|P1|Overall Study|Death|0
5518299|NCT01493531|19080416|P3|Overall Study|Withdrawal by Subject|11
5518300|NCT01493531|19080417|P2|Overall Study|Withdrawal by Subject|13
5518301|NCT01493531|19080418|P1|Overall Study|Withdrawal by Subject|16
5518302|NCT01493531|19080416|P3|Overall Study|Lost to Follow-up|11
5518303|NCT01493531|19080417|P2|Overall Study|Lost to Follow-up|7
5518304|NCT01493531|19080418|P1|Overall Study|Lost to Follow-up|5
5518305|NCT01493531|19080416|P3|Overall Study|Sponsor terminated study|3
5518306|NCT01493531|19080417|P2|Overall Study|Sponsor terminated study|2
5518307|NCT01493531|19080418|P1|Overall Study|Sponsor terminated study|5
5518308|NCT01493531|19080416|P3|Overall Study|Protocol Violation|12
5518309|NCT01493531|19080417|P2|Overall Study|Protocol Violation|15
5518310|NCT01493531|19080418|P1|Overall Study|Protocol Violation|8
5518311|NCT01493531|19080416|P3|Overall Study|Gout flare|2
5518312|NCT01493531|19080417|P2|Overall Study|Gout flare|0
5518313|NCT01493531|19080418|P1|Overall Study|Gout flare|3
5518314|NCT01493531|19080416|P3|Overall Study|Adverse Event|9
5518315|NCT01493531|19080417|P2|Overall Study|Adverse Event|12
5518316|NCT01493531|19080418|P1|Overall Study|Adverse Event|4
5518317|NCT01493427|19080432|P1|Overall Study|Other|2
5518318|NCT01493427|19080432|P1|Overall Study|Inability to Follow Instructions|2
5518319|NCT01493427|19080432|P1|Overall Study|Lost to Follow-up|2
5518320|NCT01493427|19080432|P1|Overall Study|Personal Reasons|4
5518321|NCT01493427|19080432|P1|Overall Study|Adverse Event|10
5518322|NCT01493414|19080437|P1|Overall Study|Lost to Follow-up|16
5518323|NCT01493414|19080437|P1|Overall Study|Administrative problems|25
5518324|NCT01493414|19080437|P1|Overall Study|Protocol deviation|27
5518325|NCT01493414|19080437|P1|Overall Study|Withdrawal by Subject|79
5518326|NCT01493414|19080437|P1|Overall Study|Physician Decision|93
5518327|NCT01493414|19080437|P1|Overall Study|Death|101
5518328|NCT01493414|19080437|P1|Overall Study|Disease progression|204
5518329|NCT01493414|19080437|P1|Overall Study|Adverse Event|405
5518330|NCT01493284|19080450|P1|Overall Study|Withdrawal by Subject|32
5518331|NCT01493284|19080450|P1|Overall Study|Death|29
5518332|NCT01493089|19080472|P2|Overall Study|Physician Decision|1
5518333|NCT01493089|19080473|P1|Overall Study|Physician Decision|0
5518334|NCT01493089|19080472|P2|Overall Study|Withdrawal by Subject|0
5518335|NCT01493089|19080473|P1|Overall Study|Withdrawal by Subject|1
5518336|NCT01493089|19080472|P2|Overall Study|Protocol Violation|2
5518337|NCT01493089|19080473|P1|Overall Study|Protocol Violation|2
5518338|NCT01492686|19080572|P2|Open-label Phase|Due to a discontinuation criterion|9
5518339|NCT01492686|19080573|P1|Open-label Phase|Due to a discontinuation criterion|4
5518340|NCT01492686|19080572|P2|Open-label Phase|Withdrawal by Subject|7
5518341|NCT01492686|19080573|P1|Open-label Phase|Withdrawal by Subject|6
5518342|NCT01492686|19080572|P2|Open-label Phase|Physician Decision|0
5518343|NCT01492686|19080573|P1|Open-label Phase|Physician Decision|1
5518344|NCT01492686|19080572|P2|Open-label Phase|Adverse Event|2
5518345|NCT01492686|19080573|P1|Open-label Phase|Adverse Event|1
5518346|NCT01492686|19080572|P2|Double-blind Phase|Due to a discontinuation criterion|3
5518347|NCT01492686|19080573|P1|Double-blind Phase|Due to a discontinuation criterion|2
5518348|NCT01492686|19080572|P2|Double-blind Phase|Withdrawal by Subject|2
5518349|NCT01492686|19080573|P1|Double-blind Phase|Withdrawal by Subject|0
5518350|NCT01492686|19080572|P2|Double-blind Phase|Physician Decision|1
5518351|NCT01492686|19080573|P1|Double-blind Phase|Physician Decision|0
5518352|NCT01492686|19080572|P2|Double-blind Phase|Adverse Event|2
5518353|NCT01492686|19080573|P1|Double-blind Phase|Adverse Event|0
5518354|NCT01492439|19080630|P2|Overall Study|Withdrew from RTE|9
5518355|NCT01492439|19080631|P1|Overall Study|Withdrew from RTE|4
5518356|NCT01492426|19080679|P2|Follow-Up|Lost to Follow-up|6
5518357|NCT01492426|19080680|P1|Follow-Up|Lost to Follow-up|12
5518358|NCT01492426|19080679|P2|Follow-Up|Participant Withdrew Consent|1
5518359|NCT01492426|19080680|P1|Follow-Up|Participant Withdrew Consent|6
5518360|NCT01492426|19080679|P2|Follow-Up|Other|2
5518361|NCT01492426|19080680|P1|Follow-Up|Other|4
5518362|NCT01492426|19080679|P2|Follow-Up|Death|0
5518364|NCT01492426|19080679|P2|Follow-Up|Protocol Requires no Follow-Up|1
5518365|NCT01492426|19080680|P1|Follow-Up|Protocol Requires no Follow-Up|2
5518366|NCT01492426|19080679|P2|Treatment|Participant does not meet study criteria|0
5518367|NCT01492426|19080680|P1|Treatment|Participant does not meet study criteria|1
5518368|NCT01492426|19080679|P2|Treatment|Lost to Follow-up|4
5518369|NCT01492426|19080680|P1|Treatment|Lost to Follow-up|9
5518370|NCT01492426|19080679|P2|Treatment|Subject requested discontinue study drug|3
5518371|NCT01492426|19080680|P1|Treatment|Subject requested discontinue study drug|7
5518372|NCT01492426|19080679|P2|Treatment|Poor compliance/noncompliance|0
5518373|NCT01492426|19080680|P1|Treatment|Poor compliance/noncompliance|1
5518374|NCT01492426|19080679|P2|Treatment|Participant withdrew consent|2
5518375|NCT01492426|19080680|P1|Treatment|Participant withdrew consent|1
5518376|NCT01492426|19080679|P2|Treatment|Lack of Efficacy|5
5518377|NCT01492426|19080680|P1|Treatment|Lack of Efficacy|38
5518378|NCT01492426|19080679|P2|Treatment|Adverse Event|25
5518379|NCT01492426|19080680|P1|Treatment|Adverse Event|25
5518380|NCT01492426|19080679|P2|Treatment|Other|0
5518381|NCT01492426|19080680|P1|Treatment|Other|1
5518382|NCT01492426|19080679|P2|Treatment|Death|1
5518383|NCT01492426|19080680|P1|Treatment|Death|0
5518384|NCT01492400|19080698|P2|Overall Study|Adverse Event|5
5518385|NCT01492400|19080699|P1|Overall Study|Adverse Event|10
5518386|NCT01492400|19080698|P2|Overall Study|Lack of Efficacy|1
5518387|NCT01492400|19080699|P1|Overall Study|Lack of Efficacy|1
5518388|NCT01492400|19080698|P2|Overall Study|Pregnancy|1
5518389|NCT01492400|19080699|P1|Overall Study|Pregnancy|0
5518390|NCT01492400|19080698|P2|Overall Study|Lost to Follow-up|1
5518391|NCT01492400|19080699|P1|Overall Study|Lost to Follow-up|3
5518392|NCT01492400|19080698|P2|Overall Study|Personal Reasons|5
5518393|NCT01492400|19080699|P1|Overall Study|Personal Reasons|0
5518394|NCT01492400|19080698|P2|Overall Study|Miscellaneous Reasons|3
5518395|NCT01492400|19080699|P1|Overall Study|Miscellaneous Reasons|2
5518396|NCT01492088|19080723|P3|Overall Study|Alive at Last Follow-up|11
5518397|NCT01492088|19080724|P2|Overall Study|Alive at Last Follow-up|6
5518398|NCT01492088|19080725|P1|Overall Study|Alive at Last Follow-up|0
5518399|NCT01492088|19080723|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
5518400|NCT01492088|19080724|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
5518401|NCT01492088|19080725|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
5518402|NCT01492088|19080723|P3|Overall Study|Death|2
5518403|NCT01492088|19080724|P2|Overall Study|Death|6
5518404|NCT01492088|19080725|P1|Overall Study|Death|1
5518405|NCT01492088|19080723|P3|Overall Study|Withdrawal by Patient|0
5518406|NCT01492088|19080724|P2|Overall Study|Withdrawal by Patient|2
5518407|NCT01492088|19080725|P1|Overall Study|Withdrawal by Patient|0
5518408|NCT01491919|19080806|P3|Overall Study|Insufficient PK sampling|1
5518409|NCT01491919|19080807|P2|Overall Study|Insufficient PK sampling|2
5518410|NCT01491919|19080808|P1|Overall Study|Insufficient PK sampling|1
5518411|NCT01491854|19080879|P1|Overall Study|Lost to Follow-up|33
5518412|NCT01491854|19080879|P1|Overall Study|Withdrawal by Subject|3
5518413|NCT01491854|19080879|P1|Overall Study|Death|1
5518414|NCT01491854|19080879|P1|Overall Study|mainly due to premature termination|93
5518415|NCT01491841|19080890|P1|Overall Study|Withdrawal by Subject|1
5518416|NCT01491841|19080890|P1|Overall Study|Screen Failure|10
5518417|NCT01491802|19080904|P2|Overall Study|Withdrawal by Subject|1
5518418|NCT01491802|19080905|P1|Overall Study|Withdrawal by Subject|0
5518419|NCT01491802|19080904|P2|Overall Study|Adverse Event|1
5518420|NCT01491802|19080905|P1|Overall Study|Adverse Event|1
5518421|NCT01491737|19080932|P2|Overall Study|Reason Not Specified|9
5518422|NCT01491737|19080933|P1|Overall Study|Reason Not Specified|8
5518423|NCT01491737|19080932|P2|Overall Study|Study Termination by Sponsor|36
5518424|NCT01491737|19080933|P1|Overall Study|Study Termination by Sponsor|36
5518425|NCT01491737|19080932|P2|Overall Study|Death|57
5518426|NCT01491737|19080933|P1|Overall Study|Death|63
5518427|NCT01491737|19080932|P2|Overall Study|Lost to Follow-up|10
5518428|NCT01491737|19080933|P1|Overall Study|Lost to Follow-up|2
5518429|NCT01491737|19080932|P2|Overall Study|Withdrawal by Subject|17
5518430|NCT01491737|19080933|P1|Overall Study|Withdrawal by Subject|20
5518431|NCT01491672|19080960|P3|Overall Study|Death|0
5518432|NCT01491672|19080961|P2|Overall Study|Death|4
5518433|NCT01491672|19080962|P1|Overall Study|Death|0
5518434|NCT01491672|19080960|P3|Overall Study|Protocol deviation|0
5518435|NCT01491672|19080961|P2|Overall Study|Protocol deviation|1
5518436|NCT01491672|19080962|P1|Overall Study|Protocol deviation|0
5518437|NCT01491672|19080960|P3|Overall Study|Disease progression|6
5518438|NCT01491672|19080961|P2|Overall Study|Disease progression|34
5518439|NCT01491672|19080962|P1|Overall Study|Disease progression|42
5518440|NCT01491672|19080960|P3|Overall Study|Adverse Event|4
5518441|NCT01491672|19080961|P2|Overall Study|Adverse Event|10
5518442|NCT01491672|19080962|P1|Overall Study|Adverse Event|8
5518443|NCT01491672|19080960|P3|Overall Study|Withdrawal by Subject|0
5518444|NCT01491672|19080961|P2|Overall Study|Withdrawal by Subject|7
5518445|NCT01491672|19080962|P1|Overall Study|Withdrawal by Subject|6
5518446|NCT01491672|19080960|P3|Overall Study|Lost to Follow-up|1
5518447|NCT01491672|19080961|P2|Overall Study|Lost to Follow-up|4
5518448|NCT01491672|19080962|P1|Overall Study|Lost to Follow-up|0
5518449|NCT01491607|19080999|P1|Overall Study|Withdrawal by Subject|3
5518450|NCT01491607|19080999|P1|Overall Study|Lost to Follow-up|7
5518451|NCT01491178|19081104|P1|Overall Study|Other than specified above|657
5518452|NCT01491178|19081104|P1|Overall Study|To take a contraindication|20
5518453|NCT01491178|19081104|P1|Overall Study|Lost to follow-up (changing hospital)|545
5518454|NCT01491178|19081104|P1|Overall Study|Lost to follow-up (unknown reason)|287
5518455|NCT01491178|19081104|P1|Overall Study|To conduct invasive treatment|59
5518456|NCT01491178|19081104|P1|Overall Study|Improvement of NVAF|210
5518457|NCT01491178|19081104|P1|Overall Study|Adverse Event|1016
5518458|NCT01491035|19081213|P8|Overall Study|Lost to Follow-up|0
5518459|NCT01491035|19081214|P7|Overall Study|Lost to Follow-up|0
5518460|NCT01491035|19081215|P6|Overall Study|Lost to Follow-up|0
5518461|NCT01491035|19081216|P5|Overall Study|Lost to Follow-up|1
5518462|NCT01491035|19081217|P4|Overall Study|Lost to Follow-up|0
5518463|NCT01491035|19081218|P3|Overall Study|Lost to Follow-up|0
5518464|NCT01491035|19081219|P2|Overall Study|Lost to Follow-up|0
5518465|NCT01491035|19081220|P1|Overall Study|Lost to Follow-up|0
5518466|NCT01490918|19081324|P3|Overall Study|other cause|8
5518467|NCT01490918|19081325|P2|Overall Study|other cause|5
5518468|NCT01490918|19081326|P1|Overall Study|other cause|4
5518469|NCT01490918|19081324|P3|Overall Study|Adverse Event|1
5518470|NCT01490918|19081325|P2|Overall Study|Adverse Event|0
5518471|NCT01490918|19081326|P1|Overall Study|Adverse Event|0
5518472|NCT01490918|19081324|P3|Overall Study|Withdrawal by Subject|3
5518473|NCT01490918|19081325|P2|Overall Study|Withdrawal by Subject|8
5518474|NCT01490918|19081326|P1|Overall Study|Withdrawal by Subject|7
5518475|NCT01490918|19081324|P3|Overall Study|Lost to Follow-up|0
5518476|NCT01490918|19081325|P2|Overall Study|Lost to Follow-up|1
5518477|NCT01490918|19081326|P1|Overall Study|Lost to Follow-up|2
5518478|NCT01490866|19081364|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
5518479|NCT01490866|19081364|P1|Axitinib Maintenance Therapy|Protocol Violation|2
5518480|NCT01490866|19081364|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
5518481|NCT01490866|19081364|P1|Axitinib Maintenance Therapy|Adverse Event|12
5518482|NCT01490866|19081364|P1|Axitinib Maintenance Therapy|Disease Progression|30
5518483|NCT01490866|19081364|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
5518484|NCT01490866|19081364|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
5518485|NCT01490866|19081364|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
5518486|NCT01490866|19081364|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
5518487|NCT01490866|19081364|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
5518488|NCT01490866|19081364|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
5518489|NCT01490840|19081375|P2|Phase 2|Adverse Event|1
5518490|NCT01490840|19081376|P1|Phase 2|Adverse Event|1
5518491|NCT01490840|19081375|P2|Phase 2|Lost to Follow-up|1
5518492|NCT01490840|19081376|P1|Phase 2|Lost to Follow-up|1
5518493|NCT01490840|19081375|P2|Phase 2|Permanent interruption of fingolimod|1
5518494|NCT01490840|19081376|P1|Phase 2|Permanent interruption of fingolimod|0
5518495|NCT01490840|19081375|P2|Phase 2|Withdrawal by Subject|3
5518496|NCT01490840|19081376|P1|Phase 2|Withdrawal by Subject|4
5518497|NCT01490840|19081375|P2|Phase 1|Visit 6a omitted|0
5518498|NCT01490840|19081376|P1|Phase 1|Visit 6a omitted|1
5518499|NCT01490840|19081375|P2|Phase 1|Withdrawal by Subject|5
5518500|NCT01490840|19081376|P1|Phase 1|Withdrawal by Subject|6
5518501|NCT01490840|19081375|P2|Phase 1|Adverse Event|1
5518502|NCT01490840|19081376|P1|Phase 1|Adverse Event|2
5518503|NCT01490840|19081375|P2|Phase 1|Lost to Follow-up|0
5518504|NCT01490840|19081376|P1|Phase 1|Lost to Follow-up|1
5518505|NCT01490814|19081400|P2|Overall Study|Withdrawal by Subject|5
5518506|NCT01490814|19081401|P1|Overall Study|Withdrawal by Subject|0
5518507|NCT01490814|19081400|P2|Overall Study|Physician Decision|0
5518508|NCT01490814|19081401|P1|Overall Study|Physician Decision|1
5518509|NCT01490814|19081400|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
5518510|NCT01490814|19081401|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
5518511|NCT01490697|19081444|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
5518512|NCT01490697|19081445|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
5518513|NCT01490632|19081465|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
5518514|NCT01490632|19081466|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
5518515|NCT01490632|19081467|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
5518516|NCT01490632|19081468|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518517|NCT01490632|19081469|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518518|NCT01490632|19081470|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518519|NCT01490632|19081471|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518520|NCT01490632|19081472|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518521|NCT01490632|19081473|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518522|NCT01490632|19081474|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518523|NCT01490632|19081475|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518524|NCT01490632|19081476|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518525|NCT01490632|19081477|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518526|NCT01490632|19081478|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518527|NCT01490632|19081479|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518528|NCT01490632|19081480|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518529|NCT01490632|19081481|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518530|NCT01490632|19081482|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518531|NCT01490632|19081483|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518532|NCT01490632|19081484|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
5518533|NCT01490632|19081465|P20|Part D: Re-Treatment Period|Protocol Violation|0
5518534|NCT01490632|19081466|P19|Part D: Re-Treatment Period|Protocol Violation|1
5518535|NCT01490632|19081467|P18|Part D: Re-Treatment Period|Protocol Violation|0
5518536|NCT01490632|19081468|P17|Part D: Re-Treatment Period|Protocol Violation|0
5518537|NCT01490632|19081469|P16|Part D: Re-Treatment Period|Protocol Violation|0
5518538|NCT01490632|19081470|P15|Part D: Re-Treatment Period|Protocol Violation|0
5518539|NCT01490632|19081471|P14|Part D: Re-Treatment Period|Protocol Violation|0
5518540|NCT01490632|19081472|P13|Part D: Re-Treatment Period|Protocol Violation|0
5518541|NCT01490632|19081473|P12|Part D: Re-Treatment Period|Protocol Violation|0
5518542|NCT01490632|19081474|P11|Part D: Re-Treatment Period|Protocol Violation|0
5518543|NCT01490632|19081475|P10|Part D: Re-Treatment Period|Protocol Violation|0
5518544|NCT01490632|19081476|P9|Part D: Re-Treatment Period|Protocol Violation|0
5518545|NCT01490632|19081477|P8|Part D: Re-Treatment Period|Protocol Violation|0
5518546|NCT01490632|19081478|P7|Part D: Re-Treatment Period|Protocol Violation|0
5518547|NCT01490632|19081479|P6|Part D: Re-Treatment Period|Protocol Violation|0
5518548|NCT01490632|19081480|P5|Part D: Re-Treatment Period|Protocol Violation|0
5518549|NCT01490632|19081481|P4|Part D: Re-Treatment Period|Protocol Violation|0
5518550|NCT01490632|19081482|P3|Part D: Re-Treatment Period|Protocol Violation|0
5518551|NCT01490632|19081483|P2|Part D: Re-Treatment Period|Protocol Violation|0
5518552|NCT01490632|19081484|P1|Part D: Re-Treatment Period|Protocol Violation|0
5518553|NCT01490632|19081465|P20|Part D: Re-Treatment Period|Physician Decision|1
5518554|NCT01490632|19081466|P19|Part D: Re-Treatment Period|Physician Decision|1
5518555|NCT01490632|19081467|P18|Part D: Re-Treatment Period|Physician Decision|0
5518556|NCT01490632|19081468|P17|Part D: Re-Treatment Period|Physician Decision|0
5518557|NCT01490632|19081469|P16|Part D: Re-Treatment Period|Physician Decision|0
5518558|NCT01490632|19081470|P15|Part D: Re-Treatment Period|Physician Decision|0
5518559|NCT01490632|19081471|P14|Part D: Re-Treatment Period|Physician Decision|0
5518560|NCT01490632|19081472|P13|Part D: Re-Treatment Period|Physician Decision|0
5518561|NCT01490632|19081473|P12|Part D: Re-Treatment Period|Physician Decision|0
5518562|NCT01490632|19081474|P11|Part D: Re-Treatment Period|Physician Decision|0
5518563|NCT01490632|19081475|P10|Part D: Re-Treatment Period|Physician Decision|0
5518564|NCT01490632|19081476|P9|Part D: Re-Treatment Period|Physician Decision|0
5518565|NCT01490632|19081477|P8|Part D: Re-Treatment Period|Physician Decision|0
5518566|NCT01490632|19081478|P7|Part D: Re-Treatment Period|Physician Decision|0
5518567|NCT01490632|19081479|P6|Part D: Re-Treatment Period|Physician Decision|0
5518568|NCT01490632|19081480|P5|Part D: Re-Treatment Period|Physician Decision|0
5518569|NCT01490632|19081481|P4|Part D: Re-Treatment Period|Physician Decision|0
5518570|NCT01490632|19081482|P3|Part D: Re-Treatment Period|Physician Decision|0
5518571|NCT01490632|19081483|P2|Part D: Re-Treatment Period|Physician Decision|0
5518572|NCT01490632|19081484|P1|Part D: Re-Treatment Period|Physician Decision|0
5518573|NCT01490632|19081465|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
5518574|NCT01490632|19081466|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
5518575|NCT01490632|19081467|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
5518576|NCT01490632|19081468|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
5518577|NCT01490632|19081469|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
5518578|NCT01490632|19081470|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
5518579|NCT01490632|19081471|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
5518580|NCT01490632|19081472|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
5518581|NCT01490632|19081473|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
5518582|NCT01490632|19081474|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
5518583|NCT01490632|19081475|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
5518584|NCT01490632|19081476|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
5518585|NCT01490632|19081477|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
5518586|NCT01490632|19081478|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
5518587|NCT01490632|19081479|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
5518588|NCT01490632|19081480|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
5518589|NCT01490632|19081481|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
5518590|NCT01490632|19081482|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
5518591|NCT01490632|19081483|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
5518592|NCT01490632|19081484|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
5518593|NCT01490632|19081465|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
5518594|NCT01490632|19081466|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
5518595|NCT01490632|19081467|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
5518596|NCT01490632|19081468|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
5518597|NCT01490632|19081469|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
5518598|NCT01490632|19081470|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
5518599|NCT01490632|19081471|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
5518600|NCT01490632|19081472|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
5518601|NCT01490632|19081473|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
5518602|NCT01490632|19081474|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
5518603|NCT01490632|19081475|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
5518604|NCT01490632|19081476|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
5518605|NCT01490632|19081477|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
5518606|NCT01490632|19081478|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
5518607|NCT01490632|19081479|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
5518608|NCT01490632|19081480|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
5518609|NCT01490632|19081481|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
5518610|NCT01490632|19081482|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
5518611|NCT01490632|19081483|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
5518612|NCT01490632|19081484|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
5518613|NCT01490632|19081465|P20|Part D: Re-Treatment Period|Death|0
5518614|NCT01490632|19081466|P19|Part D: Re-Treatment Period|Death|1
5518615|NCT01490632|19081467|P18|Part D: Re-Treatment Period|Death|0
5518616|NCT01490632|19081468|P17|Part D: Re-Treatment Period|Death|0
5518617|NCT01490632|19081469|P16|Part D: Re-Treatment Period|Death|0
5518618|NCT01490632|19081470|P15|Part D: Re-Treatment Period|Death|0
5518619|NCT01490632|19081471|P14|Part D: Re-Treatment Period|Death|0
5518620|NCT01490632|19081472|P13|Part D: Re-Treatment Period|Death|0
5518621|NCT01490632|19081473|P12|Part D: Re-Treatment Period|Death|0
5518622|NCT01490632|19081474|P11|Part D: Re-Treatment Period|Death|0
5518623|NCT01490632|19081475|P10|Part D: Re-Treatment Period|Death|0
5518624|NCT01490632|19081476|P9|Part D: Re-Treatment Period|Death|0
5518625|NCT01490632|19081477|P8|Part D: Re-Treatment Period|Death|0
5518626|NCT01490632|19081478|P7|Part D: Re-Treatment Period|Death|0
5518627|NCT01490632|19081479|P6|Part D: Re-Treatment Period|Death|0
5518628|NCT01490632|19081480|P5|Part D: Re-Treatment Period|Death|0
5518629|NCT01490632|19081481|P4|Part D: Re-Treatment Period|Death|0
5518630|NCT01490632|19081482|P3|Part D: Re-Treatment Period|Death|0
5518631|NCT01490632|19081483|P2|Part D: Re-Treatment Period|Death|0
5518632|NCT01490632|19081484|P1|Part D: Re-Treatment Period|Death|0
5518633|NCT01490632|19081465|P20|Part D: Re-Treatment Period|Adverse Event|3
5518634|NCT01490632|19081466|P19|Part D: Re-Treatment Period|Adverse Event|1
5518635|NCT01490632|19081467|P18|Part D: Re-Treatment Period|Adverse Event|1
5518636|NCT01490632|19081468|P17|Part D: Re-Treatment Period|Adverse Event|0
5518637|NCT01490632|19081469|P16|Part D: Re-Treatment Period|Adverse Event|0
5518638|NCT01490632|19081470|P15|Part D: Re-Treatment Period|Adverse Event|0
5518639|NCT01490632|19081471|P14|Part D: Re-Treatment Period|Adverse Event|0
5518640|NCT01490632|19081472|P13|Part D: Re-Treatment Period|Adverse Event|0
5518641|NCT01490632|19081473|P12|Part D: Re-Treatment Period|Adverse Event|0
5518642|NCT01490632|19081474|P11|Part D: Re-Treatment Period|Adverse Event|0
5518643|NCT01490632|19081475|P10|Part D: Re-Treatment Period|Adverse Event|0
5518644|NCT01490632|19081476|P9|Part D: Re-Treatment Period|Adverse Event|0
5518645|NCT01490632|19081477|P8|Part D: Re-Treatment Period|Adverse Event|0
5518646|NCT01490632|19081478|P7|Part D: Re-Treatment Period|Adverse Event|0
5518647|NCT01490632|19081479|P6|Part D: Re-Treatment Period|Adverse Event|0
5518648|NCT01490632|19081480|P5|Part D: Re-Treatment Period|Adverse Event|0
5518649|NCT01490632|19081481|P4|Part D: Re-Treatment Period|Adverse Event|0
5518650|NCT01490632|19081482|P3|Part D: Re-Treatment Period|Adverse Event|0
5518651|NCT01490632|19081483|P2|Part D: Re-Treatment Period|Adverse Event|0
5518652|NCT01490632|19081484|P1|Part D: Re-Treatment Period|Adverse Event|0
5518653|NCT01490632|19081465|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518654|NCT01490632|19081466|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518655|NCT01490632|19081467|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518656|NCT01490632|19081468|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518657|NCT01490632|19081469|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
5518658|NCT01490632|19081470|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
5518659|NCT01490632|19081471|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
5518660|NCT01490632|19081472|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
5518661|NCT01490632|19081473|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518662|NCT01490632|19081474|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518663|NCT01490632|19081475|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518664|NCT01490632|19081476|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518665|NCT01490632|19081477|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518666|NCT01490632|19081478|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518667|NCT01490632|19081479|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518668|NCT01490632|19081480|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518669|NCT01490632|19081481|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518670|NCT01490632|19081482|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518671|NCT01490632|19081483|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518672|NCT01490632|19081484|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
5518673|NCT01490632|19081465|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518674|NCT01490632|19081466|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518675|NCT01490632|19081467|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518676|NCT01490632|19081468|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518677|NCT01490632|19081469|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
5518678|NCT01490632|19081470|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
5518679|NCT01490632|19081471|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518680|NCT01490632|19081472|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518681|NCT01490632|19081473|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518682|NCT01490632|19081474|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518683|NCT01490632|19081475|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518684|NCT01490632|19081476|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518685|NCT01490632|19081477|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518686|NCT01490632|19081478|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518687|NCT01490632|19081479|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518688|NCT01490632|19081480|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518689|NCT01490632|19081481|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518690|NCT01490632|19081482|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518691|NCT01490632|19081483|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518692|NCT01490632|19081484|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
5518693|NCT01490632|19081465|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518694|NCT01490632|19081466|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518695|NCT01490632|19081467|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518696|NCT01490632|19081468|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518697|NCT01490632|19081469|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518698|NCT01490632|19081470|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518699|NCT01490632|19081471|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
5518700|NCT01490632|19081472|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518701|NCT01490632|19081473|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518702|NCT01490632|19081474|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518703|NCT01490632|19081475|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518704|NCT01490632|19081476|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518705|NCT01490632|19081477|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518706|NCT01490632|19081478|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518707|NCT01490632|19081479|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518708|NCT01490632|19081480|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518709|NCT01490632|19081481|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518710|NCT01490632|19081482|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518711|NCT01490632|19081483|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518712|NCT01490632|19081484|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
5518713|NCT01490632|19081465|P20|Part C: Washout or Step-Down Period|Adverse Event|0
5518714|NCT01490632|19081466|P19|Part C: Washout or Step-Down Period|Adverse Event|0
5518715|NCT01490632|19081467|P18|Part C: Washout or Step-Down Period|Adverse Event|0
5518716|NCT01490632|19081468|P17|Part C: Washout or Step-Down Period|Adverse Event|0
5518717|NCT01490632|19081469|P16|Part C: Washout or Step-Down Period|Adverse Event|2
5518718|NCT01490632|19081470|P15|Part C: Washout or Step-Down Period|Adverse Event|2
5518719|NCT01490632|19081471|P14|Part C: Washout or Step-Down Period|Adverse Event|0
5518720|NCT01490632|19081472|P13|Part C: Washout or Step-Down Period|Adverse Event|0
5518721|NCT01490632|19081473|P12|Part C: Washout or Step-Down Period|Adverse Event|0
5518722|NCT01490632|19081474|P11|Part C: Washout or Step-Down Period|Adverse Event|0
5518723|NCT01490632|19081475|P10|Part C: Washout or Step-Down Period|Adverse Event|0
5518724|NCT01490632|19081476|P9|Part C: Washout or Step-Down Period|Adverse Event|0
5518725|NCT01490632|19081477|P8|Part C: Washout or Step-Down Period|Adverse Event|0
5518726|NCT01490632|19081478|P7|Part C: Washout or Step-Down Period|Adverse Event|0
5518727|NCT01490632|19081479|P6|Part C: Washout or Step-Down Period|Adverse Event|0
5518728|NCT01490632|19081480|P5|Part C: Washout or Step-Down Period|Adverse Event|0
5518729|NCT01490632|19081481|P4|Part C: Washout or Step-Down Period|Adverse Event|0
5518730|NCT01490632|19081482|P3|Part C: Washout or Step-Down Period|Adverse Event|0
5518731|NCT01490632|19081483|P2|Part C: Washout or Step-Down Period|Adverse Event|0
5518732|NCT01490632|19081484|P1|Part C: Washout or Step-Down Period|Adverse Event|0
5518733|NCT01490632|19081465|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518734|NCT01490632|19081466|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518735|NCT01490632|19081467|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518736|NCT01490632|19081468|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518737|NCT01490632|19081469|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518738|NCT01490632|19081470|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518739|NCT01490632|19081471|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518740|NCT01490632|19081472|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518741|NCT01490632|19081473|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
5518742|NCT01490632|19081474|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
5518743|NCT01490632|19081475|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
5518744|NCT01490632|19081476|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
5518745|NCT01490632|19081477|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
5518746|NCT01490632|19081478|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
5518747|NCT01490632|19081479|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
5518748|NCT01490632|19081480|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518749|NCT01490632|19081481|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518750|NCT01490632|19081482|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518751|NCT01490632|19081483|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518752|NCT01490632|19081484|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
5518753|NCT01490632|19081465|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518754|NCT01490632|19081466|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518755|NCT01490632|19081467|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518756|NCT01490632|19081468|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518757|NCT01490632|19081469|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518758|NCT01490632|19081470|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518759|NCT01490632|19081471|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518760|NCT01490632|19081472|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518761|NCT01490632|19081473|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
5518762|NCT01490632|19081474|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
5518763|NCT01490632|19081475|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518764|NCT01490632|19081476|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
5518765|NCT01490632|19081477|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518766|NCT01490632|19081478|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
5518767|NCT01490632|19081479|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518768|NCT01490632|19081480|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518769|NCT01490632|19081481|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518770|NCT01490632|19081482|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518771|NCT01490632|19081483|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518772|NCT01490632|19081484|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
5518773|NCT01490632|19081465|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518774|NCT01490632|19081466|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518775|NCT01490632|19081467|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518776|NCT01490632|19081468|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518777|NCT01490632|19081469|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518778|NCT01490632|19081470|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518779|NCT01490632|19081471|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518780|NCT01490632|19081472|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518781|NCT01490632|19081473|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518782|NCT01490632|19081474|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518783|NCT01490632|19081475|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518784|NCT01490632|19081476|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518785|NCT01490632|19081477|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518786|NCT01490632|19081478|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518787|NCT01490632|19081479|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
5518788|NCT01490632|19081480|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518789|NCT01490632|19081481|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518790|NCT01490632|19081482|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518791|NCT01490632|19081483|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518792|NCT01490632|19081484|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
5518793|NCT01490632|19081465|P20|Part B: Extension or Step-Up Period|Physician Decision|0
5518794|NCT01490632|19081466|P19|Part B: Extension or Step-Up Period|Physician Decision|0
5518795|NCT01490632|19081467|P18|Part B: Extension or Step-Up Period|Physician Decision|0
5518796|NCT01490632|19081468|P17|Part B: Extension or Step-Up Period|Physician Decision|0
5518797|NCT01490632|19081469|P16|Part B: Extension or Step-Up Period|Physician Decision|0
5518798|NCT01490632|19081470|P15|Part B: Extension or Step-Up Period|Physician Decision|0
5518799|NCT01490632|19081471|P14|Part B: Extension or Step-Up Period|Physician Decision|0
5518800|NCT01490632|19081472|P13|Part B: Extension or Step-Up Period|Physician Decision|0
5518801|NCT01490632|19081473|P12|Part B: Extension or Step-Up Period|Physician Decision|0
5518802|NCT01490632|19081474|P11|Part B: Extension or Step-Up Period|Physician Decision|0
5518803|NCT01490632|19081475|P10|Part B: Extension or Step-Up Period|Physician Decision|0
5518804|NCT01490632|19081476|P9|Part B: Extension or Step-Up Period|Physician Decision|0
5518805|NCT01490632|19081477|P8|Part B: Extension or Step-Up Period|Physician Decision|0
5518806|NCT01490632|19081478|P7|Part B: Extension or Step-Up Period|Physician Decision|1
5518807|NCT01490632|19081479|P6|Part B: Extension or Step-Up Period|Physician Decision|0
5518808|NCT01490632|19081480|P5|Part B: Extension or Step-Up Period|Physician Decision|0
5518809|NCT01490632|19081481|P4|Part B: Extension or Step-Up Period|Physician Decision|0
5518810|NCT01490632|19081482|P3|Part B: Extension or Step-Up Period|Physician Decision|0
5518811|NCT01490632|19081483|P2|Part B: Extension or Step-Up Period|Physician Decision|0
5518812|NCT01490632|19081484|P1|Part B: Extension or Step-Up Period|Physician Decision|0
5518813|NCT01490632|19081465|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518814|NCT01490632|19081466|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518815|NCT01490632|19081467|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518816|NCT01490632|19081468|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518817|NCT01490632|19081469|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518818|NCT01490632|19081470|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518819|NCT01490632|19081471|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518820|NCT01490632|19081472|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518821|NCT01490632|19081473|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518822|NCT01490632|19081474|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518823|NCT01490632|19081475|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
5518824|NCT01490632|19081476|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518825|NCT01490632|19081477|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518826|NCT01490632|19081478|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
5518827|NCT01490632|19081479|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518828|NCT01490632|19081480|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518829|NCT01490632|19081481|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518830|NCT01490632|19081482|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518831|NCT01490632|19081483|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518832|NCT01490632|19081484|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
5518833|NCT01490632|19081465|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518834|NCT01490632|19081466|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518835|NCT01490632|19081467|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518836|NCT01490632|19081468|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518837|NCT01490632|19081469|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518838|NCT01490632|19081470|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518839|NCT01490632|19081471|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518840|NCT01490632|19081472|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518841|NCT01490632|19081473|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518842|NCT01490632|19081474|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
5518843|NCT01490632|19081475|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
5518844|NCT01490632|19081476|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
5518845|NCT01490632|19081477|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518846|NCT01490632|19081478|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
5518847|NCT01490632|19081479|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518848|NCT01490632|19081480|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518849|NCT01490632|19081481|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518850|NCT01490632|19081482|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518851|NCT01490632|19081483|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518852|NCT01490632|19081484|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
5518853|NCT01490632|19081465|P20|Part B: Extension or Step-Up Period|Adverse Event|0
5518854|NCT01490632|19081466|P19|Part B: Extension or Step-Up Period|Adverse Event|0
5518855|NCT01490632|19081467|P18|Part B: Extension or Step-Up Period|Adverse Event|0
5518856|NCT01490632|19081468|P17|Part B: Extension or Step-Up Period|Adverse Event|0
5518857|NCT01490632|19081469|P16|Part B: Extension or Step-Up Period|Adverse Event|0
5518858|NCT01490632|19081470|P15|Part B: Extension or Step-Up Period|Adverse Event|0
5518859|NCT01490632|19081471|P14|Part B: Extension or Step-Up Period|Adverse Event|0
5518860|NCT01490632|19081472|P13|Part B: Extension or Step-Up Period|Adverse Event|0
5518861|NCT01490632|19081473|P12|Part B: Extension or Step-Up Period|Adverse Event|1
5518862|NCT01490632|19081474|P11|Part B: Extension or Step-Up Period|Adverse Event|3
5518863|NCT01490632|19081475|P10|Part B: Extension or Step-Up Period|Adverse Event|2
5518864|NCT01490632|19081476|P9|Part B: Extension or Step-Up Period|Adverse Event|0
5518865|NCT01490632|19081477|P8|Part B: Extension or Step-Up Period|Adverse Event|0
5518866|NCT01490632|19081478|P7|Part B: Extension or Step-Up Period|Adverse Event|2
5518867|NCT01490632|19081479|P6|Part B: Extension or Step-Up Period|Adverse Event|2
5518868|NCT01490632|19081480|P5|Part B: Extension or Step-Up Period|Adverse Event|0
5518869|NCT01490632|19081481|P4|Part B: Extension or Step-Up Period|Adverse Event|0
5518870|NCT01490632|19081482|P3|Part B: Extension or Step-Up Period|Adverse Event|0
5518871|NCT01490632|19081483|P2|Part B: Extension or Step-Up Period|Adverse Event|0
5518872|NCT01490632|19081484|P1|Part B: Extension or Step-Up Period|Adverse Event|0
5518873|NCT01490632|19081465|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518874|NCT01490632|19081466|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518875|NCT01490632|19081467|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518876|NCT01490632|19081468|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518877|NCT01490632|19081469|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518878|NCT01490632|19081470|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518879|NCT01490632|19081471|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518880|NCT01490632|19081472|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518881|NCT01490632|19081473|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518882|NCT01490632|19081474|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518883|NCT01490632|19081475|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518884|NCT01490632|19081476|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518885|NCT01490632|19081477|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518886|NCT01490632|19081478|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518887|NCT01490632|19081479|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518888|NCT01490632|19081480|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
5518889|NCT01490632|19081481|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518890|NCT01490632|19081482|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518891|NCT01490632|19081483|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518892|NCT01490632|19081484|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
5518893|NCT01490632|19081465|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518894|NCT01490632|19081466|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518895|NCT01490632|19081467|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518896|NCT01490632|19081468|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518897|NCT01490632|19081469|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518898|NCT01490632|19081470|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518899|NCT01490632|19081471|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518900|NCT01490632|19081472|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518901|NCT01490632|19081473|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518902|NCT01490632|19081474|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518903|NCT01490632|19081475|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518904|NCT01490632|19081476|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518905|NCT01490632|19081477|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518906|NCT01490632|19081478|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518907|NCT01490632|19081479|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518908|NCT01490632|19081480|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
5518909|NCT01490632|19081481|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
5518910|NCT01490632|19081482|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
5518911|NCT01490632|19081483|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
5518912|NCT01490632|19081484|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
5518913|NCT01490632|19081465|P20|Part A: Initial Treatment Period|Sponsor Decision|0
5518914|NCT01490632|19081466|P19|Part A: Initial Treatment Period|Sponsor Decision|0
5518915|NCT01490632|19081467|P18|Part A: Initial Treatment Period|Sponsor Decision|0
5518916|NCT01490632|19081468|P17|Part A: Initial Treatment Period|Sponsor Decision|0
5518917|NCT01490632|19081469|P16|Part A: Initial Treatment Period|Sponsor Decision|0
5518918|NCT01490632|19081470|P15|Part A: Initial Treatment Period|Sponsor Decision|0
5518919|NCT01490632|19081471|P14|Part A: Initial Treatment Period|Sponsor Decision|0
5518920|NCT01490632|19081472|P13|Part A: Initial Treatment Period|Sponsor Decision|0
5518921|NCT01490632|19081473|P12|Part A: Initial Treatment Period|Sponsor Decision|0
5518922|NCT01490632|19081474|P11|Part A: Initial Treatment Period|Sponsor Decision|0
5518923|NCT01490632|19081475|P10|Part A: Initial Treatment Period|Sponsor Decision|0
5518924|NCT01490632|19081476|P9|Part A: Initial Treatment Period|Sponsor Decision|0
5518925|NCT01490632|19081477|P8|Part A: Initial Treatment Period|Sponsor Decision|0
5518926|NCT01490632|19081478|P7|Part A: Initial Treatment Period|Sponsor Decision|0
5518927|NCT01490632|19081479|P6|Part A: Initial Treatment Period|Sponsor Decision|0
5518928|NCT01490632|19081480|P5|Part A: Initial Treatment Period|Sponsor Decision|0
5518929|NCT01490632|19081481|P4|Part A: Initial Treatment Period|Sponsor Decision|0
5518930|NCT01490632|19081482|P3|Part A: Initial Treatment Period|Sponsor Decision|0
5518931|NCT01490632|19081483|P2|Part A: Initial Treatment Period|Sponsor Decision|0
5518932|NCT01490632|19081484|P1|Part A: Initial Treatment Period|Sponsor Decision|2
5518933|NCT01490632|19081465|P20|Part A: Initial Treatment Period|Physician Decision|0
5518934|NCT01490632|19081466|P19|Part A: Initial Treatment Period|Physician Decision|0
5518935|NCT01490632|19081467|P18|Part A: Initial Treatment Period|Physician Decision|0
5518936|NCT01490632|19081468|P17|Part A: Initial Treatment Period|Physician Decision|0
5518937|NCT01490632|19081469|P16|Part A: Initial Treatment Period|Physician Decision|0
5518938|NCT01490632|19081470|P15|Part A: Initial Treatment Period|Physician Decision|0
5518939|NCT01490632|19081471|P14|Part A: Initial Treatment Period|Physician Decision|0
5518940|NCT01490632|19081472|P13|Part A: Initial Treatment Period|Physician Decision|0
5518941|NCT01490632|19081473|P12|Part A: Initial Treatment Period|Physician Decision|0
5518942|NCT01490632|19081474|P11|Part A: Initial Treatment Period|Physician Decision|0
5518943|NCT01490632|19081475|P10|Part A: Initial Treatment Period|Physician Decision|0
5518944|NCT01490632|19081476|P9|Part A: Initial Treatment Period|Physician Decision|0
5518945|NCT01490632|19081477|P8|Part A: Initial Treatment Period|Physician Decision|0
5518946|NCT01490632|19081478|P7|Part A: Initial Treatment Period|Physician Decision|0
5518947|NCT01490632|19081479|P6|Part A: Initial Treatment Period|Physician Decision|0
5518948|NCT01490632|19081480|P5|Part A: Initial Treatment Period|Physician Decision|0
5518949|NCT01490632|19081481|P4|Part A: Initial Treatment Period|Physician Decision|1
5518950|NCT01490632|19081482|P3|Part A: Initial Treatment Period|Physician Decision|0
5518951|NCT01490632|19081483|P2|Part A: Initial Treatment Period|Physician Decision|1
5518952|NCT01490632|19081484|P1|Part A: Initial Treatment Period|Physician Decision|0
5518953|NCT01490632|19081465|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
5518954|NCT01490632|19081466|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
5518955|NCT01490632|19081467|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
5518956|NCT01490632|19081468|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
5518957|NCT01490632|19081469|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
5518958|NCT01490632|19081470|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
5518959|NCT01490632|19081471|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
5518960|NCT01490632|19081472|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
5518961|NCT01490632|19081473|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
5518962|NCT01490632|19081474|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
5518963|NCT01490632|19081475|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
5518964|NCT01490632|19081476|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
5518965|NCT01490632|19081477|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
5518966|NCT01490632|19081478|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
5518967|NCT01490632|19081479|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
5518968|NCT01490632|19081480|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
5518969|NCT01490632|19081481|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
5518970|NCT01490632|19081482|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
5518971|NCT01490632|19081483|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
5518972|NCT01490632|19081484|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
5518973|NCT01490632|19081465|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
5518974|NCT01490632|19081466|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
5518975|NCT01490632|19081467|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
5518976|NCT01490632|19081468|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
5518977|NCT01490632|19081469|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
5518978|NCT01490632|19081470|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
5518979|NCT01490632|19081471|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
5518980|NCT01490632|19081472|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
5518981|NCT01490632|19081473|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
5518982|NCT01490632|19081474|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
5518983|NCT01490632|19081475|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
5518984|NCT01490632|19081476|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
5518985|NCT01490632|19081477|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
5518986|NCT01490632|19081478|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
5518987|NCT01490632|19081479|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
5518988|NCT01490632|19081480|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
5518989|NCT01490632|19081481|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
5518990|NCT01490632|19081482|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
5518991|NCT01490632|19081483|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
5518992|NCT01490632|19081484|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
5518993|NCT01490632|19081465|P20|Part A: Initial Treatment Period|Adverse Event|0
5518994|NCT01490632|19081466|P19|Part A: Initial Treatment Period|Adverse Event|0
5518995|NCT01490632|19081467|P18|Part A: Initial Treatment Period|Adverse Event|0
5518996|NCT01490632|19081468|P17|Part A: Initial Treatment Period|Adverse Event|0
5518997|NCT01490632|19081469|P16|Part A: Initial Treatment Period|Adverse Event|0
5518998|NCT01490632|19081470|P15|Part A: Initial Treatment Period|Adverse Event|0
5518999|NCT01490632|19081471|P14|Part A: Initial Treatment Period|Adverse Event|0
5519000|NCT01490632|19081472|P13|Part A: Initial Treatment Period|Adverse Event|0
5519001|NCT01490632|19081473|P12|Part A: Initial Treatment Period|Adverse Event|0
5519002|NCT01490632|19081474|P11|Part A: Initial Treatment Period|Adverse Event|0
5519003|NCT01490632|19081475|P10|Part A: Initial Treatment Period|Adverse Event|0
5519004|NCT01490632|19081476|P9|Part A: Initial Treatment Period|Adverse Event|0
5519005|NCT01490632|19081477|P8|Part A: Initial Treatment Period|Adverse Event|0
5519006|NCT01490632|19081478|P7|Part A: Initial Treatment Period|Adverse Event|0
5519007|NCT01490632|19081479|P6|Part A: Initial Treatment Period|Adverse Event|0
5519008|NCT01490632|19081480|P5|Part A: Initial Treatment Period|Adverse Event|4
5519009|NCT01490632|19081481|P4|Part A: Initial Treatment Period|Adverse Event|4
5519010|NCT01490632|19081482|P3|Part A: Initial Treatment Period|Adverse Event|2
5519011|NCT01490632|19081483|P2|Part A: Initial Treatment Period|Adverse Event|0
5519012|NCT01490632|19081484|P1|Part A: Initial Treatment Period|Adverse Event|0
5519013|NCT01490580|19081614|P2|Overall Study|Parents withdrew consent|2
5519014|NCT01490580|19081615|P1|Overall Study|Parents withdrew consent|0
5519015|NCT01490294|19081662|P4|Overall Study|Adverse Event|0
5519016|NCT01490294|19081663|P3|Overall Study|Adverse Event|0
5519017|NCT01490294|19081664|P2|Overall Study|Adverse Event|0
5519018|NCT01490294|19081665|P1|Overall Study|Adverse Event|1
5519019|NCT01490294|19081662|P4|Overall Study|Prematurely discontinuation|1
5519020|NCT01490294|19081663|P3|Overall Study|Prematurely discontinuation|1
5519021|NCT01490294|19081664|P2|Overall Study|Prematurely discontinuation|0
5519022|NCT01490294|19081665|P1|Overall Study|Prematurely discontinuation|4
5519023|NCT01490190|19081899|P1|Overall Study|Ring expulsion|2
5519024|NCT01490190|19081899|P1|Overall Study|Inconvenience|1
5519025|NCT01490190|19081899|P1|Overall Study|Relocation|1
5519026|NCT01490190|19081899|P1|Overall Study|Lost to Follow-up|13
5519027|NCT01490190|19081899|P1|Overall Study|Protocol Violation|5
5519028|NCT01490190|19081899|P1|Overall Study|Adverse Event|17
5519029|NCT01490190|19081899|P1|Overall Study|Withdrawal by Subject|9
5519030|NCT01490125|19081926|P6|Period III|Lack of Efficacy|0
5519031|NCT01490125|19081927|P5|Period III|Lack of Efficacy|1
5519032|NCT01490125|19081928|P4|Period III|Lack of Efficacy|0
5519033|NCT01490125|19081929|P3|Period III|Lack of Efficacy|0
5519034|NCT01490125|19081930|P2|Period III|Lack of Efficacy|0
5519035|NCT01490125|19081931|P1|Period III|Lack of Efficacy|0
5519036|NCT01490125|19081926|P6|Period III|Death|0
5519037|NCT01490125|19081927|P5|Period III|Death|0
5519038|NCT01490125|19081928|P4|Period III|Death|1
5519039|NCT01490125|19081929|P3|Period III|Death|0
5519040|NCT01490125|19081930|P2|Period III|Death|0
5519041|NCT01490125|19081931|P1|Period III|Death|0
5519042|NCT01490125|19081926|P6|Period III|Adverse Event|0
5519043|NCT01490125|19081927|P5|Period III|Adverse Event|0
5519044|NCT01490125|19081928|P4|Period III|Adverse Event|1
5519045|NCT01490125|19081929|P3|Period III|Adverse Event|0
5519046|NCT01490125|19081930|P2|Period III|Adverse Event|1
5519047|NCT01490125|19081931|P1|Period III|Adverse Event|3
5519048|NCT01490125|19081926|P6|Period II|Withdrawal by Subject|0
5519049|NCT01490125|19081927|P5|Period II|Withdrawal by Subject|0
5519050|NCT01490125|19081928|P4|Period II|Withdrawal by Subject|0
5519051|NCT01490125|19081929|P3|Period II|Withdrawal by Subject|0
5519052|NCT01490125|19081930|P2|Period II|Withdrawal by Subject|0
5519053|NCT01490125|19081931|P1|Period II|Withdrawal by Subject|1
5519054|NCT01490125|19081926|P6|Period II|Lost to Follow-up|0
5519055|NCT01490125|19081927|P5|Period II|Lost to Follow-up|0
5519056|NCT01490125|19081928|P4|Period II|Lost to Follow-up|0
5519057|NCT01490125|19081929|P3|Period II|Lost to Follow-up|0
5519058|NCT01490125|19081930|P2|Period II|Lost to Follow-up|1
5519059|NCT01490125|19081931|P1|Period II|Lost to Follow-up|0
5519060|NCT01490125|19081926|P6|Period II|Protocol Violation|0
5519061|NCT01490125|19081927|P5|Period II|Protocol Violation|0
5519062|NCT01490125|19081928|P4|Period II|Protocol Violation|1
5519063|NCT01490125|19081929|P3|Period II|Protocol Violation|1
5519064|NCT01490125|19081930|P2|Period II|Protocol Violation|0
5519065|NCT01490125|19081931|P1|Period II|Protocol Violation|0
5519066|NCT01490125|19081926|P6|Period II|Adverse Event|2
5519067|NCT01490125|19081927|P5|Period II|Adverse Event|4
5519068|NCT01490125|19081928|P4|Period II|Adverse Event|2
5519069|NCT01490125|19081929|P3|Period II|Adverse Event|2
5519070|NCT01490125|19081930|P2|Period II|Adverse Event|3
5519071|NCT01490125|19081931|P1|Period II|Adverse Event|2
5519072|NCT01490125|19081926|P6|Period I|Withdrawal by Subject|1
5519073|NCT01490125|19081927|P5|Period I|Withdrawal by Subject|2
5519074|NCT01490125|19081928|P4|Period I|Withdrawal by Subject|1
5519075|NCT01490125|19081929|P3|Period I|Withdrawal by Subject|2
5519076|NCT01490125|19081930|P2|Period I|Withdrawal by Subject|3
5519077|NCT01490125|19081931|P1|Period I|Withdrawal by Subject|1
5519078|NCT01490125|19081926|P6|Period I|Protocol Violation|0
5519079|NCT01490125|19081927|P5|Period I|Protocol Violation|0
5519080|NCT01490125|19081928|P4|Period I|Protocol Violation|1
5519081|NCT01490125|19081929|P3|Period I|Protocol Violation|1
5519082|NCT01490125|19081930|P2|Period I|Protocol Violation|1
5519083|NCT01490125|19081931|P1|Period I|Protocol Violation|1
5519084|NCT01490125|19081926|P6|Period I|Adverse Event|4
5519085|NCT01490125|19081927|P5|Period I|Adverse Event|2
5519086|NCT01490125|19081928|P4|Period I|Adverse Event|3
5519087|NCT01490125|19081929|P3|Period I|Adverse Event|1
5519088|NCT01490125|19081930|P2|Period I|Adverse Event|1
5519089|NCT01490125|19081931|P1|Period I|Adverse Event|4
5519090|NCT01490086|19081959|P5|Overall Study|Subject left hospital|0
5519091|NCT01490086|19081960|P4|Overall Study|Subject left hospital|1
5519092|NCT01490086|19081961|P3|Overall Study|Subject left hospital|0
5519093|NCT01490086|19081962|P2|Overall Study|Subject left hospital|1
5519094|NCT01490086|19081963|P1|Overall Study|Subject left hospital|0
5519095|NCT01490086|19081959|P5|Overall Study|Subject uncontrollable and abusive|0
5519096|NCT01490086|19081960|P4|Overall Study|Subject uncontrollable and abusive|0
5519097|NCT01490086|19081961|P3|Overall Study|Subject uncontrollable and abusive|0
5519098|NCT01490086|19081962|P2|Overall Study|Subject uncontrollable and abusive|1
5519099|NCT01490086|19081963|P1|Overall Study|Subject uncontrollable and abusive|0
5519100|NCT01490086|19081959|P5|Overall Study|Worsening of symptoms|0
5519101|NCT01490086|19081960|P4|Overall Study|Worsening of symptoms|1
5519102|NCT01490086|19081961|P3|Overall Study|Worsening of symptoms|0
5519103|NCT01490086|19081962|P2|Overall Study|Worsening of symptoms|1
5519104|NCT01490086|19081963|P1|Overall Study|Worsening of symptoms|0
5519105|NCT01490086|19081959|P5|Overall Study|Lack of Efficacy|8
5519106|NCT01490086|19081960|P4|Overall Study|Lack of Efficacy|0
5519107|NCT01490086|19081961|P3|Overall Study|Lack of Efficacy|1
5519108|NCT01490086|19081962|P2|Overall Study|Lack of Efficacy|3
5519109|NCT01490086|19081963|P1|Overall Study|Lack of Efficacy|0
5519110|NCT01490086|19081959|P5|Overall Study|Adverse Event|0
5519111|NCT01490086|19081960|P4|Overall Study|Adverse Event|2
5519112|NCT01490086|19081961|P3|Overall Study|Adverse Event|1
5519113|NCT01490086|19081962|P2|Overall Study|Adverse Event|0
5519114|NCT01490086|19081963|P1|Overall Study|Adverse Event|0
5519115|NCT01490086|19081959|P5|Overall Study|Physician Decision|1
5519116|NCT01490086|19081960|P4|Overall Study|Physician Decision|3
5519117|NCT01490086|19081961|P3|Overall Study|Physician Decision|2
5519118|NCT01490086|19081962|P2|Overall Study|Physician Decision|4
5519119|NCT01490086|19081963|P1|Overall Study|Physician Decision|3
5519120|NCT01490086|19081959|P5|Overall Study|Lost to Follow-up|1
5519121|NCT01490086|19081960|P4|Overall Study|Lost to Follow-up|0
5519122|NCT01490086|19081961|P3|Overall Study|Lost to Follow-up|0
5519123|NCT01490086|19081962|P2|Overall Study|Lost to Follow-up|0
5519124|NCT01490086|19081963|P1|Overall Study|Lost to Follow-up|0
5519125|NCT01490086|19081959|P5|Overall Study|Abnormal laboratory findings|0
5519126|NCT01490086|19081960|P4|Overall Study|Abnormal laboratory findings|0
5519127|NCT01490086|19081961|P3|Overall Study|Abnormal laboratory findings|0
5519128|NCT01490086|19081962|P2|Overall Study|Abnormal laboratory findings|0
5519129|NCT01490086|19081963|P1|Overall Study|Abnormal laboratory findings|1
5519130|NCT01490086|19081959|P5|Overall Study|Non-compliance|0
5519131|NCT01490086|19081960|P4|Overall Study|Non-compliance|0
5519132|NCT01490086|19081961|P3|Overall Study|Non-compliance|0
5519133|NCT01490086|19081962|P2|Overall Study|Non-compliance|1
5519134|NCT01490086|19081963|P1|Overall Study|Non-compliance|0
5519135|NCT01490086|19081959|P5|Overall Study|Consent withdrawn|1
5519136|NCT01490086|19081960|P4|Overall Study|Consent withdrawn|0
5519137|NCT01490086|19081961|P3|Overall Study|Consent withdrawn|3
5519138|NCT01490086|19081962|P2|Overall Study|Consent withdrawn|4
5519139|NCT01490086|19081963|P1|Overall Study|Consent withdrawn|4
5519140|NCT01490060|19082008|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
5519141|NCT01490060|19082009|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
5519142|NCT01490060|19082010|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
5519143|NCT01490060|19082011|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
5519144|NCT01490060|19082008|P4|Cycle 2|Non-Compliance|0
5519145|NCT01490060|19082009|P3|Cycle 2|Non-Compliance|1
5519146|NCT01490060|19082010|P2|Cycle 2|Non-Compliance|0
5519147|NCT01490060|19082011|P1|Cycle 2|Non-Compliance|0
5519148|NCT01490060|19082008|P4|Cycle 2|Change of Treatment|0
5519149|NCT01490060|19082009|P3|Cycle 2|Change of Treatment|0
5519150|NCT01490060|19082010|P2|Cycle 2|Change of Treatment|1
5519151|NCT01490060|19082011|P1|Cycle 2|Change of Treatment|1
5519152|NCT01490060|19082008|P4|Cycle 1|Treatment at Another Facility|1
5519153|NCT01490060|19082009|P3|Cycle 1|Treatment at Another Facility|0
5519154|NCT01490060|19082010|P2|Cycle 1|Treatment at Another Facility|0
5519155|NCT01490060|19082011|P1|Cycle 1|Treatment at Another Facility|0
5519156|NCT01490060|19082008|P4|Cycle 1|Withdrawal by Subject|1
5519157|NCT01490060|19082009|P3|Cycle 1|Withdrawal by Subject|0
5519158|NCT01490060|19082010|P2|Cycle 1|Withdrawal by Subject|0
5519159|NCT01490060|19082011|P1|Cycle 1|Withdrawal by Subject|0
5519160|NCT01490060|19082008|P4|Cycle 1|Insurance Denied|0
5519161|NCT01490060|19082009|P3|Cycle 1|Insurance Denied|2
5519162|NCT01490060|19082010|P2|Cycle 1|Insurance Denied|0
5519163|NCT01490060|19082011|P1|Cycle 1|Insurance Denied|0
5519164|NCT01490060|19082008|P4|Cycle 1|Change of Treatment|1
5519165|NCT01490060|19082009|P3|Cycle 1|Change of Treatment|1
5519166|NCT01490060|19082010|P2|Cycle 1|Change of Treatment|1
5519167|NCT01490060|19082011|P1|Cycle 1|Change of Treatment|0
5519168|NCT01489956|19082040|P3|Overall Study|Withdrawal by Subject|1
5519169|NCT01489956|19082041|P2|Overall Study|Withdrawal by Subject|0
5519170|NCT01489956|19082042|P1|Overall Study|Withdrawal by Subject|0
5519171|NCT01489956|19082040|P3|Overall Study|Lost to Follow-up|0
5519172|NCT01489956|19082041|P2|Overall Study|Lost to Follow-up|0
5519173|NCT01489956|19082042|P1|Overall Study|Lost to Follow-up|1
5519174|NCT01489891|19082079|P2|Overall Study|Endoscopy failure|0
5519175|NCT01489891|19082080|P1|Overall Study|Endoscopy failure|1
5519176|NCT01489527|19082235|P2|Overall Study|Not compliant|0
5519177|NCT01489527|19082236|P1|Overall Study|Not compliant|1
5519178|NCT01489527|19082235|P2|Overall Study|Procedures|0
5519179|NCT01489527|19082236|P1|Overall Study|Procedures|1
5519180|NCT01489527|19082235|P2|Overall Study|Lost to Follow-up|1
5519181|NCT01489527|19082236|P1|Overall Study|Lost to Follow-up|5
5519182|NCT01489527|19082235|P2|Overall Study|Withdrawal by Subject|4
5519183|NCT01489527|19082236|P1|Overall Study|Withdrawal by Subject|0
5519184|NCT01489527|19082235|P2|Overall Study|Participant moved|7
5519185|NCT01489527|19082236|P1|Overall Study|Participant moved|6
5519186|NCT01489527|19082235|P2|Overall Study|Pregnancy|14
5519187|NCT01489527|19082236|P1|Overall Study|Pregnancy|9
5519188|NCT01489358|19082253|P3|Overall Study|Lost to Follow-up|2
5519189|NCT01489358|19082254|P2|Overall Study|Lost to Follow-up|0
5519190|NCT01489358|19082255|P1|Overall Study|Lost to Follow-up|0
5519191|NCT01489254|19082305|P4|Open-label Extension Part|Other reasons for not completing study|5
5519192|NCT01489254|19082306|P3|Open-label Extension Part|Other reasons for not completing study|0
5519193|NCT01489254|19082307|P2|Open-label Extension Part|Other reasons for not completing study|0
5519194|NCT01489254|19082308|P1|Open-label Extension Part|Other reasons for not completing study|0
5519195|NCT01489254|19082305|P4|Open-label Extension Part|Lost to Follow-up|9
5519196|NCT01489254|19082306|P3|Open-label Extension Part|Lost to Follow-up|0
5519197|NCT01489254|19082307|P2|Open-label Extension Part|Lost to Follow-up|0
5519198|NCT01489254|19082308|P1|Open-label Extension Part|Lost to Follow-up|0
5519199|NCT01489254|19082305|P4|Open-label Extension Part|Protocol Violation|1
5519200|NCT01489254|19082306|P3|Open-label Extension Part|Protocol Violation|0
5519201|NCT01489254|19082307|P2|Open-label Extension Part|Protocol Violation|0
5519202|NCT01489254|19082308|P1|Open-label Extension Part|Protocol Violation|0
5519203|NCT01489254|19082305|P4|Open-label Extension Part|Withdrawal by Subject|30
5519204|NCT01489254|19082306|P3|Open-label Extension Part|Withdrawal by Subject|0
5519205|NCT01489254|19082307|P2|Open-label Extension Part|Withdrawal by Subject|0
5519206|NCT01489254|19082308|P1|Open-label Extension Part|Withdrawal by Subject|0
5519207|NCT01489254|19082305|P4|Open-label Extension Part|Pregnancy|3
5519208|NCT01489254|19082306|P3|Open-label Extension Part|Pregnancy|0
5519209|NCT01489254|19082307|P2|Open-label Extension Part|Pregnancy|0
5519210|NCT01489254|19082308|P1|Open-label Extension Part|Pregnancy|0
5519211|NCT01489254|19082305|P4|Open-label Extension Part|Adverse Event|10
5519212|NCT01489254|19082306|P3|Open-label Extension Part|Adverse Event|0
5519213|NCT01489254|19082307|P2|Open-label Extension Part|Adverse Event|0
5519214|NCT01489254|19082308|P1|Open-label Extension Part|Adverse Event|0
5519215|NCT01489254|19082305|P4|Double-blind Part|Other reasons for not completing study|0
5519216|NCT01489254|19082306|P3|Double-blind Part|Other reasons for not completing study|0
5519217|NCT01489254|19082307|P2|Double-blind Part|Other reasons for not completing study|6
5519218|NCT01489254|19082308|P1|Double-blind Part|Other reasons for not completing study|4
5519219|NCT01489254|19082305|P4|Double-blind Part|Lost to Follow-up|0
5519220|NCT01489254|19082306|P3|Double-blind Part|Lost to Follow-up|0
5519221|NCT01489254|19082307|P2|Double-blind Part|Lost to Follow-up|2
5519222|NCT01489254|19082308|P1|Double-blind Part|Lost to Follow-up|1
5519223|NCT01489254|19082305|P4|Double-blind Part|Withdrawal by Subject|0
5519224|NCT01489254|19082306|P3|Double-blind Part|Withdrawal by Subject|1
5519225|NCT01489254|19082307|P2|Double-blind Part|Withdrawal by Subject|20
5519226|NCT01489254|19082308|P1|Double-blind Part|Withdrawal by Subject|12
5519227|NCT01489254|19082305|P4|Double-blind Part|Pregnancy|0
5519228|NCT01489254|19082306|P3|Double-blind Part|Pregnancy|0
5519229|NCT01489254|19082307|P2|Double-blind Part|Pregnancy|3
5519230|NCT01489254|19082308|P1|Double-blind Part|Pregnancy|1
5519231|NCT01489254|19082305|P4|Double-blind Part|Adverse Event|0
5519232|NCT01489254|19082306|P3|Double-blind Part|Adverse Event|2
5519233|NCT01489254|19082307|P2|Double-blind Part|Adverse Event|2
5519234|NCT01489254|19082308|P1|Double-blind Part|Adverse Event|7
5519235|NCT01489189|19082319|P2|Overall Study|Missed Visit|4
5519236|NCT01489189|19082320|P1|Overall Study|Missed Visit|1
5519237|NCT01489189|19082319|P2|Overall Study|Death|8
5519238|NCT01489189|19082320|P1|Overall Study|Death|10
5519239|NCT01489189|19082319|P2|Overall Study|Withdrawal by Subject|23
5519240|NCT01489189|19082320|P1|Overall Study|Withdrawal by Subject|20
5519241|NCT01489111|19082345|P1|Overall Study|Withdrawal criterion|1
5519242|NCT01489020|19082366|P6|Overall Study|Concomitant disease|0
5519243|NCT01489020|19082367|P5|Overall Study|Concomitant disease|3
5519244|NCT01489020|19082368|P4|Overall Study|Concomitant disease|0
5519245|NCT01489020|19082369|P3|Overall Study|Concomitant disease|0
5519246|NCT01489020|19082370|P2|Overall Study|Concomitant disease|0
5519247|NCT01489020|19082371|P1|Overall Study|Concomitant disease|0
5519248|NCT01489020|19082366|P6|Overall Study|Adverse Event|0
5519249|NCT01489020|19082367|P5|Overall Study|Adverse Event|3
5519250|NCT01489020|19082368|P4|Overall Study|Adverse Event|0
5519251|NCT01489020|19082369|P3|Overall Study|Adverse Event|3
5519252|NCT01489020|19082370|P2|Overall Study|Adverse Event|0
5519253|NCT01489020|19082371|P1|Overall Study|Adverse Event|0
5519254|NCT01489020|19082366|P6|Overall Study|Withdrawal by Subject|0
5519255|NCT01489020|19082367|P5|Overall Study|Withdrawal by Subject|0
5519256|NCT01489020|19082368|P4|Overall Study|Withdrawal by Subject|0
5519257|NCT01489020|19082369|P3|Overall Study|Withdrawal by Subject|0
5519258|NCT01489020|19082370|P2|Overall Study|Withdrawal by Subject|0
5519259|NCT01489020|19082371|P1|Overall Study|Withdrawal by Subject|1
5519260|NCT01488994|19082405|P2|Overall Study|Withdrawal by Subject|1
5519261|NCT01488994|19082406|P1|Overall Study|Withdrawal by Subject|0
5519262|NCT01488890|19082497|P4|Overall Study|Withdrawal by Subject|2
5519263|NCT01488890|19082498|P3|Overall Study|Withdrawal by Subject|11
5519264|NCT01488890|19082499|P2|Overall Study|Withdrawal by Subject|10
5519265|NCT01488890|19082500|P1|Overall Study|Withdrawal by Subject|14
5519266|NCT01488890|19082497|P4|Overall Study|Lost to Follow-up|3
5519267|NCT01488890|19082498|P3|Overall Study|Lost to Follow-up|20
5519268|NCT01488890|19082499|P2|Overall Study|Lost to Follow-up|10
5519269|NCT01488890|19082500|P1|Overall Study|Lost to Follow-up|13
5519270|NCT01488890|19082497|P4|Overall Study|Protocol Violation|0
5519271|NCT01488890|19082498|P3|Overall Study|Protocol Violation|4
5519272|NCT01488890|19082499|P2|Overall Study|Protocol Violation|0
5519273|NCT01488890|19082500|P1|Overall Study|Protocol Violation|3
5519274|NCT01488890|19082497|P4|Overall Study|Serious adverse event|0
5519275|NCT01488890|19082498|P3|Overall Study|Serious adverse event|0
5519276|NCT01488890|19082499|P2|Overall Study|Serious adverse event|0
5519277|NCT01488890|19082500|P1|Overall Study|Serious adverse event|2
5519278|NCT01488578|19082578|P1|Overall Study|Protocol Violation|1836
5519279|NCT01488487|19082612|P1|Overall Study|Withdrawal by Subject|2
5519280|NCT01488487|19082612|P1|Overall Study|Death|1
5519281|NCT01488487|19082612|P1|Overall Study|Adverse Event|6
5519282|NCT01488448|19082621|P2|Overall Study|Protocol Violation|3
5519283|NCT01488448|19082622|P1|Overall Study|Protocol Violation|4
5519284|NCT01488448|19082621|P2|Overall Study|Physician Decision|9
5519285|NCT01488448|19082622|P1|Overall Study|Physician Decision|4
5519286|NCT01488448|19082621|P2|Overall Study|Adverse Event|4
5519287|NCT01488448|19082622|P1|Overall Study|Adverse Event|9
5519288|NCT01488448|19082621|P2|Overall Study|Withdrawal by Subject|1
5519289|NCT01488448|19082622|P1|Overall Study|Withdrawal by Subject|3
5519290|NCT01488370|19082664|P3|Overall Study|Protocol Violation|1
5519291|NCT01488370|19082665|P2|Overall Study|Protocol Violation|1
5519292|NCT01488370|19082666|P1|Overall Study|Protocol Violation|0
5519293|NCT01488097|19082725|P1|Overall Study|Lost to Follow-up|1
5519294|NCT01488071|19082738|P2|Overall Study|Administrative or Other Reason(s)|4
5519295|NCT01488071|19082739|P1|Overall Study|Administrative or Other Reason(s)|5
5519296|NCT01488071|19082738|P2|Overall Study|Lost to Follow-up|0
5519297|NCT01488071|19082739|P1|Overall Study|Lost to Follow-up|1
5519298|NCT01488071|19082738|P2|Overall Study|Withdrawal of Consent|12
5519299|NCT01488071|19082739|P1|Overall Study|Withdrawal of Consent|14
5519300|NCT01488071|19082738|P2|Overall Study|Protocol Violation|7
5519301|NCT01488071|19082739|P1|Overall Study|Protocol Violation|5
5519302|NCT01488071|19082738|P2|Overall Study|Non-compliance with study drug|0
5519303|NCT01488071|19082739|P1|Overall Study|Non-compliance with study drug|2
5519304|NCT01488071|19082738|P2|Overall Study|Lack of Efficacy|17
5519305|NCT01488071|19082739|P1|Overall Study|Lack of Efficacy|11
5519306|NCT01488071|19082738|P2|Overall Study|Adverse Event|23
5519307|NCT01488071|19082739|P1|Overall Study|Adverse Event|15
5519308|NCT01487863|19082819|P2|Overall Study|Death|19
5519309|NCT01487863|19082820|P1|Overall Study|Death|19
5519310|NCT01487577|19082837|P1|Overall Study|Became ineligible after signing consent|1
5519311|NCT01487525|19082851|P2|Overall Study|Withdrawal by Subject|1
5519312|NCT01487525|19082852|P1|Overall Study|Withdrawal by Subject|0
5519313|NCT01487265|19082868|P1|Overall Study|Still on Treatment|1
5519314|NCT01487265|19082868|P1|Overall Study|Death|2
5519315|NCT01487265|19082868|P1|Overall Study|Disease Progression|21
5519316|NCT01487265|19082868|P1|Overall Study|Withdrawal by Subject|5
5519317|NCT01487265|19082868|P1|Overall Study|Adverse Event|8
5519318|NCT01487200|19082880|P4|Overall Study|Withdrawal by Subject|0
5519319|NCT01487200|19082881|P3|Overall Study|Withdrawal by Subject|0
5519320|NCT01487200|19082882|P2|Overall Study|Withdrawal by Subject|1
5519321|NCT01487200|19082883|P1|Overall Study|Withdrawal by Subject|0
5519322|NCT01487161|19082913|P4|Overall Study|missing data|0
5519323|NCT01487161|19082914|P3|Overall Study|missing data|0
5519324|NCT01487161|19082915|P2|Overall Study|missing data|1
5519325|NCT01487161|19082916|P1|Overall Study|missing data|0
5519326|NCT01487161|19082913|P4|Overall Study|Withdrawal by Subject|2
5519327|NCT01487161|19082914|P3|Overall Study|Withdrawal by Subject|1
5519328|NCT01487161|19082915|P2|Overall Study|Withdrawal by Subject|1
5519329|NCT01487161|19082916|P1|Overall Study|Withdrawal by Subject|1
5519330|NCT01487161|19082913|P4|Overall Study|Adverse Event|0
5519331|NCT01487161|19082914|P3|Overall Study|Adverse Event|0
5519332|NCT01487161|19082915|P2|Overall Study|Adverse Event|0
5519333|NCT01487161|19082916|P1|Overall Study|Adverse Event|1
5519334|NCT01486966|19082981|P2|Overall Study|Withdrawal by Subject|1
5519335|NCT01486966|19082982|P1|Overall Study|Withdrawal by Subject|0
5519336|NCT01486966|19082981|P2|Overall Study|Adverse Event|1
5519337|NCT01486966|19082982|P1|Overall Study|Adverse Event|0
5519338|NCT01486927|19083006|P1|Overall Study|Subject did not reach 6 mo of treatment|1
5519339|NCT01486927|19083006|P1|Overall Study|Withdrawal by Subject|8
5519340|NCT01486927|19083006|P1|Overall Study|50 Exposure days not reached|2
5519341|NCT01486927|19083006|P1|Overall Study|Physician Decision|1
5519342|NCT01486927|19083006|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
5519343|NCT01486758|19083044|P2|Overall Study|Lost to Follow-up|1
5519344|NCT01486758|19083045|P1|Overall Study|Lost to Follow-up|0
5519345|NCT01486446|19083112|P2|Overall Study|Adverse Event|0
5519346|NCT01486446|19083113|P1|Overall Study|Adverse Event|1
5519347|NCT01486316|19083136|P4|Overall Study|Death|0
5519348|NCT01486316|19083137|P3|Overall Study|Death|0
5519349|NCT01486316|19083138|P2|Overall Study|Death|1
5519350|NCT01486316|19083139|P1|Overall Study|Death|0
5519351|NCT01486316|19083136|P4|Overall Study|Physician Decision|0
5519352|NCT01486316|19083137|P3|Overall Study|Physician Decision|1
5519353|NCT01486316|19083138|P2|Overall Study|Physician Decision|0
5519354|NCT01486316|19083139|P1|Overall Study|Physician Decision|0
5519355|NCT01486316|19083136|P4|Overall Study|Withdrawal by Subject|0
5519356|NCT01486316|19083137|P3|Overall Study|Withdrawal by Subject|3
5519357|NCT01486316|19083138|P2|Overall Study|Withdrawal by Subject|0
5519358|NCT01486316|19083139|P1|Overall Study|Withdrawal by Subject|1
5519359|NCT01486316|19083136|P4|Overall Study|Not meeting eligibility criteria|0
5519360|NCT01486316|19083137|P3|Overall Study|Not meeting eligibility criteria|1
5519361|NCT01486316|19083138|P2|Overall Study|Not meeting eligibility criteria|0
5519362|NCT01486316|19083139|P1|Overall Study|Not meeting eligibility criteria|0
5519363|NCT01486316|19083136|P4|Overall Study|Device explanted with/without re-implant|2
5519364|NCT01486316|19083137|P3|Overall Study|Device explanted with/without re-implant|0
5519365|NCT01486316|19083138|P2|Overall Study|Device explanted with/without re-implant|2
5519366|NCT01486316|19083139|P1|Overall Study|Device explanted with/without re-implant|3
5519367|NCT01486264|19083151|P2|Overall Study|Not treated|1
5519368|NCT01486264|19083152|P1|Overall Study|Not treated|0
5519369|NCT01486264|19083151|P2|Overall Study|Other|11
5519370|NCT01486264|19083152|P1|Overall Study|Other|5
5519371|NCT01486264|19083151|P2|Overall Study|Lost to Follow-up|2
5519372|NCT01486264|19083152|P1|Overall Study|Lost to Follow-up|3
5519373|NCT01486264|19083151|P2|Overall Study|Protocol Violation|0
5519374|NCT01486264|19083152|P1|Overall Study|Protocol Violation|3
5519375|NCT01486264|19083151|P2|Overall Study|Physician Decision|1
5519376|NCT01486264|19083152|P1|Overall Study|Physician Decision|1
5519377|NCT01486264|19083151|P2|Overall Study|Withdrawal by Subject|18
5519378|NCT01486264|19083152|P1|Overall Study|Withdrawal by Subject|7
5519379|NCT01486264|19083151|P2|Overall Study|Lack of Efficacy|10
5519380|NCT01486264|19083152|P1|Overall Study|Lack of Efficacy|6
5519381|NCT01486264|19083151|P2|Overall Study|Adverse Event|3
5519382|NCT01486264|19083152|P1|Overall Study|Adverse Event|3
5519383|NCT01486264|19083151|P2|Overall Study|Death|1
5519384|NCT01486264|19083152|P1|Overall Study|Death|1
5519385|NCT01486238|19083184|P2|Overall Study|Lost to Follow-up|3
5519386|NCT01486238|19083185|P1|Overall Study|Lost to Follow-up|0
5519387|NCT01486238|19083184|P2|Overall Study|Withdrawal by Subject|1
5519388|NCT01486238|19083185|P1|Overall Study|Withdrawal by Subject|2
5519389|NCT01486238|19083184|P2|Overall Study|Death|2
5519390|NCT01486238|19083185|P1|Overall Study|Death|0
5519391|NCT01486199|19083193|P2|Two Year Period Between Study Days|Physician Decision|0
5519392|NCT01486199|19083194|P1|Two Year Period Between Study Days|Physician Decision|1
5519393|NCT01485991|19083214|P2|Overall Study|randomized but not treated|2
5519394|NCT01485991|19083215|P1|Overall Study|randomized but not treated|6
5519395|NCT01485991|19083214|P2|Overall Study|Withdrawal by Subject|20
5519396|NCT01485991|19083215|P1|Overall Study|Withdrawal by Subject|13
5519397|NCT01485991|19083214|P2|Overall Study|Lost to Follow-up|10
5519398|NCT01485991|19083215|P1|Overall Study|Lost to Follow-up|13
5519399|NCT01485991|19083214|P2|Overall Study|Adverse Event|4
5519400|NCT01485991|19083215|P1|Overall Study|Adverse Event|0
5519401|NCT01485887|19083225|P1|Overall Study|Primary disease markedly improved|1
5519402|NCT01485887|19083225|P1|Overall Study|Deterioration of primary disease|1
5519403|NCT01485887|19083225|P1|Overall Study|Adverse Event|8
5519404|NCT01485887|19083225|P1|Overall Study|Withdrawal by Subject|2
5519405|NCT01485796|19083237|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
5519406|NCT01485796|19083237|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
5519407|NCT01485796|19083237|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
5519408|NCT01485796|19083237|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
5519409|NCT01485796|19083237|P1|Period 2: Epoch 2|Switch to safety follow-up|26
5519410|NCT01485796|19083237|P1|Period 2: Epoch 2|Adverse Event|3
5519411|NCT01485796|19083237|P1|Period 2: Epoch 2|Withdrawal by Subject|6
5519412|NCT01485796|19083237|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
5519413|NCT01485640|19083259|P1|Overall Study|Terminated by Sponsor|95
5519414|NCT01485640|19083259|P1|Overall Study|Withdrawal by Subject|14
5519415|NCT01485640|19083259|P1|Overall Study|Protocol Violation|1
5519416|NCT01485640|19083259|P1|Overall Study|Lack of Efficacy|2
5519417|NCT01485640|19083259|P1|Overall Study|Adverse Event|10
5519418|NCT01485627|19083266|P2|Overall Study|caregiver was not bereaved|35
5519419|NCT01485627|19083267|P1|Overall Study|caregiver was not bereaved|42
5519420|NCT01485627|19083266|P2|Overall Study|Caregiver died|0
5519421|NCT01485627|19083267|P1|Overall Study|Caregiver died|1
5519422|NCT01485627|19083266|P2|Overall Study|Caregiver lost to follow up|12
5519423|NCT01485627|19083267|P1|Overall Study|Caregiver lost to follow up|11
5519424|NCT01485627|19083266|P2|Overall Study|Caregiver withdrew|3
5519425|NCT01485627|19083267|P1|Overall Study|Caregiver withdrew|3
5519426|NCT01485627|19083266|P2|Overall Study|Patient lost to followup|1
5519427|NCT01485627|19083267|P1|Overall Study|Patient lost to followup|0
5519428|NCT01485627|19083266|P2|Overall Study|Patient died|1
5519429|NCT01485627|19083267|P1|Overall Study|Patient died|3
5519430|NCT01485627|19083266|P2|Overall Study|Patient withdrew|5
5519431|NCT01485627|19083267|P1|Overall Study|Patient withdrew|6
5519432|NCT01485614|19083289|P4|Weeks 20-54|Withdrawal by Subject|0
5519433|NCT01485614|19083290|P3|Weeks 20-54|Withdrawal by Subject|0
5519434|NCT01485614|19083291|P2|Weeks 20-54|Withdrawal by Subject|3
5519435|NCT01485614|19083292|P1|Weeks 20-54|Withdrawal by Subject|5
5519436|NCT01485614|19083289|P4|Weeks 20-54|Withdrawal by Parent/Guardian|0
5519437|NCT01485614|19083290|P3|Weeks 20-54|Withdrawal by Parent/Guardian|1
5519438|NCT01485614|19083291|P2|Weeks 20-54|Withdrawal by Parent/Guardian|2
5519439|NCT01485614|19083292|P1|Weeks 20-54|Withdrawal by Parent/Guardian|2
5519440|NCT01485614|19083289|P4|Weeks 20-54|Lost to Follow-up|0
5519441|NCT01485614|19083290|P3|Weeks 20-54|Lost to Follow-up|1
5519442|NCT01485614|19083291|P2|Weeks 20-54|Lost to Follow-up|3
5519443|NCT01485614|19083292|P1|Weeks 20-54|Lost to Follow-up|4
5519444|NCT01485614|19083289|P4|Weeks 0-20|Withdrawal by Subject|0
5519445|NCT01485614|19083290|P3|Weeks 0-20|Withdrawal by Subject|1
5519446|NCT01485614|19083291|P2|Weeks 0-20|Withdrawal by Subject|2
5519447|NCT01485614|19083292|P1|Weeks 0-20|Withdrawal by Subject|3
5519448|NCT01485614|19083289|P4|Weeks 0-20|Withdrawal by Parent/Guardian|0
5519449|NCT01485614|19083290|P3|Weeks 0-20|Withdrawal by Parent/Guardian|0
5519450|NCT01485614|19083291|P2|Weeks 0-20|Withdrawal by Parent/Guardian|2
5519451|NCT01485614|19083292|P1|Weeks 0-20|Withdrawal by Parent/Guardian|5
5519452|NCT01485614|19083289|P4|Weeks 0-20|Lost to Follow-up|0
5519453|NCT01485614|19083290|P3|Weeks 0-20|Lost to Follow-up|0
5519454|NCT01485614|19083291|P2|Weeks 0-20|Lost to Follow-up|0
5519455|NCT01485614|19083292|P1|Weeks 0-20|Lost to Follow-up|2
5519456|NCT01485614|19083289|P4|Randomization|Not Treated|0
5519457|NCT01485614|19083290|P3|Randomization|Not Treated|0
5519458|NCT01485614|19083291|P2|Randomization|Not Treated|0
5519459|NCT01485614|19083292|P1|Randomization|Not Treated|1
5519460|NCT01485536|19083664|P1|Overall Study|Adverse Event|1
5519461|NCT01485536|19083664|P1|Overall Study|Withdrawal by Subject|3
5519462|NCT01485354|19083682|P1|Overall Study|Withdrawal by Subject|5
5519463|NCT01485172|19083696|P6|Overall Study|Withdrawal by Subject|1
5519464|NCT01485172|19083697|P5|Overall Study|Withdrawal by Subject|1
5519465|NCT01485172|19083698|P4|Overall Study|Withdrawal by Subject|1
5519466|NCT01485172|19083699|P3|Overall Study|Withdrawal by Subject|0
5519467|NCT01485172|19083700|P2|Overall Study|Withdrawal by Subject|0
5519468|NCT01485172|19083701|P1|Overall Study|Withdrawal by Subject|2
5519469|NCT01485172|19083696|P6|Overall Study|Physician Decision|0
5519470|NCT01485172|19083697|P5|Overall Study|Physician Decision|1
5519471|NCT01485172|19083698|P4|Overall Study|Physician Decision|0
5519472|NCT01485172|19083699|P3|Overall Study|Physician Decision|0
5519473|NCT01485172|19083700|P2|Overall Study|Physician Decision|0
5519474|NCT01485172|19083701|P1|Overall Study|Physician Decision|0
5519475|NCT01485172|19083696|P6|Overall Study|Lost to Follow-up|1
5519476|NCT01485172|19083697|P5|Overall Study|Lost to Follow-up|0
5519477|NCT01485172|19083698|P4|Overall Study|Lost to Follow-up|0
5519478|NCT01485172|19083699|P3|Overall Study|Lost to Follow-up|1
5519479|NCT01485172|19083700|P2|Overall Study|Lost to Follow-up|0
5519480|NCT01485172|19083701|P1|Overall Study|Lost to Follow-up|0
5519481|NCT01485172|19083696|P6|Overall Study|Protocol defined stopping criteria|0
5519482|NCT01485172|19083697|P5|Overall Study|Protocol defined stopping criteria|1
5519483|NCT01485172|19083698|P4|Overall Study|Protocol defined stopping criteria|0
5519484|NCT01485172|19083699|P3|Overall Study|Protocol defined stopping criteria|0
5519485|NCT01485172|19083700|P2|Overall Study|Protocol defined stopping criteria|0
5519486|NCT01485172|19083701|P1|Overall Study|Protocol defined stopping criteria|1
5519487|NCT01485172|19083696|P6|Overall Study|Protocol Violation|0
5519488|NCT01485172|19083697|P5|Overall Study|Protocol Violation|1
5519489|NCT01485172|19083698|P4|Overall Study|Protocol Violation|5
5519490|NCT01485172|19083699|P3|Overall Study|Protocol Violation|4
5519491|NCT01485172|19083700|P2|Overall Study|Protocol Violation|0
5519492|NCT01485172|19083701|P1|Overall Study|Protocol Violation|0
5519493|NCT01485172|19083696|P6|Overall Study|Lack of Efficacy|0
5519494|NCT01485172|19083697|P5|Overall Study|Lack of Efficacy|0
5519495|NCT01485172|19083698|P4|Overall Study|Lack of Efficacy|0
5519496|NCT01485172|19083699|P3|Overall Study|Lack of Efficacy|0
5519497|NCT01485172|19083700|P2|Overall Study|Lack of Efficacy|0
5519498|NCT01485172|19083701|P1|Overall Study|Lack of Efficacy|2
5519499|NCT01485172|19083696|P6|Overall Study|Adverse Event|2
5519500|NCT01485172|19083697|P5|Overall Study|Adverse Event|1
5519501|NCT01485172|19083698|P4|Overall Study|Adverse Event|2
5519502|NCT01485172|19083699|P3|Overall Study|Adverse Event|2
5519503|NCT01485172|19083700|P2|Overall Study|Adverse Event|1
5519504|NCT01485172|19083701|P1|Overall Study|Adverse Event|2
5519505|NCT01485120|19083775|P1|Overall Study|Withdrawal by Subject|2
5519506|NCT01485094|19083783|P3|Overall Study|Withdrawal by Subject|0
5519507|NCT01485094|19083784|P2|Overall Study|Withdrawal by Subject|1
5519508|NCT01485094|19083785|P1|Overall Study|Withdrawal by Subject|1
5519509|NCT01485094|19083783|P3|Overall Study|Lost to Follow-up|0
5519510|NCT01485094|19083784|P2|Overall Study|Lost to Follow-up|0
5519511|NCT01485094|19083785|P1|Overall Study|Lost to Follow-up|1
5519512|NCT01485094|19083783|P3|Overall Study|Adverse Event|1
5519513|NCT01485094|19083784|P2|Overall Study|Adverse Event|1
5519514|NCT01485094|19083785|P1|Overall Study|Adverse Event|1
5519515|NCT01484977|19083830|P1|Overall Study|Lack of Compliance|1
5519516|NCT01484977|19083830|P1|Overall Study|Low White Blood Cell Count|1
5519517|NCT01484977|19083830|P1|Overall Study|Moving Overseas|1
5519518|NCT01484977|19083830|P1|Overall Study|Subject Protocol Non-compliant|1
5519519|NCT01484977|19083830|P1|Overall Study|Withdrawal by Subject|4
5519520|NCT01484977|19083830|P1|Overall Study|Lost to Follow-up|1
5519521|NCT01484977|19083830|P1|Overall Study|Protocol Violation|6
5519522|NCT01484977|19083830|P1|Overall Study|Lack of Efficacy|4
5519523|NCT01484977|19083830|P1|Overall Study|Adverse Event|8
5519524|NCT01484951|19083834|P1|Overall Study|Non-Compliance|1
5519525|NCT01484951|19083834|P1|Overall Study|Personal Reasons|1
5519526|NCT01484951|19083834|P1|Overall Study|Adverse Event|3
5519527|NCT01484938|19083839|P1|Overall Study|Noncompliance|1
5519528|NCT01484938|19083839|P1|Overall Study|Lost to Follow-up|1
5519529|NCT01484938|19083839|P1|Overall Study|Adverse Event|2
5519530|NCT01484912|19083846|P2|Overall Study|Physician Decision|1
5519531|NCT01484912|19083847|P1|Overall Study|Physician Decision|0
5519532|NCT01484912|19083846|P2|Overall Study|Withdrawal by Subject|0
5519533|NCT01484912|19083847|P1|Overall Study|Withdrawal by Subject|1
5519534|NCT01484873|19083857|P1|Overall Study|Withdrawal by Subject|2
5519535|NCT01484834|19083869|P4|Overall Study|Lost to Follow-up|4
5519536|NCT01484834|19083870|P3|Overall Study|Lost to Follow-up|1
5519537|NCT01484834|19083871|P2|Overall Study|Lost to Follow-up|8
5519538|NCT01484834|19083872|P1|Overall Study|Lost to Follow-up|5
5519539|NCT01484561|19083913|P2|Overall Study|Adverse Event|4
5519540|NCT01484561|19083914|P1|Overall Study|Adverse Event|1
5519541|NCT01484561|19083913|P2|Overall Study|Other|1
5519542|NCT01484561|19083914|P1|Overall Study|Other|1
5519543|NCT01484561|19083913|P2|Overall Study|Withdrawal by Subject|0
5519544|NCT01484561|19083914|P1|Overall Study|Withdrawal by Subject|3
5519545|NCT01484561|19083913|P2|Overall Study|Lost to Follow-up|0
5519546|NCT01484561|19083914|P1|Overall Study|Lost to Follow-up|1
5519547|NCT01484561|19083913|P2|Overall Study|Lack of Efficacy|1
5519548|NCT01484561|19083914|P1|Overall Study|Lack of Efficacy|3
5519549|NCT01484496|19084004|P4|Period 2|Other|6
5519550|NCT01484496|19084005|P3|Period 2|Other|9
5519551|NCT01484496|19084006|P2|Period 2|Other|0
5519552|NCT01484496|19084007|P1|Period 2|Other|0
5519553|NCT01484496|19084004|P4|Period 2|Adverse Event|13
5519554|NCT01484496|19084005|P3|Period 2|Adverse Event|5
5519555|NCT01484496|19084006|P2|Period 2|Adverse Event|0
5519556|NCT01484496|19084007|P1|Period 2|Adverse Event|0
5519557|NCT01484496|19084004|P4|Period 2|Lack of Efficacy|3
5519558|NCT01484496|19084005|P3|Period 2|Lack of Efficacy|1
5519559|NCT01484496|19084006|P2|Period 2|Lack of Efficacy|0
5519560|NCT01484496|19084007|P1|Period 2|Lack of Efficacy|0
5519561|NCT01484496|19084004|P4|Period 1|Unable to Visit Site|0
5519562|NCT01484496|19084005|P3|Period 1|Unable to Visit Site|0
5519563|NCT01484496|19084006|P2|Period 1|Unable to Visit Site|2
5519564|NCT01484496|19084007|P1|Period 1|Unable to Visit Site|0
5519565|NCT01484496|19084004|P4|Period 1|Lack of Compliance|0
5519566|NCT01484496|19084005|P3|Period 1|Lack of Compliance|0
5519567|NCT01484496|19084006|P2|Period 1|Lack of Compliance|1
5519568|NCT01484496|19084007|P1|Period 1|Lack of Compliance|2
5519569|NCT01484496|19084004|P4|Period 1|Treatment Failure|0
5519570|NCT01484496|19084005|P3|Period 1|Treatment Failure|0
5519571|NCT01484496|19084006|P2|Period 1|Treatment Failure|6
5519572|NCT01484496|19084007|P1|Period 1|Treatment Failure|3
5519573|NCT01484496|19084004|P4|Period 1|Positive Pregnancy|0
5519574|NCT01484496|19084005|P3|Period 1|Positive Pregnancy|0
5519575|NCT01484496|19084006|P2|Period 1|Positive Pregnancy|6
5519576|NCT01484496|19084007|P1|Period 1|Positive Pregnancy|1
5519577|NCT01484496|19084004|P4|Period 1|Lost to Follow-up|0
5519578|NCT01484496|19084005|P3|Period 1|Lost to Follow-up|0
5519579|NCT01484496|19084006|P2|Period 1|Lost to Follow-up|6
5519580|NCT01484496|19084007|P1|Period 1|Lost to Follow-up|2
5519581|NCT01484496|19084004|P4|Period 1|Withdrawal by Subject|0
5519582|NCT01484496|19084005|P3|Period 1|Withdrawal by Subject|0
5519583|NCT01484496|19084006|P2|Period 1|Withdrawal by Subject|12
5519584|NCT01484496|19084007|P1|Period 1|Withdrawal by Subject|15
5519585|NCT01484496|19084004|P4|Period 1|Adverse Event|0
5519586|NCT01484496|19084005|P3|Period 1|Adverse Event|0
5519587|NCT01484496|19084006|P2|Period 1|Adverse Event|40
5519588|NCT01484496|19084007|P1|Period 1|Adverse Event|25
5519589|NCT01484496|19084004|P4|Period 1|Lack of Efficacy|0
5519590|NCT01484496|19084005|P3|Period 1|Lack of Efficacy|0
5519591|NCT01484496|19084006|P2|Period 1|Lack of Efficacy|15
5519592|NCT01484496|19084007|P1|Period 1|Lack of Efficacy|10
5519593|NCT01484496|19084004|P4|Period 1|Physician Decision|0
5519594|NCT01484496|19084005|P3|Period 1|Physician Decision|0
5519595|NCT01484496|19084006|P2|Period 1|Physician Decision|1
5519596|NCT01484496|19084007|P1|Period 1|Physician Decision|5
5519597|NCT01484496|19084004|P4|Period 1|Protocol Violation|0
5519598|NCT01484496|19084005|P3|Period 1|Protocol Violation|0
5519599|NCT01484496|19084006|P2|Period 1|Protocol Violation|4
5519600|NCT01484496|19084007|P1|Period 1|Protocol Violation|3
5519601|NCT01484431|19084022|P3|Period 2|Non-Compliance with Study Drug|0
5519602|NCT01484431|19084023|P2|Period 2|Non-Compliance with Study Drug|0
5519603|NCT01484431|19084024|P1|Period 2|Non-Compliance with Study Drug|1
5519604|NCT01484431|19084022|P3|Period 2|Physician Decision|1
5519605|NCT01484431|19084023|P2|Period 2|Physician Decision|0
5519606|NCT01484431|19084024|P1|Period 2|Physician Decision|0
5519607|NCT01484431|19084022|P3|Period 2|Death|1
5519608|NCT01484431|19084023|P2|Period 2|Death|1
5519609|NCT01484431|19084024|P1|Period 2|Death|0
5519610|NCT01484431|19084022|P3|Period 1: High Dose|Physician Decision|0
5519611|NCT01484431|19084023|P2|Period 1: High Dose|Physician Decision|1
5519612|NCT01484431|19084024|P1|Period 1: High Dose|Physician Decision|0
5519613|NCT01484275|19084062|P2|Overall Study|Lost to Follow-up|1
5519614|NCT01484275|19084063|P1|Overall Study|Lost to Follow-up|1
5519615|NCT01484275|19084062|P2|Overall Study|Withdrawal by Subject|5
5519616|NCT01484275|19084063|P1|Overall Study|Withdrawal by Subject|1
5519617|NCT01484275|19084062|P2|Overall Study|Death|4
5519618|NCT01484275|19084063|P1|Overall Study|Death|3
5519619|NCT01484275|19084062|P2|Overall Study|Other|0
5519620|NCT01484275|19084063|P1|Overall Study|Other|10
5519621|NCT01484275|19084062|P2|Overall Study|Study terminated by sponsor|32
5519622|NCT01484275|19084063|P1|Overall Study|Study terminated by sponsor|28
5519623|NCT01484197|19084085|P4|Treatment Period 2|Subject withdrew consent|1
5519624|NCT01484197|19084086|P3|Treatment Period 2|Subject withdrew consent|0
5519625|NCT01484197|19084087|P2|Treatment Period 2|Subject withdrew consent|0
5519626|NCT01484197|19084088|P1|Treatment Period 2|Subject withdrew consent|0
5519627|NCT01484197|19084085|P4|Treatment Period 1|Adverse Event|0
5519628|NCT01484197|19084086|P3|Treatment Period 1|Adverse Event|0
5519629|NCT01484197|19084087|P2|Treatment Period 1|Adverse Event|0
5519630|NCT01484197|19084088|P1|Treatment Period 1|Adverse Event|1
5519631|NCT01484132|19084171|P1|Overall Study|No post-treatment urine sample collected|10
5519632|NCT01484132|19084171|P1|Overall Study|No pre-treatment urine sample collected|1
5519633|NCT01484132|19084171|P1|Overall Study|Ineligible|1
5519634|NCT01484132|19084171|P1|Overall Study|Difficulty with time commitment|2
5519635|NCT01484132|19084171|P1|Overall Study|Lost to Follow-up|8
5519636|NCT01484054|19084179|P2|Period 1|Withdrawal by Subject|1
5519637|NCT01484054|19084180|P1|Period 1|Withdrawal by Subject|0
5519638|NCT01484028|19084198|P4|Period 1|Lens Discomfort|0
5519639|NCT01484028|19084199|P3|Period 1|Lens Discomfort|0
5519640|NCT01484028|19084200|P2|Period 1|Lens Discomfort|1
5519641|NCT01484028|19084201|P1|Period 1|Lens Discomfort|0
5519642|NCT01484028|19084198|P4|Period 1|Non-Compliance to Protocol|1
5519643|NCT01484028|19084199|P3|Period 1|Non-Compliance to Protocol|0
5519644|NCT01484028|19084200|P2|Period 1|Non-Compliance to Protocol|1
5519645|NCT01484028|19084201|P1|Period 1|Non-Compliance to Protocol|0
5519646|NCT01484028|19084198|P4|Period 1|Lost to Follow-up|0
5519647|NCT01484028|19084199|P3|Period 1|Lost to Follow-up|0
5519648|NCT01484028|19084200|P2|Period 1|Lost to Follow-up|1
5519649|NCT01484028|19084201|P1|Period 1|Lost to Follow-up|0
5519650|NCT01483937|19084294|P2|Overall Study|Withdrawal by Subject|3
5519651|NCT01483937|19084295|P1|Overall Study|Withdrawal by Subject|4
5519652|NCT01483924|19084322|P5|Overall Study|Sponsor concern over ECG result|0
5519653|NCT01483924|19084323|P4|Overall Study|Sponsor concern over ECG result|1
5519654|NCT01483924|19084324|P3|Overall Study|Sponsor concern over ECG result|0
5519655|NCT01483924|19084325|P2|Overall Study|Sponsor concern over ECG result|0
5519656|NCT01483924|19084326|P1|Overall Study|Sponsor concern over ECG result|0
5519657|NCT01483924|19084322|P5|Overall Study|Non-compliance|1
5519658|NCT01483924|19084323|P4|Overall Study|Non-compliance|1
5519659|NCT01483924|19084324|P3|Overall Study|Non-compliance|0
5519660|NCT01483924|19084325|P2|Overall Study|Non-compliance|0
5519661|NCT01483924|19084326|P1|Overall Study|Non-compliance|0
5519662|NCT01483924|19084322|P5|Overall Study|Adverse Event|0
5519663|NCT01483924|19084323|P4|Overall Study|Adverse Event|1
5519664|NCT01483924|19084324|P3|Overall Study|Adverse Event|1
5519665|NCT01483924|19084325|P2|Overall Study|Adverse Event|0
5519666|NCT01483924|19084326|P1|Overall Study|Adverse Event|0
5519667|NCT01483924|19084322|P5|Overall Study|Withdrawal by Subject|1
5519668|NCT01483924|19084323|P4|Overall Study|Withdrawal by Subject|1
5519669|NCT01483924|19084324|P3|Overall Study|Withdrawal by Subject|0
5519670|NCT01483924|19084325|P2|Overall Study|Withdrawal by Subject|0
5519671|NCT01483924|19084326|P1|Overall Study|Withdrawal by Subject|2
5519672|NCT01483820|19084379|P1|Overall Study|Death|1
5519673|NCT01483820|19084379|P1|Overall Study|Adverse Event|1
5519674|NCT01483820|19084379|P1|Overall Study|Lack of Efficacy|6
5519675|NCT01483690|19084402|P2|Overall Study|exclusionary procedure|1
5519676|NCT01483690|19084403|P1|Overall Study|exclusionary procedure|0
5519677|NCT01483690|19084402|P2|Overall Study|Physician Decision|2
5519678|NCT01483690|19084403|P1|Overall Study|Physician Decision|0
5519679|NCT01483690|19084402|P2|Overall Study|clinical deterioration|0
5519680|NCT01483690|19084403|P1|Overall Study|clinical deterioration|1
5519681|NCT01483690|19084402|P2|Overall Study|Adverse Event|2
5519682|NCT01483690|19084403|P1|Overall Study|Adverse Event|1
5519683|NCT01483651|19084411|P6|Overall Study|Withdrawal by Subject|1
5519684|NCT01483651|19084412|P5|Overall Study|Withdrawal by Subject|0
5519685|NCT01483651|19084413|P4|Overall Study|Withdrawal by Subject|0
5519686|NCT01483651|19084414|P3|Overall Study|Withdrawal by Subject|1
5519687|NCT01483651|19084415|P2|Overall Study|Withdrawal by Subject|1
5519688|NCT01483651|19084416|P1|Overall Study|Withdrawal by Subject|0
5519689|NCT01483625|19084426|P2|Overall Study|Due to other reason|0
5519690|NCT01483625|19084427|P1|Overall Study|Due to other reason|1
5519691|NCT01483625|19084426|P2|Overall Study|Refused to continue medication|1
5519692|NCT01483625|19084427|P1|Overall Study|Refused to continue medication|2
5519693|NCT01483625|19084426|P2|Overall Study|Adverse Event|1
5519694|NCT01483625|19084427|P1|Overall Study|Adverse Event|1
5519695|NCT01483599|19084450|P14|After Controlled Period(Week 16-Week 40)|Other|0
5519696|NCT01483599|19084451|P13|After Controlled Period(Week 16-Week 40)|Other|1
5519697|NCT01483599|19084452|P12|After Controlled Period(Week 16-Week 40)|Other|0
5519698|NCT01483599|19084453|P11|After Controlled Period(Week 16-Week 40)|Other|0
5519699|NCT01483599|19084454|P10|After Controlled Period(Week 16-Week 40)|Other|4
5519700|NCT01483599|19084455|P9|After Controlled Period(Week 16-Week 40)|Other|0
5519701|NCT01483599|19084456|P8|After Controlled Period(Week 16-Week 40)|Other|1
5519702|NCT01483599|19084457|P7|After Controlled Period(Week 16-Week 40)|Other|0
5519703|NCT01483599|19084458|P6|After Controlled Period(Week 16-Week 40)|Other|0
5519704|NCT01483599|19084459|P5|After Controlled Period(Week 16-Week 40)|Other|0
5519705|NCT01483599|19084460|P4|After Controlled Period(Week 16-Week 40)|Other|0
5519706|NCT01483599|19084461|P3|After Controlled Period(Week 16-Week 40)|Other|0
5519707|NCT01483599|19084462|P2|After Controlled Period(Week 16-Week 40)|Other|0
5519708|NCT01483599|19084463|P1|After Controlled Period(Week 16-Week 40)|Other|0
5519709|NCT01483599|19084450|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
5519710|NCT01483599|19084451|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
5519711|NCT01483599|19084452|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519712|NCT01483599|19084453|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519713|NCT01483599|19084454|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519714|NCT01483599|19084455|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
5519715|NCT01483599|19084456|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519716|NCT01483599|19084457|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519717|NCT01483599|19084458|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519718|NCT01483599|19084459|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519719|NCT01483599|19084460|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519720|NCT01483599|19084461|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519721|NCT01483599|19084462|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519722|NCT01483599|19084463|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
5519723|NCT01483599|19084450|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
5519724|NCT01483599|19084451|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519725|NCT01483599|19084452|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519726|NCT01483599|19084453|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
5519727|NCT01483599|19084454|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519728|NCT01483599|19084455|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
5519729|NCT01483599|19084456|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519730|NCT01483599|19084457|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519731|NCT01483599|19084458|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519732|NCT01483599|19084459|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519733|NCT01483599|19084460|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519734|NCT01483599|19084461|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519735|NCT01483599|19084462|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519736|NCT01483599|19084463|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
5519737|NCT01483599|19084450|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
5519738|NCT01483599|19084451|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519739|NCT01483599|19084452|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
5519740|NCT01483599|19084453|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519741|NCT01483599|19084454|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519742|NCT01483599|19084455|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
5519743|NCT01483599|19084456|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519744|NCT01483599|19084457|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519745|NCT01483599|19084458|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519746|NCT01483599|19084459|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519747|NCT01483599|19084460|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519748|NCT01483599|19084461|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519749|NCT01483599|19084462|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519750|NCT01483599|19084463|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
5519751|NCT01483599|19084450|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5519752|NCT01483599|19084451|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5519753|NCT01483599|19084452|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519754|NCT01483599|19084453|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519755|NCT01483599|19084454|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519756|NCT01483599|19084455|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5519757|NCT01483599|19084456|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
5519758|NCT01483599|19084457|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519759|NCT01483599|19084458|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519760|NCT01483599|19084459|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519761|NCT01483599|19084460|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519762|NCT01483599|19084461|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519763|NCT01483599|19084462|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519764|NCT01483599|19084463|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
5519765|NCT01483599|19084450|P14|After Controlled Period(Week 16-Week 40)|Death|0
5519766|NCT01483599|19084451|P13|After Controlled Period(Week 16-Week 40)|Death|0
5519767|NCT01483599|19084452|P12|After Controlled Period(Week 16-Week 40)|Death|0
5519768|NCT01483599|19084453|P11|After Controlled Period(Week 16-Week 40)|Death|0
5519769|NCT01483599|19084454|P10|After Controlled Period(Week 16-Week 40)|Death|0
5519770|NCT01483599|19084455|P9|After Controlled Period(Week 16-Week 40)|Death|1
5519771|NCT01483599|19084456|P8|After Controlled Period(Week 16-Week 40)|Death|0
5519772|NCT01483599|19084457|P7|After Controlled Period(Week 16-Week 40)|Death|0
5519773|NCT01483599|19084458|P6|After Controlled Period(Week 16-Week 40)|Death|0
5519774|NCT01483599|19084459|P5|After Controlled Period(Week 16-Week 40)|Death|0
5519775|NCT01483599|19084460|P4|After Controlled Period(Week 16-Week 40)|Death|0
5519776|NCT01483599|19084461|P3|After Controlled Period(Week 16-Week 40)|Death|0
5519777|NCT01483599|19084462|P2|After Controlled Period(Week 16-Week 40)|Death|0
5519778|NCT01483599|19084463|P1|After Controlled Period(Week 16-Week 40)|Death|0
5519779|NCT01483599|19084450|P14|Controlled Period (CP) (up to Week 16)|Other|0
5519780|NCT01483599|19084451|P13|Controlled Period (CP) (up to Week 16)|Other|0
5519781|NCT01483599|19084452|P12|Controlled Period (CP) (up to Week 16)|Other|0
5519782|NCT01483599|19084453|P11|Controlled Period (CP) (up to Week 16)|Other|0
5519783|NCT01483599|19084454|P10|Controlled Period (CP) (up to Week 16)|Other|0
5519784|NCT01483599|19084455|P9|Controlled Period (CP) (up to Week 16)|Other|0
5519785|NCT01483599|19084456|P8|Controlled Period (CP) (up to Week 16)|Other|0
5519786|NCT01483599|19084457|P7|Controlled Period (CP) (up to Week 16)|Other|0
5519787|NCT01483599|19084458|P6|Controlled Period (CP) (up to Week 16)|Other|0
5519788|NCT01483599|19084459|P5|Controlled Period (CP) (up to Week 16)|Other|1
5519789|NCT01483599|19084460|P4|Controlled Period (CP) (up to Week 16)|Other|1
5519790|NCT01483599|19084461|P3|Controlled Period (CP) (up to Week 16)|Other|0
5519791|NCT01483599|19084462|P2|Controlled Period (CP) (up to Week 16)|Other|2
5519792|NCT01483599|19084463|P1|Controlled Period (CP) (up to Week 16)|Other|0
5519793|NCT01483599|19084450|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519794|NCT01483599|19084451|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519795|NCT01483599|19084452|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519796|NCT01483599|19084453|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519797|NCT01483599|19084454|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519798|NCT01483599|19084455|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519799|NCT01483599|19084456|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519800|NCT01483599|19084457|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519801|NCT01483599|19084458|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519802|NCT01483599|19084459|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519803|NCT01483599|19084460|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519804|NCT01483599|19084461|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519805|NCT01483599|19084462|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
5519806|NCT01483599|19084463|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
5519807|NCT01483599|19084450|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519808|NCT01483599|19084451|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519809|NCT01483599|19084452|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519810|NCT01483599|19084453|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519811|NCT01483599|19084454|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519812|NCT01483599|19084455|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519813|NCT01483599|19084456|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519814|NCT01483599|19084457|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
5519815|NCT01483599|19084458|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519816|NCT01483599|19084459|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519817|NCT01483599|19084460|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
5519818|NCT01483599|19084461|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519991|NCT01481116|19085185|P1|Overall Study|Non-Compliant With Study Drug|0
5519819|NCT01483599|19084462|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
5519820|NCT01483599|19084463|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
5519821|NCT01483599|19084450|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5519822|NCT01483599|19084451|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5519823|NCT01483599|19084452|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5519824|NCT01483599|19084453|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5519825|NCT01483599|19084454|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5519826|NCT01483599|19084455|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5519827|NCT01483599|19084456|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5519828|NCT01483599|19084457|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
5519829|NCT01483599|19084458|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
5519830|NCT01483599|19084459|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
5519831|NCT01483599|19084460|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
5519832|NCT01483599|19084461|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5519833|NCT01483599|19084462|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
5519834|NCT01483599|19084463|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
5519835|NCT01483183|19084576|P10|Overall Study|Withdrawal by Subject|1
5519836|NCT01483183|19084577|P9|Overall Study|Withdrawal by Subject|0
5519837|NCT01483183|19084578|P8|Overall Study|Withdrawal by Subject|0
5519838|NCT01483183|19084579|P7|Overall Study|Withdrawal by Subject|0
5519839|NCT01483183|19084580|P6|Overall Study|Withdrawal by Subject|0
5519840|NCT01483183|19084581|P5|Overall Study|Withdrawal by Subject|0
5519841|NCT01483183|19084582|P4|Overall Study|Withdrawal by Subject|0
5519842|NCT01483183|19084583|P3|Overall Study|Withdrawal by Subject|0
5519843|NCT01483183|19084584|P2|Overall Study|Withdrawal by Subject|0
5519844|NCT01483183|19084585|P1|Overall Study|Withdrawal by Subject|0
5519845|NCT01483183|19084576|P10|Overall Study|Physician Decision|0
5519846|NCT01483183|19084577|P9|Overall Study|Physician Decision|0
5519847|NCT01483183|19084578|P8|Overall Study|Physician Decision|0
5519848|NCT01483183|19084579|P7|Overall Study|Physician Decision|2
5519849|NCT01483183|19084580|P6|Overall Study|Physician Decision|0
5519850|NCT01483183|19084581|P5|Overall Study|Physician Decision|0
5519851|NCT01483183|19084582|P4|Overall Study|Physician Decision|0
5519852|NCT01483183|19084583|P3|Overall Study|Physician Decision|0
5519853|NCT01483183|19084584|P2|Overall Study|Physician Decision|0
5519854|NCT01483183|19084585|P1|Overall Study|Physician Decision|0
5519855|NCT01483118|19084655|P2|Overall Study|Lost to Follow-up|16
5519856|NCT01483118|19084656|P1|Overall Study|Lost to Follow-up|12
5519857|NCT01482962|19084668|P2|Overall Study|Did not Receive Study Drug|6
5519858|NCT01482962|19084669|P1|Overall Study|Did not Receive Study Drug|1
5519859|NCT01482962|19084668|P2|Overall Study|Study Terminated by Sponsor|2
5519860|NCT01482962|19084669|P1|Overall Study|Study Terminated by Sponsor|5
5519861|NCT01482962|19084668|P2|Overall Study|Other Reason|5
5519862|NCT01482962|19084669|P1|Overall Study|Other Reason|1
5519863|NCT01482962|19084668|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
5519864|NCT01482962|19084669|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
5519865|NCT01482962|19084668|P2|Overall Study|Withdrawal by Participant|13
5519866|NCT01482962|19084669|P1|Overall Study|Withdrawal by Participant|8
5519867|NCT01482962|19084668|P2|Overall Study|Adverse Event|22
5519868|NCT01482962|19084669|P1|Overall Study|Adverse Event|18
5519869|NCT01482962|19084668|P2|Overall Study|Unsatisfactory Therapeutic Response|23
5519870|NCT01482962|19084669|P1|Overall Study|Unsatisfactory Therapeutic Response|37
5519871|NCT01482962|19084668|P2|Overall Study|Progressive Disease|53
5519872|NCT01482962|19084669|P1|Overall Study|Progressive Disease|65
5519873|NCT01482910|19084702|P2|Overall Study|Death|0
5519874|NCT01482910|19084703|P1|Overall Study|Death|1
5519875|NCT01482910|19084702|P2|Overall Study|Withdrawal by Subject|2
5519876|NCT01482910|19084703|P1|Overall Study|Withdrawal by Subject|7
5519877|NCT01482910|19084702|P2|Overall Study|Protocol Violation|1
5519878|NCT01482910|19084703|P1|Overall Study|Protocol Violation|1
5519879|NCT01482910|19084702|P2|Overall Study|Lost to Follow-up|1
5519880|NCT01482910|19084703|P1|Overall Study|Lost to Follow-up|0
5519881|NCT01482910|19084702|P2|Overall Study|Adverse Event|5
5519882|NCT01482910|19084703|P1|Overall Study|Adverse Event|6
5519883|NCT01482884|19084715|P2|Overall Study|Withdrawal by Subject|13
5519884|NCT01482884|19084716|P1|Overall Study|Withdrawal by Subject|8
5519885|NCT01482884|19084715|P2|Overall Study|Adverse Event|1
5519886|NCT01482884|19084716|P1|Overall Study|Adverse Event|2
5519887|NCT01482884|19084715|P2|Overall Study|Lack of Efficacy|1
5519888|NCT01482884|19084716|P1|Overall Study|Lack of Efficacy|0
5519889|NCT01482884|19084715|P2|Overall Study|Lost to Follow-up|2
5519890|NCT01482884|19084716|P1|Overall Study|Lost to Follow-up|2
5519891|NCT01482884|19084715|P2|Overall Study|Protocol Violation|0
5519892|NCT01482884|19084716|P1|Overall Study|Protocol Violation|1
5519893|NCT01482884|19084715|P2|Overall Study|Medical decision due to lack of efficacy|1
5519894|NCT01482884|19084716|P1|Overall Study|Medical decision due to lack of efficacy|0
5519895|NCT01482819|19084742|P1|Overall Study|Lost to Follow-up|2
5519896|NCT01482767|19084762|P2|Overall Study|Nurse error|0
5519897|NCT01482767|19084763|P1|Overall Study|Nurse error|1
5519898|NCT01482767|19084762|P2|Overall Study|Ineligible|5
5519899|NCT01482767|19084763|P1|Overall Study|Ineligible|0
5519900|NCT01482767|19084762|P2|Overall Study|Alternate HCV treatment|8
5519901|NCT01482767|19084763|P1|Overall Study|Alternate HCV treatment|7
5519902|NCT01482767|19084762|P2|Overall Study|Non-adherence to study requirements|7
5519903|NCT01482767|19084763|P1|Overall Study|Non-adherence to study requirements|4
5519904|NCT01482767|19084762|P2|Overall Study|Site closure|14
5519905|NCT01482767|19084763|P1|Overall Study|Site closure|22
5519906|NCT01482767|19084762|P2|Overall Study|Adverse Event|3
5519907|NCT01482767|19084763|P1|Overall Study|Adverse Event|0
5519908|NCT01482767|19084762|P2|Overall Study|Lost to Follow-up|6
5519909|NCT01482767|19084763|P1|Overall Study|Lost to Follow-up|12
5519910|NCT01482767|19084762|P2|Overall Study|Withdrawal by Subject|5
5519911|NCT01482767|19084763|P1|Overall Study|Withdrawal by Subject|7
5519912|NCT01482767|19084762|P2|Overall Study|Death|1
5519913|NCT01482767|19084763|P1|Overall Study|Death|1
5519914|NCT01482598|19084891|P2|Overall Study|Lost to Follow-up|4
5519915|NCT01482598|19084892|P1|Overall Study|Lost to Follow-up|5
5519916|NCT01482598|19084891|P2|Overall Study|Withdrawal by Subject|5
5519917|NCT01482598|19084892|P1|Overall Study|Withdrawal by Subject|4
5519918|NCT01482598|19084891|P2|Overall Study|Physician Decision|3
5519919|NCT01482598|19084892|P1|Overall Study|Physician Decision|0
5519920|NCT01482598|19084891|P2|Overall Study|Death|10
5519921|NCT01482598|19084892|P1|Overall Study|Death|7
5519922|NCT01482429|19084900|P2|Protocol|Protocol Violation|0
5519923|NCT01482429|19084901|P1|Protocol|Protocol Violation|275
5519924|NCT01482429|19084900|P2|Care Usual|Lost to Follow-up|1
5519925|NCT01482429|19084901|P1|Care Usual|Lost to Follow-up|0
5519926|NCT01482429|19084900|P2|Care Usual|Protocol Violation|172
5519927|NCT01482429|19084901|P1|Care Usual|Protocol Violation|0
5519928|NCT01482312|19084937|P3|Period 2, 90 Minutes of Wear|Other|0
5519929|NCT01482312|19084938|P2|Period 2, 90 Minutes of Wear|Other|0
5519930|NCT01482312|19084939|P1|Period 2, 90 Minutes of Wear|Other|1
5519931|NCT01482312|19084937|P3|Period 1, 90 Minutes of Wear|Other|0
5519932|NCT01482312|19084938|P2|Period 1, 90 Minutes of Wear|Other|0
5519933|NCT01482312|19084939|P1|Period 1, 90 Minutes of Wear|Other|1
5519934|NCT01482221|19084953|P3|Overall Study|Physician Decision|0
5519935|NCT01482221|19084954|P2|Overall Study|Physician Decision|1
5519936|NCT01482221|19084955|P1|Overall Study|Physician Decision|0
5519937|NCT01482221|19084953|P3|Overall Study|Incorrect randomization|0
5519938|NCT01482221|19084954|P2|Overall Study|Incorrect randomization|1
5519939|NCT01482221|19084955|P1|Overall Study|Incorrect randomization|0
5519940|NCT01482221|19084953|P3|Overall Study|Withdrawal by Subject|12
5519941|NCT01482221|19084954|P2|Overall Study|Withdrawal by Subject|7
5519942|NCT01482221|19084955|P1|Overall Study|Withdrawal by Subject|10
5519943|NCT01482221|19084953|P3|Overall Study|Adverse Event|3
5519944|NCT01482221|19084954|P2|Overall Study|Adverse Event|7
5519945|NCT01482221|19084955|P1|Overall Study|Adverse Event|1
5519946|NCT01482221|19084953|P3|Overall Study|Severe Non-Compliance to Protocol|1
5519947|NCT01482221|19084954|P2|Overall Study|Severe Non-Compliance to Protocol|0
5519948|NCT01482221|19084955|P1|Overall Study|Severe Non-Compliance to Protocol|1
5519949|NCT01482221|19084953|P3|Overall Study|Condition under Investigation Worsened|4
5519950|NCT01482221|19084954|P2|Overall Study|Condition under Investigation Worsened|2
5519951|NCT01482221|19084955|P1|Overall Study|Condition under Investigation Worsened|3
5519952|NCT01482221|19084953|P3|Overall Study|Study-Specific Withdrawal Criteria|1
5519953|NCT01482221|19084954|P2|Overall Study|Study-Specific Withdrawal Criteria|0
5519954|NCT01482221|19084955|P1|Overall Study|Study-Specific Withdrawal Criteria|2
5519955|NCT01482221|19084953|P3|Overall Study|Lost to Follow-up|1
5519956|NCT01482221|19084954|P2|Overall Study|Lost to Follow-up|2
5519957|NCT01482221|19084955|P1|Overall Study|Lost to Follow-up|3
5519958|NCT01482221|19084953|P3|Overall Study|Lack of Efficacy|1
5519959|NCT01482221|19084954|P2|Overall Study|Lack of Efficacy|0
5519960|NCT01482221|19084955|P1|Overall Study|Lack of Efficacy|1
5519961|NCT01482169|19084996|P1|Overall Study|Physician Decision|2
5519962|NCT01482065|19085038|P2|Overall Study|Withdrawal by Subject|1
5519963|NCT01482065|19085039|P1|Overall Study|Withdrawal by Subject|0
5519964|NCT01481896|19085060|P1|Overall Study|Lost to Follow-up|12
5519965|NCT01481779|19085076|P2|Overall Study|Sponsor Decision|1
5519966|NCT01481779|19085077|P1|Overall Study|Sponsor Decision|3
5519967|NCT01481779|19085076|P2|Overall Study|Physician Decision|4
5519968|NCT01481779|19085077|P1|Overall Study|Physician Decision|13
5519969|NCT01481779|19085076|P2|Overall Study|Withdrawal by Subject|13
5519970|NCT01481779|19085077|P1|Overall Study|Withdrawal by Subject|26
5519971|NCT01481779|19085076|P2|Overall Study|Protocol Violation|3
5519972|NCT01481779|19085077|P1|Overall Study|Protocol Violation|2
5519973|NCT01481779|19085076|P2|Overall Study|Lost to Follow-up|2
5519974|NCT01481779|19085077|P1|Overall Study|Lost to Follow-up|3
5519975|NCT01481779|19085076|P2|Overall Study|Adverse Event|5
5519976|NCT01481779|19085077|P1|Overall Study|Adverse Event|23
5519977|NCT01481324|19085162|P3|Overall Study|Missing Data|2
5519978|NCT01481324|19085163|P2|Overall Study|Missing Data|2
5519979|NCT01481324|19085164|P1|Overall Study|Missing Data|0
5519980|NCT01481116|19085183|P3|Overall Study|Hypoglycemic Event|0
5519981|NCT01481116|19085184|P2|Overall Study|Hypoglycemic Event|0
5519982|NCT01481116|19085185|P1|Overall Study|Hypoglycemic Event|4
5519983|NCT01481116|19085183|P3|Overall Study|Death|0
5519984|NCT01481116|19085184|P2|Overall Study|Death|1
5519985|NCT01481116|19085185|P1|Overall Study|Death|2
5519986|NCT01481116|19085183|P3|Overall Study|Investigator's Discretion|0
5519987|NCT01481116|19085184|P2|Overall Study|Investigator's Discretion|0
5519988|NCT01481116|19085185|P1|Overall Study|Investigator's Discretion|2
5519989|NCT01481116|19085183|P3|Overall Study|Non-Compliant With Study Drug|1
5519990|NCT01481116|19085184|P2|Overall Study|Non-Compliant With Study Drug|1
5519992|NCT01481116|19085183|P3|Overall Study|Sponsor Decision|3
5519993|NCT01481116|19085184|P2|Overall Study|Sponsor Decision|1
5519994|NCT01481116|19085185|P1|Overall Study|Sponsor Decision|0
5519995|NCT01481116|19085183|P3|Overall Study|Investigator Decision|1
5519996|NCT01481116|19085184|P2|Overall Study|Investigator Decision|2
5519997|NCT01481116|19085185|P1|Overall Study|Investigator Decision|3
5519998|NCT01481116|19085183|P3|Overall Study|Participant Moved Out of Country|1
5519999|NCT01481116|19085184|P2|Overall Study|Participant Moved Out of Country|0
5520000|NCT01481116|19085185|P1|Overall Study|Participant Moved Out of Country|1
5520001|NCT01481116|19085183|P3|Overall Study|Participant Moved Out of Area|1
5520002|NCT01481116|19085184|P2|Overall Study|Participant Moved Out of Area|0
5520003|NCT01481116|19085185|P1|Overall Study|Participant Moved Out of Area|2
5520004|NCT01481116|19085183|P3|Overall Study|Participant Started Taking Glipizide|0
5520005|NCT01481116|19085184|P2|Overall Study|Participant Started Taking Glipizide|0
5520006|NCT01481116|19085185|P1|Overall Study|Participant Started Taking Glipizide|1
5520007|NCT01481116|19085183|P3|Overall Study|Other|0
5520008|NCT01481116|19085184|P2|Overall Study|Other|1
5520009|NCT01481116|19085185|P1|Overall Study|Other|1
5520010|NCT01481116|19085183|P3|Overall Study|Contraindications|0
5520011|NCT01481116|19085184|P2|Overall Study|Contraindications|1
5520012|NCT01481116|19085185|P1|Overall Study|Contraindications|1
5520013|NCT01481116|19085183|P3|Overall Study|Lack of Efficacy|1
5520014|NCT01481116|19085184|P2|Overall Study|Lack of Efficacy|3
5520015|NCT01481116|19085185|P1|Overall Study|Lack of Efficacy|3
5520016|NCT01481116|19085183|P3|Overall Study|Pregnancy|1
5520017|NCT01481116|19085184|P2|Overall Study|Pregnancy|0
5520018|NCT01481116|19085185|P1|Overall Study|Pregnancy|0
5520019|NCT01481116|19085183|P3|Overall Study|Study Termination|713
5520020|NCT01481116|19085184|P2|Overall Study|Study Termination|729
5520021|NCT01481116|19085185|P1|Overall Study|Study Termination|730
5520022|NCT01481116|19085183|P3|Overall Study|Withdrawal by Subject|37
5520023|NCT01481116|19085184|P2|Overall Study|Withdrawal by Subject|33
5520024|NCT01481116|19085185|P1|Overall Study|Withdrawal by Subject|37
5520025|NCT01481116|19085183|P3|Overall Study|Lost to Follow-up|11
5520026|NCT01481116|19085184|P2|Overall Study|Lost to Follow-up|12
5520027|NCT01481116|19085185|P1|Overall Study|Lost to Follow-up|8
5520028|NCT01481116|19085183|P3|Overall Study|Major Protocol Deviation|1
5520029|NCT01481116|19085184|P2|Overall Study|Major Protocol Deviation|7
5520030|NCT01481116|19085185|P1|Overall Study|Major Protocol Deviation|3
5520031|NCT01481116|19085183|P3|Overall Study|Adverse Event|42
5520032|NCT01481116|19085184|P2|Overall Study|Adverse Event|26
5520033|NCT01481116|19085185|P1|Overall Study|Adverse Event|26
5520034|NCT01480674|19085216|P1|Overall Study|visit not done|10
5520035|NCT01480674|19085216|P1|Overall Study|Lost to Follow-up|2
5520036|NCT01480674|19085216|P1|Overall Study|Death|23
5520037|NCT01480596|19085230|P2|Overall Study|MG exacerbation or change in medication|2
5520038|NCT01480596|19085231|P1|Overall Study|MG exacerbation or change in medication|2
5520039|NCT01480596|19085230|P2|Overall Study|Adverse Event|0
5520040|NCT01480596|19085231|P1|Overall Study|Adverse Event|3
5520041|NCT01480284|19085279|P2|Overall Study|Physician Decision|0
5520042|NCT01480284|19085280|P1|Overall Study|Physician Decision|1
5520043|NCT01480284|19085279|P2|Overall Study|Lost to Follow-up|0
5520044|NCT01480284|19085280|P1|Overall Study|Lost to Follow-up|1
5520045|NCT01480284|19085279|P2|Overall Study|Study closed/terminated|0
5520046|NCT01480284|19085280|P1|Overall Study|Study closed/terminated|3
5520047|NCT01480284|19085279|P2|Overall Study|Adverse Event|0
5520048|NCT01480284|19085280|P1|Overall Study|Adverse Event|1
5520049|NCT01480284|19085279|P2|Overall Study|Withdrawal by Subject|0
5520050|NCT01480284|19085280|P1|Overall Study|Withdrawal by Subject|2
5520051|NCT01480258|19085310|P2|Interim Period|Withdrawal by Subject|6
5520052|NCT01480258|19085311|P1|Interim Period|Withdrawal by Subject|9
5520053|NCT01480258|19085310|P2|Interim Period|Protocol Violation|1
5520054|NCT01480258|19085311|P1|Interim Period|Protocol Violation|0
5520055|NCT01480258|19085310|P2|Interim Period|Physician Decision|0
5520056|NCT01480258|19085311|P1|Interim Period|Physician Decision|1
5520057|NCT01480258|19085310|P2|Interim Period|Lost to Follow-up|2
5520058|NCT01480258|19085311|P1|Interim Period|Lost to Follow-up|0
5520059|NCT01480258|19085310|P2|Infant Series|Withdrawal by Subject|6
5520060|NCT01480258|19085311|P1|Infant Series|Withdrawal by Subject|1
5520061|NCT01480258|19085310|P2|Infant Series|Adverse Event|1
5520062|NCT01480258|19085311|P1|Infant Series|Adverse Event|1
5520063|NCT01480258|19085310|P2|Infant Series|Not Vaccinated|0
5520064|NCT01480258|19085311|P1|Infant Series|Not Vaccinated|3
5520065|NCT01480258|19085310|P2|Infant Series|Physician Decision|1
5520066|NCT01480258|19085311|P1|Infant Series|Physician Decision|0
5520067|NCT01480258|19085310|P2|Infant Series|Protocol Violation|0
5520068|NCT01480258|19085311|P1|Infant Series|Protocol Violation|2
5520069|NCT01480180|19085377|P6|Extension Phase, Part 2|Unclassified|0
5520070|NCT01480180|19085378|P5|Extension Phase, Part 2|Unclassified|1
5520071|NCT01480180|19085379|P4|Extension Phase, Part 2|Unclassified|1
5520072|NCT01480180|19085380|P3|Extension Phase, Part 2|Unclassified|3
5520073|NCT01480180|19085381|P2|Extension Phase, Part 2|Unclassified|0
5520074|NCT01480180|19085382|P1|Extension Phase, Part 2|Unclassified|0
5520075|NCT01480180|19085377|P6|Extension Phase, Part 2|Lack of Efficacy|0
5520076|NCT01480180|19085378|P5|Extension Phase, Part 2|Lack of Efficacy|0
5520077|NCT01480180|19085379|P4|Extension Phase, Part 2|Lack of Efficacy|0
5520078|NCT01480180|19085380|P3|Extension Phase, Part 2|Lack of Efficacy|4
5520079|NCT01480180|19085381|P2|Extension Phase, Part 2|Lack of Efficacy|0
5520080|NCT01480180|19085382|P1|Extension Phase, Part 2|Lack of Efficacy|0
5520081|NCT01480180|19085377|P6|Extension Phase, Part 2|Withdrawal criteria|0
5520082|NCT01480180|19085378|P5|Extension Phase, Part 2|Withdrawal criteria|1
5520083|NCT01480180|19085379|P4|Extension Phase, Part 2|Withdrawal criteria|6
5520084|NCT01480180|19085380|P3|Extension Phase, Part 2|Withdrawal criteria|10
5520085|NCT01480180|19085381|P2|Extension Phase, Part 2|Withdrawal criteria|0
5520086|NCT01480180|19085382|P1|Extension Phase, Part 2|Withdrawal criteria|0
5520087|NCT01480180|19085377|P6|Extension Phase, Part 1|Change of treatment|0
5520088|NCT01480180|19085378|P5|Extension Phase, Part 1|Change of treatment|0
5520089|NCT01480180|19085379|P4|Extension Phase, Part 1|Change of treatment|9
5520090|NCT01480180|19085380|P3|Extension Phase, Part 1|Change of treatment|0
5520091|NCT01480180|19085381|P2|Extension Phase, Part 1|Change of treatment|0
5520092|NCT01480180|19085382|P1|Extension Phase, Part 1|Change of treatment|0
5520093|NCT01480180|19085377|P6|Extension Phase, Part 1|Adverse Event|0
5520094|NCT01480180|19085378|P5|Extension Phase, Part 1|Adverse Event|0
5520095|NCT01480180|19085379|P4|Extension Phase, Part 1|Adverse Event|1
5520096|NCT01480180|19085380|P3|Extension Phase, Part 1|Adverse Event|4
5520097|NCT01480180|19085381|P2|Extension Phase, Part 1|Adverse Event|0
5520098|NCT01480180|19085382|P1|Extension Phase, Part 1|Adverse Event|0
5520099|NCT01480180|19085377|P6|Extension Phase, Part 1|Unclassified|0
5520100|NCT01480180|19085378|P5|Extension Phase, Part 1|Unclassified|0
5520101|NCT01480180|19085379|P4|Extension Phase, Part 1|Unclassified|0
5520102|NCT01480180|19085380|P3|Extension Phase, Part 1|Unclassified|1
5520103|NCT01480180|19085381|P2|Extension Phase, Part 1|Unclassified|0
5520104|NCT01480180|19085382|P1|Extension Phase, Part 1|Unclassified|0
5520105|NCT01480180|19085377|P6|Extension Phase, Part 1|Withdrawal criteria|0
5520106|NCT01480180|19085378|P5|Extension Phase, Part 1|Withdrawal criteria|0
5520107|NCT01480180|19085379|P4|Extension Phase, Part 1|Withdrawal criteria|0
5520108|NCT01480180|19085380|P3|Extension Phase, Part 1|Withdrawal criteria|5
5520109|NCT01480180|19085381|P2|Extension Phase, Part 1|Withdrawal criteria|0
5520110|NCT01480180|19085382|P1|Extension Phase, Part 1|Withdrawal criteria|0
5520111|NCT01480180|19085377|P6|Main Phase|Unclassified|0
5520112|NCT01480180|19085378|P5|Main Phase|Unclassified|0
5520113|NCT01480180|19085379|P4|Main Phase|Unclassified|0
5520114|NCT01480180|19085380|P3|Main Phase|Unclassified|0
5520115|NCT01480180|19085381|P2|Main Phase|Unclassified|0
5520116|NCT01480180|19085382|P1|Main Phase|Unclassified|3
5520117|NCT01480180|19085377|P6|Main Phase|Non-compliance|0
5520118|NCT01480180|19085378|P5|Main Phase|Non-compliance|0
5520119|NCT01480180|19085379|P4|Main Phase|Non-compliance|0
5520120|NCT01480180|19085380|P3|Main Phase|Non-compliance|0
5520121|NCT01480180|19085381|P2|Main Phase|Non-compliance|0
5520122|NCT01480180|19085382|P1|Main Phase|Non-compliance|3
5520123|NCT01480180|19085377|P6|Main Phase|Lack of Efficacy|0
5520124|NCT01480180|19085378|P5|Main Phase|Lack of Efficacy|0
5520125|NCT01480180|19085379|P4|Main Phase|Lack of Efficacy|0
5520126|NCT01480180|19085380|P3|Main Phase|Lack of Efficacy|0
5520127|NCT01480180|19085381|P2|Main Phase|Lack of Efficacy|0
5520128|NCT01480180|19085382|P1|Main Phase|Lack of Efficacy|1
5520129|NCT01480180|19085377|P6|Main Phase|Withdrawal criteria|0
5520130|NCT01480180|19085378|P5|Main Phase|Withdrawal criteria|0
5520131|NCT01480180|19085379|P4|Main Phase|Withdrawal criteria|0
5520132|NCT01480180|19085380|P3|Main Phase|Withdrawal criteria|0
5520133|NCT01480180|19085381|P2|Main Phase|Withdrawal criteria|1
5520134|NCT01480180|19085382|P1|Main Phase|Withdrawal criteria|12
5520135|NCT01480076|19085550|P1|Overall Study|Other|52
5520136|NCT01480076|19085550|P1|Overall Study|Investigator Decision|13
5520137|NCT01480076|19085550|P1|Overall Study|Lost to Follow-up|7
5520138|NCT01480076|19085550|P1|Overall Study|Withdrawal by Subject|105
5520139|NCT01480076|19085550|P1|Overall Study|Non-compliance With Study Protocol|15
5520140|NCT01480076|19085550|P1|Overall Study|Disease Progression|5
5520141|NCT01480076|19085550|P1|Overall Study|Death|2
5520142|NCT01480076|19085550|P1|Overall Study|Adverse Event|39
5520143|NCT01480076|19085550|P1|Overall Study|Run-in Failure|52
5520144|NCT01479985|19085671|P2|Overall Study|No post-visit survey|3
5520145|NCT01479985|19085672|P1|Overall Study|No post-visit survey|5
5520146|NCT01479985|19085671|P2|Overall Study|No decisional conflict scale responses|2
5520147|NCT01479985|19085672|P1|Overall Study|No decisional conflict scale responses|0
5520148|NCT01479985|19085671|P2|Overall Study|Tablet malfunction, no data saved|1
5520149|NCT01479985|19085672|P1|Overall Study|Tablet malfunction, no data saved|1
5520150|NCT01479868|19085680|P1|Overall Study|Initiation of new HCV Therapy|1
5520151|NCT01479868|19085680|P1|Overall Study|Sponsor's Decision|1
5520152|NCT01479868|19085680|P1|Overall Study|Withdrawal by Subject|1
5520153|NCT01479868|19085680|P1|Overall Study|Protocol Violation|1
5520154|NCT01479868|19085680|P1|Overall Study|Lost to Follow-up|4
5520155|NCT01479868|19085680|P1|Overall Study|Adverse Event|1
5520156|NCT01479777|19085695|P1|Overall Study|Physician Decision|2
5520157|NCT01479764|19085707|P2|Treated|Lost to Follow-up|2
5520158|NCT01479764|19085708|P1|Treated|Lost to Follow-up|0
5520159|NCT01479764|19085707|P2|Randomized|Withdrawal by Subject|0
5520160|NCT01479764|19085708|P1|Randomized|Withdrawal by Subject|1
5520161|NCT01479764|19085707|P2|Randomized|Adverse Event|1
5520162|NCT01479764|19085708|P1|Randomized|Adverse Event|1
5520163|NCT01479621|19085731|P7|Treatment Period|Met stopping criteria|6
5520164|NCT01479621|19085732|P6|Treatment Period|Met stopping criteria|20
5520165|NCT01479621|19085733|P5|Treatment Period|Met stopping criteria|9
5520166|NCT01479621|19085734|P4|Treatment Period|Met stopping criteria|4
5520167|NCT01479621|19085735|P3|Treatment Period|Met stopping criteria|7
5520168|NCT01479621|19085736|P2|Treatment Period|Met stopping criteria|8
5520169|NCT01479621|19085737|P1|Treatment Period|Met stopping criteria|0
5520170|NCT01479621|19085731|P7|Treatment Period|Lost to Follow-up|1
5520171|NCT01479621|19085732|P6|Treatment Period|Lost to Follow-up|2
5520172|NCT01479621|19085733|P5|Treatment Period|Lost to Follow-up|2
5520173|NCT01479621|19085734|P4|Treatment Period|Lost to Follow-up|0
5520174|NCT01479621|19085735|P3|Treatment Period|Lost to Follow-up|1
5520175|NCT01479621|19085736|P2|Treatment Period|Lost to Follow-up|0
5520176|NCT01479621|19085737|P1|Treatment Period|Lost to Follow-up|0
5520177|NCT01479621|19085731|P7|Treatment Period|Sponsor request subject to be withdrawn|3
5520178|NCT01479621|19085732|P6|Treatment Period|Sponsor request subject to be withdrawn|1
5520179|NCT01479621|19085733|P5|Treatment Period|Sponsor request subject to be withdrawn|1
5520180|NCT01479621|19085734|P4|Treatment Period|Sponsor request subject to be withdrawn|1
5520181|NCT01479621|19085735|P3|Treatment Period|Sponsor request subject to be withdrawn|3
5520182|NCT01479621|19085736|P2|Treatment Period|Sponsor request subject to be withdrawn|2
5520183|NCT01479621|19085737|P1|Treatment Period|Sponsor request subject to be withdrawn|0
5520184|NCT01479621|19085731|P7|Treatment Period|Pregnancy|0
5520185|NCT01479621|19085732|P6|Treatment Period|Pregnancy|0
5520186|NCT01479621|19085733|P5|Treatment Period|Pregnancy|0
5520187|NCT01479621|19085734|P4|Treatment Period|Pregnancy|0
5520188|NCT01479621|19085735|P3|Treatment Period|Pregnancy|2
5520189|NCT01479621|19085736|P2|Treatment Period|Pregnancy|0
5520190|NCT01479621|19085737|P1|Treatment Period|Pregnancy|0
5520191|NCT01479621|19085731|P7|Treatment Period|Protocol Violation|6
5520192|NCT01479621|19085732|P6|Treatment Period|Protocol Violation|10
5520193|NCT01479621|19085733|P5|Treatment Period|Protocol Violation|2
5520194|NCT01479621|19085734|P4|Treatment Period|Protocol Violation|5
5520195|NCT01479621|19085735|P3|Treatment Period|Protocol Violation|6
5520196|NCT01479621|19085736|P2|Treatment Period|Protocol Violation|9
5520197|NCT01479621|19085737|P1|Treatment Period|Protocol Violation|0
5520198|NCT01479621|19085731|P7|Treatment Period|Non-compliance to study drug|1
5520199|NCT01479621|19085732|P6|Treatment Period|Non-compliance to study drug|0
5520200|NCT01479621|19085733|P5|Treatment Period|Non-compliance to study drug|0
5520201|NCT01479621|19085734|P4|Treatment Period|Non-compliance to study drug|0
5520202|NCT01479621|19085735|P3|Treatment Period|Non-compliance to study drug|0
5520203|NCT01479621|19085736|P2|Treatment Period|Non-compliance to study drug|1
5520204|NCT01479621|19085737|P1|Treatment Period|Non-compliance to study drug|0
5520205|NCT01479621|19085731|P7|Treatment Period|Physician Decision|0
5520206|NCT01479621|19085732|P6|Treatment Period|Physician Decision|1
5520207|NCT01479621|19085733|P5|Treatment Period|Physician Decision|1
5520208|NCT01479621|19085734|P4|Treatment Period|Physician Decision|0
5520209|NCT01479621|19085735|P3|Treatment Period|Physician Decision|0
5520210|NCT01479621|19085736|P2|Treatment Period|Physician Decision|0
5520211|NCT01479621|19085737|P1|Treatment Period|Physician Decision|0
5520212|NCT01479621|19085731|P7|Treatment Period|Withdrawal by Subject|1
5520213|NCT01479621|19085732|P6|Treatment Period|Withdrawal by Subject|5
5520214|NCT01479621|19085733|P5|Treatment Period|Withdrawal by Subject|5
5520215|NCT01479621|19085734|P4|Treatment Period|Withdrawal by Subject|2
5520216|NCT01479621|19085735|P3|Treatment Period|Withdrawal by Subject|2
5520217|NCT01479621|19085736|P2|Treatment Period|Withdrawal by Subject|4
5520218|NCT01479621|19085737|P1|Treatment Period|Withdrawal by Subject|0
5520219|NCT01479621|19085731|P7|Treatment Period|Adverse Event|2
5520220|NCT01479621|19085732|P6|Treatment Period|Adverse Event|2
5520221|NCT01479621|19085733|P5|Treatment Period|Adverse Event|1
5520222|NCT01479621|19085734|P4|Treatment Period|Adverse Event|0
5520223|NCT01479621|19085735|P3|Treatment Period|Adverse Event|0
5520224|NCT01479621|19085736|P2|Treatment Period|Adverse Event|0
5520225|NCT01479621|19085737|P1|Treatment Period|Adverse Event|0
5520226|NCT01479621|19085731|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
5520227|NCT01479621|19085732|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
5520228|NCT01479621|19085733|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
5520229|NCT01479621|19085734|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
5520230|NCT01479621|19085735|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
5520231|NCT01479621|19085736|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
5520232|NCT01479621|19085737|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
5520233|NCT01479621|19085731|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5520234|NCT01479621|19085732|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5520235|NCT01479621|19085733|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5520236|NCT01479621|19085734|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5520237|NCT01479621|19085735|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5520238|NCT01479621|19085736|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
5520239|NCT01479621|19085737|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
5520240|NCT01479621|19085731|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5520241|NCT01479621|19085732|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5520242|NCT01479621|19085733|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5520243|NCT01479621|19085734|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5520244|NCT01479621|19085735|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5520245|NCT01479621|19085736|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
5520246|NCT01479621|19085737|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
5520247|NCT01479621|19085731|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5520248|NCT01479621|19085732|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5520249|NCT01479621|19085733|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5520250|NCT01479621|19085734|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5520251|NCT01479621|19085735|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5520252|NCT01479621|19085736|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
5520253|NCT01479621|19085737|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
5520254|NCT01479621|19085731|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5520255|NCT01479621|19085732|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5520256|NCT01479621|19085733|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5520257|NCT01479621|19085734|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5520258|NCT01479621|19085735|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5520259|NCT01479621|19085736|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
5520260|NCT01479621|19085737|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
5520261|NCT01479595|19085825|P2|Overall Study|Adverse Event|1
5520262|NCT01479595|19085826|P1|Overall Study|Adverse Event|2
5520263|NCT01479595|19085825|P2|Overall Study|Protocol deviation|1
5520264|NCT01479595|19085826|P1|Overall Study|Protocol deviation|0
5520265|NCT01479530|19085871|P2|Overall Study|Withdrawal of Consent|2
5520266|NCT01479530|19085872|P1|Overall Study|Withdrawal of Consent|3
5520267|NCT01479530|19085871|P2|Overall Study|Protocol Violation|3
5520268|NCT01479530|19085872|P1|Overall Study|Protocol Violation|2
5520269|NCT01479530|19085871|P2|Overall Study|Lack of Efficacy|1
5520270|NCT01479530|19085872|P1|Overall Study|Lack of Efficacy|0
5520271|NCT01479530|19085871|P2|Overall Study|Adverse Event|6
5520272|NCT01479530|19085872|P1|Overall Study|Adverse Event|5
5520273|NCT01479465|19085953|P4|Overall Study|Lost to Follow-up|0
5520274|NCT01479465|19085954|P3|Overall Study|Lost to Follow-up|1
5520275|NCT01479465|19085955|P2|Overall Study|Lost to Follow-up|0
5520276|NCT01479465|19085956|P1|Overall Study|Lost to Follow-up|0
5520277|NCT01479465|19085953|P4|Overall Study|Death|1
5520278|NCT01479465|19085954|P3|Overall Study|Death|0
5520279|NCT01479465|19085955|P2|Overall Study|Death|0
5520280|NCT01479465|19085956|P1|Overall Study|Death|0
5520281|NCT01479465|19085953|P4|Overall Study|Protocol Violation|0
5520282|NCT01479465|19085954|P3|Overall Study|Protocol Violation|1
5520283|NCT01479465|19085955|P2|Overall Study|Protocol Violation|1
5520284|NCT01479465|19085956|P1|Overall Study|Protocol Violation|0
5520285|NCT01479465|19085953|P4|Overall Study|Subject Withdrew Consent|1
5520286|NCT01479465|19085954|P3|Overall Study|Subject Withdrew Consent|2
5520287|NCT01479465|19085955|P2|Overall Study|Subject Withdrew Consent|5
5520288|NCT01479465|19085956|P1|Overall Study|Subject Withdrew Consent|0
5520289|NCT01479465|19085953|P4|Overall Study|Subject Request|2
5520290|NCT01479465|19085954|P3|Overall Study|Subject Request|4
5520291|NCT01479465|19085955|P2|Overall Study|Subject Request|3
5520292|NCT01479465|19085956|P1|Overall Study|Subject Request|1
5520293|NCT01479465|19085953|P4|Overall Study|Investigator Discretion|4
5520294|NCT01479465|19085954|P3|Overall Study|Investigator Discretion|2
5520295|NCT01479465|19085955|P2|Overall Study|Investigator Discretion|4
5520296|NCT01479465|19085956|P1|Overall Study|Investigator Discretion|1
5520297|NCT01479465|19085953|P4|Overall Study|Adverse Event|4
5520298|NCT01479465|19085954|P3|Overall Study|Adverse Event|6
5520299|NCT01479465|19085955|P2|Overall Study|Adverse Event|3
5520300|NCT01479465|19085956|P1|Overall Study|Adverse Event|0
5520301|NCT01479465|19085953|P4|Overall Study|Study Discontinued by Sponsor|3
5520302|NCT01479465|19085954|P3|Overall Study|Study Discontinued by Sponsor|5
5520303|NCT01479465|19085955|P2|Overall Study|Study Discontinued by Sponsor|7
5520304|NCT01479465|19085956|P1|Overall Study|Study Discontinued by Sponsor|0
5520305|NCT01479465|19085953|P4|Overall Study|Disease Progression|70
5520306|NCT01479465|19085954|P3|Overall Study|Disease Progression|65
5520307|NCT01479465|19085955|P2|Overall Study|Disease Progression|61
5520308|NCT01479465|19085956|P1|Overall Study|Disease Progression|9
5520309|NCT01479439|19085977|P3|Overall Study|Protocol Violation|2
5520310|NCT01479439|19085978|P2|Overall Study|Protocol Violation|0
5520311|NCT01479439|19085979|P1|Overall Study|Protocol Violation|0
5520312|NCT01479439|19085977|P3|Overall Study|Lost to Follow-up|0
5520313|NCT01479439|19085978|P2|Overall Study|Lost to Follow-up|1
5520314|NCT01479439|19085979|P1|Overall Study|Lost to Follow-up|0
5520315|NCT01479439|19085977|P3|Overall Study|Adverse Event|0
5520316|NCT01479439|19085978|P2|Overall Study|Adverse Event|0
5520317|NCT01479439|19085979|P1|Overall Study|Adverse Event|1
5520318|NCT01479374|19086011|P3|Overall Study|Other|5
5520319|NCT01479374|19086012|P2|Overall Study|Other|4
5520320|NCT01479374|19086013|P1|Overall Study|Other|0
5520321|NCT01479374|19086011|P3|Overall Study|Decision Unrelated to Adverse Event|0
5520322|NCT01479374|19086012|P2|Overall Study|Decision Unrelated to Adverse Event|1
5520323|NCT01479374|19086013|P1|Overall Study|Decision Unrelated to Adverse Event|0
5520324|NCT01479374|19086011|P3|Overall Study|Lost to Follow-up|0
5520325|NCT01479374|19086012|P2|Overall Study|Lost to Follow-up|2
5520326|NCT01479374|19086013|P1|Overall Study|Lost to Follow-up|1
5520327|NCT01479374|19086011|P3|Overall Study|Adverse Event|0
5520328|NCT01479374|19086012|P2|Overall Study|Adverse Event|1
5520329|NCT01479374|19086013|P1|Overall Study|Adverse Event|2
5520330|NCT01478971|19086107|P1|Peginesatide Treatment Period|Other|4
5520331|NCT01478971|19086107|P1|Peginesatide Treatment Period|Lost to Follow-up|4
5520332|NCT01478971|19086107|P1|Peginesatide Treatment Period|Death|4
5520333|NCT01478971|19086107|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
5520334|NCT01478971|19086107|P1|Peginesatide Treatment Period|Adverse Event|1
5520335|NCT01478971|19086107|P1|Standard of Care Period|Other|4
5520336|NCT01478971|19086107|P1|Standard of Care Period|Lost to Follow-up|9
5520337|NCT01478971|19086107|P1|Standard of Care Period|Death|8
5520338|NCT01478971|19086107|P1|Standard of Care Period|Withdrawal by Subject|3
5520339|NCT01478971|19086107|P1|Standard of Care Period|Adverse Event|1
5520340|NCT01478958|19086124|P3|Overall Study|Unable to comply|2
5520341|NCT01478958|19086125|P2|Overall Study|Unable to comply|0
5520342|NCT01478958|19086126|P1|Overall Study|Unable to comply|0
5520343|NCT01478958|19086124|P3|Overall Study|Re-located|0
5520344|NCT01478958|19086125|P2|Overall Study|Re-located|1
5520345|NCT01478958|19086126|P1|Overall Study|Re-located|0
5520346|NCT01478958|19086124|P3|Overall Study|Weight loss|0
5520347|NCT01478958|19086125|P2|Overall Study|Weight loss|0
5520348|NCT01478958|19086126|P1|Overall Study|Weight loss|1
5520349|NCT01478958|19086124|P3|Overall Study|Withdrawal by Subject|1
5520350|NCT01478958|19086125|P2|Overall Study|Withdrawal by Subject|1
5520351|NCT01478958|19086126|P1|Overall Study|Withdrawal by Subject|1
5520352|NCT01478828|19086146|P1|Overall Study|Adverse Event|1
5520353|NCT01478620|19086157|P1|Overall Study|Lost to Follow-up|6
5520354|NCT01478594|19086163|P2|Overall Study|Study Closed by Sponsor|5
5520355|NCT01478594|19086164|P1|Overall Study|Study Closed by Sponsor|8
5520356|NCT01478594|19086163|P2|Overall Study|Withdrawal by Subject|3
5520357|NCT01478594|19086164|P1|Overall Study|Withdrawal by Subject|9
5520358|NCT01478594|19086163|P2|Overall Study|Lost to Follow-up|1
5520359|NCT01478594|19086164|P1|Overall Study|Lost to Follow-up|3
5520360|NCT01478594|19086163|P2|Overall Study|Death|18
5520361|NCT01478594|19086164|P1|Overall Study|Death|45
5520362|NCT01478594|19086163|P2|Overall Study|Randomized but Never Received Study Drug|1
5520363|NCT01478594|19086164|P1|Overall Study|Randomized but Never Received Study Drug|0
5520364|NCT01478373|19086293|P1|Survival Phase|Progressive Disease|27
5520365|NCT01478373|19086293|P1|Survival Phase|crossover to another study|2
5520366|NCT01478373|19086293|P1|Survival Phase|Protocol Violation|1
5520367|NCT01478373|19086293|P1|Survival Phase|Adverse Event|8
5520368|NCT01478373|19086293|P1|Treatment Phase|Protocol Violation|1
5520369|NCT01478360|19086306|P2|Overall Study|Administrative problems|2
5520370|NCT01478360|19086307|P1|Overall Study|Administrative problems|1
5520371|NCT01478360|19086306|P2|Overall Study|Adverse Event|1
5520372|NCT01478360|19086307|P1|Overall Study|Adverse Event|0
5520373|NCT01478360|19086306|P2|Overall Study|Lost to Follow-up|0
5520374|NCT01478360|19086307|P1|Overall Study|Lost to Follow-up|1
5520375|NCT01478347|19086313|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
5520376|NCT01478347|19086313|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
5520377|NCT01478347|19086313|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
5520378|NCT01478321|19086318|P1|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
5520379|NCT01478321|19086318|P1|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
5520380|NCT01478321|19086318|P1|Adjuvant Therapy Until PD or Toxicity|Death|1
5520381|NCT01478321|19086318|P1|Started Adjuvant Therapy|Withdrawal by Subject|1
5520382|NCT01478321|19086318|P1|Concurrent Therapy (5 Weeks)|Progressive Disease|5
5520383|NCT01478321|19086318|P1|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
5520384|NCT01478321|19086318|P1|Concurrent Therapy (5 Weeks)|Death|2
5520385|NCT01478321|19086318|P1|Concurrent Therapy (5 Weeks)|Adverse Event|4
5520386|NCT01478113|19086341|P2|Overall Study|Physician Decision|0
5520387|NCT01478113|19086342|P1|Overall Study|Physician Decision|1
5520388|NCT01478113|19086341|P2|Overall Study|Withdrawal by Subject|1
5520389|NCT01478113|19086342|P1|Overall Study|Withdrawal by Subject|0
5520390|NCT01478087|19086360|P1|Overall Study|due to sponsor closing study|1
5520391|NCT01478048|19086367|P2|Overall Study|no longer meets study criteria|0
5520392|NCT01478048|19086368|P1|Overall Study|no longer meets study criteria|1
5520393|NCT01478048|19086367|P2|Overall Study|poor/non-compliance|1
5520394|NCT01478048|19086368|P1|Overall Study|poor/non-compliance|0
5520395|NCT01478048|19086367|P2|Overall Study|non-specified|4
5520396|NCT01478048|19086368|P1|Overall Study|non-specified|6
5520397|NCT01478048|19086367|P2|Overall Study|Withdrawal by Subject|5
5520398|NCT01478048|19086368|P1|Overall Study|Withdrawal by Subject|2
5520399|NCT01478048|19086367|P2|Overall Study|subject request to discontinue treatment|5
5520400|NCT01478048|19086368|P1|Overall Study|subject request to discontinue treatment|3
5520401|NCT01478048|19086367|P2|Overall Study|Adverse Event|11
5520402|NCT01478048|19086368|P1|Overall Study|Adverse Event|2
5520403|NCT01478048|19086367|P2|Overall Study|study drug toxicity|14
5520404|NCT01478048|19086368|P1|Overall Study|study drug toxicity|11
5520405|NCT01478048|19086367|P2|Overall Study|Disease Progression|35
5520406|NCT01478048|19086368|P1|Overall Study|Disease Progression|52
5520407|NCT01477892|19086397|P2|Overall Study|Withdrawal by Subject|2
5520408|NCT01477892|19086398|P1|Overall Study|Withdrawal by Subject|0
5520409|NCT01477853|19086409|P3|Phase B|Study terminated by sponsor|11
5520410|NCT01477853|19086410|P2|Phase B|Study terminated by sponsor|10
5520411|NCT01477853|19086411|P1|Phase B|Study terminated by sponsor|12
5520412|NCT01477853|19086409|P3|Phase B|Lost to Follow-up|0
5520413|NCT01477853|19086410|P2|Phase B|Lost to Follow-up|1
5520414|NCT01477853|19086411|P1|Phase B|Lost to Follow-up|0
5520415|NCT01477853|19086409|P3|Phase A|Study terminated by sponsor|39
5520416|NCT01477853|19086410|P2|Phase A|Study terminated by sponsor|40
5520417|NCT01477853|19086411|P1|Phase A|Study terminated by sponsor|37
5520418|NCT01477853|19086409|P3|Phase A|Physician Decision|1
5520419|NCT01477853|19086410|P2|Phase A|Physician Decision|0
5520420|NCT01477853|19086411|P1|Phase A|Physician Decision|1
5520421|NCT01477853|19086409|P3|Phase A|Lost to Follow-up|2
5520422|NCT01477853|19086410|P2|Phase A|Lost to Follow-up|3
5520423|NCT01477853|19086411|P1|Phase A|Lost to Follow-up|4
5520424|NCT01477853|19086409|P3|Phase A|Adverse Event|2
5520425|NCT01477853|19086410|P2|Phase A|Adverse Event|2
5520426|NCT01477853|19086411|P1|Phase A|Adverse Event|1
5520427|NCT01477749|19086478|P1|Overall Study|Physician Decision|4
5520428|NCT01477333|19086586|P1|Overall Study|Clinical Deterioration|1
5520429|NCT01477333|19086586|P1|Overall Study|Withdrawal by Subject|1
5520430|NCT01477333|19086586|P1|Overall Study|Adverse Event|1
5520431|NCT01476722|19086637|P1|Overall Study|Adverse Event|1
5520432|NCT01476696|19086644|P3|Overall Study|Withdrawal by Subject|0
5520433|NCT01476696|19086645|P2|Overall Study|Withdrawal by Subject|0
5520434|NCT01476696|19086646|P1|Overall Study|Withdrawal by Subject|1
5520435|NCT01476696|19086644|P3|Overall Study|Sponsor decision|0
5520436|NCT01476696|19086645|P2|Overall Study|Sponsor decision|1
5520437|NCT01476696|19086646|P1|Overall Study|Sponsor decision|2
5520438|NCT01476644|19086660|P1|Overall Study|Withdrawal by Subject|13
5520439|NCT01476644|19086660|P1|Overall Study|Lost to Follow-up|19
5520440|NCT01476644|19086660|P1|Overall Study|moved to another state|2
5520441|NCT01476644|19086660|P1|Overall Study|Death|5
5520442|NCT01476475|19086667|P2|Overall Study|Other reasons|2
5520443|NCT01476475|19086668|P1|Overall Study|Other reasons|4
5520444|NCT01476475|19086667|P2|Overall Study|Poor compliance to protocol|1
5520445|NCT01476475|19086668|P1|Overall Study|Poor compliance to protocol|1
5520446|NCT01476475|19086667|P2|Overall Study|Adverse Event|0
5520447|NCT01476475|19086668|P1|Overall Study|Adverse Event|6
5520448|NCT01475851|19087119|P2|Overall Study|Protocol defined stopping criteria|0
5520449|NCT01475851|19087120|P1|Overall Study|Protocol defined stopping criteria|1
5520450|NCT01475838|19087148|P2|Extension Phase|Participant Noncompliance|0
5520451|NCT01475838|19087149|P1|Extension Phase|Participant Noncompliance|1
5520452|NCT01475838|19087148|P2|Randomized Phase|Protocol Violation|4
5520453|NCT01475838|19087149|P1|Randomized Phase|Protocol Violation|9
5520454|NCT01475838|19087148|P2|Randomized Phase|Participant Noncompliance|5
5520455|NCT01475838|19087149|P1|Randomized Phase|Participant Noncompliance|1
5520456|NCT01475838|19087148|P2|Randomized Phase|Lost to Follow-up|4
5520457|NCT01475838|19087149|P1|Randomized Phase|Lost to Follow-up|3
5520458|NCT01475838|19087148|P2|Randomized Phase|Withdrew Consent|14
5520459|NCT01475838|19087149|P1|Randomized Phase|Withdrew Consent|10
5520460|NCT01475838|19087148|P2|Randomized Phase|Investigators Discretion|2
5520461|NCT01475838|19087149|P1|Randomized Phase|Investigators Discretion|1
5520462|NCT01475838|19087148|P2|Randomized Phase|Pregnancy|1
5520463|NCT01475838|19087149|P1|Randomized Phase|Pregnancy|0
5520464|NCT01475838|19087148|P2|Randomized Phase|Adverse Event|1
5520465|NCT01475838|19087149|P1|Randomized Phase|Adverse Event|6
5520466|NCT01475838|19087148|P2|Randomized Phase|Randomized but Not Treated|5
5520467|NCT01475838|19087149|P1|Randomized Phase|Randomized but Not Treated|0
5520468|NCT01475825|19087166|P4|Overall Study|Did not enter OLC|11
5520469|NCT01475825|19087167|P3|Overall Study|Did not enter OLC|15
5520470|NCT01475825|19087168|P2|Overall Study|Did not enter OLC|11
5520471|NCT01475825|19087169|P1|Overall Study|Did not enter OLC|15
5520472|NCT01475825|19087166|P4|Overall Study|Withdrawal by Subject|7
5520473|NCT01475825|19087167|P3|Overall Study|Withdrawal by Subject|11
5520474|NCT01475825|19087168|P2|Overall Study|Withdrawal by Subject|3
5520475|NCT01475825|19087169|P1|Overall Study|Withdrawal by Subject|8
5520476|NCT01475825|19087166|P4|Overall Study|Physician Decision|0
5520477|NCT01475825|19087167|P3|Overall Study|Physician Decision|0
5520478|NCT01475825|19087168|P2|Overall Study|Physician Decision|1
5520479|NCT01475825|19087169|P1|Overall Study|Physician Decision|0
5520480|NCT01475825|19087166|P4|Overall Study|Protocol Violation|0
5520481|NCT01475825|19087167|P3|Overall Study|Protocol Violation|0
5520482|NCT01475825|19087168|P2|Overall Study|Protocol Violation|0
5520483|NCT01475825|19087169|P1|Overall Study|Protocol Violation|1
5520484|NCT01475825|19087166|P4|Overall Study|Other: Not available|0
5520485|NCT01475825|19087167|P3|Overall Study|Other: Not available|2
5520486|NCT01475825|19087168|P2|Overall Study|Other: Not available|0
5520487|NCT01475825|19087169|P1|Overall Study|Other: Not available|0
5520488|NCT01475825|19087166|P4|Overall Study|Non-compliance with Study Drug|0
5520489|NCT01475825|19087167|P3|Overall Study|Non-compliance with Study Drug|4
5520490|NCT01475825|19087168|P2|Overall Study|Non-compliance with Study Drug|2
5520491|NCT01475825|19087169|P1|Overall Study|Non-compliance with Study Drug|1
5520492|NCT01475825|19087166|P4|Overall Study|Lost to Follow-up|1
5520493|NCT01475825|19087167|P3|Overall Study|Lost to Follow-up|3
5520494|NCT01475825|19087168|P2|Overall Study|Lost to Follow-up|0
5520495|NCT01475825|19087169|P1|Overall Study|Lost to Follow-up|0
5520496|NCT01475825|19087166|P4|Overall Study|Lack of Efficacy|0
5520497|NCT01475825|19087167|P3|Overall Study|Lack of Efficacy|1
5520498|NCT01475825|19087168|P2|Overall Study|Lack of Efficacy|0
5520499|NCT01475825|19087169|P1|Overall Study|Lack of Efficacy|0
5520500|NCT01475825|19087166|P4|Overall Study|Death|0
5520501|NCT01475825|19087167|P3|Overall Study|Death|1
5520502|NCT01475825|19087168|P2|Overall Study|Death|0
5520503|NCT01475825|19087169|P1|Overall Study|Death|1
5520504|NCT01475825|19087166|P4|Overall Study|Adverse Event|11
5520505|NCT01475825|19087167|P3|Overall Study|Adverse Event|27
5520506|NCT01475825|19087168|P2|Overall Study|Adverse Event|15
5520507|NCT01475825|19087169|P1|Overall Study|Adverse Event|41
5520508|NCT01475734|19087201|P2|Overall Study|Physician Decision|1
5520509|NCT01475734|19087202|P1|Overall Study|Physician Decision|0
5520510|NCT01475734|19087201|P2|Overall Study|Protocol Violation|0
5520511|NCT01475734|19087202|P1|Overall Study|Protocol Violation|1
5520512|NCT01475734|19087201|P2|Overall Study|Withdrawal by Subject|0
5520513|NCT01475734|19087202|P1|Overall Study|Withdrawal by Subject|1
5520514|NCT01475721|19087230|P2|Overall Study|Withdrawal by Subject|8
5520515|NCT01475721|19087231|P1|Overall Study|Withdrawal by Subject|8
5520516|NCT01475721|19087230|P2|Overall Study|Death|6
5520517|NCT01475721|19087231|P1|Overall Study|Death|3
5520518|NCT01475487|19087297|P2|Overall Study|had to leave early for personal reasons|1
5520519|NCT01475487|19087298|P1|Overall Study|had to leave early for personal reasons|2
5520520|NCT01475474|19087310|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
5520521|NCT01475474|19087310|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
5520522|NCT01475461|19087321|P7|Treatment Period|Adverse Event|0
5520523|NCT01475461|19087322|P6|Treatment Period|Adverse Event|0
5520524|NCT01475461|19087323|P5|Treatment Period|Adverse Event|0
5520525|NCT01475461|19087324|P4|Treatment Period|Adverse Event|1
5520526|NCT01475461|19087325|P3|Treatment Period|Adverse Event|0
5520527|NCT01475461|19087326|P2|Treatment Period|Adverse Event|0
5520528|NCT01475461|19087327|P1|Treatment Period|Adverse Event|0
5520529|NCT01475461|19087321|P7|Treatment Period|Medication Error|0
5520530|NCT01475461|19087322|P6|Treatment Period|Medication Error|0
5520531|NCT01475461|19087323|P5|Treatment Period|Medication Error|0
5520532|NCT01475461|19087324|P4|Treatment Period|Medication Error|1
5520533|NCT01475461|19087325|P3|Treatment Period|Medication Error|0
5520534|NCT01475461|19087326|P2|Treatment Period|Medication Error|0
5520535|NCT01475461|19087327|P1|Treatment Period|Medication Error|0
5520536|NCT01475461|19087321|P7|Treatment Period|Lack of Efficacy|0
5520537|NCT01475461|19087322|P6|Treatment Period|Lack of Efficacy|1
5520538|NCT01475461|19087323|P5|Treatment Period|Lack of Efficacy|1
5520539|NCT01475461|19087324|P4|Treatment Period|Lack of Efficacy|2
5520540|NCT01475461|19087325|P3|Treatment Period|Lack of Efficacy|0
5520541|NCT01475461|19087326|P2|Treatment Period|Lack of Efficacy|2
5520542|NCT01475461|19087327|P1|Treatment Period|Lack of Efficacy|0
5520543|NCT01475461|19087321|P7|Treatment Period|Protocol Violation|1
5520544|NCT01475461|19087322|P6|Treatment Period|Protocol Violation|0
5520545|NCT01475461|19087323|P5|Treatment Period|Protocol Violation|0
5520546|NCT01475461|19087324|P4|Treatment Period|Protocol Violation|0
5520547|NCT01475461|19087325|P3|Treatment Period|Protocol Violation|0
5520548|NCT01475461|19087326|P2|Treatment Period|Protocol Violation|1
5520549|NCT01475461|19087327|P1|Treatment Period|Protocol Violation|0
5520550|NCT01475461|19087321|P7|Treatment Period|Other|0
5520551|NCT01475461|19087322|P6|Treatment Period|Other|0
5520552|NCT01475461|19087323|P5|Treatment Period|Other|0
5520553|NCT01475461|19087324|P4|Treatment Period|Other|0
5520554|NCT01475461|19087325|P3|Treatment Period|Other|0
5520555|NCT01475461|19087326|P2|Treatment Period|Other|1
5520556|NCT01475461|19087327|P1|Treatment Period|Other|0
5520557|NCT01475461|19087321|P7|Treatment Period|Withdrawal by Subject|0
5520558|NCT01475461|19087322|P6|Treatment Period|Withdrawal by Subject|2
5520559|NCT01475461|19087323|P5|Treatment Period|Withdrawal by Subject|2
5520560|NCT01475461|19087324|P4|Treatment Period|Withdrawal by Subject|0
5520561|NCT01475461|19087325|P3|Treatment Period|Withdrawal by Subject|2
5520562|NCT01475461|19087326|P2|Treatment Period|Withdrawal by Subject|2
5520563|NCT01475461|19087327|P1|Treatment Period|Withdrawal by Subject|0
5520564|NCT01475461|19087321|P7|Treatment Period|Lost to Follow-up|1
5520565|NCT01475461|19087322|P6|Treatment Period|Lost to Follow-up|2
5520566|NCT01475461|19087323|P5|Treatment Period|Lost to Follow-up|1
5520567|NCT01475461|19087324|P4|Treatment Period|Lost to Follow-up|3
5520568|NCT01475461|19087325|P3|Treatment Period|Lost to Follow-up|2
5520569|NCT01475461|19087326|P2|Treatment Period|Lost to Follow-up|3
5520570|NCT01475461|19087327|P1|Treatment Period|Lost to Follow-up|0
5520571|NCT01475461|19087321|P7|Treatment Period|Death|0
5520572|NCT01475461|19087322|P6|Treatment Period|Death|0
5520573|NCT01475461|19087323|P5|Treatment Period|Death|0
5520574|NCT01475461|19087324|P4|Treatment Period|Death|1
5520575|NCT01475461|19087325|P3|Treatment Period|Death|0
5520576|NCT01475461|19087326|P2|Treatment Period|Death|0
5520577|NCT01475461|19087327|P1|Treatment Period|Death|0
5520578|NCT01475461|19087321|P7|Run-in Period|Protocol Violation|0
5520579|NCT01475461|19087322|P6|Run-in Period|Protocol Violation|0
5520580|NCT01475461|19087323|P5|Run-in Period|Protocol Violation|0
5520581|NCT01475461|19087324|P4|Run-in Period|Protocol Violation|0
5520582|NCT01475461|19087325|P3|Run-in Period|Protocol Violation|0
5520583|NCT01475461|19087326|P2|Run-in Period|Protocol Violation|0
5520584|NCT01475461|19087327|P1|Run-in Period|Protocol Violation|4
5520585|NCT01475461|19087321|P7|Run-in Period|Other|0
5520586|NCT01475461|19087322|P6|Run-in Period|Other|0
5520587|NCT01475461|19087323|P5|Run-in Period|Other|0
5520588|NCT01475461|19087324|P4|Run-in Period|Other|0
5520589|NCT01475461|19087325|P3|Run-in Period|Other|0
5520590|NCT01475461|19087326|P2|Run-in Period|Other|0
5520591|NCT01475461|19087327|P1|Run-in Period|Other|3
5520592|NCT01475461|19087321|P7|Run-in Period|Withdrawal by Subject|0
5520593|NCT01475461|19087322|P6|Run-in Period|Withdrawal by Subject|0
5520594|NCT01475461|19087323|P5|Run-in Period|Withdrawal by Subject|0
5520595|NCT01475461|19087324|P4|Run-in Period|Withdrawal by Subject|0
5520596|NCT01475461|19087325|P3|Run-in Period|Withdrawal by Subject|0
5520597|NCT01475461|19087326|P2|Run-in Period|Withdrawal by Subject|0
5520598|NCT01475461|19087327|P1|Run-in Period|Withdrawal by Subject|11
5520599|NCT01475461|19087321|P7|Run-in Period|Lost to Follow-up|0
5520600|NCT01475461|19087322|P6|Run-in Period|Lost to Follow-up|0
5520601|NCT01475461|19087323|P5|Run-in Period|Lost to Follow-up|0
5520602|NCT01475461|19087324|P4|Run-in Period|Lost to Follow-up|0
5520603|NCT01475461|19087325|P3|Run-in Period|Lost to Follow-up|0
5520604|NCT01475461|19087326|P2|Run-in Period|Lost to Follow-up|0
5520605|NCT01475461|19087327|P1|Run-in Period|Lost to Follow-up|7
5520606|NCT01475461|19087321|P7|Run-in Period|Not meet eligibility criteria|0
5520607|NCT01475461|19087322|P6|Run-in Period|Not meet eligibility criteria|0
5520608|NCT01475461|19087323|P5|Run-in Period|Not meet eligibility criteria|0
5520609|NCT01475461|19087324|P4|Run-in Period|Not meet eligibility criteria|0
5520610|NCT01475461|19087325|P3|Run-in Period|Not meet eligibility criteria|0
5520611|NCT01475461|19087326|P2|Run-in Period|Not meet eligibility criteria|0
5520612|NCT01475461|19087327|P1|Run-in Period|Not meet eligibility criteria|16
5520613|NCT01475331|19087407|P2|Overall Study|cyst found to be prohibitively small|1
5520614|NCT01475331|19087408|P1|Overall Study|cyst found to be prohibitively small|0
5520615|NCT01475331|19087407|P2|Overall Study|Sign of malignancy during the procedure|0
5520616|NCT01475331|19087408|P1|Overall Study|Sign of malignancy during the procedure|2
5520617|NCT01475331|19087407|P2|Overall Study|Loss of needle positioning due pt. cough|0
5520618|NCT01475331|19087408|P1|Overall Study|Loss of needle positioning due pt. cough|1
5520619|NCT01475331|19087407|P2|Overall Study|excessive main duct communication|1
5520620|NCT01475331|19087408|P1|Overall Study|excessive main duct communication|1
5520621|NCT01475331|19087407|P2|Overall Study|Osteophyte obstruction of the proximal|0
5520622|NCT01475331|19087408|P1|Overall Study|Osteophyte obstruction of the proximal|1
5520623|NCT01475253|19087460|P4|Randomized, Blinded Study|Lost to Follow-up|0
5520624|NCT01475253|19087461|P3|Randomized, Blinded Study|Lost to Follow-up|0
5520625|NCT01475253|19087462|P2|Randomized, Blinded Study|Lost to Follow-up|0
5520626|NCT01475253|19087463|P1|Randomized, Blinded Study|Lost to Follow-up|1
5520627|NCT01475253|19087460|P4|Randomized, Blinded Study|Withdrawal by Subject|0
5520628|NCT01475253|19087461|P3|Randomized, Blinded Study|Withdrawal by Subject|0
5520629|NCT01475253|19087462|P2|Randomized, Blinded Study|Withdrawal by Subject|1
5520630|NCT01475253|19087463|P1|Randomized, Blinded Study|Withdrawal by Subject|1
5520631|NCT01475214|19087492|P3|Overall Study|Withdrawal by Subject|1
5520632|NCT01475214|19087493|P2|Overall Study|Withdrawal by Subject|4
5520633|NCT01475214|19087494|P1|Overall Study|Withdrawal by Subject|2
5520634|NCT01475214|19087492|P3|Overall Study|Physician Decision|0
5520635|NCT01475214|19087493|P2|Overall Study|Physician Decision|0
5520636|NCT01475214|19087494|P1|Overall Study|Physician Decision|2
5520637|NCT01475214|19087492|P3|Overall Study|Lost to Follow-up|1
5520638|NCT01475214|19087493|P2|Overall Study|Lost to Follow-up|0
5520639|NCT01475214|19087494|P1|Overall Study|Lost to Follow-up|1
5520640|NCT01475162|19087517|P1|Overall Study|Study closed for safety|3
5520641|NCT01475162|19087517|P1|Overall Study|Death|10
5520642|NCT01475162|19087517|P1|Overall Study|Physician Decision|1
5520643|NCT01475097|19087530|P2|Overall Study|Protocol Violation|1
5520644|NCT01475097|19087531|P1|Overall Study|Protocol Violation|1
5520645|NCT01475071|19087539|P1|Overall Study|Lost to Follow-up|1
5520646|NCT01475071|19087539|P1|Overall Study|Withdrawal by Subject|6
5520647|NCT01475071|19087539|P1|Overall Study|Physician Decision|1
5520648|NCT01474993|19087549|P2|Overall Study|Adverse Event|1
5520649|NCT01474993|19087550|P1|Overall Study|Adverse Event|0
5520650|NCT01474993|19087549|P2|Overall Study|Lost to Follow-up|2
5520651|NCT01474993|19087550|P1|Overall Study|Lost to Follow-up|1
5520652|NCT01474876|19087592|P3|Overall Study|Investigator's decision and pt request|0
5520653|NCT01474876|19087593|P2|Overall Study|Investigator's decision and pt request|0
5520654|NCT01474876|19087594|P1|Overall Study|Investigator's decision and pt request|1
5520655|NCT01474876|19087592|P3|Overall Study|Patient's request|0
5520656|NCT01474876|19087593|P2|Overall Study|Patient's request|5
5520657|NCT01474876|19087594|P1|Overall Study|Patient's request|19
5520658|NCT01474876|19087592|P3|Overall Study|Investigator's decision|0
5520659|NCT01474876|19087593|P2|Overall Study|Investigator's decision|6
5520660|NCT01474876|19087594|P1|Overall Study|Investigator's decision|28
5520661|NCT01474876|19087592|P3|Overall Study|Lost to Follow-up|0
5520662|NCT01474876|19087593|P2|Overall Study|Lost to Follow-up|4
5520663|NCT01474876|19087594|P1|Overall Study|Lost to Follow-up|5
5520664|NCT01474876|19087592|P3|Overall Study|Serious Adverse Event|0
5520665|NCT01474876|19087593|P2|Overall Study|Serious Adverse Event|3
5520666|NCT01474876|19087594|P1|Overall Study|Serious Adverse Event|2
5520667|NCT01474876|19087592|P3|Overall Study|Adverse Event|0
5520668|NCT01474876|19087593|P2|Overall Study|Adverse Event|5
5520669|NCT01474876|19087594|P1|Overall Study|Adverse Event|11
5520670|NCT01474772|19087640|P2|Follow-up|AE not Related to Study Drug|1
5520671|NCT01474772|19087641|P1|Follow-up|AE not Related to Study Drug|0
5520672|NCT01474772|19087640|P2|Period 2|Reason not Specified|2
5520673|NCT01474772|19087641|P1|Period 2|Reason not Specified|0
5520674|NCT01474772|19087640|P2|Period 2|Lost to Follow-up|1
5520675|NCT01474772|19087641|P1|Period 2|Lost to Follow-up|1
5520676|NCT01474772|19087640|P2|Period 2|Withdrawal by Subject|4
5520677|NCT01474772|19087641|P1|Period 2|Withdrawal by Subject|3
5520678|NCT01474772|19087640|P2|Period 2|Lack of Efficacy|0
5520679|NCT01474772|19087641|P1|Period 2|Lack of Efficacy|1
5520680|NCT01474772|19087640|P2|Period 2|AE not Related to Study Drug|1
5520681|NCT01474772|19087641|P1|Period 2|AE not Related to Study Drug|4
5520682|NCT01474772|19087640|P2|Period 2|AE Related to Study Drug|1
5520683|NCT01474772|19087641|P1|Period 2|AE Related to Study Drug|0
5520684|NCT01474772|19087640|P2|Period 2|Death|1
5520685|NCT01474772|19087641|P1|Period 2|Death|0
5520686|NCT01474772|19087640|P2|Washout|Reason not Specified|1
5520687|NCT01474772|19087641|P1|Washout|Reason not Specified|0
5520688|NCT01474772|19087640|P2|Washout|Lost to Follow-up|1
5520689|NCT01474772|19087641|P1|Washout|Lost to Follow-up|0
5520690|NCT01474772|19087640|P2|Washout|Withdrawal by Subject|0
5520691|NCT01474772|19087641|P1|Washout|Withdrawal by Subject|1
5520692|NCT01474772|19087640|P2|Washout|AE not Related to Study Drug|0
5520693|NCT01474772|19087641|P1|Washout|AE not Related to Study Drug|2
5520694|NCT01474772|19087640|P2|Period 1|Reason not Specified|1
5520695|NCT01474772|19087641|P1|Period 1|Reason not Specified|1
5520696|NCT01474772|19087640|P2|Period 1|Lost to Follow-up|0
5520697|NCT01474772|19087641|P1|Period 1|Lost to Follow-up|1
5520698|NCT01474772|19087640|P2|Period 1|Withdrawal by Subject|1
5520699|NCT01474772|19087641|P1|Period 1|Withdrawal by Subject|3
5520700|NCT01474772|19087640|P2|Period 1|AE not Related to Study Drug|0
5520701|NCT01474772|19087641|P1|Period 1|AE not Related to Study Drug|1
5520702|NCT01474772|19087640|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
5520703|NCT01474772|19087641|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
5520704|NCT01474746|19087691|P2|Overall Study|Withdrawal by Subject|1
5520705|NCT01474746|19087692|P1|Overall Study|Withdrawal by Subject|2
5520706|NCT01474746|19087691|P2|Overall Study|Lost to Follow-up|1
5520707|NCT01474746|19087692|P1|Overall Study|Lost to Follow-up|1
5520708|NCT01474681|19087756|P4|Overall Study|Death|6
5520709|NCT01474681|19087757|P3|Overall Study|Death|2
5520710|NCT01474681|19087758|P2|Overall Study|Death|3
5520711|NCT01474681|19087759|P1|Overall Study|Death|0
5520712|NCT01474551|19087810|P1|Overall Study|Death|1
5520713|NCT01474538|19087816|P2|Treatment Period 2|Protocol Violation|0
5520714|NCT01474538|19087817|P1|Treatment Period 2|Protocol Violation|1
5520715|NCT01474538|19087816|P2|Treatment Period 2|Physician Decision|1
5520716|NCT01474538|19087817|P1|Treatment Period 2|Physician Decision|0
5520717|NCT01474538|19087816|P2|Treatment Period 2|Sponsor decision|0
5520718|NCT01474538|19087817|P1|Treatment Period 2|Sponsor decision|1
5520719|NCT01474538|19087816|P2|Treatment Period 2|Withdrawal by Subject|0
5520720|NCT01474538|19087817|P1|Treatment Period 2|Withdrawal by Subject|2
5520721|NCT01474538|19087816|P2|Treatment Period 2|Adverse Event|1
5520722|NCT01474538|19087817|P1|Treatment Period 2|Adverse Event|1
5520723|NCT01474538|19087816|P2|Treatment Period 2|Death|0
5520724|NCT01474538|19087817|P1|Treatment Period 2|Death|1
5520725|NCT01474538|19087816|P2|Treatment Period 1|Protocol Violation|1
5520726|NCT01474538|19087817|P1|Treatment Period 1|Protocol Violation|0
5520727|NCT01474538|19087816|P2|Treatment Period 1|Withdrawal by Subject|3
5520728|NCT01474538|19087817|P1|Treatment Period 1|Withdrawal by Subject|1
5520729|NCT01474538|19087816|P2|Treatment Period 1|Physician Decision|0
5520730|NCT01474538|19087817|P1|Treatment Period 1|Physician Decision|1
5520731|NCT01474538|19087816|P2|Treatment Period 1|Death|0
5520732|NCT01474538|19087817|P1|Treatment Period 1|Death|1
5520733|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Death|0
5520734|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Death|1
5520735|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Death|0
5520736|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Death|0
5520737|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Death|0
5520738|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Death|0
5520739|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Death|0
5520740|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Death|0
5520741|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Death|0
5520742|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Death|0
5520743|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Death|0
5520744|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Death|0
5520745|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Death|0
5520746|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Death|0
5520747|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Death|0
5520748|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Death|0
5520749|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Death|0
5520750|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Death|0
5520751|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
5520752|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520753|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520754|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
5520755|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520756|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520757|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520758|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520759|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520760|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520761|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520762|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520763|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520764|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520765|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520766|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520767|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520768|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
5520769|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Sponsor Decision|0
5520770|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Sponsor Decision|4
5520771|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Sponsor Decision|0
5520772|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Sponsor Decision|1
5520773|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Sponsor Decision|0
5520774|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Sponsor Decision|0
5520775|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Sponsor Decision|0
5520776|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Sponsor Decision|0
5520777|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Sponsor Decision|0
5520778|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Sponsor Decision|0
5520779|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Sponsor Decision|0
5520780|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Sponsor Decision|0
5520781|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Sponsor Decision|0
5520782|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Sponsor Decision|0
5520783|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Sponsor Decision|0
5520784|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Sponsor Decision|0
5520785|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Sponsor Decision|0
5520786|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Sponsor Decision|0
5520787|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Protocol Violation|0
5520788|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Protocol Violation|4
5520789|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Protocol Violation|2
5520790|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Protocol Violation|2
5520791|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Protocol Violation|0
5520792|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Protocol Violation|0
5520793|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Protocol Violation|0
5520794|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Protocol Violation|0
5520795|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Protocol Violation|0
5520796|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Protocol Violation|0
5520797|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Protocol Violation|0
5520798|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Protocol Violation|0
5520799|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Protocol Violation|0
5520800|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Protocol Violation|0
5520801|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Protocol Violation|0
5520802|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Protocol Violation|0
5520803|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Protocol Violation|0
5520804|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Protocol Violation|0
5520805|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Clinical Relapse|2
5520806|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Clinical Relapse|6
5520807|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Clinical Relapse|0
5520808|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Clinical Relapse|0
5520809|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Clinical Relapse|0
5520810|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Clinical Relapse|0
5520811|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Clinical Relapse|0
5520812|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Clinical Relapse|0
5520813|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Clinical Relapse|0
5520814|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Clinical Relapse|0
5520815|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Clinical Relapse|0
5520816|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Clinical Relapse|0
5520817|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Clinical Relapse|0
5520818|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Clinical Relapse|0
5520819|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Clinical Relapse|0
5520820|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Clinical Relapse|0
5520821|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Clinical Relapse|0
5520822|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Clinical Relapse|0
5520823|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Physician Decision|5
5520824|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Physician Decision|4
5520825|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Physician Decision|0
5520826|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Physician Decision|0
5520827|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Physician Decision|0
5520828|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Physician Decision|0
5520829|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Physician Decision|0
5520830|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Physician Decision|0
5520831|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Physician Decision|0
5520832|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Physician Decision|0
5520833|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Physician Decision|0
5520834|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Physician Decision|0
5520835|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Physician Decision|0
5520836|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Physician Decision|0
5520837|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Physician Decision|0
5520838|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Physician Decision|0
5520839|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Physician Decision|0
5520840|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Physician Decision|0
5520841|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Lost to Follow-up|7
5520842|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Lost to Follow-up|12
5520843|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Lost to Follow-up|0
5520844|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Lost to Follow-up|0
5520845|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Lost to Follow-up|0
5520846|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Lost to Follow-up|0
5520847|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Lost to Follow-up|0
5520848|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Lost to Follow-up|0
5520849|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Lost to Follow-up|0
5520850|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Lost to Follow-up|0
5520851|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Lost to Follow-up|0
5520852|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Lost to Follow-up|0
5520853|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Lost to Follow-up|0
5520854|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Lost to Follow-up|0
5520855|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Lost to Follow-up|0
5520856|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Lost to Follow-up|0
5520857|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Lost to Follow-up|0
5520858|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Lost to Follow-up|0
5520859|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Lack of Efficacy|3
5520860|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Lack of Efficacy|31
5520861|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Lack of Efficacy|2
5520862|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Lack of Efficacy|3
5520863|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Lack of Efficacy|0
5520864|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Lack of Efficacy|0
5520865|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Lack of Efficacy|0
5520866|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Lack of Efficacy|0
5520867|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Lack of Efficacy|0
5520868|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Lack of Efficacy|0
5520869|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Lack of Efficacy|0
5520870|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Lack of Efficacy|0
5520871|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Lack of Efficacy|0
5520872|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Lack of Efficacy|0
5520873|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Lack of Efficacy|0
5520874|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Lack of Efficacy|0
5520875|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Lack of Efficacy|0
5520876|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Lack of Efficacy|0
5520877|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Withdrawal by Subject|17
5520878|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Withdrawal by Subject|36
5520879|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Withdrawal by Subject|2
5520880|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Withdrawal by Subject|3
5520881|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520882|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520883|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520884|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520885|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520886|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520887|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520888|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520889|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520890|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520891|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520892|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520893|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520894|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Withdrawal by Subject|0
5520895|NCT01474512|19087834|P18|Post-Treatment Follow-Up|Adverse Event|11
5520896|NCT01474512|19087835|P17|Post-Treatment Follow-Up|Adverse Event|58
5520897|NCT01474512|19087836|P16|Post-Treatment Follow-Up|Adverse Event|2
5520898|NCT01474512|19087837|P15|Post-Treatment Follow-Up|Adverse Event|8
5520899|NCT01474512|19087838|P14|Post-Treatment Follow-Up|Adverse Event|0
5520900|NCT01474512|19087839|P13|Post-Treatment Follow-Up|Adverse Event|0
5520901|NCT01474512|19087840|P12|Post-Treatment Follow-Up|Adverse Event|0
5520902|NCT01474512|19087841|P11|Post-Treatment Follow-Up|Adverse Event|0
5520903|NCT01474512|19087842|P10|Post-Treatment Follow-Up|Adverse Event|0
5520904|NCT01474512|19087843|P9|Post-Treatment Follow-Up|Adverse Event|0
5520905|NCT01474512|19087844|P8|Post-Treatment Follow-Up|Adverse Event|0
5520906|NCT01474512|19087845|P7|Post-Treatment Follow-Up|Adverse Event|0
5520907|NCT01474512|19087846|P6|Post-Treatment Follow-Up|Adverse Event|0
5520908|NCT01474512|19087847|P5|Post-Treatment Follow-Up|Adverse Event|0
5520909|NCT01474512|19087848|P4|Post-Treatment Follow-Up|Adverse Event|0
5520910|NCT01474512|19087849|P3|Post-Treatment Follow-Up|Adverse Event|0
5520911|NCT01474512|19087850|P2|Post-Treatment Follow-Up|Adverse Event|0
5520912|NCT01474512|19087851|P1|Post-Treatment Follow-Up|Adverse Event|0
5520913|NCT01474512|19087834|P18|Long-Term Extension Period|Switched From PBO to Ixe|0
5520914|NCT01474512|19087835|P17|Long-Term Extension Period|Switched From PBO to Ixe|0
5520915|NCT01474512|19087836|P16|Long-Term Extension Period|Switched From PBO to Ixe|0
5520916|NCT01474512|19087837|P15|Long-Term Extension Period|Switched From PBO to Ixe|0
5520917|NCT01474512|19087838|P14|Long-Term Extension Period|Switched From PBO to Ixe|0
5520918|NCT01474512|19087839|P13|Long-Term Extension Period|Switched From PBO to Ixe|0
5520919|NCT01474512|19087840|P12|Long-Term Extension Period|Switched From PBO to Ixe|21
5520920|NCT01474512|19087841|P11|Long-Term Extension Period|Switched From PBO to Ixe|0
5520921|NCT01474512|19087842|P10|Long-Term Extension Period|Switched From PBO to Ixe|0
5520922|NCT01474512|19087843|P9|Long-Term Extension Period|Switched From PBO to Ixe|0
5520923|NCT01474512|19087844|P8|Long-Term Extension Period|Switched From PBO to Ixe|0
5520924|NCT01474512|19087845|P7|Long-Term Extension Period|Switched From PBO to Ixe|0
5520925|NCT01474512|19087846|P6|Long-Term Extension Period|Switched From PBO to Ixe|0
5520926|NCT01474512|19087847|P5|Long-Term Extension Period|Switched From PBO to Ixe|0
5520927|NCT01474512|19087848|P4|Long-Term Extension Period|Switched From PBO to Ixe|0
5520928|NCT01474512|19087849|P3|Long-Term Extension Period|Switched From PBO to Ixe|0
5520929|NCT01474512|19087850|P2|Long-Term Extension Period|Switched From PBO to Ixe|0
5520930|NCT01474512|19087851|P1|Long-Term Extension Period|Switched From PBO to Ixe|0
5520931|NCT01474512|19087834|P18|Long-Term Extension Period|Parent/Caregiver Decision|0
5520932|NCT01474512|19087835|P17|Long-Term Extension Period|Parent/Caregiver Decision|0
5520933|NCT01474512|19087836|P16|Long-Term Extension Period|Parent/Caregiver Decision|0
5520934|NCT01474512|19087837|P15|Long-Term Extension Period|Parent/Caregiver Decision|0
5520935|NCT01474512|19087838|P14|Long-Term Extension Period|Parent/Caregiver Decision|1
5520936|NCT01474512|19087839|P13|Long-Term Extension Period|Parent/Caregiver Decision|1
5520937|NCT01474512|19087840|P12|Long-Term Extension Period|Parent/Caregiver Decision|0
5520938|NCT01474512|19087841|P11|Long-Term Extension Period|Parent/Caregiver Decision|0
5520939|NCT01474512|19087842|P10|Long-Term Extension Period|Parent/Caregiver Decision|0
5520940|NCT01474512|19087843|P9|Long-Term Extension Period|Parent/Caregiver Decision|0
5520941|NCT01474512|19087844|P8|Long-Term Extension Period|Parent/Caregiver Decision|0
5520942|NCT01474512|19087845|P7|Long-Term Extension Period|Parent/Caregiver Decision|0
5520943|NCT01474512|19087846|P6|Long-Term Extension Period|Parent/Caregiver Decision|0
5520944|NCT01474512|19087847|P5|Long-Term Extension Period|Parent/Caregiver Decision|0
5520945|NCT01474512|19087848|P4|Long-Term Extension Period|Parent/Caregiver Decision|0
5520946|NCT01474512|19087849|P3|Long-Term Extension Period|Parent/Caregiver Decision|0
5520947|NCT01474512|19087850|P2|Long-Term Extension Period|Parent/Caregiver Decision|0
5520948|NCT01474512|19087851|P1|Long-Term Extension Period|Parent/Caregiver Decision|0
5520949|NCT01474512|19087834|P18|Long-Term Extension Period|Protocol Violation|0
5520950|NCT01474512|19087835|P17|Long-Term Extension Period|Protocol Violation|0
5520951|NCT01474512|19087836|P16|Long-Term Extension Period|Protocol Violation|0
5520952|NCT01474512|19087837|P15|Long-Term Extension Period|Protocol Violation|0
5520953|NCT01474512|19087838|P14|Long-Term Extension Period|Protocol Violation|5
5520954|NCT01474512|19087839|P13|Long-Term Extension Period|Protocol Violation|5
5520955|NCT01474512|19087840|P12|Long-Term Extension Period|Protocol Violation|0
5520956|NCT01474512|19087841|P11|Long-Term Extension Period|Protocol Violation|0
5520957|NCT01474512|19087842|P10|Long-Term Extension Period|Protocol Violation|0
5520958|NCT01474512|19087843|P9|Long-Term Extension Period|Protocol Violation|0
5520959|NCT01474512|19087844|P8|Long-Term Extension Period|Protocol Violation|0
5520960|NCT01474512|19087845|P7|Long-Term Extension Period|Protocol Violation|0
5520961|NCT01474512|19087846|P6|Long-Term Extension Period|Protocol Violation|0
5520962|NCT01474512|19087847|P5|Long-Term Extension Period|Protocol Violation|0
5520963|NCT01474512|19087848|P4|Long-Term Extension Period|Protocol Violation|0
5520964|NCT01474512|19087849|P3|Long-Term Extension Period|Protocol Violation|0
5520965|NCT01474512|19087850|P2|Long-Term Extension Period|Protocol Violation|0
5520966|NCT01474512|19087851|P1|Long-Term Extension Period|Protocol Violation|0
5520967|NCT01474512|19087834|P18|Long-Term Extension Period|Sponsor Decision|0
5520968|NCT01474512|19087835|P17|Long-Term Extension Period|Sponsor Decision|0
5520969|NCT01474512|19087836|P16|Long-Term Extension Period|Sponsor Decision|0
5520970|NCT01474512|19087837|P15|Long-Term Extension Period|Sponsor Decision|0
5520971|NCT01474512|19087838|P14|Long-Term Extension Period|Sponsor Decision|6
5520972|NCT01474512|19087839|P13|Long-Term Extension Period|Sponsor Decision|6
5520973|NCT01474512|19087840|P12|Long-Term Extension Period|Sponsor Decision|0
5520974|NCT01474512|19087841|P11|Long-Term Extension Period|Sponsor Decision|0
5520975|NCT01474512|19087842|P10|Long-Term Extension Period|Sponsor Decision|0
5520976|NCT01474512|19087843|P9|Long-Term Extension Period|Sponsor Decision|0
5520977|NCT01474512|19087844|P8|Long-Term Extension Period|Sponsor Decision|0
5520978|NCT01474512|19087845|P7|Long-Term Extension Period|Sponsor Decision|0
5520979|NCT01474512|19087846|P6|Long-Term Extension Period|Sponsor Decision|0
5520980|NCT01474512|19087847|P5|Long-Term Extension Period|Sponsor Decision|0
5520981|NCT01474512|19087848|P4|Long-Term Extension Period|Sponsor Decision|0
5520982|NCT01474512|19087849|P3|Long-Term Extension Period|Sponsor Decision|0
5520983|NCT01474512|19087850|P2|Long-Term Extension Period|Sponsor Decision|0
5520984|NCT01474512|19087851|P1|Long-Term Extension Period|Sponsor Decision|0
5520985|NCT01474512|19087834|P18|Long-Term Extension Period|Death|0
5520986|NCT01474512|19087835|P17|Long-Term Extension Period|Death|0
5520987|NCT01474512|19087836|P16|Long-Term Extension Period|Death|0
5520988|NCT01474512|19087837|P15|Long-Term Extension Period|Death|0
5520989|NCT01474512|19087838|P14|Long-Term Extension Period|Death|9
5520990|NCT01474512|19087839|P13|Long-Term Extension Period|Death|9
5520991|NCT01474512|19087840|P12|Long-Term Extension Period|Death|0
5520992|NCT01474512|19087841|P11|Long-Term Extension Period|Death|0
5520993|NCT01474512|19087842|P10|Long-Term Extension Period|Death|0
5520994|NCT01474512|19087843|P9|Long-Term Extension Period|Death|0
5520995|NCT01474512|19087844|P8|Long-Term Extension Period|Death|0
5520996|NCT01474512|19087845|P7|Long-Term Extension Period|Death|0
5520997|NCT01474512|19087846|P6|Long-Term Extension Period|Death|0
5520998|NCT01474512|19087847|P5|Long-Term Extension Period|Death|0
5520999|NCT01474512|19087848|P4|Long-Term Extension Period|Death|0
5521000|NCT01474512|19087849|P3|Long-Term Extension Period|Death|0
5521001|NCT01474512|19087850|P2|Long-Term Extension Period|Death|0
5521002|NCT01474512|19087851|P1|Long-Term Extension Period|Death|0
5521003|NCT01474512|19087834|P18|Long-Term Extension Period|Clinical Relapse|0
5521004|NCT01474512|19087835|P17|Long-Term Extension Period|Clinical Relapse|0
5521005|NCT01474512|19087836|P16|Long-Term Extension Period|Clinical Relapse|0
5521006|NCT01474512|19087837|P15|Long-Term Extension Period|Clinical Relapse|0
5521007|NCT01474512|19087838|P14|Long-Term Extension Period|Clinical Relapse|9
5521008|NCT01474512|19087839|P13|Long-Term Extension Period|Clinical Relapse|9
5521009|NCT01474512|19087840|P12|Long-Term Extension Period|Clinical Relapse|0
5521010|NCT01474512|19087841|P11|Long-Term Extension Period|Clinical Relapse|0
5521011|NCT01474512|19087842|P10|Long-Term Extension Period|Clinical Relapse|0
5521012|NCT01474512|19087843|P9|Long-Term Extension Period|Clinical Relapse|0
5521013|NCT01474512|19087844|P8|Long-Term Extension Period|Clinical Relapse|0
5521014|NCT01474512|19087845|P7|Long-Term Extension Period|Clinical Relapse|0
5521015|NCT01474512|19087846|P6|Long-Term Extension Period|Clinical Relapse|0
5521016|NCT01474512|19087847|P5|Long-Term Extension Period|Clinical Relapse|0
5521017|NCT01474512|19087848|P4|Long-Term Extension Period|Clinical Relapse|0
5521018|NCT01474512|19087849|P3|Long-Term Extension Period|Clinical Relapse|0
5521019|NCT01474512|19087850|P2|Long-Term Extension Period|Clinical Relapse|0
5521020|NCT01474512|19087851|P1|Long-Term Extension Period|Clinical Relapse|0
5521021|NCT01474512|19087834|P18|Long-Term Extension Period|Physician Decision|0
5521022|NCT01474512|19087835|P17|Long-Term Extension Period|Physician Decision|0
5521023|NCT01474512|19087836|P16|Long-Term Extension Period|Physician Decision|0
5521024|NCT01474512|19087837|P15|Long-Term Extension Period|Physician Decision|0
5521025|NCT01474512|19087838|P14|Long-Term Extension Period|Physician Decision|21
5521026|NCT01474512|19087839|P13|Long-Term Extension Period|Physician Decision|21
5521027|NCT01474512|19087840|P12|Long-Term Extension Period|Physician Decision|0
5521028|NCT01474512|19087841|P11|Long-Term Extension Period|Physician Decision|0
5521029|NCT01474512|19087842|P10|Long-Term Extension Period|Physician Decision|0
5521030|NCT01474512|19087843|P9|Long-Term Extension Period|Physician Decision|0
5521031|NCT01474512|19087844|P8|Long-Term Extension Period|Physician Decision|0
5521032|NCT01474512|19087845|P7|Long-Term Extension Period|Physician Decision|0
5521033|NCT01474512|19087846|P6|Long-Term Extension Period|Physician Decision|0
5521034|NCT01474512|19087847|P5|Long-Term Extension Period|Physician Decision|0
5521035|NCT01474512|19087848|P4|Long-Term Extension Period|Physician Decision|0
5521036|NCT01474512|19087849|P3|Long-Term Extension Period|Physician Decision|0
5521037|NCT01474512|19087850|P2|Long-Term Extension Period|Physician Decision|0
5521038|NCT01474512|19087851|P1|Long-Term Extension Period|Physician Decision|0
5521039|NCT01474512|19087834|P18|Long-Term Extension Period|Lack of Efficacy|0
5521040|NCT01474512|19087835|P17|Long-Term Extension Period|Lack of Efficacy|0
5521041|NCT01474512|19087836|P16|Long-Term Extension Period|Lack of Efficacy|0
5521042|NCT01474512|19087837|P15|Long-Term Extension Period|Lack of Efficacy|0
5521043|NCT01474512|19087838|P14|Long-Term Extension Period|Lack of Efficacy|25
5521044|NCT01474512|19087839|P13|Long-Term Extension Period|Lack of Efficacy|24
5521045|NCT01474512|19087840|P12|Long-Term Extension Period|Lack of Efficacy|1
5521046|NCT01474512|19087841|P11|Long-Term Extension Period|Lack of Efficacy|0
5521047|NCT01474512|19087842|P10|Long-Term Extension Period|Lack of Efficacy|0
5521048|NCT01474512|19087843|P9|Long-Term Extension Period|Lack of Efficacy|0
5521049|NCT01474512|19087844|P8|Long-Term Extension Period|Lack of Efficacy|0
5521050|NCT01474512|19087845|P7|Long-Term Extension Period|Lack of Efficacy|0
5521051|NCT01474512|19087846|P6|Long-Term Extension Period|Lack of Efficacy|0
5521052|NCT01474512|19087847|P5|Long-Term Extension Period|Lack of Efficacy|0
5521053|NCT01474512|19087848|P4|Long-Term Extension Period|Lack of Efficacy|0
5521054|NCT01474512|19087849|P3|Long-Term Extension Period|Lack of Efficacy|0
5521055|NCT01474512|19087850|P2|Long-Term Extension Period|Lack of Efficacy|0
5521056|NCT01474512|19087851|P1|Long-Term Extension Period|Lack of Efficacy|0
5521057|NCT01474512|19087834|P18|Long-Term Extension Period|Lost to Follow-up|0
5521058|NCT01474512|19087835|P17|Long-Term Extension Period|Lost to Follow-up|0
5521059|NCT01474512|19087836|P16|Long-Term Extension Period|Lost to Follow-up|0
5521060|NCT01474512|19087837|P15|Long-Term Extension Period|Lost to Follow-up|0
5521061|NCT01474512|19087838|P14|Long-Term Extension Period|Lost to Follow-up|25
5521062|NCT01474512|19087839|P13|Long-Term Extension Period|Lost to Follow-up|25
5521063|NCT01474512|19087840|P12|Long-Term Extension Period|Lost to Follow-up|0
5521064|NCT01474512|19087841|P11|Long-Term Extension Period|Lost to Follow-up|0
5521065|NCT01474512|19087842|P10|Long-Term Extension Period|Lost to Follow-up|0
5521066|NCT01474512|19087843|P9|Long-Term Extension Period|Lost to Follow-up|0
5521067|NCT01474512|19087844|P8|Long-Term Extension Period|Lost to Follow-up|0
5521068|NCT01474512|19087845|P7|Long-Term Extension Period|Lost to Follow-up|0
5521069|NCT01474512|19087846|P6|Long-Term Extension Period|Lost to Follow-up|0
5521070|NCT01474512|19087847|P5|Long-Term Extension Period|Lost to Follow-up|0
5521071|NCT01474512|19087848|P4|Long-Term Extension Period|Lost to Follow-up|0
5521072|NCT01474512|19087849|P3|Long-Term Extension Period|Lost to Follow-up|0
5521073|NCT01474512|19087850|P2|Long-Term Extension Period|Lost to Follow-up|0
5521074|NCT01474512|19087851|P1|Long-Term Extension Period|Lost to Follow-up|0
5521075|NCT01474512|19087834|P18|Long-Term Extension Period|Adverse Event|0
5521076|NCT01474512|19087835|P17|Long-Term Extension Period|Adverse Event|0
5521077|NCT01474512|19087836|P16|Long-Term Extension Period|Adverse Event|0
5521078|NCT01474512|19087837|P15|Long-Term Extension Period|Adverse Event|0
5521079|NCT01474512|19087838|P14|Long-Term Extension Period|Adverse Event|58
5521080|NCT01474512|19087839|P13|Long-Term Extension Period|Adverse Event|57
5521081|NCT01474512|19087840|P12|Long-Term Extension Period|Adverse Event|1
5521082|NCT01474512|19087841|P11|Long-Term Extension Period|Adverse Event|0
5521083|NCT01474512|19087842|P10|Long-Term Extension Period|Adverse Event|0
5521084|NCT01474512|19087843|P9|Long-Term Extension Period|Adverse Event|0
5521085|NCT01474512|19087844|P8|Long-Term Extension Period|Adverse Event|0
5521086|NCT01474512|19087845|P7|Long-Term Extension Period|Adverse Event|0
5521087|NCT01474512|19087846|P6|Long-Term Extension Period|Adverse Event|0
5521088|NCT01474512|19087847|P5|Long-Term Extension Period|Adverse Event|0
5521089|NCT01474512|19087848|P4|Long-Term Extension Period|Adverse Event|0
5521090|NCT01474512|19087849|P3|Long-Term Extension Period|Adverse Event|0
5521091|NCT01474512|19087850|P2|Long-Term Extension Period|Adverse Event|0
5521092|NCT01474512|19087851|P1|Long-Term Extension Period|Adverse Event|0
5521093|NCT01474512|19087834|P18|Long-Term Extension Period|Withdrawal by Subject|0
5521094|NCT01474512|19087835|P17|Long-Term Extension Period|Withdrawal by Subject|0
5521095|NCT01474512|19087836|P16|Long-Term Extension Period|Withdrawal by Subject|0
5521096|NCT01474512|19087837|P15|Long-Term Extension Period|Withdrawal by Subject|0
5521097|NCT01474512|19087838|P14|Long-Term Extension Period|Withdrawal by Subject|61
5521098|NCT01474512|19087839|P13|Long-Term Extension Period|Withdrawal by Subject|61
5521099|NCT01474512|19087840|P12|Long-Term Extension Period|Withdrawal by Subject|3
5521100|NCT01474512|19087841|P11|Long-Term Extension Period|Withdrawal by Subject|0
5521101|NCT01474512|19087842|P10|Long-Term Extension Period|Withdrawal by Subject|0
5521102|NCT01474512|19087843|P9|Long-Term Extension Period|Withdrawal by Subject|0
5521103|NCT01474512|19087844|P8|Long-Term Extension Period|Withdrawal by Subject|0
5521104|NCT01474512|19087845|P7|Long-Term Extension Period|Withdrawal by Subject|0
5521105|NCT01474512|19087846|P6|Long-Term Extension Period|Withdrawal by Subject|0
5521106|NCT01474512|19087847|P5|Long-Term Extension Period|Withdrawal by Subject|0
5521107|NCT01474512|19087848|P4|Long-Term Extension Period|Withdrawal by Subject|0
5521108|NCT01474512|19087849|P3|Long-Term Extension Period|Withdrawal by Subject|0
5521109|NCT01474512|19087850|P2|Long-Term Extension Period|Withdrawal by Subject|0
5521110|NCT01474512|19087851|P1|Long-Term Extension Period|Withdrawal by Subject|0
5521111|NCT01474512|19087834|P18|Maintenance Period|Treated but Discontinued in Induction|0
5521112|NCT01474512|19087835|P17|Maintenance Period|Treated but Discontinued in Induction|0
5521113|NCT01474512|19087836|P16|Maintenance Period|Treated but Discontinued in Induction|0
5521114|NCT01474512|19087837|P15|Maintenance Period|Treated but Discontinued in Induction|0
5521115|NCT01474512|19087838|P14|Maintenance Period|Treated but Discontinued in Induction|0
5521116|NCT01474512|19087839|P13|Maintenance Period|Treated but Discontinued in Induction|0
5521117|NCT01474512|19087840|P12|Maintenance Period|Treated but Discontinued in Induction|0
5521118|NCT01474512|19087841|P11|Maintenance Period|Treated but Discontinued in Induction|0
5521119|NCT01474512|19087842|P10|Maintenance Period|Treated but Discontinued in Induction|0
5521120|NCT01474512|19087843|P9|Maintenance Period|Treated but Discontinued in Induction|0
5521121|NCT01474512|19087844|P8|Maintenance Period|Treated but Discontinued in Induction|0
5521122|NCT01474512|19087845|P7|Maintenance Period|Treated but Discontinued in Induction|0
5521123|NCT01474512|19087846|P6|Maintenance Period|Treated but Discontinued in Induction|0
5521124|NCT01474512|19087847|P5|Maintenance Period|Treated but Discontinued in Induction|1
5521125|NCT01474512|19087848|P4|Maintenance Period|Treated but Discontinued in Induction|0
5521126|NCT01474512|19087849|P3|Maintenance Period|Treated but Discontinued in Induction|0
5521127|NCT01474512|19087850|P2|Maintenance Period|Treated but Discontinued in Induction|0
5521128|NCT01474512|19087851|P1|Maintenance Period|Treated but Discontinued in Induction|0
5521129|NCT01474512|19087834|P18|Maintenance Period|Protocol Violation|0
5521130|NCT01474512|19087835|P17|Maintenance Period|Protocol Violation|0
5521131|NCT01474512|19087836|P16|Maintenance Period|Protocol Violation|0
5521132|NCT01474512|19087837|P15|Maintenance Period|Protocol Violation|0
5521133|NCT01474512|19087838|P14|Maintenance Period|Protocol Violation|0
5521134|NCT01474512|19087839|P13|Maintenance Period|Protocol Violation|0
5521135|NCT01474512|19087840|P12|Maintenance Period|Protocol Violation|0
5521136|NCT01474512|19087841|P11|Maintenance Period|Protocol Violation|0
5521137|NCT01474512|19087842|P10|Maintenance Period|Protocol Violation|1
5521138|NCT01474512|19087843|P9|Maintenance Period|Protocol Violation|0
5521139|NCT01474512|19087844|P8|Maintenance Period|Protocol Violation|1
5521140|NCT01474512|19087845|P7|Maintenance Period|Protocol Violation|0
5521141|NCT01474512|19087846|P6|Maintenance Period|Protocol Violation|0
5521142|NCT01474512|19087847|P5|Maintenance Period|Protocol Violation|0
5521143|NCT01474512|19087848|P4|Maintenance Period|Protocol Violation|1
5521144|NCT01474512|19087849|P3|Maintenance Period|Protocol Violation|0
5521145|NCT01474512|19087850|P2|Maintenance Period|Protocol Violation|0
5521146|NCT01474512|19087851|P1|Maintenance Period|Protocol Violation|0
5521147|NCT01474512|19087834|P18|Maintenance Period|Lack of Efficacy|0
5521148|NCT01474512|19087835|P17|Maintenance Period|Lack of Efficacy|0
5521149|NCT01474512|19087836|P16|Maintenance Period|Lack of Efficacy|0
5521150|NCT01474512|19087837|P15|Maintenance Period|Lack of Efficacy|0
5521151|NCT01474512|19087838|P14|Maintenance Period|Lack of Efficacy|0
5521152|NCT01474512|19087839|P13|Maintenance Period|Lack of Efficacy|0
5521153|NCT01474512|19087840|P12|Maintenance Period|Lack of Efficacy|0
5521154|NCT01474512|19087841|P11|Maintenance Period|Lack of Efficacy|0
5521155|NCT01474512|19087842|P10|Maintenance Period|Lack of Efficacy|12
5521156|NCT01474512|19087843|P9|Maintenance Period|Lack of Efficacy|11
5521157|NCT01474512|19087844|P8|Maintenance Period|Lack of Efficacy|11
5521158|NCT01474512|19087845|P7|Maintenance Period|Lack of Efficacy|0
5521159|NCT01474512|19087846|P6|Maintenance Period|Lack of Efficacy|0
5521160|NCT01474512|19087847|P5|Maintenance Period|Lack of Efficacy|0
5521161|NCT01474512|19087848|P4|Maintenance Period|Lack of Efficacy|1
5521162|NCT01474512|19087849|P3|Maintenance Period|Lack of Efficacy|0
5521163|NCT01474512|19087850|P2|Maintenance Period|Lack of Efficacy|0
5521164|NCT01474512|19087851|P1|Maintenance Period|Lack of Efficacy|0
5521165|NCT01474512|19087834|P18|Maintenance Period|Clinical Relapse|0
5521166|NCT01474512|19087835|P17|Maintenance Period|Clinical Relapse|0
5521167|NCT01474512|19087836|P16|Maintenance Period|Clinical Relapse|0
5521168|NCT01474512|19087837|P15|Maintenance Period|Clinical Relapse|0
5521169|NCT01474512|19087838|P14|Maintenance Period|Clinical Relapse|0
5521170|NCT01474512|19087839|P13|Maintenance Period|Clinical Relapse|0
5521171|NCT01474512|19087840|P12|Maintenance Period|Clinical Relapse|0
5521172|NCT01474512|19087841|P11|Maintenance Period|Clinical Relapse|0
5521173|NCT01474512|19087842|P10|Maintenance Period|Clinical Relapse|0
5521174|NCT01474512|19087843|P9|Maintenance Period|Clinical Relapse|0
5521175|NCT01474512|19087844|P8|Maintenance Period|Clinical Relapse|0
5521176|NCT01474512|19087845|P7|Maintenance Period|Clinical Relapse|0
5521177|NCT01474512|19087846|P6|Maintenance Period|Clinical Relapse|0
5521178|NCT01474512|19087847|P5|Maintenance Period|Clinical Relapse|0
5521179|NCT01474512|19087848|P4|Maintenance Period|Clinical Relapse|1
5521180|NCT01474512|19087849|P3|Maintenance Period|Clinical Relapse|0
5521181|NCT01474512|19087850|P2|Maintenance Period|Clinical Relapse|0
5521182|NCT01474512|19087851|P1|Maintenance Period|Clinical Relapse|0
5521183|NCT01474512|19087834|P18|Maintenance Period|Physician Decision|0
5521184|NCT01474512|19087835|P17|Maintenance Period|Physician Decision|0
5521185|NCT01474512|19087836|P16|Maintenance Period|Physician Decision|0
5521186|NCT01474512|19087837|P15|Maintenance Period|Physician Decision|0
5521187|NCT01474512|19087838|P14|Maintenance Period|Physician Decision|0
5521188|NCT01474512|19087839|P13|Maintenance Period|Physician Decision|0
5521189|NCT01474512|19087840|P12|Maintenance Period|Physician Decision|0
5521190|NCT01474512|19087841|P11|Maintenance Period|Physician Decision|0
5521191|NCT01474512|19087842|P10|Maintenance Period|Physician Decision|0
5521192|NCT01474512|19087843|P9|Maintenance Period|Physician Decision|0
5521193|NCT01474512|19087844|P8|Maintenance Period|Physician Decision|2
5521194|NCT01474512|19087845|P7|Maintenance Period|Physician Decision|0
5521195|NCT01474512|19087846|P6|Maintenance Period|Physician Decision|1
5521196|NCT01474512|19087847|P5|Maintenance Period|Physician Decision|0
5521197|NCT01474512|19087848|P4|Maintenance Period|Physician Decision|0
5521198|NCT01474512|19087849|P3|Maintenance Period|Physician Decision|0
5521199|NCT01474512|19087850|P2|Maintenance Period|Physician Decision|0
5521200|NCT01474512|19087851|P1|Maintenance Period|Physician Decision|0
5521201|NCT01474512|19087834|P18|Maintenance Period|Death|0
5521202|NCT01474512|19087835|P17|Maintenance Period|Death|0
5521203|NCT01474512|19087836|P16|Maintenance Period|Death|0
5521204|NCT01474512|19087837|P15|Maintenance Period|Death|0
5521205|NCT01474512|19087838|P14|Maintenance Period|Death|0
5521206|NCT01474512|19087839|P13|Maintenance Period|Death|0
5521207|NCT01474512|19087840|P12|Maintenance Period|Death|0
5521208|NCT01474512|19087841|P11|Maintenance Period|Death|0
5521209|NCT01474512|19087842|P10|Maintenance Period|Death|0
5521210|NCT01474512|19087843|P9|Maintenance Period|Death|0
5521211|NCT01474512|19087844|P8|Maintenance Period|Death|0
5521212|NCT01474512|19087845|P7|Maintenance Period|Death|0
5521213|NCT01474512|19087846|P6|Maintenance Period|Death|2
5521214|NCT01474512|19087847|P5|Maintenance Period|Death|0
5521215|NCT01474512|19087848|P4|Maintenance Period|Death|0
5521216|NCT01474512|19087849|P3|Maintenance Period|Death|0
5521217|NCT01474512|19087850|P2|Maintenance Period|Death|0
5521218|NCT01474512|19087851|P1|Maintenance Period|Death|0
5521219|NCT01474512|19087834|P18|Maintenance Period|Lost to Follow-up|0
5521220|NCT01474512|19087835|P17|Maintenance Period|Lost to Follow-up|0
5521221|NCT01474512|19087836|P16|Maintenance Period|Lost to Follow-up|0
5521222|NCT01474512|19087837|P15|Maintenance Period|Lost to Follow-up|0
5521223|NCT01474512|19087838|P14|Maintenance Period|Lost to Follow-up|0
5521224|NCT01474512|19087839|P13|Maintenance Period|Lost to Follow-up|0
5521225|NCT01474512|19087840|P12|Maintenance Period|Lost to Follow-up|0
5521226|NCT01474512|19087841|P11|Maintenance Period|Lost to Follow-up|0
5521227|NCT01474512|19087842|P10|Maintenance Period|Lost to Follow-up|1
5521228|NCT01474512|19087843|P9|Maintenance Period|Lost to Follow-up|1
5521229|NCT01474512|19087844|P8|Maintenance Period|Lost to Follow-up|2
5521230|NCT01474512|19087845|P7|Maintenance Period|Lost to Follow-up|0
5521231|NCT01474512|19087846|P6|Maintenance Period|Lost to Follow-up|0
5521232|NCT01474512|19087847|P5|Maintenance Period|Lost to Follow-up|3
5521233|NCT01474512|19087848|P4|Maintenance Period|Lost to Follow-up|3
5521234|NCT01474512|19087849|P3|Maintenance Period|Lost to Follow-up|0
5521235|NCT01474512|19087850|P2|Maintenance Period|Lost to Follow-up|0
5521236|NCT01474512|19087851|P1|Maintenance Period|Lost to Follow-up|0
5521237|NCT01474512|19087834|P18|Maintenance Period|Withdrawal by Subject|0
5521238|NCT01474512|19087835|P17|Maintenance Period|Withdrawal by Subject|0
5521239|NCT01474512|19087836|P16|Maintenance Period|Withdrawal by Subject|0
5521240|NCT01474512|19087837|P15|Maintenance Period|Withdrawal by Subject|0
5521241|NCT01474512|19087838|P14|Maintenance Period|Withdrawal by Subject|0
5521242|NCT01474512|19087839|P13|Maintenance Period|Withdrawal by Subject|0
5521243|NCT01474512|19087840|P12|Maintenance Period|Withdrawal by Subject|0
5521244|NCT01474512|19087841|P11|Maintenance Period|Withdrawal by Subject|0
5521245|NCT01474512|19087842|P10|Maintenance Period|Withdrawal by Subject|1
5521246|NCT01474512|19087843|P9|Maintenance Period|Withdrawal by Subject|3
5521247|NCT01474512|19087844|P8|Maintenance Period|Withdrawal by Subject|6
5521248|NCT01474512|19087845|P7|Maintenance Period|Withdrawal by Subject|1
5521249|NCT01474512|19087846|P6|Maintenance Period|Withdrawal by Subject|3
5521250|NCT01474512|19087847|P5|Maintenance Period|Withdrawal by Subject|2
5521251|NCT01474512|19087848|P4|Maintenance Period|Withdrawal by Subject|6
5521252|NCT01474512|19087849|P3|Maintenance Period|Withdrawal by Subject|0
5521253|NCT01474512|19087850|P2|Maintenance Period|Withdrawal by Subject|0
5521254|NCT01474512|19087851|P1|Maintenance Period|Withdrawal by Subject|0
5521255|NCT01474512|19087834|P18|Maintenance Period|Adverse Event|0
5521256|NCT01474512|19087835|P17|Maintenance Period|Adverse Event|0
5521257|NCT01474512|19087836|P16|Maintenance Period|Adverse Event|0
5521258|NCT01474512|19087837|P15|Maintenance Period|Adverse Event|0
5521259|NCT01474512|19087838|P14|Maintenance Period|Adverse Event|0
5521260|NCT01474512|19087839|P13|Maintenance Period|Adverse Event|0
5521261|NCT01474512|19087840|P12|Maintenance Period|Adverse Event|0
5521262|NCT01474512|19087841|P11|Maintenance Period|Adverse Event|0
5521263|NCT01474512|19087842|P10|Maintenance Period|Adverse Event|3
5521264|NCT01474512|19087843|P9|Maintenance Period|Adverse Event|1
5521265|NCT01474512|19087844|P8|Maintenance Period|Adverse Event|19
5521266|NCT01474512|19087845|P7|Maintenance Period|Adverse Event|0
5521267|NCT01474512|19087846|P6|Maintenance Period|Adverse Event|7
5521268|NCT01474512|19087847|P5|Maintenance Period|Adverse Event|2
5521269|NCT01474512|19087848|P4|Maintenance Period|Adverse Event|4
5521270|NCT01474512|19087849|P3|Maintenance Period|Adverse Event|0
5521271|NCT01474512|19087850|P2|Maintenance Period|Adverse Event|0
5521272|NCT01474512|19087851|P1|Maintenance Period|Adverse Event|0
5521273|NCT01474512|19087834|P18|Maintenance Period|Relapsed (sPGA ≥3)|0
5521274|NCT01474512|19087835|P17|Maintenance Period|Relapsed (sPGA ≥3)|0
5521275|NCT01474512|19087836|P16|Maintenance Period|Relapsed (sPGA ≥3)|0
5521276|NCT01474512|19087837|P15|Maintenance Period|Relapsed (sPGA ≥3)|0
5521277|NCT01474512|19087838|P14|Maintenance Period|Relapsed (sPGA ≥3)|0
5521278|NCT01474512|19087839|P13|Maintenance Period|Relapsed (sPGA ≥3)|0
5521279|NCT01474512|19087840|P12|Maintenance Period|Relapsed (sPGA ≥3)|0
5521280|NCT01474512|19087841|P11|Maintenance Period|Relapsed (sPGA ≥3)|0
5521281|NCT01474512|19087842|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
5521282|NCT01474512|19087843|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
5521283|NCT01474512|19087844|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
5521284|NCT01474512|19087845|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
5521285|NCT01474512|19087846|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
5521286|NCT01474512|19087847|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
5521287|NCT01474512|19087848|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
5521288|NCT01474512|19087849|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
5521289|NCT01474512|19087850|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
5521290|NCT01474512|19087851|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
5521291|NCT01474512|19087834|P18|Induction Period|Lost to Follow-up|0
5521292|NCT01474512|19087835|P17|Induction Period|Lost to Follow-up|0
5521293|NCT01474512|19087836|P16|Induction Period|Lost to Follow-up|0
5521294|NCT01474512|19087837|P15|Induction Period|Lost to Follow-up|0
5521295|NCT01474512|19087838|P14|Induction Period|Lost to Follow-up|0
5521296|NCT01474512|19087839|P13|Induction Period|Lost to Follow-up|0
5521297|NCT01474512|19087840|P12|Induction Period|Lost to Follow-up|0
5521298|NCT01474512|19087841|P11|Induction Period|Lost to Follow-up|0
5521299|NCT01474512|19087842|P10|Induction Period|Lost to Follow-up|0
5521300|NCT01474512|19087843|P9|Induction Period|Lost to Follow-up|0
5521301|NCT01474512|19087844|P8|Induction Period|Lost to Follow-up|0
5521302|NCT01474512|19087845|P7|Induction Period|Lost to Follow-up|0
5521303|NCT01474512|19087846|P6|Induction Period|Lost to Follow-up|0
5521304|NCT01474512|19087847|P5|Induction Period|Lost to Follow-up|0
5521305|NCT01474512|19087848|P4|Induction Period|Lost to Follow-up|0
5521306|NCT01474512|19087849|P3|Induction Period|Lost to Follow-up|2
5521307|NCT01474512|19087850|P2|Induction Period|Lost to Follow-up|0
5521308|NCT01474512|19087851|P1|Induction Period|Lost to Follow-up|1
5521309|NCT01474512|19087834|P18|Induction Period|Sponsor Decision|0
5521310|NCT01474512|19087835|P17|Induction Period|Sponsor Decision|0
5521311|NCT01474512|19087836|P16|Induction Period|Sponsor Decision|0
5521312|NCT01474512|19087837|P15|Induction Period|Sponsor Decision|0
5521313|NCT01474512|19087838|P14|Induction Period|Sponsor Decision|0
5521314|NCT01474512|19087839|P13|Induction Period|Sponsor Decision|0
5521315|NCT01474512|19087840|P12|Induction Period|Sponsor Decision|0
5521316|NCT01474512|19087841|P11|Induction Period|Sponsor Decision|0
5521317|NCT01474512|19087842|P10|Induction Period|Sponsor Decision|0
5521318|NCT01474512|19087843|P9|Induction Period|Sponsor Decision|0
5521319|NCT01474512|19087844|P8|Induction Period|Sponsor Decision|0
5521320|NCT01474512|19087845|P7|Induction Period|Sponsor Decision|0
5521321|NCT01474512|19087846|P6|Induction Period|Sponsor Decision|0
5521322|NCT01474512|19087847|P5|Induction Period|Sponsor Decision|0
5521323|NCT01474512|19087848|P4|Induction Period|Sponsor Decision|0
5521324|NCT01474512|19087849|P3|Induction Period|Sponsor Decision|1
5521325|NCT01474512|19087850|P2|Induction Period|Sponsor Decision|1
5521326|NCT01474512|19087851|P1|Induction Period|Sponsor Decision|1
5521327|NCT01474512|19087834|P18|Induction Period|Protocol Violation|0
5521328|NCT01474512|19087835|P17|Induction Period|Protocol Violation|0
5521329|NCT01474512|19087836|P16|Induction Period|Protocol Violation|0
5521330|NCT01474512|19087837|P15|Induction Period|Protocol Violation|0
5521331|NCT01474512|19087838|P14|Induction Period|Protocol Violation|0
5521332|NCT01474512|19087839|P13|Induction Period|Protocol Violation|0
5521333|NCT01474512|19087840|P12|Induction Period|Protocol Violation|0
5521334|NCT01474512|19087841|P11|Induction Period|Protocol Violation|0
5521335|NCT01474512|19087842|P10|Induction Period|Protocol Violation|0
5521336|NCT01474512|19087843|P9|Induction Period|Protocol Violation|0
5521337|NCT01474512|19087844|P8|Induction Period|Protocol Violation|0
5521338|NCT01474512|19087845|P7|Induction Period|Protocol Violation|0
5521339|NCT01474512|19087846|P6|Induction Period|Protocol Violation|0
5521340|NCT01474512|19087847|P5|Induction Period|Protocol Violation|0
5521341|NCT01474512|19087848|P4|Induction Period|Protocol Violation|0
5521342|NCT01474512|19087849|P3|Induction Period|Protocol Violation|0
5521343|NCT01474512|19087850|P2|Induction Period|Protocol Violation|6
5521344|NCT01474512|19087851|P1|Induction Period|Protocol Violation|3
5521345|NCT01474512|19087834|P18|Induction Period|Withdrawal by Subject|0
5521346|NCT01474512|19087835|P17|Induction Period|Withdrawal by Subject|0
5521347|NCT01474512|19087836|P16|Induction Period|Withdrawal by Subject|0
5521348|NCT01474512|19087837|P15|Induction Period|Withdrawal by Subject|0
5521349|NCT01474512|19087838|P14|Induction Period|Withdrawal by Subject|0
5521350|NCT01474512|19087839|P13|Induction Period|Withdrawal by Subject|0
5521351|NCT01474512|19087840|P12|Induction Period|Withdrawal by Subject|0
5521352|NCT01474512|19087841|P11|Induction Period|Withdrawal by Subject|0
5521353|NCT01474512|19087842|P10|Induction Period|Withdrawal by Subject|0
5521354|NCT01474512|19087843|P9|Induction Period|Withdrawal by Subject|0
5521355|NCT01474512|19087844|P8|Induction Period|Withdrawal by Subject|0
5521356|NCT01474512|19087845|P7|Induction Period|Withdrawal by Subject|0
5521357|NCT01474512|19087846|P6|Induction Period|Withdrawal by Subject|0
5521358|NCT01474512|19087847|P5|Induction Period|Withdrawal by Subject|0
5521359|NCT01474512|19087848|P4|Induction Period|Withdrawal by Subject|0
5521360|NCT01474512|19087849|P3|Induction Period|Withdrawal by Subject|5
5521361|NCT01474512|19087850|P2|Induction Period|Withdrawal by Subject|6
5521362|NCT01474512|19087851|P1|Induction Period|Withdrawal by Subject|6
5521363|NCT01474512|19087834|P18|Induction Period|Lack of Efficacy|0
5521364|NCT01474512|19087835|P17|Induction Period|Lack of Efficacy|0
5521365|NCT01474512|19087836|P16|Induction Period|Lack of Efficacy|0
5521366|NCT01474512|19087837|P15|Induction Period|Lack of Efficacy|0
5521367|NCT01474512|19087838|P14|Induction Period|Lack of Efficacy|0
5521368|NCT01474512|19087839|P13|Induction Period|Lack of Efficacy|0
5521369|NCT01474512|19087840|P12|Induction Period|Lack of Efficacy|0
5521370|NCT01474512|19087841|P11|Induction Period|Lack of Efficacy|0
5521371|NCT01474512|19087842|P10|Induction Period|Lack of Efficacy|0
5521372|NCT01474512|19087843|P9|Induction Period|Lack of Efficacy|0
5521373|NCT01474512|19087844|P8|Induction Period|Lack of Efficacy|0
5521374|NCT01474512|19087845|P7|Induction Period|Lack of Efficacy|0
5521375|NCT01474512|19087846|P6|Induction Period|Lack of Efficacy|0
5521376|NCT01474512|19087847|P5|Induction Period|Lack of Efficacy|0
5521377|NCT01474512|19087848|P4|Induction Period|Lack of Efficacy|0
5521378|NCT01474512|19087849|P3|Induction Period|Lack of Efficacy|0
5521379|NCT01474512|19087850|P2|Induction Period|Lack of Efficacy|1
5521380|NCT01474512|19087851|P1|Induction Period|Lack of Efficacy|7
5521381|NCT01474512|19087834|P18|Induction Period|Adverse Event|0
5521382|NCT01474512|19087835|P17|Induction Period|Adverse Event|0
5521383|NCT01474512|19087836|P16|Induction Period|Adverse Event|0
5521384|NCT01474512|19087837|P15|Induction Period|Adverse Event|0
5521385|NCT01474512|19087838|P14|Induction Period|Adverse Event|0
5521386|NCT01474512|19087839|P13|Induction Period|Adverse Event|0
5521387|NCT01474512|19087840|P12|Induction Period|Adverse Event|0
5521388|NCT01474512|19087841|P11|Induction Period|Adverse Event|0
5521389|NCT01474512|19087842|P10|Induction Period|Adverse Event|0
5521390|NCT01474512|19087843|P9|Induction Period|Adverse Event|0
5521391|NCT01474512|19087844|P8|Induction Period|Adverse Event|0
5521392|NCT01474512|19087845|P7|Induction Period|Adverse Event|0
5521393|NCT01474512|19087846|P6|Induction Period|Adverse Event|0
5521394|NCT01474512|19087847|P5|Induction Period|Adverse Event|0
5521395|NCT01474512|19087848|P4|Induction Period|Adverse Event|0
5521396|NCT01474512|19087849|P3|Induction Period|Adverse Event|10
5521397|NCT01474512|19087850|P2|Induction Period|Adverse Event|10
5521398|NCT01474512|19087851|P1|Induction Period|Adverse Event|6
5521399|NCT01474434|19087927|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
5521400|NCT01474434|19087928|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
5521401|NCT01474434|19087929|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
5521402|NCT01474434|19087930|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
5521403|NCT01474434|19087927|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
5521404|NCT01474434|19087928|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
5521405|NCT01474434|19087929|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
5521406|NCT01474434|19087930|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
5521407|NCT01474434|19087927|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
5521408|NCT01474434|19087928|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
5521409|NCT01474434|19087929|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
5521410|NCT01474434|19087930|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
5521411|NCT01474317|19087972|P1|Overall Study|Subject ineligible for study|1
5521412|NCT01474317|19087972|P1|Overall Study|Adverse Event|1
5521413|NCT01474291|19087981|P1|Overall Study|Death|2
5521414|NCT01474291|19087981|P1|Overall Study|No Reason Reported|10
5521415|NCT01474291|19087981|P1|Overall Study|Patient No Longer Wanted to Participate|12
5521416|NCT01474291|19087981|P1|Overall Study|Lost to Follow-up|29
5521417|NCT01474291|19087981|P1|Overall Study|Adverse Event|53
5521418|NCT01474291|19087981|P1|Overall Study|Lack of Treatment Efficacy|88
5521419|NCT01474291|19087981|P1|Overall Study|Not Evaluable for Efficacy|26
5521420|NCT01474239|19088025|P2|Overall Study|Withdrawal for Economic Reason|0
5521421|NCT01474239|19088026|P1|Overall Study|Withdrawal for Economic Reason|1
5521422|NCT01474239|19088025|P2|Overall Study|Clinical Disease Progression|1
5521423|NCT01474239|19088026|P1|Overall Study|Clinical Disease Progression|7
5521424|NCT01474239|19088025|P2|Overall Study|Death|1
5521425|NCT01474239|19088026|P1|Overall Study|Death|1
5521426|NCT01474239|19088025|P2|Overall Study|Withdrawal by Subject|2
5521427|NCT01474239|19088026|P1|Overall Study|Withdrawal by Subject|1
5521428|NCT01474239|19088025|P2|Overall Study|Adverse Event|3
5521429|NCT01474239|19088026|P1|Overall Study|Adverse Event|12
5521430|NCT01474239|19088025|P2|Overall Study|Disease Progression|25
5521431|NCT01474239|19088026|P1|Overall Study|Disease Progression|37
5521432|NCT01474018|19088198|P2|Overall Study|Withdrawal by Subject|2
5521433|NCT01474018|19088199|P1|Overall Study|Withdrawal by Subject|0
5521434|NCT01474018|19088198|P2|Overall Study|Lost to Follow-up|1
5521435|NCT01474018|19088199|P1|Overall Study|Lost to Follow-up|0
5521436|NCT01473953|19088231|P5|Overall Study|Other|0
5521437|NCT01473953|19088232|P4|Overall Study|Other|0
5521438|NCT01473953|19088233|P3|Overall Study|Other|0
5521439|NCT01473953|19088234|P2|Overall Study|Other|0
5521440|NCT01473953|19088235|P1|Overall Study|Other|1
5521441|NCT01473940|19088281|P4|Maintenance Therapy|Progressive Disease|4
5521442|NCT01473940|19088282|P3|Maintenance Therapy|Progressive Disease|1
5521443|NCT01473940|19088283|P2|Maintenance Therapy|Progressive Disease|2
5521444|NCT01473940|19088284|P1|Maintenance Therapy|Progressive Disease|1
5521445|NCT01473940|19088281|P4|Induction Therapy|Progressive Disease|0
5521446|NCT01473940|19088282|P3|Induction Therapy|Progressive Disease|1
5521447|NCT01473940|19088283|P2|Induction Therapy|Progressive Disease|1
5521448|NCT01473940|19088284|P1|Induction Therapy|Progressive Disease|0
5521449|NCT01473940|19088281|P4|Induction Therapy|Death|1
5521450|NCT01473940|19088282|P3|Induction Therapy|Death|1
5521451|NCT01473940|19088283|P2|Induction Therapy|Death|0
5521452|NCT01473940|19088284|P1|Induction Therapy|Death|0
5521453|NCT01473836|19088314|P1|Overall Study|Does not meet entrance criteria|1
5521454|NCT01473836|19088314|P1|Overall Study|Lack of Efficacy|1
5521455|NCT01473836|19088314|P1|Overall Study|Adverse Event|4
5521456|NCT01473758|19088325|P4|Cycle 2|Adverse Event|0
5521457|NCT01473758|19088326|P3|Cycle 2|Adverse Event|5
5521458|NCT01473758|19088327|P2|Cycle 2|Adverse Event|0
5521459|NCT01473758|19088328|P1|Cycle 2|Adverse Event|0
5521460|NCT01473758|19088325|P4|Cycle 1|Withdrawal by Subject|0
5521461|NCT01473758|19088326|P3|Cycle 1|Withdrawal by Subject|0
5521462|NCT01473758|19088327|P2|Cycle 1|Withdrawal by Subject|1
5521463|NCT01473758|19088328|P1|Cycle 1|Withdrawal by Subject|1
5521464|NCT01473758|19088325|P4|Cycle 1|Adverse Event|0
5521465|NCT01473758|19088326|P3|Cycle 1|Adverse Event|0
5521466|NCT01473758|19088327|P2|Cycle 1|Adverse Event|2
5521467|NCT01473758|19088328|P1|Cycle 1|Adverse Event|10
5521468|NCT01473732|19088465|P2|Overall Study|Death|0
5521469|NCT01473732|19088466|P1|Overall Study|Death|1
5521470|NCT01473732|19088465|P2|Overall Study|Adverse Event|0
5521471|NCT01473732|19088466|P1|Overall Study|Adverse Event|1
5521472|NCT01473602|19088474|P2|Overall Study|Physician Decision|0
5521473|NCT01473602|19088475|P1|Overall Study|Physician Decision|1
5521474|NCT01473602|19088474|P2|Overall Study|Withdrawal by Subject|4
5521475|NCT01473602|19088475|P1|Overall Study|Withdrawal by Subject|5
5521476|NCT01473602|19088474|P2|Overall Study|Lost to Follow-up|1
5521477|NCT01473602|19088475|P1|Overall Study|Lost to Follow-up|1
5521478|NCT01473602|19088474|P2|Overall Study|Death|1
5521479|NCT01473602|19088475|P1|Overall Study|Death|0
5521480|NCT01473602|19088474|P2|Overall Study|Adverse Event|2
5521481|NCT01473602|19088475|P1|Overall Study|Adverse Event|1
5521482|NCT01473589|19088511|P2|Overall Study|Entry criteria not met|1
5521483|NCT01473589|19088512|P1|Overall Study|Entry criteria not met|0
5521484|NCT01473589|19088511|P2|Overall Study|Physician Decision|1
5521485|NCT01473589|19088512|P1|Overall Study|Physician Decision|0
5521486|NCT01473589|19088511|P2|Overall Study|Withdrawal by Subject|11
5521487|NCT01473589|19088512|P1|Overall Study|Withdrawal by Subject|5
5521488|NCT01473589|19088511|P2|Overall Study|Protocol Violation|0
5521489|NCT01473589|19088512|P1|Overall Study|Protocol Violation|1
5521490|NCT01473589|19088511|P2|Overall Study|Lost to Follow-up|2
5521491|NCT01473589|19088512|P1|Overall Study|Lost to Follow-up|2
5521492|NCT01473589|19088511|P2|Overall Study|Death|0
5521493|NCT01473589|19088512|P1|Overall Study|Death|2
5521494|NCT01473589|19088511|P2|Overall Study|Adverse Event|1
5521495|NCT01473589|19088512|P1|Overall Study|Adverse Event|1
5521496|NCT01473563|19088546|P1|Overall Study|Lost to FU post tx discontinuation|1
5521497|NCT01473524|19088568|P6|LTSE Phase|Protocol Violation|1
5521498|NCT01473524|19088569|P5|LTSE Phase|Protocol Violation|0
5521499|NCT01473524|19088570|P4|LTSE Phase|Protocol Violation|0
5521500|NCT01473524|19088571|P3|LTSE Phase|Protocol Violation|0
5521501|NCT01473524|19088572|P2|LTSE Phase|Protocol Violation|0
5521502|NCT01473524|19088573|P1|LTSE Phase|Protocol Violation|0
5521503|NCT01473524|19088568|P6|LTSE Phase|Pregnancy|0
5521504|NCT01473524|19088569|P5|LTSE Phase|Pregnancy|0
5521505|NCT01473524|19088570|P4|LTSE Phase|Pregnancy|1
5521506|NCT01473524|19088571|P3|LTSE Phase|Pregnancy|0
5521507|NCT01473524|19088572|P2|LTSE Phase|Pregnancy|0
5521508|NCT01473524|19088573|P1|LTSE Phase|Pregnancy|0
5521509|NCT01473524|19088568|P6|LTSE Phase|Liver Transplantation|1
5521510|NCT01473524|19088569|P5|LTSE Phase|Liver Transplantation|0
5521511|NCT01473524|19088570|P4|LTSE Phase|Liver Transplantation|0
5521512|NCT01473524|19088571|P3|LTSE Phase|Liver Transplantation|0
5521513|NCT01473524|19088572|P2|LTSE Phase|Liver Transplantation|0
5521514|NCT01473524|19088573|P1|LTSE Phase|Liver Transplantation|0
5521515|NCT01473524|19088568|P6|LTSE Phase|Principal Investigator Decision|3
5521516|NCT01473524|19088569|P5|LTSE Phase|Principal Investigator Decision|1
5521517|NCT01473524|19088570|P4|LTSE Phase|Principal Investigator Decision|1
5521518|NCT01473524|19088571|P3|LTSE Phase|Principal Investigator Decision|0
5521519|NCT01473524|19088572|P2|LTSE Phase|Principal Investigator Decision|0
5521520|NCT01473524|19088573|P1|LTSE Phase|Principal Investigator Decision|0
5521521|NCT01473524|19088568|P6|LTSE Phase|Lost to Follow-up|2
5521522|NCT01473524|19088569|P5|LTSE Phase|Lost to Follow-up|3
5521523|NCT01473524|19088570|P4|LTSE Phase|Lost to Follow-up|1
5521524|NCT01473524|19088571|P3|LTSE Phase|Lost to Follow-up|0
5521525|NCT01473524|19088572|P2|LTSE Phase|Lost to Follow-up|0
5521526|NCT01473524|19088573|P1|LTSE Phase|Lost to Follow-up|0
5521527|NCT01473524|19088568|P6|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
5521528|NCT01473524|19088569|P5|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
5521529|NCT01473524|19088570|P4|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
5521530|NCT01473524|19088571|P3|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
5521531|NCT01473524|19088572|P2|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
5521532|NCT01473524|19088573|P1|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
5521533|NCT01473524|19088568|P6|LTSE Phase|Adverse Event of Pruritus|2
5521534|NCT01473524|19088569|P5|LTSE Phase|Adverse Event of Pruritus|5
5521535|NCT01473524|19088570|P4|LTSE Phase|Adverse Event of Pruritus|1
5521536|NCT01473524|19088571|P3|LTSE Phase|Adverse Event of Pruritus|0
5521537|NCT01473524|19088572|P2|LTSE Phase|Adverse Event of Pruritus|0
5521538|NCT01473524|19088573|P1|LTSE Phase|Adverse Event of Pruritus|0
5521539|NCT01473524|19088568|P6|LTSE Phase|Death|0
5521540|NCT01473524|19088569|P5|LTSE Phase|Death|1
5521541|NCT01473524|19088570|P4|LTSE Phase|Death|0
5521542|NCT01473524|19088571|P3|LTSE Phase|Death|0
5521543|NCT01473524|19088572|P2|LTSE Phase|Death|0
5521544|NCT01473524|19088573|P1|LTSE Phase|Death|0
5521545|NCT01473524|19088568|P6|LTSE Phase|Withdrawal by Subject|6
5521546|NCT01473524|19088569|P5|LTSE Phase|Withdrawal by Subject|3
5521547|NCT01473524|19088570|P4|LTSE Phase|Withdrawal by Subject|3
5521548|NCT01473524|19088571|P3|LTSE Phase|Withdrawal by Subject|0
5521549|NCT01473524|19088572|P2|LTSE Phase|Withdrawal by Subject|0
5521550|NCT01473524|19088573|P1|LTSE Phase|Withdrawal by Subject|0
5521551|NCT01473524|19088568|P6|DB Phase|Withdrawal by Subject|0
5521552|NCT01473524|19088569|P5|DB Phase|Withdrawal by Subject|0
5521553|NCT01473524|19088570|P4|DB Phase|Withdrawal by Subject|0
5521554|NCT01473524|19088571|P3|DB Phase|Withdrawal by Subject|1
5521555|NCT01473524|19088572|P2|DB Phase|Withdrawal by Subject|1
5521556|NCT01473524|19088573|P1|DB Phase|Withdrawal by Subject|2
5521557|NCT01473524|19088568|P6|DB Phase|Death|0
5521558|NCT01473524|19088569|P5|DB Phase|Death|0
5521559|NCT01473524|19088570|P4|DB Phase|Death|0
5521560|NCT01473524|19088571|P3|DB Phase|Death|0
5521561|NCT01473524|19088572|P2|DB Phase|Death|0
5521562|NCT01473524|19088573|P1|DB Phase|Death|1
5521563|NCT01473524|19088568|P6|DB Phase|Adverse Event|0
5521564|NCT01473524|19088569|P5|DB Phase|Adverse Event|0
5521565|NCT01473524|19088570|P4|DB Phase|Adverse Event|0
5521566|NCT01473524|19088571|P3|DB Phase|Adverse Event|2
5521567|NCT01473524|19088572|P2|DB Phase|Adverse Event|8
5521568|NCT01473524|19088573|P1|DB Phase|Adverse Event|4
5521569|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
5521570|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
5521571|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
5521572|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
5521573|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
5521574|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
5521575|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
5521576|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
5521577|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Site closure|1
5521578|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Site closure|3
5521579|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
5521580|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
5521581|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
5521582|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
5521583|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
5521584|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
5521585|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
5521586|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
5521587|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Physician Decision|2
5521588|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Physician Decision|1
5521589|NCT01473420|19088622|P2|Maintenance Period (16 Weeks)|Adverse Event|2
5521590|NCT01473420|19088623|P1|Maintenance Period (16 Weeks)|Adverse Event|3
5521591|NCT01473420|19088622|P2|Titration Period (18 Weeks)|Did not meet criteria|32
5521592|NCT01473420|19088623|P1|Titration Period (18 Weeks)|Did not meet criteria|32
5521593|NCT01473420|19088622|P2|Titration Period (18 Weeks)|Adverse Event|6
5521594|NCT01473420|19088623|P1|Titration Period (18 Weeks)|Adverse Event|4
5521595|NCT01473407|19088707|P2|Overall Study|Site Closure|0
5521596|NCT01473407|19088708|P1|Overall Study|Site Closure|1
5521597|NCT01473407|19088707|P2|Overall Study|Sponsor's Decision|10
5521598|NCT01473407|19088708|P1|Overall Study|Sponsor's Decision|10
5521599|NCT01473407|19088707|P2|Overall Study|Transfer to Another Facility/Unit|3
5521600|NCT01473407|19088708|P1|Overall Study|Transfer to Another Facility/Unit|4
5521601|NCT01473407|19088707|P2|Overall Study|Temperature Excursion|3
5521602|NCT01473407|19088708|P1|Overall Study|Temperature Excursion|2
5521603|NCT01473407|19088707|P2|Overall Study|Patient Lost Green Card Status|0
5521604|NCT01473407|19088708|P1|Overall Study|Patient Lost Green Card Status|1
5521605|NCT01473407|19088707|P2|Overall Study|Patient Received Aranesp|0
5521606|NCT01473407|19088708|P1|Overall Study|Patient Received Aranesp|1
5521607|NCT01473407|19088707|P2|Overall Study|Elevated Hemoglobin|0
5521608|NCT01473407|19088708|P1|Overall Study|Elevated Hemoglobin|1
5521609|NCT01473407|19088707|P2|Overall Study|Vacation/Travel|1
5521610|NCT01473407|19088708|P1|Overall Study|Vacation/Travel|1
5521611|NCT01473407|19088707|P2|Overall Study|Kidney Transplant|6
5521612|NCT01473407|19088708|P1|Overall Study|Kidney Transplant|7
5521613|NCT01473407|19088707|P2|Overall Study|Withdrawal by Subject|7
5521614|NCT01473407|19088708|P1|Overall Study|Withdrawal by Subject|4
5521615|NCT01473407|19088707|P2|Overall Study|Randomization Error|1
5521616|NCT01473407|19088708|P1|Overall Study|Randomization Error|3
5521617|NCT01473407|19088707|P2|Overall Study|Adverse Event|8
5521618|NCT01473407|19088708|P1|Overall Study|Adverse Event|8
5521619|NCT01473407|19088707|P2|Overall Study|Lost to Follow-up|4
5521620|NCT01473407|19088708|P1|Overall Study|Lost to Follow-up|10
5521621|NCT01473407|19088707|P2|Overall Study|Physician Decision|4
5521622|NCT01473407|19088708|P1|Overall Study|Physician Decision|1
5521623|NCT01473394|19088762|P2|Overall Study|Lost to Follow-up|11
5521624|NCT01473394|19088763|P1|Overall Study|Lost to Follow-up|9
5521625|NCT01473394|19088762|P2|Overall Study|Withdrew Consent|10
5521626|NCT01473394|19088763|P1|Overall Study|Withdrew Consent|12
5521627|NCT01473394|19088762|P2|Overall Study|Protocol Violation|5
5521628|NCT01473394|19088763|P1|Overall Study|Protocol Violation|7
5521629|NCT01473394|19088762|P2|Overall Study|Insufficient Therapeutic Response|1
5521630|NCT01473394|19088763|P1|Overall Study|Insufficient Therapeutic Response|4
5521631|NCT01473394|19088762|P2|Overall Study|Adverse Event|16
5521632|NCT01473394|19088763|P1|Overall Study|Adverse Event|13
5521633|NCT01473381|19088777|P4|Overall Study|Other Reasons|3
5521634|NCT01473381|19088778|P3|Overall Study|Other Reasons|1
5521635|NCT01473381|19088779|P2|Overall Study|Other Reasons|0
5521636|NCT01473381|19088780|P1|Overall Study|Other Reasons|0
5521637|NCT01473381|19088777|P4|Overall Study|Lost to Follow-up|23
5521638|NCT01473381|19088778|P3|Overall Study|Lost to Follow-up|35
5521639|NCT01473381|19088779|P2|Overall Study|Lost to Follow-up|28
5521640|NCT01473381|19088780|P1|Overall Study|Lost to Follow-up|25
5521641|NCT01473381|19088777|P4|Overall Study|Withdrawal of Consent|26
5521642|NCT01473381|19088778|P3|Overall Study|Withdrawal of Consent|20
5521643|NCT01473381|19088779|P2|Overall Study|Withdrawal of Consent|21
5521644|NCT01473381|19088780|P1|Overall Study|Withdrawal of Consent|20
5521645|NCT01473381|19088777|P4|Overall Study|Protocol Violation|17
5521646|NCT01473381|19088778|P3|Overall Study|Protocol Violation|19
5521647|NCT01473381|19088779|P2|Overall Study|Protocol Violation|23
5521648|NCT01473381|19088780|P1|Overall Study|Protocol Violation|17
5521649|NCT01473381|19088777|P4|Overall Study|Insufficient Therapeutic Response|3
5521650|NCT01473381|19088778|P3|Overall Study|Insufficient Therapeutic Response|2
5521651|NCT01473381|19088779|P2|Overall Study|Insufficient Therapeutic Response|1
5521652|NCT01473381|19088780|P1|Overall Study|Insufficient Therapeutic Response|10
5521653|NCT01473381|19088777|P4|Overall Study|Adverse Event|17
5521654|NCT01473381|19088778|P3|Overall Study|Adverse Event|25
5521655|NCT01473381|19088779|P2|Overall Study|Adverse Event|20
5521656|NCT01473381|19088780|P1|Overall Study|Adverse Event|8
5521657|NCT01473355|19088842|P1|Overall Study|Lost to Follow-up|2
5521658|NCT01473355|19088842|P1|Overall Study|Adverse Event|2
5521659|NCT01473355|19088842|P1|Overall Study|Protocol Violation|2
5521660|NCT01472965|19088871|P2|Overall Study|Withdrawal by Subject|0
5521661|NCT01472965|19088872|P1|Overall Study|Withdrawal by Subject|1
5521662|NCT01472939|19088892|P4|Overall Study|Withdrawal by Subject|4
5521663|NCT01472939|19088893|P3|Overall Study|Withdrawal by Subject|1
5521664|NCT01472939|19088894|P2|Overall Study|Withdrawal by Subject|3
5521665|NCT01472939|19088895|P1|Overall Study|Withdrawal by Subject|9
5521666|NCT01472939|19088892|P4|Overall Study|Protocol Violation|1
5521667|NCT01472939|19088893|P3|Overall Study|Protocol Violation|0
5521668|NCT01472939|19088894|P2|Overall Study|Protocol Violation|3
5521669|NCT01472939|19088895|P1|Overall Study|Protocol Violation|3
5521670|NCT01472939|19088892|P4|Overall Study|Withdrawal By PI|0
5521671|NCT01472939|19088893|P3|Overall Study|Withdrawal By PI|0
5521672|NCT01472939|19088894|P2|Overall Study|Withdrawal By PI|0
5521673|NCT01472939|19088895|P1|Overall Study|Withdrawal By PI|1
5521674|NCT01472939|19088892|P4|Overall Study|Prohibited Medication|0
5521675|NCT01472939|19088893|P3|Overall Study|Prohibited Medication|0
5521676|NCT01472939|19088894|P2|Overall Study|Prohibited Medication|1
5521677|NCT01472939|19088895|P1|Overall Study|Prohibited Medication|0
5521678|NCT01472939|19088892|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
5521679|NCT01472939|19088893|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
5521680|NCT01472939|19088894|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
5521681|NCT01472939|19088895|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
5521682|NCT01472939|19088892|P4|Overall Study|Lost to Follow-up|0
5521683|NCT01472939|19088893|P3|Overall Study|Lost to Follow-up|2
5521684|NCT01472939|19088894|P2|Overall Study|Lost to Follow-up|0
5521685|NCT01472939|19088895|P1|Overall Study|Lost to Follow-up|3
5521686|NCT01472939|19088892|P4|Overall Study|Lack of Efficacy|1
5521687|NCT01472939|19088893|P3|Overall Study|Lack of Efficacy|0
5521688|NCT01472939|19088894|P2|Overall Study|Lack of Efficacy|0
5521689|NCT01472939|19088895|P1|Overall Study|Lack of Efficacy|1
5521690|NCT01472939|19088892|P4|Overall Study|Adverse Event|14
5521691|NCT01472939|19088893|P3|Overall Study|Adverse Event|7
5521692|NCT01472939|19088894|P2|Overall Study|Adverse Event|7
5521693|NCT01472939|19088895|P1|Overall Study|Adverse Event|3
5521694|NCT01472835|19088939|P2|Overall Study|Lost to Follow-up|0
5521695|NCT01472835|19088940|P1|Overall Study|Lost to Follow-up|2
5521696|NCT01472757|19088975|P4|Overall Study|Other reasons|2
5521697|NCT01472757|19088976|P3|Overall Study|Other reasons|2
5521698|NCT01472757|19088977|P2|Overall Study|Other reasons|0
5521699|NCT01472757|19088978|P1|Overall Study|Other reasons|1
5521700|NCT01472757|19088975|P4|Overall Study|Protocol Violation|4
5521701|NCT01472757|19088976|P3|Overall Study|Protocol Violation|4
5521702|NCT01472757|19088977|P2|Overall Study|Protocol Violation|2
5521703|NCT01472757|19088978|P1|Overall Study|Protocol Violation|3
5521704|NCT01472757|19088975|P4|Overall Study|Treatment period withdrawal criteria met|12
5521705|NCT01472757|19088976|P3|Overall Study|Treatment period withdrawal criteria met|9
5521706|NCT01472757|19088977|P2|Overall Study|Treatment period withdrawal criteria met|8
5521707|NCT01472757|19088978|P1|Overall Study|Treatment period withdrawal criteria met|21
5521708|NCT01472757|19088975|P4|Overall Study|Asthma exacerbation|1
5521709|NCT01472757|19088976|P3|Overall Study|Asthma exacerbation|2
5521710|NCT01472757|19088977|P2|Overall Study|Asthma exacerbation|1
5521711|NCT01472757|19088978|P1|Overall Study|Asthma exacerbation|4
5521712|NCT01472757|19088975|P4|Overall Study|Withdrawal by Subject|0
5521713|NCT01472757|19088976|P3|Overall Study|Withdrawal by Subject|2
5521714|NCT01472757|19088977|P2|Overall Study|Withdrawal by Subject|2
5521715|NCT01472757|19088978|P1|Overall Study|Withdrawal by Subject|1
5521716|NCT01472380|19089093|P1|1 Day Period Between Dosing|Protocol Violation|1
5521717|NCT01472380|19089093|P1|Efavirenz Alone|Withdrawal by Subject|1
5521718|NCT01472341|19089104|P1|Overall Study|Death|9
5521719|NCT01472341|19089104|P1|Overall Study|Laboratory parameters unavailable|25
5521720|NCT01472341|19089104|P1|Overall Study|Lost to Follow-up|52
5521721|NCT01472341|19089104|P1|Overall Study|Withdrawal by Subject|39
5521722|NCT01472341|19089104|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
5521723|NCT01472341|19089104|P1|Overall Study|Started insulin therapy|55
5521724|NCT01472289|19089110|P1|Overall Study|Death|2
5521725|NCT01472185|19089122|P2|Overall Study|Subject Withdrew Consent|3
5521726|NCT01472185|19089123|P1|Overall Study|Subject Withdrew Consent|6
5521727|NCT01472185|19089122|P2|Overall Study|Subject Noncompliance|15
5521728|NCT01472185|19089123|P1|Overall Study|Subject Noncompliance|8
5521729|NCT01472185|19089122|P2|Overall Study|Protocol Violation|1
5521730|NCT01472185|19089123|P1|Overall Study|Protocol Violation|5
5521731|NCT01472185|19089122|P2|Overall Study|Lost to Follow-up|1
5521732|NCT01472185|19089123|P1|Overall Study|Lost to Follow-up|4
5521733|NCT01472185|19089122|P2|Overall Study|Investigator's Discretion|1
5521734|NCT01472185|19089123|P1|Overall Study|Investigator's Discretion|3
5521735|NCT01472185|19089122|P2|Overall Study|Hyperglycemia|2
5521736|NCT01472185|19089123|P1|Overall Study|Hyperglycemia|5
5521737|NCT01472185|19089122|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
5521738|NCT01472185|19089123|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
5521739|NCT01472185|19089122|P2|Overall Study|Randomized but Not Treated|1
5521740|NCT01472185|19089123|P1|Overall Study|Randomized but Not Treated|0
5521741|NCT01472081|19089143|P6|Overall Study|Subject request to discontinue treatment|0
5521742|NCT01472081|19089144|P5|Overall Study|Subject request to discontinue treatment|0
5521743|NCT01472081|19089145|P4|Overall Study|Subject request to discontinue treatment|1
5521744|NCT01472081|19089146|P3|Overall Study|Subject request to discontinue treatment|1
5521745|NCT01472081|19089147|P2|Overall Study|Subject request to discontinue treatment|3
5521746|NCT01472081|19089148|P1|Overall Study|Subject request to discontinue treatment|0
5521747|NCT01472081|19089143|P6|Overall Study|No longer meets study criteria|0
5521748|NCT01472081|19089144|P5|Overall Study|No longer meets study criteria|0
5521749|NCT01472081|19089145|P4|Overall Study|No longer meets study criteria|0
5521750|NCT01472081|19089146|P3|Overall Study|No longer meets study criteria|1
5521751|NCT01472081|19089147|P2|Overall Study|No longer meets study criteria|0
5521752|NCT01472081|19089148|P1|Overall Study|No longer meets study criteria|0
5521753|NCT01472081|19089143|P6|Overall Study|Poor/non-compliance|0
5521754|NCT01472081|19089144|P5|Overall Study|Poor/non-compliance|1
5521755|NCT01472081|19089145|P4|Overall Study|Poor/non-compliance|0
5521756|NCT01472081|19089146|P3|Overall Study|Poor/non-compliance|1
5521757|NCT01472081|19089147|P2|Overall Study|Poor/non-compliance|0
5521758|NCT01472081|19089148|P1|Overall Study|Poor/non-compliance|0
5521759|NCT01472081|19089143|P6|Overall Study|Withdrawal by Subject|1
5521760|NCT01472081|19089144|P5|Overall Study|Withdrawal by Subject|0
5521761|NCT01472081|19089145|P4|Overall Study|Withdrawal by Subject|0
5521762|NCT01472081|19089146|P3|Overall Study|Withdrawal by Subject|0
5521763|NCT01472081|19089147|P2|Overall Study|Withdrawal by Subject|0
5521764|NCT01472081|19089148|P1|Overall Study|Withdrawal by Subject|0
5521765|NCT01472081|19089143|P6|Overall Study|Adverse Event unrelated to study drug|0
5521766|NCT01472081|19089144|P5|Overall Study|Adverse Event unrelated to study drug|1
5521767|NCT01472081|19089145|P4|Overall Study|Adverse Event unrelated to study drug|0
5521768|NCT01472081|19089146|P3|Overall Study|Adverse Event unrelated to study drug|0
5521769|NCT01472081|19089147|P2|Overall Study|Adverse Event unrelated to study drug|0
5521770|NCT01472081|19089148|P1|Overall Study|Adverse Event unrelated to study drug|0
5521771|NCT01472081|19089143|P6|Overall Study|Death|0
5521772|NCT01472081|19089144|P5|Overall Study|Death|1
5521773|NCT01472081|19089145|P4|Overall Study|Death|0
5521774|NCT01472081|19089146|P3|Overall Study|Death|0
5521775|NCT01472081|19089147|P2|Overall Study|Death|0
5521776|NCT01472081|19089148|P1|Overall Study|Death|0
5521777|NCT01472081|19089143|P6|Overall Study|Study drug toxicity|2
5521778|NCT01472081|19089144|P5|Overall Study|Study drug toxicity|13
5521779|NCT01472081|19089145|P4|Overall Study|Study drug toxicity|6
5521780|NCT01472081|19089146|P3|Overall Study|Study drug toxicity|4
5521781|NCT01472081|19089147|P2|Overall Study|Study drug toxicity|9
5521782|NCT01472081|19089148|P1|Overall Study|Study drug toxicity|2
5521783|NCT01472081|19089143|P6|Overall Study|Disease Progression|3
5521784|NCT01472081|19089144|P5|Overall Study|Disease Progression|22
5521785|NCT01472081|19089145|P4|Overall Study|Disease Progression|31
5521786|NCT01472081|19089146|P3|Overall Study|Disease Progression|12
5521787|NCT01472081|19089147|P2|Overall Study|Disease Progression|10
5521788|NCT01472081|19089148|P1|Overall Study|Disease Progression|4
5521789|NCT01472081|19089143|P6|Overall Study|Continuing treatment at time of analysis|0
5521790|NCT01472081|19089144|P5|Overall Study|Continuing treatment at time of analysis|9
5521791|NCT01472081|19089145|P4|Overall Study|Continuing treatment at time of analysis|8
5521792|NCT01472081|19089146|P3|Overall Study|Continuing treatment at time of analysis|1
5521793|NCT01472081|19089147|P2|Overall Study|Continuing treatment at time of analysis|4
5521794|NCT01472081|19089148|P1|Overall Study|Continuing treatment at time of analysis|1
5521795|NCT01471782|19089197|P6|Overall Study|Death|1
5521796|NCT01471782|19089198|P5|Overall Study|Death|0
5521797|NCT01471782|19089199|P4|Overall Study|Death|0
5521798|NCT01471782|19089200|P3|Overall Study|Death|0
5521799|NCT01471782|19089201|P2|Overall Study|Death|0
5521800|NCT01471782|19089202|P1|Overall Study|Death|0
5521801|NCT01471782|19089197|P6|Overall Study|Withdrawal by Parent/Guardian|0
5521802|NCT01471782|19089198|P5|Overall Study|Withdrawal by Parent/Guardian|1
5521803|NCT01471782|19089199|P4|Overall Study|Withdrawal by Parent/Guardian|0
5521804|NCT01471782|19089200|P3|Overall Study|Withdrawal by Parent/Guardian|0
5521805|NCT01471782|19089201|P2|Overall Study|Withdrawal by Parent/Guardian|0
5521806|NCT01471782|19089202|P1|Overall Study|Withdrawal by Parent/Guardian|0
5521807|NCT01471782|19089197|P6|Overall Study|Physician Decision|8
5521808|NCT01471782|19089198|P5|Overall Study|Physician Decision|3
5521809|NCT01471782|19089199|P4|Overall Study|Physician Decision|0
5521810|NCT01471782|19089200|P3|Overall Study|Physician Decision|0
5521811|NCT01471782|19089201|P2|Overall Study|Physician Decision|0
5521812|NCT01471782|19089202|P1|Overall Study|Physician Decision|0
5521813|NCT01471782|19089197|P6|Overall Study|Disease Relapse|1
5521814|NCT01471782|19089198|P5|Overall Study|Disease Relapse|2
5521815|NCT01471782|19089199|P4|Overall Study|Disease Relapse|1
5521816|NCT01471782|19089200|P3|Overall Study|Disease Relapse|0
5521817|NCT01471782|19089201|P2|Overall Study|Disease Relapse|0
5521818|NCT01471782|19089202|P1|Overall Study|Disease Relapse|0
5521819|NCT01471782|19089197|P6|Overall Study|Change of Chemotherapy|4
5521820|NCT01471782|19089198|P5|Overall Study|Change of Chemotherapy|1
5521821|NCT01471782|19089199|P4|Overall Study|Change of Chemotherapy|0
5521822|NCT01471782|19089200|P3|Overall Study|Change of Chemotherapy|0
5521823|NCT01471782|19089201|P2|Overall Study|Change of Chemotherapy|1
5521824|NCT01471782|19089202|P1|Overall Study|Change of Chemotherapy|1
5521825|NCT01471782|19089197|P6|Overall Study|Other|5
5521826|NCT01471782|19089198|P5|Overall Study|Other|6
5521827|NCT01471782|19089199|P4|Overall Study|Other|1
5521828|NCT01471782|19089200|P3|Overall Study|Other|1
5521829|NCT01471782|19089201|P2|Overall Study|Other|0
5521830|NCT01471782|19089202|P1|Overall Study|Other|0
5521831|NCT01471782|19089197|P6|Overall Study|Adverse Event|1
5521832|NCT01471782|19089198|P5|Overall Study|Adverse Event|3
5521833|NCT01471782|19089199|P4|Overall Study|Adverse Event|2
5521834|NCT01471782|19089200|P3|Overall Study|Adverse Event|2
5521835|NCT01471782|19089201|P2|Overall Study|Adverse Event|1
5521836|NCT01471782|19089202|P1|Overall Study|Adverse Event|1
5521837|NCT01471782|19089197|P6|Overall Study|Lack of Efficacy|18
5521838|NCT01471782|19089198|P5|Overall Study|Lack of Efficacy|5
5521839|NCT01471782|19089199|P4|Overall Study|Lack of Efficacy|1
5521840|NCT01471782|19089200|P3|Overall Study|Lack of Efficacy|1
5521841|NCT01471782|19089201|P2|Overall Study|Lack of Efficacy|2
5521842|NCT01471782|19089202|P1|Overall Study|Lack of Efficacy|1
5521843|NCT01471782|19089197|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
5521844|NCT01471782|19089198|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
5521845|NCT01471782|19089199|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
5521846|NCT01471782|19089200|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
5521847|NCT01471782|19089201|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
5521848|NCT01471782|19089202|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
5521849|NCT01471691|19089256|P2|Overall Study|Lack of Efficacy|1
5521850|NCT01471691|19089257|P1|Overall Study|Lack of Efficacy|0
5521851|NCT01471379|19089266|P3|Overall Study|Study terminated|0
5521852|NCT01471379|19089267|P2|Overall Study|Study terminated|1
5521853|NCT01471379|19089268|P1|Overall Study|Study terminated|0
5521854|NCT01471379|19089266|P3|Overall Study|Adverse Event|0
5521855|NCT01471379|19089267|P2|Overall Study|Adverse Event|0
5521856|NCT01471379|19089268|P1|Overall Study|Adverse Event|1
5521857|NCT01471353|19089288|P1|Overall Study|remain on study|3
5521858|NCT01471340|19089299|P2|Overall Study|Invalid informed consent|0
5521859|NCT01471340|19089300|P1|Overall Study|Invalid informed consent|1
5521860|NCT01471340|19089299|P2|Overall Study|Investigational site closure|1
5521861|NCT01471340|19089300|P1|Overall Study|Investigational site closure|0
5521862|NCT01471340|19089299|P2|Overall Study|Lost to Follow-up|1
5521863|NCT01471340|19089300|P1|Overall Study|Lost to Follow-up|0
5521864|NCT01471340|19089299|P2|Overall Study|Death|4
5521865|NCT01471340|19089300|P1|Overall Study|Death|5
5521866|NCT01471574|19089323|P4|Follow-up Period|Follow-up no longer required|0
5521867|NCT01471574|19089324|P3|Follow-up Period|Follow-up no longer required|0
5521868|NCT01471574|19089325|P2|Follow-up Period|Follow-up no longer required|1
5521869|NCT01471574|19089326|P1|Follow-up Period|Follow-up no longer required|0
5521870|NCT01471574|19089323|P4|Follow-up Period|Death|0
5521871|NCT01471574|19089324|P3|Follow-up Period|Death|1
5521872|NCT01471574|19089325|P2|Follow-up Period|Death|0
5521873|NCT01471574|19089326|P1|Follow-up Period|Death|0
5521874|NCT01471574|19089323|P4|Follow-up Period|Lost to Follow-up|2
5521875|NCT01471574|19089324|P3|Follow-up Period|Lost to Follow-up|3
5521876|NCT01471574|19089325|P2|Follow-up Period|Lost to Follow-up|1
5521877|NCT01471574|19089326|P1|Follow-up Period|Lost to Follow-up|4
5521878|NCT01471574|19089323|P4|Follow-up Period|Withdrawal by Subject|1
5521879|NCT01471574|19089324|P3|Follow-up Period|Withdrawal by Subject|3
5521880|NCT01471574|19089325|P2|Follow-up Period|Withdrawal by Subject|0
5521881|NCT01471574|19089326|P1|Follow-up Period|Withdrawal by Subject|3
5521882|NCT01471574|19089323|P4|Treatment Period|Other|0
5521883|NCT01471574|19089324|P3|Treatment Period|Other|0
5521884|NCT01471574|19089325|P2|Treatment Period|Other|0
5521885|NCT01471574|19089326|P1|Treatment Period|Other|1
5521886|NCT01471574|19089323|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
5521887|NCT01471574|19089324|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
5521888|NCT01471574|19089325|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
5521889|NCT01471574|19089326|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
5521890|NCT01471574|19089323|P4|Treatment Period|Lost to Follow-up|0
5521891|NCT01471574|19089324|P3|Treatment Period|Lost to Follow-up|2
5521892|NCT01471574|19089325|P2|Treatment Period|Lost to Follow-up|2
5521893|NCT01471574|19089326|P1|Treatment Period|Lost to Follow-up|1
5521894|NCT01471574|19089323|P4|Treatment Period|Patient Requested Discontinue Study drug|1
5521895|NCT01471574|19089324|P3|Treatment Period|Patient Requested Discontinue Study drug|1
5521896|NCT01471574|19089325|P2|Treatment Period|Patient Requested Discontinue Study drug|0
5521897|NCT01471574|19089326|P1|Treatment Period|Patient Requested Discontinue Study drug|4
5521898|NCT01471574|19089323|P4|Treatment Period|Withdrawal by Subject|0
5521899|NCT01471574|19089324|P3|Treatment Period|Withdrawal by Subject|1
5521900|NCT01471574|19089325|P2|Treatment Period|Withdrawal by Subject|1
5521901|NCT01471574|19089326|P1|Treatment Period|Withdrawal by Subject|5
5521902|NCT01471574|19089323|P4|Treatment Period|Adverse Event|1
5521903|NCT01471574|19089324|P3|Treatment Period|Adverse Event|6
5521904|NCT01471574|19089325|P2|Treatment Period|Adverse Event|3
5521905|NCT01471574|19089326|P1|Treatment Period|Adverse Event|7
5521906|NCT01471574|19089323|P4|Treatment Period|Lack of Efficacy|1
5521907|NCT01471574|19089324|P3|Treatment Period|Lack of Efficacy|14
5521908|NCT01471574|19089325|P2|Treatment Period|Lack of Efficacy|4
5521909|NCT01471574|19089326|P1|Treatment Period|Lack of Efficacy|12
5521910|NCT01471522|19089357|P2|Overall Study|Lost to Follow-up|26
5521911|NCT01471522|19089358|P1|Overall Study|Lost to Follow-up|36
5521912|NCT01471522|19089357|P2|Overall Study|Withdrawal by Subject|22
5521913|NCT01471522|19089358|P1|Overall Study|Withdrawal by Subject|28
5521914|NCT01471197|19089395|P2|Overall Study|Study Drug Toxicity|0
5521915|NCT01471197|19089396|P1|Overall Study|Study Drug Toxicity|1
5521916|NCT01471197|19089395|P2|Overall Study|Death|0
5521917|NCT01471197|19089396|P1|Overall Study|Death|1
5521918|NCT01471197|19089395|P2|Overall Study|Disease Progression|2
5521919|NCT01471197|19089396|P1|Overall Study|Disease Progression|4
5521920|NCT01471171|19089406|P2|Treatment Period 2|Adverse Event|0
5521921|NCT01471171|19089407|P1|Treatment Period 2|Adverse Event|1
5521922|NCT01471171|19089406|P2|Treatment Period 1|Adverse Event|1
5521923|NCT01471171|19089407|P1|Treatment Period 1|Adverse Event|4
5521924|NCT01471054|19089419|P2|Overall Study|Study terminated prematurely|0
5521925|NCT01471054|19089420|P1|Overall Study|Study terminated prematurely|4
5521926|NCT01471028|19089443|P2|VTI-208E|Lost to Follow-up|2
5521927|NCT01471028|19089444|P1|VTI-208E|Lost to Follow-up|0
5521928|NCT01471028|19089443|P2|VTI-208E|Withdrawal by Subject|0
5521929|NCT01471028|19089444|P1|VTI-208E|Withdrawal by Subject|1
5521930|NCT01471028|19089443|P2|VTI-208E|Death|10
5521931|NCT01471028|19089444|P1|VTI-208E|Death|7
5521932|NCT01471028|19089443|P2|VTI-208|Lost to Follow-up|1
5521933|NCT01471028|19089444|P1|VTI-208|Lost to Follow-up|1
5521934|NCT01471028|19089443|P2|VTI-208|Withdrawal by Subject|2
5521935|NCT01471028|19089444|P1|VTI-208|Withdrawal by Subject|0
5521936|NCT01471028|19089443|P2|VTI-208|Adverse Event|41
5521937|NCT01471028|19089444|P1|VTI-208|Adverse Event|39
5521938|NCT01471015|19089459|P3|Overall Study|Death|1
5521939|NCT01471015|19089460|P2|Overall Study|Death|1
5521940|NCT01471015|19089461|P1|Overall Study|Death|0
5521941|NCT01470599|19089522|P2|Overall Study|Adverse event not related to study drug|5
5521942|NCT01470599|19089523|P1|Overall Study|Adverse event not related to study drug|1
5521943|NCT01470599|19089522|P2|Overall Study|Insufficient clinical response|27
5521944|NCT01470599|19089523|P1|Overall Study|Insufficient clinical response|6
5521945|NCT01470599|19089522|P2|Overall Study|Adverse event related to study drug|5
5521946|NCT01470599|19089523|P1|Overall Study|Adverse event related to study drug|2
5521947|NCT01470599|19089522|P2|Overall Study|Protocol Violation|1
5521948|NCT01470599|19089523|P1|Overall Study|Protocol Violation|3
5521949|NCT01470599|19089522|P2|Overall Study|Other|0
5521950|NCT01470599|19089523|P1|Overall Study|Other|1
5521951|NCT01470599|19089522|P2|Overall Study|Withdrawal by Subject|4
5521952|NCT01470599|19089523|P1|Overall Study|Withdrawal by Subject|3
5521953|NCT01470599|19089522|P2|Overall Study|Lost to Follow-up|1
5521954|NCT01470599|19089523|P1|Overall Study|Lost to Follow-up|2
5521955|NCT01470599|19089522|P2|Overall Study|Did not meet entrance criteria|0
5521956|NCT01470599|19089523|P1|Overall Study|Did not meet entrance criteria|1
5521957|NCT01470469|19089587|P2|Overall Study|Other|1
5521958|NCT01470469|19089588|P1|Overall Study|Other|2
5521959|NCT01470469|19089587|P2|Overall Study|Protocol Violation|1
5521960|NCT01470469|19089588|P1|Overall Study|Protocol Violation|1
5521961|NCT01470469|19089587|P2|Overall Study|Lost to Follow-up|2
5521962|NCT01470469|19089588|P1|Overall Study|Lost to Follow-up|2
5521963|NCT01470469|19089587|P2|Overall Study|Adverse Event|7
5521964|NCT01470469|19089588|P1|Overall Study|Adverse Event|0
5521965|NCT01470469|19089587|P2|Overall Study|Lack of Efficacy|7
5521966|NCT01470469|19089588|P1|Overall Study|Lack of Efficacy|1
5521967|NCT01470469|19089587|P2|Overall Study|Withdrawal by Subject|6
5521968|NCT01470469|19089588|P1|Overall Study|Withdrawal by Subject|4
5521969|NCT01470417|19089608|P2|Overall Study|Disease progression|2
5521970|NCT01470417|19089609|P1|Overall Study|Disease progression|0
5521971|NCT01470326|19089621|P1|Overall Study|No Visit After 1st Day of Treatment|119
5521972|NCT01470326|19089621|P1|Overall Study|No Drug Administration Information|2
5521973|NCT01470326|19089621|P1|Overall Study|Protocol Violation|32
5521974|NCT01470248|19089632|P1|Overall Study|Withdrawal by Subject|1
5521975|NCT01470144|19089688|P1|Overall Study|Patient's and investigator's decision|1
5521976|NCT01470144|19089688|P1|Overall Study|Lung transplant|6
5521977|NCT01470144|19089688|P1|Overall Study|Death|1
5521978|NCT01470144|19089688|P1|Overall Study|Adverse Event|2
5521979|NCT01470001|19089793|P2|Overall Study|Withdrawal by Subject|1
5521980|NCT01470001|19089794|P1|Overall Study|Withdrawal by Subject|2
5521981|NCT01470001|19089793|P2|Overall Study|Physician Decision|0
5521982|NCT01470001|19089794|P1|Overall Study|Physician Decision|2
5521983|NCT01470001|19089793|P2|Overall Study|Lost to Follow-up|1
5521984|NCT01470001|19089794|P1|Overall Study|Lost to Follow-up|1
5521985|NCT01469819|19089804|P1|Overall Study|Technical malfunction of SmartPill data|3
5521986|NCT01469819|19089804|P1|Overall Study|Could not swallow SmartPill|2
5521987|NCT01469819|19089804|P1|Overall Study|Did not meet inclusionary criteria|2
5521988|NCT01469819|19089804|P1|Overall Study|Withdrawal by Subject|1
5521989|NCT01469637|19089828|P2|Second Intervention|Incarcerated|0
5521990|NCT01469637|19089829|P1|Second Intervention|Incarcerated|1
5521991|NCT01469637|19089828|P2|First Intervention|Unacceptable behavior|1
5521992|NCT01469637|19089829|P1|First Intervention|Unacceptable behavior|0
5521993|NCT01469546|19089848|P1|Received 5 mg Dose|Physician Decision|3
5521994|NCT01469546|19089848|P1|Received 5 mg Dose|Progressive Disease|3
5521995|NCT01469546|19089848|P1|Received 5 mg Dose|Protocol Violation|2
5521996|NCT01469546|19089848|P1|Received 5 mg Dose|Death|2
5521997|NCT01469546|19089848|P1|Received 5 mg Dose|Adverse Event|13
5521998|NCT01469377|19089858|P3|Overall Study|Other Miscellaneous Reasons|0
5521999|NCT01469377|19089859|P2|Overall Study|Other Miscellaneous Reasons|0
5522000|NCT01469377|19089860|P1|Overall Study|Other Miscellaneous Reasons|2
5522001|NCT01469377|19089858|P3|Overall Study|Insufficient Therapeutic Response|0
5522002|NCT01469377|19089859|P2|Overall Study|Insufficient Therapeutic Response|4
5522003|NCT01469377|19089860|P1|Overall Study|Insufficient Therapeutic Response|3
5522004|NCT01469377|19089858|P3|Overall Study|Adverse Event|36
5522005|NCT01469377|19089859|P2|Overall Study|Adverse Event|18
5522006|NCT01469377|19089860|P1|Overall Study|Adverse Event|8
5522007|NCT01469377|19089858|P3|Overall Study|Withdrawal of Consent|15
5522008|NCT01469377|19089859|P2|Overall Study|Withdrawal of Consent|14
5522009|NCT01469377|19089860|P1|Overall Study|Withdrawal of Consent|12
5522010|NCT01469377|19089858|P3|Overall Study|Lost to Follow-up|5
5522011|NCT01469377|19089859|P2|Overall Study|Lost to Follow-up|2
5522012|NCT01469377|19089860|P1|Overall Study|Lost to Follow-up|3
5522013|NCT01469377|19089858|P3|Overall Study|Protocol Deviation|10
5522014|NCT01469377|19089859|P2|Overall Study|Protocol Deviation|10
5522015|NCT01469377|19089860|P1|Overall Study|Protocol Deviation|7
5522016|NCT01469364|19089871|P1|Overall Study|Withdrawal by Subject|1
5522017|NCT01469364|19089871|P1|Overall Study|Adverse Event|1
5522018|NCT01469221|19089922|P3|Double Blind Phase|Sponsor Terminate Study|0
5522019|NCT01469221|19089923|P2|Double Blind Phase|Sponsor Terminate Study|16
5522020|NCT01469221|19089924|P1|Double Blind Phase|Sponsor Terminate Study|12
5522021|NCT01469221|19089922|P3|Double Blind Phase|Physician Decision|0
5522022|NCT01469221|19089923|P2|Double Blind Phase|Physician Decision|1
5522023|NCT01469221|19089924|P1|Double Blind Phase|Physician Decision|1
5522024|NCT01469221|19089922|P3|Double Blind Phase|Protocol Violation|0
5522025|NCT01469221|19089923|P2|Double Blind Phase|Protocol Violation|0
5522026|NCT01469221|19089924|P1|Double Blind Phase|Protocol Violation|1
5522027|NCT01469182|19089935|P2|Overall Study|Did not meet Protocol Eligibility|0
5522028|NCT01469182|19089936|P1|Overall Study|Did not meet Protocol Eligibility|3
5522029|NCT01469182|19089935|P2|Overall Study|Protocol Violation|2
5522030|NCT01469182|19089936|P1|Overall Study|Protocol Violation|4
5522031|NCT01469182|19089935|P2|Overall Study|Withdrawal by Subject|1
5522032|NCT01469182|19089936|P1|Overall Study|Withdrawal by Subject|4
5522033|NCT01469182|19089935|P2|Overall Study|Lost to Follow-up|0
5522034|NCT01469182|19089936|P1|Overall Study|Lost to Follow-up|3
5522035|NCT01469182|19089935|P2|Overall Study|Adverse Event|3
5522036|NCT01469182|19089936|P1|Overall Study|Adverse Event|21
5522037|NCT01469065|19089963|P5|Overall Study|Other|0
5522038|NCT01469065|19089964|P4|Overall Study|Other|0
5522039|NCT01469065|19089965|P3|Overall Study|Other|0
5522040|NCT01469065|19089966|P2|Overall Study|Other|1
5522041|NCT01469065|19089967|P1|Overall Study|Other|0
5522042|NCT01469065|19089963|P5|Overall Study|Lack of Efficacy|1
5522043|NCT01469065|19089964|P4|Overall Study|Lack of Efficacy|0
5522044|NCT01469065|19089965|P3|Overall Study|Lack of Efficacy|0
5522045|NCT01469065|19089966|P2|Overall Study|Lack of Efficacy|0
5522046|NCT01469065|19089967|P1|Overall Study|Lack of Efficacy|0
5522047|NCT01469052|19090063|P6|Overall Study|Other|0
5522048|NCT01469052|19090064|P5|Overall Study|Other|1
5522049|NCT01469052|19090065|P4|Overall Study|Other|0
5522050|NCT01469052|19090066|P3|Overall Study|Other|0
5522051|NCT01469052|19090067|P2|Overall Study|Other|1
5522052|NCT01469052|19090068|P1|Overall Study|Other|0
5522053|NCT01469052|19090063|P6|Overall Study|Moved to rollover protocol|1
5522054|NCT01469052|19090064|P5|Overall Study|Moved to rollover protocol|0
5522055|NCT01469052|19090065|P4|Overall Study|Moved to rollover protocol|0
5522056|NCT01469052|19090066|P3|Overall Study|Moved to rollover protocol|1
5522057|NCT01469052|19090067|P2|Overall Study|Moved to rollover protocol|0
5522058|NCT01469052|19090068|P1|Overall Study|Moved to rollover protocol|1
5522059|NCT01469052|19090063|P6|Overall Study|Lack of Efficacy|2
5522060|NCT01469052|19090064|P5|Overall Study|Lack of Efficacy|0
5522061|NCT01469052|19090065|P4|Overall Study|Lack of Efficacy|0
5522062|NCT01469052|19090066|P3|Overall Study|Lack of Efficacy|0
5522063|NCT01469052|19090067|P2|Overall Study|Lack of Efficacy|0
5522064|NCT01469052|19090068|P1|Overall Study|Lack of Efficacy|0
5522065|NCT01469052|19090063|P6|Overall Study|Progressive disease|2
5522066|NCT01469052|19090064|P5|Overall Study|Progressive disease|7
5522067|NCT01469052|19090065|P4|Overall Study|Progressive disease|3
5522068|NCT01469052|19090066|P3|Overall Study|Progressive disease|5
5522069|NCT01469052|19090067|P2|Overall Study|Progressive disease|0
5522070|NCT01469052|19090068|P1|Overall Study|Progressive disease|3
5522071|NCT01469052|19090063|P6|Overall Study|Adverse Event|1
5522072|NCT01469052|19090064|P5|Overall Study|Adverse Event|0
5522073|NCT01469052|19090065|P4|Overall Study|Adverse Event|2
5522074|NCT01469052|19090066|P3|Overall Study|Adverse Event|0
5522075|NCT01469052|19090067|P2|Overall Study|Adverse Event|3
5522076|NCT01469052|19090068|P1|Overall Study|Adverse Event|2
5522077|NCT01469013|19090133|P13|Part B (Extension Period)|Withdrawal by Subject|3
5522078|NCT01469013|19090134|P12|Part B (Extension Period)|Withdrawal by Subject|0
5522079|NCT01469013|19090135|P11|Part B (Extension Period)|Withdrawal by Subject|1
5522080|NCT01469013|19090136|P10|Part B (Extension Period)|Withdrawal by Subject|0
5522081|NCT01469013|19090137|P9|Part B (Extension Period)|Withdrawal by Subject|1
5522082|NCT01469013|19090138|P8|Part B (Extension Period)|Withdrawal by Subject|0
5522083|NCT01469013|19090139|P7|Part B (Extension Period)|Withdrawal by Subject|0
5522084|NCT01469013|19090140|P6|Part B (Extension Period)|Withdrawal by Subject|0
5522085|NCT01469013|19090141|P5|Part B (Extension Period)|Withdrawal by Subject|0
5522086|NCT01469013|19090142|P4|Part B (Extension Period)|Withdrawal by Subject|0
5522087|NCT01469013|19090143|P3|Part B (Extension Period)|Withdrawal by Subject|0
5522088|NCT01469013|19090144|P2|Part B (Extension Period)|Withdrawal by Subject|0
5522089|NCT01469013|19090145|P1|Part B (Extension Period)|Withdrawal by Subject|0
5522090|NCT01469013|19090133|P13|Part B (Extension Period)|Adverse Event|3
5522091|NCT01469013|19090134|P12|Part B (Extension Period)|Adverse Event|6
5522092|NCT01469013|19090135|P11|Part B (Extension Period)|Adverse Event|1
5522093|NCT01469013|19090136|P10|Part B (Extension Period)|Adverse Event|3
5522094|NCT01469013|19090137|P9|Part B (Extension Period)|Adverse Event|3
5522095|NCT01469013|19090138|P8|Part B (Extension Period)|Adverse Event|5
5522096|NCT01469013|19090139|P7|Part B (Extension Period)|Adverse Event|5
5522097|NCT01469013|19090140|P6|Part B (Extension Period)|Adverse Event|2
5522098|NCT01469013|19090141|P5|Part B (Extension Period)|Adverse Event|0
5522099|NCT01469013|19090142|P4|Part B (Extension Period)|Adverse Event|0
5522100|NCT01469013|19090143|P3|Part B (Extension Period)|Adverse Event|0
5522101|NCT01469013|19090144|P2|Part B (Extension Period)|Adverse Event|0
5522102|NCT01469013|19090145|P1|Part B (Extension Period)|Adverse Event|0
5522103|NCT01469013|19090133|P13|Part A (Treatment Period)|Withdrawal by Subject|0
5522104|NCT01469013|19090134|P12|Part A (Treatment Period)|Withdrawal by Subject|0
5522105|NCT01469013|19090135|P11|Part A (Treatment Period)|Withdrawal by Subject|0
5522106|NCT01469013|19090136|P10|Part A (Treatment Period)|Withdrawal by Subject|0
5522107|NCT01469013|19090137|P9|Part A (Treatment Period)|Withdrawal by Subject|0
5522108|NCT01469013|19090138|P8|Part A (Treatment Period)|Withdrawal by Subject|0
5522109|NCT01469013|19090139|P7|Part A (Treatment Period)|Withdrawal by Subject|0
5522110|NCT01469013|19090140|P6|Part A (Treatment Period)|Withdrawal by Subject|0
5522111|NCT01469013|19090141|P5|Part A (Treatment Period)|Withdrawal by Subject|0
5522112|NCT01469013|19090142|P4|Part A (Treatment Period)|Withdrawal by Subject|0
5522113|NCT01469013|19090143|P3|Part A (Treatment Period)|Withdrawal by Subject|1
5522114|NCT01469013|19090144|P2|Part A (Treatment Period)|Withdrawal by Subject|0
5522115|NCT01469013|19090145|P1|Part A (Treatment Period)|Withdrawal by Subject|0
5522116|NCT01469013|19090133|P13|Part A (Treatment Period)|Adverse Event|0
5522117|NCT01469013|19090134|P12|Part A (Treatment Period)|Adverse Event|0
5522118|NCT01469013|19090135|P11|Part A (Treatment Period)|Adverse Event|0
5522119|NCT01469013|19090136|P10|Part A (Treatment Period)|Adverse Event|0
5522120|NCT01469013|19090137|P9|Part A (Treatment Period)|Adverse Event|0
5522121|NCT01469013|19090138|P8|Part A (Treatment Period)|Adverse Event|0
5522122|NCT01469013|19090139|P7|Part A (Treatment Period)|Adverse Event|0
5522123|NCT01469013|19090140|P6|Part A (Treatment Period)|Adverse Event|0
5522124|NCT01469013|19090141|P5|Part A (Treatment Period)|Adverse Event|1
5522125|NCT01469013|19090142|P4|Part A (Treatment Period)|Adverse Event|0
5522126|NCT01469013|19090143|P3|Part A (Treatment Period)|Adverse Event|0
5522127|NCT01469013|19090144|P2|Part A (Treatment Period)|Adverse Event|0
5522128|NCT01469013|19090145|P1|Part A (Treatment Period)|Adverse Event|1
5522129|NCT01469000|19090230|P2|Overall Study|Sponsor Decision|1
5522130|NCT01469000|19090231|P1|Overall Study|Sponsor Decision|4
5522131|NCT01469000|19090230|P2|Overall Study|Withdrawal by Subject|3
5522132|NCT01469000|19090231|P1|Overall Study|Withdrawal by Subject|16
5522133|NCT01468987|19090251|P2|Overall Study|Sponsor Decision|0
5522134|NCT01468987|19090252|P1|Overall Study|Sponsor Decision|1
5522135|NCT01468987|19090251|P2|Overall Study|Physician Decision|15
5522136|NCT01468987|19090252|P1|Overall Study|Physician Decision|8
5522137|NCT01468987|19090251|P2|Overall Study|Withdrawal by Subject|28
5522138|NCT01468987|19090252|P1|Overall Study|Withdrawal by Subject|28
5522139|NCT01468987|19090251|P2|Overall Study|Protocol Violation|2
5522140|NCT01468987|19090252|P1|Overall Study|Protocol Violation|8
5522141|NCT01468987|19090251|P2|Overall Study|Lost to Follow-up|5
5522142|NCT01468987|19090252|P1|Overall Study|Lost to Follow-up|10
5522143|NCT01468987|19090251|P2|Overall Study|Death|1
5522144|NCT01468987|19090252|P1|Overall Study|Death|4
5522145|NCT01468987|19090251|P2|Overall Study|Adverse Event|9
5522146|NCT01468987|19090252|P1|Overall Study|Adverse Event|12
5522147|NCT01468909|19090429|P2|Overall Study|Never Treated|2
5522148|NCT01468909|19090430|P1|Overall Study|Never Treated|2
5522149|NCT01468818|19090463|P1|Overall Study|Death during treatment|2
5522150|NCT01468597|19090477|P1|Overall Study|no platelet function data|5
5522151|NCT01468597|19090477|P1|Overall Study|off-pump CABG|1
5522152|NCT01468597|19090477|P1|Overall Study|concomitant valves|12
5522153|NCT01468597|19090477|P1|Overall Study|Found ineligible|17
5522154|NCT01468311|19090526|P1|Overall Study|Withdrawal by Subject|1
5522155|NCT01468311|19090526|P1|Overall Study|mobilization failure|1
5522156|NCT01468233|19090538|P6|Treatment Period 2|Other|0
5522157|NCT01468233|19090539|P5|Treatment Period 2|Other|1
5522158|NCT01468233|19090540|P4|Treatment Period 2|Other|0
5522159|NCT01468233|19090541|P3|Treatment Period 2|Other|3
5522160|NCT01468233|19090542|P2|Treatment Period 2|Other|0
5522161|NCT01468233|19090543|P1|Treatment Period 2|Other|0
5522162|NCT01468233|19090538|P6|Treatment Period 2|Lost to Follow-up|0
5522163|NCT01468233|19090539|P5|Treatment Period 2|Lost to Follow-up|2
5522164|NCT01468233|19090540|P4|Treatment Period 2|Lost to Follow-up|0
5522165|NCT01468233|19090541|P3|Treatment Period 2|Lost to Follow-up|3
5522166|NCT01468233|19090542|P2|Treatment Period 2|Lost to Follow-up|0
5522167|NCT01468233|19090543|P1|Treatment Period 2|Lost to Follow-up|0
5522168|NCT01468233|19090538|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
5522169|NCT01468233|19090539|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
5522170|NCT01468233|19090540|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
5522171|NCT01468233|19090541|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
5522172|NCT01468233|19090542|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
5522173|NCT01468233|19090543|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
5522174|NCT01468233|19090538|P6|Treatment Period 2|Withdrawal by Subject|1
5522175|NCT01468233|19090539|P5|Treatment Period 2|Withdrawal by Subject|1
5522176|NCT01468233|19090540|P4|Treatment Period 2|Withdrawal by Subject|1
5522177|NCT01468233|19090541|P3|Treatment Period 2|Withdrawal by Subject|9
5522178|NCT01468233|19090542|P2|Treatment Period 2|Withdrawal by Subject|0
5522179|NCT01468233|19090543|P1|Treatment Period 2|Withdrawal by Subject|0
5522180|NCT01468233|19090538|P6|Treatment Period 2|Lack of Efficacy|1
5522181|NCT01468233|19090539|P5|Treatment Period 2|Lack of Efficacy|0
5522182|NCT01468233|19090540|P4|Treatment Period 2|Lack of Efficacy|2
5522183|NCT01468233|19090541|P3|Treatment Period 2|Lack of Efficacy|9
5522184|NCT01468233|19090542|P2|Treatment Period 2|Lack of Efficacy|0
5522185|NCT01468233|19090543|P1|Treatment Period 2|Lack of Efficacy|0
5522186|NCT01468233|19090538|P6|Treatment Period 2|Adverse Event|1
5522187|NCT01468233|19090539|P5|Treatment Period 2|Adverse Event|2
5522188|NCT01468233|19090540|P4|Treatment Period 2|Adverse Event|0
5522189|NCT01468233|19090541|P3|Treatment Period 2|Adverse Event|3
5522190|NCT01468233|19090542|P2|Treatment Period 2|Adverse Event|0
5522191|NCT01468233|19090543|P1|Treatment Period 2|Adverse Event|0
5522192|NCT01468233|19090538|P6|Treatment Period 1|Other|0
5522193|NCT01468233|19090539|P5|Treatment Period 1|Other|0
5522194|NCT01468233|19090540|P4|Treatment Period 1|Other|0
5522195|NCT01468233|19090541|P3|Treatment Period 1|Other|0
5522196|NCT01468233|19090542|P2|Treatment Period 1|Other|1
5522197|NCT01468233|19090543|P1|Treatment Period 1|Other|1
5522198|NCT01468233|19090538|P6|Treatment Period 1|Lost to Follow-up|0
5522199|NCT01468233|19090539|P5|Treatment Period 1|Lost to Follow-up|0
5522200|NCT01468233|19090540|P4|Treatment Period 1|Lost to Follow-up|0
5522201|NCT01468233|19090541|P3|Treatment Period 1|Lost to Follow-up|0
5522202|NCT01468233|19090542|P2|Treatment Period 1|Lost to Follow-up|0
5522203|NCT01468233|19090543|P1|Treatment Period 1|Lost to Follow-up|3
5522204|NCT01468233|19090538|P6|Treatment Period 1|Withdrawal by Subject|0
5522205|NCT01468233|19090539|P5|Treatment Period 1|Withdrawal by Subject|0
5522206|NCT01468233|19090540|P4|Treatment Period 1|Withdrawal by Subject|0
5522207|NCT01468233|19090541|P3|Treatment Period 1|Withdrawal by Subject|0
5522208|NCT01468233|19090542|P2|Treatment Period 1|Withdrawal by Subject|4
5522209|NCT01468233|19090543|P1|Treatment Period 1|Withdrawal by Subject|3
5522210|NCT01468233|19090538|P6|Treatment Period 1|Adverse Event|0
5522211|NCT01468233|19090539|P5|Treatment Period 1|Adverse Event|0
5522212|NCT01468233|19090540|P4|Treatment Period 1|Adverse Event|0
5522213|NCT01468233|19090541|P3|Treatment Period 1|Adverse Event|0
5522214|NCT01468233|19090542|P2|Treatment Period 1|Adverse Event|3
5522215|NCT01468233|19090543|P1|Treatment Period 1|Adverse Event|5
5522216|NCT01468207|19090565|P6|Treatment Period 2|Other|2
5522217|NCT01468207|19090566|P5|Treatment Period 2|Other|1
5522218|NCT01468207|19090567|P4|Treatment Period 2|Other|1
5522219|NCT01468207|19090568|P3|Treatment Period 2|Other|5
5522220|NCT01468207|19090569|P2|Treatment Period 2|Other|0
5522221|NCT01468207|19090570|P1|Treatment Period 2|Other|0
5522222|NCT01468207|19090565|P6|Treatment Period 2|Lost to Follow-up|0
5522223|NCT01468207|19090566|P5|Treatment Period 2|Lost to Follow-up|0
5522224|NCT01468207|19090567|P4|Treatment Period 2|Lost to Follow-up|1
5522225|NCT01468207|19090568|P3|Treatment Period 2|Lost to Follow-up|5
5522226|NCT01468207|19090569|P2|Treatment Period 2|Lost to Follow-up|0
5522227|NCT01468207|19090570|P1|Treatment Period 2|Lost to Follow-up|0
5522228|NCT01468207|19090565|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
5522229|NCT01468207|19090566|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
5522230|NCT01468207|19090567|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
5522231|NCT01468207|19090568|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
5522232|NCT01468207|19090569|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
5522233|NCT01468207|19090570|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
5522234|NCT01468207|19090565|P6|Treatment Period 2|Withdrawal by Subject|2
5522235|NCT01468207|19090566|P5|Treatment Period 2|Withdrawal by Subject|0
5522236|NCT01468207|19090567|P4|Treatment Period 2|Withdrawal by Subject|0
5522237|NCT01468207|19090568|P3|Treatment Period 2|Withdrawal by Subject|5
5522238|NCT01468207|19090569|P2|Treatment Period 2|Withdrawal by Subject|0
5522239|NCT01468207|19090570|P1|Treatment Period 2|Withdrawal by Subject|0
5522240|NCT01468207|19090565|P6|Treatment Period 2|Lack of Efficacy|2
5522241|NCT01468207|19090566|P5|Treatment Period 2|Lack of Efficacy|0
5522242|NCT01468207|19090567|P4|Treatment Period 2|Lack of Efficacy|1
5522243|NCT01468207|19090568|P3|Treatment Period 2|Lack of Efficacy|1
5522244|NCT01468207|19090569|P2|Treatment Period 2|Lack of Efficacy|0
5522245|NCT01468207|19090570|P1|Treatment Period 2|Lack of Efficacy|0
5522246|NCT01468207|19090565|P6|Treatment Period 2|Adverse Event|1
5522247|NCT01468207|19090566|P5|Treatment Period 2|Adverse Event|2
5522248|NCT01468207|19090567|P4|Treatment Period 2|Adverse Event|1
5522249|NCT01468207|19090568|P3|Treatment Period 2|Adverse Event|6
5522250|NCT01468207|19090569|P2|Treatment Period 2|Adverse Event|0
5522251|NCT01468207|19090570|P1|Treatment Period 2|Adverse Event|0
5522252|NCT01468207|19090565|P6|Treatment Period 1|Other|0
5522253|NCT01468207|19090566|P5|Treatment Period 1|Other|0
5522254|NCT01468207|19090567|P4|Treatment Period 1|Other|0
5522255|NCT01468207|19090568|P3|Treatment Period 1|Other|0
5522256|NCT01468207|19090569|P2|Treatment Period 1|Other|2
5522257|NCT01468207|19090570|P1|Treatment Period 1|Other|0
5522258|NCT01468207|19090565|P6|Treatment Period 1|Lost to Follow-up|0
5522259|NCT01468207|19090566|P5|Treatment Period 1|Lost to Follow-up|0
5522260|NCT01468207|19090567|P4|Treatment Period 1|Lost to Follow-up|0
5522261|NCT01468207|19090568|P3|Treatment Period 1|Lost to Follow-up|0
5522262|NCT01468207|19090569|P2|Treatment Period 1|Lost to Follow-up|1
5522263|NCT01468207|19090570|P1|Treatment Period 1|Lost to Follow-up|2
5522264|NCT01468207|19090565|P6|Treatment Period 1|Withdrawal by Subject|0
5522265|NCT01468207|19090566|P5|Treatment Period 1|Withdrawal by Subject|0
5522266|NCT01468207|19090567|P4|Treatment Period 1|Withdrawal by Subject|0
5522267|NCT01468207|19090568|P3|Treatment Period 1|Withdrawal by Subject|0
5522268|NCT01468207|19090569|P2|Treatment Period 1|Withdrawal by Subject|4
5522269|NCT01468207|19090570|P1|Treatment Period 1|Withdrawal by Subject|5
5522270|NCT01468207|19090565|P6|Treatment Period 1|Protocol Violation|0
5522271|NCT01468207|19090566|P5|Treatment Period 1|Protocol Violation|0
5522272|NCT01468207|19090567|P4|Treatment Period 1|Protocol Violation|0
5522273|NCT01468207|19090568|P3|Treatment Period 1|Protocol Violation|0
5522274|NCT01468207|19090569|P2|Treatment Period 1|Protocol Violation|1
5522275|NCT01468207|19090570|P1|Treatment Period 1|Protocol Violation|1
5522276|NCT01468207|19090565|P6|Treatment Period 1|Adverse Event|0
5522277|NCT01468207|19090566|P5|Treatment Period 1|Adverse Event|0
5522278|NCT01468207|19090567|P4|Treatment Period 1|Adverse Event|0
5522279|NCT01468207|19090568|P3|Treatment Period 1|Adverse Event|0
5522280|NCT01468207|19090569|P2|Treatment Period 1|Adverse Event|0
5522281|NCT01468207|19090570|P1|Treatment Period 1|Adverse Event|1
5522282|NCT01468181|19090595|P5|Overall Study|Withdrawal by Subject|0
5522283|NCT01468181|19090596|P4|Overall Study|Withdrawal by Subject|0
5522284|NCT01468181|19090597|P3|Overall Study|Withdrawal by Subject|0
5522285|NCT01468181|19090598|P2|Overall Study|Withdrawal by Subject|1
5522286|NCT01468181|19090599|P1|Overall Study|Withdrawal by Subject|0
5522287|NCT01468181|19090595|P5|Overall Study|Lost to Follow-up|1
5522288|NCT01468181|19090596|P4|Overall Study|Lost to Follow-up|0
5522289|NCT01468181|19090597|P3|Overall Study|Lost to Follow-up|1
5522290|NCT01468181|19090598|P2|Overall Study|Lost to Follow-up|0
5522291|NCT01468181|19090599|P1|Overall Study|Lost to Follow-up|0
5522292|NCT01468181|19090595|P5|Overall Study|Physician Decision|1
5522293|NCT01468181|19090596|P4|Overall Study|Physician Decision|1
5522294|NCT01468181|19090597|P3|Overall Study|Physician Decision|0
5522295|NCT01468181|19090598|P2|Overall Study|Physician Decision|0
5522296|NCT01468181|19090599|P1|Overall Study|Physician Decision|0
5522297|NCT01468181|19090595|P5|Overall Study|Protocol Violation|1
5522298|NCT01468181|19090596|P4|Overall Study|Protocol Violation|0
5522299|NCT01468181|19090597|P3|Overall Study|Protocol Violation|1
5522300|NCT01468181|19090598|P2|Overall Study|Protocol Violation|0
5522301|NCT01468181|19090599|P1|Overall Study|Protocol Violation|2
5522302|NCT01468181|19090595|P5|Overall Study|Adverse Event|2
5522303|NCT01468181|19090596|P4|Overall Study|Adverse Event|2
5522304|NCT01468181|19090597|P3|Overall Study|Adverse Event|6
5522305|NCT01468181|19090598|P2|Overall Study|Adverse Event|1
5522306|NCT01468181|19090599|P1|Overall Study|Adverse Event|8
5522307|NCT01468077|19090648|P2|Overall Study|Physician Decision|0
5522308|NCT01468077|19090649|P1|Overall Study|Physician Decision|1
5522309|NCT01468077|19090648|P2|Overall Study|Lack of Efficacy|1
5522310|NCT01468077|19090649|P1|Overall Study|Lack of Efficacy|1
5522311|NCT01468077|19090648|P2|Overall Study|Adverse Event|2
5522312|NCT01468077|19090649|P1|Overall Study|Adverse Event|2
5522313|NCT01467960|19090711|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
5522314|NCT01467960|19090712|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
5522315|NCT01467960|19090713|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
5522316|NCT01467960|19090714|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
5522317|NCT01467960|19090715|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
5522318|NCT01467960|19090716|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
5522319|NCT01467713|19090775|P4|Overall Study|Reason not Specified|7
5522320|NCT01467713|19090776|P3|Overall Study|Reason not Specified|8
5522321|NCT01467713|19090777|P2|Overall Study|Reason not Specified|11
5522322|NCT01467713|19090778|P1|Overall Study|Reason not Specified|6
5522323|NCT01467713|19090775|P4|Overall Study|Relapse|35
5522324|NCT01467713|19090776|P3|Overall Study|Relapse|28
5522325|NCT01467713|19090777|P2|Overall Study|Relapse|25
5522326|NCT01467713|19090778|P1|Overall Study|Relapse|35
5522327|NCT01467713|19090775|P4|Overall Study|Pregnancy|3
5522328|NCT01467713|19090776|P3|Overall Study|Pregnancy|1
5522329|NCT01467713|19090777|P2|Overall Study|Pregnancy|1
5522330|NCT01467713|19090778|P1|Overall Study|Pregnancy|0
5522331|NCT01467713|19090775|P4|Overall Study|Study Termination|29
5522332|NCT01467713|19090776|P3|Overall Study|Study Termination|28
5522333|NCT01467713|19090777|P2|Overall Study|Study Termination|33
5522334|NCT01467713|19090778|P1|Overall Study|Study Termination|23
5522335|NCT01467713|19090775|P4|Overall Study|Voluntary Withdrawal|20
5522336|NCT01467713|19090776|P3|Overall Study|Voluntary Withdrawal|21
5522337|NCT01467713|19090777|P2|Overall Study|Voluntary Withdrawal|14
5522338|NCT01467713|19090778|P1|Overall Study|Voluntary Withdrawal|18
5522339|NCT01467713|19090775|P4|Overall Study|Lost to Follow-up|9
5522340|NCT01467713|19090776|P3|Overall Study|Lost to Follow-up|6
5522341|NCT01467713|19090777|P2|Overall Study|Lost to Follow-up|12
5522342|NCT01467713|19090778|P1|Overall Study|Lost to Follow-up|9
5522343|NCT01467713|19090775|P4|Overall Study|Major Protocol Deviation|1
5522344|NCT01467713|19090776|P3|Overall Study|Major Protocol Deviation|4
5522345|NCT01467713|19090777|P2|Overall Study|Major Protocol Deviation|4
5522346|NCT01467713|19090778|P1|Overall Study|Major Protocol Deviation|2
5522347|NCT01467713|19090775|P4|Overall Study|Pretreatment Event or Adverse Event|5
5522348|NCT01467713|19090776|P3|Overall Study|Pretreatment Event or Adverse Event|6
5522349|NCT01467713|19090777|P2|Overall Study|Pretreatment Event or Adverse Event|4
5522350|NCT01467713|19090778|P1|Overall Study|Pretreatment Event or Adverse Event|9
5522351|NCT01467700|19090832|P4|Overall Study|Reason not Specified|8
5522352|NCT01467700|19090833|P3|Overall Study|Reason not Specified|2
5522353|NCT01467700|19090834|P2|Overall Study|Reason not Specified|3
5522354|NCT01467700|19090835|P1|Overall Study|Reason not Specified|1
5522355|NCT01467700|19090832|P4|Overall Study|Lack of Efficacy|1
5522356|NCT01467700|19090833|P3|Overall Study|Lack of Efficacy|2
5522357|NCT01467700|19090834|P2|Overall Study|Lack of Efficacy|0
5522358|NCT01467700|19090835|P1|Overall Study|Lack of Efficacy|2
5522359|NCT01467700|19090832|P4|Overall Study|Pregnancy|0
5522360|NCT01467700|19090833|P3|Overall Study|Pregnancy|1
5522361|NCT01467700|19090834|P2|Overall Study|Pregnancy|1
5522362|NCT01467700|19090835|P1|Overall Study|Pregnancy|0
5522363|NCT01467700|19090832|P4|Overall Study|Study Termination|7
5522364|NCT01467700|19090833|P3|Overall Study|Study Termination|10
5522365|NCT01467700|19090834|P2|Overall Study|Study Termination|5
5522366|NCT01467700|19090835|P1|Overall Study|Study Termination|6
5522367|NCT01467700|19090832|P4|Overall Study|Voluntary Withdrawal|2
5522368|NCT01467700|19090833|P3|Overall Study|Voluntary Withdrawal|6
5522369|NCT01467700|19090834|P2|Overall Study|Voluntary Withdrawal|7
5522370|NCT01467700|19090835|P1|Overall Study|Voluntary Withdrawal|5
5522371|NCT01467700|19090832|P4|Overall Study|Lost to Follow-up|3
5522372|NCT01467700|19090833|P3|Overall Study|Lost to Follow-up|2
5522373|NCT01467700|19090834|P2|Overall Study|Lost to Follow-up|5
5522374|NCT01467700|19090835|P1|Overall Study|Lost to Follow-up|6
5522375|NCT01467700|19090832|P4|Overall Study|Major Protocol Deviation|3
5522376|NCT01467700|19090833|P3|Overall Study|Major Protocol Deviation|2
5522377|NCT01467700|19090834|P2|Overall Study|Major Protocol Deviation|3
5522378|NCT01467700|19090835|P1|Overall Study|Major Protocol Deviation|3
5522379|NCT01467700|19090832|P4|Overall Study|Pretreatment Event or Adverse Event|3
5522380|NCT01467700|19090833|P3|Overall Study|Pretreatment Event or Adverse Event|2
5522381|NCT01467700|19090834|P2|Overall Study|Pretreatment Event or Adverse Event|4
5522382|NCT01467700|19090835|P1|Overall Study|Pretreatment Event or Adverse Event|6
5522383|NCT01467661|19090877|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
5522384|NCT01467661|19090877|P1|Overall Study|Lack of Efficacy|3
5522385|NCT01467661|19090877|P1|Overall Study|Withdrawal by Subject|1
5522386|NCT01467661|19090877|P1|Overall Study|Adverse Event|16
5522387|NCT01467583|19090897|P3|Overall Study|Protocol Violation|2
5522388|NCT01467583|19090898|P2|Overall Study|Protocol Violation|0
5522389|NCT01467583|19090899|P1|Overall Study|Protocol Violation|0
5522390|NCT01467583|19090897|P3|Overall Study|Withdrawal by Subject|0
5522391|NCT01467583|19090898|P2|Overall Study|Withdrawal by Subject|0
5522392|NCT01467583|19090899|P1|Overall Study|Withdrawal by Subject|1
5522393|NCT01467583|19090897|P3|Overall Study|Death|0
5522394|NCT01467583|19090898|P2|Overall Study|Death|1
5522395|NCT01467583|19090899|P1|Overall Study|Death|1
5522396|NCT01467570|19090912|P2|Overall Study|Lost to Follow-up|9
5522397|NCT01467570|19090913|P1|Overall Study|Lost to Follow-up|8
5522398|NCT01467505|19090950|P2|Overall Study|Study Terminated by Sponsor|3
5522399|NCT01467505|19090951|P1|Overall Study|Study Terminated by Sponsor|28
5522400|NCT01467505|19090950|P2|Overall Study|Withdrawal by Subject|0
5522401|NCT01467505|19090951|P1|Overall Study|Withdrawal by Subject|4
5522402|NCT01467505|19090950|P2|Overall Study|Adverse Event|0
5522403|NCT01467505|19090951|P1|Overall Study|Adverse Event|1
5522404|NCT01467492|19090983|P2|Overall Study|Enrolled But Not Treated|0
5522405|NCT01467492|19090984|P1|Overall Study|Enrolled But Not Treated|1
5522406|NCT01467492|19090983|P2|Overall Study|Undefined|0
5522407|NCT01467492|19090984|P1|Overall Study|Undefined|2
5522408|NCT01467492|19090983|P2|Overall Study|Lost to Follow-up|2
5522409|NCT01467492|19090984|P1|Overall Study|Lost to Follow-up|3
5522410|NCT01467492|19090983|P2|Overall Study|Adverse Event|3
5522411|NCT01467492|19090984|P1|Overall Study|Adverse Event|4
5522412|NCT01467492|19090983|P2|Overall Study|Study Terminated by Sponsor|4
5522413|NCT01467492|19090984|P1|Overall Study|Study Terminated by Sponsor|6
5522414|NCT01467492|19090983|P2|Overall Study|Withdrawal by Subject|4
5522415|NCT01467492|19090984|P1|Overall Study|Withdrawal by Subject|6
5522416|NCT01467479|19091008|P3|Overall Study|Other|0
5522417|NCT01467479|19091009|P2|Overall Study|Other|0
5522418|NCT01467479|19091010|P1|Overall Study|Other|1
5522419|NCT01467479|19091008|P3|Overall Study|Study Terminated by Sponsor|3
5522420|NCT01467479|19091009|P2|Overall Study|Study Terminated by Sponsor|3
5522421|NCT01467479|19091010|P1|Overall Study|Study Terminated by Sponsor|1
5522422|NCT01467479|19091008|P3|Overall Study|Withdrawal of Consent|7
5522423|NCT01467479|19091009|P2|Overall Study|Withdrawal of Consent|7
5522424|NCT01467479|19091010|P1|Overall Study|Withdrawal of Consent|3
5522425|NCT01467479|19091008|P3|Overall Study|Lost to Follow-up|3
5522426|NCT01467479|19091009|P2|Overall Study|Lost to Follow-up|5
5522427|NCT01467479|19091010|P1|Overall Study|Lost to Follow-up|2
5522428|NCT01467479|19091008|P3|Overall Study|Death|1
5522429|NCT01467479|19091009|P2|Overall Study|Death|0
5522430|NCT01467479|19091010|P1|Overall Study|Death|0
5522431|NCT01467479|19091008|P3|Overall Study|Adverse Event|0
5522432|NCT01467479|19091009|P2|Overall Study|Adverse Event|2
5522433|NCT01467479|19091010|P1|Overall Study|Adverse Event|1
5522434|NCT01467479|19091008|P3|Overall Study|No Study Medication|2
5522435|NCT01467479|19091009|P2|Overall Study|No Study Medication|0
5522436|NCT01467479|19091010|P1|Overall Study|No Study Medication|1
5522437|NCT01467466|19091041|P4|Overall Study|No Endpoint Blood Draw|43
5522438|NCT01467466|19091042|P3|Overall Study|No Endpoint Blood Draw|51
5522439|NCT01467466|19091043|P2|Overall Study|No Endpoint Blood Draw|32
5522440|NCT01467466|19091044|P1|Overall Study|No Endpoint Blood Draw|38
5522441|NCT01467466|19091041|P4|Overall Study|Procedure Cancelled|29
5522442|NCT01467466|19091042|P3|Overall Study|Procedure Cancelled|25
5522443|NCT01467466|19091043|P2|Overall Study|Procedure Cancelled|45
5522444|NCT01467466|19091044|P1|Overall Study|Procedure Cancelled|46
5522445|NCT01467466|19091041|P4|Overall Study|Revoked Consent Prior To Procedure|5
5522446|NCT01467466|19091042|P3|Overall Study|Revoked Consent Prior To Procedure|15
5522447|NCT01467466|19091043|P2|Overall Study|Revoked Consent Prior To Procedure|9
5522448|NCT01467466|19091044|P1|Overall Study|Revoked Consent Prior To Procedure|10
5522449|NCT01467466|19091041|P4|Overall Study|Withdrawal by Subject|11
5522450|NCT01467466|19091042|P3|Overall Study|Withdrawal by Subject|13
5522451|NCT01467466|19091043|P2|Overall Study|Withdrawal by Subject|18
5522452|NCT01467466|19091044|P1|Overall Study|Withdrawal by Subject|15
5522453|NCT01467427|19091056|P2|Overall Study|Not continuing in extension phase|2
5522454|NCT01467427|19091057|P1|Overall Study|Not continuing in extension phase|0
5522455|NCT01467427|19091056|P2|Overall Study|Entered extension phase|11
5522456|NCT01467427|19091057|P1|Overall Study|Entered extension phase|11
5522457|NCT01467427|19091056|P2|Overall Study|Withdrawal by Subject|0
5522458|NCT01467427|19091057|P1|Overall Study|Withdrawal by Subject|1
5522459|NCT01467271|19091075|P1|Overall Study|Other reason|14
5522460|NCT01467271|19091075|P1|Overall Study|Retraction of patient's consent|21
5522461|NCT01467271|19091075|P1|Overall Study|Lost to Follow-up|83
5522462|NCT01467271|19091075|P1|Overall Study|Death|84
5522463|NCT01467076|19091082|P3|Overall Study|Lost to Follow-up|0
5522464|NCT01467076|19091083|P2|Overall Study|Lost to Follow-up|0
5522465|NCT01467076|19091084|P1|Overall Study|Lost to Follow-up|1
5522466|NCT01466881|19091156|P1|Overall Study|Other reason not protocol specified|5
5522467|NCT01466881|19091156|P1|Overall Study|Death|4
5522468|NCT01466881|19091156|P1|Overall Study|Progression/relapse|20
5522469|NCT01466881|19091156|P1|Overall Study|Adverse Event|6
5522470|NCT01466881|19091156|P1|Overall Study|Ineligible|5
5522471|NCT01466790|19091173|P8|Overall Study|Withdrawal by Subject|1
5522472|NCT01466790|19091174|P7|Overall Study|Withdrawal by Subject|1
5522473|NCT01466790|19091175|P6|Overall Study|Withdrawal by Subject|0
5522474|NCT01466790|19091176|P5|Overall Study|Withdrawal by Subject|1
5522475|NCT01466790|19091177|P4|Overall Study|Withdrawal by Subject|0
5522476|NCT01466790|19091178|P3|Overall Study|Withdrawal by Subject|0
5522477|NCT01466790|19091179|P2|Overall Study|Withdrawal by Subject|1
5522478|NCT01466790|19091180|P1|Overall Study|Withdrawal by Subject|1
5522479|NCT01466790|19091173|P8|Overall Study|Lost to Follow-up|0
5522480|NCT01466790|19091174|P7|Overall Study|Lost to Follow-up|0
5522481|NCT01466790|19091175|P6|Overall Study|Lost to Follow-up|0
5522482|NCT01466790|19091176|P5|Overall Study|Lost to Follow-up|0
5522483|NCT01466790|19091177|P4|Overall Study|Lost to Follow-up|0
5522484|NCT01466790|19091178|P3|Overall Study|Lost to Follow-up|0
5522485|NCT01466790|19091179|P2|Overall Study|Lost to Follow-up|0
5522486|NCT01466790|19091180|P1|Overall Study|Lost to Follow-up|2
5522487|NCT01466790|19091173|P8|Overall Study|Adverse Event|0
5522488|NCT01466790|19091174|P7|Overall Study|Adverse Event|0
5522489|NCT01466790|19091175|P6|Overall Study|Adverse Event|0
5522490|NCT01466790|19091176|P5|Overall Study|Adverse Event|2
5522491|NCT01466790|19091177|P4|Overall Study|Adverse Event|0
5522492|NCT01466790|19091178|P3|Overall Study|Adverse Event|0
5522493|NCT01466790|19091179|P2|Overall Study|Adverse Event|0
5522494|NCT01466790|19091180|P1|Overall Study|Adverse Event|1
5522495|NCT01466673|19091276|P2|Overall Study|Adverse Event|1
5522496|NCT01466673|19091277|P1|Overall Study|Adverse Event|2
5522497|NCT01466673|19091276|P2|Overall Study|Lost to Follow-up|5
5522498|NCT01466673|19091277|P1|Overall Study|Lost to Follow-up|3
5522499|NCT01466673|19091276|P2|Overall Study|Non-compliance with study treatment|0
5522500|NCT01466673|19091277|P1|Overall Study|Non-compliance with study treatment|2
5522501|NCT01466660|19091303|P2|Overall Study|Other reason not defined above|8
5522502|NCT01466660|19091304|P1|Overall Study|Other reason not defined above|10
5522503|NCT01466660|19091303|P2|Overall Study|Refused continuation of trial medication|3
5522504|NCT01466660|19091304|P1|Overall Study|Refused continuation of trial medication|4
5522505|NCT01466660|19091303|P2|Overall Study|Protocol Violation|1
5522506|NCT01466660|19091304|P1|Overall Study|Protocol Violation|2
5522507|NCT01466660|19091303|P2|Overall Study|Other adverse event|18
5522508|NCT01466660|19091304|P1|Overall Study|Other adverse event|19
5522509|NCT01466660|19091303|P2|Overall Study|Worsening of underlying cancer disease|2
5522510|NCT01466660|19091304|P1|Overall Study|Worsening of underlying cancer disease|5
5522511|NCT01466660|19091303|P2|Overall Study|Progressive Disease (RECIST 1.1)|127
5522512|NCT01466660|19091304|P1|Overall Study|Progressive Disease (RECIST 1.1)|120
5522513|NCT01466595|19091330|P2|Overall Study|Withdrawal by Subject|1
5522514|NCT01466595|19091331|P1|Overall Study|Withdrawal by Subject|0
5522515|NCT01466491|19091425|P4|Overall Study|Missing Data|0
5522516|NCT01466491|19091426|P3|Overall Study|Missing Data|1
5522517|NCT01466491|19091427|P2|Overall Study|Missing Data|0
5522518|NCT01466491|19091428|P1|Overall Study|Missing Data|0
5522519|NCT01466491|19091425|P4|Overall Study|Protocol Violation|0
5522520|NCT01466491|19091426|P3|Overall Study|Protocol Violation|2
5522521|NCT01466491|19091427|P2|Overall Study|Protocol Violation|3
5522522|NCT01466491|19091428|P1|Overall Study|Protocol Violation|0
5522523|NCT01466387|19091448|P6|Overall Study|Protocol Violation|0
5522524|NCT01466387|19091449|P5|Overall Study|Protocol Violation|0
5522525|NCT01466387|19091450|P4|Overall Study|Protocol Violation|1
5522526|NCT01466387|19091451|P3|Overall Study|Protocol Violation|0
5522527|NCT01466387|19091452|P2|Overall Study|Protocol Violation|0
5522528|NCT01466387|19091453|P1|Overall Study|Protocol Violation|1
5522529|NCT01466387|19091448|P6|Overall Study|Lost to Follow-up|1
5522530|NCT01466387|19091449|P5|Overall Study|Lost to Follow-up|0
5522531|NCT01466387|19091450|P4|Overall Study|Lost to Follow-up|0
5522532|NCT01466387|19091451|P3|Overall Study|Lost to Follow-up|0
5522533|NCT01466387|19091452|P2|Overall Study|Lost to Follow-up|0
5522534|NCT01466387|19091453|P1|Overall Study|Lost to Follow-up|0
5522535|NCT01466387|19091448|P6|Overall Study|Adverse Event|0
5522536|NCT01466387|19091449|P5|Overall Study|Adverse Event|0
5522537|NCT01466387|19091450|P4|Overall Study|Adverse Event|1
5522538|NCT01466387|19091451|P3|Overall Study|Adverse Event|1
5522539|NCT01466387|19091452|P2|Overall Study|Adverse Event|0
5522540|NCT01466387|19091453|P1|Overall Study|Adverse Event|0
5522541|NCT01466348|19091514|P2|Period I - First Intervention|Withdrawal by Subject|1
5522542|NCT01466348|19091515|P1|Period I - First Intervention|Withdrawal by Subject|0
5522543|NCT01466270|19091543|P2|Overall Study|Multiple|1
5522544|NCT01466270|19091544|P1|Overall Study|Multiple|1
5522545|NCT01466270|19091543|P2|Overall Study|Toxicity|1
5522546|NCT01466270|19091544|P1|Overall Study|Toxicity|4
5522547|NCT01466270|19091543|P2|Overall Study|Progression|0
5522548|NCT01466270|19091544|P1|Overall Study|Progression|1
5522549|NCT01466270|19091543|P2|Overall Study|Lost to Follow-up|3
5522550|NCT01466270|19091544|P1|Overall Study|Lost to Follow-up|1
5522551|NCT01466270|19091543|P2|Overall Study|Physician Decision|0
5522552|NCT01466270|19091544|P1|Overall Study|Physician Decision|1
5522553|NCT01466270|19091543|P2|Overall Study|Withdrawal by Subject|1
5522554|NCT01466270|19091544|P1|Overall Study|Withdrawal by Subject|4
5522555|NCT01466192|19091556|P1|Overall Study|Withdrawal by Subject|3
5522556|NCT01466192|19091556|P1|Overall Study|Physician Decision|1
5522557|NCT01466179|19091560|P1|Overall Study|Other|3
5522558|NCT01466179|19091560|P1|Overall Study|Protocol Violation|2
5522559|NCT01466179|19091560|P1|Overall Study|Withdrawal by Subject|7
5522560|NCT01466179|19091560|P1|Overall Study|Death|7
5522561|NCT01466179|19091560|P1|Overall Study|Lack of Efficacy|14
5522562|NCT01466179|19091560|P1|Overall Study|Disease relapse|23
5522563|NCT01466179|19091560|P1|Overall Study|Adverse Event|32
5522564|NCT01466179|19091560|P1|Overall Study|Progressive disease|43
5522565|NCT01466179|19091560|P1|Overall Study|Physician Decision|46
5522566|NCT01466179|19091560|P1|Overall Study|Ongoing in core study|2
5522567|NCT01466166|19091580|P1|Overall Study|Other|20
5522568|NCT01466166|19091580|P1|Overall Study|Protocol Violation/Noncompliance|2
5522569|NCT01466166|19091580|P1|Overall Study|Sponsor Decision|4
5522570|NCT01466166|19091580|P1|Overall Study|Withdrawal by Subject|13
5522571|NCT01466166|19091580|P1|Overall Study|Elevated Serum Uric Acid|78
5522572|NCT01466166|19091580|P1|Overall Study|Adverse Event (Other than IR)|11
5522573|NCT01466166|19091580|P1|Overall Study|Infusion Reaction (IR)|27
5522574|NCT01466166|19091580|P1|Overall Study|Lost to Follow-up|7
5522575|NCT01466166|19091580|P1|Overall Study|Death|1
5522576|NCT01466153|19091594|P3|Overall Study|Other-Unspecified|2
5522577|NCT01466153|19091595|P2|Overall Study|Other-Unspecified|4
5522578|NCT01466153|19091596|P1|Overall Study|Other-Unspecified|6
5522579|NCT01466153|19091594|P3|Overall Study|Randomized-Not Treated|4
5522580|NCT01466153|19091595|P2|Overall Study|Randomized-Not Treated|3
5522581|NCT01466153|19091596|P1|Overall Study|Randomized-Not Treated|2
5522582|NCT01466153|19091594|P3|Overall Study|Investigator Discretion|2
5522583|NCT01466153|19091595|P2|Overall Study|Investigator Discretion|2
5522584|NCT01466153|19091596|P1|Overall Study|Investigator Discretion|3
5522585|NCT01466153|19091594|P3|Overall Study|Withdrawal of Consent|0
5522586|NCT01466153|19091595|P2|Overall Study|Withdrawal of Consent|0
5522587|NCT01466153|19091596|P1|Overall Study|Withdrawal of Consent|2
5522588|NCT01466153|19091594|P3|Overall Study|Adverse Event|17
5522589|NCT01466153|19091595|P2|Overall Study|Adverse Event|13
5522590|NCT01466153|19091596|P1|Overall Study|Adverse Event|14
5522591|NCT01466153|19091594|P3|Overall Study|Disease Progression|0
5522592|NCT01466153|19091595|P2|Overall Study|Disease Progression|2
5522593|NCT01466153|19091596|P1|Overall Study|Disease Progression|2
5522594|NCT01466062|19091651|P1|Overall Study|Withdrawal by Subject|1
5522595|NCT01466062|19091651|P1|Overall Study|Adverse Event|1
5522596|NCT01465997|19091674|P2|Overall Study|subject left participation SP0993|1
5522597|NCT01465997|19091675|P1|Overall Study|subject left participation SP0993|0
5522598|NCT01465997|19091674|P2|Overall Study|decision by site staff|1
5522599|NCT01465997|19091675|P1|Overall Study|decision by site staff|0
5522600|NCT01465997|19091674|P2|Overall Study|withdrew before follow-up|13
5522601|NCT01465997|19091675|P1|Overall Study|withdrew before follow-up|0
5522602|NCT01465997|19091674|P2|Overall Study|local lab unblinded site|0
5522603|NCT01465997|19091675|P1|Overall Study|local lab unblinded site|1
5522604|NCT01465997|19091674|P2|Overall Study|subject withdrew consent|0
5522605|NCT01465997|19091675|P1|Overall Study|subject withdrew consent|1
5522606|NCT01465997|19091674|P2|Overall Study|sponsor's decision|1
5522607|NCT01465997|19091675|P1|Overall Study|sponsor's decision|1
5522608|NCT01465997|19091674|P2|Overall Study|Death|1
5522609|NCT01465997|19091675|P1|Overall Study|Death|0
5522610|NCT01465997|19091674|P2|Overall Study|investigator's decision|1
5522611|NCT01465997|19091675|P1|Overall Study|investigator's decision|1
5522612|NCT01465997|19091674|P2|Overall Study|Withdrawal by Subject|35
5522613|NCT01465997|19091675|P1|Overall Study|Withdrawal by Subject|32
5522614|NCT01465997|19091674|P2|Overall Study|Lost to Follow-up|9
5522615|NCT01465997|19091675|P1|Overall Study|Lost to Follow-up|6
5522616|NCT01465997|19091674|P2|Overall Study|Protocol Violation|4
5522617|NCT01465997|19091675|P1|Overall Study|Protocol Violation|1
5522618|NCT01465997|19091674|P2|Overall Study|Lack of Efficacy|1
5522619|NCT01465997|19091675|P1|Overall Study|Lack of Efficacy|13
5522620|NCT01465997|19091674|P2|Overall Study|Adverse Event|22
5522621|NCT01465997|19091675|P1|Overall Study|Adverse Event|12
5522622|NCT01465958|19091685|P2|Subcutaneous (SC) Phase|Adverse Event|1
5522623|NCT01465958|19091686|P1|Subcutaneous (SC) Phase|Adverse Event|0
5522624|NCT01465958|19091685|P2|Run-in Phase|Protocol Violation|0
5522625|NCT01465958|19091686|P1|Run-in Phase|Protocol Violation|1
5522626|NCT01465802|19091707|P5|Overall Study|Death|2
5522627|NCT01465802|19091708|P4|Overall Study|Death|10
5522628|NCT01465802|19091709|P3|Overall Study|Death|0
5522629|NCT01465802|19091710|P2|Overall Study|Death|12
5522630|NCT01465802|19091711|P1|Overall Study|Death|15
5522631|NCT01465802|19091707|P5|Overall Study|Reason not specified|2
5522632|NCT01465802|19091708|P4|Overall Study|Reason not specified|10
5522633|NCT01465802|19091709|P3|Overall Study|Reason not specified|0
5522634|NCT01465802|19091710|P2|Overall Study|Reason not specified|4
5522635|NCT01465802|19091711|P1|Overall Study|Reason not specified|9
5522636|NCT01465802|19091707|P5|Overall Study|Lost to Follow-up|0
5522637|NCT01465802|19091708|P4|Overall Study|Lost to Follow-up|0
5522638|NCT01465802|19091709|P3|Overall Study|Lost to Follow-up|0
5522639|NCT01465802|19091710|P2|Overall Study|Lost to Follow-up|1
5522640|NCT01465802|19091711|P1|Overall Study|Lost to Follow-up|1
5522641|NCT01465802|19091707|P5|Overall Study|Withdrawal by Subject|1
5522642|NCT01465802|19091708|P4|Overall Study|Withdrawal by Subject|8
5522643|NCT01465802|19091709|P3|Overall Study|Withdrawal by Subject|0
5522644|NCT01465802|19091710|P2|Overall Study|Withdrawal by Subject|7
5522645|NCT01465802|19091711|P1|Overall Study|Withdrawal by Subject|7
5522646|NCT01465802|19091707|P5|Overall Study|Study terminated by sponsor|7
5522647|NCT01465802|19091708|P4|Overall Study|Study terminated by sponsor|1
5522648|NCT01465802|19091709|P3|Overall Study|Study terminated by sponsor|0
5522649|NCT01465802|19091710|P2|Overall Study|Study terminated by sponsor|0
5522650|NCT01465802|19091711|P1|Overall Study|Study terminated by sponsor|1
5522651|NCT01465763|19091763|P3|Overall Study|Death|0
5522652|NCT01465763|19091764|P2|Overall Study|Death|0
5522653|NCT01465763|19091765|P1|Overall Study|Death|1
5522654|NCT01465763|19091763|P3|Overall Study|Protocol Violation|1
5522655|NCT01465763|19091764|P2|Overall Study|Protocol Violation|1
5522656|NCT01465763|19091765|P1|Overall Study|Protocol Violation|4
5522657|NCT01465763|19091763|P3|Overall Study|Other|0
5522658|NCT01465763|19091764|P2|Overall Study|Other|0
5522659|NCT01465763|19091765|P1|Overall Study|Other|2
5522660|NCT01465763|19091763|P3|Overall Study|Adverse Event|1
5522661|NCT01465763|19091764|P2|Overall Study|Adverse Event|0
5522662|NCT01465763|19091765|P1|Overall Study|Adverse Event|9
5522663|NCT01465763|19091763|P3|Overall Study|Insufficient Clinical Response|1
5522664|NCT01465763|19091764|P2|Overall Study|Insufficient Clinical Response|0
5522665|NCT01465763|19091765|P1|Overall Study|Insufficient Clinical Response|11
5522666|NCT01465763|19091763|P3|Overall Study|Withdrawal by Subject|1
5522667|NCT01465763|19091764|P2|Overall Study|Withdrawal by Subject|0
5522668|NCT01465763|19091765|P1|Overall Study|Withdrawal by Subject|4
5522669|NCT01465659|19091794|P4|Completed Follow for 1 Year|Still in FU|2
5522670|NCT01465659|19091795|P3|Completed Follow for 1 Year|Still in FU|1
5522671|NCT01465659|19091796|P2|Completed Follow for 1 Year|Still in FU|0
5522672|NCT01465659|19091797|P1|Completed Follow for 1 Year|Still in FU|0
5522673|NCT01465659|19091794|P4|Completed Follow for 1 Year|Death|4
5522674|NCT01465659|19091795|P3|Completed Follow for 1 Year|Death|1
5522675|NCT01465659|19091796|P2|Completed Follow for 1 Year|Death|3
5522676|NCT01465659|19091797|P1|Completed Follow for 1 Year|Death|6
5522677|NCT01465659|19091794|P4|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
5522678|NCT01465659|19091795|P3|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
5522679|NCT01465659|19091796|P2|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
5522680|NCT01465659|19091797|P1|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
5522681|NCT01465659|19091794|P4|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
5522682|NCT01465659|19091795|P3|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
5522683|NCT01465659|19091796|P2|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
5522684|NCT01465659|19091797|P1|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
5522685|NCT01465659|19091794|P4|Completed 1 Cycle of Treatment|Adverse Event|1
5522686|NCT01465659|19091795|P3|Completed 1 Cycle of Treatment|Adverse Event|0
5522687|NCT01465659|19091796|P2|Completed 1 Cycle of Treatment|Adverse Event|0
5522688|NCT01465659|19091797|P1|Completed 1 Cycle of Treatment|Adverse Event|0
5522689|NCT01465659|19091794|P4|Completed 1 Cycle of Treatment|Death|0
5522690|NCT01465659|19091795|P3|Completed 1 Cycle of Treatment|Death|0
5522691|NCT01465659|19091796|P2|Completed 1 Cycle of Treatment|Death|1
5522692|NCT01465659|19091797|P1|Completed 1 Cycle of Treatment|Death|0
5522693|NCT01465464|19091807|P2|Overall Study|Ongoing treatment at cutoff date|166
5522694|NCT01465464|19091808|P1|Overall Study|Ongoing treatment at cutoff date|140
5522695|NCT01465464|19091807|P2|Overall Study|Other|3
5522696|NCT01465464|19091808|P1|Overall Study|Other|9
5522697|NCT01465464|19091807|P2|Overall Study|Withdrawal by Subject|30
5522698|NCT01465464|19091808|P1|Overall Study|Withdrawal by Subject|46
5522699|NCT01465464|19091807|P2|Overall Study|Protocol Violation|1
5522700|NCT01465464|19091808|P1|Overall Study|Protocol Violation|1
5522701|NCT01465464|19091807|P2|Overall Study|Physician Decision|5
5522702|NCT01465464|19091808|P1|Overall Study|Physician Decision|13
5522703|NCT01465464|19091807|P2|Overall Study|Lack of Efficacy|190
5522704|NCT01465464|19091808|P1|Overall Study|Lack of Efficacy|139
5522705|NCT01465464|19091807|P2|Overall Study|Adverse Event|49
5522706|NCT01465464|19091808|P1|Overall Study|Adverse Event|96
5522707|NCT01465386|19091861|P1|Overall Study|Adverse Event|1
5522708|NCT01465386|19091861|P1|Overall Study|Lack of Efficacy|3
5522709|NCT01465347|19091865|P2|Overall Study|Admitted to hospice|1
5522710|NCT01465347|19091866|P1|Overall Study|Admitted to hospice|0
5522711|NCT01465347|19091865|P2|Overall Study|Physician Decision|1
5522712|NCT01465347|19091866|P1|Overall Study|Physician Decision|0
5522713|NCT01465347|19091865|P2|Overall Study|Withdrawal by Subject|1
5522714|NCT01465347|19091866|P1|Overall Study|Withdrawal by Subject|1
5522715|NCT01465334|19091878|P2|Overall Study|Refractory Disease|3
5522716|NCT01465334|19091879|P1|Overall Study|Refractory Disease|0
5522717|NCT01465334|19091878|P2|Overall Study|Richter's transformation|3
5522718|NCT01465334|19091879|P1|Overall Study|Richter's transformation|0
5522719|NCT01465334|19091878|P2|Overall Study|Adverse Event|0
5522720|NCT01465334|19091879|P1|Overall Study|Adverse Event|1
5522721|NCT01465334|19091878|P2|Overall Study|Disease Progression|0
5522722|NCT01465334|19091879|P1|Overall Study|Disease Progression|1
5522723|NCT01465230|19091905|P1|Overall Study|Withdrawal by Subject|2
5522724|NCT01465191|19091912|P3|Overall Study|Lost to Follow-up|4
5522725|NCT01465191|19091913|P2|Overall Study|Lost to Follow-up|6
5522726|NCT01465191|19091914|P1|Overall Study|Lost to Follow-up|3
5522727|NCT01465191|19091912|P3|Overall Study|Protocol Violation|3
5522728|NCT01465191|19091913|P2|Overall Study|Protocol Violation|3
5522729|NCT01465191|19091914|P1|Overall Study|Protocol Violation|6
5522730|NCT01465178|19091963|P2|Overall Study|Withdrawal by Subject|0
5522731|NCT01465178|19091964|P1|Overall Study|Withdrawal by Subject|1
5522732|NCT01465022|19091988|P3|Overall Study|Not Randomized|70
5522733|NCT01465022|19091989|P2|Overall Study|Not Randomized|0
5522734|NCT01465022|19091990|P1|Overall Study|Not Randomized|0
5522735|NCT01465022|19091988|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
5522736|NCT01465022|19091989|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
5522737|NCT01465022|19091990|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
5522738|NCT01465022|19091988|P3|Overall Study|Lost to Follow-up|0
5522739|NCT01465022|19091989|P2|Overall Study|Lost to Follow-up|14
5522740|NCT01465022|19091990|P1|Overall Study|Lost to Follow-up|15
5522741|NCT01464931|19092024|P2|Overall Study|Withdrawal by Subject|0
5522742|NCT01464931|19092025|P1|Overall Study|Withdrawal by Subject|1
5522743|NCT01464879|19092062|P1|Overall Study|Non-compliance|1
5522744|NCT01464879|19092062|P1|Overall Study|Physician Decision|1
5522745|NCT01464827|19092123|P14|Overall Study|Not Treated|2
5522746|NCT01464827|19092124|P13|Overall Study|Not Treated|0
5522747|NCT01464827|19092125|P12|Overall Study|Not Treated|1
5522748|NCT01464827|19092126|P11|Overall Study|Not Treated|0
5522749|NCT01464827|19092127|P10|Overall Study|Not Treated|2
5522750|NCT01464827|19092128|P9|Overall Study|Not Treated|0
5522751|NCT01464827|19092129|P8|Overall Study|Not Treated|0
5522752|NCT01464827|19092130|P7|Overall Study|Not Treated|1
5522753|NCT01464827|19092131|P6|Overall Study|Not Treated|0
5522754|NCT01464827|19092132|P5|Overall Study|Not Treated|1
5522755|NCT01464827|19092133|P4|Overall Study|Not Treated|0
5522756|NCT01464827|19092134|P3|Overall Study|Not Treated|0
5522757|NCT01464827|19092135|P2|Overall Study|Not Treated|2
5522758|NCT01464827|19092136|P1|Overall Study|Not Treated|0
5522759|NCT01464827|19092123|P14|Overall Study|Other|0
5522760|NCT01464827|19092124|P13|Overall Study|Other|1
5522761|NCT01464827|19092125|P12|Overall Study|Other|0
5522762|NCT01464827|19092126|P11|Overall Study|Other|2
5522763|NCT01464827|19092127|P10|Overall Study|Other|1
5522764|NCT01464827|19092128|P9|Overall Study|Other|3
5522765|NCT01464827|19092129|P8|Overall Study|Other|0
5522766|NCT01464827|19092130|P7|Overall Study|Other|1
5522767|NCT01464827|19092131|P6|Overall Study|Other|0
5522768|NCT01464827|19092132|P5|Overall Study|Other|3
5522769|NCT01464827|19092133|P4|Overall Study|Other|2
5522770|NCT01464827|19092134|P3|Overall Study|Other|0
5522771|NCT01464827|19092135|P2|Overall Study|Other|3
5522772|NCT01464827|19092136|P1|Overall Study|Other|2
5522773|NCT01464827|19092123|P14|Overall Study|Lost to Follow-up|1
5522774|NCT01464827|19092124|P13|Overall Study|Lost to Follow-up|0
5522775|NCT01464827|19092125|P12|Overall Study|Lost to Follow-up|1
5522776|NCT01464827|19092126|P11|Overall Study|Lost to Follow-up|0
5522777|NCT01464827|19092127|P10|Overall Study|Lost to Follow-up|0
5522778|NCT01464827|19092128|P9|Overall Study|Lost to Follow-up|0
5522779|NCT01464827|19092129|P8|Overall Study|Lost to Follow-up|2
5522780|NCT01464827|19092130|P7|Overall Study|Lost to Follow-up|2
5522781|NCT01464827|19092131|P6|Overall Study|Lost to Follow-up|1
5522782|NCT01464827|19092132|P5|Overall Study|Lost to Follow-up|3
5522783|NCT01464827|19092133|P4|Overall Study|Lost to Follow-up|2
5522784|NCT01464827|19092134|P3|Overall Study|Lost to Follow-up|0
5522785|NCT01464827|19092135|P2|Overall Study|Lost to Follow-up|2
5522786|NCT01464827|19092136|P1|Overall Study|Lost to Follow-up|0
5522787|NCT01464827|19092123|P14|Overall Study|Withdrawal by Subject|0
5522788|NCT01464827|19092124|P13|Overall Study|Withdrawal by Subject|0
5522789|NCT01464827|19092125|P12|Overall Study|Withdrawal by Subject|0
5522790|NCT01464827|19092126|P11|Overall Study|Withdrawal by Subject|0
5522791|NCT01464827|19092127|P10|Overall Study|Withdrawal by Subject|0
5522792|NCT01464827|19092128|P9|Overall Study|Withdrawal by Subject|0
5522793|NCT01464827|19092129|P8|Overall Study|Withdrawal by Subject|1
5522794|NCT01464827|19092130|P7|Overall Study|Withdrawal by Subject|0
5522795|NCT01464827|19092131|P6|Overall Study|Withdrawal by Subject|0
5522796|NCT01464827|19092132|P5|Overall Study|Withdrawal by Subject|1
5522797|NCT01464827|19092133|P4|Overall Study|Withdrawal by Subject|0
5522798|NCT01464827|19092134|P3|Overall Study|Withdrawal by Subject|0
5522799|NCT01464827|19092135|P2|Overall Study|Withdrawal by Subject|0
5522800|NCT01464827|19092136|P1|Overall Study|Withdrawal by Subject|1
5522801|NCT01464827|19092123|P14|Overall Study|Adverse Event|0
5522802|NCT01464827|19092124|P13|Overall Study|Adverse Event|1
5522803|NCT01464827|19092125|P12|Overall Study|Adverse Event|0
5522804|NCT01464827|19092126|P11|Overall Study|Adverse Event|0
5522805|NCT01464827|19092127|P10|Overall Study|Adverse Event|0
5522806|NCT01464827|19092128|P9|Overall Study|Adverse Event|0
5522807|NCT01464827|19092129|P8|Overall Study|Adverse Event|0
5522808|NCT01464827|19092130|P7|Overall Study|Adverse Event|0
5522809|NCT01464827|19092131|P6|Overall Study|Adverse Event|0
5522810|NCT01464827|19092132|P5|Overall Study|Adverse Event|0
5522811|NCT01464827|19092133|P4|Overall Study|Adverse Event|0
5522812|NCT01464827|19092134|P3|Overall Study|Adverse Event|0
5522813|NCT01464827|19092135|P2|Overall Study|Adverse Event|0
5522814|NCT01464827|19092136|P1|Overall Study|Adverse Event|0
5522815|NCT01464788|19092183|P3|Overall Study|Patient had hemorrhage after tPA started|0
5522816|NCT01464788|19092184|P2|Overall Study|Patient had hemorrhage after tPA started|1
5522817|NCT01464788|19092185|P1|Overall Study|Patient had hemorrhage after tPA started|0
5522818|NCT01464788|19092183|P3|Overall Study|Lost to Follow-up|0
5522819|NCT01464788|19092184|P2|Overall Study|Lost to Follow-up|1
5522820|NCT01464788|19092185|P1|Overall Study|Lost to Follow-up|0
5522821|NCT01464619|19092271|P2|Overall Study|Lost to Follow-up|4
5522822|NCT01464619|19092272|P1|Overall Study|Lost to Follow-up|3
5522823|NCT01464424|19092292|P2|Period 1, First 6 Weeks|Adverse Event|1
5522824|NCT01464424|19092293|P1|Period 1, First 6 Weeks|Adverse Event|0
5522825|NCT01464346|19092313|P3|Overall Study|Withdrawal by Subject|1
5522826|NCT01464346|19092314|P2|Overall Study|Withdrawal by Subject|0
5522827|NCT01464346|19092315|P1|Overall Study|Withdrawal by Subject|0
5522828|NCT01464333|19092324|P1|Overall Study|No Hospital Visit|42
5522829|NCT01464333|19092324|P1|Overall Study|Other|4
5522830|NCT01464333|19092324|P1|Overall Study|Withdrawal by Subject|11
5522831|NCT01464333|19092324|P1|Overall Study|Lack of Efficacy|72
5522832|NCT01464333|19092324|P1|Overall Study|Adverse Event|34
5522833|NCT01464307|19092337|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
5522834|NCT01464307|19092338|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
5522835|NCT01464307|19092337|P2|Open-Label Extension Period|Non-compliance|0
5522836|NCT01464307|19092338|P1|Open-Label Extension Period|Non-compliance|9
5522837|NCT01464307|19092337|P2|Open-Label Extension Period|Lost to Follow-up|0
5522838|NCT01464307|19092338|P1|Open-Label Extension Period|Lost to Follow-up|1
5522839|NCT01464307|19092337|P2|Open-Label Extension Period|Death|0
5522840|NCT01464307|19092338|P1|Open-Label Extension Period|Death|1
5522841|NCT01464307|19092337|P2|Open-Label Extension Period|Lack of Efficacy|0
5522842|NCT01464307|19092338|P1|Open-Label Extension Period|Lack of Efficacy|5
5522843|NCT01464307|19092337|P2|Open-Label Extension Period|Withdrawal by Subject|0
5522844|NCT01464307|19092338|P1|Open-Label Extension Period|Withdrawal by Subject|14
5522845|NCT01464307|19092337|P2|Open-Label Extension Period|Adverse Event|0
5522846|NCT01464307|19092338|P1|Open-Label Extension Period|Adverse Event|15
5522847|NCT01464307|19092337|P2|Main Period|Predefined discontinuation criteria|1
5522848|NCT01464307|19092338|P1|Main Period|Predefined discontinuation criteria|2
5522849|NCT01464307|19092337|P2|Main Period|Withdrawal by Subject|2
5522850|NCT01464307|19092338|P1|Main Period|Withdrawal by Subject|5
5522851|NCT01464307|19092337|P2|Main Period|Lack of Efficacy|0
5522852|NCT01464307|19092338|P1|Main Period|Lack of Efficacy|2
5522853|NCT01464307|19092337|P2|Main Period|Adverse Event|1
5522854|NCT01464307|19092338|P1|Main Period|Adverse Event|6
5522855|NCT01464307|19092337|P2|Main Period|Death|1
5522856|NCT01464307|19092338|P1|Main Period|Death|0
5522857|NCT01464255|19092353|P2|Overall Study|unresolve corneal staining|1
5522858|NCT01464255|19092354|P1|Overall Study|unresolve corneal staining|0
5522859|NCT01464021|19092399|P1|Overall Study|various|11
5522860|NCT01464021|19092399|P1|Overall Study|Lack of Efficacy|1
5522861|NCT01464021|19092399|P1|Overall Study|Lost to Follow-up|1
5522862|NCT01464021|19092399|P1|Overall Study|Withdrawal by Subject|13
5522863|NCT01463982|19092415|P4|Overall Study|Treatment delay over 5 week|0
5522864|NCT01463982|19092416|P3|Overall Study|Treatment delay over 5 week|1
5522865|NCT01463982|19092417|P2|Overall Study|Treatment delay over 5 week|0
5522866|NCT01463982|19092418|P1|Overall Study|Treatment delay over 5 week|0
5522867|NCT01463982|19092415|P4|Overall Study|Withdrawal by Subject|0
5522868|NCT01463982|19092416|P3|Overall Study|Withdrawal by Subject|1
5522869|NCT01463982|19092417|P2|Overall Study|Withdrawal by Subject|1
5522870|NCT01463982|19092418|P1|Overall Study|Withdrawal by Subject|0
5522871|NCT01463878|19092434|P2|Overall Study|no longer met criteria for tube feed|2
5522872|NCT01463878|19092435|P1|Overall Study|no longer met criteria for tube feed|2
5522873|NCT01463696|19092449|P8|Overall Study|Not Treated|0
5522874|NCT01463696|19092450|P7|Overall Study|Not Treated|1
5522875|NCT01463696|19092451|P6|Overall Study|Not Treated|0
5522876|NCT01463696|19092452|P5|Overall Study|Not Treated|0
5522877|NCT01463696|19092453|P4|Overall Study|Not Treated|0
5522878|NCT01463696|19092454|P3|Overall Study|Not Treated|0
5522879|NCT01463696|19092455|P2|Overall Study|Not Treated|0
5522880|NCT01463696|19092456|P1|Overall Study|Not Treated|0
5522881|NCT01463696|19092449|P8|Overall Study|Withdrawal by Subject|0
5522882|NCT01463696|19092450|P7|Overall Study|Withdrawal by Subject|2
5522883|NCT01463696|19092451|P6|Overall Study|Withdrawal by Subject|1
5522884|NCT01463696|19092452|P5|Overall Study|Withdrawal by Subject|1
5522885|NCT01463696|19092453|P4|Overall Study|Withdrawal by Subject|1
5522886|NCT01463696|19092454|P3|Overall Study|Withdrawal by Subject|0
5522887|NCT01463696|19092455|P2|Overall Study|Withdrawal by Subject|0
5522888|NCT01463696|19092456|P1|Overall Study|Withdrawal by Subject|0
5522889|NCT01463696|19092449|P8|Overall Study|Progressive Disease|2
5522890|NCT01463696|19092450|P7|Overall Study|Progressive Disease|4
5522891|NCT01463696|19092451|P6|Overall Study|Progressive Disease|1
5522892|NCT01463696|19092452|P5|Overall Study|Progressive Disease|0
5522893|NCT01463696|19092453|P4|Overall Study|Progressive Disease|1
5522894|NCT01463696|19092454|P3|Overall Study|Progressive Disease|0
5522895|NCT01463696|19092455|P2|Overall Study|Progressive Disease|1
5522896|NCT01463696|19092456|P1|Overall Study|Progressive Disease|0
5522897|NCT01463696|19092449|P8|Overall Study|Lost to Follow-up|0
5522898|NCT01463696|19092450|P7|Overall Study|Lost to Follow-up|0
5522899|NCT01463696|19092451|P6|Overall Study|Lost to Follow-up|0
5522900|NCT01463696|19092452|P5|Overall Study|Lost to Follow-up|0
5522901|NCT01463696|19092453|P4|Overall Study|Lost to Follow-up|0
5522902|NCT01463696|19092454|P3|Overall Study|Lost to Follow-up|1
5522903|NCT01463696|19092455|P2|Overall Study|Lost to Follow-up|0
5522904|NCT01463696|19092456|P1|Overall Study|Lost to Follow-up|0
5522905|NCT01463696|19092449|P8|Overall Study|Adverse Event|2
5522906|NCT01463696|19092450|P7|Overall Study|Adverse Event|3
5522907|NCT01463696|19092451|P6|Overall Study|Adverse Event|1
5522908|NCT01463696|19092452|P5|Overall Study|Adverse Event|0
5522909|NCT01463696|19092453|P4|Overall Study|Adverse Event|2
5522910|NCT01463696|19092454|P3|Overall Study|Adverse Event|0
5522911|NCT01463696|19092455|P2|Overall Study|Adverse Event|1
5522912|NCT01463696|19092456|P1|Overall Study|Adverse Event|0
5522913|NCT01463683|19092509|P3|Overall Study|Withdrawal by Subject|2
5522914|NCT01463683|19092510|P2|Overall Study|Withdrawal by Subject|17
5522915|NCT01463683|19092511|P1|Overall Study|Withdrawal by Subject|5
5522916|NCT01463683|19092509|P3|Overall Study|Pregnancy|1
5522917|NCT01463683|19092510|P2|Overall Study|Pregnancy|2
5522918|NCT01463683|19092511|P1|Overall Study|Pregnancy|2
5522919|NCT01463683|19092509|P3|Overall Study|Physician Decision|1
5522920|NCT01463683|19092510|P2|Overall Study|Physician Decision|3
5522921|NCT01463683|19092511|P1|Overall Study|Physician Decision|0
5522922|NCT01463683|19092509|P3|Overall Study|Lost to Follow-up|7
5522923|NCT01463683|19092510|P2|Overall Study|Lost to Follow-up|9
5522924|NCT01463683|19092511|P1|Overall Study|Lost to Follow-up|10
5522925|NCT01463683|19092509|P3|Overall Study|Adverse Event|0
5522926|NCT01463683|19092510|P2|Overall Study|Adverse Event|0
5522927|NCT01463683|19092511|P1|Overall Study|Adverse Event|2
5522928|NCT01463631|19092528|P4|Overall Study|Progressive Disease|5
5522929|NCT01463631|19092529|P3|Overall Study|Progressive Disease|0
5522930|NCT01463631|19092530|P2|Overall Study|Progressive Disease|0
5522931|NCT01463631|19092531|P1|Overall Study|Progressive Disease|0
5522932|NCT01463631|19092528|P4|Overall Study|Death|0
5522933|NCT01463631|19092529|P3|Overall Study|Death|1
5522934|NCT01463631|19092530|P2|Overall Study|Death|0
5522935|NCT01463631|19092531|P1|Overall Study|Death|0
5522936|NCT01463631|19092528|P4|Overall Study|Withdrawal by Subject|1
5522937|NCT01463631|19092529|P3|Overall Study|Withdrawal by Subject|0
5522938|NCT01463631|19092530|P2|Overall Study|Withdrawal by Subject|0
5522939|NCT01463631|19092531|P1|Overall Study|Withdrawal by Subject|0
5522940|NCT01463527|19092553|P2|Overall Study|Crying >20% of sedation|6
5522941|NCT01463527|19092554|P1|Overall Study|Crying >20% of sedation|5
5522942|NCT01463527|19092553|P2|Overall Study|Protocol Violation|1
5522943|NCT01463527|19092554|P1|Overall Study|Protocol Violation|1
5522944|NCT01463306|19092577|P3|Overall Study|Approval expiry at site|0
5522945|NCT01463306|19092578|P2|Overall Study|Approval expiry at site|0
5522946|NCT01463306|19092579|P1|Overall Study|Approval expiry at site|1
5522947|NCT01463306|19092577|P3|Overall Study|Other|0
5522948|NCT01463306|19092578|P2|Overall Study|Other|13
5522949|NCT01463306|19092579|P1|Overall Study|Other|26
5522950|NCT01463306|19092577|P3|Overall Study|Withdrawal by Subject|1
5522951|NCT01463306|19092578|P2|Overall Study|Withdrawal by Subject|9
5522952|NCT01463306|19092579|P1|Overall Study|Withdrawal by Subject|19
5522953|NCT01463306|19092577|P3|Overall Study|Protocol Violation|0
5522954|NCT01463306|19092578|P2|Overall Study|Protocol Violation|0
5522955|NCT01463306|19092579|P1|Overall Study|Protocol Violation|4
5522956|NCT01463306|19092577|P3|Overall Study|Lost to Follow-up|0
5522957|NCT01463306|19092578|P2|Overall Study|Lost to Follow-up|2
5522958|NCT01463306|19092579|P1|Overall Study|Lost to Follow-up|5
5522959|NCT01463306|19092577|P3|Overall Study|Lack of Efficacy|1
5522960|NCT01463306|19092578|P2|Overall Study|Lack of Efficacy|16
5522961|NCT01463306|19092579|P1|Overall Study|Lack of Efficacy|22
5522962|NCT01463306|19092577|P3|Overall Study|Death|0
5522963|NCT01463306|19092578|P2|Overall Study|Death|3
5522964|NCT01463306|19092579|P1|Overall Study|Death|3
5522965|NCT01463306|19092577|P3|Overall Study|Adverse Event|3
5522966|NCT01463306|19092578|P2|Overall Study|Adverse Event|9
5522967|NCT01463306|19092579|P1|Overall Study|Adverse Event|6
5522968|NCT01463293|19092650|P3|Overall Study|Other|2
5522969|NCT01463293|19092651|P2|Overall Study|Other|0
5522970|NCT01463293|19092652|P1|Overall Study|Other|0
5522971|NCT01463293|19092650|P3|Overall Study|Withdrawal by Subject|5
5522972|NCT01463293|19092651|P2|Overall Study|Withdrawal by Subject|10
5522973|NCT01463293|19092652|P1|Overall Study|Withdrawal by Subject|4
5522974|NCT01463293|19092650|P3|Overall Study|Adverse Event|0
5522975|NCT01463293|19092651|P2|Overall Study|Adverse Event|2
5522976|NCT01463293|19092652|P1|Overall Study|Adverse Event|1
5522977|NCT01463293|19092650|P3|Overall Study|Lost to Follow-up|5
5522978|NCT01463293|19092651|P2|Overall Study|Lost to Follow-up|4
5522979|NCT01463293|19092652|P1|Overall Study|Lost to Follow-up|1
5522980|NCT01463111|19092696|P1|Overall Study|Physician Decision|2
5522981|NCT01463111|19092696|P1|Overall Study|Lost to Follow-up|5
5522982|NCT01463111|19092696|P1|Overall Study|Withdrawal by Subject|2
5522983|NCT01463098|19092718|P14|Part B (11 Days)|Participant Choice|0
5522984|NCT01463098|19092719|P13|Part B (11 Days)|Participant Choice|0
5522985|NCT01463098|19092720|P12|Part B (11 Days)|Participant Choice|1
5522986|NCT01463098|19092721|P11|Part B (11 Days)|Participant Choice|0
5522987|NCT01463098|19092722|P10|Part B (11 Days)|Participant Choice|0
5522988|NCT01463098|19092723|P9|Part B (11 Days)|Participant Choice|0
5522989|NCT01463098|19092724|P8|Part B (11 Days)|Participant Choice|0
5522990|NCT01463098|19092725|P7|Part B (11 Days)|Participant Choice|0
5522991|NCT01463098|19092726|P6|Part B (11 Days)|Participant Choice|0
5522992|NCT01463098|19092727|P5|Part B (11 Days)|Participant Choice|0
5522993|NCT01463098|19092728|P4|Part B (11 Days)|Participant Choice|0
5522994|NCT01463098|19092729|P3|Part B (11 Days)|Participant Choice|0
5522995|NCT01463098|19092730|P2|Part B (11 Days)|Participant Choice|0
5522996|NCT01463098|19092731|P1|Part B (11 Days)|Participant Choice|0
5522997|NCT01463098|19092718|P14|Part A (11 Days)|Lost to Follow-up|0
5522998|NCT01463098|19092719|P13|Part A (11 Days)|Lost to Follow-up|0
5522999|NCT01463098|19092720|P12|Part A (11 Days)|Lost to Follow-up|0
5523000|NCT01463098|19092721|P11|Part A (11 Days)|Lost to Follow-up|0
5523001|NCT01463098|19092722|P10|Part A (11 Days)|Lost to Follow-up|0
5523002|NCT01463098|19092723|P9|Part A (11 Days)|Lost to Follow-up|0
5523003|NCT01463098|19092724|P8|Part A (11 Days)|Lost to Follow-up|0
5523004|NCT01463098|19092725|P7|Part A (11 Days)|Lost to Follow-up|0
5523005|NCT01463098|19092726|P6|Part A (11 Days)|Lost to Follow-up|0
5523006|NCT01463098|19092727|P5|Part A (11 Days)|Lost to Follow-up|1
5523007|NCT01463098|19092728|P4|Part A (11 Days)|Lost to Follow-up|0
5523008|NCT01463098|19092729|P3|Part A (11 Days)|Lost to Follow-up|0
5523009|NCT01463098|19092730|P2|Part A (11 Days)|Lost to Follow-up|0
5523010|NCT01463098|19092731|P1|Part A (11 Days)|Lost to Follow-up|0
5523011|NCT01463098|19092718|P14|Part A (11 Days)|Participant Choice|0
5523012|NCT01463098|19092719|P13|Part A (11 Days)|Participant Choice|0
5523013|NCT01463098|19092720|P12|Part A (11 Days)|Participant Choice|0
5523014|NCT01463098|19092721|P11|Part A (11 Days)|Participant Choice|0
5523015|NCT01463098|19092722|P10|Part A (11 Days)|Participant Choice|0
5523016|NCT01463098|19092723|P9|Part A (11 Days)|Participant Choice|1
5523017|NCT01463098|19092724|P8|Part A (11 Days)|Participant Choice|0
5523018|NCT01463098|19092725|P7|Part A (11 Days)|Participant Choice|0
5523019|NCT01463098|19092726|P6|Part A (11 Days)|Participant Choice|0
5523020|NCT01463098|19092727|P5|Part A (11 Days)|Participant Choice|0
5523021|NCT01463098|19092728|P4|Part A (11 Days)|Participant Choice|0
5523022|NCT01463098|19092729|P3|Part A (11 Days)|Participant Choice|0
5523023|NCT01463098|19092730|P2|Part A (11 Days)|Participant Choice|0
5523024|NCT01463098|19092731|P1|Part A (11 Days)|Participant Choice|2
5523025|NCT01463033|19093054|P2|Overall Study|Death|2
5523026|NCT01463033|19093055|P1|Overall Study|Death|3
5523027|NCT01463033|19093054|P2|Overall Study|Lost to Follow-up|4
5523028|NCT01463033|19093055|P1|Overall Study|Lost to Follow-up|4
5523029|NCT01463007|19093062|P1|Overall Study|Physician Decision|1
5523030|NCT01462942|19093073|P5|Overall Study|Protocol Violation|6
5523031|NCT01462942|19093074|P4|Overall Study|Protocol Violation|9
5523032|NCT01462942|19093075|P3|Overall Study|Protocol Violation|9
5523033|NCT01462942|19093076|P2|Overall Study|Protocol Violation|6
5523034|NCT01462942|19093077|P1|Overall Study|Protocol Violation|4
5523035|NCT01462942|19093073|P5|Overall Study|Lost to Follow-up|1
5523036|NCT01462942|19093074|P4|Overall Study|Lost to Follow-up|1
5523037|NCT01462942|19093075|P3|Overall Study|Lost to Follow-up|1
5523038|NCT01462942|19093076|P2|Overall Study|Lost to Follow-up|1
5523039|NCT01462942|19093077|P1|Overall Study|Lost to Follow-up|0
5523040|NCT01462942|19093073|P5|Overall Study|Lack of Efficacy|3
5523041|NCT01462942|19093074|P4|Overall Study|Lack of Efficacy|5
5523042|NCT01462942|19093075|P3|Overall Study|Lack of Efficacy|4
5523043|NCT01462942|19093076|P2|Overall Study|Lack of Efficacy|0
5523044|NCT01462942|19093077|P1|Overall Study|Lack of Efficacy|6
5523045|NCT01462942|19093073|P5|Overall Study|Withdrawal by Subject|19
5523046|NCT01462942|19093074|P4|Overall Study|Withdrawal by Subject|16
5523047|NCT01462942|19093075|P3|Overall Study|Withdrawal by Subject|14
5523048|NCT01462942|19093076|P2|Overall Study|Withdrawal by Subject|10
5523049|NCT01462942|19093077|P1|Overall Study|Withdrawal by Subject|14
5523050|NCT01462942|19093073|P5|Overall Study|Other, including COPD exacerbation|5
5523051|NCT01462942|19093074|P4|Overall Study|Other, including COPD exacerbation|8
5523052|NCT01462942|19093075|P3|Overall Study|Other, including COPD exacerbation|2
5523053|NCT01462942|19093076|P2|Overall Study|Other, including COPD exacerbation|5
5523054|NCT01462942|19093077|P1|Overall Study|Other, including COPD exacerbation|3
5523055|NCT01462942|19093073|P5|Overall Study|Adverse Event|11
5523056|NCT01462942|19093074|P4|Overall Study|Adverse Event|11
5523057|NCT01462942|19093075|P3|Overall Study|Adverse Event|10
5523058|NCT01462942|19093076|P2|Overall Study|Adverse Event|12
5523059|NCT01462942|19093077|P1|Overall Study|Adverse Event|7
5523060|NCT01462929|19093107|P3|Overall Study|Lack of Efficacy|1
5523061|NCT01462929|19093108|P2|Overall Study|Lack of Efficacy|0
5523062|NCT01462929|19093109|P1|Overall Study|Lack of Efficacy|0
5523063|NCT01462929|19093107|P3|Overall Study|Withdrawal by Subject|0
5523064|NCT01462929|19093108|P2|Overall Study|Withdrawal by Subject|1
5523065|NCT01462929|19093109|P1|Overall Study|Withdrawal by Subject|2
5523066|NCT01462929|19093107|P3|Overall Study|Adverse Event|4
5523067|NCT01462929|19093108|P2|Overall Study|Adverse Event|3
5523068|NCT01462929|19093109|P1|Overall Study|Adverse Event|3
5523069|NCT01462695|19093150|P2|Overall Study|Inevaluable (did not receive study drug)|0
5523070|NCT01462695|19093151|P1|Overall Study|Inevaluable (did not receive study drug)|1
5523071|NCT01462695|19093150|P2|Overall Study|Withdrawal by Subject|0
5523072|NCT01462695|19093151|P1|Overall Study|Withdrawal by Subject|2
5523073|NCT01462695|19093150|P2|Overall Study|Physician Decision|0
5523074|NCT01462695|19093151|P1|Overall Study|Physician Decision|5
5523075|NCT01462695|19093150|P2|Overall Study|Lack of Efficacy|12
5523076|NCT01462695|19093151|P1|Overall Study|Lack of Efficacy|6
5523077|NCT01462695|19093150|P2|Overall Study|Death|0
5523078|NCT01462695|19093151|P1|Overall Study|Death|2
5523079|NCT01462695|19093150|P2|Overall Study|Adverse Event|1
5523080|NCT01462695|19093151|P1|Overall Study|Adverse Event|1
5523081|NCT01462435|19093179|P4|Overall Study|Lost to Follow-up|1
5523082|NCT01462435|19093180|P3|Overall Study|Lost to Follow-up|0
5523083|NCT01462435|19093181|P2|Overall Study|Lost to Follow-up|0
5523084|NCT01462435|19093182|P1|Overall Study|Lost to Follow-up|0
5523085|NCT01462435|19093179|P4|Overall Study|Withdrawal by Subject|1
5523086|NCT01462435|19093180|P3|Overall Study|Withdrawal by Subject|0
5523087|NCT01462435|19093181|P2|Overall Study|Withdrawal by Subject|0
5523088|NCT01462435|19093182|P1|Overall Study|Withdrawal by Subject|0
5523089|NCT01462435|19093179|P4|Overall Study|Physician Decision|0
5523090|NCT01462435|19093180|P3|Overall Study|Physician Decision|1
5523091|NCT01462435|19093181|P2|Overall Study|Physician Decision|0
5523092|NCT01462435|19093182|P1|Overall Study|Physician Decision|0
5523093|NCT01462435|19093179|P4|Overall Study|Lack of Efficacy|3
5523094|NCT01462435|19093180|P3|Overall Study|Lack of Efficacy|0
5523095|NCT01462435|19093181|P2|Overall Study|Lack of Efficacy|0
5523096|NCT01462435|19093182|P1|Overall Study|Lack of Efficacy|1
5523097|NCT01462370|19093220|P2|Overall Study|Withdrawal by Subject|3
5523098|NCT01462370|19093221|P1|Overall Study|Withdrawal by Subject|0
5523099|NCT01462370|19093220|P2|Overall Study|Physician Decision|1
5523100|NCT01462370|19093221|P1|Overall Study|Physician Decision|0
5523101|NCT01462370|19093220|P2|Overall Study|Lack of Qualifying Event|1
5523102|NCT01462370|19093221|P1|Overall Study|Lack of Qualifying Event|1
5523103|NCT01462357|19093256|P3|Overall Study|Lost to Follow-up|7
5523104|NCT01462357|19093257|P2|Overall Study|Lost to Follow-up|5
5523105|NCT01462357|19093258|P1|Overall Study|Lost to Follow-up|3
5523106|NCT01462357|19093256|P3|Overall Study|Migrated/moved from study area|1
5523107|NCT01462357|19093257|P2|Overall Study|Migrated/moved from study area|3
5523108|NCT01462357|19093258|P1|Overall Study|Migrated/moved from study area|2
5523109|NCT01462357|19093256|P3|Overall Study|Withdrawal by Subject|3
5523110|NCT01462357|19093257|P2|Overall Study|Withdrawal by Subject|11
5523111|NCT01462357|19093258|P1|Overall Study|Withdrawal by Subject|3
5523112|NCT01462357|19093256|P3|Overall Study|Death|1
5523113|NCT01462357|19093257|P2|Overall Study|Death|0
5523114|NCT01462357|19093258|P1|Overall Study|Death|0
5523115|NCT01462344|19093331|P2|Overall Study|Lost to Follow-up|7
5523116|NCT01462344|19093332|P1|Overall Study|Lost to Follow-up|7
5523117|NCT01462344|19093331|P2|Overall Study|Protocol Violation|53
5523118|NCT01462344|19093332|P1|Overall Study|Protocol Violation|68
5523119|NCT01462344|19093331|P2|Overall Study|Lack of Efficacy|6
5523120|NCT01462344|19093332|P1|Overall Study|Lack of Efficacy|5
5523121|NCT01462344|19093331|P2|Overall Study|Asthma Exacerbation|35
5523122|NCT01462344|19093332|P1|Overall Study|Asthma Exacerbation|34
5523123|NCT01462344|19093331|P2|Overall Study|Adverse Event|23
5523124|NCT01462344|19093332|P1|Overall Study|Adverse Event|24
5523125|NCT01462344|19093331|P2|Overall Study|Withdrawal by Subject|226
5523126|NCT01462344|19093332|P1|Overall Study|Withdrawal by Subject|245
5523127|NCT01462318|19093354|P3|Extension Phase|Adverse Event|22
5523128|NCT01462318|19093355|P2|Extension Phase|Adverse Event|0
5523129|NCT01462318|19093356|P1|Extension Phase|Adverse Event|0
5523130|NCT01462318|19093354|P3|Extension Phase|Investigator Decision|5
5523131|NCT01462318|19093355|P2|Extension Phase|Investigator Decision|0
5523132|NCT01462318|19093356|P1|Extension Phase|Investigator Decision|0
5523133|NCT01462318|19093354|P3|Extension Phase|Withdrawal by Subject|15
5523134|NCT01462318|19093355|P2|Extension Phase|Withdrawal by Subject|0
5523135|NCT01462318|19093356|P1|Extension Phase|Withdrawal by Subject|0
5523136|NCT01462318|19093354|P3|Extension Phase|Disease Progression|1
5523137|NCT01462318|19093355|P2|Extension Phase|Disease Progression|0
5523138|NCT01462318|19093356|P1|Extension Phase|Disease Progression|0
5523139|NCT01462318|19093354|P3|Extension Phase|Other|1
5523140|NCT01462318|19093355|P2|Extension Phase|Other|0
5523141|NCT01462318|19093356|P1|Extension Phase|Other|0
5523142|NCT01462318|19093354|P3|Extension Phase|Lost to Follow-up|1
5523143|NCT01462318|19093355|P2|Extension Phase|Lost to Follow-up|0
5523144|NCT01462318|19093356|P1|Extension Phase|Lost to Follow-up|0
5523145|NCT01462318|19093354|P3|Main Study / TP-DI Study|Adverse Event|0
5523146|NCT01462318|19093355|P2|Main Study / TP-DI Study|Adverse Event|0
5523147|NCT01462318|19093356|P1|Main Study / TP-DI Study|Adverse Event|4
5523148|NCT01462318|19093354|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
5523149|NCT01462318|19093355|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
5523150|NCT01462318|19093356|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
5523151|NCT01462318|19093354|P3|Main Study / TP-DI Study|Other|0
5523152|NCT01462318|19093355|P2|Main Study / TP-DI Study|Other|0
5523153|NCT01462318|19093356|P1|Main Study / TP-DI Study|Other|2
5523154|NCT01462266|19093457|P2|Overall Study|Screen failure|1
5523155|NCT01462266|19093458|P1|Overall Study|Screen failure|1
5523156|NCT01462266|19093457|P2|Overall Study|Withdrawal by Subject|2
5523157|NCT01462266|19093458|P1|Overall Study|Withdrawal by Subject|7
5523158|NCT01462266|19093457|P2|Overall Study|Protocol Violation|3
5523159|NCT01462266|19093458|P1|Overall Study|Protocol Violation|1
5523160|NCT01462266|19093457|P2|Overall Study|Physician Decision|5
5523161|NCT01462266|19093458|P1|Overall Study|Physician Decision|2
5523162|NCT01462266|19093457|P2|Overall Study|Creatinine and eGFR, excluded medication|4
5523163|NCT01462266|19093458|P1|Overall Study|Creatinine and eGFR, excluded medication|8
5523164|NCT01462266|19093457|P2|Overall Study|Non-compliance with study drug|0
5523165|NCT01462266|19093458|P1|Overall Study|Non-compliance with study drug|3
5523166|NCT01462266|19093457|P2|Overall Study|Lost to Follow-up|3
5523167|NCT01462266|19093458|P1|Overall Study|Lost to Follow-up|4
5523168|NCT01462266|19093457|P2|Overall Study|Lack of Efficacy|2
5523169|NCT01462266|19093458|P1|Overall Study|Lack of Efficacy|0
5523170|NCT01462266|19093457|P2|Overall Study|Death|1
5523171|NCT01462266|19093458|P1|Overall Study|Death|2
5523172|NCT01462266|19093457|P2|Overall Study|Adverse Event|6
5523173|NCT01462266|19093458|P1|Overall Study|Adverse Event|7
5523174|NCT01462227|19093483|P4|Second Assignment|Protocol Violation|0
5523175|NCT01462227|19093484|P3|Second Assignment|Protocol Violation|1
5523176|NCT01462227|19093485|P2|Second Assignment|Protocol Violation|1
5523177|NCT01462227|19093486|P1|Second Assignment|Protocol Violation|0
5523178|NCT01462227|19093483|P4|Second Assignment|Lost to Follow-up|0
5523179|NCT01462227|19093484|P3|Second Assignment|Lost to Follow-up|0
5523180|NCT01462227|19093485|P2|Second Assignment|Lost to Follow-up|0
5523181|NCT01462227|19093486|P1|Second Assignment|Lost to Follow-up|1
5523182|NCT01462162|19093504|P1|Overall Study|Other|2
5523183|NCT01462162|19093504|P1|Overall Study|Abnormal laboratory parameters|1
5523184|NCT01462162|19093504|P1|Overall Study|Lack of Efficacy|4
5523185|NCT01462162|19093504|P1|Overall Study|Adverse Event|5
5523186|NCT01462110|19093531|P2|Overall Study|Adverse Event|0
5523187|NCT01462110|19093532|P1|Overall Study|Adverse Event|1
5523188|NCT01462084|19093552|P2|Overall Study|Protocol Violation|1
5523189|NCT01462084|19093553|P1|Overall Study|Protocol Violation|1
5523190|NCT01462084|19093552|P2|Overall Study|Withdrawal by Subject|0
5523191|NCT01462084|19093553|P1|Overall Study|Withdrawal by Subject|1
5523192|NCT01462045|19093564|P3|Overall Study|Family matter|0
5523193|NCT01462045|19093565|P2|Overall Study|Family matter|1
5523194|NCT01462045|19093566|P1|Overall Study|Family matter|0
5523195|NCT01461993|19093580|P3|Overall Study|Other|6
5523196|NCT01461993|19093581|P2|Overall Study|Other|15
5523197|NCT01461993|19093582|P1|Overall Study|Other|13
5523198|NCT01461993|19093580|P3|Overall Study|Did not meet entrance criteria|0
5523199|NCT01461993|19093581|P2|Overall Study|Did not meet entrance criteria|3
5523200|NCT01461993|19093582|P1|Overall Study|Did not meet entrance criteria|2
5523201|NCT01461993|19093580|P3|Overall Study|No longer met eligibility criteria|10
5523202|NCT01461993|19093581|P2|Overall Study|No longer met eligibility criteria|18
5523203|NCT01461993|19093582|P1|Overall Study|No longer met eligibility criteria|13
5523204|NCT01461993|19093580|P3|Overall Study|Adverse Event|3
5523205|NCT01461993|19093581|P2|Overall Study|Adverse Event|11
5523206|NCT01461993|19093582|P1|Overall Study|Adverse Event|9
5523207|NCT01461993|19093580|P3|Overall Study|Protocol Violation|7
5523208|NCT01461993|19093581|P2|Overall Study|Protocol Violation|9
5523209|NCT01461993|19093582|P1|Overall Study|Protocol Violation|10
5523210|NCT01461993|19093580|P3|Overall Study|Lost to Follow-up|22
5523211|NCT01461993|19093581|P2|Overall Study|Lost to Follow-up|48
5523212|NCT01461993|19093582|P1|Overall Study|Lost to Follow-up|44
5523213|NCT01461993|19093580|P3|Overall Study|Withdrawal by Subject|16
5523214|NCT01461993|19093581|P2|Overall Study|Withdrawal by Subject|53
5523215|NCT01461993|19093582|P1|Overall Study|Withdrawal by Subject|60
5523216|NCT01461980|19093607|P3|Overall Study|Randomized but not vaccinated|7
5523217|NCT01461980|19093608|P2|Overall Study|Randomized but not vaccinated|8
5523218|NCT01461980|19093609|P1|Overall Study|Randomized but not vaccinated|4
5523219|NCT01461980|19093607|P3|Overall Study|No longer willing to participate|54
5523220|NCT01461980|19093608|P2|Overall Study|No longer willing to participate|38
5523221|NCT01461980|19093609|P1|Overall Study|No longer willing to participate|52
5523222|NCT01461980|19093607|P3|Overall Study|Lost to Follow-up|51
5523223|NCT01461980|19093608|P2|Overall Study|Lost to Follow-up|53
5523224|NCT01461980|19093609|P1|Overall Study|Lost to Follow-up|52
5523225|NCT01461980|19093607|P3|Overall Study|No longer meets eligibility criteria|19
5523226|NCT01461980|19093608|P2|Overall Study|No longer meets eligibility criteria|9
5523227|NCT01461980|19093609|P1|Overall Study|No longer meets eligibility criteria|18
5523228|NCT01461980|19093607|P3|Overall Study|Protocol Violation|16
5523229|NCT01461980|19093608|P2|Overall Study|Protocol Violation|19
5523230|NCT01461980|19093609|P1|Overall Study|Protocol Violation|12
5523231|NCT01461980|19093607|P3|Overall Study|Adverse Event|6
5523232|NCT01461980|19093608|P2|Overall Study|Adverse Event|5
5523233|NCT01461980|19093609|P1|Overall Study|Adverse Event|12
5523234|NCT01461980|19093607|P3|Overall Study|Medication error|6
5523235|NCT01461980|19093608|P2|Overall Study|Medication error|5
5523236|NCT01461980|19093609|P1|Overall Study|Medication error|7
5523237|NCT01461980|19093607|P3|Overall Study|Other|6
5523238|NCT01461980|19093608|P2|Overall Study|Other|8
5523239|NCT01461980|19093609|P1|Overall Study|Other|9
5523240|NCT01461928|19093639|P3|Maintenance II (15 Months)|Refused to be transferred to other site|1
5523241|NCT01461928|19093640|P2|Maintenance II (15 Months)|Refused to be transferred to other site|0
5523242|NCT01461928|19093641|P1|Maintenance II (15 Months)|Refused to be transferred to other site|0
5523243|NCT01461928|19093639|P3|Maintenance II (15 Months)|Withdrew informed consent|1
5523244|NCT01461928|19093640|P2|Maintenance II (15 Months)|Withdrew informed consent|0
5523245|NCT01461928|19093641|P1|Maintenance II (15 Months)|Withdrew informed consent|0
5523246|NCT01461928|19093639|P3|Maintenance II (15 Months)|Squamous lung carcinoma|1
5523247|NCT01461928|19093640|P2|Maintenance II (15 Months)|Squamous lung carcinoma|0
5523248|NCT01461928|19093641|P1|Maintenance II (15 Months)|Squamous lung carcinoma|0
5523249|NCT01461928|19093639|P3|Maintenance II (15 Months)|Changed physician in another hospital|1
5523250|NCT01461928|19093640|P2|Maintenance II (15 Months)|Changed physician in another hospital|0
5523251|NCT01461928|19093641|P1|Maintenance II (15 Months)|Changed physician in another hospital|0
5523252|NCT01461928|19093639|P3|Maintenance II (15 Months)|Withdrawal by Subject|8
5523253|NCT01461928|19093640|P2|Maintenance II (15 Months)|Withdrawal by Subject|9
5523254|NCT01461928|19093641|P1|Maintenance II (15 Months)|Withdrawal by Subject|0
5523255|NCT01461928|19093639|P3|Maintenance II (15 Months)|Disease progression|3
5523256|NCT01461928|19093640|P2|Maintenance II (15 Months)|Disease progression|0
5523257|NCT01461928|19093641|P1|Maintenance II (15 Months)|Disease progression|0
5523258|NCT01461928|19093639|P3|Maintenance II (15 Months)|Moved to another town|0
5523259|NCT01461928|19093640|P2|Maintenance II (15 Months)|Moved to another town|1
5523260|NCT01461928|19093641|P1|Maintenance II (15 Months)|Moved to another town|0
5523261|NCT01461928|19093639|P3|Maintenance II (15 Months)|Lost to Follow-up|0
5523262|NCT01461928|19093640|P2|Maintenance II (15 Months)|Lost to Follow-up|1
5523263|NCT01461928|19093641|P1|Maintenance II (15 Months)|Lost to Follow-up|0
5523264|NCT01461928|19093639|P3|Maintenance II (15 Months)|Physician Decision|4
5523265|NCT01461928|19093640|P2|Maintenance II (15 Months)|Physician Decision|0
5523266|NCT01461928|19093641|P1|Maintenance II (15 Months)|Physician Decision|0
5523267|NCT01461928|19093639|P3|Maintenance II (15 Months)|Death|8
5523268|NCT01461928|19093640|P2|Maintenance II (15 Months)|Death|10
5523269|NCT01461928|19093641|P1|Maintenance II (15 Months)|Death|0
5523270|NCT01461928|19093639|P3|Maintenance II (15 Months)|Adverse Event|0
5523271|NCT01461928|19093640|P2|Maintenance II (15 Months)|Adverse Event|2
5523272|NCT01461928|19093641|P1|Maintenance II (15 Months)|Adverse Event|0
5523273|NCT01461928|19093639|P3|Maintenance I (24 Months)|Did not meet criteria|0
5523274|NCT01461928|19093640|P2|Maintenance I (24 Months)|Did not meet criteria|0
5523275|NCT01461928|19093641|P1|Maintenance I (24 Months)|Did not meet criteria|5
5523276|NCT01461928|19093639|P3|Maintenance I (24 Months)|Not compliant|0
5523277|NCT01461928|19093640|P2|Maintenance I (24 Months)|Not compliant|0
5523278|NCT01461928|19093641|P1|Maintenance I (24 Months)|Not compliant|1
5523279|NCT01461928|19093639|P3|Maintenance I (24 Months)|Delay in rituximab administration|0
5523280|NCT01461928|19093640|P2|Maintenance I (24 Months)|Delay in rituximab administration|0
5523281|NCT01461928|19093641|P1|Maintenance I (24 Months)|Delay in rituximab administration|1
5523282|NCT01461928|19093639|P3|Maintenance I (24 Months)|Did not perform scheduled assessment|0
5523283|NCT01461928|19093640|P2|Maintenance I (24 Months)|Did not perform scheduled assessment|0
5523284|NCT01461928|19093641|P1|Maintenance I (24 Months)|Did not perform scheduled assessment|2
5523285|NCT01461928|19093639|P3|Maintenance I (24 Months)|Did not meet randomization criteria|0
5523286|NCT01461928|19093640|P2|Maintenance I (24 Months)|Did not meet randomization criteria|0
5523287|NCT01461928|19093641|P1|Maintenance I (24 Months)|Did not meet randomization criteria|2
5523288|NCT01461928|19093639|P3|Maintenance I (24 Months)|Physician Decision|0
5523289|NCT01461928|19093640|P2|Maintenance I (24 Months)|Physician Decision|0
5523290|NCT01461928|19093641|P1|Maintenance I (24 Months)|Physician Decision|9
5523291|NCT01461928|19093639|P3|Maintenance I (24 Months)|Adverse Event|0
5523292|NCT01461928|19093640|P2|Maintenance I (24 Months)|Adverse Event|0
5523293|NCT01461928|19093641|P1|Maintenance I (24 Months)|Adverse Event|70
5523294|NCT01461928|19093639|P3|Maintenance I (24 Months)|Diseases progression|0
5523295|NCT01461928|19093640|P2|Maintenance I (24 Months)|Diseases progression|0
5523296|NCT01461928|19093641|P1|Maintenance I (24 Months)|Diseases progression|91
5523297|NCT01461928|19093639|P3|Maintenance I (24 Months)|Lost to Follow-up|0
5523298|NCT01461928|19093640|P2|Maintenance I (24 Months)|Lost to Follow-up|0
5523299|NCT01461928|19093641|P1|Maintenance I (24 Months)|Lost to Follow-up|2
5523300|NCT01461928|19093639|P3|Maintenance I (24 Months)|Withdrawal by Subject|0
5523301|NCT01461928|19093640|P2|Maintenance I (24 Months)|Withdrawal by Subject|0
5523302|NCT01461928|19093641|P1|Maintenance I (24 Months)|Withdrawal by Subject|32
5523303|NCT01461928|19093639|P3|Maintenance I (24 Months)|Death|0
5523304|NCT01461928|19093640|P2|Maintenance I (24 Months)|Death|0
5523305|NCT01461928|19093641|P1|Maintenance I (24 Months)|Death|3
5523306|NCT01461928|19093639|P3|Induction (up to 8 Months)|Medical advisor request|0
5523307|NCT01461928|19093640|P2|Induction (up to 8 Months)|Medical advisor request|0
5523308|NCT01461928|19093641|P1|Induction (up to 8 Months)|Medical advisor request|1
5523309|NCT01461928|19093639|P3|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
5523310|NCT01461928|19093640|P2|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
5523311|NCT01461928|19093641|P1|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
5523312|NCT01461928|19093639|P3|Induction (up to 8 Months)|Promotor request|0
5523313|NCT01461928|19093640|P2|Induction (up to 8 Months)|Promotor request|0
5523314|NCT01461928|19093641|P1|Induction (up to 8 Months)|Promotor request|1
5523315|NCT01461928|19093639|P3|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
5523316|NCT01461928|19093640|P2|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
5523317|NCT01461928|19093641|P1|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
5523318|NCT01461928|19093639|P3|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
5523319|NCT01461928|19093640|P2|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
5523320|NCT01461928|19093641|P1|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
5523321|NCT01461928|19093639|P3|Induction (up to 8 Months)|Protocol deviation|0
5523322|NCT01461928|19093640|P2|Induction (up to 8 Months)|Protocol deviation|0
5523323|NCT01461928|19093641|P1|Induction (up to 8 Months)|Protocol deviation|2
5523324|NCT01461928|19093639|P3|Induction (up to 8 Months)|Sponsor decision|0
5523325|NCT01461928|19093640|P2|Induction (up to 8 Months)|Sponsor decision|0
5523326|NCT01461928|19093641|P1|Induction (up to 8 Months)|Sponsor decision|1
5523327|NCT01461928|19093639|P3|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
5523328|NCT01461928|19093640|P2|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
5523329|NCT01461928|19093641|P1|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
5523330|NCT01461928|19093639|P3|Induction (up to 8 Months)|Termination of study in Switzerland|0
5523331|NCT01461928|19093640|P2|Induction (up to 8 Months)|Termination of study in Switzerland|0
5523332|NCT01461928|19093641|P1|Induction (up to 8 Months)|Termination of study in Switzerland|1
5523333|NCT01461928|19093639|P3|Induction (up to 8 Months)|Not responding to treatment|0
5523334|NCT01461928|19093640|P2|Induction (up to 8 Months)|Not responding to treatment|0
5523335|NCT01461928|19093641|P1|Induction (up to 8 Months)|Not responding to treatment|11
5523336|NCT01461928|19093639|P3|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
5523337|NCT01461928|19093640|P2|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
5523338|NCT01461928|19093641|P1|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
5523339|NCT01461928|19093639|P3|Induction (up to 8 Months)|Eligibility criteria deviation|0
5523340|NCT01461928|19093640|P2|Induction (up to 8 Months)|Eligibility criteria deviation|0
5523341|NCT01461928|19093641|P1|Induction (up to 8 Months)|Eligibility criteria deviation|10
5523342|NCT01461928|19093639|P3|Induction (up to 8 Months)|Disease progression|0
5523343|NCT01461928|19093640|P2|Induction (up to 8 Months)|Disease progression|0
5523344|NCT01461928|19093641|P1|Induction (up to 8 Months)|Disease progression|45
5523345|NCT01461928|19093639|P3|Induction (up to 8 Months)|Withdrawal by Subject|0
5523346|NCT01461928|19093640|P2|Induction (up to 8 Months)|Withdrawal by Subject|0
5523347|NCT01461928|19093641|P1|Induction (up to 8 Months)|Withdrawal by Subject|18
5523348|NCT01461928|19093639|P3|Induction (up to 8 Months)|Physician Decision|0
5523349|NCT01461928|19093640|P2|Induction (up to 8 Months)|Physician Decision|0
5523350|NCT01461928|19093641|P1|Induction (up to 8 Months)|Physician Decision|9
5523351|NCT01461928|19093639|P3|Induction (up to 8 Months)|Lost to Follow-up|0
5523352|NCT01461928|19093640|P2|Induction (up to 8 Months)|Lost to Follow-up|0
5523353|NCT01461928|19093641|P1|Induction (up to 8 Months)|Lost to Follow-up|5
5523354|NCT01461928|19093639|P3|Induction (up to 8 Months)|Death|0
5523355|NCT01461928|19093640|P2|Induction (up to 8 Months)|Death|0
5523356|NCT01461928|19093641|P1|Induction (up to 8 Months)|Death|3
5523357|NCT01461928|19093639|P3|Induction (up to 8 Months)|Adverse Event|0
5523358|NCT01461928|19093640|P2|Induction (up to 8 Months)|Adverse Event|0
5523359|NCT01461928|19093641|P1|Induction (up to 8 Months)|Adverse Event|76
5523360|NCT01461811|19093692|P2|Overall Study|Noncompliance|1
5523361|NCT01461811|19093693|P1|Overall Study|Noncompliance|1
5523362|NCT01461811|19093692|P2|Overall Study|Subject decision unrelated to an AE|1
5523363|NCT01461811|19093693|P1|Overall Study|Subject decision unrelated to an AE|1
5523364|NCT01461811|19093692|P2|Overall Study|Adverse Event|1
5523365|NCT01461811|19093693|P1|Overall Study|Adverse Event|2
5523366|NCT01461707|19093732|P2|Overall Study|Withdrawal by Subject|0
5523367|NCT01461707|19093733|P1|Overall Study|Withdrawal by Subject|1
5523368|NCT01461551|19093770|P3|Overall Study|Physician Decision|2
5523369|NCT01461551|19093771|P2|Overall Study|Physician Decision|1
5523370|NCT01461551|19093772|P1|Overall Study|Physician Decision|2
5523371|NCT01461538|19093783|P3|Overall Study|Withdrawal by Subject|0
5523372|NCT01461538|19093784|P2|Overall Study|Withdrawal by Subject|1
5523373|NCT01461538|19093785|P1|Overall Study|Withdrawal by Subject|1
5523374|NCT01461538|19093783|P3|Overall Study|Study Stopped by Sponsor|0
5523375|NCT01461538|19093784|P2|Overall Study|Study Stopped by Sponsor|1
5523376|NCT01461538|19093785|P1|Overall Study|Study Stopped by Sponsor|2
5523377|NCT01461538|19093783|P3|Overall Study|Death|2
5523378|NCT01461538|19093784|P2|Overall Study|Death|6
5523379|NCT01461538|19093785|P1|Overall Study|Death|15
5523380|NCT01461369|19093854|P3|Overall Study|Withdrawal by Subject|2
5523381|NCT01461369|19093855|P2|Overall Study|Withdrawal by Subject|3
5523382|NCT01461369|19093856|P1|Overall Study|Withdrawal by Subject|1
5523383|NCT01461369|19093854|P3|Overall Study|Protocol Violation|2
5523384|NCT01461369|19093855|P2|Overall Study|Protocol Violation|2
5523385|NCT01461369|19093856|P1|Overall Study|Protocol Violation|1
5523386|NCT01461369|19093854|P3|Overall Study|Adverse Event|4
5523387|NCT01461369|19093855|P2|Overall Study|Adverse Event|12
5523388|NCT01461369|19093856|P1|Overall Study|Adverse Event|9
5523389|NCT01461369|19093854|P3|Overall Study|Lost to Follow-up|3
5523390|NCT01461369|19093855|P2|Overall Study|Lost to Follow-up|0
5523391|NCT01461369|19093856|P1|Overall Study|Lost to Follow-up|0
5523392|NCT01461369|19093854|P3|Overall Study|Lack of Efficacy|6
5523393|NCT01461369|19093855|P2|Overall Study|Lack of Efficacy|0
5523394|NCT01461369|19093856|P1|Overall Study|Lack of Efficacy|2
5523395|NCT01461096|19093881|P2|Overall Study|Lost to Follow-up|4
5523396|NCT01461096|19093882|P1|Overall Study|Lost to Follow-up|8
5523397|NCT01461096|19093881|P2|Overall Study|Subj not willing to adhere to reqs|4
5523398|NCT01461096|19093882|P1|Overall Study|Subj not willing to adhere to reqs|3
5523399|NCT01461096|19093881|P2|Overall Study|Withdrawal by Subject|3
5523400|NCT01461096|19093882|P1|Overall Study|Withdrawal by Subject|5
5523401|NCT01461096|19093881|P2|Overall Study|Site is closing|30
5523402|NCT01461096|19093882|P1|Overall Study|Site is closing|27
5523403|NCT01461096|19093881|P2|Overall Study|Subj not able to get to clinic|13
5523404|NCT01461096|19093882|P1|Overall Study|Subj not able to get to clinic|15
5523405|NCT01461096|19093881|P2|Overall Study|Severe debilitation, unable to continue|1
5523406|NCT01461096|19093882|P1|Overall Study|Severe debilitation, unable to continue|1
5523407|NCT01461096|19093881|P2|Overall Study|Death|6
5523408|NCT01461096|19093882|P1|Overall Study|Death|3
5523409|NCT01461057|19093898|P2|Overall Study|Study Terminated by Sponsor|0
5523410|NCT01461057|19093899|P1|Overall Study|Study Terminated by Sponsor|2
5523411|NCT01461057|19093898|P2|Overall Study|Progression of Disease|0
5523412|NCT01461057|19093899|P1|Overall Study|Progression of Disease|1
5523413|NCT01461057|19093898|P2|Overall Study|Adverse Event|1
5523414|NCT01461057|19093899|P1|Overall Study|Adverse Event|0
5523415|NCT01461057|19093898|P2|Overall Study|Physician Decision|2
5523416|NCT01461057|19093899|P1|Overall Study|Physician Decision|0
5523417|NCT01461057|19093898|P2|Overall Study|Withdrawal by Subject|3
5523418|NCT01461057|19093899|P1|Overall Study|Withdrawal by Subject|2
5523419|NCT01461057|19093898|P2|Overall Study|Death|9
5523420|NCT01461057|19093899|P1|Overall Study|Death|10
5523421|NCT01461044|19093909|P2|Overall Study|Lost to Follow-up|5
5523422|NCT01461044|19093910|P1|Overall Study|Lost to Follow-up|12
5523423|NCT01461044|19093909|P2|Overall Study|Death|35
5523424|NCT01461044|19093910|P1|Overall Study|Death|58
5523425|NCT01461005|19093983|P1|Overall Study|FDA reclassified Dynamic Stabilization D|1
5523426|NCT01460901|19094006|P1|Overall Study|Withdrawal by Subject|2
5523427|NCT01460719|19094038|P1|Overall Study|Withdrawal by Subject|1
5523428|NCT01460719|19094038|P1|Overall Study|Adverse Event|1
5523429|NCT01460628|19094048|P1|Overall Study|Withdrawal by Subject|2
5523430|NCT01460628|19094048|P1|Overall Study|Adverse Event|3
5523431|NCT01460446|19094060|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
5523432|NCT01460446|19094061|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
5523433|NCT01460446|19094060|P2|Overall Study|Pregnancy|0
5523434|NCT01460446|19094061|P1|Overall Study|Pregnancy|1
5523435|NCT01460446|19094060|P2|Overall Study|Surgery/Illness|1
5523436|NCT01460446|19094061|P1|Overall Study|Surgery/Illness|1
5523437|NCT01460446|19094060|P2|Overall Study|Non-compliance & Consent Withdrawn|3
5523438|NCT01460446|19094061|P1|Overall Study|Non-compliance & Consent Withdrawn|1
5523439|NCT01460446|19094060|P2|Overall Study|Consent Withdrawn|4
5523440|NCT01460446|19094061|P1|Overall Study|Consent Withdrawn|0
5523441|NCT01460446|19094060|P2|Overall Study|Non-compliance|9
5523442|NCT01460446|19094061|P1|Overall Study|Non-compliance|2
5523443|NCT01460407|19094088|P2|Period 2: Day 6 to Day 14|Adverse Event|1
5523444|NCT01460407|19094089|P1|Period 2: Day 6 to Day 14|Adverse Event|0
5523445|NCT01460381|19094102|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
5523446|NCT01460381|19094103|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
5523447|NCT01460368|19094119|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5523448|NCT01460368|19094120|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
5523449|NCT01460368|19094121|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5523450|NCT01460368|19094122|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
5523451|NCT01460368|19094123|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
5523452|NCT01460368|19094124|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5523453|NCT01460368|19094125|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
5523454|NCT01460368|19094119|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
5523455|NCT01460368|19094120|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
5523456|NCT01460368|19094121|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
5523457|NCT01460368|19094122|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
5523458|NCT01460368|19094123|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
5523459|NCT01460368|19094124|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
5523460|NCT01460368|19094125|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
5523461|NCT01460368|19094119|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5523462|NCT01460368|19094120|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5523463|NCT01460368|19094121|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5523464|NCT01460368|19094122|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5523465|NCT01460368|19094123|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5523466|NCT01460368|19094124|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
5523467|NCT01460368|19094125|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
5523468|NCT01460368|19094119|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
5523469|NCT01460368|19094120|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5523470|NCT01460368|19094121|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5523471|NCT01460368|19094122|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5523472|NCT01460368|19094123|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5523473|NCT01460368|19094124|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
5523474|NCT01460368|19094125|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
5523475|NCT01460368|19094119|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5523476|NCT01460368|19094120|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5523477|NCT01460368|19094121|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
5523478|NCT01460368|19094122|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5523479|NCT01460368|19094123|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5523480|NCT01460368|19094124|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5523481|NCT01460368|19094125|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
5523482|NCT01460342|19094137|P2|Overall Study|Lack of Efficacy|0
5523483|NCT01460342|19094138|P1|Overall Study|Lack of Efficacy|1
5523484|NCT01460342|19094137|P2|Overall Study|Physician Decision|3
5523485|NCT01460342|19094138|P1|Overall Study|Physician Decision|1
5523486|NCT01460342|19094137|P2|Overall Study|Withdrawal by Subject|4
5523487|NCT01460342|19094138|P1|Overall Study|Withdrawal by Subject|3
5523488|NCT01460342|19094137|P2|Overall Study|Protocol Violation|1
5523489|NCT01460342|19094138|P1|Overall Study|Protocol Violation|0
5523490|NCT01460342|19094137|P2|Overall Study|Lost to Follow-up|2
5523491|NCT01460342|19094138|P1|Overall Study|Lost to Follow-up|1
5523492|NCT01460342|19094137|P2|Overall Study|Adverse Event|4
5523493|NCT01460342|19094138|P1|Overall Study|Adverse Event|5
5523494|NCT01460290|19094169|P1|Overall Study|Elevated liver function|1
5523495|NCT01460290|19094169|P1|Overall Study|Adverse Event|3
5523496|NCT01460160|19094196|P2|Follow-up|Lost to Follow-up|0
5523497|NCT01460160|19094197|P1|Follow-up|Lost to Follow-up|1
5523498|NCT01460160|19094196|P2|Follow-up|Death|2
5523499|NCT01460160|19094197|P1|Follow-up|Death|7
5523500|NCT01460160|19094196|P2|Follow-up|Withdrawal by Subject|0
5523501|NCT01460160|19094197|P1|Follow-up|Withdrawal by Subject|3
5523502|NCT01460160|19094196|P2|Treatment|Subject refused to continue Chemo|0
5523503|NCT01460160|19094197|P1|Treatment|Subject refused to continue Chemo|1
5523504|NCT01460160|19094196|P2|Treatment|Family did not wish to restart after SCT|0
5523505|NCT01460160|19094197|P1|Treatment|Family did not wish to restart after SCT|1
5523506|NCT01460160|19094196|P2|Treatment|PI decision to pursue other options|1
5523507|NCT01460160|19094197|P1|Treatment|PI decision to pursue other options|1
5523508|NCT01460160|19094196|P2|Treatment|PI not to follow protocol therapy|0
5523509|NCT01460160|19094197|P1|Treatment|PI not to follow protocol therapy|1
5523510|NCT01460160|19094196|P2|Treatment|PI decision to not re-initiate after SCT|2
5523511|NCT01460160|19094197|P1|Treatment|PI decision to not re-initiate after SCT|2
5523512|NCT01460160|19094196|P2|Treatment|Death|2
5523513|NCT01460160|19094197|P1|Treatment|Death|0
5523514|NCT01460160|19094196|P2|Treatment|Withdrawal by Subject|0
5523515|NCT01460160|19094197|P1|Treatment|Withdrawal by Subject|4
5523516|NCT01460160|19094196|P2|Treatment|Adverse Event|0
5523517|NCT01460160|19094197|P1|Treatment|Adverse Event|8
5523518|NCT01460160|19094196|P2|Treatment|Study Drug Toxicity|0
5523519|NCT01460160|19094197|P1|Treatment|Study Drug Toxicity|2
5523520|NCT01460160|19094196|P2|Treatment|Lack of Efficacy|0
5523521|NCT01460160|19094197|P1|Treatment|Lack of Efficacy|3
5523522|NCT01459913|19094238|P4|Overall Study|Did Not Meet Inclusion Criteria|1
5523523|NCT01459913|19094239|P3|Overall Study|Did Not Meet Inclusion Criteria|0
5523524|NCT01459913|19094240|P2|Overall Study|Did Not Meet Inclusion Criteria|0
5523525|NCT01459913|19094241|P1|Overall Study|Did Not Meet Inclusion Criteria|0
5523526|NCT01459913|19094238|P4|Overall Study|Other|1
5523527|NCT01459913|19094239|P3|Overall Study|Other|3
5523528|NCT01459913|19094240|P2|Overall Study|Other|0
5523529|NCT01459913|19094241|P1|Overall Study|Other|0
5523530|NCT01459913|19094238|P4|Overall Study|Study Terminated by Sponsor|11
5523531|NCT01459913|19094239|P3|Overall Study|Study Terminated by Sponsor|9
5523532|NCT01459913|19094240|P2|Overall Study|Study Terminated by Sponsor|15
5523533|NCT01459913|19094241|P1|Overall Study|Study Terminated by Sponsor|30
5523534|NCT01459913|19094238|P4|Overall Study|Physician Decision|0
5523535|NCT01459913|19094239|P3|Overall Study|Physician Decision|0
5523536|NCT01459913|19094240|P2|Overall Study|Physician Decision|1
5523537|NCT01459913|19094241|P1|Overall Study|Physician Decision|0
5523538|NCT01459913|19094238|P4|Overall Study|Non- Compliance|3
5523539|NCT01459913|19094239|P3|Overall Study|Non- Compliance|0
5523540|NCT01459913|19094240|P2|Overall Study|Non- Compliance|0
5523541|NCT01459913|19094241|P1|Overall Study|Non- Compliance|0
5523542|NCT01459913|19094238|P4|Overall Study|Death|1
5523543|NCT01459913|19094239|P3|Overall Study|Death|0
5523544|NCT01459913|19094240|P2|Overall Study|Death|0
5523545|NCT01459913|19094241|P1|Overall Study|Death|0
5523546|NCT01459913|19094238|P4|Overall Study|Lost to Follow-up|8
5523547|NCT01459913|19094239|P3|Overall Study|Lost to Follow-up|1
5523548|NCT01459913|19094240|P2|Overall Study|Lost to Follow-up|4
5523549|NCT01459913|19094241|P1|Overall Study|Lost to Follow-up|7
5523550|NCT01459913|19094238|P4|Overall Study|Withdrawal by Subject|5
5523551|NCT01459913|19094239|P3|Overall Study|Withdrawal by Subject|0
5523552|NCT01459913|19094240|P2|Overall Study|Withdrawal by Subject|0
5523553|NCT01459913|19094241|P1|Overall Study|Withdrawal by Subject|4
5523554|NCT01459913|19094238|P4|Overall Study|Adverse Event|3
5523555|NCT01459913|19094239|P3|Overall Study|Adverse Event|0
5523556|NCT01459913|19094240|P2|Overall Study|Adverse Event|0
5523557|NCT01459913|19094241|P1|Overall Study|Adverse Event|0
5523558|NCT01459796|19094272|P2|Overall Study|Decision by the sponsor|108
5523559|NCT01459796|19094273|P1|Overall Study|Decision by the sponsor|75
5523560|NCT01459796|19094272|P2|Overall Study|Reason unspecified|2
5523561|NCT01459796|19094273|P1|Overall Study|Reason unspecified|1
5523562|NCT01459796|19094272|P2|Overall Study|Lost to Follow-up|4
5523563|NCT01459796|19094273|P1|Overall Study|Lost to Follow-up|5
5523564|NCT01459796|19094272|P2|Overall Study|Withdrawal by Subject|3
5523565|NCT01459796|19094273|P1|Overall Study|Withdrawal by Subject|6
5523566|NCT01459796|19094272|P2|Overall Study|Adverse Event|5
5523567|NCT01459796|19094273|P1|Overall Study|Adverse Event|5
5523568|NCT01459796|19094272|P2|Overall Study|Non compliance with protocol|4
5523569|NCT01459796|19094273|P1|Overall Study|Non compliance with protocol|2
5523570|NCT01459783|19094291|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
5523571|NCT01459783|19094292|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
5523572|NCT01459783|19094291|P2|6 Months to 12 Months|Lost to Follow-up|7
5523573|NCT01459783|19094292|P1|6 Months to 12 Months|Lost to Follow-up|2
5523574|NCT01459783|19094291|P2|6 Months to 12 Months|Withdrawal by Subject|5
5523575|NCT01459783|19094292|P1|6 Months to 12 Months|Withdrawal by Subject|6
5523576|NCT01459783|19094291|P2|6 Months to 12 Months|Death|1
5523577|NCT01459783|19094292|P1|6 Months to 12 Months|Death|0
5523578|NCT01459783|19094291|P2|Baseline to 6 Months|Lost to Follow-up|14
5523579|NCT01459783|19094292|P1|Baseline to 6 Months|Lost to Follow-up|19
5523580|NCT01459783|19094291|P2|Baseline to 6 Months|Withdrawal by Subject|6
5523581|NCT01459783|19094292|P1|Baseline to 6 Months|Withdrawal by Subject|12
5523582|NCT01459783|19094291|P2|Baseline to 6 Months|Death|0
5523583|NCT01459783|19094292|P1|Baseline to 6 Months|Death|1
5523584|NCT01459718|19094300|P1|Overall Study|Adverse Event|1
5523585|NCT01459718|19094300|P1|Overall Study|Lost to Follow-up|1
5523586|NCT01459718|19094300|P1|Overall Study|Physician Decision|1
5523587|NCT01459614|19094482|P2|Overall Study|Adverse Event|0
5523588|NCT01459614|19094483|P1|Overall Study|Adverse Event|1
5523589|NCT01459068|19094530|P2|Overall Study|Death|1
5523590|NCT01459068|19094531|P1|Overall Study|Death|0
5523591|NCT01459068|19094530|P2|Overall Study|Lost to Follow-up|15
5523592|NCT01459068|19094531|P1|Overall Study|Lost to Follow-up|31
5523593|NCT01459068|19094530|P2|Overall Study|Withdrawal by Subject|18
5523594|NCT01459068|19094531|P1|Overall Study|Withdrawal by Subject|8
5523595|NCT01459016|19094547|P1|Overall Study|Amendment Discontinuation Criteria|4
5523596|NCT01459016|19094547|P1|Overall Study|Withdrawal by Subject|11
5523597|NCT01458951|19094575|P3|Overall Study|Insufficient Clinical Response|11
5523598|NCT01458951|19094576|P2|Overall Study|Insufficient Clinical Response|0
5523599|NCT01458951|19094577|P1|Overall Study|Insufficient Clinical Response|17
5523600|NCT01458951|19094575|P3|Overall Study|Adverse Event|2
5523601|NCT01458951|19094576|P2|Overall Study|Adverse Event|0
5523602|NCT01458951|19094577|P1|Overall Study|Adverse Event|7
5523603|NCT01458951|19094575|P3|Overall Study|Withdrawal by Subject|2
5523604|NCT01458951|19094576|P2|Overall Study|Withdrawal by Subject|0
5523605|NCT01458951|19094577|P1|Overall Study|Withdrawal by Subject|2
5523606|NCT01458951|19094575|P3|Overall Study|Protocol Violation|0
5523607|NCT01458951|19094576|P2|Overall Study|Protocol Violation|1
5523608|NCT01458951|19094577|P1|Overall Study|Protocol Violation|5
5523609|NCT01458951|19094575|P3|Overall Study|Other|0
5523610|NCT01458951|19094576|P2|Overall Study|Other|0
5523611|NCT01458951|19094577|P1|Overall Study|Other|1
5523612|NCT01458639|19094602|P1|Overall Study|Inability to obtain subject blood sample|1
5523613|NCT01458639|19094602|P1|Overall Study|Equipment issue|1
5523614|NCT01458639|19094602|P1|Overall Study|Physician Decision|4
5523615|NCT01458587|19094614|P2|Overall Study|Withdrawal by Subject|0
5523616|NCT01458587|19094615|P1|Overall Study|Withdrawal by Subject|1
5523617|NCT01458574|19094778|P3|Overall Study|Randomized but not treated|0
5523618|NCT01458574|19094779|P2|Overall Study|Randomized but not treated|1
5523619|NCT01458574|19094780|P1|Overall Study|Randomized but not treated|0
5523620|NCT01458574|19094778|P3|Overall Study|Other|0
5523621|NCT01458574|19094779|P2|Overall Study|Other|1
5523622|NCT01458574|19094780|P1|Overall Study|Other|2
5523623|NCT01458574|19094778|P3|Overall Study|Withdrawal by Subject|5
5523624|NCT01458574|19094779|P2|Overall Study|Withdrawal by Subject|3
5523625|NCT01458574|19094780|P1|Overall Study|Withdrawal by Subject|6
5523626|NCT01458574|19094778|P3|Overall Study|Protocol Violation|0
5523627|NCT01458574|19094779|P2|Overall Study|Protocol Violation|1
5523628|NCT01458574|19094780|P1|Overall Study|Protocol Violation|0
5523629|NCT01458574|19094778|P3|Overall Study|Pregnancy|0
5523630|NCT01458574|19094779|P2|Overall Study|Pregnancy|1
5523631|NCT01458574|19094780|P1|Overall Study|Pregnancy|1
5523632|NCT01458574|19094778|P3|Overall Study|Lost to Follow-up|1
5523633|NCT01458574|19094779|P2|Overall Study|Lost to Follow-up|2
5523634|NCT01458574|19094780|P1|Overall Study|Lost to Follow-up|3
5523635|NCT01458574|19094778|P3|Overall Study|Lack of Efficacy|132
5523636|NCT01458574|19094779|P2|Overall Study|Lack of Efficacy|53
5523637|NCT01458574|19094780|P1|Overall Study|Lack of Efficacy|70
5523638|NCT01458574|19094778|P3|Overall Study|Adverse Event|7
5523639|NCT01458574|19094779|P2|Overall Study|Adverse Event|9
5523640|NCT01458574|19094780|P1|Overall Study|Adverse Event|5
5523641|NCT01458535|19094910|P6|Overall Study|Adverse Event|0
5523642|NCT01458535|19094911|P5|Overall Study|Adverse Event|0
5523643|NCT01458535|19094912|P4|Overall Study|Adverse Event|1
5523644|NCT01458535|19094913|P3|Overall Study|Adverse Event|0
5523645|NCT01458535|19094914|P2|Overall Study|Adverse Event|0
5523646|NCT01458535|19094915|P1|Overall Study|Adverse Event|0
5523647|NCT01458535|19094910|P6|Overall Study|Lost to Follow-up|2
5523648|NCT01458535|19094911|P5|Overall Study|Lost to Follow-up|2
5523649|NCT01458535|19094912|P4|Overall Study|Lost to Follow-up|3
5523650|NCT01458535|19094913|P3|Overall Study|Lost to Follow-up|0
5523651|NCT01458535|19094914|P2|Overall Study|Lost to Follow-up|2
5523652|NCT01458535|19094915|P1|Overall Study|Lost to Follow-up|0
5523653|NCT01458535|19094910|P6|Overall Study|Withdrawal by Subject|1
5523654|NCT01458535|19094911|P5|Overall Study|Withdrawal by Subject|1
5523655|NCT01458535|19094912|P4|Overall Study|Withdrawal by Subject|0
5523656|NCT01458535|19094913|P3|Overall Study|Withdrawal by Subject|2
5523657|NCT01458535|19094914|P2|Overall Study|Withdrawal by Subject|0
5523658|NCT01458535|19094915|P1|Overall Study|Withdrawal by Subject|0
5523659|NCT01458535|19094910|P6|Overall Study|Other|1
5523660|NCT01458535|19094911|P5|Overall Study|Other|1
5523661|NCT01458535|19094912|P4|Overall Study|Other|0
5523662|NCT01458535|19094913|P3|Overall Study|Other|0
5523663|NCT01458535|19094914|P2|Overall Study|Other|0
5523664|NCT01458535|19094915|P1|Overall Study|Other|0
5523665|NCT01458522|19094967|P2|Overall Study|Physician Decision|9
5523666|NCT01458522|19094968|P1|Overall Study|Physician Decision|1
5523667|NCT01458522|19094967|P2|Overall Study|Withdrawal by Subject|2
5523668|NCT01458522|19094968|P1|Overall Study|Withdrawal by Subject|2
5523669|NCT01458392|19095014|P3|Overall Study|Patient unwilling to comply with protoco|2
5523670|NCT01458392|19095015|P2|Overall Study|Patient unwilling to comply with protoco|0
5523671|NCT01458392|19095016|P1|Overall Study|Patient unwilling to comply with protoco|0
5523672|NCT01458392|19095014|P3|Overall Study|At the discretion of the sponsor|7
5523673|NCT01458392|19095015|P2|Overall Study|At the discretion of the sponsor|2
5523674|NCT01458392|19095016|P1|Overall Study|At the discretion of the sponsor|0
5523675|NCT01458392|19095014|P3|Overall Study|Death|22
5523676|NCT01458392|19095015|P2|Overall Study|Death|11
5523677|NCT01458392|19095016|P1|Overall Study|Death|2
5523678|NCT01458366|19095041|P5|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
5523679|NCT01458366|19095042|P4|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5523680|NCT01458366|19095043|P3|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5523681|NCT01458366|19095044|P2|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5523682|NCT01458366|19095045|P1|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
5523683|NCT01458366|19095041|P5|Period 1: 70mg/m^2|Physician Decision|0
5523684|NCT01458366|19095042|P4|Period 1: 70mg/m^2|Physician Decision|0
5523685|NCT01458366|19095043|P3|Period 1: 70mg/m^2|Physician Decision|0
5523686|NCT01458366|19095044|P2|Period 1: 70mg/m^2|Physician Decision|0
5523687|NCT01458366|19095045|P1|Period 1: 70mg/m^2|Physician Decision|2
5523688|NCT01458275|19095072|P3|Overall Study|Withdrawal by Subject|1
5523689|NCT01458275|19095073|P2|Overall Study|Withdrawal by Subject|2
5523690|NCT01458275|19095074|P1|Overall Study|Withdrawal by Subject|3
5523691|NCT01458275|19095072|P3|Overall Study|Protocol Violation|2
5523692|NCT01458275|19095073|P2|Overall Study|Protocol Violation|5
5523693|NCT01458275|19095074|P1|Overall Study|Protocol Violation|5
5523694|NCT01458275|19095072|P3|Overall Study|Lost to Follow-up|5
5523695|NCT01458275|19095073|P2|Overall Study|Lost to Follow-up|2
5523696|NCT01458275|19095074|P1|Overall Study|Lost to Follow-up|3
5523697|NCT01458275|19095072|P3|Overall Study|Adverse Event|1
5523698|NCT01458275|19095073|P2|Overall Study|Adverse Event|4
5523699|NCT01458275|19095074|P1|Overall Study|Adverse Event|3
5523700|NCT01458249|19095116|P1|Overall Study|Ongoing|1
5523701|NCT01458249|19095116|P1|Overall Study|Other|2
5523702|NCT01458249|19095116|P1|Overall Study|Adverse Event|4
5523703|NCT01458249|19095116|P1|Overall Study|Not treated|1
5523704|NCT01458210|19095135|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
5523705|NCT01458210|19095135|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
5523706|NCT01458210|19095135|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
5523707|NCT01458210|19095135|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
5523708|NCT01458171|19095152|P1|Overall Study|Adverse Event|1
5523709|NCT01458132|19095175|P2|Overall Study|Other|3
5523710|NCT01458132|19095176|P1|Overall Study|Other|15
5523711|NCT01458119|19095184|P1|Overall Study|Non-compliance With Study Drug|3
5523712|NCT01458119|19095184|P1|Overall Study|Consent Withdrawn by Participant|8
5523713|NCT01458119|19095184|P1|Overall Study|Adverse Event|1
5523714|NCT01458119|19095184|P1|Overall Study|Death|2
5523715|NCT01458119|19095184|P1|Overall Study|Pregnancy|1
5523716|NCT01458119|19095184|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
5523717|NCT01458119|19095184|P1|Overall Study|Physician Decision|4
5523718|NCT01458106|19095191|P2|Overall Study|Withdrawn Per Protocol|1
5523719|NCT01458106|19095192|P1|Overall Study|Withdrawn Per Protocol|0
5523720|NCT01458106|19095191|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
5523721|NCT01458106|19095192|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
5523722|NCT01458106|19095191|P2|Overall Study|Withdrawal by Subject|0
5523723|NCT01458106|19095192|P1|Overall Study|Withdrawal by Subject|2
5523724|NCT01457950|19095269|P4|Open-Label Phase|Withdrawal by Subject|0
5523725|NCT01457950|19095270|P3|Open-Label Phase|Withdrawal by Subject|2
5523726|NCT01457950|19095271|P2|Open-Label Phase|Withdrawal by Subject|0
5523727|NCT01457950|19095272|P1|Open-Label Phase|Withdrawal by Subject|0
5523728|NCT01457950|19095269|P4|Open-Label Phase|Protocol Violation|1
5523729|NCT01457950|19095270|P3|Open-Label Phase|Protocol Violation|0
5523730|NCT01457950|19095271|P2|Open-Label Phase|Protocol Violation|0
5523731|NCT01457950|19095272|P1|Open-Label Phase|Protocol Violation|0
5523732|NCT01457950|19095269|P4|Open-Label Phase|Adverse Event|1
5523733|NCT01457950|19095270|P3|Open-Label Phase|Adverse Event|0
5523734|NCT01457950|19095271|P2|Open-Label Phase|Adverse Event|0
5523735|NCT01457950|19095272|P1|Open-Label Phase|Adverse Event|0
5523736|NCT01457950|19095269|P4|Double-Blind Phase|Withdrawal by Subject|0
5523737|NCT01457950|19095270|P3|Double-Blind Phase|Withdrawal by Subject|0
5523738|NCT01457950|19095271|P2|Double-Blind Phase|Withdrawal by Subject|2
5523739|NCT01457950|19095272|P1|Double-Blind Phase|Withdrawal by Subject|6
5523740|NCT01457950|19095269|P4|Double-Blind Phase|Protocol Violation|0
5523741|NCT01457950|19095270|P3|Double-Blind Phase|Protocol Violation|0
5523742|NCT01457950|19095271|P2|Double-Blind Phase|Protocol Violation|1
5523743|NCT01457950|19095272|P1|Double-Blind Phase|Protocol Violation|2
5523744|NCT01457950|19095269|P4|Double-Blind Phase|Continuation Criteria Not Met|0
5523745|NCT01457950|19095270|P3|Double-Blind Phase|Continuation Criteria Not Met|0
5523746|NCT01457950|19095271|P2|Double-Blind Phase|Continuation Criteria Not Met|0
5523747|NCT01457950|19095272|P1|Double-Blind Phase|Continuation Criteria Not Met|1
5523748|NCT01457924|19095351|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
5523749|NCT01457924|19095352|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
5523750|NCT01457924|19095353|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
5523751|NCT01457924|19095354|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
5523752|NCT01457924|19095355|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
5523753|NCT01457924|19095351|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
5523754|NCT01457924|19095352|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
5523755|NCT01457924|19095353|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
5523756|NCT01457924|19095354|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
5523757|NCT01457924|19095355|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
5523758|NCT01457924|19095351|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
5523759|NCT01457924|19095352|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
5523760|NCT01457924|19095353|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
5523761|NCT01457924|19095354|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
5523762|NCT01457924|19095355|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
5523763|NCT01457924|19095351|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
5523764|NCT01457924|19095352|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
5523765|NCT01457924|19095353|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
5523766|NCT01457924|19095354|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
5523767|NCT01457924|19095355|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
5523768|NCT01457924|19095351|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
5523769|NCT01457924|19095352|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
5523770|NCT01457924|19095353|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
5523771|NCT01457924|19095354|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
5523772|NCT01457924|19095355|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
5523773|NCT01457924|19095351|P5|FUP (Weeks 24-48)|Physician Decision|0
5523774|NCT01457924|19095352|P4|FUP (Weeks 24-48)|Physician Decision|0
5523775|NCT01457924|19095353|P3|FUP (Weeks 24-48)|Physician Decision|1
5523776|NCT01457924|19095354|P2|FUP (Weeks 24-48)|Physician Decision|0
5523777|NCT01457924|19095355|P1|FUP (Weeks 24-48)|Physician Decision|1
5523778|NCT01457924|19095351|P5|FUP (Weeks 24-48)|Adverse Event|0
5523779|NCT01457924|19095352|P4|FUP (Weeks 24-48)|Adverse Event|0
5523780|NCT01457924|19095353|P3|FUP (Weeks 24-48)|Adverse Event|1
5523781|NCT01457924|19095354|P2|FUP (Weeks 24-48)|Adverse Event|0
5523782|NCT01457924|19095355|P1|FUP (Weeks 24-48)|Adverse Event|0
5523783|NCT01457924|19095351|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
5523784|NCT01457924|19095352|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
5523785|NCT01457924|19095353|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
5523786|NCT01457924|19095354|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
5523787|NCT01457924|19095355|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
5523788|NCT01457924|19095351|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
5523789|NCT01457924|19095352|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
5523790|NCT01457924|19095353|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
5523791|NCT01457924|19095354|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
5523792|NCT01457924|19095355|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
5523793|NCT01457924|19095351|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
5523794|NCT01457924|19095352|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
5523795|NCT01457924|19095353|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
5523796|NCT01457924|19095354|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
5523797|NCT01457924|19095355|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
5523798|NCT01457924|19095351|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5523799|NCT01457924|19095352|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5523800|NCT01457924|19095353|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5523801|NCT01457924|19095354|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
5523802|NCT01457924|19095355|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
5523803|NCT01457924|19095351|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
5523804|NCT01457924|19095352|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
5523805|NCT01457924|19095353|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
5523806|NCT01457924|19095354|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
5523807|NCT01457924|19095355|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
5523808|NCT01457924|19095351|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
5523809|NCT01457924|19095352|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
5523810|NCT01457924|19095353|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
5523811|NCT01457924|19095354|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
5523812|NCT01457924|19095355|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
5523813|NCT01457846|19095425|P2|Overall Study|Lost to Follow-up|0
5523814|NCT01457846|19095426|P1|Overall Study|Lost to Follow-up|1
5523815|NCT01457846|19095425|P2|Overall Study|Withdrawal by Subject|1
5523816|NCT01457846|19095426|P1|Overall Study|Withdrawal by Subject|1
5523817|NCT01457846|19095425|P2|Overall Study|Unclassified reason for not completed|10
5523818|NCT01457846|19095426|P1|Overall Study|Unclassified reason for not completed|11
5523819|NCT01457846|19095425|P2|Overall Study|Death|16
5523820|NCT01457846|19095426|P1|Overall Study|Death|27
5523821|NCT01457846|19095425|P2|Overall Study|Did not receive treatment|1
5523822|NCT01457846|19095426|P1|Overall Study|Did not receive treatment|0
5523823|NCT01457846|19095425|P2|Overall Study|Death before treatment|2
5523824|NCT01457846|19095426|P1|Overall Study|Death before treatment|1
5523825|NCT01457703|19095442|P2|Overall Study|Withdrawal by Subject|4
5523826|NCT01457703|19095443|P1|Overall Study|Withdrawal by Subject|1
5523827|NCT01457703|19095442|P2|Overall Study|Screen Failure|7
5523828|NCT01457703|19095443|P1|Overall Study|Screen Failure|5
5523829|NCT01457352|19095554|P2|Period 3|Sponsor's withdrawal|1
5523830|NCT01457352|19095555|P1|Period 3|Sponsor's withdrawal|0
5523831|NCT01457352|19095554|P2|Period 3|incorrect treatment|1
5523832|NCT01457352|19095555|P1|Period 3|incorrect treatment|0
5523833|NCT01457352|19095554|P2|Period 3|Withdrawal by Subject|2
5523834|NCT01457352|19095555|P1|Period 3|Withdrawal by Subject|0
5523835|NCT01457352|19095554|P2|Period 3|Adverse Event|1
5523836|NCT01457352|19095555|P1|Period 3|Adverse Event|1
5523837|NCT01457352|19095554|P2|Period 2|Did not meet eligibility criteria|0
5523838|NCT01457352|19095555|P1|Period 2|Did not meet eligibility criteria|3
5523839|NCT01457352|19095554|P2|Period 2|Physician Decision|0
5523840|NCT01457352|19095555|P1|Period 2|Physician Decision|1
5523841|NCT01457352|19095554|P2|Period 2|dose change|0
5523842|NCT01457352|19095555|P1|Period 2|dose change|1
5523843|NCT01457352|19095554|P2|Period 2|Lost to Follow-up|0
5523844|NCT01457352|19095555|P1|Period 2|Lost to Follow-up|1
5523845|NCT01457352|19095554|P2|Period 2|Sponsor's withdrawal|0
5523846|NCT01457352|19095555|P1|Period 2|Sponsor's withdrawal|7
5523847|NCT01457352|19095554|P2|Period 2|Protocol Violation|0
5523848|NCT01457352|19095555|P1|Period 2|Protocol Violation|4
5523849|NCT01457352|19095554|P2|Period 2|Lack of Efficacy|0
5523850|NCT01457352|19095555|P1|Period 2|Lack of Efficacy|8
5523851|NCT01457352|19095554|P2|Period 2|no analysis|0
5523852|NCT01457352|19095555|P1|Period 2|no analysis|10
5523853|NCT01457352|19095554|P2|Period 2|Adverse Event|0
5523854|NCT01457352|19095555|P1|Period 2|Adverse Event|22
5523855|NCT01457352|19095554|P2|Period 2|Withdrawal by Subject|0
5523856|NCT01457352|19095555|P1|Period 2|Withdrawal by Subject|23
5523857|NCT01457352|19095554|P2|Period 1|Did not meet eligibility criteria|0
5523858|NCT01457352|19095555|P1|Period 1|Did not meet eligibility criteria|3
5523859|NCT01457352|19095554|P2|Period 1|Protocol Violation|0
5523860|NCT01457352|19095555|P1|Period 1|Protocol Violation|4
5523861|NCT01457352|19095554|P2|Period 1|withdrew per sponsor|0
5523862|NCT01457352|19095555|P1|Period 1|withdrew per sponsor|1
5523863|NCT01457352|19095554|P2|Period 1|Withdrawn|0
5523864|NCT01457352|19095555|P1|Period 1|Withdrawn|1
5523865|NCT01457352|19095554|P2|Period 1|MS related disease progression|0
5523866|NCT01457352|19095555|P1|Period 1|MS related disease progression|1
5523867|NCT01457352|19095554|P2|Period 1|Physician Decision|0
5523868|NCT01457352|19095555|P1|Period 1|Physician Decision|2
5523869|NCT01457352|19095554|P2|Period 1|Withdrawal by Subject|0
5523870|NCT01457352|19095555|P1|Period 1|Withdrawal by Subject|2
5523871|NCT01457352|19095554|P2|Period 1|Adverse Event|0
5523872|NCT01457352|19095555|P1|Period 1|Adverse Event|2
5523873|NCT01457339|19095567|P2|Period 6 (250 mg)|Personal appointment|1
5523874|NCT01457339|19095568|P1|Period 6 (250 mg)|Personal appointment|0
5523875|NCT01457339|19095567|P2|Period 6 (250 mg)|Family Emergency|0
5523876|NCT01457339|19095568|P1|Period 6 (250 mg)|Family Emergency|1
5523877|NCT01457339|19095567|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
5523878|NCT01457339|19095568|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
5523879|NCT01457339|19095567|P2|Period 3 (100 mg)|Adverse Event|1
5523880|NCT01457339|19095568|P1|Period 3 (100 mg)|Adverse Event|0
5523881|NCT01457053|19095740|P2|Overall Study|Unable to undergo selected treatment|1
5523882|NCT01457053|19095741|P1|Overall Study|Unable to undergo selected treatment|1
5523883|NCT01457014|19095747|P4|First Night|Withdrawal by Subject|0
5523884|NCT01457014|19095748|P3|First Night|Withdrawal by Subject|0
5523885|NCT01457014|19095749|P2|First Night|Withdrawal by Subject|0
5523886|NCT01457014|19095750|P1|First Night|Withdrawal by Subject|3
5523887|NCT01457014|19095747|P4|First Night|Didn't meet inclusion/exclusion criteria|0
5523888|NCT01457014|19095748|P3|First Night|Didn't meet inclusion/exclusion criteria|0
5523889|NCT01457014|19095749|P2|First Night|Didn't meet inclusion/exclusion criteria|0
5523890|NCT01457014|19095750|P1|First Night|Didn't meet inclusion/exclusion criteria|37
5523891|NCT01456962|19095767|P2|Overall Study|Lost to Follow-up|1
5523892|NCT01456962|19095768|P1|Overall Study|Lost to Follow-up|2
5523893|NCT01456949|19095774|P1|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
5523894|NCT01456949|19095774|P1|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
5523895|NCT01456949|19095774|P1|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
5523896|NCT01456949|19095774|P1|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
5523897|NCT01456949|19095774|P1|Study Cryoablation Procedure & Follow-up|Physician Decision|1
5523898|NCT01456949|19095774|P1|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
5523899|NCT01456949|19095774|P1|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
5523900|NCT01456949|19095774|P1|Study Cryoablation Procedure & Follow-up|Death|5
5523901|NCT01456949|19095774|P1|Enrollment|Withdrawal by Subject|7
5523902|NCT01456949|19095774|P1|Enrollment|Physician Decision|10
5523903|NCT01456949|19095774|P1|Enrollment|I/E criteria not met prior to procedure|13
5523904|NCT01456949|19095774|P1|Enrollment|Death|1
5523905|NCT01456949|19095774|P1|Enrollment|PI death- incomplete data|6
5523906|NCT01456936|19095785|P4|Overall Study|Randomized but not treated|21
5523907|NCT01456936|19095786|P3|Overall Study|Randomized but not treated|16
5523908|NCT01456936|19095787|P2|Overall Study|Randomized but not treated|28
5523909|NCT01456936|19095788|P1|Overall Study|Randomized but not treated|21
5523910|NCT01456936|19095785|P4|Overall Study|Death|3
5523911|NCT01456936|19095786|P3|Overall Study|Death|1
5523912|NCT01456936|19095787|P2|Overall Study|Death|3
5523913|NCT01456936|19095788|P1|Overall Study|Death|0
5523914|NCT01456936|19095785|P4|Overall Study|Adverse event (study drug unrelated)|9
5523915|NCT01456936|19095786|P3|Overall Study|Adverse event (study drug unrelated)|9
5523916|NCT01456936|19095787|P2|Overall Study|Adverse event (study drug unrelated)|7
5523917|NCT01456936|19095788|P1|Overall Study|Adverse event (study drug unrelated)|9
5523918|NCT01456936|19095785|P4|Overall Study|Adverse event (study drug)|17
5523919|NCT01456936|19095786|P3|Overall Study|Adverse event (study drug)|26
5523920|NCT01456936|19095787|P2|Overall Study|Adverse event (study drug)|21
5523921|NCT01456936|19095788|P1|Overall Study|Adverse event (study drug)|25
5523922|NCT01456936|19095785|P4|Overall Study|Medication error|1
5523923|NCT01456936|19095786|P3|Overall Study|Medication error|0
5523924|NCT01456936|19095787|P2|Overall Study|Medication error|1
5523925|NCT01456936|19095788|P1|Overall Study|Medication error|0
5523926|NCT01456936|19095785|P4|Overall Study|Lost to Follow-up|127
5523927|NCT01456936|19095786|P3|Overall Study|Lost to Follow-up|144
5523928|NCT01456936|19095787|P2|Overall Study|Lost to Follow-up|126
5523929|NCT01456936|19095788|P1|Overall Study|Lost to Follow-up|135
5523930|NCT01456936|19095785|P4|Overall Study|No longer willing to participate|248
5523931|NCT01456936|19095786|P3|Overall Study|No longer willing to participate|224
5523932|NCT01456936|19095787|P2|Overall Study|No longer willing to participate|218
5523933|NCT01456936|19095788|P1|Overall Study|No longer willing to participate|195
5523934|NCT01456936|19095785|P4|Overall Study|Insufficient clinical response|13
5523935|NCT01456936|19095786|P3|Overall Study|Insufficient clinical response|14
5523936|NCT01456936|19095787|P2|Overall Study|Insufficient clinical response|4
5523937|NCT01456936|19095788|P1|Overall Study|Insufficient clinical response|4
5523938|NCT01456936|19095785|P4|Overall Study|Pregnancy|1
5523939|NCT01456936|19095786|P3|Overall Study|Pregnancy|0
5523940|NCT01456936|19095787|P2|Overall Study|Pregnancy|0
5523941|NCT01456936|19095788|P1|Overall Study|Pregnancy|1
5523942|NCT01456936|19095785|P4|Overall Study|Protocol Violation|5
5523943|NCT01456936|19095786|P3|Overall Study|Protocol Violation|5
5523944|NCT01456936|19095787|P2|Overall Study|Protocol Violation|2
5523945|NCT01456936|19095788|P1|Overall Study|Protocol Violation|4
5523946|NCT01456936|19095785|P4|Overall Study|No longer meets eligibility criteria|5
5523947|NCT01456936|19095786|P3|Overall Study|No longer meets eligibility criteria|6
5523948|NCT01456936|19095787|P2|Overall Study|No longer meets eligibility criteria|8
5523949|NCT01456936|19095788|P1|Overall Study|No longer meets eligibility criteria|4
5523950|NCT01456936|19095785|P4|Overall Study|Other reason|33
5523951|NCT01456936|19095786|P3|Overall Study|Other reason|36
5523952|NCT01456936|19095787|P2|Overall Study|Other reason|30
5523953|NCT01456936|19095788|P1|Overall Study|Other reason|41
5523954|NCT01456897|19095896|P2|Overall Study|Lack of Efficacy|11
5523955|NCT01456897|19095897|P1|Overall Study|Lack of Efficacy|4
5523956|NCT01456897|19095896|P2|Overall Study|Withdrawal by Subject|17
5523957|NCT01456897|19095897|P1|Overall Study|Withdrawal by Subject|44
5523958|NCT01456897|19095896|P2|Overall Study|Physician Decision|3
5523959|NCT01456897|19095897|P1|Overall Study|Physician Decision|5
5523960|NCT01456897|19095896|P2|Overall Study|Protocol Violation|4
5523961|NCT01456897|19095897|P1|Overall Study|Protocol Violation|3
5523962|NCT01456897|19095896|P2|Overall Study|Adverse Event|22
5523963|NCT01456897|19095897|P1|Overall Study|Adverse Event|19
5523964|NCT01456780|19095916|P3|Overall Study|Lost to Follow-up|0
5523965|NCT01456780|19095917|P2|Overall Study|Lost to Follow-up|3
5523966|NCT01456780|19095918|P1|Overall Study|Lost to Follow-up|3
5523967|NCT01456221|19095967|P2|Overall Study|Incomplete data|2
5523968|NCT01456221|19095968|P1|Overall Study|Incomplete data|4
5523969|NCT01456221|19095967|P2|Overall Study|Received medication|2
5523970|NCT01456221|19095968|P1|Overall Study|Received medication|3
5523971|NCT01456221|19095967|P2|Overall Study|Lost to Follow-up|4
5523972|NCT01456221|19095968|P1|Overall Study|Lost to Follow-up|1
5523973|NCT01456221|19095967|P2|Overall Study|Withdrawal by Subject|49
5523974|NCT01456221|19095968|P1|Overall Study|Withdrawal by Subject|56
5523975|NCT01456195|19095983|P3|Overall Study|Other Reasons|3
5523976|NCT01456195|19095984|P2|Overall Study|Other Reasons|1
5523977|NCT01456195|19095985|P1|Overall Study|Other Reasons|2
5523978|NCT01456195|19095983|P3|Overall Study|Lack of Efficacy|0
5523979|NCT01456195|19095984|P2|Overall Study|Lack of Efficacy|1
5523980|NCT01456195|19095985|P1|Overall Study|Lack of Efficacy|0
5523981|NCT01456195|19095983|P3|Overall Study|Voluntary Withdrawal|7
5523982|NCT01456195|19095984|P2|Overall Study|Voluntary Withdrawal|3
5523983|NCT01456195|19095985|P1|Overall Study|Voluntary Withdrawal|5
5523984|NCT01456195|19095983|P3|Overall Study|Lost to Follow-up|3
5523985|NCT01456195|19095984|P2|Overall Study|Lost to Follow-up|1
5523986|NCT01456195|19095985|P1|Overall Study|Lost to Follow-up|3
5523987|NCT01456195|19095983|P3|Overall Study|Pretreatment Event/Adverse Event|1
5523988|NCT01456195|19095984|P2|Overall Study|Pretreatment Event/Adverse Event|4
5523989|NCT01456195|19095985|P1|Overall Study|Pretreatment Event/Adverse Event|1
5523990|NCT01456169|19096005|P3|Overall Study|Other|0
5523991|NCT01456169|19096006|P2|Overall Study|Other|1
5523992|NCT01456169|19096007|P1|Overall Study|Other|1
5523993|NCT01456169|19096005|P3|Overall Study|Lack of Efficacy|0
5523994|NCT01456169|19096006|P2|Overall Study|Lack of Efficacy|0
5523995|NCT01456169|19096007|P1|Overall Study|Lack of Efficacy|2
5523996|NCT01456169|19096005|P3|Overall Study|Voluntary Withdrawal|2
5523997|NCT01456169|19096006|P2|Overall Study|Voluntary Withdrawal|0
5523998|NCT01456169|19096007|P1|Overall Study|Voluntary Withdrawal|3
5523999|NCT01456169|19096005|P3|Overall Study|Major Protocol Deviation|3
5524000|NCT01456169|19096006|P2|Overall Study|Major Protocol Deviation|2
5524001|NCT01456169|19096007|P1|Overall Study|Major Protocol Deviation|3
5524002|NCT01456169|19096005|P3|Overall Study|Adverse Event|7
5524003|NCT01456169|19096006|P2|Overall Study|Adverse Event|2
5524004|NCT01456169|19096007|P1|Overall Study|Adverse Event|1
5524005|NCT01456130|19096067|P1|Overall Study|Other|1
5524006|NCT01456130|19096067|P1|Overall Study|Lack of Efficacy|4
5524007|NCT01456130|19096067|P1|Overall Study|Voluntary Withdrawal|1
5524008|NCT01456130|19096067|P1|Overall Study|Adverse Event|4
5524009|NCT01456052|19096077|P3|Overall Study|Treatment Failure|1
5524010|NCT01456052|19096078|P2|Overall Study|Treatment Failure|1
5524011|NCT01456052|19096079|P1|Overall Study|Treatment Failure|0
5524012|NCT01456052|19096077|P3|Overall Study|Physician Decision|1
5524013|NCT01456052|19096078|P2|Overall Study|Physician Decision|0
5524014|NCT01456052|19096079|P1|Overall Study|Physician Decision|1
5524015|NCT01456052|19096077|P3|Overall Study|Protocol Violation|0
5524016|NCT01456052|19096078|P2|Overall Study|Protocol Violation|1
5524017|NCT01456052|19096079|P1|Overall Study|Protocol Violation|0
5524018|NCT01456052|19096077|P3|Overall Study|Consent withdrawn|1
5524019|NCT01456052|19096078|P2|Overall Study|Consent withdrawn|2
5524020|NCT01456052|19096079|P1|Overall Study|Consent withdrawn|0
5524021|NCT01456052|19096077|P3|Overall Study|Adverse Event|2
5524022|NCT01456052|19096078|P2|Overall Study|Adverse Event|1
5524023|NCT01456052|19096079|P1|Overall Study|Adverse Event|1
5524024|NCT01456039|19096099|P3|Phase 2 (Second Step)|Other|1
5524025|NCT01456039|19096100|P2|Phase 2 (Second Step)|Other|0
5524026|NCT01456039|19096101|P1|Phase 2 (Second Step)|Other|0
5524027|NCT01456039|19096099|P3|Phase 2 (Second Step)|Protocol Violation|1
5524028|NCT01456039|19096100|P2|Phase 2 (Second Step)|Protocol Violation|0
5524029|NCT01456039|19096101|P1|Phase 2 (Second Step)|Protocol Violation|0
5524030|NCT01456039|19096099|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
5524031|NCT01456039|19096100|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
5524032|NCT01456039|19096101|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
5524033|NCT01456039|19096099|P3|Phase 2 (Second Step)|Adverse Event|10
5524034|NCT01456039|19096100|P2|Phase 2 (Second Step)|Adverse Event|0
5524035|NCT01456039|19096101|P1|Phase 2 (Second Step)|Adverse Event|0
5524036|NCT01456039|19096099|P3|Phase 2 (Second Step)|Disease Progression|17
5524037|NCT01456039|19096100|P2|Phase 2 (Second Step)|Disease Progression|0
5524038|NCT01456039|19096101|P1|Phase 2 (Second Step)|Disease Progression|0
5524039|NCT01456039|19096099|P3|Phase 1 (First Step)|Other|0
5524040|NCT01456039|19096100|P2|Phase 1 (First Step)|Other|1
5524041|NCT01456039|19096101|P1|Phase 1 (First Step)|Other|0
5524042|NCT01456039|19096099|P3|Phase 1 (First Step)|Adverse Event|0
5524043|NCT01456039|19096100|P2|Phase 1 (First Step)|Adverse Event|3
5524044|NCT01456039|19096101|P1|Phase 1 (First Step)|Adverse Event|0
5524045|NCT01456039|19096099|P3|Phase 1 (First Step)|Withdrawal by Subject|0
5524046|NCT01456039|19096100|P2|Phase 1 (First Step)|Withdrawal by Subject|2
5524047|NCT01456039|19096101|P1|Phase 1 (First Step)|Withdrawal by Subject|1
5524048|NCT01456039|19096099|P3|Phase 1 (First Step)|Disease Progression|0
5524049|NCT01456039|19096100|P2|Phase 1 (First Step)|Disease Progression|1
5524050|NCT01456039|19096101|P1|Phase 1 (First Step)|Disease Progression|1
5524051|NCT01455428|19096244|P2|Overall Study|Other|4
5524052|NCT01455428|19096245|P1|Overall Study|Other|2
5524053|NCT01455428|19096244|P2|Overall Study|Did not receive treatment|1
5524054|NCT01455428|19096245|P1|Overall Study|Did not receive treatment|1
5524055|NCT01455428|19096244|P2|Overall Study|Insufficient clinical response|2
5524056|NCT01455428|19096245|P1|Overall Study|Insufficient clinical response|0
5524057|NCT01455428|19096244|P2|Overall Study|Did not meet entrance criteria|2
5524058|NCT01455428|19096245|P1|Overall Study|Did not meet entrance criteria|0
5524059|NCT01455428|19096244|P2|Overall Study|Withdrawal by Subject|5
5524060|NCT01455428|19096245|P1|Overall Study|Withdrawal by Subject|2
5524061|NCT01455428|19096244|P2|Overall Study|Lost to Follow-up|1
5524062|NCT01455428|19096245|P1|Overall Study|Lost to Follow-up|1
5524063|NCT01455428|19096244|P2|Overall Study|Adverse Event|2
5524064|NCT01455428|19096245|P1|Overall Study|Adverse Event|6
5524065|NCT01455428|19096244|P2|Overall Study|Protocol Violation|1
5524066|NCT01455428|19096245|P1|Overall Study|Protocol Violation|2
5524067|NCT01455415|19096301|P2|Follow-up|Unspecified Reason|0
5524068|NCT01455415|19096302|P1|Follow-up|Unspecified Reason|1
5524069|NCT01455415|19096301|P2|Follow-up|Withdrawal by Subject|0
5524070|NCT01455415|19096302|P1|Follow-up|Withdrawal by Subject|2
5524071|NCT01455415|19096301|P2|Follow-up|Lack of Efficacy|1
5524072|NCT01455415|19096302|P1|Follow-up|Lack of Efficacy|0
5524073|NCT01455415|19096301|P2|Follow-up|AE Related to Study Drug|1
5524074|NCT01455415|19096302|P1|Follow-up|AE Related to Study Drug|0
5524075|NCT01455415|19096301|P2|Period 2|Protocol Violation|0
5524076|NCT01455415|19096302|P1|Period 2|Protocol Violation|2
5524077|NCT01455415|19096301|P2|Period 2|Unspecified Reason|3
5524078|NCT01455415|19096302|P1|Period 2|Unspecified Reason|2
5524079|NCT01455415|19096301|P2|Period 2|Withdrawal by Subject|3
5524080|NCT01455415|19096302|P1|Period 2|Withdrawal by Subject|2
5524081|NCT01455415|19096301|P2|Period 2|Lack of Efficacy|0
5524082|NCT01455415|19096302|P1|Period 2|Lack of Efficacy|2
5524083|NCT01455415|19096301|P2|Period 2|AE Not Related to Study Drug|1
5524084|NCT01455415|19096302|P1|Period 2|AE Not Related to Study Drug|2
5524085|NCT01455415|19096301|P2|Period 2|Lost to Follow-up|1
5524086|NCT01455415|19096302|P1|Period 2|Lost to Follow-up|2
5524087|NCT01455415|19096301|P2|Period 2|AE Related to Study Drug|2
5524088|NCT01455415|19096302|P1|Period 2|AE Related to Study Drug|1
5524089|NCT01455415|19096301|P2|Washout|Protocol Violation|1
5524090|NCT01455415|19096302|P1|Washout|Protocol Violation|0
5524091|NCT01455415|19096301|P2|Washout|Unspecified Reason|2
5524092|NCT01455415|19096302|P1|Washout|Unspecified Reason|1
5524093|NCT01455415|19096301|P2|Washout|AE Not Related to Study Drug|3
5524094|NCT01455415|19096302|P1|Washout|AE Not Related to Study Drug|2
5524095|NCT01455415|19096301|P2|Washout|Drug Error not Associated to AE|1
5524096|NCT01455415|19096302|P1|Washout|Drug Error not Associated to AE|2
5524097|NCT01455415|19096301|P2|Washout|Lost to Follow-up|0
5524098|NCT01455415|19096302|P1|Washout|Lost to Follow-up|1
5524099|NCT01455415|19096301|P2|Washout|AE Related to Study Drug|0
5524100|NCT01455415|19096302|P1|Washout|AE Related to Study Drug|2
5524101|NCT01455415|19096301|P2|Period 1|Protocol Violation|2
5524102|NCT01455415|19096302|P1|Period 1|Protocol Violation|0
5524103|NCT01455415|19096301|P2|Period 1|Unspecified Reason|1
5524104|NCT01455415|19096302|P1|Period 1|Unspecified Reason|1
5524105|NCT01455415|19096301|P2|Period 1|Withdrawal by Subject|5
5524106|NCT01455415|19096302|P1|Period 1|Withdrawal by Subject|4
5524107|NCT01455415|19096301|P2|Period 1|AE Not Related to Study Drug|6
5524108|NCT01455415|19096302|P1|Period 1|AE Not Related to Study Drug|2
5524109|NCT01455415|19096301|P2|Period 1|Drug Error not Associated to AE|1
5524110|NCT01455415|19096302|P1|Period 1|Drug Error not Associated to AE|0
5524111|NCT01455415|19096301|P2|Period 1|Lost To Follow-up Related to Study Drug|3
5524112|NCT01455415|19096302|P1|Period 1|Lost To Follow-up Related to Study Drug|3
5524113|NCT01455415|19096301|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
5524114|NCT01455415|19096302|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
5524115|NCT01455220|19096352|P1|Overall Study|screen fail|30
5524116|NCT01455194|19096362|P4|Overall Study|Miscellaneous|4
5524117|NCT01455194|19096363|P3|Overall Study|Miscellaneous|1
5524118|NCT01455194|19096364|P2|Overall Study|Miscellaneous|5
5524119|NCT01455194|19096365|P1|Overall Study|Miscellaneous|4
5524120|NCT01455194|19096362|P4|Overall Study|Discontinuation criterion fulfilled|2
5524121|NCT01455194|19096363|P3|Overall Study|Discontinuation criterion fulfilled|0
5524122|NCT01455194|19096364|P2|Overall Study|Discontinuation criterion fulfilled|2
5524123|NCT01455194|19096365|P1|Overall Study|Discontinuation criterion fulfilled|3
5524124|NCT01455194|19096362|P4|Overall Study|Pregnancy|0
5524125|NCT01455194|19096363|P3|Overall Study|Pregnancy|1
5524126|NCT01455194|19096364|P2|Overall Study|Pregnancy|1
5524127|NCT01455194|19096365|P1|Overall Study|Pregnancy|0
5524128|NCT01455194|19096362|P4|Overall Study|Lost to Follow-up|1
5524129|NCT01455194|19096363|P3|Overall Study|Lost to Follow-up|1
5524130|NCT01455194|19096364|P2|Overall Study|Lost to Follow-up|0
5524131|NCT01455194|19096365|P1|Overall Study|Lost to Follow-up|2
5524132|NCT01455194|19096362|P4|Overall Study|Withdrawal by Subject|9
5524133|NCT01455194|19096363|P3|Overall Study|Withdrawal by Subject|12
5524134|NCT01455194|19096364|P2|Overall Study|Withdrawal by Subject|16
5524135|NCT01455194|19096365|P1|Overall Study|Withdrawal by Subject|21
5524136|NCT01455194|19096362|P4|Overall Study|Adverse Event|3
5524137|NCT01455194|19096363|P3|Overall Study|Adverse Event|1
5524138|NCT01455194|19096364|P2|Overall Study|Adverse Event|1
5524139|NCT01455194|19096365|P1|Overall Study|Adverse Event|1
5524140|NCT01455194|19096362|P4|Overall Study|Deterioration in asthma|9
5524141|NCT01455194|19096363|P3|Overall Study|Deterioration in asthma|14
5524142|NCT01455194|19096364|P2|Overall Study|Deterioration in asthma|6
5524143|NCT01455194|19096365|P1|Overall Study|Deterioration in asthma|12
5524144|NCT01455194|19096362|P4|Overall Study|Randomisation Failure|0
5524145|NCT01455194|19096363|P3|Overall Study|Randomisation Failure|0
5524146|NCT01455194|19096364|P2|Overall Study|Randomisation Failure|0
5524147|NCT01455194|19096365|P1|Overall Study|Randomisation Failure|90
5524148|NCT01455194|19096362|P4|Overall Study|Screen Failure|0
5524149|NCT01455194|19096363|P3|Overall Study|Screen Failure|0
5524150|NCT01455194|19096364|P2|Overall Study|Screen Failure|0
5524151|NCT01455194|19096365|P1|Overall Study|Screen Failure|20
5524152|NCT01455012|19096428|P2|Overall Study|Unknown reason|0
5524153|NCT01455012|19096429|P1|Overall Study|Unknown reason|2
5524154|NCT01455012|19096428|P2|Overall Study|Withdrawal by Subject|1
5524155|NCT01455012|19096429|P1|Overall Study|Withdrawal by Subject|3
5524156|NCT01455012|19096428|P2|Overall Study|Lack of Efficacy|1
5524157|NCT01455012|19096429|P1|Overall Study|Lack of Efficacy|6
5524158|NCT01455012|19096428|P2|Overall Study|Adverse Event|2
5524159|NCT01455012|19096429|P1|Overall Study|Adverse Event|0
5524160|NCT01454934|19096496|P2|Overall Study|Not treated|2
5524161|NCT01454934|19096497|P1|Overall Study|Not treated|1
5524162|NCT01454934|19096496|P2|Overall Study|Lost to Follow-up|1
5524163|NCT01454934|19096497|P1|Overall Study|Lost to Follow-up|0
5524164|NCT01454934|19096496|P2|Overall Study|Disease progression|181
5524165|NCT01454934|19096497|P1|Overall Study|Disease progression|194
5524166|NCT01454934|19096496|P2|Overall Study|Withdrawal by Subject|15
5524167|NCT01454934|19096497|P1|Overall Study|Withdrawal by Subject|11
5524168|NCT01454934|19096496|P2|Overall Study|Withdrawn consent|5
5524169|NCT01454934|19096497|P1|Overall Study|Withdrawn consent|2
5524170|NCT01454934|19096496|P2|Overall Study|Adverse Event|24
5524171|NCT01454934|19096497|P1|Overall Study|Adverse Event|28
5524172|NCT01454934|19096496|P2|Overall Study|Other|17
5524173|NCT01454934|19096497|P1|Overall Study|Other|6
5524174|NCT01454934|19096496|P2|Overall Study|Clinical progression|25
5524175|NCT01454934|19096497|P1|Overall Study|Clinical progression|28
5524176|NCT01454830|19096509|P2|Overall Study|Withdrawal - no polysomnography|2
5524177|NCT01454830|19096510|P1|Overall Study|Withdrawal - no polysomnography|3
5524178|NCT01454830|19096509|P2|Overall Study|Post-allocation Exclude-other treatment|7
5524179|NCT01454830|19096510|P1|Overall Study|Post-allocation Exclude-other treatment|6
5524180|NCT01454830|19096509|P2|Overall Study|Post-allocation Exclude-refused PAP|2
5524181|NCT01454830|19096510|P1|Overall Study|Post-allocation Exclude-refused PAP|0
5524182|NCT01454830|19096509|P2|Overall Study|Post-allocation Exclude- AHI<10|12
5524183|NCT01454830|19096510|P1|Overall Study|Post-allocation Exclude- AHI<10|18
5524184|NCT01454830|19096509|P2|Overall Study|Withdrawal by Subject|4
5524185|NCT01454830|19096510|P1|Overall Study|Withdrawal by Subject|4
5524186|NCT01454778|19096541|P1|Overall Study|Death|1
5524187|NCT01454778|19096541|P1|Overall Study|Lost to Follow-up|2
5524188|NCT01454739|19096552|P2|Overall Study|Adverse Event|1
5524189|NCT01454739|19096553|P1|Overall Study|Adverse Event|0
5524190|NCT01454739|19096552|P2|Overall Study|Lost to Follow-up|1
5524191|NCT01454739|19096553|P1|Overall Study|Lost to Follow-up|0
5524192|NCT01454739|19096552|P2|Overall Study|Physician Decision|5
5524193|NCT01454739|19096553|P1|Overall Study|Physician Decision|0
5524194|NCT01454739|19096552|P2|Overall Study|Other|5
5524195|NCT01454739|19096553|P1|Overall Study|Other|3
5524196|NCT01454739|19096552|P2|Overall Study|Withdrawal by Subject|6
5524197|NCT01454739|19096553|P1|Overall Study|Withdrawal by Subject|2
5524198|NCT01454739|19096552|P2|Overall Study|Protocol Violation|3
5524199|NCT01454739|19096553|P1|Overall Study|Protocol Violation|2
5524200|NCT01454726|19096582|P2|Overall Study|Withdrawal by Subject|1
5524201|NCT01454726|19096583|P1|Overall Study|Withdrawal by Subject|0
5524202|NCT01454596|19096601|P12|Overall Study|Death|0
5524203|NCT01454596|19096602|P11|Overall Study|Death|1
5524204|NCT01454596|19096603|P10|Overall Study|Death|1
5524205|NCT01454596|19096604|P9|Overall Study|Death|0
5524206|NCT01454596|19096605|P8|Overall Study|Death|0
5524207|NCT01454596|19096606|P7|Overall Study|Death|0
5524208|NCT01454596|19096607|P6|Overall Study|Death|0
5524209|NCT01454596|19096608|P5|Overall Study|Death|0
5524210|NCT01454596|19096609|P4|Overall Study|Death|0
5524211|NCT01454596|19096610|P3|Overall Study|Death|0
5524212|NCT01454596|19096611|P2|Overall Study|Death|0
5524213|NCT01454596|19096612|P1|Overall Study|Death|0
5524214|NCT01454583|19096689|P3|3rd Year|Lost to Follow-up|297
5524215|NCT01454583|19096690|P2|3rd Year|Lost to Follow-up|512
5524216|NCT01454583|19096691|P1|3rd Year|Lost to Follow-up|1959
5524217|NCT01454583|19096689|P3|2nd Year|Lost to Follow-up|737
5524218|NCT01454583|19096690|P2|2nd Year|Lost to Follow-up|1049
5524219|NCT01454583|19096691|P1|2nd Year|Lost to Follow-up|3965
5524220|NCT01454583|19096689|P3|1st Year|Lost to Follow-up|180
5524221|NCT01454583|19096690|P2|1st Year|Lost to Follow-up|318
5524222|NCT01454583|19096691|P1|1st Year|Lost to Follow-up|1057
5524223|NCT01454570|19096759|P1|Overall Study|Screen Failure|7
5524224|NCT01454570|19096759|P1|Overall Study|Withdrawal by Subject|2
5524225|NCT01454531|19096763|P1|Overall Study|Other|1
5524226|NCT01454531|19096763|P1|Overall Study|Delay in IMP administration|1
5524227|NCT01454531|19096763|P1|Overall Study|Physician Decision|1
5524228|NCT01454531|19096763|P1|Overall Study|Lost to Follow-up|1
5524229|NCT01454531|19096763|P1|Overall Study|Withdrawal by Subject|5
5524230|NCT01454531|19096763|P1|Overall Study|Adverse Event|14
5524231|NCT01454401|19096799|P1|Overall Study|non-adherence|1
5524232|NCT01454401|19096799|P1|Overall Study|osteomyelitis|2
5524233|NCT01454401|19096799|P1|Overall Study|hospitalised|1
5524234|NCT01454401|19096799|P1|Overall Study|Death|1
5524235|NCT01454284|19096823|P2|Overall Study|Sponsor Decision|2
5524236|NCT01454284|19096824|P1|Overall Study|Sponsor Decision|0
5524237|NCT01454284|19096823|P2|Overall Study|Physician Decision|11
5524238|NCT01454284|19096824|P1|Overall Study|Physician Decision|16
5524239|NCT01454284|19096823|P2|Overall Study|Withdrawal by Subject|36
5524240|NCT01454284|19096824|P1|Overall Study|Withdrawal by Subject|58
5524241|NCT01454284|19096823|P2|Overall Study|Protocol Violation|6
5524242|NCT01454284|19096824|P1|Overall Study|Protocol Violation|9
5524243|NCT01454284|19096823|P2|Overall Study|Lost to Follow-up|8
5524244|NCT01454284|19096824|P1|Overall Study|Lost to Follow-up|13
5524245|NCT01454284|19096823|P2|Overall Study|Death|3
5524246|NCT01454284|19096824|P1|Overall Study|Death|0
5524247|NCT01454284|19096823|P2|Overall Study|Adverse Event|7
5524248|NCT01454284|19096824|P1|Overall Study|Adverse Event|20
5524249|NCT01454102|19096894|P16|Overall Study|Continuing in the treatment period|1
5524250|NCT01454102|19096895|P15|Overall Study|Continuing in the treatment period|3
5524251|NCT01454102|19096896|P14|Overall Study|Continuing in the treatment period|4
5524252|NCT01454102|19096897|P13|Overall Study|Continuing in the treatment period|7
5524253|NCT01454102|19096898|P12|Overall Study|Continuing in the treatment period|4
5524254|NCT01454102|19096899|P11|Overall Study|Continuing in the treatment period|0
5524255|NCT01454102|19096900|P10|Overall Study|Continuing in the treatment period|0
5524256|NCT01454102|19096901|P9|Overall Study|Continuing in the treatment period|1
5524257|NCT01454102|19096902|P8|Overall Study|Continuing in the treatment period|0
5524258|NCT01454102|19096903|P7|Overall Study|Continuing in the treatment period|2
5524259|NCT01454102|19096904|P6|Overall Study|Continuing in the treatment period|3
5524260|NCT01454102|19096905|P5|Overall Study|Continuing in the treatment period|3
5524261|NCT01454102|19096906|P4|Overall Study|Continuing in the treatment period|0
5524262|NCT01454102|19096907|P3|Overall Study|Continuing in the treatment period|0
5524263|NCT01454102|19096908|P2|Overall Study|Continuing in the treatment period|0
5524264|NCT01454102|19096909|P1|Overall Study|Continuing in the treatment period|0
5524265|NCT01454076|19097029|P5|Overall Study|Adverse Event|2
5524266|NCT01454076|19097030|P4|Overall Study|Adverse Event|0
5524267|NCT01454076|19097031|P3|Overall Study|Adverse Event|7
5524268|NCT01454076|19097032|P2|Overall Study|Adverse Event|2
5524269|NCT01454076|19097033|P1|Overall Study|Adverse Event|8
5524270|NCT01454076|19097029|P5|Overall Study|Withdrawal by Subject|2
5524271|NCT01454076|19097030|P4|Overall Study|Withdrawal by Subject|1
5524272|NCT01454076|19097031|P3|Overall Study|Withdrawal by Subject|2
5524273|NCT01454076|19097032|P2|Overall Study|Withdrawal by Subject|4
5524274|NCT01454076|19097033|P1|Overall Study|Withdrawal by Subject|3
5524275|NCT01454076|19097029|P5|Overall Study|Other|2
5524276|NCT01454076|19097030|P4|Overall Study|Other|1
5524277|NCT01454076|19097031|P3|Overall Study|Other|0
5524278|NCT01454076|19097032|P2|Overall Study|Other|0
5524279|NCT01454076|19097033|P1|Overall Study|Other|2
5524280|NCT01454063|19097086|P2|Randomized|Protocol Violation|1
5524281|NCT01454063|19097087|P1|Randomized|Protocol Violation|0
5524282|NCT01454063|19097086|P2|Randomized|Adverse Event|1
5524283|NCT01454063|19097087|P1|Randomized|Adverse Event|1
5524284|NCT01453998|19097108|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
5524285|NCT01453998|19097109|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
5524286|NCT01453998|19097110|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
5524287|NCT01453946|19097274|P1|Overall Study|Adverse Event|3
5524288|NCT01453946|19097274|P1|Overall Study|Lack of Efficacy|3
5524289|NCT01453946|19097274|P1|Overall Study|Protocol Violation|2
5524290|NCT01453946|19097274|P1|Overall Study|Did not receive drug for the taper phase|1
5524291|NCT01453855|19097291|P2|Overall Study|Other|1
5524292|NCT01453855|19097292|P1|Overall Study|Other|0
5524293|NCT01453855|19097291|P2|Overall Study|Inadequate Control of IOP|5
5524294|NCT01453855|19097292|P1|Overall Study|Inadequate Control of IOP|1
5524295|NCT01453855|19097291|P2|Overall Study|Noncompliance|0
5524296|NCT01453855|19097292|P1|Overall Study|Noncompliance|1
5524297|NCT01453855|19097291|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
5524298|NCT01453855|19097292|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
5524299|NCT01453855|19097291|P2|Overall Study|Lost to Follow-up|1
5524300|NCT01453855|19097292|P1|Overall Study|Lost to Follow-up|2
5524301|NCT01453855|19097291|P2|Overall Study|Adverse Event|4
5524302|NCT01453855|19097292|P1|Overall Study|Adverse Event|3
5524303|NCT01453725|19097300|P2|Overall Study|Physician Decision|1
5524304|NCT01453725|19097301|P1|Overall Study|Physician Decision|1
5524305|NCT01453725|19097300|P2|Overall Study|Pregnancy|0
5524306|NCT01453725|19097301|P1|Overall Study|Pregnancy|1
5524307|NCT01453725|19097300|P2|Overall Study|Pregnancy Wish|2
5524308|NCT01453725|19097301|P1|Overall Study|Pregnancy Wish|0
5524309|NCT01453725|19097300|P2|Overall Study|Withdrawal by Subject|3
5524310|NCT01453725|19097301|P1|Overall Study|Withdrawal by Subject|2
5524311|NCT01453725|19097300|P2|Overall Study|Protocol Violation|0
5524312|NCT01453725|19097301|P1|Overall Study|Protocol Violation|1
5524313|NCT01453725|19097300|P2|Overall Study|Non-compliance With Protocol|2
5524314|NCT01453725|19097301|P1|Overall Study|Non-compliance With Protocol|1
5524315|NCT01453725|19097300|P2|Overall Study|Lost to Follow-up|0
5524316|NCT01453725|19097301|P1|Overall Study|Lost to Follow-up|4
5524317|NCT01453725|19097300|P2|Overall Study|Adverse Event|3
5524318|NCT01453725|19097301|P1|Overall Study|Adverse Event|3
5524319|NCT01453595|19097324|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
5524320|NCT01453595|19097325|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
5524321|NCT01453595|19097326|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
5524322|NCT01453439|19097356|P2|Follow-up|Lost to Follow-up|10
5524323|NCT01453439|19097357|P1|Follow-up|Lost to Follow-up|5
5524324|NCT01453439|19097356|P2|Follow-up|Withdrawal by Subject|1
5524325|NCT01453439|19097357|P1|Follow-up|Withdrawal by Subject|0
5524326|NCT01453439|19097356|P2|Treatment Phase|Therapist conflict of interest|0
5524327|NCT01453439|19097357|P1|Treatment Phase|Therapist conflict of interest|1
5524328|NCT01453439|19097356|P2|Treatment Phase|Need for higher level of care|1
5524329|NCT01453439|19097357|P1|Treatment Phase|Need for higher level of care|1
5524330|NCT01453439|19097356|P2|Treatment Phase|Suicidal Ideation|0
5524331|NCT01453439|19097357|P1|Treatment Phase|Suicidal Ideation|2
5524332|NCT01453439|19097356|P2|Treatment Phase|Withdrawal by Subject|10
5524333|NCT01453439|19097357|P1|Treatment Phase|Withdrawal by Subject|13
5524334|NCT01453374|19097468|P1|Overall Study|Incarcerated|2
5524335|NCT01453374|19097468|P1|Overall Study|Withdrawal by Subject|5
5524336|NCT01453374|19097468|P1|Overall Study|Lost to Follow-up|3
5524337|NCT01453374|19097468|P1|Overall Study|Lack of Efficacy|1
5524338|NCT01453374|19097468|P1|Overall Study|Adverse Event|7
5524339|NCT01453361|19097484|P1|Overall Study|Screen-Failures|10
5524340|NCT01453361|19097484|P1|Overall Study|Disease Progression|6
5524341|NCT01453348|19097492|P3|Overall Study|Protocol Violation|0
5524342|NCT01453348|19097493|P2|Overall Study|Protocol Violation|0
5524343|NCT01453348|19097494|P1|Overall Study|Protocol Violation|1
5524344|NCT01453348|19097492|P3|Overall Study|Withdrawal by Subject|0
5524345|NCT01453348|19097493|P2|Overall Study|Withdrawal by Subject|1
5524346|NCT01453348|19097494|P1|Overall Study|Withdrawal by Subject|0
5524347|NCT01453348|19097492|P3|Overall Study|Death|1
5524348|NCT01453348|19097493|P2|Overall Study|Death|0
5524349|NCT01453348|19097494|P1|Overall Study|Death|0
5524350|NCT01453296|19097510|P2|Treatment Period 2|Withdrawal by Subject|0
5524351|NCT01453296|19097511|P1|Treatment Period 2|Withdrawal by Subject|1
5524352|NCT01453296|19097510|P2|Treatment Period 2|Adverse Event|0
5524353|NCT01453296|19097511|P1|Treatment Period 2|Adverse Event|1
5524354|NCT01453296|19097510|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
5524355|NCT01453296|19097511|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
5524356|NCT01453296|19097510|P2|Treatment Period 1|Adverse Event|1
5524357|NCT01453296|19097511|P1|Treatment Period 1|Adverse Event|0
5524358|NCT01453205|19097578|P3|Overall Study|Other|35
5524359|NCT01453205|19097579|P2|Overall Study|Other|27
5524360|NCT01453205|19097580|P1|Overall Study|Other|45
5524361|NCT01453205|19097578|P3|Overall Study|Death|18
5524362|NCT01453205|19097579|P2|Overall Study|Death|22
5524363|NCT01453205|19097580|P1|Overall Study|Death|24
5524364|NCT01453205|19097578|P3|Overall Study|Withdrawal by Subject|0
5524365|NCT01453205|19097579|P2|Overall Study|Withdrawal by Subject|3
5524366|NCT01453205|19097580|P1|Overall Study|Withdrawal by Subject|8
5524367|NCT01453205|19097578|P3|Overall Study|Lost to Follow-up|1
5524368|NCT01453205|19097579|P2|Overall Study|Lost to Follow-up|0
5524369|NCT01453205|19097580|P1|Overall Study|Lost to Follow-up|3
5524370|NCT01453153|19097656|P3|Overall Study|Adverse Event|1
5524371|NCT01453153|19097657|P2|Overall Study|Adverse Event|1
5524372|NCT01453153|19097658|P1|Overall Study|Adverse Event|1
5524373|NCT01453153|19097656|P3|Overall Study|Withdrawal by Subject|2
5524374|NCT01453153|19097657|P2|Overall Study|Withdrawal by Subject|1
5524375|NCT01453153|19097658|P1|Overall Study|Withdrawal by Subject|0
5524376|NCT01453153|19097656|P3|Overall Study|Progressive Disease|16
5524377|NCT01453153|19097657|P2|Overall Study|Progressive Disease|2
5524378|NCT01453153|19097658|P1|Overall Study|Progressive Disease|3
5524379|NCT01453153|19097656|P3|Overall Study|Physician Decision|1
5524380|NCT01453153|19097657|P2|Overall Study|Physician Decision|0
5524381|NCT01453153|19097658|P1|Overall Study|Physician Decision|0
5524382|NCT01453049|19097740|P2|Overall Study|Randomized in Error|0
5524383|NCT01453049|19097741|P1|Overall Study|Randomized in Error|1
5524384|NCT01453049|19097740|P2|Overall Study|Withdrawal by Subject|0
5524385|NCT01453049|19097741|P1|Overall Study|Withdrawal by Subject|1
5524386|NCT01453049|19097740|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
5524387|NCT01453049|19097741|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
5524388|NCT01453049|19097740|P2|Overall Study|Lost to Follow-up|1
5524389|NCT01453049|19097741|P1|Overall Study|Lost to Follow-up|2
5524390|NCT01453049|19097740|P2|Overall Study|Protocol Violation|5
5524391|NCT01453049|19097741|P1|Overall Study|Protocol Violation|2
5524392|NCT01453036|19097814|P3|Overall Study|Lost to Follow-up|31
5524393|NCT01453036|19097815|P2|Overall Study|Lost to Follow-up|115
5524394|NCT01453036|19097816|P1|Overall Study|Lost to Follow-up|26
5524395|NCT01453023|19097824|P2|Treatment Period 2|Protocol Violation|1
5524396|NCT01453023|19097825|P1|Treatment Period 2|Protocol Violation|0
5524397|NCT01453023|19097824|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
5524398|NCT01453023|19097825|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
5524399|NCT01453023|19097824|P2|Treatment Period (TP) 1|Protocol Violation|0
5524400|NCT01453023|19097825|P1|Treatment Period (TP) 1|Protocol Violation|1
5524401|NCT01452789|19097899|P2|Overall Study|Withdrawal by Subject|2
5524402|NCT01452789|19097900|P1|Overall Study|Withdrawal by Subject|3
5524403|NCT01452529|19097914|P3|Double-blind (DB) Period|Administrative|7
5524404|NCT01452529|19097915|P2|Double-blind (DB) Period|Administrative|11
5524405|NCT01452529|19097916|P1|Double-blind (DB) Period|Administrative|0
5524406|NCT01452529|19097914|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
5524407|NCT01452529|19097915|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
5524408|NCT01452529|19097916|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
5524409|NCT01452529|19097914|P3|Double-blind (DB) Period|Lack of Efficacy|44
5524410|NCT01452529|19097915|P2|Double-blind (DB) Period|Lack of Efficacy|16
5524411|NCT01452529|19097916|P1|Double-blind (DB) Period|Lack of Efficacy|0
5524412|NCT01452529|19097914|P3|Double-blind (DB) Period|Lost to Follow-up|3
5524413|NCT01452529|19097915|P2|Double-blind (DB) Period|Lost to Follow-up|5
5524414|NCT01452529|19097916|P1|Double-blind (DB) Period|Lost to Follow-up|0
5524415|NCT01452529|19097914|P3|Double-blind (DB) Period|Withdrawal by Subject|14
5524416|NCT01452529|19097915|P2|Double-blind (DB) Period|Withdrawal by Subject|15
5524417|NCT01452529|19097916|P1|Double-blind (DB) Period|Withdrawal by Subject|0
5524418|NCT01452529|19097914|P3|Double-blind (DB) Period|Adverse Event|11
5524419|NCT01452529|19097915|P2|Double-blind (DB) Period|Adverse Event|18
5524420|NCT01452529|19097916|P1|Double-blind (DB) Period|Adverse Event|0
5524421|NCT01452529|19097914|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
5524422|NCT01452529|19097915|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
5524423|NCT01452529|19097916|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
5524424|NCT01452529|19097914|P3|Run-in Period|Administrative|0
5524425|NCT01452529|19097915|P2|Run-in Period|Administrative|0
5524426|NCT01452529|19097916|P1|Run-in Period|Administrative|21
5524427|NCT01452529|19097914|P3|Run-in Period|Confirmed or suspected diversion|0
5524428|NCT01452529|19097915|P2|Run-in Period|Confirmed or suspected diversion|0
5524429|NCT01452529|19097916|P1|Run-in Period|Confirmed or suspected diversion|23
5524430|NCT01452529|19097914|P3|Run-in Period|Lack of Efficacy|0
5524431|NCT01452529|19097915|P2|Run-in Period|Lack of Efficacy|0
5524432|NCT01452529|19097916|P1|Run-in Period|Lack of Efficacy|46
5524433|NCT01452529|19097914|P3|Run-in Period|Lost to Follow-up|0
5524434|NCT01452529|19097915|P2|Run-in Period|Lost to Follow-up|0
5524435|NCT01452529|19097916|P1|Run-in Period|Lost to Follow-up|19
5524436|NCT01452529|19097914|P3|Run-in Period|Withdrawal by Subject|0
5524437|NCT01452529|19097915|P2|Run-in Period|Withdrawal by Subject|0
5524438|NCT01452529|19097916|P1|Run-in Period|Withdrawal by Subject|49
5524439|NCT01452529|19097914|P3|Run-in Period|Adverse Event|0
5524440|NCT01452529|19097915|P2|Run-in Period|Adverse Event|0
5524441|NCT01452529|19097916|P1|Run-in Period|Adverse Event|96
5524442|NCT01452412|19097938|P2|Overall Study|Other|0
5524443|NCT01452412|19097939|P1|Overall Study|Other|2
5524444|NCT01452412|19097938|P2|Overall Study|Initiated dialysis|0
5524445|NCT01452412|19097939|P1|Overall Study|Initiated dialysis|1
5524446|NCT01452412|19097938|P2|Overall Study|Death|0
5524447|NCT01452412|19097939|P1|Overall Study|Death|1
5524448|NCT01452412|19097938|P2|Overall Study|Lost to Follow-up|3
5524449|NCT01452412|19097939|P1|Overall Study|Lost to Follow-up|5
5524450|NCT01452412|19097938|P2|Overall Study|Adverse Event|3
5524451|NCT01452412|19097939|P1|Overall Study|Adverse Event|4
5524452|NCT01452412|19097938|P2|Overall Study|Withdrawal by Subject|11
5524453|NCT01452412|19097939|P1|Overall Study|Withdrawal by Subject|15
5524454|NCT01452347|19097955|P2|Overall Study|Other reason not defined above|0
5524455|NCT01452347|19097956|P1|Overall Study|Other reason not defined above|2
5524456|NCT01452347|19097955|P2|Overall Study|Not treated|3
5524457|NCT01452347|19097956|P1|Overall Study|Not treated|6
5524458|NCT01452347|19097955|P2|Overall Study|Withdrawal by Subject|3
5524459|NCT01452347|19097956|P1|Overall Study|Withdrawal by Subject|3
5524460|NCT01452347|19097955|P2|Overall Study|Lost to Follow-up|0
5524461|NCT01452347|19097956|P1|Overall Study|Lost to Follow-up|2
5524462|NCT01452347|19097955|P2|Overall Study|Non compliance protocol|0
5524463|NCT01452347|19097956|P1|Overall Study|Non compliance protocol|2
5524464|NCT01452347|19097955|P2|Overall Study|Adverse Event|1
5524465|NCT01452347|19097956|P1|Overall Study|Adverse Event|2
5524466|NCT01452152|19098016|P3|Overall Study|Study termination by sponsor|4
5524467|NCT01452152|19098017|P2|Overall Study|Study termination by sponsor|0
5524468|NCT01452152|19098018|P1|Overall Study|Study termination by sponsor|5
5524469|NCT01451931|19098090|P3|Overall Study|Withdrawal by Subject|22
5524470|NCT01451931|19098091|P2|Overall Study|Withdrawal by Subject|22
5524471|NCT01451931|19098092|P1|Overall Study|Withdrawal by Subject|16
5524472|NCT01451931|19098090|P3|Overall Study|Lost to Follow-up|21
5524473|NCT01451931|19098091|P2|Overall Study|Lost to Follow-up|36
5524474|NCT01451931|19098092|P1|Overall Study|Lost to Follow-up|17
5524475|NCT01451827|19098116|P4|Overall Study|Withdrawal by Subject|1
5524476|NCT01451827|19098117|P3|Overall Study|Withdrawal by Subject|1
5524477|NCT01451827|19098118|P2|Overall Study|Withdrawal by Subject|0
5524478|NCT01451827|19098119|P1|Overall Study|Withdrawal by Subject|0
5524479|NCT01451827|19098116|P4|Overall Study|Participant met withdrawal criteria|0
5524480|NCT01451827|19098117|P3|Overall Study|Participant met withdrawal criteria|0
5524481|NCT01451827|19098118|P2|Overall Study|Participant met withdrawal criteria|2
5524482|NCT01451827|19098119|P1|Overall Study|Participant met withdrawal criteria|0
5524483|NCT01451827|19098116|P4|Overall Study|Lost to Follow-up|2
5524484|NCT01451827|19098117|P3|Overall Study|Lost to Follow-up|0
5524485|NCT01451827|19098118|P2|Overall Study|Lost to Follow-up|3
5524486|NCT01451827|19098119|P1|Overall Study|Lost to Follow-up|0
5524487|NCT01451827|19098116|P4|Overall Study|Protocol deviation|0
5524488|NCT01451827|19098117|P3|Overall Study|Protocol deviation|0
5524489|NCT01451827|19098118|P2|Overall Study|Protocol deviation|0
5524490|NCT01451827|19098119|P1|Overall Study|Protocol deviation|1
5524491|NCT01451827|19098116|P4|Overall Study|Adverse Event|1
5524492|NCT01451827|19098117|P3|Overall Study|Adverse Event|1
5524493|NCT01451827|19098118|P2|Overall Study|Adverse Event|0
5524494|NCT01451827|19098119|P1|Overall Study|Adverse Event|2
5524495|NCT01451814|19098139|P2|Overall Study|Lost to Follow-up|4
5524496|NCT01451814|19098140|P1|Overall Study|Lost to Follow-up|5
5524497|NCT01451814|19098139|P2|Overall Study|Withdrawal by Subject|1
5524498|NCT01451814|19098140|P1|Overall Study|Withdrawal by Subject|1
5524499|NCT01451762|19098172|P3|Overall Study|Lost to Follow-up|6
5524500|NCT01451762|19098173|P2|Overall Study|Lost to Follow-up|6
5524501|NCT01451762|19098174|P1|Overall Study|Lost to Follow-up|3
5524502|NCT01451749|19098184|P2|Overall Study|Withdrawal by Subject|1
5524503|NCT01451749|19098185|P1|Overall Study|Withdrawal by Subject|0
5524504|NCT01451749|19098184|P2|Overall Study|Adverse Event|0
5524505|NCT01451749|19098185|P1|Overall Study|Adverse Event|2
5524506|NCT01451749|19098184|P2|Overall Study|Meet the exclusion criteria,and|1
5524507|NCT01451749|19098185|P1|Overall Study|Meet the exclusion criteria,and|1
5524508|NCT01451749|19098184|P2|Overall Study|Lost to Follow-up|5
5524509|NCT01451749|19098185|P1|Overall Study|Lost to Follow-up|15
5524510|NCT01451749|19098184|P2|Overall Study|Protocol Violation|7
5524511|NCT01451749|19098185|P1|Overall Study|Protocol Violation|14
5524512|NCT01451723|19098197|P2|Overall Study|study halted|5
5524513|NCT01451723|19098198|P1|Overall Study|study halted|6
5524514|NCT01451645|19098208|P2|Overall Study|Lost to Follow-up|3
5524515|NCT01451645|19098209|P1|Overall Study|Lost to Follow-up|4
5524516|NCT01451645|19098208|P2|Overall Study|Withdrawal by Subject|2
5524517|NCT01451645|19098209|P1|Overall Study|Withdrawal by Subject|4
5524518|NCT01451645|19098208|P2|Overall Study|Adverse Event|3
5524519|NCT01451645|19098209|P1|Overall Study|Adverse Event|0
5524520|NCT01451645|19098208|P2|Overall Study|Protocol Violation|0
5524521|NCT01451645|19098209|P1|Overall Study|Protocol Violation|1
5524522|NCT01451606|19098280|P2|Overall Study|Withdrawal by Subject|3
5524523|NCT01451606|19098281|P1|Overall Study|Withdrawal by Subject|4
5524524|NCT01451554|19098291|P2|Overall Study|Withdrawal by Subject|9
5524525|NCT01451554|19098292|P1|Overall Study|Withdrawal by Subject|14
5524526|NCT01451541|19098303|P3|Overall Study|randomization error, noncompliance|8
5524527|NCT01451541|19098304|P2|Overall Study|randomization error, noncompliance|10
5524528|NCT01451541|19098305|P1|Overall Study|randomization error, noncompliance|11
5524529|NCT01451541|19098303|P3|Overall Study|Withdrawal by Subject|6
5524530|NCT01451541|19098304|P2|Overall Study|Withdrawal by Subject|8
5524531|NCT01451541|19098305|P1|Overall Study|Withdrawal by Subject|15
5524532|NCT01451541|19098303|P3|Overall Study|Lost to Follow-up|7
5524533|NCT01451541|19098304|P2|Overall Study|Lost to Follow-up|4
5524534|NCT01451541|19098305|P1|Overall Study|Lost to Follow-up|4
5524535|NCT01451541|19098303|P3|Overall Study|Lack of Efficacy|0
5524536|NCT01451541|19098304|P2|Overall Study|Lack of Efficacy|0
5524537|NCT01451541|19098305|P1|Overall Study|Lack of Efficacy|2
5524538|NCT01451541|19098303|P3|Overall Study|Adverse Event|6
5524539|NCT01451541|19098304|P2|Overall Study|Adverse Event|3
5524540|NCT01451541|19098305|P1|Overall Study|Adverse Event|4
5524541|NCT01451437|19098363|P9|Overall Study|Withdrawal by Subject|0
5524542|NCT01451437|19098364|P8|Overall Study|Withdrawal by Subject|0
5524543|NCT01451437|19098365|P7|Overall Study|Withdrawal by Subject|1
5524544|NCT01451437|19098366|P6|Overall Study|Withdrawal by Subject|0
5524545|NCT01451437|19098367|P5|Overall Study|Withdrawal by Subject|1
5524546|NCT01451437|19098368|P4|Overall Study|Withdrawal by Subject|0
5524547|NCT01451437|19098369|P3|Overall Study|Withdrawal by Subject|0
5524548|NCT01451437|19098370|P2|Overall Study|Withdrawal by Subject|0
5524549|NCT01451437|19098371|P1|Overall Study|Withdrawal by Subject|0
5524550|NCT01451437|19098363|P9|Overall Study|Protocol Violation|0
5524551|NCT01451437|19098364|P8|Overall Study|Protocol Violation|0
5524552|NCT01451437|19098365|P7|Overall Study|Protocol Violation|1
5524553|NCT01451437|19098366|P6|Overall Study|Protocol Violation|0
5524554|NCT01451437|19098367|P5|Overall Study|Protocol Violation|0
5524555|NCT01451437|19098368|P4|Overall Study|Protocol Violation|0
5524556|NCT01451437|19098369|P3|Overall Study|Protocol Violation|0
5524557|NCT01451437|19098370|P2|Overall Study|Protocol Violation|0
5524558|NCT01451437|19098371|P1|Overall Study|Protocol Violation|0
5524559|NCT01451437|19098363|P9|Overall Study|Disease Progression|3
5524560|NCT01451437|19098364|P8|Overall Study|Disease Progression|1
5524561|NCT01451437|19098365|P7|Overall Study|Disease Progression|3
5524562|NCT01451437|19098366|P6|Overall Study|Disease Progression|2
5524563|NCT01451437|19098367|P5|Overall Study|Disease Progression|3
5524564|NCT01451437|19098368|P4|Overall Study|Disease Progression|1
5524565|NCT01451437|19098369|P3|Overall Study|Disease Progression|1
5524566|NCT01451437|19098370|P2|Overall Study|Disease Progression|0
5524567|NCT01451437|19098371|P1|Overall Study|Disease Progression|0
5524568|NCT01451437|19098363|P9|Overall Study|Physician Decision|0
5524569|NCT01451437|19098364|P8|Overall Study|Physician Decision|0
5524570|NCT01451437|19098365|P7|Overall Study|Physician Decision|0
5524571|NCT01451437|19098366|P6|Overall Study|Physician Decision|0
5524572|NCT01451437|19098367|P5|Overall Study|Physician Decision|0
5524573|NCT01451437|19098368|P4|Overall Study|Physician Decision|0
5524574|NCT01451437|19098369|P3|Overall Study|Physician Decision|2
5524575|NCT01451437|19098370|P2|Overall Study|Physician Decision|1
5524576|NCT01451437|19098371|P1|Overall Study|Physician Decision|1
5524577|NCT01451437|19098363|P9|Overall Study|Adverse Event|1
5524578|NCT01451437|19098364|P8|Overall Study|Adverse Event|2
5524579|NCT01451437|19098365|P7|Overall Study|Adverse Event|1
5524580|NCT01451437|19098366|P6|Overall Study|Adverse Event|1
5524581|NCT01451437|19098367|P5|Overall Study|Adverse Event|0
5524582|NCT01451437|19098368|P4|Overall Study|Adverse Event|0
5524583|NCT01451437|19098369|P3|Overall Study|Adverse Event|0
5524584|NCT01451437|19098370|P2|Overall Study|Adverse Event|0
5524585|NCT01451437|19098371|P1|Overall Study|Adverse Event|0
5524586|NCT01451424|19098503|P4|Overall Study|Adverse Event|1
5524587|NCT01451424|19098504|P3|Overall Study|Adverse Event|0
5524588|NCT01451424|19098505|P2|Overall Study|Adverse Event|0
5524589|NCT01451424|19098506|P1|Overall Study|Adverse Event|0
5524590|NCT01451424|19098503|P4|Overall Study|Physician Decision|1
5524591|NCT01451424|19098504|P3|Overall Study|Physician Decision|1
5524592|NCT01451424|19098505|P2|Overall Study|Physician Decision|0
5524593|NCT01451424|19098506|P1|Overall Study|Physician Decision|0
5524594|NCT01451424|19098503|P4|Overall Study|Lost to Follow-up|1
5524595|NCT01451424|19098504|P3|Overall Study|Lost to Follow-up|0
5524596|NCT01451424|19098505|P2|Overall Study|Lost to Follow-up|1
5524597|NCT01451424|19098506|P1|Overall Study|Lost to Follow-up|0
5524598|NCT01451424|19098503|P4|Overall Study|Withdrawal by Subject|2
5524599|NCT01451424|19098504|P3|Overall Study|Withdrawal by Subject|0
5524600|NCT01451424|19098505|P2|Overall Study|Withdrawal by Subject|1
5524601|NCT01451424|19098506|P1|Overall Study|Withdrawal by Subject|1
5524602|NCT01451398|19098564|P2|Overall Study|Lack of Efficacy|1
5524603|NCT01451398|19098565|P1|Overall Study|Lack of Efficacy|0
5524604|NCT01451398|19098564|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
5524605|NCT01451398|19098565|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
5524606|NCT01451398|19098564|P2|Overall Study|Moved out of country|1
5524607|NCT01451398|19098565|P1|Overall Study|Moved out of country|0
5524608|NCT01451398|19098564|P2|Overall Study|Non-compliance with protocol|1
5524609|NCT01451398|19098565|P1|Overall Study|Non-compliance with protocol|1
5524610|NCT01451398|19098564|P2|Overall Study|Non-compliance with study drug|3
5524611|NCT01451398|19098565|P1|Overall Study|Non-compliance with study drug|1
5524612|NCT01451398|19098564|P2|Overall Study|Lost to Follow-up|4
5524613|NCT01451398|19098565|P1|Overall Study|Lost to Follow-up|6
5524614|NCT01451398|19098564|P2|Overall Study|Withdrawal by Subject|14
5524615|NCT01451398|19098565|P1|Overall Study|Withdrawal by Subject|10
5524616|NCT01451398|19098564|P2|Overall Study|Physician Decision|1
5524617|NCT01451398|19098565|P1|Overall Study|Physician Decision|1
5524618|NCT01451398|19098564|P2|Overall Study|Protocol Violation|2
5524619|NCT01451398|19098565|P1|Overall Study|Protocol Violation|1
5524620|NCT01451398|19098564|P2|Overall Study|Adverse Event|9
5524621|NCT01451398|19098565|P1|Overall Study|Adverse Event|7
5524622|NCT01451203|19098616|P2|Post-treatment Period|Investigator decision|1
5524623|NCT01451203|19098617|P1|Post-treatment Period|Investigator decision|0
5524624|NCT01451203|19098616|P2|Post-treatment Period|Adverse Event|1
5524625|NCT01451203|19098617|P1|Post-treatment Period|Adverse Event|0
5524626|NCT01451203|19098616|P2|Post-treatment Period|Lack of Efficacy|28
5524627|NCT01451203|19098617|P1|Post-treatment Period|Lack of Efficacy|12
5524628|NCT01451203|19098616|P2|Post-treatment Period|Consent withdrawn|4
5524629|NCT01451203|19098617|P1|Post-treatment Period|Consent withdrawn|2
5524630|NCT01451203|19098616|P2|Double-blind Treatment Period|Investigator decision|0
5524631|NCT01451203|19098617|P1|Double-blind Treatment Period|Investigator decision|2
5524632|NCT01451203|19098616|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
5524633|NCT01451203|19098617|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
5524634|NCT01451203|19098616|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
5524635|NCT01451203|19098617|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
5524636|NCT01451203|19098616|P2|Double-blind Treatment Period|Adverse Event|9
5524637|NCT01451203|19098617|P1|Double-blind Treatment Period|Adverse Event|6
5524638|NCT01451203|19098616|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
5524639|NCT01451203|19098617|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
5524640|NCT01451203|19098616|P2|Double-blind Treatment Period|Lack of Efficacy|36
5524641|NCT01451203|19098617|P1|Double-blind Treatment Period|Lack of Efficacy|71
5524642|NCT01451203|19098616|P2|Double-blind Treatment Period|Consent Withdrawn|2
5524643|NCT01451203|19098617|P1|Double-blind Treatment Period|Consent Withdrawn|3
5524644|NCT01451203|19098616|P2|Double-blind Treatment Period|Did not receive treatment|2
5524645|NCT01451203|19098617|P1|Double-blind Treatment Period|Did not receive treatment|1
5524646|NCT01451164|19098635|P4|Overall Study|Lack of Efficacy|7
5524647|NCT01451164|19098636|P3|Overall Study|Lack of Efficacy|9
5524648|NCT01451164|19098637|P2|Overall Study|Lack of Efficacy|9
5524649|NCT01451164|19098638|P1|Overall Study|Lack of Efficacy|7
5524650|NCT01451164|19098635|P4|Overall Study|Protocol Violation|0
5524651|NCT01451164|19098636|P3|Overall Study|Protocol Violation|0
5524652|NCT01451164|19098637|P2|Overall Study|Protocol Violation|1
5524653|NCT01451164|19098638|P1|Overall Study|Protocol Violation|0
5524654|NCT01451164|19098635|P4|Overall Study|Withdrawal by Subject|17
5524655|NCT01451164|19098636|P3|Overall Study|Withdrawal by Subject|16
5524656|NCT01451164|19098637|P2|Overall Study|Withdrawal by Subject|11
5524657|NCT01451164|19098638|P1|Overall Study|Withdrawal by Subject|14
5524658|NCT01451164|19098635|P4|Overall Study|Physician Decision|0
5524659|NCT01451164|19098636|P3|Overall Study|Physician Decision|1
5524660|NCT01451164|19098637|P2|Overall Study|Physician Decision|0
5524661|NCT01451164|19098638|P1|Overall Study|Physician Decision|2
5524662|NCT01451164|19098635|P4|Overall Study|Withdrawal Criteria|1
5524663|NCT01451164|19098636|P3|Overall Study|Withdrawal Criteria|1
5524664|NCT01451164|19098637|P2|Overall Study|Withdrawal Criteria|1
5524665|NCT01451164|19098638|P1|Overall Study|Withdrawal Criteria|1
5524666|NCT01451164|19098635|P4|Overall Study|Adverse Event|21
5524667|NCT01451164|19098636|P3|Overall Study|Adverse Event|18
5524668|NCT01451164|19098637|P2|Overall Study|Adverse Event|12
5524669|NCT01451164|19098638|P1|Overall Study|Adverse Event|19
5524670|NCT01450943|19098667|P3|Overall Study|Screen failure, loss to follow-up|6
5524671|NCT01450943|19098668|P2|Overall Study|Screen failure, loss to follow-up|7
5524672|NCT01450943|19098669|P1|Overall Study|Screen failure, loss to follow-up|2
5524673|NCT01450813|19098702|P4|Overall Study|Physician Decision|3
5524674|NCT01450813|19098703|P3|Overall Study|Physician Decision|0
5524675|NCT01450813|19098704|P2|Overall Study|Physician Decision|1
5524676|NCT01450813|19098705|P1|Overall Study|Physician Decision|1
5524677|NCT01450800|19098719|P2|Overall Study|Protocol Violation|3
5524678|NCT01450800|19098720|P1|Overall Study|Protocol Violation|1
5524679|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
5524680|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
5524681|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
5524682|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
5524683|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Not reported|2
5524684|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Not reported|2
5524685|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
5524686|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
5524687|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
5524688|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
5524689|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
5524690|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
5524691|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
5524692|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
5524693|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Death|6
5524694|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Death|5
5524695|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
5524696|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
5524697|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
5524698|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
5524699|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
5524700|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
5524701|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
5524702|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
5524703|NCT01450761|19098755|P2|Treatment With Blinded Study Therapy|Disease progression|415
5524704|NCT01450761|19098756|P1|Treatment With Blinded Study Therapy|Disease progression|318
5524705|NCT01450761|19098755|P2|Lead-in Chemotherapy|Lost to Follow-up|0
5524706|NCT01450761|19098756|P1|Lead-in Chemotherapy|Lost to Follow-up|2
5524707|NCT01450761|19098755|P2|Lead-in Chemotherapy|Other|2
5524708|NCT01450761|19098756|P1|Lead-in Chemotherapy|Other|2
5524709|NCT01450761|19098755|P2|Lead-in Chemotherapy|Death|3
5524710|NCT01450761|19098756|P1|Lead-in Chemotherapy|Death|3
5524711|NCT01450761|19098755|P2|Lead-in Chemotherapy|No longer meets study criteria|7
5524712|NCT01450761|19098756|P1|Lead-in Chemotherapy|No longer meets study criteria|3
5524713|NCT01450761|19098755|P2|Lead-in Chemotherapy|Study drug toxicity|10
5524714|NCT01450761|19098756|P1|Lead-in Chemotherapy|Study drug toxicity|6
5524715|NCT01450761|19098755|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
5524716|NCT01450761|19098756|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
5524717|NCT01450761|19098755|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
5524718|NCT01450761|19098756|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
5524719|NCT01450761|19098755|P2|Lead-in Chemotherapy|Disease progression|32
5524720|NCT01450761|19098756|P1|Lead-in Chemotherapy|Disease progression|33
5524721|NCT01450761|19098755|P2|Randomization|Other|1
5524722|NCT01450761|19098756|P1|Randomization|Other|0
5524723|NCT01450761|19098755|P2|Randomization|Adverse Event unrelated to study drug|0
5524724|NCT01450761|19098756|P1|Randomization|Adverse Event unrelated to study drug|1
5524725|NCT01450761|19098755|P2|Randomization|Disease progression|2
5524726|NCT01450761|19098756|P1|Randomization|Disease progression|0
5524727|NCT01450761|19098755|P2|Randomization|Withdrawal by Subject|0
5524728|NCT01450761|19098756|P1|Randomization|Withdrawal by Subject|2
5524729|NCT01450761|19098755|P2|Randomization|Subject no longer meets study criteria|2
5524730|NCT01450761|19098756|P1|Randomization|Subject no longer meets study criteria|1
5524731|NCT01450696|19098768|P2|Overall Study|Study Terminated by Sponsor|58
5524732|NCT01450696|19098769|P1|Overall Study|Study Terminated by Sponsor|53
5524733|NCT01450696|19098768|P2|Overall Study|Withdrawal by Subject|2
5524734|NCT01450696|19098769|P1|Overall Study|Withdrawal by Subject|13
5524735|NCT01450696|19098768|P2|Overall Study|Non-Compliance|0
5524736|NCT01450696|19098769|P1|Overall Study|Non-Compliance|1
5524737|NCT01450696|19098768|P2|Overall Study|Lost to Follow-up|3
5524738|NCT01450696|19098769|P1|Overall Study|Lost to Follow-up|3
5524739|NCT01450696|19098768|P2|Overall Study|Death|84
5524740|NCT01450696|19098769|P1|Overall Study|Death|77
5524741|NCT01450696|19098768|P2|Overall Study|Never Treated|1
5524742|NCT01450696|19098769|P1|Overall Study|Never Treated|1
5524743|NCT01450683|19098791|P1|Overall Study|Adverse Event|2
5524744|NCT01450631|19098797|P2|Overall Study|Withdrawal by Subject|0
5524745|NCT01450631|19098798|P1|Overall Study|Withdrawal by Subject|1
5524746|NCT01450631|19098797|P2|Overall Study|Lost to Follow-up|4
5524747|NCT01450631|19098798|P1|Overall Study|Lost to Follow-up|2
5524748|NCT01450137|19098928|P2|Week 12 to Study End|Withdrawal by Subject|1
5524749|NCT01450137|19098929|P1|Week 12 to Study End|Withdrawal by Subject|0
5524750|NCT01450137|19098928|P2|Week 12 to Study End|Death|1
5524751|NCT01450137|19098929|P1|Week 12 to Study End|Death|0
5524752|NCT01450137|19098928|P2|Up to Week 12|Withdrawal by Subject|2
5524753|NCT01450137|19098929|P1|Up to Week 12|Withdrawal by Subject|0
5524754|NCT01450137|19098928|P2|Up to Week 12|Adverse Event|1
5524755|NCT01450137|19098929|P1|Up to Week 12|Adverse Event|2
5524756|NCT01450098|19098943|P2|Period 3|Withdrawal by Subject|2
5524757|NCT01450098|19098944|P1|Period 3|Withdrawal by Subject|0
5524758|NCT01450098|19098943|P2|Period 3|Protocol Violation|1
5524759|NCT01450098|19098944|P1|Period 3|Protocol Violation|0
5524760|NCT01450007|19098963|P3|Overall Study|Adverse Event|0
5524761|NCT01450007|19098964|P2|Overall Study|Adverse Event|1
5524762|NCT01450007|19098965|P1|Overall Study|Adverse Event|0
5524763|NCT01450007|19098963|P3|Overall Study|Protocol Violation|1
5524764|NCT01450007|19098964|P2|Overall Study|Protocol Violation|1
5524765|NCT01450007|19098965|P1|Overall Study|Protocol Violation|0
5524766|NCT01450007|19098963|P3|Overall Study|Late exclusion before treatment|2
5524767|NCT01450007|19098964|P2|Overall Study|Late exclusion before treatment|3
5524768|NCT01450007|19098965|P1|Overall Study|Late exclusion before treatment|2
5524769|NCT01449955|19098984|P2|Overall Study|Withdrawal by Subject|2
5524770|NCT01449955|19098985|P1|Overall Study|Withdrawal by Subject|1
5524771|NCT01449929|19099013|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
5524772|NCT01449929|19099014|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
5524773|NCT01449929|19099015|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
5524774|NCT01449929|19099013|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
5524775|NCT01449929|19099014|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
5524776|NCT01449929|19099015|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
5524777|NCT01449929|19099013|P3|Extension Phase Approximately 3 Years|Adverse Event|2
5524778|NCT01449929|19099014|P2|Extension Phase Approximately 3 Years|Adverse Event|0
5524779|NCT01449929|19099015|P1|Extension Phase Approximately 3 Years|Adverse Event|0
5524780|NCT01449929|19099013|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
5524781|NCT01449929|19099014|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
5524782|NCT01449929|19099015|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
5524783|NCT01449929|19099013|P3|Randomization Phase 96 Week|Physician Decision|0
5524784|NCT01449929|19099014|P2|Randomization Phase 96 Week|Physician Decision|3
5524785|NCT01449929|19099015|P1|Randomization Phase 96 Week|Physician Decision|2
5524786|NCT01449929|19099013|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
5524787|NCT01449929|19099014|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
5524788|NCT01449929|19099015|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
5524789|NCT01449929|19099013|P3|Randomization Phase 96 Week|Lost to Follow-up|0
5524790|NCT01449929|19099014|P2|Randomization Phase 96 Week|Lost to Follow-up|18
5524791|NCT01449929|19099015|P1|Randomization Phase 96 Week|Lost to Follow-up|15
5524792|NCT01449929|19099013|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
5524793|NCT01449929|19099014|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
5524794|NCT01449929|19099015|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
5524795|NCT01449929|19099013|P3|Randomization Phase 96 Week|Protocol Violation|0
5524796|NCT01449929|19099014|P2|Randomization Phase 96 Week|Protocol Violation|6
5524797|NCT01449929|19099015|P1|Randomization Phase 96 Week|Protocol Violation|5
5524798|NCT01449929|19099013|P3|Randomization Phase 96 Week|Lack of Efficacy|0
5524799|NCT01449929|19099014|P2|Randomization Phase 96 Week|Lack of Efficacy|4
5524800|NCT01449929|19099015|P1|Randomization Phase 96 Week|Lack of Efficacy|3
5524801|NCT01449929|19099013|P3|Randomization Phase 96 Week|Adverse Event|0
5524802|NCT01449929|19099014|P2|Randomization Phase 96 Week|Adverse Event|13
5524803|NCT01449929|19099015|P1|Randomization Phase 96 Week|Adverse Event|5
5524804|NCT01449812|19099060|P3|Overall Study|Lost to Follow-up|0
5524805|NCT01449812|19099061|P2|Overall Study|Lost to Follow-up|0
5524806|NCT01449812|19099062|P1|Overall Study|Lost to Follow-up|1
5524807|NCT01449812|19099060|P3|Overall Study|Withdrawal by Subject|1
5524808|NCT01449812|19099061|P2|Overall Study|Withdrawal by Subject|0
5524809|NCT01449812|19099062|P1|Overall Study|Withdrawal by Subject|0
5524810|NCT01449812|19099060|P3|Overall Study|Migrated/moved from study area|0
5524811|NCT01449812|19099061|P2|Overall Study|Migrated/moved from study area|0
5524812|NCT01449812|19099062|P1|Overall Study|Migrated/moved from study area|1
5524813|NCT01449721|19099177|P2|Overall Study|Physician Decision|1
5524814|NCT01449721|19099178|P1|Overall Study|Physician Decision|0
5524815|NCT01449721|19099177|P2|Overall Study|Physician Decision|1
5524816|NCT01449721|19099178|P1|Overall Study|Physician Decision|0
5524817|NCT01449708|19099190|P2|Overall Study|respiratory failure|0
5524818|NCT01449708|19099191|P1|Overall Study|respiratory failure|1
5524819|NCT01449708|19099190|P2|Overall Study|surgical complication|2
5524820|NCT01449708|19099191|P1|Overall Study|surgical complication|1
5524821|NCT01449708|19099190|P2|Overall Study|Protocol Violation|1
5524822|NCT01449708|19099191|P1|Overall Study|Protocol Violation|0
5524823|NCT01449682|19099202|P2|Overall Study|Adverse Event|0
5524824|NCT01449682|19099203|P1|Overall Study|Adverse Event|1
5524825|NCT01449682|19099202|P2|Overall Study|Death|1
5524826|NCT01449682|19099203|P1|Overall Study|Death|0
5524827|NCT01449630|19099224|P9|Period 2|Sponsor Decision|0
5524828|NCT01449630|19099225|P8|Period 2|Sponsor Decision|0
5524829|NCT01449630|19099226|P7|Period 2|Sponsor Decision|1
5524830|NCT01449630|19099227|P6|Period 2|Sponsor Decision|0
5524831|NCT01449630|19099228|P5|Period 2|Sponsor Decision|0
5524832|NCT01449630|19099229|P4|Period 2|Sponsor Decision|0
5524833|NCT01449630|19099230|P3|Period 2|Sponsor Decision|0
5524834|NCT01449630|19099231|P2|Period 2|Sponsor Decision|0
5524835|NCT01449630|19099232|P1|Period 2|Sponsor Decision|0
5524836|NCT01449630|19099224|P9|Period 1|Sponsor Decision|0
5524837|NCT01449630|19099225|P8|Period 1|Sponsor Decision|0
5524838|NCT01449630|19099226|P7|Period 1|Sponsor Decision|0
5524839|NCT01449630|19099227|P6|Period 1|Sponsor Decision|1
5524840|NCT01449630|19099228|P5|Period 1|Sponsor Decision|0
5524841|NCT01449630|19099229|P4|Period 1|Sponsor Decision|0
5524842|NCT01449630|19099230|P3|Period 1|Sponsor Decision|0
5524843|NCT01449630|19099231|P2|Period 1|Sponsor Decision|0
5524844|NCT01449630|19099232|P1|Period 1|Sponsor Decision|0
5524845|NCT01449630|19099224|P9|Period 1|Physician Decision|0
5524846|NCT01449630|19099225|P8|Period 1|Physician Decision|0
5524847|NCT01449630|19099226|P7|Period 1|Physician Decision|0
5524848|NCT01449630|19099227|P6|Period 1|Physician Decision|0
5524849|NCT01449630|19099228|P5|Period 1|Physician Decision|0
5524850|NCT01449630|19099229|P4|Period 1|Physician Decision|1
5524851|NCT01449630|19099230|P3|Period 1|Physician Decision|0
5524852|NCT01449630|19099231|P2|Period 1|Physician Decision|0
5524853|NCT01449630|19099232|P1|Period 1|Physician Decision|1
5524854|NCT01449539|19099302|P1|Overall Study|Toxicity not study related|1
5524855|NCT01449539|19099302|P1|Overall Study|Withdrawal by Subject|3
5524856|NCT01449526|19099308|P2|Overall Study|Cannot maintain visits|1
5524857|NCT01449526|19099309|P1|Overall Study|Cannot maintain visits|0
5524858|NCT01449526|19099308|P2|Overall Study|Lack of Motivation|1
5524859|NCT01449526|19099309|P1|Overall Study|Lack of Motivation|0
5524860|NCT01449526|19099308|P2|Overall Study|Symptoms/complaints|1
5524861|NCT01449526|19099309|P1|Overall Study|Symptoms/complaints|0
5524862|NCT01449526|19099308|P2|Overall Study|Withdrawal by Subject|1
5524863|NCT01449526|19099309|P1|Overall Study|Withdrawal by Subject|1
5524864|NCT01449526|19099308|P2|Overall Study|Lost to Follow-up|2
5524865|NCT01449526|19099309|P1|Overall Study|Lost to Follow-up|1
5524866|NCT01449461|19099378|P6|Overall Study|Reason not specified|1
5524867|NCT01449461|19099379|P5|Overall Study|Reason not specified|0
5524868|NCT01449461|19099380|P4|Overall Study|Reason not specified|3
5524869|NCT01449461|19099381|P3|Overall Study|Reason not specified|0
5524870|NCT01449461|19099382|P2|Overall Study|Reason not specified|1
5524871|NCT01449461|19099383|P1|Overall Study|Reason not specified|0
5524872|NCT01449461|19099378|P6|Overall Study|Clinical progressive disease|3
5524873|NCT01449461|19099379|P5|Overall Study|Clinical progressive disease|3
5524874|NCT01449461|19099380|P4|Overall Study|Clinical progressive disease|0
5524875|NCT01449461|19099381|P3|Overall Study|Clinical progressive disease|0
5524876|NCT01449461|19099382|P2|Overall Study|Clinical progressive disease|1
5524877|NCT01449461|19099383|P1|Overall Study|Clinical progressive disease|2
5524878|NCT01449461|19099378|P6|Overall Study|Documented progressive disease|5
5524879|NCT01449461|19099379|P5|Overall Study|Documented progressive disease|21
5524880|NCT01449461|19099380|P4|Overall Study|Documented progressive disease|11
5524881|NCT01449461|19099381|P3|Overall Study|Documented progressive disease|14
5524882|NCT01449461|19099382|P2|Overall Study|Documented progressive disease|6
5524883|NCT01449461|19099383|P1|Overall Study|Documented progressive disease|4
5524884|NCT01449461|19099378|P6|Overall Study|Death|1
5524885|NCT01449461|19099379|P5|Overall Study|Death|4
5524886|NCT01449461|19099380|P4|Overall Study|Death|0
5524887|NCT01449461|19099381|P3|Overall Study|Death|0
5524888|NCT01449461|19099382|P2|Overall Study|Death|1
5524889|NCT01449461|19099383|P1|Overall Study|Death|0
5524890|NCT01449461|19099378|P6|Overall Study|Adverse Event|3
5524891|NCT01449461|19099379|P5|Overall Study|Adverse Event|3
5524892|NCT01449461|19099380|P4|Overall Study|Adverse Event|3
5524893|NCT01449461|19099381|P3|Overall Study|Adverse Event|2
5524894|NCT01449461|19099382|P2|Overall Study|Adverse Event|3
5524895|NCT01449461|19099383|P1|Overall Study|Adverse Event|0
5524896|NCT01449461|19099378|P6|Overall Study|Ongoing|2
5524897|NCT01449461|19099379|P5|Overall Study|Ongoing|17
5524898|NCT01449461|19099380|P4|Overall Study|Ongoing|15
5524899|NCT01449461|19099381|P3|Overall Study|Ongoing|2
5524900|NCT01449461|19099382|P2|Overall Study|Ongoing|6
5524901|NCT01449461|19099383|P1|Overall Study|Ongoing|0
5524902|NCT01449370|19099520|P25|Overall Study|Death|1
5524903|NCT01449370|19099521|P24|Overall Study|Death|0
5524904|NCT01449370|19099522|P23|Overall Study|Death|0
5524905|NCT01449370|19099523|P22|Overall Study|Death|0
5524906|NCT01449370|19099524|P21|Overall Study|Death|0
5524907|NCT01449370|19099525|P20|Overall Study|Death|0
5524908|NCT01449370|19099526|P19|Overall Study|Death|0
5524909|NCT01449370|19099527|P18|Overall Study|Death|0
5524910|NCT01449370|19099528|P17|Overall Study|Death|0
5524911|NCT01449370|19099529|P16|Overall Study|Death|0
5524912|NCT01449370|19099530|P15|Overall Study|Death|0
5524913|NCT01449370|19099531|P14|Overall Study|Death|0
5524914|NCT01449370|19099532|P13|Overall Study|Death|0
5524915|NCT01449370|19099533|P12|Overall Study|Death|0
5524916|NCT01449370|19099534|P11|Overall Study|Death|0
5524917|NCT01449370|19099535|P10|Overall Study|Death|0
5524918|NCT01449370|19099536|P9|Overall Study|Death|0
5524919|NCT01449370|19099537|P8|Overall Study|Death|0
5524920|NCT01449370|19099538|P7|Overall Study|Death|0
5524921|NCT01449370|19099539|P6|Overall Study|Death|0
5524922|NCT01449370|19099540|P5|Overall Study|Death|0
5524923|NCT01449370|19099541|P4|Overall Study|Death|0
5524924|NCT01449370|19099542|P3|Overall Study|Death|0
5524925|NCT01449370|19099543|P2|Overall Study|Death|0
5524926|NCT01449370|19099544|P1|Overall Study|Death|0
5524927|NCT01449370|19099520|P25|Overall Study|Medication Prohibited by Protocol|0
5524928|NCT01449370|19099521|P24|Overall Study|Medication Prohibited by Protocol|1
5524929|NCT01449370|19099522|P23|Overall Study|Medication Prohibited by Protocol|0
5524930|NCT01449370|19099523|P22|Overall Study|Medication Prohibited by Protocol|0
5524931|NCT01449370|19099524|P21|Overall Study|Medication Prohibited by Protocol|0
5524932|NCT01449370|19099525|P20|Overall Study|Medication Prohibited by Protocol|0
5524933|NCT01449370|19099526|P19|Overall Study|Medication Prohibited by Protocol|0
5524934|NCT01449370|19099527|P18|Overall Study|Medication Prohibited by Protocol|0
5524935|NCT01449370|19099528|P17|Overall Study|Medication Prohibited by Protocol|0
5524936|NCT01449370|19099529|P16|Overall Study|Medication Prohibited by Protocol|0
5524937|NCT01449370|19099530|P15|Overall Study|Medication Prohibited by Protocol|0
5524938|NCT01449370|19099531|P14|Overall Study|Medication Prohibited by Protocol|0
5524939|NCT01449370|19099532|P13|Overall Study|Medication Prohibited by Protocol|0
5524940|NCT01449370|19099533|P12|Overall Study|Medication Prohibited by Protocol|0
5524941|NCT01449370|19099534|P11|Overall Study|Medication Prohibited by Protocol|0
5524942|NCT01449370|19099535|P10|Overall Study|Medication Prohibited by Protocol|0
5524943|NCT01449370|19099536|P9|Overall Study|Medication Prohibited by Protocol|0
5524944|NCT01449370|19099537|P8|Overall Study|Medication Prohibited by Protocol|0
5524945|NCT01449370|19099538|P7|Overall Study|Medication Prohibited by Protocol|0
5524946|NCT01449370|19099539|P6|Overall Study|Medication Prohibited by Protocol|0
5524947|NCT01449370|19099540|P5|Overall Study|Medication Prohibited by Protocol|0
5524948|NCT01449370|19099541|P4|Overall Study|Medication Prohibited by Protocol|0
5524949|NCT01449370|19099542|P3|Overall Study|Medication Prohibited by Protocol|0
5524950|NCT01449370|19099543|P2|Overall Study|Medication Prohibited by Protocol|0
5524951|NCT01449370|19099544|P1|Overall Study|Medication Prohibited by Protocol|0
5524952|NCT01449370|19099520|P25|Overall Study|Other|0
5524953|NCT01449370|19099521|P24|Overall Study|Other|1
5524954|NCT01449370|19099522|P23|Overall Study|Other|1
5524955|NCT01449370|19099523|P22|Overall Study|Other|0
5524956|NCT01449370|19099524|P21|Overall Study|Other|0
5524957|NCT01449370|19099525|P20|Overall Study|Other|0
5524958|NCT01449370|19099526|P19|Overall Study|Other|0
5524959|NCT01449370|19099527|P18|Overall Study|Other|0
5524960|NCT01449370|19099528|P17|Overall Study|Other|0
5524961|NCT01449370|19099529|P16|Overall Study|Other|0
5524962|NCT01449370|19099530|P15|Overall Study|Other|0
5524963|NCT01449370|19099531|P14|Overall Study|Other|0
5524964|NCT01449370|19099532|P13|Overall Study|Other|0
5524965|NCT01449370|19099533|P12|Overall Study|Other|0
5524966|NCT01449370|19099534|P11|Overall Study|Other|0
5524967|NCT01449370|19099535|P10|Overall Study|Other|1
5524968|NCT01449370|19099536|P9|Overall Study|Other|1
5524969|NCT01449370|19099537|P8|Overall Study|Other|0
5524970|NCT01449370|19099538|P7|Overall Study|Other|0
5524971|NCT01449370|19099539|P6|Overall Study|Other|0
5524972|NCT01449370|19099540|P5|Overall Study|Other|0
5524973|NCT01449370|19099541|P4|Overall Study|Other|0
5524974|NCT01449370|19099542|P3|Overall Study|Other|0
5524975|NCT01449370|19099543|P2|Overall Study|Other|0
5524976|NCT01449370|19099544|P1|Overall Study|Other|0
5524977|NCT01449370|19099520|P25|Overall Study|Lost to Follow-up|0
5524978|NCT01449370|19099521|P24|Overall Study|Lost to Follow-up|0
5524979|NCT01449370|19099522|P23|Overall Study|Lost to Follow-up|0
5524980|NCT01449370|19099523|P22|Overall Study|Lost to Follow-up|0
5524981|NCT01449370|19099524|P21|Overall Study|Lost to Follow-up|1
5524982|NCT01449370|19099525|P20|Overall Study|Lost to Follow-up|0
5524983|NCT01449370|19099526|P19|Overall Study|Lost to Follow-up|0
5524984|NCT01449370|19099527|P18|Overall Study|Lost to Follow-up|0
5524985|NCT01449370|19099528|P17|Overall Study|Lost to Follow-up|0
5524986|NCT01449370|19099529|P16|Overall Study|Lost to Follow-up|0
5524987|NCT01449370|19099530|P15|Overall Study|Lost to Follow-up|0
5524988|NCT01449370|19099531|P14|Overall Study|Lost to Follow-up|0
5524989|NCT01449370|19099532|P13|Overall Study|Lost to Follow-up|0
5524990|NCT01449370|19099533|P12|Overall Study|Lost to Follow-up|0
5524991|NCT01449370|19099534|P11|Overall Study|Lost to Follow-up|0
5524992|NCT01449370|19099535|P10|Overall Study|Lost to Follow-up|0
5524993|NCT01449370|19099536|P9|Overall Study|Lost to Follow-up|0
5524994|NCT01449370|19099537|P8|Overall Study|Lost to Follow-up|0
5524995|NCT01449370|19099538|P7|Overall Study|Lost to Follow-up|0
5524996|NCT01449370|19099539|P6|Overall Study|Lost to Follow-up|0
5524997|NCT01449370|19099540|P5|Overall Study|Lost to Follow-up|0
5524998|NCT01449370|19099541|P4|Overall Study|Lost to Follow-up|0
5524999|NCT01449370|19099542|P3|Overall Study|Lost to Follow-up|0
5525000|NCT01449370|19099543|P2|Overall Study|Lost to Follow-up|0
5525001|NCT01449370|19099544|P1|Overall Study|Lost to Follow-up|0
5525002|NCT01449370|19099520|P25|Overall Study|Participant Decision|1
5525003|NCT01449370|19099521|P24|Overall Study|Participant Decision|0
5525004|NCT01449370|19099522|P23|Overall Study|Participant Decision|0
5525005|NCT01449370|19099523|P22|Overall Study|Participant Decision|1
5525006|NCT01449370|19099524|P21|Overall Study|Participant Decision|0
5525007|NCT01449370|19099525|P20|Overall Study|Participant Decision|0
5525008|NCT01449370|19099526|P19|Overall Study|Participant Decision|1
5525009|NCT01449370|19099527|P18|Overall Study|Participant Decision|0
5525010|NCT01449370|19099528|P17|Overall Study|Participant Decision|3
5525011|NCT01449370|19099529|P16|Overall Study|Participant Decision|1
5525012|NCT01449370|19099530|P15|Overall Study|Participant Decision|0
5525013|NCT01449370|19099531|P14|Overall Study|Participant Decision|1
5525014|NCT01449370|19099532|P13|Overall Study|Participant Decision|1
5525015|NCT01449370|19099533|P12|Overall Study|Participant Decision|0
5525016|NCT01449370|19099534|P11|Overall Study|Participant Decision|0
5525017|NCT01449370|19099535|P10|Overall Study|Participant Decision|0
5525018|NCT01449370|19099536|P9|Overall Study|Participant Decision|1
5525019|NCT01449370|19099537|P8|Overall Study|Participant Decision|1
5525020|NCT01449370|19099538|P7|Overall Study|Participant Decision|0
5525021|NCT01449370|19099539|P6|Overall Study|Participant Decision|0
5525022|NCT01449370|19099540|P5|Overall Study|Participant Decision|0
5525023|NCT01449370|19099541|P4|Overall Study|Participant Decision|0
5525024|NCT01449370|19099542|P3|Overall Study|Participant Decision|0
5525025|NCT01449370|19099543|P2|Overall Study|Participant Decision|0
5525026|NCT01449370|19099544|P1|Overall Study|Participant Decision|0
5525027|NCT01449370|19099520|P25|Overall Study|Adverse Event|3
5525028|NCT01449370|19099521|P24|Overall Study|Adverse Event|1
5525029|NCT01449370|19099522|P23|Overall Study|Adverse Event|0
5525030|NCT01449370|19099523|P22|Overall Study|Adverse Event|1
5525031|NCT01449370|19099524|P21|Overall Study|Adverse Event|0
5525032|NCT01449370|19099525|P20|Overall Study|Adverse Event|1
5525033|NCT01449370|19099526|P19|Overall Study|Adverse Event|1
5525034|NCT01449370|19099527|P18|Overall Study|Adverse Event|0
5525035|NCT01449370|19099528|P17|Overall Study|Adverse Event|0
5525036|NCT01449370|19099529|P16|Overall Study|Adverse Event|1
5525037|NCT01449370|19099530|P15|Overall Study|Adverse Event|0
5525038|NCT01449370|19099531|P14|Overall Study|Adverse Event|2
5525039|NCT01449370|19099532|P13|Overall Study|Adverse Event|0
5525040|NCT01449370|19099533|P12|Overall Study|Adverse Event|0
5525041|NCT01449370|19099534|P11|Overall Study|Adverse Event|0
5525042|NCT01449370|19099535|P10|Overall Study|Adverse Event|1
5525043|NCT01449370|19099536|P9|Overall Study|Adverse Event|1
5525044|NCT01449370|19099537|P8|Overall Study|Adverse Event|0
5525045|NCT01449370|19099538|P7|Overall Study|Adverse Event|0
5525046|NCT01449370|19099539|P6|Overall Study|Adverse Event|0
5525047|NCT01449370|19099540|P5|Overall Study|Adverse Event|0
5525048|NCT01449370|19099541|P4|Overall Study|Adverse Event|1
5525049|NCT01449370|19099542|P3|Overall Study|Adverse Event|0
5525050|NCT01449370|19099543|P2|Overall Study|Adverse Event|2
5525051|NCT01449370|19099544|P1|Overall Study|Adverse Event|1
5525052|NCT01449370|19099520|P25|Overall Study|Disease Progression|3
5525053|NCT01449370|19099521|P24|Overall Study|Disease Progression|7
5525054|NCT01449370|19099522|P23|Overall Study|Disease Progression|3
5525055|NCT01449370|19099523|P22|Overall Study|Disease Progression|2
5525056|NCT01449370|19099524|P21|Overall Study|Disease Progression|5
5525057|NCT01449370|19099525|P20|Overall Study|Disease Progression|2
5525058|NCT01449370|19099526|P19|Overall Study|Disease Progression|1
5525059|NCT01449370|19099527|P18|Overall Study|Disease Progression|3
5525060|NCT01449370|19099528|P17|Overall Study|Disease Progression|4
5525061|NCT01449370|19099529|P16|Overall Study|Disease Progression|1
5525062|NCT01449370|19099530|P15|Overall Study|Disease Progression|3
5525063|NCT01449370|19099531|P14|Overall Study|Disease Progression|8
5525064|NCT01449370|19099532|P13|Overall Study|Disease Progression|2
5525065|NCT01449370|19099533|P12|Overall Study|Disease Progression|3
5525066|NCT01449370|19099534|P11|Overall Study|Disease Progression|3
5525067|NCT01449370|19099535|P10|Overall Study|Disease Progression|1
5525068|NCT01449370|19099536|P9|Overall Study|Disease Progression|9
5525069|NCT01449370|19099537|P8|Overall Study|Disease Progression|2
5525070|NCT01449370|19099538|P7|Overall Study|Disease Progression|3
5525071|NCT01449370|19099539|P6|Overall Study|Disease Progression|3
5525072|NCT01449370|19099540|P5|Overall Study|Disease Progression|3
5525073|NCT01449370|19099541|P4|Overall Study|Disease Progression|3
5525074|NCT01449370|19099542|P3|Overall Study|Disease Progression|8
5525075|NCT01449370|19099543|P2|Overall Study|Disease Progression|4
5525076|NCT01449370|19099544|P1|Overall Study|Disease Progression|5
5525077|NCT01449279|19099922|P1|Overall Study|Toxicity|2
5525078|NCT01449279|19099922|P1|Overall Study|Lack of Efficacy|5
5525079|NCT01449006|19099947|P2|Overall Study|Protocol Violation|0
5525080|NCT01449006|19099948|P1|Overall Study|Protocol Violation|1
5525081|NCT01449006|19099947|P2|Overall Study|Withdrawal by Subject|0
5525082|NCT01449006|19099948|P1|Overall Study|Withdrawal by Subject|1
5525083|NCT01449006|19099947|P2|Overall Study|Lost to Follow-up|0
5525084|NCT01449006|19099948|P1|Overall Study|Lost to Follow-up|1
5525085|NCT01448850|19099962|P2|Overall Study|Other|12
5525086|NCT01448850|19099963|P1|Overall Study|Other|15
5525087|NCT01448850|19099962|P2|Overall Study|Lost to Follow-up|1
5525088|NCT01448850|19099963|P1|Overall Study|Lost to Follow-up|3
5525089|NCT01448850|19099962|P2|Overall Study|Withdrawal by Subject|21
5525090|NCT01448850|19099963|P1|Overall Study|Withdrawal by Subject|13
5525091|NCT01448850|19099962|P2|Overall Study|Death|6
5525092|NCT01448850|19099963|P1|Overall Study|Death|3
5525093|NCT01448824|19099994|P8|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
5525094|NCT01448824|19099995|P7|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5525095|NCT01448824|19099996|P6|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5525096|NCT01448824|19099997|P5|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5525097|NCT01448824|19099998|P4|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5525098|NCT01448824|19099999|P3|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5525099|NCT01448824|19100000|P2|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5525100|NCT01448824|19100001|P1|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
5525101|NCT01448824|19099994|P8|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
5525102|NCT01448824|19099995|P7|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5525103|NCT01448824|19099996|P6|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5525104|NCT01448824|19099997|P5|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5525105|NCT01448824|19099998|P4|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5525106|NCT01448824|19099999|P3|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5525107|NCT01448824|19100000|P2|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5525108|NCT01448824|19100001|P1|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
5525109|NCT01448824|19099994|P8|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
5525110|NCT01448824|19099995|P7|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5525111|NCT01448824|19099996|P6|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5525112|NCT01448824|19099997|P5|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5525113|NCT01448824|19099998|P4|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5525114|NCT01448824|19099999|P3|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5525115|NCT01448824|19100000|P2|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5525116|NCT01448824|19100001|P1|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
5525117|NCT01448824|19099994|P8|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
5525118|NCT01448824|19099995|P7|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5525119|NCT01448824|19099996|P6|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5525120|NCT01448824|19099997|P5|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5525121|NCT01448824|19099998|P4|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5525122|NCT01448824|19099999|P3|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5525123|NCT01448824|19100000|P2|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5525124|NCT01448824|19100001|P1|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
5525125|NCT01448824|19099994|P8|Part 1: Washout Period|Lost to Follow-up|0
5525126|NCT01448824|19099995|P7|Part 1: Washout Period|Lost to Follow-up|0
5525127|NCT01448824|19099996|P6|Part 1: Washout Period|Lost to Follow-up|0
5525128|NCT01448824|19099997|P5|Part 1: Washout Period|Lost to Follow-up|0
5525129|NCT01448824|19099998|P4|Part 1: Washout Period|Lost to Follow-up|0
5525130|NCT01448824|19099999|P3|Part 1: Washout Period|Lost to Follow-up|0
5525131|NCT01448824|19100000|P2|Part 1: Washout Period|Lost to Follow-up|0
5525132|NCT01448824|19100001|P1|Part 1: Washout Period|Lost to Follow-up|1
5525133|NCT01448824|19099994|P8|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5525134|NCT01448824|19099995|P7|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5525135|NCT01448824|19099996|P6|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
5525300|NCT01447420|19100398|P1|Overall Study|Adverse Event|2
5525136|NCT01448824|19099997|P5|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5525137|NCT01448824|19099998|P4|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5525138|NCT01448824|19099999|P3|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5525139|NCT01448824|19100000|P2|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5525140|NCT01448824|19100001|P1|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
5525141|NCT01448824|19099994|P8|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5525142|NCT01448824|19099995|P7|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5525143|NCT01448824|19099996|P6|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
5525144|NCT01448824|19099997|P5|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
5525145|NCT01448824|19099998|P4|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
5525146|NCT01448824|19099999|P3|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5525147|NCT01448824|19100000|P2|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5525148|NCT01448824|19100001|P1|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
5525149|NCT01448824|19099994|P8|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5525150|NCT01448824|19099995|P7|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
5525151|NCT01448824|19099996|P6|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5525152|NCT01448824|19099997|P5|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5525153|NCT01448824|19099998|P4|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5525154|NCT01448824|19099999|P3|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5525155|NCT01448824|19100000|P2|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5525156|NCT01448824|19100001|P1|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
5525157|NCT01448707|19100052|P2|Overall Study|Other|4
5525158|NCT01448707|19100053|P1|Overall Study|Other|7
5525159|NCT01448707|19100052|P2|Overall Study|Withdrawal by Subject|7
5525160|NCT01448707|19100053|P1|Overall Study|Withdrawal by Subject|6
5525161|NCT01448707|19100052|P2|Overall Study|Lost to Follow-up|6
5525162|NCT01448707|19100053|P1|Overall Study|Lost to Follow-up|2
5525163|NCT01448707|19100052|P2|Overall Study|Adverse Event|1
5525164|NCT01448707|19100053|P1|Overall Study|Adverse Event|3
5525165|NCT01448616|19100074|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
5525166|NCT01448616|19100075|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
5525167|NCT01448616|19100076|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
5525168|NCT01448616|19100077|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
5525169|NCT01448616|19100074|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
5525170|NCT01448616|19100075|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
5525171|NCT01448616|19100076|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
5525172|NCT01448616|19100077|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
5525173|NCT01448616|19100074|P4|Study Drug (Treatment Phase)|Adverse Event|0
5525174|NCT01448616|19100075|P3|Study Drug (Treatment Phase)|Adverse Event|1
5525175|NCT01448616|19100076|P2|Study Drug (Treatment Phase)|Adverse Event|1
5525176|NCT01448616|19100077|P1|Study Drug (Treatment Phase)|Adverse Event|0
5525177|NCT01448616|19100074|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
5525178|NCT01448616|19100075|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
5525179|NCT01448616|19100076|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
5525180|NCT01448616|19100077|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
5525181|NCT01448616|19100074|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
5525182|NCT01448616|19100075|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
5525183|NCT01448616|19100076|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
5525184|NCT01448616|19100077|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
5525185|NCT01448213|19100129|P2|Overall Study|Protocol Violation|2
5525186|NCT01448213|19100130|P1|Overall Study|Protocol Violation|1
5525187|NCT01448213|19100129|P2|Overall Study|Adverse Event|10
5525188|NCT01448213|19100130|P1|Overall Study|Adverse Event|4
5525189|NCT01448213|19100129|P2|Overall Study|Lost to Follow-up|10
5525190|NCT01448213|19100130|P1|Overall Study|Lost to Follow-up|12
5525191|NCT01448057|19100140|P2|Overall Study|Withdrawal by Subject|0
5525192|NCT01448057|19100141|P1|Overall Study|Withdrawal by Subject|2
5525193|NCT01448057|19100140|P2|Overall Study|Adverse Event|2
5525194|NCT01448057|19100141|P1|Overall Study|Adverse Event|0
5525195|NCT01448057|19100140|P2|Overall Study|Lost to Follow-up|0
5525196|NCT01448057|19100141|P1|Overall Study|Lost to Follow-up|3
5525197|NCT01448057|19100140|P2|Overall Study|Protocol Violation|2
5525198|NCT01448057|19100141|P1|Overall Study|Protocol Violation|3
5525199|NCT01448044|19100151|P2|Follow Up Period|Other|11
5525200|NCT01448044|19100152|P1|Follow Up Period|Other|5
5525201|NCT01448044|19100151|P2|Follow Up Period|Lost to Follow-up|2
5525202|NCT01448044|19100152|P1|Follow Up Period|Lost to Follow-up|6
5525203|NCT01448044|19100151|P2|Follow Up Period|Withdrawal by Subject|1
5525204|NCT01448044|19100152|P1|Follow Up Period|Withdrawal by Subject|1
5525205|NCT01448044|19100151|P2|Treatment Period|Other reason|0
5525206|NCT01448044|19100152|P1|Treatment Period|Other reason|2
5525207|NCT01448044|19100151|P2|Treatment Period|Lost to Follow-up|1
5525208|NCT01448044|19100152|P1|Treatment Period|Lost to Follow-up|2
5525209|NCT01448044|19100151|P2|Treatment Period|Participant does not meet study criteria|0
5525210|NCT01448044|19100152|P1|Treatment Period|Participant does not meet study criteria|1
5525211|NCT01448044|19100151|P2|Treatment Period|Completed 24 weeks treatment period only|0
5525212|NCT01448044|19100152|P1|Treatment Period|Completed 24 weeks treatment period only|8
5525213|NCT01448044|19100151|P2|Treatment Period|Subject requested discontinue study drug|0
5525214|NCT01448044|19100152|P1|Treatment Period|Subject requested discontinue study drug|1
5525215|NCT01448044|19100151|P2|Treatment Period|Lack of Efficacy|12
5525216|NCT01448044|19100152|P1|Treatment Period|Lack of Efficacy|5
5525217|NCT01448044|19100151|P2|Treatment Period|Adverse Event|3
5525218|NCT01448044|19100152|P1|Treatment Period|Adverse Event|4
5525219|NCT01447927|19100168|P2|Overall Study|Withdrawal by Subject|0
5525220|NCT01447927|19100169|P1|Overall Study|Withdrawal by Subject|1
5525221|NCT01447927|19100168|P2|Overall Study|Adverse Event|3
5525222|NCT01447927|19100169|P1|Overall Study|Adverse Event|4
5525223|NCT01447719|19100214|P1|Overall Study|Family withdrew autopsy consent|7
5525224|NCT01447719|19100214|P1|Overall Study|Withdrawal by Subject|2
5525225|NCT01447719|19100214|P1|Overall Study|Subject still living at end of study|79
5525226|NCT01447719|19100214|P1|Overall Study|Invalid image or not imaged|3
5525227|NCT01447719|19100214|P1|Overall Study|Image acquisition failure|2
5525228|NCT01447576|19100240|P1|Overall Study|Physician Decision|6
5525229|NCT01447576|19100240|P1|Overall Study|Lack of Efficacy|68
5525230|NCT01447576|19100240|P1|Overall Study|Protocol deviation|83
5525231|NCT01447576|19100240|P1|Overall Study|Withdrawal by Subject|100
5525232|NCT01447576|19100240|P1|Overall Study|Participant met withdrawal criteria|40
5525233|NCT01447576|19100240|P1|Overall Study|Adverse Event|127
5525234|NCT01447576|19100240|P1|Overall Study|Lost to Follow-up|52
5525235|NCT01447446|19100273|P6|Overall Study|Reason not Specified|0
5525236|NCT01447446|19100274|P5|Overall Study|Reason not Specified|1
5525237|NCT01447446|19100275|P4|Overall Study|Reason not Specified|1
5525238|NCT01447446|19100276|P3|Overall Study|Reason not Specified|1
5525239|NCT01447446|19100277|P2|Overall Study|Reason not Specified|1
5525240|NCT01447446|19100278|P1|Overall Study|Reason not Specified|1
5525241|NCT01447446|19100273|P6|Overall Study|New Treatment Started|0
5525242|NCT01447446|19100274|P5|Overall Study|New Treatment Started|2
5525243|NCT01447446|19100275|P4|Overall Study|New Treatment Started|0
5525244|NCT01447446|19100276|P3|Overall Study|New Treatment Started|1
5525245|NCT01447446|19100277|P2|Overall Study|New Treatment Started|2
5525246|NCT01447446|19100278|P1|Overall Study|New Treatment Started|8
5525247|NCT01447446|19100273|P6|Overall Study|SVR12 Assessment|5
5525248|NCT01447446|19100274|P5|Overall Study|SVR12 Assessment|5
5525249|NCT01447446|19100275|P4|Overall Study|SVR12 Assessment|1
5525250|NCT01447446|19100276|P3|Overall Study|SVR12 Assessment|2
5525251|NCT01447446|19100277|P2|Overall Study|SVR12 Assessment|1
5525252|NCT01447446|19100278|P1|Overall Study|SVR12 Assessment|13
5525253|NCT01447446|19100273|P6|Overall Study|Administrative/Other|4
5525254|NCT01447446|19100274|P5|Overall Study|Administrative/Other|33
5525255|NCT01447446|19100275|P4|Overall Study|Administrative/Other|2
5525256|NCT01447446|19100276|P3|Overall Study|Administrative/Other|10
5525257|NCT01447446|19100277|P2|Overall Study|Administrative/Other|9
5525258|NCT01447446|19100278|P1|Overall Study|Administrative/Other|34
5525259|NCT01447446|19100273|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
5525260|NCT01447446|19100274|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
5525261|NCT01447446|19100275|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
5525262|NCT01447446|19100276|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
5525263|NCT01447446|19100277|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
5525264|NCT01447446|19100278|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
5525265|NCT01447446|19100273|P6|Overall Study|Failure to Return/Consent Withdrawn|9
5525266|NCT01447446|19100274|P5|Overall Study|Failure to Return/Consent Withdrawn|69
5525267|NCT01447446|19100275|P4|Overall Study|Failure to Return/Consent Withdrawn|7
5525268|NCT01447446|19100276|P3|Overall Study|Failure to Return/Consent Withdrawn|31
5525269|NCT01447446|19100277|P2|Overall Study|Failure to Return/Consent Withdrawn|78
5525270|NCT01447446|19100278|P1|Overall Study|Failure to Return/Consent Withdrawn|357
5525271|NCT01447446|19100273|P6|Overall Study|Adverse Event|0
5525272|NCT01447446|19100274|P5|Overall Study|Adverse Event|2
5525273|NCT01447446|19100275|P4|Overall Study|Adverse Event|0
5525274|NCT01447446|19100276|P3|Overall Study|Adverse Event|1
5525275|NCT01447446|19100277|P2|Overall Study|Adverse Event|0
5525276|NCT01447446|19100278|P1|Overall Study|Adverse Event|3
5525277|NCT01447446|19100273|P6|Overall Study|Death|0
5525278|NCT01447446|19100274|P5|Overall Study|Death|7
5525279|NCT01447446|19100275|P4|Overall Study|Death|1
5525280|NCT01447446|19100276|P3|Overall Study|Death|2
5525281|NCT01447446|19100277|P2|Overall Study|Death|3
5525282|NCT01447446|19100278|P1|Overall Study|Death|6
5525283|NCT01447433|19100368|P2|Overall Study|Protocol Violation|1
5525284|NCT01447433|19100369|P1|Overall Study|Protocol Violation|1
5525285|NCT01447433|19100368|P2|Overall Study|Withdrawal by Subject|3
5525286|NCT01447433|19100369|P1|Overall Study|Withdrawal by Subject|3
5525287|NCT01447433|19100368|P2|Overall Study|Lost to Follow-up|2
5525288|NCT01447433|19100369|P1|Overall Study|Lost to Follow-up|0
5525289|NCT01447420|19100396|P3|Overall Study|Lack of Efficacy|8
5525290|NCT01447420|19100397|P2|Overall Study|Lack of Efficacy|19
5525291|NCT01447420|19100398|P1|Overall Study|Lack of Efficacy|1
5525292|NCT01447420|19100396|P3|Overall Study|Withdrawal by Subject|0
5525293|NCT01447420|19100397|P2|Overall Study|Withdrawal by Subject|1
5525294|NCT01447420|19100398|P1|Overall Study|Withdrawal by Subject|4
5525295|NCT01447420|19100396|P3|Overall Study|Protocol Violation|0
5525296|NCT01447420|19100397|P2|Overall Study|Protocol Violation|3
5525297|NCT01447420|19100398|P1|Overall Study|Protocol Violation|3
5525298|NCT01447420|19100396|P3|Overall Study|Adverse Event|2
5525299|NCT01447420|19100397|P2|Overall Study|Adverse Event|4
5525301|NCT01447407|19100418|P4|Overall Study|Physician Decision|1
5525302|NCT01447407|19100419|P3|Overall Study|Physician Decision|1
5525303|NCT01447407|19100420|P2|Overall Study|Physician Decision|0
5525304|NCT01447407|19100421|P1|Overall Study|Physician Decision|0
5525305|NCT01447407|19100418|P4|Overall Study|Withdrawal by Subject|1
5525306|NCT01447407|19100419|P3|Overall Study|Withdrawal by Subject|0
5525307|NCT01447407|19100420|P2|Overall Study|Withdrawal by Subject|0
5525308|NCT01447407|19100421|P1|Overall Study|Withdrawal by Subject|2
5525309|NCT01446913|19100555|P3|Overall Study|Lost to Follow-up|3
5525310|NCT01446913|19100556|P2|Overall Study|Lost to Follow-up|5
5525311|NCT01446913|19100557|P1|Overall Study|Lost to Follow-up|3
5525312|NCT01446913|19100555|P3|Overall Study|Physician Decision|2
5525313|NCT01446913|19100556|P2|Overall Study|Physician Decision|0
5525314|NCT01446913|19100557|P1|Overall Study|Physician Decision|0
5525315|NCT01446913|19100555|P3|Overall Study|Withdrawal by Subject|5
5525316|NCT01446913|19100556|P2|Overall Study|Withdrawal by Subject|3
5525317|NCT01446913|19100557|P1|Overall Study|Withdrawal by Subject|5
5525318|NCT01446913|19100555|P3|Overall Study|Significant illness|1
5525319|NCT01446913|19100556|P2|Overall Study|Significant illness|1
5525320|NCT01446913|19100557|P1|Overall Study|Significant illness|1
5525321|NCT01446874|19100618|P3|Overall Study|Withdrawal by Subject|4
5525322|NCT01446874|19100619|P2|Overall Study|Withdrawal by Subject|0
5525323|NCT01446874|19100620|P1|Overall Study|Withdrawal by Subject|0
5525324|NCT01446874|19100618|P3|Overall Study|Antibiotics for pre-op infection|2
5525325|NCT01446874|19100619|P2|Overall Study|Antibiotics for pre-op infection|0
5525326|NCT01446874|19100620|P1|Overall Study|Antibiotics for pre-op infection|0
5525327|NCT01446874|19100618|P3|Overall Study|Non-compliance|0
5525328|NCT01446874|19100619|P2|Overall Study|Non-compliance|4
5525329|NCT01446874|19100620|P1|Overall Study|Non-compliance|0
5525330|NCT01446874|19100618|P3|Overall Study|No surgery/No qualifying surgery|12
5525331|NCT01446874|19100619|P2|Overall Study|No surgery/No qualifying surgery|0
5525332|NCT01446874|19100620|P1|Overall Study|No surgery/No qualifying surgery|1
5525333|NCT01446874|19100618|P3|Overall Study|Not eligible|0
5525334|NCT01446874|19100619|P2|Overall Study|Not eligible|0
5525335|NCT01446874|19100620|P1|Overall Study|Not eligible|1
5525336|NCT01446809|19100648|P3|Overall Study|Failure to complete study procedures|1
5525337|NCT01446809|19100649|P2|Overall Study|Failure to complete study procedures|0
5525338|NCT01446809|19100650|P1|Overall Study|Failure to complete study procedures|0
5525339|NCT01446809|19100648|P3|Overall Study|Adverse Event|1
5525340|NCT01446809|19100649|P2|Overall Study|Adverse Event|0
5525341|NCT01446809|19100650|P1|Overall Study|Adverse Event|0
5525342|NCT01446796|19100673|P2|Overall Study|Withdrawal by Subject|0
5525343|NCT01446796|19100674|P1|Overall Study|Withdrawal by Subject|1
5525344|NCT01446419|19100720|P2|Overall Study|Terminated per protocol|0
5525345|NCT01446419|19100721|P1|Overall Study|Terminated per protocol|3
5525346|NCT01446419|19100720|P2|Overall Study|Withdrawal by Subject|1
5525347|NCT01446419|19100721|P1|Overall Study|Withdrawal by Subject|1
5525348|NCT01446419|19100720|P2|Overall Study|Death|0
5525349|NCT01446419|19100721|P1|Overall Study|Death|1
5525350|NCT01446289|19100735|P4|Overall Study|Withdrawal by Subject|0
5525351|NCT01446289|19100736|P3|Overall Study|Withdrawal by Subject|1
5525352|NCT01446289|19100737|P2|Overall Study|Withdrawal by Subject|0
5525353|NCT01446289|19100738|P1|Overall Study|Withdrawal by Subject|1
5525354|NCT01446237|19100781|P1|Overall Study|Withdrawal by Subject|7
5525355|NCT01446237|19100781|P1|Overall Study|Lost to Follow-up|2
5525356|NCT01446237|19100781|P1|Overall Study|Adverse Event|1
5525357|NCT01446159|19100793|P4|Overall Study|Other|13
5525358|NCT01446159|19100794|P3|Overall Study|Other|13
5525359|NCT01446159|19100795|P2|Overall Study|Other|0
5525360|NCT01446159|19100796|P1|Overall Study|Other|0
5525361|NCT01446159|19100793|P4|Overall Study|Death|36
5525362|NCT01446159|19100794|P3|Overall Study|Death|43
5525363|NCT01446159|19100795|P2|Overall Study|Death|3
5525364|NCT01446159|19100796|P1|Overall Study|Death|2
5525365|NCT01446159|19100793|P4|Overall Study|Lost to Follow-up|2
5525366|NCT01446159|19100794|P3|Overall Study|Lost to Follow-up|1
5525367|NCT01446159|19100795|P2|Overall Study|Lost to Follow-up|0
5525368|NCT01446159|19100796|P1|Overall Study|Lost to Follow-up|0
5525369|NCT01446159|19100793|P4|Overall Study|Withdrawal by Subject|11
5525370|NCT01446159|19100794|P3|Overall Study|Withdrawal by Subject|14
5525371|NCT01446159|19100795|P2|Overall Study|Withdrawal by Subject|0
5525372|NCT01446159|19100796|P1|Overall Study|Withdrawal by Subject|1
5525373|NCT01446042|19100871|P3|Overall Study|Other reasons|1
5525374|NCT01446042|19100872|P2|Overall Study|Other reasons|1
5525375|NCT01446042|19100873|P1|Overall Study|Other reasons|2
5525376|NCT01446042|19100871|P3|Overall Study|Lost to Follow-up|0
5525377|NCT01446042|19100872|P2|Overall Study|Lost to Follow-up|0
5525378|NCT01446042|19100873|P1|Overall Study|Lost to Follow-up|5
5525379|NCT01446042|19100871|P3|Overall Study|Adverse Event|4
5525380|NCT01446042|19100872|P2|Overall Study|Adverse Event|0
5525381|NCT01446042|19100873|P1|Overall Study|Adverse Event|1
5525382|NCT01446042|19100871|P3|Overall Study|Withdrawal by Subject|4
5525383|NCT01446042|19100872|P2|Overall Study|Withdrawal by Subject|2
5525384|NCT01446042|19100873|P1|Overall Study|Withdrawal by Subject|12
5525385|NCT01446003|19100884|P2|Period 2|Adverse Event|0
5525386|NCT01446003|19100885|P1|Period 2|Adverse Event|1
5525387|NCT01446003|19100884|P2|Period 1|Protocol Violation|0
5525388|NCT01446003|19100885|P1|Period 1|Protocol Violation|2
5525389|NCT01445951|19100906|P3|Overall Study|Cough|0
5525390|NCT01445951|19100907|P2|Overall Study|Cough|1
5525391|NCT01445951|19100908|P1|Overall Study|Cough|0
5525392|NCT01445951|19100906|P3|Overall Study|Sponsor decision - subject travel|0
5525393|NCT01445951|19100907|P2|Overall Study|Sponsor decision - subject travel|1
5525394|NCT01445951|19100908|P1|Overall Study|Sponsor decision - subject travel|0
5525395|NCT01445951|19100906|P3|Overall Study|Non-compliance with protocol|0
5525396|NCT01445951|19100907|P2|Overall Study|Non-compliance with protocol|1
5525397|NCT01445951|19100908|P1|Overall Study|Non-compliance with protocol|0
5525398|NCT01445951|19100906|P3|Overall Study|Non-compliance with study drug|0
5525399|NCT01445951|19100907|P2|Overall Study|Non-compliance with study drug|2
5525400|NCT01445951|19100908|P1|Overall Study|Non-compliance with study drug|1
5525401|NCT01445951|19100906|P3|Overall Study|Death|1
5525402|NCT01445951|19100907|P2|Overall Study|Death|0
5525403|NCT01445951|19100908|P1|Overall Study|Death|0
5525404|NCT01445951|19100906|P3|Overall Study|Pregnancy|4
5525405|NCT01445951|19100907|P2|Overall Study|Pregnancy|1
5525406|NCT01445951|19100908|P1|Overall Study|Pregnancy|0
5525407|NCT01445951|19100906|P3|Overall Study|Lost to Follow-up|4
5525408|NCT01445951|19100907|P2|Overall Study|Lost to Follow-up|2
5525409|NCT01445951|19100908|P1|Overall Study|Lost to Follow-up|1
5525410|NCT01445951|19100906|P3|Overall Study|Physician Decision|0
5525411|NCT01445951|19100907|P2|Overall Study|Physician Decision|1
5525412|NCT01445951|19100908|P1|Overall Study|Physician Decision|3
5525413|NCT01445951|19100906|P3|Overall Study|Withdrawal by Subject|8
5525414|NCT01445951|19100907|P2|Overall Study|Withdrawal by Subject|16
5525415|NCT01445951|19100908|P1|Overall Study|Withdrawal by Subject|21
5525416|NCT01445951|19100906|P3|Overall Study|Protocol Violation|2
5525417|NCT01445951|19100907|P2|Overall Study|Protocol Violation|2
5525418|NCT01445951|19100908|P1|Overall Study|Protocol Violation|2
5525419|NCT01445951|19100906|P3|Overall Study|Adverse Event|0
5525420|NCT01445951|19100907|P2|Overall Study|Adverse Event|9
5525421|NCT01445951|19100908|P1|Overall Study|Adverse Event|16
5525422|NCT01445886|19100946|P1|Overall Study|Protocol Violation|3
5525423|NCT01445886|19100946|P1|Overall Study|Lost to Follow-up|2
5525424|NCT01445847|19100986|P2|Overall Study|Missed Data|0
5525425|NCT01445847|19100987|P1|Overall Study|Missed Data|1
5525426|NCT01445847|19100986|P2|Overall Study|Protocol Violation|14
5525427|NCT01445847|19100987|P1|Overall Study|Protocol Violation|13
5525428|NCT01445769|19101004|P1|Overall Study|Lost to Follow-up|5
5525429|NCT01445769|19101004|P1|Overall Study|Disease Progression|1
5525430|NCT01445769|19101004|P1|Overall Study|Consent Withdrawn|2
5525431|NCT01445678|19101024|P2|Overall Study|Withdrawal by Subject|5
5525432|NCT01445678|19101025|P1|Overall Study|Withdrawal by Subject|9
5525433|NCT01445678|19101024|P2|Overall Study|Protocol Violation|1
5525434|NCT01445678|19101025|P1|Overall Study|Protocol Violation|1
5525435|NCT01445678|19101024|P2|Overall Study|Lost to Follow-up|5
5525436|NCT01445678|19101025|P1|Overall Study|Lost to Follow-up|8
5525437|NCT01445678|19101024|P2|Overall Study|Lack of Efficacy|2
5525438|NCT01445678|19101025|P1|Overall Study|Lack of Efficacy|0
5525439|NCT01445678|19101024|P2|Overall Study|Adverse Event|8
5525440|NCT01445678|19101025|P1|Overall Study|Adverse Event|12
5525441|NCT01445652|19101043|P2|Overall Study|Adverse Event|0
5525442|NCT01445652|19101044|P1|Overall Study|Adverse Event|1
5525443|NCT01445652|19101043|P2|Overall Study|Failed teach session|0
5525444|NCT01445652|19101044|P1|Overall Study|Failed teach session|2
5525445|NCT01445652|19101043|P2|Overall Study|Failed to attend scheduled visit|3
5525446|NCT01445652|19101044|P1|Overall Study|Failed to attend scheduled visit|2
5525447|NCT01445652|19101043|P2|Overall Study|Not comfortable in lenses|0
5525448|NCT01445652|19101044|P1|Overall Study|Not comfortable in lenses|5
5525449|NCT01445613|19101062|P1|1-year Follow-up|Received a non-study stent|2
5525450|NCT01445613|19101062|P1|1-year Follow-up|Physician Decision|2
5525451|NCT01445613|19101062|P1|1-year Follow-up|Death|30
5525452|NCT01445613|19101062|P1|1-year Follow-up|Lost to Follow-up|2
5525453|NCT01445613|19101062|P1|1-year Follow-up|Missed visit|29
5525454|NCT01445613|19101062|P1|1-year Follow-up|Withdrawal by Subject|12
5525455|NCT01445613|19101062|P1|30-day Follow-up|Death|3
5525456|NCT01445613|19101062|P1|30-day Follow-up|Missed visit|23
5525457|NCT01445613|19101062|P1|30-day Follow-up|Physician Decision|3
5525458|NCT01445613|19101062|P1|30-day Follow-up|Withdrawal by Subject|6
5525459|NCT01445548|19101080|P1|Overall Study|Adverse Event|1
5525460|NCT01445535|19101106|P4|Overall Study|PI discretion|1
5525461|NCT01445535|19101107|P3|Overall Study|PI discretion|0
5525462|NCT01445535|19101108|P2|Overall Study|PI discretion|0
5525463|NCT01445535|19101109|P1|Overall Study|PI discretion|0
5525464|NCT01445535|19101106|P4|Overall Study|Disease progression|0
5525465|NCT01445535|19101107|P3|Overall Study|Disease progression|1
5525466|NCT01445535|19101108|P2|Overall Study|Disease progression|0
5525467|NCT01445535|19101109|P1|Overall Study|Disease progression|1
5525468|NCT01445535|19101106|P4|Overall Study|Enrolled/taken off study, no drug avail.|1
5525469|NCT01445535|19101107|P3|Overall Study|Enrolled/taken off study, no drug avail.|0
5525470|NCT01445535|19101108|P2|Overall Study|Enrolled/taken off study, no drug avail.|0
5525471|NCT01445535|19101109|P1|Overall Study|Enrolled/taken off study, no drug avail.|0
5525472|NCT01445301|19101133|P3|Overall Study|Withdrawal by Subject|4
5525473|NCT01445301|19101134|P2|Overall Study|Withdrawal by Subject|6
5525474|NCT01445301|19101135|P1|Overall Study|Withdrawal by Subject|5
5525475|NCT01445301|19101133|P3|Overall Study|Physician Decision|0
5525476|NCT01445301|19101134|P2|Overall Study|Physician Decision|2
5525477|NCT01445301|19101135|P1|Overall Study|Physician Decision|0
5525478|NCT01445301|19101133|P3|Overall Study|Protocol-Defined Stopping Criteria|1
5525479|NCT01445301|19101134|P2|Overall Study|Protocol-Defined Stopping Criteria|1
5525480|NCT01445301|19101135|P1|Overall Study|Protocol-Defined Stopping Criteria|0
5525481|NCT01445301|19101133|P3|Overall Study|Protocol Violation|0
5525482|NCT01445301|19101134|P2|Overall Study|Protocol Violation|0
5525483|NCT01445301|19101135|P1|Overall Study|Protocol Violation|1
5525484|NCT01445301|19101133|P3|Overall Study|Lack of Efficacy|0
5525485|NCT01445301|19101134|P2|Overall Study|Lack of Efficacy|1
5525486|NCT01445301|19101135|P1|Overall Study|Lack of Efficacy|0
5525487|NCT01445301|19101133|P3|Overall Study|Adverse Event|4
5525488|NCT01445301|19101134|P2|Overall Study|Adverse Event|25
5525489|NCT01445301|19101135|P1|Overall Study|Adverse Event|15
5525490|NCT01445171|19101170|P1|Overall Study|Consented but did not receive device|8
5525491|NCT01445171|19101170|P1|Overall Study|Subjects declined to return for followup|9
5525492|NCT01445171|19101170|P1|Overall Study|Death|51
5525493|NCT01445171|19101170|P1|Overall Study|Withdrawal by Subject|16
5525494|NCT01445171|19101170|P1|Overall Study|Lost to Follow-up|11
5525495|NCT01444898|19101226|P1|Overall Study|Withdrawal by Subject|1
5525496|NCT01444781|19101241|P3|Overall Study|Withdrawal by Subject|2
5525497|NCT01444781|19101242|P2|Overall Study|Withdrawal by Subject|1
5525498|NCT01444781|19101243|P1|Overall Study|Withdrawal by Subject|3
5525499|NCT01444781|19101241|P3|Overall Study|Lost to Follow-up|1
5525500|NCT01444781|19101242|P2|Overall Study|Lost to Follow-up|3
5525501|NCT01444781|19101243|P1|Overall Study|Lost to Follow-up|0
5525502|NCT01444742|19101281|P1|Overall Study|Death|1
5525503|NCT01444651|19101288|P2|Overall Study|Missing data|1
5525504|NCT01444651|19101289|P1|Overall Study|Missing data|1
5525505|NCT01444651|19101288|P2|Overall Study|Non-fasting|1
5525506|NCT01444651|19101289|P1|Overall Study|Non-fasting|2
5525507|NCT01444651|19101288|P2|Overall Study|Lost to Follow-up|5
5525508|NCT01444651|19101289|P1|Overall Study|Lost to Follow-up|5
5525509|NCT01444651|19101288|P2|Overall Study|Adverse Event|2
5525510|NCT01444651|19101289|P1|Overall Study|Adverse Event|3
5525511|NCT01444456|19101305|P1|Overall Study|Not treated|104
5525512|NCT01444456|19101305|P1|Overall Study|Other|18
5525513|NCT01444456|19101305|P1|Overall Study|Ineligibility determined|23
5525514|NCT01444456|19101305|P1|Overall Study|Death|73
5525515|NCT01444456|19101305|P1|Overall Study|Lost to Follow-up|37
5525516|NCT01444456|19101305|P1|Overall Study|Physician Decision|9
5525517|NCT01444456|19101305|P1|Overall Study|Withdrawal by Subject|21
5525518|NCT01444430|19101316|P2|Overall Study|CRF termination module not completed.|1
5525519|NCT01444430|19101317|P1|Overall Study|CRF termination module not completed.|0
5525520|NCT01444430|19101316|P2|Overall Study|Lost to Follow-up|0
5525521|NCT01444430|19101317|P1|Overall Study|Lost to Follow-up|2
5525522|NCT01444430|19101316|P2|Overall Study|Death|8
5525523|NCT01444430|19101317|P1|Overall Study|Death|6
5525524|NCT01444430|19101316|P2|Overall Study|Withdrawal by Subject|72
5525525|NCT01444430|19101317|P1|Overall Study|Withdrawal by Subject|53
5525526|NCT01444417|19101339|P2|Overall Study|Withdrawal by Subject|0
5525527|NCT01444417|19101340|P1|Overall Study|Withdrawal by Subject|2
5525528|NCT01444417|19101339|P2|Overall Study|Ineligibility Determined|1
5525529|NCT01444417|19101340|P1|Overall Study|Ineligibility Determined|0
5525530|NCT01444391|19101356|P1|Overall Study|Death|1
5525531|NCT01444378|19101364|P1|Overall Study|Missed Visits|10
5525532|NCT01444378|19101364|P1|Overall Study|Administrative Closure Of The Study|2
5525533|NCT01444378|19101364|P1|Overall Study|Death|3
5525534|NCT01444378|19101364|P1|Overall Study|Withdrawal by Subject|1
5525535|NCT01444378|19101364|P1|Overall Study|Lost to Follow-up|1
5525536|NCT01444300|19101476|P2|Overall Study|Adverse Event|0
5525537|NCT01444300|19101477|P1|Overall Study|Adverse Event|4
5525538|NCT01444092|19101509|P1|Overall Study|Other Eligibility criteria|7
5525539|NCT01444092|19101509|P1|Overall Study|Withdrawal by Subject|1
5525540|NCT01444092|19101509|P1|Overall Study|Protocol Violation|1
5525541|NCT01444092|19101509|P1|Overall Study|Adverse Event|8
5525542|NCT01444027|19101518|P3|Overall Study|Lost to Follow-up|14
5525543|NCT01444027|19101519|P2|Overall Study|Lost to Follow-up|20
5525544|NCT01444027|19101520|P1|Overall Study|Lost to Follow-up|26
5525545|NCT01444027|19101518|P3|Overall Study|Withdrawal by Subject|24
5525546|NCT01444027|19101519|P2|Overall Study|Withdrawal by Subject|10
5525547|NCT01444027|19101520|P1|Overall Study|Withdrawal by Subject|4
5525548|NCT01443923|19101542|P2|Overall Study|Adverse Event|0
5525549|NCT01443923|19101543|P1|Overall Study|Adverse Event|1
5525550|NCT01443858|19101560|P3|Overall Study|Lost to Follow-up|2
5525551|NCT01443858|19101561|P2|Overall Study|Lost to Follow-up|5
5525552|NCT01443858|19101562|P1|Overall Study|Lost to Follow-up|5
5525553|NCT01443858|19101560|P3|Overall Study|Lack of Efficacy|0
5525554|NCT01443858|19101561|P2|Overall Study|Lack of Efficacy|0
5525555|NCT01443858|19101562|P1|Overall Study|Lack of Efficacy|1
5525556|NCT01443858|19101560|P3|Overall Study|Withdrawal by Subject|5
5525557|NCT01443858|19101561|P2|Overall Study|Withdrawal by Subject|8
5525558|NCT01443858|19101562|P1|Overall Study|Withdrawal by Subject|9
5525559|NCT01443845|19101584|P2|Overall Study|Lost to Follow-up|13
5525560|NCT01443845|19101585|P1|Overall Study|Lost to Follow-up|9
5525561|NCT01443845|19101584|P2|Overall Study|Military Conflict - Site Terminated|21
5525562|NCT01443845|19101585|P1|Overall Study|Military Conflict - Site Terminated|20
5525563|NCT01443845|19101584|P2|Overall Study|Withdrawal by Subject|67
5525564|NCT01443845|19101585|P1|Overall Study|Withdrawal by Subject|63
5525565|NCT01443845|19101584|P2|Overall Study|Adverse Event|138
5525566|NCT01443845|19101585|P1|Overall Study|Adverse Event|64
5525567|NCT01443845|19101584|P2|Overall Study|Lack of Efficacy|5
5525568|NCT01443845|19101585|P1|Overall Study|Lack of Efficacy|10
5525569|NCT01443845|19101584|P2|Overall Study|Deterioration in pulmonary function|4
5525570|NCT01443845|19101585|P1|Overall Study|Deterioration in pulmonary function|1
5525571|NCT01443845|19101584|P2|Overall Study|Other reasons, such as COPD exacerbation|44
5525572|NCT01443845|19101585|P1|Overall Study|Other reasons, such as COPD exacerbation|44
5525573|NCT01443845|19101584|P2|Overall Study|Protocol Violation|45
5525574|NCT01443845|19101585|P1|Overall Study|Protocol Violation|43
5525575|NCT01443403|19101640|P4|Overall Study|Other - Miscellaneous|1
5525576|NCT01443403|19101641|P3|Overall Study|Other - Miscellaneous|0
5525577|NCT01443403|19101642|P2|Overall Study|Other - Miscellaneous|0
5525578|NCT01443403|19101643|P1|Overall Study|Other - Miscellaneous|1
5525579|NCT01443403|19101640|P4|Overall Study|Use of Prohibited Treatment|0
5525580|NCT01443403|19101641|P3|Overall Study|Use of Prohibited Treatment|0
5525581|NCT01443403|19101642|P2|Overall Study|Use of Prohibited Treatment|3
5525582|NCT01443403|19101643|P1|Overall Study|Use of Prohibited Treatment|2
5525583|NCT01443403|19101640|P4|Overall Study|Protocol Violation|1
5525584|NCT01443403|19101641|P3|Overall Study|Protocol Violation|1
5525585|NCT01443403|19101642|P2|Overall Study|Protocol Violation|1
5525586|NCT01443403|19101643|P1|Overall Study|Protocol Violation|2
5525587|NCT01443403|19101640|P4|Overall Study|Lost to Follow-up|1
5525588|NCT01443403|19101641|P3|Overall Study|Lost to Follow-up|0
5525589|NCT01443403|19101642|P2|Overall Study|Lost to Follow-up|0
5525590|NCT01443403|19101643|P1|Overall Study|Lost to Follow-up|0
5525591|NCT01443403|19101640|P4|Overall Study|Withdrawal by Subject|1
5525592|NCT01443403|19101641|P3|Overall Study|Withdrawal by Subject|2
5525593|NCT01443403|19101642|P2|Overall Study|Withdrawal by Subject|1
5525594|NCT01443403|19101643|P1|Overall Study|Withdrawal by Subject|0
5525595|NCT01443403|19101640|P4|Overall Study|Adverse Event|5
5525596|NCT01443403|19101641|P3|Overall Study|Adverse Event|4
5525597|NCT01443403|19101642|P2|Overall Study|Adverse Event|1
5525598|NCT01443403|19101643|P1|Overall Study|Adverse Event|1
5525599|NCT01443364|19101790|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5525600|NCT01443364|19101790|P1|Overall Study|AE, non-serious non-fatal|8
5525601|NCT01443364|19101790|P1|Overall Study|SAE, non-fatal|6
5525602|NCT01443364|19101790|P1|Overall Study|Other Reason|4
5525603|NCT01443364|19101790|P1|Overall Study|Withdrawal by Subject|5
5525604|NCT01443364|19101790|P1|Overall Study|Lost to Follow-up|3
5525605|NCT01443364|19101790|P1|Overall Study|Lack of Efficacy|14
5525606|NCT01443130|19101919|P6|Overall Study|Death of Subject's Infant|0
5525607|NCT01443130|19101920|P5|Overall Study|Death of Subject's Infant|0
5525608|NCT01443130|19101921|P4|Overall Study|Death of Subject's Infant|0
5525609|NCT01443130|19101922|P3|Overall Study|Death of Subject's Infant|11
5525610|NCT01443130|19101923|P2|Overall Study|Death of Subject's Infant|10
5525611|NCT01443130|19101924|P1|Overall Study|Death of Subject's Infant|5
5525612|NCT01443130|19101919|P6|Overall Study|Withdrawal by Subject|2
5525613|NCT01443130|19101920|P5|Overall Study|Withdrawal by Subject|7
5525614|NCT01443130|19101921|P4|Overall Study|Withdrawal by Subject|7
5525615|NCT01443130|19101922|P3|Overall Study|Withdrawal by Subject|12
5525616|NCT01443130|19101923|P2|Overall Study|Withdrawal by Subject|14
5525617|NCT01443130|19101924|P1|Overall Study|Withdrawal by Subject|15
5525618|NCT01443130|19101919|P6|Overall Study|Protocol Violation|3
5525619|NCT01443130|19101920|P5|Overall Study|Protocol Violation|2
5525620|NCT01443130|19101921|P4|Overall Study|Protocol Violation|2
5525621|NCT01443130|19101922|P3|Overall Study|Protocol Violation|3
5525622|NCT01443130|19101923|P2|Overall Study|Protocol Violation|1
5525623|NCT01443130|19101924|P1|Overall Study|Protocol Violation|2
5525624|NCT01443130|19101919|P6|Overall Study|Adverse Event|0
5525625|NCT01443130|19101920|P5|Overall Study|Adverse Event|0
5525626|NCT01443130|19101921|P4|Overall Study|Adverse Event|0
5525627|NCT01443130|19101922|P3|Overall Study|Adverse Event|1
5525628|NCT01443130|19101923|P2|Overall Study|Adverse Event|1
5525629|NCT01443130|19101924|P1|Overall Study|Adverse Event|2
5525630|NCT01443130|19101919|P6|Overall Study|Death|8
5525631|NCT01443130|19101920|P5|Overall Study|Death|10
5525632|NCT01443130|19101921|P4|Overall Study|Death|7
5525633|NCT01443130|19101922|P3|Overall Study|Death|0
5525634|NCT01443130|19101923|P2|Overall Study|Death|1
5525635|NCT01443130|19101924|P1|Overall Study|Death|0
5525636|NCT01443130|19101919|P6|Overall Study|Lost to Follow-up|21
5525637|NCT01443130|19101920|P5|Overall Study|Lost to Follow-up|25
5525638|NCT01443130|19101921|P4|Overall Study|Lost to Follow-up|23
5525639|NCT01443130|19101922|P3|Overall Study|Lost to Follow-up|50
5525640|NCT01443130|19101923|P2|Overall Study|Lost to Follow-up|42
5525641|NCT01443130|19101924|P1|Overall Study|Lost to Follow-up|44
5525642|NCT01443078|19101974|P1|Overall Study|Patient had brain mets|1
5525643|NCT01443078|19101974|P1|Overall Study|Withdrawal by Subject|1
5525644|NCT01443078|19101974|P1|Overall Study|Responded to neoadjuvant platinum txt|27
5525645|NCT01443026|19101981|P2|Overall Study|Lost to Follow-up|1
5525646|NCT01443026|19101982|P1|Overall Study|Lost to Follow-up|2
5525647|NCT01443026|19101981|P2|Overall Study|Withdrawal by Subject|3
5525648|NCT01443026|19101982|P1|Overall Study|Withdrawal by Subject|0
5525649|NCT01443026|19101981|P2|Overall Study|Death|1
5525650|NCT01443026|19101982|P1|Overall Study|Death|0
5525651|NCT01443026|19101981|P2|Overall Study|Physician Decision|0
5525652|NCT01443026|19101982|P1|Overall Study|Physician Decision|1
5525653|NCT01442779|19101997|P1|Overall Study|Non-compliance|1
5525654|NCT01442779|19101997|P1|Overall Study|Death|3
5525655|NCT01442779|19101997|P1|Overall Study|Withdrawal by Subject|3
5525656|NCT01442714|19102003|P1|Overall Study|Withdrawal by Subject|1
5525657|NCT01442714|19102003|P1|Overall Study|Death|11
5525658|NCT01442688|19102011|P2|Second Intervention|Adverse Event|0
5525659|NCT01442688|19102012|P1|Second Intervention|Adverse Event|1
5525660|NCT01442688|19102011|P2|First Intervention|subject incarcerated|0
5525661|NCT01442688|19102012|P1|First Intervention|subject incarcerated|1
5525662|NCT01442688|19102011|P2|First Intervention|Withdrawal by Subject|0
5525663|NCT01442688|19102012|P1|First Intervention|Withdrawal by Subject|1
5525664|NCT01442675|19102020|P1|Overall Study|Withdrawal by Subject|4
5525665|NCT01442675|19102020|P1|Overall Study|Lost to Follow-up|2
5525666|NCT01442675|19102020|P1|Overall Study|Protocol Violation|6
5525667|NCT01442493|19102032|P2|Overall Study|withdrawn from study|2
5525668|NCT01442493|19102033|P1|Overall Study|withdrawn from study|3
5525669|NCT01442376|19102054|P3|Overall Study|Not eligible for subsequent cycles|0
5525670|NCT01442376|19102055|P2|Overall Study|Not eligible for subsequent cycles|2
5525671|NCT01442376|19102056|P1|Overall Study|Not eligible for subsequent cycles|1
5525672|NCT01442376|19102054|P3|Overall Study|Patients not treated|1
5525673|NCT01442376|19102055|P2|Overall Study|Patients not treated|3
5525674|NCT01442376|19102056|P1|Overall Study|Patients not treated|2
5525675|NCT01442376|19102054|P3|Overall Study|Withdrawal of consent|1
5525676|NCT01442376|19102055|P2|Overall Study|Withdrawal of consent|0
5525677|NCT01442376|19102056|P1|Overall Study|Withdrawal of consent|0
5525678|NCT01442376|19102054|P3|Overall Study|Death|1
5525679|NCT01442376|19102055|P2|Overall Study|Death|1
5525680|NCT01442376|19102056|P1|Overall Study|Death|0
5525681|NCT01442376|19102054|P3|Overall Study|Adverse Event|2
5525682|NCT01442376|19102055|P2|Overall Study|Adverse Event|3
5525683|NCT01442376|19102056|P1|Overall Study|Adverse Event|0
5525684|NCT01442181|19102069|P2|Overall Study|atrial fibrillation not noted|1
5525685|NCT01442181|19102070|P1|Overall Study|atrial fibrillation not noted|0
5525686|NCT01442181|19102069|P2|Overall Study|patient in an additional study|0
5525687|NCT01442181|19102070|P1|Overall Study|patient in an additional study|1
5525688|NCT01442181|19102069|P2|Overall Study|Lost to Follow-up|1
5525689|NCT01442181|19102070|P1|Overall Study|Lost to Follow-up|1
5525690|NCT01442181|19102069|P2|Overall Study|low ejection factor|1
5525691|NCT01442181|19102070|P1|Overall Study|low ejection factor|0
5525692|NCT01442181|19102069|P2|Overall Study|no insurance for surgery|0
5525693|NCT01442181|19102070|P1|Overall Study|no insurance for surgery|1
5525694|NCT01442181|19102069|P2|Overall Study|patient refused surgery|0
5525695|NCT01442181|19102070|P1|Overall Study|patient refused surgery|1
5525696|NCT01442155|19102094|P1|Overall Study|Lost to Follow-up|2
5525697|NCT01442155|19102094|P1|Overall Study|Adverse Event|2
5525698|NCT01442155|19102094|P1|Overall Study|Recurrence|26
5525699|NCT01442155|19102094|P1|Overall Study|Complete remission|35
5525700|NCT01442103|19102110|P1|Overall Study|Lost to Follow-up|2
5525701|NCT01442064|19102120|P6|Overall Study|Condition mandated other intervention|2
5525702|NCT01442064|19102121|P5|Overall Study|Condition mandated other intervention|0
5525703|NCT01442064|19102122|P4|Overall Study|Condition mandated other intervention|0
5525704|NCT01442064|19102123|P3|Overall Study|Condition mandated other intervention|2
5525705|NCT01442064|19102124|P2|Overall Study|Condition mandated other intervention|1
5525706|NCT01442064|19102125|P1|Overall Study|Condition mandated other intervention|1
5525707|NCT01442064|19102120|P6|Overall Study|Subject non-compliance|2
5525708|NCT01442064|19102121|P5|Overall Study|Subject non-compliance|0
5525709|NCT01442064|19102122|P4|Overall Study|Subject non-compliance|0
5525710|NCT01442064|19102123|P3|Overall Study|Subject non-compliance|0
5525711|NCT01442064|19102124|P2|Overall Study|Subject non-compliance|0
5525712|NCT01442064|19102125|P1|Overall Study|Subject non-compliance|0
5525713|NCT01442064|19102120|P6|Overall Study|Sponsor decision|87
5525714|NCT01442064|19102121|P5|Overall Study|Sponsor decision|95
5525715|NCT01442064|19102122|P4|Overall Study|Sponsor decision|88
5525716|NCT01442064|19102123|P3|Overall Study|Sponsor decision|92
5525717|NCT01442064|19102124|P2|Overall Study|Sponsor decision|88
5525718|NCT01442064|19102125|P1|Overall Study|Sponsor decision|82
5525719|NCT01442064|19102120|P6|Overall Study|Withdrawal by Subject|1
5525720|NCT01442064|19102121|P5|Overall Study|Withdrawal by Subject|2
5525721|NCT01442064|19102122|P4|Overall Study|Withdrawal by Subject|2
5525722|NCT01442064|19102123|P3|Overall Study|Withdrawal by Subject|2
5525723|NCT01442064|19102124|P2|Overall Study|Withdrawal by Subject|3
5525724|NCT01442064|19102125|P1|Overall Study|Withdrawal by Subject|6
5525725|NCT01442064|19102120|P6|Overall Study|Physician Decision|1
5525726|NCT01442064|19102121|P5|Overall Study|Physician Decision|3
5525727|NCT01442064|19102122|P4|Overall Study|Physician Decision|3
5525728|NCT01442064|19102123|P3|Overall Study|Physician Decision|2
5525729|NCT01442064|19102124|P2|Overall Study|Physician Decision|1
5525730|NCT01442064|19102125|P1|Overall Study|Physician Decision|1
5525731|NCT01442064|19102120|P6|Overall Study|Lost to Follow-up|3
5525732|NCT01442064|19102121|P5|Overall Study|Lost to Follow-up|3
5525733|NCT01442064|19102122|P4|Overall Study|Lost to Follow-up|1
5525734|NCT01442064|19102123|P3|Overall Study|Lost to Follow-up|1
5525735|NCT01442064|19102124|P2|Overall Study|Lost to Follow-up|5
5525736|NCT01442064|19102125|P1|Overall Study|Lost to Follow-up|5
5525737|NCT01442064|19102120|P6|Overall Study|Death|3
5525738|NCT01442064|19102121|P5|Overall Study|Death|1
5525739|NCT01442064|19102122|P4|Overall Study|Death|3
5525740|NCT01442064|19102123|P3|Overall Study|Death|3
5525741|NCT01442064|19102124|P2|Overall Study|Death|1
5525742|NCT01442064|19102125|P1|Overall Study|Death|0
5525743|NCT01442064|19102120|P6|Overall Study|Adverse Event|0
5525744|NCT01442064|19102121|P5|Overall Study|Adverse Event|2
5525745|NCT01442064|19102122|P4|Overall Study|Adverse Event|1
5525746|NCT01442064|19102123|P3|Overall Study|Adverse Event|2
5525747|NCT01442064|19102124|P2|Overall Study|Adverse Event|2
5525748|NCT01442064|19102125|P1|Overall Study|Adverse Event|2
5525749|NCT01442038|19102162|P2|Overall Study|Study Terminated By Sponsor|3
5525750|NCT01442038|19102163|P1|Overall Study|Study Terminated By Sponsor|2
5525751|NCT01442038|19102162|P2|Overall Study|Investigator's Discretion|16
5525752|NCT01442038|19102163|P1|Overall Study|Investigator's Discretion|13
5525753|NCT01442038|19102162|P2|Overall Study|Protocol Deviation|20
5525754|NCT01442038|19102163|P1|Overall Study|Protocol Deviation|9
5525755|NCT01442038|19102162|P2|Overall Study|Adverse Event|15
5525756|NCT01442038|19102163|P1|Overall Study|Adverse Event|26
5525757|NCT01442038|19102162|P2|Overall Study|Lost to Follow-up|51
5525758|NCT01442038|19102163|P1|Overall Study|Lost to Follow-up|37
5525759|NCT01442038|19102162|P2|Overall Study|Participant Withdrew Consent|102
5525760|NCT01442038|19102163|P1|Overall Study|Participant Withdrew Consent|137
5525761|NCT01442038|19102162|P2|Overall Study|Investigator-Initiated Early Closure|43
5525762|NCT01442038|19102163|P1|Overall Study|Investigator-Initiated Early Closure|44
5525763|NCT01442038|19102162|P2|Overall Study|Death|29
5525764|NCT01442038|19102163|P1|Overall Study|Death|35
5525765|NCT01441973|19102177|P2|Overall Study|Participant withdrew consent|1
5525766|NCT01441973|19102178|P1|Overall Study|Participant withdrew consent|0
5525767|NCT01441973|19102177|P2|Overall Study|Administrative reason by sponsor|5
5525768|NCT01441973|19102178|P1|Overall Study|Administrative reason by sponsor|3
5525769|NCT01441973|19102177|P2|Overall Study|Poor compliance/noncompliance|1
5525770|NCT01441973|19102178|P1|Overall Study|Poor compliance/noncompliance|0
5525771|NCT01441973|19102177|P2|Overall Study|Participant request to discontinue|1
5525772|NCT01441973|19102178|P1|Overall Study|Participant request to discontinue|1
5525773|NCT01441973|19102177|P2|Overall Study|Adverse event unrelated to study drug|2
5525774|NCT01441973|19102178|P1|Overall Study|Adverse event unrelated to study drug|3
5525775|NCT01441973|19102177|P2|Overall Study|Disease progression|6
5525776|NCT01441973|19102178|P1|Overall Study|Disease progression|8
5525777|NCT01441960|19102200|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
5525778|NCT01441960|19102201|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
5525779|NCT01441960|19102200|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
5525780|NCT01441960|19102201|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
5525781|NCT01441960|19102200|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
5525782|NCT01441960|19102201|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
5525783|NCT01441765|19102226|P2|Overall Study|Death|0
5525784|NCT01441765|19102227|P1|Overall Study|Death|1
5525785|NCT01441635|19102251|P10|Overall Study|Other|0
5525786|NCT01441635|19102252|P9|Overall Study|Other|0
5525787|NCT01441635|19102253|P8|Overall Study|Other|1
5525788|NCT01441635|19102254|P7|Overall Study|Other|0
5525789|NCT01441635|19102255|P6|Overall Study|Other|0
5525790|NCT01441635|19102256|P5|Overall Study|Other|0
5525791|NCT01441635|19102257|P4|Overall Study|Other|0
5525792|NCT01441635|19102258|P3|Overall Study|Other|0
5525793|NCT01441635|19102259|P2|Overall Study|Other|0
5525794|NCT01441635|19102260|P1|Overall Study|Other|0
5525795|NCT01441635|19102251|P10|Overall Study|Received Exclusionary Medication|0
5525796|NCT01441635|19102252|P9|Overall Study|Received Exclusionary Medication|0
5525797|NCT01441635|19102253|P8|Overall Study|Received Exclusionary Medication|0
5525798|NCT01441635|19102254|P7|Overall Study|Received Exclusionary Medication|0
5525799|NCT01441635|19102255|P6|Overall Study|Received Exclusionary Medication|0
5525800|NCT01441635|19102256|P5|Overall Study|Received Exclusionary Medication|0
5525801|NCT01441635|19102257|P4|Overall Study|Received Exclusionary Medication|0
5525802|NCT01441635|19102258|P3|Overall Study|Received Exclusionary Medication|0
5525803|NCT01441635|19102259|P2|Overall Study|Received Exclusionary Medication|0
5525804|NCT01441635|19102260|P1|Overall Study|Received Exclusionary Medication|1
5525805|NCT01441635|19102251|P10|Overall Study|Surgery or Invasive Intervention|0
5525806|NCT01441635|19102252|P9|Overall Study|Surgery or Invasive Intervention|0
5525807|NCT01441635|19102253|P8|Overall Study|Surgery or Invasive Intervention|0
5525808|NCT01441635|19102254|P7|Overall Study|Surgery or Invasive Intervention|0
5525809|NCT01441635|19102255|P6|Overall Study|Surgery or Invasive Intervention|0
5525810|NCT01441635|19102256|P5|Overall Study|Surgery or Invasive Intervention|0
5525811|NCT01441635|19102257|P4|Overall Study|Surgery or Invasive Intervention|0
5525812|NCT01441635|19102258|P3|Overall Study|Surgery or Invasive Intervention|1
5525813|NCT01441635|19102259|P2|Overall Study|Surgery or Invasive Intervention|0
5525814|NCT01441635|19102260|P1|Overall Study|Surgery or Invasive Intervention|0
5525815|NCT01441635|19102251|P10|Overall Study|Noncompliance|0
5525816|NCT01441635|19102252|P9|Overall Study|Noncompliance|0
5525817|NCT01441635|19102253|P8|Overall Study|Noncompliance|0
5525818|NCT01441635|19102254|P7|Overall Study|Noncompliance|1
5525819|NCT01441635|19102255|P6|Overall Study|Noncompliance|0
5525820|NCT01441635|19102256|P5|Overall Study|Noncompliance|0
5525821|NCT01441635|19102257|P4|Overall Study|Noncompliance|0
5525822|NCT01441635|19102258|P3|Overall Study|Noncompliance|0
5525823|NCT01441635|19102259|P2|Overall Study|Noncompliance|1
5525824|NCT01441635|19102260|P1|Overall Study|Noncompliance|0
5525825|NCT01441635|19102251|P10|Overall Study|Lost to Follow-up|1
5525826|NCT01441635|19102252|P9|Overall Study|Lost to Follow-up|0
5525827|NCT01441635|19102253|P8|Overall Study|Lost to Follow-up|1
5525828|NCT01441635|19102254|P7|Overall Study|Lost to Follow-up|1
5525829|NCT01441635|19102255|P6|Overall Study|Lost to Follow-up|3
5525830|NCT01441635|19102256|P5|Overall Study|Lost to Follow-up|1
5525831|NCT01441635|19102257|P4|Overall Study|Lost to Follow-up|1
5525832|NCT01441635|19102258|P3|Overall Study|Lost to Follow-up|1
5525833|NCT01441635|19102259|P2|Overall Study|Lost to Follow-up|1
5525834|NCT01441635|19102260|P1|Overall Study|Lost to Follow-up|0
5525835|NCT01441635|19102251|P10|Overall Study|Withdrawal by Subject|1
5525836|NCT01441635|19102252|P9|Overall Study|Withdrawal by Subject|1
5525837|NCT01441635|19102253|P8|Overall Study|Withdrawal by Subject|0
5525838|NCT01441635|19102254|P7|Overall Study|Withdrawal by Subject|2
5525839|NCT01441635|19102255|P6|Overall Study|Withdrawal by Subject|0
5525840|NCT01441635|19102256|P5|Overall Study|Withdrawal by Subject|0
5525841|NCT01441635|19102257|P4|Overall Study|Withdrawal by Subject|1
5525842|NCT01441635|19102258|P3|Overall Study|Withdrawal by Subject|0
5525843|NCT01441635|19102259|P2|Overall Study|Withdrawal by Subject|1
5525844|NCT01441635|19102260|P1|Overall Study|Withdrawal by Subject|1
5525845|NCT01441635|19102251|P10|Overall Study|Adverse Event|0
5525846|NCT01441635|19102252|P9|Overall Study|Adverse Event|1
5525847|NCT01441635|19102253|P8|Overall Study|Adverse Event|2
5525848|NCT01441635|19102254|P7|Overall Study|Adverse Event|2
5525849|NCT01441635|19102255|P6|Overall Study|Adverse Event|2
5525850|NCT01441635|19102256|P5|Overall Study|Adverse Event|1
5525851|NCT01441635|19102257|P4|Overall Study|Adverse Event|5
5525852|NCT01441635|19102258|P3|Overall Study|Adverse Event|1
5525853|NCT01441635|19102259|P2|Overall Study|Adverse Event|3
5525854|NCT01441635|19102260|P1|Overall Study|Adverse Event|4
5525855|NCT01441596|19102475|P3|Overall Study|Not treated|1
5525856|NCT01441596|19102476|P2|Overall Study|Not treated|1
5525857|NCT01441596|19102477|P1|Overall Study|Not treated|0
5525858|NCT01441596|19102475|P3|Overall Study|Withdrawal by Subject|2
5525859|NCT01441596|19102476|P2|Overall Study|Withdrawal by Subject|0
5525860|NCT01441596|19102477|P1|Overall Study|Withdrawal by Subject|4
5525861|NCT01441596|19102475|P3|Overall Study|Other reason not defined below|1
5525862|NCT01441596|19102476|P2|Overall Study|Other reason not defined below|2
5525863|NCT01441596|19102477|P1|Overall Study|Other reason not defined below|0
5525864|NCT01441440|19102551|P3|Overall Study|Difficllty in keeping the schedule|0
5525865|NCT01441440|19102552|P2|Overall Study|Difficllty in keeping the schedule|1
5525866|NCT01441440|19102553|P1|Overall Study|Difficllty in keeping the schedule|1
5525867|NCT01441440|19102551|P3|Overall Study|Work-related matter|0
5525868|NCT01441440|19102552|P2|Overall Study|Work-related matter|1
5525869|NCT01441440|19102553|P1|Overall Study|Work-related matter|0
5525870|NCT01441440|19102551|P3|Overall Study|Moving|1
5525871|NCT01441440|19102552|P2|Overall Study|Moving|1
5525872|NCT01441440|19102553|P1|Overall Study|Moving|0
5525873|NCT01441440|19102551|P3|Overall Study|Lack of Efficacy|1
5525874|NCT01441440|19102552|P2|Overall Study|Lack of Efficacy|0
5525875|NCT01441440|19102553|P1|Overall Study|Lack of Efficacy|1
5525876|NCT01441440|19102551|P3|Overall Study|Pregnancy|0
5525877|NCT01441440|19102552|P2|Overall Study|Pregnancy|0
5525878|NCT01441440|19102553|P1|Overall Study|Pregnancy|1
5525879|NCT01441440|19102551|P3|Overall Study|Withdrawal by Subject|9
5525880|NCT01441440|19102552|P2|Overall Study|Withdrawal by Subject|9
5525881|NCT01441440|19102553|P1|Overall Study|Withdrawal by Subject|11
5525882|NCT01441440|19102551|P3|Overall Study|Lost to Follow-up|1
5525883|NCT01441440|19102552|P2|Overall Study|Lost to Follow-up|2
5525884|NCT01441440|19102553|P1|Overall Study|Lost to Follow-up|0
5525885|NCT01441440|19102551|P3|Overall Study|Adverse Event|9
5525886|NCT01441440|19102552|P2|Overall Study|Adverse Event|9
5525887|NCT01441440|19102553|P1|Overall Study|Adverse Event|2
5525888|NCT01441440|19102551|P3|Overall Study|Death|1
5525889|NCT01441440|19102552|P2|Overall Study|Death|0
5525890|NCT01441440|19102553|P1|Overall Study|Death|1
5525891|NCT01441414|19102576|P1|Overall Study|Subject refused further follow-up|1
5525892|NCT01441414|19102576|P1|Overall Study|Study terminated by sponsor|2
5525893|NCT01441414|19102576|P1|Overall Study|Other reasons|3
5525894|NCT01441414|19102576|P1|Overall Study|Participant died|9
5525895|NCT01441180|19102655|P3|Overall Study|Discontinued|2
5525896|NCT01441180|19102656|P2|Overall Study|Discontinued|0
5525897|NCT01441180|19102657|P1|Overall Study|Discontinued|0
5525898|NCT01441180|19102655|P3|Overall Study|Lost to Follow-up|1
5525899|NCT01441180|19102656|P2|Overall Study|Lost to Follow-up|1
5525900|NCT01441180|19102657|P1|Overall Study|Lost to Follow-up|1
5525901|NCT01441102|19102668|P1|Overall Study|Withdrawal by Subject|2
5525902|NCT01441102|19102668|P1|Overall Study|Adverse Event|1
5525903|NCT01441063|19102706|P1|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
5525904|NCT01441063|19102706|P1|Tocilizumab Alone|Required AZT/VGC addition|3
5525905|NCT01440972|19102741|P2|Overall Study|Withdrawal by Subject|2
5525906|NCT01440972|19102742|P1|Overall Study|Withdrawal by Subject|3
5525907|NCT01440946|19102766|P2|Overall Study|Physician Decision|0
5525908|NCT01440946|19102767|P1|Overall Study|Physician Decision|1
5525909|NCT01440946|19102766|P2|Overall Study|Lost to Follow-up|1
5525910|NCT01440946|19102767|P1|Overall Study|Lost to Follow-up|1
5525911|NCT01440881|19102806|P2|Overall Study|Death|1
5525912|NCT01440881|19102807|P1|Overall Study|Death|0
5525913|NCT01440816|19102821|P2|Overall Study|To Be Seen By Local Oncologist|2
5525914|NCT01440816|19102822|P1|Overall Study|To Be Seen By Local Oncologist|1
5525915|NCT01440816|19102821|P2|Overall Study|Disease Progression|9
5525916|NCT01440816|19102822|P1|Overall Study|Disease Progression|0
5525917|NCT01440803|19102838|P2|Overall Study|Withdrawal by Subject|1
5525918|NCT01440803|19102839|P1|Overall Study|Withdrawal by Subject|0
5525919|NCT01440803|19102838|P2|Overall Study|Lost to Follow-up|2
5525920|NCT01440803|19102839|P1|Overall Study|Lost to Follow-up|0
5525921|NCT01440803|19102838|P2|Overall Study|Met study stopping rule|1
5525922|NCT01440803|19102839|P1|Overall Study|Met study stopping rule|2
5525923|NCT01440647|19102875|P2|Overall Study|Death|3
5525924|NCT01440647|19102876|P1|Overall Study|Death|2
5525925|NCT01440595|19102895|P3|Overall Study|Study terminated by sponsor.|1
5525926|NCT01440595|19102896|P2|Overall Study|Study terminated by sponsor.|2
5525927|NCT01440595|19102897|P1|Overall Study|Study terminated by sponsor.|1
5525928|NCT01440595|19102895|P3|Overall Study|Lost to Follow-up|0
5525929|NCT01440595|19102896|P2|Overall Study|Lost to Follow-up|1
5525930|NCT01440595|19102897|P1|Overall Study|Lost to Follow-up|0
5525931|NCT01440569|19102917|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
5525932|NCT01440569|19102918|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
5525933|NCT01440569|19102917|P2|Open-Label Rollover Phase|Lost to Follow-up|3
5525934|NCT01440569|19102918|P1|Open-Label Rollover Phase|Lost to Follow-up|26
5525935|NCT01440569|19102917|P2|Open-Label Rollover Phase|Withdrew Consent|1
5525936|NCT01440569|19102918|P1|Open-Label Rollover Phase|Withdrew Consent|11
5525937|NCT01440569|19102917|P2|Open-Label Rollover Phase|Investigator's Discretion|1
5525938|NCT01440569|19102918|P1|Open-Label Rollover Phase|Investigator's Discretion|3
5525939|NCT01440569|19102917|P2|Open-Label Rollover Phase|Lack of Efficacy|0
5525940|NCT01440569|19102918|P1|Open-Label Rollover Phase|Lack of Efficacy|2
5525941|NCT01440569|19102917|P2|Open-Label Rollover Phase|Pregnancy|0
5525942|NCT01440569|19102918|P1|Open-Label Rollover Phase|Pregnancy|1
5525943|NCT01440569|19102917|P2|Open-Label Rollover Phase|Adverse Event|0
5525944|NCT01440569|19102918|P1|Open-Label Rollover Phase|Adverse Event|3
5525945|NCT01440569|19102917|P2|Main Study|Protocol Violation|0
5525946|NCT01440569|19102918|P1|Main Study|Protocol Violation|1
5525947|NCT01440569|19102917|P2|Main Study|Subject Non-Compliance|0
5525948|NCT01440569|19102918|P1|Main Study|Subject Non-Compliance|3
5525949|NCT01440569|19102917|P2|Main Study|Lost to Follow-up|2
5525950|NCT01440569|19102918|P1|Main Study|Lost to Follow-up|13
5525951|NCT01440569|19102917|P2|Main Study|Withdrew Consent|1
5525952|NCT01440569|19102918|P1|Main Study|Withdrew Consent|7
5525953|NCT01440569|19102917|P2|Main Study|Investigator's Discretion|1
5525954|NCT01440569|19102918|P1|Main Study|Investigator's Discretion|1
5525955|NCT01440569|19102917|P2|Main Study|Pregnancy|0
5525956|NCT01440569|19102918|P1|Main Study|Pregnancy|1
5525957|NCT01440569|19102917|P2|Main Study|Adverse Event|0
5525958|NCT01440569|19102918|P1|Main Study|Adverse Event|9
5525959|NCT01440569|19102917|P2|Main Study|Enrolled but not treated|0
5525960|NCT01440569|19102918|P1|Main Study|Enrolled but not treated|1
5525961|NCT01440517|19102953|P1|Overall Study|Subject withdrawn prior to dosing|1
5525962|NCT01440374|19103029|P4|Part 3: Extension|Physician Decision|14
5525963|NCT01440374|19103030|P3|Part 3: Extension|Physician Decision|0
5525964|NCT01440374|19103031|P2|Part 3: Extension|Physician Decision|0
5525965|NCT01440374|19103032|P1|Part 3: Extension|Physician Decision|0
5525966|NCT01440374|19103029|P4|Part 3: Extension|Adverse Event|13
5525967|NCT01440374|19103030|P3|Part 3: Extension|Adverse Event|0
5525968|NCT01440374|19103031|P2|Part 3: Extension|Adverse Event|0
5525969|NCT01440374|19103032|P1|Part 3: Extension|Adverse Event|0
5525970|NCT01440374|19103029|P4|Part 3: Extension|Withdrawal by Subject|5
5525971|NCT01440374|19103030|P3|Part 3: Extension|Withdrawal by Subject|0
5525972|NCT01440374|19103031|P2|Part 3: Extension|Withdrawal by Subject|0
5525973|NCT01440374|19103032|P1|Part 3: Extension|Withdrawal by Subject|0
5525974|NCT01440374|19103029|P4|Part 2; Double-blind Phase|Not treated|0
5525975|NCT01440374|19103030|P3|Part 2; Double-blind Phase|Not treated|1
5525976|NCT01440374|19103031|P2|Part 2; Double-blind Phase|Not treated|0
5525977|NCT01440374|19103032|P1|Part 2; Double-blind Phase|Not treated|0
5525978|NCT01440374|19103029|P4|Part 2; Double-blind Phase|Adverse Event|0
5525979|NCT01440374|19103030|P3|Part 2; Double-blind Phase|Adverse Event|31
5525980|NCT01440374|19103031|P2|Part 2; Double-blind Phase|Adverse Event|7
5525981|NCT01440374|19103032|P1|Part 2; Double-blind Phase|Adverse Event|0
5525982|NCT01440374|19103029|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
5525983|NCT01440374|19103030|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
5525984|NCT01440374|19103031|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
5525985|NCT01440374|19103032|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
5525986|NCT01440374|19103029|P4|Part 2; Double-blind Phase|Protocol Violation|0
5525987|NCT01440374|19103030|P3|Part 2; Double-blind Phase|Protocol Violation|1
5525988|NCT01440374|19103031|P2|Part 2; Double-blind Phase|Protocol Violation|0
5525989|NCT01440374|19103032|P1|Part 2; Double-blind Phase|Protocol Violation|0
5525990|NCT01440374|19103029|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
5525991|NCT01440374|19103030|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
5525992|NCT01440374|19103031|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
5525993|NCT01440374|19103032|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
5525994|NCT01440374|19103029|P4|Part 2; Double-blind Phase|Physician Decision|0
5525995|NCT01440374|19103030|P3|Part 2; Double-blind Phase|Physician Decision|17
5525996|NCT01440374|19103031|P2|Part 2; Double-blind Phase|Physician Decision|8
5525997|NCT01440374|19103032|P1|Part 2; Double-blind Phase|Physician Decision|0
5525998|NCT01440374|19103029|P4|Part 1: Open-label Phase|Physician Decision|0
5525999|NCT01440374|19103030|P3|Part 1: Open-label Phase|Physician Decision|0
5526000|NCT01440374|19103031|P2|Part 1: Open-label Phase|Physician Decision|0
5526001|NCT01440374|19103032|P1|Part 1: Open-label Phase|Physician Decision|1
5526002|NCT01440374|19103029|P4|Part 1: Open-label Phase|Adverse Event|0
5526003|NCT01440374|19103030|P3|Part 1: Open-label Phase|Adverse Event|0
5526004|NCT01440374|19103031|P2|Part 1: Open-label Phase|Adverse Event|0
5526005|NCT01440374|19103032|P1|Part 1: Open-label Phase|Adverse Event|5
5526006|NCT01440322|19103067|P2|Overall Study|Other Non-Product Related|0
5526007|NCT01440322|19103068|P1|Overall Study|Other Non-Product Related|1
5526008|NCT01440322|19103067|P2|Overall Study|Unrelated Medical Problem|1
5526009|NCT01440322|19103068|P1|Overall Study|Unrelated Medical Problem|0
5526010|NCT01440322|19103067|P2|Overall Study|Other Product Related|0
5526011|NCT01440322|19103068|P1|Overall Study|Other Product Related|1
5526012|NCT01440322|19103067|P2|Overall Study|Unacceptable Subjective Vision|0
5526013|NCT01440322|19103068|P1|Overall Study|Unacceptable Subjective Vision|1
5526014|NCT01440322|19103067|P2|Overall Study|Symptoms and Problems|0
5526015|NCT01440322|19103068|P1|Overall Study|Symptoms and Problems|1
5526016|NCT01440322|19103067|P2|Overall Study|Biomicroscopy|0
5526017|NCT01440322|19103068|P1|Overall Study|Biomicroscopy|1
5526018|NCT01440322|19103067|P2|Overall Study|Discomfort|0
5526019|NCT01440322|19103068|P1|Overall Study|Discomfort|2
5526020|NCT01440283|19103090|P1|Overall Study|Physician Decision|3
5526021|NCT01440283|19103090|P1|Overall Study|Withdrawal by Subject|4
5526022|NCT01440283|19103090|P1|Overall Study|Death|3
5526023|NCT01440101|19103105|P3|Overall Study|Other|0
5526024|NCT01440101|19103106|P2|Overall Study|Other|1
5526025|NCT01440101|19103107|P1|Overall Study|Other|0
5526026|NCT01440101|19103105|P3|Overall Study|Withdrawal by Subject|1
5526027|NCT01440101|19103106|P2|Overall Study|Withdrawal by Subject|3
5526028|NCT01440101|19103107|P1|Overall Study|Withdrawal by Subject|0
5526029|NCT01440101|19103105|P3|Overall Study|Adverse Event|0
5526030|NCT01440101|19103106|P2|Overall Study|Adverse Event|0
5526031|NCT01440101|19103107|P1|Overall Study|Adverse Event|2
5526032|NCT01440049|19103140|P1|Overall Study|Adverse Event|5
5526033|NCT01439971|19103172|P5|Overall Study|Required number in cohort dosed|1
5526034|NCT01439971|19103173|P4|Overall Study|Required number in cohort dosed|0
5526035|NCT01439971|19103174|P3|Overall Study|Required number in cohort dosed|2
5526036|NCT01439971|19103175|P2|Overall Study|Required number in cohort dosed|1
5526037|NCT01439971|19103176|P1|Overall Study|Required number in cohort dosed|0
5526038|NCT01439945|19103356|P4|Double-Blind Treatment Phase|Ineligible|1
5526039|NCT01439945|19103357|P3|Double-Blind Treatment Phase|Ineligible|0
5526040|NCT01439945|19103358|P2|Double-Blind Treatment Phase|Ineligible|2
5526041|NCT01439945|19103359|P1|Double-Blind Treatment Phase|Ineligible|1
5526042|NCT01439945|19103356|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
5526043|NCT01439945|19103357|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
5526044|NCT01439945|19103358|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
5526045|NCT01439945|19103359|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
5526046|NCT01439880|19103384|P2|All-IP Period (Years 2 to 5)|Reason Missing|0
5526047|NCT01439880|19103385|P1|All-IP Period (Years 2 to 5)|Reason Missing|1
5526048|NCT01439880|19103384|P2|All-IP Period (Years 2 to 5)|Other|31
5526049|NCT01439880|19103385|P1|All-IP Period (Years 2 to 5)|Other|14
5526050|NCT01439880|19103384|P2|All-IP Period (Years 2 to 5)|Sponsor Decision|0
5526051|NCT01439880|19103385|P1|All-IP Period (Years 2 to 5)|Sponsor Decision|1
5526052|NCT01439880|19103384|P2|All-IP Period (Years 2 to 5)|Death|13
5526053|NCT01439880|19103385|P1|All-IP Period (Years 2 to 5)|Death|3
5526054|NCT01439880|19103384|P2|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
5526055|NCT01439880|19103385|P1|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
5526056|NCT01439880|19103384|P2|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
5526057|NCT01439880|19103385|P1|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
5526058|NCT01439880|19103384|P2|SOC-controlled Period (Year 1)|Reason Missing|2
5526059|NCT01439880|19103385|P1|SOC-controlled Period (Year 1)|Reason Missing|0
5526060|NCT01439880|19103384|P2|SOC-controlled Period (Year 1)|Other|13
5526061|NCT01439880|19103385|P1|SOC-controlled Period (Year 1)|Other|8
5526062|NCT01439880|19103384|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|5
5526063|NCT01439880|19103385|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|10
5526064|NCT01439880|19103384|P2|SOC-controlled Period (Year 1)|Sponsor Decision|1
5526065|NCT01439880|19103385|P1|SOC-controlled Period (Year 1)|Sponsor Decision|0
5526066|NCT01439880|19103384|P2|SOC-controlled Period (Year 1)|Death|1
5526067|NCT01439880|19103385|P1|SOC-controlled Period (Year 1)|Death|2
5526068|NCT01439880|19103384|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
5526069|NCT01439880|19103385|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
5526070|NCT01439867|19103428|P2|Overall Study|Protocol-specified Criteria|0
5526071|NCT01439867|19103429|P1|Overall Study|Protocol-specified Criteria|1
5526072|NCT01439867|19103428|P2|Overall Study|Administrative Decision|5
5526073|NCT01439867|19103429|P1|Overall Study|Administrative Decision|4
5526074|NCT01439867|19103428|P2|Overall Study|Withdrawal by Subject|2
5526075|NCT01439867|19103429|P1|Overall Study|Withdrawal by Subject|1
5526076|NCT01439867|19103428|P2|Overall Study|Non-compliance|1
5526077|NCT01439867|19103429|P1|Overall Study|Non-compliance|0
5526078|NCT01439724|19103481|P2|Overall Study|missing consultation|8
5526079|NCT01439724|19103482|P1|Overall Study|missing consultation|9
5526080|NCT01439711|19103488|P1|Overall Study|No MRI|9
5526081|NCT01439711|19103488|P1|Overall Study|Noncompliance|3
5526082|NCT01439711|19103488|P1|Overall Study|Progression During Active Tx|3
5526083|NCT01439711|19103488|P1|Overall Study|Withdrawal by Subject|3
5526084|NCT01439711|19103488|P1|Overall Study|Adverse Event|5
5526085|NCT01439711|19103488|P1|Overall Study|Progression Prior to Beginning Tx|1
5526086|NCT01439711|19103488|P1|Overall Study|Cancel|3
5526087|NCT01439711|19103488|P1|Overall Study|Ineligible|13
5526088|NCT01439568|19103526|P2|Overall Study|Withdrawal by Subject|2
5526089|NCT01439568|19103527|P1|Overall Study|Withdrawal by Subject|2
5526090|NCT01439568|19103526|P2|Overall Study|Lost to Follow-up|0
5526091|NCT01439568|19103527|P1|Overall Study|Lost to Follow-up|1
5526092|NCT01439555|19103539|P1|Overall Study|Protocol Violation|1
5526093|NCT01439373|19103551|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
5526094|NCT01439373|19103552|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
5526095|NCT01439373|19103551|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
5526096|NCT01439373|19103552|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
5526097|NCT01439360|19103595|P2|Overall Study|Withdrawal by Subject|129
5526098|NCT01439360|19103596|P1|Overall Study|Withdrawal by Subject|140
5526099|NCT01439360|19103595|P2|Overall Study|Protocol Violation|0
5526100|NCT01439360|19103596|P1|Overall Study|Protocol Violation|1
5526101|NCT01439360|19103595|P2|Overall Study|Others|5
5526102|NCT01439360|19103596|P1|Overall Study|Others|10
5526103|NCT01439360|19103595|P2|Overall Study|Lost to Follow-up|58
5526104|NCT01439360|19103596|P1|Overall Study|Lost to Follow-up|43
5526105|NCT01439360|19103595|P2|Overall Study|Adverse Event|16
5526106|NCT01439360|19103596|P1|Overall Study|Adverse Event|4
5526107|NCT01439282|19103646|P2|Overall Study|Other|1
5526108|NCT01439282|19103647|P1|Overall Study|Other|1
5526109|NCT01439282|19103646|P2|Overall Study|Withdrawal by Subject|0
5526110|NCT01439282|19103647|P1|Overall Study|Withdrawal by Subject|2
5526111|NCT01439282|19103646|P2|Overall Study|Adverse Event|0
5526112|NCT01439282|19103647|P1|Overall Study|Adverse Event|5
5526113|NCT01439204|19103659|P2|Overall Study|poor/non-compliance|0
5526114|NCT01439204|19103660|P1|Overall Study|poor/non-compliance|3
5526115|NCT01439204|19103659|P2|Overall Study|No longer meets study criteria|0
5526116|NCT01439204|19103660|P1|Overall Study|No longer meets study criteria|1
5526117|NCT01439204|19103659|P2|Overall Study|Lost to Follow-up|2
5526118|NCT01439204|19103660|P1|Overall Study|Lost to Follow-up|0
5526119|NCT01439204|19103659|P2|Overall Study|Withdrawal by Subject|1
5526120|NCT01439204|19103660|P1|Overall Study|Withdrawal by Subject|0
5526121|NCT01439165|19103694|P2|Overall Study|Withdrawal by Subject|1
5526122|NCT01439165|19103695|P1|Overall Study|Withdrawal by Subject|7
5526123|NCT01439165|19103694|P2|Overall Study|Lost to Follow-up|1
5526124|NCT01439165|19103695|P1|Overall Study|Lost to Follow-up|11
5526125|NCT01439165|19103694|P2|Overall Study|Protocol Violation|0
5526126|NCT01439165|19103695|P1|Overall Study|Protocol Violation|3
5526127|NCT01439126|19103709|P2|Overall Study|Other-Miscellaneous|12
5526128|NCT01439126|19103710|P1|Overall Study|Other-Miscellaneous|12
5526129|NCT01439126|19103709|P2|Overall Study|Other-Use of prohibited treatment|2
5526130|NCT01439126|19103710|P1|Overall Study|Other-Use of prohibited treatment|0
5526131|NCT01439126|19103709|P2|Overall Study|Lost to Follow-up|3
5526132|NCT01439126|19103710|P1|Overall Study|Lost to Follow-up|6
5526133|NCT01439126|19103709|P2|Overall Study|Protocol Violation|4
5526134|NCT01439126|19103710|P1|Overall Study|Protocol Violation|6
5526135|NCT01439126|19103709|P2|Overall Study|Withdrawal by Subject|21
5526136|NCT01439126|19103710|P1|Overall Study|Withdrawal by Subject|5
5526137|NCT01439126|19103709|P2|Overall Study|Adverse Event|0
5526138|NCT01439126|19103710|P1|Overall Study|Adverse Event|2
5526139|NCT01439074|19103736|P2|Overall Study|Other|4
5526140|NCT01439074|19103737|P1|Overall Study|Other|4
5526141|NCT01439074|19103736|P2|Overall Study|Withdrawal by Subject|5
5526142|NCT01439074|19103737|P1|Overall Study|Withdrawal by Subject|1
5526143|NCT01439074|19103736|P2|Overall Study|Subject shedding|0
5526144|NCT01439074|19103737|P1|Overall Study|Subject shedding|1
5526145|NCT01439074|19103736|P2|Overall Study|Lost to Follow-up|4
5526146|NCT01439074|19103737|P1|Overall Study|Lost to Follow-up|3
5526147|NCT01439009|19103755|P2|Overall Study|Deviation of exclusion criteria|0
5526148|NCT01439009|19103756|P1|Overall Study|Deviation of exclusion criteria|1
5526149|NCT01439009|19103755|P2|Overall Study|Protocol Violation|0
5526150|NCT01439009|19103756|P1|Overall Study|Protocol Violation|2
5526151|NCT01439009|19103755|P2|Overall Study|Physician Decision|3
5526152|NCT01439009|19103756|P1|Overall Study|Physician Decision|5
5526153|NCT01438996|19103789|P3|Overall Study|Not meeting Inclusion Criteria|0
5526154|NCT01438996|19103790|P2|Overall Study|Not meeting Inclusion Criteria|1
5526155|NCT01438996|19103791|P1|Overall Study|Not meeting Inclusion Criteria|4
5526156|NCT01438840|19103825|P3|Extension Phase|Other|1
5526157|NCT01438840|19103826|P2|Extension Phase|Other|0
5526158|NCT01438840|19103827|P1|Extension Phase|Other|0
5526159|NCT01438840|19103825|P3|Extension Phase|Lack of Efficacy|2
5526160|NCT01438840|19103826|P2|Extension Phase|Lack of Efficacy|0
5526161|NCT01438840|19103827|P1|Extension Phase|Lack of Efficacy|0
5526162|NCT01438840|19103825|P3|Extension Phase|Withdrawal by Subject|3
5526163|NCT01438840|19103826|P2|Extension Phase|Withdrawal by Subject|0
5526164|NCT01438840|19103827|P1|Extension Phase|Withdrawal by Subject|0
5526165|NCT01438840|19103825|P3|Extension Phase|Lost to Follow-up|1
5526166|NCT01438840|19103826|P2|Extension Phase|Lost to Follow-up|0
5526167|NCT01438840|19103827|P1|Extension Phase|Lost to Follow-up|0
5526168|NCT01438840|19103825|P3|Extension Phase|Adverse Event|3
5526169|NCT01438840|19103826|P2|Extension Phase|Adverse Event|0
5526170|NCT01438840|19103827|P1|Extension Phase|Adverse Event|0
5526171|NCT01438840|19103825|P3|Core Study|Withdrawal of consent|0
5526172|NCT01438840|19103826|P2|Core Study|Withdrawal of consent|0
5526173|NCT01438840|19103827|P1|Core Study|Withdrawal of consent|1
5526174|NCT01438840|19103825|P3|Core Study|Lack of Efficacy|0
5526175|NCT01438840|19103826|P2|Core Study|Lack of Efficacy|7
5526176|NCT01438840|19103827|P1|Core Study|Lack of Efficacy|15
5526177|NCT01438840|19103825|P3|Core Study|Adverse Event|0
5526178|NCT01438840|19103826|P2|Core Study|Adverse Event|3
5526179|NCT01438840|19103827|P1|Core Study|Adverse Event|0
5526180|NCT01438814|19103840|P2|Overall Study|Other|4
5526181|NCT01438814|19103841|P1|Overall Study|Other|2
5526182|NCT01438814|19103840|P2|Overall Study|Withdrawal by Subject|2
5526183|NCT01438814|19103841|P1|Overall Study|Withdrawal by Subject|4
5526184|NCT01438814|19103840|P2|Overall Study|Lost to Follow-up|3
5526185|NCT01438814|19103841|P1|Overall Study|Lost to Follow-up|4
5526186|NCT01438814|19103840|P2|Overall Study|Protocol Violation|2
5526187|NCT01438814|19103841|P1|Overall Study|Protocol Violation|1
5526188|NCT01438814|19103840|P2|Overall Study|Adverse Event|3
5526189|NCT01438814|19103841|P1|Overall Study|Adverse Event|3
5526190|NCT01438541|19103877|P1|Overall Study|discharge from the hospital|5
5526191|NCT01438541|19103877|P1|Overall Study|Withdrawal by Subject|1
5526192|NCT01438541|19103877|P1|Overall Study|Physician Decision|1
5526193|NCT01438489|19103886|P3|Overall Study|Inadequate venous access|0
5526194|NCT01438489|19103887|P2|Overall Study|Inadequate venous access|2
5526195|NCT01438489|19103888|P1|Overall Study|Inadequate venous access|0
5526196|NCT01438489|19103886|P3|Overall Study|Did not complete all 3 follow-up visits|2
5526197|NCT01438489|19103887|P2|Overall Study|Did not complete all 3 follow-up visits|5
5526198|NCT01438489|19103888|P1|Overall Study|Did not complete all 3 follow-up visits|2
5526199|NCT01438489|19103886|P3|Overall Study|Received prohibited medication|0
5526200|NCT01438489|19103887|P2|Overall Study|Received prohibited medication|0
5526201|NCT01438489|19103888|P1|Overall Study|Received prohibited medication|1
5526202|NCT01438489|19103886|P3|Overall Study|AE/SAEs|1
5526203|NCT01438489|19103887|P2|Overall Study|AE/SAEs|1
5526204|NCT01438489|19103888|P1|Overall Study|AE/SAEs|2
5526205|NCT01438489|19103886|P3|Overall Study|Investigator decision|0
5526206|NCT01438489|19103887|P2|Overall Study|Investigator decision|1
5526207|NCT01438489|19103888|P1|Overall Study|Investigator decision|0
5526208|NCT01438489|19103886|P3|Overall Study|Subject choice/Subject moved|1
5526209|NCT01438489|19103887|P2|Overall Study|Subject choice/Subject moved|1
5526210|NCT01438489|19103888|P1|Overall Study|Subject choice/Subject moved|2
5526211|NCT01438489|19103886|P3|Overall Study|Sponsor decision|4
5526212|NCT01438489|19103887|P2|Overall Study|Sponsor decision|1
5526213|NCT01438489|19103888|P1|Overall Study|Sponsor decision|4
5526214|NCT01438489|19103886|P3|Overall Study|Death|1
5526215|NCT01438489|19103887|P2|Overall Study|Death|0
5526216|NCT01438489|19103888|P1|Overall Study|Death|0
5526217|NCT01438489|19103886|P3|Overall Study|Withdrawal by Subject|8
5526218|NCT01438489|19103887|P2|Overall Study|Withdrawal by Subject|3
5526219|NCT01438489|19103888|P1|Overall Study|Withdrawal by Subject|11
5526220|NCT01438489|19103886|P3|Overall Study|Lost to Follow-up|2
5526221|NCT01438489|19103887|P2|Overall Study|Lost to Follow-up|2
5526222|NCT01438489|19103888|P1|Overall Study|Lost to Follow-up|4
5526223|NCT01438476|19103933|P2|Overall Study|Communication barrier|1
5526224|NCT01438476|19103934|P1|Overall Study|Communication barrier|0
5526225|NCT01438476|19103933|P2|Overall Study|No Surgery- Disease|10
5526226|NCT01438476|19103934|P1|Overall Study|No Surgery- Disease|8
5526227|NCT01438476|19103933|P2|Overall Study|Withdrawal by Subject|0
5526228|NCT01438476|19103934|P1|Overall Study|Withdrawal by Subject|1
5526229|NCT01438476|19103933|P2|Overall Study|Protocol Violation|0
5526230|NCT01438476|19103934|P1|Overall Study|Protocol Violation|1
5526231|NCT01438424|19103940|P1|Overall Study|Participant noncompliance|20
5526232|NCT01438424|19103940|P1|Overall Study|No longer met inclusion criteria|1
5526233|NCT01438424|19103940|P1|Overall Study|Pregnancy|7
5526234|NCT01438424|19103940|P1|Overall Study|Need for drug prohibited by protocol|14
5526235|NCT01438424|19103940|P1|Overall Study|Abnormal laboratory test result|14
5526236|NCT01438424|19103940|P1|Overall Study|Lost to Follow-up|17
5526237|NCT01438424|19103940|P1|Overall Study|Adverse Event|17
5526238|NCT01438424|19103940|P1|Overall Study|Death|22
5526239|NCT01438424|19103940|P1|Overall Study|Progression of chronic hepatitis B|22
5526240|NCT01438424|19103940|P1|Overall Study|Withdrawal by Subject|104
5526241|NCT01438424|19103940|P1|Overall Study|Not identified|55
5526242|NCT01438424|19103940|P1|Overall Study|Minimal virologic response|95
5526243|NCT01438424|19103940|P1|Overall Study|Continuing treatment|29
5526244|NCT01438411|19103976|P1|Overall Study|Withdrawal by Subject|3
5526245|NCT01438411|19103976|P1|Overall Study|Lack of Efficacy|1
5526246|NCT01438411|19103976|P1|Overall Study|Lost to Follow-up|1
5526247|NCT01438411|19103976|P1|Overall Study|Adverse Event|8
5526248|NCT01438307|19103991|P2|Overall Study|Death|1
5526249|NCT01438307|19103992|P1|Overall Study|Death|1
5526250|NCT01438294|19104006|P2|Overall Study|Lost to Follow-up|7
5526251|NCT01438294|19104007|P1|Overall Study|Lost to Follow-up|3
5526252|NCT01438177|19104050|P1|Overall Study|Initiation of new therapy|1
5526253|NCT01438177|19104050|P1|Overall Study|Withdrawal by Subject|1
5526254|NCT01438151|19104057|P1|Overall Study|study terminated|8
5526255|NCT01438060|19104063|P2|On Study Beyond Week 140|Other Reason|3
5526256|NCT01438060|19104064|P1|On Study Beyond Week 140|Other Reason|0
5526257|NCT01438060|19104063|P2|On Study Beyond Week 140|Death|1
5526258|NCT01438060|19104064|P1|On Study Beyond Week 140|Death|0
5526259|NCT01438060|19104063|P2|On Study Beyond Week 140|Withdrawal by Subject|1
5526260|NCT01438060|19104064|P1|On Study Beyond Week 140|Withdrawal by Subject|0
5526261|NCT01438060|19104063|P2|On Study Beyond Week 140|Lack of Efficacy|1
5526262|NCT01438060|19104064|P1|On Study Beyond Week 140|Lack of Efficacy|0
5526263|NCT01438060|19104063|P2|On Study Beyond Week 140|Adverse Event|2
5526264|NCT01438060|19104064|P1|On Study Beyond Week 140|Adverse Event|0
5526265|NCT01438060|19104063|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
5526266|NCT01438060|19104064|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
5526267|NCT01438060|19104063|P2|Extension Phase: Week 10 to Week 130|Death|12
5526268|NCT01438060|19104064|P1|Extension Phase: Week 10 to Week 130|Death|22
5526269|NCT01438060|19104063|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
5526270|NCT01438060|19104064|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
5526271|NCT01438060|19104063|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
5526272|NCT01438060|19104064|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
5526273|NCT01438060|19104063|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
5526274|NCT01438060|19104064|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
5526275|NCT01438060|19104063|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
5526276|NCT01438060|19104064|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
5526277|NCT01438060|19104063|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
5526278|NCT01438060|19104064|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
5526279|NCT01438060|19104063|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
5526280|NCT01438060|19104064|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
5526281|NCT01438060|19104063|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
5526282|NCT01438060|19104064|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
5526283|NCT01438060|19104063|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
5526284|NCT01438060|19104064|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
5526285|NCT01438060|19104063|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
5526286|NCT01438060|19104064|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
5526287|NCT01438060|19104063|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
5526288|NCT01438060|19104064|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
5526289|NCT01438060|19104063|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
5526290|NCT01438060|19104064|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
5526291|NCT01437995|19104156|P3|Overall Study|Lost to Follow-up|20
5526292|NCT01437995|19104157|P2|Overall Study|Lost to Follow-up|18
5526293|NCT01437995|19104158|P1|Overall Study|Lost to Follow-up|11
5526294|NCT01437943|19104180|P2|Overall Study|Adverse Event|0
5526295|NCT01437943|19104181|P1|Overall Study|Adverse Event|2
5526296|NCT01437943|19104180|P2|Overall Study|Subject expressed pregnancy plans|0
5526297|NCT01437943|19104181|P1|Overall Study|Subject expressed pregnancy plans|1
5526298|NCT01437943|19104180|P2|Overall Study|Aliskiren trials terminated by Novartis|2
5526299|NCT01437943|19104181|P1|Overall Study|Aliskiren trials terminated by Novartis|4
5526300|NCT01437878|19104189|P2|Overall Study|Withdrawal by Subject|0
5526301|NCT01437878|19104190|P1|Overall Study|Withdrawal by Subject|1
5526302|NCT01437540|19104257|P2|Overall Study|Withdrawal by Subject|15
5526303|NCT01437540|19104258|P1|Overall Study|Withdrawal by Subject|31
5526304|NCT01437540|19104257|P2|Overall Study|Adverse Event|13
5526305|NCT01437540|19104258|P1|Overall Study|Adverse Event|26
5526306|NCT01437540|19104257|P2|Overall Study|Protocol Violation|12
5526307|NCT01437540|19104258|P1|Overall Study|Protocol Violation|24
5526308|NCT01437540|19104257|P2|Overall Study|Lack of Efficacy|11
5526309|NCT01437540|19104258|P1|Overall Study|Lack of Efficacy|23
5526310|NCT01437540|19104257|P2|Overall Study|Lost to Follow-up|5
5526311|NCT01437540|19104258|P1|Overall Study|Lost to Follow-up|3
5526312|NCT01437540|19104257|P2|Overall Study|COPD exacerbation|3
5526313|NCT01437540|19104258|P1|Overall Study|COPD exacerbation|13
5526314|NCT01437540|19104257|P2|Overall Study|Not listed below|6
5526315|NCT01437540|19104258|P1|Overall Study|Not listed below|7
5526316|NCT01437423|19104295|P1|Overall Study|Off label usage|3
5526317|NCT01437423|19104295|P1|Overall Study|Lost to Follow-up|12
5526318|NCT01437397|19104307|P5|Overall Study|Site termination/COPD exacerbation/other|14
5526319|NCT01437397|19104308|P4|Overall Study|Site termination/COPD exacerbation/other|9
5526320|NCT01437397|19104309|P3|Overall Study|Site termination/COPD exacerbation/other|9
5526321|NCT01437397|19104310|P2|Overall Study|Site termination/COPD exacerbation/other|8
5526322|NCT01437397|19104311|P1|Overall Study|Site termination/COPD exacerbation/other|10
5526323|NCT01437397|19104307|P5|Overall Study|Adverse Event|21
5526324|NCT01437397|19104308|P4|Overall Study|Adverse Event|14
5526325|NCT01437397|19104309|P3|Overall Study|Adverse Event|16
5526326|NCT01437397|19104310|P2|Overall Study|Adverse Event|22
5526327|NCT01437397|19104311|P1|Overall Study|Adverse Event|21
5526328|NCT01437397|19104307|P5|Overall Study|Lack of Efficacy|20
5526329|NCT01437397|19104308|P4|Overall Study|Lack of Efficacy|10
5526330|NCT01437397|19104309|P3|Overall Study|Lack of Efficacy|8
5526331|NCT01437397|19104310|P2|Overall Study|Lack of Efficacy|4
5526332|NCT01437397|19104311|P1|Overall Study|Lack of Efficacy|5
5526333|NCT01437397|19104307|P5|Overall Study|Protocol Violation|19
5526334|NCT01437397|19104308|P4|Overall Study|Protocol Violation|21
5526335|NCT01437397|19104309|P3|Overall Study|Protocol Violation|13
5526336|NCT01437397|19104310|P2|Overall Study|Protocol Violation|12
5526337|NCT01437397|19104311|P1|Overall Study|Protocol Violation|10
5526338|NCT01437397|19104307|P5|Overall Study|Withdrawal by Subject|22
5526339|NCT01437397|19104308|P4|Overall Study|Withdrawal by Subject|11
5526340|NCT01437397|19104309|P3|Overall Study|Withdrawal by Subject|24
5526341|NCT01437397|19104310|P2|Overall Study|Withdrawal by Subject|12
5526342|NCT01437397|19104311|P1|Overall Study|Withdrawal by Subject|11
5526343|NCT01437397|19104307|P5|Overall Study|Lost to Follow-up|5
5526344|NCT01437397|19104308|P4|Overall Study|Lost to Follow-up|4
5526345|NCT01437397|19104309|P3|Overall Study|Lost to Follow-up|2
5526346|NCT01437397|19104310|P2|Overall Study|Lost to Follow-up|4
5526347|NCT01437397|19104311|P1|Overall Study|Lost to Follow-up|9
5526348|NCT01437319|19104338|P3|Phase II|Protocol Violation|0
5526349|NCT01437319|19104339|P2|Phase II|Protocol Violation|1
5526350|NCT01437319|19104340|P1|Phase II|Protocol Violation|0
5526351|NCT01437319|19104338|P3|Phase II|Study related symptoms/complaints|19
5526352|NCT01437319|19104339|P2|Phase II|Study related symptoms/complaints|28
5526353|NCT01437319|19104340|P1|Phase II|Study related symptoms/complaints|0
5526354|NCT01437319|19104338|P3|Phase II|Lost to Follow-up|2
5526355|NCT01437319|19104339|P2|Phase II|Lost to Follow-up|7
5526356|NCT01437319|19104340|P1|Phase II|Lost to Follow-up|0
5526357|NCT01437319|19104338|P3|Phase II|Withdrawal by Subject|16
5526358|NCT01437319|19104339|P2|Phase II|Withdrawal by Subject|8
5526359|NCT01437319|19104340|P1|Phase II|Withdrawal by Subject|0
5526360|NCT01437319|19104338|P3|Phase I|Withdrawal by Subject|0
5526361|NCT01437319|19104339|P2|Phase I|Withdrawal by Subject|0
5526362|NCT01437319|19104340|P1|Phase I|Withdrawal by Subject|25
5526363|NCT01437319|19104338|P3|Phase I|Study related symptoms/complaints|0
5526364|NCT01437319|19104339|P2|Phase I|Study related symptoms/complaints|0
5526365|NCT01437319|19104340|P1|Phase I|Study related symptoms/complaints|27
5526366|NCT01437319|19104338|P3|Phase I|Protocol Violation|0
5526367|NCT01437319|19104339|P2|Phase I|Protocol Violation|0
5526368|NCT01437319|19104340|P1|Phase I|Protocol Violation|1
5526369|NCT01437319|19104338|P3|Phase I|Lost to Follow-up|0
5526370|NCT01437319|19104339|P2|Phase I|Lost to Follow-up|0
5526371|NCT01437319|19104340|P1|Phase I|Lost to Follow-up|2
5526372|NCT01437267|19104355|P6|Overall Study|Protocol Violation|0
5526373|NCT01437267|19104356|P5|Overall Study|Protocol Violation|0
5526374|NCT01437267|19104357|P4|Overall Study|Protocol Violation|0
5526375|NCT01437267|19104358|P3|Overall Study|Protocol Violation|0
5526376|NCT01437267|19104359|P2|Overall Study|Protocol Violation|1
5526377|NCT01437267|19104360|P1|Overall Study|Protocol Violation|0
5526378|NCT01437267|19104355|P6|Overall Study|Withdrawal by Subject|0
5526379|NCT01437267|19104356|P5|Overall Study|Withdrawal by Subject|0
5526380|NCT01437267|19104357|P4|Overall Study|Withdrawal by Subject|1
5526381|NCT01437267|19104358|P3|Overall Study|Withdrawal by Subject|0
5526382|NCT01437267|19104359|P2|Overall Study|Withdrawal by Subject|0
5526383|NCT01437267|19104360|P1|Overall Study|Withdrawal by Subject|0
5526384|NCT01437111|19104403|P1|Overall Study|Protocol Violation|1
5526385|NCT01437111|19104403|P1|Overall Study|Lost to Follow-up|5
5526386|NCT01437111|19104403|P1|Overall Study|Physician Decision|1
5526387|NCT01437111|19104403|P1|Overall Study|Not reported|5
5526388|NCT01437111|19104403|P1|Overall Study|Withdrawal by Subject|4
5526389|NCT01437111|19104403|P1|Overall Study|Adverse Event|2
5526390|NCT01436643|19104481|P4|Core Phase (16 Weeks)|Protocol Violation|0
5526391|NCT01436643|19104482|P3|Core Phase (16 Weeks)|Protocol Violation|1
5526392|NCT01436643|19104483|P2|Core Phase (16 Weeks)|Protocol Violation|1
5526393|NCT01436643|19104484|P1|Core Phase (16 Weeks)|Protocol Violation|1
5526394|NCT01436643|19104481|P4|Core Phase (16 Weeks)|Abnormal Test result|0
5526395|NCT01436643|19104482|P3|Core Phase (16 Weeks)|Abnormal Test result|1
5526396|NCT01436643|19104483|P2|Core Phase (16 Weeks)|Abnormal Test result|0
5526397|NCT01436643|19104484|P1|Core Phase (16 Weeks)|Abnormal Test result|0
5526398|NCT01436643|19104481|P4|Core Phase (16 Weeks)|Adverse Event|0
5526399|NCT01436643|19104482|P3|Core Phase (16 Weeks)|Adverse Event|1
5526400|NCT01436643|19104483|P2|Core Phase (16 Weeks)|Adverse Event|3
5526401|NCT01436643|19104484|P1|Core Phase (16 Weeks)|Adverse Event|0
5526402|NCT01436643|19104481|P4|2-week Pre-treatment|Protocol Violation|4
5526403|NCT01436643|19104482|P3|2-week Pre-treatment|Protocol Violation|0
5526404|NCT01436643|19104483|P2|2-week Pre-treatment|Protocol Violation|0
5526405|NCT01436643|19104484|P1|2-week Pre-treatment|Protocol Violation|0
5526406|NCT01436643|19104481|P4|2-week Pre-treatment|Adverse Event|5
5526407|NCT01436643|19104482|P3|2-week Pre-treatment|Adverse Event|0
5526408|NCT01436643|19104483|P2|2-week Pre-treatment|Adverse Event|0
5526409|NCT01436643|19104484|P1|2-week Pre-treatment|Adverse Event|0
5526410|NCT01436643|19104481|P4|2-week Pre-treatment|Abnormal test result|1
5526411|NCT01436643|19104482|P3|2-week Pre-treatment|Abnormal test result|0
5526412|NCT01436643|19104483|P2|2-week Pre-treatment|Abnormal test result|0
5526413|NCT01436643|19104484|P1|2-week Pre-treatment|Abnormal test result|0
5526414|NCT01436500|19104519|P5|Overall Study|Other|0
5526415|NCT01436500|19104520|P4|Overall Study|Other|1
5526416|NCT01436500|19104521|P3|Overall Study|Other|0
5526417|NCT01436500|19104522|P2|Overall Study|Other|1
5526418|NCT01436500|19104523|P1|Overall Study|Other|0
5526419|NCT01436500|19104519|P5|Overall Study|discontinued study drug|0
5526420|NCT01436500|19104520|P4|Overall Study|discontinued study drug|0
5526421|NCT01436500|19104521|P3|Overall Study|discontinued study drug|0
5526422|NCT01436500|19104522|P2|Overall Study|discontinued study drug|0
5526423|NCT01436500|19104523|P1|Overall Study|discontinued study drug|1
5526424|NCT01436500|19104519|P5|Overall Study|initiation of dialysis|1
5526425|NCT01436500|19104520|P4|Overall Study|initiation of dialysis|0
5526426|NCT01436500|19104521|P3|Overall Study|initiation of dialysis|0
5526427|NCT01436500|19104522|P2|Overall Study|initiation of dialysis|0
5526428|NCT01436500|19104523|P1|Overall Study|initiation of dialysis|0
5526429|NCT01436500|19104519|P5|Overall Study|liver transplant|0
5526430|NCT01436500|19104520|P4|Overall Study|liver transplant|0
5526431|NCT01436500|19104521|P3|Overall Study|liver transplant|0
5526432|NCT01436500|19104522|P2|Overall Study|liver transplant|0
5526433|NCT01436500|19104523|P1|Overall Study|liver transplant|1
5526434|NCT01436500|19104519|P5|Overall Study|Physician Decision|0
5526435|NCT01436500|19104520|P4|Overall Study|Physician Decision|0
5526436|NCT01436500|19104521|P3|Overall Study|Physician Decision|1
5526437|NCT01436500|19104522|P2|Overall Study|Physician Decision|0
5526438|NCT01436500|19104523|P1|Overall Study|Physician Decision|0
5526439|NCT01436500|19104519|P5|Overall Study|Withdrawal by Subject|2
5526440|NCT01436500|19104520|P4|Overall Study|Withdrawal by Subject|0
5526441|NCT01436500|19104521|P3|Overall Study|Withdrawal by Subject|2
5526442|NCT01436500|19104522|P2|Overall Study|Withdrawal by Subject|0
5526443|NCT01436500|19104523|P1|Overall Study|Withdrawal by Subject|0
5526444|NCT01436500|19104519|P5|Overall Study|Adverse Event|1
5526445|NCT01436500|19104520|P4|Overall Study|Adverse Event|0
5526446|NCT01436500|19104521|P3|Overall Study|Adverse Event|2
5526447|NCT01436500|19104522|P2|Overall Study|Adverse Event|2
5526448|NCT01436500|19104523|P1|Overall Study|Adverse Event|0
5526449|NCT01436500|19104519|P5|Overall Study|Death|0
5526450|NCT01436500|19104520|P4|Overall Study|Death|0
5526451|NCT01436500|19104521|P3|Overall Study|Death|0
5526452|NCT01436500|19104522|P2|Overall Study|Death|0
5526453|NCT01436500|19104523|P1|Overall Study|Death|1
5526454|NCT01436396|19104567|P2|Overall Study|Lost to Follow-up|3
5526455|NCT01436396|19104568|P1|Overall Study|Lost to Follow-up|3
5526456|NCT01436396|19104567|P2|Overall Study|Serious adverse event|3
5526457|NCT01436396|19104568|P1|Overall Study|Serious adverse event|2
5526458|NCT01436396|19104567|P2|Overall Study|Withdrawal by Subject|29
5526459|NCT01436396|19104568|P1|Overall Study|Withdrawal by Subject|19
5526460|NCT01436396|19104567|P2|Overall Study|Adverse Event|2
5526461|NCT01436396|19104568|P1|Overall Study|Adverse Event|1
5526462|NCT01436396|19104567|P2|Overall Study|Protocol Violation|5
5526463|NCT01436396|19104568|P1|Overall Study|Protocol Violation|7
5526464|NCT01436370|19104608|P8|Overall Study|Lost to Follow-up|0
5526465|NCT01436370|19104609|P7|Overall Study|Lost to Follow-up|0
5526466|NCT01436370|19104610|P6|Overall Study|Lost to Follow-up|0
5526467|NCT01436370|19104611|P5|Overall Study|Lost to Follow-up|1
5526468|NCT01436370|19104612|P4|Overall Study|Lost to Follow-up|0
5526469|NCT01436370|19104613|P3|Overall Study|Lost to Follow-up|0
5526470|NCT01436370|19104614|P2|Overall Study|Lost to Follow-up|0
5526471|NCT01436370|19104615|P1|Overall Study|Lost to Follow-up|0
5526472|NCT01436357|19104695|P2|Overall Study|Subject in rehab|1
5526473|NCT01436357|19104696|P1|Overall Study|Subject in rehab|0
5526474|NCT01436357|19104695|P2|Overall Study|Moved out of area|2
5526475|NCT01436357|19104696|P1|Overall Study|Moved out of area|1
5526476|NCT01436357|19104695|P2|Overall Study|Physician Decision|4
5526477|NCT01436357|19104696|P1|Overall Study|Physician Decision|3
5526478|NCT01436357|19104695|P2|Overall Study|Withdrawal by Subject|38
5526479|NCT01436357|19104696|P1|Overall Study|Withdrawal by Subject|26
5526480|NCT01436357|19104695|P2|Overall Study|Protocol Violation|0
5526481|NCT01436357|19104696|P1|Overall Study|Protocol Violation|1
5526482|NCT01436357|19104695|P2|Overall Study|Lost to Follow-up|61
5526483|NCT01436357|19104696|P1|Overall Study|Lost to Follow-up|67
5526484|NCT01436357|19104695|P2|Overall Study|Incarceration|20
5526485|NCT01436357|19104696|P1|Overall Study|Incarceration|18
5526486|NCT01436357|19104695|P2|Overall Study|Enrolled but not vaccinated|1
5526487|NCT01436357|19104696|P1|Overall Study|Enrolled but not vaccinated|1
5526488|NCT01436357|19104695|P2|Overall Study|Death|1
5526489|NCT01436357|19104696|P1|Overall Study|Death|5
5526490|NCT01436305|19104717|P3|Overall Study|Withdrawal by Subject|0
5526491|NCT01436305|19104718|P2|Overall Study|Withdrawal by Subject|3
5526492|NCT01436305|19104719|P1|Overall Study|Withdrawal by Subject|1
5526493|NCT01436305|19104717|P3|Overall Study|Lost to Follow-up|0
5526494|NCT01436305|19104718|P2|Overall Study|Lost to Follow-up|1
5526495|NCT01436305|19104719|P1|Overall Study|Lost to Follow-up|0
5526496|NCT01436305|19104717|P3|Overall Study|Death|0
5526497|NCT01436305|19104718|P2|Overall Study|Death|0
5526498|NCT01436305|19104719|P1|Overall Study|Death|1
5526499|NCT01436253|19104846|P1|Overall Study|Not meeting all eligibility criteria|117
5526500|NCT01436253|19104846|P1|Overall Study|Lost to Follow-up|182
5526501|NCT01436201|19104851|P1|Overall Study|Protocol Violation|1
5526502|NCT01436201|19104851|P1|Overall Study|Withdrawal by Subject|1
5526503|NCT01436201|19104851|P1|Overall Study|Adverse Event|2
5526504|NCT01436175|19104861|P1|Overall Study|Other|826
5526505|NCT01436175|19104861|P1|Overall Study|Met blood pressure or pulse withdrawal|63
5526506|NCT01436175|19104861|P1|Overall Study|Lack of Efficacy|24
5526507|NCT01436175|19104861|P1|Overall Study|Lost to Follow-up|89
5526508|NCT01436175|19104861|P1|Overall Study|Withdrawal by Subject|108
5526509|NCT01436175|19104861|P1|Overall Study|Protocol Violation|49
5526510|NCT01436175|19104861|P1|Overall Study|Adverse Event|111
5526511|NCT01436162|19104888|P3|Randomized Phase|Other|4
5526512|NCT01436162|19104889|P2|Randomized Phase|Other|5
5526513|NCT01436162|19104890|P1|Randomized Phase|Other|2
5526514|NCT01436162|19104888|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
5526515|NCT01436162|19104889|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
5526516|NCT01436162|19104890|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
5526517|NCT01436162|19104888|P3|Randomized Phase|Lack of Efficacy|1
5526518|NCT01436162|19104889|P2|Randomized Phase|Lack of Efficacy|1
5526519|NCT01436162|19104890|P1|Randomized Phase|Lack of Efficacy|0
5526520|NCT01436162|19104888|P3|Randomized Phase|Lost to Follow-up|4
5526521|NCT01436162|19104889|P2|Randomized Phase|Lost to Follow-up|5
5526522|NCT01436162|19104890|P1|Randomized Phase|Lost to Follow-up|17
5526523|NCT01436162|19104888|P3|Randomized Phase|Withdrawal by Subject|8
5526524|NCT01436162|19104889|P2|Randomized Phase|Withdrawal by Subject|9
5526525|NCT01436162|19104890|P1|Randomized Phase|Withdrawal by Subject|16
5526526|NCT01436162|19104888|P3|Randomized Phase|Protocol Violation|2
5526527|NCT01436162|19104889|P2|Randomized Phase|Protocol Violation|4
5526528|NCT01436162|19104890|P1|Randomized Phase|Protocol Violation|4
5526529|NCT01436162|19104888|P3|Randomized Phase|Adverse Event|6
5526530|NCT01436162|19104889|P2|Randomized Phase|Adverse Event|5
5526531|NCT01436162|19104890|P1|Randomized Phase|Adverse Event|1
5526532|NCT01436162|19104888|P3|Single-blind Lead-in Phase|Other|0
5526533|NCT01436162|19104889|P2|Single-blind Lead-in Phase|Other|0
5526534|NCT01436162|19104890|P1|Single-blind Lead-in Phase|Other|107
5526535|NCT01436162|19104888|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5526536|NCT01436162|19104889|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5526537|NCT01436162|19104890|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
5526538|NCT01436162|19104888|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
5526539|NCT01436162|19104889|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
5526540|NCT01436162|19104890|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
5526541|NCT01436162|19104888|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
5526542|NCT01436162|19104889|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
5526543|NCT01436162|19104890|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
5526544|NCT01436162|19104888|P3|Single-blind Lead-in Phase|Protocol Violation|0
5526545|NCT01436162|19104889|P2|Single-blind Lead-in Phase|Protocol Violation|0
5526546|NCT01436162|19104890|P1|Single-blind Lead-in Phase|Protocol Violation|24
5526547|NCT01436162|19104888|P3|Single-blind Lead-in Phase|Adverse Event|0
5526548|NCT01436162|19104889|P2|Single-blind Lead-in Phase|Adverse Event|0
5526549|NCT01436162|19104890|P1|Single-blind Lead-in Phase|Adverse Event|26
5526550|NCT01436149|19104924|P3|Randomized Phase|Other|11
5526551|NCT01436149|19104925|P2|Randomized Phase|Other|5
5526552|NCT01436149|19104926|P1|Randomized Phase|Other|12
5526553|NCT01436149|19104924|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
5526554|NCT01436149|19104925|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
5526555|NCT01436149|19104926|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
5526556|NCT01436149|19104924|P3|Randomized Phase|Lack of Efficacy|1
5526557|NCT01436149|19104925|P2|Randomized Phase|Lack of Efficacy|0
5526558|NCT01436149|19104926|P1|Randomized Phase|Lack of Efficacy|0
5526559|NCT01436149|19104924|P3|Randomized Phase|Lost to Follow-up|6
5526560|NCT01436149|19104925|P2|Randomized Phase|Lost to Follow-up|5
5526561|NCT01436149|19104926|P1|Randomized Phase|Lost to Follow-up|34
5526562|NCT01436149|19104924|P3|Randomized Phase|Withdrawal by Subject|10
5526563|NCT01436149|19104925|P2|Randomized Phase|Withdrawal by Subject|10
5526564|NCT01436149|19104926|P1|Randomized Phase|Withdrawal by Subject|16
5526565|NCT01436149|19104924|P3|Randomized Phase|Protocol Violation|0
5526566|NCT01436149|19104925|P2|Randomized Phase|Protocol Violation|5
5526567|NCT01436149|19104926|P1|Randomized Phase|Protocol Violation|4
5526568|NCT01436149|19104924|P3|Randomized Phase|Adverse Event|11
5526569|NCT01436149|19104925|P2|Randomized Phase|Adverse Event|10
5526570|NCT01436149|19104926|P1|Randomized Phase|Adverse Event|9
5526571|NCT01436149|19104924|P3|Antidepressant Lead-in Phase|Other|0
5526572|NCT01436149|19104925|P2|Antidepressant Lead-in Phase|Other|0
5526573|NCT01436149|19104926|P1|Antidepressant Lead-in Phase|Other|119
5526574|NCT01436149|19104924|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
5526575|NCT01436149|19104925|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
5526576|NCT01436149|19104926|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
5526577|NCT01436149|19104924|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
5526578|NCT01436149|19104925|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
5526579|NCT01436149|19104926|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
5526580|NCT01436149|19104924|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5526581|NCT01436149|19104925|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5526582|NCT01436149|19104926|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
5526583|NCT01436149|19104924|P3|Antidepressant Lead-in Phase|Protocol Violation|0
5526584|NCT01436149|19104925|P2|Antidepressant Lead-in Phase|Protocol Violation|0
5526585|NCT01436149|19104926|P1|Antidepressant Lead-in Phase|Protocol Violation|29
5526586|NCT01436149|19104924|P3|Antidepressant Lead-in Phase|Adverse Event|0
5526587|NCT01436149|19104925|P2|Antidepressant Lead-in Phase|Adverse Event|0
5526588|NCT01436149|19104926|P1|Antidepressant Lead-in Phase|Adverse Event|39
5526589|NCT01436110|19104957|P3|Overall Study|Did Not Receive Trial Medication|3
5526590|NCT01436110|19104958|P2|Overall Study|Did Not Receive Trial Medication|0
5526591|NCT01436110|19104959|P1|Overall Study|Did Not Receive Trial Medication|1
5526592|NCT01436110|19104957|P3|Overall Study|Protocol Violation|1
5526593|NCT01436110|19104958|P2|Overall Study|Protocol Violation|1
5526594|NCT01436110|19104959|P1|Overall Study|Protocol Violation|3
5526595|NCT01436110|19104957|P3|Overall Study|Lost to Follow-up|3
5526596|NCT01436110|19104958|P2|Overall Study|Lost to Follow-up|1
5526597|NCT01436110|19104959|P1|Overall Study|Lost to Follow-up|1
5526598|NCT01436110|19104957|P3|Overall Study|Physician Decision|1
5526599|NCT01436110|19104958|P2|Overall Study|Physician Decision|1
5526600|NCT01436110|19104959|P1|Overall Study|Physician Decision|3
5526601|NCT01436110|19104957|P3|Overall Study|Adverse Event|2
5526602|NCT01436110|19104958|P2|Overall Study|Adverse Event|1
5526603|NCT01436110|19104959|P1|Overall Study|Adverse Event|2
5526604|NCT01436110|19104957|P3|Overall Study|Withdrawal by Subject|4
5526605|NCT01436110|19104958|P2|Overall Study|Withdrawal by Subject|8
5526606|NCT01436110|19104959|P1|Overall Study|Withdrawal by Subject|6
5526607|NCT01436110|19104957|P3|Overall Study|Lack of Efficacy|9
5526608|NCT01436110|19104958|P2|Overall Study|Lack of Efficacy|14
5526609|NCT01436110|19104959|P1|Overall Study|Lack of Efficacy|23
5526610|NCT01436084|19104982|P1|Overall Study|Early Closure of Study|1
5526611|NCT01436084|19104982|P1|Overall Study|Withdrawal by Subject|1
5526612|NCT01436084|19104982|P1|Overall Study|Disease Progression|2
5526613|NCT01436071|19104988|P2|Overall Study|Did Not Receive Trial Medication|3
5526614|NCT01436071|19104989|P1|Overall Study|Did Not Receive Trial Medication|3
5526615|NCT01436071|19104988|P2|Overall Study|Withdrawal by Subject|2
5526616|NCT01436071|19104989|P1|Overall Study|Withdrawal by Subject|2
5526617|NCT01436071|19104988|P2|Overall Study|Physician Decision|0
5526618|NCT01436071|19104989|P1|Overall Study|Physician Decision|1
5526619|NCT01436071|19104988|P2|Overall Study|Lost to Follow-up|1
5526620|NCT01436071|19104989|P1|Overall Study|Lost to Follow-up|3
5526621|NCT01436071|19104988|P2|Overall Study|Protocol Violation|1
5526622|NCT01436071|19104989|P1|Overall Study|Protocol Violation|0
5526623|NCT01436071|19104988|P2|Overall Study|Lack of Efficacy|7
5526624|NCT01436071|19104989|P1|Overall Study|Lack of Efficacy|16
5526625|NCT01436071|19104988|P2|Overall Study|Adverse Event|0
5526626|NCT01436071|19104989|P1|Overall Study|Adverse Event|1
5526627|NCT01435928|19105031|P3|Double Blind Phase - 28 Weeks|Administrative|2
5526628|NCT01435928|19105032|P2|Double Blind Phase - 28 Weeks|Administrative|5
5526629|NCT01435928|19105033|P1|Double Blind Phase - 28 Weeks|Administrative|0
5526630|NCT01435928|19105031|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
5526631|NCT01435928|19105032|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
5526632|NCT01435928|19105033|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
5526633|NCT01435928|19105031|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
5526634|NCT01435928|19105032|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
5526635|NCT01435928|19105033|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
5526636|NCT01435928|19105031|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
5526637|NCT01435928|19105032|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
5526638|NCT01435928|19105033|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
5526639|NCT01435928|19105031|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
5526640|NCT01435928|19105032|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
5526641|NCT01435928|19105033|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
5526642|NCT01435928|19105031|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
5526643|NCT01435928|19105032|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
5526644|NCT01435928|19105033|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
5526645|NCT01435928|19105031|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
5526646|NCT01435928|19105032|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
5526647|NCT01435928|19105033|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
5526648|NCT01435928|19105031|P3|Open Label Phase - up to 24 Weeks|Administrative|0
5526649|NCT01435928|19105032|P2|Open Label Phase - up to 24 Weeks|Administrative|0
5526650|NCT01435928|19105033|P1|Open Label Phase - up to 24 Weeks|Administrative|14
5526651|NCT01435928|19105031|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
5526652|NCT01435928|19105032|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
5526653|NCT01435928|19105033|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
5526654|NCT01435928|19105031|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
5526655|NCT01435928|19105032|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
5526656|NCT01435928|19105033|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
5526657|NCT01435928|19105031|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
5526658|NCT01435928|19105032|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
5526659|NCT01435928|19105033|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
5526660|NCT01435928|19105031|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
5526661|NCT01435928|19105032|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
5526662|NCT01435928|19105033|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
5526663|NCT01435928|19105031|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
5526664|NCT01435928|19105032|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
5526665|NCT01435928|19105033|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
5526666|NCT01435928|19105031|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
5526667|NCT01435928|19105032|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
5526668|NCT01435928|19105033|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
5526669|NCT01435928|19105031|P3|Open Label Phase - up to 24 Weeks|Death|0
5526670|NCT01435928|19105032|P2|Open Label Phase - up to 24 Weeks|Death|0
5526671|NCT01435928|19105033|P1|Open Label Phase - up to 24 Weeks|Death|1
5526672|NCT01435928|19105031|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
5526673|NCT01435928|19105032|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
5526674|NCT01435928|19105033|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
5526675|NCT01435798|19105079|P1|Overall Study|Withdrawal by Subject|1
5526676|NCT01435772|19105096|P3|Overall Study|Other - study termination|10
5526677|NCT01435772|19105097|P2|Overall Study|Other - study termination|2
5526678|NCT01435772|19105098|P1|Overall Study|Other - study termination|2
5526679|NCT01435772|19105096|P3|Overall Study|Withdrawal by Subject|3
5526680|NCT01435772|19105097|P2|Overall Study|Withdrawal by Subject|1
5526681|NCT01435772|19105098|P1|Overall Study|Withdrawal by Subject|0
5526682|NCT01435772|19105096|P3|Overall Study|Adverse Event|2
5526683|NCT01435772|19105097|P2|Overall Study|Adverse Event|0
5526684|NCT01435772|19105098|P1|Overall Study|Adverse Event|1
5526685|NCT01435759|19105148|P6|Double-blind Phase|Other|0
5526686|NCT01435759|19105149|P5|Double-blind Phase|Other|0
5526687|NCT01435759|19105150|P4|Double-blind Phase|Other|2
5526688|NCT01435759|19105151|P3|Double-blind Phase|Other|0
5526689|NCT01435759|19105152|P2|Double-blind Phase|Other|2
5526690|NCT01435759|19105153|P1|Double-blind Phase|Other|8
5526691|NCT01435759|19105148|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5526692|NCT01435759|19105149|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
5526693|NCT01435759|19105150|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5526694|NCT01435759|19105151|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5526695|NCT01435759|19105152|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
5526696|NCT01435759|19105153|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
5526697|NCT01435759|19105148|P6|Double-blind Phase|Lost to Follow-up|3
5526698|NCT01435759|19105149|P5|Double-blind Phase|Lost to Follow-up|3
5526699|NCT01435759|19105150|P4|Double-blind Phase|Lost to Follow-up|0
5526700|NCT01435759|19105151|P3|Double-blind Phase|Lost to Follow-up|2
5526701|NCT01435759|19105152|P2|Double-blind Phase|Lost to Follow-up|1
5526702|NCT01435759|19105153|P1|Double-blind Phase|Lost to Follow-up|31
5526703|NCT01435759|19105148|P6|Double-blind Phase|Withdrawal by Subject|2
5526704|NCT01435759|19105149|P5|Double-blind Phase|Withdrawal by Subject|2
5526705|NCT01435759|19105150|P4|Double-blind Phase|Withdrawal by Subject|4
5526706|NCT01435759|19105151|P3|Double-blind Phase|Withdrawal by Subject|3
5526707|NCT01435759|19105152|P2|Double-blind Phase|Withdrawal by Subject|4
5526708|NCT01435759|19105153|P1|Double-blind Phase|Withdrawal by Subject|17
5526709|NCT01435759|19105148|P6|Double-blind Phase|Protocol Violation|1
5526710|NCT01435759|19105149|P5|Double-blind Phase|Protocol Violation|0
5526711|NCT01435759|19105150|P4|Double-blind Phase|Protocol Violation|2
5526712|NCT01435759|19105151|P3|Double-blind Phase|Protocol Violation|1
5526713|NCT01435759|19105152|P2|Double-blind Phase|Protocol Violation|0
5526714|NCT01435759|19105153|P1|Double-blind Phase|Protocol Violation|2
5526715|NCT01435759|19105148|P6|Double-blind Phase|Adverse Event|3
5526716|NCT01435759|19105149|P5|Double-blind Phase|Adverse Event|1
5526717|NCT01435759|19105150|P4|Double-blind Phase|Adverse Event|1
5526718|NCT01435759|19105151|P3|Double-blind Phase|Adverse Event|1
5526719|NCT01435759|19105152|P2|Double-blind Phase|Adverse Event|0
5526720|NCT01435759|19105153|P1|Double-blind Phase|Adverse Event|7
5526721|NCT01435759|19105148|P6|Antidepressant Lead-in Phase|Other|0
5526722|NCT01435759|19105149|P5|Antidepressant Lead-in Phase|Other|0
5526723|NCT01435759|19105150|P4|Antidepressant Lead-in Phase|Other|0
5526724|NCT01435759|19105151|P3|Antidepressant Lead-in Phase|Other|0
5526725|NCT01435759|19105152|P2|Antidepressant Lead-in Phase|Other|0
5526726|NCT01435759|19105153|P1|Antidepressant Lead-in Phase|Other|119
5526727|NCT01435759|19105148|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5526728|NCT01435759|19105149|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5526729|NCT01435759|19105150|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5526730|NCT01435759|19105151|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5526731|NCT01435759|19105152|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
5526732|NCT01435759|19105153|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
5526733|NCT01435759|19105148|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
5526734|NCT01435759|19105149|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
5526735|NCT01435759|19105150|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
5526736|NCT01435759|19105151|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
5526737|NCT01435759|19105152|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
5526738|NCT01435759|19105153|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
5526739|NCT01435759|19105148|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5526740|NCT01435759|19105149|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5526741|NCT01435759|19105150|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5526742|NCT01435759|19105151|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5526743|NCT01435759|19105152|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
5526744|NCT01435759|19105153|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
5526745|NCT01435759|19105148|P6|Antidepressant Lead-in Phase|Protocol Violation|0
5526746|NCT01435759|19105149|P5|Antidepressant Lead-in Phase|Protocol Violation|0
5526747|NCT01435759|19105150|P4|Antidepressant Lead-in Phase|Protocol Violation|0
5526748|NCT01435759|19105151|P3|Antidepressant Lead-in Phase|Protocol Violation|0
5526749|NCT01435759|19105152|P2|Antidepressant Lead-in Phase|Protocol Violation|0
5526750|NCT01435759|19105153|P1|Antidepressant Lead-in Phase|Protocol Violation|16
5526751|NCT01435759|19105148|P6|Antidepressant Lead-in Phase|Adverse Event|0
5526752|NCT01435759|19105149|P5|Antidepressant Lead-in Phase|Adverse Event|0
5526753|NCT01435759|19105150|P4|Antidepressant Lead-in Phase|Adverse Event|0
5526754|NCT01435759|19105151|P3|Antidepressant Lead-in Phase|Adverse Event|0
5526755|NCT01435759|19105152|P2|Antidepressant Lead-in Phase|Adverse Event|0
5526756|NCT01435759|19105153|P1|Antidepressant Lead-in Phase|Adverse Event|40
5526757|NCT01435655|19105180|P1|Overall Study|Other|1
5526758|NCT01435655|19105180|P1|Overall Study|Death|2
5526759|NCT01435616|19105194|P2|Overall Study|Sponsor Decision|0
5526760|NCT01435616|19105195|P1|Overall Study|Sponsor Decision|1
5526761|NCT01435616|19105194|P2|Overall Study|Physician Decision|7
5526762|NCT01435616|19105195|P1|Overall Study|Physician Decision|20
5526763|NCT01435616|19105194|P2|Overall Study|Withdrawal by Subject|24
5526764|NCT01435616|19105195|P1|Overall Study|Withdrawal by Subject|66
5526765|NCT01435616|19105194|P2|Overall Study|Protocol Violation|13
5526766|NCT01435616|19105195|P1|Overall Study|Protocol Violation|16
5526767|NCT01435616|19105194|P2|Overall Study|Lost to Follow-up|13
5526768|NCT01435616|19105195|P1|Overall Study|Lost to Follow-up|22
5526769|NCT01435616|19105194|P2|Overall Study|Death|2
5526770|NCT01435616|19105195|P1|Overall Study|Death|7
5526771|NCT01435616|19105194|P2|Overall Study|Adverse Event|21
5526772|NCT01435616|19105195|P1|Overall Study|Adverse Event|39
5526773|NCT01435577|19105250|P2|Overall Study|Alternative treatment started|1
5526774|NCT01435577|19105251|P1|Overall Study|Alternative treatment started|0
5526775|NCT01435577|19105250|P2|Overall Study|Lack of Efficacy|51
5526776|NCT01435577|19105251|P1|Overall Study|Lack of Efficacy|7
5526777|NCT01435577|19105250|P2|Overall Study|Adverse Event|0
5526778|NCT01435577|19105251|P1|Overall Study|Adverse Event|10
5526779|NCT01435460|19105312|P2|Overall Study|Did not meet eligibility criteria|0
5526780|NCT01435460|19105313|P1|Overall Study|Did not meet eligibility criteria|2
5526781|NCT01435460|19105312|P2|Overall Study|Protocol Violation|1
5526782|NCT01435460|19105313|P1|Overall Study|Protocol Violation|0
5526783|NCT01435460|19105312|P2|Overall Study|Withdrawal by Subject|3
5526784|NCT01435460|19105313|P1|Overall Study|Withdrawal by Subject|1
5526785|NCT01435460|19105312|P2|Overall Study|Lost to Follow-up|1
5526786|NCT01435460|19105313|P1|Overall Study|Lost to Follow-up|6
5526787|NCT01435460|19105312|P2|Overall Study|Adverse Event|1
5526788|NCT01435460|19105313|P1|Overall Study|Adverse Event|2
5526789|NCT01435382|19105329|P4|Overall Study|Withdrawal by Subject|1
5526790|NCT01435382|19105330|P3|Overall Study|Withdrawal by Subject|0
5526791|NCT01435382|19105331|P2|Overall Study|Withdrawal by Subject|2
5526792|NCT01435382|19105332|P1|Overall Study|Withdrawal by Subject|0
5526793|NCT01435382|19105329|P4|Overall Study|Lost to Follow-up|0
5526794|NCT01435382|19105330|P3|Overall Study|Lost to Follow-up|1
5526795|NCT01435382|19105331|P2|Overall Study|Lost to Follow-up|0
5526796|NCT01435382|19105332|P1|Overall Study|Lost to Follow-up|1
5526797|NCT01435356|19105421|P2|Overall Study|Patient moved to another city|1
5526798|NCT01435356|19105422|P1|Overall Study|Patient moved to another city|1
5526799|NCT01435356|19105421|P2|Overall Study|Patient decision|0
5526800|NCT01435356|19105422|P1|Overall Study|Patient decision|3
5526801|NCT01435356|19105421|P2|Overall Study|Physician Decision|0
5526802|NCT01435356|19105422|P1|Overall Study|Physician Decision|1
5526803|NCT01435356|19105421|P2|Overall Study|IC withdrawal due to study cancellation|0
5526804|NCT01435356|19105422|P1|Overall Study|IC withdrawal due to study cancellation|1
5526805|NCT01435356|19105421|P2|Overall Study|Facial palsy|0
5526806|NCT01435356|19105422|P1|Overall Study|Facial palsy|1
5526807|NCT01435356|19105421|P2|Overall Study|Withdrawal by Subject|1
5526808|NCT01435356|19105422|P1|Overall Study|Withdrawal by Subject|1
5526809|NCT01435356|19105421|P2|Overall Study|Study Discontinuation, amendment 4|11
5526810|NCT01435356|19105422|P1|Overall Study|Study Discontinuation, amendment 4|5
5526811|NCT01435356|19105421|P2|Overall Study|Protocol Violation|1
5526812|NCT01435356|19105422|P1|Overall Study|Protocol Violation|0
5526813|NCT01435356|19105421|P2|Overall Study|Disease progression/recurrence|10
5526814|NCT01435356|19105422|P1|Overall Study|Disease progression/recurrence|17
5526815|NCT01435356|19105421|P2|Overall Study|Adverse Event|0
5526816|NCT01435356|19105422|P1|Overall Study|Adverse Event|2
5526817|NCT01435265|19105455|P2|Overall Study|Lost to Follow-up|1
5526818|NCT01435265|19105456|P1|Overall Study|Lost to Follow-up|0
5526819|NCT01435122|19105470|P1|Overall Study|Early withdrawal due to toxicity|8
5526820|NCT01435031|19105479|P1|ITT at 4 Years|Lost to Follow-up|1
5526821|NCT01435031|19105479|P1|ITT at 4 Years|Withdrawal by Subject|2
5526822|NCT01435031|19105479|P1|ITT at 4 Years|Death|4
5526823|NCT01435031|19105479|P1|ITT at 3 Years|Lost to Follow-up|4
5526824|NCT01435031|19105479|P1|ITT at 3 Years|Withdrawal by Subject|2
5526825|NCT01435031|19105479|P1|ITT at 3 Years|Death|5
5526826|NCT01435031|19105479|P1|ITT at 2 Years|Lost to Follow-up|4
5526827|NCT01435031|19105479|P1|ITT at 2 Years|Withdrawal by Subject|2
5526828|NCT01435031|19105479|P1|ITT at 2 Years|Death|7
5526829|NCT01435031|19105479|P1|ITT at 1 Year|Lost to Follow-up|6
5526830|NCT01435031|19105479|P1|ITT at 1 Year|Withdrawal by Subject|2
5526831|NCT01435031|19105479|P1|ITT at 1 Year|Death|1
5526832|NCT01435031|19105479|P1|ITT at 6 Months|Lost to Follow-up|3
5526833|NCT01435031|19105479|P1|ITT at 6 Months|Death|2
5526834|NCT01435031|19105479|P1|ITT at 1 Month|Lost to Follow-up|4
5526835|NCT01435031|19105479|P1|ITT at 1 Month|Death|1
5526836|NCT01435031|19105479|P1|ITT at 1 Month|Withdrawal by Subject|1
5526837|NCT01435018|19105580|P3|Overall Study|Never started chemotherapy|1
5526838|NCT01435018|19105581|P2|Overall Study|Never started chemotherapy|0
5526839|NCT01435018|19105582|P1|Overall Study|Never started chemotherapy|3
5526840|NCT01435018|19105580|P3|Overall Study|Enrollment Violation|0
5526841|NCT01435018|19105581|P2|Overall Study|Enrollment Violation|1
5526842|NCT01435018|19105582|P1|Overall Study|Enrollment Violation|0
5526843|NCT01435018|19105580|P3|Overall Study|Unable to contact participant/parent|1
5526844|NCT01435018|19105581|P2|Overall Study|Unable to contact participant/parent|1
5526845|NCT01435018|19105582|P1|Overall Study|Unable to contact participant/parent|1
5526846|NCT01435018|19105580|P3|Overall Study|Severe debilitation, unable to continue|1
5526847|NCT01435018|19105581|P2|Overall Study|Severe debilitation, unable to continue|0
5526848|NCT01435018|19105582|P1|Overall Study|Severe debilitation, unable to continue|0
5526849|NCT01435018|19105580|P3|Overall Study|Not able to get to clinic|2
5526850|NCT01435018|19105581|P2|Overall Study|Not able to get to clinic|0
5526851|NCT01435018|19105582|P1|Overall Study|Not able to get to clinic|2
5526852|NCT01435018|19105580|P3|Overall Study|Not willing to adhere to requirements|3
5526853|NCT01435018|19105581|P2|Overall Study|Not willing to adhere to requirements|2
5526854|NCT01435018|19105582|P1|Overall Study|Not willing to adhere to requirements|0
5526855|NCT01435018|19105580|P3|Overall Study|Withdrew consent|1
5526856|NCT01435018|19105581|P2|Overall Study|Withdrew consent|3
5526857|NCT01435018|19105582|P1|Overall Study|Withdrew consent|0
5526858|NCT01435018|19105580|P3|Overall Study|Site is closing|7
5526859|NCT01435018|19105581|P2|Overall Study|Site is closing|9
5526860|NCT01435018|19105582|P1|Overall Study|Site is closing|4
5526861|NCT01435018|19105580|P3|Overall Study|Death|25
5526862|NCT01435018|19105581|P2|Overall Study|Death|18
5526863|NCT01435018|19105582|P1|Overall Study|Death|37
5526864|NCT01434823|19105675|P2|Overall Study|Incomplete data in medical record|7
5526865|NCT01434823|19105676|P1|Overall Study|Incomplete data in medical record|4
5526866|NCT01434810|19105694|P2|Overall Study|Missing data/received <5hr phototherapy|7
5526867|NCT01434810|19105695|P1|Overall Study|Missing data/received <5hr phototherapy|12
5526868|NCT01434810|19105694|P2|Overall Study|Did not receive treatment|3
5526869|NCT01434810|19105695|P1|Overall Study|Did not receive treatment|11
5526870|NCT01434693|19105730|P4|Overall Study|Lost to Follow-up|0
5526871|NCT01434693|19105731|P3|Overall Study|Lost to Follow-up|0
5526872|NCT01434693|19105732|P2|Overall Study|Lost to Follow-up|0
5526873|NCT01434693|19105733|P1|Overall Study|Lost to Follow-up|1
5526874|NCT01434693|19105730|P4|Overall Study|Withdrawal by Subject|1
5526875|NCT01434693|19105731|P3|Overall Study|Withdrawal by Subject|1
5526876|NCT01434693|19105732|P2|Overall Study|Withdrawal by Subject|0
5526877|NCT01434693|19105733|P1|Overall Study|Withdrawal by Subject|1
5526878|NCT01434693|19105730|P4|Overall Study|Adverse Event|0
5526879|NCT01434693|19105731|P3|Overall Study|Adverse Event|0
5526880|NCT01434693|19105732|P2|Overall Study|Adverse Event|0
5526881|NCT01434693|19105733|P1|Overall Study|Adverse Event|1
5526882|NCT01434680|19105747|P4|Overall Study|Protocol Violation|0
5526883|NCT01434680|19105748|P3|Overall Study|Protocol Violation|0
5526884|NCT01434680|19105749|P2|Overall Study|Protocol Violation|1
5526885|NCT01434680|19105750|P1|Overall Study|Protocol Violation|1
5526886|NCT01434680|19105747|P4|Overall Study|Lost to Follow-up|0
5526887|NCT01434680|19105748|P3|Overall Study|Lost to Follow-up|0
5526888|NCT01434680|19105749|P2|Overall Study|Lost to Follow-up|1
5526889|NCT01434680|19105750|P1|Overall Study|Lost to Follow-up|1
5526890|NCT01434680|19105747|P4|Overall Study|Withdrawal by Subject|0
5526891|NCT01434680|19105748|P3|Overall Study|Withdrawal by Subject|2
5526892|NCT01434680|19105749|P2|Overall Study|Withdrawal by Subject|0
5526893|NCT01434680|19105750|P1|Overall Study|Withdrawal by Subject|1
5526894|NCT01434667|19105767|P2|Overall Study|Lost to Follow-up|10
5526895|NCT01434667|19105768|P1|Overall Study|Lost to Follow-up|5
5526896|NCT01434654|19105794|P2|Overall Study|Lost to Follow-up|0
5526897|NCT01434654|19105795|P1|Overall Study|Lost to Follow-up|1
5526898|NCT01434654|19105794|P2|Overall Study|Withdrawal by Subject|0
5526899|NCT01434654|19105795|P1|Overall Study|Withdrawal by Subject|1
5526900|NCT01434290|19105842|P2|Overall Study|No protocol treatment|4
5526901|NCT01434290|19105843|P1|Overall Study|No protocol treatment|2
5526902|NCT01434290|19105842|P2|Overall Study|Protocol Violation|3
5526903|NCT01434290|19105843|P1|Overall Study|Protocol Violation|6
5526904|NCT01433978|19105916|P3|Extension Phase|Study Terminated by Sponsor|4
5526905|NCT01433978|19105917|P2|Extension Phase|Study Terminated by Sponsor|0
5526906|NCT01433978|19105918|P1|Extension Phase|Study Terminated by Sponsor|0
5526907|NCT01433978|19105916|P3|Extension Phase|Lack of Efficacy|1
5526908|NCT01433978|19105917|P2|Extension Phase|Lack of Efficacy|0
5526909|NCT01433978|19105918|P1|Extension Phase|Lack of Efficacy|0
5526910|NCT01433978|19105916|P3|Extension Phase|Adverse Event, Non-Fatal|1
5526911|NCT01433978|19105917|P2|Extension Phase|Adverse Event, Non-Fatal|0
5526912|NCT01433978|19105918|P1|Extension Phase|Adverse Event, Non-Fatal|0
5526913|NCT01433978|19105916|P3|Core Study|Study Terminated by Sponsor|0
5526914|NCT01433978|19105917|P2|Core Study|Study Terminated by Sponsor|9
5526915|NCT01433978|19105918|P1|Core Study|Study Terminated by Sponsor|6
5526916|NCT01433978|19105916|P3|Core Study|Lack of Efficacy|0
5526917|NCT01433978|19105917|P2|Core Study|Lack of Efficacy|1
5526918|NCT01433978|19105918|P1|Core Study|Lack of Efficacy|5
5526919|NCT01433978|19105916|P3|Core Study|Adverse Event, Non-Fatal|0
5526920|NCT01433978|19105917|P2|Core Study|Adverse Event, Non-Fatal|1
5526921|NCT01433978|19105918|P1|Core Study|Adverse Event, Non-Fatal|0
5526922|NCT01433549|19105975|P2|Phase 2: Second Study Product|Adverse Event|1
5526923|NCT01433549|19105976|P1|Phase 2: Second Study Product|Adverse Event|0
5526924|NCT01433471|19105986|P2|Overall Study|Withdrawal by Subject|1
5526925|NCT01433471|19105987|P1|Overall Study|Withdrawal by Subject|0
5526926|NCT01433354|19106003|P1|Overall Study|Subject Withdrew Consent|3
5526927|NCT01433354|19106003|P1|Overall Study|Lack of Efficacy|17
5526928|NCT01433354|19106003|P1|Overall Study|Protocol Violation|2
5526929|NCT01433354|19106003|P1|Overall Study|Administrative problems|90
5526930|NCT01433354|19106003|P1|Overall Study|Lost to Follow-up|1
5526931|NCT01433354|19106003|P1|Overall Study|Adverse Event|6
5526932|NCT01433263|19106019|P2|Overall Study|Withdrawal by Subject|7
5526933|NCT01433263|19106020|P1|Overall Study|Withdrawal by Subject|10
5526934|NCT01433263|19106019|P2|Overall Study|Protocol Deviation|0
5526935|NCT01433263|19106020|P1|Overall Study|Protocol Deviation|1
5526936|NCT01433263|19106019|P2|Overall Study|Lost to Follow-up|1
5526937|NCT01433263|19106020|P1|Overall Study|Lost to Follow-up|0
5526938|NCT01433263|19106019|P2|Overall Study|Death|3
5526939|NCT01433263|19106020|P1|Overall Study|Death|5
5526940|NCT01433263|19106019|P2|Overall Study|Adverse Event|1
5526941|NCT01433263|19106020|P1|Overall Study|Adverse Event|3
5526942|NCT01433250|19106049|P2|Overall Study|Withdrawal by Subject|2
5526943|NCT01433250|19106050|P1|Overall Study|Withdrawal by Subject|3
5526944|NCT01433250|19106049|P2|Overall Study|Protocol Violation|1
5526945|NCT01433250|19106050|P1|Overall Study|Protocol Violation|0
5526946|NCT01433172|19106069|P3|Overall Study|Death|0
5526947|NCT01433172|19106070|P2|Overall Study|Death|2
5526948|NCT01433172|19106071|P1|Overall Study|Death|0
5526949|NCT01433172|19106069|P3|Overall Study|Disease Progression|1
5526950|NCT01433172|19106070|P2|Overall Study|Disease Progression|0
5526951|NCT01433172|19106071|P1|Overall Study|Disease Progression|0
5526952|NCT01433172|19106069|P3|Overall Study|Withdrawal by Subject|0
5526953|NCT01433172|19106070|P2|Overall Study|Withdrawal by Subject|1
5526954|NCT01433172|19106071|P1|Overall Study|Withdrawal by Subject|0
5526955|NCT01433159|19106083|P2|Overall Study|Protocol Violation|1
5526956|NCT01433159|19106084|P1|Overall Study|Protocol Violation|0
5526957|NCT01433159|19106083|P2|Overall Study|Physician Decision|0
5526958|NCT01433159|19106084|P1|Overall Study|Physician Decision|1
5526959|NCT01433159|19106083|P2|Overall Study|Adverse Event|0
5526960|NCT01433159|19106084|P1|Overall Study|Adverse Event|1
5526961|NCT01433055|19106116|P2|Overall Study|Severely elevated triglycerides at entry|0
5526962|NCT01433055|19106117|P1|Overall Study|Severely elevated triglycerides at entry|1
5526963|NCT01433055|19106116|P2|Overall Study|Diagnosed with cancer unrelated to study|0
5526964|NCT01433055|19106117|P1|Overall Study|Diagnosed with cancer unrelated to study|1
5526965|NCT01432951|19106139|P1|Treatment Phase (Day 1 to 30)|Never Treated|1
5526966|NCT01432938|19106148|P2|Second Intervention|Adverse Event|0
5526967|NCT01432938|19106149|P1|Second Intervention|Adverse Event|1
5526968|NCT01432938|19106148|P2|First Intervention|Physician Decision|0
5526969|NCT01432938|19106149|P1|First Intervention|Physician Decision|1
5526970|NCT01432938|19106148|P2|First Intervention|Protocol Violation|0
5526971|NCT01432938|19106149|P1|First Intervention|Protocol Violation|1
5526972|NCT01432756|19106179|P4|Overall Study|Lost to Follow-up|1
5526973|NCT01432756|19106180|P3|Overall Study|Lost to Follow-up|2
5526974|NCT01432756|19106181|P2|Overall Study|Lost to Follow-up|0
5526975|NCT01432756|19106182|P1|Overall Study|Lost to Follow-up|1
5526976|NCT01432730|19106190|P2|Period 2|Adverse Event|4
5526977|NCT01432730|19106191|P1|Period 2|Adverse Event|0
5526978|NCT01432730|19106190|P2|Period 1|Adverse Event|0
5526979|NCT01432730|19106191|P1|Period 1|Adverse Event|2
5526980|NCT01432626|19106227|P1|Overall Study|Imaging agent not available|1
5526981|NCT01432626|19106227|P1|Overall Study|Only 1 image competed|2
5526982|NCT01432626|19106227|P1|Overall Study|Withdrawal by Subject|2
5526983|NCT01432626|19106227|P1|Overall Study|LV function recovered|2
5526984|NCT01432600|19106234|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
5526985|NCT01432600|19106235|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
5526986|NCT01432600|19106236|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
5526987|NCT01432574|19106252|P1|Overall Study|Not interested|1
5526988|NCT01432574|19106252|P1|Overall Study|Moved|2
5526989|NCT01432457|19106298|P3|Overall Study|Did not take study drug|3
5526990|NCT01432457|19106299|P2|Overall Study|Did not take study drug|6
5526991|NCT01432457|19106300|P1|Overall Study|Did not take study drug|6
5526992|NCT01432457|19106298|P3|Overall Study|Reasons not defined|4
5526993|NCT01432457|19106299|P2|Overall Study|Reasons not defined|3
5526994|NCT01432457|19106300|P1|Overall Study|Reasons not defined|2
5526995|NCT01432457|19106298|P3|Overall Study|Withdrawal by Subject|9
5526996|NCT01432457|19106299|P2|Overall Study|Withdrawal by Subject|11
5526997|NCT01432457|19106300|P1|Overall Study|Withdrawal by Subject|6
5526998|NCT01432457|19106298|P3|Overall Study|Protocol Violation|6
5526999|NCT01432457|19106299|P2|Overall Study|Protocol Violation|2
5527000|NCT01432457|19106300|P1|Overall Study|Protocol Violation|3
5527001|NCT01432457|19106298|P3|Overall Study|Lost to Follow-up|20
5527002|NCT01432457|19106299|P2|Overall Study|Lost to Follow-up|15
5527003|NCT01432457|19106300|P1|Overall Study|Lost to Follow-up|11
5527004|NCT01432457|19106298|P3|Overall Study|Lack of Efficacy|1
5527005|NCT01432457|19106299|P2|Overall Study|Lack of Efficacy|1
5527006|NCT01432457|19106300|P1|Overall Study|Lack of Efficacy|2
5527007|NCT01432457|19106298|P3|Overall Study|Adverse Event|16
5527008|NCT01432457|19106299|P2|Overall Study|Adverse Event|10
5527009|NCT01432457|19106300|P1|Overall Study|Adverse Event|7
5527010|NCT01432444|19106329|P3|Extension Phase|Withdrawal by Subject|13
5527011|NCT01432444|19106330|P2|Extension Phase|Withdrawal by Subject|0
5527012|NCT01432444|19106331|P1|Extension Phase|Withdrawal by Subject|0
5527013|NCT01432444|19106329|P3|Extension Phase|Physician Decision|1
5527014|NCT01432444|19106330|P2|Extension Phase|Physician Decision|0
5527015|NCT01432444|19106331|P1|Extension Phase|Physician Decision|0
5527016|NCT01432444|19106329|P3|Extension Phase|Met Withdrawal Criteria|144
5527017|NCT01432444|19106330|P2|Extension Phase|Met Withdrawal Criteria|0
5527018|NCT01432444|19106331|P1|Extension Phase|Met Withdrawal Criteria|0
5527019|NCT01432444|19106329|P3|Extension Phase|Sponsor Discontinued Trial|7
5527020|NCT01432444|19106330|P2|Extension Phase|Sponsor Discontinued Trial|0
5527021|NCT01432444|19106331|P1|Extension Phase|Sponsor Discontinued Trial|0
5527022|NCT01432444|19106329|P3|Extension Phase|Adverse Event|10
5527023|NCT01432444|19106330|P2|Extension Phase|Adverse Event|0
5527024|NCT01432444|19106331|P1|Extension Phase|Adverse Event|0
5527025|NCT01432444|19106329|P3|Extension Phase|Lost to Follow-up|17
5527026|NCT01432444|19106330|P2|Extension Phase|Lost to Follow-up|0
5527027|NCT01432444|19106331|P1|Extension Phase|Lost to Follow-up|0
5527028|NCT01432444|19106329|P3|Treatment Phase|Lack of Efficacy|0
5527029|NCT01432444|19106330|P2|Treatment Phase|Lack of Efficacy|10
5527030|NCT01432444|19106331|P1|Treatment Phase|Lack of Efficacy|0
5527031|NCT01432444|19106329|P3|Treatment Phase|Protocol Deviation|0
5527032|NCT01432444|19106330|P2|Treatment Phase|Protocol Deviation|3
5527033|NCT01432444|19106331|P1|Treatment Phase|Protocol Deviation|0
5527034|NCT01432444|19106329|P3|Treatment Phase|Withdrawal by Subject|0
5527035|NCT01432444|19106330|P2|Treatment Phase|Withdrawal by Subject|41
5527036|NCT01432444|19106331|P1|Treatment Phase|Withdrawal by Subject|0
5527037|NCT01432444|19106329|P3|Treatment Phase|Physician Decision|0
5527038|NCT01432444|19106330|P2|Treatment Phase|Physician Decision|5
5527039|NCT01432444|19106331|P1|Treatment Phase|Physician Decision|0
5527040|NCT01432444|19106329|P3|Treatment Phase|Met Withdrawal Criteria|0
5527041|NCT01432444|19106330|P2|Treatment Phase|Met Withdrawal Criteria|11
5527042|NCT01432444|19106331|P1|Treatment Phase|Met Withdrawal Criteria|0
5527043|NCT01432444|19106329|P3|Treatment Phase|Adverse Event|0
5527044|NCT01432444|19106330|P2|Treatment Phase|Adverse Event|37
5527045|NCT01432444|19106331|P1|Treatment Phase|Adverse Event|0
5527046|NCT01432444|19106329|P3|Treatment Phase|Lost to Follow-up|0
5527047|NCT01432444|19106330|P2|Treatment Phase|Lost to Follow-up|33
5527048|NCT01432444|19106331|P1|Treatment Phase|Lost to Follow-up|0
5527049|NCT01432444|19106329|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
5527050|NCT01432444|19106330|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
5527051|NCT01432444|19106331|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
5527052|NCT01432444|19106329|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
5527053|NCT01432444|19106330|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
5527054|NCT01432444|19106331|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
5527055|NCT01432444|19106329|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
5527056|NCT01432444|19106330|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
5527057|NCT01432444|19106331|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
5527058|NCT01432444|19106329|P3|Tolerability/Cross-titration Phase|Physician Decision|0
5527059|NCT01432444|19106330|P2|Tolerability/Cross-titration Phase|Physician Decision|0
5527060|NCT01432444|19106331|P1|Tolerability/Cross-titration Phase|Physician Decision|8
5527061|NCT01432444|19106329|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
5527062|NCT01432444|19106330|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
5527063|NCT01432444|19106331|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
5527064|NCT01432444|19106329|P3|Tolerability/Cross-titration Phase|Adverse Event|0
5527065|NCT01432444|19106330|P2|Tolerability/Cross-titration Phase|Adverse Event|0
5527066|NCT01432444|19106331|P1|Tolerability/Cross-titration Phase|Adverse Event|16
5527067|NCT01432444|19106329|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
5527068|NCT01432444|19106330|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
5527069|NCT01432444|19106331|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
5527070|NCT01432366|19106357|P1|Overall Study|Other|14
5527071|NCT01432366|19106357|P1|Overall Study|Investigator Forget to Complete Visits|1
5527072|NCT01432366|19106357|P1|Overall Study|Site Closed|20
5527073|NCT01432366|19106357|P1|Overall Study|Lack of Efficacy|1
5527074|NCT01432366|19106357|P1|Overall Study|Lost to Follow-up|13
5527075|NCT01432366|19106357|P1|Overall Study|Pregnancy|1
5527076|NCT01432366|19106357|P1|Overall Study|Withdrawal Due to Non-Compliance|3
5527077|NCT01432366|19106357|P1|Overall Study|Adverse Event|8
5527078|NCT01432366|19106357|P1|Overall Study|Non-Responder|7
5527079|NCT01432327|19106379|P4|Posttest 1 Year|Allergic reaction|1
5527080|NCT01432327|19106380|P3|Posttest 1 Year|Allergic reaction|1
5527081|NCT01432327|19106381|P2|Posttest 1 Year|Allergic reaction|0
5527082|NCT01432327|19106382|P1|Posttest 1 Year|Allergic reaction|0
5527083|NCT01432327|19106379|P4|Posttest 1 Year|Lost to Follow-up|2
5527084|NCT01432327|19106380|P3|Posttest 1 Year|Lost to Follow-up|4
5527085|NCT01432327|19106381|P2|Posttest 1 Year|Lost to Follow-up|0
5527086|NCT01432327|19106382|P1|Posttest 1 Year|Lost to Follow-up|0
5527087|NCT01432327|19106379|P4|Posttest 1 Year|Measurement have to take place in future|20
5527088|NCT01432327|19106380|P3|Posttest 1 Year|Measurement have to take place in future|15
5527089|NCT01432327|19106381|P2|Posttest 1 Year|Measurement have to take place in future|28
5527090|NCT01432327|19106382|P1|Posttest 1 Year|Measurement have to take place in future|24
5527091|NCT01432327|19106379|P4|Posttest 6 Months|Withdrawal by Subject|0
5527092|NCT01432327|19106380|P3|Posttest 6 Months|Withdrawal by Subject|1
5527093|NCT01432327|19106381|P2|Posttest 6 Months|Withdrawal by Subject|0
5527094|NCT01432327|19106382|P1|Posttest 6 Months|Withdrawal by Subject|0
5527095|NCT01432327|19106379|P4|Posttest 6 Months|Allergic reaction|0
5527096|NCT01432327|19106380|P3|Posttest 6 Months|Allergic reaction|1
5527097|NCT01432327|19106381|P2|Posttest 6 Months|Allergic reaction|0
5527098|NCT01432327|19106382|P1|Posttest 6 Months|Allergic reaction|0
5527099|NCT01432327|19106379|P4|Posttest 6 Months|Lost to Follow-up|2
5527100|NCT01432327|19106380|P3|Posttest 6 Months|Lost to Follow-up|3
5527101|NCT01432327|19106381|P2|Posttest 6 Months|Lost to Follow-up|0
5527102|NCT01432327|19106382|P1|Posttest 6 Months|Lost to Follow-up|0
5527103|NCT01432327|19106379|P4|Posttest 3 Months|Allergic reaction|0
5527104|NCT01432327|19106380|P3|Posttest 3 Months|Allergic reaction|0
5527105|NCT01432327|19106381|P2|Posttest 3 Months|Allergic reaction|2
5527106|NCT01432327|19106382|P1|Posttest 3 Months|Allergic reaction|0
5527107|NCT01432327|19106379|P4|Posttest 3 Months|Lost to Follow-up|1
5527108|NCT01432327|19106380|P3|Posttest 3 Months|Lost to Follow-up|2
5527109|NCT01432327|19106381|P2|Posttest 3 Months|Lost to Follow-up|0
5527110|NCT01432327|19106382|P1|Posttest 3 Months|Lost to Follow-up|1
5527111|NCT01432327|19106379|P4|Posttest 3 Months|depression|0
5527112|NCT01432327|19106380|P3|Posttest 3 Months|depression|0
5527113|NCT01432327|19106381|P2|Posttest 3 Months|depression|0
5527114|NCT01432327|19106382|P1|Posttest 3 Months|depression|3
5527115|NCT01432275|19106392|P2|ADC With Calculator (10 Days)|Protocol Violation|1
5527116|NCT01432275|19106393|P1|ADC With Calculator (10 Days)|Protocol Violation|0
5527117|NCT01432275|19106392|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
5527118|NCT01432275|19106393|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
5527119|NCT01432275|19106392|P2|ADC With Calculator (10 Days)|Physician Decision|1
5527120|NCT01432275|19106393|P1|ADC With Calculator (10 Days)|Physician Decision|1
5527121|NCT01432275|19106392|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
5527122|NCT01432275|19106393|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
5527123|NCT01432275|19106392|P2|Second BG Meter System (7 Days)|Physician Decision|1
5527124|NCT01432275|19106393|P1|Second BG Meter System (7 Days)|Physician Decision|0
5527125|NCT01432275|19106392|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
5527126|NCT01432275|19106393|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
5527127|NCT01432275|19106392|P2|Second BG Meter System (7 Days)|Adverse Event|1
5527128|NCT01432275|19106393|P1|Second BG Meter System (7 Days)|Adverse Event|1
5527129|NCT01432275|19106392|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
5527130|NCT01432275|19106393|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
5527131|NCT01432275|19106392|P2|First BG Meter System (7 Days)|Adverse Event|2
5527132|NCT01432275|19106393|P1|First BG Meter System (7 Days)|Adverse Event|0
5527133|NCT01432262|19106402|P2|Overall Study|Withdrawal by Subject|1
5527134|NCT01432262|19106403|P1|Overall Study|Withdrawal by Subject|2
5527135|NCT01432171|19106469|P2|Overall Study|Patient moved to palliative care|0
5527136|NCT01432171|19106470|P1|Overall Study|Patient moved to palliative care|1
5527137|NCT01432171|19106469|P2|Overall Study|Insurance denial trial coverage|0
5527138|NCT01432171|19106470|P1|Overall Study|Insurance denial trial coverage|1
5527139|NCT01432171|19106469|P2|Overall Study|Noncompliance|3
5527140|NCT01432171|19106470|P1|Overall Study|Noncompliance|2
5527141|NCT01432171|19106469|P2|Overall Study|Withdrawal by Subject|1
5527142|NCT01432171|19106470|P1|Overall Study|Withdrawal by Subject|3
5527143|NCT01432171|19106469|P2|Overall Study|Lost to Follow-up|5
5527144|NCT01432171|19106470|P1|Overall Study|Lost to Follow-up|6
5527145|NCT01432171|19106469|P2|Overall Study|Death|2
5527146|NCT01432171|19106470|P1|Overall Study|Death|1
5527147|NCT01431976|19106511|P1|Overall Study|Withdrawal by Subject|1
5527148|NCT01431976|19106511|P1|Overall Study|Physician Decision|1
5527149|NCT01431976|19106511|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
5527150|NCT01431976|19106511|P1|Overall Study|Lack of Efficacy|2
5527151|NCT01431976|19106511|P1|Overall Study|Adverse Event|6
5527152|NCT01431963|19106522|P1|Overall Study|Withdrawal by Subject|3
5527153|NCT01431963|19106522|P1|Overall Study|Physician Decision|4
5527154|NCT01431963|19106522|P1|Overall Study|Protocol-defined Stopping Criteria|2
5527155|NCT01431963|19106522|P1|Overall Study|Protocol Violation|1
5527156|NCT01431963|19106522|P1|Overall Study|Lack of Efficacy|7
5527157|NCT01431963|19106522|P1|Overall Study|Adverse Event|18
5527158|NCT01431950|19106530|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
5527159|NCT01431950|19106531|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
5527160|NCT01431950|19106530|P2|Overall Study|Lost to Follow-up|1
5527161|NCT01431950|19106531|P1|Overall Study|Lost to Follow-up|0
5527162|NCT01431950|19106530|P2|Overall Study|Lack of Efficacy|1
5527163|NCT01431950|19106531|P1|Overall Study|Lack of Efficacy|2
5527164|NCT01431950|19106530|P2|Overall Study|Physician Decision|1
5527165|NCT01431950|19106531|P1|Overall Study|Physician Decision|2
5527166|NCT01431950|19106530|P2|Overall Study|Adverse Event|2
5527167|NCT01431950|19106531|P1|Overall Study|Adverse Event|2
5527168|NCT01431950|19106530|P2|Overall Study|Protocol Violation|3
5527169|NCT01431950|19106531|P1|Overall Study|Protocol Violation|2
5527170|NCT01431950|19106530|P2|Overall Study|Withdrawal by Subject|3
5527171|NCT01431950|19106531|P1|Overall Study|Withdrawal by Subject|4
5527172|NCT01431950|19106530|P2|Overall Study|Study Site Closed/Terminated|3
5527173|NCT01431950|19106531|P1|Overall Study|Study Site Closed/Terminated|7
5527174|NCT01431716|19106596|P1|Overall Study|Withdrawal of consent|1
5527175|NCT01431534|19106620|P3|Treatment Phase|Progressive Disease|10
5527176|NCT01431534|19106621|P2|Treatment Phase|Progressive Disease|3
5527177|NCT01431534|19106622|P1|Treatment Phase|Progressive Disease|4
5527178|NCT01431534|19106620|P3|Treatment Phase|Adverse Event|1
5527179|NCT01431534|19106621|P2|Treatment Phase|Adverse Event|0
5527180|NCT01431534|19106622|P1|Treatment Phase|Adverse Event|0
5527181|NCT01431521|19106637|P4|Overall Study|Withdrawal by Subject|0
5527182|NCT01431521|19106638|P3|Overall Study|Withdrawal by Subject|1
5527183|NCT01431521|19106639|P2|Overall Study|Withdrawal by Subject|0
5527184|NCT01431521|19106640|P1|Overall Study|Withdrawal by Subject|0
5527185|NCT01431508|19106661|P1|Overall Study|Unable to Follow Protocol Procedures|1
5527186|NCT01431508|19106661|P1|Overall Study|Lack of Efficacy|1
5527187|NCT01431287|19106746|P5|Overall Study|not stated above|1
5527188|NCT01431287|19106747|P4|Overall Study|not stated above|2
5527189|NCT01431287|19106748|P3|Overall Study|not stated above|2
5527190|NCT01431287|19106749|P2|Overall Study|not stated above|2
5527191|NCT01431287|19106750|P1|Overall Study|not stated above|4
5527192|NCT01431287|19106746|P5|Overall Study|Consent withdrawn not due to AE|29
5527193|NCT01431287|19106747|P4|Overall Study|Consent withdrawn not due to AE|19
5527194|NCT01431287|19106748|P3|Overall Study|Consent withdrawn not due to AE|34
5527195|NCT01431287|19106749|P2|Overall Study|Consent withdrawn not due to AE|30
5527196|NCT01431287|19106750|P1|Overall Study|Consent withdrawn not due to AE|29
5527197|NCT01431287|19106746|P5|Overall Study|Lost to Follow-up|1
5527198|NCT01431287|19106747|P4|Overall Study|Lost to Follow-up|3
5527199|NCT01431287|19106748|P3|Overall Study|Lost to Follow-up|2
5527200|NCT01431287|19106749|P2|Overall Study|Lost to Follow-up|3
5527201|NCT01431287|19106750|P1|Overall Study|Lost to Follow-up|0
5527202|NCT01431287|19106746|P5|Overall Study|Non compliant with protocol|5
5527203|NCT01431287|19106747|P4|Overall Study|Non compliant with protocol|6
5527204|NCT01431287|19106748|P3|Overall Study|Non compliant with protocol|5
5527205|NCT01431287|19106749|P2|Overall Study|Non compliant with protocol|6
5527206|NCT01431287|19106750|P1|Overall Study|Non compliant with protocol|6
5527207|NCT01431287|19106746|P5|Overall Study|Adverse Event|41
5527208|NCT01431287|19106747|P4|Overall Study|Adverse Event|33
5527209|NCT01431287|19106748|P3|Overall Study|Adverse Event|53
5527210|NCT01431287|19106749|P2|Overall Study|Adverse Event|57
5527211|NCT01431287|19106750|P1|Overall Study|Adverse Event|59
5527212|NCT01431287|19106746|P5|Overall Study|not treated|0
5527213|NCT01431287|19106747|P4|Overall Study|not treated|0
5527214|NCT01431287|19106748|P3|Overall Study|not treated|1
5527215|NCT01431287|19106749|P2|Overall Study|not treated|0
5527216|NCT01431287|19106750|P1|Overall Study|not treated|0
5527217|NCT01431274|19106912|P5|Overall Study|Other reason not stated above|4
5527218|NCT01431274|19106913|P4|Overall Study|Other reason not stated above|2
5527219|NCT01431274|19106914|P3|Overall Study|Other reason not stated above|7
5527220|NCT01431274|19106915|P2|Overall Study|Other reason not stated above|5
5527221|NCT01431274|19106916|P1|Overall Study|Other reason not stated above|6
5527222|NCT01431274|19106912|P5|Overall Study|Lost to Follow-up|0
5527223|NCT01431274|19106913|P4|Overall Study|Lost to Follow-up|4
5527224|NCT01431274|19106914|P3|Overall Study|Lost to Follow-up|1
5527225|NCT01431274|19106915|P2|Overall Study|Lost to Follow-up|7
5527226|NCT01431274|19106916|P1|Overall Study|Lost to Follow-up|6
5527227|NCT01431274|19106912|P5|Overall Study|Non compliant with protocol|4
5527228|NCT01431274|19106913|P4|Overall Study|Non compliant with protocol|4
5527229|NCT01431274|19106914|P3|Overall Study|Non compliant with protocol|4
5527230|NCT01431274|19106915|P2|Overall Study|Non compliant with protocol|8
5527231|NCT01431274|19106916|P1|Overall Study|Non compliant with protocol|5
5527232|NCT01431274|19106912|P5|Overall Study|Consent withdrawn not due to AE|11
5527233|NCT01431274|19106913|P4|Overall Study|Consent withdrawn not due to AE|20
5527234|NCT01431274|19106914|P3|Overall Study|Consent withdrawn not due to AE|17
5527235|NCT01431274|19106915|P2|Overall Study|Consent withdrawn not due to AE|20
5527236|NCT01431274|19106916|P1|Overall Study|Consent withdrawn not due to AE|29
5527237|NCT01431274|19106912|P5|Overall Study|Adverse Event|37
5527238|NCT01431274|19106913|P4|Overall Study|Adverse Event|30
5527239|NCT01431274|19106914|P3|Overall Study|Adverse Event|43
5527240|NCT01431274|19106915|P2|Overall Study|Adverse Event|37
5527241|NCT01431274|19106916|P1|Overall Study|Adverse Event|51
5527242|NCT01431144|19107094|P2|Overall Study|Implant mobility and removal|0
5527243|NCT01431144|19107095|P1|Overall Study|Implant mobility and removal|2
5527244|NCT01431079|19107118|P2|Overall Study|Lost to Follow-up|39
5527245|NCT01431079|19107119|P1|Overall Study|Lost to Follow-up|35
5527246|NCT01430754|19107198|P2|Run-In Phase|Lost to Follow-up|0
5527247|NCT01430754|19107199|P1|Run-In Phase|Lost to Follow-up|1
5527248|NCT01430754|19107198|P2|Run-In Phase|Withdrawal by Subject|0
5527249|NCT01430754|19107199|P1|Run-In Phase|Withdrawal by Subject|2
5527250|NCT01430754|19107198|P2|Run-In Phase|Other|0
5527251|NCT01430754|19107199|P1|Run-In Phase|Other|2
5527252|NCT01430754|19107198|P2|Run-In Phase|Adverse Event|0
5527253|NCT01430754|19107199|P1|Run-In Phase|Adverse Event|2
5527254|NCT01430754|19107198|P2|Run-In Phase|Protocol Violation|0
5527255|NCT01430754|19107199|P1|Run-In Phase|Protocol Violation|6
5527256|NCT01430754|19107198|P2|Run-In Phase|Circadian Period Ineligible|0
5527257|NCT01430754|19107199|P1|Run-In Phase|Circadian Period Ineligible|24
5527258|NCT01430624|19107257|P3|Overall Study|technical or eligibility|2
5527259|NCT01430624|19107258|P2|Overall Study|technical or eligibility|5
5527260|NCT01430624|19107259|P1|Overall Study|technical or eligibility|5
5527261|NCT01430624|19107257|P3|Overall Study|Lost to Follow-up|27
5527262|NCT01430624|19107258|P2|Overall Study|Lost to Follow-up|29
5527263|NCT01430624|19107259|P1|Overall Study|Lost to Follow-up|23
5527264|NCT01430611|19107290|P2|Overall Study|Withdrawal by Subject|14
5527265|NCT01430611|19107291|P1|Overall Study|Withdrawal by Subject|15
5527266|NCT01430611|19107290|P2|Overall Study|Lost to Follow-up|0
5527267|NCT01430611|19107291|P1|Overall Study|Lost to Follow-up|1
5527268|NCT01430611|19107290|P2|Overall Study|Protocol Violation|0
5527269|NCT01430611|19107291|P1|Overall Study|Protocol Violation|1
5527270|NCT01430611|19107290|P2|Overall Study|Adverse Event|1
5527271|NCT01430611|19107291|P1|Overall Study|Adverse Event|0
5527272|NCT01430585|19107309|P1|Overall Study|Other|7
5527273|NCT01430585|19107309|P1|Overall Study|Study Terminated by Sponsor|3
5527274|NCT01430585|19107309|P1|Overall Study|Objective Progression or Relapse|3
5527275|NCT01430585|19107309|P1|Overall Study|Death|1
5527276|NCT01430559|19107344|P2|Overall Study|Randomized, Not Treated|3
5527277|NCT01430559|19107345|P1|Overall Study|Randomized, Not Treated|3
5527278|NCT01430559|19107344|P2|Overall Study|Other|3
5527279|NCT01430559|19107345|P1|Overall Study|Other|3
5527280|NCT01430559|19107344|P2|Overall Study|Protocol Violation|0
5527281|NCT01430559|19107345|P1|Overall Study|Protocol Violation|1
5527282|NCT01430559|19107344|P2|Overall Study|Withdrawal by Subject|2
5527283|NCT01430559|19107345|P1|Overall Study|Withdrawal by Subject|3
5527284|NCT01430559|19107344|P2|Overall Study|Medication error|0
5527285|NCT01430559|19107345|P1|Overall Study|Medication error|1
5527286|NCT01430559|19107344|P2|Overall Study|Lost to Follow-up|0
5527287|NCT01430559|19107345|P1|Overall Study|Lost to Follow-up|1
5527288|NCT01430559|19107344|P2|Overall Study|Entry criteria not met|1
5527289|NCT01430559|19107345|P1|Overall Study|Entry criteria not met|1
5527290|NCT01430559|19107344|P2|Overall Study|Adverse Event|3
5527291|NCT01430559|19107345|P1|Overall Study|Adverse Event|7
5527292|NCT01430468|19107381|P2|Overall Study|Withdrawal by Subject|5
5527293|NCT01430468|19107382|P1|Overall Study|Withdrawal by Subject|5
5527294|NCT01430468|19107381|P2|Overall Study|Physician Decision|1
5527295|NCT01430468|19107382|P1|Overall Study|Physician Decision|2
5527296|NCT01430455|19107390|P1|Overall Study|Switched to follow-up phase|1
5527297|NCT01430455|19107390|P1|Overall Study|Withdrawal by Subject|1
5527298|NCT01430442|19107402|P8|Overall Study|Patient No Longer Meets Study Criteria|6
5527299|NCT01430442|19107403|P7|Overall Study|Patient No Longer Meets Study Criteria|9
5527300|NCT01430442|19107404|P6|Overall Study|Patient No Longer Meets Study Criteria|5
5527301|NCT01430442|19107405|P5|Overall Study|Patient No Longer Meets Study Criteria|5
5527302|NCT01430442|19107406|P4|Overall Study|Patient No Longer Meets Study Criteria|2
5527303|NCT01430442|19107407|P3|Overall Study|Patient No Longer Meets Study Criteria|3
5527304|NCT01430442|19107408|P2|Overall Study|Patient No Longer Meets Study Criteria|6
5527305|NCT01430442|19107409|P1|Overall Study|Patient No Longer Meets Study Criteria|7
5527306|NCT01430442|19107402|P8|Overall Study|Pregnancy|0
5527307|NCT01430442|19107403|P7|Overall Study|Pregnancy|0
5527308|NCT01430442|19107404|P6|Overall Study|Pregnancy|1
5527309|NCT01430442|19107405|P5|Overall Study|Pregnancy|0
5527310|NCT01430442|19107406|P4|Overall Study|Pregnancy|0
5527311|NCT01430442|19107407|P3|Overall Study|Pregnancy|0
5527312|NCT01430442|19107408|P2|Overall Study|Pregnancy|0
5527313|NCT01430442|19107409|P1|Overall Study|Pregnancy|1
5527314|NCT01430442|19107402|P8|Overall Study|Lost to Follow-up|1
5527315|NCT01430442|19107403|P7|Overall Study|Lost to Follow-up|5
5527316|NCT01430442|19107404|P6|Overall Study|Lost to Follow-up|1
5527317|NCT01430442|19107405|P5|Overall Study|Lost to Follow-up|2
5527318|NCT01430442|19107406|P4|Overall Study|Lost to Follow-up|2
5527319|NCT01430442|19107407|P3|Overall Study|Lost to Follow-up|1
5527320|NCT01430442|19107408|P2|Overall Study|Lost to Follow-up|0
5527321|NCT01430442|19107409|P1|Overall Study|Lost to Follow-up|2
5527322|NCT01430442|19107402|P8|Overall Study|Subject Withdrew Consent|2
5527323|NCT01430442|19107403|P7|Overall Study|Subject Withdrew Consent|5
5527324|NCT01430442|19107404|P6|Overall Study|Subject Withdrew Consent|1
5527325|NCT01430442|19107405|P5|Overall Study|Subject Withdrew Consent|2
5527326|NCT01430442|19107406|P4|Overall Study|Subject Withdrew Consent|0
5527327|NCT01430442|19107407|P3|Overall Study|Subject Withdrew Consent|1
5527328|NCT01430442|19107408|P2|Overall Study|Subject Withdrew Consent|0
5527329|NCT01430442|19107409|P1|Overall Study|Subject Withdrew Consent|3
5527330|NCT01430403|19107462|P3|Overall Study|Withdrawal by Subject|3
5527331|NCT01430403|19107463|P2|Overall Study|Withdrawal by Subject|1
5527332|NCT01430403|19107464|P1|Overall Study|Withdrawal by Subject|9
5527333|NCT01430403|19107462|P3|Overall Study|Protocol Violation|2
5527334|NCT01430403|19107463|P2|Overall Study|Protocol Violation|3
5527335|NCT01430403|19107464|P1|Overall Study|Protocol Violation|2
5527336|NCT01430403|19107462|P3|Overall Study|Physician Decision|0
5527337|NCT01430403|19107463|P2|Overall Study|Physician Decision|0
5527338|NCT01430403|19107464|P1|Overall Study|Physician Decision|1
5527339|NCT01430403|19107462|P3|Overall Study|Lost to Follow-up|3
5527340|NCT01430403|19107463|P2|Overall Study|Lost to Follow-up|5
5527341|NCT01430403|19107464|P1|Overall Study|Lost to Follow-up|5
5527342|NCT01430130|19107571|P1|Overall Study|Infection on Control Side of Incision|1
5527343|NCT01430130|19107571|P1|Overall Study|Lost to Follow-up|1
5527344|NCT01430104|19107577|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
5527345|NCT01429792|19107644|P1|Overall Study|Lost to Follow-up|88
5527346|NCT01429792|19107644|P1|Overall Study|Withdrawal by Subject|70
5527347|NCT01429792|19107644|P1|Overall Study|Positive HCV-RNA at Week 24|50
5527348|NCT01429792|19107644|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
5527349|NCT01429792|19107644|P1|Overall Study|Negative HCV-RNA at Week 12|4
5527350|NCT01429792|19107644|P1|Overall Study|Negative HCV-RNA at Week 4|1
5527351|NCT01429792|19107644|P1|Overall Study|Unknown Disposition|94
5527352|NCT01429792|19107644|P1|Overall Study|Other Reasons|67
5527353|NCT01429623|19107658|P2|Overall Study|No post baseline data|4
5527354|NCT01429623|19107659|P1|Overall Study|No post baseline data|4
5527355|NCT01429623|19107658|P2|Overall Study|Conversion to Alzheimer's disease|21
5527356|NCT01429623|19107659|P1|Overall Study|Conversion to Alzheimer's disease|14
5527357|NCT01429623|19107658|P2|Overall Study|Assorted|2
5527358|NCT01429623|19107659|P1|Overall Study|Assorted|1
5527359|NCT01429623|19107658|P2|Overall Study|Protocol Violation|2
5527360|NCT01429623|19107659|P1|Overall Study|Protocol Violation|3
5527361|NCT01429623|19107658|P2|Overall Study|Physician Decision|3
5527362|NCT01429623|19107659|P1|Overall Study|Physician Decision|2
5527363|NCT01429623|19107658|P2|Overall Study|Withdrawal by Subject|13
5527364|NCT01429623|19107659|P1|Overall Study|Withdrawal by Subject|19
5527365|NCT01429623|19107658|P2|Overall Study|Adverse Event|14
5527366|NCT01429623|19107659|P1|Overall Study|Adverse Event|7
5527367|NCT01429623|19107658|P2|Overall Study|Death|0
5527368|NCT01429623|19107659|P1|Overall Study|Death|1
5527369|NCT01429584|19107673|P2|Overall Study|Protocol Violation|1
5527370|NCT01429584|19107674|P1|Overall Study|Protocol Violation|0
5527371|NCT01429584|19107673|P2|Overall Study|Withdrawal by Subject|0
5527372|NCT01429584|19107674|P1|Overall Study|Withdrawal by Subject|1
5527373|NCT01429441|19107716|P2|Overall Study|Withdrawal by Subject|18
5527374|NCT01429441|19107717|P1|Overall Study|Withdrawal by Subject|27
5527375|NCT01429441|19107716|P2|Overall Study|Physician Decision|0
5527376|NCT01429441|19107717|P1|Overall Study|Physician Decision|1
5527377|NCT01429441|19107716|P2|Overall Study|Lost to Follow-up|2
5527378|NCT01429441|19107717|P1|Overall Study|Lost to Follow-up|5
5527379|NCT01429441|19107716|P2|Overall Study|Death|2
5527380|NCT01429441|19107717|P1|Overall Study|Death|0
5527381|NCT01429441|19107716|P2|Overall Study|Adverse Event|1
5527382|NCT01429441|19107717|P1|Overall Study|Adverse Event|5
5527383|NCT01429298|19107742|P2|Overall Study|Protocol Violation|6
5527384|NCT01429298|19107743|P1|Overall Study|Protocol Violation|4
5527385|NCT01429285|19107759|P2|Overall Study|Erroneously Enrolled Twice|2
5527386|NCT01429285|19107760|P1|Overall Study|Erroneously Enrolled Twice|8
5527387|NCT01429285|19107759|P2|Overall Study|Missing Data|3
5527388|NCT01429285|19107760|P1|Overall Study|Missing Data|5
5527389|NCT01429285|19107759|P2|Overall Study|Protocol Violation|4
5527390|NCT01429285|19107760|P1|Overall Study|Protocol Violation|9
5527391|NCT01429077|19107806|P2|Overall Study|Lost to Follow-up|3
5527392|NCT01429077|19107807|P1|Overall Study|Lost to Follow-up|0
5527393|NCT01429051|19107830|P1|Tolerability Phase|Other|2
5527394|NCT01429051|19107830|P1|Tolerability Phase|Physician Decision|1
5527395|NCT01429051|19107830|P1|Tolerability Phase|Withdrawal by Subject|5
5527396|NCT01429051|19107830|P1|Tolerability Phase|Adverse Event|2
5527397|NCT01429051|19107830|P1|Tolerability Phase|Death|5
5527398|NCT01429051|19107830|P1|Efficacy Phase|Death|1
5527399|NCT01429051|19107830|P1|Efficacy Phase|Adverse Event|1
5527400|NCT01429051|19107830|P1|Titration Phase|Less than 3 BTP episodes per week|2
5527401|NCT01429051|19107830|P1|Titration Phase|Unsuccessful titration at any dose|1
5527402|NCT01429051|19107830|P1|Titration Phase|Physician Decision|1
5527403|NCT01429051|19107830|P1|Titration Phase|Withdrawal by Subject|7
5527404|NCT01429051|19107830|P1|Titration Phase|Death|1
5527405|NCT01428882|19107853|P2|Overall Study|Protocol Violation|3
5527406|NCT01428882|19107854|P1|Overall Study|Protocol Violation|4
5527407|NCT01428882|19107853|P2|Overall Study|Lack of Efficacy|7
5527408|NCT01428882|19107854|P1|Overall Study|Lack of Efficacy|2
5527409|NCT01428713|19107877|P2|Overall Study|Adverse Event|2
5527410|NCT01428713|19107878|P1|Overall Study|Adverse Event|0
5527411|NCT01428713|19107877|P2|Overall Study|Withdrawal by Subject|1
5527412|NCT01428713|19107878|P1|Overall Study|Withdrawal by Subject|1
5527413|NCT01428713|19107877|P2|Overall Study|Non-compliance|2
5527414|NCT01428713|19107878|P1|Overall Study|Non-compliance|2
5527415|NCT01428661|19107887|P3|Open Label Extension|**Various|185
5527416|NCT01428661|19107888|P2|Open Label Extension|**Various|0
5527417|NCT01428661|19107889|P1|Open Label Extension|**Various|0
5527418|NCT01428661|19107887|P3|Open Label Extension|Lack of Efficacy|24
5527419|NCT01428661|19107888|P2|Open Label Extension|Lack of Efficacy|0
5527420|NCT01428661|19107889|P1|Open Label Extension|Lack of Efficacy|0
5527421|NCT01428661|19107887|P3|Open Label Extension|Withdrawal by Subject|49
5527422|NCT01428661|19107888|P2|Open Label Extension|Withdrawal by Subject|0
5527423|NCT01428661|19107889|P1|Open Label Extension|Withdrawal by Subject|0
5527424|NCT01428661|19107887|P3|Open Label Extension|Lost to Follow-up|38
5527425|NCT01428661|19107888|P2|Open Label Extension|Lost to Follow-up|0
5527426|NCT01428661|19107889|P1|Open Label Extension|Lost to Follow-up|0
5527427|NCT01428661|19107887|P3|Open Label Extension|Adverse Event|15
5527428|NCT01428661|19107888|P2|Open Label Extension|Adverse Event|0
5527429|NCT01428661|19107889|P1|Open Label Extension|Adverse Event|0
5527430|NCT01428661|19107887|P3|Open Label Extension|Protocol Violation|9
5527431|NCT01428661|19107888|P2|Open Label Extension|Protocol Violation|0
5527432|NCT01428661|19107889|P1|Open Label Extension|Protocol Violation|0
5527433|NCT01428661|19107887|P3|Double-Masked Phase|*Various|0
5527434|NCT01428661|19107888|P2|Double-Masked Phase|*Various|6
5527435|NCT01428661|19107889|P1|Double-Masked Phase|*Various|1
5527436|NCT01428661|19107887|P3|Double-Masked Phase|Lack of Efficacy|0
5527437|NCT01428661|19107888|P2|Double-Masked Phase|Lack of Efficacy|1
5527438|NCT01428661|19107889|P1|Double-Masked Phase|Lack of Efficacy|2
5527439|NCT01428661|19107887|P3|Double-Masked Phase|Withdrawal by Subject|0
5527440|NCT01428661|19107888|P2|Double-Masked Phase|Withdrawal by Subject|20
5527441|NCT01428661|19107889|P1|Double-Masked Phase|Withdrawal by Subject|18
5527442|NCT01428661|19107887|P3|Double-Masked Phase|Lost to Follow-up|0
5527443|NCT01428661|19107888|P2|Double-Masked Phase|Lost to Follow-up|14
5527444|NCT01428661|19107889|P1|Double-Masked Phase|Lost to Follow-up|14
5527445|NCT01428661|19107887|P3|Double-Masked Phase|Adverse Event|0
5527446|NCT01428661|19107888|P2|Double-Masked Phase|Adverse Event|4
5527447|NCT01428661|19107889|P1|Double-Masked Phase|Adverse Event|13
5527448|NCT01428661|19107887|P3|Double-Masked Phase|Protocol Violation|0
5527449|NCT01428661|19107888|P2|Double-Masked Phase|Protocol Violation|4
5527450|NCT01428661|19107889|P1|Double-Masked Phase|Protocol Violation|9
5527451|NCT01428583|19107897|P1|Overall Study|Other|6
5527452|NCT01428583|19107897|P1|Overall Study|Sponsor's request|3
5527453|NCT01428583|19107897|P1|Overall Study|Confirmed positive urine drug test|8
5527454|NCT01428583|19107897|P1|Overall Study|Non-compliant|25
5527455|NCT01428583|19107897|P1|Overall Study|Physician Decision|12
5527456|NCT01428583|19107897|P1|Overall Study|Protocol Violation|1
5527457|NCT01428583|19107897|P1|Overall Study|Pregnancy|1
5527458|NCT01428583|19107897|P1|Overall Study|Death|1
5527459|NCT01428583|19107897|P1|Overall Study|Lost to Follow-up|17
5527460|NCT01428583|19107897|P1|Overall Study|Lack of Efficacy|37
5527461|NCT01428583|19107897|P1|Overall Study|Withdrawal by Subject|51
5527462|NCT01428583|19107897|P1|Overall Study|Adverse Event|75
5527463|NCT01428453|19107921|P2|Overall Study|Withdrawal by Subject|1
5527464|NCT01428453|19107922|P1|Overall Study|Withdrawal by Subject|3
5527465|NCT01428453|19107921|P2|Overall Study|Lost to Follow-up|1
5527466|NCT01428453|19107922|P1|Overall Study|Lost to Follow-up|0
5527467|NCT01428453|19107921|P2|Overall Study|Protocol Violation|0
5527468|NCT01428453|19107922|P1|Overall Study|Protocol Violation|1
5527469|NCT01428453|19107921|P2|Overall Study|Adverse Event|7
5527470|NCT01428453|19107922|P1|Overall Study|Adverse Event|2
5527471|NCT01428258|19107961|P2|Intervention 1|Withdrawal by Subject|0
5527472|NCT01428258|19107962|P1|Intervention 1|Withdrawal by Subject|2
5527473|NCT01428219|19107984|P1|Overall Study|25 patients enrolled, 3 were not treated|3
5527474|NCT01428193|19107995|P1|Overall Study|Elevated screening liver enzymes|1
5527475|NCT01428193|19107995|P1|Overall Study|Physician Decision|1
5527476|NCT01428128|19107999|P1|Overall Study|Adverse Event|1
5527477|NCT01428128|19107999|P1|Overall Study|Received Neulasta in one cycle|2
5527478|NCT01428128|19107999|P1|Overall Study|Screen failure by p53|10
5527479|NCT01428128|19107999|P1|Overall Study|Withdrawal by Subject|4
5527480|NCT01428115|19108004|P1|Overall Study|Withdrawal by Subject|4
5527481|NCT01428115|19108004|P1|Overall Study|Protocol Violation|3
5527482|NCT01428115|19108004|P1|Overall Study|Pregnancy|1
5527483|NCT01428115|19108004|P1|Overall Study|Lost to Follow-up|10
5527484|NCT01428115|19108004|P1|Overall Study|Lack of Efficacy|3
5527485|NCT01428076|19108019|P2|Overall Study|Adverse Event|1
5527486|NCT01428076|19108020|P1|Overall Study|Adverse Event|0
5527487|NCT01428063|19108031|P3|Overall Study|No longer meets study criteria|0
5527488|NCT01428063|19108032|P2|Overall Study|No longer meets study criteria|1
5527489|NCT01428063|19108033|P1|Overall Study|No longer meets study criteria|0
5527490|NCT01428063|19108031|P3|Overall Study|Lost to Follow-up|0
5527491|NCT01428063|19108032|P2|Overall Study|Lost to Follow-up|2
5527492|NCT01428063|19108033|P1|Overall Study|Lost to Follow-up|0
5527493|NCT01428063|19108031|P3|Overall Study|Adverse Event|0
5527494|NCT01428063|19108032|P2|Overall Study|Adverse Event|3
5527495|NCT01428063|19108033|P1|Overall Study|Adverse Event|2
5527496|NCT01428063|19108031|P3|Overall Study|Lack of Efficacy|1
5527497|NCT01428063|19108032|P2|Overall Study|Lack of Efficacy|4
5527498|NCT01428063|19108033|P1|Overall Study|Lack of Efficacy|8
5527499|NCT01427972|19108134|P12|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527500|NCT01427972|19108135|P11|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527501|NCT01427972|19108136|P10|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527502|NCT01427972|19108137|P9|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527503|NCT01427972|19108138|P8|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527504|NCT01427972|19108139|P7|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527505|NCT01427972|19108140|P6|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527506|NCT01427972|19108141|P5|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527507|NCT01427972|19108142|P4|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527508|NCT01427972|19108143|P3|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527509|NCT01427972|19108144|P2|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
5527510|NCT01427972|19108145|P1|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
5527511|NCT01427972|19108134|P12|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527512|NCT01427972|19108135|P11|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527513|NCT01427972|19108136|P10|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527514|NCT01427972|19108137|P9|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527515|NCT01427972|19108138|P8|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527516|NCT01427972|19108139|P7|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527517|NCT01427972|19108140|P6|Washout (at Least 28 Days)|Withdrawal by Subject|2
5527518|NCT01427972|19108141|P5|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527519|NCT01427972|19108142|P4|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527520|NCT01427972|19108143|P3|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527521|NCT01427972|19108144|P2|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527522|NCT01427972|19108145|P1|Washout (at Least 28 Days)|Withdrawal by Subject|0
5527523|NCT01427972|19108134|P12|Treatment Period 1 (21 Days)|Protocol Violation|0
5527524|NCT01427972|19108135|P11|Treatment Period 1 (21 Days)|Protocol Violation|0
5527525|NCT01427972|19108136|P10|Treatment Period 1 (21 Days)|Protocol Violation|0
5527526|NCT01427972|19108137|P9|Treatment Period 1 (21 Days)|Protocol Violation|0
5527527|NCT01427972|19108138|P8|Treatment Period 1 (21 Days)|Protocol Violation|1
5527528|NCT01427972|19108139|P7|Treatment Period 1 (21 Days)|Protocol Violation|0
5527529|NCT01427972|19108140|P6|Treatment Period 1 (21 Days)|Protocol Violation|0
5527530|NCT01427972|19108141|P5|Treatment Period 1 (21 Days)|Protocol Violation|0
5527531|NCT01427972|19108142|P4|Treatment Period 1 (21 Days)|Protocol Violation|0
5527532|NCT01427972|19108143|P3|Treatment Period 1 (21 Days)|Protocol Violation|0
5527533|NCT01427972|19108144|P2|Treatment Period 1 (21 Days)|Protocol Violation|0
5527534|NCT01427972|19108145|P1|Treatment Period 1 (21 Days)|Protocol Violation|0
5527535|NCT01427933|19108171|P2|Overall Study|Investigator's Decision|0
5527536|NCT01427933|19108172|P1|Overall Study|Investigator's Decision|1
5527537|NCT01427933|19108171|P2|Overall Study|Other|0
5527538|NCT01427933|19108172|P1|Overall Study|Other|1
5527539|NCT01427933|19108171|P2|Overall Study|Lost to Follow-up|5
5527540|NCT01427933|19108172|P1|Overall Study|Lost to Follow-up|1
5527541|NCT01427933|19108171|P2|Overall Study|Withdrawal by Subject|8
5527542|NCT01427933|19108172|P1|Overall Study|Withdrawal by Subject|5
5527543|NCT01427920|19108192|P2|Overall Study|Unclassified|8
5527544|NCT01427920|19108193|P1|Overall Study|Unclassified|2
5527545|NCT01427920|19108192|P2|Overall Study|Withdrawal Criteria|4
5527546|NCT01427920|19108193|P1|Overall Study|Withdrawal Criteria|4
5527547|NCT01427920|19108192|P2|Overall Study|Protocol Violation|3
5527548|NCT01427920|19108193|P1|Overall Study|Protocol Violation|1
5527549|NCT01427920|19108192|P2|Overall Study|Lack of Efficacy|0
5527550|NCT01427920|19108193|P1|Overall Study|Lack of Efficacy|1
5527551|NCT01427920|19108192|P2|Overall Study|Adverse Event|2
5527552|NCT01427920|19108193|P1|Overall Study|Adverse Event|1
5527553|NCT01427907|19108213|P2|Overall Study|Withdrawal by Subject|4
5527554|NCT01427907|19108214|P1|Overall Study|Withdrawal by Subject|3
5527555|NCT01427803|19108235|P2|Overall Study|did not take product|0
5527556|NCT01427803|19108236|P1|Overall Study|did not take product|1
5527557|NCT01427803|19108235|P2|Overall Study|Physician Decision|0
5527558|NCT01427803|19108236|P1|Overall Study|Physician Decision|3
5527559|NCT01427803|19108235|P2|Overall Study|Protocol Violation|0
5527560|NCT01427803|19108236|P1|Overall Study|Protocol Violation|1
5527561|NCT01427803|19108235|P2|Overall Study|Unable to complete full treatment period|0
5527562|NCT01427803|19108236|P1|Overall Study|Unable to complete full treatment period|6
5527563|NCT01427803|19108235|P2|Overall Study|Withdrawal by Subject|0
5527564|NCT01427803|19108236|P1|Overall Study|Withdrawal by Subject|20
5527565|NCT01427803|19108235|P2|Overall Study|Lost to Follow-up|26
5527566|NCT01427803|19108236|P1|Overall Study|Lost to Follow-up|32
5527567|NCT01427751|19108250|P2|Overall Study|Other miscellaneous reasons|4
5527568|NCT01427751|19108251|P1|Overall Study|Other miscellaneous reasons|6
5527569|NCT01427751|19108250|P2|Overall Study|Death|0
5527570|NCT01427751|19108251|P1|Overall Study|Death|2
5527571|NCT01427751|19108250|P2|Overall Study|Protocol Violation|4
5527572|NCT01427751|19108251|P1|Overall Study|Protocol Violation|6
5527573|NCT01427751|19108250|P2|Overall Study|Withdrawal of consent|2
5527574|NCT01427751|19108251|P1|Overall Study|Withdrawal of consent|2
5527575|NCT01427751|19108250|P2|Overall Study|Lost to Follow-up|1
5527576|NCT01427751|19108251|P1|Overall Study|Lost to Follow-up|3
5527577|NCT01427751|19108250|P2|Overall Study|No further treatment benefit expected|1
5527578|NCT01427751|19108251|P1|Overall Study|No further treatment benefit expected|5
5527579|NCT01427751|19108250|P2|Overall Study|Adverse Event|2
5527580|NCT01427751|19108251|P1|Overall Study|Adverse Event|18
5527581|NCT01427738|19108271|P2|Overall Study|Lost to Follow-up|5
5527582|NCT01427738|19108272|P1|Overall Study|Lost to Follow-up|1
5527583|NCT01427738|19108271|P2|Overall Study|Subject not willing to adhere to reqs|2
5527584|NCT01427738|19108272|P1|Overall Study|Subject not willing to adhere to reqs|1
5527585|NCT01427738|19108271|P2|Overall Study|Withdrawal by Subject|2
5527586|NCT01427738|19108272|P1|Overall Study|Withdrawal by Subject|0
5527587|NCT01427738|19108271|P2|Overall Study|Subject unable to get to clinic|2
5527588|NCT01427738|19108272|P1|Overall Study|Subject unable to get to clinic|5
5527589|NCT01427738|19108271|P2|Overall Study|Severe debilitation, unable to continue|1
5527590|NCT01427738|19108272|P1|Overall Study|Severe debilitation, unable to continue|0
5527591|NCT01427738|19108271|P2|Overall Study|Death|9
5527592|NCT01427738|19108272|P1|Overall Study|Death|12
5527593|NCT01427608|19108292|P2|Overall Study|Events not attributed to study meds|1
5527594|NCT01427608|19108293|P1|Overall Study|Events not attributed to study meds|0
5527595|NCT01427608|19108292|P2|Overall Study|Relapsed-all cause|34
5527596|NCT01427608|19108293|P1|Overall Study|Relapsed-all cause|13
5527597|NCT01427608|19108292|P2|Overall Study|Withdrawal by Subject|3
5527598|NCT01427608|19108293|P1|Overall Study|Withdrawal by Subject|7
5527599|NCT01427608|19108292|P2|Overall Study|Death|0
5527600|NCT01427608|19108293|P1|Overall Study|Death|1
5527601|NCT01427309|19108350|P4|Overall Study|Withdrawal by Subject|55
5527602|NCT01427309|19108351|P3|Overall Study|Withdrawal by Subject|61
5527603|NCT01427309|19108352|P2|Overall Study|Withdrawal by Subject|148
5527604|NCT01427309|19108353|P1|Overall Study|Withdrawal by Subject|148
5527605|NCT01427309|19108350|P4|Overall Study|Serious adverse event|61
5527606|NCT01427309|19108351|P3|Overall Study|Serious adverse event|50
5527607|NCT01427309|19108352|P2|Overall Study|Serious adverse event|45
5527608|NCT01427309|19108353|P1|Overall Study|Serious adverse event|52
5527609|NCT01427309|19108350|P4|Overall Study|Adverse Event|1
5527610|NCT01427309|19108351|P3|Overall Study|Adverse Event|3
5527611|NCT01427309|19108352|P2|Overall Study|Adverse Event|0
5527612|NCT01427309|19108353|P1|Overall Study|Adverse Event|0
5527613|NCT01427309|19108350|P4|Overall Study|Protocol Violation|124
5527614|NCT01427309|19108351|P3|Overall Study|Protocol Violation|125
5527615|NCT01427309|19108352|P2|Overall Study|Protocol Violation|69
5527616|NCT01427309|19108353|P1|Overall Study|Protocol Violation|42
5527617|NCT01427309|19108350|P4|Overall Study|Lost to Follow-up|135
5527618|NCT01427309|19108351|P3|Overall Study|Lost to Follow-up|122
5527619|NCT01427309|19108352|P2|Overall Study|Lost to Follow-up|145
5527620|NCT01427309|19108353|P1|Overall Study|Lost to Follow-up|130
5527621|NCT01426958|19108400|P1|Overall Study|Adverse Event|2
5527622|NCT01426854|19108429|P2|Overall Study|Other|2
5527623|NCT01426854|19108430|P1|Overall Study|Other|3
5527624|NCT01426854|19108429|P2|Overall Study|Protocol Deviation|1
5527625|NCT01426854|19108430|P1|Overall Study|Protocol Deviation|0
5527626|NCT01426854|19108429|P2|Overall Study|Treatment Failure|16
5527627|NCT01426854|19108430|P1|Overall Study|Treatment Failure|0
5527628|NCT01426854|19108429|P2|Overall Study|Noncompliance|1
5527629|NCT01426854|19108430|P1|Overall Study|Noncompliance|0
5527630|NCT01426854|19108429|P2|Overall Study|Lost to Follow-up|0
5527631|NCT01426854|19108430|P1|Overall Study|Lost to Follow-up|3
5527632|NCT01426854|19108429|P2|Overall Study|Subject Decision Unrelated to AE|6
5527633|NCT01426854|19108430|P1|Overall Study|Subject Decision Unrelated to AE|5
5527634|NCT01426854|19108429|P2|Overall Study|Adverse Event|5
5527635|NCT01426854|19108430|P1|Overall Study|Adverse Event|1
5527636|NCT01426789|19108449|P6|Part 2|Adverse Event|0
5527637|NCT01426789|19108450|P5|Part 2|Adverse Event|1
5527638|NCT01426789|19108451|P4|Part 2|Adverse Event|0
5527639|NCT01426789|19108452|P3|Part 2|Adverse Event|2
5527640|NCT01426789|19108453|P2|Part 2|Adverse Event|0
5527641|NCT01426789|19108454|P1|Part 2|Adverse Event|0
5527642|NCT01426789|19108449|P6|Part 2|Lack of Efficacy|0
5527643|NCT01426789|19108450|P5|Part 2|Lack of Efficacy|2
5527644|NCT01426789|19108451|P4|Part 2|Lack of Efficacy|0
5527645|NCT01426789|19108452|P3|Part 2|Lack of Efficacy|5
5527646|NCT01426789|19108453|P2|Part 2|Lack of Efficacy|0
5527647|NCT01426789|19108454|P1|Part 2|Lack of Efficacy|0
5527648|NCT01426789|19108449|P6|Part 2|Withdrawal by Subject|0
5527649|NCT01426789|19108450|P5|Part 2|Withdrawal by Subject|2
5527650|NCT01426789|19108451|P4|Part 2|Withdrawal by Subject|1
5527651|NCT01426789|19108452|P3|Part 2|Withdrawal by Subject|0
5527652|NCT01426789|19108453|P2|Part 2|Withdrawal by Subject|0
5527653|NCT01426789|19108454|P1|Part 2|Withdrawal by Subject|0
5527654|NCT01426789|19108449|P6|Part 2|Lost to Follow-up|0
5527655|NCT01426789|19108450|P5|Part 2|Lost to Follow-up|1
5527656|NCT01426789|19108451|P4|Part 2|Lost to Follow-up|0
5527657|NCT01426789|19108452|P3|Part 2|Lost to Follow-up|4
5527658|NCT01426789|19108453|P2|Part 2|Lost to Follow-up|0
5527659|NCT01426789|19108454|P1|Part 2|Lost to Follow-up|0
5527660|NCT01426789|19108449|P6|Part 2|Administrative problems|0
5527661|NCT01426789|19108450|P5|Part 2|Administrative problems|1
5527662|NCT01426789|19108451|P4|Part 2|Administrative problems|0
5527663|NCT01426789|19108452|P3|Part 2|Administrative problems|2
5527664|NCT01426789|19108453|P2|Part 2|Administrative problems|0
5527665|NCT01426789|19108454|P1|Part 2|Administrative problems|0
5527666|NCT01426789|19108449|P6|Part 2|Death|0
5527667|NCT01426789|19108450|P5|Part 2|Death|1
5527668|NCT01426789|19108451|P4|Part 2|Death|0
5527669|NCT01426789|19108452|P3|Part 2|Death|1
5527670|NCT01426789|19108453|P2|Part 2|Death|0
5527671|NCT01426789|19108454|P1|Part 2|Death|0
5527672|NCT01426789|19108449|P6|Part 2|Protocol deviation|0
5527673|NCT01426789|19108450|P5|Part 2|Protocol deviation|0
5527674|NCT01426789|19108451|P4|Part 2|Protocol deviation|0
5527675|NCT01426789|19108452|P3|Part 2|Protocol deviation|1
5527676|NCT01426789|19108453|P2|Part 2|Protocol deviation|0
5527677|NCT01426789|19108454|P1|Part 2|Protocol deviation|0
5527678|NCT01426789|19108449|P6|Part 1|Adverse Event|0
5527679|NCT01426789|19108450|P5|Part 1|Adverse Event|0
5527680|NCT01426789|19108451|P4|Part 1|Adverse Event|0
5527681|NCT01426789|19108452|P3|Part 1|Adverse Event|0
5527682|NCT01426789|19108453|P2|Part 1|Adverse Event|0
5527683|NCT01426789|19108454|P1|Part 1|Adverse Event|3
5527684|NCT01426789|19108449|P6|Part 1|Lack of Efficacy|0
5527685|NCT01426789|19108450|P5|Part 1|Lack of Efficacy|0
5527686|NCT01426789|19108451|P4|Part 1|Lack of Efficacy|0
5527687|NCT01426789|19108452|P3|Part 1|Lack of Efficacy|0
5527688|NCT01426789|19108453|P2|Part 1|Lack of Efficacy|1
5527689|NCT01426789|19108454|P1|Part 1|Lack of Efficacy|2
5527690|NCT01426789|19108449|P6|Part 1|Lost to Follow-up|0
5527691|NCT01426789|19108450|P5|Part 1|Lost to Follow-up|0
5527692|NCT01426789|19108451|P4|Part 1|Lost to Follow-up|0
5527693|NCT01426789|19108452|P3|Part 1|Lost to Follow-up|0
5527694|NCT01426789|19108453|P2|Part 1|Lost to Follow-up|2
5527695|NCT01426789|19108454|P1|Part 1|Lost to Follow-up|1
5527696|NCT01426789|19108449|P6|Part 1|Protocol deviation|0
5527697|NCT01426789|19108450|P5|Part 1|Protocol deviation|0
5527698|NCT01426789|19108451|P4|Part 1|Protocol deviation|0
5527699|NCT01426789|19108452|P3|Part 1|Protocol deviation|0
5527700|NCT01426789|19108453|P2|Part 1|Protocol deviation|1
5527701|NCT01426789|19108454|P1|Part 1|Protocol deviation|0
5527702|NCT01426438|19108516|P2|Overall Study|Missed Scan|2
5527703|NCT01426438|19108517|P1|Overall Study|Missed Scan|2
5527704|NCT01426438|19108516|P2|Overall Study|Poor scan quality|2
5527705|NCT01426438|19108517|P1|Overall Study|Poor scan quality|3
5527706|NCT01426438|19108516|P2|Overall Study|Off study Treatment|3
5527707|NCT01426438|19108517|P1|Overall Study|Off study Treatment|9
5527708|NCT01426438|19108516|P2|Overall Study|Lost to Follow-up|3
5527709|NCT01426438|19108517|P1|Overall Study|Lost to Follow-up|1
5527710|NCT01426425|19108549|P1|Overall Study|Met inclusion/exclusion, not treated|2
5527711|NCT01426425|19108549|P1|Overall Study|Inclusion/exclusion criteria not met|151
5527712|NCT01426425|19108549|P1|Overall Study|Exited prior to EP study|22
5527713|NCT01426412|19108564|P9|Overall Study|Withdrawal by Subject|1
5527714|NCT01426412|19108565|P8|Overall Study|Withdrawal by Subject|3
5527715|NCT01426412|19108566|P7|Overall Study|Withdrawal by Subject|0
5527716|NCT01426412|19108567|P6|Overall Study|Withdrawal by Subject|0
5527717|NCT01426412|19108568|P5|Overall Study|Withdrawal by Subject|1
5527718|NCT01426412|19108569|P4|Overall Study|Withdrawal by Subject|0
5527719|NCT01426412|19108570|P3|Overall Study|Withdrawal by Subject|0
5527720|NCT01426412|19108571|P2|Overall Study|Withdrawal by Subject|0
5527721|NCT01426412|19108572|P1|Overall Study|Withdrawal by Subject|1
5527722|NCT01426386|19108635|P6|Overall Study|Personal reasons|0
5527723|NCT01426386|19108636|P5|Overall Study|Personal reasons|1
5527724|NCT01426386|19108637|P4|Overall Study|Personal reasons|0
5527725|NCT01426386|19108638|P3|Overall Study|Personal reasons|0
5527726|NCT01426386|19108639|P2|Overall Study|Personal reasons|0
5527727|NCT01426386|19108640|P1|Overall Study|Personal reasons|0
5527728|NCT01426386|19108635|P6|Overall Study|Poor response|0
5527729|NCT01426386|19108636|P5|Overall Study|Poor response|1
5527730|NCT01426386|19108637|P4|Overall Study|Poor response|0
5527731|NCT01426386|19108638|P3|Overall Study|Poor response|2
5527732|NCT01426386|19108639|P2|Overall Study|Poor response|1
5527733|NCT01426386|19108640|P1|Overall Study|Poor response|2
5527734|NCT01426386|19108635|P6|Overall Study|Did not attend scheduled visit|1
5527735|NCT01426386|19108636|P5|Overall Study|Did not attend scheduled visit|2
5527736|NCT01426386|19108637|P4|Overall Study|Did not attend scheduled visit|0
5527737|NCT01426386|19108638|P3|Overall Study|Did not attend scheduled visit|0
5527738|NCT01426386|19108639|P2|Overall Study|Did not attend scheduled visit|4
5527739|NCT01426386|19108640|P1|Overall Study|Did not attend scheduled visit|1
5527740|NCT01426386|19108635|P6|Overall Study|Adverse Event|0
5527741|NCT01426386|19108636|P5|Overall Study|Adverse Event|0
5527742|NCT01426386|19108637|P4|Overall Study|Adverse Event|0
5527743|NCT01426386|19108638|P3|Overall Study|Adverse Event|0
5527744|NCT01426386|19108639|P2|Overall Study|Adverse Event|1
5527745|NCT01426386|19108640|P1|Overall Study|Adverse Event|0
5527746|NCT01426373|19108696|P1|Overall Study|Miscellaneous Reasons|4
5527747|NCT01426373|19108696|P1|Overall Study|Participant Convenience|10
5527748|NCT01426373|19108696|P1|Overall Study|Lost to Follow-up|14
5527749|NCT01426373|19108696|P1|Overall Study|Adverse Event|6
5527750|NCT01426347|19108729|P2|Overall Study|Withdrawal by Subject|0
5527751|NCT01426347|19108730|P1|Overall Study|Withdrawal by Subject|5
5527752|NCT01426347|19108729|P2|Overall Study|Protocol Violation|0
5527753|NCT01426347|19108730|P1|Overall Study|Protocol Violation|2
5527754|NCT01426347|19108729|P2|Overall Study|Lost to Follow-up|3
5527755|NCT01426347|19108730|P1|Overall Study|Lost to Follow-up|0
5527756|NCT01426269|19108738|P3|Period 2: 40 Weeks|Relapsed|18
5527757|NCT01426269|19108739|P2|Period 2: 40 Weeks|Relapsed|9
5527758|NCT01426269|19108740|P1|Period 2: 40 Weeks|Relapsed|0
5527759|NCT01426269|19108738|P3|Period 2: 40 Weeks|Site closed|5
5527760|NCT01426269|19108739|P2|Period 2: 40 Weeks|Site closed|6
5527761|NCT01426269|19108740|P1|Period 2: 40 Weeks|Site closed|0
5527762|NCT01426269|19108738|P3|Period 2: 40 Weeks|Lost to Follow-up|6
5527763|NCT01426269|19108739|P2|Period 2: 40 Weeks|Lost to Follow-up|8
5527764|NCT01426269|19108740|P1|Period 2: 40 Weeks|Lost to Follow-up|0
5527765|NCT01426269|19108738|P3|Period 2: 40 Weeks|Protocol Violation|5
5527766|NCT01426269|19108739|P2|Period 2: 40 Weeks|Protocol Violation|5
5527767|NCT01426269|19108740|P1|Period 2: 40 Weeks|Protocol Violation|0
5527768|NCT01426269|19108738|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
5527769|NCT01426269|19108739|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
5527770|NCT01426269|19108740|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
5527771|NCT01426269|19108738|P3|Period 2: 40 Weeks|Adverse Event|2
5527772|NCT01426269|19108739|P2|Period 2: 40 Weeks|Adverse Event|1
5527773|NCT01426269|19108740|P1|Period 2: 40 Weeks|Adverse Event|0
5527774|NCT01426269|19108738|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
5527775|NCT01426269|19108739|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
5527776|NCT01426269|19108740|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
5527777|NCT01426269|19108738|P3|Eligibility for Period 2, Randomization|Did not qualify|0
5527778|NCT01426269|19108739|P2|Eligibility for Period 2, Randomization|Did not qualify|0
5527779|NCT01426269|19108740|P1|Eligibility for Period 2, Randomization|Did not qualify|42
5527780|NCT01426269|19108738|P3|Period 1: 12 Weeks|Pregnancy|0
5527781|NCT01426269|19108739|P2|Period 1: 12 Weeks|Pregnancy|0
5527782|NCT01426269|19108740|P1|Period 1: 12 Weeks|Pregnancy|1
5527783|NCT01426269|19108738|P3|Period 1: 12 Weeks|Lost to Follow-up|0
5527784|NCT01426269|19108739|P2|Period 1: 12 Weeks|Lost to Follow-up|0
5527785|NCT01426269|19108740|P1|Period 1: 12 Weeks|Lost to Follow-up|22
5527786|NCT01426269|19108738|P3|Period 1: 12 Weeks|Protocol Violation|0
5527787|NCT01426269|19108739|P2|Period 1: 12 Weeks|Protocol Violation|0
5527788|NCT01426269|19108740|P1|Period 1: 12 Weeks|Protocol Violation|5
5527789|NCT01426269|19108738|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
5527790|NCT01426269|19108739|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
5527791|NCT01426269|19108740|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
5527792|NCT01426269|19108738|P3|Period 1: 12 Weeks|Adverse Event|0
5527793|NCT01426269|19108739|P2|Period 1: 12 Weeks|Adverse Event|0
5527794|NCT01426269|19108740|P1|Period 1: 12 Weeks|Adverse Event|5
5527795|NCT01426217|19108775|P2|Overall Study|lost sample|14
5527796|NCT01426217|19108776|P1|Overall Study|lost sample|8
5527797|NCT01426113|19108789|P2|Overall Study|Adverse Event|1
5527798|NCT01426113|19108790|P1|Overall Study|Adverse Event|0
5527799|NCT01426113|19108789|P2|Overall Study|Study Discontinued|1
5527800|NCT01426113|19108790|P1|Overall Study|Study Discontinued|1
5527801|NCT01426009|19108796|P1|Washout 4|Lost to Follow-up|1
5527802|NCT01426009|19108796|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
5527803|NCT01426009|19108796|P1|Washout 3|personal reasons|1
5527804|NCT01426009|19108796|P1|Washout 2|electrive surgery|1
5527805|NCT01426009|19108796|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
5527806|NCT01426009|19108796|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
5527807|NCT01426009|19108796|P1|Washout 1|Personal Reasons|1
5527808|NCT01426009|19108796|P1|Washout 1|Withdrawal by Subject|1
5527809|NCT01426009|19108796|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
5527810|NCT01426009|19108796|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
5527811|NCT01425814|19108892|P6|Period 5|Stability criteria not fulfilled|1
5527812|NCT01425814|19108893|P5|Period 5|Stability criteria not fulfilled|0
5527813|NCT01425814|19108894|P4|Period 5|Stability criteria not fulfilled|0
5527814|NCT01425814|19108895|P3|Period 5|Stability criteria not fulfilled|1
5527815|NCT01425814|19108896|P2|Period 5|Stability criteria not fulfilled|0
5527816|NCT01425814|19108897|P1|Period 5|Stability criteria not fulfilled|0
5527817|NCT01425814|19108892|P6|Period 4|Adverse Event|0
5527818|NCT01425814|19108893|P5|Period 4|Adverse Event|0
5527819|NCT01425814|19108894|P4|Period 4|Adverse Event|0
5527820|NCT01425814|19108895|P3|Period 4|Adverse Event|1
5527821|NCT01425814|19108896|P2|Period 4|Adverse Event|0
5527822|NCT01425814|19108897|P1|Period 4|Adverse Event|1
5527823|NCT01425814|19108892|P6|Period 3|Adverse Event|1
5527824|NCT01425814|19108893|P5|Period 3|Adverse Event|0
5527825|NCT01425814|19108894|P4|Period 3|Adverse Event|0
5527826|NCT01425814|19108895|P3|Period 3|Adverse Event|0
5527827|NCT01425814|19108896|P2|Period 3|Adverse Event|0
5527828|NCT01425814|19108897|P1|Period 3|Adverse Event|0
5527829|NCT01425814|19108892|P6|Period 2|Stability criteria not fulfilled|0
5527830|NCT01425814|19108893|P5|Period 2|Stability criteria not fulfilled|0
5527831|NCT01425814|19108894|P4|Period 2|Stability criteria not fulfilled|0
5527832|NCT01425814|19108895|P3|Period 2|Stability criteria not fulfilled|0
5527833|NCT01425814|19108896|P2|Period 2|Stability criteria not fulfilled|1
5527834|NCT01425814|19108897|P1|Period 2|Stability criteria not fulfilled|0
5527835|NCT01425814|19108892|P6|Period 1|Stability criteria not fulfilled|0
5527836|NCT01425814|19108893|P5|Period 1|Stability criteria not fulfilled|0
5527837|NCT01425814|19108894|P4|Period 1|Stability criteria not fulfilled|0
5527838|NCT01425814|19108895|P3|Period 1|Stability criteria not fulfilled|0
5527839|NCT01425814|19108896|P2|Period 1|Stability criteria not fulfilled|1
5527840|NCT01425814|19108897|P1|Period 1|Stability criteria not fulfilled|0
5527841|NCT01425801|19108989|P6|Period 4|Not able to maintain visit schedule|0
5527842|NCT01425801|19108990|P5|Period 4|Not able to maintain visit schedule|0
5527843|NCT01425801|19108991|P4|Period 4|Not able to maintain visit schedule|0
5527844|NCT01425801|19108992|P3|Period 4|Not able to maintain visit schedule|1
5527845|NCT01425801|19108993|P2|Period 4|Not able to maintain visit schedule|0
5527846|NCT01425801|19108994|P1|Period 4|Not able to maintain visit schedule|0
5527847|NCT01425801|19108989|P6|Period 3|Stability criteria not fullfilled|0
5527848|NCT01425801|19108990|P5|Period 3|Stability criteria not fullfilled|0
5527849|NCT01425801|19108991|P4|Period 3|Stability criteria not fullfilled|0
5527850|NCT01425801|19108992|P3|Period 3|Stability criteria not fullfilled|1
5527851|NCT01425801|19108993|P2|Period 3|Stability criteria not fullfilled|0
5527852|NCT01425801|19108994|P1|Period 3|Stability criteria not fullfilled|0
5527853|NCT01425801|19108989|P6|Period 2|Withdrawal by Subject|0
5527854|NCT01425801|19108990|P5|Period 2|Withdrawal by Subject|1
5527855|NCT01425801|19108991|P4|Period 2|Withdrawal by Subject|0
5527856|NCT01425801|19108992|P3|Period 2|Withdrawal by Subject|0
5527857|NCT01425801|19108993|P2|Period 2|Withdrawal by Subject|0
5527858|NCT01425801|19108994|P1|Period 2|Withdrawal by Subject|0
5527859|NCT01425801|19108989|P6|Period 1|Withdrawal by Subject|0
5527860|NCT01425801|19108990|P5|Period 1|Withdrawal by Subject|1
5527861|NCT01425801|19108991|P4|Period 1|Withdrawal by Subject|0
5527862|NCT01425801|19108992|P3|Period 1|Withdrawal by Subject|0
5527863|NCT01425801|19108993|P2|Period 1|Withdrawal by Subject|0
5527864|NCT01425801|19108994|P1|Period 1|Withdrawal by Subject|0
5527865|NCT01425749|19109100|P2|Overall Study|progression of melanoma|1
5527866|NCT01425749|19109101|P1|Overall Study|progression of melanoma|0
5527867|NCT01425723|19109118|P2|Overall Study|Other|10
5527868|NCT01425723|19109119|P1|Overall Study|Other|1
5527869|NCT01425723|19109118|P2|Overall Study|Physician Decision|0
5527870|NCT01425723|19109119|P1|Overall Study|Physician Decision|2
5527871|NCT01425723|19109118|P2|Overall Study|Lost to Follow-up|3
5527872|NCT01425723|19109119|P1|Overall Study|Lost to Follow-up|0
5527873|NCT01425723|19109118|P2|Overall Study|Withdrawal by Subject|4
5527874|NCT01425723|19109119|P1|Overall Study|Withdrawal by Subject|1
5527875|NCT01425723|19109118|P2|Overall Study|Lack of Efficacy|1
5527876|NCT01425723|19109119|P1|Overall Study|Lack of Efficacy|0
5527877|NCT01425632|19109149|P3|Overall Study|Withdrawal by Subject|1
5527878|NCT01425632|19109150|P2|Overall Study|Withdrawal by Subject|0
5527879|NCT01425632|19109151|P1|Overall Study|Withdrawal by Subject|0
5527880|NCT01425632|19109149|P3|Overall Study|Protocol Violation|2
5527881|NCT01425632|19109150|P2|Overall Study|Protocol Violation|0
5527882|NCT01425632|19109151|P1|Overall Study|Protocol Violation|0
5527883|NCT01425632|19109149|P3|Overall Study|Physician Decision|0
5527884|NCT01425632|19109150|P2|Overall Study|Physician Decision|0
5527885|NCT01425632|19109151|P1|Overall Study|Physician Decision|1
5527886|NCT01425632|19109149|P3|Overall Study|Adverse Event|1
5527887|NCT01425632|19109150|P2|Overall Study|Adverse Event|1
5527888|NCT01425632|19109151|P1|Overall Study|Adverse Event|0
5527889|NCT01425528|19109161|P2|Overall Study|Withdrawal by Subject|1
5527890|NCT01425528|19109162|P1|Overall Study|Withdrawal by Subject|1
5527891|NCT01425463|19109170|P2|Overall Study|Unknown Reason|7
5527892|NCT01425463|19109171|P1|Overall Study|Unknown Reason|4
5527893|NCT01425463|19109170|P2|Overall Study|Withdrawal by Subject|5
5527894|NCT01425463|19109171|P1|Overall Study|Withdrawal by Subject|7
5527895|NCT01425463|19109170|P2|Overall Study|Lost to Follow-up|2
5527896|NCT01425463|19109171|P1|Overall Study|Lost to Follow-up|5
5527897|NCT01425463|19109170|P2|Overall Study|Protocol Violation|2
5527898|NCT01425463|19109171|P1|Overall Study|Protocol Violation|2
5527899|NCT01425463|19109170|P2|Overall Study|Lack of Efficacy|1
5527900|NCT01425463|19109171|P1|Overall Study|Lack of Efficacy|1
5527901|NCT01425463|19109170|P2|Overall Study|Adverse Event|7
5527902|NCT01425463|19109171|P1|Overall Study|Adverse Event|5
5527903|NCT01425359|19109187|P2|Overall Study|Did Not Meet Qualifying Criteria|5
5527904|NCT01425359|19109188|P1|Overall Study|Did Not Meet Qualifying Criteria|3
5527905|NCT01425359|19109187|P2|Overall Study|Investigator's Discretion|0
5527906|NCT01425359|19109188|P1|Overall Study|Investigator's Discretion|2
5527907|NCT01425359|19109187|P2|Overall Study|Subject Withdrew Consent|2
5527908|NCT01425359|19109188|P1|Overall Study|Subject Withdrew Consent|1
5527909|NCT01425359|19109187|P2|Overall Study|Protocol Violation|2
5527910|NCT01425359|19109188|P1|Overall Study|Protocol Violation|1
5527911|NCT01425359|19109187|P2|Overall Study|Unsatisfactory Response|0
5527912|NCT01425359|19109188|P1|Overall Study|Unsatisfactory Response|1
5527913|NCT01425359|19109187|P2|Overall Study|Death|1
5527914|NCT01425359|19109188|P1|Overall Study|Death|0
5527915|NCT01425359|19109187|P2|Overall Study|Revascularization|1
5527916|NCT01425359|19109188|P1|Overall Study|Revascularization|0
5527917|NCT01425359|19109187|P2|Overall Study|Adverse Event|8
5527918|NCT01425359|19109188|P1|Overall Study|Adverse Event|9
5527919|NCT01425359|19109187|P2|Overall Study|Randomized but Not Treated|3
5527920|NCT01425359|19109188|P1|Overall Study|Randomized but Not Treated|2
5527921|NCT01425281|19109219|P2|At 5-year Clinical Follow-up|Refused/terminated|3
5527922|NCT01425281|19109220|P1|At 5-year Clinical Follow-up|Refused/terminated|9
5527923|NCT01425281|19109219|P2|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
5527924|NCT01425281|19109220|P1|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
5527925|NCT01425281|19109219|P2|At 5-year Clinical Follow-up|Lost to Follow-up|1
5527926|NCT01425281|19109220|P1|At 5-year Clinical Follow-up|Lost to Follow-up|2
5527927|NCT01425281|19109219|P2|At 5-year Clinical Follow-up|Death|0
5527928|NCT01425281|19109220|P1|At 5-year Clinical Follow-up|Death|2
5527929|NCT01425281|19109219|P2|At 4-year Clinical Follow-up|Lost to Follow-up|1
5527930|NCT01425281|19109220|P1|At 4-year Clinical Follow-up|Lost to Follow-up|4
5527931|NCT01425281|19109219|P2|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
5527932|NCT01425281|19109220|P1|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
5527933|NCT01425281|19109219|P2|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
5527934|NCT01425281|19109220|P1|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
5527935|NCT01425281|19109219|P2|At 4-year Clinical Follow-up|Withdrawal by Subject|2
5527936|NCT01425281|19109220|P1|At 4-year Clinical Follow-up|Withdrawal by Subject|3
5527937|NCT01425281|19109219|P2|At 4-year Clinical Follow-up|Death|3
5527938|NCT01425281|19109220|P1|At 4-year Clinical Follow-up|Death|7
5527939|NCT01425281|19109219|P2|At 3-year Clinical Follow-up|Death|3
5527940|NCT01425281|19109220|P1|At 3-year Clinical Follow-up|Death|2
5527941|NCT01425281|19109219|P2|At 3-year Clinical Follow-up|Withdrawal by Subject|3
5527942|NCT01425281|19109220|P1|At 3-year Clinical Follow-up|Withdrawal by Subject|3
5527943|NCT01425281|19109219|P2|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
5527944|NCT01425281|19109220|P1|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
5527945|NCT01425281|19109219|P2|At 2-year Clinical Follow-up|Lost to Follow-up|0
5527946|NCT01425281|19109220|P1|At 2-year Clinical Follow-up|Lost to Follow-up|1
5527947|NCT01425281|19109219|P2|At 2-year Clinical Follow-up|Death|0
5527948|NCT01425281|19109220|P1|At 2-year Clinical Follow-up|Death|2
5527949|NCT01425281|19109219|P2|At 2-year Clinical Follow-up|Withdrawal by Subject|1
5527950|NCT01425281|19109220|P1|At 2-year Clinical Follow-up|Withdrawal by Subject|2
5527951|NCT01425281|19109219|P2|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
5527952|NCT01425281|19109220|P1|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
5527953|NCT01425281|19109219|P2|At 1-year Clinical Follow-up|Withdrawal by Subject|1
5527954|NCT01425281|19109220|P1|At 1-year Clinical Follow-up|Withdrawal by Subject|1
5527955|NCT01425281|19109219|P2|At 180-day Clinical Follow-up|Death|1
5527956|NCT01425281|19109220|P1|At 180-day Clinical Follow-up|Death|0
5527957|NCT01425281|19109219|P2|At 180-day Clinical Follow-up|Withdrawal by Subject|0
5527958|NCT01425281|19109220|P1|At 180-day Clinical Follow-up|Withdrawal by Subject|3
5527959|NCT01425281|19109219|P2|At 30-day Clinical Follow-up|Withdrawal by Subject|0
5527960|NCT01425281|19109220|P1|At 30-day Clinical Follow-up|Withdrawal by Subject|1
5527961|NCT01425268|19109438|P2|Overall Study|Physician Decision|0
5527962|NCT01425268|19109439|P1|Overall Study|Physician Decision|1
5527963|NCT01425268|19109438|P2|Overall Study|Sponsor Decision|0
5527964|NCT01425268|19109439|P1|Overall Study|Sponsor Decision|5
5527965|NCT01425268|19109438|P2|Overall Study|Withdrawal by Subject|0
5527966|NCT01425268|19109439|P1|Overall Study|Withdrawal by Subject|2
5527967|NCT01425203|19109460|P3|Crossover Phase|Other virologic failure criteria|3
5527968|NCT01425203|19109461|P2|Crossover Phase|Other virologic failure criteria|0
5527969|NCT01425203|19109462|P1|Crossover Phase|Other virologic failure criteria|0
5527970|NCT01425203|19109460|P3|Crossover Phase|Failure at futility timepoint|3
5527971|NCT01425203|19109461|P2|Crossover Phase|Failure at futility timepoint|0
5527972|NCT01425203|19109462|P1|Crossover Phase|Failure at futility timepoint|0
5527973|NCT01425203|19109460|P3|Treatment Phase|Did not receive treatment|0
5527974|NCT01425203|19109461|P2|Treatment Phase|Did not receive treatment|1
5527975|NCT01425203|19109462|P1|Treatment Phase|Did not receive treatment|0
5527976|NCT01425203|19109460|P3|Treatment Phase|Unidentified reasons|0
5527977|NCT01425203|19109461|P2|Treatment Phase|Unidentified reasons|5
5527978|NCT01425203|19109462|P1|Treatment Phase|Unidentified reasons|11
5527979|NCT01425203|19109460|P3|Treatment Phase|Other virologic failure criteria|0
5527980|NCT01425203|19109461|P2|Treatment Phase|Other virologic failure criteria|3
5527981|NCT01425203|19109462|P1|Treatment Phase|Other virologic failure criteria|5
5527982|NCT01425203|19109460|P3|Treatment Phase|Failure at futility timepoint|0
5527983|NCT01425203|19109461|P2|Treatment Phase|Failure at futility timepoint|27
5527984|NCT01425203|19109462|P1|Treatment Phase|Failure at futility timepoint|8
5527985|NCT01425203|19109460|P3|Treatment Phase|DC during PR Lead-in Phase|0
5527986|NCT01425203|19109461|P2|Treatment Phase|DC during PR Lead-in Phase|1
5527987|NCT01425203|19109462|P1|Treatment Phase|DC during PR Lead-in Phase|3
5527988|NCT01425190|19109479|P3|Overall Study|Full dose not consumed.|0
5527989|NCT01425190|19109480|P2|Overall Study|Full dose not consumed.|0
5527990|NCT01425190|19109481|P1|Overall Study|Full dose not consumed.|1
5527991|NCT01425008|19109517|P19|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
5527992|NCT01425008|19109518|P18|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5527993|NCT01425008|19109519|P17|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5527994|NCT01425008|19109520|P16|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5527995|NCT01425008|19109521|P15|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5527996|NCT01425008|19109522|P14|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5527997|NCT01425008|19109523|P13|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5527998|NCT01425008|19109524|P12|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5527999|NCT01425008|19109525|P11|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528000|NCT01425008|19109526|P10|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528001|NCT01425008|19109527|P9|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528002|NCT01425008|19109528|P8|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528003|NCT01425008|19109529|P7|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528004|NCT01425008|19109530|P6|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528005|NCT01425008|19109531|P5|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528006|NCT01425008|19109532|P4|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528007|NCT01425008|19109533|P3|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528008|NCT01425008|19109534|P2|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528009|NCT01425008|19109535|P1|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
5528010|NCT01425008|19109517|P19|Dose Expansion Phase|Lost to Follow-up|0
5528011|NCT01425008|19109518|P18|Dose Expansion Phase|Lost to Follow-up|0
5528012|NCT01425008|19109519|P17|Dose Expansion Phase|Lost to Follow-up|1
5528013|NCT01425008|19109520|P16|Dose Expansion Phase|Lost to Follow-up|0
5528014|NCT01425008|19109521|P15|Dose Expansion Phase|Lost to Follow-up|0
5528015|NCT01425008|19109522|P14|Dose Expansion Phase|Lost to Follow-up|0
5528016|NCT01425008|19109523|P13|Dose Expansion Phase|Lost to Follow-up|0
5528017|NCT01425008|19109524|P12|Dose Expansion Phase|Lost to Follow-up|0
5528018|NCT01425008|19109525|P11|Dose Expansion Phase|Lost to Follow-up|0
5528019|NCT01425008|19109526|P10|Dose Expansion Phase|Lost to Follow-up|0
5528020|NCT01425008|19109527|P9|Dose Expansion Phase|Lost to Follow-up|0
5528021|NCT01425008|19109528|P8|Dose Expansion Phase|Lost to Follow-up|0
5528022|NCT01425008|19109529|P7|Dose Expansion Phase|Lost to Follow-up|0
5528023|NCT01425008|19109530|P6|Dose Expansion Phase|Lost to Follow-up|0
5528024|NCT01425008|19109531|P5|Dose Expansion Phase|Lost to Follow-up|0
5528025|NCT01425008|19109532|P4|Dose Expansion Phase|Lost to Follow-up|0
5528026|NCT01425008|19109533|P3|Dose Expansion Phase|Lost to Follow-up|0
5528027|NCT01425008|19109534|P2|Dose Expansion Phase|Lost to Follow-up|0
5528028|NCT01425008|19109535|P1|Dose Expansion Phase|Lost to Follow-up|0
5528029|NCT01425008|19109517|P19|Dose Expansion Phase|Adverse Event|3
5528030|NCT01425008|19109518|P18|Dose Expansion Phase|Adverse Event|0
5528031|NCT01425008|19109519|P17|Dose Expansion Phase|Adverse Event|5
5528032|NCT01425008|19109520|P16|Dose Expansion Phase|Adverse Event|1
5528033|NCT01425008|19109521|P15|Dose Expansion Phase|Adverse Event|1
5528034|NCT01425008|19109522|P14|Dose Expansion Phase|Adverse Event|0
5528035|NCT01425008|19109523|P13|Dose Expansion Phase|Adverse Event|3
5528036|NCT01425008|19109524|P12|Dose Expansion Phase|Adverse Event|3
5528037|NCT01425008|19109525|P11|Dose Expansion Phase|Adverse Event|2
5528038|NCT01425008|19109526|P10|Dose Expansion Phase|Adverse Event|0
5528039|NCT01425008|19109527|P9|Dose Expansion Phase|Adverse Event|0
5528040|NCT01425008|19109528|P8|Dose Expansion Phase|Adverse Event|0
5528041|NCT01425008|19109529|P7|Dose Expansion Phase|Adverse Event|0
5528042|NCT01425008|19109530|P6|Dose Expansion Phase|Adverse Event|0
5528043|NCT01425008|19109531|P5|Dose Expansion Phase|Adverse Event|0
5528044|NCT01425008|19109532|P4|Dose Expansion Phase|Adverse Event|0
5528045|NCT01425008|19109533|P3|Dose Expansion Phase|Adverse Event|0
5528046|NCT01425008|19109534|P2|Dose Expansion Phase|Adverse Event|0
5528047|NCT01425008|19109535|P1|Dose Expansion Phase|Adverse Event|0
5528048|NCT01425008|19109517|P19|Dose Expansion Phase|Symptomatic Deterioration|1
5528049|NCT01425008|19109518|P18|Dose Expansion Phase|Symptomatic Deterioration|0
5528050|NCT01425008|19109519|P17|Dose Expansion Phase|Symptomatic Deterioration|2
5528051|NCT01425008|19109520|P16|Dose Expansion Phase|Symptomatic Deterioration|1
5528052|NCT01425008|19109521|P15|Dose Expansion Phase|Symptomatic Deterioration|0
5528053|NCT01425008|19109522|P14|Dose Expansion Phase|Symptomatic Deterioration|0
5528054|NCT01425008|19109523|P13|Dose Expansion Phase|Symptomatic Deterioration|0
5528055|NCT01425008|19109524|P12|Dose Expansion Phase|Symptomatic Deterioration|1
5528056|NCT01425008|19109525|P11|Dose Expansion Phase|Symptomatic Deterioration|2
5528057|NCT01425008|19109526|P10|Dose Expansion Phase|Symptomatic Deterioration|0
5528058|NCT01425008|19109527|P9|Dose Expansion Phase|Symptomatic Deterioration|0
5528059|NCT01425008|19109528|P8|Dose Expansion Phase|Symptomatic Deterioration|0
5528060|NCT01425008|19109529|P7|Dose Expansion Phase|Symptomatic Deterioration|0
5528061|NCT01425008|19109530|P6|Dose Expansion Phase|Symptomatic Deterioration|0
5528062|NCT01425008|19109531|P5|Dose Expansion Phase|Symptomatic Deterioration|0
5528063|NCT01425008|19109532|P4|Dose Expansion Phase|Symptomatic Deterioration|0
5528064|NCT01425008|19109533|P3|Dose Expansion Phase|Symptomatic Deterioration|0
5528065|NCT01425008|19109534|P2|Dose Expansion Phase|Symptomatic Deterioration|0
5528066|NCT01425008|19109535|P1|Dose Expansion Phase|Symptomatic Deterioration|0
5528067|NCT01425008|19109517|P19|Dose Expansion Phase|Other|4
5528068|NCT01425008|19109518|P18|Dose Expansion Phase|Other|0
5528069|NCT01425008|19109519|P17|Dose Expansion Phase|Other|2
5528070|NCT01425008|19109520|P16|Dose Expansion Phase|Other|0
5528071|NCT01425008|19109521|P15|Dose Expansion Phase|Other|0
5528072|NCT01425008|19109522|P14|Dose Expansion Phase|Other|0
5528073|NCT01425008|19109523|P13|Dose Expansion Phase|Other|1
5528074|NCT01425008|19109524|P12|Dose Expansion Phase|Other|0
5528075|NCT01425008|19109525|P11|Dose Expansion Phase|Other|0
5528076|NCT01425008|19109526|P10|Dose Expansion Phase|Other|0
5528077|NCT01425008|19109527|P9|Dose Expansion Phase|Other|0
5528078|NCT01425008|19109528|P8|Dose Expansion Phase|Other|0
5528079|NCT01425008|19109529|P7|Dose Expansion Phase|Other|0
5528080|NCT01425008|19109530|P6|Dose Expansion Phase|Other|0
5528081|NCT01425008|19109531|P5|Dose Expansion Phase|Other|0
5528082|NCT01425008|19109532|P4|Dose Expansion Phase|Other|0
5528083|NCT01425008|19109533|P3|Dose Expansion Phase|Other|0
5528084|NCT01425008|19109534|P2|Dose Expansion Phase|Other|0
5528085|NCT01425008|19109535|P1|Dose Expansion Phase|Other|0
5528086|NCT01425008|19109517|P19|Dose Expansion Phase|Withdrawal by Subject|0
5528087|NCT01425008|19109518|P18|Dose Expansion Phase|Withdrawal by Subject|0
5528088|NCT01425008|19109519|P17|Dose Expansion Phase|Withdrawal by Subject|1
5528089|NCT01425008|19109520|P16|Dose Expansion Phase|Withdrawal by Subject|1
5528090|NCT01425008|19109521|P15|Dose Expansion Phase|Withdrawal by Subject|0
5528091|NCT01425008|19109522|P14|Dose Expansion Phase|Withdrawal by Subject|0
5528092|NCT01425008|19109523|P13|Dose Expansion Phase|Withdrawal by Subject|0
5528093|NCT01425008|19109524|P12|Dose Expansion Phase|Withdrawal by Subject|0
5528094|NCT01425008|19109525|P11|Dose Expansion Phase|Withdrawal by Subject|1
5528095|NCT01425008|19109526|P10|Dose Expansion Phase|Withdrawal by Subject|0
5528096|NCT01425008|19109527|P9|Dose Expansion Phase|Withdrawal by Subject|0
5528097|NCT01425008|19109528|P8|Dose Expansion Phase|Withdrawal by Subject|0
5528098|NCT01425008|19109529|P7|Dose Expansion Phase|Withdrawal by Subject|0
5528099|NCT01425008|19109530|P6|Dose Expansion Phase|Withdrawal by Subject|0
5528100|NCT01425008|19109531|P5|Dose Expansion Phase|Withdrawal by Subject|0
5528101|NCT01425008|19109532|P4|Dose Expansion Phase|Withdrawal by Subject|0
5528102|NCT01425008|19109533|P3|Dose Expansion Phase|Withdrawal by Subject|0
5528103|NCT01425008|19109534|P2|Dose Expansion Phase|Withdrawal by Subject|0
5528104|NCT01425008|19109535|P1|Dose Expansion Phase|Withdrawal by Subject|0
5528105|NCT01425008|19109517|P19|Dose Expansion Phase|Progressive Disease|10
5528106|NCT01425008|19109518|P18|Dose Expansion Phase|Progressive Disease|2
5528107|NCT01425008|19109519|P17|Dose Expansion Phase|Progressive Disease|9
5528108|NCT01425008|19109520|P16|Dose Expansion Phase|Progressive Disease|8
5528109|NCT01425008|19109521|P15|Dose Expansion Phase|Progressive Disease|5
5528110|NCT01425008|19109522|P14|Dose Expansion Phase|Progressive Disease|1
5528111|NCT01425008|19109523|P13|Dose Expansion Phase|Progressive Disease|12
5528112|NCT01425008|19109524|P12|Dose Expansion Phase|Progressive Disease|4
5528113|NCT01425008|19109525|P11|Dose Expansion Phase|Progressive Disease|10
5528114|NCT01425008|19109526|P10|Dose Expansion Phase|Progressive Disease|0
5528115|NCT01425008|19109527|P9|Dose Expansion Phase|Progressive Disease|0
5528116|NCT01425008|19109528|P8|Dose Expansion Phase|Progressive Disease|0
5528117|NCT01425008|19109529|P7|Dose Expansion Phase|Progressive Disease|0
5528118|NCT01425008|19109530|P6|Dose Expansion Phase|Progressive Disease|0
5528119|NCT01425008|19109531|P5|Dose Expansion Phase|Progressive Disease|0
5528120|NCT01425008|19109532|P4|Dose Expansion Phase|Progressive Disease|0
5528121|NCT01425008|19109533|P3|Dose Expansion Phase|Progressive Disease|0
5528122|NCT01425008|19109534|P2|Dose Expansion Phase|Progressive Disease|0
5528123|NCT01425008|19109535|P1|Dose Expansion Phase|Progressive Disease|0
5528124|NCT01425008|19109517|P19|Dose Escalation Phase|Other|0
5528125|NCT01425008|19109518|P18|Dose Escalation Phase|Other|0
5528126|NCT01425008|19109519|P17|Dose Escalation Phase|Other|0
5528127|NCT01425008|19109520|P16|Dose Escalation Phase|Other|0
5528128|NCT01425008|19109521|P15|Dose Escalation Phase|Other|0
5528129|NCT01425008|19109522|P14|Dose Escalation Phase|Other|0
5528130|NCT01425008|19109523|P13|Dose Escalation Phase|Other|0
5528131|NCT01425008|19109524|P12|Dose Escalation Phase|Other|0
5528132|NCT01425008|19109525|P11|Dose Escalation Phase|Other|0
5528133|NCT01425008|19109526|P10|Dose Escalation Phase|Other|0
5528134|NCT01425008|19109527|P9|Dose Escalation Phase|Other|1
5528135|NCT01425008|19109528|P8|Dose Escalation Phase|Other|0
5528136|NCT01425008|19109529|P7|Dose Escalation Phase|Other|0
5528137|NCT01425008|19109530|P6|Dose Escalation Phase|Other|0
5528138|NCT01425008|19109531|P5|Dose Escalation Phase|Other|0
5528139|NCT01425008|19109532|P4|Dose Escalation Phase|Other|0
5528140|NCT01425008|19109533|P3|Dose Escalation Phase|Other|0
5528141|NCT01425008|19109534|P2|Dose Escalation Phase|Other|0
5528142|NCT01425008|19109535|P1|Dose Escalation Phase|Other|0
5528143|NCT01425008|19109517|P19|Dose Escalation Phase|Symptomatic Deterioration|0
5528144|NCT01425008|19109518|P18|Dose Escalation Phase|Symptomatic Deterioration|0
5528145|NCT01425008|19109519|P17|Dose Escalation Phase|Symptomatic Deterioration|0
5528146|NCT01425008|19109520|P16|Dose Escalation Phase|Symptomatic Deterioration|0
5528147|NCT01425008|19109521|P15|Dose Escalation Phase|Symptomatic Deterioration|0
5528148|NCT01425008|19109522|P14|Dose Escalation Phase|Symptomatic Deterioration|0
5528149|NCT01425008|19109523|P13|Dose Escalation Phase|Symptomatic Deterioration|0
5528150|NCT01425008|19109524|P12|Dose Escalation Phase|Symptomatic Deterioration|0
5528151|NCT01425008|19109525|P11|Dose Escalation Phase|Symptomatic Deterioration|0
5528152|NCT01425008|19109526|P10|Dose Escalation Phase|Symptomatic Deterioration|2
5528153|NCT01425008|19109527|P9|Dose Escalation Phase|Symptomatic Deterioration|2
5528154|NCT01425008|19109528|P8|Dose Escalation Phase|Symptomatic Deterioration|0
5528155|NCT01425008|19109529|P7|Dose Escalation Phase|Symptomatic Deterioration|0
5528156|NCT01425008|19109530|P6|Dose Escalation Phase|Symptomatic Deterioration|0
5528157|NCT01425008|19109531|P5|Dose Escalation Phase|Symptomatic Deterioration|0
5528158|NCT01425008|19109532|P4|Dose Escalation Phase|Symptomatic Deterioration|0
5528159|NCT01425008|19109533|P3|Dose Escalation Phase|Symptomatic Deterioration|1
5528160|NCT01425008|19109534|P2|Dose Escalation Phase|Symptomatic Deterioration|0
5528161|NCT01425008|19109535|P1|Dose Escalation Phase|Symptomatic Deterioration|0
5528162|NCT01425008|19109517|P19|Dose Escalation Phase|Withdrawal by Subject|0
5528163|NCT01425008|19109518|P18|Dose Escalation Phase|Withdrawal by Subject|0
5528164|NCT01425008|19109519|P17|Dose Escalation Phase|Withdrawal by Subject|0
5528165|NCT01425008|19109520|P16|Dose Escalation Phase|Withdrawal by Subject|0
5528166|NCT01425008|19109521|P15|Dose Escalation Phase|Withdrawal by Subject|0
5528167|NCT01425008|19109522|P14|Dose Escalation Phase|Withdrawal by Subject|0
5528168|NCT01425008|19109523|P13|Dose Escalation Phase|Withdrawal by Subject|0
5528169|NCT01425008|19109524|P12|Dose Escalation Phase|Withdrawal by Subject|0
5528170|NCT01425008|19109525|P11|Dose Escalation Phase|Withdrawal by Subject|0
5528171|NCT01425008|19109526|P10|Dose Escalation Phase|Withdrawal by Subject|0
5528172|NCT01425008|19109527|P9|Dose Escalation Phase|Withdrawal by Subject|1
5528173|NCT01425008|19109528|P8|Dose Escalation Phase|Withdrawal by Subject|0
5528174|NCT01425008|19109529|P7|Dose Escalation Phase|Withdrawal by Subject|1
5528175|NCT01425008|19109530|P6|Dose Escalation Phase|Withdrawal by Subject|1
5528176|NCT01425008|19109531|P5|Dose Escalation Phase|Withdrawal by Subject|1
5528177|NCT01425008|19109532|P4|Dose Escalation Phase|Withdrawal by Subject|0
5528178|NCT01425008|19109533|P3|Dose Escalation Phase|Withdrawal by Subject|0
5528179|NCT01425008|19109534|P2|Dose Escalation Phase|Withdrawal by Subject|0
5528180|NCT01425008|19109535|P1|Dose Escalation Phase|Withdrawal by Subject|0
5528181|NCT01425008|19109517|P19|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528182|NCT01425008|19109518|P18|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528183|NCT01425008|19109519|P17|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528184|NCT01425008|19109520|P16|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528185|NCT01425008|19109521|P15|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528186|NCT01425008|19109522|P14|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528187|NCT01425008|19109523|P13|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528188|NCT01425008|19109524|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528189|NCT01425008|19109525|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528190|NCT01425008|19109526|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528191|NCT01425008|19109527|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5528192|NCT01425008|19109528|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5528193|NCT01425008|19109529|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
5528194|NCT01425008|19109530|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528195|NCT01425008|19109531|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5528196|NCT01425008|19109532|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528197|NCT01425008|19109533|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528198|NCT01425008|19109534|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528199|NCT01425008|19109535|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5528200|NCT01425008|19109517|P19|Dose Escalation Phase|Adverse Event|0
5528201|NCT01425008|19109518|P18|Dose Escalation Phase|Adverse Event|0
5528202|NCT01425008|19109519|P17|Dose Escalation Phase|Adverse Event|0
5528203|NCT01425008|19109520|P16|Dose Escalation Phase|Adverse Event|0
5528204|NCT01425008|19109521|P15|Dose Escalation Phase|Adverse Event|0
5528205|NCT01425008|19109522|P14|Dose Escalation Phase|Adverse Event|0
5528206|NCT01425008|19109523|P13|Dose Escalation Phase|Adverse Event|0
5528207|NCT01425008|19109524|P12|Dose Escalation Phase|Adverse Event|0
5528208|NCT01425008|19109525|P11|Dose Escalation Phase|Adverse Event|0
5528209|NCT01425008|19109526|P10|Dose Escalation Phase|Adverse Event|0
5528210|NCT01425008|19109527|P9|Dose Escalation Phase|Adverse Event|2
5528211|NCT01425008|19109528|P8|Dose Escalation Phase|Adverse Event|0
5528212|NCT01425008|19109529|P7|Dose Escalation Phase|Adverse Event|0
5528213|NCT01425008|19109530|P6|Dose Escalation Phase|Adverse Event|2
5528214|NCT01425008|19109531|P5|Dose Escalation Phase|Adverse Event|0
5528215|NCT01425008|19109532|P4|Dose Escalation Phase|Adverse Event|0
5528216|NCT01425008|19109533|P3|Dose Escalation Phase|Adverse Event|0
5528217|NCT01425008|19109534|P2|Dose Escalation Phase|Adverse Event|0
5528218|NCT01425008|19109535|P1|Dose Escalation Phase|Adverse Event|2
5528219|NCT01425008|19109517|P19|Dose Escalation Phase|Progressive Disease|0
5528220|NCT01425008|19109518|P18|Dose Escalation Phase|Progressive Disease|0
5528221|NCT01425008|19109519|P17|Dose Escalation Phase|Progressive Disease|0
5528222|NCT01425008|19109520|P16|Dose Escalation Phase|Progressive Disease|0
5528223|NCT01425008|19109521|P15|Dose Escalation Phase|Progressive Disease|0
5528224|NCT01425008|19109522|P14|Dose Escalation Phase|Progressive Disease|0
5528225|NCT01425008|19109523|P13|Dose Escalation Phase|Progressive Disease|0
5528226|NCT01425008|19109524|P12|Dose Escalation Phase|Progressive Disease|0
5528227|NCT01425008|19109525|P11|Dose Escalation Phase|Progressive Disease|0
5528228|NCT01425008|19109526|P10|Dose Escalation Phase|Progressive Disease|2
5528229|NCT01425008|19109527|P9|Dose Escalation Phase|Progressive Disease|6
5528230|NCT01425008|19109528|P8|Dose Escalation Phase|Progressive Disease|2
5528231|NCT01425008|19109529|P7|Dose Escalation Phase|Progressive Disease|0
5528232|NCT01425008|19109530|P6|Dose Escalation Phase|Progressive Disease|4
5528233|NCT01425008|19109531|P5|Dose Escalation Phase|Progressive Disease|5
5528234|NCT01425008|19109532|P4|Dose Escalation Phase|Progressive Disease|3
5528235|NCT01425008|19109533|P3|Dose Escalation Phase|Progressive Disease|2
5528236|NCT01425008|19109534|P2|Dose Escalation Phase|Progressive Disease|3
5528237|NCT01425008|19109535|P1|Dose Escalation Phase|Progressive Disease|2
5528238|NCT01424930|19109838|P2|Overall Study|Reason not specified|6
5528239|NCT01424930|19109839|P1|Overall Study|Reason not specified|0
5528240|NCT01424930|19109838|P2|Overall Study|Screen Failure|1
5528241|NCT01424930|19109839|P1|Overall Study|Screen Failure|0
5528242|NCT01424930|19109838|P2|Overall Study|Progressive Disease|6
5528243|NCT01424930|19109839|P1|Overall Study|Progressive Disease|3
5528244|NCT01424930|19109838|P2|Overall Study|Death|0
5528245|NCT01424930|19109839|P1|Overall Study|Death|1
5528246|NCT01424930|19109838|P2|Overall Study|Adverse Event|1
5528247|NCT01424930|19109839|P1|Overall Study|Adverse Event|0
5528248|NCT01424813|19109853|P2|Overall Study|Other|2
5528249|NCT01424813|19109854|P1|Overall Study|Other|1
5528250|NCT01424813|19109853|P2|Overall Study|Protocol Violation|0
5528251|NCT01424813|19109854|P1|Overall Study|Protocol Violation|1
5528252|NCT01424813|19109853|P2|Overall Study|Withdrawal by Subject|0
5528253|NCT01424813|19109854|P1|Overall Study|Withdrawal by Subject|3
5528254|NCT01424670|19109874|P2|Continuation Period|Withdrawal by Subject|4
5528255|NCT01424670|19109875|P1|Continuation Period|Withdrawal by Subject|13
5528256|NCT01424670|19109874|P2|Continuation Period|Physician Decision|4
5528257|NCT01424670|19109875|P1|Continuation Period|Physician Decision|5
5528258|NCT01424670|19109874|P2|Continuation Period|Met Protocol Withdrawal Criteria|1
5528259|NCT01424670|19109875|P1|Continuation Period|Met Protocol Withdrawal Criteria|1
5528260|NCT01424670|19109874|P2|Continuation Period|Lost to Follow-up|0
5528261|NCT01424670|19109875|P1|Continuation Period|Lost to Follow-up|2
5528262|NCT01424670|19109874|P2|Continuation Period|Adverse Event|5
5528263|NCT01424670|19109875|P1|Continuation Period|Adverse Event|13
5528264|NCT01424670|19109874|P2|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
5528265|NCT01424670|19109875|P1|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
5528266|NCT01424670|19109874|P2|6-Month Intensive Period (182 Days)|Physician Decision|3
5528267|NCT01424670|19109875|P1|6-Month Intensive Period (182 Days)|Physician Decision|2
5528268|NCT01424670|19109874|P2|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
5528269|NCT01424670|19109875|P1|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
5528270|NCT01424670|19109874|P2|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
5528271|NCT01424670|19109875|P1|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
5528272|NCT01424670|19109874|P2|6-Month Intensive Period (182 Days)|Adverse Event|2
5528273|NCT01424670|19109875|P1|6-Month Intensive Period (182 Days)|Adverse Event|2
5528274|NCT01424644|19109897|P2|Overall Study|Unable to Classify|0
5528275|NCT01424644|19109898|P1|Overall Study|Unable to Classify|1
5528276|NCT01424644|19109897|P2|Overall Study|Administrative Reason|0
5528277|NCT01424644|19109898|P1|Overall Study|Administrative Reason|1
5528278|NCT01424644|19109897|P2|Overall Study|Protocol Violation|3
5528279|NCT01424644|19109898|P1|Overall Study|Protocol Violation|4
5528280|NCT01424644|19109897|P2|Overall Study|Lost to Follow-up|12
5528281|NCT01424644|19109898|P1|Overall Study|Lost to Follow-up|16
5528282|NCT01424644|19109897|P2|Overall Study|Withdrawal by Subject|12
5528283|NCT01424644|19109898|P1|Overall Study|Withdrawal by Subject|9
5528284|NCT01424644|19109897|P2|Overall Study|Adverse Event|0
5528285|NCT01424644|19109898|P1|Overall Study|Adverse Event|2
5528286|NCT01424566|19109912|P3|Double-blind Treatment|Lack of Efficacy|1
5528287|NCT01424566|19109913|P2|Double-blind Treatment|Lack of Efficacy|1
5528288|NCT01424566|19109914|P1|Double-blind Treatment|Lack of Efficacy|0
5528289|NCT01424566|19109912|P3|Double-blind Treatment|Withdrawal by Investigator|1
5528290|NCT01424566|19109913|P2|Double-blind Treatment|Withdrawal by Investigator|1
5528291|NCT01424566|19109914|P1|Double-blind Treatment|Withdrawal by Investigator|0
5528292|NCT01424566|19109912|P3|Double-blind Treatment|Withdrawal by Subject|0
5528293|NCT01424566|19109913|P2|Double-blind Treatment|Withdrawal by Subject|2
5528294|NCT01424566|19109914|P1|Double-blind Treatment|Withdrawal by Subject|0
5528295|NCT01424566|19109912|P3|Double-blind Treatment|Adverse Event|13
5528296|NCT01424566|19109913|P2|Double-blind Treatment|Adverse Event|21
5528297|NCT01424566|19109914|P1|Double-blind Treatment|Adverse Event|0
5528298|NCT01424566|19109912|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
5528299|NCT01424566|19109913|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
5528300|NCT01424566|19109914|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
5528301|NCT01424566|19109912|P3|Single-blind Treatment|Met Exclusion Criteria|0
5528302|NCT01424566|19109913|P2|Single-blind Treatment|Met Exclusion Criteria|0
5528303|NCT01424566|19109914|P1|Single-blind Treatment|Met Exclusion Criteria|1
5528304|NCT01424566|19109912|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
5528305|NCT01424566|19109913|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
5528306|NCT01424566|19109914|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
5528307|NCT01424566|19109912|P3|Single-blind Treatment|Withdrawal by Investigator|0
5528308|NCT01424566|19109913|P2|Single-blind Treatment|Withdrawal by Investigator|0
5528309|NCT01424566|19109914|P1|Single-blind Treatment|Withdrawal by Investigator|2
5528310|NCT01424566|19109912|P3|Single-blind Treatment|Withdrawal by Subject|0
5528311|NCT01424566|19109913|P2|Single-blind Treatment|Withdrawal by Subject|0
5528312|NCT01424566|19109914|P1|Single-blind Treatment|Withdrawal by Subject|16
5528313|NCT01424566|19109912|P3|Single-blind Treatment|Adverse Event|0
5528314|NCT01424566|19109913|P2|Single-blind Treatment|Adverse Event|0
5528315|NCT01424566|19109914|P1|Single-blind Treatment|Adverse Event|71
5528316|NCT01424514|19109941|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
5528317|NCT01424514|19109942|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
5528318|NCT01424514|19109941|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
5528319|NCT01424514|19109942|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
5528320|NCT01424501|19109987|P6|Overall Study|Lost to Follow-up|0
5528321|NCT01424501|19109988|P5|Overall Study|Lost to Follow-up|0
5528322|NCT01424501|19109989|P4|Overall Study|Lost to Follow-up|0
5528323|NCT01424501|19109990|P3|Overall Study|Lost to Follow-up|1
5528324|NCT01424501|19109991|P2|Overall Study|Lost to Follow-up|1
5528325|NCT01424501|19109992|P1|Overall Study|Lost to Follow-up|0
5528326|NCT01424501|19109987|P6|Overall Study|Withdrawal by Subject|0
5528327|NCT01424501|19109988|P5|Overall Study|Withdrawal by Subject|0
5528328|NCT01424501|19109989|P4|Overall Study|Withdrawal by Subject|0
5528329|NCT01424501|19109990|P3|Overall Study|Withdrawal by Subject|1
5528330|NCT01424501|19109991|P2|Overall Study|Withdrawal by Subject|0
5528331|NCT01424501|19109992|P1|Overall Study|Withdrawal by Subject|1
5528332|NCT01424397|19110168|P12|Period-2 (8 Days)|Withdrawal by Subject|0
5528333|NCT01424397|19110169|P11|Period-2 (8 Days)|Withdrawal by Subject|0
5528334|NCT01424397|19110170|P10|Period-2 (8 Days)|Withdrawal by Subject|0
5528335|NCT01424397|19110171|P9|Period-2 (8 Days)|Withdrawal by Subject|0
5528336|NCT01424397|19110172|P8|Period-2 (8 Days)|Withdrawal by Subject|0
5528337|NCT01424397|19110173|P7|Period-2 (8 Days)|Withdrawal by Subject|0
5528338|NCT01424397|19110174|P6|Period-2 (8 Days)|Withdrawal by Subject|0
5528339|NCT01424397|19110175|P5|Period-2 (8 Days)|Withdrawal by Subject|0
5528340|NCT01424397|19110176|P4|Period-2 (8 Days)|Withdrawal by Subject|0
5528341|NCT01424397|19110177|P3|Period-2 (8 Days)|Withdrawal by Subject|1
5528342|NCT01424397|19110178|P2|Period-2 (8 Days)|Withdrawal by Subject|0
5528343|NCT01424397|19110179|P1|Period-2 (8 Days)|Withdrawal by Subject|0
5528344|NCT01424306|19110225|P6|Overall Study|Protocol Violation|0
5528345|NCT01424306|19110226|P5|Overall Study|Protocol Violation|1
5528346|NCT01424306|19110227|P4|Overall Study|Protocol Violation|0
5528347|NCT01424306|19110228|P3|Overall Study|Protocol Violation|0
5528348|NCT01424306|19110229|P2|Overall Study|Protocol Violation|0
5528349|NCT01424306|19110230|P1|Overall Study|Protocol Violation|0
5528350|NCT01424228|19110279|P2|Overall Study|Unplanned journey|1
5528351|NCT01424228|19110280|P1|Overall Study|Unplanned journey|0
5528352|NCT01424228|19110279|P2|Overall Study|Worsening of symptoms|0
5528353|NCT01424228|19110280|P1|Overall Study|Worsening of symptoms|1
5528354|NCT01424228|19110279|P2|Overall Study|Non-compliance|0
5528355|NCT01424228|19110280|P1|Overall Study|Non-compliance|2
5528356|NCT01424228|19110279|P2|Overall Study|inclusion/exclusion criteria not met|2
5528357|NCT01424228|19110280|P1|Overall Study|inclusion/exclusion criteria not met|2
5528358|NCT01424228|19110279|P2|Overall Study|Lack of Efficacy|7
5528359|NCT01424228|19110280|P1|Overall Study|Lack of Efficacy|5
5528360|NCT01424228|19110279|P2|Overall Study|Sponsor's decision|12
5528361|NCT01424228|19110280|P1|Overall Study|Sponsor's decision|9
5528362|NCT01424228|19110279|P2|Overall Study|Adverse Event|14
5528363|NCT01424228|19110280|P1|Overall Study|Adverse Event|10
5528364|NCT01424228|19110279|P2|Overall Study|Withdrawal by Subject|11
5528365|NCT01424228|19110280|P1|Overall Study|Withdrawal by Subject|27
5528366|NCT01424189|19110331|P2|Overall Study|Death|1
5528367|NCT01424189|19110332|P1|Overall Study|Death|3
5528368|NCT01424189|19110331|P2|Overall Study|Subject moved|0
5528369|NCT01424189|19110332|P1|Overall Study|Subject moved|1
5528370|NCT01424189|19110331|P2|Overall Study|Withdrawal by Subject|4
5528371|NCT01424189|19110332|P1|Overall Study|Withdrawal by Subject|4
5528372|NCT01424189|19110331|P2|Overall Study|Lost to Follow-up|1
5528373|NCT01424189|19110332|P1|Overall Study|Lost to Follow-up|4
5528374|NCT01424189|19110331|P2|Overall Study|Adverse Event|0
5528375|NCT01424189|19110332|P1|Overall Study|Adverse Event|1
5528376|NCT01423916|19110373|P3|Overall Study|Protocol Deviation|0
5528377|NCT01423916|19110374|P2|Overall Study|Protocol Deviation|0
5528378|NCT01423916|19110375|P1|Overall Study|Protocol Deviation|1
5528379|NCT01423916|19110373|P3|Overall Study|Withdrawal by Subject|3
5528380|NCT01423916|19110374|P2|Overall Study|Withdrawal by Subject|10
5528381|NCT01423916|19110375|P1|Overall Study|Withdrawal by Subject|3
5528382|NCT01423916|19110373|P3|Overall Study|Physician Decision|1
5528383|NCT01423916|19110374|P2|Overall Study|Physician Decision|0
5528384|NCT01423916|19110375|P1|Overall Study|Physician Decision|1
5528385|NCT01423916|19110373|P3|Overall Study|Met Withdrawal Criteria|1
5528386|NCT01423916|19110374|P2|Overall Study|Met Withdrawal Criteria|1
5528387|NCT01423916|19110375|P1|Overall Study|Met Withdrawal Criteria|1
5528388|NCT01423916|19110373|P3|Overall Study|Adverse Event|2
5528389|NCT01423916|19110374|P2|Overall Study|Adverse Event|9
5528390|NCT01423916|19110375|P1|Overall Study|Adverse Event|5
5528391|NCT01423812|19110431|P2|Overall Study|Withdrawal by Subject|2
5528392|NCT01423812|19110432|P1|Overall Study|Withdrawal by Subject|1
5528393|NCT01423812|19110431|P2|Overall Study|Lost to Follow-up|2
5528394|NCT01423812|19110432|P1|Overall Study|Lost to Follow-up|2
5528395|NCT01423617|19110460|P2|Overall Study|Lost to Follow-up|1
5528396|NCT01423617|19110461|P1|Overall Study|Lost to Follow-up|0
5528397|NCT01423604|19110478|P2|Randomized|Patient decision|9
5528398|NCT01423604|19110479|P1|Randomized|Patient decision|5
5528399|NCT01423604|19110478|P2|Randomized|Other - unspecified|31
5528400|NCT01423604|19110479|P1|Randomized|Other - unspecified|37
5528401|NCT01423604|19110478|P2|Randomized|Physician Decision|13
5528402|NCT01423604|19110479|P1|Randomized|Physician Decision|16
5528403|NCT01423604|19110478|P2|Randomized|Death|0
5528404|NCT01423604|19110479|P1|Randomized|Death|1
5528405|NCT01423604|19110478|P2|Randomized|Adverse Event|10
5528406|NCT01423604|19110479|P1|Randomized|Adverse Event|4
5528407|NCT01423604|19110478|P2|Safety Run-In|Patient decision|0
5528408|NCT01423604|19110479|P1|Safety Run-In|Patient decision|1
5528409|NCT01423604|19110478|P2|Safety Run-In|Disease progression|0
5528410|NCT01423604|19110479|P1|Safety Run-In|Disease progression|3
5528411|NCT01423604|19110478|P2|Safety Run-In|Physician Decision|0
5528412|NCT01423604|19110479|P1|Safety Run-In|Physician Decision|1
5528413|NCT01423604|19110478|P2|Safety Run-In|Death|0
5528414|NCT01423604|19110479|P1|Safety Run-In|Death|1
5528415|NCT01423604|19110478|P2|Safety Run-In|Adverse Event|0
5528416|NCT01423604|19110479|P1|Safety Run-In|Adverse Event|3
5528417|NCT01423253|19110494|P1|Overall Study|Withdrawal by Subject|2
5528418|NCT01423253|19110494|P1|Overall Study|Protocol Violation|2
5528419|NCT01423253|19110494|P1|Overall Study|Lost to Follow-up|1
5528420|NCT01423253|19110494|P1|Overall Study|Lack of Efficacy|2
5528421|NCT01423253|19110494|P1|Overall Study|Adverse Event|2
5528422|NCT01423084|19110516|P2|Overall Study|Withdrawal by Subject|3
5528423|NCT01423084|19110517|P1|Overall Study|Withdrawal by Subject|2
5528424|NCT01423084|19110516|P2|Overall Study|Adverse Event|1
5528425|NCT01423084|19110517|P1|Overall Study|Adverse Event|0
5528426|NCT01422915|19110547|P1|Overall Study|Adverse Event|1
5528427|NCT01422889|19110552|P1|Overall Study|No Data Entered for Study Stent|9
5528428|NCT01422876|19110567|P10|Week 52|Death|0
5528429|NCT01422876|19110568|P9|Week 52|Death|1
5528430|NCT01422876|19110569|P8|Week 52|Death|3
5528431|NCT01422876|19110570|P7|Week 52|Death|1
5528432|NCT01422876|19110571|P6|Week 52|Death|0
5528433|NCT01422876|19110572|P5|Week 52|Death|0
5528434|NCT01422876|19110573|P4|Week 52|Death|1
5528435|NCT01422876|19110574|P3|Week 52|Death|0
5528436|NCT01422876|19110575|P2|Week 52|Death|1
5528437|NCT01422876|19110576|P1|Week 52|Death|0
5528438|NCT01422876|19110567|P10|Week 52|Consent withdrawn|9
5528439|NCT01422876|19110568|P9|Week 52|Consent withdrawn|13
5528440|NCT01422876|19110569|P8|Week 52|Consent withdrawn|12
5528441|NCT01422876|19110570|P7|Week 52|Consent withdrawn|10
5528442|NCT01422876|19110571|P6|Week 52|Consent withdrawn|12
5528443|NCT01422876|19110572|P5|Week 52|Consent withdrawn|7
5528444|NCT01422876|19110573|P4|Week 52|Consent withdrawn|12
5528445|NCT01422876|19110574|P3|Week 52|Consent withdrawn|6
5528446|NCT01422876|19110575|P2|Week 52|Consent withdrawn|4
5528447|NCT01422876|19110576|P1|Week 52|Consent withdrawn|9
5528448|NCT01422876|19110567|P10|Week 52|Lost to Follow-up|8
5528449|NCT01422876|19110568|P9|Week 52|Lost to Follow-up|7
5528450|NCT01422876|19110569|P8|Week 52|Lost to Follow-up|8
5528451|NCT01422876|19110570|P7|Week 52|Lost to Follow-up|5
5528452|NCT01422876|19110571|P6|Week 52|Lost to Follow-up|5
5528453|NCT01422876|19110572|P5|Week 52|Lost to Follow-up|8
5528454|NCT01422876|19110573|P4|Week 52|Lost to Follow-up|5
5528455|NCT01422876|19110574|P3|Week 52|Lost to Follow-up|7
5528456|NCT01422876|19110575|P2|Week 52|Lost to Follow-up|5
5528457|NCT01422876|19110576|P1|Week 52|Lost to Follow-up|3
5528458|NCT01422876|19110567|P10|Week 24|Death|0
5528459|NCT01422876|19110568|P9|Week 24|Death|0
5528460|NCT01422876|19110569|P8|Week 24|Death|0
5528461|NCT01422876|19110570|P7|Week 24|Death|0
5528462|NCT01422876|19110571|P6|Week 24|Death|0
5528463|NCT01422876|19110572|P5|Week 24|Death|0
5528464|NCT01422876|19110573|P4|Week 24|Death|0
5528465|NCT01422876|19110574|P3|Week 24|Death|0
5528466|NCT01422876|19110575|P2|Week 24|Death|1
5528467|NCT01422876|19110576|P1|Week 24|Death|0
5528468|NCT01422876|19110567|P10|Week 24|Consent withdrawn|6
5528469|NCT01422876|19110568|P9|Week 24|Consent withdrawn|3
5528470|NCT01422876|19110569|P8|Week 24|Consent withdrawn|4
5528471|NCT01422876|19110570|P7|Week 24|Consent withdrawn|5
5528472|NCT01422876|19110571|P6|Week 24|Consent withdrawn|6
5528473|NCT01422876|19110572|P5|Week 24|Consent withdrawn|5
5528474|NCT01422876|19110573|P4|Week 24|Consent withdrawn|4
5528475|NCT01422876|19110574|P3|Week 24|Consent withdrawn|3
5528476|NCT01422876|19110575|P2|Week 24|Consent withdrawn|1
5528477|NCT01422876|19110576|P1|Week 24|Consent withdrawn|5
5528478|NCT01422876|19110567|P10|Week 24|Lost to Follow-up|4
5528479|NCT01422876|19110568|P9|Week 24|Lost to Follow-up|3
5528480|NCT01422876|19110569|P8|Week 24|Lost to Follow-up|3
5528481|NCT01422876|19110570|P7|Week 24|Lost to Follow-up|1
5528482|NCT01422876|19110571|P6|Week 24|Lost to Follow-up|0
5528483|NCT01422876|19110572|P5|Week 24|Lost to Follow-up|2
5528484|NCT01422876|19110573|P4|Week 24|Lost to Follow-up|4
5528485|NCT01422876|19110574|P3|Week 24|Lost to Follow-up|2
5528486|NCT01422876|19110575|P2|Week 24|Lost to Follow-up|1
5528487|NCT01422876|19110576|P1|Week 24|Lost to Follow-up|1
5528488|NCT01422850|19110623|P1|Overall Study|Physician Decision|3
5528489|NCT01422824|19110629|P1|Overall Study|Lost to Follow-up|37
5528490|NCT01422824|19110629|P1|Overall Study|Case record form not evaluated|1
5528491|NCT01422720|19110634|P1|Overall Study|Ineligibility|1
5528492|NCT01422720|19110634|P1|Overall Study|Withdrawal by Subject|4
5528493|NCT01422720|19110634|P1|Overall Study|Lack of Efficacy|1
5528494|NCT01422720|19110634|P1|Overall Study|Adverse Event|16
5528495|NCT01422538|19110645|P3|Overall Study|Missed visit|1
5528496|NCT01422538|19110646|P2|Overall Study|Missed visit|1
5528497|NCT01422538|19110647|P1|Overall Study|Missed visit|0
5528498|NCT01422538|19110645|P3|Overall Study|Lost to Follow-up|1
5528499|NCT01422538|19110646|P2|Overall Study|Lost to Follow-up|1
5528500|NCT01422538|19110647|P1|Overall Study|Lost to Follow-up|0
5528501|NCT01422408|19110691|P1|Overall Study|Withdrawal by Subject|3
5528502|NCT01422408|19110691|P1|Overall Study|Adverse Event|1
5528503|NCT01422382|19110720|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
5528504|NCT01422304|19110736|P2|Overall Study|Not Treated|11
5528505|NCT01422304|19110737|P1|Overall Study|Not Treated|3
5528506|NCT01422304|19110736|P2|Overall Study|Did Not Meet Protocol Eligibility|2
5528507|NCT01422304|19110737|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5528508|NCT01422304|19110736|P2|Overall Study|Withdrawal by Subject|2
5528509|NCT01422304|19110737|P1|Overall Study|Withdrawal by Subject|4
5528510|NCT01422304|19110736|P2|Overall Study|Protocol Violation|0
5528511|NCT01422304|19110737|P1|Overall Study|Protocol Violation|1
5528512|NCT01422304|19110736|P2|Overall Study|Never Entered Follow-up|1
5528513|NCT01422304|19110737|P1|Overall Study|Never Entered Follow-up|2
5528514|NCT01422304|19110736|P2|Overall Study|Lost to Follow-up|20
5528515|NCT01422304|19110737|P1|Overall Study|Lost to Follow-up|14
5528516|NCT01422304|19110736|P2|Overall Study|Adverse Event|1
5528517|NCT01422304|19110737|P1|Overall Study|Adverse Event|0
5528518|NCT01422239|19110769|P2|Overall Study|Lost to Follow-up|3
5528519|NCT01422239|19110770|P1|Overall Study|Lost to Follow-up|4
5528520|NCT01422213|19110792|P3|Overall Study|Administrative or Other Reason(s)|2
5528521|NCT01422213|19110793|P2|Overall Study|Administrative or Other Reason(s)|4
5528522|NCT01422213|19110794|P1|Overall Study|Administrative or Other Reason(s)|5
5528523|NCT01422213|19110792|P3|Overall Study|Lost to Follow-up|5
5528524|NCT01422213|19110793|P2|Overall Study|Lost to Follow-up|3
5528525|NCT01422213|19110794|P1|Overall Study|Lost to Follow-up|3
5528526|NCT01422213|19110792|P3|Overall Study|Withdrawal of Consent|5
5528527|NCT01422213|19110793|P2|Overall Study|Withdrawal of Consent|3
5528528|NCT01422213|19110794|P1|Overall Study|Withdrawal of Consent|7
5528529|NCT01422213|19110792|P3|Overall Study|Protocol Violation|4
5528530|NCT01422213|19110793|P2|Overall Study|Protocol Violation|2
5528531|NCT01422213|19110794|P1|Overall Study|Protocol Violation|0
5528532|NCT01422213|19110792|P3|Overall Study|Non-compliance with study drug|0
5528533|NCT01422213|19110793|P2|Overall Study|Non-compliance with study drug|1
5528534|NCT01422213|19110794|P1|Overall Study|Non-compliance with study drug|0
5528535|NCT01422213|19110792|P3|Overall Study|Lack of Efficacy|2
5528536|NCT01422213|19110793|P2|Overall Study|Lack of Efficacy|2
5528537|NCT01422213|19110794|P1|Overall Study|Lack of Efficacy|10
5528538|NCT01422213|19110792|P3|Overall Study|Adverse Event|11
5528539|NCT01422213|19110793|P2|Overall Study|Adverse Event|7
5528540|NCT01422213|19110794|P1|Overall Study|Adverse Event|8
5528541|NCT01422187|19110866|P3|Overall Study|Lost to Follow-up|0
5528542|NCT01422187|19110867|P2|Overall Study|Lost to Follow-up|1
5528543|NCT01422187|19110868|P1|Overall Study|Lost to Follow-up|0
5528544|NCT01422187|19110866|P3|Overall Study|Personal reason|0
5528545|NCT01422187|19110867|P2|Overall Study|Personal reason|0
5528546|NCT01422187|19110868|P1|Overall Study|Personal reason|1
5528547|NCT01421719|19110932|P1|Overall Study|Withdrawal by Subject|4
5528548|NCT01421667|19110941|P4|Overall Study|Lost to Follow-up|0
5528549|NCT01421667|19110942|P3|Overall Study|Lost to Follow-up|0
5528550|NCT01421667|19110943|P2|Overall Study|Lost to Follow-up|1
5528551|NCT01421667|19110944|P1|Overall Study|Lost to Follow-up|0
5528552|NCT01421667|19110941|P4|Overall Study|Withdrawal by Subject|1
5528553|NCT01421667|19110942|P3|Overall Study|Withdrawal by Subject|2
5528554|NCT01421667|19110943|P2|Overall Study|Withdrawal by Subject|1
5528555|NCT01421667|19110944|P1|Overall Study|Withdrawal by Subject|0
5528556|NCT01421641|19111005|P2|Overall Study|Protocol Violation|2
5528557|NCT01421641|19111006|P1|Overall Study|Protocol Violation|2
5528558|NCT01421511|19111028|P2|Overall Study|Death|1
5528559|NCT01421511|19111029|P1|Overall Study|Death|1
5528560|NCT01421511|19111028|P2|Overall Study|Withdrawal by Subject|5
5528561|NCT01421511|19111029|P1|Overall Study|Withdrawal by Subject|6
5528562|NCT01421511|19111028|P2|Overall Study|Physician Decision|1
5528563|NCT01421511|19111029|P1|Overall Study|Physician Decision|0
5528564|NCT01421511|19111028|P2|Overall Study|Randomized but didn't receive study drug|7
5528565|NCT01421511|19111029|P1|Overall Study|Randomized but didn't receive study drug|1
5528566|NCT01421511|19111028|P2|Overall Study|Lost to Follow-up|14
5528567|NCT01421511|19111029|P1|Overall Study|Lost to Follow-up|11
5528568|NCT01421459|19111079|P2|Overall Study|Withdrawal by Subject|16
5528569|NCT01421459|19111080|P1|Overall Study|Withdrawal by Subject|12
5528570|NCT01421459|19111079|P2|Overall Study|Protocol Violation|5
5528571|NCT01421459|19111080|P1|Overall Study|Protocol Violation|8
5528572|NCT01421459|19111079|P2|Overall Study|Physician Decision|9
5528573|NCT01421459|19111080|P1|Overall Study|Physician Decision|9
5528574|NCT01421459|19111079|P2|Overall Study|Lost to Follow-up|9
5528575|NCT01421459|19111080|P1|Overall Study|Lost to Follow-up|8
5528576|NCT01421459|19111079|P2|Overall Study|Lack of Efficacy|2
5528577|NCT01421459|19111080|P1|Overall Study|Lack of Efficacy|1
5528578|NCT01421459|19111079|P2|Overall Study|Death|1
5528579|NCT01421459|19111080|P1|Overall Study|Death|1
5528580|NCT01421459|19111079|P2|Overall Study|Adverse Event|10
5528581|NCT01421459|19111080|P1|Overall Study|Adverse Event|6
5528582|NCT01421342|19111121|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
5528583|NCT01421342|19111122|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
5528584|NCT01421342|19111123|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
5528585|NCT01421342|19111121|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
5528586|NCT01421342|19111122|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
5528587|NCT01421342|19111123|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
5528588|NCT01421342|19111121|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
5528589|NCT01421342|19111122|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
5528590|NCT01421342|19111123|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
5528591|NCT01421342|19111121|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
5528592|NCT01421342|19111122|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
5528593|NCT01421342|19111123|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
5528594|NCT01421342|19111121|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
5528595|NCT01421342|19111122|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
5528596|NCT01421342|19111123|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
5528597|NCT01421342|19111121|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
5528598|NCT01421342|19111122|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
5528599|NCT01421342|19111123|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
5528600|NCT01421342|19111121|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
5528601|NCT01421342|19111122|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
5528602|NCT01421342|19111123|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
5528603|NCT01421342|19111121|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
5528604|NCT01421342|19111122|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
5528605|NCT01421342|19111123|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
5528606|NCT01421342|19111121|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
5528607|NCT01421342|19111122|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
5528608|NCT01421342|19111123|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
5528609|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
5528610|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
5528611|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
5528612|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
5528613|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
5528614|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
5528615|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
5528616|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
5528617|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
5528618|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
5528619|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
5528620|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
5528621|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
5528622|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
5528623|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
5528624|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
5528625|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
5528626|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
5528627|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
5528628|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
5528629|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
5528630|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
5528631|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
5528632|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
5528633|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
5528634|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
5528635|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
5528636|NCT01421342|19111121|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
5528637|NCT01421342|19111122|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
5528638|NCT01421342|19111123|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
5528639|NCT01421342|19111121|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
5528640|NCT01421342|19111122|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
5528641|NCT01421342|19111123|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
5528642|NCT01421342|19111121|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
5528643|NCT01421342|19111122|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
5528644|NCT01421342|19111123|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
5528645|NCT01421342|19111121|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
5528646|NCT01421342|19111122|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
5528647|NCT01421342|19111123|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
5528648|NCT01421342|19111121|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
5528649|NCT01421342|19111122|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
5528650|NCT01421342|19111123|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
5528651|NCT01421342|19111121|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
5528652|NCT01421342|19111122|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
5528653|NCT01421342|19111123|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
5528654|NCT01421342|19111121|P3|Acute Treatment Phase (12 Weeks)|Death|3
5528655|NCT01421342|19111122|P2|Acute Treatment Phase (12 Weeks)|Death|0
5528656|NCT01421342|19111123|P1|Acute Treatment Phase (12 Weeks)|Death|0
5528657|NCT01421342|19111121|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
5528658|NCT01421342|19111122|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
5528659|NCT01421342|19111123|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
5528660|NCT01421342|19111121|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
5528661|NCT01421342|19111122|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
5528662|NCT01421342|19111123|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
5528663|NCT01421342|19111121|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
5528664|NCT01421342|19111122|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
5528665|NCT01421342|19111123|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
5528666|NCT01421303|19111140|P1|Overall Study|Withdrawal by Subject|1
5528667|NCT01421303|19111140|P1|Overall Study|Other|7
5528668|NCT01421303|19111140|P1|Overall Study|Non compliance with study procedure|1
5528669|NCT01421303|19111140|P1|Overall Study|Lost to Follow-up|13
5528670|NCT01421277|19111167|P2|Overall Study|Incomplete baseline data|31
5528671|NCT01421277|19111168|P1|Overall Study|Incomplete baseline data|0
5528672|NCT01421277|19111167|P2|Overall Study|Lack of qualifying event|61
5528673|NCT01421277|19111168|P1|Overall Study|Lack of qualifying event|0
5528674|NCT01421225|19111180|P2|Overall Study|Withdrawal by Subject|1
5528675|NCT01421225|19111181|P1|Overall Study|Withdrawal by Subject|0
5528676|NCT01421147|19111195|P2|Extension Period|Withdrawal by Subject|3
5528677|NCT01421147|19111196|P1|Extension Period|Withdrawal by Subject|5
5528678|NCT01421147|19111195|P2|Extension Period|Physician Decision|0
5528679|NCT01421147|19111196|P1|Extension Period|Physician Decision|1
5528680|NCT01421147|19111195|P2|Extension Period|Lost to Follow-up|5
5528681|NCT01421147|19111196|P1|Extension Period|Lost to Follow-up|2
5528682|NCT01421147|19111195|P2|Extension Period|Death|1
5528683|NCT01421147|19111196|P1|Extension Period|Death|0
5528684|NCT01421147|19111195|P2|Extension Period|Adverse Event|2
5528685|NCT01421147|19111196|P1|Extension Period|Adverse Event|0
5528686|NCT01421147|19111195|P2|Treatment Period|Withdrawal by Subject|5
5528687|NCT01421147|19111196|P1|Treatment Period|Withdrawal by Subject|10
5528688|NCT01421147|19111195|P2|Treatment Period|Physician Decision|2
5528689|NCT01421147|19111196|P1|Treatment Period|Physician Decision|2
5528690|NCT01421147|19111195|P2|Treatment Period|Lost to Follow-up|1
5528691|NCT01421147|19111196|P1|Treatment Period|Lost to Follow-up|2
5528692|NCT01421147|19111195|P2|Treatment Period|Adverse Event|3
5528693|NCT01421147|19111196|P1|Treatment Period|Adverse Event|2
5528694|NCT01421134|19111228|P2|Overall Study|Lost to Follow-up|1
5528695|NCT01421134|19111229|P1|Overall Study|Lost to Follow-up|1
5528696|NCT01421134|19111228|P2|Overall Study|Administrative|1
5528697|NCT01421134|19111229|P1|Overall Study|Administrative|0
5528698|NCT01421134|19111228|P2|Overall Study|Withdrawal by Subject|1
5528699|NCT01421134|19111229|P1|Overall Study|Withdrawal by Subject|1
5528700|NCT01421134|19111228|P2|Overall Study|Protocol Violation|3
5528701|NCT01421134|19111229|P1|Overall Study|Protocol Violation|0
5528702|NCT01421134|19111228|P2|Overall Study|Lack of Efficacy|4
5528703|NCT01421134|19111229|P1|Overall Study|Lack of Efficacy|2
5528704|NCT01421134|19111228|P2|Overall Study|Adverse Event|5
5528705|NCT01421134|19111229|P1|Overall Study|Adverse Event|3
5528706|NCT01420965|19111250|P3|Overall Study|Adverse Event|0
5528707|NCT01420965|19111251|P2|Overall Study|Adverse Event|1
5528708|NCT01420965|19111252|P1|Overall Study|Adverse Event|0
5528709|NCT01420965|19111250|P3|Overall Study|Withdrawal by Subject|0
5528710|NCT01420965|19111251|P2|Overall Study|Withdrawal by Subject|0
5528711|NCT01420965|19111252|P1|Overall Study|Withdrawal by Subject|1
5528712|NCT01420926|19111265|P2|Overall Study|Continues on active treatment|3
5528713|NCT01420926|19111266|P1|Overall Study|Continues on active treatment|1
5528714|NCT01420926|19111265|P2|Overall Study|Physician Decision|5
5528715|NCT01420926|19111266|P1|Overall Study|Physician Decision|7
5528716|NCT01420926|19111265|P2|Overall Study|Non-protocol treatment|20
5528717|NCT01420926|19111266|P1|Overall Study|Non-protocol treatment|17
5528718|NCT01420926|19111265|P2|Overall Study|Withdrawal by Subject|16
5528719|NCT01420926|19111266|P1|Overall Study|Withdrawal by Subject|11
5528720|NCT01420926|19111265|P2|Overall Study|Death|17
5528721|NCT01420926|19111266|P1|Overall Study|Death|18
5528722|NCT01420926|19111265|P2|Overall Study|Adverse Event|4
5528723|NCT01420926|19111266|P1|Overall Study|Adverse Event|6
5528724|NCT01420627|19111313|P1|EZN-2279 Treatment Period|Adverse Event|1
5528725|NCT01420549|19111329|P2|Overall Study|Non-adherence to medication|1
5528726|NCT01420549|19111330|P1|Overall Study|Non-adherence to medication|4
5528727|NCT01420549|19111329|P2|Overall Study|Protocol Violation|1
5528728|NCT01420549|19111330|P1|Overall Study|Protocol Violation|0
5528729|NCT01420549|19111329|P2|Overall Study|Lost to Follow-up|2
5528730|NCT01420549|19111330|P1|Overall Study|Lost to Follow-up|2
5528731|NCT01420549|19111329|P2|Overall Study|Adverse Event|1
5528732|NCT01420549|19111330|P1|Overall Study|Adverse Event|1
5528733|NCT01420081|19111364|P9|Overall Study|Other Reasons|0
5528734|NCT01420081|19111365|P8|Overall Study|Other Reasons|0
5528735|NCT01420081|19111366|P7|Overall Study|Other Reasons|0
5528736|NCT01420081|19111367|P6|Overall Study|Other Reasons|0
5528737|NCT01420081|19111368|P5|Overall Study|Other Reasons|0
5528738|NCT01420081|19111369|P4|Overall Study|Other Reasons|0
5528739|NCT01420081|19111370|P3|Overall Study|Other Reasons|1
5528740|NCT01420081|19111371|P2|Overall Study|Other Reasons|0
5528741|NCT01420081|19111372|P1|Overall Study|Other Reasons|0
5528742|NCT01420081|19111364|P9|Overall Study|Subject Refused Futher Follow-up|0
5528743|NCT01420081|19111365|P8|Overall Study|Subject Refused Futher Follow-up|0
5528744|NCT01420081|19111366|P7|Overall Study|Subject Refused Futher Follow-up|0
5528745|NCT01420081|19111367|P6|Overall Study|Subject Refused Futher Follow-up|0
5528746|NCT01420081|19111368|P5|Overall Study|Subject Refused Futher Follow-up|1
5528747|NCT01420081|19111369|P4|Overall Study|Subject Refused Futher Follow-up|0
5528748|NCT01420081|19111370|P3|Overall Study|Subject Refused Futher Follow-up|1
5528749|NCT01420081|19111371|P2|Overall Study|Subject Refused Futher Follow-up|0
5528750|NCT01420081|19111372|P1|Overall Study|Subject Refused Futher Follow-up|0
5528751|NCT01420081|19111364|P9|Overall Study|Study Terminated by Sponsor|2
5528752|NCT01420081|19111365|P8|Overall Study|Study Terminated by Sponsor|2
5528753|NCT01420081|19111366|P7|Overall Study|Study Terminated by Sponsor|3
5528754|NCT01420081|19111367|P6|Overall Study|Study Terminated by Sponsor|7
5528755|NCT01420081|19111368|P5|Overall Study|Study Terminated by Sponsor|11
5528756|NCT01420081|19111369|P4|Overall Study|Study Terminated by Sponsor|3
5528757|NCT01420081|19111370|P3|Overall Study|Study Terminated by Sponsor|1
5528758|NCT01420081|19111371|P2|Overall Study|Study Terminated by Sponsor|1
5528759|NCT01420081|19111372|P1|Overall Study|Study Terminated by Sponsor|2
5528760|NCT01420081|19111364|P9|Overall Study|Lost to Follow-up|0
5528761|NCT01420081|19111365|P8|Overall Study|Lost to Follow-up|0
5528762|NCT01420081|19111366|P7|Overall Study|Lost to Follow-up|0
5528763|NCT01420081|19111367|P6|Overall Study|Lost to Follow-up|1
5528764|NCT01420081|19111368|P5|Overall Study|Lost to Follow-up|1
5528765|NCT01420081|19111369|P4|Overall Study|Lost to Follow-up|0
5528766|NCT01420081|19111370|P3|Overall Study|Lost to Follow-up|0
5528767|NCT01420081|19111371|P2|Overall Study|Lost to Follow-up|0
5528768|NCT01420081|19111372|P1|Overall Study|Lost to Follow-up|0
5528769|NCT01420081|19111364|P9|Overall Study|Death|1
5528770|NCT01420081|19111365|P8|Overall Study|Death|1
5528771|NCT01420081|19111366|P7|Overall Study|Death|0
5528772|NCT01420081|19111367|P6|Overall Study|Death|12
5528773|NCT01420081|19111368|P5|Overall Study|Death|7
5528774|NCT01420081|19111369|P4|Overall Study|Death|0
5528775|NCT01420081|19111370|P3|Overall Study|Death|8
5528776|NCT01420081|19111371|P2|Overall Study|Death|0
5528777|NCT01420081|19111372|P1|Overall Study|Death|1
5528778|NCT01420068|19111453|P2|Overall Study|Withdrawal by Subject|2
5528779|NCT01420068|19111454|P1|Overall Study|Withdrawal by Subject|1
5528780|NCT01420068|19111453|P2|Overall Study|Administrative problems|3
5528781|NCT01420068|19111454|P1|Overall Study|Administrative problems|1
5528782|NCT01419769|19111525|P1|Overall Study|Not evaluable due to pigtail stents|1
5528783|NCT01419769|19111525|P1|Overall Study|Did not receive the AXIOS stent|3
5528784|NCT01419717|19111538|P1|Overall Study|Noncompliance|1
5528785|NCT01419717|19111538|P1|Overall Study|Administrative Decision|1
5528786|NCT01419717|19111538|P1|Overall Study|Lost to Follow-up|2
5528787|NCT01419717|19111538|P1|Overall Study|Other|4
5528788|NCT01419717|19111538|P1|Overall Study|Disease Progression|9
5528789|NCT01419717|19111538|P1|Overall Study|Withdrawal by Subject|10
5528790|NCT01419717|19111538|P1|Overall Study|Death|17
5528791|NCT01419717|19111538|P1|Overall Study|Adverse Event|19
5528792|NCT01419717|19111538|P1|Overall Study|Protocol-specified Criteria|62
5528793|NCT01419626|19111552|P3|Overall Study|Lost to Follow-up|1
5528794|NCT01419626|19111553|P2|Overall Study|Lost to Follow-up|1
5528795|NCT01419626|19111554|P1|Overall Study|Lost to Follow-up|0
5528796|NCT01419626|19111552|P3|Overall Study|Withdrawal by Subject|0
5528797|NCT01419626|19111553|P2|Overall Study|Withdrawal by Subject|0
5528798|NCT01419626|19111554|P1|Overall Study|Withdrawal by Subject|1
5528799|NCT01419626|19111552|P3|Overall Study|Protocol Violation|2
5528800|NCT01419626|19111553|P2|Overall Study|Protocol Violation|2
5528801|NCT01419626|19111554|P1|Overall Study|Protocol Violation|3
5528802|NCT01419314|19111585|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
5528803|NCT01419314|19111586|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
5528804|NCT01419314|19111585|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
5528805|NCT01419314|19111586|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
5528806|NCT01419314|19111585|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
5528807|NCT01419314|19111586|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
5528808|NCT01419236|19111627|P2|Overall Study|Entry Criteria Not Met|0
5528809|NCT01419236|19111628|P1|Overall Study|Entry Criteria Not Met|1
5528810|NCT01419236|19111627|P2|Overall Study|Withdrawal by Subject|4
5528811|NCT01419236|19111628|P1|Overall Study|Withdrawal by Subject|1
5528812|NCT01419236|19111627|P2|Overall Study|Physician Decision|0
5528813|NCT01419236|19111628|P1|Overall Study|Physician Decision|1
5528814|NCT01419236|19111627|P2|Overall Study|Lost to Follow-up|0
5528815|NCT01419236|19111628|P1|Overall Study|Lost to Follow-up|1
5528816|NCT01419236|19111627|P2|Overall Study|Lack of Efficacy|1
5528817|NCT01419236|19111628|P1|Overall Study|Lack of Efficacy|0
5528818|NCT01419236|19111627|P2|Overall Study|Adverse Event|0
5528819|NCT01419236|19111628|P1|Overall Study|Adverse Event|1
5528820|NCT01419197|19111652|P2|Overall Study|Lost to Follow-up|4
5528821|NCT01419197|19111653|P1|Overall Study|Lost to Follow-up|14
5528822|NCT01419197|19111652|P2|Overall Study|Reason Not Specified|1
5528823|NCT01419197|19111653|P1|Overall Study|Reason Not Specified|0
5528824|NCT01419197|19111652|P2|Overall Study|Study Completed by Sponsor|34
5528825|NCT01419197|19111653|P1|Overall Study|Study Completed by Sponsor|103
5528826|NCT01419197|19111652|P2|Overall Study|Withdrawal by Subject|32
5528827|NCT01419197|19111653|P1|Overall Study|Withdrawal by Subject|33
5528828|NCT01419197|19111652|P2|Overall Study|Non-compliance|1
5528829|NCT01419197|19111653|P1|Overall Study|Non-compliance|3
5528830|NCT01419197|19111652|P2|Overall Study|Physician Decision|4
5528831|NCT01419197|19111653|P1|Overall Study|Physician Decision|4
5528832|NCT01419197|19111652|P2|Overall Study|Death|122
5528833|NCT01419197|19111653|P1|Overall Study|Death|247
5528834|NCT01419184|19111678|P2|Overall Study|Participant randomized, not treated|0
5528835|NCT01419184|19111679|P1|Overall Study|Participant randomized, not treated|1
5528836|NCT01419184|19111678|P2|Overall Study|No IRLOS-No adverse event treatment date|1
5528837|NCT01419184|19111679|P1|Overall Study|No IRLOS-No adverse event treatment date|0
5528838|NCT01419184|19111678|P2|Overall Study|No IRLOS-non trial antibiotic used|2
5528839|NCT01419184|19111679|P1|Overall Study|No IRLOS-non trial antibiotic used|1
5528840|NCT01419184|19111678|P2|Overall Study|No IRLOS-randomized, not treated|4
5528841|NCT01419184|19111679|P1|Overall Study|No IRLOS-randomized, not treated|2
5528842|NCT01419184|19111678|P2|Overall Study|No IRLOS-No in-patient end date reported|6
5528843|NCT01419184|19111679|P1|Overall Study|No IRLOS-No in-patient end date reported|3
5528844|NCT01419184|19111678|P2|Overall Study|Site data not available|2
5528845|NCT01419184|19111679|P1|Overall Study|Site data not available|3
5528846|NCT01419080|19111712|P1|Overall Study|Too Ill|3
5528847|NCT01419080|19111712|P1|Overall Study|Lost to Follow-up|23
5528848|NCT01419080|19111712|P1|Overall Study|Death|30
5528849|NCT01419080|19111712|P1|Overall Study|Withdrawal by Subject|75
5528850|NCT01419015|19111723|P1|Overall Study|Death|2
5528851|NCT01418937|19111727|P1|Overall Study|Withdrawal by Subject|1
5528852|NCT01418937|19111727|P1|Overall Study|Pregnancy|1
5528853|NCT01418937|19111727|P1|Overall Study|Protocol Violation|1
5528854|NCT01418937|19111727|P1|Overall Study|Lost to Follow-up|5
5528855|NCT01418378|19111758|P2|Overall Study|developed chronic myopathy|1
5528856|NCT01418378|19111759|P1|Overall Study|developed chronic myopathy|0
5528857|NCT01418378|19111758|P2|Overall Study|ligament imbalance|1
5528858|NCT01418378|19111759|P1|Overall Study|ligament imbalance|0
5528859|NCT01418378|19111758|P2|Overall Study|Physician Decision|1
5528860|NCT01418378|19111759|P1|Overall Study|Physician Decision|0
5528861|NCT01418378|19111758|P2|Overall Study|Death|2
5528862|NCT01418378|19111759|P1|Overall Study|Death|1
5528863|NCT01418365|19111833|P2|Second Intervention|Withdrawal by Subject|1
5528864|NCT01418365|19111834|P1|Second Intervention|Withdrawal by Subject|0
5528865|NCT01418365|19111833|P2|First Intervention|Non-compliance|0
5528866|NCT01418365|19111834|P1|First Intervention|Non-compliance|1
5528867|NCT01418365|19111833|P2|First Intervention|Withdrawal by Subject|1
5528868|NCT01418365|19111834|P1|First Intervention|Withdrawal by Subject|0
5528869|NCT01418209|19111845|P3|Overall Study|Did not provide hot flash diary data|3
5528870|NCT01418209|19111846|P2|Overall Study|Did not provide hot flash diary data|3
5528871|NCT01418209|19111847|P1|Overall Study|Did not provide hot flash diary data|1
5528872|NCT01418209|19111845|P3|Overall Study|Withdrawal by Subject|1
5528873|NCT01418209|19111846|P2|Overall Study|Withdrawal by Subject|0
5528874|NCT01418209|19111847|P1|Overall Study|Withdrawal by Subject|1
5528875|NCT01417481|19111911|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
5528876|NCT01417481|19111912|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
5528877|NCT01417377|19111977|P1|Overall Study|Enrolled, but not treated|1
5528878|NCT01417377|19111977|P1|Overall Study|Lost to Follow-up|12
5528879|NCT01417234|19111984|P1|Overall Study|Subject non-compliant|3
5528880|NCT01417195|19111993|P2|Overall Study|No transfer due to elevated progesterone|0
5528881|NCT01417195|19111994|P1|Overall Study|No transfer due to elevated progesterone|1
5528882|NCT01417195|19111993|P2|Overall Study|No transfer due to risk of OHSS|0
5528883|NCT01417195|19111994|P1|Overall Study|No transfer due to risk of OHSS|1
5528884|NCT01417195|19111993|P2|Overall Study|No embryos for transfer|1
5528885|NCT01417195|19111994|P1|Overall Study|No embryos for transfer|0
5528886|NCT01417195|19111993|P2|Overall Study|Stimulation failure|0
5528887|NCT01417195|19111994|P1|Overall Study|Stimulation failure|1
5528888|NCT01417156|19112010|P1|Overall Study|Protocol Violation|2
5528889|NCT01417156|19112010|P1|Overall Study|Adverse Event|12
5528890|NCT01417104|19112020|P2|Overall Study|Adverse Event|0
5528891|NCT01417104|19112021|P1|Overall Study|Adverse Event|1
5528892|NCT01417104|19112020|P2|Overall Study|Failure to make contact|1
5528893|NCT01417104|19112021|P1|Overall Study|Failure to make contact|0
5528894|NCT01417104|19112020|P2|Overall Study|Withdrawal by Subject|1
5528895|NCT01417104|19112021|P1|Overall Study|Withdrawal by Subject|5
5528896|NCT01417078|19112031|P1|Overall Study|Withdrawal by Subject|1
5528897|NCT01417000|19112056|P2|Overall Study|Study Terminated by Sponsor|1
5528898|NCT01417000|19112057|P1|Overall Study|Study Terminated by Sponsor|1
5528899|NCT01417000|19112056|P2|Overall Study|Lost to Follow-up|0
5528900|NCT01417000|19112057|P1|Overall Study|Lost to Follow-up|1
5528901|NCT01417000|19112056|P2|Overall Study|Death|28
5528902|NCT01417000|19112057|P1|Overall Study|Death|59
5528903|NCT01416805|19112074|P2|Overall Study|Lost to Follow-up|4
5528904|NCT01416805|19112075|P1|Overall Study|Lost to Follow-up|4
5528905|NCT01416610|19112114|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
5528906|NCT01416610|19112114|P1|Overall Study|Lost to Follow-up|7
5528907|NCT01416610|19112114|P1|Overall Study|Withdrawal by Subject|13
5528908|NCT01416610|19112114|P1|Overall Study|No reason given|5
5528909|NCT01416610|19112114|P1|Overall Study|Lack of Efficacy|4
5528910|NCT01416610|19112114|P1|Overall Study|Adverse Event -Patient decision|3
5528911|NCT01416610|19112114|P1|Overall Study|Adverse Event|4
5528912|NCT01416571|19112168|P1|Overall Study|Lost to Follow-up|2
5528913|NCT01416389|19112197|P2|Overall Study|Started New Therapy|0
5528914|NCT01416389|19112198|P1|Overall Study|Started New Therapy|2
5528915|NCT01416389|19112197|P2|Overall Study|Lost to Follow-up|0
5528916|NCT01416389|19112198|P1|Overall Study|Lost to Follow-up|1
5528917|NCT01416272|19112215|P1|Overall Study|Study related complaints|1
5528918|NCT01416272|19112215|P1|Overall Study|Lost to Follow-up|1
5528919|NCT01416272|19112215|P1|Overall Study|Unacceptable distance visual acuity|2
5528920|NCT01416181|19112272|P2|Part 2|Lost to Follow-up|2
5528921|NCT01416181|19112273|P1|Part 2|Lost to Follow-up|2
5528922|NCT01416181|19112272|P2|Part 2|Lack of Efficacy|1
5528923|NCT01416181|19112273|P1|Part 2|Lack of Efficacy|4
5528924|NCT01416181|19112272|P2|Part 2|Withdrawal by Subject|5
5528925|NCT01416181|19112273|P1|Part 2|Withdrawal by Subject|14
5528926|NCT01416181|19112272|P2|Part 2|Investigator Decision|7
5528927|NCT01416181|19112273|P1|Part 2|Investigator Decision|6
5528928|NCT01416181|19112272|P2|Part 2|Other|267
5528929|NCT01416181|19112273|P1|Part 2|Other|234
5528930|NCT01416181|19112272|P2|Part 2|Adverse Event|4
5528931|NCT01416181|19112273|P1|Part 2|Adverse Event|11
5528932|NCT01416181|19112272|P2|Part 1|Ongoing in Follow-Up|8
5528933|NCT01416181|19112273|P1|Part 1|Ongoing in Follow-Up|14
5528934|NCT01416181|19112272|P2|Part 1|Adverse Event|18
5528935|NCT01416181|19112273|P1|Part 1|Adverse Event|15
5528936|NCT01416181|19112272|P2|Part 1|Lost to Follow-up|1
5528937|NCT01416181|19112273|P1|Part 1|Lost to Follow-up|1
5528938|NCT01416181|19112272|P2|Part 1|Lack of Efficacy|8
5528939|NCT01416181|19112273|P1|Part 1|Lack of Efficacy|16
5528940|NCT01416181|19112272|P2|Part 1|Withdrawal by Subject|48
5528941|NCT01416181|19112273|P1|Part 1|Withdrawal by Subject|74
5528942|NCT01416181|19112272|P2|Part 1|Investigator Decision|6
5528943|NCT01416181|19112273|P1|Part 1|Investigator Decision|7
5528944|NCT01416181|19112272|P2|Part 1|Death|1
5528945|NCT01416181|19112273|P1|Part 1|Death|0
5528946|NCT01416181|19112272|P2|Part 1|Other|24
5528947|NCT01416181|19112273|P1|Part 1|Other|10
5528948|NCT01416155|19112335|P1|Overall Study|Other|7
5528949|NCT01416155|19112335|P1|Overall Study|Investigator decision|8
5528950|NCT01416155|19112335|P1|Overall Study|Withdrawal by Subject|33
5528951|NCT01416155|19112335|P1|Overall Study|Positive for anti-BG00002 antibodies|2
5528952|NCT01416155|19112335|P1|Overall Study|Adverse Event|8
5528953|NCT01416142|19112342|P3|PureVision2 HD|Inability to maintain lens wear|1
5528954|NCT01416142|19112343|P2|PureVision2 HD|Inability to maintain lens wear|0
5528955|NCT01416142|19112344|P1|PureVision2 HD|Inability to maintain lens wear|0
5528956|NCT01415986|19112371|P1|Overall Study|Lost to Follow-up|1
5528957|NCT01415921|19112397|P2|Overall Study|Other|0
5528958|NCT01415921|19112398|P1|Overall Study|Other|2
5528959|NCT01415921|19112397|P2|Overall Study|Withdrawal by Subject|1
5528960|NCT01415921|19112398|P1|Overall Study|Withdrawal by Subject|0
5528961|NCT01415921|19112397|P2|Overall Study|Physician Decision|1
5528962|NCT01415921|19112398|P1|Overall Study|Physician Decision|1
5528963|NCT01415921|19112397|P2|Overall Study|Adverse Event|1
5528964|NCT01415921|19112398|P1|Overall Study|Adverse Event|0
5528965|NCT01415908|19112408|P2|Overall Study|Withdrawal by Subject|0
5528966|NCT01415908|19112409|P1|Overall Study|Withdrawal by Subject|1
5528967|NCT01415531|19112446|P2|Overall Study|Other Reasons|2
5528968|NCT01415531|19112447|P1|Overall Study|Other Reasons|3
5528969|NCT01415531|19112446|P2|Overall Study|Lack of Compliance|4
5528970|NCT01415531|19112447|P1|Overall Study|Lack of Compliance|1
5528971|NCT01415531|19112446|P2|Overall Study|Lost to Follow-up|14
5528972|NCT01415531|19112447|P1|Overall Study|Lost to Follow-up|6
5528973|NCT01415531|19112446|P2|Overall Study|Withdrawal by Subject|4
5528974|NCT01415531|19112447|P1|Overall Study|Withdrawal by Subject|5
5528975|NCT01415531|19112446|P2|Overall Study|Protocol Violation|1
5528976|NCT01415531|19112447|P1|Overall Study|Protocol Violation|0
5528977|NCT01415531|19112446|P2|Overall Study|Lack of Efficacy|2
5528978|NCT01415531|19112447|P1|Overall Study|Lack of Efficacy|3
5528979|NCT01415531|19112446|P2|Overall Study|Adverse Event|10
5528980|NCT01415531|19112447|P1|Overall Study|Adverse Event|7
5528981|NCT01415518|19112457|P2|Overall Study|Condition under Investigation Worsened|1
5528982|NCT01415518|19112458|P1|Overall Study|Condition under Investigation Worsened|1
5528983|NCT01415518|19112457|P2|Overall Study|Death|1
5528984|NCT01415518|19112458|P1|Overall Study|Death|1
5528985|NCT01415518|19112457|P2|Overall Study|Adverse Event|4
5528986|NCT01415518|19112458|P1|Overall Study|Adverse Event|3
5528987|NCT01415518|19112457|P2|Overall Study|Lost to Follow-up|5
5528988|NCT01415518|19112458|P1|Overall Study|Lost to Follow-up|3
5528989|NCT01415518|19112457|P2|Overall Study|Protocol Violation|8
5528990|NCT01415518|19112458|P1|Overall Study|Protocol Violation|6
5528991|NCT01415518|19112457|P2|Overall Study|Withdrawal by Subject|12
5528992|NCT01415518|19112458|P1|Overall Study|Withdrawal by Subject|2
5528993|NCT01415440|19112517|P3|Overall Study|Withdrawal by Subject|0
5528994|NCT01415440|19112518|P2|Overall Study|Withdrawal by Subject|0
5528995|NCT01415440|19112519|P1|Overall Study|Withdrawal by Subject|1
5528996|NCT01415440|19112517|P3|Overall Study|Physician Decision|0
5528997|NCT01415440|19112518|P2|Overall Study|Physician Decision|0
5528998|NCT01415440|19112519|P1|Overall Study|Physician Decision|3
5528999|NCT01415440|19112517|P3|Overall Study|Lost to Follow-up|2
5529000|NCT01415440|19112518|P2|Overall Study|Lost to Follow-up|1
5529001|NCT01415440|19112519|P1|Overall Study|Lost to Follow-up|0
5529002|NCT01415401|19112570|P1|Overall Study|Terminated by Sponsor|1
5529003|NCT01415401|19112570|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
5529004|NCT01415401|19112570|P1|Overall Study|Adverse Event|5
5529005|NCT01415349|19112575|P2|Treatment Period 1|Withdrawal by Subject|1
5529006|NCT01415349|19112576|P1|Treatment Period 1|Withdrawal by Subject|0
5529007|NCT01415349|19112575|P2|Treatment Period 1|Adverse Event|1
5529008|NCT01415349|19112576|P1|Treatment Period 1|Adverse Event|0
5529009|NCT01414855|19112588|P1|Overall Study|Withdrawal by Subject|7
5529010|NCT01414855|19112588|P1|Overall Study|Lost to Follow-up|5
5529011|NCT01414855|19112588|P1|Overall Study|Death|17
5529012|NCT01414257|19112637|P1|Overall Study|Protocol Violation|10
5529013|NCT01414257|19112637|P1|Overall Study|No Visit After First Day of Treatment|12
5529014|NCT01414205|19112665|P2|Overall Study|Randomized but not Treated|1
5529015|NCT01414205|19112666|P1|Overall Study|Randomized but not Treated|1
5529016|NCT01414205|19112665|P2|Overall Study|Physician Decision|1
5529017|NCT01414205|19112666|P1|Overall Study|Physician Decision|0
5529018|NCT01414205|19112665|P2|Overall Study|Lost to Follow-up|4
5529019|NCT01414205|19112666|P1|Overall Study|Lost to Follow-up|1
5529020|NCT01414205|19112665|P2|Overall Study|Death|1
5529021|NCT01414205|19112666|P1|Overall Study|Death|5
5529022|NCT01414166|19112735|P2|Overall Study|Withdrawal by Subject|5
5529023|NCT01414166|19112736|P1|Overall Study|Withdrawal by Subject|3
5529024|NCT01414166|19112735|P2|Overall Study|Study terminated by Sponsor|75
5529025|NCT01414166|19112736|P1|Overall Study|Study terminated by Sponsor|68
5529026|NCT01414166|19112735|P2|Overall Study|Protocol Violation|0
5529027|NCT01414166|19112736|P1|Overall Study|Protocol Violation|2
5529028|NCT01414166|19112735|P2|Overall Study|Physician Decision|0
5529029|NCT01414166|19112736|P1|Overall Study|Physician Decision|2
5529030|NCT01414166|19112735|P2|Overall Study|Non-compliance with study drug|0
5529031|NCT01414166|19112736|P1|Overall Study|Non-compliance with study drug|2
5529032|NCT01414166|19112735|P2|Overall Study|Lost to Follow-up|1
5529033|NCT01414166|19112736|P1|Overall Study|Lost to Follow-up|4
5529034|NCT01414166|19112735|P2|Overall Study|Adverse Event|2
5529035|NCT01414166|19112736|P1|Overall Study|Adverse Event|10
5529036|NCT01414114|19112799|P1|Overall Study|Other|2
5529037|NCT01414114|19112799|P1|Overall Study|Withdrawal by Subject|1
5529038|NCT01414114|19112799|P1|Overall Study|Adverse Event|2
5529039|NCT01413958|19112855|P2|Overall Study|Lost to Follow-up|1
5529040|NCT01413958|19112856|P1|Overall Study|Lost to Follow-up|0
5529041|NCT01413542|19112907|P4|Overall Study|Adverse Event|1
5529042|NCT01413542|19112908|P3|Overall Study|Adverse Event|0
5529043|NCT01413542|19112909|P2|Overall Study|Adverse Event|0
5529044|NCT01413542|19112910|P1|Overall Study|Adverse Event|0
5529045|NCT01413542|19112907|P4|Overall Study|Physician Decision|0
5529046|NCT01413542|19112908|P3|Overall Study|Physician Decision|3
5529047|NCT01413542|19112909|P2|Overall Study|Physician Decision|0
5529048|NCT01413542|19112910|P1|Overall Study|Physician Decision|1
5529049|NCT01413503|19112932|P1|Overall Study|Lost to Follow-up|1
5529050|NCT01413360|19112936|P1|Overall Study|Adverse Event|1
5529051|NCT01413360|19112936|P1|Overall Study|Lost to Follow-up|2
5529052|NCT01413204|19112944|P3|Overall Study|Fasting plasma glucose level increased|10
5529053|NCT01413204|19112945|P2|Overall Study|Fasting plasma glucose level increased|0
5529054|NCT01413204|19112946|P1|Overall Study|Fasting plasma glucose level increased|1
5529055|NCT01413204|19112944|P3|Overall Study|Clearly not eligible for the study|1
5529056|NCT01413204|19112945|P2|Overall Study|Clearly not eligible for the study|0
5529057|NCT01413204|19112946|P1|Overall Study|Clearly not eligible for the study|0
5529058|NCT01413204|19112944|P3|Overall Study|Withdrawal by Subject|4
5529059|NCT01413204|19112945|P2|Overall Study|Withdrawal by Subject|4
5529060|NCT01413204|19112946|P1|Overall Study|Withdrawal by Subject|1
5529061|NCT01413204|19112944|P3|Overall Study|Physician Decision|2
5529062|NCT01413204|19112945|P2|Overall Study|Physician Decision|0
5529063|NCT01413204|19112946|P1|Overall Study|Physician Decision|3
5529064|NCT01413204|19112944|P3|Overall Study|Adverse Event|2
5529065|NCT01413204|19112945|P2|Overall Study|Adverse Event|2
5529066|NCT01413204|19112946|P1|Overall Study|Adverse Event|1
5529067|NCT01413191|19112954|P1|Overall Study|Death|1
5529068|NCT01413191|19112954|P1|Overall Study|Disease Progression|5
5529069|NCT01413191|19112954|P1|Overall Study|Lost to Follow-up|5
5529070|NCT01413178|19112966|P2|Overall Study|Ineligible|2
5529071|NCT01413178|19112967|P1|Overall Study|Ineligible|0
5529072|NCT01413178|19112966|P2|Overall Study|Toxicity|0
5529073|NCT01413178|19112967|P1|Overall Study|Toxicity|1
5529074|NCT01412983|19113010|P2|1st Period|Inability to maintain wear|1
5529075|NCT01412983|19113011|P1|1st Period|Inability to maintain wear|0
5529076|NCT01412983|19113010|P2|1st Period|Unacceptable lens movement|1
5529077|NCT01412983|19113011|P1|1st Period|Unacceptable lens movement|0
5529078|NCT01412983|19113010|P2|1st Period|Positive slit lamp finding|1
5529079|NCT01412983|19113011|P1|1st Period|Positive slit lamp finding|0
5529080|NCT01412983|19113010|P2|1st Period|Ineligible|1
5529081|NCT01412983|19113011|P1|1st Period|Ineligible|0
5529082|NCT01412957|19113021|P2|Overall Study|Death|133
5529083|NCT01412957|19113022|P1|Overall Study|Death|136
5529084|NCT01412957|19113021|P2|Overall Study|Lost to Follow-up|2
5529085|NCT01412957|19113022|P1|Overall Study|Lost to Follow-up|7
5529086|NCT01412957|19113021|P2|Overall Study|Withdrawal by Subject|22
5529087|NCT01412957|19113022|P1|Overall Study|Withdrawal by Subject|6
5529088|NCT01412944|19113044|P6|Entire: IV + Maintenance|Adverse Event|0
5529089|NCT01412944|19113045|P5|Entire: IV + Maintenance|Adverse Event|0
5529090|NCT01412944|19113046|P4|Entire: IV + Maintenance|Adverse Event|0
5529091|NCT01412944|19113047|P3|Entire: IV + Maintenance|Adverse Event|0
5529092|NCT01412944|19113048|P2|Entire: IV + Maintenance|Adverse Event|1
5529093|NCT01412944|19113049|P1|Entire: IV + Maintenance|Adverse Event|0
5529094|NCT01412944|19113044|P6|Entire: IV + Maintenance|Lack of Efficacy|0
5529095|NCT01412944|19113045|P5|Entire: IV + Maintenance|Lack of Efficacy|0
5529096|NCT01412944|19113046|P4|Entire: IV + Maintenance|Lack of Efficacy|0
5529097|NCT01412944|19113047|P3|Entire: IV + Maintenance|Lack of Efficacy|0
5529098|NCT01412944|19113048|P2|Entire: IV + Maintenance|Lack of Efficacy|1
5529099|NCT01412944|19113049|P1|Entire: IV + Maintenance|Lack of Efficacy|0
5529100|NCT01412944|19113044|P6|Entire: IV + Maintenance|Lost to Follow-up|0
5529101|NCT01412944|19113045|P5|Entire: IV + Maintenance|Lost to Follow-up|0
5529102|NCT01412944|19113046|P4|Entire: IV + Maintenance|Lost to Follow-up|0
5529103|NCT01412944|19113047|P3|Entire: IV + Maintenance|Lost to Follow-up|0
5529104|NCT01412944|19113048|P2|Entire: IV + Maintenance|Lost to Follow-up|1
5529105|NCT01412944|19113049|P1|Entire: IV + Maintenance|Lost to Follow-up|0
5529106|NCT01412944|19113044|P6|Entire: IV + Maintenance|Protocol deviation|0
5529107|NCT01412944|19113045|P5|Entire: IV + Maintenance|Protocol deviation|0
5529108|NCT01412944|19113046|P4|Entire: IV + Maintenance|Protocol deviation|0
5529109|NCT01412944|19113047|P3|Entire: IV + Maintenance|Protocol deviation|0
5529110|NCT01412944|19113048|P2|Entire: IV + Maintenance|Protocol deviation|1
5529111|NCT01412944|19113049|P1|Entire: IV + Maintenance|Protocol deviation|0
5529112|NCT01412944|19113044|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
5529113|NCT01412944|19113045|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
5529114|NCT01412944|19113046|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
5529115|NCT01412944|19113047|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
5529116|NCT01412944|19113048|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
5529117|NCT01412944|19113049|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
5529118|NCT01412944|19113044|P6|Entire: IV + Maintenance|Lack of Efficacy|0
5529119|NCT01412944|19113045|P5|Entire: IV + Maintenance|Lack of Efficacy|1
5529120|NCT01412944|19113046|P4|Entire: IV + Maintenance|Lack of Efficacy|0
5529121|NCT01412944|19113047|P3|Entire: IV + Maintenance|Lack of Efficacy|0
5529122|NCT01412944|19113048|P2|Entire: IV + Maintenance|Lack of Efficacy|0
5529123|NCT01412944|19113049|P1|Entire: IV + Maintenance|Lack of Efficacy|0
5529124|NCT01412944|19113044|P6|Entire: IV + Maintenance|Lost to Follow-up|1
5529125|NCT01412944|19113045|P5|Entire: IV + Maintenance|Lost to Follow-up|0
5529126|NCT01412944|19113046|P4|Entire: IV + Maintenance|Lost to Follow-up|0
5529127|NCT01412944|19113047|P3|Entire: IV + Maintenance|Lost to Follow-up|0
5529128|NCT01412944|19113048|P2|Entire: IV + Maintenance|Lost to Follow-up|0
5529129|NCT01412944|19113049|P1|Entire: IV + Maintenance|Lost to Follow-up|0
5529130|NCT01412944|19113044|P6|Entire: IV + Maintenance|Protocol deviation|1
5529131|NCT01412944|19113045|P5|Entire: IV + Maintenance|Protocol deviation|0
5529132|NCT01412944|19113046|P4|Entire: IV + Maintenance|Protocol deviation|0
5529133|NCT01412944|19113047|P3|Entire: IV + Maintenance|Protocol deviation|0
5529134|NCT01412944|19113048|P2|Entire: IV + Maintenance|Protocol deviation|0
5529135|NCT01412944|19113049|P1|Entire: IV + Maintenance|Protocol deviation|0
5529136|NCT01412944|19113044|P6|Entire: IV + Maintenance|Adverse Event|0
5529137|NCT01412944|19113045|P5|Entire: IV + Maintenance|Adverse Event|1
5529138|NCT01412944|19113046|P4|Entire: IV + Maintenance|Adverse Event|0
5529139|NCT01412944|19113047|P3|Entire: IV + Maintenance|Adverse Event|0
5529140|NCT01412944|19113048|P2|Entire: IV + Maintenance|Adverse Event|0
5529141|NCT01412944|19113049|P1|Entire: IV + Maintenance|Adverse Event|0
5529142|NCT01412944|19113044|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
5529143|NCT01412944|19113045|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
5529144|NCT01412944|19113046|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
5529145|NCT01412944|19113047|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
5529146|NCT01412944|19113048|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
5529147|NCT01412944|19113049|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
5529148|NCT01412944|19113044|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
5529149|NCT01412944|19113045|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
5529150|NCT01412944|19113046|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
5529151|NCT01412944|19113047|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
5529152|NCT01412944|19113048|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
5529153|NCT01412944|19113049|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
5529154|NCT01412944|19113044|P6|IV: Per CAIN457A2307|Protocol deviation|0
5529155|NCT01412944|19113045|P5|IV: Per CAIN457A2307|Protocol deviation|0
5529156|NCT01412944|19113046|P4|IV: Per CAIN457A2307|Protocol deviation|0
5529157|NCT01412944|19113047|P3|IV: Per CAIN457A2307|Protocol deviation|0
5529158|NCT01412944|19113048|P2|IV: Per CAIN457A2307|Protocol deviation|1
5529159|NCT01412944|19113049|P1|IV: Per CAIN457A2307|Protocol deviation|0
5529160|NCT01412944|19113044|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
5529161|NCT01412944|19113045|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
5529162|NCT01412944|19113046|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
5529163|NCT01412944|19113047|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
5529164|NCT01412944|19113048|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
5529165|NCT01412944|19113049|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
5529166|NCT01412944|19113044|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
5529167|NCT01412944|19113045|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5529168|NCT01412944|19113046|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5529169|NCT01412944|19113047|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5529170|NCT01412944|19113048|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5529171|NCT01412944|19113049|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
5529172|NCT01412944|19113044|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
5529173|NCT01412944|19113045|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5529174|NCT01412944|19113046|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5529175|NCT01412944|19113047|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5529176|NCT01412944|19113048|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5529177|NCT01412944|19113049|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
5529178|NCT01412944|19113044|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5529179|NCT01412944|19113045|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5529180|NCT01412944|19113046|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5529181|NCT01412944|19113047|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
5529182|NCT01412944|19113048|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5529183|NCT01412944|19113049|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
5529184|NCT01412879|19113095|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
5529185|NCT01412879|19113096|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
5529186|NCT01412879|19113097|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
5529187|NCT01412879|19113095|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
5529188|NCT01412879|19113096|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
5529189|NCT01412879|19113097|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
5529190|NCT01412879|19113095|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
5529191|NCT01412879|19113096|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
5529192|NCT01412879|19113097|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
5529193|NCT01412879|19113095|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
5529194|NCT01412879|19113096|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
5529195|NCT01412879|19113097|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
5529196|NCT01412879|19113095|P3|Initial Registration (Induction Therapy)|Adverse Event|0
5529197|NCT01412879|19113096|P2|Initial Registration (Induction Therapy)|Adverse Event|3
5529198|NCT01412879|19113097|P1|Initial Registration (Induction Therapy)|Adverse Event|5
5529199|NCT01412801|19113126|P6|Overall Study|Relocated to another area|0
5529200|NCT01412801|19113127|P5|Overall Study|Relocated to another area|0
5529201|NCT01412801|19113128|P4|Overall Study|Relocated to another area|0
5529202|NCT01412801|19113129|P3|Overall Study|Relocated to another area|2
5529203|NCT01412801|19113130|P2|Overall Study|Relocated to another area|0
5529204|NCT01412801|19113131|P1|Overall Study|Relocated to another area|0
5529205|NCT01412801|19113126|P6|Overall Study|Withdrawal by Subject|0
5529206|NCT01412801|19113127|P5|Overall Study|Withdrawal by Subject|0
5529207|NCT01412801|19113128|P4|Overall Study|Withdrawal by Subject|0
5529208|NCT01412801|19113129|P3|Overall Study|Withdrawal by Subject|1
5529209|NCT01412801|19113130|P2|Overall Study|Withdrawal by Subject|2
5529210|NCT01412801|19113131|P1|Overall Study|Withdrawal by Subject|3
5529211|NCT01412801|19113126|P6|Overall Study|Lost to Follow-up|1
5529212|NCT01412801|19113127|P5|Overall Study|Lost to Follow-up|1
5529213|NCT01412801|19113128|P4|Overall Study|Lost to Follow-up|0
5529214|NCT01412801|19113129|P3|Overall Study|Lost to Follow-up|4
5529215|NCT01412801|19113130|P2|Overall Study|Lost to Follow-up|2
5529216|NCT01412801|19113131|P1|Overall Study|Lost to Follow-up|1
5529217|NCT01412801|19113126|P6|Overall Study|Death|2
5529218|NCT01412801|19113127|P5|Overall Study|Death|2
5529219|NCT01412801|19113128|P4|Overall Study|Death|4
5529220|NCT01412801|19113129|P3|Overall Study|Death|0
5529221|NCT01412801|19113130|P2|Overall Study|Death|1
5529222|NCT01412801|19113131|P1|Overall Study|Death|0
5529223|NCT01412424|19113226|P1|Extension Treatment Period|Patient Request|2
5529224|NCT01412424|19113226|P1|Extension Treatment Period|Treatment Failure|2
5529225|NCT01412424|19113226|P1|Extension Treatment Period|Adverse Event|2
5529226|NCT01412424|19113226|P1|Core Treatment Period|Sponsor Request|1
5529227|NCT01412424|19113226|P1|Core Treatment Period|Lost to Follow-up|2
5529228|NCT01412424|19113226|P1|Core Treatment Period|Patient Request|5
5529229|NCT01412424|19113226|P1|Core Treatment Period|Adverse Event|21
5529230|NCT01412424|19113226|P1|Core Treatment Period|Treatment Failure|24
5529231|NCT01412333|19113263|P2|Overall Study|Lost to Follow-up|6
5529232|NCT01412333|19113264|P1|Overall Study|Lost to Follow-up|10
5529233|NCT01412333|19113263|P2|Overall Study|Adverse Event|16
5529234|NCT01412333|19113264|P1|Overall Study|Adverse Event|25
5529235|NCT01412333|19113263|P2|Overall Study|Consent withdrawn by participant|12
5529236|NCT01412333|19113264|P1|Overall Study|Consent withdrawn by participant|25
5529237|NCT01412333|19113263|P2|Overall Study|Pregnancy|0
5529238|NCT01412333|19113264|P1|Overall Study|Pregnancy|3
5529239|NCT01412333|19113263|P2|Overall Study|Lack of Efficacy|6
5529240|NCT01412333|19113264|P1|Overall Study|Lack of Efficacy|15
5529241|NCT01412333|19113263|P2|Overall Study|Non-compliance|3
5529242|NCT01412333|19113264|P1|Overall Study|Non-compliance|1
5529243|NCT01412333|19113263|P2|Overall Study|Protocol Violation|1
5529244|NCT01412333|19113264|P1|Overall Study|Protocol Violation|1
5529245|NCT01412333|19113263|P2|Overall Study|Non-compliance with study drug|1
5529246|NCT01412333|19113264|P1|Overall Study|Non-compliance with study drug|1
5529247|NCT01412333|19113263|P2|Overall Study|Reason not specified|10
5529248|NCT01412333|19113264|P1|Overall Study|Reason not specified|16
5529249|NCT01412333|19113263|P2|Overall Study|Physician Decision|1
5529250|NCT01412333|19113264|P1|Overall Study|Physician Decision|0
5529251|NCT01412333|19113263|P2|Overall Study|Death|1
5529252|NCT01412333|19113264|P1|Overall Study|Death|1
5529253|NCT01412229|19113324|P1|Overall Study|Physician Decision|1
5529254|NCT01412151|19113347|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
5529255|NCT01412151|19113347|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
5529256|NCT01412151|19113347|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
5529257|NCT01412151|19113347|P1|Week 0 - 306 - Treatment Period|Death|1
5529258|NCT01412060|19113358|P3|Double-blind Treatment Phase (DBP)|Relapse|25
5529259|NCT01412060|19113359|P2|Double-blind Treatment Phase (DBP)|Relapse|47
5529260|NCT01412060|19113360|P1|Double-blind Treatment Phase (DBP)|Relapse|0
5529261|NCT01412060|19113358|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
5529262|NCT01412060|19113359|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
5529263|NCT01412060|19113360|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
5529264|NCT01412060|19113358|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
5529265|NCT01412060|19113359|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
5529266|NCT01412060|19113360|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
5529267|NCT01412060|19113358|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
5529268|NCT01412060|19113359|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
5529269|NCT01412060|19113360|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
5529270|NCT01412060|19113358|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
5529271|NCT01412060|19113359|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
5529272|NCT01412060|19113360|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
5529273|NCT01412060|19113358|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
5529274|NCT01412060|19113359|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
5529275|NCT01412060|19113360|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
5529276|NCT01412060|19113358|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
5529277|NCT01412060|19113359|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
5529278|NCT01412060|19113360|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
5529279|NCT01412060|19113358|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
5529280|NCT01412060|19113359|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
5529281|NCT01412060|19113360|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
5529282|NCT01412060|19113358|P3|Period Between SP and DBP|Lost to Follow-up|0
5529283|NCT01412060|19113359|P2|Period Between SP and DBP|Lost to Follow-up|0
5529284|NCT01412060|19113360|P1|Period Between SP and DBP|Lost to Follow-up|1
5529285|NCT01412060|19113358|P3|Period Between SP and DBP|Withdrawal of Consent|0
5529286|NCT01412060|19113359|P2|Period Between SP and DBP|Withdrawal of Consent|0
5529287|NCT01412060|19113360|P1|Period Between SP and DBP|Withdrawal of Consent|2
5529288|NCT01412060|19113358|P3|Period Between SP and DBP|Protocol Violation|0
5529289|NCT01412060|19113359|P2|Period Between SP and DBP|Protocol Violation|0
5529290|NCT01412060|19113360|P1|Period Between SP and DBP|Protocol Violation|2
5529291|NCT01412060|19113358|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
5529292|NCT01412060|19113359|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
5529293|NCT01412060|19113360|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
5529294|NCT01412060|19113358|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
5529295|NCT01412060|19113359|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
5529296|NCT01412060|19113360|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
5529297|NCT01412060|19113358|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
5529298|NCT01412060|19113359|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
5529299|NCT01412060|19113360|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
5529300|NCT01412060|19113358|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
5529301|NCT01412060|19113359|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
5529302|NCT01412060|19113360|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
5529303|NCT01412060|19113358|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
5529304|NCT01412060|19113359|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
5529305|NCT01412060|19113360|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
5529306|NCT01412060|19113358|P3|Open-label Stabilization Period (SP)|Adverse Event|0
5529307|NCT01412060|19113359|P2|Open-label Stabilization Period (SP)|Adverse Event|0
5529308|NCT01412060|19113360|P1|Open-label Stabilization Period (SP)|Adverse Event|9
5529309|NCT01412060|19113358|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
5529310|NCT01412060|19113359|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
5529311|NCT01412060|19113360|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
5529312|NCT01412060|19113358|P3|Period Between RIP and SP|Lost to Follow-up|0
5529313|NCT01412060|19113359|P2|Period Between RIP and SP|Lost to Follow-up|0
5529314|NCT01412060|19113360|P1|Period Between RIP and SP|Lost to Follow-up|5
5529315|NCT01412060|19113358|P3|Period Between RIP and SP|Withdrawal of Consent|0
5529316|NCT01412060|19113359|P2|Period Between RIP and SP|Withdrawal of Consent|0
5529317|NCT01412060|19113360|P1|Period Between RIP and SP|Withdrawal of Consent|1
5529318|NCT01412060|19113358|P3|Period Between RIP and SP|Protocol Violation|0
5529319|NCT01412060|19113359|P2|Period Between RIP and SP|Protocol Violation|0
5529320|NCT01412060|19113360|P1|Period Between RIP and SP|Protocol Violation|2
5529321|NCT01412060|19113358|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
5529322|NCT01412060|19113359|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
5529323|NCT01412060|19113360|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
5529324|NCT01412060|19113358|P3|Period Between RIP and SP|Adverse Event|0
5529325|NCT01412060|19113359|P2|Period Between RIP and SP|Adverse Event|0
5529326|NCT01412060|19113360|P1|Period Between RIP and SP|Adverse Event|4
5529327|NCT01412060|19113358|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
5529328|NCT01412060|19113359|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
5529329|NCT01412060|19113360|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
5529330|NCT01412060|19113358|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
5529331|NCT01412060|19113359|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
5529332|NCT01412060|19113360|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
5529333|NCT01412060|19113358|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
5529334|NCT01412060|19113359|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
5529335|NCT01412060|19113360|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
5529336|NCT01412060|19113358|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
5529337|NCT01412060|19113359|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
5529338|NCT01412060|19113360|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
5529339|NCT01412060|19113358|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
5529340|NCT01412060|19113359|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
5529341|NCT01412060|19113360|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
5529342|NCT01412060|19113358|P3|Open-label Run-in Period (RIP)|Adverse Event|0
5529343|NCT01412060|19113359|P2|Open-label Run-in Period (RIP)|Adverse Event|0
5529344|NCT01412060|19113360|P1|Open-label Run-in Period (RIP)|Adverse Event|86
5529345|NCT01412021|19113370|P1|Overall Study|Transferred to Other Hospital|9
5529346|NCT01412021|19113370|P1|Overall Study|Treatment Prior to Approval|3
5529347|NCT01412021|19113370|P1|Overall Study|Case Report Forms Not Retrieved|7
5529348|NCT01411995|19113407|P2|Overall Study|Failed IUD insertion|1
5529349|NCT01411995|19113408|P1|Overall Study|Failed IUD insertion|0
5529350|NCT01411917|19113416|P2|Overall Study|Patient did not undergo scheduled surger|1
5529351|NCT01411917|19113417|P1|Overall Study|Patient did not undergo scheduled surger|0
5529352|NCT01411891|19113439|P2|Overall Study|Catheter dislodgement or loss to follow-|2
5529353|NCT01411891|19113440|P1|Overall Study|Catheter dislodgement or loss to follow-|3
5529354|NCT01411852|19113450|P2|Hospital Intervention Phase|Vascular access failed|0
5529355|NCT01411852|19113451|P1|Hospital Intervention Phase|Vascular access failed|1
5529356|NCT01411852|19113450|P2|Hospital Intervention Phase|Withdrawal by Subject|0
5529357|NCT01411852|19113451|P1|Hospital Intervention Phase|Withdrawal by Subject|1
5529358|NCT01411852|19113450|P2|Hospital Intervention Phase|Spinal cord injury|0
5529359|NCT01411852|19113451|P1|Hospital Intervention Phase|Spinal cord injury|2
5529360|NCT01411852|19113450|P2|Hospital Intervention Phase|Other ineligible|2
5529361|NCT01411852|19113451|P1|Hospital Intervention Phase|Other ineligible|2
5529362|NCT01411852|19113450|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
5529363|NCT01411852|19113451|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
5529364|NCT01411852|19113450|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
5529365|NCT01411852|19113451|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
5529366|NCT01411852|19113450|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
5529367|NCT01411852|19113451|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
5529368|NCT01411852|19113450|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
5529369|NCT01411852|19113451|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
5529370|NCT01411852|19113450|P2|Hospital Intervention Phase|CPR administered|1
5529371|NCT01411852|19113451|P1|Hospital Intervention Phase|CPR administered|3
5529372|NCT01411852|19113450|P2|Hospital Intervention Phase|Miscommunication error|2
5529373|NCT01411852|19113451|P1|Hospital Intervention Phase|Miscommunication error|1
5529374|NCT01411852|19113450|P2|Hospital Intervention Phase|No qualifying SBP|1
5529375|NCT01411852|19113451|P1|Hospital Intervention Phase|No qualifying SBP|5
5529376|NCT01411852|19113450|P2|Hospital Intervention Phase|Severe head injury|4
5529377|NCT01411852|19113451|P1|Hospital Intervention Phase|Severe head injury|5
5529378|NCT01411852|19113450|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
5529379|NCT01411852|19113451|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
5529380|NCT01411852|19113450|P2|Prehospital Intervention Phase|Found to be under age|1
5529381|NCT01411852|19113451|P1|Prehospital Intervention Phase|Found to be under age|0
5529470|NCT01410227|19114043|P2|Overall Study|Withdrawal by Subject|0
5529382|NCT01411852|19113450|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
5529383|NCT01411852|19113451|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
5529384|NCT01411852|19113450|P2|Prehospital Intervention Phase|No qualifying SBP|4
5529385|NCT01411852|19113451|P1|Prehospital Intervention Phase|No qualifying SBP|5
5529386|NCT01411839|19113496|P2|Overall Study|Lost to Follow-up|3
5529387|NCT01411839|19113497|P1|Overall Study|Lost to Follow-up|4
5529388|NCT01411774|19113509|P2|Overall Study|Withdrawal by Subject|3
5529389|NCT01411774|19113510|P1|Overall Study|Withdrawal by Subject|0
5529390|NCT01411241|19113625|P2|Overall Study|Lost to Follow-up|4
5529391|NCT01411241|19113626|P1|Overall Study|Lost to Follow-up|2
5529392|NCT01411241|19113625|P2|Overall Study|Serious Adverse Event|3
5529393|NCT01411241|19113626|P1|Overall Study|Serious Adverse Event|0
5529394|NCT01411241|19113625|P2|Overall Study|Withdrawal by Subject|10
5529395|NCT01411241|19113626|P1|Overall Study|Withdrawal by Subject|9
5529396|NCT01411241|19113625|P2|Overall Study|Protocol Violation|5
5529397|NCT01411241|19113626|P1|Overall Study|Protocol Violation|0
5529398|NCT01411228|19113651|P3|Overall Study|Withdrawal by Subject|0
5529399|NCT01411228|19113652|P2|Overall Study|Withdrawal by Subject|0
5529400|NCT01411228|19113653|P1|Overall Study|Withdrawal by Subject|1
5529401|NCT01411228|19113651|P3|Overall Study|Lost to Follow-up|1
5529402|NCT01411228|19113652|P2|Overall Study|Lost to Follow-up|0
5529403|NCT01411228|19113653|P1|Overall Study|Lost to Follow-up|0
5529404|NCT01411215|19113675|P2|Overall Study|Screen failure|1
5529405|NCT01411215|19113676|P1|Overall Study|Screen failure|0
5529406|NCT01411215|19113675|P2|Overall Study|Other|17
5529407|NCT01411215|19113676|P1|Overall Study|Other|12
5529408|NCT01411215|19113675|P2|Overall Study|Withdrawal by Subject|21
5529409|NCT01411215|19113676|P1|Overall Study|Withdrawal by Subject|34
5529410|NCT01411215|19113675|P2|Overall Study|Protocol Violation|5
5529411|NCT01411215|19113676|P1|Overall Study|Protocol Violation|3
5529412|NCT01411215|19113675|P2|Overall Study|Study terminated by sponsor|15
5529413|NCT01411215|19113676|P1|Overall Study|Study terminated by sponsor|2
5529414|NCT01411215|19113675|P2|Overall Study|Did not meet entrance criteria|1
5529415|NCT01411215|19113676|P1|Overall Study|Did not meet entrance criteria|0
5529416|NCT01411215|19113675|P2|Overall Study|Lost to Follow-up|18
5529417|NCT01411215|19113676|P1|Overall Study|Lost to Follow-up|12
5529418|NCT01411215|19113675|P2|Overall Study|Lack of Efficacy|4
5529419|NCT01411215|19113676|P1|Overall Study|Lack of Efficacy|2
5529420|NCT01411215|19113675|P2|Overall Study|Adverse Event|2
5529421|NCT01411215|19113676|P1|Overall Study|Adverse Event|1
5529422|NCT01411085|19113728|P1|Overall Study|Adverse Event|1
5529423|NCT01411085|19113728|P1|Overall Study|Protocol Violation|1
5529424|NCT01411085|19113728|P1|Overall Study|Physician Decision|1
5529425|NCT01410799|19113748|P1|Overall Study|PI decision|13
5529426|NCT01410604|19113764|P2|Overall Study|Physician Decision|1
5529427|NCT01410604|19113765|P1|Overall Study|Physician Decision|0
5529428|NCT01410604|19113764|P2|Overall Study|Lost to Follow-up|0
5529429|NCT01410604|19113765|P1|Overall Study|Lost to Follow-up|1
5529430|NCT01410604|19113764|P2|Overall Study|Adverse Event|1
5529431|NCT01410604|19113765|P1|Overall Study|Adverse Event|2
5529432|NCT01410474|19113806|P2|Overall Study|Withdrawal by Subject|1
5529433|NCT01410474|19113807|P1|Overall Study|Withdrawal by Subject|0
5529434|NCT01410448|19113830|P2|Overall Study|Death|3
5529435|NCT01410448|19113831|P1|Overall Study|Death|2
5529436|NCT01410448|19113830|P2|Overall Study|Protocol Violation|4
5529437|NCT01410448|19113831|P1|Overall Study|Protocol Violation|0
5529438|NCT01410448|19113830|P2|Overall Study|Withdrawal by Subject|2
5529439|NCT01410448|19113831|P1|Overall Study|Withdrawal by Subject|3
5529440|NCT01410448|19113830|P2|Overall Study|Lost to Follow-up|0
5529441|NCT01410448|19113831|P1|Overall Study|Lost to Follow-up|1
5529442|NCT01410448|19113830|P2|Overall Study|Administrative issues|1
5529443|NCT01410448|19113831|P1|Overall Study|Administrative issues|2
5529444|NCT01410448|19113830|P2|Overall Study|Graft loss|1
5529445|NCT01410448|19113831|P1|Overall Study|Graft loss|4
5529446|NCT01410448|19113830|P2|Overall Study|No conversion to everolimus|24
5529447|NCT01410448|19113831|P1|Overall Study|No conversion to everolimus|0
5529448|NCT01410357|19113896|P2|Overall Study|Lost to Follow-up|21
5529449|NCT01410357|19113897|P1|Overall Study|Lost to Follow-up|23
5529450|NCT01410357|19113896|P2|Overall Study|Withdrawal by Subject|2
5529451|NCT01410357|19113897|P1|Overall Study|Withdrawal by Subject|1
5529452|NCT01410357|19113896|P2|Overall Study|Death|1
5529453|NCT01410357|19113897|P1|Overall Study|Death|2
5529454|NCT01410240|19113968|P3|Overall Study|Missed week 6 assessments|1
5529455|NCT01410240|19113969|P2|Overall Study|Missed week 6 assessments|1
5529456|NCT01410240|19113970|P1|Overall Study|Missed week 6 assessments|1
5529457|NCT01410240|19113968|P3|Overall Study|Physician Decision|1
5529458|NCT01410240|19113969|P2|Overall Study|Physician Decision|0
5529459|NCT01410240|19113970|P1|Overall Study|Physician Decision|0
5529460|NCT01410227|19114041|P4|Overall Study|Met Excl. Criteria After Starting Study|0
5529461|NCT01410227|19114042|P3|Overall Study|Met Excl. Criteria After Starting Study|1
5529462|NCT01410227|19114043|P2|Overall Study|Met Excl. Criteria After Starting Study|0
5529463|NCT01410227|19114044|P1|Overall Study|Met Excl. Criteria After Starting Study|0
5529464|NCT01410227|19114041|P4|Overall Study|Pregnancy|1
5529465|NCT01410227|19114042|P3|Overall Study|Pregnancy|0
5529466|NCT01410227|19114043|P2|Overall Study|Pregnancy|0
5529467|NCT01410227|19114044|P1|Overall Study|Pregnancy|0
5529468|NCT01410227|19114041|P4|Overall Study|Withdrawal by Subject|0
5529469|NCT01410227|19114042|P3|Overall Study|Withdrawal by Subject|1
5529471|NCT01410227|19114044|P1|Overall Study|Withdrawal by Subject|3
5529472|NCT01410227|19114041|P4|Overall Study|Adverse Event|0
5529473|NCT01410227|19114042|P3|Overall Study|Adverse Event|0
5529474|NCT01410227|19114043|P2|Overall Study|Adverse Event|0
5529475|NCT01410227|19114044|P1|Overall Study|Adverse Event|1
5529476|NCT01410110|19114116|P2|Overall Study|Withdrawal by Subject|2
5529477|NCT01410110|19114117|P1|Overall Study|Withdrawal by Subject|4
5529478|NCT01409993|19114192|P4|Overall Study|Lost to Follow-up|0
5529479|NCT01409993|19114193|P3|Overall Study|Lost to Follow-up|0
5529480|NCT01409993|19114194|P2|Overall Study|Lost to Follow-up|1
5529481|NCT01409993|19114195|P1|Overall Study|Lost to Follow-up|0
5529482|NCT01409993|19114192|P4|Overall Study|Withdrawal by Subject|4
5529483|NCT01409993|19114193|P3|Overall Study|Withdrawal by Subject|0
5529484|NCT01409993|19114194|P2|Overall Study|Withdrawal by Subject|0
5529485|NCT01409993|19114195|P1|Overall Study|Withdrawal by Subject|0
5529486|NCT01409993|19114192|P4|Overall Study|Adverse Event|1
5529487|NCT01409993|19114193|P3|Overall Study|Adverse Event|3
5529488|NCT01409993|19114194|P2|Overall Study|Adverse Event|4
5529489|NCT01409993|19114195|P1|Overall Study|Adverse Event|4
5529490|NCT01409928|19114213|P1|Overall Study|Physician Decision|12
5529491|NCT01409837|19114219|P2|Overall Study|Physician Decision|1
5529492|NCT01409837|19114220|P1|Overall Study|Physician Decision|0
5529493|NCT01409837|19114219|P2|Overall Study|Lost to Follow-up|0
5529494|NCT01409837|19114220|P1|Overall Study|Lost to Follow-up|1
5529495|NCT01409837|19114219|P2|Overall Study|Withdrawal by Subject|1
5529496|NCT01409837|19114220|P1|Overall Study|Withdrawal by Subject|2
5529497|NCT01409811|19114242|P1|Overall Study|Insurance denial|1
5529498|NCT01409707|19114249|P3|Overall Study|Withdrawal by Subject|16
5529499|NCT01409707|19114250|P2|Overall Study|Withdrawal by Subject|17
5529500|NCT01409707|19114251|P1|Overall Study|Withdrawal by Subject|5
5529501|NCT01409564|19114263|P2|Overall Study|brain abnormalities found in T1 MR|2
5529502|NCT01409564|19114264|P1|Overall Study|brain abnormalities found in T1 MR|1
5529503|NCT01409564|19114263|P2|Overall Study|low medication compliance|3
5529504|NCT01409564|19114264|P1|Overall Study|low medication compliance|4
5529505|NCT01409434|19114282|P1|Overall Study|Protocol Violation|4
5529506|NCT01409382|19114292|P2|Overall Study|Had a 2nd trimester loss after accident|0
5529507|NCT01409382|19114293|P1|Overall Study|Had a 2nd trimester loss after accident|1
5529508|NCT01409382|19114292|P2|Overall Study|Did not manage to get pregnant|70
5529509|NCT01409382|19114293|P1|Overall Study|Did not manage to get pregnant|64
5529510|NCT01409382|19114292|P2|Overall Study|Still pregnant when study ended|2
5529511|NCT01409382|19114293|P1|Overall Study|Still pregnant when study ended|13
5529512|NCT01409382|19114292|P2|Overall Study|Multiple pregnancy|4
5529513|NCT01409382|19114293|P1|Overall Study|Multiple pregnancy|2
5529514|NCT01409382|19114292|P2|Overall Study|Protocol Violation|3
5529515|NCT01409382|19114293|P1|Overall Study|Protocol Violation|0
5529516|NCT01409382|19114292|P2|Overall Study|Lost to Follow-up|1
5529517|NCT01409382|19114293|P1|Overall Study|Lost to Follow-up|1
5529518|NCT01409031|19114347|P2|Overall Study|transferred to other hosp|0
5529519|NCT01409031|19114348|P1|Overall Study|transferred to other hosp|1
5529520|NCT01408914|19114379|P3|Overall Study|Change in local TB/HIV norms|1
5529521|NCT01408914|19114380|P2|Overall Study|Change in local TB/HIV norms|1
5529522|NCT01408914|19114381|P1|Overall Study|Change in local TB/HIV norms|0
5529523|NCT01408914|19114379|P3|Overall Study|Late exclusion|3
5529524|NCT01408914|19114380|P2|Overall Study|Late exclusion|3
5529525|NCT01408914|19114381|P1|Overall Study|Late exclusion|0
5529526|NCT01408914|19114379|P3|Overall Study|Moved out of study jurisdiction|0
5529527|NCT01408914|19114380|P2|Overall Study|Moved out of study jurisdiction|1
5529528|NCT01408914|19114381|P1|Overall Study|Moved out of study jurisdiction|1
5529529|NCT01408914|19114379|P3|Overall Study|Withdrawal by Subject|1
5529530|NCT01408914|19114380|P2|Overall Study|Withdrawal by Subject|0
5529531|NCT01408914|19114381|P1|Overall Study|Withdrawal by Subject|1
5529532|NCT01408914|19114379|P3|Overall Study|Physician Decision|0
5529533|NCT01408914|19114380|P2|Overall Study|Physician Decision|1
5529534|NCT01408914|19114381|P1|Overall Study|Physician Decision|1
5529535|NCT01408914|19114379|P3|Overall Study|Lost to Follow-up|2
5529536|NCT01408914|19114380|P2|Overall Study|Lost to Follow-up|1
5529537|NCT01408914|19114381|P1|Overall Study|Lost to Follow-up|4
5529538|NCT01408914|19114379|P3|Overall Study|Could not complete tx in protocol period|6
5529539|NCT01408914|19114380|P2|Overall Study|Could not complete tx in protocol period|5
5529540|NCT01408914|19114381|P1|Overall Study|Could not complete tx in protocol period|5
5529541|NCT01408901|19114399|P4|26-Week Follow-Up|Death|0
5529542|NCT01408901|19114400|P3|26-Week Follow-Up|Death|0
5529543|NCT01408901|19114401|P2|26-Week Follow-Up|Death|1
5529544|NCT01408901|19114402|P1|26-Week Follow-Up|Death|0
5529545|NCT01408901|19114399|P4|26-Week Follow-Up|Lost to Follow-up|1
5529546|NCT01408901|19114400|P3|26-Week Follow-Up|Lost to Follow-up|0
5529547|NCT01408901|19114401|P2|26-Week Follow-Up|Lost to Follow-up|1
5529548|NCT01408901|19114402|P1|26-Week Follow-Up|Lost to Follow-up|1
5529549|NCT01408901|19114399|P4|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
5529550|NCT01408901|19114400|P3|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
5529551|NCT01408901|19114401|P2|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
5529552|NCT01408901|19114402|P1|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
5529553|NCT01408901|19114399|P4|12-Week Follow-Up (Primary Endpoint)|Death|0
5529554|NCT01408901|19114400|P3|12-Week Follow-Up (Primary Endpoint)|Death|0
5529555|NCT01408901|19114401|P2|12-Week Follow-Up (Primary Endpoint)|Death|0
5529556|NCT01408901|19114402|P1|12-Week Follow-Up (Primary Endpoint)|Death|1
5529557|NCT01408901|19114399|P4|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
5529558|NCT01408901|19114400|P3|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
5529559|NCT01408901|19114401|P2|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
5529560|NCT01408901|19114402|P1|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
5529561|NCT01408901|19114399|P4|6-Week Follow-Up|Cancelled visit|2
5529562|NCT01408901|19114400|P3|6-Week Follow-Up|Cancelled visit|0
5529563|NCT01408901|19114401|P2|6-Week Follow-Up|Cancelled visit|1
5529564|NCT01408901|19114402|P1|6-Week Follow-Up|Cancelled visit|0
5529565|NCT01408901|19114399|P4|6-Week Follow-Up|Death|0
5529566|NCT01408901|19114400|P3|6-Week Follow-Up|Death|0
5529567|NCT01408901|19114401|P2|6-Week Follow-Up|Death|0
5529568|NCT01408901|19114402|P1|6-Week Follow-Up|Death|1
5529569|NCT01408901|19114399|P4|6-Week Follow-Up|Lost to Follow-up|2
5529570|NCT01408901|19114400|P3|6-Week Follow-Up|Lost to Follow-up|3
5529571|NCT01408901|19114401|P2|6-Week Follow-Up|Lost to Follow-up|1
5529572|NCT01408901|19114402|P1|6-Week Follow-Up|Lost to Follow-up|2
5529573|NCT01408888|19114428|P2|Second Intervention|Adverse Event|0
5529574|NCT01408888|19114429|P1|Second Intervention|Adverse Event|1
5529575|NCT01408888|19114428|P2|Second Intervention|Withdrawal by Subject|0
5529576|NCT01408888|19114429|P1|Second Intervention|Withdrawal by Subject|1
5529577|NCT01408888|19114428|P2|First Intervention|Withdrawal by Subject|2
5529578|NCT01408888|19114429|P1|First Intervention|Withdrawal by Subject|0
5529579|NCT01408888|19114428|P2|First Intervention|Adverse Event|1
5529580|NCT01408888|19114429|P1|First Intervention|Adverse Event|0
5529581|NCT01408732|19114457|P2|Overall Study|Withdrawal by Subject|2
5529582|NCT01408732|19114458|P1|Overall Study|Withdrawal by Subject|2
5529583|NCT01408706|19114515|P2|Overall Study|Physician Decision|0
5529584|NCT01408706|19114516|P1|Overall Study|Physician Decision|1
5529585|NCT01408641|19114528|P2|Overall Study|Physician Decision|0
5529586|NCT01408641|19114529|P1|Overall Study|Physician Decision|1
5529587|NCT01408628|19114537|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
5529588|NCT01408628|19114537|P1|Completed 6 Month Follow-Up|Protocol Violation|6
5529589|NCT01408628|19114537|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
5529590|NCT01408628|19114537|P1|Consented|Withdrawal by Subject|12
5529591|NCT01408576|19114546|P3|Overall Study|Other|18
5529592|NCT01408576|19114547|P2|Overall Study|Other|16
5529593|NCT01408576|19114548|P1|Overall Study|Other|10
5529594|NCT01408576|19114546|P3|Overall Study|AE, unknown type|0
5529595|NCT01408576|19114547|P2|Overall Study|AE, unknown type|1
5529596|NCT01408576|19114548|P1|Overall Study|AE, unknown type|0
5529597|NCT01408576|19114546|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5529598|NCT01408576|19114547|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5529599|NCT01408576|19114548|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5529600|NCT01408576|19114546|P3|Overall Study|AE, non-serious non-fatal|11
5529601|NCT01408576|19114547|P2|Overall Study|AE, non-serious non-fatal|19
5529602|NCT01408576|19114548|P1|Overall Study|AE, non-serious non-fatal|12
5529603|NCT01408576|19114546|P3|Overall Study|SAE, non-fatal|14
5529604|NCT01408576|19114547|P2|Overall Study|SAE, non-fatal|23
5529605|NCT01408576|19114548|P1|Overall Study|SAE, non-fatal|11
5529606|NCT01408576|19114546|P3|Overall Study|AE, serious fatal|1
5529607|NCT01408576|19114547|P2|Overall Study|AE, serious fatal|4
5529608|NCT01408576|19114548|P1|Overall Study|AE, serious fatal|4
5529609|NCT01408576|19114546|P3|Overall Study|Sponsor terminated study|330
5529610|NCT01408576|19114547|P2|Overall Study|Sponsor terminated study|333
5529611|NCT01408576|19114548|P1|Overall Study|Sponsor terminated study|89
5529612|NCT01408576|19114546|P3|Overall Study|Withdrawal by Subject|66
5529613|NCT01408576|19114547|P2|Overall Study|Withdrawal by Subject|60
5529614|NCT01408576|19114548|P1|Overall Study|Withdrawal by Subject|34
5529615|NCT01408576|19114546|P3|Overall Study|Lost to Follow-up|17
5529616|NCT01408576|19114547|P2|Overall Study|Lost to Follow-up|9
5529617|NCT01408576|19114548|P1|Overall Study|Lost to Follow-up|10
5529618|NCT01408576|19114546|P3|Overall Study|Protocol Violation|2
5529619|NCT01408576|19114547|P2|Overall Study|Protocol Violation|2
5529620|NCT01408576|19114548|P1|Overall Study|Protocol Violation|1
5529621|NCT01408576|19114546|P3|Overall Study|Lack of Efficacy|48
5529622|NCT01408576|19114547|P2|Overall Study|Lack of Efficacy|30
5529623|NCT01408576|19114548|P1|Overall Study|Lack of Efficacy|17
5529624|NCT01408563|19114595|P1|Overall Study|Ineligible after consent/ registration|2
5529625|NCT01408537|19114611|P1|Overall Study|Lost to Follow-up|3
5529626|NCT01408537|19114611|P1|Overall Study|Protocol Violation|3
5529627|NCT01408537|19114611|P1|Overall Study|Withdrawal by Subject|2
5529628|NCT01408485|19114627|P1|Overall Study|Withdrawal by Subject|21
5529629|NCT01408303|19114645|P3|Overall Study|Noncompliance|1
5529630|NCT01408303|19114646|P2|Overall Study|Noncompliance|0
5529631|NCT01408303|19114647|P1|Overall Study|Noncompliance|1
5529632|NCT01408303|19114645|P3|Overall Study|Protocol Violation|0
5529633|NCT01408303|19114646|P2|Overall Study|Protocol Violation|1
5529634|NCT01408303|19114647|P1|Overall Study|Protocol Violation|0
5529635|NCT01408303|19114645|P3|Overall Study|Withdrawal by Subject|1
5529636|NCT01408303|19114646|P2|Overall Study|Withdrawal by Subject|3
5529637|NCT01408303|19114647|P1|Overall Study|Withdrawal by Subject|2
5529638|NCT01408303|19114645|P3|Overall Study|Lost to Follow-up|2
5529639|NCT01408303|19114646|P2|Overall Study|Lost to Follow-up|1
5529640|NCT01408303|19114647|P1|Overall Study|Lost to Follow-up|0
5529641|NCT01408303|19114645|P3|Overall Study|Adverse Event|2
5529642|NCT01408303|19114646|P2|Overall Study|Adverse Event|7
5529643|NCT01408303|19114647|P1|Overall Study|Adverse Event|3
5529644|NCT01408277|19114657|P2|Overall Study|Protocol Violation|0
5529645|NCT01408277|19114658|P1|Overall Study|Protocol Violation|2
5529646|NCT01408277|19114657|P2|Overall Study|Withdrawal by Subject|0
5529647|NCT01408277|19114658|P1|Overall Study|Withdrawal by Subject|2
5529648|NCT01408277|19114657|P2|Overall Study|Lost to Follow-up|0
5529649|NCT01408277|19114658|P1|Overall Study|Lost to Follow-up|1
5529650|NCT01408277|19114657|P2|Overall Study|Adverse Event|4
5529651|NCT01408277|19114658|P1|Overall Study|Adverse Event|3
5529652|NCT01408147|19114666|P2|Overall Study|Withdrawal by Subject|1
5529653|NCT01408147|19114667|P1|Overall Study|Withdrawal by Subject|0
5529654|NCT01408043|19114675|P1|Overall Study|unable to collect cells|1
5529655|NCT01408030|19114694|P4|Observation Phase (Off Drug)|Other|1
5529656|NCT01408030|19114695|P3|Observation Phase (Off Drug)|Other|1
5529657|NCT01408030|19114696|P2|Observation Phase (Off Drug)|Other|1
5529658|NCT01408030|19114697|P1|Observation Phase (Off Drug)|Other|1
5529659|NCT01408030|19114694|P4|Observation Phase (Off Drug)|Physician Decision|0
5529660|NCT01408030|19114695|P3|Observation Phase (Off Drug)|Physician Decision|2
5529661|NCT01408030|19114696|P2|Observation Phase (Off Drug)|Physician Decision|1
5529662|NCT01408030|19114697|P1|Observation Phase (Off Drug)|Physician Decision|0
5529663|NCT01408030|19114694|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
5529664|NCT01408030|19114695|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
5529665|NCT01408030|19114696|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
5529666|NCT01408030|19114697|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
5529667|NCT01408030|19114694|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
5529668|NCT01408030|19114695|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
5529669|NCT01408030|19114696|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
5529670|NCT01408030|19114697|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
5529671|NCT01408030|19114694|P4|Treatment Phase (on Drug)|Protocol Violation|0
5529672|NCT01408030|19114695|P3|Treatment Phase (on Drug)|Protocol Violation|0
5529673|NCT01408030|19114696|P2|Treatment Phase (on Drug)|Protocol Violation|1
5529674|NCT01408030|19114697|P1|Treatment Phase (on Drug)|Protocol Violation|0
5529675|NCT01408030|19114694|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
5529676|NCT01408030|19114695|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
5529677|NCT01408030|19114696|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
5529678|NCT01408030|19114697|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
5529679|NCT01408030|19114694|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
5529680|NCT01408030|19114695|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
5529681|NCT01408030|19114696|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
5529682|NCT01408030|19114697|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
5529683|NCT01407926|19114756|P1|Overall Study|Lost to Follow-up|55
5529684|NCT01407367|19114804|P2|Overall Study|Lost to Follow-up|2
5529685|NCT01407367|19114805|P1|Overall Study|Lost to Follow-up|0
5529686|NCT01407367|19114804|P2|Overall Study|Withdrawal by Subject|15
5529687|NCT01407367|19114805|P1|Overall Study|Withdrawal by Subject|4
5529688|NCT01407367|19114804|P2|Overall Study|Renal Replacement Therapy (RRT)|29
5529689|NCT01407367|19114805|P1|Overall Study|Renal Replacement Therapy (RRT)|12
5529690|NCT01407367|19114804|P2|Overall Study|Death|32
5529691|NCT01407367|19114805|P1|Overall Study|Death|24
5529692|NCT01407354|19114819|P2|First Intervention|Physician Decision|0
5529693|NCT01407354|19114820|P1|First Intervention|Physician Decision|1
5529694|NCT01407354|19114819|P2|First Intervention|Adverse Event|0
5529695|NCT01407354|19114820|P1|First Intervention|Adverse Event|1
5529696|NCT01407354|19114819|P2|First Intervention|Withdrawal by Subject|2
5529697|NCT01407354|19114820|P1|First Intervention|Withdrawal by Subject|0
5529698|NCT01407276|19114836|P8|Overall Study|Withdrawal by Subject|1
5529699|NCT01407276|19114837|P7|Overall Study|Withdrawal by Subject|0
5529700|NCT01407276|19114838|P6|Overall Study|Withdrawal by Subject|0
5529701|NCT01407276|19114839|P5|Overall Study|Withdrawal by Subject|0
5529702|NCT01407276|19114840|P4|Overall Study|Withdrawal by Subject|0
5529703|NCT01407276|19114841|P3|Overall Study|Withdrawal by Subject|0
5529704|NCT01407276|19114842|P2|Overall Study|Withdrawal by Subject|0
5529705|NCT01407276|19114843|P1|Overall Study|Withdrawal by Subject|0
5529706|NCT01406938|19114995|P6|Follow up|Lost to Follow-up|1
5529707|NCT01406938|19114996|P5|Follow up|Lost to Follow-up|2
5529708|NCT01406938|19114997|P4|Follow up|Lost to Follow-up|1
5529709|NCT01406938|19114998|P3|Follow up|Lost to Follow-up|0
5529710|NCT01406938|19114999|P2|Follow up|Lost to Follow-up|1
5529711|NCT01406938|19115000|P1|Follow up|Lost to Follow-up|1
5529712|NCT01406938|19114995|P6|Follow up|Physician Decision|1
5529713|NCT01406938|19114996|P5|Follow up|Physician Decision|3
5529714|NCT01406938|19114997|P4|Follow up|Physician Decision|0
5529715|NCT01406938|19114998|P3|Follow up|Physician Decision|2
5529716|NCT01406938|19114999|P2|Follow up|Physician Decision|0
5529717|NCT01406938|19115000|P1|Follow up|Physician Decision|0
5529718|NCT01406938|19114995|P6|Follow up|Protocol Violation|0
5529719|NCT01406938|19114996|P5|Follow up|Protocol Violation|0
5529720|NCT01406938|19114997|P4|Follow up|Protocol Violation|0
5529721|NCT01406938|19114998|P3|Follow up|Protocol Violation|1
5529722|NCT01406938|19114999|P2|Follow up|Protocol Violation|0
5529723|NCT01406938|19115000|P1|Follow up|Protocol Violation|0
5529724|NCT01406938|19114995|P6|Follow up|Patient/guardian decision|1
5529725|NCT01406938|19114996|P5|Follow up|Patient/guardian decision|4
5529726|NCT01406938|19114997|P4|Follow up|Patient/guardian decision|2
5529727|NCT01406938|19114998|P3|Follow up|Patient/guardian decision|4
5529728|NCT01406938|19114999|P2|Follow up|Patient/guardian decision|2
5529729|NCT01406938|19115000|P1|Follow up|Patient/guardian decision|4
5529730|NCT01406938|19114995|P6|Follow up|Lack of Efficacy|0
5529731|NCT01406938|19114996|P5|Follow up|Lack of Efficacy|0
5529732|NCT01406938|19114997|P4|Follow up|Lack of Efficacy|0
5529733|NCT01406938|19114998|P3|Follow up|Lack of Efficacy|1
5529734|NCT01406938|19114999|P2|Follow up|Lack of Efficacy|2
5529735|NCT01406938|19115000|P1|Follow up|Lack of Efficacy|3
5529736|NCT01406938|19114995|P6|Maintenance Period|Lack of Efficacy|5
5529737|NCT01406938|19114996|P5|Maintenance Period|Lack of Efficacy|3
5529738|NCT01406938|19114997|P4|Maintenance Period|Lack of Efficacy|1
5529739|NCT01406938|19114998|P3|Maintenance Period|Lack of Efficacy|2
5529740|NCT01406938|19114999|P2|Maintenance Period|Lack of Efficacy|0
5529741|NCT01406938|19115000|P1|Maintenance Period|Lack of Efficacy|0
5529742|NCT01406938|19114995|P6|Maintenance Period|Lost to Follow-up|0
5529743|NCT01406938|19114996|P5|Maintenance Period|Lost to Follow-up|4
5529744|NCT01406938|19114997|P4|Maintenance Period|Lost to Follow-up|0
5529745|NCT01406938|19114998|P3|Maintenance Period|Lost to Follow-up|0
5529746|NCT01406938|19114999|P2|Maintenance Period|Lost to Follow-up|0
5529747|NCT01406938|19115000|P1|Maintenance Period|Lost to Follow-up|0
5529748|NCT01406938|19114995|P6|Maintenance Period|Pregnancy|0
5529749|NCT01406938|19114996|P5|Maintenance Period|Pregnancy|1
5529750|NCT01406938|19114997|P4|Maintenance Period|Pregnancy|0
5529751|NCT01406938|19114998|P3|Maintenance Period|Pregnancy|0
5529752|NCT01406938|19114999|P2|Maintenance Period|Pregnancy|0
5529753|NCT01406938|19115000|P1|Maintenance Period|Pregnancy|0
5529754|NCT01406938|19114995|P6|Maintenance Period|Protocol Violation|2
5529755|NCT01406938|19114996|P5|Maintenance Period|Protocol Violation|2
5529756|NCT01406938|19114997|P4|Maintenance Period|Protocol Violation|2
5529757|NCT01406938|19114998|P3|Maintenance Period|Protocol Violation|2
5529758|NCT01406938|19114999|P2|Maintenance Period|Protocol Violation|0
5529759|NCT01406938|19115000|P1|Maintenance Period|Protocol Violation|0
5529760|NCT01406938|19114995|P6|Maintenance Period|Subject/guardian decision|7
5529761|NCT01406938|19114996|P5|Maintenance Period|Subject/guardian decision|10
5529762|NCT01406938|19114997|P4|Maintenance Period|Subject/guardian decision|7
5529763|NCT01406938|19114998|P3|Maintenance Period|Subject/guardian decision|11
5529764|NCT01406938|19114999|P2|Maintenance Period|Subject/guardian decision|0
5529765|NCT01406938|19115000|P1|Maintenance Period|Subject/guardian decision|0
5529766|NCT01406938|19114995|P6|Maintenance Period|Death|0
5529767|NCT01406938|19114996|P5|Maintenance Period|Death|1
5529768|NCT01406938|19114997|P4|Maintenance Period|Death|0
5529769|NCT01406938|19114998|P3|Maintenance Period|Death|0
5529770|NCT01406938|19114999|P2|Maintenance Period|Death|0
5529771|NCT01406938|19115000|P1|Maintenance Period|Death|0
5529772|NCT01406938|19114995|P6|Maintenance Period|Adverse Event|2
5529773|NCT01406938|19114996|P5|Maintenance Period|Adverse Event|4
5529774|NCT01406938|19114997|P4|Maintenance Period|Adverse Event|8
5529775|NCT01406938|19114998|P3|Maintenance Period|Adverse Event|2
5529776|NCT01406938|19114999|P2|Maintenance Period|Adverse Event|0
5529777|NCT01406938|19115000|P1|Maintenance Period|Adverse Event|0
5529778|NCT01406938|19114995|P6|Induction Period|Lost to Follow-up|0
5529779|NCT01406938|19114996|P5|Induction Period|Lost to Follow-up|0
5529780|NCT01406938|19114997|P4|Induction Period|Lost to Follow-up|0
5529781|NCT01406938|19114998|P3|Induction Period|Lost to Follow-up|0
5529782|NCT01406938|19114999|P2|Induction Period|Lost to Follow-up|3
5529783|NCT01406938|19115000|P1|Induction Period|Lost to Follow-up|2
5529784|NCT01406938|19114995|P6|Induction Period|Lack of Efficacy|0
5529785|NCT01406938|19114996|P5|Induction Period|Lack of Efficacy|0
5529786|NCT01406938|19114997|P4|Induction Period|Lack of Efficacy|0
5529787|NCT01406938|19114998|P3|Induction Period|Lack of Efficacy|0
5529788|NCT01406938|19114999|P2|Induction Period|Lack of Efficacy|0
5529789|NCT01406938|19115000|P1|Induction Period|Lack of Efficacy|1
5529790|NCT01406938|19114995|P6|Induction Period|Adverse Event|0
5529791|NCT01406938|19114996|P5|Induction Period|Adverse Event|0
5529792|NCT01406938|19114997|P4|Induction Period|Adverse Event|0
5529793|NCT01406938|19114998|P3|Induction Period|Adverse Event|0
5529794|NCT01406938|19114999|P2|Induction Period|Adverse Event|9
5529795|NCT01406938|19115000|P1|Induction Period|Adverse Event|8
5529796|NCT01406938|19114995|P6|Induction Period|Protocol deviation|0
5529797|NCT01406938|19114996|P5|Induction Period|Protocol deviation|0
5529798|NCT01406938|19114997|P4|Induction Period|Protocol deviation|0
5529799|NCT01406938|19114998|P3|Induction Period|Protocol deviation|0
5529800|NCT01406938|19114999|P2|Induction Period|Protocol deviation|0
5529801|NCT01406938|19115000|P1|Induction Period|Protocol deviation|1
5529802|NCT01406938|19114995|P6|Induction Period|Subject/guardian decision|0
5529803|NCT01406938|19114996|P5|Induction Period|Subject/guardian decision|0
5529804|NCT01406938|19114997|P4|Induction Period|Subject/guardian decision|0
5529805|NCT01406938|19114998|P3|Induction Period|Subject/guardian decision|0
5529806|NCT01406938|19114999|P2|Induction Period|Subject/guardian decision|8
5529807|NCT01406938|19115000|P1|Induction Period|Subject/guardian decision|6
5529808|NCT01406873|19115118|P2|Overall Study|Withdrawal by Subject|1
5529809|NCT01406873|19115119|P1|Overall Study|Withdrawal by Subject|1
5529810|NCT01406795|19115150|P1|Overall Study|Withdrawal by Subject|1
5529811|NCT01406717|19115166|P2|Overall Study|Non-completion of visit activity|1
5529812|NCT01406717|19115167|P1|Overall Study|Non-completion of visit activity|0
5529813|NCT01406717|19115166|P2|Overall Study|Lack of Efficacy|1
5529814|NCT01406717|19115167|P1|Overall Study|Lack of Efficacy|0
5529815|NCT01406717|19115166|P2|Overall Study|Adverse Event|2
5529816|NCT01406717|19115167|P1|Overall Study|Adverse Event|1
5529817|NCT01406717|19115166|P2|Overall Study|Withdrawal by Subject|15
5529818|NCT01406717|19115167|P1|Overall Study|Withdrawal by Subject|19
5529819|NCT01406717|19115166|P2|Overall Study|Lost to Follow-up|8
5529820|NCT01406717|19115167|P1|Overall Study|Lost to Follow-up|14
5529821|NCT01406717|19115166|P2|Overall Study|Protocol Violation|1
5529822|NCT01406717|19115167|P1|Overall Study|Protocol Violation|5
5529823|NCT01406717|19115166|P2|Overall Study|Subject non-compliance|3
5529824|NCT01406717|19115167|P1|Overall Study|Subject non-compliance|4
5529825|NCT01406652|19115197|P2|Overall Study|Infection not sure|10
5529826|NCT01406652|19115198|P1|Overall Study|Infection not sure|10
5529827|NCT01406652|19115197|P2|Overall Study|Insufficient follow-up|4
5529828|NCT01406652|19115198|P1|Overall Study|Insufficient follow-up|5
5529829|NCT01406652|19115197|P2|Overall Study|Withdrawal by Subject|2
5529830|NCT01406652|19115198|P1|Overall Study|Withdrawal by Subject|2
5529831|NCT01406652|19115197|P2|Overall Study|Lost-to-follow-up|4
5529832|NCT01406652|19115198|P1|Overall Study|Lost-to-follow-up|3
5529833|NCT01406574|19115206|P4|Overall Study|Definite progression of primary disease|0
5529834|NCT01406574|19115207|P3|Overall Study|Definite progression of primary disease|0
5529835|NCT01406574|19115208|P2|Overall Study|Definite progression of primary disease|0
5529836|NCT01406574|19115209|P1|Overall Study|Definite progression of primary disease|1
5529837|NCT01406574|19115206|P4|Overall Study|Withdrawal by Subject|0
5529838|NCT01406574|19115207|P3|Overall Study|Withdrawal by Subject|0
5529839|NCT01406574|19115208|P2|Overall Study|Withdrawal by Subject|1
5529840|NCT01406574|19115209|P1|Overall Study|Withdrawal by Subject|0
5529841|NCT01406574|19115206|P4|Overall Study|Physician Decision|1
5529842|NCT01406574|19115207|P3|Overall Study|Physician Decision|0
5529843|NCT01406574|19115208|P2|Overall Study|Physician Decision|0
5529844|NCT01406574|19115209|P1|Overall Study|Physician Decision|0
5529845|NCT01406574|19115206|P4|Overall Study|Adverse Event|3
5529846|NCT01406574|19115207|P3|Overall Study|Adverse Event|1
5529847|NCT01406574|19115208|P2|Overall Study|Adverse Event|0
5529848|NCT01406574|19115209|P1|Overall Study|Adverse Event|0
5529849|NCT01406015|19115260|P2|Overall Study|Withdrawal by Subject|3
5529850|NCT01406015|19115261|P1|Overall Study|Withdrawal by Subject|3
5529851|NCT01405950|19115277|P4|Overall Study|Withdrawal by Subject|0
5529852|NCT01405950|19115278|P3|Overall Study|Withdrawal by Subject|0
5529853|NCT01405950|19115279|P2|Overall Study|Withdrawal by Subject|0
5529854|NCT01405950|19115280|P1|Overall Study|Withdrawal by Subject|1
5529855|NCT01405924|19115315|P1|Overall Study|Missing/Incomplete Data|2
5529856|NCT01405924|19115315|P1|Overall Study|Protocol Violation|8
5529857|NCT01405911|19115328|P3|Overall Study|Withdrawal by Subject|1
5529858|NCT01405911|19115329|P2|Overall Study|Withdrawal by Subject|1
5529859|NCT01405911|19115330|P1|Overall Study|Withdrawal by Subject|3
5529860|NCT01405911|19115328|P3|Overall Study|Protocol Violation|0
5529861|NCT01405911|19115329|P2|Overall Study|Protocol Violation|0
5529862|NCT01405911|19115330|P1|Overall Study|Protocol Violation|1
5529863|NCT01405911|19115328|P3|Overall Study|Lost to Follow-up|0
5529864|NCT01405911|19115329|P2|Overall Study|Lost to Follow-up|1
5529865|NCT01405911|19115330|P1|Overall Study|Lost to Follow-up|0
5529866|NCT01405911|19115328|P3|Overall Study|Pre-treatment lab AE|0
5529867|NCT01405911|19115329|P2|Overall Study|Pre-treatment lab AE|1
5529868|NCT01405911|19115330|P1|Overall Study|Pre-treatment lab AE|0
5529869|NCT01405898|19115349|P2|Overall Study|Withdrawal by Subject|2
5529870|NCT01405898|19115350|P1|Overall Study|Withdrawal by Subject|2
5529871|NCT01405820|19115374|P6|Open-Label Treatment Period|Adverse Event|0
5529872|NCT01405820|19115375|P5|Open-Label Treatment Period|Adverse Event|0
5529873|NCT01405820|19115376|P4|Open-Label Treatment Period|Adverse Event|1
5529874|NCT01405820|19115377|P3|Open-Label Treatment Period|Adverse Event|0
5529875|NCT01405820|19115378|P2|Open-Label Treatment Period|Adverse Event|0
5529876|NCT01405820|19115379|P1|Open-Label Treatment Period|Adverse Event|0
5529877|NCT01405820|19115374|P6|Open-Label Treatment Period|Physician Decision|0
5529878|NCT01405820|19115375|P5|Open-Label Treatment Period|Physician Decision|1
5529879|NCT01405820|19115376|P4|Open-Label Treatment Period|Physician Decision|2
5529880|NCT01405820|19115377|P3|Open-Label Treatment Period|Physician Decision|1
5529881|NCT01405820|19115378|P2|Open-Label Treatment Period|Physician Decision|0
5529882|NCT01405820|19115379|P1|Open-Label Treatment Period|Physician Decision|0
5529883|NCT01405820|19115374|P6|Open-Label Treatment Period|Other|1
5529884|NCT01405820|19115375|P5|Open-Label Treatment Period|Other|1
5529885|NCT01405820|19115376|P4|Open-Label Treatment Period|Other|1
5529886|NCT01405820|19115377|P3|Open-Label Treatment Period|Other|1
5529887|NCT01405820|19115378|P2|Open-Label Treatment Period|Other|1
5529888|NCT01405820|19115379|P1|Open-Label Treatment Period|Other|1
5529889|NCT01405820|19115374|P6|Open-Label Treatment Period|Withdrawal by Subject|1
5529890|NCT01405820|19115375|P5|Open-Label Treatment Period|Withdrawal by Subject|0
5529891|NCT01405820|19115376|P4|Open-Label Treatment Period|Withdrawal by Subject|1
5529892|NCT01405820|19115377|P3|Open-Label Treatment Period|Withdrawal by Subject|1
5529893|NCT01405820|19115378|P2|Open-Label Treatment Period|Withdrawal by Subject|1
5529894|NCT01405820|19115379|P1|Open-Label Treatment Period|Withdrawal by Subject|3
5529895|NCT01405820|19115374|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
5529896|NCT01405820|19115375|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
5529897|NCT01405820|19115376|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
5529898|NCT01405820|19115377|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
5529899|NCT01405820|19115378|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
5529900|NCT01405820|19115379|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
5529901|NCT01405820|19115374|P6|Randomized Treatment Period|Death|0
5529902|NCT01405820|19115375|P5|Randomized Treatment Period|Death|0
5529903|NCT01405820|19115376|P4|Randomized Treatment Period|Death|1
5529904|NCT01405820|19115377|P3|Randomized Treatment Period|Death|0
5529905|NCT01405820|19115378|P2|Randomized Treatment Period|Death|0
5529906|NCT01405820|19115379|P1|Randomized Treatment Period|Death|0
5529907|NCT01405820|19115374|P6|Randomized Treatment Period|Treatment Arm Closed|28
5529908|NCT01405820|19115375|P5|Randomized Treatment Period|Treatment Arm Closed|33
5529909|NCT01405820|19115376|P4|Randomized Treatment Period|Treatment Arm Closed|36
5529910|NCT01405820|19115377|P3|Randomized Treatment Period|Treatment Arm Closed|20
5529911|NCT01405820|19115378|P2|Randomized Treatment Period|Treatment Arm Closed|0
5529912|NCT01405820|19115379|P1|Randomized Treatment Period|Treatment Arm Closed|0
5529913|NCT01405820|19115374|P6|Randomized Treatment Period|Incorrect Study Treatment|0
5529914|NCT01405820|19115375|P5|Randomized Treatment Period|Incorrect Study Treatment|2
5529915|NCT01405820|19115376|P4|Randomized Treatment Period|Incorrect Study Treatment|0
5529916|NCT01405820|19115377|P3|Randomized Treatment Period|Incorrect Study Treatment|3
5529917|NCT01405820|19115378|P2|Randomized Treatment Period|Incorrect Study Treatment|0
5529918|NCT01405820|19115379|P1|Randomized Treatment Period|Incorrect Study Treatment|0
5529919|NCT01405820|19115374|P6|Randomized Treatment Period|Rescue|8
5529920|NCT01405820|19115375|P5|Randomized Treatment Period|Rescue|8
5529921|NCT01405820|19115376|P4|Randomized Treatment Period|Rescue|10
5529922|NCT01405820|19115377|P3|Randomized Treatment Period|Rescue|13
5529923|NCT01405820|19115378|P2|Randomized Treatment Period|Rescue|1
5529924|NCT01405820|19115379|P1|Randomized Treatment Period|Rescue|0
5529925|NCT01405820|19115374|P6|Randomized Treatment Period|Physician Decision|0
5529926|NCT01405820|19115375|P5|Randomized Treatment Period|Physician Decision|0
5529927|NCT01405820|19115376|P4|Randomized Treatment Period|Physician Decision|0
5529928|NCT01405820|19115377|P3|Randomized Treatment Period|Physician Decision|1
5529929|NCT01405820|19115378|P2|Randomized Treatment Period|Physician Decision|2
5529930|NCT01405820|19115379|P1|Randomized Treatment Period|Physician Decision|0
5529931|NCT01405820|19115374|P6|Randomized Treatment Period|Other|0
5529932|NCT01405820|19115375|P5|Randomized Treatment Period|Other|0
5529933|NCT01405820|19115376|P4|Randomized Treatment Period|Other|1
5529934|NCT01405820|19115377|P3|Randomized Treatment Period|Other|1
5529935|NCT01405820|19115378|P2|Randomized Treatment Period|Other|2
5529936|NCT01405820|19115379|P1|Randomized Treatment Period|Other|2
5529937|NCT01405820|19115374|P6|Randomized Treatment Period|Withdrawal by Subject|0
5529938|NCT01405820|19115375|P5|Randomized Treatment Period|Withdrawal by Subject|0
5529939|NCT01405820|19115376|P4|Randomized Treatment Period|Withdrawal by Subject|2
5529940|NCT01405820|19115377|P3|Randomized Treatment Period|Withdrawal by Subject|2
5529941|NCT01405820|19115378|P2|Randomized Treatment Period|Withdrawal by Subject|2
5529942|NCT01405820|19115379|P1|Randomized Treatment Period|Withdrawal by Subject|6
5529943|NCT01405820|19115374|P6|Randomized Treatment Period|Adverse Event|1
5529944|NCT01405820|19115375|P5|Randomized Treatment Period|Adverse Event|2
5529945|NCT01405820|19115376|P4|Randomized Treatment Period|Adverse Event|0
5529946|NCT01405820|19115377|P3|Randomized Treatment Period|Adverse Event|3
5529947|NCT01405820|19115378|P2|Randomized Treatment Period|Adverse Event|3
5529948|NCT01405820|19115379|P1|Randomized Treatment Period|Adverse Event|3
5529949|NCT01405768|19115475|P2|Overall Study|Didn't complete questionnaire correctly|0
5529950|NCT01405768|19115476|P1|Overall Study|Didn't complete questionnaire correctly|4
5529951|NCT01405742|19115488|P2|Overall Study|Lost to Follow-up|0
5529952|NCT01405742|19115489|P1|Overall Study|Lost to Follow-up|1
5529953|NCT01405560|19115499|P1|Overall Study|Physician Decision|1
5529954|NCT01405508|19115514|P4|Overall Study|AE, non-serious non-fatal|0
5529955|NCT01405508|19115515|P3|Overall Study|AE, non-serious non-fatal|0
5529956|NCT01405508|19115516|P2|Overall Study|AE, non-serious non-fatal|1
5529957|NCT01405508|19115517|P1|Overall Study|AE, non-serious non-fatal|1
5529958|NCT01405456|19115549|P2|Overall Study|Physician Decision|0
5529959|NCT01405456|19115550|P1|Overall Study|Physician Decision|1
5529960|NCT01405456|19115549|P2|Overall Study|Lost to Follow-up|1
5529961|NCT01405456|19115550|P1|Overall Study|Lost to Follow-up|2
5529962|NCT01405196|19115590|P4|Overall Study|Lost to Follow-up|1
5529963|NCT01405196|19115591|P3|Overall Study|Lost to Follow-up|3
5529964|NCT01405196|19115592|P2|Overall Study|Lost to Follow-up|2
5529965|NCT01405196|19115593|P1|Overall Study|Lost to Follow-up|2
5529966|NCT01405196|19115590|P4|Overall Study|Death|0
5529967|NCT01405196|19115591|P3|Overall Study|Death|3
5529968|NCT01405196|19115592|P2|Overall Study|Death|0
5529969|NCT01405196|19115593|P1|Overall Study|Death|1
5529970|NCT01405196|19115590|P4|Overall Study|Adverse Event|2
5529971|NCT01405196|19115591|P3|Overall Study|Adverse Event|0
5529972|NCT01405196|19115592|P2|Overall Study|Adverse Event|2
5529973|NCT01405196|19115593|P1|Overall Study|Adverse Event|2
5529974|NCT01405196|19115590|P4|Overall Study|Withdrawal by Subject|6
5529975|NCT01405196|19115591|P3|Overall Study|Withdrawal by Subject|3
5529976|NCT01405196|19115592|P2|Overall Study|Withdrawal by Subject|6
5529977|NCT01405196|19115593|P1|Overall Study|Withdrawal by Subject|4
5529978|NCT01405196|19115590|P4|Overall Study|Other|0
5529979|NCT01405196|19115591|P3|Overall Study|Other|5
5529980|NCT01405196|19115592|P2|Overall Study|Other|2
5529981|NCT01405196|19115593|P1|Overall Study|Other|2
5529982|NCT01405196|19115590|P4|Overall Study|Study Terminated by Sponsor|0
5529983|NCT01405196|19115591|P3|Overall Study|Study Terminated by Sponsor|9
5529984|NCT01405196|19115592|P2|Overall Study|Study Terminated by Sponsor|0
5529985|NCT01405196|19115593|P1|Overall Study|Study Terminated by Sponsor|0
5529986|NCT01405053|19115680|P2|Overall Study|Other|1
5529987|NCT01405053|19115681|P1|Overall Study|Other|0
5529988|NCT01405053|19115680|P2|Overall Study|Withdrawal by Subject|4
5529989|NCT01405053|19115681|P1|Overall Study|Withdrawal by Subject|3
5529990|NCT01405053|19115680|P2|Overall Study|Inadequate therapeutic effect|1
5529991|NCT01405053|19115681|P1|Overall Study|Inadequate therapeutic effect|2
5529992|NCT01405053|19115680|P2|Overall Study|Participant choice|1
5529993|NCT01405053|19115681|P1|Overall Study|Participant choice|2
5529994|NCT01405053|19115680|P2|Overall Study|Lost to Follow-up|1
5529995|NCT01405053|19115681|P1|Overall Study|Lost to Follow-up|0
5529996|NCT01405053|19115680|P2|Overall Study|Adverse Event|0
5529997|NCT01405053|19115681|P1|Overall Study|Adverse Event|3
5529998|NCT01405027|19115707|P2|Overall Study|Other or Unknown|25
5529999|NCT01405027|19115708|P1|Overall Study|Other or Unknown|12
5530000|NCT01405027|19115707|P2|Overall Study|Death|0
5530001|NCT01405027|19115708|P1|Overall Study|Death|1
5530002|NCT01405027|19115707|P2|Overall Study|Investigator judgement|2
5530003|NCT01405027|19115708|P1|Overall Study|Investigator judgement|0
5530004|NCT01405027|19115707|P2|Overall Study|Lost to Follow-up|24
5530005|NCT01405027|19115708|P1|Overall Study|Lost to Follow-up|16
5530006|NCT01405027|19115707|P2|Overall Study|Withdrawn consent|0
5530007|NCT01405027|19115708|P1|Overall Study|Withdrawn consent|3
5530008|NCT01404988|19115725|P3|Overall Study|Lost to Follow-up|1
5530009|NCT01404988|19115726|P2|Overall Study|Lost to Follow-up|2
5530010|NCT01404988|19115727|P1|Overall Study|Lost to Follow-up|1
5530011|NCT01404988|19115725|P3|Overall Study|Withdrawal by Subject|0
5530012|NCT01404988|19115726|P2|Overall Study|Withdrawal by Subject|2
5530013|NCT01404988|19115727|P1|Overall Study|Withdrawal by Subject|2
5530014|NCT01404988|19115725|P3|Overall Study|Adverse Event|0
5530015|NCT01404988|19115726|P2|Overall Study|Adverse Event|0
5530016|NCT01404988|19115727|P1|Overall Study|Adverse Event|1
5530017|NCT01404988|19115725|P3|Overall Study|Death|2
5530018|NCT01404988|19115726|P2|Overall Study|Death|0
5530019|NCT01404988|19115727|P1|Overall Study|Death|2
5530020|NCT01404325|19115848|P2|Overall Study|non-specified reason|2
5530021|NCT01404325|19115849|P1|Overall Study|non-specified reason|0
5530022|NCT01404325|19115848|P2|Overall Study|Graft loss/Retransplantation|0
5530023|NCT01404325|19115849|P1|Overall Study|Graft loss/Retransplantation|1
5530024|NCT01404325|19115848|P2|Overall Study|Death|0
5530025|NCT01404325|19115849|P1|Overall Study|Death|2
5530026|NCT01404325|19115848|P2|Overall Study|Lost to Follow-up|0
5530027|NCT01404325|19115849|P1|Overall Study|Lost to Follow-up|1
5530028|NCT01404312|19115907|P2|Overall Study|Severe debilitation, unable to continue|2
5530029|NCT01404312|19115908|P1|Overall Study|Severe debilitation, unable to continue|1
5530030|NCT01404312|19115907|P2|Overall Study|Participant not willing to adhere to req|29
5530031|NCT01404312|19115908|P1|Overall Study|Participant not willing to adhere to req|31
5530032|NCT01404312|19115907|P2|Overall Study|Site closed|21
5530033|NCT01404312|19115908|P1|Overall Study|Site closed|22
5530034|NCT01404312|19115907|P2|Overall Study|Lost to Follow-up|111
5530035|NCT01404312|19115908|P1|Overall Study|Lost to Follow-up|115
5530036|NCT01404312|19115907|P2|Overall Study|Participant Unable to get to clinic|103
5530037|NCT01404312|19115908|P1|Overall Study|Participant Unable to get to clinic|93
5530038|NCT01404312|19115907|P2|Overall Study|Withdrawal by Subject|18
5530039|NCT01404312|19115908|P1|Overall Study|Withdrawal by Subject|15
5530040|NCT01404312|19115907|P2|Overall Study|Death|27
5530041|NCT01404312|19115908|P1|Overall Study|Death|21
5530042|NCT01404234|19115937|P1|Overall Study|Withdrawal by Subject|2
5530043|NCT01404208|19115953|P2|Overall Study|Discontinued|0
5530044|NCT01404208|19115954|P1|Overall Study|Discontinued|3
5530045|NCT01403987|19116019|P3|Overall Study|Residents forgot their secret PIN|18
5530046|NCT01403987|19116020|P2|Overall Study|Residents forgot their secret PIN|17
5530047|NCT01403987|19116021|P1|Overall Study|Residents forgot their secret PIN|18
5530048|NCT01403948|19116045|P10|Overall Study|other than above|0
5530049|NCT01403948|19116046|P9|Overall Study|other than above|0
5530050|NCT01403948|19116047|P8|Overall Study|other than above|0
5530051|NCT01403948|19116048|P7|Overall Study|other than above|2
5530052|NCT01403948|19116049|P6|Overall Study|other than above|1
5530053|NCT01403948|19116050|P5|Overall Study|other than above|1
5530054|NCT01403948|19116051|P4|Overall Study|other than above|0
5530055|NCT01403948|19116052|P3|Overall Study|other than above|1
5530056|NCT01403948|19116053|P2|Overall Study|other than above|2
5530057|NCT01403948|19116054|P1|Overall Study|other than above|1
5530058|NCT01403948|19116045|P10|Overall Study|Refused cont. medication|1
5530059|NCT01403948|19116046|P9|Overall Study|Refused cont. medication|0
5530060|NCT01403948|19116047|P8|Overall Study|Refused cont. medication|0
5530061|NCT01403948|19116048|P7|Overall Study|Refused cont. medication|0
5530062|NCT01403948|19116049|P6|Overall Study|Refused cont. medication|0
5530063|NCT01403948|19116050|P5|Overall Study|Refused cont. medication|1
5530064|NCT01403948|19116051|P4|Overall Study|Refused cont. medication|0
5530065|NCT01403948|19116052|P3|Overall Study|Refused cont. medication|0
5530066|NCT01403948|19116053|P2|Overall Study|Refused cont. medication|0
5530067|NCT01403948|19116054|P1|Overall Study|Refused cont. medication|0
5530068|NCT01403948|19116045|P10|Overall Study|Lost to Follow-up|1
5530069|NCT01403948|19116046|P9|Overall Study|Lost to Follow-up|0
5530070|NCT01403948|19116047|P8|Overall Study|Lost to Follow-up|0
5530071|NCT01403948|19116048|P7|Overall Study|Lost to Follow-up|0
5530072|NCT01403948|19116049|P6|Overall Study|Lost to Follow-up|0
5530073|NCT01403948|19116050|P5|Overall Study|Lost to Follow-up|0
5530074|NCT01403948|19116051|P4|Overall Study|Lost to Follow-up|0
5530075|NCT01403948|19116052|P3|Overall Study|Lost to Follow-up|0
5530076|NCT01403948|19116053|P2|Overall Study|Lost to Follow-up|0
5530077|NCT01403948|19116054|P1|Overall Study|Lost to Follow-up|0
5530078|NCT01403948|19116045|P10|Overall Study|Other Adverse Event (Other than DLT)|0
5530079|NCT01403948|19116046|P9|Overall Study|Other Adverse Event (Other than DLT)|1
5530080|NCT01403948|19116047|P8|Overall Study|Other Adverse Event (Other than DLT)|0
5530081|NCT01403948|19116048|P7|Overall Study|Other Adverse Event (Other than DLT)|2
5530082|NCT01403948|19116049|P6|Overall Study|Other Adverse Event (Other than DLT)|0
5530083|NCT01403948|19116050|P5|Overall Study|Other Adverse Event (Other than DLT)|2
5530084|NCT01403948|19116051|P4|Overall Study|Other Adverse Event (Other than DLT)|0
5530085|NCT01403948|19116052|P3|Overall Study|Other Adverse Event (Other than DLT)|0
5530086|NCT01403948|19116053|P2|Overall Study|Other Adverse Event (Other than DLT)|0
5530087|NCT01403948|19116054|P1|Overall Study|Other Adverse Event (Other than DLT)|0
5530088|NCT01403948|19116045|P10|Overall Study|Progressive disease|5
5530089|NCT01403948|19116046|P9|Overall Study|Progressive disease|5
5530090|NCT01403948|19116047|P8|Overall Study|Progressive disease|4
5530091|NCT01403948|19116048|P7|Overall Study|Progressive disease|2
5530092|NCT01403948|19116049|P6|Overall Study|Progressive disease|6
5530093|NCT01403948|19116050|P5|Overall Study|Progressive disease|2
5530094|NCT01403948|19116051|P4|Overall Study|Progressive disease|4
5530095|NCT01403948|19116052|P3|Overall Study|Progressive disease|2
5530096|NCT01403948|19116053|P2|Overall Study|Progressive disease|2
5530097|NCT01403948|19116054|P1|Overall Study|Progressive disease|0
5530098|NCT01403805|19116127|P2|Overall Study|Death|1
5530099|NCT01403805|19116128|P1|Overall Study|Death|0
5530100|NCT01403805|19116127|P2|Overall Study|Lost to Follow-up|2
5530101|NCT01403805|19116128|P1|Overall Study|Lost to Follow-up|0
5530102|NCT01403805|19116127|P2|Overall Study|Withdrawal by Subject|4
5530103|NCT01403805|19116128|P1|Overall Study|Withdrawal by Subject|0
5530104|NCT01403610|19116144|P4|Overall Study|Didn't recover from surgery sufficiently|0
5530105|NCT01403610|19116145|P3|Overall Study|Didn't recover from surgery sufficiently|0
5530106|NCT01403610|19116146|P2|Overall Study|Didn't recover from surgery sufficiently|3
5530107|NCT01403610|19116147|P1|Overall Study|Didn't recover from surgery sufficiently|0
5530108|NCT01403610|19116144|P4|Overall Study|Withdrawal by Subject|0
5530109|NCT01403610|19116145|P3|Overall Study|Withdrawal by Subject|0
5530110|NCT01403610|19116146|P2|Overall Study|Withdrawal by Subject|0
5530111|NCT01403610|19116147|P1|Overall Study|Withdrawal by Subject|2
5530112|NCT01403194|19116193|P1|Overall Study|Lost to Follow-up|8
5530113|NCT01403194|19116193|P1|Overall Study|Screen Failure|2
5530114|NCT01403116|19116201|P2|Overall Study|unable to keep appointments|2
5530115|NCT01403116|19116202|P1|Overall Study|unable to keep appointments|0
5530116|NCT01403116|19116201|P2|Overall Study|Hct >54%|0
5530117|NCT01403116|19116202|P1|Overall Study|Hct >54%|2
5530118|NCT01403116|19116201|P2|Overall Study|undisclosed Hx of Prostate Ca|0
5530119|NCT01403116|19116202|P1|Overall Study|undisclosed Hx of Prostate Ca|1
5530120|NCT01403116|19116201|P2|Overall Study|Protocol Violation|1
5530121|NCT01403116|19116202|P1|Overall Study|Protocol Violation|0
5530122|NCT01403116|19116201|P2|Overall Study|Non-compliance of study drug|0
5530123|NCT01403116|19116202|P1|Overall Study|Non-compliance of study drug|3
5530124|NCT01403116|19116201|P2|Overall Study|Withdrawal by Subject|15
5530125|NCT01403116|19116202|P1|Overall Study|Withdrawal by Subject|12
5530126|NCT01403116|19116201|P2|Overall Study|Lost to Follow-up|5
5530127|NCT01403116|19116202|P1|Overall Study|Lost to Follow-up|7
5530128|NCT01403116|19116201|P2|Overall Study|Adverse Event|4
5530129|NCT01403116|19116202|P1|Overall Study|Adverse Event|7
5530130|NCT01403051|19116215|P2|Overall Study|Lost to Follow-up|5
5530131|NCT01403051|19116216|P1|Overall Study|Lost to Follow-up|5
5530132|NCT01403051|19116215|P2|Overall Study|Withdrawal by Subject|1
5530133|NCT01403051|19116216|P1|Overall Study|Withdrawal by Subject|2
5530134|NCT01403051|19116215|P2|Overall Study|Death|0
5530135|NCT01403051|19116216|P1|Overall Study|Death|1
5530136|NCT01403051|19116215|P2|Overall Study|Protocol Violation|0
5530137|NCT01403051|19116216|P1|Overall Study|Protocol Violation|2
5530138|NCT01402986|19116252|P4|Overall Study|Other|6
5530139|NCT01402986|19116253|P3|Overall Study|Other|1
5530140|NCT01402986|19116254|P2|Overall Study|Other|5
5530141|NCT01402986|19116255|P1|Overall Study|Other|2
5530142|NCT01402986|19116252|P4|Overall Study|Lost to Follow-up|1
5530143|NCT01402986|19116253|P3|Overall Study|Lost to Follow-up|0
5530144|NCT01402986|19116254|P2|Overall Study|Lost to Follow-up|0
5530145|NCT01402986|19116255|P1|Overall Study|Lost to Follow-up|0
5530146|NCT01402986|19116252|P4|Overall Study|Death|2
5530147|NCT01402986|19116253|P3|Overall Study|Death|0
5530148|NCT01402986|19116254|P2|Overall Study|Death|0
5530149|NCT01402986|19116255|P1|Overall Study|Death|0
5530150|NCT01402986|19116252|P4|Overall Study|Withdrawal by Subject|13
5530151|NCT01402986|19116253|P3|Overall Study|Withdrawal by Subject|7
5530152|NCT01402986|19116254|P2|Overall Study|Withdrawal by Subject|10
5530153|NCT01402986|19116255|P1|Overall Study|Withdrawal by Subject|7
5530154|NCT01402947|19116390|P2|First Intervention|Adverse Event|1
5530155|NCT01402947|19116391|P1|First Intervention|Adverse Event|0
5530156|NCT01402908|19116401|P2|Overall Study|Physician Decision|0
5530157|NCT01402908|19116402|P1|Overall Study|Physician Decision|1
5530158|NCT01402908|19116401|P2|Overall Study|Lost to Follow-up|1
5530159|NCT01402908|19116402|P1|Overall Study|Lost to Follow-up|3
5530160|NCT01402908|19116401|P2|Overall Study|Withdrawal by Subject|17
5530161|NCT01402908|19116402|P1|Overall Study|Withdrawal by Subject|30
5530162|NCT01402869|19116417|P3|Overall Study|Required Tooth Extraction|1
5530163|NCT01402869|19116418|P2|Overall Study|Required Tooth Extraction|0
5530164|NCT01402869|19116419|P1|Overall Study|Required Tooth Extraction|0
5530165|NCT01402817|19116433|P1|Overall Study|Study Suspended by FDA|8
5530166|NCT01402817|19116433|P1|Overall Study|Withdrawal by Subject|3
5530167|NCT01402700|19116438|P1|Overall Study|Missed Visit|1
5530168|NCT01402700|19116438|P1|Overall Study|Withdrawal by Subject|3
5530169|NCT01402700|19116438|P1|Overall Study|Death|3
5530170|NCT01402570|19116442|P1|Overall Study|Adverse Event|1
5530171|NCT01402544|19116449|P1|Overall Study|Withdrawal by Subject|6
5530172|NCT01402284|19116523|P1|Overall Study|Disease progression on study|10
5530173|NCT01402284|19116523|P1|Overall Study|Physician Decision|1
5530174|NCT01402284|19116523|P1|Overall Study|Follows up at Memorial Sloan Kettering|1
5530175|NCT01402284|19116523|P1|Overall Study|Withdrawal consent|2
5530176|NCT01402102|19116605|P2|Overall Study|Withdrawal by Subject|2
5530177|NCT01402102|19116606|P1|Overall Study|Withdrawal by Subject|0
5530178|NCT01402102|19116605|P2|Overall Study|Insufficiency of compliance|1
5530179|NCT01402102|19116606|P1|Overall Study|Insufficiency of compliance|1
5530180|NCT01402102|19116605|P2|Overall Study|Protocol Violation|0
5530181|NCT01402102|19116606|P1|Overall Study|Protocol Violation|1
5530182|NCT01402063|19116626|P2|Overall Study|Withdrawal by Subject|3
5530183|NCT01402063|19116627|P1|Overall Study|Withdrawal by Subject|3
5530184|NCT01402011|19116645|P3|Nine Month Follow-up|Withdrawal by Subject|0
5530185|NCT01402011|19116646|P2|Nine Month Follow-up|Withdrawal by Subject|1
5530186|NCT01402011|19116647|P1|Nine Month Follow-up|Withdrawal by Subject|0
5530187|NCT01402011|19116645|P3|Active Treatment Period|Withdrawal by Subject|0
5530188|NCT01402011|19116646|P2|Active Treatment Period|Withdrawal by Subject|3
5530189|NCT01402011|19116647|P1|Active Treatment Period|Withdrawal by Subject|1
5530190|NCT01402011|19116645|P3|Delayed Treatment Period|Withdrawal by Subject|0
5530191|NCT01402011|19116646|P2|Delayed Treatment Period|Withdrawal by Subject|0
5530192|NCT01402011|19116647|P1|Delayed Treatment Period|Withdrawal by Subject|1
5530193|NCT01401959|19116676|P3|Treated|Protocol Violation|0
5530194|NCT01401959|19116677|P2|Treated|Protocol Violation|1
5530195|NCT01401959|19116678|P1|Treated|Protocol Violation|0
5530196|NCT01401959|19116676|P3|Treated|Withdrawal by Subject|2
5530197|NCT01401959|19116677|P2|Treated|Withdrawal by Subject|2
5530198|NCT01401959|19116678|P1|Treated|Withdrawal by Subject|1
5530199|NCT01401959|19116676|P3|Treated|Adverse Event|2
5530200|NCT01401959|19116677|P2|Treated|Adverse Event|3
5530201|NCT01401959|19116678|P1|Treated|Adverse Event|4
5530202|NCT01401959|19116676|P3|Treated|Disease Progression|1
5530203|NCT01401959|19116677|P2|Treated|Disease Progression|2
5530204|NCT01401959|19116678|P1|Treated|Disease Progression|2
5530205|NCT01401959|19116676|P3|Enrolled|Withdrawal by Subject|0
5530206|NCT01401959|19116677|P2|Enrolled|Withdrawal by Subject|0
5530207|NCT01401959|19116678|P1|Enrolled|Withdrawal by Subject|1
5530208|NCT01401842|19116717|P2|Overall Study|other/unknown|17
5530209|NCT01401842|19116718|P1|Overall Study|other/unknown|28
5530210|NCT01401842|19116717|P2|Overall Study|on profile|5
5530211|NCT01401842|19116718|P1|Overall Study|on profile|9
5530212|NCT01401842|19116717|P2|Overall Study|invalid follow-up strength data|4
5530213|NCT01401842|19116718|P1|Overall Study|invalid follow-up strength data|1
5530214|NCT01401842|19116717|P2|Overall Study|discharged from US Army|4
5530215|NCT01401842|19116718|P1|Overall Study|discharged from US Army|3
5530216|NCT01401842|19116717|P2|Overall Study|changed companies|34
5530217|NCT01401842|19116718|P1|Overall Study|changed companies|20
5530218|NCT01401842|19116717|P2|Overall Study|academic reason|1
5530219|NCT01401842|19116718|P1|Overall Study|academic reason|4
5530220|NCT01401842|19116717|P2|Overall Study|Withdrawal by Subject|2
5530221|NCT01401842|19116718|P1|Overall Study|Withdrawal by Subject|3
5530222|NCT01401647|19116735|P3|Overall Study|Lost to Follow-up|1
5530223|NCT01401647|19116736|P2|Overall Study|Lost to Follow-up|3
5530224|NCT01401647|19116737|P1|Overall Study|Lost to Follow-up|3
5530225|NCT01401647|19116735|P3|Overall Study|Withdrawal by Subject|2
5530226|NCT01401647|19116736|P2|Overall Study|Withdrawal by Subject|5
5530227|NCT01401647|19116737|P1|Overall Study|Withdrawal by Subject|1
5530228|NCT01401530|19116807|P3|Overall Study|Physician Decision|0
5530229|NCT01401530|19116808|P2|Overall Study|Physician Decision|1
5530230|NCT01401530|19116809|P1|Overall Study|Physician Decision|0
5530231|NCT01401530|19116807|P3|Overall Study|Participant Choice|1
5530232|NCT01401530|19116808|P2|Overall Study|Participant Choice|2
5530233|NCT01401530|19116809|P1|Overall Study|Participant Choice|1
5530234|NCT01401530|19116807|P3|Overall Study|Adverse Event|1
5530235|NCT01401530|19116808|P2|Overall Study|Adverse Event|1
5530236|NCT01401530|19116809|P1|Overall Study|Adverse Event|1
5530237|NCT01401530|19116807|P3|Overall Study|Disease Progression|1
5530238|NCT01401530|19116808|P2|Overall Study|Disease Progression|2
5530239|NCT01401530|19116809|P1|Overall Study|Disease Progression|1
5530240|NCT01401478|19116868|P1|Overall Study|Serious adverse event|1
5530241|NCT01401478|19116868|P1|Overall Study|Low intact parathyroid hormone|1
5530242|NCT01401478|19116868|P1|Overall Study|Hyperphosphatemia and adverse event|1
5530243|NCT01401478|19116868|P1|Overall Study|Blood samples not available|1
5530244|NCT01401478|19116868|P1|Overall Study|Withdrawal by Subject|3
5530245|NCT01401478|19116868|P1|Overall Study|Kidney transplantation|3
5530246|NCT01401478|19116868|P1|Overall Study|Lost to Follow-up|5
5530247|NCT01401478|19116868|P1|Overall Study|Hyperphosphatemia|5
5530248|NCT01401478|19116868|P1|Overall Study|Adverse Event|5
5530249|NCT01401478|19116868|P1|Overall Study|Study drug not available|6
5530250|NCT01401465|19116881|P2|Treatment Period 2|Withdrawal by Subject|1
5530251|NCT01401465|19116882|P1|Treatment Period 2|Withdrawal by Subject|0
5530252|NCT01401465|19116881|P2|Treatment Period 2|Lost to Follow-up|1
5530253|NCT01401465|19116882|P1|Treatment Period 2|Lost to Follow-up|0
5530254|NCT01401465|19116881|P2|Treatment Period 1|Scheduling Difficulties|1
5530255|NCT01401465|19116882|P1|Treatment Period 1|Scheduling Difficulties|1
5530256|NCT01401465|19116881|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
5530257|NCT01401465|19116882|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
5530258|NCT01401465|19116881|P2|Treatment Period 1|Non-Compliance to Study Drug|0
5530259|NCT01401465|19116882|P1|Treatment Period 1|Non-Compliance to Study Drug|1
5530260|NCT01401465|19116881|P2|Treatment Period 1|Withdrawal by Subject|4
5530261|NCT01401465|19116882|P1|Treatment Period 1|Withdrawal by Subject|1
5530262|NCT01401465|19116881|P2|Treatment Period 1|Protocol Violation|0
5530263|NCT01401465|19116882|P1|Treatment Period 1|Protocol Violation|5
5530264|NCT01401465|19116881|P2|Treatment Period 1|Pregnancy|1
5530265|NCT01401465|19116882|P1|Treatment Period 1|Pregnancy|0
5530266|NCT01401465|19116881|P2|Treatment Period 1|Adverse Event|1
5530267|NCT01401465|19116882|P1|Treatment Period 1|Adverse Event|4
5530268|NCT01401452|19116945|P1|Overall Study|Participant withdrew consent|1
5530269|NCT01401452|19116945|P1|Overall Study|Subject chose to discontinue treatment|1
5530270|NCT01401452|19116945|P1|Overall Study|Subject withdrew because of Tx success|1
5530271|NCT01401452|19116945|P1|Overall Study|Unsatisfactory output|1
5530272|NCT01401452|19116945|P1|Overall Study|Treatment failure|1
5530273|NCT01401452|19116945|P1|Overall Study|Discontinuation for personal reasons|1
5530274|NCT01401452|19116945|P1|Overall Study|Participant stopped Tx|2
5530275|NCT01401452|19116945|P1|Overall Study|Psoriatic arthritis|1
5530276|NCT01401452|19116945|P1|Overall Study|Subject's wife wants to get pregnant|1
5530277|NCT01401452|19116945|P1|Overall Study|Subject moved to another city|1
5530278|NCT01401452|19116945|P1|Overall Study|Subject didn't return for routine visits|1
5530279|NCT01401452|19116945|P1|Overall Study|Subject did not come to follow up visits|2
5530280|NCT01401452|19116945|P1|Overall Study|No more visits within the 36 wk followup|4
5530281|NCT01401452|19116945|P1|Overall Study|Tx stopped by psychiatrist|1
5530282|NCT01401452|19116945|P1|Overall Study|Tx stopped due to financial reasons|1
5530283|NCT01401452|19116945|P1|Overall Study|Participant developed breast cancer|1
5530284|NCT01401452|19116945|P1|Overall Study|Lack of Efficacy|30
5530285|NCT01401452|19116945|P1|Overall Study|Lost to Follow-up|12
5530286|NCT01401452|19116945|P1|Overall Study|Adverse reaction|9
5530287|NCT01401361|19116957|P1|Overall Study|Subject/family decision post procedure|2
5530288|NCT01401361|19116957|P1|Overall Study|Lost to Follow-up|3
5530289|NCT01401361|19116957|P1|Overall Study|Physician Decision|1
5530290|NCT01401361|19116957|P1|Overall Study|Lack of Efficacy|6
5530291|NCT01401361|19116957|P1|Overall Study|Withdrawal by Subject|16
5530292|NCT01401322|19116963|P1|Overall Study|Physician Decision|1
5530293|NCT01401322|19116963|P1|Overall Study|Withdrawal by Subject|1
5530294|NCT01401283|19116969|P2|Overall Study|suspicion of malignant hyperthermia|1
5530295|NCT01401283|19116970|P1|Overall Study|suspicion of malignant hyperthermia|0
5530296|NCT01401283|19116969|P2|Overall Study|no central venous access|1
5530297|NCT01401283|19116970|P1|Overall Study|no central venous access|0
5530298|NCT01401283|19116969|P2|Overall Study|preoperative arrhythmia|0
5530299|NCT01401283|19116970|P1|Overall Study|preoperative arrhythmia|5
5530300|NCT01401283|19116969|P2|Overall Study|surgery cancelled|8
5530301|NCT01401283|19116970|P1|Overall Study|surgery cancelled|5
5530302|NCT01401153|19117036|P2|Second Test Day|illness|5
5530303|NCT01401153|19117037|P1|Second Test Day|illness|0
5530304|NCT01401153|19117036|P2|First Test Day|Learning disabilities; illness|10
5530305|NCT01401153|19117037|P1|First Test Day|Learning disabilities; illness|1
5530306|NCT01401062|19117084|P2|Overall Study|Withdrawal by Subject|1
5530307|NCT01401062|19117085|P1|Overall Study|Withdrawal by Subject|1
5530308|NCT01401062|19117084|P2|Overall Study|Physician Decision|0
5530309|NCT01401062|19117085|P1|Overall Study|Physician Decision|1
5530310|NCT01401062|19117084|P2|Overall Study|Death|7
5530311|NCT01401062|19117085|P1|Overall Study|Death|9
5530312|NCT01401010|19117112|P2|Overall Study|Could not interpret assay results|0
5530313|NCT01401010|19117113|P1|Overall Study|Could not interpret assay results|1
5530314|NCT01400971|19117136|P1|Overall Study|Other|422
5530315|NCT01400971|19117136|P1|Overall Study|Withdrawal by Subject|158
5530316|NCT01400971|19117136|P1|Overall Study|Physician Decision|57
5530317|NCT01400971|19117136|P1|Overall Study|Lost to follow up + Subject Decision|2
5530318|NCT01400971|19117136|P1|Overall Study|Lost to Follow-up|196
5530319|NCT01400971|19117136|P1|Overall Study|Death|82
5530320|NCT01400958|19117145|P2|Overall Study|Adverse Event|0
5530321|NCT01400958|19117146|P1|Overall Study|Adverse Event|1
5530322|NCT01400958|19117145|P2|Overall Study|Withdrawal by Subject|1
5530323|NCT01400958|19117146|P1|Overall Study|Withdrawal by Subject|0
5530324|NCT01400958|19117145|P2|Overall Study|Physician Decision|1
5530325|NCT01400958|19117146|P1|Overall Study|Physician Decision|0
5530326|NCT01400932|19117156|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
5530327|NCT01400932|19117157|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
5530328|NCT01400932|19117156|P2|Overall Study|Protocol Deviation|1
5530329|NCT01400932|19117157|P1|Overall Study|Protocol Deviation|0
5530330|NCT01400932|19117156|P2|Overall Study|Lost to Follow-up|0
5530331|NCT01400932|19117157|P1|Overall Study|Lost to Follow-up|1
5530332|NCT01400932|19117156|P2|Overall Study|Withdrawal by Subject|6
5530333|NCT01400932|19117157|P1|Overall Study|Withdrawal by Subject|2
5530334|NCT01400932|19117156|P2|Overall Study|Lack of Efficacy|3
5530335|NCT01400932|19117157|P1|Overall Study|Lack of Efficacy|0
5530336|NCT01400932|19117156|P2|Overall Study|Adverse Event|5
5530337|NCT01400932|19117157|P1|Overall Study|Adverse Event|10
5530338|NCT01400919|19117179|P1|Overall Study|Missed visit|2
5530339|NCT01400919|19117179|P1|Overall Study|Lost to Follow-up|2
5530340|NCT01400919|19117179|P1|Overall Study|Withdrawal by Subject|4
5530341|NCT01400893|19117222|P2|Overall Study|Lost to Follow-up|6
5530342|NCT01400893|19117223|P1|Overall Study|Lost to Follow-up|0
5530343|NCT01400893|19117222|P2|Overall Study|Death|21
5530344|NCT01400893|19117223|P1|Overall Study|Death|27
5530345|NCT01400841|19117235|P1|Extended Study Phase (2 Years)|Adverse Event|2
5530346|NCT01400841|19117235|P1|Initial Study Phase (6 Months)|Death|1
5530347|NCT01400698|19117273|P6|Overall Study|Other|0
5530348|NCT01400698|19117274|P5|Overall Study|Other|1
5530349|NCT01400698|19117275|P4|Overall Study|Other|2
5530350|NCT01400698|19117276|P3|Overall Study|Other|0
5530351|NCT01400698|19117277|P2|Overall Study|Other|2
5530352|NCT01400698|19117278|P1|Overall Study|Other|4
5530353|NCT01400698|19117273|P6|Overall Study|Adverse Event|0
5530354|NCT01400698|19117274|P5|Overall Study|Adverse Event|0
5530355|NCT01400698|19117275|P4|Overall Study|Adverse Event|0
5530356|NCT01400698|19117276|P3|Overall Study|Adverse Event|0
5530357|NCT01400698|19117277|P2|Overall Study|Adverse Event|0
5530358|NCT01400698|19117278|P1|Overall Study|Adverse Event|1
5530359|NCT01400698|19117273|P6|Overall Study|Non-compliance|0
5530360|NCT01400698|19117274|P5|Overall Study|Non-compliance|0
5530361|NCT01400698|19117275|P4|Overall Study|Non-compliance|1
5530362|NCT01400698|19117276|P3|Overall Study|Non-compliance|0
5530363|NCT01400698|19117277|P2|Overall Study|Non-compliance|1
5530364|NCT01400698|19117278|P1|Overall Study|Non-compliance|0
5530365|NCT01400698|19117273|P6|Overall Study|Protocol Violation|0
5530366|NCT01400698|19117274|P5|Overall Study|Protocol Violation|1
5530367|NCT01400698|19117275|P4|Overall Study|Protocol Violation|0
5530368|NCT01400698|19117276|P3|Overall Study|Protocol Violation|0
5530369|NCT01400698|19117277|P2|Overall Study|Protocol Violation|1
5530370|NCT01400698|19117278|P1|Overall Study|Protocol Violation|0
5530371|NCT01400698|19117273|P6|Overall Study|Withdrawal by Subject|3
5530372|NCT01400698|19117274|P5|Overall Study|Withdrawal by Subject|1
5530373|NCT01400698|19117275|P4|Overall Study|Withdrawal by Subject|4
5530374|NCT01400698|19117276|P3|Overall Study|Withdrawal by Subject|0
5530375|NCT01400698|19117277|P2|Overall Study|Withdrawal by Subject|2
5530376|NCT01400698|19117278|P1|Overall Study|Withdrawal by Subject|8
5530377|NCT01400698|19117273|P6|Overall Study|Lost to Follow-up|3
5530378|NCT01400698|19117274|P5|Overall Study|Lost to Follow-up|4
5530379|NCT01400698|19117275|P4|Overall Study|Lost to Follow-up|1
5530380|NCT01400698|19117276|P3|Overall Study|Lost to Follow-up|2
5530381|NCT01400698|19117277|P2|Overall Study|Lost to Follow-up|5
5530382|NCT01400698|19117278|P1|Overall Study|Lost to Follow-up|2
5530383|NCT01400516|19117302|P2|Primary Trial|Withdrawal by Subject|2
5530384|NCT01400516|19117303|P1|Primary Trial|Withdrawal by Subject|0
5530385|NCT01400503|19117313|P1|Overall Study|Other|1
5530386|NCT01400503|19117313|P1|Overall Study|Study Terminated by Sponsor|58
5530387|NCT01400503|19117313|P1|Overall Study|Withdrawal by Subject|1
5530388|NCT01400451|19117336|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
5530389|NCT01400451|19117337|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
5530390|NCT01400451|19117338|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
5530391|NCT01400451|19117336|P3|Combination Treatment (or Intended)|Disease Progression|1
5530392|NCT01400451|19117337|P2|Combination Treatment (or Intended)|Disease Progression|1
5530393|NCT01400451|19117338|P1|Combination Treatment (or Intended)|Disease Progression|3
5530394|NCT01400451|19117336|P3|Combination Treatment (or Intended)|Adverse Event|0
5530395|NCT01400451|19117337|P2|Combination Treatment (or Intended)|Adverse Event|0
5530396|NCT01400451|19117338|P1|Combination Treatment (or Intended)|Adverse Event|1
5530397|NCT01400451|19117336|P3|Combination Treatment (or Intended)|Drug Toxicity|0
5530398|NCT01400451|19117337|P2|Combination Treatment (or Intended)|Drug Toxicity|1
5530399|NCT01400451|19117338|P1|Combination Treatment (or Intended)|Drug Toxicity|0
5530400|NCT01400451|19117336|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
5530401|NCT01400451|19117337|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
5530402|NCT01400451|19117338|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
5530403|NCT01400425|19117352|P1|Overall Study|Withdrawal by Subject|10
5530404|NCT01400412|19117365|P2|Overall Study|Never started study treatment|3
5530405|NCT01400412|19117366|P1|Overall Study|Never started study treatment|0
5530406|NCT01400412|19117365|P2|Overall Study|Unable to complete|3
5530407|NCT01400412|19117366|P1|Overall Study|Unable to complete|3
5530408|NCT01400412|19117365|P2|Overall Study|Withdrawal by Subject|4
5530409|NCT01400412|19117366|P1|Overall Study|Withdrawal by Subject|3
5530410|NCT01400412|19117365|P2|Overall Study|Lost to Follow-up|7
5530411|NCT01400412|19117366|P1|Overall Study|Lost to Follow-up|4
5530412|NCT01400243|19117412|P2|Overall Study|Protocol Violation|11
5530413|NCT01400243|19117413|P1|Overall Study|Protocol Violation|8
5530414|NCT01400139|19117435|P1|HYD Extension Period|Administrative|10
5530415|NCT01400139|19117435|P1|HYD Extension Period|Withdrawal by Subject|5
5530416|NCT01400139|19117435|P1|HYD Extension Period|Adverse Event|8
5530417|NCT01400139|19117435|P1|HYD Core Study|Did not qualify for Maintenance Period|14
5530418|NCT01400139|19117435|P1|HYD Core Study|Administrative|56
5530419|NCT01400139|19117435|P1|HYD Core Study|Confirmed or suspected diversion|20
5530420|NCT01400139|19117435|P1|HYD Core Study|Lost to Follow-up|39
5530421|NCT01400139|19117435|P1|HYD Core Study|Withdrawal by Subject|114
5530422|NCT01400139|19117435|P1|HYD Core Study|Lack of Efficacy|59
5530423|NCT01400139|19117435|P1|HYD Core Study|Adverse Event|210
5530424|NCT01400113|19117458|P2|Overall Study|Withdrawal by Subject|1
5530425|NCT01400113|19117459|P1|Overall Study|Withdrawal by Subject|1
5530426|NCT01399905|19117467|P2|Overall Study|Withdrawal by Subject|1
5530427|NCT01399905|19117468|P1|Overall Study|Withdrawal by Subject|1
5530428|NCT01399788|19117516|P2|First Intervention Period|Adverse Event|0
5530429|NCT01399788|19117517|P1|First Intervention Period|Adverse Event|1
5530430|NCT01399736|19117539|P2|Overall Study|Lost to Follow-up|2
5530431|NCT01399736|19117540|P1|Overall Study|Lost to Follow-up|0
5530432|NCT01399736|19117539|P2|Overall Study|Withdrawal by Subject|2
5530433|NCT01399736|19117540|P1|Overall Study|Withdrawal by Subject|4
5530434|NCT01399723|19117616|P2|Overall Study|Lost to Follow-up|1
5530435|NCT01399723|19117617|P1|Overall Study|Lost to Follow-up|0
5530436|NCT01399697|19117630|P3|Overall Study|Sponsor Decision|0
5530437|NCT01399697|19117631|P2|Overall Study|Sponsor Decision|0
5530438|NCT01399697|19117632|P1|Overall Study|Sponsor Decision|1
5530439|NCT01399697|19117630|P3|Overall Study|Clinical RA remission|0
5530440|NCT01399697|19117631|P2|Overall Study|Clinical RA remission|0
5530441|NCT01399697|19117632|P1|Overall Study|Clinical RA remission|1
5530442|NCT01399697|19117630|P3|Overall Study|Positive result for hepatitis B|0
5530443|NCT01399697|19117631|P2|Overall Study|Positive result for hepatitis B|0
5530444|NCT01399697|19117632|P1|Overall Study|Positive result for hepatitis B|1
5530445|NCT01399697|19117630|P3|Overall Study|Inclusion Error|0
5530446|NCT01399697|19117631|P2|Overall Study|Inclusion Error|0
5530447|NCT01399697|19117632|P1|Overall Study|Inclusion Error|2
5530448|NCT01399697|19117630|P3|Overall Study|Non-Compliant|0
5530449|NCT01399697|19117631|P2|Overall Study|Non-Compliant|0
5530450|NCT01399697|19117632|P1|Overall Study|Non-Compliant|1
5530451|NCT01399697|19117630|P3|Overall Study|Protocol Violation|0
5530452|NCT01399697|19117631|P2|Overall Study|Protocol Violation|0
5530453|NCT01399697|19117632|P1|Overall Study|Protocol Violation|2
5530454|NCT01399697|19117630|P3|Overall Study|Lack of Efficacy|1
5530455|NCT01399697|19117631|P2|Overall Study|Lack of Efficacy|0
5530456|NCT01399697|19117632|P1|Overall Study|Lack of Efficacy|9
5530457|NCT01399697|19117630|P3|Overall Study|Investigator Decisión|2
5530458|NCT01399697|19117631|P2|Overall Study|Investigator Decisión|0
5530459|NCT01399697|19117632|P1|Overall Study|Investigator Decisión|1
5530460|NCT01399697|19117630|P3|Overall Study|Withdrawal by Subject|0
5530461|NCT01399697|19117631|P2|Overall Study|Withdrawal by Subject|0
5530462|NCT01399697|19117632|P1|Overall Study|Withdrawal by Subject|8
5530463|NCT01399697|19117630|P3|Overall Study|Lost to Follow-up|0
5530464|NCT01399697|19117631|P2|Overall Study|Lost to Follow-up|0
5530465|NCT01399697|19117632|P1|Overall Study|Lost to Follow-up|2
5530466|NCT01399697|19117630|P3|Overall Study|Adverse Event|1
5530467|NCT01399697|19117631|P2|Overall Study|Adverse Event|3
5530468|NCT01399697|19117632|P1|Overall Study|Adverse Event|13
5530469|NCT01399619|19117659|P4|Overall Study|Not treated|2
5530470|NCT01399619|19117660|P3|Overall Study|Not treated|0
5530471|NCT01399619|19117661|P2|Overall Study|Not treated|0
5530472|NCT01399619|19117662|P1|Overall Study|Not treated|0
5530473|NCT01399619|19117659|P4|Overall Study|Protocol Violation|1
5530474|NCT01399619|19117660|P3|Overall Study|Protocol Violation|0
5530475|NCT01399619|19117661|P2|Overall Study|Protocol Violation|0
5530476|NCT01399619|19117662|P1|Overall Study|Protocol Violation|0
5530477|NCT01399619|19117659|P4|Overall Study|Withdrawal by Subject|4
5530478|NCT01399619|19117660|P3|Overall Study|Withdrawal by Subject|3
5530479|NCT01399619|19117661|P2|Overall Study|Withdrawal by Subject|0
5530480|NCT01399619|19117662|P1|Overall Study|Withdrawal by Subject|6
5530481|NCT01399619|19117659|P4|Overall Study|Lack of Efficacy|0
5530482|NCT01399619|19117660|P3|Overall Study|Lack of Efficacy|5
5530483|NCT01399619|19117661|P2|Overall Study|Lack of Efficacy|0
5530484|NCT01399619|19117662|P1|Overall Study|Lack of Efficacy|9
5530485|NCT01399619|19117659|P4|Overall Study|Adverse Event|10
5530486|NCT01399619|19117660|P3|Overall Study|Adverse Event|4
5530487|NCT01399619|19117661|P2|Overall Study|Adverse Event|0
5530488|NCT01399619|19117662|P1|Overall Study|Adverse Event|10
5530489|NCT01399593|19117725|P2|Overall Study|Transplantectomy|1
5530490|NCT01399593|19117726|P1|Overall Study|Transplantectomy|0
5530491|NCT01399593|19117725|P2|Overall Study|Death|1
5530492|NCT01399593|19117726|P1|Overall Study|Death|1
5530493|NCT01399593|19117725|P2|Overall Study|Adverse Event|0
5530494|NCT01399593|19117726|P1|Overall Study|Adverse Event|1
5530495|NCT01399593|19117725|P2|Overall Study|Physician Decision|0
5530496|NCT01399593|19117726|P1|Overall Study|Physician Decision|1
5530497|NCT01399190|19117759|P1|Overall Study|Physician Decision|2
5530498|NCT01399190|19117759|P1|Overall Study|Participant's Request|5
5530499|NCT01399190|19117759|P1|Overall Study|Adverse Event|8
5530500|NCT01399190|19117759|P1|Overall Study|Not Eligible for Final Analysis|5
5530501|NCT01399125|19117767|P2|Overall Study|Protocol Deviation|2
5530502|NCT01399125|19117768|P1|Overall Study|Protocol Deviation|5
5530503|NCT01399125|19117767|P2|Overall Study|Death|1
5530504|NCT01399125|19117768|P1|Overall Study|Death|0
5530505|NCT01399125|19117767|P2|Overall Study|Administrative Problems|11
5530506|NCT01399125|19117768|P1|Overall Study|Administrative Problems|7
5530507|NCT01399125|19117767|P2|Overall Study|Lost to Follow-up|3
5530508|NCT01399125|19117768|P1|Overall Study|Lost to Follow-up|2
5530509|NCT01399125|19117767|P2|Overall Study|Withdrawal by Subject|8
5530510|NCT01399125|19117768|P1|Overall Study|Withdrawal by Subject|5
5530511|NCT01399125|19117767|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
5530512|NCT01399125|19117768|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
5530513|NCT01399125|19117767|P2|Overall Study|Abnormal Lab values|1
5530514|NCT01399125|19117768|P1|Overall Study|Abnormal Lab values|0
5530515|NCT01399125|19117767|P2|Overall Study|Adverse Event|30
5530516|NCT01399125|19117768|P1|Overall Study|Adverse Event|32
5530517|NCT01399099|19117782|P1|Overall Study|Miscellaneous|4
5530518|NCT01399099|19117782|P1|Overall Study|Infection|1
5530519|NCT01399099|19117782|P1|Overall Study|Skin Irritation|13
5530520|NCT01399099|19117782|P1|Overall Study|Protocol Violation|1
5530521|NCT01399099|19117782|P1|Overall Study|Physician Decision|1
5530522|NCT01399099|19117782|P1|Overall Study|Lost to Follow-up|11
5530523|NCT01399047|19117789|P2|Overall Study|Withdrawal by Subject|1
5530524|NCT01399047|19117790|P1|Overall Study|Withdrawal by Subject|0
5530525|NCT01398956|19117826|P1|Overall Study|Subject moved a long distance|1
5530526|NCT01398956|19117826|P1|Overall Study|Withdrawal Criteria No.3|1
5530527|NCT01398956|19117826|P1|Overall Study|AE, non-serious non-fatal|4
5530528|NCT01398956|19117826|P1|Overall Study|Withdrawal by Subject|4
5530529|NCT01398787|19117858|P1|Overall Study|Adverse Event|1
5530530|NCT01398514|19117876|P2|Overall Study|Failure to show a conditioned response|3
5530531|NCT01398514|19117877|P1|Overall Study|Failure to show a conditioned response|4
5530532|NCT01398514|19117876|P2|Overall Study|Physiologic non-responsiveness|3
5530533|NCT01398514|19117877|P1|Overall Study|Physiologic non-responsiveness|1
5530534|NCT01398514|19117876|P2|Overall Study|Non-compliance with study procedures|0
5530535|NCT01398514|19117877|P1|Overall Study|Non-compliance with study procedures|2
5530536|NCT01398514|19117876|P2|Overall Study|Adverse Event|0
5530537|NCT01398514|19117877|P1|Overall Study|Adverse Event|1
5530538|NCT01398410|19117912|P2|Overall Study|Other|29
5530539|NCT01398410|19117913|P1|Overall Study|Other|36
5530540|NCT01398410|19117912|P2|Overall Study|Inadequate Therapeutic Effect|0
5530541|NCT01398410|19117913|P1|Overall Study|Inadequate Therapeutic Effect|2
5530542|NCT01398410|19117912|P2|Overall Study|Participants Choice|11
5530543|NCT01398410|19117913|P1|Overall Study|Participants Choice|8
5530544|NCT01398410|19117912|P2|Overall Study|Adverse Event|16
5530545|NCT01398410|19117913|P1|Overall Study|Adverse Event|12
5530546|NCT01398358|19117924|P3|Overall Study|no longer eligible|1
5530547|NCT01398358|19117925|P2|Overall Study|no longer eligible|0
5530548|NCT01398358|19117926|P1|Overall Study|no longer eligible|1
5530549|NCT01398358|19117924|P3|Overall Study|Withdrawal by Subject|2
5530550|NCT01398358|19117925|P2|Overall Study|Withdrawal by Subject|2
5530551|NCT01398358|19117926|P1|Overall Study|Withdrawal by Subject|3
5530552|NCT01398358|19117924|P3|Overall Study|Lost to Follow-up|18
5530553|NCT01398358|19117925|P2|Overall Study|Lost to Follow-up|21
5530554|NCT01398358|19117926|P1|Overall Study|Lost to Follow-up|11
5530555|NCT01398176|19117948|P2|Overall Study|Physician Decision|3
5530556|NCT01398176|19117949|P1|Overall Study|Physician Decision|2
5530557|NCT01398176|19117948|P2|Overall Study|Lost to Follow-up|3
5530558|NCT01398176|19117949|P1|Overall Study|Lost to Follow-up|1
5530559|NCT01397890|19117982|P2|Overall Study|Others|1
5530560|NCT01397890|19117983|P1|Overall Study|Others|2
5530561|NCT01397890|19117982|P2|Overall Study|Severe Non-Compliance to Protocol|1
5530562|NCT01397890|19117983|P1|Overall Study|Severe Non-Compliance to Protocol|2
5530563|NCT01397890|19117982|P2|Overall Study|Adverse Event|2
5530564|NCT01397890|19117983|P1|Overall Study|Adverse Event|1
5530565|NCT01397890|19117982|P2|Overall Study|Condition under Investigation Worsened|3
5530566|NCT01397890|19117983|P1|Overall Study|Condition under Investigation Worsened|1
5530567|NCT01397890|19117982|P2|Overall Study|Lost to Follow-up|4
5530568|NCT01397890|19117983|P1|Overall Study|Lost to Follow-up|1
5530569|NCT01397890|19117982|P2|Overall Study|Death|3
5530570|NCT01397890|19117983|P1|Overall Study|Death|2
5530571|NCT01397890|19117982|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
5530572|NCT01397890|19117983|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
5530573|NCT01397890|19117982|P2|Overall Study|Withdrawal by Subject|11
5530574|NCT01397890|19117983|P1|Overall Study|Withdrawal by Subject|7
5530575|NCT01397825|19118054|P5|Overall Study|Withdrawal by Subject|0
5530576|NCT01397825|19118055|P4|Overall Study|Withdrawal by Subject|1
5530577|NCT01397825|19118056|P3|Overall Study|Withdrawal by Subject|5
5530578|NCT01397825|19118057|P2|Overall Study|Withdrawal by Subject|0
5530579|NCT01397825|19118058|P1|Overall Study|Withdrawal by Subject|1
5530580|NCT01397825|19118054|P5|Overall Study|Adverse Event|0
5530581|NCT01397825|19118055|P4|Overall Study|Adverse Event|1
5530582|NCT01397825|19118056|P3|Overall Study|Adverse Event|5
5530583|NCT01397825|19118057|P2|Overall Study|Adverse Event|1
5530584|NCT01397825|19118058|P1|Overall Study|Adverse Event|0
5530585|NCT01397825|19118054|P5|Overall Study|Symptomatic Deterioration|0
5530586|NCT01397825|19118055|P4|Overall Study|Symptomatic Deterioration|0
5530587|NCT01397825|19118056|P3|Overall Study|Symptomatic Deterioration|4
5530588|NCT01397825|19118057|P2|Overall Study|Symptomatic Deterioration|0
5530589|NCT01397825|19118058|P1|Overall Study|Symptomatic Deterioration|2
5530590|NCT01397825|19118054|P5|Overall Study|Progressive Disease|0
5530591|NCT01397825|19118055|P4|Overall Study|Progressive Disease|1
5530592|NCT01397825|19118056|P3|Overall Study|Progressive Disease|11
5530593|NCT01397825|19118057|P2|Overall Study|Progressive Disease|3
5530594|NCT01397825|19118058|P1|Overall Study|Progressive Disease|10
5530595|NCT01397786|19118128|P3|Phase B|Lack of Efficacy|14
5530596|NCT01397786|19118129|P2|Phase B|Lack of Efficacy|7
5530597|NCT01397786|19118130|P1|Phase B|Lack of Efficacy|22
5530598|NCT01397786|19118128|P3|Phase B|Protocol Deviation|4
5530599|NCT01397786|19118129|P2|Phase B|Protocol Deviation|2
5530600|NCT01397786|19118130|P1|Phase B|Protocol Deviation|1
5530601|NCT01397786|19118128|P3|Phase B|Withdrawal by Subject|30
5530602|NCT01397786|19118129|P2|Phase B|Withdrawal by Subject|45
5530603|NCT01397786|19118130|P1|Phase B|Withdrawal by Subject|102
5530604|NCT01397786|19118128|P3|Phase B|Physician Decision|3
5530605|NCT01397786|19118129|P2|Phase B|Physician Decision|1
5530606|NCT01397786|19118130|P1|Phase B|Physician Decision|9
5530607|NCT01397786|19118128|P3|Phase B|Subject Met Withdrawal Criteria|38
5530608|NCT01397786|19118129|P2|Phase B|Subject Met Withdrawal Criteria|5
5530609|NCT01397786|19118130|P1|Phase B|Subject Met Withdrawal Criteria|38
5530610|NCT01397786|19118128|P3|Phase B|Adverse Event|27
5530611|NCT01397786|19118129|P2|Phase B|Adverse Event|23
5530612|NCT01397786|19118130|P1|Phase B|Adverse Event|109
5530613|NCT01397786|19118128|P3|Phase B|Lost to Follow-up|22
5530614|NCT01397786|19118129|P2|Phase B|Lost to Follow-up|12
5530615|NCT01397786|19118130|P1|Phase B|Lost to Follow-up|22
5530616|NCT01397786|19118128|P3|Phase A|Lack of Efficacy|1
5530617|NCT01397786|19118129|P2|Phase A|Lack of Efficacy|0
5530618|NCT01397786|19118130|P1|Phase A|Lack of Efficacy|0
5530619|NCT01397786|19118128|P3|Phase A|Withdrawal by Subject|5
5530620|NCT01397786|19118129|P2|Phase A|Withdrawal by Subject|0
5530621|NCT01397786|19118130|P1|Phase A|Withdrawal by Subject|0
5530622|NCT01397786|19118128|P3|Phase A|Physician Decision|1
5530623|NCT01397786|19118129|P2|Phase A|Physician Decision|0
5530624|NCT01397786|19118130|P1|Phase A|Physician Decision|0
5530625|NCT01397786|19118128|P3|Phase A|Subject Met Withdrawal Criteria|7
5530626|NCT01397786|19118129|P2|Phase A|Subject Met Withdrawal Criteria|0
5530627|NCT01397786|19118130|P1|Phase A|Subject Met Withdrawal Criteria|0
5530628|NCT01397786|19118128|P3|Phase A|Adverse Event|8
5530629|NCT01397786|19118129|P2|Phase A|Adverse Event|0
5530630|NCT01397786|19118130|P1|Phase A|Adverse Event|0
5530631|NCT01397786|19118128|P3|Phase A|Lost to Follow-up|6
5530632|NCT01397786|19118129|P2|Phase A|Lost to Follow-up|0
5530633|NCT01397786|19118130|P1|Phase A|Lost to Follow-up|0
5530634|NCT01397747|19118196|P1|Overall Study|FIT excluded|34
5530635|NCT01397747|19118196|P1|Overall Study|Colonoscopy excluded|304
5530636|NCT01397747|19118196|P1|Overall Study|Multitarget DNA test excluded|689
5530637|NCT01397552|19118246|P2|Overall Study|Withdrawal by Subject|1
5530638|NCT01397552|19118247|P1|Overall Study|Withdrawal by Subject|2
5530639|NCT01397552|19118246|P2|Overall Study|Adverse Event|0
5530640|NCT01397552|19118247|P1|Overall Study|Adverse Event|1
5530641|NCT01397461|19118256|P3|Overall Study|Not treated|1
5530642|NCT01397461|19118257|P2|Overall Study|Not treated|0
5530643|NCT01397461|19118258|P1|Overall Study|Not treated|0
5530644|NCT01397461|19118256|P3|Overall Study|Lack of Efficacy|0
5530645|NCT01397461|19118257|P2|Overall Study|Lack of Efficacy|3
5530646|NCT01397461|19118258|P1|Overall Study|Lack of Efficacy|0
5530647|NCT01397461|19118256|P3|Overall Study|Lost to Follow-up|1
5530648|NCT01397461|19118257|P2|Overall Study|Lost to Follow-up|2
5530649|NCT01397461|19118258|P1|Overall Study|Lost to Follow-up|0
5530650|NCT01397461|19118256|P3|Overall Study|Withdrawal by Subject|0
5530651|NCT01397461|19118257|P2|Overall Study|Withdrawal by Subject|1
5530652|NCT01397461|19118258|P1|Overall Study|Withdrawal by Subject|2
5530653|NCT01397448|19118269|P3|Overall Study|Other|4
5530654|NCT01397448|19118270|P2|Overall Study|Other|7
5530655|NCT01397448|19118271|P1|Overall Study|Other|8
5530656|NCT01397448|19118269|P3|Overall Study|Lack of Efficacy|5
5530657|NCT01397448|19118270|P2|Overall Study|Lack of Efficacy|0
5530658|NCT01397448|19118271|P1|Overall Study|Lack of Efficacy|2
5530659|NCT01397448|19118269|P3|Overall Study|Withdrawal by Subject|3
5530660|NCT01397448|19118270|P2|Overall Study|Withdrawal by Subject|4
5530661|NCT01397448|19118271|P1|Overall Study|Withdrawal by Subject|4
5530662|NCT01397448|19118269|P3|Overall Study|Adverse Event|6
5530663|NCT01397448|19118270|P2|Overall Study|Adverse Event|4
5530664|NCT01397448|19118271|P1|Overall Study|Adverse Event|4
5530665|NCT01397422|19118286|P4|Overall Study|Increased bradykinesia related to PD|0
5530666|NCT01397422|19118287|P3|Overall Study|Increased bradykinesia related to PD|0
5530667|NCT01397422|19118288|P2|Overall Study|Increased bradykinesia related to PD|0
5530668|NCT01397422|19118289|P1|Overall Study|Increased bradykinesia related to PD|1
5530669|NCT01397422|19118286|P4|Overall Study|Withdrawal by Subject|0
5530670|NCT01397422|19118287|P3|Overall Study|Withdrawal by Subject|0
5530671|NCT01397422|19118288|P2|Overall Study|Withdrawal by Subject|0
5530672|NCT01397422|19118289|P1|Overall Study|Withdrawal by Subject|1
5530673|NCT01397422|19118286|P4|Overall Study|Adverse Event|8
5530674|NCT01397422|19118287|P3|Overall Study|Adverse Event|3
5530675|NCT01397422|19118288|P2|Overall Study|Adverse Event|3
5530676|NCT01397422|19118289|P1|Overall Study|Adverse Event|0
5530677|NCT01397409|19118329|P10|Stage 3|Other Miscellaneous Reasons|0
5530678|NCT01397409|19118330|P9|Stage 3|Other Miscellaneous Reasons|0
5530679|NCT01397409|19118331|P8|Stage 3|Other Miscellaneous Reasons|1
5530680|NCT01397409|19118332|P7|Stage 3|Other Miscellaneous Reasons|0
5530681|NCT01397409|19118333|P6|Stage 3|Other Miscellaneous Reasons|0
5530682|NCT01397409|19118334|P5|Stage 3|Other Miscellaneous Reasons|0
5530683|NCT01397409|19118335|P4|Stage 3|Other Miscellaneous Reasons|0
5530684|NCT01397409|19118336|P3|Stage 3|Other Miscellaneous Reasons|0
5530685|NCT01397409|19118337|P2|Stage 3|Other Miscellaneous Reasons|0
5530686|NCT01397409|19118338|P1|Stage 3|Other Miscellaneous Reasons|0
5530687|NCT01397409|19118329|P10|Stage 3|Adverse Event|0
5530688|NCT01397409|19118330|P9|Stage 3|Adverse Event|0
5530689|NCT01397409|19118331|P8|Stage 3|Adverse Event|1
5530690|NCT01397409|19118332|P7|Stage 3|Adverse Event|0
5530691|NCT01397409|19118333|P6|Stage 3|Adverse Event|0
5530692|NCT01397409|19118334|P5|Stage 3|Adverse Event|0
5530693|NCT01397409|19118335|P4|Stage 3|Adverse Event|0
5530694|NCT01397409|19118336|P3|Stage 3|Adverse Event|0
5530695|NCT01397409|19118337|P2|Stage 3|Adverse Event|0
5530696|NCT01397409|19118338|P1|Stage 3|Adverse Event|0
5530697|NCT01397409|19118329|P10|Stage 2|Other Miscellaneous Reasons|0
5530698|NCT01397409|19118330|P9|Stage 2|Other Miscellaneous Reasons|0
5530699|NCT01397409|19118331|P8|Stage 2|Other Miscellaneous Reasons|0
5530700|NCT01397409|19118332|P7|Stage 2|Other Miscellaneous Reasons|0
5530701|NCT01397409|19118333|P6|Stage 2|Other Miscellaneous Reasons|1
5530702|NCT01397409|19118334|P5|Stage 2|Other Miscellaneous Reasons|1
5530703|NCT01397409|19118335|P4|Stage 2|Other Miscellaneous Reasons|0
5530704|NCT01397409|19118336|P3|Stage 2|Other Miscellaneous Reasons|0
5530705|NCT01397409|19118337|P2|Stage 2|Other Miscellaneous Reasons|0
5530706|NCT01397409|19118338|P1|Stage 2|Other Miscellaneous Reasons|0
5530707|NCT01397409|19118329|P10|Stage 2|Personal Reasons|0
5530708|NCT01397409|19118330|P9|Stage 2|Personal Reasons|0
5530709|NCT01397409|19118331|P8|Stage 2|Personal Reasons|0
5530710|NCT01397409|19118332|P7|Stage 2|Personal Reasons|0
5530711|NCT01397409|19118333|P6|Stage 2|Personal Reasons|0
5530712|NCT01397409|19118334|P5|Stage 2|Personal Reasons|1
5530713|NCT01397409|19118335|P4|Stage 2|Personal Reasons|0
5530714|NCT01397409|19118336|P3|Stage 2|Personal Reasons|0
5530715|NCT01397409|19118337|P2|Stage 2|Personal Reasons|0
5530716|NCT01397409|19118338|P1|Stage 2|Personal Reasons|0
5530717|NCT01397409|19118329|P10|Stage 2|Adverse Event|0
5530718|NCT01397409|19118330|P9|Stage 2|Adverse Event|0
5530719|NCT01397409|19118331|P8|Stage 2|Adverse Event|0
5530720|NCT01397409|19118332|P7|Stage 2|Adverse Event|0
5530721|NCT01397409|19118333|P6|Stage 2|Adverse Event|3
5530722|NCT01397409|19118334|P5|Stage 2|Adverse Event|6
5530723|NCT01397409|19118335|P4|Stage 2|Adverse Event|0
5530724|NCT01397409|19118336|P3|Stage 2|Adverse Event|0
5530725|NCT01397409|19118337|P2|Stage 2|Adverse Event|0
5530726|NCT01397409|19118338|P1|Stage 2|Adverse Event|0
5530727|NCT01397253|19118378|P2|Overall Study|Reviewed by only 1 pharmacist|149
5530728|NCT01397253|19118379|P1|Overall Study|Reviewed by only 1 pharmacist|126
5530729|NCT01397084|19118385|P1|Overall Study|Used other proton pump inhibitor|1
5530730|NCT01397084|19118385|P1|Overall Study|Lost to Follow-up|1
5530731|NCT01397084|19118385|P1|Overall Study|Withdrawal by Subject|1
5530732|NCT01397084|19118385|P1|Overall Study|Adverse Event|2
5530733|NCT01397084|19118385|P1|Overall Study|Protocol Violation|2
5530734|NCT01397084|19118385|P1|Overall Study|Severe Non-Compliance to Protocol|1
5530735|NCT01396525|19118411|P1|Overall Study|Lost to Follow-up|4
5530736|NCT01396525|19118411|P1|Overall Study|Death|14
5530737|NCT01396525|19118411|P1|Overall Study|Withdrawal by Subject|8
5530738|NCT01396512|19118511|P2|Overall Study|Withdrawal by Subject|1
5530739|NCT01396512|19118512|P1|Overall Study|Withdrawal by Subject|0
5530740|NCT01396447|19118544|P4|Overall Study|Other Miscellaneous Reasons|0
5530741|NCT01396447|19118545|P3|Overall Study|Other Miscellaneous Reasons|1
5530742|NCT01396447|19118546|P2|Overall Study|Other Miscellaneous Reasons|2
5530743|NCT01396447|19118547|P1|Overall Study|Other Miscellaneous Reasons|0
5530744|NCT01396447|19118544|P4|Overall Study|Lost to Follow-up|9
5530745|NCT01396447|19118545|P3|Overall Study|Lost to Follow-up|7
5530746|NCT01396447|19118546|P2|Overall Study|Lost to Follow-up|8
5530747|NCT01396447|19118547|P1|Overall Study|Lost to Follow-up|4
5530748|NCT01396447|19118544|P4|Overall Study|Withdrawal of Consent|15
5530749|NCT01396447|19118545|P3|Overall Study|Withdrawal of Consent|4
5530750|NCT01396447|19118546|P2|Overall Study|Withdrawal of Consent|9
5530751|NCT01396447|19118547|P1|Overall Study|Withdrawal of Consent|11
5530752|NCT01396447|19118544|P4|Overall Study|Protocol Violation|7
5530753|NCT01396447|19118545|P3|Overall Study|Protocol Violation|3
5530754|NCT01396447|19118546|P2|Overall Study|Protocol Violation|2
5530755|NCT01396447|19118547|P1|Overall Study|Protocol Violation|5
5530756|NCT01396447|19118544|P4|Overall Study|Insufficient Therapeutic Response|4
5530757|NCT01396447|19118545|P3|Overall Study|Insufficient Therapeutic Response|2
5530758|NCT01396447|19118546|P2|Overall Study|Insufficient Therapeutic Response|5
5530759|NCT01396447|19118547|P1|Overall Study|Insufficient Therapeutic Response|5
5530760|NCT01396447|19118544|P4|Overall Study|Adverse Event|17
5530761|NCT01396447|19118545|P3|Overall Study|Adverse Event|12
5530762|NCT01396447|19118546|P2|Overall Study|Adverse Event|12
5530763|NCT01396447|19118547|P1|Overall Study|Adverse Event|15
5530764|NCT01396447|19118544|P4|Overall Study|Did Not Receive Treatment|0
5530765|NCT01396447|19118545|P3|Overall Study|Did Not Receive Treatment|1
5530766|NCT01396447|19118546|P2|Overall Study|Did Not Receive Treatment|2
5530767|NCT01396447|19118547|P1|Overall Study|Did Not Receive Treatment|3
5530768|NCT01396434|19118564|P3|Overall Study|Other|0
5530769|NCT01396434|19118565|P2|Overall Study|Other|0
5530770|NCT01396434|19118566|P1|Overall Study|Other|10
5530771|NCT01396434|19118564|P3|Overall Study|Lost to Follow-up|0
5530772|NCT01396434|19118565|P2|Overall Study|Lost to Follow-up|0
5530773|NCT01396434|19118566|P1|Overall Study|Lost to Follow-up|1
5530774|NCT01396421|19118578|P4|Overall Study|Lack of Efficacy|18
5530775|NCT01396421|19118579|P3|Overall Study|Lack of Efficacy|7
5530776|NCT01396421|19118580|P2|Overall Study|Lack of Efficacy|17
5530777|NCT01396421|19118581|P1|Overall Study|Lack of Efficacy|7
5530778|NCT01396421|19118578|P4|Overall Study|Protocol Deviation|0
5530779|NCT01396421|19118579|P3|Overall Study|Protocol Deviation|1
5530780|NCT01396421|19118580|P2|Overall Study|Protocol Deviation|1
5530781|NCT01396421|19118581|P1|Overall Study|Protocol Deviation|2
5530782|NCT01396421|19118578|P4|Overall Study|Withdrawal by Subject|21
5530783|NCT01396421|19118579|P3|Overall Study|Withdrawal by Subject|13
5530784|NCT01396421|19118580|P2|Overall Study|Withdrawal by Subject|24
5530785|NCT01396421|19118581|P1|Overall Study|Withdrawal by Subject|31
5530786|NCT01396421|19118578|P4|Overall Study|Physician Decision|3
5530787|NCT01396421|19118579|P3|Overall Study|Physician Decision|0
5530788|NCT01396421|19118580|P2|Overall Study|Physician Decision|1
5530789|NCT01396421|19118581|P1|Overall Study|Physician Decision|1
5530790|NCT01396421|19118578|P4|Overall Study|Participant Met Withdrawal Criteria|0
5530791|NCT01396421|19118579|P3|Overall Study|Participant Met Withdrawal Criteria|1
5530792|NCT01396421|19118580|P2|Overall Study|Participant Met Withdrawal Criteria|0
5530793|NCT01396421|19118581|P1|Overall Study|Participant Met Withdrawal Criteria|1
5530794|NCT01396421|19118578|P4|Overall Study|Adverse Event|32
5530795|NCT01396421|19118579|P3|Overall Study|Adverse Event|12
5530796|NCT01396421|19118580|P2|Overall Study|Adverse Event|15
5530797|NCT01396421|19118581|P1|Overall Study|Adverse Event|17
5530798|NCT01396421|19118578|P4|Overall Study|Lost to Follow-up|1
5530799|NCT01396421|19118579|P3|Overall Study|Lost to Follow-up|0
5530800|NCT01396421|19118580|P2|Overall Study|Lost to Follow-up|0
5530801|NCT01396421|19118581|P1|Overall Study|Lost to Follow-up|0
5530802|NCT01396395|19118653|P2|Overall Study|Other|1
5530803|NCT01396395|19118654|P1|Overall Study|Other|0
5530804|NCT01396395|19118653|P2|Overall Study|Lost to Follow-up|11
5530805|NCT01396395|19118654|P1|Overall Study|Lost to Follow-up|17
5530806|NCT01396395|19118653|P2|Overall Study|Adverse Event|2
5530807|NCT01396395|19118654|P1|Overall Study|Adverse Event|10
5530808|NCT01396395|19118653|P2|Overall Study|Protocol Violation|1
5530809|NCT01396395|19118654|P1|Overall Study|Protocol Violation|3
5530810|NCT01396395|19118653|P2|Overall Study|Withdrawal by Subject|12
5530811|NCT01396395|19118654|P1|Overall Study|Withdrawal by Subject|10
5530812|NCT01396317|19118696|P2|Overall Study|Adverse Event|0
5530813|NCT01396317|19118697|P1|Overall Study|Adverse Event|1
5530814|NCT01396265|19118711|P1|Rifa+Afatinib|Withdrawal by Subject|1
5530815|NCT01396187|19118800|P5|Overall Study|Other|1
5530816|NCT01396187|19118801|P4|Overall Study|Other|0
5530817|NCT01396187|19118802|P3|Overall Study|Other|0
5530818|NCT01396187|19118803|P2|Overall Study|Other|1
5530819|NCT01396187|19118804|P1|Overall Study|Other|1
5530820|NCT01396187|19118800|P5|Overall Study|Withdrawal by Subject|0
5530821|NCT01396187|19118801|P4|Overall Study|Withdrawal by Subject|0
5530822|NCT01396187|19118802|P3|Overall Study|Withdrawal by Subject|1
5530823|NCT01396187|19118803|P2|Overall Study|Withdrawal by Subject|1
5530824|NCT01396187|19118804|P1|Overall Study|Withdrawal by Subject|0
5530825|NCT01396187|19118800|P5|Overall Study|Adverse Event|0
5530826|NCT01396187|19118801|P4|Overall Study|Adverse Event|0
5530827|NCT01396187|19118802|P3|Overall Study|Adverse Event|0
5530828|NCT01396187|19118803|P2|Overall Study|Adverse Event|1
5530829|NCT01396187|19118804|P1|Overall Study|Adverse Event|0
5530830|NCT01396161|19118904|P7|Overall Study|Other|1
5530831|NCT01396161|19118905|P6|Overall Study|Other|0
5530832|NCT01396161|19118906|P5|Overall Study|Other|0
5530833|NCT01396161|19118907|P4|Overall Study|Other|0
5530834|NCT01396161|19118908|P3|Overall Study|Other|0
5530835|NCT01396161|19118909|P2|Overall Study|Other|0
5530836|NCT01396161|19118910|P1|Overall Study|Other|0
5530837|NCT01396161|19118904|P7|Overall Study|Withdrawal by Subject|0
5530838|NCT01396161|19118905|P6|Overall Study|Withdrawal by Subject|0
5530839|NCT01396161|19118906|P5|Overall Study|Withdrawal by Subject|1
5530840|NCT01396161|19118907|P4|Overall Study|Withdrawal by Subject|0
5530841|NCT01396161|19118908|P3|Overall Study|Withdrawal by Subject|0
5530842|NCT01396161|19118909|P2|Overall Study|Withdrawal by Subject|0
5530843|NCT01396161|19118910|P1|Overall Study|Withdrawal by Subject|0
5530844|NCT01396148|19118963|P1|Overall Study|Patient Decision|1
5530845|NCT01396083|19118993|P2|Overall Study|Lost to Follow-up|0
5530846|NCT01396083|19118994|P1|Overall Study|Lost to Follow-up|1
5530847|NCT01396083|19118993|P2|Overall Study|Administrative problems|0
5530848|NCT01396083|19118994|P1|Overall Study|Administrative problems|1
5530849|NCT01396083|19118993|P2|Overall Study|Abnormal laboratory value(s)|0
5530850|NCT01396083|19118994|P1|Overall Study|Abnormal laboratory value(s)|1
5530851|NCT01396083|19118993|P2|Overall Study|Protocol deviation(s)|1
5530852|NCT01396083|19118994|P1|Overall Study|Protocol deviation(s)|0
5530853|NCT01396083|19118993|P2|Overall Study|Consent withdrawn|5
5530854|NCT01396083|19118994|P1|Overall Study|Consent withdrawn|4
5530855|NCT01396083|19118993|P2|Overall Study|Unsatisfactory therapeutic effect|13
5530856|NCT01396083|19118994|P1|Overall Study|Unsatisfactory therapeutic effect|2
5530857|NCT01396083|19118993|P2|Overall Study|Adverse Event|28
5530858|NCT01396083|19118994|P1|Overall Study|Adverse Event|2
5530859|NCT01396070|19119018|P1|Overall Study|Lack of Efficacy|4
5530860|NCT01396070|19119018|P1|Overall Study|Physician Decision|3
5530861|NCT01396070|19119018|P1|Overall Study|Adverse Event|8
5530862|NCT01396070|19119018|P1|Overall Study|Death|2
5530863|NCT01396070|19119018|P1|Overall Study|Withdrawal by Subject|2
5530864|NCT01396057|19119027|P2|Overall Study|Consent withdrawn|2
5530865|NCT01396057|19119028|P1|Overall Study|Consent withdrawn|3
5530866|NCT01396057|19119027|P2|Overall Study|Protocol deviation|4
5530867|NCT01396057|19119028|P1|Overall Study|Protocol deviation|4
5530868|NCT01396057|19119027|P2|Overall Study|Unsatisfactory therapeutic effect|6
5530869|NCT01396057|19119028|P1|Overall Study|Unsatisfactory therapeutic effect|2
5530870|NCT01396057|19119027|P2|Overall Study|Adverse Event|6
5530871|NCT01396057|19119028|P1|Overall Study|Adverse Event|2
5530872|NCT01396005|19119077|P2|Overall Study|Non-compliance with protocol|1
5530873|NCT01396005|19119078|P1|Overall Study|Non-compliance with protocol|0
5530874|NCT01396005|19119077|P2|Overall Study|Withdrawal by Subject|1
5530875|NCT01396005|19119078|P1|Overall Study|Withdrawal by Subject|0
5530876|NCT01395914|19119109|P2|Overall Study|Lost to Follow-up|2
5530877|NCT01395914|19119110|P1|Overall Study|Lost to Follow-up|6
5530878|NCT01395914|19119109|P2|Overall Study|Study drug-related AE|0
5530879|NCT01395914|19119110|P1|Overall Study|Study drug-related AE|1
5530880|NCT01395914|19119109|P2|Overall Study|Withdrawal by patient|14
5530881|NCT01395914|19119110|P1|Overall Study|Withdrawal by patient|27
5530882|NCT01395914|19119109|P2|Overall Study|Other|3
5530883|NCT01395914|19119110|P1|Overall Study|Other|9
5530884|NCT01395914|19119109|P2|Overall Study|Death|17
5530885|NCT01395914|19119110|P1|Overall Study|Death|23
5530886|NCT01395914|19119109|P2|Overall Study|Unrelated to study drug AE|1
5530887|NCT01395914|19119110|P1|Overall Study|Unrelated to study drug AE|6
5530888|NCT01395901|19119124|P2|Overall Study|Withdrawal of consent|0
5530889|NCT01395901|19119125|P1|Overall Study|Withdrawal of consent|1
5530890|NCT01395901|19119124|P2|Overall Study|Adverse Event|1
5530891|NCT01395901|19119125|P1|Overall Study|Adverse Event|0
5530892|NCT01395901|19119124|P2|Overall Study|Randomized but not received study drug|4
5530893|NCT01395901|19119125|P1|Overall Study|Randomized but not received study drug|5
5530894|NCT01395901|19119124|P2|Overall Study|Lost to Follow-up|0
5530895|NCT01395901|19119125|P1|Overall Study|Lost to Follow-up|4
5530896|NCT01395888|19119141|P3|Treatment Period (TP)|Withdrawal by Subject|3
5530897|NCT01395888|19119142|P2|Treatment Period (TP)|Withdrawal by Subject|2
5530898|NCT01395888|19119143|P1|Treatment Period (TP)|Withdrawal by Subject|0
5530899|NCT01395888|19119141|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
5530900|NCT01395888|19119142|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
5530901|NCT01395888|19119143|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
5530902|NCT01395888|19119141|P3|Treatment Period (TP)|Protocol Violation|5
5530903|NCT01395888|19119142|P2|Treatment Period (TP)|Protocol Violation|1
5530904|NCT01395888|19119143|P1|Treatment Period (TP)|Protocol Violation|0
5530905|NCT01395888|19119141|P3|Treatment Period (TP)|Lack of Efficacy|3
5530906|NCT01395888|19119142|P2|Treatment Period (TP)|Lack of Efficacy|4
5530907|NCT01395888|19119143|P1|Treatment Period (TP)|Lack of Efficacy|0
5530908|NCT01395888|19119141|P3|Treatment Period (TP)|Adverse Event|6
5530909|NCT01395888|19119142|P2|Treatment Period (TP)|Adverse Event|7
5530910|NCT01395888|19119143|P1|Treatment Period (TP)|Adverse Event|0
5530911|NCT01395888|19119141|P3|2-week Run-in Period|Withdrawal by Subject|0
5530912|NCT01395888|19119142|P2|2-week Run-in Period|Withdrawal by Subject|0
5530913|NCT01395888|19119143|P1|2-week Run-in Period|Withdrawal by Subject|4
5530914|NCT01395888|19119141|P3|2-week Run-in Period|Protocol Violation|0
5530915|NCT01395888|19119142|P2|2-week Run-in Period|Protocol Violation|0
5530916|NCT01395888|19119143|P1|2-week Run-in Period|Protocol Violation|2
5530917|NCT01395888|19119141|P3|2-week Run-in Period|Lost to Follow-up|0
5530918|NCT01395888|19119142|P2|2-week Run-in Period|Lost to Follow-up|0
5530919|NCT01395888|19119143|P1|2-week Run-in Period|Lost to Follow-up|1
5530920|NCT01395888|19119141|P3|2-week Run-in Period|Continuation Criteria Not Met|0
5530921|NCT01395888|19119142|P2|2-week Run-in Period|Continuation Criteria Not Met|0
5530922|NCT01395888|19119143|P1|2-week Run-in Period|Continuation Criteria Not Met|13
5530923|NCT01395888|19119141|P3|2-week Run-in Period|Adverse Event|0
5530924|NCT01395888|19119142|P2|2-week Run-in Period|Adverse Event|0
5530925|NCT01395888|19119143|P1|2-week Run-in Period|Adverse Event|2
5530926|NCT01395823|19119151|P2|Overall Study|Withdrawal by Subject|4
5530927|NCT01395823|19119152|P1|Overall Study|Withdrawal by Subject|5
5530928|NCT01395823|19119151|P2|Overall Study|GI symptoms|0
5530929|NCT01395823|19119152|P1|Overall Study|GI symptoms|1
5530930|NCT01395823|19119151|P2|Overall Study|Transplant|0
5530931|NCT01395823|19119152|P1|Overall Study|Transplant|1
5530932|NCT01395823|19119151|P2|Overall Study|Lost to Follow-up|0
5530933|NCT01395823|19119152|P1|Overall Study|Lost to Follow-up|1
5530934|NCT01395823|19119151|P2|Overall Study|Physician Decision|1
5530935|NCT01395823|19119152|P1|Overall Study|Physician Decision|3
5530936|NCT01395823|19119151|P2|Overall Study|Death|4
5530937|NCT01395823|19119152|P1|Overall Study|Death|4
5530938|NCT01395810|19119162|P4|Overall Study|Unclassified|0
5530939|NCT01395810|19119163|P3|Overall Study|Unclassified|0
5530940|NCT01395810|19119164|P2|Overall Study|Unclassified|0
5530941|NCT01395810|19119165|P1|Overall Study|Unclassified|2
5530942|NCT01395810|19119162|P4|Overall Study|Withdrawal criteria|0
5530943|NCT01395810|19119163|P3|Overall Study|Withdrawal criteria|0
5530944|NCT01395810|19119164|P2|Overall Study|Withdrawal criteria|2
5530945|NCT01395810|19119165|P1|Overall Study|Withdrawal criteria|0
5530946|NCT01395810|19119162|P4|Overall Study|Lack of Efficacy|0
5530947|NCT01395810|19119163|P3|Overall Study|Lack of Efficacy|0
5530948|NCT01395810|19119164|P2|Overall Study|Lack of Efficacy|1
5530949|NCT01395810|19119165|P1|Overall Study|Lack of Efficacy|0
5530950|NCT01395810|19119162|P4|Overall Study|Adverse Event|0
5530951|NCT01395810|19119163|P3|Overall Study|Adverse Event|0
5530952|NCT01395810|19119164|P2|Overall Study|Adverse Event|1
5530953|NCT01395810|19119165|P1|Overall Study|Adverse Event|0
5530954|NCT01395784|19119224|P1|Overall Study|Physician Decision|5
5530955|NCT01395784|19119224|P1|Overall Study|Withdrawal by Subject|3
5530956|NCT01395784|19119224|P1|Overall Study|Lost to Follow-up|7
5530957|NCT01395758|19119231|P3|Open-label Treatment Period|Withdrawal by Subject|0
5530958|NCT01395758|19119232|P2|Open-label Treatment Period|Withdrawal by Subject|0
5530959|NCT01395758|19119233|P1|Open-label Treatment Period|Withdrawal by Subject|4
5530960|NCT01395524|19119253|P3|Overall Study|Subject had spinal surgery|1
5530961|NCT01395524|19119254|P2|Overall Study|Subject had spinal surgery|0
5530962|NCT01395524|19119255|P1|Overall Study|Subject had spinal surgery|0
5530963|NCT01395524|19119253|P3|Overall Study|Did not receive treatment|3
5530964|NCT01395524|19119254|P2|Overall Study|Did not receive treatment|1
5530965|NCT01395524|19119255|P1|Overall Study|Did not receive treatment|1
5530966|NCT01395524|19119253|P3|Overall Study|Withdrawal by Subject|8
5530967|NCT01395524|19119254|P2|Overall Study|Withdrawal by Subject|8
5530968|NCT01395524|19119255|P1|Overall Study|Withdrawal by Subject|4
5530969|NCT01395524|19119253|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
5530970|NCT01395524|19119254|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
5530971|NCT01395524|19119255|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
5530972|NCT01395524|19119253|P3|Overall Study|Death|0
5530973|NCT01395524|19119254|P2|Overall Study|Death|0
5530974|NCT01395524|19119255|P1|Overall Study|Death|1
5530975|NCT01395524|19119253|P3|Overall Study|Adverse Event|3
5530976|NCT01395524|19119254|P2|Overall Study|Adverse Event|4
5530977|NCT01395524|19119255|P1|Overall Study|Adverse Event|4
5530978|NCT01395524|19119253|P3|Overall Study|Severe noncompliance with protocol|0
5530979|NCT01395524|19119254|P2|Overall Study|Severe noncompliance with protocol|0
5530980|NCT01395524|19119255|P1|Overall Study|Severe noncompliance with protocol|1
5530981|NCT01395524|19119253|P3|Overall Study|Study-Specific Withdrawal Criteria|0
5530982|NCT01395524|19119254|P2|Overall Study|Study-Specific Withdrawal Criteria|2
5530983|NCT01395524|19119255|P1|Overall Study|Study-Specific Withdrawal Criteria|1
5530984|NCT01395524|19119253|P3|Overall Study|Lost to Follow-up|1
5530985|NCT01395524|19119254|P2|Overall Study|Lost to Follow-up|1
5530986|NCT01395524|19119255|P1|Overall Study|Lost to Follow-up|3
5530987|NCT01395524|19119253|P3|Overall Study|Non-compliance with study schedule|1
5530988|NCT01395524|19119254|P2|Overall Study|Non-compliance with study schedule|0
5530989|NCT01395524|19119255|P1|Overall Study|Non-compliance with study schedule|1
5530990|NCT01395394|19119278|P3|Baseline Study Visit|Protocol Violation|0
5530991|NCT01395394|19119279|P2|Baseline Study Visit|Protocol Violation|0
5530992|NCT01395394|19119280|P1|Baseline Study Visit|Protocol Violation|1
5530993|NCT01395368|19119291|P1|Overall Study|Withdrawal by Subject|2
5530994|NCT01395368|19119291|P1|Overall Study|Physician Decision|14
5530995|NCT01395316|19119347|P1|Overall Study|poor MRI quality|1
5530996|NCT01395316|19119347|P1|Overall Study|Lost to Follow-up|2
5530997|NCT01395030|19119367|P1|Overall Study|Did not complete FCH PET/CT|7
5530998|NCT01395017|19119377|P2|Overall Study|Sponsor discontinued study|4
5530999|NCT01395017|19119378|P1|Overall Study|Sponsor discontinued study|1
5531000|NCT01395017|19119377|P2|Overall Study|Disease progression|58
5531001|NCT01395017|19119378|P1|Overall Study|Disease progression|42
5531002|NCT01395017|19119377|P2|Overall Study|Death|3
5531003|NCT01395017|19119378|P1|Overall Study|Death|4
5531004|NCT01395017|19119377|P2|Overall Study|Protocol deviation|2
5531005|NCT01395017|19119378|P1|Overall Study|Protocol deviation|1
5531006|NCT01395017|19119377|P2|Overall Study|Withdrawal by Subject|8
5531007|NCT01395017|19119378|P1|Overall Study|Withdrawal by Subject|14
5531008|NCT01395017|19119377|P2|Overall Study|Physician Decision|15
5531009|NCT01395017|19119378|P1|Overall Study|Physician Decision|11
5531010|NCT01395017|19119377|P2|Overall Study|Adverse Event|12
5531011|NCT01395017|19119378|P1|Overall Study|Adverse Event|26
5531012|NCT01395017|19119377|P2|Overall Study|Lost to Follow-up|0
5531013|NCT01395017|19119378|P1|Overall Study|Lost to Follow-up|1
5531014|NCT01394991|19119388|P2|Overall Study|Prematurely Termination of Trial|10
5531015|NCT01394991|19119389|P1|Overall Study|Prematurely Termination of Trial|9
5531016|NCT01394991|19119388|P2|Overall Study|Disease Progression|7
5531017|NCT01394991|19119389|P1|Overall Study|Disease Progression|7
5531018|NCT01394991|19119388|P2|Overall Study|Chemotherapy Termination|15
5531019|NCT01394991|19119389|P1|Overall Study|Chemotherapy Termination|10
5531020|NCT01394991|19119388|P2|Overall Study|Withdrawal by Subject|17
5531021|NCT01394991|19119389|P1|Overall Study|Withdrawal by Subject|20
5531022|NCT01394991|19119388|P2|Overall Study|Protocol Violation|1
5531023|NCT01394991|19119389|P1|Overall Study|Protocol Violation|1
5531024|NCT01394991|19119388|P2|Overall Study|Physician Decision|3
5531025|NCT01394991|19119389|P1|Overall Study|Physician Decision|1
5531026|NCT01394991|19119388|P2|Overall Study|Lost to Follow-up|8
5531027|NCT01394991|19119389|P1|Overall Study|Lost to Follow-up|6
5531028|NCT01394991|19119388|P2|Overall Study|Lack of Efficacy|7
5531029|NCT01394991|19119389|P1|Overall Study|Lack of Efficacy|5
5531030|NCT01394991|19119388|P2|Overall Study|Adverse Event|4
5531031|NCT01394991|19119389|P1|Overall Study|Adverse Event|0
5531032|NCT01394978|19119411|P2|Overall Study|Death|7
5531033|NCT01394978|19119412|P1|Overall Study|Death|6
5531034|NCT01394978|19119411|P2|Overall Study|Lost to Follow-up|20
5531035|NCT01394978|19119412|P1|Overall Study|Lost to Follow-up|13
5531036|NCT01394978|19119411|P2|Overall Study|Withdrawal by Subject|4
5531037|NCT01394978|19119412|P1|Overall Study|Withdrawal by Subject|2
5531038|NCT01394952|19119420|P2|Overall Study|Sponsor Decision|7
5531039|NCT01394952|19119421|P1|Overall Study|Sponsor Decision|5
5531040|NCT01394952|19119420|P2|Overall Study|Physician Decision|0
5531041|NCT01394952|19119421|P1|Overall Study|Physician Decision|2
5531042|NCT01394952|19119420|P2|Overall Study|Withdrawal by Subject|5
5531043|NCT01394952|19119421|P1|Overall Study|Withdrawal by Subject|10
5531044|NCT01394952|19119420|P2|Overall Study|Lost to Follow-up|5
5531045|NCT01394952|19119421|P1|Overall Study|Lost to Follow-up|0
5531046|NCT01394718|19119448|P2|Overall Study|Met protocol-specific stopping criteria|1
5531047|NCT01394718|19119449|P1|Overall Study|Met protocol-specific stopping criteria|2
5531048|NCT01394627|19119481|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
5531049|NCT01394627|19119482|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
5531050|NCT01394627|19119481|P2|First Intervention (1 Day)|poor intravenous access|1
5531051|NCT01394627|19119482|P1|First Intervention (1 Day)|poor intravenous access|0
5531052|NCT01394523|19119502|P3|Overall Study|Unable to place block|0
5531053|NCT01394523|19119503|P2|Overall Study|Unable to place block|0
5531054|NCT01394523|19119504|P1|Overall Study|Unable to place block|1
5531055|NCT01394276|19119518|P1|Overall Study|Symptoms of concurrent diseases|1
5531056|NCT01394276|19119518|P1|Overall Study|unavailability of drug at the Hospital|2
5531057|NCT01394276|19119518|P1|Overall Study|Pregnancy|1
5531058|NCT01394276|19119518|P1|Overall Study|Participant moved to another site|1
5531059|NCT01394276|19119518|P1|Overall Study|Lost to Follow-up|5
5531060|NCT01394276|19119518|P1|Overall Study|Insufficient compliance|9
5531061|NCT01394276|19119518|P1|Overall Study|Insufficient therapeutic effect|17
5531062|NCT01394276|19119518|P1|Overall Study|Remission of disease|2
5531063|NCT01394276|19119518|P1|Overall Study|Not related AEs|9
5531064|NCT01394276|19119518|P1|Overall Study|Related Adverse event (AEs)|15
5531065|NCT01394250|19119542|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
5531066|NCT01394250|19119543|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
5531067|NCT01394250|19119542|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
5531068|NCT01394250|19119543|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
5531069|NCT01394185|19119557|P6|Overall Study|Protocol Violation|1
5531070|NCT01394185|19119558|P5|Overall Study|Protocol Violation|0
5531071|NCT01394185|19119559|P4|Overall Study|Protocol Violation|1
5531072|NCT01394185|19119560|P3|Overall Study|Protocol Violation|0
5531073|NCT01394185|19119561|P2|Overall Study|Protocol Violation|0
5531074|NCT01394185|19119562|P1|Overall Study|Protocol Violation|1
5531075|NCT01394185|19119557|P6|Overall Study|Change in protocol|0
5531076|NCT01394185|19119558|P5|Overall Study|Change in protocol|3
5531077|NCT01394185|19119559|P4|Overall Study|Change in protocol|0
5531078|NCT01394185|19119560|P3|Overall Study|Change in protocol|0
5531079|NCT01394185|19119561|P2|Overall Study|Change in protocol|0
5531080|NCT01394185|19119562|P1|Overall Study|Change in protocol|3
5531081|NCT01394185|19119557|P6|Overall Study|Withdrawal by Subject|0
5531082|NCT01394185|19119558|P5|Overall Study|Withdrawal by Subject|1
5531083|NCT01394185|19119559|P4|Overall Study|Withdrawal by Subject|0
5531084|NCT01394185|19119560|P3|Overall Study|Withdrawal by Subject|0
5531085|NCT01394185|19119561|P2|Overall Study|Withdrawal by Subject|0
5531086|NCT01394185|19119562|P1|Overall Study|Withdrawal by Subject|2
5531087|NCT01393990|19119666|P18|Overall Study|Withdrawal by Subject|0
5531088|NCT01393990|19119667|P17|Overall Study|Withdrawal by Subject|0
5531089|NCT01393990|19119668|P16|Overall Study|Withdrawal by Subject|1
5531090|NCT01393990|19119669|P15|Overall Study|Withdrawal by Subject|1
5531091|NCT01393990|19119670|P14|Overall Study|Withdrawal by Subject|0
5531092|NCT01393990|19119671|P13|Overall Study|Withdrawal by Subject|0
5531093|NCT01393990|19119672|P12|Overall Study|Withdrawal by Subject|0
5531094|NCT01393990|19119673|P11|Overall Study|Withdrawal by Subject|0
5531095|NCT01393990|19119674|P10|Overall Study|Withdrawal by Subject|0
5531096|NCT01393990|19119675|P9|Overall Study|Withdrawal by Subject|0
5531097|NCT01393990|19119676|P8|Overall Study|Withdrawal by Subject|0
5531098|NCT01393990|19119677|P7|Overall Study|Withdrawal by Subject|0
5531099|NCT01393990|19119678|P6|Overall Study|Withdrawal by Subject|0
5531100|NCT01393990|19119679|P5|Overall Study|Withdrawal by Subject|0
5531101|NCT01393990|19119680|P4|Overall Study|Withdrawal by Subject|0
5531102|NCT01393990|19119681|P3|Overall Study|Withdrawal by Subject|0
5531103|NCT01393990|19119682|P2|Overall Study|Withdrawal by Subject|0
5531104|NCT01393990|19119683|P1|Overall Study|Withdrawal by Subject|0
5531105|NCT01393990|19119666|P18|Overall Study|Death|0
5531106|NCT01393990|19119667|P17|Overall Study|Death|0
5531107|NCT01393990|19119668|P16|Overall Study|Death|0
5531108|NCT01393990|19119669|P15|Overall Study|Death|1
5531109|NCT01393990|19119670|P14|Overall Study|Death|1
5531110|NCT01393990|19119671|P13|Overall Study|Death|0
5531111|NCT01393990|19119672|P12|Overall Study|Death|0
5531112|NCT01393990|19119673|P11|Overall Study|Death|0
5531113|NCT01393990|19119674|P10|Overall Study|Death|0
5531114|NCT01393990|19119675|P9|Overall Study|Death|0
5531115|NCT01393990|19119676|P8|Overall Study|Death|0
5531116|NCT01393990|19119677|P7|Overall Study|Death|0
5531117|NCT01393990|19119678|P6|Overall Study|Death|0
5531118|NCT01393990|19119679|P5|Overall Study|Death|1
5531119|NCT01393990|19119680|P4|Overall Study|Death|0
5531120|NCT01393990|19119681|P3|Overall Study|Death|0
5531121|NCT01393990|19119682|P2|Overall Study|Death|0
5531122|NCT01393990|19119683|P1|Overall Study|Death|0
5531123|NCT01393990|19119666|P18|Overall Study|Progressive Disease|0
5531124|NCT01393990|19119667|P17|Overall Study|Progressive Disease|0
5531125|NCT01393990|19119668|P16|Overall Study|Progressive Disease|1
5531126|NCT01393990|19119669|P15|Overall Study|Progressive Disease|6
5531127|NCT01393990|19119670|P14|Overall Study|Progressive Disease|1
5531128|NCT01393990|19119671|P13|Overall Study|Progressive Disease|0
5531129|NCT01393990|19119672|P12|Overall Study|Progressive Disease|0
5531130|NCT01393990|19119673|P11|Overall Study|Progressive Disease|0
5531131|NCT01393990|19119674|P10|Overall Study|Progressive Disease|1
5531132|NCT01393990|19119675|P9|Overall Study|Progressive Disease|3
5531133|NCT01393990|19119676|P8|Overall Study|Progressive Disease|1
5531134|NCT01393990|19119677|P7|Overall Study|Progressive Disease|1
5531135|NCT01393990|19119678|P6|Overall Study|Progressive Disease|1
5531136|NCT01393990|19119679|P5|Overall Study|Progressive Disease|1
5531137|NCT01393990|19119680|P4|Overall Study|Progressive Disease|1
5531138|NCT01393990|19119681|P3|Overall Study|Progressive Disease|0
5531139|NCT01393990|19119682|P2|Overall Study|Progressive Disease|0
5531140|NCT01393990|19119683|P1|Overall Study|Progressive Disease|1
5531141|NCT01393990|19119666|P18|Overall Study|Adverse Event|0
5531142|NCT01393990|19119667|P17|Overall Study|Adverse Event|0
5531143|NCT01393990|19119668|P16|Overall Study|Adverse Event|1
5531144|NCT01393990|19119669|P15|Overall Study|Adverse Event|1
5531145|NCT01393990|19119670|P14|Overall Study|Adverse Event|0
5531146|NCT01393990|19119671|P13|Overall Study|Adverse Event|0
5531147|NCT01393990|19119672|P12|Overall Study|Adverse Event|0
5531148|NCT01393990|19119673|P11|Overall Study|Adverse Event|0
5531149|NCT01393990|19119674|P10|Overall Study|Adverse Event|0
5531150|NCT01393990|19119675|P9|Overall Study|Adverse Event|0
5531151|NCT01393990|19119676|P8|Overall Study|Adverse Event|0
5531152|NCT01393990|19119677|P7|Overall Study|Adverse Event|0
5531153|NCT01393990|19119678|P6|Overall Study|Adverse Event|0
5531154|NCT01393990|19119679|P5|Overall Study|Adverse Event|0
5531155|NCT01393990|19119680|P4|Overall Study|Adverse Event|0
5531156|NCT01393990|19119681|P3|Overall Study|Adverse Event|0
5531157|NCT01393990|19119682|P2|Overall Study|Adverse Event|0
5531158|NCT01393990|19119683|P1|Overall Study|Adverse Event|0
5531159|NCT01393964|19119774|P3|Overall Study|Subject to receive non-protocol therapy|1
5531160|NCT01393964|19119775|P2|Overall Study|Subject to receive non-protocol therapy|0
5531161|NCT01393964|19119776|P1|Overall Study|Subject to receive non-protocol therapy|0
5531162|NCT01393964|19119774|P3|Overall Study|Subject converted to roll-over study|0
5531163|NCT01393964|19119775|P2|Overall Study|Subject converted to roll-over study|1
5531164|NCT01393964|19119776|P1|Overall Study|Subject converted to roll-over study|0
5531165|NCT01393964|19119774|P3|Overall Study|Investigator removed subject from study|0
5531166|NCT01393964|19119775|P2|Overall Study|Investigator removed subject from study|1
5531167|NCT01393964|19119776|P1|Overall Study|Investigator removed subject from study|0
5531168|NCT01393964|19119774|P3|Overall Study|Subject plateaued in terms of effect|0
5531169|NCT01393964|19119775|P2|Overall Study|Subject plateaued in terms of effect|0
5531170|NCT01393964|19119776|P1|Overall Study|Subject plateaued in terms of effect|1
5531171|NCT01393964|19119774|P3|Overall Study|Subject switched to commercial supply|2
5531172|NCT01393964|19119775|P2|Overall Study|Subject switched to commercial supply|0
5531173|NCT01393964|19119776|P1|Overall Study|Subject switched to commercial supply|1
5531174|NCT01393964|19119774|P3|Overall Study|Subject decided to move to transplant|0
5531175|NCT01393964|19119775|P2|Overall Study|Subject decided to move to transplant|0
5531176|NCT01393964|19119776|P1|Overall Study|Subject decided to move to transplant|1
5531177|NCT01393964|19119774|P3|Overall Study|Subject request stop study treatment|0
5531178|NCT01393964|19119775|P2|Overall Study|Subject request stop study treatment|1
5531179|NCT01393964|19119776|P1|Overall Study|Subject request stop study treatment|0
5531180|NCT01393964|19119774|P3|Overall Study|Adverse event unrelated to study drug|0
5531181|NCT01393964|19119775|P2|Overall Study|Adverse event unrelated to study drug|3
5531182|NCT01393964|19119776|P1|Overall Study|Adverse event unrelated to study drug|0
5531183|NCT01393964|19119774|P3|Overall Study|Withdrawal by Subject|1
5531184|NCT01393964|19119775|P2|Overall Study|Withdrawal by Subject|0
5531185|NCT01393964|19119776|P1|Overall Study|Withdrawal by Subject|0
5531186|NCT01393964|19119774|P3|Overall Study|Study drug toxicity|0
5531187|NCT01393964|19119775|P2|Overall Study|Study drug toxicity|0
5531188|NCT01393964|19119776|P1|Overall Study|Study drug toxicity|1
5531189|NCT01393964|19119774|P3|Overall Study|Disease Progression|5
5531190|NCT01393964|19119775|P2|Overall Study|Disease Progression|3
5531191|NCT01393964|19119776|P1|Overall Study|Disease Progression|4
5531192|NCT01393899|19119817|P3|Overall Study|Adverse Event|3
5531193|NCT01393899|19119818|P2|Overall Study|Adverse Event|5
5531194|NCT01393899|19119819|P1|Overall Study|Adverse Event|1
5531195|NCT01393899|19119817|P3|Overall Study|Lack of Efficacy|16
5531196|NCT01393899|19119818|P2|Overall Study|Lack of Efficacy|21
5531197|NCT01393899|19119819|P1|Overall Study|Lack of Efficacy|26
5531198|NCT01393899|19119817|P3|Overall Study|Does not meet entrance criteria|1
5531199|NCT01393899|19119818|P2|Overall Study|Does not meet entrance criteria|0
5531200|NCT01393899|19119819|P1|Overall Study|Does not meet entrance criteria|1
5531201|NCT01393899|19119817|P3|Overall Study|Lost to Follow-up|1
5531202|NCT01393899|19119818|P2|Overall Study|Lost to Follow-up|0
5531203|NCT01393899|19119819|P1|Overall Study|Lost to Follow-up|0
5531204|NCT01393899|19119817|P3|Overall Study|Withdrawal by Subject|1
5531205|NCT01393899|19119818|P2|Overall Study|Withdrawal by Subject|2
5531206|NCT01393899|19119819|P1|Overall Study|Withdrawal by Subject|2
5531207|NCT01393899|19119817|P3|Overall Study|Other|0
5531208|NCT01393899|19119818|P2|Overall Study|Other|0
5531209|NCT01393899|19119819|P1|Overall Study|Other|1
5531210|NCT01393899|19119817|P3|Overall Study|Study terminated by sponsor|1
5531211|NCT01393899|19119818|P2|Overall Study|Study terminated by sponsor|0
5531212|NCT01393899|19119819|P1|Overall Study|Study terminated by sponsor|1
5531213|NCT01393821|19119873|P2|Overall Study|not evaluable for primary endpoint|2
5531214|NCT01393821|19119874|P1|Overall Study|not evaluable for primary endpoint|4
5531215|NCT01393821|19119873|P2|Overall Study|Cancel|1
5531216|NCT01393821|19119874|P1|Overall Study|Cancel|1
5531217|NCT01393743|19119888|P3|Extension Phase|Other|14
5531218|NCT01393743|19119889|P2|Extension Phase|Other|0
5531219|NCT01393743|19119890|P1|Extension Phase|Other|0
5531220|NCT01393743|19119888|P3|Extension Phase|Pregnancy|1
5531221|NCT01393743|19119889|P2|Extension Phase|Pregnancy|0
5531222|NCT01393743|19119890|P1|Extension Phase|Pregnancy|0
5531223|NCT01393743|19119888|P3|Extension Phase|Withdrawal by Subject|8
5531224|NCT01393743|19119889|P2|Extension Phase|Withdrawal by Subject|0
5531225|NCT01393743|19119890|P1|Extension Phase|Withdrawal by Subject|0
5531226|NCT01393743|19119888|P3|Extension Phase|Inadequate therapeutic effect|7
5531227|NCT01393743|19119889|P2|Extension Phase|Inadequate therapeutic effect|0
5531228|NCT01393743|19119890|P1|Extension Phase|Inadequate therapeutic effect|0
5531229|NCT01393743|19119888|P3|Extension Phase|Participant choice|16
5531230|NCT01393743|19119889|P2|Extension Phase|Participant choice|0
5531231|NCT01393743|19119890|P1|Extension Phase|Participant choice|0
5531232|NCT01393743|19119888|P3|Extension Phase|Lost to Follow-up|2
5531233|NCT01393743|19119889|P2|Extension Phase|Lost to Follow-up|0
5531234|NCT01393743|19119890|P1|Extension Phase|Lost to Follow-up|0
5531235|NCT01393743|19119888|P3|Extension Phase|Adverse Event|12
5531236|NCT01393743|19119889|P2|Extension Phase|Adverse Event|0
5531237|NCT01393743|19119890|P1|Extension Phase|Adverse Event|0
5531238|NCT01393743|19119888|P3|Core Study|Inadequate therapeutic effect|0
5531239|NCT01393743|19119889|P2|Core Study|Inadequate therapeutic effect|0
5531240|NCT01393743|19119890|P1|Core Study|Inadequate therapeutic effect|2
5531241|NCT01393743|19119888|P3|Core Study|Participant's Choice|0
5531242|NCT01393743|19119889|P2|Core Study|Participant's Choice|3
5531243|NCT01393743|19119890|P1|Core Study|Participant's Choice|2
5531244|NCT01393743|19119888|P3|Core Study|Lost to Follow-up|0
5531245|NCT01393743|19119889|P2|Core Study|Lost to Follow-up|1
5531246|NCT01393743|19119890|P1|Core Study|Lost to Follow-up|1
5531247|NCT01393743|19119888|P3|Core Study|Adverse Event|0
5531248|NCT01393743|19119889|P2|Core Study|Adverse Event|9
5531249|NCT01393743|19119890|P1|Core Study|Adverse Event|5
5531250|NCT01393730|19119913|P1|Overall Study|Adverse Event|1
5531251|NCT01393730|19119913|P1|Overall Study|Other|2
5531252|NCT01393730|19119913|P1|Overall Study|Withdrawal by Subject|3
5531253|NCT01393626|19119959|P4|Overall Study|Protocol Violation|0
5531254|NCT01393626|19119960|P3|Overall Study|Protocol Violation|2
5531255|NCT01393626|19119961|P2|Overall Study|Protocol Violation|0
5531256|NCT01393626|19119962|P1|Overall Study|Protocol Violation|1
5531257|NCT01393626|19119959|P4|Overall Study|Other|0
5531258|NCT01393626|19119960|P3|Overall Study|Other|0
5531259|NCT01393626|19119961|P2|Overall Study|Other|0
5531260|NCT01393626|19119962|P1|Overall Study|Other|1
5531261|NCT01393626|19119959|P4|Overall Study|Withdrawal by Subject|0
5531262|NCT01393626|19119960|P3|Overall Study|Withdrawal by Subject|0
5531263|NCT01393626|19119961|P2|Overall Study|Withdrawal by Subject|4
5531264|NCT01393626|19119962|P1|Overall Study|Withdrawal by Subject|6
5531265|NCT01393626|19119959|P4|Overall Study|Lost to Follow-up|0
5531266|NCT01393626|19119960|P3|Overall Study|Lost to Follow-up|1
5531267|NCT01393626|19119961|P2|Overall Study|Lost to Follow-up|1
5531268|NCT01393626|19119962|P1|Overall Study|Lost to Follow-up|1
5531269|NCT01393626|19119959|P4|Overall Study|Lack of Efficacy|1
5531270|NCT01393626|19119960|P3|Overall Study|Lack of Efficacy|4
5531271|NCT01393626|19119961|P2|Overall Study|Lack of Efficacy|6
5531272|NCT01393626|19119962|P1|Overall Study|Lack of Efficacy|6
5531273|NCT01393626|19119959|P4|Overall Study|Did not meet entrance criteria|0
5531274|NCT01393626|19119960|P3|Overall Study|Did not meet entrance criteria|0
5531275|NCT01393626|19119961|P2|Overall Study|Did not meet entrance criteria|0
5531276|NCT01393626|19119962|P1|Overall Study|Did not meet entrance criteria|1
5531277|NCT01393626|19119959|P4|Overall Study|Adverse Event|0
5531278|NCT01393626|19119960|P3|Overall Study|Adverse Event|5
5531279|NCT01393626|19119961|P2|Overall Study|Adverse Event|1
5531280|NCT01393626|19119962|P1|Overall Study|Adverse Event|2
5531281|NCT01393613|19120042|P4|Overall Study|Lack of Efficacy|21
5531282|NCT01393613|19120043|P3|Overall Study|Lack of Efficacy|16
5531283|NCT01393613|19120044|P2|Overall Study|Lack of Efficacy|20
5531284|NCT01393613|19120045|P1|Overall Study|Lack of Efficacy|9
5531285|NCT01393613|19120042|P4|Overall Study|Protocol Deviation|0
5531286|NCT01393613|19120043|P3|Overall Study|Protocol Deviation|0
5531287|NCT01393613|19120044|P2|Overall Study|Protocol Deviation|1
5531288|NCT01393613|19120045|P1|Overall Study|Protocol Deviation|2
5531289|NCT01393613|19120042|P4|Overall Study|Withdrawal by Subject|21
5531290|NCT01393613|19120043|P3|Overall Study|Withdrawal by Subject|23
5531291|NCT01393613|19120044|P2|Overall Study|Withdrawal by Subject|25
5531292|NCT01393613|19120045|P1|Overall Study|Withdrawal by Subject|15
5531293|NCT01393613|19120042|P4|Overall Study|Physician Decision|1
5531294|NCT01393613|19120043|P3|Overall Study|Physician Decision|0
5531295|NCT01393613|19120044|P2|Overall Study|Physician Decision|0
5531296|NCT01393613|19120045|P1|Overall Study|Physician Decision|2
5531297|NCT01393613|19120042|P4|Overall Study|Participant Met Withdrawal Criteria|1
5531298|NCT01393613|19120043|P3|Overall Study|Participant Met Withdrawal Criteria|2
5531299|NCT01393613|19120044|P2|Overall Study|Participant Met Withdrawal Criteria|0
5531300|NCT01393613|19120045|P1|Overall Study|Participant Met Withdrawal Criteria|0
5531301|NCT01393613|19120042|P4|Overall Study|Adverse Event|22
5531302|NCT01393613|19120043|P3|Overall Study|Adverse Event|13
5531303|NCT01393613|19120044|P2|Overall Study|Adverse Event|11
5531304|NCT01393613|19120045|P1|Overall Study|Adverse Event|11
5531305|NCT01393600|19120107|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
5531306|NCT01393600|19120108|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
5531307|NCT01393600|19120109|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
5531308|NCT01393600|19120110|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
5531309|NCT01393600|19120107|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
5531310|NCT01393600|19120108|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
5531311|NCT01393600|19120109|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
5531312|NCT01393600|19120110|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
5531313|NCT01393600|19120107|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
5531314|NCT01393600|19120108|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
5531315|NCT01393600|19120109|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
5531316|NCT01393600|19120110|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
5531317|NCT01393600|19120107|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
5531318|NCT01393600|19120108|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
5531319|NCT01393600|19120109|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
5531320|NCT01393600|19120110|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
5531321|NCT01393600|19120107|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
5531322|NCT01393600|19120108|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
5531323|NCT01393600|19120109|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
5531324|NCT01393600|19120110|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
5531325|NCT01393600|19120107|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
5531326|NCT01393600|19120108|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
5531327|NCT01393600|19120109|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
5531328|NCT01393600|19120110|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
5531329|NCT01393600|19120107|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
5531330|NCT01393600|19120108|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
5531331|NCT01393600|19120109|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
5531332|NCT01393600|19120110|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
5531333|NCT01393444|19120146|P1|Overall Study|Determined ineligible during screening.|2
5531334|NCT01393444|19120146|P1|Overall Study|Withdrawal by Subject|1
5531335|NCT01393405|19120151|P3|Maintenance Period Week|Lost to Follow-up|0
5531336|NCT01393405|19120152|P2|Maintenance Period Week|Lost to Follow-up|1
5531337|NCT01393405|19120153|P1|Maintenance Period Week|Lost to Follow-up|0
5531338|NCT01393405|19120151|P3|Maintenance Period Week|Withdrawal by Subject|0
5531339|NCT01393405|19120152|P2|Maintenance Period Week|Withdrawal by Subject|1
5531340|NCT01393405|19120153|P1|Maintenance Period Week|Withdrawal by Subject|0
5531341|NCT01393405|19120151|P3|Maintenance Period Week|Adverse Event|2
5531342|NCT01393405|19120152|P2|Maintenance Period Week|Adverse Event|5
5531343|NCT01393405|19120153|P1|Maintenance Period Week|Adverse Event|0
5531344|NCT01393405|19120151|P3|Maintenance Period Week|Lack of Efficacy|22
5531345|NCT01393405|19120152|P2|Maintenance Period Week|Lack of Efficacy|22
5531346|NCT01393405|19120153|P1|Maintenance Period Week|Lack of Efficacy|0
5531347|NCT01393405|19120151|P3|Induction Period (week1-16)|Withdrawal by Subject|0
5531348|NCT01393405|19120152|P2|Induction Period (week1-16)|Withdrawal by Subject|0
5531349|NCT01393405|19120153|P1|Induction Period (week1-16)|Withdrawal by Subject|9
5531350|NCT01393405|19120151|P3|Induction Period (week1-16)|Adverse Event|0
5531351|NCT01393405|19120152|P2|Induction Period (week1-16)|Adverse Event|0
5531352|NCT01393405|19120153|P1|Induction Period (week1-16)|Adverse Event|16
5531353|NCT01393405|19120151|P3|Induction Period (week1-16)|Lack of Efficacy|0
5531354|NCT01393405|19120152|P2|Induction Period (week1-16)|Lack of Efficacy|0
5531355|NCT01393405|19120153|P1|Induction Period (week1-16)|Lack of Efficacy|70
5531356|NCT01393301|19120191|P2|Overall Study|Completed <7 sessions (intervention)|0
5531357|NCT01393301|19120192|P1|Overall Study|Completed <7 sessions (intervention)|2
5531358|NCT01393301|19120191|P2|Overall Study|Withdrawal by Subject|0
5531359|NCT01393301|19120192|P1|Overall Study|Withdrawal by Subject|2
5531360|NCT01393301|19120191|P2|Overall Study|Lost to Follow-up|3
5531361|NCT01393301|19120192|P1|Overall Study|Lost to Follow-up|5
5531362|NCT01393158|19120205|P2|Overall Study|Adverse Event|0
5531363|NCT01393158|19120206|P1|Overall Study|Adverse Event|1
5531364|NCT01393106|19120233|P1|Overall Study|Lack of Efficacy|1
5531365|NCT01393106|19120233|P1|Overall Study|Withdrawal by Subject|1
5531366|NCT01393106|19120233|P1|Overall Study|Adverse Event|3
5531367|NCT01392963|19120260|P2|Week 24 Follow-up|Lost to Follow-up|0
5531368|NCT01392963|19120261|P1|Week 24 Follow-up|Lost to Follow-up|2
5531369|NCT01392963|19120260|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
5531370|NCT01392963|19120261|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
5531371|NCT01392963|19120260|P2|Week 0 (First Intervention)|Lost to Follow-up|1
5531372|NCT01392963|19120261|P1|Week 0 (First Intervention)|Lost to Follow-up|0
5531373|NCT01392742|19120269|P1|Overall Study|Missing information|13
5531374|NCT01392742|19120269|P1|Overall Study|Other|3
5531375|NCT01392742|19120269|P1|Overall Study|Protocol Violation|14
5531376|NCT01392742|19120269|P1|Overall Study|Adverse event/intercurrent illness|17
5531377|NCT01392742|19120269|P1|Overall Study|ITR and Protocol deviation|1
5531378|NCT01392742|19120269|P1|Overall Study|Insufficient therapeutic response (ITR)|30
5531379|NCT01392742|19120269|P1|Overall Study|Lost to Follow-up|34
5531380|NCT01392742|19120269|P1|Overall Study|No treatment/no cooperation/withdrew|12
5531381|NCT01392742|19120269|P1|Overall Study|Failure to return|35
5531382|NCT01392742|19120269|P1|Overall Study|Premature study termination|42
5531383|NCT01392677|19120315|P2|Overall Study|Other reason|2
5531384|NCT01392677|19120316|P1|Overall Study|Other reason|3
5531385|NCT01392677|19120315|P2|Overall Study|Incorrect enrollment|3
5531386|NCT01392677|19120316|P1|Overall Study|Incorrect enrollment|2
5531387|NCT01392677|19120315|P2|Overall Study|Withdrawal by Subject|2
5531388|NCT01392677|19120316|P1|Overall Study|Withdrawal by Subject|0
5531389|NCT01392677|19120315|P2|Overall Study|Adverse Event|1
5531390|NCT01392677|19120316|P1|Overall Study|Adverse Event|3
5531391|NCT01392573|19120351|P2|Overall Study|Unclassified|6
5531392|NCT01392573|19120352|P1|Overall Study|Unclassified|9
5531393|NCT01392573|19120351|P2|Overall Study|Site closure|7
5531394|NCT01392573|19120352|P1|Overall Study|Site closure|8
5531395|NCT01392573|19120351|P2|Overall Study|Withdrawal Criteria|15
5531396|NCT01392573|19120352|P1|Overall Study|Withdrawal Criteria|13
5531397|NCT01392573|19120351|P2|Overall Study|Protocol Violation|2
5531398|NCT01392573|19120352|P1|Overall Study|Protocol Violation|0
5531399|NCT01392573|19120351|P2|Overall Study|Lack of Efficacy|2
5531400|NCT01392573|19120352|P1|Overall Study|Lack of Efficacy|1
5531401|NCT01392573|19120351|P2|Overall Study|Adverse Event|3
5531402|NCT01392573|19120352|P1|Overall Study|Adverse Event|1
5531403|NCT01392560|19120360|P1|Overall Study|discontinued during placebo run-in|2
5531404|NCT01392560|19120360|P1|Overall Study|not entered|8
5531405|NCT01392560|19120360|P1|Overall Study|Adverse Event|2
5531406|NCT01392547|19120366|P1|Overall Study|Unclassified|1
5531407|NCT01392547|19120366|P1|Overall Study|Withdrawal criteria|3
5531408|NCT01392547|19120366|P1|Overall Study|Non-compliance|2
5531409|NCT01392547|19120366|P1|Overall Study|Adverse Event|2
5531410|NCT01392495|19120380|P1|Overall Study|Adverse Event|3
5531411|NCT01392495|19120380|P1|Overall Study|Withdrawal by Subject|2
5531412|NCT01392495|19120380|P1|Overall Study|Administrative problems|8
5531413|NCT01392495|19120380|P1|Overall Study|Death|3
5531414|NCT01392443|19120392|P1|Overall Study|Protocol Violation|1
5531415|NCT01392443|19120392|P1|Overall Study|Lost to Follow-up|1
5531416|NCT01392443|19120392|P1|Overall Study|Withdrawal by Subject|5
5531417|NCT01392443|19120392|P1|Overall Study|Death|7
5531418|NCT01392443|19120392|P1|Overall Study|Adverse Event|24
5531419|NCT01392443|19120392|P1|Overall Study|Disease progression|30
5531420|NCT01392378|19120405|P5|Toddler Dose|Withdrawal by Parent|1
5531421|NCT01392378|19120406|P4|Toddler Dose|Withdrawal by Parent|1
5531422|NCT01392378|19120407|P3|Toddler Dose|Withdrawal by Parent|0
5531423|NCT01392378|19120408|P2|Toddler Dose|Withdrawal by Parent|1
5531424|NCT01392378|19120409|P1|Toddler Dose|Withdrawal by Parent|0
5531425|NCT01392378|19120405|P5|Toddler Dose|Lost to Follow-up|0
5531426|NCT01392378|19120406|P4|Toddler Dose|Lost to Follow-up|1
5531427|NCT01392378|19120407|P3|Toddler Dose|Lost to Follow-up|0
5531428|NCT01392378|19120408|P2|Toddler Dose|Lost to Follow-up|0
5531429|NCT01392378|19120409|P1|Toddler Dose|Lost to Follow-up|0
5531430|NCT01392378|19120405|P5|After Infant Series|Withdrawal by Parent|1
5531431|NCT01392378|19120406|P4|After Infant Series|Withdrawal by Parent|0
5531432|NCT01392378|19120407|P3|After Infant Series|Withdrawal by Parent|1
5531433|NCT01392378|19120408|P2|After Infant Series|Withdrawal by Parent|1
5531434|NCT01392378|19120409|P1|After Infant Series|Withdrawal by Parent|0
5531435|NCT01392378|19120405|P5|After Infant Series|Lost to Follow-up|0
5531436|NCT01392378|19120406|P4|After Infant Series|Lost to Follow-up|0
5531437|NCT01392378|19120407|P3|After Infant Series|Lost to Follow-up|1
5531438|NCT01392378|19120408|P2|After Infant Series|Lost to Follow-up|0
5531439|NCT01392378|19120409|P1|After Infant Series|Lost to Follow-up|0
5531440|NCT01392378|19120405|P5|Infant Series|Withdrawal by Parent|0
5531441|NCT01392378|19120406|P4|Infant Series|Withdrawal by Parent|0
5531442|NCT01392378|19120407|P3|Infant Series|Withdrawal by Parent|0
5531443|NCT01392378|19120408|P2|Infant Series|Withdrawal by Parent|1
5531444|NCT01392378|19120409|P1|Infant Series|Withdrawal by Parent|4
5531445|NCT01392378|19120405|P5|Infant Series|Protocol Violation|0
5531446|NCT01392378|19120406|P4|Infant Series|Protocol Violation|0
5531447|NCT01392378|19120407|P3|Infant Series|Protocol Violation|0
5531448|NCT01392378|19120408|P2|Infant Series|Protocol Violation|1
5531449|NCT01392378|19120409|P1|Infant Series|Protocol Violation|0
5531450|NCT01392378|19120405|P5|Infant Series|Lost to Follow-up|0
5531451|NCT01392378|19120406|P4|Infant Series|Lost to Follow-up|1
5531452|NCT01392378|19120407|P3|Infant Series|Lost to Follow-up|0
5531453|NCT01392378|19120408|P2|Infant Series|Lost to Follow-up|0
5531454|NCT01392378|19120409|P1|Infant Series|Lost to Follow-up|0
5531455|NCT01392378|19120405|P5|Infant Series|Adverse Event|0
5531456|NCT01392378|19120406|P4|Infant Series|Adverse Event|1
5531457|NCT01392378|19120407|P3|Infant Series|Adverse Event|0
5531458|NCT01392378|19120408|P2|Infant Series|Adverse Event|0
5531459|NCT01392378|19120409|P1|Infant Series|Adverse Event|0
5531460|NCT01392326|19120549|P3|Overall Study|Adverse Event|11
5531461|NCT01392326|19120550|P2|Overall Study|Adverse Event|6
5531462|NCT01392326|19120551|P1|Overall Study|Adverse Event|9
5531463|NCT01392326|19120549|P3|Overall Study|Lack of Efficacy|15
5531464|NCT01392326|19120550|P2|Overall Study|Lack of Efficacy|10
5531465|NCT01392326|19120551|P1|Overall Study|Lack of Efficacy|14
5531466|NCT01392326|19120549|P3|Overall Study|Lost to Follow-up|4
5531467|NCT01392326|19120550|P2|Overall Study|Lost to Follow-up|3
5531468|NCT01392326|19120551|P1|Overall Study|Lost to Follow-up|1
5531469|NCT01392326|19120549|P3|Overall Study|Physician Decision|2
5531470|NCT01392326|19120550|P2|Overall Study|Physician Decision|5
5531471|NCT01392326|19120551|P1|Overall Study|Physician Decision|7
5531472|NCT01392326|19120549|P3|Overall Study|Pregnancy|1
5531473|NCT01392326|19120550|P2|Overall Study|Pregnancy|0
5531474|NCT01392326|19120551|P1|Overall Study|Pregnancy|0
5531475|NCT01392326|19120549|P3|Overall Study|Protocol Violation|0
5531476|NCT01392326|19120550|P2|Overall Study|Protocol Violation|0
5531477|NCT01392326|19120551|P1|Overall Study|Protocol Violation|2
5531478|NCT01392326|19120549|P3|Overall Study|Withdrawal by Subject|15
5531479|NCT01392326|19120550|P2|Overall Study|Withdrawal by Subject|11
5531480|NCT01392326|19120551|P1|Overall Study|Withdrawal by Subject|12
5531481|NCT01392326|19120549|P3|Overall Study|Death|0
5531482|NCT01392326|19120550|P2|Overall Study|Death|0
5531483|NCT01392326|19120551|P1|Overall Study|Death|2
5531484|NCT01392300|19120588|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
5531485|NCT01392300|19120589|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
5531486|NCT01392300|19120590|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
5531487|NCT01392300|19120588|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
5531488|NCT01392300|19120589|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
5531489|NCT01392300|19120590|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
5531490|NCT01392300|19120588|P3|Open Label Extension (OLEX) Period|Adverse Event|7
5531491|NCT01392300|19120589|P2|Open Label Extension (OLEX) Period|Adverse Event|0
5531492|NCT01392300|19120590|P1|Open Label Extension (OLEX) Period|Adverse Event|0
5531493|NCT01392300|19120588|P3|Open Label Extension (OLEX) Period|Death|4
5531494|NCT01392300|19120589|P2|Open Label Extension (OLEX) Period|Death|0
5531495|NCT01392300|19120590|P1|Open Label Extension (OLEX) Period|Death|0
5531496|NCT01392300|19120588|P3|Open Label Extension (OLEX) Period|Non-compliance|1
5531497|NCT01392300|19120589|P2|Open Label Extension (OLEX) Period|Non-compliance|0
5531498|NCT01392300|19120590|P1|Open Label Extension (OLEX) Period|Non-compliance|0
5531499|NCT01392300|19120588|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
5531500|NCT01392300|19120589|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
5531501|NCT01392300|19120590|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
5531502|NCT01392300|19120588|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
5531503|NCT01392300|19120589|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
5531504|NCT01392300|19120590|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
5531505|NCT01392300|19120588|P3|Main Period (MP)|Non-compliance|0
5531506|NCT01392300|19120589|P2|Main Period (MP)|Non-compliance|0
5531507|NCT01392300|19120590|P1|Main Period (MP)|Non-compliance|1
5531508|NCT01392300|19120588|P3|Main Period (MP)|Lost to Follow-up|0
5531509|NCT01392300|19120589|P2|Main Period (MP)|Lost to Follow-up|3
5531510|NCT01392300|19120590|P1|Main Period (MP)|Lost to Follow-up|3
5531511|NCT01392300|19120588|P3|Main Period (MP)|Withdrawal by Subject|0
5531512|NCT01392300|19120589|P2|Main Period (MP)|Withdrawal by Subject|1
5531513|NCT01392300|19120590|P1|Main Period (MP)|Withdrawal by Subject|5
5531514|NCT01392300|19120588|P3|Main Period (MP)|Predefined discontinuation criteria|0
5531515|NCT01392300|19120589|P2|Main Period (MP)|Predefined discontinuation criteria|3
5531516|NCT01392300|19120590|P1|Main Period (MP)|Predefined discontinuation criteria|2
5531517|NCT01392170|19120695|P1|Overall Study|Ineligible|1
5531518|NCT01392170|19120695|P1|Overall Study|Withdrawal by Subject|1
5531519|NCT01391832|19120745|P2|Overall Study|Lost to Follow-up|1
5531520|NCT01391832|19120746|P1|Overall Study|Lost to Follow-up|0
5531521|NCT01391832|19120745|P2|Overall Study|Withdrawal by Subject|22
5531522|NCT01391832|19120746|P1|Overall Study|Withdrawal by Subject|21
5531523|NCT01391819|19120754|P1|Overall Study|Other|9
5531524|NCT01391819|19120754|P1|Overall Study|Death|3
5531525|NCT01391819|19120754|P1|Overall Study|Lost to Follow-up|252
5531526|NCT01391819|19120754|P1|Overall Study|Migrated/moved from study area|82
5531527|NCT01391819|19120754|P1|Overall Study|Withdrawal by Subject|56
5531528|NCT01391793|19120798|P2|Overall Study|No DMSA|57
5531529|NCT01391793|19120799|P1|Overall Study|No DMSA|73
5531530|NCT01391793|19120798|P2|Overall Study|Urine Culture Negative or Indeterminate|87
5531531|NCT01391793|19120799|P1|Overall Study|Urine Culture Negative or Indeterminate|71
5531532|NCT01391793|19120798|P2|Overall Study|Ineligible|0
5531533|NCT01391793|19120799|P1|Overall Study|Ineligible|3
5531534|NCT01391663|19120813|P4|Overall Study|Withdrawal by Subject|0
5531535|NCT01391663|19120814|P3|Overall Study|Withdrawal by Subject|1
5531536|NCT01391663|19120815|P2|Overall Study|Withdrawal by Subject|0
5531537|NCT01391663|19120816|P1|Overall Study|Withdrawal by Subject|0
5531538|NCT01391546|19120860|P2|Overall Study|History of Herpes Zoster (HZ)|0
5531539|NCT01391546|19120861|P1|Overall Study|History of Herpes Zoster (HZ)|1
5531540|NCT01391507|19120883|P4|Overall Study|Protocol Violation|2
5531541|NCT01391507|19120884|P3|Overall Study|Protocol Violation|1
5531542|NCT01391507|19120885|P2|Overall Study|Protocol Violation|1
5531543|NCT01391507|19120886|P1|Overall Study|Protocol Violation|2
5531544|NCT01391507|19120883|P4|Overall Study|Lack of Efficacy|1
5531545|NCT01391507|19120884|P3|Overall Study|Lack of Efficacy|0
5531546|NCT01391507|19120885|P2|Overall Study|Lack of Efficacy|0
5531547|NCT01391507|19120886|P1|Overall Study|Lack of Efficacy|0
5531548|NCT01391507|19120883|P4|Overall Study|Withdrawal by Subject|1
5531549|NCT01391507|19120884|P3|Overall Study|Withdrawal by Subject|1
5531550|NCT01391507|19120885|P2|Overall Study|Withdrawal by Subject|2
5531551|NCT01391507|19120886|P1|Overall Study|Withdrawal by Subject|1
5531552|NCT01391507|19120883|P4|Overall Study|Adverse Event|2
5531553|NCT01391507|19120884|P3|Overall Study|Adverse Event|2
5531554|NCT01391507|19120885|P2|Overall Study|Adverse Event|1
5531555|NCT01391507|19120886|P1|Overall Study|Adverse Event|1
5531556|NCT01391507|19120883|P4|Overall Study|Death|1
5531557|NCT01391507|19120884|P3|Overall Study|Death|0
5531558|NCT01391507|19120885|P2|Overall Study|Death|0
5531559|NCT01391507|19120886|P1|Overall Study|Death|0
5531560|NCT01391130|19121037|P2|Overall Study|Did not Receive Drug|1
5531561|NCT01391130|19121038|P1|Overall Study|Did not Receive Drug|1
5531562|NCT01391130|19121037|P2|Overall Study|Physician Decision|3
5531563|NCT01391130|19121038|P1|Overall Study|Physician Decision|2
5531564|NCT01391130|19121037|P2|Overall Study|Withdrawal by Subject|2
5531565|NCT01391130|19121038|P1|Overall Study|Withdrawal by Subject|3
5531566|NCT01391000|19121095|P2|Overall Study|Lost to Follow-up|0
5531567|NCT01391000|19121096|P1|Overall Study|Lost to Follow-up|2
5531568|NCT01390948|19121109|P3|Overall Study|Death during follow-up|1
5531569|NCT01390948|19121110|P2|Overall Study|Death during follow-up|11
5531570|NCT01390948|19121111|P1|Overall Study|Death during follow-up|10
5531571|NCT01390948|19121109|P3|Overall Study|Progressive Disease|0
5531572|NCT01390948|19121110|P2|Overall Study|Progressive Disease|5
5531573|NCT01390948|19121111|P1|Overall Study|Progressive Disease|2
5531574|NCT01390948|19121109|P3|Overall Study|Withdrew consent|0
5531575|NCT01390948|19121110|P2|Overall Study|Withdrew consent|2
5531576|NCT01390948|19121111|P1|Overall Study|Withdrew consent|2
5531577|NCT01390948|19121109|P3|Overall Study|End of Study|0
5531578|NCT01390948|19121110|P2|Overall Study|End of Study|0
5531579|NCT01390948|19121111|P1|Overall Study|End of Study|1
5531580|NCT01390857|19121179|P1|Overall Study|No Visit after the First Visit|7
5531581|NCT01390857|19121179|P1|Overall Study|Lost to Follow-up|1
5531582|NCT01390857|19121179|P1|Overall Study|Protocol Violation|2
5531583|NCT01390844|19121190|P4|Follow-Up Phase|Non-Medical Reasons|0
5531584|NCT01390844|19121191|P3|Follow-Up Phase|Non-Medical Reasons|1
5531585|NCT01390844|19121192|P2|Follow-Up Phase|Non-Medical Reasons|1
5531586|NCT01390844|19121193|P1|Follow-Up Phase|Non-Medical Reasons|1
5531587|NCT01390844|19121190|P4|Treatment Phase|Non-GCP Compliant|3
5531588|NCT01390844|19121191|P3|Treatment Phase|Non-GCP Compliant|10
5531589|NCT01390844|19121192|P2|Treatment Phase|Non-GCP Compliant|0
5531590|NCT01390844|19121193|P1|Treatment Phase|Non-GCP Compliant|0
5531591|NCT01390844|19121190|P4|Treatment Phase|Non-Medical Reasons|1
5531592|NCT01390844|19121191|P3|Treatment Phase|Non-Medical Reasons|8
5531593|NCT01390844|19121192|P2|Treatment Phase|Non-Medical Reasons|1
5531594|NCT01390844|19121193|P1|Treatment Phase|Non-Medical Reasons|5
5531595|NCT01390844|19121190|P4|Treatment Phase|Treatment Failure|13
5531596|NCT01390844|19121191|P3|Treatment Phase|Treatment Failure|10
5531597|NCT01390844|19121192|P2|Treatment Phase|Treatment Failure|25
5531598|NCT01390844|19121193|P1|Treatment Phase|Treatment Failure|23
5531599|NCT01390844|19121190|P4|Treatment Phase|Adverse Event|2
5531600|NCT01390844|19121191|P3|Treatment Phase|Adverse Event|3
5531601|NCT01390844|19121192|P2|Treatment Phase|Adverse Event|2
5531602|NCT01390844|19121193|P1|Treatment Phase|Adverse Event|12
5531603|NCT01390779|19121520|P1|Overall Study|Physician Decision|1
5531604|NCT01390649|19121525|P1|Overall Study|Physician Decision|1
5531605|NCT01390584|19121532|P3|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1
5531606|NCT01390584|19121533|P2|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
5531607|NCT01390584|19121534|P1|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
5531608|NCT01390441|19121556|P5|Extension Period|Protocol Violation|0
5531609|NCT01390441|19121557|P4|Extension Period|Protocol Violation|1
5531610|NCT01390441|19121558|P3|Extension Period|Protocol Violation|0
5531611|NCT01390441|19121559|P2|Extension Period|Protocol Violation|1
5531612|NCT01390441|19121560|P1|Extension Period|Protocol Violation|3
5531613|NCT01390441|19121556|P5|Treatment Period|Lost to Follow-up|0
5531614|NCT01390441|19121557|P4|Treatment Period|Lost to Follow-up|0
5531615|NCT01390441|19121558|P3|Treatment Period|Lost to Follow-up|0
5531616|NCT01390441|19121559|P2|Treatment Period|Lost to Follow-up|0
5531617|NCT01390441|19121560|P1|Treatment Period|Lost to Follow-up|1
5531618|NCT01390441|19121556|P5|Treatment Period|Withdrawal by Subject|1
5531619|NCT01390441|19121557|P4|Treatment Period|Withdrawal by Subject|0
5531620|NCT01390441|19121558|P3|Treatment Period|Withdrawal by Subject|1
5531621|NCT01390441|19121559|P2|Treatment Period|Withdrawal by Subject|0
5531622|NCT01390441|19121560|P1|Treatment Period|Withdrawal by Subject|0
5531623|NCT01390441|19121556|P5|Treatment Period|Adverse Event|2
5531624|NCT01390441|19121557|P4|Treatment Period|Adverse Event|1
5531625|NCT01390441|19121558|P3|Treatment Period|Adverse Event|1
5531626|NCT01390441|19121559|P2|Treatment Period|Adverse Event|0
5531627|NCT01390441|19121560|P1|Treatment Period|Adverse Event|0
5531628|NCT01390441|19121556|P5|Treatment Period|Unknown due to early stopping of study|7
5531629|NCT01390441|19121557|P4|Treatment Period|Unknown due to early stopping of study|11
5531630|NCT01390441|19121558|P3|Treatment Period|Unknown due to early stopping of study|8
5531631|NCT01390441|19121559|P2|Treatment Period|Unknown due to early stopping of study|0
5531632|NCT01390441|19121560|P1|Treatment Period|Unknown due to early stopping of study|0
5531633|NCT01390441|19121556|P5|Treatment Period|Lack of Efficacy|1
5531634|NCT01390441|19121557|P4|Treatment Period|Lack of Efficacy|0
5531635|NCT01390441|19121558|P3|Treatment Period|Lack of Efficacy|0
5531636|NCT01390441|19121559|P2|Treatment Period|Lack of Efficacy|0
5531637|NCT01390441|19121560|P1|Treatment Period|Lack of Efficacy|0
5531638|NCT01390441|19121556|P5|Treatment Period|Physician Decision|0
5531639|NCT01390441|19121557|P4|Treatment Period|Physician Decision|1
5531640|NCT01390441|19121558|P3|Treatment Period|Physician Decision|0
5531641|NCT01390441|19121559|P2|Treatment Period|Physician Decision|0
5531642|NCT01390441|19121560|P1|Treatment Period|Physician Decision|0
5531643|NCT01390441|19121556|P5|Treatment Period|Protocol Violation|0
5531644|NCT01390441|19121557|P4|Treatment Period|Protocol Violation|0
5531645|NCT01390441|19121558|P3|Treatment Period|Protocol Violation|0
5531646|NCT01390441|19121559|P2|Treatment Period|Protocol Violation|1
5531647|NCT01390441|19121560|P1|Treatment Period|Protocol Violation|0
5531648|NCT01390428|19121625|P6|Overall Study|Withdrawal by Subject|0
5531649|NCT01390428|19121626|P5|Overall Study|Withdrawal by Subject|0
5531650|NCT01390428|19121627|P4|Overall Study|Withdrawal by Subject|0
5531651|NCT01390428|19121628|P3|Overall Study|Withdrawal by Subject|1
5531652|NCT01390428|19121629|P2|Overall Study|Withdrawal by Subject|0
5531653|NCT01390428|19121630|P1|Overall Study|Withdrawal by Subject|0
5531654|NCT01390428|19121625|P6|Overall Study|Elective Surgery|0
5531655|NCT01390428|19121626|P5|Overall Study|Elective Surgery|1
5531656|NCT01390428|19121627|P4|Overall Study|Elective Surgery|0
5531657|NCT01390428|19121628|P3|Overall Study|Elective Surgery|0
5531658|NCT01390428|19121629|P2|Overall Study|Elective Surgery|0
5531659|NCT01390428|19121630|P1|Overall Study|Elective Surgery|0
5531660|NCT01390402|19121693|P1|Overall Study|Disease Progression|4
5531661|NCT01390402|19121693|P1|Overall Study|Death|1
5531662|NCT01390389|19121699|P2|Overall Study|Screen Fail|1
5531663|NCT01390389|19121700|P1|Overall Study|Screen Fail|2
5531664|NCT01390389|19121699|P2|Overall Study|Withdrawal by Subject|0
5531665|NCT01390389|19121700|P1|Overall Study|Withdrawal by Subject|2
5531666|NCT01390298|19121710|P1|Overall Study|Surgery cancelled|1
5531667|NCT01390298|19121710|P1|Overall Study|Lost to Follow-up|7
5531668|NCT01390298|19121710|P1|Overall Study|Withdrawal by Subject|14
5531669|NCT01390298|19121710|P1|Overall Study|long term ICU admission|1
5531670|NCT01390298|19121710|P1|Overall Study|Death|1
5531671|NCT01390272|19121716|P2|Overall Study|Patient moved, no longer eligible|8
5531672|NCT01390272|19121717|P1|Overall Study|Patient moved, no longer eligible|5
5531673|NCT01390272|19121716|P2|Overall Study|Withdrawal by Subject|5
5531674|NCT01390272|19121717|P1|Overall Study|Withdrawal by Subject|9
5531675|NCT01390272|19121716|P2|Overall Study|Death|2
5531676|NCT01390272|19121717|P1|Overall Study|Death|3
5531677|NCT01390220|19121785|P3|Comparative Phase|Withdrawal by Subject|0
5531678|NCT01390220|19121786|P2|Comparative Phase|Withdrawal by Subject|1
5531679|NCT01390220|19121787|P1|Comparative Phase|Withdrawal by Subject|0
5531680|NCT01390220|19121785|P3|Test Dose Phase|Logistical|0
5531681|NCT01390220|19121786|P2|Test Dose Phase|Logistical|0
5531682|NCT01390220|19121787|P1|Test Dose Phase|Logistical|6
5531683|NCT01390220|19121785|P3|Test Dose Phase|Noncompliance|0
5531684|NCT01390220|19121786|P2|Test Dose Phase|Noncompliance|0
5531685|NCT01390220|19121787|P1|Test Dose Phase|Noncompliance|2
5531686|NCT01390220|19121785|P3|Test Dose Phase|Caregiver no longer available|0
5531687|NCT01390220|19121786|P2|Test Dose Phase|Caregiver no longer available|0
5531688|NCT01390220|19121787|P1|Test Dose Phase|Caregiver no longer available|5
5531689|NCT01390220|19121785|P3|Test Dose Phase|Study/Site closure|0
5531690|NCT01390220|19121786|P2|Test Dose Phase|Study/Site closure|0
5531691|NCT01390220|19121787|P1|Test Dose Phase|Study/Site closure|6
5531692|NCT01390220|19121785|P3|Test Dose Phase|No treated seizure cluster episode|0
5531693|NCT01390220|19121786|P2|Test Dose Phase|No treated seizure cluster episode|0
5531694|NCT01390220|19121787|P1|Test Dose Phase|No treated seizure cluster episode|37
5531695|NCT01390220|19121785|P3|Test Dose Phase|Protocol Violation|0
5531696|NCT01390220|19121786|P2|Test Dose Phase|Protocol Violation|0
5531697|NCT01390220|19121787|P1|Test Dose Phase|Protocol Violation|8
5531698|NCT01390220|19121785|P3|Test Dose Phase|Lost to Follow-up|0
5531699|NCT01390220|19121786|P2|Test Dose Phase|Lost to Follow-up|0
5531700|NCT01390220|19121787|P1|Test Dose Phase|Lost to Follow-up|2
5531701|NCT01390220|19121785|P3|Test Dose Phase|Withdrawal by Subject|0
5531702|NCT01390220|19121786|P2|Test Dose Phase|Withdrawal by Subject|0
5531703|NCT01390220|19121787|P1|Test Dose Phase|Withdrawal by Subject|8
5531704|NCT01390220|19121785|P3|Test Dose Phase|Adverse Event|0
5531705|NCT01390220|19121786|P2|Test Dose Phase|Adverse Event|0
5531706|NCT01390220|19121787|P1|Test Dose Phase|Adverse Event|17
5531707|NCT01390181|19121802|P1|Overall Study|Study Terminated due to Low Accrual|3
5531708|NCT01390181|19121802|P1|Overall Study|Lost to Follow-up|1
5531709|NCT01390038|19121815|P1|Overall Study|Simpliciti System Removal|2
5531710|NCT01390038|19121815|P1|Overall Study|Withdrawal by Subject|4
5531711|NCT01390038|19121815|P1|Overall Study|Lost to Follow-up|1
5531712|NCT01390038|19121815|P1|Overall Study|Death|1
5531713|NCT01389973|19121825|P1|Overall Study|Other|10
5531714|NCT01389973|19121825|P1|Overall Study|Trial Stopped by Sponsor|9
5531715|NCT01389973|19121825|P1|Overall Study|Lost to Follow-up|1
5531716|NCT01389882|19121835|P2|Overall Study|Withdrawal by Subject|1
5531717|NCT01389882|19121836|P1|Overall Study|Withdrawal by Subject|0
5531718|NCT01389882|19121835|P2|Overall Study|Respiratory rate > 80/min during study|3
5531719|NCT01389882|19121836|P1|Overall Study|Respiratory rate > 80/min during study|1
5531720|NCT01389817|19121924|P2|Overall Study|Withdrawal by Subject|0
5531721|NCT01389817|19121925|P1|Overall Study|Withdrawal by Subject|2
5531722|NCT01389817|19121924|P2|Overall Study|Lost to Follow-up|0
5531723|NCT01389817|19121925|P1|Overall Study|Lost to Follow-up|1
5531724|NCT01389817|19121924|P2|Overall Study|Physician Decision|0
5531725|NCT01389817|19121925|P1|Overall Study|Physician Decision|1
5531726|NCT01389752|19121942|P2|Study Period 2|Sponsor decision|0
5531727|NCT01389752|19121943|P1|Study Period 2|Sponsor decision|1
5531728|NCT01389752|19121942|P2|Study Period 1|Sponsor decision|2
5531729|NCT01389752|19121943|P1|Study Period 1|Sponsor decision|0
5531730|NCT01389596|19121956|P3|Overall Study|Other Unspecified|0
5531731|NCT01389596|19121957|P2|Overall Study|Other Unspecified|1
5531732|NCT01389596|19121958|P1|Overall Study|Other Unspecified|2
5531733|NCT01389596|19121956|P3|Overall Study|Death|0
5531734|NCT01389596|19121957|P2|Overall Study|Death|1
5531735|NCT01389596|19121958|P1|Overall Study|Death|0
5531736|NCT01389596|19121956|P3|Overall Study|Adverse Event|0
5531737|NCT01389596|19121957|P2|Overall Study|Adverse Event|4
5531738|NCT01389596|19121958|P1|Overall Study|Adverse Event|1
5531739|NCT01389596|19121956|P3|Overall Study|Insufficient Clinical Response|5
5531740|NCT01389596|19121957|P2|Overall Study|Insufficient Clinical Response|4
5531741|NCT01389596|19121958|P1|Overall Study|Insufficient Clinical Response|3
5531742|NCT01389596|19121956|P3|Overall Study|Withdrawal by Subject|2
5531743|NCT01389596|19121957|P2|Overall Study|Withdrawal by Subject|2
5531744|NCT01389596|19121958|P1|Overall Study|Withdrawal by Subject|1
5531745|NCT01389596|19121956|P3|Overall Study|Protocol Violation|3
5531746|NCT01389596|19121957|P2|Overall Study|Protocol Violation|4
5531747|NCT01389596|19121958|P1|Overall Study|Protocol Violation|3
5531748|NCT01389323|19122017|P1|Follow-up Period (up to 48 Weeks)|Other|3
5531749|NCT01389323|19122017|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
5531750|NCT01389323|19122017|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
5531751|NCT01389323|19122017|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
5531752|NCT01389323|19122017|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
5531753|NCT01389323|19122017|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
5531754|NCT01389323|19122017|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
5531755|NCT01389323|19122017|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
5531756|NCT01389323|19122017|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
5531757|NCT01389323|19122017|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
5531758|NCT01389323|19122017|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
5531759|NCT01389258|19122074|P1|Overall Study|Lost to Follow-up|5
5531760|NCT01389245|19122084|P1|Overall Study|Withdrawal by Subject|2
5531761|NCT01389245|19122084|P1|Overall Study|Lost to Follow-up|3
5531762|NCT01389245|19122084|P1|Overall Study|Protocol Violation|10
5531763|NCT01389128|19122094|P2|Overall Study|Intolerance to procedure|2
5531764|NCT01389128|19122095|P1|Overall Study|Intolerance to procedure|0
5531765|NCT01389128|19122094|P2|Overall Study|Rapid labor evolution|2
5531766|NCT01389128|19122095|P1|Overall Study|Rapid labor evolution|3
5531767|NCT01389128|19122094|P2|Overall Study|Cervix dilation stop|2
5531768|NCT01389128|19122095|P1|Overall Study|Cervix dilation stop|1
5531769|NCT01389128|19122094|P2|Overall Study|Fetal distress|0
5531770|NCT01389128|19122095|P1|Overall Study|Fetal distress|1
5531771|NCT01389102|19122119|P6|Overall Study|Investigator Judgement|0
5531772|NCT01389102|19122120|P5|Overall Study|Investigator Judgement|0
5531773|NCT01389102|19122121|P4|Overall Study|Investigator Judgement|0
5531774|NCT01389102|19122122|P3|Overall Study|Investigator Judgement|0
5531775|NCT01389102|19122123|P2|Overall Study|Investigator Judgement|1
5531776|NCT01389102|19122124|P1|Overall Study|Investigator Judgement|0
5531777|NCT01389102|19122119|P6|Overall Study|Unavailable due to husband's illness|0
5531778|NCT01389102|19122120|P5|Overall Study|Unavailable due to husband's illness|0
5531779|NCT01389102|19122121|P4|Overall Study|Unavailable due to husband's illness|0
5531780|NCT01389102|19122122|P3|Overall Study|Unavailable due to husband's illness|0
5531781|NCT01389102|19122123|P2|Overall Study|Unavailable due to husband's illness|1
5531782|NCT01389102|19122124|P1|Overall Study|Unavailable due to husband's illness|0
5531783|NCT01389102|19122119|P6|Overall Study|Subject Moved|0
5531784|NCT01389102|19122120|P5|Overall Study|Subject Moved|0
5531785|NCT01389102|19122121|P4|Overall Study|Subject Moved|0
5531786|NCT01389102|19122122|P3|Overall Study|Subject Moved|1
5531787|NCT01389102|19122123|P2|Overall Study|Subject Moved|0
5531788|NCT01389102|19122124|P1|Overall Study|Subject Moved|2
5531789|NCT01389102|19122119|P6|Overall Study|Subject Traveling Out of Country|0
5531790|NCT01389102|19122120|P5|Overall Study|Subject Traveling Out of Country|0
5531791|NCT01389102|19122121|P4|Overall Study|Subject Traveling Out of Country|1
5531792|NCT01389102|19122122|P3|Overall Study|Subject Traveling Out of Country|0
5531793|NCT01389102|19122123|P2|Overall Study|Subject Traveling Out of Country|0
5531794|NCT01389102|19122124|P1|Overall Study|Subject Traveling Out of Country|0
5531795|NCT01389102|19122119|P6|Overall Study|Withdrawal by Subject|3
5531796|NCT01389102|19122120|P5|Overall Study|Withdrawal by Subject|3
5531797|NCT01389102|19122121|P4|Overall Study|Withdrawal by Subject|2
5531798|NCT01389102|19122122|P3|Overall Study|Withdrawal by Subject|9
5531799|NCT01389102|19122123|P2|Overall Study|Withdrawal by Subject|4
5531800|NCT01389102|19122124|P1|Overall Study|Withdrawal by Subject|7
5531801|NCT01389102|19122119|P6|Overall Study|Protocol Violation|1
5531802|NCT01389102|19122120|P5|Overall Study|Protocol Violation|1
5531803|NCT01389102|19122121|P4|Overall Study|Protocol Violation|0
5531804|NCT01389102|19122122|P3|Overall Study|Protocol Violation|3
5531805|NCT01389102|19122123|P2|Overall Study|Protocol Violation|0
5531806|NCT01389102|19122124|P1|Overall Study|Protocol Violation|0
5531807|NCT01389102|19122119|P6|Overall Study|Lost to Follow-up|1
5531808|NCT01389102|19122120|P5|Overall Study|Lost to Follow-up|4
5531809|NCT01389102|19122121|P4|Overall Study|Lost to Follow-up|2
5531810|NCT01389102|19122122|P3|Overall Study|Lost to Follow-up|1
5531811|NCT01389102|19122123|P2|Overall Study|Lost to Follow-up|1
5531812|NCT01389102|19122124|P1|Overall Study|Lost to Follow-up|4
5531813|NCT01389102|19122119|P6|Overall Study|Hurricane Katrina|1
5531814|NCT01389102|19122120|P5|Overall Study|Hurricane Katrina|3
5531815|NCT01389102|19122121|P4|Overall Study|Hurricane Katrina|0
5531816|NCT01389102|19122122|P3|Overall Study|Hurricane Katrina|3
5531817|NCT01389102|19122123|P2|Overall Study|Hurricane Katrina|2
5531818|NCT01389102|19122124|P1|Overall Study|Hurricane Katrina|4
5531819|NCT01389102|19122119|P6|Overall Study|Adverse Event|2
5531820|NCT01389102|19122120|P5|Overall Study|Adverse Event|2
5531821|NCT01389102|19122121|P4|Overall Study|Adverse Event|2
5531822|NCT01389102|19122122|P3|Overall Study|Adverse Event|2
5531823|NCT01389102|19122123|P2|Overall Study|Adverse Event|3
5531824|NCT01389102|19122124|P1|Overall Study|Adverse Event|1
5531825|NCT01388985|19122154|P2|Overall Study|Error of nurse|1
5531826|NCT01388985|19122155|P1|Overall Study|Error of nurse|5
5531827|NCT01388985|19122154|P2|Overall Study|Other (no reason)|1
5531828|NCT01388985|19122155|P1|Overall Study|Other (no reason)|0
5531829|NCT01388985|19122154|P2|Overall Study|Subject unavailable|1
5531830|NCT01388985|19122155|P1|Overall Study|Subject unavailable|1
5531831|NCT01388985|19122154|P2|Overall Study|Withdrawal by Subject|4
5531832|NCT01388985|19122155|P1|Overall Study|Withdrawal by Subject|13
5531833|NCT01388985|19122154|P2|Overall Study|Lost to Follow-up|30
5531834|NCT01388985|19122155|P1|Overall Study|Lost to Follow-up|30
5531835|NCT01388985|19122154|P2|Overall Study|Death|1
5531836|NCT01388985|19122155|P1|Overall Study|Death|0
5531837|NCT01388907|19122219|P2|Overall Study|Adverse Event|0
5531838|NCT01388907|19122220|P1|Overall Study|Adverse Event|2
5531839|NCT01388816|19122236|P4|Overall Study|Protocol Violation|0
5531840|NCT01388816|19122237|P3|Overall Study|Protocol Violation|2
5531841|NCT01388816|19122238|P2|Overall Study|Protocol Violation|0
5531842|NCT01388816|19122239|P1|Overall Study|Protocol Violation|0
5531843|NCT01388816|19122236|P4|Overall Study|Withdrawal by Subject|0
5531844|NCT01388816|19122237|P3|Overall Study|Withdrawal by Subject|1
5531845|NCT01388816|19122238|P2|Overall Study|Withdrawal by Subject|1
5531846|NCT01388816|19122239|P1|Overall Study|Withdrawal by Subject|2
5531847|NCT01388816|19122236|P4|Overall Study|Lost to Follow-up|0
5531848|NCT01388816|19122237|P3|Overall Study|Lost to Follow-up|0
5531849|NCT01388816|19122238|P2|Overall Study|Lost to Follow-up|1
5531850|NCT01388816|19122239|P1|Overall Study|Lost to Follow-up|0
5531851|NCT01388816|19122236|P4|Overall Study|Adverse Event|0
5531852|NCT01388816|19122237|P3|Overall Study|Adverse Event|0
5531853|NCT01388816|19122238|P2|Overall Study|Adverse Event|2
5531854|NCT01388816|19122239|P1|Overall Study|Adverse Event|0
5531855|NCT01388790|19122268|P1|Overall Study|Ongoing at data cut-off date|8
5531856|NCT01388647|19122279|P2|Overall Study|Adverse Event|2
5531857|NCT01388647|19122280|P1|Overall Study|Adverse Event|1
5531858|NCT01388543|19122293|P2|Day 14|Adverse Event|4
5531859|NCT01388543|19122294|P1|Day 14|Adverse Event|1
5531860|NCT01388530|19122300|P1|Overall Study|Lost to Follow-up|5
5531861|NCT01388491|19122309|P2|Overall Study|Pregnancy|0
5531862|NCT01388491|19122310|P1|Overall Study|Pregnancy|1
5531863|NCT01388491|19122309|P2|Overall Study|Noncompliance|0
5531864|NCT01388491|19122310|P1|Overall Study|Noncompliance|2
5531865|NCT01388491|19122309|P2|Overall Study|Protocol Violation|0
5531866|NCT01388491|19122310|P1|Overall Study|Protocol Violation|2
5531867|NCT01388491|19122309|P2|Overall Study|Lost to Follow-up|3
5531868|NCT01388491|19122310|P1|Overall Study|Lost to Follow-up|4
5531869|NCT01388491|19122309|P2|Overall Study|Withdrawal by Subject|10
5531870|NCT01388491|19122310|P1|Overall Study|Withdrawal by Subject|6
5531871|NCT01388491|19122309|P2|Overall Study|Sponsor Request|7
5531872|NCT01388491|19122310|P1|Overall Study|Sponsor Request|9
5531873|NCT01388491|19122309|P2|Overall Study|Adverse Event|9
5531874|NCT01388491|19122310|P1|Overall Study|Adverse Event|10
5531875|NCT01388361|19122345|P3|Overall Study|Unclassified|1
5531876|NCT01388361|19122346|P2|Overall Study|Unclassified|0
5531877|NCT01388361|19122347|P1|Overall Study|Unclassified|0
5531878|NCT01388361|19122345|P3|Overall Study|Withdrawal criteria|10
5531879|NCT01388361|19122346|P2|Overall Study|Withdrawal criteria|7
5531880|NCT01388361|19122347|P1|Overall Study|Withdrawal criteria|12
5531881|NCT01388361|19122345|P3|Overall Study|Protocol Violation|2
5531882|NCT01388361|19122346|P2|Overall Study|Protocol Violation|0
5531883|NCT01388361|19122347|P1|Overall Study|Protocol Violation|0
5531884|NCT01388361|19122345|P3|Overall Study|Adverse Event|1
5531885|NCT01388361|19122346|P2|Overall Study|Adverse Event|5
5531886|NCT01388361|19122347|P1|Overall Study|Adverse Event|0
5531887|NCT01388335|19122364|P1|Safety Extension|Progressive Disease|7
5531888|NCT01388335|19122364|P1|Period 2|Sponsor Decision|1
5531889|NCT01388335|19122364|P1|Period 2|Progressive Disease|2
5531890|NCT01388335|19122364|P1|Period 1|Progressive Disease|1
5531891|NCT01388166|19122391|P1|Overall Study|Others than specified above|13
5531892|NCT01388166|19122391|P1|Overall Study|Lost to Follow-up|30
5531893|NCT01388166|19122391|P1|Overall Study|Adverse Event|16
5531894|NCT01387789|19122694|P1|Overall Study|Lost to Follow-up|1
5531895|NCT01387789|19122694|P1|Overall Study|Lack of Efficacy|2
5531896|NCT01387789|19122694|P1|Overall Study|Adverse Event|5
5531897|NCT01387737|19122708|P2|Overall Study|Clearly not eligible for the study|3
5531898|NCT01387737|19122709|P1|Overall Study|Clearly not eligible for the study|1
5531899|NCT01387737|19122708|P2|Overall Study|Withdrawal by Subject|31
5531900|NCT01387737|19122709|P1|Overall Study|Withdrawal by Subject|27
5531901|NCT01387737|19122708|P2|Overall Study|Physician Decision|10
5531902|NCT01387737|19122709|P1|Overall Study|Physician Decision|3
5531903|NCT01387737|19122708|P2|Overall Study|Lack of Efficacy|0
5531904|NCT01387737|19122709|P1|Overall Study|Lack of Efficacy|1
5531905|NCT01387737|19122708|P2|Overall Study|Adverse Event|30
5531906|NCT01387737|19122709|P1|Overall Study|Adverse Event|20
5531907|NCT01387607|19122743|P2|Overall Study|Randomized, not treated|6
5531908|NCT01387607|19122744|P1|Overall Study|Randomized, not treated|3
5531909|NCT01387607|19122743|P2|Overall Study|Other|1
5531910|NCT01387607|19122744|P1|Overall Study|Other|1
5531911|NCT01387607|19122743|P2|Overall Study|Withdrawal by Subject|14
5531912|NCT01387607|19122744|P1|Overall Study|Withdrawal by Subject|13
5531913|NCT01387607|19122743|P2|Overall Study|Protocol Violation|5
5531914|NCT01387607|19122744|P1|Overall Study|Protocol Violation|1
5531915|NCT01387607|19122743|P2|Overall Study|No longer meets eligibility criteria|1
5531916|NCT01387607|19122744|P1|Overall Study|No longer meets eligibility criteria|0
5531917|NCT01387607|19122743|P2|Overall Study|Lost to Follow-up|1
5531918|NCT01387607|19122744|P1|Overall Study|Lost to Follow-up|2
5531919|NCT01387607|19122743|P2|Overall Study|Lack of Efficacy|6
5531920|NCT01387607|19122744|P1|Overall Study|Lack of Efficacy|8
5531921|NCT01387607|19122743|P2|Overall Study|Adverse Event|11
5531922|NCT01387607|19122744|P1|Overall Study|Adverse Event|23
5531923|NCT01387594|19122798|P2|Overall Study|Lost to Follow-up|1
5531924|NCT01387594|19122799|P1|Overall Study|Lost to Follow-up|0
5531925|NCT01387594|19122798|P2|Overall Study|Withdrawal by Subject|2
5531926|NCT01387594|19122799|P1|Overall Study|Withdrawal by Subject|0
5531927|NCT01387542|19122827|P1|Overall Study|Lost to Follow-up|1
5531928|NCT01387542|19122827|P1|Overall Study|Non-compliant|1
5531929|NCT01387542|19122827|P1|Overall Study|Insufficient response|1
5531930|NCT01387542|19122827|P1|Overall Study|Changed diagnosis|1
5531931|NCT01387542|19122827|P1|Overall Study|Withdrawal by Subject|1
5531932|NCT01387542|19122827|P1|Overall Study|Adverse Event|3
5531933|NCT01387516|19122838|P4|Overall Study|Death|1
5531934|NCT01387516|19122839|P3|Overall Study|Death|0
5531935|NCT01387516|19122840|P2|Overall Study|Death|0
5531936|NCT01387516|19122841|P1|Overall Study|Death|0
5531937|NCT01387516|19122838|P4|Overall Study|Withdrawal by Subject|0
5531938|NCT01387516|19122839|P3|Overall Study|Withdrawal by Subject|2
5531939|NCT01387516|19122840|P2|Overall Study|Withdrawal by Subject|1
5531940|NCT01387516|19122841|P1|Overall Study|Withdrawal by Subject|1
5531941|NCT01387516|19122838|P4|Overall Study|Lost to Follow-up|3
5531942|NCT01387516|19122839|P3|Overall Study|Lost to Follow-up|2
5531943|NCT01387516|19122840|P2|Overall Study|Lost to Follow-up|4
5531944|NCT01387516|19122841|P1|Overall Study|Lost to Follow-up|4
5531945|NCT01387347|19122874|P2|Overall Study|Lost to Follow-up|1
5531946|NCT01387347|19122875|P1|Overall Study|Lost to Follow-up|2
5531947|NCT01387282|19122887|P2|Overall Study|Lost to Follow-up|1
5531948|NCT01387282|19122888|P1|Overall Study|Lost to Follow-up|4
5531949|NCT01387282|19122887|P2|Overall Study|Study drug-related AE|2
5531950|NCT01387282|19122888|P1|Overall Study|Study drug-related AE|2
5531951|NCT01387282|19122887|P2|Overall Study|Withdrawal by patient|23
5531952|NCT01387282|19122888|P1|Overall Study|Withdrawal by patient|33
5531953|NCT01387282|19122887|P2|Overall Study|Unrelated AE|4
5531954|NCT01387282|19122888|P1|Overall Study|Unrelated AE|6
5531955|NCT01387282|19122887|P2|Overall Study|Other|1
5531956|NCT01387282|19122888|P1|Overall Study|Other|5
5531957|NCT01387282|19122887|P2|Overall Study|Death|16
5531958|NCT01387282|19122888|P1|Overall Study|Death|47
5531959|NCT01387269|19122904|P2|Overall Study|Lost to Follow-up|0
5531960|NCT01387269|19122905|P1|Overall Study|Lost to Follow-up|1
5531961|NCT01387269|19122904|P2|Overall Study|Study drug-related AE|0
5531962|NCT01387269|19122905|P1|Overall Study|Study drug-related AE|1
5531963|NCT01387269|19122904|P2|Overall Study|Withdrawal by patient|10
5531964|NCT01387269|19122905|P1|Overall Study|Withdrawal by patient|32
5531965|NCT01387269|19122904|P2|Overall Study|Unrelated AE|3
5531966|NCT01387269|19122905|P1|Overall Study|Unrelated AE|12
5531967|NCT01387269|19122904|P2|Overall Study|Other|7
5531968|NCT01387269|19122905|P1|Overall Study|Other|8
5531969|NCT01387269|19122904|P2|Overall Study|Death|20
5531970|NCT01387269|19122905|P1|Overall Study|Death|38
5531971|NCT01387230|19122922|P3|Overall Study|Withdrawal by Subject|0
5531972|NCT01387230|19122923|P2|Overall Study|Withdrawal by Subject|1
5531973|NCT01387230|19122924|P1|Overall Study|Withdrawal by Subject|4
5531974|NCT01387230|19122922|P3|Overall Study|Lost to Follow-up|1
5531975|NCT01387230|19122923|P2|Overall Study|Lost to Follow-up|0
5531976|NCT01387230|19122924|P1|Overall Study|Lost to Follow-up|0
5531977|NCT01387230|19122922|P3|Overall Study|Protocol-defined Stopping Criteria|5
5531978|NCT01387230|19122923|P2|Overall Study|Protocol-defined Stopping Criteria|0
5531979|NCT01387230|19122924|P1|Overall Study|Protocol-defined Stopping Criteria|6
5531980|NCT01387230|19122922|P3|Overall Study|Lack of Efficacy|4
5531981|NCT01387230|19122923|P2|Overall Study|Lack of Efficacy|5
5531982|NCT01387230|19122924|P1|Overall Study|Lack of Efficacy|8
5531983|NCT01387230|19122922|P3|Overall Study|Adverse Event|3
5531984|NCT01387230|19122923|P2|Overall Study|Adverse Event|1
5531985|NCT01387230|19122924|P1|Overall Study|Adverse Event|0
5531986|NCT01387074|19122970|P1|Overall Study|Lack of Efficacy|1
5531987|NCT01387074|19122970|P1|Overall Study|Lost to Follow-up|7
5531988|NCT01387022|19122983|P2|Overall Study|Lost to Follow-up|3
5531989|NCT01387022|19122984|P1|Overall Study|Lost to Follow-up|0
5531990|NCT01387022|19122983|P2|Overall Study|Death|1
5531991|NCT01387022|19122984|P1|Overall Study|Death|1
5531992|NCT01386970|19123013|P2|Overall Study|Adverse Event|1
5531993|NCT01386970|19123014|P1|Overall Study|Adverse Event|4
5531994|NCT01386970|19123013|P2|Overall Study|Withdrawal by Subject|1
5531995|NCT01386970|19123014|P1|Overall Study|Withdrawal by Subject|0
5531996|NCT01386944|19123022|P1|Overall Study|Unspecified reason|8
5531997|NCT01386944|19123022|P1|Overall Study|Lost to Follow-up|8
5531998|NCT01386944|19123022|P1|Overall Study|Lack of Efficacy|14
5531999|NCT01386944|19123022|P1|Overall Study|Adverse Event|26
5532000|NCT01386788|19123032|P1|Overall Study|Lost to Follow-up|2
5532001|NCT01386684|19123037|P1|Overall Study|Missing|3
5532002|NCT01386684|19123037|P1|Overall Study|Protocol Violation|4
5532003|NCT01386684|19123037|P1|Overall Study|Noncompliance|8
5532004|NCT01386684|19123037|P1|Overall Study|Adverse Event|20
5532005|NCT01386684|19123037|P1|Overall Study|Disease Progression|28
5532006|NCT01386684|19123037|P1|Overall Study|Alternative Therapy Required|37
5532007|NCT01386684|19123037|P1|Overall Study|Withdrawal of Consent|44
5532008|NCT01386684|19123037|P1|Overall Study|Death|47
5532009|NCT01386684|19123037|P1|Overall Study|Other|51
5532010|NCT01386684|19123037|P1|Overall Study|Lost to Follow-up|51
5532011|NCT01386658|19123078|P2|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
5532012|NCT01386658|19123079|P1|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
5532013|NCT01386658|19123078|P2|Initial Icatibant Exposure|Withdrawal by Subject|9
5532014|NCT01386658|19123079|P1|Initial Icatibant Exposure|Withdrawal by Subject|0
5532015|NCT01386645|19123145|P3|Overall Study|Withdrawal by Subject|1
5532016|NCT01386645|19123146|P2|Overall Study|Withdrawal by Subject|1
5532017|NCT01386645|19123147|P1|Overall Study|Withdrawal by Subject|0
5532018|NCT01386645|19123145|P3|Overall Study|Physician Decision|1
5532019|NCT01386645|19123146|P2|Overall Study|Physician Decision|0
5532020|NCT01386645|19123147|P1|Overall Study|Physician Decision|0
5532021|NCT01386606|19123176|P4|Overall Study|T levels too high|0
5532022|NCT01386606|19123177|P3|Overall Study|T levels too high|1
5532023|NCT01386606|19123178|P2|Overall Study|T levels too high|1
5532024|NCT01386606|19123179|P1|Overall Study|T levels too high|0
5532025|NCT01386606|19123176|P4|Overall Study|Unable to draw PK|0
5532026|NCT01386606|19123177|P3|Overall Study|Unable to draw PK|0
5532027|NCT01386606|19123178|P2|Overall Study|Unable to draw PK|0
5532028|NCT01386606|19123179|P1|Overall Study|Unable to draw PK|1
5532029|NCT01386606|19123176|P4|Overall Study|Subject incarcerated|0
5532030|NCT01386606|19123177|P3|Overall Study|Subject incarcerated|0
5532031|NCT01386606|19123178|P2|Overall Study|Subject incarcerated|1
5532032|NCT01386606|19123179|P1|Overall Study|Subject incarcerated|0
5532033|NCT01386606|19123176|P4|Overall Study|Lost to Follow-up|0
5532034|NCT01386606|19123177|P3|Overall Study|Lost to Follow-up|0
5532035|NCT01386606|19123178|P2|Overall Study|Lost to Follow-up|0
5532036|NCT01386606|19123179|P1|Overall Study|Lost to Follow-up|2
5532037|NCT01386606|19123176|P4|Overall Study|Protocol Violation|1
5532038|NCT01386606|19123177|P3|Overall Study|Protocol Violation|1
5532039|NCT01386606|19123178|P2|Overall Study|Protocol Violation|0
5532040|NCT01386606|19123179|P1|Overall Study|Protocol Violation|1
5532041|NCT01386606|19123176|P4|Overall Study|Withdrawal by Subject|0
5532042|NCT01386606|19123177|P3|Overall Study|Withdrawal by Subject|1
5532043|NCT01386606|19123178|P2|Overall Study|Withdrawal by Subject|1
5532044|NCT01386606|19123179|P1|Overall Study|Withdrawal by Subject|0
5532045|NCT01386606|19123176|P4|Overall Study|Adverse Event|0
5532046|NCT01386606|19123177|P3|Overall Study|Adverse Event|0
5532047|NCT01386606|19123178|P2|Overall Study|Adverse Event|1
5532048|NCT01386606|19123179|P1|Overall Study|Adverse Event|0
5532049|NCT01386554|19123210|P3|Overall Study|Reason not collected|0
5532050|NCT01386554|19123211|P2|Overall Study|Reason not collected|1
5532051|NCT01386554|19123212|P1|Overall Study|Reason not collected|0
5532052|NCT01386554|19123210|P3|Overall Study|Investigator discretion|1
5532053|NCT01386554|19123211|P2|Overall Study|Investigator discretion|0
5532054|NCT01386554|19123212|P1|Overall Study|Investigator discretion|0
5532055|NCT01386554|19123210|P3|Overall Study|Administration of live vaccines|0
5532056|NCT01386554|19123211|P2|Overall Study|Administration of live vaccines|1
5532057|NCT01386554|19123212|P1|Overall Study|Administration of live vaccines|0
5532058|NCT01386554|19123210|P3|Overall Study|Progressive disease|2
5532059|NCT01386554|19123211|P2|Overall Study|Progressive disease|2
5532060|NCT01386554|19123212|P1|Overall Study|Progressive disease|1
5532061|NCT01386554|19123210|P3|Overall Study|Adverse Event|2
5532062|NCT01386554|19123211|P2|Overall Study|Adverse Event|5
5532063|NCT01386554|19123212|P1|Overall Study|Adverse Event|2
5532064|NCT01386554|19123210|P3|Overall Study|Lost to Follow-up|1
5532065|NCT01386554|19123211|P2|Overall Study|Lost to Follow-up|0
5532066|NCT01386554|19123212|P1|Overall Study|Lost to Follow-up|0
5532067|NCT01386125|19123235|P2|Overall Study|Participant Leaving Country|0
5532068|NCT01386125|19123236|P1|Overall Study|Participant Leaving Country|1
5532069|NCT01386125|19123235|P2|Overall Study|Lack of Efficacy|1
5532070|NCT01386125|19123236|P1|Overall Study|Lack of Efficacy|0
5532071|NCT01386125|19123235|P2|Overall Study|Adverse Event|5
5532072|NCT01386125|19123236|P1|Overall Study|Adverse Event|2
5532073|NCT01386125|19123235|P2|Overall Study|Withdrawal by Subject|12
5532074|NCT01386125|19123236|P1|Overall Study|Withdrawal by Subject|13
5532075|NCT01386125|19123235|P2|Overall Study|Disease Progress|2
5532076|NCT01386125|19123236|P1|Overall Study|Disease Progress|1
5532077|NCT01386125|19123235|P2|Overall Study|Protocol Violation|7
5532078|NCT01386125|19123236|P1|Overall Study|Protocol Violation|5
5532079|NCT01386125|19123235|P2|Overall Study|Physician Decision|1
5532080|NCT01386125|19123236|P1|Overall Study|Physician Decision|0
5532081|NCT01386125|19123235|P2|Overall Study|Lost to Follow-up|9
5532082|NCT01386125|19123236|P1|Overall Study|Lost to Follow-up|3
5532083|NCT01386008|19123244|P1|Overall Study|Adverse Event|3
5532084|NCT01386008|19123244|P1|Overall Study|exited w/o incident /study discontinued|17
5532085|NCT01385995|19123253|P2|Period 1, 2 Months|Physician Decision|0
5532086|NCT01385995|19123254|P1|Period 1, 2 Months|Physician Decision|1
5532087|NCT01385748|19123271|P3|Overall Study|Adverse Event|1
5532088|NCT01385748|19123272|P2|Overall Study|Adverse Event|2
5532089|NCT01385748|19123273|P1|Overall Study|Adverse Event|4
5532090|NCT01385748|19123271|P3|Overall Study|Other|1
5532091|NCT01385748|19123272|P2|Overall Study|Other|7
5532092|NCT01385748|19123273|P1|Overall Study|Other|1
5532093|NCT01385748|19123271|P3|Overall Study|Noncompliance|6
5532094|NCT01385748|19123272|P2|Overall Study|Noncompliance|1
5532095|NCT01385748|19123273|P1|Overall Study|Noncompliance|3
5532096|NCT01385748|19123271|P3|Overall Study|Withdrawal by Subject|5
5532097|NCT01385748|19123272|P2|Overall Study|Withdrawal by Subject|4
5532098|NCT01385748|19123273|P1|Overall Study|Withdrawal by Subject|7
5532099|NCT01385566|19123358|P6|Overall Study|Withdrawal by Subject|0
5532100|NCT01385566|19123359|P5|Overall Study|Withdrawal by Subject|0
5532101|NCT01385566|19123360|P4|Overall Study|Withdrawal by Subject|1
5532102|NCT01385566|19123361|P3|Overall Study|Withdrawal by Subject|0
5532103|NCT01385566|19123362|P2|Overall Study|Withdrawal by Subject|0
5532104|NCT01385566|19123363|P1|Overall Study|Withdrawal by Subject|0
5532105|NCT01385566|19123358|P6|Overall Study|Lost to Follow-up|0
5532106|NCT01385566|19123359|P5|Overall Study|Lost to Follow-up|0
5532107|NCT01385566|19123360|P4|Overall Study|Lost to Follow-up|0
5532108|NCT01385566|19123361|P3|Overall Study|Lost to Follow-up|0
5532109|NCT01385566|19123362|P2|Overall Study|Lost to Follow-up|0
5532110|NCT01385566|19123363|P1|Overall Study|Lost to Follow-up|1
5532111|NCT01385371|19123417|P2|Overall Study|Administrative|2
5532112|NCT01385371|19123418|P1|Overall Study|Administrative|2
5532113|NCT01385371|19123417|P2|Overall Study|Protocol Violation|21
5532114|NCT01385371|19123418|P1|Overall Study|Protocol Violation|25
5532115|NCT01385371|19123417|P2|Overall Study|Withdrawal by Subject|39
5532116|NCT01385371|19123418|P1|Overall Study|Withdrawal by Subject|52
5532117|NCT01385371|19123417|P2|Overall Study|Lost to Follow-up|16
5532118|NCT01385371|19123418|P1|Overall Study|Lost to Follow-up|16
5532119|NCT01385371|19123417|P2|Overall Study|Adverse Event|19
5532120|NCT01385371|19123418|P1|Overall Study|Adverse Event|54
5532121|NCT01385202|19123466|P1|Overall Study|Withdrawn|1
5532122|NCT01385202|19123466|P1|Overall Study|Not Eligible|11
5532123|NCT01385202|19123466|P1|Overall Study|Lost to Follow-up|6
5532124|NCT01385176|19123503|P2|6-18 Month All VNS Active|Heart Transplant|0
5532125|NCT01385176|19123504|P1|6-18 Month All VNS Active|Heart Transplant|1
5532126|NCT01385176|19123503|P2|6-18 Month All VNS Active|Withdrawal by Subject|0
5532127|NCT01385176|19123504|P1|6-18 Month All VNS Active|Withdrawal by Subject|2
5532128|NCT01385176|19123503|P2|6-18 Month All VNS Active|Physician Decision|1
5532129|NCT01385176|19123504|P1|6-18 Month All VNS Active|Physician Decision|0
5532130|NCT01385176|19123503|P2|6-18 Month All VNS Active|Death|2
5532131|NCT01385176|19123504|P1|6-18 Month All VNS Active|Death|1
5532132|NCT01385176|19123503|P2|Randomization Phase|Death|2
5532133|NCT01385176|19123504|P1|Randomization Phase|Death|1
5532134|NCT01385098|19123535|P1|Overall Study|Lost to Follow-up|4
5532135|NCT01385098|19123535|P1|Overall Study|Adverse Event|10
5532136|NCT01384877|19123557|P2|Treatment 2|Lost to Follow-up|2
5532137|NCT01384877|19123558|P1|Treatment 2|Lost to Follow-up|2
5532138|NCT01384760|19123584|P2|Overall Study|Protocol Violation|0
5532139|NCT01384760|19123585|P1|Overall Study|Protocol Violation|16
5532140|NCT01384760|19123584|P2|Overall Study|Lost to Follow-up|6
5532141|NCT01384760|19123585|P1|Overall Study|Lost to Follow-up|0
5532142|NCT01384734|19123598|P5|Overall Study|Physician Decision|0
5532143|NCT01384734|19123599|P4|Overall Study|Physician Decision|0
5532144|NCT01384734|19123600|P3|Overall Study|Physician Decision|0
5532145|NCT01384734|19123601|P2|Overall Study|Physician Decision|0
5532146|NCT01384734|19123602|P1|Overall Study|Physician Decision|1
5532147|NCT01384734|19123598|P5|Overall Study|Early termination|1
5532148|NCT01384734|19123599|P4|Overall Study|Early termination|0
5532149|NCT01384734|19123600|P3|Overall Study|Early termination|0
5532150|NCT01384734|19123601|P2|Overall Study|Early termination|0
5532151|NCT01384734|19123602|P1|Overall Study|Early termination|0
5532152|NCT01384734|19123598|P5|Overall Study|Adhesion problem|0
5532153|NCT01384734|19123599|P4|Overall Study|Adhesion problem|1
5532154|NCT01384734|19123600|P3|Overall Study|Adhesion problem|0
5532155|NCT01384734|19123601|P2|Overall Study|Adhesion problem|0
5532156|NCT01384734|19123602|P1|Overall Study|Adhesion problem|0
5532157|NCT01384734|19123598|P5|Overall Study|Missed End of treatment visit|0
5532158|NCT01384734|19123599|P4|Overall Study|Missed End of treatment visit|1
5532159|NCT01384734|19123600|P3|Overall Study|Missed End of treatment visit|0
5532160|NCT01384734|19123601|P2|Overall Study|Missed End of treatment visit|0
5532161|NCT01384734|19123602|P1|Overall Study|Missed End of treatment visit|0
5532162|NCT01384734|19123598|P5|Overall Study|As per Exclusion criteria|0
5532163|NCT01384734|19123599|P4|Overall Study|As per Exclusion criteria|0
5532164|NCT01384734|19123600|P3|Overall Study|As per Exclusion criteria|0
5532165|NCT01384734|19123601|P2|Overall Study|As per Exclusion criteria|1
5532166|NCT01384734|19123602|P1|Overall Study|As per Exclusion criteria|0
5532167|NCT01384734|19123598|P5|Overall Study|Prison|0
5532168|NCT01384734|19123599|P4|Overall Study|Prison|0
5532169|NCT01384734|19123600|P3|Overall Study|Prison|1
5532170|NCT01384734|19123601|P2|Overall Study|Prison|0
5532171|NCT01384734|19123602|P1|Overall Study|Prison|0
5532172|NCT01384734|19123598|P5|Overall Study|Unable to come back for visit|0
5532173|NCT01384734|19123599|P4|Overall Study|Unable to come back for visit|1
5532174|NCT01384734|19123600|P3|Overall Study|Unable to come back for visit|1
5532175|NCT01384734|19123601|P2|Overall Study|Unable to come back for visit|0
5532176|NCT01384734|19123602|P1|Overall Study|Unable to come back for visit|1
5532177|NCT01384734|19123598|P5|Overall Study|Investigator relocating|1
5532178|NCT01384734|19123599|P4|Overall Study|Investigator relocating|3
5532179|NCT01384734|19123600|P3|Overall Study|Investigator relocating|0
5532180|NCT01384734|19123601|P2|Overall Study|Investigator relocating|2
5532181|NCT01384734|19123602|P1|Overall Study|Investigator relocating|0
5532182|NCT01384734|19123598|P5|Overall Study|Withdrawal by Subject|9
5532183|NCT01384734|19123599|P4|Overall Study|Withdrawal by Subject|7
5532184|NCT01384734|19123600|P3|Overall Study|Withdrawal by Subject|6
5532185|NCT01384734|19123601|P2|Overall Study|Withdrawal by Subject|5
5532186|NCT01384734|19123602|P1|Overall Study|Withdrawal by Subject|5
5532187|NCT01384734|19123598|P5|Overall Study|Sponsor terminated|1
5532188|NCT01384734|19123599|P4|Overall Study|Sponsor terminated|0
5532189|NCT01384734|19123600|P3|Overall Study|Sponsor terminated|0
5532190|NCT01384734|19123601|P2|Overall Study|Sponsor terminated|0
5532191|NCT01384734|19123602|P1|Overall Study|Sponsor terminated|0
5532192|NCT01384734|19123598|P5|Overall Study|Pregnancy|1
5532193|NCT01384734|19123599|P4|Overall Study|Pregnancy|0
5532194|NCT01384734|19123600|P3|Overall Study|Pregnancy|0
5532195|NCT01384734|19123601|P2|Overall Study|Pregnancy|1
5532196|NCT01384734|19123602|P1|Overall Study|Pregnancy|0
5532197|NCT01384734|19123598|P5|Overall Study|Non-compliance with study drug|2
5532198|NCT01384734|19123599|P4|Overall Study|Non-compliance with study drug|0
5532199|NCT01384734|19123600|P3|Overall Study|Non-compliance with study drug|6
5532200|NCT01384734|19123601|P2|Overall Study|Non-compliance with study drug|2
5532201|NCT01384734|19123602|P1|Overall Study|Non-compliance with study drug|1
5532202|NCT01384734|19123598|P5|Overall Study|Lost to Follow-up|5
5532203|NCT01384734|19123599|P4|Overall Study|Lost to Follow-up|8
5532204|NCT01384734|19123600|P3|Overall Study|Lost to Follow-up|3
5532205|NCT01384734|19123601|P2|Overall Study|Lost to Follow-up|3
5532206|NCT01384734|19123602|P1|Overall Study|Lost to Follow-up|5
5532207|NCT01384734|19123598|P5|Overall Study|Lack of Efficacy|2
5532208|NCT01384734|19123599|P4|Overall Study|Lack of Efficacy|4
5532209|NCT01384734|19123600|P3|Overall Study|Lack of Efficacy|4
5532210|NCT01384734|19123601|P2|Overall Study|Lack of Efficacy|7
5532211|NCT01384734|19123602|P1|Overall Study|Lack of Efficacy|3
5532212|NCT01384734|19123598|P5|Overall Study|Continuation criteria not met|0
5532213|NCT01384734|19123599|P4|Overall Study|Continuation criteria not met|1
5532214|NCT01384734|19123600|P3|Overall Study|Continuation criteria not met|1
5532215|NCT01384734|19123601|P2|Overall Study|Continuation criteria not met|0
5532216|NCT01384734|19123602|P1|Overall Study|Continuation criteria not met|0
5532217|NCT01384734|19123598|P5|Overall Study|Death|0
5532218|NCT01384734|19123599|P4|Overall Study|Death|0
5532219|NCT01384734|19123600|P3|Overall Study|Death|1
5532220|NCT01384734|19123601|P2|Overall Study|Death|0
5532221|NCT01384734|19123602|P1|Overall Study|Death|1
5532222|NCT01384734|19123598|P5|Overall Study|Adverse Event|7
5532223|NCT01384734|19123599|P4|Overall Study|Adverse Event|2
5532224|NCT01384734|19123600|P3|Overall Study|Adverse Event|0
5532225|NCT01384734|19123601|P2|Overall Study|Adverse Event|3
5532226|NCT01384734|19123602|P1|Overall Study|Adverse Event|0
5532227|NCT01384292|19123831|P3|Part B|Severe non-compliance to protocol|0
5532228|NCT01384292|19123832|P2|Part B|Severe non-compliance to protocol|0
5532229|NCT01384292|19123833|P1|Part B|Severe non-compliance to protocol|1
5532230|NCT01384019|19123845|P2|Overall Study|MRI refusal|6
5532231|NCT01384019|19123846|P1|Overall Study|MRI refusal|6
5532232|NCT01384019|19123845|P2|Overall Study|Death|0
5532233|NCT01384019|19123846|P1|Overall Study|Death|1
5532234|NCT01384019|19123845|P2|Overall Study|Withdrawal by Subject|0
5532235|NCT01384019|19123846|P1|Overall Study|Withdrawal by Subject|3
5532236|NCT01383993|19123855|P3|Overall Study|Marketed voriconazole in post-therapy|0
5532237|NCT01383993|19123856|P2|Overall Study|Marketed voriconazole in post-therapy|0
5532238|NCT01383993|19123857|P1|Overall Study|Marketed voriconazole in post-therapy|2
5532239|NCT01383993|19123855|P3|Overall Study|Withdrawal by Subject|1
5532240|NCT01383993|19123856|P2|Overall Study|Withdrawal by Subject|0
5532241|NCT01383993|19123857|P1|Overall Study|Withdrawal by Subject|0
5532242|NCT01383993|19123855|P3|Overall Study|Adverse Event|0
5532243|NCT01383993|19123856|P2|Overall Study|Adverse Event|1
5532244|NCT01383993|19123857|P1|Overall Study|Adverse Event|1
5532245|NCT01383954|19123904|P1|Overall Study|Reason Not Specified|9
5532246|NCT01383954|19123904|P1|Overall Study|Adverse Event|1
5532247|NCT01383954|19123904|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
5532248|NCT01383954|19123904|P1|Overall Study|Lack of Efficacy|2
5532249|NCT01383928|19123912|P3|Overall Study|Unsatisfactory Therapeutic Response|1
5532250|NCT01383928|19123913|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5532251|NCT01383928|19123914|P1|Overall Study|Unsatisfactory Therapeutic Response|0
5532252|NCT01383928|19123912|P3|Overall Study|Withdrawal by Subject|4
5532253|NCT01383928|19123913|P2|Overall Study|Withdrawal by Subject|0
5532254|NCT01383928|19123914|P1|Overall Study|Withdrawal by Subject|0
5532255|NCT01383928|19123912|P3|Overall Study|Progressive Disease|5
5532256|NCT01383928|19123913|P2|Overall Study|Progressive Disease|1
5532257|NCT01383928|19123914|P1|Overall Study|Progressive Disease|1
5532258|NCT01383928|19123912|P3|Overall Study|Other|4
5532259|NCT01383928|19123913|P2|Overall Study|Other|3
5532260|NCT01383928|19123914|P1|Overall Study|Other|1
5532261|NCT01383928|19123912|P3|Overall Study|Adverse Event|8
5532262|NCT01383928|19123913|P2|Overall Study|Adverse Event|2
5532263|NCT01383928|19123914|P1|Overall Study|Adverse Event|1
5532264|NCT01383928|19123912|P3|Overall Study|Initiation of ASCT|18
5532265|NCT01383928|19123913|P2|Overall Study|Initiation of ASCT|1
5532266|NCT01383928|19123914|P1|Overall Study|Initiation of ASCT|2
5532267|NCT01383707|19123995|P1|Overall Study|Progressive disease|23
5532268|NCT01383707|19123995|P1|Overall Study|Adverse Event|14
5532269|NCT01383707|19123995|P1|Overall Study|Sponsor's decision|2
5532270|NCT01383707|19123995|P1|Overall Study|Other|8
5532271|NCT01383707|19123995|P1|Overall Study|Death|19
5532272|NCT01383707|19123995|P1|Overall Study|Consent withdrawal|6
5532273|NCT01383499|19124035|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
5532274|NCT01383499|19124036|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
5532275|NCT01383499|19124037|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
5532276|NCT01383499|19124038|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
5532277|NCT01383486|19124088|P1|Overall Study|Did not take any product|6
5532278|NCT01383486|19124088|P1|Overall Study|Incomplete information for analysis|2
5532279|NCT01383486|19124088|P1|Overall Study|Lost to Follow-up|10
5532280|NCT01383356|19124165|P2|Period 1|Personal|2
5532281|NCT01383356|19124166|P1|Period 1|Personal|0
5532282|NCT01383356|19124165|P2|Period 1|Out of Range Mid-study-Test|1
5532283|NCT01383356|19124166|P1|Period 1|Out of Range Mid-study-Test|0
5532284|NCT01383356|19124165|P2|Period 1|Non-compliance|0
5532285|NCT01383356|19124166|P1|Period 1|Non-compliance|3
5532286|NCT01383356|19124165|P2|Period 1|Adverse Event|3
5532287|NCT01383356|19124166|P1|Period 1|Adverse Event|5
5532288|NCT01383317|19124178|P2|Overall Study|Adverse Event|1
5532289|NCT01383317|19124179|P1|Overall Study|Adverse Event|0
5532290|NCT01383317|19124178|P2|Overall Study|Death|0
5532291|NCT01383317|19124179|P1|Overall Study|Death|1
5532292|NCT01383317|19124178|P2|Overall Study|Lost to Follow-up|1
5532293|NCT01383317|19124179|P1|Overall Study|Lost to Follow-up|2
5532294|NCT01383174|19124221|P2|6 Month Assessment|Refused to complete|0
5532295|NCT01383174|19124222|P1|6 Month Assessment|Refused to complete|4
5532296|NCT01383174|19124221|P2|6 Month Assessment|Lost to Follow-up|1
5532297|NCT01383174|19124222|P1|6 Month Assessment|Lost to Follow-up|1
5532298|NCT01383174|19124221|P2|3 Month Assessment|Refused to complete|0
5532299|NCT01383174|19124222|P1|3 Month Assessment|Refused to complete|4
5532300|NCT01383174|19124221|P2|3 Month Assessment|Lost to Follow-up|0
5532301|NCT01383174|19124222|P1|3 Month Assessment|Lost to Follow-up|2
5532302|NCT01383174|19124221|P2|3 Month Assessment|Death|1
5532303|NCT01383174|19124222|P1|3 Month Assessment|Death|0
5532304|NCT01383161|19124248|P2|Overall Study|Lack of Efficacy|1
5532305|NCT01383161|19124249|P1|Overall Study|Lack of Efficacy|0
5532306|NCT01383161|19124248|P2|Overall Study|Withdrawal by Subject|2
5532307|NCT01383161|19124249|P1|Overall Study|Withdrawal by Subject|0
5532308|NCT01383161|19124248|P2|Overall Study|Adverse Event|1
5532309|NCT01383161|19124249|P1|Overall Study|Adverse Event|5
5532310|NCT01383096|19124268|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
5532311|NCT01383096|19124269|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
5532312|NCT01383096|19124270|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
5532313|NCT01383096|19124268|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
5532314|NCT01383096|19124269|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
5532315|NCT01383096|19124270|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
5532316|NCT01383096|19124268|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
5532317|NCT01383096|19124269|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
5532318|NCT01383096|19124270|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
5532319|NCT01383096|19124268|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
5532320|NCT01383096|19124269|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
5532321|NCT01383096|19124270|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
5532322|NCT01383096|19124268|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
5532323|NCT01383096|19124269|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
5532324|NCT01383096|19124270|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
5532325|NCT01383096|19124268|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
5532326|NCT01383096|19124269|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
5532327|NCT01383096|19124270|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
5532328|NCT01383096|19124268|P3|Third Intervention (8 Days)|Adverse Event|0
5532329|NCT01383096|19124269|P2|Third Intervention (8 Days)|Adverse Event|0
5532330|NCT01383096|19124270|P1|Third Intervention (8 Days)|Adverse Event|1
5532331|NCT01383096|19124268|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
5532332|NCT01383096|19124269|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
5532333|NCT01383096|19124270|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
5532334|NCT01383096|19124268|P3|Third Intervention (8 Days)|Elevated AST|0
5532335|NCT01383096|19124269|P2|Third Intervention (8 Days)|Elevated AST|1
5532336|NCT01383096|19124270|P1|Third Intervention (8 Days)|Elevated AST|0
5532337|NCT01383096|19124268|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
5532338|NCT01383096|19124269|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
5532339|NCT01383096|19124270|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
5532340|NCT01383096|19124268|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
5532341|NCT01383096|19124269|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
5532342|NCT01383096|19124270|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
5532343|NCT01383018|19124316|P1|Overall Study|Subject Incarcerated|1
5532344|NCT01383018|19124316|P1|Overall Study|Patient moved away from site|1
5532345|NCT01383018|19124316|P1|Overall Study|Site closed early-not compliance related|7
5532346|NCT01383018|19124316|P1|Overall Study|Missed Visit|247
5532347|NCT01383018|19124316|P1|Overall Study|Subject not implanted|76
5532348|NCT01383018|19124316|P1|Overall Study|Withdrawal by Subject|9
5532349|NCT01383018|19124316|P1|Overall Study|Physician Decision|5
5532350|NCT01383018|19124316|P1|Overall Study|Lost to Follow-up|5
5532351|NCT01383018|19124316|P1|Overall Study|Death|10
5532352|NCT01383018|19124316|P1|Overall Study|Adverse Event|14
5532353|NCT01382940|19124378|P1|Overall Study|Protocol Violation|20
5532354|NCT01382940|19124378|P1|Overall Study|Withdrawal by Subject|23
5532355|NCT01382940|19124378|P1|Overall Study|Physician Decision|7
5532356|NCT01382940|19124378|P1|Overall Study|Lost to Follow-up|4
5532357|NCT01382940|19124378|P1|Overall Study|Adverse Event|19
5532358|NCT01382602|19124440|P2|Overall Study|Withdrawal by Subject|1
5532359|NCT01382602|19124441|P1|Overall Study|Withdrawal by Subject|0
5532360|NCT01382602|19124440|P2|Overall Study|Protocol Violation|3
5532361|NCT01382602|19124441|P1|Overall Study|Protocol Violation|0
5532362|NCT01382446|19124449|P2|Overall Study|Removal from Mechanical Ventilation|3
5532363|NCT01382446|19124450|P1|Overall Study|Removal from Mechanical Ventilation|3
5532364|NCT01382446|19124449|P2|Overall Study|Withdrawal by Subject|1
5532365|NCT01382446|19124450|P1|Overall Study|Withdrawal by Subject|0
5532366|NCT01382251|19124477|P2|Overall Study|Contacted after study closed|1
5532367|NCT01382251|19124478|P1|Overall Study|Contacted after study closed|1
5532368|NCT01382251|19124477|P2|Overall Study|Lost to Follow-up|4
5532369|NCT01382251|19124478|P1|Overall Study|Lost to Follow-up|4
5532370|NCT01382251|19124477|P2|Overall Study|Surgeries cancelled or delayed|16
5532371|NCT01382251|19124478|P1|Overall Study|Surgeries cancelled or delayed|16
5532372|NCT01382225|19124491|P2|Overall Study|Other|2
5532373|NCT01382225|19124492|P1|Overall Study|Other|4
5532374|NCT01382225|19124491|P2|Overall Study|Subject Withdrew Consent|2
5532375|NCT01382225|19124492|P1|Overall Study|Subject Withdrew Consent|5
5532376|NCT01382225|19124491|P2|Overall Study|Protocol Violation|1
5532377|NCT01382225|19124492|P1|Overall Study|Protocol Violation|2
5532378|NCT01382225|19124491|P2|Overall Study|Adverse Event|2
5532379|NCT01382225|19124492|P1|Overall Study|Adverse Event|3
5532380|NCT01382212|19124514|P1|Overall Study|Withdrew consent|1
5532381|NCT01382212|19124514|P1|Overall Study|Kidney transplant|1
5532382|NCT01381926|19124577|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
5532383|NCT01381926|19124578|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
5532384|NCT01381926|19124577|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
5532385|NCT01381926|19124578|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
5532386|NCT01381900|19124591|P3|Overall Study|Early withdraw|1
5532387|NCT01381900|19124592|P2|Overall Study|Early withdraw|1
5532388|NCT01381900|19124593|P1|Overall Study|Early withdraw|3
5532389|NCT01381900|19124591|P3|Overall Study|Withdrawal by Subject|1
5532390|NCT01381900|19124592|P2|Overall Study|Withdrawal by Subject|0
5532391|NCT01381900|19124593|P1|Overall Study|Withdrawal by Subject|0
5532392|NCT01381900|19124591|P3|Overall Study|Protocol Violation|1
5532393|NCT01381900|19124592|P2|Overall Study|Protocol Violation|1
5532394|NCT01381900|19124593|P1|Overall Study|Protocol Violation|0
5532395|NCT01381900|19124591|P3|Overall Study|Physician Decision|1
5532396|NCT01381900|19124592|P2|Overall Study|Physician Decision|1
5532397|NCT01381900|19124593|P1|Overall Study|Physician Decision|0
5532398|NCT01381900|19124591|P3|Overall Study|Noncompliance with study drug|1
5532399|NCT01381900|19124592|P2|Overall Study|Noncompliance with study drug|0
5532400|NCT01381900|19124593|P1|Overall Study|Noncompliance with study drug|0
5532401|NCT01381900|19124591|P3|Overall Study|Adverse Event|7
5532402|NCT01381900|19124592|P2|Overall Study|Adverse Event|6
5532403|NCT01381900|19124593|P1|Overall Study|Adverse Event|4
5532404|NCT01381900|19124591|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
5532405|NCT01381900|19124592|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
5532406|NCT01381900|19124593|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
5532407|NCT01381874|19124616|P3|Overall Study|Other|67
5532408|NCT01381874|19124617|P2|Overall Study|Other|52
5532409|NCT01381874|19124618|P1|Overall Study|Other|67
5532410|NCT01381874|19124616|P3|Overall Study|Withdrawal by Subject|9
5532411|NCT01381874|19124617|P2|Overall Study|Withdrawal by Subject|10
5532412|NCT01381874|19124618|P1|Overall Study|Withdrawal by Subject|9
5532413|NCT01381874|19124616|P3|Overall Study|Lost to Follow-up|0
5532414|NCT01381874|19124617|P2|Overall Study|Lost to Follow-up|1
5532415|NCT01381874|19124618|P1|Overall Study|Lost to Follow-up|1
5532416|NCT01381679|19124655|P1|Overall Study|Lost to Follow-up|885
5532417|NCT01381679|19124655|P1|Overall Study|Adverse Event|3
5532418|NCT01381575|19124670|P3|Overall Study|Lost to Follow-up|9
5532419|NCT01381575|19124671|P2|Overall Study|Lost to Follow-up|17
5532420|NCT01381575|19124672|P1|Overall Study|Lost to Follow-up|8
5532421|NCT01381575|19124670|P3|Overall Study|Migrated/moved from study area|2
5532422|NCT01381575|19124671|P2|Overall Study|Migrated/moved from study area|12
5532423|NCT01381575|19124672|P1|Overall Study|Migrated/moved from study area|2
5532424|NCT01381575|19124670|P3|Overall Study|Withdrawal by Subject|7
5532425|NCT01381575|19124671|P2|Overall Study|Withdrawal by Subject|9
5532426|NCT01381575|19124672|P1|Overall Study|Withdrawal by Subject|15
5532427|NCT01381575|19124670|P3|Overall Study|Protocol Violation|1
5532428|NCT01381575|19124671|P2|Overall Study|Protocol Violation|1
5532429|NCT01381575|19124672|P1|Overall Study|Protocol Violation|0
5532430|NCT01381575|19124670|P3|Overall Study|Non-Serious Adverse Event|1
5532431|NCT01381575|19124671|P2|Overall Study|Non-Serious Adverse Event|0
5532432|NCT01381575|19124672|P1|Overall Study|Non-Serious Adverse Event|0
5532433|NCT01381575|19124670|P3|Overall Study|Serious Adverse Event|0
5532434|NCT01381575|19124671|P2|Overall Study|Serious Adverse Event|0
5532435|NCT01381575|19124672|P1|Overall Study|Serious Adverse Event|1
5532436|NCT01381562|19124729|P3|Overall Study|Adverse Event|0
5532437|NCT01381562|19124730|P2|Overall Study|Adverse Event|1
5532438|NCT01381562|19124731|P1|Overall Study|Adverse Event|0
5532439|NCT01381549|19124799|P3|Overall Study|Ineligible: No organisms isolated|1
5532440|NCT01381549|19124800|P2|Overall Study|Ineligible: No organisms isolated|0
5532441|NCT01381549|19124801|P1|Overall Study|Ineligible: No organisms isolated|0
5532442|NCT01381068|19124927|P2|Overall Study|Death|0
5532443|NCT01381068|19124928|P1|Overall Study|Death|1
5532444|NCT01381016|19124948|P2|Overall Study|Physician Decision|2
5532445|NCT01381016|19124949|P1|Overall Study|Physician Decision|0
5532446|NCT01381016|19124948|P2|Overall Study|Withdrawal by Subject|1
5532447|NCT01381016|19124949|P1|Overall Study|Withdrawal by Subject|0
5532448|NCT01381016|19124948|P2|Overall Study|Screen Failure|2
5532449|NCT01381016|19124949|P1|Overall Study|Screen Failure|2
5532450|NCT01381016|19124948|P2|Overall Study|Lost to Follow-up|1
5532451|NCT01381016|19124949|P1|Overall Study|Lost to Follow-up|1
5532452|NCT01380834|19124959|P2|Overall Study|Physician Decision|0
5532453|NCT01380834|19124960|P1|Overall Study|Physician Decision|1
5532454|NCT01380782|19124972|P4|Overall Study|Withdrawal by Subject|1
5532455|NCT01380782|19124973|P3|Overall Study|Withdrawal by Subject|1
5532456|NCT01380782|19124974|P2|Overall Study|Withdrawal by Subject|0
5532457|NCT01380782|19124975|P1|Overall Study|Withdrawal by Subject|0
5532458|NCT01380782|19124972|P4|Overall Study|Physician Decision|0
5532459|NCT01380782|19124973|P3|Overall Study|Physician Decision|0
5532460|NCT01380782|19124974|P2|Overall Study|Physician Decision|0
5532461|NCT01380782|19124975|P1|Overall Study|Physician Decision|1
5532462|NCT01380782|19124972|P4|Overall Study|Lack of Efficacy|3
5532463|NCT01380782|19124973|P3|Overall Study|Lack of Efficacy|10
5532464|NCT01380782|19124974|P2|Overall Study|Lack of Efficacy|9
5532465|NCT01380782|19124975|P1|Overall Study|Lack of Efficacy|10
5532466|NCT01380782|19124972|P4|Overall Study|Death|0
5532467|NCT01380782|19124973|P3|Overall Study|Death|0
5532468|NCT01380782|19124974|P2|Overall Study|Death|0
5532469|NCT01380782|19124975|P1|Overall Study|Death|1
5532470|NCT01380782|19124972|P4|Overall Study|Adverse Event|0
5532471|NCT01380782|19124973|P3|Overall Study|Adverse Event|0
5532472|NCT01380782|19124974|P2|Overall Study|Adverse Event|1
5532473|NCT01380782|19124975|P1|Overall Study|Adverse Event|0
5532474|NCT01380769|19124998|P2|Overall Study|Protocol Violation|1
5532475|NCT01380769|19124999|P1|Overall Study|Protocol Violation|0
5532476|NCT01380769|19124998|P2|Overall Study|Adverse Event|1
5532477|NCT01380769|19124999|P1|Overall Study|Adverse Event|1
5532478|NCT01380769|19124998|P2|Overall Study|Physician Decision|1
5532479|NCT01380769|19124999|P1|Overall Study|Physician Decision|1
5532480|NCT01380769|19124998|P2|Overall Study|Withdrawal by Subject|11
5532481|NCT01380769|19124999|P1|Overall Study|Withdrawal by Subject|7
5532482|NCT01380730|19125060|P8|Overall Study|Death|0
5532483|NCT01380730|19125061|P7|Overall Study|Death|0
5532484|NCT01380730|19125062|P6|Overall Study|Death|0
5532485|NCT01380730|19125063|P5|Overall Study|Death|1
5532486|NCT01380730|19125064|P4|Overall Study|Death|0
5532487|NCT01380730|19125065|P3|Overall Study|Death|0
5532488|NCT01380730|19125066|P2|Overall Study|Death|0
5532489|NCT01380730|19125067|P1|Overall Study|Death|0
5532490|NCT01380691|19125125|P4|Washout (7 Days)|Withdrawal by Subject|0
5532491|NCT01380691|19125126|P3|Washout (7 Days)|Withdrawal by Subject|1
5532492|NCT01380691|19125127|P2|Washout (7 Days)|Withdrawal by Subject|0
5532493|NCT01380691|19125128|P1|Washout (7 Days)|Withdrawal by Subject|0
5532494|NCT01380691|19125125|P4|Washout (7 Days)|Protocol Violation|1
5532495|NCT01380691|19125126|P3|Washout (7 Days)|Protocol Violation|0
5532496|NCT01380691|19125127|P2|Washout (7 Days)|Protocol Violation|0
5532497|NCT01380691|19125128|P1|Washout (7 Days)|Protocol Violation|0
5532498|NCT01380535|19125189|P2|Overall Study|Lack of Efficacy|3
5532499|NCT01380535|19125190|P1|Overall Study|Lack of Efficacy|0
5532500|NCT01380535|19125189|P2|Overall Study|Protocol Violation|2
5532501|NCT01380535|19125190|P1|Overall Study|Protocol Violation|0
5532502|NCT01380535|19125189|P2|Overall Study|Withdrawal by Subject|2
5532503|NCT01380535|19125190|P1|Overall Study|Withdrawal by Subject|1
5532504|NCT01380535|19125189|P2|Overall Study|Study site closed|5
5532505|NCT01380535|19125190|P1|Overall Study|Study site closed|0
5532506|NCT01380535|19125189|P2|Overall Study|Death|0
5532507|NCT01380535|19125190|P1|Overall Study|Death|3
5532508|NCT01380535|19125189|P2|Overall Study|Adverse Event|3
5532509|NCT01380535|19125190|P1|Overall Study|Adverse Event|3
5532510|NCT01380379|19125196|P1|Overall Study|Pregnancy|1
5532511|NCT01380327|19125209|P3|Overall Study|Questionable onset of epilepsy|1
5532512|NCT01380327|19125210|P2|Overall Study|Questionable onset of epilepsy|0
5532513|NCT01380327|19125211|P1|Overall Study|Questionable onset of epilepsy|0
5532514|NCT01380327|19125209|P3|Overall Study|Housing situation precluded ability to k|1
5532515|NCT01380327|19125210|P2|Overall Study|Housing situation precluded ability to k|0
5532516|NCT01380327|19125211|P1|Overall Study|Housing situation precluded ability to k|0
5532517|NCT01380327|19125209|P3|Overall Study|Withdrawal by Subject|1
5532518|NCT01380327|19125210|P2|Overall Study|Withdrawal by Subject|0
5532519|NCT01380327|19125211|P1|Overall Study|Withdrawal by Subject|0
5532520|NCT01380327|19125209|P3|Overall Study|Protocol Violation|3
5532521|NCT01380327|19125210|P2|Overall Study|Protocol Violation|2
5532522|NCT01380327|19125211|P1|Overall Study|Protocol Violation|3
5532523|NCT01380327|19125209|P3|Overall Study|Lost to Follow-up|1
5532524|NCT01380327|19125210|P2|Overall Study|Lost to Follow-up|1
5532525|NCT01380327|19125211|P1|Overall Study|Lost to Follow-up|0
5532526|NCT01380184|19125242|P1|Part 2|Lost to Follow-up|1
5532527|NCT01380184|19125242|P1|Part 2|Disease Progression|8
5532528|NCT01380184|19125242|P1|Part 2|Adverse Event|5
5532529|NCT01380184|19125242|P1|Part 1 (19 Days)|Adverse Event|1
5532530|NCT01380145|19125253|P1|Overall Study|Progressive disease|4
5532531|NCT01380093|19125261|P9|Treatment Phase: Third Intervention|Other|1
5532532|NCT01380093|19125262|P8|Treatment Phase: Third Intervention|Other|0
5532533|NCT01380093|19125263|P7|Treatment Phase: Third Intervention|Other|0
5532534|NCT01380093|19125264|P6|Treatment Phase: Third Intervention|Other|0
5532535|NCT01380093|19125265|P5|Treatment Phase: Third Intervention|Other|0
5532536|NCT01380093|19125266|P4|Treatment Phase: Third Intervention|Other|0
5532537|NCT01380093|19125267|P3|Treatment Phase: Third Intervention|Other|0
5532538|NCT01380093|19125268|P2|Treatment Phase: Third Intervention|Other|0
5532539|NCT01380093|19125269|P1|Treatment Phase: Third Intervention|Other|0
5532540|NCT01380093|19125261|P9|Treatment Phase: Third Intervention|Non-compliance|1
5532541|NCT01380093|19125262|P8|Treatment Phase: Third Intervention|Non-compliance|0
5532542|NCT01380093|19125263|P7|Treatment Phase: Third Intervention|Non-compliance|0
5532543|NCT01380093|19125264|P6|Treatment Phase: Third Intervention|Non-compliance|0
5532544|NCT01380093|19125265|P5|Treatment Phase: Third Intervention|Non-compliance|0
5532545|NCT01380093|19125266|P4|Treatment Phase: Third Intervention|Non-compliance|0
5532546|NCT01380093|19125267|P3|Treatment Phase: Third Intervention|Non-compliance|0
5532547|NCT01380093|19125268|P2|Treatment Phase: Third Intervention|Non-compliance|0
5532548|NCT01380093|19125269|P1|Treatment Phase: Third Intervention|Non-compliance|0
5532549|NCT01380093|19125261|P9|Treatment Phase: Second Intervention|Other|0
5532550|NCT01380093|19125262|P8|Treatment Phase: Second Intervention|Other|0
5532551|NCT01380093|19125263|P7|Treatment Phase: Second Intervention|Other|0
5532552|NCT01380093|19125264|P6|Treatment Phase: Second Intervention|Other|0
5532553|NCT01380093|19125265|P5|Treatment Phase: Second Intervention|Other|0
5532554|NCT01380093|19125266|P4|Treatment Phase: Second Intervention|Other|1
5532555|NCT01380093|19125267|P3|Treatment Phase: Second Intervention|Other|0
5532556|NCT01380093|19125268|P2|Treatment Phase: Second Intervention|Other|0
5532557|NCT01380093|19125269|P1|Treatment Phase: Second Intervention|Other|0
5532558|NCT01380093|19125261|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
5532559|NCT01380093|19125262|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
5532560|NCT01380093|19125263|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
5532561|NCT01380093|19125264|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
5532562|NCT01380093|19125265|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
5532563|NCT01380093|19125266|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
5532564|NCT01380093|19125267|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
5532565|NCT01380093|19125268|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
5532566|NCT01380093|19125269|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
5532567|NCT01380093|19125261|P9|Drug Discrimination Phase: Day 2|Backup participant|0
5532568|NCT01380093|19125262|P8|Drug Discrimination Phase: Day 2|Backup participant|0
5532569|NCT01380093|19125263|P7|Drug Discrimination Phase: Day 2|Backup participant|0
5532570|NCT01380093|19125264|P6|Drug Discrimination Phase: Day 2|Backup participant|0
5532571|NCT01380093|19125265|P5|Drug Discrimination Phase: Day 2|Backup participant|0
5532572|NCT01380093|19125266|P4|Drug Discrimination Phase: Day 2|Backup participant|0
5532573|NCT01380093|19125267|P3|Drug Discrimination Phase: Day 2|Backup participant|1
5532574|NCT01380093|19125268|P2|Drug Discrimination Phase: Day 2|Backup participant|0
5532575|NCT01380093|19125269|P1|Drug Discrimination Phase: Day 2|Backup participant|0
5532576|NCT01380093|19125261|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5532577|NCT01380093|19125262|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5532578|NCT01380093|19125263|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5532579|NCT01380093|19125264|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5532580|NCT01380093|19125265|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5532581|NCT01380093|19125266|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5532582|NCT01380093|19125267|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
5532583|NCT01380093|19125268|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
5532584|NCT01380093|19125269|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
5532585|NCT01380093|19125261|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
5532586|NCT01380093|19125262|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
5532587|NCT01380093|19125263|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
5532588|NCT01380093|19125264|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
5532589|NCT01380093|19125265|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
5532590|NCT01380093|19125266|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
5532591|NCT01380093|19125267|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
5532592|NCT01380093|19125268|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
5532593|NCT01380093|19125269|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
5532594|NCT01380093|19125261|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5532595|NCT01380093|19125262|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5532596|NCT01380093|19125263|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5532597|NCT01380093|19125264|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5532837|NCT01377480|19126433|P1|Overall Study|Serious adverse event|0
5532598|NCT01380093|19125265|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5532599|NCT01380093|19125266|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5532600|NCT01380093|19125267|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5532601|NCT01380093|19125268|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
5532602|NCT01380093|19125269|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
5532603|NCT01380093|19125261|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
5532604|NCT01380093|19125262|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
5532605|NCT01380093|19125263|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
5532606|NCT01380093|19125264|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
5532607|NCT01380093|19125265|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
5532608|NCT01380093|19125266|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
5532609|NCT01380093|19125267|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
5532610|NCT01380093|19125268|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
5532611|NCT01380093|19125269|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
5532612|NCT01380093|19125261|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
5532613|NCT01380093|19125262|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
5532614|NCT01380093|19125263|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
5532615|NCT01380093|19125264|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
5532616|NCT01380093|19125265|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
5532617|NCT01380093|19125266|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
5532618|NCT01380093|19125267|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
5532619|NCT01380093|19125268|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
5532620|NCT01380093|19125269|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
5532621|NCT01380093|19125261|P9|Naloxone Challenge Phase|Screen failures|0
5532622|NCT01380093|19125262|P8|Naloxone Challenge Phase|Screen failures|0
5532623|NCT01380093|19125263|P7|Naloxone Challenge Phase|Screen failures|0
5532624|NCT01380093|19125264|P6|Naloxone Challenge Phase|Screen failures|0
5532625|NCT01380093|19125265|P5|Naloxone Challenge Phase|Screen failures|0
5532626|NCT01380093|19125266|P4|Naloxone Challenge Phase|Screen failures|0
5532627|NCT01380093|19125267|P3|Naloxone Challenge Phase|Screen failures|0
5532628|NCT01380093|19125268|P2|Naloxone Challenge Phase|Screen failures|0
5532629|NCT01380093|19125269|P1|Naloxone Challenge Phase|Screen failures|21
5532630|NCT01380080|19125561|P2|Overall Study|Lost to Follow-up|0
5532631|NCT01380080|19125562|P1|Overall Study|Lost to Follow-up|2
5532632|NCT01380080|19125561|P2|Overall Study|Not willing to adhere to requirements|1
5532633|NCT01380080|19125562|P1|Overall Study|Not willing to adhere to requirements|3
5532634|NCT01380080|19125561|P2|Overall Study|Not able to get to clinic|0
5532635|NCT01380080|19125562|P1|Overall Study|Not able to get to clinic|4
5532636|NCT01380080|19125561|P2|Overall Study|Withdrawal by Subject|0
5532637|NCT01380080|19125562|P1|Overall Study|Withdrawal by Subject|4
5532638|NCT01380080|19125561|P2|Overall Study|Death|22
5532639|NCT01380080|19125562|P1|Overall Study|Death|20
5532640|NCT01379937|19125587|P4|Overall Study|Lost to Follow-up|0
5532641|NCT01379937|19125588|P3|Overall Study|Lost to Follow-up|2
5532642|NCT01379937|19125589|P2|Overall Study|Lost to Follow-up|2
5532643|NCT01379937|19125590|P1|Overall Study|Lost to Follow-up|1
5532644|NCT01379937|19125587|P4|Overall Study|Consent withdrawal|0
5532645|NCT01379937|19125588|P3|Overall Study|Consent withdrawal|0
5532646|NCT01379937|19125589|P2|Overall Study|Consent withdrawal|1
5532647|NCT01379937|19125590|P1|Overall Study|Consent withdrawal|0
5532648|NCT01379937|19125587|P4|Overall Study|Protocol Violation|1
5532649|NCT01379937|19125588|P3|Overall Study|Protocol Violation|0
5532650|NCT01379937|19125589|P2|Overall Study|Protocol Violation|0
5532651|NCT01379937|19125590|P1|Overall Study|Protocol Violation|0
5532652|NCT01379781|19125710|P2|Overall Study|Lost to Follow-up|8
5532653|NCT01379781|19125711|P1|Overall Study|Lost to Follow-up|11
5532654|NCT01379768|19125720|P3|Overall Study|Lost to Follow-up|0
5532655|NCT01379768|19125721|P2|Overall Study|Lost to Follow-up|0
5532656|NCT01379768|19125722|P1|Overall Study|Lost to Follow-up|2
5532657|NCT01379768|19125720|P3|Overall Study|Adverse Event|0
5532658|NCT01379768|19125721|P2|Overall Study|Adverse Event|1
5532659|NCT01379768|19125722|P1|Overall Study|Adverse Event|1
5532660|NCT01379703|19125745|P3|9 Months Through 18 Months|Reason Unknown|0
5532661|NCT01379703|19125746|P2|9 Months Through 18 Months|Reason Unknown|23
5532662|NCT01379703|19125747|P1|9 Months Through 18 Months|Reason Unknown|0
5532663|NCT01379703|19125745|P3|9 Months Through 18 Months|Fatigue|0
5532664|NCT01379703|19125746|P2|9 Months Through 18 Months|Fatigue|1
5532665|NCT01379703|19125747|P1|9 Months Through 18 Months|Fatigue|0
5532666|NCT01379703|19125745|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
5532667|NCT01379703|19125746|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
5532668|NCT01379703|19125747|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
5532669|NCT01379703|19125745|P3|9 Months Through 18 Months|Patient Noncompliance|0
5532670|NCT01379703|19125746|P2|9 Months Through 18 Months|Patient Noncompliance|4
5532671|NCT01379703|19125747|P1|9 Months Through 18 Months|Patient Noncompliance|0
5532672|NCT01379703|19125745|P3|9 Months Through 18 Months|Treatment failure|0
5532673|NCT01379703|19125746|P2|9 Months Through 18 Months|Treatment failure|5
5532674|NCT01379703|19125747|P1|9 Months Through 18 Months|Treatment failure|0
5532675|NCT01379703|19125745|P3|9 Months Through 18 Months|Adverse Event|0
5532676|NCT01379703|19125746|P2|9 Months Through 18 Months|Adverse Event|6
5532677|NCT01379703|19125747|P1|9 Months Through 18 Months|Adverse Event|0
5532678|NCT01379703|19125745|P3|9 Months Through 18 Months|Withdrawal by Subject|0
5532679|NCT01379703|19125746|P2|9 Months Through 18 Months|Withdrawal by Subject|11
5532680|NCT01379703|19125747|P1|9 Months Through 18 Months|Withdrawal by Subject|0
5532681|NCT01379703|19125745|P3|9 Months Through 18 Months|Lost to Follow-up|0
5532682|NCT01379703|19125746|P2|9 Months Through 18 Months|Lost to Follow-up|178
5532683|NCT01379703|19125747|P1|9 Months Through 18 Months|Lost to Follow-up|0
5532684|NCT01379703|19125745|P3|Study Start Through 9 Months|Reason unknown|24
5532685|NCT01379703|19125746|P2|Study Start Through 9 Months|Reason unknown|31
5532686|NCT01379703|19125747|P1|Study Start Through 9 Months|Reason unknown|2
5532687|NCT01379703|19125745|P3|Study Start Through 9 Months|Increased triglycerides|0
5532688|NCT01379703|19125746|P2|Study Start Through 9 Months|Increased triglycerides|1
5532689|NCT01379703|19125747|P1|Study Start Through 9 Months|Increased triglycerides|0
5532690|NCT01379703|19125745|P3|Study Start Through 9 Months|Poor general condition|0
5532691|NCT01379703|19125746|P2|Study Start Through 9 Months|Poor general condition|1
5532692|NCT01379703|19125747|P1|Study Start Through 9 Months|Poor general condition|0
5532693|NCT01379703|19125745|P3|Study Start Through 9 Months|Medication not available|1
5532694|NCT01379703|19125746|P2|Study Start Through 9 Months|Medication not available|2
5532695|NCT01379703|19125747|P1|Study Start Through 9 Months|Medication not available|0
5532696|NCT01379703|19125745|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
5532697|NCT01379703|19125746|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
5532698|NCT01379703|19125747|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
5532699|NCT01379703|19125745|P3|Study Start Through 9 Months|Patient Noncompliance|1
5532700|NCT01379703|19125746|P2|Study Start Through 9 Months|Patient Noncompliance|0
5532701|NCT01379703|19125747|P1|Study Start Through 9 Months|Patient Noncompliance|0
5532702|NCT01379703|19125745|P3|Study Start Through 9 Months|Treatment Failure|2
5532703|NCT01379703|19125746|P2|Study Start Through 9 Months|Treatment Failure|2
5532704|NCT01379703|19125747|P1|Study Start Through 9 Months|Treatment Failure|0
5532705|NCT01379703|19125745|P3|Study Start Through 9 Months|Withdrawal by Subject|1
5532706|NCT01379703|19125746|P2|Study Start Through 9 Months|Withdrawal by Subject|6
5532707|NCT01379703|19125747|P1|Study Start Through 9 Months|Withdrawal by Subject|0
5532708|NCT01379703|19125745|P3|Study Start Through 9 Months|Adverse Event|10
5532709|NCT01379703|19125746|P2|Study Start Through 9 Months|Adverse Event|14
5532710|NCT01379703|19125747|P1|Study Start Through 9 Months|Adverse Event|0
5532711|NCT01379703|19125745|P3|Study Start Through 9 Months|Lost to Follow-up|104
5532712|NCT01379703|19125746|P2|Study Start Through 9 Months|Lost to Follow-up|61
5532713|NCT01379703|19125747|P1|Study Start Through 9 Months|Lost to Follow-up|2
5532714|NCT01379573|19125845|P1|Overall Study|Screen Failure|10
5532715|NCT01379573|19125845|P1|Overall Study|Lost to Follow-up|1
5532716|NCT01379534|19125859|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
5532717|NCT01379534|19125860|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
5532718|NCT01379534|19125859|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
5532719|NCT01379534|19125860|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
5532720|NCT01379534|19125859|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
5532721|NCT01379534|19125860|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
5532722|NCT01379534|19125859|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
5532723|NCT01379534|19125860|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
5532724|NCT01379534|19125859|P2|Treatment Phase|Adverse Event|7
5532725|NCT01379534|19125860|P1|Treatment Phase|Adverse Event|7
5532726|NCT01379534|19125859|P2|Treatment Phase|Progressive disease|22
5532727|NCT01379534|19125860|P1|Treatment Phase|Progressive disease|13
5532728|NCT01379534|19125859|P2|Treatment Phase|Withdrawal by Subject|2
5532729|NCT01379534|19125860|P1|Treatment Phase|Withdrawal by Subject|2
5532730|NCT01379521|19125880|P2|Post-Treatment Evaluations|Death|0
5532731|NCT01379521|19125881|P1|Post-Treatment Evaluations|Death|1
5532732|NCT01379521|19125880|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
5532733|NCT01379521|19125881|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
5532734|NCT01379521|19125880|P2|Post-Treatment Evaluations|Disease Progression|20
5532735|NCT01379521|19125881|P1|Post-Treatment Evaluations|Disease Progression|22
5532736|NCT01379521|19125880|P2|Overall Study -Treatment Period|Death|1
5532737|NCT01379521|19125881|P1|Overall Study -Treatment Period|Death|2
5532738|NCT01379521|19125880|P2|Overall Study -Treatment Period|Administrative Problems|0
5532739|NCT01379521|19125881|P1|Overall Study -Treatment Period|Administrative Problems|1
5532740|NCT01379521|19125880|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
5532741|NCT01379521|19125881|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
5532742|NCT01379521|19125880|P2|Overall Study -Treatment Period|Protocol Deviation|2
5532743|NCT01379521|19125881|P1|Overall Study -Treatment Period|Protocol Deviation|0
5532744|NCT01379521|19125880|P2|Overall Study -Treatment Period|New Cancer Therapy|0
5532745|NCT01379521|19125881|P1|Overall Study -Treatment Period|New Cancer Therapy|1
5532746|NCT01379521|19125880|P2|Overall Study -Treatment Period|Disease Progression|22
5532747|NCT01379521|19125881|P1|Overall Study -Treatment Period|Disease Progression|23
5532748|NCT01379521|19125880|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
5532749|NCT01379521|19125881|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
5532750|NCT01379521|19125880|P2|Overall Study -Treatment Period|Adverse Event|0
5532751|NCT01379521|19125881|P1|Overall Study -Treatment Period|Adverse Event|3
5532752|NCT01379508|19125903|P4|Extension Period Weeks 109-156|Protocol Violation|0
5532753|NCT01379508|19125904|P3|Extension Period Weeks 109-156|Protocol Violation|0
5532754|NCT01379508|19125905|P2|Extension Period Weeks 109-156|Protocol Violation|1
5532755|NCT01379508|19125906|P1|Extension Period Weeks 109-156|Protocol Violation|2
5532756|NCT01379508|19125903|P4|Extension Period Weeks 109-156|Administrative problems|0
5532757|NCT01379508|19125904|P3|Extension Period Weeks 109-156|Administrative problems|1
5532758|NCT01379508|19125905|P2|Extension Period Weeks 109-156|Administrative problems|0
5532759|NCT01379508|19125906|P1|Extension Period Weeks 109-156|Administrative problems|3
5532760|NCT01379508|19125903|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
5532761|NCT01379508|19125904|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
5532762|NCT01379508|19125905|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
5532763|NCT01379508|19125906|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
5532764|NCT01379508|19125903|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
5532765|NCT01379508|19125904|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
5532766|NCT01379508|19125905|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
5532767|NCT01379508|19125906|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
5532768|NCT01379508|19125903|P4|Treatment to Week 104|Protocol Violation|0
5532769|NCT01379508|19125904|P3|Treatment to Week 104|Protocol Violation|1
5532770|NCT01379508|19125905|P2|Treatment to Week 104|Protocol Violation|1
5532771|NCT01379508|19125906|P1|Treatment to Week 104|Protocol Violation|1
5532772|NCT01379508|19125903|P4|Treatment to Week 104|Administrative problems|0
5532773|NCT01379508|19125904|P3|Treatment to Week 104|Administrative problems|0
5532774|NCT01379508|19125905|P2|Treatment to Week 104|Administrative problems|1
5532775|NCT01379508|19125906|P1|Treatment to Week 104|Administrative problems|3
5532776|NCT01379508|19125903|P4|Treatment to Week 104|Lost to Follow-up|0
5532777|NCT01379508|19125904|P3|Treatment to Week 104|Lost to Follow-up|3
5532778|NCT01379508|19125905|P2|Treatment to Week 104|Lost to Follow-up|0
5532779|NCT01379508|19125906|P1|Treatment to Week 104|Lost to Follow-up|5
5532780|NCT01379508|19125903|P4|Treatment to Week 104|Withdrawal by Subject|0
5532781|NCT01379508|19125904|P3|Treatment to Week 104|Withdrawal by Subject|4
5532782|NCT01379508|19125905|P2|Treatment to Week 104|Withdrawal by Subject|1
5532783|NCT01379508|19125906|P1|Treatment to Week 104|Withdrawal by Subject|6
5532784|NCT01379508|19125903|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
5532785|NCT01379508|19125904|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
5532786|NCT01379508|19125905|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
5532787|NCT01379508|19125906|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
5532788|NCT01379508|19125903|P4|Treatment to Week 104|Abnormal lab value|0
5532789|NCT01379508|19125904|P3|Treatment to Week 104|Abnormal lab value|0
5532790|NCT01379508|19125905|P2|Treatment to Week 104|Abnormal lab value|0
5532791|NCT01379508|19125906|P1|Treatment to Week 104|Abnormal lab value|1
5532792|NCT01379508|19125903|P4|Treatment to Week 104|Adverse Event|0
5532793|NCT01379508|19125904|P3|Treatment to Week 104|Adverse Event|5
5532794|NCT01379508|19125905|P2|Treatment to Week 104|Adverse Event|0
5532795|NCT01379508|19125906|P1|Treatment to Week 104|Adverse Event|2
5532796|NCT01379274|19125932|P1|Overall Study|funding withdrawn|1
5532797|NCT01378975|19125992|P2|Overall Study|Withdrew Consent|3
5532798|NCT01378975|19125993|P1|Overall Study|Withdrew Consent|4
5532799|NCT01378975|19125992|P2|Overall Study|Lost to Follow-up|1
5532800|NCT01378975|19125993|P1|Overall Study|Lost to Follow-up|4
5532801|NCT01378975|19125992|P2|Overall Study|Investigator Request|0
5532802|NCT01378975|19125993|P1|Overall Study|Investigator Request|1
5532803|NCT01378975|19125992|P2|Overall Study|Death|46
5532804|NCT01378975|19125993|P1|Overall Study|Death|77
5532805|NCT01378962|19126019|P1|Overall Study|Other|2
5532806|NCT01378962|19126019|P1|Overall Study|Lost to Follow-up|1
5532807|NCT01378962|19126019|P1|Overall Study|Death|14
5532808|NCT01378429|19126045|P2|Overall Study|Noncompliance with study drug|0
5532809|NCT01378429|19126046|P1|Overall Study|Noncompliance with study drug|1
5532810|NCT01378325|19126159|P2|Overall Study|Protocol Violation|1
5532811|NCT01378325|19126160|P1|Overall Study|Protocol Violation|0
5532812|NCT01378195|19126229|P2|Overall Study|Lost to Follow-up|18
5532813|NCT01378195|19126230|P1|Overall Study|Lost to Follow-up|29
5532814|NCT01378117|19126243|P3|Overall Study|discharged before med given|1
5532815|NCT01378117|19126244|P2|Overall Study|discharged before med given|0
5532816|NCT01378117|19126245|P1|Overall Study|discharged before med given|2
5532817|NCT01378117|19126243|P3|Overall Study|withdrawal|2
5532818|NCT01378117|19126244|P2|Overall Study|withdrawal|1
5532819|NCT01378117|19126245|P1|Overall Study|withdrawal|2
5532820|NCT01378104|19126279|P2|Overall Study|Withdrawal by Subject|13
5532821|NCT01378104|19126280|P1|Overall Study|Withdrawal by Subject|12
5532822|NCT01378104|19126279|P2|Overall Study|Lack of Efficacy|5
5532823|NCT01378104|19126280|P1|Overall Study|Lack of Efficacy|7
5532824|NCT01378104|19126279|P2|Overall Study|Adverse Event|8
5532825|NCT01378104|19126280|P1|Overall Study|Adverse Event|8
5532826|NCT01377987|19126325|P2|Washout (7 Days)|Withdrawal by Subject|1
5532827|NCT01377987|19126326|P1|Washout (7 Days)|Withdrawal by Subject|1
5532828|NCT01377922|19126344|P2|Overall Study|rescue tx after part 2, entered part 4|0
5532829|NCT01377922|19126345|P1|Overall Study|rescue tx after part 2, entered part 4|1
5532830|NCT01377480|19126430|P4|Overall Study|Other|6
5532831|NCT01377480|19126431|P3|Overall Study|Other|7
5532832|NCT01377480|19126432|P2|Overall Study|Other|0
5532833|NCT01377480|19126433|P1|Overall Study|Other|0
5532834|NCT01377480|19126430|P4|Overall Study|Serious adverse event|1
5532835|NCT01377480|19126431|P3|Overall Study|Serious adverse event|1
5532836|NCT01377480|19126432|P2|Overall Study|Serious adverse event|0
5532838|NCT01377480|19126430|P4|Overall Study|Withdrawal by Subject|0
5532839|NCT01377480|19126431|P3|Overall Study|Withdrawal by Subject|1
5532840|NCT01377480|19126432|P2|Overall Study|Withdrawal by Subject|0
5532841|NCT01377480|19126433|P1|Overall Study|Withdrawal by Subject|0
5532842|NCT01377480|19126430|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
5532843|NCT01377480|19126431|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
5532844|NCT01377480|19126432|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
5532845|NCT01377480|19126433|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
5532846|NCT01377480|19126430|P4|Overall Study|Protocol Violation|4
5532847|NCT01377480|19126431|P3|Overall Study|Protocol Violation|0
5532848|NCT01377480|19126432|P2|Overall Study|Protocol Violation|0
5532849|NCT01377480|19126433|P1|Overall Study|Protocol Violation|0
5532850|NCT01377389|19126509|P1|Overall Study|Screen failure|2
5532851|NCT01377389|19126509|P1|Overall Study|Withdrawal by Subject|1
5532852|NCT01377233|19126523|P5|Double-blind|Administrative or other|1
5532853|NCT01377233|19126524|P4|Double-blind|Administrative or other|1
5532854|NCT01377233|19126525|P3|Double-blind|Administrative or other|0
5532855|NCT01377233|19126526|P2|Double-blind|Administrative or other|0
5532856|NCT01377233|19126527|P1|Double-blind|Administrative or other|0
5532857|NCT01377233|19126523|P5|Double-blind|Withdrawal by Subject|0
5532858|NCT01377233|19126524|P4|Double-blind|Withdrawal by Subject|1
5532859|NCT01377233|19126525|P3|Double-blind|Withdrawal by Subject|0
5532860|NCT01377233|19126526|P2|Double-blind|Withdrawal by Subject|0
5532861|NCT01377233|19126527|P1|Double-blind|Withdrawal by Subject|0
5532862|NCT01377233|19126523|P5|Double-blind|Protocol Violation|1
5532863|NCT01377233|19126524|P4|Double-blind|Protocol Violation|0
5532864|NCT01377233|19126525|P3|Double-blind|Protocol Violation|0
5532865|NCT01377233|19126526|P2|Double-blind|Protocol Violation|0
5532866|NCT01377233|19126527|P1|Double-blind|Protocol Violation|0
5532867|NCT01377233|19126523|P5|Double-blind|Adverse Event|0
5532868|NCT01377233|19126524|P4|Double-blind|Adverse Event|2
5532869|NCT01377233|19126525|P3|Double-blind|Adverse Event|2
5532870|NCT01377233|19126526|P2|Double-blind|Adverse Event|1
5532871|NCT01377233|19126527|P1|Double-blind|Adverse Event|0
5532872|NCT01377233|19126523|P5|Open-label|Withdrawal by Subject|0
5532873|NCT01377233|19126524|P4|Open-label|Withdrawal by Subject|0
5532874|NCT01377233|19126525|P3|Open-label|Withdrawal by Subject|0
5532875|NCT01377233|19126526|P2|Open-label|Withdrawal by Subject|0
5532876|NCT01377233|19126527|P1|Open-label|Withdrawal by Subject|3
5532877|NCT01377233|19126523|P5|Open-label|Adverse Event|0
5532878|NCT01377233|19126524|P4|Open-label|Adverse Event|0
5532879|NCT01377233|19126525|P3|Open-label|Adverse Event|0
5532880|NCT01377233|19126526|P2|Open-label|Adverse Event|0
5532881|NCT01377233|19126527|P1|Open-label|Adverse Event|1
5532882|NCT01377194|19126554|P3|Overall Study|Lost to Follow-up|11
5532883|NCT01377194|19126555|P2|Overall Study|Lost to Follow-up|8
5532884|NCT01377194|19126556|P1|Overall Study|Lost to Follow-up|14
5532885|NCT01377194|19126554|P3|Overall Study|Withdrawal by Subject|7
5532886|NCT01377194|19126555|P2|Overall Study|Withdrawal by Subject|10
5532887|NCT01377194|19126556|P1|Overall Study|Withdrawal by Subject|8
5532888|NCT01377194|19126554|P3|Overall Study|Protocol Violation|6
5532889|NCT01377194|19126555|P2|Overall Study|Protocol Violation|10
5532890|NCT01377194|19126556|P1|Overall Study|Protocol Violation|4
5532891|NCT01377194|19126554|P3|Overall Study|Lack of Efficacy|3
5532892|NCT01377194|19126555|P2|Overall Study|Lack of Efficacy|3
5532893|NCT01377194|19126556|P1|Overall Study|Lack of Efficacy|3
5532894|NCT01377194|19126554|P3|Overall Study|Adverse Event|19
5532895|NCT01377194|19126555|P2|Overall Study|Adverse Event|12
5532896|NCT01377194|19126556|P1|Overall Study|Adverse Event|3
5532897|NCT01377012|19126570|P3|Extension Study, Weeks 104-260|Adverse Event|1
5532898|NCT01377012|19126571|P2|Extension Study, Weeks 104-260|Adverse Event|2
5532899|NCT01377012|19126572|P1|Extension Study, Weeks 104-260|Adverse Event|0
5532900|NCT01377012|19126570|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
5532901|NCT01377012|19126571|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
5532902|NCT01377012|19126572|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
5532903|NCT01377012|19126570|P3|Extension Study, Weeks 104-260|Physician Decision|0
5532904|NCT01377012|19126571|P2|Extension Study, Weeks 104-260|Physician Decision|0
5532905|NCT01377012|19126572|P1|Extension Study, Weeks 104-260|Physician Decision|1
5532906|NCT01377012|19126570|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
5532907|NCT01377012|19126571|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
5532908|NCT01377012|19126572|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
5532909|NCT01377012|19126570|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
5532910|NCT01377012|19126571|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
5532911|NCT01377012|19126572|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
5532912|NCT01377012|19126570|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
5532913|NCT01377012|19126571|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
5532914|NCT01377012|19126572|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
5532915|NCT01377012|19126570|P3|Core Study|Adverse Event|13
5532916|NCT01377012|19126571|P2|Core Study|Adverse Event|14
5532917|NCT01377012|19126572|P1|Core Study|Adverse Event|10
5532918|NCT01377012|19126570|P3|Core Study|Death|1
5532919|NCT01377012|19126571|P2|Core Study|Death|1
5532920|NCT01377012|19126572|P1|Core Study|Death|1
5532921|NCT01377012|19126570|P3|Core Study|Lack of Efficacy|37
5532922|NCT01377012|19126571|P2|Core Study|Lack of Efficacy|28
5532923|NCT01377012|19126572|P1|Core Study|Lack of Efficacy|41
5532924|NCT01377012|19126570|P3|Core Study|Lost to Follow-up|4
5532925|NCT01377012|19126571|P2|Core Study|Lost to Follow-up|5
5532926|NCT01377012|19126572|P1|Core Study|Lost to Follow-up|7
5532927|NCT01377012|19126570|P3|Core Study|No Longer require treatment|1
5532928|NCT01377012|19126571|P2|Core Study|No Longer require treatment|0
5532929|NCT01377012|19126572|P1|Core Study|No Longer require treatment|0
5532930|NCT01377012|19126570|P3|Core Study|Non-Compliant with study treatment|1
5532931|NCT01377012|19126571|P2|Core Study|Non-Compliant with study treatment|0
5532932|NCT01377012|19126572|P1|Core Study|Non-Compliant with study treatment|0
5532933|NCT01377012|19126570|P3|Core Study|Physician Decision|10
5532934|NCT01377012|19126571|P2|Core Study|Physician Decision|4
5532935|NCT01377012|19126572|P1|Core Study|Physician Decision|5
5532936|NCT01377012|19126570|P3|Core Study|Pregnancy|1
5532937|NCT01377012|19126571|P2|Core Study|Pregnancy|0
5532938|NCT01377012|19126572|P1|Core Study|Pregnancy|0
5532939|NCT01377012|19126570|P3|Core Study|Protocol Violation|2
5532940|NCT01377012|19126571|P2|Core Study|Protocol Violation|3
5532941|NCT01377012|19126572|P1|Core Study|Protocol Violation|7
5532942|NCT01377012|19126570|P3|Core Study|Withdrawal by Subject|18
5532943|NCT01377012|19126571|P2|Core Study|Withdrawal by Subject|23
5532944|NCT01377012|19126572|P1|Core Study|Withdrawal by Subject|15
5532945|NCT01377012|19126570|P3|Core Study|Technical problems|0
5532946|NCT01377012|19126571|P2|Core Study|Technical problems|0
5532947|NCT01377012|19126572|P1|Core Study|Technical problems|1
5532948|NCT01377012|19126570|P3|Core Study|Study terminated by Sponsor|46
5532949|NCT01377012|19126571|P2|Core Study|Study terminated by Sponsor|54
5532950|NCT01377012|19126572|P1|Core Study|Study terminated by Sponsor|47
5532951|NCT01376908|19126609|P2|Overall Study|Withdrawal by Subject|2
5532952|NCT01376908|19126610|P1|Overall Study|Withdrawal by Subject|1
5532953|NCT01376908|19126609|P2|Overall Study|Protocol Violation|1
5532954|NCT01376908|19126610|P1|Overall Study|Protocol Violation|1
5532955|NCT01376804|19126643|P1|Treatment Period|Patient did not receive study drug|1
5532956|NCT01376804|19126643|P1|Treatment Period|Adverse Event|6
5532957|NCT01376804|19126643|P1|Treatment Period|Withdrawal by Subject|1
5532958|NCT01376700|19126654|P1|Overall Study|Low or high titer inhibitor|8
5532959|NCT01376700|19126654|P1|Overall Study|Sponsor terminated study early|8
5532960|NCT01376388|19126716|P1|Overall Study|Withdrawal by Subject|3
5532961|NCT01376388|19126716|P1|Overall Study|Lack of Efficacy|2
5532962|NCT01376388|19126716|P1|Overall Study|Adverse Event|13
5532963|NCT01376349|19126754|P3|Raondomized Treatment|Alternative Treatment|1
5532964|NCT01376349|19126755|P2|Raondomized Treatment|Alternative Treatment|0
5532965|NCT01376349|19126756|P1|Raondomized Treatment|Alternative Treatment|0
5532966|NCT01376349|19126754|P3|Raondomized Treatment|Unkown|1
5532967|NCT01376349|19126755|P2|Raondomized Treatment|Unkown|2
5532968|NCT01376349|19126756|P1|Raondomized Treatment|Unkown|1
5532969|NCT01376349|19126754|P3|Raondomized Treatment|Adverse Event|14
5532970|NCT01376349|19126755|P2|Raondomized Treatment|Adverse Event|17
5532971|NCT01376349|19126756|P1|Raondomized Treatment|Adverse Event|13
5532972|NCT01376349|19126754|P3|Raondomized Treatment|Withdrawal by Subject|13
5532973|NCT01376349|19126755|P2|Raondomized Treatment|Withdrawal by Subject|16
5532974|NCT01376349|19126756|P1|Raondomized Treatment|Withdrawal by Subject|10
5532975|NCT01376323|19126770|P5|Overall Study|Withdrawal by Subject|0
5532976|NCT01376323|19126771|P4|Overall Study|Withdrawal by Subject|0
5532977|NCT01376323|19126772|P3|Overall Study|Withdrawal by Subject|1
5532978|NCT01376323|19126773|P2|Overall Study|Withdrawal by Subject|1
5532979|NCT01376323|19126774|P1|Overall Study|Withdrawal by Subject|0
5532980|NCT01376323|19126770|P5|Overall Study|Physician Decision|1
5532981|NCT01376323|19126771|P4|Overall Study|Physician Decision|1
5532982|NCT01376323|19126772|P3|Overall Study|Physician Decision|2
5532983|NCT01376323|19126773|P2|Overall Study|Physician Decision|0
5532984|NCT01376323|19126774|P1|Overall Study|Physician Decision|1
5532985|NCT01376323|19126770|P5|Overall Study|Lost to Follow-up|0
5532986|NCT01376323|19126771|P4|Overall Study|Lost to Follow-up|2
5532987|NCT01376323|19126772|P3|Overall Study|Lost to Follow-up|0
5532988|NCT01376323|19126773|P2|Overall Study|Lost to Follow-up|0
5532989|NCT01376323|19126774|P1|Overall Study|Lost to Follow-up|0
5532990|NCT01376323|19126770|P5|Overall Study|Adverse Event|0
5532991|NCT01376323|19126771|P4|Overall Study|Adverse Event|2
5532992|NCT01376323|19126772|P3|Overall Study|Adverse Event|0
5532993|NCT01376323|19126773|P2|Overall Study|Adverse Event|0
5532994|NCT01376323|19126774|P1|Overall Study|Adverse Event|1
5532995|NCT01376310|19126858|P2|Overall Study|Lost to Follow-up|0
5532996|NCT01376310|19126859|P1|Overall Study|Lost to Follow-up|1
5532997|NCT01376310|19126858|P2|Overall Study|Physician Decision|7
5532998|NCT01376310|19126859|P1|Overall Study|Physician Decision|26
5532999|NCT01376310|19126858|P2|Overall Study|Withdrawal by Subject|2
5533000|NCT01376310|19126859|P1|Overall Study|Withdrawal by Subject|8
5533001|NCT01376310|19126858|P2|Overall Study|Study closed/terminated|2
5533002|NCT01376310|19126859|P1|Overall Study|Study closed/terminated|1
5533003|NCT01376245|19126878|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
5533004|NCT01376245|19126879|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
5533005|NCT01376245|19126880|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5533006|NCT01376245|19126881|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
5533007|NCT01376245|19126882|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5533008|NCT01376245|19126878|P5|24-week, Double-blind Treatment Period|Physician Decision|0
5533009|NCT01376245|19126879|P4|24-week, Double-blind Treatment Period|Physician Decision|1
5533010|NCT01376245|19126880|P3|24-week, Double-blind Treatment Period|Physician Decision|1
5533011|NCT01376245|19126881|P2|24-week, Double-blind Treatment Period|Physician Decision|0
5533012|NCT01376245|19126882|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5533013|NCT01376245|19126878|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5533014|NCT01376245|19126879|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5533015|NCT01376245|19126880|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5533016|NCT01376245|19126881|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5533017|NCT01376245|19126882|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5533018|NCT01376245|19126878|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5533019|NCT01376245|19126879|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
5533020|NCT01376245|19126880|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
5533021|NCT01376245|19126881|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
5533022|NCT01376245|19126882|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5533023|NCT01376245|19126878|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
5533024|NCT01376245|19126879|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
5533025|NCT01376245|19126880|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
5533026|NCT01376245|19126881|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
5533027|NCT01376245|19126882|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5533028|NCT01376245|19126878|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
5533029|NCT01376245|19126879|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
5533030|NCT01376245|19126880|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
5533031|NCT01376245|19126881|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
5533032|NCT01376245|19126882|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
5533033|NCT01376245|19126878|P5|24-week, Double-blind Treatment Period|Adverse Event|18
5533034|NCT01376245|19126879|P4|24-week, Double-blind Treatment Period|Adverse Event|8
5533035|NCT01376245|19126880|P3|24-week, Double-blind Treatment Period|Adverse Event|7
5533036|NCT01376245|19126881|P2|24-week, Double-blind Treatment Period|Adverse Event|16
5533037|NCT01376245|19126882|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5533038|NCT01376245|19126878|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5533039|NCT01376245|19126879|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5533040|NCT01376245|19126880|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5533041|NCT01376245|19126881|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
5533042|NCT01376245|19126882|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
5533043|NCT01376245|19126878|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5533044|NCT01376245|19126879|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5533045|NCT01376245|19126880|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5533046|NCT01376245|19126881|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
5533047|NCT01376245|19126882|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
5533048|NCT01376245|19126878|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5533049|NCT01376245|19126879|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5533050|NCT01376245|19126880|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5533051|NCT01376245|19126881|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
5533052|NCT01376245|19126882|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
5533053|NCT01376245|19126878|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5533054|NCT01376245|19126879|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5533055|NCT01376245|19126880|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5533056|NCT01376245|19126881|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
5533057|NCT01376245|19126882|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
5533058|NCT01376245|19126878|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5533059|NCT01376245|19126879|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5533060|NCT01376245|19126880|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5533061|NCT01376245|19126881|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
5533062|NCT01376245|19126882|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
5533063|NCT01376167|19126899|P3|Overall Study|Withdrawal by Subject|4
5533064|NCT01376167|19126900|P2|Overall Study|Withdrawal by Subject|5
5533065|NCT01376167|19126901|P1|Overall Study|Withdrawal by Subject|1
5533066|NCT01376167|19126899|P3|Overall Study|Physician Decision|0
5533067|NCT01376167|19126900|P2|Overall Study|Physician Decision|1
5533068|NCT01376167|19126901|P1|Overall Study|Physician Decision|1
5533069|NCT01376167|19126899|P3|Overall Study|Lost to Follow-up|2
5533070|NCT01376167|19126900|P2|Overall Study|Lost to Follow-up|4
5533071|NCT01376167|19126901|P1|Overall Study|Lost to Follow-up|2
5533072|NCT01376089|19126972|P2|Overall Study|Patient received no contrast media|4
5533073|NCT01376089|19126973|P1|Overall Study|Patient received no contrast media|3
5533074|NCT01376037|19126996|P2|Overall Study|Lost to Follow-up|2
5533075|NCT01376037|19126997|P1|Overall Study|Lost to Follow-up|0
5533076|NCT01375959|19127005|P2|Second Intervention (6 Weeks)|Adverse Event|2
5533077|NCT01375959|19127006|P1|Second Intervention (6 Weeks)|Adverse Event|0
5533078|NCT01375959|19127005|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|1
5533079|NCT01375959|19127006|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|0
5533080|NCT01375959|19127005|P2|First Intervention (6 Weeks)|Adverse Event|3
5533081|NCT01375959|19127006|P1|First Intervention (6 Weeks)|Adverse Event|2
5533082|NCT01375777|19127034|P9|Overall Study|Other|1
5533083|NCT01375777|19127035|P8|Overall Study|Other|0
5533084|NCT01375777|19127036|P7|Overall Study|Other|0
5533085|NCT01375777|19127037|P6|Overall Study|Other|0
5533086|NCT01375777|19127038|P5|Overall Study|Other|0
5533087|NCT01375777|19127039|P4|Overall Study|Other|0
5533088|NCT01375777|19127040|P3|Overall Study|Other|0
5533089|NCT01375777|19127041|P2|Overall Study|Other|1
5533090|NCT01375777|19127042|P1|Overall Study|Other|1
5533091|NCT01375777|19127034|P9|Overall Study|Lost to Follow-up|0
5533092|NCT01375777|19127035|P8|Overall Study|Lost to Follow-up|0
5533093|NCT01375777|19127036|P7|Overall Study|Lost to Follow-up|1
5533094|NCT01375777|19127037|P6|Overall Study|Lost to Follow-up|0
5533095|NCT01375777|19127038|P5|Overall Study|Lost to Follow-up|0
5533096|NCT01375777|19127039|P4|Overall Study|Lost to Follow-up|0
5533097|NCT01375777|19127040|P3|Overall Study|Lost to Follow-up|0
5533098|NCT01375777|19127041|P2|Overall Study|Lost to Follow-up|0
5533099|NCT01375777|19127042|P1|Overall Study|Lost to Follow-up|1
5533100|NCT01375777|19127034|P9|Overall Study|Withdrawal by Subject|1
5533101|NCT01375777|19127035|P8|Overall Study|Withdrawal by Subject|2
5533102|NCT01375777|19127036|P7|Overall Study|Withdrawal by Subject|1
5533103|NCT01375777|19127037|P6|Overall Study|Withdrawal by Subject|1
5533104|NCT01375777|19127038|P5|Overall Study|Withdrawal by Subject|1
5533105|NCT01375777|19127039|P4|Overall Study|Withdrawal by Subject|0
5533106|NCT01375777|19127040|P3|Overall Study|Withdrawal by Subject|1
5533107|NCT01375777|19127041|P2|Overall Study|Withdrawal by Subject|2
5533108|NCT01375777|19127042|P1|Overall Study|Withdrawal by Subject|0
5533109|NCT01375764|19127112|P5|Overall Study|Other|0
5533110|NCT01375764|19127113|P4|Overall Study|Other|1
5533111|NCT01375764|19127114|P3|Overall Study|Other|0
5533112|NCT01375764|19127115|P2|Overall Study|Other|0
5533113|NCT01375764|19127116|P1|Overall Study|Other|0
5533114|NCT01375764|19127112|P5|Overall Study|Withdrawal by Subject|1
5533115|NCT01375764|19127113|P4|Overall Study|Withdrawal by Subject|0
5533116|NCT01375764|19127114|P3|Overall Study|Withdrawal by Subject|0
5533117|NCT01375764|19127115|P2|Overall Study|Withdrawal by Subject|0
5533118|NCT01375764|19127116|P1|Overall Study|Withdrawal by Subject|2
5533119|NCT01375764|19127112|P5|Overall Study|Lost to Follow-up|0
5533120|NCT01375764|19127113|P4|Overall Study|Lost to Follow-up|0
5533121|NCT01375764|19127114|P3|Overall Study|Lost to Follow-up|0
5533122|NCT01375764|19127115|P2|Overall Study|Lost to Follow-up|1
5533123|NCT01375764|19127116|P1|Overall Study|Lost to Follow-up|0
5533124|NCT01375751|19127162|P3|Overall Study|Other|0
5533125|NCT01375751|19127163|P2|Overall Study|Other|1
5533126|NCT01375751|19127164|P1|Overall Study|Other|0
5533127|NCT01375673|19127189|P2|Overall Study|Withdrawal by Subject|1
5533128|NCT01375673|19127190|P1|Overall Study|Withdrawal by Subject|0
5533129|NCT01375608|19127221|P1|Overall Study|Withdrawal by Subject|2
5533130|NCT01375374|19127249|P1|Overall Study|Adverse Event|1
5533131|NCT01375205|19127258|P2|Overall Study|Withdrawal by Subject|1
5533132|NCT01375205|19127259|P1|Overall Study|Withdrawal by Subject|6
5533133|NCT01375205|19127258|P2|Overall Study|Lost to Follow-up|12
5533134|NCT01375205|19127259|P1|Overall Study|Lost to Follow-up|15
5533135|NCT01375075|19127332|P6|Overall Study|Withdrawal by Subject|1
5533136|NCT01375075|19127333|P5|Overall Study|Withdrawal by Subject|0
5533137|NCT01375075|19127334|P4|Overall Study|Withdrawal by Subject|0
5533138|NCT01375075|19127335|P3|Overall Study|Withdrawal by Subject|0
5533139|NCT01375075|19127336|P2|Overall Study|Withdrawal by Subject|1
5533140|NCT01375075|19127337|P1|Overall Study|Withdrawal by Subject|0
5533141|NCT01375075|19127332|P6|Overall Study|Entry Criterion Not Met|1
5533142|NCT01375075|19127333|P5|Overall Study|Entry Criterion Not Met|0
5533143|NCT01375075|19127334|P4|Overall Study|Entry Criterion Not Met|0
5533144|NCT01375075|19127335|P3|Overall Study|Entry Criterion Not Met|0
5533145|NCT01375075|19127336|P2|Overall Study|Entry Criterion Not Met|0
5533146|NCT01375075|19127337|P1|Overall Study|Entry Criterion Not Met|1
5533147|NCT01375075|19127332|P6|Overall Study|Adverse Event|1
5533148|NCT01375075|19127333|P5|Overall Study|Adverse Event|0
5533149|NCT01375075|19127334|P4|Overall Study|Adverse Event|1
5533150|NCT01375075|19127335|P3|Overall Study|Adverse Event|3
5533151|NCT01375075|19127336|P2|Overall Study|Adverse Event|0
5533152|NCT01375075|19127337|P1|Overall Study|Adverse Event|0
5533153|NCT01375049|19127421|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
5533154|NCT01375049|19127421|P1|Overall Study|Withdrawal by Subject|2
5533155|NCT01375049|19127421|P1|Overall Study|Lost to Follow-up|1
5533156|NCT01375049|19127421|P1|Overall Study|Adverse Event|2
5533157|NCT01375010|19127438|P2|Overall Study|Withdrawal by Subject|2
5533158|NCT01375010|19127439|P1|Overall Study|Withdrawal by Subject|4
5533159|NCT01375010|19127438|P2|Overall Study|Lost to Follow-up|2
5533160|NCT01375010|19127439|P1|Overall Study|Lost to Follow-up|8
5533161|NCT01374971|19127453|P1|Overall Study|Withdrawal by Subject|1
5533162|NCT01374919|19127458|P1|Overall Study|Withdrawal by Subject|2
5533163|NCT01374906|19127465|P2|Overall Study|Unsatisfactory therapeutic effect|19
5533164|NCT01374906|19127466|P1|Overall Study|Unsatisfactory therapeutic effect|11
5533165|NCT01374906|19127465|P2|Overall Study|Withdrawal by Subject|9
5533166|NCT01374906|19127466|P1|Overall Study|Withdrawal by Subject|15
5533167|NCT01374906|19127465|P2|Overall Study|Protocol Violation|2
5533168|NCT01374906|19127466|P1|Overall Study|Protocol Violation|2
5533169|NCT01374906|19127465|P2|Overall Study|Death|2
5533170|NCT01374906|19127466|P1|Overall Study|Death|0
5533171|NCT01374906|19127465|P2|Overall Study|Adverse Event|11
5533172|NCT01374906|19127466|P1|Overall Study|Adverse Event|10
5533173|NCT01374906|19127465|P2|Overall Study|Administrative problems|2
5533174|NCT01374906|19127466|P1|Overall Study|Administrative problems|2
5533175|NCT01374906|19127465|P2|Overall Study|Abnormal laboratory value(s)|3
5533176|NCT01374906|19127466|P1|Overall Study|Abnormal laboratory value(s)|0
5533177|NCT01374568|19127547|P2|Overall Study|Lab unable to analyze BTM|2
5533178|NCT01374568|19127548|P1|Overall Study|Lab unable to analyze BTM|0
5533179|NCT01374516|19127558|P2|Surveillance Expansion Period|Serious adverse event|5
5533180|NCT01374516|19127559|P1|Surveillance Expansion Period|Serious adverse event|20
5533181|NCT01374516|19127558|P2|Surveillance Expansion Period|Lost to Follow-up|45
5533182|NCT01374516|19127559|P1|Surveillance Expansion Period|Lost to Follow-up|73
5533183|NCT01374516|19127558|P2|Surveillance Expansion Period|Withdrawal by Subject|986
5533184|NCT01374516|19127559|P1|Surveillance Expansion Period|Withdrawal by Subject|1870
5533185|NCT01374516|19127558|P2|Surveillance Expansion Period|Protocol Violation|217
5533186|NCT01374516|19127559|P1|Surveillance Expansion Period|Protocol Violation|386
5533187|NCT01374516|19127558|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
5533188|NCT01374516|19127559|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
5533189|NCT01374516|19127558|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
5533190|NCT01374516|19127559|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
5533191|NCT01374516|19127558|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
5533192|NCT01374516|19127559|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
5533193|NCT01374516|19127558|P2|Vaccination Phase (Up to 25 Months)|Adverse Event|0
5533194|NCT01374516|19127559|P1|Vaccination Phase (Up to 25 Months)|Adverse Event|3
5533195|NCT01374516|19127558|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
5533196|NCT01374516|19127559|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
5533197|NCT01374451|19127597|P2|Overall Study|Administrative problems|0
5533198|NCT01374451|19127598|P1|Overall Study|Administrative problems|1
5533199|NCT01374425|19127644|P2|Overall Study|Other|43
5533200|NCT01374425|19127645|P1|Overall Study|Other|41
5533201|NCT01374425|19127644|P2|Overall Study|Lost to Follow-up|1
5533202|NCT01374425|19127645|P1|Overall Study|Lost to Follow-up|2
5533203|NCT01374425|19127644|P2|Overall Study|Sponsor Decision|1
5533204|NCT01374425|19127645|P1|Overall Study|Sponsor Decision|0
5533205|NCT01374425|19127644|P2|Overall Study|Protocol Violation|3
5533206|NCT01374425|19127645|P1|Overall Study|Protocol Violation|2
5533207|NCT01374425|19127644|P2|Overall Study|Refused Treatment|24
5533208|NCT01374425|19127645|P1|Overall Study|Refused Treatment|10
5533209|NCT01374425|19127644|P2|Overall Study|Withdrawal by Subject|7
5533210|NCT01374425|19127645|P1|Overall Study|Withdrawal by Subject|6
5533211|NCT01374425|19127644|P2|Overall Study|Death (Adverse Event)|4
5533212|NCT01374425|19127645|P1|Overall Study|Death (Adverse Event)|2
5533213|NCT01374425|19127644|P2|Overall Study|Death (Progression of Disease)|0
5533214|NCT01374425|19127645|P1|Overall Study|Death (Progression of Disease)|1
5533215|NCT01374425|19127644|P2|Overall Study|Adverse Event|18
5533216|NCT01374425|19127645|P1|Overall Study|Adverse Event|29
5533217|NCT01374425|19127644|P2|Overall Study|Clinical Disease Progression|6
5533218|NCT01374425|19127645|P1|Overall Study|Clinical Disease Progression|9
5533219|NCT01374425|19127644|P2|Overall Study|Radiographic Disease Progression|81
5533220|NCT01374425|19127645|P1|Overall Study|Radiographic Disease Progression|86
5533221|NCT01374269|19127725|P2|Overall Study|closed research|2
5533222|NCT01374269|19127726|P1|Overall Study|closed research|1
5533223|NCT01374269|19127725|P2|Overall Study|Lost to Follow-up|3
5533224|NCT01374269|19127726|P1|Overall Study|Lost to Follow-up|1
5533225|NCT01374269|19127725|P2|Overall Study|Withdrawal by Subject|0
5533226|NCT01374269|19127726|P1|Overall Study|Withdrawal by Subject|4
5533227|NCT01374217|19127854|P1|Overall Study|Lack of Efficacy|13
5533228|NCT01374178|19127862|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
5533229|NCT01374178|19127863|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
5533230|NCT01374178|19127862|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
5533231|NCT01374178|19127863|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
5533232|NCT01374087|19127881|P2|Overall Study|Study discontinued|13
5533233|NCT01374087|19127882|P1|Overall Study|Study discontinued|13
5533234|NCT01374087|19127881|P2|Overall Study|Disease progression|2
5533235|NCT01374087|19127882|P1|Overall Study|Disease progression|2
5533236|NCT01374087|19127881|P2|Overall Study|Adverse Event|0
5533237|NCT01374087|19127882|P1|Overall Study|Adverse Event|1
5533238|NCT01373931|19127902|P2|Period 1|Withdrawal by Subject|2
5533239|NCT01373931|19127903|P1|Period 1|Withdrawal by Subject|0
5533240|NCT01373931|19127902|P2|Period 1|Adverse Event|0
5533241|NCT01373931|19127903|P1|Period 1|Adverse Event|2
5533242|NCT01373931|19127902|P2|Lead-in Period|Adverse Event|0
5533243|NCT01373931|19127903|P1|Lead-in Period|Adverse Event|2
5533244|NCT01373918|19127916|P2|Overall Study|Physician Decision|1
5533245|NCT01373918|19127917|P1|Overall Study|Physician Decision|0
5533246|NCT01373346|19127976|P1|Overall Study|Death|1
5533247|NCT01373294|19127999|P2|Overall Study|Adverse Event|0
5533248|NCT01373294|19128000|P1|Overall Study|Adverse Event|1
5533249|NCT01373281|19128009|P2|Surveillance Expansion Period|Serious adverse event|4
5533250|NCT01373281|19128010|P1|Surveillance Expansion Period|Serious adverse event|3
5533251|NCT01373281|19128009|P2|Surveillance Expansion Period|Lost to Follow-up|8
5533252|NCT01373281|19128010|P1|Surveillance Expansion Period|Lost to Follow-up|10
5533253|NCT01373281|19128009|P2|Surveillance Expansion Period|Protocol Violation|1
5533254|NCT01373281|19128010|P1|Surveillance Expansion Period|Protocol Violation|9
5533255|NCT01373281|19128009|P2|Surveillance Expansion Period|Withdrawal by Subject|105
5533256|NCT01373281|19128010|P1|Surveillance Expansion Period|Withdrawal by Subject|180
5533257|NCT01373281|19128009|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
5533258|NCT01373281|19128010|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
5533259|NCT01373281|19128009|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
5533260|NCT01373281|19128010|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
5533261|NCT01373281|19128009|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
5533262|NCT01373281|19128010|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
5533263|NCT01373281|19128009|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
5533264|NCT01373281|19128010|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
5533265|NCT01373229|19128058|P1|Overall Study|Physician Decision|3
5533266|NCT01373229|19128058|P1|Overall Study|Death|3
5533267|NCT01373164|19128072|P5|Overall Study|Withdrawal by Subject|2
5533268|NCT01373164|19128073|P4|Overall Study|Withdrawal by Subject|10
5533269|NCT01373164|19128074|P3|Overall Study|Withdrawal by Subject|0
5533270|NCT01373164|19128075|P2|Overall Study|Withdrawal by Subject|1
5533271|NCT01373164|19128076|P1|Overall Study|Withdrawal by Subject|0
5533272|NCT01373164|19128072|P5|Overall Study|Lost to Follow-up|0
5533273|NCT01373164|19128073|P4|Overall Study|Lost to Follow-up|2
5533274|NCT01373164|19128074|P3|Overall Study|Lost to Follow-up|1
5533275|NCT01373164|19128075|P2|Overall Study|Lost to Follow-up|0
5533276|NCT01373164|19128076|P1|Overall Study|Lost to Follow-up|0
5533277|NCT01372995|19128110|P3|Overall Study|Physician Decision|1
5533278|NCT01372995|19128111|P2|Overall Study|Physician Decision|0
5533279|NCT01372995|19128112|P1|Overall Study|Physician Decision|0
5533280|NCT01372995|19128110|P3|Overall Study|Spouse withdrew participant from study|0
5533281|NCT01372995|19128111|P2|Overall Study|Spouse withdrew participant from study|1
5533282|NCT01372995|19128112|P1|Overall Study|Spouse withdrew participant from study|0
5533283|NCT01372878|19128159|P1|Overall Study|incomplete study procedure|104
5533284|NCT01372878|19128159|P1|Overall Study|Protocol Violation|17
5533285|NCT01372878|19128159|P1|Overall Study|Withdrawal by Subject|63
5533286|NCT01372774|19128179|P2|Overall Study|Withdrawal prior to treatment|5
5533287|NCT01372774|19128180|P1|Overall Study|Withdrawal prior to treatment|4
5533288|NCT01372748|19128196|P2|Overall Study|Withdrawal by Subject|5
5533289|NCT01372748|19128197|P1|Overall Study|Withdrawal by Subject|7
5533290|NCT01372748|19128196|P2|Overall Study|Lost to Follow-up|34
5533291|NCT01372748|19128197|P1|Overall Study|Lost to Follow-up|16
5533292|NCT01372618|19128205|P1|Overall Study|PI Died. Study Terminated|9
5533293|NCT01372605|19128213|P2|Overall Study|Changed medical home|0
5533294|NCT01372605|19128214|P1|Overall Study|Changed medical home|2
5533295|NCT01372605|19128213|P2|Overall Study|Moved|0
5533296|NCT01372605|19128214|P1|Overall Study|Moved|3
5533297|NCT01372605|19128213|P2|Overall Study|Withdrawal by Subject|7
5533298|NCT01372605|19128214|P1|Overall Study|Withdrawal by Subject|4
5533299|NCT01372605|19128213|P2|Overall Study|Lost to Follow-up|1
5533300|NCT01372605|19128214|P1|Overall Study|Lost to Follow-up|2
5533301|NCT01372605|19128213|P2|Overall Study|Death|2
5533302|NCT01372605|19128214|P1|Overall Study|Death|1
5533303|NCT01372501|19128240|P1|Overall Study|Device migration|1
5533304|NCT01372501|19128240|P1|Overall Study|Adverse Event|4
5533305|NCT01372410|19128263|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
5533306|NCT01372410|19128264|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
5533307|NCT01372410|19128265|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
5533308|NCT01372410|19128266|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
5533309|NCT01372410|19128267|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
5533310|NCT01372410|19128268|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
5533311|NCT01372410|19128269|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
5533312|NCT01372410|19128270|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
5533313|NCT01372410|19128263|P8|Treatment Period 3 (7 Days)|Adverse Event|0
5533314|NCT01372410|19128264|P7|Treatment Period 3 (7 Days)|Adverse Event|0
5533315|NCT01372410|19128265|P6|Treatment Period 3 (7 Days)|Adverse Event|0
5533316|NCT01372410|19128266|P5|Treatment Period 3 (7 Days)|Adverse Event|0
5533317|NCT01372410|19128267|P4|Treatment Period 3 (7 Days)|Adverse Event|0
5533318|NCT01372410|19128268|P3|Treatment Period 3 (7 Days)|Adverse Event|1
5533319|NCT01372410|19128269|P2|Treatment Period 3 (7 Days)|Adverse Event|0
5533320|NCT01372410|19128270|P1|Treatment Period 3 (7 Days)|Adverse Event|0
5533321|NCT01372410|19128263|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
5533322|NCT01372410|19128264|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5533323|NCT01372410|19128265|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5533324|NCT01372410|19128266|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5533325|NCT01372410|19128267|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5533326|NCT01372410|19128268|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5533327|NCT01372410|19128269|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5533328|NCT01372410|19128270|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
5533329|NCT01372410|19128263|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
5533330|NCT01372410|19128264|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
5533331|NCT01372410|19128265|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5533332|NCT01372410|19128266|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
5533333|NCT01372410|19128267|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5533334|NCT01372410|19128268|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5533335|NCT01372410|19128269|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5533336|NCT01372410|19128270|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
5533337|NCT01372410|19128263|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
5533338|NCT01372410|19128264|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
5533339|NCT01372410|19128265|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
5533340|NCT01372410|19128266|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
5533341|NCT01372410|19128267|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
5533342|NCT01372410|19128268|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
5533343|NCT01372410|19128269|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
5533344|NCT01372410|19128270|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
5533345|NCT01372410|19128263|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
5533346|NCT01372410|19128264|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5533347|NCT01372410|19128265|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5533348|NCT01372410|19128266|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5533349|NCT01372410|19128267|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5533350|NCT01372410|19128268|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5533351|NCT01372410|19128269|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
5533352|NCT01372410|19128270|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
5533353|NCT01372410|19128263|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5533354|NCT01372410|19128264|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
5533355|NCT01372410|19128265|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5533356|NCT01372410|19128266|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5533357|NCT01372410|19128267|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5533358|NCT01372410|19128268|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5533359|NCT01372410|19128269|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5533360|NCT01372410|19128270|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
5533361|NCT01372410|19128263|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5533362|NCT01372410|19128264|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5533363|NCT01372410|19128265|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5533364|NCT01372410|19128266|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
5533365|NCT01372410|19128267|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5533366|NCT01372410|19128268|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5533367|NCT01372410|19128269|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5533368|NCT01372410|19128270|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
5533369|NCT01372410|19128263|P8|Treatment Period 1 (7 Days)|Adverse Event|0
5533370|NCT01372410|19128264|P7|Treatment Period 1 (7 Days)|Adverse Event|1
5533371|NCT01372410|19128265|P6|Treatment Period 1 (7 Days)|Adverse Event|0
5533372|NCT01372410|19128266|P5|Treatment Period 1 (7 Days)|Adverse Event|0
5533373|NCT01372410|19128267|P4|Treatment Period 1 (7 Days)|Adverse Event|0
5533374|NCT01372410|19128268|P3|Treatment Period 1 (7 Days)|Adverse Event|0
5533375|NCT01372410|19128269|P2|Treatment Period 1 (7 Days)|Adverse Event|1
5533376|NCT01372410|19128270|P1|Treatment Period 1 (7 Days)|Adverse Event|0
5533377|NCT01372410|19128263|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5533378|NCT01372410|19128264|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5533379|NCT01372410|19128265|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5533380|NCT01372410|19128266|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
5533381|NCT01372410|19128267|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5533382|NCT01372410|19128268|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
5533383|NCT01372410|19128269|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
5533384|NCT01372410|19128270|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
5533385|NCT01372384|19128307|P1|Overall Study|Progression of disease|3
5533386|NCT01372150|19128348|P3|Overall Study|Randomized but not treated|0
5533387|NCT01372150|19128349|P2|Overall Study|Randomized but not treated|1
5533388|NCT01372150|19128350|P1|Overall Study|Randomized but not treated|0
5533389|NCT01372150|19128348|P3|Overall Study|Adverse Event|2
5533390|NCT01372150|19128349|P2|Overall Study|Adverse Event|1
5533391|NCT01372150|19128350|P1|Overall Study|Adverse Event|2
5533392|NCT01372150|19128348|P3|Overall Study|Other|2
5533393|NCT01372150|19128349|P2|Overall Study|Other|0
5533394|NCT01372150|19128350|P1|Overall Study|Other|1
5533395|NCT01372150|19128348|P3|Overall Study|Withdrawal by Subject|2
5533396|NCT01372150|19128349|P2|Overall Study|Withdrawal by Subject|7
5533397|NCT01372150|19128350|P1|Overall Study|Withdrawal by Subject|2
5533398|NCT01372150|19128348|P3|Overall Study|Protocol Violation|3
5533399|NCT01372150|19128349|P2|Overall Study|Protocol Violation|0
5533400|NCT01372150|19128350|P1|Overall Study|Protocol Violation|1
5533401|NCT01372150|19128348|P3|Overall Study|Lost to Follow-up|6
5533402|NCT01372150|19128349|P2|Overall Study|Lost to Follow-up|5
5533403|NCT01372150|19128350|P1|Overall Study|Lost to Follow-up|4
5533404|NCT01372150|19128348|P3|Overall Study|Lack of Efficacy|1
5533405|NCT01372150|19128349|P2|Overall Study|Lack of Efficacy|0
5533406|NCT01372150|19128350|P1|Overall Study|Lack of Efficacy|3
5533407|NCT01372085|19128377|P10|Washout Period 3|Withdrawal by Subject|0
5533408|NCT01372085|19128378|P9|Washout Period 3|Withdrawal by Subject|0
5533409|NCT01372085|19128379|P8|Washout Period 3|Withdrawal by Subject|0
5533410|NCT01372085|19128380|P7|Washout Period 3|Withdrawal by Subject|0
5533411|NCT01372085|19128381|P6|Washout Period 3|Withdrawal by Subject|2
5533412|NCT01372085|19128382|P5|Washout Period 3|Withdrawal by Subject|0
5533413|NCT01372085|19128383|P4|Washout Period 3|Withdrawal by Subject|0
5533414|NCT01372085|19128384|P3|Washout Period 3|Withdrawal by Subject|0
5533415|NCT01372085|19128385|P2|Washout Period 3|Withdrawal by Subject|0
5533416|NCT01372085|19128386|P1|Washout Period 3|Withdrawal by Subject|0
5533417|NCT01372085|19128377|P10|Washout Period 2|Physician Decision|0
5533418|NCT01372085|19128378|P9|Washout Period 2|Physician Decision|0
5533419|NCT01372085|19128379|P8|Washout Period 2|Physician Decision|0
5533420|NCT01372085|19128380|P7|Washout Period 2|Physician Decision|0
5533421|NCT01372085|19128381|P6|Washout Period 2|Physician Decision|0
5533422|NCT01372085|19128382|P5|Washout Period 2|Physician Decision|1
5533423|NCT01372085|19128383|P4|Washout Period 2|Physician Decision|0
5533424|NCT01372085|19128384|P3|Washout Period 2|Physician Decision|0
5533425|NCT01372085|19128385|P2|Washout Period 2|Physician Decision|0
5533426|NCT01372085|19128386|P1|Washout Period 2|Physician Decision|0
5533427|NCT01371994|19128418|P2|Overall Study|Miscellaneous Reasons|4
5533428|NCT01371994|19128419|P1|Overall Study|Miscellaneous Reasons|6
5533429|NCT01371994|19128418|P2|Overall Study|Physician Decision|1
5533430|NCT01371994|19128419|P1|Overall Study|Physician Decision|1
5533431|NCT01371994|19128418|P2|Overall Study|Randomized but Never Received Study Drug|6
5533432|NCT01371994|19128419|P1|Overall Study|Randomized but Never Received Study Drug|6
5533433|NCT01371994|19128418|P2|Overall Study|Protocol Violation|17
5533434|NCT01371994|19128419|P1|Overall Study|Protocol Violation|24
5533435|NCT01371994|19128418|P2|Overall Study|Lost to Follow-up|1
5533436|NCT01371994|19128419|P1|Overall Study|Lost to Follow-up|1
5533437|NCT01371994|19128418|P2|Overall Study|Withdrawal by Subject|7
5533438|NCT01371994|19128419|P1|Overall Study|Withdrawal by Subject|13
5533439|NCT01371994|19128418|P2|Overall Study|Lack of Efficacy|0
5533440|NCT01371994|19128419|P1|Overall Study|Lack of Efficacy|3
5533441|NCT01371994|19128418|P2|Overall Study|Adverse Event|6
5533442|NCT01371994|19128419|P1|Overall Study|Adverse Event|3
5533443|NCT01371981|19128467|P6|Overall Study|Did not start treatment|2
5533444|NCT01371981|19128468|P5|Overall Study|Did not start treatment|0
5533445|NCT01371981|19128469|P4|Overall Study|Did not start treatment|0
5533446|NCT01371981|19128470|P3|Overall Study|Did not start treatment|0
5533447|NCT01371981|19128471|P2|Overall Study|Did not start treatment|3
5533448|NCT01371981|19128472|P1|Overall Study|Did not start treatment|2
5533449|NCT01371981|19128467|P6|Overall Study|Ineligible|4
5533450|NCT01371981|19128468|P5|Overall Study|Ineligible|0
5533451|NCT01371981|19128469|P4|Overall Study|Ineligible|0
5533452|NCT01371981|19128470|P3|Overall Study|Ineligible|0
5533453|NCT01371981|19128471|P2|Overall Study|Ineligible|13
5533454|NCT01371981|19128472|P1|Overall Study|Ineligible|19
5533455|NCT01371981|19128467|P6|Overall Study|Withdrawal by Subject|3
5533456|NCT01371981|19128468|P5|Overall Study|Withdrawal by Subject|10
5533457|NCT01371981|19128469|P4|Overall Study|Withdrawal by Subject|2
5533458|NCT01371981|19128470|P3|Overall Study|Withdrawal by Subject|1
5533459|NCT01371981|19128471|P2|Overall Study|Withdrawal by Subject|19
5533460|NCT01371981|19128472|P1|Overall Study|Withdrawal by Subject|12
5533461|NCT01371981|19128467|P6|Overall Study|Physician Decision|3
5533462|NCT01371981|19128468|P5|Overall Study|Physician Decision|14
5533463|NCT01371981|19128469|P4|Overall Study|Physician Decision|7
5533464|NCT01371981|19128470|P3|Overall Study|Physician Decision|1
5533465|NCT01371981|19128471|P2|Overall Study|Physician Decision|63
5533466|NCT01371981|19128472|P1|Overall Study|Physician Decision|48
5533467|NCT01371981|19128467|P6|Overall Study|Lack of Efficacy|0
5533468|NCT01371981|19128468|P5|Overall Study|Lack of Efficacy|5
5533469|NCT01371981|19128469|P4|Overall Study|Lack of Efficacy|8
5533470|NCT01371981|19128470|P3|Overall Study|Lack of Efficacy|4
5533471|NCT01371981|19128471|P2|Overall Study|Lack of Efficacy|61
5533472|NCT01371981|19128472|P1|Overall Study|Lack of Efficacy|69
5533473|NCT01371981|19128467|P6|Overall Study|Death|2
5533474|NCT01371981|19128468|P5|Overall Study|Death|2
5533475|NCT01371981|19128469|P4|Overall Study|Death|0
5533476|NCT01371981|19128470|P3|Overall Study|Death|0
5533477|NCT01371981|19128471|P2|Overall Study|Death|16
5533478|NCT01371981|19128472|P1|Overall Study|Death|22
5533479|NCT01371981|19128467|P6|Overall Study|Adverse Event|0
5533480|NCT01371981|19128468|P5|Overall Study|Adverse Event|1
5533481|NCT01371981|19128469|P4|Overall Study|Adverse Event|4
5533482|NCT01371981|19128470|P3|Overall Study|Adverse Event|0
5533483|NCT01371981|19128471|P2|Overall Study|Adverse Event|17
5533484|NCT01371981|19128472|P1|Overall Study|Adverse Event|12
5533485|NCT01371877|19128531|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
5533486|NCT01371877|19128532|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
5533487|NCT01371851|19128544|P2|Overall Study|Blood Pressure outside study parameters|0
5533488|NCT01371851|19128545|P1|Overall Study|Blood Pressure outside study parameters|2
5533489|NCT01371851|19128544|P2|Overall Study|non study related adverse event|0
5533490|NCT01371851|19128545|P1|Overall Study|non study related adverse event|1
5533491|NCT01371851|19128544|P2|Overall Study|was arrested and put in jail|1
5533492|NCT01371851|19128545|P1|Overall Study|was arrested and put in jail|0
5533493|NCT01371851|19128544|P2|Overall Study|Lost to Follow-up|8
5533494|NCT01371851|19128545|P1|Overall Study|Lost to Follow-up|5
5533495|NCT01371838|19128553|P2|Overall Study|Surgery|0
5533496|NCT01371838|19128554|P1|Overall Study|Surgery|1
5533497|NCT01371838|19128553|P2|Overall Study|Lack of therapeutic response|1
5533498|NCT01371838|19128554|P1|Overall Study|Lack of therapeutic response|0
5533499|NCT01371838|19128553|P2|Overall Study|Last follow-up visit not conducted|0
5533500|NCT01371838|19128554|P1|Overall Study|Last follow-up visit not conducted|2
5533501|NCT01371838|19128553|P2|Overall Study|Investigator Decision|8
5533502|NCT01371838|19128554|P1|Overall Study|Investigator Decision|3
5533503|NCT01371838|19128553|P2|Overall Study|Protocol Violation|0
5533504|NCT01371838|19128554|P1|Overall Study|Protocol Violation|3
5533505|NCT01371838|19128553|P2|Overall Study|Death|4
5533506|NCT01371838|19128554|P1|Overall Study|Death|3
5533507|NCT01371838|19128553|P2|Overall Study|Lost to Follow-up|20
5533508|NCT01371838|19128554|P1|Overall Study|Lost to Follow-up|10
5533509|NCT01371838|19128553|P2|Overall Study|Withdrawal by Subject|33
5533510|NCT01371838|19128554|P1|Overall Study|Withdrawal by Subject|27
5533511|NCT01371825|19128590|P1|Overall Study|Death|4
5533512|NCT01371747|19128624|P6|Overall Study|Other Reasons|1
5533513|NCT01371747|19128625|P5|Overall Study|Other Reasons|0
5533514|NCT01371747|19128626|P4|Overall Study|Other Reasons|0
5533515|NCT01371747|19128627|P3|Overall Study|Other Reasons|2
5533516|NCT01371747|19128628|P2|Overall Study|Other Reasons|1
5533517|NCT01371747|19128629|P1|Overall Study|Other Reasons|2
5533518|NCT01371747|19128624|P6|Overall Study|Withdrawal by Subject|4
5533519|NCT01371747|19128625|P5|Overall Study|Withdrawal by Subject|2
5533520|NCT01371747|19128626|P4|Overall Study|Withdrawal by Subject|2
5533521|NCT01371747|19128627|P3|Overall Study|Withdrawal by Subject|5
5533522|NCT01371747|19128628|P2|Overall Study|Withdrawal by Subject|12
5533523|NCT01371747|19128629|P1|Overall Study|Withdrawal by Subject|6
5533524|NCT01371747|19128624|P6|Overall Study|Physician Decision|0
5533525|NCT01371747|19128625|P5|Overall Study|Physician Decision|1
5533526|NCT01371747|19128626|P4|Overall Study|Physician Decision|0
5533527|NCT01371747|19128627|P3|Overall Study|Physician Decision|0
5533528|NCT01371747|19128628|P2|Overall Study|Physician Decision|0
5533529|NCT01371747|19128629|P1|Overall Study|Physician Decision|0
5533530|NCT01371747|19128624|P6|Overall Study|Non-Compliance|1
5533531|NCT01371747|19128625|P5|Overall Study|Non-Compliance|0
5533532|NCT01371747|19128626|P4|Overall Study|Non-Compliance|0
5533533|NCT01371747|19128627|P3|Overall Study|Non-Compliance|3
5533534|NCT01371747|19128628|P2|Overall Study|Non-Compliance|4
5533535|NCT01371747|19128629|P1|Overall Study|Non-Compliance|3
5533536|NCT01371747|19128624|P6|Overall Study|Protocol Violation|0
5533537|NCT01371747|19128625|P5|Overall Study|Protocol Violation|0
5533538|NCT01371747|19128626|P4|Overall Study|Protocol Violation|0
5533539|NCT01371747|19128627|P3|Overall Study|Protocol Violation|1
5533540|NCT01371747|19128628|P2|Overall Study|Protocol Violation|0
5533541|NCT01371747|19128629|P1|Overall Study|Protocol Violation|0
5533542|NCT01371747|19128624|P6|Overall Study|Low Serum Potassium Results|3
5533543|NCT01371747|19128625|P5|Overall Study|Low Serum Potassium Results|0
5533544|NCT01371747|19128626|P4|Overall Study|Low Serum Potassium Results|1
5533545|NCT01371747|19128627|P3|Overall Study|Low Serum Potassium Results|1
5533546|NCT01371747|19128628|P2|Overall Study|Low Serum Potassium Results|1
5533547|NCT01371747|19128629|P1|Overall Study|Low Serum Potassium Results|1
5533548|NCT01371747|19128624|P6|Overall Study|High Serum Potassium Results|2
5533549|NCT01371747|19128625|P5|Overall Study|High Serum Potassium Results|0
5533550|NCT01371747|19128626|P4|Overall Study|High Serum Potassium Results|2
5533551|NCT01371747|19128627|P3|Overall Study|High Serum Potassium Results|1
5533552|NCT01371747|19128628|P2|Overall Study|High Serum Potassium Results|1
5533553|NCT01371747|19128629|P1|Overall Study|High Serum Potassium Results|1
5533554|NCT01371747|19128624|P6|Overall Study|Abnormal Renal Function|1
5533555|NCT01371747|19128625|P5|Overall Study|Abnormal Renal Function|0
5533556|NCT01371747|19128626|P4|Overall Study|Abnormal Renal Function|1
5533557|NCT01371747|19128627|P3|Overall Study|Abnormal Renal Function|0
5533558|NCT01371747|19128628|P2|Overall Study|Abnormal Renal Function|2
5533559|NCT01371747|19128629|P1|Overall Study|Abnormal Renal Function|0
5533560|NCT01371747|19128624|P6|Overall Study|Death|0
5533561|NCT01371747|19128625|P5|Overall Study|Death|2
5533562|NCT01371747|19128626|P4|Overall Study|Death|1
5533563|NCT01371747|19128627|P3|Overall Study|Death|4
5533564|NCT01371747|19128628|P2|Overall Study|Death|0
5533565|NCT01371747|19128629|P1|Overall Study|Death|1
5533566|NCT01371747|19128624|P6|Overall Study|Adverse Event|2
5533567|NCT01371747|19128625|P5|Overall Study|Adverse Event|2
5533568|NCT01371747|19128626|P4|Overall Study|Adverse Event|2
5533569|NCT01371747|19128627|P3|Overall Study|Adverse Event|7
5533570|NCT01371747|19128628|P2|Overall Study|Adverse Event|2
5533571|NCT01371747|19128629|P1|Overall Study|Adverse Event|4
5533572|NCT01371734|19128694|P3|Overall Study|Lack of Efficacy|0
5533573|NCT01371734|19128695|P2|Overall Study|Lack of Efficacy|2
5533574|NCT01371734|19128696|P1|Overall Study|Lack of Efficacy|2
5533575|NCT01371734|19128694|P3|Overall Study|Adverse Event|3
5533576|NCT01371734|19128695|P2|Overall Study|Adverse Event|8
5533577|NCT01371734|19128696|P1|Overall Study|Adverse Event|8
5533578|NCT01371734|19128694|P3|Overall Study|Protocol Violation|2
5533579|NCT01371734|19128695|P2|Overall Study|Protocol Violation|1
5533580|NCT01371734|19128696|P1|Overall Study|Protocol Violation|3
5533581|NCT01371734|19128694|P3|Overall Study|Lost to Follow-up|1
5533582|NCT01371734|19128695|P2|Overall Study|Lost to Follow-up|3
5533583|NCT01371734|19128696|P1|Overall Study|Lost to Follow-up|5
5533584|NCT01371734|19128694|P3|Overall Study|Withdrawal by Subject|9
5533585|NCT01371734|19128695|P2|Overall Study|Withdrawal by Subject|4
5533586|NCT01371734|19128696|P1|Overall Study|Withdrawal by Subject|3
5533587|NCT01371734|19128694|P3|Overall Study|Other|2
5533588|NCT01371734|19128695|P2|Overall Study|Other|1
5533589|NCT01371734|19128696|P1|Overall Study|Other|2
5533590|NCT01371721|19128716|P3|Overall Study|Randomized but not treated|0
5533591|NCT01371721|19128717|P2|Overall Study|Randomized but not treated|0
5533592|NCT01371721|19128718|P1|Overall Study|Randomized but not treated|1
5533593|NCT01371721|19128716|P3|Overall Study|Lack of Efficacy|3
5533594|NCT01371721|19128717|P2|Overall Study|Lack of Efficacy|4
5533595|NCT01371721|19128718|P1|Overall Study|Lack of Efficacy|2
5533596|NCT01371721|19128716|P3|Overall Study|Other|0
5533597|NCT01371721|19128717|P2|Overall Study|Other|3
5533598|NCT01371721|19128718|P1|Overall Study|Other|2
5533599|NCT01371721|19128716|P3|Overall Study|Withdrawal by Subject|11
5533600|NCT01371721|19128717|P2|Overall Study|Withdrawal by Subject|7
5533601|NCT01371721|19128718|P1|Overall Study|Withdrawal by Subject|5
5533602|NCT01371721|19128716|P3|Overall Study|Lost to Follow-up|6
5533603|NCT01371721|19128717|P2|Overall Study|Lost to Follow-up|2
5533604|NCT01371721|19128718|P1|Overall Study|Lost to Follow-up|8
5533605|NCT01371721|19128716|P3|Overall Study|Protocol Violation|5
5533606|NCT01371721|19128717|P2|Overall Study|Protocol Violation|4
5533607|NCT01371721|19128718|P1|Overall Study|Protocol Violation|6
5533608|NCT01371721|19128716|P3|Overall Study|Adverse Event|5
5533609|NCT01371721|19128717|P2|Overall Study|Adverse Event|4
5533610|NCT01371721|19128718|P1|Overall Study|Adverse Event|5
5533611|NCT01371708|19128751|P3|Overall Study|Started but did not receive treatment|1
5533612|NCT01371708|19128752|P2|Overall Study|Started but did not receive treatment|0
5533613|NCT01371708|19128753|P1|Overall Study|Started but did not receive treatment|1
5533614|NCT01371708|19128751|P3|Overall Study|Adverse Event|12
5533615|NCT01371708|19128752|P2|Overall Study|Adverse Event|8
5533616|NCT01371708|19128753|P1|Overall Study|Adverse Event|5
5533617|NCT01371708|19128751|P3|Overall Study|Other|4
5533618|NCT01371708|19128752|P2|Overall Study|Other|2
5533619|NCT01371708|19128753|P1|Overall Study|Other|3
5533620|NCT01371708|19128751|P3|Overall Study|Medication error/not related to AE|0
5533621|NCT01371708|19128752|P2|Overall Study|Medication error/not related to AE|1
5533622|NCT01371708|19128753|P1|Overall Study|Medication error/not related to AE|0
5533623|NCT01371708|19128751|P3|Overall Study|No longer willing to participate|13
5533624|NCT01371708|19128752|P2|Overall Study|No longer willing to participate|7
5533625|NCT01371708|19128753|P1|Overall Study|No longer willing to participate|7
5533626|NCT01371708|19128751|P3|Overall Study|Protocol Violation|2
5533627|NCT01371708|19128752|P2|Overall Study|Protocol Violation|1
5533628|NCT01371708|19128753|P1|Overall Study|Protocol Violation|2
5533629|NCT01371708|19128751|P3|Overall Study|Lost to Follow-up|7
5533630|NCT01371708|19128752|P2|Overall Study|Lost to Follow-up|9
5533631|NCT01371708|19128753|P1|Overall Study|Lost to Follow-up|5
5533632|NCT01371708|19128751|P3|Overall Study|Insufficient clinical response|0
5533633|NCT01371708|19128752|P2|Overall Study|Insufficient clinical response|2
5533634|NCT01371708|19128753|P1|Overall Study|Insufficient clinical response|3
5533635|NCT01371656|19128785|P2|Overall Study|Ineligible|3
5533636|NCT01371656|19128786|P1|Overall Study|Ineligible|4
5533637|NCT01371656|19128785|P2|Overall Study|Withdrawal by Subject|0
5533638|NCT01371656|19128786|P1|Overall Study|Withdrawal by Subject|7
5533639|NCT01371656|19128785|P2|Overall Study|Physician Decision|7
5533640|NCT01371656|19128786|P1|Overall Study|Physician Decision|46
5533641|NCT01371656|19128785|P2|Overall Study|Death|4
5533642|NCT01371656|19128786|P1|Overall Study|Death|7
5533643|NCT01371643|19128806|P2|Overall Study|Withdrawal by Subject|0
5533644|NCT01371643|19128807|P1|Overall Study|Withdrawal by Subject|3
5533645|NCT01371565|19128817|P1|Overall Study|Resection of neuroendocrine tumor|1
5533646|NCT01371565|19128817|P1|Overall Study|Death|1
5533647|NCT01371565|19128817|P1|Overall Study|Withdrawal by Subject|1
5533648|NCT01371552|19128821|P6|Part 1, First 3 Days|Inconvenience|0
5533649|NCT01371552|19128822|P5|Part 1, First 3 Days|Inconvenience|0
5533650|NCT01371552|19128823|P4|Part 1, First 3 Days|Inconvenience|0
5533651|NCT01371552|19128824|P3|Part 1, First 3 Days|Inconvenience|1
5533652|NCT01371552|19128825|P2|Part 1, First 3 Days|Inconvenience|0
5533653|NCT01371552|19128826|P1|Part 1, First 3 Days|Inconvenience|0
5533654|NCT01371539|19128853|P2|Period Two: One Week|Time/job conflict|1
5533655|NCT01371539|19128854|P1|Period Two: One Week|Time/job conflict|0
5533656|NCT01371539|19128853|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
5533657|NCT01371539|19128854|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
5533658|NCT01371539|19128853|P2|Period Two: One Week|Lost to Follow-up|1
5533659|NCT01371539|19128854|P1|Period Two: One Week|Lost to Follow-up|0
5533660|NCT01371539|19128853|P2|Period One: One Week|Lost to Follow-up|1
5533661|NCT01371539|19128854|P1|Period One: One Week|Lost to Follow-up|0
5533662|NCT01371305|19128868|P6|Overall Study|Subject request|1
5533663|NCT01371305|19128869|P5|Overall Study|Subject request|0
5533664|NCT01371305|19128870|P4|Overall Study|Subject request|0
5533665|NCT01371305|19128871|P3|Overall Study|Subject request|0
5533666|NCT01371305|19128872|P2|Overall Study|Subject request|0
5533667|NCT01371305|19128873|P1|Overall Study|Subject request|0
5533668|NCT01371305|19128868|P6|Overall Study|Study terminated by sponsor|1
5533669|NCT01371305|19128869|P5|Overall Study|Study terminated by sponsor|3
5533670|NCT01371305|19128870|P4|Overall Study|Study terminated by sponsor|0
5533671|NCT01371305|19128871|P3|Overall Study|Study terminated by sponsor|0
5533672|NCT01371305|19128872|P2|Overall Study|Study terminated by sponsor|0
5533673|NCT01371305|19128873|P1|Overall Study|Study terminated by sponsor|0
5533674|NCT01371305|19128868|P6|Overall Study|Adverse Event|0
5533675|NCT01371305|19128869|P5|Overall Study|Adverse Event|1
5533676|NCT01371305|19128870|P4|Overall Study|Adverse Event|2
5533677|NCT01371305|19128871|P3|Overall Study|Adverse Event|0
5533678|NCT01371305|19128872|P2|Overall Study|Adverse Event|0
5533679|NCT01371305|19128873|P1|Overall Study|Adverse Event|0
5533680|NCT01371006|19128957|P2|Overall Study|Adverse Event|0
5533681|NCT01371006|19128958|P1|Overall Study|Adverse Event|1
5533682|NCT01370863|19128999|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
5533683|NCT01370863|19129000|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
5533684|NCT01370863|19128999|P2|Overall Study|Did not want second pH/MII monitoring|1
5533685|NCT01370863|19129000|P1|Overall Study|Did not want second pH/MII monitoring|1
5533686|NCT01370863|19128999|P2|Overall Study|Adverse Event|1
5533687|NCT01370863|19129000|P1|Overall Study|Adverse Event|1
5533688|NCT01370733|19129025|P2|Overall Study|Protocol Violation|3
5533689|NCT01370733|19129026|P1|Overall Study|Protocol Violation|1
5533690|NCT01370733|19129025|P2|Overall Study|Physician Decision|2
5533691|NCT01370733|19129026|P1|Overall Study|Physician Decision|0
5533692|NCT01370733|19129025|P2|Overall Study|Lack of Efficacy|5
5533693|NCT01370733|19129026|P1|Overall Study|Lack of Efficacy|3
5533694|NCT01370733|19129025|P2|Overall Study|Adverse Event|4
5533695|NCT01370733|19129026|P1|Overall Study|Adverse Event|2
5533696|NCT01370733|19129025|P2|Overall Study|Lost to Follow-up|0
5533697|NCT01370733|19129026|P1|Overall Study|Lost to Follow-up|3
5533698|NCT01370733|19129025|P2|Overall Study|Withdrawal by Subject|8
5533699|NCT01370733|19129026|P1|Overall Study|Withdrawal by Subject|8
5533700|NCT01370694|19129048|P1|Overall Study|Progressive disease|2
5533701|NCT01370694|19129048|P1|Overall Study|Switched to rituximab|4
5533702|NCT01370655|19129070|P12|Period 2|Withdrawal by Subject|0
5533703|NCT01370655|19129071|P11|Period 2|Withdrawal by Subject|0
5533704|NCT01370655|19129072|P10|Period 2|Withdrawal by Subject|0
5533705|NCT01370655|19129073|P9|Period 2|Withdrawal by Subject|1
5533706|NCT01370655|19129074|P8|Period 2|Withdrawal by Subject|0
5533707|NCT01370655|19129075|P7|Period 2|Withdrawal by Subject|0
5533708|NCT01370655|19129076|P6|Period 2|Withdrawal by Subject|0
5533709|NCT01370655|19129077|P5|Period 2|Withdrawal by Subject|0
5533710|NCT01370655|19129078|P4|Period 2|Withdrawal by Subject|0
5533711|NCT01370655|19129079|P3|Period 2|Withdrawal by Subject|0
5533712|NCT01370655|19129080|P2|Period 2|Withdrawal by Subject|0
5533713|NCT01370655|19129081|P1|Period 2|Withdrawal by Subject|0
5533714|NCT01370655|19129070|P12|Period 2|met protocol specified stopping criteria|0
5533715|NCT01370655|19129071|P11|Period 2|met protocol specified stopping criteria|1
5533716|NCT01370655|19129072|P10|Period 2|met protocol specified stopping criteria|0
5533717|NCT01370655|19129073|P9|Period 2|met protocol specified stopping criteria|1
5533718|NCT01370655|19129074|P8|Period 2|met protocol specified stopping criteria|0
5533719|NCT01370655|19129075|P7|Period 2|met protocol specified stopping criteria|1
5533720|NCT01370655|19129076|P6|Period 2|met protocol specified stopping criteria|0
5533721|NCT01370655|19129077|P5|Period 2|met protocol specified stopping criteria|0
5533722|NCT01370655|19129078|P4|Period 2|met protocol specified stopping criteria|0
5533723|NCT01370655|19129079|P3|Period 2|met protocol specified stopping criteria|1
5533724|NCT01370655|19129080|P2|Period 2|met protocol specified stopping criteria|0
5533725|NCT01370655|19129081|P1|Period 2|met protocol specified stopping criteria|0
5533726|NCT01370655|19129070|P12|Period 2|Adverse Event|0
5533727|NCT01370655|19129071|P11|Period 2|Adverse Event|0
5533728|NCT01370655|19129072|P10|Period 2|Adverse Event|0
5533729|NCT01370655|19129073|P9|Period 2|Adverse Event|0
5533730|NCT01370655|19129074|P8|Period 2|Adverse Event|1
5533731|NCT01370655|19129075|P7|Period 2|Adverse Event|0
5533732|NCT01370655|19129076|P6|Period 2|Adverse Event|0
5533733|NCT01370655|19129077|P5|Period 2|Adverse Event|1
5533734|NCT01370655|19129078|P4|Period 2|Adverse Event|0
5533735|NCT01370655|19129079|P3|Period 2|Adverse Event|1
5533736|NCT01370655|19129080|P2|Period 2|Adverse Event|0
5533737|NCT01370655|19129081|P1|Period 2|Adverse Event|0
5533738|NCT01370655|19129070|P12|Period 1|Adverse Event|0
5533739|NCT01370655|19129071|P11|Period 1|Adverse Event|0
5533740|NCT01370655|19129072|P10|Period 1|Adverse Event|0
5533741|NCT01370655|19129073|P9|Period 1|Adverse Event|0
5533742|NCT01370655|19129074|P8|Period 1|Adverse Event|0
5533743|NCT01370655|19129075|P7|Period 1|Adverse Event|1
5533744|NCT01370655|19129076|P6|Period 1|Adverse Event|0
5533745|NCT01370655|19129077|P5|Period 1|Adverse Event|0
5533746|NCT01370655|19129078|P4|Period 1|Adverse Event|0
5533747|NCT01370655|19129079|P3|Period 1|Adverse Event|0
5533748|NCT01370655|19129080|P2|Period 1|Adverse Event|0
5533749|NCT01370655|19129081|P1|Period 1|Adverse Event|2
5533750|NCT01370642|19129118|P3|Overall Study|Withdrawal by Subject|3
5533751|NCT01370642|19129119|P2|Overall Study|Withdrawal by Subject|4
5533752|NCT01370642|19129120|P1|Overall Study|Withdrawal by Subject|2
5533753|NCT01370642|19129118|P3|Overall Study|Physician Decision|2
5533754|NCT01370642|19129119|P2|Overall Study|Physician Decision|1
5533755|NCT01370642|19129120|P1|Overall Study|Physician Decision|4
5533756|NCT01370642|19129118|P3|Overall Study|Lost to Follow-up|1
5533757|NCT01370642|19129119|P2|Overall Study|Lost to Follow-up|0
5533758|NCT01370642|19129120|P1|Overall Study|Lost to Follow-up|0
5533759|NCT01370642|19129118|P3|Overall Study|Detectable HCV RNA|22
5533760|NCT01370642|19129119|P2|Overall Study|Detectable HCV RNA|0
5533761|NCT01370642|19129120|P1|Overall Study|Detectable HCV RNA|0
5533762|NCT01370642|19129118|P3|Overall Study|Adverse Event|1
5533763|NCT01370642|19129119|P2|Overall Study|Adverse Event|1
5533764|NCT01370642|19129120|P1|Overall Study|Adverse Event|2
5533765|NCT01370616|19129159|P2|Overall Study|Withdrawal by Subject|34
5533766|NCT01370616|19129160|P1|Overall Study|Withdrawal by Subject|34
5533767|NCT01370616|19129159|P2|Overall Study|Technical Problems|5
5533768|NCT01370616|19129160|P1|Overall Study|Technical Problems|3
5533769|NCT01370616|19129159|P2|Overall Study|Recovery|0
5533770|NCT01370616|19129160|P1|Overall Study|Recovery|1
5533771|NCT01370616|19129159|P2|Overall Study|Progressive Disease|1
5533772|NCT01370616|19129160|P1|Overall Study|Progressive Disease|0
5533773|NCT01370616|19129159|P2|Overall Study|Physician Decision|6
5533774|NCT01370616|19129160|P1|Overall Study|Physician Decision|6
5533775|NCT01370616|19129159|P2|Overall Study|Lost to Follow-up|3
5533776|NCT01370616|19129160|P1|Overall Study|Lost to Follow-up|0
5533777|NCT01370616|19129159|P2|Overall Study|Lack of Efficacy|2
5533778|NCT01370616|19129160|P1|Overall Study|Lack of Efficacy|6
5533779|NCT01370616|19129159|P2|Overall Study|Death|0
5533780|NCT01370616|19129160|P1|Overall Study|Death|1
5533781|NCT01370616|19129159|P2|Overall Study|Adverse Event|16
5533782|NCT01370616|19129160|P1|Overall Study|Adverse Event|11
5533783|NCT01370603|19129184|P2|Period 2|Withdrawal by Subject|0
5533784|NCT01370603|19129185|P1|Period 2|Withdrawal by Subject|1
5533785|NCT01370603|19129184|P2|Period 2|Lost to Follow-up|0
5533786|NCT01370603|19129185|P1|Period 2|Lost to Follow-up|1
5533787|NCT01370603|19129184|P2|Period 2|Adverse Event|4
5533788|NCT01370603|19129185|P1|Period 2|Adverse Event|1
5533789|NCT01370603|19129184|P2|Crossover Washout|Non-compliance with Study Drug|2
5533790|NCT01370603|19129185|P1|Crossover Washout|Non-compliance with Study Drug|0
5533791|NCT01370603|19129184|P2|Crossover Washout|Withdrawal by Subject|1
5533792|NCT01370603|19129185|P1|Crossover Washout|Withdrawal by Subject|4
5533793|NCT01370603|19129184|P2|Crossover Washout|Protocol Violation|0
5533794|NCT01370603|19129185|P1|Crossover Washout|Protocol Violation|1
5533795|NCT01370603|19129184|P2|Crossover Washout|Lost to Follow-up|0
5533796|NCT01370603|19129185|P1|Crossover Washout|Lost to Follow-up|2
5533797|NCT01370603|19129184|P2|Crossover Washout|Adverse Event|1
5533798|NCT01370603|19129185|P1|Crossover Washout|Adverse Event|2
5533799|NCT01370603|19129184|P2|Period 1|Withdrawal by Subject|5
5533800|NCT01370603|19129185|P1|Period 1|Withdrawal by Subject|5
5533801|NCT01370603|19129184|P2|Period 1|Protocol Violation|2
5533802|NCT01370603|19129185|P1|Period 1|Protocol Violation|2
5533803|NCT01370603|19129184|P2|Period 1|Lost to Follow-up|0
5533804|NCT01370603|19129185|P1|Period 1|Lost to Follow-up|2
5533805|NCT01370603|19129184|P2|Period 1|Adverse Event|3
5533806|NCT01370603|19129185|P1|Period 1|Adverse Event|5
5533807|NCT01370590|19129203|P2|Period 2|Withdrawal by Subject|1
5533808|NCT01370590|19129204|P1|Period 2|Withdrawal by Subject|1
5533809|NCT01370590|19129203|P2|Period 2|Adverse Event|1
5533810|NCT01370590|19129204|P1|Period 2|Adverse Event|0
5533811|NCT01370590|19129203|P2|Crossover Washout Period|Withdrawal by Subject|2
5533812|NCT01370590|19129204|P1|Crossover Washout Period|Withdrawal by Subject|2
5533813|NCT01370590|19129203|P2|Crossover Washout Period|Non-compliance with Study Drug|0
5533814|NCT01370590|19129204|P1|Crossover Washout Period|Non-compliance with Study Drug|1
5533815|NCT01370590|19129203|P2|Crossover Washout Period|Lost to Follow-up|0
5533816|NCT01370590|19129204|P1|Crossover Washout Period|Lost to Follow-up|2
5533817|NCT01370590|19129203|P2|Crossover Washout Period|Adverse Event|4
5533818|NCT01370590|19129204|P1|Crossover Washout Period|Adverse Event|1
5533819|NCT01370590|19129203|P2|Period 1|Could not access randomization system|1
5533820|NCT01370590|19129204|P1|Period 1|Could not access randomization system|0
5533821|NCT01370590|19129203|P2|Period 1|Withdrawal by Subject|2
5533822|NCT01370590|19129204|P1|Period 1|Withdrawal by Subject|4
5533823|NCT01370590|19129203|P2|Period 1|Protocol Violation|2
5533824|NCT01370590|19129204|P1|Period 1|Protocol Violation|2
5533825|NCT01370590|19129203|P2|Period 1|Lost to Follow-up|2
5533826|NCT01370590|19129204|P1|Period 1|Lost to Follow-up|2
5533827|NCT01370590|19129203|P2|Period 1|Adverse Event|4
5533828|NCT01370590|19129204|P1|Period 1|Adverse Event|8
5533829|NCT01370538|19129232|P2|Overall Study|Lost to follow up|10
5533830|NCT01370538|19129233|P1|Overall Study|Lost to follow up|6
5533831|NCT01370538|19129232|P2|Overall Study|Development of study specific withdrawal|1
5533832|NCT01370538|19129233|P1|Overall Study|Development of study specific withdrawal|1
5533833|NCT01370538|19129232|P2|Overall Study|Protocol Violation|5
5533834|NCT01370538|19129233|P1|Overall Study|Protocol Violation|8
5533835|NCT01370538|19129232|P2|Overall Study|Adverse Event|0
5533836|NCT01370538|19129233|P1|Overall Study|Adverse Event|1
5533837|NCT01370538|19129232|P2|Overall Study|Eligibility criteria not fulfilled|1
5533838|NCT01370538|19129233|P1|Overall Study|Eligibility criteria not fulfilled|0
5533839|NCT01370538|19129232|P2|Overall Study|Voluntary Discontinuation by Subject|2
5533840|NCT01370538|19129233|P1|Overall Study|Voluntary Discontinuation by Subject|3
5533841|NCT01370525|19129249|P2|Overall Study|Lost to follow up|6
5533842|NCT01370525|19129250|P1|Overall Study|Lost to follow up|2
5533843|NCT01370525|19129249|P2|Overall Study|Protocol Violation|1
5533844|NCT01370525|19129250|P1|Overall Study|Protocol Violation|2
5533845|NCT01370525|19129249|P2|Overall Study|Adverse Event|1
5533846|NCT01370525|19129250|P1|Overall Study|Adverse Event|0
5533847|NCT01370525|19129249|P2|Overall Study|Eligibility criteria not fulfilled|0
5533848|NCT01370525|19129250|P1|Overall Study|Eligibility criteria not fulfilled|2
5533849|NCT01370525|19129249|P2|Overall Study|Voluntary Discontinuation by Subject|3
5533850|NCT01370525|19129250|P1|Overall Study|Voluntary Discontinuation by Subject|2
5533851|NCT01370499|19129266|P2|Overall Study|Sponsor Decision|15
5533852|NCT01370499|19129267|P1|Overall Study|Sponsor Decision|41
5533853|NCT01370499|19129266|P2|Overall Study|Withdrawal by Subject|7
5533854|NCT01370499|19129267|P1|Overall Study|Withdrawal by Subject|18
5533855|NCT01370499|19129266|P2|Overall Study|Protocol Violation|4
5533856|NCT01370499|19129267|P1|Overall Study|Protocol Violation|5
5533857|NCT01370499|19129266|P2|Overall Study|Physician Decision|3
5533858|NCT01370499|19129267|P1|Overall Study|Physician Decision|3
5533859|NCT01370499|19129266|P2|Overall Study|Lost to Follow-up|1
5533860|NCT01370499|19129267|P1|Overall Study|Lost to Follow-up|2
5533861|NCT01370499|19129266|P2|Overall Study|Lack of Efficacy|2
5533862|NCT01370499|19129267|P1|Overall Study|Lack of Efficacy|4
5533863|NCT01370499|19129266|P2|Overall Study|Adverse Event|12
5533864|NCT01370499|19129267|P1|Overall Study|Adverse Event|38
5533865|NCT01370408|19129309|P1|Overall Study|treatment failure|9
5533866|NCT01370356|19129369|P2|Overall Study|AE Not Related to Study Drug|4
5533867|NCT01370356|19129370|P1|Overall Study|AE Not Related to Study Drug|1
5533868|NCT01370356|19129369|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
5533869|NCT01370356|19129370|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
5533870|NCT01370356|19129369|P2|Overall Study|Protocol Violation|3
5533871|NCT01370356|19129370|P1|Overall Study|Protocol Violation|3
5533872|NCT01370356|19129369|P2|Overall Study|Reason not specified|43
5533873|NCT01370356|19129370|P1|Overall Study|Reason not specified|39
5533874|NCT01370356|19129369|P2|Overall Study|Withdrawal by Subject|59
5533875|NCT01370356|19129370|P1|Overall Study|Withdrawal by Subject|54
5533876|NCT01370356|19129369|P2|Overall Study|Lost to Follow-up|81
5533877|NCT01370356|19129370|P1|Overall Study|Lost to Follow-up|76
5533878|NCT01370356|19129369|P2|Overall Study|Lack of Efficacy|28
5533879|NCT01370356|19129370|P1|Overall Study|Lack of Efficacy|6
5533880|NCT01370356|19129369|P2|Overall Study|Death|0
5533881|NCT01370356|19129370|P1|Overall Study|Death|1
5533882|NCT01370317|19129386|P2|Overall Study|Protocol deviation|1
5533883|NCT01370317|19129387|P1|Overall Study|Protocol deviation|0
5533884|NCT01370317|19129386|P2|Overall Study|Participant withdrew consent|0
5533885|NCT01370317|19129387|P1|Overall Study|Participant withdrew consent|1
5533886|NCT01370265|19129398|P2|First Intervention|Adverse Event|1
5533887|NCT01370265|19129399|P1|First Intervention|Adverse Event|1
5533888|NCT01370213|19129419|P3|Overall Study|Not evaluable|0
5533889|NCT01370213|19129420|P2|Overall Study|Not evaluable|2
5533890|NCT01370213|19129421|P1|Overall Study|Not evaluable|0
5533891|NCT01370213|19129419|P3|Overall Study|Early Death|0
5533892|NCT01370213|19129420|P2|Overall Study|Early Death|0
5533893|NCT01370213|19129421|P1|Overall Study|Early Death|1
5533894|NCT01370083|19129441|P2|Overall Study|Adverse Event|1
5533895|NCT01370083|19129442|P1|Overall Study|Adverse Event|0
5533896|NCT01370083|19129441|P2|Overall Study|Lost to Follow-up|0
5533897|NCT01370083|19129442|P1|Overall Study|Lost to Follow-up|2
5533898|NCT01370005|19129455|P3|Overall Study|Other reason not defined above|2
5533899|NCT01370005|19129456|P2|Overall Study|Other reason not defined above|0
5533900|NCT01370005|19129457|P1|Overall Study|Other reason not defined above|3
5533901|NCT01370005|19129455|P3|Overall Study|Patient refusal to continue,not due toAE|0
5533902|NCT01370005|19129456|P2|Overall Study|Patient refusal to continue,not due toAE|4
5533903|NCT01370005|19129457|P1|Overall Study|Patient refusal to continue,not due toAE|5
5533904|NCT01370005|19129455|P3|Overall Study|Lost to Follow-up|1
5533905|NCT01370005|19129456|P2|Overall Study|Lost to Follow-up|1
5533906|NCT01370005|19129457|P1|Overall Study|Lost to Follow-up|1
5533907|NCT01370005|19129455|P3|Overall Study|Non compliant with protocol|2
5533908|NCT01370005|19129456|P2|Overall Study|Non compliant with protocol|1
5533909|NCT01370005|19129457|P1|Overall Study|Non compliant with protocol|0
5533910|NCT01370005|19129455|P3|Overall Study|Lack of Efficacy|0
5533911|NCT01370005|19129456|P2|Overall Study|Lack of Efficacy|0
5533912|NCT01370005|19129457|P1|Overall Study|Lack of Efficacy|1
5533913|NCT01370005|19129455|P3|Overall Study|Adverse Event|6
5533914|NCT01370005|19129456|P2|Overall Study|Adverse Event|5
5533915|NCT01370005|19129457|P1|Overall Study|Adverse Event|5
5533916|NCT01370005|19129455|P3|Overall Study|Not treated|0
5533917|NCT01370005|19129456|P2|Overall Study|Not treated|0
5533918|NCT01370005|19129457|P1|Overall Study|Not treated|1
5533919|NCT01369849|19129539|P3|Overall Study|Ineligible after receiving treatment|0
5533920|NCT01369849|19129540|P2|Overall Study|Ineligible after receiving treatment|1
5533921|NCT01369849|19129541|P1|Overall Study|Ineligible after receiving treatment|0
5533922|NCT01369849|19129539|P3|Overall Study|Ineligible prior to treatment|1
5533923|NCT01369849|19129540|P2|Overall Study|Ineligible prior to treatment|0
5533924|NCT01369849|19129541|P1|Overall Study|Ineligible prior to treatment|0
5533925|NCT01369784|19129563|P1|Overall Study|Protocol Violation|12
5533926|NCT01369680|19129651|P4|Overall Study|Lost to Follow-up|2
5533927|NCT01369680|19129652|P3|Overall Study|Lost to Follow-up|1
5533928|NCT01369680|19129653|P2|Overall Study|Lost to Follow-up|0
5533929|NCT01369680|19129654|P1|Overall Study|Lost to Follow-up|0
5533930|NCT01369641|19129675|P1|Overall Study|Withdrawal by Subject|1
5533931|NCT01369615|19129681|P2|Overall Study|Lost to Follow-up|1
5533932|NCT01369615|19129682|P1|Overall Study|Lost to Follow-up|0
5533933|NCT01369615|19129681|P2|Overall Study|Withdrawal by Subject|1
5533934|NCT01369615|19129682|P1|Overall Study|Withdrawal by Subject|0
5533935|NCT01369511|19129692|P4|Overall Study|Withdrawal by Subject|6
5533936|NCT01369511|19129693|P3|Overall Study|Withdrawal by Subject|4
5533937|NCT01369511|19129694|P2|Overall Study|Withdrawal by Subject|6
5533938|NCT01369511|19129695|P1|Overall Study|Withdrawal by Subject|5
5533939|NCT01369511|19129692|P4|Overall Study|Sponsor decision|0
5533940|NCT01369511|19129693|P3|Overall Study|Sponsor decision|1
5533941|NCT01369511|19129694|P2|Overall Study|Sponsor decision|0
5533942|NCT01369511|19129695|P1|Overall Study|Sponsor decision|2
5533943|NCT01369511|19129692|P4|Overall Study|Physician Decision|0
5533944|NCT01369511|19129693|P3|Overall Study|Physician Decision|0
5533945|NCT01369511|19129694|P2|Overall Study|Physician Decision|4
5533946|NCT01369511|19129695|P1|Overall Study|Physician Decision|3
5533947|NCT01369511|19129692|P4|Overall Study|Protocol Violation|2
5533948|NCT01369511|19129693|P3|Overall Study|Protocol Violation|0
5533949|NCT01369511|19129694|P2|Overall Study|Protocol Violation|1
5533950|NCT01369511|19129695|P1|Overall Study|Protocol Violation|0
5533951|NCT01369511|19129692|P4|Overall Study|Lost to Follow-up|2
5533952|NCT01369511|19129693|P3|Overall Study|Lost to Follow-up|1
5533953|NCT01369511|19129694|P2|Overall Study|Lost to Follow-up|1
5533954|NCT01369511|19129695|P1|Overall Study|Lost to Follow-up|0
5533955|NCT01369511|19129692|P4|Overall Study|Entry criteria not met|1
5533956|NCT01369511|19129693|P3|Overall Study|Entry criteria not met|0
5533957|NCT01369511|19129694|P2|Overall Study|Entry criteria not met|0
5533958|NCT01369511|19129695|P1|Overall Study|Entry criteria not met|2
5533959|NCT01369511|19129692|P4|Overall Study|Adverse Event|0
5533960|NCT01369511|19129693|P3|Overall Study|Adverse Event|5
5533961|NCT01369511|19129694|P2|Overall Study|Adverse Event|1
5533962|NCT01369511|19129695|P1|Overall Study|Adverse Event|1
5533963|NCT01369498|19129713|P4|Overall Study|Disease Progression|1
5533964|NCT01369498|19129714|P3|Overall Study|Disease Progression|0
5533965|NCT01369498|19129715|P2|Overall Study|Disease Progression|0
5533966|NCT01369498|19129716|P1|Overall Study|Disease Progression|0
5533967|NCT01369498|19129713|P4|Overall Study|Unknown Reason|6
5533968|NCT01369498|19129714|P3|Overall Study|Unknown Reason|11
5533969|NCT01369498|19129715|P2|Overall Study|Unknown Reason|0
5533970|NCT01369498|19129716|P1|Overall Study|Unknown Reason|1
5533971|NCT01369498|19129713|P4|Overall Study|Investigator's Discretion|3
5533972|NCT01369498|19129714|P3|Overall Study|Investigator's Discretion|1
5533973|NCT01369498|19129715|P2|Overall Study|Investigator's Discretion|0
5533974|NCT01369498|19129716|P1|Overall Study|Investigator's Discretion|1
5533975|NCT01369498|19129713|P4|Overall Study|Death|0
5533976|NCT01369498|19129714|P3|Overall Study|Death|1
5533977|NCT01369498|19129715|P2|Overall Study|Death|0
5533978|NCT01369498|19129716|P1|Overall Study|Death|0
5533979|NCT01369498|19129713|P4|Overall Study|Withdrawal of Consent|1
5533980|NCT01369498|19129714|P3|Overall Study|Withdrawal of Consent|1
5533981|NCT01369498|19129715|P2|Overall Study|Withdrawal of Consent|1
5533982|NCT01369498|19129716|P1|Overall Study|Withdrawal of Consent|0
5533983|NCT01369498|19129713|P4|Overall Study|Adverse Event|1
5533984|NCT01369498|19129714|P3|Overall Study|Adverse Event|0
5533985|NCT01369498|19129715|P2|Overall Study|Adverse Event|2
5533986|NCT01369498|19129716|P1|Overall Study|Adverse Event|1
5533987|NCT01369498|19129713|P4|Overall Study|Lack of Efficacy|3
5533988|NCT01369498|19129714|P3|Overall Study|Lack of Efficacy|1
5533989|NCT01369498|19129715|P2|Overall Study|Lack of Efficacy|9
5533990|NCT01369498|19129716|P1|Overall Study|Lack of Efficacy|9
5533991|NCT01369485|19129748|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
5533992|NCT01369485|19129749|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
5533993|NCT01369485|19129748|P2|Open Label Phase (Week 12 to Month 12)|Death|1
5533994|NCT01369485|19129749|P1|Open Label Phase (Week 12 to Month 12)|Death|0
5533995|NCT01369485|19129748|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
5533996|NCT01369485|19129749|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
5533997|NCT01369485|19129748|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
5533998|NCT01369485|19129749|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
5533999|NCT01369485|19129748|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
5534000|NCT01369485|19129749|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
5534001|NCT01369485|19129748|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
5534002|NCT01369485|19129749|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
5534003|NCT01369485|19129748|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
5534004|NCT01369485|19129749|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
5534005|NCT01369485|19129748|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
5534006|NCT01369485|19129749|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
5534007|NCT01369485|19129748|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
5534008|NCT01369485|19129749|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
5534009|NCT01369485|19129748|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
5534010|NCT01369485|19129749|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
5534011|NCT01369433|19129791|P2|Overall Study|Progressive Disease|12
5534012|NCT01369433|19129792|P1|Overall Study|Progressive Disease|92
5534013|NCT01369433|19129791|P2|Overall Study|Investigator discretion|1
5534014|NCT01369433|19129792|P1|Overall Study|Investigator discretion|6
5534015|NCT01369433|19129791|P2|Overall Study|Death|0
5534016|NCT01369433|19129792|P1|Overall Study|Death|5
5534017|NCT01369433|19129791|P2|Overall Study|Lost to Follow-up|0
5534018|NCT01369433|19129792|P1|Overall Study|Lost to Follow-up|1
5534019|NCT01369433|19129791|P2|Overall Study|Study terminated by Sponsor|0
5534020|NCT01369433|19129792|P1|Overall Study|Study terminated by Sponsor|67
5534021|NCT01369433|19129791|P2|Overall Study|Withdrawal by Subject|2
5534022|NCT01369433|19129792|P1|Overall Study|Withdrawal by Subject|5
5534023|NCT01369433|19129791|P2|Overall Study|Non-compliance|0
5534024|NCT01369433|19129792|P1|Overall Study|Non-compliance|1
5534025|NCT01369433|19129791|P2|Overall Study|Required significant surgical procedure|0
5534026|NCT01369433|19129792|P1|Overall Study|Required significant surgical procedure|1
5534027|NCT01369433|19129791|P2|Overall Study|Adverse Event|1
5534028|NCT01369433|19129792|P1|Overall Study|Adverse Event|31
5534029|NCT01369355|19129804|P9|Long-term Extension (Week 44-272)|Other|17
5534030|NCT01369355|19129805|P8|Long-term Extension (Week 44-272)|Other|9
5534031|NCT01369355|19129806|P7|Long-term Extension (Week 44-272)|Other|110
5534032|NCT01369355|19129807|P6|Long-term Extension (Week 44-272)|Other|0
5534033|NCT01369355|19129808|P5|Long-term Extension (Week 44-272)|Other|0
5534034|NCT01369355|19129809|P4|Long-term Extension (Week 44-272)|Other|0
5534035|NCT01369355|19129810|P3|Long-term Extension (Week 44-272)|Other|0
5534036|NCT01369355|19129811|P2|Long-term Extension (Week 44-272)|Other|0
5534037|NCT01369355|19129812|P1|Long-term Extension (Week 44-272)|Other|0
5534038|NCT01369355|19129804|P9|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
5534039|NCT01369355|19129805|P8|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
5534040|NCT01369355|19129806|P7|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
5534041|NCT01369355|19129807|P6|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5534042|NCT01369355|19129808|P5|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5534043|NCT01369355|19129809|P4|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5534044|NCT01369355|19129810|P3|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5534045|NCT01369355|19129811|P2|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5534046|NCT01369355|19129812|P1|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
5534047|NCT01369355|19129804|P9|Long-term Extension (Week 44-272)|Lost to Follow-up|9
5534048|NCT01369355|19129805|P8|Long-term Extension (Week 44-272)|Lost to Follow-up|5
5534049|NCT01369355|19129806|P7|Long-term Extension (Week 44-272)|Lost to Follow-up|1
5534050|NCT01369355|19129807|P6|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5534051|NCT01369355|19129808|P5|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5534052|NCT01369355|19129809|P4|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5534053|NCT01369355|19129810|P3|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5534054|NCT01369355|19129811|P2|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5534055|NCT01369355|19129812|P1|Long-term Extension (Week 44-272)|Lost to Follow-up|0
5534056|NCT01369355|19129804|P9|Long-term Extension (Week 44-272)|Physician Decision|11
5534057|NCT01369355|19129805|P8|Long-term Extension (Week 44-272)|Physician Decision|5
5534058|NCT01369355|19129806|P7|Long-term Extension (Week 44-272)|Physician Decision|1
5534059|NCT01369355|19129807|P6|Long-term Extension (Week 44-272)|Physician Decision|0
5534060|NCT01369355|19129808|P5|Long-term Extension (Week 44-272)|Physician Decision|0
5534061|NCT01369355|19129809|P4|Long-term Extension (Week 44-272)|Physician Decision|0
5534062|NCT01369355|19129810|P3|Long-term Extension (Week 44-272)|Physician Decision|0
5534063|NCT01369355|19129811|P2|Long-term Extension (Week 44-272)|Physician Decision|0
5534064|NCT01369355|19129812|P1|Long-term Extension (Week 44-272)|Physician Decision|0
5534065|NCT01369355|19129804|P9|Long-term Extension (Week 44-272)|Protocol Violation|2
5534066|NCT01369355|19129805|P8|Long-term Extension (Week 44-272)|Protocol Violation|1
5534067|NCT01369355|19129806|P7|Long-term Extension (Week 44-272)|Protocol Violation|0
5534068|NCT01369355|19129807|P6|Long-term Extension (Week 44-272)|Protocol Violation|0
5534069|NCT01369355|19129808|P5|Long-term Extension (Week 44-272)|Protocol Violation|0
5534070|NCT01369355|19129809|P4|Long-term Extension (Week 44-272)|Protocol Violation|0
5534071|NCT01369355|19129810|P3|Long-term Extension (Week 44-272)|Protocol Violation|0
5534072|NCT01369355|19129811|P2|Long-term Extension (Week 44-272)|Protocol Violation|0
5534073|NCT01369355|19129812|P1|Long-term Extension (Week 44-272)|Protocol Violation|0
5534074|NCT01369355|19129804|P9|Long-term Extension (Week 44-272)|Lack of Efficacy|29
5534075|NCT01369355|19129805|P8|Long-term Extension (Week 44-272)|Lack of Efficacy|26
5534076|NCT01369355|19129806|P7|Long-term Extension (Week 44-272)|Lack of Efficacy|12
5534077|NCT01369355|19129807|P6|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5534078|NCT01369355|19129808|P5|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5534079|NCT01369355|19129809|P4|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5534080|NCT01369355|19129810|P3|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5534081|NCT01369355|19129811|P2|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5534082|NCT01369355|19129812|P1|Long-term Extension (Week 44-272)|Lack of Efficacy|0
5534083|NCT01369355|19129804|P9|Long-term Extension (Week 44-272)|Death|3
5534084|NCT01369355|19129805|P8|Long-term Extension (Week 44-272)|Death|1
5534085|NCT01369355|19129806|P7|Long-term Extension (Week 44-272)|Death|0
5534086|NCT01369355|19129807|P6|Long-term Extension (Week 44-272)|Death|0
5534087|NCT01369355|19129808|P5|Long-term Extension (Week 44-272)|Death|0
5534088|NCT01369355|19129809|P4|Long-term Extension (Week 44-272)|Death|0
5534089|NCT01369355|19129810|P3|Long-term Extension (Week 44-272)|Death|0
5534090|NCT01369355|19129811|P2|Long-term Extension (Week 44-272)|Death|0
5534091|NCT01369355|19129812|P1|Long-term Extension (Week 44-272)|Death|0
5534092|NCT01369355|19129804|P9|Long-term Extension (Week 44-272)|Adverse Event|53
5534093|NCT01369355|19129805|P8|Long-term Extension (Week 44-272)|Adverse Event|29
5534094|NCT01369355|19129806|P7|Long-term Extension (Week 44-272)|Adverse Event|15
5534095|NCT01369355|19129807|P6|Long-term Extension (Week 44-272)|Adverse Event|0
5534096|NCT01369355|19129808|P5|Long-term Extension (Week 44-272)|Adverse Event|0
5534097|NCT01369355|19129809|P4|Long-term Extension (Week 44-272)|Adverse Event|0
5534098|NCT01369355|19129810|P3|Long-term Extension (Week 44-272)|Adverse Event|0
5534099|NCT01369355|19129811|P2|Long-term Extension (Week 44-272)|Adverse Event|0
5534100|NCT01369355|19129812|P1|Long-term Extension (Week 44-272)|Adverse Event|0
5534101|NCT01369355|19129804|P9|Week 0 - Week 44 (Maintenance)|Other|0
5534102|NCT01369355|19129805|P8|Week 0 - Week 44 (Maintenance)|Other|0
5534103|NCT01369355|19129806|P7|Week 0 - Week 44 (Maintenance)|Other|0
5534104|NCT01369355|19129807|P6|Week 0 - Week 44 (Maintenance)|Other|0
5534105|NCT01369355|19129808|P5|Week 0 - Week 44 (Maintenance)|Other|1
5534106|NCT01369355|19129809|P4|Week 0 - Week 44 (Maintenance)|Other|0
5534107|NCT01369355|19129810|P3|Week 0 - Week 44 (Maintenance)|Other|1
5534108|NCT01369355|19129811|P2|Week 0 - Week 44 (Maintenance)|Other|0
5534109|NCT01369355|19129812|P1|Week 0 - Week 44 (Maintenance)|Other|0
5534110|NCT01369355|19129804|P9|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
5534111|NCT01369355|19129805|P8|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
5534112|NCT01369355|19129806|P7|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
5534113|NCT01369355|19129807|P6|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
5534114|NCT01369355|19129808|P5|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
5534115|NCT01369355|19129809|P4|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
5534116|NCT01369355|19129810|P3|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
5534117|NCT01369355|19129811|P2|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
5534118|NCT01369355|19129812|P1|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
5534119|NCT01369355|19129804|P9|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5534120|NCT01369355|19129805|P8|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5534121|NCT01369355|19129806|P7|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5534122|NCT01369355|19129807|P6|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
5534123|NCT01369355|19129808|P5|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
5534124|NCT01369355|19129809|P4|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
5534125|NCT01369355|19129810|P3|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
5534126|NCT01369355|19129811|P2|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
5534127|NCT01369355|19129812|P1|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
5534128|NCT01369355|19129804|P9|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5534129|NCT01369355|19129805|P8|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5534130|NCT01369355|19129806|P7|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5534131|NCT01369355|19129807|P6|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
5534132|NCT01369355|19129808|P5|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5534133|NCT01369355|19129809|P4|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5534134|NCT01369355|19129810|P3|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
5534135|NCT01369355|19129811|P2|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
5534136|NCT01369355|19129812|P1|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
5534137|NCT01369355|19129804|P9|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
5534138|NCT01369355|19129805|P8|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
5534139|NCT01369355|19129806|P7|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
5534140|NCT01369355|19129807|P6|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
5534141|NCT01369355|19129808|P5|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
5534142|NCT01369355|19129809|P4|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
5534143|NCT01369355|19129810|P3|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
5534144|NCT01369355|19129811|P2|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
5534145|NCT01369355|19129812|P1|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
5534146|NCT01369355|19129804|P9|Week 0 - Week 44 (Maintenance)|Adverse Event|0
5534147|NCT01369355|19129805|P8|Week 0 - Week 44 (Maintenance)|Adverse Event|0
5534148|NCT01369355|19129806|P7|Week 0 - Week 44 (Maintenance)|Adverse Event|0
5534149|NCT01369355|19129807|P6|Week 0 - Week 44 (Maintenance)|Adverse Event|25
5534150|NCT01369355|19129808|P5|Week 0 - Week 44 (Maintenance)|Adverse Event|14
5534151|NCT01369355|19129809|P4|Week 0 - Week 44 (Maintenance)|Adverse Event|7
5534152|NCT01369355|19129810|P3|Week 0 - Week 44 (Maintenance)|Adverse Event|6
5534153|NCT01369355|19129811|P2|Week 0 - Week 44 (Maintenance)|Adverse Event|12
5534154|NCT01369355|19129812|P1|Week 0 - Week 44 (Maintenance)|Adverse Event|9
5534155|NCT01369342|19129844|P3|Overall Study|Not Treated|0
5534156|NCT01369342|19129845|P2|Overall Study|Not Treated|0
5534157|NCT01369342|19129846|P1|Overall Study|Not Treated|1
5534158|NCT01369342|19129844|P3|Overall Study|Lost to Follow-up|1
5534159|NCT01369342|19129845|P2|Overall Study|Lost to Follow-up|2
5534160|NCT01369342|19129846|P1|Overall Study|Lost to Follow-up|5
5534161|NCT01369342|19129844|P3|Overall Study|Withdrawal by Subject|2
5534162|NCT01369342|19129845|P2|Overall Study|Withdrawal by Subject|7
5534163|NCT01369342|19129846|P1|Overall Study|Withdrawal by Subject|7
5534164|NCT01369329|19129869|P3|Overall Study|Other|2
5534165|NCT01369329|19129870|P2|Overall Study|Other|3
5534166|NCT01369329|19129871|P1|Overall Study|Other|2
5534167|NCT01369329|19129869|P3|Overall Study|Lost to Follow-up|2
5534168|NCT01369329|19129870|P2|Overall Study|Lost to Follow-up|2
5534169|NCT01369329|19129871|P1|Overall Study|Lost to Follow-up|2
5534170|NCT01369329|19129869|P3|Overall Study|Withdrawal by Subject|10
5534171|NCT01369329|19129870|P2|Overall Study|Withdrawal by Subject|6
5534172|NCT01369329|19129871|P1|Overall Study|Withdrawal by Subject|8
5534173|NCT01369225|19129897|P6|Overall Study|Adverse Event|0
5534174|NCT01369225|19129898|P5|Overall Study|Adverse Event|1
5534175|NCT01369225|19129899|P4|Overall Study|Adverse Event|1
5534176|NCT01369225|19129900|P3|Overall Study|Adverse Event|0
5534177|NCT01369225|19129901|P2|Overall Study|Adverse Event|0
5534178|NCT01369225|19129902|P1|Overall Study|Adverse Event|0
5534179|NCT01369225|19129897|P6|Overall Study|Other|0
5534180|NCT01369225|19129898|P5|Overall Study|Other|1
5534181|NCT01369225|19129899|P4|Overall Study|Other|0
5534182|NCT01369225|19129900|P3|Overall Study|Other|0
5534183|NCT01369225|19129901|P2|Overall Study|Other|0
5534184|NCT01369225|19129902|P1|Overall Study|Other|1
5534185|NCT01369225|19129897|P6|Overall Study|Does Not Meet Entrance Criteria|0
5534186|NCT01369225|19129898|P5|Overall Study|Does Not Meet Entrance Criteria|0
5534187|NCT01369225|19129899|P4|Overall Study|Does Not Meet Entrance Criteria|0
5534188|NCT01369225|19129900|P3|Overall Study|Does Not Meet Entrance Criteria|1
5534189|NCT01369225|19129901|P2|Overall Study|Does Not Meet Entrance Criteria|0
5534190|NCT01369225|19129902|P1|Overall Study|Does Not Meet Entrance Criteria|0
5534191|NCT01369225|19129897|P6|Overall Study|Withdrawal by Subject|0
5534192|NCT01369225|19129898|P5|Overall Study|Withdrawal by Subject|0
5534193|NCT01369225|19129899|P4|Overall Study|Withdrawal by Subject|1
5534194|NCT01369225|19129900|P3|Overall Study|Withdrawal by Subject|2
5534195|NCT01369225|19129901|P2|Overall Study|Withdrawal by Subject|0
5534196|NCT01369225|19129902|P1|Overall Study|Withdrawal by Subject|1
5534197|NCT01369199|19129994|P1|Overall Study|Lost to Follow-up|2
5534198|NCT01369199|19129994|P1|Overall Study|Withdrawal by Subject|1
5534199|NCT01369069|19130026|P2|Overall Study|Withdrawal by Subject|7
5534200|NCT01369069|19130027|P1|Overall Study|Withdrawal by Subject|9
5534201|NCT01369069|19130026|P2|Overall Study|Lost to Follow-up|9
5534202|NCT01369069|19130027|P1|Overall Study|Lost to Follow-up|8
5534203|NCT01368965|19130049|P1|Overall Study|Lost to Follow-up|12
5534204|NCT01368900|19130058|P1|Overall Study|Lost to Follow-up|7
5534205|NCT01368835|19130133|P1|Overall Study|Lost to Follow-up|11
5534206|NCT01368835|19130133|P1|Overall Study|Inclusion criteria/photography quality|22
5534207|NCT01368614|19130172|P4|Study Period|Lost to Follow-up|0
5534208|NCT01368614|19130173|P3|Study Period|Lost to Follow-up|1
5534209|NCT01368614|19130174|P2|Study Period|Lost to Follow-up|0
5534210|NCT01368614|19130175|P1|Study Period|Lost to Follow-up|0
5534211|NCT01368614|19130172|P4|Study Period|Withdrawal by Subject|3
5534212|NCT01368614|19130173|P3|Study Period|Withdrawal by Subject|1
5534213|NCT01368614|19130174|P2|Study Period|Withdrawal by Subject|1
5534214|NCT01368614|19130175|P1|Study Period|Withdrawal by Subject|0
5534215|NCT01368614|19130172|P4|Screening Period|Screen Failure|0
5534216|NCT01368614|19130173|P3|Screening Period|Screen Failure|0
5534217|NCT01368614|19130174|P2|Screening Period|Screen Failure|0
5534218|NCT01368614|19130175|P1|Screening Period|Screen Failure|58
5534219|NCT01368562|19130228|P1|Overall Study|Other than specified|2
5534220|NCT01368562|19130228|P1|Overall Study|Other|3
5534221|NCT01368562|19130228|P1|Overall Study|Unresponsive to treatment|5
5534222|NCT01368562|19130228|P1|Overall Study|Death|6
5534223|NCT01368562|19130228|P1|Overall Study|Lost to Follow-up|1
5534224|NCT01368562|19130228|P1|Overall Study|Disease progression|1
5534225|NCT01368562|19130228|P1|Overall Study|Adverse Event|1
5534226|NCT01368536|19130235|P3|Overall Study|Protocol deviation|1
5534227|NCT01368536|19130236|P2|Overall Study|Protocol deviation|3
5534228|NCT01368536|19130237|P1|Overall Study|Protocol deviation|0
5534229|NCT01368536|19130235|P3|Overall Study|Administrative problems|35
5534230|NCT01368536|19130236|P2|Overall Study|Administrative problems|39
5534231|NCT01368536|19130237|P1|Overall Study|Administrative problems|34
5534232|NCT01368536|19130235|P3|Overall Study|Lost to Follow-up|5
5534233|NCT01368536|19130236|P2|Overall Study|Lost to Follow-up|3
5534234|NCT01368536|19130237|P1|Overall Study|Lost to Follow-up|3
5534235|NCT01368536|19130235|P3|Overall Study|Withdrawal by Subject|4
5534236|NCT01368536|19130236|P2|Overall Study|Withdrawal by Subject|5
5534237|NCT01368536|19130237|P1|Overall Study|Withdrawal by Subject|2
5534238|NCT01368536|19130235|P3|Overall Study|No longer required study medication|1
5534239|NCT01368536|19130236|P2|Overall Study|No longer required study medication|0
5534240|NCT01368536|19130237|P1|Overall Study|No longer required study medication|0
5534241|NCT01368536|19130235|P3|Overall Study|Unsatisfactory therapeutic effect|2
5534242|NCT01368536|19130236|P2|Overall Study|Unsatisfactory therapeutic effect|2
5534243|NCT01368536|19130237|P1|Overall Study|Unsatisfactory therapeutic effect|7
5534244|NCT01368536|19130235|P3|Overall Study|Abnormal test procedure result(s)|1
5534245|NCT01368536|19130236|P2|Overall Study|Abnormal test procedure result(s)|0
5534246|NCT01368536|19130237|P1|Overall Study|Abnormal test procedure result(s)|0
5534247|NCT01368536|19130235|P3|Overall Study|Abnormal laboratory value(s)|2
5534248|NCT01368536|19130236|P2|Overall Study|Abnormal laboratory value(s)|1
5534249|NCT01368536|19130237|P1|Overall Study|Abnormal laboratory value(s)|0
5534250|NCT01368536|19130235|P3|Overall Study|Adverse Event|8
5534251|NCT01368536|19130236|P2|Overall Study|Adverse Event|6
5534252|NCT01368536|19130237|P1|Overall Study|Adverse Event|5
5534253|NCT01368497|19130258|P1|Overall Study|Lost to Follow-up|2
5534254|NCT01368432|19130287|P2|Overall Study|Lost to Follow-up|1
5534255|NCT01368432|19130288|P1|Overall Study|Lost to Follow-up|0
5534256|NCT01368406|19130322|P2|Overall Study|started working|3
5534257|NCT01368406|19130323|P1|Overall Study|started working|2
5534258|NCT01368406|19130322|P2|Overall Study|relapse of the disease|2
5534259|NCT01368406|19130323|P1|Overall Study|relapse of the disease|3
5534260|NCT01368406|19130322|P2|Overall Study|Withdrawal by Subject|4
5534261|NCT01368406|19130323|P1|Overall Study|Withdrawal by Subject|8
5534262|NCT01368406|19130322|P2|Overall Study|Lost to Follow-up|4
5534263|NCT01368406|19130323|P1|Overall Study|Lost to Follow-up|8
5534264|NCT01368276|19130331|P2|Overall Study|Death|10
5534265|NCT01368276|19130332|P1|Overall Study|Death|1
5534266|NCT01368211|19130369|P2|Second Platelets Transfusion|No need for additional transfusion|2
5534267|NCT01368211|19130370|P1|Second Platelets Transfusion|No need for additional transfusion|1
5534268|NCT01368081|19130398|P13|Overall Study|Other reason not defined above|3
5534269|NCT01368081|19130399|P12|Overall Study|Other reason not defined above|0
5534270|NCT01368081|19130400|P11|Overall Study|Other reason not defined above|0
5534271|NCT01368081|19130401|P10|Overall Study|Other reason not defined above|1
5534272|NCT01368081|19130402|P9|Overall Study|Other reason not defined above|0
5534273|NCT01368081|19130403|P8|Overall Study|Other reason not defined above|0
5534274|NCT01368081|19130404|P7|Overall Study|Other reason not defined above|2
5534275|NCT01368081|19130405|P6|Overall Study|Other reason not defined above|1
5534276|NCT01368081|19130406|P5|Overall Study|Other reason not defined above|0
5534277|NCT01368081|19130407|P4|Overall Study|Other reason not defined above|1
5534278|NCT01368081|19130408|P3|Overall Study|Other reason not defined above|0
5534279|NCT01368081|19130409|P2|Overall Study|Other reason not defined above|0
5534280|NCT01368081|19130410|P1|Overall Study|Other reason not defined above|2
5534281|NCT01368081|19130398|P13|Overall Study|Withdrawal by Subject|0
5534282|NCT01368081|19130399|P12|Overall Study|Withdrawal by Subject|2
5534283|NCT01368081|19130400|P11|Overall Study|Withdrawal by Subject|3
5534284|NCT01368081|19130401|P10|Overall Study|Withdrawal by Subject|4
5534285|NCT01368081|19130402|P9|Overall Study|Withdrawal by Subject|5
5534286|NCT01368081|19130403|P8|Overall Study|Withdrawal by Subject|2
5534287|NCT01368081|19130404|P7|Overall Study|Withdrawal by Subject|4
5534288|NCT01368081|19130405|P6|Overall Study|Withdrawal by Subject|3
5534289|NCT01368081|19130406|P5|Overall Study|Withdrawal by Subject|0
5534290|NCT01368081|19130407|P4|Overall Study|Withdrawal by Subject|1
5534291|NCT01368081|19130408|P3|Overall Study|Withdrawal by Subject|1
5534292|NCT01368081|19130409|P2|Overall Study|Withdrawal by Subject|4
5534293|NCT01368081|19130410|P1|Overall Study|Withdrawal by Subject|4
5534294|NCT01368081|19130398|P13|Overall Study|Lost to Follow-up|1
5534295|NCT01368081|19130399|P12|Overall Study|Lost to Follow-up|0
5534296|NCT01368081|19130400|P11|Overall Study|Lost to Follow-up|0
5534297|NCT01368081|19130401|P10|Overall Study|Lost to Follow-up|0
5534298|NCT01368081|19130402|P9|Overall Study|Lost to Follow-up|0
5534299|NCT01368081|19130403|P8|Overall Study|Lost to Follow-up|0
5534300|NCT01368081|19130404|P7|Overall Study|Lost to Follow-up|0
5534301|NCT01368081|19130405|P6|Overall Study|Lost to Follow-up|0
5534302|NCT01368081|19130406|P5|Overall Study|Lost to Follow-up|0
5534303|NCT01368081|19130407|P4|Overall Study|Lost to Follow-up|0
5534304|NCT01368081|19130408|P3|Overall Study|Lost to Follow-up|0
5534305|NCT01368081|19130409|P2|Overall Study|Lost to Follow-up|0
5534306|NCT01368081|19130410|P1|Overall Study|Lost to Follow-up|0
5534307|NCT01368081|19130398|P13|Overall Study|Protocol Violation|0
5534308|NCT01368081|19130399|P12|Overall Study|Protocol Violation|0
5534309|NCT01368081|19130400|P11|Overall Study|Protocol Violation|0
5534310|NCT01368081|19130401|P10|Overall Study|Protocol Violation|0
5534311|NCT01368081|19130402|P9|Overall Study|Protocol Violation|0
5534312|NCT01368081|19130403|P8|Overall Study|Protocol Violation|1
5534313|NCT01368081|19130404|P7|Overall Study|Protocol Violation|0
5534314|NCT01368081|19130405|P6|Overall Study|Protocol Violation|1
5534315|NCT01368081|19130406|P5|Overall Study|Protocol Violation|0
5534316|NCT01368081|19130407|P4|Overall Study|Protocol Violation|0
5534317|NCT01368081|19130408|P3|Overall Study|Protocol Violation|0
5534318|NCT01368081|19130409|P2|Overall Study|Protocol Violation|0
5534319|NCT01368081|19130410|P1|Overall Study|Protocol Violation|0
5534320|NCT01368081|19130398|P13|Overall Study|Lack of Efficacy|0
5534321|NCT01368081|19130399|P12|Overall Study|Lack of Efficacy|0
5534322|NCT01368081|19130400|P11|Overall Study|Lack of Efficacy|0
5534323|NCT01368081|19130401|P10|Overall Study|Lack of Efficacy|0
5534324|NCT01368081|19130402|P9|Overall Study|Lack of Efficacy|0
5534325|NCT01368081|19130403|P8|Overall Study|Lack of Efficacy|2
5534326|NCT01368081|19130404|P7|Overall Study|Lack of Efficacy|0
5534327|NCT01368081|19130405|P6|Overall Study|Lack of Efficacy|0
5534328|NCT01368081|19130406|P5|Overall Study|Lack of Efficacy|0
5534329|NCT01368081|19130407|P4|Overall Study|Lack of Efficacy|1
5534330|NCT01368081|19130408|P3|Overall Study|Lack of Efficacy|0
5534331|NCT01368081|19130409|P2|Overall Study|Lack of Efficacy|1
5534332|NCT01368081|19130410|P1|Overall Study|Lack of Efficacy|0
5534333|NCT01368081|19130398|P13|Overall Study|Adverse Event|3
5534334|NCT01368081|19130399|P12|Overall Study|Adverse Event|1
5534335|NCT01368081|19130400|P11|Overall Study|Adverse Event|6
5534336|NCT01368081|19130401|P10|Overall Study|Adverse Event|5
5534337|NCT01368081|19130402|P9|Overall Study|Adverse Event|3
5534338|NCT01368081|19130403|P8|Overall Study|Adverse Event|2
5534339|NCT01368081|19130404|P7|Overall Study|Adverse Event|6
5534340|NCT01368081|19130405|P6|Overall Study|Adverse Event|5
5534341|NCT01368081|19130406|P5|Overall Study|Adverse Event|2
5534342|NCT01368081|19130407|P4|Overall Study|Adverse Event|2
5534343|NCT01368081|19130408|P3|Overall Study|Adverse Event|3
5534344|NCT01368081|19130409|P2|Overall Study|Adverse Event|4
5534345|NCT01368081|19130410|P1|Overall Study|Adverse Event|4
5534346|NCT01368042|19130464|P1|Overall Study|Transplanted|1
5534347|NCT01368042|19130464|P1|Overall Study|Lost to Follow-up|4
5534348|NCT01368042|19130464|P1|Overall Study|Protocol Violation|11
5534349|NCT01368042|19130464|P1|Overall Study|Death|14
5534350|NCT01367886|19130484|P1|Overall Study|Death|1
5534351|NCT01367886|19130484|P1|Overall Study|Lack of Efficacy|2
5534352|NCT01367886|19130484|P1|Overall Study|Lost to Follow-up|4
5534353|NCT01367847|19130534|P2|Overall Study|Withdrawal by Subject|2
5534354|NCT01367847|19130535|P1|Overall Study|Withdrawal by Subject|2
5534355|NCT01367834|19130551|P2|Overall Study|Study was ended.|1
5534356|NCT01367834|19130552|P1|Overall Study|Study was ended.|0
5534357|NCT01367834|19130551|P2|Overall Study|Withdrawal by Subject|2
5534358|NCT01367834|19130552|P1|Overall Study|Withdrawal by Subject|2
5534359|NCT01367704|19130576|P2|Overall Study|Lost to Follow-up|161
5534360|NCT01367704|19130577|P1|Overall Study|Lost to Follow-up|47
5534361|NCT01367665|19130589|P2|Overall Study|Not Done|14
5534362|NCT01367665|19130590|P1|Overall Study|Not Done|118
5534363|NCT01367665|19130589|P2|Overall Study|Lost to Follow-up|22
5534364|NCT01367665|19130590|P1|Overall Study|Lost to Follow-up|222
5534365|NCT01367665|19130589|P2|Overall Study|Death|19
5534366|NCT01367665|19130590|P1|Overall Study|Death|102
5534367|NCT01367457|19130621|P3|Overall Study|Suspected DP/suspected active infection|0
5534368|NCT01367457|19130622|P2|Overall Study|Suspected DP/suspected active infection|0
5534369|NCT01367457|19130623|P1|Overall Study|Suspected DP/suspected active infection|1
5534370|NCT01367457|19130621|P3|Overall Study|Palliative. Overall decline|0
5534371|NCT01367457|19130622|P2|Overall Study|Palliative. Overall decline|0
5534372|NCT01367457|19130623|P1|Overall Study|Palliative. Overall decline|1
5534373|NCT01367457|19130621|P3|Overall Study|Patient's Wish|0
5534374|NCT01367457|19130622|P2|Overall Study|Patient's Wish|0
5534375|NCT01367457|19130623|P1|Overall Study|Patient's Wish|1
5534376|NCT01367457|19130621|P3|Overall Study|CD, Suspected disease progression (DP)|0
5534377|NCT01367457|19130622|P2|Overall Study|CD, Suspected disease progression (DP)|0
5534378|NCT01367457|19130623|P1|Overall Study|CD, Suspected disease progression (DP)|1
5534379|NCT01367457|19130621|P3|Overall Study|Death from septic shock|0
5534380|NCT01367457|19130622|P2|Overall Study|Death from septic shock|0
5534381|NCT01367457|19130623|P1|Overall Study|Death from septic shock|1
5534382|NCT01367457|19130621|P3|Overall Study|Lost to Follow-up|0
5534383|NCT01367457|19130622|P2|Overall Study|Lost to Follow-up|0
5534384|NCT01367457|19130623|P1|Overall Study|Lost to Follow-up|1
5534385|NCT01367457|19130621|P3|Overall Study|Rejection of treatment|0
5534386|NCT01367457|19130622|P2|Overall Study|Rejection of treatment|0
5534387|NCT01367457|19130623|P1|Overall Study|Rejection of treatment|1
5534388|NCT01367457|19130621|P3|Overall Study|Overall decline|0
5534389|NCT01367457|19130622|P2|Overall Study|Overall decline|0
5534390|NCT01367457|19130623|P1|Overall Study|Overall decline|1
5534391|NCT01367457|19130621|P3|Overall Study|Intestinal obstruction with necrosis|0
5534392|NCT01367457|19130622|P2|Overall Study|Intestinal obstruction with necrosis|0
5534393|NCT01367457|19130623|P1|Overall Study|Intestinal obstruction with necrosis|1
5534394|NCT01367457|19130621|P3|Overall Study|No clinical benefit|0
5534395|NCT01367457|19130622|P2|Overall Study|No clinical benefit|0
5534396|NCT01367457|19130623|P1|Overall Study|No clinical benefit|1
5534397|NCT01367457|19130621|P3|Overall Study|Stabilisation + frequent infections|0
5534398|NCT01367457|19130622|P2|Overall Study|Stabilisation + frequent infections|0
5534399|NCT01367457|19130623|P1|Overall Study|Stabilisation + frequent infections|1
5534400|NCT01367457|19130621|P3|Overall Study|Overall status worsens to grade 4|0
5534401|NCT01367457|19130622|P2|Overall Study|Overall status worsens to grade 4|0
5534402|NCT01367457|19130623|P1|Overall Study|Overall status worsens to grade 4|1
5534403|NCT01367457|19130621|P3|Overall Study|Uncontrolled pain|0
5534404|NCT01367457|19130622|P2|Overall Study|Uncontrolled pain|0
5534405|NCT01367457|19130623|P1|Overall Study|Uncontrolled pain|1
5534406|NCT01367457|19130621|P3|Overall Study|CD, associated leukaemia|0
5534407|NCT01367457|19130622|P2|Overall Study|CD, associated leukaemia|0
5534408|NCT01367457|19130623|P1|Overall Study|CD, associated leukaemia|1
5534409|NCT01367457|19130621|P3|Overall Study|Withdrawal by Subject|0
5534410|NCT01367457|19130622|P2|Overall Study|Withdrawal by Subject|0
5534411|NCT01367457|19130623|P1|Overall Study|Withdrawal by Subject|1
5534412|NCT01367457|19130621|P3|Overall Study|Choledocolithiasis and pancreatitis|0
5534413|NCT01367457|19130622|P2|Overall Study|Choledocolithiasis and pancreatitis|0
5534414|NCT01367457|19130623|P1|Overall Study|Choledocolithiasis and pancreatitis|1
5534415|NCT01367457|19130621|P3|Overall Study|low grade toxicities + stable disease|0
5534416|NCT01367457|19130622|P2|Overall Study|low grade toxicities + stable disease|0
5534417|NCT01367457|19130623|P1|Overall Study|low grade toxicities + stable disease|1
5534418|NCT01367457|19130621|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
5534419|NCT01367457|19130622|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
5534420|NCT01367457|19130623|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
5534421|NCT01367457|19130621|P3|Overall Study|Bleeding from cavernous haemangioma|0
5534422|NCT01367457|19130622|P2|Overall Study|Bleeding from cavernous haemangioma|0
5534423|NCT01367457|19130623|P1|Overall Study|Bleeding from cavernous haemangioma|1
5534424|NCT01367457|19130621|P3|Overall Study|Investigator's opinion, stable disease|0
5534425|NCT01367457|19130622|P2|Overall Study|Investigator's opinion, stable disease|0
5534426|NCT01367457|19130623|P1|Overall Study|Investigator's opinion, stable disease|1
5534427|NCT01367457|19130621|P3|Overall Study|Patient asks for rest + slow progression|0
5534428|NCT01367457|19130622|P2|Overall Study|Patient asks for rest + slow progression|0
5534429|NCT01367457|19130623|P1|Overall Study|Patient asks for rest + slow progression|1
5534430|NCT01367457|19130621|P3|Overall Study|Progression|0
5534431|NCT01367457|19130622|P2|Overall Study|Progression|0
5534432|NCT01367457|19130623|P1|Overall Study|Progression|137
5534433|NCT01367457|19130621|P3|Overall Study|Toxicity|0
5534434|NCT01367457|19130622|P2|Overall Study|Toxicity|0
5534435|NCT01367457|19130623|P1|Overall Study|Toxicity|16
5534436|NCT01367457|19130621|P3|Overall Study|Progression and death|0
5534437|NCT01367457|19130622|P2|Overall Study|Progression and death|0
5534438|NCT01367457|19130623|P1|Overall Study|Progression and death|8
5534439|NCT01367457|19130621|P3|Overall Study|Clinical decline (CD)|0
5534440|NCT01367457|19130622|P2|Overall Study|Clinical decline (CD)|0
5534441|NCT01367457|19130623|P1|Overall Study|Clinical decline (CD)|2
5534442|NCT01367457|19130621|P3|Overall Study|Investigator's decision|0
5534443|NCT01367457|19130622|P2|Overall Study|Investigator's decision|0
5534444|NCT01367457|19130623|P1|Overall Study|Investigator's decision|2
5534445|NCT01367457|19130621|P3|Overall Study|Death|0
5534446|NCT01367457|19130622|P2|Overall Study|Death|0
5534447|NCT01367457|19130623|P1|Overall Study|Death|2
5534448|NCT01367275|19130679|P1|Overall Study|Disease Progression|2
5534449|NCT01367275|19130679|P1|Overall Study|Ineligible|1
5534450|NCT01367249|19130696|P2|Overall Study|Other|10
5534451|NCT01367249|19130697|P1|Overall Study|Other|3
5534452|NCT01367249|19130696|P2|Overall Study|Withdrawal by Subject|6
5534453|NCT01367249|19130697|P1|Overall Study|Withdrawal by Subject|6
5534454|NCT01367236|19130707|P2|Overall Study|Withdrawal by Subject|1
5534455|NCT01367236|19130708|P1|Overall Study|Withdrawal by Subject|3
5534456|NCT01367158|19130727|P11|Overall Study|Protocol Violation|0
5534457|NCT01367158|19130728|P10|Overall Study|Protocol Violation|0
5534458|NCT01367158|19130729|P9|Overall Study|Protocol Violation|0
5534459|NCT01367158|19130730|P8|Overall Study|Protocol Violation|0
5534460|NCT01367158|19130731|P7|Overall Study|Protocol Violation|0
5534461|NCT01367158|19130732|P6|Overall Study|Protocol Violation|0
5534462|NCT01367158|19130733|P5|Overall Study|Protocol Violation|0
5534463|NCT01367158|19130734|P4|Overall Study|Protocol Violation|0
5534464|NCT01367158|19130735|P3|Overall Study|Protocol Violation|0
5534465|NCT01367158|19130736|P2|Overall Study|Protocol Violation|1
5534466|NCT01367158|19130737|P1|Overall Study|Protocol Violation|0
5534467|NCT01367158|19130727|P11|Overall Study|Lost to Follow-up|1
5534468|NCT01367158|19130728|P10|Overall Study|Lost to Follow-up|0
5534469|NCT01367158|19130729|P9|Overall Study|Lost to Follow-up|0
5534470|NCT01367158|19130730|P8|Overall Study|Lost to Follow-up|1
5534471|NCT01367158|19130731|P7|Overall Study|Lost to Follow-up|0
5534472|NCT01367158|19130732|P6|Overall Study|Lost to Follow-up|2
5534473|NCT01367158|19130733|P5|Overall Study|Lost to Follow-up|0
5534474|NCT01367158|19130734|P4|Overall Study|Lost to Follow-up|1
5534475|NCT01367158|19130735|P3|Overall Study|Lost to Follow-up|0
5534476|NCT01367158|19130736|P2|Overall Study|Lost to Follow-up|0
5534477|NCT01367158|19130737|P1|Overall Study|Lost to Follow-up|0
5534478|NCT01367158|19130727|P11|Overall Study|Withdrew consent|0
5534479|NCT01367158|19130728|P10|Overall Study|Withdrew consent|0
5534480|NCT01367158|19130729|P9|Overall Study|Withdrew consent|0
5534481|NCT01367158|19130730|P8|Overall Study|Withdrew consent|1
5534482|NCT01367158|19130731|P7|Overall Study|Withdrew consent|0
5534483|NCT01367158|19130732|P6|Overall Study|Withdrew consent|0
5534484|NCT01367158|19130733|P5|Overall Study|Withdrew consent|2
5534485|NCT01367158|19130734|P4|Overall Study|Withdrew consent|0
5534486|NCT01367158|19130735|P3|Overall Study|Withdrew consent|1
5534487|NCT01367158|19130736|P2|Overall Study|Withdrew consent|2
5534488|NCT01367158|19130737|P1|Overall Study|Withdrew consent|0
5534489|NCT01367119|19130881|P2|Overall Study|Withdrawal by Subject|1
5534490|NCT01367119|19130882|P1|Overall Study|Withdrawal by Subject|1
5534491|NCT01367119|19130881|P2|Overall Study|Adverse Event|0
5534492|NCT01367119|19130882|P1|Overall Study|Adverse Event|1
5534493|NCT01366846|19130937|P4|Overall Study|Scheduling Conflicts|0
5534494|NCT01366846|19130938|P3|Overall Study|Scheduling Conflicts|1
5534495|NCT01366846|19130939|P2|Overall Study|Scheduling Conflicts|0
5534496|NCT01366846|19130940|P1|Overall Study|Scheduling Conflicts|0
5534497|NCT01366846|19130937|P4|Overall Study|Communication Difficulties|1
5534498|NCT01366846|19130938|P3|Overall Study|Communication Difficulties|0
5534499|NCT01366846|19130939|P2|Overall Study|Communication Difficulties|4
5534500|NCT01366846|19130940|P1|Overall Study|Communication Difficulties|1
5534501|NCT01366846|19130937|P4|Overall Study|Withdrawal by Subject|0
5534502|NCT01366846|19130938|P3|Overall Study|Withdrawal by Subject|0
5534503|NCT01366846|19130939|P2|Overall Study|Withdrawal by Subject|0
5534504|NCT01366846|19130940|P1|Overall Study|Withdrawal by Subject|2
5534505|NCT01366638|19130963|P3|Overall Study|Other|0
5534506|NCT01366638|19130964|P2|Overall Study|Other|0
5534507|NCT01366638|19130965|P1|Overall Study|Other|1
5534508|NCT01366638|19130963|P3|Overall Study|Withdrawal by Subject|6
5534509|NCT01366638|19130964|P2|Overall Study|Withdrawal by Subject|0
5534510|NCT01366638|19130965|P1|Overall Study|Withdrawal by Subject|0
5534511|NCT01366534|19131002|P3|Overall Study|Declined challenged|0
5534512|NCT01366534|19131003|P2|Overall Study|Declined challenged|1
5534513|NCT01366534|19131004|P1|Overall Study|Declined challenged|0
5534514|NCT01366534|19131002|P3|Overall Study|Migrated|0
5534515|NCT01366534|19131003|P2|Overall Study|Migrated|1
5534516|NCT01366534|19131004|P1|Overall Study|Migrated|1
5534517|NCT01366534|19131002|P3|Overall Study|Lost to Follow-up|0
5534518|NCT01366534|19131003|P2|Overall Study|Lost to Follow-up|0
5534519|NCT01366534|19131004|P1|Overall Study|Lost to Follow-up|1
5534520|NCT01366521|19131054|P4|Overall Study|Withdrawal by Subject|0
5534521|NCT01366521|19131055|P3|Overall Study|Withdrawal by Subject|0
5534522|NCT01366521|19131056|P2|Overall Study|Withdrawal by Subject|1
5534523|NCT01366521|19131057|P1|Overall Study|Withdrawal by Subject|0
5534524|NCT01366521|19131054|P4|Overall Study|Physician Decision|0
5534525|NCT01366521|19131055|P3|Overall Study|Physician Decision|1
5534526|NCT01366521|19131056|P2|Overall Study|Physician Decision|0
5534527|NCT01366521|19131057|P1|Overall Study|Physician Decision|0
5534528|NCT01366521|19131054|P4|Overall Study|Protocol Violation|0
5534529|NCT01366521|19131055|P3|Overall Study|Protocol Violation|1
5534530|NCT01366521|19131056|P2|Overall Study|Protocol Violation|0
5534531|NCT01366521|19131057|P1|Overall Study|Protocol Violation|0
5534532|NCT01366521|19131054|P4|Overall Study|Adverse Event|0
5534533|NCT01366521|19131055|P3|Overall Study|Adverse Event|0
5534534|NCT01366521|19131056|P2|Overall Study|Adverse Event|0
5534535|NCT01366521|19131057|P1|Overall Study|Adverse Event|1
5534536|NCT01366443|19131153|P1|Overall Study|Under 18 yo|1
5534537|NCT01366443|19131153|P1|Overall Study|Lost to Follow-up|2
5534538|NCT01366209|19131167|P2|Overall Study|Withdrew consent|3
5534539|NCT01366209|19131168|P1|Overall Study|Withdrew consent|4
5534540|NCT01366209|19131167|P2|Overall Study|Sponsors decision|1
5534541|NCT01366209|19131168|P1|Overall Study|Sponsors decision|0
5534542|NCT01366209|19131167|P2|Overall Study|Physician Decision|0
5534543|NCT01366209|19131168|P1|Overall Study|Physician Decision|1
5534544|NCT01366209|19131167|P2|Overall Study|Lost to Follow-up|1
5534545|NCT01366209|19131168|P1|Overall Study|Lost to Follow-up|2
5534546|NCT01366209|19131167|P2|Overall Study|Lung transplantation|1
5534547|NCT01366209|19131168|P1|Overall Study|Lung transplantation|6
5534548|NCT01366209|19131167|P2|Overall Study|Death|19
5534549|NCT01366209|19131168|P1|Overall Study|Death|12
5534550|NCT01366209|19131167|P2|Overall Study|Withdrawal by Subject|4
5534551|NCT01366209|19131168|P1|Overall Study|Withdrawal by Subject|4
5534552|NCT01366209|19131167|P2|Overall Study|Adverse Event|7
5534553|NCT01366209|19131168|P1|Overall Study|Adverse Event|6
5534554|NCT01366092|19131191|P1|Overall Study|Withdrawal by Subject|1
5534555|NCT01366092|19131191|P1|Overall Study|Physician Decision|1
5534556|NCT01366092|19131191|P1|Overall Study|Progressive cGVHD|2
5534557|NCT01365910|19131200|P1|Overall Study|pt did not get tx, nausea/vomiting|1
5534558|NCT01365910|19131200|P1|Overall Study|other complicating disease|1
5534559|NCT01365910|19131200|P1|Overall Study|Adverse Event|3
5534560|NCT01365910|19131200|P1|Overall Study|disease progression|18
5534561|NCT01365910|19131200|P1|Overall Study|Withdrawal by Subject|7
5534562|NCT01365546|19131336|P1|Overall Study|Study termination|1
5534563|NCT01365546|19131336|P1|Overall Study|Screen failure|9
5534564|NCT01365546|19131336|P1|Overall Study|Withdrawal by Subject|1
5534565|NCT01365507|19131346|P2|Overall Study|Unclassified|4
5534566|NCT01365507|19131347|P1|Overall Study|Unclassified|1
5534567|NCT01365507|19131346|P2|Overall Study|Withdrawal Criteria|5
5534568|NCT01365507|19131347|P1|Overall Study|Withdrawal Criteria|8
5534569|NCT01365494|19131363|P2|Overall Study|Lost to Follow-up|2
5534570|NCT01365494|19131364|P1|Overall Study|Lost to Follow-up|1
5534571|NCT01365494|19131363|P2|Overall Study|Withdrawal by Subject|1
5534572|NCT01365494|19131364|P1|Overall Study|Withdrawal by Subject|0
5534573|NCT01365494|19131363|P2|Overall Study|Adverse Event|0
5534574|NCT01365494|19131364|P1|Overall Study|Adverse Event|1
5534575|NCT01365481|19131380|P4|Overall Study|Unsatisfactory therapeutic effect|0
5534576|NCT01365481|19131381|P3|Overall Study|Unsatisfactory therapeutic effect|1
5534577|NCT01365481|19131382|P2|Overall Study|Unsatisfactory therapeutic effect|0
5534578|NCT01365481|19131383|P1|Overall Study|Unsatisfactory therapeutic effect|0
5534579|NCT01365481|19131380|P4|Overall Study|Protocol deviation|1
5534580|NCT01365481|19131381|P3|Overall Study|Protocol deviation|0
5534581|NCT01365481|19131382|P2|Overall Study|Protocol deviation|1
5534582|NCT01365481|19131383|P1|Overall Study|Protocol deviation|0
5534583|NCT01365481|19131380|P4|Overall Study|Administrative problems|0
5534584|NCT01365481|19131381|P3|Overall Study|Administrative problems|0
5534585|NCT01365481|19131382|P2|Overall Study|Administrative problems|1
5534586|NCT01365481|19131383|P1|Overall Study|Administrative problems|0
5534587|NCT01365481|19131380|P4|Overall Study|Abnormal laboratory value(s)|0
5534588|NCT01365481|19131381|P3|Overall Study|Abnormal laboratory value(s)|0
5534589|NCT01365481|19131382|P2|Overall Study|Abnormal laboratory value(s)|1
5534590|NCT01365481|19131383|P1|Overall Study|Abnormal laboratory value(s)|0
5534591|NCT01365481|19131380|P4|Overall Study|Lost to Follow-up|3
5534592|NCT01365481|19131381|P3|Overall Study|Lost to Follow-up|2
5534593|NCT01365481|19131382|P2|Overall Study|Lost to Follow-up|1
5534594|NCT01365481|19131383|P1|Overall Study|Lost to Follow-up|1
5534595|NCT01365481|19131380|P4|Overall Study|Withdrawal by Subject|1
5534596|NCT01365481|19131381|P3|Overall Study|Withdrawal by Subject|1
5534597|NCT01365481|19131382|P2|Overall Study|Withdrawal by Subject|2
5534598|NCT01365481|19131383|P1|Overall Study|Withdrawal by Subject|0
5534599|NCT01365481|19131380|P4|Overall Study|Adverse Event|2
5534600|NCT01365481|19131381|P3|Overall Study|Adverse Event|0
5534601|NCT01365481|19131382|P2|Overall Study|Adverse Event|9
5534602|NCT01365481|19131383|P1|Overall Study|Adverse Event|6
5534603|NCT01365468|19131403|P2|Overall Study|Lost to Follow-up|0
5534604|NCT01365468|19131404|P1|Overall Study|Lost to Follow-up|2
5534605|NCT01365468|19131403|P2|Overall Study|Disease progression|0
5534606|NCT01365468|19131404|P1|Overall Study|Disease progression|1
5534607|NCT01365468|19131403|P2|Overall Study|Physician Decision|0
5534608|NCT01365468|19131404|P1|Overall Study|Physician Decision|1
5534609|NCT01365455|19131419|P5|Maintenance Period|Subject/guardian decision|1
5534610|NCT01365455|19131420|P4|Maintenance Period|Subject/guardian decision|4
5534611|NCT01365455|19131421|P3|Maintenance Period|Subject/guardian decision|2
5534612|NCT01365455|19131422|P2|Maintenance Period|Subject/guardian decision|6
5534613|NCT01365455|19131423|P1|Maintenance Period|Subject/guardian decision|4
5534614|NCT01365455|19131419|P5|Maintenance Period|Protocol deviation|0
5534615|NCT01365455|19131420|P4|Maintenance Period|Protocol deviation|0
5534616|NCT01365455|19131421|P3|Maintenance Period|Protocol deviation|0
5534617|NCT01365455|19131422|P2|Maintenance Period|Protocol deviation|1
5534618|NCT01365455|19131423|P1|Maintenance Period|Protocol deviation|1
5534619|NCT01365455|19131419|P5|Maintenance Period|Pregnancy|2
5534620|NCT01365455|19131420|P4|Maintenance Period|Pregnancy|0
5534621|NCT01365455|19131421|P3|Maintenance Period|Pregnancy|0
5534622|NCT01365455|19131422|P2|Maintenance Period|Pregnancy|4
5534623|NCT01365455|19131423|P1|Maintenance Period|Pregnancy|0
5534624|NCT01365455|19131419|P5|Maintenance Period|Physician Decision|1
5534625|NCT01365455|19131420|P4|Maintenance Period|Physician Decision|0
5534626|NCT01365455|19131421|P3|Maintenance Period|Physician Decision|0
5534627|NCT01365455|19131422|P2|Maintenance Period|Physician Decision|1
5534628|NCT01365455|19131423|P1|Maintenance Period|Physician Decision|0
5534629|NCT01365455|19131419|P5|Maintenance Period|Non-compliance with study treatment|0
5534630|NCT01365455|19131420|P4|Maintenance Period|Non-compliance with study treatment|1
5534631|NCT01365455|19131421|P3|Maintenance Period|Non-compliance with study treatment|0
5534632|NCT01365455|19131422|P2|Maintenance Period|Non-compliance with study treatment|0
5534633|NCT01365455|19131423|P1|Maintenance Period|Non-compliance with study treatment|0
5534634|NCT01365455|19131419|P5|Maintenance Period|Lost to Follow-up|3
5534635|NCT01365455|19131420|P4|Maintenance Period|Lost to Follow-up|0
5534636|NCT01365455|19131421|P3|Maintenance Period|Lost to Follow-up|0
5534637|NCT01365455|19131422|P2|Maintenance Period|Lost to Follow-up|4
5534638|NCT01365455|19131423|P1|Maintenance Period|Lost to Follow-up|2
5534639|NCT01365455|19131419|P5|Maintenance Period|Lack of Efficacy|2
5534640|NCT01365455|19131420|P4|Maintenance Period|Lack of Efficacy|2
5534641|NCT01365455|19131421|P3|Maintenance Period|Lack of Efficacy|0
5534642|NCT01365455|19131422|P2|Maintenance Period|Lack of Efficacy|2
5534643|NCT01365455|19131423|P1|Maintenance Period|Lack of Efficacy|10
5534644|NCT01365455|19131419|P5|Maintenance Period|Adverse Event|4
5534645|NCT01365455|19131420|P4|Maintenance Period|Adverse Event|2
5534646|NCT01365455|19131421|P3|Maintenance Period|Adverse Event|1
5534647|NCT01365455|19131422|P2|Maintenance Period|Adverse Event|5
5534648|NCT01365455|19131423|P1|Maintenance Period|Adverse Event|12
5534649|NCT01365455|19131419|P5|Induction Period|Lost to Follow-up|0
5534650|NCT01365455|19131420|P4|Induction Period|Lost to Follow-up|0
5534651|NCT01365455|19131421|P3|Induction Period|Lost to Follow-up|3
5534652|NCT01365455|19131422|P2|Induction Period|Lost to Follow-up|0
5534653|NCT01365455|19131423|P1|Induction Period|Lost to Follow-up|0
5534654|NCT01365455|19131419|P5|Induction Period|Subject/guardian decision|0
5534655|NCT01365455|19131420|P4|Induction Period|Subject/guardian decision|0
5534656|NCT01365455|19131421|P3|Induction Period|Subject/guardian decision|8
5534657|NCT01365455|19131422|P2|Induction Period|Subject/guardian decision|1
5534658|NCT01365455|19131423|P1|Induction Period|Subject/guardian decision|9
5534659|NCT01365455|19131419|P5|Induction Period|Protocol deviation|0
5534660|NCT01365455|19131420|P4|Induction Period|Protocol deviation|0
5534661|NCT01365455|19131421|P3|Induction Period|Protocol deviation|1
5534662|NCT01365455|19131422|P2|Induction Period|Protocol deviation|1
5534663|NCT01365455|19131423|P1|Induction Period|Protocol deviation|0
5534664|NCT01365455|19131419|P5|Induction Period|Pregnancy|0
5534665|NCT01365455|19131420|P4|Induction Period|Pregnancy|0
5534666|NCT01365455|19131421|P3|Induction Period|Pregnancy|0
5534667|NCT01365455|19131422|P2|Induction Period|Pregnancy|1
5534668|NCT01365455|19131423|P1|Induction Period|Pregnancy|0
5534669|NCT01365455|19131419|P5|Induction Period|Lack of Efficacy|0
5534670|NCT01365455|19131420|P4|Induction Period|Lack of Efficacy|0
5534671|NCT01365455|19131421|P3|Induction Period|Lack of Efficacy|0
5534672|NCT01365455|19131422|P2|Induction Period|Lack of Efficacy|1
5534673|NCT01365455|19131423|P1|Induction Period|Lack of Efficacy|1
5534674|NCT01365455|19131419|P5|Induction Period|Adverse Event|0
5534675|NCT01365455|19131420|P4|Induction Period|Adverse Event|0
5534676|NCT01365455|19131421|P3|Induction Period|Adverse Event|4
5534677|NCT01365455|19131422|P2|Induction Period|Adverse Event|3
5534678|NCT01365455|19131423|P1|Induction Period|Adverse Event|5
5534679|NCT01365273|19131513|P2|Overall Study|Physician Decision|0
5534680|NCT01365273|19131514|P1|Overall Study|Physician Decision|1
5534681|NCT01365273|19131513|P2|Overall Study|Protocol Violation|1
5534682|NCT01365273|19131514|P1|Overall Study|Protocol Violation|0
5534683|NCT01365273|19131513|P2|Overall Study|Lost to Follow-up|0
5534684|NCT01365273|19131514|P1|Overall Study|Lost to Follow-up|1
5534685|NCT01365130|19131524|P1|Overall Study|Progression/worsening of Dx prior to txt|2
5534686|NCT01365091|19131533|P4|Period 2|Adverse Event|0
5534687|NCT01365091|19131534|P3|Period 2|Adverse Event|1
5534688|NCT01365091|19131535|P2|Period 2|Adverse Event|0
5534689|NCT01365091|19131536|P1|Period 2|Adverse Event|0
5534690|NCT01365091|19131533|P4|Period 2|Withdrawal by Subject|0
5534691|NCT01365091|19131534|P3|Period 2|Withdrawal by Subject|0
5534692|NCT01365091|19131535|P2|Period 2|Withdrawal by Subject|0
5534693|NCT01365091|19131536|P1|Period 2|Withdrawal by Subject|1
5534694|NCT01365091|19131533|P4|Period 1|Personal reasons|0
5534695|NCT01365091|19131534|P3|Period 1|Personal reasons|1
5534696|NCT01365091|19131535|P2|Period 1|Personal reasons|0
5534697|NCT01365091|19131536|P1|Period 1|Personal reasons|0
5534698|NCT01365091|19131533|P4|Period 1|Withdrawal by Subject|0
5534699|NCT01365091|19131534|P3|Period 1|Withdrawal by Subject|0
5534700|NCT01365091|19131535|P2|Period 1|Withdrawal by Subject|1
5534701|NCT01365091|19131536|P1|Period 1|Withdrawal by Subject|0
5534702|NCT01365091|19131533|P4|Period 1|No longer met study criteria|0
5534703|NCT01365091|19131534|P3|Period 1|No longer met study criteria|0
5534704|NCT01365091|19131535|P2|Period 1|No longer met study criteria|1
5534705|NCT01365091|19131536|P1|Period 1|No longer met study criteria|0
5534706|NCT01365091|19131533|P4|Period 1|Positive test result for drugs of abuse|0
5534707|NCT01365091|19131534|P3|Period 1|Positive test result for drugs of abuse|0
5534708|NCT01365091|19131535|P2|Period 1|Positive test result for drugs of abuse|0
5534709|NCT01365091|19131536|P1|Period 1|Positive test result for drugs of abuse|1
5534710|NCT01365091|19131533|P4|Period 1|Adverse Event|3
5534711|NCT01365091|19131534|P3|Period 1|Adverse Event|2
5534712|NCT01365091|19131535|P2|Period 1|Adverse Event|0
5534713|NCT01365091|19131536|P1|Period 1|Adverse Event|1
5534714|NCT01365052|19131564|P2|Overall Study|Adverse Event|4
5534715|NCT01365052|19131565|P1|Overall Study|Adverse Event|4
5534716|NCT01365039|19131581|P2|Overall Study|Study related symptoms and complaints|0
5534717|NCT01365039|19131582|P1|Overall Study|Study related symptoms and complaints|1
5534718|NCT01364922|19131593|P3|Double-Blind (DB) Period|Other, Unspecified|0
5534719|NCT01364922|19131594|P2|Double-Blind (DB) Period|Other, Unspecified|1
5534720|NCT01364922|19131595|P1|Double-Blind (DB) Period|Other, Unspecified|0
5534721|NCT01364922|19131593|P3|Double-Blind (DB) Period|Adverse Event|1
5534722|NCT01364922|19131594|P2|Double-Blind (DB) Period|Adverse Event|0
5534723|NCT01364922|19131595|P1|Double-Blind (DB) Period|Adverse Event|0
5534724|NCT01364922|19131593|P3|Double-Blind (DB) Period|Subject Noncompliant|0
5534725|NCT01364922|19131594|P2|Double-Blind (DB) Period|Subject Noncompliant|1
5534726|NCT01364922|19131595|P1|Double-Blind (DB) Period|Subject Noncompliant|0
5534727|NCT01364922|19131593|P3|Double-Blind (DB) Period|Lack of Efficacy|4
5534728|NCT01364922|19131594|P2|Double-Blind (DB) Period|Lack of Efficacy|3
5534729|NCT01364922|19131595|P1|Double-Blind (DB) Period|Lack of Efficacy|0
5534730|NCT01364922|19131593|P3|Open-label (OL) Period|Other, Unspecified|0
5534731|NCT01364922|19131594|P2|Open-label (OL) Period|Other, Unspecified|0
5534732|NCT01364922|19131595|P1|Open-label (OL) Period|Other, Unspecified|1
5534733|NCT01364922|19131593|P3|Open-label (OL) Period|Lost to Follow-up|0
5534734|NCT01364922|19131594|P2|Open-label (OL) Period|Lost to Follow-up|0
5534735|NCT01364922|19131595|P1|Open-label (OL) Period|Lost to Follow-up|1
5534736|NCT01364922|19131593|P3|Open-label (OL) Period|Lack of Efficacy|0
5534737|NCT01364922|19131594|P2|Open-label (OL) Period|Lack of Efficacy|0
5534738|NCT01364922|19131595|P1|Open-label (OL) Period|Lack of Efficacy|3
5534739|NCT01364922|19131593|P3|Open-label (OL) Period|Withdrawal by Subject|0
5534740|NCT01364922|19131594|P2|Open-label (OL) Period|Withdrawal by Subject|0
5534741|NCT01364922|19131595|P1|Open-label (OL) Period|Withdrawal by Subject|4
5534742|NCT01364922|19131593|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
5534743|NCT01364922|19131594|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
5534744|NCT01364922|19131595|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
5534745|NCT01364922|19131593|P3|Open-label (OL) Period|Adverse Event|0
5534746|NCT01364922|19131594|P2|Open-label (OL) Period|Adverse Event|0
5534747|NCT01364922|19131595|P1|Open-label (OL) Period|Adverse Event|7
5534748|NCT01364870|19131617|P3|Overall Study|Protocol Violation|0
5534749|NCT01364870|19131618|P2|Overall Study|Protocol Violation|0
5534750|NCT01364870|19131619|P1|Overall Study|Protocol Violation|1
5534751|NCT01364870|19131617|P3|Overall Study|Adverse Event|4
5534752|NCT01364870|19131618|P2|Overall Study|Adverse Event|6
5534753|NCT01364870|19131619|P1|Overall Study|Adverse Event|8
5534754|NCT01364870|19131617|P3|Overall Study|Withdrawal by Subject|10
5534755|NCT01364870|19131618|P2|Overall Study|Withdrawal by Subject|24
5534756|NCT01364870|19131619|P1|Overall Study|Withdrawal by Subject|13
5534757|NCT01364727|19131638|P1|Overall Study|Not Eligible|2
5534758|NCT01364649|19131646|P2|Overall Study|Other|1
5534759|NCT01364649|19131647|P1|Overall Study|Other|4
5534760|NCT01364649|19131646|P2|Overall Study|Lost to Follow-up|13
5534761|NCT01364649|19131647|P1|Overall Study|Lost to Follow-up|12
5534762|NCT01364649|19131646|P2|Overall Study|Withdrawal of Consent|7
5534763|NCT01364649|19131647|P1|Overall Study|Withdrawal of Consent|9
5534764|NCT01364649|19131646|P2|Overall Study|Protocol Deviations|8
5534765|NCT01364649|19131647|P1|Overall Study|Protocol Deviations|4
5534766|NCT01364649|19131646|P2|Overall Study|Non-compliance with Investigational Drug|0
5534767|NCT01364649|19131647|P1|Overall Study|Non-compliance with Investigational Drug|1
5534768|NCT01364649|19131646|P2|Overall Study|Lack of Efficacy|0
5534769|NCT01364649|19131647|P1|Overall Study|Lack of Efficacy|6
5534770|NCT01364649|19131646|P2|Overall Study|Pretreatment Event or Adverse Event|14
5534771|NCT01364649|19131647|P1|Overall Study|Pretreatment Event or Adverse Event|20
5534772|NCT01364467|19131735|P2|Overall Study|Lost to Follow-up|2
5534773|NCT01364467|19131736|P1|Overall Study|Lost to Follow-up|1
5534774|NCT01364428|19131748|P2|Overall Study|Other|3
5534775|NCT01364428|19131749|P1|Overall Study|Other|3
5534776|NCT01364428|19131748|P2|Overall Study|Withdrawal Criteria|10
5534777|NCT01364428|19131749|P1|Overall Study|Withdrawal Criteria|14
5534778|NCT01364428|19131748|P2|Overall Study|Protocol Violation|0
5534779|NCT01364428|19131749|P1|Overall Study|Protocol Violation|2
5534780|NCT01364428|19131748|P2|Overall Study|Adverse Event|2
5534781|NCT01364428|19131749|P1|Overall Study|Adverse Event|1
5534782|NCT01364389|19131766|P3|Overall Study|Adverse Event|0
5534783|NCT01364389|19131767|P2|Overall Study|Adverse Event|0
5534784|NCT01364389|19131768|P1|Overall Study|Adverse Event|1
5534785|NCT01364389|19131766|P3|Overall Study|Administrative problems|0
5534786|NCT01364389|19131767|P2|Overall Study|Administrative problems|0
5534787|NCT01364389|19131768|P1|Overall Study|Administrative problems|1
5534788|NCT01364389|19131766|P3|Overall Study|Protocol deviation|1
5534789|NCT01364389|19131767|P2|Overall Study|Protocol deviation|0
5534790|NCT01364389|19131768|P1|Overall Study|Protocol deviation|0
5534791|NCT01364389|19131766|P3|Overall Study|Withdrawal by Subject|0
5534792|NCT01364389|19131767|P2|Overall Study|Withdrawal by Subject|1
5534793|NCT01364389|19131768|P1|Overall Study|Withdrawal by Subject|0
5534794|NCT01364298|19131787|P2|Overall Study|Other|3
5534795|NCT01364298|19131788|P1|Overall Study|Other|1
5534796|NCT01364298|19131787|P2|Overall Study|Withdrawal by Subject|3
5534797|NCT01364298|19131788|P1|Overall Study|Withdrawal by Subject|3
5534798|NCT01364298|19131787|P2|Overall Study|Lost to Follow-up|10
5534799|NCT01364298|19131788|P1|Overall Study|Lost to Follow-up|5
5534800|NCT01364298|19131787|P2|Overall Study|Lack of Efficacy|0
5534801|NCT01364298|19131788|P1|Overall Study|Lack of Efficacy|1
5534802|NCT01364298|19131787|P2|Overall Study|Lack of adherence to treatment|3
5534803|NCT01364298|19131788|P1|Overall Study|Lack of adherence to treatment|1
5534804|NCT01364298|19131787|P2|Overall Study|Adverse Event|4
5534805|NCT01364298|19131788|P1|Overall Study|Adverse Event|3
5534806|NCT01364233|19131821|P1|Overall Study|Lost to Follow-up|1
5534807|NCT01363986|19131866|P1|Overall Study|Disease progression|1
5534808|NCT01363908|19131876|P2|Chronic Dosing (CD) Phase|Early study termination|3
5534809|NCT01363908|19131877|P1|Chronic Dosing (CD) Phase|Early study termination|9
5534810|NCT01363908|19131876|P2|Chronic Dosing (CD) Phase|Physician Decision|1
5534811|NCT01363908|19131877|P1|Chronic Dosing (CD) Phase|Physician Decision|0
5534812|NCT01363908|19131876|P2|Chronic Dosing (CD) Phase|Patient decision|1
5534813|NCT01363908|19131877|P1|Chronic Dosing (CD) Phase|Patient decision|0
5534814|NCT01363908|19131876|P2|Chronic Dosing (CD) Phase|Adverse Event|1
5534815|NCT01363908|19131877|P1|Chronic Dosing (CD) Phase|Adverse Event|1
5534816|NCT01363765|19131914|P2|Overall Study|smear during intervention|0
5534817|NCT01363765|19131915|P1|Overall Study|smear during intervention|2170
5534818|NCT01363765|19131914|P2|Overall Study|age not recorded (used for cross-linkage|354
5534819|NCT01363765|19131915|P1|Overall Study|age not recorded (used for cross-linkage|117
5534820|NCT01363765|19131914|P2|Overall Study|non-resident|76
5534821|NCT01363765|19131915|P1|Overall Study|non-resident|156
5534822|NCT01363765|19131914|P2|Overall Study|duplicate records|3177
5534823|NCT01363765|19131915|P1|Overall Study|duplicate records|736
5534824|NCT01363765|19131914|P2|Overall Study|non-diagnostic|1124
5534825|NCT01363765|19131915|P1|Overall Study|non-diagnostic|2621
5534826|NCT01363713|19131927|P1|Overall Study|Withdrawal by Subject|2
5534827|NCT01363713|19131927|P1|Overall Study|Protocol Violation|3
5534828|NCT01363713|19131927|P1|Overall Study|Adverse Event|1
5534829|NCT01363700|19131936|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5534830|NCT01363700|19131937|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5534831|NCT01363700|19131938|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5534832|NCT01363700|19131939|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
5534833|NCT01363700|19131940|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
5534834|NCT01363661|19131959|P2|Overall Study|Lost to Follow-up|1
5534835|NCT01363661|19131960|P1|Overall Study|Lost to Follow-up|3
5534836|NCT01363661|19131959|P2|Overall Study|Protocol Violation|0
5534837|NCT01363661|19131960|P1|Overall Study|Protocol Violation|1
5534838|NCT01363661|19131959|P2|Overall Study|Withdrawal by Subject|1
5534839|NCT01363661|19131960|P1|Overall Study|Withdrawal by Subject|1
5534840|NCT01363661|19131959|P2|Overall Study|Adverse Event|2
5534841|NCT01363661|19131960|P1|Overall Study|Adverse Event|9
5534842|NCT01363440|19132001|P3|Overall Study|Other|2
5534843|NCT01363440|19132002|P2|Overall Study|Other|5
5534844|NCT01363440|19132003|P1|Overall Study|Other|4
5534845|NCT01363440|19132001|P3|Overall Study|Lost to Follow-up|5
5534846|NCT01363440|19132002|P2|Overall Study|Lost to Follow-up|4
5534847|NCT01363440|19132003|P1|Overall Study|Lost to Follow-up|2
5534848|NCT01363440|19132001|P3|Overall Study|Withdrawal by Subject|11
5534849|NCT01363440|19132002|P2|Overall Study|Withdrawal by Subject|11
5534850|NCT01363440|19132003|P1|Overall Study|Withdrawal by Subject|9
5534851|NCT01363440|19132001|P3|Overall Study|Death|5
5534852|NCT01363440|19132002|P2|Overall Study|Death|7
5534853|NCT01363440|19132003|P1|Overall Study|Death|3
5534854|NCT01363440|19132001|P3|Overall Study|Adverse Event|4
5534855|NCT01363440|19132002|P2|Overall Study|Adverse Event|4
5534856|NCT01363440|19132003|P1|Overall Study|Adverse Event|5
5534857|NCT01363349|19132062|P2|Overall Study|missing|2
5534858|NCT01363349|19132063|P1|Overall Study|missing|1
5534859|NCT01363349|19132062|P2|Overall Study|Not reported|37
5534860|NCT01363349|19132063|P1|Overall Study|Not reported|36
5534861|NCT01363349|19132062|P2|Overall Study|Lost to Follow-up|6
5534862|NCT01363349|19132063|P1|Overall Study|Lost to Follow-up|5
5534863|NCT01363349|19132062|P2|Overall Study|Withdrawal by Subject|6
5534864|NCT01363349|19132063|P1|Overall Study|Withdrawal by Subject|14
5534865|NCT01363349|19132062|P2|Overall Study|Non compliance/Protocol deviations|2
5534866|NCT01363349|19132063|P1|Overall Study|Non compliance/Protocol deviations|2
5534867|NCT01363349|19132062|P2|Overall Study|Lack of Efficacy|10
5534868|NCT01363349|19132063|P1|Overall Study|Lack of Efficacy|3
5534869|NCT01363349|19132062|P2|Overall Study|Adverse Event|7
5534870|NCT01363349|19132063|P1|Overall Study|Adverse Event|6
5534871|NCT01363297|19132074|P5|Overall Study|Death|30
5534872|NCT01363297|19132075|P4|Overall Study|Death|10
5534873|NCT01363297|19132076|P3|Overall Study|Death|6
5534874|NCT01363297|19132077|P2|Overall Study|Death|6
5534875|NCT01363297|19132078|P1|Overall Study|Death|3
5534876|NCT01363297|19132074|P5|Overall Study|Other|1
5534877|NCT01363297|19132075|P4|Overall Study|Other|0
5534878|NCT01363297|19132076|P3|Overall Study|Other|0
5534879|NCT01363297|19132077|P2|Overall Study|Other|0
5534880|NCT01363297|19132078|P1|Overall Study|Other|0
5534881|NCT01363076|19132181|P2|Overall Study|Withdrawal by Subject|1
5534882|NCT01363076|19132182|P1|Overall Study|Withdrawal by Subject|0
5534883|NCT01363011|19132214|P2|Extension Phase|Rolled Over to Another Gilead Study|1
5534884|NCT01363011|19132215|P1|Extension Phase|Rolled Over to Another Gilead Study|2
5534885|NCT01363011|19132214|P2|Extension Phase|Lost to Follow-up|2
5534886|NCT01363011|19132215|P1|Extension Phase|Lost to Follow-up|0
5534887|NCT01363011|19132214|P2|Extension Phase|Withdrew Consent|1
5534888|NCT01363011|19132215|P1|Extension Phase|Withdrew Consent|0
5534889|NCT01363011|19132214|P2|Extension Phase|Investigator's Discretion|2
5534890|NCT01363011|19132215|P1|Extension Phase|Investigator's Discretion|2
5534891|NCT01363011|19132214|P2|Extension Phase|Lack of Efficacy|1
5534892|NCT01363011|19132215|P1|Extension Phase|Lack of Efficacy|0
5534893|NCT01363011|19132214|P2|Extension Phase|Adverse Event|1
5534894|NCT01363011|19132215|P1|Extension Phase|Adverse Event|1
5534895|NCT01363011|19132214|P2|Main Study|Protocol Violation|1
5534896|NCT01363011|19132215|P1|Main Study|Protocol Violation|0
5534897|NCT01363011|19132214|P2|Main Study|Withdrew Consent|4
5534898|NCT01363011|19132215|P1|Main Study|Withdrew Consent|1
5534899|NCT01363011|19132214|P2|Main Study|Investigator's Discretion|1
5534900|NCT01363011|19132215|P1|Main Study|Investigator's Discretion|1
5534901|NCT01363011|19132214|P2|Main Study|Adverse Event|3
5534902|NCT01363011|19132215|P1|Main Study|Adverse Event|2
5534903|NCT01362790|19132342|P7|Dose De-escalation of Regimen A|Progressive disease|0
5534904|NCT01362790|19132343|P6|Dose De-escalation of Regimen A|Progressive disease|0
5534905|NCT01362790|19132344|P5|Dose De-escalation of Regimen A|Progressive disease|2
5534906|NCT01362790|19132345|P4|Dose De-escalation of Regimen A|Progressive disease|0
5534907|NCT01362790|19132346|P3|Dose De-escalation of Regimen A|Progressive disease|0
5534908|NCT01362790|19132347|P2|Dose De-escalation of Regimen A|Progressive disease|0
5534909|NCT01362790|19132348|P1|Dose De-escalation of Regimen A|Progressive disease|0
5534910|NCT01362790|19132342|P7|Dose De-escalation of Regimen A|Deveoped antibodies|0
5534911|NCT01362790|19132343|P6|Dose De-escalation of Regimen A|Deveoped antibodies|0
5534912|NCT01362790|19132344|P5|Dose De-escalation of Regimen A|Deveoped antibodies|3
5534913|NCT01362790|19132345|P4|Dose De-escalation of Regimen A|Deveoped antibodies|0
5534914|NCT01362790|19132346|P3|Dose De-escalation of Regimen A|Deveoped antibodies|0
5534915|NCT01362790|19132347|P2|Dose De-escalation of Regimen A|Deveoped antibodies|0
5534916|NCT01362790|19132348|P1|Dose De-escalation of Regimen A|Deveoped antibodies|0
5534917|NCT01362790|19132342|P7|Dose De-escalation of Regimen A|Adverse Event|0
5534918|NCT01362790|19132343|P6|Dose De-escalation of Regimen A|Adverse Event|0
5534919|NCT01362790|19132344|P5|Dose De-escalation of Regimen A|Adverse Event|1
5534920|NCT01362790|19132345|P4|Dose De-escalation of Regimen A|Adverse Event|0
5534921|NCT01362790|19132346|P3|Dose De-escalation of Regimen A|Adverse Event|0
5534922|NCT01362790|19132347|P2|Dose De-escalation of Regimen A|Adverse Event|0
5534923|NCT01362790|19132348|P1|Dose De-escalation of Regimen A|Adverse Event|0
5534924|NCT01362790|19132342|P7|Pilot Phase & Phase 2|Death on study|0
5534925|NCT01362790|19132343|P6|Pilot Phase & Phase 2|Death on study|0
5534926|NCT01362790|19132344|P5|Pilot Phase & Phase 2|Death on study|0
5534927|NCT01362790|19132345|P4|Pilot Phase & Phase 2|Death on study|1
5534928|NCT01362790|19132346|P3|Pilot Phase & Phase 2|Death on study|0
5534929|NCT01362790|19132347|P2|Pilot Phase & Phase 2|Death on study|0
5534930|NCT01362790|19132348|P1|Pilot Phase & Phase 2|Death on study|0
5534931|NCT01362790|19132342|P7|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5534932|NCT01362790|19132343|P6|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5534933|NCT01362790|19132344|P5|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5534934|NCT01362790|19132345|P4|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5534935|NCT01362790|19132346|P3|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5534936|NCT01362790|19132347|P2|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
5534937|NCT01362790|19132348|P1|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
5534938|NCT01362790|19132342|P7|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5534939|NCT01362790|19132343|P6|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5534940|NCT01362790|19132344|P5|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5534941|NCT01362790|19132345|P4|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5534942|NCT01362790|19132346|P3|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5534943|NCT01362790|19132347|P2|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
5534944|NCT01362790|19132348|P1|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
5534945|NCT01362790|19132342|P7|Pilot Phase & Phase 2|Progressive disease|0
5534946|NCT01362790|19132343|P6|Pilot Phase & Phase 2|Progressive disease|2
5534947|NCT01362790|19132344|P5|Pilot Phase & Phase 2|Progressive disease|0
5534948|NCT01362790|19132345|P4|Pilot Phase & Phase 2|Progressive disease|3
5534949|NCT01362790|19132346|P3|Pilot Phase & Phase 2|Progressive disease|2
5534950|NCT01362790|19132347|P2|Pilot Phase & Phase 2|Progressive disease|2
5534951|NCT01362790|19132348|P1|Pilot Phase & Phase 2|Progressive disease|1
5534952|NCT01362790|19132342|P7|Pilot Phase & Phase 2|Refused further treatment|0
5534953|NCT01362790|19132343|P6|Pilot Phase & Phase 2|Refused further treatment|0
5534954|NCT01362790|19132344|P5|Pilot Phase & Phase 2|Refused further treatment|0
5534955|NCT01362790|19132345|P4|Pilot Phase & Phase 2|Refused further treatment|0
5534956|NCT01362790|19132346|P3|Pilot Phase & Phase 2|Refused further treatment|0
5534957|NCT01362790|19132347|P2|Pilot Phase & Phase 2|Refused further treatment|1
5534958|NCT01362790|19132348|P1|Pilot Phase & Phase 2|Refused further treatment|0
5534959|NCT01362790|19132342|P7|Pilot Phase & Phase 2|Developed antibodies|0
5534960|NCT01362790|19132343|P6|Pilot Phase & Phase 2|Developed antibodies|0
5534961|NCT01362790|19132344|P5|Pilot Phase & Phase 2|Developed antibodies|0
5534962|NCT01362790|19132345|P4|Pilot Phase & Phase 2|Developed antibodies|8
5534963|NCT01362790|19132346|P3|Pilot Phase & Phase 2|Developed antibodies|3
5534964|NCT01362790|19132347|P2|Pilot Phase & Phase 2|Developed antibodies|2
5534965|NCT01362790|19132348|P1|Pilot Phase & Phase 2|Developed antibodies|7
5534966|NCT01362790|19132342|P7|Pilot Phase & Phase 2|Physician Decision|0
5534967|NCT01362790|19132343|P6|Pilot Phase & Phase 2|Physician Decision|0
5534968|NCT01362790|19132344|P5|Pilot Phase & Phase 2|Physician Decision|0
5534969|NCT01362790|19132345|P4|Pilot Phase & Phase 2|Physician Decision|1
5534970|NCT01362790|19132346|P3|Pilot Phase & Phase 2|Physician Decision|0
5534971|NCT01362790|19132347|P2|Pilot Phase & Phase 2|Physician Decision|0
5534972|NCT01362790|19132348|P1|Pilot Phase & Phase 2|Physician Decision|0
5534973|NCT01362790|19132342|P7|Pilot Phase & Phase 2|Adverse Event|0
5534974|NCT01362790|19132343|P6|Pilot Phase & Phase 2|Adverse Event|2
5534975|NCT01362790|19132344|P5|Pilot Phase & Phase 2|Adverse Event|0
5534976|NCT01362790|19132345|P4|Pilot Phase & Phase 2|Adverse Event|1
5534977|NCT01362790|19132346|P3|Pilot Phase & Phase 2|Adverse Event|0
5534978|NCT01362790|19132347|P2|Pilot Phase & Phase 2|Adverse Event|1
5534979|NCT01362790|19132348|P1|Pilot Phase & Phase 2|Adverse Event|0
5534980|NCT01362790|19132342|P7|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5534981|NCT01362790|19132343|P6|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5534982|NCT01362790|19132344|P5|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5534983|NCT01362790|19132345|P4|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5534984|NCT01362790|19132346|P3|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5534985|NCT01362790|19132347|P2|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
5534986|NCT01362790|19132348|P1|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
5534987|NCT01362608|19132416|P2|Overall Study|Adverse Event|2
5534988|NCT01362608|19132417|P1|Overall Study|Adverse Event|0
5534989|NCT01362608|19132416|P2|Overall Study|Lack of Efficacy|2
5534990|NCT01362608|19132417|P1|Overall Study|Lack of Efficacy|0
5534991|NCT01362608|19132416|P2|Overall Study|Withdrawal by Subject|2
5534992|NCT01362608|19132417|P1|Overall Study|Withdrawal by Subject|1
5534993|NCT01362608|19132416|P2|Overall Study|Lost to Follow-up|1
5534994|NCT01362608|19132417|P1|Overall Study|Lost to Follow-up|3
5534995|NCT01362608|19132416|P2|Overall Study|Protocol Violation|1
5534996|NCT01362608|19132417|P1|Overall Study|Protocol Violation|0
5534997|NCT01362530|19132455|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
5534998|NCT01362530|19132456|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
5534999|NCT01362530|19132455|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
5535000|NCT01362530|19132456|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
5535001|NCT01362530|19132455|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
5535002|NCT01362530|19132456|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
5535003|NCT01362530|19132455|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
5535004|NCT01362530|19132456|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
5535005|NCT01362530|19132455|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
5535006|NCT01362530|19132456|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
5535007|NCT01362530|19132455|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
5535008|NCT01362530|19132456|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
5535009|NCT01362530|19132455|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
5535010|NCT01362530|19132456|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
5535011|NCT01362530|19132455|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
5535012|NCT01362530|19132456|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
5535013|NCT01362530|19132455|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
5535014|NCT01362530|19132456|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
5535015|NCT01362530|19132455|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
5535016|NCT01362530|19132456|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
5535017|NCT01362530|19132455|P2|Base Study (Cycle 1)|Protocol Violation|0
5535018|NCT01362530|19132456|P1|Base Study (Cycle 1)|Protocol Violation|2
5535019|NCT01362530|19132455|P2|Base Study (Cycle 1)|Physician Decision|1
5535020|NCT01362530|19132456|P1|Base Study (Cycle 1)|Physician Decision|0
5535021|NCT01362530|19132455|P2|Base Study (Cycle 1)|Adverse Event|0
5535022|NCT01362530|19132456|P1|Base Study (Cycle 1)|Adverse Event|2
5535023|NCT01362517|19132469|P1|Overall Study|Lost to Follow-up|1
5535024|NCT01362517|19132469|P1|Overall Study|Protocol Violation|1
5535025|NCT01362491|19132480|P3|Overall Study|Ineligible|0
5535026|NCT01362491|19132481|P2|Overall Study|Ineligible|0
5535027|NCT01362491|19132482|P1|Overall Study|Ineligible|1
5535028|NCT01362439|19132530|P1|Overall Study|Participant who withdrew consent|8
5535029|NCT01362439|19132530|P1|Overall Study|Study medication non-compliant|1
5535030|NCT01362439|19132530|P1|Overall Study|Lost to Follow-up|2
5535031|NCT01362439|19132530|P1|Overall Study|Lack of Efficacy|3
5535032|NCT01362439|19132530|P1|Overall Study|Adverse Event|1
5535033|NCT01362348|19132545|P1|Overall Study|Study closed/terminated|5
5535034|NCT01362348|19132545|P1|Overall Study|Protocol-defined stopping criteria|9
5535035|NCT01362322|19132564|P2|Overall Study|Lost to Follow-up|6
5535036|NCT01362322|19132565|P1|Overall Study|Lost to Follow-up|2
5535037|NCT01362322|19132564|P2|Overall Study|Withdrawal by Subject|1
5535038|NCT01362322|19132565|P1|Overall Study|Withdrawal by Subject|3
5535039|NCT01362296|19132597|P4|Crossover Phase|Study Closed/Terminated|0
5535040|NCT01362296|19132598|P3|Crossover Phase|Study Closed/Terminated|1
5535041|NCT01362296|19132599|P2|Crossover Phase|Study Closed/Terminated|0
5535042|NCT01362296|19132600|P1|Crossover Phase|Study Closed/Terminated|0
5535043|NCT01362296|19132597|P4|Crossover Phase|Adverse Event|0
5535044|NCT01362296|19132598|P3|Crossover Phase|Adverse Event|4
5535045|NCT01362296|19132599|P2|Crossover Phase|Adverse Event|0
5535046|NCT01362296|19132600|P1|Crossover Phase|Adverse Event|0
5535047|NCT01362296|19132597|P4|Crossover Phase|Withdrawal by Subject|1
5535048|NCT01362296|19132598|P3|Crossover Phase|Withdrawal by Subject|2
5535049|NCT01362296|19132599|P2|Crossover Phase|Withdrawal by Subject|0
5535050|NCT01362296|19132600|P1|Crossover Phase|Withdrawal by Subject|0
5535051|NCT01362296|19132597|P4|Crossover Phase|PD including Death due to PD|1
5535052|NCT01362296|19132598|P3|Crossover Phase|PD including Death due to PD|16
5535053|NCT01362296|19132599|P2|Crossover Phase|PD including Death due to PD|0
5535054|NCT01362296|19132600|P1|Crossover Phase|PD including Death due to PD|0
5535055|NCT01362296|19132597|P4|Randomized Phase (RP)|Study Closed/Terminated|0
5535056|NCT01362296|19132598|P3|Randomized Phase (RP)|Study Closed/Terminated|0
5535057|NCT01362296|19132599|P2|Randomized Phase (RP)|Study Closed/Terminated|1
5535058|NCT01362296|19132600|P1|Randomized Phase (RP)|Study Closed/Terminated|8
5535059|NCT01362296|19132597|P4|Randomized Phase (RP)|Adverse Event|0
5535060|NCT01362296|19132598|P3|Randomized Phase (RP)|Adverse Event|0
5535061|NCT01362296|19132599|P2|Randomized Phase (RP)|Adverse Event|4
5535062|NCT01362296|19132600|P1|Randomized Phase (RP)|Adverse Event|20
5535063|NCT01362296|19132597|P4|Randomized Phase (RP)|Withdrawal by Subject|0
5535064|NCT01362296|19132598|P3|Randomized Phase (RP)|Withdrawal by Subject|0
5535065|NCT01362296|19132599|P2|Randomized Phase (RP)|Withdrawal by Subject|1
5535066|NCT01362296|19132600|P1|Randomized Phase (RP)|Withdrawal by Subject|2
5535067|NCT01362296|19132597|P4|Randomized Phase (RP)|Physician Decision|0
5535068|NCT01362296|19132598|P3|Randomized Phase (RP)|Physician Decision|0
5535069|NCT01362296|19132599|P2|Randomized Phase (RP)|Physician Decision|9
5535070|NCT01362296|19132600|P1|Randomized Phase (RP)|Physician Decision|1
5535071|NCT01362296|19132597|P4|Randomized Phase (RP)|PD including Death due to PD|0
5535072|NCT01362296|19132598|P3|Randomized Phase (RP)|PD including Death due to PD|0
5535073|NCT01362296|19132599|P2|Randomized Phase (RP)|PD including Death due to PD|28
5535074|NCT01362296|19132600|P1|Randomized Phase (RP)|PD including Death due to PD|56
5535075|NCT01362270|19132648|P2|Overall Study|Met excl. criteria before 1st session|1
5535076|NCT01362270|19132649|P1|Overall Study|Met excl. criteria before 1st session|1
5535077|NCT01362270|19132648|P2|Overall Study|Met exclusion criteria after 1st session|1
5535078|NCT01362270|19132649|P1|Overall Study|Met exclusion criteria after 1st session|0
5535079|NCT01362270|19132648|P2|Overall Study|Withdrawal by Subject|0
5535080|NCT01362270|19132649|P1|Overall Study|Withdrawal by Subject|1
5535081|NCT01362244|19132661|P2|Overall Study|Protocol Defined Stopping Criteria|1
5535082|NCT01362244|19132662|P1|Overall Study|Protocol Defined Stopping Criteria|0
5535083|NCT01362244|19132661|P2|Overall Study|Did not Meet Continuation Criteria|11
5535084|NCT01362244|19132662|P1|Overall Study|Did not Meet Continuation Criteria|17
5535085|NCT01362244|19132661|P2|Overall Study|Withdrawal by Subject|1
5535086|NCT01362244|19132662|P1|Overall Study|Withdrawal by Subject|2
5535087|NCT01362244|19132661|P2|Overall Study|Protocol Violation|1
5535088|NCT01362244|19132662|P1|Overall Study|Protocol Violation|5
5535089|NCT01362244|19132661|P2|Overall Study|Lost to Follow-up|2
5535090|NCT01362244|19132662|P1|Overall Study|Lost to Follow-up|0
5535091|NCT01362244|19132661|P2|Overall Study|Lack of Efficacy|11
5535092|NCT01362244|19132662|P1|Overall Study|Lack of Efficacy|5
5535093|NCT01362244|19132661|P2|Overall Study|Adverse Event|5
5535094|NCT01362244|19132662|P1|Overall Study|Adverse Event|3
5535095|NCT01362140|19132774|P2|Overall Study|Discontinued Without Receiving Treatment|1
5535096|NCT01362140|19132775|P1|Overall Study|Discontinued Without Receiving Treatment|0
5535097|NCT01362140|19132774|P2|Overall Study|Protocol-specified Criteria|2
5535098|NCT01362140|19132775|P1|Overall Study|Protocol-specified Criteria|1
5535099|NCT01362140|19132774|P2|Overall Study|Other|1
5535100|NCT01362140|19132775|P1|Overall Study|Other|1
5535101|NCT01362140|19132774|P2|Overall Study|Death|1
5535102|NCT01362140|19132775|P1|Overall Study|Death|2
5535103|NCT01362140|19132774|P2|Overall Study|Administrative Decision|1
5535104|NCT01362140|19132775|P1|Overall Study|Administrative Decision|0
5535105|NCT01362140|19132774|P2|Overall Study|Withdrawal by Subject|3
5535106|NCT01362140|19132775|P1|Overall Study|Withdrawal by Subject|3
5535107|NCT01362140|19132774|P2|Overall Study|Adverse Event|2
5535108|NCT01362140|19132775|P1|Overall Study|Adverse Event|2
5535109|NCT01362140|19132774|P2|Overall Study|Noncompliance|0
5535110|NCT01362140|19132775|P1|Overall Study|Noncompliance|1
5535111|NCT01362062|19132812|P2|Overall Study|Had significant improvement|0
5535112|NCT01362062|19132813|P1|Overall Study|Had significant improvement|9
5535113|NCT01362062|19132812|P2|Overall Study|Detected with Spondylo-arthritis|0
5535114|NCT01362062|19132813|P1|Overall Study|Detected with Spondylo-arthritis|1
5535115|NCT01362062|19132812|P2|Overall Study|Non-compliant participant|0
5535116|NCT01362062|19132813|P1|Overall Study|Non-compliant participant|2
5535117|NCT01362062|19132812|P2|Overall Study|Withdrawal by Subject|0
5535118|NCT01362062|19132813|P1|Overall Study|Withdrawal by Subject|2
5535119|NCT01362062|19132812|P2|Overall Study|Lost to Follow-up|0
5535120|NCT01362062|19132813|P1|Overall Study|Lost to Follow-up|11
5535121|NCT01362062|19132812|P2|Overall Study|Adverse Event|0
5535122|NCT01362062|19132813|P1|Overall Study|Adverse Event|1
5535123|NCT01362049|19132834|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
5535124|NCT01362049|19132835|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
5535125|NCT01362049|19132836|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
5535126|NCT01362049|19132837|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
5535127|NCT01362049|19132834|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
5535128|NCT01362049|19132835|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
5535129|NCT01362049|19132836|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
5535130|NCT01362049|19132837|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
5535131|NCT01361919|19132878|P3|Overall Study|technical issues|10
5535132|NCT01361919|19132879|P2|Overall Study|technical issues|12
5535133|NCT01361919|19132880|P1|Overall Study|technical issues|10
5535134|NCT01361607|19132921|P2|Overall Study|Met Withdrawal Criteria|1
5535135|NCT01361607|19132922|P1|Overall Study|Met Withdrawal Criteria|1
5535136|NCT01361607|19132921|P2|Overall Study|Lost to Follow-up|0
5535137|NCT01361607|19132922|P1|Overall Study|Lost to Follow-up|1
5535138|NCT01361607|19132921|P2|Overall Study|Withdrawal by Investigator|3
5535139|NCT01361607|19132922|P1|Overall Study|Withdrawal by Investigator|5
5535140|NCT01361607|19132921|P2|Overall Study|Withdrawal by Subject|8
5535141|NCT01361607|19132922|P1|Overall Study|Withdrawal by Subject|19
5535142|NCT01361607|19132921|P2|Overall Study|Adverse Event|29
5535143|NCT01361607|19132922|P1|Overall Study|Adverse Event|38
5535144|NCT01361594|19132950|P2|Overall Study|Withdrawal by Subject|2
5535145|NCT01361594|19132951|P1|Overall Study|Withdrawal by Subject|1
5535146|NCT01361568|19132965|P6|Overall Study|Withdrawal by Subject|1
5535147|NCT01361568|19132966|P5|Overall Study|Withdrawal by Subject|0
5535148|NCT01361568|19132967|P4|Overall Study|Withdrawal by Subject|0
5535149|NCT01361568|19132968|P3|Overall Study|Withdrawal by Subject|0
5535150|NCT01361568|19132969|P2|Overall Study|Withdrawal by Subject|1
5535151|NCT01361568|19132970|P1|Overall Study|Withdrawal by Subject|2
5535152|NCT01361568|19132965|P6|Overall Study|Physician Decision|1
5535153|NCT01361568|19132966|P5|Overall Study|Physician Decision|0
5535154|NCT01361568|19132967|P4|Overall Study|Physician Decision|0
5535155|NCT01361568|19132968|P3|Overall Study|Physician Decision|0
5535156|NCT01361568|19132969|P2|Overall Study|Physician Decision|0
5535157|NCT01361568|19132970|P1|Overall Study|Physician Decision|0
5535158|NCT01361568|19132965|P6|Overall Study|Adverse Event|0
5535159|NCT01361568|19132966|P5|Overall Study|Adverse Event|1
5535160|NCT01361568|19132967|P4|Overall Study|Adverse Event|0
5535161|NCT01361568|19132968|P3|Overall Study|Adverse Event|0
5535162|NCT01361568|19132969|P2|Overall Study|Adverse Event|0
5535163|NCT01361568|19132970|P1|Overall Study|Adverse Event|0
5535164|NCT01361464|19133000|P1|Overall Study|Withdrawal by Subject|2
5535165|NCT01361464|19133000|P1|Overall Study|Death|1
5535166|NCT01361308|19133009|P2|Overall Study|Other|1
5535167|NCT01361308|19133010|P1|Overall Study|Other|0
5535168|NCT01361308|19133009|P2|Overall Study|Failed C-SSRS|2
5535169|NCT01361308|19133010|P1|Overall Study|Failed C-SSRS|5
5535170|NCT01361308|19133009|P2|Overall Study|Eligibility Criteria Not Met|3
5535171|NCT01361308|19133010|P1|Overall Study|Eligibility Criteria Not Met|2
5535172|NCT01361308|19133009|P2|Overall Study|Adverse Event|4
5535173|NCT01361308|19133010|P1|Overall Study|Adverse Event|8
5535174|NCT01361308|19133009|P2|Overall Study|Lost to Follow-up|4
5535175|NCT01361308|19133010|P1|Overall Study|Lost to Follow-up|5
5535176|NCT01361308|19133009|P2|Overall Study|Protocol Violation|0
5535177|NCT01361308|19133010|P1|Overall Study|Protocol Violation|1
5535178|NCT01361308|19133009|P2|Overall Study|Lack of Efficacy|0
5535179|NCT01361308|19133010|P1|Overall Study|Lack of Efficacy|2
5535180|NCT01361308|19133009|P2|Overall Study|Physician Decision|3
5535181|NCT01361308|19133010|P1|Overall Study|Physician Decision|3
5535182|NCT01361308|19133009|P2|Overall Study|Withdrawal by Subject|13
5535183|NCT01361308|19133010|P1|Overall Study|Withdrawal by Subject|9
5535184|NCT01361178|19133058|P2|Overall Study|Death|0
5535185|NCT01361178|19133059|P1|Overall Study|Death|13
5535186|NCT01361126|19133067|P2|Overall Study|Sponsor decision|2
5535187|NCT01361126|19133068|P1|Overall Study|Sponsor decision|0
5535188|NCT01361009|19133107|P1|Overall Study|Protocol Violation|116
5535189|NCT01360996|19133117|P3|Overall Study|Noncompliant|0
5535190|NCT01360996|19133118|P2|Overall Study|Noncompliant|0
5535191|NCT01360996|19133119|P1|Overall Study|Noncompliant|2
5535192|NCT01360996|19133117|P3|Overall Study|Withdrawal by Subject|2
5535193|NCT01360996|19133118|P2|Overall Study|Withdrawal by Subject|3
5535194|NCT01360996|19133119|P1|Overall Study|Withdrawal by Subject|4
5535195|NCT01360866|19133142|P4|Overall Study|Lack of Efficacy|4
5535196|NCT01360866|19133143|P3|Overall Study|Lack of Efficacy|30
5535197|NCT01360866|19133144|P2|Overall Study|Lack of Efficacy|40
5535198|NCT01360866|19133145|P1|Overall Study|Lack of Efficacy|30
5535199|NCT01360866|19133142|P4|Overall Study|Protocol Deviation|2
5535200|NCT01360866|19133143|P3|Overall Study|Protocol Deviation|61
5535201|NCT01360866|19133144|P2|Overall Study|Protocol Deviation|33
5535202|NCT01360866|19133145|P1|Overall Study|Protocol Deviation|25
5535203|NCT01360866|19133142|P4|Overall Study|Withdrawal by participant|8
5535204|NCT01360866|19133143|P3|Overall Study|Withdrawal by participant|168
5535205|NCT01360866|19133144|P2|Overall Study|Withdrawal by participant|89
5535206|NCT01360866|19133145|P1|Overall Study|Withdrawal by participant|79
5535207|NCT01360866|19133142|P4|Overall Study|Withdrawn by Investigator|2
5535208|NCT01360866|19133143|P3|Overall Study|Withdrawn by Investigator|31
5535209|NCT01360866|19133144|P2|Overall Study|Withdrawn by Investigator|8
5535210|NCT01360866|19133145|P1|Overall Study|Withdrawn by Investigator|9
5535211|NCT01360866|19133142|P4|Overall Study|Paticipant met withdrawal criteria|0
5535212|NCT01360866|19133143|P3|Overall Study|Paticipant met withdrawal criteria|54
5535213|NCT01360866|19133144|P2|Overall Study|Paticipant met withdrawal criteria|28
5535214|NCT01360866|19133145|P1|Overall Study|Paticipant met withdrawal criteria|11
5535215|NCT01360866|19133142|P4|Overall Study|Adverse Event|6
5535216|NCT01360866|19133143|P3|Overall Study|Adverse Event|134
5535217|NCT01360866|19133144|P2|Overall Study|Adverse Event|61
5535218|NCT01360866|19133145|P1|Overall Study|Adverse Event|56
5535219|NCT01360866|19133142|P4|Overall Study|Lost to Follow-up|0
5535220|NCT01360866|19133143|P3|Overall Study|Lost to Follow-up|41
5535221|NCT01360866|19133144|P2|Overall Study|Lost to Follow-up|28
5535222|NCT01360866|19133145|P1|Overall Study|Lost to Follow-up|11
5535223|NCT01360840|19133174|P3|Overall Study|Ongoing at data cut-off|9
5535224|NCT01360840|19133175|P2|Overall Study|Ongoing at data cut-off|10
5535225|NCT01360840|19133176|P1|Overall Study|Ongoing at data cut-off|10
5535226|NCT01360762|19133226|P1|Whole Study Period|Discontinuation of study drug for safety|1
5535227|NCT01360762|19133226|P1|Whole Study Period|Patient relapsed|18
5535228|NCT01360762|19133226|P1|Whole Study Period|Death|7
5535229|NCT01360762|19133226|P1|Whole Study Period|Lost to Follow-up|10
5535230|NCT01360762|19133226|P1|Main Study Period (12-month Treatment)|Discontinuation|1
5535231|NCT01360762|19133226|P1|Main Study Period (12-month Treatment)|Patient relapsed|15
5535232|NCT01360762|19133226|P1|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
5535233|NCT01360762|19133226|P1|Main Study Period (12-month Treatment)|Death|5
5535234|NCT01360762|19133226|P1|Main Study Period (12-month Treatment)|Lost to Follow-up|7
5535235|NCT01360645|19133236|P4|Phase A+|Protocol Deviation|4
5535236|NCT01360645|19133237|P3|Phase A+|Protocol Deviation|0
5535237|NCT01360645|19133238|P2|Phase A+|Protocol Deviation|0
5535238|NCT01360645|19133239|P1|Phase A+|Protocol Deviation|0
5535239|NCT01360645|19133236|P4|Phase A+|Withdrawal by Subject|5
5535240|NCT01360645|19133237|P3|Phase A+|Withdrawal by Subject|0
5535241|NCT01360645|19133238|P2|Phase A+|Withdrawal by Subject|0
5535242|NCT01360645|19133239|P1|Phase A+|Withdrawal by Subject|0
5535243|NCT01360645|19133236|P4|Phase A+|Physician Decision|2
5535244|NCT01360645|19133237|P3|Phase A+|Physician Decision|0
5535245|NCT01360645|19133238|P2|Phase A+|Physician Decision|0
5535246|NCT01360645|19133239|P1|Phase A+|Physician Decision|0
5535247|NCT01360645|19133236|P4|Phase A+|Met Withdrawal Criteria|4
5535248|NCT01360645|19133237|P3|Phase A+|Met Withdrawal Criteria|0
5535249|NCT01360645|19133238|P2|Phase A+|Met Withdrawal Criteria|0
5535250|NCT01360645|19133239|P1|Phase A+|Met Withdrawal Criteria|0
5535251|NCT01360645|19133236|P4|Phase A+|Adverse Event|2
5535252|NCT01360645|19133237|P3|Phase A+|Adverse Event|0
5535253|NCT01360645|19133238|P2|Phase A+|Adverse Event|0
5535254|NCT01360645|19133239|P1|Phase A+|Adverse Event|0
5535255|NCT01360645|19133236|P4|Phase A+|Lost to Follow-up|7
5535256|NCT01360645|19133237|P3|Phase A+|Lost to Follow-up|0
5535257|NCT01360645|19133238|P2|Phase A+|Lost to Follow-up|0
5535258|NCT01360645|19133239|P1|Phase A+|Lost to Follow-up|0
5535259|NCT01360645|19133236|P4|Phase B (6 Weeks)|Protocol Deviation|0
5535260|NCT01360645|19133237|P3|Phase B (6 Weeks)|Protocol Deviation|3
5535261|NCT01360645|19133238|P2|Phase B (6 Weeks)|Protocol Deviation|1
5535262|NCT01360645|19133239|P1|Phase B (6 Weeks)|Protocol Deviation|0
5535263|NCT01360645|19133236|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
5535264|NCT01360645|19133237|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
5535265|NCT01360645|19133238|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
5535266|NCT01360645|19133239|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
5535267|NCT01360645|19133236|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5535268|NCT01360645|19133237|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
5535269|NCT01360645|19133238|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
5535270|NCT01360645|19133239|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5535271|NCT01360645|19133236|P4|Phase B (6 Weeks)|Adverse Event|0
5535272|NCT01360645|19133237|P3|Phase B (6 Weeks)|Adverse Event|0
5535273|NCT01360645|19133238|P2|Phase B (6 Weeks)|Adverse Event|6
5535274|NCT01360645|19133239|P1|Phase B (6 Weeks)|Adverse Event|0
5535275|NCT01360645|19133236|P4|Phase B (6 Weeks)|Lost to Follow-up|0
5535276|NCT01360645|19133237|P3|Phase B (6 Weeks)|Lost to Follow-up|0
5535277|NCT01360645|19133238|P2|Phase B (6 Weeks)|Lost to Follow-up|1
5535278|NCT01360645|19133239|P1|Phase B (6 Weeks)|Lost to Follow-up|0
5535279|NCT01360645|19133236|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
5535280|NCT01360645|19133237|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
5535281|NCT01360645|19133238|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
5535282|NCT01360645|19133239|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
5535283|NCT01360645|19133236|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
5535284|NCT01360645|19133237|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
5535285|NCT01360645|19133238|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
5535286|NCT01360645|19133239|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
5535287|NCT01360645|19133236|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
5535288|NCT01360645|19133237|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
5535289|NCT01360645|19133238|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
5535290|NCT01360645|19133239|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
5535291|NCT01360645|19133236|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
5535292|NCT01360645|19133237|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
5535293|NCT01360645|19133238|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
5535294|NCT01360645|19133239|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
5535295|NCT01360645|19133236|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
5535296|NCT01360645|19133237|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
5535297|NCT01360645|19133238|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
5535298|NCT01360645|19133239|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
5535299|NCT01360645|19133236|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
5535300|NCT01360645|19133237|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
5535301|NCT01360645|19133238|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
5535302|NCT01360645|19133239|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
5535303|NCT01360632|19133294|P5|Phase A+|Protocol Deviation|3
5535304|NCT01360632|19133295|P4|Phase A+|Protocol Deviation|0
5535305|NCT01360632|19133296|P3|Phase A+|Protocol Deviation|0
5535306|NCT01360632|19133297|P2|Phase A+|Protocol Deviation|0
5535307|NCT01360632|19133298|P1|Phase A+|Protocol Deviation|0
5535308|NCT01360632|19133294|P5|Phase A+|Withdrawal by Subject|8
5535309|NCT01360632|19133295|P4|Phase A+|Withdrawal by Subject|0
5535310|NCT01360632|19133296|P3|Phase A+|Withdrawal by Subject|0
5535311|NCT01360632|19133297|P2|Phase A+|Withdrawal by Subject|0
5535312|NCT01360632|19133298|P1|Phase A+|Withdrawal by Subject|0
5535313|NCT01360632|19133294|P5|Phase A+|Physician Decision|3
5535314|NCT01360632|19133295|P4|Phase A+|Physician Decision|0
5535315|NCT01360632|19133296|P3|Phase A+|Physician Decision|0
5535316|NCT01360632|19133297|P2|Phase A+|Physician Decision|0
5535317|NCT01360632|19133298|P1|Phase A+|Physician Decision|0
5535318|NCT01360632|19133294|P5|Phase A+|Met Withdrawal Criteria|7
5535319|NCT01360632|19133295|P4|Phase A+|Met Withdrawal Criteria|0
5535320|NCT01360632|19133296|P3|Phase A+|Met Withdrawal Criteria|0
5535321|NCT01360632|19133297|P2|Phase A+|Met Withdrawal Criteria|0
5535322|NCT01360632|19133298|P1|Phase A+|Met Withdrawal Criteria|0
5535323|NCT01360632|19133294|P5|Phase A+|Adverse Event|2
5535324|NCT01360632|19133295|P4|Phase A+|Adverse Event|0
5535325|NCT01360632|19133296|P3|Phase A+|Adverse Event|0
5535326|NCT01360632|19133297|P2|Phase A+|Adverse Event|0
5535327|NCT01360632|19133298|P1|Phase A+|Adverse Event|0
5535328|NCT01360632|19133294|P5|Phase A+|Lost to Follow-up|2
5535329|NCT01360632|19133295|P4|Phase A+|Lost to Follow-up|0
5535330|NCT01360632|19133296|P3|Phase A+|Lost to Follow-up|0
5535331|NCT01360632|19133297|P2|Phase A+|Lost to Follow-up|0
5535332|NCT01360632|19133298|P1|Phase A+|Lost to Follow-up|0
5535333|NCT01360632|19133294|P5|Phase B (6 Weeks)|Lack of Efficacy|0
5535334|NCT01360632|19133295|P4|Phase B (6 Weeks)|Lack of Efficacy|0
5535335|NCT01360632|19133296|P3|Phase B (6 Weeks)|Lack of Efficacy|0
5535336|NCT01360632|19133297|P2|Phase B (6 Weeks)|Lack of Efficacy|1
5535337|NCT01360632|19133298|P1|Phase B (6 Weeks)|Lack of Efficacy|0
5535338|NCT01360632|19133294|P5|Phase B (6 Weeks)|Protocol Deviation|0
5535339|NCT01360632|19133295|P4|Phase B (6 Weeks)|Protocol Deviation|1
5535340|NCT01360632|19133296|P3|Phase B (6 Weeks)|Protocol Deviation|4
5535341|NCT01360632|19133297|P2|Phase B (6 Weeks)|Protocol Deviation|1
5535342|NCT01360632|19133298|P1|Phase B (6 Weeks)|Protocol Deviation|0
5535343|NCT01360632|19133294|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
5535344|NCT01360632|19133295|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
5535345|NCT01360632|19133296|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
5535346|NCT01360632|19133297|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
5535347|NCT01360632|19133298|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
5535348|NCT01360632|19133294|P5|Phase B (6 Weeks)|Physician Decision|0
5535349|NCT01360632|19133295|P4|Phase B (6 Weeks)|Physician Decision|1
5535350|NCT01360632|19133296|P3|Phase B (6 Weeks)|Physician Decision|0
5535351|NCT01360632|19133297|P2|Phase B (6 Weeks)|Physician Decision|0
5535352|NCT01360632|19133298|P1|Phase B (6 Weeks)|Physician Decision|0
5535353|NCT01360632|19133294|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5535354|NCT01360632|19133295|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
5535355|NCT01360632|19133296|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
5535356|NCT01360632|19133297|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5535357|NCT01360632|19133298|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
5535358|NCT01360632|19133294|P5|Phase B (6 Weeks)|Adverse Event|0
5535359|NCT01360632|19133295|P4|Phase B (6 Weeks)|Adverse Event|3
5535360|NCT01360632|19133296|P3|Phase B (6 Weeks)|Adverse Event|9
5535361|NCT01360632|19133297|P2|Phase B (6 Weeks)|Adverse Event|3
5535362|NCT01360632|19133298|P1|Phase B (6 Weeks)|Adverse Event|0
5535363|NCT01360632|19133294|P5|Phase B (6 Weeks)|Lost to Follow-up|0
5535364|NCT01360632|19133295|P4|Phase B (6 Weeks)|Lost to Follow-up|0
5535365|NCT01360632|19133296|P3|Phase B (6 Weeks)|Lost to Follow-up|1
5535366|NCT01360632|19133297|P2|Phase B (6 Weeks)|Lost to Follow-up|1
5535367|NCT01360632|19133298|P1|Phase B (6 Weeks)|Lost to Follow-up|0
5535368|NCT01360632|19133294|P5|Phase A (8 Weeks)|Protocol Deviation|0
5535369|NCT01360632|19133295|P4|Phase A (8 Weeks)|Protocol Deviation|0
5535370|NCT01360632|19133296|P3|Phase A (8 Weeks)|Protocol Deviation|0
5535371|NCT01360632|19133297|P2|Phase A (8 Weeks)|Protocol Deviation|0
5535372|NCT01360632|19133298|P1|Phase A (8 Weeks)|Protocol Deviation|39
5535373|NCT01360632|19133294|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
5535374|NCT01360632|19133295|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
5535375|NCT01360632|19133296|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
5535376|NCT01360632|19133297|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
5535377|NCT01360632|19133298|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
5535378|NCT01360632|19133294|P5|Phase A (8 Weeks)|Physician Decision|0
5535379|NCT01360632|19133295|P4|Phase A (8 Weeks)|Physician Decision|0
5535380|NCT01360632|19133296|P3|Phase A (8 Weeks)|Physician Decision|0
5535381|NCT01360632|19133297|P2|Phase A (8 Weeks)|Physician Decision|0
5535382|NCT01360632|19133298|P1|Phase A (8 Weeks)|Physician Decision|10
5535383|NCT01360632|19133294|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5535384|NCT01360632|19133295|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5535385|NCT01360632|19133296|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5535386|NCT01360632|19133297|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
5535387|NCT01360632|19133298|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
5535388|NCT01360632|19133294|P5|Phase A (8 Weeks)|Adverse Event|0
5535389|NCT01360632|19133295|P4|Phase A (8 Weeks)|Adverse Event|0
5535390|NCT01360632|19133296|P3|Phase A (8 Weeks)|Adverse Event|0
5535391|NCT01360632|19133297|P2|Phase A (8 Weeks)|Adverse Event|0
5535392|NCT01360632|19133298|P1|Phase A (8 Weeks)|Adverse Event|60
5535393|NCT01360632|19133294|P5|Phase A (8 Weeks)|Lost to Follow-up|0
5535394|NCT01360632|19133295|P4|Phase A (8 Weeks)|Lost to Follow-up|0
5535395|NCT01360632|19133296|P3|Phase A (8 Weeks)|Lost to Follow-up|0
5535396|NCT01360632|19133297|P2|Phase A (8 Weeks)|Lost to Follow-up|0
5535397|NCT01360632|19133298|P1|Phase A (8 Weeks)|Lost to Follow-up|27
5535398|NCT01360554|19133377|P2|Overall Study|Randomized but not treated.|3
5535399|NCT01360554|19133378|P1|Overall Study|Randomized but not treated.|3
5535400|NCT01360554|19133377|P2|Overall Study|Other, not specified|0
5535401|NCT01360554|19133378|P1|Overall Study|Other, not specified|1
5535402|NCT01360554|19133377|P2|Overall Study|Study terminated by sponsor|37
5535403|NCT01360554|19133378|P1|Overall Study|Study terminated by sponsor|49
5535404|NCT01360554|19133377|P2|Overall Study|Withdrawal by Subject|24
5535405|NCT01360554|19133378|P1|Overall Study|Withdrawal by Subject|23
5535406|NCT01360554|19133377|P2|Overall Study|Lost to Follow-up|4
5535407|NCT01360554|19133378|P1|Overall Study|Lost to Follow-up|4
5535408|NCT01360554|19133377|P2|Overall Study|Death|371
5535409|NCT01360554|19133378|P1|Overall Study|Death|359
5535410|NCT01360398|19133427|P1|Overall Study|Migrated/moved from study area|1
5535411|NCT01360398|19133427|P1|Overall Study|Other|7
5535412|NCT01360398|19133427|P1|Overall Study|Withdrawal by Subject|14
5535413|NCT01360021|19133461|P3|Overall Study|Adverse Event|3
5535414|NCT01360021|19133462|P2|Overall Study|Adverse Event|3
5535415|NCT01360021|19133463|P1|Overall Study|Adverse Event|2
5535416|NCT01360021|19133461|P3|Overall Study|Withdrawal by Subject|2
5535417|NCT01360021|19133462|P2|Overall Study|Withdrawal by Subject|0
5535418|NCT01360021|19133463|P1|Overall Study|Withdrawal by Subject|4
5535419|NCT01360021|19133461|P3|Overall Study|Protocol Violation|1
5535420|NCT01360021|19133462|P2|Overall Study|Protocol Violation|0
5535421|NCT01360021|19133463|P1|Overall Study|Protocol Violation|0
5535422|NCT01360021|19133461|P3|Overall Study|Eligibility criteria + other|1
5535423|NCT01360021|19133462|P2|Overall Study|Eligibility criteria + other|1
5535424|NCT01360021|19133463|P1|Overall Study|Eligibility criteria + other|2
5535425|NCT01359956|19133490|P4|Overall Study|Death|58
5535426|NCT01359956|19133491|P3|Overall Study|Death|67
5535427|NCT01359956|19133492|P2|Overall Study|Death|64
5535428|NCT01359956|19133493|P1|Overall Study|Death|61
5535429|NCT01359943|19133518|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
5535430|NCT01359943|19133519|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
5535431|NCT01359943|19133520|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
5535432|NCT01359943|19133518|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
5535433|NCT01359943|19133519|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
5535434|NCT01359943|19133520|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
5535435|NCT01359943|19133518|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
5535436|NCT01359943|19133519|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
5535437|NCT01359943|19133520|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
5535438|NCT01359943|19133518|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
5535439|NCT01359943|19133519|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
5535440|NCT01359943|19133520|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
5535441|NCT01359943|19133518|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
5535442|NCT01359943|19133519|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
5535443|NCT01359943|19133520|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
5535444|NCT01359943|19133518|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
5535445|NCT01359943|19133519|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
5535446|NCT01359943|19133520|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
5535447|NCT01359943|19133518|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
5535448|NCT01359943|19133519|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
5535449|NCT01359943|19133520|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
5535450|NCT01359943|19133518|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
5535451|NCT01359943|19133519|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
5535452|NCT01359943|19133520|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
5535453|NCT01359943|19133518|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
5535454|NCT01359943|19133519|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
5535455|NCT01359943|19133520|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
5535456|NCT01359943|19133518|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
5535457|NCT01359943|19133519|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
5535458|NCT01359943|19133520|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
5535459|NCT01359943|19133518|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
5535460|NCT01359943|19133519|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
5535461|NCT01359943|19133520|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
5535462|NCT01359943|19133518|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
5535463|NCT01359943|19133519|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
5535464|NCT01359943|19133520|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
5535465|NCT01359943|19133518|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
5535466|NCT01359943|19133519|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
5535467|NCT01359943|19133520|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
5535468|NCT01359943|19133518|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
5535469|NCT01359943|19133519|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
5535470|NCT01359943|19133520|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
5535471|NCT01359943|19133518|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
5535472|NCT01359943|19133519|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
5535473|NCT01359943|19133520|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
5535474|NCT01359904|19133568|P2|Overall Study|Withdrawal by Subject|0
5535475|NCT01359904|19133569|P1|Overall Study|Withdrawal by Subject|1
5535476|NCT01359644|19133623|P10|Follow-up Period|Lost to Follow-up|0
5535477|NCT01359644|19133624|P9|Follow-up Period|Lost to Follow-up|0
5535478|NCT01359644|19133625|P8|Follow-up Period|Lost to Follow-up|2
5535479|NCT01359644|19133626|P7|Follow-up Period|Lost to Follow-up|1
5535480|NCT01359644|19133627|P6|Follow-up Period|Lost to Follow-up|0
5535481|NCT01359644|19133628|P5|Follow-up Period|Lost to Follow-up|0
5535482|NCT01359644|19133629|P4|Follow-up Period|Lost to Follow-up|0
5535483|NCT01359644|19133630|P3|Follow-up Period|Lost to Follow-up|0
5535484|NCT01359644|19133631|P2|Follow-up Period|Lost to Follow-up|0
5535485|NCT01359644|19133632|P1|Follow-up Period|Lost to Follow-up|0
5535486|NCT01359644|19133623|P10|Follow-up Period|Withdrawal by Subject|0
5535487|NCT01359644|19133624|P9|Follow-up Period|Withdrawal by Subject|0
5535488|NCT01359644|19133625|P8|Follow-up Period|Withdrawal by Subject|0
5535489|NCT01359644|19133626|P7|Follow-up Period|Withdrawal by Subject|0
5535490|NCT01359644|19133627|P6|Follow-up Period|Withdrawal by Subject|1
5535491|NCT01359644|19133628|P5|Follow-up Period|Withdrawal by Subject|0
5535492|NCT01359644|19133629|P4|Follow-up Period|Withdrawal by Subject|0
5535493|NCT01359644|19133630|P3|Follow-up Period|Withdrawal by Subject|0
5535494|NCT01359644|19133631|P2|Follow-up Period|Withdrawal by Subject|0
5535495|NCT01359644|19133632|P1|Follow-up Period|Withdrawal by Subject|0
5535496|NCT01359644|19133623|P10|Treatment Period|Lost to Follow-up|0
5535497|NCT01359644|19133624|P9|Treatment Period|Lost to Follow-up|0
5535498|NCT01359644|19133625|P8|Treatment Period|Lost to Follow-up|0
5535499|NCT01359644|19133626|P7|Treatment Period|Lost to Follow-up|0
5535500|NCT01359644|19133627|P6|Treatment Period|Lost to Follow-up|1
5535501|NCT01359644|19133628|P5|Treatment Period|Lost to Follow-up|0
5535502|NCT01359644|19133629|P4|Treatment Period|Lost to Follow-up|0
5535503|NCT01359644|19133630|P3|Treatment Period|Lost to Follow-up|0
5535504|NCT01359644|19133631|P2|Treatment Period|Lost to Follow-up|0
5535505|NCT01359644|19133632|P1|Treatment Period|Lost to Follow-up|0
5535506|NCT01359644|19133623|P10|Treatment Period|Adverse Event|0
5535507|NCT01359644|19133624|P9|Treatment Period|Adverse Event|0
5535508|NCT01359644|19133625|P8|Treatment Period|Adverse Event|0
5535509|NCT01359644|19133626|P7|Treatment Period|Adverse Event|0
5535510|NCT01359644|19133627|P6|Treatment Period|Adverse Event|1
5535511|NCT01359644|19133628|P5|Treatment Period|Adverse Event|0
5535512|NCT01359644|19133629|P4|Treatment Period|Adverse Event|0
5535513|NCT01359644|19133630|P3|Treatment Period|Adverse Event|1
5535514|NCT01359644|19133631|P2|Treatment Period|Adverse Event|0
5535515|NCT01359644|19133632|P1|Treatment Period|Adverse Event|0
5535516|NCT01359644|19133623|P10|Treatment Period|Lack of Efficacy|0
5535517|NCT01359644|19133624|P9|Treatment Period|Lack of Efficacy|0
5535518|NCT01359644|19133625|P8|Treatment Period|Lack of Efficacy|0
5535519|NCT01359644|19133626|P7|Treatment Period|Lack of Efficacy|0
5535520|NCT01359644|19133627|P6|Treatment Period|Lack of Efficacy|0
5535521|NCT01359644|19133628|P5|Treatment Period|Lack of Efficacy|0
5535522|NCT01359644|19133629|P4|Treatment Period|Lack of Efficacy|0
5535523|NCT01359644|19133630|P3|Treatment Period|Lack of Efficacy|0
5535524|NCT01359644|19133631|P2|Treatment Period|Lack of Efficacy|1
5535525|NCT01359644|19133632|P1|Treatment Period|Lack of Efficacy|0
5535526|NCT01359449|19133676|P2|Overall Study|Withdrawal by Subject|2
5535527|NCT01359449|19133677|P1|Overall Study|Withdrawal by Subject|3
5535528|NCT01359449|19133676|P2|Overall Study|Protocol Violation|2
5535529|NCT01359449|19133677|P1|Overall Study|Protocol Violation|0
5535530|NCT01359449|19133676|P2|Overall Study|Lost to Follow-up|0
5535531|NCT01359449|19133677|P1|Overall Study|Lost to Follow-up|1
5535532|NCT01359254|19133727|P2|Overall Study|Death|0
5535533|NCT01359254|19133728|P1|Overall Study|Death|1
5535534|NCT01359150|19133738|P2|Overall Study|Other|0
5535535|NCT01359150|19133739|P1|Overall Study|Other|1
5535536|NCT01359150|19133738|P2|Overall Study|Adverse Event|3
5535537|NCT01359150|19133739|P1|Overall Study|Adverse Event|4
5535538|NCT01359150|19133738|P2|Overall Study|Withdrawal by Subject|1
5535539|NCT01359150|19133739|P1|Overall Study|Withdrawal by Subject|1
5535540|NCT01359150|19133738|P2|Overall Study|Lack of Efficacy|1
5535541|NCT01359150|19133739|P1|Overall Study|Lack of Efficacy|1
5535542|NCT01359046|19133770|P2|Overall Study|Physician Decision|11
5535543|NCT01359046|19133771|P1|Overall Study|Physician Decision|1
5535544|NCT01359046|19133770|P2|Overall Study|Did not receive allocated intervention|6
5535545|NCT01359046|19133771|P1|Overall Study|Did not receive allocated intervention|6
5535546|NCT01358981|19133794|P7|Period 1|Withdrawal by Subject|0
5535547|NCT01358981|19133795|P6|Period 1|Withdrawal by Subject|0
5535548|NCT01358981|19133796|P5|Period 1|Withdrawal by Subject|0
5535549|NCT01358981|19133797|P4|Period 1|Withdrawal by Subject|1
5535550|NCT01358981|19133798|P3|Period 1|Withdrawal by Subject|0
5535551|NCT01358981|19133799|P2|Period 1|Withdrawal by Subject|0
5535552|NCT01358981|19133800|P1|Period 1|Withdrawal by Subject|0
5535553|NCT01358968|19133861|P4|Continued Access Phase|Death|1
5535554|NCT01358968|19133862|P3|Continued Access Phase|Death|1
5535555|NCT01358968|19133863|P2|Continued Access Phase|Death|0
5535556|NCT01358968|19133864|P1|Continued Access Phase|Death|0
5535557|NCT01358968|19133861|P4|Continued Access Phase|Withdrawal by Subject|0
5535558|NCT01358968|19133862|P3|Continued Access Phase|Withdrawal by Subject|3
5535559|NCT01358968|19133863|P2|Continued Access Phase|Withdrawal by Subject|0
5535560|NCT01358968|19133864|P1|Continued Access Phase|Withdrawal by Subject|0
5535561|NCT01358968|19133861|P4|Continued Access Phase|Protocol Violation|2
5535562|NCT01358968|19133862|P3|Continued Access Phase|Protocol Violation|0
5535563|NCT01358968|19133863|P2|Continued Access Phase|Protocol Violation|0
5535564|NCT01358968|19133864|P1|Continued Access Phase|Protocol Violation|0
5535565|NCT01358968|19133861|P4|Continued Access Phase|Progression of Disease|4
5535566|NCT01358968|19133862|P3|Continued Access Phase|Progression of Disease|8
5535567|NCT01358968|19133863|P2|Continued Access Phase|Progression of Disease|0
5535568|NCT01358968|19133864|P1|Continued Access Phase|Progression of Disease|0
5535569|NCT01358968|19133861|P4|Period 2|Adverse Event|0
5535570|NCT01358968|19133862|P3|Period 2|Adverse Event|0
5535571|NCT01358968|19133863|P2|Period 2|Adverse Event|1
5535572|NCT01358968|19133864|P1|Period 2|Adverse Event|0
5535573|NCT01358877|19133880|P2|Overall Study|Other|129
5535574|NCT01358877|19133881|P1|Overall Study|Other|142
5535575|NCT01358877|19133880|P2|Overall Study|Ongoing follow-up for overall survival|5
5535576|NCT01358877|19133881|P1|Overall Study|Ongoing follow-up for overall survival|7
5535577|NCT01358877|19133880|P2|Overall Study|Ongoing follow-up for IDFS event|2073
5535578|NCT01358877|19133881|P1|Overall Study|Ongoing follow-up for IDFS event|2084
5535579|NCT01358877|19133880|P2|Overall Study|Ongoing follow-up for post-recurrence|108
5535580|NCT01358877|19133881|P1|Overall Study|Ongoing follow-up for post-recurrence|87
5535581|NCT01358877|19133880|P2|Overall Study|Death|89
5535582|NCT01358877|19133881|P1|Overall Study|Death|80
5535583|NCT01358864|19133951|P8|Overall Study|Not treated|0
5535584|NCT01358864|19133952|P7|Overall Study|Not treated|1
5535585|NCT01358864|19133953|P6|Overall Study|Not treated|0
5535586|NCT01358864|19133954|P5|Overall Study|Not treated|0
5535587|NCT01358864|19133955|P4|Overall Study|Not treated|0
5535588|NCT01358864|19133956|P3|Overall Study|Not treated|0
5535589|NCT01358864|19133957|P2|Overall Study|Not treated|0
5535590|NCT01358864|19133958|P1|Overall Study|Not treated|0
5535591|NCT01358864|19133951|P8|Overall Study|Other reason not defined above|0
5535592|NCT01358864|19133952|P7|Overall Study|Other reason not defined above|2
5535593|NCT01358864|19133953|P6|Overall Study|Other reason not defined above|0
5535594|NCT01358864|19133954|P5|Overall Study|Other reason not defined above|0
5535595|NCT01358864|19133955|P4|Overall Study|Other reason not defined above|0
5535596|NCT01358864|19133956|P3|Overall Study|Other reason not defined above|0
5535597|NCT01358864|19133957|P2|Overall Study|Other reason not defined above|0
5535598|NCT01358864|19133958|P1|Overall Study|Other reason not defined above|2
5535599|NCT01358864|19133951|P8|Overall Study|Withdrawal by Subject|3
5535600|NCT01358864|19133952|P7|Overall Study|Withdrawal by Subject|1
5535601|NCT01358864|19133953|P6|Overall Study|Withdrawal by Subject|1
5535602|NCT01358864|19133954|P5|Overall Study|Withdrawal by Subject|0
5535603|NCT01358864|19133955|P4|Overall Study|Withdrawal by Subject|0
5535604|NCT01358864|19133956|P3|Overall Study|Withdrawal by Subject|2
5535605|NCT01358864|19133957|P2|Overall Study|Withdrawal by Subject|4
5535606|NCT01358864|19133958|P1|Overall Study|Withdrawal by Subject|3
5535607|NCT01358864|19133951|P8|Overall Study|Lost to Follow-up|1
5535608|NCT01358864|19133952|P7|Overall Study|Lost to Follow-up|0
5535609|NCT01358864|19133953|P6|Overall Study|Lost to Follow-up|0
5535610|NCT01358864|19133954|P5|Overall Study|Lost to Follow-up|0
5535611|NCT01358864|19133955|P4|Overall Study|Lost to Follow-up|0
5535612|NCT01358864|19133956|P3|Overall Study|Lost to Follow-up|1
5535613|NCT01358864|19133957|P2|Overall Study|Lost to Follow-up|0
5535614|NCT01358864|19133958|P1|Overall Study|Lost to Follow-up|0
5535615|NCT01358864|19133951|P8|Overall Study|Lack of Efficacy|44
5535616|NCT01358864|19133952|P7|Overall Study|Lack of Efficacy|49
5535617|NCT01358864|19133953|P6|Overall Study|Lack of Efficacy|4
5535618|NCT01358864|19133954|P5|Overall Study|Lack of Efficacy|7
5535619|NCT01358864|19133955|P4|Overall Study|Lack of Efficacy|19
5535620|NCT01358864|19133956|P3|Overall Study|Lack of Efficacy|4
5535621|NCT01358864|19133957|P2|Overall Study|Lack of Efficacy|3
5535622|NCT01358864|19133958|P1|Overall Study|Lack of Efficacy|26
5535623|NCT01358864|19133951|P8|Overall Study|Adverse Event|7
5535624|NCT01358864|19133952|P7|Overall Study|Adverse Event|12
5535625|NCT01358864|19133953|P6|Overall Study|Adverse Event|8
5535626|NCT01358864|19133954|P5|Overall Study|Adverse Event|4
5535627|NCT01358864|19133955|P4|Overall Study|Adverse Event|0
5535628|NCT01358864|19133956|P3|Overall Study|Adverse Event|9
5535629|NCT01358864|19133957|P2|Overall Study|Adverse Event|6
5535630|NCT01358864|19133958|P1|Overall Study|Adverse Event|0
5535631|NCT01358825|19134049|P2|Overall Study|Blood sample not drawn|1
5535632|NCT01358825|19134050|P1|Overall Study|Blood sample not drawn|0
5535633|NCT01358760|19134074|P3|Overall Study|Entry criteria not met/Non-compliance|16
5535634|NCT01358760|19134075|P2|Overall Study|Entry criteria not met/Non-compliance|12
5535635|NCT01358760|19134076|P1|Overall Study|Entry criteria not met/Non-compliance|12
5535636|NCT01358760|19134074|P3|Overall Study|Physician Decision|1
5535637|NCT01358760|19134075|P2|Overall Study|Physician Decision|0
5535638|NCT01358760|19134076|P1|Overall Study|Physician Decision|1
5535639|NCT01358760|19134074|P3|Overall Study|Withdrawal by Subject|2
5535640|NCT01358760|19134075|P2|Overall Study|Withdrawal by Subject|3
5535641|NCT01358760|19134076|P1|Overall Study|Withdrawal by Subject|5
5535642|NCT01358760|19134074|P3|Overall Study|Lost to Follow-up|3
5535643|NCT01358760|19134075|P2|Overall Study|Lost to Follow-up|1
5535644|NCT01358760|19134076|P1|Overall Study|Lost to Follow-up|1
5535645|NCT01358760|19134074|P3|Overall Study|Adverse Event|3
5535646|NCT01358760|19134075|P2|Overall Study|Adverse Event|4
5535647|NCT01358760|19134076|P1|Overall Study|Adverse Event|3
5535648|NCT01358734|19134111|P3|Overall Study|Protocol Violation|2
5535649|NCT01358734|19134112|P2|Overall Study|Protocol Violation|0
5535650|NCT01358734|19134113|P1|Overall Study|Protocol Violation|0
5535651|NCT01358734|19134111|P3|Overall Study|Other|4
5535652|NCT01358734|19134112|P2|Overall Study|Other|5
5535653|NCT01358734|19134113|P1|Overall Study|Other|2
5535654|NCT01358734|19134111|P3|Overall Study|Non-compliance with study drug|1
5535655|NCT01358734|19134112|P2|Overall Study|Non-compliance with study drug|0
5535656|NCT01358734|19134113|P1|Overall Study|Non-compliance with study drug|0
5535657|NCT01358734|19134111|P3|Overall Study|Progressive Disease|16
5535658|NCT01358734|19134112|P2|Overall Study|Progressive Disease|13
5535659|NCT01358734|19134113|P1|Overall Study|Progressive Disease|5
5535660|NCT01358734|19134111|P3|Overall Study|Death|2
5535661|NCT01358734|19134112|P2|Overall Study|Death|7
5535662|NCT01358734|19134113|P1|Overall Study|Death|3
5535663|NCT01358734|19134111|P3|Overall Study|Withdrawal by Subject|3
5535664|NCT01358734|19134112|P2|Overall Study|Withdrawal by Subject|6
5535665|NCT01358734|19134113|P1|Overall Study|Withdrawal by Subject|1
5535666|NCT01358734|19134111|P3|Overall Study|Lack of Efficacy|3
5535667|NCT01358734|19134112|P2|Overall Study|Lack of Efficacy|1
5535668|NCT01358734|19134113|P1|Overall Study|Lack of Efficacy|0
5535669|NCT01358734|19134111|P3|Overall Study|Adverse Event|3
5535670|NCT01358734|19134112|P2|Overall Study|Adverse Event|7
5535671|NCT01358734|19134113|P1|Overall Study|Adverse Event|4
5535672|NCT01358721|19134161|P4|Overall Study|Out of State/Unmet Criteria|0
5535673|NCT01358721|19134162|P3|Overall Study|Out of State/Unmet Criteria|1
5535674|NCT01358721|19134163|P2|Overall Study|Out of State/Unmet Criteria|0
5535675|NCT01358721|19134164|P1|Overall Study|Out of State/Unmet Criteria|0
5535676|NCT01358721|19134161|P4|Overall Study|Disease Progression|15
5535677|NCT01358721|19134162|P3|Overall Study|Disease Progression|17
5535678|NCT01358721|19134163|P2|Overall Study|Disease Progression|15
5535679|NCT01358721|19134164|P1|Overall Study|Disease Progression|19
5535680|NCT01358721|19134161|P4|Overall Study|Adverse Event related to study drug|1
5535681|NCT01358721|19134162|P3|Overall Study|Adverse Event related to study drug|0
5535682|NCT01358721|19134163|P2|Overall Study|Adverse Event related to study drug|0
5535683|NCT01358721|19134164|P1|Overall Study|Adverse Event related to study drug|1
5535684|NCT01358721|19134161|P4|Overall Study|Subject No Longer Meets Study Criteria|1
5535685|NCT01358721|19134162|P3|Overall Study|Subject No Longer Meets Study Criteria|0
5535686|NCT01358721|19134163|P2|Overall Study|Subject No Longer Meets Study Criteria|2
5535687|NCT01358721|19134164|P1|Overall Study|Subject No Longer Meets Study Criteria|0
5535688|NCT01358721|19134161|P4|Overall Study|SUBJ request to discontinue study TRT|1
5535689|NCT01358721|19134162|P3|Overall Study|SUBJ request to discontinue study TRT|0
5535690|NCT01358721|19134163|P2|Overall Study|SUBJ request to discontinue study TRT|0
5535691|NCT01358721|19134164|P1|Overall Study|SUBJ request to discontinue study TRT|0
5535692|NCT01358721|19134161|P4|Overall Study|Study Drug Toxicity|5
5535693|NCT01358721|19134162|P3|Overall Study|Study Drug Toxicity|4
5535694|NCT01358721|19134163|P2|Overall Study|Study Drug Toxicity|3
5535695|NCT01358721|19134164|P1|Overall Study|Study Drug Toxicity|1
5535696|NCT01358721|19134161|P4|Overall Study|Death|0
5535697|NCT01358721|19134162|P3|Overall Study|Death|0
5535698|NCT01358721|19134163|P2|Overall Study|Death|2
5535699|NCT01358721|19134164|P1|Overall Study|Death|0
5535700|NCT01358721|19134161|P4|Overall Study|Withdrawal by Subject|1
5535701|NCT01358721|19134162|P3|Overall Study|Withdrawal by Subject|0
5535702|NCT01358721|19134163|P2|Overall Study|Withdrawal by Subject|0
5535703|NCT01358721|19134164|P1|Overall Study|Withdrawal by Subject|0
5535704|NCT01358708|19134216|P2|Double-Blind Treatment Phase|Protocol Violation|0
5535705|NCT01358708|19134217|P1|Double-Blind Treatment Phase|Protocol Violation|1
5535706|NCT01358708|19134216|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
5535707|NCT01358708|19134217|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
5535708|NCT01358578|19134240|P6|Follow-up Period|Physician Decision|0
5535709|NCT01358578|19134241|P5|Follow-up Period|Physician Decision|0
5535710|NCT01358578|19134242|P4|Follow-up Period|Physician Decision|2
5535711|NCT01358578|19134243|P3|Follow-up Period|Physician Decision|0
5535712|NCT01358578|19134244|P2|Follow-up Period|Physician Decision|1
5535713|NCT01358578|19134245|P1|Follow-up Period|Physician Decision|1
5535714|NCT01358578|19134240|P6|Follow-up Period|Withdrawal by Subject|0
5535715|NCT01358578|19134241|P5|Follow-up Period|Withdrawal by Subject|0
5535716|NCT01358578|19134242|P4|Follow-up Period|Withdrawal by Subject|12
5535717|NCT01358578|19134243|P3|Follow-up Period|Withdrawal by Subject|1
5535718|NCT01358578|19134244|P2|Follow-up Period|Withdrawal by Subject|3
5535719|NCT01358578|19134245|P1|Follow-up Period|Withdrawal by Subject|3
5535720|NCT01358578|19134240|P6|Follow-up Period|Pregnancy|0
5535721|NCT01358578|19134241|P5|Follow-up Period|Pregnancy|0
5535722|NCT01358578|19134242|P4|Follow-up Period|Pregnancy|0
5535723|NCT01358578|19134243|P3|Follow-up Period|Pregnancy|0
5535724|NCT01358578|19134244|P2|Follow-up Period|Pregnancy|0
5535725|NCT01358578|19134245|P1|Follow-up Period|Pregnancy|1
5535726|NCT01358578|19134240|P6|Follow-up Period|non- compliance with study treatment|0
5535727|NCT01358578|19134241|P5|Follow-up Period|non- compliance with study treatment|0
5535728|NCT01358578|19134242|P4|Follow-up Period|non- compliance with study treatment|0
5535729|NCT01358578|19134243|P3|Follow-up Period|non- compliance with study treatment|0
5535730|NCT01358578|19134244|P2|Follow-up Period|non- compliance with study treatment|0
5535731|NCT01358578|19134245|P1|Follow-up Period|non- compliance with study treatment|1
5535732|NCT01358578|19134240|P6|Follow-up Period|Lost to Follow-up|0
5535733|NCT01358578|19134241|P5|Follow-up Period|Lost to Follow-up|0
5535734|NCT01358578|19134242|P4|Follow-up Period|Lost to Follow-up|4
5535735|NCT01358578|19134243|P3|Follow-up Period|Lost to Follow-up|0
5535736|NCT01358578|19134244|P2|Follow-up Period|Lost to Follow-up|1
5535737|NCT01358578|19134245|P1|Follow-up Period|Lost to Follow-up|0
5535738|NCT01358578|19134240|P6|Follow-up Period|Lack of Efficacy|0
5535739|NCT01358578|19134241|P5|Follow-up Period|Lack of Efficacy|0
5535740|NCT01358578|19134242|P4|Follow-up Period|Lack of Efficacy|1
5535741|NCT01358578|19134243|P3|Follow-up Period|Lack of Efficacy|4
5535742|NCT01358578|19134244|P2|Follow-up Period|Lack of Efficacy|0
5535743|NCT01358578|19134245|P1|Follow-up Period|Lack of Efficacy|3
5535744|NCT01358578|19134240|P6|Follow-up Period|Adverse Event|0
5535745|NCT01358578|19134241|P5|Follow-up Period|Adverse Event|0
5535746|NCT01358578|19134242|P4|Follow-up Period|Adverse Event|0
5535747|NCT01358578|19134243|P3|Follow-up Period|Adverse Event|0
5535748|NCT01358578|19134244|P2|Follow-up Period|Adverse Event|1
5535749|NCT01358578|19134245|P1|Follow-up Period|Adverse Event|1
5535750|NCT01358578|19134240|P6|Maintenance Period|Withdrawal by Subject|3
5535751|NCT01358578|19134241|P5|Maintenance Period|Withdrawal by Subject|6
5535752|NCT01358578|19134242|P4|Maintenance Period|Withdrawal by Subject|15
5535753|NCT01358578|19134243|P3|Maintenance Period|Withdrawal by Subject|2
5535754|NCT01358578|19134244|P2|Maintenance Period|Withdrawal by Subject|7
5535755|NCT01358578|19134245|P1|Maintenance Period|Withdrawal by Subject|12
5535756|NCT01358578|19134240|P6|Maintenance Period|Protocol deviation|2
5535757|NCT01358578|19134241|P5|Maintenance Period|Protocol deviation|2
5535758|NCT01358578|19134242|P4|Maintenance Period|Protocol deviation|2
5535759|NCT01358578|19134243|P3|Maintenance Period|Protocol deviation|0
5535760|NCT01358578|19134244|P2|Maintenance Period|Protocol deviation|4
5535761|NCT01358578|19134245|P1|Maintenance Period|Protocol deviation|7
5535762|NCT01358578|19134240|P6|Maintenance Period|Pregnancy|0
5535763|NCT01358578|19134241|P5|Maintenance Period|Pregnancy|0
5535764|NCT01358578|19134242|P4|Maintenance Period|Pregnancy|0
5535765|NCT01358578|19134243|P3|Maintenance Period|Pregnancy|0
5535766|NCT01358578|19134244|P2|Maintenance Period|Pregnancy|0
5535767|NCT01358578|19134245|P1|Maintenance Period|Pregnancy|1
5535768|NCT01358578|19134240|P6|Maintenance Period|Physician Decision|0
5535769|NCT01358578|19134241|P5|Maintenance Period|Physician Decision|0
5535770|NCT01358578|19134242|P4|Maintenance Period|Physician Decision|1
5535771|NCT01358578|19134243|P3|Maintenance Period|Physician Decision|0
5535772|NCT01358578|19134244|P2|Maintenance Period|Physician Decision|1
5535773|NCT01358578|19134245|P1|Maintenance Period|Physician Decision|0
5535774|NCT01358578|19134240|P6|Maintenance Period|Non-compliance with study treatment|2
5535775|NCT01358578|19134241|P5|Maintenance Period|Non-compliance with study treatment|1
5535776|NCT01358578|19134242|P4|Maintenance Period|Non-compliance with study treatment|2
5535777|NCT01358578|19134243|P3|Maintenance Period|Non-compliance with study treatment|0
5535778|NCT01358578|19134244|P2|Maintenance Period|Non-compliance with study treatment|1
5535779|NCT01358578|19134245|P1|Maintenance Period|Non-compliance with study treatment|3
5535780|NCT01358578|19134240|P6|Maintenance Period|Lost to Follow-up|1
5535781|NCT01358578|19134241|P5|Maintenance Period|Lost to Follow-up|1
5535782|NCT01358578|19134242|P4|Maintenance Period|Lost to Follow-up|5
5535783|NCT01358578|19134243|P3|Maintenance Period|Lost to Follow-up|0
5535784|NCT01358578|19134244|P2|Maintenance Period|Lost to Follow-up|0
5535785|NCT01358578|19134245|P1|Maintenance Period|Lost to Follow-up|4
5535786|NCT01358578|19134240|P6|Maintenance Period|Lack of Efficacy|0
5535787|NCT01358578|19134241|P5|Maintenance Period|Lack of Efficacy|3
5535788|NCT01358578|19134242|P4|Maintenance Period|Lack of Efficacy|11
5535789|NCT01358578|19134243|P3|Maintenance Period|Lack of Efficacy|0
5535790|NCT01358578|19134244|P2|Maintenance Period|Lack of Efficacy|2
5535791|NCT01358578|19134245|P1|Maintenance Period|Lack of Efficacy|10
5535792|NCT01358578|19134240|P6|Maintenance Period|Adverse Event|3
5535793|NCT01358578|19134241|P5|Maintenance Period|Adverse Event|4
5535794|NCT01358578|19134242|P4|Maintenance Period|Adverse Event|6
5535795|NCT01358578|19134243|P3|Maintenance Period|Adverse Event|0
5535796|NCT01358578|19134244|P2|Maintenance Period|Adverse Event|7
5535797|NCT01358578|19134245|P1|Maintenance Period|Adverse Event|2
5535798|NCT01358578|19134240|P6|Induction Period|Withdrawal by Subject|0
5535799|NCT01358578|19134241|P5|Induction Period|Withdrawal by Subject|0
5535800|NCT01358578|19134242|P4|Induction Period|Withdrawal by Subject|6
5535801|NCT01358578|19134243|P3|Induction Period|Withdrawal by Subject|10
5535802|NCT01358578|19134244|P2|Induction Period|Withdrawal by Subject|5
5535803|NCT01358578|19134245|P1|Induction Period|Withdrawal by Subject|5
5535804|NCT01358578|19134240|P6|Induction Period|technical problems|0
5535805|NCT01358578|19134241|P5|Induction Period|technical problems|0
5535806|NCT01358578|19134242|P4|Induction Period|technical problems|1
5535807|NCT01358578|19134243|P3|Induction Period|technical problems|1
5535808|NCT01358578|19134244|P2|Induction Period|technical problems|0
5535809|NCT01358578|19134245|P1|Induction Period|technical problems|0
5535810|NCT01358578|19134240|P6|Induction Period|Protocol Deviation|0
5535811|NCT01358578|19134241|P5|Induction Period|Protocol Deviation|0
5535812|NCT01358578|19134242|P4|Induction Period|Protocol Deviation|3
5535813|NCT01358578|19134243|P3|Induction Period|Protocol Deviation|0
5535814|NCT01358578|19134244|P2|Induction Period|Protocol Deviation|5
5535815|NCT01358578|19134245|P1|Induction Period|Protocol Deviation|3
5535816|NCT01358578|19134240|P6|Induction Period|Physician Decision|0
5535817|NCT01358578|19134241|P5|Induction Period|Physician Decision|0
5535818|NCT01358578|19134242|P4|Induction Period|Physician Decision|0
5535819|NCT01358578|19134243|P3|Induction Period|Physician Decision|2
5535820|NCT01358578|19134244|P2|Induction Period|Physician Decision|1
5535821|NCT01358578|19134245|P1|Induction Period|Physician Decision|2
5535822|NCT01358578|19134240|P6|Induction Period|Lost to Follow-up|0
5535823|NCT01358578|19134241|P5|Induction Period|Lost to Follow-up|0
5535824|NCT01358578|19134242|P4|Induction Period|Lost to Follow-up|4
5535825|NCT01358578|19134243|P3|Induction Period|Lost to Follow-up|1
5535826|NCT01358578|19134244|P2|Induction Period|Lost to Follow-up|0
5535827|NCT01358578|19134245|P1|Induction Period|Lost to Follow-up|0
5535828|NCT01358578|19134240|P6|Induction Period|Lack of Efficacy|0
5535829|NCT01358578|19134241|P5|Induction Period|Lack of Efficacy|0
5535830|NCT01358578|19134242|P4|Induction Period|Lack of Efficacy|1
5535831|NCT01358578|19134243|P3|Induction Period|Lack of Efficacy|9
5535832|NCT01358578|19134244|P2|Induction Period|Lack of Efficacy|0
5535833|NCT01358578|19134245|P1|Induction Period|Lack of Efficacy|0
5535834|NCT01358578|19134240|P6|Induction Period|Adverse Event|0
5535835|NCT01358578|19134241|P5|Induction Period|Adverse Event|0
5535836|NCT01358578|19134242|P4|Induction Period|Adverse Event|6
5535837|NCT01358578|19134243|P3|Induction Period|Adverse Event|2
5535838|NCT01358578|19134244|P2|Induction Period|Adverse Event|4
5535839|NCT01358578|19134245|P1|Induction Period|Adverse Event|2
5535840|NCT01358526|19134297|P3|Double-blind Phase|Administrative|10
5535841|NCT01358526|19134298|P2|Double-blind Phase|Administrative|6
5535842|NCT01358526|19134299|P1|Double-blind Phase|Administrative|0
5535843|NCT01358526|19134297|P3|Double-blind Phase|Confirmed or suspected diversion|6
5535844|NCT01358526|19134298|P2|Double-blind Phase|Confirmed or suspected diversion|5
5535845|NCT01358526|19134299|P1|Double-blind Phase|Confirmed or suspected diversion|0
5535846|NCT01358526|19134297|P3|Double-blind Phase|Lack of Efficacy|73
5535847|NCT01358526|19134298|P2|Double-blind Phase|Lack of Efficacy|31
5535848|NCT01358526|19134299|P1|Double-blind Phase|Lack of Efficacy|0
5535849|NCT01358526|19134297|P3|Double-blind Phase|Lost to Follow-up|1
5535850|NCT01358526|19134298|P2|Double-blind Phase|Lost to Follow-up|4
5535851|NCT01358526|19134299|P1|Double-blind Phase|Lost to Follow-up|0
5535852|NCT01358526|19134297|P3|Double-blind Phase|Withdrawal by Subject|8
5535853|NCT01358526|19134298|P2|Double-blind Phase|Withdrawal by Subject|10
5535854|NCT01358526|19134299|P1|Double-blind Phase|Withdrawal by Subject|0
5535855|NCT01358526|19134297|P3|Double-blind Phase|Adverse Event|23
5535856|NCT01358526|19134298|P2|Double-blind Phase|Adverse Event|24
5535857|NCT01358526|19134299|P1|Double-blind Phase|Adverse Event|0
5535858|NCT01358526|19134297|P3|Open-label Titration Period|Did not qualify|0
5535859|NCT01358526|19134298|P2|Open-label Titration Period|Did not qualify|0
5535860|NCT01358526|19134299|P1|Open-label Titration Period|Did not qualify|178
5535861|NCT01358526|19134297|P3|Open-label Titration Period|Administrative|0
5535862|NCT01358526|19134298|P2|Open-label Titration Period|Administrative|0
5535863|NCT01358526|19134299|P1|Open-label Titration Period|Administrative|8
5535864|NCT01358526|19134297|P3|Open-label Titration Period|Confirmed or suspected diversion|0
5535865|NCT01358526|19134298|P2|Open-label Titration Period|Confirmed or suspected diversion|0
5535866|NCT01358526|19134299|P1|Open-label Titration Period|Confirmed or suspected diversion|16
5535867|NCT01358526|19134297|P3|Open-label Titration Period|Lack of Efficacy|0
5535868|NCT01358526|19134298|P2|Open-label Titration Period|Lack of Efficacy|0
5535869|NCT01358526|19134299|P1|Open-label Titration Period|Lack of Efficacy|107
5535870|NCT01358526|19134297|P3|Open-label Titration Period|Lost to Follow-up|0
5535871|NCT01358526|19134298|P2|Open-label Titration Period|Lost to Follow-up|0
5535872|NCT01358526|19134299|P1|Open-label Titration Period|Lost to Follow-up|25
5535873|NCT01358526|19134297|P3|Open-label Titration Period|Withdrawal by Subject|0
5535874|NCT01358526|19134298|P2|Open-label Titration Period|Withdrawal by Subject|0
5535875|NCT01358526|19134299|P1|Open-label Titration Period|Withdrawal by Subject|65
5535876|NCT01358526|19134297|P3|Open-label Titration Period|Adverse Event|0
5535877|NCT01358526|19134298|P2|Open-label Titration Period|Adverse Event|0
5535878|NCT01358526|19134299|P1|Open-label Titration Period|Adverse Event|95
5535879|NCT01358357|19134316|P3|Double-Blind Phase|Administrative|0
5535880|NCT01358357|19134317|P2|Double-Blind Phase|Administrative|1
5535881|NCT01358357|19134318|P1|Double-Blind Phase|Administrative|0
5535882|NCT01358357|19134316|P3|Double-Blind Phase|Recurrence of mood event|0
5535883|NCT01358357|19134317|P2|Double-Blind Phase|Recurrence of mood event|64
5535884|NCT01358357|19134318|P1|Double-Blind Phase|Recurrence of mood event|48
5535885|NCT01358357|19134316|P3|Double-Blind Phase|Terminated at study completion|0
5535886|NCT01358357|19134317|P2|Double-Blind Phase|Terminated at study completion|0
5535887|NCT01358357|19134318|P1|Double-Blind Phase|Terminated at study completion|2
5535888|NCT01358357|19134316|P3|Double-Blind Phase|Protocol Violation|0
5535889|NCT01358357|19134317|P2|Double-Blind Phase|Protocol Violation|12
5535890|NCT01358357|19134318|P1|Double-Blind Phase|Protocol Violation|16
5535891|NCT01358357|19134316|P3|Double-Blind Phase|Protocol Violation|0
5535892|NCT01358357|19134317|P2|Double-Blind Phase|Protocol Violation|11
5535893|NCT01358357|19134318|P1|Double-Blind Phase|Protocol Violation|1
5535894|NCT01358357|19134316|P3|Double-Blind Phase|Lost to Follow-up|0
5535895|NCT01358357|19134317|P2|Double-Blind Phase|Lost to Follow-up|7
5535896|NCT01358357|19134318|P1|Double-Blind Phase|Lost to Follow-up|5
5535897|NCT01358357|19134316|P3|Double-Blind Phase|Adverse Event|0
5535898|NCT01358357|19134317|P2|Double-Blind Phase|Adverse Event|5
5535899|NCT01358357|19134318|P1|Double-Blind Phase|Adverse Event|8
5535900|NCT01358357|19134316|P3|Open Label Phase|Mood episode|42
5535901|NCT01358357|19134317|P2|Open Label Phase|Mood episode|0
5535902|NCT01358357|19134318|P1|Open Label Phase|Mood episode|0
5535903|NCT01358357|19134316|P3|Open Label Phase|Terminated at study completion|5
5535904|NCT01358357|19134317|P2|Open Label Phase|Terminated at study completion|0
5535905|NCT01358357|19134318|P1|Open Label Phase|Terminated at study completion|0
5535906|NCT01358357|19134316|P3|Open Label Phase|Did not meet criteria for DB phase|16
5535907|NCT01358357|19134317|P2|Open Label Phase|Did not meet criteria for DB phase|0
5535908|NCT01358357|19134318|P1|Open Label Phase|Did not meet criteria for DB phase|0
5535909|NCT01358357|19134316|P3|Open Label Phase|Withdrawal by Subject|112
5535910|NCT01358357|19134317|P2|Open Label Phase|Withdrawal by Subject|0
5535911|NCT01358357|19134318|P1|Open Label Phase|Withdrawal by Subject|0
5535912|NCT01358357|19134316|P3|Open Label Phase|Protocol Violation|45
5535913|NCT01358357|19134317|P2|Open Label Phase|Protocol Violation|0
5535914|NCT01358357|19134318|P1|Open Label Phase|Protocol Violation|0
5535915|NCT01358357|19134316|P3|Open Label Phase|Lost to Follow-up|76
5535916|NCT01358357|19134317|P2|Open Label Phase|Lost to Follow-up|0
5535917|NCT01358357|19134318|P1|Open Label Phase|Lost to Follow-up|0
5535918|NCT01358357|19134316|P3|Open Label Phase|Lack of Efficacy|107
5535919|NCT01358357|19134317|P2|Open Label Phase|Lack of Efficacy|0
5535920|NCT01358357|19134318|P1|Open Label Phase|Lack of Efficacy|0
5535921|NCT01358357|19134316|P3|Open Label Phase|Adverse Event|59
5535922|NCT01358357|19134317|P2|Open Label Phase|Adverse Event|0
5535923|NCT01358357|19134318|P1|Open Label Phase|Adverse Event|0
5535924|NCT01358331|19134357|P6|Overall Study|Progress of disease under investigation|0
5535925|NCT01358331|19134358|P5|Overall Study|Progress of disease under investigation|3
5535926|NCT01358331|19134359|P4|Overall Study|Progress of disease under investigation|1
5535927|NCT01358331|19134360|P3|Overall Study|Progress of disease under investigation|3
5535928|NCT01358331|19134361|P2|Overall Study|Progress of disease under investigation|2
5535929|NCT01358331|19134362|P1|Overall Study|Progress of disease under investigation|1
5535930|NCT01358331|19134357|P6|Overall Study|Participants did not wish to continue|0
5535931|NCT01358331|19134358|P5|Overall Study|Participants did not wish to continue|1
5535932|NCT01358331|19134359|P4|Overall Study|Participants did not wish to continue|0
5535933|NCT01358331|19134360|P3|Overall Study|Participants did not wish to continue|0
5535934|NCT01358331|19134361|P2|Overall Study|Participants did not wish to continue|0
5535935|NCT01358331|19134362|P1|Overall Study|Participants did not wish to continue|0
5535936|NCT01358331|19134357|P6|Overall Study|Symptomatic Deterioration|0
5535937|NCT01358331|19134358|P5|Overall Study|Symptomatic Deterioration|1
5535938|NCT01358331|19134359|P4|Overall Study|Symptomatic Deterioration|0
5535939|NCT01358331|19134360|P3|Overall Study|Symptomatic Deterioration|0
5535940|NCT01358331|19134361|P2|Overall Study|Symptomatic Deterioration|0
5535941|NCT01358331|19134362|P1|Overall Study|Symptomatic Deterioration|0
5535942|NCT01358331|19134357|P6|Overall Study|Adverse Events|5
5535943|NCT01358331|19134358|P5|Overall Study|Adverse Events|1
5535944|NCT01358331|19134359|P4|Overall Study|Adverse Events|0
5535945|NCT01358331|19134360|P3|Overall Study|Adverse Events|1
5535946|NCT01358331|19134361|P2|Overall Study|Adverse Events|1
5535947|NCT01358331|19134362|P1|Overall Study|Adverse Events|1
5535948|NCT01358331|19134357|P6|Overall Study|Withdrawal by Subject|1
5535949|NCT01358331|19134358|P5|Overall Study|Withdrawal by Subject|1
5535950|NCT01358331|19134359|P4|Overall Study|Withdrawal by Subject|1
5535951|NCT01358331|19134360|P3|Overall Study|Withdrawal by Subject|0
5535952|NCT01358331|19134361|P2|Overall Study|Withdrawal by Subject|0
5535953|NCT01358331|19134362|P1|Overall Study|Withdrawal by Subject|0
5535954|NCT01358331|19134357|P6|Overall Study|Lost to Follow-up|0
5535955|NCT01358331|19134358|P5|Overall Study|Lost to Follow-up|0
5535956|NCT01358331|19134359|P4|Overall Study|Lost to Follow-up|1
5535957|NCT01358331|19134360|P3|Overall Study|Lost to Follow-up|0
5535958|NCT01358331|19134361|P2|Overall Study|Lost to Follow-up|0
5535959|NCT01358331|19134362|P1|Overall Study|Lost to Follow-up|0
5535960|NCT01358175|19134414|P3|Overall Study|Adverse Event|11
5535961|NCT01358175|19134415|P2|Overall Study|Adverse Event|11
5535962|NCT01358175|19134416|P1|Overall Study|Adverse Event|6
5535963|NCT01358175|19134414|P3|Overall Study|Lack of Efficacy|6
5535964|NCT01358175|19134415|P2|Overall Study|Lack of Efficacy|8
5535965|NCT01358175|19134416|P1|Overall Study|Lack of Efficacy|3
5535966|NCT01358175|19134414|P3|Overall Study|Lost to Follow-up|3
5535967|NCT01358175|19134415|P2|Overall Study|Lost to Follow-up|1
5535968|NCT01358175|19134416|P1|Overall Study|Lost to Follow-up|1
5535969|NCT01358175|19134414|P3|Overall Study|Non Compliance with Study Treatment|1
5535970|NCT01358175|19134415|P2|Overall Study|Non Compliance with Study Treatment|1
5535971|NCT01358175|19134416|P1|Overall Study|Non Compliance with Study Treatment|0
5535972|NCT01358175|19134414|P3|Overall Study|Physician Decision|0
5535973|NCT01358175|19134415|P2|Overall Study|Physician Decision|0
5535974|NCT01358175|19134416|P1|Overall Study|Physician Decision|1
5535975|NCT01358175|19134414|P3|Overall Study|Pregnancy|0
5535976|NCT01358175|19134415|P2|Overall Study|Pregnancy|1
5535977|NCT01358175|19134416|P1|Overall Study|Pregnancy|0
5535978|NCT01358175|19134414|P3|Overall Study|Technical issues|0
5535979|NCT01358175|19134415|P2|Overall Study|Technical issues|1
5535980|NCT01358175|19134416|P1|Overall Study|Technical issues|0
5535981|NCT01358175|19134414|P3|Overall Study|Withdrawal by Subject|10
5535982|NCT01358175|19134415|P2|Overall Study|Withdrawal by Subject|5
5535983|NCT01358175|19134416|P1|Overall Study|Withdrawal by Subject|9
5535984|NCT01358175|19134414|P3|Overall Study|Death|1
5535985|NCT01358175|19134415|P2|Overall Study|Death|0
5535986|NCT01358175|19134416|P1|Overall Study|Death|1
5535987|NCT01357980|19134453|P4|Overall Study|Consent withdrawn|0
5535988|NCT01357980|19134454|P3|Overall Study|Consent withdrawn|1
5535989|NCT01357980|19134455|P2|Overall Study|Consent withdrawn|0
5535990|NCT01357980|19134456|P1|Overall Study|Consent withdrawn|0
5535991|NCT01357980|19134453|P4|Overall Study|Lack of Efficacy|0
5535992|NCT01357980|19134454|P3|Overall Study|Lack of Efficacy|0
5535993|NCT01357980|19134455|P2|Overall Study|Lack of Efficacy|1
5535994|NCT01357980|19134456|P1|Overall Study|Lack of Efficacy|0
5535995|NCT01357915|19134500|P2|Overall Study|Lost to Follow-up|0
5535996|NCT01357915|19134501|P1|Overall Study|Lost to Follow-up|3
5535997|NCT01357889|19134519|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
5535998|NCT01357889|19134520|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
5535999|NCT01357889|19134519|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
5536000|NCT01357889|19134520|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
5536001|NCT01357889|19134519|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
5536002|NCT01357889|19134520|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
5536003|NCT01357889|19134519|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
5536004|NCT01357889|19134520|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
5536005|NCT01357889|19134519|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
5536006|NCT01357889|19134520|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
5536007|NCT01357889|19134519|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
5536008|NCT01357889|19134520|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
5536009|NCT01357889|19134519|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
5536010|NCT01357889|19134520|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
5536011|NCT01357889|19134519|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
5536012|NCT01357889|19134520|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
5536013|NCT01357889|19134519|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
5536014|NCT01357889|19134520|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
5536015|NCT01357889|19134519|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
5536016|NCT01357889|19134520|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
5536017|NCT01357889|19134519|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
5536018|NCT01357889|19134520|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
5536019|NCT01357889|19134519|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
5536020|NCT01357889|19134520|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
5536021|NCT01357889|19134519|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
5536022|NCT01357889|19134520|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
5536023|NCT01357850|19134564|P4|Overall Study|Lost to Follow-up|0
5536024|NCT01357850|19134565|P3|Overall Study|Lost to Follow-up|0
5536025|NCT01357850|19134566|P2|Overall Study|Lost to Follow-up|0
5536026|NCT01357850|19134567|P1|Overall Study|Lost to Follow-up|1
5536027|NCT01357655|19134658|P2|Overall Study|Subject Withdrew Consent|0
5536028|NCT01357655|19134659|P1|Overall Study|Subject Withdrew Consent|1
5536029|NCT01357655|19134658|P2|Overall Study|Study Drug Toxicity|0
5536030|NCT01357655|19134659|P1|Overall Study|Study Drug Toxicity|11
5536031|NCT01357655|19134658|P2|Overall Study|Reason Unspecified|0
5536032|NCT01357655|19134659|P1|Overall Study|Reason Unspecified|1
5536033|NCT01357655|19134658|P2|Overall Study|Maximum Clinical Benefit|0
5536034|NCT01357655|19134659|P1|Overall Study|Maximum Clinical Benefit|2
5536035|NCT01357655|19134658|P2|Overall Study|Lost to Follow-up|0
5536036|NCT01357655|19134659|P1|Overall Study|Lost to Follow-up|2
5536037|NCT01357655|19134658|P2|Overall Study|Disease Progression|0
5536038|NCT01357655|19134659|P1|Overall Study|Disease Progression|1
5536039|NCT01357655|19134658|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
5536040|NCT01357655|19134659|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
5536041|NCT01357655|19134658|P2|Overall Study|Administrative Reason by Sponsor|0
5536042|NCT01357655|19134659|P1|Overall Study|Administrative Reason by Sponsor|45
5536043|NCT01357616|19134676|P2|Overall Study|Withdrawal by Subject|0
5536044|NCT01357616|19134677|P1|Overall Study|Withdrawal by Subject|1
5536045|NCT01357616|19134676|P2|Overall Study|Decision Unrelated to Adverse Event|1
5536046|NCT01357616|19134677|P1|Overall Study|Decision Unrelated to Adverse Event|3
5536047|NCT01357616|19134676|P2|Overall Study|Inadequate Control of IOP|2
5536048|NCT01357616|19134677|P1|Overall Study|Inadequate Control of IOP|1
5536049|NCT01357616|19134676|P2|Overall Study|Protocol Violation|2
5536050|NCT01357616|19134677|P1|Overall Study|Protocol Violation|0
5536051|NCT01357616|19134676|P2|Overall Study|Lost to Follow-up|3
5536052|NCT01357616|19134677|P1|Overall Study|Lost to Follow-up|4
5536053|NCT01357616|19134676|P2|Overall Study|Adverse Event|1
5536054|NCT01357616|19134677|P1|Overall Study|Adverse Event|1
5536055|NCT01357577|19134691|P2|Overall Study|look at data in database?|2
5536056|NCT01357577|19134692|P1|Overall Study|look at data in database?|1
5536057|NCT01357577|19134691|P2|Overall Study|Withdrawal by Subject|8
5536058|NCT01357577|19134692|P1|Overall Study|Withdrawal by Subject|16
5536059|NCT01357577|19134691|P2|Overall Study|Lost to Follow-up|16
5536060|NCT01357577|19134692|P1|Overall Study|Lost to Follow-up|20
5536061|NCT01357551|19134719|P2|Overall Study|Lost to Follow-up|6
5536062|NCT01357551|19134720|P1|Overall Study|Lost to Follow-up|16
5536063|NCT01357551|19134719|P2|Overall Study|Death|1
5536064|NCT01357551|19134720|P1|Overall Study|Death|0
5536065|NCT01357551|19134719|P2|Overall Study|Withdrawal by Subject|4
5536066|NCT01357551|19134720|P1|Overall Study|Withdrawal by Subject|6
5536067|NCT01357239|19134768|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
5536068|NCT01357239|19134769|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
5536069|NCT01357239|19134770|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
5536070|NCT01357239|19134771|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
5536071|NCT01357239|19134768|P4|Stratum II: Partially-Methylated|Adverse Event|1
5536072|NCT01357239|19134769|P3|Stratum II: Partially-Methylated|Adverse Event|0
5536073|NCT01357239|19134770|P2|Stratum II: Partially-Methylated|Adverse Event|0
5536074|NCT01357239|19134771|P1|Stratum II: Partially-Methylated|Adverse Event|0
5536075|NCT01357239|19134768|P4|Stratum I: Fully-Methylated|Adverse Event|0
5536076|NCT01357239|19134769|P3|Stratum I: Fully-Methylated|Adverse Event|1
5536077|NCT01357239|19134770|P2|Stratum I: Fully-Methylated|Adverse Event|0
5536078|NCT01357239|19134771|P1|Stratum I: Fully-Methylated|Adverse Event|0
5536079|NCT01357239|19134768|P4|Stratum: All Patients|Subject withdrew consent|1
5536080|NCT01357239|19134769|P3|Stratum: All Patients|Subject withdrew consent|1
5536081|NCT01357239|19134770|P2|Stratum: All Patients|Subject withdrew consent|0
5536082|NCT01357239|19134771|P1|Stratum: All Patients|Subject withdrew consent|0
5536083|NCT01357239|19134768|P4|Stratum: All Patients|Adverse Event|1
5536084|NCT01357239|19134769|P3|Stratum: All Patients|Adverse Event|1
5536085|NCT01357239|19134770|P2|Stratum: All Patients|Adverse Event|0
5536086|NCT01357239|19134771|P1|Stratum: All Patients|Adverse Event|0
5536087|NCT01357161|19134829|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
5536088|NCT01357161|19134830|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
5536089|NCT01357161|19134831|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
5536090|NCT01357161|19134829|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
5536091|NCT01357161|19134830|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
5536092|NCT01357161|19134831|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
5536093|NCT01357161|19134829|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
5536094|NCT01357161|19134830|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
5536095|NCT01357161|19134831|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
5536096|NCT01357161|19134829|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
5536097|NCT01357161|19134830|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
5536098|NCT01357161|19134831|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
5536099|NCT01357161|19134829|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
5536100|NCT01357161|19134830|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
5536101|NCT01357161|19134831|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
5536102|NCT01357161|19134829|P3|Part 2 (Double-Blind Comparison)|Death|19
5536103|NCT01357161|19134830|P2|Part 2 (Double-Blind Comparison)|Death|22
5536104|NCT01357161|19134831|P1|Part 2 (Double-Blind Comparison)|Death|0
5536105|NCT01357161|19134829|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
5536106|NCT01357161|19134830|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
5536107|NCT01357161|19134831|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
5536108|NCT01357161|19134829|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
5536109|NCT01357161|19134830|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
5536110|NCT01357161|19134831|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
5536111|NCT01357161|19134829|P3|Part 1 (Open Label Run-in)|Physician Decision|0
5536112|NCT01357161|19134830|P2|Part 1 (Open Label Run-in)|Physician Decision|0
5536113|NCT01357161|19134831|P1|Part 1 (Open Label Run-in)|Physician Decision|1
5536114|NCT01357161|19134829|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
5536115|NCT01357161|19134830|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
5536116|NCT01357161|19134831|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
5536117|NCT01357161|19134829|P3|Part 1 (Open Label Run-in)|Death|0
5536118|NCT01357161|19134830|P2|Part 1 (Open Label Run-in)|Death|0
5536119|NCT01357161|19134831|P1|Part 1 (Open Label Run-in)|Death|5
5536120|NCT01356966|19134883|P2|Overall Study|Physician Decision|0
5536121|NCT01356966|19134884|P1|Overall Study|Physician Decision|1
5536122|NCT01356966|19134883|P2|Overall Study|Withdrawal by Subject|2
5536123|NCT01356966|19134884|P1|Overall Study|Withdrawal by Subject|1
5536124|NCT01356940|19134896|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
5536125|NCT01356940|19134897|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
5536126|NCT01356940|19134896|P2|First Intervention (28 Days)|Adverse Event|0
5536127|NCT01356940|19134897|P1|First Intervention (28 Days)|Adverse Event|1
5536128|NCT01356602|19134926|P3|Overall Study|Adverse Event|1
5536129|NCT01356602|19134927|P2|Overall Study|Adverse Event|1
5536130|NCT01356602|19134928|P1|Overall Study|Adverse Event|0
5536131|NCT01356602|19134926|P3|Overall Study|Lack of Efficacy|4
5536132|NCT01356602|19134927|P2|Overall Study|Lack of Efficacy|1
5536133|NCT01356602|19134928|P1|Overall Study|Lack of Efficacy|0
5536134|NCT01356602|19134926|P3|Overall Study|Withdrawal by Subject|7
5536135|NCT01356602|19134927|P2|Overall Study|Withdrawal by Subject|3
5536136|NCT01356602|19134928|P1|Overall Study|Withdrawal by Subject|4
5536137|NCT01356602|19134926|P3|Overall Study|Lost to Follow-up|6
5536138|NCT01356602|19134927|P2|Overall Study|Lost to Follow-up|5
5536139|NCT01356602|19134928|P1|Overall Study|Lost to Follow-up|4
5536140|NCT01356602|19134926|P3|Overall Study|Administrative Problems|5
5536141|NCT01356602|19134927|P2|Overall Study|Administrative Problems|4
5536142|NCT01356602|19134928|P1|Overall Study|Administrative Problems|1
5536143|NCT01356602|19134926|P3|Overall Study|Protocol Deviation|1
5536144|NCT01356602|19134927|P2|Overall Study|Protocol Deviation|1
5536145|NCT01356602|19134928|P1|Overall Study|Protocol Deviation|0
5536146|NCT01356589|19134987|P1|Overall Study|Dose data not recorded|2
5536147|NCT01356589|19134987|P1|Overall Study|Enrolled, but not treated|3
5536148|NCT01356407|19135044|P2|Overall Study|Not complete Endoscopy|2
5536149|NCT01356407|19135045|P1|Overall Study|Not complete Endoscopy|2
5536150|NCT01356407|19135044|P2|Overall Study|Could not afford IMP administration|1
5536151|NCT01356407|19135045|P1|Overall Study|Could not afford IMP administration|0
5536152|NCT01356407|19135044|P2|Overall Study|Patient Withdrew Consent|1
5536153|NCT01356407|19135045|P1|Overall Study|Patient Withdrew Consent|2
5536154|NCT01356407|19135044|P2|Overall Study|Lost to Follow-up|0
5536155|NCT01356407|19135045|P1|Overall Study|Lost to Follow-up|2
5536156|NCT01355679|19135117|P1|Overall Study|benign tumor types found at biopsy|2
5536157|NCT01355627|19135126|P2|Overall Study|Other|1
5536158|NCT01355627|19135127|P1|Overall Study|Other|1
5536159|NCT01355627|19135126|P2|Overall Study|Fatal Adverse Event|23
5536160|NCT01355627|19135127|P1|Overall Study|Fatal Adverse Event|19
5536161|NCT01355627|19135126|P2|Overall Study|Lost to Follow-up|7
5536162|NCT01355627|19135127|P1|Overall Study|Lost to Follow-up|8
5536163|NCT01355627|19135126|P2|Overall Study|Request By the Patient to Discontinue|7
5536164|NCT01355627|19135127|P1|Overall Study|Request By the Patient to Discontinue|5
5536165|NCT01355575|19135164|P1|Overall Study|Withdrawal by Subject|2
5536166|NCT01355523|19135176|P2|Overall Study|Adverse Event|2
5536167|NCT01355523|19135177|P1|Overall Study|Adverse Event|0
5536168|NCT01355523|19135176|P2|Overall Study|Protocol Violation|2
5536169|NCT01355523|19135177|P1|Overall Study|Protocol Violation|0
5536170|NCT01355523|19135176|P2|Overall Study|Lost to Follow-up|2
5536171|NCT01355523|19135177|P1|Overall Study|Lost to Follow-up|0
5536172|NCT01355523|19135176|P2|Overall Study|Withdrawal by Subject|4
5536173|NCT01355523|19135177|P1|Overall Study|Withdrawal by Subject|1
5536174|NCT01355497|19135221|P2|Overall Study|Adverse Event|10
5536175|NCT01355497|19135222|P1|Overall Study|Adverse Event|11
5536176|NCT01355497|19135221|P2|Overall Study|progressive disease|8
5536177|NCT01355497|19135222|P1|Overall Study|progressive disease|11
5536178|NCT01355497|19135221|P2|Overall Study|noncompliance|2
5536179|NCT01355497|19135222|P1|Overall Study|noncompliance|1
5536180|NCT01355497|19135221|P2|Overall Study|Withdrawal by Subject|20
5536181|NCT01355497|19135222|P1|Overall Study|Withdrawal by Subject|12
5536182|NCT01355497|19135221|P2|Overall Study|other-not provided|4
5536183|NCT01355497|19135222|P1|Overall Study|other-not provided|9
5536184|NCT01355497|19135221|P2|Overall Study|Protocol Violation|1
5536185|NCT01355497|19135222|P1|Overall Study|Protocol Violation|0
5536186|NCT01355497|19135221|P2|Overall Study|Lost to Follow-up|0
5536187|NCT01355497|19135222|P1|Overall Study|Lost to Follow-up|3
5536188|NCT01355497|19135221|P2|Overall Study|Death|18
5536189|NCT01355497|19135222|P1|Overall Study|Death|19
5536190|NCT01355302|19135264|P3|Phase 1b|Study terminated by sponsor|0
5536191|NCT01355302|19135265|P2|Phase 1b|Study terminated by sponsor|0
5536192|NCT01355302|19135266|P1|Phase 1b|Study terminated by sponsor|2
5536193|NCT01355302|19135264|P3|Phase 1b|Death|0
5536194|NCT01355302|19135265|P2|Phase 1b|Death|0
5536195|NCT01355302|19135266|P1|Phase 1b|Death|4
5536196|NCT01355289|19135281|P5|Open Label Extension|Other|3
5536197|NCT01355289|19135282|P4|Open Label Extension|Other|0
5536198|NCT01355289|19135283|P3|Open Label Extension|Other|0
5536199|NCT01355289|19135284|P2|Open Label Extension|Other|0
5536200|NCT01355289|19135285|P1|Open Label Extension|Other|0
5536201|NCT01355289|19135281|P5|Open Label Extension|Inadequate Therapeutic Effect|29
5536202|NCT01355289|19135282|P4|Open Label Extension|Inadequate Therapeutic Effect|0
5536203|NCT01355289|19135283|P3|Open Label Extension|Inadequate Therapeutic Effect|0
5536204|NCT01355289|19135284|P2|Open Label Extension|Inadequate Therapeutic Effect|0
5536205|NCT01355289|19135285|P1|Open Label Extension|Inadequate Therapeutic Effect|0
5536206|NCT01355289|19135281|P5|Open Label Extension|Lost to Follow-up|1
5536207|NCT01355289|19135282|P4|Open Label Extension|Lost to Follow-up|0
5536208|NCT01355289|19135283|P3|Open Label Extension|Lost to Follow-up|0
5536209|NCT01355289|19135284|P2|Open Label Extension|Lost to Follow-up|0
5536210|NCT01355289|19135285|P1|Open Label Extension|Lost to Follow-up|0
5536211|NCT01355289|19135281|P5|Open Label Extension|Adverse Event, Non-Fatal|1
5536212|NCT01355289|19135282|P4|Open Label Extension|Adverse Event, Non-Fatal|0
5536213|NCT01355289|19135283|P3|Open Label Extension|Adverse Event, Non-Fatal|0
5536214|NCT01355289|19135284|P2|Open Label Extension|Adverse Event, Non-Fatal|0
5536215|NCT01355289|19135285|P1|Open Label Extension|Adverse Event, Non-Fatal|0
5536216|NCT01355289|19135281|P5|Core Study|Other|0
5536217|NCT01355289|19135282|P4|Core Study|Other|1
5536218|NCT01355289|19135283|P3|Core Study|Other|0
5536219|NCT01355289|19135284|P2|Core Study|Other|0
5536220|NCT01355289|19135285|P1|Core Study|Other|0
5536221|NCT01355289|19135281|P5|Core Study|Inadequate Therapeutic Effect|0
5536222|NCT01355289|19135282|P4|Core Study|Inadequate Therapeutic Effect|1
5536223|NCT01355289|19135283|P3|Core Study|Inadequate Therapeutic Effect|0
5536224|NCT01355289|19135284|P2|Core Study|Inadequate Therapeutic Effect|0
5536225|NCT01355289|19135285|P1|Core Study|Inadequate Therapeutic Effect|0
5536226|NCT01355289|19135281|P5|Core Study|Adverse Event, Non-Fatal|0
5536227|NCT01355289|19135282|P4|Core Study|Adverse Event, Non-Fatal|0
5536228|NCT01355289|19135283|P3|Core Study|Adverse Event, Non-Fatal|0
5536229|NCT01355289|19135284|P2|Core Study|Adverse Event, Non-Fatal|0
5536230|NCT01355289|19135285|P1|Core Study|Adverse Event, Non-Fatal|1
5536231|NCT01355159|19135337|P2|Overall Study|Early intrauterine fetal death|6
5536232|NCT01355159|19135338|P1|Overall Study|Early intrauterine fetal death|6
5536233|NCT01355159|19135337|P2|Overall Study|Spontaneous abortion (<20 weeks)|15
5536234|NCT01355159|19135338|P1|Overall Study|Spontaneous abortion (<20 weeks)|22
5536235|NCT01355159|19135337|P2|Overall Study|No primary outcome data|11
5536236|NCT01355159|19135338|P1|Overall Study|No primary outcome data|17
5536237|NCT01355159|19135337|P2|Overall Study|Withdrew consent|47
5536238|NCT01355159|19135338|P1|Overall Study|Withdrew consent|39
5536239|NCT01355081|19135395|P3|Overall Study|Non Compliance with Study Medication|0
5536240|NCT01355081|19135396|P2|Overall Study|Non Compliance with Study Medication|1
5536241|NCT01355081|19135397|P1|Overall Study|Non Compliance with Study Medication|0
5536242|NCT01355081|19135395|P3|Overall Study|Lack of Efficacy|1
5536243|NCT01355081|19135396|P2|Overall Study|Lack of Efficacy|1
5536244|NCT01355081|19135397|P1|Overall Study|Lack of Efficacy|2
5536245|NCT01355081|19135395|P3|Overall Study|Withdrawal of Consent|3
5536246|NCT01355081|19135396|P2|Overall Study|Withdrawal of Consent|3
5536247|NCT01355081|19135397|P1|Overall Study|Withdrawal of Consent|2
5536248|NCT01355081|19135395|P3|Overall Study|Lost to Follow-up|1
5536249|NCT01355081|19135396|P2|Overall Study|Lost to Follow-up|0
5536250|NCT01355081|19135397|P1|Overall Study|Lost to Follow-up|0
5536251|NCT01355081|19135395|P3|Overall Study|Major Protocol Deviation|0
5536252|NCT01355081|19135396|P2|Overall Study|Major Protocol Deviation|1
5536253|NCT01355081|19135397|P1|Overall Study|Major Protocol Deviation|0
5536254|NCT01355081|19135395|P3|Overall Study|Pretreatment Event or Adverse Event|6
5536255|NCT01355081|19135396|P2|Overall Study|Pretreatment Event or Adverse Event|4
5536256|NCT01355081|19135397|P1|Overall Study|Pretreatment Event or Adverse Event|3
5536257|NCT01355068|19135420|P2|First Intervention Period|Withdrawal by Subject|1
5536258|NCT01355068|19135421|P1|First Intervention Period|Withdrawal by Subject|0
5536259|NCT01355068|19135420|P2|First Intervention Period|Adverse Event|1
5536260|NCT01355068|19135421|P1|First Intervention Period|Adverse Event|0
5536261|NCT01354964|19135446|P2|Overall Study|Physician Decision|0
5536262|NCT01354964|19135447|P1|Overall Study|Physician Decision|1
5536263|NCT01354964|19135446|P2|Overall Study|IV access issues|1
5536264|NCT01354964|19135447|P1|Overall Study|IV access issues|1
5536265|NCT01354964|19135446|P2|Overall Study|Lost to Follow-up|0
5536266|NCT01354964|19135447|P1|Overall Study|Lost to Follow-up|2
5536267|NCT01354938|19135470|P1|Overall Study|Lost to Follow-up|1
5536268|NCT01354899|19135476|P1|Overall Study|Protocol Violation|1
5536269|NCT01354899|19135476|P1|Overall Study|discharge from the hospital|2
5536270|NCT01354496|19135528|P6|Washout (at Least 14 Days)|Scheduling Conflict|0
5536271|NCT01354496|19135529|P5|Washout (at Least 14 Days)|Scheduling Conflict|0
5536272|NCT01354496|19135530|P4|Washout (at Least 14 Days)|Scheduling Conflict|1
5536273|NCT01354496|19135531|P3|Washout (at Least 14 Days)|Scheduling Conflict|0
5536274|NCT01354496|19135532|P2|Washout (at Least 14 Days)|Scheduling Conflict|1
5536275|NCT01354496|19135533|P1|Washout (at Least 14 Days)|Scheduling Conflict|0
5536276|NCT01354496|19135528|P6|Period 2|Adverse Event|0
5536277|NCT01354496|19135529|P5|Period 2|Adverse Event|0
5536278|NCT01354496|19135530|P4|Period 2|Adverse Event|1
5536279|NCT01354496|19135531|P3|Period 2|Adverse Event|0
5536280|NCT01354496|19135532|P2|Period 2|Adverse Event|0
5536281|NCT01354496|19135533|P1|Period 2|Adverse Event|0
5536282|NCT01354496|19135528|P6|Period 1|Physician Decision|0
5536283|NCT01354496|19135529|P5|Period 1|Physician Decision|0
5536284|NCT01354496|19135530|P4|Period 1|Physician Decision|0
5536285|NCT01354496|19135531|P3|Period 1|Physician Decision|1
5536286|NCT01354496|19135532|P2|Period 1|Physician Decision|0
5536287|NCT01354496|19135533|P1|Period 1|Physician Decision|0
5536288|NCT01354496|19135528|P6|Period 1|Adverse Event|0
5536289|NCT01354496|19135529|P5|Period 1|Adverse Event|0
5536290|NCT01354496|19135530|P4|Period 1|Adverse Event|0
5536291|NCT01354496|19135531|P3|Period 1|Adverse Event|1
5536292|NCT01354496|19135532|P2|Period 1|Adverse Event|0
5536293|NCT01354496|19135533|P1|Period 1|Adverse Event|0
5536294|NCT01354431|19135576|P3|Participants Treated|Withdrawal by Subject|1
5536295|NCT01354431|19135577|P2|Participants Treated|Withdrawal by Subject|2
5536296|NCT01354431|19135578|P1|Participants Treated|Withdrawal by Subject|1
5536297|NCT01354431|19135576|P3|Participants Treated|Adverse Event|4
5536298|NCT01354431|19135577|P2|Participants Treated|Adverse Event|2
5536299|NCT01354431|19135578|P1|Participants Treated|Adverse Event|1
5536300|NCT01354431|19135576|P3|Participants Treated|Death|0
5536301|NCT01354431|19135577|P2|Participants Treated|Death|1
5536302|NCT01354431|19135578|P1|Participants Treated|Death|0
5536303|NCT01354431|19135576|P3|Participants Treated|Study Drug Toxicity|4
5536304|NCT01354431|19135577|P2|Participants Treated|Study Drug Toxicity|7
5536305|NCT01354431|19135578|P1|Participants Treated|Study Drug Toxicity|2
5536306|NCT01354431|19135576|P3|Participants Treated|Disease Progression|41
5536307|NCT01354431|19135577|P2|Participants Treated|Disease Progression|40
5536308|NCT01354431|19135578|P1|Participants Treated|Disease Progression|49
5536309|NCT01354431|19135576|P3|Participants Treated|Continuing Treatment|4
5536310|NCT01354431|19135577|P2|Participants Treated|Continuing Treatment|2
5536311|NCT01354431|19135578|P1|Participants Treated|Continuing Treatment|6
5536312|NCT01354431|19135576|P3|Randomized to Enter Treatment Period|No longer met criteria|0
5536313|NCT01354431|19135577|P2|Randomized to Enter Treatment Period|No longer met criteria|0
5536314|NCT01354431|19135578|P1|Randomized to Enter Treatment Period|No longer met criteria|1
5536315|NCT01354314|19135602|P4|Overall Study|Less than 90% Adherence|4
5536316|NCT01354314|19135603|P3|Overall Study|Less than 90% Adherence|6
5536317|NCT01354314|19135604|P2|Overall Study|Less than 90% Adherence|2
5536318|NCT01354314|19135605|P1|Overall Study|Less than 90% Adherence|4
5536319|NCT01354314|19135602|P4|Overall Study|Protocol Violation|0
5536320|NCT01354314|19135603|P3|Overall Study|Protocol Violation|0
5536321|NCT01354314|19135604|P2|Overall Study|Protocol Violation|1
5536322|NCT01354314|19135605|P1|Overall Study|Protocol Violation|1
5536323|NCT01354314|19135602|P4|Overall Study|Adverse Event|1
5536324|NCT01354314|19135603|P3|Overall Study|Adverse Event|0
5536325|NCT01354314|19135604|P2|Overall Study|Adverse Event|0
5536326|NCT01354314|19135605|P1|Overall Study|Adverse Event|0
5536327|NCT01354314|19135602|P4|Overall Study|Withdrawal by Subject|0
5536328|NCT01354314|19135603|P3|Overall Study|Withdrawal by Subject|1
5536329|NCT01354314|19135604|P2|Overall Study|Withdrawal by Subject|0
5536330|NCT01354314|19135605|P1|Overall Study|Withdrawal by Subject|0
5536331|NCT01354314|19135602|P4|Overall Study|Lost to Follow-up|1
5536332|NCT01354314|19135603|P3|Overall Study|Lost to Follow-up|1
5536333|NCT01354314|19135604|P2|Overall Study|Lost to Follow-up|0
5536334|NCT01354314|19135605|P1|Overall Study|Lost to Follow-up|1
5536335|NCT01354223|19135741|P2|Overall Study|Withdrawal by Subject|1
5536336|NCT01354223|19135742|P1|Overall Study|Withdrawal by Subject|3
5536337|NCT01354132|19135801|P2|1 Month Post Study Medication|Withdrawal by Subject|3
5536338|NCT01354132|19135802|P1|1 Month Post Study Medication|Withdrawal by Subject|1
5536339|NCT01354132|19135801|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
5536340|NCT01354132|19135802|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
5536341|NCT01354132|19135801|P2|Double Blind (Visits 1-7)|Adverse Event|0
5536342|NCT01354132|19135802|P1|Double Blind (Visits 1-7)|Adverse Event|1
5536343|NCT01354132|19135801|P2|Randomization|Withdrawal by Subject|1
5536344|NCT01354132|19135802|P1|Randomization|Withdrawal by Subject|0
5536345|NCT01354132|19135801|P2|Randomization|Physician Decision|0
5536346|NCT01354132|19135802|P1|Randomization|Physician Decision|1
5536347|NCT01354106|19135840|P1|Overall Study|Withdrawal by Subject|2
5536348|NCT01354028|19135846|P2|Overall Study|No quiet alert state|1
5536349|NCT01354028|19135847|P1|Overall Study|No quiet alert state|0
5536350|NCT01354028|19135846|P2|Overall Study|Discharged before study start|2
5536351|NCT01354028|19135847|P1|Overall Study|Discharged before study start|2
5536352|NCT01354028|19135846|P2|Overall Study|Physician Decision|2
5536353|NCT01354028|19135847|P1|Overall Study|Physician Decision|0
5536354|NCT01353963|19135883|P1|Overall Study|Adverse Event|2
5536355|NCT01353911|19135901|P8|Overall Study|Status Not Recorded|0
5536356|NCT01353911|19135902|P7|Overall Study|Status Not Recorded|0
5536357|NCT01353911|19135903|P6|Overall Study|Status Not Recorded|0
5536358|NCT01353911|19135904|P5|Overall Study|Status Not Recorded|0
5536359|NCT01353911|19135905|P4|Overall Study|Status Not Recorded|0
5536360|NCT01353911|19135906|P3|Overall Study|Status Not Recorded|1
5536361|NCT01353911|19135907|P2|Overall Study|Status Not Recorded|0
5536362|NCT01353911|19135908|P1|Overall Study|Status Not Recorded|4
5536363|NCT01353911|19135901|P8|Overall Study|Withdrawal by Subject|9
5536364|NCT01353911|19135902|P7|Overall Study|Withdrawal by Subject|3
5536365|NCT01353911|19135903|P6|Overall Study|Withdrawal by Subject|3
5536366|NCT01353911|19135904|P5|Overall Study|Withdrawal by Subject|2
5536367|NCT01353911|19135905|P4|Overall Study|Withdrawal by Subject|2
5536368|NCT01353911|19135906|P3|Overall Study|Withdrawal by Subject|4
5536369|NCT01353911|19135907|P2|Overall Study|Withdrawal by Subject|3
5536370|NCT01353911|19135908|P1|Overall Study|Withdrawal by Subject|2
5536371|NCT01353911|19135901|P8|Overall Study|Lost to Follow-up|6
5536372|NCT01353911|19135902|P7|Overall Study|Lost to Follow-up|3
5536373|NCT01353911|19135903|P6|Overall Study|Lost to Follow-up|4
5536374|NCT01353911|19135904|P5|Overall Study|Lost to Follow-up|4
5536375|NCT01353911|19135905|P4|Overall Study|Lost to Follow-up|0
5536376|NCT01353911|19135906|P3|Overall Study|Lost to Follow-up|4
5536377|NCT01353911|19135907|P2|Overall Study|Lost to Follow-up|6
5536378|NCT01353911|19135908|P1|Overall Study|Lost to Follow-up|2
5536379|NCT01353898|19135988|P6|Overall Study|Study site terminated|1
5536380|NCT01353898|19135989|P5|Overall Study|Study site terminated|0
5536381|NCT01353898|19135990|P4|Overall Study|Study site terminated|0
5536382|NCT01353898|19135991|P3|Overall Study|Study site terminated|0
5536383|NCT01353898|19135992|P2|Overall Study|Study site terminated|0
5536384|NCT01353898|19135993|P1|Overall Study|Study site terminated|0
5536385|NCT01353859|19136019|P1|Overall Study|Lack of Efficacy|1
5536386|NCT01353859|19136019|P1|Overall Study|Adverse Event|3
5536387|NCT01353703|19136034|P2|Overall Study|Migrated/moved from study area|0
5536388|NCT01353703|19136035|P1|Overall Study|Migrated/moved from study area|1
5536389|NCT01353664|19136081|P1|Overall Study|Disease Progression|16
5536390|NCT01353664|19136081|P1|Overall Study|Other|3
5536391|NCT01353586|19136087|P2|Overall Study|Neurological exam not done|1
5536392|NCT01353586|19136088|P1|Overall Study|Neurological exam not done|0
5536393|NCT01353586|19136087|P2|Overall Study|Never had insertion of study catheter|1
5536394|NCT01353586|19136088|P1|Overall Study|Never had insertion of study catheter|4
5536395|NCT01353586|19136087|P2|Overall Study|Procedure terminated prior to ablation|0
5536396|NCT01353586|19136088|P1|Overall Study|Procedure terminated prior to ablation|3
5536397|NCT01353508|19136106|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
5536398|NCT01353508|19136107|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
5536399|NCT01353508|19136108|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
5536400|NCT01353508|19136109|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
5536401|NCT01353508|19136106|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
5536402|NCT01353508|19136107|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
5536403|NCT01353508|19136108|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
5536404|NCT01353508|19136109|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
5536405|NCT01353274|19136187|P1|Overall Study|No case report form (CRF) collected|28
5536406|NCT01353222|19136197|P2|Overall Study|Site closed research department|0
5536407|NCT01353222|19136198|P1|Overall Study|Site closed research department|1
5536408|NCT01353222|19136197|P2|Overall Study|Study Terminated|37
5536409|NCT01353222|19136198|P1|Overall Study|Study Terminated|31
5536410|NCT01353222|19136197|P2|Overall Study|Withdrawal by Subject|5
5536411|NCT01353222|19136198|P1|Overall Study|Withdrawal by Subject|8
5536412|NCT01353222|19136197|P2|Overall Study|Death|30
5536413|NCT01353222|19136198|P1|Overall Study|Death|30
5536414|NCT01352845|19136241|P2|Overall Study|Death|0
5536415|NCT01352845|19136242|P1|Overall Study|Death|3
5536416|NCT01352845|19136241|P2|Overall Study|Protocol Violation|6
5536417|NCT01352845|19136242|P1|Overall Study|Protocol Violation|12
5536418|NCT01352845|19136241|P2|Overall Study|Other|7
5536419|NCT01352845|19136242|P1|Overall Study|Other|17
5536420|NCT01352845|19136241|P2|Overall Study|Adverse Event|6
5536421|NCT01352845|19136242|P1|Overall Study|Adverse Event|22
5536422|NCT01352845|19136241|P2|Overall Study|Pregnancy|7
5536423|NCT01352845|19136242|P1|Overall Study|Pregnancy|27
5536424|NCT01352845|19136241|P2|Overall Study|No Longer Meets Eligibility Criteria|11
5536425|NCT01352845|19136242|P1|Overall Study|No Longer Meets Eligibility Criteria|24
5536426|NCT01352845|19136241|P2|Overall Study|Withdrawal by Subject|16
5536427|NCT01352845|19136242|P1|Overall Study|Withdrawal by Subject|48
5536428|NCT01352845|19136241|P2|Overall Study|No Longer Willing to Participate|58
5536429|NCT01352845|19136242|P1|Overall Study|No Longer Willing to Participate|205
5536430|NCT01352845|19136241|P2|Overall Study|Lost to Follow-up|92
5536431|NCT01352845|19136242|P1|Overall Study|Lost to Follow-up|313
5536432|NCT01352793|19136331|P2|Overall Study|No longer meets eligibility criteria|15
5536433|NCT01352793|19136332|P1|Overall Study|No longer meets eligibility criteria|25
5536434|NCT01352793|19136331|P2|Overall Study|Randomized but not vaccinated|0
5536435|NCT01352793|19136332|P1|Overall Study|Randomized but not vaccinated|8
5536436|NCT01352793|19136331|P2|Overall Study|Death|0
5536437|NCT01352793|19136332|P1|Overall Study|Death|1
5536438|NCT01352793|19136331|P2|Overall Study|Medication error|2
5536439|NCT01352793|19136332|P1|Overall Study|Medication error|2
5536440|NCT01352793|19136331|P2|Overall Study|Other|7
5536441|NCT01352793|19136332|P1|Overall Study|Other|25
5536442|NCT01352793|19136331|P2|Overall Study|Pregnancy|8
5536443|NCT01352793|19136332|P1|Overall Study|Pregnancy|26
5536444|NCT01352793|19136331|P2|Overall Study|Physician Decision|0
5536445|NCT01352793|19136332|P1|Overall Study|Physician Decision|1
5536446|NCT01352793|19136331|P2|Overall Study|Adverse Event|10
5536447|NCT01352793|19136332|P1|Overall Study|Adverse Event|44
5536448|NCT01352793|19136331|P2|Overall Study|Protocol Violation|23
5536449|NCT01352793|19136332|P1|Overall Study|Protocol Violation|44
5536450|NCT01352793|19136331|P2|Overall Study|Withdrawal by Subject|55
5536451|NCT01352793|19136332|P1|Overall Study|Withdrawal by Subject|120
5536452|NCT01352793|19136331|P2|Overall Study|Lost to Follow-up|125
5536453|NCT01352793|19136332|P1|Overall Study|Lost to Follow-up|289
5536454|NCT01352741|19136356|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
5536455|NCT01352741|19136357|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
5536456|NCT01352741|19136356|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
5536457|NCT01352741|19136357|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
5536458|NCT01352741|19136356|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
5536459|NCT01352741|19136357|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
5536460|NCT01352741|19136356|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
5536461|NCT01352741|19136357|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
5536462|NCT01352741|19136356|P2|Double-blind Comparative Period|Other|2
5536463|NCT01352741|19136357|P1|Double-blind Comparative Period|Other|1
5536464|NCT01352741|19136356|P2|Double-blind Comparative Period|Withdrawal of consent|3
5536465|NCT01352741|19136357|P1|Double-blind Comparative Period|Withdrawal of consent|8
5536466|NCT01352741|19136356|P2|Double-blind Comparative Period|Death|1
5536467|NCT01352741|19136357|P1|Double-blind Comparative Period|Death|0
5536468|NCT01352741|19136356|P2|Double-blind Comparative Period|Lost to Follow-up|0
5536469|NCT01352741|19136357|P1|Double-blind Comparative Period|Lost to Follow-up|1
5536470|NCT01352741|19136356|P2|Double-blind Comparative Period|Adverse Event|17
5536471|NCT01352741|19136357|P1|Double-blind Comparative Period|Adverse Event|16
5536472|NCT01352741|19136356|P2|Double-blind Comparative Period|Lack of Efficacy|3
5536473|NCT01352741|19136357|P1|Double-blind Comparative Period|Lack of Efficacy|0
5536474|NCT01352741|19136356|P2|Double-blind Comparative Period|Protocol Violation|0
5536475|NCT01352741|19136357|P1|Double-blind Comparative Period|Protocol Violation|2
5536476|NCT01352741|19136356|P2|Open-label Tapentadol Titration Period|Other|0
5536477|NCT01352741|19136357|P1|Open-label Tapentadol Titration Period|Other|4
5536478|NCT01352741|19136356|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
5536479|NCT01352741|19136357|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
5536480|NCT01352741|19136356|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
5536481|NCT01352741|19136357|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
5536482|NCT01352741|19136356|P2|Open-label Tapentadol Titration Period|Adverse Event|0
5536483|NCT01352741|19136357|P1|Open-label Tapentadol Titration Period|Adverse Event|34
5536484|NCT01352741|19136356|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
5536485|NCT01352741|19136357|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
5536486|NCT01352741|19136356|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
5536487|NCT01352741|19136357|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
5536488|NCT01352715|19136451|P2|Overall Study|major ineligibility|1
5536489|NCT01352715|19136452|P1|Overall Study|major ineligibility|2
5536490|NCT01352715|19136451|P2|Overall Study|no final visit in closeout period|12
5536491|NCT01352715|19136452|P1|Overall Study|no final visit in closeout period|15
5536492|NCT01352715|19136451|P2|Overall Study|site closure|15
5536493|NCT01352715|19136452|P1|Overall Study|site closure|16
5536494|NCT01352715|19136451|P2|Overall Study|Withdrawal by Subject|8
5536495|NCT01352715|19136452|P1|Overall Study|Withdrawal by Subject|4
5536496|NCT01352715|19136451|P2|Overall Study|Lost to Follow-up|7
5536497|NCT01352715|19136452|P1|Overall Study|Lost to Follow-up|5
5536498|NCT01352715|19136451|P2|Overall Study|Death|3
5536499|NCT01352715|19136452|P1|Overall Study|Death|3
5536500|NCT01352585|19136496|P1|Overall Study|Other|7
5536501|NCT01352585|19136496|P1|Overall Study|Lost to Follow-up|1
5536502|NCT01352585|19136496|P1|Overall Study|Adverse Event|3
5536503|NCT01352507|19136513|P2|Treatment Period 2|Lack of Efficacy|0
5536504|NCT01352507|19136514|P1|Treatment Period 2|Lack of Efficacy|1
5536505|NCT01352507|19136513|P2|Treatment Period 2|Withdrawal by Subject|3
5536506|NCT01352507|19136514|P1|Treatment Period 2|Withdrawal by Subject|4
5536507|NCT01352507|19136513|P2|Treatment Period 2|Entry Criteria Not Met|0
5536508|NCT01352507|19136514|P1|Treatment Period 2|Entry Criteria Not Met|1
5536509|NCT01352507|19136513|P2|Washout Period|Withdrawal by Subject|1
5536510|NCT01352507|19136514|P1|Washout Period|Withdrawal by Subject|0
5536511|NCT01352507|19136513|P2|Treatment Period 1|Physician Decision|0
5536512|NCT01352507|19136514|P1|Treatment Period 1|Physician Decision|1
5536513|NCT01352507|19136513|P2|Treatment Period 1|Withdrawal by Subject|5
5536514|NCT01352507|19136514|P1|Treatment Period 1|Withdrawal by Subject|7
5536515|NCT01352507|19136513|P2|Treatment Period 1|Lost to Follow-up|4
5536516|NCT01352507|19136514|P1|Treatment Period 1|Lost to Follow-up|3
5536517|NCT01352507|19136513|P2|Treatment Period 1|Adverse Event|0
5536518|NCT01352507|19136514|P1|Treatment Period 1|Adverse Event|3
5536519|NCT01352416|19136567|P4|Overall Study|Physician Decision|1
5536520|NCT01352416|19136568|P3|Overall Study|Physician Decision|2
5536521|NCT01352416|19136569|P2|Overall Study|Physician Decision|2
5536522|NCT01352416|19136570|P1|Overall Study|Physician Decision|1
5536523|NCT01352221|19136592|P4|Open-label Phase|Worsening of IBD|0
5536524|NCT01352221|19136593|P3|Open-label Phase|Worsening of IBD|1
5536525|NCT01352221|19136594|P2|Open-label Phase|Worsening of IBD|0
5536526|NCT01352221|19136595|P1|Open-label Phase|Worsening of IBD|0
5536527|NCT01352221|19136592|P4|Open-label Phase|Withdrawal by Subject|6
5536528|NCT01352221|19136593|P3|Open-label Phase|Withdrawal by Subject|1
5536529|NCT01352221|19136594|P2|Open-label Phase|Withdrawal by Subject|0
5536530|NCT01352221|19136595|P1|Open-label Phase|Withdrawal by Subject|0
5536531|NCT01352221|19136592|P4|Open-label Phase|Adverse Event|4
5536532|NCT01352221|19136593|P3|Open-label Phase|Adverse Event|8
5536533|NCT01352221|19136594|P2|Open-label Phase|Adverse Event|0
5536534|NCT01352221|19136595|P1|Open-label Phase|Adverse Event|0
5536535|NCT01352221|19136592|P4|Open-label Phase|Pregnancy|0
5536536|NCT01352221|19136593|P3|Open-label Phase|Pregnancy|1
5536537|NCT01352221|19136594|P2|Open-label Phase|Pregnancy|0
5536538|NCT01352221|19136595|P1|Open-label Phase|Pregnancy|0
5536539|NCT01352221|19136592|P4|Open-label Phase|Physician Decision|1
5536540|NCT01352221|19136593|P3|Open-label Phase|Physician Decision|2
5536541|NCT01352221|19136594|P2|Open-label Phase|Physician Decision|0
5536542|NCT01352221|19136595|P1|Open-label Phase|Physician Decision|0
5536543|NCT01352221|19136592|P4|Double-blind Phase|Protocol Violation|0
5536544|NCT01352221|19136593|P3|Double-blind Phase|Protocol Violation|0
5536545|NCT01352221|19136594|P2|Double-blind Phase|Protocol Violation|1
5536546|NCT01352221|19136595|P1|Double-blind Phase|Protocol Violation|0
5536547|NCT01352221|19136592|P4|Double-blind Phase|Lost to Follow-up|0
5536548|NCT01352221|19136593|P3|Double-blind Phase|Lost to Follow-up|0
5536549|NCT01352221|19136594|P2|Double-blind Phase|Lost to Follow-up|1
5536550|NCT01352221|19136595|P1|Double-blind Phase|Lost to Follow-up|0
5536551|NCT01352221|19136592|P4|Double-blind Phase|Withdrawal by Subject|0
5536552|NCT01352221|19136593|P3|Double-blind Phase|Withdrawal by Subject|0
5536553|NCT01352221|19136594|P2|Double-blind Phase|Withdrawal by Subject|5
5536554|NCT01352221|19136595|P1|Double-blind Phase|Withdrawal by Subject|3
5536555|NCT01352221|19136592|P4|Double-blind Phase|Adverse Event|0
5536556|NCT01352221|19136593|P3|Double-blind Phase|Adverse Event|0
5536557|NCT01352221|19136594|P2|Double-blind Phase|Adverse Event|4
5536558|NCT01352221|19136595|P1|Double-blind Phase|Adverse Event|6
5536559|NCT01352117|19136674|P2|Overall Study|Ineligible (no KS diagnosis)|0
5536560|NCT01352117|19136675|P1|Overall Study|Ineligible (no KS diagnosis)|1
5536561|NCT01352117|19136674|P2|Overall Study|Did not initiate study treatment|0
5536562|NCT01352117|19136675|P1|Overall Study|Did not initiate study treatment|1
5536563|NCT01352117|19136674|P2|Overall Study|Non-adherent to study requirements|1
5536564|NCT01352117|19136675|P1|Overall Study|Non-adherent to study requirements|1
5536565|NCT01352117|19136674|P2|Overall Study|Lost to Follow-up|7
5536566|NCT01352117|19136675|P1|Overall Study|Lost to Follow-up|2
5536567|NCT01352117|19136674|P2|Overall Study|Withdrawal by Subject|0
5536568|NCT01352117|19136675|P1|Overall Study|Withdrawal by Subject|1
5536569|NCT01352117|19136674|P2|Overall Study|Death|16
5536570|NCT01352117|19136675|P1|Overall Study|Death|15
5536571|NCT01351623|19136742|P1|Overall Study|Death|2
5536572|NCT01351623|19136742|P1|Overall Study|Withdrawal by Subject|1
5536573|NCT01351623|19136742|P1|Overall Study|Adverse Event|4
5536574|NCT01351623|19136742|P1|Overall Study|Protocol Violation|2
5536575|NCT01351415|19136768|P2|Overall Study|Never Started|5
5536576|NCT01351415|19136769|P1|Overall Study|Never Started|5
5536577|NCT01351415|19136768|P2|Overall Study|Reason unknown|2
5536578|NCT01351415|19136769|P1|Overall Study|Reason unknown|0
5536579|NCT01351415|19136768|P2|Overall Study|Physician Decision|3
5536580|NCT01351415|19136769|P1|Overall Study|Physician Decision|2
5536581|NCT01351415|19136768|P2|Overall Study|Death|187
5536582|NCT01351415|19136769|P1|Overall Study|Death|190
5536583|NCT01351415|19136768|P2|Overall Study|Lost to Follow-up|7
5536584|NCT01351415|19136769|P1|Overall Study|Lost to Follow-up|5
5536585|NCT01351415|19136768|P2|Overall Study|Trial termination by the Sponsor|19
5536586|NCT01351415|19136769|P1|Overall Study|Trial termination by the Sponsor|28
5536587|NCT01351415|19136768|P2|Overall Study|Withdrawal by Subject|17
5536588|NCT01351415|19136769|P1|Overall Study|Withdrawal by Subject|15
5536589|NCT01351350|19136805|P5|Overall Study|Enrolled but not Treated|0
5536590|NCT01351350|19136806|P4|Overall Study|Enrolled but not Treated|0
5536591|NCT01351350|19136807|P3|Overall Study|Enrolled but not Treated|1
5536592|NCT01351350|19136808|P2|Overall Study|Enrolled but not Treated|0
5536593|NCT01351350|19136809|P1|Overall Study|Enrolled but not Treated|0
5536594|NCT01351350|19136805|P5|Overall Study|Participant Decision|2
5536595|NCT01351350|19136806|P4|Overall Study|Participant Decision|3
5536596|NCT01351350|19136807|P3|Overall Study|Participant Decision|3
5536597|NCT01351350|19136808|P2|Overall Study|Participant Decision|6
5536598|NCT01351350|19136809|P1|Overall Study|Participant Decision|2
5536599|NCT01351350|19136805|P5|Overall Study|Adverse Event|0
5536600|NCT01351350|19136806|P4|Overall Study|Adverse Event|2
5536601|NCT01351350|19136807|P3|Overall Study|Adverse Event|1
5536602|NCT01351350|19136808|P2|Overall Study|Adverse Event|10
5536603|NCT01351350|19136809|P1|Overall Study|Adverse Event|1
5536604|NCT01351350|19136805|P5|Overall Study|Disease Progression|5
5536605|NCT01351350|19136806|P4|Overall Study|Disease Progression|8
5536606|NCT01351350|19136807|P3|Overall Study|Disease Progression|6
5536607|NCT01351350|19136808|P2|Overall Study|Disease Progression|13
5536608|NCT01351350|19136809|P1|Overall Study|Disease Progression|5
5536609|NCT01351025|19136980|P2|Week 24 - 44|unable to get to clinic|1
5536610|NCT01351025|19136981|P1|Week 24 - 44|unable to get to clinic|1
5536611|NCT01351025|19136980|P2|Week 24 - 44|Site closed|1
5536612|NCT01351025|19136981|P1|Week 24 - 44|Site closed|0
5536613|NCT01351025|19136980|P2|Week 24 - 44|Lost to Follow-up|2
5536614|NCT01351025|19136981|P1|Week 24 - 44|Lost to Follow-up|0
5536615|NCT01351025|19136980|P2|Week 0 - 20|Withdrawal by Subject|0
5536616|NCT01351025|19136981|P1|Week 0 - 20|Withdrawal by Subject|1
5536617|NCT01351025|19136980|P2|Week 0 - 20|Lost to Follow-up|1
5536618|NCT01351025|19136981|P1|Week 0 - 20|Lost to Follow-up|2
5536619|NCT01350999|19137014|P3|Overall Study|Difficulty Making it to Study Visit|5
5536620|NCT01350999|19137015|P2|Overall Study|Difficulty Making it to Study Visit|1
5536621|NCT01350999|19137016|P1|Overall Study|Difficulty Making it to Study Visit|1
5536622|NCT01350999|19137014|P3|Overall Study|Voluntary withdrawal|6
5536623|NCT01350999|19137015|P2|Overall Study|Voluntary withdrawal|4
5536624|NCT01350999|19137016|P1|Overall Study|Voluntary withdrawal|3
5536625|NCT01350999|19137014|P3|Overall Study|Adverse Event|10
5536626|NCT01350999|19137015|P2|Overall Study|Adverse Event|9
5536627|NCT01350999|19137016|P1|Overall Study|Adverse Event|4
5536628|NCT01350973|19137054|P3|Overall Study|Voluntary Withdrawal|1
5536629|NCT01350973|19137055|P2|Overall Study|Voluntary Withdrawal|1
5536630|NCT01350973|19137056|P1|Overall Study|Voluntary Withdrawal|2
5536631|NCT01350973|19137054|P3|Overall Study|Adverse Event|7
5536632|NCT01350973|19137055|P2|Overall Study|Adverse Event|7
5536633|NCT01350973|19137056|P1|Overall Study|Adverse Event|4
5536634|NCT01350934|19137097|P2|Extension Study|Withdrawal by Subject|1
5536635|NCT01350934|19137098|P1|Extension Study|Withdrawal by Subject|0
5536636|NCT01350934|19137097|P2|Extension Study|Lack of Efficacy|1
5536637|NCT01350934|19137098|P1|Extension Study|Lack of Efficacy|0
5536638|NCT01350934|19137097|P2|Extension Study|Protocol Violation|1
5536639|NCT01350934|19137098|P1|Extension Study|Protocol Violation|1
5536640|NCT01350934|19137097|P2|Extension Study|Lost to Follow-up|0
5536641|NCT01350934|19137098|P1|Extension Study|Lost to Follow-up|2
5536642|NCT01350934|19137097|P2|Extension Study|Adverse Event|1
5536643|NCT01350934|19137098|P1|Extension Study|Adverse Event|2
5536644|NCT01350934|19137097|P2|Base Study|Non-Compliance With Study Drug|0
5536645|NCT01350934|19137098|P1|Base Study|Non-Compliance With Study Drug|2
5536646|NCT01350934|19137097|P2|Base Study|Withdrawal by Subject|2
5536647|NCT01350934|19137098|P1|Base Study|Withdrawal by Subject|1
5536648|NCT01350934|19137097|P2|Base Study|Protocol Violation|1
5536649|NCT01350934|19137098|P1|Base Study|Protocol Violation|1
5536650|NCT01350934|19137097|P2|Base Study|Lost to Follow-up|0
5536651|NCT01350934|19137098|P1|Base Study|Lost to Follow-up|1
5536652|NCT01350934|19137097|P2|Base Study|Adverse Event|0
5536653|NCT01350934|19137098|P1|Base Study|Adverse Event|6
5536654|NCT01350804|19137120|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
5536655|NCT01350804|19137121|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
5536656|NCT01350804|19137122|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
5536657|NCT01350804|19137123|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
5536658|NCT01350804|19137120|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
5536659|NCT01350804|19137121|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
5536660|NCT01350804|19137122|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
5536661|NCT01350804|19137123|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
5536662|NCT01350804|19137120|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
5536663|NCT01350804|19137121|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
5536664|NCT01350804|19137122|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
5536665|NCT01350804|19137123|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
5536666|NCT01350804|19137120|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
5536667|NCT01350804|19137121|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
5536668|NCT01350804|19137122|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
5536669|NCT01350804|19137123|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
5536670|NCT01350804|19137120|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
5536671|NCT01350804|19137121|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
5536672|NCT01350804|19137122|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
5536673|NCT01350804|19137123|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
5536674|NCT01350804|19137120|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
5536675|NCT01350804|19137121|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
5536676|NCT01350804|19137122|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
5536677|NCT01350804|19137123|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
5536678|NCT01350804|19137120|P4|Core Study|Adverse Event|8
5536679|NCT01350804|19137121|P3|Core Study|Adverse Event|8
5536680|NCT01350804|19137122|P2|Core Study|Adverse Event|10
5536681|NCT01350804|19137123|P1|Core Study|Adverse Event|8
5536682|NCT01350804|19137120|P4|Core Study|Death|0
5536683|NCT01350804|19137121|P3|Core Study|Death|1
5536684|NCT01350804|19137122|P2|Core Study|Death|1
5536685|NCT01350804|19137123|P1|Core Study|Death|1
5536686|NCT01350804|19137120|P4|Core Study|Lack of Efficacy|5
5536687|NCT01350804|19137121|P3|Core Study|Lack of Efficacy|18
5536688|NCT01350804|19137122|P2|Core Study|Lack of Efficacy|19
5536689|NCT01350804|19137123|P1|Core Study|Lack of Efficacy|16
5536690|NCT01350804|19137120|P4|Core Study|Lost to Follow-up|1
5536691|NCT01350804|19137121|P3|Core Study|Lost to Follow-up|2
5536692|NCT01350804|19137122|P2|Core Study|Lost to Follow-up|0
5536693|NCT01350804|19137123|P1|Core Study|Lost to Follow-up|3
5536694|NCT01350804|19137120|P4|Core Study|Physician Decision|3
5536695|NCT01350804|19137121|P3|Core Study|Physician Decision|1
5536696|NCT01350804|19137122|P2|Core Study|Physician Decision|0
5536697|NCT01350804|19137123|P1|Core Study|Physician Decision|1
5536698|NCT01350804|19137120|P4|Core Study|Protocol deviation|0
5536699|NCT01350804|19137121|P3|Core Study|Protocol deviation|1
5536700|NCT01350804|19137122|P2|Core Study|Protocol deviation|0
5536701|NCT01350804|19137123|P1|Core Study|Protocol deviation|1
5536702|NCT01350804|19137120|P4|Core Study|Study terminated by Sponsor|2
5536703|NCT01350804|19137121|P3|Core Study|Study terminated by Sponsor|0
5536704|NCT01350804|19137122|P2|Core Study|Study terminated by Sponsor|0
5536705|NCT01350804|19137123|P1|Core Study|Study terminated by Sponsor|0
5536706|NCT01350804|19137120|P4|Core Study|Withdrawal by Subject|7
5536707|NCT01350804|19137121|P3|Core Study|Withdrawal by Subject|16
5536708|NCT01350804|19137122|P2|Core Study|Withdrawal by Subject|17
5536709|NCT01350804|19137123|P1|Core Study|Withdrawal by Subject|11
5536710|NCT01350544|19137220|P2|Overall Study|Lost to Follow-up|15
5536711|NCT01350544|19137221|P1|Overall Study|Lost to Follow-up|18
5536712|NCT01350544|19137220|P2|Overall Study|Incarceration|0
5536713|NCT01350544|19137221|P1|Overall Study|Incarceration|1
5536714|NCT01350544|19137220|P2|Overall Study|Withdrawal by Subject|1
5536715|NCT01350544|19137221|P1|Overall Study|Withdrawal by Subject|0
5536716|NCT01350544|19137220|P2|Overall Study|Medical Issues|1
5536717|NCT01350544|19137221|P1|Overall Study|Medical Issues|1
5536718|NCT01350544|19137220|P2|Overall Study|Moved out of LA County|2
5536719|NCT01350544|19137221|P1|Overall Study|Moved out of LA County|2
5536720|NCT01350544|19137220|P2|Overall Study|Death|2
5536721|NCT01350544|19137221|P1|Overall Study|Death|1
5536722|NCT01350544|19137220|P2|Overall Study|Administrative Withdrawal|1
5536723|NCT01350544|19137221|P1|Overall Study|Administrative Withdrawal|0
5536724|NCT01350505|19137227|P1|Overall Study|Lost to Follow-up|4
5536725|NCT01350492|19137233|P2|Post Intervention Follow-Up|Withdrawal by Subject|1
5536726|NCT01350492|19137234|P1|Post Intervention Follow-Up|Withdrawal by Subject|0
5536727|NCT01350492|19137233|P2|Post Intervention Follow-Up|Lost to Follow-up|1
5536728|NCT01350492|19137234|P1|Post Intervention Follow-Up|Lost to Follow-up|6
5536729|NCT01350492|19137233|P2|Intervention|Withdrawal by Subject|1
5536730|NCT01350492|19137234|P1|Intervention|Withdrawal by Subject|3
5536731|NCT01350492|19137233|P2|Intervention|Lost to Follow-up|5
5536732|NCT01350492|19137234|P1|Intervention|Lost to Follow-up|2
5536733|NCT01350414|19137276|P1|Overall Study|Physician Decision|2
5536734|NCT01350414|19137276|P1|Overall Study|Withdrawal by Subject|4
5536735|NCT01350414|19137276|P1|Overall Study|Lost to Follow-up|13
5536736|NCT01350271|19137325|P3|Overall Study|Lost to Follow-up|26
5536737|NCT01350271|19137326|P2|Overall Study|Lost to Follow-up|17
5536738|NCT01350271|19137327|P1|Overall Study|Lost to Follow-up|21
5536739|NCT01350141|19137369|P3|Overall Study|Randomized but not treated|0
5536740|NCT01350141|19137370|P2|Overall Study|Randomized but not treated|0
5536741|NCT01350141|19137371|P1|Overall Study|Randomized but not treated|1
5536742|NCT01350141|19137369|P3|Overall Study|Withdrawal by Subject|0
5536743|NCT01350141|19137370|P2|Overall Study|Withdrawal by Subject|0
5536744|NCT01350141|19137371|P1|Overall Study|Withdrawal by Subject|1
5536745|NCT01350141|19137369|P3|Overall Study|Lost to Follow-up|1
5536746|NCT01350141|19137370|P2|Overall Study|Lost to Follow-up|0
5536747|NCT01350141|19137371|P1|Overall Study|Lost to Follow-up|1
5536748|NCT01350128|19137405|P1|Overall Study|Lost to Follow-up|2
5536749|NCT01350128|19137405|P1|Overall Study|Physician Decision|1
5536750|NCT01350128|19137405|P1|Overall Study|Protocol discontinuation criteria|8
5536751|NCT01350128|19137405|P1|Overall Study|Withdrawal by Subject|3
5536752|NCT01350115|19137469|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
5536753|NCT01350115|19137470|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
5536754|NCT01350115|19137469|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
5536755|NCT01350115|19137470|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
5536756|NCT01350115|19137469|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
5536757|NCT01350115|19137470|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
5536758|NCT01350102|19137486|P4|Overall Study|Adverse Event|0
5536759|NCT01350102|19137487|P3|Overall Study|Adverse Event|1
5536760|NCT01350102|19137488|P2|Overall Study|Adverse Event|0
5536761|NCT01350102|19137489|P1|Overall Study|Adverse Event|0
5536762|NCT01349959|19137526|P1|Overall Study|Adverse Event|7
5536763|NCT01349907|19137567|P2|Overall Study|Administrative|1
5536764|NCT01349907|19137568|P1|Overall Study|Administrative|1
5536765|NCT01349907|19137567|P2|Overall Study|Protocol Violation|13
5536766|NCT01349907|19137568|P1|Overall Study|Protocol Violation|33
5536767|NCT01349907|19137567|P2|Overall Study|Withdrawal by Subject|8
5536768|NCT01349907|19137568|P1|Overall Study|Withdrawal by Subject|30
5536769|NCT01349907|19137567|P2|Overall Study|Lost to Follow-up|6
5536770|NCT01349907|19137568|P1|Overall Study|Lost to Follow-up|25
5536771|NCT01349907|19137567|P2|Overall Study|Treatment failure|4
5536772|NCT01349907|19137568|P1|Overall Study|Treatment failure|13
5536773|NCT01349907|19137567|P2|Overall Study|Adverse Event|11
5536774|NCT01349907|19137568|P1|Overall Study|Adverse Event|37
5536775|NCT01349829|19137606|P2|Overall Study|Migrated/moved|7
5536776|NCT01349829|19137607|P1|Overall Study|Migrated/moved|2
5536777|NCT01349829|19137606|P2|Overall Study|Consent withdrawal|8
5536778|NCT01349829|19137607|P1|Overall Study|Consent withdrawal|3
5536779|NCT01349829|19137606|P2|Overall Study|Lost to Follow-up|8
5536780|NCT01349829|19137607|P1|Overall Study|Lost to Follow-up|4
5536781|NCT01349816|19137625|P1|Overall Study|Protocol-specified criteria|8
5536782|NCT01349816|19137625|P1|Overall Study|Protocol Violation|1
5536783|NCT01349816|19137625|P1|Overall Study|Lost to Follow-up|2
5536784|NCT01349816|19137625|P1|Overall Study|Adverse Event|14
5536785|NCT01349816|19137625|P1|Overall Study|Physician Decision|1
5536786|NCT01349816|19137625|P1|Overall Study|Withdrawal by Subject|4
5536787|NCT01349803|19137691|P4|Overall Study|Protocol-specified criteria|0
5536788|NCT01349803|19137692|P3|Overall Study|Protocol-specified criteria|3
5536789|NCT01349803|19137693|P2|Overall Study|Protocol-specified criteria|1
5536790|NCT01349803|19137694|P1|Overall Study|Protocol-specified criteria|0
5536791|NCT01349803|19137691|P4|Overall Study|Withdrawal by Subject|0
5536792|NCT01349803|19137692|P3|Overall Study|Withdrawal by Subject|0
5536793|NCT01349803|19137693|P2|Overall Study|Withdrawal by Subject|0
5536794|NCT01349803|19137694|P1|Overall Study|Withdrawal by Subject|1
5536795|NCT01349803|19137691|P4|Overall Study|Adverse Event|2
5536796|NCT01349803|19137692|P3|Overall Study|Adverse Event|0
5536797|NCT01349803|19137693|P2|Overall Study|Adverse Event|0
5536798|NCT01349803|19137694|P1|Overall Study|Adverse Event|0
5536799|NCT01349790|19137764|P1|Overall Study|Lost to Follow-up|1
5536800|NCT01349790|19137764|P1|Overall Study|Adverse Event|1
5536801|NCT01349790|19137764|P1|Overall Study|Withdrawal by Patient|2
5536802|NCT01349790|19137764|P1|Overall Study|Death|2
5536803|NCT01349790|19137764|P1|Overall Study|Investigator Judgement|3
5536804|NCT01349673|19137783|P1|Overall Study|Lack of Efficacy|8
5536805|NCT01349673|19137783|P1|Overall Study|Study Terminated By Sponsor|50
5536806|NCT01349673|19137783|P1|Overall Study|Adverse Event|17
5536807|NCT01349673|19137783|P1|Overall Study|Lost to Follow-up|6
5536808|NCT01349673|19137783|P1|Overall Study|Withdrawal by Subject|21
5536809|NCT01349673|19137783|P1|Overall Study|Site Closure|10
5536810|NCT01349673|19137783|P1|Overall Study|No Longer Qualified For Study|1
5536811|NCT01349673|19137783|P1|Overall Study|Progression Of Disease Past 40 cm|1
5536812|NCT01349660|19137793|P3|Overall Study|Declining Performance Status|1
5536813|NCT01349660|19137794|P2|Overall Study|Declining Performance Status|0
5536814|NCT01349660|19137795|P1|Overall Study|Declining Performance Status|0
5536815|NCT01349660|19137793|P3|Overall Study|Study Compliance|1
5536816|NCT01349660|19137794|P2|Overall Study|Study Compliance|0
5536817|NCT01349660|19137795|P1|Overall Study|Study Compliance|0
5536818|NCT01349660|19137793|P3|Overall Study|Non-Permitted Interventions|2
5536819|NCT01349660|19137794|P2|Overall Study|Non-Permitted Interventions|0
5536820|NCT01349660|19137795|P1|Overall Study|Non-Permitted Interventions|0
5536821|NCT01349660|19137793|P3|Overall Study|Death|0
5536822|NCT01349660|19137794|P2|Overall Study|Death|1
5536823|NCT01349660|19137795|P1|Overall Study|Death|1
5536824|NCT01349660|19137793|P3|Overall Study|Withdrawal by Subject|9
5536825|NCT01349660|19137794|P2|Overall Study|Withdrawal by Subject|0
5536826|NCT01349660|19137795|P1|Overall Study|Withdrawal by Subject|2
5536827|NCT01349660|19137793|P3|Overall Study|Adverse Event|12
5536828|NCT01349660|19137794|P2|Overall Study|Adverse Event|1
5536829|NCT01349660|19137795|P1|Overall Study|Adverse Event|1
5536830|NCT01349660|19137793|P3|Overall Study|Disease Progression|50
5536831|NCT01349660|19137794|P2|Overall Study|Disease Progression|4
5536832|NCT01349660|19137795|P1|Overall Study|Disease Progression|2
5536833|NCT01349660|19137793|P3|Overall Study|Still Receiving Study Treatment|1
5536834|NCT01349660|19137794|P2|Overall Study|Still Receiving Study Treatment|0
5536835|NCT01349660|19137795|P1|Overall Study|Still Receiving Study Treatment|0
5536836|NCT01349595|19137813|P2|Overall Study|Lack of funding|2
5536837|NCT01349595|19137814|P1|Overall Study|Lack of funding|2
5536838|NCT01349569|19137820|P1|Overall Study|Lack of Efficacy|4
5536839|NCT01349465|19137841|P2|Overall Study|Subject Ineligible To Continue The Trial|19
5536840|NCT01349465|19137842|P1|Overall Study|Subject Ineligible To Continue The Trial|0
5536841|NCT01349465|19137841|P2|Overall Study|Withdrawal by Subject|2
5536842|NCT01349465|19137842|P1|Overall Study|Withdrawal by Subject|4
5536843|NCT01349465|19137841|P2|Overall Study|Lost to Follow-up|1
5536844|NCT01349465|19137842|P1|Overall Study|Lost to Follow-up|10
5536845|NCT01349465|19137841|P2|Overall Study|Death|0
5536846|NCT01349465|19137842|P1|Overall Study|Death|3
5536847|NCT01349465|19137841|P2|Overall Study|Adverse Event|0
5536848|NCT01349465|19137842|P1|Overall Study|Adverse Event|1
5536849|NCT01349192|19137863|P2|Overall Study|Failure to adhere to Protocol|0
5536850|NCT01349192|19137864|P1|Overall Study|Failure to adhere to Protocol|2
5536851|NCT01349192|19137863|P2|Overall Study|Lost to Follow-up|3
5536852|NCT01349192|19137864|P1|Overall Study|Lost to Follow-up|1
5536853|NCT01349192|19137863|P2|Overall Study|Withdrawal by Subject|2
5536854|NCT01349192|19137864|P1|Overall Study|Withdrawal by Subject|0
5536855|NCT01349192|19137863|P2|Overall Study|Protocol Violation|1
5536856|NCT01349192|19137864|P1|Overall Study|Protocol Violation|0
5536857|NCT01349049|19137896|P9|Overall Study|Withdrawal by Subject|6
5536858|NCT01349049|19137897|P8|Overall Study|Withdrawal by Subject|0
5536859|NCT01349049|19137898|P7|Overall Study|Withdrawal by Subject|0
5536860|NCT01349049|19137899|P6|Overall Study|Withdrawal by Subject|0
5536861|NCT01349049|19137900|P5|Overall Study|Withdrawal by Subject|0
5536862|NCT01349049|19137901|P4|Overall Study|Withdrawal by Subject|0
5536863|NCT01349049|19137902|P3|Overall Study|Withdrawal by Subject|0
5536864|NCT01349049|19137903|P2|Overall Study|Withdrawal by Subject|0
5536865|NCT01349049|19137904|P1|Overall Study|Withdrawal by Subject|0
5536866|NCT01349049|19137896|P9|Overall Study|Non-compliance|0
5536867|NCT01349049|19137897|P8|Overall Study|Non-compliance|0
5536868|NCT01349049|19137898|P7|Overall Study|Non-compliance|0
5536869|NCT01349049|19137899|P6|Overall Study|Non-compliance|0
5536870|NCT01349049|19137900|P5|Overall Study|Non-compliance|0
5536871|NCT01349049|19137901|P4|Overall Study|Non-compliance|1
5536872|NCT01349049|19137902|P3|Overall Study|Non-compliance|0
5536873|NCT01349049|19137903|P2|Overall Study|Non-compliance|0
5536874|NCT01349049|19137904|P1|Overall Study|Non-compliance|0
5536875|NCT01349049|19137896|P9|Overall Study|Death|5
5536876|NCT01349049|19137897|P8|Overall Study|Death|1
5536877|NCT01349049|19137898|P7|Overall Study|Death|0
5536878|NCT01349049|19137899|P6|Overall Study|Death|0
5536879|NCT01349049|19137900|P5|Overall Study|Death|0
5536880|NCT01349049|19137901|P4|Overall Study|Death|0
5536881|NCT01349049|19137902|P3|Overall Study|Death|0
5536882|NCT01349049|19137903|P2|Overall Study|Death|0
5536883|NCT01349049|19137904|P1|Overall Study|Death|0
5536884|NCT01349049|19137896|P9|Overall Study|Other|4
5536885|NCT01349049|19137897|P8|Overall Study|Other|0
5536886|NCT01349049|19137898|P7|Overall Study|Other|0
5536887|NCT01349049|19137899|P6|Overall Study|Other|1
5536888|NCT01349049|19137900|P5|Overall Study|Other|0
5536889|NCT01349049|19137901|P4|Overall Study|Other|0
5536890|NCT01349049|19137902|P3|Overall Study|Other|0
5536891|NCT01349049|19137903|P2|Overall Study|Other|0
5536892|NCT01349049|19137904|P1|Overall Study|Other|0
5536893|NCT01349049|19137896|P9|Overall Study|Hematopoietic stem cell transplant|0
5536894|NCT01349049|19137897|P8|Overall Study|Hematopoietic stem cell transplant|1
5536895|NCT01349049|19137898|P7|Overall Study|Hematopoietic stem cell transplant|1
5536896|NCT01349049|19137899|P6|Overall Study|Hematopoietic stem cell transplant|0
5536897|NCT01349049|19137900|P5|Overall Study|Hematopoietic stem cell transplant|1
5536898|NCT01349049|19137901|P4|Overall Study|Hematopoietic stem cell transplant|0
5536899|NCT01349049|19137902|P3|Overall Study|Hematopoietic stem cell transplant|0
5536900|NCT01349049|19137903|P2|Overall Study|Hematopoietic stem cell transplant|0
5536901|NCT01349049|19137904|P1|Overall Study|Hematopoietic stem cell transplant|0
5536902|NCT01349049|19137896|P9|Overall Study|Protocol Violation|1
5536903|NCT01349049|19137897|P8|Overall Study|Protocol Violation|0
5536904|NCT01349049|19137898|P7|Overall Study|Protocol Violation|0
5536905|NCT01349049|19137899|P6|Overall Study|Protocol Violation|0
5536906|NCT01349049|19137900|P5|Overall Study|Protocol Violation|0
5536907|NCT01349049|19137901|P4|Overall Study|Protocol Violation|0
5536908|NCT01349049|19137902|P3|Overall Study|Protocol Violation|0
5536909|NCT01349049|19137903|P2|Overall Study|Protocol Violation|0
5536910|NCT01349049|19137904|P1|Overall Study|Protocol Violation|0
5536911|NCT01349049|19137896|P9|Overall Study|Physician Decision|2
5536912|NCT01349049|19137897|P8|Overall Study|Physician Decision|0
5536913|NCT01349049|19137898|P7|Overall Study|Physician Decision|0
5536914|NCT01349049|19137899|P6|Overall Study|Physician Decision|0
5536915|NCT01349049|19137900|P5|Overall Study|Physician Decision|0
5536916|NCT01349049|19137901|P4|Overall Study|Physician Decision|0
5536917|NCT01349049|19137902|P3|Overall Study|Physician Decision|0
5536918|NCT01349049|19137903|P2|Overall Study|Physician Decision|1
5536919|NCT01349049|19137904|P1|Overall Study|Physician Decision|0
5536920|NCT01349049|19137896|P9|Overall Study|Adverse Event|4
5536921|NCT01349049|19137897|P8|Overall Study|Adverse Event|0
5536922|NCT01349049|19137898|P7|Overall Study|Adverse Event|1
5536923|NCT01349049|19137899|P6|Overall Study|Adverse Event|3
5536924|NCT01349049|19137900|P5|Overall Study|Adverse Event|0
5536925|NCT01349049|19137901|P4|Overall Study|Adverse Event|0
5536926|NCT01349049|19137902|P3|Overall Study|Adverse Event|0
5536927|NCT01349049|19137903|P2|Overall Study|Adverse Event|1
5536928|NCT01349049|19137904|P1|Overall Study|Adverse Event|0
5536929|NCT01349049|19137896|P9|Overall Study|Disease progression|33
5536930|NCT01349049|19137897|P8|Overall Study|Disease progression|2
5536931|NCT01349049|19137898|P7|Overall Study|Disease progression|3
5536932|NCT01349049|19137899|P6|Overall Study|Disease progression|2
5536933|NCT01349049|19137900|P5|Overall Study|Disease progression|2
5536934|NCT01349049|19137901|P4|Overall Study|Disease progression|2
5536935|NCT01349049|19137902|P3|Overall Study|Disease progression|3
5536936|NCT01349049|19137903|P2|Overall Study|Disease progression|5
5536937|NCT01349049|19137904|P1|Overall Study|Disease progression|3
5536938|NCT01349036|19137958|P2|Overall Study|Withdrawal by Subject|2
5536939|NCT01349036|19137959|P1|Overall Study|Withdrawal by Subject|0
5536940|NCT01349036|19137958|P2|Overall Study|Other|0
5536941|NCT01349036|19137959|P1|Overall Study|Other|1
5536942|NCT01349036|19137958|P2|Overall Study|Disease progression|22
5536943|NCT01349036|19137959|P1|Overall Study|Disease progression|13
5536944|NCT01348854|19137977|P2|Overall Study|Withdrawal by Subject|0
5536945|NCT01348854|19137978|P1|Overall Study|Withdrawal by Subject|1
5536946|NCT01348854|19137977|P2|Overall Study|Lost to Follow-up|1
5536947|NCT01348854|19137978|P1|Overall Study|Lost to Follow-up|2
5536948|NCT01348789|19137986|P1|Overall Study|Withdrawal by Subject|2
5536949|NCT01348789|19137986|P1|Overall Study|Protocol Violation|2
5536950|NCT01348776|19137997|P1|Overall Study|Lost to Follow-up|3
5536951|NCT01348763|19138010|P1|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
5536952|NCT01348763|19138010|P1|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
5536953|NCT01348698|19138015|P1|Overall Study|PI decision to close study|68
5536954|NCT01348698|19138015|P1|Overall Study|Death|3
5536955|NCT01348698|19138015|P1|Overall Study|Does not meet lesion size criteria|1
5536956|NCT01348542|19138040|P2|Overall Study|Withdrawal by Subject|0
5536957|NCT01348542|19138041|P1|Overall Study|Withdrawal by Subject|3
5536958|NCT01348490|19138057|P1|Overall Study|Other Unspecified|8
5536959|NCT01348490|19138057|P1|Overall Study|Termination of clinical trial by sponsor|1
5536960|NCT01348490|19138057|P1|Overall Study|Lost to Follow-up|1
5536961|NCT01348490|19138057|P1|Overall Study|Disease progression|3
5536962|NCT01348490|19138057|P1|Overall Study|Consent withdrawn|7
5536963|NCT01348490|19138057|P1|Overall Study|Adverse Event|3
5536964|NCT01348490|19138057|P1|Overall Study|Death|1
5536965|NCT01348425|19138115|P2|Overall Study|Imaging was not taken.|1
5536966|NCT01348425|19138116|P1|Overall Study|Imaging was not taken.|1
5536967|NCT01348347|19138124|P3|Overall Study|Progressive disease|5
5536968|NCT01348347|19138125|P2|Overall Study|Progressive disease|5
5536969|NCT01348347|19138126|P1|Overall Study|Progressive disease|2
5536970|NCT01348347|19138124|P3|Overall Study|Withdrawal by Subject|1
5536971|NCT01348347|19138125|P2|Overall Study|Withdrawal by Subject|1
5536972|NCT01348347|19138126|P1|Overall Study|Withdrawal by Subject|1
5536973|NCT01348165|19138157|P7|Overall Study|Adverse Event|1
5536974|NCT01348165|19138158|P6|Overall Study|Adverse Event|0
5536975|NCT01348165|19138159|P5|Overall Study|Adverse Event|0
5536976|NCT01348165|19138160|P4|Overall Study|Adverse Event|0
5536977|NCT01348165|19138161|P3|Overall Study|Adverse Event|0
5536978|NCT01348165|19138162|P2|Overall Study|Adverse Event|0
5536979|NCT01348165|19138163|P1|Overall Study|Adverse Event|0
5536980|NCT01348139|19138292|P6|Period 1|Adverse Event|0
5536981|NCT01348139|19138293|P5|Period 1|Adverse Event|0
5536982|NCT01348139|19138294|P4|Period 1|Adverse Event|0
5536983|NCT01348139|19138295|P3|Period 1|Adverse Event|0
5536984|NCT01348139|19138296|P2|Period 1|Adverse Event|0
5536985|NCT01348139|19138297|P1|Period 1|Adverse Event|1
5536986|NCT01348100|19138378|P7|Overall Study|Administrative Problems|1
5536987|NCT01348100|19138379|P6|Overall Study|Administrative Problems|1
5536988|NCT01348100|19138380|P5|Overall Study|Administrative Problems|0
5536989|NCT01348100|19138381|P4|Overall Study|Administrative Problems|0
5536990|NCT01348100|19138382|P3|Overall Study|Administrative Problems|0
5536991|NCT01348100|19138383|P2|Overall Study|Administrative Problems|0
5536992|NCT01348100|19138384|P1|Overall Study|Administrative Problems|0
5536993|NCT01348100|19138378|P7|Overall Study|Lost to Follow-up|1
5536994|NCT01348100|19138379|P6|Overall Study|Lost to Follow-up|0
5536995|NCT01348100|19138380|P5|Overall Study|Lost to Follow-up|0
5536996|NCT01348100|19138381|P4|Overall Study|Lost to Follow-up|0
5536997|NCT01348100|19138382|P3|Overall Study|Lost to Follow-up|0
5536998|NCT01348100|19138383|P2|Overall Study|Lost to Follow-up|0
5536999|NCT01348100|19138384|P1|Overall Study|Lost to Follow-up|0
5537000|NCT01348100|19138378|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
5537001|NCT01348100|19138379|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
5537002|NCT01348100|19138380|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
5537003|NCT01348100|19138381|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
5537004|NCT01348100|19138382|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
5537005|NCT01348100|19138383|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
5537006|NCT01348100|19138384|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
5537007|NCT01348100|19138378|P7|Overall Study|Protocol Deviation|0
5537008|NCT01348100|19138379|P6|Overall Study|Protocol Deviation|0
5537009|NCT01348100|19138380|P5|Overall Study|Protocol Deviation|0
5537010|NCT01348100|19138381|P4|Overall Study|Protocol Deviation|1
5537011|NCT01348100|19138382|P3|Overall Study|Protocol Deviation|0
5537012|NCT01348100|19138383|P2|Overall Study|Protocol Deviation|0
5537013|NCT01348100|19138384|P1|Overall Study|Protocol Deviation|0
5537014|NCT01348100|19138378|P7|Overall Study|Subject Withdrew Consent|1
5537015|NCT01348100|19138379|P6|Overall Study|Subject Withdrew Consent|0
5537016|NCT01348100|19138380|P5|Overall Study|Subject Withdrew Consent|1
5537017|NCT01348100|19138381|P4|Overall Study|Subject Withdrew Consent|0
5537018|NCT01348100|19138382|P3|Overall Study|Subject Withdrew Consent|2
5537019|NCT01348100|19138383|P2|Overall Study|Subject Withdrew Consent|0
5537020|NCT01348100|19138384|P1|Overall Study|Subject Withdrew Consent|0
5537021|NCT01348087|19138429|P1|Overall Study|Adverse Event|25
5537022|NCT01348087|19138429|P1|Overall Study|Subject withdrew consent|7
5537023|NCT01348087|19138429|P1|Overall Study|Lost to Follow-up|1
5537024|NCT01348087|19138429|P1|Overall Study|protocol deviation|1
5537025|NCT01348087|19138429|P1|Overall Study|Administrative problems|79
5537026|NCT01348087|19138429|P1|Overall Study|Unsatisfactory therapeutic effect|35
5537027|NCT01347931|19138443|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
5537028|NCT01347879|19138455|P2|Overall Study|Other|3
5537029|NCT01347879|19138456|P1|Overall Study|Other|2
5537030|NCT01347879|19138455|P2|Overall Study|Withdrawal by Subject|2
5537031|NCT01347879|19138456|P1|Overall Study|Withdrawal by Subject|3
5537032|NCT01347879|19138455|P2|Overall Study|Lost to Follow-up|0
5537033|NCT01347879|19138456|P1|Overall Study|Lost to Follow-up|2
5537034|NCT01347879|19138455|P2|Overall Study|Adverse Event|12
5537035|NCT01347879|19138456|P1|Overall Study|Adverse Event|0
5537036|NCT01347866|19138505|P17|Overall Study|Subject refused further follow-up|2
5537037|NCT01347866|19138506|P16|Overall Study|Subject refused further follow-up|0
5537038|NCT01347866|19138507|P15|Overall Study|Subject refused further follow-up|1
5537039|NCT01347866|19138508|P14|Overall Study|Subject refused further follow-up|3
5537040|NCT01347866|19138509|P13|Overall Study|Subject refused further follow-up|1
5537041|NCT01347866|19138510|P12|Overall Study|Subject refused further follow-up|0
5537042|NCT01347866|19138511|P11|Overall Study|Subject refused further follow-up|0
5537043|NCT01347866|19138512|P10|Overall Study|Subject refused further follow-up|1
5537044|NCT01347866|19138513|P9|Overall Study|Subject refused further follow-up|4
5537045|NCT01347866|19138514|P8|Overall Study|Subject refused further follow-up|0
5537046|NCT01347866|19138515|P7|Overall Study|Subject refused further follow-up|0
5537047|NCT01347866|19138516|P6|Overall Study|Subject refused further follow-up|1
5537048|NCT01347866|19138517|P5|Overall Study|Subject refused further follow-up|0
5537049|NCT01347866|19138518|P4|Overall Study|Subject refused further follow-up|2
5537050|NCT01347866|19138519|P3|Overall Study|Subject refused further follow-up|0
5537051|NCT01347866|19138520|P2|Overall Study|Subject refused further follow-up|0
5537052|NCT01347866|19138521|P1|Overall Study|Subject refused further follow-up|2
5537053|NCT01347866|19138505|P17|Overall Study|Other|0
5537054|NCT01347866|19138506|P16|Overall Study|Other|3
5537055|NCT01347866|19138507|P15|Overall Study|Other|2
5537056|NCT01347866|19138508|P14|Overall Study|Other|4
5537057|NCT01347866|19138509|P13|Overall Study|Other|4
5537058|NCT01347866|19138510|P12|Overall Study|Other|3
5537059|NCT01347866|19138511|P11|Overall Study|Other|0
5537060|NCT01347866|19138512|P10|Overall Study|Other|5
5537061|NCT01347866|19138513|P9|Overall Study|Other|22
5537062|NCT01347866|19138514|P8|Overall Study|Other|3
5537063|NCT01347866|19138515|P7|Overall Study|Other|5
5537064|NCT01347866|19138516|P6|Overall Study|Other|0
5537065|NCT01347866|19138517|P5|Overall Study|Other|5
5537066|NCT01347866|19138518|P4|Overall Study|Other|4
5537067|NCT01347866|19138519|P3|Overall Study|Other|1
5537068|NCT01347866|19138520|P2|Overall Study|Other|1
5537069|NCT01347866|19138521|P1|Overall Study|Other|3
5537070|NCT01347866|19138505|P17|Overall Study|Lost to Follow-up|0
5537071|NCT01347866|19138506|P16|Overall Study|Lost to Follow-up|0
5537072|NCT01347866|19138507|P15|Overall Study|Lost to Follow-up|0
5537073|NCT01347866|19138508|P14|Overall Study|Lost to Follow-up|0
5537074|NCT01347866|19138509|P13|Overall Study|Lost to Follow-up|0
5537075|NCT01347866|19138510|P12|Overall Study|Lost to Follow-up|0
5537076|NCT01347866|19138511|P11|Overall Study|Lost to Follow-up|0
5537077|NCT01347866|19138512|P10|Overall Study|Lost to Follow-up|0
5537078|NCT01347866|19138513|P9|Overall Study|Lost to Follow-up|1
5537079|NCT01347866|19138514|P8|Overall Study|Lost to Follow-up|1
5537080|NCT01347866|19138515|P7|Overall Study|Lost to Follow-up|0
5537081|NCT01347866|19138516|P6|Overall Study|Lost to Follow-up|0
5537082|NCT01347866|19138517|P5|Overall Study|Lost to Follow-up|0
5537083|NCT01347866|19138518|P4|Overall Study|Lost to Follow-up|0
5537084|NCT01347866|19138519|P3|Overall Study|Lost to Follow-up|0
5537085|NCT01347866|19138520|P2|Overall Study|Lost to Follow-up|0
5537086|NCT01347866|19138521|P1|Overall Study|Lost to Follow-up|0
5537087|NCT01347866|19138505|P17|Overall Study|Death|0
5537088|NCT01347866|19138506|P16|Overall Study|Death|1
5537089|NCT01347866|19138507|P15|Overall Study|Death|0
5537090|NCT01347866|19138508|P14|Overall Study|Death|0
5537091|NCT01347866|19138509|P13|Overall Study|Death|2
5537092|NCT01347866|19138510|P12|Overall Study|Death|1
5537093|NCT01347866|19138511|P11|Overall Study|Death|3
5537094|NCT01347866|19138512|P10|Overall Study|Death|1
5537095|NCT01347866|19138513|P9|Overall Study|Death|4
5537096|NCT01347866|19138514|P8|Overall Study|Death|0
5537097|NCT01347866|19138515|P7|Overall Study|Death|1
5537098|NCT01347866|19138516|P6|Overall Study|Death|2
5537099|NCT01347866|19138517|P5|Overall Study|Death|2
5537100|NCT01347866|19138518|P4|Overall Study|Death|1
5537101|NCT01347866|19138519|P3|Overall Study|Death|0
5537102|NCT01347866|19138520|P2|Overall Study|Death|0
5537103|NCT01347866|19138521|P1|Overall Study|Death|0
5537104|NCT01347840|19138895|P1|Overall Study|Withdrawal by Subject|1
5537105|NCT01347762|19138922|P4|Overall Study|Withdrawal by Subject|3
5537106|NCT01347762|19138923|P3|Overall Study|Withdrawal by Subject|3
5537107|NCT01347762|19138924|P2|Overall Study|Withdrawal by Subject|1
5537108|NCT01347762|19138925|P1|Overall Study|Withdrawal by Subject|4
5537109|NCT01347762|19138922|P4|Overall Study|Lost to Follow-up|5
5537110|NCT01347762|19138923|P3|Overall Study|Lost to Follow-up|6
5537111|NCT01347762|19138924|P2|Overall Study|Lost to Follow-up|1
5537112|NCT01347762|19138925|P1|Overall Study|Lost to Follow-up|0
5537113|NCT01347710|19138951|P1|Overall Study|Other|3
5537114|NCT01347710|19138951|P1|Overall Study|Physician Decision|2
5537115|NCT01347710|19138951|P1|Overall Study|Lost to Follow-up|1
5537116|NCT01347710|19138951|P1|Overall Study|issue with vitals prior to dosing|1
5537117|NCT01347710|19138951|P1|Overall Study|Angio or SPECT not completed|18
5537118|NCT01347710|19138951|P1|Overall Study|Adverse Event|4
5537119|NCT01347710|19138951|P1|Overall Study|Withdrawal by Subject|2
5537120|NCT01347580|19138973|P2|Overall Study|Had other reason|6
5537121|NCT01347580|19138974|P1|Overall Study|Had other reason|9
5537122|NCT01347580|19138973|P2|Overall Study|Lost to Follow-up|1
5537123|NCT01347580|19138974|P1|Overall Study|Lost to Follow-up|3
5537124|NCT01347580|19138973|P2|Overall Study|Protocol Violation|7
5537125|NCT01347580|19138974|P1|Overall Study|Protocol Violation|10
5537126|NCT01347580|19138973|P2|Overall Study|Death|19
5537127|NCT01347580|19138974|P1|Overall Study|Death|30
5537128|NCT01347580|19138973|P2|Overall Study|Withdrawal by Subject|23
5537129|NCT01347580|19138974|P1|Overall Study|Withdrawal by Subject|13
5537130|NCT01347554|19139004|P2|Overall Study|Lack of Efficacy|11
5537131|NCT01347554|19139005|P1|Overall Study|Lack of Efficacy|7
5537132|NCT01347307|19139030|P2|Overall Study|Physician Decision|1
5537133|NCT01347307|19139031|P1|Overall Study|Physician Decision|0
5537134|NCT01347307|19139030|P2|Overall Study|Death|4
5537135|NCT01347307|19139031|P1|Overall Study|Death|0
5537136|NCT01347112|19139066|P2|Overall Study|Lost to Follow-up|5
5537137|NCT01347112|19139067|P1|Overall Study|Lost to Follow-up|3
5537138|NCT01347112|19139066|P2|Overall Study|Withdrawal by Subject|7
5537139|NCT01347112|19139067|P1|Overall Study|Withdrawal by Subject|1
5537140|NCT01347086|19139087|P10|Overall Study|failed screening visit|1
5537141|NCT01347086|19139088|P9|Overall Study|failed screening visit|0
5537142|NCT01347086|19139089|P8|Overall Study|failed screening visit|1
5537143|NCT01347086|19139090|P7|Overall Study|failed screening visit|1
5537144|NCT01347086|19139091|P6|Overall Study|failed screening visit|0
5537145|NCT01347086|19139092|P5|Overall Study|failed screening visit|0
5537146|NCT01347086|19139093|P4|Overall Study|failed screening visit|0
5537147|NCT01347086|19139094|P3|Overall Study|failed screening visit|1
5537148|NCT01347086|19139095|P2|Overall Study|failed screening visit|0
5537149|NCT01347086|19139096|P1|Overall Study|failed screening visit|0
5537150|NCT01347073|19139195|P1|Overall Study|Liver Transplant|1
5537151|NCT01347073|19139195|P1|Overall Study|Adverse Event|1
5537152|NCT01346774|19139274|P2|Overall Study|Adverse Event|2
5537153|NCT01346774|19139275|P1|Overall Study|Adverse Event|1
5537154|NCT01346774|19139274|P2|Overall Study|Protocol Violation|3
5537155|NCT01346774|19139275|P1|Overall Study|Protocol Violation|2
5537156|NCT01346774|19139274|P2|Overall Study|Withdrawal by Subject|4
5537157|NCT01346774|19139275|P1|Overall Study|Withdrawal by Subject|1
5537158|NCT01346774|19139274|P2|Overall Study|Lost to Follow-up|4
5537159|NCT01346774|19139275|P1|Overall Study|Lost to Follow-up|3
5537160|NCT01346774|19139274|P2|Overall Study|Did not take a single dose|4
5537161|NCT01346774|19139275|P1|Overall Study|Did not take a single dose|6
5537162|NCT01346696|19139281|P1|Overall Study|Death|1
5537163|NCT01346592|19139303|P3|Overall Study|Unable to Classify|6
5537164|NCT01346592|19139304|P2|Overall Study|Unable to Classify|3
5537165|NCT01346592|19139305|P1|Overall Study|Unable to Classify|7
5537166|NCT01346592|19139303|P3|Overall Study|Administrative reason|0
5537167|NCT01346592|19139304|P2|Overall Study|Administrative reason|0
5537168|NCT01346592|19139305|P1|Overall Study|Administrative reason|1
5537169|NCT01346592|19139303|P3|Overall Study|Inappropriate enrollment|1
5537170|NCT01346592|19139304|P2|Overall Study|Inappropriate enrollment|1
5537171|NCT01346592|19139305|P1|Overall Study|Inappropriate enrollment|3
5537172|NCT01346592|19139303|P3|Overall Study|Withdrawal by Subject|38
5537173|NCT01346592|19139304|P2|Overall Study|Withdrawal by Subject|51
5537174|NCT01346592|19139305|P1|Overall Study|Withdrawal by Subject|77
5537175|NCT01346592|19139303|P3|Overall Study|Adverse Event|0
5537176|NCT01346592|19139304|P2|Overall Study|Adverse Event|1
5537177|NCT01346592|19139305|P1|Overall Study|Adverse Event|0
5537178|NCT01346592|19139303|P3|Overall Study|Death|4
5537179|NCT01346592|19139304|P2|Overall Study|Death|3
5537180|NCT01346592|19139305|P1|Overall Study|Death|1
5537181|NCT01346592|19139303|P3|Overall Study|Protocol Violation|0
5537182|NCT01346592|19139304|P2|Overall Study|Protocol Violation|1
5537183|NCT01346592|19139305|P1|Overall Study|Protocol Violation|2
5537184|NCT01346592|19139303|P3|Overall Study|Lost to Follow-up|29
5537185|NCT01346592|19139304|P2|Overall Study|Lost to Follow-up|29
5537186|NCT01346592|19139305|P1|Overall Study|Lost to Follow-up|62
5537187|NCT01346540|19139397|P2|Overall Study|Adverse Event|4
5537188|NCT01346540|19139398|P1|Overall Study|Adverse Event|0
5537189|NCT01346540|19139397|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
5537190|NCT01346540|19139398|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
5537191|NCT01346514|19139409|P2|Overall Study|Death|4
5537192|NCT01346514|19139410|P1|Overall Study|Death|3
5537193|NCT01346514|19139409|P2|Overall Study|Withdrawal by Subject|3
5537194|NCT01346514|19139410|P1|Overall Study|Withdrawal by Subject|7
5537195|NCT01346514|19139409|P2|Overall Study|Lost to Follow-up|30
5537196|NCT01346514|19139410|P1|Overall Study|Lost to Follow-up|19
5537197|NCT01346501|19139430|P2|Overall Study|Other|12
5537198|NCT01346501|19139431|P1|Overall Study|Other|8
5537199|NCT01346501|19139430|P2|Overall Study|Initiated Other Biological Agents|1
5537200|NCT01346501|19139431|P1|Overall Study|Initiated Other Biological Agents|3
5537201|NCT01346475|19139464|P2|First Intervention|Lost to Follow-up|3
5537202|NCT01346475|19139465|P1|First Intervention|Lost to Follow-up|4
5537203|NCT01346410|19139477|P1|Overall Study|Death|1
5537204|NCT01346371|19139495|P2|Overall Study|Lost to Follow-up|0
5537205|NCT01346371|19139496|P1|Overall Study|Lost to Follow-up|2
5537206|NCT01346293|19139504|P2|Overall Study|Other|0
5537207|NCT01346293|19139505|P1|Overall Study|Other|1
5537208|NCT01346293|19139504|P2|Overall Study|Withdrawal by Subject|4
5537209|NCT01346293|19139505|P1|Overall Study|Withdrawal by Subject|15
5537210|NCT01346293|19139504|P2|Overall Study|Lost to Follow-up|8
5537211|NCT01346293|19139505|P1|Overall Study|Lost to Follow-up|21
5537212|NCT01346293|19139504|P2|Overall Study|Protocol Violation|9
5537213|NCT01346293|19139505|P1|Overall Study|Protocol Violation|30
5537214|NCT01346189|19139535|P4|Overall Study|Travel|3
5537215|NCT01346189|19139536|P3|Overall Study|Travel|0
5537216|NCT01346189|19139537|P2|Overall Study|Travel|0
5537217|NCT01346189|19139538|P1|Overall Study|Travel|0
5537218|NCT01346189|19139535|P4|Overall Study|Non-health system primary care physician|0
5537219|NCT01346189|19139536|P3|Overall Study|Non-health system primary care physician|0
5537220|NCT01346189|19139537|P2|Overall Study|Non-health system primary care physician|5
5537221|NCT01346189|19139538|P1|Overall Study|Non-health system primary care physician|0
5537222|NCT01346189|19139535|P4|Overall Study|Death|0
5537223|NCT01346189|19139536|P3|Overall Study|Death|0
5537224|NCT01346189|19139537|P2|Overall Study|Death|3
5537225|NCT01346189|19139538|P1|Overall Study|Death|0
5537226|NCT01346189|19139535|P4|Overall Study|Other|3
5537227|NCT01346189|19139536|P3|Overall Study|Other|7
5537228|NCT01346189|19139537|P2|Overall Study|Other|4
5537229|NCT01346189|19139538|P1|Overall Study|Other|2
5537230|NCT01346189|19139535|P4|Overall Study|Moved|0
5537231|NCT01346189|19139536|P3|Overall Study|Moved|4
5537232|NCT01346189|19139537|P2|Overall Study|Moved|0
5537233|NCT01346189|19139538|P1|Overall Study|Moved|3
5537234|NCT01346189|19139535|P4|Overall Study|Physician Decision|0
5537235|NCT01346189|19139536|P3|Overall Study|Physician Decision|0
5537236|NCT01346189|19139537|P2|Overall Study|Physician Decision|0
5537237|NCT01346189|19139538|P1|Overall Study|Physician Decision|4
5537238|NCT01346189|19139535|P4|Overall Study|Withdrawal by Subject|5
5537239|NCT01346189|19139536|P3|Overall Study|Withdrawal by Subject|3
5537240|NCT01346189|19139537|P2|Overall Study|Withdrawal by Subject|5
5537241|NCT01346189|19139538|P1|Overall Study|Withdrawal by Subject|7
5537242|NCT01346176|19139555|P3|Completed Satisfaction Survey|Lost to Follow-up|4
5537243|NCT01346176|19139556|P2|Completed Satisfaction Survey|Lost to Follow-up|4
5537244|NCT01346176|19139557|P1|Completed Satisfaction Survey|Lost to Follow-up|3
5537245|NCT01346176|19139555|P3|Completed Satisfaction Survey|Death|2
5537246|NCT01346176|19139556|P2|Completed Satisfaction Survey|Death|0
5537247|NCT01346176|19139557|P1|Completed Satisfaction Survey|Death|3
5537248|NCT01346176|19139555|P3|Completed Advance Directive|Other reason did not complete AD|7
5537249|NCT01346176|19139556|P2|Completed Advance Directive|Other reason did not complete AD|12
5537250|NCT01346176|19139557|P1|Completed Advance Directive|Other reason did not complete AD|7
5537251|NCT01346176|19139555|P3|Completed Advance Directive|Became Ineligible|1
5537252|NCT01346176|19139556|P2|Completed Advance Directive|Became Ineligible|0
5537253|NCT01346176|19139557|P1|Completed Advance Directive|Became Ineligible|3
5537254|NCT01346176|19139555|P3|Completed Advance Directive|Death|2
5537255|NCT01346176|19139556|P2|Completed Advance Directive|Death|2
5537256|NCT01346176|19139557|P1|Completed Advance Directive|Death|3
5537257|NCT01346176|19139555|P3|Recruited|Protocol Violation|0
5537258|NCT01346176|19139556|P2|Recruited|Protocol Violation|0
5537259|NCT01346176|19139557|P1|Recruited|Protocol Violation|1
5537260|NCT01346059|19139586|P2|Overall Study|Withdrawal by Subject|0
5537261|NCT01346059|19139587|P1|Overall Study|Withdrawal by Subject|1
5537262|NCT01345929|19139599|P2|Overall Study|Patient withdrawal|1
5537263|NCT01345929|19139600|P1|Overall Study|Patient withdrawal|0
5537264|NCT01345929|19139599|P2|Overall Study|40,000 CFU/ML|0
5537265|NCT01345929|19139600|P1|Overall Study|40,000 CFU/ML|1
5537266|NCT01345929|19139599|P2|Overall Study|Didn't meet eligibility criteria|0
5537267|NCT01345929|19139600|P1|Overall Study|Didn't meet eligibility criteria|2
5537268|NCT01345929|19139599|P2|Overall Study|Adverse Event|1
5537269|NCT01345929|19139600|P1|Overall Study|Adverse Event|0
5537270|NCT01345929|19139599|P2|Overall Study|Lost to Follow-up|9
5537271|NCT01345929|19139600|P1|Overall Study|Lost to Follow-up|9
5537272|NCT01345929|19139599|P2|Overall Study|Withdrawal by Subject|8
5537273|NCT01345929|19139600|P1|Overall Study|Withdrawal by Subject|9
5537274|NCT01345786|19139612|P4|Overall Study|Lost to Follow-up|2
5537275|NCT01345786|19139613|P3|Overall Study|Lost to Follow-up|0
5537276|NCT01345786|19139614|P2|Overall Study|Lost to Follow-up|0
5537277|NCT01345786|19139615|P1|Overall Study|Lost to Follow-up|0
5537278|NCT01345786|19139612|P4|Overall Study|Administrative|0
5537279|NCT01345786|19139613|P3|Overall Study|Administrative|0
5537280|NCT01345786|19139614|P2|Overall Study|Administrative|5
5537281|NCT01345786|19139615|P1|Overall Study|Administrative|3
5537282|NCT01345786|19139612|P4|Overall Study|Noncompliance with protocol|0
5537283|NCT01345786|19139613|P3|Overall Study|Noncompliance with protocol|1
5537284|NCT01345786|19139614|P2|Overall Study|Noncompliance with protocol|0
5537285|NCT01345786|19139615|P1|Overall Study|Noncompliance with protocol|1
5537286|NCT01345786|19139612|P4|Overall Study|Subject withdrew consent|0
5537287|NCT01345786|19139613|P3|Overall Study|Subject withdrew consent|1
5537288|NCT01345786|19139614|P2|Overall Study|Subject withdrew consent|2
5537289|NCT01345786|19139615|P1|Overall Study|Subject withdrew consent|2
5537290|NCT01345786|19139612|P4|Overall Study|Adverse Event|1
5537291|NCT01345786|19139613|P3|Overall Study|Adverse Event|3
5537292|NCT01345786|19139614|P2|Overall Study|Adverse Event|1
5537293|NCT01345786|19139615|P1|Overall Study|Adverse Event|0
5537294|NCT01345682|19139695|P2|Overall Study|Reason other than those specified above|3
5537295|NCT01345682|19139696|P1|Overall Study|Reason other than those specified above|4
5537296|NCT01345682|19139695|P2|Overall Study|Not treated|1
5537297|NCT01345682|19139696|P1|Overall Study|Not treated|2
5537298|NCT01345682|19139695|P2|Overall Study|Refused to continue trial medication|9
5537299|NCT01345682|19139696|P1|Overall Study|Refused to continue trial medication|16
5537300|NCT01345682|19139695|P2|Overall Study|Lost to Follow-up|1
5537301|NCT01345682|19139696|P1|Overall Study|Lost to Follow-up|0
5537302|NCT01345682|19139695|P2|Overall Study|Non-compliance with protocol|1
5537303|NCT01345682|19139696|P1|Overall Study|Non-compliance with protocol|0
5537304|NCT01345682|19139695|P2|Overall Study|Adverse Event|41
5537305|NCT01345682|19139696|P1|Overall Study|Adverse Event|51
5537306|NCT01345682|19139695|P2|Overall Study|Worsening of underlying cancer disease|12
5537307|NCT01345682|19139696|P1|Overall Study|Worsening of underlying cancer disease|23
5537308|NCT01345682|19139695|P2|Overall Study|Progressive disease per RECIST|93
5537309|NCT01345682|19139696|P1|Overall Study|Progressive disease per RECIST|226
5537310|NCT01345669|19139730|P2|Overall Study|Other Reasons|60
5537311|NCT01345669|19139731|P1|Overall Study|Other Reasons|111
5537312|NCT01345669|19139730|P2|Overall Study|Withdrawal by Subject|13
5537313|NCT01345669|19139731|P1|Overall Study|Withdrawal by Subject|52
5537314|NCT01345669|19139730|P2|Overall Study|Lost to Follow-up|1
5537315|NCT01345669|19139731|P1|Overall Study|Lost to Follow-up|1
5537316|NCT01345669|19139730|P2|Overall Study|Protocol Violation|1
5537317|NCT01345669|19139731|P1|Overall Study|Protocol Violation|3
5537318|NCT01345669|19139730|P2|Overall Study|Adverse Event|9
5537319|NCT01345669|19139731|P1|Overall Study|Adverse Event|63
5537320|NCT01345669|19139730|P2|Overall Study|Second primary tumour|3
5537321|NCT01345669|19139731|P1|Overall Study|Second primary tumour|4
5537322|NCT01345669|19139730|P2|Overall Study|Primary tumour recurrence|32
5537323|NCT01345669|19139731|P1|Overall Study|Primary tumour recurrence|53
5537324|NCT01345630|19139749|P2|Overall Study|Insufficient clinical response|11
5537325|NCT01345630|19139750|P1|Overall Study|Insufficient clinical response|48
5537326|NCT01345630|19139749|P2|Overall Study|No longer willing to participate|12
5537327|NCT01345630|19139750|P1|Overall Study|No longer willing to participate|9
5537328|NCT01345630|19139749|P2|Overall Study|Withdrawn due to pregnancy|2
5537329|NCT01345630|19139750|P1|Overall Study|Withdrawn due to pregnancy|1
5537330|NCT01345630|19139749|P2|Overall Study|Other reasons|8
5537331|NCT01345630|19139750|P1|Overall Study|Other reasons|6
5537332|NCT01345630|19139749|P2|Overall Study|Study terminated by sponsor|285
5537333|NCT01345630|19139750|P1|Overall Study|Study terminated by sponsor|254
5537334|NCT01345630|19139749|P2|Overall Study|Medication error without associated AE|1
5537335|NCT01345630|19139750|P1|Overall Study|Medication error without associated AE|0
5537336|NCT01345630|19139749|P2|Overall Study|Protocol Violation|1
5537337|NCT01345630|19139750|P1|Overall Study|Protocol Violation|4
5537338|NCT01345630|19139749|P2|Overall Study|Lost to Follow-up|16
5537339|NCT01345630|19139750|P1|Overall Study|Lost to Follow-up|17
5537340|NCT01345630|19139749|P2|Overall Study|Adverse Event|23
5537341|NCT01345630|19139750|P1|Overall Study|Adverse Event|22
5537342|NCT01345591|19139806|P1|Overall Study|Lost to Follow-up|1
5537343|NCT01345318|19139822|P1|Overall Study|Other|3
5537344|NCT01345318|19139822|P1|Overall Study|Withdrawal by Subject|41
5537345|NCT01345318|19139822|P1|Overall Study|Protocol Violation|1
5537346|NCT01345318|19139822|P1|Overall Study|Lost to Follow-up|2
5537347|NCT01345318|19139822|P1|Overall Study|Lack of Efficacy|17
5537348|NCT01345318|19139822|P1|Overall Study|Adverse Event|16
5537349|NCT01345292|19139830|P3|Overall Study|Withdrawal by Subject|1
5537350|NCT01345292|19139831|P2|Overall Study|Withdrawal by Subject|0
5537351|NCT01345292|19139832|P1|Overall Study|Withdrawal by Subject|2
5537352|NCT01345253|19139863|P2|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
5537353|NCT01345253|19139864|P1|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
5537354|NCT01345253|19139863|P2|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
5537355|NCT01345253|19139864|P1|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
5537356|NCT01345253|19139863|P2|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
5537357|NCT01345253|19139864|P1|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
5537358|NCT01345253|19139863|P2|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
5537359|NCT01345253|19139864|P1|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
5537360|NCT01345253|19139863|P2|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
5537361|NCT01345253|19139864|P1|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
5537362|NCT01345253|19139863|P2|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
5537363|NCT01345253|19139864|P1|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
5537364|NCT01345253|19139863|P2|Open-label Phase (Up to Year 5 Week 44)|Death|1
5537365|NCT01345253|19139864|P1|Open-label Phase (Up to Year 5 Week 44)|Death|0
5537366|NCT01345253|19139863|P2|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
5537367|NCT01345253|19139864|P1|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
5537368|NCT01345253|19139863|P2|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
5537369|NCT01345253|19139864|P1|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
5537370|NCT01345253|19139863|P2|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
5537371|NCT01345253|19139864|P1|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
5537372|NCT01345253|19139863|P2|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
5537373|NCT01345253|19139864|P1|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
5537374|NCT01345253|19139863|P2|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
5537375|NCT01345253|19139864|P1|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
5537376|NCT01345253|19139863|P2|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
5537377|NCT01345253|19139864|P1|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
5537378|NCT01345253|19139863|P2|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
5537379|NCT01345253|19139864|P1|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
5537380|NCT01345253|19139863|P2|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
5537381|NCT01345253|19139864|P1|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
5537382|NCT01345240|19139885|P5|Overall Study|Lost to Follow-up|9
5537383|NCT01345240|19139886|P4|Overall Study|Lost to Follow-up|7
5537384|NCT01345240|19139887|P3|Overall Study|Lost to Follow-up|14
5537385|NCT01345240|19139888|P2|Overall Study|Lost to Follow-up|9
5537386|NCT01345240|19139889|P1|Overall Study|Lost to Follow-up|8
5537387|NCT01345240|19139885|P5|Overall Study|Adverse Event|1
5537388|NCT01345240|19139886|P4|Overall Study|Adverse Event|2
5537389|NCT01345240|19139887|P3|Overall Study|Adverse Event|4
5537390|NCT01345240|19139888|P2|Overall Study|Adverse Event|5
5537391|NCT01345240|19139889|P1|Overall Study|Adverse Event|3
5537392|NCT01345188|19140009|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
5537393|NCT01345188|19140009|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
5537394|NCT01345162|19140021|P2|Overall Study|Protocol Violation|4
5537395|NCT01345162|19140022|P1|Overall Study|Protocol Violation|2
5537396|NCT01345123|19140031|P3|Overall Study|participants no longer with health plan|88
5537397|NCT01345123|19140032|P2|Overall Study|participants no longer with health plan|85
5537398|NCT01345123|19140033|P1|Overall Study|participants no longer with health plan|79
5537399|NCT01345058|19140055|P2|Overall Study|Participant No-Show at Multiple Visits|0
5537400|NCT01345058|19140056|P1|Overall Study|Participant No-Show at Multiple Visits|1
5537401|NCT01345058|19140055|P2|Overall Study|Participant Stopped Taking Study Drug|0
5537402|NCT01345058|19140056|P1|Overall Study|Participant Stopped Taking Study Drug|1
5537403|NCT01345058|19140055|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
5537404|NCT01345058|19140056|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
5537405|NCT01345058|19140055|P2|Overall Study|Participant Reported Increase in Events|0
5537406|NCT01345058|19140056|P1|Overall Study|Participant Reported Increase in Events|1
5537407|NCT01345058|19140055|P2|Overall Study|Withdrawal by Subject|0
5537408|NCT01345058|19140056|P1|Overall Study|Withdrawal by Subject|1
5537409|NCT01345019|19140072|P2|Open Label Treatment Phase|Protocol Violation|1
5537410|NCT01345019|19140073|P1|Open Label Treatment Phase|Protocol Violation|0
5537411|NCT01345019|19140072|P2|Open Label Treatment Phase|Other, Not Specified|7
5537412|NCT01345019|19140073|P1|Open Label Treatment Phase|Other, Not Specified|9
5537413|NCT01345019|19140072|P2|Open Label Treatment Phase|Pregnancy|0
5537414|NCT01345019|19140073|P1|Open Label Treatment Phase|Pregnancy|1
5537415|NCT01345019|19140072|P2|Open Label Treatment Phase|Lost to Follow-up|2
5537416|NCT01345019|19140073|P1|Open Label Treatment Phase|Lost to Follow-up|1
5537417|NCT01345019|19140072|P2|Open Label Treatment Phase|Noncompliance|4
5537418|NCT01345019|19140073|P1|Open Label Treatment Phase|Noncompliance|5
5537419|NCT01345019|19140072|P2|Open Label Treatment Phase|Disease Progression|18
5537420|NCT01345019|19140073|P1|Open Label Treatment Phase|Disease Progression|17
5537421|NCT01345019|19140072|P2|Open Label Treatment Phase|Administrative Decision|15
5537422|NCT01345019|19140073|P1|Open Label Treatment Phase|Administrative Decision|30
5537423|NCT01345019|19140072|P2|Open Label Treatment Phase|Adverse Event|51
5537424|NCT01345019|19140073|P1|Open Label Treatment Phase|Adverse Event|30
5537425|NCT01345019|19140072|P2|Open Label Treatment Phase|Withdrawal by Subject|47
5537426|NCT01345019|19140073|P1|Open Label Treatment Phase|Withdrawal by Subject|49
5537427|NCT01345019|19140072|P2|Open Label Treatment Phase|Death|48
5537428|NCT01345019|19140073|P1|Open Label Treatment Phase|Death|49
5537429|NCT01345019|19140072|P2|Blinded Treatment Phase|Lost to Follow-up|3
5537430|NCT01345019|19140073|P1|Blinded Treatment Phase|Lost to Follow-up|6
5537431|NCT01345019|19140072|P2|Blinded Treatment Phase|Other, Not Specified|3
5537432|NCT01345019|19140073|P1|Blinded Treatment Phase|Other, Not Specified|2
5537433|NCT01345019|19140072|P2|Blinded Treatment Phase|Protocol Deviation|0
5537434|NCT01345019|19140073|P1|Blinded Treatment Phase|Protocol Deviation|5
5537435|NCT01345019|19140072|P2|Blinded Treatment Phase|Ineligibility Determined|6
5537436|NCT01345019|19140073|P1|Blinded Treatment Phase|Ineligibility Determined|1
5537437|NCT01345019|19140072|P2|Blinded Treatment Phase|Noncompliance|3
5537438|NCT01345019|19140073|P1|Blinded Treatment Phase|Noncompliance|5
5537439|NCT01345019|19140072|P2|Blinded Treatment Phase|Administrative Decision|8
5537440|NCT01345019|19140073|P1|Blinded Treatment Phase|Administrative Decision|10
5537441|NCT01345019|19140072|P2|Blinded Treatment Phase|Adverse Event|13
5537442|NCT01345019|19140073|P1|Blinded Treatment Phase|Adverse Event|6
5537443|NCT01345019|19140072|P2|Blinded Treatment Phase|Disease Progression|10
5537444|NCT01345019|19140073|P1|Blinded Treatment Phase|Disease Progression|12
5537445|NCT01345019|19140072|P2|Blinded Treatment Phase|Completed Survival Follow-up|9
5537446|NCT01345019|19140073|P1|Blinded Treatment Phase|Completed Survival Follow-up|21
5537447|NCT01345019|19140072|P2|Blinded Treatment Phase|Withdrawal by Subject|112
5537448|NCT01345019|19140073|P1|Blinded Treatment Phase|Withdrawal by Subject|103
5537449|NCT01345019|19140072|P2|Blinded Treatment Phase|Death|137
5537450|NCT01345019|19140073|P1|Blinded Treatment Phase|Death|147
5537451|NCT01344876|19140095|P5|Overall Study|Definite progression of primary disease|0
5537452|NCT01344876|19140096|P4|Overall Study|Definite progression of primary disease|3
5537453|NCT01344876|19140097|P3|Overall Study|Definite progression of primary disease|0
5537454|NCT01344876|19140098|P2|Overall Study|Definite progression of primary disease|0
5537455|NCT01344876|19140099|P1|Overall Study|Definite progression of primary disease|1
5537456|NCT01344876|19140095|P5|Overall Study|Withdrawal by Subject|0
5537457|NCT01344876|19140096|P4|Overall Study|Withdrawal by Subject|0
5537458|NCT01344876|19140097|P3|Overall Study|Withdrawal by Subject|1
5537459|NCT01344876|19140098|P2|Overall Study|Withdrawal by Subject|0
5537460|NCT01344876|19140099|P1|Overall Study|Withdrawal by Subject|0
5537461|NCT01344876|19140095|P5|Overall Study|Adverse Event|1
5537462|NCT01344876|19140096|P4|Overall Study|Adverse Event|0
5537463|NCT01344876|19140097|P3|Overall Study|Adverse Event|0
5537464|NCT01344876|19140098|P2|Overall Study|Adverse Event|0
5537465|NCT01344876|19140099|P1|Overall Study|Adverse Event|0
5537466|NCT01344824|19140113|P1|Overall Study|Progression|15
5537467|NCT01344824|19140113|P1|Overall Study|Other complicating disease|1
5537468|NCT01344824|19140113|P1|Overall Study|Withdrawal by Subject|6
5537469|NCT01344824|19140113|P1|Overall Study|Adverse Event|15
5537470|NCT01344759|19140121|P2|Overall Study|Patients failed to reach sedation level|2
5537471|NCT01344759|19140122|P1|Overall Study|Patients failed to reach sedation level|0
5537472|NCT01344629|19140154|P2|Crossover Period 2|Withdrawal by Subject|1
5537473|NCT01344629|19140155|P1|Crossover Period 2|Withdrawal by Subject|0
5537474|NCT01344538|19140184|P2|Overall Study|Lost to Follow-up|0
5537475|NCT01344538|19140185|P1|Overall Study|Lost to Follow-up|1
5537476|NCT01344538|19140184|P2|Overall Study|Adverse Event|1
5537477|NCT01344538|19140185|P1|Overall Study|Adverse Event|1
5537478|NCT01344460|19140191|P1|Overall Study|Lost to Follow-up|2
5537479|NCT01344460|19140191|P1|Overall Study|Withdrawal by Subject|1
5537480|NCT01344447|19140236|P1|Overall Study|Error of power injector|1
5537481|NCT01344447|19140236|P1|Overall Study|Bolus tracking failed|1
5537482|NCT01344447|19140236|P1|Overall Study|MRA unsuccessful|1
5537483|NCT01344447|19140236|P1|Overall Study|Physician Decision|1
5537484|NCT01344447|19140236|P1|Overall Study|The contrast was not seen|1
5537485|NCT01344447|19140236|P1|Overall Study|Withdrawal by Subject|1
5537486|NCT01344447|19140236|P1|Overall Study|Protocol Violation|1
5537487|NCT01344447|19140236|P1|Overall Study|Adverse Event|1
5537488|NCT01344369|19140280|P2|Second Intervention|Emesis within 2 x Tmax|1
5537489|NCT01344369|19140281|P1|Second Intervention|Emesis within 2 x Tmax|0
5537490|NCT01344369|19140280|P2|Washout of 28 Days|Physician Decision|1
5537491|NCT01344369|19140281|P1|Washout of 28 Days|Physician Decision|0
5537492|NCT01344369|19140280|P2|Washout of 28 Days|Withdrawal by Subject|0
5537493|NCT01344369|19140281|P1|Washout of 28 Days|Withdrawal by Subject|1
5537494|NCT01344356|19140299|P2|Overall Study|Lost to Follow-up|6
5537495|NCT01344356|19140300|P1|Overall Study|Lost to Follow-up|0
5537496|NCT01344356|19140299|P2|Overall Study|Physician Decision|3
5537497|NCT01344356|19140300|P1|Overall Study|Physician Decision|0
5537498|NCT01344226|19140312|P1|Overall Study|Lack of Efficacy|3
5537499|NCT01344226|19140312|P1|Overall Study|Withdrawal by Subject|3
5537500|NCT01344226|19140312|P1|Overall Study|Protocol Violation|2
5537501|NCT01344161|19140321|P2|Overall Study|Protocol Violation|1
5537502|NCT01344161|19140322|P1|Overall Study|Protocol Violation|1
5537503|NCT01344161|19140321|P2|Overall Study|Pregnancy|1
5537504|NCT01344161|19140322|P1|Overall Study|Pregnancy|0
5537505|NCT01344161|19140321|P2|Overall Study|Lost to Follow-up|1
5537506|NCT01344161|19140322|P1|Overall Study|Lost to Follow-up|4
5537507|NCT01344057|19140334|P1|Overall Study|Premature Withdrawal|1
5537508|NCT01343901|19140341|P1|Overall Study|Participant decision|1
5537509|NCT01343901|19140341|P1|Overall Study|Management by another medical team|11
5537510|NCT01343901|19140341|P1|Overall Study|Lost to Follow-up|12
5537511|NCT01343901|19140341|P1|Overall Study|Physician Decision|4
5537512|NCT01343901|19140341|P1|Overall Study|Death|85
5537513|NCT01343888|19140365|P3|Overall Study|other than stated above|1
5537514|NCT01343888|19140366|P2|Overall Study|other than stated above|0
5537515|NCT01343888|19140367|P1|Overall Study|other than stated above|0
5537516|NCT01343888|19140365|P3|Overall Study|Withdrawal by Subject|2
5537517|NCT01343888|19140366|P2|Overall Study|Withdrawal by Subject|4
5537518|NCT01343888|19140367|P1|Overall Study|Withdrawal by Subject|4
5537519|NCT01343888|19140365|P3|Overall Study|Protocol Violation|0
5537520|NCT01343888|19140366|P2|Overall Study|Protocol Violation|2
5537521|NCT01343888|19140367|P1|Overall Study|Protocol Violation|0
5537522|NCT01343888|19140365|P3|Overall Study|Lost to Follow-up|1
5537523|NCT01343888|19140366|P2|Overall Study|Lost to Follow-up|2
5537524|NCT01343888|19140367|P1|Overall Study|Lost to Follow-up|0
5537525|NCT01343888|19140365|P3|Overall Study|Lack of Efficacy|13
5537526|NCT01343888|19140366|P2|Overall Study|Lack of Efficacy|9
5537527|NCT01343888|19140367|P1|Overall Study|Lack of Efficacy|9
5537528|NCT01343888|19140365|P3|Overall Study|Adverse Event|5
5537529|NCT01343888|19140366|P2|Overall Study|Adverse Event|22
5537530|NCT01343888|19140367|P1|Overall Study|Adverse Event|12
5537531|NCT01343823|19140409|P4|Overall Study|Withdrawal by Subject|0
5537532|NCT01343823|19140410|P3|Overall Study|Withdrawal by Subject|0
5537533|NCT01343823|19140411|P2|Overall Study|Withdrawal by Subject|0
5537534|NCT01343823|19140412|P1|Overall Study|Withdrawal by Subject|1
5537535|NCT01343823|19140409|P4|Overall Study|Study Terminated|1
5537536|NCT01343823|19140410|P3|Overall Study|Study Terminated|0
5537537|NCT01343823|19140411|P2|Overall Study|Study Terminated|0
5537538|NCT01343823|19140412|P1|Overall Study|Study Terminated|1
5537539|NCT01343693|19140426|P1|Overall Study|Lost to Follow-up|9
5537540|NCT01343407|19140449|P6|Second Washout (Part 2)|Withdrawal by Subject|0
5537541|NCT01343407|19140450|P5|Second Washout (Part 2)|Withdrawal by Subject|0
5537542|NCT01343407|19140451|P4|Second Washout (Part 2)|Withdrawal by Subject|0
5537543|NCT01343407|19140452|P3|Second Washout (Part 2)|Withdrawal by Subject|1
5537544|NCT01343407|19140453|P2|Second Washout (Part 2)|Withdrawal by Subject|0
5537545|NCT01343407|19140454|P1|Second Washout (Part 2)|Withdrawal by Subject|0
5537546|NCT01343407|19140449|P6|Second Treatment Period (Part 2)|Adverse Event|0
5537547|NCT01343407|19140450|P5|Second Treatment Period (Part 2)|Adverse Event|0
5537548|NCT01343407|19140451|P4|Second Treatment Period (Part 2)|Adverse Event|0
5537549|NCT01343407|19140452|P3|Second Treatment Period (Part 2)|Adverse Event|1
5537550|NCT01343407|19140453|P2|Second Treatment Period (Part 2)|Adverse Event|0
5537551|NCT01343407|19140454|P1|Second Treatment Period (Part 2)|Adverse Event|0
5537552|NCT01343368|19140482|P2|Overall Study|Lost to Follow-up|0
5537553|NCT01343368|19140483|P1|Overall Study|Lost to Follow-up|1
5537554|NCT01343368|19140482|P2|Overall Study|Death|0
5537555|NCT01343368|19140483|P1|Overall Study|Death|1
5537556|NCT01343277|19140519|P2|Overall Study|Subsequent anticancer therapy|0
5537557|NCT01343277|19140520|P1|Overall Study|Subsequent anticancer therapy|1
5537558|NCT01343277|19140519|P2|Overall Study|Treatment ongoing|2
5537559|NCT01343277|19140520|P1|Overall Study|Treatment ongoing|8
5537560|NCT01343277|19140519|P2|Overall Study|Randomized not treated|21
5537561|NCT01343277|19140520|P1|Overall Study|Randomized not treated|6
5537562|NCT01343277|19140519|P2|Overall Study|Disease progression|138
5537563|NCT01343277|19140520|P1|Overall Study|Disease progression|270
5537564|NCT01343277|19140519|P2|Overall Study|Adverse Event|13
5537565|NCT01343277|19140520|P1|Overall Study|Adverse Event|67
5537566|NCT01343277|19140519|P2|Overall Study|Death|1
5537567|NCT01343277|19140520|P1|Overall Study|Death|10
5537568|NCT01343277|19140519|P2|Overall Study|Physician Decision|2
5537569|NCT01343277|19140520|P1|Overall Study|Physician Decision|1
5537570|NCT01343277|19140519|P2|Overall Study|Withdrawal by Subject|13
5537571|NCT01343277|19140520|P1|Overall Study|Withdrawal by Subject|18
5537572|NCT01343277|19140519|P2|Overall Study|Other|3
5537573|NCT01343277|19140520|P1|Overall Study|Other|3
5537574|NCT01343082|19140581|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
5537575|NCT01343082|19140582|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
5537576|NCT01343082|19140583|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
5537577|NCT01343082|19140581|P3|Treatment Period , Switched to DE-111|Physician Decision|2
5537578|NCT01343082|19140582|P2|Treatment Period , Switched to DE-111|Physician Decision|2
5537579|NCT01343082|19140583|P1|Treatment Period , Switched to DE-111|Physician Decision|0
5537580|NCT01343082|19140581|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
5537581|NCT01343082|19140582|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
5537582|NCT01343082|19140583|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
5537583|NCT01343082|19140581|P3|Treatment Period , Switched to DE-111|Adverse Event|3
5537584|NCT01343082|19140582|P2|Treatment Period , Switched to DE-111|Adverse Event|4
5537585|NCT01343082|19140583|P1|Treatment Period , Switched to DE-111|Adverse Event|1
5537586|NCT01343082|19140581|P3|The run-in Period|Not meeting criteria|5
5537587|NCT01343082|19140582|P2|The run-in Period|Not meeting criteria|4
5537588|NCT01343082|19140583|P1|The run-in Period|Not meeting criteria|3
5537589|NCT01343056|19140591|P4|Overall Study|Lost to Follow-up|9
5537590|NCT01343056|19140592|P3|Overall Study|Lost to Follow-up|3
5537591|NCT01343056|19140593|P2|Overall Study|Lost to Follow-up|5
5537592|NCT01343056|19140594|P1|Overall Study|Lost to Follow-up|7
5537593|NCT01343043|19140636|P4|Overall Study|Death|1
5537594|NCT01343043|19140637|P3|Overall Study|Death|0
5537595|NCT01343043|19140638|P2|Overall Study|Death|1
5537596|NCT01343043|19140639|P1|Overall Study|Death|1
5537597|NCT01343043|19140636|P4|Overall Study|Withdrawal by Subject|0
5537598|NCT01343043|19140637|P3|Overall Study|Withdrawal by Subject|0
5537599|NCT01343043|19140638|P2|Overall Study|Withdrawal by Subject|0
5537600|NCT01343043|19140639|P1|Overall Study|Withdrawal by Subject|1
5537601|NCT01343043|19140636|P4|Overall Study|Disease progression before treatment|0
5537602|NCT01343043|19140637|P3|Overall Study|Disease progression before treatment|0
5537603|NCT01343043|19140638|P2|Overall Study|Disease progression before treatment|0
5537604|NCT01343043|19140639|P1|Overall Study|Disease progression before treatment|1
5537605|NCT01342965|19140727|P2|Overall Study|Withdrawal by Subject|9
5537606|NCT01342965|19140728|P1|Overall Study|Withdrawal by Subject|2
5537607|NCT01342965|19140727|P2|Overall Study|Other Reasons- Unspecified|38
5537608|NCT01342965|19140728|P1|Overall Study|Other Reasons- Unspecified|44
5537609|NCT01342965|19140727|P2|Overall Study|Lost to Follow-up|3
5537610|NCT01342965|19140728|P1|Overall Study|Lost to Follow-up|5
5537611|NCT01342965|19140727|P2|Overall Study|Death|57
5537612|NCT01342965|19140728|P1|Overall Study|Death|58
5537613|NCT01342926|19140746|P4|Overall Study|Withdrawal by Subject|5
5537614|NCT01342926|19140747|P3|Overall Study|Withdrawal by Subject|3
5537615|NCT01342926|19140748|P2|Overall Study|Withdrawal by Subject|4
5537616|NCT01342926|19140749|P1|Overall Study|Withdrawal by Subject|2
5537617|NCT01342926|19140746|P4|Overall Study|Investigator Discretion|0
5537618|NCT01342926|19140747|P3|Overall Study|Investigator Discretion|0
5537619|NCT01342926|19140748|P2|Overall Study|Investigator Discretion|2
5537620|NCT01342926|19140749|P1|Overall Study|Investigator Discretion|2
5537621|NCT01342926|19140746|P4|Overall Study|Lost to Follow-up|0
5537622|NCT01342926|19140747|P3|Overall Study|Lost to Follow-up|1
5537623|NCT01342926|19140748|P2|Overall Study|Lost to Follow-up|1
5537624|NCT01342926|19140749|P1|Overall Study|Lost to Follow-up|0
5537625|NCT01342926|19140746|P4|Overall Study|Adverse Event|7
5537626|NCT01342926|19140747|P3|Overall Study|Adverse Event|10
5537627|NCT01342926|19140748|P2|Overall Study|Adverse Event|8
5537628|NCT01342926|19140749|P1|Overall Study|Adverse Event|5
5537629|NCT01342913|19140829|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
5537630|NCT01342913|19140830|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
5537631|NCT01342913|19140831|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5537632|NCT01342913|19140829|P3|Double-Blind Treatment Period|Physician Decision|0
5537633|NCT01342913|19140830|P2|Double-Blind Treatment Period|Physician Decision|2
5537634|NCT01342913|19140831|P1|Double-Blind Treatment Period|Physician Decision|0
5537635|NCT01342913|19140829|P3|Double-Blind Treatment Period|Lost to Follow-up|3
5537636|NCT01342913|19140830|P2|Double-Blind Treatment Period|Lost to Follow-up|1
5537637|NCT01342913|19140831|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5537638|NCT01342913|19140829|P3|Double-Blind Treatment Period|Protocol Violation|9
5537639|NCT01342913|19140830|P2|Double-Blind Treatment Period|Protocol Violation|6
5537640|NCT01342913|19140831|P1|Double-Blind Treatment Period|Protocol Violation|0
5537641|NCT01342913|19140829|P3|Double-Blind Treatment Period|Lack of Efficacy|3
5537642|NCT01342913|19140830|P2|Double-Blind Treatment Period|Lack of Efficacy|2
5537643|NCT01342913|19140831|P1|Double-Blind Treatment Period|Lack of Efficacy|0
5537644|NCT01342913|19140829|P3|Double-Blind Treatment Period|Adverse Event|6
5537645|NCT01342913|19140830|P2|Double-Blind Treatment Period|Adverse Event|3
5537646|NCT01342913|19140831|P1|Double-Blind Treatment Period|Adverse Event|0
5537647|NCT01342913|19140829|P3|2-week Run-in Period|Continuation Criteria Not Met|0
5537648|NCT01342913|19140830|P2|2-week Run-in Period|Continuation Criteria Not Met|0
5537649|NCT01342913|19140831|P1|2-week Run-in Period|Continuation Criteria Not Met|88
5537650|NCT01342913|19140829|P3|2-week Run-in Period|Protocol Violation|0
5537651|NCT01342913|19140830|P2|2-week Run-in Period|Protocol Violation|0
5537652|NCT01342913|19140831|P1|2-week Run-in Period|Protocol Violation|5
5537653|NCT01342913|19140829|P3|2-week Run-in Period|Adverse Event|0
5537654|NCT01342913|19140830|P2|2-week Run-in Period|Adverse Event|0
5537655|NCT01342913|19140831|P1|2-week Run-in Period|Adverse Event|2
5537656|NCT01342913|19140829|P3|2-week Run-in Period|Withdrawal by Subject|0
5537657|NCT01342913|19140830|P2|2-week Run-in Period|Withdrawal by Subject|0
5537658|NCT01342913|19140831|P1|2-week Run-in Period|Withdrawal by Subject|7
5537659|NCT01342913|19140829|P3|2-week Run-in Period|Physician Decision|0
5537660|NCT01342913|19140830|P2|2-week Run-in Period|Physician Decision|0
5537661|NCT01342913|19140831|P1|2-week Run-in Period|Physician Decision|6
5537662|NCT01342913|19140829|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5537663|NCT01342913|19140830|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
5537664|NCT01342913|19140831|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
5537665|NCT01342887|19140841|P1|Overall Study|Death|2
5537666|NCT01342640|19140882|P1|Overall Study|Other|1
5537667|NCT01342640|19140882|P1|Overall Study|Lost to Follow-up|21
5537668|NCT01342640|19140882|P1|Overall Study|Protocol Violation|16
5537669|NCT01342640|19140882|P1|Overall Study|Adverse Event|3
5537670|NCT01342510|19140977|P4|Overall Study|Protocol Violation|11
5537671|NCT01342510|19140978|P3|Overall Study|Protocol Violation|13
5537672|NCT01342510|19140979|P2|Overall Study|Protocol Violation|6
5537673|NCT01342510|19140980|P1|Overall Study|Protocol Violation|12
5537674|NCT01342484|19140997|P3|Overall Study|Withdrawal by Subject|0
5537675|NCT01342484|19140998|P2|Overall Study|Withdrawal by Subject|0
5537676|NCT01342484|19140999|P1|Overall Study|Withdrawal by Subject|1
5537677|NCT01342484|19140997|P3|Overall Study|Protocol Violation|1
5537678|NCT01342484|19140998|P2|Overall Study|Protocol Violation|0
5537679|NCT01342484|19140999|P1|Overall Study|Protocol Violation|0
5537680|NCT01342484|19140997|P3|Overall Study|Other Reasons|0
5537681|NCT01342484|19140998|P2|Overall Study|Other Reasons|0
5537682|NCT01342484|19140999|P1|Overall Study|Other Reasons|1
5537683|NCT01342445|19141055|P2|Overall Study|Experienced side effects|2
5537684|NCT01342445|19141056|P1|Overall Study|Experienced side effects|0
5537685|NCT01342341|19141072|P2|Overall Study|Lost to Follow-up|4
5537686|NCT01342341|19141073|P1|Overall Study|Lost to Follow-up|4
5537687|NCT01342211|19141084|P5|Overall Study|Randomized, but not Treated|1
5537688|NCT01342211|19141085|P4|Overall Study|Randomized, but not Treated|0
5537689|NCT01342211|19141086|P3|Overall Study|Randomized, but not Treated|0
5537690|NCT01342211|19141087|P2|Overall Study|Randomized, but not Treated|2
5537691|NCT01342211|19141088|P1|Overall Study|Randomized, but not Treated|0
5537692|NCT01342211|19141084|P5|Overall Study|Withdrawal by Subject|0
5537693|NCT01342211|19141085|P4|Overall Study|Withdrawal by Subject|1
5537694|NCT01342211|19141086|P3|Overall Study|Withdrawal by Subject|0
5537695|NCT01342211|19141087|P2|Overall Study|Withdrawal by Subject|0
5537696|NCT01342211|19141088|P1|Overall Study|Withdrawal by Subject|0
5537697|NCT01342211|19141084|P5|Overall Study|Adverse Event|1
5537698|NCT01342211|19141085|P4|Overall Study|Adverse Event|0
5537699|NCT01342211|19141086|P3|Overall Study|Adverse Event|0
5537700|NCT01342211|19141087|P2|Overall Study|Adverse Event|0
5537701|NCT01342211|19141088|P1|Overall Study|Adverse Event|0
5537702|NCT01342211|19141084|P5|Overall Study|Lost to Follow-up|0
5537703|NCT01342211|19141085|P4|Overall Study|Lost to Follow-up|1
5537704|NCT01342211|19141086|P3|Overall Study|Lost to Follow-up|0
5537705|NCT01342211|19141087|P2|Overall Study|Lost to Follow-up|0
5537706|NCT01342211|19141088|P1|Overall Study|Lost to Follow-up|0
5537707|NCT01342094|19141176|P2|Overall Study|Withdrawal by Subject|2
5537708|NCT01342094|19141177|P1|Overall Study|Withdrawal by Subject|0
5537709|NCT01342094|19141176|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
5537710|NCT01342094|19141177|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
5537711|NCT01342094|19141176|P2|Overall Study|Adverse Event|0
5537712|NCT01342094|19141177|P1|Overall Study|Adverse Event|5
5537713|NCT01342081|19141186|P3|Overall Study|Withdrawal by Subject|0
5537714|NCT01342081|19141187|P2|Overall Study|Withdrawal by Subject|1
5537715|NCT01342081|19141188|P1|Overall Study|Withdrawal by Subject|1
5537716|NCT01342081|19141186|P3|Overall Study|Physician Decision|0
5537717|NCT01342081|19141187|P2|Overall Study|Physician Decision|1
5537718|NCT01342081|19141188|P1|Overall Study|Physician Decision|0
5537719|NCT01342081|19141186|P3|Overall Study|Adverse Event|0
5537720|NCT01342081|19141187|P2|Overall Study|Adverse Event|0
5537721|NCT01342081|19141188|P1|Overall Study|Adverse Event|1
5537722|NCT01342081|19141186|P3|Overall Study|Did not receive allocated intervention|1
5537723|NCT01342081|19141187|P2|Overall Study|Did not receive allocated intervention|0
5537724|NCT01342081|19141188|P1|Overall Study|Did not receive allocated intervention|0
5537725|NCT01341990|19141207|P2|Overall Study|Withdrawal by Subject|0
5537726|NCT01341990|19141208|P1|Overall Study|Withdrawal by Subject|2
5537727|NCT01341990|19141207|P2|Overall Study|Torn Study Lens|0
5537728|NCT01341990|19141208|P1|Overall Study|Torn Study Lens|1
5537729|NCT01341990|19141207|P2|Overall Study|Adverse Event|1
5537730|NCT01341990|19141208|P1|Overall Study|Adverse Event|0
5537731|NCT01341782|19141232|P2|Overall Study|Other|0
5537732|NCT01341782|19141233|P1|Overall Study|Other|5
5537733|NCT01341782|19141232|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
5537734|NCT01341782|19141233|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
5537735|NCT01341782|19141232|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
5537736|NCT01341782|19141233|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
5537737|NCT01341782|19141232|P2|Overall Study|Missed 3 consecutive doses|4
5537738|NCT01341782|19141233|P1|Overall Study|Missed 3 consecutive doses|0
5537739|NCT01341782|19141232|P2|Overall Study|Withdrawal by Subject|5
5537740|NCT01341782|19141233|P1|Overall Study|Withdrawal by Subject|6
5537741|NCT01341782|19141232|P2|Overall Study|Adverse Event|1
5537742|NCT01341782|19141233|P1|Overall Study|Adverse Event|1
5537743|NCT01341652|19141262|P2|Overall Study|ineligible; presence metastatic disease|1
5537744|NCT01341652|19141263|P1|Overall Study|ineligible; presence metastatic disease|0
5537745|NCT01341652|19141262|P2|Overall Study|Incorrect Random Assignment|1
5537746|NCT01341652|19141263|P1|Overall Study|Incorrect Random Assignment|0
5537747|NCT01341639|19141279|P2|Post-Treatment|Adverse Event|2
5537748|NCT01341639|19141280|P1|Post-Treatment|Adverse Event|0
5537749|NCT01341639|19141279|P2|Post-Treatment|Withdrawal by Subject|1
5537750|NCT01341639|19141280|P1|Post-Treatment|Withdrawal by Subject|0
5537751|NCT01341639|19141279|P2|Interim Period|Protocol Violation|1
5537752|NCT01341639|19141280|P1|Interim Period|Protocol Violation|0
5537753|NCT01341639|19141279|P2|Interim Period|Physician Decision|1
5537754|NCT01341639|19141280|P1|Interim Period|Physician Decision|0
5537755|NCT01341639|19141279|P2|Interim Period|Lost to Follow-up|0
5537756|NCT01341639|19141280|P1|Interim Period|Lost to Follow-up|2
5537757|NCT01341639|19141279|P2|Interim Period|Withdrawal by Subject|7
5537758|NCT01341639|19141280|P1|Interim Period|Withdrawal by Subject|6
5537759|NCT01341639|19141279|P2|Infant Series|Site 0048 Participants|16
5537760|NCT01341639|19141280|P1|Infant Series|Site 0048 Participants|17
5537761|NCT01341639|19141279|P2|Infant Series|Lost to Follow-up|2
5537762|NCT01341639|19141280|P1|Infant Series|Lost to Follow-up|0
5537763|NCT01341639|19141279|P2|Infant Series|Withdrawal by Subject|8
5537764|NCT01341639|19141280|P1|Infant Series|Withdrawal by Subject|11
5537765|NCT01341639|19141279|P2|Infant Series|Adverse Event|5
5537766|NCT01341639|19141280|P1|Infant Series|Adverse Event|0
5537767|NCT01341639|19141279|P2|Infant Series|Not Vaccinated|1
5537768|NCT01341639|19141280|P1|Infant Series|Not Vaccinated|0
5537769|NCT01341639|19141279|P2|Infant Series|Protocol Violation|0
5537770|NCT01341639|19141280|P1|Infant Series|Protocol Violation|1
5537771|NCT01341587|19141325|P2|Overall Study|stopped using the meters|10
5537772|NCT01341587|19141326|P1|Overall Study|stopped using the meters|2
5537773|NCT01341587|19141325|P2|Overall Study|Lost to Follow-up|0
5537774|NCT01341587|19141326|P1|Overall Study|Lost to Follow-up|2
5537775|NCT01341470|19141338|P6|Overall Study|Sponsor decision|1
5537776|NCT01341470|19141339|P5|Overall Study|Sponsor decision|0
5537777|NCT01341470|19141340|P4|Overall Study|Sponsor decision|1
5537778|NCT01341470|19141341|P3|Overall Study|Sponsor decision|1
5537779|NCT01341470|19141342|P2|Overall Study|Sponsor decision|0
5537780|NCT01341470|19141343|P1|Overall Study|Sponsor decision|0
5537781|NCT01341457|19141377|P2|Overall Study|Adverse Event|0
5537782|NCT01341457|19141378|P1|Overall Study|Adverse Event|2
5537783|NCT01340976|19141423|P6|Overall Study|Adverse Event|0
5537784|NCT01340976|19141424|P5|Overall Study|Adverse Event|0
5537785|NCT01340976|19141425|P4|Overall Study|Adverse Event|0
5537786|NCT01340976|19141426|P3|Overall Study|Adverse Event|0
5537787|NCT01340976|19141427|P2|Overall Study|Adverse Event|1
5537788|NCT01340976|19141428|P1|Overall Study|Adverse Event|0
5537789|NCT01340976|19141423|P6|Overall Study|Other anemia treatment|1
5537790|NCT01340976|19141424|P5|Overall Study|Other anemia treatment|0
5537791|NCT01340976|19141425|P4|Overall Study|Other anemia treatment|1
5537792|NCT01340976|19141426|P3|Overall Study|Other anemia treatment|2
5537793|NCT01340976|19141427|P2|Overall Study|Other anemia treatment|0
5537794|NCT01340976|19141428|P1|Overall Study|Other anemia treatment|1
5537795|NCT01340976|19141423|P6|Overall Study|Withdrawal by Subject|0
5537796|NCT01340976|19141424|P5|Overall Study|Withdrawal by Subject|1
5537797|NCT01340976|19141425|P4|Overall Study|Withdrawal by Subject|1
5537798|NCT01340976|19141426|P3|Overall Study|Withdrawal by Subject|0
5537799|NCT01340976|19141427|P2|Overall Study|Withdrawal by Subject|0
5537800|NCT01340976|19141428|P1|Overall Study|Withdrawal by Subject|0
5537801|NCT01340976|19141423|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5537802|NCT01340976|19141424|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5537803|NCT01340976|19141425|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5537804|NCT01340976|19141426|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5537805|NCT01340976|19141427|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
5537806|NCT01340976|19141428|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
5537807|NCT01340976|19141423|P6|Overall Study|Death|0
5537808|NCT01340976|19141424|P5|Overall Study|Death|0
5537809|NCT01340976|19141425|P4|Overall Study|Death|0
5537810|NCT01340976|19141426|P3|Overall Study|Death|0
5537811|NCT01340976|19141427|P2|Overall Study|Death|1
5537812|NCT01340976|19141428|P1|Overall Study|Death|0
5537813|NCT01340976|19141423|P6|Overall Study|Physician Decision|0
5537814|NCT01340976|19141424|P5|Overall Study|Physician Decision|1
5537815|NCT01340976|19141425|P4|Overall Study|Physician Decision|1
5537816|NCT01340976|19141426|P3|Overall Study|Physician Decision|1
5537817|NCT01340976|19141427|P2|Overall Study|Physician Decision|0
5537818|NCT01340976|19141428|P1|Overall Study|Physician Decision|2
5537819|NCT01340937|19141466|P4|Period 3: Toddler Vaccinations|Technical problem|0
5537820|NCT01340937|19141467|P3|Period 3: Toddler Vaccinations|Technical problem|1
5537821|NCT01340937|19141468|P2|Period 3: Toddler Vaccinations|Technical problem|1
5537822|NCT01340937|19141469|P1|Period 3: Toddler Vaccinations|Technical problem|1
5537823|NCT01340937|19141466|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
5537824|NCT01340937|19141467|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
5537825|NCT01340937|19141468|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
5537826|NCT01340937|19141469|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
5537827|NCT01340937|19141466|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
5537828|NCT01340937|19141467|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
5537829|NCT01340937|19141468|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
5537830|NCT01340937|19141469|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
5537831|NCT01340937|19141466|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
5537832|NCT01340937|19141467|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
5537833|NCT01340937|19141468|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
5537834|NCT01340937|19141469|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
5537835|NCT01340937|19141466|P4|Period 2: Interim Period|Technical problems|3
5537836|NCT01340937|19141467|P3|Period 2: Interim Period|Technical problems|6
5537837|NCT01340937|19141468|P2|Period 2: Interim Period|Technical problems|4
5537838|NCT01340937|19141469|P1|Period 2: Interim Period|Technical problems|4
5537839|NCT01340937|19141466|P4|Period 2: Interim Period|Protocol Violation|3
5537840|NCT01340937|19141467|P3|Period 2: Interim Period|Protocol Violation|6
5537841|NCT01340937|19141468|P2|Period 2: Interim Period|Protocol Violation|3
5537842|NCT01340937|19141469|P1|Period 2: Interim Period|Protocol Violation|5
5537843|NCT01340937|19141466|P4|Period 2: Interim Period|Physician Decision|0
5537844|NCT01340937|19141467|P3|Period 2: Interim Period|Physician Decision|1
5537845|NCT01340937|19141468|P2|Period 2: Interim Period|Physician Decision|1
5537846|NCT01340937|19141469|P1|Period 2: Interim Period|Physician Decision|0
5537847|NCT01340937|19141466|P4|Period 2: Interim Period|Lost to Follow-up|23
5537848|NCT01340937|19141467|P3|Period 2: Interim Period|Lost to Follow-up|53
5537849|NCT01340937|19141468|P2|Period 2: Interim Period|Lost to Follow-up|48
5537850|NCT01340937|19141469|P1|Period 2: Interim Period|Lost to Follow-up|29
5537851|NCT01340937|19141466|P4|Period 2: Interim Period|Adverse Event|0
5537852|NCT01340937|19141467|P3|Period 2: Interim Period|Adverse Event|1
5537853|NCT01340937|19141468|P2|Period 2: Interim Period|Adverse Event|0
5537854|NCT01340937|19141469|P1|Period 2: Interim Period|Adverse Event|1
5537855|NCT01340937|19141466|P4|Period 2: Interim Period|Withdrawal by Subject|12
5537856|NCT01340937|19141467|P3|Period 2: Interim Period|Withdrawal by Subject|17
5537857|NCT01340937|19141468|P2|Period 2: Interim Period|Withdrawal by Subject|23
5537858|NCT01340937|19141469|P1|Period 2: Interim Period|Withdrawal by Subject|28
5537859|NCT01340937|19141466|P4|Period 1: Infant Series|Randomized but not vaccinated|1
5537860|NCT01340937|19141467|P3|Period 1: Infant Series|Randomized but not vaccinated|2
5537861|NCT01340937|19141468|P2|Period 1: Infant Series|Randomized but not vaccinated|5
5537862|NCT01340937|19141469|P1|Period 1: Infant Series|Randomized but not vaccinated|0
5537863|NCT01340937|19141466|P4|Period 1: Infant Series|Withdrawal by Subject|15
5537864|NCT01340937|19141467|P3|Period 1: Infant Series|Withdrawal by Subject|30
5537865|NCT01340937|19141468|P2|Period 1: Infant Series|Withdrawal by Subject|32
5537866|NCT01340937|19141469|P1|Period 1: Infant Series|Withdrawal by Subject|33
5537867|NCT01340937|19141466|P4|Period 1: Infant Series|Protocol Violation|3
5537868|NCT01340937|19141467|P3|Period 1: Infant Series|Protocol Violation|4
5537869|NCT01340937|19141468|P2|Period 1: Infant Series|Protocol Violation|4
5537870|NCT01340937|19141469|P1|Period 1: Infant Series|Protocol Violation|1
5537871|NCT01340937|19141466|P4|Period 1: Infant Series|Physician Decision|0
5537872|NCT01340937|19141467|P3|Period 1: Infant Series|Physician Decision|1
5537873|NCT01340937|19141468|P2|Period 1: Infant Series|Physician Decision|3
5537874|NCT01340937|19141469|P1|Period 1: Infant Series|Physician Decision|2
5537875|NCT01340937|19141466|P4|Period 1: Infant Series|Lost to Follow-up|13
5537876|NCT01340937|19141467|P3|Period 1: Infant Series|Lost to Follow-up|12
5537877|NCT01340937|19141468|P2|Period 1: Infant Series|Lost to Follow-up|14
5537878|NCT01340937|19141469|P1|Period 1: Infant Series|Lost to Follow-up|20
5537879|NCT01340937|19141466|P4|Period 1: Infant Series|Death|0
5537880|NCT01340937|19141467|P3|Period 1: Infant Series|Death|2
5537881|NCT01340937|19141468|P2|Period 1: Infant Series|Death|0
5537882|NCT01340937|19141469|P1|Period 1: Infant Series|Death|2
5537883|NCT01340937|19141466|P4|Period 1: Infant Series|Adverse Event|0
5537884|NCT01340937|19141467|P3|Period 1: Infant Series|Adverse Event|4
5537885|NCT01340937|19141468|P2|Period 1: Infant Series|Adverse Event|1
5537886|NCT01340937|19141469|P1|Period 1: Infant Series|Adverse Event|0
5537887|NCT01340937|19141466|P4|Period 1: Infant Series|Other protocol criterion not met|0
5537888|NCT01340937|19141467|P3|Period 1: Infant Series|Other protocol criterion not met|1
5537889|NCT01340937|19141468|P2|Period 1: Infant Series|Other protocol criterion not met|1
5537890|NCT01340937|19141469|P1|Period 1: Infant Series|Other protocol criterion not met|0
5537891|NCT01340898|19141629|P3|Booster Phase|Lost to Follow-up|3
5537892|NCT01340898|19141630|P2|Booster Phase|Lost to Follow-up|2
5537893|NCT01340898|19141631|P1|Booster Phase|Lost to Follow-up|4
5537894|NCT01340898|19141629|P3|Booster Phase|Migrated/moved from study area|0
5537895|NCT01340898|19141630|P2|Booster Phase|Migrated/moved from study area|0
5537896|NCT01340898|19141631|P1|Booster Phase|Migrated/moved from study area|3
5537897|NCT01340898|19141629|P3|Booster Phase|Withdrawal by Subject|4
5537898|NCT01340898|19141630|P2|Booster Phase|Withdrawal by Subject|0
5537899|NCT01340898|19141631|P1|Booster Phase|Withdrawal by Subject|3
5537900|NCT01340898|19141629|P3|Primary Phase|Lost to Follow-up|0
5537901|NCT01340898|19141630|P2|Primary Phase|Lost to Follow-up|1
5537902|NCT01340898|19141631|P1|Primary Phase|Lost to Follow-up|4
5537903|NCT01340898|19141629|P3|Primary Phase|Migrated/moved from study area|0
5537904|NCT01340898|19141630|P2|Primary Phase|Migrated/moved from study area|1
5537905|NCT01340898|19141631|P1|Primary Phase|Migrated/moved from study area|4
5537906|NCT01340898|19141629|P3|Primary Phase|Withdrawal by Subject|5
5537907|NCT01340898|19141630|P2|Primary Phase|Withdrawal by Subject|7
5537908|NCT01340898|19141631|P1|Primary Phase|Withdrawal by Subject|8
5537909|NCT01340898|19141629|P3|Primary Phase|Serious Adverse Events|1
5537910|NCT01340898|19141630|P2|Primary Phase|Serious Adverse Events|0
5537911|NCT01340898|19141631|P1|Primary Phase|Serious Adverse Events|0
5537912|NCT01340872|19141761|P4|Open-label Phase|Worsening of IBD|0
5537913|NCT01340872|19141762|P3|Open-label Phase|Worsening of IBD|1
5537914|NCT01340872|19141763|P2|Open-label Phase|Worsening of IBD|0
5537915|NCT01340872|19141764|P1|Open-label Phase|Worsening of IBD|0
5537916|NCT01340872|19141761|P4|Open-label Phase|Withdrawal by Subject|6
5537917|NCT01340872|19141762|P3|Open-label Phase|Withdrawal by Subject|1
5537918|NCT01340872|19141763|P2|Open-label Phase|Withdrawal by Subject|0
5537919|NCT01340872|19141764|P1|Open-label Phase|Withdrawal by Subject|0
5537920|NCT01340872|19141761|P4|Open-label Phase|Adverse Event|4
5537921|NCT01340872|19141762|P3|Open-label Phase|Adverse Event|8
5537922|NCT01340872|19141763|P2|Open-label Phase|Adverse Event|0
5537923|NCT01340872|19141764|P1|Open-label Phase|Adverse Event|0
5537924|NCT01340872|19141761|P4|Open-label Phase|Pregnancy|0
5537925|NCT01340872|19141762|P3|Open-label Phase|Pregnancy|1
5537926|NCT01340872|19141763|P2|Open-label Phase|Pregnancy|0
5537927|NCT01340872|19141764|P1|Open-label Phase|Pregnancy|0
5537928|NCT01340872|19141761|P4|Open-label Phase|Physician Decision|1
5537929|NCT01340872|19141762|P3|Open-label Phase|Physician Decision|2
5537930|NCT01340872|19141763|P2|Open-label Phase|Physician Decision|0
5537931|NCT01340872|19141764|P1|Open-label Phase|Physician Decision|0
5537932|NCT01340872|19141761|P4|Double-blind Phase|Protocol Violation|0
5537933|NCT01340872|19141762|P3|Double-blind Phase|Protocol Violation|0
5537934|NCT01340872|19141763|P2|Double-blind Phase|Protocol Violation|1
5537935|NCT01340872|19141764|P1|Double-blind Phase|Protocol Violation|0
5537936|NCT01340872|19141761|P4|Double-blind Phase|Lost to Follow-up|0
5537937|NCT01340872|19141762|P3|Double-blind Phase|Lost to Follow-up|0
5537938|NCT01340872|19141763|P2|Double-blind Phase|Lost to Follow-up|1
5537939|NCT01340872|19141764|P1|Double-blind Phase|Lost to Follow-up|0
5537940|NCT01340872|19141761|P4|Double-blind Phase|Withdrawal by Subject|0
5537941|NCT01340872|19141762|P3|Double-blind Phase|Withdrawal by Subject|0
5537942|NCT01340872|19141763|P2|Double-blind Phase|Withdrawal by Subject|5
5537943|NCT01340872|19141764|P1|Double-blind Phase|Withdrawal by Subject|3
5537944|NCT01340872|19141761|P4|Double-blind Phase|Adverse Event|0
5537945|NCT01340872|19141762|P3|Double-blind Phase|Adverse Event|0
5537946|NCT01340872|19141763|P2|Double-blind Phase|Adverse Event|4
5537947|NCT01340872|19141764|P1|Double-blind Phase|Adverse Event|6
5537948|NCT01340794|19141824|P2|Overall Study|Withdrawal by Subject|1
5537949|NCT01340794|19141825|P1|Overall Study|Withdrawal by Subject|0
5537950|NCT01340768|19141841|P2|Overall Study|Other|0
5537951|NCT01340768|19141842|P1|Overall Study|Other|2
5537952|NCT01340768|19141841|P2|Overall Study|Withdrawal by Subject|1
5537953|NCT01340768|19141842|P1|Overall Study|Withdrawal by Subject|5
5537954|NCT01340768|19141841|P2|Overall Study|Lost to Follow-up|4
5537955|NCT01340768|19141842|P1|Overall Study|Lost to Follow-up|10
5537956|NCT01340664|19141853|P3|Overall Study|Other|2
5537957|NCT01340664|19141854|P2|Overall Study|Other|2
5537958|NCT01340664|19141855|P1|Overall Study|Other|1
5537959|NCT01340664|19141853|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
5537960|NCT01340664|19141854|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
5537961|NCT01340664|19141855|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
5537962|NCT01340664|19141853|P3|Overall Study|Glycemic withdrawal criteria|0
5537963|NCT01340664|19141854|P2|Overall Study|Glycemic withdrawal criteria|0
5537964|NCT01340664|19141855|P1|Overall Study|Glycemic withdrawal criteria|2
5537965|NCT01340664|19141853|P3|Overall Study|Withdrawal by Subject|0
5537966|NCT01340664|19141854|P2|Overall Study|Withdrawal by Subject|4
5537967|NCT01340664|19141855|P1|Overall Study|Withdrawal by Subject|2
5537968|NCT01340664|19141853|P3|Overall Study|Lost to Follow-up|2
5537969|NCT01340664|19141854|P2|Overall Study|Lost to Follow-up|0
5537970|NCT01340664|19141855|P1|Overall Study|Lost to Follow-up|2
5537971|NCT01340664|19141853|P3|Overall Study|Adverse Event|7
5537972|NCT01340664|19141854|P2|Overall Study|Adverse Event|1
5537973|NCT01340664|19141855|P1|Overall Study|Adverse Event|0
5537974|NCT01340651|19141872|P1|Overall Study|Commercial Supply per Sponsor|12
5537975|NCT01340651|19141872|P1|Overall Study|Consent Withdrawn|2
5537976|NCT01340651|19141872|P1|Overall Study|Adverse Event|3
5537977|NCT01340625|19141888|P2|Washout Period of 28 Days|Withdrawal by Subject|0
5537978|NCT01340625|19141889|P1|Washout Period of 28 Days|Withdrawal by Subject|1
5537979|NCT01340625|19141888|P2|First Intervention|Adverse Event|0
5537980|NCT01340625|19141889|P1|First Intervention|Adverse Event|1
5537981|NCT01340495|19141994|P1|Overall Study|Withdrawal by Subject|1
5537982|NCT01340482|19142004|P3|Overall Study|Adverse Event|0
5537983|NCT01340482|19142005|P2|Overall Study|Adverse Event|0
5537984|NCT01340482|19142006|P1|Overall Study|Adverse Event|2
5537985|NCT01340300|19142021|P4|Overall Study|Unrelated sickness|1
5537986|NCT01340300|19142022|P3|Overall Study|Unrelated sickness|0
5537987|NCT01340300|19142023|P2|Overall Study|Unrelated sickness|2
5537988|NCT01340300|19142024|P1|Overall Study|Unrelated sickness|0
5537989|NCT01340300|19142021|P4|Overall Study|Physician Decision|0
5537990|NCT01340300|19142022|P3|Overall Study|Physician Decision|0
5537991|NCT01340300|19142023|P2|Overall Study|Physician Decision|1
5537992|NCT01340300|19142024|P1|Overall Study|Physician Decision|0
5537993|NCT01340300|19142021|P4|Overall Study|Adverse Event|0
5537994|NCT01340300|19142022|P3|Overall Study|Adverse Event|4
5537995|NCT01340300|19142023|P2|Overall Study|Adverse Event|0
5537996|NCT01340300|19142024|P1|Overall Study|Adverse Event|1
5537997|NCT01340300|19142021|P4|Overall Study|Withdrawal by Subject|3
5537998|NCT01340300|19142022|P3|Overall Study|Withdrawal by Subject|6
5537999|NCT01340300|19142023|P2|Overall Study|Withdrawal by Subject|6
5538000|NCT01340300|19142024|P1|Overall Study|Withdrawal by Subject|5
5538001|NCT01340300|19142021|P4|Overall Study|Lost to Follow-up|10
5538002|NCT01340300|19142022|P3|Overall Study|Lost to Follow-up|5
5538003|NCT01340300|19142023|P2|Overall Study|Lost to Follow-up|0
5538004|NCT01340300|19142024|P1|Overall Study|Lost to Follow-up|3
5538005|NCT01340209|19142057|P3|Overall Study|Other reason not defined above|4
5538006|NCT01340209|19142058|P2|Overall Study|Other reason not defined above|5
5538007|NCT01340209|19142059|P1|Overall Study|Other reason not defined above|3
5538008|NCT01340209|19142057|P3|Overall Study|Withdrawal by Subject|1
5538009|NCT01340209|19142058|P2|Overall Study|Withdrawal by Subject|0
5538010|NCT01340209|19142059|P1|Overall Study|Withdrawal by Subject|0
5538011|NCT01340209|19142057|P3|Overall Study|Protocol Violation|1
5538012|NCT01340209|19142058|P2|Overall Study|Protocol Violation|2
5538013|NCT01340209|19142059|P1|Overall Study|Protocol Violation|1
5538014|NCT01340209|19142057|P3|Overall Study|Adverse Event|2
5538015|NCT01340209|19142058|P2|Overall Study|Adverse Event|1
5538016|NCT01340209|19142059|P1|Overall Study|Adverse Event|1
5538017|NCT01340196|19142094|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
5538018|NCT01340066|19142134|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
5538019|NCT01340066|19142135|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
5538020|NCT01340066|19142136|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
5538021|NCT01340066|19142134|P3|5 Week Double Blind Randomization Period|Physician Decision|0
5538022|NCT01340066|19142135|P2|5 Week Double Blind Randomization Period|Physician Decision|1
5538023|NCT01340066|19142136|P1|5 Week Double Blind Randomization Period|Physician Decision|0
5538024|NCT01340066|19142134|P3|5 Week Double Blind Randomization Period|Adverse Event|2
5538025|NCT01340066|19142135|P2|5 Week Double Blind Randomization Period|Adverse Event|2
5538026|NCT01340066|19142136|P1|5 Week Double Blind Randomization Period|Adverse Event|0
5538027|NCT01340066|19142134|P3|Placebo Run in Period|Screen Failures|0
5538028|NCT01340066|19142135|P2|Placebo Run in Period|Screen Failures|0
5538029|NCT01340066|19142136|P1|Placebo Run in Period|Screen Failures|27
5538030|NCT01340027|19142176|P12|Overall Study|Miscellaneous|0
5538031|NCT01340027|19142177|P11|Overall Study|Miscellaneous|1
5538032|NCT01340027|19142178|P10|Overall Study|Miscellaneous|0
5538033|NCT01340027|19142179|P9|Overall Study|Miscellaneous|0
5538034|NCT01340027|19142180|P8|Overall Study|Miscellaneous|0
5538035|NCT01340027|19142181|P7|Overall Study|Miscellaneous|0
5538036|NCT01340027|19142182|P6|Overall Study|Miscellaneous|0
5538037|NCT01340027|19142183|P5|Overall Study|Miscellaneous|0
5538038|NCT01340027|19142184|P4|Overall Study|Miscellaneous|1
5538039|NCT01340027|19142185|P3|Overall Study|Miscellaneous|0
5538040|NCT01340027|19142186|P2|Overall Study|Miscellaneous|0
5538041|NCT01340027|19142187|P1|Overall Study|Miscellaneous|0
5538042|NCT01340027|19142176|P12|Overall Study|Withdrawal by Subject|1
5538043|NCT01340027|19142177|P11|Overall Study|Withdrawal by Subject|0
5538044|NCT01340027|19142178|P10|Overall Study|Withdrawal by Subject|2
5538045|NCT01340027|19142179|P9|Overall Study|Withdrawal by Subject|1
5538046|NCT01340027|19142180|P8|Overall Study|Withdrawal by Subject|4
5538047|NCT01340027|19142181|P7|Overall Study|Withdrawal by Subject|3
5538048|NCT01340027|19142182|P6|Overall Study|Withdrawal by Subject|2
5538049|NCT01340027|19142183|P5|Overall Study|Withdrawal by Subject|3
5538050|NCT01340027|19142184|P4|Overall Study|Withdrawal by Subject|3
5538051|NCT01340027|19142185|P3|Overall Study|Withdrawal by Subject|1
5538052|NCT01340027|19142186|P2|Overall Study|Withdrawal by Subject|3
5538053|NCT01340027|19142187|P1|Overall Study|Withdrawal by Subject|4
5538054|NCT01340027|19142176|P12|Overall Study|Protocol Violation|0
5538055|NCT01340027|19142177|P11|Overall Study|Protocol Violation|0
5538056|NCT01340027|19142178|P10|Overall Study|Protocol Violation|2
5538057|NCT01340027|19142179|P9|Overall Study|Protocol Violation|2
5538058|NCT01340027|19142180|P8|Overall Study|Protocol Violation|1
5538059|NCT01340027|19142181|P7|Overall Study|Protocol Violation|0
5538060|NCT01340027|19142182|P6|Overall Study|Protocol Violation|0
5538061|NCT01340027|19142183|P5|Overall Study|Protocol Violation|6
5538062|NCT01340027|19142184|P4|Overall Study|Protocol Violation|0
5538063|NCT01340027|19142185|P3|Overall Study|Protocol Violation|0
5538064|NCT01340027|19142186|P2|Overall Study|Protocol Violation|2
5538065|NCT01340027|19142187|P1|Overall Study|Protocol Violation|1
5538066|NCT01340027|19142176|P12|Overall Study|Lost to Follow-up|0
5538067|NCT01340027|19142177|P11|Overall Study|Lost to Follow-up|0
5538068|NCT01340027|19142178|P10|Overall Study|Lost to Follow-up|1
5538069|NCT01340027|19142179|P9|Overall Study|Lost to Follow-up|0
5538070|NCT01340027|19142180|P8|Overall Study|Lost to Follow-up|0
5538071|NCT01340027|19142181|P7|Overall Study|Lost to Follow-up|1
5538072|NCT01340027|19142182|P6|Overall Study|Lost to Follow-up|0
5538073|NCT01340027|19142183|P5|Overall Study|Lost to Follow-up|0
5538074|NCT01340027|19142184|P4|Overall Study|Lost to Follow-up|0
5538075|NCT01340027|19142185|P3|Overall Study|Lost to Follow-up|0
5538076|NCT01340027|19142186|P2|Overall Study|Lost to Follow-up|1
5538077|NCT01340027|19142187|P1|Overall Study|Lost to Follow-up|0
5538078|NCT01340027|19142176|P12|Overall Study|Lack of Efficacy|0
5538079|NCT01340027|19142177|P11|Overall Study|Lack of Efficacy|0
5538080|NCT01340027|19142178|P10|Overall Study|Lack of Efficacy|0
5538081|NCT01340027|19142179|P9|Overall Study|Lack of Efficacy|1
5538082|NCT01340027|19142180|P8|Overall Study|Lack of Efficacy|1
5538083|NCT01340027|19142181|P7|Overall Study|Lack of Efficacy|1
5538084|NCT01340027|19142182|P6|Overall Study|Lack of Efficacy|0
5538085|NCT01340027|19142183|P5|Overall Study|Lack of Efficacy|0
5538086|NCT01340027|19142184|P4|Overall Study|Lack of Efficacy|0
5538087|NCT01340027|19142185|P3|Overall Study|Lack of Efficacy|0
5538088|NCT01340027|19142186|P2|Overall Study|Lack of Efficacy|0
5538089|NCT01340027|19142187|P1|Overall Study|Lack of Efficacy|0
5538090|NCT01340027|19142176|P12|Overall Study|Adverse Event|3
5538091|NCT01340027|19142177|P11|Overall Study|Adverse Event|1
5538092|NCT01340027|19142178|P10|Overall Study|Adverse Event|1
5538093|NCT01340027|19142179|P9|Overall Study|Adverse Event|4
5538094|NCT01340027|19142180|P8|Overall Study|Adverse Event|1
5538095|NCT01340027|19142181|P7|Overall Study|Adverse Event|2
5538096|NCT01340027|19142182|P6|Overall Study|Adverse Event|2
5538097|NCT01340027|19142183|P5|Overall Study|Adverse Event|1
5538098|NCT01340027|19142184|P4|Overall Study|Adverse Event|0
5538099|NCT01340027|19142185|P3|Overall Study|Adverse Event|2
5538100|NCT01340027|19142186|P2|Overall Study|Adverse Event|1
5538101|NCT01340027|19142187|P1|Overall Study|Adverse Event|0
5538102|NCT01340027|19142176|P12|Overall Study|Randomized but Never Received Study Drug|0
5538103|NCT01340027|19142177|P11|Overall Study|Randomized but Never Received Study Drug|0
5538104|NCT01340027|19142178|P10|Overall Study|Randomized but Never Received Study Drug|0
5538105|NCT01340027|19142179|P9|Overall Study|Randomized but Never Received Study Drug|0
5538106|NCT01340027|19142180|P8|Overall Study|Randomized but Never Received Study Drug|0
5538107|NCT01340027|19142181|P7|Overall Study|Randomized but Never Received Study Drug|0
5538108|NCT01340027|19142182|P6|Overall Study|Randomized but Never Received Study Drug|0
5538109|NCT01340027|19142183|P5|Overall Study|Randomized but Never Received Study Drug|0
5538110|NCT01340027|19142184|P4|Overall Study|Randomized but Never Received Study Drug|0
5538111|NCT01340027|19142185|P3|Overall Study|Randomized but Never Received Study Drug|1
5538112|NCT01340027|19142186|P2|Overall Study|Randomized but Never Received Study Drug|0
5538113|NCT01340027|19142187|P1|Overall Study|Randomized but Never Received Study Drug|0
5538114|NCT01340014|19142563|P2|Period 2, Second 7 Days|Adverse Event|1
5538115|NCT01340014|19142564|P1|Period 2, Second 7 Days|Adverse Event|0
5538116|NCT01340014|19142563|P2|Period 1, First 7 Days|Personal Reasons|0
5538117|NCT01340014|19142564|P1|Period 1, First 7 Days|Personal Reasons|1
5538118|NCT01340014|19142563|P2|Period 1, First 7 Days|Adverse Event|0
5538119|NCT01340014|19142564|P1|Period 1, First 7 Days|Adverse Event|1
5538120|NCT01339923|19142585|P7|Overall Study|Withdrawal by Subject|2
5538121|NCT01339923|19142586|P6|Overall Study|Withdrawal by Subject|3
5538122|NCT01339923|19142587|P5|Overall Study|Withdrawal by Subject|4
5538123|NCT01339923|19142588|P4|Overall Study|Withdrawal by Subject|1
5538124|NCT01339923|19142589|P3|Overall Study|Withdrawal by Subject|6
5538125|NCT01339923|19142590|P2|Overall Study|Withdrawal by Subject|11
5538126|NCT01339923|19142591|P1|Overall Study|Withdrawal by Subject|7
5538127|NCT01339923|19142585|P7|Overall Study|Unable to Classify|5
5538128|NCT01339923|19142586|P6|Overall Study|Unable to Classify|1
5538129|NCT01339923|19142587|P5|Overall Study|Unable to Classify|0
5538130|NCT01339923|19142588|P4|Overall Study|Unable to Classify|0
5538131|NCT01339923|19142589|P3|Overall Study|Unable to Classify|1
5538132|NCT01339923|19142590|P2|Overall Study|Unable to Classify|0
5538133|NCT01339923|19142591|P1|Overall Study|Unable to Classify|1
5538134|NCT01339923|19142585|P7|Overall Study|Protocol Violation|1
5538135|NCT01339923|19142586|P6|Overall Study|Protocol Violation|3
5538136|NCT01339923|19142587|P5|Overall Study|Protocol Violation|0
5538137|NCT01339923|19142588|P4|Overall Study|Protocol Violation|0
5538138|NCT01339923|19142589|P3|Overall Study|Protocol Violation|0
5538139|NCT01339923|19142590|P2|Overall Study|Protocol Violation|0
5538140|NCT01339923|19142591|P1|Overall Study|Protocol Violation|0
5538141|NCT01339923|19142585|P7|Overall Study|Lost to Follow-up|5
5538142|NCT01339923|19142586|P6|Overall Study|Lost to Follow-up|1
5538143|NCT01339923|19142587|P5|Overall Study|Lost to Follow-up|1
5538144|NCT01339923|19142588|P4|Overall Study|Lost to Follow-up|3
5538145|NCT01339923|19142589|P3|Overall Study|Lost to Follow-up|0
5538146|NCT01339923|19142590|P2|Overall Study|Lost to Follow-up|4
5538147|NCT01339923|19142591|P1|Overall Study|Lost to Follow-up|4
5538148|NCT01339923|19142585|P7|Overall Study|Inappropriate Enrollment|0
5538149|NCT01339923|19142586|P6|Overall Study|Inappropriate Enrollment|1
5538150|NCT01339923|19142587|P5|Overall Study|Inappropriate Enrollment|0
5538151|NCT01339923|19142588|P4|Overall Study|Inappropriate Enrollment|0
5538152|NCT01339923|19142589|P3|Overall Study|Inappropriate Enrollment|0
5538153|NCT01339923|19142590|P2|Overall Study|Inappropriate Enrollment|0
5538154|NCT01339923|19142591|P1|Overall Study|Inappropriate Enrollment|1
5538155|NCT01339923|19142585|P7|Overall Study|Adverse Event|1
5538156|NCT01339923|19142586|P6|Overall Study|Adverse Event|0
5538157|NCT01339923|19142587|P5|Overall Study|Adverse Event|0
5538158|NCT01339923|19142588|P4|Overall Study|Adverse Event|0
5538159|NCT01339923|19142589|P3|Overall Study|Adverse Event|1
5538160|NCT01339923|19142590|P2|Overall Study|Adverse Event|1
5538161|NCT01339923|19142591|P1|Overall Study|Adverse Event|1
5538162|NCT01339910|19142662|P2|Overall Study|Disease relapse|4
5538163|NCT01339910|19142663|P1|Overall Study|Disease relapse|1
5538164|NCT01339910|19142662|P2|Overall Study|Physician Decision|0
5538165|NCT01339910|19142663|P1|Overall Study|Physician Decision|1
5538166|NCT01339910|19142662|P2|Overall Study|Withdrawal by Subject|0
5538167|NCT01339910|19142663|P1|Overall Study|Withdrawal by Subject|1
5538168|NCT01339897|19142701|P4|Overall Study|Adverse Event|1
5538169|NCT01339897|19142702|P3|Overall Study|Adverse Event|0
5538170|NCT01339897|19142703|P2|Overall Study|Adverse Event|0
5538171|NCT01339897|19142704|P1|Overall Study|Adverse Event|1
5538172|NCT01339832|19142757|P1|Overall Study|Death|11
5538173|NCT01339832|19142757|P1|Overall Study|Lost to Follow-up|3
5538174|NCT01339559|19142768|P1|Overall Study|PI decision|1
5538175|NCT01339559|19142768|P1|Overall Study|Patient didn't wish to continue|1
5538176|NCT01339559|19142768|P1|Overall Study|Investigator decision|2
5538177|NCT01339559|19142768|P1|Overall Study|Left the country|1
5538178|NCT01339559|19142768|P1|Overall Study|Pregnancy planned|2
5538179|NCT01339559|19142768|P1|Overall Study|Epilepsy surgery|1
5538180|NCT01339559|19142768|P1|Overall Study|Incarcerated|2
5538181|NCT01339559|19142768|P1|Overall Study|Study closure at site|1
5538182|NCT01339559|19142768|P1|Overall Study|Protocol Violation|15
5538183|NCT01339559|19142768|P1|Overall Study|Subject choice|89
5538184|NCT01339559|19142768|P1|Overall Study|Lost to Follow-up|22
5538185|NCT01339559|19142768|P1|Overall Study|Lack of Efficacy|164
5538186|NCT01339559|19142768|P1|Overall Study|Death|5
5538187|NCT01339559|19142768|P1|Overall Study|Adverse Event|92
5538188|NCT01339429|19142777|P1|Overall Study|Physician Decision|3
5538189|NCT01339429|19142777|P1|Overall Study|Withdrawal by Subject|1
5538190|NCT01339390|19142817|P2|Overall Study|Lost to Follow-up|127
5538191|NCT01339390|19142818|P1|Overall Study|Lost to Follow-up|125
5538192|NCT01339390|19142817|P2|Overall Study|Death|29
5538193|NCT01339390|19142818|P1|Overall Study|Death|32
5538194|NCT01339273|19142835|P2|Overall Study|Lost to Follow-up|8
5538195|NCT01339273|19142836|P1|Overall Study|Lost to Follow-up|8
5538196|NCT01339052|19142911|P2|Overall Study|Physician Decision|0
5538197|NCT01339052|19142912|P1|Overall Study|Physician Decision|1
5538198|NCT01339052|19142911|P2|Overall Study|Withdrawal by Subject|3
5538199|NCT01339052|19142912|P1|Overall Study|Withdrawal by Subject|0
5538200|NCT01339052|19142911|P2|Overall Study|Adverse Event|1
5538201|NCT01339052|19142912|P1|Overall Study|Adverse Event|1
5538202|NCT01339052|19142911|P2|Overall Study|Disease progression|46
5538203|NCT01339052|19142912|P1|Overall Study|Disease progression|13
5538204|NCT01339000|19142938|P2|Overall Study|study closed due to lack of drug supply|0
5538205|NCT01339000|19142939|P1|Overall Study|study closed due to lack of drug supply|1
5538206|NCT01338987|19142958|P5|Overall Study|Disease progression on study|0
5538207|NCT01338987|19142959|P4|Overall Study|Disease progression on study|0
5538208|NCT01338987|19142960|P3|Overall Study|Disease progression on study|1
5538209|NCT01338987|19142961|P2|Overall Study|Disease progression on study|1
5538210|NCT01338987|19142962|P1|Overall Study|Disease progression on study|2
5538211|NCT01338987|19142958|P5|Overall Study|enrolled on new protocol|0
5538212|NCT01338987|19142959|P4|Overall Study|enrolled on new protocol|0
5538213|NCT01338987|19142960|P3|Overall Study|enrolled on new protocol|1
5538214|NCT01338987|19142961|P2|Overall Study|enrolled on new protocol|0
5538215|NCT01338987|19142962|P1|Overall Study|enrolled on new protocol|0
5538216|NCT01338870|19142983|P6|Overall Study|Adverse Event|1
5538217|NCT01338870|19142984|P5|Overall Study|Adverse Event|4
5538218|NCT01338870|19142985|P4|Overall Study|Adverse Event|5
5538219|NCT01338870|19142986|P3|Overall Study|Adverse Event|1
5538220|NCT01338870|19142987|P2|Overall Study|Adverse Event|4
5538221|NCT01338870|19142988|P1|Overall Study|Adverse Event|4
5538222|NCT01338870|19142983|P6|Overall Study|Protocol Violation|1
5538223|NCT01338870|19142984|P5|Overall Study|Protocol Violation|1
5538224|NCT01338870|19142985|P4|Overall Study|Protocol Violation|2
5538225|NCT01338870|19142986|P3|Overall Study|Protocol Violation|2
5538226|NCT01338870|19142987|P2|Overall Study|Protocol Violation|2
5538227|NCT01338870|19142988|P1|Overall Study|Protocol Violation|0
5538228|NCT01338870|19142983|P6|Overall Study|Other|2
5538229|NCT01338870|19142984|P5|Overall Study|Other|0
5538230|NCT01338870|19142985|P4|Overall Study|Other|2
5538231|NCT01338870|19142986|P3|Overall Study|Other|3
5538232|NCT01338870|19142987|P2|Overall Study|Other|3
5538233|NCT01338870|19142988|P1|Overall Study|Other|3
5538234|NCT01338870|19142983|P6|Overall Study|Withdrawal by Subject|2
5538235|NCT01338870|19142984|P5|Overall Study|Withdrawal by Subject|0
5538236|NCT01338870|19142985|P4|Overall Study|Withdrawal by Subject|0
5538237|NCT01338870|19142986|P3|Overall Study|Withdrawal by Subject|4
5538238|NCT01338870|19142987|P2|Overall Study|Withdrawal by Subject|3
5538239|NCT01338870|19142988|P1|Overall Study|Withdrawal by Subject|2
5538240|NCT01338870|19142983|P6|Overall Study|Lost to Follow-up|0
5538241|NCT01338870|19142984|P5|Overall Study|Lost to Follow-up|1
5538242|NCT01338870|19142985|P4|Overall Study|Lost to Follow-up|0
5538243|NCT01338870|19142986|P3|Overall Study|Lost to Follow-up|1
5538244|NCT01338870|19142987|P2|Overall Study|Lost to Follow-up|0
5538245|NCT01338870|19142988|P1|Overall Study|Lost to Follow-up|0
5538246|NCT01338818|19143043|P1|Overall Study|Protocol Deviation|4
5538247|NCT01338818|19143043|P1|Overall Study|Administrative problems|3
5538248|NCT01338818|19143043|P1|Overall Study|Lost to Follow-up|4
5538249|NCT01338818|19143043|P1|Overall Study|Withdrawal by Subject|11
5538250|NCT01338818|19143043|P1|Overall Study|no longer require study drug|1
5538251|NCT01338818|19143043|P1|Overall Study|Lack of Efficacy|5
5538252|NCT01338818|19143043|P1|Overall Study|Adverse Event|8
5538253|NCT01338792|19143049|P1|Overall Study|Withdrawal by Subject|1
5538254|NCT01338792|19143049|P1|Overall Study|Death|1
5538255|NCT01338792|19143049|P1|Overall Study|Adverse Event|2
5538256|NCT01338636|19143064|P1|Overall Study|Withdrawn due to lack of improvement|8
5538257|NCT01338610|19143078|P3|Overall Study|Adverse Event|0
5538258|NCT01338610|19143079|P2|Overall Study|Adverse Event|0
5538259|NCT01338610|19143080|P1|Overall Study|Adverse Event|3
5538260|NCT01338610|19143078|P3|Overall Study|Protocol Violation|1
5538261|NCT01338610|19143079|P2|Overall Study|Protocol Violation|0
5538262|NCT01338610|19143080|P1|Overall Study|Protocol Violation|1
5538263|NCT01338610|19143078|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
5538264|NCT01338610|19143079|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
5538265|NCT01338610|19143080|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
5538266|NCT01338493|19143106|P1|12 Months Follow up|Lost to Follow-up|9
5538267|NCT01338493|19143106|P1|6 Months Follow up|Missed visit|8
5538268|NCT01338493|19143106|P1|6 Months Follow up|Lost to Follow-up|11
5538269|NCT01338493|19143106|P1|Discharge|Missed visit|1
5538270|NCT01338493|19143106|P1|Discharge|Death|1
5538271|NCT01338493|19143106|P1|Enrolled|Patient not implanted|4
5538272|NCT01338493|19143106|P1|Enrolled|Withdrawal by Subject|1
5538273|NCT01338415|19143113|P2|Overall Study|Other (administrative reason)|0
5538274|NCT01338415|19143114|P1|Overall Study|Other (administrative reason)|1
5538275|NCT01338415|19143113|P2|Overall Study|Other (PAH not the main etiology of PH)|2
5538276|NCT01338415|19143114|P1|Overall Study|Other (PAH not the main etiology of PH)|0
5538277|NCT01338415|19143113|P2|Overall Study|Withdrawal by Subject|1
5538278|NCT01338415|19143114|P1|Overall Study|Withdrawal by Subject|1
5538279|NCT01338415|19143113|P2|Overall Study|Adverse Event|6
5538280|NCT01338415|19143114|P1|Overall Study|Adverse Event|8
5538281|NCT01338298|19143136|P2|Overall Study|Non-adherence|0
5538282|NCT01338298|19143137|P1|Overall Study|Non-adherence|1
5538283|NCT01338298|19143136|P2|Overall Study|Depressive symptoms and nausea|0
5538284|NCT01338298|19143137|P1|Overall Study|Depressive symptoms and nausea|1
5538285|NCT01338298|19143136|P2|Overall Study|Positive symptom worsening|0
5538286|NCT01338298|19143137|P1|Overall Study|Positive symptom worsening|1
5538287|NCT01338298|19143136|P2|Overall Study|Administrative error|1
5538288|NCT01338298|19143137|P1|Overall Study|Administrative error|0
5538289|NCT01338298|19143136|P2|Overall Study|Abdominal Pain and scheduled surgery|1
5538290|NCT01338298|19143137|P1|Overall Study|Abdominal Pain and scheduled surgery|0
5538291|NCT01338298|19143136|P2|Overall Study|Withdrawal by Subject|1
5538292|NCT01338298|19143137|P1|Overall Study|Withdrawal by Subject|1
5538293|NCT01338025|19143147|P2|Overall Study|Found ineligible after starting|0
5538294|NCT01338025|19143148|P1|Overall Study|Found ineligible after starting|1
5538295|NCT01338025|19143147|P2|Overall Study|Withdrawal by Subject|2
5538296|NCT01338025|19143148|P1|Overall Study|Withdrawal by Subject|0
5538297|NCT01338025|19143147|P2|Overall Study|Unexpected closure of study|9
5538298|NCT01338025|19143148|P1|Overall Study|Unexpected closure of study|10
5538299|NCT01338012|19143160|P1|Overall Study|Study terminated|4
5538300|NCT01338012|19143160|P1|Overall Study|Death|4
5538301|NCT01337986|19143166|P2|Overall Study|Protocol Violation|3
5538302|NCT01337986|19143167|P1|Overall Study|Protocol Violation|0
5538303|NCT01337986|19143166|P2|Overall Study|Lost to Follow-up|0
5538304|NCT01337986|19143167|P1|Overall Study|Lost to Follow-up|1
5538305|NCT01337986|19143166|P2|Overall Study|Adverse Event|2
5538306|NCT01337986|19143167|P1|Overall Study|Adverse Event|2
5538307|NCT01337973|19143204|P3|Overall Study|missing data on primary outcome|3
5538308|NCT01337973|19143205|P2|Overall Study|missing data on primary outcome|1
5538309|NCT01337973|19143206|P1|Overall Study|missing data on primary outcome|3
5538310|NCT01337973|19143204|P3|Overall Study|Withdrawal by Subject|4
5538311|NCT01337973|19143205|P2|Overall Study|Withdrawal by Subject|8
5538312|NCT01337973|19143206|P1|Overall Study|Withdrawal by Subject|10
5538313|NCT01337973|19143204|P3|Overall Study|Death|1
5538314|NCT01337973|19143205|P2|Overall Study|Death|2
5538315|NCT01337973|19143206|P1|Overall Study|Death|1
5538316|NCT01337973|19143204|P3|Overall Study|Lost to Follow-up|3
5538317|NCT01337973|19143205|P2|Overall Study|Lost to Follow-up|4
5538318|NCT01337973|19143206|P1|Overall Study|Lost to Follow-up|2
5538319|NCT01337960|19143220|P3|Overall Study|Withdrawal by Subject|0
5538320|NCT01337960|19143221|P2|Overall Study|Withdrawal by Subject|0
5538321|NCT01337960|19143222|P1|Overall Study|Withdrawal by Subject|1
5538322|NCT01337960|19143220|P3|Overall Study|Lost to Follow-up|0
5538323|NCT01337960|19143221|P2|Overall Study|Lost to Follow-up|0
5538324|NCT01337960|19143222|P1|Overall Study|Lost to Follow-up|1
5538325|NCT01337674|19143287|P4|Treatment Period 2|Withdrawal by Subject|0
5538326|NCT01337674|19143288|P3|Treatment Period 2|Withdrawal by Subject|1
5538327|NCT01337674|19143289|P2|Treatment Period 2|Withdrawal by Subject|0
5538328|NCT01337674|19143290|P1|Treatment Period 2|Withdrawal by Subject|0
5538329|NCT01337674|19143287|P4|Treatment Period 1|Discontinued due to blood draws|1
5538330|NCT01337674|19143288|P3|Treatment Period 1|Discontinued due to blood draws|0
5538331|NCT01337674|19143289|P2|Treatment Period 1|Discontinued due to blood draws|0
5538332|NCT01337674|19143290|P1|Treatment Period 1|Discontinued due to blood draws|0
5538333|NCT01337674|19143287|P4|Treatment Period 1|Adverse Event|0
5538334|NCT01337674|19143288|P3|Treatment Period 1|Adverse Event|0
5538335|NCT01337674|19143289|P2|Treatment Period 1|Adverse Event|1
5538336|NCT01337674|19143290|P1|Treatment Period 1|Adverse Event|0
5538337|NCT01337635|19143308|P2|Overall Study|Lost to Follow-up|1
5538338|NCT01337635|19143309|P1|Overall Study|Lost to Follow-up|0
5538339|NCT01337596|19143351|P9|Overall Study|Withdrawal by Subject|0
5538340|NCT01337596|19143352|P8|Overall Study|Withdrawal by Subject|0
5538341|NCT01337596|19143353|P7|Overall Study|Withdrawal by Subject|0
5538342|NCT01337596|19143354|P6|Overall Study|Withdrawal by Subject|0
5538343|NCT01337596|19143355|P5|Overall Study|Withdrawal by Subject|2
5538344|NCT01337596|19143356|P4|Overall Study|Withdrawal by Subject|0
5538345|NCT01337596|19143357|P3|Overall Study|Withdrawal by Subject|0
5538346|NCT01337596|19143358|P2|Overall Study|Withdrawal by Subject|0
5538347|NCT01337596|19143359|P1|Overall Study|Withdrawal by Subject|0
5538348|NCT01337297|19143410|P2|Overall Study|Lost to Follow-up|3
5538349|NCT01337297|19143411|P1|Overall Study|Lost to Follow-up|1
5538350|NCT01337297|19143410|P2|Overall Study|They entered to single anodal tDCS|3
5538351|NCT01337297|19143411|P1|Overall Study|They entered to single anodal tDCS|4
5538352|NCT01337167|19143419|P2|Toddler Vaccinations|Withdrawal by Subject|0
5538353|NCT01337167|19143420|P1|Toddler Vaccinations|Withdrawal by Subject|3
5538354|NCT01337167|19143419|P2|Toddler Vaccinations|Protocol Violation|1
5538355|NCT01337167|19143420|P1|Toddler Vaccinations|Protocol Violation|0
5538356|NCT01337167|19143419|P2|Toddler Vaccinations|Lost to Follow-up|12
5538357|NCT01337167|19143420|P1|Toddler Vaccinations|Lost to Follow-up|11
5538358|NCT01337167|19143419|P2|Interim Period|Other protocol criterion not met|1
5538359|NCT01337167|19143420|P1|Interim Period|Other protocol criterion not met|0
5538360|NCT01337167|19143419|P2|Interim Period|Withdrawal by Subject|10
5538361|NCT01337167|19143420|P1|Interim Period|Withdrawal by Subject|18
5538362|NCT01337167|19143419|P2|Interim Period|Protocol Violation|3
5538363|NCT01337167|19143420|P1|Interim Period|Protocol Violation|5
5538364|NCT01337167|19143419|P2|Interim Period|Physician Decision|3
5538365|NCT01337167|19143420|P1|Interim Period|Physician Decision|6
5538366|NCT01337167|19143419|P2|Interim Period|Non-compliance with study drug|0
5538367|NCT01337167|19143420|P1|Interim Period|Non-compliance with study drug|1
5538368|NCT01337167|19143419|P2|Interim Period|Lost to Follow-up|23
5538369|NCT01337167|19143420|P1|Interim Period|Lost to Follow-up|51
5538370|NCT01337167|19143419|P2|Infant Series|Randomized but not vaccinated|3
5538371|NCT01337167|19143420|P1|Infant Series|Randomized but not vaccinated|5
5538372|NCT01337167|19143419|P2|Infant Series|Withdrawal by Subject|4
5538373|NCT01337167|19143420|P1|Infant Series|Withdrawal by Subject|15
5538374|NCT01337167|19143419|P2|Infant Series|Protocol Violation|9
5538375|NCT01337167|19143420|P1|Infant Series|Protocol Violation|22
5538376|NCT01337167|19143419|P2|Infant Series|Physician Decision|1
5538377|NCT01337167|19143420|P1|Infant Series|Physician Decision|3
5538378|NCT01337167|19143419|P2|Infant Series|Non-compliance with study drug|1
5538379|NCT01337167|19143420|P1|Infant Series|Non-compliance with study drug|2
5538380|NCT01337167|19143419|P2|Infant Series|Lost to Follow-up|7
5538381|NCT01337167|19143420|P1|Infant Series|Lost to Follow-up|13
5538382|NCT01337167|19143419|P2|Infant Series|Death|1
5538383|NCT01337167|19143420|P1|Infant Series|Death|1
5538384|NCT01337167|19143419|P2|Infant Series|Adverse Event|1
5538385|NCT01337167|19143420|P1|Infant Series|Adverse Event|1
5538386|NCT01337115|19143488|P2|Overall Study|Protocol Violation|0
5538387|NCT01337115|19143489|P1|Overall Study|Protocol Violation|2
5538388|NCT01337089|19143501|P1|Overall Study|Lost to Follow-up|2
5538389|NCT01337089|19143501|P1|Overall Study|Met Withdrawal Criteria|3
5538390|NCT01337089|19143501|P1|Overall Study|Withdrawal by Investigator|33
5538391|NCT01337089|19143501|P1|Overall Study|Withdrawal by Subject|129
5538392|NCT01337089|19143501|P1|Overall Study|Adverse Event|237
5538393|NCT01337050|19143516|P3|Overall Study|Participants refused further follow-up|7
5538394|NCT01337050|19143517|P2|Overall Study|Participants refused further follow-up|7
5538395|NCT01337050|19143518|P1|Overall Study|Participants refused further follow-up|0
5538396|NCT01337050|19143516|P3|Overall Study|Other|8
5538397|NCT01337050|19143517|P2|Overall Study|Other|6
5538398|NCT01337050|19143518|P1|Overall Study|Other|4
5538399|NCT01337050|19143516|P3|Overall Study|Death|4
5538400|NCT01337050|19143517|P2|Overall Study|Death|0
5538401|NCT01337050|19143518|P1|Overall Study|Death|0
5538402|NCT01336972|19143579|P3|Overall Study|Adverse Event|0
5538403|NCT01336972|19143580|P2|Overall Study|Adverse Event|1
5538404|NCT01336972|19143581|P1|Overall Study|Adverse Event|1
5538405|NCT01336894|19143643|P2|Follow-up|Study terminated prematurely|7
5538406|NCT01336894|19143644|P1|Follow-up|Study terminated prematurely|2
5538407|NCT01336764|19143676|P2|Overall Study|Withdrawal by Subject|5
5538408|NCT01336764|19143677|P1|Overall Study|Withdrawal by Subject|5
5538409|NCT01336738|19143688|P5|Overall Study|Other|4
5538410|NCT01336738|19143689|P4|Overall Study|Other|3
5538411|NCT01336738|19143690|P3|Overall Study|Other|2
5538412|NCT01336738|19143691|P2|Overall Study|Other|3
5538413|NCT01336738|19143692|P1|Overall Study|Other|3
5538414|NCT01336738|19143688|P5|Overall Study|Withdrawal by Subject|1
5538415|NCT01336738|19143689|P4|Overall Study|Withdrawal by Subject|1
5538416|NCT01336738|19143690|P3|Overall Study|Withdrawal by Subject|2
5538417|NCT01336738|19143691|P2|Overall Study|Withdrawal by Subject|0
5538418|NCT01336738|19143692|P1|Overall Study|Withdrawal by Subject|2
5538419|NCT01336738|19143688|P5|Overall Study|Protocol Violation|0
5538420|NCT01336738|19143689|P4|Overall Study|Protocol Violation|0
5538421|NCT01336738|19143690|P3|Overall Study|Protocol Violation|0
5538422|NCT01336738|19143691|P2|Overall Study|Protocol Violation|1
5538423|NCT01336738|19143692|P1|Overall Study|Protocol Violation|0
5538424|NCT01336738|19143688|P5|Overall Study|Did not meet entrance criteria|0
5538425|NCT01336738|19143689|P4|Overall Study|Did not meet entrance criteria|0
5538426|NCT01336738|19143690|P3|Overall Study|Did not meet entrance criteria|0
5538427|NCT01336738|19143691|P2|Overall Study|Did not meet entrance criteria|1
5538428|NCT01336738|19143692|P1|Overall Study|Did not meet entrance criteria|0
5538429|NCT01336738|19143688|P5|Overall Study|Lost to Follow-up|2
5538430|NCT01336738|19143689|P4|Overall Study|Lost to Follow-up|2
5538431|NCT01336738|19143690|P3|Overall Study|Lost to Follow-up|2
5538432|NCT01336738|19143691|P2|Overall Study|Lost to Follow-up|1
5538433|NCT01336738|19143692|P1|Overall Study|Lost to Follow-up|2
5538434|NCT01336738|19143688|P5|Overall Study|Adverse Event|3
5538435|NCT01336738|19143689|P4|Overall Study|Adverse Event|1
5538436|NCT01336738|19143690|P3|Overall Study|Adverse Event|2
5538437|NCT01336738|19143691|P2|Overall Study|Adverse Event|3
5538438|NCT01336738|19143692|P1|Overall Study|Adverse Event|0
5538439|NCT01336712|19143734|P1|Overall Study|Lack of Efficacy|1
5538440|NCT01336712|19143734|P1|Overall Study|Death|2
5538441|NCT01336647|19143747|P3|Overall Study|Lost to Follow-up|3
5538442|NCT01336647|19143748|P2|Overall Study|Lost to Follow-up|1
5538443|NCT01336647|19143749|P1|Overall Study|Lost to Follow-up|4
5538444|NCT01336634|19143763|P3|Overall Study|Ongoing|24
5538445|NCT01336634|19143764|P2|Overall Study|Ongoing|22
5538446|NCT01336634|19143765|P1|Overall Study|Ongoing|15
5538447|NCT01336634|19143763|P3|Overall Study|Physician Decision|0
5538448|NCT01336634|19143764|P2|Overall Study|Physician Decision|1
5538449|NCT01336634|19143765|P1|Overall Study|Physician Decision|1
5538450|NCT01336634|19143763|P3|Overall Study|Withdrawal by Subject|1
5538451|NCT01336634|19143764|P2|Overall Study|Withdrawal by Subject|0
5538452|NCT01336634|19143765|P1|Overall Study|Withdrawal by Subject|6
5538453|NCT01336634|19143763|P3|Overall Study|Lost to Follow-up|1
5538454|NCT01336634|19143764|P2|Overall Study|Lost to Follow-up|1
5538455|NCT01336634|19143765|P1|Overall Study|Lost to Follow-up|2
5538456|NCT01336634|19143763|P3|Overall Study|Death|10
5538457|NCT01336634|19143764|P2|Overall Study|Death|33
5538458|NCT01336634|19143765|P1|Overall Study|Death|60
5538459|NCT01336621|19143806|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
5538460|NCT01336621|19143806|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
5538461|NCT01336621|19143806|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
5538462|NCT01336621|19143806|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
5538463|NCT01336621|19143806|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
5538464|NCT01336621|19143806|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
5538465|NCT01336621|19143806|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
5538466|NCT01336621|19143806|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
5538467|NCT01336621|19143806|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
5538468|NCT01336621|19143806|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
5538469|NCT01336621|19143806|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
5538470|NCT01336621|19143806|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
5538471|NCT01336621|19143806|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
5538472|NCT01336621|19143806|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
5538473|NCT01336608|19143856|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
5538474|NCT01336608|19143857|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
5538475|NCT01336608|19143858|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
5538476|NCT01336608|19143859|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5538477|NCT01336608|19143856|P4|24-week, Double-blind Treatment Period|Physician Decision|1
5538478|NCT01336608|19143857|P3|24-week, Double-blind Treatment Period|Physician Decision|1
5538479|NCT01336608|19143858|P2|24-week, Double-blind Treatment Period|Physician Decision|3
5538480|NCT01336608|19143859|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5538481|NCT01336608|19143856|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5538482|NCT01336608|19143857|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5538483|NCT01336608|19143858|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
5538484|NCT01336608|19143859|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5538485|NCT01336608|19143856|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
5538486|NCT01336608|19143857|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
5538487|NCT01336608|19143858|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
5538488|NCT01336608|19143859|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
5538489|NCT01336608|19143856|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
5538490|NCT01336608|19143857|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
5538491|NCT01336608|19143858|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
5538492|NCT01336608|19143859|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5538493|NCT01336608|19143856|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
5538494|NCT01336608|19143857|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
5538495|NCT01336608|19143858|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
5538496|NCT01336608|19143859|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
5538497|NCT01336608|19143856|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5538498|NCT01336608|19143857|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5538499|NCT01336608|19143858|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
5538500|NCT01336608|19143859|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5538501|NCT01336608|19143856|P4|24-week, Double-blind Treatment Period|Adverse Event|7
5538502|NCT01336608|19143857|P3|24-week, Double-blind Treatment Period|Adverse Event|6
5538503|NCT01336608|19143858|P2|24-week, Double-blind Treatment Period|Adverse Event|8
5538504|NCT01336608|19143859|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5538505|NCT01336608|19143856|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5538506|NCT01336608|19143857|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5538507|NCT01336608|19143858|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5538508|NCT01336608|19143859|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
5538509|NCT01336608|19143856|P4|2-week, Single-blind Run-In Period|Physician Decision|0
5538510|NCT01336608|19143857|P3|2-week, Single-blind Run-In Period|Physician Decision|0
5538511|NCT01336608|19143858|P2|2-week, Single-blind Run-In Period|Physician Decision|0
5538512|NCT01336608|19143859|P1|2-week, Single-blind Run-In Period|Physician Decision|1
5538513|NCT01336608|19143856|P4|2-week, Single-blind Run-In Period|Adverse Event|0
5538514|NCT01336608|19143857|P3|2-week, Single-blind Run-In Period|Adverse Event|0
5538515|NCT01336608|19143858|P2|2-week, Single-blind Run-In Period|Adverse Event|0
5538516|NCT01336608|19143859|P1|2-week, Single-blind Run-In Period|Adverse Event|1
5538517|NCT01336608|19143856|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5538518|NCT01336608|19143857|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5538519|NCT01336608|19143858|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5538520|NCT01336608|19143859|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
5538521|NCT01336608|19143856|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5538522|NCT01336608|19143857|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5538523|NCT01336608|19143858|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5538524|NCT01336608|19143859|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
5538525|NCT01336569|19143873|P1|Overall Study|Lost to Follow-up|4
5538526|NCT01336205|19143921|P2|Overall Study|Did not receive treatment|0
5538527|NCT01336205|19143922|P1|Overall Study|Did not receive treatment|4
5538528|NCT01336205|19143921|P2|Overall Study|Withdrawal by Subject|38
5538529|NCT01336205|19143922|P1|Overall Study|Withdrawal by Subject|72
5538530|NCT01336205|19143921|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
5538531|NCT01336205|19143922|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
5538532|NCT01336205|19143921|P2|Overall Study|Death|1
5538533|NCT01336205|19143922|P1|Overall Study|Death|1
5538534|NCT01336205|19143921|P2|Overall Study|Adverse Event|6
5538535|NCT01336205|19143922|P1|Overall Study|Adverse Event|56
5538536|NCT01336205|19143921|P2|Overall Study|Severe noncompliance with protocol|2
5538537|NCT01336205|19143922|P1|Overall Study|Severe noncompliance with protocol|9
5538538|NCT01336205|19143921|P2|Overall Study|Lack of Efficacy|0
5538539|NCT01336205|19143922|P1|Overall Study|Lack of Efficacy|4
5538540|NCT01336205|19143921|P2|Overall Study|Study-Specific Withdrawal Criteria|7
5538541|NCT01336205|19143922|P1|Overall Study|Study-Specific Withdrawal Criteria|16
5538542|NCT01336205|19143921|P2|Overall Study|Lost to Follow-up|20
5538543|NCT01336205|19143922|P1|Overall Study|Lost to Follow-up|40
5538544|NCT01336205|19143921|P2|Overall Study|Other|9
5538545|NCT01336205|19143922|P1|Overall Study|Other|22
5538546|NCT01336023|19143950|P3|Week 27 to 52|Unclassified|9
5538547|NCT01336023|19143951|P2|Week 27 to 52|Unclassified|18
5538548|NCT01336023|19143952|P1|Week 27 to 52|Unclassified|13
5538549|NCT01336023|19143950|P3|Week 27 to 52|Withdrawal Criteria|16
5538550|NCT01336023|19143951|P2|Week 27 to 52|Withdrawal Criteria|19
5538551|NCT01336023|19143952|P1|Week 27 to 52|Withdrawal Criteria|14
5538552|NCT01336023|19143950|P3|Week 27 to 52|Protocol Violation|1
5538553|NCT01336023|19143951|P2|Week 27 to 52|Protocol Violation|2
5538554|NCT01336023|19143952|P1|Week 27 to 52|Protocol Violation|0
5538555|NCT01336023|19143950|P3|Week 27 to 52|Adverse Event|2
5538556|NCT01336023|19143951|P2|Week 27 to 52|Adverse Event|5
5538557|NCT01336023|19143952|P1|Week 27 to 52|Adverse Event|1
5538558|NCT01336023|19143950|P3|Week 0 to Week 26|Unclassified|9
5538559|NCT01336023|19143951|P2|Week 0 to Week 26|Unclassified|16
5538560|NCT01336023|19143952|P1|Week 0 to Week 26|Unclassified|5
5538561|NCT01336023|19143950|P3|Week 0 to Week 26|Withdrawal Criteria|40
5538562|NCT01336023|19143951|P2|Week 0 to Week 26|Withdrawal Criteria|69
5538563|NCT01336023|19143952|P1|Week 0 to Week 26|Withdrawal Criteria|34
5538564|NCT01336023|19143950|P3|Week 0 to Week 26|Protocol Violation|0
5538565|NCT01336023|19143951|P2|Week 0 to Week 26|Protocol Violation|2
5538566|NCT01336023|19143952|P1|Week 0 to Week 26|Protocol Violation|1
5538567|NCT01336023|19143950|P3|Week 0 to Week 26|Lack of Efficacy|0
5538568|NCT01336023|19143951|P2|Week 0 to Week 26|Lack of Efficacy|1
5538569|NCT01336023|19143952|P1|Week 0 to Week 26|Lack of Efficacy|0
5538570|NCT01336023|19143950|P3|Week 0 to Week 26|Adverse Event|24
5538571|NCT01336023|19143951|P2|Week 0 to Week 26|Adverse Event|10
5538572|NCT01336023|19143952|P1|Week 0 to Week 26|Adverse Event|8
5538573|NCT01335997|19143973|P2|Period III|Lost to Follow-up|0
5538574|NCT01335997|19143974|P1|Period III|Lost to Follow-up|1
5538575|NCT01335997|19143973|P2|Period III|Protocol Violation|1
5538576|NCT01335997|19143974|P1|Period III|Protocol Violation|0
5538577|NCT01335997|19143973|P2|Period III|Study Terminated by Sponsor|76
5538578|NCT01335997|19143974|P1|Period III|Study Terminated by Sponsor|77
5538579|NCT01335997|19143973|P2|Period III|Adverse Event|2
5538580|NCT01335997|19143974|P1|Period III|Adverse Event|0
5538581|NCT01335997|19143973|P2|Period I and II|Physician Decision|1
5538582|NCT01335997|19143974|P1|Period I and II|Physician Decision|2
5538583|NCT01335997|19143973|P2|Period I and II|Protocol Violation|10
5538584|NCT01335997|19143974|P1|Period I and II|Protocol Violation|9
5538585|NCT01335997|19143973|P2|Period I and II|Study Terminated by Sponsor|415
5538586|NCT01335997|19143974|P1|Period I and II|Study Terminated by Sponsor|406
5538587|NCT01335997|19143973|P2|Period I and II|Withdrawal by Subject|4
5538588|NCT01335997|19143974|P1|Period I and II|Withdrawal by Subject|9
5538589|NCT01335997|19143973|P2|Period I and II|Lost to Follow-up|5
5538590|NCT01335997|19143974|P1|Period I and II|Lost to Follow-up|3
5538591|NCT01335997|19143973|P2|Period I and II|Noncompliance with Study Drug|1
5538592|NCT01335997|19143974|P1|Period I and II|Noncompliance with Study Drug|1
5538593|NCT01335997|19143973|P2|Period I and II|Adverse Event|43
5538594|NCT01335997|19143974|P1|Period I and II|Adverse Event|63
5538595|NCT01335971|19143987|P3|Overall Study|Did not complete bronchoscopy|1
5538596|NCT01335971|19143988|P2|Overall Study|Did not complete bronchoscopy|1
5538597|NCT01335971|19143989|P1|Overall Study|Did not complete bronchoscopy|1
5538598|NCT01335971|19143987|P3|Overall Study|Withdrawal by Subject|0
5538599|NCT01335971|19143988|P2|Overall Study|Withdrawal by Subject|0
5538600|NCT01335971|19143989|P1|Overall Study|Withdrawal by Subject|1
5538601|NCT01335698|19144232|P5|Treatment Stage 2|Switched to another formulation|0
5538602|NCT01335698|19144233|P4|Treatment Stage 2|Switched to another formulation|0
5538603|NCT01335698|19144234|P3|Treatment Stage 2|Switched to another formulation|0
5538604|NCT01335698|19144235|P2|Treatment Stage 2|Switched to another formulation|1
5538605|NCT01335698|19144236|P1|Treatment Stage 2|Switched to another formulation|1
5538606|NCT01335698|19144232|P5|Treatment Stage 2|Subject no longer meets study criteria|0
5538607|NCT01335698|19144233|P4|Treatment Stage 2|Subject no longer meets study criteria|1
5538608|NCT01335698|19144234|P3|Treatment Stage 2|Subject no longer meets study criteria|0
5538609|NCT01335698|19144235|P2|Treatment Stage 2|Subject no longer meets study criteria|0
5538610|NCT01335698|19144236|P1|Treatment Stage 2|Subject no longer meets study criteria|0
5538611|NCT01335698|19144232|P5|Treatment Stage 2|Capsules received at state hospital|0
5538612|NCT01335698|19144233|P4|Treatment Stage 2|Capsules received at state hospital|0
5538613|NCT01335698|19144234|P3|Treatment Stage 2|Capsules received at state hospital|0
5538698|NCT01335685|19144307|P2|Overall Study|Study Terminated by Sponsor|1
5538614|NCT01335698|19144235|P2|Treatment Stage 2|Capsules received at state hospital|0
5538615|NCT01335698|19144236|P1|Treatment Stage 2|Capsules received at state hospital|1
5538616|NCT01335698|19144232|P5|Treatment Stage 2|Lost to Follow-up|0
5538617|NCT01335698|19144233|P4|Treatment Stage 2|Lost to Follow-up|0
5538618|NCT01335698|19144234|P3|Treatment Stage 2|Lost to Follow-up|0
5538619|NCT01335698|19144235|P2|Treatment Stage 2|Lost to Follow-up|0
5538620|NCT01335698|19144236|P1|Treatment Stage 2|Lost to Follow-up|1
5538621|NCT01335698|19144232|P5|Treatment Stage 2|Poor compliance/noncompliance|1
5538622|NCT01335698|19144233|P4|Treatment Stage 2|Poor compliance/noncompliance|3
5538623|NCT01335698|19144234|P3|Treatment Stage 2|Poor compliance/noncompliance|1
5538624|NCT01335698|19144235|P2|Treatment Stage 2|Poor compliance/noncompliance|0
5538625|NCT01335698|19144236|P1|Treatment Stage 2|Poor compliance/noncompliance|1
5538626|NCT01335698|19144232|P5|Treatment Stage 2|Withdrawal by Subject|0
5538627|NCT01335698|19144233|P4|Treatment Stage 2|Withdrawal by Subject|0
5538628|NCT01335698|19144234|P3|Treatment Stage 2|Withdrawal by Subject|1
5538629|NCT01335698|19144235|P2|Treatment Stage 2|Withdrawal by Subject|1
5538630|NCT01335698|19144236|P1|Treatment Stage 2|Withdrawal by Subject|3
5538631|NCT01335698|19144232|P5|Treatment Stage 2|Adverse Event|0
5538632|NCT01335698|19144233|P4|Treatment Stage 2|Adverse Event|3
5538633|NCT01335698|19144234|P3|Treatment Stage 2|Adverse Event|0
5538634|NCT01335698|19144235|P2|Treatment Stage 2|Adverse Event|0
5538635|NCT01335698|19144236|P1|Treatment Stage 2|Adverse Event|2
5538636|NCT01335698|19144232|P5|Treatment Stage 2|Lack of Efficacy|0
5538637|NCT01335698|19144233|P4|Treatment Stage 2|Lack of Efficacy|1
5538638|NCT01335698|19144234|P3|Treatment Stage 2|Lack of Efficacy|3
5538639|NCT01335698|19144235|P2|Treatment Stage 2|Lack of Efficacy|1
5538640|NCT01335698|19144236|P1|Treatment Stage 2|Lack of Efficacy|2
5538641|NCT01335698|19144232|P5|Treatment Stage 1|Other|0
5538642|NCT01335698|19144233|P4|Treatment Stage 1|Other|1
5538643|NCT01335698|19144234|P3|Treatment Stage 1|Other|0
5538644|NCT01335698|19144235|P2|Treatment Stage 1|Other|0
5538645|NCT01335698|19144236|P1|Treatment Stage 1|Other|1
5538646|NCT01335698|19144232|P5|Treatment Stage 1|No longer meets study criteria|0
5538647|NCT01335698|19144233|P4|Treatment Stage 1|No longer meets study criteria|1
5538648|NCT01335698|19144234|P3|Treatment Stage 1|No longer meets study criteria|0
5538649|NCT01335698|19144235|P2|Treatment Stage 1|No longer meets study criteria|1
5538650|NCT01335698|19144236|P1|Treatment Stage 1|No longer meets study criteria|1
5538651|NCT01335698|19144232|P5|Treatment Stage 1|Poor compliance/noncompliance|0
5538652|NCT01335698|19144233|P4|Treatment Stage 1|Poor compliance/noncompliance|2
5538653|NCT01335698|19144234|P3|Treatment Stage 1|Poor compliance/noncompliance|0
5538654|NCT01335698|19144235|P2|Treatment Stage 1|Poor compliance/noncompliance|1
5538655|NCT01335698|19144236|P1|Treatment Stage 1|Poor compliance/noncompliance|0
5538656|NCT01335698|19144232|P5|Treatment Stage 1|Lost to Follow-up|0
5538657|NCT01335698|19144233|P4|Treatment Stage 1|Lost to Follow-up|0
5538658|NCT01335698|19144234|P3|Treatment Stage 1|Lost to Follow-up|0
5538659|NCT01335698|19144235|P2|Treatment Stage 1|Lost to Follow-up|1
5538660|NCT01335698|19144236|P1|Treatment Stage 1|Lost to Follow-up|1
5538661|NCT01335698|19144232|P5|Treatment Stage 1|Withdrawal by Subject|0
5538662|NCT01335698|19144233|P4|Treatment Stage 1|Withdrawal by Subject|1
5538663|NCT01335698|19144234|P3|Treatment Stage 1|Withdrawal by Subject|0
5538664|NCT01335698|19144235|P2|Treatment Stage 1|Withdrawal by Subject|2
5538665|NCT01335698|19144236|P1|Treatment Stage 1|Withdrawal by Subject|1
5538666|NCT01335698|19144232|P5|Treatment Stage 1|Adverse Event|1
5538667|NCT01335698|19144233|P4|Treatment Stage 1|Adverse Event|1
5538668|NCT01335698|19144234|P3|Treatment Stage 1|Adverse Event|2
5538669|NCT01335698|19144235|P2|Treatment Stage 1|Adverse Event|2
5538670|NCT01335698|19144236|P1|Treatment Stage 1|Adverse Event|1
5538671|NCT01335698|19144232|P5|Treatment Stage 1|Lack of Efficacy|1
5538672|NCT01335698|19144233|P4|Treatment Stage 1|Lack of Efficacy|3
5538673|NCT01335698|19144234|P3|Treatment Stage 1|Lack of Efficacy|3
5538674|NCT01335698|19144235|P2|Treatment Stage 1|Lack of Efficacy|1
5538675|NCT01335698|19144236|P1|Treatment Stage 1|Lack of Efficacy|3
5538676|NCT01335685|19144301|P8|Overall Study|Reason not Specified|0
5538677|NCT01335685|19144302|P7|Overall Study|Reason not Specified|0
5538678|NCT01335685|19144303|P6|Overall Study|Reason not Specified|1
5538679|NCT01335685|19144304|P5|Overall Study|Reason not Specified|0
5538680|NCT01335685|19144305|P4|Overall Study|Reason not Specified|0
5538681|NCT01335685|19144306|P3|Overall Study|Reason not Specified|1
5538682|NCT01335685|19144307|P2|Overall Study|Reason not Specified|0
5538683|NCT01335685|19144308|P1|Overall Study|Reason not Specified|0
5538684|NCT01335685|19144301|P8|Overall Study|Withdrawal by Subject|0
5538685|NCT01335685|19144302|P7|Overall Study|Withdrawal by Subject|0
5538686|NCT01335685|19144303|P6|Overall Study|Withdrawal by Subject|0
5538687|NCT01335685|19144304|P5|Overall Study|Withdrawal by Subject|0
5538688|NCT01335685|19144305|P4|Overall Study|Withdrawal by Subject|1
5538689|NCT01335685|19144306|P3|Overall Study|Withdrawal by Subject|0
5538690|NCT01335685|19144307|P2|Overall Study|Withdrawal by Subject|0
5538691|NCT01335685|19144308|P1|Overall Study|Withdrawal by Subject|1
5538692|NCT01335685|19144301|P8|Overall Study|Study Terminated by Sponsor|3
5538693|NCT01335685|19144302|P7|Overall Study|Study Terminated by Sponsor|2
5538694|NCT01335685|19144303|P6|Overall Study|Study Terminated by Sponsor|4
5538695|NCT01335685|19144304|P5|Overall Study|Study Terminated by Sponsor|0
5538696|NCT01335685|19144305|P4|Overall Study|Study Terminated by Sponsor|10
5538697|NCT01335685|19144306|P3|Overall Study|Study Terminated by Sponsor|1
5538699|NCT01335685|19144308|P1|Overall Study|Study Terminated by Sponsor|2
5538700|NCT01335477|19144432|P2|Overall Study|Reason other than those stated above|2
5538701|NCT01335477|19144433|P1|Overall Study|Reason other than those stated above|2
5538702|NCT01335477|19144432|P2|Overall Study|Not treated|2
5538703|NCT01335477|19144433|P1|Overall Study|Not treated|1
5538704|NCT01335477|19144432|P2|Overall Study|Consent withdrawn, not due to AE|9
5538705|NCT01335477|19144433|P1|Overall Study|Consent withdrawn, not due to AE|7
5538706|NCT01335477|19144432|P2|Overall Study|Lost to Follow-up|2
5538707|NCT01335477|19144433|P1|Overall Study|Lost to Follow-up|1
5538708|NCT01335477|19144432|P2|Overall Study|Non compliant with protocol|2
5538709|NCT01335477|19144433|P1|Overall Study|Non compliant with protocol|0
5538710|NCT01335477|19144432|P2|Overall Study|Adverse Event|42
5538711|NCT01335477|19144433|P1|Overall Study|Adverse Event|30
5538712|NCT01335464|19144497|P2|Overall Study|Reason other than those stated above|1
5538713|NCT01335464|19144498|P1|Overall Study|Reason other than those stated above|1
5538714|NCT01335464|19144497|P2|Overall Study|Not treated|0
5538715|NCT01335464|19144498|P1|Overall Study|Not treated|2
5538716|NCT01335464|19144497|P2|Overall Study|Consent withdrawn, not due to AE|23
5538717|NCT01335464|19144498|P1|Overall Study|Consent withdrawn, not due to AE|12
5538718|NCT01335464|19144497|P2|Overall Study|Non compliant with protocol|0
5538719|NCT01335464|19144498|P1|Overall Study|Non compliant with protocol|2
5538720|NCT01335464|19144497|P2|Overall Study|Adverse Event|25
5538721|NCT01335464|19144498|P1|Overall Study|Adverse Event|15
5538722|NCT01335399|19144562|P2|Treatment Period|Not reported|0
5538723|NCT01335399|19144563|P1|Treatment Period|Not reported|1
5538724|NCT01335399|19144562|P2|Treatment Period|No longer meet study criteria|1
5538725|NCT01335399|19144563|P1|Treatment Period|No longer meet study criteria|0
5538726|NCT01335399|19144562|P2|Treatment Period|Maximum clinical benefit|1
5538727|NCT01335399|19144563|P1|Treatment Period|Maximum clinical benefit|1
5538728|NCT01335399|19144562|P2|Treatment Period|Lost to Follow-up|2
5538729|NCT01335399|19144563|P1|Treatment Period|Lost to Follow-up|0
5538730|NCT01335399|19144562|P2|Treatment Period|Poor/Non-compliance|4
5538731|NCT01335399|19144563|P1|Treatment Period|Poor/Non-compliance|3
5538732|NCT01335399|19144562|P2|Treatment Period|Death|8
5538733|NCT01335399|19144563|P1|Treatment Period|Death|7
5538734|NCT01335399|19144562|P2|Treatment Period|Consent withdrawal|6
5538735|NCT01335399|19144563|P1|Treatment Period|Consent withdrawal|10
5538736|NCT01335399|19144562|P2|Treatment Period|Other reasons|26
5538737|NCT01335399|19144563|P1|Treatment Period|Other reasons|14
5538738|NCT01335399|19144562|P2|Treatment Period|Participant request to discontinue|21
5538739|NCT01335399|19144563|P1|Treatment Period|Participant request to discontinue|27
5538740|NCT01335399|19144562|P2|Treatment Period|Study drug toxicity|64
5538741|NCT01335399|19144563|P1|Treatment Period|Study drug toxicity|51
5538742|NCT01335399|19144562|P2|Treatment Period|Adverse event unrelated to study drug|65
5538743|NCT01335399|19144563|P1|Treatment Period|Adverse event unrelated to study drug|105
5538744|NCT01335399|19144562|P2|Treatment Period|Disease progression|141
5538745|NCT01335399|19144563|P1|Treatment Period|Disease progression|114
5538746|NCT01335399|19144562|P2|Pre-treatment Period|Consent withdrawal|0
5538747|NCT01335399|19144563|P1|Pre-treatment Period|Consent withdrawal|3
5538748|NCT01335399|19144562|P2|Pre-treatment Period|Adverse event unrelated to study drug|1
5538749|NCT01335399|19144563|P1|Pre-treatment Period|Adverse event unrelated to study drug|0
5538750|NCT01335399|19144562|P2|Pre-treatment Period|Participant request to discontinue|1
5538751|NCT01335399|19144563|P1|Pre-treatment Period|Participant request to discontinue|0
5538752|NCT01335399|19144562|P2|Pre-treatment Period|No longer meeting study criteria|1
5538753|NCT01335399|19144563|P1|Pre-treatment Period|No longer meeting study criteria|0
5538754|NCT01334918|19144684|P2|Overall Study|Withdrawal by Subject|1
5538755|NCT01334918|19144685|P1|Overall Study|Withdrawal by Subject|0
5538756|NCT01334918|19144684|P2|Overall Study|Adverse Event|0
5538757|NCT01334918|19144685|P1|Overall Study|Adverse Event|2
5538758|NCT01334918|19144684|P2|Overall Study|Did not receive study drug|0
5538759|NCT01334918|19144685|P1|Overall Study|Did not receive study drug|6
5538760|NCT01334866|19144711|P1|Overall Study|medically necessary post-procedure|1
5538761|NCT01334866|19144711|P1|Overall Study|medically necessary prior to procedure|2
5538762|NCT01334866|19144711|P1|Overall Study|Physician Decision|3
5538763|NCT01334866|19144711|P1|Overall Study|Lost to Follow-up|3
5538764|NCT01334866|19144711|P1|Overall Study|Withdrawal by Subject|10
5538765|NCT01334710|19144756|P1|Overall Study|Trial was terminated|3
5538766|NCT01334606|19144761|P1|Overall Study|Study Terminated due to slow enrolment|18
5538767|NCT01334554|19144769|P2|Overall Study|Adverse Event|2
5538768|NCT01334554|19144770|P1|Overall Study|Adverse Event|4
5538769|NCT01334515|19144780|P2|Overall Study|Withdrawal by Subject|1
5538770|NCT01334515|19144781|P1|Overall Study|Withdrawal by Subject|1
5538771|NCT01334515|19144780|P2|Overall Study|Physician Decision|1
5538772|NCT01334515|19144781|P1|Overall Study|Physician Decision|1
5538773|NCT01334515|19144780|P2|Overall Study|Lack of Efficacy|21
5538774|NCT01334515|19144781|P1|Overall Study|Lack of Efficacy|8
5538775|NCT01334515|19144780|P2|Overall Study|Death|0
5538776|NCT01334515|19144781|P1|Overall Study|Death|1
5538777|NCT01334515|19144780|P2|Overall Study|Adverse Event|6
5538778|NCT01334515|19144781|P1|Overall Study|Adverse Event|1
5538779|NCT01334125|19144819|P2|Overall Study|Lost to Follow-up|3
5538780|NCT01334125|19144820|P1|Overall Study|Lost to Follow-up|3
5538781|NCT01333956|19144836|P4|Overall Study|Withdrawal by Subject|0
5538782|NCT01333956|19144837|P3|Overall Study|Withdrawal by Subject|1
5538783|NCT01333956|19144838|P2|Overall Study|Withdrawal by Subject|2
5538784|NCT01333956|19144839|P1|Overall Study|Withdrawal by Subject|0
5538785|NCT01333956|19144836|P4|Overall Study|Unable to complete study procedure|1
5538786|NCT01333956|19144837|P3|Overall Study|Unable to complete study procedure|0
5538787|NCT01333956|19144838|P2|Overall Study|Unable to complete study procedure|0
5538788|NCT01333956|19144839|P1|Overall Study|Unable to complete study procedure|1
5538789|NCT01333956|19144836|P4|Overall Study|Lost to Follow-up|1
5538790|NCT01333956|19144837|P3|Overall Study|Lost to Follow-up|0
5538791|NCT01333956|19144838|P2|Overall Study|Lost to Follow-up|2
5538792|NCT01333956|19144839|P1|Overall Study|Lost to Follow-up|1
5538793|NCT01333943|19144875|P2|Overall Study|Known neuropathy|0
5538794|NCT01333943|19144876|P1|Overall Study|Known neuropathy|1
5538795|NCT01333865|19144892|P1|Overall Study|Adverse Event|2
5538796|NCT01333722|19144912|P2|Overall Study|Withdrawal by Subject|1
5538797|NCT01333722|19144913|P1|Overall Study|Withdrawal by Subject|0
5538798|NCT01333722|19144912|P2|Overall Study|Lack of Efficacy|2
5538799|NCT01333722|19144913|P1|Overall Study|Lack of Efficacy|0
5538800|NCT01333501|19144938|P2|Overall Study|Withdrawn consent|12
5538801|NCT01333501|19144939|P1|Overall Study|Withdrawn consent|3
5538802|NCT01333501|19144938|P2|Overall Study|Unsatisfactory therapeutic effect|7
5538803|NCT01333501|19144939|P1|Overall Study|Unsatisfactory therapeutic effect|1
5538804|NCT01333501|19144938|P2|Overall Study|Abnormal laboratory value|1
5538805|NCT01333501|19144939|P1|Overall Study|Abnormal laboratory value|2
5538806|NCT01333501|19144938|P2|Overall Study|Adverse Event|1
5538807|NCT01333501|19144939|P1|Overall Study|Adverse Event|3
5538808|NCT01333475|19145006|P2|Overall Study|Toxicity|3
5538809|NCT01333475|19145007|P1|Overall Study|Toxicity|1
5538810|NCT01333475|19145006|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
5538811|NCT01333475|19145007|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
5538812|NCT01333397|19145033|P5|Overall Study|Lost to Follow-up|0
5538813|NCT01333397|19145034|P4|Overall Study|Lost to Follow-up|1
5538814|NCT01333397|19145035|P3|Overall Study|Lost to Follow-up|0
5538815|NCT01333397|19145036|P2|Overall Study|Lost to Follow-up|0
5538816|NCT01333397|19145037|P1|Overall Study|Lost to Follow-up|1
5538817|NCT01333189|19145111|P2|Overall Study|Moved from region|1
5538818|NCT01333189|19145112|P1|Overall Study|Moved from region|0
5538819|NCT01333189|19145111|P2|Overall Study|Transportation difficulties|1
5538820|NCT01333189|19145112|P1|Overall Study|Transportation difficulties|0
5538821|NCT01333189|19145111|P2|Overall Study|Adverse Event|0
5538822|NCT01333189|19145112|P1|Overall Study|Adverse Event|1
5538823|NCT01333189|19145111|P2|Overall Study|Time constraints|0
5538824|NCT01333189|19145112|P1|Overall Study|Time constraints|1
5538825|NCT01333111|19145143|P3|Overall Study|Ineffective therapy|1
5538826|NCT01333111|19145144|P2|Overall Study|Ineffective therapy|0
5538827|NCT01333111|19145145|P1|Overall Study|Ineffective therapy|0
5538828|NCT01333111|19145143|P3|Overall Study|Non-compliance|0
5538829|NCT01333111|19145144|P2|Overall Study|Non-compliance|0
5538830|NCT01333111|19145145|P1|Overall Study|Non-compliance|1
5538831|NCT01333111|19145143|P3|Overall Study|withdrawal criteria|0
5538832|NCT01333111|19145144|P2|Overall Study|withdrawal criteria|1
5538833|NCT01333111|19145145|P1|Overall Study|withdrawal criteria|0
5538834|NCT01333111|19145143|P3|Overall Study|unclassified|0
5538835|NCT01333111|19145144|P2|Overall Study|unclassified|0
5538836|NCT01333111|19145145|P1|Overall Study|unclassified|1
5538837|NCT01333111|19145143|P3|Overall Study|personal reasons|1
5538838|NCT01333111|19145144|P2|Overall Study|personal reasons|0
5538839|NCT01333111|19145145|P1|Overall Study|personal reasons|0
5538840|NCT01333111|19145143|P3|Overall Study|patient undergoing major surgery|0
5538841|NCT01333111|19145144|P2|Overall Study|patient undergoing major surgery|2
5538842|NCT01333111|19145145|P1|Overall Study|patient undergoing major surgery|0
5538843|NCT01333072|19145180|P2|Overall Study|Physician Decision|0
5538844|NCT01333072|19145181|P1|Overall Study|Physician Decision|1
5538845|NCT01333072|19145180|P2|Overall Study|Adverse Event|4
5538846|NCT01333072|19145181|P1|Overall Study|Adverse Event|2
5538847|NCT01333072|19145180|P2|Overall Study|Lost to Follow-up|0
5538848|NCT01333072|19145181|P1|Overall Study|Lost to Follow-up|3
5538849|NCT01333059|19145189|P2|Overall Study|Protocol Violation|0
5538850|NCT01333059|19145190|P1|Overall Study|Protocol Violation|3
5538851|NCT01333059|19145189|P2|Overall Study|Physician Decision|3
5538852|NCT01333059|19145190|P1|Overall Study|Physician Decision|3
5538853|NCT01332994|19145200|P1|Overall Study|Other|8
5538854|NCT01332994|19145200|P1|Overall Study|Administrative Problem|2
5538855|NCT01332994|19145200|P1|Overall Study|Withdrawal by Subject|15
5538856|NCT01332994|19145200|P1|Overall Study|Protocol Violation|6
5538857|NCT01332994|19145200|P1|Overall Study|Lost to Follow-up|4
5538858|NCT01332994|19145200|P1|Overall Study|Lack of Efficacy|1
5538859|NCT01332994|19145200|P1|Overall Study|Death|1
5538860|NCT01332994|19145200|P1|Overall Study|Adverse Event|34
5538861|NCT01332968|19145269|P8|Follow-Up Period|Lost to Follow-up|2
5538862|NCT01332968|19145270|P7|Follow-Up Period|Lost to Follow-up|1
5538863|NCT01332968|19145271|P6|Follow-Up Period|Lost to Follow-up|0
5538864|NCT01332968|19145272|P5|Follow-Up Period|Lost to Follow-up|0
5538865|NCT01332968|19145273|P4|Follow-Up Period|Lost to Follow-up|0
5538866|NCT01332968|19145274|P3|Follow-Up Period|Lost to Follow-up|0
5538867|NCT01332968|19145275|P2|Follow-Up Period|Lost to Follow-up|0
5538868|NCT01332968|19145276|P1|Follow-Up Period|Lost to Follow-up|0
5538869|NCT01332968|19145269|P8|Follow-Up Period|Withdrawal by Subject|2
5538870|NCT01332968|19145270|P7|Follow-Up Period|Withdrawal by Subject|1
5538871|NCT01332968|19145271|P6|Follow-Up Period|Withdrawal by Subject|0
5538872|NCT01332968|19145272|P5|Follow-Up Period|Withdrawal by Subject|0
5538873|NCT01332968|19145273|P4|Follow-Up Period|Withdrawal by Subject|0
5538874|NCT01332968|19145274|P3|Follow-Up Period|Withdrawal by Subject|0
5538875|NCT01332968|19145275|P2|Follow-Up Period|Withdrawal by Subject|0
5538876|NCT01332968|19145276|P1|Follow-Up Period|Withdrawal by Subject|0
5538877|NCT01332968|19145269|P8|Follow-Up Period|Follow-up ongoing|505
5538878|NCT01332968|19145270|P7|Follow-Up Period|Follow-up ongoing|502
5538879|NCT01332968|19145271|P6|Follow-Up Period|Follow-up ongoing|0
5538880|NCT01332968|19145272|P5|Follow-Up Period|Follow-up ongoing|0
5538881|NCT01332968|19145273|P4|Follow-Up Period|Follow-up ongoing|0
5538882|NCT01332968|19145274|P3|Follow-Up Period|Follow-up ongoing|0
5538883|NCT01332968|19145275|P2|Follow-Up Period|Follow-up ongoing|0
5538884|NCT01332968|19145276|P1|Follow-Up Period|Follow-up ongoing|0
5538885|NCT01332968|19145269|P8|Follow-Up Period|Death|22
5538886|NCT01332968|19145270|P7|Follow-Up Period|Death|38
5538887|NCT01332968|19145271|P6|Follow-Up Period|Death|0
5538888|NCT01332968|19145272|P5|Follow-Up Period|Death|0
5538889|NCT01332968|19145273|P4|Follow-Up Period|Death|0
5538890|NCT01332968|19145274|P3|Follow-Up Period|Death|0
5538891|NCT01332968|19145275|P2|Follow-Up Period|Death|0
5538892|NCT01332968|19145276|P1|Follow-Up Period|Death|0
5538893|NCT01332968|19145269|P8|Maintenance/Observation Period|Treatment ongoing|0
5538894|NCT01332968|19145270|P7|Maintenance/Observation Period|Treatment ongoing|0
5538895|NCT01332968|19145271|P6|Maintenance/Observation Period|Treatment ongoing|8
5538896|NCT01332968|19145272|P5|Maintenance/Observation Period|Treatment ongoing|10
5538897|NCT01332968|19145273|P4|Maintenance/Observation Period|Treatment ongoing|62
5538898|NCT01332968|19145274|P3|Maintenance/Observation Period|Treatment ongoing|54
5538899|NCT01332968|19145275|P2|Maintenance/Observation Period|Treatment ongoing|0
5538900|NCT01332968|19145276|P1|Maintenance/Observation Period|Treatment ongoing|0
5538901|NCT01332968|19145269|P8|Maintenance/Observation Period|Adverse Event|0
5538902|NCT01332968|19145270|P7|Maintenance/Observation Period|Adverse Event|0
5538903|NCT01332968|19145271|P6|Maintenance/Observation Period|Adverse Event|0
5538904|NCT01332968|19145272|P5|Maintenance/Observation Period|Adverse Event|0
5538905|NCT01332968|19145273|P4|Maintenance/Observation Period|Adverse Event|65
5538906|NCT01332968|19145274|P3|Maintenance/Observation Period|Adverse Event|50
5538907|NCT01332968|19145275|P2|Maintenance/Observation Period|Adverse Event|0
5538908|NCT01332968|19145276|P1|Maintenance/Observation Period|Adverse Event|0
5538909|NCT01332968|19145269|P8|Maintenance/Observation Period|Death|0
5538910|NCT01332968|19145270|P7|Maintenance/Observation Period|Death|0
5538911|NCT01332968|19145271|P6|Maintenance/Observation Period|Death|0
5538912|NCT01332968|19145272|P5|Maintenance/Observation Period|Death|0
5538913|NCT01332968|19145273|P4|Maintenance/Observation Period|Death|6
5538914|NCT01332968|19145274|P3|Maintenance/Observation Period|Death|5
5538915|NCT01332968|19145275|P2|Maintenance/Observation Period|Death|0
5538916|NCT01332968|19145276|P1|Maintenance/Observation Period|Death|0
5538917|NCT01332968|19145269|P8|Maintenance/Observation Period|Lost to Follow-up|0
5538918|NCT01332968|19145270|P7|Maintenance/Observation Period|Lost to Follow-up|0
5538919|NCT01332968|19145271|P6|Maintenance/Observation Period|Lost to Follow-up|0
5538920|NCT01332968|19145272|P5|Maintenance/Observation Period|Lost to Follow-up|0
5538921|NCT01332968|19145273|P4|Maintenance/Observation Period|Lost to Follow-up|2
5538922|NCT01332968|19145274|P3|Maintenance/Observation Period|Lost to Follow-up|1
5538923|NCT01332968|19145275|P2|Maintenance/Observation Period|Lost to Follow-up|0
5538924|NCT01332968|19145276|P1|Maintenance/Observation Period|Lost to Follow-up|0
5538925|NCT01332968|19145269|P8|Maintenance/Observation Period|Non-compliance|0
5538926|NCT01332968|19145270|P7|Maintenance/Observation Period|Non-compliance|0
5538927|NCT01332968|19145271|P6|Maintenance/Observation Period|Non-compliance|1
5538928|NCT01332968|19145272|P5|Maintenance/Observation Period|Non-compliance|0
5538929|NCT01332968|19145273|P4|Maintenance/Observation Period|Non-compliance|3
5538930|NCT01332968|19145274|P3|Maintenance/Observation Period|Non-compliance|2
5538931|NCT01332968|19145275|P2|Maintenance/Observation Period|Non-compliance|0
5538932|NCT01332968|19145276|P1|Maintenance/Observation Period|Non-compliance|0
5538933|NCT01332968|19145269|P8|Maintenance/Observation Period|Other|0
5538934|NCT01332968|19145270|P7|Maintenance/Observation Period|Other|0
5538935|NCT01332968|19145271|P6|Maintenance/Observation Period|Other|0
5538936|NCT01332968|19145272|P5|Maintenance/Observation Period|Other|0
5538937|NCT01332968|19145273|P4|Maintenance/Observation Period|Other|5
5538938|NCT01332968|19145274|P3|Maintenance/Observation Period|Other|4
5538939|NCT01332968|19145275|P2|Maintenance/Observation Period|Other|0
5538940|NCT01332968|19145276|P1|Maintenance/Observation Period|Other|0
5538941|NCT01332968|19145269|P8|Maintenance/Observation Period|Physician Decision|0
5538942|NCT01332968|19145270|P7|Maintenance/Observation Period|Physician Decision|0
5538943|NCT01332968|19145271|P6|Maintenance/Observation Period|Physician Decision|0
5538944|NCT01332968|19145272|P5|Maintenance/Observation Period|Physician Decision|0
5538945|NCT01332968|19145273|P4|Maintenance/Observation Period|Physician Decision|19
5538946|NCT01332968|19145274|P3|Maintenance/Observation Period|Physician Decision|14
5538947|NCT01332968|19145275|P2|Maintenance/Observation Period|Physician Decision|0
5538948|NCT01332968|19145276|P1|Maintenance/Observation Period|Physician Decision|0
5538949|NCT01332968|19145269|P8|Maintenance/Observation Period|Progressive disease|0
5538950|NCT01332968|19145270|P7|Maintenance/Observation Period|Progressive disease|0
5538951|NCT01332968|19145271|P6|Maintenance/Observation Period|Progressive disease|0
5538952|NCT01332968|19145272|P5|Maintenance/Observation Period|Progressive disease|0
5538953|NCT01332968|19145273|P4|Maintenance/Observation Period|Progressive disease|39
5538954|NCT01332968|19145274|P3|Maintenance/Observation Period|Progressive disease|72
5538955|NCT01332968|19145275|P2|Maintenance/Observation Period|Progressive disease|0
5538956|NCT01332968|19145276|P1|Maintenance/Observation Period|Progressive disease|0
5538957|NCT01332968|19145269|P8|Maintenance/Observation Period|Protocol Violation|0
5538958|NCT01332968|19145270|P7|Maintenance/Observation Period|Protocol Violation|0
5538959|NCT01332968|19145271|P6|Maintenance/Observation Period|Protocol Violation|0
5538960|NCT01332968|19145272|P5|Maintenance/Observation Period|Protocol Violation|0
5538961|NCT01332968|19145273|P4|Maintenance/Observation Period|Protocol Violation|1
5538962|NCT01332968|19145274|P3|Maintenance/Observation Period|Protocol Violation|1
5538963|NCT01332968|19145275|P2|Maintenance/Observation Period|Protocol Violation|0
5538964|NCT01332968|19145276|P1|Maintenance/Observation Period|Protocol Violation|0
5538965|NCT01332968|19145269|P8|Maintenance/Observation Period|Withdrawal by Subject|0
5538966|NCT01332968|19145270|P7|Maintenance/Observation Period|Withdrawal by Subject|0
5538967|NCT01332968|19145271|P6|Maintenance/Observation Period|Withdrawal by Subject|0
5538968|NCT01332968|19145272|P5|Maintenance/Observation Period|Withdrawal by Subject|0
5538969|NCT01332968|19145273|P4|Maintenance/Observation Period|Withdrawal by Subject|5
5538970|NCT01332968|19145274|P3|Maintenance/Observation Period|Withdrawal by Subject|10
5538971|NCT01332968|19145275|P2|Maintenance/Observation Period|Withdrawal by Subject|0
5538972|NCT01332968|19145276|P1|Maintenance/Observation Period|Withdrawal by Subject|0
5538973|NCT01332968|19145269|P8|Induction Period|Randomized, but not treated|0
5538974|NCT01332968|19145270|P7|Induction Period|Randomized, but not treated|0
5538975|NCT01332968|19145271|P6|Induction Period|Randomized, but not treated|0
5538976|NCT01332968|19145272|P5|Induction Period|Randomized, but not treated|0
5538977|NCT01332968|19145273|P4|Induction Period|Randomized, but not treated|0
5538978|NCT01332968|19145274|P3|Induction Period|Randomized, but not treated|0
5538979|NCT01332968|19145275|P2|Induction Period|Randomized, but not treated|7
5538980|NCT01332968|19145276|P1|Induction Period|Randomized, but not treated|4
5538981|NCT01332968|19145269|P8|Induction Period|Adverse Event|0
5538982|NCT01332968|19145270|P7|Induction Period|Adverse Event|0
5538983|NCT01332968|19145271|P6|Induction Period|Adverse Event|0
5538984|NCT01332968|19145272|P5|Induction Period|Adverse Event|0
5538985|NCT01332968|19145273|P4|Induction Period|Adverse Event|0
5538986|NCT01332968|19145274|P3|Induction Period|Adverse Event|0
5538987|NCT01332968|19145275|P2|Induction Period|Adverse Event|26
5538988|NCT01332968|19145276|P1|Induction Period|Adverse Event|23
5538989|NCT01332968|19145269|P8|Induction Period|Death|0
5538990|NCT01332968|19145270|P7|Induction Period|Death|0
5538991|NCT01332968|19145271|P6|Induction Period|Death|0
5538992|NCT01332968|19145272|P5|Induction Period|Death|0
5538993|NCT01332968|19145273|P4|Induction Period|Death|0
5538994|NCT01332968|19145274|P3|Induction Period|Death|0
5538995|NCT01332968|19145275|P2|Induction Period|Death|4
5538996|NCT01332968|19145276|P1|Induction Period|Death|1
5538997|NCT01332968|19145269|P8|Induction Period|Non-compliance|0
5538998|NCT01332968|19145270|P7|Induction Period|Non-compliance|0
5538999|NCT01332968|19145271|P6|Induction Period|Non-compliance|0
5539000|NCT01332968|19145272|P5|Induction Period|Non-compliance|0
5539001|NCT01332968|19145273|P4|Induction Period|Non-compliance|0
5539002|NCT01332968|19145274|P3|Induction Period|Non-compliance|0
5539003|NCT01332968|19145275|P2|Induction Period|Non-compliance|0
5539004|NCT01332968|19145276|P1|Induction Period|Non-compliance|1
5539005|NCT01332968|19145269|P8|Induction Period|Other|0
5539006|NCT01332968|19145270|P7|Induction Period|Other|0
5539007|NCT01332968|19145271|P6|Induction Period|Other|0
5539008|NCT01332968|19145272|P5|Induction Period|Other|0
5539009|NCT01332968|19145273|P4|Induction Period|Other|0
5539010|NCT01332968|19145274|P3|Induction Period|Other|0
5539011|NCT01332968|19145275|P2|Induction Period|Other|2
5539012|NCT01332968|19145276|P1|Induction Period|Other|2
5539013|NCT01332968|19145269|P8|Induction Period|Physician Decision|0
5539014|NCT01332968|19145270|P7|Induction Period|Physician Decision|0
5539015|NCT01332968|19145271|P6|Induction Period|Physician Decision|0
5539016|NCT01332968|19145272|P5|Induction Period|Physician Decision|0
5539017|NCT01332968|19145273|P4|Induction Period|Physician Decision|0
5539018|NCT01332968|19145274|P3|Induction Period|Physician Decision|0
5539019|NCT01332968|19145275|P2|Induction Period|Physician Decision|1
5539020|NCT01332968|19145276|P1|Induction Period|Physician Decision|6
5539021|NCT01332968|19145269|P8|Induction Period|Progressive disease|0
5539022|NCT01332968|19145270|P7|Induction Period|Progressive disease|0
5539023|NCT01332968|19145271|P6|Induction Period|Progressive disease|0
5539024|NCT01332968|19145272|P5|Induction Period|Progressive disease|0
5539025|NCT01332968|19145273|P4|Induction Period|Progressive disease|0
5539026|NCT01332968|19145274|P3|Induction Period|Progressive disease|0
5539027|NCT01332968|19145275|P2|Induction Period|Progressive disease|7
5539028|NCT01332968|19145276|P1|Induction Period|Progressive disease|15
5539029|NCT01332968|19145269|P8|Induction Period|Protocol Violation|0
5539030|NCT01332968|19145270|P7|Induction Period|Protocol Violation|0
5539031|NCT01332968|19145271|P6|Induction Period|Protocol Violation|0
5539032|NCT01332968|19145272|P5|Induction Period|Protocol Violation|0
5539033|NCT01332968|19145273|P4|Induction Period|Protocol Violation|0
5539034|NCT01332968|19145274|P3|Induction Period|Protocol Violation|0
5539035|NCT01332968|19145275|P2|Induction Period|Protocol Violation|4
5539036|NCT01332968|19145276|P1|Induction Period|Protocol Violation|3
5539037|NCT01332968|19145269|P8|Induction Period|Withdrawal by Subject|0
5539038|NCT01332968|19145270|P7|Induction Period|Withdrawal by Subject|0
5539039|NCT01332968|19145271|P6|Induction Period|Withdrawal by Subject|0
5539040|NCT01332968|19145272|P5|Induction Period|Withdrawal by Subject|0
5539041|NCT01332968|19145273|P4|Induction Period|Withdrawal by Subject|0
5539042|NCT01332968|19145274|P3|Induction Period|Withdrawal by Subject|0
5539043|NCT01332968|19145275|P2|Induction Period|Withdrawal by Subject|5
5539044|NCT01332968|19145276|P1|Induction Period|Withdrawal by Subject|3
5539045|NCT01332851|19145342|P2|Overall Study|Lost to Follow-up|11
5539046|NCT01332851|19145343|P1|Overall Study|Lost to Follow-up|7
5539047|NCT01332851|19145342|P2|Overall Study|Withdrawal by Subject|2
5539048|NCT01332851|19145343|P1|Overall Study|Withdrawal by Subject|4
5539049|NCT01332799|19145377|P2|Overall Study|Insufficient funding|10
5539050|NCT01332799|19145378|P1|Overall Study|Insufficient funding|10
5539051|NCT01332630|19145394|P1|Overall Study|Withdrawal by Subject|3
5539052|NCT01332331|19145510|P2|Overall Study|Physician Decision|0
5539053|NCT01332331|19145511|P1|Overall Study|Physician Decision|1
5539054|NCT01332331|19145510|P2|Overall Study|Adverse Event|1
5539055|NCT01332331|19145511|P1|Overall Study|Adverse Event|1
5539056|NCT01332331|19145510|P2|Overall Study|Lost to Follow-up|1
5539057|NCT01332331|19145511|P1|Overall Study|Lost to Follow-up|0
5539058|NCT01332318|19145563|P4|Overall Study|Protocol Violation|1
5539059|NCT01332318|19145564|P3|Overall Study|Protocol Violation|1
5539060|NCT01332318|19145565|P2|Overall Study|Protocol Violation|0
5539061|NCT01332318|19145566|P1|Overall Study|Protocol Violation|1
5539062|NCT01332318|19145563|P4|Overall Study|Withdrawal by Subject|1
5539063|NCT01332318|19145564|P3|Overall Study|Withdrawal by Subject|0
5539064|NCT01332318|19145565|P2|Overall Study|Withdrawal by Subject|1
5539065|NCT01332318|19145566|P1|Overall Study|Withdrawal by Subject|1
5539066|NCT01332318|19145563|P4|Overall Study|Adverse Event|0
5539067|NCT01332318|19145564|P3|Overall Study|Adverse Event|0
5539068|NCT01332318|19145565|P2|Overall Study|Adverse Event|3
5539069|NCT01332318|19145566|P1|Overall Study|Adverse Event|0
5539070|NCT01332305|19145677|P5|Overall Study|Physician Decision|0
5539071|NCT01332305|19145678|P4|Overall Study|Physician Decision|1
5539072|NCT01332305|19145679|P3|Overall Study|Physician Decision|0
5539073|NCT01332305|19145680|P2|Overall Study|Physician Decision|0
5539074|NCT01332305|19145681|P1|Overall Study|Physician Decision|0
5539075|NCT01332305|19145677|P5|Overall Study|Treatment Failure|0
5539076|NCT01332305|19145678|P4|Overall Study|Treatment Failure|0
5539077|NCT01332305|19145679|P3|Overall Study|Treatment Failure|0
5539078|NCT01332305|19145680|P2|Overall Study|Treatment Failure|1
5539079|NCT01332305|19145681|P1|Overall Study|Treatment Failure|1
5539080|NCT01332305|19145677|P5|Overall Study|Withdrawal by Sponsor|1
5539081|NCT01332305|19145678|P4|Overall Study|Withdrawal by Sponsor|1
5539082|NCT01332305|19145679|P3|Overall Study|Withdrawal by Sponsor|0
5539083|NCT01332305|19145680|P2|Overall Study|Withdrawal by Sponsor|0
5539084|NCT01332305|19145681|P1|Overall Study|Withdrawal by Sponsor|1
5539085|NCT01332305|19145677|P5|Overall Study|Protocol Violation|3
5539086|NCT01332305|19145678|P4|Overall Study|Protocol Violation|0
5539087|NCT01332305|19145679|P3|Overall Study|Protocol Violation|1
5539088|NCT01332305|19145680|P2|Overall Study|Protocol Violation|2
5539089|NCT01332305|19145681|P1|Overall Study|Protocol Violation|1
5539090|NCT01332305|19145677|P5|Overall Study|Lost to Follow-up|3
5539091|NCT01332305|19145678|P4|Overall Study|Lost to Follow-up|2
5539092|NCT01332305|19145679|P3|Overall Study|Lost to Follow-up|3
5539093|NCT01332305|19145680|P2|Overall Study|Lost to Follow-up|2
5539094|NCT01332305|19145681|P1|Overall Study|Lost to Follow-up|0
5539095|NCT01332305|19145677|P5|Overall Study|Withdrawal by Subject|0
5539096|NCT01332305|19145678|P4|Overall Study|Withdrawal by Subject|1
5539097|NCT01332305|19145679|P3|Overall Study|Withdrawal by Subject|4
5539098|NCT01332305|19145680|P2|Overall Study|Withdrawal by Subject|5
5539099|NCT01332305|19145681|P1|Overall Study|Withdrawal by Subject|6
5539100|NCT01332305|19145677|P5|Overall Study|Adverse Event|5
5539101|NCT01332305|19145678|P4|Overall Study|Adverse Event|3
5539102|NCT01332305|19145679|P3|Overall Study|Adverse Event|6
5539103|NCT01332305|19145680|P2|Overall Study|Adverse Event|4
5539104|NCT01332305|19145681|P1|Overall Study|Adverse Event|1
5539105|NCT01332292|19145703|P2|Treatment Period 2 (14 Days)|Physician Decision|1
5539106|NCT01332292|19145704|P1|Treatment Period 2 (14 Days)|Physician Decision|1
5539107|NCT01332292|19145703|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
5539108|NCT01332292|19145704|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
5539109|NCT01332292|19145703|P2|Treatment Period 1 (14 Days)|Adverse Event|0
5539110|NCT01332292|19145704|P1|Treatment Period 1 (14 Days)|Adverse Event|1
5539111|NCT01332227|19145795|P2|Overall Study|Patient began prohibited medication|1
5539112|NCT01332227|19145796|P1|Overall Study|Patient began prohibited medication|0
5539113|NCT01332227|19145795|P2|Overall Study|Patient moved from area|0
5539114|NCT01332227|19145796|P1|Overall Study|Patient moved from area|1
5539115|NCT01332227|19145795|P2|Overall Study|Poor compliance/noncompliance|1
5539116|NCT01332227|19145796|P1|Overall Study|Poor compliance/noncompliance|1
5539117|NCT01332227|19145795|P2|Overall Study|Lack of Efficacy|1
5539118|NCT01332227|19145796|P1|Overall Study|Lack of Efficacy|3
5539119|NCT01332227|19145795|P2|Overall Study|Lost to Follow-up|0
5539120|NCT01332227|19145796|P1|Overall Study|Lost to Follow-up|2
5539121|NCT01332227|19145795|P2|Overall Study|Withdrawal by Subject|1
5539122|NCT01332227|19145796|P1|Overall Study|Withdrawal by Subject|5
5539123|NCT01332227|19145795|P2|Overall Study|Adverse Event|1
5539124|NCT01332227|19145796|P1|Overall Study|Adverse Event|4
5539125|NCT01332149|19145977|P2|Overall Study|Randomized but not treated|2
5539126|NCT01332149|19145978|P1|Overall Study|Randomized but not treated|1
5539127|NCT01332149|19145977|P2|Overall Study|Did not meet entrance criteria|4
5539128|NCT01332149|19145978|P1|Overall Study|Did not meet entrance criteria|3
5539129|NCT01332149|19145977|P2|Overall Study|Insufficient clinical response|7
5539130|NCT01332149|19145978|P1|Overall Study|Insufficient clinical response|4
5539131|NCT01332149|19145977|P2|Overall Study|Lost to Follow-up|1
5539132|NCT01332149|19145978|P1|Overall Study|Lost to Follow-up|1
5539133|NCT01332149|19145977|P2|Overall Study|Withdrawal by Subject|5
5539134|NCT01332149|19145978|P1|Overall Study|Withdrawal by Subject|4
5539135|NCT01332149|19145977|P2|Overall Study|Protocol Violation|3
5539136|NCT01332149|19145978|P1|Overall Study|Protocol Violation|1
5539137|NCT01332149|19145977|P2|Overall Study|Other unspecified|7
5539138|NCT01332149|19145978|P1|Overall Study|Other unspecified|5
5539139|NCT01332149|19145977|P2|Overall Study|Adverse Event|9
5539140|NCT01332149|19145978|P1|Overall Study|Adverse Event|11
5539141|NCT01332019|19146056|P2|Overall Study|Adverse Event|22
5539142|NCT01332019|19146057|P1|Overall Study|Adverse Event|13
5539143|NCT01332019|19146056|P2|Overall Study|Lost to Follow-up|7
5539144|NCT01332019|19146057|P1|Overall Study|Lost to Follow-up|4
5539145|NCT01332019|19146056|P2|Overall Study|Withdrawal by Subject|71
5539146|NCT01332019|19146057|P1|Overall Study|Withdrawal by Subject|73
5539147|NCT01332019|19146056|P2|Overall Study|Physician Decision|3
5539148|NCT01332019|19146057|P1|Overall Study|Physician Decision|4
5539149|NCT01332019|19146056|P2|Overall Study|Death|1
5539150|NCT01332019|19146057|P1|Overall Study|Death|2
5539151|NCT01332019|19146056|P2|Overall Study|Other|18
5539152|NCT01332019|19146057|P1|Overall Study|Other|16
5539153|NCT01332019|19146056|P2|Overall Study|Was Not Dosed|0
5539154|NCT01332019|19146057|P1|Overall Study|Was Not Dosed|1
5539155|NCT01331837|19146141|P2|Overall Study|Withdrawal by Subject|16
5539156|NCT01331837|19146142|P1|Overall Study|Withdrawal by Subject|13
5539157|NCT01331837|19146141|P2|Overall Study|Info not recorded|16
5539158|NCT01331837|19146142|P1|Overall Study|Info not recorded|10
5539159|NCT01331837|19146141|P2|Overall Study|Lost to Follow-up|1
5539160|NCT01331837|19146142|P1|Overall Study|Lost to Follow-up|3
5539161|NCT01331837|19146141|P2|Overall Study|Death|34
5539162|NCT01331837|19146142|P1|Overall Study|Death|30
5539163|NCT01331824|19146182|P1|Overall Study|Withdrawal by Subject|1
5539164|NCT01331824|19146182|P1|Overall Study|Disease Progression|9
5539165|NCT01331824|19146182|P1|Overall Study|Death|1
5539166|NCT01331824|19146182|P1|Overall Study|Adverse Event|2
5539167|NCT01331681|19146217|P3|Overall Study|Not Received Study Treatment|2
5539168|NCT01331681|19146218|P2|Overall Study|Not Received Study Treatment|0
5539169|NCT01331681|19146219|P1|Overall Study|Not Received Study Treatment|0
5539170|NCT01331681|19146217|P3|Overall Study|Switching to other therapy|1
5539171|NCT01331681|19146218|P2|Overall Study|Switching to other therapy|0
5539172|NCT01331681|19146219|P1|Overall Study|Switching to other therapy|0
5539173|NCT01331681|19146217|P3|Overall Study|Sponsor decision|0
5539174|NCT01331681|19146218|P2|Overall Study|Sponsor decision|1
5539175|NCT01331681|19146219|P1|Overall Study|Sponsor decision|1
5539176|NCT01331681|19146217|P3|Overall Study|Therapeutic procedure required|0
5539177|NCT01331681|19146218|P2|Overall Study|Therapeutic procedure required|0
5539178|NCT01331681|19146219|P1|Overall Study|Therapeutic procedure required|1
5539179|NCT01331681|19146217|P3|Overall Study|Physician Decision|4
5539180|NCT01331681|19146218|P2|Overall Study|Physician Decision|0
5539181|NCT01331681|19146219|P1|Overall Study|Physician Decision|2
5539182|NCT01331681|19146217|P3|Overall Study|Lost to Follow-up|1
5539183|NCT01331681|19146218|P2|Overall Study|Lost to Follow-up|4
5539184|NCT01331681|19146219|P1|Overall Study|Lost to Follow-up|2
5539185|NCT01331681|19146217|P3|Overall Study|Protocol Violation|0
5539186|NCT01331681|19146218|P2|Overall Study|Protocol Violation|1
5539187|NCT01331681|19146219|P1|Overall Study|Protocol Violation|1
5539188|NCT01331681|19146217|P3|Overall Study|Withdrawal by Subject|15
5539189|NCT01331681|19146218|P2|Overall Study|Withdrawal by Subject|8
5539190|NCT01331681|19146219|P1|Overall Study|Withdrawal by Subject|12
5539191|NCT01331681|19146217|P3|Overall Study|Lack of Efficacy|0
5539192|NCT01331681|19146218|P2|Overall Study|Lack of Efficacy|1
5539193|NCT01331681|19146219|P1|Overall Study|Lack of Efficacy|0
5539194|NCT01331681|19146217|P3|Overall Study|Death|2
5539195|NCT01331681|19146218|P2|Overall Study|Death|6
5539196|NCT01331681|19146219|P1|Overall Study|Death|6
5539197|NCT01331681|19146217|P3|Overall Study|Adverse Event|10
5539198|NCT01331681|19146218|P2|Overall Study|Adverse Event|13
5539199|NCT01331681|19146219|P1|Overall Study|Adverse Event|10
5539200|NCT01331291|19146268|P2|Overall Study|Death|1
5539201|NCT01331291|19146269|P1|Overall Study|Death|0
5539202|NCT01331291|19146268|P2|Overall Study|Lack of Efficacy|8
5539203|NCT01331291|19146269|P1|Overall Study|Lack of Efficacy|2
5539204|NCT01331161|19146303|P2|Overall Study|Pregnancy|1
5539205|NCT01331161|19146304|P1|Overall Study|Pregnancy|0
5539206|NCT01331161|19146303|P2|Overall Study|Lost to Follow-up|1
5539207|NCT01331161|19146304|P1|Overall Study|Lost to Follow-up|0
5539208|NCT01331161|19146303|P2|Overall Study|Physician Decision|0
5539209|NCT01331161|19146304|P1|Overall Study|Physician Decision|1
5539210|NCT01331109|19146312|P1|Overall Study|Study Terminated by Sponsor|38
5539211|NCT01331109|19146312|P1|Overall Study|Lost to Follow-up|1
5539212|NCT01331109|19146312|P1|Overall Study|Withdrawal by Subject|7
5539213|NCT01331109|19146312|P1|Overall Study|Protocol Violation|3
5539214|NCT01331109|19146312|P1|Overall Study|Lack of Efficacy|2
5539215|NCT01331109|19146312|P1|Overall Study|Adverse Event|6
5539216|NCT01331005|19146339|P2|Overall Study|Withdrawal by Subject|3
5539217|NCT01331005|19146340|P1|Overall Study|Withdrawal by Subject|2
5539218|NCT01331005|19146339|P2|Overall Study|Lost to Follow-up|1
5539219|NCT01331005|19146340|P1|Overall Study|Lost to Follow-up|2
5539220|NCT01330914|19146411|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
5539221|NCT01330914|19146411|P1|Overall Study|Withdrawal by Subject|4
5539222|NCT01330628|19146419|P2|Overall Study|Didn't receive study treatment|0
5539223|NCT01330628|19146420|P1|Overall Study|Didn't receive study treatment|1
5539224|NCT01330628|19146419|P2|Overall Study|Withdrawn|6
5539225|NCT01330628|19146420|P1|Overall Study|Withdrawn|18
5539226|NCT01330628|19146419|P2|Overall Study|Adverse Event|25
5539227|NCT01330628|19146420|P1|Overall Study|Adverse Event|44
5539228|NCT01330628|19146419|P2|Overall Study|Lost to Follow-up|6
5539229|NCT01330628|19146420|P1|Overall Study|Lost to Follow-up|5
5539230|NCT01330628|19146419|P2|Overall Study|Death|3
5539231|NCT01330628|19146420|P1|Overall Study|Death|2
5539232|NCT01330459|19146430|P2|Overall Study|Physician Decision|2
5539233|NCT01330459|19146431|P1|Overall Study|Physician Decision|0
5539234|NCT01330433|19146447|P2|Overall Study|Lost to Follow-up|0
5539235|NCT01330433|19146448|P1|Overall Study|Lost to Follow-up|1
5539236|NCT01330433|19146447|P2|Overall Study|Death|3
5539237|NCT01330433|19146448|P1|Overall Study|Death|1
5539238|NCT01330381|19146487|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
5539239|NCT01330381|19146488|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
5539240|NCT01330381|19146489|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
5539241|NCT01330381|19146487|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
5539242|NCT01330381|19146488|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
5539243|NCT01330381|19146489|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
5539244|NCT01330381|19146487|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
5539245|NCT01330381|19146488|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
5539246|NCT01330381|19146489|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
5539247|NCT01330381|19146487|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
5539248|NCT01330381|19146488|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
5539249|NCT01330381|19146489|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
5539250|NCT01330381|19146487|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
5539251|NCT01330381|19146488|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
5539252|NCT01330381|19146489|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
5539253|NCT01330381|19146487|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
5539254|NCT01330381|19146488|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
5539255|NCT01330381|19146489|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
5539256|NCT01330381|19146487|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
5539257|NCT01330381|19146488|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
5539258|NCT01330381|19146489|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
5539259|NCT01330381|19146487|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
5539260|NCT01330381|19146488|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
5539261|NCT01330381|19146489|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
5539262|NCT01330381|19146487|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
5539263|NCT01330381|19146488|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
5539264|NCT01330381|19146489|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
5539265|NCT01330381|19146487|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
5539266|NCT01330381|19146488|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
5539267|NCT01330381|19146489|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
5539268|NCT01330316|19146550|P2|Overall Study|other than above|1
5539269|NCT01330316|19146551|P1|Overall Study|other than above|0
5539270|NCT01330316|19146550|P2|Overall Study|Withdrawal by Subject|1
5539271|NCT01330316|19146551|P1|Overall Study|Withdrawal by Subject|0
5539272|NCT01330316|19146550|P2|Overall Study|Lost to Follow-up|1
5539273|NCT01330316|19146551|P1|Overall Study|Lost to Follow-up|0
5539274|NCT01330316|19146550|P2|Overall Study|Lack of Efficacy|10
5539275|NCT01330316|19146551|P1|Overall Study|Lack of Efficacy|0
5539276|NCT01330316|19146550|P2|Overall Study|Adverse Event|2
5539277|NCT01330316|19146551|P1|Overall Study|Adverse Event|2
5539278|NCT01330303|19146587|P2|Period 1|Withdrawal by Subject|1
5539279|NCT01330303|19146588|P1|Period 1|Withdrawal by Subject|0
5539280|NCT01330303|19146587|P2|Period 1|Protocol Violation|1
5539281|NCT01330303|19146588|P1|Period 1|Protocol Violation|0
5539282|NCT01330303|19146587|P2|Period 1|Adverse Event|0
5539283|NCT01330303|19146588|P1|Period 1|Adverse Event|1
5539284|NCT01330108|19146635|P1|Overall Study|Withdrawal by Subject|4
5539285|NCT01330030|19146653|P2|Overall Study|Lost to Follow-up|17
5539286|NCT01330030|19146654|P1|Overall Study|Lost to Follow-up|16
5539287|NCT01330017|19146665|P5|Overall Study|Unknown Reason|2
5539288|NCT01330017|19146666|P4|Overall Study|Unknown Reason|7
5539289|NCT01330017|19146667|P3|Overall Study|Unknown Reason|5
5539290|NCT01330017|19146668|P2|Overall Study|Unknown Reason|3
5539291|NCT01330017|19146669|P1|Overall Study|Unknown Reason|5
5539292|NCT01330017|19146665|P5|Overall Study|Protocol Violation|0
5539293|NCT01330017|19146666|P4|Overall Study|Protocol Violation|1
5539294|NCT01330017|19146667|P3|Overall Study|Protocol Violation|0
5539295|NCT01330017|19146668|P2|Overall Study|Protocol Violation|0
5539296|NCT01330017|19146669|P1|Overall Study|Protocol Violation|0
5539297|NCT01330017|19146665|P5|Overall Study|Lost to Follow-up|0
5539298|NCT01330017|19146666|P4|Overall Study|Lost to Follow-up|0
5539299|NCT01330017|19146667|P3|Overall Study|Lost to Follow-up|1
5539300|NCT01330017|19146668|P2|Overall Study|Lost to Follow-up|0
5539301|NCT01330017|19146669|P1|Overall Study|Lost to Follow-up|0
5539302|NCT01330017|19146665|P5|Overall Study|Withdrawal by Subject|1
5539303|NCT01330017|19146666|P4|Overall Study|Withdrawal by Subject|0
5539304|NCT01330017|19146667|P3|Overall Study|Withdrawal by Subject|1
5539305|NCT01330017|19146668|P2|Overall Study|Withdrawal by Subject|0
5539306|NCT01330017|19146669|P1|Overall Study|Withdrawal by Subject|0
5539307|NCT01330017|19146665|P5|Overall Study|Adverse Event|0
5539308|NCT01330017|19146666|P4|Overall Study|Adverse Event|4
5539309|NCT01330017|19146667|P3|Overall Study|Adverse Event|1
5539310|NCT01330017|19146668|P2|Overall Study|Adverse Event|1
5539311|NCT01330017|19146669|P1|Overall Study|Adverse Event|0
5539312|NCT01329978|19146718|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
5539313|NCT01329978|19146719|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
5539314|NCT01329978|19146720|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
5539315|NCT01329978|19146721|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
5539316|NCT01329978|19146722|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
5539317|NCT01329978|19146718|P5|Rerandomization Treatment Period|Lost to Follow-up|3
5539318|NCT01329978|19146719|P4|Rerandomization Treatment Period|Lost to Follow-up|5
5539319|NCT01329978|19146720|P3|Rerandomization Treatment Period|Lost to Follow-up|0
5539320|NCT01329978|19146721|P2|Rerandomization Treatment Period|Lost to Follow-up|0
5539321|NCT01329978|19146722|P1|Rerandomization Treatment Period|Lost to Follow-up|0
5539322|NCT01329978|19146718|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5539323|NCT01329978|19146719|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5539324|NCT01329978|19146720|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5539325|NCT01329978|19146721|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
5539326|NCT01329978|19146722|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
5539327|NCT01329978|19146718|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5539328|NCT01329978|19146719|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5539329|NCT01329978|19146720|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5539330|NCT01329978|19146721|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
5539331|NCT01329978|19146722|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
5539332|NCT01329978|19146718|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
5539333|NCT01329978|19146719|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
5539334|NCT01329978|19146720|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
5539335|NCT01329978|19146721|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
5539336|NCT01329978|19146722|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
5539337|NCT01329978|19146718|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
5539338|NCT01329978|19146719|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
5539339|NCT01329978|19146720|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
5539340|NCT01329978|19146721|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
5539341|NCT01329978|19146722|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
5539342|NCT01329978|19146718|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
5539343|NCT01329978|19146719|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
5539344|NCT01329978|19146720|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
5539345|NCT01329978|19146721|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
5539346|NCT01329978|19146722|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
5539347|NCT01329939|19146796|P4|Overall Study|Adverse Event|3
5539348|NCT01329939|19146797|P3|Overall Study|Adverse Event|0
5539349|NCT01329939|19146798|P2|Overall Study|Adverse Event|0
5539350|NCT01329939|19146799|P1|Overall Study|Adverse Event|0
5539351|NCT01329939|19146796|P4|Overall Study|Withdrawal by Subject|0
5539352|NCT01329939|19146797|P3|Overall Study|Withdrawal by Subject|0
5539353|NCT01329939|19146798|P2|Overall Study|Withdrawal by Subject|1
5539354|NCT01329939|19146799|P1|Overall Study|Withdrawal by Subject|0
5539355|NCT01329939|19146796|P4|Overall Study|Lost to Follow-up|2
5539356|NCT01329939|19146797|P3|Overall Study|Lost to Follow-up|1
5539357|NCT01329939|19146798|P2|Overall Study|Lost to Follow-up|0
5539358|NCT01329939|19146799|P1|Overall Study|Lost to Follow-up|3
5539359|NCT01329900|19146837|P1|Overall Study|Elevated creatinine/renal function|1
5539360|NCT01329562|19146867|P2|Overall Study|Physician Decision|1
5539361|NCT01329562|19146868|P1|Overall Study|Physician Decision|0
5539362|NCT01329562|19146867|P2|Overall Study|Subject withdrew due to personal issues.|2
5539363|NCT01329562|19146868|P1|Overall Study|Subject withdrew due to personal issues.|3
5539364|NCT01329562|19146867|P2|Overall Study|Lost to Follow-up|1
5539365|NCT01329562|19146868|P1|Overall Study|Lost to Follow-up|1
5539366|NCT01329562|19146867|P2|Overall Study|Protocol Violation|3
5539367|NCT01329562|19146868|P1|Overall Study|Protocol Violation|5
5539368|NCT01329549|19146917|P1|Overall Study|Adverse Event|1
5539369|NCT01329549|19146917|P1|Overall Study|Withdrawal by Subject|1
5539370|NCT01329419|19146928|P1|Overall Study|Protocol Violation|235
5539371|NCT01329328|19146947|P3|Overall Study|Withdrawal by Subject|3
5539372|NCT01329328|19146948|P2|Overall Study|Withdrawal by Subject|4
5539373|NCT01329328|19146949|P1|Overall Study|Withdrawal by Subject|2
5539374|NCT01329263|19146962|P2|Overall Study|Withdrawal by Subject|2
5539375|NCT01329263|19146963|P1|Overall Study|Withdrawal by Subject|1
5539376|NCT01329263|19146962|P2|Overall Study|Lost to Follow-up|21
5539377|NCT01329263|19146963|P1|Overall Study|Lost to Follow-up|4
5539378|NCT01329029|19147000|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
5539379|NCT01329029|19147001|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
5539380|NCT01329029|19147000|P2|Overall Study|Lost to Follow-up|5
5539381|NCT01329029|19147001|P1|Overall Study|Lost to Follow-up|8
5539382|NCT01329029|19147000|P2|Overall Study|Physician Decision|13
5539383|NCT01329029|19147001|P1|Overall Study|Physician Decision|16
5539384|NCT01329029|19147000|P2|Overall Study|COPD Exacerbation|18
5539385|NCT01329029|19147001|P1|Overall Study|COPD Exacerbation|11
5539386|NCT01329029|19147000|P2|Overall Study|Other|20
5539387|NCT01329029|19147001|P1|Overall Study|Other|14
5539388|NCT01329029|19147000|P2|Overall Study|Death|19
5539389|NCT01329029|19147001|P1|Overall Study|Death|16
5539390|NCT01329029|19147000|P2|Overall Study|Adverse Event|29
5539391|NCT01329029|19147001|P1|Overall Study|Adverse Event|82
5539392|NCT01329029|19147000|P2|Overall Study|Withdrawal by Subject|87
5539393|NCT01329029|19147001|P1|Overall Study|Withdrawal by Subject|117
5539394|NCT01328951|19147091|P2|Overall Study|Other|6
5539395|NCT01328951|19147092|P1|Overall Study|Other|11
5539396|NCT01328951|19147091|P2|Overall Study|Study Closed by the Sponsor|31
5539397|NCT01328951|19147092|P1|Overall Study|Study Closed by the Sponsor|36
5539398|NCT01328951|19147091|P2|Overall Study|Withdrawal by Subject|6
5539399|NCT01328951|19147092|P1|Overall Study|Withdrawal by Subject|6
5539400|NCT01328951|19147091|P2|Overall Study|Lost to Follow-up|7
5539401|NCT01328951|19147092|P1|Overall Study|Lost to Follow-up|6
5539402|NCT01328951|19147091|P2|Overall Study|Death|258
5539403|NCT01328951|19147092|P1|Overall Study|Death|243
5539404|NCT01328951|19147091|P2|Overall Study|Adverse Event|0
5539405|NCT01328951|19147092|P1|Overall Study|Adverse Event|2
5539406|NCT01328951|19147091|P2|Overall Study|Disease Progression|14
5539407|NCT01328951|19147092|P1|Overall Study|Disease Progression|17
5539408|NCT01328756|19147161|P1|Overall Study|Other|29
5539409|NCT01328756|19147161|P1|Overall Study|Lost to Follow-up|5
5539410|NCT01328756|19147161|P1|Overall Study|Withdrawal by Subject|41
5539411|NCT01328756|19147161|P1|Overall Study|Lack of Efficacy|5
5539412|NCT01328756|19147161|P1|Overall Study|Adverse Event|39
5539413|NCT01328756|19147161|P1|Overall Study|Protocol Violation|4
5539414|NCT01328717|19147197|P1|Overall Study|Adverse Event|1
5539415|NCT01328574|19147206|P1|Overall Study|Refused further treatment|1
5539416|NCT01328548|19147220|P2|Overall Study|Protocol Violation|0
5539417|NCT01328548|19147221|P1|Overall Study|Protocol Violation|1
5539418|NCT01328548|19147220|P2|Overall Study|Death|0
5539419|NCT01328548|19147221|P1|Overall Study|Death|3
5539420|NCT01328535|19147239|P1|Overall Study|Ineligible|1
5539421|NCT01328496|19147250|P2|Overall Study|Significant Change in Health Status|0
5539422|NCT01328496|19147251|P1|Overall Study|Significant Change in Health Status|1
5539423|NCT01328444|19147269|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5539424|NCT01328444|19147270|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5539425|NCT01328444|19147271|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5539426|NCT01328444|19147272|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5539427|NCT01328444|19147273|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5539428|NCT01328444|19147274|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5539429|NCT01328444|19147269|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
5539430|NCT01328444|19147270|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5539431|NCT01328444|19147271|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5539432|NCT01328444|19147272|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5539433|NCT01328444|19147273|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5539434|NCT01328444|19147274|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5539435|NCT01328444|19147269|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5539436|NCT01328444|19147270|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
5539437|NCT01328444|19147271|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
5539438|NCT01328444|19147272|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5539439|NCT01328444|19147273|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5539440|NCT01328444|19147274|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
5539441|NCT01328444|19147269|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5539442|NCT01328444|19147270|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
5539443|NCT01328444|19147271|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5539444|NCT01328444|19147272|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5539445|NCT01328444|19147273|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
5539446|NCT01328444|19147274|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
5539447|NCT01328444|19147269|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
5539448|NCT01328444|19147270|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
5539449|NCT01328444|19147271|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
5539450|NCT01328444|19147272|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5539451|NCT01328444|19147273|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5539452|NCT01328444|19147274|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
5539453|NCT01328444|19147269|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
5539454|NCT01328444|19147270|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
5539455|NCT01328444|19147271|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
5539456|NCT01328444|19147272|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
5539457|NCT01328444|19147273|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
5539458|NCT01328444|19147274|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
5539459|NCT01328444|19147269|P6|Washout Period (14 Days)|Withdrawal by Subject|1
5539460|NCT01328444|19147270|P5|Washout Period (14 Days)|Withdrawal by Subject|0
5539461|NCT01328444|19147271|P4|Washout Period (14 Days)|Withdrawal by Subject|0
5539462|NCT01328444|19147272|P3|Washout Period (14 Days)|Withdrawal by Subject|0
5539463|NCT01328444|19147273|P2|Washout Period (14 Days)|Withdrawal by Subject|0
5539464|NCT01328444|19147274|P1|Washout Period (14 Days)|Withdrawal by Subject|0
5539465|NCT01328444|19147269|P6|Washout Period (14 Days)|Lack of Efficacy|1
5539466|NCT01328444|19147270|P5|Washout Period (14 Days)|Lack of Efficacy|0
5539467|NCT01328444|19147271|P4|Washout Period (14 Days)|Lack of Efficacy|0
5539468|NCT01328444|19147272|P3|Washout Period (14 Days)|Lack of Efficacy|0
5539469|NCT01328444|19147273|P2|Washout Period (14 Days)|Lack of Efficacy|0
5539470|NCT01328444|19147274|P1|Washout Period (14 Days)|Lack of Efficacy|0
5539471|NCT01328444|19147269|P6|Washout Period (14 Days)|Adverse Event|2
5539472|NCT01328444|19147270|P5|Washout Period (14 Days)|Adverse Event|1
5539473|NCT01328444|19147271|P4|Washout Period (14 Days)|Adverse Event|1
5539474|NCT01328444|19147272|P3|Washout Period (14 Days)|Adverse Event|0
5539475|NCT01328444|19147273|P2|Washout Period (14 Days)|Adverse Event|1
5539476|NCT01328444|19147274|P1|Washout Period (14 Days)|Adverse Event|1
5539477|NCT01328444|19147269|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5539478|NCT01328444|19147270|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5539479|NCT01328444|19147271|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
5539480|NCT01328444|19147272|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5539481|NCT01328444|19147273|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
5539482|NCT01328444|19147274|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5539483|NCT01328444|19147269|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5539484|NCT01328444|19147270|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5539485|NCT01328444|19147271|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5539486|NCT01328444|19147272|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5539487|NCT01328444|19147273|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5539488|NCT01328444|19147274|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
5539489|NCT01328444|19147269|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5539490|NCT01328444|19147270|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
5539491|NCT01328444|19147271|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5539492|NCT01328444|19147272|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5539493|NCT01328444|19147273|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
5539494|NCT01328444|19147274|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
5539495|NCT01328444|19147269|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5539496|NCT01328444|19147270|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5539497|NCT01328444|19147271|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5539498|NCT01328444|19147272|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5539499|NCT01328444|19147273|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5539500|NCT01328444|19147274|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5539501|NCT01328444|19147269|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
5539502|NCT01328444|19147270|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
5539503|NCT01328444|19147271|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5539504|NCT01328444|19147272|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5539505|NCT01328444|19147273|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5539506|NCT01328444|19147274|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
5539507|NCT01328444|19147269|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
5539508|NCT01328444|19147270|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
5539509|NCT01328444|19147271|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
5539510|NCT01328444|19147272|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
5539511|NCT01328444|19147273|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
5539512|NCT01328444|19147274|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
5539513|NCT01328431|19147320|P2|12 Month (12M)|Lost to Follow-up|91
5539514|NCT01328431|19147321|P1|12 Month (12M)|Lost to Follow-up|82
5539515|NCT01328431|19147320|P2|12 Month (12M)|Death|6
5539516|NCT01328431|19147321|P1|12 Month (12M)|Death|2
5539517|NCT01328431|19147320|P2|3 Month (3M)|Lost to Follow-up|70
5539518|NCT01328431|19147321|P1|3 Month (3M)|Lost to Follow-up|75
5539519|NCT01328431|19147320|P2|3 Month (3M)|Death|2
5539520|NCT01328431|19147321|P1|3 Month (3M)|Death|2
5539521|NCT01328431|19147320|P2|1 Month (1M)|Lost to Follow-up|58
5539522|NCT01328431|19147321|P1|1 Month (1M)|Lost to Follow-up|55
5539523|NCT01328431|19147320|P2|Baseline|Protocol Violation|2
5539524|NCT01328431|19147321|P1|Baseline|Protocol Violation|0
5539525|NCT01328366|19147377|P1|Overall Study|Lost to Follow-up|7
5539526|NCT01328366|19147377|P1|Overall Study|Withdrawal by Subject|2
5539527|NCT01328366|19147377|P1|Overall Study|Death|1
5539528|NCT01328249|19147397|P2|Overall Study|Protocol Violation|1
5539529|NCT01328249|19147398|P1|Overall Study|Protocol Violation|0
5539530|NCT01328249|19147397|P2|Overall Study|Subject choice|1
5539531|NCT01328249|19147398|P1|Overall Study|Subject choice|1
5539532|NCT01328249|19147397|P2|Overall Study|Moved before end of treatment visit|0
5539533|NCT01328249|19147398|P1|Overall Study|Moved before end of treatment visit|1
5539534|NCT01328249|19147397|P2|Overall Study|Withdrawal by Subject|1
5539535|NCT01328249|19147398|P1|Overall Study|Withdrawal by Subject|1
5539536|NCT01328249|19147397|P2|Overall Study|Disease progression|0
5539537|NCT01328249|19147398|P1|Overall Study|Disease progression|1
5539538|NCT01328249|19147397|P2|Overall Study|Adverse Event|0
5539539|NCT01328249|19147398|P1|Overall Study|Adverse Event|3
5539540|NCT01328080|19147484|P1|Overall Study|Lost to Follow-up|5
5539541|NCT01328054|19147488|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
5539542|NCT01328054|19147489|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
5539543|NCT01328054|19147488|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
5539544|NCT01328054|19147489|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
5539545|NCT01328054|19147488|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
5539546|NCT01328054|19147489|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
5539547|NCT01328041|19147514|P1|Overall Study|Withdrawal by Subject|7
5539548|NCT01328041|19147514|P1|Overall Study|Physician Decision|2
5539549|NCT01328041|19147514|P1|Overall Study|Lost to Follow-up|7
5539550|NCT01328041|19147514|P1|Overall Study|Protocol Violation|7
5539551|NCT01328041|19147514|P1|Overall Study|Lack of Efficacy|27
5539552|NCT01328041|19147514|P1|Overall Study|Adverse Event|7
5539553|NCT01328002|19147536|P2|Double-Blind Period|Lack of Efficacy|0
5539554|NCT01328002|19147537|P1|Double-Blind Period|Lack of Efficacy|1
5539555|NCT01328002|19147536|P2|Double-Blind Period|Adverse Event|0
5539556|NCT01328002|19147537|P1|Double-Blind Period|Adverse Event|1
5539557|NCT01328002|19147536|P2|Open-Label Period|Other Reason|0
5539558|NCT01328002|19147537|P1|Open-Label Period|Other Reason|2
5539559|NCT01328002|19147536|P2|Open-Label Period|Lost to Follow-up|0
5539560|NCT01328002|19147537|P1|Open-Label Period|Lost to Follow-up|6
5539561|NCT01328002|19147536|P2|Open-Label Period|Withdrawal by Subject|0
5539562|NCT01328002|19147537|P1|Open-Label Period|Withdrawal by Subject|9
5539563|NCT01328002|19147536|P2|Open-Label Period|Protocol Violation|0
5539564|NCT01328002|19147537|P1|Open-Label Period|Protocol Violation|2
5539565|NCT01328002|19147536|P2|Open-Label Period|Lack of Efficacy|0
5539566|NCT01328002|19147537|P1|Open-Label Period|Lack of Efficacy|3
5539567|NCT01328002|19147536|P2|Open-Label Period|Adverse Event|0
5539568|NCT01328002|19147537|P1|Open-Label Period|Adverse Event|8
5539569|NCT01328002|19147536|P2|Open-Label Period|Inclusion/exclusion criteria not met|0
5539570|NCT01328002|19147537|P1|Open-Label Period|Inclusion/exclusion criteria not met|66
5539571|NCT01327885|19147582|P2|Overall Study|Administrative decision|1
5539572|NCT01327885|19147583|P1|Overall Study|Administrative decision|0
5539573|NCT01327885|19147582|P2|Overall Study|Not treated|1
5539574|NCT01327885|19147583|P1|Overall Study|Not treated|1
5539575|NCT01327885|19147582|P2|Overall Study|Withdrawal of consent from study|4
5539576|NCT01327885|19147583|P1|Overall Study|Withdrawal of consent from study|3
5539577|NCT01327885|19147582|P2|Overall Study|Other|6
5539578|NCT01327885|19147583|P1|Overall Study|Other|8
5539579|NCT01327885|19147582|P2|Overall Study|Subject choice|10
5539580|NCT01327885|19147583|P1|Overall Study|Subject choice|5
5539581|NCT01327885|19147582|P2|Overall Study|Adverse Event|10
5539582|NCT01327885|19147583|P1|Overall Study|Adverse Event|14
5539583|NCT01327885|19147582|P2|Overall Study|Clinical progression|27
5539584|NCT01327885|19147583|P1|Overall Study|Clinical progression|24
5539585|NCT01327885|19147582|P2|Overall Study|Disease progression-according to RECIST|165
5539586|NCT01327885|19147583|P1|Overall Study|Disease progression-according to RECIST|173
5539587|NCT01327846|19147599|P4|Extension Phase|Technical Problems|2
5539588|NCT01327846|19147600|P3|Extension Phase|Technical Problems|2
5539589|NCT01327846|19147601|P2|Extension Phase|Technical Problems|4
5539590|NCT01327846|19147602|P1|Extension Phase|Technical Problems|2
5539591|NCT01327846|19147599|P4|Extension Phase|Lost to Follow-up|7
5539592|NCT01327846|19147600|P3|Extension Phase|Lost to Follow-up|4
5539593|NCT01327846|19147601|P2|Extension Phase|Lost to Follow-up|3
5539594|NCT01327846|19147602|P1|Extension Phase|Lost to Follow-up|4
5539595|NCT01327846|19147599|P4|Extension Phase|Withdrawal by Subject|37
5539596|NCT01327846|19147600|P3|Extension Phase|Withdrawal by Subject|19
5539597|NCT01327846|19147601|P2|Extension Phase|Withdrawal by Subject|13
5539598|NCT01327846|19147602|P1|Extension Phase|Withdrawal by Subject|20
5539599|NCT01327846|19147599|P4|Extension Phase|Study terminated by sponsor|1660
5539600|NCT01327846|19147600|P3|Extension Phase|Study terminated by sponsor|1067
5539601|NCT01327846|19147601|P2|Extension Phase|Study terminated by sponsor|1124
5539602|NCT01327846|19147602|P1|Extension Phase|Study terminated by sponsor|1073
5539603|NCT01327846|19147599|P4|Core Phase|Lost to Follow-up|5
5539604|NCT01327846|19147600|P3|Core Phase|Lost to Follow-up|4
5539605|NCT01327846|19147601|P2|Core Phase|Lost to Follow-up|3
5539606|NCT01327846|19147602|P1|Core Phase|Lost to Follow-up|3
5539607|NCT01327846|19147599|P4|Core Phase|Subject decision (vital stat: alive)|20
5539608|NCT01327846|19147600|P3|Core Phase|Subject decision (vital stat: alive)|13
5539609|NCT01327846|19147601|P2|Core Phase|Subject decision (vital stat: alive)|24
5539610|NCT01327846|19147602|P1|Core Phase|Subject decision (vital stat: alive)|23
5539611|NCT01327846|19147599|P4|Core Phase|Subject decision (vital stat: dead)|4
5539612|NCT01327846|19147600|P3|Core Phase|Subject decision (vital stat: dead)|4
5539613|NCT01327846|19147601|P2|Core Phase|Subject decision (vital stat: dead)|3
5539614|NCT01327846|19147602|P1|Core Phase|Subject decision (vital stat: dead)|1
5539615|NCT01327846|19147599|P4|Core Phase|Subject decision (vital stat: unkn)|3
5539616|NCT01327846|19147600|P3|Core Phase|Subject decision (vital stat: unkn)|3
5539617|NCT01327846|19147601|P2|Core Phase|Subject decision (vital stat: unkn)|0
5539618|NCT01327846|19147602|P1|Core Phase|Subject decision (vital stat: unkn)|0
5539619|NCT01327846|19147599|P4|Core Phase|Subject decision (vital status: missing)|1
5539620|NCT01327846|19147600|P3|Core Phase|Subject decision (vital status: missing)|2
5539621|NCT01327846|19147601|P2|Core Phase|Subject decision (vital status: missing)|2
5539622|NCT01327846|19147602|P1|Core Phase|Subject decision (vital status: missing)|1
5539623|NCT01327703|19147677|P2|Second Treatment Period|Protocol Violation|1
5539624|NCT01327703|19147678|P1|Second Treatment Period|Protocol Violation|0
5539625|NCT01327703|19147677|P2|Second Treatment Period|Adverse Event|1
5539626|NCT01327703|19147678|P1|Second Treatment Period|Adverse Event|1
5539627|NCT01327651|19147734|P9|Post Study Follow-up|Lost to Follow-up|2
5539628|NCT01327651|19147735|P8|Post Study Follow-up|Lost to Follow-up|1
5539629|NCT01327651|19147736|P7|Post Study Follow-up|Lost to Follow-up|4
5539630|NCT01327651|19147737|P6|Post Study Follow-up|Lost to Follow-up|0
5539631|NCT01327651|19147738|P5|Post Study Follow-up|Lost to Follow-up|0
5539632|NCT01327651|19147739|P4|Post Study Follow-up|Lost to Follow-up|0
5539633|NCT01327651|19147740|P3|Post Study Follow-up|Lost to Follow-up|1
5539634|NCT01327651|19147741|P2|Post Study Follow-up|Lost to Follow-up|1
5539635|NCT01327651|19147742|P1|Post Study Follow-up|Lost to Follow-up|0
5539636|NCT01327651|19147734|P9|Self-administered Dosing Period|Withdrawal by Subject|1
5539637|NCT01327651|19147735|P8|Self-administered Dosing Period|Withdrawal by Subject|1
5539638|NCT01327651|19147736|P7|Self-administered Dosing Period|Withdrawal by Subject|2
5539639|NCT01327651|19147737|P6|Self-administered Dosing Period|Withdrawal by Subject|0
5539640|NCT01327651|19147738|P5|Self-administered Dosing Period|Withdrawal by Subject|0
5539641|NCT01327651|19147739|P4|Self-administered Dosing Period|Withdrawal by Subject|1
5539642|NCT01327651|19147740|P3|Self-administered Dosing Period|Withdrawal by Subject|0
5539643|NCT01327651|19147741|P2|Self-administered Dosing Period|Withdrawal by Subject|1
5539644|NCT01327651|19147742|P1|Self-administered Dosing Period|Withdrawal by Subject|0
5539645|NCT01327651|19147734|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
5539646|NCT01327651|19147735|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
5539647|NCT01327651|19147736|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
5539648|NCT01327651|19147737|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
5539649|NCT01327651|19147738|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
5539650|NCT01327651|19147739|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
5539651|NCT01327651|19147740|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
5539652|NCT01327651|19147741|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
5539653|NCT01327651|19147742|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
5539654|NCT01327651|19147734|P9|Self-administered Dosing Period|Lost to Follow-up|10
5539655|NCT01327651|19147735|P8|Self-administered Dosing Period|Lost to Follow-up|9
5539656|NCT01327651|19147736|P7|Self-administered Dosing Period|Lost to Follow-up|8
5539657|NCT01327651|19147737|P6|Self-administered Dosing Period|Lost to Follow-up|0
5539658|NCT01327651|19147738|P5|Self-administered Dosing Period|Lost to Follow-up|3
5539659|NCT01327651|19147739|P4|Self-administered Dosing Period|Lost to Follow-up|2
5539660|NCT01327651|19147740|P3|Self-administered Dosing Period|Lost to Follow-up|4
5539661|NCT01327651|19147741|P2|Self-administered Dosing Period|Lost to Follow-up|2
5539662|NCT01327651|19147742|P1|Self-administered Dosing Period|Lost to Follow-up|3
5539663|NCT01327599|19147861|P1|Overall Study|Withdrawal of Consent|1
5539664|NCT01327599|19147861|P1|Overall Study|Could Not Attend Visit|1
5539665|NCT01327599|19147861|P1|Overall Study|Adverse Event|1
5539666|NCT01327573|19147871|P2|Overall Study|Physician Decision|1
5539667|NCT01327573|19147872|P1|Overall Study|Physician Decision|3
5539668|NCT01327547|19147883|P2|Overall Study|By investigator in subject's interest|1
5539669|NCT01327547|19147884|P1|Overall Study|By investigator in subject's interest|0
5539670|NCT01327547|19147883|P2|Overall Study|Non-compliance with study procedures|0
5539671|NCT01327547|19147884|P1|Overall Study|Non-compliance with study procedures|1
5539672|NCT01327547|19147883|P2|Overall Study|Required prohibited medication|0
5539673|NCT01327547|19147884|P1|Overall Study|Required prohibited medication|2
5539674|NCT01327547|19147883|P2|Overall Study|Non-compliance due to alcohol intake|1
5539675|NCT01327547|19147884|P1|Overall Study|Non-compliance due to alcohol intake|0
5539676|NCT01327547|19147883|P2|Overall Study|Protocol Violation|0
5539677|NCT01327547|19147884|P1|Overall Study|Protocol Violation|1
5539678|NCT01327547|19147883|P2|Overall Study|Does Not Meet Entrance Criteria|2
5539679|NCT01327547|19147884|P1|Overall Study|Does Not Meet Entrance Criteria|2
5539680|NCT01327547|19147883|P2|Overall Study|Withdrawal by Subject|7
5539681|NCT01327547|19147884|P1|Overall Study|Withdrawal by Subject|3
5539682|NCT01327547|19147883|P2|Overall Study|Non-Compliance With Study Treatment|2
5539683|NCT01327547|19147884|P1|Overall Study|Non-Compliance With Study Treatment|0
5539684|NCT01327547|19147883|P2|Overall Study|Lost to Follow-up|6
5539685|NCT01327547|19147884|P1|Overall Study|Lost to Follow-up|6
5539686|NCT01327547|19147883|P2|Overall Study|Death|2
5539687|NCT01327547|19147884|P1|Overall Study|Death|1
5539688|NCT01327547|19147883|P2|Overall Study|Adverse Event|1
5539689|NCT01327547|19147884|P1|Overall Study|Adverse Event|4
5539690|NCT01327495|19147952|P6|Overall Study|Physician Decision|0
5539691|NCT01327495|19147953|P5|Overall Study|Physician Decision|2
5539692|NCT01327495|19147954|P4|Overall Study|Physician Decision|0
5539693|NCT01327495|19147955|P3|Overall Study|Physician Decision|0
5539694|NCT01327495|19147956|P2|Overall Study|Physician Decision|0
5539695|NCT01327495|19147957|P1|Overall Study|Physician Decision|0
5539696|NCT01327495|19147952|P6|Overall Study|Withdrawal by Subject|0
5539697|NCT01327495|19147953|P5|Overall Study|Withdrawal by Subject|1
5539698|NCT01327495|19147954|P4|Overall Study|Withdrawal by Subject|0
5539699|NCT01327495|19147955|P3|Overall Study|Withdrawal by Subject|1
5539700|NCT01327495|19147956|P2|Overall Study|Withdrawal by Subject|1
5539701|NCT01327495|19147957|P1|Overall Study|Withdrawal by Subject|0
5539702|NCT01327495|19147952|P6|Overall Study|Adverse Event|2
5539703|NCT01327495|19147953|P5|Overall Study|Adverse Event|0
5539704|NCT01327495|19147954|P4|Overall Study|Adverse Event|0
5539705|NCT01327495|19147955|P3|Overall Study|Adverse Event|1
5539706|NCT01327495|19147956|P2|Overall Study|Adverse Event|1
5539707|NCT01327495|19147957|P1|Overall Study|Adverse Event|2
5539708|NCT01327482|19148049|P1|Overall Study|Adverse Event|1
5539709|NCT01327339|19148054|P1|Overall Study|Protocol Violation|8
5539710|NCT01327300|19148189|P2|Washout (3 Weeks)|Withdrawal by Subject|0
5539711|NCT01327300|19148190|P1|Washout (3 Weeks)|Withdrawal by Subject|1
5539712|NCT01327053|19148230|P2|Overall Study|Untreated|1
5539713|NCT01327053|19148231|P1|Overall Study|Untreated|0
5539714|NCT01327053|19148230|P2|Overall Study|Protocol Violation|1
5539715|NCT01327053|19148231|P1|Overall Study|Protocol Violation|0
5539716|NCT01327053|19148230|P2|Overall Study|Progressive disease|26
5539717|NCT01327053|19148231|P1|Overall Study|Progressive disease|31
5539718|NCT01327053|19148230|P2|Overall Study|Study terminated by Sponsor|3
5539719|NCT01327053|19148231|P1|Overall Study|Study terminated by Sponsor|1
5539720|NCT01327053|19148230|P2|Overall Study|Non-compliance with study treatment|5
5539721|NCT01327053|19148231|P1|Overall Study|Non-compliance with study treatment|0
5539722|NCT01327053|19148230|P2|Overall Study|Lost to Follow-up|4
5539723|NCT01327053|19148231|P1|Overall Study|Lost to Follow-up|2
5539724|NCT01327053|19148230|P2|Overall Study|Death|5
5539725|NCT01327053|19148231|P1|Overall Study|Death|1
5539726|NCT01327053|19148230|P2|Overall Study|Physician Decision|14
5539727|NCT01327053|19148231|P1|Overall Study|Physician Decision|10
5539728|NCT01327053|19148230|P2|Overall Study|Patient/guardian decision|35
5539729|NCT01327053|19148231|P1|Overall Study|Patient/guardian decision|11
5539730|NCT01327053|19148230|P2|Overall Study|Adverse Event|57
5539731|NCT01327053|19148231|P1|Overall Study|Adverse Event|23
5539732|NCT01326962|19148305|P1|Overall Study|Other|2
5539733|NCT01326962|19148305|P1|Overall Study|Lost to Follow-up|3
5539734|NCT01326962|19148305|P1|Overall Study|Withdrawal by Subject|1
5539735|NCT01326962|19148305|P1|Overall Study|Adverse Event|1
5539736|NCT01326910|19148328|P2|Overall Study|Protocol Violation|1
5539737|NCT01326910|19148329|P1|Overall Study|Protocol Violation|1
5539738|NCT01326910|19148328|P2|Overall Study|Withdrawal by Subject|2
5539739|NCT01326910|19148329|P1|Overall Study|Withdrawal by Subject|3
5539740|NCT01326845|19148343|P2|Overall Study|Misisng|3
5539741|NCT01326845|19148344|P1|Overall Study|Misisng|1
5539742|NCT01326845|19148343|P2|Overall Study|Adverse Event|0
5539743|NCT01326845|19148344|P1|Overall Study|Adverse Event|1
5539744|NCT01326845|19148343|P2|Overall Study|Administrative Problems|2
5539745|NCT01326845|19148344|P1|Overall Study|Administrative Problems|5
5539746|NCT01326728|19148405|P2|Overall Study|Early closure of study|9
5539747|NCT01326728|19148406|P1|Overall Study|Early closure of study|34
5539748|NCT01326728|19148405|P2|Overall Study|Death|0
5539749|NCT01326728|19148406|P1|Overall Study|Death|13
5539750|NCT01326702|19148430|P7|Overall Study|Not Treated|0
5539751|NCT01326702|19148431|P6|Overall Study|Not Treated|1
5539752|NCT01326702|19148432|P5|Overall Study|Not Treated|0
5539753|NCT01326702|19148433|P4|Overall Study|Not Treated|1
5539754|NCT01326702|19148434|P3|Overall Study|Not Treated|0
5539755|NCT01326702|19148435|P2|Overall Study|Not Treated|0
5539756|NCT01326702|19148436|P1|Overall Study|Not Treated|0
5539757|NCT01326702|19148430|P7|Overall Study|Withdrawal by Subject|3
5539758|NCT01326702|19148431|P6|Overall Study|Withdrawal by Subject|1
5539759|NCT01326702|19148432|P5|Overall Study|Withdrawal by Subject|1
5539760|NCT01326702|19148433|P4|Overall Study|Withdrawal by Subject|0
5539761|NCT01326702|19148434|P3|Overall Study|Withdrawal by Subject|1
5539762|NCT01326702|19148435|P2|Overall Study|Withdrawal by Subject|0
5539763|NCT01326702|19148436|P1|Overall Study|Withdrawal by Subject|0
5539764|NCT01326702|19148430|P7|Overall Study|Adverse Event|1
5539765|NCT01326702|19148431|P6|Overall Study|Adverse Event|3
5539766|NCT01326702|19148432|P5|Overall Study|Adverse Event|0
5539767|NCT01326702|19148433|P4|Overall Study|Adverse Event|1
5539768|NCT01326702|19148434|P3|Overall Study|Adverse Event|1
5539769|NCT01326702|19148435|P2|Overall Study|Adverse Event|0
5539770|NCT01326702|19148436|P1|Overall Study|Adverse Event|0
5539771|NCT01326702|19148430|P7|Overall Study|Death|0
5539772|NCT01326702|19148431|P6|Overall Study|Death|0
5539773|NCT01326702|19148432|P5|Overall Study|Death|0
5539774|NCT01326702|19148433|P4|Overall Study|Death|0
5539775|NCT01326702|19148434|P3|Overall Study|Death|0
5539776|NCT01326702|19148435|P2|Overall Study|Death|1
5539777|NCT01326702|19148436|P1|Overall Study|Death|0
5539778|NCT01326702|19148430|P7|Overall Study|progressive disease|3
5539779|NCT01326702|19148431|P6|Overall Study|progressive disease|2
5539780|NCT01326702|19148432|P5|Overall Study|progressive disease|3
5539781|NCT01326702|19148433|P4|Overall Study|progressive disease|1
5539782|NCT01326702|19148434|P3|Overall Study|progressive disease|3
5539783|NCT01326702|19148435|P2|Overall Study|progressive disease|1
5539784|NCT01326702|19148436|P1|Overall Study|progressive disease|1
5539785|NCT01326702|19148430|P7|Overall Study|Other|0
5539786|NCT01326702|19148431|P6|Overall Study|Other|1
5539787|NCT01326702|19148432|P5|Overall Study|Other|0
5539788|NCT01326702|19148433|P4|Overall Study|Other|0
5539789|NCT01326702|19148434|P3|Overall Study|Other|0
5539790|NCT01326702|19148435|P2|Overall Study|Other|0
5539791|NCT01326702|19148436|P1|Overall Study|Other|1
5539792|NCT01326546|19148492|P2|Overall Study|Withdrawal by Subject|1
5539793|NCT01326546|19148493|P1|Overall Study|Withdrawal by Subject|5
5539794|NCT01326546|19148492|P2|Overall Study|Adverse Event|0
5539795|NCT01326546|19148493|P1|Overall Study|Adverse Event|1
5539796|NCT01326546|19148492|P2|Overall Study|Pregnancy|1
5539797|NCT01326546|19148493|P1|Overall Study|Pregnancy|0
5539798|NCT01326546|19148492|P2|Overall Study|Protocol Violation|4
5539799|NCT01326546|19148493|P1|Overall Study|Protocol Violation|3
5539800|NCT01326546|19148492|P2|Overall Study|Lost to Follow-up|7
5539801|NCT01326546|19148493|P1|Overall Study|Lost to Follow-up|8
5539802|NCT01326533|19148501|P2|Overall Study|Adverse Event|0
5539803|NCT01326533|19148502|P1|Overall Study|Adverse Event|1
5539804|NCT01326533|19148501|P2|Overall Study|Withdrawal by Subject|0
5539805|NCT01326533|19148502|P1|Overall Study|Withdrawal by Subject|1
5539806|NCT01326533|19148501|P2|Overall Study|Lost to Follow-up|0
5539807|NCT01326533|19148502|P1|Overall Study|Lost to Follow-up|2
5539808|NCT01326481|19148510|P1|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
5539809|NCT01326026|19148519|P2|Overall Study|Other|3
5539810|NCT01326026|19148520|P1|Overall Study|Other|3
5539811|NCT01326026|19148519|P2|Overall Study|Withdrawal Criteria|7
5539812|NCT01326026|19148520|P1|Overall Study|Withdrawal Criteria|5
5539813|NCT01326026|19148519|P2|Overall Study|Adverse Event|3
5539814|NCT01326026|19148520|P1|Overall Study|Adverse Event|4
5539815|NCT01325701|19148585|P2|Overall Study|Rollerover Extension Study|0
5539816|NCT01325701|19148586|P1|Overall Study|Rollerover Extension Study|4
5539817|NCT01325701|19148585|P2|Overall Study|Withdrawal by Subject|1
5539818|NCT01325701|19148586|P1|Overall Study|Withdrawal by Subject|2
5539819|NCT01325701|19148585|P2|Overall Study|Physician Decision|2
5539820|NCT01325701|19148586|P1|Overall Study|Physician Decision|2
5539821|NCT01325701|19148585|P2|Overall Study|Protocol Violation|0
5539822|NCT01325701|19148586|P1|Overall Study|Protocol Violation|1
5539823|NCT01325701|19148585|P2|Overall Study|Adverse Event|0
5539824|NCT01325701|19148586|P1|Overall Study|Adverse Event|12
5539825|NCT01325623|19148596|P1|Overall Study|Withdrawal by Subject|3
5539826|NCT01325584|19148638|P1|Overall Study|Death|1
5539827|NCT01325532|19148648|P2|Overall Study|Withdrawal by Subject|0
5539828|NCT01325532|19148649|P1|Overall Study|Withdrawal by Subject|2
5539829|NCT01325493|19148661|P2|Overall Study|Allergy|0
5539830|NCT01325493|19148662|P1|Overall Study|Allergy|1
5539831|NCT01325493|19148661|P2|Overall Study|loss of neuromonitoring signals|2
5539832|NCT01325493|19148662|P1|Overall Study|loss of neuromonitoring signals|0
5539833|NCT01325493|19148661|P2|Overall Study|Protocol Violation|1
5539834|NCT01325493|19148662|P1|Overall Study|Protocol Violation|0
5539835|NCT01325428|19148674|P1|Part B|Other reason not defined above|1
5539836|NCT01325428|19148674|P1|Part B|Refused continue taking trial medication|2
5539837|NCT01325428|19148674|P1|Part A|Other reason not defined above|2
5539838|NCT01325428|19148674|P1|Part A|Refused continue taking trial medication|2
5539839|NCT01325428|19148674|P1|Part A|Other adverse event|1
5539840|NCT01325428|19148674|P1|Part A|Clinical signs, symptoms of progression|2
5539841|NCT01325428|19148674|P1|Part A|Progressive disease according to RECIST|9
5539842|NCT01325350|19148694|P5|Overall Study|Did Not Receive Treatment|1
5539843|NCT01325350|19148695|P4|Overall Study|Did Not Receive Treatment|0
5539844|NCT01325350|19148696|P3|Overall Study|Did Not Receive Treatment|1
5539845|NCT01325350|19148697|P2|Overall Study|Did Not Receive Treatment|1
5539846|NCT01325350|19148698|P1|Overall Study|Did Not Receive Treatment|0
5539847|NCT01325350|19148694|P5|Overall Study|Withdrawal by Subject|0
5539848|NCT01325350|19148695|P4|Overall Study|Withdrawal by Subject|1
5539849|NCT01325350|19148696|P3|Overall Study|Withdrawal by Subject|1
5539850|NCT01325350|19148697|P2|Overall Study|Withdrawal by Subject|0
5539851|NCT01325350|19148698|P1|Overall Study|Withdrawal by Subject|0
5539852|NCT01325350|19148694|P5|Overall Study|Protocol Violation|0
5539853|NCT01325350|19148695|P4|Overall Study|Protocol Violation|1
5539854|NCT01325350|19148696|P3|Overall Study|Protocol Violation|0
5539855|NCT01325350|19148697|P2|Overall Study|Protocol Violation|0
5539856|NCT01325350|19148698|P1|Overall Study|Protocol Violation|0
5539857|NCT01325350|19148694|P5|Overall Study|Personal Reasons|3
5539858|NCT01325350|19148695|P4|Overall Study|Personal Reasons|5
5539859|NCT01325350|19148696|P3|Overall Study|Personal Reasons|6
5539860|NCT01325350|19148697|P2|Overall Study|Personal Reasons|1
5539861|NCT01325350|19148698|P1|Overall Study|Personal Reasons|2
5539862|NCT01325350|19148694|P5|Overall Study|Lost to Follow-up|5
5539863|NCT01325350|19148695|P4|Overall Study|Lost to Follow-up|1
5539864|NCT01325350|19148696|P3|Overall Study|Lost to Follow-up|5
5539865|NCT01325350|19148697|P2|Overall Study|Lost to Follow-up|0
5539866|NCT01325350|19148698|P1|Overall Study|Lost to Follow-up|1
5539867|NCT01325350|19148694|P5|Overall Study|Pregnancy|1
5539868|NCT01325350|19148695|P4|Overall Study|Pregnancy|0
5539869|NCT01325350|19148696|P3|Overall Study|Pregnancy|1
5539870|NCT01325350|19148697|P2|Overall Study|Pregnancy|0
5539871|NCT01325350|19148698|P1|Overall Study|Pregnancy|0
5539872|NCT01325350|19148694|P5|Overall Study|Adverse Event|2
5539873|NCT01325350|19148695|P4|Overall Study|Adverse Event|1
5539874|NCT01325350|19148696|P3|Overall Study|Adverse Event|3
5539875|NCT01325350|19148697|P2|Overall Study|Adverse Event|3
5539876|NCT01325350|19148698|P1|Overall Study|Adverse Event|3
5539877|NCT01325337|19148740|P5|Overall Study|Withdrawal by Subject|1
5539878|NCT01325337|19148741|P4|Overall Study|Withdrawal by Subject|0
5539879|NCT01325337|19148742|P3|Overall Study|Withdrawal by Subject|1
5539880|NCT01325337|19148743|P2|Overall Study|Withdrawal by Subject|0
5539881|NCT01325337|19148744|P1|Overall Study|Withdrawal by Subject|1
5539882|NCT01325337|19148740|P5|Overall Study|Personal Reasons|3
5539883|NCT01325337|19148741|P4|Overall Study|Personal Reasons|8
5539884|NCT01325337|19148742|P3|Overall Study|Personal Reasons|4
5539885|NCT01325337|19148743|P2|Overall Study|Personal Reasons|5
5539886|NCT01325337|19148744|P1|Overall Study|Personal Reasons|2
5539887|NCT01325337|19148740|P5|Overall Study|Lost to Follow-up|2
5539888|NCT01325337|19148741|P4|Overall Study|Lost to Follow-up|1
5539889|NCT01325337|19148742|P3|Overall Study|Lost to Follow-up|2
5539890|NCT01325337|19148743|P2|Overall Study|Lost to Follow-up|2
5539891|NCT01325337|19148744|P1|Overall Study|Lost to Follow-up|2
5539892|NCT01325337|19148740|P5|Overall Study|Adverse Event|2
5539893|NCT01325337|19148741|P4|Overall Study|Adverse Event|1
5539894|NCT01325337|19148742|P3|Overall Study|Adverse Event|2
5539895|NCT01325337|19148743|P2|Overall Study|Adverse Event|2
5539896|NCT01325337|19148744|P1|Overall Study|Adverse Event|0
5539897|NCT01325207|19148824|P6|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5539898|NCT01325207|19148825|P5|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
5539899|NCT01325207|19148826|P4|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5539900|NCT01325207|19148827|P3|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5539901|NCT01325207|19148828|P2|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5539902|NCT01325207|19148829|P1|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
5539903|NCT01325207|19148824|P6|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
5539904|NCT01325207|19148825|P5|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5539905|NCT01325207|19148826|P4|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5539906|NCT01325207|19148827|P3|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5539907|NCT01325207|19148828|P2|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5539908|NCT01325207|19148829|P1|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
5539909|NCT01325207|19148824|P6|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
5539910|NCT01325207|19148825|P5|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5539911|NCT01325207|19148826|P4|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5539912|NCT01325207|19148827|P3|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5539913|NCT01325207|19148828|P2|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5539914|NCT01325207|19148829|P1|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
5539915|NCT01325207|19148824|P6|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5539916|NCT01325207|19148825|P5|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5539917|NCT01325207|19148826|P4|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5539918|NCT01325207|19148827|P3|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5539919|NCT01325207|19148828|P2|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
5539920|NCT01325207|19148829|P1|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
5539921|NCT01325207|19148824|P6|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
5539922|NCT01325207|19148825|P5|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
5539923|NCT01325207|19148826|P4|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5539924|NCT01325207|19148827|P3|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5539925|NCT01325207|19148828|P2|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5539926|NCT01325207|19148829|P1|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
5539927|NCT01325207|19148824|P6|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
5539928|NCT01325207|19148825|P5|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
5539929|NCT01325207|19148826|P4|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
5539930|NCT01325207|19148827|P3|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
5539931|NCT01325207|19148828|P2|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
5539932|NCT01325207|19148829|P1|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
5539933|NCT01325207|19148824|P6|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5539934|NCT01325207|19148825|P5|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
5539935|NCT01325207|19148826|P4|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5539936|NCT01325207|19148827|P3|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5539937|NCT01325207|19148828|P2|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5539938|NCT01325207|19148829|P1|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
5539939|NCT01324999|19148861|P1|Overall Study|Withdrawal by Subject|2
5539940|NCT01324999|19148861|P1|Overall Study|Adverse Event|3
5539941|NCT01324947|19148872|P1|Overall Study|1 discontinued before starting drug|1
5539942|NCT01324947|19148872|P1|Overall Study|Withdrawal by Subject|3
5539943|NCT01324947|19148872|P1|Overall Study|Progressive Disease|50
5539944|NCT01324947|19148872|P1|Overall Study|Other|3
5539945|NCT01324947|19148872|P1|Overall Study|Death|10
5539946|NCT01324947|19148872|P1|Overall Study|Adverse Event|7
5539947|NCT01324830|19148913|P19|Overall Study|Withdrawal by Subject|1
5539948|NCT01324830|19148914|P18|Overall Study|Withdrawal by Subject|0
5539949|NCT01324830|19148915|P17|Overall Study|Withdrawal by Subject|0
5539950|NCT01324830|19148916|P16|Overall Study|Withdrawal by Subject|0
5539951|NCT01324830|19148917|P15|Overall Study|Withdrawal by Subject|0
5539952|NCT01324830|19148918|P14|Overall Study|Withdrawal by Subject|0
5539953|NCT01324830|19148919|P13|Overall Study|Withdrawal by Subject|0
5539954|NCT01324830|19148920|P12|Overall Study|Withdrawal by Subject|0
5539955|NCT01324830|19148921|P11|Overall Study|Withdrawal by Subject|1
5539956|NCT01324830|19148922|P10|Overall Study|Withdrawal by Subject|0
5539957|NCT01324830|19148923|P9|Overall Study|Withdrawal by Subject|0
5539958|NCT01324830|19148924|P8|Overall Study|Withdrawal by Subject|0
5539959|NCT01324830|19148925|P7|Overall Study|Withdrawal by Subject|0
5539960|NCT01324830|19148926|P6|Overall Study|Withdrawal by Subject|1
5539961|NCT01324830|19148927|P5|Overall Study|Withdrawal by Subject|0
5539962|NCT01324830|19148928|P4|Overall Study|Withdrawal by Subject|0
5539963|NCT01324830|19148929|P3|Overall Study|Withdrawal by Subject|0
5539964|NCT01324830|19148930|P2|Overall Study|Withdrawal by Subject|0
5539965|NCT01324830|19148931|P1|Overall Study|Withdrawal by Subject|0
5539966|NCT01324830|19148913|P19|Overall Study|Adverse Event, non-fatal|0
5539967|NCT01324830|19148914|P18|Overall Study|Adverse Event, non-fatal|1
5539968|NCT01324830|19148915|P17|Overall Study|Adverse Event, non-fatal|0
5539969|NCT01324830|19148916|P16|Overall Study|Adverse Event, non-fatal|0
5539970|NCT01324830|19148917|P15|Overall Study|Adverse Event, non-fatal|0
5539971|NCT01324830|19148918|P14|Overall Study|Adverse Event, non-fatal|0
5539972|NCT01324830|19148919|P13|Overall Study|Adverse Event, non-fatal|0
5539973|NCT01324830|19148920|P12|Overall Study|Adverse Event, non-fatal|0
5539974|NCT01324830|19148921|P11|Overall Study|Adverse Event, non-fatal|1
5539975|NCT01324830|19148922|P10|Overall Study|Adverse Event, non-fatal|0
5539976|NCT01324830|19148923|P9|Overall Study|Adverse Event, non-fatal|2
5539977|NCT01324830|19148924|P8|Overall Study|Adverse Event, non-fatal|0
5539978|NCT01324830|19148925|P7|Overall Study|Adverse Event, non-fatal|0
5539979|NCT01324830|19148926|P6|Overall Study|Adverse Event, non-fatal|0
5539980|NCT01324830|19148927|P5|Overall Study|Adverse Event, non-fatal|0
5539981|NCT01324830|19148928|P4|Overall Study|Adverse Event, non-fatal|0
5539982|NCT01324830|19148929|P3|Overall Study|Adverse Event, non-fatal|0
5539983|NCT01324830|19148930|P2|Overall Study|Adverse Event, non-fatal|0
5539984|NCT01324830|19148931|P1|Overall Study|Adverse Event, non-fatal|0
5539985|NCT01324830|19148913|P19|Overall Study|Adverse Event, serious fatal|0
5539986|NCT01324830|19148914|P18|Overall Study|Adverse Event, serious fatal|0
5539987|NCT01324830|19148915|P17|Overall Study|Adverse Event, serious fatal|0
5539988|NCT01324830|19148916|P16|Overall Study|Adverse Event, serious fatal|0
5539989|NCT01324830|19148917|P15|Overall Study|Adverse Event, serious fatal|0
5539990|NCT01324830|19148918|P14|Overall Study|Adverse Event, serious fatal|0
5539991|NCT01324830|19148919|P13|Overall Study|Adverse Event, serious fatal|0
5539992|NCT01324830|19148920|P12|Overall Study|Adverse Event, serious fatal|0
5539993|NCT01324830|19148921|P11|Overall Study|Adverse Event, serious fatal|0
5539994|NCT01324830|19148922|P10|Overall Study|Adverse Event, serious fatal|0
5539995|NCT01324830|19148923|P9|Overall Study|Adverse Event, serious fatal|0
5539996|NCT01324830|19148924|P8|Overall Study|Adverse Event, serious fatal|0
5539997|NCT01324830|19148925|P7|Overall Study|Adverse Event, serious fatal|0
5539998|NCT01324830|19148926|P6|Overall Study|Adverse Event, serious fatal|0
5539999|NCT01324830|19148927|P5|Overall Study|Adverse Event, serious fatal|0
5540000|NCT01324830|19148928|P4|Overall Study|Adverse Event, serious fatal|0
5540001|NCT01324830|19148929|P3|Overall Study|Adverse Event, serious fatal|0
5540002|NCT01324830|19148930|P2|Overall Study|Adverse Event, serious fatal|1
5540003|NCT01324830|19148931|P1|Overall Study|Adverse Event, serious fatal|0
5540004|NCT01324830|19148913|P19|Overall Study|Reason not mentioned above|0
5540005|NCT01324830|19148914|P18|Overall Study|Reason not mentioned above|1
5540006|NCT01324830|19148915|P17|Overall Study|Reason not mentioned above|0
5540007|NCT01324830|19148916|P16|Overall Study|Reason not mentioned above|0
5540008|NCT01324830|19148917|P15|Overall Study|Reason not mentioned above|0
5540009|NCT01324830|19148918|P14|Overall Study|Reason not mentioned above|0
5540010|NCT01324830|19148919|P13|Overall Study|Reason not mentioned above|0
5540011|NCT01324830|19148920|P12|Overall Study|Reason not mentioned above|0
5540012|NCT01324830|19148921|P11|Overall Study|Reason not mentioned above|0
5540013|NCT01324830|19148922|P10|Overall Study|Reason not mentioned above|0
5540014|NCT01324830|19148923|P9|Overall Study|Reason not mentioned above|0
5540015|NCT01324830|19148924|P8|Overall Study|Reason not mentioned above|0
5540016|NCT01324830|19148925|P7|Overall Study|Reason not mentioned above|0
5540017|NCT01324830|19148926|P6|Overall Study|Reason not mentioned above|0
5540018|NCT01324830|19148927|P5|Overall Study|Reason not mentioned above|0
5540019|NCT01324830|19148928|P4|Overall Study|Reason not mentioned above|0
5540020|NCT01324830|19148929|P3|Overall Study|Reason not mentioned above|0
5540021|NCT01324830|19148930|P2|Overall Study|Reason not mentioned above|0
5540022|NCT01324830|19148931|P1|Overall Study|Reason not mentioned above|0
5540023|NCT01324830|19148913|P19|Overall Study|Dose limiting toxicity|1
5540024|NCT01324830|19148914|P18|Overall Study|Dose limiting toxicity|1
5540025|NCT01324830|19148915|P17|Overall Study|Dose limiting toxicity|1
5540026|NCT01324830|19148916|P16|Overall Study|Dose limiting toxicity|0
5540027|NCT01324830|19148917|P15|Overall Study|Dose limiting toxicity|0
5540028|NCT01324830|19148918|P14|Overall Study|Dose limiting toxicity|0
5540029|NCT01324830|19148919|P13|Overall Study|Dose limiting toxicity|0
5540030|NCT01324830|19148920|P12|Overall Study|Dose limiting toxicity|0
5540031|NCT01324830|19148921|P11|Overall Study|Dose limiting toxicity|0
5540032|NCT01324830|19148922|P10|Overall Study|Dose limiting toxicity|0
5540033|NCT01324830|19148923|P9|Overall Study|Dose limiting toxicity|0
5540034|NCT01324830|19148924|P8|Overall Study|Dose limiting toxicity|0
5540035|NCT01324830|19148925|P7|Overall Study|Dose limiting toxicity|0
5540036|NCT01324830|19148926|P6|Overall Study|Dose limiting toxicity|0
5540037|NCT01324830|19148927|P5|Overall Study|Dose limiting toxicity|1
5540038|NCT01324830|19148928|P4|Overall Study|Dose limiting toxicity|0
5540039|NCT01324830|19148929|P3|Overall Study|Dose limiting toxicity|0
5540040|NCT01324830|19148930|P2|Overall Study|Dose limiting toxicity|0
5540041|NCT01324830|19148931|P1|Overall Study|Dose limiting toxicity|0
5540042|NCT01324830|19148913|P19|Overall Study|Progressive Disease|4
5540043|NCT01324830|19148914|P18|Overall Study|Progressive Disease|3
5540044|NCT01324830|19148915|P17|Overall Study|Progressive Disease|2
5540045|NCT01324830|19148916|P16|Overall Study|Progressive Disease|3
5540046|NCT01324830|19148917|P15|Overall Study|Progressive Disease|1
5540047|NCT01324830|19148918|P14|Overall Study|Progressive Disease|1
5540048|NCT01324830|19148919|P13|Overall Study|Progressive Disease|1
5540049|NCT01324830|19148920|P12|Overall Study|Progressive Disease|1
5540050|NCT01324830|19148921|P11|Overall Study|Progressive Disease|2
5540051|NCT01324830|19148922|P10|Overall Study|Progressive Disease|6
5540052|NCT01324830|19148923|P9|Overall Study|Progressive Disease|3
5540053|NCT01324830|19148924|P8|Overall Study|Progressive Disease|3
5540054|NCT01324830|19148925|P7|Overall Study|Progressive Disease|3
5540055|NCT01324830|19148926|P6|Overall Study|Progressive Disease|6
5540056|NCT01324830|19148927|P5|Overall Study|Progressive Disease|6
5540057|NCT01324830|19148928|P4|Overall Study|Progressive Disease|3
5540058|NCT01324830|19148929|P3|Overall Study|Progressive Disease|3
5540059|NCT01324830|19148930|P2|Overall Study|Progressive Disease|2
5540060|NCT01324830|19148931|P1|Overall Study|Progressive Disease|3
5540061|NCT01324622|19149077|P2|Overall Study|Lack of Efficacy|0
5540062|NCT01324622|19149078|P1|Overall Study|Lack of Efficacy|1
5540063|NCT01324622|19149077|P2|Overall Study|Death|0
5540064|NCT01324622|19149078|P1|Overall Study|Death|1
5540065|NCT01324622|19149077|P2|Overall Study|Lost to Follow-up|7
5540066|NCT01324622|19149078|P1|Overall Study|Lost to Follow-up|7
5540067|NCT01324570|19149108|P2|Overall Study|Administrative|2
5540068|NCT01324570|19149109|P1|Overall Study|Administrative|0
5540069|NCT01324570|19149108|P2|Overall Study|Confirmed or suspected diversion|1
5540070|NCT01324570|19149109|P1|Overall Study|Confirmed or suspected diversion|0
5540071|NCT01324570|19149108|P2|Overall Study|Lack of Efficacy|1
5540072|NCT01324570|19149109|P1|Overall Study|Lack of Efficacy|0
5540073|NCT01324570|19149108|P2|Overall Study|Withdrawal by Subject|3
5540074|NCT01324570|19149109|P1|Overall Study|Withdrawal by Subject|0
5540075|NCT01324570|19149108|P2|Overall Study|Adverse Event|7
5540076|NCT01324570|19149109|P1|Overall Study|Adverse Event|4
5540077|NCT01324440|19149146|P2|Overall Study|Subject moved|1
5540078|NCT01324440|19149147|P1|Overall Study|Subject moved|0
5540079|NCT01324401|19149161|P2|Overall Study|Adverse Event|3
5540080|NCT01324401|19149162|P1|Overall Study|Adverse Event|1
5540081|NCT01324401|19149161|P2|Overall Study|Withdrawn before any treatment|3
5540082|NCT01324401|19149162|P1|Overall Study|Withdrawn before any treatment|0
5540083|NCT01324388|19149173|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
5540084|NCT01324388|19149174|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
5540085|NCT01324388|19149175|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
5540086|NCT01324388|19149176|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
5540087|NCT01324388|19149173|P4|Part 2 of Study: First Intervention|Protocol Violation|1
5540088|NCT01324388|19149174|P3|Part 2 of Study: First Intervention|Protocol Violation|0
5540089|NCT01324388|19149175|P2|Part 2 of Study: First Intervention|Protocol Violation|0
5540090|NCT01324388|19149176|P1|Part 2 of Study: First Intervention|Protocol Violation|0
5540091|NCT01324388|19149173|P4|Part 1 of Study|Physician Decision|0
5540092|NCT01324388|19149174|P3|Part 1 of Study|Physician Decision|0
5540093|NCT01324388|19149175|P2|Part 1 of Study|Physician Decision|0
5540094|NCT01324388|19149176|P1|Part 1 of Study|Physician Decision|1
5540095|NCT01324388|19149173|P4|Part 1 of Study|Protocol Violation|0
5540096|NCT01324388|19149174|P3|Part 1 of Study|Protocol Violation|0
5540097|NCT01324388|19149175|P2|Part 1 of Study|Protocol Violation|2
5540098|NCT01324388|19149176|P1|Part 1 of Study|Protocol Violation|1
5540099|NCT01324388|19149173|P4|Part 1 of Study|Adverse Event|0
5540100|NCT01324388|19149174|P3|Part 1 of Study|Adverse Event|0
5540101|NCT01324388|19149175|P2|Part 1 of Study|Adverse Event|0
5540102|NCT01324388|19149176|P1|Part 1 of Study|Adverse Event|2
5540103|NCT01324349|19149197|P2|Overall Study|Withdrawal by Subject|1
5540104|NCT01324349|19149198|P1|Overall Study|Withdrawal by Subject|0
5540105|NCT01324349|19149197|P2|Overall Study|Death|1
5540106|NCT01324349|19149198|P1|Overall Study|Death|1
5540107|NCT01324323|19149208|P1|Overall Study|Withdrawal by Subject|1
5540108|NCT01324310|19149228|P1|Overall Study|Disease Progression|1
5540109|NCT01324310|19149228|P1|Overall Study|Adverse Event|1
5540110|NCT01324271|19149248|P2|Overall Study|Physician Decision|0
5540111|NCT01324271|19149249|P1|Overall Study|Physician Decision|1
5540112|NCT01324271|19149248|P2|Overall Study|Lost to Follow-up|0
5540113|NCT01324271|19149249|P1|Overall Study|Lost to Follow-up|3
5540114|NCT01324102|19149272|P2|Overall Study|illness|6
5540115|NCT01324102|19149273|P1|Overall Study|illness|1
5540116|NCT01324024|19149280|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5540117|NCT01324024|19149281|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
5540118|NCT01323972|19149319|P4|Overall Study|Lost to Follow-up|1
5540119|NCT01323972|19149320|P3|Overall Study|Lost to Follow-up|1
5540120|NCT01323972|19149321|P2|Overall Study|Lost to Follow-up|1
5540121|NCT01323972|19149322|P1|Overall Study|Lost to Follow-up|0
5540122|NCT01323972|19149319|P4|Overall Study|Migrated/moved from study area|0
5540123|NCT01323972|19149320|P3|Overall Study|Migrated/moved from study area|0
5540124|NCT01323972|19149321|P2|Overall Study|Migrated/moved from study area|2
5540125|NCT01323972|19149322|P1|Overall Study|Migrated/moved from study area|1
5540126|NCT01323972|19149319|P4|Overall Study|Withdrawal by Subject|0
5540127|NCT01323972|19149320|P3|Overall Study|Withdrawal by Subject|1
5540128|NCT01323972|19149321|P2|Overall Study|Withdrawal by Subject|0
5540129|NCT01323972|19149322|P1|Overall Study|Withdrawal by Subject|1
5540130|NCT01323946|19149418|P3|Overall Study|Withdrawal by Subject|0
5540131|NCT01323946|19149419|P2|Overall Study|Withdrawal by Subject|2
5540132|NCT01323946|19149420|P1|Overall Study|Withdrawal by Subject|2
5540133|NCT01323946|19149418|P3|Overall Study|Parents refused the last blood draw|0
5540134|NCT01323946|19149419|P2|Overall Study|Parents refused the last blood draw|0
5540135|NCT01323946|19149420|P1|Overall Study|Parents refused the last blood draw|1
5540136|NCT01323946|19149418|P3|Overall Study|Lost to Follow-up|0
5540137|NCT01323946|19149419|P2|Overall Study|Lost to Follow-up|1
5540138|NCT01323946|19149420|P1|Overall Study|Lost to Follow-up|0
5540139|NCT01323920|19149541|P1|Overall Study|Withdrawal by Subject|1
5540140|NCT01323920|19149541|P1|Overall Study|Death|5
5540141|NCT01323790|19149582|P3|Overall Study|Severe non-compliance with protocol|2
5540142|NCT01323790|19149583|P2|Overall Study|Severe non-compliance with protocol|2
5540143|NCT01323790|19149584|P1|Overall Study|Severe non-compliance with protocol|2
5540144|NCT01323790|19149582|P3|Overall Study|Did Not Receive Treatment|1
5540145|NCT01323790|19149583|P2|Overall Study|Did Not Receive Treatment|0
5540146|NCT01323790|19149584|P1|Overall Study|Did Not Receive Treatment|2
5540147|NCT01323790|19149582|P3|Overall Study|Withdrawal by Subject|13
5540148|NCT01323790|19149583|P2|Overall Study|Withdrawal by Subject|20
5540149|NCT01323790|19149584|P1|Overall Study|Withdrawal by Subject|23
5540150|NCT01323790|19149582|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
5540151|NCT01323790|19149583|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
5540152|NCT01323790|19149584|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
5540153|NCT01323790|19149582|P3|Overall Study|Adverse Event|12
5540154|NCT01323790|19149583|P2|Overall Study|Adverse Event|24
5540155|NCT01323790|19149584|P1|Overall Study|Adverse Event|11
5540156|NCT01323790|19149582|P3|Overall Study|Lack of Efficacy|3
5540157|NCT01323790|19149583|P2|Overall Study|Lack of Efficacy|0
5540158|NCT01323790|19149584|P1|Overall Study|Lack of Efficacy|3
5540159|NCT01323790|19149582|P3|Overall Study|Study-Specific Withdrawal Criteria|3
5540160|NCT01323790|19149583|P2|Overall Study|Study-Specific Withdrawal Criteria|3
5540161|NCT01323790|19149584|P1|Overall Study|Study-Specific Withdrawal Criteria|0
5540162|NCT01323790|19149582|P3|Overall Study|Lost to Follow-up|9
5540163|NCT01323790|19149583|P2|Overall Study|Lost to Follow-up|9
5540164|NCT01323790|19149584|P1|Overall Study|Lost to Follow-up|11
5540165|NCT01323790|19149582|P3|Overall Study|Other|1
5540166|NCT01323790|19149583|P2|Overall Study|Other|2
5540167|NCT01323790|19149584|P1|Overall Study|Other|3
5540168|NCT01323673|19149635|P2|Overall Study|Withdrawal by Subject|3
5540169|NCT01323673|19149636|P1|Overall Study|Withdrawal by Subject|2
5540170|NCT01323673|19149635|P2|Overall Study|Protocol Violation|0
5540171|NCT01323673|19149636|P1|Overall Study|Protocol Violation|1
5540172|NCT01323673|19149635|P2|Overall Study|Lost to Follow-up|1
5540173|NCT01323673|19149636|P1|Overall Study|Lost to Follow-up|0
5540174|NCT01323673|19149635|P2|Overall Study|Adverse Event|1
5540175|NCT01323673|19149636|P1|Overall Study|Adverse Event|0
5540176|NCT01323660|19149656|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5540177|NCT01323660|19149657|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
5540178|NCT01323660|19149658|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
5540179|NCT01323660|19149659|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5540180|NCT01323660|19149660|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5540181|NCT01323660|19149661|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
5540182|NCT01323660|19149656|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5540183|NCT01323660|19149657|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5540184|NCT01323660|19149658|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5540185|NCT01323660|19149659|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5540186|NCT01323660|19149660|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
5540187|NCT01323660|19149661|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
5540188|NCT01323660|19149656|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
5540189|NCT01323660|19149657|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5540190|NCT01323660|19149658|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5540191|NCT01323660|19149659|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5540192|NCT01323660|19149660|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5540193|NCT01323660|19149661|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
5540194|NCT01323660|19149656|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
5540195|NCT01323660|19149657|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
5540196|NCT01323660|19149658|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
5540197|NCT01323660|19149659|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
5540198|NCT01323660|19149660|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
5540199|NCT01323660|19149661|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
5540200|NCT01323660|19149656|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
5540201|NCT01323660|19149657|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
5540202|NCT01323660|19149658|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
5540203|NCT01323660|19149659|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
5540204|NCT01323660|19149660|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
5540205|NCT01323660|19149661|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
5540206|NCT01323660|19149656|P6|Washout Period (14 Days)|Lack of Efficacy|2
5540207|NCT01323660|19149657|P5|Washout Period (14 Days)|Lack of Efficacy|2
5540208|NCT01323660|19149658|P4|Washout Period (14 Days)|Lack of Efficacy|3
5540209|NCT01323660|19149659|P3|Washout Period (14 Days)|Lack of Efficacy|1
5540210|NCT01323660|19149660|P2|Washout Period (14 Days)|Lack of Efficacy|0
5540211|NCT01323660|19149661|P1|Washout Period (14 Days)|Lack of Efficacy|0
5540212|NCT01323660|19149656|P6|Washout Period (14 Days)|Adverse Event|0
5540213|NCT01323660|19149657|P5|Washout Period (14 Days)|Adverse Event|1
5540214|NCT01323660|19149658|P4|Washout Period (14 Days)|Adverse Event|0
5540215|NCT01323660|19149659|P3|Washout Period (14 Days)|Adverse Event|0
5540216|NCT01323660|19149660|P2|Washout Period (14 Days)|Adverse Event|0
5540217|NCT01323660|19149661|P1|Washout Period (14 Days)|Adverse Event|0
5540218|NCT01323660|19149656|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5540219|NCT01323660|19149657|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
5540220|NCT01323660|19149658|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5540221|NCT01323660|19149659|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
5540222|NCT01323660|19149660|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
5540223|NCT01323660|19149661|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
5540224|NCT01323660|19149656|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5540225|NCT01323660|19149657|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5540226|NCT01323660|19149658|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5540227|NCT01323660|19149659|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5540228|NCT01323660|19149660|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5540229|NCT01323660|19149661|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5540230|NCT01323660|19149656|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5540231|NCT01323660|19149657|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
5540232|NCT01323660|19149658|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5540233|NCT01323660|19149659|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5540234|NCT01323660|19149660|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5540235|NCT01323660|19149661|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
5540236|NCT01323660|19149656|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5540237|NCT01323660|19149657|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5540238|NCT01323660|19149658|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5540239|NCT01323660|19149659|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
5540240|NCT01323660|19149660|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
5540241|NCT01323660|19149661|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5540242|NCT01323660|19149656|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
5540243|NCT01323660|19149657|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
5540244|NCT01323660|19149658|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
5540245|NCT01323660|19149659|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
5540246|NCT01323660|19149660|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
5540247|NCT01323660|19149661|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
5540248|NCT01323660|19149656|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
5540249|NCT01323660|19149657|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
5540250|NCT01323660|19149658|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
5540251|NCT01323660|19149659|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
5540252|NCT01323660|19149660|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
5540253|NCT01323660|19149661|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
5540254|NCT01323647|19149707|P2|Overall Study|Lost to Follow-up|0
5540255|NCT01323647|19149708|P1|Overall Study|Lost to Follow-up|2
5540256|NCT01323647|19149707|P2|Overall Study|Withdrawal by Subject|0
5540257|NCT01323647|19149708|P1|Overall Study|Withdrawal by Subject|5
5540258|NCT01323647|19149707|P2|Overall Study|Migrated/moved from study area|0
5540259|NCT01323647|19149708|P1|Overall Study|Migrated/moved from study area|2
5540260|NCT01323634|19149725|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
5540261|NCT01323634|19149726|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
5540262|NCT01323634|19149727|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
5540263|NCT01323634|19149725|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
5540264|NCT01323634|19149726|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
5540265|NCT01323634|19149727|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
5540266|NCT01323634|19149725|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
5540267|NCT01323634|19149726|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
5540268|NCT01323634|19149727|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
5540269|NCT01323634|19149725|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5540270|NCT01323634|19149726|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
5540271|NCT01323634|19149727|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
5540272|NCT01323634|19149725|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
5540273|NCT01323634|19149726|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
5540274|NCT01323634|19149727|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
5540275|NCT01323634|19149725|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
5540276|NCT01323634|19149726|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5540277|NCT01323634|19149727|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
5540278|NCT01323634|19149725|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
5540279|NCT01323634|19149726|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
5540280|NCT01323634|19149727|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
5540281|NCT01323634|19149725|P3|2-week Run-in Period|Adverse Event|0
5540282|NCT01323634|19149726|P2|2-week Run-in Period|Adverse Event|0
5540283|NCT01323634|19149727|P1|2-week Run-in Period|Adverse Event|1
5540284|NCT01323634|19149725|P3|2-week Run-in Period|Protocol Violation|0
5540285|NCT01323634|19149726|P2|2-week Run-in Period|Protocol Violation|0
5540286|NCT01323634|19149727|P1|2-week Run-in Period|Protocol Violation|1
5540287|NCT01323634|19149725|P3|2-week Run-in Period|Physician Decision|0
5540288|NCT01323634|19149726|P2|2-week Run-in Period|Physician Decision|0
5540289|NCT01323634|19149727|P1|2-week Run-in Period|Physician Decision|5
5540290|NCT01323634|19149725|P3|2-week Run-in Period|Withdrawal by Subject|0
5540291|NCT01323634|19149726|P2|2-week Run-in Period|Withdrawal by Subject|0
5540292|NCT01323634|19149727|P1|2-week Run-in Period|Withdrawal by Subject|7
5540293|NCT01323634|19149725|P3|2-week Run-in Period|Continuation Criteria not Met|0
5540294|NCT01323634|19149726|P2|2-week Run-in Period|Continuation Criteria not Met|0
5540295|NCT01323634|19149727|P1|2-week Run-in Period|Continuation Criteria not Met|73
5540296|NCT01323634|19149725|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
5540297|NCT01323634|19149726|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
5540298|NCT01323634|19149727|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
5540299|NCT01323621|19149737|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
5540300|NCT01323621|19149738|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
5540301|NCT01323621|19149739|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
5540302|NCT01323621|19149737|P3|12-week, Double-blind Treatment Period|Physician Decision|1
5540303|NCT01323621|19149738|P2|12-week, Double-blind Treatment Period|Physician Decision|2
5540304|NCT01323621|19149739|P1|12-week, Double-blind Treatment Period|Physician Decision|0
5540305|NCT01323621|19149737|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
5540306|NCT01323621|19149738|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
5540307|NCT01323621|19149739|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
5540308|NCT01323621|19149737|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
5540309|NCT01323621|19149738|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
5540310|NCT01323621|19149739|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
5540311|NCT01323621|19149737|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
5540312|NCT01323621|19149738|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
5540313|NCT01323621|19149739|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
5540314|NCT01323621|19149737|P3|12-week, Double-blind Treatment Period|Adverse Event|5
5540315|NCT01323621|19149738|P2|12-week, Double-blind Treatment Period|Adverse Event|1
5540316|NCT01323621|19149739|P1|12-week, Double-blind Treatment Period|Adverse Event|0
5540317|NCT01323621|19149737|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
5540318|NCT01323621|19149738|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
5540319|NCT01323621|19149739|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
5540320|NCT01323621|19149737|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
5540321|NCT01323621|19149738|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
5540322|NCT01323621|19149739|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
5540323|NCT01323621|19149737|P3|2-week, Single-blind Run In Period|Protocol Violation|0
5540324|NCT01323621|19149738|P2|2-week, Single-blind Run In Period|Protocol Violation|0
5540325|NCT01323621|19149739|P1|2-week, Single-blind Run In Period|Protocol Violation|1
5540326|NCT01323621|19149737|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
5540327|NCT01323621|19149738|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
5540328|NCT01323621|19149739|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
5540329|NCT01323621|19149737|P3|2-week, Single-blind Run In Period|Physician Decision|0
5540330|NCT01323621|19149738|P2|2-week, Single-blind Run In Period|Physician Decision|0
5540331|NCT01323621|19149739|P1|2-week, Single-blind Run In Period|Physician Decision|7
5540332|NCT01323621|19149737|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
5540333|NCT01323621|19149738|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
5540334|NCT01323621|19149739|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
5540335|NCT01323582|19149760|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
5540336|NCT01323582|19149761|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
5540337|NCT01323582|19149760|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
5540338|NCT01323582|19149761|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
5540339|NCT01323582|19149760|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
5540340|NCT01323582|19149761|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
5540341|NCT01323478|19149784|P1|Overall Study|Administrative or Other Reasons|8
5540342|NCT01323478|19149784|P1|Overall Study|Withdrawal of Consent|1
5540343|NCT01323478|19149784|P1|Overall Study|Protocol Violation|1
5540344|NCT01323478|19149784|P1|Overall Study|Non-compliance With Study Product|3
5540345|NCT01323478|19149784|P1|Overall Study|Lack of Efficacy|4
5540346|NCT01323478|19149784|P1|Overall Study|Adverse Event|7
5540347|NCT01323387|19149797|P1|Overall Study|Randomized but Never Treated|16
5540348|NCT01323387|19149797|P1|Overall Study|Protocol Violation|12
5540349|NCT01323387|19149797|P1|Overall Study|Revision|14
5540350|NCT01323387|19149797|P1|Overall Study|Radiographic Data Unavailable|1
5540351|NCT01323387|19149797|P1|Overall Study|Withdrawal by Subject|41
5540352|NCT01323270|19149810|P2|Overall Study|Randomized, but not vaccinated|0
5540353|NCT01323270|19149811|P1|Overall Study|Randomized, but not vaccinated|1
5540354|NCT01323270|19149810|P2|Overall Study|Death|0
5540355|NCT01323270|19149811|P1|Overall Study|Death|1
5540356|NCT01323270|19149810|P2|Overall Study|Not eligible|1
5540357|NCT01323270|19149811|P1|Overall Study|Not eligible|1
5540358|NCT01323270|19149810|P2|Overall Study|Physician Decision|2
5540359|NCT01323270|19149811|P1|Overall Study|Physician Decision|0
5540360|NCT01323270|19149810|P2|Overall Study|Other|3
5540361|NCT01323270|19149811|P1|Overall Study|Other|0
5540362|NCT01323270|19149810|P2|Overall Study|Adverse Event|0
5540363|NCT01323270|19149811|P1|Overall Study|Adverse Event|8
5540364|NCT01323270|19149810|P2|Overall Study|Lost to Follow-up|6
5540365|NCT01323270|19149811|P1|Overall Study|Lost to Follow-up|4
5540366|NCT01323270|19149810|P2|Overall Study|Protocol Violation|7
5540367|NCT01323270|19149811|P1|Overall Study|Protocol Violation|9
5540368|NCT01323270|19149810|P2|Overall Study|Withdrawal by Subject|10
5540369|NCT01323270|19149811|P1|Overall Study|Withdrawal by Subject|19
5540370|NCT01323192|19149833|P2|Overall Study|Nonmedical reasons|1
5540371|NCT01323192|19149834|P1|Overall Study|Nonmedical reasons|0
5540372|NCT01323192|19149833|P2|Overall Study|Noncompliance with study medication|3
5540373|NCT01323192|19149834|P1|Overall Study|Noncompliance with study medication|0
5540374|NCT01323192|19149833|P2|Overall Study|Withdrawal by Subject|1
5540375|NCT01323192|19149834|P1|Overall Study|Withdrawal by Subject|3
5540376|NCT01323192|19149833|P2|Overall Study|Adverse Event|1
5540377|NCT01323192|19149834|P1|Overall Study|Adverse Event|6
5540378|NCT01322490|19150083|P3|Long Term Follow-up Period|Unknown/Missing|1
5540379|NCT01322490|19150084|P2|Long Term Follow-up Period|Unknown/Missing|1
5540380|NCT01322490|19150085|P1|Long Term Follow-up Period|Unknown/Missing|0
5540381|NCT01322490|19150083|P3|Long Term Follow-up Period|Other per report|2
5540382|NCT01322490|19150084|P2|Long Term Follow-up Period|Other per report|2
5540383|NCT01322490|19150085|P1|Long Term Follow-up Period|Other per report|3
5540384|NCT01322490|19150083|P3|Long Term Follow-up Period|Study Terminated by Sponsor|165
5540385|NCT01322490|19150084|P2|Long Term Follow-up Period|Study Terminated by Sponsor|158
5540386|NCT01322490|19150085|P1|Long Term Follow-up Period|Study Terminated by Sponsor|160
5540387|NCT01322490|19150083|P3|Long Term Follow-up Period|Withdrawal by Subject|6
5540388|NCT01322490|19150084|P2|Long Term Follow-up Period|Withdrawal by Subject|6
5540389|NCT01322490|19150085|P1|Long Term Follow-up Period|Withdrawal by Subject|9
5540390|NCT01322490|19150083|P3|Long Term Follow-up Period|Lost to Follow-up|3
5540391|NCT01322490|19150084|P2|Long Term Follow-up Period|Lost to Follow-up|2
5540392|NCT01322490|19150085|P1|Long Term Follow-up Period|Lost to Follow-up|2
5540393|NCT01322490|19150083|P3|Long Term Follow-up Period|Death|236
5540394|NCT01322490|19150084|P2|Long Term Follow-up Period|Death|239
5540395|NCT01322490|19150085|P1|Long Term Follow-up Period|Death|235
5540396|NCT01322490|19150083|P3|Treatment Period|Randomized but Not Treated|5
5540397|NCT01322490|19150084|P2|Treatment Period|Randomized but Not Treated|3
5540398|NCT01322490|19150085|P1|Treatment Period|Randomized but Not Treated|3
5540399|NCT01322490|19150083|P3|Treatment Period|Other per report|1
5540400|NCT01322490|19150084|P2|Treatment Period|Other per report|2
5540401|NCT01322490|19150085|P1|Treatment Period|Other per report|2
5540402|NCT01322490|19150083|P3|Treatment Period|Non-compliance with study drug|1
5540403|NCT01322490|19150084|P2|Treatment Period|Non-compliance with study drug|0
5540404|NCT01322490|19150085|P1|Treatment Period|Non-compliance with study drug|0
5540405|NCT01322490|19150083|P3|Treatment Period|Withdrawal by Subject|11
5540406|NCT01322490|19150084|P2|Treatment Period|Withdrawal by Subject|16
5540407|NCT01322490|19150085|P1|Treatment Period|Withdrawal by Subject|14
5540408|NCT01322490|19150083|P3|Treatment Period|Protocol Violation|4
5540409|NCT01322490|19150084|P2|Treatment Period|Protocol Violation|5
5540410|NCT01322490|19150085|P1|Treatment Period|Protocol Violation|7
5540411|NCT01322490|19150083|P3|Treatment Period|Physician Decision|1
5540412|NCT01322490|19150084|P2|Treatment Period|Physician Decision|2
5540413|NCT01322490|19150085|P1|Treatment Period|Physician Decision|0
5540414|NCT01322490|19150083|P3|Treatment Period|Lack of Efficacy|112
5540415|NCT01322490|19150084|P2|Treatment Period|Lack of Efficacy|100
5540416|NCT01322490|19150085|P1|Treatment Period|Lack of Efficacy|89
5540417|NCT01322490|19150083|P3|Treatment Period|Death|3
5540418|NCT01322490|19150084|P2|Treatment Period|Death|7
5540419|NCT01322490|19150085|P1|Treatment Period|Death|5
5540420|NCT01322490|19150083|P3|Treatment Period|Adverse Event|15
5540421|NCT01322490|19150084|P2|Treatment Period|Adverse Event|18
5540422|NCT01322490|19150085|P1|Treatment Period|Adverse Event|12
5540423|NCT01322386|19150098|P2|Overall Study|Physician Decision|1
5540424|NCT01322386|19150099|P1|Overall Study|Physician Decision|0
5540425|NCT01322386|19150098|P2|Overall Study|Protocol Violation|1
5540426|NCT01322386|19150099|P1|Overall Study|Protocol Violation|0
5540427|NCT01322347|19150114|P2|Overall Study|moved/changed dialysis|4
5540428|NCT01322347|19150115|P1|Overall Study|moved/changed dialysis|2
5540429|NCT01322347|19150114|P2|Overall Study|study drug withheld > 12 wks|1
5540430|NCT01322347|19150115|P1|Overall Study|study drug withheld > 12 wks|0
5540431|NCT01322347|19150114|P2|Overall Study|kidney transplant|1
5540432|NCT01322347|19150115|P1|Overall Study|kidney transplant|3
5540433|NCT01322347|19150114|P2|Overall Study|ineligible|3
5540434|NCT01322347|19150115|P1|Overall Study|ineligible|6
5540435|NCT01322347|19150114|P2|Overall Study|sponsor decision|3
5540436|NCT01322347|19150115|P1|Overall Study|sponsor decision|1
5540437|NCT01322347|19150114|P2|Overall Study|blood transfusion|5
5540438|NCT01322347|19150115|P1|Overall Study|blood transfusion|5
5540439|NCT01322347|19150114|P2|Overall Study|non-protocol change to ESA or IV iron|6
5540440|NCT01322347|19150115|P1|Overall Study|non-protocol change to ESA or IV iron|14
5540441|NCT01322347|19150114|P2|Overall Study|Withdrawal by Subject|4
5540442|NCT01322347|19150115|P1|Overall Study|Withdrawal by Subject|1
5540443|NCT01322347|19150114|P2|Overall Study|Protocol Violation|2
5540444|NCT01322347|19150115|P1|Overall Study|Protocol Violation|5
5540445|NCT01322347|19150114|P2|Overall Study|Physician Decision|1
5540446|NCT01322347|19150115|P1|Overall Study|Physician Decision|2
5540447|NCT01322347|19150114|P2|Overall Study|Death|3
5540448|NCT01322347|19150115|P1|Overall Study|Death|5
5540449|NCT01322347|19150114|P2|Overall Study|Adverse Event|2
5540450|NCT01322347|19150115|P1|Overall Study|Adverse Event|7
5540451|NCT01322009|19150178|P2|Overall Study|ng tube discontinued|1
5540452|NCT01322009|19150179|P1|Overall Study|ng tube discontinued|0
5540453|NCT01322009|19150178|P2|Overall Study|Adverse Event|1
5540454|NCT01322009|19150179|P1|Overall Study|Adverse Event|0
5540455|NCT01322009|19150178|P2|Overall Study|Death|1
5540456|NCT01322009|19150179|P1|Overall Study|Death|0
5540457|NCT01321879|19150187|P1|Overall Study|Withdrawal by Subject|1
5540458|NCT01321879|19150187|P1|Overall Study|Death|3
5540459|NCT01321879|19150187|P1|Overall Study|Adverse Event|5
5540460|NCT01321879|19150187|P1|Overall Study|Lack of Efficacy|5
5540461|NCT01321749|19150193|P2|Overall Study|Withdrawal by Subject|4
5540462|NCT01321749|19150194|P1|Overall Study|Withdrawal by Subject|5
5540463|NCT01321749|19150193|P2|Overall Study|Protocol Violation|7
5540464|NCT01321749|19150194|P1|Overall Study|Protocol Violation|4
5540465|NCT01321749|19150193|P2|Overall Study|Lost to Follow-up|11
5540466|NCT01321749|19150194|P1|Overall Study|Lost to Follow-up|4
5540467|NCT01321723|19150203|P3|Overall Study|Withdrawal by Subject|2
5540468|NCT01321723|19150204|P2|Overall Study|Withdrawal by Subject|0
5540469|NCT01321723|19150205|P1|Overall Study|Withdrawal by Subject|2
5540470|NCT01321723|19150203|P3|Overall Study|Adverse Event|2
5540471|NCT01321723|19150204|P2|Overall Study|Adverse Event|5
5540472|NCT01321723|19150205|P1|Overall Study|Adverse Event|3
5540473|NCT01321710|19150227|P3|Overall Study|Lost to Follow-up|0
5540474|NCT01321710|19150228|P2|Overall Study|Lost to Follow-up|5
5540475|NCT01321710|19150229|P1|Overall Study|Lost to Follow-up|4
5540476|NCT01321697|19150244|P1|Overall Study|Study Terminated|7
5540477|NCT01321606|19150250|P4|Overall Study|Lost to Follow-up|1
5540478|NCT01321606|19150251|P3|Overall Study|Lost to Follow-up|0
5540479|NCT01321606|19150252|P2|Overall Study|Lost to Follow-up|0
5540480|NCT01321606|19150253|P1|Overall Study|Lost to Follow-up|0
5540481|NCT01321073|19150289|P1|Overall Study|Death|3
5540482|NCT01321073|19150289|P1|Overall Study|Did not attempt implant|4
5540483|NCT01321008|19150293|P1|Overall Study|Early Study Termination|1
5540484|NCT01320943|19150299|P2|Overall Study|Randomized but not Treated|1
5540485|NCT01320943|19150300|P1|Overall Study|Randomized but not Treated|0
5540486|NCT01320943|19150299|P2|Overall Study|Physician Decision|1
5540487|NCT01320943|19150300|P1|Overall Study|Physician Decision|0
5540488|NCT01320943|19150299|P2|Overall Study|Lost to Follow-up|0
5540489|NCT01320943|19150300|P1|Overall Study|Lost to Follow-up|1
5540490|NCT01320735|19150334|P1|Overall Study|Investigator Unable to be Contacted|17
5540491|NCT01320735|19150334|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
5540492|NCT01320735|19150334|P1|Overall Study|Other|1
5540493|NCT01320735|19150334|P1|Overall Study|Protocol Violation|1
5540494|NCT01320735|19150334|P1|Overall Study|Progression/Hormone-Refractory Pca|55
5540495|NCT01320735|19150334|P1|Overall Study|Administrative Reason|6
5540496|NCT01320735|19150334|P1|Overall Study|Lost to Follow-up|13
5540497|NCT01320735|19150334|P1|Overall Study|Withdrawal by Subject|3
5540498|NCT01320735|19150334|P1|Overall Study|Adverse Event|3
5540499|NCT01320722|19150356|P5|Overall Study|Withdrew due to Health Condition|1
5540500|NCT01320722|19150357|P4|Overall Study|Withdrew due to Health Condition|0
5540501|NCT01320722|19150358|P3|Overall Study|Withdrew due to Health Condition|0
5540502|NCT01320722|19150359|P2|Overall Study|Withdrew due to Health Condition|0
5540503|NCT01320722|19150360|P1|Overall Study|Withdrew due to Health Condition|0
5540504|NCT01320722|19150356|P5|Overall Study|Started an Exclusionary Medication|1
5540505|NCT01320722|19150357|P4|Overall Study|Started an Exclusionary Medication|0
5540506|NCT01320722|19150358|P3|Overall Study|Started an Exclusionary Medication|0
5540507|NCT01320722|19150359|P2|Overall Study|Started an Exclusionary Medication|0
5540508|NCT01320722|19150360|P1|Overall Study|Started an Exclusionary Medication|0
5540509|NCT01320722|19150356|P5|Overall Study|Pregnancy|0
5540510|NCT01320722|19150357|P4|Overall Study|Pregnancy|1
5540511|NCT01320722|19150358|P3|Overall Study|Pregnancy|0
5540512|NCT01320722|19150359|P2|Overall Study|Pregnancy|0
5540513|NCT01320722|19150360|P1|Overall Study|Pregnancy|0
5540514|NCT01320722|19150356|P5|Overall Study|Not Compliant with Study Procedures|0
5540515|NCT01320722|19150357|P4|Overall Study|Not Compliant with Study Procedures|4
5540516|NCT01320722|19150358|P3|Overall Study|Not Compliant with Study Procedures|0
5540517|NCT01320722|19150359|P2|Overall Study|Not Compliant with Study Procedures|0
5540518|NCT01320722|19150360|P1|Overall Study|Not Compliant with Study Procedures|0
5540519|NCT01320722|19150356|P5|Overall Study|Adverse Event|0
5540520|NCT01320722|19150357|P4|Overall Study|Adverse Event|6
5540521|NCT01320722|19150358|P3|Overall Study|Adverse Event|3
5540522|NCT01320722|19150359|P2|Overall Study|Adverse Event|0
5540523|NCT01320722|19150360|P1|Overall Study|Adverse Event|0
5540524|NCT01320722|19150356|P5|Overall Study|Non-compliant with Medication|0
5540525|NCT01320722|19150357|P4|Overall Study|Non-compliant with Medication|0
5540526|NCT01320722|19150358|P3|Overall Study|Non-compliant with Medication|1
5540527|NCT01320722|19150359|P2|Overall Study|Non-compliant with Medication|0
5540528|NCT01320722|19150360|P1|Overall Study|Non-compliant with Medication|0
5540529|NCT01320722|19150356|P5|Overall Study|Participant Developed a Rash|1
5540530|NCT01320722|19150357|P4|Overall Study|Participant Developed a Rash|1
5540531|NCT01320722|19150358|P3|Overall Study|Participant Developed a Rash|2
5540532|NCT01320722|19150359|P2|Overall Study|Participant Developed a Rash|0
5540533|NCT01320722|19150360|P1|Overall Study|Participant Developed a Rash|0
5540534|NCT01320722|19150356|P5|Overall Study|Not Available for the 8 Week Visit|0
5540535|NCT01320722|19150357|P4|Overall Study|Not Available for the 8 Week Visit|0
5540536|NCT01320722|19150358|P3|Overall Study|Not Available for the 8 Week Visit|0
5540537|NCT01320722|19150359|P2|Overall Study|Not Available for the 8 Week Visit|3
5540538|NCT01320722|19150360|P1|Overall Study|Not Available for the 8 Week Visit|0
5540539|NCT01320722|19150356|P5|Overall Study|Lost to Follow-up|3
5540540|NCT01320722|19150357|P4|Overall Study|Lost to Follow-up|1
5540541|NCT01320722|19150358|P3|Overall Study|Lost to Follow-up|0
5540542|NCT01320722|19150359|P2|Overall Study|Lost to Follow-up|1
5540543|NCT01320722|19150360|P1|Overall Study|Lost to Follow-up|0
5540544|NCT01320722|19150356|P5|Overall Study|Did not Receive Intervention|2
5540545|NCT01320722|19150357|P4|Overall Study|Did not Receive Intervention|1
5540546|NCT01320722|19150358|P3|Overall Study|Did not Receive Intervention|1
5540547|NCT01320722|19150359|P2|Overall Study|Did not Receive Intervention|2
5540548|NCT01320722|19150360|P1|Overall Study|Did not Receive Intervention|3
5540549|NCT01320683|19150397|P1|Overall Study|Positive antibody response|1
5540550|NCT01320293|19150423|P1|Overall Study|Adverse Event|1
5540551|NCT01320293|19150423|P1|Overall Study|Lack of Efficacy|1
5540552|NCT01320202|19150431|P2|Overall Study|regained renal function|0
5540553|NCT01320202|19150432|P1|Overall Study|regained renal function|1
5540554|NCT01320202|19150431|P2|Overall Study|ineligible|0
5540555|NCT01320202|19150432|P1|Overall Study|ineligible|3
5540556|NCT01320202|19150431|P2|Overall Study|sponsor request|0
5540557|NCT01320202|19150432|P1|Overall Study|sponsor request|2
5540558|NCT01320202|19150431|P2|Overall Study|moved/changed dialysis|2
5540559|NCT01320202|19150432|P1|Overall Study|moved/changed dialysis|5
5540560|NCT01320202|19150431|P2|Overall Study|blood transfusion|7
5540561|NCT01320202|19150432|P1|Overall Study|blood transfusion|1
5540562|NCT01320202|19150431|P2|Overall Study|kidney transplant|2
5540563|NCT01320202|19150432|P1|Overall Study|kidney transplant|1
5540564|NCT01320202|19150431|P2|Overall Study|non-protocol change to ESA or IV iron|20
5540565|NCT01320202|19150432|P1|Overall Study|non-protocol change to ESA or IV iron|17
5540566|NCT01320202|19150431|P2|Overall Study|Withdrawal by Subject|3
5540567|NCT01320202|19150432|P1|Overall Study|Withdrawal by Subject|10
5540568|NCT01320202|19150431|P2|Overall Study|Protocol Violation|1
5540569|NCT01320202|19150432|P1|Overall Study|Protocol Violation|2
5540570|NCT01320202|19150431|P2|Overall Study|Physician Decision|1
5540571|NCT01320202|19150432|P1|Overall Study|Physician Decision|3
5540572|NCT01320202|19150431|P2|Overall Study|Lost to Follow-up|0
5540573|NCT01320202|19150432|P1|Overall Study|Lost to Follow-up|1
5540574|NCT01320202|19150431|P2|Overall Study|Death|3
5540575|NCT01320202|19150432|P1|Overall Study|Death|5
5540576|NCT01320202|19150431|P2|Overall Study|Adverse Event|5
5540577|NCT01320202|19150432|P1|Overall Study|Adverse Event|5
5540578|NCT01320150|19150469|P1|Overall Study|Lost to Follow-up|44
5540579|NCT01320150|19150469|P1|Overall Study|Death|2
5540580|NCT01320150|19150469|P1|Overall Study|Withdrawal by Subject|5
5540581|NCT01320150|19150469|P1|Overall Study|Protocol Violation|15
5540582|NCT01320033|19150503|P3|Overall Study|Other|1
5540583|NCT01320033|19150504|P2|Overall Study|Other|3
5540584|NCT01320033|19150505|P1|Overall Study|Other|2
5540585|NCT01320033|19150503|P3|Overall Study|Lost to Follow-up|17
5540586|NCT01320033|19150504|P2|Overall Study|Lost to Follow-up|26
5540587|NCT01320033|19150505|P1|Overall Study|Lost to Follow-up|22
5540588|NCT01320033|19150503|P3|Overall Study|Protocol Violation|3
5540589|NCT01320033|19150504|P2|Overall Study|Protocol Violation|5
5540590|NCT01320033|19150505|P1|Overall Study|Protocol Violation|3
5540591|NCT01320033|19150503|P3|Overall Study|Withdrawal by Subject|23
5540592|NCT01320033|19150504|P2|Overall Study|Withdrawal by Subject|23
5540593|NCT01320033|19150505|P1|Overall Study|Withdrawal by Subject|22
5540594|NCT01320033|19150503|P3|Overall Study|Adverse Event|8
5540595|NCT01320033|19150504|P2|Overall Study|Adverse Event|7
5540596|NCT01320033|19150505|P1|Overall Study|Adverse Event|9
5540597|NCT01320033|19150503|P3|Overall Study|Lack of Efficacy|1
5540598|NCT01320033|19150504|P2|Overall Study|Lack of Efficacy|0
5540599|NCT01320033|19150505|P1|Overall Study|Lack of Efficacy|0
5540600|NCT01319994|19150533|P2|Overall Study|Protocol Violation|6
5540601|NCT01319994|19150534|P1|Overall Study|Protocol Violation|7
5540602|NCT01319929|19150544|P2|Second Treatment Period (4 Weeks)|Sponsor Decision|1
5540603|NCT01319929|19150545|P1|Second Treatment Period (4 Weeks)|Sponsor Decision|0
5540604|NCT01319929|19150544|P2|Second Treatment Period (4 Weeks)|Adverse Event|0
5540605|NCT01319929|19150545|P1|Second Treatment Period (4 Weeks)|Adverse Event|1
5540606|NCT01319929|19150544|P2|First Treatment Period (4 Weeks)|Protocol Violation|1
5540607|NCT01319929|19150545|P1|First Treatment Period (4 Weeks)|Protocol Violation|0
5540608|NCT01319929|19150544|P2|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
5540609|NCT01319929|19150545|P1|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
5540610|NCT01319929|19150544|P2|First Treatment Period (4 Weeks)|Adverse Event|0
5540611|NCT01319929|19150545|P1|First Treatment Period (4 Weeks)|Adverse Event|2
5540612|NCT01319877|19150577|P2|Overall Study|Reason Not Specified|5
5540613|NCT01319877|19150578|P1|Overall Study|Reason Not Specified|4
5540614|NCT01319877|19150577|P2|Overall Study|Withdrawal by Subject|1
5540615|NCT01319877|19150578|P1|Overall Study|Withdrawal by Subject|0
5540616|NCT01319877|19150577|P2|Overall Study|Disease Progression|2
5540617|NCT01319877|19150578|P1|Overall Study|Disease Progression|2
5540618|NCT01319877|19150577|P2|Overall Study|Physician Decision|0
5540619|NCT01319877|19150578|P1|Overall Study|Physician Decision|2
5540620|NCT01319877|19150577|P2|Overall Study|Lost to Follow-up|37
5540621|NCT01319877|19150578|P1|Overall Study|Lost to Follow-up|100
5540622|NCT01319721|19150746|P2|Overall Study|Lost to Follow-up|6
5540623|NCT01319721|19150747|P1|Overall Study|Lost to Follow-up|1
5540624|NCT01319422|19150800|P2|Overall Study|Withdrawal by Subject|0
5540625|NCT01319422|19150801|P1|Overall Study|Withdrawal by Subject|1
5540626|NCT01319383|19150819|P2|Overall Study|No in vivo response to interval doses|1
5540627|NCT01319383|19150820|P1|Overall Study|No in vivo response to interval doses|0
5540628|NCT01319383|19150819|P2|Overall Study|Lack of Efficacy|9
5540629|NCT01319383|19150820|P1|Overall Study|Lack of Efficacy|5
5540630|NCT01319383|19150819|P2|Overall Study|Physician Decision|0
5540631|NCT01319383|19150820|P1|Overall Study|Physician Decision|3
5540632|NCT01319383|19150819|P2|Overall Study|No ex vivo or in vivo response|0
5540633|NCT01319383|19150820|P1|Overall Study|No ex vivo or in vivo response|4
5540634|NCT01318993|19150859|P1|Overall Study|Withdrawal by Subject|24
5540635|NCT01318993|19150859|P1|Overall Study|Physician Decision|13
5540636|NCT01318993|19150859|P1|Overall Study|Lost to Follow-up|4
5540637|NCT01318993|19150859|P1|Overall Study|Study closed or terminated|174
5540638|NCT01318993|19150859|P1|Overall Study|Protocol based stopping criteria|6
5540639|NCT01318993|19150859|P1|Overall Study|Protocol Violation|3
5540640|NCT01318993|19150859|P1|Overall Study|Lack of Efficacy|121
5540641|NCT01318993|19150859|P1|Overall Study|Adverse Event|53
5540642|NCT01318915|19150880|P1|Overall Study|Lost to Follow-up|1
5540643|NCT01318902|19150909|P4|Overall Study|Terminated by Sponsor|0
5540644|NCT01318902|19150910|P3|Overall Study|Terminated by Sponsor|1
5540645|NCT01318902|19150911|P2|Overall Study|Terminated by Sponsor|0
5540646|NCT01318902|19150912|P1|Overall Study|Terminated by Sponsor|0
5540647|NCT01318902|19150909|P4|Overall Study|Adverse Event|0
5540648|NCT01318902|19150910|P3|Overall Study|Adverse Event|0
5540649|NCT01318902|19150911|P2|Overall Study|Adverse Event|1
5540650|NCT01318902|19150912|P1|Overall Study|Adverse Event|0
5540651|NCT01318902|19150909|P4|Overall Study|Unsatisfactory Therapeutic Response|1
5540652|NCT01318902|19150910|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5540653|NCT01318902|19150911|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5540654|NCT01318902|19150912|P1|Overall Study|Unsatisfactory Therapeutic Response|1
5540655|NCT01318902|19150909|P4|Overall Study|Withdrawal by Patient|3
5540656|NCT01318902|19150910|P3|Overall Study|Withdrawal by Patient|0
5540657|NCT01318902|19150911|P2|Overall Study|Withdrawal by Patient|1
5540658|NCT01318902|19150912|P1|Overall Study|Withdrawal by Patient|0
5540659|NCT01318902|19150909|P4|Overall Study|Symptomatic Deterioration|2
5540660|NCT01318902|19150910|P3|Overall Study|Symptomatic Deterioration|1
5540661|NCT01318902|19150911|P2|Overall Study|Symptomatic Deterioration|1
5540662|NCT01318902|19150912|P1|Overall Study|Symptomatic Deterioration|0
5540663|NCT01318876|19150989|P1|Day 29 Survey|survey not completed-don't know why|1825
5540664|NCT01318876|19150989|P1|Day 8 Survey|survey not completed-don't know why|1724
5540665|NCT01318876|19150989|P1|Day 8 Survey|email address invalid|96
5540666|NCT01318811|19150996|P2|Overall Study|CRRT stopped for head MRI|1
5540667|NCT01318811|19150997|P1|Overall Study|CRRT stopped for head MRI|0
5540668|NCT01318811|19150996|P2|Overall Study|Death|1
5540669|NCT01318811|19150997|P1|Overall Study|Death|0
5540670|NCT01318811|19150996|P2|Overall Study|CRRT stopped for head CT|1
5540671|NCT01318811|19150997|P1|Overall Study|CRRT stopped for head CT|0
5540672|NCT01318811|19150996|P2|Overall Study|Physician Decision|1
5540673|NCT01318811|19150997|P1|Overall Study|Physician Decision|1
5540674|NCT01318512|19151107|P1|Maintenance Period (6 Months)|Protocol Violation|9
5540675|NCT01318512|19151107|P1|Maintenance Period (6 Months)|Death|2
5540676|NCT01318499|19151126|P3|Overall Study|Other|22
5540677|NCT01318499|19151127|P2|Overall Study|Other|10
5540678|NCT01318499|19151128|P1|Overall Study|Other|7
5540679|NCT01318499|19151126|P3|Overall Study|Patient Did Not Use Study Medication|14
5540680|NCT01318499|19151127|P2|Overall Study|Patient Did Not Use Study Medication|28
5540681|NCT01318499|19151128|P1|Overall Study|Patient Did Not Use Study Medication|18
5540682|NCT01318499|19151126|P3|Overall Study|Protocol Violation|2
5540683|NCT01318499|19151127|P2|Overall Study|Protocol Violation|4
5540684|NCT01318499|19151128|P1|Overall Study|Protocol Violation|2
5540685|NCT01318499|19151126|P3|Overall Study|Treatment Failure|101
5540686|NCT01318499|19151127|P2|Overall Study|Treatment Failure|19
5540687|NCT01318499|19151128|P1|Overall Study|Treatment Failure|19
5540688|NCT01318499|19151126|P3|Overall Study|Noncompliance|0
5540689|NCT01318499|19151127|P2|Overall Study|Noncompliance|3
5540690|NCT01318499|19151128|P1|Overall Study|Noncompliance|2
5540691|NCT01318499|19151126|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
5540692|NCT01318499|19151127|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
5540693|NCT01318499|19151128|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
5540694|NCT01318499|19151126|P3|Overall Study|Adverse Event|6
5540695|NCT01318499|19151127|P2|Overall Study|Adverse Event|11
5540696|NCT01318499|19151128|P1|Overall Study|Adverse Event|16
5540697|NCT01318382|19151151|P1|Overall Study|Protocol Violation|1
5540698|NCT01318382|19151151|P1|Overall Study|Device Malfunction|10
5540699|NCT01318382|19151151|P1|Overall Study|Physician Decision|2
5540700|NCT01318135|19151209|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
5540701|NCT01318135|19151210|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5540702|NCT01318135|19151211|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5540703|NCT01318135|19151212|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5540704|NCT01318135|19151213|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5540705|NCT01318135|19151214|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5540706|NCT01318135|19151215|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5540707|NCT01318135|19151216|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
5540708|NCT01318135|19151209|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
5540709|NCT01318135|19151210|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
5540710|NCT01318135|19151211|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
5540711|NCT01318135|19151212|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
5540712|NCT01318135|19151213|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
5540713|NCT01318135|19151214|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
5540714|NCT01318135|19151215|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
5540715|NCT01318135|19151216|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
5540716|NCT01318135|19151209|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5540717|NCT01318135|19151210|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5540718|NCT01318135|19151211|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5540719|NCT01318135|19151212|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5540720|NCT01318135|19151213|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5540721|NCT01318135|19151214|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5540722|NCT01318135|19151215|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5540723|NCT01318135|19151216|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5540724|NCT01318135|19151209|P8|Entered - Long-Term Extension Study|Protocol Violation|0
5540725|NCT01318135|19151210|P7|Entered - Long-Term Extension Study|Protocol Violation|0
5540726|NCT01318135|19151211|P6|Entered - Long-Term Extension Study|Protocol Violation|0
5540727|NCT01318135|19151212|P5|Entered - Long-Term Extension Study|Protocol Violation|1
5540728|NCT01318135|19151213|P4|Entered - Long-Term Extension Study|Protocol Violation|0
5540729|NCT01318135|19151214|P3|Entered - Long-Term Extension Study|Protocol Violation|0
5540730|NCT01318135|19151215|P2|Entered - Long-Term Extension Study|Protocol Violation|1
5540731|NCT01318135|19151216|P1|Entered - Long-Term Extension Study|Protocol Violation|1
5540732|NCT01318135|19151209|P8|Entered - Long-Term Extension Study|Adverse Event|0
5540733|NCT01318135|19151210|P7|Entered - Long-Term Extension Study|Adverse Event|0
5540734|NCT01318135|19151211|P6|Entered - Long-Term Extension Study|Adverse Event|2
5540735|NCT01318135|19151212|P5|Entered - Long-Term Extension Study|Adverse Event|4
5540736|NCT01318135|19151213|P4|Entered - Long-Term Extension Study|Adverse Event|3
5540737|NCT01318135|19151214|P3|Entered - Long-Term Extension Study|Adverse Event|4
5540738|NCT01318135|19151215|P2|Entered - Long-Term Extension Study|Adverse Event|3
5540739|NCT01318135|19151216|P1|Entered - Long-Term Extension Study|Adverse Event|9
5540740|NCT01318135|19151209|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
5540741|NCT01318135|19151210|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
5540742|NCT01318135|19151211|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
5540743|NCT01318135|19151212|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
5540744|NCT01318135|19151213|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
5540745|NCT01318135|19151214|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
5540746|NCT01318135|19151215|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
5540747|NCT01318135|19151216|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
5540748|NCT01318135|19151209|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
5540749|NCT01318135|19151210|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
5540750|NCT01318135|19151211|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
5540751|NCT01318135|19151212|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
5540752|NCT01318135|19151213|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
5540753|NCT01318135|19151214|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
5540754|NCT01318135|19151215|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
5540755|NCT01318135|19151216|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
5540756|NCT01318122|19151348|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
5540757|NCT01318122|19151349|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
5540758|NCT01318122|19151350|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
5540759|NCT01318122|19151351|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
5540760|NCT01318122|19151348|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5540761|NCT01318122|19151349|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5540762|NCT01318122|19151350|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
5540763|NCT01318122|19151351|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5540764|NCT01318122|19151348|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
5540765|NCT01318122|19151349|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
5540766|NCT01318122|19151350|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
5540767|NCT01318122|19151351|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
5540768|NCT01318122|19151348|P4|Entered - Long-Term Extension Study|Adverse Event|4
5540769|NCT01318122|19151349|P3|Entered - Long-Term Extension Study|Adverse Event|2
5540770|NCT01318122|19151350|P2|Entered - Long-Term Extension Study|Adverse Event|6
5540771|NCT01318122|19151351|P1|Entered - Long-Term Extension Study|Adverse Event|6
5540772|NCT01318122|19151348|P4|Enrolled - Long-Term Extension Study|Other|0
5540773|NCT01318122|19151349|P3|Enrolled - Long-Term Extension Study|Other|0
5540774|NCT01318122|19151350|P2|Enrolled - Long-Term Extension Study|Other|0
5540775|NCT01318122|19151351|P1|Enrolled - Long-Term Extension Study|Other|1
5540776|NCT01318122|19151348|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
5540777|NCT01318122|19151349|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
5540778|NCT01318122|19151350|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
5540779|NCT01318122|19151351|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
5540780|NCT01318109|19151420|P3|Overall Study|Schedule Conflict|0
5540781|NCT01318109|19151421|P2|Overall Study|Schedule Conflict|1
5540782|NCT01318109|19151422|P1|Overall Study|Schedule Conflict|0
5540783|NCT01318109|19151420|P3|Overall Study|Withdrawal by Subject|0
5540784|NCT01318109|19151421|P2|Overall Study|Withdrawal by Subject|0
5540785|NCT01318109|19151422|P1|Overall Study|Withdrawal by Subject|1
5540786|NCT01318109|19151420|P3|Overall Study|Adverse Event|0
5540787|NCT01318109|19151421|P2|Overall Study|Adverse Event|2
5540788|NCT01318109|19151422|P1|Overall Study|Adverse Event|0
5540789|NCT01318083|19151457|P3|Overall Study|Lack of Study Medication Compliance|0
5540790|NCT01318083|19151458|P2|Overall Study|Lack of Study Medication Compliance|1
5540791|NCT01318083|19151459|P1|Overall Study|Lack of Study Medication Compliance|0
5540792|NCT01318083|19151457|P3|Overall Study|Treatment Complications|0
5540793|NCT01318083|19151458|P2|Overall Study|Treatment Complications|0
5540794|NCT01318083|19151459|P1|Overall Study|Treatment Complications|1
5540795|NCT01318083|19151457|P3|Overall Study|Lack of Efficacy|1
5540796|NCT01318083|19151458|P2|Overall Study|Lack of Efficacy|0
5540797|NCT01318083|19151459|P1|Overall Study|Lack of Efficacy|0
5540798|NCT01318083|19151457|P3|Overall Study|Withdrawal by Subject|2
5540799|NCT01318083|19151458|P2|Overall Study|Withdrawal by Subject|0
5540800|NCT01318083|19151459|P1|Overall Study|Withdrawal by Subject|1
5540801|NCT01318083|19151457|P3|Overall Study|Adverse Event|2
5540802|NCT01318083|19151458|P2|Overall Study|Adverse Event|1
5540803|NCT01318083|19151459|P1|Overall Study|Adverse Event|4
5540804|NCT01318070|19151494|P3|Overall Study|Principal Investigator Discretion|0
5540805|NCT01318070|19151495|P2|Overall Study|Principal Investigator Discretion|0
5540806|NCT01318070|19151496|P1|Overall Study|Principal Investigator Discretion|1
5540807|NCT01318070|19151494|P3|Overall Study|Lack of Efficacy|1
5540808|NCT01318070|19151495|P2|Overall Study|Lack of Efficacy|0
5540809|NCT01318070|19151496|P1|Overall Study|Lack of Efficacy|0
5540810|NCT01318070|19151494|P3|Overall Study|Withdrawal by Subject|1
5540811|NCT01318070|19151495|P2|Overall Study|Withdrawal by Subject|1
5540812|NCT01318070|19151496|P1|Overall Study|Withdrawal by Subject|0
5540813|NCT01318070|19151494|P3|Overall Study|Adverse Event|5
5540814|NCT01318070|19151495|P2|Overall Study|Adverse Event|1
5540815|NCT01318070|19151496|P1|Overall Study|Adverse Event|1
5540816|NCT01317940|19151543|P6|Overall Study|Change in therapy plan|0
5540817|NCT01317940|19151544|P5|Overall Study|Change in therapy plan|0
5540818|NCT01317940|19151545|P4|Overall Study|Change in therapy plan|0
5540819|NCT01317940|19151546|P3|Overall Study|Change in therapy plan|3
5540820|NCT01317940|19151547|P2|Overall Study|Change in therapy plan|0
5540821|NCT01317940|19151548|P1|Overall Study|Change in therapy plan|0
5540822|NCT01317940|19151543|P6|Overall Study|Lost to Follow-up|0
5540823|NCT01317940|19151544|P5|Overall Study|Lost to Follow-up|1
5540824|NCT01317940|19151545|P4|Overall Study|Lost to Follow-up|1
5540825|NCT01317940|19151546|P3|Overall Study|Lost to Follow-up|1
5540826|NCT01317940|19151547|P2|Overall Study|Lost to Follow-up|0
5540827|NCT01317940|19151548|P1|Overall Study|Lost to Follow-up|0
5540828|NCT01317940|19151543|P6|Overall Study|Death|0
5540829|NCT01317940|19151544|P5|Overall Study|Death|0
5540830|NCT01317940|19151545|P4|Overall Study|Death|0
5540831|NCT01317940|19151546|P3|Overall Study|Death|1
5540832|NCT01317940|19151547|P2|Overall Study|Death|0
5540833|NCT01317940|19151548|P1|Overall Study|Death|1
5540834|NCT01317797|19151579|P3|Overall Study|Withdrawal of Patient|1
5540835|NCT01317797|19151580|P2|Overall Study|Withdrawal of Patient|0
5540836|NCT01317797|19151581|P1|Overall Study|Withdrawal of Patient|0
5540837|NCT01317797|19151579|P3|Overall Study|Other|0
5540838|NCT01317797|19151580|P2|Overall Study|Other|1
5540839|NCT01317797|19151581|P1|Overall Study|Other|0
5540840|NCT01317641|19151658|P9|Overall Study|Withdrawal by Subject|0
5540841|NCT01317641|19151659|P8|Overall Study|Withdrawal by Subject|0
5540842|NCT01317641|19151660|P7|Overall Study|Withdrawal by Subject|1
5540843|NCT01317641|19151661|P6|Overall Study|Withdrawal by Subject|0
5540844|NCT01317641|19151662|P5|Overall Study|Withdrawal by Subject|0
5540845|NCT01317641|19151663|P4|Overall Study|Withdrawal by Subject|0
5540846|NCT01317641|19151664|P3|Overall Study|Withdrawal by Subject|0
5540847|NCT01317641|19151665|P2|Overall Study|Withdrawal by Subject|0
5540848|NCT01317641|19151666|P1|Overall Study|Withdrawal by Subject|0
5540849|NCT01317641|19151658|P9|Overall Study|Disease progression|4
5540850|NCT01317641|19151659|P8|Overall Study|Disease progression|3
5540851|NCT01317641|19151660|P7|Overall Study|Disease progression|0
5540852|NCT01317641|19151661|P6|Overall Study|Disease progression|0
5540853|NCT01317641|19151662|P5|Overall Study|Disease progression|0
5540854|NCT01317641|19151663|P4|Overall Study|Disease progression|0
5540855|NCT01317641|19151664|P3|Overall Study|Disease progression|0
5540856|NCT01317641|19151665|P2|Overall Study|Disease progression|0
5540857|NCT01317641|19151666|P1|Overall Study|Disease progression|0
5540858|NCT01317641|19151658|P9|Overall Study|Protocol Violation|0
5540859|NCT01317641|19151659|P8|Overall Study|Protocol Violation|0
5540860|NCT01317641|19151660|P7|Overall Study|Protocol Violation|0
5540861|NCT01317641|19151661|P6|Overall Study|Protocol Violation|0
5540862|NCT01317641|19151662|P5|Overall Study|Protocol Violation|0
5540863|NCT01317641|19151663|P4|Overall Study|Protocol Violation|0
5540864|NCT01317641|19151664|P3|Overall Study|Protocol Violation|0
5540865|NCT01317641|19151665|P2|Overall Study|Protocol Violation|0
5540866|NCT01317641|19151666|P1|Overall Study|Protocol Violation|1
5540867|NCT01317641|19151658|P9|Overall Study|Adverse Event|0
5540868|NCT01317641|19151659|P8|Overall Study|Adverse Event|1
5540869|NCT01317641|19151660|P7|Overall Study|Adverse Event|2
5540870|NCT01317641|19151661|P6|Overall Study|Adverse Event|0
5540871|NCT01317641|19151662|P5|Overall Study|Adverse Event|0
5540872|NCT01317641|19151663|P4|Overall Study|Adverse Event|1
5540873|NCT01317641|19151664|P3|Overall Study|Adverse Event|0
5540874|NCT01317641|19151665|P2|Overall Study|Adverse Event|1
5540875|NCT01317641|19151666|P1|Overall Study|Adverse Event|0
5540876|NCT01317641|19151658|P9|Overall Study|Not treated|1
5540877|NCT01317641|19151659|P8|Overall Study|Not treated|1
5540878|NCT01317641|19151660|P7|Overall Study|Not treated|0
5540879|NCT01317641|19151661|P6|Overall Study|Not treated|0
5540880|NCT01317641|19151662|P5|Overall Study|Not treated|0
5540881|NCT01317641|19151663|P4|Overall Study|Not treated|0
5540882|NCT01317641|19151664|P3|Overall Study|Not treated|0
5540883|NCT01317641|19151665|P2|Overall Study|Not treated|0
5540884|NCT01317641|19151666|P1|Overall Study|Not treated|0
5540885|NCT01317615|19151768|P1|Overall Study|Adverse Event|7
5540886|NCT01317615|19151768|P1|Overall Study|Abnormal laboratory value(s)|1
5540887|NCT01317615|19151768|P1|Overall Study|Withdrawal by Subject|5
5540888|NCT01317615|19151768|P1|Overall Study|Death|6
5540889|NCT01317615|19151768|P1|Overall Study|New cancer therapy|5
5540890|NCT01317615|19151768|P1|Overall Study|Disease progression|25
5540891|NCT01317550|19151781|P4|Overall Study|Lack of compliance study med|0
5540892|NCT01317550|19151782|P3|Overall Study|Lack of compliance study med|0
5540893|NCT01317550|19151783|P2|Overall Study|Lack of compliance study med|0
5540894|NCT01317550|19151784|P1|Overall Study|Lack of compliance study med|1
5540895|NCT01317550|19151781|P4|Overall Study|Withdrawal by Subject|0
5540896|NCT01317550|19151782|P3|Overall Study|Withdrawal by Subject|0
5540897|NCT01317550|19151783|P2|Overall Study|Withdrawal by Subject|0
5540898|NCT01317550|19151784|P1|Overall Study|Withdrawal by Subject|1
5540899|NCT01317472|19151796|P2|Overall Study|Unrelated hospitalization|0
5540900|NCT01317472|19151797|P1|Overall Study|Unrelated hospitalization|1
5540901|NCT01317472|19151796|P2|Overall Study|Withdrawal by Subject|0
5540902|NCT01317472|19151797|P1|Overall Study|Withdrawal by Subject|1
5540903|NCT01317199|19151807|P4|Randomized Phase 2|Patient transferred to other facility|0
5540904|NCT01317199|19151808|P3|Randomized Phase 2|Patient transferred to other facility|1
5540905|NCT01317199|19151809|P2|Randomized Phase 2|Patient transferred to other facility|0
5540906|NCT01317199|19151810|P1|Randomized Phase 2|Patient transferred to other facility|0
5540907|NCT01317199|19151807|P4|Randomized Phase 2|Patient stopped taking study drug|1
5540908|NCT01317199|19151808|P3|Randomized Phase 2|Patient stopped taking study drug|0
5540909|NCT01317199|19151809|P2|Randomized Phase 2|Patient stopped taking study drug|0
5540910|NCT01317199|19151810|P1|Randomized Phase 2|Patient stopped taking study drug|0
5540911|NCT01317199|19151807|P4|Randomized Phase 2|Disenrolled before treatment|2
5540912|NCT01317199|19151808|P3|Randomized Phase 2|Disenrolled before treatment|1
5540913|NCT01317199|19151809|P2|Randomized Phase 2|Disenrolled before treatment|1
5540914|NCT01317199|19151810|P1|Randomized Phase 2|Disenrolled before treatment|0
5540915|NCT01317199|19151807|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
5540916|NCT01317199|19151808|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
5540917|NCT01317199|19151809|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
5540918|NCT01317199|19151810|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
5540919|NCT01317199|19151807|P4|Randomized Phase 2|Comorbidities|2
5540920|NCT01317199|19151808|P3|Randomized Phase 2|Comorbidities|2
5540921|NCT01317199|19151809|P2|Randomized Phase 2|Comorbidities|2
5540922|NCT01317199|19151810|P1|Randomized Phase 2|Comorbidities|0
5540923|NCT01317199|19151807|P4|Randomized Phase 2|Adverse Event|1
5540924|NCT01317199|19151808|P3|Randomized Phase 2|Adverse Event|0
5540925|NCT01317199|19151809|P2|Randomized Phase 2|Adverse Event|0
5540926|NCT01317199|19151810|P1|Randomized Phase 2|Adverse Event|0
5540927|NCT01317199|19151807|P4|Randomized Phase 2|Withdrawal by Subject|4
5540928|NCT01317199|19151808|P3|Randomized Phase 2|Withdrawal by Subject|5
5540929|NCT01317199|19151809|P2|Randomized Phase 2|Withdrawal by Subject|3
5540930|NCT01317199|19151810|P1|Randomized Phase 2|Withdrawal by Subject|0
5540931|NCT01317199|19151807|P4|Randomized Phase 2|Disease progression|5
5540932|NCT01317199|19151808|P3|Randomized Phase 2|Disease progression|7
5540933|NCT01317199|19151809|P2|Randomized Phase 2|Disease progression|3
5540934|NCT01317199|19151810|P1|Randomized Phase 2|Disease progression|0
5540935|NCT01317199|19151807|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
5540936|NCT01317199|19151808|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
5540937|NCT01317199|19151809|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
5540938|NCT01317199|19151810|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
5540939|NCT01317199|19151807|P4|Dose-escalation Phase 1|Disease progression|0
5540940|NCT01317199|19151808|P3|Dose-escalation Phase 1|Disease progression|0
5540941|NCT01317199|19151809|P2|Dose-escalation Phase 1|Disease progression|0
5540942|NCT01317199|19151810|P1|Dose-escalation Phase 1|Disease progression|1
5540943|NCT01317199|19151807|P4|Dose-escalation Phase 1|Physician Decision|0
5540944|NCT01317199|19151808|P3|Dose-escalation Phase 1|Physician Decision|0
5540945|NCT01317199|19151809|P2|Dose-escalation Phase 1|Physician Decision|0
5540946|NCT01317199|19151810|P1|Dose-escalation Phase 1|Physician Decision|5
5540947|NCT01317160|19151839|P2|Overall Study|Withdrawal by Subject|2
5540948|NCT01317160|19151840|P1|Overall Study|Withdrawal by Subject|0
5540949|NCT01317160|19151839|P2|Overall Study|Lost to Follow-up|3
5540950|NCT01317160|19151840|P1|Overall Study|Lost to Follow-up|3
5540951|NCT01317160|19151839|P2|Overall Study|Incorrect inclusion|1
5540952|NCT01317160|19151840|P1|Overall Study|Incorrect inclusion|1
5540953|NCT01317004|19151874|P2|Overall Study|Adverse Event|3
5540954|NCT01317004|19151875|P1|Overall Study|Adverse Event|3
5540955|NCT01317004|19151874|P2|Overall Study|Protocol Violation|2
5540956|NCT01317004|19151875|P1|Overall Study|Protocol Violation|0
5540957|NCT01317004|19151874|P2|Overall Study|Withdrawal by Subject|4
5540958|NCT01317004|19151875|P1|Overall Study|Withdrawal by Subject|1
5540959|NCT01316939|19151896|P3|Overall Study|Protocol Violation|0
5540960|NCT01316939|19151897|P2|Overall Study|Protocol Violation|1
5540961|NCT01316939|19151898|P1|Overall Study|Protocol Violation|0
5540962|NCT01316939|19151896|P3|Overall Study|Met Liver chemistry stopping criteria|1
5540963|NCT01316939|19151897|P2|Overall Study|Met Liver chemistry stopping criteria|0
5540964|NCT01316939|19151898|P1|Overall Study|Met Liver chemistry stopping criteria|1
5540965|NCT01316939|19151896|P3|Overall Study|Lost to Follow-up|2
5540966|NCT01316939|19151897|P2|Overall Study|Lost to Follow-up|0
5540967|NCT01316939|19151898|P1|Overall Study|Lost to Follow-up|0
5540968|NCT01316939|19151896|P3|Overall Study|Physician Decision|1
5540969|NCT01316939|19151897|P2|Overall Study|Physician Decision|2
5540970|NCT01316939|19151898|P1|Overall Study|Physician Decision|2
5540971|NCT01316939|19151896|P3|Overall Study|Withdrawal by Subject|6
5540972|NCT01316939|19151897|P2|Overall Study|Withdrawal by Subject|3
5540973|NCT01316939|19151898|P1|Overall Study|Withdrawal by Subject|1
5540974|NCT01316939|19151896|P3|Overall Study|Adverse Event|11
5540975|NCT01316939|19151897|P2|Overall Study|Adverse Event|12
5540976|NCT01316939|19151898|P1|Overall Study|Adverse Event|9
5540977|NCT01316939|19151896|P3|Overall Study|Lack of Efficacy|25
5540978|NCT01316939|19151897|P2|Overall Study|Lack of Efficacy|25
5540979|NCT01316939|19151898|P1|Overall Study|Lack of Efficacy|24
5540980|NCT01316939|19151896|P3|Overall Study|Study closed/terminated|23
5540981|NCT01316939|19151897|P2|Overall Study|Study closed/terminated|25
5540982|NCT01316939|19151898|P1|Overall Study|Study closed/terminated|26
5540983|NCT01316913|19151993|P4|Overall Study|Withdrawal by Subject|6
5540984|NCT01316913|19151994|P3|Overall Study|Withdrawal by Subject|10
5540985|NCT01316913|19151995|P2|Overall Study|Withdrawal by Subject|9
5540986|NCT01316913|19151996|P1|Overall Study|Withdrawal by Subject|10
5540987|NCT01316913|19151993|P4|Overall Study|Lost to Follow-up|2
5540988|NCT01316913|19151994|P3|Overall Study|Lost to Follow-up|0
5540989|NCT01316913|19151995|P2|Overall Study|Lost to Follow-up|1
5540990|NCT01316913|19151996|P1|Overall Study|Lost to Follow-up|0
5540991|NCT01316913|19151993|P4|Overall Study|Protocol-defined Stopping Criteria|6
5540992|NCT01316913|19151994|P3|Overall Study|Protocol-defined Stopping Criteria|11
5540993|NCT01316913|19151995|P2|Overall Study|Protocol-defined Stopping Criteria|8
5540994|NCT01316913|19151996|P1|Overall Study|Protocol-defined Stopping Criteria|7
5540995|NCT01316913|19151993|P4|Overall Study|Protocol Violation|1
5540996|NCT01316913|19151994|P3|Overall Study|Protocol Violation|4
5540997|NCT01316913|19151995|P2|Overall Study|Protocol Violation|4
5540998|NCT01316913|19151996|P1|Overall Study|Protocol Violation|1
5540999|NCT01316913|19151993|P4|Overall Study|Lack of Efficacy|13
5541000|NCT01316913|19151994|P3|Overall Study|Lack of Efficacy|9
5541001|NCT01316913|19151995|P2|Overall Study|Lack of Efficacy|12
5541002|NCT01316913|19151996|P1|Overall Study|Lack of Efficacy|22
5541003|NCT01316913|19151993|P4|Overall Study|Adverse Event|11
5541004|NCT01316913|19151994|P3|Overall Study|Adverse Event|15
5541005|NCT01316913|19151995|P2|Overall Study|Adverse Event|20
5541006|NCT01316913|19151996|P1|Overall Study|Adverse Event|17
5541007|NCT01316900|19152018|P4|Overall Study|Withdrawal by Subject|9
5541008|NCT01316900|19152019|P3|Overall Study|Withdrawal by Subject|6
5541009|NCT01316900|19152020|P2|Overall Study|Withdrawal by Subject|8
5541010|NCT01316900|19152021|P1|Overall Study|Withdrawal by Subject|7
5541011|NCT01316900|19152018|P4|Overall Study|Lost to Follow-up|1
5541012|NCT01316900|19152019|P3|Overall Study|Lost to Follow-up|1
5541013|NCT01316900|19152020|P2|Overall Study|Lost to Follow-up|0
5541014|NCT01316900|19152021|P1|Overall Study|Lost to Follow-up|1
5541015|NCT01316900|19152018|P4|Overall Study|Protocol-defined Stopping Criteria|5
5541016|NCT01316900|19152019|P3|Overall Study|Protocol-defined Stopping Criteria|10
5541017|NCT01316900|19152020|P2|Overall Study|Protocol-defined Stopping Criteria|3
5541018|NCT01316900|19152021|P1|Overall Study|Protocol-defined Stopping Criteria|2
5541019|NCT01316900|19152018|P4|Overall Study|Protocol Violation|0
5541020|NCT01316900|19152019|P3|Overall Study|Protocol Violation|4
5541021|NCT01316900|19152020|P2|Overall Study|Protocol Violation|1
5541022|NCT01316900|19152021|P1|Overall Study|Protocol Violation|7
5541023|NCT01316900|19152018|P4|Overall Study|Lack of Efficacy|7
5541024|NCT01316900|19152019|P3|Overall Study|Lack of Efficacy|5
5541025|NCT01316900|19152020|P2|Overall Study|Lack of Efficacy|9
5541026|NCT01316900|19152021|P1|Overall Study|Lack of Efficacy|17
5541027|NCT01316900|19152018|P4|Overall Study|Adverse Event|9
5541028|NCT01316900|19152019|P3|Overall Study|Adverse Event|15
5541029|NCT01316900|19152020|P2|Overall Study|Adverse Event|10
5541030|NCT01316900|19152021|P1|Overall Study|Adverse Event|10
5541031|NCT01316887|19152042|P3|Overall Study|Withdrawal by Subject|15
5541032|NCT01316887|19152043|P2|Overall Study|Withdrawal by Subject|16
5541033|NCT01316887|19152044|P1|Overall Study|Withdrawal by Subject|8
5541034|NCT01316887|19152042|P3|Overall Study|Lost to Follow-up|5
5541035|NCT01316887|19152043|P2|Overall Study|Lost to Follow-up|7
5541036|NCT01316887|19152044|P1|Overall Study|Lost to Follow-up|1
5541037|NCT01316887|19152042|P3|Overall Study|Study Closed/Terminated|3
5541038|NCT01316887|19152043|P2|Overall Study|Study Closed/Terminated|4
5541039|NCT01316887|19152044|P1|Overall Study|Study Closed/Terminated|2
5541040|NCT01316887|19152042|P3|Overall Study|Protocol-defined Stopping Criteria|36
5541041|NCT01316887|19152043|P2|Overall Study|Protocol-defined Stopping Criteria|37
5541042|NCT01316887|19152044|P1|Overall Study|Protocol-defined Stopping Criteria|8
5541043|NCT01316887|19152042|P3|Overall Study|Protocol Violation|6
5541044|NCT01316887|19152043|P2|Overall Study|Protocol Violation|6
5541045|NCT01316887|19152044|P1|Overall Study|Protocol Violation|2
5541046|NCT01316887|19152042|P3|Overall Study|Lack of Efficacy|1
5541047|NCT01316887|19152043|P2|Overall Study|Lack of Efficacy|3
5541048|NCT01316887|19152044|P1|Overall Study|Lack of Efficacy|9
5541049|NCT01316887|19152042|P3|Overall Study|Adverse Event|17
5541050|NCT01316887|19152043|P2|Overall Study|Adverse Event|21
5541051|NCT01316887|19152044|P1|Overall Study|Adverse Event|13
5541052|NCT01316692|19152169|P1|Overall Study|Disease Progression|7
5541053|NCT01316692|19152169|P1|Overall Study|Adverse Event|5
5541054|NCT01316614|19152178|P1|Overall Study|Medically unstable|1
5541055|NCT01316614|19152178|P1|Overall Study|Inadequate number of passes|2
5541056|NCT01316614|19152178|P1|Overall Study|Cystic lesion|5
5541057|NCT01316614|19152178|P1|Overall Study|Cytology slides not available for review|4
5541058|NCT01316614|19152178|P1|Overall Study|No solid lesion and FNA not indicated|25
5541059|NCT01316575|19152195|P2|Overall Study|Required alternate treatment|1
5541060|NCT01316575|19152196|P1|Overall Study|Required alternate treatment|0
5541061|NCT01316575|19152195|P2|Overall Study|Withdrawal by Subject|0
5541062|NCT01316575|19152196|P1|Overall Study|Withdrawal by Subject|2
5541063|NCT01316419|19152219|P1|Overall Study|Lost to Follow-up|19
5541064|NCT01316419|19152219|P1|Overall Study|Violated inclusion/exclusion criterion|143
5541065|NCT01316419|19152219|P1|Overall Study|Not treated|103
5541066|NCT01316380|19152245|P3|Overall Study|Not treated|0
5541067|NCT01316380|19152246|P2|Overall Study|Not treated|0
5541068|NCT01316380|19152247|P1|Overall Study|Not treated|1
5541069|NCT01316380|19152245|P3|Overall Study|Other|1
5541070|NCT01316380|19152246|P2|Overall Study|Other|1
5541071|NCT01316380|19152247|P1|Overall Study|Other|0
5541072|NCT01316380|19152245|P3|Overall Study|Withdrawal by Subject|0
5541073|NCT01316380|19152246|P2|Overall Study|Withdrawal by Subject|2
5541074|NCT01316380|19152247|P1|Overall Study|Withdrawal by Subject|1
5541075|NCT01316380|19152245|P3|Overall Study|Protocol Violation|1
5541076|NCT01316380|19152246|P2|Overall Study|Protocol Violation|0
5541077|NCT01316380|19152247|P1|Overall Study|Protocol Violation|0
5541078|NCT01316380|19152245|P3|Overall Study|Adverse Event|1
5541079|NCT01316380|19152246|P2|Overall Study|Adverse Event|2
5541080|NCT01316380|19152247|P1|Overall Study|Adverse Event|0
5541081|NCT01316276|19152384|P1|Overall Study|Other|22
5541082|NCT01316276|19152384|P1|Overall Study|Lost to Follow-up|1
5541083|NCT01316276|19152384|P1|Overall Study|Withdrawal of consent|24
5541084|NCT01316276|19152384|P1|Overall Study|Adverse Event|19
5541085|NCT01316276|19152384|P1|Overall Study|Death|1
5541086|NCT01316224|19152432|P1|Overall Study|Other|1
5541087|NCT01316224|19152432|P1|Overall Study|Adverse Event With Treatment Failure|1
5541088|NCT01316224|19152432|P1|Overall Study|Withdrawal by Subject|1
5541089|NCT01316224|19152432|P1|Overall Study|Lack of Efficacy|1
5541090|NCT01316224|19152432|P1|Overall Study|Adverse Event|3
5541091|NCT01316224|19152432|P1|Overall Study|Protocol Violation|3
5541092|NCT01316055|19152485|P3|Overall Study|Lost to Follow-up|0
5541093|NCT01316055|19152486|P2|Overall Study|Lost to Follow-up|0
5541094|NCT01316055|19152487|P1|Overall Study|Lost to Follow-up|1
5541095|NCT01315847|19152518|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
5541096|NCT01315847|19152519|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
5541097|NCT01315847|19152518|P2|Part I, Period 1|Reached maximum number of arterial lines|0
5541098|NCT01315847|19152519|P1|Part I, Period 1|Reached maximum number of arterial lines|3
5541099|NCT01315678|19152533|P2|Overall Study|similar reason to those listed above|2
5541100|NCT01315678|19152534|P1|Overall Study|similar reason to those listed above|3
5541101|NCT01315678|19152533|P2|Overall Study|Lost to Follow-up|0
5541102|NCT01315678|19152534|P1|Overall Study|Lost to Follow-up|1
5541103|NCT01315678|19152533|P2|Overall Study|Adverse Event|1
5541104|NCT01315678|19152534|P1|Overall Study|Adverse Event|3
5541105|NCT01315678|19152533|P2|Overall Study|Withdrawal by Subject|3
5541106|NCT01315678|19152534|P1|Overall Study|Withdrawal by Subject|7
5541107|NCT01315353|19152585|P3|Overall Study|Inadvertent randomization/assignment|2
5541108|NCT01315353|19152586|P2|Overall Study|Inadvertent randomization/assignment|0
5541109|NCT01315353|19152587|P1|Overall Study|Inadvertent randomization/assignment|0
5541110|NCT01315353|19152585|P3|Overall Study|Taken off study by site in error|0
5541111|NCT01315353|19152586|P2|Overall Study|Taken off study by site in error|1
5541112|NCT01315353|19152587|P1|Overall Study|Taken off study by site in error|0
5541113|NCT01315353|19152585|P3|Overall Study|Site closing|0
5541114|NCT01315353|19152586|P2|Overall Study|Site closing|4
5541115|NCT01315353|19152587|P1|Overall Study|Site closing|7
5541116|NCT01315353|19152585|P3|Overall Study|Unwilling to adhere to requirements|4
5541117|NCT01315353|19152586|P2|Overall Study|Unwilling to adhere to requirements|5
5541118|NCT01315353|19152587|P1|Overall Study|Unwilling to adhere to requirements|5
5541119|NCT01315353|19152585|P3|Overall Study|Lost to Follow-up|6
5541120|NCT01315353|19152586|P2|Overall Study|Lost to Follow-up|6
5541121|NCT01315353|19152587|P1|Overall Study|Lost to Follow-up|13
5541122|NCT01315353|19152585|P3|Overall Study|Withdrawal by Subject|1
5541123|NCT01315353|19152586|P2|Overall Study|Withdrawal by Subject|6
5541124|NCT01315353|19152587|P1|Overall Study|Withdrawal by Subject|2
5541125|NCT01315353|19152585|P3|Overall Study|Death|0
5541126|NCT01315353|19152586|P2|Overall Study|Death|1
5541127|NCT01315353|19152587|P1|Overall Study|Death|2
5541128|NCT01315249|19152614|P2|Overall Study|Death|1
5541129|NCT01315249|19152615|P1|Overall Study|Death|0
5541130|NCT01315249|19152614|P2|Overall Study|Lost to Follow-up|2
5541131|NCT01315249|19152615|P1|Overall Study|Lost to Follow-up|0
5541132|NCT01315249|19152614|P2|Overall Study|Lack of Efficacy|1
5541133|NCT01315249|19152615|P1|Overall Study|Lack of Efficacy|0
5541134|NCT01315249|19152614|P2|Overall Study|inability to use device|0
5541135|NCT01315249|19152615|P1|Overall Study|inability to use device|1
5541136|NCT01315249|19152614|P2|Overall Study|Administrative problems|0
5541137|NCT01315249|19152615|P1|Overall Study|Administrative problems|1
5541138|NCT01315249|19152614|P2|Overall Study|Abnormal test results|2
5541139|NCT01315249|19152615|P1|Overall Study|Abnormal test results|1
5541140|NCT01315249|19152614|P2|Overall Study|Protocol Violation|5
5541141|NCT01315249|19152615|P1|Overall Study|Protocol Violation|8
5541142|NCT01315249|19152614|P2|Overall Study|Withdrawal by Subject|10
5541143|NCT01315249|19152615|P1|Overall Study|Withdrawal by Subject|11
5541144|NCT01315249|19152614|P2|Overall Study|Adverse Event|26
5541145|NCT01315249|19152615|P1|Overall Study|Adverse Event|22
5541146|NCT01315236|19152643|P2|12-Month Follow-up Period|Did not return to the site for Month 12|0
5541147|NCT01315236|19152644|P1|12-Month Follow-up Period|Did not return to the site for Month 12|1
5541148|NCT01315236|19152643|P2|12-Month Follow-up Period|Death|1
5541149|NCT01315236|19152644|P1|12-Month Follow-up Period|Death|0
5541150|NCT01315236|19152643|P2|Open-label Phase|Other|1
5541151|NCT01315236|19152644|P1|Open-label Phase|Other|0
5541152|NCT01315236|19152643|P2|Open-label Phase|Adverse Event|1
5541153|NCT01315236|19152644|P1|Open-label Phase|Adverse Event|0
5541154|NCT01315236|19152643|P2|Open-label Phase|Death|0
5541155|NCT01315236|19152644|P1|Open-label Phase|Death|1
5541156|NCT01315236|19152643|P2|Double-blind Phase|Lost to Follow-up|0
5541157|NCT01315236|19152644|P1|Double-blind Phase|Lost to Follow-up|1
5541158|NCT01315236|19152643|P2|Double-blind Phase|Withdrawal of Consent|0
5541159|NCT01315236|19152644|P1|Double-blind Phase|Withdrawal of Consent|1
5541160|NCT01315236|19152643|P2|Double-blind Phase|Adverse Event|0
5541161|NCT01315236|19152644|P1|Double-blind Phase|Adverse Event|1
5541162|NCT01315236|19152643|P2|Double-blind Phase|Death|0
5541163|NCT01315236|19152644|P1|Double-blind Phase|Death|1
5541164|NCT01315132|19152700|P1|Overall Study|not treated due to disease progression|1
5541165|NCT01315028|19152707|P2|Overall Study|Death|1
5541166|NCT01315028|19152708|P1|Overall Study|Death|0
5541167|NCT01315028|19152707|P2|Overall Study|Lost to Follow-up|0
5541168|NCT01315028|19152708|P1|Overall Study|Lost to Follow-up|1
5541169|NCT01314911|19152735|P2|Overall Study|Never Started Treatment|0
5541170|NCT01314911|19152736|P1|Overall Study|Never Started Treatment|1
5541171|NCT01314911|19152735|P2|Overall Study|Received Non-randomized Study Drug|1
5541172|NCT01314911|19152736|P1|Overall Study|Received Non-randomized Study Drug|0
5541173|NCT01314911|19152735|P2|Overall Study|Withdrawal by Subject|3
5541174|NCT01314911|19152736|P1|Overall Study|Withdrawal by Subject|1
5541175|NCT01314911|19152735|P2|Overall Study|Lost to Follow-up|2
5541176|NCT01314911|19152736|P1|Overall Study|Lost to Follow-up|3
5541177|NCT01314872|19152787|P15|Period 2|Lost to Follow-up|6
5541178|NCT01314872|19152788|P14|Period 2|Lost to Follow-up|2
5541179|NCT01314872|19152789|P13|Period 2|Lost to Follow-up|7
5541180|NCT01314872|19152790|P12|Period 2|Lost to Follow-up|6
5541181|NCT01314872|19152791|P11|Period 2|Lost to Follow-up|0
5541182|NCT01314872|19152792|P10|Period 2|Lost to Follow-up|0
5541183|NCT01314872|19152793|P9|Period 2|Lost to Follow-up|0
5541184|NCT01314872|19152794|P8|Period 2|Lost to Follow-up|0
5541185|NCT01314872|19152795|P7|Period 2|Lost to Follow-up|0
5541186|NCT01314872|19152796|P6|Period 2|Lost to Follow-up|0
5541187|NCT01314872|19152797|P5|Period 2|Lost to Follow-up|0
5541188|NCT01314872|19152798|P4|Period 2|Lost to Follow-up|0
5541189|NCT01314872|19152799|P3|Period 2|Lost to Follow-up|0
5541190|NCT01314872|19152800|P2|Period 2|Lost to Follow-up|0
5541191|NCT01314872|19152801|P1|Period 2|Lost to Follow-up|0
5541192|NCT01314872|19152787|P15|Period 2|Withdrawal by Subject|4
5541193|NCT01314872|19152788|P14|Period 2|Withdrawal by Subject|12
5541194|NCT01314872|19152789|P13|Period 2|Withdrawal by Subject|17
5541195|NCT01314872|19152790|P12|Period 2|Withdrawal by Subject|14
5541196|NCT01314872|19152791|P11|Period 2|Withdrawal by Subject|0
5541197|NCT01314872|19152792|P10|Period 2|Withdrawal by Subject|0
5541198|NCT01314872|19152793|P9|Period 2|Withdrawal by Subject|0
5541199|NCT01314872|19152794|P8|Period 2|Withdrawal by Subject|0
5541200|NCT01314872|19152795|P7|Period 2|Withdrawal by Subject|0
5541201|NCT01314872|19152796|P6|Period 2|Withdrawal by Subject|0
5541202|NCT01314872|19152797|P5|Period 2|Withdrawal by Subject|0
5541203|NCT01314872|19152798|P4|Period 2|Withdrawal by Subject|0
5541204|NCT01314872|19152799|P3|Period 2|Withdrawal by Subject|0
5541205|NCT01314872|19152800|P2|Period 2|Withdrawal by Subject|0
5541206|NCT01314872|19152801|P1|Period 2|Withdrawal by Subject|0
5541207|NCT01314872|19152787|P15|Period 2|Adverse event, non-fatal|9
5541208|NCT01314872|19152788|P14|Period 2|Adverse event, non-fatal|24
5541209|NCT01314872|19152789|P13|Period 2|Adverse event, non-fatal|16
5541210|NCT01314872|19152790|P12|Period 2|Adverse event, non-fatal|13
5541211|NCT01314872|19152791|P11|Period 2|Adverse event, non-fatal|0
5541212|NCT01314872|19152792|P10|Period 2|Adverse event, non-fatal|0
5541213|NCT01314872|19152793|P9|Period 2|Adverse event, non-fatal|0
5541214|NCT01314872|19152794|P8|Period 2|Adverse event, non-fatal|0
5541215|NCT01314872|19152795|P7|Period 2|Adverse event, non-fatal|0
5541216|NCT01314872|19152796|P6|Period 2|Adverse event, non-fatal|0
5541217|NCT01314872|19152797|P5|Period 2|Adverse event, non-fatal|0
5541218|NCT01314872|19152798|P4|Period 2|Adverse event, non-fatal|0
5541219|NCT01314872|19152799|P3|Period 2|Adverse event, non-fatal|0
5541220|NCT01314872|19152800|P2|Period 2|Adverse event, non-fatal|0
5541221|NCT01314872|19152801|P1|Period 2|Adverse event, non-fatal|0
5541222|NCT01314872|19152787|P15|Period 2|Study terminated by Sponsor|0
5541223|NCT01314872|19152788|P14|Period 2|Study terminated by Sponsor|3
5541224|NCT01314872|19152789|P13|Period 2|Study terminated by Sponsor|2
5541225|NCT01314872|19152790|P12|Period 2|Study terminated by Sponsor|2
5541226|NCT01314872|19152791|P11|Period 2|Study terminated by Sponsor|0
5541227|NCT01314872|19152792|P10|Period 2|Study terminated by Sponsor|0
5541228|NCT01314872|19152793|P9|Period 2|Study terminated by Sponsor|0
5541229|NCT01314872|19152794|P8|Period 2|Study terminated by Sponsor|0
5541230|NCT01314872|19152795|P7|Period 2|Study terminated by Sponsor|0
5541231|NCT01314872|19152796|P6|Period 2|Study terminated by Sponsor|0
5541232|NCT01314872|19152797|P5|Period 2|Study terminated by Sponsor|0
5541233|NCT01314872|19152798|P4|Period 2|Study terminated by Sponsor|0
5541234|NCT01314872|19152799|P3|Period 2|Study terminated by Sponsor|0
5541235|NCT01314872|19152800|P2|Period 2|Study terminated by Sponsor|0
5541236|NCT01314872|19152801|P1|Period 2|Study terminated by Sponsor|0
5541237|NCT01314872|19152787|P15|Period 2|Pregnancy|1
5541238|NCT01314872|19152788|P14|Period 2|Pregnancy|0
5541239|NCT01314872|19152789|P13|Period 2|Pregnancy|0
5541240|NCT01314872|19152790|P12|Period 2|Pregnancy|0
5541241|NCT01314872|19152791|P11|Period 2|Pregnancy|0
5541242|NCT01314872|19152792|P10|Period 2|Pregnancy|0
5541243|NCT01314872|19152793|P9|Period 2|Pregnancy|0
5541244|NCT01314872|19152794|P8|Period 2|Pregnancy|0
5541245|NCT01314872|19152795|P7|Period 2|Pregnancy|0
5541246|NCT01314872|19152796|P6|Period 2|Pregnancy|0
5541247|NCT01314872|19152797|P5|Period 2|Pregnancy|0
5541248|NCT01314872|19152798|P4|Period 2|Pregnancy|0
5541249|NCT01314872|19152799|P3|Period 2|Pregnancy|0
5541250|NCT01314872|19152800|P2|Period 2|Pregnancy|0
5541251|NCT01314872|19152801|P1|Period 2|Pregnancy|0
5541252|NCT01314872|19152787|P15|Period 2|Lack of Efficacy|2
5541253|NCT01314872|19152788|P14|Period 2|Lack of Efficacy|9
5541254|NCT01314872|19152789|P13|Period 2|Lack of Efficacy|12
5541255|NCT01314872|19152790|P12|Period 2|Lack of Efficacy|7
5541256|NCT01314872|19152791|P11|Period 2|Lack of Efficacy|0
5541257|NCT01314872|19152792|P10|Period 2|Lack of Efficacy|0
5541258|NCT01314872|19152793|P9|Period 2|Lack of Efficacy|0
5541259|NCT01314872|19152794|P8|Period 2|Lack of Efficacy|0
5541260|NCT01314872|19152795|P7|Period 2|Lack of Efficacy|0
5541261|NCT01314872|19152796|P6|Period 2|Lack of Efficacy|0
5541262|NCT01314872|19152797|P5|Period 2|Lack of Efficacy|0
5541263|NCT01314872|19152798|P4|Period 2|Lack of Efficacy|0
5541264|NCT01314872|19152799|P3|Period 2|Lack of Efficacy|0
5541265|NCT01314872|19152800|P2|Period 2|Lack of Efficacy|0
5541266|NCT01314872|19152801|P1|Period 2|Lack of Efficacy|0
5541267|NCT01314872|19152787|P15|Period 2|Non-compliance with study drug|2
5541268|NCT01314872|19152788|P14|Period 2|Non-compliance with study drug|1
5541269|NCT01314872|19152789|P13|Period 2|Non-compliance with study drug|3
5541270|NCT01314872|19152790|P12|Period 2|Non-compliance with study drug|3
5541271|NCT01314872|19152791|P11|Period 2|Non-compliance with study drug|0
5541272|NCT01314872|19152792|P10|Period 2|Non-compliance with study drug|0
5541273|NCT01314872|19152793|P9|Period 2|Non-compliance with study drug|0
5541274|NCT01314872|19152794|P8|Period 2|Non-compliance with study drug|0
5541275|NCT01314872|19152795|P7|Period 2|Non-compliance with study drug|0
5541276|NCT01314872|19152796|P6|Period 2|Non-compliance with study drug|0
5541277|NCT01314872|19152797|P5|Period 2|Non-compliance with study drug|0
5541278|NCT01314872|19152798|P4|Period 2|Non-compliance with study drug|0
5541279|NCT01314872|19152799|P3|Period 2|Non-compliance with study drug|0
5541280|NCT01314872|19152800|P2|Period 2|Non-compliance with study drug|0
5541281|NCT01314872|19152801|P1|Period 2|Non-compliance with study drug|0
5541282|NCT01314872|19152787|P15|Period 2|Protocol Violation|0
5541283|NCT01314872|19152788|P14|Period 2|Protocol Violation|2
5541284|NCT01314872|19152789|P13|Period 2|Protocol Violation|3
5541285|NCT01314872|19152790|P12|Period 2|Protocol Violation|3
5541286|NCT01314872|19152791|P11|Period 2|Protocol Violation|0
5541287|NCT01314872|19152792|P10|Period 2|Protocol Violation|0
5541288|NCT01314872|19152793|P9|Period 2|Protocol Violation|0
5541289|NCT01314872|19152794|P8|Period 2|Protocol Violation|0
5541290|NCT01314872|19152795|P7|Period 2|Protocol Violation|0
5541291|NCT01314872|19152796|P6|Period 2|Protocol Violation|0
5541292|NCT01314872|19152797|P5|Period 2|Protocol Violation|0
5541293|NCT01314872|19152798|P4|Period 2|Protocol Violation|0
5541294|NCT01314872|19152799|P3|Period 2|Protocol Violation|0
5541295|NCT01314872|19152800|P2|Period 2|Protocol Violation|0
5541296|NCT01314872|19152801|P1|Period 2|Protocol Violation|0
5541297|NCT01314872|19152787|P15|Treatment Period 1|Lost to Follow-up|0
5541298|NCT01314872|19152788|P14|Treatment Period 1|Lost to Follow-up|0
5541299|NCT01314872|19152789|P13|Treatment Period 1|Lost to Follow-up|0
5541300|NCT01314872|19152790|P12|Treatment Period 1|Lost to Follow-up|0
5541301|NCT01314872|19152791|P11|Treatment Period 1|Lost to Follow-up|0
5541302|NCT01314872|19152792|P10|Treatment Period 1|Lost to Follow-up|0
5541303|NCT01314872|19152793|P9|Treatment Period 1|Lost to Follow-up|1
5541304|NCT01314872|19152794|P8|Treatment Period 1|Lost to Follow-up|1
5541305|NCT01314872|19152795|P7|Treatment Period 1|Lost to Follow-up|1
5541306|NCT01314872|19152796|P6|Treatment Period 1|Lost to Follow-up|1
5541307|NCT01314872|19152797|P5|Treatment Period 1|Lost to Follow-up|1
5541308|NCT01314872|19152798|P4|Treatment Period 1|Lost to Follow-up|2
5541309|NCT01314872|19152799|P3|Treatment Period 1|Lost to Follow-up|2
5541310|NCT01314872|19152800|P2|Treatment Period 1|Lost to Follow-up|1
5541311|NCT01314872|19152801|P1|Treatment Period 1|Lost to Follow-up|0
5541312|NCT01314872|19152787|P15|Treatment Period 1|Withdrawal by Subject|0
5541313|NCT01314872|19152788|P14|Treatment Period 1|Withdrawal by Subject|0
5541314|NCT01314872|19152789|P13|Treatment Period 1|Withdrawal by Subject|0
5541315|NCT01314872|19152790|P12|Treatment Period 1|Withdrawal by Subject|0
5541316|NCT01314872|19152791|P11|Treatment Period 1|Withdrawal by Subject|1
5541317|NCT01314872|19152792|P10|Treatment Period 1|Withdrawal by Subject|2
5541318|NCT01314872|19152793|P9|Treatment Period 1|Withdrawal by Subject|2
5541319|NCT01314872|19152794|P8|Treatment Period 1|Withdrawal by Subject|2
5541320|NCT01314872|19152795|P7|Treatment Period 1|Withdrawal by Subject|3
5541321|NCT01314872|19152796|P6|Treatment Period 1|Withdrawal by Subject|1
5541322|NCT01314872|19152797|P5|Treatment Period 1|Withdrawal by Subject|3
5541323|NCT01314872|19152798|P4|Treatment Period 1|Withdrawal by Subject|2
5541324|NCT01314872|19152799|P3|Treatment Period 1|Withdrawal by Subject|0
5541325|NCT01314872|19152800|P2|Treatment Period 1|Withdrawal by Subject|1
5541326|NCT01314872|19152801|P1|Treatment Period 1|Withdrawal by Subject|3
5541327|NCT01314872|19152787|P15|Treatment Period 1|Adverse event, non-fatal|0
5541328|NCT01314872|19152788|P14|Treatment Period 1|Adverse event, non-fatal|0
5541329|NCT01314872|19152789|P13|Treatment Period 1|Adverse event, non-fatal|0
5541330|NCT01314872|19152790|P12|Treatment Period 1|Adverse event, non-fatal|0
5541331|NCT01314872|19152791|P11|Treatment Period 1|Adverse event, non-fatal|1
5541332|NCT01314872|19152792|P10|Treatment Period 1|Adverse event, non-fatal|0
5541333|NCT01314872|19152793|P9|Treatment Period 1|Adverse event, non-fatal|3
5541334|NCT01314872|19152794|P8|Treatment Period 1|Adverse event, non-fatal|2
5541335|NCT01314872|19152795|P7|Treatment Period 1|Adverse event, non-fatal|4
5541336|NCT01314872|19152796|P6|Treatment Period 1|Adverse event, non-fatal|4
5541337|NCT01314872|19152797|P5|Treatment Period 1|Adverse event, non-fatal|2
5541338|NCT01314872|19152798|P4|Treatment Period 1|Adverse event, non-fatal|2
5541339|NCT01314872|19152799|P3|Treatment Period 1|Adverse event, non-fatal|3
5541340|NCT01314872|19152800|P2|Treatment Period 1|Adverse event, non-fatal|2
5541341|NCT01314872|19152801|P1|Treatment Period 1|Adverse event, non-fatal|4
5541342|NCT01314872|19152787|P15|Treatment Period 1|Lack of Efficacy|0
5541343|NCT01314872|19152788|P14|Treatment Period 1|Lack of Efficacy|0
5541344|NCT01314872|19152789|P13|Treatment Period 1|Lack of Efficacy|0
5541345|NCT01314872|19152790|P12|Treatment Period 1|Lack of Efficacy|0
5541346|NCT01314872|19152791|P11|Treatment Period 1|Lack of Efficacy|0
5541347|NCT01314872|19152792|P10|Treatment Period 1|Lack of Efficacy|0
5541348|NCT01314872|19152793|P9|Treatment Period 1|Lack of Efficacy|0
5541349|NCT01314872|19152794|P8|Treatment Period 1|Lack of Efficacy|2
5541350|NCT01314872|19152795|P7|Treatment Period 1|Lack of Efficacy|0
5541351|NCT01314872|19152796|P6|Treatment Period 1|Lack of Efficacy|1
5541352|NCT01314872|19152797|P5|Treatment Period 1|Lack of Efficacy|0
5541353|NCT01314872|19152798|P4|Treatment Period 1|Lack of Efficacy|0
5541354|NCT01314872|19152799|P3|Treatment Period 1|Lack of Efficacy|0
5541355|NCT01314872|19152800|P2|Treatment Period 1|Lack of Efficacy|0
5541356|NCT01314872|19152801|P1|Treatment Period 1|Lack of Efficacy|1
5541357|NCT01314872|19152787|P15|Treatment Period 1|Physician Decision|0
5541358|NCT01314872|19152788|P14|Treatment Period 1|Physician Decision|0
5541359|NCT01314872|19152789|P13|Treatment Period 1|Physician Decision|0
5541360|NCT01314872|19152790|P12|Treatment Period 1|Physician Decision|0
5541361|NCT01314872|19152791|P11|Treatment Period 1|Physician Decision|0
5541362|NCT01314872|19152792|P10|Treatment Period 1|Physician Decision|1
5541363|NCT01314872|19152793|P9|Treatment Period 1|Physician Decision|0
5541364|NCT01314872|19152794|P8|Treatment Period 1|Physician Decision|0
5541365|NCT01314872|19152795|P7|Treatment Period 1|Physician Decision|0
5541366|NCT01314872|19152796|P6|Treatment Period 1|Physician Decision|0
5541367|NCT01314872|19152797|P5|Treatment Period 1|Physician Decision|0
5541368|NCT01314872|19152798|P4|Treatment Period 1|Physician Decision|1
5541369|NCT01314872|19152799|P3|Treatment Period 1|Physician Decision|0
5541370|NCT01314872|19152800|P2|Treatment Period 1|Physician Decision|1
5541371|NCT01314872|19152801|P1|Treatment Period 1|Physician Decision|0
5541372|NCT01314872|19152787|P15|Treatment Period 1|Protocol Violation|0
5541373|NCT01314872|19152788|P14|Treatment Period 1|Protocol Violation|0
5541374|NCT01314872|19152789|P13|Treatment Period 1|Protocol Violation|0
5541375|NCT01314872|19152790|P12|Treatment Period 1|Protocol Violation|0
5541376|NCT01314872|19152791|P11|Treatment Period 1|Protocol Violation|1
5541377|NCT01314872|19152792|P10|Treatment Period 1|Protocol Violation|1
5541378|NCT01314872|19152793|P9|Treatment Period 1|Protocol Violation|0
5541379|NCT01314872|19152794|P8|Treatment Period 1|Protocol Violation|0
5541380|NCT01314872|19152795|P7|Treatment Period 1|Protocol Violation|0
5541381|NCT01314872|19152796|P6|Treatment Period 1|Protocol Violation|0
5541382|NCT01314872|19152797|P5|Treatment Period 1|Protocol Violation|1
5541383|NCT01314872|19152798|P4|Treatment Period 1|Protocol Violation|0
5541384|NCT01314872|19152799|P3|Treatment Period 1|Protocol Violation|1
5541385|NCT01314872|19152800|P2|Treatment Period 1|Protocol Violation|1
5541386|NCT01314872|19152801|P1|Treatment Period 1|Protocol Violation|2
5541387|NCT01314716|19152905|P2|Open-Label Phase|Physician Decision|4
5541388|NCT01314716|19152906|P1|Open-Label Phase|Physician Decision|5
5541389|NCT01314716|19152905|P2|Open-Label Phase|Withdrawal by Subject|2
5541390|NCT01314716|19152906|P1|Open-Label Phase|Withdrawal by Subject|1
5541391|NCT01314716|19152905|P2|Open-Label Phase|Adverse Event|6
5541392|NCT01314716|19152906|P1|Open-Label Phase|Adverse Event|4
5541393|NCT01314716|19152905|P2|Double-Blind Phase|Physician Decision|1
5541394|NCT01314716|19152906|P1|Double-Blind Phase|Physician Decision|0
5541395|NCT01314716|19152905|P2|Double-Blind Phase|Sponsor request|2
5541396|NCT01314716|19152906|P1|Double-Blind Phase|Sponsor request|1
5541397|NCT01314716|19152905|P2|Double-Blind Phase|Lost to Follow-up|1
5541398|NCT01314716|19152906|P1|Double-Blind Phase|Lost to Follow-up|0
5541399|NCT01314716|19152905|P2|Double-Blind Phase|Withdrawal by Subject|6
5541400|NCT01314716|19152906|P1|Double-Blind Phase|Withdrawal by Subject|5
5541401|NCT01314716|19152905|P2|Double-Blind Phase|Adverse Event|4
5541402|NCT01314716|19152906|P1|Double-Blind Phase|Adverse Event|10
5541403|NCT01314716|19152905|P2|Double-Blind Phase|Randomized but not treated|1
5541404|NCT01314716|19152906|P1|Double-Blind Phase|Randomized but not treated|1
5541405|NCT01314703|19152918|P1|Overall Study|screen failure and closed enrollment|8
5541406|NCT01314443|19152927|P4|Overall Study|Protocol Violation|1
5541407|NCT01314443|19152928|P3|Overall Study|Protocol Violation|1
5541408|NCT01314443|19152929|P2|Overall Study|Protocol Violation|2
5541409|NCT01314443|19152930|P1|Overall Study|Protocol Violation|2
5541410|NCT01314443|19152927|P4|Overall Study|Withdrawal by Subject|1
5541411|NCT01314443|19152928|P3|Overall Study|Withdrawal by Subject|1
5541412|NCT01314443|19152929|P2|Overall Study|Withdrawal by Subject|1
5541413|NCT01314443|19152930|P1|Overall Study|Withdrawal by Subject|2
5541414|NCT01314261|19153000|P4|Overall Study|Virologic Failure|1
5541415|NCT01314261|19153001|P3|Overall Study|Virologic Failure|0
5541416|NCT01314261|19153002|P2|Overall Study|Virologic Failure|1
5541417|NCT01314261|19153003|P1|Overall Study|Virologic Failure|0
5541418|NCT01314261|19153000|P4|Overall Study|Lost to Follow-up|2
5541419|NCT01314261|19153001|P3|Overall Study|Lost to Follow-up|2
5541420|NCT01314261|19153002|P2|Overall Study|Lost to Follow-up|0
5541421|NCT01314261|19153003|P1|Overall Study|Lost to Follow-up|1
5541422|NCT01314261|19153000|P4|Overall Study|Withdrawal by Subject|0
5541423|NCT01314261|19153001|P3|Overall Study|Withdrawal by Subject|1
5541424|NCT01314261|19153002|P2|Overall Study|Withdrawal by Subject|3
5541425|NCT01314261|19153003|P1|Overall Study|Withdrawal by Subject|0
5541426|NCT01314261|19153000|P4|Overall Study|Adverse Event|0
5541427|NCT01314261|19153001|P3|Overall Study|Adverse Event|0
5541428|NCT01314261|19153002|P2|Overall Study|Adverse Event|0
5541429|NCT01314261|19153003|P1|Overall Study|Adverse Event|1
5541430|NCT01314118|19153054|P1|Overall Study|Ongoing|62
5541431|NCT01314118|19153054|P1|Overall Study|Other|2
5541432|NCT01314118|19153054|P1|Overall Study|Withdrawal by Subject|11
5541433|NCT01314118|19153054|P1|Overall Study|Protocol Violation|5
5541434|NCT01314118|19153054|P1|Overall Study|Death|4
5541435|NCT01314118|19153054|P1|Overall Study|Physician Decision|11
5541436|NCT01314118|19153054|P1|Overall Study|Progressive disease|27
5541437|NCT01314118|19153054|P1|Overall Study|Adverse Event|9
5541438|NCT01314105|19153063|P2|Overall Study|Other Adverse Event|1
5541439|NCT01314105|19153064|P1|Overall Study|Other Adverse Event|1
5541440|NCT01314105|19153063|P2|Overall Study|Refused to continue taking medication|1
5541441|NCT01314105|19153064|P1|Overall Study|Refused to continue taking medication|0
5541442|NCT01314105|19153063|P2|Overall Study|Progressive Disease|10
5541443|NCT01314105|19153064|P1|Overall Study|Progressive Disease|6
5541444|NCT01313923|19153182|P1|Overall Study|Physician Decision|3
5541445|NCT01313884|19153198|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
5541446|NCT01313858|19153206|P3|Overall Study|Lost to Follow-up|47
5541447|NCT01313858|19153207|P2|Overall Study|Lost to Follow-up|51
5541448|NCT01313858|19153208|P1|Overall Study|Lost to Follow-up|35
5541449|NCT01313858|19153206|P3|Overall Study|Premature Treatment Termination|191
5541450|NCT01313858|19153207|P2|Overall Study|Premature Treatment Termination|219
5541451|NCT01313858|19153208|P1|Overall Study|Premature Treatment Termination|251
5541452|NCT01313780|19153231|P2|Overall Study|missing data|3
5541453|NCT01313780|19153232|P1|Overall Study|missing data|3
5541454|NCT01313780|19153231|P2|Overall Study|Protocol Violation|4
5541455|NCT01313780|19153232|P1|Overall Study|Protocol Violation|10
5541456|NCT01313780|19153231|P2|Overall Study|Withdrawal by Subject|8
5541457|NCT01313780|19153232|P1|Overall Study|Withdrawal by Subject|2
5541458|NCT01313780|19153231|P2|Overall Study|Adverse Event|11
5541459|NCT01313780|19153232|P1|Overall Study|Adverse Event|6
5541460|NCT01313780|19153231|P2|Overall Study|Lack of Efficacy|2
5541461|NCT01313780|19153232|P1|Overall Study|Lack of Efficacy|4
5541462|NCT01313767|19153242|P2|Overall Study|Protocol Violation|1
5541463|NCT01313767|19153243|P1|Overall Study|Protocol Violation|3
5541464|NCT01313767|19153242|P2|Overall Study|Withdrawal by Subject|1
5541465|NCT01313767|19153243|P1|Overall Study|Withdrawal by Subject|2
5541466|NCT01313767|19153242|P2|Overall Study|Lost to Follow-up|0
5541467|NCT01313767|19153243|P1|Overall Study|Lost to Follow-up|1
5541468|NCT01313767|19153242|P2|Overall Study|Adverse Event|0
5541469|NCT01313767|19153243|P1|Overall Study|Adverse Event|1
5541470|NCT01313728|19153285|P1|Informed Consent to Baseline|Withdrawal by Subject|1
5541471|NCT01313689|19153305|P5|24-Week Randomization 2|Physician Decision|4
5541472|NCT01313689|19153306|P4|24-Week Randomization 2|Physician Decision|0
5541473|NCT01313689|19153307|P3|24-Week Randomization 2|Physician Decision|0
5541474|NCT01313689|19153308|P2|24-Week Randomization 2|Physician Decision|0
5541475|NCT01313689|19153309|P1|24-Week Randomization 2|Physician Decision|0
5541476|NCT01313689|19153305|P5|24-Week Randomization 2|Withdrawal by Subject|3
5541477|NCT01313689|19153306|P4|24-Week Randomization 2|Withdrawal by Subject|1
5541478|NCT01313689|19153307|P3|24-Week Randomization 2|Withdrawal by Subject|1
5541479|NCT01313689|19153308|P2|24-Week Randomization 2|Withdrawal by Subject|0
5541480|NCT01313689|19153309|P1|24-Week Randomization 2|Withdrawal by Subject|0
5541481|NCT01313689|19153305|P5|24-Week Randomization 2|Adverse Event|8
5541482|NCT01313689|19153306|P4|24-Week Randomization 2|Adverse Event|0
5541483|NCT01313689|19153307|P3|24-Week Randomization 2|Adverse Event|2
5541484|NCT01313689|19153308|P2|24-Week Randomization 2|Adverse Event|0
5541485|NCT01313689|19153309|P1|24-Week Randomization 2|Adverse Event|0
5541486|NCT01313689|19153305|P5|24-Week Randomization 1|Withdrawal by Subject|0
5541487|NCT01313689|19153306|P4|24-Week Randomization 1|Withdrawal by Subject|0
5541488|NCT01313689|19153307|P3|24-Week Randomization 1|Withdrawal by Subject|0
5541489|NCT01313689|19153308|P2|24-Week Randomization 1|Withdrawal by Subject|0
5541490|NCT01313689|19153309|P1|24-Week Randomization 1|Withdrawal by Subject|5
5541491|NCT01313689|19153305|P5|24-Week Randomization 1|Physician Decision|0
5541492|NCT01313689|19153306|P4|24-Week Randomization 1|Physician Decision|0
5541493|NCT01313689|19153307|P3|24-Week Randomization 1|Physician Decision|0
5541494|NCT01313689|19153308|P2|24-Week Randomization 1|Physician Decision|5
5541495|NCT01313689|19153309|P1|24-Week Randomization 1|Physician Decision|4
5541496|NCT01313689|19153305|P5|24-Week Randomization 1|Adverse Event|0
5541497|NCT01313689|19153306|P4|24-Week Randomization 1|Adverse Event|0
5541498|NCT01313689|19153307|P3|24-Week Randomization 1|Adverse Event|0
5541499|NCT01313689|19153308|P2|24-Week Randomization 1|Adverse Event|5
5541500|NCT01313689|19153309|P1|24-Week Randomization 1|Adverse Event|10
5541501|NCT01313676|19153388|P4|Overall Study|Missing|0
5541502|NCT01313676|19153389|P3|Overall Study|Missing|1
5541503|NCT01313676|19153390|P2|Overall Study|Missing|1
5541504|NCT01313676|19153391|P1|Overall Study|Missing|1
5541505|NCT01313676|19153388|P4|Overall Study|Investigator Site Closed|10
5541506|NCT01313676|19153389|P3|Overall Study|Investigator Site Closed|15
5541507|NCT01313676|19153390|P2|Overall Study|Investigator Site Closed|11
5541508|NCT01313676|19153391|P1|Overall Study|Investigator Site Closed|12
5541509|NCT01313676|19153388|P4|Overall Study|Sponsor Terminated Study Treatment|1
5541510|NCT01313676|19153389|P3|Overall Study|Sponsor Terminated Study Treatment|0
5541511|NCT01313676|19153390|P2|Overall Study|Sponsor Terminated Study Treatment|1
5541512|NCT01313676|19153391|P1|Overall Study|Sponsor Terminated Study Treatment|1
5541513|NCT01313676|19153388|P4|Overall Study|Decision by Participant or Proxy|492
5541514|NCT01313676|19153389|P3|Overall Study|Decision by Participant or Proxy|515
5541515|NCT01313676|19153390|P2|Overall Study|Decision by Participant or Proxy|527
5541516|NCT01313676|19153391|P1|Overall Study|Decision by Participant or Proxy|643
5541517|NCT01313676|19153388|P4|Overall Study|Physician Decision|48
5541518|NCT01313676|19153389|P3|Overall Study|Physician Decision|62
5541519|NCT01313676|19153390|P2|Overall Study|Physician Decision|64
5541520|NCT01313676|19153391|P1|Overall Study|Physician Decision|53
5541521|NCT01313676|19153388|P4|Overall Study|Lost to Follow-up|0
5541522|NCT01313676|19153389|P3|Overall Study|Lost to Follow-up|1
5541523|NCT01313676|19153390|P2|Overall Study|Lost to Follow-up|0
5541524|NCT01313676|19153391|P1|Overall Study|Lost to Follow-up|0
5541525|NCT01313676|19153388|P4|Overall Study|Study Closed/terminated|9
5541526|NCT01313676|19153389|P3|Overall Study|Study Closed/terminated|9
5541527|NCT01313676|19153390|P2|Overall Study|Study Closed/terminated|6
5541528|NCT01313676|19153391|P1|Overall Study|Study Closed/terminated|7
5541529|NCT01313676|19153388|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
5541530|NCT01313676|19153389|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
5541531|NCT01313676|19153390|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
5541532|NCT01313676|19153391|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
5541533|NCT01313676|19153388|P4|Overall Study|Protocol Violation|44
5541534|NCT01313676|19153389|P3|Overall Study|Protocol Violation|46
5541535|NCT01313676|19153390|P2|Overall Study|Protocol Violation|44
5541536|NCT01313676|19153391|P1|Overall Study|Protocol Violation|37
5541537|NCT01313676|19153388|P4|Overall Study|Lack of Efficacy|46
5541538|NCT01313676|19153389|P3|Overall Study|Lack of Efficacy|65
5541539|NCT01313676|19153390|P2|Overall Study|Lack of Efficacy|90
5541540|NCT01313676|19153391|P1|Overall Study|Lack of Efficacy|98
5541541|NCT01313676|19153388|P4|Overall Study|Adverse Event|333
5541542|NCT01313676|19153389|P3|Overall Study|Adverse Event|372
5541543|NCT01313676|19153390|P2|Overall Study|Adverse Event|365
5541544|NCT01313676|19153391|P1|Overall Study|Adverse Event|395
5541545|NCT01313663|19153411|P2|Overall Study|Withdrawal by Subject|1
5541546|NCT01313663|19153412|P1|Overall Study|Withdrawal by Subject|2
5541547|NCT01313663|19153411|P2|Overall Study|Physician Decision|2
5541548|NCT01313663|19153412|P1|Overall Study|Physician Decision|0
5541549|NCT01313663|19153411|P2|Overall Study|Lost to Follow-up|1
5541550|NCT01313663|19153412|P1|Overall Study|Lost to Follow-up|0
5541551|NCT01313663|19153411|P2|Overall Study|Study Closed/Terminated|4
5541552|NCT01313663|19153412|P1|Overall Study|Study Closed/Terminated|2
5541553|NCT01313650|19153450|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
5541554|NCT01313650|19153451|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
5541555|NCT01313650|19153452|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
5541556|NCT01313650|19153453|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
5541557|NCT01313650|19153450|P4|Overall Study|Protocol Violation|6
5541558|NCT01313650|19153451|P3|Overall Study|Protocol Violation|5
5541559|NCT01313650|19153452|P2|Overall Study|Protocol Violation|7
5541560|NCT01313650|19153453|P1|Overall Study|Protocol Violation|4
5541561|NCT01313650|19153450|P4|Overall Study|Withdrawal by Subject|15
5541562|NCT01313650|19153451|P3|Overall Study|Withdrawal by Subject|15
5541563|NCT01313650|19153452|P2|Overall Study|Withdrawal by Subject|20
5541564|NCT01313650|19153453|P1|Overall Study|Withdrawal by Subject|16
5541565|NCT01313650|19153450|P4|Overall Study|Lost to Follow-up|2
5541566|NCT01313650|19153451|P3|Overall Study|Lost to Follow-up|3
5541567|NCT01313650|19153452|P2|Overall Study|Lost to Follow-up|0
5541568|NCT01313650|19153453|P1|Overall Study|Lost to Follow-up|1
5541569|NCT01313650|19153450|P4|Overall Study|Lack of Efficacy|20
5541570|NCT01313650|19153451|P3|Overall Study|Lack of Efficacy|32
5541571|NCT01313650|19153452|P2|Overall Study|Lack of Efficacy|20
5541572|NCT01313650|19153453|P1|Overall Study|Lack of Efficacy|37
5541573|NCT01313650|19153450|P4|Overall Study|Adverse Event|23
5541574|NCT01313650|19153451|P3|Overall Study|Adverse Event|24
5541575|NCT01313650|19153452|P2|Overall Study|Adverse Event|34
5541576|NCT01313650|19153453|P1|Overall Study|Adverse Event|9
5541577|NCT01313637|19153479|P4|Overall Study|Withdrawal by Subject|15
5541578|NCT01313637|19153480|P3|Overall Study|Withdrawal by Subject|18
5541579|NCT01313637|19153481|P2|Overall Study|Withdrawal by Subject|13
5541580|NCT01313637|19153482|P1|Overall Study|Withdrawal by Subject|11
5541581|NCT01313637|19153479|P4|Overall Study|Lost to Follow-up|3
5541582|NCT01313637|19153480|P3|Overall Study|Lost to Follow-up|1
5541583|NCT01313637|19153481|P2|Overall Study|Lost to Follow-up|2
5541584|NCT01313637|19153482|P1|Overall Study|Lost to Follow-up|0
5541585|NCT01313637|19153479|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
5541586|NCT01313637|19153480|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
5541587|NCT01313637|19153481|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
5541588|NCT01313637|19153482|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
5541589|NCT01313637|19153479|P4|Overall Study|Protocol Violation|5
5541590|NCT01313637|19153480|P3|Overall Study|Protocol Violation|11
5541591|NCT01313637|19153481|P2|Overall Study|Protocol Violation|3
5541592|NCT01313637|19153482|P1|Overall Study|Protocol Violation|4
5541593|NCT01313637|19153479|P4|Overall Study|Lack of Efficacy|24
5541594|NCT01313637|19153480|P3|Overall Study|Lack of Efficacy|37
5541595|NCT01313637|19153481|P2|Overall Study|Lack of Efficacy|38
5541596|NCT01313637|19153482|P1|Overall Study|Lack of Efficacy|44
5541597|NCT01313637|19153479|P4|Overall Study|Adverse Event|18
5541598|NCT01313637|19153480|P3|Overall Study|Adverse Event|25
5541599|NCT01313637|19153481|P2|Overall Study|Adverse Event|24
5541600|NCT01313637|19153482|P1|Overall Study|Adverse Event|17
5541601|NCT01313624|19153506|P2|Open-Label Phase|Lost to Follow-up|1
5541602|NCT01313624|19153507|P1|Open-Label Phase|Lost to Follow-up|1
5541603|NCT01313624|19153506|P2|Open-Label Phase|Withdrawal by Subject|2
5541604|NCT01313624|19153507|P1|Open-Label Phase|Withdrawal by Subject|2
5541605|NCT01313624|19153506|P2|Open-Label Phase|Adverse Event|10
5541606|NCT01313624|19153507|P1|Open-Label Phase|Adverse Event|1
5541607|NCT01313624|19153506|P2|Double-Blind Phase|Lack of Efficacy|0
5541608|NCT01313624|19153507|P1|Double-Blind Phase|Lack of Efficacy|1
5541609|NCT01313624|19153506|P2|Double-Blind Phase|Physician Decision|0
5541610|NCT01313624|19153507|P1|Double-Blind Phase|Physician Decision|1
5541611|NCT01313624|19153506|P2|Double-Blind Phase|Lost to Follow-up|2
5541612|NCT01313624|19153507|P1|Double-Blind Phase|Lost to Follow-up|0
5541613|NCT01313624|19153506|P2|Double-Blind Phase|Withdrawal by Subject|4
5541614|NCT01313624|19153507|P1|Double-Blind Phase|Withdrawal by Subject|9
5541615|NCT01313624|19153506|P2|Double-Blind Phase|Adverse Event|4
5541616|NCT01313624|19153507|P1|Double-Blind Phase|Adverse Event|27
5541617|NCT01313559|19153521|P2|Overall Study|Rising PSA|0
5541618|NCT01313559|19153522|P1|Overall Study|Rising PSA|2
5541619|NCT01313559|19153521|P2|Overall Study|Disease progression|0
5541620|NCT01313559|19153522|P1|Overall Study|Disease progression|1
5541621|NCT01313559|19153521|P2|Overall Study|Withdrawal by Subject|2
5541622|NCT01313559|19153522|P1|Overall Study|Withdrawal by Subject|1
5541623|NCT01313312|19153623|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
5541624|NCT01313312|19153623|P1|Overall Study|Subject Withdrawn Early in Error|4
5541625|NCT01313312|19153623|P1|Overall Study|Observational Phase|1
5541626|NCT01313312|19153623|P1|Overall Study|Investigator Decision|1
5541627|NCT01313312|19153623|P1|Overall Study|Lack of Efficacy|3
5541628|NCT01313312|19153623|P1|Overall Study|Withdrawal by Subject|18
5541629|NCT01313312|19153623|P1|Overall Study|Adverse Event|5
5541630|NCT01313299|19153670|P3|Overall Study|Lack of subject compliance|1
5541631|NCT01313299|19153671|P2|Overall Study|Lack of subject compliance|0
5541632|NCT01313299|19153672|P1|Overall Study|Lack of subject compliance|0
5541633|NCT01313299|19153670|P3|Overall Study|Family reason and moved out of state|0
5541634|NCT01313299|19153671|P2|Overall Study|Family reason and moved out of state|2
5541635|NCT01313299|19153672|P1|Overall Study|Family reason and moved out of state|0
5541636|NCT01313299|19153670|P3|Overall Study|Withdrawal by Subject|2
5541637|NCT01313299|19153671|P2|Overall Study|Withdrawal by Subject|0
5541638|NCT01313299|19153672|P1|Overall Study|Withdrawal by Subject|1
5541639|NCT01313299|19153670|P3|Overall Study|Protocol Violation|0
5541640|NCT01313299|19153671|P2|Overall Study|Protocol Violation|0
5541641|NCT01313299|19153672|P1|Overall Study|Protocol Violation|2
5541642|NCT01313299|19153670|P3|Overall Study|Lost to Follow-up|0
5541643|NCT01313299|19153671|P2|Overall Study|Lost to Follow-up|0
5541644|NCT01313299|19153672|P1|Overall Study|Lost to Follow-up|1
5541645|NCT01313299|19153670|P3|Overall Study|Adverse Event|1
5541646|NCT01313299|19153671|P2|Overall Study|Adverse Event|1
5541647|NCT01313299|19153672|P1|Overall Study|Adverse Event|3
5541648|NCT01313286|19153686|P2|Period 1|Withdrawal by Subject|0
5541649|NCT01313286|19153687|P1|Period 1|Withdrawal by Subject|2
5541650|NCT01313273|19153697|P2|Overall Study|Screening Chromogranin A-in normal range|1
5541651|NCT01313273|19153698|P1|Overall Study|Screening Chromogranin A-in normal range|0
5541652|NCT01313273|19153697|P2|Overall Study|Withdrawal by Subject|0
5541653|NCT01313273|19153698|P1|Overall Study|Withdrawal by Subject|1
5541654|NCT01313273|19153697|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
5541655|NCT01313273|19153698|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
5541656|NCT01313221|19153713|P3|Overall Study|Pregnancy|2
5541657|NCT01313221|19153714|P2|Overall Study|Pregnancy|0
5541658|NCT01313221|19153715|P1|Overall Study|Pregnancy|0
5541659|NCT01313221|19153713|P3|Overall Study|Physician Decision|2
5541660|NCT01313221|19153714|P2|Overall Study|Physician Decision|0
5541661|NCT01313221|19153715|P1|Overall Study|Physician Decision|0
5541662|NCT01313221|19153713|P3|Overall Study|Disease progression|2
5541663|NCT01313221|19153714|P2|Overall Study|Disease progression|0
5541664|NCT01313221|19153715|P1|Overall Study|Disease progression|0
5541665|NCT01313221|19153713|P3|Overall Study|Adverse Event|7
5541666|NCT01313221|19153714|P2|Overall Study|Adverse Event|0
5541667|NCT01313221|19153715|P1|Overall Study|Adverse Event|0
5541668|NCT01313221|19153713|P3|Overall Study|Other|0
5541669|NCT01313221|19153714|P2|Overall Study|Other|0
5541670|NCT01313221|19153715|P1|Overall Study|Other|1
5541671|NCT01313221|19153713|P3|Overall Study|Lost to Follow-up|1
5541672|NCT01313221|19153714|P2|Overall Study|Lost to Follow-up|3
5541673|NCT01313221|19153715|P1|Overall Study|Lost to Follow-up|6
5541674|NCT01313221|19153713|P3|Overall Study|Requirement for alternative therapy|1
5541675|NCT01313221|19153714|P2|Overall Study|Requirement for alternative therapy|1
5541676|NCT01313221|19153715|P1|Overall Study|Requirement for alternative therapy|0
5541677|NCT01313221|19153713|P3|Overall Study|Withdrawal by Subject|5
5541678|NCT01313221|19153714|P2|Overall Study|Withdrawal by Subject|3
5541679|NCT01313221|19153715|P1|Overall Study|Withdrawal by Subject|2
5541680|NCT01313221|19153713|P3|Overall Study|Non-compliance|2
5541681|NCT01313221|19153714|P2|Overall Study|Non-compliance|0
5541682|NCT01313221|19153715|P1|Overall Study|Non-compliance|3
5541683|NCT01313221|19153713|P3|Overall Study|Protocol Violation|1
5541684|NCT01313221|19153714|P2|Overall Study|Protocol Violation|1
5541685|NCT01313221|19153715|P1|Overall Study|Protocol Violation|0
5541686|NCT01313208|19153767|P2|Open-label Phase (Weeks 13 - 24)|Other|0
5541687|NCT01313208|19153768|P1|Open-label Phase (Weeks 13 - 24)|Other|2
5541688|NCT01313208|19153767|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
5541689|NCT01313208|19153768|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
5541690|NCT01313208|19153767|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
5541691|NCT01313208|19153768|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
5541692|NCT01313208|19153767|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
5541693|NCT01313208|19153768|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
5541694|NCT01313208|19153767|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
5541695|NCT01313208|19153768|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
5541696|NCT01313208|19153767|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
5541697|NCT01313208|19153768|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
5541698|NCT01313208|19153767|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
5541699|NCT01313208|19153768|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
5541700|NCT01313208|19153767|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
5541701|NCT01313208|19153768|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
5541702|NCT01313208|19153767|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
5541703|NCT01313208|19153768|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
5541704|NCT01313182|19153858|P2|Overall Study|Protocol Violation|92
5541705|NCT01313182|19153859|P1|Overall Study|Protocol Violation|66
5541706|NCT01313117|19153871|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
5541707|NCT01313117|19153871|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
5541708|NCT01313078|19153878|P1|Overall Study|Withdrawal by Subject|1
5541709|NCT01313078|19153878|P1|Overall Study|Discontinued study drug|1
5541710|NCT01313078|19153878|P1|Overall Study|Death|1
5541711|NCT01313039|19153883|P1|Overall Study|Adverse Event|1
5541712|NCT01313039|19153883|P1|Overall Study|Physician Decision|1
5541713|NCT01312961|19153889|P2|Overall Study|Other than specified above|3
5541714|NCT01312961|19153890|P1|Overall Study|Other than specified above|2
5541715|NCT01312961|19153889|P2|Overall Study|Poor compliance to protocol|0
5541716|NCT01312961|19153890|P1|Overall Study|Poor compliance to protocol|1
5541717|NCT01312961|19153889|P2|Overall Study|Lack of Efficacy|1
5541718|NCT01312961|19153890|P1|Overall Study|Lack of Efficacy|11
5541719|NCT01312961|19153889|P2|Overall Study|Adverse Event|3
5541720|NCT01312961|19153890|P1|Overall Study|Adverse Event|3
5541721|NCT01312909|19153926|P3|Overall Study|Entrance criteria not met|2
5541722|NCT01312909|19153927|P2|Overall Study|Entrance criteria not met|0
5541723|NCT01312909|19153928|P1|Overall Study|Entrance criteria not met|0
5541724|NCT01312909|19153926|P3|Overall Study|Insufficient clinical response|1
5541725|NCT01312909|19153927|P2|Overall Study|Insufficient clinical response|0
5541726|NCT01312909|19153928|P1|Overall Study|Insufficient clinical response|0
5541727|NCT01312909|19153926|P3|Overall Study|Lost to Follow-up|20
5541728|NCT01312909|19153927|P2|Overall Study|Lost to Follow-up|17
5541729|NCT01312909|19153928|P1|Overall Study|Lost to Follow-up|21
5541730|NCT01312909|19153926|P3|Overall Study|Withdrawal by Subject|7
5541731|NCT01312909|19153927|P2|Overall Study|Withdrawal by Subject|10
5541732|NCT01312909|19153928|P1|Overall Study|Withdrawal by Subject|8
5541733|NCT01312909|19153926|P3|Overall Study|Other|11
5541734|NCT01312909|19153927|P2|Overall Study|Other|6
5541735|NCT01312909|19153928|P1|Overall Study|Other|9
5541736|NCT01312909|19153926|P3|Overall Study|Protocol Violation|2
5541737|NCT01312909|19153927|P2|Overall Study|Protocol Violation|0
5541738|NCT01312909|19153928|P1|Overall Study|Protocol Violation|2
5541739|NCT01312909|19153926|P3|Overall Study|Adverse Event|3
5541740|NCT01312909|19153927|P2|Overall Study|Adverse Event|0
5541741|NCT01312909|19153928|P1|Overall Study|Adverse Event|1
5541742|NCT01312909|19153926|P3|Overall Study|Randomized but not treated|1
5541743|NCT01312909|19153927|P2|Overall Study|Randomized but not treated|3
5541744|NCT01312909|19153928|P1|Overall Study|Randomized but not treated|1
5541745|NCT01312779|19154015|P1|Overall Study|Not Implanted with Device|27
5541746|NCT01312779|19154015|P1|Overall Study|Death|3
5541747|NCT01312779|19154015|P1|Overall Study|Withdrawal by Subject|2
5541748|NCT01312467|19154098|P1|Overall Study|Ineligible|4
5541749|NCT01312467|19154098|P1|Overall Study|Another medical condition|1
5541750|NCT01312467|19154098|P1|Overall Study|Deported to country of origin|1
5541751|NCT01312467|19154098|P1|Overall Study|Withdrawal by Subject|2
5541752|NCT01312467|19154098|P1|Overall Study|Lost to Follow-up|1
5541753|NCT01312467|19154098|P1|Overall Study|Adverse Event|4
5541754|NCT01312428|19154107|P2|Overall Study|Study Termination|4
5541755|NCT01312428|19154108|P1|Overall Study|Study Termination|3
5541756|NCT01312129|19154178|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
5541757|NCT01312129|19154179|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
5541758|NCT01311661|19154264|P1|Overall Study|Withdrawal by Subject|2
5541759|NCT01311661|19154264|P1|Overall Study|Protocol Violation|3
5541760|NCT01311661|19154264|P1|Overall Study|Adverse Event|2
5541761|NCT01311648|19154409|P3|Overall Study|Withdrawal by Subject|2
5541762|NCT01311648|19154410|P2|Overall Study|Withdrawal by Subject|0
5541763|NCT01311648|19154411|P1|Overall Study|Withdrawal by Subject|0
5541764|NCT01311648|19154409|P3|Overall Study|Inhibitor management|17
5541765|NCT01311648|19154410|P2|Overall Study|Inhibitor management|0
5541766|NCT01311648|19154411|P1|Overall Study|Inhibitor management|0
5541767|NCT01311648|19154409|P3|Overall Study|Adverse Event|1
5541768|NCT01311648|19154410|P2|Overall Study|Adverse Event|0
5541769|NCT01311648|19154411|P1|Overall Study|Adverse Event|0
5541770|NCT01311648|19154409|P3|Overall Study|Protocol Violation|1
5541771|NCT01311648|19154410|P2|Overall Study|Protocol Violation|0
5541772|NCT01311648|19154411|P1|Overall Study|Protocol Violation|0
5541773|NCT01311557|19154456|P2|Overall Study|Withdrawal by Subject|2
5541774|NCT01311557|19154457|P1|Overall Study|Withdrawal by Subject|1
5541775|NCT01311557|19154456|P2|Overall Study|Lost to Follow-up|1
5541776|NCT01311557|19154457|P1|Overall Study|Lost to Follow-up|0
5541777|NCT01311557|19154456|P2|Overall Study|Protocol Violation|2
5541778|NCT01311557|19154457|P1|Overall Study|Protocol Violation|4
5541779|NCT01311557|19154456|P2|Overall Study|Serious adverse event|1
5541780|NCT01311557|19154457|P1|Overall Study|Serious adverse event|0
5541781|NCT01311505|19154473|P2|First Intervention Period|Protocol Violation|1
5541782|NCT01311505|19154474|P1|First Intervention Period|Protocol Violation|0
5541783|NCT01311024|19154530|P2|Overall Study|Protocol Violation|22
5541784|NCT01311024|19154531|P1|Overall Study|Protocol Violation|35
5541785|NCT01310868|19154537|P1|Overall Study|Do not have histologically confirmed GBM|13
5541786|NCT01310803|19154554|P2|Overall Study|Subject terminated by Sponsor|0
5541787|NCT01310803|19154555|P1|Overall Study|Subject terminated by Sponsor|1
5541788|NCT01310777|19154566|P3|Overall Study|Other|2
5541789|NCT01310777|19154567|P2|Overall Study|Other|1
5541790|NCT01310777|19154568|P1|Overall Study|Other|4
5541791|NCT01310777|19154566|P3|Overall Study|Inadequate Control of IOP|10
5541792|NCT01310777|19154567|P2|Overall Study|Inadequate Control of IOP|7
5541793|NCT01310777|19154568|P1|Overall Study|Inadequate Control of IOP|5
5541794|NCT01310777|19154566|P3|Overall Study|Patient's Decision Unrelated to AE|2
5541795|NCT01310777|19154567|P2|Overall Study|Patient's Decision Unrelated to AE|1
5541796|NCT01310777|19154568|P1|Overall Study|Patient's Decision Unrelated to AE|1
5541797|NCT01310777|19154566|P3|Overall Study|Lost to Follow-up|1
5541798|NCT01310777|19154567|P2|Overall Study|Lost to Follow-up|4
5541799|NCT01310777|19154568|P1|Overall Study|Lost to Follow-up|0
5541800|NCT01310777|19154566|P3|Overall Study|Adverse Event|15
5541801|NCT01310777|19154567|P2|Overall Study|Adverse Event|1
5541802|NCT01310777|19154568|P1|Overall Study|Adverse Event|23
5541803|NCT01310699|19154578|P2|Overall Study|Patients did not complete tandem.|6
5541804|NCT01310699|19154579|P1|Overall Study|Patients did not complete tandem.|4
5541805|NCT01310413|19154606|P7|From Day U0 to Day U385|Lost to Follow-up|2
5541806|NCT01310413|19154607|P6|From Day U0 to Day U385|Lost to Follow-up|0
5541807|NCT01310413|19154608|P5|From Day U0 to Day U385|Lost to Follow-up|0
5541808|NCT01310413|19154609|P4|From Day U0 to Day U385|Lost to Follow-up|0
5541809|NCT01310413|19154610|P3|From Day U0 to Day U385|Lost to Follow-up|0
5541810|NCT01310413|19154611|P2|From Day U0 to Day U385|Lost to Follow-up|0
5541811|NCT01310413|19154612|P1|From Day U0 to Day U385|Lost to Follow-up|0
5541812|NCT01310413|19154606|P7|From Day U0 to Day U385|Withdrawal by Subject|1
5541813|NCT01310413|19154607|P6|From Day U0 to Day U385|Withdrawal by Subject|0
5541814|NCT01310413|19154608|P5|From Day U0 to Day U385|Withdrawal by Subject|0
5541815|NCT01310413|19154609|P4|From Day U0 to Day U385|Withdrawal by Subject|0
5541816|NCT01310413|19154610|P3|From Day U0 to Day U385|Withdrawal by Subject|0
5541817|NCT01310413|19154611|P2|From Day U0 to Day U385|Withdrawal by Subject|0
5541818|NCT01310413|19154612|P1|From Day U0 to Day U385|Withdrawal by Subject|0
5541819|NCT01310413|19154606|P7|Day 0 to Day 385|Other|0
5541820|NCT01310413|19154607|P6|Day 0 to Day 385|Other|0
5541821|NCT01310413|19154608|P5|Day 0 to Day 385|Other|0
5541822|NCT01310413|19154609|P4|Day 0 to Day 385|Other|0
5541823|NCT01310413|19154610|P3|Day 0 to Day 385|Other|3
5541824|NCT01310413|19154611|P2|Day 0 to Day 385|Other|0
5541825|NCT01310413|19154612|P1|Day 0 to Day 385|Other|1
5541826|NCT01310413|19154606|P7|Day 0 to Day 385|Migrated/moved from study area|0
5541827|NCT01310413|19154607|P6|Day 0 to Day 385|Migrated/moved from study area|0
5541828|NCT01310413|19154608|P5|Day 0 to Day 385|Migrated/moved from study area|1
5541829|NCT01310413|19154609|P4|Day 0 to Day 385|Migrated/moved from study area|1
5541830|NCT01310413|19154610|P3|Day 0 to Day 385|Migrated/moved from study area|1
5541831|NCT01310413|19154611|P2|Day 0 to Day 385|Migrated/moved from study area|3
5541832|NCT01310413|19154612|P1|Day 0 to Day 385|Migrated/moved from study area|3
5541833|NCT01310413|19154606|P7|Day 0 to Day 385|Lost to Follow-up|0
5541834|NCT01310413|19154607|P6|Day 0 to Day 385|Lost to Follow-up|2
5541835|NCT01310413|19154608|P5|Day 0 to Day 385|Lost to Follow-up|1
5541836|NCT01310413|19154609|P4|Day 0 to Day 385|Lost to Follow-up|5
5541837|NCT01310413|19154610|P3|Day 0 to Day 385|Lost to Follow-up|3
5541838|NCT01310413|19154611|P2|Day 0 to Day 385|Lost to Follow-up|3
5541839|NCT01310413|19154612|P1|Day 0 to Day 385|Lost to Follow-up|18
5541840|NCT01310413|19154606|P7|Day 0 to Day 385|Withdrawal by Subject|0
5541841|NCT01310413|19154607|P6|Day 0 to Day 385|Withdrawal by Subject|1
5541842|NCT01310413|19154608|P5|Day 0 to Day 385|Withdrawal by Subject|1
5541843|NCT01310413|19154609|P4|Day 0 to Day 385|Withdrawal by Subject|2
5541844|NCT01310413|19154610|P3|Day 0 to Day 385|Withdrawal by Subject|0
5541845|NCT01310413|19154611|P2|Day 0 to Day 385|Withdrawal by Subject|2
5541846|NCT01310413|19154612|P1|Day 0 to Day 385|Withdrawal by Subject|5
5541847|NCT01310127|19154794|P2|Overall Study|advanced psc cataract outlier|0
5541848|NCT01310127|19154795|P1|Overall Study|advanced psc cataract outlier|1
5541849|NCT01310127|19154794|P2|Overall Study|Protocol Violation|1
5541850|NCT01310127|19154795|P1|Overall Study|Protocol Violation|1
5541851|NCT01310075|19154809|P2|Overall Study|Withdrawal by Subject|1
5541852|NCT01310075|19154810|P1|Overall Study|Withdrawal by Subject|1
5541853|NCT01310075|19154809|P2|Overall Study|Protocol Violation|2
5541854|NCT01310075|19154810|P1|Overall Study|Protocol Violation|2
5541855|NCT01310075|19154809|P2|Overall Study|Physician Decision|7
5541856|NCT01310075|19154810|P1|Overall Study|Physician Decision|10
5541857|NCT01310075|19154809|P2|Overall Study|Lost to Follow-up|0
5541858|NCT01310075|19154810|P1|Overall Study|Lost to Follow-up|1
5541859|NCT01310036|19154816|P1|Overall Study|Adverse event or intercurrent illness|12
5541860|NCT01310036|19154816|P1|Overall Study|Death|1
5541861|NCT01310036|19154816|P1|Overall Study|Progression of Disease|164
5541862|NCT01310036|19154816|P1|Overall Study|Refused Treatment/Did not Cooperate|4
5541863|NCT01310036|19154816|P1|Overall Study|Withdrew Consent|11
5541864|NCT01310036|19154816|P1|Overall Study|Administrative/other|10
5541865|NCT01309997|19154829|P2|Overall Study|Withdrawal by Subject|1
5541866|NCT01309997|19154830|P1|Overall Study|Withdrawal by Subject|1
5541867|NCT01309997|19154829|P2|Overall Study|Lack of Efficacy|2
5541868|NCT01309997|19154830|P1|Overall Study|Lack of Efficacy|2
5541869|NCT01309997|19154829|P2|Overall Study|Death|3
5541870|NCT01309997|19154830|P1|Overall Study|Death|1
5541871|NCT01309997|19154829|P2|Overall Study|Adverse Event|0
5541872|NCT01309997|19154830|P1|Overall Study|Adverse Event|1
5541873|NCT01309919|19154854|P2|Overall Study|Did not receive a postpartum IUD|48
5541874|NCT01309919|19154855|P1|Overall Study|Did not receive a postpartum IUD|17
5541875|NCT01309893|19154878|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
5541876|NCT01309893|19154879|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
5541877|NCT01309893|19154878|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
5541878|NCT01309893|19154879|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
5541879|NCT01309841|19154916|P3|Overall Study|Severe non-compliance with protocol|2
5541880|NCT01309841|19154917|P2|Overall Study|Severe non-compliance with protocol|5
5541881|NCT01309841|19154918|P1|Overall Study|Severe non-compliance with protocol|0
5541882|NCT01309841|19154916|P3|Overall Study|Did Not Receive Treatment|1
5541883|NCT01309841|19154917|P2|Overall Study|Did Not Receive Treatment|0
5541884|NCT01309841|19154918|P1|Overall Study|Did Not Receive Treatment|2
5541885|NCT01309841|19154916|P3|Overall Study|Withdrawal by Subject|13
5541886|NCT01309841|19154917|P2|Overall Study|Withdrawal by Subject|6
5541887|NCT01309841|19154918|P1|Overall Study|Withdrawal by Subject|17
5541888|NCT01309841|19154916|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
5541889|NCT01309841|19154917|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
5541890|NCT01309841|19154918|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
5541891|NCT01309841|19154916|P3|Overall Study|Death|0
5541892|NCT01309841|19154917|P2|Overall Study|Death|0
5541893|NCT01309841|19154918|P1|Overall Study|Death|1
5541894|NCT01309841|19154916|P3|Overall Study|Adverse Event|11
5541895|NCT01309841|19154917|P2|Overall Study|Adverse Event|22
5541896|NCT01309841|19154918|P1|Overall Study|Adverse Event|9
5541897|NCT01309841|19154916|P3|Overall Study|Lack of Efficacy|2
5541898|NCT01309841|19154917|P2|Overall Study|Lack of Efficacy|0
5541899|NCT01309841|19154918|P1|Overall Study|Lack of Efficacy|0
5541900|NCT01309841|19154916|P3|Overall Study|Study-Specific Withdrawal Criteria|2
5541901|NCT01309841|19154917|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5541902|NCT01309841|19154918|P1|Overall Study|Study-Specific Withdrawal Criteria|3
5541903|NCT01309841|19154916|P3|Overall Study|Lost to Follow-up|4
5541904|NCT01309841|19154917|P2|Overall Study|Lost to Follow-up|6
5541905|NCT01309841|19154918|P1|Overall Study|Lost to Follow-up|7
5541906|NCT01309841|19154916|P3|Overall Study|Other|1
5541907|NCT01309841|19154917|P2|Overall Study|Other|1
5541908|NCT01309841|19154918|P1|Overall Study|Other|0
5541909|NCT01309828|19154958|P2|Overall Study|Other|0
5541910|NCT01309828|19154959|P1|Overall Study|Other|1
5541911|NCT01309828|19154958|P2|Overall Study|Major Protocol Deviation|1
5541912|NCT01309828|19154959|P1|Overall Study|Major Protocol Deviation|0
5541913|NCT01309828|19154958|P2|Overall Study|Voluntary Withdrawal|4
5541914|NCT01309828|19154959|P1|Overall Study|Voluntary Withdrawal|5
5541915|NCT01309828|19154958|P2|Overall Study|Adverse Event|11
5541916|NCT01309828|19154959|P1|Overall Study|Adverse Event|10
5541917|NCT01309737|19154993|P5|Week 16 to 52|Other|0
5541918|NCT01309737|19154994|P4|Week 16 to 52|Other|2
5541919|NCT01309737|19154995|P3|Week 16 to 52|Other|0
5541920|NCT01309737|19154996|P2|Week 16 to 52|Other|12
5541921|NCT01309737|19154997|P1|Week 16 to 52|Other|10
5541922|NCT01309737|19154993|P5|Week 16 to 52|Withdrawal by Subject|2
5541923|NCT01309737|19154994|P4|Week 16 to 52|Withdrawal by Subject|0
5541924|NCT01309737|19154995|P3|Week 16 to 52|Withdrawal by Subject|0
5541925|NCT01309737|19154996|P2|Week 16 to 52|Withdrawal by Subject|6
5541926|NCT01309737|19154997|P1|Week 16 to 52|Withdrawal by Subject|5
5541927|NCT01309737|19154993|P5|Week 16 to 52|Lost to Follow-up|4
5541928|NCT01309737|19154994|P4|Week 16 to 52|Lost to Follow-up|1
5541929|NCT01309737|19154995|P3|Week 16 to 52|Lost to Follow-up|0
5541930|NCT01309737|19154996|P2|Week 16 to 52|Lost to Follow-up|2
5541931|NCT01309737|19154997|P1|Week 16 to 52|Lost to Follow-up|4
5541932|NCT01309737|19154993|P5|Week 16 to 52|Lack of Efficacy|21
5541933|NCT01309737|19154994|P4|Week 16 to 52|Lack of Efficacy|25
5541934|NCT01309737|19154995|P3|Week 16 to 52|Lack of Efficacy|0
5541935|NCT01309737|19154996|P2|Week 16 to 52|Lack of Efficacy|76
5541936|NCT01309737|19154997|P1|Week 16 to 52|Lack of Efficacy|107
5541937|NCT01309737|19154993|P5|Week 16 to 52|Adverse Event|5
5541938|NCT01309737|19154994|P4|Week 16 to 52|Adverse Event|6
5541939|NCT01309737|19154995|P3|Week 16 to 52|Adverse Event|0
5541940|NCT01309737|19154996|P2|Week 16 to 52|Adverse Event|7
5541941|NCT01309737|19154997|P1|Week 16 to 52|Adverse Event|7
5541942|NCT01309737|19154993|P5|Week 16 to 52|Death|1
5541943|NCT01309737|19154994|P4|Week 16 to 52|Death|0
5541944|NCT01309737|19154995|P3|Week 16 to 52|Death|0
5541945|NCT01309737|19154996|P2|Week 16 to 52|Death|0
5541946|NCT01309737|19154997|P1|Week 16 to 52|Death|0
5541947|NCT01309737|19154993|P5|Week 0 to 16|Randomized, but not treated|0
5541948|NCT01309737|19154994|P4|Week 0 to 16|Randomized, but not treated|0
5541949|NCT01309737|19154995|P3|Week 0 to 16|Randomized, but not treated|0
5541950|NCT01309737|19154996|P2|Week 0 to 16|Randomized, but not treated|0
5541951|NCT01309737|19154997|P1|Week 0 to 16|Randomized, but not treated|1
5541952|NCT01309737|19154993|P5|Week 0 to 16|Other|0
5541953|NCT01309737|19154994|P4|Week 0 to 16|Other|0
5541954|NCT01309737|19154995|P3|Week 0 to 16|Other|4
5541955|NCT01309737|19154996|P2|Week 0 to 16|Other|14
5541956|NCT01309737|19154997|P1|Week 0 to 16|Other|10
5541957|NCT01309737|19154993|P5|Week 0 to 16|Withdrawal by Subject|0
5541958|NCT01309737|19154994|P4|Week 0 to 16|Withdrawal by Subject|0
5541959|NCT01309737|19154995|P3|Week 0 to 16|Withdrawal by Subject|7
5541960|NCT01309737|19154996|P2|Week 0 to 16|Withdrawal by Subject|6
5541961|NCT01309737|19154997|P1|Week 0 to 16|Withdrawal by Subject|7
5541962|NCT01309737|19154993|P5|Week 0 to 16|Lost to Follow-up|0
5541963|NCT01309737|19154994|P4|Week 0 to 16|Lost to Follow-up|0
5541964|NCT01309737|19154995|P3|Week 0 to 16|Lost to Follow-up|3
5541965|NCT01309737|19154996|P2|Week 0 to 16|Lost to Follow-up|8
5541966|NCT01309737|19154997|P1|Week 0 to 16|Lost to Follow-up|7
5541967|NCT01309737|19154993|P5|Week 0 to 16|Lack of Efficacy|0
5541968|NCT01309737|19154994|P4|Week 0 to 16|Lack of Efficacy|0
5541969|NCT01309737|19154995|P3|Week 0 to 16|Lack of Efficacy|24
5541970|NCT01309737|19154996|P2|Week 0 to 16|Lack of Efficacy|2
5541971|NCT01309737|19154997|P1|Week 0 to 16|Lack of Efficacy|15
5541972|NCT01309737|19154993|P5|Week 0 to 16|Adverse Event|0
5541973|NCT01309737|19154994|P4|Week 0 to 16|Adverse Event|0
5541974|NCT01309737|19154995|P3|Week 0 to 16|Adverse Event|5
5541975|NCT01309737|19154996|P2|Week 0 to 16|Adverse Event|10
5541976|NCT01309737|19154997|P1|Week 0 to 16|Adverse Event|11
5541977|NCT01309737|19154993|P5|Week 0 to 16|Death|0
5541978|NCT01309737|19154994|P4|Week 0 to 16|Death|0
5541979|NCT01309737|19154995|P3|Week 0 to 16|Death|1
5541980|NCT01309737|19154996|P2|Week 0 to 16|Death|0
5541981|NCT01309737|19154997|P1|Week 0 to 16|Death|1
5541982|NCT01309672|19155192|P1|Overall Study|Withdrawal by Subject|3
5541983|NCT01309672|19155192|P1|Overall Study|Adverse Event|5
5541984|NCT01309672|19155192|P1|Overall Study|Other|9
5541985|NCT01309672|19155192|P1|Overall Study|Lack of Efficacy|20
5541986|NCT01309659|19155202|P2|Overall Study|Protocol Violation|1
5541987|NCT01309659|19155203|P1|Overall Study|Protocol Violation|0
5541988|NCT01309386|19155308|P2|Overall Study|Adverse Event|8
5541989|NCT01309386|19155309|P1|Overall Study|Adverse Event|5
5541990|NCT01309386|19155308|P2|Overall Study|Lack of Efficacy|1
5541991|NCT01309386|19155309|P1|Overall Study|Lack of Efficacy|3
5541992|NCT01309386|19155308|P2|Overall Study|Physician Decision|1
5541993|NCT01309386|19155309|P1|Overall Study|Physician Decision|1
5541994|NCT01309386|19155308|P2|Overall Study|Progressive disease|11
5541995|NCT01309386|19155309|P1|Overall Study|Progressive disease|9
5541996|NCT01309386|19155308|P2|Overall Study|Withdrawal by Subject|0
5541997|NCT01309386|19155309|P1|Overall Study|Withdrawal by Subject|2
5541998|NCT01309386|19155308|P2|Overall Study|Other|0
5541999|NCT01309386|19155309|P1|Overall Study|Other|2
5542000|NCT01309308|19155357|P2|Overall Study|Lost to Follow-up|4
5542001|NCT01309308|19155358|P1|Overall Study|Lost to Follow-up|6
5542002|NCT01309282|19155366|P1|Overall Study|Lost to Follow-up|1
5542003|NCT01309269|19155383|P1|Overall Study|Enrolled but not Treated|107
5542004|NCT01309269|19155383|P1|Overall Study|Study Completion Data Not Recorded|95
5542005|NCT01309269|19155383|P1|Overall Study|Other|1
5542006|NCT01309269|19155383|P1|Overall Study|Other|256
5542007|NCT01309269|19155383|P1|Overall Study|Administrative Problems|141
5542008|NCT01309269|19155383|P1|Overall Study|Kidney Transplant|25
5542009|NCT01309269|19155383|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
5542010|NCT01309269|19155383|P1|Overall Study|Lack of Acceptance|15
5542011|NCT01309269|19155383|P1|Overall Study|Withdrawal by Subject|25
5542012|NCT01309269|19155383|P1|Overall Study|Adverse Event|56
5542013|NCT01309243|19155391|P2|Extension Phase|Lost to Follow-up|0
5542014|NCT01309243|19155392|P1|Extension Phase|Lost to Follow-up|6
5542015|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Protocol Violation|1
5542016|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Protocol Violation|1
5542017|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
5542018|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
5542019|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
5542020|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
5542021|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Withdrew Consent|18
5542022|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Withdrew Consent|12
5542023|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Investigators Discretion|6
5542024|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Investigators Discretion|3
5542025|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
5542026|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
5542027|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Pregnancy|0
5542028|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Pregnancy|2
5542029|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Death|1
5542030|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Death|0
5542031|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Adverse Event|43
5542032|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Adverse Event|12
5542033|NCT01309243|19155391|P2|Randomized Phase Through Week 96|Randomized but not treated|7
5542034|NCT01309243|19155392|P1|Randomized Phase Through Week 96|Randomized but not treated|6
5542035|NCT01309204|19155418|P2|Overall Study|Other|1
5542036|NCT01309204|19155419|P1|Overall Study|Other|4
5542037|NCT01309204|19155418|P2|Overall Study|Inadequate control of IOP|4
5542038|NCT01309204|19155419|P1|Overall Study|Inadequate control of IOP|4
5542039|NCT01309204|19155418|P2|Overall Study|Subject's decision unrelated to an AE|10
5542040|NCT01309204|19155419|P1|Overall Study|Subject's decision unrelated to an AE|9
5542041|NCT01309204|19155418|P2|Overall Study|Lost to Follow-up|2
5542042|NCT01309204|19155419|P1|Overall Study|Lost to Follow-up|2
5542043|NCT01309204|19155418|P2|Overall Study|Adverse Event|58
5542044|NCT01309204|19155419|P1|Overall Study|Adverse Event|48
5542045|NCT01309165|19155427|P2|Overall Study|Admitted to hospital for second stroke|0
5542046|NCT01309165|19155428|P1|Overall Study|Admitted to hospital for second stroke|1
5542047|NCT01309165|19155427|P2|Overall Study|No transportation|1
5542048|NCT01309165|19155428|P1|Overall Study|No transportation|0
5542049|NCT01309165|19155427|P2|Overall Study|Left country|1
5542050|NCT01309165|19155428|P1|Overall Study|Left country|0
5542051|NCT01309165|19155427|P2|Overall Study|Return to work|2
5542052|NCT01309165|19155428|P1|Overall Study|Return to work|1
5542053|NCT01309165|19155427|P2|Overall Study|Lost to Follow-up|3
5542054|NCT01309165|19155428|P1|Overall Study|Lost to Follow-up|4
5542055|NCT01309100|19155440|P1|Overall Study|Positive Slit lamp finding|1
5542056|NCT01309100|19155440|P1|Overall Study|Protocol Violation|1
5542057|NCT01308853|19155458|P1|Overall Study|Insertion of permanent implants|1
5542058|NCT01308853|19155458|P1|Overall Study|Lost to Follow-up|2
5542059|NCT01308853|19155458|P1|Overall Study|Adverse Event|1
5542060|NCT01308788|19155493|P2|2-year Treatment|medication change by treating physician|11
5542061|NCT01308788|19155494|P1|2-year Treatment|medication change by treating physician|4
5542062|NCT01308762|19155529|P3|Overall Study|Protocol Violation|0
5542063|NCT01308762|19155530|P2|Overall Study|Protocol Violation|1
5542064|NCT01308762|19155531|P1|Overall Study|Protocol Violation|0
5542065|NCT01308749|19155544|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
5542066|NCT01308749|19155545|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
5542067|NCT01308749|19155544|P2|Period 2: Open Label Treatment|Adverse Event|1
5542068|NCT01308749|19155545|P1|Period 2: Open Label Treatment|Adverse Event|0
5542069|NCT01308749|19155544|P2|Period 1: Double Blind Treatment|Adverse Event|0
5542070|NCT01308749|19155545|P1|Period 1: Double Blind Treatment|Adverse Event|1
5542071|NCT01308736|19155575|P2|Overall Study|Did not attend a single session|5
5542072|NCT01308736|19155576|P1|Overall Study|Did not attend a single session|6
5542073|NCT01308580|19155599|P2|Overall Study|Lost to Follow-up|7
5542074|NCT01308580|19155600|P1|Overall Study|Lost to Follow-up|12
5542075|NCT01308567|19155643|P3|Overall Study|Lost to Follow-up|4
5542076|NCT01308567|19155644|P2|Overall Study|Lost to Follow-up|4
5542077|NCT01308567|19155645|P1|Overall Study|Lost to Follow-up|2
5542078|NCT01308476|19155685|P2|Overall Study|Other|0
5542079|NCT01308476|19155686|P1|Overall Study|Other|1
5542080|NCT01308476|19155685|P2|Overall Study|Lost to Follow-up|2
5542081|NCT01308476|19155686|P1|Overall Study|Lost to Follow-up|2
5542082|NCT01308463|19155706|P1|Overall Study|Revision|2
5542083|NCT01308463|19155706|P1|Overall Study|Death|4
5542084|NCT01308463|19155706|P1|Overall Study|Study Discontinued|23
5542085|NCT01308424|19155719|P3|Randomization|Physician Decision|1
5542086|NCT01308424|19155720|P2|Randomization|Physician Decision|1
5542087|NCT01308424|19155721|P1|Randomization|Physician Decision|0
5542088|NCT01308424|19155719|P3|Randomization|Lost to Follow-up|0
5542089|NCT01308424|19155720|P2|Randomization|Lost to Follow-up|1
5542090|NCT01308424|19155721|P1|Randomization|Lost to Follow-up|0
5542091|NCT01308424|19155719|P3|Randomization|Adverse Event|1
5542092|NCT01308424|19155720|P2|Randomization|Adverse Event|1
5542093|NCT01308424|19155721|P1|Randomization|Adverse Event|0
5542094|NCT01308424|19155719|P3|Baseline Eligibility|Screen Failures|0
5542095|NCT01308424|19155720|P2|Baseline Eligibility|Screen Failures|0
5542096|NCT01308424|19155721|P1|Baseline Eligibility|Screen Failures|71
5542097|NCT01308008|19155773|P2|4 Weeks|Illness, disinterest, time|2
5542098|NCT01308008|19155774|P1|4 Weeks|Illness, disinterest, time|9
5542099|NCT01307891|19155797|P2|Overall Study|Progressive Disease|1
5542100|NCT01307891|19155798|P1|Overall Study|Progressive Disease|3
5542101|NCT01307787|19155810|P2|Overall Study|Withdrawal by Subject|0
5542102|NCT01307787|19155811|P1|Overall Study|Withdrawal by Subject|2
5542103|NCT01307579|19155880|P2|Overall Study|Ineligible|4
5542104|NCT01307579|19155881|P1|Overall Study|Ineligible|3
5542105|NCT01307579|19155880|P2|Overall Study|Refractory or relapsed AML|23
5542106|NCT01307579|19155881|P1|Overall Study|Refractory or relapsed AML|38
5542107|NCT01307579|19155880|P2|Overall Study|Begin conditioning for HSCT|44
5542108|NCT01307579|19155881|P1|Overall Study|Begin conditioning for HSCT|42
5542109|NCT01307579|19155880|P2|Overall Study|Institutional diagnosis of IFD|36
5542110|NCT01307579|19155881|P1|Overall Study|Institutional diagnosis of IFD|21
5542111|NCT01307579|19155880|P2|Overall Study|Withdrawal by Subject|3
5542112|NCT01307579|19155881|P1|Overall Study|Withdrawal by Subject|7
5542113|NCT01307579|19155880|P2|Overall Study|Physician Decision|29
5542114|NCT01307579|19155881|P1|Overall Study|Physician Decision|26
5542115|NCT01307579|19155880|P2|Overall Study|Death|6
5542116|NCT01307579|19155881|P1|Overall Study|Death|3
5542117|NCT01307501|19155893|P1|Overall Study|Starting Hospice|1
5542118|NCT01307501|19155893|P1|Overall Study|Lost to Follow-up|1
5542119|NCT01307501|19155893|P1|Overall Study|Death|20
5542120|NCT01307501|19155893|P1|Overall Study|Treatment Failure|1
5542121|NCT01307449|19155923|P4|Overall Study|Adverse Event|0
5542122|NCT01307449|19155924|P3|Overall Study|Adverse Event|0
5542123|NCT01307449|19155925|P2|Overall Study|Adverse Event|0
5542124|NCT01307449|19155926|P1|Overall Study|Adverse Event|1
5542125|NCT01307423|19155959|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
5542126|NCT01307423|19155960|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
5542127|NCT01307423|19155961|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
5542128|NCT01307423|19155962|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
5542129|NCT01307423|19155963|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
5542130|NCT01307423|19155964|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
5542131|NCT01307423|19155965|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
5542132|NCT01307423|19155966|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
5542133|NCT01307423|19155967|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
5542134|NCT01307423|19155959|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5542135|NCT01307423|19155960|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5542136|NCT01307423|19155961|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5542137|NCT01307423|19155962|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5542138|NCT01307423|19155963|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5542139|NCT01307423|19155964|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5542140|NCT01307423|19155965|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5542141|NCT01307423|19155966|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
5542142|NCT01307423|19155967|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
5542143|NCT01307423|19155959|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
5542144|NCT01307423|19155960|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5542145|NCT01307423|19155961|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5542146|NCT01307423|19155962|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5542147|NCT01307423|19155963|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5542148|NCT01307423|19155964|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5542149|NCT01307423|19155965|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
5542150|NCT01307423|19155966|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
5542151|NCT01307423|19155967|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5542152|NCT01307423|19155959|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5542153|NCT01307423|19155960|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5542154|NCT01307423|19155961|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5542155|NCT01307423|19155962|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5542156|NCT01307423|19155963|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5542157|NCT01307423|19155964|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5542158|NCT01307423|19155965|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
5542159|NCT01307423|19155966|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
5542160|NCT01307423|19155967|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5542161|NCT01307423|19155959|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
5542162|NCT01307423|19155960|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
5542163|NCT01307423|19155961|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
5542164|NCT01307423|19155962|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
5542165|NCT01307423|19155963|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
5542166|NCT01307423|19155964|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
5542167|NCT01307423|19155965|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
5542168|NCT01307423|19155966|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
5542169|NCT01307423|19155967|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
5542170|NCT01307423|19155959|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
5542171|NCT01307423|19155960|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
5542172|NCT01307423|19155961|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
5542173|NCT01307423|19155962|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
5542174|NCT01307423|19155963|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
5542175|NCT01307423|19155964|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
5542176|NCT01307423|19155965|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
5542177|NCT01307423|19155966|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
5542178|NCT01307423|19155967|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
5542179|NCT01307423|19155959|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5542180|NCT01307423|19155960|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5542181|NCT01307423|19155961|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5542182|NCT01307423|19155962|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5542183|NCT01307423|19155963|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5542184|NCT01307423|19155964|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5542185|NCT01307423|19155965|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
5542186|NCT01307423|19155966|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5542187|NCT01307423|19155967|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5542188|NCT01307423|19155959|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
5542189|NCT01307423|19155960|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
5542190|NCT01307423|19155961|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5542191|NCT01307423|19155962|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5542192|NCT01307423|19155963|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5542193|NCT01307423|19155964|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5542194|NCT01307423|19155965|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
5542195|NCT01307423|19155966|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
5542196|NCT01307423|19155967|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5542197|NCT01307423|19155959|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
5542198|NCT01307423|19155960|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5542199|NCT01307423|19155961|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5542200|NCT01307423|19155962|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5542201|NCT01307423|19155963|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5542202|NCT01307423|19155964|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5542203|NCT01307423|19155965|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5542204|NCT01307423|19155966|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
5542205|NCT01307423|19155967|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5542206|NCT01307423|19155959|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
5542207|NCT01307423|19155960|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
5542208|NCT01307423|19155961|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
5542209|NCT01307423|19155962|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
5542210|NCT01307423|19155963|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
5542211|NCT01307423|19155964|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
5542212|NCT01307423|19155965|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
5542213|NCT01307423|19155966|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
5542214|NCT01307423|19155967|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
5542215|NCT01307423|19155959|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
5542216|NCT01307423|19155960|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
5542217|NCT01307423|19155961|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
5542218|NCT01307423|19155962|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
5542219|NCT01307423|19155963|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
5542220|NCT01307423|19155964|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
5542221|NCT01307423|19155965|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
5542222|NCT01307423|19155966|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
5542223|NCT01307423|19155967|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
5542224|NCT01307423|19155959|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
5542225|NCT01307423|19155960|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
5542226|NCT01307423|19155961|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5542227|NCT01307423|19155962|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5542228|NCT01307423|19155963|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5542229|NCT01307423|19155964|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5542230|NCT01307423|19155965|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
5542231|NCT01307423|19155966|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
5542538|NCT01307267|19156214|P18|Overall Study|Death|1
5542232|NCT01307423|19155967|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5542233|NCT01307423|19155959|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
5542234|NCT01307423|19155960|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
5542235|NCT01307423|19155961|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5542236|NCT01307423|19155962|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5542237|NCT01307423|19155963|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5542238|NCT01307423|19155964|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5542239|NCT01307423|19155965|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
5542240|NCT01307423|19155966|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
5542241|NCT01307423|19155967|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5542242|NCT01307423|19155959|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5542243|NCT01307423|19155960|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5542244|NCT01307423|19155961|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5542245|NCT01307423|19155962|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5542246|NCT01307423|19155963|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5542247|NCT01307423|19155964|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5542248|NCT01307423|19155965|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
5542249|NCT01307423|19155966|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
5542250|NCT01307423|19155967|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
5542251|NCT01307423|19155959|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5542252|NCT01307423|19155960|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
5542253|NCT01307423|19155961|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5542254|NCT01307423|19155962|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5542255|NCT01307423|19155963|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5542256|NCT01307423|19155964|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5542257|NCT01307423|19155965|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
5542258|NCT01307423|19155966|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5542259|NCT01307423|19155967|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5542260|NCT01307423|19155959|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
5542261|NCT01307423|19155960|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
5542262|NCT01307423|19155961|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
5542263|NCT01307423|19155962|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
5542264|NCT01307423|19155963|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
5542265|NCT01307423|19155964|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
5542266|NCT01307423|19155965|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
5542267|NCT01307423|19155966|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
5542268|NCT01307423|19155967|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
5542269|NCT01307423|19155959|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
5542270|NCT01307423|19155960|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
5542271|NCT01307423|19155961|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
5542272|NCT01307423|19155962|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
5542273|NCT01307423|19155963|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
5542274|NCT01307423|19155964|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
5542275|NCT01307423|19155965|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
5542276|NCT01307423|19155966|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
5542277|NCT01307423|19155967|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
5542278|NCT01307423|19155959|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
5542279|NCT01307423|19155960|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
5542280|NCT01307423|19155961|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5542281|NCT01307423|19155962|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5542282|NCT01307423|19155963|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5542283|NCT01307423|19155964|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5542284|NCT01307423|19155965|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
5542285|NCT01307423|19155966|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
5542286|NCT01307423|19155967|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5542287|NCT01307423|19155959|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5542288|NCT01307423|19155960|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5542289|NCT01307423|19155961|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5542290|NCT01307423|19155962|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5542291|NCT01307423|19155963|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5542292|NCT01307423|19155964|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5542293|NCT01307423|19155965|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
5542294|NCT01307423|19155966|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5542295|NCT01307423|19155967|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
5542296|NCT01307423|19155959|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
5542297|NCT01307423|19155960|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
5542298|NCT01307423|19155961|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5542299|NCT01307423|19155962|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5542300|NCT01307423|19155963|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5542301|NCT01307423|19155964|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5542302|NCT01307423|19155965|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
5542303|NCT01307423|19155966|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
5542304|NCT01307423|19155967|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5542305|NCT01307423|19155959|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
5542306|NCT01307423|19155960|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
5542307|NCT01307423|19155961|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
5542308|NCT01307423|19155962|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
5542309|NCT01307423|19155963|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
5542310|NCT01307423|19155964|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
5542311|NCT01307423|19155965|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
5542312|NCT01307423|19155966|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
5542313|NCT01307423|19155967|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
5542314|NCT01307423|19155959|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5542315|NCT01307423|19155960|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5542316|NCT01307423|19155961|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5542317|NCT01307423|19155962|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
5542318|NCT01307423|19155963|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5542319|NCT01307423|19155964|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5542320|NCT01307423|19155965|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5542321|NCT01307423|19155966|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5542322|NCT01307423|19155967|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
5542323|NCT01307423|19155959|P9|Active Treatment Phase (Week 25-52)|Other|0
5542324|NCT01307423|19155960|P8|Active Treatment Phase (Week 25-52)|Other|0
5542325|NCT01307423|19155961|P7|Active Treatment Phase (Week 25-52)|Other|0
5542326|NCT01307423|19155962|P6|Active Treatment Phase (Week 25-52)|Other|0
5542327|NCT01307423|19155963|P5|Active Treatment Phase (Week 25-52)|Other|0
5542328|NCT01307423|19155964|P4|Active Treatment Phase (Week 25-52)|Other|1
5542329|NCT01307423|19155965|P3|Active Treatment Phase (Week 25-52)|Other|0
5542330|NCT01307423|19155966|P2|Active Treatment Phase (Week 25-52)|Other|0
5542331|NCT01307423|19155967|P1|Active Treatment Phase (Week 25-52)|Other|0
5542332|NCT01307423|19155959|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5542333|NCT01307423|19155960|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5542334|NCT01307423|19155961|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5542335|NCT01307423|19155962|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5542336|NCT01307423|19155963|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5542337|NCT01307423|19155964|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
5542338|NCT01307423|19155965|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5542339|NCT01307423|19155966|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5542340|NCT01307423|19155967|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
5542341|NCT01307423|19155959|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5542342|NCT01307423|19155960|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5542343|NCT01307423|19155961|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
5542344|NCT01307423|19155962|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
5542345|NCT01307423|19155963|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5542346|NCT01307423|19155964|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5542347|NCT01307423|19155965|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
5542348|NCT01307423|19155966|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
5542349|NCT01307423|19155967|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
5542350|NCT01307423|19155959|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5542351|NCT01307423|19155960|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5542352|NCT01307423|19155961|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5542353|NCT01307423|19155962|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
5542354|NCT01307423|19155963|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5542355|NCT01307423|19155964|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5542356|NCT01307423|19155965|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5542357|NCT01307423|19155966|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5542358|NCT01307423|19155967|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
5542359|NCT01307423|19155959|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5542360|NCT01307423|19155960|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5542361|NCT01307423|19155961|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5542362|NCT01307423|19155962|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5542363|NCT01307423|19155963|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
5542364|NCT01307423|19155964|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
5542365|NCT01307423|19155965|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
5542366|NCT01307423|19155966|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
5542367|NCT01307423|19155967|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
5542368|NCT01307423|19155959|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
5542369|NCT01307423|19155960|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
5542370|NCT01307423|19155961|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
5542371|NCT01307423|19155962|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
5542372|NCT01307423|19155963|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
5542373|NCT01307423|19155964|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
5542374|NCT01307423|19155965|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
5542539|NCT01307267|19156215|P17|Overall Study|Death|1
5542375|NCT01307423|19155966|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
5542376|NCT01307423|19155967|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
5542377|NCT01307423|19155959|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5542378|NCT01307423|19155960|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5542379|NCT01307423|19155961|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5542380|NCT01307423|19155962|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5542381|NCT01307423|19155963|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5542382|NCT01307423|19155964|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5542383|NCT01307423|19155965|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
5542384|NCT01307423|19155966|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
5542385|NCT01307423|19155967|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
5542386|NCT01307423|19155959|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
5542387|NCT01307423|19155960|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
5542388|NCT01307423|19155961|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
5542389|NCT01307423|19155962|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
5542390|NCT01307423|19155963|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
5542391|NCT01307423|19155964|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
5542392|NCT01307423|19155965|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
5542393|NCT01307423|19155966|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
5542394|NCT01307423|19155967|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
5542395|NCT01307423|19155959|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5542396|NCT01307423|19155960|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5542397|NCT01307423|19155961|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5542398|NCT01307423|19155962|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5542399|NCT01307423|19155963|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5542400|NCT01307423|19155964|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5542401|NCT01307423|19155965|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5542402|NCT01307423|19155966|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5542403|NCT01307423|19155967|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5542404|NCT01307423|19155959|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5542405|NCT01307423|19155960|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5542406|NCT01307423|19155961|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5542407|NCT01307423|19155962|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5542408|NCT01307423|19155963|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5542409|NCT01307423|19155964|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5542410|NCT01307423|19155965|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
5542411|NCT01307423|19155966|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5542412|NCT01307423|19155967|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
5542413|NCT01307423|19155959|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5542414|NCT01307423|19155960|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5542415|NCT01307423|19155961|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5542416|NCT01307423|19155962|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5542417|NCT01307423|19155963|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5542418|NCT01307423|19155964|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5542419|NCT01307423|19155965|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
5542420|NCT01307423|19155966|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5542421|NCT01307423|19155967|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5542422|NCT01307423|19155959|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5542423|NCT01307423|19155960|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5542424|NCT01307423|19155961|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5542425|NCT01307423|19155962|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5542426|NCT01307423|19155963|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5542427|NCT01307423|19155964|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5542428|NCT01307423|19155965|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
5542429|NCT01307423|19155966|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
5542430|NCT01307423|19155967|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
5542431|NCT01307423|19155959|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5542432|NCT01307423|19155960|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5542433|NCT01307423|19155961|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5542434|NCT01307423|19155962|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5542435|NCT01307423|19155963|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5542436|NCT01307423|19155964|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5542437|NCT01307423|19155965|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
5542438|NCT01307423|19155966|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
5542439|NCT01307423|19155967|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
5542440|NCT01307423|19155959|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5542441|NCT01307423|19155960|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5542442|NCT01307423|19155961|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5542443|NCT01307423|19155962|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5542444|NCT01307423|19155963|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5542540|NCT01307267|19156216|P16|Overall Study|Death|0
5542445|NCT01307423|19155964|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5542446|NCT01307423|19155965|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
5542447|NCT01307423|19155966|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
5542448|NCT01307423|19155967|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
5542449|NCT01307319|19156173|P3|Overall Study|Other|3
5542450|NCT01307319|19156174|P2|Overall Study|Other|4
5542451|NCT01307319|19156175|P1|Overall Study|Other|0
5542452|NCT01307319|19156173|P3|Overall Study|Withdrawal by Subject|2
5542453|NCT01307319|19156174|P2|Overall Study|Withdrawal by Subject|1
5542454|NCT01307319|19156175|P1|Overall Study|Withdrawal by Subject|0
5542455|NCT01307319|19156173|P3|Overall Study|Protocol Violation|0
5542456|NCT01307319|19156174|P2|Overall Study|Protocol Violation|1
5542457|NCT01307319|19156175|P1|Overall Study|Protocol Violation|1
5542458|NCT01307319|19156173|P3|Overall Study|Lost to Follow-up|1
5542459|NCT01307319|19156174|P2|Overall Study|Lost to Follow-up|0
5542460|NCT01307319|19156175|P1|Overall Study|Lost to Follow-up|1
5542461|NCT01307319|19156173|P3|Overall Study|Adverse Event|1
5542462|NCT01307319|19156174|P2|Overall Study|Adverse Event|2
5542463|NCT01307319|19156175|P1|Overall Study|Adverse Event|2
5542464|NCT01307267|19156209|P23|Overall Study|Other|2
5542465|NCT01307267|19156210|P22|Overall Study|Other|3
5542466|NCT01307267|19156211|P21|Overall Study|Other|2
5542467|NCT01307267|19156212|P20|Overall Study|Other|19
5542468|NCT01307267|19156213|P19|Overall Study|Other|0
5542469|NCT01307267|19156214|P18|Overall Study|Other|0
5542470|NCT01307267|19156215|P17|Overall Study|Other|0
5542471|NCT01307267|19156216|P16|Overall Study|Other|1
5542472|NCT01307267|19156217|P15|Overall Study|Other|2
5542473|NCT01307267|19156218|P14|Overall Study|Other|0
5542474|NCT01307267|19156219|P13|Overall Study|Other|1
5542475|NCT01307267|19156220|P12|Overall Study|Other|1
5542476|NCT01307267|19156221|P11|Overall Study|Other|1
5542477|NCT01307267|19156222|P10|Overall Study|Other|0
5542478|NCT01307267|19156223|P9|Overall Study|Other|3
5542479|NCT01307267|19156224|P8|Overall Study|Other|1
5542480|NCT01307267|19156225|P7|Overall Study|Other|0
5542481|NCT01307267|19156226|P6|Overall Study|Other|7
5542482|NCT01307267|19156227|P5|Overall Study|Other|0
5542483|NCT01307267|19156228|P4|Overall Study|Other|0
5542484|NCT01307267|19156229|P3|Overall Study|Other|0
5542485|NCT01307267|19156230|P2|Overall Study|Other|0
5542486|NCT01307267|19156231|P1|Overall Study|Other|0
5542487|NCT01307267|19156209|P23|Overall Study|Withdrawal by Subject|0
5542488|NCT01307267|19156210|P22|Overall Study|Withdrawal by Subject|0
5542489|NCT01307267|19156211|P21|Overall Study|Withdrawal by Subject|0
5542490|NCT01307267|19156212|P20|Overall Study|Withdrawal by Subject|3
5542491|NCT01307267|19156213|P19|Overall Study|Withdrawal by Subject|0
5542492|NCT01307267|19156214|P18|Overall Study|Withdrawal by Subject|0
5542493|NCT01307267|19156215|P17|Overall Study|Withdrawal by Subject|0
5542494|NCT01307267|19156216|P16|Overall Study|Withdrawal by Subject|0
5542495|NCT01307267|19156217|P15|Overall Study|Withdrawal by Subject|0
5542496|NCT01307267|19156218|P14|Overall Study|Withdrawal by Subject|0
5542497|NCT01307267|19156219|P13|Overall Study|Withdrawal by Subject|0
5542498|NCT01307267|19156220|P12|Overall Study|Withdrawal by Subject|1
5542499|NCT01307267|19156221|P11|Overall Study|Withdrawal by Subject|1
5542500|NCT01307267|19156222|P10|Overall Study|Withdrawal by Subject|1
5542501|NCT01307267|19156223|P9|Overall Study|Withdrawal by Subject|5
5542502|NCT01307267|19156224|P8|Overall Study|Withdrawal by Subject|1
5542503|NCT01307267|19156225|P7|Overall Study|Withdrawal by Subject|0
5542504|NCT01307267|19156226|P6|Overall Study|Withdrawal by Subject|1
5542505|NCT01307267|19156227|P5|Overall Study|Withdrawal by Subject|0
5542506|NCT01307267|19156228|P4|Overall Study|Withdrawal by Subject|0
5542507|NCT01307267|19156229|P3|Overall Study|Withdrawal by Subject|0
5542508|NCT01307267|19156230|P2|Overall Study|Withdrawal by Subject|0
5542509|NCT01307267|19156231|P1|Overall Study|Withdrawal by Subject|0
5542510|NCT01307267|19156209|P23|Overall Study|Lost to Follow-up|0
5542511|NCT01307267|19156210|P22|Overall Study|Lost to Follow-up|0
5542512|NCT01307267|19156211|P21|Overall Study|Lost to Follow-up|0
5542513|NCT01307267|19156212|P20|Overall Study|Lost to Follow-up|2
5542514|NCT01307267|19156213|P19|Overall Study|Lost to Follow-up|0
5542515|NCT01307267|19156214|P18|Overall Study|Lost to Follow-up|0
5542516|NCT01307267|19156215|P17|Overall Study|Lost to Follow-up|0
5542517|NCT01307267|19156216|P16|Overall Study|Lost to Follow-up|0
5542518|NCT01307267|19156217|P15|Overall Study|Lost to Follow-up|0
5542519|NCT01307267|19156218|P14|Overall Study|Lost to Follow-up|0
5542520|NCT01307267|19156219|P13|Overall Study|Lost to Follow-up|0
5542521|NCT01307267|19156220|P12|Overall Study|Lost to Follow-up|0
5542522|NCT01307267|19156221|P11|Overall Study|Lost to Follow-up|1
5542523|NCT01307267|19156222|P10|Overall Study|Lost to Follow-up|2
5542524|NCT01307267|19156223|P9|Overall Study|Lost to Follow-up|1
5542525|NCT01307267|19156224|P8|Overall Study|Lost to Follow-up|0
5542526|NCT01307267|19156225|P7|Overall Study|Lost to Follow-up|0
5542527|NCT01307267|19156226|P6|Overall Study|Lost to Follow-up|7
5542528|NCT01307267|19156227|P5|Overall Study|Lost to Follow-up|0
5542529|NCT01307267|19156228|P4|Overall Study|Lost to Follow-up|0
5542530|NCT01307267|19156229|P3|Overall Study|Lost to Follow-up|0
5542531|NCT01307267|19156230|P2|Overall Study|Lost to Follow-up|0
5542532|NCT01307267|19156231|P1|Overall Study|Lost to Follow-up|0
5542533|NCT01307267|19156209|P23|Overall Study|Death|2
5542534|NCT01307267|19156210|P22|Overall Study|Death|2
5542535|NCT01307267|19156211|P21|Overall Study|Death|1
5542536|NCT01307267|19156212|P20|Overall Study|Death|8
5542537|NCT01307267|19156213|P19|Overall Study|Death|2
5542541|NCT01307267|19156217|P15|Overall Study|Death|0
5542542|NCT01307267|19156218|P14|Overall Study|Death|0
5542543|NCT01307267|19156219|P13|Overall Study|Death|0
5542544|NCT01307267|19156220|P12|Overall Study|Death|9
5542545|NCT01307267|19156221|P11|Overall Study|Death|3
5542546|NCT01307267|19156222|P10|Overall Study|Death|2
5542547|NCT01307267|19156223|P9|Overall Study|Death|21
5542548|NCT01307267|19156224|P8|Overall Study|Death|2
5542549|NCT01307267|19156225|P7|Overall Study|Death|2
5542550|NCT01307267|19156226|P6|Overall Study|Death|26
5542551|NCT01307267|19156227|P5|Overall Study|Death|1
5542552|NCT01307267|19156228|P4|Overall Study|Death|3
5542553|NCT01307267|19156229|P3|Overall Study|Death|5
5542554|NCT01307267|19156230|P2|Overall Study|Death|3
5542555|NCT01307267|19156231|P1|Overall Study|Death|4
5542556|NCT01307111|19156822|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
5542557|NCT01307111|19156823|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
5542558|NCT01307111|19156822|P2|IUD Insertion|Lost to Follow-up|0
5542559|NCT01307111|19156823|P1|IUD Insertion|Lost to Follow-up|2
5542560|NCT01307046|19156846|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
5542561|NCT01307046|19156847|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
5542562|NCT01307046|19156846|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
5542563|NCT01307046|19156847|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
5542564|NCT01307046|19156846|P2|Overall Study|Withdrawal by Subject|1
5542565|NCT01307046|19156847|P1|Overall Study|Withdrawal by Subject|1
5542566|NCT01307046|19156846|P2|Overall Study|Physician Decision|0
5542567|NCT01307046|19156847|P1|Overall Study|Physician Decision|2
5542568|NCT01307046|19156846|P2|Overall Study|Lack of Efficacy|2
5542569|NCT01307046|19156847|P1|Overall Study|Lack of Efficacy|0
5542570|NCT01307046|19156846|P2|Overall Study|Adverse Event|3
5542571|NCT01307046|19156847|P1|Overall Study|Adverse Event|3
5542572|NCT01307033|19156859|P4|44-week Open-label Extension|Death|1
5542573|NCT01307033|19156860|P3|44-week Open-label Extension|Death|0
5542574|NCT01307033|19156861|P2|44-week Open-label Extension|Death|0
5542575|NCT01307033|19156862|P1|44-week Open-label Extension|Death|0
5542576|NCT01307033|19156859|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
5542577|NCT01307033|19156860|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
5542578|NCT01307033|19156861|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
5542579|NCT01307033|19156862|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
5542580|NCT01307033|19156859|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
5542581|NCT01307033|19156860|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
5542582|NCT01307033|19156861|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
5542583|NCT01307033|19156862|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
5542584|NCT01307033|19156859|P4|44-week Open-label Extension|Physician Decision|0
5542585|NCT01307033|19156860|P3|44-week Open-label Extension|Physician Decision|1
5542586|NCT01307033|19156861|P2|44-week Open-label Extension|Physician Decision|0
5542587|NCT01307033|19156862|P1|44-week Open-label Extension|Physician Decision|0
5542588|NCT01307033|19156859|P4|44-week Open-label Extension|Withdrawal by Subject|1
5542589|NCT01307033|19156860|P3|44-week Open-label Extension|Withdrawal by Subject|2
5542590|NCT01307033|19156861|P2|44-week Open-label Extension|Withdrawal by Subject|0
5542591|NCT01307033|19156862|P1|44-week Open-label Extension|Withdrawal by Subject|0
5542592|NCT01307033|19156859|P4|44-week Open-label Extension|Adverse Event|1
5542593|NCT01307033|19156860|P3|44-week Open-label Extension|Adverse Event|2
5542594|NCT01307033|19156861|P2|44-week Open-label Extension|Adverse Event|0
5542595|NCT01307033|19156862|P1|44-week Open-label Extension|Adverse Event|0
5542596|NCT01307033|19156859|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
5542597|NCT01307033|19156860|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
5542598|NCT01307033|19156861|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
5542599|NCT01307033|19156862|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
5542600|NCT01307033|19156859|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
5542601|NCT01307033|19156860|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
5542602|NCT01307033|19156861|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
5542603|NCT01307033|19156862|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
5542604|NCT01307033|19156859|P4|8-week Double-blind Period|Lack of Efficacy|0
5542605|NCT01307033|19156860|P3|8-week Double-blind Period|Lack of Efficacy|0
5542606|NCT01307033|19156861|P2|8-week Double-blind Period|Lack of Efficacy|0
5542607|NCT01307033|19156862|P1|8-week Double-blind Period|Lack of Efficacy|1
5542608|NCT01307033|19156859|P4|8-week Double-blind Period|Withdrawal by Subject|0
5542609|NCT01307033|19156860|P3|8-week Double-blind Period|Withdrawal by Subject|0
5542610|NCT01307033|19156861|P2|8-week Double-blind Period|Withdrawal by Subject|1
5542611|NCT01307033|19156862|P1|8-week Double-blind Period|Withdrawal by Subject|4
5542612|NCT01307033|19156859|P4|8-week Double-blind Period|Adverse Event|0
5542613|NCT01307033|19156860|P3|8-week Double-blind Period|Adverse Event|0
5542614|NCT01307033|19156861|P2|8-week Double-blind Period|Adverse Event|0
5542615|NCT01307033|19156862|P1|8-week Double-blind Period|Adverse Event|2
5542616|NCT01307020|19156884|P10|Overall Study|Electronic data capture failure|0
5542617|NCT01307020|19156885|P9|Overall Study|Electronic data capture failure|0
5542618|NCT01307020|19156886|P8|Overall Study|Electronic data capture failure|0
5542619|NCT01307020|19156887|P7|Overall Study|Electronic data capture failure|0
5542620|NCT01307020|19156888|P6|Overall Study|Electronic data capture failure|0
5542621|NCT01307020|19156889|P5|Overall Study|Electronic data capture failure|0
5542622|NCT01307020|19156890|P4|Overall Study|Electronic data capture failure|0
5542623|NCT01307020|19156891|P3|Overall Study|Electronic data capture failure|0
5542624|NCT01307020|19156892|P2|Overall Study|Electronic data capture failure|1
5542625|NCT01307020|19156893|P1|Overall Study|Electronic data capture failure|0
5542626|NCT01307020|19156884|P10|Overall Study|Lost to Follow-up|0
5542627|NCT01307020|19156885|P9|Overall Study|Lost to Follow-up|0
5542628|NCT01307020|19156886|P8|Overall Study|Lost to Follow-up|0
5542629|NCT01307020|19156887|P7|Overall Study|Lost to Follow-up|1
5542630|NCT01307020|19156888|P6|Overall Study|Lost to Follow-up|0
5542631|NCT01307020|19156889|P5|Overall Study|Lost to Follow-up|0
5542632|NCT01307020|19156890|P4|Overall Study|Lost to Follow-up|1
5542633|NCT01307020|19156891|P3|Overall Study|Lost to Follow-up|1
5542634|NCT01307020|19156892|P2|Overall Study|Lost to Follow-up|0
5542635|NCT01307020|19156893|P1|Overall Study|Lost to Follow-up|0
5542636|NCT01306968|19156948|P4|Overall Study|Withdrew over privacy concerns|1
5542637|NCT01306968|19156949|P3|Overall Study|Withdrew over privacy concerns|0
5542638|NCT01306968|19156950|P2|Overall Study|Withdrew over privacy concerns|0
5542639|NCT01306968|19156951|P1|Overall Study|Withdrew over privacy concerns|0
5542640|NCT01306968|19156948|P4|Overall Study|Withdrew - time commitment|2
5542641|NCT01306968|19156949|P3|Overall Study|Withdrew - time commitment|0
5542642|NCT01306968|19156950|P2|Overall Study|Withdrew - time commitment|0
5542643|NCT01306968|19156951|P1|Overall Study|Withdrew - time commitment|0
5542644|NCT01306968|19156948|P4|Overall Study|Relocated and left active duty|1
5542645|NCT01306968|19156949|P3|Overall Study|Relocated and left active duty|1
5542646|NCT01306968|19156950|P2|Overall Study|Relocated and left active duty|1
5542647|NCT01306968|19156951|P1|Overall Study|Relocated and left active duty|0
5542648|NCT01306968|19156948|P4|Overall Study|Physician Decision|0
5542649|NCT01306968|19156949|P3|Overall Study|Physician Decision|0
5542650|NCT01306968|19156950|P2|Overall Study|Physician Decision|1
5542651|NCT01306968|19156951|P1|Overall Study|Physician Decision|0
5542652|NCT01306968|19156948|P4|Overall Study|Lost to Follow-up|0
5542653|NCT01306968|19156949|P3|Overall Study|Lost to Follow-up|0
5542654|NCT01306968|19156950|P2|Overall Study|Lost to Follow-up|1
5542655|NCT01306968|19156951|P1|Overall Study|Lost to Follow-up|1
5542656|NCT01306942|19156976|P4|Phase II|Protocol Violation|1
5542657|NCT01306942|19156977|P3|Phase II|Protocol Violation|0
5542658|NCT01306942|19156978|P2|Phase II|Protocol Violation|0
5542659|NCT01306942|19156979|P1|Phase II|Protocol Violation|0
5542660|NCT01306942|19156976|P4|Phase II|Not finished treatment|1
5542661|NCT01306942|19156977|P3|Phase II|Not finished treatment|0
5542662|NCT01306942|19156978|P2|Phase II|Not finished treatment|0
5542663|NCT01306942|19156979|P1|Phase II|Not finished treatment|0
5542664|NCT01306942|19156976|P4|Phase II|Death|1
5542665|NCT01306942|19156977|P3|Phase II|Death|0
5542666|NCT01306942|19156978|P2|Phase II|Death|0
5542667|NCT01306942|19156979|P1|Phase II|Death|0
5542668|NCT01306942|19156976|P4|Phase II|Withdrawal by Subject|2
5542669|NCT01306942|19156977|P3|Phase II|Withdrawal by Subject|0
5542670|NCT01306942|19156978|P2|Phase II|Withdrawal by Subject|0
5542671|NCT01306942|19156979|P1|Phase II|Withdrawal by Subject|0
5542672|NCT01306942|19156976|P4|Phase II|Physician Decision|5
5542673|NCT01306942|19156977|P3|Phase II|Physician Decision|0
5542674|NCT01306942|19156978|P2|Phase II|Physician Decision|0
5542675|NCT01306942|19156979|P1|Phase II|Physician Decision|2
5542676|NCT01306942|19156976|P4|Phase II|Adverse Event|6
5542677|NCT01306942|19156977|P3|Phase II|Adverse Event|0
5542678|NCT01306942|19156978|P2|Phase II|Adverse Event|0
5542679|NCT01306942|19156979|P1|Phase II|Adverse Event|0
5542680|NCT01306942|19156976|P4|Phase I|Physician Decision|0
5542681|NCT01306942|19156977|P3|Phase I|Physician Decision|0
5542682|NCT01306942|19156978|P2|Phase I|Physician Decision|1
5542683|NCT01306942|19156979|P1|Phase I|Physician Decision|3
5542684|NCT01306942|19156976|P4|Phase I|Adverse Event|0
5542685|NCT01306942|19156977|P3|Phase I|Adverse Event|0
5542686|NCT01306942|19156978|P2|Phase I|Adverse Event|2
5542687|NCT01306942|19156979|P1|Phase I|Adverse Event|2
5542688|NCT01306890|19157011|P1|Overall Study|No discontinuation documentation|41
5542689|NCT01306890|19157011|P1|Overall Study|Study Termination|3
5542690|NCT01306890|19157011|P1|Overall Study|Unspecified reasons|104
5542691|NCT01306890|19157011|P1|Overall Study|Withdrawal by Subject|88
5542692|NCT01306890|19157011|P1|Overall Study|Lost to Follow-up|58
5542693|NCT01306890|19157011|P1|Overall Study|Death|1223
5542694|NCT01306890|19157011|P1|Overall Study|Adverse Event|2
5542695|NCT01306877|19157018|P2|Overall Study|Physician Decision|1
5542696|NCT01306877|19157019|P1|Overall Study|Physician Decision|0
5542697|NCT01306877|19157018|P2|Overall Study|Lost to Follow-up|3
5542698|NCT01306877|19157019|P1|Overall Study|Lost to Follow-up|3
5542699|NCT01306656|19157039|P2|Overall Study|Lost to Follow-up|0
5542700|NCT01306656|19157040|P1|Overall Study|Lost to Follow-up|1
5542701|NCT01306643|19157052|P1|Overall Study|Other: Change in Eligibility Status|1
5542702|NCT01306643|19157052|P1|Overall Study|Disease Progression|7
5542703|NCT01306643|19157052|P1|Overall Study|Adverse Event|5
5542704|NCT01306617|19157064|P3|Overall Study|Non-compliance|0
5542705|NCT01306617|19157065|P2|Overall Study|Non-compliance|1
5542706|NCT01306617|19157066|P1|Overall Study|Non-compliance|0
5542707|NCT01306617|19157064|P3|Overall Study|Virologic Failure|5
5542708|NCT01306617|19157065|P2|Overall Study|Virologic Failure|0
5542709|NCT01306617|19157066|P1|Overall Study|Virologic Failure|0
5542710|NCT01306617|19157064|P3|Overall Study|Adverse Event|0
5542711|NCT01306617|19157065|P2|Overall Study|Adverse Event|0
5542712|NCT01306617|19157066|P1|Overall Study|Adverse Event|1
5542713|NCT01306331|19157109|P2|Overall Study|Other|32
5542714|NCT01306331|19157110|P1|Overall Study|Other|34
5542715|NCT01306331|19157109|P2|Overall Study|Meth. no longer prim. meth. birth cntrl|20
5542716|NCT01306331|19157110|P1|Overall Study|Meth. no longer prim. meth. birth cntrl|10
5542717|NCT01306331|19157109|P2|Overall Study|Not sexually active|28
5542718|NCT01306331|19157110|P1|Overall Study|Not sexually active|29
5542719|NCT01306331|19157109|P2|Overall Study|Withdrawal by Subject|152
5542720|NCT01306331|19157110|P1|Overall Study|Withdrawal by Subject|163
5542721|NCT01306331|19157109|P2|Overall Study|Protocol Violation|124
5542722|NCT01306331|19157110|P1|Overall Study|Protocol Violation|154
5542723|NCT01306331|19157109|P2|Overall Study|Pregnancy|151
5542724|NCT01306331|19157110|P1|Overall Study|Pregnancy|136
5542725|NCT01306331|19157109|P2|Overall Study|Physician Decision|22
5542726|NCT01306331|19157110|P1|Overall Study|Physician Decision|26
5542727|NCT01306331|19157109|P2|Overall Study|Lost to Follow-up|323
5542728|NCT01306331|19157110|P1|Overall Study|Lost to Follow-up|321
5542729|NCT01306331|19157109|P2|Overall Study|Adverse Event|25
5542730|NCT01306331|19157110|P1|Overall Study|Adverse Event|28
5542731|NCT01306305|19157120|P2|Overall Study|Withdrew consent|0
5542732|NCT01306305|19157121|P1|Overall Study|Withdrew consent|1
5542733|NCT01306305|19157120|P2|Overall Study|Lost to Follow-up|0
5542734|NCT01306305|19157121|P1|Overall Study|Lost to Follow-up|1
5542735|NCT01306253|19157158|P2|Overall Study|Lost to Follow-up|1
5542736|NCT01306253|19157159|P1|Overall Study|Lost to Follow-up|1
5542737|NCT01306214|19157176|P3|Overall Study|Not treated|1
5542738|NCT01306214|19157177|P2|Overall Study|Not treated|1
5542739|NCT01306214|19157178|P1|Overall Study|Not treated|1
5542740|NCT01306214|19157176|P3|Overall Study|Withdrawal by Subject|16
5542741|NCT01306214|19157177|P2|Overall Study|Withdrawal by Subject|22
5542742|NCT01306214|19157178|P1|Overall Study|Withdrawal by Subject|24
5542743|NCT01306214|19157176|P3|Overall Study|Lost to Follow-up|4
5542744|NCT01306214|19157177|P2|Overall Study|Lost to Follow-up|5
5542745|NCT01306214|19157178|P1|Overall Study|Lost to Follow-up|3
5542746|NCT01306214|19157176|P3|Overall Study|Death|1
5542747|NCT01306214|19157177|P2|Overall Study|Death|0
5542748|NCT01306214|19157178|P1|Overall Study|Death|0
5542749|NCT01306201|19157195|P1|Overall Study|Files unreadable|3
5542750|NCT01306201|19157195|P1|Overall Study|Files could not be processed|3
5542751|NCT01306201|19157195|P1|Overall Study|Arrhythmia|4
5542752|NCT01306162|19157217|P4|Washout 1|Non-compliance to protocol|0
5542753|NCT01306162|19157218|P3|Washout 1|Non-compliance to protocol|0
5542754|NCT01306162|19157219|P2|Washout 1|Non-compliance to protocol|1
5542755|NCT01306162|19157220|P1|Washout 1|Non-compliance to protocol|0
5542756|NCT01306162|19157217|P4|Period 1|Adverse Event|1
5542757|NCT01306162|19157218|P3|Period 1|Adverse Event|0
5542758|NCT01306162|19157219|P2|Period 1|Adverse Event|0
5542759|NCT01306162|19157220|P1|Period 1|Adverse Event|0
5542760|NCT01306058|19157248|P1|Overall Study|Enrolled but did not get treatment|1
5542761|NCT01306058|19157248|P1|Overall Study|Death|1
5542762|NCT01306032|19157275|P6|Disease Progression/Crossover|other/symptomatic progression|0
5542763|NCT01306032|19157276|P5|Disease Progression/Crossover|other/symptomatic progression|0
5542764|NCT01306032|19157277|P4|Disease Progression/Crossover|other/symptomatic progression|2
5542765|NCT01306032|19157278|P3|Disease Progression/Crossover|other/symptomatic progression|0
5542766|NCT01306032|19157279|P2|Disease Progression/Crossover|other/symptomatic progression|2
5542767|NCT01306032|19157280|P1|Disease Progression/Crossover|other/symptomatic progression|0
5542768|NCT01306032|19157275|P6|Disease Progression/Crossover|Withdrawal by Subject|0
5542769|NCT01306032|19157276|P5|Disease Progression/Crossover|Withdrawal by Subject|0
5542770|NCT01306032|19157277|P4|Disease Progression/Crossover|Withdrawal by Subject|1
5542771|NCT01306032|19157278|P3|Disease Progression/Crossover|Withdrawal by Subject|0
5542772|NCT01306032|19157279|P2|Disease Progression/Crossover|Withdrawal by Subject|0
5542773|NCT01306032|19157280|P1|Disease Progression/Crossover|Withdrawal by Subject|0
5542774|NCT01306032|19157275|P6|First Intervention|Progressive disease|0
5542775|NCT01306032|19157276|P5|First Intervention|Progressive disease|2
5542776|NCT01306032|19157277|P4|First Intervention|Progressive disease|0
5542777|NCT01306032|19157278|P3|First Intervention|Progressive disease|0
5542778|NCT01306032|19157279|P2|First Intervention|Progressive disease|0
5542779|NCT01306032|19157280|P1|First Intervention|Progressive disease|0
5542780|NCT01306032|19157275|P6|First Intervention|Ineligible|1
5542781|NCT01306032|19157276|P5|First Intervention|Ineligible|0
5542782|NCT01306032|19157277|P4|First Intervention|Ineligible|0
5542783|NCT01306032|19157278|P3|First Intervention|Ineligible|0
5542784|NCT01306032|19157279|P2|First Intervention|Ineligible|0
5542785|NCT01306032|19157280|P1|First Intervention|Ineligible|0
5542786|NCT01306032|19157275|P6|First Intervention|Death|0
5542787|NCT01306032|19157276|P5|First Intervention|Death|0
5542788|NCT01306032|19157277|P4|First Intervention|Death|0
5542789|NCT01306032|19157278|P3|First Intervention|Death|1
5542790|NCT01306032|19157279|P2|First Intervention|Death|0
5542791|NCT01306032|19157280|P1|First Intervention|Death|0
5542792|NCT01306032|19157275|P6|First Intervention|Withdrawal by Subject|0
5542793|NCT01306032|19157276|P5|First Intervention|Withdrawal by Subject|0
5542794|NCT01306032|19157277|P4|First Intervention|Withdrawal by Subject|1
5542795|NCT01306032|19157278|P3|First Intervention|Withdrawal by Subject|0
5542796|NCT01306032|19157279|P2|First Intervention|Withdrawal by Subject|2
5542797|NCT01306032|19157280|P1|First Intervention|Withdrawal by Subject|0
5542798|NCT01306032|19157275|P6|First Intervention|Adverse Event|1
5542799|NCT01306032|19157276|P5|First Intervention|Adverse Event|0
5542800|NCT01306032|19157277|P4|First Intervention|Adverse Event|0
5542801|NCT01306032|19157278|P3|First Intervention|Adverse Event|1
5542802|NCT01306032|19157279|P2|First Intervention|Adverse Event|0
5542803|NCT01306032|19157280|P1|First Intervention|Adverse Event|1
5542804|NCT01305941|19157332|P1|Overall Study|Death|1
5542805|NCT01305941|19157332|P1|Overall Study|Withdrawal by Subject|1
5542806|NCT01305941|19157332|P1|Overall Study|Clinical decline|2
5542807|NCT01305941|19157332|P1|Overall Study|Adverse Event|6
5542808|NCT01305577|19157372|P3|Overall Study|Protocol Deviation|1
5542809|NCT01305577|19157373|P2|Overall Study|Protocol Deviation|1
5542810|NCT01305577|19157374|P1|Overall Study|Protocol Deviation|0
5542811|NCT01305577|19157372|P3|Overall Study|Lost to Follow-up|2
5542812|NCT01305577|19157373|P2|Overall Study|Lost to Follow-up|3
5542813|NCT01305577|19157374|P1|Overall Study|Lost to Follow-up|4
5542814|NCT01305577|19157372|P3|Overall Study|Withdrawal by Subject|6
5542815|NCT01305577|19157373|P2|Overall Study|Withdrawal by Subject|5
5542816|NCT01305577|19157374|P1|Overall Study|Withdrawal by Subject|7
5542817|NCT01305577|19157372|P3|Overall Study|Adverse Event|1
5542818|NCT01305577|19157373|P2|Overall Study|Adverse Event|2
5542819|NCT01305577|19157374|P1|Overall Study|Adverse Event|2
5542820|NCT01305564|19157403|P1|Overall Study|Physician Decision|3
5542821|NCT01305564|19157403|P1|Overall Study|Withdrawal by Subject|1
5542822|NCT01305564|19157403|P1|Overall Study|Lost to Follow-up|12
5542823|NCT01305564|19157403|P1|Overall Study|Death|21
5542824|NCT01305408|19157430|P2|Overall Study|Other|0
5542825|NCT01305408|19157431|P1|Overall Study|Other|1
5542826|NCT01305408|19157430|P2|Overall Study|Noncompliance with study procedures|1
5542827|NCT01305408|19157431|P1|Overall Study|Noncompliance with study procedures|0
5542828|NCT01305408|19157430|P2|Overall Study|Noncompliance with study medication|1
5542829|NCT01305408|19157431|P1|Overall Study|Noncompliance with study medication|0
5542830|NCT01305408|19157430|P2|Overall Study|Lost to Follow-up|3
5542831|NCT01305408|19157431|P1|Overall Study|Lost to Follow-up|5
5542832|NCT01305408|19157430|P2|Overall Study|Protocol Violation|6
5542833|NCT01305408|19157431|P1|Overall Study|Protocol Violation|4
5542834|NCT01305408|19157430|P2|Overall Study|Withdrawal by Subject|9
5542835|NCT01305408|19157431|P1|Overall Study|Withdrawal by Subject|9
5542836|NCT01305408|19157430|P2|Overall Study|Lack of Efficacy|4
5542837|NCT01305408|19157431|P1|Overall Study|Lack of Efficacy|3
5542838|NCT01305408|19157430|P2|Overall Study|Adverse Event|7
5542839|NCT01305408|19157431|P1|Overall Study|Adverse Event|10
5542840|NCT01305239|19157524|P1|Overall Study|Exemestane taken prior to inclusion only|1
5542841|NCT01305239|19157524|P1|Overall Study|Adverse Event|22
5542842|NCT01305200|19157554|P3|Overall Study|Death|0
5542843|NCT01305200|19157555|P2|Overall Study|Death|2
5542844|NCT01305200|19157556|P1|Overall Study|Death|0
5542845|NCT01305200|19157554|P3|Overall Study|Ineligible|1
5542846|NCT01305200|19157555|P2|Overall Study|Ineligible|2
5542847|NCT01305200|19157556|P1|Overall Study|Ineligible|1
5542848|NCT01305200|19157554|P3|Overall Study|Withdrawal by Subject|1
5542849|NCT01305200|19157555|P2|Overall Study|Withdrawal by Subject|21
5542850|NCT01305200|19157556|P1|Overall Study|Withdrawal by Subject|24
5542851|NCT01305200|19157554|P3|Overall Study|Physician Decision|1
5542852|NCT01305200|19157555|P2|Overall Study|Physician Decision|6
5542853|NCT01305200|19157556|P1|Overall Study|Physician Decision|4
5542854|NCT01305044|19157586|P2|Overall Study|Withdrawal by Subject|6
5542855|NCT01305044|19157587|P1|Overall Study|Withdrawal by Subject|3
5542856|NCT01304940|19157619|P2|Overall Study|not meet symptom severity requirement|0
5542857|NCT01304940|19157620|P1|Overall Study|not meet symptom severity requirement|3
5542858|NCT01304706|19157626|P1|Overall Study|Discontinued due to failed drug admin.|1
5542859|NCT01304706|19157626|P1|Overall Study|Lost to Follow-up|7
5542860|NCT01304706|19157626|P1|Overall Study|Withdrawal by Subject|3
5542861|NCT01304706|19157626|P1|Overall Study|Death|3
5542862|NCT01304706|19157626|P1|Overall Study|Lack of Efficacy|1
5542863|NCT01304706|19157626|P1|Overall Study|Adverse Event|2
5542864|NCT01304693|19157635|P5|Overall Study|Decision Unrelated to an Adverse Event|0
5542865|NCT01304693|19157636|P4|Overall Study|Decision Unrelated to an Adverse Event|1
5542866|NCT01304693|19157637|P3|Overall Study|Decision Unrelated to an Adverse Event|1
5542867|NCT01304693|19157638|P2|Overall Study|Decision Unrelated to an Adverse Event|0
5542868|NCT01304693|19157639|P1|Overall Study|Decision Unrelated to an Adverse Event|0
5542869|NCT01304693|19157635|P5|Overall Study|Adverse Event|1
5542870|NCT01304693|19157636|P4|Overall Study|Adverse Event|0
5542871|NCT01304693|19157637|P3|Overall Study|Adverse Event|0
5542872|NCT01304693|19157638|P2|Overall Study|Adverse Event|0
5542873|NCT01304693|19157639|P1|Overall Study|Adverse Event|0
5542874|NCT01304498|19157686|P2|Overall Study|Lost to Follow-up|1
5542875|NCT01304498|19157687|P1|Overall Study|Lost to Follow-up|2
5542876|NCT01304498|19157686|P2|Overall Study|Protocol Violation|0
5542877|NCT01304498|19157687|P1|Overall Study|Protocol Violation|1
5542878|NCT01304498|19157686|P2|Overall Study|Withdrawal by Subject|3
5542879|NCT01304498|19157687|P1|Overall Study|Withdrawal by Subject|2
5542880|NCT01304498|19157686|P2|Overall Study|Adverse Event|1
5542881|NCT01304498|19157687|P1|Overall Study|Adverse Event|1
5542882|NCT01304329|19157711|P6|Third Intervention (3 Days)|Adverse Event|0
5542883|NCT01304329|19157712|P5|Third Intervention (3 Days)|Adverse Event|0
5542884|NCT01304329|19157713|P4|Third Intervention (3 Days)|Adverse Event|0
5542885|NCT01304329|19157714|P3|Third Intervention (3 Days)|Adverse Event|0
5542886|NCT01304329|19157715|P2|Third Intervention (3 Days)|Adverse Event|1
5542887|NCT01304329|19157716|P1|Third Intervention (3 Days)|Adverse Event|0
5542888|NCT01304147|19157850|P2|Second Intervention (7days)|Withdrawal by Subject|1
5542889|NCT01304147|19157851|P1|Second Intervention (7days)|Withdrawal by Subject|1
5542890|NCT01303965|19157882|P2|Overall Study|Disease Progression|6
5542891|NCT01303965|19157883|P1|Overall Study|Disease Progression|1
5542892|NCT01303965|19157882|P2|Overall Study|Withdrawal by Subject|0
5542893|NCT01303965|19157883|P1|Overall Study|Withdrawal by Subject|1
5542894|NCT01303965|19157882|P2|Overall Study|Death|3
5542895|NCT01303965|19157883|P1|Overall Study|Death|0
5542896|NCT01303965|19157882|P2|Overall Study|Adverse Event|1
5542897|NCT01303965|19157883|P1|Overall Study|Adverse Event|1
5542898|NCT01303861|19157911|P4|Overall Study|Pregnancy|0
5542899|NCT01303861|19157912|P3|Overall Study|Pregnancy|0
5542900|NCT01303861|19157913|P2|Overall Study|Pregnancy|0
5542901|NCT01303861|19157914|P1|Overall Study|Pregnancy|1
5542902|NCT01303861|19157911|P4|Overall Study|Adverse Event|5
5542903|NCT01303861|19157912|P3|Overall Study|Adverse Event|0
5542904|NCT01303861|19157913|P2|Overall Study|Adverse Event|1
5542905|NCT01303861|19157914|P1|Overall Study|Adverse Event|4
5542906|NCT01303861|19157911|P4|Overall Study|Withdrawal by Subject|23
5542907|NCT01303861|19157912|P3|Overall Study|Withdrawal by Subject|8
5542908|NCT01303861|19157913|P2|Overall Study|Withdrawal by Subject|8
5542909|NCT01303861|19157914|P1|Overall Study|Withdrawal by Subject|16
5542910|NCT01303861|19157911|P4|Overall Study|Lack of Efficacy|0
5542911|NCT01303861|19157912|P3|Overall Study|Lack of Efficacy|1
5542912|NCT01303861|19157913|P2|Overall Study|Lack of Efficacy|2
5542913|NCT01303861|19157914|P1|Overall Study|Lack of Efficacy|3
5542914|NCT01303861|19157911|P4|Overall Study|Lost to Follow-up|31
5542915|NCT01303861|19157912|P3|Overall Study|Lost to Follow-up|27
5542916|NCT01303861|19157913|P2|Overall Study|Lost to Follow-up|14
5542917|NCT01303861|19157914|P1|Overall Study|Lost to Follow-up|34
5542918|NCT01303627|19157973|P2|Overall Study|the failure while performing URS|1
5542919|NCT01303627|19157974|P1|Overall Study|the failure while performing URS|0
5542920|NCT01303510|19157982|P2|Overall Study|Lost to Follow-up|0
5542921|NCT01303510|19157983|P1|Overall Study|Lost to Follow-up|1
5542922|NCT01303445|19157997|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
5542923|NCT01303445|19157998|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
5542924|NCT01303445|19157997|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
5542925|NCT01303445|19157998|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
5542926|NCT01303445|19157997|P2|Washout (14 Days)|Lost to Follow-up|2
5542927|NCT01303445|19157998|P1|Washout (14 Days)|Lost to Follow-up|0
5542928|NCT01303445|19157997|P2|Washout (14 Days)|Protocol Violation|0
5542929|NCT01303445|19157998|P1|Washout (14 Days)|Protocol Violation|1
5542930|NCT01303445|19157997|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
5542931|NCT01303445|19157998|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
5542932|NCT01303445|19157997|P2|Second Intervention (7 Days)|Adverse Event|2
5542933|NCT01303445|19157998|P1|Second Intervention (7 Days)|Adverse Event|0
5542934|NCT01303445|19157997|P2|First Intervention (7 Days)|Withdrawal by Subject|0
5542935|NCT01303445|19157998|P1|First Intervention (7 Days)|Withdrawal by Subject|1
5542936|NCT01303419|19158028|P1|Overall Study|Did not meet all I/E after screening|31
5542937|NCT01303419|19158028|P1|Overall Study|Did not complete both imaging methods|5
5542938|NCT01303419|19158028|P1|Overall Study|Discontinuation of study|60
5542939|NCT01303380|19158047|P1|Overall Study|Lack of compliance to study procedures|1
5542940|NCT01303159|19158106|P1|Overall Study|Study Termination|7
5542941|NCT01303159|19158106|P1|Overall Study|Death|16
5542942|NCT01302964|19158124|P2|Overall Study|Adverse Event|0
5542943|NCT01302964|19158125|P1|Overall Study|Adverse Event|1
5542944|NCT01302938|19158135|P2|Overall Study|Adverse Event|0
5542945|NCT01302938|19158136|P1|Overall Study|Adverse Event|1
5542946|NCT01302938|19158135|P2|Overall Study|Withdrawal by Subject|0
5542947|NCT01302938|19158136|P1|Overall Study|Withdrawal by Subject|1
5542948|NCT01302899|19158181|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
5542949|NCT01302899|19158182|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
5542950|NCT01302899|19158181|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
5542951|NCT01302899|19158182|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
5542952|NCT01302834|19158246|P2|Overall Study|HIV positive|3
5542953|NCT01302834|19158247|P1|Overall Study|HIV positive|1
5542954|NCT01302834|19158246|P2|Overall Study|Protocol Violation|23
5542955|NCT01302834|19158247|P1|Overall Study|Protocol Violation|17
5542956|NCT01302691|19158307|P2|Overall Study|Protocol Violation|0
5542957|NCT01302691|19158308|P1|Overall Study|Protocol Violation|1
5542958|NCT01302691|19158307|P2|Overall Study|Physician Decision|1
5542959|NCT01302691|19158308|P1|Overall Study|Physician Decision|0
5542960|NCT01302691|19158307|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
5542961|NCT01302691|19158308|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
5542962|NCT01302691|19158307|P2|Overall Study|Lost to Follow-up|0
5542963|NCT01302691|19158308|P1|Overall Study|Lost to Follow-up|1
5542964|NCT01302691|19158307|P2|Overall Study|Death|1
5542965|NCT01302691|19158308|P1|Overall Study|Death|0
5542966|NCT01302691|19158307|P2|Overall Study|Adverse Event|0
5542967|NCT01302691|19158308|P1|Overall Study|Adverse Event|2
5542968|NCT01302548|19158328|P2|Overall Study|Lost to Follow-up|1
5542969|NCT01302548|19158329|P1|Overall Study|Lost to Follow-up|2
5542970|NCT01302418|19158379|P1|Overall Study|Non-evaluable|9
5542971|NCT01302418|19158379|P1|Overall Study|Protocol Violation|9
5542972|NCT01302392|19158385|P2|Overall Study|Withdrawal by Subject|1
5542973|NCT01302392|19158386|P1|Overall Study|Withdrawal by Subject|6
5542974|NCT01302392|19158385|P2|Overall Study|Lost to Follow-up|0
5542975|NCT01302392|19158386|P1|Overall Study|Lost to Follow-up|1
5542976|NCT01302366|19158437|P1|Overall Study|patient choice or noncompliance|5
5542977|NCT01302119|19158445|P2|Overall Study|Non-specific|1
5542978|NCT01302119|19158446|P1|Overall Study|Non-specific|4
5542979|NCT01302119|19158445|P2|Overall Study|Non-compliance|2
5542980|NCT01302119|19158446|P1|Overall Study|Non-compliance|4
5542981|NCT01302119|19158445|P2|Overall Study|Adverse Event|1
5542982|NCT01302119|19158446|P1|Overall Study|Adverse Event|2
5542983|NCT01302119|19158445|P2|Overall Study|Lost to Follow-up|4
5542984|NCT01302119|19158446|P1|Overall Study|Lost to Follow-up|10
5542985|NCT01302119|19158445|P2|Overall Study|Withdrawal by Subject|20
5542986|NCT01302119|19158446|P1|Overall Study|Withdrawal by Subject|30
5542987|NCT01302067|19158461|P3|Overall Study|Adverse Event|45
5542988|NCT01302067|19158462|P2|Overall Study|Adverse Event|14
5542989|NCT01302067|19158463|P1|Overall Study|Adverse Event|27
5542990|NCT01302067|19158461|P3|Overall Study|Protocol Violation|8
5542991|NCT01302067|19158462|P2|Overall Study|Protocol Violation|0
5542992|NCT01302067|19158463|P1|Overall Study|Protocol Violation|11
5542993|NCT01302067|19158461|P3|Overall Study|Other|3
5542994|NCT01302067|19158462|P2|Overall Study|Other|1
5542995|NCT01302067|19158463|P1|Overall Study|Other|1
5542996|NCT01302067|19158461|P3|Overall Study|Withdrawal by Subject|10
5542997|NCT01302067|19158462|P2|Overall Study|Withdrawal by Subject|6
5542998|NCT01302067|19158463|P1|Overall Study|Withdrawal by Subject|13
5542999|NCT01302067|19158461|P3|Overall Study|Lost to Follow-up|15
5543000|NCT01302067|19158462|P2|Overall Study|Lost to Follow-up|4
5543001|NCT01302067|19158463|P1|Overall Study|Lost to Follow-up|9
5543002|NCT01302067|19158461|P3|Overall Study|Lack of Efficacy|2
5543003|NCT01302067|19158462|P2|Overall Study|Lack of Efficacy|4
5543004|NCT01302067|19158463|P1|Overall Study|Lack of Efficacy|8
5543005|NCT01302067|19158461|P3|Overall Study|Physician Decision|14
5543006|NCT01302067|19158462|P2|Overall Study|Physician Decision|5
5543007|NCT01302067|19158463|P1|Overall Study|Physician Decision|9
5543008|NCT01302067|19158461|P3|Overall Study|Death|1
5543009|NCT01302067|19158462|P2|Overall Study|Death|0
5543010|NCT01302067|19158463|P1|Overall Study|Death|0
5543011|NCT01302054|19158534|P3|Double-Blind Treatment Phase|Other|9
5543012|NCT01302054|19158535|P2|Double-Blind Treatment Phase|Other|4
5543013|NCT01302054|19158536|P1|Double-Blind Treatment Phase|Other|0
5543014|NCT01302054|19158534|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
5543015|NCT01302054|19158535|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
5543016|NCT01302054|19158536|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
5543017|NCT01302054|19158534|P3|Double-Blind Treatment Phase|Adverse Event|10
5543018|NCT01302054|19158535|P2|Double-Blind Treatment Phase|Adverse Event|10
5543019|NCT01302054|19158536|P1|Double-Blind Treatment Phase|Adverse Event|0
5543020|NCT01302054|19158534|P3|Double-Blind Treatment Phase|Protocol Violation|6
5543021|NCT01302054|19158535|P2|Double-Blind Treatment Phase|Protocol Violation|3
5543022|NCT01302054|19158536|P1|Double-Blind Treatment Phase|Protocol Violation|0
5543023|NCT01302054|19158534|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
5543024|NCT01302054|19158535|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
5543025|NCT01302054|19158536|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
5543026|NCT01302054|19158534|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
5543027|NCT01302054|19158535|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
5543028|NCT01302054|19158536|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
5543029|NCT01302054|19158534|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
5543030|NCT01302054|19158535|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
5543031|NCT01302054|19158536|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
5543032|NCT01302054|19158534|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
5543033|NCT01302054|19158535|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
5543034|NCT01302054|19158536|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
5543035|NCT01302054|19158534|P3|Tolterodine Open-Label Run-In Phase|Other|0
5543036|NCT01302054|19158535|P2|Tolterodine Open-Label Run-In Phase|Other|0
5543037|NCT01302054|19158536|P1|Tolterodine Open-Label Run-In Phase|Other|7
5543038|NCT01302054|19158534|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
5543039|NCT01302054|19158535|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
5543040|NCT01302054|19158536|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
5543041|NCT01302054|19158534|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
5543042|NCT01302054|19158535|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
5543043|NCT01302054|19158536|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
5543044|NCT01302054|19158534|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
5543045|NCT01302054|19158535|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
5543046|NCT01302054|19158536|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
5543047|NCT01302054|19158534|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
5543048|NCT01302054|19158535|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
5543049|NCT01302054|19158536|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
5543050|NCT01302054|19158534|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
5543051|NCT01302054|19158535|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
5543052|NCT01302054|19158536|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
5543053|NCT01302054|19158534|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
5543054|NCT01302054|19158535|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
5543055|NCT01302054|19158536|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
5543056|NCT01302041|19158563|P1|Overall Study|Other-Miscellaneous Reason|2
5543057|NCT01302041|19158563|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
5543058|NCT01302041|19158563|P1|Overall Study|Withdrawal by Subject|4
5543059|NCT01302041|19158563|P1|Overall Study|Death|5
5543060|NCT01301950|19158605|P2|Overall Study|Surgery was cancelled by patient|1
5543061|NCT01301950|19158606|P1|Overall Study|Surgery was cancelled by patient|0
5543062|NCT01301833|19158624|P4|Overall Study|Personal matter|0
5543063|NCT01301833|19158625|P3|Overall Study|Personal matter|0
5543064|NCT01301833|19158626|P2|Overall Study|Personal matter|0
5543065|NCT01301833|19158627|P1|Overall Study|Personal matter|1
5543066|NCT01301833|19158624|P4|Overall Study|Withdrawal by Subject|2
5543067|NCT01301833|19158625|P3|Overall Study|Withdrawal by Subject|1
5543068|NCT01301833|19158626|P2|Overall Study|Withdrawal by Subject|1
5543069|NCT01301833|19158627|P1|Overall Study|Withdrawal by Subject|3
5543070|NCT01301833|19158624|P4|Overall Study|Physician Decision|0
5543071|NCT01301833|19158625|P3|Overall Study|Physician Decision|1
5543072|NCT01301833|19158626|P2|Overall Study|Physician Decision|1
5543073|NCT01301833|19158627|P1|Overall Study|Physician Decision|3
5543074|NCT01301833|19158624|P4|Overall Study|Lack of Efficacy|0
5543075|NCT01301833|19158625|P3|Overall Study|Lack of Efficacy|0
5543076|NCT01301833|19158626|P2|Overall Study|Lack of Efficacy|1
5543077|NCT01301833|19158627|P1|Overall Study|Lack of Efficacy|1
5543078|NCT01301833|19158624|P4|Overall Study|Adverse Event|5
5543079|NCT01301833|19158625|P3|Overall Study|Adverse Event|5
5543080|NCT01301833|19158626|P2|Overall Study|Adverse Event|5
5543081|NCT01301833|19158627|P1|Overall Study|Adverse Event|7
5543082|NCT01301729|19158665|P1|Overall Study|Violated Selection Criteria|1
5543083|NCT01301729|19158665|P1|Overall Study|Participant did not Return for Treatment|1
5543084|NCT01301729|19158665|P1|Overall Study|Withdrawal by Subject|2
5543085|NCT01301625|19158676|P1|Overall Study|Lost to Follow-up|1
5543086|NCT01301625|19158676|P1|Overall Study|Expected|8
5543087|NCT01301625|19158676|P1|Overall Study|Not Due|21
5543088|NCT01301625|19158676|P1|Overall Study|Death|5
5543089|NCT01301508|19158748|P2|Overall Study|Lost to Follow-up|1
5543090|NCT01301508|19158749|P1|Overall Study|Lost to Follow-up|0
5543091|NCT01301508|19158748|P2|Overall Study|Withdrawal by Subject|2
5543092|NCT01301508|19158749|P1|Overall Study|Withdrawal by Subject|1
5543093|NCT01301456|19158779|P12|Stage 2|Adverse Event|0
5543094|NCT01301456|19158780|P11|Stage 2|Adverse Event|1
5543095|NCT01301456|19158781|P10|Stage 2|Adverse Event|0
5543096|NCT01301456|19158782|P9|Stage 2|Adverse Event|0
5543097|NCT01301456|19158783|P8|Stage 2|Adverse Event|0
5543098|NCT01301456|19158784|P7|Stage 2|Adverse Event|0
5543099|NCT01301456|19158785|P6|Stage 2|Adverse Event|0
5543100|NCT01301456|19158786|P5|Stage 2|Adverse Event|0
5543101|NCT01301456|19158787|P4|Stage 2|Adverse Event|0
5543102|NCT01301456|19158788|P3|Stage 2|Adverse Event|0
5543103|NCT01301456|19158789|P2|Stage 2|Adverse Event|0
5543104|NCT01301456|19158790|P1|Stage 2|Adverse Event|0
5543105|NCT01301456|19158779|P12|Stage 1|Randomized but not treated|0
5543106|NCT01301456|19158780|P11|Stage 1|Randomized but not treated|0
5543107|NCT01301456|19158781|P10|Stage 1|Randomized but not treated|0
5543108|NCT01301456|19158782|P9|Stage 1|Randomized but not treated|0
5543109|NCT01301456|19158783|P8|Stage 1|Randomized but not treated|0
5543110|NCT01301456|19158784|P7|Stage 1|Randomized but not treated|1
5543111|NCT01301456|19158785|P6|Stage 1|Randomized but not treated|0
5543112|NCT01301456|19158786|P5|Stage 1|Randomized but not treated|0
5543113|NCT01301456|19158787|P4|Stage 1|Randomized but not treated|0
5543114|NCT01301456|19158788|P3|Stage 1|Randomized but not treated|0
5543115|NCT01301456|19158789|P2|Stage 1|Randomized but not treated|0
5543116|NCT01301456|19158790|P1|Stage 1|Randomized but not treated|0
5543117|NCT01301456|19158779|P12|Stage 1|Withdrawal by Subject|0
5543118|NCT01301456|19158780|P11|Stage 1|Withdrawal by Subject|0
5543119|NCT01301456|19158781|P10|Stage 1|Withdrawal by Subject|0
5543120|NCT01301456|19158782|P9|Stage 1|Withdrawal by Subject|0
5543121|NCT01301456|19158783|P8|Stage 1|Withdrawal by Subject|0
5543122|NCT01301456|19158784|P7|Stage 1|Withdrawal by Subject|0
5543123|NCT01301456|19158785|P6|Stage 1|Withdrawal by Subject|0
5543124|NCT01301456|19158786|P5|Stage 1|Withdrawal by Subject|1
5543125|NCT01301456|19158787|P4|Stage 1|Withdrawal by Subject|0
5543126|NCT01301456|19158788|P3|Stage 1|Withdrawal by Subject|1
5543127|NCT01301456|19158789|P2|Stage 1|Withdrawal by Subject|0
5543128|NCT01301456|19158790|P1|Stage 1|Withdrawal by Subject|0
5543129|NCT01301391|19159016|P1|Overall Study|Sponsor's decision|8
5543130|NCT01301391|19159016|P1|Overall Study|Physician Decision|2
5543131|NCT01301391|19159016|P1|Overall Study|Lost to Follow-up|3
5543132|NCT01301391|19159016|P1|Overall Study|Death|13
5543133|NCT01301274|19159028|P2|Overall Study|Physician Decision|1
5543134|NCT01301274|19159029|P1|Overall Study|Physician Decision|2
5543135|NCT01301092|19159044|P3|Overall Study|Lost to Follow-up|1
5543136|NCT01301092|19159045|P2|Overall Study|Lost to Follow-up|0
5543137|NCT01301092|19159046|P1|Overall Study|Lost to Follow-up|0
5543138|NCT01301079|19159063|P2|Overall Study|Lost to Follow-up|2
5543139|NCT01301079|19159064|P1|Overall Study|Lost to Follow-up|2
5543140|NCT01301066|19159142|P2|Overall Study|Other|0
5543141|NCT01301066|19159143|P1|Overall Study|Other|2
5543142|NCT01301066|19159142|P2|Overall Study|Physician Decision|1
5543143|NCT01301066|19159143|P1|Overall Study|Physician Decision|0
5543144|NCT01301066|19159142|P2|Overall Study|Sponsor Decision|1
5543145|NCT01301066|19159143|P1|Overall Study|Sponsor Decision|2
5543146|NCT01301066|19159142|P2|Overall Study|Adverse Event|6
5543147|NCT01301066|19159143|P1|Overall Study|Adverse Event|6
5543148|NCT01301066|19159142|P2|Overall Study|Withdrawal by Subject|9
5543149|NCT01301066|19159143|P1|Overall Study|Withdrawal by Subject|4
5543150|NCT01301066|19159142|P2|Overall Study|Protocol Violation|7
5543151|NCT01301066|19159143|P1|Overall Study|Protocol Violation|8
5543152|NCT01301066|19159142|P2|Overall Study|Lost to Follow-up|11
5543153|NCT01301066|19159143|P1|Overall Study|Lost to Follow-up|5
5543154|NCT01301027|19159151|P2|Overall Study|Volume Overload|0
5543155|NCT01301027|19159152|P1|Overall Study|Volume Overload|3
5543156|NCT01301027|19159151|P2|Overall Study|Transplant|2
5543157|NCT01301027|19159152|P1|Overall Study|Transplant|0
5543158|NCT01301027|19159151|P2|Overall Study|Fracture|3
5543159|NCT01301027|19159152|P1|Overall Study|Fracture|1
5543160|NCT01301027|19159151|P2|Overall Study|Adverse Event|2
5543161|NCT01301027|19159152|P1|Overall Study|Adverse Event|0
5543162|NCT01301027|19159151|P2|Overall Study|Withdrawal by Subject|3
5543163|NCT01301027|19159152|P1|Overall Study|Withdrawal by Subject|2
5543164|NCT01301027|19159151|P2|Overall Study|Physician Decision|0
5543165|NCT01301027|19159152|P1|Overall Study|Physician Decision|2
5543166|NCT01301001|19159164|P2|Second Intervention|Withdrawal by Subject|0
5543167|NCT01301001|19159165|P1|Second Intervention|Withdrawal by Subject|2
5543168|NCT01301001|19159164|P2|Second Intervention|Adverse Event|0
5543169|NCT01301001|19159165|P1|Second Intervention|Adverse Event|2
5543170|NCT01301001|19159164|P2|First Intervention|Protocol Violation|1
5543171|NCT01301001|19159165|P1|First Intervention|Protocol Violation|0
5543172|NCT01301001|19159164|P2|First Intervention|Adverse Event|0
5543173|NCT01301001|19159165|P1|First Intervention|Adverse Event|5
5543174|NCT01301001|19159164|P2|First Intervention|Withdrawal by Subject|4
5543175|NCT01301001|19159165|P1|First Intervention|Withdrawal by Subject|1
5543176|NCT01301001|19159164|P2|First Intervention|Lost to Follow-up|4
5543177|NCT01301001|19159165|P1|First Intervention|Lost to Follow-up|4
5543178|NCT01300923|19159188|P2|Overall Study|Physician Decision|2
5543179|NCT01300923|19159189|P1|Overall Study|Physician Decision|0
5543180|NCT01300819|19159202|P2|Overall Study|Follow up call was not done|0
5543181|NCT01300819|19159203|P1|Overall Study|Follow up call was not done|1
5543182|NCT01300819|19159202|P2|Overall Study|Safety follow up not done by mistake|1
5543183|NCT01300819|19159203|P1|Overall Study|Safety follow up not done by mistake|0
5543184|NCT01300819|19159202|P2|Overall Study|Administrative reason|1
5543185|NCT01300819|19159203|P1|Overall Study|Administrative reason|0
5543186|NCT01300819|19159202|P2|Overall Study|Refusal to down titrate study drug|1
5543187|NCT01300819|19159203|P1|Overall Study|Refusal to down titrate study drug|0
5543188|NCT01300819|19159202|P2|Overall Study|Patient was 1 month late for Visit 10|1
5543189|NCT01300819|19159203|P1|Overall Study|Patient was 1 month late for Visit 10|0
5543190|NCT01300819|19159202|P2|Overall Study|Withdrawal by Subject|12
5543191|NCT01300819|19159203|P1|Overall Study|Withdrawal by Subject|10
5543192|NCT01300819|19159202|P2|Overall Study|Lack of Efficacy|1
5543193|NCT01300819|19159203|P1|Overall Study|Lack of Efficacy|2
5543194|NCT01300819|19159202|P2|Overall Study|Adverse Event|27
5543195|NCT01300819|19159203|P1|Overall Study|Adverse Event|9
5543196|NCT01300767|19159231|P1|Overall Study|Unacceptable fit|1
5543197|NCT01300767|19159231|P1|Overall Study|Biomicroscopy|1
5543198|NCT01300767|19159231|P1|Overall Study|Discomfort|2
5543199|NCT01300741|19159259|P1|Overall Study|Discomfort|1
5543200|NCT01300741|19159259|P1|Overall Study|Lost to Follow-up|1
5543201|NCT01300741|19159259|P1|Overall Study|Lens deposits|1
5543202|NCT01300728|19159289|P2|Overall Study|Physician Decision|0
5543203|NCT01300728|19159290|P1|Overall Study|Physician Decision|1
5543204|NCT01300728|19159289|P2|Overall Study|Withdrawal by Subject|1
5543205|NCT01300728|19159290|P1|Overall Study|Withdrawal by Subject|1
5543206|NCT01300650|19159304|P1|Overall Study|Adverse Event|1
5543207|NCT01300572|19159320|P1|Overall Study|HAMA + post dosimetry|1
5543208|NCT01300546|19159344|P2|Overall Study|Adverse Event|1
5543209|NCT01300546|19159345|P1|Overall Study|Adverse Event|0
5543210|NCT01300546|19159344|P2|Overall Study|Lack of Efficacy|3
5543211|NCT01300546|19159345|P1|Overall Study|Lack of Efficacy|0
5543212|NCT01300546|19159344|P2|Overall Study|Lost to Follow-up|2
5543213|NCT01300546|19159345|P1|Overall Study|Lost to Follow-up|0
5543214|NCT01300546|19159344|P2|Overall Study|Withdrawal by Subject|0
5543215|NCT01300546|19159345|P1|Overall Study|Withdrawal by Subject|1
5543216|NCT01300455|19159375|P2|Washout|Withdrawal by Subject|0
5543217|NCT01300455|19159376|P1|Washout|Withdrawal by Subject|1
5543218|NCT01300351|19159396|P2|Overall Study|Withdrawal by Subject|10
5543219|NCT01300351|19159397|P1|Overall Study|Withdrawal by Subject|7
5543220|NCT01300351|19159396|P2|Overall Study|Adverse Event|4
5543221|NCT01300351|19159397|P1|Overall Study|Adverse Event|0
5543222|NCT01300351|19159396|P2|Overall Study|Lost to Follow-up|1
5543223|NCT01300351|19159397|P1|Overall Study|Lost to Follow-up|0
5543224|NCT01300351|19159396|P2|Overall Study|Ongoing treatment at data cut-off|23
5543225|NCT01300351|19159397|P1|Overall Study|Ongoing treatment at data cut-off|27
5543226|NCT01300351|19159396|P2|Overall Study|Did not receive treatment|0
5543227|NCT01300351|19159397|P1|Overall Study|Did not receive treatment|2
5543228|NCT01300338|19159413|P2|Overall Study|Lost to Follow-up|0
5543229|NCT01300338|19159414|P1|Overall Study|Lost to Follow-up|5
5543230|NCT01300286|19159422|P1|Overall Study|did not get dosed|1
5543231|NCT01300260|19159432|P2|Period 2 of Study: Second Intervention|Adverse Event|1
5543232|NCT01300260|19159433|P1|Period 2 of Study: Second Intervention|Adverse Event|0
5543233|NCT01300260|19159432|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
5543234|NCT01300260|19159433|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
5543235|NCT01300260|19159432|P2|Period 1 of Study: First Intervention|Adverse Event|1
5543236|NCT01300260|19159433|P1|Period 1 of Study: First Intervention|Adverse Event|0
5543237|NCT01300247|19159465|P2|Overall Study|Non-Compliance|1
5543238|NCT01300247|19159466|P1|Overall Study|Non-Compliance|0
5543239|NCT01300247|19159465|P2|Overall Study|Withdrawal by Subject|0
5543240|NCT01300247|19159466|P1|Overall Study|Withdrawal by Subject|1
5543241|NCT01300247|19159465|P2|Overall Study|Lost to Follow-up|0
5543242|NCT01300247|19159466|P1|Overall Study|Lost to Follow-up|2
5543243|NCT01300247|19159465|P2|Overall Study|Death|1
5543244|NCT01300247|19159466|P1|Overall Study|Death|1
5543245|NCT01300234|19159498|P2|Overall Study|Participant refused return to hospital|0
5543246|NCT01300234|19159499|P1|Overall Study|Participant refused return to hospital|1
5543247|NCT01300234|19159498|P2|Overall Study|Participant stopped medication|1
5543248|NCT01300234|19159499|P1|Overall Study|Participant stopped medication|1
5543249|NCT01300234|19159498|P2|Overall Study|Participant reached stopping critera|0
5543250|NCT01300234|19159499|P1|Overall Study|Participant reached stopping critera|2
5543251|NCT01300234|19159498|P2|Overall Study|Pregnancy|1
5543252|NCT01300234|19159499|P1|Overall Study|Pregnancy|2
5543253|NCT01300234|19159498|P2|Overall Study|Lost to Follow-up|12
5543254|NCT01300234|19159499|P1|Overall Study|Lost to Follow-up|14
5543255|NCT01300234|19159498|P2|Overall Study|Withdrawal by Subject|9
5543256|NCT01300234|19159499|P1|Overall Study|Withdrawal by Subject|5
5543257|NCT01300234|19159498|P2|Overall Study|Protocol Violation|3
5543258|NCT01300234|19159499|P1|Overall Study|Protocol Violation|2
5543259|NCT01300234|19159498|P2|Overall Study|Adverse Event|1
5543260|NCT01300234|19159499|P1|Overall Study|Adverse Event|1
5543261|NCT01300052|19159546|P2|Overall Study|Protocol Violation|1
5543262|NCT01300052|19159547|P1|Overall Study|Protocol Violation|1
5543263|NCT01300052|19159546|P2|Overall Study|Withdrawal by Subject|2
5543264|NCT01300052|19159547|P1|Overall Study|Withdrawal by Subject|2
5543265|NCT01300052|19159546|P2|Overall Study|Adverse Event|0
5543266|NCT01300052|19159547|P1|Overall Study|Adverse Event|3
5543267|NCT01299961|19159565|P1|Overall Study|Lost to Follow-up|1
5543268|NCT01299961|19159565|P1|Overall Study|Lack of Efficacy|2
5543269|NCT01299961|19159565|P1|Overall Study|Adverse Event|3
5543270|NCT01299909|19159574|P3|Overall Study|Lost to Follow-up|17
5543271|NCT01299909|19159575|P2|Overall Study|Lost to Follow-up|18
5543272|NCT01299909|19159576|P1|Overall Study|Lost to Follow-up|22
5543273|NCT01299896|19159591|P2|Overall Study|Lost to Follow-up|11
5543274|NCT01299896|19159592|P1|Overall Study|Lost to Follow-up|0
5543275|NCT01299896|19159591|P2|Overall Study|Withdrawal by Subject|7
5543276|NCT01299896|19159592|P1|Overall Study|Withdrawal by Subject|1
5543277|NCT01299805|19159600|P2|Overall Study|Adverse Event|0
5543278|NCT01299805|19159601|P1|Overall Study|Adverse Event|2
5543279|NCT01299766|19159631|P2|Overall Study|Withdrawal by Subject|19
5543280|NCT01299766|19159632|P1|Overall Study|Withdrawal by Subject|29
5543281|NCT01299766|19159631|P2|Overall Study|Death|4
5543282|NCT01299766|19159632|P1|Overall Study|Death|5
5543283|NCT01299727|19159643|P3|Overall Study|Completed the Treatment Period|3
5543284|NCT01299727|19159644|P2|Overall Study|Completed the Treatment Period|4
5543285|NCT01299727|19159645|P1|Overall Study|Completed the Treatment Period|3
5543286|NCT01299727|19159643|P3|Overall Study|Adverse Event|1
5543287|NCT01299727|19159644|P2|Overall Study|Adverse Event|0
5543288|NCT01299727|19159645|P1|Overall Study|Adverse Event|0
5543289|NCT01299727|19159643|P3|Overall Study|Withdrawal by Subject|0
5543290|NCT01299727|19159644|P2|Overall Study|Withdrawal by Subject|0
5543291|NCT01299727|19159645|P1|Overall Study|Withdrawal by Subject|1
5543292|NCT01299584|19159739|P1|Overall Study|Protocol Violation|9
5543293|NCT01299571|19159746|P1|Overall Study|Protocol Violation|107
5543294|NCT01299480|19159757|P5|Overall Study|Started, but not vaccinated|0
5543295|NCT01299480|19159758|P4|Overall Study|Started, but not vaccinated|1
5543296|NCT01299480|19159759|P3|Overall Study|Started, but not vaccinated|1
5543297|NCT01299480|19159760|P2|Overall Study|Started, but not vaccinated|0
5543298|NCT01299480|19159761|P1|Overall Study|Started, but not vaccinated|0
5543299|NCT01299480|19159757|P5|Overall Study|Other|3
5543300|NCT01299480|19159758|P4|Overall Study|Other|0
5543301|NCT01299480|19159759|P3|Overall Study|Other|3
5543302|NCT01299480|19159760|P2|Overall Study|Other|2
5543303|NCT01299480|19159761|P1|Overall Study|Other|3
5543304|NCT01299480|19159757|P5|Overall Study|Lost to Follow-up|2
5543305|NCT01299480|19159758|P4|Overall Study|Lost to Follow-up|1
5543306|NCT01299480|19159759|P3|Overall Study|Lost to Follow-up|2
5543307|NCT01299480|19159760|P2|Overall Study|Lost to Follow-up|1
5543308|NCT01299480|19159761|P1|Overall Study|Lost to Follow-up|3
5543309|NCT01299480|19159757|P5|Overall Study|Physician Decision|0
5543310|NCT01299480|19159758|P4|Overall Study|Physician Decision|2
5543311|NCT01299480|19159759|P3|Overall Study|Physician Decision|0
5543312|NCT01299480|19159760|P2|Overall Study|Physician Decision|1
5543313|NCT01299480|19159761|P1|Overall Study|Physician Decision|1
5543314|NCT01299480|19159757|P5|Overall Study|Withdrawal due to pregnancy|0
5543315|NCT01299480|19159758|P4|Overall Study|Withdrawal due to pregnancy|0
5543316|NCT01299480|19159759|P3|Overall Study|Withdrawal due to pregnancy|1
5543317|NCT01299480|19159760|P2|Overall Study|Withdrawal due to pregnancy|1
5543318|NCT01299480|19159761|P1|Overall Study|Withdrawal due to pregnancy|0
5543319|NCT01299480|19159757|P5|Overall Study|Adverse Event|0
5543320|NCT01299480|19159758|P4|Overall Study|Adverse Event|4
5543321|NCT01299480|19159759|P3|Overall Study|Adverse Event|5
5543322|NCT01299480|19159760|P2|Overall Study|Adverse Event|4
5543323|NCT01299480|19159761|P1|Overall Study|Adverse Event|6
5543324|NCT01299480|19159757|P5|Overall Study|Withdrawal by Subject|4
5543325|NCT01299480|19159758|P4|Overall Study|Withdrawal by Subject|3
5543326|NCT01299480|19159759|P3|Overall Study|Withdrawal by Subject|7
5543327|NCT01299480|19159760|P2|Overall Study|Withdrawal by Subject|4
5543328|NCT01299480|19159761|P1|Overall Study|Withdrawal by Subject|3
5543329|NCT01299480|19159757|P5|Overall Study|Protocol Violation|1
5543330|NCT01299480|19159758|P4|Overall Study|Protocol Violation|1
5543331|NCT01299480|19159759|P3|Overall Study|Protocol Violation|8
5543332|NCT01299480|19159760|P2|Overall Study|Protocol Violation|5
5543333|NCT01299480|19159761|P1|Overall Study|Protocol Violation|7
5543334|NCT01299480|19159757|P5|Overall Study|No longer willing to participate|10
5543335|NCT01299480|19159758|P4|Overall Study|No longer willing to participate|13
5543336|NCT01299480|19159759|P3|Overall Study|No longer willing to participate|14
5543337|NCT01299480|19159760|P2|Overall Study|No longer willing to participate|17
5543338|NCT01299480|19159761|P1|Overall Study|No longer willing to participate|19
5543339|NCT01299389|19159963|P4|Post-observational|Other|6
5543340|NCT01299389|19159964|P3|Post-observational|Other|12
5543341|NCT01299389|19159965|P2|Post-observational|Other|0
5543342|NCT01299389|19159966|P1|Post-observational|Other|0
5543343|NCT01299389|19159963|P4|Double-blind|"fail to meet study population criteria"|0
5543344|NCT01299389|19159964|P3|Double-blind|"fail to meet study population criteria"|0
5543345|NCT01299389|19159965|P2|Double-blind|"fail to meet study population criteria"|1
5543346|NCT01299389|19159966|P1|Double-blind|"fail to meet study population criteria"|0
5543347|NCT01299389|19159963|P4|Double-blind|Other|0
5543348|NCT01299389|19159964|P3|Double-blind|Other|0
5543349|NCT01299389|19159965|P2|Double-blind|Other|1
5543350|NCT01299389|19159966|P1|Double-blind|Other|1
5543351|NCT01299389|19159963|P4|Double-blind|Withdrawal by Subject|0
5543352|NCT01299389|19159964|P3|Double-blind|Withdrawal by Subject|0
5543353|NCT01299389|19159965|P2|Double-blind|Withdrawal by Subject|13
5543354|NCT01299389|19159966|P1|Double-blind|Withdrawal by Subject|16
5543355|NCT01299389|19159963|P4|Double-blind|Lost to Follow-up|0
5543356|NCT01299389|19159964|P3|Double-blind|Lost to Follow-up|0
5543357|NCT01299389|19159965|P2|Double-blind|Lost to Follow-up|1
5543358|NCT01299389|19159966|P1|Double-blind|Lost to Follow-up|2
5543359|NCT01299389|19159963|P4|Double-blind|Lack of Efficacy|0
5543360|NCT01299389|19159964|P3|Double-blind|Lack of Efficacy|0
5543361|NCT01299389|19159965|P2|Double-blind|Lack of Efficacy|21
5543362|NCT01299389|19159966|P1|Double-blind|Lack of Efficacy|45
5543363|NCT01299389|19159963|P4|Double-blind|Adverse Event|0
5543364|NCT01299389|19159964|P3|Double-blind|Adverse Event|0
5543365|NCT01299389|19159965|P2|Double-blind|Adverse Event|27
5543366|NCT01299389|19159966|P1|Double-blind|Adverse Event|45
5543367|NCT01299376|19159988|P2|Extension (Weeks 9 to 52)|Physician Decision|0
5543368|NCT01299376|19159989|P1|Extension (Weeks 9 to 52)|Physician Decision|1
5543369|NCT01299376|19159988|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
5543370|NCT01299376|19159989|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
5543371|NCT01299376|19159988|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
5543372|NCT01299376|19159989|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
5543373|NCT01299376|19159988|P2|Extension (Weeks 9 to 52)|Adverse Event|3
5543374|NCT01299376|19159989|P1|Extension (Weeks 9 to 52)|Adverse Event|2
5543375|NCT01299376|19159988|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
5543376|NCT01299376|19159989|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
5543377|NCT01299376|19159988|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
5543378|NCT01299376|19159989|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
5543379|NCT01299376|19159988|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
5543380|NCT01299376|19159989|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
5543381|NCT01299376|19159988|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
5543382|NCT01299376|19159989|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
5543383|NCT01299376|19159988|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
5543384|NCT01299376|19159989|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
5543385|NCT01299376|19159988|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
5543386|NCT01299376|19159989|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
5543387|NCT01299376|19159988|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
5543388|NCT01299376|19159989|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
5543389|NCT01299272|19160032|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
5543390|NCT01299272|19160033|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
5543391|NCT01299272|19160034|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
5543392|NCT01299272|19160035|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
5543393|NCT01299272|19160032|P4|Double-blind (DB) Randomized Period|Physician Decision|1
5543394|NCT01299272|19160033|P3|Double-blind (DB) Randomized Period|Physician Decision|2
5543395|NCT01299272|19160034|P2|Double-blind (DB) Randomized Period|Physician Decision|0
5543396|NCT01299272|19160035|P1|Double-blind (DB) Randomized Period|Physician Decision|0
5543397|NCT01299272|19160032|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
5543398|NCT01299272|19160033|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
5543554|NCT01298570|19160328|P2|Overall Study|Surgery|1
5543399|NCT01299272|19160034|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
5543400|NCT01299272|19160035|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
5543401|NCT01299272|19160032|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
5543402|NCT01299272|19160033|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
5543403|NCT01299272|19160034|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
5543404|NCT01299272|19160035|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
5543405|NCT01299272|19160032|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
5543406|NCT01299272|19160033|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
5543407|NCT01299272|19160034|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
5543408|NCT01299272|19160035|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
5543409|NCT01299272|19160032|P4|Double-blind (DB) Randomized Period|Adverse Event|9
5543410|NCT01299272|19160033|P3|Double-blind (DB) Randomized Period|Adverse Event|8
5543411|NCT01299272|19160034|P2|Double-blind (DB) Randomized Period|Adverse Event|0
5543412|NCT01299272|19160035|P1|Double-blind (DB) Randomized Period|Adverse Event|0
5543413|NCT01299272|19160032|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
5543414|NCT01299272|19160033|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
5543415|NCT01299272|19160034|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
5543416|NCT01299272|19160035|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
5543417|NCT01299272|19160032|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
5543418|NCT01299272|19160033|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
5543419|NCT01299272|19160034|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
5543420|NCT01299272|19160035|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
5543421|NCT01299272|19160032|P4|Stabilization Open-label (OL) Period|Physician Decision|0
5543422|NCT01299272|19160033|P3|Stabilization Open-label (OL) Period|Physician Decision|0
5543423|NCT01299272|19160034|P2|Stabilization Open-label (OL) Period|Physician Decision|3
5543424|NCT01299272|19160035|P1|Stabilization Open-label (OL) Period|Physician Decision|0
5543425|NCT01299272|19160032|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
5543426|NCT01299272|19160033|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
5543427|NCT01299272|19160034|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
5543428|NCT01299272|19160035|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
5543429|NCT01299272|19160032|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
5543430|NCT01299272|19160033|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
5543431|NCT01299272|19160034|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
5543432|NCT01299272|19160035|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
5543433|NCT01299272|19160032|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
5543434|NCT01299272|19160033|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
5543435|NCT01299272|19160034|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
5543436|NCT01299272|19160035|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
5543437|NCT01299272|19160032|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
5543438|NCT01299272|19160033|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
5543439|NCT01299272|19160034|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
5543440|NCT01299272|19160035|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
5543441|NCT01299272|19160032|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
5543442|NCT01299272|19160033|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
5543443|NCT01299272|19160034|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
5543444|NCT01299272|19160035|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
5543445|NCT01299272|19160032|P4|Stabilization Open-label (OL) Period|Adverse Event|0
5543446|NCT01299272|19160033|P3|Stabilization Open-label (OL) Period|Adverse Event|0
5543447|NCT01299272|19160034|P2|Stabilization Open-label (OL) Period|Adverse Event|42
5543448|NCT01299272|19160035|P1|Stabilization Open-label (OL) Period|Adverse Event|0
5543449|NCT01299272|19160032|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
5543450|NCT01299272|19160033|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
5543451|NCT01299272|19160034|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
5543452|NCT01299272|19160035|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
5543453|NCT01299272|19160032|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
5543454|NCT01299272|19160033|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
5543455|NCT01299272|19160034|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
5543456|NCT01299272|19160035|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
5543457|NCT01299272|19160032|P4|Acute Open-label (OL) Period|Physician Decision|0
5543458|NCT01299272|19160033|P3|Acute Open-label (OL) Period|Physician Decision|0
5543459|NCT01299272|19160034|P2|Acute Open-label (OL) Period|Physician Decision|0
5543460|NCT01299272|19160035|P1|Acute Open-label (OL) Period|Physician Decision|5
5543461|NCT01299272|19160032|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
5543462|NCT01299272|19160033|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
5543463|NCT01299272|19160034|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
5543464|NCT01299272|19160035|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
5543465|NCT01299272|19160032|P4|Acute Open-label (OL) Period|Sponsor Decision|0
5543466|NCT01299272|19160033|P3|Acute Open-label (OL) Period|Sponsor Decision|0
5543467|NCT01299272|19160034|P2|Acute Open-label (OL) Period|Sponsor Decision|0
5543468|NCT01299272|19160035|P1|Acute Open-label (OL) Period|Sponsor Decision|13
5543469|NCT01299272|19160032|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
5543470|NCT01299272|19160033|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
5543471|NCT01299272|19160034|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
5543472|NCT01299272|19160035|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
5543473|NCT01299272|19160032|P4|Acute Open-label (OL) Period|Protocol Violation|0
5543474|NCT01299272|19160033|P3|Acute Open-label (OL) Period|Protocol Violation|0
5543475|NCT01299272|19160034|P2|Acute Open-label (OL) Period|Protocol Violation|0
5543476|NCT01299272|19160035|P1|Acute Open-label (OL) Period|Protocol Violation|36
5543477|NCT01299272|19160032|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
5543478|NCT01299272|19160033|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
5543479|NCT01299272|19160034|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
5543480|NCT01299272|19160035|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
5543481|NCT01299272|19160032|P4|Acute Open-label (OL) Period|Adverse Event|0
5543482|NCT01299272|19160033|P3|Acute Open-label (OL) Period|Adverse Event|0
5543483|NCT01299272|19160034|P2|Acute Open-label (OL) Period|Adverse Event|0
5543484|NCT01299272|19160035|P1|Acute Open-label (OL) Period|Adverse Event|140
5543485|NCT01299272|19160032|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
5543486|NCT01299272|19160033|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
5543487|NCT01299272|19160034|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
5543488|NCT01299272|19160035|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
5543489|NCT01299116|19160090|P3|Overall Study|Lost to Follow-up|11
5543490|NCT01299116|19160091|P2|Overall Study|Lost to Follow-up|9
5543491|NCT01299116|19160092|P1|Overall Study|Lost to Follow-up|65
5543492|NCT01299038|19160137|P2|Overall Study|Withdrawal by Subject|0
5543493|NCT01299038|19160138|P1|Overall Study|Withdrawal by Subject|1
5543494|NCT01299025|19160146|P2|Overall Study|Lost to Follow-up|0
5543495|NCT01299025|19160147|P1|Overall Study|Lost to Follow-up|1
5543496|NCT01299025|19160146|P2|Overall Study|Withdrawal by Subject|1
5543497|NCT01299025|19160147|P1|Overall Study|Withdrawal by Subject|2
5543498|NCT01298778|19160172|P2|Overall Study|not meet inclusion/exclusion criteria|1
5543499|NCT01298778|19160173|P1|Overall Study|not meet inclusion/exclusion criteria|0
5543500|NCT01298778|19160172|P2|Overall Study|Protocol Violation|1
5543501|NCT01298778|19160173|P1|Overall Study|Protocol Violation|0
5543502|NCT01298778|19160172|P2|Overall Study|Withdrawal by Subject|1
5543503|NCT01298778|19160173|P1|Overall Study|Withdrawal by Subject|0
5543504|NCT01298778|19160172|P2|Overall Study|Incorrect use of VAS|0
5543505|NCT01298778|19160173|P1|Overall Study|Incorrect use of VAS|1
5543506|NCT01298778|19160172|P2|Overall Study|Lost to Follow-up|3
5543507|NCT01298778|19160173|P1|Overall Study|Lost to Follow-up|2
5543508|NCT01298765|19160193|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
5543509|NCT01298765|19160193|P1|Long-Term Treatment Period|Physician Decision|1
5543510|NCT01298765|19160193|P1|Long-Term Treatment Period|Withdrawal by Subject|19
5543511|NCT01298765|19160193|P1|Long-Term Treatment Period|Lost to Follow-up|8
5543512|NCT01298765|19160193|P1|Long-Term Treatment Period|Lack of Efficacy|6
5543513|NCT01298765|19160193|P1|Long-Term Treatment Period|Adverse Event|19
5543514|NCT01298765|19160193|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
5543515|NCT01298765|19160193|P1|Titration Period|Withdrawal by Subject|10
5543516|NCT01298765|19160193|P1|Titration Period|Physician Decision|1
5543517|NCT01298765|19160193|P1|Titration Period|Lost to Follow-up|9
5543518|NCT01298765|19160193|P1|Titration Period|Lack of Efficacy|21
5543519|NCT01298765|19160193|P1|Titration Period|Death|1
5543520|NCT01298765|19160193|P1|Titration Period|Adverse Event|26
5543521|NCT01298700|19160214|P2|Overall Study|Did not Receive Study Drug|5
5543522|NCT01298700|19160215|P1|Overall Study|Did not Receive Study Drug|3
5543523|NCT01298700|19160214|P2|Overall Study|Other Miscellaneous Reasons|15
5543524|NCT01298700|19160215|P1|Overall Study|Other Miscellaneous Reasons|16
5543525|NCT01298700|19160214|P2|Overall Study|Protocol Violation|4
5543526|NCT01298700|19160215|P1|Overall Study|Protocol Violation|6
5543527|NCT01298700|19160214|P2|Overall Study|Withdrawal by Subject|9
5543528|NCT01298700|19160215|P1|Overall Study|Withdrawal by Subject|12
5543529|NCT01298700|19160214|P2|Overall Study|Lost to Follow-up|2
5543530|NCT01298700|19160215|P1|Overall Study|Lost to Follow-up|5
5543531|NCT01298700|19160214|P2|Overall Study|Lack of Efficacy|14
5543532|NCT01298700|19160215|P1|Overall Study|Lack of Efficacy|9
5543533|NCT01298700|19160214|P2|Overall Study|Adverse Event|51
5543534|NCT01298700|19160215|P1|Overall Study|Adverse Event|50
5543535|NCT01298661|19160226|P3|Overall Study|Withdrawal by Subject|2
5543536|NCT01298661|19160227|P2|Overall Study|Withdrawal by Subject|0
5543537|NCT01298661|19160228|P1|Overall Study|Withdrawal by Subject|2
5543538|NCT01298648|19160306|P1|Overall Study|Lost to Follow-up|21
5543539|NCT01298648|19160306|P1|Overall Study|Withdrawal by Subject|2
5543540|NCT01298596|19160317|P2|Overall Study|Referred for further management|15
5543541|NCT01298596|19160318|P1|Overall Study|Referred for further management|16
5543542|NCT01298596|19160317|P2|Overall Study|Lost to Follow-up|14
5543543|NCT01298596|19160318|P1|Overall Study|Lost to Follow-up|6
5543544|NCT01298596|19160317|P2|Overall Study|Death|3
5543545|NCT01298596|19160318|P1|Overall Study|Death|5
5543546|NCT01298596|19160317|P2|Overall Study|Withdrawal by Subject|1
5543547|NCT01298596|19160318|P1|Overall Study|Withdrawal by Subject|1
5543548|NCT01298570|19160328|P2|Overall Study|Ineligibility|1
5543549|NCT01298570|19160329|P1|Overall Study|Ineligibility|0
5543550|NCT01298570|19160328|P2|Overall Study|Death|1
5543551|NCT01298570|19160329|P1|Overall Study|Death|0
5543552|NCT01298570|19160328|P2|Overall Study|Symptomatic progression/deterioration|2
5543553|NCT01298570|19160329|P1|Overall Study|Symptomatic progression/deterioration|3
5543555|NCT01298570|19160329|P1|Overall Study|Surgery|2
5543556|NCT01298570|19160328|P2|Overall Study|Other complicating disease|1
5543557|NCT01298570|19160329|P1|Overall Study|Other complicating disease|2
5543558|NCT01298570|19160328|P2|Overall Study|Physician Decision|2
5543559|NCT01298570|19160329|P1|Overall Study|Physician Decision|4
5543560|NCT01298570|19160328|P2|Overall Study|Treatment delay > 4 weeks|5
5543561|NCT01298570|19160329|P1|Overall Study|Treatment delay > 4 weeks|4
5543562|NCT01298570|19160328|P2|Overall Study|Withdrawal by Subject|6
5543563|NCT01298570|19160329|P1|Overall Study|Withdrawal by Subject|21
5543564|NCT01298570|19160328|P2|Overall Study|Adverse Event|2
5543565|NCT01298570|19160329|P1|Overall Study|Adverse Event|20
5543566|NCT01298570|19160328|P2|Overall Study|Disease progression, relapse during acti|40
5543567|NCT01298570|19160329|P1|Overall Study|Disease progression, relapse during acti|64
5543568|NCT01298531|19160356|P2|Overall Study|Other|1
5543569|NCT01298531|19160357|P1|Overall Study|Other|2
5543570|NCT01298531|19160356|P2|Overall Study|Does not meet entrance criteria|1
5543571|NCT01298531|19160357|P1|Overall Study|Does not meet entrance criteria|0
5543572|NCT01298531|19160356|P2|Overall Study|Adverse Event|3
5543573|NCT01298531|19160357|P1|Overall Study|Adverse Event|4
5543574|NCT01298531|19160356|P2|Overall Study|Protocol Violation|1
5543575|NCT01298531|19160357|P1|Overall Study|Protocol Violation|1
5543576|NCT01298531|19160356|P2|Overall Study|Lost to Follow-up|0
5543577|NCT01298531|19160357|P1|Overall Study|Lost to Follow-up|2
5543578|NCT01298531|19160356|P2|Overall Study|Lack of Efficacy|1
5543579|NCT01298531|19160357|P1|Overall Study|Lack of Efficacy|0
5543580|NCT01298518|19160486|P3|Overall Study|Withdrawal by Subject|1
5543581|NCT01298518|19160487|P2|Overall Study|Withdrawal by Subject|0
5543582|NCT01298518|19160488|P1|Overall Study|Withdrawal by Subject|0
5543583|NCT01298492|19160540|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
5543584|NCT01298492|19160540|P1|Overall Study|Adverse Event(Related to Study Drug)|8
5543585|NCT01298492|19160540|P1|Overall Study|Protocol Violation|2
5543586|NCT01298492|19160540|P1|Overall Study|Withdrawn Due to Pregnancy|1
5543587|NCT01298492|19160540|P1|Overall Study|Other (Unspecified)|7
5543588|NCT01298492|19160540|P1|Overall Study|Withdrawal by Subject|47
5543589|NCT01298492|19160540|P1|Overall Study|Lost to Follow-up|12
5543590|NCT01298492|19160540|P1|Overall Study|Insufficient Clinical Response|22
5543591|NCT01298492|19160540|P1|Overall Study|Death|2
5543592|NCT01298362|19160548|P2|Overall Study|Did not provide 12month BMD measurements|43
5543593|NCT01298362|19160549|P1|Overall Study|Did not provide 12month BMD measurements|38
5543594|NCT01298323|19160569|P2|Overall Study|Eligibility criteria not fulfilled|1
5543595|NCT01298323|19160570|P1|Overall Study|Eligibility criteria not fulfilled|0
5543596|NCT01298323|19160569|P2|Overall Study|Ongoing|55
5543597|NCT01298323|19160570|P1|Overall Study|Ongoing|55
5543598|NCT01298323|19160569|P2|Overall Study|Other|9
5543599|NCT01298323|19160570|P1|Overall Study|Other|10
5543600|NCT01298323|19160569|P2|Overall Study|Protocol Violation|0
5543601|NCT01298323|19160570|P1|Overall Study|Protocol Violation|1
5543602|NCT01298323|19160569|P2|Overall Study|Withdrawal by Subject|3
5543603|NCT01298323|19160570|P1|Overall Study|Withdrawal by Subject|6
5543604|NCT01298323|19160569|P2|Overall Study|Lost to Follow-up|0
5543605|NCT01298323|19160570|P1|Overall Study|Lost to Follow-up|1
5543606|NCT01298323|19160569|P2|Overall Study|Death|16
5543607|NCT01298323|19160570|P1|Overall Study|Death|11
5543608|NCT01298323|19160569|P2|Overall Study|Adverse Event|4
5543609|NCT01298323|19160570|P1|Overall Study|Adverse Event|2
5543610|NCT01298193|19160593|P1|Efficacy Phase (Second Cycle)|Death|1
5543611|NCT01298193|19160593|P1|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
5543612|NCT01298193|19160593|P1|Observational Phase (First Cycle)|Received TC at a different dose|16
5543613|NCT01298193|19160593|P1|Observational Phase (First Cycle)|Withdrawal by Subject|2
5543614|NCT01298141|19160615|P1|Overall Study|Not treated|4
5543615|NCT01298141|19160615|P1|Overall Study|Death|6
5543616|NCT01298141|19160615|P1|Overall Study|Lost to Follow-up|1
5543617|NCT01298141|19160615|P1|Overall Study|Other|5
5543618|NCT01298141|19160615|P1|Overall Study|Termination of Study by the Investigator|5
5543619|NCT01298141|19160615|P1|Overall Study|Withdrawal by Subject|6
5543620|NCT01298141|19160615|P1|Overall Study|Refusal of Required Study Procedures|1
5543621|NCT01298141|19160615|P1|Overall Study|Adverse Event|3
5543622|NCT01297920|19160690|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
5543623|NCT01297920|19160691|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
5543624|NCT01297920|19160692|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
5543625|NCT01297920|19160690|P3|Overall Study|Inadequate Control of IOP|17
5543626|NCT01297920|19160691|P2|Overall Study|Inadequate Control of IOP|9
5543627|NCT01297920|19160692|P1|Overall Study|Inadequate Control of IOP|7
5543628|NCT01297920|19160690|P3|Overall Study|Protocol Violation|0
5543629|NCT01297920|19160691|P2|Overall Study|Protocol Violation|3
5543630|NCT01297920|19160692|P1|Overall Study|Protocol Violation|1
5543631|NCT01297920|19160690|P3|Overall Study|Noncompliance|0
5543632|NCT01297920|19160691|P2|Overall Study|Noncompliance|0
5543633|NCT01297920|19160692|P1|Overall Study|Noncompliance|1
5543634|NCT01297920|19160690|P3|Overall Study|Patient Decision Unrelated to AE|2
5543635|NCT01297920|19160691|P2|Overall Study|Patient Decision Unrelated to AE|5
5543636|NCT01297920|19160692|P1|Overall Study|Patient Decision Unrelated to AE|6
5543637|NCT01297920|19160690|P3|Overall Study|Adverse Event|38
5543638|NCT01297920|19160691|P2|Overall Study|Adverse Event|10
5543639|NCT01297920|19160692|P1|Overall Study|Adverse Event|42
5543640|NCT01297517|19160736|P3|Overall Study|Inadequate Control of IOP|2
5543641|NCT01297517|19160737|P2|Overall Study|Inadequate Control of IOP|1
5543642|NCT01297517|19160738|P1|Overall Study|Inadequate Control of IOP|1
5543643|NCT01297517|19160736|P3|Overall Study|Protocol Violation|1
5543644|NCT01297517|19160737|P2|Overall Study|Protocol Violation|1
5543645|NCT01297517|19160738|P1|Overall Study|Protocol Violation|1
5543646|NCT01297517|19160736|P3|Overall Study|Noncompliance|0
5543647|NCT01297517|19160737|P2|Overall Study|Noncompliance|0
5543648|NCT01297517|19160738|P1|Overall Study|Noncompliance|1
5543649|NCT01297517|19160736|P3|Overall Study|Patient Decision Unrelated to AE|7
5543650|NCT01297517|19160737|P2|Overall Study|Patient Decision Unrelated to AE|3
5543651|NCT01297517|19160738|P1|Overall Study|Patient Decision Unrelated to AE|2
5543652|NCT01297517|19160736|P3|Overall Study|Lost to Follow-up|1
5543653|NCT01297517|19160737|P2|Overall Study|Lost to Follow-up|0
5543654|NCT01297517|19160738|P1|Overall Study|Lost to Follow-up|1
5543655|NCT01297517|19160736|P3|Overall Study|Adverse Event|16
5543656|NCT01297517|19160737|P2|Overall Study|Adverse Event|7
5543657|NCT01297517|19160738|P1|Overall Study|Adverse Event|21
5543658|NCT01297504|19160746|P1|Overall Study|Protocol Violation|3
5543659|NCT01297504|19160746|P1|Overall Study|Site Closure|3
5543660|NCT01297504|19160746|P1|Overall Study|Withdrawal by Subject|9
5543661|NCT01297504|19160746|P1|Overall Study|Lost to Follow-up|43
5543662|NCT01297504|19160746|P1|Overall Study|Death|3
5543663|NCT01297504|19160746|P1|Overall Study|No Study Visits|4
5543664|NCT01297504|19160746|P1|Overall Study|Received Palivizumab in Previous Season|1
5543665|NCT01297504|19160746|P1|Overall Study|Invalid Consent|1
5543666|NCT01297491|19160760|P2|Overall Study|Death|1
5543667|NCT01297491|19160761|P1|Overall Study|Death|2
5543668|NCT01297491|19160760|P2|Overall Study|Patient/Guardian decision|4
5543669|NCT01297491|19160761|P1|Overall Study|Patient/Guardian decision|3
5543670|NCT01297491|19160760|P2|Overall Study|Progressive disease|20
5543671|NCT01297491|19160761|P1|Overall Study|Progressive disease|11
5543672|NCT01297491|19160760|P2|Overall Study|Physician Decision|2
5543673|NCT01297491|19160761|P1|Overall Study|Physician Decision|3
5543674|NCT01297491|19160760|P2|Overall Study|Adverse Event|6
5543675|NCT01297491|19160761|P1|Overall Study|Adverse Event|11
5543676|NCT01297465|19160779|P2|Overall Study|Intention to Freeze all Embryos|1
5543677|NCT01297465|19160780|P1|Overall Study|Intention to Freeze all Embryos|0
5543678|NCT01297465|19160779|P2|Overall Study|All Embryos Discarded|1
5543679|NCT01297465|19160780|P1|Overall Study|All Embryos Discarded|0
5543680|NCT01297465|19160779|P2|Overall Study|No Fertilization|4
5543681|NCT01297465|19160780|P1|Overall Study|No Fertilization|6
5543682|NCT01297465|19160779|P2|Overall Study|Poor oocyte quality|1
5543683|NCT01297465|19160780|P1|Overall Study|Poor oocyte quality|0
5543684|NCT01297465|19160779|P2|Overall Study|No Oocytes Retrieved|1
5543685|NCT01297465|19160780|P1|Overall Study|No Oocytes Retrieved|1
5543686|NCT01297465|19160779|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
5543687|NCT01297465|19160780|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
5543688|NCT01297465|19160779|P2|Overall Study|Lack of Ovarian Response|1
5543689|NCT01297465|19160780|P1|Overall Study|Lack of Ovarian Response|1
5543690|NCT01297322|19160833|P2|Overall Study|Protocol Violation|3
5543691|NCT01297322|19160834|P1|Overall Study|Protocol Violation|0
5543692|NCT01297322|19160833|P2|Overall Study|Withdrawal by Subject|1
5543693|NCT01297322|19160834|P1|Overall Study|Withdrawal by Subject|0
5543694|NCT01297322|19160833|P2|Overall Study|Lost to Follow-up|0
5543695|NCT01297322|19160834|P1|Overall Study|Lost to Follow-up|1
5543696|NCT01297309|19160853|P1|Overall Study|Participant not entering extensionperiod|1
5543697|NCT01297309|19160853|P1|Overall Study|Death|1
5543698|NCT01297309|19160853|P1|Overall Study|Investigator Decision|2
5543699|NCT01297309|19160853|P1|Overall Study|Adverse Event|1
5543700|NCT01297309|19160853|P1|Overall Study|Withdrawal by Subject|5
5543701|NCT01297309|19160853|P1|Overall Study|Screen failure|2
5543702|NCT01297309|19160853|P1|Overall Study|Eligibility failure|2
5543703|NCT01297270|19160878|P3|Overall Study|Not treated|0
5543704|NCT01297270|19160879|P2|Overall Study|Not treated|1
5543705|NCT01297270|19160880|P1|Overall Study|Not treated|0
5543706|NCT01297270|19160878|P3|Overall Study|Other reason not defined above|1
5543707|NCT01297270|19160879|P2|Overall Study|Other reason not defined above|3
5543708|NCT01297270|19160880|P1|Overall Study|Other reason not defined above|3
5543709|NCT01297270|19160878|P3|Overall Study|Withdrawal by Subject|7
5543710|NCT01297270|19160879|P2|Overall Study|Withdrawal by Subject|15
5543711|NCT01297270|19160880|P1|Overall Study|Withdrawal by Subject|7
5543712|NCT01297270|19160878|P3|Overall Study|Protocol Violation|0
5543713|NCT01297270|19160879|P2|Overall Study|Protocol Violation|2
5543714|NCT01297270|19160880|P1|Overall Study|Protocol Violation|0
5543715|NCT01297270|19160878|P3|Overall Study|Lost to Follow-up|1
5543716|NCT01297270|19160879|P2|Overall Study|Lost to Follow-up|2
5543717|NCT01297270|19160880|P1|Overall Study|Lost to Follow-up|1
5543718|NCT01297270|19160878|P3|Overall Study|Lack of Efficacy|15
5543719|NCT01297270|19160879|P2|Overall Study|Lack of Efficacy|17
5543720|NCT01297270|19160880|P1|Overall Study|Lack of Efficacy|15
5543721|NCT01297270|19160878|P3|Overall Study|Adverse Event|5
5543722|NCT01297270|19160879|P2|Overall Study|Adverse Event|32
5543723|NCT01297270|19160880|P1|Overall Study|Adverse Event|19
5543724|NCT01297244|19160925|P2|Overall Study|Withdrawal by Subject|0
5543725|NCT01297244|19160926|P1|Overall Study|Withdrawal by Subject|2
5543726|NCT01297244|19160925|P2|Overall Study|Clinical progression|1
5543727|NCT01297244|19160926|P1|Overall Study|Clinical progression|1
5543728|NCT01297244|19160925|P2|Overall Study|Death|1
5543729|NCT01297244|19160926|P1|Overall Study|Death|1
5543730|NCT01297244|19160925|P2|Overall Study|Adverse Event|1
5543731|NCT01297244|19160926|P1|Overall Study|Adverse Event|9
5543732|NCT01297244|19160925|P2|Overall Study|Progressive disease|3
5543733|NCT01297244|19160926|P1|Overall Study|Progressive disease|22
5543734|NCT01297062|19160946|P7|Overall Study|Subject Decision|2
5543735|NCT01297062|19160947|P6|Overall Study|Subject Decision|1
5543736|NCT01297062|19160948|P5|Overall Study|Subject Decision|1
5543737|NCT01297062|19160949|P4|Overall Study|Subject Decision|1
5543738|NCT01297062|19160950|P3|Overall Study|Subject Decision|0
5543739|NCT01297062|19160951|P2|Overall Study|Subject Decision|1
5543740|NCT01297062|19160952|P1|Overall Study|Subject Decision|1
5543741|NCT01297062|19160946|P7|Overall Study|Protocol Violation|0
5543742|NCT01297062|19160947|P6|Overall Study|Protocol Violation|0
5543743|NCT01297062|19160948|P5|Overall Study|Protocol Violation|1
5543744|NCT01297062|19160949|P4|Overall Study|Protocol Violation|0
5543745|NCT01297062|19160950|P3|Overall Study|Protocol Violation|0
5543746|NCT01297062|19160951|P2|Overall Study|Protocol Violation|0
5543747|NCT01297062|19160952|P1|Overall Study|Protocol Violation|0
5543748|NCT01297062|19160946|P7|Overall Study|Physician Decision|6
5543749|NCT01297062|19160947|P6|Overall Study|Physician Decision|0
5543750|NCT01297062|19160948|P5|Overall Study|Physician Decision|0
5543751|NCT01297062|19160949|P4|Overall Study|Physician Decision|0
5543752|NCT01297062|19160950|P3|Overall Study|Physician Decision|1
5543753|NCT01297062|19160951|P2|Overall Study|Physician Decision|0
5543754|NCT01297062|19160952|P1|Overall Study|Physician Decision|1
5543755|NCT01297062|19160946|P7|Overall Study|Adverse Event|0
5543756|NCT01297062|19160947|P6|Overall Study|Adverse Event|0
5543757|NCT01297062|19160948|P5|Overall Study|Adverse Event|0
5543758|NCT01297062|19160949|P4|Overall Study|Adverse Event|0
5543759|NCT01297062|19160950|P3|Overall Study|Adverse Event|1
5543760|NCT01297062|19160951|P2|Overall Study|Adverse Event|0
5543761|NCT01297062|19160952|P1|Overall Study|Adverse Event|2
5543762|NCT01296932|19160983|P9|Overall Study|Dosage already reduced, AE still present|1
5543763|NCT01296932|19160984|P8|Overall Study|Dosage already reduced, AE still present|0
5543764|NCT01296932|19160985|P7|Overall Study|Dosage already reduced, AE still present|0
5543765|NCT01296932|19160986|P6|Overall Study|Dosage already reduced, AE still present|0
5543766|NCT01296932|19160987|P5|Overall Study|Dosage already reduced, AE still present|0
5543767|NCT01296932|19160988|P4|Overall Study|Dosage already reduced, AE still present|0
5543768|NCT01296932|19160989|P3|Overall Study|Dosage already reduced, AE still present|0
5543769|NCT01296932|19160990|P2|Overall Study|Dosage already reduced, AE still present|0
5543770|NCT01296932|19160991|P1|Overall Study|Dosage already reduced, AE still present|0
5543771|NCT01296932|19160983|P9|Overall Study|No adequate treatment response|0
5543772|NCT01296932|19160984|P8|Overall Study|No adequate treatment response|1
5543773|NCT01296932|19160985|P7|Overall Study|No adequate treatment response|0
5543774|NCT01296932|19160986|P6|Overall Study|No adequate treatment response|0
5543775|NCT01296932|19160987|P5|Overall Study|No adequate treatment response|0
5543776|NCT01296932|19160988|P4|Overall Study|No adequate treatment response|0
5543777|NCT01296932|19160989|P3|Overall Study|No adequate treatment response|0
5543778|NCT01296932|19160990|P2|Overall Study|No adequate treatment response|0
5543779|NCT01296932|19160991|P1|Overall Study|No adequate treatment response|0
5543780|NCT01296932|19160983|P9|Overall Study|Low benefit and too many side effects|0
5543781|NCT01296932|19160984|P8|Overall Study|Low benefit and too many side effects|1
5543782|NCT01296932|19160985|P7|Overall Study|Low benefit and too many side effects|0
5543783|NCT01296932|19160986|P6|Overall Study|Low benefit and too many side effects|0
5543784|NCT01296932|19160987|P5|Overall Study|Low benefit and too many side effects|0
5543785|NCT01296932|19160988|P4|Overall Study|Low benefit and too many side effects|0
5543786|NCT01296932|19160989|P3|Overall Study|Low benefit and too many side effects|0
5543787|NCT01296932|19160990|P2|Overall Study|Low benefit and too many side effects|0
5543788|NCT01296932|19160991|P1|Overall Study|Low benefit and too many side effects|0
5543789|NCT01296932|19160983|P9|Overall Study|per protocol|0
5543790|NCT01296932|19160984|P8|Overall Study|per protocol|0
5543791|NCT01296932|19160985|P7|Overall Study|per protocol|0
5543792|NCT01296932|19160986|P6|Overall Study|per protocol|0
5543793|NCT01296932|19160987|P5|Overall Study|per protocol|0
5543794|NCT01296932|19160988|P4|Overall Study|per protocol|1
5543795|NCT01296932|19160989|P3|Overall Study|per protocol|1
5543796|NCT01296932|19160990|P2|Overall Study|per protocol|0
5543797|NCT01296932|19160991|P1|Overall Study|per protocol|0
5543798|NCT01296932|19160983|P9|Overall Study|IV problems, administration not possible|0
5543799|NCT01296932|19160984|P8|Overall Study|IV problems, administration not possible|0
5543800|NCT01296932|19160985|P7|Overall Study|IV problems, administration not possible|0
5543801|NCT01296932|19160986|P6|Overall Study|IV problems, administration not possible|0
5543802|NCT01296932|19160987|P5|Overall Study|IV problems, administration not possible|0
5543803|NCT01296932|19160988|P4|Overall Study|IV problems, administration not possible|0
5543804|NCT01296932|19160989|P3|Overall Study|IV problems, administration not possible|1
5543805|NCT01296932|19160990|P2|Overall Study|IV problems, administration not possible|0
5543806|NCT01296932|19160991|P1|Overall Study|IV problems, administration not possible|0
5543807|NCT01296932|19160983|P9|Overall Study|Physician Decision|0
5543808|NCT01296932|19160984|P8|Overall Study|Physician Decision|0
5543809|NCT01296932|19160985|P7|Overall Study|Physician Decision|0
5543810|NCT01296932|19160986|P6|Overall Study|Physician Decision|0
5543811|NCT01296932|19160987|P5|Overall Study|Physician Decision|0
5543812|NCT01296932|19160988|P4|Overall Study|Physician Decision|0
5543813|NCT01296932|19160989|P3|Overall Study|Physician Decision|1
5543814|NCT01296932|19160990|P2|Overall Study|Physician Decision|0
5543815|NCT01296932|19160991|P1|Overall Study|Physician Decision|0
5543816|NCT01296932|19160983|P9|Overall Study|No clinical benefit anymore|0
5543817|NCT01296932|19160984|P8|Overall Study|No clinical benefit anymore|0
5543818|NCT01296932|19160985|P7|Overall Study|No clinical benefit anymore|0
5543819|NCT01296932|19160986|P6|Overall Study|No clinical benefit anymore|0
5543820|NCT01296932|19160987|P5|Overall Study|No clinical benefit anymore|0
5543821|NCT01296932|19160988|P4|Overall Study|No clinical benefit anymore|0
5543822|NCT01296932|19160989|P3|Overall Study|No clinical benefit anymore|0
5543823|NCT01296932|19160990|P2|Overall Study|No clinical benefit anymore|1
5543824|NCT01296932|19160991|P1|Overall Study|No clinical benefit anymore|0
5543825|NCT01296932|19160983|P9|Overall Study|Investigator decision|1
5543826|NCT01296932|19160984|P8|Overall Study|Investigator decision|0
5543827|NCT01296932|19160985|P7|Overall Study|Investigator decision|1
5543828|NCT01296932|19160986|P6|Overall Study|Investigator decision|0
5543829|NCT01296932|19160987|P5|Overall Study|Investigator decision|0
5543830|NCT01296932|19160988|P4|Overall Study|Investigator decision|1
5543831|NCT01296932|19160989|P3|Overall Study|Investigator decision|0
5543832|NCT01296932|19160990|P2|Overall Study|Investigator decision|1
5543833|NCT01296932|19160991|P1|Overall Study|Investigator decision|0
5543834|NCT01296932|19160983|P9|Overall Study|Adverse Event|1
5543835|NCT01296932|19160984|P8|Overall Study|Adverse Event|0
5543836|NCT01296932|19160985|P7|Overall Study|Adverse Event|0
5543837|NCT01296932|19160986|P6|Overall Study|Adverse Event|0
5543838|NCT01296932|19160987|P5|Overall Study|Adverse Event|1
5543839|NCT01296932|19160988|P4|Overall Study|Adverse Event|2
5543840|NCT01296932|19160989|P3|Overall Study|Adverse Event|1
5543841|NCT01296932|19160990|P2|Overall Study|Adverse Event|1
5543842|NCT01296932|19160991|P1|Overall Study|Adverse Event|1
5543843|NCT01296932|19160983|P9|Overall Study|Withdrawal by Subject|0
5543844|NCT01296932|19160984|P8|Overall Study|Withdrawal by Subject|0
5543845|NCT01296932|19160985|P7|Overall Study|Withdrawal by Subject|3
5543846|NCT01296932|19160986|P6|Overall Study|Withdrawal by Subject|0
5543847|NCT01296932|19160987|P5|Overall Study|Withdrawal by Subject|0
5543848|NCT01296932|19160988|P4|Overall Study|Withdrawal by Subject|1
5543849|NCT01296932|19160989|P3|Overall Study|Withdrawal by Subject|1
5543850|NCT01296932|19160990|P2|Overall Study|Withdrawal by Subject|0
5543851|NCT01296932|19160991|P1|Overall Study|Withdrawal by Subject|0
5543852|NCT01296932|19160983|P9|Overall Study|Progressive disease|0
5543853|NCT01296932|19160984|P8|Overall Study|Progressive disease|0
5543854|NCT01296932|19160985|P7|Overall Study|Progressive disease|1
5543855|NCT01296932|19160986|P6|Overall Study|Progressive disease|3
5543856|NCT01296932|19160987|P5|Overall Study|Progressive disease|2
5543857|NCT01296932|19160988|P4|Overall Study|Progressive disease|1
5543858|NCT01296932|19160989|P3|Overall Study|Progressive disease|1
5543859|NCT01296932|19160990|P2|Overall Study|Progressive disease|0
5543860|NCT01296932|19160991|P1|Overall Study|Progressive disease|2
5543861|NCT01296932|19160983|P9|Overall Study|Dose limiting toxicity|1
5543862|NCT01296932|19160984|P8|Overall Study|Dose limiting toxicity|0
5543863|NCT01296932|19160985|P7|Overall Study|Dose limiting toxicity|1
5543864|NCT01296932|19160986|P6|Overall Study|Dose limiting toxicity|0
5543865|NCT01296932|19160987|P5|Overall Study|Dose limiting toxicity|0
5543866|NCT01296932|19160988|P4|Overall Study|Dose limiting toxicity|0
5543867|NCT01296932|19160989|P3|Overall Study|Dose limiting toxicity|0
5543868|NCT01296932|19160990|P2|Overall Study|Dose limiting toxicity|0
5543869|NCT01296932|19160991|P1|Overall Study|Dose limiting toxicity|0
5543870|NCT01296698|19161115|P2|Overall Study|Study Terminated by Sponsor|12
5543871|NCT01296698|19161116|P1|Overall Study|Study Terminated by Sponsor|209
5543872|NCT01296698|19161115|P2|Overall Study|Difficulty Contacting Subject|0
5543873|NCT01296698|19161116|P1|Overall Study|Difficulty Contacting Subject|2
5543874|NCT01296698|19161115|P2|Overall Study|Withdrawal by Subject|0
5543875|NCT01296698|19161116|P1|Overall Study|Withdrawal by Subject|12
5543876|NCT01296698|19161115|P2|Overall Study|Lost to Follow-up|1
5543877|NCT01296698|19161116|P1|Overall Study|Lost to Follow-up|19
5543878|NCT01296698|19161115|P2|Overall Study|Death|0
5543879|NCT01296698|19161116|P1|Overall Study|Death|1
5543880|NCT01296698|19161115|P2|Overall Study|Adverse Event|0
5543881|NCT01296698|19161116|P1|Overall Study|Adverse Event|1
5543882|NCT01296672|19161170|P2|Overall Study|Lost to Follow-up|18
5543883|NCT01296672|19161171|P1|Overall Study|Lost to Follow-up|73
5543884|NCT01296568|19161192|P1|Continued Access Phase|Disease Progression|1
5543885|NCT01296568|19161192|P1|Continued Access Phase|Withdrawal by Subject|1
5543886|NCT01296568|19161192|P1|Continued Access Phase|Lost to Follow-up|1
5543887|NCT01296412|19161217|P2|Overall Study|Withdrawal by Subject|13
5543888|NCT01296412|19161218|P1|Overall Study|Withdrawal by Subject|10
5543889|NCT01296412|19161217|P2|Overall Study|Pregnancy|1
5543890|NCT01296412|19161218|P1|Overall Study|Pregnancy|0
5543891|NCT01296412|19161217|P2|Overall Study|Physician Decision|3
5543892|NCT01296412|19161218|P1|Overall Study|Physician Decision|1
5543893|NCT01296412|19161217|P2|Overall Study|Other reason not specified|15
5543894|NCT01296412|19161218|P1|Overall Study|Other reason not specified|20
5543895|NCT01296412|19161217|P2|Overall Study|Non-compliance with study drug|2
5543896|NCT01296412|19161218|P1|Overall Study|Non-compliance with study drug|1
5543897|NCT01296412|19161217|P2|Overall Study|Lost to Follow-up|7
5543898|NCT01296412|19161218|P1|Overall Study|Lost to Follow-up|10
5543899|NCT01296412|19161217|P2|Overall Study|Lack of Efficacy|0
5543900|NCT01296412|19161218|P1|Overall Study|Lack of Efficacy|1
5543901|NCT01296412|19161217|P2|Overall Study|Adverse Event|29
5543902|NCT01296412|19161218|P1|Overall Study|Adverse Event|8
5543903|NCT01296347|19161241|P2|12 Month Follow up|Withdrawal by Subject|1
5543904|NCT01296347|19161242|P1|12 Month Follow up|Withdrawal by Subject|0
5543905|NCT01296347|19161241|P2|12 Month Follow up|Death|1
5543906|NCT01296347|19161242|P1|12 Month Follow up|Death|1
5543907|NCT01296347|19161241|P2|12 Month Follow up|Lost to Follow-up|1
5543908|NCT01296347|19161242|P1|12 Month Follow up|Lost to Follow-up|3
5543909|NCT01296347|19161241|P2|6 Month Follow up|Lost to Follow-up|1
5543910|NCT01296347|19161242|P1|6 Month Follow up|Lost to Follow-up|0
5543911|NCT01296347|19161241|P2|6 Month Follow up|Death|1
5543912|NCT01296347|19161242|P1|6 Month Follow up|Death|2
5543913|NCT01296347|19161241|P2|3 Month Follow up|Lost to Follow-up|1
5543914|NCT01296347|19161242|P1|3 Month Follow up|Lost to Follow-up|0
5543915|NCT01296347|19161241|P2|3 Month Follow up|Death|0
5543916|NCT01296347|19161242|P1|3 Month Follow up|Death|1
5543917|NCT01296347|19161241|P2|6 Week Follow up|Death|1
5543918|NCT01296347|19161242|P1|6 Week Follow up|Death|0
5543919|NCT01296347|19161241|P2|Allocation|not received infusion|0
5543920|NCT01296347|19161242|P1|Allocation|not received infusion|1
5543921|NCT01296347|19161241|P2|Allocation|Lack of Efficacy|2
5543922|NCT01296347|19161242|P1|Allocation|Lack of Efficacy|1
5543923|NCT01296347|19161241|P2|Allocation|Withdrawal by Subject|2
5543924|NCT01296347|19161242|P1|Allocation|Withdrawal by Subject|1
5543925|NCT01296152|19161267|P1|Overall Study|Unwilling to adhere to study requirement|1
5543926|NCT01296035|19161294|P1|Overall Study|Withdrawal by Subject|1
5543927|NCT01295905|19161301|P2|Overall Study|Met exclusion criteria|0
5543928|NCT01295905|19161302|P1|Overall Study|Met exclusion criteria|1
5543929|NCT01295905|19161301|P2|Overall Study|Did not meet inclusion criteria|0
5543930|NCT01295905|19161302|P1|Overall Study|Did not meet inclusion criteria|1
5543931|NCT01295827|19161346|P15|Overall Study|Other|0
5543932|NCT01295827|19161347|P14|Overall Study|Other|0
5543933|NCT01295827|19161348|P13|Overall Study|Other|0
5543934|NCT01295827|19161349|P12|Overall Study|Other|0
5543935|NCT01295827|19161350|P11|Overall Study|Other|2
5543936|NCT01295827|19161351|P10|Overall Study|Other|0
5543937|NCT01295827|19161352|P9|Overall Study|Other|1
5543938|NCT01295827|19161353|P8|Overall Study|Other|1
5543939|NCT01295827|19161354|P7|Overall Study|Other|1
5543940|NCT01295827|19161355|P6|Overall Study|Other|0
5543941|NCT01295827|19161356|P5|Overall Study|Other|0
5543942|NCT01295827|19161357|P4|Overall Study|Other|0
5543943|NCT01295827|19161358|P3|Overall Study|Other|0
5543944|NCT01295827|19161359|P2|Overall Study|Other|0
5543945|NCT01295827|19161360|P1|Overall Study|Other|0
5543946|NCT01295827|19161346|P15|Overall Study|Withdrawal by Subject|0
5543947|NCT01295827|19161347|P14|Overall Study|Withdrawal by Subject|0
5543948|NCT01295827|19161348|P13|Overall Study|Withdrawal by Subject|0
5543949|NCT01295827|19161349|P12|Overall Study|Withdrawal by Subject|13
5543950|NCT01295827|19161350|P11|Overall Study|Withdrawal by Subject|18
5543951|NCT01295827|19161351|P10|Overall Study|Withdrawal by Subject|2
5543952|NCT01295827|19161352|P9|Overall Study|Withdrawal by Subject|11
5543953|NCT01295827|19161353|P8|Overall Study|Withdrawal by Subject|35
5543954|NCT01295827|19161354|P7|Overall Study|Withdrawal by Subject|13
5543955|NCT01295827|19161355|P6|Overall Study|Withdrawal by Subject|1
5543956|NCT01295827|19161356|P5|Overall Study|Withdrawal by Subject|0
5543957|NCT01295827|19161357|P4|Overall Study|Withdrawal by Subject|0
5543958|NCT01295827|19161358|P3|Overall Study|Withdrawal by Subject|2
5543959|NCT01295827|19161359|P2|Overall Study|Withdrawal by Subject|0
5543960|NCT01295827|19161360|P1|Overall Study|Withdrawal by Subject|1
5543961|NCT01295827|19161346|P15|Overall Study|Screen Failure|0
5543962|NCT01295827|19161347|P14|Overall Study|Screen Failure|0
5543963|NCT01295827|19161348|P13|Overall Study|Screen Failure|0
5543964|NCT01295827|19161349|P12|Overall Study|Screen Failure|0
5543965|NCT01295827|19161350|P11|Overall Study|Screen Failure|1
5543966|NCT01295827|19161351|P10|Overall Study|Screen Failure|0
5543967|NCT01295827|19161352|P9|Overall Study|Screen Failure|2
5543968|NCT01295827|19161353|P8|Overall Study|Screen Failure|2
5543969|NCT01295827|19161354|P7|Overall Study|Screen Failure|2
5543970|NCT01295827|19161355|P6|Overall Study|Screen Failure|0
5543971|NCT01295827|19161356|P5|Overall Study|Screen Failure|0
5543972|NCT01295827|19161357|P4|Overall Study|Screen Failure|0
5543973|NCT01295827|19161358|P3|Overall Study|Screen Failure|0
5543974|NCT01295827|19161359|P2|Overall Study|Screen Failure|0
5543975|NCT01295827|19161360|P1|Overall Study|Screen Failure|0
5543976|NCT01295827|19161346|P15|Overall Study|Progressive Disease|0
5543977|NCT01295827|19161347|P14|Overall Study|Progressive Disease|0
5543978|NCT01295827|19161348|P13|Overall Study|Progressive Disease|0
5543979|NCT01295827|19161349|P12|Overall Study|Progressive Disease|136
5543980|NCT01295827|19161350|P11|Overall Study|Progressive Disease|175
5543981|NCT01295827|19161351|P10|Overall Study|Progressive Disease|40
5543982|NCT01295827|19161352|P9|Overall Study|Progressive Disease|85
5543983|NCT01295827|19161353|P8|Overall Study|Progressive Disease|144
5543984|NCT01295827|19161354|P7|Overall Study|Progressive Disease|87
5543985|NCT01295827|19161355|P6|Overall Study|Progressive Disease|1
5543986|NCT01295827|19161356|P5|Overall Study|Progressive Disease|0
5543987|NCT01295827|19161357|P4|Overall Study|Progressive Disease|2
5543988|NCT01295827|19161358|P3|Overall Study|Progressive Disease|5
5543989|NCT01295827|19161359|P2|Overall Study|Progressive Disease|1
5543990|NCT01295827|19161360|P1|Overall Study|Progressive Disease|2
5543991|NCT01295827|19161346|P15|Overall Study|Not Reported|0
5543992|NCT01295827|19161347|P14|Overall Study|Not Reported|0
5543993|NCT01295827|19161348|P13|Overall Study|Not Reported|0
5543994|NCT01295827|19161349|P12|Overall Study|Not Reported|13
5543995|NCT01295827|19161350|P11|Overall Study|Not Reported|23
5543996|NCT01295827|19161351|P10|Overall Study|Not Reported|2
5543997|NCT01295827|19161352|P9|Overall Study|Not Reported|41
5543998|NCT01295827|19161353|P8|Overall Study|Not Reported|58
5543999|NCT01295827|19161354|P7|Overall Study|Not Reported|24
5544000|NCT01295827|19161355|P6|Overall Study|Not Reported|0
5544001|NCT01295827|19161356|P5|Overall Study|Not Reported|0
5544002|NCT01295827|19161357|P4|Overall Study|Not Reported|1
5544003|NCT01295827|19161358|P3|Overall Study|Not Reported|0
5544004|NCT01295827|19161359|P2|Overall Study|Not Reported|0
5544005|NCT01295827|19161360|P1|Overall Study|Not Reported|0
5544006|NCT01295827|19161346|P15|Overall Study|Lost to Follow-up|0
5544007|NCT01295827|19161347|P14|Overall Study|Lost to Follow-up|0
5544008|NCT01295827|19161348|P13|Overall Study|Lost to Follow-up|0
5544009|NCT01295827|19161349|P12|Overall Study|Lost to Follow-up|3
5544010|NCT01295827|19161350|P11|Overall Study|Lost to Follow-up|7
5544011|NCT01295827|19161351|P10|Overall Study|Lost to Follow-up|4
5544012|NCT01295827|19161352|P9|Overall Study|Lost to Follow-up|7
5544013|NCT01295827|19161353|P8|Overall Study|Lost to Follow-up|8
5544014|NCT01295827|19161354|P7|Overall Study|Lost to Follow-up|4
5544015|NCT01295827|19161355|P6|Overall Study|Lost to Follow-up|0
5544016|NCT01295827|19161356|P5|Overall Study|Lost to Follow-up|1
5544017|NCT01295827|19161357|P4|Overall Study|Lost to Follow-up|0
5544018|NCT01295827|19161358|P3|Overall Study|Lost to Follow-up|3
5544019|NCT01295827|19161359|P2|Overall Study|Lost to Follow-up|0
5544020|NCT01295827|19161360|P1|Overall Study|Lost to Follow-up|0
5544021|NCT01295827|19161346|P15|Overall Study|Adverse Event|0
5544022|NCT01295827|19161347|P14|Overall Study|Adverse Event|0
5544023|NCT01295827|19161348|P13|Overall Study|Adverse Event|0
5544024|NCT01295827|19161349|P12|Overall Study|Adverse Event|21
5544025|NCT01295827|19161350|P11|Overall Study|Adverse Event|50
5544026|NCT01295827|19161351|P10|Overall Study|Adverse Event|7
5544027|NCT01295827|19161352|P9|Overall Study|Adverse Event|22
5544028|NCT01295827|19161353|P8|Overall Study|Adverse Event|49
5544029|NCT01295827|19161354|P7|Overall Study|Adverse Event|15
5544030|NCT01295827|19161355|P6|Overall Study|Adverse Event|4
5544031|NCT01295827|19161356|P5|Overall Study|Adverse Event|1
5544032|NCT01295827|19161357|P4|Overall Study|Adverse Event|1
5544033|NCT01295827|19161358|P3|Overall Study|Adverse Event|2
5544034|NCT01295827|19161359|P2|Overall Study|Adverse Event|2
5544035|NCT01295827|19161360|P1|Overall Study|Adverse Event|1
5544036|NCT01295814|19161733|P2|Overall Study|Withdrawal by Subject|0
5544037|NCT01295814|19161734|P1|Overall Study|Withdrawal by Subject|2
5544038|NCT01295814|19161733|P2|Overall Study|Lack of Efficacy|2
5544039|NCT01295814|19161734|P1|Overall Study|Lack of Efficacy|0
5544040|NCT01295671|19161814|P3|Overall Study|Withdrawal by Subject|0
5544041|NCT01295671|19161815|P2|Overall Study|Withdrawal by Subject|1
5544042|NCT01295671|19161816|P1|Overall Study|Withdrawal by Subject|3
5544043|NCT01295671|19161814|P3|Overall Study|Lost to Follow-up|3
5544044|NCT01295671|19161815|P2|Overall Study|Lost to Follow-up|6
5544045|NCT01295671|19161816|P1|Overall Study|Lost to Follow-up|4
5544046|NCT01295320|19161862|P1|Overall Study|Unable to travel|1
5544047|NCT01295320|19161862|P1|Overall Study|Subject was bedridden|1
5544048|NCT01295320|19161862|P1|Overall Study|Withdrawal by Subject|2
5544049|NCT01295320|19161862|P1|Overall Study|Lost to Follow-up|4
5544050|NCT01295320|19161862|P1|Overall Study|Adverse Event|2
5544051|NCT01295281|19161879|P2|First Intervention (7 Days)|Death|1
5544052|NCT01295281|19161880|P1|First Intervention (7 Days)|Death|0
5544053|NCT01295034|19161918|P2|Overall Study|Lost to Follow-up|5
5544054|NCT01295034|19161919|P1|Overall Study|Lost to Follow-up|5
5544055|NCT01294917|19161927|P1|Overall Study|Inconvenience|1
5544056|NCT01294917|19161927|P1|Overall Study|Relocation|5
5544057|NCT01294800|19161937|P4|Overall Study|Did Not Meet Protocol Eligibility|0
5544058|NCT01294800|19161938|P3|Overall Study|Did Not Meet Protocol Eligibility|1
5544059|NCT01294800|19161939|P2|Overall Study|Did Not Meet Protocol Eligibility|1
5544060|NCT01294800|19161940|P1|Overall Study|Did Not Meet Protocol Eligibility|2
5544061|NCT01294800|19161937|P4|Overall Study|Non-compliance With Protocol|0
5544062|NCT01294800|19161938|P3|Overall Study|Non-compliance With Protocol|1
5544063|NCT01294800|19161939|P2|Overall Study|Non-compliance With Protocol|1
5544064|NCT01294800|19161940|P1|Overall Study|Non-compliance With Protocol|0
5544065|NCT01294800|19161937|P4|Overall Study|Lost to Follow-up|0
5544066|NCT01294800|19161938|P3|Overall Study|Lost to Follow-up|1
5544067|NCT01294800|19161939|P2|Overall Study|Lost to Follow-up|0
5544068|NCT01294800|19161940|P1|Overall Study|Lost to Follow-up|0
5544069|NCT01294800|19161937|P4|Overall Study|Subject Withdrew Consent|11
5544070|NCT01294800|19161938|P3|Overall Study|Subject Withdrew Consent|2
5544071|NCT01294800|19161939|P2|Overall Study|Subject Withdrew Consent|2
5544072|NCT01294800|19161940|P1|Overall Study|Subject Withdrew Consent|2
5544073|NCT01294800|19161937|P4|Overall Study|Adverse Event|5
5544074|NCT01294800|19161938|P3|Overall Study|Adverse Event|12
5544075|NCT01294800|19161939|P2|Overall Study|Adverse Event|6
5544076|NCT01294800|19161940|P1|Overall Study|Adverse Event|7
5544077|NCT01294787|19161966|P6|Period 3|Adverse Event|0
5544078|NCT01294787|19161967|P5|Period 3|Adverse Event|1
5544079|NCT01294787|19161968|P4|Period 3|Adverse Event|0
5544080|NCT01294787|19161969|P3|Period 3|Adverse Event|0
5544081|NCT01294787|19161970|P2|Period 3|Adverse Event|0
5544082|NCT01294787|19161971|P1|Period 3|Adverse Event|0
5544083|NCT01294787|19161966|P6|Period 2|No longer needs study drug|0
5544084|NCT01294787|19161967|P5|Period 2|No longer needs study drug|0
5544085|NCT01294787|19161968|P4|Period 2|No longer needs study drug|1
5544086|NCT01294787|19161969|P3|Period 2|No longer needs study drug|0
5544087|NCT01294787|19161970|P2|Period 2|No longer needs study drug|0
5544088|NCT01294787|19161971|P1|Period 2|No longer needs study drug|0
5544089|NCT01294787|19161966|P6|Period 2|Adverse Event|0
5544090|NCT01294787|19161967|P5|Period 2|Adverse Event|0
5544091|NCT01294787|19161968|P4|Period 2|Adverse Event|1
5544092|NCT01294787|19161969|P3|Period 2|Adverse Event|0
5544093|NCT01294787|19161970|P2|Period 2|Adverse Event|3
5544094|NCT01294787|19161971|P1|Period 2|Adverse Event|0
5544095|NCT01294787|19161966|P6|Period 1|Administrative problem|1
5544096|NCT01294787|19161967|P5|Period 1|Administrative problem|0
5544097|NCT01294787|19161968|P4|Period 1|Administrative problem|0
5544098|NCT01294787|19161969|P3|Period 1|Administrative problem|1
5544099|NCT01294787|19161970|P2|Period 1|Administrative problem|0
5544100|NCT01294787|19161971|P1|Period 1|Administrative problem|0
5544101|NCT01294787|19161966|P6|Period 1|Withdrawal by Subject|1
5544102|NCT01294787|19161967|P5|Period 1|Withdrawal by Subject|1
5544103|NCT01294787|19161968|P4|Period 1|Withdrawal by Subject|1
5544104|NCT01294787|19161969|P3|Period 1|Withdrawal by Subject|0
5544105|NCT01294787|19161970|P2|Period 1|Withdrawal by Subject|0
5544106|NCT01294787|19161971|P1|Period 1|Withdrawal by Subject|0
5544107|NCT01294787|19161966|P6|Period 1|Adverse Event|0
5544108|NCT01294787|19161967|P5|Period 1|Adverse Event|1
5544109|NCT01294787|19161968|P4|Period 1|Adverse Event|0
5544110|NCT01294787|19161969|P3|Period 1|Adverse Event|0
5544111|NCT01294787|19161970|P2|Period 1|Adverse Event|0
5544112|NCT01294787|19161971|P1|Period 1|Adverse Event|0
5544113|NCT01294696|19162062|P1|Overall Study|Site closure|52
5544114|NCT01294696|19162062|P1|Overall Study|Missing BPI Response|7
5544115|NCT01294696|19162062|P1|Overall Study|Protocol Violation|8
5544116|NCT01294696|19162062|P1|Overall Study|Screening failures|7
5544117|NCT01294683|19162076|P2|Post Crossover (Period III)|Withdrawal by Subject|2
5544118|NCT01294683|19162077|P1|Post Crossover (Period III)|Withdrawal by Subject|3
5544119|NCT01294683|19162076|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
5544120|NCT01294683|19162077|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
5544121|NCT01294683|19162076|P2|Post Crossover (Period III)|Lost to Follow-up|3
5544122|NCT01294683|19162077|P1|Post Crossover (Period III)|Lost to Follow-up|1
5544123|NCT01294683|19162076|P2|Post Crossover (Period III)|Adverse Event|6
5544124|NCT01294683|19162077|P1|Post Crossover (Period III)|Adverse Event|6
5544125|NCT01294683|19162076|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
5544126|NCT01294683|19162077|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
5544127|NCT01294683|19162076|P2|Precrossover (Periods I/II)|Technical Problems|1
5544128|NCT01294683|19162077|P1|Precrossover (Periods I/II)|Technical Problems|0
5544129|NCT01294683|19162076|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
5544130|NCT01294683|19162077|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
5544131|NCT01294683|19162076|P2|Precrossover (Periods I/II)|Protocol Violation|5
5544132|NCT01294683|19162077|P1|Precrossover (Periods I/II)|Protocol Violation|5
5544133|NCT01294683|19162076|P2|Precrossover (Periods I/II)|Physician Decision|0
5544134|NCT01294683|19162077|P1|Precrossover (Periods I/II)|Physician Decision|1
5544135|NCT01294683|19162076|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
5544136|NCT01294683|19162077|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
5544137|NCT01294683|19162076|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
5544138|NCT01294683|19162077|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
5544139|NCT01294683|19162076|P2|Precrossover (Periods I/II)|Adverse Event|52
5544140|NCT01294683|19162077|P1|Precrossover (Periods I/II)|Adverse Event|49
5544141|NCT01294644|19162130|P3|Overall Study|Miscellaneous Reason|4
5544142|NCT01294644|19162131|P2|Overall Study|Miscellaneous Reason|1
5544143|NCT01294644|19162132|P1|Overall Study|Miscellaneous Reason|2
5544144|NCT01294644|19162130|P3|Overall Study|Lost to Follow-up|5
5544145|NCT01294644|19162131|P2|Overall Study|Lost to Follow-up|2
5544146|NCT01294644|19162132|P1|Overall Study|Lost to Follow-up|3
5544147|NCT01294644|19162130|P3|Overall Study|Withdrawal by Subject|4
5544148|NCT01294644|19162131|P2|Overall Study|Withdrawal by Subject|7
5544149|NCT01294644|19162132|P1|Overall Study|Withdrawal by Subject|3
5544150|NCT01294644|19162130|P3|Overall Study|Adverse Event|1
5544151|NCT01294644|19162131|P2|Overall Study|Adverse Event|0
5544152|NCT01294644|19162132|P1|Overall Study|Adverse Event|2
5544153|NCT01294592|19162163|P2|Overall Study|Withdrawal by Subject|28
5544154|NCT01294592|19162164|P1|Overall Study|Withdrawal by Subject|28
5544155|NCT01294592|19162163|P2|Overall Study|Physician Decision|11
5544156|NCT01294592|19162164|P1|Overall Study|Physician Decision|6
5544157|NCT01294592|19162163|P2|Overall Study|Lost to Follow-up|9
5544158|NCT01294592|19162164|P1|Overall Study|Lost to Follow-up|7
5544159|NCT01294592|19162163|P2|Overall Study|Protocol Violation|7
5544160|NCT01294592|19162164|P1|Overall Study|Protocol Violation|1
5544161|NCT01294592|19162163|P2|Overall Study|Lack of Efficacy|5
5544162|NCT01294592|19162164|P1|Overall Study|Lack of Efficacy|7
5544163|NCT01294592|19162163|P2|Overall Study|Adverse Event|13
5544164|NCT01294592|19162164|P1|Overall Study|Adverse Event|28
5544165|NCT01294579|19162192|P1|Overall Study|Withdrawal by Subject|5
5544166|NCT01294579|19162192|P1|Overall Study|Physician Decision|3
5544167|NCT01294579|19162192|P1|Overall Study|Lost to Follow-up|1
5544938|NCT01288430|19164747|P5|Part 2|Other|0
5544168|NCT01294579|19162192|P1|Overall Study|Study closed/terminated|3
5544169|NCT01294579|19162192|P1|Overall Study|Adverse Event|11
5544170|NCT01294579|19162192|P1|Overall Study|Disease progression|12
5544171|NCT01294553|19162202|P1|Overall Study|Protocol Violation|268
5544172|NCT01294553|19162202|P1|Overall Study|Duplicated Participants|1
5544173|NCT01294514|19162208|P1|Overall Study|Excluded due to Arrhythmia|1
5544174|NCT01294462|19162218|P2|Overall Study|Withdrawal by Subject|63
5544175|NCT01294462|19162219|P1|Overall Study|Withdrawal by Subject|65
5544176|NCT01294462|19162218|P2|Overall Study|Lost to Follow-up|0
5544177|NCT01294462|19162219|P1|Overall Study|Lost to Follow-up|1
5544178|NCT01294449|19162233|P2|Overall Study|Withdrawal by Subject|3
5544179|NCT01294449|19162234|P1|Overall Study|Withdrawal by Subject|1
5544180|NCT01294449|19162233|P2|Overall Study|Death|12
5544181|NCT01294449|19162234|P1|Overall Study|Death|11
5544182|NCT01294436|19162242|P2|Overall Study|poor/non-compliance|5
5544183|NCT01294436|19162243|P1|Overall Study|poor/non-compliance|2
5544184|NCT01294436|19162242|P2|Overall Study|subject no longer meets study criteria|20
5544185|NCT01294436|19162243|P1|Overall Study|subject no longer meets study criteria|5
5544186|NCT01294436|19162242|P2|Overall Study|Withdrawal by Subject|28
5544187|NCT01294436|19162243|P1|Overall Study|Withdrawal by Subject|11
5544188|NCT01294436|19162242|P2|Overall Study|Adverse Event|17
5544189|NCT01294436|19162243|P1|Overall Study|Adverse Event|10
5544190|NCT01294423|19162278|P3|Overall Study|poor/non-compliance|1
5544191|NCT01294423|19162279|P2|Overall Study|poor/non-compliance|0
5544192|NCT01294423|19162280|P1|Overall Study|poor/non-compliance|1
5544193|NCT01294423|19162278|P3|Overall Study|subject no longer meets study criteria|2
5544194|NCT01294423|19162279|P2|Overall Study|subject no longer meets study criteria|5
5544195|NCT01294423|19162280|P1|Overall Study|subject no longer meets study criteria|2
5544196|NCT01294423|19162278|P3|Overall Study|Withdrawal by Subject|2
5544197|NCT01294423|19162279|P2|Overall Study|Withdrawal by Subject|2
5544198|NCT01294423|19162280|P1|Overall Study|Withdrawal by Subject|1
5544199|NCT01294423|19162278|P3|Overall Study|Adverse Event|3
5544200|NCT01294423|19162279|P2|Overall Study|Adverse Event|2
5544201|NCT01294423|19162280|P1|Overall Study|Adverse Event|1
5544202|NCT01294397|19162294|P1|Overall Study|Administrative Decision|1
5544203|NCT01294397|19162294|P1|Overall Study|Withdrawal by Subject|1
5544204|NCT01294371|19162338|P1|Overall Study|Other|14
5544205|NCT01294371|19162338|P1|Overall Study|Administrative Reason|1
5544206|NCT01294371|19162338|P1|Overall Study|Lost to Follow-up|6
5544207|NCT01294371|19162338|P1|Overall Study|Withdrawal by Subject|12
5544208|NCT01294371|19162338|P1|Overall Study|Adverse Event|1
5544209|NCT01294358|19162346|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
5544210|NCT01294358|19162347|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5544211|NCT01294358|19162348|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5544212|NCT01294358|19162349|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5544213|NCT01294358|19162350|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
5544214|NCT01294358|19162346|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5544215|NCT01294358|19162347|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
5544216|NCT01294358|19162348|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5544217|NCT01294358|19162349|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5544218|NCT01294358|19162350|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
5544219|NCT01294358|19162346|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5544220|NCT01294358|19162347|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5544221|NCT01294358|19162348|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
5544222|NCT01294358|19162349|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5544223|NCT01294358|19162350|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
5544224|NCT01294358|19162346|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5544225|NCT01294358|19162347|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5544226|NCT01294358|19162348|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5544227|NCT01294358|19162349|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
5544228|NCT01294358|19162350|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
5544229|NCT01294150|19162478|P2|Overall Study|Physician Decision|2
5544230|NCT01294150|19162479|P1|Overall Study|Physician Decision|2
5544231|NCT01294046|19162508|P1|Overall Study|Stimulation response inadqequate|1
5544232|NCT01294046|19162508|P1|Overall Study|Eligibility criteria expanded|1
5544233|NCT01294046|19162508|P1|Overall Study|Infection and surgical explant|1
5544234|NCT01293968|19162523|P2|Overall Study|non-cooperation|3
5544235|NCT01293968|19162524|P1|Overall Study|non-cooperation|3
5544236|NCT01293695|19162544|P2|Overall Study|Lost to Follow-up|6
5544237|NCT01293695|19162545|P1|Overall Study|Lost to Follow-up|8
5544238|NCT01293695|19162544|P2|Overall Study|Withdrawal by Subject|1
5544239|NCT01293695|19162545|P1|Overall Study|Withdrawal by Subject|7
5544240|NCT01293539|19162564|P1|Overall Study|Physician Decision|1
5544241|NCT01293240|19162568|P1|Overall Study|Noncompliance|2
5544242|NCT01293123|19162585|P2|Overall Study|Lost to Follow-up|1
5544243|NCT01293123|19162586|P1|Overall Study|Lost to Follow-up|0
5544244|NCT01293084|19162600|P1|Overall Study|Withdrawal by Subject|2
5544245|NCT01293084|19162600|P1|Overall Study|Physician Decision|3
5544246|NCT01293032|19162612|P4|Treatment|Disease Progression, relapse|0
5544247|NCT01293032|19162613|P3|Treatment|Disease Progression, relapse|0
5544248|NCT01293032|19162614|P2|Treatment|Disease Progression, relapse|1
5544249|NCT01293032|19162615|P1|Treatment|Disease Progression, relapse|0
5544250|NCT01293032|19162612|P4|Treatment|Withdrawal by Subject|0
5544939|NCT01288430|19164748|P4|Part 2|Other|0
5544251|NCT01293032|19162613|P3|Treatment|Withdrawal by Subject|0
5544252|NCT01293032|19162614|P2|Treatment|Withdrawal by Subject|4
5544253|NCT01293032|19162615|P1|Treatment|Withdrawal by Subject|2
5544254|NCT01293032|19162612|P4|Treatment|Adverse Event|1
5544255|NCT01293032|19162613|P3|Treatment|Adverse Event|1
5544256|NCT01293032|19162614|P2|Treatment|Adverse Event|0
5544257|NCT01293032|19162615|P1|Treatment|Adverse Event|0
5544258|NCT01293032|19162612|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
5544259|NCT01293032|19162613|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
5544260|NCT01293032|19162614|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
5544261|NCT01293032|19162615|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
5544262|NCT01293006|19162626|P4|Period 2|Lost to Follow-up|0
5544263|NCT01293006|19162627|P3|Period 2|Lost to Follow-up|0
5544264|NCT01293006|19162628|P2|Period 2|Lost to Follow-up|0
5544265|NCT01293006|19162629|P1|Period 2|Lost to Follow-up|1
5544266|NCT01292928|19162650|P1|Overall Study|Physician Decision|2
5544267|NCT01292928|19162650|P1|Overall Study|Lost to Follow-up|6
5544268|NCT01292928|19162650|P1|Overall Study|Withdrawal by Subject|8
5544269|NCT01292928|19162650|P1|Overall Study|Death|8
5544270|NCT01292876|19162667|P1|Overall Study|Physician Decision|4
5544271|NCT01292837|19162673|P1|Overall Study|Further treatment determined|1
5544272|NCT01292837|19162673|P1|Overall Study|Adverse Event|1
5544273|NCT01292603|19162710|P6|Overall Survival Status|Death|10
5544274|NCT01292603|19162711|P5|Overall Survival Status|Death|16
5544275|NCT01292603|19162712|P4|Overall Survival Status|Death|1
5544276|NCT01292603|19162713|P3|Overall Survival Status|Death|3
5544277|NCT01292603|19162714|P2|Overall Survival Status|Death|1
5544278|NCT01292603|19162715|P1|Overall Survival Status|Death|3
5544279|NCT01292603|19162710|P6|Part 2: Regular Follow-Up|Adverse Event|2
5544280|NCT01292603|19162711|P5|Part 2: Regular Follow-Up|Adverse Event|2
5544281|NCT01292603|19162712|P4|Part 2: Regular Follow-Up|Adverse Event|0
5544282|NCT01292603|19162713|P3|Part 2: Regular Follow-Up|Adverse Event|0
5544283|NCT01292603|19162714|P2|Part 2: Regular Follow-Up|Adverse Event|0
5544284|NCT01292603|19162715|P1|Part 2: Regular Follow-Up|Adverse Event|0
5544285|NCT01292603|19162710|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
5544286|NCT01292603|19162711|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
5544287|NCT01292603|19162712|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
5544288|NCT01292603|19162713|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
5544289|NCT01292603|19162714|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
5544290|NCT01292603|19162715|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
5544291|NCT01292603|19162710|P6|Part 2: Regular Follow-Up|Physician Decision|0
5544292|NCT01292603|19162711|P5|Part 2: Regular Follow-Up|Physician Decision|2
5544293|NCT01292603|19162712|P4|Part 2: Regular Follow-Up|Physician Decision|0
5544294|NCT01292603|19162713|P3|Part 2: Regular Follow-Up|Physician Decision|0
5544295|NCT01292603|19162714|P2|Part 2: Regular Follow-Up|Physician Decision|0
5544296|NCT01292603|19162715|P1|Part 2: Regular Follow-Up|Physician Decision|0
5544297|NCT01292603|19162710|P6|Part 2: Regular Follow-Up|Protocol Violation|0
5544298|NCT01292603|19162711|P5|Part 2: Regular Follow-Up|Protocol Violation|2
5544299|NCT01292603|19162712|P4|Part 2: Regular Follow-Up|Protocol Violation|0
5544300|NCT01292603|19162713|P3|Part 2: Regular Follow-Up|Protocol Violation|0
5544301|NCT01292603|19162714|P2|Part 2: Regular Follow-Up|Protocol Violation|0
5544302|NCT01292603|19162715|P1|Part 2: Regular Follow-Up|Protocol Violation|0
5544303|NCT01292603|19162710|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
5544304|NCT01292603|19162711|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5544305|NCT01292603|19162712|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5544306|NCT01292603|19162713|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5544307|NCT01292603|19162714|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5544308|NCT01292603|19162715|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
5544309|NCT01292603|19162710|P6|Part 2: Regular Follow-Up|Noncompliance|0
5544310|NCT01292603|19162711|P5|Part 2: Regular Follow-Up|Noncompliance|1
5544311|NCT01292603|19162712|P4|Part 2: Regular Follow-Up|Noncompliance|0
5544312|NCT01292603|19162713|P3|Part 2: Regular Follow-Up|Noncompliance|0
5544313|NCT01292603|19162714|P2|Part 2: Regular Follow-Up|Noncompliance|0
5544314|NCT01292603|19162715|P1|Part 2: Regular Follow-Up|Noncompliance|0
5544315|NCT01292603|19162710|P6|Part 2: Regular Follow-Up|Disease Progression|5
5544316|NCT01292603|19162711|P5|Part 2: Regular Follow-Up|Disease Progression|5
5544317|NCT01292603|19162712|P4|Part 2: Regular Follow-Up|Disease Progression|0
5544318|NCT01292603|19162713|P3|Part 2: Regular Follow-Up|Disease Progression|0
5544319|NCT01292603|19162714|P2|Part 2: Regular Follow-Up|Disease Progression|0
5544320|NCT01292603|19162715|P1|Part 2: Regular Follow-Up|Disease Progression|0
5544321|NCT01292603|19162710|P6|Part 2: Regular Follow-Up|Death|3
5544322|NCT01292603|19162711|P5|Part 2: Regular Follow-Up|Death|6
5544323|NCT01292603|19162712|P4|Part 2: Regular Follow-Up|Death|0
5544324|NCT01292603|19162713|P3|Part 2: Regular Follow-Up|Death|0
5544325|NCT01292603|19162714|P2|Part 2: Regular Follow-Up|Death|0
5544326|NCT01292603|19162715|P1|Part 2: Regular Follow-Up|Death|0
5544327|NCT01292603|19162710|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
5544328|NCT01292603|19162711|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5544329|NCT01292603|19162712|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5544330|NCT01292603|19162713|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5544331|NCT01292603|19162714|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5544332|NCT01292603|19162715|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
5544333|NCT01292603|19162710|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
5544334|NCT01292603|19162711|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
5544335|NCT01292603|19162712|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
5544336|NCT01292603|19162713|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
5544337|NCT01292603|19162714|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
5544338|NCT01292603|19162715|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
5544339|NCT01292603|19162710|P6|Part 2: Dose Confirmation Period|Adverse Event|9
5544340|NCT01292603|19162711|P5|Part 2: Dose Confirmation Period|Adverse Event|7
5544341|NCT01292603|19162712|P4|Part 2: Dose Confirmation Period|Adverse Event|0
5544342|NCT01292603|19162713|P3|Part 2: Dose Confirmation Period|Adverse Event|0
5544343|NCT01292603|19162714|P2|Part 2: Dose Confirmation Period|Adverse Event|0
5544344|NCT01292603|19162715|P1|Part 2: Dose Confirmation Period|Adverse Event|0
5544345|NCT01292603|19162710|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
5544346|NCT01292603|19162711|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
5544347|NCT01292603|19162712|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5544348|NCT01292603|19162713|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5544349|NCT01292603|19162714|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5544350|NCT01292603|19162715|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
5544351|NCT01292603|19162710|P6|Part 2: Dose Confirmation Period|Physician Decision|0
5544352|NCT01292603|19162711|P5|Part 2: Dose Confirmation Period|Physician Decision|2
5544353|NCT01292603|19162712|P4|Part 2: Dose Confirmation Period|Physician Decision|0
5544354|NCT01292603|19162713|P3|Part 2: Dose Confirmation Period|Physician Decision|0
5544355|NCT01292603|19162714|P2|Part 2: Dose Confirmation Period|Physician Decision|0
5544356|NCT01292603|19162715|P1|Part 2: Dose Confirmation Period|Physician Decision|0
5544357|NCT01292603|19162710|P6|Part 2: Dose Confirmation Period|Death|0
5544358|NCT01292603|19162711|P5|Part 2: Dose Confirmation Period|Death|1
5544359|NCT01292603|19162712|P4|Part 2: Dose Confirmation Period|Death|0
5544360|NCT01292603|19162713|P3|Part 2: Dose Confirmation Period|Death|0
5544361|NCT01292603|19162714|P2|Part 2: Dose Confirmation Period|Death|0
5544362|NCT01292603|19162715|P1|Part 2: Dose Confirmation Period|Death|0
5544363|NCT01292603|19162710|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
5544364|NCT01292603|19162711|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
5544365|NCT01292603|19162712|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
5544366|NCT01292603|19162713|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
5544367|NCT01292603|19162714|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
5544368|NCT01292603|19162715|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
5544369|NCT01292603|19162710|P6|Part 1: Regular Follow-Up Period|Death|0
5544370|NCT01292603|19162711|P5|Part 1: Regular Follow-Up Period|Death|0
5544371|NCT01292603|19162712|P4|Part 1: Regular Follow-Up Period|Death|1
5544372|NCT01292603|19162713|P3|Part 1: Regular Follow-Up Period|Death|3
5544373|NCT01292603|19162714|P2|Part 1: Regular Follow-Up Period|Death|1
5544374|NCT01292603|19162715|P1|Part 1: Regular Follow-Up Period|Death|3
5544375|NCT01292603|19162710|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5544376|NCT01292603|19162711|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5544377|NCT01292603|19162712|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
5544378|NCT01292603|19162713|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5544379|NCT01292603|19162714|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5544380|NCT01292603|19162715|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
5544381|NCT01292603|19162710|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5544382|NCT01292603|19162711|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5544383|NCT01292603|19162712|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
5544384|NCT01292603|19162713|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5544385|NCT01292603|19162714|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5544386|NCT01292603|19162715|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
5544387|NCT01292603|19162710|P6|Part 1: Pilot Dose Selection Period|Death|0
5544388|NCT01292603|19162711|P5|Part 1: Pilot Dose Selection Period|Death|0
5544389|NCT01292603|19162712|P4|Part 1: Pilot Dose Selection Period|Death|1
5544390|NCT01292603|19162713|P3|Part 1: Pilot Dose Selection Period|Death|0
5544391|NCT01292603|19162714|P2|Part 1: Pilot Dose Selection Period|Death|0
5544392|NCT01292603|19162715|P1|Part 1: Pilot Dose Selection Period|Death|0
5544393|NCT01292603|19162710|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
5544394|NCT01292603|19162711|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
5544395|NCT01292603|19162712|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
5544396|NCT01292603|19162713|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
5544397|NCT01292603|19162714|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
5544398|NCT01292603|19162715|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
5544399|NCT01292486|19162768|P1|Overall Study|Physician Decision|1
5544400|NCT01292486|19162768|P1|Overall Study|Adverse Event|1
5544401|NCT01292486|19162768|P1|Overall Study|Did not meet screening criteria|2
5544402|NCT01292486|19162768|P1|Overall Study|Protocol Violation|2
5544403|NCT01292473|19162782|P4|Overall Study|Disease Progression|6
5544404|NCT01292473|19162783|P3|Overall Study|Disease Progression|3
5544405|NCT01292473|19162784|P2|Overall Study|Disease Progression|1
5544406|NCT01292473|19162785|P1|Overall Study|Disease Progression|0
5544407|NCT01292473|19162782|P4|Overall Study|Physician Decision|0
5544408|NCT01292473|19162783|P3|Overall Study|Physician Decision|0
5544409|NCT01292473|19162784|P2|Overall Study|Physician Decision|1
5544410|NCT01292473|19162785|P1|Overall Study|Physician Decision|0
5544411|NCT01292473|19162782|P4|Overall Study|Withdrawal by Subject|3
5544412|NCT01292473|19162783|P3|Overall Study|Withdrawal by Subject|3
5544413|NCT01292473|19162784|P2|Overall Study|Withdrawal by Subject|4
5544414|NCT01292473|19162785|P1|Overall Study|Withdrawal by Subject|3
5544415|NCT01292473|19162782|P4|Overall Study|Lost to Follow-up|2
5544416|NCT01292473|19162783|P3|Overall Study|Lost to Follow-up|2
5544417|NCT01292473|19162784|P2|Overall Study|Lost to Follow-up|1
5544418|NCT01292473|19162785|P1|Overall Study|Lost to Follow-up|1
5544419|NCT01292473|19162782|P4|Overall Study|Adverse Event|1
5544420|NCT01292473|19162783|P3|Overall Study|Adverse Event|1
5544421|NCT01292473|19162784|P2|Overall Study|Adverse Event|0
5544422|NCT01292473|19162785|P1|Overall Study|Adverse Event|1
5544423|NCT01292239|19162853|P2|Overall Study|Withdrawal by Subject|6
5544424|NCT01292239|19162854|P1|Overall Study|Withdrawal by Subject|3
5544425|NCT01292239|19162853|P2|Overall Study|Other|1
5544426|NCT01292239|19162854|P1|Overall Study|Other|1
5544427|NCT01292226|19162875|P1|Overall Study|Other|2
5544428|NCT01292226|19162875|P1|Overall Study|Withdrawal by Subject|1
5544429|NCT01292226|19162875|P1|Overall Study|Protocol Violation|3
5544430|NCT01292226|19162875|P1|Overall Study|Graft loss|1
5544431|NCT01292226|19162875|P1|Overall Study|Death|1
5544432|NCT01292226|19162875|P1|Overall Study|Adverse Event|5
5544433|NCT01292187|19162908|P2|Overall Study|All other reasons|3
5544434|NCT01292187|19162909|P1|Overall Study|All other reasons|1
5544435|NCT01292187|19162908|P2|Overall Study|Withdrawal by Subject|5
5544436|NCT01292187|19162909|P1|Overall Study|Withdrawal by Subject|6
5544437|NCT01292187|19162908|P2|Overall Study|Adverse Event|5
5544438|NCT01292187|19162909|P1|Overall Study|Adverse Event|10
5544439|NCT01292057|19162944|P2|Overall Study|Lost to Follow-up|1
5544440|NCT01292057|19162945|P1|Overall Study|Lost to Follow-up|1
5544441|NCT01292057|19162944|P2|Overall Study|Protocol Violation|1
5544442|NCT01292057|19162945|P1|Overall Study|Protocol Violation|1
5544443|NCT01291277|19163017|P2|Overall Study|Lost to Follow-up|1
5544444|NCT01291277|19163018|P1|Overall Study|Lost to Follow-up|3
5544445|NCT01291277|19163017|P2|Overall Study|Death|2
5544446|NCT01291277|19163018|P1|Overall Study|Death|2
5544447|NCT01291225|19163030|P2|Overall Study|Lost to Follow-up|39
5544448|NCT01291225|19163031|P1|Overall Study|Lost to Follow-up|85
5544449|NCT01291173|19163045|P4|Overall Study|Excluded therapy|0
5544450|NCT01291173|19163046|P3|Overall Study|Excluded therapy|1
5544451|NCT01291173|19163047|P2|Overall Study|Excluded therapy|0
5544452|NCT01291173|19163048|P1|Overall Study|Excluded therapy|0
5544453|NCT01291173|19163045|P4|Overall Study|Subject was unblinded|0
5544454|NCT01291173|19163046|P3|Overall Study|Subject was unblinded|1
5544455|NCT01291173|19163047|P2|Overall Study|Subject was unblinded|0
5544456|NCT01291173|19163048|P1|Overall Study|Subject was unblinded|0
5544457|NCT01291173|19163045|P4|Overall Study|Lack of compliance|1
5544458|NCT01291173|19163046|P3|Overall Study|Lack of compliance|0
5544459|NCT01291173|19163047|P2|Overall Study|Lack of compliance|0
5544460|NCT01291173|19163048|P1|Overall Study|Lack of compliance|0
5544461|NCT01291173|19163045|P4|Overall Study|Unable to meet visit schedule|0
5544462|NCT01291173|19163046|P3|Overall Study|Unable to meet visit schedule|1
5544463|NCT01291173|19163047|P2|Overall Study|Unable to meet visit schedule|0
5544464|NCT01291173|19163048|P1|Overall Study|Unable to meet visit schedule|0
5544465|NCT01291173|19163045|P4|Overall Study|Lost to Follow-up|2
5544466|NCT01291173|19163046|P3|Overall Study|Lost to Follow-up|3
5544467|NCT01291173|19163047|P2|Overall Study|Lost to Follow-up|6
5544468|NCT01291173|19163048|P1|Overall Study|Lost to Follow-up|4
5544469|NCT01291173|19163045|P4|Overall Study|Withdrawal by Subject|2
5544470|NCT01291173|19163046|P3|Overall Study|Withdrawal by Subject|4
5544471|NCT01291173|19163047|P2|Overall Study|Withdrawal by Subject|4
5544472|NCT01291173|19163048|P1|Overall Study|Withdrawal by Subject|6
5544473|NCT01291173|19163045|P4|Overall Study|Protocol Violation|5
5544474|NCT01291173|19163046|P3|Overall Study|Protocol Violation|2
5544475|NCT01291173|19163047|P2|Overall Study|Protocol Violation|2
5544476|NCT01291173|19163048|P1|Overall Study|Protocol Violation|7
5544477|NCT01291173|19163045|P4|Overall Study|Adverse Event|3
5544478|NCT01291173|19163046|P3|Overall Study|Adverse Event|1
5544479|NCT01291173|19163047|P2|Overall Study|Adverse Event|3
5544480|NCT01291173|19163048|P1|Overall Study|Adverse Event|0
5544481|NCT01291017|19163157|P1|Overall Study|Withdrawal by Subject|3
5544482|NCT01291017|19163157|P1|Overall Study|Lost to Follow-up|2
5544483|NCT01290887|19163190|P2|Overall Study|Other|6
5544484|NCT01290887|19163191|P1|Overall Study|Other|3
5544485|NCT01290887|19163190|P2|Overall Study|Sponsor closure of study|476
5544486|NCT01290887|19163191|P1|Overall Study|Sponsor closure of study|420
5544487|NCT01290887|19163190|P2|Overall Study|Non-compliance to study medications|0
5544488|NCT01290887|19163191|P1|Overall Study|Non-compliance to study medications|1
5544489|NCT01290887|19163190|P2|Overall Study|Non-compliance to study procedures|1
5544490|NCT01290887|19163191|P1|Overall Study|Non-compliance to study procedures|0
5544491|NCT01290887|19163190|P2|Overall Study|Lost to Follow-up|4
5544492|NCT01290887|19163191|P1|Overall Study|Lost to Follow-up|4
5544493|NCT01290887|19163190|P2|Overall Study|Protocol Violation|1
5544494|NCT01290887|19163191|P1|Overall Study|Protocol Violation|2
5544495|NCT01290887|19163190|P2|Overall Study|Withdrawal by Subject|32
5544496|NCT01290887|19163191|P1|Overall Study|Withdrawal by Subject|26
5544497|NCT01290887|19163190|P2|Overall Study|Lack of Efficacy|5
5544498|NCT01290887|19163191|P1|Overall Study|Lack of Efficacy|4
5544499|NCT01290887|19163190|P2|Overall Study|Adverse Event|11
5544500|NCT01290887|19163191|P1|Overall Study|Adverse Event|6
5544501|NCT01290822|19163252|P1|Overall Study|Physician Decision|10
5544502|NCT01290822|19163252|P1|Overall Study|Withdrawal by Subject|1
5544503|NCT01290796|19163261|P1|Overall Study|Withdrawal by Sponsor|1
5544504|NCT01290796|19163261|P1|Overall Study|Secondary Surgical Intervention|2
5544505|NCT01290796|19163261|P1|Overall Study|Physician Decision|2
5544506|NCT01290796|19163261|P1|Overall Study|Withdrawal by Subject|4
5544507|NCT01290796|19163261|P1|Overall Study|Lost to Follow-up|21
5544508|NCT01290757|19163277|P2|Overall Study|Other|1
5544509|NCT01290757|19163278|P1|Overall Study|Other|0
5544510|NCT01290757|19163277|P2|Overall Study|Protocol Violation|1
5544511|NCT01290757|19163278|P1|Overall Study|Protocol Violation|1
5544512|NCT01290757|19163277|P2|Overall Study|Adverse Event|0
5544513|NCT01290757|19163278|P1|Overall Study|Adverse Event|1
5544514|NCT01290731|19163294|P1|Overall Study|Withdrawal by Subject|1
5544515|NCT01290718|19163306|P1|Overall Study|Early termination of the study|4
5544516|NCT01290679|19163315|P2|Overall Study|Subject Entered Another Trial|5
5544517|NCT01290679|19163316|P1|Overall Study|Subject Entered Another Trial|0
5544518|NCT01290679|19163315|P2|Overall Study|Withdrawal by Subject|5
5544519|NCT01290679|19163316|P1|Overall Study|Withdrawal by Subject|6
5544520|NCT01290679|19163315|P2|Overall Study|Protocol Violation|1
5544521|NCT01290679|19163316|P1|Overall Study|Protocol Violation|0
5544522|NCT01290679|19163315|P2|Overall Study|Lost to Follow-up|10
5544523|NCT01290679|19163316|P1|Overall Study|Lost to Follow-up|8
5544524|NCT01290679|19163315|P2|Overall Study|Adverse Event|0
5544525|NCT01290679|19163316|P1|Overall Study|Adverse Event|2
5544526|NCT01290666|19163385|P1|Overall Study|Early Termination of Study|4
5544527|NCT01290666|19163385|P1|Overall Study|Withdrawal by Subject|23
5544528|NCT01290666|19163385|P1|Overall Study|Lost to Follow-up|11
5544529|NCT01290601|19163438|P4|Overall Study|Protocol Violation|0
5544530|NCT01290601|19163439|P3|Overall Study|Protocol Violation|0
5544531|NCT01290601|19163440|P2|Overall Study|Protocol Violation|0
5544532|NCT01290601|19163441|P1|Overall Study|Protocol Violation|1
5544533|NCT01290601|19163438|P4|Overall Study|Other|0
5544534|NCT01290601|19163439|P3|Overall Study|Other|0
5544535|NCT01290601|19163440|P2|Overall Study|Other|0
5544536|NCT01290601|19163441|P1|Overall Study|Other|1
5544537|NCT01290601|19163438|P4|Overall Study|Lost to Follow-up|0
5544538|NCT01290601|19163439|P3|Overall Study|Lost to Follow-up|0
5544539|NCT01290601|19163440|P2|Overall Study|Lost to Follow-up|2
5544540|NCT01290601|19163441|P1|Overall Study|Lost to Follow-up|7
5544541|NCT01290601|19163438|P4|Overall Study|Lack of Efficacy|0
5544542|NCT01290601|19163439|P3|Overall Study|Lack of Efficacy|0
5544543|NCT01290601|19163440|P2|Overall Study|Lack of Efficacy|1
5544544|NCT01290601|19163441|P1|Overall Study|Lack of Efficacy|2
5544545|NCT01290601|19163438|P4|Overall Study|Adverse Event|0
5544546|NCT01290601|19163439|P3|Overall Study|Adverse Event|0
5544547|NCT01290601|19163440|P2|Overall Study|Adverse Event|2
5544548|NCT01290601|19163441|P1|Overall Study|Adverse Event|0
5544549|NCT01290523|19163462|P1|Overall Study|Death|3
5544550|NCT01290341|19163501|P2|Overall Study|Negative baseline culture and others|11
5544551|NCT01290341|19163502|P1|Overall Study|Negative baseline culture and others|44
5544552|NCT01290341|19163501|P2|Overall Study|Withdrawal by Subject|5
5544553|NCT01290341|19163502|P1|Overall Study|Withdrawal by Subject|19
5544554|NCT01290341|19163501|P2|Overall Study|Lost to Follow-up|10
5544555|NCT01290341|19163502|P1|Overall Study|Lost to Follow-up|21
5544556|NCT01290341|19163501|P2|Overall Study|Adverse Event|0
5544557|NCT01290341|19163502|P1|Overall Study|Adverse Event|1
5544558|NCT01290341|19163501|P2|Overall Study|Protocol Violation|3
5544559|NCT01290341|19163502|P1|Overall Study|Protocol Violation|7
5544560|NCT01290315|19163514|P4|Overall Study|Withdrawal by Subject|0
5544561|NCT01290315|19163515|P3|Overall Study|Withdrawal by Subject|0
5544562|NCT01290315|19163516|P2|Overall Study|Withdrawal by Subject|1
5544563|NCT01290315|19163517|P1|Overall Study|Withdrawal by Subject|1
5544564|NCT01290315|19163514|P4|Overall Study|Lost to Follow-up|0
5544565|NCT01290315|19163515|P3|Overall Study|Lost to Follow-up|0
5544566|NCT01290315|19163516|P2|Overall Study|Lost to Follow-up|1
5544567|NCT01290315|19163517|P1|Overall Study|Lost to Follow-up|0
5544568|NCT01290315|19163514|P4|Overall Study|Selection criteria/compliance|2
5544569|NCT01290315|19163515|P3|Overall Study|Selection criteria/compliance|0
5544570|NCT01290315|19163516|P2|Overall Study|Selection criteria/compliance|1
5544571|NCT01290315|19163517|P1|Overall Study|Selection criteria/compliance|2
5544572|NCT01290315|19163514|P4|Overall Study|Adverse Event|3
5544573|NCT01290315|19163515|P3|Overall Study|Adverse Event|0
5544574|NCT01290315|19163516|P2|Overall Study|Adverse Event|0
5544575|NCT01290315|19163517|P1|Overall Study|Adverse Event|0
5544576|NCT01290263|19163539|P5|Overall Study|Participant Non-Compliance|1
5544577|NCT01290263|19163540|P4|Overall Study|Participant Non-Compliance|1
5544578|NCT01290263|19163541|P3|Overall Study|Participant Non-Compliance|0
5544579|NCT01290263|19163542|P2|Overall Study|Participant Non-Compliance|0
5544580|NCT01290263|19163543|P1|Overall Study|Participant Non-Compliance|0
5544581|NCT01290263|19163539|P5|Overall Study|Withdrawal by Subject|2
5544582|NCT01290263|19163540|P4|Overall Study|Withdrawal by Subject|1
5544583|NCT01290263|19163541|P3|Overall Study|Withdrawal by Subject|0
5544584|NCT01290263|19163542|P2|Overall Study|Withdrawal by Subject|1
5544585|NCT01290263|19163543|P1|Overall Study|Withdrawal by Subject|3
5544586|NCT01290263|19163539|P5|Overall Study|Lack of Efficacy|33
5544587|NCT01290263|19163540|P4|Overall Study|Lack of Efficacy|24
5544940|NCT01288430|19164749|P3|Part 2|Other|0
5544588|NCT01290263|19163541|P3|Overall Study|Lack of Efficacy|7
5544589|NCT01290263|19163542|P2|Overall Study|Lack of Efficacy|2
5544590|NCT01290263|19163543|P1|Overall Study|Lack of Efficacy|8
5544591|NCT01290263|19163539|P5|Overall Study|Adverse Event|1
5544592|NCT01290263|19163540|P4|Overall Study|Adverse Event|1
5544593|NCT01290263|19163541|P3|Overall Study|Adverse Event|0
5544594|NCT01290263|19163542|P2|Overall Study|Adverse Event|0
5544595|NCT01290263|19163543|P1|Overall Study|Adverse Event|0
5544596|NCT01290224|19163570|P1|Overall Study|Refused Further Treatment|4
5544597|NCT01290224|19163570|P1|Overall Study|Adverse Event|1
5544598|NCT01290094|19163581|P1|Overall Study|Lost to Follow-up|5
5544599|NCT01290094|19163581|P1|Overall Study|Withdrawal by Subject|1
5544600|NCT01290068|19163594|P2|Overall Study|Other|1
5544601|NCT01290068|19163595|P1|Overall Study|Other|3
5544602|NCT01290068|19163594|P2|Overall Study|Withdrawal by subject prior to implant|2
5544603|NCT01290068|19163595|P1|Overall Study|Withdrawal by subject prior to implant|0
5544604|NCT01290068|19163594|P2|Overall Study|Lost to Follow-up|0
5544605|NCT01290068|19163595|P1|Overall Study|Lost to Follow-up|3
5544606|NCT01290068|19163594|P2|Overall Study|Adverse Event|3
5544607|NCT01290068|19163595|P1|Overall Study|Adverse Event|1
5544608|NCT01290029|19163607|P1|Overall Study|Other|2
5544609|NCT01289990|19163633|P13|Overall Study|Not treated|0
5544610|NCT01289990|19163634|P12|Overall Study|Not treated|2
5544611|NCT01289990|19163635|P11|Overall Study|Not treated|1
5544612|NCT01289990|19163636|P10|Overall Study|Not treated|0
5544613|NCT01289990|19163637|P9|Overall Study|Not treated|1
5544614|NCT01289990|19163638|P8|Overall Study|Not treated|0
5544615|NCT01289990|19163639|P7|Overall Study|Not treated|1
5544616|NCT01289990|19163640|P6|Overall Study|Not treated|0
5544617|NCT01289990|19163641|P5|Overall Study|Not treated|0
5544618|NCT01289990|19163642|P4|Overall Study|Not treated|0
5544619|NCT01289990|19163643|P3|Overall Study|Not treated|0
5544620|NCT01289990|19163644|P2|Overall Study|Not treated|0
5544621|NCT01289990|19163645|P1|Overall Study|Not treated|0
5544622|NCT01289990|19163633|P13|Overall Study|did not continue in extension|56
5544623|NCT01289990|19163634|P12|Overall Study|did not continue in extension|34
5544624|NCT01289990|19163635|P11|Overall Study|did not continue in extension|45
5544625|NCT01289990|19163636|P10|Overall Study|did not continue in extension|48
5544626|NCT01289990|19163637|P9|Overall Study|did not continue in extension|44
5544627|NCT01289990|19163638|P8|Overall Study|did not continue in extension|36
5544628|NCT01289990|19163639|P7|Overall Study|did not continue in extension|54
5544629|NCT01289990|19163640|P6|Overall Study|did not continue in extension|50
5544630|NCT01289990|19163641|P5|Overall Study|did not continue in extension|48
5544631|NCT01289990|19163642|P4|Overall Study|did not continue in extension|51
5544632|NCT01289990|19163643|P3|Overall Study|did not continue in extension|51
5544633|NCT01289990|19163644|P2|Overall Study|did not continue in extension|45
5544634|NCT01289990|19163645|P1|Overall Study|did not continue in extension|41
5544635|NCT01289990|19163633|P13|Overall Study|discontinued in preceding trial|24
5544636|NCT01289990|19163634|P12|Overall Study|discontinued in preceding trial|17
5544637|NCT01289990|19163635|P11|Overall Study|discontinued in preceding trial|17
5544638|NCT01289990|19163636|P10|Overall Study|discontinued in preceding trial|21
5544639|NCT01289990|19163637|P9|Overall Study|discontinued in preceding trial|17
5544640|NCT01289990|19163638|P8|Overall Study|discontinued in preceding trial|8
5544641|NCT01289990|19163639|P7|Overall Study|discontinued in preceding trial|18
5544642|NCT01289990|19163640|P6|Overall Study|discontinued in preceding trial|12
5544643|NCT01289990|19163641|P5|Overall Study|discontinued in preceding trial|11
5544644|NCT01289990|19163642|P4|Overall Study|discontinued in preceding trial|17
5544645|NCT01289990|19163643|P3|Overall Study|discontinued in preceding trial|41
5544646|NCT01289990|19163644|P2|Overall Study|discontinued in preceding trial|20
5544647|NCT01289990|19163645|P1|Overall Study|discontinued in preceding trial|18
5544648|NCT01289990|19163633|P13|Overall Study|Withdrawal by Subject|16
5544649|NCT01289990|19163634|P12|Overall Study|Withdrawal by Subject|13
5544650|NCT01289990|19163635|P11|Overall Study|Withdrawal by Subject|11
5544651|NCT01289990|19163636|P10|Overall Study|Withdrawal by Subject|13
5544652|NCT01289990|19163637|P9|Overall Study|Withdrawal by Subject|12
5544653|NCT01289990|19163638|P8|Overall Study|Withdrawal by Subject|9
5544654|NCT01289990|19163639|P7|Overall Study|Withdrawal by Subject|13
5544655|NCT01289990|19163640|P6|Overall Study|Withdrawal by Subject|7
5544656|NCT01289990|19163641|P5|Overall Study|Withdrawal by Subject|8
5544657|NCT01289990|19163642|P4|Overall Study|Withdrawal by Subject|13
5544658|NCT01289990|19163643|P3|Overall Study|Withdrawal by Subject|12
5544659|NCT01289990|19163644|P2|Overall Study|Withdrawal by Subject|14
5544660|NCT01289990|19163645|P1|Overall Study|Withdrawal by Subject|15
5544661|NCT01289990|19163633|P13|Overall Study|Lost to Follow-up|2
5544662|NCT01289990|19163634|P12|Overall Study|Lost to Follow-up|1
5544663|NCT01289990|19163635|P11|Overall Study|Lost to Follow-up|2
5544664|NCT01289990|19163636|P10|Overall Study|Lost to Follow-up|4
5544665|NCT01289990|19163637|P9|Overall Study|Lost to Follow-up|1
5544666|NCT01289990|19163638|P8|Overall Study|Lost to Follow-up|2
5544667|NCT01289990|19163639|P7|Overall Study|Lost to Follow-up|2
5544668|NCT01289990|19163640|P6|Overall Study|Lost to Follow-up|4
5544669|NCT01289990|19163641|P5|Overall Study|Lost to Follow-up|3
5544670|NCT01289990|19163642|P4|Overall Study|Lost to Follow-up|5
5544671|NCT01289990|19163643|P3|Overall Study|Lost to Follow-up|5
5544672|NCT01289990|19163644|P2|Overall Study|Lost to Follow-up|2
5544673|NCT01289990|19163645|P1|Overall Study|Lost to Follow-up|3
5544674|NCT01289990|19163633|P13|Overall Study|Death|0
5544675|NCT01289990|19163634|P12|Overall Study|Death|1
5544676|NCT01289990|19163635|P11|Overall Study|Death|0
5544677|NCT01289990|19163636|P10|Overall Study|Death|0
5544678|NCT01289990|19163637|P9|Overall Study|Death|0
5544679|NCT01289990|19163638|P8|Overall Study|Death|0
5544680|NCT01289990|19163639|P7|Overall Study|Death|0
5544681|NCT01289990|19163640|P6|Overall Study|Death|1
5544682|NCT01289990|19163641|P5|Overall Study|Death|2
5544683|NCT01289990|19163642|P4|Overall Study|Death|1
5544684|NCT01289990|19163643|P3|Overall Study|Death|0
5544685|NCT01289990|19163644|P2|Overall Study|Death|0
5544686|NCT01289990|19163645|P1|Overall Study|Death|0
5544687|NCT01289847|19163862|P1|Overall Study|Patient could not comply with visits|1
5544688|NCT01289821|19163871|P1|Survival Follow-up Period|Clinical endpoint reached|16
5544689|NCT01289821|19163871|P1|Survival Follow-up Period|Lost to Follow-up|1
5544690|NCT01289821|19163871|P1|Survival Follow-up Period|Protocol Violation|1
5544691|NCT01289821|19163871|P1|Safety Follow-up Period|Unspecified reason|1
5544692|NCT01289821|19163871|P1|Safety Follow-up Period|Protocol Violation|3
5544693|NCT01289821|19163871|P1|Safety Follow-up Period|Withdrawal by Subject|1
5544694|NCT01289821|19163871|P1|Treatment Period|Therapeutic procedure required|1
5544695|NCT01289821|19163871|P1|Treatment Period|Clinical Progression|2
5544696|NCT01289821|19163871|P1|Treatment Period|Radiological Progression|43
5544697|NCT01289821|19163871|P1|Treatment Period|Adverse Event|4
5544698|NCT01289821|19163871|P1|Treatment Period|Physician Decision|3
5544699|NCT01289821|19163871|P1|Treatment Period|Withdrawal by Subject|1
5544700|NCT01289782|19163882|P2|Overall Study|Reason not specified|2
5544701|NCT01289782|19163883|P1|Overall Study|Reason not specified|1
5544702|NCT01289782|19163882|P2|Overall Study|Sponsor's Decision|0
5544703|NCT01289782|19163883|P1|Overall Study|Sponsor's Decision|1
5544704|NCT01289782|19163882|P2|Overall Study|Withdrawal by Subject|2
5544705|NCT01289782|19163883|P1|Overall Study|Withdrawal by Subject|8
5544706|NCT01289782|19163882|P2|Overall Study|Protocol Violation|1
5544707|NCT01289782|19163883|P1|Overall Study|Protocol Violation|1
5544708|NCT01289782|19163882|P2|Overall Study|Lost to Follow-up|7
5544709|NCT01289782|19163883|P1|Overall Study|Lost to Follow-up|14
5544710|NCT01289678|19163952|P1|Overall Study|Physician Decision|6
5544711|NCT01289639|19163968|P3|Overall Study|Lost to Follow-up|0
5544712|NCT01289639|19163969|P2|Overall Study|Lost to Follow-up|0
5544713|NCT01289639|19163970|P1|Overall Study|Lost to Follow-up|1
5544714|NCT01289574|19163996|P3|Overall Study|Subject wanted alternate treatment|0
5544715|NCT01289574|19163997|P2|Overall Study|Subject wanted alternate treatment|1
5544716|NCT01289574|19163998|P1|Overall Study|Subject wanted alternate treatment|0
5544717|NCT01289574|19163996|P3|Overall Study|Adverse Event|0
5544718|NCT01289574|19163997|P2|Overall Study|Adverse Event|1
5544719|NCT01289574|19163998|P1|Overall Study|Adverse Event|0
5544720|NCT01289574|19163996|P3|Overall Study|Withdrawal by Subject|1
5544721|NCT01289574|19163997|P2|Overall Study|Withdrawal by Subject|1
5544722|NCT01289574|19163998|P1|Overall Study|Withdrawal by Subject|1
5544723|NCT01289574|19163996|P3|Overall Study|Lost to Follow-up|1
5544724|NCT01289574|19163997|P2|Overall Study|Lost to Follow-up|0
5544725|NCT01289574|19163998|P1|Overall Study|Lost to Follow-up|2
5544726|NCT01289574|19163996|P3|Overall Study|Lack of Efficacy|1
5544727|NCT01289574|19163997|P2|Overall Study|Lack of Efficacy|0
5544728|NCT01289574|19163998|P1|Overall Study|Lack of Efficacy|4
5544729|NCT01289418|19164142|P1|Day 29 Survey|participants did not complete the survey|2185
5544730|NCT01289418|19164142|P1|Day 29 Survey|email address invalid|283
5544731|NCT01289418|19164142|P1|Day 8 Survey|participants did not complete the survey|1935
5544732|NCT01289418|19164142|P1|Day 8 Survey|email address invalid|283
5544733|NCT01289210|19164190|P1|Overall Study|Adverse Event|1
5544734|NCT01289119|19164200|P6|Overall Study|Other|0
5544735|NCT01289119|19164201|P5|Overall Study|Other|0
5544736|NCT01289119|19164202|P4|Overall Study|Other|0
5544737|NCT01289119|19164203|P3|Overall Study|Other|1
5544738|NCT01289119|19164204|P2|Overall Study|Other|0
5544739|NCT01289119|19164205|P1|Overall Study|Other|1
5544740|NCT01289119|19164200|P6|Overall Study|Lack of Efficacy|1
5544741|NCT01289119|19164201|P5|Overall Study|Lack of Efficacy|1
5544742|NCT01289119|19164202|P4|Overall Study|Lack of Efficacy|1
5544743|NCT01289119|19164203|P3|Overall Study|Lack of Efficacy|1
5544744|NCT01289119|19164204|P2|Overall Study|Lack of Efficacy|1
5544745|NCT01289119|19164205|P1|Overall Study|Lack of Efficacy|0
5544746|NCT01289119|19164200|P6|Overall Study|Pregnancy|0
5544747|NCT01289119|19164201|P5|Overall Study|Pregnancy|0
5544748|NCT01289119|19164202|P4|Overall Study|Pregnancy|0
5544749|NCT01289119|19164203|P3|Overall Study|Pregnancy|0
5544750|NCT01289119|19164204|P2|Overall Study|Pregnancy|1
5544751|NCT01289119|19164205|P1|Overall Study|Pregnancy|0
5544752|NCT01289119|19164200|P6|Overall Study|Withdrawal by Subject|1
5544753|NCT01289119|19164201|P5|Overall Study|Withdrawal by Subject|1
5544754|NCT01289119|19164202|P4|Overall Study|Withdrawal by Subject|3
5544755|NCT01289119|19164203|P3|Overall Study|Withdrawal by Subject|4
5544756|NCT01289119|19164204|P2|Overall Study|Withdrawal by Subject|2
5544757|NCT01289119|19164205|P1|Overall Study|Withdrawal by Subject|4
5544758|NCT01289119|19164200|P6|Overall Study|Lost to Follow-up|1
5544759|NCT01289119|19164201|P5|Overall Study|Lost to Follow-up|0
5544760|NCT01289119|19164202|P4|Overall Study|Lost to Follow-up|0
5544761|NCT01289119|19164203|P3|Overall Study|Lost to Follow-up|0
5544762|NCT01289119|19164204|P2|Overall Study|Lost to Follow-up|3
5544763|NCT01289119|19164205|P1|Overall Study|Lost to Follow-up|0
5544764|NCT01289119|19164200|P6|Overall Study|Major Protocol Deviation|1
5544765|NCT01289119|19164201|P5|Overall Study|Major Protocol Deviation|2
5544766|NCT01289119|19164202|P4|Overall Study|Major Protocol Deviation|0
5544767|NCT01289119|19164203|P3|Overall Study|Major Protocol Deviation|3
5544768|NCT01289119|19164204|P2|Overall Study|Major Protocol Deviation|1
5544769|NCT01289119|19164205|P1|Overall Study|Major Protocol Deviation|2
5544770|NCT01289119|19164200|P6|Overall Study|Adverse Event|0
5544771|NCT01289119|19164201|P5|Overall Study|Adverse Event|1
5544772|NCT01289119|19164202|P4|Overall Study|Adverse Event|2
5544773|NCT01289119|19164203|P3|Overall Study|Adverse Event|0
5544774|NCT01289119|19164204|P2|Overall Study|Adverse Event|1
5544775|NCT01289119|19164205|P1|Overall Study|Adverse Event|2
5544776|NCT01289041|19164326|P1|Overall Study|Death|1
5544777|NCT01289041|19164326|P1|Overall Study|Withdrawal by Subject|3
5544778|NCT01289041|19164326|P1|Overall Study|Progressive Disease|41
5544779|NCT01289041|19164326|P1|Overall Study|Physician Decision|1
5544780|NCT01289041|19164326|P1|Overall Study|Adverse Event|24
5544781|NCT01289028|19164338|P1|Overall Study|Missing reason for discon|1
5544782|NCT01289028|19164338|P1|Overall Study|Abnormal Lab Value|1
5544783|NCT01289028|19164338|P1|Overall Study|New Cancer Therapy|2
5544784|NCT01289028|19164338|P1|Overall Study|Lost to Follow-up|2
5544785|NCT01289028|19164338|P1|Overall Study|No longer required|2
5544786|NCT01289028|19164338|P1|Overall Study|Lack of Efficacy|2
5544787|NCT01289028|19164338|P1|Overall Study|Death|4
5544788|NCT01289028|19164338|P1|Overall Study|Withdrawal by Subject|6
5544789|NCT01289028|19164338|P1|Overall Study|Adverse Event|14
5544790|NCT01289028|19164338|P1|Overall Study|Progressive Disease|49
5544791|NCT01289015|19164352|P2|Overall Study|Negative baseline culture and others|20
5544792|NCT01289015|19164353|P1|Overall Study|Negative baseline culture and others|33
5544793|NCT01289015|19164352|P2|Overall Study|Disease progression|0
5544794|NCT01289015|19164353|P1|Overall Study|Disease progression|1
5544795|NCT01289015|19164352|P2|Overall Study|Withdrawal by Subject|8
5544796|NCT01289015|19164353|P1|Overall Study|Withdrawal by Subject|17
5544797|NCT01289015|19164352|P2|Overall Study|Lost to Follow-up|17
5544798|NCT01289015|19164353|P1|Overall Study|Lost to Follow-up|33
5544799|NCT01289015|19164352|P2|Overall Study|Adverse Event|0
5544800|NCT01289015|19164353|P1|Overall Study|Adverse Event|3
5544801|NCT01289015|19164352|P2|Overall Study|Protocol Violation|9
5544802|NCT01289015|19164353|P1|Overall Study|Protocol Violation|12
5544803|NCT01288989|19164366|P5|Overall Study|Withdrawal by Subject|3
5544804|NCT01288989|19164367|P4|Overall Study|Withdrawal by Subject|0
5544805|NCT01288989|19164368|P3|Overall Study|Withdrawal by Subject|0
5544806|NCT01288989|19164369|P2|Overall Study|Withdrawal by Subject|0
5544807|NCT01288989|19164370|P1|Overall Study|Withdrawal by Subject|0
5544808|NCT01288989|19164366|P5|Overall Study|Physician Decision|1
5544809|NCT01288989|19164367|P4|Overall Study|Physician Decision|0
5544810|NCT01288989|19164368|P3|Overall Study|Physician Decision|0
5544811|NCT01288989|19164369|P2|Overall Study|Physician Decision|0
5544812|NCT01288989|19164370|P1|Overall Study|Physician Decision|0
5544813|NCT01288989|19164366|P5|Overall Study|Adverse Event|2
5544814|NCT01288989|19164367|P4|Overall Study|Adverse Event|0
5544815|NCT01288989|19164368|P3|Overall Study|Adverse Event|0
5544816|NCT01288989|19164369|P2|Overall Study|Adverse Event|0
5544817|NCT01288989|19164370|P1|Overall Study|Adverse Event|0
5544818|NCT01288989|19164366|P5|Overall Study|Dose limiting toxicity|0
5544819|NCT01288989|19164367|P4|Overall Study|Dose limiting toxicity|0
5544820|NCT01288989|19164368|P3|Overall Study|Dose limiting toxicity|0
5544821|NCT01288989|19164369|P2|Overall Study|Dose limiting toxicity|0
5544822|NCT01288989|19164370|P1|Overall Study|Dose limiting toxicity|1
5544823|NCT01288989|19164366|P5|Overall Study|Death|0
5544824|NCT01288989|19164367|P4|Overall Study|Death|1
5544825|NCT01288989|19164368|P3|Overall Study|Death|0
5544826|NCT01288989|19164369|P2|Overall Study|Death|0
5544827|NCT01288989|19164370|P1|Overall Study|Death|0
5544828|NCT01288976|19164431|P3|Overall Study|Data unavailable|7
5544829|NCT01288976|19164432|P2|Overall Study|Data unavailable|9
5544830|NCT01288976|19164433|P1|Overall Study|Data unavailable|22
5544831|NCT01288976|19164431|P3|Overall Study|Death|4
5544832|NCT01288976|19164432|P2|Overall Study|Death|6
5544833|NCT01288976|19164433|P1|Overall Study|Death|98
5544834|NCT01288976|19164431|P3|Overall Study|Withdrawal by Subject|9
5544835|NCT01288976|19164432|P2|Overall Study|Withdrawal by Subject|12
5544836|NCT01288976|19164433|P1|Overall Study|Withdrawal by Subject|58
5544837|NCT01288937|19164462|P2|Overall Study|Adverse Event|0
5544838|NCT01288937|19164463|P1|Overall Study|Adverse Event|1
5544839|NCT01288911|19164471|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
5544840|NCT01288911|19164472|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
5544841|NCT01288911|19164471|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
5544842|NCT01288911|19164472|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
5544843|NCT01288911|19164471|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
5544844|NCT01288911|19164472|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
5544845|NCT01288911|19164471|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
5544846|NCT01288911|19164472|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
5544847|NCT01288911|19164471|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
5544848|NCT01288911|19164472|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
5544849|NCT01288911|19164471|P2|Open-label Period (All Enzalutamide)|Death|1
5544850|NCT01288911|19164472|P1|Open-label Period (All Enzalutamide)|Death|0
5544851|NCT01288911|19164471|P2|Double-blind Period|Randomized but never received study drug|2
5544852|NCT01288911|19164472|P1|Double-blind Period|Randomized but never received study drug|1
5544853|NCT01288911|19164471|P2|Double-blind Period|Miscellaneous Reason|42
5544854|NCT01288911|19164472|P1|Double-blind Period|Miscellaneous Reason|29
5544855|NCT01288911|19164471|P2|Double-blind Period|Withdrawal by Subject|26
5544856|NCT01288911|19164472|P1|Double-blind Period|Withdrawal by Subject|25
5544857|NCT01288911|19164471|P2|Double-blind Period|Protocol Violation|0
5544858|NCT01288911|19164472|P1|Double-blind Period|Protocol Violation|1
5544859|NCT01288911|19164471|P2|Double-blind Period|Progressive Disease|103
5544860|NCT01288911|19164472|P1|Double-blind Period|Progressive Disease|75
5544861|NCT01288911|19164471|P2|Double-blind Period|Lost to Follow-up|2
5544862|NCT01288911|19164472|P1|Double-blind Period|Lost to Follow-up|0
5544863|NCT01288911|19164471|P2|Double-blind Period|Death|7
5544864|NCT01288911|19164472|P1|Double-blind Period|Death|11
5544865|NCT01288729|19164582|P2|Overall Study|Withdrawal by Subject|0
5544866|NCT01288729|19164583|P1|Overall Study|Withdrawal by Subject|1
5544867|NCT01288612|19164592|P3|Overall Study|Unable to intubate|0
5544868|NCT01288612|19164593|P2|Overall Study|Unable to intubate|3
5544869|NCT01288612|19164594|P1|Overall Study|Unable to intubate|0
5544870|NCT01288612|19164592|P3|Overall Study|Declined|62
5544871|NCT01288612|19164593|P2|Overall Study|Declined|63
5544872|NCT01288612|19164594|P1|Overall Study|Declined|78
5544873|NCT01288612|19164592|P3|Overall Study|Unable to contact|20
5544874|NCT01288612|19164593|P2|Overall Study|Unable to contact|16
5544875|NCT01288612|19164594|P1|Overall Study|Unable to contact|11
5544876|NCT01288469|19164643|P3|Overall Study|Exclusion criteria finally met|0
5544877|NCT01288469|19164644|P2|Overall Study|Exclusion criteria finally met|0
5544878|NCT01288469|19164645|P1|Overall Study|Exclusion criteria finally met|1
5544879|NCT01288469|19164643|P3|Overall Study|Consent withdrawn by subject|1
5544880|NCT01288469|19164644|P2|Overall Study|Consent withdrawn by subject|1
5544881|NCT01288469|19164645|P1|Overall Study|Consent withdrawn by subject|1
5544882|NCT01288469|19164643|P3|Overall Study|Participant Moved|0
5544883|NCT01288469|19164644|P2|Overall Study|Participant Moved|0
5544884|NCT01288469|19164645|P1|Overall Study|Participant Moved|1
5544885|NCT01288469|19164643|P3|Overall Study|Poor compliance to protocol|0
5544886|NCT01288469|19164644|P2|Overall Study|Poor compliance to protocol|1
5544887|NCT01288469|19164645|P1|Overall Study|Poor compliance to protocol|0
5544888|NCT01288469|19164643|P3|Overall Study|Adverse Event|1
5544889|NCT01288469|19164644|P2|Overall Study|Adverse Event|1
5544890|NCT01288469|19164645|P1|Overall Study|Adverse Event|4
5544891|NCT01288443|19164677|P6|Overall Study|Other than above|0
5544892|NCT01288443|19164678|P5|Overall Study|Other than above|1
5544893|NCT01288443|19164679|P4|Overall Study|Other than above|2
5544894|NCT01288443|19164680|P3|Overall Study|Other than above|0
5544895|NCT01288443|19164681|P2|Overall Study|Other than above|0
5544896|NCT01288443|19164682|P1|Overall Study|Other than above|0
5544897|NCT01288443|19164677|P6|Overall Study|Study drug auto-injector administration|1
5544898|NCT01288443|19164678|P5|Overall Study|Study drug auto-injector administration|1
5544899|NCT01288443|19164679|P4|Overall Study|Study drug auto-injector administration|0
5544900|NCT01288443|19164680|P3|Overall Study|Study drug auto-injector administration|0
5544901|NCT01288443|19164681|P2|Overall Study|Study drug auto-injector administration|0
5544902|NCT01288443|19164682|P1|Overall Study|Study drug auto-injector administration|0
5544903|NCT01288443|19164677|P6|Overall Study|Lost to Follow-up|0
5544904|NCT01288443|19164678|P5|Overall Study|Lost to Follow-up|0
5544905|NCT01288443|19164679|P4|Overall Study|Lost to Follow-up|0
5544906|NCT01288443|19164680|P3|Overall Study|Lost to Follow-up|0
5544907|NCT01288443|19164681|P2|Overall Study|Lost to Follow-up|1
5544908|NCT01288443|19164682|P1|Overall Study|Lost to Follow-up|0
5544909|NCT01288443|19164677|P6|Overall Study|Consent withdrawn by Participant|1
5544910|NCT01288443|19164678|P5|Overall Study|Consent withdrawn by Participant|0
5544911|NCT01288443|19164679|P4|Overall Study|Consent withdrawn by Participant|0
5544912|NCT01288443|19164680|P3|Overall Study|Consent withdrawn by Participant|0
5544913|NCT01288443|19164681|P2|Overall Study|Consent withdrawn by Participant|0
5544914|NCT01288443|19164682|P1|Overall Study|Consent withdrawn by Participant|0
5544915|NCT01288443|19164677|P6|Overall Study|Participant Moved|1
5544916|NCT01288443|19164678|P5|Overall Study|Participant Moved|2
5544917|NCT01288443|19164679|P4|Overall Study|Participant Moved|1
5544918|NCT01288443|19164680|P3|Overall Study|Participant Moved|0
5544919|NCT01288443|19164681|P2|Overall Study|Participant Moved|0
5544920|NCT01288443|19164682|P1|Overall Study|Participant Moved|0
5544921|NCT01288443|19164677|P6|Overall Study|Poor compliance to protocol|1
5544922|NCT01288443|19164678|P5|Overall Study|Poor compliance to protocol|0
5544923|NCT01288443|19164679|P4|Overall Study|Poor compliance to protocol|0
5544924|NCT01288443|19164680|P3|Overall Study|Poor compliance to protocol|0
5544925|NCT01288443|19164681|P2|Overall Study|Poor compliance to protocol|0
5544926|NCT01288443|19164682|P1|Overall Study|Poor compliance to protocol|0
5544927|NCT01288443|19164677|P6|Overall Study|Adverse Event|1
5544928|NCT01288443|19164678|P5|Overall Study|Adverse Event|3
5544929|NCT01288443|19164679|P4|Overall Study|Adverse Event|1
5544930|NCT01288443|19164680|P3|Overall Study|Adverse Event|1
5544931|NCT01288443|19164681|P2|Overall Study|Adverse Event|0
5544932|NCT01288443|19164682|P1|Overall Study|Adverse Event|0
5544933|NCT01288430|19164742|P10|Part 2|Other|1
5544934|NCT01288430|19164743|P9|Part 2|Other|0
5544935|NCT01288430|19164744|P8|Part 2|Other|0
5544936|NCT01288430|19164745|P7|Part 2|Other|0
5544937|NCT01288430|19164746|P6|Part 2|Other|0
5544943|NCT01288430|19164742|P10|Part 2|Adverse Event|0
5544944|NCT01288430|19164743|P9|Part 2|Adverse Event|1
5544945|NCT01288430|19164744|P8|Part 2|Adverse Event|1
5544946|NCT01288430|19164745|P7|Part 2|Adverse Event|0
5544947|NCT01288430|19164746|P6|Part 2|Adverse Event|0
5544948|NCT01288430|19164747|P5|Part 2|Adverse Event|0
5544949|NCT01288430|19164748|P4|Part 2|Adverse Event|0
5544950|NCT01288430|19164749|P3|Part 2|Adverse Event|0
5544951|NCT01288430|19164750|P2|Part 2|Adverse Event|0
5544952|NCT01288430|19164751|P1|Part 2|Adverse Event|0
5544953|NCT01288430|19164742|P10|Part 2|Withdrawal by Subject|0
5544954|NCT01288430|19164743|P9|Part 2|Withdrawal by Subject|4
5544955|NCT01288430|19164744|P8|Part 2|Withdrawal by Subject|1
5544956|NCT01288430|19164745|P7|Part 2|Withdrawal by Subject|0
5544957|NCT01288430|19164746|P6|Part 2|Withdrawal by Subject|0
5544958|NCT01288430|19164747|P5|Part 2|Withdrawal by Subject|0
5544959|NCT01288430|19164748|P4|Part 2|Withdrawal by Subject|0
5544960|NCT01288430|19164749|P3|Part 2|Withdrawal by Subject|0
5544961|NCT01288430|19164750|P2|Part 2|Withdrawal by Subject|0
5544962|NCT01288430|19164751|P1|Part 2|Withdrawal by Subject|0
5544963|NCT01288430|19164742|P10|Part 2|Clinical disease progression|0
5544964|NCT01288430|19164743|P9|Part 2|Clinical disease progression|0
5544965|NCT01288430|19164744|P8|Part 2|Clinical disease progression|2
5544966|NCT01288430|19164745|P7|Part 2|Clinical disease progression|0
5544967|NCT01288430|19164746|P6|Part 2|Clinical disease progression|0
5544968|NCT01288430|19164747|P5|Part 2|Clinical disease progression|0
5544969|NCT01288430|19164748|P4|Part 2|Clinical disease progression|0
5544970|NCT01288430|19164749|P3|Part 2|Clinical disease progression|0
5544971|NCT01288430|19164750|P2|Part 2|Clinical disease progression|0
5544972|NCT01288430|19164751|P1|Part 2|Clinical disease progression|0
5544973|NCT01288430|19164742|P10|Part 2|Progressive disease|2
5544974|NCT01288430|19164743|P9|Part 2|Progressive disease|7
5544975|NCT01288430|19164744|P8|Part 2|Progressive disease|8
5544976|NCT01288430|19164745|P7|Part 2|Progressive disease|0
5544977|NCT01288430|19164746|P6|Part 2|Progressive disease|0
5544978|NCT01288430|19164747|P5|Part 2|Progressive disease|0
5544979|NCT01288430|19164748|P4|Part 2|Progressive disease|0
5544980|NCT01288430|19164749|P3|Part 2|Progressive disease|0
5544981|NCT01288430|19164750|P2|Part 2|Progressive disease|0
5544982|NCT01288430|19164751|P1|Part 2|Progressive disease|0
5544983|NCT01288430|19164742|P10|Part 1|Other|0
5544984|NCT01288430|19164743|P9|Part 1|Other|0
5544985|NCT01288430|19164744|P8|Part 1|Other|0
5544986|NCT01288430|19164745|P7|Part 1|Other|1
5544987|NCT01288430|19164746|P6|Part 1|Other|0
5544988|NCT01288430|19164747|P5|Part 1|Other|0
5544989|NCT01288430|19164748|P4|Part 1|Other|0
5544990|NCT01288430|19164749|P3|Part 1|Other|0
5544991|NCT01288430|19164750|P2|Part 1|Other|2
5544992|NCT01288430|19164751|P1|Part 1|Other|0
5544993|NCT01288430|19164742|P10|Part 1|Adverse Event|0
5544994|NCT01288430|19164743|P9|Part 1|Adverse Event|0
5544995|NCT01288430|19164744|P8|Part 1|Adverse Event|0
5544996|NCT01288430|19164745|P7|Part 1|Adverse Event|2
5544997|NCT01288430|19164746|P6|Part 1|Adverse Event|0
5544998|NCT01288430|19164747|P5|Part 1|Adverse Event|0
5544999|NCT01288430|19164748|P4|Part 1|Adverse Event|1
5545000|NCT01288430|19164749|P3|Part 1|Adverse Event|3
5545001|NCT01288430|19164750|P2|Part 1|Adverse Event|0
5545002|NCT01288430|19164751|P1|Part 1|Adverse Event|0
5545003|NCT01288430|19164742|P10|Part 1|Death due to disease progression|0
5545004|NCT01288430|19164743|P9|Part 1|Death due to disease progression|0
5545005|NCT01288430|19164744|P8|Part 1|Death due to disease progression|0
5545006|NCT01288430|19164745|P7|Part 1|Death due to disease progression|0
5545007|NCT01288430|19164746|P6|Part 1|Death due to disease progression|0
5545008|NCT01288430|19164747|P5|Part 1|Death due to disease progression|1
5545009|NCT01288430|19164748|P4|Part 1|Death due to disease progression|0
5545010|NCT01288430|19164749|P3|Part 1|Death due to disease progression|0
5545011|NCT01288430|19164750|P2|Part 1|Death due to disease progression|0
5545012|NCT01288430|19164751|P1|Part 1|Death due to disease progression|0
5545013|NCT01288430|19164742|P10|Part 1|Clinical disease progression|0
5545014|NCT01288430|19164743|P9|Part 1|Clinical disease progression|0
5545015|NCT01288430|19164744|P8|Part 1|Clinical disease progression|0
5545016|NCT01288430|19164745|P7|Part 1|Clinical disease progression|2
5545017|NCT01288430|19164746|P6|Part 1|Clinical disease progression|2
5545018|NCT01288430|19164747|P5|Part 1|Clinical disease progression|0
5545019|NCT01288430|19164748|P4|Part 1|Clinical disease progression|0
5545020|NCT01288430|19164749|P3|Part 1|Clinical disease progression|1
5545021|NCT01288430|19164750|P2|Part 1|Clinical disease progression|0
5545022|NCT01288430|19164751|P1|Part 1|Clinical disease progression|0
5545023|NCT01288430|19164742|P10|Part 1|Progressive disease|0
5545024|NCT01288430|19164743|P9|Part 1|Progressive disease|0
5545025|NCT01288430|19164744|P8|Part 1|Progressive disease|0
5545026|NCT01288430|19164745|P7|Part 1|Progressive disease|2
5545027|NCT01288430|19164746|P6|Part 1|Progressive disease|4
5545028|NCT01288430|19164747|P5|Part 1|Progressive disease|2
5545029|NCT01288430|19164748|P4|Part 1|Progressive disease|6
5545030|NCT01288430|19164749|P3|Part 1|Progressive disease|1
5545031|NCT01288430|19164750|P2|Part 1|Progressive disease|1
5545032|NCT01288430|19164751|P1|Part 1|Progressive disease|2
5545033|NCT01288287|19164875|P1|Overall Study|Unknown Status|7
5545034|NCT01288287|19164875|P1|Overall Study|Unknown Reason|1
5545035|NCT01288287|19164875|P1|Overall Study|Other Reason|13
5545036|NCT01288287|19164875|P1|Overall Study|Lack of Efficacy|13
5545037|NCT01288287|19164875|P1|Overall Study|Withdrawal by Subject|4
5545038|NCT01288287|19164875|P1|Overall Study|Lost to Follow-up|8
5545039|NCT01288209|19164890|P2|Overall Study|Other|0
5545040|NCT01288209|19164891|P1|Overall Study|Other|1
5545041|NCT01288209|19164890|P2|Overall Study|Withdrawal by Subject|3
5545042|NCT01288209|19164891|P1|Overall Study|Withdrawal by Subject|1
5545043|NCT01288079|19164921|P4|Overall Study|Other or Study Termination|8
5545044|NCT01288079|19164922|P3|Overall Study|Other or Study Termination|14
5545045|NCT01288079|19164923|P2|Overall Study|Other or Study Termination|15
5545046|NCT01288079|19164924|P1|Overall Study|Other or Study Termination|11
5545047|NCT01288079|19164921|P4|Overall Study|Lost to Follow-up|0
5545048|NCT01288079|19164922|P3|Overall Study|Lost to Follow-up|1
5545049|NCT01288079|19164923|P2|Overall Study|Lost to Follow-up|1
5545050|NCT01288079|19164924|P1|Overall Study|Lost to Follow-up|1
5545051|NCT01288079|19164921|P4|Overall Study|Study-Specific Withdrawal Criteria|0
5545052|NCT01288079|19164922|P3|Overall Study|Study-Specific Withdrawal Criteria|0
5545053|NCT01288079|19164923|P2|Overall Study|Study-Specific Withdrawal Criteria|1
5545054|NCT01288079|19164924|P1|Overall Study|Study-Specific Withdrawal Criteria|1
5545055|NCT01288079|19164921|P4|Overall Study|Lack of Efficacy|2
5545056|NCT01288079|19164922|P3|Overall Study|Lack of Efficacy|0
5545057|NCT01288079|19164923|P2|Overall Study|Lack of Efficacy|2
5545058|NCT01288079|19164924|P1|Overall Study|Lack of Efficacy|2
5545059|NCT01288079|19164921|P4|Overall Study|Condition under Investigation Worsened|1
5545060|NCT01288079|19164922|P3|Overall Study|Condition under Investigation Worsened|0
5545061|NCT01288079|19164923|P2|Overall Study|Condition under Investigation Worsened|0
5545062|NCT01288079|19164924|P1|Overall Study|Condition under Investigation Worsened|0
5545063|NCT01288079|19164921|P4|Overall Study|Severe Non-Compliance to Protocol|3
5545064|NCT01288079|19164922|P3|Overall Study|Severe Non-Compliance to Protocol|1
5545065|NCT01288079|19164923|P2|Overall Study|Severe Non-Compliance to Protocol|3
5545066|NCT01288079|19164924|P1|Overall Study|Severe Non-Compliance to Protocol|1
5545067|NCT01288079|19164921|P4|Overall Study|Adverse Event|3
5545068|NCT01288079|19164922|P3|Overall Study|Adverse Event|2
5545069|NCT01288079|19164923|P2|Overall Study|Adverse Event|1
5545070|NCT01288079|19164924|P1|Overall Study|Adverse Event|2
5545071|NCT01288079|19164921|P4|Overall Study|Withdrawal by Subject|0
5545072|NCT01288079|19164922|P3|Overall Study|Withdrawal by Subject|1
5545073|NCT01288079|19164923|P2|Overall Study|Withdrawal by Subject|4
5545074|NCT01288079|19164924|P1|Overall Study|Withdrawal by Subject|2
5545075|NCT01288053|19164934|P1|Overall Study|Death|1
5545076|NCT01287897|19164952|P4|Overall Study|Other|0
5545077|NCT01287897|19164953|P3|Overall Study|Other|1
5545078|NCT01287897|19164954|P2|Overall Study|Other|0
5545079|NCT01287897|19164955|P1|Overall Study|Other|1
5545080|NCT01287897|19164952|P4|Overall Study|Not meeting entrance criteria|0
5545081|NCT01287897|19164953|P3|Overall Study|Not meeting entrance criteria|0
5545082|NCT01287897|19164954|P2|Overall Study|Not meeting entrance criteria|1
5545083|NCT01287897|19164955|P1|Overall Study|Not meeting entrance criteria|1
5545084|NCT01287897|19164952|P4|Overall Study|Not consented properly|0
5545085|NCT01287897|19164953|P3|Overall Study|Not consented properly|0
5545086|NCT01287897|19164954|P2|Overall Study|Not consented properly|1
5545087|NCT01287897|19164955|P1|Overall Study|Not consented properly|0
5545088|NCT01287897|19164952|P4|Overall Study|Withdrawal by Subject|2
5545089|NCT01287897|19164953|P3|Overall Study|Withdrawal by Subject|3
5545090|NCT01287897|19164954|P2|Overall Study|Withdrawal by Subject|5
5545091|NCT01287897|19164955|P1|Overall Study|Withdrawal by Subject|1
5545092|NCT01287897|19164952|P4|Overall Study|Lost to Follow-up|0
5545093|NCT01287897|19164953|P3|Overall Study|Lost to Follow-up|2
5545094|NCT01287897|19164954|P2|Overall Study|Lost to Follow-up|0
5545095|NCT01287897|19164955|P1|Overall Study|Lost to Follow-up|0
5545096|NCT01287897|19164952|P4|Overall Study|Protocol Violation|1
5545097|NCT01287897|19164953|P3|Overall Study|Protocol Violation|0
5545098|NCT01287897|19164954|P2|Overall Study|Protocol Violation|1
5545099|NCT01287897|19164955|P1|Overall Study|Protocol Violation|1
5545100|NCT01287897|19164952|P4|Overall Study|Lack of Efficacy|0
5545101|NCT01287897|19164953|P3|Overall Study|Lack of Efficacy|0
5545102|NCT01287897|19164954|P2|Overall Study|Lack of Efficacy|0
5545103|NCT01287897|19164955|P1|Overall Study|Lack of Efficacy|2
5545104|NCT01287897|19164952|P4|Overall Study|Adverse Event|4
5545105|NCT01287897|19164953|P3|Overall Study|Adverse Event|6
5545106|NCT01287897|19164954|P2|Overall Study|Adverse Event|3
5545107|NCT01287897|19164955|P1|Overall Study|Adverse Event|5
5545108|NCT01287832|19165006|P2|Overall Study|Death|1
5545109|NCT01287832|19165007|P1|Overall Study|Death|0
5545110|NCT01287832|19165006|P2|Overall Study|Adverse Event|0
5545111|NCT01287832|19165007|P1|Overall Study|Adverse Event|1
5545112|NCT01287754|19165015|P2|Overall Study|Protocol Violation|3
5545113|NCT01287754|19165016|P1|Overall Study|Protocol Violation|0
5545114|NCT01287754|19165015|P2|Overall Study|Lost to Follow-up|6
5545115|NCT01287754|19165016|P1|Overall Study|Lost to Follow-up|1
5545116|NCT01287754|19165015|P2|Overall Study|Death|12
5545117|NCT01287754|19165016|P1|Overall Study|Death|2
5545118|NCT01287741|19165028|P2|Overall Study|Reason not specified|9
5545119|NCT01287741|19165029|P1|Overall Study|Reason not specified|23
5545120|NCT01287741|19165028|P2|Overall Study|Progressive disease|166
5545121|NCT01287741|19165029|P1|Overall Study|Progressive disease|190
5545122|NCT01287741|19165028|P2|Overall Study|Study terminated by Sponsor|315
5545123|NCT01287741|19165029|P1|Overall Study|Study terminated by Sponsor|307
5545124|NCT01287741|19165028|P2|Overall Study|Adverse Event|6
5545125|NCT01287741|19165029|P1|Overall Study|Adverse Event|4
5545126|NCT01287741|19165028|P2|Overall Study|Death|44
5545127|NCT01287741|19165029|P1|Overall Study|Death|32
5545128|NCT01287741|19165028|P2|Overall Study|Lost to Follow-up|8
5545129|NCT01287741|19165029|P1|Overall Study|Lost to Follow-up|10
5545130|NCT01287741|19165028|P2|Overall Study|Non-compliance|6
5545131|NCT01287741|19165029|P1|Overall Study|Non-compliance|8
5545132|NCT01287741|19165028|P2|Overall Study|Physician Decision|23
5545133|NCT01287741|19165029|P1|Overall Study|Physician Decision|15
5545134|NCT01287741|19165028|P2|Overall Study|Protocol Violation|0
5545135|NCT01287741|19165029|P1|Overall Study|Protocol Violation|2
5545136|NCT01287741|19165028|P2|Overall Study|Withdrawal by Subject|38
5545137|NCT01287741|19165029|P1|Overall Study|Withdrawal by Subject|35
5545138|NCT01287611|19165065|P2|Overall Study|Exclusion due to expanded Kerr incision|3
5545139|NCT01287611|19165066|P1|Overall Study|Exclusion due to expanded Kerr incision|4
5545140|NCT01287611|19165065|P2|Overall Study|Lost to Follow-up|16
5545141|NCT01287611|19165066|P1|Overall Study|Lost to Follow-up|29
5545142|NCT01287520|19165083|P9|Overall Study|Withdrawal by Subject|1
5545143|NCT01287520|19165084|P8|Overall Study|Withdrawal by Subject|0
5545144|NCT01287520|19165085|P7|Overall Study|Withdrawal by Subject|0
5545145|NCT01287520|19165086|P6|Overall Study|Withdrawal by Subject|1
5545146|NCT01287520|19165087|P5|Overall Study|Withdrawal by Subject|0
5545147|NCT01287520|19165088|P4|Overall Study|Withdrawal by Subject|0
5545148|NCT01287520|19165089|P3|Overall Study|Withdrawal by Subject|0
5545149|NCT01287520|19165090|P2|Overall Study|Withdrawal by Subject|0
5545150|NCT01287520|19165091|P1|Overall Study|Withdrawal by Subject|0
5545151|NCT01287520|19165083|P9|Overall Study|Progressive disease|4
5545152|NCT01287520|19165084|P8|Overall Study|Progressive disease|2
5545153|NCT01287520|19165085|P7|Overall Study|Progressive disease|2
5545154|NCT01287520|19165086|P6|Overall Study|Progressive disease|0
5545155|NCT01287520|19165087|P5|Overall Study|Progressive disease|1
5545156|NCT01287520|19165088|P4|Overall Study|Progressive disease|6
5545157|NCT01287520|19165089|P3|Overall Study|Progressive disease|1
5545158|NCT01287520|19165090|P2|Overall Study|Progressive disease|4
5545159|NCT01287520|19165091|P1|Overall Study|Progressive disease|0
5545160|NCT01287520|19165083|P9|Overall Study|Physician Decision|0
5545161|NCT01287520|19165084|P8|Overall Study|Physician Decision|1
5545162|NCT01287520|19165085|P7|Overall Study|Physician Decision|0
5545163|NCT01287520|19165086|P6|Overall Study|Physician Decision|1
5545164|NCT01287520|19165087|P5|Overall Study|Physician Decision|1
5545165|NCT01287520|19165088|P4|Overall Study|Physician Decision|0
5545166|NCT01287520|19165089|P3|Overall Study|Physician Decision|2
5545167|NCT01287520|19165090|P2|Overall Study|Physician Decision|1
5545168|NCT01287520|19165091|P1|Overall Study|Physician Decision|1
5545169|NCT01287520|19165083|P9|Overall Study|Adverse Event|0
5545170|NCT01287520|19165084|P8|Overall Study|Adverse Event|2
5545171|NCT01287520|19165085|P7|Overall Study|Adverse Event|0
5545172|NCT01287520|19165086|P6|Overall Study|Adverse Event|2
5545173|NCT01287520|19165087|P5|Overall Study|Adverse Event|1
5545174|NCT01287520|19165088|P4|Overall Study|Adverse Event|1
5545175|NCT01287520|19165089|P3|Overall Study|Adverse Event|2
5545176|NCT01287520|19165090|P2|Overall Study|Adverse Event|2
5545177|NCT01287520|19165091|P1|Overall Study|Adverse Event|2
5545178|NCT01287416|19165155|P2|6 Month Follow-up|Lost to Follow-up|2
5545179|NCT01287416|19165156|P1|6 Month Follow-up|Lost to Follow-up|3
5545180|NCT01287416|19165155|P2|Pre-post Training|Lost to Follow-up|1
5545181|NCT01287416|19165156|P1|Pre-post Training|Lost to Follow-up|5
5545182|NCT01287416|19165155|P2|Pre-post Training|Withdrawal by Subject|24
5545183|NCT01287416|19165156|P1|Pre-post Training|Withdrawal by Subject|17
5545184|NCT01287403|19165192|P1|1st Intervention (1 Day)|Adverse Event|1
5545185|NCT01287364|19165224|P2|Overall Study|Other Reason|2
5545186|NCT01287364|19165225|P1|Overall Study|Other Reason|4
5545187|NCT01287364|19165224|P2|Overall Study|Protocol Violation|5
5545188|NCT01287364|19165225|P1|Overall Study|Protocol Violation|5
5545189|NCT01287364|19165224|P2|Overall Study|Adverse Event|3
5545190|NCT01287364|19165225|P1|Overall Study|Adverse Event|0
5545191|NCT01287221|19165247|P2|Overall Study|Withdrawal by Subject|1
5545192|NCT01287221|19165248|P1|Overall Study|Withdrawal by Subject|0
5545193|NCT01287221|19165247|P2|Overall Study|Adverse Event|3
5545194|NCT01287221|19165248|P1|Overall Study|Adverse Event|3
5545195|NCT01287221|19165247|P2|Overall Study|Lack of Perceived Benefit|1
5545196|NCT01287221|19165248|P1|Overall Study|Lack of Perceived Benefit|1
5545197|NCT01287195|19165283|P1|Overall Study|Withdrawal by Subject|2
5545198|NCT01287117|19165298|P4|Overall Study|Disease Progression|5
5545199|NCT01287117|19165299|P3|Overall Study|Disease Progression|6
5545200|NCT01287117|19165300|P2|Overall Study|Disease Progression|5
5545201|NCT01287117|19165301|P1|Overall Study|Disease Progression|10
5545202|NCT01287117|19165298|P4|Overall Study|Patient/Legal Guardian's Decision|5
5545203|NCT01287117|19165299|P3|Overall Study|Patient/Legal Guardian's Decision|8
5545204|NCT01287117|19165300|P2|Overall Study|Patient/Legal Guardian's Decision|6
5545205|NCT01287117|19165301|P1|Overall Study|Patient/Legal Guardian's Decision|2
5545206|NCT01287117|19165298|P4|Overall Study|Physician Decision|1
5545207|NCT01287117|19165299|P3|Overall Study|Physician Decision|1
5545208|NCT01287117|19165300|P2|Overall Study|Physician Decision|1
5545209|NCT01287117|19165301|P1|Overall Study|Physician Decision|0
5545210|NCT01287117|19165298|P4|Overall Study|Lost to Follow-up|0
5545211|NCT01287117|19165299|P3|Overall Study|Lost to Follow-up|0
5545212|NCT01287117|19165300|P2|Overall Study|Lost to Follow-up|1
5545213|NCT01287117|19165301|P1|Overall Study|Lost to Follow-up|1
5545214|NCT01287117|19165298|P4|Overall Study|Adverse Event|1
5545215|NCT01287117|19165299|P3|Overall Study|Adverse Event|1
5545216|NCT01287117|19165300|P2|Overall Study|Adverse Event|1
5545217|NCT01287117|19165301|P1|Overall Study|Adverse Event|2
5545218|NCT01287104|19165351|P4|Overall Study|NK cells did not meet release criteria|0
5545219|NCT01287104|19165352|P3|Overall Study|NK cells did not meet release criteria|0
5545220|NCT01287104|19165353|P2|Overall Study|NK cells did not meet release criteria|1
5545221|NCT01287104|19165354|P1|Overall Study|NK cells did not meet release criteria|0
5545222|NCT01287104|19165351|P4|Overall Study|Low donor chimerism|0
5545223|NCT01287104|19165352|P3|Overall Study|Low donor chimerism|0
5545224|NCT01287104|19165353|P2|Overall Study|Low donor chimerism|1
5545225|NCT01287104|19165354|P1|Overall Study|Low donor chimerism|0
5545226|NCT01287104|19165351|P4|Overall Study|Developed GVHD or complications of BMT|0
5545227|NCT01287104|19165352|P3|Overall Study|Developed GVHD or complications of BMT|4
5545228|NCT01287104|19165353|P2|Overall Study|Developed GVHD or complications of BMT|1
5545229|NCT01287104|19165354|P1|Overall Study|Developed GVHD or complications of BMT|0
5545230|NCT01287104|19165351|P4|Overall Study|Donor anaphylaxis|1
5545231|NCT01287104|19165352|P3|Overall Study|Donor anaphylaxis|0
5545232|NCT01287104|19165353|P2|Overall Study|Donor anaphylaxis|1
5545233|NCT01287104|19165354|P1|Overall Study|Donor anaphylaxis|0
5545234|NCT01287104|19165351|P4|Overall Study|Patient developed progressive disease|2
5545235|NCT01287104|19165352|P3|Overall Study|Patient developed progressive disease|3
5545236|NCT01287104|19165353|P2|Overall Study|Patient developed progressive disease|1
5545237|NCT01287104|19165354|P1|Overall Study|Patient developed progressive disease|1
5545238|NCT01287065|19165410|P6|Treatment Period 1|Withdrawal by Subject|1
5545239|NCT01287065|19165411|P5|Treatment Period 1|Withdrawal by Subject|0
5545240|NCT01287065|19165412|P4|Treatment Period 1|Withdrawal by Subject|0
5545241|NCT01287065|19165413|P3|Treatment Period 1|Withdrawal by Subject|0
5545242|NCT01287065|19165414|P2|Treatment Period 1|Withdrawal by Subject|0
5545243|NCT01287065|19165415|P1|Treatment Period 1|Withdrawal by Subject|0
5545244|NCT01287065|19165410|P6|Treatment Period 1|Adverse Event|0
5545245|NCT01287065|19165411|P5|Treatment Period 1|Adverse Event|1
5545246|NCT01287065|19165412|P4|Treatment Period 1|Adverse Event|0
5545247|NCT01287065|19165413|P3|Treatment Period 1|Adverse Event|0
5545248|NCT01287065|19165414|P2|Treatment Period 1|Adverse Event|0
5545249|NCT01287065|19165415|P1|Treatment Period 1|Adverse Event|0
5545250|NCT01287039|19165434|P2|Overall Study|Lost to Follow-up|2
5545251|NCT01287039|19165435|P1|Overall Study|Lost to Follow-up|3
5545252|NCT01287039|19165434|P2|Overall Study|Withdrawal by Subject|11
5545253|NCT01287039|19165435|P1|Overall Study|Withdrawal by Subject|14
5545254|NCT01287039|19165434|P2|Overall Study|Adverse Event|4
5545255|NCT01287039|19165435|P1|Overall Study|Adverse Event|7
5545256|NCT01287039|19165434|P2|Overall Study|Change of residence|0
5545257|NCT01287039|19165435|P1|Overall Study|Change of residence|1
5545258|NCT01287039|19165434|P2|Overall Study|Death|0
5545259|NCT01287039|19165435|P1|Overall Study|Death|1
5545260|NCT01287039|19165434|P2|Overall Study|Problem with travel|1
5545261|NCT01287039|19165435|P1|Overall Study|Problem with travel|0
5545262|NCT01287039|19165434|P2|Overall Study|Noncompliance with study medication|1
5545263|NCT01287039|19165435|P1|Overall Study|Noncompliance with study medication|0
5545264|NCT01287039|19165434|P2|Overall Study|Excluded medication taken|0
5545265|NCT01287039|19165435|P1|Overall Study|Excluded medication taken|1
5545266|NCT01287039|19165434|P2|Overall Study|Protocol Violation|3
5545267|NCT01287039|19165435|P1|Overall Study|Protocol Violation|2
5545268|NCT01287039|19165434|P2|Overall Study|Elective surgery|1
5545269|NCT01287039|19165435|P1|Overall Study|Elective surgery|0
5545270|NCT01287039|19165434|P2|Overall Study|Change of location/residence|3
5545271|NCT01287039|19165435|P1|Overall Study|Change of location/residence|0
5545272|NCT01287039|19165434|P2|Overall Study|Noncompliance with study procedures|1
5545273|NCT01287039|19165435|P1|Overall Study|Noncompliance with study procedures|0
5545274|NCT01287013|19165468|P3|Overall Study|Non-evaluable|21
5545275|NCT01287013|19165469|P2|Overall Study|Non-evaluable|5
5545276|NCT01287013|19165470|P1|Overall Study|Non-evaluable|3
5545277|NCT01286987|19165500|P15|Part 2: Dose Expansion|Withdrawal by Subject|0
5545278|NCT01286987|19165501|P14|Part 2: Dose Expansion|Withdrawal by Subject|0
5545279|NCT01286987|19165502|P13|Part 2: Dose Expansion|Withdrawal by Subject|0
5545280|NCT01286987|19165503|P12|Part 2: Dose Expansion|Withdrawal by Subject|0
5545281|NCT01286987|19165504|P11|Part 2: Dose Expansion|Withdrawal by Subject|1
5545282|NCT01286987|19165505|P10|Part 2: Dose Expansion|Withdrawal by Subject|0
5545283|NCT01286987|19165506|P9|Part 2: Dose Expansion|Withdrawal by Subject|0
5545284|NCT01286987|19165507|P8|Part 2: Dose Expansion|Withdrawal by Subject|0
5545285|NCT01286987|19165508|P7|Part 2: Dose Expansion|Withdrawal by Subject|0
5545286|NCT01286987|19165509|P6|Part 2: Dose Expansion|Withdrawal by Subject|0
5545287|NCT01286987|19165510|P5|Part 2: Dose Expansion|Withdrawal by Subject|0
5545288|NCT01286987|19165511|P4|Part 2: Dose Expansion|Withdrawal by Subject|0
5545289|NCT01286987|19165512|P3|Part 2: Dose Expansion|Withdrawal by Subject|0
5545290|NCT01286987|19165513|P2|Part 2: Dose Expansion|Withdrawal by Subject|0
5545291|NCT01286987|19165514|P1|Part 2: Dose Expansion|Withdrawal by Subject|0
5545292|NCT01286987|19165500|P15|Part 2: Dose Expansion|Clinical Progression|0
5545293|NCT01286987|19165501|P14|Part 2: Dose Expansion|Clinical Progression|2
5545294|NCT01286987|19165502|P13|Part 2: Dose Expansion|Clinical Progression|0
5545295|NCT01286987|19165503|P12|Part 2: Dose Expansion|Clinical Progression|2
5545296|NCT01286987|19165504|P11|Part 2: Dose Expansion|Clinical Progression|2
5545297|NCT01286987|19165505|P10|Part 2: Dose Expansion|Clinical Progression|0
5545298|NCT01286987|19165506|P9|Part 2: Dose Expansion|Clinical Progression|0
5545299|NCT01286987|19165507|P8|Part 2: Dose Expansion|Clinical Progression|0
5545300|NCT01286987|19165508|P7|Part 2: Dose Expansion|Clinical Progression|0
5545301|NCT01286987|19165509|P6|Part 2: Dose Expansion|Clinical Progression|0
5545302|NCT01286987|19165510|P5|Part 2: Dose Expansion|Clinical Progression|0
5545303|NCT01286987|19165511|P4|Part 2: Dose Expansion|Clinical Progression|0
5545304|NCT01286987|19165512|P3|Part 2: Dose Expansion|Clinical Progression|0
5545305|NCT01286987|19165513|P2|Part 2: Dose Expansion|Clinical Progression|0
5545306|NCT01286987|19165514|P1|Part 2: Dose Expansion|Clinical Progression|0
5545307|NCT01286987|19165500|P15|Part 2: Dose Expansion|Progressive Disease|2
5545308|NCT01286987|19165501|P14|Part 2: Dose Expansion|Progressive Disease|19
5545309|NCT01286987|19165502|P13|Part 2: Dose Expansion|Progressive Disease|11
5545310|NCT01286987|19165503|P12|Part 2: Dose Expansion|Progressive Disease|7
5545311|NCT01286987|19165504|P11|Part 2: Dose Expansion|Progressive Disease|6
5545312|NCT01286987|19165505|P10|Part 2: Dose Expansion|Progressive Disease|11
5545313|NCT01286987|19165506|P9|Part 2: Dose Expansion|Progressive Disease|0
5545314|NCT01286987|19165507|P8|Part 2: Dose Expansion|Progressive Disease|0
5545315|NCT01286987|19165508|P7|Part 2: Dose Expansion|Progressive Disease|0
5545316|NCT01286987|19165509|P6|Part 2: Dose Expansion|Progressive Disease|0
5545317|NCT01286987|19165510|P5|Part 2: Dose Expansion|Progressive Disease|0
5545318|NCT01286987|19165511|P4|Part 2: Dose Expansion|Progressive Disease|0
5545319|NCT01286987|19165512|P3|Part 2: Dose Expansion|Progressive Disease|0
5545320|NCT01286987|19165513|P2|Part 2: Dose Expansion|Progressive Disease|0
5545321|NCT01286987|19165514|P1|Part 2: Dose Expansion|Progressive Disease|0
5545322|NCT01286987|19165500|P15|Part 2: Dose Expansion|Other|0
5545323|NCT01286987|19165501|P14|Part 2: Dose Expansion|Other|1
5545324|NCT01286987|19165502|P13|Part 2: Dose Expansion|Other|0
5545325|NCT01286987|19165503|P12|Part 2: Dose Expansion|Other|0
5545326|NCT01286987|19165504|P11|Part 2: Dose Expansion|Other|0
5545327|NCT01286987|19165505|P10|Part 2: Dose Expansion|Other|0
5545328|NCT01286987|19165506|P9|Part 2: Dose Expansion|Other|0
5545329|NCT01286987|19165507|P8|Part 2: Dose Expansion|Other|0
5545330|NCT01286987|19165508|P7|Part 2: Dose Expansion|Other|0
5545331|NCT01286987|19165509|P6|Part 2: Dose Expansion|Other|0
5545332|NCT01286987|19165510|P5|Part 2: Dose Expansion|Other|0
5545333|NCT01286987|19165511|P4|Part 2: Dose Expansion|Other|0
5545334|NCT01286987|19165512|P3|Part 2: Dose Expansion|Other|0
5545335|NCT01286987|19165513|P2|Part 2: Dose Expansion|Other|0
5545336|NCT01286987|19165514|P1|Part 2: Dose Expansion|Other|0
5545337|NCT01286987|19165500|P15|Part 2: Dose Expansion|Physician Decision|0
5545338|NCT01286987|19165501|P14|Part 2: Dose Expansion|Physician Decision|1
5545339|NCT01286987|19165502|P13|Part 2: Dose Expansion|Physician Decision|0
5545340|NCT01286987|19165503|P12|Part 2: Dose Expansion|Physician Decision|1
5545341|NCT01286987|19165504|P11|Part 2: Dose Expansion|Physician Decision|1
5545342|NCT01286987|19165505|P10|Part 2: Dose Expansion|Physician Decision|0
5545343|NCT01286987|19165506|P9|Part 2: Dose Expansion|Physician Decision|0
5545344|NCT01286987|19165507|P8|Part 2: Dose Expansion|Physician Decision|0
5545345|NCT01286987|19165508|P7|Part 2: Dose Expansion|Physician Decision|0
5545346|NCT01286987|19165509|P6|Part 2: Dose Expansion|Physician Decision|0
5545347|NCT01286987|19165510|P5|Part 2: Dose Expansion|Physician Decision|0
5545348|NCT01286987|19165511|P4|Part 2: Dose Expansion|Physician Decision|0
5545349|NCT01286987|19165512|P3|Part 2: Dose Expansion|Physician Decision|0
5545350|NCT01286987|19165513|P2|Part 2: Dose Expansion|Physician Decision|0
5545351|NCT01286987|19165514|P1|Part 2: Dose Expansion|Physician Decision|0
5545352|NCT01286987|19165500|P15|Part 2: Dose Expansion|Death|0
5545353|NCT01286987|19165501|P14|Part 2: Dose Expansion|Death|1
5545354|NCT01286987|19165502|P13|Part 2: Dose Expansion|Death|1
5545355|NCT01286987|19165503|P12|Part 2: Dose Expansion|Death|0
5545356|NCT01286987|19165504|P11|Part 2: Dose Expansion|Death|0
5545357|NCT01286987|19165505|P10|Part 2: Dose Expansion|Death|0
5545358|NCT01286987|19165506|P9|Part 2: Dose Expansion|Death|0
5545359|NCT01286987|19165507|P8|Part 2: Dose Expansion|Death|0
5545360|NCT01286987|19165508|P7|Part 2: Dose Expansion|Death|0
5545361|NCT01286987|19165509|P6|Part 2: Dose Expansion|Death|0
5545362|NCT01286987|19165510|P5|Part 2: Dose Expansion|Death|0
5545363|NCT01286987|19165511|P4|Part 2: Dose Expansion|Death|0
5545364|NCT01286987|19165512|P3|Part 2: Dose Expansion|Death|0
5545365|NCT01286987|19165513|P2|Part 2: Dose Expansion|Death|0
5545366|NCT01286987|19165514|P1|Part 2: Dose Expansion|Death|0
5545367|NCT01286987|19165500|P15|Part 1: Dose Escalation|Physician Decision|0
5545368|NCT01286987|19165501|P14|Part 1: Dose Escalation|Physician Decision|0
5545369|NCT01286987|19165502|P13|Part 1: Dose Escalation|Physician Decision|0
5545370|NCT01286987|19165503|P12|Part 1: Dose Escalation|Physician Decision|0
5545371|NCT01286987|19165504|P11|Part 1: Dose Escalation|Physician Decision|0
5545372|NCT01286987|19165505|P10|Part 1: Dose Escalation|Physician Decision|0
5545373|NCT01286987|19165506|P9|Part 1: Dose Escalation|Physician Decision|0
5545374|NCT01286987|19165507|P8|Part 1: Dose Escalation|Physician Decision|0
5545375|NCT01286987|19165508|P7|Part 1: Dose Escalation|Physician Decision|0
5545376|NCT01286987|19165509|P6|Part 1: Dose Escalation|Physician Decision|0
5545377|NCT01286987|19165510|P5|Part 1: Dose Escalation|Physician Decision|1
5545378|NCT01286987|19165511|P4|Part 1: Dose Escalation|Physician Decision|0
5545379|NCT01286987|19165512|P3|Part 1: Dose Escalation|Physician Decision|0
5545380|NCT01286987|19165513|P2|Part 1: Dose Escalation|Physician Decision|0
5545381|NCT01286987|19165514|P1|Part 1: Dose Escalation|Physician Decision|0
5545382|NCT01286987|19165500|P15|Part 1: Dose Escalation|Progressive Disease|0
5545383|NCT01286987|19165501|P14|Part 1: Dose Escalation|Progressive Disease|0
5545384|NCT01286987|19165502|P13|Part 1: Dose Escalation|Progressive Disease|0
5545385|NCT01286987|19165503|P12|Part 1: Dose Escalation|Progressive Disease|0
5545386|NCT01286987|19165504|P11|Part 1: Dose Escalation|Progressive Disease|0
5545387|NCT01286987|19165505|P10|Part 1: Dose Escalation|Progressive Disease|0
5545388|NCT01286987|19165506|P9|Part 1: Dose Escalation|Progressive Disease|5
5545389|NCT01286987|19165507|P8|Part 1: Dose Escalation|Progressive Disease|3
5545390|NCT01286987|19165508|P7|Part 1: Dose Escalation|Progressive Disease|5
5545391|NCT01286987|19165509|P6|Part 1: Dose Escalation|Progressive Disease|5
5545392|NCT01286987|19165510|P5|Part 1: Dose Escalation|Progressive Disease|1
5545393|NCT01286987|19165511|P4|Part 1: Dose Escalation|Progressive Disease|2
5545394|NCT01286987|19165512|P3|Part 1: Dose Escalation|Progressive Disease|3
5545395|NCT01286987|19165513|P2|Part 1: Dose Escalation|Progressive Disease|2
5545396|NCT01286987|19165514|P1|Part 1: Dose Escalation|Progressive Disease|2
5545397|NCT01286987|19165500|P15|Part 1: Dose Escalation|Clinical Progression|0
5545398|NCT01286987|19165501|P14|Part 1: Dose Escalation|Clinical Progression|0
5545399|NCT01286987|19165502|P13|Part 1: Dose Escalation|Clinical Progression|0
5545400|NCT01286987|19165503|P12|Part 1: Dose Escalation|Clinical Progression|0
5545401|NCT01286987|19165504|P11|Part 1: Dose Escalation|Clinical Progression|0
5545402|NCT01286987|19165505|P10|Part 1: Dose Escalation|Clinical Progression|0
5545403|NCT01286987|19165506|P9|Part 1: Dose Escalation|Clinical Progression|1
5545404|NCT01286987|19165507|P8|Part 1: Dose Escalation|Clinical Progression|2
5545405|NCT01286987|19165508|P7|Part 1: Dose Escalation|Clinical Progression|0
5545406|NCT01286987|19165509|P6|Part 1: Dose Escalation|Clinical Progression|1
5545407|NCT01286987|19165510|P5|Part 1: Dose Escalation|Clinical Progression|1
5545408|NCT01286987|19165511|P4|Part 1: Dose Escalation|Clinical Progression|1
5545409|NCT01286987|19165512|P3|Part 1: Dose Escalation|Clinical Progression|0
5545410|NCT01286987|19165513|P2|Part 1: Dose Escalation|Clinical Progression|1
5545411|NCT01286987|19165514|P1|Part 1: Dose Escalation|Clinical Progression|1
5545412|NCT01286779|19165695|P1|Overall Study|Discontinued by sponsor|1
5545413|NCT01286779|19165695|P1|Overall Study|Participant moved to another country|1
5545414|NCT01286779|19165695|P1|Overall Study|Participant had scheduled surgery|1
5545415|NCT01286779|19165695|P1|Overall Study|Physician Decision|2
5545416|NCT01286779|19165695|P1|Overall Study|Protocol Violation|5
5545417|NCT01286779|19165695|P1|Overall Study|Withdrawal by Subject|9
5545418|NCT01286753|19165747|P2|Overall Study|Participant to Receive Radiotherapy|0
5545419|NCT01286753|19165748|P1|Overall Study|Participant to Receive Radiotherapy|1
5545420|NCT01286753|19165747|P2|Overall Study|Discontinued to Join Extension Study|4
5545421|NCT01286753|19165748|P1|Overall Study|Discontinued to Join Extension Study|6
5545422|NCT01286753|19165747|P2|Overall Study|Withdrawal of Consent|2
5545423|NCT01286753|19165748|P1|Overall Study|Withdrawal of Consent|0
5545424|NCT01286753|19165747|P2|Overall Study|Refused Treatment|0
5545425|NCT01286753|19165748|P1|Overall Study|Refused Treatment|1
5545426|NCT01286753|19165747|P2|Overall Study|Progression|13
5545427|NCT01286753|19165748|P1|Overall Study|Progression|11
5545428|NCT01286753|19165747|P2|Overall Study|Adverse Event|6
5545429|NCT01286753|19165748|P1|Overall Study|Adverse Event|7
5545430|NCT01286740|19165766|P1|Overall Study|Protocol Violation|1
5545431|NCT01286740|19165766|P1|Overall Study|Enrolled but not treated|1
5545432|NCT01286558|19165784|P2|Overall Study|Withdrawal by Subject|1
5545433|NCT01286558|19165785|P1|Overall Study|Withdrawal by Subject|0
5545434|NCT01286558|19165784|P2|Overall Study|Adverse Event|1
5545435|NCT01286558|19165785|P1|Overall Study|Adverse Event|1
5545436|NCT01286480|19165821|P2|Overall Study|Withdrawal by Subject|3
5545437|NCT01286480|19165822|P1|Overall Study|Withdrawal by Subject|5
5545438|NCT01286311|19165929|P2|Overall Study|Physician did not want outreach sent|0
5545439|NCT01286311|19165930|P1|Overall Study|Physician did not want outreach sent|14
5545440|NCT01286272|19165946|P2|Overall Study|Ineligible after beginning treatment|3
5545441|NCT01286272|19165947|P1|Overall Study|Ineligible after beginning treatment|1
5545442|NCT01286207|19165967|P3|Overall Study|Other|13
5545443|NCT01286207|19165968|P2|Overall Study|Other|47
5545444|NCT01286207|19165969|P1|Overall Study|Other|37
5545445|NCT01286207|19165967|P3|Overall Study|Lack of Response|8
5545446|NCT01286207|19165968|P2|Overall Study|Lack of Response|38
5545447|NCT01286207|19165969|P1|Overall Study|Lack of Response|92
5545448|NCT01286207|19165967|P3|Overall Study|Withdrawal by Subject|41
5545449|NCT01286207|19165968|P2|Overall Study|Withdrawal by Subject|79
5545450|NCT01286207|19165969|P1|Overall Study|Withdrawal by Subject|93
5545451|NCT01286207|19165967|P3|Overall Study|Lost to Follow-up|20
5545452|NCT01286207|19165968|P2|Overall Study|Lost to Follow-up|43
5545453|NCT01286207|19165969|P1|Overall Study|Lost to Follow-up|49
5545454|NCT01286207|19165967|P3|Overall Study|Adverse Event|8
5545455|NCT01286207|19165968|P2|Overall Study|Adverse Event|41
5545456|NCT01286207|19165969|P1|Overall Study|Adverse Event|27
5545457|NCT01286168|19165989|P1|Overall Study|Surgical Drains Fell Out at Home|2
5545458|NCT01286168|19165989|P1|Overall Study|Withdrawal by Subject|1
5545459|NCT01286129|19166003|P2|Overall Study|Could not comply with study requirements|4
5545460|NCT01286129|19166004|P1|Overall Study|Could not comply with study requirements|4
5545461|NCT01286129|19166003|P2|Overall Study|Withdrawal by Subject|1
5545462|NCT01286129|19166004|P1|Overall Study|Withdrawal by Subject|4
5545463|NCT01286077|19166014|P2|Overall Study|refill medication not received in time|0
5545464|NCT01286077|19166015|P1|Overall Study|refill medication not received in time|1
5545465|NCT01286077|19166014|P2|Overall Study|Progression of disease|1
5545466|NCT01286077|19166015|P1|Overall Study|Progression of disease|0
5545467|NCT01286077|19166014|P2|Overall Study|Patient's decision to stop treatment|0
5545468|NCT01286077|19166015|P1|Overall Study|Patient's decision to stop treatment|3
5545469|NCT01286077|19166014|P2|Overall Study|The subject starts with alternative MMY|3
5545470|NCT01286077|19166015|P1|Overall Study|The subject starts with alternative MMY|0
5545471|NCT01286077|19166014|P2|Overall Study|Non-compliance|0
5545472|NCT01286077|19166015|P1|Overall Study|Non-compliance|1
5545473|NCT01286077|19166014|P2|Overall Study|Intercurrent illness|0
5545474|NCT01286077|19166015|P1|Overall Study|Intercurrent illness|1
5545475|NCT01286077|19166014|P2|Overall Study|Withdrawal by Subject|2
5545476|NCT01286077|19166015|P1|Overall Study|Withdrawal by Subject|0
5545477|NCT01286077|19166014|P2|Overall Study|Protocol Violation|1
5545478|NCT01286077|19166015|P1|Overall Study|Protocol Violation|1
5545479|NCT01286077|19166014|P2|Overall Study|Death|0
5545480|NCT01286077|19166015|P1|Overall Study|Death|1
5545481|NCT01286077|19166014|P2|Overall Study|Adverse Event|0
5545482|NCT01286077|19166015|P1|Overall Study|Adverse Event|2
5545483|NCT01286012|19166051|P2|Overall Study|peritoneal dialysis, randomized in error|3
5545484|NCT01286012|19166052|P1|Overall Study|peritoneal dialysis, randomized in error|1
5545485|NCT01286012|19166051|P2|Overall Study|Physician Decision|0
5545486|NCT01286012|19166052|P1|Overall Study|Physician Decision|2
5545487|NCT01286012|19166051|P2|Overall Study|Withdrawal by Subject|4
5545488|NCT01286012|19166052|P1|Overall Study|Withdrawal by Subject|4
5545489|NCT01286012|19166051|P2|Overall Study|Protocol Violation|1
5545490|NCT01286012|19166052|P1|Overall Study|Protocol Violation|1
5545491|NCT01286012|19166051|P2|Overall Study|Death|3
5545492|NCT01286012|19166052|P1|Overall Study|Death|2
5545493|NCT01286012|19166051|P2|Overall Study|Adverse Event|3
5545494|NCT01286012|19166052|P1|Overall Study|Adverse Event|3
5545495|NCT01285960|19166066|P1|Overall Study|2 subjects received less 10 sonications|2
5545496|NCT01285960|19166066|P1|Overall Study|Lost to Follow-up|2
5545497|NCT01285960|19166066|P1|Overall Study|Withdrawal by Subject|2
5545498|NCT01285908|19166079|P3|Baseline Measurement|unable to tolerate procedure|0
5545499|NCT01285908|19166080|P2|Baseline Measurement|unable to tolerate procedure|0
5545500|NCT01285908|19166081|P1|Baseline Measurement|unable to tolerate procedure|1
5545501|NCT01285908|19166079|P3|Baseline Measurement|History of stroke, exclusion criteria|0
5545502|NCT01285908|19166080|P2|Baseline Measurement|History of stroke, exclusion criteria|0
5545503|NCT01285908|19166081|P1|Baseline Measurement|History of stroke, exclusion criteria|1
5545504|NCT01285908|19166079|P3|Baseline Measurement|unable to insert catheter|0
5545505|NCT01285908|19166080|P2|Baseline Measurement|unable to insert catheter|0
5545506|NCT01285908|19166081|P1|Baseline Measurement|unable to insert catheter|1
5545507|NCT01285609|19166175|P2|Treated With Blinded Therapy|Worsening of general condition|1
5545508|NCT01285609|19166176|P1|Treated With Blinded Therapy|Worsening of general condition|0
5545509|NCT01285609|19166175|P2|Treated With Blinded Therapy|PI decision to discontinue|1
5545510|NCT01285609|19166176|P1|Treated With Blinded Therapy|PI decision to discontinue|0
5545511|NCT01285609|19166175|P2|Treated With Blinded Therapy|Investigator's assessment|0
5545512|NCT01285609|19166176|P1|Treated With Blinded Therapy|Investigator's assessment|1
5545513|NCT01285609|19166175|P2|Treated With Blinded Therapy|Participant hospitalized|0
5545514|NCT01285609|19166176|P1|Treated With Blinded Therapy|Participant hospitalized|1
5545515|NCT01285609|19166175|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
5545516|NCT01285609|19166176|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
5545517|NCT01285609|19166175|P2|Treated With Blinded Therapy|Participant refused participation|0
5545518|NCT01285609|19166176|P1|Treated With Blinded Therapy|Participant refused participation|1
5545519|NCT01285609|19166175|P2|Treated With Blinded Therapy|Physician and Patient decision|3
5545520|NCT01285609|19166176|P1|Treated With Blinded Therapy|Physician and Patient decision|1
5545521|NCT01285609|19166175|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
5545522|NCT01285609|19166176|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
5545523|NCT01285609|19166175|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
5545524|NCT01285609|19166176|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
5545525|NCT01285609|19166175|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
5545526|NCT01285609|19166176|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
5545527|NCT01285609|19166175|P2|Treated With Blinded Therapy|Not Reported|2
5545528|NCT01285609|19166176|P1|Treated With Blinded Therapy|Not Reported|0
5545529|NCT01285609|19166175|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
5545530|NCT01285609|19166176|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
5545531|NCT01285609|19166175|P2|Treated With Blinded Therapy|Death|3
5545532|NCT01285609|19166176|P1|Treated With Blinded Therapy|Death|11
5545533|NCT01285609|19166175|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
5545534|NCT01285609|19166176|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
5545535|NCT01285609|19166175|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
5545536|NCT01285609|19166176|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
5545537|NCT01285609|19166175|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
5545538|NCT01285609|19166176|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
5545539|NCT01285609|19166175|P2|Treated With Blinded Therapy|Progressive Disease|305
5545540|NCT01285609|19166176|P1|Treated With Blinded Therapy|Progressive Disease|223
5545541|NCT01285609|19166175|P2|Randomized|Randomized but not Treated|4
5545542|NCT01285609|19166176|P1|Randomized|Randomized but not Treated|4
5545543|NCT01285609|19166175|P2|Randomized|Undisclosed Reasons|0
5545544|NCT01285609|19166176|P1|Randomized|Undisclosed Reasons|1
5545545|NCT01285609|19166175|P2|Randomized|Subject No Longer Met Study Criteria|1
5545546|NCT01285609|19166176|P1|Randomized|Subject No Longer Met Study Criteria|1
5545547|NCT01285609|19166175|P2|Randomized|Withdrawal by Subject|11
5545548|NCT01285609|19166176|P1|Randomized|Withdrawal by Subject|8
5545549|NCT01285609|19166175|P2|Randomized|Death|7
5545550|NCT01285609|19166176|P1|Randomized|Death|5
5545551|NCT01285609|19166175|P2|Randomized|Study Drug Toxicity|14
5545552|NCT01285609|19166176|P1|Randomized|Study Drug Toxicity|13
5545553|NCT01285609|19166175|P2|Randomized|Adverse Event Unrelated to Study Drug|18
5545554|NCT01285609|19166176|P1|Randomized|Adverse Event Unrelated to Study Drug|18
5545555|NCT01285609|19166175|P2|Randomized|Progressive Disease|61
5545556|NCT01285609|19166176|P1|Randomized|Progressive Disease|41
5545557|NCT01285518|19166194|P8|Overall Study|Lost to Follow-up|0
5545558|NCT01285518|19166195|P7|Overall Study|Lost to Follow-up|0
5545559|NCT01285518|19166196|P6|Overall Study|Lost to Follow-up|1
5545560|NCT01285518|19166197|P5|Overall Study|Lost to Follow-up|0
5545561|NCT01285518|19166198|P4|Overall Study|Lost to Follow-up|0
5545562|NCT01285518|19166199|P3|Overall Study|Lost to Follow-up|0
5545563|NCT01285518|19166200|P2|Overall Study|Lost to Follow-up|0
5545564|NCT01285518|19166201|P1|Overall Study|Lost to Follow-up|0
5545565|NCT01285492|19166461|P2|Overall Study|Death|0
5545566|NCT01285492|19166462|P1|Overall Study|Death|1
5545567|NCT01285492|19166461|P2|Overall Study|Withdrawal by Subject|1
5545568|NCT01285492|19166462|P1|Overall Study|Withdrawal by Subject|2
5545569|NCT01285492|19166461|P2|Overall Study|Protocol Violation|0
5545570|NCT01285492|19166462|P1|Overall Study|Protocol Violation|3
5545571|NCT01285492|19166461|P2|Overall Study|Adverse Event|0
5545572|NCT01285492|19166462|P1|Overall Study|Adverse Event|11
5545573|NCT01285401|19166494|P2|Overall Study|Prematurely withdrawn from the study|29
5545574|NCT01285401|19166495|P1|Overall Study|Prematurely withdrawn from the study|17
5545575|NCT01285349|19166536|P3|Overall Study|Lost to Follow-up|27
5545576|NCT01285349|19166537|P2|Overall Study|Lost to Follow-up|20
5545577|NCT01285349|19166538|P1|Overall Study|Lost to Follow-up|27
5545578|NCT01285323|19166551|P2|Overall Study|Other|3
5545579|NCT01285323|19166552|P1|Overall Study|Other|1
5545580|NCT01285323|19166551|P2|Overall Study|Lost to Follow-up|1
5545581|NCT01285323|19166552|P1|Overall Study|Lost to Follow-up|1
5545582|NCT01285323|19166551|P2|Overall Study|Non-compliance with study procedures|3
5545583|NCT01285323|19166552|P1|Overall Study|Non-compliance with study procedures|2
5545584|NCT01285323|19166551|P2|Overall Study|Protocol Violation|2
5545585|NCT01285323|19166552|P1|Overall Study|Protocol Violation|1
5545586|NCT01285323|19166551|P2|Overall Study|Withdrawal by Subject|11
5545587|NCT01285323|19166552|P1|Overall Study|Withdrawal by Subject|15
5545588|NCT01285323|19166551|P2|Overall Study|Lack of Efficacy|2
5545589|NCT01285323|19166552|P1|Overall Study|Lack of Efficacy|4
5545590|NCT01285323|19166551|P2|Overall Study|Adverse Event|8
5545591|NCT01285323|19166552|P1|Overall Study|Adverse Event|9
5545592|NCT01285310|19166587|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
5545593|NCT01285310|19166588|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
5545594|NCT01285310|19166589|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
5545595|NCT01285310|19166590|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
5545596|NCT01285310|19166591|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
5545597|NCT01285310|19166587|P5|Active Treatment Phase: Weeks 25-52|Other|0
5545598|NCT01285310|19166588|P4|Active Treatment Phase: Weeks 25-52|Other|0
5545599|NCT01285310|19166589|P3|Active Treatment Phase: Weeks 25-52|Other|0
5545600|NCT01285310|19166590|P2|Active Treatment Phase: Weeks 25-52|Other|1
5545601|NCT01285310|19166591|P1|Active Treatment Phase: Weeks 25-52|Other|0
5545602|NCT01285310|19166587|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
5545603|NCT01285310|19166588|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
5545604|NCT01285310|19166589|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
5545605|NCT01285310|19166590|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
5545606|NCT01285310|19166591|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
5545607|NCT01285310|19166587|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
5545608|NCT01285310|19166588|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
5545609|NCT01285310|19166589|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
5545610|NCT01285310|19166590|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
5545611|NCT01285310|19166591|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
5545612|NCT01285310|19166587|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
5545613|NCT01285310|19166588|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
5545614|NCT01285310|19166589|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
5545615|NCT01285310|19166590|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
5545616|NCT01285310|19166591|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
5545617|NCT01285310|19166587|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
5545618|NCT01285310|19166588|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
5545619|NCT01285310|19166589|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
5545620|NCT01285310|19166590|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
5545621|NCT01285310|19166591|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
5545622|NCT01285310|19166587|P5|Placebo Controlled Phase: Weeks 0-24|Other|0
5545623|NCT01285310|19166588|P4|Placebo Controlled Phase: Weeks 0-24|Other|0
5545624|NCT01285310|19166589|P3|Placebo Controlled Phase: Weeks 0-24|Other|1
5545625|NCT01285310|19166590|P2|Placebo Controlled Phase: Weeks 0-24|Other|0
5545626|NCT01285310|19166591|P1|Placebo Controlled Phase: Weeks 0-24|Other|1
5545627|NCT01285310|19166587|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
5545628|NCT01285310|19166588|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
5545629|NCT01285310|19166589|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
5545630|NCT01285310|19166590|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
5545631|NCT01285310|19166591|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
5545632|NCT01285310|19166587|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
5545633|NCT01285310|19166588|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
5545634|NCT01285310|19166589|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
5545635|NCT01285310|19166590|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
5545636|NCT01285310|19166591|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
5545637|NCT01285310|19166587|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
5545638|NCT01285310|19166588|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
5545639|NCT01285310|19166589|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
5545640|NCT01285310|19166590|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
5545641|NCT01285310|19166591|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
5545642|NCT01285310|19166587|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
5545643|NCT01285310|19166588|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
5545644|NCT01285310|19166589|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
5545645|NCT01285310|19166590|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
5545646|NCT01285310|19166591|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
5545647|NCT01285310|19166587|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
5545648|NCT01285310|19166588|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
5545649|NCT01285310|19166589|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
5545650|NCT01285310|19166590|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
5545651|NCT01285310|19166591|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
5545652|NCT01284959|19166856|P3|Overall Study|Adverse Event|1
5545653|NCT01284959|19166857|P2|Overall Study|Adverse Event|0
5545654|NCT01284959|19166858|P1|Overall Study|Adverse Event|0
5545655|NCT01284959|19166856|P3|Overall Study|Withdrawal by Subject|0
5545656|NCT01284959|19166857|P2|Overall Study|Withdrawal by Subject|0
5545657|NCT01284959|19166858|P1|Overall Study|Withdrawal by Subject|1
5545658|NCT01284634|19166888|P4|Overall Study|Adverse Event|1
5545659|NCT01284634|19166889|P3|Overall Study|Adverse Event|2
5545660|NCT01284634|19166890|P2|Overall Study|Adverse Event|0
5545661|NCT01284634|19166891|P1|Overall Study|Adverse Event|1
5545662|NCT01284621|19166921|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5545663|NCT01284621|19166922|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
5545664|NCT01284621|19166923|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5545665|NCT01284621|19166924|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5545666|NCT01284621|19166925|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5545667|NCT01284621|19166926|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
5545668|NCT01284491|19166994|P1|Overall Study|Study termination|13
5545669|NCT01284361|19167004|P1|Overall Study|Lost to Follow-up|2
5545670|NCT01284361|19167004|P1|Overall Study|Adverse Event|1
5545671|NCT01284361|19167004|P1|Overall Study|Protocol Violation|5
5545672|NCT01284361|19167004|P1|Overall Study|Withdrawal by Subject|1
5545673|NCT01284140|19167100|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
5545674|NCT01284140|19167101|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
5545675|NCT01284140|19167100|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
5545676|NCT01284140|19167101|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
5545677|NCT01284127|19167115|P1|Overall Study|Physician Decision|1
5545678|NCT01284127|19167115|P1|Overall Study|Withdrawal by Subject|4
5545679|NCT01284127|19167115|P1|Overall Study|Adverse Event|2
5545680|NCT01284114|19167124|P1|Overall Study|dizziness|1
5545681|NCT01284114|19167124|P1|Overall Study|Symptomatic hypotension|1
5545682|NCT01284114|19167124|P1|Overall Study|From the results of ALLTITUDE study|1
5545683|NCT01284114|19167124|P1|Overall Study|viral infection|1
5545684|NCT01284062|19167136|P4|Overall Study|Site Closed|0
5545685|NCT01284062|19167137|P3|Overall Study|Site Closed|1
5545686|NCT01284062|19167138|P2|Overall Study|Site Closed|0
5545687|NCT01284062|19167139|P1|Overall Study|Site Closed|0
5545688|NCT01284062|19167136|P4|Overall Study|Other|1
5545689|NCT01284062|19167137|P3|Overall Study|Other|0
5545690|NCT01284062|19167138|P2|Overall Study|Other|0
5545691|NCT01284062|19167139|P1|Overall Study|Other|0
5545692|NCT01284062|19167136|P4|Overall Study|Withdrawal by Subject|5
5545693|NCT01284062|19167137|P3|Overall Study|Withdrawal by Subject|2
5545694|NCT01284062|19167138|P2|Overall Study|Withdrawal by Subject|1
5545695|NCT01284062|19167139|P1|Overall Study|Withdrawal by Subject|3
5545696|NCT01284062|19167136|P4|Overall Study|Protocol Violation|2
5545697|NCT01284062|19167137|P3|Overall Study|Protocol Violation|0
5545698|NCT01284062|19167138|P2|Overall Study|Protocol Violation|0
5545699|NCT01284062|19167139|P1|Overall Study|Protocol Violation|1
5545700|NCT01284062|19167136|P4|Overall Study|Medication error without adverse event|0
5545701|NCT01284062|19167137|P3|Overall Study|Medication error without adverse event|1
5545702|NCT01284062|19167138|P2|Overall Study|Medication error without adverse event|0
5545703|NCT01284062|19167139|P1|Overall Study|Medication error without adverse event|0
5545704|NCT01284062|19167136|P4|Overall Study|Lack of Efficacy|1
5545705|NCT01284062|19167137|P3|Overall Study|Lack of Efficacy|2
5545706|NCT01284062|19167138|P2|Overall Study|Lack of Efficacy|2
5545707|NCT01284062|19167139|P1|Overall Study|Lack of Efficacy|3
5545708|NCT01284062|19167136|P4|Overall Study|Adverse Event|5
5545709|NCT01284062|19167137|P3|Overall Study|Adverse Event|0
5545710|NCT01284062|19167138|P2|Overall Study|Adverse Event|5
5545711|NCT01284062|19167139|P1|Overall Study|Adverse Event|4
5545712|NCT01283971|19167213|P2|Overall Study|Administrative reasons|1
5545713|NCT01283971|19167214|P1|Overall Study|Administrative reasons|1
5545714|NCT01283971|19167213|P2|Overall Study|Failure to return|1
5545715|NCT01283971|19167214|P1|Overall Study|Failure to return|0
5545716|NCT01283971|19167213|P2|Overall Study|Refused treatment|1
5545717|NCT01283971|19167214|P1|Overall Study|Refused treatment|3
5545718|NCT01283971|19167213|P2|Overall Study|Protocol Violation|1
5545719|NCT01283971|19167214|P1|Overall Study|Protocol Violation|5
5545720|NCT01283971|19167213|P2|Overall Study|Insufficient therapeutic responses|3
5545721|NCT01283971|19167214|P1|Overall Study|Insufficient therapeutic responses|3
5545722|NCT01283971|19167213|P2|Overall Study|Adverse Event|5
5545723|NCT01283971|19167214|P1|Overall Study|Adverse Event|3
5545724|NCT01283581|19167261|P3|Overall Study|"Early termination"|1
5545725|NCT01283581|19167262|P2|Overall Study|"Early termination"|0
5545726|NCT01283581|19167263|P1|Overall Study|"Early termination"|0
5545727|NCT01283581|19167261|P3|Overall Study|Investigator unblinded|1
5545728|NCT01283581|19167262|P2|Overall Study|Investigator unblinded|0
5545729|NCT01283581|19167263|P1|Overall Study|Investigator unblinded|0
5545730|NCT01283581|19167261|P3|Overall Study|Noncompliance|0
5545731|NCT01283581|19167262|P2|Overall Study|Noncompliance|0
5545732|NCT01283581|19167263|P1|Overall Study|Noncompliance|1
5545733|NCT01283581|19167261|P3|Overall Study|Protocol Violation|2
5545734|NCT01283581|19167262|P2|Overall Study|Protocol Violation|1
5545735|NCT01283581|19167263|P1|Overall Study|Protocol Violation|0
5545736|NCT01283581|19167261|P3|Overall Study|Physician Decision|2
5545737|NCT01283581|19167262|P2|Overall Study|Physician Decision|1
5545738|NCT01283581|19167263|P1|Overall Study|Physician Decision|0
5545739|NCT01283581|19167261|P3|Overall Study|Adverse Event|4
5545740|NCT01283581|19167262|P2|Overall Study|Adverse Event|1
5545741|NCT01283581|19167263|P1|Overall Study|Adverse Event|1
5545742|NCT01283581|19167261|P3|Overall Study|Withdrawal by Subject|2
5545743|NCT01283581|19167262|P2|Overall Study|Withdrawal by Subject|5
5545744|NCT01283581|19167263|P1|Overall Study|Withdrawal by Subject|2
5545745|NCT01283581|19167261|P3|Overall Study|Lost to Follow-up|8
5545746|NCT01283581|19167262|P2|Overall Study|Lost to Follow-up|6
5545747|NCT01283581|19167263|P1|Overall Study|Lost to Follow-up|8
5545748|NCT01283542|19167333|P1|Extension Phase|Administrative problems|1
5545749|NCT01283542|19167333|P1|Extension Phase|Adverse Event|1
5545750|NCT01283542|19167333|P1|Extension Phase|Physician Decision|1
5545751|NCT01283542|19167333|P1|Main Phase|abnormal laboratory values|5
5545752|NCT01283542|19167333|P1|Main Phase|Uncontrolled diabetes mellitus|1
5545753|NCT01283542|19167333|P1|Main Phase|Acute or progressive vision loss|1
5545754|NCT01283516|19167398|P9|Overall Study|Lost to Follow-up|1
5545755|NCT01283516|19167399|P8|Overall Study|Lost to Follow-up|0
5545756|NCT01283516|19167400|P7|Overall Study|Lost to Follow-up|0
5545757|NCT01283516|19167401|P6|Overall Study|Lost to Follow-up|0
5545758|NCT01283516|19167402|P5|Overall Study|Lost to Follow-up|0
5545759|NCT01283516|19167403|P4|Overall Study|Lost to Follow-up|0
5545760|NCT01283516|19167404|P3|Overall Study|Lost to Follow-up|0
5545761|NCT01283516|19167405|P2|Overall Study|Lost to Follow-up|0
5545762|NCT01283516|19167406|P1|Overall Study|Lost to Follow-up|0
5545763|NCT01283516|19167398|P9|Overall Study|Administrative problems|39
5545764|NCT01283516|19167399|P8|Overall Study|Administrative problems|1
5545765|NCT01283516|19167400|P7|Overall Study|Administrative problems|1
5545766|NCT01283516|19167401|P6|Overall Study|Administrative problems|1
5545767|NCT01283516|19167402|P5|Overall Study|Administrative problems|0
5545768|NCT01283516|19167403|P4|Overall Study|Administrative problems|0
5545769|NCT01283516|19167404|P3|Overall Study|Administrative problems|0
5545770|NCT01283516|19167405|P2|Overall Study|Administrative problems|0
5545771|NCT01283516|19167406|P1|Overall Study|Administrative problems|0
5545772|NCT01283516|19167398|P9|Overall Study|Withdrawal by Subject|36
5545773|NCT01283516|19167399|P8|Overall Study|Withdrawal by Subject|0
5545774|NCT01283516|19167400|P7|Overall Study|Withdrawal by Subject|1
5545775|NCT01283516|19167401|P6|Overall Study|Withdrawal by Subject|0
5545776|NCT01283516|19167402|P5|Overall Study|Withdrawal by Subject|1
5545777|NCT01283516|19167403|P4|Overall Study|Withdrawal by Subject|0
5545778|NCT01283516|19167404|P3|Overall Study|Withdrawal by Subject|0
5545779|NCT01283516|19167405|P2|Overall Study|Withdrawal by Subject|0
5545780|NCT01283516|19167406|P1|Overall Study|Withdrawal by Subject|0
5545781|NCT01283516|19167398|P9|Overall Study|Disease Progression|139
5545782|NCT01283516|19167399|P8|Overall Study|Disease Progression|3
5545783|NCT01283516|19167400|P7|Overall Study|Disease Progression|6
5545784|NCT01283516|19167401|P6|Overall Study|Disease Progression|8
5545785|NCT01283516|19167402|P5|Overall Study|Disease Progression|13
5545786|NCT01283516|19167403|P4|Overall Study|Disease Progression|3
5545787|NCT01283516|19167404|P3|Overall Study|Disease Progression|3
5545788|NCT01283516|19167405|P2|Overall Study|Disease Progression|2
5545789|NCT01283516|19167406|P1|Overall Study|Disease Progression|2
5545790|NCT01283516|19167398|P9|Overall Study|Death|12
5545791|NCT01283516|19167399|P8|Overall Study|Death|1
5545792|NCT01283516|19167400|P7|Overall Study|Death|0
5545793|NCT01283516|19167401|P6|Overall Study|Death|1
5545794|NCT01283516|19167402|P5|Overall Study|Death|0
5545795|NCT01283516|19167403|P4|Overall Study|Death|0
5545796|NCT01283516|19167404|P3|Overall Study|Death|0
5545797|NCT01283516|19167405|P2|Overall Study|Death|0
5545798|NCT01283516|19167406|P1|Overall Study|Death|0
5545799|NCT01283516|19167398|P9|Overall Study|Adverse Event|28
5545800|NCT01283516|19167399|P8|Overall Study|Adverse Event|0
5545801|NCT01283516|19167400|P7|Overall Study|Adverse Event|2
5545802|NCT01283516|19167401|P6|Overall Study|Adverse Event|0
5545803|NCT01283516|19167402|P5|Overall Study|Adverse Event|0
5545804|NCT01283516|19167403|P4|Overall Study|Adverse Event|0
5545805|NCT01283516|19167404|P3|Overall Study|Adverse Event|0
5545806|NCT01283516|19167405|P2|Overall Study|Adverse Event|0
5545807|NCT01283516|19167406|P1|Overall Study|Adverse Event|0
5545808|NCT01283464|19167528|P2|Overall Study|Physician Decision|0
5545809|NCT01283464|19167529|P1|Overall Study|Physician Decision|1
5545810|NCT01283464|19167528|P2|Overall Study|Withdrawal by Subject|0
5545811|NCT01283464|19167529|P1|Overall Study|Withdrawal by Subject|1
5545812|NCT01283464|19167528|P2|Overall Study|Lost to Follow-up|1
5545813|NCT01283464|19167529|P1|Overall Study|Lost to Follow-up|0
5545814|NCT01283386|19167537|P2|Overall Study|Protocol Violation|1
5545815|NCT01283386|19167538|P1|Overall Study|Protocol Violation|0
5545816|NCT01283386|19167537|P2|Overall Study|Reason not specified|0
5545817|NCT01283386|19167538|P1|Overall Study|Reason not specified|1
5545818|NCT01283386|19167537|P2|Overall Study|Progression of underlying disease|7
5545819|NCT01283386|19167538|P1|Overall Study|Progression of underlying disease|2
5545820|NCT01283386|19167537|P2|Overall Study|Relapse of underlying disease|3
5545821|NCT01283386|19167538|P1|Overall Study|Relapse of underlying disease|1
5545822|NCT01283386|19167537|P2|Overall Study|Withdrawal by Subject|1
5545823|NCT01283386|19167538|P1|Overall Study|Withdrawal by Subject|2
5545824|NCT01283386|19167537|P2|Overall Study|Death|0
5545825|NCT01283386|19167538|P1|Overall Study|Death|2
5545826|NCT01283334|19167562|P1|Overall Study|Physician Decision|1
5545827|NCT01283334|19167562|P1|Overall Study|Adverse Event|4
5545828|NCT01283334|19167562|P1|Overall Study|Inability to Swallow Everolimus Pills|1
5545829|NCT01283334|19167562|P1|Overall Study|Withdrawal by Subject|1
5545830|NCT01283282|19167585|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
5545831|NCT01283282|19167586|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
5545832|NCT01283282|19167585|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
5545833|NCT01283282|19167586|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
5545834|NCT01283282|19167585|P2|First Intervention (6 Weeks)|Physician Decision|1
5545835|NCT01283282|19167586|P1|First Intervention (6 Weeks)|Physician Decision|0
5545836|NCT01283152|19167606|P2|Overall Study|Refused HESA|0
5545837|NCT01283152|19167607|P1|Overall Study|Refused HESA|1
5545838|NCT01283152|19167606|P2|Overall Study|Discharged prior to 24 hr assessment|0
5545839|NCT01283152|19167607|P1|Overall Study|Discharged prior to 24 hr assessment|1
5545840|NCT01283139|19167621|P4|Overall Study|Participant randomized in error|0
5545841|NCT01283139|19167622|P3|Overall Study|Participant randomized in error|1
5545842|NCT01283139|19167623|P2|Overall Study|Participant randomized in error|0
5545843|NCT01283139|19167624|P1|Overall Study|Participant randomized in error|0
5545844|NCT01283139|19167621|P4|Overall Study|Missed follow-up visit|2
5545845|NCT01283139|19167622|P3|Overall Study|Missed follow-up visit|2
5545846|NCT01283139|19167623|P2|Overall Study|Missed follow-up visit|1
5545847|NCT01283139|19167624|P1|Overall Study|Missed follow-up visit|0
5545848|NCT01283139|19167621|P4|Overall Study|Pregnancy|0
5545849|NCT01283139|19167622|P3|Overall Study|Pregnancy|1
5545850|NCT01283139|19167623|P2|Overall Study|Pregnancy|1
5545851|NCT01283139|19167624|P1|Overall Study|Pregnancy|0
5545852|NCT01283139|19167621|P4|Overall Study|Participant's refusal to continue|1
5545853|NCT01283139|19167622|P3|Overall Study|Participant's refusal to continue|1
5545854|NCT01283139|19167623|P2|Overall Study|Participant's refusal to continue|3
5545855|NCT01283139|19167624|P1|Overall Study|Participant's refusal to continue|0
5545856|NCT01283139|19167621|P4|Overall Study|Early termination due to AE/SAE|0
5545857|NCT01283139|19167622|P3|Overall Study|Early termination due to AE/SAE|0
5545858|NCT01283139|19167623|P2|Overall Study|Early termination due to AE/SAE|1
5545859|NCT01283139|19167624|P1|Overall Study|Early termination due to AE/SAE|1
5545860|NCT01283139|19167621|P4|Overall Study|Lack of Efficacy|1
5545861|NCT01283139|19167622|P3|Overall Study|Lack of Efficacy|2
5545862|NCT01283139|19167623|P2|Overall Study|Lack of Efficacy|2
5545863|NCT01283139|19167624|P1|Overall Study|Lack of Efficacy|1
5545864|NCT01283139|19167621|P4|Overall Study|Death|2
5545865|NCT01283139|19167622|P3|Overall Study|Death|2
5545866|NCT01283139|19167623|P2|Overall Study|Death|0
5545867|NCT01283139|19167624|P1|Overall Study|Death|2
5545868|NCT01283139|19167621|P4|Overall Study|Withdrawal by Subject|8
5545869|NCT01283139|19167622|P3|Overall Study|Withdrawal by Subject|6
5545870|NCT01283139|19167623|P2|Overall Study|Withdrawal by Subject|8
5545871|NCT01283139|19167624|P1|Overall Study|Withdrawal by Subject|8
5545872|NCT01283139|19167621|P4|Overall Study|Lost to Follow-up|1
5545873|NCT01283139|19167622|P3|Overall Study|Lost to Follow-up|3
5545874|NCT01283139|19167623|P2|Overall Study|Lost to Follow-up|2
5545875|NCT01283139|19167624|P1|Overall Study|Lost to Follow-up|5
5545876|NCT01283035|19167666|P1|Overall Study|Subject later found ineligible|1
5545877|NCT01283009|19167683|P2|Overall Study|Patient Withdrawn by LAR/DPOA|4
5545878|NCT01283009|19167684|P1|Overall Study|Patient Withdrawn by LAR/DPOA|0
5545879|NCT01283009|19167683|P2|Overall Study|Lost to Follow-up|0
5545880|NCT01283009|19167684|P1|Overall Study|Lost to Follow-up|1
5545881|NCT01283009|19167683|P2|Overall Study|Physician Decision|1
5545882|NCT01283009|19167684|P1|Overall Study|Physician Decision|1
5545883|NCT01283009|19167683|P2|Overall Study|Withdrawal by Subject|8
5545884|NCT01283009|19167684|P1|Overall Study|Withdrawal by Subject|10
5545885|NCT01283009|19167683|P2|Overall Study|Study ended early|26
5545886|NCT01283009|19167684|P1|Overall Study|Study ended early|23
5545887|NCT01283009|19167683|P2|Overall Study|Death|78
5545888|NCT01283009|19167684|P1|Overall Study|Death|83
5545889|NCT01282866|19167690|P1|Overall Study|Adverse Event|1
5545890|NCT01282814|19167698|P2|Washout of 7 Days|Withdrawal by Subject|0
5545891|NCT01282814|19167699|P1|Washout of 7 Days|Withdrawal by Subject|2
5545892|NCT01282814|19167698|P2|First Intervention|Emesis During Dosing Interval|3
5545893|NCT01282814|19167699|P1|First Intervention|Emesis During Dosing Interval|0
5545894|NCT01282801|19167711|P2|Second Intervention|Emesis During Critical Breakfast|1
5545895|NCT01282801|19167712|P1|Second Intervention|Emesis During Critical Breakfast|0
5545896|NCT01282476|19167736|P1|Overall Study|Death|11
5545897|NCT01282463|19167745|P3|Overall Study|Physician Decision|0
5545898|NCT01282463|19167746|P2|Overall Study|Physician Decision|0
5545899|NCT01282463|19167747|P1|Overall Study|Physician Decision|1
5545900|NCT01282463|19167745|P3|Overall Study|Protocol Violation|1
5545901|NCT01282463|19167746|P2|Overall Study|Protocol Violation|0
5545902|NCT01282463|19167747|P1|Overall Study|Protocol Violation|0
5545903|NCT01282463|19167745|P3|Overall Study|"Never Treated PD"|0
5545904|NCT01282463|19167746|P2|Overall Study|"Never Treated PD"|1
5545905|NCT01282463|19167747|P1|Overall Study|"Never Treated PD"|0
5545906|NCT01282463|19167745|P3|Overall Study|"Never Treated Death"|0
5545907|NCT01282463|19167746|P2|Overall Study|"Never Treated Death"|1
5545908|NCT01282463|19167747|P1|Overall Study|"Never Treated Death"|0
5545909|NCT01282463|19167745|P3|Overall Study|Withdrawal by Subject|3
5545910|NCT01282463|19167746|P2|Overall Study|Withdrawal by Subject|2
5545911|NCT01282463|19167747|P1|Overall Study|Withdrawal by Subject|6
5545912|NCT01282463|19167745|P3|Overall Study|Lost to Follow-up|0
5545913|NCT01282463|19167746|P2|Overall Study|Lost to Follow-up|0
5545914|NCT01282463|19167747|P1|Overall Study|Lost to Follow-up|1
5545915|NCT01282424|19167785|P1|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
5545916|NCT01282424|19167785|P1|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
5545917|NCT01282424|19167785|P1|Long-term Follow-up Period (5 Years)|Death|40
5545918|NCT01282424|19167785|P1|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
5545919|NCT01282424|19167785|P1|Treatment Period (TP) (81 Months)|Other (Unknown)|3
5545920|NCT01282424|19167785|P1|Treatment Period (TP) (81 Months)|Investigator Request|7
5545921|NCT01282424|19167785|P1|Treatment Period (TP) (81 Months)|Withdrew Consent|6
5545922|NCT01282424|19167785|P1|Treatment Period (TP) (81 Months)|Adverse Event|30
5545923|NCT01282372|19167802|P1|Overall Study|Adverse Event|12
5545924|NCT01282372|19167802|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
5545925|NCT01282372|19167802|P1|Overall Study|Presence of AE, Regression of Symptoms|1
5545926|NCT01282372|19167802|P1|Overall Study|Presence of AE, Lack of Efficacy|1
5545927|NCT01282372|19167802|P1|Overall Study|Death|1
5545928|NCT01282372|19167802|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
5545929|NCT01282372|19167802|P1|Overall Study|Withdrawal by Subject|11
5545930|NCT01282372|19167802|P1|Overall Study|Lost to Follow-up|23
5545931|NCT01282372|19167802|P1|Overall Study|Lack of Efficacy / Exacerbation|25
5545932|NCT01282294|19167830|P1|Overall Study|Physician Decision|1
5545933|NCT01282294|19167830|P1|Overall Study|Patient non-compliance|2
5545934|NCT01282294|19167830|P1|Overall Study|Adverse Event|1
5545935|NCT01282294|19167830|P1|Overall Study|Screening failure|1
5545936|NCT01282294|19167830|P1|Overall Study|Lost to Follow-up|14
5545937|NCT01282229|19167859|P1|Overall Study|Protocol Violation|2
5545938|NCT01282216|19167891|P4|Overall Study|Death|0
5545939|NCT01282216|19167892|P3|Overall Study|Death|2
5545940|NCT01282216|19167893|P2|Overall Study|Death|0
5545941|NCT01282216|19167894|P1|Overall Study|Death|0
5545942|NCT01282216|19167891|P4|Overall Study|Relapse|6
5545943|NCT01282216|19167892|P3|Overall Study|Relapse|17
5545944|NCT01282216|19167893|P2|Overall Study|Relapse|0
5545945|NCT01282216|19167894|P1|Overall Study|Relapse|0
5545946|NCT01282216|19167891|P4|Overall Study|Physician Decision|0
5545947|NCT01282216|19167892|P3|Overall Study|Physician Decision|11
5545948|NCT01282216|19167893|P2|Overall Study|Physician Decision|0
5545949|NCT01282216|19167894|P1|Overall Study|Physician Decision|0
5545950|NCT01282216|19167891|P4|Overall Study|Graft failure|2
5545951|NCT01282216|19167892|P3|Overall Study|Graft failure|3
5545952|NCT01282216|19167893|P2|Overall Study|Graft failure|0
5545953|NCT01282216|19167894|P1|Overall Study|Graft failure|0
5545954|NCT01282203|19167904|P1|Overall Study|Adverse Event|1
5545955|NCT01282164|19167926|P2|Overall Study|Lack of hypoglycemia during ITT|0
5545956|NCT01282164|19167927|P1|Overall Study|Lack of hypoglycemia during ITT|1
5545957|NCT01281969|19167980|P3|Overall Study|not randomized, child consent not given|2
5545958|NCT01281969|19167981|P2|Overall Study|not randomized, child consent not given|0
5545959|NCT01281969|19167982|P1|Overall Study|not randomized, child consent not given|0
5545960|NCT01281969|19167980|P3|Overall Study|AE during LP prior to IVIG admin|3
5545961|NCT01281969|19167981|P2|Overall Study|AE during LP prior to IVIG admin|0
5545962|NCT01281969|19167982|P1|Overall Study|AE during LP prior to IVIG admin|1
5545963|NCT01281969|19167980|P3|Overall Study|not randomized didn't meet criteria|7
5545964|NCT01281969|19167981|P2|Overall Study|not randomized didn't meet criteria|0
5545965|NCT01281969|19167982|P1|Overall Study|not randomized didn't meet criteria|0
5545966|NCT01281956|19167994|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
5545967|NCT01281956|19167995|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
5545968|NCT01281917|19168026|P1|Overall Study|Withdrawal by Subject|1
5545969|NCT01281865|19168038|P2|Overall Study|Lack of Efficacy|0
5545970|NCT01281865|19168039|P1|Overall Study|Lack of Efficacy|1
5545971|NCT01281865|19168038|P2|Overall Study|Withdrawal by Subject|0
5545972|NCT01281865|19168039|P1|Overall Study|Withdrawal by Subject|1
5545973|NCT01281865|19168038|P2|Overall Study|Adverse Event|1
5545974|NCT01281865|19168039|P1|Overall Study|Adverse Event|1
5545975|NCT01281839|19168047|P2|Overall Study|Reason not specified|1
5545976|NCT01281839|19168048|P1|Overall Study|Reason not specified|0
5545977|NCT01281839|19168047|P2|Overall Study|Withdrawal by Subject|10
5545978|NCT01281839|19168048|P1|Overall Study|Withdrawal by Subject|4
5545979|NCT01281839|19168047|P2|Overall Study|Lost to Follow-up|3
5545980|NCT01281839|19168048|P1|Overall Study|Lost to Follow-up|6
5545981|NCT01281644|19168109|P1|Overall Study|Withdrawal by Subject|2
5545982|NCT01281644|19168109|P1|Overall Study|Lost to Follow-up|3
5545983|NCT01281306|19168150|P7|Overall Study|Randomized in error|0
5545984|NCT01281306|19168151|P6|Overall Study|Randomized in error|0
5545985|NCT01281306|19168152|P5|Overall Study|Randomized in error|0
5545986|NCT01281306|19168153|P4|Overall Study|Randomized in error|1
5545987|NCT01281306|19168154|P3|Overall Study|Randomized in error|0
5545988|NCT01281306|19168155|P2|Overall Study|Randomized in error|0
5545989|NCT01281306|19168156|P1|Overall Study|Randomized in error|1
5545990|NCT01281306|19168150|P7|Overall Study|Adverse Event|3
5545991|NCT01281306|19168151|P6|Overall Study|Adverse Event|3
5545992|NCT01281306|19168152|P5|Overall Study|Adverse Event|5
5545993|NCT01281306|19168153|P4|Overall Study|Adverse Event|3
5545994|NCT01281306|19168154|P3|Overall Study|Adverse Event|2
5545995|NCT01281306|19168155|P2|Overall Study|Adverse Event|2
5545996|NCT01281306|19168156|P1|Overall Study|Adverse Event|3
5545997|NCT01281306|19168150|P7|Overall Study|Death|0
5545998|NCT01281306|19168151|P6|Overall Study|Death|0
5545999|NCT01281306|19168152|P5|Overall Study|Death|0
5546000|NCT01281306|19168153|P4|Overall Study|Death|0
5546001|NCT01281306|19168154|P3|Overall Study|Death|0
5546002|NCT01281306|19168155|P2|Overall Study|Death|0
5546003|NCT01281306|19168156|P1|Overall Study|Death|1
5546004|NCT01281306|19168150|P7|Overall Study|Lost to Follow-up|1
5546005|NCT01281306|19168151|P6|Overall Study|Lost to Follow-up|0
5546006|NCT01281306|19168152|P5|Overall Study|Lost to Follow-up|0
5546007|NCT01281306|19168153|P4|Overall Study|Lost to Follow-up|2
5546008|NCT01281306|19168154|P3|Overall Study|Lost to Follow-up|0
5546009|NCT01281306|19168155|P2|Overall Study|Lost to Follow-up|0
5546010|NCT01281306|19168156|P1|Overall Study|Lost to Follow-up|1
5546011|NCT01281306|19168150|P7|Overall Study|Condition no longer requires study drug|1
5546012|NCT01281306|19168151|P6|Overall Study|Condition no longer requires study drug|1
5546013|NCT01281306|19168152|P5|Overall Study|Condition no longer requires study drug|0
5546014|NCT01281306|19168153|P4|Overall Study|Condition no longer requires study drug|0
5546015|NCT01281306|19168154|P3|Overall Study|Condition no longer requires study drug|0
5546016|NCT01281306|19168155|P2|Overall Study|Condition no longer requires study drug|0
5546017|NCT01281306|19168156|P1|Overall Study|Condition no longer requires study drug|1
5546018|NCT01281306|19168150|P7|Overall Study|Protocol deviation|0
5546019|NCT01281306|19168151|P6|Overall Study|Protocol deviation|0
5546020|NCT01281306|19168152|P5|Overall Study|Protocol deviation|1
5546021|NCT01281306|19168153|P4|Overall Study|Protocol deviation|1
5546022|NCT01281306|19168154|P3|Overall Study|Protocol deviation|1
5546023|NCT01281306|19168155|P2|Overall Study|Protocol deviation|1
5546024|NCT01281306|19168156|P1|Overall Study|Protocol deviation|0
5546025|NCT01281306|19168150|P7|Overall Study|Withdrawal by Subject|1
5546026|NCT01281306|19168151|P6|Overall Study|Withdrawal by Subject|3
5546027|NCT01281306|19168152|P5|Overall Study|Withdrawal by Subject|1
5546028|NCT01281306|19168153|P4|Overall Study|Withdrawal by Subject|4
5546029|NCT01281306|19168154|P3|Overall Study|Withdrawal by Subject|2
5546030|NCT01281306|19168155|P2|Overall Study|Withdrawal by Subject|0
5546031|NCT01281306|19168156|P1|Overall Study|Withdrawal by Subject|1
5546032|NCT01281306|19168150|P7|Overall Study|Lack of Efficacy|1
5546033|NCT01281306|19168151|P6|Overall Study|Lack of Efficacy|0
5546034|NCT01281306|19168152|P5|Overall Study|Lack of Efficacy|2
5546035|NCT01281306|19168153|P4|Overall Study|Lack of Efficacy|0
5546036|NCT01281306|19168154|P3|Overall Study|Lack of Efficacy|3
5546037|NCT01281306|19168155|P2|Overall Study|Lack of Efficacy|1
5546038|NCT01281306|19168156|P1|Overall Study|Lack of Efficacy|0
5546039|NCT01281202|19168272|P2|Overall Study|Incarceration|3
5546040|NCT01281202|19168273|P1|Overall Study|Incarceration|0
5546041|NCT01281202|19168272|P2|Overall Study|Lost to Follow-up|13
5546042|NCT01281202|19168273|P1|Overall Study|Lost to Follow-up|11
5546043|NCT01281202|19168272|P2|Overall Study|Administrative|8
5546044|NCT01281202|19168273|P1|Overall Study|Administrative|2
5546045|NCT01281202|19168272|P2|Overall Study|Protocol Violation|10
5546046|NCT01281202|19168273|P1|Overall Study|Protocol Violation|11
5546047|NCT01281202|19168272|P2|Overall Study|Withdrawal by Subject|2
5546048|NCT01281202|19168273|P1|Overall Study|Withdrawal by Subject|2
5546049|NCT01281202|19168272|P2|Overall Study|Adverse Event|0
5546050|NCT01281202|19168273|P1|Overall Study|Adverse Event|2
5546051|NCT01281124|19168281|P1|Overall Study|Death|1
5546052|NCT01280981|19168296|P1|Overall Study|Study site closure|1
5546053|NCT01280981|19168296|P1|Overall Study|Elective surgery|2
5546054|NCT01280981|19168296|P1|Overall Study|Withdrawal of consent|3
5546055|NCT01280981|19168296|P1|Overall Study|Non-compliance with protocol|3
5546056|NCT01280981|19168296|P1|Overall Study|Failed to return|45
5546057|NCT01280981|19168296|P1|Overall Study|Irregular or discontinued menses|3
5546058|NCT01280981|19168296|P1|Overall Study|Adverse Event|6
5546059|NCT01280981|19168296|P1|Overall Study|Lost to Follow-up|3
5546060|NCT01280981|19168296|P1|Overall Study|Lack of Efficacy|13
5546061|NCT01280981|19168296|P1|Overall Study|Protocol Violation|2
5546062|NCT01280981|19168296|P1|Overall Study|Withdrawal by Subject|11
5546063|NCT01280968|19168307|P2|Overall Study|Unable to Smoke in Supine Position|0
5546064|NCT01280968|19168308|P1|Overall Study|Unable to Smoke in Supine Position|1
5546065|NCT01280968|19168307|P2|Overall Study|Pre-existing Neurological Condition|0
5546066|NCT01280968|19168308|P1|Overall Study|Pre-existing Neurological Condition|1
5546067|NCT01280968|19168307|P2|Overall Study|Scheduling Conflicts|1
5546068|NCT01280968|19168308|P1|Overall Study|Scheduling Conflicts|1
5546069|NCT01280968|19168307|P2|Overall Study|Adverse Event|0
5546070|NCT01280968|19168308|P1|Overall Study|Adverse Event|1
5546071|NCT01280968|19168307|P2|Overall Study|Anxiety|0
5546072|NCT01280968|19168308|P1|Overall Study|Anxiety|2
5546073|NCT01280968|19168307|P2|Overall Study|Commuting Problems|0
5546074|NCT01280968|19168308|P1|Overall Study|Commuting Problems|2
5546075|NCT01280968|19168307|P2|Overall Study|Unable to Follow Experimental Protocol|0
5546076|NCT01280968|19168308|P1|Overall Study|Unable to Follow Experimental Protocol|2
5546077|NCT01280968|19168307|P2|Overall Study|Lost to Follow-up|2
5546078|NCT01280968|19168308|P1|Overall Study|Lost to Follow-up|8
5546079|NCT01280955|19168324|P1|Overall Study|Withdrawal by Subject|1
5546080|NCT01280955|19168324|P1|Overall Study|Death|2
5546081|NCT01280903|19168368|P2|Overall Study|Lost to Follow-up|16
5546082|NCT01280903|19168369|P1|Overall Study|Lost to Follow-up|23
5546083|NCT01280812|19168436|P3|Overall Study|Lost to Follow-up|1
5546084|NCT01280812|19168437|P2|Overall Study|Lost to Follow-up|1
5546085|NCT01280812|19168438|P1|Overall Study|Lost to Follow-up|1
5546086|NCT01280812|19168436|P3|Overall Study|Withdrawal by Subject|0
5546087|NCT01280812|19168437|P2|Overall Study|Withdrawal by Subject|1
5546088|NCT01280812|19168438|P1|Overall Study|Withdrawal by Subject|2
5546089|NCT01280721|19168461|P1|Overall Study|No tolerability for the lowest dose|2
5546090|NCT01280721|19168461|P1|Overall Study|eGFR under the withdrawal criteria|7
5546091|NCT01280721|19168461|P1|Overall Study|Withdrawal by Subject|6
5546092|NCT01280721|19168461|P1|Overall Study|Physician Decision|3
5546093|NCT01280721|19168461|P1|Overall Study|Adverse Event|4
5546094|NCT01280656|19168525|P3|Overall Study|Other|7
5546095|NCT01280656|19168526|P2|Overall Study|Other|7
5546096|NCT01280656|19168527|P1|Overall Study|Other|1
5546097|NCT01280656|19168525|P3|Overall Study|Treatment shortening (RGT)|5
5546098|NCT01280656|19168526|P2|Overall Study|Treatment shortening (RGT)|4
5546099|NCT01280656|19168527|P1|Overall Study|Treatment shortening (RGT)|0
5546100|NCT01280656|19168525|P3|Overall Study|Lack of Efficacy|38
5546101|NCT01280656|19168526|P2|Overall Study|Lack of Efficacy|22
5546102|NCT01280656|19168527|P1|Overall Study|Lack of Efficacy|1
5546103|NCT01280656|19168525|P3|Overall Study|Adverse Event|13
5546104|NCT01280656|19168526|P2|Overall Study|Adverse Event|14
5546105|NCT01280656|19168527|P1|Overall Study|Adverse Event|1
5546106|NCT01280591|19168594|P4|Overall Study|Does not meet exclusion #27 criteria|1
5546107|NCT01280591|19168595|P3|Overall Study|Does not meet exclusion #27 criteria|0
5546108|NCT01280591|19168596|P2|Overall Study|Does not meet exclusion #27 criteria|0
5546109|NCT01280591|19168597|P1|Overall Study|Does not meet exclusion #27 criteria|0
5546110|NCT01280591|19168594|P4|Overall Study|Withdrawal by Subject|2
5546111|NCT01280591|19168595|P3|Overall Study|Withdrawal by Subject|0
5546112|NCT01280591|19168596|P2|Overall Study|Withdrawal by Subject|0
5546113|NCT01280591|19168597|P1|Overall Study|Withdrawal by Subject|0
5546114|NCT01280357|19168735|P1|Overall Study|IInsufficient data/No data supplied|12
5546115|NCT01280357|19168735|P1|Overall Study|Excluded no internal monitoring|14
5546116|NCT01280266|19168744|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
5546117|NCT01280266|19168745|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
5546118|NCT01280266|19168744|P2|First Intervention (Week 1-4)|Adverse Event|0
5546119|NCT01280266|19168745|P1|First Intervention (Week 1-4)|Adverse Event|1
5546120|NCT01279954|19168836|P2|Overall Study|Lack of Efficacy|4
5546121|NCT01279954|19168837|P1|Overall Study|Lack of Efficacy|3
5546122|NCT01279850|19168848|P1|Overall Study|No Visit After Treatment|34
5546123|NCT01279850|19168848|P1|Overall Study|No Drug Administration Information|7
5546124|NCT01279850|19168848|P1|Overall Study|Protocol Violation|50
5546125|NCT01279681|19168864|P2|Overall Study|Other Reason|2
5546126|NCT01279681|19168865|P1|Overall Study|Other Reason|0
5546127|NCT01279681|19168864|P2|Overall Study|Physician Decision|0
5546128|NCT01279681|19168865|P1|Overall Study|Physician Decision|1
5546129|NCT01279681|19168864|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
5546130|NCT01279681|19168865|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
5546131|NCT01279681|19168864|P2|Overall Study|Death|1
5546132|NCT01279681|19168865|P1|Overall Study|Death|0
5546133|NCT01279681|19168864|P2|Overall Study|Adverse Event|3
5546134|NCT01279681|19168865|P1|Overall Study|Adverse Event|2
5546135|NCT01279681|19168864|P2|Overall Study|Withdrawal by Subject|4
5546136|NCT01279681|19168865|P1|Overall Study|Withdrawal by Subject|3
5546137|NCT01279681|19168864|P2|Overall Study|Disease Progression|6
5546138|NCT01279681|19168865|P1|Overall Study|Disease Progression|9
5546139|NCT01279616|19168877|P1|Overall Study|no signs of sickle cell disease|2
5546140|NCT01279616|19168877|P1|Overall Study|donor could not be located|5
5546141|NCT01279486|19168890|P1|Overall Study|Lost to Follow-up|1
5546142|NCT01279447|19168896|P2|Overall Study|Lost to Follow-up|1
5546143|NCT01279447|19168897|P1|Overall Study|Lost to Follow-up|3
5546144|NCT01279343|19168905|P2|Overall Study|Did not receive treatment|6
5546145|NCT01279343|19168906|P1|Overall Study|Did not receive treatment|2
5546146|NCT01279200|19168951|P2|Overall Study|Adverse Event|0
5546147|NCT01279200|19168952|P1|Overall Study|Adverse Event|1
5546148|NCT01279200|19168951|P2|Overall Study|Lost to Follow-up|1
5546149|NCT01279200|19168952|P1|Overall Study|Lost to Follow-up|0
5546150|NCT01279200|19168951|P2|Overall Study|ultrasound screening failure|1
5546151|NCT01279200|19168952|P1|Overall Study|ultrasound screening failure|0
5546152|NCT01279200|19168951|P2|Overall Study|Inconvenience of ultrasound visit|1
5546153|NCT01279200|19168952|P1|Overall Study|Inconvenience of ultrasound visit|0
5546154|NCT01279200|19168951|P2|Overall Study|Patient withdrawal due to high cost|1
5546155|NCT01279200|19168952|P1|Overall Study|Patient withdrawal due to high cost|0
5546156|NCT01279200|19168951|P2|Overall Study|Withdrawal by Subject|3
5546157|NCT01279200|19168952|P1|Overall Study|Withdrawal by Subject|1
5546158|NCT01279070|19168990|P2|Overall Study|Acute exacerbation|1
5546159|NCT01279070|19168991|P1|Overall Study|Acute exacerbation|3
5546160|NCT01279070|19168990|P2|Overall Study|Withdrawal by Subject|3
5546161|NCT01279070|19168991|P1|Overall Study|Withdrawal by Subject|2
5546162|NCT01279044|19169010|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
5546163|NCT01279044|19169011|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
5546164|NCT01279044|19169012|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
5546165|NCT01279044|19169010|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
5546166|NCT01279044|19169011|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
5546167|NCT01279044|19169012|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
5546168|NCT01279044|19169010|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
5546169|NCT01279044|19169011|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
5546170|NCT01279044|19169012|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
5546171|NCT01278862|19169088|P2|Overall Study|Lost to Follow-up|1
5546172|NCT01278862|19169089|P1|Overall Study|Lost to Follow-up|1
5546173|NCT01278797|19169097|P2|Period 1|Protocol Violation|0
5546174|NCT01278797|19169098|P1|Period 1|Protocol Violation|1
5546175|NCT01278797|19169097|P2|Period 1|Adverse Event|1
5546176|NCT01278797|19169098|P1|Period 1|Adverse Event|0
5546177|NCT01278745|19169110|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
5546178|NCT01278745|19169111|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
5546179|NCT01278745|19169112|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
5546180|NCT01278745|19169113|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
5546181|NCT01278745|19169110|P4|Overall Study|Ineligible|61
5546182|NCT01278745|19169111|P3|Overall Study|Ineligible|42
5546183|NCT01278745|19169112|P2|Overall Study|Ineligible|0
5546184|NCT01278745|19169113|P1|Overall Study|Ineligible|0
5546185|NCT01278745|19169110|P4|Overall Study|Sponsor Decision|6
5546186|NCT01278745|19169111|P3|Overall Study|Sponsor Decision|62
5546187|NCT01278745|19169112|P2|Overall Study|Sponsor Decision|0
5546188|NCT01278745|19169113|P1|Overall Study|Sponsor Decision|1
5546189|NCT01278745|19169110|P4|Overall Study|Withdrawal by Subject|1
5546190|NCT01278745|19169111|P3|Overall Study|Withdrawal by Subject|5
5546191|NCT01278745|19169112|P2|Overall Study|Withdrawal by Subject|1
5546192|NCT01278745|19169113|P1|Overall Study|Withdrawal by Subject|1
5546193|NCT01278745|19169110|P4|Overall Study|Physician Decision|9
5546194|NCT01278745|19169111|P3|Overall Study|Physician Decision|0
5546195|NCT01278745|19169112|P2|Overall Study|Physician Decision|0
5546196|NCT01278745|19169113|P1|Overall Study|Physician Decision|1
5546197|NCT01278745|19169110|P4|Overall Study|Death|0
5546198|NCT01278745|19169111|P3|Overall Study|Death|7
5546199|NCT01278745|19169112|P2|Overall Study|Death|5
5546200|NCT01278745|19169113|P1|Overall Study|Death|2
5546201|NCT01278615|19169145|P1|Overall Study|Withdrawal by Subject|2
5546202|NCT01278407|19169171|P5|Extension Phase|Other|3
5546203|NCT01278407|19169172|P4|Extension Phase|Other|1
5546204|NCT01278407|19169173|P3|Extension Phase|Other|0
5546205|NCT01278407|19169174|P2|Extension Phase|Other|0
5546206|NCT01278407|19169175|P1|Extension Phase|Other|0
5546207|NCT01278407|19169171|P5|Extension Phase|Participant's Choice|11
5546208|NCT01278407|19169172|P4|Extension Phase|Participant's Choice|4
5546209|NCT01278407|19169173|P3|Extension Phase|Participant's Choice|0
5546210|NCT01278407|19169174|P2|Extension Phase|Participant's Choice|0
5546211|NCT01278407|19169175|P1|Extension Phase|Participant's Choice|0
5546212|NCT01278407|19169171|P5|Extension Phase|Adverse Event|16
5546213|NCT01278407|19169172|P4|Extension Phase|Adverse Event|7
5546214|NCT01278407|19169173|P3|Extension Phase|Adverse Event|0
5546215|NCT01278407|19169174|P2|Extension Phase|Adverse Event|0
5546216|NCT01278407|19169175|P1|Extension Phase|Adverse Event|0
5546217|NCT01278407|19169171|P5|Confirmatory Phase|Other|0
5546218|NCT01278407|19169172|P4|Confirmatory Phase|Other|0
5546219|NCT01278407|19169173|P3|Confirmatory Phase|Other|2
5546220|NCT01278407|19169174|P2|Confirmatory Phase|Other|1
5546221|NCT01278407|19169175|P1|Confirmatory Phase|Other|1
5546222|NCT01278407|19169171|P5|Confirmatory Phase|Participant's Choice|0
5546223|NCT01278407|19169172|P4|Confirmatory Phase|Participant's Choice|0
5546224|NCT01278407|19169173|P3|Confirmatory Phase|Participant's Choice|3
5546225|NCT01278407|19169174|P2|Confirmatory Phase|Participant's Choice|5
5546226|NCT01278407|19169175|P1|Confirmatory Phase|Participant's Choice|3
5546227|NCT01278407|19169171|P5|Confirmatory Phase|Adverse Event|0
5546228|NCT01278407|19169172|P4|Confirmatory Phase|Adverse Event|0
5546229|NCT01278407|19169173|P3|Confirmatory Phase|Adverse Event|1
5546230|NCT01278407|19169174|P2|Confirmatory Phase|Adverse Event|10
5546231|NCT01278407|19169175|P1|Confirmatory Phase|Adverse Event|5
5546232|NCT01278394|19169188|P1|Overall Study|Lost to Follow-up|1
5546233|NCT01278342|19169201|P3|Overall Study|Other|0
5546234|NCT01278342|19169202|P2|Overall Study|Other|0
5546235|NCT01278342|19169203|P1|Overall Study|Other|1
5546236|NCT01278342|19169201|P3|Overall Study|Administrative problems|0
5546237|NCT01278342|19169202|P2|Overall Study|Administrative problems|0
5546238|NCT01278342|19169203|P1|Overall Study|Administrative problems|2
5546239|NCT01278342|19169201|P3|Overall Study|Lost to Follow-up|0
5546240|NCT01278342|19169202|P2|Overall Study|Lost to Follow-up|0
5546241|NCT01278342|19169203|P1|Overall Study|Lost to Follow-up|1
5546242|NCT01278342|19169201|P3|Overall Study|Physician Decision|0
5546243|NCT01278342|19169202|P2|Overall Study|Physician Decision|1
5546244|NCT01278342|19169203|P1|Overall Study|Physician Decision|0
5546245|NCT01278173|19169223|P1|Overall Study|Withdrawal by Subject|1
5546246|NCT01278173|19169223|P1|Overall Study|Protocol Violation|1
5546247|NCT01278173|19169223|P1|Overall Study|Administrative or other reason|4
5546248|NCT01278173|19169223|P1|Overall Study|Adverse Event|8
5546249|NCT01278173|19169223|P1|Overall Study|Lack of Efficacy|13
5546250|NCT01278160|19169230|P2|Overall Study|Unclassified|2
5546251|NCT01278160|19169231|P1|Overall Study|Unclassified|1
5546252|NCT01278160|19169230|P2|Overall Study|Withdrawal by Subject|2
5546253|NCT01278160|19169231|P1|Overall Study|Withdrawal by Subject|3
5546254|NCT01278160|19169230|P2|Overall Study|Lost to Follow-up|1
5546255|NCT01278160|19169231|P1|Overall Study|Lost to Follow-up|0
5546256|NCT01278160|19169230|P2|Overall Study|Adverse Event|1
5546257|NCT01278160|19169231|P1|Overall Study|Adverse Event|1
5546258|NCT01278030|19169247|P2|Overall Study|Withdrawal by Subject|4
5546259|NCT01278030|19169248|P1|Overall Study|Withdrawal by Subject|8
5546260|NCT01277887|19169256|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
5546261|NCT01277887|19169257|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
5546262|NCT01277887|19169256|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
5546263|NCT01277887|19169257|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
5546264|NCT01277887|19169256|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
5546265|NCT01277887|19169257|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
5546266|NCT01277861|19169269|P2|Overall Study|Physician Decision|2
5546267|NCT01277861|19169270|P1|Overall Study|Physician Decision|2
5546268|NCT01277822|19169282|P2|Overall Study|Participant moved|0
5546269|NCT01277822|19169283|P1|Overall Study|Participant moved|1
5546270|NCT01277822|19169282|P2|Overall Study|Contraindicated medication used|1
5546271|NCT01277822|19169283|P1|Overall Study|Contraindicated medication used|2
5546272|NCT01277822|19169282|P2|Overall Study|Lost to Follow-up|1
5546273|NCT01277822|19169283|P1|Overall Study|Lost to Follow-up|2
5546274|NCT01277822|19169282|P2|Overall Study|Protocol Violation|0
5546275|NCT01277822|19169283|P1|Overall Study|Protocol Violation|1
5546276|NCT01277822|19169282|P2|Overall Study|Physician Decision|1
5546277|NCT01277822|19169283|P1|Overall Study|Physician Decision|1
5546278|NCT01277822|19169282|P2|Overall Study|Withdrawal by Subject|7
5546279|NCT01277822|19169283|P1|Overall Study|Withdrawal by Subject|6
5546280|NCT01277822|19169282|P2|Overall Study|Adverse Event|1
5546281|NCT01277822|19169283|P1|Overall Study|Adverse Event|2
5546282|NCT01277757|19169319|P1|Overall Study|Withdrawal by Subject|1
5546283|NCT01277757|19169319|P1|Overall Study|Disease Progression|1
5546284|NCT01277744|19169326|P1|Overall Study|Physician Decision|2
5546285|NCT01277718|19169331|P2|Period 2 - Second Intervention|Physician Decision|2
5546286|NCT01277718|19169332|P1|Period 2 - Second Intervention|Physician Decision|0
5546287|NCT01277718|19169331|P2|Period 2 - Second Intervention|Protocol Violation|1
5546288|NCT01277718|19169332|P1|Period 2 - Second Intervention|Protocol Violation|0
5546289|NCT01277666|19169346|P3|Overall Study|Death|1
5546290|NCT01277666|19169347|P2|Overall Study|Death|0
5546291|NCT01277666|19169348|P1|Overall Study|Death|0
5546292|NCT01277666|19169346|P3|Overall Study|Withdrawal by Subject|6
5546293|NCT01277666|19169347|P2|Overall Study|Withdrawal by Subject|8
5546294|NCT01277666|19169348|P1|Overall Study|Withdrawal by Subject|7
5546295|NCT01277666|19169346|P3|Overall Study|Lost to Follow-up|2
5546296|NCT01277666|19169347|P2|Overall Study|Lost to Follow-up|1
5546297|NCT01277666|19169348|P1|Overall Study|Lost to Follow-up|1
5546298|NCT01277666|19169346|P3|Overall Study|Protocol Defined Stopping criteria|6
5546299|NCT01277666|19169347|P2|Overall Study|Protocol Defined Stopping criteria|2
5546300|NCT01277666|19169348|P1|Overall Study|Protocol Defined Stopping criteria|1
5546301|NCT01277666|19169346|P3|Overall Study|Protocol Violation|2
5546302|NCT01277666|19169347|P2|Overall Study|Protocol Violation|3
5546303|NCT01277666|19169348|P1|Overall Study|Protocol Violation|2
5546304|NCT01277666|19169346|P3|Overall Study|Lack of Efficacy|12
5546305|NCT01277666|19169347|P2|Overall Study|Lack of Efficacy|20
5546306|NCT01277666|19169348|P1|Overall Study|Lack of Efficacy|8
5546307|NCT01277666|19169346|P3|Overall Study|Adverse Event|20
5546308|NCT01277666|19169347|P2|Overall Study|Adverse Event|25
5546309|NCT01277666|19169348|P1|Overall Study|Adverse Event|26
5546310|NCT01277601|19169381|P4|Overall Study|Subject Terminated from Study by Sponsor|2
5546311|NCT01277601|19169382|P3|Overall Study|Subject Terminated from Study by Sponsor|0
5546312|NCT01277601|19169383|P2|Overall Study|Subject Terminated from Study by Sponsor|1
5546313|NCT01277601|19169384|P1|Overall Study|Subject Terminated from Study by Sponsor|0
5546314|NCT01277601|19169381|P4|Overall Study|Protocol Violation|0
5546315|NCT01277601|19169382|P3|Overall Study|Protocol Violation|5
5546316|NCT01277601|19169383|P2|Overall Study|Protocol Violation|2
5546317|NCT01277601|19169384|P1|Overall Study|Protocol Violation|0
5546318|NCT01277601|19169381|P4|Overall Study|Subject Never Dosed with Study Drug|1
5546319|NCT01277601|19169382|P3|Overall Study|Subject Never Dosed with Study Drug|3
5546320|NCT01277601|19169383|P2|Overall Study|Subject Never Dosed with Study Drug|2
5546321|NCT01277601|19169384|P1|Overall Study|Subject Never Dosed with Study Drug|1
5546322|NCT01277601|19169381|P4|Overall Study|Noncompliance with Study Drug|0
5546323|NCT01277601|19169382|P3|Overall Study|Noncompliance with Study Drug|2
5546324|NCT01277601|19169383|P2|Overall Study|Noncompliance with Study Drug|3
5546325|NCT01277601|19169384|P1|Overall Study|Noncompliance with Study Drug|1
5546326|NCT01277601|19169381|P4|Overall Study|Pregnancy|1
5546327|NCT01277601|19169382|P3|Overall Study|Pregnancy|4
5546328|NCT01277601|19169383|P2|Overall Study|Pregnancy|2
5546329|NCT01277601|19169384|P1|Overall Study|Pregnancy|2
5546330|NCT01277601|19169381|P4|Overall Study|Physician Decision|6
5546331|NCT01277601|19169382|P3|Overall Study|Physician Decision|1
5546332|NCT01277601|19169383|P2|Overall Study|Physician Decision|5
5546333|NCT01277601|19169384|P1|Overall Study|Physician Decision|3
5546334|NCT01277601|19169381|P4|Overall Study|Lost to Follow-up|2
5546335|NCT01277601|19169382|P3|Overall Study|Lost to Follow-up|4
5546336|NCT01277601|19169383|P2|Overall Study|Lost to Follow-up|9
5546337|NCT01277601|19169384|P1|Overall Study|Lost to Follow-up|7
5546338|NCT01277601|19169381|P4|Overall Study|Withdrawal by Subject|17
5546339|NCT01277601|19169382|P3|Overall Study|Withdrawal by Subject|8
5546340|NCT01277601|19169383|P2|Overall Study|Withdrawal by Subject|21
5546341|NCT01277601|19169384|P1|Overall Study|Withdrawal by Subject|18
5546342|NCT01277601|19169381|P4|Overall Study|Adverse Event|7
5546343|NCT01277601|19169382|P3|Overall Study|Adverse Event|0
5546344|NCT01277601|19169383|P2|Overall Study|Adverse Event|3
5546345|NCT01277601|19169384|P1|Overall Study|Adverse Event|5
5546346|NCT01277549|19169475|P2|Overall Study|Physician Decision|1
5546347|NCT01277549|19169476|P1|Overall Study|Physician Decision|2
5546348|NCT01277549|19169475|P2|Overall Study|Protocol Violation|1
5546349|NCT01277549|19169476|P1|Overall Study|Protocol Violation|10
5546350|NCT01277549|19169475|P2|Overall Study|Withdrawal by Subject|3
5546351|NCT01277549|19169476|P1|Overall Study|Withdrawal by Subject|1
5546352|NCT01277549|19169475|P2|Overall Study|Failed to meet eligibility criteria|9
5546353|NCT01277549|19169476|P1|Overall Study|Failed to meet eligibility criteria|13
5546354|NCT01277523|19169493|P3|Overall Study|Other Reason not Defined|0
5546355|NCT01277523|19169494|P2|Overall Study|Other Reason not Defined|1
5546356|NCT01277523|19169495|P1|Overall Study|Other Reason not Defined|0
5546357|NCT01277523|19169493|P3|Overall Study|Protocol Violation|0
5546358|NCT01277523|19169494|P2|Overall Study|Protocol Violation|0
5546359|NCT01277523|19169495|P1|Overall Study|Protocol Violation|2
5546360|NCT01277523|19169493|P3|Overall Study|Adverse Event|0
5546361|NCT01277523|19169494|P2|Overall Study|Adverse Event|0
5546362|NCT01277523|19169495|P1|Overall Study|Adverse Event|1
5546363|NCT01277510|19169547|P2|Open-label Phase|Never received investigational product|0
5546364|NCT01277510|19169548|P1|Open-label Phase|Never received investigational product|2
5546365|NCT01277510|19169547|P2|Open-label Phase|Protocol-specified criteria|0
5546366|NCT01277510|19169548|P1|Open-label Phase|Protocol-specified criteria|1
5546367|NCT01277510|19169547|P2|Open-label Phase|Administrative decision|3
5546368|NCT01277510|19169548|P1|Open-label Phase|Administrative decision|4
5546369|NCT01277510|19169547|P2|Double-blind Phase|Other|1
5546370|NCT01277510|19169548|P1|Double-blind Phase|Other|1
5546371|NCT01277510|19169547|P2|Double-blind Phase|Protocol-specified criteria|6
5546372|NCT01277510|19169548|P1|Double-blind Phase|Protocol-specified criteria|2
5546373|NCT01277510|19169547|P2|Double-blind Phase|Death|1
5546374|NCT01277510|19169548|P1|Double-blind Phase|Death|0
5546375|NCT01277510|19169547|P2|Double-blind Phase|Administrative decision|9
5546376|NCT01277510|19169548|P1|Double-blind Phase|Administrative decision|7
5546377|NCT01277510|19169547|P2|Double-blind Phase|Withdrawal by Subject|0
5546378|NCT01277510|19169548|P1|Double-blind Phase|Withdrawal by Subject|2
5546379|NCT01277510|19169547|P2|Double-blind Phase|Adverse Event|0
5546380|NCT01277510|19169548|P1|Double-blind Phase|Adverse Event|1
5546381|NCT01277510|19169547|P2|Double-blind Phase|Non-compliance|1
5546382|NCT01277510|19169548|P1|Double-blind Phase|Non-compliance|0
5546383|NCT01277302|19169599|P3|8-Month Alternate Dose Regimen Period|Relocation|1
5546384|NCT01277302|19169600|P2|8-Month Alternate Dose Regimen Period|Relocation|0
5546385|NCT01277302|19169601|P1|8-Month Alternate Dose Regimen Period|Relocation|1
5546386|NCT01277302|19169599|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
5546387|NCT01277302|19169600|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
5546388|NCT01277302|19169601|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
5546389|NCT01277302|19169599|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
5546390|NCT01277302|19169600|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
5546391|NCT01277302|19169601|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
5546392|NCT01277302|19169599|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
5546393|NCT01277302|19169600|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
5546394|NCT01277302|19169601|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
5546395|NCT01277302|19169599|P3|8-Month Alternate Dose Regimen Period|Death|0
5546396|NCT01277302|19169600|P2|8-Month Alternate Dose Regimen Period|Death|1
5546397|NCT01277302|19169601|P1|8-Month Alternate Dose Regimen Period|Death|0
5546398|NCT01277302|19169599|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
5546487|NCT01276639|19169804|P3|Week 0 to 16|Withdrawal by Subject|4
5546399|NCT01277302|19169600|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
5546400|NCT01277302|19169601|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
5546401|NCT01277302|19169599|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
5546402|NCT01277302|19169600|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
5546403|NCT01277302|19169601|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
5546404|NCT01277302|19169599|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
5546405|NCT01277302|19169600|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
5546406|NCT01277302|19169601|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
5546407|NCT01277302|19169599|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
5546408|NCT01277302|19169600|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
5546409|NCT01277302|19169601|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
5546410|NCT01277211|19169633|P2|Overall Study|Discontinued prior to treatment|13
5546411|NCT01277211|19169634|P1|Overall Study|Discontinued prior to treatment|24
5546412|NCT01277211|19169633|P2|Overall Study|Pregnancy wish|2
5546413|NCT01277211|19169634|P1|Overall Study|Pregnancy wish|0
5546414|NCT01277211|19169633|P2|Overall Study|Administrative|0
5546415|NCT01277211|19169634|P1|Overall Study|Administrative|3
5546416|NCT01277211|19169633|P2|Overall Study|Did not meet protocol eligibility|0
5546417|NCT01277211|19169634|P1|Overall Study|Did not meet protocol eligibility|1
5546418|NCT01277211|19169633|P2|Overall Study|Non-compliance with protocol|4
5546419|NCT01277211|19169634|P1|Overall Study|Non-compliance with protocol|13
5546420|NCT01277211|19169633|P2|Overall Study|Withdrew Consent|9
5546421|NCT01277211|19169634|P1|Overall Study|Withdrew Consent|9
5546422|NCT01277211|19169633|P2|Overall Study|Did not wish to continue|0
5546423|NCT01277211|19169634|P1|Overall Study|Did not wish to continue|17
5546424|NCT01277211|19169633|P2|Overall Study|Lost to Follow-up|9
5546425|NCT01277211|19169634|P1|Overall Study|Lost to Follow-up|14
5546426|NCT01277211|19169633|P2|Overall Study|Pregnancy|4
5546427|NCT01277211|19169634|P1|Overall Study|Pregnancy|9
5546428|NCT01277211|19169633|P2|Overall Study|Adverse Event|22
5546429|NCT01277211|19169634|P1|Overall Study|Adverse Event|60
5546430|NCT01277042|19169686|P2|Overall Study|Withdrawal by Subject|0
5546431|NCT01277042|19169687|P1|Overall Study|Withdrawal by Subject|2
5546432|NCT01277042|19169686|P2|Overall Study|Lost to Follow-up|2
5546433|NCT01277042|19169687|P1|Overall Study|Lost to Follow-up|2
5546434|NCT01277042|19169686|P2|Overall Study|Adverse Event|3
5546435|NCT01277042|19169687|P1|Overall Study|Adverse Event|4
5546436|NCT01276847|19169723|P3|Overall Study|Withdrawal by Subject|0
5546437|NCT01276847|19169724|P2|Overall Study|Withdrawal by Subject|0
5546438|NCT01276847|19169725|P1|Overall Study|Withdrawal by Subject|1
5546439|NCT01276821|19169735|P2|Overall Study|Protocol Violation|1
5546440|NCT01276821|19169736|P1|Overall Study|Protocol Violation|0
5546441|NCT01276756|19169756|P2|Overall Study|Adverse Event|2
5546442|NCT01276756|19169757|P1|Overall Study|Adverse Event|3
5546443|NCT01276756|19169756|P2|Overall Study|Lost to Follow-up|0
5546444|NCT01276756|19169757|P1|Overall Study|Lost to Follow-up|2
5546445|NCT01276639|19169802|P5|Week 16 to 52|Other|3
5546446|NCT01276639|19169803|P4|Week 16 to 52|Other|1
5546447|NCT01276639|19169804|P3|Week 16 to 52|Other|0
5546448|NCT01276639|19169805|P2|Week 16 to 52|Other|12
5546449|NCT01276639|19169806|P1|Week 16 to 52|Other|10
5546450|NCT01276639|19169802|P5|Week 16 to 52|Withdrawal by Subject|1
5546451|NCT01276639|19169803|P4|Week 16 to 52|Withdrawal by Subject|0
5546452|NCT01276639|19169804|P3|Week 16 to 52|Withdrawal by Subject|0
5546453|NCT01276639|19169805|P2|Week 16 to 52|Withdrawal by Subject|4
5546454|NCT01276639|19169806|P1|Week 16 to 52|Withdrawal by Subject|4
5546455|NCT01276639|19169802|P5|Week 16 to 52|Lost to Follow-up|1
5546456|NCT01276639|19169803|P4|Week 16 to 52|Lost to Follow-up|0
5546457|NCT01276639|19169804|P3|Week 16 to 52|Lost to Follow-up|0
5546458|NCT01276639|19169805|P2|Week 16 to 52|Lost to Follow-up|1
5546459|NCT01276639|19169806|P1|Week 16 to 52|Lost to Follow-up|3
5546460|NCT01276639|19169802|P5|Week 16 to 52|Lack of Efficacy|13
5546461|NCT01276639|19169803|P4|Week 16 to 52|Lack of Efficacy|14
5546462|NCT01276639|19169804|P3|Week 16 to 52|Lack of Efficacy|0
5546463|NCT01276639|19169805|P2|Week 16 to 52|Lack of Efficacy|71
5546464|NCT01276639|19169806|P1|Week 16 to 52|Lack of Efficacy|99
5546465|NCT01276639|19169802|P5|Week 16 to 52|Adverse Event|3
5546466|NCT01276639|19169803|P4|Week 16 to 52|Adverse Event|1
5546467|NCT01276639|19169804|P3|Week 16 to 52|Adverse Event|0
5546468|NCT01276639|19169805|P2|Week 16 to 52|Adverse Event|13
5546469|NCT01276639|19169806|P1|Week 16 to 52|Adverse Event|10
5546470|NCT01276639|19169802|P5|Week 16 to 52|Death|0
5546471|NCT01276639|19169803|P4|Week 16 to 52|Death|0
5546472|NCT01276639|19169804|P3|Week 16 to 52|Death|0
5546473|NCT01276639|19169805|P2|Week 16 to 52|Death|0
5546474|NCT01276639|19169806|P1|Week 16 to 52|Death|1
5546475|NCT01276639|19169802|P5|Week 0 to 16|Randomized, But Not Treated|0
5546476|NCT01276639|19169803|P4|Week 0 to 16|Randomized, But Not Treated|0
5546477|NCT01276639|19169804|P3|Week 0 to 16|Randomized, But Not Treated|0
5546478|NCT01276639|19169805|P2|Week 0 to 16|Randomized, But Not Treated|1
5546479|NCT01276639|19169806|P1|Week 0 to 16|Randomized, But Not Treated|0
5546480|NCT01276639|19169802|P5|Week 0 to 16|Other|0
5546481|NCT01276639|19169803|P4|Week 0 to 16|Other|0
5546482|NCT01276639|19169804|P3|Week 0 to 16|Other|2
5546483|NCT01276639|19169805|P2|Week 0 to 16|Other|7
5546484|NCT01276639|19169806|P1|Week 0 to 16|Other|7
5546485|NCT01276639|19169802|P5|Week 0 to 16|Withdrawal by Subject|0
5546486|NCT01276639|19169803|P4|Week 0 to 16|Withdrawal by Subject|0
5546488|NCT01276639|19169805|P2|Week 0 to 16|Withdrawal by Subject|5
5546489|NCT01276639|19169806|P1|Week 0 to 16|Withdrawal by Subject|8
5546490|NCT01276639|19169802|P5|Week 0 to 16|Lost to Follow-up|0
5546491|NCT01276639|19169803|P4|Week 0 to 16|Lost to Follow-up|0
5546492|NCT01276639|19169804|P3|Week 0 to 16|Lost to Follow-up|3
5546493|NCT01276639|19169805|P2|Week 0 to 16|Lost to Follow-up|5
5546494|NCT01276639|19169806|P1|Week 0 to 16|Lost to Follow-up|3
5546495|NCT01276639|19169802|P5|Week 0 to 16|Lack of Efficacy|0
5546496|NCT01276639|19169803|P4|Week 0 to 16|Lack of Efficacy|0
5546497|NCT01276639|19169804|P3|Week 0 to 16|Lack of Efficacy|25
5546498|NCT01276639|19169805|P2|Week 0 to 16|Lack of Efficacy|15
5546499|NCT01276639|19169806|P1|Week 0 to 16|Lack of Efficacy|20
5546500|NCT01276639|19169802|P5|Week 0 to 16|Adverse Event|0
5546501|NCT01276639|19169803|P4|Week 0 to 16|Adverse Event|0
5546502|NCT01276639|19169804|P3|Week 0 to 16|Adverse Event|11
5546503|NCT01276639|19169805|P2|Week 0 to 16|Adverse Event|8
5546504|NCT01276639|19169806|P1|Week 0 to 16|Adverse Event|11
5546505|NCT01276639|19169802|P5|Week 0 to 16|Death|0
5546506|NCT01276639|19169803|P4|Week 0 to 16|Death|0
5546507|NCT01276639|19169804|P3|Week 0 to 16|Death|0
5546508|NCT01276639|19169805|P2|Week 0 to 16|Death|0
5546509|NCT01276639|19169806|P1|Week 0 to 16|Death|1
5546510|NCT01276509|19170011|P4|Overall Study|Other|0
5546511|NCT01276509|19170012|P3|Overall Study|Other|0
5546512|NCT01276509|19170013|P2|Overall Study|Other|1
5546513|NCT01276509|19170014|P1|Overall Study|Other|0
5546514|NCT01276509|19170011|P4|Overall Study|Withdrawal by Subject|0
5546515|NCT01276509|19170012|P3|Overall Study|Withdrawal by Subject|0
5546516|NCT01276509|19170013|P2|Overall Study|Withdrawal by Subject|2
5546517|NCT01276509|19170014|P1|Overall Study|Withdrawal by Subject|1
5546518|NCT01276509|19170011|P4|Overall Study|Pregnancy|0
5546519|NCT01276509|19170012|P3|Overall Study|Pregnancy|0
5546520|NCT01276509|19170013|P2|Overall Study|Pregnancy|0
5546521|NCT01276509|19170014|P1|Overall Study|Pregnancy|1
5546522|NCT01276509|19170011|P4|Overall Study|Lack of Efficacy|2
5546523|NCT01276509|19170012|P3|Overall Study|Lack of Efficacy|1
5546524|NCT01276509|19170013|P2|Overall Study|Lack of Efficacy|1
5546525|NCT01276509|19170014|P1|Overall Study|Lack of Efficacy|2
5546526|NCT01276509|19170011|P4|Overall Study|Adverse Event|3
5546527|NCT01276509|19170012|P3|Overall Study|Adverse Event|4
5546528|NCT01276509|19170013|P2|Overall Study|Adverse Event|8
5546529|NCT01276509|19170014|P1|Overall Study|Adverse Event|9
5546530|NCT01276457|19170067|P2|Extension Study|Lack of Efficacy|1
5546531|NCT01276457|19170068|P1|Extension Study|Lack of Efficacy|3
5546532|NCT01276457|19170067|P2|Extension Study|Death|1
5546533|NCT01276457|19170068|P1|Extension Study|Death|0
5546534|NCT01276457|19170067|P2|Extension Study|Lost to Follow-up|0
5546535|NCT01276457|19170068|P1|Extension Study|Lost to Follow-up|3
5546536|NCT01276457|19170067|P2|Core Study|Lack of Efficacy|12
5546537|NCT01276457|19170068|P1|Core Study|Lack of Efficacy|3
5546538|NCT01276457|19170067|P2|Core Study|Death|2
5546539|NCT01276457|19170068|P1|Core Study|Death|2
5546540|NCT01276457|19170067|P2|Core Study|Administrative problems|1
5546541|NCT01276457|19170068|P1|Core Study|Administrative problems|1
5546542|NCT01276457|19170067|P2|Core Study|Lost to Follow-up|2
5546543|NCT01276457|19170068|P1|Core Study|Lost to Follow-up|1
5546544|NCT01276457|19170067|P2|Core Study|Adverse Event|3
5546545|NCT01276457|19170068|P1|Core Study|Adverse Event|6
5546546|NCT01276353|19170082|P2|Extension|Prohibited concomitant medications|1
5546547|NCT01276353|19170083|P1|Extension|Prohibited concomitant medications|0
5546548|NCT01276353|19170082|P2|Extension|Physician Decision|0
5546549|NCT01276353|19170083|P1|Extension|Physician Decision|1
5546550|NCT01276353|19170082|P2|Extension|Withdrawal of study drug 4 days in a row|1
5546551|NCT01276353|19170083|P1|Extension|Withdrawal of study drug 4 days in a row|3
5546552|NCT01276353|19170082|P2|Extension|Withdrawal by Subject|2
5546553|NCT01276353|19170083|P1|Extension|Withdrawal by Subject|1
5546554|NCT01276353|19170082|P2|Extension|Adverse Event|5
5546555|NCT01276353|19170083|P1|Extension|Adverse Event|2
5546556|NCT01276353|19170082|P2|Double-blind|Withdrawal by Subject|0
5546557|NCT01276353|19170083|P1|Double-blind|Withdrawal by Subject|1
5546558|NCT01276353|19170082|P2|Double-blind|Adverse Event|0
5546559|NCT01276353|19170083|P1|Double-blind|Adverse Event|2
5546560|NCT01276327|19170095|P2|Overall Study|Withdrawal by Subject|0
5546561|NCT01276327|19170096|P1|Overall Study|Withdrawal by Subject|1
5546562|NCT01276327|19170095|P2|Overall Study|Adverse Event|3
5546563|NCT01276327|19170096|P1|Overall Study|Adverse Event|1
5546564|NCT01276288|19170163|P4|Overall Study|not treated|0
5546565|NCT01276288|19170164|P3|Overall Study|not treated|0
5546566|NCT01276288|19170165|P2|Overall Study|not treated|0
5546567|NCT01276288|19170166|P1|Overall Study|not treated|1
5546568|NCT01276288|19170163|P4|Overall Study|Adverse Event|0
5546569|NCT01276288|19170164|P3|Overall Study|Adverse Event|0
5546570|NCT01276288|19170165|P2|Overall Study|Adverse Event|1
5546571|NCT01276288|19170166|P1|Overall Study|Adverse Event|1
5546572|NCT01276223|19170293|P3|Overall Study|Protocol Violation|0
5546573|NCT01276223|19170294|P2|Overall Study|Protocol Violation|0
5546574|NCT01276223|19170295|P1|Overall Study|Protocol Violation|1
5546575|NCT01276223|19170293|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
5546576|NCT01276223|19170294|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
5546577|NCT01276223|19170295|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
5546578|NCT01276223|19170293|P3|Overall Study|Other|1
5546579|NCT01276223|19170294|P2|Overall Study|Other|0
5546580|NCT01276223|19170295|P1|Overall Study|Other|0
5546581|NCT01276223|19170293|P3|Overall Study|Lost to Follow-up|1
5546582|NCT01276223|19170294|P2|Overall Study|Lost to Follow-up|0
5546583|NCT01276223|19170295|P1|Overall Study|Lost to Follow-up|0
5546584|NCT01276223|19170293|P3|Overall Study|Adverse Event|1
5546585|NCT01276223|19170294|P2|Overall Study|Adverse Event|4
5546586|NCT01276223|19170295|P1|Overall Study|Adverse Event|7
5546587|NCT01276106|19170336|P4|Overall Study|Insufficient therapeutic effects|0
5546588|NCT01276106|19170337|P3|Overall Study|Insufficient therapeutic effects|2
5546589|NCT01276106|19170338|P2|Overall Study|Insufficient therapeutic effects|0
5546590|NCT01276106|19170339|P1|Overall Study|Insufficient therapeutic effects|0
5546591|NCT01276106|19170336|P4|Overall Study|Protocol Violation|2
5546592|NCT01276106|19170337|P3|Overall Study|Protocol Violation|0
5546593|NCT01276106|19170338|P2|Overall Study|Protocol Violation|1
5546594|NCT01276106|19170339|P1|Overall Study|Protocol Violation|1
5546595|NCT01276106|19170336|P4|Overall Study|Physician Decision|1
5546596|NCT01276106|19170337|P3|Overall Study|Physician Decision|1
5546597|NCT01276106|19170338|P2|Overall Study|Physician Decision|0
5546598|NCT01276106|19170339|P1|Overall Study|Physician Decision|0
5546599|NCT01276106|19170336|P4|Overall Study|Lost to Follow-up|0
5546600|NCT01276106|19170337|P3|Overall Study|Lost to Follow-up|1
5546601|NCT01276106|19170338|P2|Overall Study|Lost to Follow-up|1
5546602|NCT01276106|19170339|P1|Overall Study|Lost to Follow-up|2
5546603|NCT01276106|19170336|P4|Overall Study|Lack of Efficacy|1
5546604|NCT01276106|19170337|P3|Overall Study|Lack of Efficacy|0
5546605|NCT01276106|19170338|P2|Overall Study|Lack of Efficacy|1
5546606|NCT01276106|19170339|P1|Overall Study|Lack of Efficacy|0
5546607|NCT01276106|19170336|P4|Overall Study|Withdrawal by Subject|6
5546608|NCT01276106|19170337|P3|Overall Study|Withdrawal by Subject|1
5546609|NCT01276106|19170338|P2|Overall Study|Withdrawal by Subject|3
5546610|NCT01276106|19170339|P1|Overall Study|Withdrawal by Subject|6
5546611|NCT01276106|19170336|P4|Overall Study|Adverse Event|3
5546612|NCT01276106|19170337|P3|Overall Study|Adverse Event|11
5546613|NCT01276106|19170338|P2|Overall Study|Adverse Event|3
5546614|NCT01276106|19170339|P1|Overall Study|Adverse Event|3
5546615|NCT01276054|19170351|P2|Overall Study|No one to oversee trial after P.I. left|2
5546616|NCT01276054|19170352|P1|Overall Study|No one to oversee trial after P.I. left|2
5546617|NCT01276041|19170358|P1|Overall Study|Protocol Violation|1
5546618|NCT01276041|19170358|P1|Overall Study|Adverse Event|2
5546619|NCT01275833|19170367|P2|Overall Study|Study terminated|1
5546620|NCT01275833|19170368|P1|Overall Study|Study terminated|1
5546621|NCT01275755|19170376|P2|Run-out Placebo Period|Lost to Follow-up|0
5546622|NCT01275755|19170377|P1|Run-out Placebo Period|Lost to Follow-up|1
5546623|NCT01275755|19170376|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5546624|NCT01275755|19170377|P1|Double-blind Treatment Period|Withdrawal by Subject|1
5546625|NCT01275755|19170376|P2|Double-blind Treatment Period|Lost to Follow-up|1
5546626|NCT01275755|19170377|P1|Double-blind Treatment Period|Lost to Follow-up|1
5546627|NCT01275755|19170376|P2|Double-blind Treatment Period|Adverse Event|2
5546628|NCT01275755|19170377|P1|Double-blind Treatment Period|Adverse Event|0
5546629|NCT01275677|19170385|P2|Overall Study|No clinical follow up.|4
5546630|NCT01275677|19170386|P1|Overall Study|No clinical follow up.|1
5546631|NCT01275677|19170385|P2|Overall Study|No follow-up|37
5546632|NCT01275677|19170386|P1|Overall Study|No follow-up|26
5546633|NCT01275677|19170385|P2|Overall Study|Not at risk for recurrence.|1
5546634|NCT01275677|19170386|P1|Overall Study|Not at risk for recurrence.|1
5546635|NCT01275625|19170412|P1|Overall Study|Other|1
5546636|NCT01275625|19170412|P1|Overall Study|Adverse Event|4
5546637|NCT01275625|19170412|P1|Overall Study|Protocol Violation|1
5546638|NCT01275625|19170412|P1|Overall Study|Withdrawal by Subject|3
5546639|NCT01275625|19170412|P1|Overall Study|Lost to Follow-up|1
5546640|NCT01275625|19170412|P1|Overall Study|Lack of Efficacy|2
5546641|NCT01275625|19170412|P1|Overall Study|Death|1
5546642|NCT01275430|19170430|P1|Overall Study|Inability to achieve maximum p-wave|1
5546643|NCT01275430|19170430|P1|Overall Study|Device Malfunction|1
5546644|NCT01275430|19170430|P1|Overall Study|No Contrast Injection|6
5546645|NCT01275430|19170430|P1|Overall Study|Adverse Event|1
5546646|NCT01275339|19170495|P4|Overall Study|Withdrawal by Subject|0
5546647|NCT01275339|19170496|P3|Overall Study|Withdrawal by Subject|1
5546648|NCT01275339|19170497|P2|Overall Study|Withdrawal by Subject|0
5546649|NCT01275339|19170498|P1|Overall Study|Withdrawal by Subject|0
5546650|NCT01275339|19170495|P4|Overall Study|Referred for surgery for AS symptoms|0
5546651|NCT01275339|19170496|P3|Overall Study|Referred for surgery for AS symptoms|0
5546652|NCT01275339|19170497|P2|Overall Study|Referred for surgery for AS symptoms|0
5546653|NCT01275339|19170498|P1|Overall Study|Referred for surgery for AS symptoms|1
5546654|NCT01275196|19170526|P2|Overall Study|Suboptimal response/treatment failure|6
5546655|NCT01275196|19170527|P1|Overall Study|Suboptimal response/treatment failure|5
5546656|NCT01275196|19170526|P2|Overall Study|Protocol Violation|0
5546657|NCT01275196|19170527|P1|Overall Study|Protocol Violation|1
5546658|NCT01275196|19170526|P2|Overall Study|Disease Progression|5
5546659|NCT01275196|19170527|P1|Overall Study|Disease Progression|6
5546660|NCT01275196|19170526|P2|Overall Study|Lost to Follow-up|0
5546661|NCT01275196|19170527|P1|Overall Study|Lost to Follow-up|1
5546662|NCT01275196|19170526|P2|Overall Study|Withdrawal by Subject|5
5546663|NCT01275196|19170527|P1|Overall Study|Withdrawal by Subject|4
5546664|NCT01275196|19170526|P2|Overall Study|Adverse Event|5
5546665|NCT01275196|19170527|P1|Overall Study|Adverse Event|3
5546666|NCT01275170|19170574|P8|Part 1: Period 1|Equipment malfunction before study drug|0
5546667|NCT01275170|19170575|P7|Part 1: Period 1|Equipment malfunction before study drug|0
5546668|NCT01275170|19170576|P6|Part 1: Period 1|Equipment malfunction before study drug|0
5546669|NCT01275170|19170577|P5|Part 1: Period 1|Equipment malfunction before study drug|0
5546670|NCT01275170|19170578|P4|Part 1: Period 1|Equipment malfunction before study drug|0
5546671|NCT01275170|19170579|P3|Part 1: Period 1|Equipment malfunction before study drug|0
5546672|NCT01275170|19170580|P2|Part 1: Period 1|Equipment malfunction before study drug|0
5546673|NCT01275170|19170581|P1|Part 1: Period 1|Equipment malfunction before study drug|1
5546674|NCT01275144|19170799|P2|Second Intervention (6 Days)|Withdrawal by Subject|0
5546675|NCT01275144|19170800|P1|Second Intervention (6 Days)|Withdrawal by Subject|1
5546676|NCT01275131|19170858|P4|Period 2 (Crossover)|Withdrawal by Subject|2
5546677|NCT01275131|19170859|P3|Period 2 (Crossover)|Withdrawal by Subject|1
5546678|NCT01275131|19170860|P2|Period 2 (Crossover)|Withdrawal by Subject|0
5546679|NCT01275131|19170861|P1|Period 2 (Crossover)|Withdrawal by Subject|1
5546680|NCT01275131|19170858|P4|Period 2 (Crossover)|Adverse Event|0
5546681|NCT01275131|19170859|P3|Period 2 (Crossover)|Adverse Event|0
5546682|NCT01275131|19170860|P2|Period 2 (Crossover)|Adverse Event|1
5546683|NCT01275131|19170861|P1|Period 2 (Crossover)|Adverse Event|0
5546684|NCT01275131|19170858|P4|Period 1|Physician Decision|0
5546685|NCT01275131|19170859|P3|Period 1|Physician Decision|0
5546686|NCT01275131|19170860|P2|Period 1|Physician Decision|0
5546687|NCT01275131|19170861|P1|Period 1|Physician Decision|1
5546688|NCT01275131|19170858|P4|Period 1|Withdrawal by Subject|2
5546689|NCT01275131|19170859|P3|Period 1|Withdrawal by Subject|3
5546690|NCT01275131|19170860|P2|Period 1|Withdrawal by Subject|0
5546691|NCT01275131|19170861|P1|Period 1|Withdrawal by Subject|1
5546692|NCT01275066|19170904|P3|Overall Study|Not Diagnosed w/ Disease|0
5546693|NCT01275066|19170905|P2|Overall Study|Not Diagnosed w/ Disease|0
5546694|NCT01275066|19170906|P1|Overall Study|Not Diagnosed w/ Disease|1
5546695|NCT01275066|19170904|P3|Overall Study|Withdrawal by Subject|1
5546696|NCT01275066|19170905|P2|Overall Study|Withdrawal by Subject|0
5546697|NCT01275066|19170906|P1|Overall Study|Withdrawal by Subject|0
5546698|NCT01274715|19170939|P1|Overall Study|After consent, met exclusion criteria.|1
5546699|NCT01274715|19170939|P1|Overall Study|After consent, met exclusion criteria.|1
5546700|NCT01274715|19170939|P1|Overall Study|After consent, met exclusion criteria.|1
5546701|NCT01274715|19170939|P1|Overall Study|Lost to Follow-up|1
5546702|NCT01274637|19170946|P2|Overall Study|Lost to Follow-up|1
5546703|NCT01274637|19170947|P1|Overall Study|Lost to Follow-up|0
5546704|NCT01274637|19170946|P2|Overall Study|Withdrawal by Subject|1
5546705|NCT01274637|19170947|P1|Overall Study|Withdrawal by Subject|0
5546706|NCT01274559|19170986|P2|Overall Study|Withdrawal by Subject|13
5546707|NCT01274559|19170987|P1|Overall Study|Withdrawal by Subject|25
5546708|NCT01274559|19170986|P2|Overall Study|Study Terminated by Sponsor|87
5546709|NCT01274559|19170987|P1|Overall Study|Study Terminated by Sponsor|79
5546710|NCT01274559|19170986|P2|Overall Study|Protocol Violation|23
5546711|NCT01274559|19170987|P1|Overall Study|Protocol Violation|28
5546712|NCT01274559|19170986|P2|Overall Study|Physician Decision|1
5546713|NCT01274559|19170987|P1|Overall Study|Physician Decision|2
5546714|NCT01274559|19170986|P2|Overall Study|Non-compliance with Study Drug|4
5546715|NCT01274559|19170987|P1|Overall Study|Non-compliance with Study Drug|2
5546716|NCT01274559|19170986|P2|Overall Study|Lost to Follow-up|3
5546717|NCT01274559|19170987|P1|Overall Study|Lost to Follow-up|3
5546718|NCT01274559|19170986|P2|Overall Study|Death|1
5546719|NCT01274559|19170987|P1|Overall Study|Death|1
5546720|NCT01274559|19170986|P2|Overall Study|Adverse Event|13
5546721|NCT01274559|19170987|P1|Overall Study|Adverse Event|57
5546722|NCT01274533|19171037|P1|Overall Study|Disease progression|2
5546723|NCT01274533|19171037|P1|Overall Study|Non-compliance|1
5546724|NCT01274533|19171037|P1|Overall Study|Withdrawal by Subject|1
5546725|NCT01274429|19171073|P1|Overall Study|Study closed do to lack of funding|5
5546726|NCT01274351|19171078|P1|Overall Study|hospitalization|1
5546727|NCT01274351|19171078|P1|Overall Study|progression of disease|3
5546728|NCT01274351|19171078|P1|Overall Study|Adverse Event|8
5546729|NCT01274351|19171078|P1|Overall Study|Withdrawal by Subject|3
5546730|NCT01274351|19171078|P1|Overall Study|Death|2
5546731|NCT01274351|19171078|P1|Overall Study|Pregnancy|1
5546732|NCT01274351|19171078|P1|Overall Study|patient not compliant with the protocol|1
5546733|NCT01274351|19171078|P1|Overall Study|Lost to Follow-up|1
5546734|NCT01274182|19171090|P3|Overall Study|Death|1
5546735|NCT01274182|19171091|P2|Overall Study|Death|0
5546736|NCT01274182|19171092|P1|Overall Study|Death|1
5546737|NCT01274182|19171090|P3|Overall Study|Protocol Violation|0
5546738|NCT01274182|19171091|P2|Overall Study|Protocol Violation|2
5546739|NCT01274182|19171092|P1|Overall Study|Protocol Violation|3
5546740|NCT01274182|19171090|P3|Overall Study|Lost to Follow-up|1
5546741|NCT01274182|19171091|P2|Overall Study|Lost to Follow-up|3
5546742|NCT01274182|19171092|P1|Overall Study|Lost to Follow-up|2
5546743|NCT01274182|19171090|P3|Overall Study|Withdrawal by Subject|3
5546744|NCT01274182|19171091|P2|Overall Study|Withdrawal by Subject|5
5546745|NCT01274182|19171092|P1|Overall Study|Withdrawal by Subject|5
5546746|NCT01274182|19171090|P3|Overall Study|Adverse Event|3
5546747|NCT01274182|19171091|P2|Overall Study|Adverse Event|5
5546748|NCT01274182|19171092|P1|Overall Study|Adverse Event|4
5546749|NCT01274182|19171090|P3|Overall Study|Unsatisfactory therapeutic effect|4
5546750|NCT01274182|19171091|P2|Overall Study|Unsatisfactory therapeutic effect|3
5546751|NCT01274182|19171092|P1|Overall Study|Unsatisfactory therapeutic effect|6
5546752|NCT01273883|19171133|P2|Second Intervention|Lack of Efficacy|0
5546753|NCT01273883|19171134|P1|Second Intervention|Lack of Efficacy|1
5546754|NCT01273883|19171133|P2|Second Intervention|Lost to Follow-up|1
5546755|NCT01273883|19171134|P1|Second Intervention|Lost to Follow-up|1
5546756|NCT01273883|19171133|P2|First Intervention|Adverse Event|1
5546757|NCT01273883|19171134|P1|First Intervention|Adverse Event|2
5546758|NCT01273818|19171160|P3|Overall Study|Physician Decision|9
5546759|NCT01273818|19171161|P2|Overall Study|Physician Decision|2
5546760|NCT01273818|19171162|P1|Overall Study|Physician Decision|13
5546761|NCT01273805|19171172|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
5546762|NCT01273805|19171173|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
5546763|NCT01273623|19171204|P1|Overall Study|did not meet IVUS criteria|29
5546764|NCT01273597|19171211|P1|Overall Study|Reason Not Reported|1
5546765|NCT01273597|19171211|P1|Overall Study|Underwent Kidney Transplantation|2
5546766|NCT01273597|19171211|P1|Overall Study|Adverse Event|5
5546767|NCT01273519|19171226|P3|Overall Study|Other|1
5546768|NCT01273519|19171227|P2|Overall Study|Other|1
5546769|NCT01273519|19171228|P1|Overall Study|Other|6
5546770|NCT01273519|19171226|P3|Overall Study|Lack of Efficacy|4
5546771|NCT01273519|19171227|P2|Overall Study|Lack of Efficacy|3
5546772|NCT01273519|19171228|P1|Overall Study|Lack of Efficacy|8
5546773|NCT01273519|19171226|P3|Overall Study|Lost to Follow-up|3
5546774|NCT01273519|19171227|P2|Overall Study|Lost to Follow-up|1
5546775|NCT01273519|19171228|P1|Overall Study|Lost to Follow-up|2
5546776|NCT01273519|19171226|P3|Overall Study|Adverse Event|0
5546777|NCT01273519|19171227|P2|Overall Study|Adverse Event|0
5546778|NCT01273519|19171228|P1|Overall Study|Adverse Event|3
5546779|NCT01273181|19171271|P4|Phase 2, Dose 2|Death during treatment|1
5546780|NCT01273181|19171272|P3|Phase 2, Dose 2|Death during treatment|0
5546781|NCT01273181|19171273|P2|Phase 2, Dose 2|Death during treatment|0
5546782|NCT01273181|19171274|P1|Phase 2, Dose 2|Death during treatment|0
5546783|NCT01273181|19171271|P4|Phase 2, Dose 1|Study termination|0
5546784|NCT01273181|19171272|P3|Phase 2, Dose 1|Study termination|1
5546785|NCT01273181|19171273|P2|Phase 2, Dose 1|Study termination|0
5546786|NCT01273181|19171274|P1|Phase 2, Dose 1|Study termination|0
5546787|NCT01273181|19171271|P4|Phase I, Dose 2|Death during treatment|0
5546788|NCT01273181|19171272|P3|Phase I, Dose 2|Death during treatment|0
5546789|NCT01273181|19171273|P2|Phase I, Dose 2|Death during treatment|1
5546790|NCT01273181|19171274|P1|Phase I, Dose 2|Death during treatment|0
5546791|NCT01273181|19171271|P4|Phase I, Dose 1|Study termination|0
5546792|NCT01273181|19171272|P3|Phase I, Dose 1|Study termination|0
5546793|NCT01273181|19171273|P2|Phase I, Dose 1|Study termination|0
5546794|NCT01273181|19171274|P1|Phase I, Dose 1|Study termination|1
5546795|NCT01273155|19171292|P7|Overall Study|Withdrew during C1/refused further trmt|0
5546796|NCT01273155|19171293|P6|Overall Study|Withdrew during C1/refused further trmt|1
5546797|NCT01273155|19171294|P5|Overall Study|Withdrew during C1/refused further trmt|1
5546798|NCT01273155|19171295|P4|Overall Study|Withdrew during C1/refused further trmt|0
5546799|NCT01273155|19171296|P3|Overall Study|Withdrew during C1/refused further trmt|1
5546800|NCT01273155|19171297|P2|Overall Study|Withdrew during C1/refused further trmt|0
5546801|NCT01273155|19171298|P1|Overall Study|Withdrew during C1/refused further trmt|0
5546802|NCT01273155|19171292|P7|Overall Study|Died during Cycle 1|2
5546803|NCT01273155|19171293|P6|Overall Study|Died during Cycle 1|2
5546804|NCT01273155|19171294|P5|Overall Study|Died during Cycle 1|0
5546805|NCT01273155|19171295|P4|Overall Study|Died during Cycle 1|1
5546806|NCT01273155|19171296|P3|Overall Study|Died during Cycle 1|1
5546807|NCT01273155|19171297|P2|Overall Study|Died during Cycle 1|0
5546808|NCT01273155|19171298|P1|Overall Study|Died during Cycle 1|0
5546809|NCT01273155|19171292|P7|Overall Study|Off study prior to C1/due to toxicity|1
5546810|NCT01273155|19171293|P6|Overall Study|Off study prior to C1/due to toxicity|0
5546811|NCT01273155|19171294|P5|Overall Study|Off study prior to C1/due to toxicity|0
5546812|NCT01273155|19171295|P4|Overall Study|Off study prior to C1/due to toxicity|0
5546813|NCT01273155|19171296|P3|Overall Study|Off study prior to C1/due to toxicity|2
5546814|NCT01273155|19171297|P2|Overall Study|Off study prior to C1/due to toxicity|0
5546815|NCT01273155|19171298|P1|Overall Study|Off study prior to C1/due to toxicity|0
5546816|NCT01273155|19171292|P7|Overall Study|Change in liver function/no longer eval.|0
5546817|NCT01273155|19171293|P6|Overall Study|Change in liver function/no longer eval.|0
5546818|NCT01273155|19171294|P5|Overall Study|Change in liver function/no longer eval.|1
5546819|NCT01273155|19171295|P4|Overall Study|Change in liver function/no longer eval.|0
5546820|NCT01273155|19171296|P3|Overall Study|Change in liver function/no longer eval.|0
5546821|NCT01273155|19171297|P2|Overall Study|Change in liver function/no longer eval.|1
5546822|NCT01273155|19171298|P1|Overall Study|Change in liver function/no longer eval.|0
5546823|NCT01273155|19171292|P7|Overall Study|Off study trmt prior to end of C1/PD|3
5546824|NCT01273155|19171293|P6|Overall Study|Off study trmt prior to end of C1/PD|2
5546825|NCT01273155|19171294|P5|Overall Study|Off study trmt prior to end of C1/PD|0
5546826|NCT01273155|19171295|P4|Overall Study|Off study trmt prior to end of C1/PD|0
5546827|NCT01273155|19171296|P3|Overall Study|Off study trmt prior to end of C1/PD|8
5546828|NCT01273155|19171297|P2|Overall Study|Off study trmt prior to end of C1/PD|3
5546829|NCT01273155|19171298|P1|Overall Study|Off study trmt prior to end of C1/PD|2
5546830|NCT01273064|19171375|P5|Overall Study|Physician Decision|1
5546831|NCT01273064|19171376|P4|Overall Study|Physician Decision|0
5546832|NCT01273064|19171377|P3|Overall Study|Physician Decision|0
5546833|NCT01273064|19171378|P2|Overall Study|Physician Decision|0
5546834|NCT01273064|19171379|P1|Overall Study|Physician Decision|0
5546835|NCT01273064|19171375|P5|Overall Study|Lost to Follow-up|0
5546836|NCT01273064|19171376|P4|Overall Study|Lost to Follow-up|0
5546837|NCT01273064|19171377|P3|Overall Study|Lost to Follow-up|0
5546838|NCT01273064|19171378|P2|Overall Study|Lost to Follow-up|0
5546839|NCT01273064|19171379|P1|Overall Study|Lost to Follow-up|1
5546840|NCT01273064|19171375|P5|Overall Study|Study Termination|8
5546841|NCT01273064|19171376|P4|Overall Study|Study Termination|16
5546842|NCT01273064|19171377|P3|Overall Study|Study Termination|26
5546843|NCT01273064|19171378|P2|Overall Study|Study Termination|27
5546844|NCT01273064|19171379|P1|Overall Study|Study Termination|13
5546845|NCT01273064|19171375|P5|Overall Study|Withdrawal by Subject|0
5546846|NCT01273064|19171376|P4|Overall Study|Withdrawal by Subject|2
5546847|NCT01273064|19171377|P3|Overall Study|Withdrawal by Subject|2
5546848|NCT01273064|19171378|P2|Overall Study|Withdrawal by Subject|2
5546849|NCT01273064|19171379|P1|Overall Study|Withdrawal by Subject|4
5546850|NCT01273064|19171375|P5|Overall Study|Adverse Event|1
5546851|NCT01273064|19171376|P4|Overall Study|Adverse Event|2
5546852|NCT01273064|19171377|P3|Overall Study|Adverse Event|3
5546853|NCT01273064|19171378|P2|Overall Study|Adverse Event|1
5546854|NCT01273064|19171379|P1|Overall Study|Adverse Event|5
5546855|NCT01273038|19171398|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
5546856|NCT01273038|19171399|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
5546857|NCT01273038|19171398|P2|Second Intervention (14 Days)|Adverse Event|1
5546858|NCT01273038|19171399|P1|Second Intervention (14 Days)|Adverse Event|0
5546859|NCT01272947|19171449|P2|Overall Study|Abnormal Laboratory Value|2
5546860|NCT01272947|19171450|P1|Overall Study|Abnormal Laboratory Value|2
5546861|NCT01272934|19171460|P2|Overall Study|Abnormal Laboratory Value|1
5546862|NCT01272934|19171461|P1|Overall Study|Abnormal Laboratory Value|0
5546863|NCT01272934|19171460|P2|Overall Study|Adverse Event|1
5546864|NCT01272934|19171461|P1|Overall Study|Adverse Event|0
5546865|NCT01272921|19171471|P2|Overall Study|Protocol Violation|1
5546866|NCT01272921|19171472|P1|Overall Study|Protocol Violation|2
5546867|NCT01272908|19171480|P1|Re-Treatment Period|Withdrawal by Subject|1
5546868|NCT01272908|19171480|P1|Re-Treatment Period|Lack of Efficacy|3
5546869|NCT01272908|19171480|P1|Re-Treatment Period|Adverse Event|2
5546870|NCT01272908|19171480|P1|Initial Treatment Period|Withdrawal by Subject|1
5546871|NCT01272908|19171480|P1|Initial Treatment Period|Protocol Violation|1
5546872|NCT01272908|19171480|P1|Initial Treatment Period|Lack of Efficacy|5
5546873|NCT01272908|19171480|P1|Initial Treatment Period|Adverse Event|1
5546874|NCT01272869|19171520|P2|Period 2 (14 Days)|Adverse Event|0
5546875|NCT01272869|19171521|P1|Period 2 (14 Days)|Adverse Event|1
5546876|NCT01272804|19171548|P6|Overall Study|Adverse Event|1
5546877|NCT01272804|19171549|P5|Overall Study|Adverse Event|2
5546878|NCT01272804|19171550|P4|Overall Study|Adverse Event|0
5546879|NCT01272804|19171551|P3|Overall Study|Adverse Event|0
5546880|NCT01272804|19171552|P2|Overall Study|Adverse Event|0
5546881|NCT01272804|19171553|P1|Overall Study|Adverse Event|1
5546882|NCT01272661|19171711|P3|Overall Study|lost to followup/case closed/ no birth|72
5546883|NCT01272661|19171712|P2|Overall Study|lost to followup/case closed/ no birth|209
5546884|NCT01272661|19171713|P1|Overall Study|lost to followup/case closed/ no birth|126
5546885|NCT01272635|19171738|P4|Overall Study|Lost to Follow-up|23
5546886|NCT01272635|19171739|P3|Overall Study|Lost to Follow-up|31
5546887|NCT01272635|19171740|P2|Overall Study|Lost to Follow-up|20
5546888|NCT01272635|19171741|P1|Overall Study|Lost to Follow-up|31
5546889|NCT01272232|19171825|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
5546890|NCT01272232|19171826|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
5546891|NCT01272232|19171827|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
5546892|NCT01272232|19171825|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
5546893|NCT01272232|19171826|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
5546894|NCT01272232|19171827|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
5546895|NCT01272232|19171825|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
5546896|NCT01272232|19171826|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
5546897|NCT01272232|19171827|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
5546898|NCT01272232|19171825|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
5546899|NCT01272232|19171826|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
5546900|NCT01272232|19171827|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
5546901|NCT01272232|19171825|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
5546902|NCT01272232|19171826|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
5546903|NCT01272232|19171827|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
5546904|NCT01272232|19171825|P3|Weeks 0-56|Unclassified|12
5546905|NCT01272232|19171826|P2|Weeks 0-56|Unclassified|7
5546906|NCT01272232|19171827|P1|Weeks 0-56|Unclassified|16
5546907|NCT01272232|19171825|P3|Weeks 0-56|Withdrawal criteria|37
5546908|NCT01272232|19171826|P2|Weeks 0-56|Withdrawal criteria|14
5546909|NCT01272232|19171827|P1|Weeks 0-56|Withdrawal criteria|32
5546910|NCT01272232|19171825|P3|Weeks 0-56|Protocol Violation|13
5546911|NCT01272232|19171826|P2|Weeks 0-56|Protocol Violation|8
5546912|NCT01272232|19171827|P1|Weeks 0-56|Protocol Violation|12
5546913|NCT01272232|19171825|P3|Weeks 0-56|Lack of Efficacy|3
5546914|NCT01272232|19171826|P2|Weeks 0-56|Lack of Efficacy|0
5546915|NCT01272232|19171827|P1|Weeks 0-56|Lack of Efficacy|0
5546916|NCT01272232|19171825|P3|Weeks 0-56|Adverse Event|7
5546917|NCT01272232|19171826|P2|Weeks 0-56|Adverse Event|18
5546918|NCT01272232|19171827|P1|Weeks 0-56|Adverse Event|39
5547243|NCT01270828|19172576|P2|Double Blind Phase|Death|1
5546919|NCT01272219|19171872|P6|Main + Extension Period: Week 0-172|Unclassified|51
5546920|NCT01272219|19171873|P5|Main + Extension Period: Week 0-172|Unclassified|61
5546921|NCT01272219|19171874|P4|Main + Extension Period: Week 0-172|Unclassified|0
5546922|NCT01272219|19171875|P3|Main + Extension Period: Week 0-172|Unclassified|0
5546923|NCT01272219|19171876|P2|Main + Extension Period: Week 0-172|Unclassified|0
5546924|NCT01272219|19171877|P1|Main + Extension Period: Week 0-172|Unclassified|0
5546925|NCT01272219|19171872|P6|Main + Extension Period: Week 0-172|Missing reason|0
5546926|NCT01272219|19171873|P5|Main + Extension Period: Week 0-172|Missing reason|1
5546927|NCT01272219|19171874|P4|Main + Extension Period: Week 0-172|Missing reason|0
5546928|NCT01272219|19171875|P3|Main + Extension Period: Week 0-172|Missing reason|0
5546929|NCT01272219|19171876|P2|Main + Extension Period: Week 0-172|Missing reason|0
5546930|NCT01272219|19171877|P1|Main + Extension Period: Week 0-172|Missing reason|0
5546931|NCT01272219|19171872|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
5546932|NCT01272219|19171873|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
5546933|NCT01272219|19171874|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5546934|NCT01272219|19171875|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5546935|NCT01272219|19171876|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5546936|NCT01272219|19171877|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
5546937|NCT01272219|19171872|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
5546938|NCT01272219|19171873|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
5546939|NCT01272219|19171874|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
5546940|NCT01272219|19171875|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
5546941|NCT01272219|19171876|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
5546942|NCT01272219|19171877|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
5546943|NCT01272219|19171872|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
5546944|NCT01272219|19171873|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
5546945|NCT01272219|19171874|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5546946|NCT01272219|19171875|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5546947|NCT01272219|19171876|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5546948|NCT01272219|19171877|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
5546949|NCT01272219|19171872|P6|Main + Extension Period: Week 0-172|Adverse Event|43
5546950|NCT01272219|19171873|P5|Main + Extension Period: Week 0-172|Adverse Event|191
5546951|NCT01272219|19171874|P4|Main + Extension Period: Week 0-172|Adverse Event|0
5546952|NCT01272219|19171875|P3|Main + Extension Period: Week 0-172|Adverse Event|0
5546953|NCT01272219|19171876|P2|Main + Extension Period: Week 0-172|Adverse Event|0
5546954|NCT01272219|19171877|P1|Main + Extension Period: Week 0-172|Adverse Event|0
5546955|NCT01272219|19171872|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
5546956|NCT01272219|19171873|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
5546957|NCT01272219|19171874|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
5546958|NCT01272219|19171875|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
5546959|NCT01272219|19171876|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
5546960|NCT01272219|19171877|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
5546961|NCT01272219|19171872|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
5546962|NCT01272219|19171873|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
5546963|NCT01272219|19171874|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
5546964|NCT01272219|19171875|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
5546965|NCT01272219|19171876|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
5546966|NCT01272219|19171877|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
5546967|NCT01272219|19171872|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5546968|NCT01272219|19171873|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5546969|NCT01272219|19171874|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
5546970|NCT01272219|19171875|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5546971|NCT01272219|19171876|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
5546972|NCT01272219|19171877|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
5546973|NCT01272219|19171872|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5546974|NCT01272219|19171873|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5546975|NCT01272219|19171874|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
5546976|NCT01272219|19171875|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5546977|NCT01272219|19171876|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5546978|NCT01272219|19171877|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
5546979|NCT01272219|19171872|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
5546980|NCT01272219|19171873|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
5546981|NCT01272219|19171874|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
5546982|NCT01272219|19171875|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
5546983|NCT01272219|19171876|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
5546984|NCT01272219|19171877|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
5546985|NCT01272219|19171872|P6|Main Period: Week 0 to Week 56|Unclassified|34
5546986|NCT01272219|19171873|P5|Main Period: Week 0 to Week 56|Unclassified|42
5546987|NCT01272219|19171874|P4|Main Period: Week 0 to Week 56|Unclassified|29
5546988|NCT01272219|19171875|P3|Main Period: Week 0 to Week 56|Unclassified|0
5546989|NCT01272219|19171876|P2|Main Period: Week 0 to Week 56|Unclassified|0
5546990|NCT01272219|19171877|P1|Main Period: Week 0 to Week 56|Unclassified|36
5547244|NCT01270828|19172577|P1|Double Blind Phase|Death|0
5546991|NCT01272219|19171872|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
5546992|NCT01272219|19171873|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
5546993|NCT01272219|19171874|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
5546994|NCT01272219|19171875|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
5546995|NCT01272219|19171876|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
5546996|NCT01272219|19171877|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
5546997|NCT01272219|19171872|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
5546998|NCT01272219|19171873|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
5546999|NCT01272219|19171874|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
5547000|NCT01272219|19171875|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
5547001|NCT01272219|19171876|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
5547002|NCT01272219|19171877|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
5547003|NCT01272219|19171872|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
5547004|NCT01272219|19171873|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
5547005|NCT01272219|19171874|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
5547006|NCT01272219|19171875|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
5547007|NCT01272219|19171876|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
5547008|NCT01272219|19171877|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
5547009|NCT01272219|19171872|P6|Main Period: Week 0 to Week 56|Adverse Event|29
5547010|NCT01272219|19171873|P5|Main Period: Week 0 to Week 56|Adverse Event|152
5547011|NCT01272219|19171874|P4|Main Period: Week 0 to Week 56|Adverse Event|16
5547012|NCT01272219|19171875|P3|Main Period: Week 0 to Week 56|Adverse Event|0
5547013|NCT01272219|19171876|P2|Main Period: Week 0 to Week 56|Adverse Event|0
5547014|NCT01272219|19171877|P1|Main Period: Week 0 to Week 56|Adverse Event|86
5547015|NCT01272193|19171911|P2|Overall Study|Unclassified|7
5547016|NCT01272193|19171912|P1|Overall Study|Unclassified|8
5547017|NCT01272193|19171911|P2|Overall Study|Withdrawal Criteria|1
5547018|NCT01272193|19171912|P1|Overall Study|Withdrawal Criteria|1
5547019|NCT01272193|19171911|P2|Overall Study|Lack of Efficacy|3
5547020|NCT01272193|19171912|P1|Overall Study|Lack of Efficacy|0
5547021|NCT01272193|19171911|P2|Overall Study|Adverse Event|1
5547022|NCT01272193|19171912|P1|Overall Study|Adverse Event|1
5547023|NCT01272180|19171932|P4|Overall Study|Protocol Violation|1
5547024|NCT01272180|19171933|P3|Overall Study|Protocol Violation|0
5547025|NCT01272180|19171934|P2|Overall Study|Protocol Violation|1
5547026|NCT01272180|19171935|P1|Overall Study|Protocol Violation|0
5547027|NCT01272180|19171932|P4|Overall Study|Inappropriate enrollment|1
5547028|NCT01272180|19171933|P3|Overall Study|Inappropriate enrollment|1
5547029|NCT01272180|19171934|P2|Overall Study|Inappropriate enrollment|0
5547030|NCT01272180|19171935|P1|Overall Study|Inappropriate enrollment|0
5547031|NCT01272180|19171932|P4|Overall Study|Lost to Follow-up|10
5547032|NCT01272180|19171933|P3|Overall Study|Lost to Follow-up|8
5547033|NCT01272180|19171934|P2|Overall Study|Lost to Follow-up|14
5547034|NCT01272180|19171935|P1|Overall Study|Lost to Follow-up|15
5547035|NCT01272180|19171932|P4|Overall Study|Withdrawal by Subject|2
5547036|NCT01272180|19171933|P3|Overall Study|Withdrawal by Subject|3
5547037|NCT01272180|19171934|P2|Overall Study|Withdrawal by Subject|6
5547038|NCT01272180|19171935|P1|Overall Study|Withdrawal by Subject|2
5547039|NCT01272180|19171932|P4|Overall Study|Adverse Event|0
5547040|NCT01272180|19171933|P3|Overall Study|Adverse Event|1
5547041|NCT01272180|19171934|P2|Overall Study|Adverse Event|0
5547042|NCT01272180|19171935|P1|Overall Study|Adverse Event|0
5547043|NCT01272011|19171987|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
5547044|NCT01272011|19171988|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
5547045|NCT01272011|19171989|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
5547046|NCT01271933|19172025|P3|Double-Blind Phase|Participant request-personal reason|0
5547047|NCT01271933|19172026|P2|Double-Blind Phase|Participant request-personal reason|1
5547048|NCT01271933|19172027|P1|Double-Blind Phase|Participant request-personal reason|0
5547049|NCT01271933|19172025|P3|Double-Blind Phase|Adverse Event|0
5547050|NCT01271933|19172026|P2|Double-Blind Phase|Adverse Event|3
5547051|NCT01271933|19172027|P1|Double-Blind Phase|Adverse Event|0
5547052|NCT01271933|19172025|P3|Double-Blind Phase|Withdrawal by Subject|1
5547053|NCT01271933|19172026|P2|Double-Blind Phase|Withdrawal by Subject|6
5547054|NCT01271933|19172027|P1|Double-Blind Phase|Withdrawal by Subject|0
5547055|NCT01271933|19172025|P3|Double-Blind Phase|Lost to Follow-up|1
5547056|NCT01271933|19172026|P2|Double-Blind Phase|Lost to Follow-up|1
5547057|NCT01271933|19172027|P1|Double-Blind Phase|Lost to Follow-up|0
5547058|NCT01271933|19172025|P3|Double-Blind Phase|Lack of Efficacy|9
5547059|NCT01271933|19172026|P2|Double-Blind Phase|Lack of Efficacy|6
5547060|NCT01271933|19172027|P1|Double-Blind Phase|Lack of Efficacy|0
5547061|NCT01271933|19172025|P3|Double-Blind Phase|Randomized but not treated|1
5547062|NCT01271933|19172026|P2|Double-Blind Phase|Randomized but not treated|0
5547063|NCT01271933|19172027|P1|Double-Blind Phase|Randomized but not treated|0
5547064|NCT01271933|19172025|P3|Single-Blind Phase|(Participant request-personal reason)|0
5547065|NCT01271933|19172026|P2|Single-Blind Phase|(Participant request-personal reason)|0
5547066|NCT01271933|19172027|P1|Single-Blind Phase|(Participant request-personal reason)|1
5547067|NCT01271933|19172025|P3|Single-Blind Phase|(Protocol non-compliance)|0
5547068|NCT01271933|19172026|P2|Single-Blind Phase|(Protocol non-compliance)|0
5547069|NCT01271933|19172027|P1|Single-Blind Phase|(Protocol non-compliance)|2
5547070|NCT01271933|19172025|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
5547071|NCT01271933|19172026|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
5547072|NCT01271933|19172027|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
5547073|NCT01271933|19172025|P3|Single-Blind Phase|Adverse Event|0
5547074|NCT01271933|19172026|P2|Single-Blind Phase|Adverse Event|0
5547075|NCT01271933|19172027|P1|Single-Blind Phase|Adverse Event|52
5547076|NCT01271933|19172025|P3|Single-Blind Phase|Protocol Violation|0
5547077|NCT01271933|19172026|P2|Single-Blind Phase|Protocol Violation|0
5547078|NCT01271933|19172027|P1|Single-Blind Phase|Protocol Violation|3
5547079|NCT01271933|19172025|P3|Single-Blind Phase|Withdrawal by Subject|0
5547080|NCT01271933|19172026|P2|Single-Blind Phase|Withdrawal by Subject|0
5547081|NCT01271933|19172027|P1|Single-Blind Phase|Withdrawal by Subject|15
5547082|NCT01271933|19172025|P3|Single-Blind Phase|Lost to Follow-up|0
5547083|NCT01271933|19172026|P2|Single-Blind Phase|Lost to Follow-up|0
5547084|NCT01271933|19172027|P1|Single-Blind Phase|Lost to Follow-up|10
5547085|NCT01271933|19172025|P3|Single-Blind Phase|Lack of Efficacy|0
5547086|NCT01271933|19172026|P2|Single-Blind Phase|Lack of Efficacy|0
5547087|NCT01271933|19172027|P1|Single-Blind Phase|Lack of Efficacy|37
5547088|NCT01271803|19172170|P3|Overall Study|Lost to Follow-up|0
5547089|NCT01271803|19172171|P2|Overall Study|Lost to Follow-up|0
5547090|NCT01271803|19172172|P1|Overall Study|Lost to Follow-up|1
5547091|NCT01271803|19172170|P3|Overall Study|Withdrawal by Subject|0
5547092|NCT01271803|19172171|P2|Overall Study|Withdrawal by Subject|5
5547093|NCT01271803|19172172|P1|Overall Study|Withdrawal by Subject|1
5547094|NCT01271803|19172170|P3|Overall Study|Death|0
5547095|NCT01271803|19172171|P2|Overall Study|Death|34
5547096|NCT01271803|19172172|P1|Overall Study|Death|53
5547097|NCT01271803|19172170|P3|Overall Study|Progressive disease|2
5547098|NCT01271803|19172171|P2|Overall Study|Progressive disease|0
5547099|NCT01271803|19172172|P1|Overall Study|Progressive disease|0
5547100|NCT01271725|19172334|P2|Part B|Withdrawal by Subject|6
5547101|NCT01271725|19172335|P1|Part B|Withdrawal by Subject|0
5547102|NCT01271725|19172334|P2|Part B|Protocol Violation|1
5547103|NCT01271725|19172335|P1|Part B|Protocol Violation|0
5547104|NCT01271725|19172334|P2|Part B|Other Adverse Event|1
5547105|NCT01271725|19172335|P1|Part B|Other Adverse Event|0
5547106|NCT01271725|19172334|P2|Part B|Clinical signs/symptoms of progression|2
5547107|NCT01271725|19172335|P1|Part B|Clinical signs/symptoms of progression|0
5547108|NCT01271725|19172334|P2|Part B|Other than specified|2
5547109|NCT01271725|19172335|P1|Part B|Other than specified|0
5547110|NCT01271725|19172334|P2|Part A|Protocol Violation|0
5547111|NCT01271725|19172335|P1|Part A|Protocol Violation|1
5547112|NCT01271725|19172334|P2|Part A|Other than specified|0
5547113|NCT01271725|19172335|P1|Part A|Other than specified|3
5547114|NCT01271725|19172334|P2|Part A|Withdrawal by Subject|0
5547115|NCT01271725|19172335|P1|Part A|Withdrawal by Subject|12
5547116|NCT01271725|19172334|P2|Part A|Lost to Follow-up|0
5547117|NCT01271725|19172335|P1|Part A|Lost to Follow-up|1
5547118|NCT01271725|19172334|P2|Part A|Other Adverse Event|0
5547119|NCT01271725|19172335|P1|Part A|Other Adverse Event|8
5547120|NCT01271725|19172334|P2|Part A|Clinical signs/symptoms of progression|0
5547121|NCT01271725|19172335|P1|Part A|Clinical signs/symptoms of progression|2
5547122|NCT01271725|19172334|P2|Part A|Progressive disease according to RECIST|0
5547123|NCT01271725|19172335|P1|Part A|Progressive disease according to RECIST|8
5547124|NCT01271712|19172364|P2|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
5547125|NCT01271712|19172365|P1|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
5547126|NCT01271712|19172364|P2|Safety Follow-up|Progressive disease|0
5547127|NCT01271712|19172365|P1|Safety Follow-up|Progressive disease|1
5547128|NCT01271712|19172364|P2|Safety Follow-up|No follow-up|1
5547129|NCT01271712|19172365|P1|Safety Follow-up|No follow-up|1
5547130|NCT01271712|19172364|P2|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
5547131|NCT01271712|19172365|P1|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
5547132|NCT01271712|19172364|P2|Safety Follow-up|Protocol Violation|1
5547133|NCT01271712|19172365|P1|Safety Follow-up|Protocol Violation|1
5547134|NCT01271712|19172364|P2|Safety Follow-up|Withdrawal by Subject|2
5547135|NCT01271712|19172365|P1|Safety Follow-up|Withdrawal by Subject|4
5547136|NCT01271712|19172364|P2|Safety Follow-up|Death|7
5547137|NCT01271712|19172365|P1|Safety Follow-up|Death|11
5547138|NCT01271712|19172364|P2|Open Label Treatment|Switching to other therapy|1
5547139|NCT01271712|19172365|P1|Open Label Treatment|Switching to other therapy|2
5547140|NCT01271712|19172364|P2|Open Label Treatment|Protocol Violation|1
5547141|NCT01271712|19172365|P1|Open Label Treatment|Protocol Violation|0
5547142|NCT01271712|19172364|P2|Open Label Treatment|Non-compliance with study drug|0
5547143|NCT01271712|19172365|P1|Open Label Treatment|Non-compliance with study drug|1
5547144|NCT01271712|19172364|P2|Open Label Treatment|transferred to rollover study|0
5547145|NCT01271712|19172365|P1|Open Label Treatment|transferred to rollover study|1
5547146|NCT01271712|19172364|P2|Open Label Treatment|Progressive disease|32
5547147|NCT01271712|19172365|P1|Open Label Treatment|Progressive disease|59
5547148|NCT01271712|19172364|P2|Open Label Treatment|Adverse Event|8
5547149|NCT01271712|19172365|P1|Open Label Treatment|Adverse Event|14
5547150|NCT01271712|19172364|P2|Open Label Treatment|Physician Decision|0
5547151|NCT01271712|19172365|P1|Open Label Treatment|Physician Decision|2
5547152|NCT01271712|19172364|P2|Open Label Treatment|Withdrawal by Subject|11
5547153|NCT01271712|19172365|P1|Open Label Treatment|Withdrawal by Subject|6
5547154|NCT01271712|19172364|P2|Open Label Treatment|Death|5
5547155|NCT01271712|19172365|P1|Open Label Treatment|Death|6
5547156|NCT01271712|19172364|P2|Double Blind Treatment|receive no study drug|0
5547157|NCT01271712|19172365|P1|Double Blind Treatment|receive no study drug|1
5547158|NCT01271712|19172364|P2|Double Blind Treatment|Non compliance with study drug|0
5547159|NCT01271712|19172365|P1|Double Blind Treatment|Non compliance with study drug|2
5547160|NCT01271712|19172364|P2|Double Blind Treatment|Withdrawal by Subject|1
5547161|NCT01271712|19172365|P1|Double Blind Treatment|Withdrawal by Subject|4
5547162|NCT01271712|19172364|P2|Double Blind Treatment|Progressive disease|3
5547163|NCT01271712|19172365|P1|Double Blind Treatment|Progressive disease|23
5547164|NCT01271712|19172364|P2|Double Blind Treatment|Adverse Event|4
5547165|NCT01271712|19172365|P1|Double Blind Treatment|Adverse Event|9
5547166|NCT01271712|19172364|P2|Double Blind Treatment|Lack of Efficacy|0
5547167|NCT01271712|19172365|P1|Double Blind Treatment|Lack of Efficacy|1
5547168|NCT01271712|19172364|P2|Double Blind Treatment|Death|0
5547169|NCT01271712|19172365|P1|Double Blind Treatment|Death|2
5547170|NCT01271010|19172461|P1|Overall Study|Disease progression|27
5547171|NCT01271010|19172461|P1|Overall Study|Withdrawal by Subject|18
5547172|NCT01271010|19172461|P1|Overall Study|Progression and relapse of disease|1
5547173|NCT01271010|19172461|P1|Overall Study|Death|2
5547174|NCT01271010|19172461|P1|Overall Study|Protocol Violation|1
5547175|NCT01271010|19172461|P1|Overall Study|Start of new CLL therapy|1
5547176|NCT01271010|19172461|P1|Overall Study|Reason not specified|11
5547177|NCT01270971|19172476|P2|Overall Study|Non-specific|3
5547178|NCT01270971|19172477|P1|Overall Study|Non-specific|7
5547179|NCT01270971|19172476|P2|Overall Study|Non compliance|2
5547180|NCT01270971|19172477|P1|Overall Study|Non compliance|2
5547181|NCT01270971|19172476|P2|Overall Study|Adverse Event|2
5547182|NCT01270971|19172477|P1|Overall Study|Adverse Event|1
5547183|NCT01270971|19172476|P2|Overall Study|Lost to Follow-up|5
5547184|NCT01270971|19172477|P1|Overall Study|Lost to Follow-up|18
5547185|NCT01270971|19172476|P2|Overall Study|Withdrawal by Subject|11
5547186|NCT01270971|19172477|P1|Overall Study|Withdrawal by Subject|24
5547187|NCT01270958|19172489|P1|Overall Study|Did not meet inclusion criteria for age|2
5547188|NCT01270958|19172489|P1|Overall Study|Lost to Follow-up|2
5547189|NCT01270880|19172518|P1|Overall Study|Never rec'd treatment, but registered.|1
5547190|NCT01270841|19172548|P4|Overall Study|Enrolled in error|0
5547191|NCT01270841|19172549|P3|Overall Study|Enrolled in error|0
5547192|NCT01270841|19172550|P2|Overall Study|Enrolled in error|1
5547193|NCT01270841|19172551|P1|Overall Study|Enrolled in error|0
5547194|NCT01270841|19172548|P4|Overall Study|Protocol Violation|0
5547195|NCT01270841|19172549|P3|Overall Study|Protocol Violation|0
5547196|NCT01270841|19172550|P2|Overall Study|Protocol Violation|5
5547197|NCT01270841|19172551|P1|Overall Study|Protocol Violation|1
5547198|NCT01270841|19172548|P4|Overall Study|Did not qualify|5
5547199|NCT01270841|19172549|P3|Overall Study|Did not qualify|4
5547200|NCT01270841|19172550|P2|Overall Study|Did not qualify|3
5547201|NCT01270841|19172551|P1|Overall Study|Did not qualify|6
5547202|NCT01270841|19172548|P4|Overall Study|Physician Decision|0
5547203|NCT01270841|19172549|P3|Overall Study|Physician Decision|0
5547204|NCT01270841|19172550|P2|Overall Study|Physician Decision|1
5547205|NCT01270841|19172551|P1|Overall Study|Physician Decision|0
5547206|NCT01270841|19172548|P4|Overall Study|Lost to Follow-up|2
5547207|NCT01270841|19172549|P3|Overall Study|Lost to Follow-up|4
5547208|NCT01270841|19172550|P2|Overall Study|Lost to Follow-up|1
5547209|NCT01270841|19172551|P1|Overall Study|Lost to Follow-up|3
5547210|NCT01270841|19172548|P4|Overall Study|Withdrawal by Subject|3
5547211|NCT01270841|19172549|P3|Overall Study|Withdrawal by Subject|3
5547212|NCT01270841|19172550|P2|Overall Study|Withdrawal by Subject|2
5547213|NCT01270841|19172551|P1|Overall Study|Withdrawal by Subject|3
5547214|NCT01270841|19172548|P4|Overall Study|Adverse Event|3
5547215|NCT01270841|19172549|P3|Overall Study|Adverse Event|0
5547216|NCT01270841|19172550|P2|Overall Study|Adverse Event|1
5547217|NCT01270841|19172551|P1|Overall Study|Adverse Event|0
5547218|NCT01270828|19172575|P3|Double Blind Phase|Adverse event related to study drug|0
5547219|NCT01270828|19172576|P2|Double Blind Phase|Adverse event related to study drug|7
5547220|NCT01270828|19172577|P1|Double Blind Phase|Adverse event related to study drug|5
5547221|NCT01270828|19172575|P3|Double Blind Phase|Adverse event not related to study drug|0
5547222|NCT01270828|19172576|P2|Double Blind Phase|Adverse event not related to study drug|1
5547223|NCT01270828|19172577|P1|Double Blind Phase|Adverse event not related to study drug|1
5547224|NCT01270828|19172575|P3|Double Blind Phase|Lack of Efficacy|0
5547225|NCT01270828|19172576|P2|Double Blind Phase|Lack of Efficacy|11
5547226|NCT01270828|19172577|P1|Double Blind Phase|Lack of Efficacy|2
5547227|NCT01270828|19172575|P3|Double Blind Phase|Lost to Follow-up|0
5547228|NCT01270828|19172576|P2|Double Blind Phase|Lost to Follow-up|2
5547229|NCT01270828|19172577|P1|Double Blind Phase|Lost to Follow-up|1
5547230|NCT01270828|19172575|P3|Double Blind Phase|Withdrawal by Subject|0
5547231|NCT01270828|19172576|P2|Double Blind Phase|Withdrawal by Subject|15
5547232|NCT01270828|19172577|P1|Double Blind Phase|Withdrawal by Subject|6
5547233|NCT01270828|19172575|P3|Double Blind Phase|Reason Unspecified|0
5547234|NCT01270828|19172576|P2|Double Blind Phase|Reason Unspecified|4
5547235|NCT01270828|19172577|P1|Double Blind Phase|Reason Unspecified|7
5547236|NCT01270828|19172575|P3|Double Blind Phase|Protocol and GCP non-compliance|0
5547237|NCT01270828|19172576|P2|Double Blind Phase|Protocol and GCP non-compliance|3
5547238|NCT01270828|19172577|P1|Double Blind Phase|Protocol and GCP non-compliance|4
5547239|NCT01270828|19172575|P3|Double Blind Phase|Protocol Violation|0
5547240|NCT01270828|19172576|P2|Double Blind Phase|Protocol Violation|1
5547241|NCT01270828|19172577|P1|Double Blind Phase|Protocol Violation|0
5547242|NCT01270828|19172575|P3|Double Blind Phase|Death|0
5547245|NCT01270828|19172575|P3|Pregabalin CR SB|Protocol Violation|8
5547246|NCT01270828|19172576|P2|Pregabalin CR SB|Protocol Violation|0
5547247|NCT01270828|19172577|P1|Pregabalin CR SB|Protocol Violation|0
5547248|NCT01270828|19172575|P3|Pregabalin CR SB|Unrelated AE|8
5547249|NCT01270828|19172576|P2|Pregabalin CR SB|Unrelated AE|0
5547250|NCT01270828|19172577|P1|Pregabalin CR SB|Unrelated AE|0
5547251|NCT01270828|19172575|P3|Pregabalin CR SB|Lost to Follow-up|10
5547252|NCT01270828|19172576|P2|Pregabalin CR SB|Lost to Follow-up|0
5547253|NCT01270828|19172577|P1|Pregabalin CR SB|Lost to Follow-up|0
5547254|NCT01270828|19172575|P3|Pregabalin CR SB|Withdrawal by Subject|29
5547255|NCT01270828|19172576|P2|Pregabalin CR SB|Withdrawal by Subject|0
5547256|NCT01270828|19172577|P1|Pregabalin CR SB|Withdrawal by Subject|0
5547257|NCT01270828|19172575|P3|Pregabalin CR SB|Lack of Efficacy|32
5547258|NCT01270828|19172576|P2|Pregabalin CR SB|Lack of Efficacy|0
5547259|NCT01270828|19172577|P1|Pregabalin CR SB|Lack of Efficacy|0
5547260|NCT01270828|19172575|P3|Pregabalin CR SB|Related adverse event|46
5547261|NCT01270828|19172576|P2|Pregabalin CR SB|Related adverse event|0
5547262|NCT01270828|19172577|P1|Pregabalin CR SB|Related adverse event|0
5547263|NCT01270828|19172575|P3|Pregabalin CR SB|Enrolled but not treated|5
5547264|NCT01270828|19172576|P2|Pregabalin CR SB|Enrolled but not treated|0
5547265|NCT01270828|19172577|P1|Pregabalin CR SB|Enrolled but not treated|0
5547266|NCT01270828|19172575|P3|Pregabalin CR SB|Reason Unspecified|8
5547267|NCT01270828|19172576|P2|Pregabalin CR SB|Reason Unspecified|0
5547268|NCT01270828|19172577|P1|Pregabalin CR SB|Reason Unspecified|0
5547269|NCT01270802|19172619|P2|Overall Study|Lost to Follow-up|1
5547270|NCT01270802|19172620|P1|Overall Study|Lost to Follow-up|0
5547271|NCT01270802|19172619|P2|Overall Study|Adverse Event|0
5547272|NCT01270802|19172620|P1|Overall Study|Adverse Event|1
5547273|NCT01270802|19172619|P2|Overall Study|Withdrawal by Subject|0
5547274|NCT01270802|19172620|P1|Overall Study|Withdrawal by Subject|1
5547275|NCT01270620|19172767|P2|Overall Study|Withdrawal by Subject|3
5547276|NCT01270620|19172768|P1|Overall Study|Withdrawal by Subject|1
5547277|NCT01270503|19172863|P1|Overall Study|Lost to Follow-up|1
5547278|NCT01270464|19172871|P3|Overall Study|Other|3
5547279|NCT01270464|19172872|P2|Overall Study|Other|1
5547280|NCT01270464|19172873|P1|Overall Study|Other|1
5547281|NCT01270464|19172871|P3|Overall Study|Lost to Follow-up|1
5547282|NCT01270464|19172872|P2|Overall Study|Lost to Follow-up|3
5547283|NCT01270464|19172873|P1|Overall Study|Lost to Follow-up|2
5547284|NCT01270464|19172871|P3|Overall Study|Withdrawal by Subject|4
5547285|NCT01270464|19172872|P2|Overall Study|Withdrawal by Subject|1
5547286|NCT01270464|19172873|P1|Overall Study|Withdrawal by Subject|2
5547287|NCT01270464|19172871|P3|Overall Study|Adverse Event|7
5547288|NCT01270464|19172872|P2|Overall Study|Adverse Event|1
5547289|NCT01270464|19172873|P1|Overall Study|Adverse Event|9
5547290|NCT01270464|19172871|P3|Overall Study|Lack of Efficacy|1
5547291|NCT01270464|19172872|P2|Overall Study|Lack of Efficacy|3
5547292|NCT01270464|19172873|P1|Overall Study|Lack of Efficacy|2
5547293|NCT01270464|19172871|P3|Overall Study|Protocol Violation|2
5547294|NCT01270464|19172872|P2|Overall Study|Protocol Violation|3
5547295|NCT01270464|19172873|P1|Overall Study|Protocol Violation|4
5547296|NCT01270321|19172923|P3|Overall Study|Adverse Event|5
5547297|NCT01270321|19172924|P2|Overall Study|Adverse Event|9
5547298|NCT01270321|19172925|P1|Overall Study|Adverse Event|7
5547299|NCT01270321|19172923|P3|Overall Study|Death|4
5547300|NCT01270321|19172924|P2|Overall Study|Death|1
5547301|NCT01270321|19172925|P1|Overall Study|Death|3
5547302|NCT01270256|19172938|P2|Overall Study|Withdrawal by Subject|0
5547303|NCT01270256|19172939|P1|Overall Study|Withdrawal by Subject|1
5547304|NCT01270139|19172948|P3|Overall Study|Lost to Follow-up|2
5547305|NCT01270139|19172949|P2|Overall Study|Lost to Follow-up|9
5547306|NCT01270139|19172950|P1|Overall Study|Lost to Follow-up|10
5547307|NCT01270139|19172948|P3|Overall Study|Adverse Event|18
5547308|NCT01270139|19172949|P2|Overall Study|Adverse Event|17
5547309|NCT01270139|19172950|P1|Overall Study|Adverse Event|8
5547310|NCT01269918|19173019|P2|Overall Study|Did not receive study drug|3
5547311|NCT01269918|19173020|P1|Overall Study|Did not receive study drug|0
5547312|NCT01269385|19173095|P4|Overall Study|Adverse Event|0
5547313|NCT01269385|19173096|P3|Overall Study|Adverse Event|0
5547314|NCT01269385|19173097|P2|Overall Study|Adverse Event|1
5547315|NCT01269385|19173098|P1|Overall Study|Adverse Event|1
5547316|NCT01269346|19173123|P1|Extension Phase|Started a prohibited con med|1
5547317|NCT01269346|19173123|P1|Extension Phase|Clinical progression|1
5547318|NCT01269346|19173123|P1|Extension Phase|Physician decision or participant choice|9
5547319|NCT01269346|19173123|P1|Extension Phase|Disease progression|22
5547320|NCT01269346|19173123|P1|Extension Phase|Withdrawal by Subject|4
5547321|NCT01269346|19173123|P1|Extension Phase|Adverse Event|6
5547322|NCT01269346|19173123|P1|Treatment Phase|Other|2
5547323|NCT01269346|19173123|P1|Treatment Phase|Withdrawal by Subject|1
5547324|NCT01269346|19173123|P1|Treatment Phase|Adverse Event|3
5547325|NCT01269346|19173123|P1|Treatment Phase|Disease progression|3
5547326|NCT01269125|19173134|P3|Overall Study|Lost to Follow-up|0
5547327|NCT01269125|19173135|P2|Overall Study|Lost to Follow-up|0
5547328|NCT01269125|19173136|P1|Overall Study|Lost to Follow-up|4
5547329|NCT01269125|19173134|P3|Overall Study|Adverse Event|0
5547330|NCT01269125|19173135|P2|Overall Study|Adverse Event|5
5547331|NCT01269125|19173136|P1|Overall Study|Adverse Event|3
5547332|NCT01268891|19173195|P2|Overall Study|Administrative or other reason(s)|0
5547333|NCT01268891|19173196|P1|Overall Study|Administrative or other reason(s)|1
5547334|NCT01268891|19173195|P2|Overall Study|Withdrawal of Consent|1
5547335|NCT01268891|19173196|P1|Overall Study|Withdrawal of Consent|3
5547336|NCT01268891|19173195|P2|Overall Study|Lack of Efficacy|0
5547337|NCT01268891|19173196|P1|Overall Study|Lack of Efficacy|1
5547338|NCT01268891|19173195|P2|Overall Study|Adverse Event|7
5547339|NCT01268891|19173196|P1|Overall Study|Adverse Event|3
5547340|NCT01268566|19173222|P1|Overall Study|Death|30
5547341|NCT01268566|19173222|P1|Overall Study|Withdrawal by Subject|12
5547342|NCT01268566|19173222|P1|Overall Study|Lost to Follow-up|1
5547343|NCT01268514|19173249|P1|Overall Study|Withdrawal by Surgeon|5
5547344|NCT01268514|19173249|P1|Overall Study|Withdrawal by Subject|3
5547345|NCT01268514|19173249|P1|Overall Study|Lost to Follow-up|5
5547346|NCT01268514|19173249|P1|Overall Study|Death|8
5547347|NCT01268514|19173249|P1|Overall Study|Adverse Event|20
5547348|NCT01268501|19173258|P1|Overall Study|Handling Difficulties|2
5547349|NCT01268501|19173258|P1|Overall Study|Unacceptable Subjective Vision|3
5547350|NCT01268501|19173258|P1|Overall Study|Withdrawal by Subject|3
5547351|NCT01268501|19173258|P1|Overall Study|Lost to Follow-up|1
5547352|NCT01268488|19173262|P1|Overall Study|Physician Decision|2
5547353|NCT01268488|19173262|P1|Overall Study|Adverse Event|3
5547354|NCT01268306|19173269|P1|Overall Study|Lost to Follow-up|1
5547355|NCT01268293|19173273|P1|Overall Study|Subject choice|1
5547356|NCT01268293|19173273|P1|Overall Study|Adverse Event|1
5547357|NCT01268293|19173273|P1|Overall Study|Disease progression|7
5547358|NCT01268267|19173278|P1|Overall Study|Protocol Violation|1
5547359|NCT01268150|19173299|P1|Extension Phase|Other|6
5547360|NCT01268150|19173299|P1|Extension Phase|Disease progression|18
5547361|NCT01268150|19173299|P1|Extension Phase|Adverse Event|3
5547362|NCT01268150|19173299|P1|Treatment Phase|Other|4
5547363|NCT01268150|19173299|P1|Treatment Phase|Withdrawal by Subject|3
5547364|NCT01268150|19173299|P1|Treatment Phase|Adverse Event|3
5547365|NCT01268150|19173299|P1|Treatment Phase|Progression of disease|18
5547366|NCT01268098|19173318|P2|Overall Study|Adverse Event|0
5547367|NCT01268098|19173319|P1|Overall Study|Adverse Event|1
5547368|NCT01268059|19173331|P4|Overall Study|Progression of disease|0
5547369|NCT01268059|19173332|P3|Overall Study|Progression of disease|0
5547370|NCT01268059|19173333|P2|Overall Study|Progression of disease|0
5547371|NCT01268059|19173334|P1|Overall Study|Progression of disease|1
5547372|NCT01268059|19173331|P4|Overall Study|Death|5
5547373|NCT01268059|19173332|P3|Overall Study|Death|3
5547374|NCT01268059|19173333|P2|Overall Study|Death|30
5547375|NCT01268059|19173334|P1|Overall Study|Death|20
5547376|NCT01268059|19173331|P4|Overall Study|Withdrawal by Subject|0
5547377|NCT01268059|19173332|P3|Overall Study|Withdrawal by Subject|0
5547378|NCT01268059|19173333|P2|Overall Study|Withdrawal by Subject|4
5547379|NCT01268059|19173334|P1|Overall Study|Withdrawal by Subject|7
5547380|NCT01268059|19173331|P4|Overall Study|Lost to Follow-up|0
5547381|NCT01268059|19173332|P3|Overall Study|Lost to Follow-up|0
5547382|NCT01268059|19173333|P2|Overall Study|Lost to Follow-up|1
5547383|NCT01268059|19173334|P1|Overall Study|Lost to Follow-up|0
5547384|NCT01268046|19173395|P4|Overall Study|Lost to Follow-up|0
5547385|NCT01268046|19173396|P3|Overall Study|Lost to Follow-up|1
5547386|NCT01268046|19173397|P2|Overall Study|Lost to Follow-up|0
5547387|NCT01268046|19173398|P1|Overall Study|Lost to Follow-up|0
5547388|NCT01268046|19173395|P4|Overall Study|Withdrawal by Subject|1
5547389|NCT01268046|19173396|P3|Overall Study|Withdrawal by Subject|0
5547390|NCT01268046|19173397|P2|Overall Study|Withdrawal by Subject|0
5547391|NCT01268046|19173398|P1|Overall Study|Withdrawal by Subject|1
5547392|NCT01267994|19173408|P1|Overall Study|Adverse Event|2
5547393|NCT01267955|19173413|P1|Stage 2 (6 Months)|Protocol Violation|1
5547394|NCT01267955|19173413|P1|Stage 2 (6 Months)|Death|5
5547395|NCT01267955|19173413|P1|Stage 1 (6 Months)|Death|3
5547396|NCT01267825|19173450|P2|Overall Study|study terminated. no data collected.|0
5547397|NCT01267825|19173451|P1|Overall Study|study terminated. no data collected.|1
5547398|NCT01267266|19173533|P2|Lead-in Phase|Withdrawal by Subject|0
5547399|NCT01267266|19173534|P1|Lead-in Phase|Withdrawal by Subject|1
5547400|NCT01267266|19173533|P2|Lead-in Phase|Adverse Event|0
5547401|NCT01267266|19173534|P1|Lead-in Phase|Adverse Event|2
5547402|NCT01267266|19173533|P2|Lead-in Phase|Lack of Efficacy|0
5547403|NCT01267266|19173534|P1|Lead-in Phase|Lack of Efficacy|20
5547404|NCT01267266|19173533|P2|Enrollment Phase|Withdrawal by Subject|0
5547405|NCT01267266|19173534|P1|Enrollment Phase|Withdrawal by Subject|2
5547406|NCT01267253|19173547|P1|Overall Study|Inevaluable-never received study treatme|2
5547407|NCT01267253|19173547|P1|Overall Study|Ineligible - required test not done|1
5547408|NCT01267201|19173586|P6|Second Intervention Period|Withdrawal by Subject|0
5547409|NCT01267201|19173587|P5|Second Intervention Period|Withdrawal by Subject|0
5547410|NCT01267201|19173588|P4|Second Intervention Period|Withdrawal by Subject|0
5547411|NCT01267201|19173589|P3|Second Intervention Period|Withdrawal by Subject|0
5547412|NCT01267201|19173590|P2|Second Intervention Period|Withdrawal by Subject|1
5547413|NCT01267201|19173591|P1|Second Intervention Period|Withdrawal by Subject|0
5547414|NCT01267201|19173586|P6|First Intervention Period|Withdrawal by Subject|0
5547415|NCT01267201|19173587|P5|First Intervention Period|Withdrawal by Subject|0
5547416|NCT01267201|19173588|P4|First Intervention Period|Withdrawal by Subject|0
5547417|NCT01267201|19173589|P3|First Intervention Period|Withdrawal by Subject|0
5547418|NCT01267201|19173590|P2|First Intervention Period|Withdrawal by Subject|0
5547419|NCT01267201|19173591|P1|First Intervention Period|Withdrawal by Subject|1
5547420|NCT01267175|19173608|P1|Overall Study|Lost to Follow-up|1
5547421|NCT01267175|19173608|P1|Overall Study|Withdrawal by Subject|1
5547422|NCT01266993|19173680|P2|Booster Phase (Month 68-69)|Withdrawal by Subject|1
5547423|NCT01266993|19173681|P1|Booster Phase (Month 68-69)|Withdrawal by Subject|0
5547424|NCT01266993|19173680|P2|Booster Phase (Month 68-69)|Lost to Follow-up|1
5547425|NCT01266993|19173681|P1|Booster Phase (Month 68-69)|Lost to Follow-up|5
5547426|NCT01266967|19173751|P2|Overall Study|Withdrawal by Subject|3
5547427|NCT01266967|19173752|P1|Overall Study|Withdrawal by Subject|3
5547428|NCT01266967|19173751|P2|Overall Study|Physician Decision|1
5547429|NCT01266967|19173752|P1|Overall Study|Physician Decision|0
5547430|NCT01266967|19173751|P2|Overall Study|Lost to Follow-up|1
5547431|NCT01266967|19173752|P1|Overall Study|Lost to Follow-up|2
5547432|NCT01266967|19173751|P2|Overall Study|Study Closed/Terminated|17
5547433|NCT01266967|19173752|P1|Overall Study|Study Closed/Terminated|15
5547434|NCT01266967|19173751|P2|Overall Study|Death|61
5547435|NCT01266967|19173752|P1|Overall Study|Death|69
5547436|NCT01266876|19173804|P5|Overall Study|Adverse Event|0
5547437|NCT01266876|19173805|P4|Overall Study|Adverse Event|1
5547438|NCT01266876|19173806|P3|Overall Study|Adverse Event|0
5547439|NCT01266876|19173807|P2|Overall Study|Adverse Event|0
5547440|NCT01266876|19173808|P1|Overall Study|Adverse Event|0
5547441|NCT01266850|19173915|P5|Overall Study|Site Closure|0
5547442|NCT01266850|19173916|P4|Overall Study|Site Closure|1
5547443|NCT01266850|19173917|P3|Overall Study|Site Closure|1
5547444|NCT01266850|19173918|P2|Overall Study|Site Closure|1
5547445|NCT01266850|19173919|P1|Overall Study|Site Closure|0
5547446|NCT01266850|19173915|P5|Overall Study|Adverse Event|1
5547447|NCT01266850|19173916|P4|Overall Study|Adverse Event|0
5547448|NCT01266850|19173917|P3|Overall Study|Adverse Event|0
5547449|NCT01266850|19173918|P2|Overall Study|Adverse Event|0
5547450|NCT01266850|19173919|P1|Overall Study|Adverse Event|0
5547451|NCT01266850|19173915|P5|Overall Study|Protocol Violation|2
5547452|NCT01266850|19173916|P4|Overall Study|Protocol Violation|1
5547453|NCT01266850|19173917|P3|Overall Study|Protocol Violation|0
5547454|NCT01266850|19173918|P2|Overall Study|Protocol Violation|1
5547455|NCT01266850|19173919|P1|Overall Study|Protocol Violation|0
5547456|NCT01266850|19173915|P5|Overall Study|Physician Decision|3
5547457|NCT01266850|19173916|P4|Overall Study|Physician Decision|4
5547458|NCT01266850|19173917|P3|Overall Study|Physician Decision|4
5547459|NCT01266850|19173918|P2|Overall Study|Physician Decision|6
5547460|NCT01266850|19173919|P1|Overall Study|Physician Decision|3
5547461|NCT01266850|19173915|P5|Overall Study|Withdrawal by Subject|12
5547462|NCT01266850|19173916|P4|Overall Study|Withdrawal by Subject|9
5547463|NCT01266850|19173917|P3|Overall Study|Withdrawal by Subject|6
5547464|NCT01266850|19173918|P2|Overall Study|Withdrawal by Subject|9
5547465|NCT01266850|19173919|P1|Overall Study|Withdrawal by Subject|8
5547466|NCT01266850|19173915|P5|Overall Study|Lost to Follow-up|12
5547467|NCT01266850|19173916|P4|Overall Study|Lost to Follow-up|13
5547468|NCT01266850|19173917|P3|Overall Study|Lost to Follow-up|13
5547469|NCT01266850|19173918|P2|Overall Study|Lost to Follow-up|19
5547470|NCT01266850|19173919|P1|Overall Study|Lost to Follow-up|19
5547471|NCT01266824|19173973|P2|Overall Study|Study terminated prior to completion|3
5547472|NCT01266824|19173974|P1|Overall Study|Study terminated prior to completion|2
5547473|NCT01266603|19173986|P1|Overall Study|Failed screening; MAGE-A3 negative|26
5547474|NCT01266603|19173986|P1|Overall Study|Withdrawal by Subject|1
5547475|NCT01266603|19173986|P1|Overall Study|Lack of Efficacy|14
5547476|NCT01266603|19173986|P1|Overall Study|Adverse Event|1
5547477|NCT01266590|19173992|P1|Overall Study|Physician Decision|1
5547478|NCT01266590|19173992|P1|Overall Study|Withdrawal by Subject|1
5547479|NCT01266590|19173992|P1|Overall Study|Lost to Follow-up|1
5547480|NCT01266590|19173992|P1|Overall Study|Adverse Event|3
5547481|NCT01266460|19174003|P1|Overall Study|Not otherwise specified|8
5547482|NCT01266460|19174003|P1|Overall Study|Disease Progression|18
5547483|NCT01266460|19174003|P1|Overall Study|Withdrawal by Subject|5
5547484|NCT01266460|19174003|P1|Overall Study|Adverse Event|3
5547485|NCT01266317|19174021|P1|Overall Study|Withdrawal by Subject|2
5547486|NCT01266291|19174026|P1|Overall Study|Adverse Event|1
5547487|NCT01266265|19174033|P2|Overall Study|Clinical worsening|1
5547488|NCT01266265|19174034|P1|Overall Study|Clinical worsening|1
5547489|NCT01266265|19174033|P2|Overall Study|Site closed early|3
5547490|NCT01266265|19174034|P1|Overall Study|Site closed early|4
5547491|NCT01266265|19174033|P2|Overall Study|Lung transplant|5
5547492|NCT01266265|19174034|P1|Overall Study|Lung transplant|6
5547493|NCT01266265|19174033|P2|Overall Study|Non-compliance|5
5547494|NCT01266265|19174034|P1|Overall Study|Non-compliance|8
5547495|NCT01266265|19174033|P2|Overall Study|Enrolled in another clinical study|26
5547496|NCT01266265|19174034|P1|Overall Study|Enrolled in another clinical study|15
5547497|NCT01266265|19174033|P2|Overall Study|Stopped/changed PAH medication(s)|9
5547498|NCT01266265|19174034|P1|Overall Study|Stopped/changed PAH medication(s)|16
5547499|NCT01266265|19174033|P2|Overall Study|Transferred care to another provider|28
5547500|NCT01266265|19174034|P1|Overall Study|Transferred care to another provider|22
5547501|NCT01266265|19174033|P2|Overall Study|Respiratory-related adverse event|1
5547502|NCT01266265|19174034|P1|Overall Study|Respiratory-related adverse event|2
5547503|NCT01266265|19174033|P2|Overall Study|Withdrawal by Subject|11
5547504|NCT01266265|19174034|P1|Overall Study|Withdrawal by Subject|13
5547505|NCT01266265|19174033|P2|Overall Study|Lost to Follow-up|28
5547506|NCT01266265|19174034|P1|Overall Study|Lost to Follow-up|23
5547507|NCT01266265|19174033|P2|Overall Study|Death|73
5547508|NCT01266265|19174034|P1|Overall Study|Death|95
5547509|NCT01266161|19174042|P2|Overall Study|Vomited within 4 hours of dosing|0
5547510|NCT01266161|19174043|P1|Overall Study|Vomited within 4 hours of dosing|3
5547511|NCT01266161|19174042|P2|Overall Study|Lack of Efficacy|1
5547512|NCT01266161|19174043|P1|Overall Study|Lack of Efficacy|0
5547513|NCT01266161|19174042|P2|Overall Study|Ineligible|0
5547514|NCT01266161|19174043|P1|Overall Study|Ineligible|1
5547515|NCT01266148|19174075|P2|Overall Study|missing mGFR value + AE|0
5547516|NCT01266148|19174076|P1|Overall Study|missing mGFR value + AE|1
5547517|NCT01266148|19174075|P2|Overall Study|Death|3
5547518|NCT01266148|19174076|P1|Overall Study|Death|2
5547519|NCT01266148|19174075|P2|Overall Study|2 2R rejections|0
5547520|NCT01266148|19174076|P1|Overall Study|2 2R rejections|1
5547521|NCT01266148|19174075|P2|Overall Study|Ongoing rejection|0
5547522|NCT01266148|19174076|P1|Overall Study|Ongoing rejection|1
5547523|NCT01266148|19174075|P2|Overall Study|Adverse Event|0
5547524|NCT01266148|19174076|P1|Overall Study|Adverse Event|2
5547525|NCT01266122|19174104|P2|Overall Study|Lost to Follow-up|6
5547526|NCT01266122|19174105|P1|Overall Study|Lost to Follow-up|6
5547527|NCT01266070|19174113|P1|Overall Study|Protocol Violation|1
5547528|NCT01266070|19174113|P1|Overall Study|Adverse Event|3
5547529|NCT01266031|19174121|P3|Overall Study|Not treated|2
5547530|NCT01266031|19174122|P2|Overall Study|Not treated|3
5547531|NCT01266031|19174123|P1|Overall Study|Not treated|0
5547532|NCT01266018|19174150|P2|Overall Study|Progressive disease|1
5547533|NCT01266018|19174151|P1|Overall Study|Progressive disease|0
5547534|NCT01266018|19174150|P2|Overall Study|Physician Decision|0
5547535|NCT01266018|19174151|P1|Overall Study|Physician Decision|1
5547536|NCT01265992|19174162|P1|Overall Study|Did not receive treatment|1
5547537|NCT01265992|19174162|P1|Overall Study|Stopped treatment|3
5547538|NCT01265992|19174162|P1|Overall Study|Administrative reasons|2
5547539|NCT01265992|19174162|P1|Overall Study|Adverse Event|1
5547540|NCT01265992|19174162|P1|Overall Study|Withdrawal by Subject|1
5547541|NCT01265992|19174162|P1|Overall Study|Lost to Follow-up|1
5547542|NCT01265953|19174190|P2|Overall Study|Non compliance|3
5547543|NCT01265953|19174191|P1|Overall Study|Non compliance|5
5547544|NCT01265875|19174203|P1|Overall Study|Uncooperative/unreliable|1
5547545|NCT01265823|19174211|P1|Overall Study|Participant Request|1
5547546|NCT01265823|19174211|P1|Overall Study|Protocol Violation|1
5547547|NCT01265823|19174211|P1|Overall Study|Failure to Return|4
5547548|NCT01265823|19174211|P1|Overall Study|Unsatisfactory Response Efficacy|1
5547549|NCT01265797|19174240|P2|Open Label Month|Lost to Follow-up|1
5547550|NCT01265797|19174241|P1|Open Label Month|Lost to Follow-up|0
5547551|NCT01265797|19174240|P2|Blinded Month|Diary data incomplete|1
5547552|NCT01265797|19174241|P1|Blinded Month|Diary data incomplete|0
5547553|NCT01265797|19174240|P2|Blinded Month|Adverse Event|0
5547554|NCT01265797|19174241|P1|Blinded Month|Adverse Event|2
5547555|NCT01265797|19174240|P2|Blinded Month|Protocol Violation|1
5547556|NCT01265797|19174241|P1|Blinded Month|Protocol Violation|2
5547557|NCT01265797|19174240|P2|Blinded Month|Lost to Follow-up|0
5547558|NCT01265797|19174241|P1|Blinded Month|Lost to Follow-up|1
5547559|NCT01265797|19174240|P2|Blinded Month|Lack of Efficacy|0
5547560|NCT01265797|19174241|P1|Blinded Month|Lack of Efficacy|5
5547561|NCT01265797|19174240|P2|Run-in Month|1st seizure during run-in month|1
5547562|NCT01265797|19174241|P1|Run-in Month|1st seizure during run-in month|0
5547563|NCT01265797|19174240|P2|Run-in Month|Withdrawal by Subject|4
5547564|NCT01265797|19174241|P1|Run-in Month|Withdrawal by Subject|0
5547565|NCT01265784|19174272|P3|Overall Study|Incorrectly Randomized|1
5547566|NCT01265784|19174273|P2|Overall Study|Incorrectly Randomized|0
5547567|NCT01265784|19174274|P1|Overall Study|Incorrectly Randomized|0
5547568|NCT01265784|19174272|P3|Overall Study|Protocol Violation|0
5547569|NCT01265784|19174273|P2|Overall Study|Protocol Violation|0
5547570|NCT01265784|19174274|P1|Overall Study|Protocol Violation|2
5547571|NCT01265784|19174272|P3|Overall Study|Death|0
5547572|NCT01265784|19174273|P2|Overall Study|Death|0
5547573|NCT01265784|19174274|P1|Overall Study|Death|3
5547574|NCT01265784|19174272|P3|Overall Study|Adverse Event|0
5547575|NCT01265784|19174273|P2|Overall Study|Adverse Event|0
5547576|NCT01265784|19174274|P1|Overall Study|Adverse Event|1
5547577|NCT01265784|19174272|P3|Overall Study|Physician Decision|1
5547578|NCT01265784|19174273|P2|Overall Study|Physician Decision|0
5547579|NCT01265784|19174274|P1|Overall Study|Physician Decision|1
5547580|NCT01265784|19174272|P3|Overall Study|Withdrawal by Subject|0
5547581|NCT01265784|19174273|P2|Overall Study|Withdrawal by Subject|5
5547582|NCT01265784|19174274|P1|Overall Study|Withdrawal by Subject|0
5547583|NCT01265784|19174272|P3|Overall Study|Lost to Follow-up|2
5547584|NCT01265784|19174273|P2|Overall Study|Lost to Follow-up|3
5547585|NCT01265784|19174274|P1|Overall Study|Lost to Follow-up|5
5547586|NCT01265719|19174342|P2|Overall Study|Adverse Event|0
5547587|NCT01265719|19174343|P1|Overall Study|Adverse Event|2
5547588|NCT01265719|19174342|P2|Overall Study|Lost to Follow-up|7
5547589|NCT01265719|19174343|P1|Overall Study|Lost to Follow-up|2
5547590|NCT01265719|19174342|P2|Overall Study|Withdrawal by Subject|3
5547591|NCT01265719|19174343|P1|Overall Study|Withdrawal by Subject|8
5547592|NCT01265719|19174342|P2|Overall Study|Other reasons|0
5547593|NCT01265719|19174343|P1|Overall Study|Other reasons|2
5547594|NCT01265719|19174342|P2|Overall Study|Does not meet entrance criteria|3
5547595|NCT01265719|19174343|P1|Overall Study|Does not meet entrance criteria|0
5547596|NCT01265615|19174394|P4|Overall Study|Protocol Violation|3
5547597|NCT01265615|19174395|P3|Overall Study|Protocol Violation|4
5547598|NCT01265615|19174396|P2|Overall Study|Protocol Violation|2
5547599|NCT01265615|19174397|P1|Overall Study|Protocol Violation|2
5547600|NCT01265563|19174448|P5|Overall Study|Withdrawal by Subject|2
5547601|NCT01265563|19174449|P4|Overall Study|Withdrawal by Subject|0
5547602|NCT01265563|19174450|P3|Overall Study|Withdrawal by Subject|1
5547603|NCT01265563|19174451|P2|Overall Study|Withdrawal by Subject|1
5547604|NCT01265563|19174452|P1|Overall Study|Withdrawal by Subject|0
5547605|NCT01265550|19174478|P4|Pre Randomization|Functional heartburn|99
5547606|NCT01265550|19174479|P3|Pre Randomization|Functional heartburn|0
5547607|NCT01265550|19174480|P2|Pre Randomization|Functional heartburn|0
5547608|NCT01265550|19174481|P1|Pre Randomization|Functional heartburn|0
5547609|NCT01265550|19174478|P4|Pre Randomization|Non-GERD organic disorders|23
5547610|NCT01265550|19174479|P3|Pre Randomization|Non-GERD organic disorders|0
5547611|NCT01265550|19174480|P2|Pre Randomization|Non-GERD organic disorders|0
5547612|NCT01265550|19174481|P1|Pre Randomization|Non-GERD organic disorders|0
5547613|NCT01265550|19174478|P4|Pre Randomization|GERD, PPI-Responsive|42
5547614|NCT01265550|19174479|P3|Pre Randomization|GERD, PPI-Responsive|0
5547615|NCT01265550|19174480|P2|Pre Randomization|GERD, PPI-Responsive|0
5547616|NCT01265550|19174481|P1|Pre Randomization|GERD, PPI-Responsive|0
5547617|NCT01265550|19174478|P4|Pre Randomization|Technical Exclusions|54
5547618|NCT01265550|19174479|P3|Pre Randomization|Technical Exclusions|0
5547619|NCT01265550|19174480|P2|Pre Randomization|Technical Exclusions|0
5547620|NCT01265550|19174481|P1|Pre Randomization|Technical Exclusions|0
5547621|NCT01265550|19174478|P4|Pre Randomization|Withdrawal by Subject|70
5547622|NCT01265550|19174479|P3|Pre Randomization|Withdrawal by Subject|0
5547623|NCT01265550|19174480|P2|Pre Randomization|Withdrawal by Subject|0
5547624|NCT01265550|19174481|P1|Pre Randomization|Withdrawal by Subject|0
5547625|NCT01265537|19174573|P2|Overall Study|Physician Decision|1
5547626|NCT01265537|19174574|P1|Overall Study|Physician Decision|0
5547627|NCT01265537|19174573|P2|Overall Study|Adverse Event|1
5547628|NCT01265537|19174574|P1|Overall Study|Adverse Event|2
5547629|NCT01265511|19174625|P2|Overall Study|Met stopping rules|2
5547630|NCT01265511|19174626|P1|Overall Study|Met stopping rules|0
5547631|NCT01265511|19174625|P2|Overall Study|Lack of Efficacy|1
5547632|NCT01265511|19174626|P1|Overall Study|Lack of Efficacy|2
5547633|NCT01265498|19174640|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
5547634|NCT01265498|19174641|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
5547635|NCT01265420|19174777|P1|Overall Study|Lost to Follow-up|1
5547636|NCT01265394|19174781|P1|Overall Study|Subjects withdrawn|37
5547637|NCT01265056|19174788|P2|Follow up|Lost to Follow-up|3
5547638|NCT01265056|19174789|P1|Follow up|Lost to Follow-up|7
5547639|NCT01265056|19174788|P2|Initial Study Period|Withdrawal by Subject|1
5547640|NCT01265056|19174789|P1|Initial Study Period|Withdrawal by Subject|1
5547641|NCT01265056|19174788|P2|Initial Study Period|Withdrawal by Subject|1
5547642|NCT01265056|19174789|P1|Initial Study Period|Withdrawal by Subject|1
5547643|NCT01264965|19174799|P1|Overall Study|Withdrawal by Subject|10
5547644|NCT01264939|19174825|P2|Overall Study|Disease Progression|11
5547645|NCT01264939|19174826|P1|Overall Study|Disease Progression|8
5547646|NCT01264939|19174825|P2|Overall Study|Patient/Guardian Decision|10
5547647|NCT01264939|19174826|P1|Overall Study|Patient/Guardian Decision|8
5547648|NCT01264939|19174825|P2|Overall Study|Physician Decision|1
5547649|NCT01264939|19174826|P1|Overall Study|Physician Decision|1
5547650|NCT01264939|19174825|P2|Overall Study|Lost to Follow-up|3
5547651|NCT01264939|19174826|P1|Overall Study|Lost to Follow-up|0
5547652|NCT01264939|19174825|P2|Overall Study|Adverse Event|3
5547653|NCT01264939|19174826|P1|Overall Study|Adverse Event|1
5547654|NCT01264887|19174852|P1|Overall Study|Other|2
5547655|NCT01264887|19174852|P1|Overall Study|Sponsor Decision Administrative Reasons|2
5547656|NCT01264887|19174852|P1|Overall Study|Withdrawal by Subject|6
5547657|NCT01264887|19174852|P1|Overall Study|Physician Decision|4
5547658|NCT01264887|19174852|P1|Overall Study|Lack of Efficacy|5
5547659|NCT01264887|19174852|P1|Overall Study|Death|7
5547660|NCT01264887|19174852|P1|Overall Study|Adverse Event|5
5547661|NCT01264835|19174863|P1|Overall Study|Lost to Follow-up|1
5547662|NCT01264770|19174873|P6|Overall Study|Adverse Event|1
5547663|NCT01264770|19174874|P5|Overall Study|Adverse Event|2
5547664|NCT01264770|19174875|P4|Overall Study|Adverse Event|0
5547665|NCT01264770|19174876|P3|Overall Study|Adverse Event|8
5547666|NCT01264770|19174877|P2|Overall Study|Adverse Event|7
5547667|NCT01264770|19174878|P1|Overall Study|Adverse Event|7
5547668|NCT01264770|19174873|P6|Overall Study|Lost to Follow-up|0
5547669|NCT01264770|19174874|P5|Overall Study|Lost to Follow-up|0
5547670|NCT01264770|19174875|P4|Overall Study|Lost to Follow-up|1
5547671|NCT01264770|19174876|P3|Overall Study|Lost to Follow-up|1
5547672|NCT01264770|19174877|P2|Overall Study|Lost to Follow-up|0
5547673|NCT01264770|19174878|P1|Overall Study|Lost to Follow-up|0
5547674|NCT01264770|19174873|P6|Overall Study|Dev. of study specific discont. criteria|1
5547675|NCT01264770|19174874|P5|Overall Study|Dev. of study specific discont. criteria|1
5547676|NCT01264770|19174875|P4|Overall Study|Dev. of study specific discont. criteria|0
5547677|NCT01264770|19174876|P3|Overall Study|Dev. of study specific discont. criteria|0
5547678|NCT01264770|19174877|P2|Overall Study|Dev. of study specific discont. criteria|0
5547679|NCT01264770|19174878|P1|Overall Study|Dev. of study specific discont. criteria|2
5547680|NCT01264770|19174873|P6|Overall Study|Lack of therapeutic response|0
5547681|NCT01264770|19174874|P5|Overall Study|Lack of therapeutic response|1
5547682|NCT01264770|19174875|P4|Overall Study|Lack of therapeutic response|1
5547683|NCT01264770|19174876|P3|Overall Study|Lack of therapeutic response|2
5547684|NCT01264770|19174877|P2|Overall Study|Lack of therapeutic response|0
5547685|NCT01264770|19174878|P1|Overall Study|Lack of therapeutic response|1
5547686|NCT01264770|19174873|P6|Overall Study|Severe non-compliance to protocol|0
5547687|NCT01264770|19174874|P5|Overall Study|Severe non-compliance to protocol|0
5547688|NCT01264770|19174875|P4|Overall Study|Severe non-compliance to protocol|1
5547689|NCT01264770|19174876|P3|Overall Study|Severe non-compliance to protocol|1
5547690|NCT01264770|19174877|P2|Overall Study|Severe non-compliance to protocol|0
5547691|NCT01264770|19174878|P1|Overall Study|Severe non-compliance to protocol|0
5547692|NCT01264770|19174873|P6|Overall Study|e.g., change in circumstances|4
5547693|NCT01264770|19174874|P5|Overall Study|e.g., change in circumstances|4
5547694|NCT01264770|19174875|P4|Overall Study|e.g., change in circumstances|3
5547695|NCT01264770|19174876|P3|Overall Study|e.g., change in circumstances|3
5547696|NCT01264770|19174877|P2|Overall Study|e.g., change in circumstances|3
5547697|NCT01264770|19174878|P1|Overall Study|e.g., change in circumstances|8
5547698|NCT01264770|19174873|P6|Overall Study|Not reported|0
5547699|NCT01264770|19174874|P5|Overall Study|Not reported|0
5547700|NCT01264770|19174875|P4|Overall Study|Not reported|0
5547701|NCT01264770|19174876|P3|Overall Study|Not reported|1
5547702|NCT01264770|19174877|P2|Overall Study|Not reported|0
5547703|NCT01264770|19174878|P1|Overall Study|Not reported|0
5547704|NCT01264718|19174964|P2|Overall Study|Loss of Medicaid/CHIP eligibility|26
5547705|NCT01264718|19174965|P1|Overall Study|Loss of Medicaid/CHIP eligibility|37
5547706|NCT01264718|19174964|P2|Overall Study|Withdrawal by Subject|15
5547707|NCT01264718|19174965|P1|Overall Study|Withdrawal by Subject|9
5547708|NCT01264718|19174964|P2|Overall Study|Lost to Follow-up|2
5547709|NCT01264718|19174965|P1|Overall Study|Lost to Follow-up|3
5547710|NCT01264679|19175002|P1|Overall Study|Withdrawal by Subject|1
5547711|NCT01264679|19175002|P1|Overall Study|Sponsor's Suspension of Dosing|2
5547712|NCT01264679|19175002|P1|Overall Study|Physician Decision|1
5547713|NCT01264679|19175002|P1|Overall Study|Participation in Another Clinical Trial|1
5547714|NCT01264419|19175036|P1|Overall Study|Lost to Follow-up|3
5547715|NCT01264380|19175041|P3|Period C|Adverse Event|1
5547716|NCT01264380|19175042|P2|Period C|Adverse Event|0
5547717|NCT01264380|19175043|P1|Period C|Adverse Event|0
5547718|NCT01264380|19175041|P3|Period C|Withdrawal by Subject|1
5547719|NCT01264380|19175042|P2|Period C|Withdrawal by Subject|0
5547720|NCT01264380|19175043|P1|Period C|Withdrawal by Subject|0
5547721|NCT01264380|19175041|P3|Period C|Follow-up for survival status|6
5547722|NCT01264380|19175042|P2|Period C|Follow-up for survival status|0
5547723|NCT01264380|19175043|P1|Period C|Follow-up for survival status|0
5547724|NCT01264380|19175041|P3|Period C|Death|2
5547725|NCT01264380|19175042|P2|Period C|Death|0
5547726|NCT01264380|19175043|P1|Period C|Death|0
5547727|NCT01264380|19175041|P3|Period C|Disease Progression|4
5547728|NCT01264380|19175042|P2|Period C|Disease Progression|0
5547729|NCT01264380|19175043|P1|Period C|Disease Progression|0
5547730|NCT01264081|19175064|P1|Started Treatment|Not complete cycle 1 due to death|1
5547731|NCT01264081|19175064|P1|Started Treatment|Withdrawal by Subject|1
5547732|NCT01264081|19175064|P1|Participants Screened|Screening failures|30
5547733|NCT01264016|19175069|P1|Overall Study|Felt faint at sight of blood|1
5547734|NCT01264016|19175069|P1|Overall Study|Withdrawal by Subject|1
5547735|NCT01263925|19175084|P2|Overall Study|Withdrawal/ Not specified|1
5547736|NCT01263925|19175085|P1|Overall Study|Withdrawal/ Not specified|0
5547737|NCT01263925|19175084|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
5547738|NCT01263925|19175085|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
5547739|NCT01263925|19175084|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
5547740|NCT01263925|19175085|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
5547741|NCT01263925|19175084|P2|Overall Study|AE/ Withdrawal|4
5547742|NCT01263925|19175085|P1|Overall Study|AE/ Withdrawal|1
5547743|NCT01263925|19175084|P2|Overall Study|AE/ Unsatisfactory Compliance|2
5547744|NCT01263925|19175085|P1|Overall Study|AE/ Unsatisfactory Compliance|2
5547745|NCT01263925|19175084|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
5547746|NCT01263925|19175085|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
5547747|NCT01263925|19175084|P2|Overall Study|Lost to Follow-up|1
5547748|NCT01263925|19175085|P1|Overall Study|Lost to Follow-up|3
5547749|NCT01263925|19175084|P2|Overall Study|Other|4
5547750|NCT01263925|19175085|P1|Overall Study|Other|4
5547751|NCT01263925|19175084|P2|Overall Study|Withdrawal by Subject|8
5547752|NCT01263925|19175085|P1|Overall Study|Withdrawal by Subject|6
5547753|NCT01263925|19175084|P2|Overall Study|Unsatisfactory Compliance of Subject|5
5547754|NCT01263925|19175085|P1|Overall Study|Unsatisfactory Compliance of Subject|8
5547755|NCT01263925|19175084|P2|Overall Study|Adverse Event|22
5547756|NCT01263925|19175085|P1|Overall Study|Adverse Event|23
5547757|NCT01263925|19175084|P2|Overall Study|Lack of Efficacy|1
5547758|NCT01263925|19175085|P1|Overall Study|Lack of Efficacy|0
5547759|NCT01263925|19175084|P2|Overall Study|Protocol Violation|0
5547760|NCT01263925|19175085|P1|Overall Study|Protocol Violation|1
5547761|NCT01263873|19175119|P2|Overall Study|One provider unable to complete numbers|1
5547762|NCT01263873|19175120|P1|Overall Study|One provider unable to complete numbers|1
5547763|NCT01263782|19175134|P4|Overall Study|Inevaluable|0
5547764|NCT01263782|19175135|P3|Overall Study|Inevaluable|1
5547765|NCT01263782|19175136|P2|Overall Study|Inevaluable|0
5547766|NCT01263782|19175137|P1|Overall Study|Inevaluable|0
5547767|NCT01263782|19175134|P4|Overall Study|Too early|0
5547768|NCT01263782|19175135|P3|Overall Study|Too early|1
5547769|NCT01263782|19175136|P2|Overall Study|Too early|0
5547770|NCT01263782|19175137|P1|Overall Study|Too early|0
5547771|NCT01263782|19175134|P4|Overall Study|Progressive disease|1
5547772|NCT01263782|19175135|P3|Overall Study|Progressive disease|0
5547773|NCT01263782|19175136|P2|Overall Study|Progressive disease|0
5547774|NCT01263782|19175137|P1|Overall Study|Progressive disease|0
5547775|NCT01263782|19175134|P4|Overall Study|Death|0
5547776|NCT01263782|19175135|P3|Overall Study|Death|1
5547777|NCT01263782|19175136|P2|Overall Study|Death|0
5547778|NCT01263782|19175137|P1|Overall Study|Death|0
5547779|NCT01263704|19175182|P1|Overall Study|Principal Investigator (PI) decision|1
5547780|NCT01263704|19175182|P1|Overall Study|Colon metastases|1
5547781|NCT01263704|19175182|P1|Overall Study|Lost to Follow-up|1
5547782|NCT01263704|19175182|P1|Overall Study|Eligibility criteria not fulfilled|1
5547783|NCT01263704|19175182|P1|Overall Study|Patient withdrew consent|2
5547784|NCT01263704|19175182|P1|Overall Study|Death|2
5547785|NCT01263704|19175182|P1|Overall Study|Adverse Event|3
5547786|NCT01263704|19175182|P1|Overall Study|Progressive disease|18
5547787|NCT01263691|19175197|P6|Overall Study|Adverse Event|0
5547788|NCT01263691|19175198|P5|Overall Study|Adverse Event|0
5547789|NCT01263691|19175199|P4|Overall Study|Adverse Event|0
5547790|NCT01263691|19175200|P3|Overall Study|Adverse Event|0
5547791|NCT01263691|19175201|P2|Overall Study|Adverse Event|0
5547792|NCT01263691|19175202|P1|Overall Study|Adverse Event|1
5547793|NCT01263691|19175197|P6|Overall Study|Withdrawal by Subject|0
5547794|NCT01263691|19175198|P5|Overall Study|Withdrawal by Subject|0
5547795|NCT01263691|19175199|P4|Overall Study|Withdrawal by Subject|0
5547796|NCT01263691|19175200|P3|Overall Study|Withdrawal by Subject|0
5547797|NCT01263691|19175201|P2|Overall Study|Withdrawal by Subject|0
5547798|NCT01263691|19175202|P1|Overall Study|Withdrawal by Subject|1
5547799|NCT01263691|19175197|P6|Overall Study|Lost to Follow-up|0
5547800|NCT01263691|19175198|P5|Overall Study|Lost to Follow-up|0
5547801|NCT01263691|19175199|P4|Overall Study|Lost to Follow-up|1
5547802|NCT01263691|19175200|P3|Overall Study|Lost to Follow-up|1
5547803|NCT01263691|19175201|P2|Overall Study|Lost to Follow-up|0
5547804|NCT01263691|19175202|P1|Overall Study|Lost to Follow-up|1
5547805|NCT01263665|19175312|P1|Overall Study|Surgical Bypass|2
5547806|NCT01263665|19175312|P1|Overall Study|Amputation above the ankle|1
5547807|NCT01263665|19175312|P1|Overall Study|Death|2
5547808|NCT01263665|19175312|P1|Overall Study|Lost to Follow-up|3
5547809|NCT01263665|19175312|P1|Overall Study|Withdrew Consent|1
5547810|NCT01263639|19175319|P2|Overall Study|Exclusion =Admission greater than 7 days|9
5547811|NCT01263639|19175320|P1|Overall Study|Exclusion =Admission greater than 7 days|7
5547812|NCT01263639|19175319|P2|Overall Study|Lost to Follow-up|70
5547813|NCT01263639|19175320|P1|Overall Study|Lost to Follow-up|66
5547814|NCT01263561|19175328|P2|Overall Study|Death|2
5547815|NCT01263561|19175329|P1|Overall Study|Death|1
5547816|NCT01263509|19175341|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
5547817|NCT01263509|19175342|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
5547818|NCT01263509|19175343|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
5547819|NCT01263509|19175344|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
5547820|NCT01263509|19175341|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
5547821|NCT01263509|19175342|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
5547822|NCT01263509|19175343|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
5547823|NCT01263509|19175344|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
5547824|NCT01263509|19175341|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5547825|NCT01263509|19175342|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5547826|NCT01263509|19175343|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5547827|NCT01263509|19175344|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5547828|NCT01263509|19175341|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
5547829|NCT01263509|19175342|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
5547830|NCT01263509|19175343|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
5547831|NCT01263509|19175344|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
5547832|NCT01263509|19175341|P4|Entered - Long-Term Extension Study|Adverse Event|1
5547833|NCT01263509|19175342|P3|Entered - Long-Term Extension Study|Adverse Event|4
5547834|NCT01263509|19175343|P2|Entered - Long-Term Extension Study|Adverse Event|5
5547835|NCT01263509|19175344|P1|Entered - Long-Term Extension Study|Adverse Event|5
5547836|NCT01263496|19175473|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
5547837|NCT01263496|19175474|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
5547838|NCT01263496|19175475|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
5547839|NCT01263496|19175476|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
5547840|NCT01263496|19175477|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
5547841|NCT01263496|19175478|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
5547842|NCT01263496|19175479|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
5547843|NCT01263496|19175480|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
5547844|NCT01263496|19175481|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
5547845|NCT01263496|19175473|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
5547846|NCT01263496|19175474|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
5547847|NCT01263496|19175475|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
5547848|NCT01263496|19175476|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
5547849|NCT01263496|19175477|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
5547850|NCT01263496|19175478|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
5547851|NCT01263496|19175479|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
5547852|NCT01263496|19175480|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
5547853|NCT01263496|19175481|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
5547854|NCT01263496|19175473|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5547855|NCT01263496|19175474|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5547856|NCT01263496|19175475|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5547857|NCT01263496|19175476|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5547858|NCT01263496|19175477|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
5547859|NCT01263496|19175478|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5547860|NCT01263496|19175479|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
5547861|NCT01263496|19175480|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
5547862|NCT01263496|19175481|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
5547863|NCT01263496|19175473|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
5547864|NCT01263496|19175474|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
5547865|NCT01263496|19175475|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
5547866|NCT01263496|19175476|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
5547867|NCT01263496|19175477|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
5547868|NCT01263496|19175478|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
5547869|NCT01263496|19175479|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
5547870|NCT01263496|19175480|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
5547871|NCT01263496|19175481|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
5547872|NCT01263496|19175473|P9|Entered - Long-Term Extension Study|Adverse Event|1
5547873|NCT01263496|19175474|P8|Entered - Long-Term Extension Study|Adverse Event|0
5547874|NCT01263496|19175475|P7|Entered - Long-Term Extension Study|Adverse Event|0
5547875|NCT01263496|19175476|P6|Entered - Long-Term Extension Study|Adverse Event|0
5547876|NCT01263496|19175477|P5|Entered - Long-Term Extension Study|Adverse Event|1
5547877|NCT01263496|19175478|P4|Entered - Long-Term Extension Study|Adverse Event|3
5547878|NCT01263496|19175479|P3|Entered - Long-Term Extension Study|Adverse Event|6
5547879|NCT01263496|19175480|P2|Entered - Long-Term Extension Study|Adverse Event|5
5547880|NCT01263496|19175481|P1|Entered - Long-Term Extension Study|Adverse Event|0
5547881|NCT01263496|19175473|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
5547882|NCT01263496|19175474|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
5547883|NCT01263496|19175475|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
5547884|NCT01263496|19175476|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
5547885|NCT01263496|19175477|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
5547886|NCT01263496|19175478|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
5547887|NCT01263496|19175479|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
5547888|NCT01263496|19175480|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
5547889|NCT01263496|19175481|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
5547890|NCT01263496|19175473|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
5547891|NCT01263496|19175474|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
5547892|NCT01263496|19175475|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
5547893|NCT01263496|19175476|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
5547894|NCT01263496|19175477|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
5547895|NCT01263496|19175478|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
5547896|NCT01263496|19175479|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
5547897|NCT01263496|19175480|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
5547898|NCT01263496|19175481|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
5547899|NCT01263483|19175776|P3|Overall Study|Participant Unavailability|1
5547900|NCT01263483|19175777|P2|Overall Study|Participant Unavailability|1
5547901|NCT01263483|19175778|P1|Overall Study|Participant Unavailability|0
5547902|NCT01263483|19175776|P3|Overall Study|Protocol Violation|1
5547903|NCT01263483|19175777|P2|Overall Study|Protocol Violation|1
5547904|NCT01263483|19175778|P1|Overall Study|Protocol Violation|0
5547905|NCT01263483|19175776|P3|Overall Study|Lack of Efficacy|0
5547906|NCT01263483|19175777|P2|Overall Study|Lack of Efficacy|0
5547907|NCT01263483|19175778|P1|Overall Study|Lack of Efficacy|2
5547908|NCT01263483|19175776|P3|Overall Study|Withdrawal by Subject|0
5547909|NCT01263483|19175777|P2|Overall Study|Withdrawal by Subject|0
5547910|NCT01263483|19175778|P1|Overall Study|Withdrawal by Subject|1
5547911|NCT01263483|19175776|P3|Overall Study|Adverse Event|3
5547912|NCT01263483|19175777|P2|Overall Study|Adverse Event|0
5547913|NCT01263483|19175778|P1|Overall Study|Adverse Event|4
5547914|NCT01263470|19175840|P6|Overall Study|Study Drug Non-compliance|0
5547915|NCT01263470|19175841|P5|Overall Study|Study Drug Non-compliance|1
5547916|NCT01263470|19175842|P4|Overall Study|Study Drug Non-compliance|0
5547917|NCT01263470|19175843|P3|Overall Study|Study Drug Non-compliance|0
5547918|NCT01263470|19175844|P2|Overall Study|Study Drug Non-compliance|0
5547919|NCT01263470|19175845|P1|Overall Study|Study Drug Non-compliance|0
5547920|NCT01263470|19175840|P6|Overall Study|Participant Unavailability|0
5547921|NCT01263470|19175841|P5|Overall Study|Participant Unavailability|0
5547922|NCT01263470|19175842|P4|Overall Study|Participant Unavailability|0
5547923|NCT01263470|19175843|P3|Overall Study|Participant Unavailability|0
5547924|NCT01263470|19175844|P2|Overall Study|Participant Unavailability|1
5547925|NCT01263470|19175845|P1|Overall Study|Participant Unavailability|0
5547926|NCT01263470|19175840|P6|Overall Study|Lack of Efficacy|0
5547927|NCT01263470|19175841|P5|Overall Study|Lack of Efficacy|0
5547928|NCT01263470|19175842|P4|Overall Study|Lack of Efficacy|0
5547929|NCT01263470|19175843|P3|Overall Study|Lack of Efficacy|2
5547930|NCT01263470|19175844|P2|Overall Study|Lack of Efficacy|0
5547931|NCT01263470|19175845|P1|Overall Study|Lack of Efficacy|0
5547932|NCT01263470|19175840|P6|Overall Study|Withdrawal by Subject|2
5547933|NCT01263470|19175841|P5|Overall Study|Withdrawal by Subject|0
5547934|NCT01263470|19175842|P4|Overall Study|Withdrawal by Subject|2
5547935|NCT01263470|19175843|P3|Overall Study|Withdrawal by Subject|1
5547936|NCT01263470|19175844|P2|Overall Study|Withdrawal by Subject|1
5547937|NCT01263470|19175845|P1|Overall Study|Withdrawal by Subject|0
5547938|NCT01263470|19175840|P6|Overall Study|Protocol Violation|1
5547939|NCT01263470|19175841|P5|Overall Study|Protocol Violation|0
5547940|NCT01263470|19175842|P4|Overall Study|Protocol Violation|0
5547941|NCT01263470|19175843|P3|Overall Study|Protocol Violation|0
5547942|NCT01263470|19175844|P2|Overall Study|Protocol Violation|1
5547943|NCT01263470|19175845|P1|Overall Study|Protocol Violation|0
5547944|NCT01263470|19175840|P6|Overall Study|Adverse Event|2
5547945|NCT01263470|19175841|P5|Overall Study|Adverse Event|2
5547946|NCT01263470|19175842|P4|Overall Study|Adverse Event|1
5547947|NCT01263470|19175843|P3|Overall Study|Adverse Event|1
5547948|NCT01263470|19175844|P2|Overall Study|Adverse Event|2
5547949|NCT01263470|19175845|P1|Overall Study|Adverse Event|2
5547950|NCT01263444|19175955|P1|Overall Study|Protocol Violation|1
5547951|NCT01263444|19175955|P1|Overall Study|Withdrawal by Subject|1
5547952|NCT01263444|19175955|P1|Overall Study|Adverse Event|8
5547953|NCT01263223|19176092|P2|7-day Follow-up|Lost to Follow-up|0
5547954|NCT01263223|19176093|P1|7-day Follow-up|Lost to Follow-up|1
5547955|NCT01263223|19176092|P2|7-day Follow-up|Withdrawal by Subject|1
5547956|NCT01263223|19176093|P1|7-day Follow-up|Withdrawal by Subject|0
5547957|NCT01263223|19176092|P2|Period 2|Withdrawal by Subject|1
5547958|NCT01263223|19176093|P1|Period 2|Withdrawal by Subject|0
5547959|NCT01263197|19176116|P6|Third Intervention (Period 3)|Adverse Event|0
5547960|NCT01263197|19176117|P5|Third Intervention (Period 3)|Adverse Event|0
5547961|NCT01263197|19176118|P4|Third Intervention (Period 3)|Adverse Event|0
5547962|NCT01263197|19176119|P3|Third Intervention (Period 3)|Adverse Event|0
5547963|NCT01263197|19176120|P2|Third Intervention (Period 3)|Adverse Event|1
5547964|NCT01263197|19176121|P1|Third Intervention (Period 3)|Adverse Event|0
5547965|NCT01263197|19176116|P6|Washout Period 2|Protocol Violation|0
5547966|NCT01263197|19176117|P5|Washout Period 2|Protocol Violation|0
5547967|NCT01263197|19176118|P4|Washout Period 2|Protocol Violation|1
5547968|NCT01263197|19176119|P3|Washout Period 2|Protocol Violation|0
5547969|NCT01263197|19176120|P2|Washout Period 2|Protocol Violation|0
5547970|NCT01263197|19176121|P1|Washout Period 2|Protocol Violation|0
5547971|NCT01263197|19176116|P6|Washout Period 2|Physician Decision|1
5547972|NCT01263197|19176117|P5|Washout Period 2|Physician Decision|0
5547973|NCT01263197|19176118|P4|Washout Period 2|Physician Decision|0
5547974|NCT01263197|19176119|P3|Washout Period 2|Physician Decision|0
5547975|NCT01263197|19176120|P2|Washout Period 2|Physician Decision|0
5547976|NCT01263197|19176121|P1|Washout Period 2|Physician Decision|0
5547977|NCT01263197|19176116|P6|Washout Period 1|Protocol Violation|0
5547978|NCT01263197|19176117|P5|Washout Period 1|Protocol Violation|1
5547979|NCT01263197|19176118|P4|Washout Period 1|Protocol Violation|0
5547980|NCT01263197|19176119|P3|Washout Period 1|Protocol Violation|0
5547981|NCT01263197|19176120|P2|Washout Period 1|Protocol Violation|0
5547982|NCT01263197|19176121|P1|Washout Period 1|Protocol Violation|0
5547983|NCT01263197|19176116|P6|First Intervention (Period 1)|Adverse Event|1
5547984|NCT01263197|19176117|P5|First Intervention (Period 1)|Adverse Event|0
5547985|NCT01263197|19176118|P4|First Intervention (Period 1)|Adverse Event|0
5547986|NCT01263197|19176119|P3|First Intervention (Period 1)|Adverse Event|0
5547987|NCT01263197|19176120|P2|First Intervention (Period 1)|Adverse Event|0
5547988|NCT01263197|19176121|P1|First Intervention (Period 1)|Adverse Event|0
5547989|NCT01263119|19176164|P1|Period 2|Adverse Event|2
5547990|NCT01263119|19176164|P1|Period 1|Protocol Violation|2
5547991|NCT01263106|19176185|P2|Washout (at Least 7 Days)|Lost to Follow-up|1
5547992|NCT01263106|19176186|P1|Washout (at Least 7 Days)|Lost to Follow-up|1
5547993|NCT01263093|19176201|P2|Period 2|Adverse Event|0
5547994|NCT01263093|19176202|P1|Period 2|Adverse Event|1
5547995|NCT01263093|19176201|P2|Washout|Physician Decision|0
5547996|NCT01263093|19176202|P1|Washout|Physician Decision|1
5547997|NCT01263054|19176219|P2|Overall Study|Other|1
5547998|NCT01263054|19176220|P1|Overall Study|Other|0
5547999|NCT01263054|19176219|P2|Overall Study|Qualification Violation|0
5548000|NCT01263054|19176220|P1|Overall Study|Qualification Violation|1
5548001|NCT01263054|19176219|P2|Overall Study|Withdrawal by Subject|3
5548002|NCT01263054|19176220|P1|Overall Study|Withdrawal by Subject|1
5548003|NCT01263054|19176219|P2|Overall Study|Lost to Follow-up|2
5548004|NCT01263054|19176220|P1|Overall Study|Lost to Follow-up|2
5548005|NCT01263054|19176219|P2|Overall Study|Death|0
5548006|NCT01263054|19176220|P1|Overall Study|Death|1
5548007|NCT01263028|19176238|P1|Overall Study|Study terminated due to low enrollment.|4
5548008|NCT01263028|19176238|P1|Overall Study|Adverse Event|1
5548009|NCT01263028|19176238|P1|Overall Study|Withdrawal by Subject|1
5548010|NCT01263015|19176248|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
5548011|NCT01263015|19176249|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
5548012|NCT01263015|19176248|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
5548096|NCT01262976|19176292|P6|Up to Year 2|Migrated/moved from study area|2
5548013|NCT01263015|19176249|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
5548014|NCT01263015|19176248|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
5548015|NCT01263015|19176249|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
5548016|NCT01263015|19176248|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
5548017|NCT01263015|19176249|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
5548018|NCT01263015|19176248|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
5548019|NCT01263015|19176249|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
5548020|NCT01263015|19176248|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
5548021|NCT01263015|19176249|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
5548022|NCT01263015|19176248|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
5548023|NCT01263015|19176249|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
5548024|NCT01263015|19176248|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
5548025|NCT01263015|19176249|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
5548026|NCT01263015|19176248|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
5548027|NCT01263015|19176249|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
5548028|NCT01263015|19176248|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
5548029|NCT01263015|19176249|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
5548030|NCT01263015|19176248|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
5548031|NCT01263015|19176249|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
5548032|NCT01263015|19176248|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
5548033|NCT01263015|19176249|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
5548034|NCT01262989|19176275|P2|Period 2|Intercurrent disease|1
5548035|NCT01262989|19176276|P1|Period 2|Intercurrent disease|0
5548036|NCT01262989|19176275|P2|Period 1|Positive answer for exclusion criteria|1
5548037|NCT01262989|19176276|P1|Period 1|Positive answer for exclusion criteria|0
5548038|NCT01262989|19176275|P2|Period 1|Intercurrent disease|1
5548039|NCT01262989|19176276|P1|Period 1|Intercurrent disease|0
5548040|NCT01262989|19176275|P2|Period 1|Lost to Follow-up|1
5548041|NCT01262989|19176276|P1|Period 1|Lost to Follow-up|1
5548042|NCT01262976|19176292|P6|Up to Year 3|Other|0
5548043|NCT01262976|19176293|P5|Up to Year 3|Other|0
5548044|NCT01262976|19176294|P4|Up to Year 3|Other|0
5548045|NCT01262976|19176295|P3|Up to Year 3|Other|0
5548046|NCT01262976|19176296|P2|Up to Year 3|Other|0
5548047|NCT01262976|19176297|P1|Up to Year 3|Other|3
5548048|NCT01262976|19176292|P6|Up to Year 3|Subjects with unknown completion status|0
5548049|NCT01262976|19176293|P5|Up to Year 3|Subjects with unknown completion status|0
5548050|NCT01262976|19176294|P4|Up to Year 3|Subjects with unknown completion status|0
5548051|NCT01262976|19176295|P3|Up to Year 3|Subjects with unknown completion status|1
5548052|NCT01262976|19176296|P2|Up to Year 3|Subjects with unknown completion status|0
5548053|NCT01262976|19176297|P1|Up to Year 3|Subjects with unknown completion status|0
5548054|NCT01262976|19176292|P6|Up to Year 3|Lost to Follow-up|3
5548055|NCT01262976|19176293|P5|Up to Year 3|Lost to Follow-up|1
5548056|NCT01262976|19176294|P4|Up to Year 3|Lost to Follow-up|3
5548057|NCT01262976|19176295|P3|Up to Year 3|Lost to Follow-up|4
5548058|NCT01262976|19176296|P2|Up to Year 3|Lost to Follow-up|2
5548059|NCT01262976|19176297|P1|Up to Year 3|Lost to Follow-up|2
5548060|NCT01262976|19176292|P6|Up to Year 3|Migrated/moved from study area|1
5548061|NCT01262976|19176293|P5|Up to Year 3|Migrated/moved from study area|1
5548062|NCT01262976|19176294|P4|Up to Year 3|Migrated/moved from study area|2
5548063|NCT01262976|19176295|P3|Up to Year 3|Migrated/moved from study area|0
5548064|NCT01262976|19176296|P2|Up to Year 3|Migrated/moved from study area|0
5548065|NCT01262976|19176297|P1|Up to Year 3|Migrated/moved from study area|0
5548066|NCT01262976|19176292|P6|Up to Year 3|Withdrawal by Subject|0
5548067|NCT01262976|19176293|P5|Up to Year 3|Withdrawal by Subject|0
5548068|NCT01262976|19176294|P4|Up to Year 3|Withdrawal by Subject|0
5548069|NCT01262976|19176295|P3|Up to Year 3|Withdrawal by Subject|0
5548070|NCT01262976|19176296|P2|Up to Year 3|Withdrawal by Subject|0
5548071|NCT01262976|19176297|P1|Up to Year 3|Withdrawal by Subject|1
5548072|NCT01262976|19176292|P6|Up to Year 3|Serious Adverse Event|0
5548073|NCT01262976|19176293|P5|Up to Year 3|Serious Adverse Event|0
5548074|NCT01262976|19176294|P4|Up to Year 3|Serious Adverse Event|0
5548075|NCT01262976|19176295|P3|Up to Year 3|Serious Adverse Event|2
5548076|NCT01262976|19176296|P2|Up to Year 3|Serious Adverse Event|0
5548077|NCT01262976|19176297|P1|Up to Year 3|Serious Adverse Event|0
5548078|NCT01262976|19176292|P6|Up to Year 2|Other|0
5548079|NCT01262976|19176293|P5|Up to Year 2|Other|0
5548080|NCT01262976|19176294|P4|Up to Year 2|Other|0
5548081|NCT01262976|19176295|P3|Up to Year 2|Other|0
5548082|NCT01262976|19176296|P2|Up to Year 2|Other|0
5548083|NCT01262976|19176297|P1|Up to Year 2|Other|3
5548084|NCT01262976|19176292|P6|Up to Year 2|Subjects with unknown completion status|0
5548085|NCT01262976|19176293|P5|Up to Year 2|Subjects with unknown completion status|0
5548086|NCT01262976|19176294|P4|Up to Year 2|Subjects with unknown completion status|0
5548087|NCT01262976|19176295|P3|Up to Year 2|Subjects with unknown completion status|1
5548088|NCT01262976|19176296|P2|Up to Year 2|Subjects with unknown completion status|0
5548089|NCT01262976|19176297|P1|Up to Year 2|Subjects with unknown completion status|0
5548090|NCT01262976|19176292|P6|Up to Year 2|Lost to Follow-up|3
5548091|NCT01262976|19176293|P5|Up to Year 2|Lost to Follow-up|3
5548092|NCT01262976|19176294|P4|Up to Year 2|Lost to Follow-up|2
5548093|NCT01262976|19176295|P3|Up to Year 2|Lost to Follow-up|2
5548094|NCT01262976|19176296|P2|Up to Year 2|Lost to Follow-up|1
5548095|NCT01262976|19176297|P1|Up to Year 2|Lost to Follow-up|1
5548097|NCT01262976|19176293|P5|Up to Year 2|Migrated/moved from study area|1
5548098|NCT01262976|19176294|P4|Up to Year 2|Migrated/moved from study area|2
5548099|NCT01262976|19176295|P3|Up to Year 2|Migrated/moved from study area|0
5548100|NCT01262976|19176296|P2|Up to Year 2|Migrated/moved from study area|0
5548101|NCT01262976|19176297|P1|Up to Year 2|Migrated/moved from study area|0
5548102|NCT01262976|19176292|P6|Up to Year 2|Withdrawal by Subject|0
5548103|NCT01262976|19176293|P5|Up to Year 2|Withdrawal by Subject|0
5548104|NCT01262976|19176294|P4|Up to Year 2|Withdrawal by Subject|0
5548105|NCT01262976|19176295|P3|Up to Year 2|Withdrawal by Subject|0
5548106|NCT01262976|19176296|P2|Up to Year 2|Withdrawal by Subject|0
5548107|NCT01262976|19176297|P1|Up to Year 2|Withdrawal by Subject|1
5548108|NCT01262976|19176292|P6|Up to Year 2|Serious Adverse Event|0
5548109|NCT01262976|19176293|P5|Up to Year 2|Serious Adverse Event|0
5548110|NCT01262976|19176294|P4|Up to Year 2|Serious Adverse Event|0
5548111|NCT01262976|19176295|P3|Up to Year 2|Serious Adverse Event|2
5548112|NCT01262976|19176296|P2|Up to Year 2|Serious Adverse Event|0
5548113|NCT01262976|19176297|P1|Up to Year 2|Serious Adverse Event|0
5548114|NCT01262976|19176292|P6|Up to Year 1|Subjects with unknown completion status|1
5548115|NCT01262976|19176293|P5|Up to Year 1|Subjects with unknown completion status|0
5548116|NCT01262976|19176294|P4|Up to Year 1|Subjects with unknown completion status|0
5548117|NCT01262976|19176295|P3|Up to Year 1|Subjects with unknown completion status|1
5548118|NCT01262976|19176296|P2|Up to Year 1|Subjects with unknown completion status|0
5548119|NCT01262976|19176297|P1|Up to Year 1|Subjects with unknown completion status|0
5548120|NCT01262976|19176292|P6|Up to Year 1|Other|1
5548121|NCT01262976|19176293|P5|Up to Year 1|Other|2
5548122|NCT01262976|19176294|P4|Up to Year 1|Other|0
5548123|NCT01262976|19176295|P3|Up to Year 1|Other|0
5548124|NCT01262976|19176296|P2|Up to Year 1|Other|1
5548125|NCT01262976|19176297|P1|Up to Year 1|Other|3
5548126|NCT01262976|19176292|P6|Up to Year 1|Lost to Follow-up|5
5548127|NCT01262976|19176293|P5|Up to Year 1|Lost to Follow-up|6
5548128|NCT01262976|19176294|P4|Up to Year 1|Lost to Follow-up|1
5548129|NCT01262976|19176295|P3|Up to Year 1|Lost to Follow-up|0
5548130|NCT01262976|19176296|P2|Up to Year 1|Lost to Follow-up|0
5548131|NCT01262976|19176297|P1|Up to Year 1|Lost to Follow-up|4
5548132|NCT01262976|19176292|P6|Up to Year 1|Migrated/moved from study area|2
5548133|NCT01262976|19176293|P5|Up to Year 1|Migrated/moved from study area|3
5548134|NCT01262976|19176294|P4|Up to Year 1|Migrated/moved from study area|3
5548135|NCT01262976|19176295|P3|Up to Year 1|Migrated/moved from study area|0
5548136|NCT01262976|19176296|P2|Up to Year 1|Migrated/moved from study area|0
5548137|NCT01262976|19176297|P1|Up to Year 1|Migrated/moved from study area|1
5548138|NCT01262976|19176292|P6|Up to Year 1|Withdrawal by Subject|0
5548139|NCT01262976|19176293|P5|Up to Year 1|Withdrawal by Subject|0
5548140|NCT01262976|19176294|P4|Up to Year 1|Withdrawal by Subject|0
5548141|NCT01262976|19176295|P3|Up to Year 1|Withdrawal by Subject|0
5548142|NCT01262976|19176296|P2|Up to Year 1|Withdrawal by Subject|0
5548143|NCT01262976|19176297|P1|Up to Year 1|Withdrawal by Subject|1
5548144|NCT01262976|19176292|P6|Up to Year 1|Serious Adverse Event|0
5548145|NCT01262976|19176293|P5|Up to Year 1|Serious Adverse Event|0
5548146|NCT01262976|19176294|P4|Up to Year 1|Serious Adverse Event|0
5548147|NCT01262976|19176295|P3|Up to Year 1|Serious Adverse Event|2
5548148|NCT01262976|19176296|P2|Up to Year 1|Serious Adverse Event|0
5548149|NCT01262976|19176297|P1|Up to Year 1|Serious Adverse Event|0
5548150|NCT01262976|19176292|P6|Up to Month 7|Other|0
5548151|NCT01262976|19176293|P5|Up to Month 7|Other|0
5548152|NCT01262976|19176294|P4|Up to Month 7|Other|0
5548153|NCT01262976|19176295|P3|Up to Month 7|Other|2
5548154|NCT01262976|19176296|P2|Up to Month 7|Other|0
5548155|NCT01262976|19176297|P1|Up to Month 7|Other|3
5548156|NCT01262976|19176292|P6|Up to Month 7|Lost to Follow-up|3
5548157|NCT01262976|19176293|P5|Up to Month 7|Lost to Follow-up|1
5548158|NCT01262976|19176294|P4|Up to Month 7|Lost to Follow-up|3
5548159|NCT01262976|19176295|P3|Up to Month 7|Lost to Follow-up|1
5548160|NCT01262976|19176296|P2|Up to Month 7|Lost to Follow-up|0
5548161|NCT01262976|19176297|P1|Up to Month 7|Lost to Follow-up|1
5548162|NCT01262976|19176292|P6|Up to Month 7|Migrated/moved from study area|1
5548163|NCT01262976|19176293|P5|Up to Month 7|Migrated/moved from study area|1
5548164|NCT01262976|19176294|P4|Up to Month 7|Migrated/moved from study area|3
5548165|NCT01262976|19176295|P3|Up to Month 7|Migrated/moved from study area|1
5548166|NCT01262976|19176296|P2|Up to Month 7|Migrated/moved from study area|0
5548167|NCT01262976|19176297|P1|Up to Month 7|Migrated/moved from study area|0
5548168|NCT01262976|19176292|P6|Up to Month 7|Withdrawal by Subject|0
5548169|NCT01262976|19176293|P5|Up to Month 7|Withdrawal by Subject|0
5548170|NCT01262976|19176294|P4|Up to Month 7|Withdrawal by Subject|0
5548171|NCT01262976|19176295|P3|Up to Month 7|Withdrawal by Subject|0
5548172|NCT01262976|19176296|P2|Up to Month 7|Withdrawal by Subject|0
5548173|NCT01262976|19176297|P1|Up to Month 7|Withdrawal by Subject|1
5548174|NCT01262976|19176292|P6|Up to Month 7|Serious Adverse Event|0
5548175|NCT01262976|19176293|P5|Up to Month 7|Serious Adverse Event|0
5548176|NCT01262976|19176294|P4|Up to Month 7|Serious Adverse Event|0
5548177|NCT01262976|19176295|P3|Up to Month 7|Serious Adverse Event|2
5548178|NCT01262976|19176296|P2|Up to Month 7|Serious Adverse Event|0
5548179|NCT01262976|19176297|P1|Up to Month 7|Serious Adverse Event|0
5548180|NCT01262976|19176292|P6|Up to Month 2|Other|2
5548181|NCT01262976|19176293|P5|Up to Month 2|Other|0
5548182|NCT01262976|19176294|P4|Up to Month 2|Other|1
5548183|NCT01262976|19176295|P3|Up to Month 2|Other|0
5548184|NCT01262976|19176296|P2|Up to Month 2|Other|0
5548185|NCT01262976|19176297|P1|Up to Month 2|Other|1
5548186|NCT01262976|19176292|P6|Up to Month 2|Lost to Follow-up|1
5548187|NCT01262976|19176293|P5|Up to Month 2|Lost to Follow-up|1
5548188|NCT01262976|19176294|P4|Up to Month 2|Lost to Follow-up|1
5548189|NCT01262976|19176295|P3|Up to Month 2|Lost to Follow-up|0
5548190|NCT01262976|19176296|P2|Up to Month 2|Lost to Follow-up|0
5548191|NCT01262976|19176297|P1|Up to Month 2|Lost to Follow-up|1
5548192|NCT01262976|19176292|P6|Up to Month 2|Migrated/moved from study area|1
5548193|NCT01262976|19176293|P5|Up to Month 2|Migrated/moved from study area|1
5548194|NCT01262976|19176294|P4|Up to Month 2|Migrated/moved from study area|0
5548195|NCT01262976|19176295|P3|Up to Month 2|Migrated/moved from study area|0
5548196|NCT01262976|19176296|P2|Up to Month 2|Migrated/moved from study area|1
5548197|NCT01262976|19176297|P1|Up to Month 2|Migrated/moved from study area|0
5548198|NCT01262976|19176292|P6|Up to Month 2|Withdrawal by Subject|0
5548199|NCT01262976|19176293|P5|Up to Month 2|Withdrawal by Subject|0
5548200|NCT01262976|19176294|P4|Up to Month 2|Withdrawal by Subject|0
5548201|NCT01262976|19176295|P3|Up to Month 2|Withdrawal by Subject|0
5548202|NCT01262976|19176296|P2|Up to Month 2|Withdrawal by Subject|0
5548203|NCT01262976|19176297|P1|Up to Month 2|Withdrawal by Subject|1
5548204|NCT01262976|19176292|P6|Up to Month 2|Serious Adverse Event|0
5548205|NCT01262976|19176293|P5|Up to Month 2|Serious Adverse Event|0
5548206|NCT01262976|19176294|P4|Up to Month 2|Serious Adverse Event|0
5548207|NCT01262976|19176295|P3|Up to Month 2|Serious Adverse Event|1
5548208|NCT01262976|19176296|P2|Up to Month 2|Serious Adverse Event|0
5548209|NCT01262976|19176297|P1|Up to Month 2|Serious Adverse Event|0
5548210|NCT01262898|19176453|P4|Overall Study|Withdrawal by Subject|0
5548211|NCT01262898|19176454|P3|Overall Study|Withdrawal by Subject|0
5548212|NCT01262898|19176455|P2|Overall Study|Withdrawal by Subject|1
5548213|NCT01262898|19176456|P1|Overall Study|Withdrawal by Subject|1
5548214|NCT01262898|19176453|P4|Overall Study|Lost to Follow-up|0
5548215|NCT01262898|19176454|P3|Overall Study|Lost to Follow-up|0
5548216|NCT01262898|19176455|P2|Overall Study|Lost to Follow-up|0
5548217|NCT01262898|19176456|P1|Overall Study|Lost to Follow-up|1
5548218|NCT01262898|19176453|P4|Overall Study|Protocol Violation|0
5548219|NCT01262898|19176454|P3|Overall Study|Protocol Violation|0
5548220|NCT01262898|19176455|P2|Overall Study|Protocol Violation|1
5548221|NCT01262898|19176456|P1|Overall Study|Protocol Violation|1
5548222|NCT01262872|19176584|P8|Step 2|Migrated/moved from study area|3
5548223|NCT01262872|19176585|P7|Step 2|Migrated/moved from study area|2
5548224|NCT01262872|19176586|P6|Step 2|Migrated/moved from study area|6
5548225|NCT01262872|19176587|P5|Step 2|Migrated/moved from study area|2
5548226|NCT01262872|19176588|P4|Step 2|Migrated/moved from study area|3
5548227|NCT01262872|19176589|P3|Step 2|Migrated/moved from study area|4
5548228|NCT01262872|19176590|P2|Step 2|Migrated/moved from study area|0
5548229|NCT01262872|19176591|P1|Step 2|Migrated/moved from study area|0
5548230|NCT01262872|19176584|P8|Step 2|Withdrawal by Subject|1
5548231|NCT01262872|19176585|P7|Step 2|Withdrawal by Subject|2
5548232|NCT01262872|19176586|P6|Step 2|Withdrawal by Subject|1
5548233|NCT01262872|19176587|P5|Step 2|Withdrawal by Subject|3
5548234|NCT01262872|19176588|P4|Step 2|Withdrawal by Subject|6
5548235|NCT01262872|19176589|P3|Step 2|Withdrawal by Subject|4
5548236|NCT01262872|19176590|P2|Step 2|Withdrawal by Subject|0
5548237|NCT01262872|19176591|P1|Step 2|Withdrawal by Subject|0
5548238|NCT01262872|19176584|P8|Step 2|Protocol Violation|1
5548239|NCT01262872|19176585|P7|Step 2|Protocol Violation|3
5548240|NCT01262872|19176586|P6|Step 2|Protocol Violation|0
5548241|NCT01262872|19176587|P5|Step 2|Protocol Violation|0
5548242|NCT01262872|19176588|P4|Step 2|Protocol Violation|0
5548243|NCT01262872|19176589|P3|Step 2|Protocol Violation|1
5548244|NCT01262872|19176590|P2|Step 2|Protocol Violation|0
5548245|NCT01262872|19176591|P1|Step 2|Protocol Violation|0
5548246|NCT01262872|19176584|P8|Step 2|Death|1
5548247|NCT01262872|19176585|P7|Step 2|Death|2
5548248|NCT01262872|19176586|P6|Step 2|Death|2
5548249|NCT01262872|19176587|P5|Step 2|Death|0
5548250|NCT01262872|19176588|P4|Step 2|Death|1
5548251|NCT01262872|19176589|P3|Step 2|Death|0
5548252|NCT01262872|19176590|P2|Step 2|Death|0
5548253|NCT01262872|19176591|P1|Step 2|Death|0
5548254|NCT01262820|19176865|P1|Overall Study|Drug held for 21+ days|1
5548255|NCT01262820|19176865|P1|Overall Study|Lack of Efficacy|9
5548256|NCT01262820|19176865|P1|Overall Study|Adverse Event|5
5548257|NCT01262677|19176879|P3|Overall Study|Adverse Event (AE) related to study drug|3
5548258|NCT01262677|19176880|P2|Overall Study|Adverse Event (AE) related to study drug|8
5548259|NCT01262677|19176881|P1|Overall Study|Adverse Event (AE) related to study drug|3
5548260|NCT01262677|19176879|P3|Overall Study|Protocol Violation|1
5548261|NCT01262677|19176880|P2|Overall Study|Protocol Violation|1
5548262|NCT01262677|19176881|P1|Overall Study|Protocol Violation|0
5548263|NCT01262677|19176879|P3|Overall Study|Reason not provided|3
5548264|NCT01262677|19176880|P2|Overall Study|Reason not provided|1
5548265|NCT01262677|19176881|P1|Overall Study|Reason not provided|2
5548266|NCT01262677|19176879|P3|Overall Study|No longer willing to participate|2
5548267|NCT01262677|19176880|P2|Overall Study|No longer willing to participate|3
5548268|NCT01262677|19176881|P1|Overall Study|No longer willing to participate|3
5548269|NCT01262677|19176879|P3|Overall Study|Lost to Follow-up|2
5548270|NCT01262677|19176880|P2|Overall Study|Lost to Follow-up|0
5548271|NCT01262677|19176881|P1|Overall Study|Lost to Follow-up|1
5548272|NCT01262677|19176879|P3|Overall Study|Insufficient clinical response|1
5548273|NCT01262677|19176880|P2|Overall Study|Insufficient clinical response|0
5548274|NCT01262677|19176881|P1|Overall Study|Insufficient clinical response|0
5548275|NCT01262677|19176879|P3|Overall Study|Does not meet entrance criteria|0
5548276|NCT01262677|19176880|P2|Overall Study|Does not meet entrance criteria|2
5548277|NCT01262677|19176881|P1|Overall Study|Does not meet entrance criteria|0
5548278|NCT01262651|19176972|P2|Overall Study|Met Withdrawal Criteria|0
5548279|NCT01262651|19176973|P1|Overall Study|Met Withdrawal Criteria|1
5548280|NCT01262651|19176972|P2|Overall Study|Withdrawal by Investigator|2
5548281|NCT01262651|19176973|P1|Overall Study|Withdrawal by Investigator|2
5548282|NCT01262651|19176972|P2|Overall Study|Withdrawal by Subject|11
5548283|NCT01262651|19176973|P1|Overall Study|Withdrawal by Subject|15
5548284|NCT01262651|19176972|P2|Overall Study|Adverse Event|35
5548285|NCT01262651|19176973|P1|Overall Study|Adverse Event|40
5548286|NCT01262573|19177014|P2|Overall Study|Withdrawal by Subject|1
5548287|NCT01262573|19177015|P1|Overall Study|Withdrawal by Subject|0
5548288|NCT01262560|19177026|P3|Overall Study|Protocol Violation|2
5548289|NCT01262560|19177027|P2|Overall Study|Protocol Violation|1
5548290|NCT01262560|19177028|P1|Overall Study|Protocol Violation|0
5548291|NCT01262456|19177077|P3|1-Month Open-Label Extension Period|Other Reason|0
5548292|NCT01262456|19177078|P2|1-Month Open-Label Extension Period|Other Reason|1
5548293|NCT01262456|19177079|P1|1-Month Open-Label Extension Period|Other Reason|0
5548294|NCT01262456|19177077|P3|1-Month Open-Label Extension Period|Protocol Violation|2
5548295|NCT01262456|19177078|P2|1-Month Open-Label Extension Period|Protocol Violation|0
5548296|NCT01262456|19177079|P1|1-Month Open-Label Extension Period|Protocol Violation|1
5548297|NCT01262456|19177077|P3|1-Month Open-Label Extension Period|Adverse Event|2
5548298|NCT01262456|19177078|P2|1-Month Open-Label Extension Period|Adverse Event|0
5548299|NCT01262456|19177079|P1|1-Month Open-Label Extension Period|Adverse Event|2
5548300|NCT01262456|19177077|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
5548301|NCT01262456|19177078|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
5548302|NCT01262456|19177079|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
5548303|NCT01262456|19177077|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
5548304|NCT01262456|19177078|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
5548305|NCT01262456|19177079|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
5548306|NCT01262456|19177077|P3|3-Month Double-Blind Period|Protocol Violation|6
5548307|NCT01262456|19177078|P2|3-Month Double-Blind Period|Protocol Violation|6
5548308|NCT01262456|19177079|P1|3-Month Double-Blind Period|Protocol Violation|3
5548309|NCT01262456|19177077|P3|3-Month Double-Blind Period|Adverse Event|8
5548310|NCT01262456|19177078|P2|3-Month Double-Blind Period|Adverse Event|4
5548311|NCT01262456|19177079|P1|3-Month Double-Blind Period|Adverse Event|6
5548312|NCT01262456|19177077|P3|3-Month Double-Blind Period|Lost to Follow-up|3
5548313|NCT01262456|19177078|P2|3-Month Double-Blind Period|Lost to Follow-up|5
5548314|NCT01262456|19177079|P1|3-Month Double-Blind Period|Lost to Follow-up|4
5548315|NCT01262456|19177077|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
5548316|NCT01262456|19177078|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
5548317|NCT01262456|19177079|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
5548318|NCT01262365|19177123|P3|Overall Study|Patient unavailable|1
5548319|NCT01262365|19177124|P2|Overall Study|Patient unavailable|0
5548320|NCT01262365|19177125|P1|Overall Study|Patient unavailable|0
5548321|NCT01262365|19177123|P3|Overall Study|Cannot tolerate the protocol|0
5548322|NCT01262365|19177124|P2|Overall Study|Cannot tolerate the protocol|1
5548323|NCT01262365|19177125|P1|Overall Study|Cannot tolerate the protocol|0
5548324|NCT01262365|19177123|P3|Overall Study|Toxicity related to study drug|0
5548325|NCT01262365|19177124|P2|Overall Study|Toxicity related to study drug|1
5548326|NCT01262365|19177125|P1|Overall Study|Toxicity related to study drug|0
5548327|NCT01262365|19177123|P3|Overall Study|Patient pregnant|1
5548328|NCT01262365|19177124|P2|Overall Study|Patient pregnant|0
5548329|NCT01262365|19177125|P1|Overall Study|Patient pregnant|1
5548330|NCT01262365|19177123|P3|Overall Study|Suspected pregnancy|0
5548331|NCT01262365|19177124|P2|Overall Study|Suspected pregnancy|0
5548332|NCT01262365|19177125|P1|Overall Study|Suspected pregnancy|1
5548333|NCT01262365|19177123|P3|Overall Study|Non-compliance|2
5548334|NCT01262365|19177124|P2|Overall Study|Non-compliance|0
5548335|NCT01262365|19177125|P1|Overall Study|Non-compliance|1
5548336|NCT01262365|19177123|P3|Overall Study|Randomization error|2
5548337|NCT01262365|19177124|P2|Overall Study|Randomization error|0
5548338|NCT01262365|19177125|P1|Overall Study|Randomization error|1
5548339|NCT01262365|19177123|P3|Overall Study|sponsor decision|0
5548340|NCT01262365|19177124|P2|Overall Study|sponsor decision|1
5548341|NCT01262365|19177125|P1|Overall Study|sponsor decision|1
5548342|NCT01262365|19177123|P3|Overall Study|Adverse Event|11
5548343|NCT01262365|19177124|P2|Overall Study|Adverse Event|16
5548344|NCT01262365|19177125|P1|Overall Study|Adverse Event|26
5548345|NCT01262365|19177123|P3|Overall Study|Death|1
5548346|NCT01262365|19177124|P2|Overall Study|Death|2
5548347|NCT01262365|19177125|P1|Overall Study|Death|1
5548348|NCT01262365|19177123|P3|Overall Study|Withdrawal by Subject|22
5548349|NCT01262365|19177124|P2|Overall Study|Withdrawal by Subject|22
5548350|NCT01262365|19177125|P1|Overall Study|Withdrawal by Subject|17
5548351|NCT01262365|19177123|P3|Overall Study|Lost to Follow-up|6
5548352|NCT01262365|19177124|P2|Overall Study|Lost to Follow-up|7
5548353|NCT01262365|19177125|P1|Overall Study|Lost to Follow-up|3
5548354|NCT01262365|19177123|P3|Overall Study|Protocol Violation|1
5548355|NCT01262365|19177124|P2|Overall Study|Protocol Violation|1
5548356|NCT01262365|19177125|P1|Overall Study|Protocol Violation|3
5548357|NCT01262365|19177123|P3|Overall Study|Lack of Efficacy|47
5548358|NCT01262365|19177124|P2|Overall Study|Lack of Efficacy|30
5548359|NCT01262365|19177125|P1|Overall Study|Lack of Efficacy|35
5548360|NCT01262352|19177150|P2|Washout|Extended Washout|1
5548361|NCT01262352|19177151|P1|Washout|Extended Washout|0
5548362|NCT01262352|19177150|P2|Washout|Adverse Event|1
5548363|NCT01262352|19177151|P1|Washout|Adverse Event|1
5548364|NCT01262352|19177150|P2|Period 1|Illness after randomization|0
5548365|NCT01262352|19177151|P1|Period 1|Illness after randomization|1
5548366|NCT01262287|19177169|P2|Overall Study|Lost to Follow-up|1
5548367|NCT01262287|19177170|P1|Overall Study|Lost to Follow-up|2
5548368|NCT01262092|19177231|P2|Gabapentin Taper|noncompliance - missed medications|0
5548369|NCT01262092|19177232|P1|Gabapentin Taper|noncompliance - missed medications|1
5548370|NCT01262092|19177231|P2|Buprenorphine Taper|noncompliance - missed medication|1
5548371|NCT01262092|19177232|P1|Buprenorphine Taper|noncompliance - missed medication|1
5548372|NCT01262092|19177231|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
5548373|NCT01262092|19177232|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
5548374|NCT01262092|19177231|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
5548375|NCT01262092|19177232|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
5548376|NCT01262027|19177238|P1|Overall Study|Protocol Violation|1
5548377|NCT01262027|19177238|P1|Overall Study|Withdrawal by Subject|3
5548378|NCT01262027|19177238|P1|Overall Study|Adverse Event|1
5548379|NCT01261975|19177243|P1|Overall Study|Surgical complication|1
5548380|NCT01261793|19177274|P3|Overall Study|Patient unable to start IV line|1
5548381|NCT01261793|19177275|P2|Overall Study|Patient unable to start IV line|0
5548382|NCT01261793|19177276|P1|Overall Study|Patient unable to start IV line|0
5548383|NCT01261793|19177274|P3|Overall Study|Randomization error|0
5548384|NCT01261793|19177275|P2|Overall Study|Randomization error|1
5548385|NCT01261793|19177276|P1|Overall Study|Randomization error|0
5548386|NCT01261793|19177274|P3|Overall Study|Patient withdrew after cardiology visit|0
5548387|NCT01261793|19177275|P2|Overall Study|Patient withdrew after cardiology visit|1
5548388|NCT01261793|19177276|P1|Overall Study|Patient withdrew after cardiology visit|0
5548389|NCT01261793|19177274|P3|Overall Study|Lack of efficacy & patient not available|0
5548390|NCT01261793|19177275|P2|Overall Study|Lack of efficacy & patient not available|1
5548391|NCT01261793|19177276|P1|Overall Study|Lack of efficacy & patient not available|0
5548392|NCT01261793|19177274|P3|Overall Study|Outside the study area|1
5548393|NCT01261793|19177275|P2|Overall Study|Outside the study area|2
5548394|NCT01261793|19177276|P1|Overall Study|Outside the study area|0
5548395|NCT01261793|19177274|P3|Overall Study|Patient pregnant|0
5548396|NCT01261793|19177275|P2|Overall Study|Patient pregnant|0
5548397|NCT01261793|19177276|P1|Overall Study|Patient pregnant|1
5548398|NCT01261793|19177274|P3|Overall Study|Patient non-compliance|1
5548399|NCT01261793|19177275|P2|Overall Study|Patient non-compliance|0
5548400|NCT01261793|19177276|P1|Overall Study|Patient non-compliance|1
5548401|NCT01261793|19177274|P3|Overall Study|Suspected pregnancy|0
5548402|NCT01261793|19177275|P2|Overall Study|Suspected pregnancy|1
5548403|NCT01261793|19177276|P1|Overall Study|Suspected pregnancy|1
5548404|NCT01261793|19177274|P3|Overall Study|Patient non-availability|1
5548405|NCT01261793|19177275|P2|Overall Study|Patient non-availability|1
5548406|NCT01261793|19177276|P1|Overall Study|Patient non-availability|1
5548407|NCT01261793|19177274|P3|Overall Study|Adverse Event|19
5548408|NCT01261793|19177275|P2|Overall Study|Adverse Event|24
5548409|NCT01261793|19177276|P1|Overall Study|Adverse Event|9
5548410|NCT01261793|19177274|P3|Overall Study|Death|0
5548411|NCT01261793|19177275|P2|Overall Study|Death|1
5548412|NCT01261793|19177276|P1|Overall Study|Death|3
5548413|NCT01261793|19177274|P3|Overall Study|Withdrawal by Subject|14
5548414|NCT01261793|19177275|P2|Overall Study|Withdrawal by Subject|14
5548415|NCT01261793|19177276|P1|Overall Study|Withdrawal by Subject|12
5548416|NCT01261793|19177274|P3|Overall Study|Lost to Follow-up|7
5548417|NCT01261793|19177275|P2|Overall Study|Lost to Follow-up|3
5548418|NCT01261793|19177276|P1|Overall Study|Lost to Follow-up|10
5548419|NCT01261793|19177274|P3|Overall Study|Protocol Violation|6
5548420|NCT01261793|19177275|P2|Overall Study|Protocol Violation|5
5548421|NCT01261793|19177276|P1|Overall Study|Protocol Violation|3
5548422|NCT01261793|19177274|P3|Overall Study|Lack of Efficacy|32
5548423|NCT01261793|19177275|P2|Overall Study|Lack of Efficacy|37
5548424|NCT01261793|19177276|P1|Overall Study|Lack of Efficacy|44
5548425|NCT01261780|19177301|P2|Overall Study|Event not related to subject|2
5548426|NCT01261780|19177302|P1|Overall Study|Event not related to subject|1
5548427|NCT01261780|19177301|P2|Overall Study|Withdrawal by Subject|0
5548428|NCT01261780|19177302|P1|Overall Study|Withdrawal by Subject|1
5548429|NCT01261624|19177312|P2|Week 13 to Week 24|Insufficient Response|1
5548430|NCT01261624|19177313|P1|Week 13 to Week 24|Insufficient Response|0
5548431|NCT01261624|19177312|P2|Week 0 to Week 12|Insufficient Response|2
5548432|NCT01261624|19177313|P1|Week 0 to Week 12|Insufficient Response|0
5548433|NCT01261624|19177312|P2|Week 0 to Week 12|Disease Progression|1
5548434|NCT01261624|19177313|P1|Week 0 to Week 12|Disease Progression|1
5548435|NCT01261611|19177333|P3|Treatment Cycle 5|Lost to Follow-up|0
5548436|NCT01261611|19177334|P2|Treatment Cycle 5|Lost to Follow-up|0
5548437|NCT01261611|19177335|P1|Treatment Cycle 5|Lost to Follow-up|1
5548438|NCT01261611|19177333|P3|Treatment Cycle 5|Adverse Event|0
5548439|NCT01261611|19177334|P2|Treatment Cycle 5|Adverse Event|0
5548440|NCT01261611|19177335|P1|Treatment Cycle 5|Adverse Event|1
5548441|NCT01261611|19177333|P3|Treatment Cycle 5|Withdrawal by Subject|0
5548442|NCT01261611|19177334|P2|Treatment Cycle 5|Withdrawal by Subject|0
5548443|NCT01261611|19177335|P1|Treatment Cycle 5|Withdrawal by Subject|1
5548444|NCT01261611|19177333|P3|Treatment Cycle 4|Not otherwise specified|0
5548445|NCT01261611|19177334|P2|Treatment Cycle 4|Not otherwise specified|0
5548446|NCT01261611|19177335|P1|Treatment Cycle 4|Not otherwise specified|3
5548447|NCT01261611|19177333|P3|Treatment Cycle 4|Lost to Follow-up|0
5548448|NCT01261611|19177334|P2|Treatment Cycle 4|Lost to Follow-up|0
5548449|NCT01261611|19177335|P1|Treatment Cycle 4|Lost to Follow-up|2
5548450|NCT01261611|19177333|P3|Treatment Cycle 4|Adverse Event|0
5548451|NCT01261611|19177334|P2|Treatment Cycle 4|Adverse Event|0
5548452|NCT01261611|19177335|P1|Treatment Cycle 4|Adverse Event|1
5548453|NCT01261611|19177333|P3|Treatment Cycle 4|Withdrawal by Subject|0
5548454|NCT01261611|19177334|P2|Treatment Cycle 4|Withdrawal by Subject|0
5548455|NCT01261611|19177335|P1|Treatment Cycle 4|Withdrawal by Subject|3
5548456|NCT01261611|19177333|P3|Treatment Cycle 4|Completed study|0
5548457|NCT01261611|19177334|P2|Treatment Cycle 4|Completed study|0
5548458|NCT01261611|19177335|P1|Treatment Cycle 4|Completed study|87
5548459|NCT01261611|19177333|P3|Treatment Cycle 3|Lost to Follow-up|0
5548460|NCT01261611|19177334|P2|Treatment Cycle 3|Lost to Follow-up|0
5548461|NCT01261611|19177335|P1|Treatment Cycle 3|Lost to Follow-up|1
5548462|NCT01261611|19177333|P3|Treatment Cycle 3|Adverse Event|0
5548463|NCT01261611|19177334|P2|Treatment Cycle 3|Adverse Event|0
5548464|NCT01261611|19177335|P1|Treatment Cycle 3|Adverse Event|1
5548465|NCT01261611|19177333|P3|Treatment Cycle 3|Withdrawal by Subject|0
5548466|NCT01261611|19177334|P2|Treatment Cycle 3|Withdrawal by Subject|0
5548467|NCT01261611|19177335|P1|Treatment Cycle 3|Withdrawal by Subject|4
5548468|NCT01261611|19177333|P3|Treatment Cycle 3|Completed study|0
5548469|NCT01261611|19177334|P2|Treatment Cycle 3|Completed study|0
5548470|NCT01261611|19177335|P1|Treatment Cycle 3|Completed study|24
5548471|NCT01261611|19177333|P3|Treatment Cycle 2|Not otherwise specified|0
5548472|NCT01261611|19177334|P2|Treatment Cycle 2|Not otherwise specified|0
5548473|NCT01261611|19177335|P1|Treatment Cycle 2|Not otherwise specified|2
5548474|NCT01261611|19177333|P3|Treatment Cycle 2|Protocol Violation|0
5548475|NCT01261611|19177334|P2|Treatment Cycle 2|Protocol Violation|0
5548476|NCT01261611|19177335|P1|Treatment Cycle 2|Protocol Violation|2
5548477|NCT01261611|19177333|P3|Treatment Cycle 2|Adverse Event|0
5548478|NCT01261611|19177334|P2|Treatment Cycle 2|Adverse Event|0
5548479|NCT01261611|19177335|P1|Treatment Cycle 2|Adverse Event|1
5548480|NCT01261611|19177333|P3|Treatment Cycle 2|Withdrawal by Subject|0
5548481|NCT01261611|19177334|P2|Treatment Cycle 2|Withdrawal by Subject|0
5548482|NCT01261611|19177335|P1|Treatment Cycle 2|Withdrawal by Subject|4
5548483|NCT01261611|19177333|P3|Treatment Cycle 2|Completed study|0
5548484|NCT01261611|19177334|P2|Treatment Cycle 2|Completed study|0
5548485|NCT01261611|19177335|P1|Treatment Cycle 2|Completed study|4
5548486|NCT01261611|19177333|P3|Treatment Cycle 1|Protocol Violation|2
5548487|NCT01261611|19177334|P2|Treatment Cycle 1|Protocol Violation|0
5548488|NCT01261611|19177335|P1|Treatment Cycle 1|Protocol Violation|0
5548489|NCT01261611|19177333|P3|Treatment Cycle 1|Adverse Event|0
5548490|NCT01261611|19177334|P2|Treatment Cycle 1|Adverse Event|1
5548491|NCT01261611|19177335|P1|Treatment Cycle 1|Adverse Event|0
5548492|NCT01261611|19177333|P3|Treatment Cycle 1|Lost to Follow-up|0
5548493|NCT01261611|19177334|P2|Treatment Cycle 1|Lost to Follow-up|0
5548494|NCT01261611|19177335|P1|Treatment Cycle 1|Lost to Follow-up|1
5548495|NCT01261611|19177333|P3|Treatment Cycle 1|Withdrawal by Subject|0
5548496|NCT01261611|19177334|P2|Treatment Cycle 1|Withdrawal by Subject|2
5548497|NCT01261611|19177335|P1|Treatment Cycle 1|Withdrawal by Subject|3
5548498|NCT01261390|19177399|P4|Overall Study|Lost to Follow-up|6
5548499|NCT01261390|19177400|P3|Overall Study|Lost to Follow-up|5
5548500|NCT01261390|19177401|P2|Overall Study|Lost to Follow-up|6
5548501|NCT01261390|19177402|P1|Overall Study|Lost to Follow-up|1
5548502|NCT01261390|19177399|P4|Overall Study|Loss of Interest in the Study|0
5548503|NCT01261390|19177400|P3|Overall Study|Loss of Interest in the Study|0
5548504|NCT01261390|19177401|P2|Overall Study|Loss of Interest in the Study|1
5548505|NCT01261390|19177402|P1|Overall Study|Loss of Interest in the Study|3
5548506|NCT01261390|19177399|P4|Overall Study|Relocation|0
5548507|NCT01261390|19177400|P3|Overall Study|Relocation|0
5548508|NCT01261390|19177401|P2|Overall Study|Relocation|1
5548509|NCT01261390|19177402|P1|Overall Study|Relocation|0
5548510|NCT01261390|19177399|P4|Overall Study|Dissatisfaction with Treatment|2
5548511|NCT01261390|19177400|P3|Overall Study|Dissatisfaction with Treatment|1
5548512|NCT01261390|19177401|P2|Overall Study|Dissatisfaction with Treatment|1
5548513|NCT01261390|19177402|P1|Overall Study|Dissatisfaction with Treatment|2
5548514|NCT01261390|19177399|P4|Overall Study|Significant Concurrent Illness|0
5548515|NCT01261390|19177400|P3|Overall Study|Significant Concurrent Illness|1
5548516|NCT01261390|19177401|P2|Overall Study|Significant Concurrent Illness|0
5548517|NCT01261390|19177402|P1|Overall Study|Significant Concurrent Illness|1
5548518|NCT01261338|19177566|P2|Overall Study|Withdrawal by Subject|2
5548519|NCT01261338|19177567|P1|Overall Study|Withdrawal by Subject|3
5548520|NCT01261325|19177578|P3|Overall Study|AE, serious fatal|2
5548521|NCT01261325|19177579|P2|Overall Study|AE, serious fatal|0
5548522|NCT01261325|19177580|P1|Overall Study|AE, serious fatal|0
5548523|NCT01261325|19177578|P3|Overall Study|Lost to Follow-up|3
5548524|NCT01261325|19177579|P2|Overall Study|Lost to Follow-up|1
5548525|NCT01261325|19177580|P1|Overall Study|Lost to Follow-up|0
5548526|NCT01261325|19177578|P3|Overall Study|Protocol Violation|1
5548527|NCT01261325|19177579|P2|Overall Study|Protocol Violation|3
5548528|NCT01261325|19177580|P1|Overall Study|Protocol Violation|0
5548529|NCT01261325|19177578|P3|Overall Study|Randomized in Error|1
5548530|NCT01261325|19177579|P2|Overall Study|Randomized in Error|0
5548531|NCT01261325|19177580|P1|Overall Study|Randomized in Error|0
5548532|NCT01261325|19177578|P3|Overall Study|Screen Failure|0
5548533|NCT01261325|19177579|P2|Overall Study|Screen Failure|0
5548534|NCT01261325|19177580|P1|Overall Study|Screen Failure|1
5548535|NCT01261325|19177578|P3|Overall Study|Erroneously Randomized|0
5548536|NCT01261325|19177579|P2|Overall Study|Erroneously Randomized|0
5548537|NCT01261325|19177580|P1|Overall Study|Erroneously Randomized|1
5548538|NCT01261325|19177578|P3|Overall Study|Patient Randomized by Mistake|0
5548539|NCT01261325|19177579|P2|Overall Study|Patient Randomized by Mistake|1
5548540|NCT01261325|19177580|P1|Overall Study|Patient Randomized by Mistake|0
5548541|NCT01261325|19177578|P3|Overall Study|Non Compliance|0
5548542|NCT01261325|19177579|P2|Overall Study|Non Compliance|0
5548543|NCT01261325|19177580|P1|Overall Study|Non Compliance|2
5548544|NCT01261325|19177578|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5548545|NCT01261325|19177579|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5548546|NCT01261325|19177580|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5548547|NCT01261325|19177578|P3|Overall Study|AE, non-serious non-fatal|13
5548548|NCT01261325|19177579|P2|Overall Study|AE, non-serious non-fatal|15
5548549|NCT01261325|19177580|P1|Overall Study|AE, non-serious non-fatal|9
5548550|NCT01261325|19177578|P3|Overall Study|SAE, non-fatal|1
5548551|NCT01261325|19177579|P2|Overall Study|SAE, non-fatal|5
5548552|NCT01261325|19177580|P1|Overall Study|SAE, non-fatal|1
5548553|NCT01261325|19177578|P3|Overall Study|Withdrawal by Subject|4
5548554|NCT01261325|19177579|P2|Overall Study|Withdrawal by Subject|2
5548555|NCT01261325|19177580|P1|Overall Study|Withdrawal by Subject|2
5548556|NCT01261325|19177578|P3|Overall Study|Lack of Efficacy|0
5548557|NCT01261325|19177579|P2|Overall Study|Lack of Efficacy|1
5548558|NCT01261325|19177580|P1|Overall Study|Lack of Efficacy|1
5548559|NCT01261247|19177612|P1|Overall Study|Ineligible|2
5548560|NCT01261000|19177625|P1|Overall Study|Screen failure|1
5548561|NCT01260948|19177631|P2|Second Intervention|Emesis|1
5548562|NCT01260948|19177632|P1|Second Intervention|Emesis|0
5548563|NCT01260948|19177631|P2|Washout of 28 Days|Withdrawal by Subject|3
5548564|NCT01260948|19177632|P1|Washout of 28 Days|Withdrawal by Subject|1
5548565|NCT01260922|19177642|P2|Second Intervention|Emesis|2
5548566|NCT01260922|19177643|P1|Second Intervention|Emesis|0
5548567|NCT01260922|19177642|P2|Washout of 28 Days|Withdrawal by Subject|2
5548568|NCT01260922|19177643|P1|Washout of 28 Days|Withdrawal by Subject|4
5548569|NCT01260922|19177642|P2|First Intervention|Withdrawal by Subject|1
5548570|NCT01260922|19177643|P1|First Intervention|Withdrawal by Subject|0
5548571|NCT01260896|19177653|P2|First Intervention|Withdrawn Due to Emesis|0
5548572|NCT01260896|19177654|P1|First Intervention|Withdrawn Due to Emesis|2
5548573|NCT01260701|19177712|P1|Overall Study|Did not begin protocol therapy|1
5548574|NCT01260701|19177712|P1|Overall Study|Ineligible|4
5548575|NCT01260701|19177712|P1|Overall Study|Under review|1
5548576|NCT01260701|19177712|P1|Overall Study|Not protocol specified|3
5548577|NCT01260701|19177712|P1|Overall Study|Death|2
5548578|NCT01260701|19177712|P1|Overall Study|Progression|53
5548579|NCT01260701|19177712|P1|Overall Study|Withdrawal by Subject|2
5548580|NCT01260701|19177712|P1|Overall Study|Adverse Event|9
5548581|NCT01260584|19177793|P4|Period 2|Withdrawal by Subject|0
5548582|NCT01260584|19177794|P3|Period 2|Withdrawal by Subject|0
5548583|NCT01260584|19177795|P2|Period 2|Withdrawal by Subject|1
5548584|NCT01260584|19177796|P1|Period 2|Withdrawal by Subject|0
5548585|NCT01260584|19177793|P4|Period 2|Adverse Event|0
5548586|NCT01260584|19177794|P3|Period 2|Adverse Event|2
5548587|NCT01260584|19177795|P2|Period 2|Adverse Event|0
5548588|NCT01260584|19177796|P1|Period 2|Adverse Event|1
5548589|NCT01260584|19177793|P4|Period 2|Protocol Violation|1
5548590|NCT01260584|19177794|P3|Period 2|Protocol Violation|3
5548591|NCT01260584|19177795|P2|Period 2|Protocol Violation|2
5548592|NCT01260584|19177796|P1|Period 2|Protocol Violation|0
5548593|NCT01260584|19177793|P4|Period 1|Adverse Event|0
5548594|NCT01260584|19177794|P3|Period 1|Adverse Event|1
5548595|NCT01260584|19177795|P2|Period 1|Adverse Event|0
5548596|NCT01260584|19177796|P1|Period 1|Adverse Event|0
5548597|NCT01260584|19177793|P4|Period 1|Protocol Violation|1
5548598|NCT01260584|19177794|P3|Period 1|Protocol Violation|1
5548599|NCT01260584|19177795|P2|Period 1|Protocol Violation|0
5548600|NCT01260584|19177796|P1|Period 1|Protocol Violation|0
5548601|NCT01260467|19177839|P1|Overall Study|Withdrawal by Subject|2
5548602|NCT01260350|19177871|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548603|NCT01260350|19177872|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548604|NCT01260350|19177873|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548605|NCT01260350|19177874|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548606|NCT01260350|19177875|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548607|NCT01260350|19177876|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548608|NCT01260350|19177877|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548609|NCT01260350|19177878|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548610|NCT01260350|19177879|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548611|NCT01260350|19177880|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548612|NCT01260350|19177881|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548613|NCT01260350|19177882|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548614|NCT01260350|19177883|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548615|NCT01260350|19177884|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
5548616|NCT01260350|19177885|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548617|NCT01260350|19177886|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548618|NCT01260350|19177887|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548619|NCT01260350|19177888|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548620|NCT01260350|19177889|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548621|NCT01260350|19177890|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548622|NCT01260350|19177891|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548623|NCT01260350|19177892|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
5548624|NCT01260350|19177871|P22|Overall Study|Lack of Efficacy|0
5548625|NCT01260350|19177872|P21|Overall Study|Lack of Efficacy|3
5548626|NCT01260350|19177873|P20|Overall Study|Lack of Efficacy|0
5548627|NCT01260350|19177874|P19|Overall Study|Lack of Efficacy|0
5548628|NCT01260350|19177875|P18|Overall Study|Lack of Efficacy|1
5548629|NCT01260350|19177876|P17|Overall Study|Lack of Efficacy|0
5548630|NCT01260350|19177877|P16|Overall Study|Lack of Efficacy|0
5548631|NCT01260350|19177878|P15|Overall Study|Lack of Efficacy|0
5548632|NCT01260350|19177879|P14|Overall Study|Lack of Efficacy|0
5548633|NCT01260350|19177880|P13|Overall Study|Lack of Efficacy|0
5548634|NCT01260350|19177881|P12|Overall Study|Lack of Efficacy|0
5548635|NCT01260350|19177882|P11|Overall Study|Lack of Efficacy|0
5548636|NCT01260350|19177883|P10|Overall Study|Lack of Efficacy|0
5548637|NCT01260350|19177884|P9|Overall Study|Lack of Efficacy|0
5548638|NCT01260350|19177885|P8|Overall Study|Lack of Efficacy|0
5548639|NCT01260350|19177886|P7|Overall Study|Lack of Efficacy|0
5548640|NCT01260350|19177887|P6|Overall Study|Lack of Efficacy|0
5548641|NCT01260350|19177888|P5|Overall Study|Lack of Efficacy|0
5548642|NCT01260350|19177889|P4|Overall Study|Lack of Efficacy|0
5548643|NCT01260350|19177890|P3|Overall Study|Lack of Efficacy|0
5548644|NCT01260350|19177891|P2|Overall Study|Lack of Efficacy|0
5548645|NCT01260350|19177892|P1|Overall Study|Lack of Efficacy|0
5548646|NCT01260311|19178099|P1|Overall Study|Fesoterodine Started Before Enrollment|1
5548647|NCT01260311|19178099|P1|Overall Study|Medication Stopped|1
5548648|NCT01260311|19178099|P1|Overall Study|Gone to Province|2
5548649|NCT01260311|19178099|P1|Overall Study|Financial Constraints|77
5548650|NCT01260311|19178099|P1|Overall Study|Withdrawal by Subject|6
5548651|NCT01260311|19178099|P1|Overall Study|Lost to Follow-up|25
5548652|NCT01260311|19178099|P1|Overall Study|Lack of Efficacy|4
5548653|NCT01260311|19178099|P1|Overall Study|Adverse Event|11
5548654|NCT01260194|19178130|P1|Overall Study|Withdrawal of Consent|1
5548655|NCT01260181|19178142|P1|Overall Study|Decision of Investigator|1
5548656|NCT01260142|19178157|P6|Treatment Period 1|Withdrawal by Subject|1
5548657|NCT01260142|19178158|P5|Treatment Period 1|Withdrawal by Subject|0
5548658|NCT01260142|19178159|P4|Treatment Period 1|Withdrawal by Subject|0
5548659|NCT01260142|19178160|P3|Treatment Period 1|Withdrawal by Subject|0
5548660|NCT01260142|19178161|P2|Treatment Period 1|Withdrawal by Subject|0
5548661|NCT01260142|19178162|P1|Treatment Period 1|Withdrawal by Subject|0
5548662|NCT01260142|19178157|P6|Treatment Period 1|Unexplained elevated sys. BP|0
5548663|NCT01260142|19178158|P5|Treatment Period 1|Unexplained elevated sys. BP|1
5548664|NCT01260142|19178159|P4|Treatment Period 1|Unexplained elevated sys. BP|0
5548665|NCT01260142|19178160|P3|Treatment Period 1|Unexplained elevated sys. BP|0
5548666|NCT01260142|19178161|P2|Treatment Period 1|Unexplained elevated sys. BP|0
5548667|NCT01260142|19178162|P1|Treatment Period 1|Unexplained elevated sys. BP|0
5548668|NCT01260142|19178157|P6|Treatment Period 1|Study on hold|2
5548669|NCT01260142|19178158|P5|Treatment Period 1|Study on hold|1
5548670|NCT01260142|19178159|P4|Treatment Period 1|Study on hold|0
5548671|NCT01260142|19178160|P3|Treatment Period 1|Study on hold|0
5548672|NCT01260142|19178161|P2|Treatment Period 1|Study on hold|1
5548673|NCT01260142|19178162|P1|Treatment Period 1|Study on hold|1
5548674|NCT01259869|19178212|P1|Overall Study|Duplicated registration|1
5548675|NCT01259856|19178218|P2|Overall Study|Unknown/missing|2
5548676|NCT01259856|19178219|P1|Overall Study|Unknown/missing|2
5548677|NCT01259856|19178218|P2|Overall Study|Transfer to another study|1
5548678|NCT01259856|19178219|P1|Overall Study|Transfer to another study|0
5548679|NCT01259856|19178218|P2|Overall Study|Patient developed other disease|1
5548680|NCT01259856|19178219|P1|Overall Study|Patient developed other disease|0
5548681|NCT01259856|19178218|P2|Overall Study|Study closure by sponsor|41
5548682|NCT01259856|19178219|P1|Overall Study|Study closure by sponsor|40
5548683|NCT01259856|19178218|P2|Overall Study|Treatment never started|6
5548684|NCT01259856|19178219|P1|Overall Study|Treatment never started|0
5548685|NCT01259856|19178218|P2|Overall Study|Withdrawal by Subject|10
5548686|NCT01259856|19178219|P1|Overall Study|Withdrawal by Subject|9
5548687|NCT01259856|19178218|P2|Overall Study|Physician Decision|1
5548688|NCT01259856|19178219|P1|Overall Study|Physician Decision|2
5548689|NCT01259856|19178218|P2|Overall Study|Lost to Follow-up|1
5548690|NCT01259856|19178219|P1|Overall Study|Lost to Follow-up|1
5548691|NCT01259856|19178218|P2|Overall Study|Lack of Efficacy|1
5548692|NCT01259856|19178219|P1|Overall Study|Lack of Efficacy|3
5548693|NCT01259856|19178218|P2|Overall Study|Death|1
5548694|NCT01259856|19178219|P1|Overall Study|Death|0
5548695|NCT01259856|19178218|P2|Overall Study|Adverse Event|9
5548696|NCT01259856|19178219|P1|Overall Study|Adverse Event|12
5548697|NCT01259726|19178243|P4|Overall Study|Lost to Follow-up|3
5548698|NCT01259726|19178244|P3|Overall Study|Lost to Follow-up|1
5548699|NCT01259726|19178245|P2|Overall Study|Lost to Follow-up|1
5548700|NCT01259726|19178246|P1|Overall Study|Lost to Follow-up|1
5548701|NCT01259726|19178243|P4|Overall Study|Withdrawal by Subject|1
5548702|NCT01259726|19178244|P3|Overall Study|Withdrawal by Subject|2
5548703|NCT01259726|19178245|P2|Overall Study|Withdrawal by Subject|3
5548704|NCT01259726|19178246|P1|Overall Study|Withdrawal by Subject|1
5548705|NCT01259726|19178243|P4|Overall Study|Physician Decision|1
5548706|NCT01259726|19178244|P3|Overall Study|Physician Decision|1
5548707|NCT01259726|19178245|P2|Overall Study|Physician Decision|0
5548708|NCT01259726|19178246|P1|Overall Study|Physician Decision|2
5548709|NCT01259726|19178243|P4|Overall Study|Death|0
5548710|NCT01259726|19178244|P3|Overall Study|Death|0
5548711|NCT01259726|19178245|P2|Overall Study|Death|0
5548712|NCT01259726|19178246|P1|Overall Study|Death|1
5548713|NCT01259713|19178278|P2|Overall Study|Subject Withdrew Consent|7
5548714|NCT01259713|19178279|P1|Overall Study|Subject Withdrew Consent|12
5548715|NCT01259713|19178278|P2|Overall Study|Protocol Violation|4
5548716|NCT01259713|19178279|P1|Overall Study|Protocol Violation|5
5548717|NCT01259713|19178278|P2|Overall Study|Lack of Efficacy|0
5548718|NCT01259713|19178279|P1|Overall Study|Lack of Efficacy|2
5548719|NCT01259713|19178278|P2|Overall Study|Investigators Discretion|6
5548720|NCT01259713|19178279|P1|Overall Study|Investigators Discretion|14
5548721|NCT01259713|19178278|P2|Overall Study|Death Not Related to IFI|1
5548722|NCT01259713|19178279|P1|Overall Study|Death Not Related to IFI|8
5548723|NCT01259713|19178278|P2|Overall Study|Adverse Event|23
5548724|NCT01259713|19178279|P1|Overall Study|Adverse Event|54
5548725|NCT01259492|19178326|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
5548726|NCT01259492|19178327|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
5548727|NCT01259492|19178328|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
5548728|NCT01259492|19178329|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
5548729|NCT01259492|19178326|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
5548730|NCT01259492|19178327|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
5548731|NCT01259492|19178328|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
5548732|NCT01259492|19178329|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
5548733|NCT01259492|19178326|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
5548734|NCT01259492|19178327|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
5548735|NCT01259492|19178328|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
5548736|NCT01259492|19178329|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
5548737|NCT01259492|19178326|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
5548738|NCT01259492|19178327|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
5548739|NCT01259492|19178328|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
5548740|NCT01259492|19178329|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
5548741|NCT01259492|19178326|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
5548742|NCT01259492|19178327|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
5548743|NCT01259492|19178328|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
5548744|NCT01259492|19178329|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
5548745|NCT01259492|19178326|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
5548746|NCT01259492|19178327|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
5548747|NCT01259492|19178328|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
5548748|NCT01259492|19178329|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
5548749|NCT01259492|19178326|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
5548750|NCT01259492|19178327|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
5548751|NCT01259492|19178328|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
5548752|NCT01259492|19178329|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
5548753|NCT01259492|19178326|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
5548754|NCT01259492|19178327|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
5548755|NCT01259492|19178328|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
5548756|NCT01259492|19178329|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
5548757|NCT01259492|19178326|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
5548758|NCT01259492|19178327|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
5548759|NCT01259492|19178328|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
5548760|NCT01259492|19178329|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
5548761|NCT01259492|19178326|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
5548762|NCT01259492|19178327|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
5548763|NCT01259492|19178328|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
5548764|NCT01259492|19178329|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
5548765|NCT01259492|19178326|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
5548766|NCT01259492|19178327|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
5548767|NCT01259492|19178328|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
5548768|NCT01259492|19178329|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
5548769|NCT01259492|19178326|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
5548770|NCT01259492|19178327|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
5548771|NCT01259492|19178328|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
5548772|NCT01259492|19178329|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
5548773|NCT01259492|19178326|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
5548774|NCT01259492|19178327|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
5548775|NCT01259492|19178328|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
5548776|NCT01259492|19178329|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
5548777|NCT01259492|19178326|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
5548778|NCT01259492|19178327|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
5548779|NCT01259492|19178328|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
5548780|NCT01259492|19178329|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
5548781|NCT01259492|19178326|P4|Period 1 (9 Weeks)|Protocol Violation|1
5548782|NCT01259492|19178327|P3|Period 1 (9 Weeks)|Protocol Violation|3
5548783|NCT01259492|19178328|P2|Period 1 (9 Weeks)|Protocol Violation|6
5548784|NCT01259492|19178329|P1|Period 1 (9 Weeks)|Protocol Violation|5
5548785|NCT01259492|19178326|P4|Period 1 (9 Weeks)|Administrative Problems|2
5548786|NCT01259492|19178327|P3|Period 1 (9 Weeks)|Administrative Problems|1
5548787|NCT01259492|19178328|P2|Period 1 (9 Weeks)|Administrative Problems|1
5548788|NCT01259492|19178329|P1|Period 1 (9 Weeks)|Administrative Problems|0
5548789|NCT01259492|19178326|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
5548790|NCT01259492|19178327|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
5548791|NCT01259492|19178328|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
5548792|NCT01259492|19178329|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
5548793|NCT01259492|19178326|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
5548794|NCT01259492|19178327|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
5548795|NCT01259492|19178328|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
5548796|NCT01259492|19178329|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
5548797|NCT01259492|19178326|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
5548798|NCT01259492|19178327|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
5548799|NCT01259492|19178328|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
5548800|NCT01259492|19178329|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
5548801|NCT01259492|19178326|P4|Period 1 (9 Weeks)|Adverse Event|3
5548802|NCT01259492|19178327|P3|Period 1 (9 Weeks)|Adverse Event|26
5548803|NCT01259492|19178328|P2|Period 1 (9 Weeks)|Adverse Event|18
5548804|NCT01259492|19178329|P1|Period 1 (9 Weeks)|Adverse Event|13
5548805|NCT01259466|19178378|P2|Overall Study|Withdrawal by Subject|9
5548806|NCT01259466|19178379|P1|Overall Study|Withdrawal by Subject|1
5548807|NCT01259401|19178417|P2|4-month Follow-up|Lost to Follow-up|1
5548808|NCT01259401|19178418|P1|4-month Follow-up|Lost to Follow-up|0
5548809|NCT01259401|19178417|P2|4-month Follow-up|Death|1
5548810|NCT01259401|19178418|P1|4-month Follow-up|Death|0
5548811|NCT01259388|19178428|P2|Overall Study|Physician Decision|0
5548812|NCT01259388|19178429|P1|Overall Study|Physician Decision|1
5548813|NCT01259388|19178428|P2|Overall Study|Withdrawal by Subject|1
5548814|NCT01259388|19178429|P1|Overall Study|Withdrawal by Subject|1
5548815|NCT01259388|19178428|P2|Overall Study|Adverse Event|0
5548816|NCT01259388|19178429|P1|Overall Study|Adverse Event|3
5548817|NCT01259375|19178439|P1|Overall Study|Adverse Event|1
5548818|NCT01259297|19178456|P8|Double Blind Randomized Period|Other reasons|1
5548819|NCT01259297|19178457|P7|Double Blind Randomized Period|Other reasons|3
5548820|NCT01259297|19178458|P6|Double Blind Randomized Period|Other reasons|2
5548821|NCT01259297|19178459|P5|Double Blind Randomized Period|Other reasons|1
5548822|NCT01259297|19178460|P4|Double Blind Randomized Period|Other reasons|0
5548823|NCT01259297|19178461|P3|Double Blind Randomized Period|Other reasons|0
5548824|NCT01259297|19178462|P2|Double Blind Randomized Period|Other reasons|1
5548825|NCT01259297|19178463|P1|Double Blind Randomized Period|Other reasons|0
5548826|NCT01259297|19178456|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5548827|NCT01259297|19178457|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5548828|NCT01259297|19178458|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5548829|NCT01259297|19178459|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
5548830|NCT01259297|19178460|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
5548831|NCT01259297|19178461|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
5548832|NCT01259297|19178462|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5548833|NCT01259297|19178463|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
5548834|NCT01259297|19178456|P8|Double Blind Randomized Period|Death|1
5548835|NCT01259297|19178457|P7|Double Blind Randomized Period|Death|2
5548836|NCT01259297|19178458|P6|Double Blind Randomized Period|Death|5
5548837|NCT01259297|19178459|P5|Double Blind Randomized Period|Death|1
5548838|NCT01259297|19178460|P4|Double Blind Randomized Period|Death|2
5548839|NCT01259297|19178461|P3|Double Blind Randomized Period|Death|1
5548840|NCT01259297|19178462|P2|Double Blind Randomized Period|Death|1
5548841|NCT01259297|19178463|P1|Double Blind Randomized Period|Death|1
5548842|NCT01259284|19178494|P3|Overall Study|Study Termination|0
5548843|NCT01259284|19178495|P2|Overall Study|Study Termination|0
5548844|NCT01259284|19178496|P1|Overall Study|Study Termination|2
5548845|NCT01259245|19178506|P2|Overall Study|Death|2
5548846|NCT01259245|19178507|P1|Overall Study|Death|1
5548847|NCT01259245|19178506|P2|Overall Study|Withdrawal by Subject|24
5548848|NCT01259245|19178507|P1|Overall Study|Withdrawal by Subject|27
5548849|NCT01259115|19178544|P2|Period 2|Adverse Event|0
5548850|NCT01259115|19178545|P1|Period 2|Adverse Event|1
5548851|NCT01259115|19178544|P2|Period 1|Lost to Follow-up|1
5548852|NCT01259115|19178545|P1|Period 1|Lost to Follow-up|0
5548853|NCT01259115|19178544|P2|Period 1|Protocol Violation|0
5548854|NCT01259115|19178545|P1|Period 1|Protocol Violation|2
5548855|NCT01259115|19178544|P2|Period 1|Adverse Event|0
5548856|NCT01259115|19178545|P1|Period 1|Adverse Event|1
5548857|NCT01259102|19178581|P5|Overall Study|Other|1
5548858|NCT01259102|19178582|P4|Overall Study|Other|1
5548859|NCT01259102|19178583|P3|Overall Study|Other|1
5548860|NCT01259102|19178584|P2|Overall Study|Other|0
5548861|NCT01259102|19178585|P1|Overall Study|Other|0
5548862|NCT01259102|19178581|P5|Overall Study|Adverse Event|0
5548863|NCT01259102|19178582|P4|Overall Study|Adverse Event|1
5548864|NCT01259102|19178583|P3|Overall Study|Adverse Event|1
5548865|NCT01259102|19178584|P2|Overall Study|Adverse Event|0
5548866|NCT01259102|19178585|P1|Overall Study|Adverse Event|1
5548867|NCT01259089|19178642|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
5548868|NCT01259089|19178643|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
5548869|NCT01259089|19178644|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
5548870|NCT01259089|19178645|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
5548871|NCT01259089|19178646|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
5548872|NCT01259089|19178647|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
5548873|NCT01259089|19178642|P6|Survival Follow up for Two Years|Lost to Follow-up|2
5548874|NCT01259089|19178643|P5|Survival Follow up for Two Years|Lost to Follow-up|0
5548875|NCT01259089|19178644|P4|Survival Follow up for Two Years|Lost to Follow-up|0
5548876|NCT01259089|19178645|P3|Survival Follow up for Two Years|Lost to Follow-up|0
5548877|NCT01259089|19178646|P2|Survival Follow up for Two Years|Lost to Follow-up|0
5548878|NCT01259089|19178647|P1|Survival Follow up for Two Years|Lost to Follow-up|0
5548879|NCT01259089|19178642|P6|Survival Follow up for Two Years|Death|13
5548880|NCT01259089|19178643|P5|Survival Follow up for Two Years|Death|6
5548881|NCT01259089|19178644|P4|Survival Follow up for Two Years|Death|3
5548882|NCT01259089|19178645|P3|Survival Follow up for Two Years|Death|2
5548883|NCT01259089|19178646|P2|Survival Follow up for Two Years|Death|2
5548884|NCT01259089|19178647|P1|Survival Follow up for Two Years|Death|3
5548885|NCT01259089|19178642|P6|Continued Treatment After 8 Weeks|Progressive disease|0
5548886|NCT01259089|19178643|P5|Continued Treatment After 8 Weeks|Progressive disease|0
5548887|NCT01259089|19178644|P4|Continued Treatment After 8 Weeks|Progressive disease|1
5548888|NCT01259089|19178645|P3|Continued Treatment After 8 Weeks|Progressive disease|1
5548889|NCT01259089|19178646|P2|Continued Treatment After 8 Weeks|Progressive disease|1
5548890|NCT01259089|19178647|P1|Continued Treatment After 8 Weeks|Progressive disease|1
5548891|NCT01259089|19178642|P6|Continued Treatment After 8 Weeks|Adverse Event|1
5548892|NCT01259089|19178643|P5|Continued Treatment After 8 Weeks|Adverse Event|2
5548893|NCT01259089|19178644|P4|Continued Treatment After 8 Weeks|Adverse Event|0
5548894|NCT01259089|19178645|P3|Continued Treatment After 8 Weeks|Adverse Event|0
5548895|NCT01259089|19178646|P2|Continued Treatment After 8 Weeks|Adverse Event|0
5548896|NCT01259089|19178647|P1|Continued Treatment After 8 Weeks|Adverse Event|0
5548897|NCT01259089|19178642|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5548898|NCT01259089|19178643|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5548899|NCT01259089|19178644|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5548900|NCT01259089|19178645|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5548901|NCT01259089|19178646|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
5548902|NCT01259089|19178647|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
5548903|NCT01259089|19178642|P6|Confirmed Response at 8 Weeks|Progressive disease|7
5548904|NCT01259089|19178643|P5|Confirmed Response at 8 Weeks|Progressive disease|3
5548905|NCT01259089|19178644|P4|Confirmed Response at 8 Weeks|Progressive disease|1
5548906|NCT01259089|19178645|P3|Confirmed Response at 8 Weeks|Progressive disease|1
5548907|NCT01259089|19178646|P2|Confirmed Response at 8 Weeks|Progressive disease|0
5548908|NCT01259089|19178647|P1|Confirmed Response at 8 Weeks|Progressive disease|0
5548909|NCT01259089|19178642|P6|Confirmed Response at 8 Weeks|Adverse Event|2
5548910|NCT01259089|19178643|P5|Confirmed Response at 8 Weeks|Adverse Event|1
5548911|NCT01259089|19178644|P4|Confirmed Response at 8 Weeks|Adverse Event|0
5548912|NCT01259089|19178645|P3|Confirmed Response at 8 Weeks|Adverse Event|0
5548913|NCT01259089|19178646|P2|Confirmed Response at 8 Weeks|Adverse Event|0
5548914|NCT01259089|19178647|P1|Confirmed Response at 8 Weeks|Adverse Event|0
5548915|NCT01259089|19178642|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
5548916|NCT01259089|19178643|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5548917|NCT01259089|19178644|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5548918|NCT01259089|19178645|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5548919|NCT01259089|19178646|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5548920|NCT01259089|19178647|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
5548921|NCT01259089|19178642|P6|Reached First Response at 4 Weeks|Adverse Event|1
5548922|NCT01259089|19178643|P5|Reached First Response at 4 Weeks|Adverse Event|0
5548923|NCT01259089|19178644|P4|Reached First Response at 4 Weeks|Adverse Event|0
5548924|NCT01259089|19178645|P3|Reached First Response at 4 Weeks|Adverse Event|0
5548925|NCT01259089|19178646|P2|Reached First Response at 4 Weeks|Adverse Event|0
5548926|NCT01259089|19178647|P1|Reached First Response at 4 Weeks|Adverse Event|0
5548927|NCT01259089|19178642|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
5548928|NCT01259089|19178643|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
5548929|NCT01259089|19178644|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
5548930|NCT01259089|19178645|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
5548931|NCT01259089|19178646|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
5548932|NCT01259089|19178647|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
5548933|NCT01259024|19178675|P1|Overall Study|Physician Decision|1
5548934|NCT01258998|19178695|P1|Overall Study|Ineligible|1
5548935|NCT01258803|19178756|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
5548936|NCT01258803|19178757|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
5548937|NCT01258803|19178758|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
5548938|NCT01258803|19178759|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
5548939|NCT01258803|19178760|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
5548940|NCT01258803|19178761|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
5548941|NCT01258803|19178756|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5548942|NCT01258803|19178757|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5548943|NCT01258803|19178758|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5548944|NCT01258803|19178759|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5548945|NCT01258803|19178760|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
5548946|NCT01258803|19178761|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
5548947|NCT01258803|19178756|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
5548948|NCT01258803|19178757|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
5548949|NCT01258803|19178758|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
5548950|NCT01258803|19178759|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
5548951|NCT01258803|19178760|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
5548952|NCT01258803|19178761|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
5548953|NCT01258738|19178798|P2|Open-label Period|Withdrawn due to pregnancy|1
5548954|NCT01258738|19178799|P1|Open-label Period|Withdrawn due to pregnancy|1
5548955|NCT01258738|19178798|P2|Open-label Period|Other Reasons|1
5548956|NCT01258738|19178799|P1|Open-label Period|Other Reasons|0
5548957|NCT01258738|19178798|P2|Open-label Period|Adverse Event|5
5548958|NCT01258738|19178799|P1|Open-label Period|Adverse Event|4
5548959|NCT01258738|19178798|P2|Open-label Period|Protocol Violation|2
5548960|NCT01258738|19178799|P1|Open-label Period|Protocol Violation|2
5548961|NCT01258738|19178798|P2|Open-label Period|Withdrawal by Subject|6
5548962|NCT01258738|19178799|P1|Open-label Period|Withdrawal by Subject|5
5548963|NCT01258738|19178798|P2|Open-label Period|Lost to Follow-up|2
5548964|NCT01258738|19178799|P1|Open-label Period|Lost to Follow-up|0
5548965|NCT01258738|19178798|P2|Open-label Period|Insufficient clinical response|3
5548966|NCT01258738|19178799|P1|Open-label Period|Insufficient clinical response|5
5548967|NCT01258738|19178798|P2|Open-label Period|Did not meet inclusion criteria|1
5548968|NCT01258738|19178799|P1|Open-label Period|Did not meet inclusion criteria|0
5548969|NCT01258738|19178798|P2|Double-blind Period|Adverse Event|1
5548970|NCT01258738|19178799|P1|Double-blind Period|Adverse Event|3
5548971|NCT01258738|19178798|P2|Double-blind Period|Protocol Violation|1
5548972|NCT01258738|19178799|P1|Double-blind Period|Protocol Violation|1
5548973|NCT01258738|19178798|P2|Double-blind Period|Withdrawal by Subject|2
5548974|NCT01258738|19178799|P1|Double-blind Period|Withdrawal by Subject|2
5548975|NCT01258738|19178798|P2|Double-blind Period|Did not meet inclusion criteria|3
5548976|NCT01258738|19178799|P1|Double-blind Period|Did not meet inclusion criteria|3
5548977|NCT01258660|19178937|P2|Overall Study|Invalid for primary analysis data set|6
5548978|NCT01258660|19178938|P1|Overall Study|Invalid for primary analysis data set|4
5548979|NCT01258660|19178937|P2|Overall Study|Protocol Violation|1
5548980|NCT01258660|19178938|P1|Overall Study|Protocol Violation|0
5548981|NCT01258660|19178937|P2|Overall Study|due to relocation|0
5548982|NCT01258660|19178938|P1|Overall Study|due to relocation|2
5548983|NCT01258660|19178937|P2|Overall Study|Withdrawal by Subject|0
5548984|NCT01258660|19178938|P1|Overall Study|Withdrawal by Subject|3
5548985|NCT01258660|19178937|P2|Overall Study|Adverse Event|4
5548986|NCT01258660|19178938|P1|Overall Study|Adverse Event|2
5548987|NCT01258608|19178957|P2|Overall Study|Withdrawal by Subject|5
5548988|NCT01258608|19178958|P1|Overall Study|Withdrawal by Subject|6
5548989|NCT01258608|19178957|P2|Overall Study|Adverse Event|10
5548990|NCT01258608|19178958|P1|Overall Study|Adverse Event|6
5548991|NCT01258608|19178957|P2|Overall Study|Lack of Efficacy|1
5548992|NCT01258608|19178958|P1|Overall Study|Lack of Efficacy|0
5548993|NCT01258608|19178957|P2|Overall Study|Lack of compliance|0
5548994|NCT01258608|19178958|P1|Overall Study|Lack of compliance|1
5548995|NCT01258608|19178957|P2|Overall Study|Lost to Follow-up|1
5548996|NCT01258608|19178958|P1|Overall Study|Lost to Follow-up|0
5548997|NCT01258608|19178957|P2|Overall Study|Physician Decision|1
5548998|NCT01258608|19178958|P1|Overall Study|Physician Decision|6
5548999|NCT01258608|19178957|P2|Overall Study|Sponsor decision|1
5549000|NCT01258608|19178958|P1|Overall Study|Sponsor decision|0
5549001|NCT01258608|19178957|P2|Overall Study|Clinical progression|0
5549002|NCT01258608|19178958|P1|Overall Study|Clinical progression|1
5549003|NCT01258608|19178957|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
5549004|NCT01258608|19178958|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
5549005|NCT01258595|19179006|P2|Overall Study|Withdrawal by Subject|1
5549006|NCT01258595|19179007|P1|Overall Study|Withdrawal by Subject|0
5549007|NCT01258595|19179006|P2|Overall Study|Lost to Follow-up|0
5549008|NCT01258595|19179007|P1|Overall Study|Lost to Follow-up|1
5549009|NCT01258348|19179104|P5|Overall Study|Withdrawal by Subject|0
5549010|NCT01258348|19179105|P4|Overall Study|Withdrawal by Subject|0
5549011|NCT01258348|19179106|P3|Overall Study|Withdrawal by Subject|0
5549012|NCT01258348|19179107|P2|Overall Study|Withdrawal by Subject|1
5549013|NCT01258348|19179108|P1|Overall Study|Withdrawal by Subject|0
5549014|NCT01258348|19179104|P5|Overall Study|Physician Decision|0
5549015|NCT01258348|19179105|P4|Overall Study|Physician Decision|2
5549016|NCT01258348|19179106|P3|Overall Study|Physician Decision|0
5549017|NCT01258348|19179107|P2|Overall Study|Physician Decision|0
5549018|NCT01258348|19179108|P1|Overall Study|Physician Decision|0
5549019|NCT01258348|19179104|P5|Overall Study|Progressive Disease|2
5549020|NCT01258348|19179105|P4|Overall Study|Progressive Disease|2
5549021|NCT01258348|19179106|P3|Overall Study|Progressive Disease|0
5549022|NCT01258348|19179107|P2|Overall Study|Progressive Disease|3
5549023|NCT01258348|19179108|P1|Overall Study|Progressive Disease|0
5549024|NCT01258348|19179104|P5|Overall Study|Adverse Event|4
5549025|NCT01258348|19179105|P4|Overall Study|Adverse Event|2
5549026|NCT01258348|19179106|P3|Overall Study|Adverse Event|3
5549027|NCT01258348|19179107|P2|Overall Study|Adverse Event|1
5549028|NCT01258348|19179108|P1|Overall Study|Adverse Event|1
5549029|NCT01258101|19179165|P4|Overall Study|Other reason|8
5549030|NCT01258101|19179166|P3|Overall Study|Other reason|1
5549031|NCT01258101|19179167|P2|Overall Study|Other reason|8
5549032|NCT01258101|19179168|P1|Overall Study|Other reason|7
5549033|NCT01258101|19179165|P4|Overall Study|PCR positive at week 24|1
5549034|NCT01258101|19179166|P3|Overall Study|PCR positive at week 24|0
5549035|NCT01258101|19179167|P2|Overall Study|PCR positive at week 24|0
5549036|NCT01258101|19179168|P1|Overall Study|PCR positive at week 24|0
5549037|NCT01258101|19179165|P4|Overall Study|Lost to Follow-up|6
5549038|NCT01258101|19179166|P3|Overall Study|Lost to Follow-up|0
5549039|NCT01258101|19179167|P2|Overall Study|Lost to Follow-up|5
5549040|NCT01258101|19179168|P1|Overall Study|Lost to Follow-up|5
5549041|NCT01258101|19179165|P4|Overall Study|Patient´s compliance|2
5549042|NCT01258101|19179166|P3|Overall Study|Patient´s compliance|1
5549043|NCT01258101|19179167|P2|Overall Study|Patient´s compliance|3
5549044|NCT01258101|19179168|P1|Overall Study|Patient´s compliance|4
5549045|NCT01258101|19179165|P4|Overall Study|Patient is not able to attend visits|6
5549046|NCT01258101|19179166|P3|Overall Study|Patient is not able to attend visits|7
5549047|NCT01258101|19179167|P2|Overall Study|Patient is not able to attend visits|9
5549048|NCT01258101|19179168|P1|Overall Study|Patient is not able to attend visits|8
5549049|NCT01258101|19179165|P4|Overall Study|Informed consent has been withdrawn|1
5549050|NCT01258101|19179166|P3|Overall Study|Informed consent has been withdrawn|1
5549051|NCT01258101|19179167|P2|Overall Study|Informed consent has been withdrawn|2
5549052|NCT01258101|19179168|P1|Overall Study|Informed consent has been withdrawn|2
5549053|NCT01258101|19179165|P4|Overall Study|Extra exclusion criterion amended|1
5549054|NCT01258101|19179166|P3|Overall Study|Extra exclusion criterion amended|1
5549055|NCT01258101|19179167|P2|Overall Study|Extra exclusion criterion amended|1
5549056|NCT01258101|19179168|P1|Overall Study|Extra exclusion criterion amended|2
5549057|NCT01258101|19179165|P4|Overall Study|Adverse Event|0
5549058|NCT01258101|19179166|P3|Overall Study|Adverse Event|0
5549059|NCT01258101|19179167|P2|Overall Study|Adverse Event|6
5549060|NCT01258101|19179168|P1|Overall Study|Adverse Event|5
5549061|NCT01258075|19179220|P2|Overall Study|Other|5
5549062|NCT01258075|19179221|P1|Overall Study|Other|12
5549063|NCT01258075|19179220|P2|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2
5549064|NCT01258075|19179221|P1|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1
5549065|NCT01258075|19179220|P2|Overall Study|Withdrawal by Subject|7
5549066|NCT01258075|19179221|P1|Overall Study|Withdrawal by Subject|10
5549067|NCT01258075|19179220|P2|Overall Study|Lost to Follow-up|6
5549068|NCT01258075|19179221|P1|Overall Study|Lost to Follow-up|11
5549069|NCT01258075|19179220|P2|Overall Study|Adverse Event|3
5549070|NCT01258075|19179221|P1|Overall Study|Adverse Event|8
5549071|NCT01257737|19179307|P2|Overall Study|Withdrew from study|1
5549072|NCT01257737|19179308|P1|Overall Study|Withdrew from study|0
5549073|NCT01257737|19179307|P2|Overall Study|Relocation out of the country|1
5549074|NCT01257737|19179308|P1|Overall Study|Relocation out of the country|0
5549075|NCT01257737|19179307|P2|Overall Study|Liver transplant|0
5549076|NCT01257737|19179308|P1|Overall Study|Liver transplant|1
5549077|NCT01257737|19179307|P2|Overall Study|Lost to Follow-up|2
5549078|NCT01257737|19179308|P1|Overall Study|Lost to Follow-up|1
5549079|NCT01257698|19179328|P2|Overall Study|Protocol Violation|0
5549080|NCT01257698|19179329|P1|Overall Study|Protocol Violation|4
5549081|NCT01257581|19179338|P3|Overall Study|Death|4
5549082|NCT01257581|19179339|P2|Overall Study|Death|2
5549083|NCT01257581|19179340|P1|Overall Study|Death|2
5549084|NCT01257581|19179338|P3|Overall Study|Early Termination|2
5549085|NCT01257581|19179339|P2|Overall Study|Early Termination|1
5549086|NCT01257581|19179340|P1|Overall Study|Early Termination|3
5549087|NCT01257568|19179378|P1|Overall Study|Component Revision|24
5549088|NCT01257568|19179378|P1|Overall Study|Terminated|1
5549089|NCT01257568|19179378|P1|Overall Study|Withdrawal by Subject|6
5549090|NCT01257568|19179378|P1|Overall Study|Lost to Follow-up|2
5549091|NCT01257542|19179392|P2|Overall Study|Withdrawal by Subject|2
5549092|NCT01257542|19179393|P1|Overall Study|Withdrawal by Subject|0
5549093|NCT01257542|19179392|P2|Overall Study|Protocol Violation|5
5549094|NCT01257542|19179393|P1|Overall Study|Protocol Violation|3
5549095|NCT01257503|19179413|P2|Overall Study|strep culture positive at enrollment|0
5549096|NCT01257503|19179414|P1|Overall Study|strep culture positive at enrollment|1
5549097|NCT01257503|19179413|P2|Overall Study|Over 5 years old at enrollment|1
5549098|NCT01257503|19179414|P1|Overall Study|Over 5 years old at enrollment|0
5549099|NCT01257503|19179413|P2|Overall Study|Lost to Follow-up|10
5549100|NCT01257503|19179414|P1|Overall Study|Lost to Follow-up|7
5549101|NCT01257425|19179443|P2|Overall Study|Death|0
5549102|NCT01257425|19179444|P1|Overall Study|Death|1
5549103|NCT01257425|19179443|P2|Overall Study|Withdrawal by Subject|1
5549104|NCT01257425|19179444|P1|Overall Study|Withdrawal by Subject|0
5549105|NCT01257425|19179443|P2|Overall Study|Protocol Violation|1
5549106|NCT01257425|19179444|P1|Overall Study|Protocol Violation|1
5549107|NCT01257425|19179443|P2|Overall Study|Adverse Event|1
5549108|NCT01257425|19179444|P1|Overall Study|Adverse Event|1
5549109|NCT01257425|19179443|P2|Overall Study|Lack of Efficacy|3
5549110|NCT01257425|19179444|P1|Overall Study|Lack of Efficacy|3
5549111|NCT01257230|19179486|P3|Overall Study|Other reason not defined above|3
5549112|NCT01257230|19179487|P2|Overall Study|Other reason not defined above|5
5549113|NCT01257230|19179488|P1|Overall Study|Other reason not defined above|1
5549114|NCT01257230|19179486|P3|Overall Study|Withdrawal by Subject|1
5549115|NCT01257230|19179487|P2|Overall Study|Withdrawal by Subject|4
5549116|NCT01257230|19179488|P1|Overall Study|Withdrawal by Subject|0
5549117|NCT01257230|19179486|P3|Overall Study|Protocol Violation|1
5549118|NCT01257230|19179487|P2|Overall Study|Protocol Violation|0
5549119|NCT01257230|19179488|P1|Overall Study|Protocol Violation|3
5549120|NCT01257230|19179486|P3|Overall Study|Lack of Efficacy|0
5549121|NCT01257230|19179487|P2|Overall Study|Lack of Efficacy|1
5549122|NCT01257230|19179488|P1|Overall Study|Lack of Efficacy|0
5549123|NCT01257230|19179486|P3|Overall Study|Adverse Event|0
5549124|NCT01257230|19179487|P2|Overall Study|Adverse Event|0
5549125|NCT01257230|19179488|P1|Overall Study|Adverse Event|2
5549126|NCT01257230|19179486|P3|Overall Study|Not Treated|1
5549127|NCT01257230|19179487|P2|Overall Study|Not Treated|0
5549128|NCT01257230|19179488|P1|Overall Study|Not Treated|0
5549129|NCT01257204|19179565|P3|Follow-up Period (up to Week 48)|Other|5
5549130|NCT01257204|19179566|P2|Follow-up Period (up to Week 48)|Other|0
5549131|NCT01257204|19179567|P1|Follow-up Period (up to Week 48)|Other|0
5549132|NCT01257204|19179565|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
5549133|NCT01257204|19179566|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
5549134|NCT01257204|19179567|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
5549135|NCT01257204|19179565|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
5549136|NCT01257204|19179566|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
5549137|NCT01257204|19179567|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
5549138|NCT01257204|19179565|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
5549139|NCT01257204|19179566|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
5549140|NCT01257204|19179567|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
5549141|NCT01257204|19179565|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
5549142|NCT01257204|19179566|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
5549143|NCT01257204|19179567|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
5549144|NCT01257204|19179565|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
5549145|NCT01257204|19179566|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
5549146|NCT01257204|19179567|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
5549147|NCT01257204|19179565|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
5549148|NCT01257204|19179566|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
5549149|NCT01257204|19179567|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
5549150|NCT01257204|19179565|P3|Treatment Period (up to Week 24)|Adverse Event|2
5549151|NCT01257204|19179566|P2|Treatment Period (up to Week 24)|Adverse Event|1
5549152|NCT01257204|19179567|P1|Treatment Period (up to Week 24)|Adverse Event|3
5549153|NCT01257204|19179565|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
5549154|NCT01257204|19179566|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
5549155|NCT01257204|19179567|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
5549156|NCT01256879|19179675|P1|Overall Study|Withdrawal by Subject|1
5549157|NCT01256788|19179701|P3|Overall Study|Lost to Follow-up|3
5549158|NCT01256788|19179702|P2|Overall Study|Lost to Follow-up|8
5549159|NCT01256788|19179703|P1|Overall Study|Lost to Follow-up|5
5549160|NCT01256684|19179714|P3|Overall Study|Entry criteria not met/non-compliance|6
5549161|NCT01256684|19179715|P2|Overall Study|Entry criteria not met/non-compliance|7
5549162|NCT01256684|19179716|P1|Overall Study|Entry criteria not met/non-compliance|4
5549163|NCT01256684|19179714|P3|Overall Study|Lack of Efficacy|1
5549164|NCT01256684|19179715|P2|Overall Study|Lack of Efficacy|1
5549165|NCT01256684|19179716|P1|Overall Study|Lack of Efficacy|0
5549166|NCT01256684|19179714|P3|Overall Study|Physician Decision|0
5549167|NCT01256684|19179715|P2|Overall Study|Physician Decision|1
5549168|NCT01256684|19179716|P1|Overall Study|Physician Decision|0
5549169|NCT01256684|19179714|P3|Overall Study|Withdrawal by Subject|2
5549170|NCT01256684|19179715|P2|Overall Study|Withdrawal by Subject|0
5549171|NCT01256684|19179716|P1|Overall Study|Withdrawal by Subject|4
5549172|NCT01256684|19179714|P3|Overall Study|Adverse Event|2
5549173|NCT01256684|19179715|P2|Overall Study|Adverse Event|4
5549174|NCT01256684|19179716|P1|Overall Study|Adverse Event|1
5549175|NCT01256671|19179748|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
5549176|NCT01256671|19179748|P1|Overall Study|Lack of Efficacy|4
5549177|NCT01256671|19179748|P1|Overall Study|Physician Decision|3
5549178|NCT01256671|19179748|P1|Overall Study|Withdrawal by Subject|31
5549179|NCT01256671|19179748|P1|Overall Study|Lost to Follow-up|16
5549180|NCT01256671|19179748|P1|Overall Study|Adverse Event|29
5549181|NCT01256658|19179761|P2|Period 1|Death|44
5549182|NCT01256658|19179762|P1|Period 1|Death|48
5549183|NCT01256658|19179761|P2|Period 1|Withdrawal by Subject|43
5549184|NCT01256658|19179762|P1|Period 1|Withdrawal by Subject|35
5549185|NCT01256658|19179761|P2|Period 1|Lost to Follow-up|661
5549186|NCT01256658|19179762|P1|Period 1|Lost to Follow-up|837
5549187|NCT01256593|19179812|P1|Overall Study|No Visit After Treatment|186
5549188|NCT01256593|19179812|P1|Overall Study|No Drug Administration Information|2
5549189|NCT01256593|19179812|P1|Overall Study|Protocol Violation|26
5549190|NCT01256567|19179826|P1|Overall Study|Withdrawal by Subject|1
5549191|NCT01256502|19179836|P1|Overall Study|Protocol deviation|1
5549192|NCT01256502|19179836|P1|Overall Study|Personal reasons|5
5549193|NCT01256502|19179836|P1|Overall Study|Had scaffold removed|4
5549194|NCT01256476|19179848|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
5549195|NCT01256476|19179849|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
5549196|NCT01256476|19179848|P2|Overall Study|Subject non-compliance|1
5549197|NCT01256476|19179849|P1|Overall Study|Subject non-compliance|0
5549198|NCT01256476|19179848|P2|Overall Study|Physician Decision|1
5549199|NCT01256476|19179849|P1|Overall Study|Physician Decision|0
5549200|NCT01256476|19179848|P2|Overall Study|Persistent ALT or AST elevation|0
5549201|NCT01256476|19179849|P1|Overall Study|Persistent ALT or AST elevation|1
5549202|NCT01256476|19179848|P2|Overall Study|Lost to Follow-up|2
5549203|NCT01256476|19179849|P1|Overall Study|Lost to Follow-up|1
5549204|NCT01256476|19179848|P2|Overall Study|Withdrawal by Subject|1
5549205|NCT01256476|19179849|P1|Overall Study|Withdrawal by Subject|2
5549206|NCT01256476|19179848|P2|Overall Study|Adverse Event|1
5549207|NCT01256476|19179849|P1|Overall Study|Adverse Event|2
5549208|NCT01256450|19179857|P3|Double-blind Treatment|Other|12
5549209|NCT01256450|19179858|P2|Double-blind Treatment|Other|9
5549210|NCT01256450|19179859|P1|Double-blind Treatment|Other|0
5549211|NCT01256450|19179857|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
5549212|NCT01256450|19179858|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
5549213|NCT01256450|19179859|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
5549214|NCT01256450|19179857|P3|Double-blind Treatment|Non-compliance|4
5549215|NCT01256450|19179858|P2|Double-blind Treatment|Non-compliance|5
5549216|NCT01256450|19179859|P1|Double-blind Treatment|Non-compliance|0
5549217|NCT01256450|19179857|P3|Double-blind Treatment|Lack of analgesic effect|6
5549218|NCT01256450|19179858|P2|Double-blind Treatment|Lack of analgesic effect|5
5549219|NCT01256450|19179859|P1|Double-blind Treatment|Lack of analgesic effect|0
5549220|NCT01256450|19179857|P3|Double-blind Treatment|Withdrawal by Subject|1
5549221|NCT01256450|19179858|P2|Double-blind Treatment|Withdrawal by Subject|0
5549222|NCT01256450|19179859|P1|Double-blind Treatment|Withdrawal by Subject|0
5549223|NCT01256450|19179857|P3|Double-blind Treatment|Lost to Follow-up|7
5549224|NCT01256450|19179858|P2|Double-blind Treatment|Lost to Follow-up|1
5549225|NCT01256450|19179859|P1|Double-blind Treatment|Lost to Follow-up|0
5549226|NCT01256450|19179857|P3|Double-blind Treatment|Adverse Event|6
5549227|NCT01256450|19179858|P2|Double-blind Treatment|Adverse Event|8
5549228|NCT01256450|19179859|P1|Double-blind Treatment|Adverse Event|0
5549229|NCT01256450|19179857|P3|Open-label Titration|Other|0
5549230|NCT01256450|19179858|P2|Open-label Titration|Other|0
5549231|NCT01256450|19179859|P1|Open-label Titration|Other|13
5549232|NCT01256450|19179857|P3|Open-label Titration|Screen failure|0
5549233|NCT01256450|19179858|P2|Open-label Titration|Screen failure|0
5549234|NCT01256450|19179859|P1|Open-label Titration|Screen failure|1
5549235|NCT01256450|19179857|P3|Open-label Titration|Non-compliance|0
5549236|NCT01256450|19179858|P2|Open-label Titration|Non-compliance|0
5549237|NCT01256450|19179859|P1|Open-label Titration|Non-compliance|9
5549238|NCT01256450|19179857|P3|Open-label Titration|Lack of analgesic effect|0
5549239|NCT01256450|19179858|P2|Open-label Titration|Lack of analgesic effect|0
5549240|NCT01256450|19179859|P1|Open-label Titration|Lack of analgesic effect|30
5549241|NCT01256450|19179857|P3|Open-label Titration|Lost to Follow-up|0
5549242|NCT01256450|19179858|P2|Open-label Titration|Lost to Follow-up|0
5549243|NCT01256450|19179859|P1|Open-label Titration|Lost to Follow-up|7
5549244|NCT01256450|19179857|P3|Open-label Titration|Adverse Event|0
5549245|NCT01256450|19179858|P2|Open-label Titration|Adverse Event|0
5549246|NCT01256450|19179859|P1|Open-label Titration|Adverse Event|39
5549247|NCT01256411|19179917|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
5549248|NCT01256411|19179918|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
5549249|NCT01256411|19179919|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5549250|NCT01256411|19179920|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5549251|NCT01256411|19179921|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5549252|NCT01256411|19179922|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
5549253|NCT01256411|19179917|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
5549254|NCT01256411|19179918|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
5549255|NCT01256411|19179919|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5549256|NCT01256411|19179920|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5549257|NCT01256411|19179921|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5549258|NCT01256411|19179922|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
5549259|NCT01256411|19179917|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5549260|NCT01256411|19179918|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
5549261|NCT01256411|19179919|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5549262|NCT01256411|19179920|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5549263|NCT01256411|19179921|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5549264|NCT01256411|19179922|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
5549265|NCT01256411|19179917|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
5549266|NCT01256411|19179918|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
5549267|NCT01256411|19179919|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
5549268|NCT01256411|19179920|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
5549269|NCT01256411|19179921|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
5549270|NCT01256411|19179922|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
5549271|NCT01256411|19179917|P6|Extension by Mono or Combination Therapy|Adverse Event|1
5549272|NCT01256411|19179918|P5|Extension by Mono or Combination Therapy|Adverse Event|6
5549273|NCT01256411|19179919|P4|Extension by Mono or Combination Therapy|Adverse Event|0
5549274|NCT01256411|19179920|P3|Extension by Mono or Combination Therapy|Adverse Event|0
5549275|NCT01256411|19179921|P2|Extension by Mono or Combination Therapy|Adverse Event|0
5549276|NCT01256411|19179922|P1|Extension by Mono or Combination Therapy|Adverse Event|0
5549277|NCT01256411|19179917|P6|Extension by Maximum Treatment|Adverse Event|0
5549278|NCT01256411|19179918|P5|Extension by Maximum Treatment|Adverse Event|0
5549279|NCT01256411|19179919|P4|Extension by Maximum Treatment|Adverse Event|0
5549280|NCT01256411|19179920|P3|Extension by Maximum Treatment|Adverse Event|1
5549281|NCT01256411|19179921|P2|Extension by Maximum Treatment|Adverse Event|2
5549282|NCT01256411|19179922|P1|Extension by Maximum Treatment|Adverse Event|4
5549283|NCT01256411|19179917|P6|Extension by Maximum Treatment|Lack of Efficacy|0
5549284|NCT01256411|19179918|P5|Extension by Maximum Treatment|Lack of Efficacy|0
5549285|NCT01256411|19179919|P4|Extension by Maximum Treatment|Lack of Efficacy|0
5549286|NCT01256411|19179920|P3|Extension by Maximum Treatment|Lack of Efficacy|1
5549287|NCT01256411|19179921|P2|Extension by Maximum Treatment|Lack of Efficacy|0
5549288|NCT01256411|19179922|P1|Extension by Maximum Treatment|Lack of Efficacy|1
5549289|NCT01256411|19179917|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
5549290|NCT01256411|19179918|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
5549291|NCT01256411|19179919|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
5549292|NCT01256411|19179920|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
5549293|NCT01256411|19179921|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
5549294|NCT01256411|19179922|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
5549295|NCT01256411|19179917|P6|Extension by Maximum Treatment|Lost to Follow-up|0
5549296|NCT01256411|19179918|P5|Extension by Maximum Treatment|Lost to Follow-up|0
5549297|NCT01256411|19179919|P4|Extension by Maximum Treatment|Lost to Follow-up|0
5549298|NCT01256411|19179920|P3|Extension by Maximum Treatment|Lost to Follow-up|0
5549299|NCT01256411|19179921|P2|Extension by Maximum Treatment|Lost to Follow-up|2
5549300|NCT01256411|19179922|P1|Extension by Maximum Treatment|Lost to Follow-up|1
5549301|NCT01256411|19179917|P6|Extension by Maximum Treatment|Protocol deviation|0
5549302|NCT01256411|19179918|P5|Extension by Maximum Treatment|Protocol deviation|0
5549303|NCT01256411|19179919|P4|Extension by Maximum Treatment|Protocol deviation|0
5549304|NCT01256411|19179920|P3|Extension by Maximum Treatment|Protocol deviation|1
5549305|NCT01256411|19179921|P2|Extension by Maximum Treatment|Protocol deviation|0
5549306|NCT01256411|19179922|P1|Extension by Maximum Treatment|Protocol deviation|0
5549307|NCT01256398|19179946|P1|Overall Study|Withdrawal by Subject|1
5549308|NCT01256385|19179952|P2|Overall Study|Withdrawal by Subject|2
5549309|NCT01256385|19179953|P1|Overall Study|Withdrawal by Subject|2
5549310|NCT01256385|19179952|P2|Overall Study|Physician Decision|1
5549311|NCT01256385|19179953|P1|Overall Study|Physician Decision|1
5549312|NCT01256294|19179973|P2|Overall Study|Protocol deviation|1
5549313|NCT01256294|19179974|P1|Overall Study|Protocol deviation|2
5549314|NCT01256294|19179973|P2|Overall Study|Withdrawal by Subject|1
5549315|NCT01256294|19179974|P1|Overall Study|Withdrawal by Subject|1
5549316|NCT01256294|19179973|P2|Overall Study|Adverse Event|0
5549317|NCT01256294|19179974|P1|Overall Study|Adverse Event|1
5549318|NCT01256190|19179996|P2|Overall Study|Lost to Follow-up|0
5549319|NCT01256190|19179997|P1|Overall Study|Lost to Follow-up|2
5549320|NCT01256177|19180013|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
5549321|NCT01256177|19180014|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
5549322|NCT01256177|19180013|P2|Overall Study|Lack of Efficacy|2
5549323|NCT01256177|19180014|P1|Overall Study|Lack of Efficacy|11
5549324|NCT01256177|19180013|P2|Overall Study|Condition under Investigation Worsened|0
5549325|NCT01256177|19180014|P1|Overall Study|Condition under Investigation Worsened|1
5549326|NCT01256177|19180013|P2|Overall Study|Severe Non-Compliance to Protocol|2
5549327|NCT01256177|19180014|P1|Overall Study|Severe Non-Compliance to Protocol|4
5549328|NCT01256177|19180013|P2|Overall Study|Adverse Event|9
5549329|NCT01256177|19180014|P1|Overall Study|Adverse Event|8
5549330|NCT01256177|19180013|P2|Overall Study|Lost to Follow-up|2
5549331|NCT01256177|19180014|P1|Overall Study|Lost to Follow-up|2
5549332|NCT01256177|19180013|P2|Overall Study|Withdrawal by Subject|22
5549333|NCT01256177|19180014|P1|Overall Study|Withdrawal by Subject|23
5549334|NCT01256060|19180070|P4|Overall Study|Lost to Follow-up|0
5549335|NCT01256060|19180071|P3|Overall Study|Lost to Follow-up|0
5549336|NCT01256060|19180072|P2|Overall Study|Lost to Follow-up|1
5549337|NCT01256060|19180073|P1|Overall Study|Lost to Follow-up|0
5549338|NCT01256008|19180092|P3|Overall Study|Withdrawal by Subject|10
5549339|NCT01256008|19180093|P2|Overall Study|Withdrawal by Subject|3
5549340|NCT01256008|19180094|P1|Overall Study|Withdrawal by Subject|2
5549341|NCT01256008|19180092|P3|Overall Study|Lost to Follow-up|11
5549342|NCT01256008|19180093|P2|Overall Study|Lost to Follow-up|4
5549343|NCT01256008|19180094|P1|Overall Study|Lost to Follow-up|6
5549344|NCT01255904|19180116|P2|Overall Study|Physician Decision|4
5549345|NCT01255904|19180117|P1|Overall Study|Physician Decision|1
5549346|NCT01255787|19180156|P4|Overall Study|Noncompliance with Study Drug|0
5549347|NCT01255787|19180157|P3|Overall Study|Noncompliance with Study Drug|0
5549348|NCT01255787|19180158|P2|Overall Study|Noncompliance with Study Drug|1
5549349|NCT01255787|19180159|P1|Overall Study|Noncompliance with Study Drug|3
5549350|NCT01255787|19180156|P4|Overall Study|Lack of Efficacy|2
5549351|NCT01255787|19180157|P3|Overall Study|Lack of Efficacy|2
5549352|NCT01255787|19180158|P2|Overall Study|Lack of Efficacy|2
5549353|NCT01255787|19180159|P1|Overall Study|Lack of Efficacy|2
5549354|NCT01255787|19180156|P4|Overall Study|Pregnancy|1
5549355|NCT01255787|19180157|P3|Overall Study|Pregnancy|0
5549356|NCT01255787|19180158|P2|Overall Study|Pregnancy|0
5549357|NCT01255787|19180159|P1|Overall Study|Pregnancy|0
5549358|NCT01255787|19180156|P4|Overall Study|Withdrawal of Consent|4
5549359|NCT01255787|19180157|P3|Overall Study|Withdrawal of Consent|3
5549360|NCT01255787|19180158|P2|Overall Study|Withdrawal of Consent|9
5549361|NCT01255787|19180159|P1|Overall Study|Withdrawal of Consent|3
5549362|NCT01255787|19180156|P4|Overall Study|Lost to Follow-up|2
5549363|NCT01255787|19180157|P3|Overall Study|Lost to Follow-up|4
5549364|NCT01255787|19180158|P2|Overall Study|Lost to Follow-up|2
5549365|NCT01255787|19180159|P1|Overall Study|Lost to Follow-up|1
5549366|NCT01255787|19180156|P4|Overall Study|Major Protocol Deviation|4
5549367|NCT01255787|19180157|P3|Overall Study|Major Protocol Deviation|0
5549368|NCT01255787|19180158|P2|Overall Study|Major Protocol Deviation|1
5549369|NCT01255787|19180159|P1|Overall Study|Major Protocol Deviation|1
5549370|NCT01255787|19180156|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
5549371|NCT01255787|19180157|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
5549372|NCT01255787|19180158|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
5549373|NCT01255787|19180159|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
5549374|NCT01255761|19180187|P2|Overall Study|Other Reasons|18
5549375|NCT01255761|19180188|P1|Overall Study|Other Reasons|37
5549376|NCT01255761|19180187|P2|Overall Study|Withdrawal by Subject|27
5549377|NCT01255761|19180188|P1|Overall Study|Withdrawal by Subject|11
5549378|NCT01255761|19180187|P2|Overall Study|Lost to Follow-up|8
5549379|NCT01255761|19180188|P1|Overall Study|Lost to Follow-up|10
5549380|NCT01255761|19180187|P2|Overall Study|Protocol Violation|5
5549381|NCT01255761|19180188|P1|Overall Study|Protocol Violation|9
5549382|NCT01255761|19180187|P2|Overall Study|Lack of Efficacy|74
5549383|NCT01255761|19180188|P1|Overall Study|Lack of Efficacy|86
5549384|NCT01255761|19180187|P2|Overall Study|Adverse Event|43
5549385|NCT01255761|19180188|P1|Overall Study|Adverse Event|29
5549386|NCT01255722|19180273|P3|Overall Study|beta-blocker contraindicated|0
5549387|NCT01255722|19180274|P2|Overall Study|beta-blocker contraindicated|0
5549388|NCT01255722|19180275|P1|Overall Study|beta-blocker contraindicated|2
5549389|NCT01255722|19180273|P3|Overall Study|asymptomatic patient|0
5549390|NCT01255722|19180274|P2|Overall Study|asymptomatic patient|0
5549391|NCT01255722|19180275|P1|Overall Study|asymptomatic patient|1
5549392|NCT01255722|19180273|P3|Overall Study|Adverse Event|1
5549393|NCT01255722|19180274|P2|Overall Study|Adverse Event|1
5549394|NCT01255722|19180275|P1|Overall Study|Adverse Event|0
5549395|NCT01255631|19180300|P2|Overall Study|poor enrollment, no data analyzed|6
5549396|NCT01255631|19180301|P1|Overall Study|poor enrollment, no data analyzed|9
5549397|NCT01255592|19180319|P2|Overall Study|Other|1
5549398|NCT01255592|19180320|P1|Overall Study|Other|0
5549399|NCT01255592|19180319|P2|Overall Study|Withdrawal by Subject|0
5549400|NCT01255592|19180320|P1|Overall Study|Withdrawal by Subject|1
5549401|NCT01255592|19180319|P2|Overall Study|Adverse Event|0
5549402|NCT01255592|19180320|P1|Overall Study|Adverse Event|5
5549403|NCT01255436|19180383|P2|Overall Study|Death, stroke, or MI|3
5549404|NCT01255436|19180384|P1|Overall Study|Death, stroke, or MI|4
5549405|NCT01255436|19180383|P2|Overall Study|Lost to Follow-up|191
5549406|NCT01255436|19180384|P1|Overall Study|Lost to Follow-up|178
5549407|NCT01255423|19180398|P2|Overall Study|Use of prohibited medications|1
5549408|NCT01255423|19180399|P1|Overall Study|Use of prohibited medications|0
5549409|NCT01255423|19180398|P2|Overall Study|Abnormal Laboratory value|2
5549410|NCT01255423|19180399|P1|Overall Study|Abnormal Laboratory value|3
5549411|NCT01255306|19180415|P2|Overall Study|Physician Decision|1
5549412|NCT01255306|19180416|P1|Overall Study|Physician Decision|1
5549413|NCT01255163|19180427|P2|Overall Study|AstraZeneca stopped support of the study|3
5549414|NCT01255163|19180428|P1|Overall Study|AstraZeneca stopped support of the study|1
5549415|NCT01255163|19180427|P2|Overall Study|Adverse Event|2
5549416|NCT01255163|19180428|P1|Overall Study|Adverse Event|0
5549417|NCT01255163|19180427|P2|Overall Study|Lost to Follow-up|0
5549418|NCT01255163|19180428|P1|Overall Study|Lost to Follow-up|2
5549419|NCT01255163|19180427|P2|Overall Study|Withdrawal by Subject|0
5549420|NCT01255163|19180428|P1|Overall Study|Withdrawal by Subject|1
5549421|NCT01254890|19180457|P2|Overall Study|Disease Progression|5
5549422|NCT01254890|19180458|P1|Overall Study|Disease Progression|0
5549423|NCT01254890|19180457|P2|Overall Study|Withdrawal by Subject|2
5549424|NCT01254890|19180458|P1|Overall Study|Withdrawal by Subject|1
5549425|NCT01254890|19180457|P2|Overall Study|Ineligible|3
5549426|NCT01254890|19180458|P1|Overall Study|Ineligible|0
5549427|NCT01254747|19180520|P4|Overall Study|Discomfort|0
5549428|NCT01254747|19180521|P3|Overall Study|Discomfort|0
5549429|NCT01254747|19180522|P2|Overall Study|Discomfort|4
5549430|NCT01254747|19180523|P1|Overall Study|Discomfort|0
5549431|NCT01254747|19180520|P4|Overall Study|Biomicroscopy|0
5549432|NCT01254747|19180521|P3|Overall Study|Biomicroscopy|1
5549433|NCT01254747|19180522|P2|Overall Study|Biomicroscopy|0
5549434|NCT01254747|19180523|P1|Overall Study|Biomicroscopy|0
5549435|NCT01254747|19180520|P4|Overall Study|Lost to Follow-up|0
5549436|NCT01254747|19180521|P3|Overall Study|Lost to Follow-up|1
5549437|NCT01254747|19180522|P2|Overall Study|Lost to Follow-up|0
5549438|NCT01254747|19180523|P1|Overall Study|Lost to Follow-up|0
5549439|NCT01254747|19180520|P4|Overall Study|Symptoms and problems|0
5549440|NCT01254747|19180521|P3|Overall Study|Symptoms and problems|1
5549441|NCT01254747|19180522|P2|Overall Study|Symptoms and problems|2
5549442|NCT01254747|19180523|P1|Overall Study|Symptoms and problems|0
5549443|NCT01254747|19180520|P4|Overall Study|Difficult removal handling|0
5549444|NCT01254747|19180521|P3|Overall Study|Difficult removal handling|1
5549445|NCT01254747|19180522|P2|Overall Study|Difficult removal handling|0
5549446|NCT01254747|19180523|P1|Overall Study|Difficult removal handling|0
5549447|NCT01254747|19180520|P4|Overall Study|Unacceptable subjective vision|2
5549448|NCT01254747|19180521|P3|Overall Study|Unacceptable subjective vision|0
5549449|NCT01254747|19180522|P2|Overall Study|Unacceptable subjective vision|0
5549450|NCT01254747|19180523|P1|Overall Study|Unacceptable subjective vision|0
5549451|NCT01254721|19180563|P2|Overall Study|Wrongly randomization|1
5549452|NCT01254721|19180564|P1|Overall Study|Wrongly randomization|0
5549453|NCT01254721|19180563|P2|Overall Study|Withdrawal by Subject|11
5549454|NCT01254721|19180564|P1|Overall Study|Withdrawal by Subject|8
5549455|NCT01254721|19180563|P2|Overall Study|Adverse Event|3
5549456|NCT01254721|19180564|P1|Overall Study|Adverse Event|2
5549457|NCT01254721|19180563|P2|Overall Study|technical problum|0
5549458|NCT01254721|19180564|P1|Overall Study|technical problum|1
5549459|NCT01254721|19180563|P2|Overall Study|Death|1
5549460|NCT01254721|19180564|P1|Overall Study|Death|0
5549461|NCT01254721|19180563|P2|Overall Study|Lack of Efficacy|2
5549462|NCT01254721|19180564|P1|Overall Study|Lack of Efficacy|4
5549463|NCT01254721|19180563|P2|Overall Study|Lost to Follow-up|4
5549464|NCT01254721|19180564|P1|Overall Study|Lost to Follow-up|0
5549465|NCT01254669|19180574|P2|Overall Study|called to clinic during intervention|1
5549466|NCT01254669|19180575|P1|Overall Study|called to clinic during intervention|1
5549467|NCT01254669|19180574|P2|Overall Study|time constraint|2
5549468|NCT01254669|19180575|P1|Overall Study|time constraint|2
5549469|NCT01254669|19180574|P2|Overall Study|Withdrawal by Subject|1
5549470|NCT01254669|19180575|P1|Overall Study|Withdrawal by Subject|0
5549471|NCT01254656|19180586|P3|Overall Study|Death|0
5549472|NCT01254656|19180587|P2|Overall Study|Death|1
5549473|NCT01254656|19180588|P1|Overall Study|Death|0
5549474|NCT01254656|19180586|P3|Overall Study|Adverse Event|0
5549475|NCT01254656|19180587|P2|Overall Study|Adverse Event|1
5549476|NCT01254656|19180588|P1|Overall Study|Adverse Event|1
5549477|NCT01254656|19180586|P3|Overall Study|Pregnancy|2
5549478|NCT01254656|19180587|P2|Overall Study|Pregnancy|0
5549479|NCT01254656|19180588|P1|Overall Study|Pregnancy|0
5549480|NCT01254656|19180586|P3|Overall Study|Withdrawal by Subject|1
5549481|NCT01254656|19180587|P2|Overall Study|Withdrawal by Subject|2
5549482|NCT01254656|19180588|P1|Overall Study|Withdrawal by Subject|2
5549483|NCT01254656|19180586|P3|Overall Study|Lost to Follow-up|2
5549484|NCT01254656|19180587|P2|Overall Study|Lost to Follow-up|0
5549485|NCT01254656|19180588|P1|Overall Study|Lost to Follow-up|1
5549486|NCT01254656|19180586|P3|Overall Study|Lack of Efficacy|0
5549487|NCT01254656|19180587|P2|Overall Study|Lack of Efficacy|0
5549488|NCT01254656|19180588|P1|Overall Study|Lack of Efficacy|3
5549489|NCT01254656|19180586|P3|Overall Study|Discontinued due to termination of study|13
5549490|NCT01254656|19180587|P2|Overall Study|Discontinued due to termination of study|39
5549491|NCT01254656|19180588|P1|Overall Study|Discontinued due to termination of study|40
5549492|NCT01254643|19180614|P1|Overall Study|Withdrawal by Subject|1
5549493|NCT01254630|19180626|P4|Overall Study|Status not recorded|0
5549494|NCT01254630|19180627|P3|Overall Study|Status not recorded|1
5549495|NCT01254630|19180628|P2|Overall Study|Status not recorded|0
5549496|NCT01254630|19180629|P1|Overall Study|Status not recorded|0
5549497|NCT01254630|19180626|P4|Overall Study|Study terminated by sponsor|1010
5549498|NCT01254630|19180627|P3|Overall Study|Study terminated by sponsor|0
5549499|NCT01254630|19180628|P2|Overall Study|Study terminated by sponsor|994
5549500|NCT01254630|19180629|P1|Overall Study|Study terminated by sponsor|0
5549501|NCT01254630|19180626|P4|Overall Study|Withdrawal by Subject|89
5549502|NCT01254630|19180627|P3|Overall Study|Withdrawal by Subject|188
5549503|NCT01254630|19180628|P2|Overall Study|Withdrawal by Subject|94
5549504|NCT01254630|19180629|P1|Overall Study|Withdrawal by Subject|201
5549505|NCT01254630|19180626|P4|Overall Study|Physician Decision|7
5549506|NCT01254630|19180627|P3|Overall Study|Physician Decision|16
5549507|NCT01254630|19180628|P2|Overall Study|Physician Decision|8
5549508|NCT01254630|19180629|P1|Overall Study|Physician Decision|24
5549509|NCT01254630|19180626|P4|Overall Study|Lost to Follow-up|32
5549510|NCT01254630|19180627|P3|Overall Study|Lost to Follow-up|89
5549511|NCT01254630|19180628|P2|Overall Study|Lost to Follow-up|26
5549512|NCT01254630|19180629|P1|Overall Study|Lost to Follow-up|80
5549513|NCT01254630|19180626|P4|Overall Study|Death|139
5549514|NCT01254630|19180627|P3|Overall Study|Death|478
5549515|NCT01254630|19180628|P2|Overall Study|Death|151
5549516|NCT01254630|19180629|P1|Overall Study|Death|461
5549517|NCT01254630|19180626|P4|Overall Study|Adverse Event|8
5549518|NCT01254630|19180627|P3|Overall Study|Adverse Event|40
5549519|NCT01254630|19180628|P2|Overall Study|Adverse Event|15
5549520|NCT01254630|19180629|P1|Overall Study|Adverse Event|36
5549521|NCT01254604|19180649|P2|Overall Study|Adverse Event|2
5549522|NCT01254604|19180650|P1|Overall Study|Adverse Event|3
5549523|NCT01254604|19180649|P2|Overall Study|Withdrawal by Subject|4
5549524|NCT01254604|19180650|P1|Overall Study|Withdrawal by Subject|2
5549525|NCT01254604|19180649|P2|Overall Study|Protocol Violation|2
5549526|NCT01254604|19180650|P1|Overall Study|Protocol Violation|2
5549527|NCT01254604|19180649|P2|Overall Study|Lost to Follow-up|1
5549528|NCT01254604|19180650|P1|Overall Study|Lost to Follow-up|1
5549529|NCT01254565|19180668|P6|Overall Study|Other|0
5549530|NCT01254565|19180669|P5|Overall Study|Other|0
5549531|NCT01254565|19180670|P4|Overall Study|Other|1
5549532|NCT01254565|19180671|P3|Overall Study|Other|0
5549533|NCT01254565|19180672|P2|Overall Study|Other|0
5549534|NCT01254565|19180673|P1|Overall Study|Other|0
5549535|NCT01254565|19180668|P6|Overall Study|Did not Receive Treatment|4
5549536|NCT01254565|19180669|P5|Overall Study|Did not Receive Treatment|3
5549537|NCT01254565|19180670|P4|Overall Study|Did not Receive Treatment|0
5549538|NCT01254565|19180671|P3|Overall Study|Did not Receive Treatment|0
5549539|NCT01254565|19180672|P2|Overall Study|Did not Receive Treatment|1
5549540|NCT01254565|19180673|P1|Overall Study|Did not Receive Treatment|1
5549541|NCT01254565|19180668|P6|Overall Study|Non-compliance to Study Procedures|0
5549542|NCT01254565|19180669|P5|Overall Study|Non-compliance to Study Procedures|1
5549543|NCT01254565|19180670|P4|Overall Study|Non-compliance to Study Procedures|0
5549544|NCT01254565|19180671|P3|Overall Study|Non-compliance to Study Procedures|0
5549545|NCT01254565|19180672|P2|Overall Study|Non-compliance to Study Procedures|0
5549546|NCT01254565|19180673|P1|Overall Study|Non-compliance to Study Procedures|0
5549547|NCT01254422|19180733|P2|Overall Study|Lost to Follow-up|0
5549548|NCT01254422|19180734|P1|Overall Study|Lost to Follow-up|1
5549549|NCT01254422|19180733|P2|Overall Study|Serious adverse event|1
5549550|NCT01254422|19180734|P1|Overall Study|Serious adverse event|0
5549551|NCT01254422|19180733|P2|Overall Study|Adverse Event|0
5549552|NCT01254422|19180734|P1|Overall Study|Adverse Event|1
5549553|NCT01254422|19180733|P2|Overall Study|Protocol Violation|0
5549554|NCT01254422|19180734|P1|Overall Study|Protocol Violation|1
5549555|NCT01254409|19180762|P4|Overall Study|Adverse Event|0
5549556|NCT01254409|19180763|P3|Overall Study|Adverse Event|0
5549557|NCT01254409|19180764|P2|Overall Study|Adverse Event|1
5549558|NCT01254409|19180765|P1|Overall Study|Adverse Event|0
5549559|NCT01254344|19180834|P2|Overall Study|Withdrawal by Subject|6
5549560|NCT01254344|19180835|P1|Overall Study|Withdrawal by Subject|3
5549561|NCT01254344|19180834|P2|Overall Study|Protocol Violation|4
5549562|NCT01254344|19180835|P1|Overall Study|Protocol Violation|1
5549563|NCT01254344|19180834|P2|Overall Study|Physician Decision|4
5549564|NCT01254344|19180835|P1|Overall Study|Physician Decision|7
5549565|NCT01254344|19180834|P2|Overall Study|Adverse Event|5
5549566|NCT01254344|19180835|P1|Overall Study|Adverse Event|2
5549567|NCT01254331|19180843|P1|Extension Phase|Lost to Follow-up|3
5549568|NCT01254331|19180843|P1|Extension Phase|Lack of Efficacy|1
5549569|NCT01254331|19180843|P1|Initial Phase|Pregnancy|1
5549570|NCT01254331|19180843|P1|Initial Phase|Withdrawal by Subject|1
5549571|NCT01254331|19180843|P1|Initial Phase|Adverse Event|3
5549572|NCT01254318|19180861|P1|Overall Study|Death|47
5549573|NCT01254318|19180861|P1|Overall Study|Lost to Follow-up|5
5549574|NCT01254305|19180870|P3|Overall Study|Other Reasons|2
5549575|NCT01254305|19180871|P2|Overall Study|Other Reasons|0
5549576|NCT01254305|19180872|P1|Overall Study|Other Reasons|0
5549577|NCT01254305|19180870|P3|Overall Study|Lost to Follow-up|5
5549578|NCT01254305|19180871|P2|Overall Study|Lost to Follow-up|6
5549579|NCT01254305|19180872|P1|Overall Study|Lost to Follow-up|10
5549580|NCT01254305|19180870|P3|Overall Study|Withdrawal by Subject|4
5549581|NCT01254305|19180871|P2|Overall Study|Withdrawal by Subject|2
5549582|NCT01254305|19180872|P1|Overall Study|Withdrawal by Subject|4
5549583|NCT01254305|19180870|P3|Overall Study|Protocol Violation|3
5549584|NCT01254305|19180871|P2|Overall Study|Protocol Violation|7
5549585|NCT01254305|19180872|P1|Overall Study|Protocol Violation|1
5549586|NCT01254305|19180870|P3|Overall Study|Lack of Efficacy|1
5549587|NCT01254305|19180871|P2|Overall Study|Lack of Efficacy|0
5549588|NCT01254305|19180872|P1|Overall Study|Lack of Efficacy|1
5549589|NCT01254305|19180870|P3|Overall Study|Adverse Event|2
5549590|NCT01254305|19180871|P2|Overall Study|Adverse Event|3
5549591|NCT01254305|19180872|P1|Overall Study|Adverse Event|6
5549592|NCT01254292|19180888|P2|LCS12 Extension Phase|Lost to Follow-up|0
5549593|NCT01254292|19180889|P1|LCS12 Extension Phase|Lost to Follow-up|1
5549594|NCT01254292|19180888|P2|LCS12 Extension Phase|Pregnancy|0
5549595|NCT01254292|19180889|P1|LCS12 Extension Phase|Pregnancy|2
5549596|NCT01254292|19180888|P2|LCS12 Extension Phase|Other unknown|0
5549597|NCT01254292|19180889|P1|LCS12 Extension Phase|Other unknown|4
5549598|NCT01254292|19180888|P2|LCS12 Extension Phase|Withdrawal by Subject|0
5549599|NCT01254292|19180889|P1|LCS12 Extension Phase|Withdrawal by Subject|7
5549600|NCT01254292|19180888|P2|LCS12 Extension Phase|Adverse Event|0
5549601|NCT01254292|19180889|P1|LCS12 Extension Phase|Adverse Event|9
5549602|NCT01254292|19180888|P2|LCS12 Extension Phase|Wish for pregnancy|0
5549603|NCT01254292|19180889|P1|LCS12 Extension Phase|Wish for pregnancy|14
5549604|NCT01254292|19180888|P2|Comparative Phase|Wish for pregnancy|6
5549605|NCT01254292|19180889|P1|Comparative Phase|Wish for pregnancy|4
5549606|NCT01254292|19180888|P2|Comparative Phase|Protocol Violation|2
5549607|NCT01254292|19180889|P1|Comparative Phase|Protocol Violation|1
5549608|NCT01254292|19180888|P2|Comparative Phase|Withdrawal by Subject|21
5549609|NCT01254292|19180889|P1|Comparative Phase|Withdrawal by Subject|20
5549610|NCT01254292|19180888|P2|Comparative Phase|Pregnancy|6
5549611|NCT01254292|19180889|P1|Comparative Phase|Pregnancy|2
5549612|NCT01254292|19180888|P2|Comparative Phase|Lost to Follow-up|21
5549613|NCT01254292|19180889|P1|Comparative Phase|Lost to Follow-up|3
5549614|NCT01254292|19180888|P2|Comparative Phase|Adverse Event|25
5549615|NCT01254292|19180889|P1|Comparative Phase|Adverse Event|25
5549616|NCT01254188|19180966|P1|Overall Study|per investigator discretion|20
5549617|NCT01254188|19180966|P1|Overall Study|Adverse Event|43
5549618|NCT01254188|19180966|P1|Overall Study|Withdrawal by Subject|7
5549619|NCT01254188|19180966|P1|Overall Study|Lost to Follow-up|5
5549620|NCT01254188|19180966|P1|Overall Study|Death|4
5549621|NCT01254188|19180966|P1|Overall Study|Pregnancy|2
5549622|NCT01254188|19180966|P1|Overall Study|Protocol Violation|6
5549623|NCT01254188|19180966|P1|Overall Study|Disease Progression|6
5549624|NCT01254045|19180977|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5549625|NCT01254045|19180978|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5549626|NCT01254045|19180979|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5549627|NCT01254045|19180980|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5549628|NCT01254045|19180981|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
5549629|NCT01254045|19180982|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
5549630|NCT01254019|19180995|P2|Overall Study|Withdrawal by Subject|2
5549631|NCT01254019|19180996|P1|Overall Study|Withdrawal by Subject|0
5549632|NCT01254019|19180995|P2|Overall Study|Protocol Violation|0
5549633|NCT01254019|19180996|P1|Overall Study|Protocol Violation|1
5549634|NCT01254019|19180995|P2|Overall Study|Adverse Event|2
5549635|NCT01254019|19180996|P1|Overall Study|Adverse Event|0
5549636|NCT01253811|19181090|P1|Overall Study|Withdrawal criteria|1
5549637|NCT01253577|19181121|P1|Overall Study|Lost to Follow-up|3
5549638|NCT01253564|19181129|P1|Overall Study|Serious Adverse Event|1
5549639|NCT01253564|19181129|P1|Overall Study|Withdrawal by Subject|1
5549640|NCT01253564|19181129|P1|Overall Study|Disease Progression|22
5549641|NCT01253447|19181178|P1|Overall Study|Adverse Event|2
5549642|NCT01253421|19181188|P5|Drug+Scanning Visit|Physician Decision|1
5549643|NCT01253421|19181189|P4|Drug+Scanning Visit|Physician Decision|0
5549644|NCT01253421|19181190|P3|Drug+Scanning Visit|Physician Decision|0
5549645|NCT01253421|19181191|P2|Drug+Scanning Visit|Physician Decision|0
5549646|NCT01253421|19181192|P1|Drug+Scanning Visit|Physician Decision|0
5549647|NCT01253421|19181188|P5|Assessment and Scheduling|Physician Decision|0
5549648|NCT01253421|19181189|P4|Assessment and Scheduling|Physician Decision|0
5549649|NCT01253421|19181190|P3|Assessment and Scheduling|Physician Decision|0
5549650|NCT01253421|19181191|P2|Assessment and Scheduling|Physician Decision|0
5549651|NCT01253421|19181192|P1|Assessment and Scheduling|Physician Decision|1
5549652|NCT01253421|19181188|P5|Assessment and Scheduling|Withdrawal by Subject|0
5549653|NCT01253421|19181189|P4|Assessment and Scheduling|Withdrawal by Subject|0
5549654|NCT01253421|19181190|P3|Assessment and Scheduling|Withdrawal by Subject|0
5549655|NCT01253421|19181191|P2|Assessment and Scheduling|Withdrawal by Subject|0
5549656|NCT01253421|19181192|P1|Assessment and Scheduling|Withdrawal by Subject|7
5549657|NCT01253421|19181188|P5|Assessment and Scheduling|Lost to Follow-up|0
5549658|NCT01253421|19181189|P4|Assessment and Scheduling|Lost to Follow-up|0
5549659|NCT01253421|19181190|P3|Assessment and Scheduling|Lost to Follow-up|0
5549660|NCT01253421|19181191|P2|Assessment and Scheduling|Lost to Follow-up|0
5549661|NCT01253421|19181192|P1|Assessment and Scheduling|Lost to Follow-up|17
5549662|NCT01253421|19181188|P5|Assessment and Scheduling|Found to be Ineligible|0
5549663|NCT01253421|19181189|P4|Assessment and Scheduling|Found to be Ineligible|0
5549664|NCT01253421|19181190|P3|Assessment and Scheduling|Found to be Ineligible|0
5549665|NCT01253421|19181191|P2|Assessment and Scheduling|Found to be Ineligible|0
5549666|NCT01253421|19181192|P1|Assessment and Scheduling|Found to be Ineligible|74
5549667|NCT01253408|19181241|P3|Overall Study|Adverse Event|0
5549668|NCT01253408|19181242|P2|Overall Study|Adverse Event|1
5549669|NCT01253408|19181243|P1|Overall Study|Adverse Event|0
5549670|NCT01253369|19181266|P1|Overall Study|Not Evaluable|3
5549671|NCT01253369|19181266|P1|Overall Study|Progressive disease|23
5549672|NCT01253369|19181266|P1|Overall Study|Death|1
5549673|NCT01253369|19181266|P1|Overall Study|Withdrawal by Subject|2
5549674|NCT01253369|19181266|P1|Overall Study|Adverse Event|4
5549675|NCT01253317|19181296|P1|Overall Study|Adverse Event|2
5549676|NCT01253304|19181308|P4|Overall Study|Adverse Event|1
5549677|NCT01253304|19181309|P3|Overall Study|Adverse Event|0
5549678|NCT01253304|19181310|P2|Overall Study|Adverse Event|0
5549679|NCT01253304|19181311|P1|Overall Study|Adverse Event|0
5549680|NCT01253291|19181350|P5|Overall Study|Physician Decision|2
5549681|NCT01253291|19181351|P4|Overall Study|Physician Decision|0
5549682|NCT01253291|19181352|P3|Overall Study|Physician Decision|0
5549683|NCT01253291|19181353|P2|Overall Study|Physician Decision|0
5549684|NCT01253291|19181354|P1|Overall Study|Physician Decision|2
5549685|NCT01253291|19181350|P5|Overall Study|Lack of Efficacy|0
5549686|NCT01253291|19181351|P4|Overall Study|Lack of Efficacy|0
5549687|NCT01253291|19181352|P3|Overall Study|Lack of Efficacy|0
5549688|NCT01253291|19181353|P2|Overall Study|Lack of Efficacy|0
5549689|NCT01253291|19181354|P1|Overall Study|Lack of Efficacy|1
5549690|NCT01253291|19181350|P5|Overall Study|Adverse Event|0
5549691|NCT01253291|19181351|P4|Overall Study|Adverse Event|0
5549692|NCT01253291|19181352|P3|Overall Study|Adverse Event|0
5549693|NCT01253291|19181353|P2|Overall Study|Adverse Event|1
5549694|NCT01253291|19181354|P1|Overall Study|Adverse Event|0
5549695|NCT01253291|19181350|P5|Overall Study|Withdrawal by Subject|0
5549696|NCT01253291|19181351|P4|Overall Study|Withdrawal by Subject|0
5549697|NCT01253291|19181352|P3|Overall Study|Withdrawal by Subject|0
5549698|NCT01253291|19181353|P2|Overall Study|Withdrawal by Subject|1
5549699|NCT01253291|19181354|P1|Overall Study|Withdrawal by Subject|1
5549700|NCT01253265|19181378|P5|Overall Study|Withdrawal by Subject|1
5549701|NCT01253265|19181379|P4|Overall Study|Withdrawal by Subject|0
5549702|NCT01253265|19181380|P3|Overall Study|Withdrawal by Subject|0
5549703|NCT01253265|19181381|P2|Overall Study|Withdrawal by Subject|0
5549704|NCT01253265|19181382|P1|Overall Study|Withdrawal by Subject|0
5549705|NCT01253265|19181378|P5|Overall Study|Met Predefined Discontinuation Criteria|0
5549706|NCT01253265|19181379|P4|Overall Study|Met Predefined Discontinuation Criteria|0
5549707|NCT01253265|19181380|P3|Overall Study|Met Predefined Discontinuation Criteria|0
5549708|NCT01253265|19181381|P2|Overall Study|Met Predefined Discontinuation Criteria|0
5549709|NCT01253265|19181382|P1|Overall Study|Met Predefined Discontinuation Criteria|1
5549710|NCT01253226|19181431|P5|Overall Study|Withdrawal by Subject|0
5549711|NCT01253226|19181432|P4|Overall Study|Withdrawal by Subject|1
5549712|NCT01253226|19181433|P3|Overall Study|Withdrawal by Subject|0
5549713|NCT01253226|19181434|P2|Overall Study|Withdrawal by Subject|0
5549714|NCT01253226|19181435|P1|Overall Study|Withdrawal by Subject|0
5549715|NCT01253226|19181431|P5|Overall Study|Physician Decision|2
5549716|NCT01253226|19181432|P4|Overall Study|Physician Decision|0
5549717|NCT01253226|19181433|P3|Overall Study|Physician Decision|0
5549718|NCT01253226|19181434|P2|Overall Study|Physician Decision|0
5549719|NCT01253226|19181435|P1|Overall Study|Physician Decision|0
5549720|NCT01253226|19181431|P5|Overall Study|Death|0
5549721|NCT01253226|19181432|P4|Overall Study|Death|0
5549722|NCT01253226|19181433|P3|Overall Study|Death|0
5549723|NCT01253226|19181434|P2|Overall Study|Death|1
5549724|NCT01253226|19181435|P1|Overall Study|Death|0
5549725|NCT01253226|19181431|P5|Overall Study|Adverse Event|0
5549726|NCT01253226|19181432|P4|Overall Study|Adverse Event|0
5549727|NCT01253226|19181433|P3|Overall Study|Adverse Event|1
5549728|NCT01253226|19181434|P2|Overall Study|Adverse Event|0
5549729|NCT01253226|19181435|P1|Overall Study|Adverse Event|0
5549730|NCT01253200|19181495|P5|Overall Study|Attempts|0
5549731|NCT01253200|19181496|P4|Overall Study|Attempts|2
5549732|NCT01253200|19181497|P3|Overall Study|Attempts|1
5549733|NCT01253200|19181498|P2|Overall Study|Attempts|4
5549734|NCT01253200|19181499|P1|Overall Study|Attempts|6
5549735|NCT01253200|19181495|P5|Overall Study|intents|0
5549736|NCT01253200|19181496|P4|Overall Study|intents|3
5549737|NCT01253200|19181497|P3|Overall Study|intents|1
5549738|NCT01253200|19181498|P2|Overall Study|intents|10
5549739|NCT01253200|19181499|P1|Overall Study|intents|10
5549740|NCT01253200|19181495|P5|Overall Study|Protocol Violation|5
5549741|NCT01253200|19181496|P4|Overall Study|Protocol Violation|0
5549742|NCT01253200|19181497|P3|Overall Study|Protocol Violation|0
5549743|NCT01253200|19181498|P2|Overall Study|Protocol Violation|4
5549744|NCT01253200|19181499|P1|Overall Study|Protocol Violation|1
5549745|NCT01253200|19181495|P5|Overall Study|Withdrawal by Subject|0
5549746|NCT01253200|19181496|P4|Overall Study|Withdrawal by Subject|0
5549747|NCT01253200|19181497|P3|Overall Study|Withdrawal by Subject|0
5549748|NCT01253200|19181498|P2|Overall Study|Withdrawal by Subject|0
5549749|NCT01253200|19181499|P1|Overall Study|Withdrawal by Subject|2
5549750|NCT01253200|19181495|P5|Overall Study|Lost to Follow-up|0
5549751|NCT01253200|19181496|P4|Overall Study|Lost to Follow-up|0
5549752|NCT01253200|19181497|P3|Overall Study|Lost to Follow-up|0
5549753|NCT01253200|19181498|P2|Overall Study|Lost to Follow-up|1
5549754|NCT01253200|19181499|P1|Overall Study|Lost to Follow-up|1
5549755|NCT01253200|19181495|P5|Overall Study|Death|0
5549756|NCT01253200|19181496|P4|Overall Study|Death|0
5549757|NCT01253200|19181497|P3|Overall Study|Death|0
5549758|NCT01253200|19181498|P2|Overall Study|Death|0
5549759|NCT01253200|19181499|P1|Overall Study|Death|1
5549760|NCT01253187|19181514|P6|Period 3|non-compliance|0
5549761|NCT01253187|19181515|P5|Period 3|non-compliance|1
5549762|NCT01253187|19181516|P4|Period 3|non-compliance|0
5549763|NCT01253187|19181517|P3|Period 3|non-compliance|0
5549764|NCT01253187|19181518|P2|Period 3|non-compliance|0
5549765|NCT01253187|19181519|P1|Period 3|non-compliance|0
5549766|NCT01253187|19181514|P6|Period 3|difficulty with blood sampling|0
5549767|NCT01253187|19181515|P5|Period 3|difficulty with blood sampling|0
5549768|NCT01253187|19181516|P4|Period 3|difficulty with blood sampling|0
5549769|NCT01253187|19181517|P3|Period 3|difficulty with blood sampling|0
5549770|NCT01253187|19181518|P2|Period 3|difficulty with blood sampling|1
5549771|NCT01253187|19181519|P1|Period 3|difficulty with blood sampling|0
5549772|NCT01253187|19181514|P6|Period 3|Pregnancy|0
5549773|NCT01253187|19181515|P5|Period 3|Pregnancy|0
5549774|NCT01253187|19181516|P4|Period 3|Pregnancy|0
5549775|NCT01253187|19181517|P3|Period 3|Pregnancy|0
5549776|NCT01253187|19181518|P2|Period 3|Pregnancy|0
5549777|NCT01253187|19181519|P1|Period 3|Pregnancy|1
5549778|NCT01253187|19181514|P6|Period 2|Withdrawal by Subject|0
5549779|NCT01253187|19181515|P5|Period 2|Withdrawal by Subject|1
5549780|NCT01253187|19181516|P4|Period 2|Withdrawal by Subject|0
5549781|NCT01253187|19181517|P3|Period 2|Withdrawal by Subject|0
5549782|NCT01253187|19181518|P2|Period 2|Withdrawal by Subject|0
5549783|NCT01253187|19181519|P1|Period 2|Withdrawal by Subject|0
5549784|NCT01253174|19181548|P6|Period 3|Pregnancy|0
5549785|NCT01253174|19181549|P5|Period 3|Pregnancy|0
5549786|NCT01253174|19181550|P4|Period 3|Pregnancy|0
5549787|NCT01253174|19181551|P3|Period 3|Pregnancy|1
5549788|NCT01253174|19181552|P2|Period 3|Pregnancy|0
5549789|NCT01253174|19181553|P1|Period 3|Pregnancy|0
5549790|NCT01253174|19181548|P6|Period 3|Withdrawal by Subject|0
5549791|NCT01253174|19181549|P5|Period 3|Withdrawal by Subject|1
5549792|NCT01253174|19181550|P4|Period 3|Withdrawal by Subject|0
5549793|NCT01253174|19181551|P3|Period 3|Withdrawal by Subject|0
5549794|NCT01253174|19181552|P2|Period 3|Withdrawal by Subject|1
5549795|NCT01253174|19181553|P1|Period 3|Withdrawal by Subject|0
5549796|NCT01253174|19181548|P6|Period 2|Adverse Event|0
5549797|NCT01253174|19181549|P5|Period 2|Adverse Event|0
5549798|NCT01253174|19181550|P4|Period 2|Adverse Event|0
5549799|NCT01253174|19181551|P3|Period 2|Adverse Event|1
5549800|NCT01253174|19181552|P2|Period 2|Adverse Event|0
5549801|NCT01253174|19181553|P1|Period 2|Adverse Event|0
5549802|NCT01253174|19181548|P6|Period 1|Randomized but not treated|0
5549803|NCT01253174|19181549|P5|Period 1|Randomized but not treated|1
5549804|NCT01253174|19181550|P4|Period 1|Randomized but not treated|0
5549805|NCT01253174|19181551|P3|Period 1|Randomized but not treated|1
5549806|NCT01253174|19181552|P2|Period 1|Randomized but not treated|1
5549807|NCT01253174|19181553|P1|Period 1|Randomized but not treated|0
5549808|NCT01253135|19181588|P1|Amended Protocol|Non-compliance|1
5549809|NCT01253135|19181588|P1|Original Protocol|Protocol Amendment|15
5549810|NCT01253044|19181607|P2|Overall Study|Lost to Follow-up|29
5549811|NCT01253044|19181608|P1|Overall Study|Lost to Follow-up|38
5549812|NCT01253018|19181618|P2|Overall Study|Withdrawal by Subject|1
5549813|NCT01253018|19181619|P1|Overall Study|Withdrawal by Subject|1
5549814|NCT01253018|19181618|P2|Overall Study|Robot Repair Issues|0
5549815|NCT01253018|19181619|P1|Overall Study|Robot Repair Issues|2
5549816|NCT01253018|19181618|P2|Overall Study|Lost to Follow-up|1
5549817|NCT01253018|19181619|P1|Overall Study|Lost to Follow-up|1
5549818|NCT01252966|19181633|P2|Overall Study|Withdrawal by Subject|3
5549819|NCT01252966|19181634|P1|Overall Study|Withdrawal by Subject|7
5549820|NCT01252966|19181633|P2|Overall Study|Lost to Follow-up|10
5549821|NCT01252966|19181634|P1|Overall Study|Lost to Follow-up|16
5549822|NCT01252953|19181650|P2|Overall Study|Lost to Follow-up|21
5549823|NCT01252953|19181651|P1|Overall Study|Lost to Follow-up|22
5549824|NCT01252953|19181650|P2|Overall Study|Withdrawal by Subject|17
5549825|NCT01252953|19181651|P1|Overall Study|Withdrawal by Subject|16
5549826|NCT01252940|19181665|P2|Extension Phase|Withdrawal by Subject|1
5549827|NCT01252940|19181666|P1|Extension Phase|Withdrawal by Subject|1
5549828|NCT01252940|19181665|P2|Extension Phase|Subject Non-compliance|0
5549829|NCT01252940|19181666|P1|Extension Phase|Subject Non-compliance|1
5549830|NCT01252940|19181665|P2|Extension Phase|Physician Decision|1
5549831|NCT01252940|19181666|P1|Extension Phase|Physician Decision|0
5549832|NCT01252940|19181665|P2|Extension Phase|Lost to Follow-up|0
5549833|NCT01252940|19181666|P1|Extension Phase|Lost to Follow-up|5
5549834|NCT01252940|19181665|P2|Extension Phase|Lack of Efficacy|0
5549835|NCT01252940|19181666|P1|Extension Phase|Lack of Efficacy|1
5549836|NCT01252940|19181665|P2|Extension Phase|Adverse Event|1
5549837|NCT01252940|19181666|P1|Extension Phase|Adverse Event|2
5549838|NCT01252940|19181665|P2|Main Study Phase|Subject Non-compliance|1
5549839|NCT01252940|19181666|P1|Main Study Phase|Subject Non-compliance|1
5549840|NCT01252940|19181665|P2|Main Study Phase|Withdrawal by Subject|5
5549841|NCT01252940|19181666|P1|Main Study Phase|Withdrawal by Subject|6
5549842|NCT01252940|19181665|P2|Main Study Phase|Protocol Violation|2
5549843|NCT01252940|19181666|P1|Main Study Phase|Protocol Violation|4
5549844|NCT01252940|19181665|P2|Main Study Phase|Physician Decision|0
5549845|NCT01252940|19181666|P1|Main Study Phase|Physician Decision|1
5549846|NCT01252940|19181665|P2|Main Study Phase|Lost to Follow-up|1
5549847|NCT01252940|19181666|P1|Main Study Phase|Lost to Follow-up|6
5549848|NCT01252940|19181665|P2|Main Study Phase|Lack of Efficacy|0
5549849|NCT01252940|19181666|P1|Main Study Phase|Lack of Efficacy|1
5549850|NCT01252940|19181665|P2|Main Study Phase|Adverse Event|1
5549851|NCT01252940|19181666|P1|Main Study Phase|Adverse Event|3
5549852|NCT01252940|19181665|P2|Main Study Phase|Randomized but not treated|2
5549853|NCT01252940|19181666|P1|Main Study Phase|Randomized but not treated|4
5549854|NCT01252810|19181697|P2|Overall Study|Various reasons|0
5549855|NCT01252810|19181698|P1|Overall Study|Various reasons|8
5549856|NCT01252810|19181697|P2|Overall Study|Physician Decision|1
5549857|NCT01252810|19181698|P1|Overall Study|Physician Decision|2
5549858|NCT01252810|19181697|P2|Overall Study|Lost to Follow-up|1
5549859|NCT01252810|19181698|P1|Overall Study|Lost to Follow-up|0
5549860|NCT01252810|19181697|P2|Overall Study|Withdrawal by Subject|1
5549861|NCT01252810|19181698|P1|Overall Study|Withdrawal by Subject|4
5549862|NCT01252667|19181733|P6|Overall Study|Transplant aborted post-conditioning|1
5549863|NCT01252667|19181734|P5|Overall Study|Transplant aborted post-conditioning|0
5549864|NCT01252667|19181735|P4|Overall Study|Transplant aborted post-conditioning|0
5549865|NCT01252667|19181736|P3|Overall Study|Transplant aborted post-conditioning|0
5549866|NCT01252667|19181737|P2|Overall Study|Transplant aborted post-conditioning|0
5549867|NCT01252667|19181738|P1|Overall Study|Transplant aborted post-conditioning|0
5549868|NCT01252563|19181800|P1|Overall Study|No drug administration|6
5549869|NCT01252563|19181800|P1|Overall Study|No visit after first day of treatment|194
5549870|NCT01252563|19181800|P1|Overall Study|Lost to Follow-up|161
5549871|NCT01252563|19181800|P1|Overall Study|Centralized Registration Deviation|30
5549872|NCT01252563|19181800|P1|Overall Study|Contract Deviation|41
5549873|NCT01252355|19181840|P3|Overall Study|Other Than Above|7
5549874|NCT01252355|19181841|P2|Overall Study|Other Than Above|7
5549875|NCT01252355|19181842|P1|Overall Study|Other Than Above|8
5549876|NCT01252355|19181840|P3|Overall Study|Randomized but not Treated|0
5549877|NCT01252355|19181841|P2|Overall Study|Randomized but not Treated|0
5549878|NCT01252355|19181842|P1|Overall Study|Randomized but not Treated|2
5549879|NCT01252355|19181840|P3|Overall Study|Sponsor Early Termination of Study|146
5549880|NCT01252355|19181841|P2|Overall Study|Sponsor Early Termination of Study|149
5549881|NCT01252355|19181842|P1|Overall Study|Sponsor Early Termination of Study|149
5549882|NCT01252355|19181840|P3|Overall Study|Progressive Disease|0
5549883|NCT01252355|19181841|P2|Overall Study|Progressive Disease|0
5549884|NCT01252355|19181842|P1|Overall Study|Progressive Disease|2
5549885|NCT01252355|19181840|P3|Overall Study|Poor Compliance to Protocol|1
5549886|NCT01252355|19181841|P2|Overall Study|Poor Compliance to Protocol|1
5549887|NCT01252355|19181842|P1|Overall Study|Poor Compliance to Protocol|1
5549888|NCT01252355|19181840|P3|Overall Study|Lost to Follow-up|1
5549889|NCT01252355|19181841|P2|Overall Study|Lost to Follow-up|0
5549890|NCT01252355|19181842|P1|Overall Study|Lost to Follow-up|0
5549891|NCT01252355|19181840|P3|Overall Study|Lack of Efficacy|2
5549892|NCT01252355|19181841|P2|Overall Study|Lack of Efficacy|4
5549893|NCT01252355|19181842|P1|Overall Study|Lack of Efficacy|6
5549894|NCT01252355|19181840|P3|Overall Study|Adverse Event|22
5549895|NCT01252355|19181841|P2|Overall Study|Adverse Event|17
5549896|NCT01252355|19181842|P1|Overall Study|Adverse Event|9
5549897|NCT01252290|19181880|P1|Overall Study|Withdrawal by Subject|1
5549898|NCT01252251|19181896|P1|Overall Study|Withdrawal by Subject|1
5549899|NCT01252238|19181908|P3|Overall Study|Sponsor terminated study|4
5549900|NCT01252238|19181909|P2|Overall Study|Sponsor terminated study|4
5549901|NCT01252238|19181910|P1|Overall Study|Sponsor terminated study|4
5549902|NCT01252186|19181927|P3|Overall Study|Other - Miscellaneous Reasons|7
5549903|NCT01252186|19181928|P2|Overall Study|Other - Miscellaneous Reasons|5
5549904|NCT01252186|19181929|P1|Overall Study|Other - Miscellaneous Reasons|5
5549905|NCT01252186|19181927|P3|Overall Study|Lost to Follow-up|11
5549906|NCT01252186|19181928|P2|Overall Study|Lost to Follow-up|10
5549907|NCT01252186|19181929|P1|Overall Study|Lost to Follow-up|10
5549908|NCT01252186|19181927|P3|Overall Study|Sponsor Request|0
5549909|NCT01252186|19181928|P2|Overall Study|Sponsor Request|1
5549910|NCT01252186|19181929|P1|Overall Study|Sponsor Request|2
5549911|NCT01252186|19181927|P3|Overall Study|Pregnancy|0
5549912|NCT01252186|19181928|P2|Overall Study|Pregnancy|2
5549913|NCT01252186|19181929|P1|Overall Study|Pregnancy|2
5549914|NCT01252186|19181927|P3|Overall Study|Protocol Violation|1
5549915|NCT01252186|19181928|P2|Overall Study|Protocol Violation|0
5549916|NCT01252186|19181929|P1|Overall Study|Protocol Violation|0
5549917|NCT01252186|19181927|P3|Overall Study|Non-compliance|4
5549918|NCT01252186|19181928|P2|Overall Study|Non-compliance|3
5549919|NCT01252186|19181929|P1|Overall Study|Non-compliance|0
5549920|NCT01252186|19181927|P3|Overall Study|Physician Decision|1
5549921|NCT01252186|19181928|P2|Overall Study|Physician Decision|0
5549922|NCT01252186|19181929|P1|Overall Study|Physician Decision|0
5549923|NCT01252186|19181927|P3|Overall Study|Withdrawal by Subject|2
5549924|NCT01252186|19181928|P2|Overall Study|Withdrawal by Subject|5
5549925|NCT01252186|19181929|P1|Overall Study|Withdrawal by Subject|2
5549926|NCT01252186|19181927|P3|Overall Study|Adverse Event|8
5549927|NCT01252186|19181928|P2|Overall Study|Adverse Event|6
5549928|NCT01252186|19181929|P1|Overall Study|Adverse Event|9
5549929|NCT01252134|19182002|P6|Period 1, 8 Hours|Personal Reasons|0
5549930|NCT01252134|19182003|P5|Period 1, 8 Hours|Personal Reasons|0
5549931|NCT01252134|19182004|P4|Period 1, 8 Hours|Personal Reasons|0
5549932|NCT01252134|19182005|P3|Period 1, 8 Hours|Personal Reasons|1
5549933|NCT01252134|19182006|P2|Period 1, 8 Hours|Personal Reasons|1
5549934|NCT01252134|19182007|P1|Period 1, 8 Hours|Personal Reasons|0
5549935|NCT01252095|19182026|P2|Overall Study|Disease progression|0
5549936|NCT01252095|19182027|P1|Overall Study|Disease progression|1
5549937|NCT01251965|19182048|P3|Overall Study|Death|11
5549938|NCT01251965|19182049|P2|Overall Study|Death|0
5549939|NCT01251965|19182050|P1|Overall Study|Death|0
5549940|NCT01251965|19182048|P3|Overall Study|Participant/physician decision|0
5549941|NCT01251965|19182049|P2|Overall Study|Participant/physician decision|2
5549942|NCT01251965|19182050|P1|Overall Study|Participant/physician decision|1
5549943|NCT01251952|19182062|P1|Overall Study|Adverse Event|1
5549944|NCT01251861|19182068|P2|Overall Study|Potential interaction of drugs|1
5549945|NCT01251861|19182069|P1|Overall Study|Potential interaction of drugs|0
5549946|NCT01251861|19182068|P2|Overall Study|Never started therapy|1
5549947|NCT01251861|19182069|P1|Overall Study|Never started therapy|4
5549948|NCT01251861|19182068|P2|Overall Study|Other|0
5549949|NCT01251861|19182069|P1|Overall Study|Other|1
5549950|NCT01251861|19182068|P2|Overall Study|Continued treatment beyond 18 cycles|0
5549951|NCT01251861|19182069|P1|Overall Study|Continued treatment beyond 18 cycles|1
5549952|NCT01251861|19182068|P2|Overall Study|Physician Decision|0
5549953|NCT01251861|19182069|P1|Overall Study|Physician Decision|1
5549954|NCT01251861|19182068|P2|Overall Study|Other complicating disease|1
5549955|NCT01251861|19182069|P1|Overall Study|Other complicating disease|0
5549956|NCT01251861|19182068|P2|Overall Study|Alternative therapy|0
5549957|NCT01251861|19182069|P1|Overall Study|Alternative therapy|1
5549958|NCT01251861|19182068|P2|Overall Study|Withdrawal by Subject|2
5549959|NCT01251861|19182069|P1|Overall Study|Withdrawal by Subject|2
5549960|NCT01251861|19182068|P2|Overall Study|Adverse Event|17
5549961|NCT01251861|19182069|P1|Overall Study|Adverse Event|2
5549962|NCT01251861|19182068|P2|Overall Study|Disease progression|6
5549963|NCT01251861|19182069|P1|Overall Study|Disease progression|6
5549964|NCT01251770|19182097|P2|Overall Study|Protocol Violation|7
5549965|NCT01251770|19182098|P1|Overall Study|Protocol Violation|13
5549966|NCT01251744|19182142|P2|Overall Study|Lost to Follow-up|0
5549967|NCT01251744|19182143|P1|Overall Study|Lost to Follow-up|1
5549968|NCT01251653|19182201|P9|Overall Study|Other reason not mentioned above|0
5549969|NCT01251653|19182202|P8|Overall Study|Other reason not mentioned above|2
5549970|NCT01251653|19182203|P7|Overall Study|Other reason not mentioned above|0
5549971|NCT01251653|19182204|P6|Overall Study|Other reason not mentioned above|0
5549972|NCT01251653|19182205|P5|Overall Study|Other reason not mentioned above|0
5549973|NCT01251653|19182206|P4|Overall Study|Other reason not mentioned above|0
5549974|NCT01251653|19182207|P3|Overall Study|Other reason not mentioned above|0
5549975|NCT01251653|19182208|P2|Overall Study|Other reason not mentioned above|0
5549976|NCT01251653|19182209|P1|Overall Study|Other reason not mentioned above|0
5549977|NCT01251653|19182201|P9|Overall Study|Withdrawal by Subject|0
5549978|NCT01251653|19182202|P8|Overall Study|Withdrawal by Subject|1
5549979|NCT01251653|19182203|P7|Overall Study|Withdrawal by Subject|0
5549980|NCT01251653|19182204|P6|Overall Study|Withdrawal by Subject|1
5549981|NCT01251653|19182205|P5|Overall Study|Withdrawal by Subject|1
5549982|NCT01251653|19182206|P4|Overall Study|Withdrawal by Subject|0
5549983|NCT01251653|19182207|P3|Overall Study|Withdrawal by Subject|1
5549984|NCT01251653|19182208|P2|Overall Study|Withdrawal by Subject|0
5549985|NCT01251653|19182209|P1|Overall Study|Withdrawal by Subject|1
5549986|NCT01251653|19182201|P9|Overall Study|Adverse Event|1
5549987|NCT01251653|19182202|P8|Overall Study|Adverse Event|2
5549988|NCT01251653|19182203|P7|Overall Study|Adverse Event|2
5549989|NCT01251653|19182204|P6|Overall Study|Adverse Event|0
5549990|NCT01251653|19182205|P5|Overall Study|Adverse Event|1
5549991|NCT01251653|19182206|P4|Overall Study|Adverse Event|1
5549992|NCT01251653|19182207|P3|Overall Study|Adverse Event|2
5549993|NCT01251653|19182208|P2|Overall Study|Adverse Event|0
5549994|NCT01251653|19182209|P1|Overall Study|Adverse Event|1
5549995|NCT01251653|19182201|P9|Overall Study|Dose-limiting toxicity|0
5549996|NCT01251653|19182202|P8|Overall Study|Dose-limiting toxicity|0
5549997|NCT01251653|19182203|P7|Overall Study|Dose-limiting toxicity|2
5549998|NCT01251653|19182204|P6|Overall Study|Dose-limiting toxicity|0
5549999|NCT01251653|19182205|P5|Overall Study|Dose-limiting toxicity|0
5550000|NCT01251653|19182206|P4|Overall Study|Dose-limiting toxicity|1
5550001|NCT01251653|19182207|P3|Overall Study|Dose-limiting toxicity|1
5550002|NCT01251653|19182208|P2|Overall Study|Dose-limiting toxicity|1
5550003|NCT01251653|19182209|P1|Overall Study|Dose-limiting toxicity|0
5550004|NCT01251653|19182201|P9|Overall Study|Progressive Disease|5
5550005|NCT01251653|19182202|P8|Overall Study|Progressive Disease|7
5550006|NCT01251653|19182203|P7|Overall Study|Progressive Disease|14
5550007|NCT01251653|19182204|P6|Overall Study|Progressive Disease|17
5550008|NCT01251653|19182205|P5|Overall Study|Progressive Disease|0
5550009|NCT01251653|19182206|P4|Overall Study|Progressive Disease|4
5550010|NCT01251653|19182207|P3|Overall Study|Progressive Disease|16
5550011|NCT01251653|19182208|P2|Overall Study|Progressive Disease|7
5550012|NCT01251653|19182209|P1|Overall Study|Progressive Disease|1
5550013|NCT01251614|19182337|P3|Overall Study|Lost to Follow-up|0
5550014|NCT01251614|19182338|P2|Overall Study|Lost to Follow-up|1
5550015|NCT01251614|19182339|P1|Overall Study|Lost to Follow-up|0
5550016|NCT01251614|19182337|P3|Overall Study|Withdrawal by Subject|1
5550017|NCT01251614|19182338|P2|Overall Study|Withdrawal by Subject|2
5550018|NCT01251614|19182339|P1|Overall Study|Withdrawal by Subject|0
5550019|NCT01251614|19182337|P3|Overall Study|Loss of Disease Control|0
5550020|NCT01251614|19182338|P2|Overall Study|Loss of Disease Control|1
5550021|NCT01251614|19182339|P1|Overall Study|Loss of Disease Control|0
5550022|NCT01251614|19182337|P3|Overall Study|Pregnancy|2
5550023|NCT01251614|19182338|P2|Overall Study|Pregnancy|0
5550024|NCT01251614|19182339|P1|Overall Study|Pregnancy|0
5550025|NCT01251614|19182337|P3|Overall Study|Clearing of Psoriatic Lesions|0
5550026|NCT01251614|19182338|P2|Overall Study|Clearing of Psoriatic Lesions|0
5550027|NCT01251614|19182339|P1|Overall Study|Clearing of Psoriatic Lesions|1
5550028|NCT01251614|19182337|P3|Overall Study|Lack of Efficacy|4
5550029|NCT01251614|19182338|P2|Overall Study|Lack of Efficacy|9
5550030|NCT01251614|19182339|P1|Overall Study|Lack of Efficacy|1
5550031|NCT01251614|19182337|P3|Overall Study|Adverse Event|1
5550032|NCT01251614|19182338|P2|Overall Study|Adverse Event|0
5550033|NCT01251614|19182339|P1|Overall Study|Adverse Event|1
5550034|NCT01251380|19182537|P1|Overall Study|Lost to Follow-up|2
5550035|NCT01251380|19182537|P1|Overall Study|Adverse Event|1
5550036|NCT01251380|19182537|P1|Overall Study|Lack of Efficacy|1
5550037|NCT01251380|19182537|P1|Overall Study|Withdrawal by Subject|6
5550038|NCT01251380|19182537|P1|Overall Study|Other (Not otherwise specified)|12
5550039|NCT01251367|19182561|P1|Overall Study|End of Study Visit Performed in Error|1
5550040|NCT01251367|19182561|P1|Overall Study|Subject had Personal or Medical Issues|4
5550041|NCT01251367|19182561|P1|Overall Study|No Study Drug Available|1
5550042|NCT01251367|19182561|P1|Overall Study|Subject Required Alternative Treatment|7
5550043|NCT01251367|19182561|P1|Overall Study|Lost to Follow-up|5
5550044|NCT01251367|19182561|P1|Overall Study|Withdrawal by Subject|36
5550045|NCT01251367|19182561|P1|Overall Study|Adverse Event|19
5550046|NCT01251367|19182561|P1|Overall Study|Lack of Efficacy|2
5550047|NCT01251367|19182561|P1|Overall Study|Protocol Violation|1
5550048|NCT01251354|19182596|P1|Overall Study|Disease Progression|4
5550049|NCT01251354|19182596|P1|Overall Study|Investigator's Decision|1
5550050|NCT01251354|19182596|P1|Overall Study|Adverse Event|1
5550051|NCT01251276|19182639|P2|Overall Study|Lost to Follow-up|1
5550052|NCT01251276|19182640|P1|Overall Study|Lost to Follow-up|0
5550053|NCT01251276|19182639|P2|Overall Study|Protocol Violation|0
5550054|NCT01251276|19182640|P1|Overall Study|Protocol Violation|1
5550055|NCT01251146|19182658|P2|Overall Study|Lost to Follow-up|10
5550056|NCT01251146|19182659|P1|Overall Study|Lost to Follow-up|3
5550057|NCT01251120|19182681|P2|Overall Study|Lack of Efficacy|1
5550058|NCT01251120|19182682|P1|Overall Study|Lack of Efficacy|0
5550059|NCT01250925|19182762|P3|Overall Study|Adverse Event|1
5550060|NCT01250925|19182763|P2|Overall Study|Adverse Event|0
5550061|NCT01250925|19182764|P1|Overall Study|Adverse Event|0
5550062|NCT01250925|19182762|P3|Overall Study|Physician Decision|1
5550063|NCT01250925|19182763|P2|Overall Study|Physician Decision|2
5550064|NCT01250925|19182764|P1|Overall Study|Physician Decision|0
5550065|NCT01250925|19182762|P3|Overall Study|Protocol Violation|0
5550066|NCT01250925|19182763|P2|Overall Study|Protocol Violation|0
5550067|NCT01250925|19182764|P1|Overall Study|Protocol Violation|2
5550068|NCT01250925|19182762|P3|Overall Study|Withdrawal by Subject|0
5550069|NCT01250925|19182763|P2|Overall Study|Withdrawal by Subject|0
5550070|NCT01250925|19182764|P1|Overall Study|Withdrawal by Subject|2
5550071|NCT01250925|19182762|P3|Overall Study|Lost to Follow-up|0
5550072|NCT01250925|19182763|P2|Overall Study|Lost to Follow-up|1
5550073|NCT01250925|19182764|P1|Overall Study|Lost to Follow-up|1
5550074|NCT01250873|19182809|P1|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
5550075|NCT01250873|19182809|P1|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
5550076|NCT01250769|19182841|P4|Overall Study|Adverse Event|0
5550077|NCT01250769|19182842|P3|Overall Study|Adverse Event|1
5550078|NCT01250769|19182843|P2|Overall Study|Adverse Event|0
5550079|NCT01250769|19182844|P1|Overall Study|Adverse Event|0
5550080|NCT01250769|19182841|P4|Overall Study|Withdrawal by Subject|0
5550081|NCT01250769|19182842|P3|Overall Study|Withdrawal by Subject|1
5550082|NCT01250769|19182843|P2|Overall Study|Withdrawal by Subject|1
5550083|NCT01250769|19182844|P1|Overall Study|Withdrawal by Subject|0
5550084|NCT01250756|19182876|P2|After Toddler Dose|Adverse Event|1
5550085|NCT01250756|19182877|P1|After Toddler Dose|Adverse Event|0
5550086|NCT01250756|19182876|P2|Toddler Dose|Adverse Event|1
5550087|NCT01250756|19182877|P1|Toddler Dose|Adverse Event|0
5550088|NCT01250756|19182876|P2|After Infant Series|Other|1
5550089|NCT01250756|19182877|P1|After Infant Series|Other|2
5550090|NCT01250756|19182876|P2|After Infant Series|Withdrawal by Subject|1
5550091|NCT01250756|19182877|P1|After Infant Series|Withdrawal by Subject|4
5550092|NCT01250756|19182876|P2|After Infant Series|Adverse Event|2
5550093|NCT01250756|19182877|P1|After Infant Series|Adverse Event|5
5550094|NCT01250756|19182876|P2|Infant Series|Other|0
5550095|NCT01250756|19182877|P1|Infant Series|Other|22
5550096|NCT01250756|19182876|P2|Infant Series|Randomized, Not Vaccinated|2
5550097|NCT01250756|19182877|P1|Infant Series|Randomized, Not Vaccinated|2
5550098|NCT01250756|19182876|P2|Infant Series|Withdrawal by Subject|5
5550099|NCT01250756|19182877|P1|Infant Series|Withdrawal by Subject|4
5550100|NCT01250509|19182994|P2|Overall Study|Lost to Follow-up|2
5550101|NCT01250509|19182995|P1|Overall Study|Lost to Follow-up|5
5550102|NCT01250418|19183009|P2|Overall Study|monitor data failure|1
5550103|NCT01250418|19183010|P1|Overall Study|monitor data failure|1
5550104|NCT01250379|19183018|P2|Overall Study|Participant noncompliance|0
5550105|NCT01250379|19183019|P1|Overall Study|Participant noncompliance|2
5550106|NCT01250379|19183018|P2|Overall Study|Other|4
5550107|NCT01250379|19183019|P1|Overall Study|Other|0
5550108|NCT01250379|19183018|P2|Overall Study|Adverse Event|4
5550109|NCT01250379|19183019|P1|Overall Study|Adverse Event|5
5550110|NCT01250379|19183018|P2|Overall Study|Lost to Follow-up|6
5550111|NCT01250379|19183019|P1|Overall Study|Lost to Follow-up|9
5550112|NCT01250379|19183018|P2|Overall Study|Protocol Violation|8
5550113|NCT01250379|19183019|P1|Overall Study|Protocol Violation|2
5550114|NCT01250379|19183018|P2|Overall Study|Physician Decision|3
5550115|NCT01250379|19183019|P1|Overall Study|Physician Decision|11
5550116|NCT01250379|19183018|P2|Overall Study|Withdrawal by Subject|20
5550117|NCT01250379|19183019|P1|Overall Study|Withdrawal by Subject|32
5550118|NCT01250379|19183018|P2|Overall Study|Death|148
5550119|NCT01250379|19183019|P1|Overall Study|Death|141
5550120|NCT01250171|19183124|P3|Overall Study|Administrative reasons|0
5550121|NCT01250171|19183125|P2|Overall Study|Administrative reasons|0
5550122|NCT01250171|19183126|P1|Overall Study|Administrative reasons|1
5550123|NCT01250145|19183157|P2|Overall Study|Withdrawal by Subject|4
5550124|NCT01250145|19183158|P1|Overall Study|Withdrawal by Subject|0
5550125|NCT01250145|19183157|P2|Overall Study|Adverse Event|1
5550126|NCT01250145|19183158|P1|Overall Study|Adverse Event|2
5550127|NCT01250119|19183178|P2|Treatment Phase|Unknown reason|4
5550128|NCT01250119|19183179|P1|Treatment Phase|Unknown reason|0
5550129|NCT01250119|19183178|P2|Treatment Phase|Adverse Event|2
5550130|NCT01250119|19183179|P1|Treatment Phase|Adverse Event|0
5550131|NCT01250119|19183178|P2|Treatment Phase|Withdrawal by Subject|1
5550132|NCT01250119|19183179|P1|Treatment Phase|Withdrawal by Subject|0
5550133|NCT01250119|19183178|P2|Treatment Phase|Death|2
5550134|NCT01250119|19183179|P1|Treatment Phase|Death|0
5550135|NCT01250119|19183178|P2|Treatment Phase|Progressive Disease|32
5550136|NCT01250119|19183179|P1|Treatment Phase|Progressive Disease|0
5550137|NCT01250119|19183178|P2|Diagnostic Phase|Participants Not Tested|0
5550138|NCT01250119|19183179|P1|Diagnostic Phase|Participants Not Tested|44
5550139|NCT01250119|19183178|P2|Diagnostic Phase|Failed to Produce a Test Results|0
5550140|NCT01250119|19183179|P1|Diagnostic Phase|Failed to Produce a Test Results|69
5550141|NCT01250054|19183194|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
5550142|NCT01250054|19183195|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
5550143|NCT01250002|19183203|P2|Overall Study|Change to open surgical procedure|3
5550144|NCT01250002|19183204|P1|Overall Study|Change to open surgical procedure|4
5550145|NCT01249833|19183269|P2|Overall Study|Lost to Follow-up|1
5550146|NCT01249833|19183270|P1|Overall Study|Lost to Follow-up|0
5550147|NCT01249664|19183284|P2|Overall Study|Adverse Event|0
5550148|NCT01249664|19183285|P1|Overall Study|Adverse Event|1
5550149|NCT01249664|19183284|P2|Overall Study|Withdrawal by Subject|0
5550150|NCT01249664|19183285|P1|Overall Study|Withdrawal by Subject|5
5550151|NCT01249651|19183335|P1|Overall Study|Sponsor Decision|1
5550152|NCT01249651|19183335|P1|Overall Study|Protocol Violation|1
5550153|NCT01249651|19183335|P1|Overall Study|Adverse Event|1
5550154|NCT01249651|19183335|P1|Overall Study|Withdrawal by Subject|4
5550155|NCT01249417|19183364|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
5550156|NCT01249417|19183365|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
5550157|NCT01249417|19183366|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
5550158|NCT01249417|19183364|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
5550159|NCT01249417|19183365|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
5550160|NCT01249417|19183366|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
5550161|NCT01249417|19183364|P3|Treatment Phase - ITT Population|Adverse Event|1
5550162|NCT01249417|19183365|P2|Treatment Phase - ITT Population|Adverse Event|0
5550163|NCT01249417|19183366|P1|Treatment Phase - ITT Population|Adverse Event|0
5550164|NCT01249417|19183364|P3|Treatment Phase - ITT Population|Other|1
5550165|NCT01249417|19183365|P2|Treatment Phase - ITT Population|Other|0
5550166|NCT01249417|19183366|P1|Treatment Phase - ITT Population|Other|0
5550167|NCT01249417|19183364|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
5550168|NCT01249417|19183365|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
5550169|NCT01249417|19183366|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
5550170|NCT01249417|19183364|P3|Randomised Population|Study treatment not received|2
5550171|NCT01249417|19183365|P2|Randomised Population|Study treatment not received|0
5550172|NCT01249417|19183366|P1|Randomised Population|Study treatment not received|0
5550173|NCT01249404|19183383|P3|Overall Study|Non compliance to visit schedule|0
5550174|NCT01249404|19183384|P2|Overall Study|Non compliance to visit schedule|1
5550175|NCT01249404|19183385|P1|Overall Study|Non compliance to visit schedule|0
5550176|NCT01249404|19183383|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
5550177|NCT01249404|19183384|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
5550178|NCT01249404|19183385|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
5550179|NCT01249404|19183383|P3|Overall Study|Withdrawal by Subject|0
5550180|NCT01249404|19183384|P2|Overall Study|Withdrawal by Subject|2
5550181|NCT01249404|19183385|P1|Overall Study|Withdrawal by Subject|2
5550182|NCT01249404|19183383|P3|Overall Study|Adverse Event|2
5550183|NCT01249404|19183384|P2|Overall Study|Adverse Event|2
5550184|NCT01249404|19183385|P1|Overall Study|Adverse Event|2
5550185|NCT01249404|19183383|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
5550186|NCT01249404|19183384|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
5550187|NCT01249404|19183385|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
5550188|NCT01249404|19183383|P3|Overall Study|Study treatment not received|2
5550189|NCT01249404|19183384|P2|Overall Study|Study treatment not received|1
5550190|NCT01249404|19183385|P1|Overall Study|Study treatment not received|0
5550191|NCT01249365|19183462|P1|Overall Study|Lost to Follow-up|1
5550192|NCT01249274|19183470|P2|Overall Study|Received inpatient substance treatment|2
5550193|NCT01249274|19183471|P1|Overall Study|Received inpatient substance treatment|1
5550194|NCT01249274|19183470|P2|Overall Study|Lost to Follow-up|4
5550195|NCT01249274|19183471|P1|Overall Study|Lost to Follow-up|3
5550196|NCT01249261|19183497|P2|Overall Study|Withdrawal by Subject|0
5550197|NCT01249261|19183498|P1|Overall Study|Withdrawal by Subject|1
5550198|NCT01249157|19183526|P1|Overall Study|Withdrawal by Subject|1
5550199|NCT01249131|19183530|P6|Washout Period of 10 Days|Adverse Event|0
5550200|NCT01249131|19183531|P5|Washout Period of 10 Days|Adverse Event|1
5550201|NCT01249131|19183532|P4|Washout Period of 10 Days|Adverse Event|0
5550202|NCT01249131|19183533|P3|Washout Period of 10 Days|Adverse Event|0
5550203|NCT01249131|19183534|P2|Washout Period of 10 Days|Adverse Event|0
5550204|NCT01249131|19183535|P1|Washout Period of 10 Days|Adverse Event|0
5550205|NCT01249118|19183555|P3|First Washout Period|Physician Decision|0
5550206|NCT01249118|19183556|P2|First Washout Period|Physician Decision|1
5550207|NCT01249118|19183557|P1|First Washout Period|Physician Decision|0
5550208|NCT01249092|19183591|P1|Overall Study|Unable to tolerate expected SE -nausea|1
5550209|NCT01249092|19183591|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
5550210|NCT01248962|19183668|P2|Overall Study|Progression of Disease prior to 5 Cycles|13
5550211|NCT01248962|19183669|P1|Overall Study|Progression of Disease prior to 5 Cycles|12
5550212|NCT01248962|19183668|P2|Overall Study|Complete Response after 3 Cycles|1
5550213|NCT01248962|19183669|P1|Overall Study|Complete Response after 3 Cycles|0
5550214|NCT01248962|19183668|P2|Overall Study|Complete Response after 4 Cycles|0
5550215|NCT01248962|19183669|P1|Overall Study|Complete Response after 4 Cycles|1
5550216|NCT01248962|19183668|P2|Overall Study|Adverse Event|1
5550217|NCT01248962|19183669|P1|Overall Study|Adverse Event|2
5550218|NCT01248962|19183668|P2|Overall Study|Withdrawal by Subject|1
5550219|NCT01248962|19183669|P1|Overall Study|Withdrawal by Subject|1
5550220|NCT01248949|19183685|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5550221|NCT01248949|19183686|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5550222|NCT01248949|19183687|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
5550223|NCT01248949|19183688|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5550224|NCT01248949|19183689|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
5550225|NCT01248949|19183685|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
5550226|NCT01248949|19183686|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
5550227|NCT01248949|19183687|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
5550228|NCT01248949|19183688|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
5550229|NCT01248949|19183689|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
5550230|NCT01248949|19183685|P5|Overall Study|Pi Decision Due To Declining Status|0
5550231|NCT01248949|19183686|P4|Overall Study|Pi Decision Due To Declining Status|0
5550232|NCT01248949|19183687|P3|Overall Study|Pi Decision Due To Declining Status|1
5550233|NCT01248949|19183688|P2|Overall Study|Pi Decision Due To Declining Status|0
5550234|NCT01248949|19183689|P1|Overall Study|Pi Decision Due To Declining Status|0
5550235|NCT01248949|19183685|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
5550236|NCT01248949|19183686|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
5550237|NCT01248949|19183687|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
5550238|NCT01248949|19183688|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
5550239|NCT01248949|19183689|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
5550240|NCT01248949|19183685|P5|Overall Study|Participant Went To Hospice|0
5550241|NCT01248949|19183686|P4|Overall Study|Participant Went To Hospice|0
5550242|NCT01248949|19183687|P3|Overall Study|Participant Went To Hospice|1
5550243|NCT01248949|19183688|P2|Overall Study|Participant Went To Hospice|0
5550244|NCT01248949|19183689|P1|Overall Study|Participant Went To Hospice|0
5550245|NCT01248949|19183685|P5|Overall Study|Entered Hospice And Refused Follow Up|1
5550246|NCT01248949|19183686|P4|Overall Study|Entered Hospice And Refused Follow Up|0
5550247|NCT01248949|19183687|P3|Overall Study|Entered Hospice And Refused Follow Up|0
5550248|NCT01248949|19183688|P2|Overall Study|Entered Hospice And Refused Follow Up|0
5550249|NCT01248949|19183689|P1|Overall Study|Entered Hospice And Refused Follow Up|0
5550250|NCT01248949|19183685|P5|Overall Study|Palliative Radiation To Brain Metastases|0
5550251|NCT01248949|19183686|P4|Overall Study|Palliative Radiation To Brain Metastases|0
5550252|NCT01248949|19183687|P3|Overall Study|Palliative Radiation To Brain Metastases|0
5550253|NCT01248949|19183688|P2|Overall Study|Palliative Radiation To Brain Metastases|0
5550254|NCT01248949|19183689|P1|Overall Study|Palliative Radiation To Brain Metastases|1
5550255|NCT01248949|19183685|P5|Overall Study|Alternative Therapy.|0
5550256|NCT01248949|19183686|P4|Overall Study|Alternative Therapy.|0
5550257|NCT01248949|19183687|P3|Overall Study|Alternative Therapy.|0
5550258|NCT01248949|19183688|P2|Overall Study|Alternative Therapy.|0
5550259|NCT01248949|19183689|P1|Overall Study|Alternative Therapy.|1
5550260|NCT01248949|19183685|P5|Overall Study|Alternative Therapy|0
5550261|NCT01248949|19183686|P4|Overall Study|Alternative Therapy|0
5550262|NCT01248949|19183687|P3|Overall Study|Alternative Therapy|0
5550263|NCT01248949|19183688|P2|Overall Study|Alternative Therapy|0
5550264|NCT01248949|19183689|P1|Overall Study|Alternative Therapy|1
5550265|NCT01248949|19183685|P5|Overall Study|Death|2
5550266|NCT01248949|19183686|P4|Overall Study|Death|6
5550267|NCT01248949|19183687|P3|Overall Study|Death|21
5550268|NCT01248949|19183688|P2|Overall Study|Death|7
5550269|NCT01248949|19183689|P1|Overall Study|Death|22
5550270|NCT01248949|19183685|P5|Overall Study|Withdrawal by Subject|1
5550271|NCT01248949|19183686|P4|Overall Study|Withdrawal by Subject|3
5550272|NCT01248949|19183687|P3|Overall Study|Withdrawal by Subject|11
5550273|NCT01248949|19183688|P2|Overall Study|Withdrawal by Subject|3
5550274|NCT01248949|19183689|P1|Overall Study|Withdrawal by Subject|5
5550275|NCT01248949|19183685|P5|Overall Study|Lost to Follow-up|0
5550276|NCT01248949|19183686|P4|Overall Study|Lost to Follow-up|1
5550277|NCT01248949|19183687|P3|Overall Study|Lost to Follow-up|2
5550278|NCT01248949|19183688|P2|Overall Study|Lost to Follow-up|2
5550279|NCT01248949|19183689|P1|Overall Study|Lost to Follow-up|2
5550280|NCT01248936|19183801|P1|Overall Study|Other reason|3
5550281|NCT01248936|19183801|P1|Overall Study|Refused Treatment|1
5550282|NCT01248936|19183801|P1|Overall Study|Lost to Follow-up|7
5550283|NCT01248936|19183801|P1|Overall Study|Adverse Event|8
5550284|NCT01248936|19183801|P1|Overall Study|Withdrawal of Consent|20
5550285|NCT01248936|19183801|P1|Overall Study|Death|26
5550286|NCT01248936|19183801|P1|Overall Study|Progression of Disease|50
5550287|NCT01248936|19183801|P1|Overall Study|Sponsor Decision|259
5550288|NCT01248884|19183814|P3|Overall Study|Adverse Event|0
5550289|NCT01248884|19183815|P2|Overall Study|Adverse Event|0
5550290|NCT01248884|19183816|P1|Overall Study|Adverse Event|1
5550291|NCT01248884|19183814|P3|Overall Study|Withdrawal by Subject|1
5550292|NCT01248884|19183815|P2|Overall Study|Withdrawal by Subject|3
5550293|NCT01248884|19183816|P1|Overall Study|Withdrawal by Subject|1
5550294|NCT01248793|19183874|P2|Overall Study|Withdrawal by Subject|3
5550295|NCT01248793|19183875|P1|Overall Study|Withdrawal by Subject|3
5550296|NCT01248793|19183874|P2|Overall Study|Protocol Violation|1
5550297|NCT01248793|19183875|P1|Overall Study|Protocol Violation|0
5550298|NCT01248793|19183874|P2|Overall Study|Adverse Event|1
5550299|NCT01248793|19183875|P1|Overall Study|Adverse Event|1
5550300|NCT01248793|19183874|P2|Overall Study|Lost to Follow-up|1
5550301|NCT01248793|19183875|P1|Overall Study|Lost to Follow-up|0
5550302|NCT01248780|19183889|P2|Overall Study|Not treated|1
5550303|NCT01248780|19183890|P1|Overall Study|Not treated|0
5550304|NCT01248780|19183889|P2|Overall Study|Withdrawal by Subject|4
5550305|NCT01248780|19183890|P1|Overall Study|Withdrawal by Subject|4
5550306|NCT01248780|19183889|P2|Overall Study|Protocol Violation|1
5550307|NCT01248780|19183890|P1|Overall Study|Protocol Violation|1
5550308|NCT01248780|19183889|P2|Overall Study|Adverse Event|7
5550309|NCT01248780|19183890|P1|Overall Study|Adverse Event|2
5550310|NCT01248780|19183889|P2|Overall Study|Death|1
5550311|NCT01248780|19183890|P1|Overall Study|Death|0
5550312|NCT01248780|19183889|P2|Overall Study|Lost to Follow-up|1
5550313|NCT01248780|19183890|P1|Overall Study|Lost to Follow-up|0
5550314|NCT01248780|19183889|P2|Overall Study|Lack of Efficacy|0
5550315|NCT01248780|19183890|P1|Overall Study|Lack of Efficacy|2
5550316|NCT01248728|19183908|P2|Overall Study|Lack of Efficacy|0
5550317|NCT01248728|19183909|P1|Overall Study|Lack of Efficacy|1
5550318|NCT01248728|19183908|P2|Overall Study|Withdrawal by Subject|1
5550319|NCT01248728|19183909|P1|Overall Study|Withdrawal by Subject|2
5550320|NCT01248728|19183908|P2|Overall Study|Adverse Event|1
5550321|NCT01248728|19183909|P1|Overall Study|Adverse Event|1
5550322|NCT01248715|19183925|P2|Overall Study|Not influenza positive|510
5550323|NCT01248715|19183926|P1|Overall Study|Not influenza positive|501
5550324|NCT01248468|19183964|P3|Overall Study|Withdrawal by Subject|0
5550325|NCT01248468|19183965|P2|Overall Study|Withdrawal by Subject|2
5550326|NCT01248468|19183966|P1|Overall Study|Withdrawal by Subject|4
5550327|NCT01248468|19183964|P3|Overall Study|Pregnancy|0
5550328|NCT01248468|19183965|P2|Overall Study|Pregnancy|0
5550329|NCT01248468|19183966|P1|Overall Study|Pregnancy|1
5550330|NCT01248468|19183964|P3|Overall Study|Lost to Follow-up|4
5550331|NCT01248468|19183965|P2|Overall Study|Lost to Follow-up|12
5550332|NCT01248468|19183966|P1|Overall Study|Lost to Follow-up|9
5550333|NCT01248468|19183964|P3|Overall Study|Administrative problem|0
5550334|NCT01248468|19183965|P2|Overall Study|Administrative problem|0
5550335|NCT01248468|19183966|P1|Overall Study|Administrative problem|1
5550336|NCT01248455|19183983|P1|Overall Study|switched to alternate treatment|1
5550337|NCT01248364|19184028|P4|Overall Study|Adverse Event|0
5550338|NCT01248364|19184029|P3|Overall Study|Adverse Event|0
5550339|NCT01248364|19184030|P2|Overall Study|Adverse Event|1
5550340|NCT01248364|19184031|P1|Overall Study|Adverse Event|0
5550341|NCT01248130|19184094|P2|Overall Study|Ineligible|0
5550342|NCT01248130|19184095|P1|Overall Study|Ineligible|1
5550343|NCT01248130|19184094|P2|Overall Study|Protocol Violation|0
5550344|NCT01248130|19184095|P1|Overall Study|Protocol Violation|1
5550345|NCT01248065|19184114|P2|Overall Study|Other|5
5550346|NCT01248065|19184115|P1|Overall Study|Other|3
5550347|NCT01248065|19184114|P2|Overall Study|Third treatment failure event|1
5550348|NCT01248065|19184115|P1|Overall Study|Third treatment failure event|3
5550349|NCT01248065|19184114|P2|Overall Study|Adverse Event|0
5550350|NCT01248065|19184115|P1|Overall Study|Adverse Event|3
5550351|NCT01248065|19184114|P2|Overall Study|Withdrawal by Subject|11
5550352|NCT01248065|19184115|P1|Overall Study|Withdrawal by Subject|14
5550353|NCT01248065|19184114|P2|Overall Study|Lost to Follow-up|5
5550354|NCT01248065|19184115|P1|Overall Study|Lost to Follow-up|3
5550355|NCT01248013|19184125|P1|Overall Study|Withdrawal by Subject|14
5550356|NCT01247922|19184140|P1|Overall Study|Disease progression|4
5550357|NCT01247350|19184238|P5|Overall Study|Entry criteria not met|1
5550358|NCT01247350|19184239|P4|Overall Study|Entry criteria not met|0
5550359|NCT01247350|19184240|P3|Overall Study|Entry criteria not met|0
5550360|NCT01247350|19184241|P2|Overall Study|Entry criteria not met|0
5550361|NCT01247350|19184242|P1|Overall Study|Entry criteria not met|0
5550362|NCT01247350|19184238|P5|Overall Study|Withdrawal by Subject|0
5550363|NCT01247350|19184239|P4|Overall Study|Withdrawal by Subject|1
5550364|NCT01247350|19184240|P3|Overall Study|Withdrawal by Subject|0
5550365|NCT01247350|19184241|P2|Overall Study|Withdrawal by Subject|0
5550366|NCT01247350|19184242|P1|Overall Study|Withdrawal by Subject|0
5550367|NCT01247350|19184238|P5|Overall Study|Adverse Event|0
5550368|NCT01247350|19184239|P4|Overall Study|Adverse Event|0
5550369|NCT01247350|19184240|P3|Overall Study|Adverse Event|1
5550370|NCT01247350|19184241|P2|Overall Study|Adverse Event|0
5550371|NCT01247350|19184242|P1|Overall Study|Adverse Event|0
5550372|NCT01247324|19184300|P2|Overall Study|Lost to Follow-up|1
5550373|NCT01247324|19184301|P1|Overall Study|Lost to Follow-up|1
5550374|NCT01247324|19184300|P2|Overall Study|Adverse Event|13
5550375|NCT01247324|19184301|P1|Overall Study|Adverse Event|25
5550376|NCT01247324|19184300|P2|Overall Study|Consent withdrawn by participant|8
5550377|NCT01247324|19184301|P1|Overall Study|Consent withdrawn by participant|13
5550378|NCT01247324|19184300|P2|Overall Study|Reason not specified|8
5550379|NCT01247324|19184301|P1|Overall Study|Reason not specified|11
5550380|NCT01247324|19184300|P2|Overall Study|Protocol Violation|2
5550381|NCT01247324|19184301|P1|Overall Study|Protocol Violation|1
5550382|NCT01247324|19184300|P2|Overall Study|Pregnancy|3
5550383|NCT01247324|19184301|P1|Overall Study|Pregnancy|2
5550384|NCT01247324|19184300|P2|Overall Study|Non-compliance|0
5550385|NCT01247324|19184301|P1|Overall Study|Non-compliance|2
5550386|NCT01247324|19184300|P2|Overall Study|Lack of Efficacy|8
5550387|NCT01247324|19184301|P1|Overall Study|Lack of Efficacy|12
5550388|NCT01247324|19184300|P2|Overall Study|Non-compliance with study drug|0
5550389|NCT01247324|19184301|P1|Overall Study|Non-compliance with study drug|3
5550390|NCT01247324|19184300|P2|Overall Study|Physician Decision|1
5550391|NCT01247324|19184301|P1|Overall Study|Physician Decision|0
5550392|NCT01247324|19184300|P2|Overall Study|Death|0
5550393|NCT01247324|19184301|P1|Overall Study|Death|1
5550394|NCT01247090|19184394|P3|Overall Study|Withdrawal by Subject|0
5550395|NCT01247090|19184395|P2|Overall Study|Withdrawal by Subject|1
5550396|NCT01247090|19184396|P1|Overall Study|Withdrawal by Subject|0
5550397|NCT01247090|19184394|P3|Overall Study|Physician Decision|0
5550398|NCT01247090|19184395|P2|Overall Study|Physician Decision|0
5550399|NCT01247090|19184396|P1|Overall Study|Physician Decision|1
5550400|NCT01246999|19184425|P4|Overall Study|Withdrawal by Subject|2
5550401|NCT01246999|19184426|P3|Overall Study|Withdrawal by Subject|0
5550402|NCT01246999|19184427|P2|Overall Study|Withdrawal by Subject|0
5550403|NCT01246999|19184428|P1|Overall Study|Withdrawal by Subject|0
5550404|NCT01246999|19184425|P4|Overall Study|Lost to Follow-up|0
5550405|NCT01246999|19184426|P3|Overall Study|Lost to Follow-up|0
5550406|NCT01246999|19184427|P2|Overall Study|Lost to Follow-up|1
5550407|NCT01246999|19184428|P1|Overall Study|Lost to Follow-up|0
5550408|NCT01246986|19184468|P7|Overall Study|Withdrawal by Subject|0
5550409|NCT01246986|19184469|P6|Overall Study|Withdrawal by Subject|0
5550410|NCT01246986|19184470|P5|Overall Study|Withdrawal by Subject|4
5550411|NCT01246986|19184471|P4|Overall Study|Withdrawal by Subject|0
5550412|NCT01246986|19184472|P3|Overall Study|Withdrawal by Subject|3
5550413|NCT01246986|19184473|P2|Overall Study|Withdrawal by Subject|4
5550414|NCT01246986|19184474|P1|Overall Study|Withdrawal by Subject|3
5550415|NCT01246986|19184468|P7|Overall Study|On Treatment|0
5550416|NCT01246986|19184469|P6|Overall Study|On Treatment|0
5550417|NCT01246986|19184470|P5|Overall Study|On Treatment|1
5550418|NCT01246986|19184471|P4|Overall Study|On Treatment|0
5550419|NCT01246986|19184472|P3|Overall Study|On Treatment|0
5550420|NCT01246986|19184473|P2|Overall Study|On Treatment|0
5550421|NCT01246986|19184474|P1|Overall Study|On Treatment|0
5550422|NCT01246986|19184468|P7|Overall Study|Lost to Follow-up|0
5550423|NCT01246986|19184469|P6|Overall Study|Lost to Follow-up|1
5550424|NCT01246986|19184470|P5|Overall Study|Lost to Follow-up|0
5550425|NCT01246986|19184471|P4|Overall Study|Lost to Follow-up|0
5550426|NCT01246986|19184472|P3|Overall Study|Lost to Follow-up|3
5550427|NCT01246986|19184473|P2|Overall Study|Lost to Follow-up|1
5550428|NCT01246986|19184474|P1|Overall Study|Lost to Follow-up|0
5550429|NCT01246973|19184534|P2|Overall Study|Withdrawal by Subject|13
5550430|NCT01246973|19184535|P1|Overall Study|Withdrawal by Subject|7
5550431|NCT01246973|19184534|P2|Overall Study|Adverse Event|9
5550432|NCT01246973|19184535|P1|Overall Study|Adverse Event|16
5550433|NCT01246973|19184534|P2|Overall Study|Other|25
5550434|NCT01246973|19184535|P1|Overall Study|Other|38
5550435|NCT01246960|19184545|P2|Overall Study|Withdrawal (by participant or physician)|3
5550436|NCT01246960|19184546|P1|Overall Study|Withdrawal (by participant or physician)|3
5550437|NCT01246960|19184545|P2|Overall Study|Lost to Follow-up|1
5550438|NCT01246960|19184546|P1|Overall Study|Lost to Follow-up|3
5550439|NCT01246206|19184658|P1|Overall Study|Patient did not receive study regiments.|1
5550440|NCT01246011|19184736|P3|Overall Study|Withdrawal by Subject|1
5550441|NCT01246011|19184737|P2|Overall Study|Withdrawal by Subject|0
5550442|NCT01246011|19184738|P1|Overall Study|Withdrawal by Subject|0
5550443|NCT01246011|19184736|P3|Overall Study|If needed warfarin clinically, withdrawn|3
5550444|NCT01246011|19184737|P2|Overall Study|If needed warfarin clinically, withdrawn|0
5550445|NCT01246011|19184738|P1|Overall Study|If needed warfarin clinically, withdrawn|0
5550446|NCT01245764|19184766|P4|Study Phase A|Lost to Follow-up|0
5550447|NCT01245764|19184767|P3|Study Phase A|Lost to Follow-up|5
5550448|NCT01245764|19184768|P2|Study Phase A|Lost to Follow-up|0
5550449|NCT01245764|19184769|P1|Study Phase A|Lost to Follow-up|0
5550450|NCT01245764|19184766|P4|Study Phase A|Protocol Violation|2
5550451|NCT01245764|19184767|P3|Study Phase A|Protocol Violation|2
5550452|NCT01245764|19184768|P2|Study Phase A|Protocol Violation|3
5550453|NCT01245764|19184769|P1|Study Phase A|Protocol Violation|6
5550454|NCT01245764|19184766|P4|Study Phase A|Other|1
5550455|NCT01245764|19184767|P3|Study Phase A|Other|3
5550456|NCT01245764|19184768|P2|Study Phase A|Other|2
5550457|NCT01245764|19184769|P1|Study Phase A|Other|3
5550458|NCT01245751|19184807|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
5550459|NCT01245751|19184808|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
5550460|NCT01245751|19184809|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
5550461|NCT01245751|19184810|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
5550462|NCT01245751|19184807|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
5550463|NCT01245751|19184808|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
5550464|NCT01245751|19184809|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
5550465|NCT01245751|19184810|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
5550466|NCT01245751|19184807|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
5550467|NCT01245751|19184808|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
5550468|NCT01245751|19184809|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
5550469|NCT01245751|19184810|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
5550470|NCT01245673|19184859|P1|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
5550471|NCT01245387|19184927|P1|Overall Study|Missing discontinuation status|369
5550472|NCT01245387|19184927|P1|Overall Study|Other|131
5550473|NCT01245387|19184927|P1|Overall Study|Death|3
5550474|NCT01245387|19184927|P1|Overall Study|Adverse Event|9
5550475|NCT01245387|19184927|P1|Overall Study|Lack of Efficacy|195
5550476|NCT01245387|19184927|P1|Overall Study|Lost to Follow-up|106
5550477|NCT01245374|19184976|P1|Overall Study|Withdrawal by Subject|3
5550478|NCT01245374|19184976|P1|Overall Study|Protocol Violation|1
5550479|NCT01245283|19184999|P3|Overall Study|Lost to Follow-up|11
5550480|NCT01245283|19185000|P2|Overall Study|Lost to Follow-up|11
5550481|NCT01245283|19185001|P1|Overall Study|Lost to Follow-up|14
5550482|NCT01245140|19185046|P2|Overall Study|Refused Treatment/Did Not Coopera|1
5550483|NCT01245140|19185047|P1|Overall Study|Refused Treatment/Did Not Coopera|0
5550484|NCT01245140|19185046|P2|Overall Study|Withdrawal by Subject|1
5550485|NCT01245140|19185047|P1|Overall Study|Withdrawal by Subject|0
5550486|NCT01245140|19185046|P2|Overall Study|Protocol Violation|1
5550487|NCT01245140|19185047|P1|Overall Study|Protocol Violation|0
5550488|NCT01245140|19185046|P2|Overall Study|Lack of Efficacy|4
5550489|NCT01245140|19185047|P1|Overall Study|Lack of Efficacy|2
5550490|NCT01245140|19185046|P2|Overall Study|Adverse Event|3
5550491|NCT01245140|19185047|P1|Overall Study|Adverse Event|1
5550492|NCT01245101|19185103|P2|Period 3 (Treatment)|Withdrawal by Subject|0
5550493|NCT01245101|19185104|P1|Period 3 (Treatment)|Withdrawal by Subject|1
5550494|NCT01245101|19185103|P2|Period 2 (Washout)|Withdrawal by Subject|0
5550495|NCT01245101|19185104|P1|Period 2 (Washout)|Withdrawal by Subject|1
5550496|NCT01245101|19185103|P2|Period 1 (Treatment)|Withdrawal by Subject|0
5550497|NCT01245101|19185104|P1|Period 1 (Treatment)|Withdrawal by Subject|2
5550498|NCT01245062|19185114|P3|Cross-over Phase|Study closed/ terminated|11
5550499|NCT01245062|19185115|P2|Cross-over Phase|Study closed/ terminated|0
5550500|NCT01245062|19185116|P1|Cross-over Phase|Study closed/ terminated|0
5550501|NCT01245062|19185114|P3|Cross-over Phase|Withdrew Consent|4
5550502|NCT01245062|19185115|P2|Cross-over Phase|Withdrew Consent|0
5550503|NCT01245062|19185116|P1|Cross-over Phase|Withdrew Consent|0
5550504|NCT01245062|19185114|P3|Cross-over Phase|Physician Decision|1
5550505|NCT01245062|19185115|P2|Cross-over Phase|Physician Decision|0
5550506|NCT01245062|19185116|P1|Cross-over Phase|Physician Decision|0
5550507|NCT01245062|19185114|P3|Cross-over Phase|Lost to Follow-up|1
5550508|NCT01245062|19185115|P2|Cross-over Phase|Lost to Follow-up|0
5550509|NCT01245062|19185116|P1|Cross-over Phase|Lost to Follow-up|0
5550510|NCT01245062|19185114|P3|Randomization and Crossover Phase|Study closed/ terminated|0
5550511|NCT01245062|19185115|P2|Randomization and Crossover Phase|Study closed/ terminated|14
5550512|NCT01245062|19185116|P1|Randomization and Crossover Phase|Study closed/ terminated|23
5550513|NCT01245062|19185114|P3|Randomization and Crossover Phase|Withdrew Consent|0
5550514|NCT01245062|19185115|P2|Randomization and Crossover Phase|Withdrew Consent|11
5550515|NCT01245062|19185116|P1|Randomization and Crossover Phase|Withdrew Consent|12
5550516|NCT01245062|19185114|P3|Randomization and Crossover Phase|Physician Decision|0
5550517|NCT01245062|19185115|P2|Randomization and Crossover Phase|Physician Decision|4
5550518|NCT01245062|19185116|P1|Randomization and Crossover Phase|Physician Decision|2
5550519|NCT01245062|19185114|P3|Randomization and Crossover Phase|Lost to Follow-up|0
5550520|NCT01245062|19185115|P2|Randomization and Crossover Phase|Lost to Follow-up|2
5550521|NCT01245062|19185116|P1|Randomization and Crossover Phase|Lost to Follow-up|4
5550522|NCT01245049|19185154|P2|Overall Study|Lost to Follow-up|2
5550523|NCT01245049|19185155|P1|Overall Study|Lost to Follow-up|1
5550524|NCT01245049|19185154|P2|Overall Study|Withdrawal by Subject|1
5550525|NCT01245049|19185155|P1|Overall Study|Withdrawal by Subject|0
5550526|NCT01245049|19185154|P2|Overall Study|Migrated/moved from study area|1
5550527|NCT01245049|19185155|P1|Overall Study|Migrated/moved from study area|0
5550528|NCT01244984|19185208|P3|Overall Study|Withdrawal by Subject|2
5550529|NCT01244984|19185209|P2|Overall Study|Withdrawal by Subject|2
5550530|NCT01244984|19185210|P1|Overall Study|Withdrawal by Subject|1
5550531|NCT01244984|19185208|P3|Overall Study|Protocol Defined Stopping Criteria|0
5550532|NCT01244984|19185209|P2|Overall Study|Protocol Defined Stopping Criteria|1
5550533|NCT01244984|19185210|P1|Overall Study|Protocol Defined Stopping Criteria|1
5550534|NCT01244984|19185208|P3|Overall Study|Protocol Violation|0
5550535|NCT01244984|19185209|P2|Overall Study|Protocol Violation|0
5550536|NCT01244984|19185210|P1|Overall Study|Protocol Violation|1
5550537|NCT01244984|19185208|P3|Overall Study|Adverse Event|2
5550538|NCT01244984|19185209|P2|Overall Study|Adverse Event|11
5550539|NCT01244984|19185210|P1|Overall Study|Adverse Event|2
5550540|NCT01244906|19185284|P1|Overall Study|Progression of disease post treatment|6
5550541|NCT01244906|19185284|P1|Overall Study|Death|2
5550542|NCT01244893|19185293|P2|1-Week Follow Up|Lost to Follow-up|0
5550543|NCT01244893|19185294|P1|1-Week Follow Up|Lost to Follow-up|1
5550544|NCT01244893|19185293|P2|Baseline|Protocol Violation|1
5550545|NCT01244893|19185294|P1|Baseline|Protocol Violation|0
5550546|NCT01244828|19185306|P1|Overall Study|Other reason (not specified)|1
5550547|NCT01244828|19185306|P1|Overall Study|Lost to Follow-up|2
5550548|NCT01244828|19185306|P1|Overall Study|Lack of Efficacy|7
5550549|NCT01244828|19185306|P1|Overall Study|Withdrawal by Subject|31
5550550|NCT01244828|19185306|P1|Overall Study|Adverse Event|37
5550551|NCT01244815|19185322|P4|Overall Study|Did Not Meet Protocol Eligibility|0
5550552|NCT01244815|19185323|P3|Overall Study|Did Not Meet Protocol Eligibility|0
5550553|NCT01244815|19185324|P2|Overall Study|Did Not Meet Protocol Eligibility|1
5550554|NCT01244815|19185325|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5550555|NCT01244815|19185322|P4|Overall Study|Protocol Violation|1
5550556|NCT01244815|19185323|P3|Overall Study|Protocol Violation|3
5550557|NCT01244815|19185324|P2|Overall Study|Protocol Violation|4
5550558|NCT01244815|19185325|P1|Overall Study|Protocol Violation|7
5550559|NCT01244815|19185322|P4|Overall Study|Withdrawal by Subject|3
5550560|NCT01244815|19185323|P3|Overall Study|Withdrawal by Subject|0
5550561|NCT01244815|19185324|P2|Overall Study|Withdrawal by Subject|2
5550562|NCT01244815|19185325|P1|Overall Study|Withdrawal by Subject|0
5550563|NCT01244815|19185322|P4|Overall Study|Lost to Follow-up|2
5550564|NCT01244815|19185323|P3|Overall Study|Lost to Follow-up|3
5550565|NCT01244815|19185324|P2|Overall Study|Lost to Follow-up|2
5550566|NCT01244815|19185325|P1|Overall Study|Lost to Follow-up|3
5550567|NCT01244815|19185322|P4|Overall Study|Treatment Failure|1
5550568|NCT01244815|19185323|P3|Overall Study|Treatment Failure|0
5550569|NCT01244815|19185324|P2|Overall Study|Treatment Failure|0
5550570|NCT01244815|19185325|P1|Overall Study|Treatment Failure|0
5550571|NCT01244815|19185322|P4|Overall Study|Adverse Event|5
5550572|NCT01244815|19185323|P3|Overall Study|Adverse Event|5
5550573|NCT01244815|19185324|P2|Overall Study|Adverse Event|7
5550574|NCT01244815|19185325|P1|Overall Study|Adverse Event|4
5550575|NCT01244815|19185322|P4|Overall Study|Not Treated|0
5550576|NCT01244815|19185323|P3|Overall Study|Not Treated|0
5550577|NCT01244815|19185324|P2|Overall Study|Not Treated|1
5550578|NCT01244815|19185325|P1|Overall Study|Not Treated|0
5550579|NCT01244620|19185412|P4|Overall Study|Study terminated|4
5550580|NCT01244620|19185413|P3|Overall Study|Study terminated|4
5550581|NCT01244620|19185414|P2|Overall Study|Study terminated|4
5550582|NCT01244620|19185415|P1|Overall Study|Study terminated|4
5550583|NCT01244516|19185474|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
5550584|NCT01244516|19185475|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
5550585|NCT01244516|19185476|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
5550586|NCT01244516|19185474|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
5550587|NCT01244516|19185475|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
5550588|NCT01244516|19185476|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
5550589|NCT01244516|19185474|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
5550590|NCT01244516|19185475|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
5550591|NCT01244516|19185476|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
5550592|NCT01244516|19185474|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
5550593|NCT01244516|19185475|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
5550594|NCT01244516|19185476|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
5550595|NCT01244516|19185474|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
5550596|NCT01244516|19185475|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
5550597|NCT01244516|19185476|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
5550598|NCT01244516|19185474|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
5550599|NCT01244516|19185475|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
5550600|NCT01244516|19185476|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
5550601|NCT01244516|19185474|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
5550602|NCT01244516|19185475|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
5550603|NCT01244516|19185476|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
5550604|NCT01244490|19185497|P3|Overall Study|Other|1
5550605|NCT01244490|19185498|P2|Overall Study|Other|0
5550606|NCT01244490|19185499|P1|Overall Study|Other|0
5550607|NCT01244490|19185497|P3|Overall Study|Lost to Follow-up|3
5550608|NCT01244490|19185498|P2|Overall Study|Lost to Follow-up|6
5550609|NCT01244490|19185499|P1|Overall Study|Lost to Follow-up|0
5550610|NCT01244490|19185497|P3|Overall Study|Adverse Event|5
5550611|NCT01244490|19185498|P2|Overall Study|Adverse Event|9
5550612|NCT01244490|19185499|P1|Overall Study|Adverse Event|1
5550613|NCT01244490|19185497|P3|Overall Study|Withdrawal by Subject|9
5550614|NCT01244490|19185498|P2|Overall Study|Withdrawal by Subject|4
5550615|NCT01244490|19185499|P1|Overall Study|Withdrawal by Subject|4
5550616|NCT01244490|19185497|P3|Overall Study|Lack of Efficacy|5
5550617|NCT01244490|19185498|P2|Overall Study|Lack of Efficacy|5
5550618|NCT01244490|19185499|P1|Overall Study|Lack of Efficacy|14
5550619|NCT01244425|19185576|P2|Overall Study|Adverse Event|1
5550620|NCT01244425|19185577|P1|Overall Study|Adverse Event|1
5550621|NCT01244425|19185576|P2|Overall Study|Withdrawal by Subject|2
5550622|NCT01244425|19185577|P1|Overall Study|Withdrawal by Subject|2
5550623|NCT01244191|19185608|P2|Overall Study|'Missing' or 'Terminated by sponsor'|8
5550624|NCT01244191|19185609|P1|Overall Study|'Missing' or 'Terminated by sponsor'|12
5550625|NCT01244191|19185608|P2|Overall Study|Withdrawal by Subject|23
5550626|NCT01244191|19185609|P1|Overall Study|Withdrawal by Subject|31
5550627|NCT01244191|19185608|P2|Overall Study|Protocol Violation|2
5550628|NCT01244191|19185609|P1|Overall Study|Protocol Violation|1
5550629|NCT01244191|19185608|P2|Overall Study|Lost to Follow-up|2
5550630|NCT01244191|19185609|P1|Overall Study|Lost to Follow-up|0
5550631|NCT01244191|19185608|P2|Overall Study|Death|29
5550632|NCT01244191|19185609|P1|Overall Study|Death|22
5550633|NCT01244191|19185608|P2|Overall Study|Adverse Event|48
5550634|NCT01244191|19185609|P1|Overall Study|Adverse Event|65
5550635|NCT01244191|19185608|P2|Overall Study|Clinical disease progression|36
5550636|NCT01244191|19185609|P1|Overall Study|Clinical disease progression|54
5550637|NCT01244191|19185608|P2|Overall Study|Progressive disease|350
5550638|NCT01244191|19185609|P1|Overall Study|Progressive disease|295
5550639|NCT01244126|19185632|P3|Overall Study|Protocol Violation|9
5550640|NCT01244126|19185633|P2|Overall Study|Protocol Violation|3
5550641|NCT01244126|19185634|P1|Overall Study|Protocol Violation|3
5550642|NCT01244061|19185647|P2|Overall Study|Randomized but not treated|2
5550643|NCT01244061|19185648|P1|Overall Study|Randomized but not treated|2
5550644|NCT01244061|19185647|P2|Overall Study|Adverse Event|2
5550645|NCT01244061|19185648|P1|Overall Study|Adverse Event|5
5550646|NCT01244061|19185647|P2|Overall Study|Protocol Violation|1
5550647|NCT01244061|19185648|P1|Overall Study|Protocol Violation|1
5550648|NCT01244061|19185647|P2|Overall Study|Other|19
5550649|NCT01244061|19185648|P1|Overall Study|Other|8
5550650|NCT01244061|19185647|P2|Overall Study|Withdrawal by Subject|46
5550651|NCT01244061|19185648|P1|Overall Study|Withdrawal by Subject|29
5550652|NCT01244061|19185647|P2|Overall Study|Lost to Follow-up|30
5550653|NCT01244061|19185648|P1|Overall Study|Lost to Follow-up|34
5550654|NCT01244061|19185647|P2|Overall Study|Lack of Efficacy|3
5550655|NCT01244061|19185648|P1|Overall Study|Lack of Efficacy|1
5550656|NCT01244061|19185647|P2|Overall Study|Did not meet entrance criteria|0
5550657|NCT01244061|19185648|P1|Overall Study|Did not meet entrance criteria|1
5550658|NCT01244061|19185647|P2|Overall Study|Death|0
5550659|NCT01244061|19185648|P1|Overall Study|Death|1
5550660|NCT01244035|19185660|P6|Part 1: Period 3|Protocol Deviation|0
5550661|NCT01244035|19185661|P5|Part 1: Period 3|Protocol Deviation|0
5550662|NCT01244035|19185662|P4|Part 1: Period 3|Protocol Deviation|0
5550663|NCT01244035|19185663|P3|Part 1: Period 3|Protocol Deviation|0
5550664|NCT01244035|19185664|P2|Part 1: Period 3|Protocol Deviation|1
5550665|NCT01244035|19185665|P1|Part 1: Period 3|Protocol Deviation|0
5550666|NCT01244035|19185660|P6|Part 1: Period 3|Withdrawal by Subject|0
5550667|NCT01244035|19185661|P5|Part 1: Period 3|Withdrawal by Subject|1
5550668|NCT01244035|19185662|P4|Part 1: Period 3|Withdrawal by Subject|0
5550669|NCT01244035|19185663|P3|Part 1: Period 3|Withdrawal by Subject|0
5550670|NCT01244035|19185664|P2|Part 1: Period 3|Withdrawal by Subject|0
5550671|NCT01244035|19185665|P1|Part 1: Period 3|Withdrawal by Subject|0
5550672|NCT01244035|19185660|P6|Part 1: Period 3|Adverse Event|1
5550673|NCT01244035|19185661|P5|Part 1: Period 3|Adverse Event|0
5550674|NCT01244035|19185662|P4|Part 1: Period 3|Adverse Event|0
5550675|NCT01244035|19185663|P3|Part 1: Period 3|Adverse Event|0
5550676|NCT01244035|19185664|P2|Part 1: Period 3|Adverse Event|0
5550677|NCT01244035|19185665|P1|Part 1: Period 3|Adverse Event|0
5550678|NCT01244035|19185660|P6|Part 1: Period 2|Fulfilled Stopping Criteria|0
5550679|NCT01244035|19185661|P5|Part 1: Period 2|Fulfilled Stopping Criteria|0
5550680|NCT01244035|19185662|P4|Part 1: Period 2|Fulfilled Stopping Criteria|0
5550681|NCT01244035|19185663|P3|Part 1: Period 2|Fulfilled Stopping Criteria|1
5550682|NCT01244035|19185664|P2|Part 1: Period 2|Fulfilled Stopping Criteria|0
5550683|NCT01244035|19185665|P1|Part 1: Period 2|Fulfilled Stopping Criteria|0
5550684|NCT01244035|19185660|P6|Part 1: Period 1|Fulfilled Stopping Criteria|1
5550685|NCT01244035|19185661|P5|Part 1: Period 1|Fulfilled Stopping Criteria|1
5550686|NCT01244035|19185662|P4|Part 1: Period 1|Fulfilled Stopping Criteria|0
5550687|NCT01244035|19185663|P3|Part 1: Period 1|Fulfilled Stopping Criteria|2
5550688|NCT01244035|19185664|P2|Part 1: Period 1|Fulfilled Stopping Criteria|0
5550689|NCT01244035|19185665|P1|Part 1: Period 1|Fulfilled Stopping Criteria|1
5550690|NCT01244035|19185660|P6|Part 1: Period 1|Withdrawal by Subject|0
5550691|NCT01244035|19185661|P5|Part 1: Period 1|Withdrawal by Subject|0
5550692|NCT01244035|19185662|P4|Part 1: Period 1|Withdrawal by Subject|0
5550693|NCT01244035|19185663|P3|Part 1: Period 1|Withdrawal by Subject|0
5550694|NCT01244035|19185664|P2|Part 1: Period 1|Withdrawal by Subject|2
5550695|NCT01244035|19185665|P1|Part 1: Period 1|Withdrawal by Subject|0
5550696|NCT01244035|19185660|P6|Part 1: Period 1|Adverse Event|1
5550697|NCT01244035|19185661|P5|Part 1: Period 1|Adverse Event|0
5550698|NCT01244035|19185662|P4|Part 1: Period 1|Adverse Event|0
5550699|NCT01244035|19185663|P3|Part 1: Period 1|Adverse Event|0
5550700|NCT01244035|19185664|P2|Part 1: Period 1|Adverse Event|0
5550701|NCT01244035|19185665|P1|Part 1: Period 1|Adverse Event|0
5550702|NCT01243944|19185706|P2|Overall Study|Non-compliance with study treatment|0
5550703|NCT01243944|19185707|P1|Overall Study|Non-compliance with study treatment|1
5550704|NCT01243944|19185706|P2|Overall Study|Death|3
5550705|NCT01243944|19185707|P1|Overall Study|Death|2
5550706|NCT01243944|19185706|P2|Overall Study|Participant decision|15
5550707|NCT01243944|19185707|P1|Overall Study|Participant decision|10
5550708|NCT01243944|19185706|P2|Overall Study|Protocol deviation|1
5550709|NCT01243944|19185707|P1|Overall Study|Protocol deviation|1
5550710|NCT01243944|19185706|P2|Overall Study|Disease progression|11
5550711|NCT01243944|19185707|P1|Overall Study|Disease progression|12
5550712|NCT01243944|19185706|P2|Overall Study|Physician Decision|7
5550713|NCT01243944|19185707|P1|Overall Study|Physician Decision|2
5550714|NCT01243944|19185706|P2|Overall Study|Lost to Follow-up|1
5550715|NCT01243944|19185707|P1|Overall Study|Lost to Follow-up|2
5550716|NCT01243944|19185706|P2|Overall Study|Adverse Event|13
5550717|NCT01243944|19185707|P1|Overall Study|Adverse Event|15
5550718|NCT01243892|19185735|P2|Overall Study|Did not meet eligibility criteria|0
5550719|NCT01243892|19185736|P1|Overall Study|Did not meet eligibility criteria|2
5550720|NCT01243775|19185746|P1|Overall Study|Withdrawal by Subject|2
5550721|NCT01243762|19185760|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5550722|NCT01243762|19185761|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5550723|NCT01243762|19185762|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
5550724|NCT01243762|19185763|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
5550725|NCT01243762|19185764|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5550726|NCT01243762|19185765|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5550727|NCT01243762|19185766|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
5550728|NCT01243762|19185760|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5550729|NCT01243762|19185761|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5550730|NCT01243762|19185762|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
5550731|NCT01243762|19185763|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5550732|NCT01243762|19185764|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5550733|NCT01243762|19185765|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
5550734|NCT01243762|19185766|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
5550735|NCT01243762|19185760|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
5550736|NCT01243762|19185761|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
5550737|NCT01243762|19185762|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
5550738|NCT01243762|19185763|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
5550739|NCT01243762|19185764|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
5550740|NCT01243762|19185765|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
5550741|NCT01243762|19185766|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
5550742|NCT01243762|19185760|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
5550743|NCT01243762|19185761|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5550744|NCT01243762|19185762|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5550745|NCT01243762|19185763|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5550746|NCT01243762|19185764|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5550747|NCT01243762|19185765|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
5550748|NCT01243762|19185766|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
5550749|NCT01243762|19185760|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5550750|NCT01243762|19185761|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5550751|NCT01243762|19185762|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5550752|NCT01243762|19185763|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5550753|NCT01243762|19185764|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5550754|NCT01243762|19185765|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
5550755|NCT01243762|19185766|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
5550756|NCT01243762|19185760|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
5550757|NCT01243762|19185761|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
5550758|NCT01243762|19185762|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
5550759|NCT01243762|19185763|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
5550760|NCT01243762|19185764|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
5550761|NCT01243762|19185765|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
5550762|NCT01243762|19185766|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
5550763|NCT01243762|19185760|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5550764|NCT01243762|19185761|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5550765|NCT01243762|19185762|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5550766|NCT01243762|19185763|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
5550767|NCT01243762|19185764|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5550768|NCT01243762|19185765|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
5550769|NCT01243762|19185766|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
5550770|NCT01243762|19185760|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5550771|NCT01243762|19185761|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
5550772|NCT01243762|19185762|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
5550773|NCT01243762|19185763|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5550774|NCT01243762|19185764|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5550775|NCT01243762|19185765|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
5550776|NCT01243762|19185766|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
5550777|NCT01243671|19185785|P1|Overall Study|Other|1
5550778|NCT01243671|19185785|P1|Overall Study|Anti-adalimumab antibody positive|1
5550779|NCT01243671|19185785|P1|Overall Study|Adverse Event|3
5550780|NCT01243424|19185864|P2|Discontinuation From Treatment|Other than listed above|211
5550781|NCT01243424|19185865|P1|Discontinuation From Treatment|Other than listed above|230
5550782|NCT01243424|19185864|P2|Discontinuation From Treatment|Withdrawal by Subject|328
5550783|NCT01243424|19185865|P1|Discontinuation From Treatment|Withdrawal by Subject|309
5550784|NCT01243424|19185864|P2|Discontinuation From Treatment|Lost to Follow-up|28
5550785|NCT01243424|19185865|P1|Discontinuation From Treatment|Lost to Follow-up|24
5550786|NCT01243424|19185864|P2|Discontinuation From Treatment|Protocol Violation|47
5550787|NCT01243424|19185865|P1|Discontinuation From Treatment|Protocol Violation|46
5550788|NCT01243424|19185864|P2|Discontinuation From Treatment|Lack of Efficacy|41
5550789|NCT01243424|19185865|P1|Discontinuation From Treatment|Lack of Efficacy|61
5550790|NCT01243424|19185864|P2|Discontinuation From Treatment|Adverse Event|523
5550791|NCT01243424|19185865|P1|Discontinuation From Treatment|Adverse Event|457
5550792|NCT01243424|19185864|P2|Discontinuation From Treatment|Not treated|4
5550793|NCT01243424|19185865|P1|Discontinuation From Treatment|Not treated|5
5550794|NCT01243424|19185864|P2|Discontinuation From Study (Treated Set)|Not treated|4
5550795|NCT01243424|19185865|P1|Discontinuation From Study (Treated Set)|Not treated|5
5550796|NCT01243424|19185864|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
5550797|NCT01243424|19185865|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
5550798|NCT01243424|19185864|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
5550799|NCT01243424|19185865|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
5550800|NCT01243424|19185864|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
5550801|NCT01243424|19185865|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
5550802|NCT01243424|19185864|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
5550803|NCT01243424|19185865|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
5550804|NCT01243424|19185864|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
5550805|NCT01243424|19185865|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
5550806|NCT01243424|19185864|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
5550807|NCT01243424|19185865|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
5550808|NCT01243411|19185907|P1|Overall Study|Other|8
5550809|NCT01243411|19185907|P1|Overall Study|Adverse Event|5
5550810|NCT01243411|19185907|P1|Overall Study|Lost to Follow-up|10
5550811|NCT01243411|19185907|P1|Overall Study|Withdrawal by Subject|18
5550812|NCT01243268|19186018|P1|Overall Study|Duplicate subject|2
5550813|NCT01243268|19186018|P1|Overall Study|Deviation with contract date|7
5550814|NCT01243268|19186018|P1|Overall Study|Protocol Violation|51
5550815|NCT01243268|19186018|P1|Overall Study|Lost to Follow-up|4
5550816|NCT01243242|19186028|P2|Overall Study|non compliance|0
5550817|NCT01243242|19186029|P1|Overall Study|non compliance|1
5550818|NCT01243242|19186028|P2|Overall Study|sponsor decision|1
5550819|NCT01243242|19186029|P1|Overall Study|sponsor decision|0
5550820|NCT01243242|19186028|P2|Overall Study|Physician Decision|1
5550821|NCT01243242|19186029|P1|Overall Study|Physician Decision|0
5550822|NCT01243242|19186028|P2|Overall Study|Withdrawal by Subject|1
5550823|NCT01243242|19186029|P1|Overall Study|Withdrawal by Subject|1
5550824|NCT01243242|19186028|P2|Overall Study|Adverse Event|1
5550825|NCT01243242|19186029|P1|Overall Study|Adverse Event|1
5550826|NCT01243177|19186043|P2|Overall Study|Other Reason|12
5550827|NCT01243177|19186044|P1|Overall Study|Other Reason|11
5550828|NCT01243177|19186043|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
5550829|NCT01243177|19186044|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5550830|NCT01243177|19186043|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
5550831|NCT01243177|19186044|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
5550832|NCT01243177|19186043|P2|Overall Study|AE, non-serious non-fatal|58
5550833|NCT01243177|19186044|P1|Overall Study|AE, non-serious non-fatal|40
5550834|NCT01243177|19186043|P2|Overall Study|SAE, non-fatal|9
5550835|NCT01243177|19186044|P1|Overall Study|SAE, non-fatal|7
5550836|NCT01243177|19186043|P2|Overall Study|AE, serious fatal|1
5550837|NCT01243177|19186044|P1|Overall Study|AE, serious fatal|0
5550838|NCT01243177|19186043|P2|Overall Study|Withdrawal by Subject|38
5550839|NCT01243177|19186044|P1|Overall Study|Withdrawal by Subject|46
5550840|NCT01243177|19186043|P2|Overall Study|Lost to Follow-up|18
5550841|NCT01243177|19186044|P1|Overall Study|Lost to Follow-up|15
5550842|NCT01243177|19186043|P2|Overall Study|Protocol Violation|10
5550843|NCT01243177|19186044|P1|Overall Study|Protocol Violation|11
5550844|NCT01243177|19186043|P2|Overall Study|Lack of Efficacy|31
5550845|NCT01243177|19186044|P1|Overall Study|Lack of Efficacy|47
5550846|NCT01243151|19186065|P5|Overall Study|Randomized but not treated|0
5550847|NCT01243151|19186066|P4|Overall Study|Randomized but not treated|1
5550848|NCT01243151|19186067|P3|Overall Study|Randomized but not treated|0
5550849|NCT01243151|19186068|P2|Overall Study|Randomized but not treated|0
5550850|NCT01243151|19186069|P1|Overall Study|Randomized but not treated|0
5550851|NCT01243151|19186065|P5|Overall Study|Other|0
5550852|NCT01243151|19186066|P4|Overall Study|Other|1
5550853|NCT01243151|19186067|P3|Overall Study|Other|0
5550854|NCT01243151|19186068|P2|Overall Study|Other|0
5550855|NCT01243151|19186069|P1|Overall Study|Other|0
5550856|NCT01243151|19186065|P5|Overall Study|Protocol Violation|0
5550857|NCT01243151|19186066|P4|Overall Study|Protocol Violation|0
5550858|NCT01243151|19186067|P3|Overall Study|Protocol Violation|1
5550859|NCT01243151|19186068|P2|Overall Study|Protocol Violation|0
5550860|NCT01243151|19186069|P1|Overall Study|Protocol Violation|0
5550861|NCT01243151|19186065|P5|Overall Study|Adverse Event|0
5550862|NCT01243151|19186066|P4|Overall Study|Adverse Event|0
5550863|NCT01243151|19186067|P3|Overall Study|Adverse Event|0
5550864|NCT01243151|19186068|P2|Overall Study|Adverse Event|1
5550865|NCT01243151|19186069|P1|Overall Study|Adverse Event|0
5550866|NCT01242813|19186313|P1|Overall Study|Lost to Follow-up|2
5550867|NCT01242748|19186335|P2|Overall Study|Miscellaneous reasons|3
5550868|NCT01242748|19186336|P1|Overall Study|Miscellaneous reasons|8
5550869|NCT01242748|19186335|P2|Overall Study|Withdrawal by Subject|2
5550870|NCT01242748|19186336|P1|Overall Study|Withdrawal by Subject|10
5550871|NCT01242748|19186335|P2|Overall Study|Protocol Violation|0
5550872|NCT01242748|19186336|P1|Overall Study|Protocol Violation|1
5550873|NCT01242748|19186335|P2|Overall Study|Physician Decision|2
5550874|NCT01242748|19186336|P1|Overall Study|Physician Decision|3
5550875|NCT01242748|19186335|P2|Overall Study|Lost to Follow-up|2
5550876|NCT01242748|19186336|P1|Overall Study|Lost to Follow-up|6
5550877|NCT01242748|19186335|P2|Overall Study|Adverse Event|5
5550878|NCT01242748|19186336|P1|Overall Study|Adverse Event|10
5550879|NCT01242514|19186410|P3|Overall Study|Adverse Event|19
5550880|NCT01242514|19186411|P2|Overall Study|Adverse Event|18
5550881|NCT01242514|19186412|P1|Overall Study|Adverse Event|129
5550882|NCT01242514|19186410|P3|Overall Study|Lost to Follow-up|4
5550883|NCT01242514|19186411|P2|Overall Study|Lost to Follow-up|5
5550884|NCT01242514|19186412|P1|Overall Study|Lost to Follow-up|14
5550885|NCT01242514|19186410|P3|Overall Study|Dev. of study specific discont. criteria|5
5550886|NCT01242514|19186411|P2|Overall Study|Dev. of study specific discont. criteria|3
5550887|NCT01242514|19186412|P1|Overall Study|Dev. of study specific discont. criteria|21
5550888|NCT01242514|19186410|P3|Overall Study|Lack of therapeutic response|10
5550889|NCT01242514|19186411|P2|Overall Study|Lack of therapeutic response|16
5550890|NCT01242514|19186412|P1|Overall Study|Lack of therapeutic response|99
5550891|NCT01242514|19186410|P3|Overall Study|Severe non-compliance to protocol|1
5550892|NCT01242514|19186411|P2|Overall Study|Severe non-compliance to protocol|2
5550893|NCT01242514|19186412|P1|Overall Study|Severe non-compliance to protocol|5
5550894|NCT01242514|19186410|P3|Overall Study|Subject decision|2
5550895|NCT01242514|19186411|P2|Overall Study|Subject decision|8
5550896|NCT01242514|19186412|P1|Overall Study|Subject decision|33
5550897|NCT01242514|19186410|P3|Overall Study|e.g., project closure|171
5550898|NCT01242514|19186411|P2|Overall Study|e.g., project closure|305
5550899|NCT01242514|19186412|P1|Overall Study|e.g., project closure|1042
5550900|NCT01242371|19186431|P2|Overall Study|Protocol Violation|3
5550901|NCT01242371|19186432|P1|Overall Study|Protocol Violation|0
5550902|NCT01242371|19186431|P2|Overall Study|Withdrawal by Subject|2
5550903|NCT01242371|19186432|P1|Overall Study|Withdrawal by Subject|2
5550904|NCT01242176|19186449|P2|Washout Period of 7 Days|Non-compliant with protocol|0
5550905|NCT01242176|19186450|P1|Washout Period of 7 Days|Non-compliant with protocol|1
5550906|NCT01242176|19186449|P2|Washout Period of 7 Days|Adverse Event|2
5550907|NCT01242176|19186450|P1|Washout Period of 7 Days|Adverse Event|0
5550908|NCT01242111|19186460|P1|Overall Study|Did not consent to MOR-100 follow-up|1
5550909|NCT01242111|19186460|P1|Overall Study|Withdrawal by Subject|1
5550910|NCT01242111|19186460|P1|Overall Study|Adverse Event|1
5550911|NCT01242085|19186472|P3|Overall Study|medically unable to have surgery|0
5550912|NCT01242085|19186473|P2|Overall Study|medically unable to have surgery|5
5550913|NCT01242085|19186474|P1|Overall Study|medically unable to have surgery|4
5550914|NCT01242085|19186472|P3|Overall Study|Withdrawal by Subject|0
5550915|NCT01242085|19186473|P2|Overall Study|Withdrawal by Subject|2
5550916|NCT01242085|19186474|P1|Overall Study|Withdrawal by Subject|4
5550917|NCT01242020|19186484|P2|Overall Study|Failed screening|0
5550918|NCT01242020|19186485|P1|Overall Study|Failed screening|1
5550919|NCT01242020|19186484|P2|Overall Study|Withdrawal by Subject|0
5550920|NCT01242020|19186485|P1|Overall Study|Withdrawal by Subject|2
5550921|NCT01241760|19186515|P2|Overall Study|Other|1
5550922|NCT01241760|19186516|P1|Overall Study|Other|1
5550923|NCT01241760|19186515|P2|Overall Study|Switch To Commercially Available Medicat|4
5550924|NCT01241760|19186516|P1|Overall Study|Switch To Commercially Available Medicat|1
5550925|NCT01241760|19186515|P2|Overall Study|Withdrawal by Subject|13
5550926|NCT01241760|19186516|P1|Overall Study|Withdrawal by Subject|13
5550927|NCT01241760|19186515|P2|Overall Study|Lost to Follow-up|22
5550928|NCT01241760|19186516|P1|Overall Study|Lost to Follow-up|18
5550929|NCT01241760|19186515|P2|Overall Study|Adverse Event|0
5550930|NCT01241760|19186516|P1|Overall Study|Adverse Event|1
5550931|NCT01241604|19186535|P3|Screening Period|Screen Failure|0
5550932|NCT01241604|19186536|P2|Screening Period|Screen Failure|0
5550933|NCT01241604|19186537|P1|Screening Period|Screen Failure|3
5550934|NCT01241591|19186582|P4|Overall Study|Adverse Event|4
5550935|NCT01241591|19186583|P3|Overall Study|Adverse Event|12
5550936|NCT01241591|19186584|P2|Overall Study|Adverse Event|11
5550937|NCT01241591|19186585|P1|Overall Study|Adverse Event|3
5550938|NCT01241591|19186582|P4|Overall Study|Other|1
5550939|NCT01241591|19186583|P3|Overall Study|Other|0
5550940|NCT01241591|19186584|P2|Overall Study|Other|1
5550941|NCT01241591|19186585|P1|Overall Study|Other|0
5550942|NCT01241591|19186582|P4|Overall Study|Withdrawal by Subject|2
5550943|NCT01241591|19186583|P3|Overall Study|Withdrawal by Subject|2
5550944|NCT01241591|19186584|P2|Overall Study|Withdrawal by Subject|4
5550945|NCT01241591|19186585|P1|Overall Study|Withdrawal by Subject|6
5550946|NCT01241591|19186582|P4|Overall Study|Screen Failure|0
5550947|NCT01241591|19186583|P3|Overall Study|Screen Failure|1
5550948|NCT01241591|19186584|P2|Overall Study|Screen Failure|2
5550949|NCT01241591|19186585|P1|Overall Study|Screen Failure|3
5550950|NCT01241591|19186582|P4|Overall Study|Lost to Follow-up|2
5550951|NCT01241591|19186583|P3|Overall Study|Lost to Follow-up|2
5550952|NCT01241591|19186584|P2|Overall Study|Lost to Follow-up|2
5550953|NCT01241591|19186585|P1|Overall Study|Lost to Follow-up|1
5550954|NCT01241591|19186582|P4|Overall Study|Protocol Violation|0
5550955|NCT01241591|19186583|P3|Overall Study|Protocol Violation|3
5550956|NCT01241591|19186584|P2|Overall Study|Protocol Violation|2
5550957|NCT01241591|19186585|P1|Overall Study|Protocol Violation|5
5550958|NCT01241591|19186582|P4|Overall Study|Lack of Efficacy|3
5550959|NCT01241591|19186583|P3|Overall Study|Lack of Efficacy|2
5550960|NCT01241591|19186584|P2|Overall Study|Lack of Efficacy|2
5550961|NCT01241591|19186585|P1|Overall Study|Lack of Efficacy|5
5550962|NCT01241552|19186788|P4|Overall Study|Lost to Follow-up|16
5550963|NCT01241552|19186789|P3|Overall Study|Lost to Follow-up|15
5550964|NCT01241552|19186790|P2|Overall Study|Lost to Follow-up|11
5550965|NCT01241552|19186791|P1|Overall Study|Lost to Follow-up|2
5550966|NCT01241552|19186788|P4|Overall Study|Physician Decision|3
5550967|NCT01241552|19186789|P3|Overall Study|Physician Decision|2
5550968|NCT01241552|19186790|P2|Overall Study|Physician Decision|4
5550969|NCT01241552|19186791|P1|Overall Study|Physician Decision|2
5550970|NCT01241552|19186788|P4|Overall Study|Withdrawal by Subject|15
5550971|NCT01241552|19186789|P3|Overall Study|Withdrawal by Subject|14
5550972|NCT01241552|19186790|P2|Overall Study|Withdrawal by Subject|15
5550973|NCT01241552|19186791|P1|Overall Study|Withdrawal by Subject|7
5550974|NCT01241552|19186788|P4|Overall Study|Protocol Violation|1
5550975|NCT01241552|19186789|P3|Overall Study|Protocol Violation|6
5550976|NCT01241552|19186790|P2|Overall Study|Protocol Violation|2
5550977|NCT01241552|19186791|P1|Overall Study|Protocol Violation|0
5550978|NCT01241552|19186788|P4|Overall Study|Progressive Disease|2
5550979|NCT01241552|19186789|P3|Overall Study|Progressive Disease|1
5550980|NCT01241552|19186790|P2|Overall Study|Progressive Disease|0
5550981|NCT01241552|19186791|P1|Overall Study|Progressive Disease|0
5550982|NCT01241552|19186788|P4|Overall Study|Technical Problems|2
5550983|NCT01241552|19186789|P3|Overall Study|Technical Problems|2
5550984|NCT01241552|19186790|P2|Overall Study|Technical Problems|0
5550985|NCT01241552|19186791|P1|Overall Study|Technical Problems|2
5550986|NCT01241552|19186788|P4|Overall Study|Adverse Event|0
5550987|NCT01241552|19186789|P3|Overall Study|Adverse Event|0
5550988|NCT01241552|19186790|P2|Overall Study|Adverse Event|1
5550989|NCT01241552|19186791|P1|Overall Study|Adverse Event|1
5550990|NCT01241552|19186788|P4|Overall Study|Death|25
5550991|NCT01241552|19186789|P3|Overall Study|Death|20
5550992|NCT01241552|19186790|P2|Overall Study|Death|30
5550993|NCT01241552|19186791|P1|Overall Study|Death|26
5550994|NCT01241552|19186788|P4|Overall Study|Lack of Efficacy|0
5550995|NCT01241552|19186789|P3|Overall Study|Lack of Efficacy|0
5550996|NCT01241552|19186790|P2|Overall Study|Lack of Efficacy|0
5550997|NCT01241552|19186791|P1|Overall Study|Lack of Efficacy|1
5550998|NCT01241461|19186886|P2|Overall Study|Progressive Disease|6
5550999|NCT01241461|19186887|P1|Overall Study|Progressive Disease|3
5551000|NCT01241448|19186907|P4|Overall Study|Excluded due to data integrity issues|2
5551001|NCT01241448|19186908|P3|Overall Study|Excluded due to data integrity issues|2
5551002|NCT01241448|19186909|P2|Overall Study|Excluded due to data integrity issues|2
5551003|NCT01241448|19186910|P1|Overall Study|Excluded due to data integrity issues|3
5551004|NCT01241448|19186907|P4|Overall Study|Withdrawal by Subject|6
5551005|NCT01241448|19186908|P3|Overall Study|Withdrawal by Subject|3
5551006|NCT01241448|19186909|P2|Overall Study|Withdrawal by Subject|5
5551007|NCT01241448|19186910|P1|Overall Study|Withdrawal by Subject|4
5551008|NCT01241448|19186907|P4|Overall Study|Sponsor Decision|6
5551009|NCT01241448|19186908|P3|Overall Study|Sponsor Decision|12
5551010|NCT01241448|19186909|P2|Overall Study|Sponsor Decision|14
5551011|NCT01241448|19186910|P1|Overall Study|Sponsor Decision|17
5551012|NCT01241448|19186907|P4|Overall Study|Protocol Violation|6
5551013|NCT01241448|19186908|P3|Overall Study|Protocol Violation|3
5551014|NCT01241448|19186909|P2|Overall Study|Protocol Violation|5
5551015|NCT01241448|19186910|P1|Overall Study|Protocol Violation|10
5551016|NCT01241448|19186907|P4|Overall Study|Physician Decision|0
5551017|NCT01241448|19186908|P3|Overall Study|Physician Decision|0
5551018|NCT01241448|19186909|P2|Overall Study|Physician Decision|2
5551019|NCT01241448|19186910|P1|Overall Study|Physician Decision|0
5551020|NCT01241448|19186907|P4|Overall Study|Lost to Follow-up|1
5551021|NCT01241448|19186908|P3|Overall Study|Lost to Follow-up|1
5551022|NCT01241448|19186909|P2|Overall Study|Lost to Follow-up|1
5551023|NCT01241448|19186910|P1|Overall Study|Lost to Follow-up|2
5551024|NCT01241448|19186907|P4|Overall Study|Adverse Event|2
5551025|NCT01241448|19186908|P3|Overall Study|Adverse Event|2
5551026|NCT01241448|19186909|P2|Overall Study|Adverse Event|0
5551027|NCT01241448|19186910|P1|Overall Study|Adverse Event|1
5551028|NCT01241318|19187001|P2|Overall Study|Woman: Stillborn infant|146
5551029|NCT01241318|19187002|P1|Overall Study|Woman: Stillborn infant|129
5551030|NCT01241318|19187001|P2|Overall Study|Withdrew/Lost to Follow after delivery|38
5551031|NCT01241318|19187002|P1|Overall Study|Withdrew/Lost to Follow after delivery|60
5551032|NCT01241318|19187001|P2|Overall Study|Death|4
5551033|NCT01241318|19187002|P1|Overall Study|Death|2
5551034|NCT01241318|19187001|P2|Overall Study|Lost to Follow-up|455
5551035|NCT01241318|19187002|P1|Overall Study|Lost to Follow-up|740
5551036|NCT01241318|19187001|P2|Overall Study|Withdrawal by Subject|46
5551037|NCT01241318|19187002|P1|Overall Study|Withdrawal by Subject|175
5551038|NCT01241318|19187001|P2|Overall Study|Woman: miscarriage/abortion|38
5551039|NCT01241318|19187002|P1|Overall Study|Woman: miscarriage/abortion|46
5551040|NCT01241318|19187001|P2|Overall Study|Woman: false pregnancies|15
5551041|NCT01241318|19187002|P1|Overall Study|Woman: false pregnancies|27
5551042|NCT01241292|19187019|P2|Overall Study|Participant Discontinued Treatment|2
5551043|NCT01241292|19187020|P1|Overall Study|Participant Discontinued Treatment|0
5551044|NCT01241292|19187019|P2|Overall Study|Study Drug Toxicity|1
5551045|NCT01241292|19187020|P1|Overall Study|Study Drug Toxicity|0
5551046|NCT01241292|19187019|P2|Overall Study|Disease Progression|0
5551047|NCT01241292|19187020|P1|Overall Study|Disease Progression|2
5551048|NCT01241292|19187019|P2|Overall Study|Administrative Reason by Sponsor|0
5551049|NCT01241292|19187020|P1|Overall Study|Administrative Reason by Sponsor|1
5551050|NCT01241279|19187044|P2|Overall Study|Lost to Follow-up|1
5551051|NCT01241279|19187045|P1|Overall Study|Lost to Follow-up|0
5551052|NCT01241240|19187055|P2|Overall Study|Personal Reasons|1
5551053|NCT01241240|19187056|P1|Overall Study|Personal Reasons|1
5551054|NCT01241240|19187055|P2|Overall Study|Lost to Follow-up|4
5551055|NCT01241240|19187056|P1|Overall Study|Lost to Follow-up|2
5551056|NCT01241240|19187055|P2|Overall Study|Adverse Event|4
5551057|NCT01241240|19187056|P1|Overall Study|Adverse Event|5
5551058|NCT01240915|19187074|P9|Overall Study|Insufficient Clinical Response|3
5551059|NCT01240915|19187075|P8|Overall Study|Insufficient Clinical Response|0
5551060|NCT01240915|19187076|P7|Overall Study|Insufficient Clinical Response|6
5551061|NCT01240915|19187077|P6|Overall Study|Insufficient Clinical Response|3
5551062|NCT01240915|19187078|P5|Overall Study|Insufficient Clinical Response|1
5551063|NCT01240915|19187079|P4|Overall Study|Insufficient Clinical Response|0
5551064|NCT01240915|19187080|P3|Overall Study|Insufficient Clinical Response|0
5551065|NCT01240915|19187081|P2|Overall Study|Insufficient Clinical Response|0
5551066|NCT01240915|19187082|P1|Overall Study|Insufficient Clinical Response|0
5551067|NCT01240915|19187074|P9|Overall Study|Other|0
5551068|NCT01240915|19187075|P8|Overall Study|Other|0
5551069|NCT01240915|19187076|P7|Overall Study|Other|0
5551070|NCT01240915|19187077|P6|Overall Study|Other|0
5551071|NCT01240915|19187078|P5|Overall Study|Other|2
5551072|NCT01240915|19187079|P4|Overall Study|Other|0
5551073|NCT01240915|19187080|P3|Overall Study|Other|0
5551074|NCT01240915|19187081|P2|Overall Study|Other|0
5551075|NCT01240915|19187082|P1|Overall Study|Other|0
5551076|NCT01240915|19187074|P9|Overall Study|Withdrawal by Subject|3
5551077|NCT01240915|19187075|P8|Overall Study|Withdrawal by Subject|3
5551078|NCT01240915|19187076|P7|Overall Study|Withdrawal by Subject|2
5551079|NCT01240915|19187077|P6|Overall Study|Withdrawal by Subject|4
5551080|NCT01240915|19187078|P5|Overall Study|Withdrawal by Subject|0
5551081|NCT01240915|19187079|P4|Overall Study|Withdrawal by Subject|2
5551082|NCT01240915|19187080|P3|Overall Study|Withdrawal by Subject|0
5551083|NCT01240915|19187081|P2|Overall Study|Withdrawal by Subject|1
5551084|NCT01240915|19187082|P1|Overall Study|Withdrawal by Subject|2
5551085|NCT01240915|19187074|P9|Overall Study|Lost to Follow-up|1
5551086|NCT01240915|19187075|P8|Overall Study|Lost to Follow-up|1
5551087|NCT01240915|19187076|P7|Overall Study|Lost to Follow-up|0
5551088|NCT01240915|19187077|P6|Overall Study|Lost to Follow-up|1
5551089|NCT01240915|19187078|P5|Overall Study|Lost to Follow-up|1
5551090|NCT01240915|19187079|P4|Overall Study|Lost to Follow-up|0
5551091|NCT01240915|19187080|P3|Overall Study|Lost to Follow-up|0
5551092|NCT01240915|19187081|P2|Overall Study|Lost to Follow-up|0
5551093|NCT01240915|19187082|P1|Overall Study|Lost to Follow-up|0
5551094|NCT01240915|19187074|P9|Overall Study|Adverse Event|1
5551095|NCT01240915|19187075|P8|Overall Study|Adverse Event|0
5551096|NCT01240915|19187076|P7|Overall Study|Adverse Event|0
5551097|NCT01240915|19187077|P6|Overall Study|Adverse Event|2
5551098|NCT01240915|19187078|P5|Overall Study|Adverse Event|0
5551099|NCT01240915|19187079|P4|Overall Study|Adverse Event|1
5551100|NCT01240915|19187080|P3|Overall Study|Adverse Event|0
5551101|NCT01240915|19187081|P2|Overall Study|Adverse Event|0
5551102|NCT01240915|19187082|P1|Overall Study|Adverse Event|0
5551103|NCT01240863|19187356|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
5551104|NCT01240863|19187357|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
5551105|NCT01240863|19187358|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
5551106|NCT01240863|19187356|P3|Double-blind Treatment Period (12 Weeks)|Other|5
5551107|NCT01240863|19187357|P2|Double-blind Treatment Period (12 Weeks)|Other|1
5551108|NCT01240863|19187358|P1|Double-blind Treatment Period (12 Weeks)|Other|0
5551109|NCT01240863|19187356|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
5551110|NCT01240863|19187357|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
5551111|NCT01240863|19187358|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
5551112|NCT01240863|19187356|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
5551113|NCT01240863|19187357|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
5551114|NCT01240863|19187358|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
5551115|NCT01240863|19187356|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
5551116|NCT01240863|19187357|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
5551117|NCT01240863|19187358|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
5551118|NCT01240863|19187356|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
5551119|NCT01240863|19187357|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
5551120|NCT01240863|19187358|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
5551121|NCT01240863|19187356|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
5551122|NCT01240863|19187357|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
5551123|NCT01240863|19187358|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
5551124|NCT01240863|19187356|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
5551125|NCT01240863|19187357|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
5551126|NCT01240863|19187358|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
5551127|NCT01240863|19187356|P3|Open-label Titration Period|Other|0
5551128|NCT01240863|19187357|P2|Open-label Titration Period|Other|0
5551129|NCT01240863|19187358|P1|Open-label Titration Period|Other|7
5551130|NCT01240863|19187356|P3|Open-label Titration Period|Dropped out prior to dosing|0
5551131|NCT01240863|19187357|P2|Open-label Titration Period|Dropped out prior to dosing|0
5551132|NCT01240863|19187358|P1|Open-label Titration Period|Dropped out prior to dosing|2
5551133|NCT01240863|19187356|P3|Open-label Titration Period|Noncompliance to study procedures|0
5551134|NCT01240863|19187357|P2|Open-label Titration Period|Noncompliance to study procedures|0
5551135|NCT01240863|19187358|P1|Open-label Titration Period|Noncompliance to study procedures|3
5551136|NCT01240863|19187356|P3|Open-label Titration Period|Noncompliance to study drug admin|0
5551137|NCT01240863|19187357|P2|Open-label Titration Period|Noncompliance to study drug admin|0
5551138|NCT01240863|19187358|P1|Open-label Titration Period|Noncompliance to study drug admin|3
5551139|NCT01240863|19187356|P3|Open-label Titration Period|Protocol Violation|0
5551140|NCT01240863|19187357|P2|Open-label Titration Period|Protocol Violation|0
5551141|NCT01240863|19187358|P1|Open-label Titration Period|Protocol Violation|7
5551142|NCT01240863|19187356|P3|Open-label Titration Period|Withdrawal by Subject|0
5551143|NCT01240863|19187357|P2|Open-label Titration Period|Withdrawal by Subject|0
5551144|NCT01240863|19187358|P1|Open-label Titration Period|Withdrawal by Subject|9
5551145|NCT01240863|19187356|P3|Open-label Titration Period|Lack of Efficacy|0
5551146|NCT01240863|19187357|P2|Open-label Titration Period|Lack of Efficacy|0
5551147|NCT01240863|19187358|P1|Open-label Titration Period|Lack of Efficacy|19
5551148|NCT01240863|19187356|P3|Open-label Titration Period|Adverse Event|0
5551149|NCT01240863|19187357|P2|Open-label Titration Period|Adverse Event|0
5551150|NCT01240863|19187358|P1|Open-label Titration Period|Adverse Event|47
5551151|NCT01240811|19187420|P3|Overall Study|Withdrawal by Subject|1
5551152|NCT01240811|19187421|P2|Overall Study|Withdrawal by Subject|0
5551153|NCT01240811|19187422|P1|Overall Study|Withdrawal by Subject|0
5551154|NCT01240811|19187420|P3|Overall Study|Physician Decision|0
5551155|NCT01240811|19187421|P2|Overall Study|Physician Decision|1
5551156|NCT01240811|19187422|P1|Overall Study|Physician Decision|0
5551157|NCT01240785|19187438|P2|Overall Study|Protocol Violation|3
5551158|NCT01240785|19187439|P1|Overall Study|Protocol Violation|0
5551159|NCT01240785|19187438|P2|Overall Study|Lost to Follow-up|0
5551160|NCT01240785|19187439|P1|Overall Study|Lost to Follow-up|1
5551161|NCT01240746|19187470|P3|Overall Study|Withdrawal by Subject|59
5551162|NCT01240746|19187471|P2|Overall Study|Withdrawal by Subject|13
5551163|NCT01240746|19187472|P1|Overall Study|Withdrawal by Subject|10
5551164|NCT01240746|19187470|P3|Overall Study|Protocol Violation|72
5551165|NCT01240746|19187471|P2|Overall Study|Protocol Violation|15
5551166|NCT01240746|19187472|P1|Overall Study|Protocol Violation|24
5551167|NCT01240746|19187470|P3|Overall Study|Lost to Follow-up|102
5551168|NCT01240746|19187471|P2|Overall Study|Lost to Follow-up|20
5551169|NCT01240746|19187472|P1|Overall Study|Lost to Follow-up|23
5551170|NCT01240746|19187470|P3|Overall Study|Adverse Event|10
5551171|NCT01240746|19187471|P2|Overall Study|Adverse Event|0
5551172|NCT01240746|19187472|P1|Overall Study|Adverse Event|2
5551173|NCT01240590|19187527|P5|Phase II|Refused further treatment|1
5551174|NCT01240590|19187528|P4|Phase II|Refused further treatment|2
5551175|NCT01240590|19187529|P3|Phase II|Refused further treatment|0
5551176|NCT01240590|19187530|P2|Phase II|Refused further treatment|0
5551177|NCT01240590|19187531|P1|Phase II|Refused further treatment|0
5551178|NCT01240590|19187527|P5|Phase I|Refused further treatment|0
5551179|NCT01240590|19187528|P4|Phase I|Refused further treatment|0
5551180|NCT01240590|19187529|P3|Phase I|Refused further treatment|3
5551181|NCT01240590|19187530|P2|Phase I|Refused further treatment|0
5551182|NCT01240590|19187531|P1|Phase I|Refused further treatment|0
5551183|NCT01240551|19187559|P2|Overall Study|Lost to Follow-up|1
5551184|NCT01240551|19187560|P1|Overall Study|Lost to Follow-up|1
5551185|NCT01240551|19187559|P2|Overall Study|Refused further treatment|2
5551186|NCT01240551|19187560|P1|Overall Study|Refused further treatment|3
5551187|NCT01240382|19187570|P2|Overall Study|Fear of adverse events|1
5551188|NCT01240382|19187571|P1|Overall Study|Fear of adverse events|0
5551189|NCT01240382|19187570|P2|Overall Study|Lack of Efficacy|2
5551190|NCT01240382|19187571|P1|Overall Study|Lack of Efficacy|0
5551191|NCT01240382|19187570|P2|Overall Study|Adverse Event|1
5551192|NCT01240382|19187571|P1|Overall Study|Adverse Event|2
5551193|NCT01240356|19187581|P2|Overall Study|MRI contraindication|0
5551194|NCT01240356|19187582|P1|Overall Study|MRI contraindication|1
5551195|NCT01240356|19187581|P2|Overall Study|Withdrawal by Subject|0
5551196|NCT01240356|19187582|P1|Overall Study|Withdrawal by Subject|2
5551197|NCT01240200|19187605|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
5551198|NCT01240200|19187606|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
5551199|NCT01240135|19187624|P2|Period Two, 14 Days of Wear|Adverse Event|1
5551200|NCT01240135|19187625|P1|Period Two, 14 Days of Wear|Adverse Event|0
5551201|NCT01240135|19187624|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
5551202|NCT01240135|19187625|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
5551203|NCT01239992|19187642|P1|Overall Study|Withdrawal by Subject|2
5551204|NCT01239797|19187651|P2|Treated Participants|Poor/Non-compliance|1
5551205|NCT01239797|19187652|P1|Treated Participants|Poor/Non-compliance|0
5551206|NCT01239797|19187651|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
5551207|NCT01239797|19187652|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
5551208|NCT01239797|19187651|P2|Treated Participants|Death|1
5551209|NCT01239797|19187652|P1|Treated Participants|Death|1
5551210|NCT01239797|19187651|P2|Treated Participants|Non-specified|11
5551211|NCT01239797|19187652|P1|Treated Participants|Non-specified|1
5551212|NCT01239797|19187651|P2|Treated Participants|Withdrawal by Subject|23
5551213|NCT01239797|19187652|P1|Treated Participants|Withdrawal by Subject|27
5551214|NCT01239797|19187651|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
5551215|NCT01239797|19187652|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
5551216|NCT01239797|19187651|P2|Treated Participants|Study Drug Toxicity|44
5551217|NCT01239797|19187652|P1|Treated Participants|Study Drug Toxicity|30
5551218|NCT01239797|19187651|P2|Treated Participants|Disease Progression|161
5551219|NCT01239797|19187652|P1|Treated Participants|Disease Progression|153
5551220|NCT01239745|19187660|P1|Overall Study|Adverse Event|1
5551221|NCT01239745|19187660|P1|Overall Study|Study terminated by sponsor|45
5551222|NCT01239732|19187671|P1|Overall Study|Other|19
5551223|NCT01239732|19187671|P1|Overall Study|Treatment failure|2
5551224|NCT01239732|19187671|P1|Overall Study|Investigator's decision|4
5551225|NCT01239732|19187671|P1|Overall Study|Study termination by sponsor|2
5551226|NCT01239732|19187671|P1|Overall Study|Participant non compliance|5
5551227|NCT01239732|19187671|P1|Overall Study|Protocol Violation|3
5551228|NCT01239732|19187671|P1|Overall Study|Adverse Event|6
5551229|NCT01239732|19187671|P1|Overall Study|Withdrawal by Subject|87
5551230|NCT01239732|19187671|P1|Overall Study|Death|226
5551231|NCT01239732|19187671|P1|Overall Study|Termination of study per protocol|667
5551232|NCT01239680|19187684|P2|Overall Study|Withdrawal by Subject|0
5551233|NCT01239680|19187685|P1|Overall Study|Withdrawal by Subject|2
5551234|NCT01239472|19187710|P2|Overall Study|Lack of Efficacy|1
5551235|NCT01239472|19187711|P1|Overall Study|Lack of Efficacy|0
5551236|NCT01239472|19187710|P2|Overall Study|Adverse Event|1
5551237|NCT01239472|19187711|P1|Overall Study|Adverse Event|0
5551238|NCT01239472|19187710|P2|Overall Study|Withdrawal by Subject|1
5551239|NCT01239472|19187711|P1|Overall Study|Withdrawal by Subject|5
5551240|NCT01239394|19187719|P1|Overall Study|Adverse Event|1
5551241|NCT01239381|19187726|P1|Overall Study|Withdrawal by Subject|1
5551242|NCT01239381|19187726|P1|Overall Study|Protocol Violation|1
5551243|NCT01239368|19187746|P10|Overall Study|Death|0
5551244|NCT01239368|19187747|P9|Overall Study|Death|0
5551245|NCT01239368|19187748|P8|Overall Study|Death|0
5551246|NCT01239368|19187749|P7|Overall Study|Death|1
5551247|NCT01239368|19187750|P6|Overall Study|Death|0
5551248|NCT01239368|19187751|P5|Overall Study|Death|0
5551249|NCT01239368|19187752|P4|Overall Study|Death|0
5551250|NCT01239368|19187753|P3|Overall Study|Death|0
5551251|NCT01239368|19187754|P2|Overall Study|Death|0
5551252|NCT01239368|19187755|P1|Overall Study|Death|0
5551253|NCT01239368|19187746|P10|Overall Study|Refused further treatment|1
5551254|NCT01239368|19187747|P9|Overall Study|Refused further treatment|0
5551255|NCT01239368|19187748|P8|Overall Study|Refused further treatment|0
5551256|NCT01239368|19187749|P7|Overall Study|Refused further treatment|0
5551257|NCT01239368|19187750|P6|Overall Study|Refused further treatment|0
5551258|NCT01239368|19187751|P5|Overall Study|Refused further treatment|0
5551259|NCT01239368|19187752|P4|Overall Study|Refused further treatment|0
5551260|NCT01239368|19187753|P3|Overall Study|Refused further treatment|0
5551261|NCT01239368|19187754|P2|Overall Study|Refused further treatment|0
5551262|NCT01239368|19187755|P1|Overall Study|Refused further treatment|0
5551263|NCT01239368|19187746|P10|Overall Study|Disease progression on study|2
5551264|NCT01239368|19187747|P9|Overall Study|Disease progression on study|0
5551265|NCT01239368|19187748|P8|Overall Study|Disease progression on study|0
5551266|NCT01239368|19187749|P7|Overall Study|Disease progression on study|5
5551267|NCT01239368|19187750|P6|Overall Study|Disease progression on study|2
5551268|NCT01239368|19187751|P5|Overall Study|Disease progression on study|4
5551269|NCT01239368|19187752|P4|Overall Study|Disease progression on study|1
5551270|NCT01239368|19187753|P3|Overall Study|Disease progression on study|1
5551271|NCT01239368|19187754|P2|Overall Study|Disease progression on study|1
5551272|NCT01239368|19187755|P1|Overall Study|Disease progression on study|1
5551273|NCT01239368|19187746|P10|Overall Study|Principal investigator discretion|1
5551274|NCT01239368|19187747|P9|Overall Study|Principal investigator discretion|0
5551275|NCT01239368|19187748|P8|Overall Study|Principal investigator discretion|0
5551276|NCT01239368|19187749|P7|Overall Study|Principal investigator discretion|0
5551277|NCT01239368|19187750|P6|Overall Study|Principal investigator discretion|2
5551278|NCT01239368|19187751|P5|Overall Study|Principal investigator discretion|1
5551279|NCT01239368|19187752|P4|Overall Study|Principal investigator discretion|0
5551280|NCT01239368|19187753|P3|Overall Study|Principal investigator discretion|0
5551281|NCT01239368|19187754|P2|Overall Study|Principal investigator discretion|0
5551282|NCT01239368|19187755|P1|Overall Study|Principal investigator discretion|1
5551283|NCT01239342|19187807|P2|Overall Study|Reason Unknown|1
5551284|NCT01239342|19187808|P1|Overall Study|Reason Unknown|1
5551285|NCT01239342|19187807|P2|Overall Study|Withdrawal by Subject|5
5551286|NCT01239342|19187808|P1|Overall Study|Withdrawal by Subject|1
5551287|NCT01239342|19187807|P2|Overall Study|Adverse Event|0
5551288|NCT01239342|19187808|P1|Overall Study|Adverse Event|1
5551289|NCT01239316|19187824|P1|Overall Study|Adverse Event|1
5551290|NCT01239316|19187824|P1|Overall Study|Progression/Relapse|11
5551291|NCT01239160|19187838|P3|Overall Study|Early Termination Due to Study Closure|6
5551292|NCT01239160|19187839|P2|Overall Study|Early Termination Due to Study Closure|1
5551293|NCT01239160|19187840|P1|Overall Study|Early Termination Due to Study Closure|0
5551294|NCT01239160|19187838|P3|Overall Study|Physician Decision|2
5551295|NCT01239160|19187839|P2|Overall Study|Physician Decision|7
5551296|NCT01239160|19187840|P1|Overall Study|Physician Decision|5
5551297|NCT01239160|19187838|P3|Overall Study|Withdrawal by Subject|2
5551298|NCT01239160|19187839|P2|Overall Study|Withdrawal by Subject|6
5551299|NCT01239160|19187840|P1|Overall Study|Withdrawal by Subject|17
5551300|NCT01239160|19187838|P3|Overall Study|Lost to Follow-up|0
5551301|NCT01239160|19187839|P2|Overall Study|Lost to Follow-up|5
5551302|NCT01239160|19187840|P1|Overall Study|Lost to Follow-up|3
5551303|NCT01239121|19187853|P3|Overall Study|Withdrawal by Subject|0
5551304|NCT01239121|19187854|P2|Overall Study|Withdrawal by Subject|4
5551305|NCT01239121|19187855|P1|Overall Study|Withdrawal by Subject|2
5551306|NCT01239043|19187877|P2|Overall Study|Protocol Violation|1
5551307|NCT01239043|19187878|P1|Overall Study|Protocol Violation|2
5551308|NCT01238991|19187906|P10|Overall Study|Admission to a nursing home|0
5551309|NCT01238991|19187907|P9|Overall Study|Admission to a nursing home|0
5551310|NCT01238991|19187908|P8|Overall Study|Admission to a nursing home|0
5551311|NCT01238991|19187909|P7|Overall Study|Admission to a nursing home|0
5551312|NCT01238991|19187910|P6|Overall Study|Admission to a nursing home|0
5551313|NCT01238991|19187911|P5|Overall Study|Admission to a nursing home|0
5551314|NCT01238991|19187912|P4|Overall Study|Admission to a nursing home|0
5551315|NCT01238991|19187913|P3|Overall Study|Admission to a nursing home|1
5551316|NCT01238991|19187914|P2|Overall Study|Admission to a nursing home|0
5551317|NCT01238991|19187915|P1|Overall Study|Admission to a nursing home|1
5551318|NCT01238991|19187906|P10|Overall Study|Caregiver's request|0
5551319|NCT01238991|19187907|P9|Overall Study|Caregiver's request|1
5551320|NCT01238991|19187908|P8|Overall Study|Caregiver's request|0
5551321|NCT01238991|19187909|P7|Overall Study|Caregiver's request|0
5551322|NCT01238991|19187910|P6|Overall Study|Caregiver's request|0
5551323|NCT01238991|19187911|P5|Overall Study|Caregiver's request|0
5551324|NCT01238991|19187912|P4|Overall Study|Caregiver's request|0
5551325|NCT01238991|19187913|P3|Overall Study|Caregiver's request|0
5551326|NCT01238991|19187914|P2|Overall Study|Caregiver's request|0
5551327|NCT01238991|19187915|P1|Overall Study|Caregiver's request|0
5551328|NCT01238991|19187906|P10|Overall Study|Study Terminated by Sponsor|2
5551329|NCT01238991|19187907|P9|Overall Study|Study Terminated by Sponsor|2
5551330|NCT01238991|19187908|P8|Overall Study|Study Terminated by Sponsor|4
5551331|NCT01238991|19187909|P7|Overall Study|Study Terminated by Sponsor|7
5551332|NCT01238991|19187910|P6|Overall Study|Study Terminated by Sponsor|0
5551333|NCT01238991|19187911|P5|Overall Study|Study Terminated by Sponsor|1
5551334|NCT01238991|19187912|P4|Overall Study|Study Terminated by Sponsor|0
5551335|NCT01238991|19187913|P3|Overall Study|Study Terminated by Sponsor|0
5551336|NCT01238991|19187914|P2|Overall Study|Study Terminated by Sponsor|0
5551337|NCT01238991|19187915|P1|Overall Study|Study Terminated by Sponsor|0
5551338|NCT01238991|19187906|P10|Overall Study|Withdrawal by Subject|0
5551339|NCT01238991|19187907|P9|Overall Study|Withdrawal by Subject|0
5551340|NCT01238991|19187908|P8|Overall Study|Withdrawal by Subject|0
5551341|NCT01238991|19187909|P7|Overall Study|Withdrawal by Subject|0
5551342|NCT01238991|19187910|P6|Overall Study|Withdrawal by Subject|0
5551343|NCT01238991|19187911|P5|Overall Study|Withdrawal by Subject|0
5551344|NCT01238991|19187912|P4|Overall Study|Withdrawal by Subject|0
5551345|NCT01238991|19187913|P3|Overall Study|Withdrawal by Subject|1
5551346|NCT01238991|19187914|P2|Overall Study|Withdrawal by Subject|0
5551347|NCT01238991|19187915|P1|Overall Study|Withdrawal by Subject|0
5551348|NCT01238991|19187906|P10|Overall Study|Lack of Efficacy|0
5551349|NCT01238991|19187907|P9|Overall Study|Lack of Efficacy|1
5551350|NCT01238991|19187908|P8|Overall Study|Lack of Efficacy|0
5551351|NCT01238991|19187909|P7|Overall Study|Lack of Efficacy|0
5551352|NCT01238991|19187910|P6|Overall Study|Lack of Efficacy|0
5551353|NCT01238991|19187911|P5|Overall Study|Lack of Efficacy|0
5551354|NCT01238991|19187912|P4|Overall Study|Lack of Efficacy|0
5551355|NCT01238991|19187913|P3|Overall Study|Lack of Efficacy|1
5551356|NCT01238991|19187914|P2|Overall Study|Lack of Efficacy|0
5551357|NCT01238991|19187915|P1|Overall Study|Lack of Efficacy|0
5551358|NCT01238991|19187906|P10|Overall Study|Death|0
5551359|NCT01238991|19187907|P9|Overall Study|Death|0
5551360|NCT01238991|19187908|P8|Overall Study|Death|0
5551361|NCT01238991|19187909|P7|Overall Study|Death|0
5551362|NCT01238991|19187910|P6|Overall Study|Death|0
5551363|NCT01238991|19187911|P5|Overall Study|Death|0
5551364|NCT01238991|19187912|P4|Overall Study|Death|1
5551365|NCT01238991|19187913|P3|Overall Study|Death|0
5551366|NCT01238991|19187914|P2|Overall Study|Death|0
5551367|NCT01238991|19187915|P1|Overall Study|Death|0
5551368|NCT01238991|19187906|P10|Overall Study|Adverse Event|0
5551369|NCT01238991|19187907|P9|Overall Study|Adverse Event|0
5551370|NCT01238991|19187908|P8|Overall Study|Adverse Event|1
5551371|NCT01238991|19187909|P7|Overall Study|Adverse Event|1
5551372|NCT01238991|19187910|P6|Overall Study|Adverse Event|0
5551373|NCT01238991|19187911|P5|Overall Study|Adverse Event|1
5551374|NCT01238991|19187912|P4|Overall Study|Adverse Event|1
5551375|NCT01238991|19187913|P3|Overall Study|Adverse Event|3
5551376|NCT01238991|19187914|P2|Overall Study|Adverse Event|0
5551377|NCT01238991|19187915|P1|Overall Study|Adverse Event|1
5551378|NCT01238900|19188002|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
5551379|NCT01238900|19188002|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
5551380|NCT01238861|19188016|P6|Overall Study|Withdrawal by Subject|9
5551381|NCT01238861|19188017|P5|Overall Study|Withdrawal by Subject|10
5551382|NCT01238861|19188018|P4|Overall Study|Withdrawal by Subject|8
5551383|NCT01238861|19188019|P3|Overall Study|Withdrawal by Subject|4
5551384|NCT01238861|19188020|P2|Overall Study|Withdrawal by Subject|5
5551385|NCT01238861|19188021|P1|Overall Study|Withdrawal by Subject|6
5551386|NCT01238861|19188016|P6|Overall Study|Adverse Event|0
5551387|NCT01238861|19188017|P5|Overall Study|Adverse Event|0
5551388|NCT01238861|19188018|P4|Overall Study|Adverse Event|0
5551389|NCT01238861|19188019|P3|Overall Study|Adverse Event|0
5551390|NCT01238861|19188020|P2|Overall Study|Adverse Event|1
5551391|NCT01238861|19188021|P1|Overall Study|Adverse Event|0
5551392|NCT01238861|19188016|P6|Overall Study|Lack of compliance|1
5551393|NCT01238861|19188017|P5|Overall Study|Lack of compliance|0
5551394|NCT01238861|19188018|P4|Overall Study|Lack of compliance|0
5551395|NCT01238861|19188019|P3|Overall Study|Lack of compliance|0
5551396|NCT01238861|19188020|P2|Overall Study|Lack of compliance|0
5551397|NCT01238861|19188021|P1|Overall Study|Lack of compliance|0
5551398|NCT01238861|19188016|P6|Overall Study|Serious adverse event|1
5551399|NCT01238861|19188017|P5|Overall Study|Serious adverse event|0
5551400|NCT01238861|19188018|P4|Overall Study|Serious adverse event|0
5551401|NCT01238861|19188019|P3|Overall Study|Serious adverse event|0
5551402|NCT01238861|19188020|P2|Overall Study|Serious adverse event|0
5551403|NCT01238861|19188021|P1|Overall Study|Serious adverse event|0
5551404|NCT01238861|19188016|P6|Overall Study|Unable to continue visits|1
5551405|NCT01238861|19188017|P5|Overall Study|Unable to continue visits|0
5551406|NCT01238861|19188018|P4|Overall Study|Unable to continue visits|1
5551407|NCT01238861|19188019|P3|Overall Study|Unable to continue visits|0
5551408|NCT01238861|19188020|P2|Overall Study|Unable to continue visits|0
5551409|NCT01238861|19188021|P1|Overall Study|Unable to continue visits|0
5551410|NCT01238861|19188016|P6|Overall Study|Personal problems|0
5551411|NCT01238861|19188017|P5|Overall Study|Personal problems|0
5551412|NCT01238861|19188018|P4|Overall Study|Personal problems|1
5551413|NCT01238861|19188019|P3|Overall Study|Personal problems|0
5551414|NCT01238861|19188020|P2|Overall Study|Personal problems|0
5551415|NCT01238861|19188021|P1|Overall Study|Personal problems|0
5551416|NCT01238861|19188016|P6|Overall Study|Strongyloides stercoralis antibodies +|0
5551417|NCT01238861|19188017|P5|Overall Study|Strongyloides stercoralis antibodies +|0
5551418|NCT01238861|19188018|P4|Overall Study|Strongyloides stercoralis antibodies +|1
5551419|NCT01238861|19188019|P3|Overall Study|Strongyloides stercoralis antibodies +|0
5551420|NCT01238861|19188020|P2|Overall Study|Strongyloides stercoralis antibodies +|0
5551421|NCT01238861|19188021|P1|Overall Study|Strongyloides stercoralis antibodies +|0
5551422|NCT01238861|19188016|P6|Overall Study|Subject moved out of state/area|0
5551423|NCT01238861|19188017|P5|Overall Study|Subject moved out of state/area|0
5551424|NCT01238861|19188018|P4|Overall Study|Subject moved out of state/area|1
5551425|NCT01238861|19188019|P3|Overall Study|Subject moved out of state/area|1
5551426|NCT01238861|19188020|P2|Overall Study|Subject moved out of state/area|0
5551427|NCT01238861|19188021|P1|Overall Study|Subject moved out of state/area|0
5551428|NCT01238861|19188016|P6|Overall Study|Subject traveled to Argentina by 1 year|0
5551429|NCT01238861|19188017|P5|Overall Study|Subject traveled to Argentina by 1 year|0
5551430|NCT01238861|19188018|P4|Overall Study|Subject traveled to Argentina by 1 year|0
5551431|NCT01238861|19188019|P3|Overall Study|Subject traveled to Argentina by 1 year|1
5551432|NCT01238861|19188020|P2|Overall Study|Subject traveled to Argentina by 1 year|0
5551433|NCT01238861|19188021|P1|Overall Study|Subject traveled to Argentina by 1 year|0
5551434|NCT01238861|19188016|P6|Overall Study|Incorrect enrollment/randomization|0
5551435|NCT01238861|19188017|P5|Overall Study|Incorrect enrollment/randomization|1
5551436|NCT01238861|19188018|P4|Overall Study|Incorrect enrollment/randomization|0
5551437|NCT01238861|19188019|P3|Overall Study|Incorrect enrollment/randomization|1
5551438|NCT01238861|19188020|P2|Overall Study|Incorrect enrollment/randomization|0
5551439|NCT01238861|19188021|P1|Overall Study|Incorrect enrollment/randomization|0
5551440|NCT01238861|19188016|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
5551441|NCT01238861|19188017|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
5551442|NCT01238861|19188018|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
5551443|NCT01238861|19188019|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
5551444|NCT01238861|19188020|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
5551445|NCT01238861|19188021|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
5551446|NCT01238861|19188016|P6|Overall Study|Unplanned surgery|0
5551447|NCT01238861|19188017|P5|Overall Study|Unplanned surgery|0
5551448|NCT01238861|19188018|P4|Overall Study|Unplanned surgery|0
5551449|NCT01238861|19188019|P3|Overall Study|Unplanned surgery|0
5551450|NCT01238861|19188020|P2|Overall Study|Unplanned surgery|0
5551451|NCT01238861|19188021|P1|Overall Study|Unplanned surgery|1
5551452|NCT01238861|19188016|P6|Overall Study|Lost to Follow-up|2
5551453|NCT01238861|19188017|P5|Overall Study|Lost to Follow-up|1
5551454|NCT01238861|19188018|P4|Overall Study|Lost to Follow-up|1
5551455|NCT01238861|19188019|P3|Overall Study|Lost to Follow-up|3
5551456|NCT01238861|19188020|P2|Overall Study|Lost to Follow-up|2
5551457|NCT01238861|19188021|P1|Overall Study|Lost to Follow-up|4
5551458|NCT01238848|19188101|P2|Overall Study|Physician Decision|5
5551459|NCT01238848|19188102|P1|Overall Study|Physician Decision|13
5551460|NCT01238835|19188110|P1|Overall Study|Site early discontinuation|2
5551461|NCT01238835|19188110|P1|Overall Study|Lost to Follow-up|1
5551462|NCT01238835|19188110|P1|Overall Study|Withdrawal by Subject|9
5551463|NCT01238835|19188110|P1|Overall Study|Death|124
5551464|NCT01238822|19188115|P1|Overall Study|COULD NOT SWALLOW PILLS|3
5551465|NCT01238588|19188142|P1|Overall Study|Physician Decision|2
5551466|NCT01238588|19188142|P1|Overall Study|Withdrawal by Subject|1
5551467|NCT01238575|19188155|P2|Overall Study|Adverse Event|0
5551468|NCT01238575|19188156|P1|Overall Study|Adverse Event|2
5551469|NCT01238575|19188155|P2|Overall Study|Lack of Efficacy|4
5551470|NCT01238575|19188156|P1|Overall Study|Lack of Efficacy|2
5551471|NCT01238211|19188240|P1|Overall Study|Investigator/Patient Decision|3
5551472|NCT01238211|19188240|P1|Overall Study|Non-protocol treatment|4
5551473|NCT01238211|19188240|P1|Overall Study|Withdrawal by Subject|7
5551474|NCT01238211|19188240|P1|Overall Study|Relapse/Progression|2
5551475|NCT01238211|19188240|P1|Overall Study|Death|4
5551476|NCT01238211|19188240|P1|Overall Study|Adverse Event|7
5551477|NCT01238211|19188240|P1|Overall Study|Continues active treatment|31
5551478|NCT01238172|19188246|P2|Overall Study|Ineligible: based on Central Path Review|19
5551479|NCT01238172|19188247|P1|Overall Study|Ineligible: based on Central Path Review|9
5551480|NCT01238172|19188246|P2|Overall Study|Ineligible: based on Eligibility Review|5
5551481|NCT01238172|19188247|P1|Overall Study|Ineligible: based on Eligibility Review|2
5551482|NCT01237951|19188259|P1|Overall Study|Death|1
5551483|NCT01237899|19188277|P11|Washout Period of at Least 7 Days|Adverse Event|0
5551484|NCT01237899|19188278|P10|Washout Period of at Least 7 Days|Adverse Event|0
5551485|NCT01237899|19188279|P9|Washout Period of at Least 7 Days|Adverse Event|0
5551486|NCT01237899|19188280|P8|Washout Period of at Least 7 Days|Adverse Event|0
5551487|NCT01237899|19188281|P7|Washout Period of at Least 7 Days|Adverse Event|0
5551488|NCT01237899|19188282|P6|Washout Period of at Least 7 Days|Adverse Event|0
5551489|NCT01237899|19188283|P5|Washout Period of at Least 7 Days|Adverse Event|0
5551490|NCT01237899|19188284|P4|Washout Period of at Least 7 Days|Adverse Event|0
5551491|NCT01237899|19188285|P3|Washout Period of at Least 7 Days|Adverse Event|1
5551492|NCT01237899|19188286|P2|Washout Period of at Least 7 Days|Adverse Event|0
5551493|NCT01237899|19188287|P1|Washout Period of at Least 7 Days|Adverse Event|0
5551494|NCT01237678|19188367|P3|Phase II|Randomized but were not treated|3
5551495|NCT01237678|19188368|P2|Phase II|Randomized but were not treated|4
5551496|NCT01237678|19188369|P1|Phase II|Randomized but were not treated|0
5551497|NCT01237678|19188367|P3|Phase II|Sponsor Decision/Study Closed|7
5551498|NCT01237678|19188368|P2|Phase II|Sponsor Decision/Study Closed|18
5551499|NCT01237678|19188369|P1|Phase II|Sponsor Decision/Study Closed|0
5551500|NCT01237678|19188367|P3|Phase II|Completed Cycles 4-6|21
5551501|NCT01237678|19188368|P2|Phase II|Completed Cycles 4-6|11
5551502|NCT01237678|19188369|P1|Phase II|Completed Cycles 4-6|0
5551503|NCT01237678|19188367|P3|Phase II|Withdrawal by Subject|5
5551504|NCT01237678|19188368|P2|Phase II|Withdrawal by Subject|1
5551505|NCT01237678|19188369|P1|Phase II|Withdrawal by Subject|0
5551506|NCT01237678|19188367|P3|Phase II|Lack of Efficacy|3
5551507|NCT01237678|19188368|P2|Phase II|Lack of Efficacy|25
5551508|NCT01237678|19188369|P1|Phase II|Lack of Efficacy|0
5551509|NCT01237678|19188367|P3|Phase II|Death|2
5551510|NCT01237678|19188368|P2|Phase II|Death|0
5551511|NCT01237678|19188369|P1|Phase II|Death|0
5551512|NCT01237678|19188367|P3|Phase II|Adverse Event|9
5551513|NCT01237678|19188368|P2|Phase II|Adverse Event|39
5551514|NCT01237678|19188369|P1|Phase II|Adverse Event|0
5551515|NCT01237678|19188367|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
5551516|NCT01237678|19188368|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
5551517|NCT01237678|19188369|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
5551518|NCT01237678|19188367|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
5551519|NCT01237678|19188368|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
5551520|NCT01237678|19188369|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
5551521|NCT01237678|19188367|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
5551522|NCT01237678|19188368|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
5551523|NCT01237678|19188369|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
5551524|NCT01237678|19188367|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
5551525|NCT01237678|19188368|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
5551526|NCT01237678|19188369|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
5551527|NCT01237587|19188414|P2|Taper Phase|Withdrawal by Subject|1
5551528|NCT01237587|19188415|P1|Taper Phase|Withdrawal by Subject|0
5551529|NCT01237587|19188414|P2|Taper Phase|Sponsor Decision|0
5551530|NCT01237587|19188415|P1|Taper Phase|Sponsor Decision|1
5551531|NCT01237587|19188414|P2|Taper Phase|Parent/Guardian Decision|2
5551532|NCT01237587|19188415|P1|Taper Phase|Parent/Guardian Decision|0
5551533|NCT01237587|19188414|P2|Taper Phase|Lack of Efficacy|5
5551534|NCT01237587|19188415|P1|Taper Phase|Lack of Efficacy|2
5551535|NCT01237587|19188414|P2|Taper Phase|Protocol Violation|0
5551536|NCT01237587|19188415|P1|Taper Phase|Protocol Violation|2
5551537|NCT01237587|19188414|P2|Taper Phase|Adverse Event|2
5551538|NCT01237587|19188415|P1|Taper Phase|Adverse Event|0
5551539|NCT01237587|19188414|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
5551540|NCT01237587|19188415|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
5551541|NCT01237587|19188414|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
5551542|NCT01237587|19188415|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
5551543|NCT01237587|19188414|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
5551544|NCT01237587|19188415|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
5551545|NCT01237587|19188414|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
5551546|NCT01237587|19188415|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
5551547|NCT01237587|19188414|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
5551548|NCT01237587|19188415|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
5551549|NCT01237587|19188414|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
5551550|NCT01237587|19188415|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
5551551|NCT01237587|19188414|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
5551552|NCT01237587|19188415|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
5551553|NCT01237587|19188414|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
5551554|NCT01237587|19188415|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
5551555|NCT01237587|19188414|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
5551556|NCT01237587|19188415|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
5551557|NCT01237587|19188414|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
5551558|NCT01237587|19188415|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
5551559|NCT01237587|19188414|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
5551560|NCT01237587|19188415|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
5551561|NCT01237587|19188414|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
5551562|NCT01237587|19188415|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
5551563|NCT01237587|19188414|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
5551564|NCT01237587|19188415|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
5551565|NCT01237340|19188467|P1|Overall Study|Early termination of the trial|36
5551566|NCT01237340|19188467|P1|Overall Study|Withdrawal by Subject|1
5551567|NCT01237340|19188467|P1|Overall Study|Adverse Event|3
5551568|NCT01237327|19188481|P2|Overall Study|Lost to Follow-up|0
5551569|NCT01237327|19188482|P1|Overall Study|Lost to Follow-up|3
5551570|NCT01237327|19188481|P2|Overall Study|Withdrawal by Subject|3
5551571|NCT01237327|19188482|P1|Overall Study|Withdrawal by Subject|1
5551572|NCT01237327|19188481|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
5551573|NCT01237327|19188482|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
5551574|NCT01237327|19188481|P2|Overall Study|Progression of Disease: Extension Study|13
5551575|NCT01237327|19188482|P1|Overall Study|Progression of Disease: Extension Study|15
5551576|NCT01237327|19188481|P2|Overall Study|Progression of Disease: Core Study|22
5551577|NCT01237327|19188482|P1|Overall Study|Progression of Disease: Core Study|18
5551578|NCT01237327|19188481|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
5551579|NCT01237327|19188482|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
5551580|NCT01237327|19188481|P2|Overall Study|Protocol Violation: Core Study|0
5551581|NCT01237327|19188482|P1|Overall Study|Protocol Violation: Core Study|1
5551582|NCT01237223|19188517|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5551583|NCT01237223|19188518|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5551584|NCT01237223|19188519|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
5551585|NCT01237223|19188520|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5551586|NCT01237223|19188521|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
5551587|NCT01237223|19188522|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
5551588|NCT01237223|19188517|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
5551589|NCT01237223|19188518|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5551590|NCT01237223|19188519|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5551591|NCT01237223|19188520|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5551592|NCT01237223|19188521|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5551593|NCT01237223|19188522|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
5551594|NCT01237223|19188517|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
5551595|NCT01237223|19188518|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
5551596|NCT01237223|19188519|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
5551597|NCT01237223|19188520|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
5551598|NCT01237223|19188521|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
5551599|NCT01237223|19188522|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
5551600|NCT01237223|19188517|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
5551601|NCT01237223|19188518|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
5551602|NCT01237223|19188519|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
5551603|NCT01237223|19188520|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
5551604|NCT01237223|19188521|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
5551605|NCT01237223|19188522|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
5551606|NCT01237223|19188517|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
5551607|NCT01237223|19188518|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
5551608|NCT01237223|19188519|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
5551609|NCT01237223|19188520|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
5551610|NCT01237223|19188521|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
5551611|NCT01237223|19188522|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
5551612|NCT01237223|19188517|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5551613|NCT01237223|19188518|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5551614|NCT01237223|19188519|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5551615|NCT01237223|19188520|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5551616|NCT01237223|19188521|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
5551617|NCT01237223|19188522|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
5551618|NCT01237223|19188517|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5551619|NCT01237223|19188518|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5551620|NCT01237223|19188519|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5551621|NCT01237223|19188520|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5551622|NCT01237223|19188521|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
5551623|NCT01237223|19188522|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
5551624|NCT01237223|19188517|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5551625|NCT01237223|19188518|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5551626|NCT01237223|19188519|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5551627|NCT01237223|19188520|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5551628|NCT01237223|19188521|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
5551629|NCT01237223|19188522|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
5551630|NCT01237223|19188517|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5551631|NCT01237223|19188518|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5551632|NCT01237223|19188519|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5551633|NCT01237223|19188520|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5551634|NCT01237223|19188521|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
5551635|NCT01237223|19188522|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
5551636|NCT01237223|19188517|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5551637|NCT01237223|19188518|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5551638|NCT01237223|19188519|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5551639|NCT01237223|19188520|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5551640|NCT01237223|19188521|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
5551641|NCT01237223|19188522|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
5551642|NCT01237054|19188581|P1|Overall Study|imaging 10C0096|1
5551643|NCT01236755|19188650|P1|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
5551644|NCT01236755|19188650|P1|Orthokeratology Wearing Phase|Withdrawal by Subject|5
5551645|NCT01236755|19188650|P1|Spectacles Wearing Phase|Lost to Follow-up|9
5551646|NCT01236755|19188650|P1|Spectacles Wearing Phase|Withdrawal by Subject|8
5551647|NCT01236534|19188673|P2|Overall Study|Adverse Event|0
5551648|NCT01236534|19188674|P1|Overall Study|Adverse Event|3
5551649|NCT01236365|19188692|P2|Overall Study|Dropped at Randomization due to high LFT|0
5551650|NCT01236365|19188693|P1|Overall Study|Dropped at Randomization due to high LFT|1
5551651|NCT01236365|19188692|P2|Overall Study|Moved Out of State|0
5551652|NCT01236365|19188693|P1|Overall Study|Moved Out of State|1
5551653|NCT01236365|19188692|P2|Overall Study|Lost to Follow-up|2
5551654|NCT01236365|19188693|P1|Overall Study|Lost to Follow-up|0
5551655|NCT01236339|19188717|P2|Overall Study|Termination of study by sponsor|13
5551656|NCT01236339|19188718|P1|Overall Study|Termination of study by sponsor|11
5551657|NCT01235793|19188747|P1|Overall Study|Death|6
5551658|NCT01236573|19188763|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
5551659|NCT01236573|19188764|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551660|NCT01236573|19188765|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551661|NCT01236573|19188766|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551662|NCT01236573|19188767|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551663|NCT01236573|19188768|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551664|NCT01236573|19188769|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551665|NCT01236573|19188770|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551666|NCT01236573|19188771|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551667|NCT01236573|19188772|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551668|NCT01236573|19188773|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
5551669|NCT01236573|19188763|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551670|NCT01236573|19188764|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551671|NCT01236573|19188765|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
5551672|NCT01236573|19188766|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551673|NCT01236573|19188767|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551674|NCT01236573|19188768|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551675|NCT01236573|19188769|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551676|NCT01236573|19188770|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551677|NCT01236573|19188771|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551678|NCT01236573|19188772|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551679|NCT01236573|19188773|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
5551680|NCT01236573|19188763|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5551681|NCT01236573|19188764|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
5551682|NCT01236573|19188765|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
5551683|NCT01236573|19188766|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5551684|NCT01236573|19188767|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
5551685|NCT01236573|19188768|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5551686|NCT01236573|19188769|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5551687|NCT01236573|19188770|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5551688|NCT01236573|19188771|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5551689|NCT01236573|19188772|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5551690|NCT01236573|19188773|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
5551691|NCT01236560|19188815|P6|Overall Study|Progressive disease|0
5551692|NCT01236560|19188816|P5|Overall Study|Progressive disease|0
5551693|NCT01236560|19188817|P4|Overall Study|Progressive disease|16
5551694|NCT01236560|19188818|P3|Overall Study|Progressive disease|9
5551695|NCT01236560|19188819|P2|Overall Study|Progressive disease|19
5551696|NCT01236560|19188820|P1|Overall Study|Progressive disease|5
5551697|NCT01236560|19188815|P6|Overall Study|Withdrawal by Subject|0
5551698|NCT01236560|19188816|P5|Overall Study|Withdrawal by Subject|0
5551699|NCT01236560|19188817|P4|Overall Study|Withdrawal by Subject|2
5551700|NCT01236560|19188818|P3|Overall Study|Withdrawal by Subject|1
5551701|NCT01236560|19188819|P2|Overall Study|Withdrawal by Subject|0
5551702|NCT01236560|19188820|P1|Overall Study|Withdrawal by Subject|0
5551703|NCT01236560|19188815|P6|Overall Study|Physician Decision|0
5551704|NCT01236560|19188816|P5|Overall Study|Physician Decision|0
5551705|NCT01236560|19188817|P4|Overall Study|Physician Decision|0
5551706|NCT01236560|19188818|P3|Overall Study|Physician Decision|8
5551707|NCT01236560|19188819|P2|Overall Study|Physician Decision|1
5551708|NCT01236560|19188820|P1|Overall Study|Physician Decision|0
5551709|NCT01236560|19188815|P6|Overall Study|Lost to Follow-up|0
5551710|NCT01236560|19188816|P5|Overall Study|Lost to Follow-up|0
5551711|NCT01236560|19188817|P4|Overall Study|Lost to Follow-up|0
5551712|NCT01236560|19188818|P3|Overall Study|Lost to Follow-up|1
5551713|NCT01236560|19188819|P2|Overall Study|Lost to Follow-up|1
5551714|NCT01236560|19188820|P1|Overall Study|Lost to Follow-up|0
5551715|NCT01236560|19188815|P6|Overall Study|Death|0
5551716|NCT01236560|19188816|P5|Overall Study|Death|0
5551717|NCT01236560|19188817|P4|Overall Study|Death|1
5551718|NCT01236560|19188818|P3|Overall Study|Death|0
5551719|NCT01236560|19188819|P2|Overall Study|Death|1
5551720|NCT01236560|19188820|P1|Overall Study|Death|0
5551721|NCT01236560|19188815|P6|Overall Study|Adverse Event|0
5551722|NCT01236560|19188816|P5|Overall Study|Adverse Event|0
5551723|NCT01236560|19188817|P4|Overall Study|Adverse Event|3
5551724|NCT01236560|19188818|P3|Overall Study|Adverse Event|1
5551725|NCT01236560|19188819|P2|Overall Study|Adverse Event|2
5551726|NCT01236560|19188820|P1|Overall Study|Adverse Event|0
5551727|NCT01236521|19188841|P2|Overall Study|Lost to Follow-up|7
5551728|NCT01236521|19188842|P1|Overall Study|Lost to Follow-up|7
5551729|NCT01236521|19188841|P2|Overall Study|Death|1
5551730|NCT01236521|19188842|P1|Overall Study|Death|2
5551731|NCT01236521|19188841|P2|Overall Study|Withdrawal by Subject|17
5551732|NCT01236521|19188842|P1|Overall Study|Withdrawal by Subject|12
5551733|NCT01236352|19188893|P11|Overall Study|Patient transferred to IST|6
5551734|NCT01236352|19188894|P10|Overall Study|Patient transferred to IST|2
5551735|NCT01236352|19188895|P9|Overall Study|Patient transferred to IST|0
5551736|NCT01236352|19188896|P8|Overall Study|Patient transferred to IST|0
5551737|NCT01236352|19188897|P7|Overall Study|Patient transferred to IST|0
5551738|NCT01236352|19188898|P6|Overall Study|Patient transferred to IST|0
5551739|NCT01236352|19188899|P5|Overall Study|Patient transferred to IST|0
5551740|NCT01236352|19188900|P4|Overall Study|Patient transferred to IST|0
5551741|NCT01236352|19188901|P3|Overall Study|Patient transferred to IST|0
5551742|NCT01236352|19188902|P2|Overall Study|Patient transferred to IST|0
5551743|NCT01236352|19188903|P1|Overall Study|Patient transferred to IST|0
5551744|NCT01236352|19188893|P11|Overall Study|Lack of response to drug|1
5551745|NCT01236352|19188894|P10|Overall Study|Lack of response to drug|1
5551746|NCT01236352|19188895|P9|Overall Study|Lack of response to drug|0
5551747|NCT01236352|19188896|P8|Overall Study|Lack of response to drug|0
5551748|NCT01236352|19188897|P7|Overall Study|Lack of response to drug|0
5551749|NCT01236352|19188898|P6|Overall Study|Lack of response to drug|0
5551750|NCT01236352|19188899|P5|Overall Study|Lack of response to drug|0
5551751|NCT01236352|19188900|P4|Overall Study|Lack of response to drug|0
5551752|NCT01236352|19188901|P3|Overall Study|Lack of response to drug|0
5551753|NCT01236352|19188902|P2|Overall Study|Lack of response to drug|0
5551754|NCT01236352|19188903|P1|Overall Study|Lack of response to drug|0
5551755|NCT01236352|19188893|P11|Overall Study|Relapse of Splenomegaly and symptoms|1
5551756|NCT01236352|19188894|P10|Overall Study|Relapse of Splenomegaly and symptoms|0
5551757|NCT01236352|19188895|P9|Overall Study|Relapse of Splenomegaly and symptoms|0
5551758|NCT01236352|19188896|P8|Overall Study|Relapse of Splenomegaly and symptoms|0
5551759|NCT01236352|19188897|P7|Overall Study|Relapse of Splenomegaly and symptoms|0
5551760|NCT01236352|19188898|P6|Overall Study|Relapse of Splenomegaly and symptoms|0
5551761|NCT01236352|19188899|P5|Overall Study|Relapse of Splenomegaly and symptoms|0
5551762|NCT01236352|19188900|P4|Overall Study|Relapse of Splenomegaly and symptoms|0
5551763|NCT01236352|19188901|P3|Overall Study|Relapse of Splenomegaly and symptoms|0
5551764|NCT01236352|19188902|P2|Overall Study|Relapse of Splenomegaly and symptoms|0
5551765|NCT01236352|19188903|P1|Overall Study|Relapse of Splenomegaly and symptoms|0
5551766|NCT01236352|19188893|P11|Overall Study|Patient moving to allogeneic transplant|0
5551767|NCT01236352|19188894|P10|Overall Study|Patient moving to allogeneic transplant|0
5551768|NCT01236352|19188895|P9|Overall Study|Patient moving to allogeneic transplant|0
5551769|NCT01236352|19188896|P8|Overall Study|Patient moving to allogeneic transplant|0
5551770|NCT01236352|19188897|P7|Overall Study|Patient moving to allogeneic transplant|1
5551771|NCT01236352|19188898|P6|Overall Study|Patient moving to allogeneic transplant|0
5551772|NCT01236352|19188899|P5|Overall Study|Patient moving to allogeneic transplant|0
5551773|NCT01236352|19188900|P4|Overall Study|Patient moving to allogeneic transplant|0
5551774|NCT01236352|19188901|P3|Overall Study|Patient moving to allogeneic transplant|0
5551775|NCT01236352|19188902|P2|Overall Study|Patient moving to allogeneic transplant|0
5551776|NCT01236352|19188903|P1|Overall Study|Patient moving to allogeneic transplant|0
5551777|NCT01236352|19188893|P11|Overall Study|Subject to receive drug via EAP|0
5551778|NCT01236352|19188894|P10|Overall Study|Subject to receive drug via EAP|4
5551779|NCT01236352|19188895|P9|Overall Study|Subject to receive drug via EAP|0
5551780|NCT01236352|19188896|P8|Overall Study|Subject to receive drug via EAP|2
5551781|NCT01236352|19188897|P7|Overall Study|Subject to receive drug via EAP|0
5551782|NCT01236352|19188898|P6|Overall Study|Subject to receive drug via EAP|0
5551783|NCT01236352|19188899|P5|Overall Study|Subject to receive drug via EAP|0
5551784|NCT01236352|19188900|P4|Overall Study|Subject to receive drug via EAP|0
5551785|NCT01236352|19188901|P3|Overall Study|Subject to receive drug via EAP|1
5551786|NCT01236352|19188902|P2|Overall Study|Subject to receive drug via EAP|1
5551787|NCT01236352|19188903|P1|Overall Study|Subject to receive drug via EAP|1
5551788|NCT01236352|19188893|P11|Overall Study|Subject request to discontinue treatment|4
5551789|NCT01236352|19188894|P10|Overall Study|Subject request to discontinue treatment|1
5551790|NCT01236352|19188895|P9|Overall Study|Subject request to discontinue treatment|0
5551791|NCT01236352|19188896|P8|Overall Study|Subject request to discontinue treatment|0
5551792|NCT01236352|19188897|P7|Overall Study|Subject request to discontinue treatment|0
5551793|NCT01236352|19188898|P6|Overall Study|Subject request to discontinue treatment|1
5551794|NCT01236352|19188899|P5|Overall Study|Subject request to discontinue treatment|0
5551795|NCT01236352|19188900|P4|Overall Study|Subject request to discontinue treatment|1
5551796|NCT01236352|19188901|P3|Overall Study|Subject request to discontinue treatment|1
5551797|NCT01236352|19188902|P2|Overall Study|Subject request to discontinue treatment|0
5551798|NCT01236352|19188903|P1|Overall Study|Subject request to discontinue treatment|0
5551799|NCT01236352|19188893|P11|Overall Study|Maximum clinical benefit|2
5551800|NCT01236352|19188894|P10|Overall Study|Maximum clinical benefit|4
5551801|NCT01236352|19188895|P9|Overall Study|Maximum clinical benefit|1
5551802|NCT01236352|19188896|P8|Overall Study|Maximum clinical benefit|1
5551803|NCT01236352|19188897|P7|Overall Study|Maximum clinical benefit|3
5551804|NCT01236352|19188898|P6|Overall Study|Maximum clinical benefit|0
5551805|NCT01236352|19188899|P5|Overall Study|Maximum clinical benefit|2
5551806|NCT01236352|19188900|P4|Overall Study|Maximum clinical benefit|0
5551807|NCT01236352|19188901|P3|Overall Study|Maximum clinical benefit|1
5551808|NCT01236352|19188902|P2|Overall Study|Maximum clinical benefit|1
5551809|NCT01236352|19188903|P1|Overall Study|Maximum clinical benefit|1
5551810|NCT01236352|19188893|P11|Overall Study|Poor/Non-compliance|0
5551811|NCT01236352|19188894|P10|Overall Study|Poor/Non-compliance|0
5551812|NCT01236352|19188895|P9|Overall Study|Poor/Non-compliance|0
5551813|NCT01236352|19188896|P8|Overall Study|Poor/Non-compliance|0
5551814|NCT01236352|19188897|P7|Overall Study|Poor/Non-compliance|0
5551815|NCT01236352|19188898|P6|Overall Study|Poor/Non-compliance|0
5551816|NCT01236352|19188899|P5|Overall Study|Poor/Non-compliance|0
5551817|NCT01236352|19188900|P4|Overall Study|Poor/Non-compliance|0
5551818|NCT01236352|19188901|P3|Overall Study|Poor/Non-compliance|0
5551819|NCT01236352|19188902|P2|Overall Study|Poor/Non-compliance|0
5551820|NCT01236352|19188903|P1|Overall Study|Poor/Non-compliance|1
5551821|NCT01236352|19188893|P11|Overall Study|Disease progression|2
5551822|NCT01236352|19188894|P10|Overall Study|Disease progression|2
5551823|NCT01236352|19188895|P9|Overall Study|Disease progression|2
5551824|NCT01236352|19188896|P8|Overall Study|Disease progression|3
5551825|NCT01236352|19188897|P7|Overall Study|Disease progression|1
5551826|NCT01236352|19188898|P6|Overall Study|Disease progression|2
5551827|NCT01236352|19188899|P5|Overall Study|Disease progression|2
5551828|NCT01236352|19188900|P4|Overall Study|Disease progression|2
5551829|NCT01236352|19188901|P3|Overall Study|Disease progression|1
5551830|NCT01236352|19188902|P2|Overall Study|Disease progression|2
5551831|NCT01236352|19188903|P1|Overall Study|Disease progression|1
5551832|NCT01236352|19188893|P11|Overall Study|Study drug toxicity|2
5551833|NCT01236352|19188894|P10|Overall Study|Study drug toxicity|2
5551834|NCT01236352|19188895|P9|Overall Study|Study drug toxicity|0
5551835|NCT01236352|19188896|P8|Overall Study|Study drug toxicity|0
5551836|NCT01236352|19188897|P7|Overall Study|Study drug toxicity|1
5551837|NCT01236352|19188898|P6|Overall Study|Study drug toxicity|1
5551838|NCT01236352|19188899|P5|Overall Study|Study drug toxicity|0
5551839|NCT01236352|19188900|P4|Overall Study|Study drug toxicity|0
5551840|NCT01236352|19188901|P3|Overall Study|Study drug toxicity|0
5551841|NCT01236352|19188902|P2|Overall Study|Study drug toxicity|0
5551842|NCT01236352|19188903|P1|Overall Study|Study drug toxicity|0
5551843|NCT01236352|19188893|P11|Overall Study|Adverse Event|1
5551844|NCT01236352|19188894|P10|Overall Study|Adverse Event|4
5551845|NCT01236352|19188895|P9|Overall Study|Adverse Event|0
5551846|NCT01236352|19188896|P8|Overall Study|Adverse Event|0
5551847|NCT01236352|19188897|P7|Overall Study|Adverse Event|2
5551848|NCT01236352|19188898|P6|Overall Study|Adverse Event|0
5551849|NCT01236352|19188899|P5|Overall Study|Adverse Event|0
5551850|NCT01236352|19188900|P4|Overall Study|Adverse Event|0
5551851|NCT01236352|19188901|P3|Overall Study|Adverse Event|0
5551852|NCT01236352|19188902|P2|Overall Study|Adverse Event|0
5551853|NCT01236352|19188903|P1|Overall Study|Adverse Event|0
5551854|NCT01236352|19188893|P11|Overall Study|Withdrawal by Subject|1
5551855|NCT01236352|19188894|P10|Overall Study|Withdrawal by Subject|2
5551856|NCT01236352|19188895|P9|Overall Study|Withdrawal by Subject|0
5551857|NCT01236352|19188896|P8|Overall Study|Withdrawal by Subject|0
5551858|NCT01236352|19188897|P7|Overall Study|Withdrawal by Subject|0
5551859|NCT01236352|19188898|P6|Overall Study|Withdrawal by Subject|0
5551860|NCT01236352|19188899|P5|Overall Study|Withdrawal by Subject|0
5551861|NCT01236352|19188900|P4|Overall Study|Withdrawal by Subject|0
5551862|NCT01236352|19188901|P3|Overall Study|Withdrawal by Subject|0
5551863|NCT01236352|19188902|P2|Overall Study|Withdrawal by Subject|0
5551864|NCT01236352|19188903|P1|Overall Study|Withdrawal by Subject|0
5551865|NCT01236352|19188893|P11|Overall Study|Death|0
5551866|NCT01236352|19188894|P10|Overall Study|Death|0
5551867|NCT01236352|19188895|P9|Overall Study|Death|0
5551868|NCT01236352|19188896|P8|Overall Study|Death|1
5551869|NCT01236352|19188897|P7|Overall Study|Death|0
5551870|NCT01236352|19188898|P6|Overall Study|Death|0
5551871|NCT01236352|19188899|P5|Overall Study|Death|0
5551872|NCT01236352|19188900|P4|Overall Study|Death|0
5551873|NCT01236352|19188901|P3|Overall Study|Death|0
5551874|NCT01236352|19188902|P2|Overall Study|Death|0
5551875|NCT01236352|19188903|P1|Overall Study|Death|0
5551876|NCT01236118|19189121|P3|Overall Study|Withdrawal by Subject|1
5551877|NCT01236118|19189122|P2|Overall Study|Withdrawal by Subject|0
5551878|NCT01236118|19189123|P1|Overall Study|Withdrawal by Subject|0
5551879|NCT01236118|19189121|P3|Overall Study|Physician Decision|0
5551880|NCT01236118|19189122|P2|Overall Study|Physician Decision|1
5551881|NCT01236118|19189123|P1|Overall Study|Physician Decision|0
5551882|NCT01236118|19189121|P3|Overall Study|Adverse Event|2
5551883|NCT01236118|19189122|P2|Overall Study|Adverse Event|0
5551884|NCT01236118|19189123|P1|Overall Study|Adverse Event|2
5551885|NCT01236001|19189324|P2|Overall Study|Planned Visit After End of Study|1
5551886|NCT01236001|19189325|P1|Overall Study|Planned Visit After End of Study|0
5551887|NCT01236001|19189324|P2|Overall Study|Incompliance|0
5551888|NCT01236001|19189325|P1|Overall Study|Incompliance|1
5551889|NCT01236001|19189324|P2|Overall Study|Lost to Follow-up|1
5551890|NCT01236001|19189325|P1|Overall Study|Lost to Follow-up|6
5551891|NCT01236001|19189324|P2|Overall Study|Lack of Efficacy|6
5551892|NCT01236001|19189325|P1|Overall Study|Lack of Efficacy|6
5551893|NCT01236001|19189324|P2|Overall Study|Adverse Event|14
5551894|NCT01236001|19189325|P1|Overall Study|Adverse Event|5
5551895|NCT01235975|19189357|P2|Overall Study|Lost to Follow-up|3
5551896|NCT01235975|19189358|P1|Overall Study|Lost to Follow-up|7
5551897|NCT01235975|19189357|P2|Overall Study|Migrated/moved from study area|1
5551898|NCT01235975|19189358|P1|Overall Study|Migrated/moved from study area|2
5551899|NCT01235975|19189357|P2|Overall Study|Withdrawal by Subject|2
5551900|NCT01235975|19189358|P1|Overall Study|Withdrawal by Subject|8
5551901|NCT01235975|19189357|P2|Overall Study|Serious Adverse Event|1
5551902|NCT01235975|19189358|P1|Overall Study|Serious Adverse Event|0
5551903|NCT01235962|19189394|P4|Overall Study|Physician Decision|5
5551904|NCT01235962|19189395|P3|Overall Study|Physician Decision|9
5551905|NCT01235962|19189396|P2|Overall Study|Physician Decision|0
5551906|NCT01235962|19189397|P1|Overall Study|Physician Decision|5
5551907|NCT01235962|19189394|P4|Overall Study|Lost to Follow-up|32
5551908|NCT01235962|19189395|P3|Overall Study|Lost to Follow-up|47
5551909|NCT01235962|19189396|P2|Overall Study|Lost to Follow-up|16
5551910|NCT01235962|19189397|P1|Overall Study|Lost to Follow-up|21
5551911|NCT01235962|19189394|P4|Overall Study|Withdrawal by Subject|49
5551912|NCT01235962|19189395|P3|Overall Study|Withdrawal by Subject|62
5551913|NCT01235962|19189396|P2|Overall Study|Withdrawal by Subject|19
5551914|NCT01235962|19189397|P1|Overall Study|Withdrawal by Subject|20
5551915|NCT01235949|19189467|P18|Booster Phase|Lost to Follow-up|1
5551916|NCT01235949|19189468|P17|Booster Phase|Lost to Follow-up|0
5551917|NCT01235949|19189469|P16|Booster Phase|Lost to Follow-up|0
5551918|NCT01235949|19189470|P15|Booster Phase|Lost to Follow-up|0
5551919|NCT01235949|19189471|P14|Booster Phase|Lost to Follow-up|0
5551920|NCT01235949|19189472|P13|Booster Phase|Lost to Follow-up|0
5551921|NCT01235949|19189473|P12|Booster Phase|Lost to Follow-up|1
5551922|NCT01235949|19189474|P11|Booster Phase|Lost to Follow-up|1
5551923|NCT01235949|19189475|P10|Booster Phase|Lost to Follow-up|1
5551924|NCT01235949|19189476|P9|Booster Phase|Lost to Follow-up|1
5551925|NCT01235949|19189477|P8|Booster Phase|Lost to Follow-up|0
5551926|NCT01235949|19189478|P7|Booster Phase|Lost to Follow-up|0
5551927|NCT01235949|19189479|P6|Booster Phase|Lost to Follow-up|0
5551928|NCT01235949|19189480|P5|Booster Phase|Lost to Follow-up|0
5551929|NCT01235949|19189481|P4|Booster Phase|Lost to Follow-up|0
5551930|NCT01235949|19189482|P3|Booster Phase|Lost to Follow-up|0
5551931|NCT01235949|19189483|P2|Booster Phase|Lost to Follow-up|0
5551932|NCT01235949|19189484|P1|Booster Phase|Lost to Follow-up|0
5551933|NCT01235949|19189467|P18|Booster Phase|Withdrawal by Subject|0
5551934|NCT01235949|19189468|P17|Booster Phase|Withdrawal by Subject|0
5551935|NCT01235949|19189469|P16|Booster Phase|Withdrawal by Subject|0
5551936|NCT01235949|19189470|P15|Booster Phase|Withdrawal by Subject|2
5551937|NCT01235949|19189471|P14|Booster Phase|Withdrawal by Subject|0
5551938|NCT01235949|19189472|P13|Booster Phase|Withdrawal by Subject|2
5551939|NCT01235949|19189473|P12|Booster Phase|Withdrawal by Subject|1
5551940|NCT01235949|19189474|P11|Booster Phase|Withdrawal by Subject|1
5551941|NCT01235949|19189475|P10|Booster Phase|Withdrawal by Subject|0
5551942|NCT01235949|19189476|P9|Booster Phase|Withdrawal by Subject|1
5551943|NCT01235949|19189477|P8|Booster Phase|Withdrawal by Subject|1
5551944|NCT01235949|19189478|P7|Booster Phase|Withdrawal by Subject|0
5551945|NCT01235949|19189479|P6|Booster Phase|Withdrawal by Subject|0
5551946|NCT01235949|19189480|P5|Booster Phase|Withdrawal by Subject|0
5551947|NCT01235949|19189481|P4|Booster Phase|Withdrawal by Subject|0
5551948|NCT01235949|19189482|P3|Booster Phase|Withdrawal by Subject|0
5551949|NCT01235949|19189483|P2|Booster Phase|Withdrawal by Subject|0
5551950|NCT01235949|19189484|P1|Booster Phase|Withdrawal by Subject|0
5551951|NCT01235949|19189467|P18|Booster Phase|Adverse Event|0
5551952|NCT01235949|19189468|P17|Booster Phase|Adverse Event|0
5551953|NCT01235949|19189469|P16|Booster Phase|Adverse Event|1
5551954|NCT01235949|19189470|P15|Booster Phase|Adverse Event|0
5551955|NCT01235949|19189471|P14|Booster Phase|Adverse Event|0
5551956|NCT01235949|19189472|P13|Booster Phase|Adverse Event|0
5551957|NCT01235949|19189473|P12|Booster Phase|Adverse Event|0
5551958|NCT01235949|19189474|P11|Booster Phase|Adverse Event|0
5551959|NCT01235949|19189475|P10|Booster Phase|Adverse Event|0
5551960|NCT01235949|19189476|P9|Booster Phase|Adverse Event|0
5551961|NCT01235949|19189477|P8|Booster Phase|Adverse Event|0
5551962|NCT01235949|19189478|P7|Booster Phase|Adverse Event|0
5551963|NCT01235949|19189479|P6|Booster Phase|Adverse Event|0
5551964|NCT01235949|19189480|P5|Booster Phase|Adverse Event|0
5551965|NCT01235949|19189481|P4|Booster Phase|Adverse Event|0
5551966|NCT01235949|19189482|P3|Booster Phase|Adverse Event|0
5551967|NCT01235949|19189483|P2|Booster Phase|Adverse Event|0
5551968|NCT01235949|19189484|P1|Booster Phase|Adverse Event|0
5551969|NCT01235949|19189467|P18|Booster Phase|Migrated/moved from study area|1
5551970|NCT01235949|19189468|P17|Booster Phase|Migrated/moved from study area|0
5551971|NCT01235949|19189469|P16|Booster Phase|Migrated/moved from study area|0
5551972|NCT01235949|19189470|P15|Booster Phase|Migrated/moved from study area|0
5551973|NCT01235949|19189471|P14|Booster Phase|Migrated/moved from study area|0
5551974|NCT01235949|19189472|P13|Booster Phase|Migrated/moved from study area|1
5551975|NCT01235949|19189473|P12|Booster Phase|Migrated/moved from study area|1
5551976|NCT01235949|19189474|P11|Booster Phase|Migrated/moved from study area|0
5551977|NCT01235949|19189475|P10|Booster Phase|Migrated/moved from study area|0
5551978|NCT01235949|19189476|P9|Booster Phase|Migrated/moved from study area|0
5551979|NCT01235949|19189477|P8|Booster Phase|Migrated/moved from study area|0
5551980|NCT01235949|19189478|P7|Booster Phase|Migrated/moved from study area|0
5551981|NCT01235949|19189479|P6|Booster Phase|Migrated/moved from study area|0
5551982|NCT01235949|19189480|P5|Booster Phase|Migrated/moved from study area|0
5551983|NCT01235949|19189481|P4|Booster Phase|Migrated/moved from study area|0
5551984|NCT01235949|19189482|P3|Booster Phase|Migrated/moved from study area|0
5551985|NCT01235949|19189483|P2|Booster Phase|Migrated/moved from study area|0
5551986|NCT01235949|19189484|P1|Booster Phase|Migrated/moved from study area|0
5551987|NCT01235949|19189467|P18|Primary Phase|Lost to Follow-up|0
5551988|NCT01235949|19189468|P17|Primary Phase|Lost to Follow-up|0
5551989|NCT01235949|19189469|P16|Primary Phase|Lost to Follow-up|0
5551990|NCT01235949|19189470|P15|Primary Phase|Lost to Follow-up|0
5551991|NCT01235949|19189471|P14|Primary Phase|Lost to Follow-up|0
5551992|NCT01235949|19189472|P13|Primary Phase|Lost to Follow-up|0
5551993|NCT01235949|19189473|P12|Primary Phase|Lost to Follow-up|0
5551994|NCT01235949|19189474|P11|Primary Phase|Lost to Follow-up|0
5551995|NCT01235949|19189475|P10|Primary Phase|Lost to Follow-up|0
5551996|NCT01235949|19189476|P9|Primary Phase|Lost to Follow-up|0
5551997|NCT01235949|19189477|P8|Primary Phase|Lost to Follow-up|0
5551998|NCT01235949|19189478|P7|Primary Phase|Lost to Follow-up|0
5551999|NCT01235949|19189479|P6|Primary Phase|Lost to Follow-up|2
5552000|NCT01235949|19189480|P5|Primary Phase|Lost to Follow-up|0
5552001|NCT01235949|19189481|P4|Primary Phase|Lost to Follow-up|1
5552002|NCT01235949|19189482|P3|Primary Phase|Lost to Follow-up|1
5552003|NCT01235949|19189483|P2|Primary Phase|Lost to Follow-up|0
5552004|NCT01235949|19189484|P1|Primary Phase|Lost to Follow-up|0
5552005|NCT01235949|19189467|P18|Primary Phase|Withdrawal by Subject|0
5552006|NCT01235949|19189468|P17|Primary Phase|Withdrawal by Subject|0
5552007|NCT01235949|19189469|P16|Primary Phase|Withdrawal by Subject|0
5552008|NCT01235949|19189470|P15|Primary Phase|Withdrawal by Subject|0
5552009|NCT01235949|19189471|P14|Primary Phase|Withdrawal by Subject|0
5552010|NCT01235949|19189472|P13|Primary Phase|Withdrawal by Subject|0
5552011|NCT01235949|19189473|P12|Primary Phase|Withdrawal by Subject|0
5552012|NCT01235949|19189474|P11|Primary Phase|Withdrawal by Subject|0
5552013|NCT01235949|19189475|P10|Primary Phase|Withdrawal by Subject|0
5552014|NCT01235949|19189476|P9|Primary Phase|Withdrawal by Subject|0
5552015|NCT01235949|19189477|P8|Primary Phase|Withdrawal by Subject|0
5552016|NCT01235949|19189478|P7|Primary Phase|Withdrawal by Subject|0
5552017|NCT01235949|19189479|P6|Primary Phase|Withdrawal by Subject|3
5552018|NCT01235949|19189480|P5|Primary Phase|Withdrawal by Subject|0
5552019|NCT01235949|19189481|P4|Primary Phase|Withdrawal by Subject|0
5552020|NCT01235949|19189482|P3|Primary Phase|Withdrawal by Subject|2
5552021|NCT01235949|19189483|P2|Primary Phase|Withdrawal by Subject|2
5552022|NCT01235949|19189484|P1|Primary Phase|Withdrawal by Subject|3
5552023|NCT01235949|19189467|P18|Primary Phase|Adverse Event|0
5552024|NCT01235949|19189468|P17|Primary Phase|Adverse Event|0
5552025|NCT01235949|19189469|P16|Primary Phase|Adverse Event|0
5552026|NCT01235949|19189470|P15|Primary Phase|Adverse Event|0
5552027|NCT01235949|19189471|P14|Primary Phase|Adverse Event|0
5552028|NCT01235949|19189472|P13|Primary Phase|Adverse Event|0
5552029|NCT01235949|19189473|P12|Primary Phase|Adverse Event|0
5552030|NCT01235949|19189474|P11|Primary Phase|Adverse Event|0
5552031|NCT01235949|19189475|P10|Primary Phase|Adverse Event|0
5552032|NCT01235949|19189476|P9|Primary Phase|Adverse Event|0
5552033|NCT01235949|19189477|P8|Primary Phase|Adverse Event|0
5552034|NCT01235949|19189478|P7|Primary Phase|Adverse Event|0
5552035|NCT01235949|19189479|P6|Primary Phase|Adverse Event|0
5552036|NCT01235949|19189480|P5|Primary Phase|Adverse Event|0
5552037|NCT01235949|19189481|P4|Primary Phase|Adverse Event|1
5552038|NCT01235949|19189482|P3|Primary Phase|Adverse Event|0
5552039|NCT01235949|19189483|P2|Primary Phase|Adverse Event|0
5552040|NCT01235949|19189484|P1|Primary Phase|Adverse Event|0
5552041|NCT01235949|19189467|P18|Primary Phase|Migrated/moved from study area|0
5552042|NCT01235949|19189468|P17|Primary Phase|Migrated/moved from study area|0
5552043|NCT01235949|19189469|P16|Primary Phase|Migrated/moved from study area|0
5552044|NCT01235949|19189470|P15|Primary Phase|Migrated/moved from study area|0
5552045|NCT01235949|19189471|P14|Primary Phase|Migrated/moved from study area|0
5552046|NCT01235949|19189472|P13|Primary Phase|Migrated/moved from study area|0
5552047|NCT01235949|19189473|P12|Primary Phase|Migrated/moved from study area|0
5552048|NCT01235949|19189474|P11|Primary Phase|Migrated/moved from study area|0
5552049|NCT01235949|19189475|P10|Primary Phase|Migrated/moved from study area|0
5552050|NCT01235949|19189476|P9|Primary Phase|Migrated/moved from study area|0
5552051|NCT01235949|19189477|P8|Primary Phase|Migrated/moved from study area|0
5552052|NCT01235949|19189478|P7|Primary Phase|Migrated/moved from study area|0
5552053|NCT01235949|19189479|P6|Primary Phase|Migrated/moved from study area|2
5552054|NCT01235949|19189480|P5|Primary Phase|Migrated/moved from study area|1
5552055|NCT01235949|19189481|P4|Primary Phase|Migrated/moved from study area|0
5552056|NCT01235949|19189482|P3|Primary Phase|Migrated/moved from study area|0
5552057|NCT01235949|19189483|P2|Primary Phase|Migrated/moved from study area|1
5552058|NCT01235949|19189484|P1|Primary Phase|Migrated/moved from study area|1
5552059|NCT01235741|19189734|P3|Follow-Up Post Treatment up to Month 6|Other|0
5552060|NCT01235741|19189735|P2|Follow-Up Post Treatment up to Month 6|Other|1
5552061|NCT01235741|19189736|P1|Follow-Up Post Treatment up to Month 6|Other|0
5552062|NCT01235741|19189734|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
5552063|NCT01235741|19189735|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
5552064|NCT01235741|19189736|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
5552065|NCT01235741|19189734|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
5552066|NCT01235741|19189735|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
5552067|NCT01235741|19189736|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
5552068|NCT01235741|19189734|P3|Randomized to Treatment|Sponsor terminated study|34
5552069|NCT01235741|19189735|P2|Randomized to Treatment|Sponsor terminated study|35
5552070|NCT01235741|19189736|P1|Randomized to Treatment|Sponsor terminated study|0
5552071|NCT01235741|19189734|P3|Randomized to Treatment|Adverse Event|1
5552072|NCT01235741|19189735|P2|Randomized to Treatment|Adverse Event|1
5552073|NCT01235741|19189736|P1|Randomized to Treatment|Adverse Event|0
5552074|NCT01235741|19189734|P3|Randomized to Treatment|Withdrawal by Subject|1
5552075|NCT01235741|19189735|P2|Randomized to Treatment|Withdrawal by Subject|0
5552076|NCT01235741|19189736|P1|Randomized to Treatment|Withdrawal by Subject|0
5552077|NCT01235741|19189734|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
5552078|NCT01235741|19189735|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
5552079|NCT01235741|19189736|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
5552080|NCT01235741|19189734|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
5552081|NCT01235741|19189735|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
5552082|NCT01235741|19189736|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
5552083|NCT01235741|19189734|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
5552084|NCT01235741|19189735|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
5552085|NCT01235741|19189736|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
5552086|NCT01235741|19189734|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
5552087|NCT01235741|19189735|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
5552088|NCT01235741|19189736|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
5552089|NCT01235741|19189734|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
5552090|NCT01235741|19189735|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
5552091|NCT01235741|19189736|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
5552092|NCT01235741|19189734|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
5552093|NCT01235741|19189735|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
5552094|NCT01235741|19189736|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
5552095|NCT01235728|19189763|P8|Overall Study|Protocol Violation|0
5552096|NCT01235728|19189764|P7|Overall Study|Protocol Violation|0
5552097|NCT01235728|19189765|P6|Overall Study|Protocol Violation|0
5552098|NCT01235728|19189766|P5|Overall Study|Protocol Violation|0
5552099|NCT01235728|19189767|P4|Overall Study|Protocol Violation|1
5552100|NCT01235728|19189768|P3|Overall Study|Protocol Violation|0
5552101|NCT01235728|19189769|P2|Overall Study|Protocol Violation|0
5552102|NCT01235728|19189770|P1|Overall Study|Protocol Violation|0
5552103|NCT01235715|19189780|P2|Overall Study|Physician Decision|2
5552104|NCT01235715|19189781|P1|Overall Study|Physician Decision|0
5552105|NCT01235689|19189821|P2|Overall Study|Miscellaneous|5
5552106|NCT01235689|19189822|P1|Overall Study|Miscellaneous|1
5552107|NCT01235689|19189821|P2|Overall Study|Lost to Follow-up|2
5552108|NCT01235689|19189822|P1|Overall Study|Lost to Follow-up|1
5552109|NCT01235689|19189821|P2|Overall Study|Withdrawal by Subject|4
5552110|NCT01235689|19189822|P1|Overall Study|Withdrawal by Subject|3
5552111|NCT01235689|19189821|P2|Overall Study|Lack of Efficacy|5
5552112|NCT01235689|19189822|P1|Overall Study|Lack of Efficacy|12
5552113|NCT01235689|19189821|P2|Overall Study|Adverse Event|16
5552114|NCT01235689|19189822|P1|Overall Study|Adverse Event|12
5552115|NCT01235598|19189894|P2|Overall Study|Withdrawal by Subject|0
5552116|NCT01235598|19189895|P1|Overall Study|Withdrawal by Subject|1
5552117|NCT01235598|19189894|P2|Overall Study|Lack of Efficacy|1
5552118|NCT01235598|19189895|P1|Overall Study|Lack of Efficacy|0
5552119|NCT01235598|19189894|P2|Overall Study|Adverse Event|3
5552120|NCT01235598|19189895|P1|Overall Study|Adverse Event|0
5552121|NCT01235546|19189940|P2|Overall Study|Protocol Violation|1
5552122|NCT01235546|19189941|P1|Overall Study|Protocol Violation|1
5552123|NCT01235546|19189940|P2|Overall Study|Staff error, medication not administered|0
5552124|NCT01235546|19189941|P1|Overall Study|Staff error, medication not administered|1
5552125|NCT01235507|19189965|P1|Overall Study|Withdrawal by Subject|1
5552126|NCT01235507|19189965|P1|Overall Study|Adverse Event|1
5552127|NCT01235442|19189979|P2|Overall Study|Other unspecified|2
5552128|NCT01235442|19189980|P1|Overall Study|Other unspecified|1
5552129|NCT01235442|19189979|P2|Overall Study|Administrative decision|2
5552130|NCT01235442|19189980|P1|Overall Study|Administrative decision|1
5552131|NCT01235442|19189979|P2|Overall Study|Noncompliance|2
5552132|NCT01235442|19189980|P1|Overall Study|Noncompliance|1
5552133|NCT01235442|19189979|P2|Overall Study|Lack of Efficacy|3
5552134|NCT01235442|19189980|P1|Overall Study|Lack of Efficacy|1
5552135|NCT01235442|19189979|P2|Overall Study|Withdrawal by Subject|9
5552136|NCT01235442|19189980|P1|Overall Study|Withdrawal by Subject|15
5552137|NCT01235442|19189979|P2|Overall Study|Adverse Event|6
5552138|NCT01235442|19189980|P1|Overall Study|Adverse Event|4
5552139|NCT01235442|19189979|P2|Overall Study|Protocol Violation|3
5552140|NCT01235442|19189980|P1|Overall Study|Protocol Violation|3
5552141|NCT01235442|19189979|P2|Overall Study|Ineligibility determined|4
5552142|NCT01235442|19189980|P1|Overall Study|Ineligibility determined|5
5552143|NCT01235442|19189979|P2|Overall Study|Pregnancy|1
5552144|NCT01235442|19189980|P1|Overall Study|Pregnancy|1
5552145|NCT01235442|19189979|P2|Overall Study|Death|2
5552146|NCT01235442|19189980|P1|Overall Study|Death|0
5552147|NCT01235442|19189979|P2|Overall Study|Lost to Follow-up|10
5552148|NCT01235442|19189980|P1|Overall Study|Lost to Follow-up|12
5552149|NCT01235403|19189998|P1|Overall Study|Other reasons for premature termination|4
5552150|NCT01235403|19189998|P1|Overall Study|Lack of Efficacy|2
5552151|NCT01235403|19189998|P1|Overall Study|Withdrawal by Subject|4
5552152|NCT01235403|19189998|P1|Overall Study|Lost to Follow-up|2
5552153|NCT01235403|19189998|P1|Overall Study|Adverse Event|14
5552154|NCT01235351|19190015|P2|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
5552155|NCT01235351|19190016|P1|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
5552156|NCT01235338|19190028|P2|Overall Study|Prohibited meds|0
5552157|NCT01235338|19190029|P1|Overall Study|Prohibited meds|1
5552158|NCT01235338|19190028|P2|Overall Study|Positive drug screen|1
5552159|NCT01235338|19190029|P1|Overall Study|Positive drug screen|0
5552160|NCT01235338|19190028|P2|Overall Study|Exclusion criteria violations|1
5552161|NCT01235338|19190029|P1|Overall Study|Exclusion criteria violations|1
5552162|NCT01235338|19190028|P2|Overall Study|Withdrawal by Subject|0
5552163|NCT01235338|19190029|P1|Overall Study|Withdrawal by Subject|5
5552164|NCT01235338|19190028|P2|Overall Study|Protocol Violation|1
5552165|NCT01235338|19190029|P1|Overall Study|Protocol Violation|1
5552166|NCT01235338|19190028|P2|Overall Study|Adverse Event|2
5552167|NCT01235338|19190029|P1|Overall Study|Adverse Event|3
5552168|NCT01235234|19190074|P3|Overall Study|Adverse Event|1
5552169|NCT01235234|19190075|P2|Overall Study|Adverse Event|2
5552170|NCT01235234|19190076|P1|Overall Study|Adverse Event|2
5552171|NCT01234883|19190124|P2|Overall Study|Inclusion/exclusion failure|0
5552172|NCT01234883|19190125|P1|Overall Study|Inclusion/exclusion failure|1
5552173|NCT01234883|19190124|P2|Overall Study|Technical difficulties with IV infusion|1
5552174|NCT01234883|19190125|P1|Overall Study|Technical difficulties with IV infusion|0
5552175|NCT01234883|19190124|P2|Overall Study|Parent/guardian withdrew consent|2
5552176|NCT01234883|19190125|P1|Overall Study|Parent/guardian withdrew consent|1
5552177|NCT01234883|19190124|P2|Overall Study|Early treatment release|10
5552178|NCT01234883|19190125|P1|Overall Study|Early treatment release|8
5552179|NCT01234675|19190172|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
5552180|NCT01234675|19190173|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
5552181|NCT01234675|19190172|P2|First Intervention (6 Weeks)|Adverse Event|1
5552182|NCT01234675|19190173|P1|First Intervention (6 Weeks)|Adverse Event|0
5552183|NCT01234649|19190205|P2|Overall Study|Lack of Efficacy|3
5552184|NCT01234649|19190206|P1|Overall Study|Lack of Efficacy|0
5552185|NCT01234649|19190205|P2|Overall Study|Allergic reaction|0
5552186|NCT01234649|19190206|P1|Overall Study|Allergic reaction|1
5552187|NCT01234649|19190205|P2|Overall Study|intolerant to side effects|3
5552188|NCT01234649|19190206|P1|Overall Study|intolerant to side effects|4
5552189|NCT01234649|19190205|P2|Overall Study|Pregnancy|6
5552190|NCT01234649|19190206|P1|Overall Study|Pregnancy|6
5552191|NCT01234649|19190205|P2|Overall Study|Withdrawal by Subject|26
5552192|NCT01234649|19190206|P1|Overall Study|Withdrawal by Subject|32
5552193|NCT01234467|19190254|P1|Overall Study|Other complicating disease (stroke)|1
5552194|NCT01234467|19190254|P1|Overall Study|Physician Decision|1
5552195|NCT01234467|19190254|P1|Overall Study|Clinical deterioration|1
5552196|NCT01234467|19190254|P1|Overall Study|Disease Progression|2
5552197|NCT01234467|19190254|P1|Overall Study|Withdrawal by Subject|2
5552198|NCT01234467|19190254|P1|Overall Study|Death|2
5552199|NCT01234467|19190254|P1|Overall Study|Adverse Event|3
5552200|NCT01234402|19190266|P3|Overall Study|Never treated: Insurance Denied Xeloda|0
5552201|NCT01234402|19190267|P2|Overall Study|Never treated: Insurance Denied Xeloda|1
5552202|NCT01234402|19190268|P1|Overall Study|Never treated: Insurance Denied Xeloda|0
5552203|NCT01234402|19190266|P3|Overall Study|Never treated: Withdrawal By Subject|0
5552204|NCT01234402|19190267|P2|Overall Study|Never treated: Withdrawal By Subject|1
5552205|NCT01234402|19190268|P1|Overall Study|Never treated: Withdrawal By Subject|0
5552206|NCT01234402|19190266|P3|Overall Study|Never treated: Death|1
5552207|NCT01234402|19190267|P2|Overall Study|Never treated: Death|0
5552208|NCT01234402|19190268|P1|Overall Study|Never treated: Death|0
5552209|NCT01234402|19190266|P3|Overall Study|Withdrawal by Subject|4
5552210|NCT01234402|19190267|P2|Overall Study|Withdrawal by Subject|3
5552211|NCT01234402|19190268|P1|Overall Study|Withdrawal by Subject|1
5552212|NCT01234402|19190266|P3|Overall Study|Lost to Follow-up|3
5552213|NCT01234402|19190267|P2|Overall Study|Lost to Follow-up|1
5552214|NCT01234402|19190268|P1|Overall Study|Lost to Follow-up|0
5552215|NCT01234350|19190309|P2|Overall Study|Covers a diverse set of reasons|92
5552216|NCT01234350|19190310|P1|Overall Study|Covers a diverse set of reasons|234
5552217|NCT01234350|19190309|P2|Overall Study|Lost to Follow-up|47
5552218|NCT01234350|19190310|P1|Overall Study|Lost to Follow-up|115
5552219|NCT01234350|19190309|P2|Overall Study|Withdrawal by Subject|36
5552220|NCT01234350|19190310|P1|Overall Study|Withdrawal by Subject|61
5552221|NCT01234350|19190309|P2|Overall Study|Adverse Event|92
5552222|NCT01234350|19190310|P1|Overall Study|Adverse Event|277
5552223|NCT01234337|19190336|P2|Overall Study|Switch to commercial drug|1
5552224|NCT01234337|19190337|P1|Overall Study|Switch to commercial drug|0
5552225|NCT01234337|19190336|P2|Overall Study|Death|1
5552226|NCT01234337|19190337|P1|Overall Study|Death|0
5552227|NCT01234337|19190336|P2|Overall Study|Withdrawal by Subject|9
5552228|NCT01234337|19190337|P1|Overall Study|Withdrawal by Subject|11
5552229|NCT01234337|19190336|P2|Overall Study|Protocol Violation|3
5552230|NCT01234337|19190337|P1|Overall Study|Protocol Violation|2
5552231|NCT01234337|19190336|P2|Overall Study|Lost to Follow-up|1
5552232|NCT01234337|19190337|P1|Overall Study|Lost to Follow-up|0
5552233|NCT01234337|19190336|P2|Overall Study|Randomized but not treated|4
5552234|NCT01234337|19190337|P1|Overall Study|Randomized but not treated|6
5552235|NCT01234337|19190336|P2|Overall Study|Non-compliant with study medication|2
5552236|NCT01234337|19190337|P1|Overall Study|Non-compliant with study medication|3
5552237|NCT01234337|19190336|P2|Overall Study|Investi. decision not protocol driven|6
5552238|NCT01234337|19190337|P1|Overall Study|Investi. decision not protocol driven|5
5552239|NCT01234337|19190336|P2|Overall Study|Disease progression/recurrence/relapse|223
5552240|NCT01234337|19190337|P1|Overall Study|Disease progression/recurrence/relapse|181
5552241|NCT01234337|19190336|P2|Overall Study|Adverse Event|21
5552242|NCT01234337|19190337|P1|Overall Study|Adverse Event|58
5552243|NCT01233999|19190397|P1|Overall Study|Lost to Follow-up|1
5552244|NCT01233999|19190397|P1|Overall Study|Withdrawal by Subject|1
5552245|NCT01233869|19190416|P4|Extended Treatment Period (46 Months)|Adverse Event|1
5552246|NCT01233869|19190417|P3|Extended Treatment Period (46 Months)|Adverse Event|0
5552247|NCT01233869|19190418|P2|Extended Treatment Period (46 Months)|Adverse Event|0
5552248|NCT01233869|19190419|P1|Extended Treatment Period (46 Months)|Adverse Event|1
5552249|NCT01233869|19190416|P4|Extended Treatment Period (46 Months)|Other|3
5552250|NCT01233869|19190417|P3|Extended Treatment Period (46 Months)|Other|0
5552251|NCT01233869|19190418|P2|Extended Treatment Period (46 Months)|Other|0
5552252|NCT01233869|19190419|P1|Extended Treatment Period (46 Months)|Other|3
5552253|NCT01233869|19190416|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
5552254|NCT01233869|19190417|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
5552255|NCT01233869|19190418|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
5552256|NCT01233869|19190419|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
5552257|NCT01233869|19190416|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
5552258|NCT01233869|19190417|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
5552259|NCT01233869|19190418|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
5552260|NCT01233869|19190419|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
5552261|NCT01233869|19190416|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
5552262|NCT01233869|19190417|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
5552263|NCT01233869|19190418|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
5552264|NCT01233869|19190419|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
5552265|NCT01233869|19190416|P4|Initial Treatment Period (24 Months)|Adverse Event|3
5552266|NCT01233869|19190417|P3|Initial Treatment Period (24 Months)|Adverse Event|0
5552267|NCT01233869|19190418|P2|Initial Treatment Period (24 Months)|Adverse Event|17
5552268|NCT01233869|19190419|P1|Initial Treatment Period (24 Months)|Adverse Event|9
5552269|NCT01233869|19190416|P4|Initial Treatment Period (24 Months)|Death|0
5552270|NCT01233869|19190417|P3|Initial Treatment Period (24 Months)|Death|0
5552271|NCT01233869|19190418|P2|Initial Treatment Period (24 Months)|Death|0
5552272|NCT01233869|19190419|P1|Initial Treatment Period (24 Months)|Death|1
5552273|NCT01233817|19190505|P1|Overall Study|Withdrawal by Subject|2
5552274|NCT01233817|19190505|P1|Overall Study|Lost to Follow-up|1
5552275|NCT01233687|19190552|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
5552276|NCT01233687|19190552|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
5552277|NCT01233687|19190552|P1|Phase II AMG 102 + Erlotinib|Death|1
5552278|NCT01233609|19190562|P2|Overall Study|Withdrawal by Subject|0
5552279|NCT01233609|19190563|P1|Overall Study|Withdrawal by Subject|3
5552280|NCT01233609|19190562|P2|Overall Study|Adverse Event|1
5552281|NCT01233609|19190563|P1|Overall Study|Adverse Event|2
5552282|NCT01233609|19190562|P2|Overall Study|Lost to Follow-up|1
5552283|NCT01233609|19190563|P1|Overall Study|Lost to Follow-up|3
5552284|NCT01233609|19190562|P2|Overall Study|Death|0
5552285|NCT01233609|19190563|P1|Overall Study|Death|1
5552286|NCT01233284|19190587|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
5552287|NCT01233284|19190588|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
5552288|NCT01233284|19190589|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
5552289|NCT01233284|19190590|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
5552290|NCT01233284|19190591|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
5552291|NCT01233284|19190587|P5|Period 4 (4 Weeks)|Adverse Event|0
5552292|NCT01233284|19190588|P4|Period 4 (4 Weeks)|Adverse Event|0
5552293|NCT01233284|19190589|P3|Period 4 (4 Weeks)|Adverse Event|0
5552294|NCT01233284|19190590|P2|Period 4 (4 Weeks)|Adverse Event|1
5552295|NCT01233284|19190591|P1|Period 4 (4 Weeks)|Adverse Event|0
5552296|NCT01233284|19190587|P5|Period 3 (4 Weeks)|Other|0
5552297|NCT01233284|19190588|P4|Period 3 (4 Weeks)|Other|1
5552298|NCT01233284|19190589|P3|Period 3 (4 Weeks)|Other|0
5552299|NCT01233284|19190590|P2|Period 3 (4 Weeks)|Other|0
5552300|NCT01233284|19190591|P1|Period 3 (4 Weeks)|Other|0
5552301|NCT01233284|19190587|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
5552302|NCT01233284|19190588|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
5552303|NCT01233284|19190589|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
5552304|NCT01233284|19190590|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
5552305|NCT01233284|19190591|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
5552306|NCT01233284|19190587|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
5552307|NCT01233284|19190588|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
5552308|NCT01233284|19190589|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
5552309|NCT01233284|19190590|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
5552310|NCT01233284|19190591|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
5552311|NCT01233284|19190587|P5|Period 1 (4 Weeks)|Other|0
5552312|NCT01233284|19190588|P4|Period 1 (4 Weeks)|Other|0
5552313|NCT01233284|19190589|P3|Period 1 (4 Weeks)|Other|1
5552314|NCT01233284|19190590|P2|Period 1 (4 Weeks)|Other|0
5552315|NCT01233284|19190591|P1|Period 1 (4 Weeks)|Other|0
5552316|NCT01233284|19190587|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
5552317|NCT01233284|19190588|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
5552318|NCT01233284|19190589|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
5552319|NCT01233284|19190590|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
5552320|NCT01233284|19190591|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
5552321|NCT01233284|19190587|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
5552322|NCT01233284|19190588|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
5552323|NCT01233284|19190589|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
5552324|NCT01233284|19190590|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
5552325|NCT01233284|19190591|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
5552326|NCT01233258|19190672|P6|First Intervention (6 Months)|Non-compliance with study medication|0
5552327|NCT01233258|19190673|P5|First Intervention (6 Months)|Non-compliance with study medication|0
5552328|NCT01233258|19190674|P4|First Intervention (6 Months)|Non-compliance with study medication|0
5552329|NCT01233258|19190675|P3|First Intervention (6 Months)|Non-compliance with study medication|0
5552330|NCT01233258|19190676|P2|First Intervention (6 Months)|Non-compliance with study medication|0
5552331|NCT01233258|19190677|P1|First Intervention (6 Months)|Non-compliance with study medication|1
5552332|NCT01233258|19190672|P6|First Intervention (6 Months)|Protocol Violation|0
5552333|NCT01233258|19190673|P5|First Intervention (6 Months)|Protocol Violation|0
5552334|NCT01233258|19190674|P4|First Intervention (6 Months)|Protocol Violation|0
5552335|NCT01233258|19190675|P3|First Intervention (6 Months)|Protocol Violation|1
5552336|NCT01233258|19190676|P2|First Intervention (6 Months)|Protocol Violation|0
5552337|NCT01233258|19190677|P1|First Intervention (6 Months)|Protocol Violation|0
5552338|NCT01233258|19190672|P6|First Intervention (6 Months)|Withdrawal by Subject|1
5552339|NCT01233258|19190673|P5|First Intervention (6 Months)|Withdrawal by Subject|0
5552340|NCT01233258|19190674|P4|First Intervention (6 Months)|Withdrawal by Subject|1
5552341|NCT01233258|19190675|P3|First Intervention (6 Months)|Withdrawal by Subject|0
5552342|NCT01233258|19190676|P2|First Intervention (6 Months)|Withdrawal by Subject|0
5552343|NCT01233258|19190677|P1|First Intervention (6 Months)|Withdrawal by Subject|0
5552344|NCT01233232|19190697|P3|Overall Study|Voluntary Discontinuation by Subject|0
5552345|NCT01233232|19190698|P2|Overall Study|Voluntary Discontinuation by Subject|0
5552346|NCT01233232|19190699|P1|Overall Study|Voluntary Discontinuation by Subject|1
5552347|NCT01233076|19190752|P2|Period 2, One Week|Lost to Follow-up|0
5552348|NCT01233076|19190753|P1|Period 2, One Week|Lost to Follow-up|1
5552349|NCT01233050|19190761|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
5552350|NCT01233050|19190762|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
5552351|NCT01232894|19190814|P2|Overall Study|Physician Decision|1
5552352|NCT01232894|19190815|P1|Overall Study|Physician Decision|2
5552353|NCT01232894|19190814|P2|Overall Study|Withdrawal by Subject|5
5552354|NCT01232894|19190815|P1|Overall Study|Withdrawal by Subject|8
5552355|NCT01232894|19190814|P2|Overall Study|Protocol Violation|1
5552356|NCT01232894|19190815|P1|Overall Study|Protocol Violation|1
5552357|NCT01232894|19190814|P2|Overall Study|Death|0
5552358|NCT01232894|19190815|P1|Overall Study|Death|1
5552359|NCT01232894|19190814|P2|Overall Study|Lost to Follow-up|1
5552360|NCT01232894|19190815|P1|Overall Study|Lost to Follow-up|0
5552361|NCT01232868|19190823|P2|Overall Study|Lost to Follow-up|4
5552362|NCT01232868|19190824|P1|Overall Study|Lost to Follow-up|2
5552363|NCT01232790|19190838|P2|Second Crossover|Withdrawal by Subject|2
5552364|NCT01232790|19190839|P1|Second Crossover|Withdrawal by Subject|1
5552365|NCT01232790|19190838|P2|First Crossover|Withdrawal by Subject|0
5552366|NCT01232790|19190839|P1|First Crossover|Withdrawal by Subject|1
5552367|NCT01232790|19190838|P2|Initial Assessment|Withdrawal by Subject|1
5552368|NCT01232790|19190839|P1|Initial Assessment|Withdrawal by Subject|0
5552369|NCT01232790|19190838|P2|Randomization|Physician Decision|1
5552370|NCT01232790|19190839|P1|Randomization|Physician Decision|0
5552371|NCT01232790|19190838|P2|Randomization|Protocol Violation|1
5552372|NCT01232790|19190839|P1|Randomization|Protocol Violation|0
5552373|NCT01232790|19190838|P2|Randomization|Withdrawal by Subject|0
5552374|NCT01232790|19190839|P1|Randomization|Withdrawal by Subject|2
5552375|NCT01232738|19190893|P1|Overall Study|Adverse Event|5
5552376|NCT01232738|19190893|P1|Overall Study|Withdrawal by Subject|2
5552377|NCT01232738|19190893|P1|Overall Study|Lost to Follow-up|1
5552378|NCT01232738|19190893|P1|Overall Study|Physician Decision|2
5552379|NCT01232738|19190893|P1|Overall Study|Death|3
5552380|NCT01232569|19190909|P4|Double-blind Treatment Period|Death|0
5552381|NCT01232569|19190910|P3|Double-blind Treatment Period|Death|0
5552382|NCT01232569|19190911|P2|Double-blind Treatment Period|Death|0
5552383|NCT01232569|19190912|P1|Double-blind Treatment Period|Death|2
5552384|NCT01232569|19190909|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
5552385|NCT01232569|19190910|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
5552386|NCT01232569|19190911|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
5552387|NCT01232569|19190912|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
5552388|NCT01232569|19190909|P4|Double-blind Treatment Period|Physician Decision|0
5552389|NCT01232569|19190910|P3|Double-blind Treatment Period|Physician Decision|0
5552390|NCT01232569|19190911|P2|Double-blind Treatment Period|Physician Decision|0
5552391|NCT01232569|19190912|P1|Double-blind Treatment Period|Physician Decision|1
5552392|NCT01232569|19190909|P4|Double-blind Treatment Period|Lack of Efficacy|0
5552393|NCT01232569|19190910|P3|Double-blind Treatment Period|Lack of Efficacy|0
5552394|NCT01232569|19190911|P2|Double-blind Treatment Period|Lack of Efficacy|2
5552395|NCT01232569|19190912|P1|Double-blind Treatment Period|Lack of Efficacy|1
5552396|NCT01232569|19190909|P4|Double-blind Treatment Period|Lost to Follow-up|0
5552397|NCT01232569|19190910|P3|Double-blind Treatment Period|Lost to Follow-up|0
5552398|NCT01232569|19190911|P2|Double-blind Treatment Period|Lost to Follow-up|0
5552399|NCT01232569|19190912|P1|Double-blind Treatment Period|Lost to Follow-up|4
5552400|NCT01232569|19190909|P4|Double-blind Treatment Period|Escape|0
5552401|NCT01232569|19190910|P3|Double-blind Treatment Period|Escape|0
5552402|NCT01232569|19190911|P2|Double-blind Treatment Period|Escape|2
5552403|NCT01232569|19190912|P1|Double-blind Treatment Period|Escape|2
5552404|NCT01232569|19190909|P4|Double-blind Treatment Period|Withdrawal by Subject|0
5552405|NCT01232569|19190910|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5552406|NCT01232569|19190911|P2|Double-blind Treatment Period|Withdrawal by Subject|2
5552407|NCT01232569|19190912|P1|Double-blind Treatment Period|Withdrawal by Subject|9
5552408|NCT01232556|19190955|P2|Overall Study|Other|4
5552409|NCT01232556|19190956|P1|Overall Study|Other|6
5552410|NCT01232556|19190955|P2|Overall Study|Terminated by Sponsor|51
5552411|NCT01232556|19190956|P1|Overall Study|Terminated by Sponsor|35
5552412|NCT01232556|19190955|P2|Overall Study|Lost to Follow-up|2
5552413|NCT01232556|19190956|P1|Overall Study|Lost to Follow-up|0
5552414|NCT01232556|19190955|P2|Overall Study|Death|97
5552415|NCT01232556|19190956|P1|Overall Study|Death|97
5552416|NCT01232556|19190955|P2|Overall Study|Withdrawal by Subject|17
5552417|NCT01232556|19190956|P1|Overall Study|Withdrawal by Subject|21
5552418|NCT01232491|19191015|P2|Overall Study|Other|18
5552419|NCT01232491|19191016|P1|Overall Study|Other|21
5552420|NCT01232491|19191015|P2|Overall Study|Withdrawal Criteria|21
5552421|NCT01232491|19191016|P1|Overall Study|Withdrawal Criteria|12
5552422|NCT01232491|19191015|P2|Overall Study|Protocol Violation|11
5552423|NCT01232491|19191016|P1|Overall Study|Protocol Violation|13
5552424|NCT01232491|19191015|P2|Overall Study|Lack of Efficacy|5
5552425|NCT01232491|19191016|P1|Overall Study|Lack of Efficacy|1
5552426|NCT01232491|19191015|P2|Overall Study|Adverse Event|8
5552427|NCT01232491|19191016|P1|Overall Study|Adverse Event|13
5552428|NCT01232452|19191045|P2|Overall Study|Protocol Violation|1
5552429|NCT01232452|19191046|P1|Overall Study|Protocol Violation|0
5552430|NCT01232452|19191045|P2|Overall Study|Sponsor Decision|1
5552431|NCT01232452|19191046|P1|Overall Study|Sponsor Decision|3
5552432|NCT01232452|19191045|P2|Overall Study|Protocol entry criterion not met|2
5552433|NCT01232452|19191046|P1|Overall Study|Protocol entry criterion not met|0
5552434|NCT01232452|19191045|P2|Overall Study|Physician Decision|12
5552435|NCT01232452|19191046|P1|Overall Study|Physician Decision|8
5552436|NCT01232452|19191045|P2|Overall Study|Withdrawal by Subject|8
5552437|NCT01232452|19191046|P1|Overall Study|Withdrawal by Subject|11
5552438|NCT01232452|19191045|P2|Overall Study|Adverse Event|15
5552439|NCT01232452|19191046|P1|Overall Study|Adverse Event|17
5552440|NCT01232296|19191072|P2|Overall Study|Death|6
5552441|NCT01232296|19191073|P1|Overall Study|Death|1
5552442|NCT01232296|19191072|P2|Overall Study|Subject/guardian decision|2
5552443|NCT01232296|19191073|P1|Overall Study|Subject/guardian decision|10
5552444|NCT01232296|19191072|P2|Overall Study|Technical problems|0
5552445|NCT01232296|19191073|P1|Overall Study|Technical problems|3
5552446|NCT01232296|19191072|P2|Overall Study|Study terminated by sponsor|1
5552447|NCT01232296|19191073|P1|Overall Study|Study terminated by sponsor|0
5552448|NCT01232296|19191072|P2|Overall Study|Progressive disease|61
5552449|NCT01232296|19191073|P1|Overall Study|Progressive disease|43
5552450|NCT01232296|19191072|P2|Overall Study|Physician Decision|1
5552451|NCT01232296|19191073|P1|Overall Study|Physician Decision|1
5552452|NCT01232296|19191072|P2|Overall Study|Adverse Event|12
5552453|NCT01232296|19191073|P1|Overall Study|Adverse Event|24
5552454|NCT01232283|19191090|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
5552455|NCT01232283|19191091|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
5552456|NCT01232283|19191092|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5552457|NCT01232283|19191093|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5552458|NCT01232283|19191094|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5552459|NCT01232283|19191095|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5552460|NCT01232283|19191096|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5552461|NCT01232283|19191097|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5552462|NCT01232283|19191098|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5552463|NCT01232283|19191099|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
5552464|NCT01232283|19191090|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5552465|NCT01232283|19191091|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
5552466|NCT01232283|19191092|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5552467|NCT01232283|19191093|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5552468|NCT01232283|19191094|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5552469|NCT01232283|19191095|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5552470|NCT01232283|19191096|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5552471|NCT01232283|19191097|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5552472|NCT01232283|19191098|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5552473|NCT01232283|19191099|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
5552474|NCT01232283|19191090|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
5552475|NCT01232283|19191091|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
5552476|NCT01232283|19191092|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
5552477|NCT01232283|19191093|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
5552478|NCT01232283|19191094|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
5552479|NCT01232283|19191095|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
5552480|NCT01232283|19191096|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
5552481|NCT01232283|19191097|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
5552482|NCT01232283|19191098|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
5552483|NCT01232283|19191099|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
5552484|NCT01232283|19191090|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
5552485|NCT01232283|19191091|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
5552486|NCT01232283|19191092|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5552487|NCT01232283|19191093|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5552488|NCT01232283|19191094|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5552489|NCT01232283|19191095|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5552490|NCT01232283|19191096|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5552491|NCT01232283|19191097|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5552492|NCT01232283|19191098|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5552493|NCT01232283|19191099|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
5552494|NCT01232283|19191090|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
5552495|NCT01232283|19191091|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
5552496|NCT01232283|19191092|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5552497|NCT01232283|19191093|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5552498|NCT01232283|19191094|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5552499|NCT01232283|19191095|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5552500|NCT01232283|19191096|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5552501|NCT01232283|19191097|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5552502|NCT01232283|19191098|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5552503|NCT01232283|19191099|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
5552504|NCT01232283|19191090|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
5552505|NCT01232283|19191091|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
5552506|NCT01232283|19191092|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5552507|NCT01232283|19191093|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5552508|NCT01232283|19191094|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5552509|NCT01232283|19191095|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5552510|NCT01232283|19191096|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5552511|NCT01232283|19191097|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5552512|NCT01232283|19191098|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5552513|NCT01232283|19191099|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
5552514|NCT01232283|19191090|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
5552515|NCT01232283|19191091|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
5552516|NCT01232283|19191092|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5552517|NCT01232283|19191093|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5552518|NCT01232283|19191094|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5552519|NCT01232283|19191095|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5552520|NCT01232283|19191096|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5552521|NCT01232283|19191097|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5552522|NCT01232283|19191098|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5552523|NCT01232283|19191099|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
5552524|NCT01232283|19191090|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
5552525|NCT01232283|19191091|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
5552526|NCT01232283|19191092|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5552527|NCT01232283|19191093|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5552528|NCT01232283|19191094|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5552529|NCT01232283|19191095|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5552530|NCT01232283|19191096|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5552531|NCT01232283|19191097|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5552532|NCT01232283|19191098|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5552533|NCT01232283|19191099|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
5552534|NCT01232283|19191090|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5552535|NCT01232283|19191091|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5552536|NCT01232283|19191092|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5552537|NCT01232283|19191093|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5552538|NCT01232283|19191094|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
5552539|NCT01232283|19191095|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5552540|NCT01232283|19191096|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5552541|NCT01232283|19191097|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5552542|NCT01232283|19191098|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5552543|NCT01232283|19191099|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
5552544|NCT01232283|19191090|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5552545|NCT01232283|19191091|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5552546|NCT01232283|19191092|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
5552547|NCT01232283|19191093|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5552548|NCT01232283|19191094|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5552549|NCT01232283|19191095|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5552550|NCT01232283|19191096|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5552551|NCT01232283|19191097|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5552552|NCT01232283|19191098|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5552553|NCT01232283|19191099|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
5552554|NCT01232283|19191090|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5552555|NCT01232283|19191091|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5552556|NCT01232283|19191092|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
5552557|NCT01232283|19191093|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
5552558|NCT01232283|19191094|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5552559|NCT01232283|19191095|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
5552560|NCT01232283|19191096|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5552561|NCT01232283|19191097|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5552562|NCT01232283|19191098|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5552563|NCT01232283|19191099|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
5552564|NCT01232283|19191090|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5552565|NCT01232283|19191091|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5552566|NCT01232283|19191092|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5552567|NCT01232283|19191093|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5552568|NCT01232283|19191094|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5552569|NCT01232283|19191095|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
5552570|NCT01232283|19191096|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5552571|NCT01232283|19191097|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5552572|NCT01232283|19191098|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5552573|NCT01232283|19191099|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
5552574|NCT01232283|19191090|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5552575|NCT01232283|19191091|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5552576|NCT01232283|19191092|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
5552577|NCT01232283|19191093|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
5552578|NCT01232283|19191094|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
5552579|NCT01232283|19191095|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
5552580|NCT01232283|19191096|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5552581|NCT01232283|19191097|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5552582|NCT01232283|19191098|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5552583|NCT01232283|19191099|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
5552584|NCT01232283|19191090|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5552585|NCT01232283|19191091|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5552586|NCT01232283|19191092|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
5552587|NCT01232283|19191093|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
5552588|NCT01232283|19191094|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5552589|NCT01232283|19191095|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
5552590|NCT01232283|19191096|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5552591|NCT01232283|19191097|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5552592|NCT01232283|19191098|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5552593|NCT01232283|19191099|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
5552594|NCT01232283|19191090|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5552595|NCT01232283|19191091|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5552596|NCT01232283|19191092|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
5552597|NCT01232283|19191093|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5552598|NCT01232283|19191094|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
5552599|NCT01232283|19191095|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
5552600|NCT01232283|19191096|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5552601|NCT01232283|19191097|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5552602|NCT01232283|19191098|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5552603|NCT01232283|19191099|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
5552604|NCT01232283|19191090|P10|Maintenance Phase (Weeks16-32)|Other|0
5552605|NCT01232283|19191091|P9|Maintenance Phase (Weeks16-32)|Other|0
5552606|NCT01232283|19191092|P8|Maintenance Phase (Weeks16-32)|Other|0
5552607|NCT01232283|19191093|P7|Maintenance Phase (Weeks16-32)|Other|0
5552608|NCT01232283|19191094|P6|Maintenance Phase (Weeks16-32)|Other|0
5552609|NCT01232283|19191095|P5|Maintenance Phase (Weeks16-32)|Other|0
5552610|NCT01232283|19191096|P4|Maintenance Phase (Weeks16-32)|Other|0
5552611|NCT01232283|19191097|P3|Maintenance Phase (Weeks16-32)|Other|2
5552612|NCT01232283|19191098|P2|Maintenance Phase (Weeks16-32)|Other|0
5552613|NCT01232283|19191099|P1|Maintenance Phase (Weeks16-32)|Other|0
5552614|NCT01232283|19191090|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5552615|NCT01232283|19191091|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5552616|NCT01232283|19191092|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5552617|NCT01232283|19191093|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5552618|NCT01232283|19191094|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5552619|NCT01232283|19191095|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5552620|NCT01232283|19191096|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
5552621|NCT01232283|19191097|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
5552622|NCT01232283|19191098|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5552623|NCT01232283|19191099|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
5552624|NCT01232283|19191090|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5552625|NCT01232283|19191091|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5552626|NCT01232283|19191092|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5552627|NCT01232283|19191093|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5552628|NCT01232283|19191094|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5552629|NCT01232283|19191095|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5552630|NCT01232283|19191096|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
5552631|NCT01232283|19191097|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
5552632|NCT01232283|19191098|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5552633|NCT01232283|19191099|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
5552634|NCT01232283|19191090|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5552635|NCT01232283|19191091|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5552636|NCT01232283|19191092|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5552637|NCT01232283|19191093|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5552638|NCT01232283|19191094|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5552639|NCT01232283|19191095|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5552640|NCT01232283|19191096|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5552641|NCT01232283|19191097|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
5552642|NCT01232283|19191098|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5552643|NCT01232283|19191099|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
5552644|NCT01232283|19191090|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5552645|NCT01232283|19191091|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5552646|NCT01232283|19191092|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5552647|NCT01232283|19191093|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5552648|NCT01232283|19191094|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5552649|NCT01232283|19191095|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5552650|NCT01232283|19191096|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
5552651|NCT01232283|19191097|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
5552652|NCT01232283|19191098|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5552653|NCT01232283|19191099|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
5552654|NCT01232283|19191090|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
5552655|NCT01232283|19191091|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
5552656|NCT01232283|19191092|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
5552657|NCT01232283|19191093|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
5552658|NCT01232283|19191094|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
5552659|NCT01232283|19191095|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
5552660|NCT01232283|19191096|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
5552661|NCT01232283|19191097|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
5552662|NCT01232283|19191098|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
5552663|NCT01232283|19191099|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
5552664|NCT01232283|19191090|P10|Placebo Controlled Phase (Weeks 0-16)|Other|0
5552665|NCT01232283|19191091|P9|Placebo Controlled Phase (Weeks 0-16)|Other|0
5552666|NCT01232283|19191092|P8|Placebo Controlled Phase (Weeks 0-16)|Other|0
5552667|NCT01232283|19191093|P7|Placebo Controlled Phase (Weeks 0-16)|Other|0
5552668|NCT01232283|19191094|P6|Placebo Controlled Phase (Weeks 0-16)|Other|0
5552669|NCT01232283|19191095|P5|Placebo Controlled Phase (Weeks 0-16)|Other|0
5552670|NCT01232283|19191096|P4|Placebo Controlled Phase (Weeks 0-16)|Other|0
5552671|NCT01232283|19191097|P3|Placebo Controlled Phase (Weeks 0-16)|Other|0
5552672|NCT01232283|19191098|P2|Placebo Controlled Phase (Weeks 0-16)|Other|1
5552673|NCT01232283|19191099|P1|Placebo Controlled Phase (Weeks 0-16)|Other|2
5552674|NCT01232283|19191090|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5552675|NCT01232283|19191091|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5552676|NCT01232283|19191092|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5552677|NCT01232283|19191093|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5552678|NCT01232283|19191094|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5552679|NCT01232283|19191095|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5552680|NCT01232283|19191096|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5552681|NCT01232283|19191097|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
5552682|NCT01232283|19191098|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
5552683|NCT01232283|19191099|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
5552684|NCT01232283|19191090|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5552685|NCT01232283|19191091|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5552686|NCT01232283|19191092|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5552687|NCT01232283|19191093|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5552688|NCT01232283|19191094|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5552689|NCT01232283|19191095|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5552690|NCT01232283|19191096|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5552691|NCT01232283|19191097|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
5552692|NCT01232283|19191098|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
5552693|NCT01232283|19191099|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
5552694|NCT01232283|19191090|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5552695|NCT01232283|19191091|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5552696|NCT01232283|19191092|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5552697|NCT01232283|19191093|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5552698|NCT01232283|19191094|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5552699|NCT01232283|19191095|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5552700|NCT01232283|19191096|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5552701|NCT01232283|19191097|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
5552702|NCT01232283|19191098|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
5552703|NCT01232283|19191099|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
5552704|NCT01232283|19191090|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5552705|NCT01232283|19191091|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5552706|NCT01232283|19191092|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5552707|NCT01232283|19191093|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5552708|NCT01232283|19191094|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5552709|NCT01232283|19191095|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5552710|NCT01232283|19191096|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5552711|NCT01232283|19191097|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5552712|NCT01232283|19191098|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
5552713|NCT01232283|19191099|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
5552714|NCT01232283|19191090|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5552715|NCT01232283|19191091|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5552716|NCT01232283|19191092|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5552717|NCT01232283|19191093|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5552718|NCT01232283|19191094|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5552719|NCT01232283|19191095|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5552720|NCT01232283|19191096|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5552721|NCT01232283|19191097|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
5552722|NCT01232283|19191098|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
5552723|NCT01232283|19191099|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
5552724|NCT01232283|19191090|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5552725|NCT01232283|19191091|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5552726|NCT01232283|19191092|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5552727|NCT01232283|19191093|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5552728|NCT01232283|19191094|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5552729|NCT01232283|19191095|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5552730|NCT01232283|19191096|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5552731|NCT01232283|19191097|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
5552732|NCT01232283|19191098|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
5552733|NCT01232283|19191099|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
5552734|NCT01232127|19191140|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
5552735|NCT01232127|19191141|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
5552736|NCT01232127|19191142|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
5552737|NCT01231984|19191166|P4|Study Period 2|Did not continue to meet I/E Criteria|1
5552738|NCT01231984|19191167|P3|Study Period 2|Did not continue to meet I/E Criteria|0
5552739|NCT01231984|19191168|P2|Study Period 2|Did not continue to meet I/E Criteria|1
5552740|NCT01231984|19191169|P1|Study Period 2|Did not continue to meet I/E Criteria|1
5552741|NCT01231984|19191166|P4|Study Period 2|Lost to Follow-up|3
5552742|NCT01231984|19191167|P3|Study Period 2|Lost to Follow-up|0
5552743|NCT01231984|19191168|P2|Study Period 2|Lost to Follow-up|0
5552744|NCT01231984|19191169|P1|Study Period 2|Lost to Follow-up|1
5552745|NCT01231984|19191166|P4|Study Period 2|Withdrawal by Subject|0
5552746|NCT01231984|19191167|P3|Study Period 2|Withdrawal by Subject|0
5552747|NCT01231984|19191168|P2|Study Period 2|Withdrawal by Subject|1
5552748|NCT01231984|19191169|P1|Study Period 2|Withdrawal by Subject|1
5552749|NCT01231984|19191166|P4|Study Period 1|Other|1
5552750|NCT01231984|19191167|P3|Study Period 1|Other|0
5552751|NCT01231984|19191168|P2|Study Period 1|Other|0
5552752|NCT01231984|19191169|P1|Study Period 1|Other|0
5552753|NCT01231984|19191166|P4|Study Period 1|Adverse Event|0
5552754|NCT01231984|19191167|P3|Study Period 1|Adverse Event|0
5552755|NCT01231984|19191168|P2|Study Period 1|Adverse Event|0
5552756|NCT01231984|19191169|P1|Study Period 1|Adverse Event|1
5552757|NCT01231984|19191166|P4|Study Period 1|Protocol Violation|3
5552758|NCT01231984|19191167|P3|Study Period 1|Protocol Violation|2
5552759|NCT01231984|19191168|P2|Study Period 1|Protocol Violation|4
5552760|NCT01231984|19191169|P1|Study Period 1|Protocol Violation|3
5552761|NCT01231984|19191166|P4|Study Period 1|Non-compliance with study requirements|1
5552762|NCT01231984|19191167|P3|Study Period 1|Non-compliance with study requirements|2
5552763|NCT01231984|19191168|P2|Study Period 1|Non-compliance with study requirements|0
5552938|NCT01230827|19191927|P3|Overall Study|Adverse Event|3
5552764|NCT01231984|19191169|P1|Study Period 1|Non-compliance with study requirements|5
5552765|NCT01231984|19191166|P4|Study Period 1|Screen Failure|1
5552766|NCT01231984|19191167|P3|Study Period 1|Screen Failure|0
5552767|NCT01231984|19191168|P2|Study Period 1|Screen Failure|0
5552768|NCT01231984|19191169|P1|Study Period 1|Screen Failure|0
5552769|NCT01231984|19191166|P4|Study Period 1|Did not continue to meet I/E Criteria|2
5552770|NCT01231984|19191167|P3|Study Period 1|Did not continue to meet I/E Criteria|2
5552771|NCT01231984|19191168|P2|Study Period 1|Did not continue to meet I/E Criteria|2
5552772|NCT01231984|19191169|P1|Study Period 1|Did not continue to meet I/E Criteria|2
5552773|NCT01231984|19191166|P4|Study Period 1|Lost to Follow-up|0
5552774|NCT01231984|19191167|P3|Study Period 1|Lost to Follow-up|1
5552775|NCT01231984|19191168|P2|Study Period 1|Lost to Follow-up|1
5552776|NCT01231984|19191169|P1|Study Period 1|Lost to Follow-up|1
5552777|NCT01231984|19191166|P4|Study Period 1|Withdrawal by Subject|1
5552778|NCT01231984|19191167|P3|Study Period 1|Withdrawal by Subject|0
5552779|NCT01231984|19191168|P2|Study Period 1|Withdrawal by Subject|0
5552780|NCT01231984|19191169|P1|Study Period 1|Withdrawal by Subject|0
5552781|NCT01231620|19191238|P3|Overall Study|Lost to Follow-up|9
5552782|NCT01231620|19191239|P2|Overall Study|Lost to Follow-up|4
5552783|NCT01231620|19191240|P1|Overall Study|Lost to Follow-up|3
5552784|NCT01231620|19191238|P3|Overall Study|Withdrawal by Subject|8
5552785|NCT01231620|19191239|P2|Overall Study|Withdrawal by Subject|6
5552786|NCT01231620|19191240|P1|Overall Study|Withdrawal by Subject|6
5552787|NCT01231620|19191238|P3|Overall Study|Adverse Event|1
5552788|NCT01231620|19191239|P2|Overall Study|Adverse Event|2
5552789|NCT01231620|19191240|P1|Overall Study|Adverse Event|2
5552790|NCT01231620|19191238|P3|Overall Study|Death|11
5552791|NCT01231620|19191239|P2|Overall Study|Death|14
5552792|NCT01231620|19191240|P1|Overall Study|Death|12
5552793|NCT01231620|19191238|P3|Overall Study|Physician Decision|10
5552794|NCT01231620|19191239|P2|Overall Study|Physician Decision|5
5552795|NCT01231620|19191240|P1|Overall Study|Physician Decision|3
5552796|NCT01231607|19191346|P5|Overall Study|Withdrawal by Subject|9
5552797|NCT01231607|19191347|P4|Overall Study|Withdrawal by Subject|17
5552798|NCT01231607|19191348|P3|Overall Study|Withdrawal by Subject|14
5552799|NCT01231607|19191349|P2|Overall Study|Withdrawal by Subject|9
5552800|NCT01231607|19191350|P1|Overall Study|Withdrawal by Subject|9
5552801|NCT01231607|19191346|P5|Overall Study|Protocol Violation|2
5552802|NCT01231607|19191347|P4|Overall Study|Protocol Violation|2
5552803|NCT01231607|19191348|P3|Overall Study|Protocol Violation|0
5552804|NCT01231607|19191349|P2|Overall Study|Protocol Violation|2
5552805|NCT01231607|19191350|P1|Overall Study|Protocol Violation|3
5552806|NCT01231607|19191346|P5|Overall Study|Physician Decision|4
5552807|NCT01231607|19191347|P4|Overall Study|Physician Decision|5
5552808|NCT01231607|19191348|P3|Overall Study|Physician Decision|3
5552809|NCT01231607|19191349|P2|Overall Study|Physician Decision|4
5552810|NCT01231607|19191350|P1|Overall Study|Physician Decision|4
5552811|NCT01231607|19191346|P5|Overall Study|Lost to Follow-up|4
5552812|NCT01231607|19191347|P4|Overall Study|Lost to Follow-up|10
5552813|NCT01231607|19191348|P3|Overall Study|Lost to Follow-up|10
5552814|NCT01231607|19191349|P2|Overall Study|Lost to Follow-up|11
5552815|NCT01231607|19191350|P1|Overall Study|Lost to Follow-up|13
5552816|NCT01231607|19191346|P5|Overall Study|Adverse Event|5
5552817|NCT01231607|19191347|P4|Overall Study|Adverse Event|4
5552818|NCT01231607|19191348|P3|Overall Study|Adverse Event|4
5552819|NCT01231607|19191349|P2|Overall Study|Adverse Event|8
5552820|NCT01231607|19191350|P1|Overall Study|Adverse Event|0
5552821|NCT01231581|19191442|P2|Overall Study|Ongoing|0
5552822|NCT01231581|19191443|P1|Overall Study|Ongoing|1
5552823|NCT01231581|19191442|P2|Overall Study|Death|64
5552824|NCT01231581|19191443|P1|Overall Study|Death|65
5552825|NCT01231581|19191442|P2|Overall Study|Study Closed/Terminated|5
5552826|NCT01231581|19191443|P1|Overall Study|Study Closed/Terminated|6
5552827|NCT01231581|19191442|P2|Overall Study|Withdrawal by Subject|9
5552828|NCT01231581|19191443|P1|Overall Study|Withdrawal by Subject|6
5552829|NCT01231581|19191442|P2|Overall Study|Lost to Follow-up|2
5552830|NCT01231581|19191443|P1|Overall Study|Lost to Follow-up|2
5552831|NCT01231555|19191464|P3|Overall Study|Withdrawal by Subject|0
5552832|NCT01231555|19191465|P2|Overall Study|Withdrawal by Subject|2
5552833|NCT01231555|19191466|P1|Overall Study|Withdrawal by Subject|0
5552834|NCT01231555|19191464|P3|Overall Study|Study terminated|8
5552835|NCT01231555|19191465|P2|Overall Study|Study terminated|5
5552836|NCT01231555|19191466|P1|Overall Study|Study terminated|8
5552837|NCT01231516|19191497|P2|Open-label Phase|Ongoing at the time of analysis|23
5552838|NCT01231516|19191498|P1|Open-label Phase|Ongoing at the time of analysis|282
5552839|NCT01231516|19191497|P2|Open-label Phase|Withdrawal by Subject|0
5552840|NCT01231516|19191498|P1|Open-label Phase|Withdrawal by Subject|1
5552841|NCT01231516|19191497|P2|Open-label Phase|Lost to Follow-up|0
5552842|NCT01231516|19191498|P1|Open-label Phase|Lost to Follow-up|3
5552843|NCT01231516|19191497|P2|Open-label Phase|Protocol Violation|0
5552844|NCT01231516|19191498|P1|Open-label Phase|Protocol Violation|2
5552845|NCT01231516|19191497|P2|Open-label Phase|Lack of Efficacy|3
5552846|NCT01231516|19191498|P1|Open-label Phase|Lack of Efficacy|7
5552847|NCT01231516|19191497|P2|48 Week Double-blind Phase|Site Closed|1
5552848|NCT01231516|19191498|P1|48 Week Double-blind Phase|Site Closed|3
5552849|NCT01231516|19191497|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
5552850|NCT01231516|19191498|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
5552851|NCT01231516|19191497|P2|48 Week Double-blind Phase|Physician Decision|1
5552852|NCT01231516|19191498|P1|48 Week Double-blind Phase|Physician Decision|1
5552853|NCT01231516|19191497|P2|48 Week Double-blind Phase|Lost to Follow-up|10
5552854|NCT01231516|19191498|P1|48 Week Double-blind Phase|Lost to Follow-up|5
5552855|NCT01231516|19191497|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
5552856|NCT01231516|19191498|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
5552857|NCT01231516|19191497|P2|48 Week Double-blind Phase|Protocol Violation|6
5552858|NCT01231516|19191498|P1|48 Week Double-blind Phase|Protocol Violation|9
5552859|NCT01231516|19191497|P2|48 Week Double-blind Phase|Lack of Efficacy|42
5552860|NCT01231516|19191498|P1|48 Week Double-blind Phase|Lack of Efficacy|20
5552861|NCT01231516|19191497|P2|48 Week Double-blind Phase|Adverse Event|11
5552862|NCT01231516|19191498|P1|48 Week Double-blind Phase|Adverse Event|4
5552863|NCT01231503|19191528|P8|Overall Study|Protocol Violation|0
5552864|NCT01231503|19191529|P7|Overall Study|Protocol Violation|0
5552865|NCT01231503|19191530|P6|Overall Study|Protocol Violation|0
5552866|NCT01231503|19191531|P5|Overall Study|Protocol Violation|0
5552867|NCT01231503|19191532|P4|Overall Study|Protocol Violation|1
5552868|NCT01231503|19191533|P3|Overall Study|Protocol Violation|0
5552869|NCT01231503|19191534|P2|Overall Study|Protocol Violation|0
5552870|NCT01231503|19191535|P1|Overall Study|Protocol Violation|0
5552871|NCT01231503|19191528|P8|Overall Study|Lost to Follow-up|6
5552872|NCT01231503|19191529|P7|Overall Study|Lost to Follow-up|6
5552873|NCT01231503|19191530|P6|Overall Study|Lost to Follow-up|9
5552874|NCT01231503|19191531|P5|Overall Study|Lost to Follow-up|7
5552875|NCT01231503|19191532|P4|Overall Study|Lost to Follow-up|5
5552876|NCT01231503|19191533|P3|Overall Study|Lost to Follow-up|8
5552877|NCT01231503|19191534|P2|Overall Study|Lost to Follow-up|10
5552878|NCT01231503|19191535|P1|Overall Study|Lost to Follow-up|8
5552879|NCT01231503|19191528|P8|Overall Study|Withdrawal by Subject|2
5552880|NCT01231503|19191529|P7|Overall Study|Withdrawal by Subject|1
5552881|NCT01231503|19191530|P6|Overall Study|Withdrawal by Subject|5
5552882|NCT01231503|19191531|P5|Overall Study|Withdrawal by Subject|3
5552883|NCT01231503|19191532|P4|Overall Study|Withdrawal by Subject|1
5552884|NCT01231503|19191533|P3|Overall Study|Withdrawal by Subject|3
5552885|NCT01231503|19191534|P2|Overall Study|Withdrawal by Subject|3
5552886|NCT01231503|19191535|P1|Overall Study|Withdrawal by Subject|6
5552887|NCT01231503|19191528|P8|Overall Study|Adverse event, serious fatal|0
5552888|NCT01231503|19191529|P7|Overall Study|Adverse event, serious fatal|0
5552889|NCT01231503|19191530|P6|Overall Study|Adverse event, serious fatal|1
5552890|NCT01231503|19191531|P5|Overall Study|Adverse event, serious fatal|0
5552891|NCT01231503|19191532|P4|Overall Study|Adverse event, serious fatal|1
5552892|NCT01231503|19191533|P3|Overall Study|Adverse event, serious fatal|1
5552893|NCT01231503|19191534|P2|Overall Study|Adverse event, serious fatal|0
5552894|NCT01231503|19191535|P1|Overall Study|Adverse event, serious fatal|0
5552895|NCT01231503|19191528|P8|Overall Study|Adverse Event|0
5552896|NCT01231503|19191529|P7|Overall Study|Adverse Event|0
5552897|NCT01231503|19191530|P6|Overall Study|Adverse Event|1
5552898|NCT01231503|19191531|P5|Overall Study|Adverse Event|0
5552899|NCT01231503|19191532|P4|Overall Study|Adverse Event|0
5552900|NCT01231503|19191533|P3|Overall Study|Adverse Event|0
5552901|NCT01231503|19191534|P2|Overall Study|Adverse Event|0
5552902|NCT01231503|19191535|P1|Overall Study|Adverse Event|0
5552903|NCT01231464|19191775|P2|Overall Study|Withdrawal by Subject|2
5552904|NCT01231464|19191776|P1|Overall Study|Withdrawal by Subject|3
5552905|NCT01231464|19191775|P2|Overall Study|Lost to Follow-up|2
5552906|NCT01231464|19191776|P1|Overall Study|Lost to Follow-up|1
5552907|NCT01231464|19191775|P2|Overall Study|Protocol Violation|2
5552908|NCT01231464|19191776|P1|Overall Study|Protocol Violation|1
5552909|NCT01231464|19191775|P2|Overall Study|Adverse Event|1
5552910|NCT01231464|19191776|P1|Overall Study|Adverse Event|0
5552911|NCT01231373|19191825|P4|Overall Study|Withdrew Consent|0
5552912|NCT01231373|19191826|P3|Overall Study|Withdrew Consent|0
5552913|NCT01231373|19191827|P2|Overall Study|Withdrew Consent|0
5552914|NCT01231373|19191828|P1|Overall Study|Withdrew Consent|1
5552915|NCT01231373|19191825|P4|Overall Study|Lost to Follow-up|1
5552916|NCT01231373|19191826|P3|Overall Study|Lost to Follow-up|0
5552917|NCT01231373|19191827|P2|Overall Study|Lost to Follow-up|0
5552918|NCT01231373|19191828|P1|Overall Study|Lost to Follow-up|0
5552919|NCT01231373|19191825|P4|Overall Study|Withdrew consent prior to randomization|0
5552920|NCT01231373|19191826|P3|Overall Study|Withdrew consent prior to randomization|0
5552921|NCT01231373|19191827|P2|Overall Study|Withdrew consent prior to randomization|1
5552922|NCT01231373|19191828|P1|Overall Study|Withdrew consent prior to randomization|2
5552923|NCT01231321|19191867|P1|Overall Study|Lack of Efficacy|2
5552924|NCT01231321|19191867|P1|Overall Study|Adverse Event|3
5552925|NCT01230892|19191915|P2|Overall Study|Lost to Follow-up|0
5552926|NCT01230892|19191916|P1|Overall Study|Lost to Follow-up|2
5552927|NCT01230892|19191915|P2|Overall Study|Withdrawal by Subject|1
5552928|NCT01230892|19191916|P1|Overall Study|Withdrawal by Subject|1
5552929|NCT01230827|19191926|P4|Overall Study|Study terminated by Sponsor|63
5552930|NCT01230827|19191927|P3|Overall Study|Study terminated by Sponsor|56
5552931|NCT01230827|19191928|P2|Overall Study|Study terminated by Sponsor|2
5552932|NCT01230827|19191929|P1|Overall Study|Study terminated by Sponsor|0
5552933|NCT01230827|19191926|P4|Overall Study|Recovery|0
5552934|NCT01230827|19191927|P3|Overall Study|Recovery|0
5552935|NCT01230827|19191928|P2|Overall Study|Recovery|6
5552936|NCT01230827|19191929|P1|Overall Study|Recovery|0
5552937|NCT01230827|19191926|P4|Overall Study|Adverse Event|7
5552939|NCT01230827|19191928|P2|Overall Study|Adverse Event|2
5552940|NCT01230827|19191929|P1|Overall Study|Adverse Event|4
5552941|NCT01230827|19191926|P4|Overall Study|Lack of Efficacy|3
5552942|NCT01230827|19191927|P3|Overall Study|Lack of Efficacy|2
5552943|NCT01230827|19191928|P2|Overall Study|Lack of Efficacy|1
5552944|NCT01230827|19191929|P1|Overall Study|Lack of Efficacy|14
5552945|NCT01230827|19191926|P4|Overall Study|Withdrawal by Subject|2
5552946|NCT01230827|19191927|P3|Overall Study|Withdrawal by Subject|3
5552947|NCT01230827|19191928|P2|Overall Study|Withdrawal by Subject|0
5552948|NCT01230827|19191929|P1|Overall Study|Withdrawal by Subject|1
5552949|NCT01230827|19191926|P4|Overall Study|Lost to Follow-up|3
5552950|NCT01230827|19191927|P3|Overall Study|Lost to Follow-up|1
5552951|NCT01230827|19191928|P2|Overall Study|Lost to Follow-up|0
5552952|NCT01230827|19191929|P1|Overall Study|Lost to Follow-up|0
5552953|NCT01230814|19191945|P2|Overall Study|Discontinued (not due to adverse event)|1
5552954|NCT01230814|19191946|P1|Overall Study|Discontinued (not due to adverse event)|2
5552955|NCT01230814|19191945|P2|Overall Study|Lost to Follow-up|3
5552956|NCT01230814|19191946|P1|Overall Study|Lost to Follow-up|11
5552957|NCT01230788|19191996|P1|Overall Study|Prescribed exclusion drug|1
5552958|NCT01230749|19192008|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
5552959|NCT01230749|19192009|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
5552960|NCT01230749|19192010|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
5552961|NCT01230749|19192011|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
5552962|NCT01230749|19192008|P4|Overall Study|Withdrawal by Subject|0
5552963|NCT01230749|19192009|P3|Overall Study|Withdrawal by Subject|0
5552964|NCT01230749|19192010|P2|Overall Study|Withdrawal by Subject|1
5552965|NCT01230749|19192011|P1|Overall Study|Withdrawal by Subject|0
5552966|NCT01230749|19192008|P4|Overall Study|Physician Decision|0
5552967|NCT01230749|19192009|P3|Overall Study|Physician Decision|1
5552968|NCT01230749|19192010|P2|Overall Study|Physician Decision|0
5552969|NCT01230749|19192011|P1|Overall Study|Physician Decision|0
5552970|NCT01230749|19192008|P4|Overall Study|Adverse Event|1
5552971|NCT01230749|19192009|P3|Overall Study|Adverse Event|0
5552972|NCT01230749|19192010|P2|Overall Study|Adverse Event|0
5552973|NCT01230749|19192011|P1|Overall Study|Adverse Event|0
5552974|NCT01230710|19192046|P1|Overall Study|Withdrawal of Consent|1
5552975|NCT01230710|19192046|P1|Overall Study|Death|4
5552976|NCT01230710|19192046|P1|Overall Study|Lost to Follow-up|3
5552977|NCT01230710|19192046|P1|Overall Study|Disease Progression|41
5552978|NCT01230554|19192070|P1|Overall Study|Inability to maintain visit schedule|1
5552979|NCT01230554|19192070|P1|Overall Study|Lost to Follow-up|2
5552980|NCT01230489|19192093|P1|Overall Study|Treatment modality changed|1
5552981|NCT01230489|19192093|P1|Overall Study|Adverse Event|2
5552982|NCT01230489|19192093|P1|Overall Study|Death|2
5552983|NCT01230307|19192128|P2|Overall Study|LVAD Placement|2
5552984|NCT01230307|19192129|P1|Overall Study|LVAD Placement|0
5552985|NCT01230060|19192162|P1|Overall Study|Withdrawal by Subject|1
5552986|NCT01229735|19192235|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5552987|NCT01229735|19192236|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5552988|NCT01229735|19192235|P2|Overall Study|AE, non-serious non-fatal|17
5552989|NCT01229735|19192236|P1|Overall Study|AE, non-serious non-fatal|13
5552990|NCT01229735|19192235|P2|Overall Study|SAE, non-fatal|4
5552991|NCT01229735|19192236|P1|Overall Study|SAE, non-fatal|0
5552992|NCT01229735|19192235|P2|Overall Study|Other Reason|10
5552993|NCT01229735|19192236|P1|Overall Study|Other Reason|13
5552994|NCT01229735|19192235|P2|Overall Study|Withdrawal by Subject|17
5552995|NCT01229735|19192236|P1|Overall Study|Withdrawal by Subject|18
5552996|NCT01229735|19192235|P2|Overall Study|Lost to Follow-up|2
5552997|NCT01229735|19192236|P1|Overall Study|Lost to Follow-up|0
5552998|NCT01229735|19192235|P2|Overall Study|Protocol Violation|8
5552999|NCT01229735|19192236|P1|Overall Study|Protocol Violation|13
5553000|NCT01229735|19192235|P2|Overall Study|Lack of Efficacy|8
5553001|NCT01229735|19192236|P1|Overall Study|Lack of Efficacy|8
5553002|NCT01229449|19192293|P5|Overall Study|Physician Decision|0
5553003|NCT01229449|19192294|P4|Overall Study|Physician Decision|0
5553004|NCT01229449|19192295|P3|Overall Study|Physician Decision|1
5553005|NCT01229449|19192296|P2|Overall Study|Physician Decision|0
5553006|NCT01229449|19192297|P1|Overall Study|Physician Decision|0
5553007|NCT01229449|19192293|P5|Overall Study|Lost to Follow-up|0
5553008|NCT01229449|19192294|P4|Overall Study|Lost to Follow-up|0
5553009|NCT01229449|19192295|P3|Overall Study|Lost to Follow-up|1
5553010|NCT01229449|19192296|P2|Overall Study|Lost to Follow-up|1
5553011|NCT01229449|19192297|P1|Overall Study|Lost to Follow-up|1
5553012|NCT01229449|19192293|P5|Overall Study|Withdrawal by Subject|1
5553013|NCT01229449|19192294|P4|Overall Study|Withdrawal by Subject|1
5553014|NCT01229449|19192295|P3|Overall Study|Withdrawal by Subject|0
5553015|NCT01229449|19192296|P2|Overall Study|Withdrawal by Subject|3
5553016|NCT01229449|19192297|P1|Overall Study|Withdrawal by Subject|0
5553017|NCT01229436|19192354|P1|Overall Study|Lost to Follow-up|3
5553018|NCT01229436|19192354|P1|Overall Study|Withdrawal by Subject|2
5553019|NCT01229397|19192416|P2|Overall Study|Migrated/moved from study area|0
5553020|NCT01229397|19192417|P1|Overall Study|Migrated/moved from study area|1
5553021|NCT01229397|19192416|P2|Overall Study|Lost to Follow-up|6
5553022|NCT01229397|19192417|P1|Overall Study|Lost to Follow-up|7
5553023|NCT01229397|19192416|P2|Overall Study|Withdrawal by Subject|3
5553024|NCT01229397|19192417|P1|Overall Study|Withdrawal by Subject|3
5553025|NCT01229371|19192435|P4|Overall Study|Withdrawal by Subject|0
5553026|NCT01229371|19192436|P3|Overall Study|Withdrawal by Subject|0
5553027|NCT01229371|19192437|P2|Overall Study|Withdrawal by Subject|1
5553028|NCT01229371|19192438|P1|Overall Study|Withdrawal by Subject|0
5553029|NCT01229267|19192465|P5|Overall Study|Lost to Follow-up|22
5553030|NCT01229267|19192466|P4|Overall Study|Lost to Follow-up|3
5553031|NCT01229267|19192467|P3|Overall Study|Lost to Follow-up|8
5553032|NCT01229267|19192468|P2|Overall Study|Lost to Follow-up|5
5553033|NCT01229267|19192469|P1|Overall Study|Lost to Follow-up|6
5553034|NCT01229267|19192465|P5|Overall Study|Physician Decision|25
5553035|NCT01229267|19192466|P4|Overall Study|Physician Decision|3
5553036|NCT01229267|19192467|P3|Overall Study|Physician Decision|8
5553037|NCT01229267|19192468|P2|Overall Study|Physician Decision|11
5553038|NCT01229267|19192469|P1|Overall Study|Physician Decision|8
5553039|NCT01229267|19192465|P5|Overall Study|Progressive disease|1
5553040|NCT01229267|19192466|P4|Overall Study|Progressive disease|0
5553041|NCT01229267|19192467|P3|Overall Study|Progressive disease|0
5553042|NCT01229267|19192468|P2|Overall Study|Progressive disease|0
5553043|NCT01229267|19192469|P1|Overall Study|Progressive disease|0
5553044|NCT01229267|19192465|P5|Overall Study|Protocol Violation|0
5553045|NCT01229267|19192466|P4|Overall Study|Protocol Violation|0
5553046|NCT01229267|19192467|P3|Overall Study|Protocol Violation|0
5553047|NCT01229267|19192468|P2|Overall Study|Protocol Violation|1
5553048|NCT01229267|19192469|P1|Overall Study|Protocol Violation|0
5553049|NCT01229267|19192465|P5|Overall Study|Withdrawal by Subject|59
5553050|NCT01229267|19192466|P4|Overall Study|Withdrawal by Subject|14
5553051|NCT01229267|19192467|P3|Overall Study|Withdrawal by Subject|32
5553052|NCT01229267|19192468|P2|Overall Study|Withdrawal by Subject|22
5553053|NCT01229267|19192469|P1|Overall Study|Withdrawal by Subject|23
5553054|NCT01229267|19192465|P5|Overall Study|Death|103
5553055|NCT01229267|19192466|P4|Overall Study|Death|13
5553056|NCT01229267|19192467|P3|Overall Study|Death|35
5553057|NCT01229267|19192468|P2|Overall Study|Death|37
5553058|NCT01229267|19192469|P1|Overall Study|Death|40
5553059|NCT01229267|19192465|P5|Overall Study|Adverse Event|10
5553060|NCT01229267|19192466|P4|Overall Study|Adverse Event|2
5553061|NCT01229267|19192467|P3|Overall Study|Adverse Event|3
5553062|NCT01229267|19192468|P2|Overall Study|Adverse Event|6
5553063|NCT01229267|19192469|P1|Overall Study|Adverse Event|4
5553064|NCT01229254|19192488|P3|Overall Study|Non-compliance with Study Drug|1
5553065|NCT01229254|19192489|P2|Overall Study|Non-compliance with Study Drug|1
5553066|NCT01229254|19192490|P1|Overall Study|Non-compliance with Study Drug|0
5553067|NCT01229254|19192488|P3|Overall Study|Withdrawal by Subject|1
5553068|NCT01229254|19192489|P2|Overall Study|Withdrawal by Subject|0
5553069|NCT01229254|19192490|P1|Overall Study|Withdrawal by Subject|1
5553070|NCT01229254|19192488|P3|Overall Study|Protocol Violation|5
5553071|NCT01229254|19192489|P2|Overall Study|Protocol Violation|6
5553072|NCT01229254|19192490|P1|Overall Study|Protocol Violation|4
5553073|NCT01229254|19192488|P3|Overall Study|Physician Decision|0
5553074|NCT01229254|19192489|P2|Overall Study|Physician Decision|3
5553075|NCT01229254|19192490|P1|Overall Study|Physician Decision|0
5553076|NCT01229254|19192488|P3|Overall Study|Lost to Follow-up|1
5553077|NCT01229254|19192489|P2|Overall Study|Lost to Follow-up|0
5553078|NCT01229254|19192490|P1|Overall Study|Lost to Follow-up|3
5553079|NCT01229254|19192488|P3|Overall Study|Adverse Event|3
5553080|NCT01229254|19192489|P2|Overall Study|Adverse Event|5
5553081|NCT01229254|19192490|P1|Overall Study|Adverse Event|4
5553082|NCT01229254|19192488|P3|Overall Study|Not Continuing Into Safety Extension|1
5553083|NCT01229254|19192489|P2|Overall Study|Not Continuing Into Safety Extension|1
5553084|NCT01229254|19192490|P1|Overall Study|Not Continuing Into Safety Extension|3
5553085|NCT01229176|19192528|P8|Overall Study|Lost to Follow-up|2
5553086|NCT01229176|19192529|P7|Overall Study|Lost to Follow-up|0
5553087|NCT01229176|19192530|P6|Overall Study|Lost to Follow-up|1
5553088|NCT01229176|19192531|P5|Overall Study|Lost to Follow-up|1
5553089|NCT01229176|19192532|P4|Overall Study|Lost to Follow-up|0
5553090|NCT01229176|19192533|P3|Overall Study|Lost to Follow-up|0
5553091|NCT01229176|19192534|P2|Overall Study|Lost to Follow-up|3
5553092|NCT01229176|19192535|P1|Overall Study|Lost to Follow-up|0
5553093|NCT01229176|19192528|P8|Overall Study|Withdrawal by Subject|1
5553094|NCT01229176|19192529|P7|Overall Study|Withdrawal by Subject|0
5553095|NCT01229176|19192530|P6|Overall Study|Withdrawal by Subject|1
5553096|NCT01229176|19192531|P5|Overall Study|Withdrawal by Subject|1
5553097|NCT01229176|19192532|P4|Overall Study|Withdrawal by Subject|1
5553098|NCT01229176|19192533|P3|Overall Study|Withdrawal by Subject|0
5553099|NCT01229176|19192534|P2|Overall Study|Withdrawal by Subject|0
5553100|NCT01229176|19192535|P1|Overall Study|Withdrawal by Subject|0
5553101|NCT01229150|19192589|P4|Overall Study|Toxicity|0
5553102|NCT01229150|19192590|P3|Overall Study|Toxicity|0
5553103|NCT01229150|19192591|P2|Overall Study|Toxicity|2
5553104|NCT01229150|19192592|P1|Overall Study|Toxicity|2
5553105|NCT01229111|19192649|P1|Overall Study|Death|1
5553106|NCT01228747|19192698|P2|Overall Study|Other Reason|5
5553107|NCT01228747|19192699|P1|Overall Study|Other Reason|2
5553108|NCT01228747|19192698|P2|Overall Study|Withdrawal by Subject|1
5553109|NCT01228747|19192699|P1|Overall Study|Withdrawal by Subject|5
5553110|NCT01228747|19192698|P2|Overall Study|Lost to Follow-up|3
5553111|NCT01228747|19192699|P1|Overall Study|Lost to Follow-up|4
5553112|NCT01228747|19192698|P2|Overall Study|Protocol Violation|5
5553113|NCT01228747|19192699|P1|Overall Study|Protocol Violation|6
5553114|NCT01228747|19192698|P2|Overall Study|Lack of Efficacy|27
5553115|NCT01228747|19192699|P1|Overall Study|Lack of Efficacy|40
5553116|NCT01228747|19192698|P2|Overall Study|Adverse Event|4
5553117|NCT01228747|19192699|P1|Overall Study|Adverse Event|8
5553118|NCT01228734|19192715|P2|Overall Study|Randomized, but not treated|4
5553119|NCT01228734|19192716|P1|Overall Study|Randomized, but not treated|0
5553120|NCT01228591|19192730|P2|Baseline|Lack of Efficacy|2
5553121|NCT01228591|19192731|P1|Baseline|Lack of Efficacy|1
5553122|NCT01228318|19192760|P2|Overall Study|Incarcerated|0
5553123|NCT01228318|19192761|P1|Overall Study|Incarcerated|1
5553124|NCT01228318|19192760|P2|Overall Study|Moved|2
5553125|NCT01228318|19192761|P1|Overall Study|Moved|0
5553126|NCT01228318|19192760|P2|Overall Study|Unable to contact|5
5553127|NCT01228318|19192761|P1|Overall Study|Unable to contact|2
5553128|NCT01228318|19192760|P2|Overall Study|Clinic no show to receive intervention|0
5553129|NCT01228318|19192761|P1|Overall Study|Clinic no show to receive intervention|1
5553130|NCT01228175|19192777|P2|Overall Study|Physician Decision|1
5553131|NCT01228175|19192778|P1|Overall Study|Physician Decision|1
5553132|NCT01228175|19192777|P2|Overall Study|Withdrawal by Subject|2
5553133|NCT01228175|19192778|P1|Overall Study|Withdrawal by Subject|1
5553134|NCT01228175|19192777|P2|Overall Study|Lost to Follow-up|50
5553135|NCT01228175|19192778|P1|Overall Study|Lost to Follow-up|64
5553136|NCT01228071|19192820|P1|Overall Study|Withdrawal by Subject|1
5553137|NCT01228071|19192820|P1|Overall Study|Protocol Violation|1
5553138|NCT01228019|19192826|P1|Overall Study|Violation of Entry Criterion|9
5553139|NCT01228019|19192826|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
5553140|NCT01228019|19192826|P1|Overall Study|Missing pre-treatment data|72
5553141|NCT01228019|19192826|P1|Overall Study|Duplicate enrollment|1
5553142|NCT01228019|19192826|P1|Overall Study|Dose Violation|70
5553143|NCT01227967|19192892|P2|Overall Study|Taking Additional Antiviral Drug|0
5553144|NCT01227967|19192893|P1|Overall Study|Taking Additional Antiviral Drug|1
5553145|NCT01227967|19192892|P2|Overall Study|Never Started Treatment|4
5553146|NCT01227967|19192893|P1|Overall Study|Never Started Treatment|0
5553147|NCT01227967|19192892|P2|Overall Study|Physician Decision|1
5553148|NCT01227967|19192893|P1|Overall Study|Physician Decision|0
5553149|NCT01227967|19192892|P2|Overall Study|Withdrawal by Subject|3
5553150|NCT01227967|19192893|P1|Overall Study|Withdrawal by Subject|4
5553151|NCT01227967|19192892|P2|Overall Study|Lost to Follow-up|3
5553152|NCT01227967|19192893|P1|Overall Study|Lost to Follow-up|8
5553153|NCT01227967|19192892|P2|Overall Study|Death|1
5553154|NCT01227967|19192893|P1|Overall Study|Death|0
5553155|NCT01227967|19192892|P2|Overall Study|Protocol Violation|1
5553156|NCT01227967|19192893|P1|Overall Study|Protocol Violation|3
5553157|NCT01227954|19192927|P1|Overall Study|No protocol treatment|7
5553158|NCT01227954|19192927|P1|Overall Study|Protocol Violation|6
5553159|NCT01227928|19192941|P2|Overall Study|Death|12
5553160|NCT01227928|19192942|P1|Overall Study|Death|14
5553161|NCT01227928|19192941|P2|Overall Study|Withdrawal by Subject|3
5553162|NCT01227928|19192942|P1|Overall Study|Withdrawal by Subject|4
5553163|NCT01227928|19192941|P2|Overall Study|Lost to Follow-up|2
5553164|NCT01227928|19192942|P1|Overall Study|Lost to Follow-up|4
5553165|NCT01227902|19192980|P4|Overall Study|Withdrawal by Subject|3
5553166|NCT01227902|19192981|P3|Overall Study|Withdrawal by Subject|4
5553167|NCT01227902|19192982|P2|Overall Study|Withdrawal by Subject|2
5553168|NCT01227902|19192983|P1|Overall Study|Withdrawal by Subject|4
5553169|NCT01227902|19192980|P4|Overall Study|Physician Decision|0
5553170|NCT01227902|19192981|P3|Overall Study|Physician Decision|1
5553171|NCT01227902|19192982|P2|Overall Study|Physician Decision|1
5553172|NCT01227902|19192983|P1|Overall Study|Physician Decision|0
5553173|NCT01227902|19192980|P4|Overall Study|Lost to Follow-up|2
5553174|NCT01227902|19192981|P3|Overall Study|Lost to Follow-up|1
5553175|NCT01227902|19192982|P2|Overall Study|Lost to Follow-up|0
5553176|NCT01227902|19192983|P1|Overall Study|Lost to Follow-up|0
5553177|NCT01227902|19192980|P4|Overall Study|Protocol Violation|0
5553178|NCT01227902|19192981|P3|Overall Study|Protocol Violation|0
5553179|NCT01227902|19192982|P2|Overall Study|Protocol Violation|0
5553180|NCT01227902|19192983|P1|Overall Study|Protocol Violation|1
5553181|NCT01227902|19192980|P4|Overall Study|Lack of Efficacy|1
5553182|NCT01227902|19192981|P3|Overall Study|Lack of Efficacy|2
5553183|NCT01227902|19192982|P2|Overall Study|Lack of Efficacy|2
5553184|NCT01227902|19192983|P1|Overall Study|Lack of Efficacy|1
5553185|NCT01227902|19192980|P4|Overall Study|Adverse Event|4
5553186|NCT01227902|19192981|P3|Overall Study|Adverse Event|11
5553187|NCT01227902|19192982|P2|Overall Study|Adverse Event|8
5553188|NCT01227902|19192983|P1|Overall Study|Adverse Event|12
5553189|NCT01227889|19193076|P2|Crossover Phase|Withdrawal by Subject|1
5553190|NCT01227889|19193077|P1|Crossover Phase|Withdrawal by Subject|0
5553191|NCT01227889|19193076|P2|Crossover Phase|Study Terminated By Sponsor|1
5553192|NCT01227889|19193077|P1|Crossover Phase|Study Terminated By Sponsor|0
5553193|NCT01227889|19193076|P2|Crossover Phase|Progressive Disease|31
5553194|NCT01227889|19193077|P1|Crossover Phase|Progressive Disease|0
5553195|NCT01227889|19193076|P2|Crossover Phase|Physician Decision|3
5553196|NCT01227889|19193077|P1|Crossover Phase|Physician Decision|0
5553197|NCT01227889|19193076|P2|Crossover Phase|Adverse Event|1
5553198|NCT01227889|19193077|P1|Crossover Phase|Adverse Event|0
5553199|NCT01227889|19193076|P2|Randomized Phase (RP)|Withdrawal by Subject|3
5553200|NCT01227889|19193077|P1|Randomized Phase (RP)|Withdrawal by Subject|15
5553201|NCT01227889|19193076|P2|Randomized Phase (RP)|Missing|3
5553202|NCT01227889|19193077|P1|Randomized Phase (RP)|Missing|1
5553203|NCT01227889|19193076|P2|Randomized Phase (RP)|Study terminated by sponsor|0
5553204|NCT01227889|19193077|P1|Randomized Phase (RP)|Study terminated by sponsor|10
5553205|NCT01227889|19193076|P2|Randomized Phase (RP)|Progressive Disease|52
5553206|NCT01227889|19193077|P1|Randomized Phase (RP)|Progressive Disease|135
5553207|NCT01227889|19193076|P2|Randomized Phase (RP)|Physician Decision|5
5553208|NCT01227889|19193077|P1|Randomized Phase (RP)|Physician Decision|13
5553209|NCT01227889|19193076|P2|Randomized Phase (RP)|Adverse Event|0
5553210|NCT01227889|19193077|P1|Randomized Phase (RP)|Adverse Event|13
5553211|NCT01227824|19193104|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
5553212|NCT01227824|19193105|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
5553213|NCT01227824|19193106|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
5553214|NCT01227824|19193104|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
5553215|NCT01227824|19193105|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
5553216|NCT01227824|19193106|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
5553217|NCT01227824|19193104|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
5553218|NCT01227824|19193105|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
5553219|NCT01227824|19193106|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
5553220|NCT01227824|19193104|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
5553221|NCT01227824|19193105|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
5553222|NCT01227824|19193106|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
5553223|NCT01227824|19193104|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
5553224|NCT01227824|19193105|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
5553225|NCT01227824|19193106|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
5553226|NCT01227824|19193104|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
5553227|NCT01227824|19193105|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
5553228|NCT01227824|19193106|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
5553229|NCT01227824|19193104|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
5553230|NCT01227824|19193105|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
5553231|NCT01227824|19193106|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
5553232|NCT01227824|19193104|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
5553233|NCT01227824|19193105|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
5553234|NCT01227824|19193106|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
5553235|NCT01227824|19193104|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
5553236|NCT01227824|19193105|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
5553237|NCT01227824|19193106|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
5553238|NCT01227824|19193104|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
5553239|NCT01227824|19193105|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
5553240|NCT01227824|19193106|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
5553241|NCT01227824|19193104|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
5553242|NCT01227824|19193105|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
5553243|NCT01227824|19193106|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
5553244|NCT01227824|19193104|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
5553245|NCT01227824|19193105|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
5553246|NCT01227824|19193106|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
5553247|NCT01227824|19193104|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
5553248|NCT01227824|19193105|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
5553249|NCT01227824|19193106|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
5553250|NCT01227824|19193104|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
5553251|NCT01227824|19193105|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
5553252|NCT01227824|19193106|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
5553253|NCT01227824|19193104|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
5553254|NCT01227824|19193105|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
5553255|NCT01227824|19193106|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
5553256|NCT01227707|19193201|P1|Overall Study|Death|1
5553257|NCT01227707|19193201|P1|Overall Study|Medical decision|6
5553258|NCT01227707|19193201|P1|Overall Study|Patient non-compliance|3
5553259|NCT01227707|19193201|P1|Overall Study|Withdrawal by Subject|1
5553260|NCT01227707|19193201|P1|Overall Study|Progression of disease|3
5553261|NCT01227707|19193201|P1|Overall Study|Adverse Event|10
5553262|NCT01227668|19193228|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
5553263|NCT01227668|19193229|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
5553264|NCT01227668|19193228|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
5553265|NCT01227668|19193229|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
5553266|NCT01227668|19193228|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
5553267|NCT01227668|19193229|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
5553268|NCT01227668|19193228|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
5553269|NCT01227668|19193229|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
5553270|NCT01227668|19193228|P2|Phase 2 (Randomization Phase)|Adverse Event|1
5553271|NCT01227668|19193229|P1|Phase 2 (Randomization Phase)|Adverse Event|0
5553272|NCT01227668|19193228|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
5553273|NCT01227668|19193229|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
5553274|NCT01227668|19193228|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
5553275|NCT01227668|19193229|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
5553276|NCT01227668|19193228|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
5553277|NCT01227668|19193229|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
5553278|NCT01227668|19193228|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
5553279|NCT01227668|19193229|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
5553280|NCT01227668|19193228|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
5553281|NCT01227668|19193229|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
5553282|NCT01227668|19193228|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
5553283|NCT01227668|19193229|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
5553284|NCT01227668|19193228|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
5553285|NCT01227668|19193229|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
5553286|NCT01227629|19193275|P10|Overall Study|Other|1
5553287|NCT01227629|19193276|P9|Overall Study|Other|2
5553288|NCT01227629|19193277|P8|Overall Study|Other|0
5553289|NCT01227629|19193278|P7|Overall Study|Other|0
5553290|NCT01227629|19193279|P6|Overall Study|Other|0
5553291|NCT01227629|19193280|P5|Overall Study|Other|0
5553292|NCT01227629|19193281|P4|Overall Study|Other|1
5553293|NCT01227629|19193282|P3|Overall Study|Other|0
5553294|NCT01227629|19193283|P2|Overall Study|Other|0
5553295|NCT01227629|19193284|P1|Overall Study|Other|0
5553296|NCT01227629|19193275|P10|Overall Study|Withdrawal by Subject|1
5553297|NCT01227629|19193276|P9|Overall Study|Withdrawal by Subject|0
5553298|NCT01227629|19193277|P8|Overall Study|Withdrawal by Subject|0
5553299|NCT01227629|19193278|P7|Overall Study|Withdrawal by Subject|2
5553300|NCT01227629|19193279|P6|Overall Study|Withdrawal by Subject|0
5553301|NCT01227629|19193280|P5|Overall Study|Withdrawal by Subject|0
5553302|NCT01227629|19193281|P4|Overall Study|Withdrawal by Subject|0
5553303|NCT01227629|19193282|P3|Overall Study|Withdrawal by Subject|0
5553304|NCT01227629|19193283|P2|Overall Study|Withdrawal by Subject|0
5553305|NCT01227629|19193284|P1|Overall Study|Withdrawal by Subject|0
5553306|NCT01227629|19193275|P10|Overall Study|Lost to Follow-up|0
5553307|NCT01227629|19193276|P9|Overall Study|Lost to Follow-up|0
5553308|NCT01227629|19193277|P8|Overall Study|Lost to Follow-up|0
5553309|NCT01227629|19193278|P7|Overall Study|Lost to Follow-up|0
5553310|NCT01227629|19193279|P6|Overall Study|Lost to Follow-up|0
5553311|NCT01227629|19193280|P5|Overall Study|Lost to Follow-up|1
5553312|NCT01227629|19193281|P4|Overall Study|Lost to Follow-up|0
5553313|NCT01227629|19193282|P3|Overall Study|Lost to Follow-up|0
5553314|NCT01227629|19193283|P2|Overall Study|Lost to Follow-up|0
5553315|NCT01227629|19193284|P1|Overall Study|Lost to Follow-up|0
5553316|NCT01227629|19193275|P10|Overall Study|Protocol Violation|0
5553317|NCT01227629|19193276|P9|Overall Study|Protocol Violation|0
5553318|NCT01227629|19193277|P8|Overall Study|Protocol Violation|0
5553319|NCT01227629|19193278|P7|Overall Study|Protocol Violation|0
5553320|NCT01227629|19193279|P6|Overall Study|Protocol Violation|0
5553321|NCT01227629|19193280|P5|Overall Study|Protocol Violation|0
5553322|NCT01227629|19193281|P4|Overall Study|Protocol Violation|1
5553323|NCT01227629|19193282|P3|Overall Study|Protocol Violation|0
5553324|NCT01227629|19193283|P2|Overall Study|Protocol Violation|0
5553325|NCT01227629|19193284|P1|Overall Study|Protocol Violation|0
5553326|NCT01227629|19193275|P10|Overall Study|Adverse Event|0
5553327|NCT01227629|19193276|P9|Overall Study|Adverse Event|4
5553328|NCT01227629|19193277|P8|Overall Study|Adverse Event|6
5553329|NCT01227629|19193278|P7|Overall Study|Adverse Event|6
5553330|NCT01227629|19193279|P6|Overall Study|Adverse Event|1
5553331|NCT01227629|19193280|P5|Overall Study|Adverse Event|1
5553332|NCT01227629|19193281|P4|Overall Study|Adverse Event|6
5553333|NCT01227629|19193282|P3|Overall Study|Adverse Event|1
5553334|NCT01227629|19193283|P2|Overall Study|Adverse Event|2
5553335|NCT01227629|19193284|P1|Overall Study|Adverse Event|2
5553336|NCT01227577|19193533|P1|Overall Study|Adverse Event|17
5553337|NCT01227577|19193533|P1|Overall Study|Lack of Efficacy|5
5553338|NCT01227577|19193533|P1|Overall Study|Withdrawal by Subject|4
5553339|NCT01227577|19193533|P1|Overall Study|Lost to Follow-up|1
5553340|NCT01227577|19193533|P1|Overall Study|Administrative problems|2
5553341|NCT01227577|19193533|P1|Overall Study|Death|3
5553342|NCT01227577|19193533|P1|Overall Study|Protocol deviation|3
5553343|NCT01227564|19193548|P3|Overall Study|Participant moved to another town|1
5553344|NCT01227564|19193549|P2|Overall Study|Participant moved to another town|0
5553345|NCT01227564|19193550|P1|Overall Study|Participant moved to another town|0
5553346|NCT01227564|19193548|P3|Overall Study|No Longer Willing to Participate|5
5553347|NCT01227564|19193549|P2|Overall Study|No Longer Willing to Participate|2
5553348|NCT01227564|19193550|P1|Overall Study|No Longer Willing to Participate|4
5553349|NCT01227512|19193688|P2|Overall Study|Participant met withdrawal criteria|1
5553350|NCT01227512|19193689|P1|Overall Study|Participant met withdrawal criteria|0
5553351|NCT01227512|19193688|P2|Overall Study|Withdrawal by Subject|0
5553352|NCT01227512|19193689|P1|Overall Study|Withdrawal by Subject|3
5553353|NCT01227512|19193688|P2|Overall Study|Adverse Event|3
5553354|NCT01227512|19193689|P1|Overall Study|Adverse Event|4
5553355|NCT01227512|19193688|P2|Overall Study|Physician Decision|6
5553356|NCT01227512|19193689|P1|Overall Study|Physician Decision|6
5553357|NCT01227421|19193723|P3|Overall Study|Randomized in error|0
5553358|NCT01227421|19193724|P2|Overall Study|Randomized in error|1
5553359|NCT01227421|19193725|P1|Overall Study|Randomized in error|1
5553360|NCT01227421|19193723|P3|Overall Study|Protocol Violation|2
5553361|NCT01227421|19193724|P2|Overall Study|Protocol Violation|1
5553362|NCT01227421|19193725|P1|Overall Study|Protocol Violation|1
5553363|NCT01227421|19193723|P3|Overall Study|Withdrawal by Subject|1
5553364|NCT01227421|19193724|P2|Overall Study|Withdrawal by Subject|2
5553365|NCT01227421|19193725|P1|Overall Study|Withdrawal by Subject|1
5553366|NCT01227421|19193723|P3|Overall Study|Adverse Event|2
5553367|NCT01227421|19193724|P2|Overall Study|Adverse Event|7
5553368|NCT01227421|19193725|P1|Overall Study|Adverse Event|2
5553369|NCT01227421|19193723|P3|Overall Study|Lost to Follow-up|5
5553370|NCT01227421|19193724|P2|Overall Study|Lost to Follow-up|7
5553371|NCT01227421|19193725|P1|Overall Study|Lost to Follow-up|6
5553372|NCT01227395|19193777|P2|Overall Study|Protocol Violation|1
5553373|NCT01227395|19193778|P1|Overall Study|Protocol Violation|0
5553374|NCT01227278|19193818|P2|Overall Study|Other|2
5553375|NCT01227278|19193819|P1|Overall Study|Other|1
5553376|NCT01227278|19193818|P2|Overall Study|Death|2
5553377|NCT01227278|19193819|P1|Overall Study|Death|0
5553378|NCT01227278|19193818|P2|Overall Study|Withdrawal by Subject|4
5553379|NCT01227278|19193819|P1|Overall Study|Withdrawal by Subject|4
5553380|NCT01227265|19193846|P3|Overall Study|Adverse Event|5
5553381|NCT01227265|19193847|P2|Overall Study|Adverse Event|10
5553382|NCT01227265|19193848|P1|Overall Study|Adverse Event|6
5553383|NCT01227265|19193846|P3|Overall Study|Lost to Follow-up|3
5553384|NCT01227265|19193847|P2|Overall Study|Lost to Follow-up|0
5553385|NCT01227265|19193848|P1|Overall Study|Lost to Follow-up|2
5553386|NCT01227265|19193846|P3|Overall Study|Withdrawal by Subject|3
5553387|NCT01227265|19193847|P2|Overall Study|Withdrawal by Subject|7
5553388|NCT01227265|19193848|P1|Overall Study|Withdrawal by Subject|7
5553389|NCT01227265|19193846|P3|Overall Study|Protocol Violation|0
5553390|NCT01227265|19193847|P2|Overall Study|Protocol Violation|1
5553391|NCT01227265|19193848|P1|Overall Study|Protocol Violation|2
5553392|NCT01227265|19193846|P3|Overall Study|Did Not Meet Protocol Eligibility|1
5553393|NCT01227265|19193847|P2|Overall Study|Did Not Meet Protocol Eligibility|0
5553394|NCT01227265|19193848|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5553395|NCT01227265|19193846|P3|Overall Study|Administrative|2
5553396|NCT01227265|19193847|P2|Overall Study|Administrative|0
5553397|NCT01227265|19193848|P1|Overall Study|Administrative|1
5553398|NCT01227265|19193846|P3|Overall Study|Did Not Receive Treatment|0
5553399|NCT01227265|19193847|P2|Overall Study|Did Not Receive Treatment|2
5553400|NCT01227265|19193848|P1|Overall Study|Did Not Receive Treatment|1
5553401|NCT01227252|19193878|P4|Overall Study|Withdrawal by Subject|0
5553402|NCT01227252|19193879|P3|Overall Study|Withdrawal by Subject|0
5553403|NCT01227252|19193880|P2|Overall Study|Withdrawal by Subject|1
5553404|NCT01227252|19193881|P1|Overall Study|Withdrawal by Subject|0
5553405|NCT01227252|19193878|P4|Overall Study|Lost to Follow-up|0
5553406|NCT01227252|19193879|P3|Overall Study|Lost to Follow-up|0
5553407|NCT01227252|19193880|P2|Overall Study|Lost to Follow-up|1
5553408|NCT01227252|19193881|P1|Overall Study|Lost to Follow-up|0
5553409|NCT01227252|19193878|P4|Overall Study|Sponsor Decision|0
5553410|NCT01227252|19193879|P3|Overall Study|Sponsor Decision|0
5553411|NCT01227252|19193880|P2|Overall Study|Sponsor Decision|1
5553412|NCT01227252|19193881|P1|Overall Study|Sponsor Decision|0
5553413|NCT01227044|19193923|P2|Overall Study|Discontinued Intervention|2
5553414|NCT01227044|19193924|P1|Overall Study|Discontinued Intervention|1
5553415|NCT01227044|19193923|P2|Overall Study|Lost to Follow-up|7
5553416|NCT01227044|19193924|P1|Overall Study|Lost to Follow-up|5
5553417|NCT01227018|19193932|P1|Overall Study|Withdrew after beginning treatment|4
5553418|NCT01227018|19193932|P1|Overall Study|Toxicity|2
5553419|NCT01227018|19193932|P1|Overall Study|Disease progression|9
5553420|NCT01226745|19193977|P6|Overall Study|Other|1
5553421|NCT01226745|19193978|P5|Overall Study|Other|3
5553422|NCT01226745|19193979|P4|Overall Study|Other|4
5553423|NCT01226745|19193980|P3|Overall Study|Other|8
5553424|NCT01226745|19193981|P2|Overall Study|Other|7
5553425|NCT01226745|19193982|P1|Overall Study|Other|6
5553426|NCT01226745|19193977|P6|Overall Study|Death|1
5553427|NCT01226745|19193978|P5|Overall Study|Death|0
5553428|NCT01226745|19193979|P4|Overall Study|Death|0
5553429|NCT01226745|19193980|P3|Overall Study|Death|0
5553430|NCT01226745|19193981|P2|Overall Study|Death|0
5553431|NCT01226745|19193982|P1|Overall Study|Death|1
5553432|NCT01226745|19193977|P6|Overall Study|Lost to Follow-up|2
5553433|NCT01226745|19193978|P5|Overall Study|Lost to Follow-up|1
5553434|NCT01226745|19193979|P4|Overall Study|Lost to Follow-up|1
5553435|NCT01226745|19193980|P3|Overall Study|Lost to Follow-up|6
5553436|NCT01226745|19193981|P2|Overall Study|Lost to Follow-up|6
5553437|NCT01226745|19193982|P1|Overall Study|Lost to Follow-up|2
5553438|NCT01226745|19193977|P6|Overall Study|Did not complete schedule of assessments|1
5553439|NCT01226745|19193978|P5|Overall Study|Did not complete schedule of assessments|0
5553440|NCT01226745|19193979|P4|Overall Study|Did not complete schedule of assessments|0
5553441|NCT01226745|19193980|P3|Overall Study|Did not complete schedule of assessments|6
5553442|NCT01226745|19193981|P2|Overall Study|Did not complete schedule of assessments|3
5553443|NCT01226745|19193982|P1|Overall Study|Did not complete schedule of assessments|8
5553444|NCT01226511|19194178|P2|Taper Period|Parent/Caregiver Decision|1
5553445|NCT01226511|19194179|P1|Taper Period|Parent/Caregiver Decision|1
5553446|NCT01226511|19194178|P2|Taper Period|Protocol Violation|0
5553447|NCT01226511|19194179|P1|Taper Period|Protocol Violation|1
5553448|NCT01226511|19194178|P2|Taper Period|Lost to Follow-up|2
5553449|NCT01226511|19194179|P1|Taper Period|Lost to Follow-up|2
5553450|NCT01226511|19194178|P2|Taper Period|Adverse Event|0
5553451|NCT01226511|19194179|P1|Taper Period|Adverse Event|1
5553452|NCT01226511|19194178|P2|Extension Treatment Period|Sponsor Decision|1
5553453|NCT01226511|19194179|P1|Extension Treatment Period|Sponsor Decision|1
5553454|NCT01226511|19194178|P2|Extension Treatment Period|Parent/Caregiver Decision|8
5553455|NCT01226511|19194179|P1|Extension Treatment Period|Parent/Caregiver Decision|8
5553456|NCT01226511|19194178|P2|Extension Treatment Period|Withdrawal by Subject|3
5553457|NCT01226511|19194179|P1|Extension Treatment Period|Withdrawal by Subject|1
5553458|NCT01226511|19194178|P2|Extension Treatment Period|Protocol Violation|2
5553459|NCT01226511|19194179|P1|Extension Treatment Period|Protocol Violation|2
5553460|NCT01226511|19194178|P2|Extension Treatment Period|Lost to Follow-up|3
5553461|NCT01226511|19194179|P1|Extension Treatment Period|Lost to Follow-up|4
5553462|NCT01226511|19194178|P2|Extension Treatment Period|Lack of Efficacy|2
5553463|NCT01226511|19194179|P1|Extension Treatment Period|Lack of Efficacy|3
5553464|NCT01226511|19194178|P2|Extension Treatment Period|Adverse Event|8
5553465|NCT01226511|19194179|P1|Extension Treatment Period|Adverse Event|8
5553466|NCT01226511|19194178|P2|Acute Treatment Period|Withdrawal by Subject|6
5553467|NCT01226511|19194179|P1|Acute Treatment Period|Withdrawal by Subject|10
5553468|NCT01226511|19194178|P2|Acute Treatment Period|Protocol Violation|5
5553469|NCT01226511|19194179|P1|Acute Treatment Period|Protocol Violation|5
5553470|NCT01226511|19194178|P2|Acute Treatment Period|Parent/caregiver decision|7
5553471|NCT01226511|19194179|P1|Acute Treatment Period|Parent/caregiver decision|5
5553472|NCT01226511|19194178|P2|Acute Treatment Period|Lost to Follow-up|6
5553473|NCT01226511|19194179|P1|Acute Treatment Period|Lost to Follow-up|3
5553474|NCT01226511|19194178|P2|Acute Treatment Period|Lack of Efficacy|1
5553475|NCT01226511|19194179|P1|Acute Treatment Period|Lack of Efficacy|2
5553476|NCT01226511|19194178|P2|Acute Treatment Period|Adverse Event|6
5553477|NCT01226511|19194179|P1|Acute Treatment Period|Adverse Event|7
5553478|NCT01226472|19194277|P1|Overall Study|Progressive Disease|1
5553479|NCT01226459|19194284|P2|Overall Study|Pregnancy|0
5553480|NCT01226459|19194285|P1|Overall Study|Pregnancy|1
5553481|NCT01226459|19194284|P2|Overall Study|Lost to Follow-up|8
5553482|NCT01226459|19194285|P1|Overall Study|Lost to Follow-up|4
5553483|NCT01226459|19194284|P2|Overall Study|Withdrawal by Subject|13
5553484|NCT01226459|19194285|P1|Overall Study|Withdrawal by Subject|10
5553485|NCT01226459|19194284|P2|Overall Study|Protocol Violation|3
5553486|NCT01226459|19194285|P1|Overall Study|Protocol Violation|4
5553487|NCT01226459|19194284|P2|Overall Study|Adverse Event|8
5553488|NCT01226459|19194285|P1|Overall Study|Adverse Event|2
5553489|NCT01226121|19194303|P3|Overall Study|Lost to Follow-up|1
5553490|NCT01226121|19194304|P2|Overall Study|Lost to Follow-up|0
5553491|NCT01226121|19194305|P1|Overall Study|Lost to Follow-up|2
5553492|NCT01226095|19194316|P1|Overall Study|Poor compliance|1
5553493|NCT01226043|19194341|P4|30-week Observational Phase|Physician Decision|2
5553494|NCT01226043|19194342|P3|30-week Observational Phase|Physician Decision|2
5553495|NCT01226043|19194343|P2|30-week Observational Phase|Physician Decision|0
5553496|NCT01226043|19194344|P1|30-week Observational Phase|Physician Decision|0
5553497|NCT01226043|19194341|P4|30-week Observational Phase|Withdrawal by Subject|7
5553498|NCT01226043|19194342|P3|30-week Observational Phase|Withdrawal by Subject|1
5553499|NCT01226043|19194343|P2|30-week Observational Phase|Withdrawal by Subject|0
5553500|NCT01226043|19194344|P1|30-week Observational Phase|Withdrawal by Subject|0
5553501|NCT01226043|19194341|P4|30-week Observational Phase|Lost to Follow-up|2
5553502|NCT01226043|19194342|P3|30-week Observational Phase|Lost to Follow-up|2
5553503|NCT01226043|19194343|P2|30-week Observational Phase|Lost to Follow-up|0
5553504|NCT01226043|19194344|P1|30-week Observational Phase|Lost to Follow-up|0
5553505|NCT01226043|19194341|P4|30-week Observational Phase|Protocol Violation|1
5553506|NCT01226043|19194342|P3|30-week Observational Phase|Protocol Violation|0
5553507|NCT01226043|19194343|P2|30-week Observational Phase|Protocol Violation|0
5553508|NCT01226043|19194344|P1|30-week Observational Phase|Protocol Violation|0
5553509|NCT01226043|19194341|P4|30-week Observational Phase|Adverse Event|1
5553510|NCT01226043|19194342|P3|30-week Observational Phase|Adverse Event|1
5553511|NCT01226043|19194343|P2|30-week Observational Phase|Adverse Event|0
5553512|NCT01226043|19194344|P1|30-week Observational Phase|Adverse Event|0
5553513|NCT01226043|19194341|P4|6-week Re-randomization Phase|completed in error|1
5553514|NCT01226043|19194342|P3|6-week Re-randomization Phase|completed in error|0
5553515|NCT01226043|19194343|P2|6-week Re-randomization Phase|completed in error|0
5553516|NCT01226043|19194344|P1|6-week Re-randomization Phase|completed in error|0
5553517|NCT01226043|19194341|P4|6-week Re-randomization Phase|Physician Decision|2
5553518|NCT01226043|19194342|P3|6-week Re-randomization Phase|Physician Decision|3
5553519|NCT01226043|19194343|P2|6-week Re-randomization Phase|Physician Decision|0
5553520|NCT01226043|19194344|P1|6-week Re-randomization Phase|Physician Decision|0
5553521|NCT01226043|19194341|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
5553522|NCT01226043|19194342|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
5553523|NCT01226043|19194343|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
5553524|NCT01226043|19194344|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
5553525|NCT01226043|19194341|P4|6-week Re-randomization Phase|Lost to Follow-up|3
5553526|NCT01226043|19194342|P3|6-week Re-randomization Phase|Lost to Follow-up|1
5553527|NCT01226043|19194343|P2|6-week Re-randomization Phase|Lost to Follow-up|0
5553528|NCT01226043|19194344|P1|6-week Re-randomization Phase|Lost to Follow-up|0
5553529|NCT01226043|19194341|P4|6-week Re-randomization Phase|Protocol Violation|1
5553530|NCT01226043|19194342|P3|6-week Re-randomization Phase|Protocol Violation|1
5553531|NCT01226043|19194343|P2|6-week Re-randomization Phase|Protocol Violation|0
5553532|NCT01226043|19194344|P1|6-week Re-randomization Phase|Protocol Violation|0
5553533|NCT01226043|19194341|P4|6-week Re-randomization Phase|Adverse Event|1
5553534|NCT01226043|19194342|P3|6-week Re-randomization Phase|Adverse Event|1
5553535|NCT01226043|19194343|P2|6-week Re-randomization Phase|Adverse Event|0
5553536|NCT01226043|19194344|P1|6-week Re-randomization Phase|Adverse Event|0
5553537|NCT01226043|19194341|P4|4-week Crossover Phase - Period 2|Physician Decision|0
5553538|NCT01226043|19194342|P3|4-week Crossover Phase - Period 2|Physician Decision|0
5553539|NCT01226043|19194343|P2|4-week Crossover Phase - Period 2|Physician Decision|5
5553540|NCT01226043|19194344|P1|4-week Crossover Phase - Period 2|Physician Decision|4
5553541|NCT01226043|19194341|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
5553542|NCT01226043|19194342|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
5553543|NCT01226043|19194343|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
5553544|NCT01226043|19194344|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
5553545|NCT01226043|19194341|P4|4-week Crossover Phase - Period 1|Physician Decision|0
5553546|NCT01226043|19194342|P3|4-week Crossover Phase - Period 1|Physician Decision|0
5553547|NCT01226043|19194343|P2|4-week Crossover Phase - Period 1|Physician Decision|6
5553548|NCT01226043|19194344|P1|4-week Crossover Phase - Period 1|Physician Decision|0
5553549|NCT01226043|19194341|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
5553550|NCT01226043|19194342|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
5553551|NCT01226043|19194343|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
5553552|NCT01226043|19194344|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
5553553|NCT01226043|19194341|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
5553554|NCT01226043|19194342|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
5553555|NCT01226043|19194343|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
5553556|NCT01226043|19194344|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
5553557|NCT01226043|19194341|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
5553558|NCT01226043|19194342|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
5553559|NCT01226043|19194343|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
5553560|NCT01226043|19194344|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
5553561|NCT01225991|19194382|P1|Overall Study|Withdrawal by Subject|6
5553562|NCT01225952|19194393|P3|Overall Study|Surgical complications|0
5553563|NCT01225952|19194394|P2|Overall Study|Surgical complications|0
5553564|NCT01225952|19194395|P1|Overall Study|Surgical complications|1
5553565|NCT01225952|19194393|P3|Overall Study|Withdrawal by Subject|5
5553566|NCT01225952|19194394|P2|Overall Study|Withdrawal by Subject|4
5553567|NCT01225952|19194395|P1|Overall Study|Withdrawal by Subject|4
5553568|NCT01225952|19194393|P3|Overall Study|Study Eye Explanted|1
5553569|NCT01225952|19194394|P2|Overall Study|Study Eye Explanted|0
5553570|NCT01225952|19194395|P1|Overall Study|Study Eye Explanted|0
5553571|NCT01225952|19194393|P3|Overall Study|Lost to Follow-up|0
5553572|NCT01225952|19194394|P2|Overall Study|Lost to Follow-up|0
5553573|NCT01225952|19194395|P1|Overall Study|Lost to Follow-up|1
5553574|NCT01225887|19194487|P1|Overall Study|Ineligible:inadequate pathology|2
5553575|NCT01225887|19194487|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
5553576|NCT01225887|19194487|P1|Overall Study|Ineligible:required test not done|2
5553577|NCT01225835|19194497|P2|Overall Study|Other|1
5553578|NCT01225835|19194498|P1|Overall Study|Other|1
5553579|NCT01225835|19194497|P2|Overall Study|Adverse Event|1
5553580|NCT01225835|19194498|P1|Overall Study|Adverse Event|2
5553581|NCT01225835|19194497|P2|Overall Study|Did not meet hCG criterion|0
5553582|NCT01225835|19194498|P1|Overall Study|Did not meet hCG criterion|2
5553583|NCT01225835|19194497|P2|Overall Study|Completed protocol|1
5553584|NCT01225835|19194498|P1|Overall Study|Completed protocol|2
5553585|NCT01225822|19194546|P5|Overall Study|Other|7
5553586|NCT01225822|19194547|P4|Overall Study|Other|10
5553587|NCT01225822|19194548|P3|Overall Study|Other|7
5553588|NCT01225822|19194549|P2|Overall Study|Other|10
5553589|NCT01225822|19194550|P1|Overall Study|Other|13
5553590|NCT01225822|19194546|P5|Overall Study|Withdrawal by Subject|6
5553591|NCT01225822|19194547|P4|Overall Study|Withdrawal by Subject|11
5553592|NCT01225822|19194548|P3|Overall Study|Withdrawal by Subject|7
5553593|NCT01225822|19194549|P2|Overall Study|Withdrawal by Subject|7
5553594|NCT01225822|19194550|P1|Overall Study|Withdrawal by Subject|6
5553595|NCT01225822|19194546|P5|Overall Study|Lost to Follow-up|0
5553596|NCT01225822|19194547|P4|Overall Study|Lost to Follow-up|1
5553597|NCT01225822|19194548|P3|Overall Study|Lost to Follow-up|0
5553598|NCT01225822|19194549|P2|Overall Study|Lost to Follow-up|0
5553599|NCT01225822|19194550|P1|Overall Study|Lost to Follow-up|0
5553600|NCT01225822|19194546|P5|Overall Study|Protocol Violation|4
5553601|NCT01225822|19194547|P4|Overall Study|Protocol Violation|7
5553602|NCT01225822|19194548|P3|Overall Study|Protocol Violation|6
5553603|NCT01225822|19194549|P2|Overall Study|Protocol Violation|8
5553604|NCT01225822|19194550|P1|Overall Study|Protocol Violation|6
5553605|NCT01225822|19194546|P5|Overall Study|Adverse Event|14
5553606|NCT01225822|19194547|P4|Overall Study|Adverse Event|23
5553607|NCT01225822|19194548|P3|Overall Study|Adverse Event|18
5553608|NCT01225822|19194549|P2|Overall Study|Adverse Event|31
5553609|NCT01225822|19194550|P1|Overall Study|Adverse Event|13
5553610|NCT01225731|19194617|P13|Part 3|Withdrawal by Subject|4
5553611|NCT01225731|19194618|P12|Part 3|Withdrawal by Subject|6
5553612|NCT01225731|19194619|P11|Part 3|Withdrawal by Subject|4
5553613|NCT01225731|19194620|P10|Part 3|Withdrawal by Subject|0
5553614|NCT01225731|19194621|P9|Part 3|Withdrawal by Subject|0
5553615|NCT01225731|19194622|P8|Part 3|Withdrawal by Subject|0
5553616|NCT01225731|19194623|P7|Part 3|Withdrawal by Subject|0
5553617|NCT01225731|19194624|P6|Part 3|Withdrawal by Subject|0
5553618|NCT01225731|19194625|P5|Part 3|Withdrawal by Subject|0
5553619|NCT01225731|19194626|P4|Part 3|Withdrawal by Subject|0
5553620|NCT01225731|19194627|P3|Part 3|Withdrawal by Subject|0
5553621|NCT01225731|19194628|P2|Part 3|Withdrawal by Subject|0
5553622|NCT01225731|19194629|P1|Part 3|Withdrawal by Subject|0
5553623|NCT01225731|19194617|P13|Part 3|Physician Decision|2
5553624|NCT01225731|19194618|P12|Part 3|Physician Decision|1
5553625|NCT01225731|19194619|P11|Part 3|Physician Decision|0
5553626|NCT01225731|19194620|P10|Part 3|Physician Decision|0
5553627|NCT01225731|19194621|P9|Part 3|Physician Decision|0
5553628|NCT01225731|19194622|P8|Part 3|Physician Decision|0
5553629|NCT01225731|19194623|P7|Part 3|Physician Decision|0
5553630|NCT01225731|19194624|P6|Part 3|Physician Decision|0
5553631|NCT01225731|19194625|P5|Part 3|Physician Decision|0
5553632|NCT01225731|19194626|P4|Part 3|Physician Decision|0
5553633|NCT01225731|19194627|P3|Part 3|Physician Decision|0
5553634|NCT01225731|19194628|P2|Part 3|Physician Decision|0
5553635|NCT01225731|19194629|P1|Part 3|Physician Decision|0
5553636|NCT01225731|19194617|P13|Part 3|Lost to Follow-up|1
5553637|NCT01225731|19194618|P12|Part 3|Lost to Follow-up|2
5553638|NCT01225731|19194619|P11|Part 3|Lost to Follow-up|1
5553639|NCT01225731|19194620|P10|Part 3|Lost to Follow-up|0
5553640|NCT01225731|19194621|P9|Part 3|Lost to Follow-up|0
5553641|NCT01225731|19194622|P8|Part 3|Lost to Follow-up|0
5553642|NCT01225731|19194623|P7|Part 3|Lost to Follow-up|0
5553643|NCT01225731|19194624|P6|Part 3|Lost to Follow-up|0
5553644|NCT01225731|19194625|P5|Part 3|Lost to Follow-up|0
5553645|NCT01225731|19194626|P4|Part 3|Lost to Follow-up|0
5553646|NCT01225731|19194627|P3|Part 3|Lost to Follow-up|0
5553647|NCT01225731|19194628|P2|Part 3|Lost to Follow-up|0
5553648|NCT01225731|19194629|P1|Part 3|Lost to Follow-up|0
5553649|NCT01225731|19194617|P13|Part 3|Adverse Event|0
5553650|NCT01225731|19194618|P12|Part 3|Adverse Event|1
5553651|NCT01225731|19194619|P11|Part 3|Adverse Event|1
5553652|NCT01225731|19194620|P10|Part 3|Adverse Event|0
5553653|NCT01225731|19194621|P9|Part 3|Adverse Event|0
5553654|NCT01225731|19194622|P8|Part 3|Adverse Event|0
5553655|NCT01225731|19194623|P7|Part 3|Adverse Event|0
5553656|NCT01225731|19194624|P6|Part 3|Adverse Event|0
5553657|NCT01225731|19194625|P5|Part 3|Adverse Event|0
5553658|NCT01225731|19194626|P4|Part 3|Adverse Event|0
5553659|NCT01225731|19194627|P3|Part 3|Adverse Event|0
5553660|NCT01225731|19194628|P2|Part 3|Adverse Event|0
5553661|NCT01225731|19194629|P1|Part 3|Adverse Event|0
5553662|NCT01225731|19194617|P13|Part 2|Withdrawal by Subject|0
5553663|NCT01225731|19194618|P12|Part 2|Withdrawal by Subject|0
5553664|NCT01225731|19194619|P11|Part 2|Withdrawal by Subject|0
5553665|NCT01225731|19194620|P10|Part 2|Withdrawal by Subject|0
5553666|NCT01225731|19194621|P9|Part 2|Withdrawal by Subject|1
5553667|NCT01225731|19194622|P8|Part 2|Withdrawal by Subject|4
5553668|NCT01225731|19194623|P7|Part 2|Withdrawal by Subject|3
5553669|NCT01225731|19194624|P6|Part 2|Withdrawal by Subject|1
5553670|NCT01225731|19194625|P5|Part 2|Withdrawal by Subject|0
5553671|NCT01225731|19194626|P4|Part 2|Withdrawal by Subject|0
5553672|NCT01225731|19194627|P3|Part 2|Withdrawal by Subject|0
5553673|NCT01225731|19194628|P2|Part 2|Withdrawal by Subject|0
5553674|NCT01225731|19194629|P1|Part 2|Withdrawal by Subject|0
5553675|NCT01225731|19194617|P13|Part 2|Physician Decision|0
5553676|NCT01225731|19194618|P12|Part 2|Physician Decision|0
5553677|NCT01225731|19194619|P11|Part 2|Physician Decision|0
5553678|NCT01225731|19194620|P10|Part 2|Physician Decision|0
5553679|NCT01225731|19194621|P9|Part 2|Physician Decision|2
5553680|NCT01225731|19194622|P8|Part 2|Physician Decision|2
5553681|NCT01225731|19194623|P7|Part 2|Physician Decision|0
5553682|NCT01225731|19194624|P6|Part 2|Physician Decision|0
5553683|NCT01225731|19194625|P5|Part 2|Physician Decision|0
5553684|NCT01225731|19194626|P4|Part 2|Physician Decision|0
5553685|NCT01225731|19194627|P3|Part 2|Physician Decision|0
5553686|NCT01225731|19194628|P2|Part 2|Physician Decision|0
5553687|NCT01225731|19194629|P1|Part 2|Physician Decision|0
5553688|NCT01225731|19194617|P13|Part 2|Lost to Follow-up|0
5553689|NCT01225731|19194618|P12|Part 2|Lost to Follow-up|0
5553690|NCT01225731|19194619|P11|Part 2|Lost to Follow-up|0
5553691|NCT01225731|19194620|P10|Part 2|Lost to Follow-up|0
5553692|NCT01225731|19194621|P9|Part 2|Lost to Follow-up|1
5553693|NCT01225731|19194622|P8|Part 2|Lost to Follow-up|3
5553694|NCT01225731|19194623|P7|Part 2|Lost to Follow-up|0
5553695|NCT01225731|19194624|P6|Part 2|Lost to Follow-up|0
5553696|NCT01225731|19194625|P5|Part 2|Lost to Follow-up|0
5553697|NCT01225731|19194626|P4|Part 2|Lost to Follow-up|0
5553698|NCT01225731|19194627|P3|Part 2|Lost to Follow-up|0
5553699|NCT01225731|19194628|P2|Part 2|Lost to Follow-up|0
5553700|NCT01225731|19194629|P1|Part 2|Lost to Follow-up|0
5553701|NCT01225731|19194617|P13|Part 2|Pregnancy|0
5553702|NCT01225731|19194618|P12|Part 2|Pregnancy|0
5553703|NCT01225731|19194619|P11|Part 2|Pregnancy|0
5553704|NCT01225731|19194620|P10|Part 2|Pregnancy|0
5553705|NCT01225731|19194621|P9|Part 2|Pregnancy|1
5553706|NCT01225731|19194622|P8|Part 2|Pregnancy|0
5553707|NCT01225731|19194623|P7|Part 2|Pregnancy|1
5553708|NCT01225731|19194624|P6|Part 2|Pregnancy|0
5553709|NCT01225731|19194625|P5|Part 2|Pregnancy|0
5553710|NCT01225731|19194626|P4|Part 2|Pregnancy|0
5553711|NCT01225731|19194627|P3|Part 2|Pregnancy|0
5553712|NCT01225731|19194628|P2|Part 2|Pregnancy|0
5553713|NCT01225731|19194629|P1|Part 2|Pregnancy|0
5553714|NCT01225731|19194617|P13|Part 2|Lack of Efficacy|0
5553715|NCT01225731|19194618|P12|Part 2|Lack of Efficacy|0
5553716|NCT01225731|19194619|P11|Part 2|Lack of Efficacy|0
5553717|NCT01225731|19194620|P10|Part 2|Lack of Efficacy|0
5553718|NCT01225731|19194621|P9|Part 2|Lack of Efficacy|3
5553719|NCT01225731|19194622|P8|Part 2|Lack of Efficacy|12
5553720|NCT01225731|19194623|P7|Part 2|Lack of Efficacy|0
5553721|NCT01225731|19194624|P6|Part 2|Lack of Efficacy|1
5553722|NCT01225731|19194625|P5|Part 2|Lack of Efficacy|0
5553723|NCT01225731|19194626|P4|Part 2|Lack of Efficacy|0
5553724|NCT01225731|19194627|P3|Part 2|Lack of Efficacy|0
5553725|NCT01225731|19194628|P2|Part 2|Lack of Efficacy|0
5553726|NCT01225731|19194629|P1|Part 2|Lack of Efficacy|0
5553727|NCT01225731|19194617|P13|Part 2|Adverse Event|0
5553728|NCT01225731|19194618|P12|Part 2|Adverse Event|0
5553729|NCT01225731|19194619|P11|Part 2|Adverse Event|0
5553730|NCT01225731|19194620|P10|Part 2|Adverse Event|0
5553731|NCT01225731|19194621|P9|Part 2|Adverse Event|2
5553732|NCT01225731|19194622|P8|Part 2|Adverse Event|4
5553733|NCT01225731|19194623|P7|Part 2|Adverse Event|4
5553734|NCT01225731|19194624|P6|Part 2|Adverse Event|0
5553735|NCT01225731|19194625|P5|Part 2|Adverse Event|0
5553736|NCT01225731|19194626|P4|Part 2|Adverse Event|0
5553737|NCT01225731|19194627|P3|Part 2|Adverse Event|0
5553738|NCT01225731|19194628|P2|Part 2|Adverse Event|0
5553739|NCT01225731|19194629|P1|Part 2|Adverse Event|0
5553740|NCT01225731|19194617|P13|Part 2|Protocol Violation|0
5553741|NCT01225731|19194618|P12|Part 2|Protocol Violation|0
5553742|NCT01225731|19194619|P11|Part 2|Protocol Violation|0
5553743|NCT01225731|19194620|P10|Part 2|Protocol Violation|0
5553744|NCT01225731|19194621|P9|Part 2|Protocol Violation|1
5553745|NCT01225731|19194622|P8|Part 2|Protocol Violation|0
5553746|NCT01225731|19194623|P7|Part 2|Protocol Violation|0
5553747|NCT01225731|19194624|P6|Part 2|Protocol Violation|1
5553748|NCT01225731|19194625|P5|Part 2|Protocol Violation|0
5553749|NCT01225731|19194626|P4|Part 2|Protocol Violation|0
5553750|NCT01225731|19194627|P3|Part 2|Protocol Violation|0
5553751|NCT01225731|19194628|P2|Part 2|Protocol Violation|0
5553752|NCT01225731|19194629|P1|Part 2|Protocol Violation|0
5553753|NCT01225731|19194617|P13|Part 1|Protocol Violation|0
5553754|NCT01225731|19194618|P12|Part 1|Protocol Violation|0
5553755|NCT01225731|19194619|P11|Part 1|Protocol Violation|0
5553756|NCT01225731|19194620|P10|Part 1|Protocol Violation|0
5553757|NCT01225731|19194621|P9|Part 1|Protocol Violation|0
5553758|NCT01225731|19194622|P8|Part 1|Protocol Violation|0
5553759|NCT01225731|19194623|P7|Part 1|Protocol Violation|0
5553760|NCT01225731|19194624|P6|Part 1|Protocol Violation|0
5553761|NCT01225731|19194625|P5|Part 1|Protocol Violation|0
5553762|NCT01225731|19194626|P4|Part 1|Protocol Violation|1
5553763|NCT01225731|19194627|P3|Part 1|Protocol Violation|0
5553764|NCT01225731|19194628|P2|Part 1|Protocol Violation|0
5553765|NCT01225731|19194629|P1|Part 1|Protocol Violation|0
5553766|NCT01225731|19194617|P13|Part 1|Withdrawal by Subject|0
5553767|NCT01225731|19194618|P12|Part 1|Withdrawal by Subject|0
5553768|NCT01225731|19194619|P11|Part 1|Withdrawal by Subject|0
5553769|NCT01225731|19194620|P10|Part 1|Withdrawal by Subject|0
5553770|NCT01225731|19194621|P9|Part 1|Withdrawal by Subject|0
5553771|NCT01225731|19194622|P8|Part 1|Withdrawal by Subject|0
5553772|NCT01225731|19194623|P7|Part 1|Withdrawal by Subject|0
5553773|NCT01225731|19194624|P6|Part 1|Withdrawal by Subject|0
5553774|NCT01225731|19194625|P5|Part 1|Withdrawal by Subject|4
5553775|NCT01225731|19194626|P4|Part 1|Withdrawal by Subject|0
5553776|NCT01225731|19194627|P3|Part 1|Withdrawal by Subject|0
5553777|NCT01225731|19194628|P2|Part 1|Withdrawal by Subject|3
5553778|NCT01225731|19194629|P1|Part 1|Withdrawal by Subject|0
5553779|NCT01225731|19194617|P13|Part 1|Adverse Event|0
5553780|NCT01225731|19194618|P12|Part 1|Adverse Event|0
5553781|NCT01225731|19194619|P11|Part 1|Adverse Event|0
5553782|NCT01225731|19194620|P10|Part 1|Adverse Event|0
5553783|NCT01225731|19194621|P9|Part 1|Adverse Event|0
5553784|NCT01225731|19194622|P8|Part 1|Adverse Event|0
5553785|NCT01225731|19194623|P7|Part 1|Adverse Event|0
5553786|NCT01225731|19194624|P6|Part 1|Adverse Event|0
5553787|NCT01225731|19194625|P5|Part 1|Adverse Event|1
5553788|NCT01225731|19194626|P4|Part 1|Adverse Event|1
5553789|NCT01225731|19194627|P3|Part 1|Adverse Event|1
5553790|NCT01225731|19194628|P2|Part 1|Adverse Event|2
5553791|NCT01225731|19194629|P1|Part 1|Adverse Event|1
5553792|NCT01225731|19194617|P13|Part 1|Did not meet eligibility criteria|0
5553793|NCT01225731|19194618|P12|Part 1|Did not meet eligibility criteria|0
5553794|NCT01225731|19194619|P11|Part 1|Did not meet eligibility criteria|0
5553795|NCT01225731|19194620|P10|Part 1|Did not meet eligibility criteria|0
5553796|NCT01225731|19194621|P9|Part 1|Did not meet eligibility criteria|0
5553797|NCT01225731|19194622|P8|Part 1|Did not meet eligibility criteria|0
5553798|NCT01225731|19194623|P7|Part 1|Did not meet eligibility criteria|0
5553799|NCT01225731|19194624|P6|Part 1|Did not meet eligibility criteria|0
5553800|NCT01225731|19194625|P5|Part 1|Did not meet eligibility criteria|1
5553801|NCT01225731|19194626|P4|Part 1|Did not meet eligibility criteria|0
5553802|NCT01225731|19194627|P3|Part 1|Did not meet eligibility criteria|0
5553803|NCT01225731|19194628|P2|Part 1|Did not meet eligibility criteria|0
5553804|NCT01225731|19194629|P1|Part 1|Did not meet eligibility criteria|1
5553805|NCT01225562|19194724|P3|Overall Study|Lost to Follow-up|1
5553806|NCT01225562|19194725|P2|Overall Study|Lost to Follow-up|6
5553807|NCT01225562|19194726|P1|Overall Study|Lost to Follow-up|3
5553808|NCT01225562|19194724|P3|Overall Study|Withdrawal by Subject|52
5553809|NCT01225562|19194725|P2|Overall Study|Withdrawal by Subject|50
5553810|NCT01225562|19194726|P1|Overall Study|Withdrawal by Subject|52
5553811|NCT01225549|19194743|P10|Period 6 - Washout|Disallowed medication|0
5553812|NCT01225549|19194744|P9|Period 6 - Washout|Disallowed medication|0
5553813|NCT01225549|19194745|P8|Period 6 - Washout|Disallowed medication|0
5553814|NCT01225549|19194746|P7|Period 6 - Washout|Disallowed medication|0
5553815|NCT01225549|19194747|P6|Period 6 - Washout|Disallowed medication|0
5553816|NCT01225549|19194748|P5|Period 6 - Washout|Disallowed medication|0
5553817|NCT01225549|19194749|P4|Period 6 - Washout|Disallowed medication|1
5553818|NCT01225549|19194750|P3|Period 6 - Washout|Disallowed medication|0
5553819|NCT01225549|19194751|P2|Period 6 - Washout|Disallowed medication|0
5553820|NCT01225549|19194752|P1|Period 6 - Washout|Disallowed medication|0
5553821|NCT01225549|19194743|P10|Period 4 - Washout|Disallowed medication|0
5553822|NCT01225549|19194744|P9|Period 4 - Washout|Disallowed medication|0
5553823|NCT01225549|19194745|P8|Period 4 - Washout|Disallowed medication|0
5553824|NCT01225549|19194746|P7|Period 4 - Washout|Disallowed medication|0
5553825|NCT01225549|19194747|P6|Period 4 - Washout|Disallowed medication|0
5553826|NCT01225549|19194748|P5|Period 4 - Washout|Disallowed medication|0
5553827|NCT01225549|19194749|P4|Period 4 - Washout|Disallowed medication|0
5553828|NCT01225549|19194750|P3|Period 4 - Washout|Disallowed medication|0
5553829|NCT01225549|19194751|P2|Period 4 - Washout|Disallowed medication|1
5553830|NCT01225549|19194752|P1|Period 4 - Washout|Disallowed medication|0
5553831|NCT01225211|19194873|P10|Overall Study|Other|1
5553832|NCT01225211|19194874|P9|Overall Study|Other|0
5553833|NCT01225211|19194875|P8|Overall Study|Other|0
5553834|NCT01225211|19194876|P7|Overall Study|Other|0
5553835|NCT01225211|19194877|P6|Overall Study|Other|0
5553836|NCT01225211|19194878|P5|Overall Study|Other|0
5553837|NCT01225211|19194879|P4|Overall Study|Other|0
5553838|NCT01225211|19194880|P3|Overall Study|Other|0
5553839|NCT01225211|19194881|P2|Overall Study|Other|0
5553840|NCT01225211|19194882|P1|Overall Study|Other|0
5553841|NCT01225211|19194873|P10|Overall Study|Withdrawal by Subject|3
5553842|NCT01225211|19194874|P9|Overall Study|Withdrawal by Subject|1
5553843|NCT01225211|19194875|P8|Overall Study|Withdrawal by Subject|0
5553844|NCT01225211|19194876|P7|Overall Study|Withdrawal by Subject|1
5553845|NCT01225211|19194877|P6|Overall Study|Withdrawal by Subject|0
5553846|NCT01225211|19194878|P5|Overall Study|Withdrawal by Subject|0
5553847|NCT01225211|19194879|P4|Overall Study|Withdrawal by Subject|0
5553848|NCT01225211|19194880|P3|Overall Study|Withdrawal by Subject|0
5553849|NCT01225211|19194881|P2|Overall Study|Withdrawal by Subject|0
5553850|NCT01225211|19194882|P1|Overall Study|Withdrawal by Subject|0
5553851|NCT01225211|19194873|P10|Overall Study|Adverse Event|1
5553852|NCT01225211|19194874|P9|Overall Study|Adverse Event|0
5553853|NCT01225211|19194875|P8|Overall Study|Adverse Event|0
5553854|NCT01225211|19194876|P7|Overall Study|Adverse Event|0
5553855|NCT01225211|19194877|P6|Overall Study|Adverse Event|0
5553856|NCT01225211|19194878|P5|Overall Study|Adverse Event|0
5553857|NCT01225211|19194879|P4|Overall Study|Adverse Event|0
5553858|NCT01225211|19194880|P3|Overall Study|Adverse Event|1
5553859|NCT01225211|19194881|P2|Overall Study|Adverse Event|0
5553860|NCT01225211|19194882|P1|Overall Study|Adverse Event|0
5553861|NCT01225172|19194985|P2|Overall Study|Withdrawal by Subject|0
5553862|NCT01225172|19194986|P1|Overall Study|Withdrawal by Subject|1
5553863|NCT01225172|19194985|P2|Overall Study|Subject no longer meets study criteria|0
5553864|NCT01225172|19194986|P1|Overall Study|Subject no longer meets study criteria|1
5553865|NCT01225172|19194985|P2|Overall Study|Subject request to discontinue treatment|1
5553866|NCT01225172|19194986|P1|Overall Study|Subject request to discontinue treatment|3
5553867|NCT01225172|19194985|P2|Overall Study|Subject decision to stop|0
5553868|NCT01225172|19194986|P1|Overall Study|Subject decision to stop|1
5553869|NCT01225159|19195008|P2|Overall Study|Change operation|0
5553870|NCT01225159|19195009|P1|Overall Study|Change operation|1
5553871|NCT01225146|19195019|P2|Overall Study|Sponsor discontinued making 2mg drug|2
5553872|NCT01225146|19195020|P1|Overall Study|Sponsor discontinued making 2mg drug|0
5553873|NCT01224925|19195088|P2|Overall Study|Lost to Follow-up|2
5553874|NCT01224925|19195089|P1|Overall Study|Lost to Follow-up|3
5553875|NCT01224821|19195097|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
5553876|NCT01224821|19195097|P1|Long-Term Follow-Up|Death|2
5553877|NCT01224821|19195097|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
5553878|NCT01224821|19195097|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
5553879|NCT01224821|19195097|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
5553880|NCT01224821|19195097|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
5553881|NCT01224821|19195097|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
5553882|NCT01224821|19195097|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
5553883|NCT01224782|19195116|P1|Overall Study|Transplantation|1
5553884|NCT01224782|19195116|P1|Overall Study|Deterioration|1
5553885|NCT01224782|19195116|P1|Overall Study|Financial Reasons|1
5553886|NCT01224782|19195116|P1|Overall Study|Change of Treatment|1
5553887|NCT01224782|19195116|P1|Overall Study|Start of Dialysis|3
5553888|NCT01224782|19195116|P1|Overall Study|Other|4
5553889|NCT01224782|19195116|P1|Overall Study|Noncompliance|10
5553890|NCT01224782|19195116|P1|Overall Study|Adverse Reaction|11
5553891|NCT01224782|19195116|P1|Overall Study|Adverse Event|12
5553892|NCT01224782|19195116|P1|Overall Study|Improvement|13
5553893|NCT01224782|19195116|P1|Overall Study|Death|14
5553894|NCT01224782|19195116|P1|Overall Study|Withdrawal by Subject|16
5553895|NCT01224782|19195116|P1|Overall Study|Lost to Follow-up|177
5553896|NCT01224639|19195142|P8|Overall Study|Adverse Event|1
5553897|NCT01224639|19195143|P7|Overall Study|Adverse Event|0
5553898|NCT01224639|19195144|P6|Overall Study|Adverse Event|0
5553899|NCT01224639|19195145|P5|Overall Study|Adverse Event|0
5553900|NCT01224639|19195146|P4|Overall Study|Adverse Event|0
5553901|NCT01224639|19195147|P3|Overall Study|Adverse Event|0
5553902|NCT01224639|19195148|P2|Overall Study|Adverse Event|0
5553903|NCT01224639|19195149|P1|Overall Study|Adverse Event|0
5553904|NCT01224639|19195142|P8|Overall Study|Withdrawal by Subject|1
5553905|NCT01224639|19195143|P7|Overall Study|Withdrawal by Subject|1
5553906|NCT01224639|19195144|P6|Overall Study|Withdrawal by Subject|0
5553907|NCT01224639|19195145|P5|Overall Study|Withdrawal by Subject|2
5553908|NCT01224639|19195146|P4|Overall Study|Withdrawal by Subject|0
5553909|NCT01224639|19195147|P3|Overall Study|Withdrawal by Subject|0
5553910|NCT01224639|19195148|P2|Overall Study|Withdrawal by Subject|0
5553911|NCT01224639|19195149|P1|Overall Study|Withdrawal by Subject|0
5553912|NCT01224431|19195267|P2|Overall Study|no video record|1
5553913|NCT01224431|19195268|P1|Overall Study|no video record|0
5553914|NCT01224431|19195267|P2|Overall Study|not randomized|4
5553915|NCT01224431|19195268|P1|Overall Study|not randomized|0
5553916|NCT01224171|19195289|P2|Overall Study|Lost to Follow-up|3
5553917|NCT01224171|19195290|P1|Overall Study|Lost to Follow-up|0
5553918|NCT01224171|19195289|P2|Overall Study|Withdrawal of Consent|4
5553919|NCT01224171|19195290|P1|Overall Study|Withdrawal of Consent|2
5553920|NCT01224171|19195289|P2|Overall Study|Lack of Efficacy|1
5553921|NCT01224171|19195290|P1|Overall Study|Lack of Efficacy|5
5553922|NCT01224171|19195289|P2|Overall Study|Protocol Violation|1
5553923|NCT01224171|19195290|P1|Overall Study|Protocol Violation|0
5553924|NCT01224171|19195289|P2|Overall Study|Adverse Event|4
5553925|NCT01224171|19195290|P1|Overall Study|Adverse Event|8
5553926|NCT01224158|19195312|P2|Overall Study|Withdrawal by Subject|0
5553927|NCT01224158|19195313|P1|Overall Study|Withdrawal by Subject|1
5553928|NCT01223937|19195357|P2|Overall Study|Other|1
5553929|NCT01223937|19195358|P1|Overall Study|Other|4
5553930|NCT01223937|19195357|P2|Overall Study|Protocol Violation|7
5553931|NCT01223937|19195358|P1|Overall Study|Protocol Violation|8
5553932|NCT01223937|19195357|P2|Overall Study|Adverse Event|4
5553933|NCT01223937|19195358|P1|Overall Study|Adverse Event|1
5553934|NCT01223937|19195357|P2|Overall Study|Lost to Follow-up|4
5553935|NCT01223937|19195358|P1|Overall Study|Lost to Follow-up|1
5553936|NCT01223937|19195357|P2|Overall Study|Withdrawal by Subject|2
5553937|NCT01223937|19195358|P1|Overall Study|Withdrawal by Subject|3
5553938|NCT01223404|19195404|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
5553939|NCT01223404|19195405|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
5553940|NCT01223404|19195406|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
5553941|NCT01223404|19195407|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
5553942|NCT01223404|19195408|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
5553943|NCT01223404|19195409|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
5553944|NCT01223404|19195404|P6|Second Intervention (1 Day)|Adverse Event|0
5553945|NCT01223404|19195405|P5|Second Intervention (1 Day)|Adverse Event|0
5553946|NCT01223404|19195406|P4|Second Intervention (1 Day)|Adverse Event|0
5553947|NCT01223404|19195407|P3|Second Intervention (1 Day)|Adverse Event|0
5553948|NCT01223404|19195408|P2|Second Intervention (1 Day)|Adverse Event|0
5553949|NCT01223404|19195409|P1|Second Intervention (1 Day)|Adverse Event|1
5553950|NCT01223404|19195404|P6|First Intervention (1 Day)|Adverse Event|0
5553951|NCT01223404|19195405|P5|First Intervention (1 Day)|Adverse Event|0
5553952|NCT01223404|19195406|P4|First Intervention (1 Day)|Adverse Event|1
5553953|NCT01223404|19195407|P3|First Intervention (1 Day)|Adverse Event|0
5553954|NCT01223404|19195408|P2|First Intervention (1 Day)|Adverse Event|0
5553955|NCT01223404|19195409|P1|First Intervention (1 Day)|Adverse Event|0
5553956|NCT01223365|19195473|P1|Open-label Treatment Period|Physician Decision|2
5553957|NCT01223365|19195473|P1|Open-label Treatment Period|Starting physical therapy|1
5553958|NCT01223365|19195473|P1|Open-label Treatment Period|"Out of window"|1
5553959|NCT01223365|19195473|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
5553960|NCT01223365|19195473|P1|Open-label Treatment Period|Moved out of area|2
5553961|NCT01223365|19195473|P1|Open-label Treatment Period|Noncompliance with study procedures|6
5553962|NCT01223365|19195473|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
5553963|NCT01223365|19195473|P1|Open-label Treatment Period|Lost to Follow-up|7
5553964|NCT01223365|19195473|P1|Open-label Treatment Period|Protocol Violation|15
5553965|NCT01223365|19195473|P1|Open-label Treatment Period|Withdrawal by Subject|19
5553966|NCT01223365|19195473|P1|Open-label Treatment Period|Lack of Efficacy|2
5553967|NCT01223365|19195473|P1|Open-label Treatment Period|Adverse Event|39
5553968|NCT01223365|19195473|P1|Open-label Titration Period|Starting physical therapy|1
5553969|NCT01223365|19195473|P1|Open-label Titration Period|Noncompliance with study procedures|2
5553970|NCT01223365|19195473|P1|Open-label Titration Period|Noncompliance with study drug admin|1
5553971|NCT01223365|19195473|P1|Open-label Titration Period|Lost to Follow-up|2
5553972|NCT01223365|19195473|P1|Open-label Titration Period|Protocol Violation|1
5553973|NCT01223365|19195473|P1|Open-label Titration Period|Withdrawal by Subject|5
5553974|NCT01223365|19195473|P1|Open-label Titration Period|Lack of Efficacy|3
5553975|NCT01223365|19195473|P1|Open-label Titration Period|Adverse Event|23
5553976|NCT01223365|19195473|P1|Open-label Titration Period|Enrolled but not treated|1
5553977|NCT01223235|19195537|P1|Overall Study|Withdrawal by Subject|1
5553978|NCT01223196|19195545|P2|Overall Study|Withdrawal by Subject|0
5553979|NCT01223196|19195546|P1|Overall Study|Withdrawal by Subject|1
5553980|NCT01223196|19195545|P2|Overall Study|Physician Decision|0
5553981|NCT01223196|19195546|P1|Overall Study|Physician Decision|1
5553982|NCT01223196|19195545|P2|Overall Study|Lost to Follow-up|0
5553983|NCT01223196|19195546|P1|Overall Study|Lost to Follow-up|2
5553984|NCT01223183|19195558|P2|Washout Period (5-24 Days)|Physician Decision|0
5553985|NCT01223183|19195559|P1|Washout Period (5-24 Days)|Physician Decision|1
5553986|NCT01223183|19195558|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
5553987|NCT01223183|19195559|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
5553988|NCT01223183|19195558|P2|Imaging Day 1|Physician Decision|1
5553989|NCT01223183|19195559|P1|Imaging Day 1|Physician Decision|0
5553990|NCT01223027|19195569|P2|Overall Study|Study terminated by sponsor|8
5553991|NCT01223027|19195570|P1|Overall Study|Study terminated by sponsor|2
5553992|NCT01223027|19195569|P2|Overall Study|New therapy for study indication|8
5553993|NCT01223027|19195570|P1|Overall Study|New therapy for study indication|17
5553994|NCT01223027|19195569|P2|Overall Study|Subject/guardian decicion|16
5553995|NCT01223027|19195570|P1|Overall Study|Subject/guardian decicion|18
5553996|NCT01223027|19195569|P2|Overall Study|Protocol Violation|1
5553997|NCT01223027|19195570|P1|Overall Study|Protocol Violation|2
5553998|NCT01223027|19195569|P2|Overall Study|Progressive Disease|183
5553999|NCT01223027|19195570|P1|Overall Study|Progressive Disease|167
5554000|NCT01223027|19195569|P2|Overall Study|Physician Decision|8
5554001|NCT01223027|19195570|P1|Overall Study|Physician Decision|4
5554002|NCT01223027|19195569|P2|Overall Study|Lost to Follow-up|1
5554003|NCT01223027|19195570|P1|Overall Study|Lost to Follow-up|2
5554004|NCT01223027|19195569|P2|Overall Study|Death|42
5554005|NCT01223027|19195570|P1|Overall Study|Death|42
5554006|NCT01223027|19195569|P2|Overall Study|Adverse Event|10
5554007|NCT01223027|19195570|P1|Overall Study|Adverse Event|20
5554008|NCT01222715|19195632|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
5554009|NCT01222715|19195633|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
5554010|NCT01222715|19195632|P2|Overall Study|Ineligible|1
5554011|NCT01222715|19195633|P1|Overall Study|Ineligible|0
5554012|NCT01222715|19195632|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
5554013|NCT01222715|19195633|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
5554014|NCT01222715|19195632|P2|Overall Study|Refusal of further protocol therapy|4
5554015|NCT01222715|19195633|P1|Overall Study|Refusal of further protocol therapy|0
5554016|NCT01222715|19195632|P2|Overall Study|Physician Decision|2
5554017|NCT01222715|19195633|P1|Overall Study|Physician Decision|12
5554018|NCT01222715|19195632|P2|Overall Study|Lack of Efficacy|14
5554019|NCT01222715|19195633|P1|Overall Study|Lack of Efficacy|22
5554020|NCT01222715|19195632|P2|Overall Study|Death|1
5554021|NCT01222715|19195633|P1|Overall Study|Death|0
5554022|NCT01222715|19195632|P2|Overall Study|Adverse Event|4
5554023|NCT01222715|19195633|P1|Overall Study|Adverse Event|0
5554024|NCT01222533|19195672|P1|Overall Study|Other|4
5554025|NCT01222533|19195672|P1|Overall Study|Withdrawal by Subject|5
5554026|NCT01222533|19195672|P1|Overall Study|Adverse Event|5
5554027|NCT01222520|19195811|P2|Double-blind Period|Study medication stolen|0
5554028|NCT01222520|19195812|P1|Double-blind Period|Study medication stolen|1
5554029|NCT01222520|19195811|P2|Double-blind Period|Lack of Efficacy|1
5554030|NCT01222520|19195812|P1|Double-blind Period|Lack of Efficacy|0
5554031|NCT01222520|19195811|P2|Double-blind Period|Adverse Event|1
5554032|NCT01222520|19195812|P1|Double-blind Period|Adverse Event|0
5554033|NCT01222520|19195811|P2|Open-label run-in Period|Number of patients fulfilled|3
5554034|NCT01222520|19195812|P1|Open-label run-in Period|Number of patients fulfilled|0
5554035|NCT01222520|19195811|P2|Open-label run-in Period|Blood pressure criteria not met|18
5554036|NCT01222520|19195812|P1|Open-label run-in Period|Blood pressure criteria not met|0
5554037|NCT01222520|19195811|P2|Open-label run-in Period|Withdrawal by Subject|2
5554038|NCT01222520|19195812|P1|Open-label run-in Period|Withdrawal by Subject|0
5554039|NCT01222507|19195830|P1|Overall Study|Withdrawal by Subject|1
5554040|NCT01222507|19195830|P1|Overall Study|Physician Decision|1
5554041|NCT01222416|19195858|P2|Overall Study|Death|0
5554042|NCT01222416|19195859|P1|Overall Study|Death|1
5554043|NCT01222416|19195858|P2|Overall Study|missed view/scan|0
5554044|NCT01222416|19195859|P1|Overall Study|missed view/scan|1
5554045|NCT01222416|19195858|P2|Overall Study|scheduling|0
5554046|NCT01222416|19195859|P1|Overall Study|scheduling|6
5554047|NCT01222416|19195858|P2|Overall Study|Withdrawal by Subject|0
5554048|NCT01222416|19195859|P1|Overall Study|Withdrawal by Subject|5
5554049|NCT01222416|19195858|P2|Overall Study|Adverse Event|0
5554050|NCT01222416|19195859|P1|Overall Study|Adverse Event|4
5554051|NCT01222416|19195858|P2|Overall Study|ineligible;metastasis|0
5554052|NCT01222416|19195859|P1|Overall Study|ineligible;metastasis|3
5554053|NCT01222403|19195869|P2|Overall Study|Inappropriate enrollment|2
5554054|NCT01222403|19195870|P1|Overall Study|Inappropriate enrollment|0
5554055|NCT01222247|19195931|P2|Overall Study|Lost to Follow-up|2
5554056|NCT01222247|19195932|P1|Overall Study|Lost to Follow-up|2
5554057|NCT01222104|19196068|P1|Overall Study|Death|10
5554058|NCT01222104|19196068|P1|Overall Study|Lost to Follow-up|37
5554059|NCT01222078|19196091|P1|Overall Study|Early termination of the study|1
5554060|NCT01221948|19196125|P1|Overall Study|Protocol Violation|4
5554061|NCT01221948|19196125|P1|Overall Study|Death|1
5554062|NCT01221948|19196125|P1|Overall Study|not disclosed|2
5554063|NCT01221948|19196125|P1|Overall Study|Withdrawal by Subject|2
5554064|NCT01221948|19196125|P1|Overall Study|Physician Decision|5
5554065|NCT01221753|19196144|P1|Overall Study|Adverse Event|1
5554066|NCT01221727|19196151|P2|Overall Study|Withdrawal by Subject|1
5554067|NCT01221727|19196152|P1|Overall Study|Withdrawal by Subject|1
5554068|NCT01221727|19196151|P2|Overall Study|Physician Decision|0
5554069|NCT01221727|19196152|P1|Overall Study|Physician Decision|2
5554070|NCT01221623|19196173|P2|Overall Study|Other|2
5554071|NCT01221623|19196174|P1|Overall Study|Other|5
5554072|NCT01221623|19196173|P2|Overall Study|Death|0
5554073|NCT01221623|19196174|P1|Overall Study|Death|1
5554074|NCT01221623|19196173|P2|Overall Study|Adverse Event|3
5554075|NCT01221623|19196174|P1|Overall Study|Adverse Event|6
5554076|NCT01221623|19196173|P2|Overall Study|Lost to Follow-up|1
5554077|NCT01221623|19196174|P1|Overall Study|Lost to Follow-up|7
5554078|NCT01221623|19196173|P2|Overall Study|Withdrawal by Subject|8
5554079|NCT01221623|19196174|P1|Overall Study|Withdrawal by Subject|19
5554080|NCT01221597|19196198|P2|Overall Study|Death|0
5554081|NCT01221597|19196199|P1|Overall Study|Death|2
5554082|NCT01221597|19196198|P2|Overall Study|Other|4
5554083|NCT01221597|19196199|P1|Overall Study|Other|3
5554084|NCT01221597|19196198|P2|Overall Study|Protocol Violation|0
5554085|NCT01221597|19196199|P1|Overall Study|Protocol Violation|1
5554086|NCT01221597|19196198|P2|Overall Study|Lost to Follow-up|5
5554087|NCT01221597|19196199|P1|Overall Study|Lost to Follow-up|6
5554088|NCT01221597|19196198|P2|Overall Study|Withdrawal by Subject|6
5554089|NCT01221597|19196199|P1|Overall Study|Withdrawal by Subject|20
5554090|NCT01221597|19196198|P2|Overall Study|Adverse Event|1
5554091|NCT01221597|19196199|P1|Overall Study|Adverse Event|4
5554092|NCT01221363|19196256|P2|Overall Study|Withdrawal by Subject|5
5554093|NCT01221363|19196257|P1|Overall Study|Withdrawal by Subject|11
5554094|NCT01221363|19196256|P2|Overall Study|Pregnancy|0
5554095|NCT01221363|19196257|P1|Overall Study|Pregnancy|1
5554096|NCT01221350|19196267|P2|Overall Study|Withdrawal by Subject|2
5554097|NCT01221350|19196268|P1|Overall Study|Withdrawal by Subject|4
5554098|NCT01221350|19196267|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
5554099|NCT01221350|19196268|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
5554100|NCT01221350|19196267|P2|Overall Study|Discontinued intervention (GERD)|0
5554101|NCT01221350|19196268|P1|Overall Study|Discontinued intervention (GERD)|1
5554102|NCT01221285|19196327|P1|Overall Study|Withdrawal by Subject|1
5554103|NCT01221272|19196336|P2|Period 2|Adverse Event|2
5554104|NCT01221272|19196337|P1|Period 2|Adverse Event|0
5554105|NCT01221272|19196336|P2|Period 1|Significant Dosing Noncompliance|1
5554106|NCT01221272|19196337|P1|Period 1|Significant Dosing Noncompliance|0
5554107|NCT01221272|19196336|P2|Period 1|Consent Withdrawal|1
5554108|NCT01221272|19196337|P1|Period 1|Consent Withdrawal|0
5554109|NCT01221272|19196336|P2|Period 1|Adverse Event|0
5554110|NCT01221272|19196337|P1|Period 1|Adverse Event|2
5554111|NCT01221233|19196354|P2|Overall Study|Withdrawal by Subject|1
5554112|NCT01221233|19196355|P1|Overall Study|Withdrawal by Subject|3
5554113|NCT01221181|19196383|P1|Overall Study|Lost to Follow-up|1
5554114|NCT01221090|19196391|P4|Overall Study|Withdrawal by Subject|2
5554115|NCT01221090|19196392|P3|Overall Study|Withdrawal by Subject|27
5554116|NCT01221090|19196393|P2|Overall Study|Withdrawal by Subject|22
5554117|NCT01221090|19196394|P1|Overall Study|Withdrawal by Subject|0
5554118|NCT01221090|19196391|P4|Overall Study|Non-Compliant or Unable to Contact|20
5554119|NCT01221090|19196392|P3|Overall Study|Non-Compliant or Unable to Contact|15
5554120|NCT01221090|19196393|P2|Overall Study|Non-Compliant or Unable to Contact|12
5554121|NCT01221090|19196394|P1|Overall Study|Non-Compliant or Unable to Contact|15
5554122|NCT01220999|19196425|P5|Overall Study|Progressive disease|0
5554123|NCT01220999|19196426|P4|Overall Study|Progressive disease|0
5554124|NCT01220999|19196427|P3|Overall Study|Progressive disease|1
5554125|NCT01220999|19196428|P2|Overall Study|Progressive disease|0
5554126|NCT01220999|19196429|P1|Overall Study|Progressive disease|0
5554127|NCT01220609|19196579|P1|Overall Study|Ineligible-Never treated|1
5554128|NCT01220609|19196579|P1|Overall Study|Ineligible- Wrong cell type|1
5554129|NCT01220609|19196579|P1|Overall Study|Ineligible-Wrong primary cancer site|1
5554130|NCT01220557|19196593|P2|Overall Study|attended less than 6 lessons|2
5554131|NCT01220557|19196594|P1|Overall Study|attended less than 6 lessons|1
5554132|NCT01220557|19196593|P2|Overall Study|Lost to Follow-up|3
5554133|NCT01220557|19196594|P1|Overall Study|Lost to Follow-up|5
5554134|NCT01220414|19196627|P4|Overall Study|Withdrawal by Subject|1
5554135|NCT01220414|19196628|P3|Overall Study|Withdrawal by Subject|0
5554136|NCT01220414|19196629|P2|Overall Study|Withdrawal by Subject|0
5554137|NCT01220414|19196630|P1|Overall Study|Withdrawal by Subject|1
5554138|NCT01220401|19196637|P1|Overall Study|Protocol Violation|1
5554139|NCT01220401|19196637|P1|Overall Study|Withdrawal by Subject|2
5554140|NCT01220297|19196646|P1|Overall Study|Lost to Follow-up|1
5554141|NCT01220297|19196646|P1|Overall Study|Death|2
5554142|NCT01220180|19196663|P1|Overall Study|Randomized but not treated|1
5554143|NCT01220180|19196663|P1|Overall Study|Death|1
5554144|NCT01220180|19196663|P1|Overall Study|Lack of Efficacy|22
5554145|NCT01220180|19196663|P1|Overall Study|Adverse Event|35
5554146|NCT01220180|19196663|P1|Overall Study|Other|72
5554147|NCT01220180|19196663|P1|Overall Study|Lost to Follow-up|76
5554148|NCT01220167|19196689|P3|Period 3|Urine positive for substance abuse|0
5554149|NCT01220167|19196690|P2|Period 3|Urine positive for substance abuse|1
5554150|NCT01220167|19196691|P1|Period 3|Urine positive for substance abuse|0
5554151|NCT01220128|19196704|P7|Overall Study|Consent withdrawn by subject|0
5554152|NCT01220128|19196705|P6|Overall Study|Consent withdrawn by subject|0
5554153|NCT01220128|19196706|P5|Overall Study|Consent withdrawn by subject|0
5554154|NCT01220128|19196707|P4|Overall Study|Consent withdrawn by subject|0
5554155|NCT01220128|19196708|P3|Overall Study|Consent withdrawn by subject|0
5554156|NCT01220128|19196709|P2|Overall Study|Consent withdrawn by subject|0
5554157|NCT01220128|19196710|P1|Overall Study|Consent withdrawn by subject|1
5554158|NCT01220128|19196704|P7|Overall Study|Other|0
5554159|NCT01220128|19196705|P6|Overall Study|Other|0
5554160|NCT01220128|19196706|P5|Overall Study|Other|0
5554161|NCT01220128|19196707|P4|Overall Study|Other|0
5554162|NCT01220128|19196708|P3|Overall Study|Other|1
5554163|NCT01220128|19196709|P2|Overall Study|Other|0
5554164|NCT01220128|19196710|P1|Overall Study|Other|0
5554165|NCT01220128|19196704|P7|Overall Study|Adverse event, non-fatal|3
5554166|NCT01220128|19196705|P6|Overall Study|Adverse event, non-fatal|0
5554167|NCT01220128|19196706|P5|Overall Study|Adverse event, non-fatal|0
5554168|NCT01220128|19196707|P4|Overall Study|Adverse event, non-fatal|0
5554169|NCT01220128|19196708|P3|Overall Study|Adverse event, non-fatal|0
5554170|NCT01220128|19196709|P2|Overall Study|Adverse event, non-fatal|0
5554171|NCT01220128|19196710|P1|Overall Study|Adverse event, non-fatal|1
5554172|NCT01220128|19196704|P7|Overall Study|Adverse event, serious fatal|1
5554173|NCT01220128|19196705|P6|Overall Study|Adverse event, serious fatal|0
5554174|NCT01220128|19196706|P5|Overall Study|Adverse event, serious fatal|0
5554175|NCT01220128|19196707|P4|Overall Study|Adverse event, serious fatal|0
5554176|NCT01220128|19196708|P3|Overall Study|Adverse event, serious fatal|0
5554177|NCT01220128|19196709|P2|Overall Study|Adverse event, serious fatal|0
5554178|NCT01220128|19196710|P1|Overall Study|Adverse event, serious fatal|2
5554179|NCT01220128|19196704|P7|Overall Study|Sponsor study termination|1
5554180|NCT01220128|19196705|P6|Overall Study|Sponsor study termination|0
5554181|NCT01220128|19196706|P5|Overall Study|Sponsor study termination|0
5554182|NCT01220128|19196707|P4|Overall Study|Sponsor study termination|0
5554183|NCT01220128|19196708|P3|Overall Study|Sponsor study termination|0
5554184|NCT01220128|19196709|P2|Overall Study|Sponsor study termination|1
5554185|NCT01220128|19196710|P1|Overall Study|Sponsor study termination|0
5554186|NCT01220128|19196704|P7|Overall Study|Progressive disease|0
5554187|NCT01220128|19196705|P6|Overall Study|Progressive disease|0
5554188|NCT01220128|19196706|P5|Overall Study|Progressive disease|0
5554189|NCT01220128|19196707|P4|Overall Study|Progressive disease|0
5554190|NCT01220128|19196708|P3|Overall Study|Progressive disease|2
5554191|NCT01220128|19196709|P2|Overall Study|Progressive disease|0
5554192|NCT01220128|19196710|P1|Overall Study|Progressive disease|0
5554193|NCT01219985|19196915|P1|Overall Study|Physician Decision|20
5554194|NCT01219959|19196923|P2|Overall Study|Other|0
5554195|NCT01219959|19196924|P1|Overall Study|Other|1
5554196|NCT01219959|19196923|P2|Overall Study|Renal Transplantation|3
5554197|NCT01219959|19196924|P1|Overall Study|Renal Transplantation|0
5554198|NCT01219959|19196923|P2|Overall Study|Withdrawal by Subject|2
5554199|NCT01219959|19196924|P1|Overall Study|Withdrawal by Subject|0
5554200|NCT01219959|19196923|P2|Overall Study|Physician Decision|4
5554201|NCT01219959|19196924|P1|Overall Study|Physician Decision|0
5554202|NCT01219959|19196923|P2|Overall Study|Adverse Event|14
5554203|NCT01219959|19196924|P1|Overall Study|Adverse Event|6
5554204|NCT01219933|19196972|P1|Overall Study|Lack of Efficacy|1
5554205|NCT01219933|19196972|P1|Overall Study|Protocol Violation|8
5554206|NCT01219933|19196972|P1|Overall Study|Withdrawal by Subject|5
5554207|NCT01219933|19196972|P1|Overall Study|GC free|1
5554208|NCT01219933|19196972|P1|Overall Study|Lost to Follow-up|3
5554209|NCT01219933|19196972|P1|Overall Study|No LDA maintained|7
5554210|NCT01219933|19196972|P1|Overall Study|No LDA reached|5
5554211|NCT01219933|19196972|P1|Overall Study|Adverse Event|8
5554212|NCT01218867|19197182|P11|Overall Study|Death during treatment|0
5554213|NCT01218867|19197183|P10|Overall Study|Death during treatment|0
5554214|NCT01218867|19197184|P9|Overall Study|Death during treatment|0
5554215|NCT01218867|19197185|P8|Overall Study|Death during treatment|0
5554216|NCT01218867|19197186|P7|Overall Study|Death during treatment|1
5554217|NCT01218867|19197187|P6|Overall Study|Death during treatment|0
5554218|NCT01218867|19197188|P5|Overall Study|Death during treatment|0
5554219|NCT01218867|19197189|P4|Overall Study|Death during treatment|0
5554220|NCT01218867|19197190|P3|Overall Study|Death during treatment|0
5554221|NCT01218867|19197191|P2|Overall Study|Death during treatment|0
5554222|NCT01218867|19197192|P1|Overall Study|Death during treatment|0
5554223|NCT01218802|19197240|P2|Overall Study|Incarcerated|0
5554224|NCT01218802|19197241|P1|Overall Study|Incarcerated|2
5554225|NCT01218802|19197240|P2|Overall Study|Adverse Event|2
5554226|NCT01218802|19197241|P1|Overall Study|Adverse Event|0
5554227|NCT01218802|19197240|P2|Overall Study|Withdrawal by Subject|10
5554228|NCT01218802|19197241|P1|Overall Study|Withdrawal by Subject|3
5554229|NCT01218802|19197240|P2|Overall Study|Lost to Follow-up|6
5554230|NCT01218802|19197241|P1|Overall Study|Lost to Follow-up|5
5554231|NCT01218659|19197278|P3|12-Month OLE|Declined to participate in the OLE|4
5554232|NCT01218659|19197279|P2|12-Month OLE|Declined to participate in the OLE|0
5554233|NCT01218659|19197280|P1|12-Month OLE|Declined to participate in the OLE|0
5554234|NCT01218659|19197278|P3|12-Month OLE|Lack of Efficacy|1
5554235|NCT01218659|19197279|P2|12-Month OLE|Lack of Efficacy|0
5554236|NCT01218659|19197280|P1|12-Month OLE|Lack of Efficacy|0
5554237|NCT01218659|19197278|P3|12-Month OLE|Pregnancy|1
5554238|NCT01218659|19197279|P2|12-Month OLE|Pregnancy|0
5554239|NCT01218659|19197280|P1|12-Month OLE|Pregnancy|0
5554240|NCT01218659|19197278|P3|12-Month OLE|Lost to Follow-up|1
5554241|NCT01218659|19197279|P2|12-Month OLE|Lost to Follow-up|0
5554242|NCT01218659|19197280|P1|12-Month OLE|Lost to Follow-up|0
5554243|NCT01218659|19197278|P3|12-Month OLE|Physician Decision|1
5554244|NCT01218659|19197279|P2|12-Month OLE|Physician Decision|0
5554245|NCT01218659|19197280|P1|12-Month OLE|Physician Decision|0
5554246|NCT01218659|19197278|P3|12-Month OLE|Withdrawal by Subject|2
5554247|NCT01218659|19197279|P2|12-Month OLE|Withdrawal by Subject|0
5554248|NCT01218659|19197280|P1|12-Month OLE|Withdrawal by Subject|0
5554249|NCT01218659|19197278|P3|18-Month Randomized Period|Did not receive study drug|0
5554250|NCT01218659|19197279|P2|18-Month Randomized Period|Did not receive study drug|3
5554251|NCT01218659|19197280|P1|18-Month Randomized Period|Did not receive study drug|0
5554252|NCT01218659|19197278|P3|18-Month Randomized Period|Withdrawal by Subject|0
5554253|NCT01218659|19197279|P2|18-Month Randomized Period|Withdrawal by Subject|3
5554254|NCT01218659|19197280|P1|18-Month Randomized Period|Withdrawal by Subject|2
5554255|NCT01218646|19197295|P4|Overall Study|Protocol Violation|1
5554256|NCT01218646|19197296|P3|Overall Study|Protocol Violation|1
5554257|NCT01218646|19197297|P2|Overall Study|Protocol Violation|0
5554258|NCT01218646|19197298|P1|Overall Study|Protocol Violation|0
5554259|NCT01218646|19197295|P4|Overall Study|Lost to Follow-up|0
5554260|NCT01218646|19197296|P3|Overall Study|Lost to Follow-up|0
5554261|NCT01218646|19197297|P2|Overall Study|Lost to Follow-up|0
5554262|NCT01218646|19197298|P1|Overall Study|Lost to Follow-up|1
5554263|NCT01218646|19197295|P4|Overall Study|Adverse Event|0
5554264|NCT01218646|19197296|P3|Overall Study|Adverse Event|1
5554265|NCT01218646|19197297|P2|Overall Study|Adverse Event|0
5554266|NCT01218646|19197298|P1|Overall Study|Adverse Event|0
5554267|NCT01218594|19197336|P1|Overall Study|Physician Decision|6
5554268|NCT01218594|19197336|P1|Overall Study|Adverse Event|2
5554269|NCT01218594|19197336|P1|Overall Study|Withdrawal by Subject|3
5554270|NCT01218594|19197336|P1|Overall Study|Death|1
5554271|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
5554272|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
5554273|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
5554274|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
5554275|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
5554276|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
5554277|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
5554278|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
5554279|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
5554280|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
5554281|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
5554282|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
5554283|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Other|0
5554284|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Other|0
5554285|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Other|4
5554286|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Other|3
5554287|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
5554288|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
5554289|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
5554290|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
5554291|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
5554292|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
5554293|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
5554294|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
5554295|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
5554296|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
5554297|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
5554298|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
5554299|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
5554300|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
5554301|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
5554302|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
5554303|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
5554304|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
5554305|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
5554306|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
5554307|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Physician Decision|0
5554308|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Physician Decision|0
5554309|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Physician Decision|2
5554310|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Physician Decision|2
5554311|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
5554312|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
5554313|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
5554314|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
5554315|NCT01218516|19197342|P4|Combination Therapy (up to 4.5 Months)|Death|0
5554316|NCT01218516|19197343|P3|Combination Therapy (up to 4.5 Months)|Death|0
5554317|NCT01218516|19197344|P2|Combination Therapy (up to 4.5 Months)|Death|1
5554318|NCT01218516|19197345|P1|Combination Therapy (up to 4.5 Months)|Death|2
5554319|NCT01218477|19197367|P4|Overall Study|Maximum clinical benefit|0
5554320|NCT01218477|19197368|P3|Overall Study|Maximum clinical benefit|0
5554321|NCT01218477|19197369|P2|Overall Study|Maximum clinical benefit|2
5554322|NCT01218477|19197370|P1|Overall Study|Maximum clinical benefit|0
5554323|NCT01218477|19197367|P4|Overall Study|Administrative reason by sponsor|0
5554324|NCT01218477|19197368|P3|Overall Study|Administrative reason by sponsor|1
5554325|NCT01218477|19197369|P2|Overall Study|Administrative reason by sponsor|0
5554326|NCT01218477|19197370|P1|Overall Study|Administrative reason by sponsor|0
5554327|NCT01218477|19197367|P4|Overall Study|Prepared for cell transplantation|0
5554328|NCT01218477|19197368|P3|Overall Study|Prepared for cell transplantation|1
5554329|NCT01218477|19197369|P2|Overall Study|Prepared for cell transplantation|1
5554330|NCT01218477|19197370|P1|Overall Study|Prepared for cell transplantation|0
5554331|NCT01218477|19197367|P4|Overall Study|Withdrawal by Subject|0
5554332|NCT01218477|19197368|P3|Overall Study|Withdrawal by Subject|1
5554333|NCT01218477|19197369|P2|Overall Study|Withdrawal by Subject|0
5554334|NCT01218477|19197370|P1|Overall Study|Withdrawal by Subject|0
5554335|NCT01218477|19197367|P4|Overall Study|No longer meets study criteria|0
5554336|NCT01218477|19197368|P3|Overall Study|No longer meets study criteria|0
5554337|NCT01218477|19197369|P2|Overall Study|No longer meets study criteria|0
5554338|NCT01218477|19197370|P1|Overall Study|No longer meets study criteria|1
5554339|NCT01218477|19197367|P4|Overall Study|Study drug toxicity|0
5554340|NCT01218477|19197368|P3|Overall Study|Study drug toxicity|5
5554341|NCT01218477|19197369|P2|Overall Study|Study drug toxicity|2
5554342|NCT01218477|19197370|P1|Overall Study|Study drug toxicity|0
5554343|NCT01218477|19197367|P4|Overall Study|Disease progression|2
5554344|NCT01218477|19197368|P3|Overall Study|Disease progression|6
5554345|NCT01218477|19197369|P2|Overall Study|Disease progression|3
5554346|NCT01218477|19197370|P1|Overall Study|Disease progression|2
5554347|NCT01218438|19197387|P1|Epoch 4|Withdrawal by Subject|2
5554348|NCT01218438|19197387|P1|Epoch 4|Physician Decision|1
5554349|NCT01218438|19197387|P1|Epoch 3|Adverse Event|1
5554350|NCT01218438|19197387|P1|Epoch 3|Withdrawal by Subject|3
5554351|NCT01218438|19197387|P1|Epoch 1|Adverse Event|1
5554352|NCT01218438|19197387|P1|Epoch 1|Physician Decision|2
5554353|NCT01218308|19197553|P2|Overall Study|Other|21
5554354|NCT01218308|19197554|P1|Overall Study|Other|14
5554355|NCT01218308|19197553|P2|Overall Study|Lost to Follow-up|31
5554356|NCT01218308|19197554|P1|Overall Study|Lost to Follow-up|27
5554357|NCT01218308|19197553|P2|Overall Study|Withdrawal by Subject|64
5554358|NCT01218308|19197554|P1|Overall Study|Withdrawal by Subject|61
5554359|NCT01218308|19197553|P2|Overall Study|Protocol Violation|2
5554360|NCT01218308|19197554|P1|Overall Study|Protocol Violation|0
5554361|NCT01218308|19197553|P2|Overall Study|Adverse Event|2
5554362|NCT01218308|19197554|P1|Overall Study|Adverse Event|1
5554363|NCT01218243|19197598|P2|Overall Study|Protocol Violation|10
5554364|NCT01218243|19197599|P1|Overall Study|Protocol Violation|5
5554365|NCT01218243|19197598|P2|Overall Study|Lost to Follow-up|3
5554366|NCT01218243|19197599|P1|Overall Study|Lost to Follow-up|3
5554367|NCT01218243|19197598|P2|Overall Study|Lack of Efficacy|1
5554368|NCT01218243|19197599|P1|Overall Study|Lack of Efficacy|1
5554369|NCT01218204|19197615|P4|Part B Pooled Treatment Arm|Protocol Violation|1
5554370|NCT01218204|19197616|P3|Part B Pooled Treatment Arm|Protocol Violation|0
5554371|NCT01218204|19197617|P2|Part B Pooled Treatment Arm|Protocol Violation|0
5554372|NCT01218204|19197618|P1|Part B Pooled Treatment Arm|Protocol Violation|0
5554373|NCT01218204|19197615|P4|Part B Pooled Treatment Arm|Adverse Event|2
5554374|NCT01218204|19197616|P3|Part B Pooled Treatment Arm|Adverse Event|0
5554375|NCT01218204|19197617|P2|Part B Pooled Treatment Arm|Adverse Event|0
5554376|NCT01218204|19197618|P1|Part B Pooled Treatment Arm|Adverse Event|0
5554377|NCT01218204|19197615|P4|Part B Run-in|Withdrawal by Subject|0
5554378|NCT01218204|19197616|P3|Part B Run-in|Withdrawal by Subject|3
5554379|NCT01218204|19197617|P2|Part B Run-in|Withdrawal by Subject|0
5554380|NCT01218204|19197618|P1|Part B Run-in|Withdrawal by Subject|0
5554381|NCT01218204|19197615|P4|Part B Run-in|Protocol Violation|0
5554382|NCT01218204|19197616|P3|Part B Run-in|Protocol Violation|2
5554383|NCT01218204|19197617|P2|Part B Run-in|Protocol Violation|0
5554384|NCT01218204|19197618|P1|Part B Run-in|Protocol Violation|0
5554385|NCT01218204|19197615|P4|Part B Run-in|Adverse Event|0
5554386|NCT01218204|19197616|P3|Part B Run-in|Adverse Event|1
5554387|NCT01218204|19197617|P2|Part B Run-in|Adverse Event|0
5554388|NCT01218204|19197618|P1|Part B Run-in|Adverse Event|0
5554389|NCT01218204|19197615|P4|Part B Washout|Did not meet continuation criteria|0
5554390|NCT01218204|19197616|P3|Part B Washout|Did not meet continuation criteria|0
5554391|NCT01218204|19197617|P2|Part B Washout|Did not meet continuation criteria|112
5554392|NCT01218204|19197618|P1|Part B Washout|Did not meet continuation criteria|0
5554393|NCT01218204|19197615|P4|Part B Washout|Reached defined stopping criteria|0
5554394|NCT01218204|19197616|P3|Part B Washout|Reached defined stopping criteria|0
5554395|NCT01218204|19197617|P2|Part B Washout|Reached defined stopping criteria|2
5554396|NCT01218204|19197618|P1|Part B Washout|Reached defined stopping criteria|0
5554397|NCT01218204|19197615|P4|Part B Washout|Withdrawal by Subject|0
5554398|NCT01218204|19197616|P3|Part B Washout|Withdrawal by Subject|0
5554399|NCT01218204|19197617|P2|Part B Washout|Withdrawal by Subject|14
5554400|NCT01218204|19197618|P1|Part B Washout|Withdrawal by Subject|0
5554401|NCT01218204|19197615|P4|Part B Washout|Physician Decision|0
5554402|NCT01218204|19197616|P3|Part B Washout|Physician Decision|0
5554403|NCT01218204|19197617|P2|Part B Washout|Physician Decision|14
5554404|NCT01218204|19197618|P1|Part B Washout|Physician Decision|0
5554405|NCT01218204|19197615|P4|Part B Washout|Lost to Follow-up|0
5554406|NCT01218204|19197616|P3|Part B Washout|Lost to Follow-up|0
5554407|NCT01218204|19197617|P2|Part B Washout|Lost to Follow-up|2
5554408|NCT01218204|19197618|P1|Part B Washout|Lost to Follow-up|0
5554409|NCT01218204|19197615|P4|Part B Washout|Adverse Event|0
5554410|NCT01218204|19197616|P3|Part B Washout|Adverse Event|0
5554411|NCT01218204|19197617|P2|Part B Washout|Adverse Event|1
5554412|NCT01218204|19197618|P1|Part B Washout|Adverse Event|0
5554413|NCT01218126|19197882|P4|Overall Study|Withdrawal by Subject|6
5554414|NCT01218126|19197883|P3|Overall Study|Withdrawal by Subject|4
5554415|NCT01218126|19197884|P2|Overall Study|Withdrawal by Subject|5
5554416|NCT01218126|19197885|P1|Overall Study|Withdrawal by Subject|2
5554417|NCT01218126|19197882|P4|Overall Study|Physician Decision|2
5554418|NCT01218126|19197883|P3|Overall Study|Physician Decision|4
5554419|NCT01218126|19197884|P2|Overall Study|Physician Decision|2
5554420|NCT01218126|19197885|P1|Overall Study|Physician Decision|1
5554421|NCT01218126|19197882|P4|Overall Study|Lost to Follow-up|2
5554422|NCT01218126|19197883|P3|Overall Study|Lost to Follow-up|0
5554423|NCT01218126|19197884|P2|Overall Study|Lost to Follow-up|0
5554424|NCT01218126|19197885|P1|Overall Study|Lost to Follow-up|0
5554425|NCT01218126|19197882|P4|Overall Study|Protocol-defined stopping criteria|0
5554426|NCT01218126|19197883|P3|Overall Study|Protocol-defined stopping criteria|0
5554427|NCT01218126|19197884|P2|Overall Study|Protocol-defined stopping criteria|1
5554428|NCT01218126|19197885|P1|Overall Study|Protocol-defined stopping criteria|1
5554429|NCT01218126|19197882|P4|Overall Study|Protocol Violation|3
5554430|NCT01218126|19197883|P3|Overall Study|Protocol Violation|2
5554431|NCT01218126|19197884|P2|Overall Study|Protocol Violation|2
5554432|NCT01218126|19197885|P1|Overall Study|Protocol Violation|5
5554433|NCT01218126|19197882|P4|Overall Study|Lack of Efficacy|6
5554434|NCT01218126|19197883|P3|Overall Study|Lack of Efficacy|2
5554435|NCT01218126|19197884|P2|Overall Study|Lack of Efficacy|2
5554436|NCT01218126|19197885|P1|Overall Study|Lack of Efficacy|7
5554437|NCT01218126|19197882|P4|Overall Study|Adverse Event|16
5554438|NCT01218126|19197883|P3|Overall Study|Adverse Event|12
5554439|NCT01218126|19197884|P2|Overall Study|Adverse Event|10
5554440|NCT01218126|19197885|P1|Overall Study|Adverse Event|8
5554441|NCT01218113|19197926|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
5554442|NCT01218113|19197927|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
5554443|NCT01218113|19197928|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
5554444|NCT01218113|19197926|P3|Overall Study|Lost to Follow-up|4
5554445|NCT01218113|19197927|P2|Overall Study|Lost to Follow-up|1
5554446|NCT01218113|19197928|P1|Overall Study|Lost to Follow-up|4
5554447|NCT01218113|19197926|P3|Overall Study|Withdrawal by Subject|1
5554448|NCT01218113|19197927|P2|Overall Study|Withdrawal by Subject|0
5554449|NCT01218113|19197928|P1|Overall Study|Withdrawal by Subject|1
5554450|NCT01218100|19198109|P4|Overall Study|Other Reason|4
5554451|NCT01218100|19198110|P3|Overall Study|Other Reason|6
5554452|NCT01218100|19198111|P2|Overall Study|Other Reason|2
5554453|NCT01218100|19198112|P1|Overall Study|Other Reason|2
5554454|NCT01218100|19198109|P4|Overall Study|Lost to Follow-up|1
5554455|NCT01218100|19198110|P3|Overall Study|Lost to Follow-up|2
5554456|NCT01218100|19198111|P2|Overall Study|Lost to Follow-up|8
5554457|NCT01218100|19198112|P1|Overall Study|Lost to Follow-up|3
5554458|NCT01218100|19198109|P4|Overall Study|Withdrawal by Subject|7
5554459|NCT01218100|19198110|P3|Overall Study|Withdrawal by Subject|6
5554460|NCT01218100|19198111|P2|Overall Study|Withdrawal by Subject|2
5554461|NCT01218100|19198112|P1|Overall Study|Withdrawal by Subject|5
5554462|NCT01218100|19198109|P4|Overall Study|Protocol Violation|1
5554463|NCT01218100|19198110|P3|Overall Study|Protocol Violation|1
5554464|NCT01218100|19198111|P2|Overall Study|Protocol Violation|0
5554465|NCT01218100|19198112|P1|Overall Study|Protocol Violation|0
5554466|NCT01218100|19198109|P4|Overall Study|Lack of Efficacy|12
5554467|NCT01218100|19198110|P3|Overall Study|Lack of Efficacy|5
5554468|NCT01218100|19198111|P2|Overall Study|Lack of Efficacy|6
5554469|NCT01218100|19198112|P1|Overall Study|Lack of Efficacy|9
5554470|NCT01218100|19198109|P4|Overall Study|Adverse Event|7
5554471|NCT01218100|19198110|P3|Overall Study|Adverse Event|6
5554472|NCT01218100|19198111|P2|Overall Study|Adverse Event|6
5554473|NCT01218100|19198112|P1|Overall Study|Adverse Event|4
5554474|NCT01218100|19198109|P4|Overall Study|Did not meet InclusionExclusion criteria|2
5554475|NCT01218100|19198110|P3|Overall Study|Did not meet InclusionExclusion criteria|1
5554476|NCT01218100|19198111|P2|Overall Study|Did not meet InclusionExclusion criteria|1
5554477|NCT01218100|19198112|P1|Overall Study|Did not meet InclusionExclusion criteria|1
5554478|NCT01218087|19198128|P2|Overall Study|Transferred|5
5554479|NCT01218087|19198129|P1|Overall Study|Transferred|8
5554480|NCT01218087|19198128|P2|Overall Study|Withdrawal by Subject|0
5554481|NCT01218087|19198129|P1|Overall Study|Withdrawal by Subject|5
5554482|NCT01218087|19198128|P2|Overall Study|Death|1
5554483|NCT01218087|19198129|P1|Overall Study|Death|2
5554484|NCT01218009|19198151|P2|Overall Study|Sponsor terminated study|163
5554485|NCT01218009|19198152|P1|Overall Study|Sponsor terminated study|161
5554486|NCT01218009|19198151|P2|Overall Study|Withdrawal by Subject|1
5554487|NCT01218009|19198152|P1|Overall Study|Withdrawal by Subject|3
5554488|NCT01218009|19198151|P2|Overall Study|Protocol Violation|1
5554489|NCT01218009|19198152|P1|Overall Study|Protocol Violation|2
5554490|NCT01217957|19198175|P5|Phase 2|Withdrawal by Patient|1
5554491|NCT01217957|19198176|P4|Phase 2|Withdrawal by Patient|0
5554492|NCT01217957|19198177|P3|Phase 2|Withdrawal by Patient|0
5554493|NCT01217957|19198178|P2|Phase 2|Withdrawal by Patient|0
5554494|NCT01217957|19198179|P1|Phase 2|Withdrawal by Patient|0
5554495|NCT01217957|19198175|P5|Phase 1|Withdrawal by Patient|0
5554496|NCT01217957|19198176|P4|Phase 1|Withdrawal by Patient|1
5554497|NCT01217957|19198177|P3|Phase 1|Withdrawal by Patient|1
5554498|NCT01217957|19198178|P2|Phase 1|Withdrawal by Patient|0
5554499|NCT01217957|19198179|P1|Phase 1|Withdrawal by Patient|1
5554500|NCT01217944|19198238|P3|Overall Study|Lack of Efficacy|0
5554501|NCT01217944|19198239|P2|Overall Study|Lack of Efficacy|0
5554502|NCT01217944|19198240|P1|Overall Study|Lack of Efficacy|1
5554503|NCT01217944|19198238|P3|Overall Study|Withdrawal by Subject|0
5554504|NCT01217944|19198239|P2|Overall Study|Withdrawal by Subject|2
5554505|NCT01217944|19198240|P1|Overall Study|Withdrawal by Subject|1
5554506|NCT01217944|19198238|P3|Overall Study|Lost to Follow-up|0
5554507|NCT01217944|19198239|P2|Overall Study|Lost to Follow-up|1
5554508|NCT01217944|19198240|P1|Overall Study|Lost to Follow-up|3
5554509|NCT01217944|19198238|P3|Overall Study|Protocol Violation|0
5554510|NCT01217944|19198239|P2|Overall Study|Protocol Violation|1
5554511|NCT01217944|19198240|P1|Overall Study|Protocol Violation|1
5554512|NCT01217892|19198283|P4|Overall Study|Poor/Non-Compliance|0
5554513|NCT01217892|19198284|P3|Overall Study|Poor/Non-Compliance|1
5554514|NCT01217892|19198285|P2|Overall Study|Poor/Non-Compliance|0
5554515|NCT01217892|19198286|P1|Overall Study|Poor/Non-Compliance|0
5554516|NCT01217892|19198283|P4|Overall Study|Incorrect enrollment|0
5554517|NCT01217892|19198284|P3|Overall Study|Incorrect enrollment|1
5554518|NCT01217892|19198285|P2|Overall Study|Incorrect enrollment|1
5554519|NCT01217892|19198286|P1|Overall Study|Incorrect enrollment|0
5554520|NCT01217892|19198283|P4|Overall Study|Subject no longer meets study criteria|8
5554521|NCT01217892|19198284|P3|Overall Study|Subject no longer meets study criteria|4
5554522|NCT01217892|19198285|P2|Overall Study|Subject no longer meets study criteria|2
5554523|NCT01217892|19198286|P1|Overall Study|Subject no longer meets study criteria|5
5554524|NCT01217892|19198283|P4|Overall Study|Lab value|0
5554525|NCT01217892|19198284|P3|Overall Study|Lab value|1
5554526|NCT01217892|19198285|P2|Overall Study|Lab value|0
5554527|NCT01217892|19198286|P1|Overall Study|Lab value|1
5554528|NCT01217892|19198283|P4|Overall Study|Withdrawal by Subject|0
5554529|NCT01217892|19198284|P3|Overall Study|Withdrawal by Subject|1
5554530|NCT01217892|19198285|P2|Overall Study|Withdrawal by Subject|2
5554531|NCT01217892|19198286|P1|Overall Study|Withdrawal by Subject|0
5554532|NCT01217892|19198283|P4|Overall Study|Adverse Event|0
5554533|NCT01217892|19198284|P3|Overall Study|Adverse Event|1
5554534|NCT01217892|19198285|P2|Overall Study|Adverse Event|1
5554535|NCT01217892|19198286|P1|Overall Study|Adverse Event|1
5554536|NCT01217814|19198349|P3|Overall Study|Lack of Efficacy|1
5554537|NCT01217814|19198350|P2|Overall Study|Lack of Efficacy|0
5554538|NCT01217814|19198351|P1|Overall Study|Lack of Efficacy|0
5554539|NCT01217814|19198349|P3|Overall Study|Adverse Event|0
5554540|NCT01217814|19198350|P2|Overall Study|Adverse Event|1
5554541|NCT01217814|19198351|P1|Overall Study|Adverse Event|1
5554542|NCT01217801|19198377|P2|Period 1|Withdrawal by Subject|1
5554543|NCT01217801|19198378|P1|Period 1|Withdrawal by Subject|0
5554544|NCT01217801|19198377|P2|Period 1|Protocol Violation|1
5554545|NCT01217801|19198378|P1|Period 1|Protocol Violation|1
5554546|NCT01217606|19198407|P2|9-Month Masked Extension|Lack of Efficacy|0
5554547|NCT01217606|19198408|P1|9-Month Masked Extension|Lack of Efficacy|2
5554548|NCT01217606|19198407|P2|9-Month Masked Extension|Pregnancy|0
5554549|NCT01217606|19198408|P1|9-Month Masked Extension|Pregnancy|1
5554550|NCT01217606|19198407|P2|9-Month Masked Extension|Lost to Follow-up|0
5554551|NCT01217606|19198408|P1|9-Month Masked Extension|Lost to Follow-up|1
5554552|NCT01217606|19198407|P2|9-Month Masked Extension|Personal Reasons|1
5554553|NCT01217606|19198408|P1|9-Month Masked Extension|Personal Reasons|2
5554554|NCT01217606|19198407|P2|9-Month Masked Extension|Other Reasons|4
5554555|NCT01217606|19198408|P1|9-Month Masked Extension|Other Reasons|4
5554556|NCT01217606|19198407|P2|9-Month Masked Extension|Adverse Event|6
5554557|NCT01217606|19198408|P1|9-Month Masked Extension|Adverse Event|3
5554558|NCT01217606|19198407|P2|Initial Treatment Phase|Adverse Event|6
5554559|NCT01217606|19198408|P1|Initial Treatment Phase|Adverse Event|10
5554560|NCT01217606|19198407|P2|Initial Treatment Phase|Lack of Efficacy|0
5554561|NCT01217606|19198408|P1|Initial Treatment Phase|Lack of Efficacy|1
5554562|NCT01217606|19198407|P2|Initial Treatment Phase|Personal Reasons|2
5554563|NCT01217606|19198408|P1|Initial Treatment Phase|Personal Reasons|0
5554564|NCT01217606|19198407|P2|Initial Treatment Phase|Protocol Violation|2
5554565|NCT01217606|19198408|P1|Initial Treatment Phase|Protocol Violation|3
5554566|NCT01217606|19198407|P2|Initial Treatment Phase|Other Reasons|2
5554567|NCT01217606|19198408|P1|Initial Treatment Phase|Other Reasons|0
5554568|NCT01217476|19198439|P2|Overall Study|Other|0
5554569|NCT01217476|19198440|P1|Overall Study|Other|2
5554570|NCT01217476|19198439|P2|Overall Study|Protocol Deviation|0
5554571|NCT01217476|19198440|P1|Overall Study|Protocol Deviation|1
5554572|NCT01217476|19198439|P2|Overall Study|Surgery on the Target Limb|2
5554573|NCT01217476|19198440|P1|Overall Study|Surgery on the Target Limb|0
5554574|NCT01217476|19198439|P2|Overall Study|Withdrawal by Subject|3
5554575|NCT01217476|19198440|P1|Overall Study|Withdrawal by Subject|3
5554576|NCT01217476|19198439|P2|Overall Study|Physician Decision|1
5554577|NCT01217476|19198440|P1|Overall Study|Physician Decision|0
5554578|NCT01217476|19198439|P2|Overall Study|Adverse Event|1
5554579|NCT01217476|19198440|P1|Overall Study|Adverse Event|6
5554580|NCT01217463|19198450|P2|Overall Study|Other|1
5554581|NCT01217463|19198451|P1|Overall Study|Other|1
5554582|NCT01217463|19198450|P2|Overall Study|Patient Non-compliant|0
5554583|NCT01217463|19198451|P1|Overall Study|Patient Non-compliant|1
5554584|NCT01217463|19198450|P2|Overall Study|Surgery on the Target Limb|1
5554585|NCT01217463|19198451|P1|Overall Study|Surgery on the Target Limb|0
5554586|NCT01217463|19198450|P2|Overall Study|Withdrawal by Subject|0
5554587|NCT01217463|19198451|P1|Overall Study|Withdrawal by Subject|3
5554588|NCT01217463|19198450|P2|Overall Study|Physician Decision|1
5554589|NCT01217463|19198451|P1|Overall Study|Physician Decision|0
5554590|NCT01217463|19198450|P2|Overall Study|Adverse Event|5
5554591|NCT01217463|19198451|P1|Overall Study|Adverse Event|8
5554592|NCT01217437|19198461|P2|Overall Study|Ineligible|1
5554593|NCT01217437|19198462|P1|Overall Study|Ineligible|1
5554594|NCT01217437|19198461|P2|Overall Study|Withdrawal by Subject|2
5554595|NCT01217437|19198462|P1|Overall Study|Withdrawal by Subject|0
5554596|NCT01217437|19198461|P2|Overall Study|Physician Decision|5
5554597|NCT01217437|19198462|P1|Overall Study|Physician Decision|8
5554598|NCT01217437|19198461|P2|Overall Study|Lack of Efficacy|25
5554599|NCT01217437|19198462|P1|Overall Study|Lack of Efficacy|29
5554600|NCT01217437|19198461|P2|Overall Study|Death|0
5554601|NCT01217437|19198462|P1|Overall Study|Death|5
5554602|NCT01217437|19198461|P2|Overall Study|Adverse Event|8
5554603|NCT01217437|19198462|P1|Overall Study|Adverse Event|0
5554604|NCT01217385|19198483|P1|Overall Study|Normal Breast TOI not available|10
5554605|NCT01217385|19198483|P1|Overall Study|Central Path not Available|1
5554606|NCT01217385|19198483|P1|Overall Study|DOSI not performed/not eval|12
5554607|NCT01217385|19198483|P1|Overall Study|Withdrawal by Subject|3
5554608|NCT01217307|19198495|P2|Overall Study|Withdrawal by Subject|1
5554609|NCT01217307|19198496|P1|Overall Study|Withdrawal by Subject|0
5554610|NCT01217229|19198502|P1|Overall Study|Disease progression not confirmed|2
5554611|NCT01217229|19198502|P1|Overall Study|Protocol Violation|1
5554612|NCT01217229|19198502|P1|Overall Study|Disease progression, Cheson criteria|14
5554613|NCT01217229|19198502|P1|Overall Study|Disease progression, deterioration|2
5554614|NCT01217229|19198502|P1|Overall Study|Adverse Event|1
5554615|NCT01217190|19198511|P2|Second Dosing|Withdrawal by Subject|2
5554616|NCT01217190|19198512|P1|Second Dosing|Withdrawal by Subject|0
5554617|NCT01217112|19198527|P5|Overall Study|Physician Decision|1
5554618|NCT01217112|19198528|P4|Overall Study|Physician Decision|0
5554619|NCT01217112|19198529|P3|Overall Study|Physician Decision|0
5554620|NCT01217112|19198530|P2|Overall Study|Physician Decision|0
5554621|NCT01217112|19198531|P1|Overall Study|Physician Decision|0
5554622|NCT01217112|19198527|P5|Overall Study|Withdrawal by Subject|0
5554623|NCT01217112|19198528|P4|Overall Study|Withdrawal by Subject|0
5554624|NCT01217112|19198529|P3|Overall Study|Withdrawal by Subject|1
5554625|NCT01217112|19198530|P2|Overall Study|Withdrawal by Subject|0
5554626|NCT01217112|19198531|P1|Overall Study|Withdrawal by Subject|0
5554627|NCT01217112|19198527|P5|Overall Study|Adverse Event|0
5554628|NCT01217112|19198528|P4|Overall Study|Adverse Event|2
5554629|NCT01217112|19198529|P3|Overall Study|Adverse Event|0
5554630|NCT01217112|19198530|P2|Overall Study|Adverse Event|2
5554631|NCT01217112|19198531|P1|Overall Study|Adverse Event|0
5554632|NCT01217073|19198764|P8|Extension Period|Withdrawal by Subject|8
5554633|NCT01217073|19198765|P7|Extension Period|Withdrawal by Subject|30
5554634|NCT01217073|19198766|P6|Extension Period|Withdrawal by Subject|0
5554635|NCT01217073|19198767|P5|Extension Period|Withdrawal by Subject|0
5554636|NCT01217073|19198768|P4|Extension Period|Withdrawal by Subject|0
5554637|NCT01217073|19198769|P3|Extension Period|Withdrawal by Subject|0
5554638|NCT01217073|19198770|P2|Extension Period|Withdrawal by Subject|0
5554639|NCT01217073|19198771|P1|Extension Period|Withdrawal by Subject|0
5554640|NCT01217073|19198764|P8|Extension Period|Site discontinued study participation|2
5554641|NCT01217073|19198765|P7|Extension Period|Site discontinued study participation|7
5554642|NCT01217073|19198766|P6|Extension Period|Site discontinued study participation|0
5554643|NCT01217073|19198767|P5|Extension Period|Site discontinued study participation|0
5554644|NCT01217073|19198768|P4|Extension Period|Site discontinued study participation|0
5554645|NCT01217073|19198769|P3|Extension Period|Site discontinued study participation|0
5554646|NCT01217073|19198770|P2|Extension Period|Site discontinued study participation|0
5554647|NCT01217073|19198771|P1|Extension Period|Site discontinued study participation|0
5554648|NCT01217073|19198764|P8|Extension Period|Protocol Violation|1
5554649|NCT01217073|19198765|P7|Extension Period|Protocol Violation|2
5554650|NCT01217073|19198766|P6|Extension Period|Protocol Violation|0
5554651|NCT01217073|19198767|P5|Extension Period|Protocol Violation|0
5554652|NCT01217073|19198768|P4|Extension Period|Protocol Violation|0
5554653|NCT01217073|19198769|P3|Extension Period|Protocol Violation|0
5554654|NCT01217073|19198770|P2|Extension Period|Protocol Violation|0
5554655|NCT01217073|19198771|P1|Extension Period|Protocol Violation|0
5554656|NCT01217073|19198764|P8|Extension Period|Physician Decision|1
5554657|NCT01217073|19198765|P7|Extension Period|Physician Decision|4
5554658|NCT01217073|19198766|P6|Extension Period|Physician Decision|0
5554659|NCT01217073|19198767|P5|Extension Period|Physician Decision|0
5554660|NCT01217073|19198768|P4|Extension Period|Physician Decision|0
5554661|NCT01217073|19198769|P3|Extension Period|Physician Decision|0
5554662|NCT01217073|19198770|P2|Extension Period|Physician Decision|0
5554663|NCT01217073|19198771|P1|Extension Period|Physician Decision|0
5554664|NCT01217073|19198764|P8|Extension Period|Non-compliance with study drug|1
5554665|NCT01217073|19198765|P7|Extension Period|Non-compliance with study drug|0
5554666|NCT01217073|19198766|P6|Extension Period|Non-compliance with study drug|0
5554667|NCT01217073|19198767|P5|Extension Period|Non-compliance with study drug|0
5554668|NCT01217073|19198768|P4|Extension Period|Non-compliance with study drug|0
5554669|NCT01217073|19198769|P3|Extension Period|Non-compliance with study drug|0
5554670|NCT01217073|19198770|P2|Extension Period|Non-compliance with study drug|0
5554671|NCT01217073|19198771|P1|Extension Period|Non-compliance with study drug|0
5554672|NCT01217073|19198764|P8|Extension Period|Lost to Follow-up|1
5554673|NCT01217073|19198765|P7|Extension Period|Lost to Follow-up|9
5554674|NCT01217073|19198766|P6|Extension Period|Lost to Follow-up|0
5554675|NCT01217073|19198767|P5|Extension Period|Lost to Follow-up|0
5554676|NCT01217073|19198768|P4|Extension Period|Lost to Follow-up|0
5554677|NCT01217073|19198769|P3|Extension Period|Lost to Follow-up|0
5554678|NCT01217073|19198770|P2|Extension Period|Lost to Follow-up|0
5554679|NCT01217073|19198771|P1|Extension Period|Lost to Follow-up|0
5554680|NCT01217073|19198764|P8|Extension Period|Lack of Efficacy|0
5554681|NCT01217073|19198765|P7|Extension Period|Lack of Efficacy|3
5554682|NCT01217073|19198766|P6|Extension Period|Lack of Efficacy|0
5554683|NCT01217073|19198767|P5|Extension Period|Lack of Efficacy|0
5554684|NCT01217073|19198768|P4|Extension Period|Lack of Efficacy|0
5554685|NCT01217073|19198769|P3|Extension Period|Lack of Efficacy|0
5554686|NCT01217073|19198770|P2|Extension Period|Lack of Efficacy|0
5554687|NCT01217073|19198771|P1|Extension Period|Lack of Efficacy|0
5554688|NCT01217073|19198764|P8|Extension Period|Excluded medication|0
5554689|NCT01217073|19198765|P7|Extension Period|Excluded medication|2
5554690|NCT01217073|19198766|P6|Extension Period|Excluded medication|0
5554691|NCT01217073|19198767|P5|Extension Period|Excluded medication|0
5554692|NCT01217073|19198768|P4|Extension Period|Excluded medication|0
5554693|NCT01217073|19198769|P3|Extension Period|Excluded medication|0
5554694|NCT01217073|19198770|P2|Extension Period|Excluded medication|0
5554695|NCT01217073|19198771|P1|Extension Period|Excluded medication|0
5554696|NCT01217073|19198764|P8|Extension Period|Death|0
5554697|NCT01217073|19198765|P7|Extension Period|Death|1
5554698|NCT01217073|19198766|P6|Extension Period|Death|0
5554699|NCT01217073|19198767|P5|Extension Period|Death|0
5554700|NCT01217073|19198768|P4|Extension Period|Death|0
5554701|NCT01217073|19198769|P3|Extension Period|Death|0
5554702|NCT01217073|19198770|P2|Extension Period|Death|0
5554703|NCT01217073|19198771|P1|Extension Period|Death|0
5554704|NCT01217073|19198764|P8|Extension Period|Creatinine/eGFR|1
5554705|NCT01217073|19198765|P7|Extension Period|Creatinine/eGFR|11
5554706|NCT01217073|19198766|P6|Extension Period|Creatinine/eGFR|0
5554707|NCT01217073|19198767|P5|Extension Period|Creatinine/eGFR|0
5554708|NCT01217073|19198768|P4|Extension Period|Creatinine/eGFR|0
5554709|NCT01217073|19198769|P3|Extension Period|Creatinine/eGFR|0
5554710|NCT01217073|19198770|P2|Extension Period|Creatinine/eGFR|0
5554711|NCT01217073|19198771|P1|Extension Period|Creatinine/eGFR|0
5554712|NCT01217073|19198764|P8|Extension Period|Contraindication to study medication|0
5554713|NCT01217073|19198765|P7|Extension Period|Contraindication to study medication|1
5554714|NCT01217073|19198766|P6|Extension Period|Contraindication to study medication|0
5554715|NCT01217073|19198767|P5|Extension Period|Contraindication to study medication|0
5554716|NCT01217073|19198768|P4|Extension Period|Contraindication to study medication|0
5554717|NCT01217073|19198769|P3|Extension Period|Contraindication to study medication|0
5554718|NCT01217073|19198770|P2|Extension Period|Contraindication to study medication|0
5554719|NCT01217073|19198771|P1|Extension Period|Contraindication to study medication|0
5554720|NCT01217073|19198764|P8|Extension Period|ALT/AST|0
5554721|NCT01217073|19198765|P7|Extension Period|ALT/AST|2
5554722|NCT01217073|19198766|P6|Extension Period|ALT/AST|0
5554723|NCT01217073|19198767|P5|Extension Period|ALT/AST|0
5554724|NCT01217073|19198768|P4|Extension Period|ALT/AST|0
5554725|NCT01217073|19198769|P3|Extension Period|ALT/AST|0
5554726|NCT01217073|19198770|P2|Extension Period|ALT/AST|0
5554727|NCT01217073|19198771|P1|Extension Period|ALT/AST|0
5554728|NCT01217073|19198764|P8|Extension Period|Adverse Event|5
5554729|NCT01217073|19198765|P7|Extension Period|Adverse Event|19
5554730|NCT01217073|19198766|P6|Extension Period|Adverse Event|0
5554731|NCT01217073|19198767|P5|Extension Period|Adverse Event|0
5554732|NCT01217073|19198768|P4|Extension Period|Adverse Event|0
5554733|NCT01217073|19198769|P3|Extension Period|Adverse Event|0
5554734|NCT01217073|19198770|P2|Extension Period|Adverse Event|0
5554735|NCT01217073|19198771|P1|Extension Period|Adverse Event|0
5554736|NCT01217073|19198764|P8|Base Period|Withdrawal by Subject|0
5554737|NCT01217073|19198765|P7|Base Period|Withdrawal by Subject|0
5554738|NCT01217073|19198766|P6|Base Period|Withdrawal by Subject|5
5554739|NCT01217073|19198767|P5|Base Period|Withdrawal by Subject|5
5554740|NCT01217073|19198768|P4|Base Period|Withdrawal by Subject|1
5554741|NCT01217073|19198769|P3|Base Period|Withdrawal by Subject|5
5554742|NCT01217073|19198770|P2|Base Period|Withdrawal by Subject|5
5554743|NCT01217073|19198771|P1|Base Period|Withdrawal by Subject|4
5554744|NCT01217073|19198764|P8|Base Period|Protocol Violation|0
5554745|NCT01217073|19198765|P7|Base Period|Protocol Violation|0
5554746|NCT01217073|19198766|P6|Base Period|Protocol Violation|2
5554747|NCT01217073|19198767|P5|Base Period|Protocol Violation|1
5554748|NCT01217073|19198768|P4|Base Period|Protocol Violation|0
5554749|NCT01217073|19198769|P3|Base Period|Protocol Violation|0
5554750|NCT01217073|19198770|P2|Base Period|Protocol Violation|0
5554751|NCT01217073|19198771|P1|Base Period|Protocol Violation|1
5554752|NCT01217073|19198764|P8|Base Period|Physician Decision|0
5554753|NCT01217073|19198765|P7|Base Period|Physician Decision|0
5554754|NCT01217073|19198766|P6|Base Period|Physician Decision|0
5554755|NCT01217073|19198767|P5|Base Period|Physician Decision|1
5554756|NCT01217073|19198768|P4|Base Period|Physician Decision|0
5554757|NCT01217073|19198769|P3|Base Period|Physician Decision|0
5554758|NCT01217073|19198770|P2|Base Period|Physician Decision|0
5554759|NCT01217073|19198771|P1|Base Period|Physician Decision|0
5554760|NCT01217073|19198764|P8|Base Period|Lost to Follow-up|0
5554761|NCT01217073|19198765|P7|Base Period|Lost to Follow-up|0
5554762|NCT01217073|19198766|P6|Base Period|Lost to Follow-up|0
5554763|NCT01217073|19198767|P5|Base Period|Lost to Follow-up|3
5554764|NCT01217073|19198768|P4|Base Period|Lost to Follow-up|1
5554765|NCT01217073|19198769|P3|Base Period|Lost to Follow-up|1
5554766|NCT01217073|19198770|P2|Base Period|Lost to Follow-up|0
5554767|NCT01217073|19198771|P1|Base Period|Lost to Follow-up|0
5554768|NCT01217073|19198764|P8|Base Period|Lack of Efficacy|0
5554769|NCT01217073|19198765|P7|Base Period|Lack of Efficacy|0
5554770|NCT01217073|19198766|P6|Base Period|Lack of Efficacy|1
5554771|NCT01217073|19198767|P5|Base Period|Lack of Efficacy|0
5554772|NCT01217073|19198768|P4|Base Period|Lack of Efficacy|0
5554773|NCT01217073|19198769|P3|Base Period|Lack of Efficacy|0
5554774|NCT01217073|19198770|P2|Base Period|Lack of Efficacy|0
5554775|NCT01217073|19198771|P1|Base Period|Lack of Efficacy|0
5554776|NCT01217073|19198764|P8|Base Period|Excluded medication|0
5554777|NCT01217073|19198765|P7|Base Period|Excluded medication|0
5554778|NCT01217073|19198766|P6|Base Period|Excluded medication|0
5554779|NCT01217073|19198767|P5|Base Period|Excluded medication|1
5554780|NCT01217073|19198768|P4|Base Period|Excluded medication|0
5554781|NCT01217073|19198769|P3|Base Period|Excluded medication|0
5554782|NCT01217073|19198770|P2|Base Period|Excluded medication|0
5554783|NCT01217073|19198771|P1|Base Period|Excluded medication|0
5554784|NCT01217073|19198764|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
5554785|NCT01217073|19198765|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
5554786|NCT01217073|19198766|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
5554787|NCT01217073|19198767|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
5554788|NCT01217073|19198768|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
5554789|NCT01217073|19198769|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
5554790|NCT01217073|19198770|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
5554791|NCT01217073|19198771|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
5554792|NCT01217073|19198764|P8|Base Period|Adverse Event|0
5554793|NCT01217073|19198765|P7|Base Period|Adverse Event|0
5554794|NCT01217073|19198766|P6|Base Period|Adverse Event|1
5554795|NCT01217073|19198767|P5|Base Period|Adverse Event|4
5554796|NCT01217073|19198768|P4|Base Period|Adverse Event|0
5554797|NCT01217073|19198769|P3|Base Period|Adverse Event|1
5554798|NCT01217073|19198770|P2|Base Period|Adverse Event|0
5554799|NCT01217073|19198771|P1|Base Period|Adverse Event|1
5554800|NCT01216332|19198962|P2|Overall Study|Withdrawal by Subject|0
5554801|NCT01216332|19198963|P1|Overall Study|Withdrawal by Subject|4
5554802|NCT01216319|19198981|P1|Overall Study|Unanticipated chemo for breast cancer|2
5554803|NCT01216319|19198981|P1|Overall Study|Lost to Follow-up|2
5554804|NCT01216176|19198998|P3|Overall Study|Physician Decision|1
5554805|NCT01216176|19198999|P2|Overall Study|Physician Decision|0
5554806|NCT01216176|19199000|P1|Overall Study|Physician Decision|0
5554807|NCT01216176|19198998|P3|Overall Study|Adverse Event|0
5554808|NCT01216176|19198999|P2|Overall Study|Adverse Event|8
5554809|NCT01216176|19199000|P1|Overall Study|Adverse Event|0
5554810|NCT01216163|19199023|P3|Overall Study|Withdrawal by Subject|0
5554811|NCT01216163|19199024|P2|Overall Study|Withdrawal by Subject|1
5554812|NCT01216163|19199025|P1|Overall Study|Withdrawal by Subject|1
5554813|NCT01216072|19199077|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
5554814|NCT01216072|19199078|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
5554815|NCT01216072|19199077|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
5554816|NCT01216072|19199078|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
5554817|NCT01216072|19199077|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
5554818|NCT01216072|19199078|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
5554819|NCT01216072|19199077|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
5554820|NCT01216072|19199078|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
5554821|NCT01216072|19199077|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
5554822|NCT01216072|19199078|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
5554823|NCT01216072|19199077|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
5554824|NCT01216072|19199078|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
5554825|NCT01216072|19199077|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
5554826|NCT01216072|19199078|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
5554827|NCT01216072|19199077|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
5554828|NCT01216072|19199078|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
5554829|NCT01216072|19199077|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
5554830|NCT01216072|19199078|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
5554831|NCT01216072|19199077|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
5554832|NCT01216072|19199078|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
5554833|NCT01215981|19199106|P2|Overall Study|Withdrawal by Subject|0
5554834|NCT01215981|19199107|P1|Overall Study|Withdrawal by Subject|1
5554835|NCT01215981|19199106|P2|Overall Study|Protocol Violation|0
5554836|NCT01215981|19199107|P1|Overall Study|Protocol Violation|1
5554837|NCT01215981|19199106|P2|Overall Study|Physician Decision|1
5554838|NCT01215981|19199107|P1|Overall Study|Physician Decision|0
5554839|NCT01215968|19199117|P2|Overall Study|Not received study drug|1
5554840|NCT01215968|19199118|P1|Overall Study|Not received study drug|0
5554841|NCT01215968|19199117|P2|Overall Study|Protocol Violation|4
5554842|NCT01215968|19199118|P1|Overall Study|Protocol Violation|2
5554843|NCT01215968|19199117|P2|Overall Study|Adverse Event|2
5554844|NCT01215968|19199118|P1|Overall Study|Adverse Event|0
5554845|NCT01215955|19199138|P4|Overall Study|Quality Issues|2
5554846|NCT01215955|19199139|P3|Overall Study|Quality Issues|3
5554847|NCT01215955|19199140|P2|Overall Study|Quality Issues|0
5554848|NCT01215955|19199141|P1|Overall Study|Quality Issues|0
5554849|NCT01215955|19199138|P4|Overall Study|Withdrawal by Subject|9
5554850|NCT01215955|19199139|P3|Overall Study|Withdrawal by Subject|13
5554851|NCT01215955|19199140|P2|Overall Study|Withdrawal by Subject|15
5554852|NCT01215955|19199141|P1|Overall Study|Withdrawal by Subject|14
5554853|NCT01215955|19199138|P4|Overall Study|Sponsor Decision|1
5554854|NCT01215955|19199139|P3|Overall Study|Sponsor Decision|0
5554855|NCT01215955|19199140|P2|Overall Study|Sponsor Decision|2
5554856|NCT01215955|19199141|P1|Overall Study|Sponsor Decision|1
5554857|NCT01215955|19199138|P4|Overall Study|Protocol Violation|8
5554858|NCT01215955|19199139|P3|Overall Study|Protocol Violation|8
5554859|NCT01215955|19199140|P2|Overall Study|Protocol Violation|13
5554860|NCT01215955|19199141|P1|Overall Study|Protocol Violation|17
5554861|NCT01215955|19199138|P4|Overall Study|Physician Decision|11
5554862|NCT01215955|19199139|P3|Overall Study|Physician Decision|8
5554863|NCT01215955|19199140|P2|Overall Study|Physician Decision|10
5554864|NCT01215955|19199141|P1|Overall Study|Physician Decision|4
5554865|NCT01215955|19199138|P4|Overall Study|Lost to Follow-up|9
5554866|NCT01215955|19199139|P3|Overall Study|Lost to Follow-up|8
5554867|NCT01215955|19199140|P2|Overall Study|Lost to Follow-up|4
5554868|NCT01215955|19199141|P1|Overall Study|Lost to Follow-up|4
5554869|NCT01215955|19199138|P4|Overall Study|Lack of Efficacy|0
5554870|NCT01215955|19199139|P3|Overall Study|Lack of Efficacy|1
5554871|NCT01215955|19199140|P2|Overall Study|Lack of Efficacy|2
5554872|NCT01215955|19199141|P1|Overall Study|Lack of Efficacy|1
5554873|NCT01215955|19199138|P4|Overall Study|Entry Criteria Not Met|7
5554874|NCT01215955|19199139|P3|Overall Study|Entry Criteria Not Met|4
5554875|NCT01215955|19199140|P2|Overall Study|Entry Criteria Not Met|3
5554876|NCT01215955|19199141|P1|Overall Study|Entry Criteria Not Met|1
5554877|NCT01215955|19199138|P4|Overall Study|Death|3
5554878|NCT01215955|19199139|P3|Overall Study|Death|1
5554879|NCT01215955|19199140|P2|Overall Study|Death|0
5554880|NCT01215955|19199141|P1|Overall Study|Death|2
5554881|NCT01215955|19199138|P4|Overall Study|Adverse Event|3
5554882|NCT01215955|19199139|P3|Overall Study|Adverse Event|2
5554883|NCT01215955|19199140|P2|Overall Study|Adverse Event|4
5554884|NCT01215955|19199141|P1|Overall Study|Adverse Event|1
5554885|NCT01215942|19199209|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
5554886|NCT01215942|19199210|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
5554887|NCT01215942|19199209|P2|Post-Treatment Follow-Up Period|Physician Decision|2
5554888|NCT01215942|19199210|P1|Post-Treatment Follow-Up Period|Physician Decision|1
5554889|NCT01215942|19199209|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
5554890|NCT01215942|19199210|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
5554891|NCT01215942|19199209|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
5554892|NCT01215942|19199210|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
5554893|NCT01215942|19199209|P2|Post-Treatment Follow-Up Period|Death|1
5554894|NCT01215942|19199210|P1|Post-Treatment Follow-Up Period|Death|0
5554895|NCT01215942|19199209|P2|Treatment Period|Sponsor Decision|530
5554896|NCT01215942|19199210|P1|Treatment Period|Sponsor Decision|349
5554897|NCT01215942|19199209|P2|Treatment Period|Protocol Violation|1
5554898|NCT01215942|19199210|P1|Treatment Period|Protocol Violation|0
5554899|NCT01215942|19199209|P2|Treatment Period|Physician Decision|5
5554900|NCT01215942|19199210|P1|Treatment Period|Physician Decision|5
5554901|NCT01215942|19199209|P2|Treatment Period|Withdrawal by Subject|40
5554902|NCT01215942|19199210|P1|Treatment Period|Withdrawal by Subject|17
5554903|NCT01215942|19199209|P2|Treatment Period|Lost to Follow-up|4
5554904|NCT01215942|19199210|P1|Treatment Period|Lost to Follow-up|3
5554905|NCT01215942|19199209|P2|Treatment Period|Lack of Efficacy|62
5554906|NCT01215942|19199210|P1|Treatment Period|Lack of Efficacy|23
5554907|NCT01215942|19199209|P2|Treatment Period|Death|4
5554908|NCT01215942|19199210|P1|Treatment Period|Death|2
5554909|NCT01215942|19199209|P2|Treatment Period|Adverse Event|26
5554910|NCT01215942|19199210|P1|Treatment Period|Adverse Event|15
5554911|NCT01215916|19199343|P9|Overall Study|Physician Decision|0
5554912|NCT01215916|19199344|P8|Overall Study|Physician Decision|0
5554913|NCT01215916|19199345|P7|Overall Study|Physician Decision|0
5554914|NCT01215916|19199346|P6|Overall Study|Physician Decision|0
5554915|NCT01215916|19199347|P5|Overall Study|Physician Decision|0
5554916|NCT01215916|19199348|P4|Overall Study|Physician Decision|1
5554917|NCT01215916|19199349|P3|Overall Study|Physician Decision|1
5554918|NCT01215916|19199350|P2|Overall Study|Physician Decision|0
5554919|NCT01215916|19199351|P1|Overall Study|Physician Decision|0
5554920|NCT01215916|19199343|P9|Overall Study|Death|1
5554921|NCT01215916|19199344|P8|Overall Study|Death|0
5554922|NCT01215916|19199345|P7|Overall Study|Death|0
5554923|NCT01215916|19199346|P6|Overall Study|Death|0
5554924|NCT01215916|19199347|P5|Overall Study|Death|1
5554925|NCT01215916|19199348|P4|Overall Study|Death|0
5554926|NCT01215916|19199349|P3|Overall Study|Death|0
5554927|NCT01215916|19199350|P2|Overall Study|Death|1
5554928|NCT01215916|19199351|P1|Overall Study|Death|0
5554929|NCT01215916|19199343|P9|Overall Study|Withdrawal by Subject|0
5554930|NCT01215916|19199344|P8|Overall Study|Withdrawal by Subject|0
5554931|NCT01215916|19199345|P7|Overall Study|Withdrawal by Subject|1
5554932|NCT01215916|19199346|P6|Overall Study|Withdrawal by Subject|0
5554933|NCT01215916|19199347|P5|Overall Study|Withdrawal by Subject|0
5554934|NCT01215916|19199348|P4|Overall Study|Withdrawal by Subject|2
5554935|NCT01215916|19199349|P3|Overall Study|Withdrawal by Subject|1
5554936|NCT01215916|19199350|P2|Overall Study|Withdrawal by Subject|1
5554937|NCT01215916|19199351|P1|Overall Study|Withdrawal by Subject|0
5554938|NCT01215916|19199343|P9|Overall Study|Adverse Event|0
5554939|NCT01215916|19199344|P8|Overall Study|Adverse Event|0
5554940|NCT01215916|19199345|P7|Overall Study|Adverse Event|3
5554941|NCT01215916|19199346|P6|Overall Study|Adverse Event|0
5554942|NCT01215916|19199347|P5|Overall Study|Adverse Event|0
5554943|NCT01215916|19199348|P4|Overall Study|Adverse Event|1
5554944|NCT01215916|19199349|P3|Overall Study|Adverse Event|0
5554945|NCT01215916|19199350|P2|Overall Study|Adverse Event|1
5554946|NCT01215916|19199351|P1|Overall Study|Adverse Event|1
5554947|NCT01215916|19199343|P9|Overall Study|Progressive Disease|1
5554948|NCT01215916|19199344|P8|Overall Study|Progressive Disease|3
5554949|NCT01215916|19199345|P7|Overall Study|Progressive Disease|5
5554950|NCT01215916|19199346|P6|Overall Study|Progressive Disease|4
5554951|NCT01215916|19199347|P5|Overall Study|Progressive Disease|5
5554952|NCT01215916|19199348|P4|Overall Study|Progressive Disease|2
5554953|NCT01215916|19199349|P3|Overall Study|Progressive Disease|1
5554954|NCT01215916|19199350|P2|Overall Study|Progressive Disease|2
5554955|NCT01215916|19199351|P1|Overall Study|Progressive Disease|0
5554956|NCT01215851|19199385|P6|Follow up Period|Lost to Follow-up|1
5554957|NCT01215851|19199386|P5|Follow up Period|Lost to Follow-up|0
5554958|NCT01215851|19199387|P4|Follow up Period|Lost to Follow-up|0
5554959|NCT01215851|19199388|P3|Follow up Period|Lost to Follow-up|0
5554960|NCT01215851|19199389|P2|Follow up Period|Lost to Follow-up|0
5554961|NCT01215851|19199390|P1|Follow up Period|Lost to Follow-up|0
5554962|NCT01215851|19199385|P6|Treatment Period|Adverse Event|1
5554963|NCT01215851|19199386|P5|Treatment Period|Adverse Event|0
5554964|NCT01215851|19199387|P4|Treatment Period|Adverse Event|3
5554965|NCT01215851|19199388|P3|Treatment Period|Adverse Event|1
5554966|NCT01215851|19199389|P2|Treatment Period|Adverse Event|1
5554967|NCT01215851|19199390|P1|Treatment Period|Adverse Event|1
5554968|NCT01215734|19199449|P2|Overall Study|Death|1
5554969|NCT01215734|19199450|P1|Overall Study|Death|0
5554970|NCT01215721|19199458|P1|Overall Study|Adverse Event|2
5554971|NCT01215513|19199590|P1|Overall Study|Miscellaneous reasons (CS42A)|2
5554972|NCT01215513|19199590|P1|Overall Study|Withdrawal by subject (CS42A)|5
5554973|NCT01215513|19199590|P1|Overall Study|Physician decision (CS42A)|6
5554974|NCT01215513|19199590|P1|Overall Study|Adverse event (CS42A)|2
5554975|NCT01215513|19199590|P1|Overall Study|Not enrolled from CS42 to CS42A|21
5554976|NCT01215513|19199590|P1|Overall Study|Not completed CS42|9
5554977|NCT01215435|19199599|P2|Overall Study|Unclassified|5
5554978|NCT01215435|19199600|P1|Overall Study|Unclassified|5
5554979|NCT01215435|19199599|P2|Overall Study|Lost to Follow-up|0
5554980|NCT01215435|19199600|P1|Overall Study|Lost to Follow-up|3
5554981|NCT01215435|19199599|P2|Overall Study|Withdrawal Criteria|11
5554982|NCT01215435|19199600|P1|Overall Study|Withdrawal Criteria|8
5554983|NCT01215435|19199599|P2|Overall Study|Protocol Violation|0
5554984|NCT01215435|19199600|P1|Overall Study|Protocol Violation|2
5554985|NCT01215435|19199599|P2|Overall Study|Adverse Event|0
5554986|NCT01215435|19199600|P1|Overall Study|Adverse Event|1
5554987|NCT01215422|19199614|P4|Overall Study|Did not complete all intubations|0
5554988|NCT01215422|19199615|P3|Overall Study|Did not complete all intubations|0
5554989|NCT01215422|19199616|P2|Overall Study|Did not complete all intubations|0
5554990|NCT01215422|19199617|P1|Overall Study|Did not complete all intubations|7
5554991|NCT01215422|19199614|P4|Overall Study|Failed intubations|8
5554992|NCT01215422|19199615|P3|Overall Study|Failed intubations|3
5554993|NCT01215422|19199616|P2|Overall Study|Failed intubations|0
5554994|NCT01215422|19199617|P1|Overall Study|Failed intubations|0
5554995|NCT01215422|19199614|P4|Overall Study|Relocation|0
5554996|NCT01215422|19199615|P3|Overall Study|Relocation|0
5554997|NCT01215422|19199616|P2|Overall Study|Relocation|0
5554998|NCT01215422|19199617|P1|Overall Study|Relocation|1
5554999|NCT01215357|19199639|P1|Overall Study|Protocol Violation|9
5555000|NCT01215357|19199639|P1|Overall Study|Withdrawal by Subject|3
5555001|NCT01215253|19199765|P2|Overall Study|Other|12
5555002|NCT01215253|19199766|P1|Overall Study|Other|14
5555003|NCT01215253|19199765|P2|Overall Study|Lost to Follow-up|4
5555004|NCT01215253|19199766|P1|Overall Study|Lost to Follow-up|6
5555005|NCT01215253|19199765|P2|Overall Study|Physician Decision|12
5555006|NCT01215253|19199766|P1|Overall Study|Physician Decision|9
5555007|NCT01215253|19199765|P2|Overall Study|Withdrawal by Subject|35
5555008|NCT01215253|19199766|P1|Overall Study|Withdrawal by Subject|57
5555009|NCT01215227|19199819|P6|Overall Study|Randomized but not treated|1
5555010|NCT01215227|19199820|P5|Overall Study|Randomized but not treated|0
5555011|NCT01215227|19199821|P4|Overall Study|Randomized but not treated|1
5555012|NCT01215227|19199822|P3|Overall Study|Randomized but not treated|1
5555013|NCT01215227|19199823|P2|Overall Study|Randomized but not treated|0
5555014|NCT01215227|19199824|P1|Overall Study|Randomized but not treated|0
5555015|NCT01215227|19199819|P6|Overall Study|Missing Status|0
5555016|NCT01215227|19199820|P5|Overall Study|Missing Status|0
5555017|NCT01215227|19199821|P4|Overall Study|Missing Status|0
5555018|NCT01215227|19199822|P3|Overall Study|Missing Status|0
5555019|NCT01215227|19199823|P2|Overall Study|Missing Status|1
5555020|NCT01215227|19199824|P1|Overall Study|Missing Status|0
5555021|NCT01215227|19199819|P6|Overall Study|Administrative|40
5555022|NCT01215227|19199820|P5|Overall Study|Administrative|28
5555023|NCT01215227|19199821|P4|Overall Study|Administrative|24
5555024|NCT01215227|19199822|P3|Overall Study|Administrative|42
5555025|NCT01215227|19199823|P2|Overall Study|Administrative|73
5555026|NCT01215227|19199824|P1|Overall Study|Administrative|83
5555027|NCT01215227|19199819|P6|Overall Study|Non-Compliance With Protocol|0
5555028|NCT01215227|19199820|P5|Overall Study|Non-Compliance With Protocol|0
5555029|NCT01215227|19199821|P4|Overall Study|Non-Compliance With Protocol|0
5555030|NCT01215227|19199822|P3|Overall Study|Non-Compliance With Protocol|1
5555031|NCT01215227|19199823|P2|Overall Study|Non-Compliance With Protocol|6
5555032|NCT01215227|19199824|P1|Overall Study|Non-Compliance With Protocol|2
5555033|NCT01215227|19199819|P6|Overall Study|Subject Withdrew Consent|8
5555034|NCT01215227|19199820|P5|Overall Study|Subject Withdrew Consent|11
5555035|NCT01215227|19199821|P4|Overall Study|Subject Withdrew Consent|10
5555036|NCT01215227|19199822|P3|Overall Study|Subject Withdrew Consent|7
5555037|NCT01215227|19199823|P2|Overall Study|Subject Withdrew Consent|20
5555038|NCT01215227|19199824|P1|Overall Study|Subject Withdrew Consent|16
5555039|NCT01215227|19199819|P6|Overall Study|Lost to Follow-up|2
5555040|NCT01215227|19199820|P5|Overall Study|Lost to Follow-up|1
5555041|NCT01215227|19199821|P4|Overall Study|Lost to Follow-up|1
5555042|NCT01215227|19199822|P3|Overall Study|Lost to Follow-up|1
5555043|NCT01215227|19199823|P2|Overall Study|Lost to Follow-up|4
5555044|NCT01215227|19199824|P1|Overall Study|Lost to Follow-up|1
5555045|NCT01215227|19199819|P6|Overall Study|Treatment Failure|1
5555046|NCT01215227|19199820|P5|Overall Study|Treatment Failure|1
5555047|NCT01215227|19199821|P4|Overall Study|Treatment Failure|5
5555048|NCT01215227|19199822|P3|Overall Study|Treatment Failure|1
5555049|NCT01215227|19199823|P2|Overall Study|Treatment Failure|4
5555050|NCT01215227|19199824|P1|Overall Study|Treatment Failure|8
5555051|NCT01215227|19199819|P6|Overall Study|Adverse Event|6
5555052|NCT01215227|19199820|P5|Overall Study|Adverse Event|7
5555053|NCT01215227|19199821|P4|Overall Study|Adverse Event|8
5555054|NCT01215227|19199822|P3|Overall Study|Adverse Event|4
5555055|NCT01215227|19199823|P2|Overall Study|Adverse Event|11
5555056|NCT01215227|19199824|P1|Overall Study|Adverse Event|11
5555057|NCT01215188|19199871|P3|Overall Study|Withdrawal by Subject|31
5555058|NCT01215188|19199872|P2|Overall Study|Withdrawal by Subject|34
5555059|NCT01215188|19199873|P1|Overall Study|Withdrawal by Subject|32
5555060|NCT01215188|19199871|P3|Overall Study|Protocol Violation|1
5555061|NCT01215188|19199872|P2|Overall Study|Protocol Violation|1
5555062|NCT01215188|19199873|P1|Overall Study|Protocol Violation|1
5555063|NCT01215188|19199871|P3|Overall Study|Lack of Efficacy|1
5555064|NCT01215188|19199872|P2|Overall Study|Lack of Efficacy|0
5555065|NCT01215188|19199873|P1|Overall Study|Lack of Efficacy|0
5555066|NCT01215188|19199871|P3|Overall Study|Physician Decision|0
5555067|NCT01215188|19199872|P2|Overall Study|Physician Decision|1
5555068|NCT01215188|19199873|P1|Overall Study|Physician Decision|2
5555069|NCT01215188|19199871|P3|Overall Study|Adverse Event|3
5555070|NCT01215188|19199872|P2|Overall Study|Adverse Event|1
5555071|NCT01215188|19199873|P1|Overall Study|Adverse Event|1
5555072|NCT01215188|19199871|P3|Overall Study|Lost to Follow-up|16
5555073|NCT01215188|19199872|P2|Overall Study|Lost to Follow-up|22
5555074|NCT01215188|19199873|P1|Overall Study|Lost to Follow-up|22
5555075|NCT01215175|19199925|P5|Overall Study|Lost to Follow-up|0
5555076|NCT01215175|19199926|P4|Overall Study|Lost to Follow-up|1
5555077|NCT01215175|19199927|P3|Overall Study|Lost to Follow-up|0
5555078|NCT01215175|19199928|P2|Overall Study|Lost to Follow-up|1
5555079|NCT01215175|19199929|P1|Overall Study|Lost to Follow-up|0
5555080|NCT01215097|19200046|P2|Overall Study|patient's private reason|1
5555081|NCT01215097|19200047|P1|Overall Study|patient's private reason|1
5555082|NCT01215097|19200046|P2|Overall Study|patient's refusal to come|2
5555083|NCT01215097|19200047|P1|Overall Study|patient's refusal to come|2
5555084|NCT01215097|19200046|P2|Overall Study|Lack of Efficacy|3
5555085|NCT01215097|19200047|P1|Overall Study|Lack of Efficacy|0
5555086|NCT01215097|19200046|P2|Overall Study|Withdrawal by Subject|3
5555087|NCT01215097|19200047|P1|Overall Study|Withdrawal by Subject|6
5555088|NCT01215097|19200046|P2|Overall Study|Lost to Follow-up|0
5555089|NCT01215097|19200047|P1|Overall Study|Lost to Follow-up|2
5555090|NCT01215097|19200046|P2|Overall Study|Protocol Violation|2
5555091|NCT01215097|19200047|P1|Overall Study|Protocol Violation|0
5555092|NCT01215097|19200046|P2|Overall Study|Adverse Event|3
5555093|NCT01215097|19200047|P1|Overall Study|Adverse Event|1
5555094|NCT01215032|19200079|P1|Overall Study|Lack of Efficacy|17
5555095|NCT01215032|19200079|P1|Overall Study|Adverse Event|3
5555096|NCT01214915|19200104|P1|Overall Study|Lack of Efficacy|3
5555097|NCT01214915|19200104|P1|Overall Study|Adverse Event|8
5555098|NCT01214850|19200115|P3|Overall Study|Unable to classify|1
5555099|NCT01214850|19200116|P2|Overall Study|Unable to classify|1
5555100|NCT01214850|19200117|P1|Overall Study|Unable to classify|2
5555101|NCT01214850|19200115|P3|Overall Study|Administrative reason|0
5555102|NCT01214850|19200116|P2|Overall Study|Administrative reason|0
5555103|NCT01214850|19200117|P1|Overall Study|Administrative reason|1
5555104|NCT01214850|19200115|P3|Overall Study|Inappropriate enrollment|0
5555105|NCT01214850|19200116|P2|Overall Study|Inappropriate enrollment|1
5555106|NCT01214850|19200117|P1|Overall Study|Inappropriate enrollment|2
5555107|NCT01214850|19200115|P3|Overall Study|Adverse event or death|3
5555108|NCT01214850|19200116|P2|Overall Study|Adverse event or death|8
5555109|NCT01214850|19200117|P1|Overall Study|Adverse event or death|11
5555110|NCT01214850|19200115|P3|Overall Study|Protocol Violation|6
5555111|NCT01214850|19200116|P2|Overall Study|Protocol Violation|5
5555112|NCT01214850|19200117|P1|Overall Study|Protocol Violation|5
5555113|NCT01214850|19200115|P3|Overall Study|Lost to Follow-up|123
5555114|NCT01214850|19200116|P2|Overall Study|Lost to Follow-up|98
5555115|NCT01214850|19200117|P1|Overall Study|Lost to Follow-up|124
5555116|NCT01214850|19200115|P3|Overall Study|Withdrawal by Subject|28
5555117|NCT01214850|19200116|P2|Overall Study|Withdrawal by Subject|31
5555118|NCT01214850|19200117|P1|Overall Study|Withdrawal by Subject|38
5555119|NCT01214837|19200201|P3|Overall Study|Unable to Classify|0
5555120|NCT01214837|19200202|P2|Overall Study|Unable to Classify|3
5555121|NCT01214837|19200203|P1|Overall Study|Unable to Classify|1
5555122|NCT01214837|19200201|P3|Overall Study|Protocol Violation|5
5555123|NCT01214837|19200202|P2|Overall Study|Protocol Violation|1
5555124|NCT01214837|19200203|P1|Overall Study|Protocol Violation|3
5555125|NCT01214837|19200201|P3|Overall Study|Administrative Reason|4
5555126|NCT01214837|19200202|P2|Overall Study|Administrative Reason|6
5555127|NCT01214837|19200203|P1|Overall Study|Administrative Reason|2
5555128|NCT01214837|19200201|P3|Overall Study|Inappropriate Enrolment|2
5555129|NCT01214837|19200202|P2|Overall Study|Inappropriate Enrolment|1
5555130|NCT01214837|19200203|P1|Overall Study|Inappropriate Enrolment|0
5555131|NCT01214837|19200201|P3|Overall Study|Lost to Follow-up|21
5555132|NCT01214837|19200202|P2|Overall Study|Lost to Follow-up|15
5555133|NCT01214837|19200203|P1|Overall Study|Lost to Follow-up|20
5555134|NCT01214837|19200201|P3|Overall Study|Withdrawal by Subject|28
5555135|NCT01214837|19200202|P2|Overall Study|Withdrawal by Subject|36
5555136|NCT01214837|19200203|P1|Overall Study|Withdrawal by Subject|27
5555137|NCT01214837|19200201|P3|Overall Study|Adverse Event|1
5555138|NCT01214837|19200202|P2|Overall Study|Adverse Event|2
5555139|NCT01214837|19200203|P1|Overall Study|Adverse Event|1
5555140|NCT01214837|19200201|P3|Overall Study|Death|1
5555141|NCT01214837|19200202|P2|Overall Study|Death|0
5555142|NCT01214837|19200203|P1|Overall Study|Death|0
5555143|NCT01214720|19200259|P2|Overall Study|Lost to Follow-up|2
5555144|NCT01214720|19200260|P1|Overall Study|Lost to Follow-up|6
5555145|NCT01214720|19200259|P2|Overall Study|Alive and in follow-up|48
5555146|NCT01214720|19200260|P1|Overall Study|Alive and in follow-up|45
5555147|NCT01214720|19200259|P2|Overall Study|Alive and still on treatment|18
5555148|NCT01214720|19200260|P1|Overall Study|Alive and still on treatment|34
5555149|NCT01214668|19200283|P6|Overall Study|Withdrawal by Subject|0
5555150|NCT01214668|19200284|P5|Overall Study|Withdrawal by Subject|1
5555151|NCT01214668|19200285|P4|Overall Study|Withdrawal by Subject|0
5555152|NCT01214668|19200286|P3|Overall Study|Withdrawal by Subject|0
5555153|NCT01214668|19200287|P2|Overall Study|Withdrawal by Subject|0
5555154|NCT01214668|19200288|P1|Overall Study|Withdrawal by Subject|0
5555155|NCT01214668|19200283|P6|Overall Study|Progressive Disease|5
5555156|NCT01214668|19200284|P5|Overall Study|Progressive Disease|4
5555157|NCT01214668|19200285|P4|Overall Study|Progressive Disease|4
5555158|NCT01214668|19200286|P3|Overall Study|Progressive Disease|5
5555159|NCT01214668|19200287|P2|Overall Study|Progressive Disease|2
5555160|NCT01214668|19200288|P1|Overall Study|Progressive Disease|4
5555161|NCT01214668|19200283|P6|Overall Study|Death|0
5555162|NCT01214668|19200284|P5|Overall Study|Death|0
5555163|NCT01214668|19200285|P4|Overall Study|Death|0
5555164|NCT01214668|19200286|P3|Overall Study|Death|1
5555165|NCT01214668|19200287|P2|Overall Study|Death|0
5555166|NCT01214668|19200288|P1|Overall Study|Death|0
5555167|NCT01214668|19200283|P6|Overall Study|Adverse Event|1
5555168|NCT01214668|19200284|P5|Overall Study|Adverse Event|1
5555169|NCT01214668|19200285|P4|Overall Study|Adverse Event|2
5555170|NCT01214668|19200286|P3|Overall Study|Adverse Event|0
5555171|NCT01214668|19200287|P2|Overall Study|Adverse Event|1
5555172|NCT01214668|19200288|P1|Overall Study|Adverse Event|0
5555173|NCT01214655|19200325|P3|Part C|Physician Decision|1
5555174|NCT01214655|19200326|P2|Part C|Physician Decision|0
5555175|NCT01214655|19200327|P1|Part C|Physician Decision|0
5555176|NCT01214655|19200325|P3|Part C|Death|1
5555177|NCT01214655|19200326|P2|Part C|Death|0
5555178|NCT01214655|19200327|P1|Part C|Death|0
5555179|NCT01214655|19200325|P3|Part C|Progressive Disease|5
5555180|NCT01214655|19200326|P2|Part C|Progressive Disease|0
5555181|NCT01214655|19200327|P1|Part C|Progressive Disease|0
5555182|NCT01214655|19200325|P3|Part B|Withdrawal by Subject|0
5555183|NCT01214655|19200326|P2|Part B|Withdrawal by Subject|2
5555184|NCT01214655|19200327|P1|Part B|Withdrawal by Subject|0
5555185|NCT01214655|19200325|P3|Part B|Death|0
5555186|NCT01214655|19200326|P2|Part B|Death|1
5555187|NCT01214655|19200327|P1|Part B|Death|0
5555188|NCT01214655|19200325|P3|Part B|Progressive disease|0
5555189|NCT01214655|19200326|P2|Part B|Progressive disease|10
5555190|NCT01214655|19200327|P1|Part B|Progressive disease|0
5555191|NCT01214655|19200325|P3|Part A|Physician Decision|0
5555192|NCT01214655|19200326|P2|Part A|Physician Decision|0
5555193|NCT01214655|19200327|P1|Part A|Physician Decision|1
5555194|NCT01214655|19200325|P3|Part A|Progressive Disease|0
5555195|NCT01214655|19200326|P2|Part A|Progressive Disease|0
5555196|NCT01214655|19200327|P1|Part A|Progressive Disease|7
5555197|NCT01214642|19200400|P12|Overall Study|Physician Decision|2
5555198|NCT01214642|19200401|P11|Overall Study|Physician Decision|0
5555199|NCT01214642|19200402|P10|Overall Study|Physician Decision|0
5555200|NCT01214642|19200403|P9|Overall Study|Physician Decision|0
5555201|NCT01214642|19200404|P8|Overall Study|Physician Decision|0
5555202|NCT01214642|19200405|P7|Overall Study|Physician Decision|0
5555203|NCT01214642|19200406|P6|Overall Study|Physician Decision|0
5555204|NCT01214642|19200407|P5|Overall Study|Physician Decision|1
5555205|NCT01214642|19200408|P4|Overall Study|Physician Decision|1
5555206|NCT01214642|19200409|P3|Overall Study|Physician Decision|1
5555207|NCT01214642|19200410|P2|Overall Study|Physician Decision|0
5555208|NCT01214642|19200411|P1|Overall Study|Physician Decision|0
5555209|NCT01214642|19200400|P12|Overall Study|Withdrawal by Subject|0
5555210|NCT01214642|19200401|P11|Overall Study|Withdrawal by Subject|1
5555211|NCT01214642|19200402|P10|Overall Study|Withdrawal by Subject|1
5555212|NCT01214642|19200403|P9|Overall Study|Withdrawal by Subject|3
5555213|NCT01214642|19200404|P8|Overall Study|Withdrawal by Subject|0
5555214|NCT01214642|19200405|P7|Overall Study|Withdrawal by Subject|0
5555215|NCT01214642|19200406|P6|Overall Study|Withdrawal by Subject|0
5555216|NCT01214642|19200407|P5|Overall Study|Withdrawal by Subject|0
5555217|NCT01214642|19200408|P4|Overall Study|Withdrawal by Subject|0
5555218|NCT01214642|19200409|P3|Overall Study|Withdrawal by Subject|1
5555219|NCT01214642|19200410|P2|Overall Study|Withdrawal by Subject|0
5555220|NCT01214642|19200411|P1|Overall Study|Withdrawal by Subject|0
5555221|NCT01214642|19200400|P12|Overall Study|Death|0
5555222|NCT01214642|19200401|P11|Overall Study|Death|1
5555223|NCT01214642|19200402|P10|Overall Study|Death|0
5555224|NCT01214642|19200403|P9|Overall Study|Death|0
5555225|NCT01214642|19200404|P8|Overall Study|Death|0
5555226|NCT01214642|19200405|P7|Overall Study|Death|0
5555227|NCT01214642|19200406|P6|Overall Study|Death|0
5555228|NCT01214642|19200407|P5|Overall Study|Death|0
5555229|NCT01214642|19200408|P4|Overall Study|Death|0
5555230|NCT01214642|19200409|P3|Overall Study|Death|1
5555231|NCT01214642|19200410|P2|Overall Study|Death|0
5555232|NCT01214642|19200411|P1|Overall Study|Death|0
5555233|NCT01214642|19200400|P12|Overall Study|Adverse Event|0
5555234|NCT01214642|19200401|P11|Overall Study|Adverse Event|1
5555235|NCT01214642|19200402|P10|Overall Study|Adverse Event|1
5555236|NCT01214642|19200403|P9|Overall Study|Adverse Event|0
5555237|NCT01214642|19200404|P8|Overall Study|Adverse Event|0
5555238|NCT01214642|19200405|P7|Overall Study|Adverse Event|1
5555239|NCT01214642|19200406|P6|Overall Study|Adverse Event|0
5555240|NCT01214642|19200407|P5|Overall Study|Adverse Event|0
5555241|NCT01214642|19200408|P4|Overall Study|Adverse Event|0
5555242|NCT01214642|19200409|P3|Overall Study|Adverse Event|0
5555243|NCT01214642|19200410|P2|Overall Study|Adverse Event|1
5555244|NCT01214642|19200411|P1|Overall Study|Adverse Event|0
5555245|NCT01214642|19200400|P12|Overall Study|Progressive Disease|4
5555246|NCT01214642|19200401|P11|Overall Study|Progressive Disease|1
5555247|NCT01214642|19200402|P10|Overall Study|Progressive Disease|2
5555248|NCT01214642|19200403|P9|Overall Study|Progressive Disease|10
5555249|NCT01214642|19200404|P8|Overall Study|Progressive Disease|3
5555250|NCT01214642|19200405|P7|Overall Study|Progressive Disease|5
5555251|NCT01214642|19200406|P6|Overall Study|Progressive Disease|3
5555252|NCT01214642|19200407|P5|Overall Study|Progressive Disease|5
5555253|NCT01214642|19200408|P4|Overall Study|Progressive Disease|5
5555254|NCT01214642|19200409|P3|Overall Study|Progressive Disease|3
5555255|NCT01214642|19200410|P2|Overall Study|Progressive Disease|2
5555256|NCT01214642|19200411|P1|Overall Study|Progressive Disease|3
5555257|NCT01214629|19200491|P11|Overall Study|Withdrawal by Subject|0
5555258|NCT01214629|19200492|P10|Overall Study|Withdrawal by Subject|1
5555259|NCT01214629|19200493|P9|Overall Study|Withdrawal by Subject|0
5555260|NCT01214629|19200494|P8|Overall Study|Withdrawal by Subject|0
5555261|NCT01214629|19200495|P7|Overall Study|Withdrawal by Subject|0
5555262|NCT01214629|19200496|P6|Overall Study|Withdrawal by Subject|0
5555263|NCT01214629|19200497|P5|Overall Study|Withdrawal by Subject|0
5555264|NCT01214629|19200498|P4|Overall Study|Withdrawal by Subject|0
5555265|NCT01214629|19200499|P3|Overall Study|Withdrawal by Subject|0
5555266|NCT01214629|19200500|P2|Overall Study|Withdrawal by Subject|0
5555267|NCT01214629|19200501|P1|Overall Study|Withdrawal by Subject|0
5555268|NCT01214629|19200491|P11|Overall Study|Physician Decision|1
5555269|NCT01214629|19200492|P10|Overall Study|Physician Decision|0
5555270|NCT01214629|19200493|P9|Overall Study|Physician Decision|0
5555271|NCT01214629|19200494|P8|Overall Study|Physician Decision|0
5555272|NCT01214629|19200495|P7|Overall Study|Physician Decision|0
5555273|NCT01214629|19200496|P6|Overall Study|Physician Decision|0
5555274|NCT01214629|19200497|P5|Overall Study|Physician Decision|0
5555275|NCT01214629|19200498|P4|Overall Study|Physician Decision|0
5555276|NCT01214629|19200499|P3|Overall Study|Physician Decision|0
5555277|NCT01214629|19200500|P2|Overall Study|Physician Decision|0
5555278|NCT01214629|19200501|P1|Overall Study|Physician Decision|0
5555279|NCT01214629|19200491|P11|Overall Study|Adverse Event|0
5555280|NCT01214629|19200492|P10|Overall Study|Adverse Event|1
5555281|NCT01214629|19200493|P9|Overall Study|Adverse Event|0
5555282|NCT01214629|19200494|P8|Overall Study|Adverse Event|0
5555283|NCT01214629|19200495|P7|Overall Study|Adverse Event|0
5555284|NCT01214629|19200496|P6|Overall Study|Adverse Event|1
5555285|NCT01214629|19200497|P5|Overall Study|Adverse Event|0
5555286|NCT01214629|19200498|P4|Overall Study|Adverse Event|1
5555287|NCT01214629|19200499|P3|Overall Study|Adverse Event|0
5555288|NCT01214629|19200500|P2|Overall Study|Adverse Event|0
5555289|NCT01214629|19200501|P1|Overall Study|Adverse Event|0
5555290|NCT01214629|19200491|P11|Overall Study|Progressive Disease|1
5555291|NCT01214629|19200492|P10|Overall Study|Progressive Disease|5
5555292|NCT01214629|19200493|P9|Overall Study|Progressive Disease|1
5555293|NCT01214629|19200494|P8|Overall Study|Progressive Disease|1
5555294|NCT01214629|19200495|P7|Overall Study|Progressive Disease|1
5555295|NCT01214629|19200496|P6|Overall Study|Progressive Disease|3
5555296|NCT01214629|19200497|P5|Overall Study|Progressive Disease|2
5555297|NCT01214629|19200498|P4|Overall Study|Progressive Disease|1
5555298|NCT01214629|19200499|P3|Overall Study|Progressive Disease|0
5555299|NCT01214629|19200500|P2|Overall Study|Progressive Disease|1
5555300|NCT01214629|19200501|P1|Overall Study|Progressive Disease|1
5555301|NCT01214616|19200566|P4|Overall Study|Withdrawal by Subject|1
5555302|NCT01214616|19200567|P3|Overall Study|Withdrawal by Subject|0
5555303|NCT01214616|19200568|P2|Overall Study|Withdrawal by Subject|0
5555304|NCT01214616|19200569|P1|Overall Study|Withdrawal by Subject|1
5555305|NCT01214616|19200566|P4|Overall Study|Other adverse events|1
5555306|NCT01214616|19200567|P3|Overall Study|Other adverse events|1
5555307|NCT01214616|19200568|P2|Overall Study|Other adverse events|1
5555308|NCT01214616|19200569|P1|Overall Study|Other adverse events|0
5555309|NCT01214616|19200566|P4|Overall Study|Dose limiting toxicity|0
5555310|NCT01214616|19200567|P3|Overall Study|Dose limiting toxicity|0
5555311|NCT01214616|19200568|P2|Overall Study|Dose limiting toxicity|2
5555312|NCT01214616|19200569|P1|Overall Study|Dose limiting toxicity|0
5555313|NCT01214616|19200566|P4|Overall Study|Progressive disease|4
5555314|NCT01214616|19200567|P3|Overall Study|Progressive disease|2
5555315|NCT01214616|19200568|P2|Overall Study|Progressive disease|2
5555316|NCT01214616|19200569|P1|Overall Study|Progressive disease|2
5555317|NCT01214603|19200606|P3|Overall Study|Progressive Disease|3
5555318|NCT01214603|19200607|P2|Overall Study|Progressive Disease|1
5555319|NCT01214603|19200608|P1|Overall Study|Progressive Disease|4
5555320|NCT01214603|19200606|P3|Overall Study|Death|0
5555321|NCT01214603|19200607|P2|Overall Study|Death|0
5555322|NCT01214603|19200608|P1|Overall Study|Death|1
5555323|NCT01214603|19200606|P3|Overall Study|Adverse Event|1
5555324|NCT01214603|19200607|P2|Overall Study|Adverse Event|0
5555325|NCT01214603|19200608|P1|Overall Study|Adverse Event|0
5555326|NCT01214434|19200631|P2|Overall Study|Site error|0
5555327|NCT01214434|19200632|P1|Overall Study|Site error|1
5555328|NCT01214434|19200631|P2|Overall Study|Lost to Follow-up|2
5555329|NCT01214434|19200632|P1|Overall Study|Lost to Follow-up|2
5555330|NCT01214434|19200631|P2|Overall Study|Withdrawal by Subject|0
5555331|NCT01214434|19200632|P1|Overall Study|Withdrawal by Subject|1
5555332|NCT01214395|19200648|P1|Overall Study|All patients had infection|5
5555333|NCT01214252|19200677|P1|Overall Study|Not eligible per protocol|82
5555334|NCT01214239|19200685|P2|Overall Study|patient's private reason|1
5555335|NCT01214239|19200686|P1|Overall Study|patient's private reason|1
5555336|NCT01214239|19200685|P2|Overall Study|Lack of Efficacy|2
5555337|NCT01214239|19200686|P1|Overall Study|Lack of Efficacy|1
5555338|NCT01214239|19200685|P2|Overall Study|Withdrawal by Subject|9
5555339|NCT01214239|19200686|P1|Overall Study|Withdrawal by Subject|4
5555340|NCT01214239|19200685|P2|Overall Study|Lost to Follow-up|1
5555341|NCT01214239|19200686|P1|Overall Study|Lost to Follow-up|1
5555342|NCT01214239|19200685|P2|Overall Study|Protocol Violation|1
5555343|NCT01214239|19200686|P1|Overall Study|Protocol Violation|2
5555344|NCT01214239|19200685|P2|Overall Study|Adverse Event|4
5555345|NCT01214239|19200686|P1|Overall Study|Adverse Event|3
5555346|NCT01214200|19200718|P1|Overall Study|Withdrawal by Subject|2
5555347|NCT01214200|19200718|P1|Overall Study|Did not meet inclusion/exclusion|9
5555348|NCT01214187|19200732|P2|Overall Study|Withdrawal by Subject|3
5555349|NCT01214187|19200733|P1|Overall Study|Withdrawal by Subject|0
5555350|NCT01214187|19200732|P2|Overall Study|Death|1
5555351|NCT01214187|19200733|P1|Overall Study|Death|1
5555352|NCT01214187|19200732|P2|Overall Study|Adverse Event|2
5555353|NCT01214187|19200733|P1|Overall Study|Adverse Event|6
5555354|NCT01214174|19200750|P3|Overall Study|Withdrawal by Subject|1
5555355|NCT01214174|19200751|P2|Overall Study|Withdrawal by Subject|0
5555356|NCT01214174|19200752|P1|Overall Study|Withdrawal by Subject|0
5555357|NCT01214044|19200902|P1|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
5555358|NCT01214044|19200902|P1|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
5555359|NCT01214044|19200902|P1|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
5555360|NCT01214044|19200902|P1|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
5555361|NCT01214044|19200902|P1|Visit 1: Screening and Consent, Washout|Ineligible|3
5555362|NCT01214044|19200902|P1|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
5555363|NCT01213966|19200916|P4|Overall Study|Protocol Violation|1
5555364|NCT01213966|19200917|P3|Overall Study|Protocol Violation|3
5555365|NCT01213966|19200918|P2|Overall Study|Protocol Violation|0
5555366|NCT01213966|19200919|P1|Overall Study|Protocol Violation|1
5555367|NCT01213836|19200940|P2|Period 1, First Intervention|Withdrawal by Subject|1
5555368|NCT01213836|19200941|P1|Period 1, First Intervention|Withdrawal by Subject|1
5555369|NCT01213836|19200940|P2|Period 1, First Intervention|Protocol Violation|1
5555370|NCT01213836|19200941|P1|Period 1, First Intervention|Protocol Violation|0
5555371|NCT01213836|19200940|P2|Period 1, First Intervention|Adverse Event|1
5555372|NCT01213836|19200941|P1|Period 1, First Intervention|Adverse Event|2
5555373|NCT01213524|19201028|P1|Session 4|Withdrawal by Subject|2
5555374|NCT01213524|19201028|P1|Session 4|Physician Decision|1
5555375|NCT01213524|19201028|P1|Session 3|Withdrawal by Subject|4
5555376|NCT01213524|19201028|P1|Session 2|Withdrawal by Subject|5
5555377|NCT01213524|19201028|P1|Baseline|Physician Decision|1
5555378|NCT01213524|19201028|P1|Baseline|high breath alcohol levels|1
5555379|NCT01213524|19201028|P1|Baseline|Withdrawal by Subject|5
5555380|NCT01213472|19201042|P1|Overall Study|Physician Decision|1
5555381|NCT01213472|19201042|P1|Overall Study|Withdrawal by Subject|1
5555382|NCT01213472|19201042|P1|Overall Study|Recurrence/Progressive disease|25
5555383|NCT01213264|19201091|P3|Overall Study|Lost to Follow-up|6
5555384|NCT01213264|19201092|P2|Overall Study|Lost to Follow-up|2
5555385|NCT01213264|19201093|P1|Overall Study|Lost to Follow-up|1
5555386|NCT01213264|19201091|P3|Overall Study|Adverse Event|0
5555387|NCT01213264|19201092|P2|Overall Study|Adverse Event|0
5555388|NCT01213264|19201093|P1|Overall Study|Adverse Event|1
5555389|NCT01213251|19201113|P3|Overall Study|Missed 18-Month Follow-up|1
5555390|NCT01213251|19201114|P2|Overall Study|Missed 18-Month Follow-up|0
5555391|NCT01213251|19201115|P1|Overall Study|Missed 18-Month Follow-up|0
5555392|NCT01213251|19201113|P3|Overall Study|Protocol Violation|0
5555393|NCT01213251|19201114|P2|Overall Study|Protocol Violation|1
5555394|NCT01213251|19201115|P1|Overall Study|Protocol Violation|1
5555395|NCT01213251|19201113|P3|Overall Study|Exit|8
5555396|NCT01213251|19201114|P2|Overall Study|Exit|2
5555397|NCT01213251|19201115|P1|Overall Study|Exit|3
5555398|NCT01213251|19201113|P3|Overall Study|Death|2
5555399|NCT01213251|19201114|P2|Overall Study|Death|1
5555400|NCT01213251|19201115|P1|Overall Study|Death|2
5555401|NCT01213173|19201142|P2|Overall Study|Incorrect Enrollment|3
5555402|NCT01213173|19201143|P1|Overall Study|Incorrect Enrollment|1
5555403|NCT01213173|19201142|P2|Overall Study|Withdrawal by Subject|5
5555404|NCT01213173|19201143|P1|Overall Study|Withdrawal by Subject|5
5555405|NCT01213173|19201142|P2|Overall Study|Adverse Event|8
5555406|NCT01213173|19201143|P1|Overall Study|Adverse Event|4
5555407|NCT01213173|19201142|P2|Overall Study|Protocol Violation|0
5555408|NCT01213173|19201143|P1|Overall Study|Protocol Violation|2
5555409|NCT01213082|19201176|P3|Overall Study|Physician Decision|1
5555410|NCT01213082|19201177|P2|Overall Study|Physician Decision|0
5555411|NCT01213082|19201178|P1|Overall Study|Physician Decision|0
5555412|NCT01213082|19201176|P3|Overall Study|Lost to Follow-up|4
5555413|NCT01213082|19201177|P2|Overall Study|Lost to Follow-up|7
5555414|NCT01213082|19201178|P1|Overall Study|Lost to Follow-up|6
5555415|NCT01212991|19201220|P3|Open-label|Other|3
5555416|NCT01212991|19201221|P2|Open-label|Other|0
5555417|NCT01212991|19201222|P1|Open-label|Other|0
5555418|NCT01212991|19201220|P3|Open-label|Sponsor decision|53
5555419|NCT01212991|19201221|P2|Open-label|Sponsor decision|0
5555420|NCT01212991|19201222|P1|Open-label|Sponsor decision|0
5555421|NCT01212991|19201220|P3|Open-label|Withdrawal by Subject|7
5555422|NCT01212991|19201221|P2|Open-label|Withdrawal by Subject|0
5555423|NCT01212991|19201222|P1|Open-label|Withdrawal by Subject|0
5555424|NCT01212991|19201220|P3|Open-label|Lost to Follow-up|5
5555425|NCT01212991|19201221|P2|Open-label|Lost to Follow-up|0
5555426|NCT01212991|19201222|P1|Open-label|Lost to Follow-up|0
5555427|NCT01212991|19201220|P3|Open-label|Death|166
5555428|NCT01212991|19201221|P2|Open-label|Death|0
5555429|NCT01212991|19201222|P1|Open-label|Death|0
5555430|NCT01212991|19201220|P3|Double-blind|Sponsor decision|0
5555431|NCT01212991|19201221|P2|Double-blind|Sponsor decision|38
5555432|NCT01212991|19201222|P1|Double-blind|Sponsor decision|142
5555433|NCT01212991|19201220|P3|Double-blind|Other|0
5555434|NCT01212991|19201221|P2|Double-blind|Other|0
5555435|NCT01212991|19201222|P1|Double-blind|Other|7
5555436|NCT01212991|19201220|P3|Double-blind|Withdrawal by Subject|0
5555437|NCT01212991|19201221|P2|Double-blind|Withdrawal by Subject|19
5555438|NCT01212991|19201222|P1|Double-blind|Withdrawal by Subject|16
5555439|NCT01212991|19201220|P3|Double-blind|Death|0
5555440|NCT01212991|19201221|P2|Double-blind|Death|550
5555441|NCT01212991|19201222|P1|Double-blind|Death|699
5555442|NCT01212991|19201220|P3|Double-blind|Lost to Follow-up|0
5555443|NCT01212991|19201221|P2|Double-blind|Lost to Follow-up|4
5555444|NCT01212991|19201222|P1|Double-blind|Lost to Follow-up|8
5555445|NCT01212770|19201294|P9|Long-term Safety Phase (Year 5)|Death|0
5555446|NCT01212770|19201295|P8|Long-term Safety Phase (Year 5)|Death|1
5555447|NCT01212770|19201296|P7|Long-term Safety Phase (Year 5)|Death|0
5555448|NCT01212770|19201297|P6|Long-term Safety Phase (Year 5)|Death|0
5555449|NCT01212770|19201298|P5|Long-term Safety Phase (Year 5)|Death|0
5555450|NCT01212770|19201299|P4|Long-term Safety Phase (Year 5)|Death|0
5555451|NCT01212770|19201300|P3|Long-term Safety Phase (Year 5)|Death|0
5555452|NCT01212770|19201301|P2|Long-term Safety Phase (Year 5)|Death|0
5555453|NCT01212770|19201302|P1|Long-term Safety Phase (Year 5)|Death|0
5555454|NCT01212770|19201294|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5555455|NCT01212770|19201295|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
5555456|NCT01212770|19201296|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5555457|NCT01212770|19201297|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5555458|NCT01212770|19201298|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5555459|NCT01212770|19201299|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5555460|NCT01212770|19201300|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
5555461|NCT01212770|19201301|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
5555462|NCT01212770|19201302|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
5555463|NCT01212770|19201294|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5555464|NCT01212770|19201295|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5555465|NCT01212770|19201296|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5555466|NCT01212770|19201297|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5555467|NCT01212770|19201298|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5555468|NCT01212770|19201299|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5555469|NCT01212770|19201300|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
5555470|NCT01212770|19201301|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5555471|NCT01212770|19201302|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
5555472|NCT01212770|19201294|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
5555473|NCT01212770|19201295|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
5555474|NCT01212770|19201296|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
5555475|NCT01212770|19201297|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
5555476|NCT01212770|19201298|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
5555477|NCT01212770|19201299|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
5555478|NCT01212770|19201300|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
5555479|NCT01212770|19201301|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
5555480|NCT01212770|19201302|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
5555481|NCT01212770|19201294|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
5555482|NCT01212770|19201295|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
5555483|NCT01212770|19201296|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
5555484|NCT01212770|19201297|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
5555485|NCT01212770|19201298|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
5555486|NCT01212770|19201299|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
5555487|NCT01212770|19201300|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
5555488|NCT01212770|19201301|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
5555489|NCT01212770|19201302|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
5555490|NCT01212770|19201294|P9|Long-term Safety Phase (Year 5)|Missing|0
5555491|NCT01212770|19201295|P8|Long-term Safety Phase (Year 5)|Missing|0
5555492|NCT01212770|19201296|P7|Long-term Safety Phase (Year 5)|Missing|0
5555493|NCT01212770|19201297|P6|Long-term Safety Phase (Year 5)|Missing|0
5555494|NCT01212770|19201298|P5|Long-term Safety Phase (Year 5)|Missing|0
5555495|NCT01212770|19201299|P4|Long-term Safety Phase (Year 5)|Missing|0
5555496|NCT01212770|19201300|P3|Long-term Safety Phase (Year 5)|Missing|1
5555497|NCT01212770|19201301|P2|Long-term Safety Phase (Year 5)|Missing|0
5555498|NCT01212770|19201302|P1|Long-term Safety Phase (Year 5)|Missing|0
5555499|NCT01212770|19201294|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
5555500|NCT01212770|19201295|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
5555501|NCT01212770|19201296|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
5555502|NCT01212770|19201297|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
5555503|NCT01212770|19201298|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
5555504|NCT01212770|19201299|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
5555505|NCT01212770|19201300|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
5555506|NCT01212770|19201301|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
5555507|NCT01212770|19201302|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
5555508|NCT01212770|19201294|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5555509|NCT01212770|19201295|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5555510|NCT01212770|19201296|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5555511|NCT01212770|19201297|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5555512|NCT01212770|19201298|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5555513|NCT01212770|19201299|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5555514|NCT01212770|19201300|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
5555515|NCT01212770|19201301|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5555516|NCT01212770|19201302|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
5555517|NCT01212770|19201294|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5555518|NCT01212770|19201295|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5555519|NCT01212770|19201296|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5555520|NCT01212770|19201297|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5555521|NCT01212770|19201298|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5555522|NCT01212770|19201299|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5555523|NCT01212770|19201300|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
5555524|NCT01212770|19201301|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
5555525|NCT01212770|19201302|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
5555526|NCT01212770|19201294|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5555527|NCT01212770|19201295|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
5555528|NCT01212770|19201296|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5555529|NCT01212770|19201297|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5555530|NCT01212770|19201298|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5555531|NCT01212770|19201299|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5555532|NCT01212770|19201300|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
5555533|NCT01212770|19201301|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
5555534|NCT01212770|19201302|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
5555535|NCT01212770|19201294|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5555536|NCT01212770|19201295|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
5555537|NCT01212770|19201296|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5555538|NCT01212770|19201297|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5555539|NCT01212770|19201298|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5555540|NCT01212770|19201299|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5555541|NCT01212770|19201300|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
5555542|NCT01212770|19201301|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
5555543|NCT01212770|19201302|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
5555544|NCT01212770|19201294|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
5555545|NCT01212770|19201295|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
5555546|NCT01212770|19201296|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
5555547|NCT01212770|19201297|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
5555548|NCT01212770|19201298|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
5555549|NCT01212770|19201299|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
5555550|NCT01212770|19201300|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
5555551|NCT01212770|19201301|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
5555552|NCT01212770|19201302|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
5555553|NCT01212770|19201294|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
5555554|NCT01212770|19201295|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
5555555|NCT01212770|19201296|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
5555556|NCT01212770|19201297|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
5555557|NCT01212770|19201298|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
5555558|NCT01212770|19201299|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
5555559|NCT01212770|19201300|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
5555560|NCT01212770|19201301|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
5555561|NCT01212770|19201302|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
5555562|NCT01212770|19201294|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
5555563|NCT01212770|19201295|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
5555564|NCT01212770|19201296|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
5555565|NCT01212770|19201297|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
5555566|NCT01212770|19201298|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
5555567|NCT01212770|19201299|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
5555568|NCT01212770|19201300|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
5555569|NCT01212770|19201301|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
5555570|NCT01212770|19201302|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
5555571|NCT01212770|19201294|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5555572|NCT01212770|19201295|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5555573|NCT01212770|19201296|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5555574|NCT01212770|19201297|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5555575|NCT01212770|19201298|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5555576|NCT01212770|19201299|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5555577|NCT01212770|19201300|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5555578|NCT01212770|19201301|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
5555579|NCT01212770|19201302|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
5555580|NCT01212770|19201294|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
5555581|NCT01212770|19201295|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
5555582|NCT01212770|19201296|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5555583|NCT01212770|19201297|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5555584|NCT01212770|19201298|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5555585|NCT01212770|19201299|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5555586|NCT01212770|19201300|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
5555587|NCT01212770|19201301|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
5555588|NCT01212770|19201302|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
5555589|NCT01212770|19201294|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5555590|NCT01212770|19201295|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
5555591|NCT01212770|19201296|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5555592|NCT01212770|19201297|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5555593|NCT01212770|19201298|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5555594|NCT01212770|19201299|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5555595|NCT01212770|19201300|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
5555596|NCT01212770|19201301|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
5555597|NCT01212770|19201302|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
5555598|NCT01212770|19201294|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
5555599|NCT01212770|19201295|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
5555600|NCT01212770|19201296|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
5555601|NCT01212770|19201297|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
5555602|NCT01212770|19201298|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
5555603|NCT01212770|19201299|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
5555604|NCT01212770|19201300|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
5555605|NCT01212770|19201301|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
5555606|NCT01212770|19201302|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
5555607|NCT01212770|19201294|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
5555608|NCT01212770|19201295|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
5555826|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 4)|Death|0
5555609|NCT01212770|19201296|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
5555610|NCT01212770|19201297|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
5555611|NCT01212770|19201298|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
5555612|NCT01212770|19201299|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
5555613|NCT01212770|19201300|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
5555614|NCT01212770|19201301|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
5555615|NCT01212770|19201302|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
5555616|NCT01212770|19201294|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
5555617|NCT01212770|19201295|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
5555618|NCT01212770|19201296|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5555619|NCT01212770|19201297|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5555620|NCT01212770|19201298|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5555621|NCT01212770|19201299|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5555622|NCT01212770|19201300|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
5555623|NCT01212770|19201301|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
5555624|NCT01212770|19201302|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
5555625|NCT01212770|19201294|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
5555626|NCT01212770|19201295|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
5555627|NCT01212770|19201296|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5555628|NCT01212770|19201297|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5555629|NCT01212770|19201298|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5555630|NCT01212770|19201299|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5555631|NCT01212770|19201300|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
5555632|NCT01212770|19201301|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
5555633|NCT01212770|19201302|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
5555634|NCT01212770|19201294|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5555635|NCT01212770|19201295|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5555636|NCT01212770|19201296|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5555637|NCT01212770|19201297|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5555638|NCT01212770|19201298|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5555639|NCT01212770|19201299|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5555640|NCT01212770|19201300|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5555641|NCT01212770|19201301|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
5555642|NCT01212770|19201302|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
5555643|NCT01212770|19201294|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
5555644|NCT01212770|19201295|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
5555645|NCT01212770|19201296|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5555646|NCT01212770|19201297|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5555647|NCT01212770|19201298|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5555648|NCT01212770|19201299|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5555649|NCT01212770|19201300|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
5555650|NCT01212770|19201301|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
5555651|NCT01212770|19201302|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
5555652|NCT01212770|19201294|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
5555653|NCT01212770|19201295|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
5555654|NCT01212770|19201296|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
5555655|NCT01212770|19201297|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
5555656|NCT01212770|19201298|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
5555657|NCT01212770|19201299|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
5555658|NCT01212770|19201300|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
5555659|NCT01212770|19201301|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
5555660|NCT01212770|19201302|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
5555661|NCT01212770|19201294|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5555662|NCT01212770|19201295|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5555663|NCT01212770|19201296|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5555664|NCT01212770|19201297|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5555665|NCT01212770|19201298|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5555666|NCT01212770|19201299|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
5555667|NCT01212770|19201300|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
5555668|NCT01212770|19201301|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5555669|NCT01212770|19201302|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
5555670|NCT01212770|19201294|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5555671|NCT01212770|19201295|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5555672|NCT01212770|19201296|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5555673|NCT01212770|19201297|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5555674|NCT01212770|19201298|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5555675|NCT01212770|19201299|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
5555676|NCT01212770|19201300|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5555677|NCT01212770|19201301|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5555678|NCT01212770|19201302|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
5555679|NCT01212770|19201294|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5555680|NCT01212770|19201295|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5555681|NCT01212770|19201296|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5555682|NCT01212770|19201297|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5555683|NCT01212770|19201298|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5555684|NCT01212770|19201299|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5555685|NCT01212770|19201300|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
5555686|NCT01212770|19201301|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5555687|NCT01212770|19201302|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
5555688|NCT01212770|19201294|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
5555689|NCT01212770|19201295|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
5555690|NCT01212770|19201296|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
5555691|NCT01212770|19201297|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
5555692|NCT01212770|19201298|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
5555693|NCT01212770|19201299|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
5555694|NCT01212770|19201300|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
5555695|NCT01212770|19201301|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
5555696|NCT01212770|19201302|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
5555697|NCT01212770|19201294|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5555698|NCT01212770|19201295|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5555699|NCT01212770|19201296|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5555700|NCT01212770|19201297|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
5555701|NCT01212770|19201298|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
5555702|NCT01212770|19201299|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
5555703|NCT01212770|19201300|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
5555704|NCT01212770|19201301|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
5555705|NCT01212770|19201302|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
5555706|NCT01212770|19201294|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5555707|NCT01212770|19201295|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5555708|NCT01212770|19201296|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
5555709|NCT01212770|19201297|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5555710|NCT01212770|19201298|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5555711|NCT01212770|19201299|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
5555712|NCT01212770|19201300|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
5555713|NCT01212770|19201301|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
5555714|NCT01212770|19201302|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
5555715|NCT01212770|19201294|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5555716|NCT01212770|19201295|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5555717|NCT01212770|19201296|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5555718|NCT01212770|19201297|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5555719|NCT01212770|19201298|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5555720|NCT01212770|19201299|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
5555721|NCT01212770|19201300|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
5555722|NCT01212770|19201301|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
5555723|NCT01212770|19201302|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
5555724|NCT01212770|19201294|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5555725|NCT01212770|19201295|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5555726|NCT01212770|19201296|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5555727|NCT01212770|19201297|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5555728|NCT01212770|19201298|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5555729|NCT01212770|19201299|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5555730|NCT01212770|19201300|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5555731|NCT01212770|19201301|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5555732|NCT01212770|19201302|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5555733|NCT01212770|19201294|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5555734|NCT01212770|19201295|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5555735|NCT01212770|19201296|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5555736|NCT01212770|19201297|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5555737|NCT01212770|19201298|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5555738|NCT01212770|19201299|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5555739|NCT01212770|19201300|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
5555740|NCT01212770|19201301|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5555741|NCT01212770|19201302|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5555742|NCT01212770|19201294|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5555743|NCT01212770|19201295|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5555744|NCT01212770|19201296|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5555745|NCT01212770|19201297|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5555746|NCT01212770|19201298|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5555747|NCT01212770|19201299|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5555748|NCT01212770|19201300|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
5555749|NCT01212770|19201301|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
5555750|NCT01212770|19201302|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
5555751|NCT01212770|19201294|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5555752|NCT01212770|19201295|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5555753|NCT01212770|19201296|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5555754|NCT01212770|19201297|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5555755|NCT01212770|19201298|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5555756|NCT01212770|19201299|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5555757|NCT01212770|19201300|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
5555758|NCT01212770|19201301|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
5555759|NCT01212770|19201302|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
5555760|NCT01212770|19201294|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5555761|NCT01212770|19201295|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5555762|NCT01212770|19201296|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5555763|NCT01212770|19201297|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5555764|NCT01212770|19201298|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5555765|NCT01212770|19201299|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5555766|NCT01212770|19201300|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
5555767|NCT01212770|19201301|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
5555768|NCT01212770|19201302|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
5555769|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5555770|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5555771|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5555772|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5555773|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5555774|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5555775|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
5555776|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
5555777|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
5555778|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5555779|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5555780|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5555781|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5555782|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5555783|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5555784|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5555785|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
5555786|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
5555787|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
5555788|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
5555789|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5555790|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5555791|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5555792|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5555793|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
5555794|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
5555795|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
5555796|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
5555797|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
5555798|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
5555799|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
5555800|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
5555801|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
5555802|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
5555803|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
5555804|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
5555805|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
5555806|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
5555807|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5555808|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5555809|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5555810|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5555811|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
5555812|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
5555813|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
5555814|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5555815|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
5555816|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5555817|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5555818|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5555819|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5555820|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5555821|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5555822|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
5555823|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 4)|Death|1
5555824|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 4)|Death|0
5555825|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 4)|Death|0
5555827|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 4)|Death|0
5555828|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 4)|Death|0
5555829|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 4)|Death|1
5555830|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 4)|Death|0
5555831|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 4)|Death|0
5555832|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
5555833|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
5555834|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5555835|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5555836|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5555837|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5555838|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
5555839|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
5555840|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
5555841|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
5555842|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
5555843|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5555844|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5555845|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5555846|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5555847|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
5555848|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
5555849|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
5555850|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
5555851|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
5555852|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
5555853|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
5555854|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
5555855|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
5555856|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
5555857|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
5555858|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
5555859|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
5555860|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5555861|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5555862|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5555863|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5555864|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5555865|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5555866|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
5555867|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
5555868|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
5555869|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5555870|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5555871|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5555872|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5555873|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5555874|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
5555875|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5555876|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
5555877|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5555878|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5555879|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5555880|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5555881|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5555882|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5555883|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5555884|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
5555885|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
5555886|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
5555887|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5555888|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5555889|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5555890|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5555891|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5555892|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5555893|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5555894|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
5555895|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
5555896|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
5555897|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5555898|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5555899|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5555900|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5555901|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
5555902|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
5555903|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
5555904|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5555905|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5555906|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5555907|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5555908|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5555909|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5555910|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
5555911|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5555912|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
5555913|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
5555914|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
5555915|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5555916|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5555917|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5555918|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5555919|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
5555920|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
5555921|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
5555922|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
5555923|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
5555924|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
5555925|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
5555926|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
5555927|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
5555928|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
5555929|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
5555930|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
5555931|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5555932|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5555933|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5555934|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5555935|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5555936|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5555937|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
5555938|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5555939|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
5555940|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
5555941|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
5555942|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5555943|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5555944|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5555945|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5555946|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
5555947|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
5555948|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
5555949|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5555950|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
5555951|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5555952|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5555953|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5555954|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5555955|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
5555956|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
5555957|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
5555958|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
5555959|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
5555960|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
5555961|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
5555962|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
5555963|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
5555964|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
5555965|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
5555966|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
5555967|NCT01212757|19201499|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
5555968|NCT01212757|19201500|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5555969|NCT01212757|19201501|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5555970|NCT01212757|19201502|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5555971|NCT01212757|19201503|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5555972|NCT01212757|19201504|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5555973|NCT01212757|19201505|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5555974|NCT01212757|19201506|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5555975|NCT01212757|19201507|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
5555976|NCT01212757|19201499|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
5555977|NCT01212757|19201500|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
5555978|NCT01212757|19201501|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
5555979|NCT01212757|19201502|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
5555980|NCT01212757|19201503|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
5555981|NCT01212757|19201504|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
5555982|NCT01212757|19201505|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
5555983|NCT01212757|19201506|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
5555984|NCT01212757|19201507|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
5555985|NCT01212757|19201499|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5555986|NCT01212757|19201500|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5555987|NCT01212757|19201501|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5555988|NCT01212757|19201502|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5555989|NCT01212757|19201503|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
5555990|NCT01212757|19201504|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5555991|NCT01212757|19201505|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5555992|NCT01212757|19201506|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
5555993|NCT01212757|19201507|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
5555994|NCT01212757|19201499|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5555995|NCT01212757|19201500|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5555996|NCT01212757|19201501|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5555997|NCT01212757|19201502|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
5555998|NCT01212757|19201503|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
5555999|NCT01212757|19201504|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
5556000|NCT01212757|19201505|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
5556001|NCT01212757|19201506|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
5556002|NCT01212757|19201507|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
5556003|NCT01212757|19201499|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5556004|NCT01212757|19201500|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5556005|NCT01212757|19201501|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5556006|NCT01212757|19201502|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5556007|NCT01212757|19201503|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5556008|NCT01212757|19201504|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5556009|NCT01212757|19201505|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
5556010|NCT01212757|19201506|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5556011|NCT01212757|19201507|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
5556012|NCT01212757|19201499|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5556013|NCT01212757|19201500|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5556014|NCT01212757|19201501|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5556015|NCT01212757|19201502|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
5556016|NCT01212757|19201503|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5556017|NCT01212757|19201504|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
5556018|NCT01212757|19201505|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
5556019|NCT01212757|19201506|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
5556020|NCT01212757|19201507|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
5556021|NCT01212757|19201499|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5556022|NCT01212757|19201500|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5556023|NCT01212757|19201501|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5556024|NCT01212757|19201502|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
5556025|NCT01212757|19201503|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5556026|NCT01212757|19201504|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
5556027|NCT01212757|19201505|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
5556028|NCT01212757|19201506|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
5556029|NCT01212757|19201507|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
5556030|NCT01212757|19201499|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
5556031|NCT01212757|19201500|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
5556032|NCT01212757|19201501|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
5556033|NCT01212757|19201502|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
5556034|NCT01212757|19201503|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
5556035|NCT01212757|19201504|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
5556036|NCT01212757|19201505|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
5556037|NCT01212757|19201506|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
5556038|NCT01212757|19201507|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
5556039|NCT01212757|19201499|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5556040|NCT01212757|19201500|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5556041|NCT01212757|19201501|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5556042|NCT01212757|19201502|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5556043|NCT01212757|19201503|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5556044|NCT01212757|19201504|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5556045|NCT01212757|19201505|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5556046|NCT01212757|19201506|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
5556047|NCT01212757|19201507|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
5556048|NCT01212757|19201499|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5556049|NCT01212757|19201500|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5556050|NCT01212757|19201501|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5556051|NCT01212757|19201502|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5556052|NCT01212757|19201503|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5556053|NCT01212757|19201504|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
5556054|NCT01212757|19201505|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
5556055|NCT01212757|19201506|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5556056|NCT01212757|19201507|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
5556057|NCT01212757|19201499|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5556058|NCT01212757|19201500|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5556059|NCT01212757|19201501|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5556060|NCT01212757|19201502|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5556061|NCT01212757|19201503|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5556062|NCT01212757|19201504|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5556063|NCT01212757|19201505|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
5556064|NCT01212757|19201506|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
5556065|NCT01212757|19201507|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
5556066|NCT01212757|19201499|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5556067|NCT01212757|19201500|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5556068|NCT01212757|19201501|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5556069|NCT01212757|19201502|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5556070|NCT01212757|19201503|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5556071|NCT01212757|19201504|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
5556072|NCT01212757|19201505|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
5556073|NCT01212757|19201506|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
5556074|NCT01212757|19201507|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
5556075|NCT01212757|19201499|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5556076|NCT01212757|19201500|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5556077|NCT01212757|19201501|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5556078|NCT01212757|19201502|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5556079|NCT01212757|19201503|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5556080|NCT01212757|19201504|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
5556081|NCT01212757|19201505|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
5556082|NCT01212757|19201506|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
5556083|NCT01212757|19201507|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
5556084|NCT01212757|19201499|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5556085|NCT01212757|19201500|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5556086|NCT01212757|19201501|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5556087|NCT01212757|19201502|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5556088|NCT01212757|19201503|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5556089|NCT01212757|19201504|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
5556090|NCT01212757|19201505|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
5556091|NCT01212757|19201506|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
5556092|NCT01212757|19201507|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
5556093|NCT01212744|19201691|P1|Overall Study|Withdrawal by Subject|1
5556094|NCT01212588|19201710|P2|Overall Study|Protocol Violation|1
5556095|NCT01212588|19201711|P1|Overall Study|Protocol Violation|1
5556096|NCT01212588|19201710|P2|Overall Study|Physician Decision|1
5556097|NCT01212588|19201711|P1|Overall Study|Physician Decision|0
5556098|NCT01212185|19201809|P2|Overall Study|Protocol Violation|1
5556099|NCT01212185|19201810|P1|Overall Study|Protocol Violation|2
5556100|NCT01212159|19201829|P2|Overall Study|Withdrawal by Subject|12
5556101|NCT01212159|19201830|P1|Overall Study|Withdrawal by Subject|12
5556102|NCT01212094|19201929|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
5556103|NCT01212094|19201930|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
5556104|NCT01212094|19201931|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
5556105|NCT01212094|19201929|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
5556106|NCT01212094|19201930|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
5556107|NCT01212094|19201931|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
5556108|NCT01212094|19201929|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
5556109|NCT01212094|19201930|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
5556110|NCT01212094|19201931|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
5556111|NCT01212094|19201929|P3|Year 1: Baseline Monitoring|Started on DMT|0
5556112|NCT01212094|19201930|P2|Year 1: Baseline Monitoring|Started on DMT|0
5556113|NCT01212094|19201931|P1|Year 1: Baseline Monitoring|Started on DMT|2
5556114|NCT01212094|19201929|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
5556115|NCT01212094|19201930|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
5556116|NCT01212094|19201931|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
5556117|NCT01212094|19201929|P3|Year 1: Baseline Monitoring|Study terminated|0
5556118|NCT01212094|19201930|P2|Year 1: Baseline Monitoring|Study terminated|0
5556119|NCT01212094|19201931|P1|Year 1: Baseline Monitoring|Study terminated|7
5556120|NCT01211769|19201990|P4|Overall Study|Adverse Event|1
5556121|NCT01211769|19201991|P3|Overall Study|Adverse Event|1
5556122|NCT01211769|19201992|P2|Overall Study|Adverse Event|1
5556123|NCT01211769|19201993|P1|Overall Study|Adverse Event|0
5556124|NCT01211769|19201990|P4|Overall Study|Physician Decision|1
5556125|NCT01211769|19201991|P3|Overall Study|Physician Decision|2
5556126|NCT01211769|19201992|P2|Overall Study|Physician Decision|0
5556127|NCT01211769|19201993|P1|Overall Study|Physician Decision|2
5556128|NCT01211769|19201990|P4|Overall Study|Lost to Follow-up|9
5556129|NCT01211769|19201991|P3|Overall Study|Lost to Follow-up|5
5556130|NCT01211769|19201992|P2|Overall Study|Lost to Follow-up|9
5556131|NCT01211769|19201993|P1|Overall Study|Lost to Follow-up|7
5556132|NCT01211665|19202048|P2|Overall Study|Death|0
5556133|NCT01211665|19202049|P1|Overall Study|Death|1
5556134|NCT01211665|19202048|P2|Overall Study|Withdrawal by Subject|0
5556135|NCT01211665|19202049|P1|Overall Study|Withdrawal by Subject|1
5556136|NCT01211613|19202076|P3|Overall Study|Withdrawal by Subject|0
5556137|NCT01211613|19202077|P2|Overall Study|Withdrawal by Subject|0
5556138|NCT01211613|19202078|P1|Overall Study|Withdrawal by Subject|1
5556139|NCT01211613|19202076|P3|Overall Study|Lost to Follow-up|2
5556140|NCT01211613|19202077|P2|Overall Study|Lost to Follow-up|2
5556141|NCT01211613|19202078|P1|Overall Study|Lost to Follow-up|2
5556142|NCT01211535|19202124|P2|Overall Study|Adverse Event|1
5556143|NCT01211535|19202125|P1|Overall Study|Adverse Event|0
5556144|NCT01211522|19202134|P3|Overall Study|Withdrawal by Subject|5
5556145|NCT01211522|19202135|P2|Overall Study|Withdrawal by Subject|7
5556146|NCT01211522|19202136|P1|Overall Study|Withdrawal by Subject|3
5556147|NCT01211288|19202186|P2|Overall Study|Lost to Follow-up|1
5556148|NCT01211288|19202187|P1|Overall Study|Lost to Follow-up|1
5556149|NCT01211262|19202205|P2|Overall Study|Other|1
5556150|NCT01211262|19202206|P1|Overall Study|Other|0
5556151|NCT01211262|19202205|P2|Overall Study|Withdrawal of Consent|0
5556152|NCT01211262|19202206|P1|Overall Study|Withdrawal of Consent|1
5556153|NCT01211262|19202205|P2|Overall Study|Adverse Event|0
5556154|NCT01211262|19202206|P1|Overall Study|Adverse Event|4
5556155|NCT01211262|19202205|P2|Overall Study|Progressive Disease|9
5556156|NCT01211262|19202206|P1|Overall Study|Progressive Disease|18
5556157|NCT01211197|19202246|P6|Washout Period 2 (7 Days)|Adverse Event|0
5556158|NCT01211197|19202247|P5|Washout Period 2 (7 Days)|Adverse Event|0
5556159|NCT01211197|19202248|P4|Washout Period 2 (7 Days)|Adverse Event|0
5556160|NCT01211197|19202249|P3|Washout Period 2 (7 Days)|Adverse Event|0
5556161|NCT01211197|19202250|P2|Washout Period 2 (7 Days)|Adverse Event|0
5556162|NCT01211197|19202251|P1|Washout Period 2 (7 Days)|Adverse Event|1
5556163|NCT01211197|19202246|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5556164|NCT01211197|19202247|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5556165|NCT01211197|19202248|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5556166|NCT01211197|19202249|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
5556167|NCT01211197|19202250|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5556168|NCT01211197|19202251|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
5556169|NCT01211184|19202298|P3|Overall Study|Withdrawal by Subject|1
5556170|NCT01211184|19202299|P2|Overall Study|Withdrawal by Subject|2
5556171|NCT01211184|19202300|P1|Overall Study|Withdrawal by Subject|0
5556172|NCT01211145|19202315|P4|Overall Study|Patient decision|2
5556173|NCT01211145|19202316|P3|Overall Study|Patient decision|0
5556174|NCT01211145|19202317|P2|Overall Study|Patient decision|1
5556175|NCT01211145|19202318|P1|Overall Study|Patient decision|2
5556176|NCT01211145|19202315|P4|Overall Study|Eligibility criteria not fulfilled|15
5556177|NCT01211145|19202316|P3|Overall Study|Eligibility criteria not fulfilled|10
5556178|NCT01211145|19202317|P2|Overall Study|Eligibility criteria not fulfilled|12
5556179|NCT01211145|19202318|P1|Overall Study|Eligibility criteria not fulfilled|16
5556180|NCT01211145|19202315|P4|Overall Study|Severe noncompliance to protocol|0
5556181|NCT01211145|19202316|P3|Overall Study|Severe noncompliance to protocol|0
5556182|NCT01211145|19202317|P2|Overall Study|Severe noncompliance to protocol|0
5556183|NCT01211145|19202318|P1|Overall Study|Severe noncompliance to protocol|1
5556184|NCT01211145|19202315|P4|Overall Study|Study-specific withdrawal criteria|0
5556185|NCT01211145|19202316|P3|Overall Study|Study-specific withdrawal criteria|0
5556186|NCT01211145|19202317|P2|Overall Study|Study-specific withdrawal criteria|0
5556187|NCT01211145|19202318|P1|Overall Study|Study-specific withdrawal criteria|1
5556188|NCT01211145|19202315|P4|Overall Study|Lost to Follow-up|2
5556189|NCT01211145|19202316|P3|Overall Study|Lost to Follow-up|1
5556190|NCT01211145|19202317|P2|Overall Study|Lost to Follow-up|2
5556191|NCT01211145|19202318|P1|Overall Study|Lost to Follow-up|3
5556192|NCT01211145|19202315|P4|Overall Study|Reason not specified|1
5556193|NCT01211145|19202316|P3|Overall Study|Reason not specified|2
5556194|NCT01211145|19202317|P2|Overall Study|Reason not specified|2
5556195|NCT01211145|19202318|P1|Overall Study|Reason not specified|3
5556196|NCT01210807|19202372|P2|Overall Study|Not implanted bilaterally|1
5556197|NCT01210807|19202373|P1|Overall Study|Not implanted bilaterally|2
5556198|NCT01210807|19202372|P2|Overall Study|Lost to Follow-up|2
5556199|NCT01210807|19202373|P1|Overall Study|Lost to Follow-up|1
5556200|NCT01210690|19202388|P1|Overall Study|Patient could not take glucose|1
5556201|NCT01210690|19202388|P1|Overall Study|Patient refused to swallow|1
5556202|NCT01210690|19202388|P1|Overall Study|Withdrawal by Subject|1
5556203|NCT01210690|19202388|P1|Overall Study|Disease Remission|1
5556204|NCT01210690|19202388|P1|Overall Study|Lost to Follow-up|3
5556205|NCT01210690|19202388|P1|Overall Study|Lack of Efficacy|12
5556206|NCT01210690|19202388|P1|Overall Study|Adverse Event|7
5556207|NCT01210664|19202401|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
5556208|NCT01210664|19202402|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
5556209|NCT01210664|19202403|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
5556210|NCT01210664|19202404|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
5556211|NCT01210664|19202401|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
5556212|NCT01210664|19202402|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
5556213|NCT01210664|19202403|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
5556214|NCT01210664|19202404|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
5556215|NCT01210664|19202401|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
5556216|NCT01210664|19202402|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
5556217|NCT01210664|19202403|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
5556218|NCT01210664|19202404|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
5556219|NCT01210651|19202432|P2|Overall Study|Injury outside study|0
5556220|NCT01210651|19202433|P1|Overall Study|Injury outside study|2
5556221|NCT01210651|19202432|P2|Overall Study|Withdrawal by Subject|1
5556222|NCT01210651|19202433|P1|Overall Study|Withdrawal by Subject|1
5556223|NCT01210651|19202432|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
5556224|NCT01210651|19202433|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
5556225|NCT01210651|19202432|P2|Overall Study|schedule conflicts|5
5556226|NCT01210651|19202433|P1|Overall Study|schedule conflicts|1
5556227|NCT01210651|19202432|P2|Overall Study|Lost to Follow-up|1
5556228|NCT01210651|19202433|P1|Overall Study|Lost to Follow-up|1
5556229|NCT01210495|19202553|P4|Overall Study|Other unspecified|0
5556230|NCT01210495|19202554|P3|Overall Study|Other unspecified|6
5556231|NCT01210495|19202555|P2|Overall Study|Other unspecified|0
5556232|NCT01210495|19202556|P1|Overall Study|Other unspecified|0
5556233|NCT01210495|19202553|P4|Overall Study|Lost to Follow-up|1
5556234|NCT01210495|19202554|P3|Overall Study|Lost to Follow-up|1
5556235|NCT01210495|19202555|P2|Overall Study|Lost to Follow-up|0
5556236|NCT01210495|19202556|P1|Overall Study|Lost to Follow-up|0
5556237|NCT01210495|19202553|P4|Overall Study|Study Terminated by Sponsor|11
5556238|NCT01210495|19202554|P3|Overall Study|Study Terminated by Sponsor|4
5556239|NCT01210495|19202555|P2|Overall Study|Study Terminated by Sponsor|0
5556240|NCT01210495|19202556|P1|Overall Study|Study Terminated by Sponsor|0
5556241|NCT01210495|19202553|P4|Overall Study|Death|54
5556242|NCT01210495|19202554|P3|Overall Study|Death|112
5556243|NCT01210495|19202555|P2|Overall Study|Death|7
5556244|NCT01210495|19202556|P1|Overall Study|Death|14
5556245|NCT01210495|19202553|P4|Overall Study|Participant Refused Further Follow-Up|2
5556246|NCT01210495|19202554|P3|Overall Study|Participant Refused Further Follow-Up|11
5556247|NCT01210495|19202555|P2|Overall Study|Participant Refused Further Follow-Up|0
5556248|NCT01210495|19202556|P1|Overall Study|Participant Refused Further Follow-Up|1
5556249|NCT01210443|19202618|P1|Overall Study|Study terminated by sponsor|2
5556250|NCT01210352|19202635|P9|Overall Study|Patient Discharged Early|0
5556251|NCT01210352|19202636|P8|Overall Study|Patient Discharged Early|0
5556252|NCT01210352|19202637|P7|Overall Study|Patient Discharged Early|0
5556253|NCT01210352|19202638|P6|Overall Study|Patient Discharged Early|0
5556254|NCT01210352|19202639|P5|Overall Study|Patient Discharged Early|0
5556255|NCT01210352|19202640|P4|Overall Study|Patient Discharged Early|0
5556256|NCT01210352|19202641|P3|Overall Study|Patient Discharged Early|1
5556257|NCT01210352|19202642|P2|Overall Study|Patient Discharged Early|0
5556258|NCT01210352|19202643|P1|Overall Study|Patient Discharged Early|0
5556259|NCT01210352|19202635|P9|Overall Study|Withdrawal by Subject|1
5556260|NCT01210352|19202636|P8|Overall Study|Withdrawal by Subject|0
5556261|NCT01210352|19202637|P7|Overall Study|Withdrawal by Subject|1
5556262|NCT01210352|19202638|P6|Overall Study|Withdrawal by Subject|0
5556263|NCT01210352|19202639|P5|Overall Study|Withdrawal by Subject|0
5556264|NCT01210352|19202640|P4|Overall Study|Withdrawal by Subject|0
5556265|NCT01210352|19202641|P3|Overall Study|Withdrawal by Subject|1
5556266|NCT01210352|19202642|P2|Overall Study|Withdrawal by Subject|0
5556267|NCT01210352|19202643|P1|Overall Study|Withdrawal by Subject|0
5556268|NCT01210352|19202635|P9|Overall Study|Physician Decision|2
5556269|NCT01210352|19202636|P8|Overall Study|Physician Decision|1
5556270|NCT01210352|19202637|P7|Overall Study|Physician Decision|0
5556271|NCT01210352|19202638|P6|Overall Study|Physician Decision|0
5556272|NCT01210352|19202639|P5|Overall Study|Physician Decision|0
5556273|NCT01210352|19202640|P4|Overall Study|Physician Decision|0
5556274|NCT01210352|19202641|P3|Overall Study|Physician Decision|0
5556275|NCT01210352|19202642|P2|Overall Study|Physician Decision|0
5556276|NCT01210352|19202643|P1|Overall Study|Physician Decision|0
5556277|NCT01210352|19202635|P9|Overall Study|Lack of Efficacy|0
5556278|NCT01210352|19202636|P8|Overall Study|Lack of Efficacy|0
5556279|NCT01210352|19202637|P7|Overall Study|Lack of Efficacy|1
5556280|NCT01210352|19202638|P6|Overall Study|Lack of Efficacy|0
5556281|NCT01210352|19202639|P5|Overall Study|Lack of Efficacy|0
5556282|NCT01210352|19202640|P4|Overall Study|Lack of Efficacy|0
5556283|NCT01210352|19202641|P3|Overall Study|Lack of Efficacy|0
5556284|NCT01210352|19202642|P2|Overall Study|Lack of Efficacy|0
5556285|NCT01210352|19202643|P1|Overall Study|Lack of Efficacy|0
5556286|NCT01210352|19202635|P9|Overall Study|Adverse Event|1
5556287|NCT01210352|19202636|P8|Overall Study|Adverse Event|2
5556288|NCT01210352|19202637|P7|Overall Study|Adverse Event|0
5556289|NCT01210352|19202638|P6|Overall Study|Adverse Event|0
5556290|NCT01210352|19202639|P5|Overall Study|Adverse Event|0
5556291|NCT01210352|19202640|P4|Overall Study|Adverse Event|0
5556292|NCT01210352|19202641|P3|Overall Study|Adverse Event|0
5556293|NCT01210352|19202642|P2|Overall Study|Adverse Event|0
5556294|NCT01210352|19202643|P1|Overall Study|Adverse Event|0
5556295|NCT01210222|19202834|P1|Overall Study|Never treated|1
5556296|NCT01210222|19202834|P1|Overall Study|Ineligible|2
5556297|NCT01210144|19202870|P2|Overall Study|No transfer|0
5556298|NCT01210144|19202871|P1|Overall Study|No transfer|1
5556299|NCT01210144|19202870|P2|Overall Study|No fertilization|0
5556300|NCT01210144|19202871|P1|Overall Study|No fertilization|1
5556301|NCT01210144|19202870|P2|Overall Study|Lack of ovarian response|0
5556302|NCT01210144|19202871|P1|Overall Study|Lack of ovarian response|1
5556303|NCT01210118|19202893|P2|Overall Study|Spontaneous abortion|3
5556304|NCT01210118|19202894|P1|Overall Study|Spontaneous abortion|1
5556305|NCT01210118|19202893|P2|Overall Study|Protocol Violation|1
5556306|NCT01210118|19202894|P1|Overall Study|Protocol Violation|1
5556307|NCT01210118|19202893|P2|Overall Study|Lost to Follow-up|1
5556308|NCT01210118|19202894|P1|Overall Study|Lost to Follow-up|1
5556309|NCT01210001|19202918|P3|Overall Study|Other reason not defined above|1
5556310|NCT01210001|19202919|P2|Overall Study|Other reason not defined above|2
5556311|NCT01210001|19202920|P1|Overall Study|Other reason not defined above|2
5556312|NCT01210001|19202918|P3|Overall Study|Patient refusal to continue,not due toAE|1
5556313|NCT01210001|19202919|P2|Overall Study|Patient refusal to continue,not due toAE|2
5556314|NCT01210001|19202920|P1|Overall Study|Patient refusal to continue,not due toAE|6
5556315|NCT01210001|19202918|P3|Overall Study|Lost to Follow-up|2
5556316|NCT01210001|19202919|P2|Overall Study|Lost to Follow-up|3
5556317|NCT01210001|19202920|P1|Overall Study|Lost to Follow-up|4
5556318|NCT01210001|19202918|P3|Overall Study|Non compliant with protocol|3
5556319|NCT01210001|19202919|P2|Overall Study|Non compliant with protocol|2
5556320|NCT01210001|19202920|P1|Overall Study|Non compliant with protocol|2
5556321|NCT01210001|19202918|P3|Overall Study|Adverse Event|5
5556322|NCT01210001|19202919|P2|Overall Study|Adverse Event|2
5556323|NCT01210001|19202920|P1|Overall Study|Adverse Event|4
5556324|NCT01210001|19202918|P3|Overall Study|Not treated|0
5556325|NCT01210001|19202919|P2|Overall Study|Not treated|0
5556326|NCT01210001|19202920|P1|Overall Study|Not treated|1
5556327|NCT01209949|19202940|P1|Overall Study|Lost to Follow-up|3
5556328|NCT01209832|19202946|P1|Period 2|Sponsor Decision|1
5556329|NCT01209832|19202946|P1|Period 1|Sponsor Decision and was not dosed|1
5556330|NCT01209780|19202965|P5|Overall Study|Inappropriate enrollment|1
5556331|NCT01209780|19202966|P4|Overall Study|Inappropriate enrollment|0
5556332|NCT01209780|19202967|P3|Overall Study|Inappropriate enrollment|0
5556333|NCT01209780|19202968|P2|Overall Study|Inappropriate enrollment|2
5556334|NCT01209780|19202969|P1|Overall Study|Inappropriate enrollment|0
5556335|NCT01209780|19202965|P5|Overall Study|Protocol Violation|0
5556336|NCT01209780|19202966|P4|Overall Study|Protocol Violation|0
5556337|NCT01209780|19202967|P3|Overall Study|Protocol Violation|0
5556338|NCT01209780|19202968|P2|Overall Study|Protocol Violation|1
5556339|NCT01209780|19202969|P1|Overall Study|Protocol Violation|0
5556340|NCT01209780|19202965|P5|Overall Study|Lost to Follow-up|4
5556341|NCT01209780|19202966|P4|Overall Study|Lost to Follow-up|9
5556342|NCT01209780|19202967|P3|Overall Study|Lost to Follow-up|3
5556343|NCT01209780|19202968|P2|Overall Study|Lost to Follow-up|12
5556344|NCT01209780|19202969|P1|Overall Study|Lost to Follow-up|17
5556345|NCT01209780|19202965|P5|Overall Study|Withdrawal by Subject|0
5556346|NCT01209780|19202966|P4|Overall Study|Withdrawal by Subject|1
5556347|NCT01209780|19202967|P3|Overall Study|Withdrawal by Subject|1
5556348|NCT01209780|19202968|P2|Overall Study|Withdrawal by Subject|2
5556349|NCT01209780|19202969|P1|Overall Study|Withdrawal by Subject|9
5556350|NCT01209780|19202965|P5|Overall Study|Adverse Event|0
5556351|NCT01209780|19202966|P4|Overall Study|Adverse Event|0
5556352|NCT01209780|19202967|P3|Overall Study|Adverse Event|0
5556353|NCT01209780|19202968|P2|Overall Study|Adverse Event|1
5556354|NCT01209780|19202969|P1|Overall Study|Adverse Event|0
5556355|NCT01209767|19202995|P1|Overall Study|Lost to Follow-up|3
5556356|NCT01209767|19202995|P1|Overall Study|Withdrawal by Subject|1
5556357|NCT01209689|19203064|P2|Overall Study|Sponsor's Decision to Stop the Study|17
5556358|NCT01209689|19203065|P1|Overall Study|Sponsor's Decision to Stop the Study|68
5556359|NCT01209689|19203064|P2|Overall Study|Failure to Return|0
5556360|NCT01209689|19203065|P1|Overall Study|Failure to Return|3
5556361|NCT01209689|19203064|P2|Overall Study|Violation of Selection Criteria at Entry|0
5556362|NCT01209689|19203065|P1|Overall Study|Violation of Selection Criteria at Entry|1
5556363|NCT01209689|19203064|P2|Overall Study|Adverse Event|0
5556364|NCT01209689|19203065|P1|Overall Study|Adverse Event|4
5556365|NCT01209689|19203064|P2|Overall Study|Refused Treatment|3
5556366|NCT01209689|19203065|P1|Overall Study|Refused Treatment|8
5556367|NCT01209689|19203064|P2|Overall Study|Insufficient Therapeutic Response|2
5556368|NCT01209689|19203065|P1|Overall Study|Insufficient Therapeutic Response|7
5556369|NCT01209624|19203071|P1|Overall Study|Other|4
5556370|NCT01209624|19203071|P1|Overall Study|Lost to Follow-up|290
5556371|NCT01209624|19203071|P1|Overall Study|Lack of Efficacy|17
5556372|NCT01209624|19203071|P1|Overall Study|Adverse Event|13
5556373|NCT01209624|19203071|P1|Overall Study|Death|2
5556374|NCT01209598|19203104|P2|Overall Study|Withdrawal by Subject|0
5556375|NCT01209598|19203105|P1|Overall Study|Withdrawal by Subject|1
5556376|NCT01209520|19203113|P1|Overall Study|Withdrawal by Subject|3
5556377|NCT01209325|19203123|P1|Overall Study|Incarceration|2
5556378|NCT01209325|19203123|P1|Overall Study|Refusal prior to therapy|1
5556379|NCT01209325|19203123|P1|Overall Study|Protocol Violation|4
5556380|NCT01209325|19203123|P1|Overall Study|Refusal after starting therapy|8
5556381|NCT01209325|19203123|P1|Overall Study|Relocated|3
5556382|NCT01209325|19203123|P1|Overall Study|Adverse Event|1
5556383|NCT01209325|19203123|P1|Overall Study|Lost to Follow-up|24
5556384|NCT01209286|19203178|P3|Overall Study|Other|0
5556385|NCT01209286|19203179|P2|Overall Study|Other|1
5556386|NCT01209286|19203180|P1|Overall Study|Other|0
5556387|NCT01209286|19203178|P3|Overall Study|Physician Decision|0
5556388|NCT01209286|19203179|P2|Overall Study|Physician Decision|2
5556389|NCT01209286|19203180|P1|Overall Study|Physician Decision|0
5556390|NCT01209286|19203178|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
5556391|NCT01209286|19203179|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
5556392|NCT01209286|19203180|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
5556393|NCT01209286|19203178|P3|Overall Study|Hematological Relapse After Remission|1
5556394|NCT01209286|19203179|P2|Overall Study|Hematological Relapse After Remission|1
5556395|NCT01209286|19203180|P1|Overall Study|Hematological Relapse After Remission|0
5556396|NCT01209286|19203178|P3|Overall Study|Adverse Event|1
5556397|NCT01209286|19203179|P2|Overall Study|Adverse Event|3
5556398|NCT01209286|19203180|P1|Overall Study|Adverse Event|4
5556399|NCT01209143|19203300|P2|Overall Study|Disease progression|16
5556400|NCT01209143|19203301|P1|Overall Study|Disease progression|11
5556401|NCT01209143|19203300|P2|Overall Study|Withdrawal by Subject|1
5556402|NCT01209143|19203301|P1|Overall Study|Withdrawal by Subject|2
5556403|NCT01209143|19203300|P2|Overall Study|Lost to Follow-up|0
5556404|NCT01209143|19203301|P1|Overall Study|Lost to Follow-up|1
5556405|NCT01209143|19203300|P2|Overall Study|Physician Decision|1
5556406|NCT01209143|19203301|P1|Overall Study|Physician Decision|3
5556407|NCT01209143|19203300|P2|Overall Study|Death|1
5556408|NCT01209143|19203301|P1|Overall Study|Death|0
5556409|NCT01209143|19203300|P2|Overall Study|Adverse Event|1
5556410|NCT01209143|19203301|P1|Overall Study|Adverse Event|2
5556411|NCT01209078|19203311|P2|Overall Study|Withdrawal by Subject|1
5556412|NCT01209078|19203312|P1|Overall Study|Withdrawal by Subject|2
5556413|NCT01209078|19203311|P2|Overall Study|Physician Decision|2
5556414|NCT01209078|19203312|P1|Overall Study|Physician Decision|5
5556415|NCT01209078|19203311|P2|Overall Study|Lost to Follow-up|0
5556416|NCT01209078|19203312|P1|Overall Study|Lost to Follow-up|4
5556417|NCT01209078|19203311|P2|Overall Study|Adverse Event|0
5556418|NCT01209078|19203312|P1|Overall Study|Adverse Event|5
5556419|NCT01208961|19203387|P2|High-Fat Period III|Protocol Violation|0
5556420|NCT01208961|19203388|P1|High-Fat Period III|Protocol Violation|1
5556421|NCT01208870|19203410|P2|Overall Study|Lost to Follow-up|8
5556422|NCT01208870|19203411|P1|Overall Study|Lost to Follow-up|2
5556423|NCT01208415|19203427|P1|Overall Study|Still be eligible for follow-up|33
5556424|NCT01208415|19203427|P1|Overall Study|Device not placed|1
5556425|NCT01208415|19203427|P1|Overall Study|Withdrawal by Subject|3
5556426|NCT01208415|19203427|P1|Overall Study|Lost to Follow-up|2
5556427|NCT01208415|19203427|P1|Overall Study|Death|1
5556428|NCT01208402|19203433|P2|Overall Study|Withdrawal by Subject|0
5556429|NCT01208402|19203434|P1|Overall Study|Withdrawal by Subject|1
5556430|NCT01208337|19203450|P1|Overall Study|Death|3
5556431|NCT01208233|19203464|P6|Overall Study|Withdrawal by Subject|2
5556432|NCT01208233|19203465|P5|Overall Study|Withdrawal by Subject|4
5556433|NCT01208233|19203466|P4|Overall Study|Withdrawal by Subject|1
5556434|NCT01208233|19203467|P3|Overall Study|Withdrawal by Subject|1
5556435|NCT01208233|19203468|P2|Overall Study|Withdrawal by Subject|0
5556436|NCT01208233|19203469|P1|Overall Study|Withdrawal by Subject|1
5556437|NCT01208233|19203464|P6|Overall Study|Other|1
5556438|NCT01208233|19203465|P5|Overall Study|Other|0
5556439|NCT01208233|19203466|P4|Overall Study|Other|0
5556440|NCT01208233|19203467|P3|Overall Study|Other|0
5556441|NCT01208233|19203468|P2|Overall Study|Other|1
5556442|NCT01208233|19203469|P1|Overall Study|Other|2
5556443|NCT01208233|19203464|P6|Overall Study|Protocol Violation|0
5556444|NCT01208233|19203465|P5|Overall Study|Protocol Violation|3
5556445|NCT01208233|19203466|P4|Overall Study|Protocol Violation|0
5556446|NCT01208233|19203467|P3|Overall Study|Protocol Violation|0
5556447|NCT01208233|19203468|P2|Overall Study|Protocol Violation|0
5556448|NCT01208233|19203469|P1|Overall Study|Protocol Violation|0
5556449|NCT01208233|19203464|P6|Overall Study|Study terminated by sponsor|7
5556450|NCT01208233|19203465|P5|Overall Study|Study terminated by sponsor|10
5556451|NCT01208233|19203466|P4|Overall Study|Study terminated by sponsor|0
5556452|NCT01208233|19203467|P3|Overall Study|Study terminated by sponsor|0
5556453|NCT01208233|19203468|P2|Overall Study|Study terminated by sponsor|0
5556454|NCT01208233|19203469|P1|Overall Study|Study terminated by sponsor|0
5556455|NCT01208233|19203464|P6|Overall Study|Medication error without adverse event|1
5556456|NCT01208233|19203465|P5|Overall Study|Medication error without adverse event|0
5556457|NCT01208233|19203466|P4|Overall Study|Medication error without adverse event|0
5556458|NCT01208233|19203467|P3|Overall Study|Medication error without adverse event|0
5556459|NCT01208233|19203468|P2|Overall Study|Medication error without adverse event|0
5556460|NCT01208233|19203469|P1|Overall Study|Medication error without adverse event|0
5556461|NCT01208233|19203464|P6|Overall Study|Did not meet entrance criteria|0
5556462|NCT01208233|19203465|P5|Overall Study|Did not meet entrance criteria|1
5556463|NCT01208233|19203466|P4|Overall Study|Did not meet entrance criteria|0
5556464|NCT01208233|19203467|P3|Overall Study|Did not meet entrance criteria|1
5556465|NCT01208233|19203468|P2|Overall Study|Did not meet entrance criteria|1
5556466|NCT01208233|19203469|P1|Overall Study|Did not meet entrance criteria|2
5556467|NCT01208233|19203464|P6|Overall Study|Death|5
5556468|NCT01208233|19203465|P5|Overall Study|Death|3
5556469|NCT01208233|19203466|P4|Overall Study|Death|0
5556470|NCT01208233|19203467|P3|Overall Study|Death|0
5556471|NCT01208233|19203468|P2|Overall Study|Death|0
5556472|NCT01208233|19203469|P1|Overall Study|Death|0
5556473|NCT01208233|19203464|P6|Overall Study|Adverse Event|5
5556474|NCT01208233|19203465|P5|Overall Study|Adverse Event|3
5556475|NCT01208233|19203466|P4|Overall Study|Adverse Event|0
5556476|NCT01208233|19203467|P3|Overall Study|Adverse Event|2
5556477|NCT01208233|19203468|P2|Overall Study|Adverse Event|1
5556478|NCT01208233|19203469|P1|Overall Study|Adverse Event|0
5556479|NCT01208207|19203594|P7|Part II|Technical Problems|0
5556480|NCT01208207|19203595|P6|Part II|Technical Problems|1
5556481|NCT01208207|19203596|P5|Part II|Technical Problems|0
5556482|NCT01208207|19203597|P4|Part II|Technical Problems|1
5556483|NCT01208207|19203598|P3|Part II|Technical Problems|0
5556484|NCT01208207|19203599|P2|Part II|Technical Problems|0
5556485|NCT01208207|19203600|P1|Part II|Technical Problems|0
5556486|NCT01208207|19203594|P7|Part II|Protocol Violation|0
5556487|NCT01208207|19203595|P6|Part II|Protocol Violation|0
5556488|NCT01208207|19203596|P5|Part II|Protocol Violation|0
5556489|NCT01208207|19203597|P4|Part II|Protocol Violation|1
5556490|NCT01208207|19203598|P3|Part II|Protocol Violation|0
5556491|NCT01208207|19203599|P2|Part II|Protocol Violation|0
5556492|NCT01208207|19203600|P1|Part II|Protocol Violation|0
5556493|NCT01208207|19203594|P7|Part II|Physician Decision|0
5556494|NCT01208207|19203595|P6|Part II|Physician Decision|2
5556495|NCT01208207|19203596|P5|Part II|Physician Decision|0
5556496|NCT01208207|19203597|P4|Part II|Physician Decision|1
5556497|NCT01208207|19203598|P3|Part II|Physician Decision|0
5556498|NCT01208207|19203599|P2|Part II|Physician Decision|0
5556499|NCT01208207|19203600|P1|Part II|Physician Decision|0
5556500|NCT01208207|19203594|P7|Part II|Non-Compliance With Study Drug|0
5556501|NCT01208207|19203595|P6|Part II|Non-Compliance With Study Drug|1
5556502|NCT01208207|19203596|P5|Part II|Non-Compliance With Study Drug|1
5556503|NCT01208207|19203597|P4|Part II|Non-Compliance With Study Drug|4
5556504|NCT01208207|19203598|P3|Part II|Non-Compliance With Study Drug|0
5556505|NCT01208207|19203599|P2|Part II|Non-Compliance With Study Drug|0
5556506|NCT01208207|19203600|P1|Part II|Non-Compliance With Study Drug|0
5556507|NCT01208207|19203594|P7|Part II|Lost to Follow-up|1
5556508|NCT01208207|19203595|P6|Part II|Lost to Follow-up|2
5556509|NCT01208207|19203596|P5|Part II|Lost to Follow-up|0
5556510|NCT01208207|19203597|P4|Part II|Lost to Follow-up|4
5556511|NCT01208207|19203598|P3|Part II|Lost to Follow-up|0
5556512|NCT01208207|19203599|P2|Part II|Lost to Follow-up|0
5556513|NCT01208207|19203600|P1|Part II|Lost to Follow-up|0
5556514|NCT01208207|19203594|P7|Part II|Lack of Efficacy|3
5556515|NCT01208207|19203595|P6|Part II|Lack of Efficacy|3
5556516|NCT01208207|19203596|P5|Part II|Lack of Efficacy|4
5556517|NCT01208207|19203597|P4|Part II|Lack of Efficacy|6
5556518|NCT01208207|19203598|P3|Part II|Lack of Efficacy|0
5556519|NCT01208207|19203599|P2|Part II|Lack of Efficacy|0
5556520|NCT01208207|19203600|P1|Part II|Lack of Efficacy|0
5556521|NCT01208207|19203594|P7|Part II|Adverse Event|2
5556522|NCT01208207|19203595|P6|Part II|Adverse Event|4
5556523|NCT01208207|19203596|P5|Part II|Adverse Event|9
5556524|NCT01208207|19203597|P4|Part II|Adverse Event|5
5556525|NCT01208207|19203598|P3|Part II|Adverse Event|0
5556526|NCT01208207|19203599|P2|Part II|Adverse Event|0
5556527|NCT01208207|19203600|P1|Part II|Adverse Event|0
5556528|NCT01208207|19203594|P7|Part II|Withdrawal by Subject|5
5556529|NCT01208207|19203595|P6|Part II|Withdrawal by Subject|3
5556530|NCT01208207|19203596|P5|Part II|Withdrawal by Subject|9
5556531|NCT01208207|19203597|P4|Part II|Withdrawal by Subject|10
5556532|NCT01208207|19203598|P3|Part II|Withdrawal by Subject|0
5556533|NCT01208207|19203599|P2|Part II|Withdrawal by Subject|0
5556534|NCT01208207|19203600|P1|Part II|Withdrawal by Subject|0
5556535|NCT01208207|19203594|P7|Part I|Withdrawal by Subject|0
5556536|NCT01208207|19203595|P6|Part I|Withdrawal by Subject|0
5556537|NCT01208207|19203596|P5|Part I|Withdrawal by Subject|0
5556538|NCT01208207|19203597|P4|Part I|Withdrawal by Subject|0
5556539|NCT01208207|19203598|P3|Part I|Withdrawal by Subject|4
5556540|NCT01208207|19203599|P2|Part I|Withdrawal by Subject|4
5556541|NCT01208207|19203600|P1|Part I|Withdrawal by Subject|14
5556542|NCT01208207|19203594|P7|Part I|Protocol Violation|0
5556543|NCT01208207|19203595|P6|Part I|Protocol Violation|0
5556544|NCT01208207|19203596|P5|Part I|Protocol Violation|0
5556545|NCT01208207|19203597|P4|Part I|Protocol Violation|0
5556546|NCT01208207|19203598|P3|Part I|Protocol Violation|2
5556547|NCT01208207|19203599|P2|Part I|Protocol Violation|0
5556548|NCT01208207|19203600|P1|Part I|Protocol Violation|8
5556549|NCT01208207|19203594|P7|Part I|Progressive Disease|0
5556550|NCT01208207|19203595|P6|Part I|Progressive Disease|0
5556551|NCT01208207|19203596|P5|Part I|Progressive Disease|0
5556552|NCT01208207|19203597|P4|Part I|Progressive Disease|0
5556553|NCT01208207|19203598|P3|Part I|Progressive Disease|0
5556554|NCT01208207|19203599|P2|Part I|Progressive Disease|0
5556555|NCT01208207|19203600|P1|Part I|Progressive Disease|1
5556556|NCT01208207|19203594|P7|Part I|Physician Decision|0
5556557|NCT01208207|19203595|P6|Part I|Physician Decision|0
5556558|NCT01208207|19203596|P5|Part I|Physician Decision|0
5556559|NCT01208207|19203597|P4|Part I|Physician Decision|0
5556560|NCT01208207|19203598|P3|Part I|Physician Decision|0
5556561|NCT01208207|19203599|P2|Part I|Physician Decision|1
5556562|NCT01208207|19203600|P1|Part I|Physician Decision|0
5556563|NCT01208207|19203594|P7|Part I|Non-Compliance With Study Drug|0
5556564|NCT01208207|19203595|P6|Part I|Non-Compliance With Study Drug|0
5556565|NCT01208207|19203596|P5|Part I|Non-Compliance With Study Drug|0
5556566|NCT01208207|19203597|P4|Part I|Non-Compliance With Study Drug|0
5556567|NCT01208207|19203598|P3|Part I|Non-Compliance With Study Drug|1
5556568|NCT01208207|19203599|P2|Part I|Non-Compliance With Study Drug|0
5556569|NCT01208207|19203600|P1|Part I|Non-Compliance With Study Drug|1
5556570|NCT01208207|19203594|P7|Part I|Lost to Follow-up|0
5556571|NCT01208207|19203595|P6|Part I|Lost to Follow-up|0
5556572|NCT01208207|19203596|P5|Part I|Lost to Follow-up|0
5556573|NCT01208207|19203597|P4|Part I|Lost to Follow-up|0
5556574|NCT01208207|19203598|P3|Part I|Lost to Follow-up|0
5556575|NCT01208207|19203599|P2|Part I|Lost to Follow-up|1
5556576|NCT01208207|19203600|P1|Part I|Lost to Follow-up|6
5556577|NCT01208207|19203594|P7|Part I|Lack of Efficacy|0
5556578|NCT01208207|19203595|P6|Part I|Lack of Efficacy|0
5556579|NCT01208207|19203596|P5|Part I|Lack of Efficacy|0
5556580|NCT01208207|19203597|P4|Part I|Lack of Efficacy|0
5556581|NCT01208207|19203598|P3|Part I|Lack of Efficacy|2
5556582|NCT01208207|19203599|P2|Part I|Lack of Efficacy|3
5556583|NCT01208207|19203600|P1|Part I|Lack of Efficacy|21
5556584|NCT01208207|19203594|P7|Part I|Adverse Event|0
5556585|NCT01208207|19203595|P6|Part I|Adverse Event|0
5556586|NCT01208207|19203596|P5|Part I|Adverse Event|0
5556587|NCT01208207|19203597|P4|Part I|Adverse Event|0
5556588|NCT01208207|19203598|P3|Part I|Adverse Event|6
5556589|NCT01208207|19203599|P2|Part I|Adverse Event|2
5556590|NCT01208207|19203600|P1|Part I|Adverse Event|19
5556591|NCT01208181|19203627|P5|Part 2|Lack of Efficacy|0
5556592|NCT01208181|19203628|P4|Part 2|Lack of Efficacy|7
5556593|NCT01208181|19203629|P3|Part 2|Lack of Efficacy|5
5556594|NCT01208181|19203630|P2|Part 2|Lack of Efficacy|0
5556595|NCT01208181|19203631|P1|Part 2|Lack of Efficacy|0
5556596|NCT01208181|19203627|P5|Part 2|Lost to Follow-up|0
5556597|NCT01208181|19203628|P4|Part 2|Lost to Follow-up|2
5556598|NCT01208181|19203629|P3|Part 2|Lost to Follow-up|1
5556599|NCT01208181|19203630|P2|Part 2|Lost to Follow-up|0
5556600|NCT01208181|19203631|P1|Part 2|Lost to Follow-up|0
5556601|NCT01208181|19203627|P5|Part 2|Non-compliance with study drug|0
5556602|NCT01208181|19203628|P4|Part 2|Non-compliance with study drug|1
5556603|NCT01208181|19203629|P3|Part 2|Non-compliance with study drug|1
5556604|NCT01208181|19203630|P2|Part 2|Non-compliance with study drug|0
5556605|NCT01208181|19203631|P1|Part 2|Non-compliance with study drug|0
5556606|NCT01208181|19203627|P5|Part 2|Physician Decision|0
5556607|NCT01208181|19203628|P4|Part 2|Physician Decision|2
5556608|NCT01208181|19203629|P3|Part 2|Physician Decision|1
5556609|NCT01208181|19203630|P2|Part 2|Physician Decision|0
5556610|NCT01208181|19203631|P1|Part 2|Physician Decision|0
5556611|NCT01208181|19203627|P5|Part 2|Protocol Violation|0
5556612|NCT01208181|19203628|P4|Part 2|Protocol Violation|0
5556613|NCT01208181|19203629|P3|Part 2|Protocol Violation|1
5556614|NCT01208181|19203630|P2|Part 2|Protocol Violation|0
5556615|NCT01208181|19203631|P1|Part 2|Protocol Violation|0
5556616|NCT01208181|19203627|P5|Part 2|Withdrawal by Subject|0
5556617|NCT01208181|19203628|P4|Part 2|Withdrawal by Subject|1
5556618|NCT01208181|19203629|P3|Part 2|Withdrawal by Subject|1
5556619|NCT01208181|19203630|P2|Part 2|Withdrawal by Subject|0
5556620|NCT01208181|19203631|P1|Part 2|Withdrawal by Subject|0
5556621|NCT01208181|19203627|P5|Part 2|Adverse Event|0
5556622|NCT01208181|19203628|P4|Part 2|Adverse Event|7
5556623|NCT01208181|19203629|P3|Part 2|Adverse Event|6
5556624|NCT01208181|19203630|P2|Part 2|Adverse Event|0
5556625|NCT01208181|19203631|P1|Part 2|Adverse Event|0
5556626|NCT01208181|19203627|P5|Part 1|Adverse Event|4
5556627|NCT01208181|19203628|P4|Part 1|Adverse Event|0
5556628|NCT01208181|19203629|P3|Part 1|Adverse Event|0
5556629|NCT01208181|19203630|P2|Part 1|Adverse Event|24
5556630|NCT01208181|19203631|P1|Part 1|Adverse Event|26
5556631|NCT01208181|19203627|P5|Part 1|Lack of Efficacy|17
5556632|NCT01208181|19203628|P4|Part 1|Lack of Efficacy|0
5556633|NCT01208181|19203629|P3|Part 1|Lack of Efficacy|0
5556634|NCT01208181|19203630|P2|Part 1|Lack of Efficacy|12
5556635|NCT01208181|19203631|P1|Part 1|Lack of Efficacy|37
5556636|NCT01208181|19203627|P5|Part 1|Lost to Follow-up|1
5556637|NCT01208181|19203628|P4|Part 1|Lost to Follow-up|0
5556638|NCT01208181|19203629|P3|Part 1|Lost to Follow-up|0
5556639|NCT01208181|19203630|P2|Part 1|Lost to Follow-up|3
5556640|NCT01208181|19203631|P1|Part 1|Lost to Follow-up|5
5556641|NCT01208181|19203627|P5|Part 1|Non-compliance with study drug|0
5556642|NCT01208181|19203628|P4|Part 1|Non-compliance with study drug|0
5556643|NCT01208181|19203629|P3|Part 1|Non-compliance with study drug|0
5556644|NCT01208181|19203630|P2|Part 1|Non-compliance with study drug|1
5556645|NCT01208181|19203631|P1|Part 1|Non-compliance with study drug|1
5556646|NCT01208181|19203627|P5|Part 1|Physician Decision|0
5556647|NCT01208181|19203628|P4|Part 1|Physician Decision|0
5556648|NCT01208181|19203629|P3|Part 1|Physician Decision|0
5556649|NCT01208181|19203630|P2|Part 1|Physician Decision|0
5556650|NCT01208181|19203631|P1|Part 1|Physician Decision|4
5556651|NCT01208181|19203627|P5|Part 1|Protocol Violation|0
5556652|NCT01208181|19203628|P4|Part 1|Protocol Violation|0
5556653|NCT01208181|19203629|P3|Part 1|Protocol Violation|0
5556654|NCT01208181|19203630|P2|Part 1|Protocol Violation|5
5556655|NCT01208181|19203631|P1|Part 1|Protocol Violation|10
5556656|NCT01208181|19203627|P5|Part 1|Technical problem|0
5556657|NCT01208181|19203628|P4|Part 1|Technical problem|0
5556658|NCT01208181|19203629|P3|Part 1|Technical problem|0
5556659|NCT01208181|19203630|P2|Part 1|Technical problem|0
5556660|NCT01208181|19203631|P1|Part 1|Technical problem|5
5556661|NCT01208181|19203627|P5|Part 1|Withdrawal by Subject|0
5556662|NCT01208181|19203628|P4|Part 1|Withdrawal by Subject|0
5556663|NCT01208181|19203629|P3|Part 1|Withdrawal by Subject|0
5556664|NCT01208181|19203630|P2|Part 1|Withdrawal by Subject|10
5556665|NCT01208181|19203631|P1|Part 1|Withdrawal by Subject|11
5556666|NCT01208103|19203660|P1|Overall Study|Withdrawal by Subject|1
5556667|NCT01208103|19203660|P1|Overall Study|Adverse Event|1
5556668|NCT01208038|19203668|P1|Overall Study|Withdrawal by Subject|1
5556669|NCT01207687|19203724|P1|Overall Study|Withdrawal by Subject|1
5556670|NCT01207687|19203724|P1|Overall Study|Adverse Event|1
5556671|NCT01207596|19203762|P1|Overall Study|Withdrawal by Subject|1
5556672|NCT01207596|19203762|P1|Overall Study|Adverse Event|3
5556673|NCT01207596|19203762|P1|Overall Study|Lack of Efficacy|1
5556674|NCT01207596|19203762|P1|Overall Study|Physician Decision|4
5556675|NCT01207583|19203775|P3|Overall Study|Lost to Follow-up|0
5556676|NCT01207583|19203776|P2|Overall Study|Lost to Follow-up|2
5556677|NCT01207583|19203777|P1|Overall Study|Lost to Follow-up|0
5556678|NCT01207583|19203775|P3|Overall Study|Participant failed to return|0
5556679|NCT01207583|19203776|P2|Overall Study|Participant failed to return|0
5556680|NCT01207583|19203777|P1|Overall Study|Participant failed to return|1
5556681|NCT01207583|19203775|P3|Overall Study|Withdrawal by Subject|1
5556682|NCT01207583|19203776|P2|Overall Study|Withdrawal by Subject|3
5556683|NCT01207583|19203777|P1|Overall Study|Withdrawal by Subject|0
5556684|NCT01207492|19203830|P1|Overall Study|Toxicity|1
5556685|NCT01207492|19203830|P1|Overall Study|Progressive disease|3
5556686|NCT01207492|19203830|P1|Overall Study|Physician Decision|1
5556687|NCT01207492|19203830|P1|Overall Study|Withdrawal by Subject|9
5556688|NCT01207492|19203830|P1|Overall Study|Still on study|1
5556689|NCT01207453|19203845|P2|2nd Intervention|Lost to Follow-up|0
5556690|NCT01207453|19203846|P1|2nd Intervention|Lost to Follow-up|1
5556691|NCT01207453|19203845|P2|2nd Intervention|Adverse Event|2
5556692|NCT01207453|19203846|P1|2nd Intervention|Adverse Event|1
5556693|NCT01207453|19203845|P2|Washout|Lost to Follow-up|0
5556694|NCT01207453|19203846|P1|Washout|Lost to Follow-up|1
5556695|NCT01207453|19203845|P2|Washout|Adverse Event|0
5556696|NCT01207453|19203846|P1|Washout|Adverse Event|1
5556697|NCT01207453|19203845|P2|First Intervention|Adverse Event|1
5556698|NCT01207453|19203846|P1|First Intervention|Adverse Event|2
5556699|NCT01207440|19203872|P7|Overall Study|Reason Not Specified|0
5556700|NCT01207440|19203873|P6|Overall Study|Reason Not Specified|3
5556701|NCT01207440|19203874|P5|Overall Study|Reason Not Specified|4
5556702|NCT01207440|19203875|P4|Overall Study|Reason Not Specified|0
5556703|NCT01207440|19203876|P3|Overall Study|Reason Not Specified|7
5556704|NCT01207440|19203877|P2|Overall Study|Reason Not Specified|10
5556705|NCT01207440|19203878|P1|Overall Study|Reason Not Specified|10
5556706|NCT01207440|19203872|P7|Overall Study|Withdrawal by Subject|0
5556707|NCT01207440|19203873|P6|Overall Study|Withdrawal by Subject|2
5556708|NCT01207440|19203874|P5|Overall Study|Withdrawal by Subject|2
5556709|NCT01207440|19203875|P4|Overall Study|Withdrawal by Subject|3
5556710|NCT01207440|19203876|P3|Overall Study|Withdrawal by Subject|5
5556711|NCT01207440|19203877|P2|Overall Study|Withdrawal by Subject|4
5556712|NCT01207440|19203878|P1|Overall Study|Withdrawal by Subject|29
5556713|NCT01207440|19203872|P7|Overall Study|Site Terminated by Sponsor|2
5556714|NCT01207440|19203873|P6|Overall Study|Site Terminated by Sponsor|0
5556715|NCT01207440|19203874|P5|Overall Study|Site Terminated by Sponsor|3
5556716|NCT01207440|19203875|P4|Overall Study|Site Terminated by Sponsor|2
5556717|NCT01207440|19203876|P3|Overall Study|Site Terminated by Sponsor|12
5556718|NCT01207440|19203877|P2|Overall Study|Site Terminated by Sponsor|19
5556719|NCT01207440|19203878|P1|Overall Study|Site Terminated by Sponsor|69
5556720|NCT01207440|19203872|P7|Overall Study|Protocol Violation|0
5556721|NCT01207440|19203873|P6|Overall Study|Protocol Violation|0
5556722|NCT01207440|19203874|P5|Overall Study|Protocol Violation|0
5556723|NCT01207440|19203875|P4|Overall Study|Protocol Violation|0
5556724|NCT01207440|19203876|P3|Overall Study|Protocol Violation|0
5556725|NCT01207440|19203877|P2|Overall Study|Protocol Violation|0
5556726|NCT01207440|19203878|P1|Overall Study|Protocol Violation|2
5556727|NCT01207440|19203872|P7|Overall Study|Progressive Disease|0
5556728|NCT01207440|19203873|P6|Overall Study|Progressive Disease|27
5556729|NCT01207440|19203874|P5|Overall Study|Progressive Disease|23
5556730|NCT01207440|19203875|P4|Overall Study|Progressive Disease|7
5556731|NCT01207440|19203876|P3|Overall Study|Progressive Disease|19
5556732|NCT01207440|19203877|P2|Overall Study|Progressive Disease|10
5556733|NCT01207440|19203878|P1|Overall Study|Progressive Disease|19
5556734|NCT01207440|19203872|P7|Overall Study|Physician Decision|0
5556735|NCT01207440|19203873|P6|Overall Study|Physician Decision|0
5556736|NCT01207440|19203874|P5|Overall Study|Physician Decision|1
5556737|NCT01207440|19203875|P4|Overall Study|Physician Decision|0
5556738|NCT01207440|19203876|P3|Overall Study|Physician Decision|5
5556739|NCT01207440|19203877|P2|Overall Study|Physician Decision|5
5556740|NCT01207440|19203878|P1|Overall Study|Physician Decision|6
5556741|NCT01207440|19203872|P7|Overall Study|Non-compliance with Study Drug|0
5556742|NCT01207440|19203873|P6|Overall Study|Non-compliance with Study Drug|0
5556743|NCT01207440|19203874|P5|Overall Study|Non-compliance with Study Drug|0
5556744|NCT01207440|19203875|P4|Overall Study|Non-compliance with Study Drug|0
5556745|NCT01207440|19203876|P3|Overall Study|Non-compliance with Study Drug|1
5556746|NCT01207440|19203877|P2|Overall Study|Non-compliance with Study Drug|0
5556747|NCT01207440|19203878|P1|Overall Study|Non-compliance with Study Drug|3
5556748|NCT01207440|19203872|P7|Overall Study|Lost to Follow-up|0
5556749|NCT01207440|19203873|P6|Overall Study|Lost to Follow-up|0
5556750|NCT01207440|19203874|P5|Overall Study|Lost to Follow-up|0
5556751|NCT01207440|19203875|P4|Overall Study|Lost to Follow-up|1
5556752|NCT01207440|19203876|P3|Overall Study|Lost to Follow-up|2
5556753|NCT01207440|19203877|P2|Overall Study|Lost to Follow-up|0
5556754|NCT01207440|19203878|P1|Overall Study|Lost to Follow-up|0
5556755|NCT01207440|19203872|P7|Overall Study|Lack of Efficacy|0
5556756|NCT01207440|19203873|P6|Overall Study|Lack of Efficacy|3
5556757|NCT01207440|19203874|P5|Overall Study|Lack of Efficacy|2
5556758|NCT01207440|19203875|P4|Overall Study|Lack of Efficacy|1
5556759|NCT01207440|19203876|P3|Overall Study|Lack of Efficacy|5
5556760|NCT01207440|19203877|P2|Overall Study|Lack of Efficacy|2
5556761|NCT01207440|19203878|P1|Overall Study|Lack of Efficacy|13
5556762|NCT01207440|19203872|P7|Overall Study|Death|1
5556763|NCT01207440|19203873|P6|Overall Study|Death|5
5556764|NCT01207440|19203874|P5|Overall Study|Death|7
5556765|NCT01207440|19203875|P4|Overall Study|Death|2
5556766|NCT01207440|19203876|P3|Overall Study|Death|2
5556767|NCT01207440|19203877|P2|Overall Study|Death|3
5556768|NCT01207440|19203878|P1|Overall Study|Death|6
5556769|NCT01207440|19203872|P7|Overall Study|Adverse Event|2
5556770|NCT01207440|19203873|P6|Overall Study|Adverse Event|6
5556771|NCT01207440|19203874|P5|Overall Study|Adverse Event|6
5556772|NCT01207440|19203875|P4|Overall Study|Adverse Event|2
5556773|NCT01207440|19203876|P3|Overall Study|Adverse Event|7
5556774|NCT01207440|19203877|P2|Overall Study|Adverse Event|11
5556775|NCT01207440|19203878|P1|Overall Study|Adverse Event|46
5556776|NCT01207427|19203945|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5556777|NCT01207427|19203946|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5556778|NCT01207427|19203947|P1|Double-blind Treatment Period|Withdrawal by Subject|1
5556779|NCT01207427|19203945|P3|Double-blind Treatment Period|Protocol Violation|1
5556780|NCT01207427|19203946|P2|Double-blind Treatment Period|Protocol Violation|1
5556781|NCT01207427|19203947|P1|Double-blind Treatment Period|Protocol Violation|2
5556782|NCT01207427|19203945|P3|Double-blind Treatment Period|Lost to Follow-up|1
5556783|NCT01207427|19203946|P2|Double-blind Treatment Period|Lost to Follow-up|0
5556784|NCT01207427|19203947|P1|Double-blind Treatment Period|Lost to Follow-up|0
5556785|NCT01207427|19203945|P3|Double-blind Treatment Period|Adverse Event|0
5556786|NCT01207427|19203946|P2|Double-blind Treatment Period|Adverse Event|1
5556787|NCT01207427|19203947|P1|Double-blind Treatment Period|Adverse Event|0
5556788|NCT01207414|19203957|P2|Overall Study|Randomized in error|0
5556789|NCT01207414|19203958|P1|Overall Study|Randomized in error|1
5556790|NCT01207414|19203957|P2|Overall Study|Protocol deviation|9
5556791|NCT01207414|19203958|P1|Overall Study|Protocol deviation|12
5556792|NCT01207414|19203957|P2|Overall Study|Administrative problems|1
5556793|NCT01207414|19203958|P1|Overall Study|Administrative problems|1
5556794|NCT01207414|19203957|P2|Overall Study|Lost to Follow-up|17
5556795|NCT01207414|19203958|P1|Overall Study|Lost to Follow-up|15
5556796|NCT01207414|19203957|P2|Overall Study|Patient withdrew consent|11
5556797|NCT01207414|19203958|P1|Overall Study|Patient withdrew consent|14
5556798|NCT01207414|19203957|P2|Overall Study|Unsatisfactory therapeutic effect|4
5556799|NCT01207414|19203958|P1|Overall Study|Unsatisfactory therapeutic effect|5
5556800|NCT01207414|19203957|P2|Overall Study|Abnormal test procedure results|1
5556801|NCT01207414|19203958|P1|Overall Study|Abnormal test procedure results|0
5556802|NCT01207414|19203957|P2|Overall Study|Adverse Event|39
5556803|NCT01207414|19203958|P1|Overall Study|Adverse Event|25
5556804|NCT01207388|19203983|P1|Overall Study|Withdrawal by Subject|1
5556805|NCT01207388|19203983|P1|Overall Study|Death|67
5556806|NCT01207219|19204008|P3|Overall Study|Lost to Follow-up|6
5556807|NCT01207219|19204009|P2|Overall Study|Lost to Follow-up|8
5556808|NCT01207219|19204010|P1|Overall Study|Lost to Follow-up|6
5556809|NCT01207219|19204008|P3|Overall Study|changed diagnosis during study period|1
5556810|NCT01207219|19204009|P2|Overall Study|changed diagnosis during study period|3
5556811|NCT01207219|19204010|P1|Overall Study|changed diagnosis during study period|5
5556812|NCT01207102|19204030|P1|Overall Study|Withdrawal by Treating Physician|1
5556813|NCT01207102|19204030|P1|Overall Study|progression|2
5556814|NCT01207102|19204030|P1|Overall Study|Adverse Event|2
5556815|NCT01207102|19204030|P1|Overall Study|Withdrawal by Subject|5
5556816|NCT01206816|19204042|P7|Overall Study|other than stated above|1
5556817|NCT01206816|19204043|P6|Overall Study|other than stated above|0
5556818|NCT01206816|19204044|P5|Overall Study|other than stated above|0
5556819|NCT01206816|19204045|P4|Overall Study|other than stated above|0
5556820|NCT01206816|19204046|P3|Overall Study|other than stated above|1
5556821|NCT01206816|19204047|P2|Overall Study|other than stated above|0
5556822|NCT01206816|19204048|P1|Overall Study|other than stated above|0
5556823|NCT01206816|19204042|P7|Overall Study|Other AE|2
5556824|NCT01206816|19204043|P6|Overall Study|Other AE|3
5556825|NCT01206816|19204044|P5|Overall Study|Other AE|0
5556826|NCT01206816|19204045|P4|Overall Study|Other AE|0
5556827|NCT01206816|19204046|P3|Overall Study|Other AE|4
5556828|NCT01206816|19204047|P2|Overall Study|Other AE|0
5556829|NCT01206816|19204048|P1|Overall Study|Other AE|0
5556830|NCT01206816|19204042|P7|Overall Study|Progressive disease|3
5556831|NCT01206816|19204043|P6|Overall Study|Progressive disease|16
5556832|NCT01206816|19204044|P5|Overall Study|Progressive disease|3
5556833|NCT01206816|19204045|P4|Overall Study|Progressive disease|3
5556834|NCT01206816|19204046|P3|Overall Study|Progressive disease|13
5556835|NCT01206816|19204047|P2|Overall Study|Progressive disease|3
5556836|NCT01206816|19204048|P1|Overall Study|Progressive disease|3
5556837|NCT01206816|19204042|P7|Overall Study|Withdrawal by Subject|0
5556838|NCT01206816|19204043|P6|Overall Study|Withdrawal by Subject|0
5556839|NCT01206816|19204044|P5|Overall Study|Withdrawal by Subject|0
5556840|NCT01206816|19204045|P4|Overall Study|Withdrawal by Subject|0
5556841|NCT01206816|19204046|P3|Overall Study|Withdrawal by Subject|1
5556842|NCT01206816|19204047|P2|Overall Study|Withdrawal by Subject|0
5556843|NCT01206816|19204048|P1|Overall Study|Withdrawal by Subject|0
5556844|NCT01206816|19204042|P7|Overall Study|Protocol Violation|0
5556845|NCT01206816|19204043|P6|Overall Study|Protocol Violation|0
5556846|NCT01206816|19204044|P5|Overall Study|Protocol Violation|0
5556847|NCT01206816|19204045|P4|Overall Study|Protocol Violation|0
5556848|NCT01206816|19204046|P3|Overall Study|Protocol Violation|1
5556849|NCT01206816|19204047|P2|Overall Study|Protocol Violation|0
5556850|NCT01206816|19204048|P1|Overall Study|Protocol Violation|0
5556851|NCT01206777|19204094|P1|Overall Study|Adverse Event|1
5556852|NCT01206777|19204094|P1|Overall Study|Death|1
5556853|NCT01206764|19204100|P1|Overall Study|Protocol deviation|3
5556854|NCT01206764|19204100|P1|Overall Study|Disease progression|88
5556855|NCT01206764|19204100|P1|Overall Study|New cancer therapy|2
5556856|NCT01206764|19204100|P1|Overall Study|Death|11
5556857|NCT01206764|19204100|P1|Overall Study|Lost to Follow-up|6
5556858|NCT01206764|19204100|P1|Overall Study|Patient withdrew consent|5
5556859|NCT01206764|19204100|P1|Overall Study|Abnormal test procedure result|1
5556860|NCT01206764|19204100|P1|Overall Study|Abnormal laboratory value|2
5556861|NCT01206764|19204100|P1|Overall Study|Adverse Event|20
5556862|NCT01206582|19204158|P2|Overall Study|Discontinued intervention before week 8|2
5556863|NCT01206582|19204159|P1|Overall Study|Discontinued intervention before week 8|1
5556864|NCT01206582|19204158|P2|Overall Study|Withdrew prior to study|0
5556865|NCT01206582|19204159|P1|Overall Study|Withdrew prior to study|1
5556866|NCT01206517|19204191|P6|Overall Study|Withdrawal by Subject|0
5556867|NCT01206517|19204192|P5|Overall Study|Withdrawal by Subject|1
5556868|NCT01206517|19204193|P4|Overall Study|Withdrawal by Subject|0
5556869|NCT01206517|19204194|P3|Overall Study|Withdrawal by Subject|2
5556870|NCT01206517|19204195|P2|Overall Study|Withdrawal by Subject|0
5556871|NCT01206517|19204196|P1|Overall Study|Withdrawal by Subject|0
5556872|NCT01206439|19204276|P1|Overall Study|subject did not meet inclusion criteria|1
5556873|NCT01206322|19204299|P4|Overall Study|Adverse Event|1
5556874|NCT01206322|19204300|P3|Overall Study|Adverse Event|0
5556875|NCT01206322|19204301|P2|Overall Study|Adverse Event|0
5556876|NCT01206322|19204302|P1|Overall Study|Adverse Event|0
5556877|NCT01206140|19204318|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
5556878|NCT01206140|19204319|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
5556879|NCT01206101|19204331|P2|Overall Study|Unclassified|0
5556880|NCT01206101|19204332|P1|Overall Study|Unclassified|1
5556881|NCT01206101|19204331|P2|Overall Study|Physician Decision|1
5556882|NCT01206101|19204332|P1|Overall Study|Physician Decision|0
5556883|NCT01206101|19204331|P2|Overall Study|Adverse Event|0
5556884|NCT01206101|19204332|P1|Overall Study|Adverse Event|1
5556885|NCT01205776|19204373|P2|Overall Study|Withdrawal by Subject|34
5556886|NCT01205776|19204374|P1|Overall Study|Withdrawal by Subject|11
5556887|NCT01205776|19204373|P2|Overall Study|Lost to Follow-up|61
5556888|NCT01205776|19204374|P1|Overall Study|Lost to Follow-up|53
5556889|NCT01205685|19204562|P1|Overall Study|Withdrawal by Subject|1
5556890|NCT01205685|19204562|P1|Overall Study|Disease Progression|10
5556891|NCT01205581|19204582|P6|Overall Study|Withdrawal by Subject|0
5556892|NCT01205581|19204583|P5|Overall Study|Withdrawal by Subject|0
5556893|NCT01205581|19204584|P4|Overall Study|Withdrawal by Subject|0
5556894|NCT01205581|19204585|P3|Overall Study|Withdrawal by Subject|0
5556895|NCT01205581|19204586|P2|Overall Study|Withdrawal by Subject|0
5556896|NCT01205581|19204587|P1|Overall Study|Withdrawal by Subject|1
5556897|NCT01205529|19204657|P1|Overall Study|No longer met criteria|30
5556898|NCT01205529|19204657|P1|Overall Study|Unstable post op|15
5556899|NCT01205529|19204657|P1|Overall Study|Physician Decision|4
5556900|NCT01205529|19204657|P1|Overall Study|Withdrawal by Subject|2
5556901|NCT01205529|19204657|P1|Overall Study|Procedure Cancelled|4
5556902|NCT01205451|19204680|P2|Overall Study|Withdrawal by Subject|9
5556903|NCT01205451|19204681|P1|Overall Study|Withdrawal by Subject|5
5556904|NCT01205451|19204680|P2|Overall Study|Lost to Follow-up|1
5556905|NCT01205451|19204681|P1|Overall Study|Lost to Follow-up|1
5556906|NCT01205438|19204726|P3|Overall Study|Sponsor Decision|1
5556907|NCT01205438|19204727|P2|Overall Study|Sponsor Decision|1
5556908|NCT01205438|19204728|P1|Overall Study|Sponsor Decision|0
5556909|NCT01205438|19204726|P3|Overall Study|Protocol Violation|4
5556910|NCT01205438|19204727|P2|Overall Study|Protocol Violation|7
5556911|NCT01205438|19204728|P1|Overall Study|Protocol Violation|2
5556912|NCT01205438|19204726|P3|Overall Study|Physician Decision|2
5556913|NCT01205438|19204727|P2|Overall Study|Physician Decision|3
5556914|NCT01205438|19204728|P1|Overall Study|Physician Decision|0
5556915|NCT01205438|19204726|P3|Overall Study|Withdrawal by Subject|19
5556916|NCT01205438|19204727|P2|Overall Study|Withdrawal by Subject|25
5556917|NCT01205438|19204728|P1|Overall Study|Withdrawal by Subject|19
5556918|NCT01205438|19204726|P3|Overall Study|Lost to Follow-up|8
5556919|NCT01205438|19204727|P2|Overall Study|Lost to Follow-up|7
5556920|NCT01205438|19204728|P1|Overall Study|Lost to Follow-up|6
5556921|NCT01205438|19204726|P3|Overall Study|Lack of Efficacy|14
5556922|NCT01205438|19204727|P2|Overall Study|Lack of Efficacy|11
5556923|NCT01205438|19204728|P1|Overall Study|Lack of Efficacy|14
5556924|NCT01205438|19204726|P3|Overall Study|Entry Criteria Not Met|13
5556925|NCT01205438|19204727|P2|Overall Study|Entry Criteria Not Met|15
5556926|NCT01205438|19204728|P1|Overall Study|Entry Criteria Not Met|16
5556927|NCT01205438|19204726|P3|Overall Study|Death|3
5556928|NCT01205438|19204727|P2|Overall Study|Death|1
5556929|NCT01205438|19204728|P1|Overall Study|Death|1
5556930|NCT01205438|19204726|P3|Overall Study|Adverse Event|24
5556931|NCT01205438|19204727|P2|Overall Study|Adverse Event|17
5556932|NCT01205438|19204728|P1|Overall Study|Adverse Event|19
5556933|NCT01205269|19204784|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
5556934|NCT01205269|19204785|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
5556935|NCT01205269|19204786|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
5556936|NCT01205269|19204787|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
5556937|NCT01205269|19204788|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
5556938|NCT01205269|19204789|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
5556939|NCT01205230|19204829|P2|Overall Study|Physician Decision|0
5556940|NCT01205230|19204830|P1|Overall Study|Physician Decision|1
5556941|NCT01205230|19204829|P2|Overall Study|Adverse Event|0
5556942|NCT01205230|19204830|P1|Overall Study|Adverse Event|4
5556943|NCT01205165|19204873|P1|Overall Study|Lost to Follow-up|2
5556944|NCT01205152|19204886|P1|Overall Study|Death|1
5556945|NCT01205126|19204899|P2|Maintenance Phase|Withdrawal by Subject|11
5556946|NCT01205126|19204900|P1|Maintenance Phase|Withdrawal by Subject|8
5556947|NCT01205126|19204899|P2|Maintenance Phase|Lost to Follow-up|5
5556948|NCT01205126|19204900|P1|Maintenance Phase|Lost to Follow-up|5
5556949|NCT01205126|19204899|P2|Maintenance Phase|Other|8
5556950|NCT01205126|19204900|P1|Maintenance Phase|Other|11
5556951|NCT01205126|19204899|P2|Maintenance Phase|Prohibited drugs used|0
5556952|NCT01205126|19204900|P1|Maintenance Phase|Prohibited drugs used|1
5556953|NCT01205126|19204899|P2|Maintenance Phase|More than the maximum dosage required|5
5556954|NCT01205126|19204900|P1|Maintenance Phase|More than the maximum dosage required|5
5556955|NCT01205126|19204899|P2|Maintenance Phase|Death|4
5556956|NCT01205126|19204900|P1|Maintenance Phase|Death|4
5556957|NCT01205126|19204899|P2|Maintenance Phase|Adverse Event|7
5556958|NCT01205126|19204900|P1|Maintenance Phase|Adverse Event|3
5556959|NCT01205126|19204899|P2|Between Titration & Maintenance Phase|Other|4
5556960|NCT01205126|19204900|P1|Between Titration & Maintenance Phase|Other|0
5556961|NCT01205126|19204899|P2|Titration Phase|Other|6
5556962|NCT01205126|19204900|P1|Titration Phase|Other|8
5556963|NCT01205126|19204899|P2|Titration Phase|More than maximum dosage required|3
5556964|NCT01205126|19204900|P1|Titration Phase|More than maximum dosage required|2
5556965|NCT01205126|19204899|P2|Titration Phase|No stable titration dose|0
5556966|NCT01205126|19204900|P1|Titration Phase|No stable titration dose|1
5556967|NCT01205126|19204899|P2|Titration Phase|Lost to Follow-up|2
5556968|NCT01205126|19204900|P1|Titration Phase|Lost to Follow-up|2
5556969|NCT01205126|19204899|P2|Titration Phase|Withdrawal by Subject|5
5556970|NCT01205126|19204900|P1|Titration Phase|Withdrawal by Subject|5
5556971|NCT01205126|19204899|P2|Titration Phase|Adverse Event|3
5556972|NCT01205126|19204900|P1|Titration Phase|Adverse Event|5
5556973|NCT01205035|19204918|P2|Overall Study|Physician Decision|0
5556974|NCT01205035|19204919|P1|Overall Study|Physician Decision|1
5556975|NCT01205035|19204918|P2|Overall Study|Withdrawal by Subject|0
5556976|NCT01205035|19204919|P1|Overall Study|Withdrawal by Subject|1
5556977|NCT01204918|19204936|P3|Overall Study|Withdrawal by Subject|5
5556978|NCT01204918|19204937|P2|Overall Study|Withdrawal by Subject|10
5556979|NCT01204918|19204938|P1|Overall Study|Withdrawal by Subject|4
5556980|NCT01204775|19204981|P2|Overall Study|Withdrawal by Subject|0
5556981|NCT01204775|19204982|P1|Overall Study|Withdrawal by Subject|1
5556982|NCT01204775|19204981|P2|Overall Study|Poor/non-compliance|1
5556983|NCT01204775|19204982|P1|Overall Study|Poor/non-compliance|0
5556984|NCT01204710|19205007|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
5556985|NCT01204710|19205008|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
5556986|NCT01204710|19205007|P2|Optional Olaratumab Monotherapy|Physician Decision|1
5556987|NCT01204710|19205008|P1|Optional Olaratumab Monotherapy|Physician Decision|0
5556988|NCT01204710|19205007|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
5556989|NCT01204710|19205008|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
5556990|NCT01204710|19205007|P2|Randomization Treatment|Moved and Followed for Survival|1
5556991|NCT01204710|19205008|P1|Randomization Treatment|Moved and Followed for Survival|0
5556992|NCT01204710|19205007|P2|Randomization Treatment|Worsening of General condition|1
5556993|NCT01204710|19205008|P1|Randomization Treatment|Worsening of General condition|0
5556994|NCT01204710|19205007|P2|Randomization Treatment|Sponsor Decision|1
5556995|NCT01204710|19205008|P1|Randomization Treatment|Sponsor Decision|0
5556996|NCT01204710|19205007|P2|Randomization Treatment|Adverse Event|2
5556997|NCT01204710|19205008|P1|Randomization Treatment|Adverse Event|4
5556998|NCT01204710|19205007|P2|Randomization Treatment|Entry criteria not met|1
5556999|NCT01204710|19205008|P1|Randomization Treatment|Entry criteria not met|0
5557000|NCT01204710|19205007|P2|Randomization Treatment|Physician Decision|2
5557001|NCT01204710|19205008|P1|Randomization Treatment|Physician Decision|3
5557002|NCT01204710|19205007|P2|Randomization Treatment|Withdrawal by Subject|5
5557003|NCT01204710|19205008|P1|Randomization Treatment|Withdrawal by Subject|6
5557004|NCT01204710|19205007|P2|Randomization Treatment|Lost to Follow-up|0
5557005|NCT01204710|19205008|P1|Randomization Treatment|Lost to Follow-up|1
5557006|NCT01204697|19205044|P2|Overall Study|Randomized, but not treated|1
5557007|NCT01204697|19205045|P1|Overall Study|Randomized, but not treated|0
5557008|NCT01204697|19205044|P2|Overall Study|Withdrawal by Subject|4
5557009|NCT01204697|19205045|P1|Overall Study|Withdrawal by Subject|2
5557010|NCT01204697|19205044|P2|Overall Study|Lost to Follow-up|4
5557011|NCT01204697|19205045|P1|Overall Study|Lost to Follow-up|3
5557012|NCT01204697|19205044|P2|Overall Study|Death|27
5557013|NCT01204697|19205045|P1|Overall Study|Death|26
5557014|NCT01204671|19205066|P5|Overall Study|Physician Decision|0
5557015|NCT01204671|19205067|P4|Overall Study|Physician Decision|1
5557016|NCT01204671|19205068|P3|Overall Study|Physician Decision|0
5557017|NCT01204671|19205069|P2|Overall Study|Physician Decision|0
5557018|NCT01204671|19205070|P1|Overall Study|Physician Decision|0
5557019|NCT01204671|19205066|P5|Overall Study|Unknown Completion Status|0
5557020|NCT01204671|19205067|P4|Overall Study|Unknown Completion Status|0
5557021|NCT01204671|19205068|P3|Overall Study|Unknown Completion Status|0
5557022|NCT01204671|19205069|P2|Overall Study|Unknown Completion Status|1
5557023|NCT01204671|19205070|P1|Overall Study|Unknown Completion Status|1
5557024|NCT01204671|19205066|P5|Overall Study|Lost to Follow-up|0
5557025|NCT01204671|19205067|P4|Overall Study|Lost to Follow-up|4
5557026|NCT01204671|19205068|P3|Overall Study|Lost to Follow-up|6
5557027|NCT01204671|19205069|P2|Overall Study|Lost to Follow-up|8
5557028|NCT01204671|19205070|P1|Overall Study|Lost to Follow-up|7
5557029|NCT01204671|19205066|P5|Overall Study|Withdrawal by Subject|3
5557030|NCT01204671|19205067|P4|Overall Study|Withdrawal by Subject|5
5557031|NCT01204671|19205068|P3|Overall Study|Withdrawal by Subject|4
5557032|NCT01204671|19205069|P2|Overall Study|Withdrawal by Subject|3
5557033|NCT01204671|19205070|P1|Overall Study|Withdrawal by Subject|2
5557034|NCT01204671|19205066|P5|Overall Study|Adverse Event|1
5557035|NCT01204671|19205067|P4|Overall Study|Adverse Event|3
5557036|NCT01204671|19205068|P3|Overall Study|Adverse Event|3
5557037|NCT01204671|19205069|P2|Overall Study|Adverse Event|3
5557038|NCT01204671|19205070|P1|Overall Study|Adverse Event|4
5557039|NCT01204658|19205132|P4|Primary Phase|Adverse Event|0
5557040|NCT01204658|19205133|P3|Primary Phase|Adverse Event|1
5557041|NCT01204658|19205134|P2|Primary Phase|Adverse Event|0
5557042|NCT01204658|19205135|P1|Primary Phase|Adverse Event|0
5557043|NCT01204398|19205253|P1|Overall Study|Adverse Event|1
5557044|NCT01204294|19205270|P7|Overall Study|Other (house moving)|0
5557045|NCT01204294|19205271|P6|Overall Study|Other (house moving)|0
5557046|NCT01204294|19205272|P5|Overall Study|Other (house moving)|0
5557047|NCT01204294|19205273|P4|Overall Study|Other (house moving)|0
5557048|NCT01204294|19205274|P3|Overall Study|Other (house moving)|1
5557049|NCT01204294|19205275|P2|Overall Study|Other (house moving)|0
5557050|NCT01204294|19205276|P1|Overall Study|Other (house moving)|0
5557051|NCT01204294|19205270|P7|Overall Study|Lack of Efficacy|0
5557052|NCT01204294|19205271|P6|Overall Study|Lack of Efficacy|0
5557053|NCT01204294|19205272|P5|Overall Study|Lack of Efficacy|0
5557054|NCT01204294|19205273|P4|Overall Study|Lack of Efficacy|2
5557055|NCT01204294|19205274|P3|Overall Study|Lack of Efficacy|0
5557056|NCT01204294|19205275|P2|Overall Study|Lack of Efficacy|0
5557057|NCT01204294|19205276|P1|Overall Study|Lack of Efficacy|0
5557058|NCT01204294|19205270|P7|Overall Study|Withdrawal by Subject|2
5557059|NCT01204294|19205271|P6|Overall Study|Withdrawal by Subject|1
5557060|NCT01204294|19205272|P5|Overall Study|Withdrawal by Subject|1
5557061|NCT01204294|19205273|P4|Overall Study|Withdrawal by Subject|1
5557062|NCT01204294|19205274|P3|Overall Study|Withdrawal by Subject|2
5557063|NCT01204294|19205275|P2|Overall Study|Withdrawal by Subject|2
5557064|NCT01204294|19205276|P1|Overall Study|Withdrawal by Subject|0
5557065|NCT01204294|19205270|P7|Overall Study|Protocol Violation|0
5557066|NCT01204294|19205271|P6|Overall Study|Protocol Violation|0
5557067|NCT01204294|19205272|P5|Overall Study|Protocol Violation|0
5557068|NCT01204294|19205273|P4|Overall Study|Protocol Violation|1
5557069|NCT01204294|19205274|P3|Overall Study|Protocol Violation|2
5557070|NCT01204294|19205275|P2|Overall Study|Protocol Violation|0
5557071|NCT01204294|19205276|P1|Overall Study|Protocol Violation|1
5557072|NCT01204294|19205270|P7|Overall Study|Adverse Event|0
5557073|NCT01204294|19205271|P6|Overall Study|Adverse Event|4
5557074|NCT01204294|19205272|P5|Overall Study|Adverse Event|1
5557075|NCT01204294|19205273|P4|Overall Study|Adverse Event|7
5557076|NCT01204294|19205274|P3|Overall Study|Adverse Event|0
5557077|NCT01204294|19205275|P2|Overall Study|Adverse Event|6
5557078|NCT01204294|19205276|P1|Overall Study|Adverse Event|2
5557079|NCT01203956|19205310|P2|Second Two-week Period|Non-compliant: no evaluable results|6
5557080|NCT01203956|19205311|P1|Second Two-week Period|Non-compliant: no evaluable results|5
5557081|NCT01203930|19205320|P2|Overall Study|Adverse Event|5
5557082|NCT01203930|19205321|P1|Overall Study|Adverse Event|17
5557083|NCT01203930|19205320|P2|Overall Study|Poor tolerance of study drug|1
5557084|NCT01203930|19205321|P1|Overall Study|Poor tolerance of study drug|0
5557085|NCT01203930|19205320|P2|Overall Study|Study Terminated by Sponsor|12
5557086|NCT01203930|19205321|P1|Overall Study|Study Terminated by Sponsor|0
5557087|NCT01203930|19205320|P2|Overall Study|Investigator Request|8
5557088|NCT01203930|19205321|P1|Overall Study|Investigator Request|0
5557089|NCT01203930|19205320|P2|Overall Study|Withdrew Consent|10
5557090|NCT01203930|19205321|P1|Overall Study|Withdrew Consent|1
5557091|NCT01203930|19205320|P2|Overall Study|Death|1
5557092|NCT01203930|19205321|P1|Overall Study|Death|3
5557093|NCT01203930|19205320|P2|Overall Study|Disease Progression|4
5557094|NCT01203930|19205321|P1|Overall Study|Disease Progression|0
5557095|NCT01203917|19205343|P1|Overall Study|Due to EGFR M+I patient|1
5557096|NCT01203917|19205343|P1|Overall Study|Due to objective disease progression|1
5557097|NCT01203917|19205343|P1|Overall Study|Withdrawal by Subject|3
5557098|NCT01203917|19205343|P1|Overall Study|Lost to Follow-up|2
5557099|NCT01203917|19205343|P1|Overall Study|Death|29
5557100|NCT01203878|19205356|P3|Overall Study|Adverse Event|2
5557101|NCT01203878|19205357|P2|Overall Study|Adverse Event|0
5557102|NCT01203878|19205358|P1|Overall Study|Adverse Event|0
5557103|NCT01203878|19205356|P3|Overall Study|Withdrawal by Subject|1
5557104|NCT01203878|19205357|P2|Overall Study|Withdrawal by Subject|0
5557105|NCT01203878|19205358|P1|Overall Study|Withdrawal by Subject|0
5557106|NCT01203852|19205369|P1|Washout 2 Weeks|Physician Decision|46
5557107|NCT01203852|19205369|P1|Metoprolol 8 Weeks|Physician Decision|470
5557108|NCT01203787|19205387|P2|Overall Study|Adverse Event|15
5557109|NCT01203787|19205388|P1|Overall Study|Adverse Event|11
5557110|NCT01203787|19205387|P2|Overall Study|Lost to Follow-up|0
5557111|NCT01203787|19205388|P1|Overall Study|Lost to Follow-up|2
5557112|NCT01203787|19205387|P2|Overall Study|Withdrawal by Subject|2
5557113|NCT01203787|19205388|P1|Overall Study|Withdrawal by Subject|6
5557114|NCT01203787|19205387|P2|Overall Study|Death|10
5557115|NCT01203787|19205388|P1|Overall Study|Death|12
5557116|NCT01203098|19205459|P3|Overall Study|Withdrawal by Subject|3
5557117|NCT01203098|19205460|P2|Overall Study|Withdrawal by Subject|1
5557118|NCT01203098|19205461|P1|Overall Study|Withdrawal by Subject|1
5557119|NCT01203098|19205459|P3|Overall Study|Physician Decision|0
5557120|NCT01203098|19205460|P2|Overall Study|Physician Decision|2
5557121|NCT01203098|19205461|P1|Overall Study|Physician Decision|2
5557122|NCT01203098|19205459|P3|Overall Study|Lost to Follow-up|1
5557123|NCT01203098|19205460|P2|Overall Study|Lost to Follow-up|0
5557124|NCT01203098|19205461|P1|Overall Study|Lost to Follow-up|0
5557125|NCT01203098|19205459|P3|Overall Study|Adverse Event|7
5557126|NCT01203098|19205460|P2|Overall Study|Adverse Event|1
5557127|NCT01203098|19205461|P1|Overall Study|Adverse Event|3
5557128|NCT01203072|19205477|P5|Overall Study|Withdrawal by Subject|3
5557129|NCT01203072|19205478|P4|Overall Study|Withdrawal by Subject|2
5557130|NCT01203072|19205479|P3|Overall Study|Withdrawal by Subject|1
5557131|NCT01203072|19205480|P2|Overall Study|Withdrawal by Subject|2
5557132|NCT01203072|19205481|P1|Overall Study|Withdrawal by Subject|2
5557133|NCT01203072|19205477|P5|Overall Study|Protocol Violation|1
5557134|NCT01203072|19205478|P4|Overall Study|Protocol Violation|0
5557135|NCT01203072|19205479|P3|Overall Study|Protocol Violation|0
5557136|NCT01203072|19205480|P2|Overall Study|Protocol Violation|0
5557137|NCT01203072|19205481|P1|Overall Study|Protocol Violation|2
5557138|NCT01203072|19205477|P5|Overall Study|Lost to Follow-up|0
5557139|NCT01203072|19205478|P4|Overall Study|Lost to Follow-up|0
5557140|NCT01203072|19205479|P3|Overall Study|Lost to Follow-up|0
5557141|NCT01203072|19205480|P2|Overall Study|Lost to Follow-up|1
5557142|NCT01203072|19205481|P1|Overall Study|Lost to Follow-up|0
5557143|NCT01203072|19205477|P5|Overall Study|Lack of Efficacy|0
5557144|NCT01203072|19205478|P4|Overall Study|Lack of Efficacy|0
5557145|NCT01203072|19205479|P3|Overall Study|Lack of Efficacy|0
5557146|NCT01203072|19205480|P2|Overall Study|Lack of Efficacy|0
5557147|NCT01203072|19205481|P1|Overall Study|Lack of Efficacy|1
5557148|NCT01203072|19205477|P5|Overall Study|Adverse Event|2
5557149|NCT01203072|19205478|P4|Overall Study|Adverse Event|4
5557150|NCT01203072|19205479|P3|Overall Study|Adverse Event|2
5557151|NCT01203072|19205480|P2|Overall Study|Adverse Event|3
5557152|NCT01203072|19205481|P1|Overall Study|Adverse Event|5
5557153|NCT01202955|19205516|P2|Period 1: 10 Days|Withdrawal by Subject|2
5557154|NCT01202955|19205517|P1|Period 1: 10 Days|Withdrawal by Subject|0
5557155|NCT01202903|19205529|P2|Overall Study|Withdrawal by Subject|4
5557156|NCT01202903|19205530|P1|Overall Study|Withdrawal by Subject|4
5557157|NCT01202903|19205529|P2|Overall Study|Adverse Event|3
5557158|NCT01202903|19205530|P1|Overall Study|Adverse Event|3
5557159|NCT01202903|19205529|P2|Overall Study|Lack of Efficacy|3
5557160|NCT01202903|19205530|P1|Overall Study|Lack of Efficacy|1
5557161|NCT01202903|19205529|P2|Overall Study|Lost to Follow-up|1
5557162|NCT01202903|19205530|P1|Overall Study|Lost to Follow-up|1
5557163|NCT01202903|19205529|P2|Overall Study|Death|0
5557164|NCT01202903|19205530|P1|Overall Study|Death|1
5557165|NCT01202903|19205529|P2|Overall Study|Protocol Violation|1
5557166|NCT01202903|19205530|P1|Overall Study|Protocol Violation|0
5557167|NCT01202903|19205529|P2|Overall Study|Administrative Probelms|4
5557168|NCT01202903|19205530|P1|Overall Study|Administrative Probelms|1
5557169|NCT01202877|19205557|P3|Overall Study|Death|1
5557170|NCT01202877|19205558|P2|Overall Study|Death|0
5557171|NCT01202877|19205559|P1|Overall Study|Death|0
5557172|NCT01202877|19205557|P3|Overall Study|Withdrawal by Subject|1
5557173|NCT01202877|19205558|P2|Overall Study|Withdrawal by Subject|0
5557174|NCT01202877|19205559|P1|Overall Study|Withdrawal by Subject|0
5557175|NCT01202877|19205557|P3|Overall Study|Adverse Event|2
5557176|NCT01202877|19205558|P2|Overall Study|Adverse Event|0
5557177|NCT01202877|19205559|P1|Overall Study|Adverse Event|0
5557178|NCT01202877|19205557|P3|Overall Study|Disease Progression|2
5557179|NCT01202877|19205558|P2|Overall Study|Disease Progression|1
5557180|NCT01202877|19205559|P1|Overall Study|Disease Progression|0
5557181|NCT01202773|19205573|P3|Overall Study|Sponsor Decision|23
5557182|NCT01202773|19205574|P2|Overall Study|Sponsor Decision|20
5557183|NCT01202773|19205575|P1|Overall Study|Sponsor Decision|19
5557184|NCT01202773|19205573|P3|Overall Study|Protocol Violation|10
5557185|NCT01202773|19205574|P2|Overall Study|Protocol Violation|6
5557186|NCT01202773|19205575|P1|Overall Study|Protocol Violation|11
5557187|NCT01202773|19205573|P3|Overall Study|Physician Decision|0
5557188|NCT01202773|19205574|P2|Overall Study|Physician Decision|0
5557189|NCT01202773|19205575|P1|Overall Study|Physician Decision|2
5557190|NCT01202773|19205573|P3|Overall Study|Withdrawal by Subject|5
5557191|NCT01202773|19205574|P2|Overall Study|Withdrawal by Subject|6
5557192|NCT01202773|19205575|P1|Overall Study|Withdrawal by Subject|13
5557193|NCT01202773|19205573|P3|Overall Study|Lost to Follow-up|2
5557194|NCT01202773|19205574|P2|Overall Study|Lost to Follow-up|2
5557195|NCT01202773|19205575|P1|Overall Study|Lost to Follow-up|1
5557196|NCT01202773|19205573|P3|Overall Study|Entry Criteria Not Met|1
5557197|NCT01202773|19205574|P2|Overall Study|Entry Criteria Not Met|0
5557198|NCT01202773|19205575|P1|Overall Study|Entry Criteria Not Met|2
5557199|NCT01202773|19205573|P3|Overall Study|Lack of Efficacy|9
5557200|NCT01202773|19205574|P2|Overall Study|Lack of Efficacy|4
5557201|NCT01202773|19205575|P1|Overall Study|Lack of Efficacy|5
5557202|NCT01202773|19205573|P3|Overall Study|Adverse Event|5
5557203|NCT01202773|19205574|P2|Overall Study|Adverse Event|5
5557204|NCT01202773|19205575|P1|Overall Study|Adverse Event|4
5557205|NCT01202760|19205652|P3|Overall Study|Sponsor Decision|0
5557206|NCT01202760|19205653|P2|Overall Study|Sponsor Decision|4
5557207|NCT01202760|19205654|P1|Overall Study|Sponsor Decision|4
5557208|NCT01202760|19205652|P3|Overall Study|Protocol Violation|2
5557209|NCT01202760|19205653|P2|Overall Study|Protocol Violation|5
5557210|NCT01202760|19205654|P1|Overall Study|Protocol Violation|7
5557211|NCT01202760|19205652|P3|Overall Study|Physician Decision|0
5557212|NCT01202760|19205653|P2|Overall Study|Physician Decision|1
5557213|NCT01202760|19205654|P1|Overall Study|Physician Decision|0
5557214|NCT01202760|19205652|P3|Overall Study|Withdrawal by Subject|14
5557215|NCT01202760|19205653|P2|Overall Study|Withdrawal by Subject|18
5557216|NCT01202760|19205654|P1|Overall Study|Withdrawal by Subject|17
5557217|NCT01202760|19205652|P3|Overall Study|Parent / Caregiver Decision|0
5557218|NCT01202760|19205653|P2|Overall Study|Parent / Caregiver Decision|1
5557219|NCT01202760|19205654|P1|Overall Study|Parent / Caregiver Decision|0
5557220|NCT01202760|19205652|P3|Overall Study|Lost to Follow-up|1
5557221|NCT01202760|19205653|P2|Overall Study|Lost to Follow-up|2
5557222|NCT01202760|19205654|P1|Overall Study|Lost to Follow-up|0
5557223|NCT01202760|19205652|P3|Overall Study|Lack of Efficacy|7
5557224|NCT01202760|19205653|P2|Overall Study|Lack of Efficacy|8
5557225|NCT01202760|19205654|P1|Overall Study|Lack of Efficacy|6
5557226|NCT01202760|19205652|P3|Overall Study|Death|0
5557227|NCT01202760|19205653|P2|Overall Study|Death|1
5557228|NCT01202760|19205654|P1|Overall Study|Death|2
5557229|NCT01202760|19205652|P3|Overall Study|Adverse Event|10
5557230|NCT01202760|19205653|P2|Overall Study|Adverse Event|9
5557231|NCT01202760|19205654|P1|Overall Study|Adverse Event|11
5557232|NCT01202760|19205652|P3|Overall Study|Entry Criteria Not Met|1
5557233|NCT01202760|19205653|P2|Overall Study|Entry Criteria Not Met|3
5557234|NCT01202760|19205654|P1|Overall Study|Entry Criteria Not Met|0
5557235|NCT01202747|19205722|P1|Overall Study|Withdrawal by Subject|1
5557236|NCT01202591|19205775|P6|Overall Study|Objective Disease Progression|0
5557237|NCT01202591|19205776|P5|Overall Study|Objective Disease Progression|2
5557238|NCT01202591|19205777|P4|Overall Study|Objective Disease Progression|0
5557239|NCT01202591|19205778|P3|Overall Study|Objective Disease Progression|0
5557240|NCT01202591|19205779|P2|Overall Study|Objective Disease Progression|0
5557241|NCT01202591|19205780|P1|Overall Study|Objective Disease Progression|0
5557242|NCT01202591|19205775|P6|Overall Study|Withdrawal by Subject|1
5557243|NCT01202591|19205776|P5|Overall Study|Withdrawal by Subject|2
5557244|NCT01202591|19205777|P4|Overall Study|Withdrawal by Subject|0
5557245|NCT01202591|19205778|P3|Overall Study|Withdrawal by Subject|0
5557246|NCT01202591|19205779|P2|Overall Study|Withdrawal by Subject|0
5557247|NCT01202591|19205780|P1|Overall Study|Withdrawal by Subject|0
5557248|NCT01202591|19205775|P6|Overall Study|Other reason as per investigator|3
5557249|NCT01202591|19205776|P5|Overall Study|Other reason as per investigator|1
5557250|NCT01202591|19205777|P4|Overall Study|Other reason as per investigator|3
5557251|NCT01202591|19205778|P3|Overall Study|Other reason as per investigator|7
5557252|NCT01202591|19205779|P2|Overall Study|Other reason as per investigator|4
5557253|NCT01202591|19205780|P1|Overall Study|Other reason as per investigator|3
5557254|NCT01202591|19205775|P6|Overall Study|Adverse Event|0
5557255|NCT01202591|19205776|P5|Overall Study|Adverse Event|0
5557256|NCT01202591|19205777|P4|Overall Study|Adverse Event|4
5557257|NCT01202591|19205778|P3|Overall Study|Adverse Event|4
5557258|NCT01202591|19205779|P2|Overall Study|Adverse Event|1
5557259|NCT01202591|19205780|P1|Overall Study|Adverse Event|2
5557260|NCT01202409|19205824|P1|Overall Study|Ineligible - KRAS mutants|7
5557261|NCT01202409|19205824|P1|Overall Study|Adverse Event|1
5557262|NCT01202279|19205831|P2|Overall Study|study compliance|2
5557263|NCT01202279|19205832|P1|Overall Study|study compliance|5
5557264|NCT01202279|19205831|P2|Overall Study|Protocol Violation|1
5557265|NCT01202279|19205832|P1|Overall Study|Protocol Violation|1
5557266|NCT01202279|19205831|P2|Overall Study|Lost to Follow-up|7
5557267|NCT01202279|19205832|P1|Overall Study|Lost to Follow-up|10
5557268|NCT01202279|19205831|P2|Overall Study|Physician Decision|1
5557269|NCT01202279|19205832|P1|Overall Study|Physician Decision|0
5557270|NCT01202279|19205831|P2|Overall Study|Withdrawal by Subject|10
5557271|NCT01202279|19205832|P1|Overall Study|Withdrawal by Subject|13
5557272|NCT01202279|19205831|P2|Overall Study|Adverse Event|6
5557273|NCT01202279|19205832|P1|Overall Study|Adverse Event|8
5557274|NCT01202227|19205884|P1|Overall Study|Lack of Efficacy|1
5557275|NCT01202227|19205884|P1|Overall Study|Withdrawal by Subject|2
5557276|NCT01202227|19205884|P1|Overall Study|Adverse Event|16
5557277|NCT01202188|19205908|P5|Overall Study|Abnormal test procedure result (s)|0
5557278|NCT01202188|19205909|P4|Overall Study|Abnormal test procedure result (s)|0
5557279|NCT01202188|19205910|P3|Overall Study|Abnormal test procedure result (s)|2
5557280|NCT01202188|19205911|P2|Overall Study|Abnormal test procedure result (s)|0
5557281|NCT01202188|19205912|P1|Overall Study|Abnormal test procedure result (s)|0
5557282|NCT01202188|19205908|P5|Overall Study|Death|0
5557283|NCT01202188|19205909|P4|Overall Study|Death|1
5557284|NCT01202188|19205910|P3|Overall Study|Death|1
5557285|NCT01202188|19205911|P2|Overall Study|Death|1
5557286|NCT01202188|19205912|P1|Overall Study|Death|1
5557287|NCT01202188|19205908|P5|Overall Study|Lost to Follow-up|1
5557288|NCT01202188|19205909|P4|Overall Study|Lost to Follow-up|4
5557289|NCT01202188|19205910|P3|Overall Study|Lost to Follow-up|0
5557290|NCT01202188|19205911|P2|Overall Study|Lost to Follow-up|1
5557291|NCT01202188|19205912|P1|Overall Study|Lost to Follow-up|1
5557292|NCT01202188|19205908|P5|Overall Study|Unsatisfactory therapeutic effect|8
5557293|NCT01202188|19205909|P4|Overall Study|Unsatisfactory therapeutic effect|5
5557294|NCT01202188|19205910|P3|Overall Study|Unsatisfactory therapeutic effect|2
5557295|NCT01202188|19205911|P2|Overall Study|Unsatisfactory therapeutic effect|8
5557296|NCT01202188|19205912|P1|Overall Study|Unsatisfactory therapeutic effect|2
5557297|NCT01202188|19205908|P5|Overall Study|Administrative problems|2
5557298|NCT01202188|19205909|P4|Overall Study|Administrative problems|1
5557299|NCT01202188|19205910|P3|Overall Study|Administrative problems|1
5557300|NCT01202188|19205911|P2|Overall Study|Administrative problems|2
5557301|NCT01202188|19205912|P1|Overall Study|Administrative problems|3
5557302|NCT01202188|19205908|P5|Overall Study|Adverse Event|10
5557303|NCT01202188|19205909|P4|Overall Study|Adverse Event|10
5557304|NCT01202188|19205910|P3|Overall Study|Adverse Event|13
5557305|NCT01202188|19205911|P2|Overall Study|Adverse Event|23
5557306|NCT01202188|19205912|P1|Overall Study|Adverse Event|5
5557307|NCT01202188|19205908|P5|Overall Study|Subject withdrew consent|13
5557308|NCT01202188|19205909|P4|Overall Study|Subject withdrew consent|11
5557309|NCT01202188|19205910|P3|Overall Study|Subject withdrew consent|22
5557310|NCT01202188|19205911|P2|Overall Study|Subject withdrew consent|13
5557311|NCT01202188|19205912|P1|Overall Study|Subject withdrew consent|12
5557312|NCT01202188|19205908|P5|Overall Study|Protocol deviation|11
5557313|NCT01202188|19205909|P4|Overall Study|Protocol deviation|10
5557314|NCT01202188|19205910|P3|Overall Study|Protocol deviation|12
5557315|NCT01202188|19205911|P2|Overall Study|Protocol deviation|8
5557316|NCT01202188|19205912|P1|Overall Study|Protocol deviation|14
5557317|NCT01202175|19206020|P1|Overall Study|Adverse Event|2
5557318|NCT01202175|19206020|P1|Overall Study|Withdrawal by Subject|1
5557319|NCT01202175|19206020|P1|Overall Study|Lost to Follow-up|2
5557320|NCT01201967|19206088|P2|Overall Study|Lost to Follow-up|5
5557321|NCT01201967|19206089|P1|Overall Study|Lost to Follow-up|6
5557322|NCT01201915|19206114|P3|Overall Study|Target Lesion Progression|0
5557323|NCT01201915|19206115|P2|Overall Study|Target Lesion Progression|3
5557324|NCT01201915|19206116|P1|Overall Study|Target Lesion Progression|0
5557325|NCT01201915|19206114|P3|Overall Study|Subject Decision|5
5557326|NCT01201915|19206115|P2|Overall Study|Subject Decision|3
5557327|NCT01201915|19206116|P1|Overall Study|Subject Decision|3
5557328|NCT01201915|19206114|P3|Overall Study|Physician Decision|0
5557329|NCT01201915|19206115|P2|Overall Study|Physician Decision|0
5557330|NCT01201915|19206116|P1|Overall Study|Physician Decision|3
5557331|NCT01201915|19206114|P3|Overall Study|Lost to Follow-up|0
5557332|NCT01201915|19206115|P2|Overall Study|Lost to Follow-up|4
5557333|NCT01201915|19206116|P1|Overall Study|Lost to Follow-up|0
5557334|NCT01201915|19206114|P3|Overall Study|Adverse Event|1
5557335|NCT01201915|19206115|P2|Overall Study|Adverse Event|1
5557336|NCT01201915|19206116|P1|Overall Study|Adverse Event|2
5557337|NCT01201811|19206127|P1|Overall Study|Physician Decision|1
5557338|NCT01201811|19206127|P1|Overall Study|Treatment Failure|2
5557339|NCT01201811|19206127|P1|Overall Study|Death|4
5557340|NCT01201811|19206127|P1|Overall Study|Withdrawal by Subject|3
5557341|NCT01201811|19206127|P1|Overall Study|Disease progression|3
5557342|NCT01201811|19206127|P1|Overall Study|Adverse Event|6
5557343|NCT01201798|19206149|P2|Overall Study|Treatment Failure|8
5557344|NCT01201798|19206150|P1|Overall Study|Treatment Failure|1
5557345|NCT01201798|19206149|P2|Overall Study|Protocol Violation|1
5557346|NCT01201798|19206150|P1|Overall Study|Protocol Violation|1
5557347|NCT01201798|19206149|P2|Overall Study|Noncompliance|0
5557348|NCT01201798|19206150|P1|Overall Study|Noncompliance|1
5557349|NCT01201798|19206149|P2|Overall Study|Decision Unrelated to an Adverse Event|1
5557350|NCT01201798|19206150|P1|Overall Study|Decision Unrelated to an Adverse Event|1
5557351|NCT01201798|19206149|P2|Overall Study|Lost to Follow-up|5
5557352|NCT01201798|19206150|P1|Overall Study|Lost to Follow-up|3
5557353|NCT01201798|19206149|P2|Overall Study|Adverse Event|0
5557354|NCT01201798|19206150|P1|Overall Study|Adverse Event|2
5557355|NCT01201785|19206174|P1|Overall Study|Lost to Follow-up|16
5557356|NCT01201759|19206191|P2|Visit 4 Crossover|Lost to Follow-up|1
5557357|NCT01201759|19206192|P1|Visit 4 Crossover|Lost to Follow-up|0
5557358|NCT01201759|19206191|P2|Visit 3 - Washout|Lost to Follow-up|0
5557359|NCT01201759|19206192|P1|Visit 3 - Washout|Lost to Follow-up|1
5557360|NCT01201759|19206191|P2|Visit 3 - Washout|Adverse Event|3
5557361|NCT01201759|19206192|P1|Visit 3 - Washout|Adverse Event|0
5557362|NCT01201759|19206191|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
5557363|NCT01201759|19206192|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
5557364|NCT01201356|19206221|P1|Overall Study|Protocol Violation|12
5557365|NCT01201356|19206221|P1|Overall Study|Death|16
5557366|NCT01201356|19206221|P1|Overall Study|administrative problems|74
5557367|NCT01201356|19206221|P1|Overall Study|Lost to Follow-up|50
5557368|NCT01201356|19206221|P1|Overall Study|Withdrawal by Subject|144
5557369|NCT01201356|19206221|P1|Overall Study|Condition no longer requires study drug|12
5557370|NCT01201356|19206221|P1|Overall Study|Unsatisfactory therapeutic effect|112
5557371|NCT01201356|19206221|P1|Overall Study|Abnormal test procedure result(s)|3
5557372|NCT01201356|19206221|P1|Overall Study|Abnormal laboratory value(s)|51
5557373|NCT01201356|19206221|P1|Overall Study|Adverse Event|170
5557374|NCT01201343|19206235|P1|Overall Study|Randomized, not treated|3
5557375|NCT01201343|19206235|P1|Overall Study|Participant wrongly included in trial|1
5557376|NCT01201343|19206235|P1|Overall Study|Lack of Efficacy|2
5557377|NCT01201343|19206235|P1|Overall Study|Lost to Follow-up|2
5557378|NCT01201343|19206235|P1|Overall Study|Withdrawal by Subject|5
5557379|NCT01201343|19206235|P1|Overall Study|Adverse Event|6
5557380|NCT01201317|19206249|P3|Overall Study|Safety, possible history of tuberculosis|1
5557381|NCT01201317|19206250|P2|Overall Study|Safety, possible history of tuberculosis|0
5557382|NCT01201317|19206251|P1|Overall Study|Safety, possible history of tuberculosis|0
5557383|NCT01201317|19206249|P3|Overall Study|Lack of Efficacy|0
5557384|NCT01201317|19206250|P2|Overall Study|Lack of Efficacy|0
5557385|NCT01201317|19206251|P1|Overall Study|Lack of Efficacy|1
5557386|NCT01201317|19206249|P3|Overall Study|Decrease in renal function|0
5557387|NCT01201317|19206250|P2|Overall Study|Decrease in renal function|1
5557388|NCT01201317|19206251|P1|Overall Study|Decrease in renal function|0
5557389|NCT01201317|19206249|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
5557390|NCT01201317|19206250|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
5557391|NCT01201317|19206251|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
5557392|NCT01201317|19206249|P3|Overall Study|Study-specific withdrawal criteria|1
5557393|NCT01201317|19206250|P2|Overall Study|Study-specific withdrawal criteria|0
5557394|NCT01201317|19206251|P1|Overall Study|Study-specific withdrawal criteria|0
5557395|NCT01201317|19206249|P3|Overall Study|Death|0
5557396|NCT01201317|19206250|P2|Overall Study|Death|1
5557397|NCT01201317|19206251|P1|Overall Study|Death|0
5557398|NCT01201317|19206249|P3|Overall Study|Protocol Violation|1
5557399|NCT01201317|19206250|P2|Overall Study|Protocol Violation|1
5557400|NCT01201317|19206251|P1|Overall Study|Protocol Violation|0
5557401|NCT01201317|19206249|P3|Overall Study|Screen failure|0
5557402|NCT01201317|19206250|P2|Overall Study|Screen failure|1
5557403|NCT01201317|19206251|P1|Overall Study|Screen failure|1
5557404|NCT01201317|19206249|P3|Overall Study|Adverse Event|2
5557405|NCT01201317|19206250|P2|Overall Study|Adverse Event|2
5557406|NCT01201317|19206251|P1|Overall Study|Adverse Event|2
5557407|NCT01201317|19206249|P3|Overall Study|Withdrawal by Subject|3
5557408|NCT01201317|19206250|P2|Overall Study|Withdrawal by Subject|0
5557409|NCT01201317|19206251|P1|Overall Study|Withdrawal by Subject|5
5557410|NCT01201265|19206271|P1|Overall Study|Disease Progression|4
5557411|NCT01201265|19206271|P1|Overall Study|Withdrawal by Subject|7
5557412|NCT01201265|19206271|P1|Overall Study|Lost to Follow-up|10
5557413|NCT01201265|19206271|P1|Overall Study|Insufficient Therapeutic Response|3
5557414|NCT01201265|19206271|P1|Overall Study|Death|14
5557415|NCT01200992|19206318|P2|Overall Study|Randomized but not treated|0
5557416|NCT01200992|19206319|P1|Overall Study|Randomized but not treated|2
5557417|NCT01200992|19206318|P2|Overall Study|Study terminated early|41
5557418|NCT01200992|19206319|P1|Overall Study|Study terminated early|35
5557419|NCT01200810|19206350|P2|Overall Study|Sponsor stopped making study drug|3
5557420|NCT01200810|19206351|P1|Overall Study|Sponsor stopped making study drug|3
5557421|NCT01200810|19206350|P2|Overall Study|Withdrawal by Subject|2
5557422|NCT01200810|19206351|P1|Overall Study|Withdrawal by Subject|1
5557423|NCT01200810|19206350|P2|Overall Study|Physician Decision|0
5557424|NCT01200810|19206351|P1|Overall Study|Physician Decision|1
5557425|NCT01200797|19206371|P1|Overall Study|Disease Progression|13
5557426|NCT01200797|19206371|P1|Overall Study|Adverse Event|4
5557427|NCT01200797|19206371|P1|Overall Study|symptomatic deterioration|2
5557428|NCT01200758|19206381|P4|Stage 2|Death|5
5557429|NCT01200758|19206382|P3|Stage 2|Death|3
5557430|NCT01200758|19206383|P2|Stage 2|Death|0
5557431|NCT01200758|19206384|P1|Stage 2|Death|0
5557432|NCT01200758|19206381|P4|Stage 2|Protocol Violation|4
5557433|NCT01200758|19206382|P3|Stage 2|Protocol Violation|1
5557434|NCT01200758|19206383|P2|Stage 2|Protocol Violation|0
5557435|NCT01200758|19206384|P1|Stage 2|Protocol Violation|0
5557436|NCT01200758|19206381|P4|Stage 2|Lost to Follow-up|1
5557437|NCT01200758|19206382|P3|Stage 2|Lost to Follow-up|3
5557438|NCT01200758|19206383|P2|Stage 2|Lost to Follow-up|0
5557439|NCT01200758|19206384|P1|Stage 2|Lost to Follow-up|0
5557440|NCT01200758|19206381|P4|Stage 2|Withdrawal by Subject|1
5557441|NCT01200758|19206382|P3|Stage 2|Withdrawal by Subject|4
5557442|NCT01200758|19206383|P2|Stage 2|Withdrawal by Subject|0
5557443|NCT01200758|19206384|P1|Stage 2|Withdrawal by Subject|0
5557444|NCT01200758|19206381|P4|Stage 2|Adverse Event|9
5557445|NCT01200758|19206382|P3|Stage 2|Adverse Event|5
5557446|NCT01200758|19206383|P2|Stage 2|Adverse Event|0
5557447|NCT01200758|19206384|P1|Stage 2|Adverse Event|0
5557448|NCT01200758|19206381|P4|Stage 2|Physician Decision|7
5557449|NCT01200758|19206382|P3|Stage 2|Physician Decision|5
5557450|NCT01200758|19206383|P2|Stage 2|Physician Decision|0
5557451|NCT01200758|19206384|P1|Stage 2|Physician Decision|0
5557452|NCT01200758|19206381|P4|Stage 2|Lack of Efficacy|2
5557453|NCT01200758|19206382|P3|Stage 2|Lack of Efficacy|4
5557454|NCT01200758|19206383|P2|Stage 2|Lack of Efficacy|0
5557455|NCT01200758|19206384|P1|Stage 2|Lack of Efficacy|0
5557456|NCT01200758|19206381|P4|Stage 2|Disease Progression|21
5557457|NCT01200758|19206382|P3|Stage 2|Disease Progression|16
5557458|NCT01200758|19206383|P2|Stage 2|Disease Progression|0
5557459|NCT01200758|19206384|P1|Stage 2|Disease Progression|0
5557460|NCT01200758|19206381|P4|Stage I|Disease Progression|0
5557461|NCT01200758|19206382|P3|Stage I|Disease Progression|0
5557462|NCT01200758|19206383|P2|Stage I|Disease Progression|7
5557463|NCT01200758|19206384|P1|Stage I|Disease Progression|9
5557464|NCT01200758|19206381|P4|Stage I|Withdrawal by Subject|0
5557465|NCT01200758|19206382|P3|Stage I|Withdrawal by Subject|0
5557466|NCT01200758|19206383|P2|Stage I|Withdrawal by Subject|2
5557467|NCT01200758|19206384|P1|Stage I|Withdrawal by Subject|1
5557468|NCT01200758|19206381|P4|Stage I|Adverse Event|0
5557469|NCT01200758|19206382|P3|Stage I|Adverse Event|0
5557470|NCT01200758|19206383|P2|Stage I|Adverse Event|5
5557471|NCT01200758|19206384|P1|Stage I|Adverse Event|5
5557472|NCT01200758|19206381|P4|Stage I|Lack of Efficacy|0
5557473|NCT01200758|19206382|P3|Stage I|Lack of Efficacy|0
5557474|NCT01200758|19206383|P2|Stage I|Lack of Efficacy|1
5557475|NCT01200758|19206384|P1|Stage I|Lack of Efficacy|2
5557476|NCT01200758|19206381|P4|Stage I|Physician Decision|0
5557477|NCT01200758|19206382|P3|Stage I|Physician Decision|0
5557478|NCT01200758|19206383|P2|Stage I|Physician Decision|1
5557479|NCT01200758|19206384|P1|Stage I|Physician Decision|1
5557480|NCT01200758|19206381|P4|Stage I|Death|0
5557481|NCT01200758|19206382|P3|Stage I|Death|0
5557482|NCT01200758|19206383|P2|Stage I|Death|1
5557483|NCT01200758|19206384|P1|Stage I|Death|0
5557484|NCT01200589|19206457|P2|Overall Study|Study terminated|172
5557485|NCT01200589|19206458|P1|Overall Study|Study terminated|170
5557486|NCT01200589|19206457|P2|Overall Study|Lost to Follow-up|4
5557487|NCT01200589|19206458|P1|Overall Study|Lost to Follow-up|5
5557488|NCT01200589|19206457|P2|Overall Study|Physician Decision|2
5557489|NCT01200589|19206458|P1|Overall Study|Physician Decision|2
5557490|NCT01200589|19206457|P2|Overall Study|Withdrawal by Subject|11
5557491|NCT01200589|19206458|P1|Overall Study|Withdrawal by Subject|13
5557492|NCT01200524|19206485|P3|Overall Study|Non availability of study nurse|1
5557493|NCT01200524|19206486|P2|Overall Study|Non availability of study nurse|0
5557494|NCT01200524|19206487|P1|Overall Study|Non availability of study nurse|0
5557495|NCT01200524|19206485|P3|Overall Study|Adverse Event|0
5557496|NCT01200524|19206486|P2|Overall Study|Adverse Event|0
5557497|NCT01200524|19206487|P1|Overall Study|Adverse Event|1
5557498|NCT01200524|19206485|P3|Overall Study|Withdrawal by Subject|3
5557499|NCT01200524|19206486|P2|Overall Study|Withdrawal by Subject|1
5557500|NCT01200524|19206487|P1|Overall Study|Withdrawal by Subject|1
5557501|NCT01200511|19206507|P1|Overall Study|Adverse Event|1
5557502|NCT01200511|19206507|P1|Overall Study|Withdrawal by Subject|1
5557503|NCT01200511|19206507|P1|Overall Study|Lost to Follow-up|3
5557504|NCT01200485|19206519|P3|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
5557505|NCT01200485|19206520|P2|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
5557506|NCT01200485|19206521|P1|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
5557507|NCT01200485|19206519|P3|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
5557508|NCT01200485|19206520|P2|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
5557509|NCT01200485|19206521|P1|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
5557510|NCT01200394|19206555|P2|Overall Study|Other|1
5557511|NCT01200394|19206556|P1|Overall Study|Other|0
5557512|NCT01200394|19206555|P2|Overall Study|Withdrawal by Subject|5
5557513|NCT01200394|19206556|P1|Overall Study|Withdrawal by Subject|0
5557514|NCT01200394|19206555|P2|Overall Study|Protocol Violation|3
5557515|NCT01200394|19206556|P1|Overall Study|Protocol Violation|0
5557516|NCT01200394|19206555|P2|Overall Study|Did Not Meet Entrance Criteria|4
5557517|NCT01200394|19206556|P1|Overall Study|Did Not Meet Entrance Criteria|1
5557518|NCT01200394|19206555|P2|Overall Study|Lost to Follow-up|1
5557519|NCT01200394|19206556|P1|Overall Study|Lost to Follow-up|0
5557520|NCT01200394|19206555|P2|Overall Study|Death|0
5557521|NCT01200394|19206556|P1|Overall Study|Death|1
5557522|NCT01200394|19206555|P2|Overall Study|Adverse Event|14
5557523|NCT01200394|19206556|P1|Overall Study|Adverse Event|0
5557524|NCT01200368|19206594|P3|Toddler Dose|Adverse Event|1
5557525|NCT01200368|19206595|P2|Toddler Dose|Adverse Event|3
5557526|NCT01200368|19206596|P1|Toddler Dose|Adverse Event|0
5557527|NCT01200368|19206594|P3|After Infant Series|Other|2
5557528|NCT01200368|19206595|P2|After Infant Series|Other|2
5557529|NCT01200368|19206596|P1|After Infant Series|Other|1
5557530|NCT01200368|19206594|P3|After Infant Series|Lost to Follow-up|0
5557531|NCT01200368|19206595|P2|After Infant Series|Lost to Follow-up|0
5557532|NCT01200368|19206596|P1|After Infant Series|Lost to Follow-up|1
5557533|NCT01200368|19206594|P3|After Infant Series|Withdrawal by Subject|4
5557534|NCT01200368|19206595|P2|After Infant Series|Withdrawal by Subject|8
5557535|NCT01200368|19206596|P1|After Infant Series|Withdrawal by Subject|10
5557536|NCT01200368|19206594|P3|After Infant Series|Adverse Event|3
5557537|NCT01200368|19206595|P2|After Infant Series|Adverse Event|6
5557538|NCT01200368|19206596|P1|After Infant Series|Adverse Event|6
5557539|NCT01200368|19206594|P3|Infant Series|Other|0
5557540|NCT01200368|19206595|P2|Infant Series|Other|0
5557541|NCT01200368|19206596|P1|Infant Series|Other|1
5557542|NCT01200368|19206594|P3|Infant Series|Randomized, not vaccinated|1
5557543|NCT01200368|19206595|P2|Infant Series|Randomized, not vaccinated|1
5557544|NCT01200368|19206596|P1|Infant Series|Randomized, not vaccinated|0
5557545|NCT01200368|19206594|P3|Infant Series|Did not meet entrance criteria|0
5557546|NCT01200368|19206595|P2|Infant Series|Did not meet entrance criteria|1
5557547|NCT01200368|19206596|P1|Infant Series|Did not meet entrance criteria|0
5557548|NCT01200368|19206594|P3|Infant Series|Withdrawal by Subject|2
5557549|NCT01200368|19206595|P2|Infant Series|Withdrawal by Subject|2
5557550|NCT01200368|19206596|P1|Infant Series|Withdrawal by Subject|0
5557551|NCT01200368|19206594|P3|Infant Series|Adverse Event|3
5557552|NCT01200368|19206595|P2|Infant Series|Adverse Event|2
5557553|NCT01200368|19206596|P1|Infant Series|Adverse Event|2
5557554|NCT01200355|19206662|P2|Overall Study|Death|2
5557555|NCT01200355|19206663|P1|Overall Study|Death|7
5557556|NCT01200342|19206677|P1|Overall Study|Disease Progression|1
5557557|NCT01200329|19206682|P1|Overall Study|Progressive disease|1
5557558|NCT01200329|19206682|P1|Overall Study|Lack of financial coverage|2
5557559|NCT01200290|19206687|P1|Post-Treatment Follow-Up Period|Death|2
5557560|NCT01200290|19206687|P1|Treatment Period|Adverse Event|1
5557561|NCT01200238|19206700|P2|Overall Study|Withdrawal by Subject|1
5557562|NCT01200238|19206701|P1|Overall Study|Withdrawal by Subject|0
5557563|NCT01200238|19206700|P2|Overall Study|Progressive Disease|8
5557564|NCT01200238|19206701|P1|Overall Study|Progressive Disease|5
5557565|NCT01200238|19206700|P2|Overall Study|Adverse Event|1
5557566|NCT01200238|19206701|P1|Overall Study|Adverse Event|2
5557567|NCT01200069|19206725|P2|Overall Study|Withdrawal by Subject|1
5557568|NCT01200069|19206726|P1|Overall Study|Withdrawal by Subject|0
5557569|NCT01199939|19206822|P1|Overall Study|Reached a virologic endpoint|4
5557570|NCT01199939|19206822|P1|Overall Study|Lost to Follow-up|2
5557571|NCT01199939|19206822|P1|Overall Study|Protocol Violation|3
5557572|NCT01199939|19206822|P1|Overall Study|Adverse Event|4
5557573|NCT01199861|19206854|P2|Overall Study|Adverse Event|0
5557574|NCT01199861|19206855|P1|Overall Study|Adverse Event|1
5557575|NCT01199861|19206854|P2|Overall Study|Administrative problems|0
5557576|NCT01199861|19206855|P1|Overall Study|Administrative problems|1
5557577|NCT01199822|19206876|P3|Overall Study|Investigator discontinued therapy|0
5557578|NCT01199822|19206877|P2|Overall Study|Investigator discontinued therapy|1
5557579|NCT01199822|19206878|P1|Overall Study|Investigator discontinued therapy|0
5557580|NCT01199731|19206927|P3|Overall Study|Withdrawal by Subject|0
5557581|NCT01199731|19206928|P2|Overall Study|Withdrawal by Subject|0
5557582|NCT01199731|19206929|P1|Overall Study|Withdrawal by Subject|2
5557583|NCT01199731|19206927|P3|Overall Study|Physician Decision|1
5557584|NCT01199731|19206928|P2|Overall Study|Physician Decision|1
5557585|NCT01199731|19206929|P1|Overall Study|Physician Decision|0
5557586|NCT01199731|19206927|P3|Overall Study|Lost to Follow-up|2
5557587|NCT01199731|19206928|P2|Overall Study|Lost to Follow-up|0
5557588|NCT01199731|19206929|P1|Overall Study|Lost to Follow-up|0
5557589|NCT01199731|19206927|P3|Overall Study|Study closed/terminated|7
5557590|NCT01199731|19206928|P2|Overall Study|Study closed/terminated|9
5557591|NCT01199731|19206929|P1|Overall Study|Study closed/terminated|7
5557592|NCT01199731|19206927|P3|Overall Study|Adverse Event|0
5557593|NCT01199731|19206928|P2|Overall Study|Adverse Event|1
5557594|NCT01199731|19206929|P1|Overall Study|Adverse Event|0
5557595|NCT01199705|19206967|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
5557596|NCT01199601|19206999|P2|Overall Study|Insecurity prevented staff interviewing.|9
5557597|NCT01199601|19207000|P1|Overall Study|Insecurity prevented staff interviewing.|7
5557598|NCT01199601|19206999|P2|Overall Study|Withdrawal by Subject|3
5557599|NCT01199601|19207000|P1|Overall Study|Withdrawal by Subject|15
5557600|NCT01199601|19206999|P2|Overall Study|Lost to Follow-up|66
5557601|NCT01199601|19207000|P1|Overall Study|Lost to Follow-up|47
5557602|NCT01199575|19207010|P1|Overall Study|Withdrawal by Subject|5
5557603|NCT01199471|19207015|P1|Overall Study|Physician Decision|1
5557604|NCT01199471|19207015|P1|Overall Study|Withdrawal by Subject|1
5557605|NCT01199471|19207015|P1|Overall Study|Protocol Violation|4
5557606|NCT01199263|19207035|P2|Overall Study|Never Treated|0
5557607|NCT01199263|19207036|P1|Overall Study|Never Treated|6
5557608|NCT01199263|19207035|P2|Overall Study|Ineligible|2
5557609|NCT01199263|19207036|P1|Overall Study|Ineligible|0
5557610|NCT01199198|19207069|P2|Overall Study|Hospice-care transfer|2
5557611|NCT01199198|19207070|P1|Overall Study|Hospice-care transfer|1
5557612|NCT01199198|19207069|P2|Overall Study|ICU Transfer|2
5557613|NCT01199198|19207070|P1|Overall Study|ICU Transfer|1
5557614|NCT01199198|19207069|P2|Overall Study|Withdrawal by Subject|2
5557615|NCT01199198|19207070|P1|Overall Study|Withdrawal by Subject|1
5557616|NCT01199198|19207069|P2|Overall Study|Lost to Follow-up|5
5557617|NCT01199198|19207070|P1|Overall Study|Lost to Follow-up|1
5557618|NCT01199198|19207069|P2|Overall Study|Adverse Event|0
5557619|NCT01199198|19207070|P1|Overall Study|Adverse Event|3
5557620|NCT01199068|19207087|P3|Overall Study|Withdrawal by Subject|1
5557621|NCT01199068|19207088|P2|Overall Study|Withdrawal by Subject|0
5557622|NCT01199068|19207089|P1|Overall Study|Withdrawal by Subject|0
5557623|NCT01199068|19207087|P3|Overall Study|Progressive disease|6
5557624|NCT01199068|19207088|P2|Overall Study|Progressive disease|3
5557625|NCT01199068|19207089|P1|Overall Study|Progressive disease|3
5557626|NCT01199068|19207087|P3|Overall Study|Unacceptable toxicity|2
5557627|NCT01199068|19207088|P2|Overall Study|Unacceptable toxicity|0
5557628|NCT01199068|19207089|P1|Overall Study|Unacceptable toxicity|0
5557629|NCT01199055|19207123|P3|Overall Study|Withdrawal by Subject|1
5557630|NCT01199055|19207124|P2|Overall Study|Withdrawal by Subject|0
5557631|NCT01199055|19207125|P1|Overall Study|Withdrawal by Subject|0
5557632|NCT01199055|19207123|P3|Overall Study|Progressive disease|2
5557633|NCT01199055|19207124|P2|Overall Study|Progressive disease|1
5557634|NCT01199055|19207125|P1|Overall Study|Progressive disease|2
5557635|NCT01199055|19207123|P3|Overall Study|Physician Decision|1
5557636|NCT01199055|19207124|P2|Overall Study|Physician Decision|1
5557637|NCT01199055|19207125|P1|Overall Study|Physician Decision|0
5557638|NCT01199055|19207123|P3|Overall Study|Death|0
5557639|NCT01199055|19207124|P2|Overall Study|Death|1
5557640|NCT01199055|19207125|P1|Overall Study|Death|0
5557641|NCT01199042|19207150|P1|At Home (3 Months)|Lost to Follow-up|1
5557642|NCT01199042|19207150|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
5557643|NCT01199016|19207159|P1|Overall Study|Lost to Follow-up|25
5557644|NCT01199016|19207159|P1|Overall Study|Withdrawal by Subject|21
5557645|NCT01199016|19207159|P1|Overall Study|Other|13
5557646|NCT01199016|19207159|P1|Overall Study|Protocol Violation|9
5557647|NCT01199016|19207159|P1|Overall Study|Entrance criteria|5
5557648|NCT01199016|19207159|P1|Overall Study|No longer meets eligibility criteria|4
5557649|NCT01198977|19207168|P2|Overall Study|Lost to Follow-up|0
5557650|NCT01198977|19207169|P1|Overall Study|Lost to Follow-up|1
5557651|NCT01198873|19207181|P2|Overall Study|Other than above|2
5557652|NCT01198873|19207182|P1|Overall Study|Other than above|4
5557653|NCT01198873|19207181|P2|Overall Study|Study closure|23
5557654|NCT01198873|19207182|P1|Overall Study|Study closure|29
5557655|NCT01198873|19207181|P2|Overall Study|Adverse Event|7
5557656|NCT01198873|19207182|P1|Overall Study|Adverse Event|4
5557657|NCT01198795|19207196|P1|Overall Study|Other Reason|4
5557658|NCT01198795|19207196|P1|Overall Study|Protocol Violation|2
5557659|NCT01198795|19207196|P1|Overall Study|Lack of Efficacy|5
5557660|NCT01198795|19207196|P1|Overall Study|Adverse Event|9
5557661|NCT01198795|19207196|P1|Overall Study|Lost to Follow-up|15
5557662|NCT01198795|19207196|P1|Overall Study|Withdrawal by Subject|17
5557663|NCT01198795|19207196|P1|Overall Study|Did not meet InclusionExclusion criteria|30
5557664|NCT01198756|19207213|P4|Overall Study|Lost to Follow-up|18
5557665|NCT01198756|19207214|P3|Overall Study|Lost to Follow-up|23
5557666|NCT01198756|19207215|P2|Overall Study|Lost to Follow-up|36
5557667|NCT01198756|19207216|P1|Overall Study|Lost to Follow-up|29
5557668|NCT01198756|19207213|P4|Overall Study|Withdrawal by Subject|5
5557669|NCT01198756|19207214|P3|Overall Study|Withdrawal by Subject|7
5557670|NCT01198756|19207215|P2|Overall Study|Withdrawal by Subject|4
5557671|NCT01198756|19207216|P1|Overall Study|Withdrawal by Subject|9
5557672|NCT01198756|19207213|P4|Overall Study|Protocol Violation|2
5557673|NCT01198756|19207214|P3|Overall Study|Protocol Violation|0
5557674|NCT01198756|19207215|P2|Overall Study|Protocol Violation|0
5557675|NCT01198756|19207216|P1|Overall Study|Protocol Violation|0
5557676|NCT01198756|19207213|P4|Overall Study|Adverse Event|1
5557677|NCT01198756|19207214|P3|Overall Study|Adverse Event|0
5557678|NCT01198756|19207215|P2|Overall Study|Adverse Event|0
5557679|NCT01198756|19207216|P1|Overall Study|Adverse Event|0
5557680|NCT01198600|19207327|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
5557681|NCT01198600|19207328|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
5557682|NCT01198600|19207329|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
5557683|NCT01198600|19207330|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
5557684|NCT01198600|19207327|P4|Phase 2: 56 Days of Wear|Relocation|0
5557685|NCT01198600|19207328|P3|Phase 2: 56 Days of Wear|Relocation|2
5557686|NCT01198600|19207329|P2|Phase 2: 56 Days of Wear|Relocation|0
5557687|NCT01198600|19207330|P1|Phase 2: 56 Days of Wear|Relocation|0
5557688|NCT01198600|19207327|P4|Phase 2: 56 Days of Wear|Inconvenience|0
5557689|NCT01198600|19207328|P3|Phase 2: 56 Days of Wear|Inconvenience|2
5557690|NCT01198600|19207329|P2|Phase 2: 56 Days of Wear|Inconvenience|0
5557691|NCT01198600|19207330|P1|Phase 2: 56 Days of Wear|Inconvenience|0
5557692|NCT01198600|19207327|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
5557693|NCT01198600|19207328|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
5557694|NCT01198600|19207329|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
5557695|NCT01198600|19207330|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
5557696|NCT01198600|19207327|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
5557697|NCT01198600|19207328|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
5557698|NCT01198600|19207329|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
5557699|NCT01198600|19207330|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
5557700|NCT01198600|19207327|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
5557701|NCT01198600|19207328|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
5557702|NCT01198600|19207329|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
5557703|NCT01198600|19207330|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
5557704|NCT01198600|19207327|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
5557705|NCT01198600|19207328|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
5557706|NCT01198600|19207329|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
5557707|NCT01198600|19207330|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
5557708|NCT01198587|19207356|P4|Overall Study|Lost to Follow-up|0
5557709|NCT01198587|19207357|P3|Overall Study|Lost to Follow-up|9
5557710|NCT01198587|19207358|P2|Overall Study|Lost to Follow-up|0
5557711|NCT01198587|19207359|P1|Overall Study|Lost to Follow-up|8
5557712|NCT01198574|19207381|P4|Overall Study|Resigned from schools|4
5557713|NCT01198574|19207382|P3|Overall Study|Resigned from schools|1
5557714|NCT01198574|19207383|P2|Overall Study|Resigned from schools|1
5557715|NCT01198574|19207384|P1|Overall Study|Resigned from schools|4
5557716|NCT01198548|19207402|P1|Overall Study|Administrative Decision|1
5557717|NCT01198548|19207402|P1|Overall Study|Disease Progression|9
5557718|NCT01198509|19207417|P6|Overall Study|Withdrawal by Subject|0
5557719|NCT01198509|19207418|P5|Overall Study|Withdrawal by Subject|0
5557720|NCT01198509|19207419|P4|Overall Study|Withdrawal by Subject|0
5557721|NCT01198509|19207420|P3|Overall Study|Withdrawal by Subject|0
5557722|NCT01198509|19207421|P2|Overall Study|Withdrawal by Subject|0
5557723|NCT01198509|19207422|P1|Overall Study|Withdrawal by Subject|1
5557724|NCT01198470|19207439|P1|Overall Study|Adverse Event|2
5557725|NCT01198275|19207505|P2|Overall Study|spontaneous return to sinus rhythm|2
5557726|NCT01198275|19207506|P1|Overall Study|spontaneous return to sinus rhythm|4
5557727|NCT01198275|19207505|P2|Overall Study|Adverse Event|3
5557728|NCT01198275|19207506|P1|Overall Study|Adverse Event|2
5557729|NCT01198145|19207529|P2|Overall Study|Withdrawal by Subject|1
5557730|NCT01198145|19207530|P1|Overall Study|Withdrawal by Subject|1
5557731|NCT01198132|19207552|P2|Overall Study|Protocol Violation|0
5557732|NCT01198132|19207553|P1|Overall Study|Protocol Violation|1
5557733|NCT01198132|19207552|P2|Overall Study|Adverse Event|1
5557734|NCT01198132|19207553|P1|Overall Study|Adverse Event|0
5557735|NCT01198132|19207552|P2|Overall Study|Abnormal/clinically significant biologic|1
5557736|NCT01198132|19207553|P1|Overall Study|Abnormal/clinically significant biologic|1
5557737|NCT01198132|19207552|P2|Overall Study|Sign/symptoms of underlying disease|1
5557738|NCT01198132|19207553|P1|Overall Study|Sign/symptoms of underlying disease|2
5557739|NCT01198132|19207552|P2|Overall Study|Lack of Efficacy|3
5557740|NCT01198132|19207553|P1|Overall Study|Lack of Efficacy|2
5557741|NCT01198132|19207552|P2|Overall Study|Other Unspecified|6
5557742|NCT01198132|19207553|P1|Overall Study|Other Unspecified|3
5557743|NCT01198132|19207552|P2|Overall Study|Physician Decision|4
5557744|NCT01198132|19207553|P1|Overall Study|Physician Decision|5
5557745|NCT01198132|19207552|P2|Overall Study|Withdrawal by Subject|5
5557746|NCT01198132|19207553|P1|Overall Study|Withdrawal by Subject|4
5557747|NCT01198028|19207577|P1|Overall Study|Physician Decision|2
5557748|NCT01198028|19207577|P1|Overall Study|Death|3
5557749|NCT01198028|19207577|P1|Overall Study|Adverse Event|5
5557750|NCT01198002|19207589|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
5557751|NCT01198002|19207590|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
5557752|NCT01198002|19207591|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
5557753|NCT01198002|19207589|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
5557754|NCT01198002|19207590|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
5557755|NCT01198002|19207591|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
5557756|NCT01198002|19207589|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
5557757|NCT01198002|19207590|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
5557758|NCT01198002|19207591|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
5557759|NCT01198002|19207589|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
5557760|NCT01198002|19207590|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
5557761|NCT01198002|19207591|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
5557762|NCT01198002|19207589|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
5557763|NCT01198002|19207590|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
5557764|NCT01198002|19207591|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
5557765|NCT01198002|19207589|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
5557766|NCT01198002|19207590|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
5557767|NCT01198002|19207591|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
5557768|NCT01198002|19207589|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
5557769|NCT01198002|19207590|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
5557770|NCT01198002|19207591|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
5557771|NCT01198002|19207589|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
5557772|NCT01198002|19207590|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
5557773|NCT01198002|19207591|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
5557774|NCT01198002|19207589|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
5557775|NCT01198002|19207590|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
5557776|NCT01198002|19207591|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
5557777|NCT01198002|19207589|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
5557778|NCT01198002|19207590|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
5557779|NCT01198002|19207591|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
5557780|NCT01198002|19207589|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
5557781|NCT01198002|19207590|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
5557782|NCT01198002|19207591|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
5557783|NCT01198002|19207589|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
5557784|NCT01198002|19207590|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
5557785|NCT01198002|19207591|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
5557786|NCT01198002|19207589|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
5557787|NCT01198002|19207590|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
5557788|NCT01198002|19207591|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
5557789|NCT01198002|19207589|P3|Treatment Period 1 (Weeks 0-52)|Death|1
5557790|NCT01198002|19207590|P2|Treatment Period 1 (Weeks 0-52)|Death|0
5557791|NCT01198002|19207591|P1|Treatment Period 1 (Weeks 0-52)|Death|2
5557792|NCT01198002|19207589|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
5557793|NCT01198002|19207590|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
5557794|NCT01198002|19207591|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
5557795|NCT01197911|19207706|P3|Overall Study|Adverse Event|1
5557796|NCT01197911|19207707|P2|Overall Study|Adverse Event|0
5557797|NCT01197911|19207708|P1|Overall Study|Adverse Event|0
5557798|NCT01197794|19207823|P7|Overall Study|Other|4
5557799|NCT01197794|19207824|P6|Overall Study|Other|2
5557800|NCT01197794|19207825|P5|Overall Study|Other|2
5557801|NCT01197794|19207826|P4|Overall Study|Other|0
5557802|NCT01197794|19207827|P3|Overall Study|Other|3
5557803|NCT01197794|19207828|P2|Overall Study|Other|1
5557804|NCT01197794|19207829|P1|Overall Study|Other|1
5557805|NCT01197794|19207823|P7|Overall Study|Lost to Follow-up|0
5557806|NCT01197794|19207824|P6|Overall Study|Lost to Follow-up|1
5557807|NCT01197794|19207825|P5|Overall Study|Lost to Follow-up|0
5557808|NCT01197794|19207826|P4|Overall Study|Lost to Follow-up|1
5557809|NCT01197794|19207827|P3|Overall Study|Lost to Follow-up|0
5557810|NCT01197794|19207828|P2|Overall Study|Lost to Follow-up|1
5557811|NCT01197794|19207829|P1|Overall Study|Lost to Follow-up|1
5557812|NCT01197794|19207823|P7|Overall Study|Withdrawal by Subject|6
5557813|NCT01197794|19207824|P6|Overall Study|Withdrawal by Subject|5
5557814|NCT01197794|19207825|P5|Overall Study|Withdrawal by Subject|1
5557815|NCT01197794|19207826|P4|Overall Study|Withdrawal by Subject|1
5557816|NCT01197794|19207827|P3|Overall Study|Withdrawal by Subject|4
5557817|NCT01197794|19207828|P2|Overall Study|Withdrawal by Subject|3
5557818|NCT01197794|19207829|P1|Overall Study|Withdrawal by Subject|3
5557819|NCT01197794|19207823|P7|Overall Study|Eligibility criteria not fulfilled|6
5557820|NCT01197794|19207824|P6|Overall Study|Eligibility criteria not fulfilled|9
5557821|NCT01197794|19207825|P5|Overall Study|Eligibility criteria not fulfilled|5
5557822|NCT01197794|19207826|P4|Overall Study|Eligibility criteria not fulfilled|5
5557823|NCT01197794|19207827|P3|Overall Study|Eligibility criteria not fulfilled|2
5557824|NCT01197794|19207828|P2|Overall Study|Eligibility criteria not fulfilled|8
5557825|NCT01197794|19207829|P1|Overall Study|Eligibility criteria not fulfilled|5
5557826|NCT01197794|19207823|P7|Overall Study|Development of study withdrawal criteria|1
5557827|NCT01197794|19207824|P6|Overall Study|Development of study withdrawal criteria|0
5557828|NCT01197794|19207825|P5|Overall Study|Development of study withdrawal criteria|0
5557829|NCT01197794|19207826|P4|Overall Study|Development of study withdrawal criteria|1
5557830|NCT01197794|19207827|P3|Overall Study|Development of study withdrawal criteria|0
5557831|NCT01197794|19207828|P2|Overall Study|Development of study withdrawal criteria|0
5557832|NCT01197794|19207829|P1|Overall Study|Development of study withdrawal criteria|3
5557833|NCT01197794|19207823|P7|Overall Study|Protocol Violation|1
5557834|NCT01197794|19207824|P6|Overall Study|Protocol Violation|0
5557835|NCT01197794|19207825|P5|Overall Study|Protocol Violation|2
5557836|NCT01197794|19207826|P4|Overall Study|Protocol Violation|0
5557837|NCT01197794|19207827|P3|Overall Study|Protocol Violation|0
5557838|NCT01197794|19207828|P2|Overall Study|Protocol Violation|0
5557839|NCT01197794|19207829|P1|Overall Study|Protocol Violation|0
5557840|NCT01197794|19207823|P7|Overall Study|Adverse Event|3
5557841|NCT01197794|19207824|P6|Overall Study|Adverse Event|2
5557842|NCT01197794|19207825|P5|Overall Study|Adverse Event|4
5557843|NCT01197794|19207826|P4|Overall Study|Adverse Event|4
5557844|NCT01197794|19207827|P3|Overall Study|Adverse Event|4
5557845|NCT01197794|19207828|P2|Overall Study|Adverse Event|2
5557846|NCT01197794|19207829|P1|Overall Study|Adverse Event|3
5557847|NCT01197755|19207911|P3|Overall Study|eg, change in circumstances|2
5557848|NCT01197755|19207912|P2|Overall Study|eg, change in circumstances|3
5557849|NCT01197755|19207913|P1|Overall Study|eg, change in circumstances|7
5557850|NCT01197755|19207911|P3|Overall Study|Lost to Follow-up|1
5557851|NCT01197755|19207912|P2|Overall Study|Lost to Follow-up|0
5557852|NCT01197755|19207913|P1|Overall Study|Lost to Follow-up|0
5557853|NCT01197755|19207911|P3|Overall Study|Withdrawal by Subject|0
5557854|NCT01197755|19207912|P2|Overall Study|Withdrawal by Subject|0
5557855|NCT01197755|19207913|P1|Overall Study|Withdrawal by Subject|1
5557856|NCT01197755|19207911|P3|Overall Study|Severe non-compliance to the protocol|2
5557857|NCT01197755|19207912|P2|Overall Study|Severe non-compliance to the protocol|1
5557858|NCT01197755|19207913|P1|Overall Study|Severe non-compliance to the protocol|2
5557859|NCT01197755|19207911|P3|Overall Study|Lack of therapeutic response|4
5557860|NCT01197755|19207912|P2|Overall Study|Lack of therapeutic response|7
5557861|NCT01197755|19207913|P1|Overall Study|Lack of therapeutic response|0
5557862|NCT01197755|19207911|P3|Overall Study|Entered the long-term extension study|35
5557863|NCT01197755|19207912|P2|Overall Study|Entered the long-term extension study|21
5557864|NCT01197755|19207913|P1|Overall Study|Entered the long-term extension study|18
5557865|NCT01197755|19207911|P3|Overall Study|Study-specific discontinuation criteria|0
5557866|NCT01197755|19207912|P2|Overall Study|Study-specific discontinuation criteria|1
5557867|NCT01197755|19207913|P1|Overall Study|Study-specific discontinuation criteria|2
5557868|NCT01197755|19207911|P3|Overall Study|Adverse Event|10
5557869|NCT01197755|19207912|P2|Overall Study|Adverse Event|10
5557870|NCT01197755|19207913|P1|Overall Study|Adverse Event|8
5557871|NCT01197560|19207985|P2|Overall Study|Missing|1
5557872|NCT01197560|19207986|P1|Overall Study|Missing|0
5557873|NCT01197560|19207985|P2|Overall Study|Miscellaneous|3
5557874|NCT01197560|19207986|P1|Overall Study|Miscellaneous|4
5557875|NCT01197560|19207985|P2|Overall Study|Disease progression|35
5557876|NCT01197560|19207986|P1|Overall Study|Disease progression|40
5557877|NCT01197560|19207985|P2|Overall Study|Withdrawal by Subject|1
5557878|NCT01197560|19207986|P1|Overall Study|Withdrawal by Subject|1
5557879|NCT01197560|19207985|P2|Overall Study|Death|5
5557880|NCT01197560|19207986|P1|Overall Study|Death|3
5557881|NCT01197560|19207985|P2|Overall Study|Adverse Event|8
5557882|NCT01197560|19207986|P1|Overall Study|Adverse Event|6
5557883|NCT01197534|19208033|P3|Overall Study|Adverse Event|24
5557884|NCT01197534|19208034|P2|Overall Study|Adverse Event|36
5557885|NCT01197534|19208035|P1|Overall Study|Adverse Event|35
5557886|NCT01197534|19208033|P3|Overall Study|Lost to Follow-up|2
5557887|NCT01197534|19208034|P2|Overall Study|Lost to Follow-up|4
5557888|NCT01197534|19208035|P1|Overall Study|Lost to Follow-up|1
5557889|NCT01197534|19208033|P3|Overall Study|Dev. of study specific discont. criteria|2
5557890|NCT01197534|19208034|P2|Overall Study|Dev. of study specific discont. criteria|6
5557891|NCT01197534|19208035|P1|Overall Study|Dev. of study specific discont. criteria|13
5557892|NCT01197534|19208033|P3|Overall Study|Lack of therapeutic response|9
5557893|NCT01197534|19208034|P2|Overall Study|Lack of therapeutic response|4
5557894|NCT01197534|19208035|P1|Overall Study|Lack of therapeutic response|9
5557895|NCT01197534|19208033|P3|Overall Study|Severe non-compliance to protocol|1
5557896|NCT01197534|19208034|P2|Overall Study|Severe non-compliance to protocol|4
5557897|NCT01197534|19208035|P1|Overall Study|Severe non-compliance to protocol|3
5557898|NCT01197534|19208033|P3|Overall Study|Enrolment in long term extension|119
5557899|NCT01197534|19208034|P2|Overall Study|Enrolment in long term extension|66
5557900|NCT01197534|19208035|P1|Overall Study|Enrolment in long term extension|57
5557901|NCT01197534|19208033|P3|Overall Study|Not reported|16
5557902|NCT01197534|19208034|P2|Overall Study|Not reported|10
5557903|NCT01197534|19208035|P1|Overall Study|Not reported|16
5557904|NCT01197521|19208079|P3|Overall Study|Adverse Event|24
5557905|NCT01197521|19208080|P2|Overall Study|Adverse Event|28
5557906|NCT01197521|19208081|P1|Overall Study|Adverse Event|25
5557907|NCT01197521|19208079|P3|Overall Study|Lost to Follow-up|2
5557908|NCT01197521|19208080|P2|Overall Study|Lost to Follow-up|2
5557909|NCT01197521|19208081|P1|Overall Study|Lost to Follow-up|3
5557910|NCT01197521|19208079|P3|Overall Study|Dev. of study specific discont. criteria|2
5557911|NCT01197521|19208080|P2|Overall Study|Dev. of study specific discont. criteria|16
5557912|NCT01197521|19208081|P1|Overall Study|Dev. of study specific discont. criteria|6
5557913|NCT01197521|19208079|P3|Overall Study|Lack of therapeutic response|4
5557914|NCT01197521|19208080|P2|Overall Study|Lack of therapeutic response|3
5557915|NCT01197521|19208081|P1|Overall Study|Lack of therapeutic response|2
5557916|NCT01197521|19208079|P3|Overall Study|Severe non-compliance to protocol|3
5557917|NCT01197521|19208080|P2|Overall Study|Severe non-compliance to protocol|3
5557918|NCT01197521|19208081|P1|Overall Study|Severe non-compliance to protocol|1
5557919|NCT01197521|19208079|P3|Overall Study|Enrolment in long term extension|87
5557920|NCT01197521|19208080|P2|Overall Study|Enrolment in long term extension|36
5557921|NCT01197521|19208081|P1|Overall Study|Enrolment in long term extension|42
5557922|NCT01197521|19208079|P3|Overall Study|Not reported|21
5557923|NCT01197521|19208080|P2|Overall Study|Not reported|25
5557924|NCT01197521|19208081|P1|Overall Study|Not reported|24
5557925|NCT01197508|19208126|P4|Overall Study|Other|2
5557926|NCT01197508|19208127|P3|Overall Study|Other|2
5557927|NCT01197508|19208128|P2|Overall Study|Other|3
5557928|NCT01197508|19208129|P1|Overall Study|Other|2
5557929|NCT01197508|19208126|P4|Overall Study|Lost to Follow-up|0
5557930|NCT01197508|19208127|P3|Overall Study|Lost to Follow-up|2
5557931|NCT01197508|19208128|P2|Overall Study|Lost to Follow-up|1
5557932|NCT01197508|19208129|P1|Overall Study|Lost to Follow-up|1
5557933|NCT01197508|19208126|P4|Overall Study|Study-specific withdrawal criteria|2
5557934|NCT01197508|19208127|P3|Overall Study|Study-specific withdrawal criteria|1
5557935|NCT01197508|19208128|P2|Overall Study|Study-specific withdrawal criteria|0
5557936|NCT01197508|19208129|P1|Overall Study|Study-specific withdrawal criteria|0
5557937|NCT01197508|19208126|P4|Overall Study|Lack of Efficacy|1
5557938|NCT01197508|19208127|P3|Overall Study|Lack of Efficacy|2
5557939|NCT01197508|19208128|P2|Overall Study|Lack of Efficacy|2
5557940|NCT01197508|19208129|P1|Overall Study|Lack of Efficacy|1
5557941|NCT01197508|19208126|P4|Overall Study|Condition under investigation worsened|1
5557942|NCT01197508|19208127|P3|Overall Study|Condition under investigation worsened|1
5557943|NCT01197508|19208128|P2|Overall Study|Condition under investigation worsened|1
5557944|NCT01197508|19208129|P1|Overall Study|Condition under investigation worsened|1
5557945|NCT01197508|19208126|P4|Overall Study|Severe non-compliance to protocol|3
5557946|NCT01197508|19208127|P3|Overall Study|Severe non-compliance to protocol|1
5557947|NCT01197508|19208128|P2|Overall Study|Severe non-compliance to protocol|3
5557948|NCT01197508|19208129|P1|Overall Study|Severe non-compliance to protocol|0
5557949|NCT01197508|19208126|P4|Overall Study|Adverse Event|3
5557950|NCT01197508|19208127|P3|Overall Study|Adverse Event|23
5557951|NCT01197508|19208128|P2|Overall Study|Adverse Event|13
5557952|NCT01197508|19208129|P1|Overall Study|Adverse Event|10
5557953|NCT01197508|19208126|P4|Overall Study|Eligiblity criteria not fulfilled|0
5557954|NCT01197508|19208127|P3|Overall Study|Eligiblity criteria not fulfilled|2
5557955|NCT01197508|19208128|P2|Overall Study|Eligiblity criteria not fulfilled|0
5557956|NCT01197508|19208129|P1|Overall Study|Eligiblity criteria not fulfilled|0
5557957|NCT01197508|19208126|P4|Overall Study|Withdrawal by Subject|4
5557958|NCT01197508|19208127|P3|Overall Study|Withdrawal by Subject|15
5557959|NCT01197508|19208128|P2|Overall Study|Withdrawal by Subject|7
5557960|NCT01197508|19208129|P1|Overall Study|Withdrawal by Subject|8
5557961|NCT01197417|19208250|P2|Overall Study|No 25-hour magnesium level|2
5557962|NCT01197417|19208251|P1|Overall Study|No 25-hour magnesium level|0
5557963|NCT01197417|19208250|P2|Overall Study|Found to be ineligible|5
5557964|NCT01197417|19208251|P1|Overall Study|Found to be ineligible|2
5557965|NCT01197417|19208250|P2|Overall Study|Hypotension|2
5557966|NCT01197417|19208251|P1|Overall Study|Hypotension|1
5557967|NCT01197417|19208250|P2|Overall Study|Not consented in time to receive drug|1
5557968|NCT01197417|19208251|P1|Overall Study|Not consented in time to receive drug|0
5557969|NCT01197417|19208250|P2|Overall Study|Subject transferred to intensive care|1
5557970|NCT01197417|19208251|P1|Overall Study|Subject transferred to intensive care|0
5557971|NCT01197417|19208250|P2|Overall Study|Site miscommunication|1
5557972|NCT01197417|19208251|P1|Overall Study|Site miscommunication|0
5557973|NCT01197417|19208250|P2|Overall Study|Withdrawal by Subject|4
5557974|NCT01197417|19208251|P1|Overall Study|Withdrawal by Subject|2
5557975|NCT01197417|19208250|P2|Overall Study|Physician Decision|2
5557976|NCT01197417|19208251|P1|Overall Study|Physician Decision|3
5557977|NCT01197378|19208269|P1|Overall Study|Other|2
5557978|NCT01197378|19208269|P1|Overall Study|Physician Decision|1
5557979|NCT01197378|19208269|P1|Overall Study|Withdrawal by Subject|1
5557980|NCT01197378|19208269|P1|Overall Study|Adverse Event|3
5557981|NCT01197300|19208288|P2|Overall Study|Protocol Violation|1
5557982|NCT01197300|19208289|P1|Overall Study|Protocol Violation|0
5557983|NCT01197300|19208288|P2|Overall Study|Lost to Follow-up|1
5557984|NCT01197300|19208289|P1|Overall Study|Lost to Follow-up|0
5557985|NCT01196988|19208321|P4|Overall Study|Other|0
5557986|NCT01196988|19208322|P3|Overall Study|Other|0
5557987|NCT01196988|19208323|P2|Overall Study|Other|0
5557988|NCT01196988|19208324|P1|Overall Study|Other|2
5557989|NCT01196988|19208321|P4|Overall Study|Lost to Follow-up|1
5557990|NCT01196988|19208322|P3|Overall Study|Lost to Follow-up|21
5557991|NCT01196988|19208323|P2|Overall Study|Lost to Follow-up|29
5557992|NCT01196988|19208324|P1|Overall Study|Lost to Follow-up|16
5557993|NCT01196988|19208321|P4|Overall Study|Withdrawal by Subject|0
5557994|NCT01196988|19208322|P3|Overall Study|Withdrawal by Subject|4
5557995|NCT01196988|19208323|P2|Overall Study|Withdrawal by Subject|1
5557996|NCT01196988|19208324|P1|Overall Study|Withdrawal by Subject|5
5557997|NCT01196988|19208321|P4|Overall Study|Adverse Event|0
5557998|NCT01196988|19208322|P3|Overall Study|Adverse Event|0
5557999|NCT01196988|19208323|P2|Overall Study|Adverse Event|2
5558000|NCT01196988|19208324|P1|Overall Study|Adverse Event|1
5558001|NCT01196975|19208418|P5|Overall Study|Lost to Follow-up|11
5558002|NCT01196975|19208419|P4|Overall Study|Lost to Follow-up|5
5558003|NCT01196975|19208420|P3|Overall Study|Lost to Follow-up|5
5558004|NCT01196975|19208421|P2|Overall Study|Lost to Follow-up|6
5558005|NCT01196975|19208422|P1|Overall Study|Lost to Follow-up|11
5558006|NCT01196975|19208418|P5|Overall Study|Withdrawal by Subject|0
5558007|NCT01196975|19208419|P4|Overall Study|Withdrawal by Subject|1
5558008|NCT01196975|19208420|P3|Overall Study|Withdrawal by Subject|0
5558009|NCT01196975|19208421|P2|Overall Study|Withdrawal by Subject|1
5558010|NCT01196975|19208422|P1|Overall Study|Withdrawal by Subject|2
5558011|NCT01196975|19208418|P5|Overall Study|Adverse Event|2
5558012|NCT01196975|19208419|P4|Overall Study|Adverse Event|0
5558013|NCT01196975|19208420|P3|Overall Study|Adverse Event|0
5558014|NCT01196975|19208421|P2|Overall Study|Adverse Event|2
5558015|NCT01196975|19208422|P1|Overall Study|Adverse Event|2
5558016|NCT01196741|19208706|P2|Overall Study|Protocol Violation|1
5558017|NCT01196741|19208707|P1|Overall Study|Protocol Violation|2
5558018|NCT01196741|19208706|P2|Overall Study|Other|2
5558019|NCT01196741|19208707|P1|Overall Study|Other|3
5558020|NCT01196741|19208706|P2|Overall Study|Other reason|3
5558021|NCT01196741|19208707|P1|Overall Study|Other reason|3
5558022|NCT01196741|19208706|P2|Overall Study|Withdrawal by Subject|0
5558023|NCT01196741|19208707|P1|Overall Study|Withdrawal by Subject|3
5558024|NCT01196741|19208706|P2|Overall Study|Dose limiting Adverse Event|1
5558025|NCT01196741|19208707|P1|Overall Study|Dose limiting Adverse Event|2
5558026|NCT01196741|19208706|P2|Overall Study|Serious Adverse Event|1
5558027|NCT01196741|19208707|P1|Overall Study|Serious Adverse Event|3
5558028|NCT01196741|19208706|P2|Overall Study|Adverse Event|6
5558029|NCT01196741|19208707|P1|Overall Study|Adverse Event|10
5558030|NCT01196741|19208706|P2|Overall Study|Disease progression|14
5558031|NCT01196741|19208707|P1|Overall Study|Disease progression|34
5558032|NCT01196429|19208737|P2|Overall Study|Refused - Never Treated|0
5558033|NCT01196429|19208738|P1|Overall Study|Refused - Never Treated|1
5558034|NCT01196429|19208737|P2|Overall Study|Ineligible - wrong cell type|0
5558035|NCT01196429|19208738|P1|Overall Study|Ineligible - wrong cell type|1
5558036|NCT01196429|19208737|P2|Overall Study|Ineligible - inadequate pathology|0
5558037|NCT01196429|19208738|P1|Overall Study|Ineligible - inadequate pathology|1
5558038|NCT01196416|19208754|P1|Overall Study|Withdrawal by Subject|2
5558039|NCT01196104|19208812|P2|Overall Study|Various|1
5558040|NCT01196104|19208813|P1|Overall Study|Various|0
5558041|NCT01196104|19208812|P2|Overall Study|Withdrawal by Subject|3
5558042|NCT01196104|19208813|P1|Overall Study|Withdrawal by Subject|3
5558043|NCT01196104|19208812|P2|Overall Study|Physician Decision|1
5558044|NCT01196104|19208813|P1|Overall Study|Physician Decision|0
5558045|NCT01196104|19208812|P2|Overall Study|Lost to Follow-up|0
5558046|NCT01196104|19208813|P1|Overall Study|Lost to Follow-up|1
5558047|NCT01196091|19208856|P3|Overall Study|Randomized, No Study Drug Received|1
5558048|NCT01196091|19208857|P2|Overall Study|Randomized, No Study Drug Received|0
5558049|NCT01196091|19208858|P1|Overall Study|Randomized, No Study Drug Received|1
5558050|NCT01196091|19208856|P3|Overall Study|Excluded Site|8
5558051|NCT01196091|19208857|P2|Overall Study|Excluded Site|11
5558052|NCT01196091|19208858|P1|Overall Study|Excluded Site|5
5558053|NCT01196091|19208856|P3|Overall Study|Sponsor Decision|4
5558054|NCT01196091|19208857|P2|Overall Study|Sponsor Decision|5
5558055|NCT01196091|19208858|P1|Overall Study|Sponsor Decision|6
5558056|NCT01196091|19208856|P3|Overall Study|Protocol Violation|3
5558057|NCT01196091|19208857|P2|Overall Study|Protocol Violation|3
5558058|NCT01196091|19208858|P1|Overall Study|Protocol Violation|1
5558059|NCT01196091|19208856|P3|Overall Study|Physician Decision|4
5558060|NCT01196091|19208857|P2|Overall Study|Physician Decision|3
5558061|NCT01196091|19208858|P1|Overall Study|Physician Decision|3
5558062|NCT01196091|19208856|P3|Overall Study|Withdrawal by Subject|22
5558063|NCT01196091|19208857|P2|Overall Study|Withdrawal by Subject|19
5558064|NCT01196091|19208858|P1|Overall Study|Withdrawal by Subject|16
5558065|NCT01196091|19208856|P3|Overall Study|Parent/Caregiver Decision|1
5558066|NCT01196091|19208857|P2|Overall Study|Parent/Caregiver Decision|0
5558067|NCT01196091|19208858|P1|Overall Study|Parent/Caregiver Decision|0
5558068|NCT01196091|19208856|P3|Overall Study|Lost to Follow-up|6
5558069|NCT01196091|19208857|P2|Overall Study|Lost to Follow-up|5
5558070|NCT01196091|19208858|P1|Overall Study|Lost to Follow-up|5
5558071|NCT01196091|19208856|P3|Overall Study|Lack of Efficacy|17
5558072|NCT01196091|19208857|P2|Overall Study|Lack of Efficacy|12
5558073|NCT01196091|19208858|P1|Overall Study|Lack of Efficacy|15
5558074|NCT01196091|19208856|P3|Overall Study|Entry Criteria Not Met|10
5558075|NCT01196091|19208857|P2|Overall Study|Entry Criteria Not Met|11
5558076|NCT01196091|19208858|P1|Overall Study|Entry Criteria Not Met|11
5558077|NCT01196091|19208856|P3|Overall Study|Death|2
5558078|NCT01196091|19208857|P2|Overall Study|Death|2
5558079|NCT01196091|19208858|P1|Overall Study|Death|3
5558080|NCT01196091|19208856|P3|Overall Study|Adverse Event|26
5558081|NCT01196091|19208857|P2|Overall Study|Adverse Event|27
5558082|NCT01196091|19208858|P1|Overall Study|Adverse Event|22
5558083|NCT01196078|19208910|P2|Overall Study|Death|4
5558084|NCT01196078|19208911|P1|Overall Study|Death|6
5558085|NCT01196078|19208910|P2|Overall Study|Lost to Follow-up|0
5558086|NCT01196078|19208911|P1|Overall Study|Lost to Follow-up|1
5558087|NCT01196078|19208910|P2|Overall Study|Lack of Efficacy|23
5558088|NCT01196078|19208911|P1|Overall Study|Lack of Efficacy|17
5558089|NCT01196078|19208910|P2|Overall Study|Protocol Violation|1
5558090|NCT01196078|19208911|P1|Overall Study|Protocol Violation|2
5558091|NCT01196078|19208910|P2|Overall Study|Adverse Event|4
5558092|NCT01196078|19208911|P1|Overall Study|Adverse Event|4
5558093|NCT01196078|19208910|P2|Overall Study|Withdrawal by Subject|5
5558094|NCT01196078|19208911|P1|Overall Study|Withdrawal by Subject|3
5558095|NCT01196052|19208939|P1|Overall Study|Withdrawal by Subject|6
5558096|NCT01196052|19208939|P1|Overall Study|Reason not Specified|5
5558097|NCT01196052|19208939|P1|Overall Study|Noncompliance to Protocol Requirements|2
5558098|NCT01196052|19208939|P1|Overall Study|Lost to Follow-up|1
5558099|NCT01196052|19208939|P1|Overall Study|Adverse Event|9
5558100|NCT01196026|19208956|P6|Overall Study|Other|0
5558101|NCT01196026|19208957|P5|Overall Study|Other|0
5558102|NCT01196026|19208958|P4|Overall Study|Other|0
5558103|NCT01196026|19208959|P3|Overall Study|Other|0
5558104|NCT01196026|19208960|P2|Overall Study|Other|1
5558105|NCT01196026|19208961|P1|Overall Study|Other|0
5558106|NCT01196026|19208956|P6|Overall Study|Lost to Follow-up|0
5558107|NCT01196026|19208957|P5|Overall Study|Lost to Follow-up|1
5558108|NCT01196026|19208958|P4|Overall Study|Lost to Follow-up|0
5558109|NCT01196026|19208959|P3|Overall Study|Lost to Follow-up|0
5558110|NCT01196026|19208960|P2|Overall Study|Lost to Follow-up|3
5558111|NCT01196026|19208961|P1|Overall Study|Lost to Follow-up|0
5558112|NCT01196026|19208956|P6|Overall Study|Withdrawal by Subject|0
5558113|NCT01196026|19208957|P5|Overall Study|Withdrawal by Subject|0
5558114|NCT01196026|19208958|P4|Overall Study|Withdrawal by Subject|0
5558115|NCT01196026|19208959|P3|Overall Study|Withdrawal by Subject|0
5558116|NCT01196026|19208960|P2|Overall Study|Withdrawal by Subject|4
5558117|NCT01196026|19208961|P1|Overall Study|Withdrawal by Subject|1
5558118|NCT01195948|19209195|P3|Overall Study|Lost to Follow-up|2
5558119|NCT01195948|19209196|P2|Overall Study|Lost to Follow-up|1
5558120|NCT01195948|19209197|P1|Overall Study|Lost to Follow-up|0
5558121|NCT01195844|19209250|P1|Overall Study|Fecal sample not collected|40
5558122|NCT01195831|19209267|P2|Overall Study|Protocol Violation|2
5558123|NCT01195831|19209268|P1|Overall Study|Protocol Violation|0
5558124|NCT01195831|19209267|P2|Overall Study|Adverse Event|2
5558125|NCT01195831|19209268|P1|Overall Study|Adverse Event|4
5558126|NCT01195831|19209267|P2|Overall Study|Withdrawal by Subject|2
5558127|NCT01195831|19209268|P1|Overall Study|Withdrawal by Subject|2
5558128|NCT01195831|19209267|P2|Overall Study|Lost to Follow-up|4
5558129|NCT01195831|19209268|P1|Overall Study|Lost to Follow-up|2
5558130|NCT01195675|19209508|P1|Overall Study|Withdrawal by Subject|2
5558131|NCT01195675|19209508|P1|Overall Study|Adverse Event|1
5558132|NCT01195662|19209541|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
5558133|NCT01195662|19209542|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
5558134|NCT01195662|19209543|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
5558135|NCT01195662|19209541|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
5558136|NCT01195662|19209542|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
5558137|NCT01195662|19209543|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
5558138|NCT01195662|19209541|P3|Double Blind Treatment Period|Missing disposition information|1
5558139|NCT01195662|19209542|P2|Double Blind Treatment Period|Missing disposition information|1
5558140|NCT01195662|19209543|P1|Double Blind Treatment Period|Missing disposition information|0
5558141|NCT01195662|19209541|P3|Double Blind Treatment Period|Non-specified|0
5558142|NCT01195662|19209542|P2|Double Blind Treatment Period|Non-specified|0
5558143|NCT01195662|19209543|P1|Double Blind Treatment Period|Non-specified|3
5558144|NCT01195662|19209541|P3|Double Blind Treatment Period|Lack of Efficacy|0
5558145|NCT01195662|19209542|P2|Double Blind Treatment Period|Lack of Efficacy|0
5558146|NCT01195662|19209543|P1|Double Blind Treatment Period|Lack of Efficacy|2
5558147|NCT01195662|19209541|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
5558148|NCT01195662|19209542|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
5558149|NCT01195662|19209543|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
5558150|NCT01195662|19209541|P3|Double Blind Treatment Period|Requested discontinue treatment|1
5558151|NCT01195662|19209542|P2|Double Blind Treatment Period|Requested discontinue treatment|0
5558152|NCT01195662|19209543|P1|Double Blind Treatment Period|Requested discontinue treatment|1
5558153|NCT01195662|19209541|P3|Double Blind Treatment Period|Administrative reason|1
5558154|NCT01195662|19209542|P2|Double Blind Treatment Period|Administrative reason|1
5558155|NCT01195662|19209543|P1|Double Blind Treatment Period|Administrative reason|2
5558156|NCT01195662|19209541|P3|Double Blind Treatment Period|Lost to Follow-up|3
5558157|NCT01195662|19209542|P2|Double Blind Treatment Period|Lost to Follow-up|2
5558158|NCT01195662|19209543|P1|Double Blind Treatment Period|Lost to Follow-up|3
5558159|NCT01195662|19209541|P3|Double Blind Treatment Period|Withdrawal by Subject|4
5558160|NCT01195662|19209542|P2|Double Blind Treatment Period|Withdrawal by Subject|4
5558161|NCT01195662|19209543|P1|Double Blind Treatment Period|Withdrawal by Subject|6
5558162|NCT01195662|19209541|P3|Double Blind Treatment Period|Adverse Event|2
5558163|NCT01195662|19209542|P2|Double Blind Treatment Period|Adverse Event|1
5558164|NCT01195662|19209543|P1|Double Blind Treatment Period|Adverse Event|4
5558165|NCT01195636|19209573|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
5558166|NCT01195636|19209574|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
5558167|NCT01195636|19209573|P2|Second Intervention (3 Weeks)|Adverse Event|1
5558168|NCT01195636|19209574|P1|Second Intervention (3 Weeks)|Adverse Event|1
5558169|NCT01195636|19209573|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
5558170|NCT01195636|19209574|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
5558171|NCT01195636|19209573|P2|Washout Period (2 Weeks)|Adverse Event|1
5558172|NCT01195636|19209574|P1|Washout Period (2 Weeks)|Adverse Event|1
5558173|NCT01195636|19209573|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
5558174|NCT01195636|19209574|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
5558175|NCT01195636|19209573|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
5558176|NCT01195636|19209574|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
5558177|NCT01195636|19209573|P2|First Intervention (3 Weeks)|Protocol Violation|0
5558178|NCT01195636|19209574|P1|First Intervention (3 Weeks)|Protocol Violation|1
5558179|NCT01195636|19209573|P2|First Intervention (3 Weeks)|Adverse Event|3
5558180|NCT01195636|19209574|P1|First Intervention (3 Weeks)|Adverse Event|2
5558181|NCT01195623|19209600|P2|Overall Study|Lost to Follow-up|37
5558182|NCT01195623|19209601|P1|Overall Study|Lost to Follow-up|35
5558183|NCT01195545|19209630|P1|Overall Study|Protocol Violation|4
5558184|NCT01195415|19209642|P1|Overall Study|No repeat biopsy due to progression|2
5558185|NCT01195363|19209651|P2|Overall Study|incarceration|0
5558186|NCT01195363|19209652|P1|Overall Study|incarceration|1
5558187|NCT01195363|19209651|P2|Overall Study|Lack of Efficacy|4
5558188|NCT01195363|19209652|P1|Overall Study|Lack of Efficacy|0
5558189|NCT01195363|19209651|P2|Overall Study|Adverse Event|1
5558190|NCT01195363|19209652|P1|Overall Study|Adverse Event|3
5558191|NCT01195363|19209651|P2|Overall Study|Lost to Follow-up|4
5558192|NCT01195363|19209652|P1|Overall Study|Lost to Follow-up|7
5558193|NCT01195272|19209658|P1|Overall Study|Lack of Efficacy|3
5558194|NCT01195272|19209658|P1|Overall Study|Adverse Event|1
5558195|NCT01195103|19209687|P3|Overall Study|Withdrawal by Subject|0
5558196|NCT01195103|19209688|P2|Overall Study|Withdrawal by Subject|0
5558197|NCT01195103|19209689|P1|Overall Study|Withdrawal by Subject|1
5558198|NCT01195090|19209699|P2|Overall Study|Protocol Violation|4
5558199|NCT01195090|19209700|P1|Overall Study|Protocol Violation|3
5558200|NCT01195090|19209699|P2|Overall Study|Lost to Follow-up|2
5558201|NCT01195090|19209700|P1|Overall Study|Lost to Follow-up|2
5558202|NCT01195090|19209699|P2|Overall Study|Adverse Event|2
5558203|NCT01195090|19209700|P1|Overall Study|Adverse Event|1
5558204|NCT01194999|19209769|P1|Overall Study|Lost to Follow-up|17
5558205|NCT01194973|19209773|P1|26 Week Treatment Period|Pregnancy|1
5558206|NCT01194973|19209773|P1|26 Week Treatment Period|Lack of Efficacy|1
5558207|NCT01194973|19209773|P1|26 Week Treatment Period|Adverse Event|1
5558208|NCT01194973|19209773|P1|Screening Period|Screen Failure|3
5558209|NCT01194869|19209793|P1|Overall Study|Toxicity|2
5558210|NCT01194869|19209793|P1|Overall Study|Disease Progression|2
5558211|NCT01194830|19209824|P2|Overall Study|Other Reason|8
5558212|NCT01194830|19209825|P1|Overall Study|Other Reason|12
5558213|NCT01194830|19209824|P2|Overall Study|Non-compliance issues|4
5558214|NCT01194830|19209825|P1|Overall Study|Non-compliance issues|4
5558215|NCT01194830|19209824|P2|Overall Study|Lack of Efficacy|1
5558216|NCT01194830|19209825|P1|Overall Study|Lack of Efficacy|1
5558217|NCT01194830|19209824|P2|Overall Study|Withdrawal by Subject|1
5558218|NCT01194830|19209825|P1|Overall Study|Withdrawal by Subject|2
5558219|NCT01194830|19209824|P2|Overall Study|Lost to Follow-up|7
5558220|NCT01194830|19209825|P1|Overall Study|Lost to Follow-up|9
5558221|NCT01194830|19209824|P2|Overall Study|Protocol Violation|4
5558222|NCT01194830|19209825|P1|Overall Study|Protocol Violation|5
5558223|NCT01194830|19209824|P2|Overall Study|Adverse Event|2
5558224|NCT01194830|19209825|P1|Overall Study|Adverse Event|3
5558225|NCT01194804|19209847|P1|Overall Study|Withdrawal by Subject|1
5558226|NCT01194570|19209869|P2|Overall Study|Lost to Follow-up|4
5558227|NCT01194570|19209870|P1|Overall Study|Lost to Follow-up|1
5558228|NCT01194570|19209869|P2|Overall Study|Pregnancy|1
5558229|NCT01194570|19209870|P1|Overall Study|Pregnancy|1
5558230|NCT01194570|19209869|P2|Overall Study|Withdrawal by Subject|22
5558231|NCT01194570|19209870|P1|Overall Study|Withdrawal by Subject|21
5558232|NCT01194570|19209869|P2|Overall Study|Lack of Efficacy|21
5558233|NCT01194570|19209870|P1|Overall Study|Lack of Efficacy|27
5558234|NCT01194570|19209869|P2|Overall Study|Non-compliance|2
5558235|NCT01194570|19209870|P1|Overall Study|Non-compliance|2
5558236|NCT01194570|19209869|P2|Overall Study|Adverse Event|18
5558237|NCT01194570|19209870|P1|Overall Study|Adverse Event|12
5558238|NCT01194570|19209869|P2|Overall Study|Non-compliance with study drug|2
5558239|NCT01194570|19209870|P1|Overall Study|Non-compliance with study drug|2
5558240|NCT01194570|19209869|P2|Overall Study|Protocol Violation|2
5558241|NCT01194570|19209870|P1|Overall Study|Protocol Violation|0
5558242|NCT01194570|19209869|P2|Overall Study|Reason not specified|20
5558243|NCT01194570|19209870|P1|Overall Study|Reason not specified|13
5558244|NCT01194570|19209869|P2|Overall Study|Physician Decision|6
5558245|NCT01194570|19209870|P1|Overall Study|Physician Decision|2
5558246|NCT01194570|19209869|P2|Overall Study|Ongoing at CCOD|387
5558247|NCT01194570|19209870|P1|Overall Study|Ongoing at CCOD|162
5558248|NCT01194570|19209869|P2|Overall Study|Death|3
5558249|NCT01194570|19209870|P1|Overall Study|Death|1
5558250|NCT01194531|19209890|P2|Overall Study|Physician Decision|2
5558251|NCT01194531|19209891|P1|Overall Study|Physician Decision|0
5558252|NCT01194531|19209890|P2|Overall Study|Protocol Violation|1
5558253|NCT01194531|19209891|P1|Overall Study|Protocol Violation|4
5558254|NCT01194531|19209890|P2|Overall Study|Withdrawal by Subject|0
5558255|NCT01194531|19209891|P1|Overall Study|Withdrawal by Subject|1
5558256|NCT01194440|19209945|P1|6-months (2nd Dose)|Change in therapy|4
5558257|NCT01194440|19209945|P1|Baseline (First Dose)|Adverse Event|1
5558258|NCT01194440|19209945|P1|Baseline (First Dose)|Change in therapy|1
5558259|NCT01194440|19209945|P1|Baseline (First Dose)|Lack of Efficacy|1
5558260|NCT01194440|19209945|P1|Baseline (First Dose)|Reason not specified|4
5558261|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Death|2
5558262|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Death|0
5558263|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Death|2
5558264|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Death|1
5558265|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
5558266|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
5558267|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
5558268|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
5558269|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Adverse Event|12
5558270|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Adverse Event|2
5558271|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Adverse Event|21
5558272|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Adverse Event|35
5558273|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Protocol Violation|1
5558274|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Protocol Violation|0
5558275|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Protocol Violation|0
5558276|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Protocol Violation|0
5558277|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Other|0
5558278|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Other|0
5558279|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Other|1
5558280|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Other|2
5558281|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Pregnancy|1
5558282|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Pregnancy|1
5558283|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Pregnancy|3
5558284|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Pregnancy|1
5558285|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
5558286|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
5558287|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
5558288|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
5558289|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
5558290|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
5558291|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
5558292|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
5558293|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
5558294|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
5558295|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
5558296|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
5558297|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
5558298|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
5558299|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
5558300|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
5558301|NCT01194414|19209958|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
5558302|NCT01194414|19209959|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
5558303|NCT01194414|19209960|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
5558304|NCT01194414|19209961|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
5558305|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Death|0
5558306|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Death|0
5558307|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Death|1
5558308|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Death|0
5558309|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
5558310|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
5558311|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
5558312|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
5558313|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Adverse Event|0
5558314|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Adverse Event|0
5558315|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Adverse Event|40
5558316|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Adverse Event|28
5558317|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Other|0
5558318|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Other|0
5558319|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Other|1
5558320|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Other|0
5558321|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
5558322|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
5558323|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
5558324|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
5558325|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Pregnancy|0
5558326|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Pregnancy|0
5558327|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Pregnancy|2
5558328|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Pregnancy|2
5558329|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
5558330|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
5558331|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
5558332|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
5558333|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Protocol Violation|0
5558334|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Protocol Violation|0
5558335|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Protocol Violation|3
5558336|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Protocol Violation|5
5558337|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
5558338|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
5558339|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
5558340|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
5558341|NCT01194414|19209958|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
5558342|NCT01194414|19209959|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
5558343|NCT01194414|19209960|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
5558344|NCT01194414|19209961|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
5558345|NCT01194271|19210032|P1|Overall Study|Death|1
5558346|NCT01194271|19210032|P1|Overall Study|Ineligible, Screen Failure|1
5558347|NCT01194271|19210032|P1|Overall Study|Withdrawal by Subject|1
5558348|NCT01194258|19210036|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
5558349|NCT01194258|19210037|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
5558350|NCT01194258|19210038|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
5558351|NCT01194258|19210039|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
5558352|NCT01194258|19210040|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
5558353|NCT01194258|19210036|P5|Period 2 (12 Weeks)|Adverse Event|0
5558354|NCT01194258|19210037|P4|Period 2 (12 Weeks)|Adverse Event|0
5558355|NCT01194258|19210038|P3|Period 2 (12 Weeks)|Adverse Event|0
5558356|NCT01194258|19210039|P2|Period 2 (12 Weeks)|Adverse Event|1
5558357|NCT01194258|19210040|P1|Period 2 (12 Weeks)|Adverse Event|0
5558358|NCT01194258|19210036|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
5558359|NCT01194258|19210037|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
5558360|NCT01194258|19210038|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
5558361|NCT01194258|19210039|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
5558362|NCT01194258|19210040|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
5558363|NCT01194258|19210036|P5|Period 1 (12 Weeks)|Death|1
5558364|NCT01194258|19210037|P4|Period 1 (12 Weeks)|Death|0
5558365|NCT01194258|19210038|P3|Period 1 (12 Weeks)|Death|0
5558366|NCT01194258|19210039|P2|Period 1 (12 Weeks)|Death|0
5558367|NCT01194258|19210040|P1|Period 1 (12 Weeks)|Death|0
5558368|NCT01194258|19210036|P5|Titration Period|Titration failure|0
5558369|NCT01194258|19210037|P4|Titration Period|Titration failure|0
5558370|NCT01194258|19210038|P3|Titration Period|Titration failure|0
5558371|NCT01194258|19210039|P2|Titration Period|Titration failure|0
5558372|NCT01194258|19210040|P1|Titration Period|Titration failure|3
5558373|NCT01194258|19210036|P5|Titration Period|Lost to Follow-up|0
5558374|NCT01194258|19210037|P4|Titration Period|Lost to Follow-up|0
5558375|NCT01194258|19210038|P3|Titration Period|Lost to Follow-up|0
5558376|NCT01194258|19210039|P2|Titration Period|Lost to Follow-up|0
5558377|NCT01194258|19210040|P1|Titration Period|Lost to Follow-up|2
5558378|NCT01194258|19210036|P5|Titration Period|Withdrawal by Subject|0
5558379|NCT01194258|19210037|P4|Titration Period|Withdrawal by Subject|0
5558380|NCT01194258|19210038|P3|Titration Period|Withdrawal by Subject|0
5558381|NCT01194258|19210039|P2|Titration Period|Withdrawal by Subject|0
5558382|NCT01194258|19210040|P1|Titration Period|Withdrawal by Subject|6
5558383|NCT01194245|19210064|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
5558384|NCT01194245|19210065|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
5558385|NCT01194245|19210066|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
5558386|NCT01194245|19210067|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
5558387|NCT01194245|19210068|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
5558388|NCT01194245|19210064|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
5558389|NCT01194245|19210065|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5558390|NCT01194245|19210066|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5558391|NCT01194245|19210067|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5558392|NCT01194245|19210068|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
5558393|NCT01194245|19210064|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5558394|NCT01194245|19210065|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5558395|NCT01194245|19210066|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5558396|NCT01194245|19210067|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
5558397|NCT01194245|19210068|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
5558398|NCT01194245|19210064|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
5558399|NCT01194245|19210065|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
5558400|NCT01194245|19210066|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
5558401|NCT01194245|19210067|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
5558402|NCT01194245|19210068|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
5558403|NCT01194245|19210064|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
5558404|NCT01194245|19210065|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
5558405|NCT01194245|19210066|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
5558406|NCT01194245|19210067|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
5558407|NCT01194245|19210068|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
5558408|NCT01194245|19210064|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5558409|NCT01194245|19210065|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5558410|NCT01194245|19210066|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5558411|NCT01194245|19210067|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
5558412|NCT01194245|19210068|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
5558413|NCT01194219|19210089|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
5558414|NCT01194219|19210090|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
5558415|NCT01194219|19210091|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5558416|NCT01194219|19210092|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5558417|NCT01194219|19210093|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5558418|NCT01194219|19210094|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5558419|NCT01194219|19210095|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5558420|NCT01194219|19210096|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5558421|NCT01194219|19210097|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5558422|NCT01194219|19210098|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
5558423|NCT01194219|19210089|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5558424|NCT01194219|19210090|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
5558425|NCT01194219|19210091|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5558426|NCT01194219|19210092|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5558427|NCT01194219|19210093|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5558428|NCT01194219|19210094|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5558429|NCT01194219|19210095|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5558430|NCT01194219|19210096|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5558431|NCT01194219|19210097|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5558432|NCT01194219|19210098|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
5558433|NCT01194219|19210089|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
5558434|NCT01194219|19210090|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
5558435|NCT01194219|19210091|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5558436|NCT01194219|19210092|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5558437|NCT01194219|19210093|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5558438|NCT01194219|19210094|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5558439|NCT01194219|19210095|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5558440|NCT01194219|19210096|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5558441|NCT01194219|19210097|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5558442|NCT01194219|19210098|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
5558443|NCT01194219|19210089|P10|Long-Term Extension Weeks 52 to 260|Death|1
5558444|NCT01194219|19210090|P9|Long-Term Extension Weeks 52 to 260|Death|1
5558445|NCT01194219|19210091|P8|Long-Term Extension Weeks 52 to 260|Death|0
5558446|NCT01194219|19210092|P7|Long-Term Extension Weeks 52 to 260|Death|0
5558447|NCT01194219|19210093|P6|Long-Term Extension Weeks 52 to 260|Death|0
5558448|NCT01194219|19210094|P5|Long-Term Extension Weeks 52 to 260|Death|0
5558449|NCT01194219|19210095|P4|Long-Term Extension Weeks 52 to 260|Death|0
5558450|NCT01194219|19210096|P3|Long-Term Extension Weeks 52 to 260|Death|0
5558451|NCT01194219|19210097|P2|Long-Term Extension Weeks 52 to 260|Death|0
5558452|NCT01194219|19210098|P1|Long-Term Extension Weeks 52 to 260|Death|0
5558453|NCT01194219|19210089|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
5558454|NCT01194219|19210090|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
5558455|NCT01194219|19210091|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5558456|NCT01194219|19210092|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5558457|NCT01194219|19210093|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5558458|NCT01194219|19210094|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5558459|NCT01194219|19210095|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5558460|NCT01194219|19210096|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5558461|NCT01194219|19210097|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5558462|NCT01194219|19210098|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
5558463|NCT01194219|19210089|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
5558464|NCT01194219|19210090|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
5558465|NCT01194219|19210091|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5558466|NCT01194219|19210092|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5558467|NCT01194219|19210093|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5558468|NCT01194219|19210094|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5558469|NCT01194219|19210095|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5558470|NCT01194219|19210096|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5558471|NCT01194219|19210097|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5558472|NCT01194219|19210098|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
5558473|NCT01194219|19210089|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
5558474|NCT01194219|19210090|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
5558475|NCT01194219|19210091|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5558476|NCT01194219|19210092|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5558477|NCT01194219|19210093|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5558478|NCT01194219|19210094|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5558479|NCT01194219|19210095|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5558480|NCT01194219|19210096|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5558481|NCT01194219|19210097|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5558482|NCT01194219|19210098|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
5558483|NCT01194219|19210089|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
5558484|NCT01194219|19210090|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
5558485|NCT01194219|19210091|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5558486|NCT01194219|19210092|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5558487|NCT01194219|19210093|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5558488|NCT01194219|19210094|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5558489|NCT01194219|19210095|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5558490|NCT01194219|19210096|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5558491|NCT01194219|19210097|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5558492|NCT01194219|19210098|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
5558493|NCT01194219|19210089|P10|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5558494|NCT01194219|19210090|P9|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5558495|NCT01194219|19210091|P8|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5558496|NCT01194219|19210092|P7|Randomized Withdrawal Phase-Weeks 32-52|Other|1
5558497|NCT01194219|19210093|P6|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5558498|NCT01194219|19210094|P5|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5558499|NCT01194219|19210095|P4|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5558500|NCT01194219|19210096|P3|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5558501|NCT01194219|19210097|P2|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5558502|NCT01194219|19210098|P1|Randomized Withdrawal Phase-Weeks 32-52|Other|0
5558503|NCT01194219|19210089|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5558504|NCT01194219|19210090|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5558505|NCT01194219|19210091|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
5558506|NCT01194219|19210092|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5558507|NCT01194219|19210093|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5558508|NCT01194219|19210094|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5558509|NCT01194219|19210095|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5558510|NCT01194219|19210096|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5558511|NCT01194219|19210097|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5558512|NCT01194219|19210098|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
5558513|NCT01194219|19210089|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5558514|NCT01194219|19210090|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5558515|NCT01194219|19210091|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5558516|NCT01194219|19210092|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
5558517|NCT01194219|19210093|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
5558518|NCT01194219|19210094|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
5558519|NCT01194219|19210095|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5558520|NCT01194219|19210096|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5558521|NCT01194219|19210097|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5558522|NCT01194219|19210098|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
5558523|NCT01194219|19210089|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5558524|NCT01194219|19210090|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5558525|NCT01194219|19210091|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
5558526|NCT01194219|19210092|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
5558527|NCT01194219|19210093|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5558528|NCT01194219|19210094|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
5558529|NCT01194219|19210095|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5558530|NCT01194219|19210096|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5558531|NCT01194219|19210097|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5558532|NCT01194219|19210098|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
5558533|NCT01194219|19210089|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5558534|NCT01194219|19210090|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5558535|NCT01194219|19210091|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5558536|NCT01194219|19210092|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
5558537|NCT01194219|19210093|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5558538|NCT01194219|19210094|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
5558539|NCT01194219|19210095|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5558540|NCT01194219|19210096|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5558541|NCT01194219|19210097|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5558542|NCT01194219|19210098|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
5558543|NCT01194219|19210089|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5558544|NCT01194219|19210090|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5558545|NCT01194219|19210091|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
5558546|NCT01194219|19210092|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
5558547|NCT01194219|19210093|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
5558548|NCT01194219|19210094|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
5558549|NCT01194219|19210095|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5558550|NCT01194219|19210096|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5558551|NCT01194219|19210097|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5558552|NCT01194219|19210098|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
5558553|NCT01194219|19210089|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5558554|NCT01194219|19210090|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5558555|NCT01194219|19210091|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
5558556|NCT01194219|19210092|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
5558557|NCT01194219|19210093|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
5558558|NCT01194219|19210094|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5558559|NCT01194219|19210095|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5558560|NCT01194219|19210096|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5558561|NCT01194219|19210097|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5558562|NCT01194219|19210098|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
5558563|NCT01194219|19210089|P10|Maintenance Phase Weeks16-32|Other|0
5558564|NCT01194219|19210090|P9|Maintenance Phase Weeks16-32|Other|0
5558565|NCT01194219|19210091|P8|Maintenance Phase Weeks16-32|Other|0
5558566|NCT01194219|19210092|P7|Maintenance Phase Weeks16-32|Other|0
5558567|NCT01194219|19210093|P6|Maintenance Phase Weeks16-32|Other|0
5558568|NCT01194219|19210094|P5|Maintenance Phase Weeks16-32|Other|0
5558569|NCT01194219|19210095|P4|Maintenance Phase Weeks16-32|Other|1
5558570|NCT01194219|19210096|P3|Maintenance Phase Weeks16-32|Other|2
5558571|NCT01194219|19210097|P2|Maintenance Phase Weeks16-32|Other|0
5558572|NCT01194219|19210098|P1|Maintenance Phase Weeks16-32|Other|0
5558573|NCT01194219|19210089|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
5558574|NCT01194219|19210090|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
5558575|NCT01194219|19210091|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
5558576|NCT01194219|19210092|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
5558577|NCT01194219|19210093|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
5558578|NCT01194219|19210094|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
5558579|NCT01194219|19210095|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
5558580|NCT01194219|19210096|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
5558581|NCT01194219|19210097|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
5558582|NCT01194219|19210098|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
5558583|NCT01194219|19210089|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5558584|NCT01194219|19210090|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5558585|NCT01194219|19210091|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5558586|NCT01194219|19210092|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5558587|NCT01194219|19210093|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5558588|NCT01194219|19210094|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5558589|NCT01194219|19210095|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5558590|NCT01194219|19210096|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
5558591|NCT01194219|19210097|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5558592|NCT01194219|19210098|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
5558593|NCT01194219|19210089|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5558594|NCT01194219|19210090|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5558595|NCT01194219|19210091|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5558596|NCT01194219|19210092|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5558597|NCT01194219|19210093|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5558598|NCT01194219|19210094|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5558599|NCT01194219|19210095|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
5558600|NCT01194219|19210096|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
5558601|NCT01194219|19210097|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5558602|NCT01194219|19210098|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
5558603|NCT01194219|19210089|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5558604|NCT01194219|19210090|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5558605|NCT01194219|19210091|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5558606|NCT01194219|19210092|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5558607|NCT01194219|19210093|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5558608|NCT01194219|19210094|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5558609|NCT01194219|19210095|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
5558610|NCT01194219|19210096|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
5558611|NCT01194219|19210097|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5558612|NCT01194219|19210098|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
5558613|NCT01194219|19210089|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5558614|NCT01194219|19210090|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5558615|NCT01194219|19210091|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5558616|NCT01194219|19210092|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5558617|NCT01194219|19210093|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5558618|NCT01194219|19210094|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5558619|NCT01194219|19210095|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
5558620|NCT01194219|19210096|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
5558621|NCT01194219|19210097|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5558622|NCT01194219|19210098|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
5558623|NCT01194219|19210089|P10|Maintenance Phase Weeks16-32|Adverse Event|0
5558624|NCT01194219|19210090|P9|Maintenance Phase Weeks16-32|Adverse Event|0
5558625|NCT01194219|19210091|P8|Maintenance Phase Weeks16-32|Adverse Event|0
5558626|NCT01194219|19210092|P7|Maintenance Phase Weeks16-32|Adverse Event|0
5558627|NCT01194219|19210093|P6|Maintenance Phase Weeks16-32|Adverse Event|0
5558628|NCT01194219|19210094|P5|Maintenance Phase Weeks16-32|Adverse Event|0
5558629|NCT01194219|19210095|P4|Maintenance Phase Weeks16-32|Adverse Event|9
5558630|NCT01194219|19210096|P3|Maintenance Phase Weeks16-32|Adverse Event|8
5558631|NCT01194219|19210097|P2|Maintenance Phase Weeks16-32|Adverse Event|0
5558632|NCT01194219|19210098|P1|Maintenance Phase Weeks16-32|Adverse Event|0
5558633|NCT01194219|19210089|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5558634|NCT01194219|19210090|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5558635|NCT01194219|19210091|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5558636|NCT01194219|19210092|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5558637|NCT01194219|19210093|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5558638|NCT01194219|19210094|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5558639|NCT01194219|19210095|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5558640|NCT01194219|19210096|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
5558641|NCT01194219|19210097|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
5558642|NCT01194219|19210098|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
5558643|NCT01194219|19210089|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5558644|NCT01194219|19210090|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5558645|NCT01194219|19210091|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5558646|NCT01194219|19210092|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5558647|NCT01194219|19210093|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5558648|NCT01194219|19210094|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5558649|NCT01194219|19210095|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5558650|NCT01194219|19210096|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
5558651|NCT01194219|19210097|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
5558652|NCT01194219|19210098|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
5558653|NCT01194219|19210089|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5558654|NCT01194219|19210090|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5558655|NCT01194219|19210091|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5558656|NCT01194219|19210092|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5558657|NCT01194219|19210093|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5558658|NCT01194219|19210094|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5558659|NCT01194219|19210095|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5558660|NCT01194219|19210096|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
5558661|NCT01194219|19210097|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
5558662|NCT01194219|19210098|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
5558663|NCT01194219|19210089|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
5558664|NCT01194219|19210090|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
5558665|NCT01194219|19210091|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
5558666|NCT01194219|19210092|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
5558667|NCT01194219|19210093|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
5558668|NCT01194219|19210094|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
5558669|NCT01194219|19210095|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
5558670|NCT01194219|19210096|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
5558671|NCT01194219|19210097|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
5558672|NCT01194219|19210098|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
5558673|NCT01194219|19210089|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5558674|NCT01194219|19210090|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5558675|NCT01194219|19210091|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5558676|NCT01194219|19210092|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5558677|NCT01194219|19210093|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5558678|NCT01194219|19210094|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5558679|NCT01194219|19210095|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5558680|NCT01194219|19210096|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
5558681|NCT01194219|19210097|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
5558682|NCT01194219|19210098|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
5558683|NCT01194219|19210089|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5558684|NCT01194219|19210090|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5558685|NCT01194219|19210091|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5558686|NCT01194219|19210092|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5558687|NCT01194219|19210093|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5558688|NCT01194219|19210094|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5558689|NCT01194219|19210095|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5558690|NCT01194219|19210096|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5558691|NCT01194219|19210097|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
5558692|NCT01194219|19210098|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
5558693|NCT01194219|19210089|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5558694|NCT01194219|19210090|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5558695|NCT01194219|19210091|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5558696|NCT01194219|19210092|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5558697|NCT01194219|19210093|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5558698|NCT01194219|19210094|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5558699|NCT01194219|19210095|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5558700|NCT01194219|19210096|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
5558701|NCT01194219|19210097|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
5558702|NCT01194219|19210098|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
5558703|NCT01194219|19210089|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5558704|NCT01194219|19210090|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5558705|NCT01194219|19210091|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5558706|NCT01194219|19210092|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5558707|NCT01194219|19210093|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5558708|NCT01194219|19210094|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5558709|NCT01194219|19210095|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5558710|NCT01194219|19210096|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
5558711|NCT01194219|19210097|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
5558712|NCT01194219|19210098|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
5558713|NCT01194154|19210132|P2|Overall Study|Did not receive study medication|4
5558714|NCT01194154|19210133|P1|Overall Study|Did not receive study medication|2
5558715|NCT01194154|19210132|P2|Overall Study|Other|0
5558716|NCT01194154|19210133|P1|Overall Study|Other|4
5558717|NCT01194154|19210132|P2|Overall Study|Treatment with prohibited medication|5
5558718|NCT01194154|19210133|P1|Overall Study|Treatment with prohibited medication|4
5558719|NCT01194154|19210132|P2|Overall Study|Skipping of CERA treatment at two visits|0
5558720|NCT01194154|19210133|P1|Overall Study|Skipping of CERA treatment at two visits|3
5558721|NCT01194154|19210132|P2|Overall Study|Hemoglobin increase|3
5558722|NCT01194154|19210133|P1|Overall Study|Hemoglobin increase|12
5558723|NCT01194154|19210132|P2|Overall Study|Hemoglobin decrease|1
5558724|NCT01194154|19210133|P1|Overall Study|Hemoglobin decrease|0
5558725|NCT01194154|19210132|P2|Overall Study|Blood pressure increase|3
5558726|NCT01194154|19210133|P1|Overall Study|Blood pressure increase|5
5558727|NCT01194154|19210132|P2|Overall Study|Withdrawal by Subject|6
5558728|NCT01194154|19210133|P1|Overall Study|Withdrawal by Subject|5
5558729|NCT01194154|19210132|P2|Overall Study|Protocol Violation|1
5558730|NCT01194154|19210133|P1|Overall Study|Protocol Violation|0
5558731|NCT01194154|19210132|P2|Overall Study|Lost to Follow-up|3
5558732|NCT01194154|19210133|P1|Overall Study|Lost to Follow-up|2
5558733|NCT01194154|19210132|P2|Overall Study|Adverse Event|7
5558734|NCT01194154|19210133|P1|Overall Study|Adverse Event|12
5558735|NCT01193920|19210174|P10|Overall Study|Unable to classify|0
5558736|NCT01193920|19210175|P9|Overall Study|Unable to classify|0
5558737|NCT01193920|19210176|P8|Overall Study|Unable to classify|1
5558738|NCT01193920|19210177|P7|Overall Study|Unable to classify|0
5558739|NCT01193920|19210178|P6|Overall Study|Unable to classify|0
5558740|NCT01193920|19210179|P5|Overall Study|Unable to classify|0
5558741|NCT01193920|19210180|P4|Overall Study|Unable to classify|1
5558742|NCT01193920|19210181|P3|Overall Study|Unable to classify|0
5558743|NCT01193920|19210182|P2|Overall Study|Unable to classify|0
5558744|NCT01193920|19210183|P1|Overall Study|Unable to classify|0
5558745|NCT01193920|19210174|P10|Overall Study|Death|4
5558746|NCT01193920|19210175|P9|Overall Study|Death|2
5558747|NCT01193920|19210176|P8|Overall Study|Death|3
5558748|NCT01193920|19210177|P7|Overall Study|Death|2
5558749|NCT01193920|19210178|P6|Overall Study|Death|0
5558750|NCT01193920|19210179|P5|Overall Study|Death|0
5558751|NCT01193920|19210180|P4|Overall Study|Death|1
5558752|NCT01193920|19210181|P3|Overall Study|Death|0
5558753|NCT01193920|19210182|P2|Overall Study|Death|0
5558754|NCT01193920|19210183|P1|Overall Study|Death|0
5558755|NCT01193920|19210174|P10|Overall Study|Protocol Violation|0
5558756|NCT01193920|19210175|P9|Overall Study|Protocol Violation|0
5558757|NCT01193920|19210176|P8|Overall Study|Protocol Violation|0
5558758|NCT01193920|19210177|P7|Overall Study|Protocol Violation|0
5558759|NCT01193920|19210178|P6|Overall Study|Protocol Violation|0
5558760|NCT01193920|19210179|P5|Overall Study|Protocol Violation|0
5558761|NCT01193920|19210180|P4|Overall Study|Protocol Violation|0
5558762|NCT01193920|19210181|P3|Overall Study|Protocol Violation|0
5558763|NCT01193920|19210182|P2|Overall Study|Protocol Violation|0
5558764|NCT01193920|19210183|P1|Overall Study|Protocol Violation|1
5558765|NCT01193920|19210174|P10|Overall Study|Lost to Follow-up|3
5558766|NCT01193920|19210175|P9|Overall Study|Lost to Follow-up|2
5558767|NCT01193920|19210176|P8|Overall Study|Lost to Follow-up|0
5558768|NCT01193920|19210177|P7|Overall Study|Lost to Follow-up|1
5558769|NCT01193920|19210178|P6|Overall Study|Lost to Follow-up|3
5558770|NCT01193920|19210179|P5|Overall Study|Lost to Follow-up|3
5558771|NCT01193920|19210180|P4|Overall Study|Lost to Follow-up|1
5558772|NCT01193920|19210181|P3|Overall Study|Lost to Follow-up|1
5558773|NCT01193920|19210182|P2|Overall Study|Lost to Follow-up|0
5558774|NCT01193920|19210183|P1|Overall Study|Lost to Follow-up|1
5558775|NCT01193920|19210174|P10|Overall Study|Withdrawal by Subject|0
5558776|NCT01193920|19210175|P9|Overall Study|Withdrawal by Subject|1
5558777|NCT01193920|19210176|P8|Overall Study|Withdrawal by Subject|0
5558778|NCT01193920|19210177|P7|Overall Study|Withdrawal by Subject|3
5558779|NCT01193920|19210178|P6|Overall Study|Withdrawal by Subject|1
5558780|NCT01193920|19210179|P5|Overall Study|Withdrawal by Subject|3
5558781|NCT01193920|19210180|P4|Overall Study|Withdrawal by Subject|1
5558782|NCT01193920|19210181|P3|Overall Study|Withdrawal by Subject|5
5558783|NCT01193920|19210182|P2|Overall Study|Withdrawal by Subject|0
5558784|NCT01193920|19210183|P1|Overall Study|Withdrawal by Subject|1
5558785|NCT01193842|19210279|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
5558786|NCT01193842|19210280|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
5558787|NCT01193842|19210281|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
5558788|NCT01193842|19210282|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
5558789|NCT01193842|19210283|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
5558790|NCT01193842|19210279|P5|Phase II: Randomized Groups|Ineligible|1
5558791|NCT01193842|19210280|P4|Phase II: Randomized Groups|Ineligible|0
5558792|NCT01193842|19210281|P3|Phase II: Randomized Groups|Ineligible|0
5558793|NCT01193842|19210282|P2|Phase II: Randomized Groups|Ineligible|0
5558794|NCT01193842|19210283|P1|Phase II: Randomized Groups|Ineligible|0
5558795|NCT01193842|19210279|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
5558796|NCT01193842|19210280|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
5558797|NCT01193842|19210281|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
5558798|NCT01193842|19210282|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
5558799|NCT01193842|19210283|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
5558800|NCT01193842|19210279|P5|Phase II: Randomized Groups|Adverse Event|3
5558801|NCT01193842|19210280|P4|Phase II: Randomized Groups|Adverse Event|5
5558802|NCT01193842|19210281|P3|Phase II: Randomized Groups|Adverse Event|0
5558803|NCT01193842|19210282|P2|Phase II: Randomized Groups|Adverse Event|0
5558804|NCT01193842|19210283|P1|Phase II: Randomized Groups|Adverse Event|0
5558805|NCT01193842|19210279|P5|Phase II: Randomized Groups|Death|1
5558806|NCT01193842|19210280|P4|Phase II: Randomized Groups|Death|1
5558807|NCT01193842|19210281|P3|Phase II: Randomized Groups|Death|0
5558808|NCT01193842|19210282|P2|Phase II: Randomized Groups|Death|0
5558809|NCT01193842|19210283|P1|Phase II: Randomized Groups|Death|0
5558810|NCT01193842|19210279|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5558811|NCT01193842|19210280|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5558812|NCT01193842|19210281|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
5558813|NCT01193842|19210282|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5558814|NCT01193842|19210283|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
5558815|NCT01193842|19210279|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5558816|NCT01193842|19210280|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5558817|NCT01193842|19210281|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5558818|NCT01193842|19210282|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
5558819|NCT01193842|19210283|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
5558820|NCT01193842|19210279|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5558821|NCT01193842|19210280|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5558822|NCT01193842|19210281|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5558823|NCT01193842|19210282|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
5558824|NCT01193842|19210283|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
5558825|NCT01193686|19210318|P2|Overall Study|Removed by Investigators; unable to matc|0
5558913|NCT01193257|19210812|P1|Overall Study|Withdrawal by Subject|26
5558826|NCT01193686|19210319|P1|Overall Study|Removed by Investigators; unable to matc|3
5558827|NCT01193686|19210318|P2|Overall Study|Withdrawal by Subject|1
5558828|NCT01193686|19210319|P1|Overall Study|Withdrawal by Subject|4
5558829|NCT01193660|19210336|P3|Overall Study|Physician Decision|1
5558830|NCT01193660|19210337|P2|Overall Study|Physician Decision|0
5558831|NCT01193660|19210338|P1|Overall Study|Physician Decision|1
5558832|NCT01193660|19210336|P3|Overall Study|Death|0
5558833|NCT01193660|19210337|P2|Overall Study|Death|0
5558834|NCT01193660|19210338|P1|Overall Study|Death|1
5558835|NCT01193660|19210336|P3|Overall Study|Withdrawal by Subject|1
5558836|NCT01193660|19210337|P2|Overall Study|Withdrawal by Subject|3
5558837|NCT01193660|19210338|P1|Overall Study|Withdrawal by Subject|2
5558838|NCT01193608|19210382|P6|Overall Study|Adverse Event|0
5558839|NCT01193608|19210383|P5|Overall Study|Adverse Event|1
5558840|NCT01193608|19210384|P4|Overall Study|Adverse Event|0
5558841|NCT01193608|19210385|P3|Overall Study|Adverse Event|0
5558842|NCT01193608|19210386|P2|Overall Study|Adverse Event|0
5558843|NCT01193608|19210387|P1|Overall Study|Adverse Event|0
5558844|NCT01193608|19210382|P6|Overall Study|Lost to Follow-up|2
5558845|NCT01193608|19210383|P5|Overall Study|Lost to Follow-up|1
5558846|NCT01193608|19210384|P4|Overall Study|Lost to Follow-up|0
5558847|NCT01193608|19210385|P3|Overall Study|Lost to Follow-up|0
5558848|NCT01193608|19210386|P2|Overall Study|Lost to Follow-up|0
5558849|NCT01193608|19210387|P1|Overall Study|Lost to Follow-up|0
5558850|NCT01193608|19210382|P6|Overall Study|Withdrawal by Subject|0
5558851|NCT01193608|19210383|P5|Overall Study|Withdrawal by Subject|3
5558852|NCT01193608|19210384|P4|Overall Study|Withdrawal by Subject|3
5558853|NCT01193608|19210385|P3|Overall Study|Withdrawal by Subject|2
5558854|NCT01193608|19210386|P2|Overall Study|Withdrawal by Subject|1
5558855|NCT01193608|19210387|P1|Overall Study|Withdrawal by Subject|0
5558856|NCT01193608|19210382|P6|Overall Study|Other|0
5558857|NCT01193608|19210383|P5|Overall Study|Other|0
5558858|NCT01193608|19210384|P4|Overall Study|Other|0
5558859|NCT01193608|19210385|P3|Overall Study|Other|0
5558860|NCT01193608|19210386|P2|Overall Study|Other|1
5558861|NCT01193608|19210387|P1|Overall Study|Other|0
5558862|NCT01193582|19210624|P4|12 Month Follow-up|Withdrawal by Subject|11
5558863|NCT01193582|19210625|P3|12 Month Follow-up|Withdrawal by Subject|3
5558864|NCT01193582|19210626|P2|12 Month Follow-up|Withdrawal by Subject|0
5558865|NCT01193582|19210627|P1|12 Month Follow-up|Withdrawal by Subject|6
5558866|NCT01193582|19210624|P4|12 Month Follow-up|Death|0
5558867|NCT01193582|19210625|P3|12 Month Follow-up|Death|1
5558868|NCT01193582|19210626|P2|12 Month Follow-up|Death|0
5558869|NCT01193582|19210627|P1|12 Month Follow-up|Death|0
5558870|NCT01193582|19210624|P4|Vaccination Series|Withdrawal by Subject|3
5558871|NCT01193582|19210625|P3|Vaccination Series|Withdrawal by Subject|8
5558872|NCT01193582|19210626|P2|Vaccination Series|Withdrawal by Subject|13
5558873|NCT01193582|19210627|P1|Vaccination Series|Withdrawal by Subject|11
5558874|NCT01193556|19210657|P2|Overall Study|Study termination|25
5558875|NCT01193556|19210658|P1|Overall Study|Study termination|26
5558876|NCT01193530|19210668|P2|Overall Study|Non-Compliance|1
5558877|NCT01193530|19210669|P1|Overall Study|Non-Compliance|0
5558878|NCT01193530|19210668|P2|Overall Study|Returned home - out of state|1
5558879|NCT01193530|19210669|P1|Overall Study|Returned home - out of state|0
5558880|NCT01193530|19210668|P2|Overall Study|Lost Light Box|1
5558881|NCT01193530|19210669|P1|Overall Study|Lost Light Box|0
5558882|NCT01193530|19210668|P2|Overall Study|Began Contraindicated Therapy|0
5558883|NCT01193530|19210669|P1|Overall Study|Began Contraindicated Therapy|1
5558884|NCT01193530|19210668|P2|Overall Study|Withdrawal by Subject|2
5558885|NCT01193530|19210669|P1|Overall Study|Withdrawal by Subject|2
5558886|NCT01193517|19210678|P3|Overall Study|Early Progression|0
5558887|NCT01193517|19210679|P2|Overall Study|Early Progression|0
5558888|NCT01193517|19210680|P1|Overall Study|Early Progression|1
5558889|NCT01193348|19210689|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
5558890|NCT01193348|19210689|P1|Extension Treatment Period|Physician Decision|1
5558891|NCT01193348|19210689|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
5558892|NCT01193348|19210689|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
5558893|NCT01193348|19210689|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
5558894|NCT01193348|19210689|P1|Screening Period|Screen Failure|5
5558895|NCT01193335|19210709|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
5558896|NCT01193335|19210710|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
5558897|NCT01193335|19210709|P2|2-Year Follow-up|No Longer Willing to Participate|6
5558898|NCT01193335|19210710|P1|2-Year Follow-up|No Longer Willing to Participate|5
5558899|NCT01193335|19210709|P2|1-Year Follow-up|Lost to Follow-up|0
5558900|NCT01193335|19210710|P1|1-Year Follow-up|Lost to Follow-up|4
5558901|NCT01193335|19210709|P2|1-Year Follow-up|No Longer Willing to Participate|9
5558902|NCT01193335|19210710|P1|1-Year Follow-up|No Longer Willing to Participate|7
5558903|NCT01193335|19210709|P2|After Infant Series|No Longer Met Eligibility Criteria|1
5558904|NCT01193335|19210710|P1|After Infant Series|No Longer Met Eligibility Criteria|0
5558905|NCT01193335|19210709|P2|After Infant Series|Lost to Follow-up|2
5558906|NCT01193335|19210710|P1|After Infant Series|Lost to Follow-up|1
5558907|NCT01193283|19210805|P1|Overall Study|Death|1
5558908|NCT01193257|19210811|P2|Overall Study|Unblinded due to futility|251
5558909|NCT01193257|19210812|P1|Overall Study|Unblinded due to futility|135
5558910|NCT01193257|19210811|P2|Overall Study|Lost to Follow-up|3
5558911|NCT01193257|19210812|P1|Overall Study|Lost to Follow-up|2
5558912|NCT01193257|19210811|P2|Overall Study|Withdrawal by Subject|86
5558914|NCT01193257|19210811|P2|Overall Study|Study termination by sponsor|3
5558915|NCT01193257|19210812|P1|Overall Study|Study termination by sponsor|0
5558916|NCT01193257|19210811|P2|Overall Study|Death|391
5558917|NCT01193257|19210812|P1|Overall Study|Death|202
5558918|NCT01193244|19210862|P2|Overall Study|Lost to Follow-up|15
5558919|NCT01193244|19210863|P1|Overall Study|Lost to Follow-up|6
5558920|NCT01193244|19210862|P2|Overall Study|Other|278
5558921|NCT01193244|19210863|P1|Overall Study|Other|303
5558922|NCT01193244|19210862|P2|Overall Study|Withdrawal by Subject|97
5558923|NCT01193244|19210863|P1|Overall Study|Withdrawal by Subject|79
5558924|NCT01193218|19210918|P8|12-52 Weeks|Other reason than above|0
5558925|NCT01193218|19210919|P7|12-52 Weeks|Other reason than above|0
5558926|NCT01193218|19210920|P6|12-52 Weeks|Other reason than above|0
5558927|NCT01193218|19210921|P5|12-52 Weeks|Other reason than above|1
5558928|NCT01193218|19210922|P4|12-52 Weeks|Other reason than above|1
5558929|NCT01193218|19210923|P3|12-52 Weeks|Other reason than above|0
5558930|NCT01193218|19210924|P2|12-52 Weeks|Other reason than above|0
5558931|NCT01193218|19210925|P1|12-52 Weeks|Other reason than above|1
5558932|NCT01193218|19210918|P8|12-52 Weeks|Withdrawal by Subject|2
5558933|NCT01193218|19210919|P7|12-52 Weeks|Withdrawal by Subject|1
5558934|NCT01193218|19210920|P6|12-52 Weeks|Withdrawal by Subject|2
5558935|NCT01193218|19210921|P5|12-52 Weeks|Withdrawal by Subject|0
5558936|NCT01193218|19210922|P4|12-52 Weeks|Withdrawal by Subject|0
5558937|NCT01193218|19210923|P3|12-52 Weeks|Withdrawal by Subject|3
5558938|NCT01193218|19210924|P2|12-52 Weeks|Withdrawal by Subject|0
5558939|NCT01193218|19210925|P1|12-52 Weeks|Withdrawal by Subject|3
5558940|NCT01193218|19210918|P8|12-52 Weeks|Lack of Efficacy|0
5558941|NCT01193218|19210919|P7|12-52 Weeks|Lack of Efficacy|1
5558942|NCT01193218|19210920|P6|12-52 Weeks|Lack of Efficacy|0
5558943|NCT01193218|19210921|P5|12-52 Weeks|Lack of Efficacy|0
5558944|NCT01193218|19210922|P4|12-52 Weeks|Lack of Efficacy|0
5558945|NCT01193218|19210923|P3|12-52 Weeks|Lack of Efficacy|0
5558946|NCT01193218|19210924|P2|12-52 Weeks|Lack of Efficacy|0
5558947|NCT01193218|19210925|P1|12-52 Weeks|Lack of Efficacy|0
5558948|NCT01193218|19210918|P8|12-52 Weeks|Adverse Event|2
5558949|NCT01193218|19210919|P7|12-52 Weeks|Adverse Event|1
5558950|NCT01193218|19210920|P6|12-52 Weeks|Adverse Event|3
5558951|NCT01193218|19210921|P5|12-52 Weeks|Adverse Event|3
5558952|NCT01193218|19210922|P4|12-52 Weeks|Adverse Event|2
5558953|NCT01193218|19210923|P3|12-52 Weeks|Adverse Event|1
5558954|NCT01193218|19210924|P2|12-52 Weeks|Adverse Event|0
5558955|NCT01193218|19210925|P1|12-52 Weeks|Adverse Event|1
5558956|NCT01193218|19210918|P8|0-12 Weeks|Withdrawal by Subject|0
5558957|NCT01193218|19210919|P7|0-12 Weeks|Withdrawal by Subject|1
5558958|NCT01193218|19210920|P6|0-12 Weeks|Withdrawal by Subject|0
5558959|NCT01193218|19210921|P5|0-12 Weeks|Withdrawal by Subject|0
5558960|NCT01193218|19210922|P4|0-12 Weeks|Withdrawal by Subject|0
5558961|NCT01193218|19210923|P3|0-12 Weeks|Withdrawal by Subject|2
5558962|NCT01193218|19210924|P2|0-12 Weeks|Withdrawal by Subject|0
5558963|NCT01193218|19210925|P1|0-12 Weeks|Withdrawal by Subject|3
5558964|NCT01193218|19210918|P8|0-12 Weeks|Protocol Violation|0
5558965|NCT01193218|19210919|P7|0-12 Weeks|Protocol Violation|0
5558966|NCT01193218|19210920|P6|0-12 Weeks|Protocol Violation|1
5558967|NCT01193218|19210921|P5|0-12 Weeks|Protocol Violation|1
5558968|NCT01193218|19210922|P4|0-12 Weeks|Protocol Violation|0
5558969|NCT01193218|19210923|P3|0-12 Weeks|Protocol Violation|0
5558970|NCT01193218|19210924|P2|0-12 Weeks|Protocol Violation|0
5558971|NCT01193218|19210925|P1|0-12 Weeks|Protocol Violation|0
5558972|NCT01193218|19210918|P8|0-12 Weeks|Adverse Event|0
5558973|NCT01193218|19210919|P7|0-12 Weeks|Adverse Event|2
5558974|NCT01193218|19210920|P6|0-12 Weeks|Adverse Event|2
5558975|NCT01193218|19210921|P5|0-12 Weeks|Adverse Event|0
5558976|NCT01193218|19210922|P4|0-12 Weeks|Adverse Event|0
5558977|NCT01193218|19210923|P3|0-12 Weeks|Adverse Event|1
5558978|NCT01193218|19210924|P2|0-12 Weeks|Adverse Event|0
5558979|NCT01193218|19210925|P1|0-12 Weeks|Adverse Event|6
5558980|NCT01193153|19210956|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
5558981|NCT01193153|19210957|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
5558982|NCT01193153|19210956|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
5558983|NCT01193153|19210957|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
5558984|NCT01193153|19210956|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
5558985|NCT01193153|19210957|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
5558986|NCT01193153|19210956|P2|Double Blind Relapse Prevention Period|Pregnancy|0
5558987|NCT01193153|19210957|P1|Double Blind Relapse Prevention Period|Pregnancy|1
5558988|NCT01193153|19210956|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
5558989|NCT01193153|19210957|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
5558990|NCT01193153|19210956|P2|Double Blind Relapse Prevention Period|Death|0
5558991|NCT01193153|19210957|P1|Double Blind Relapse Prevention Period|Death|2
5558992|NCT01193153|19210956|P2|Double Blind Relapse Prevention Period|Adverse Event|3
5558993|NCT01193153|19210957|P1|Double Blind Relapse Prevention Period|Adverse Event|12
5558994|NCT01193153|19210956|P2|Double Blind Relapse Prevention Period|Other|3
5558995|NCT01193153|19210957|P1|Double Blind Relapse Prevention Period|Other|2
5558996|NCT01193153|19210956|P2|Open-label Stabilization Period|Other|0
5558997|NCT01193153|19210957|P1|Open-label Stabilization Period|Other|8
5558998|NCT01193153|19210956|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
5558999|NCT01193153|19210957|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
5559000|NCT01193153|19210956|P2|Open-label Stabilization Period|Withdrawal by Subject|0
5559001|NCT01193153|19210957|P1|Open-label Stabilization Period|Withdrawal by Subject|29
5559002|NCT01193153|19210956|P2|Open-label Stabilization Period|Lack of Efficacy|0
5559003|NCT01193153|19210957|P1|Open-label Stabilization Period|Lack of Efficacy|5
5559004|NCT01193153|19210956|P2|Open-label Stabilization Period|Lost to Follow-up|0
5559005|NCT01193153|19210957|P1|Open-label Stabilization Period|Lost to Follow-up|10
5559006|NCT01193153|19210956|P2|Open-label Stabilization Period|Death|0
5559007|NCT01193153|19210957|P1|Open-label Stabilization Period|Death|2
5559008|NCT01193153|19210956|P2|Open-label Stabilization Period|Adverse Event|0
5559009|NCT01193153|19210957|P1|Open-label Stabilization Period|Adverse Event|9
5559010|NCT01193153|19210956|P2|Open-label Lead in Period|Lack of Efficacy|0
5559011|NCT01193153|19210957|P1|Open-label Lead in Period|Lack of Efficacy|26
5559012|NCT01193153|19210956|P2|Open-label Lead in Period|Death|0
5559013|NCT01193153|19210957|P1|Open-label Lead in Period|Death|1
5559014|NCT01193153|19210956|P2|Open-label Lead in Period|Adverse Event|0
5559015|NCT01193153|19210957|P1|Open-label Lead in Period|Adverse Event|41
5559016|NCT01193153|19210956|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
5559017|NCT01193153|19210957|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
5559018|NCT01193153|19210956|P2|Open-label Lead in Period|Other|0
5559019|NCT01193153|19210957|P1|Open-label Lead in Period|Other|14
5559020|NCT01193153|19210956|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
5559021|NCT01193153|19210957|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
5559022|NCT01193153|19210956|P2|Open-label Lead in Period|Withdrawal by Subject|0
5559023|NCT01193153|19210957|P1|Open-label Lead in Period|Withdrawal by Subject|69
5559024|NCT01193153|19210956|P2|Open-label Lead in Period|Pregnancy|0
5559025|NCT01193153|19210957|P1|Open-label Lead in Period|Pregnancy|1
5559026|NCT01193153|19210956|P2|Open-label Lead in Period|Lost to Follow-up|0
5559027|NCT01193153|19210957|P1|Open-label Lead in Period|Lost to Follow-up|32
5559028|NCT01193127|19210992|P4|Treated|Withdrawal by Subject|1
5559029|NCT01193127|19210993|P3|Treated|Withdrawal by Subject|0
5559030|NCT01193127|19210994|P2|Treated|Withdrawal by Subject|0
5559031|NCT01193127|19210995|P1|Treated|Withdrawal by Subject|0
5559032|NCT01193127|19210992|P4|Randomized|Surgery Cancelled|1
5559033|NCT01193127|19210993|P3|Randomized|Surgery Cancelled|0
5559034|NCT01193127|19210994|P2|Randomized|Surgery Cancelled|0
5559035|NCT01193127|19210995|P1|Randomized|Surgery Cancelled|0
5559036|NCT01193101|19211320|P4|Overall Study|Abnormal test procedure results|0
5559037|NCT01193101|19211321|P3|Overall Study|Abnormal test procedure results|0
5559038|NCT01193101|19211322|P2|Overall Study|Abnormal test procedure results|1
5559039|NCT01193101|19211323|P1|Overall Study|Abnormal test procedure results|0
5559040|NCT01193101|19211320|P4|Overall Study|Administrative problems|0
5559041|NCT01193101|19211321|P3|Overall Study|Administrative problems|1
5559042|NCT01193101|19211322|P2|Overall Study|Administrative problems|0
5559043|NCT01193101|19211323|P1|Overall Study|Administrative problems|0
5559044|NCT01193101|19211320|P4|Overall Study|Withdrawal by Subject|1
5559045|NCT01193101|19211321|P3|Overall Study|Withdrawal by Subject|1
5559046|NCT01193101|19211322|P2|Overall Study|Withdrawal by Subject|4
5559047|NCT01193101|19211323|P1|Overall Study|Withdrawal by Subject|2
5559048|NCT01193101|19211320|P4|Overall Study|Lack of Efficacy|8
5559049|NCT01193101|19211321|P3|Overall Study|Lack of Efficacy|0
5559050|NCT01193101|19211322|P2|Overall Study|Lack of Efficacy|1
5559051|NCT01193101|19211323|P1|Overall Study|Lack of Efficacy|3
5559052|NCT01193101|19211320|P4|Overall Study|Adverse Event|3
5559053|NCT01193101|19211321|P3|Overall Study|Adverse Event|1
5559054|NCT01193101|19211322|P2|Overall Study|Adverse Event|1
5559055|NCT01193101|19211323|P1|Overall Study|Adverse Event|0
5559056|NCT01192815|19211440|P1|Overall Study|Lack of Efficacy|1
5559057|NCT01192815|19211440|P1|Overall Study|Withdrawal by Subject|1
5559058|NCT01192776|19211455|P4|Overall Study|Lost to Follow-up|5
5559059|NCT01192776|19211456|P3|Overall Study|Lost to Follow-up|3
5559060|NCT01192776|19211457|P2|Overall Study|Lost to Follow-up|6
5559061|NCT01192776|19211458|P1|Overall Study|Lost to Follow-up|3
5559062|NCT01192776|19211455|P4|Overall Study|Death|15
5559063|NCT01192776|19211456|P3|Overall Study|Death|18
5559064|NCT01192776|19211457|P2|Overall Study|Death|15
5559065|NCT01192776|19211458|P1|Overall Study|Death|8
5559066|NCT01192516|19211536|P3|Overall Study|Unable to follow Actiwatch instructions|0
5559067|NCT01192516|19211537|P2|Overall Study|Unable to follow Actiwatch instructions|2
5559068|NCT01192516|19211538|P1|Overall Study|Unable to follow Actiwatch instructions|4
5559069|NCT01192516|19211536|P3|Overall Study|started new treatment|0
5559070|NCT01192516|19211537|P2|Overall Study|started new treatment|1
5559071|NCT01192516|19211538|P1|Overall Study|started new treatment|5
5559072|NCT01192516|19211536|P3|Overall Study|Withdrawal by Subject|1
5559073|NCT01192516|19211537|P2|Overall Study|Withdrawal by Subject|4
5559074|NCT01192516|19211538|P1|Overall Study|Withdrawal by Subject|4
5559075|NCT01192516|19211536|P3|Overall Study|Lost to Follow-up|7
5559076|NCT01192516|19211537|P2|Overall Study|Lost to Follow-up|10
5559077|NCT01192516|19211538|P1|Overall Study|Lost to Follow-up|7
5559078|NCT01192412|19211572|P2|Overall Study|Withdrawal by Subject|1
5559079|NCT01192412|19211573|P1|Overall Study|Withdrawal by Subject|2
5559080|NCT01192412|19211572|P2|Overall Study|Lost to Follow-up|1
5559081|NCT01192412|19211573|P1|Overall Study|Lost to Follow-up|2
5559082|NCT01192399|19211581|P1|Overall Study|Lack of Efficacy|2
5559083|NCT01192347|19211591|P1|Overall Study|Patient did not show up for visits|1
5559084|NCT01192347|19211591|P1|Overall Study|Patient not visiting hospital regularly|1
5559085|NCT01192347|19211591|P1|Overall Study|Patient seen in different hospital|1
5559086|NCT01192347|19211591|P1|Overall Study|Suspected serious adverse drug reaction|1
5559087|NCT01192347|19211591|P1|Overall Study|Adverse Event|1
5559088|NCT01192347|19211591|P1|Overall Study|Withdrawal by Subject|1
5559089|NCT01192347|19211591|P1|Overall Study|Lost to Follow-up|3
5559090|NCT01192347|19211591|P1|Overall Study|Death|3
5559091|NCT01192295|19211614|P2|Overall Study|Administrative|6
5559092|NCT01192295|19211615|P1|Overall Study|Administrative|4
5559093|NCT01192295|19211614|P2|Overall Study|Lack of Efficacy|5
5559094|NCT01192295|19211615|P1|Overall Study|Lack of Efficacy|0
5559095|NCT01192295|19211614|P2|Overall Study|Lost to Follow-up|1
5559096|NCT01192295|19211615|P1|Overall Study|Lost to Follow-up|0
5559097|NCT01192295|19211614|P2|Overall Study|Withdrawal by Subject|4
5559098|NCT01192295|19211615|P1|Overall Study|Withdrawal by Subject|3
5559099|NCT01192295|19211614|P2|Overall Study|Adverse Event|7
5559100|NCT01192295|19211615|P1|Overall Study|Adverse Event|3
5559101|NCT01192204|19211653|P2|Overall Study|could not keep recall appointments|0
5559102|NCT01192204|19211654|P1|Overall Study|could not keep recall appointments|1
5559103|NCT01192191|19211666|P2|Overall Study|Withdrawal by Subject|6
5559104|NCT01192191|19211667|P1|Overall Study|Withdrawal by Subject|1
5559105|NCT01192191|19211666|P2|Overall Study|Lost to Follow-up|1
5559106|NCT01192191|19211667|P1|Overall Study|Lost to Follow-up|0
5559107|NCT01192191|19211666|P2|Overall Study|Participants Reached Stopping Criteria|2
5559108|NCT01192191|19211667|P1|Overall Study|Participants Reached Stopping Criteria|3
5559109|NCT01192191|19211666|P2|Overall Study|Adverse Event|12
5559110|NCT01192191|19211667|P1|Overall Study|Adverse Event|7
5559111|NCT01192178|19211693|P2|Overall Study|Lack of Efficacy|2
5559112|NCT01192178|19211694|P1|Overall Study|Lack of Efficacy|1
5559113|NCT01192178|19211693|P2|Overall Study|Adverse Event|1
5559114|NCT01192178|19211694|P1|Overall Study|Adverse Event|2
5559115|NCT01192178|19211693|P2|Overall Study|Lost to Follow-up|3
5559116|NCT01192178|19211694|P1|Overall Study|Lost to Follow-up|3
5559117|NCT01192178|19211693|P2|Overall Study|Physician Decision|4
5559118|NCT01192178|19211694|P1|Overall Study|Physician Decision|2
5559119|NCT01192178|19211693|P2|Overall Study|Protocol Violation|3
5559120|NCT01192178|19211694|P1|Overall Study|Protocol Violation|10
5559121|NCT01192178|19211693|P2|Overall Study|Withdrawal by Subject|10
5559122|NCT01192178|19211694|P1|Overall Study|Withdrawal by Subject|6
5559123|NCT01192152|19211714|P2|Period 3|family emergency|0
5559124|NCT01192152|19211715|P1|Period 3|family emergency|1
5559125|NCT01192152|19211714|P2|Period 1|left prematurely (while on treatment B)|1
5559126|NCT01192152|19211715|P1|Period 1|left prematurely (while on treatment B)|0
5559127|NCT01192126|19211886|P2|First Intervention (1 Week)|Lost to Follow-up|1
5559128|NCT01192126|19211887|P1|First Intervention (1 Week)|Lost to Follow-up|1
5559129|NCT01192126|19211886|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
5559130|NCT01192126|19211887|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
5559131|NCT01192100|19211895|P6|Overall Study|Protocol Violation|0
5559132|NCT01192100|19211896|P5|Overall Study|Protocol Violation|0
5559133|NCT01192100|19211897|P4|Overall Study|Protocol Violation|1
5559134|NCT01192100|19211898|P3|Overall Study|Protocol Violation|0
5559135|NCT01192100|19211899|P2|Overall Study|Protocol Violation|0
5559136|NCT01192100|19211900|P1|Overall Study|Protocol Violation|0
5559137|NCT01192100|19211895|P6|Overall Study|Withdrawal by Subject|0
5559138|NCT01192100|19211896|P5|Overall Study|Withdrawal by Subject|1
5559139|NCT01192100|19211897|P4|Overall Study|Withdrawal by Subject|0
5559140|NCT01192100|19211898|P3|Overall Study|Withdrawal by Subject|0
5559141|NCT01192100|19211899|P2|Overall Study|Withdrawal by Subject|0
5559142|NCT01192100|19211900|P1|Overall Study|Withdrawal by Subject|0
5559143|NCT01192022|19211920|P5|Overall Study|Parents did not allow all follow up|0
5559144|NCT01192022|19211921|P4|Overall Study|Parents did not allow all follow up|1
5559145|NCT01192022|19211922|P3|Overall Study|Parents did not allow all follow up|0
5559146|NCT01192022|19211923|P2|Overall Study|Parents did not allow all follow up|0
5559147|NCT01192022|19211924|P1|Overall Study|Parents did not allow all follow up|0
5559148|NCT01192022|19211920|P5|Overall Study|Patient needed surgery|0
5559149|NCT01192022|19211921|P4|Overall Study|Patient needed surgery|0
5559150|NCT01192022|19211922|P3|Overall Study|Patient needed surgery|0
5559151|NCT01192022|19211923|P2|Overall Study|Patient needed surgery|1
5559152|NCT01192022|19211924|P1|Overall Study|Patient needed surgery|0
5559153|NCT01192022|19211920|P5|Overall Study|Patient too sick from chemotherapy|0
5559154|NCT01192022|19211921|P4|Overall Study|Patient too sick from chemotherapy|0
5559155|NCT01192022|19211922|P3|Overall Study|Patient too sick from chemotherapy|0
5559156|NCT01192022|19211923|P2|Overall Study|Patient too sick from chemotherapy|1
5559157|NCT01192022|19211924|P1|Overall Study|Patient too sick from chemotherapy|0
5559158|NCT01192022|19211920|P5|Overall Study|Physician withdrew-patient hardship|0
5559159|NCT01192022|19211921|P4|Overall Study|Physician withdrew-patient hardship|0
5559160|NCT01192022|19211922|P3|Overall Study|Physician withdrew-patient hardship|0
5559161|NCT01192022|19211923|P2|Overall Study|Physician withdrew-patient hardship|0
5559162|NCT01192022|19211924|P1|Overall Study|Physician withdrew-patient hardship|1
5559163|NCT01192022|19211920|P5|Overall Study|Fatal Adverse Event|1
5559164|NCT01192022|19211921|P4|Overall Study|Fatal Adverse Event|0
5559165|NCT01192022|19211922|P3|Overall Study|Fatal Adverse Event|0
5559166|NCT01192022|19211923|P2|Overall Study|Fatal Adverse Event|6
5559167|NCT01192022|19211924|P1|Overall Study|Fatal Adverse Event|4
5559168|NCT01192022|19211920|P5|Overall Study|Adverse Event|0
5559169|NCT01192022|19211921|P4|Overall Study|Adverse Event|0
5559170|NCT01192022|19211922|P3|Overall Study|Adverse Event|0
5559171|NCT01192022|19211923|P2|Overall Study|Adverse Event|0
5559172|NCT01192022|19211924|P1|Overall Study|Adverse Event|1
5559173|NCT01192022|19211920|P5|Overall Study|Lost to Follow-up|0
5559174|NCT01192022|19211921|P4|Overall Study|Lost to Follow-up|1
5559175|NCT01192022|19211922|P3|Overall Study|Lost to Follow-up|1
5559176|NCT01192022|19211923|P2|Overall Study|Lost to Follow-up|2
5559177|NCT01192022|19211924|P1|Overall Study|Lost to Follow-up|4
5559178|NCT01192022|19211920|P5|Overall Study|Withdrawal of Consent|0
5559179|NCT01192022|19211921|P4|Overall Study|Withdrawal of Consent|0
5559180|NCT01192022|19211922|P3|Overall Study|Withdrawal of Consent|0
5559181|NCT01192022|19211923|P2|Overall Study|Withdrawal of Consent|1
5559182|NCT01192022|19211924|P1|Overall Study|Withdrawal of Consent|3
5559183|NCT01191944|19211947|P2|Overall Study|Other|3
5559184|NCT01191944|19211948|P1|Overall Study|Other|1
5559185|NCT01191944|19211947|P2|Overall Study|Withdrawal by Subject|2
5559186|NCT01191944|19211948|P1|Overall Study|Withdrawal by Subject|4
5559187|NCT01191944|19211947|P2|Overall Study|Protocol Violation|2
5559188|NCT01191944|19211948|P1|Overall Study|Protocol Violation|1
5559189|NCT01191944|19211947|P2|Overall Study|Adverse Event|12
5559190|NCT01191944|19211948|P1|Overall Study|Adverse Event|11
5559191|NCT01191840|19211994|P2|Overall Study|Withdrawal by Subject|0
5559192|NCT01191840|19211995|P1|Overall Study|Withdrawal by Subject|2
5559193|NCT01191840|19211994|P2|Overall Study|lab error speciation - non Staph infecti|1
5559194|NCT01191840|19211995|P1|Overall Study|lab error speciation - non Staph infecti|0
5559195|NCT01191840|19211994|P2|Overall Study|IRB approval lapse|2
5559196|NCT01191840|19211995|P1|Overall Study|IRB approval lapse|0
5559197|NCT01191840|19211994|P2|Overall Study|ineligible at enrollment|0
5559198|NCT01191840|19211995|P1|Overall Study|ineligible at enrollment|1
5559199|NCT01191840|19211994|P2|Overall Study|Non Staph Infection|3
5559200|NCT01191840|19211995|P1|Overall Study|Non Staph Infection|4
5559201|NCT01191840|19211994|P2|Overall Study|Lost to Follow-up|6
5559202|NCT01191840|19211995|P1|Overall Study|Lost to Follow-up|4
5559203|NCT01191840|19211994|P2|Overall Study|Subject discontinued treatment|2
5559204|NCT01191840|19211995|P1|Overall Study|Subject discontinued treatment|1
5559205|NCT01191840|19211994|P2|Overall Study|withdrew consent|1
5559206|NCT01191840|19211995|P1|Overall Study|withdrew consent|2
5559207|NCT01191801|19212020|P2|Overall Study|Not Provided|27
5559208|NCT01191801|19212021|P1|Overall Study|Not Provided|45
5559209|NCT01191801|19212020|P2|Overall Study|Withdrawal by Subject|4
5559210|NCT01191801|19212021|P1|Overall Study|Withdrawal by Subject|1
5559211|NCT01191801|19212020|P2|Overall Study|Physician Decision|24
5559212|NCT01191801|19212021|P1|Overall Study|Physician Decision|47
5559213|NCT01191801|19212020|P2|Overall Study|Protocol Violation|4
5559214|NCT01191801|19212021|P1|Overall Study|Protocol Violation|2
5559215|NCT01191801|19212020|P2|Overall Study|Adverse Event|8
5559216|NCT01191801|19212021|P1|Overall Study|Adverse Event|9
5559217|NCT01191801|19212020|P2|Overall Study|Lack of Efficacy|258
5559218|NCT01191801|19212021|P1|Overall Study|Lack of Efficacy|176
5559219|NCT01191801|19212020|P2|Overall Study|Death|12
5559220|NCT01191801|19212021|P1|Overall Study|Death|36
5559221|NCT01191788|19212041|P2|Overall Study|Lost to Follow-up|22
5559222|NCT01191788|19212042|P1|Overall Study|Lost to Follow-up|21
5559223|NCT01191762|19212052|P2|Overall Study|Adverse Event|0
5559224|NCT01191762|19212053|P1|Overall Study|Adverse Event|1
5559225|NCT01191268|19212211|P3|Overall Study|Sponsor Decision|0
5559226|NCT01191268|19212212|P2|Overall Study|Sponsor Decision|2
5559227|NCT01191268|19212213|P1|Overall Study|Sponsor Decision|0
5559228|NCT01191268|19212211|P3|Overall Study|Protocol Violation|1
5559229|NCT01191268|19212212|P2|Overall Study|Protocol Violation|0
5559230|NCT01191268|19212213|P1|Overall Study|Protocol Violation|1
5559231|NCT01191268|19212211|P3|Overall Study|Death|3
5559232|NCT01191268|19212212|P2|Overall Study|Death|1
5559233|NCT01191268|19212213|P1|Overall Study|Death|0
5559234|NCT01191268|19212211|P3|Overall Study|Entry Criteria Not Met|1
5559235|NCT01191268|19212212|P2|Overall Study|Entry Criteria Not Met|1
5559236|NCT01191268|19212213|P1|Overall Study|Entry Criteria Not Met|3
5559237|NCT01191268|19212211|P3|Overall Study|Lost to Follow-up|9
5559238|NCT01191268|19212212|P2|Overall Study|Lost to Follow-up|5
5559239|NCT01191268|19212213|P1|Overall Study|Lost to Follow-up|8
5559240|NCT01191268|19212211|P3|Overall Study|Physician Decision|9
5559241|NCT01191268|19212212|P2|Overall Study|Physician Decision|8
5559242|NCT01191268|19212213|P1|Overall Study|Physician Decision|6
5559243|NCT01191268|19212211|P3|Overall Study|Adverse Event|8
5559244|NCT01191268|19212212|P2|Overall Study|Adverse Event|13
5559245|NCT01191268|19212213|P1|Overall Study|Adverse Event|21
5559246|NCT01191268|19212211|P3|Overall Study|Withdrawal by Subject|21
5559247|NCT01191268|19212212|P2|Overall Study|Withdrawal by Subject|25
5559248|NCT01191268|19212213|P1|Overall Study|Withdrawal by Subject|19
5559249|NCT01191190|19212354|P1|Overall Study|Withdrawal by Subject|1
5559250|NCT01191086|19212367|P1|Overall Study|Other|1
5559251|NCT01191086|19212367|P1|Overall Study|Discontinuation criterion met|1
5559252|NCT01191086|19212367|P1|Overall Study|Withdrawal by Subject|24
5559253|NCT01191086|19212367|P1|Overall Study|Physician Decision|2
5559254|NCT01191086|19212367|P1|Overall Study|Lost to Follow-up|4
5559255|NCT01191086|19212367|P1|Overall Study|Lack of Efficacy|10
5559256|NCT01191086|19212367|P1|Overall Study|Adverse Event|20
5559257|NCT01191008|19212371|P1|Overall Study|Lost to Follow-up|8
5559258|NCT01191008|19212371|P1|Overall Study|Protocol Violation|7
5559259|NCT01190930|19212379|P10|Maintenance|Still on therapy|0
5559260|NCT01190930|19212380|P9|Maintenance|Still on therapy|0
5559261|NCT01190930|19212381|P8|Maintenance|Still on therapy|0
5559262|NCT01190930|19212382|P7|Maintenance|Still on therapy|0
5559263|NCT01190930|19212383|P6|Maintenance|Still on therapy|0
5559264|NCT01190930|19212384|P5|Maintenance|Still on therapy|0
5559265|NCT01190930|19212385|P4|Maintenance|Still on therapy|29
5559266|NCT01190930|19212386|P3|Maintenance|Still on therapy|0
5559267|NCT01190930|19212387|P2|Maintenance|Still on therapy|8
5559268|NCT01190930|19212388|P1|Maintenance|Still on therapy|0
5559269|NCT01190930|19212379|P10|Maintenance|Relapse|11
5559270|NCT01190930|19212380|P9|Maintenance|Relapse|11
5559271|NCT01190930|19212381|P8|Maintenance|Relapse|13
5559272|NCT01190930|19212382|P7|Maintenance|Relapse|6
5559273|NCT01190930|19212383|P6|Maintenance|Relapse|1
5559274|NCT01190930|19212384|P5|Maintenance|Relapse|0
5559275|NCT01190930|19212385|P4|Maintenance|Relapse|2
5559276|NCT01190930|19212386|P3|Maintenance|Relapse|0
5559277|NCT01190930|19212387|P2|Maintenance|Relapse|0
5559278|NCT01190930|19212388|P1|Maintenance|Relapse|0
5559279|NCT01190930|19212379|P10|Maintenance|Enrollment onto another COG Protocol|0
5559280|NCT01190930|19212380|P9|Maintenance|Enrollment onto another COG Protocol|1
5559281|NCT01190930|19212381|P8|Maintenance|Enrollment onto another COG Protocol|0
5559282|NCT01190930|19212382|P7|Maintenance|Enrollment onto another COG Protocol|0
5559283|NCT01190930|19212383|P6|Maintenance|Enrollment onto another COG Protocol|0
5559284|NCT01190930|19212384|P5|Maintenance|Enrollment onto another COG Protocol|0
5559285|NCT01190930|19212385|P4|Maintenance|Enrollment onto another COG Protocol|0
5559286|NCT01190930|19212386|P3|Maintenance|Enrollment onto another COG Protocol|0
5559287|NCT01190930|19212387|P2|Maintenance|Enrollment onto another COG Protocol|0
5559288|NCT01190930|19212388|P1|Maintenance|Enrollment onto another COG Protocol|0
5559289|NCT01190930|19212379|P10|Maintenance|Inevaluable|0
5559290|NCT01190930|19212380|P9|Maintenance|Inevaluable|0
5559291|NCT01190930|19212381|P8|Maintenance|Inevaluable|1
5559292|NCT01190930|19212382|P7|Maintenance|Inevaluable|1
5559293|NCT01190930|19212383|P6|Maintenance|Inevaluable|1
5559294|NCT01190930|19212384|P5|Maintenance|Inevaluable|0
5559295|NCT01190930|19212385|P4|Maintenance|Inevaluable|0
5559296|NCT01190930|19212386|P3|Maintenance|Inevaluable|0
5559297|NCT01190930|19212387|P2|Maintenance|Inevaluable|0
5559298|NCT01190930|19212388|P1|Maintenance|Inevaluable|0
5559299|NCT01190930|19212379|P10|Maintenance|second malignant neoplasm|0
5559300|NCT01190930|19212380|P9|Maintenance|second malignant neoplasm|1
5559301|NCT01190930|19212381|P8|Maintenance|second malignant neoplasm|0
5559302|NCT01190930|19212382|P7|Maintenance|second malignant neoplasm|0
5559303|NCT01190930|19212383|P6|Maintenance|second malignant neoplasm|1
5559304|NCT01190930|19212384|P5|Maintenance|second malignant neoplasm|0
5559305|NCT01190930|19212385|P4|Maintenance|second malignant neoplasm|1
5559306|NCT01190930|19212386|P3|Maintenance|second malignant neoplasm|0
5559307|NCT01190930|19212387|P2|Maintenance|second malignant neoplasm|0
5559308|NCT01190930|19212388|P1|Maintenance|second malignant neoplasm|0
5559309|NCT01190930|19212379|P10|Maintenance|Refusal|6
5559310|NCT01190930|19212380|P9|Maintenance|Refusal|13
5559311|NCT01190930|19212381|P8|Maintenance|Refusal|17
5559312|NCT01190930|19212382|P7|Maintenance|Refusal|5
5559313|NCT01190930|19212383|P6|Maintenance|Refusal|4
5559314|NCT01190930|19212384|P5|Maintenance|Refusal|0
5559315|NCT01190930|19212385|P4|Maintenance|Refusal|2
5559316|NCT01190930|19212386|P3|Maintenance|Refusal|0
5559317|NCT01190930|19212387|P2|Maintenance|Refusal|1
5559318|NCT01190930|19212388|P1|Maintenance|Refusal|0
5559319|NCT01190930|19212379|P10|Maintenance|Withdrawal by Subject|1
5559320|NCT01190930|19212380|P9|Maintenance|Withdrawal by Subject|4
5559321|NCT01190930|19212381|P8|Maintenance|Withdrawal by Subject|1
5559322|NCT01190930|19212382|P7|Maintenance|Withdrawal by Subject|2
5559323|NCT01190930|19212383|P6|Maintenance|Withdrawal by Subject|0
5559324|NCT01190930|19212384|P5|Maintenance|Withdrawal by Subject|0
5559325|NCT01190930|19212385|P4|Maintenance|Withdrawal by Subject|0
5559326|NCT01190930|19212386|P3|Maintenance|Withdrawal by Subject|0
5559327|NCT01190930|19212387|P2|Maintenance|Withdrawal by Subject|0
5559328|NCT01190930|19212388|P1|Maintenance|Withdrawal by Subject|0
5559329|NCT01190930|19212379|P10|Maintenance|Physician Decision|17
5559330|NCT01190930|19212380|P9|Maintenance|Physician Decision|10
5559331|NCT01190930|19212381|P8|Maintenance|Physician Decision|8
5559332|NCT01190930|19212382|P7|Maintenance|Physician Decision|8
5559333|NCT01190930|19212383|P6|Maintenance|Physician Decision|4
5559334|NCT01190930|19212384|P5|Maintenance|Physician Decision|9
5559335|NCT01190930|19212385|P4|Maintenance|Physician Decision|5
5559336|NCT01190930|19212386|P3|Maintenance|Physician Decision|0
5559337|NCT01190930|19212387|P2|Maintenance|Physician Decision|1
5559338|NCT01190930|19212388|P1|Maintenance|Physician Decision|0
5559339|NCT01190930|19212379|P10|Maintenance|Lost to Follow-up|0
5559340|NCT01190930|19212380|P9|Maintenance|Lost to Follow-up|1
5559341|NCT01190930|19212381|P8|Maintenance|Lost to Follow-up|1
5559342|NCT01190930|19212382|P7|Maintenance|Lost to Follow-up|1
5559343|NCT01190930|19212383|P6|Maintenance|Lost to Follow-up|0
5559344|NCT01190930|19212384|P5|Maintenance|Lost to Follow-up|0
5559345|NCT01190930|19212385|P4|Maintenance|Lost to Follow-up|0
5559346|NCT01190930|19212386|P3|Maintenance|Lost to Follow-up|0
5559347|NCT01190930|19212387|P2|Maintenance|Lost to Follow-up|0
5559348|NCT01190930|19212388|P1|Maintenance|Lost to Follow-up|0
5559349|NCT01190930|19212379|P10|Maintenance|Death|2
5559350|NCT01190930|19212380|P9|Maintenance|Death|2
5559351|NCT01190930|19212381|P8|Maintenance|Death|2
5559352|NCT01190930|19212382|P7|Maintenance|Death|2
5559353|NCT01190930|19212383|P6|Maintenance|Death|0
5559354|NCT01190930|19212384|P5|Maintenance|Death|0
5559355|NCT01190930|19212385|P4|Maintenance|Death|1
5559356|NCT01190930|19212386|P3|Maintenance|Death|0
5559357|NCT01190930|19212387|P2|Maintenance|Death|0
5559358|NCT01190930|19212388|P1|Maintenance|Death|0
5559359|NCT01190930|19212379|P10|Maintenance|Adverse Event|0
5559360|NCT01190930|19212380|P9|Maintenance|Adverse Event|3
5559361|NCT01190930|19212381|P8|Maintenance|Adverse Event|3
5559362|NCT01190930|19212382|P7|Maintenance|Adverse Event|1
5559363|NCT01190930|19212383|P6|Maintenance|Adverse Event|1
5559364|NCT01190930|19212384|P5|Maintenance|Adverse Event|0
5559365|NCT01190930|19212385|P4|Maintenance|Adverse Event|0
5559366|NCT01190930|19212386|P3|Maintenance|Adverse Event|0
5559367|NCT01190930|19212387|P2|Maintenance|Adverse Event|0
5559368|NCT01190930|19212388|P1|Maintenance|Adverse Event|0
5559369|NCT01190930|19212379|P10|Post Induction Pre-Maintenance|Relapse|0
5559370|NCT01190930|19212380|P9|Post Induction Pre-Maintenance|Relapse|0
5559371|NCT01190930|19212381|P8|Post Induction Pre-Maintenance|Relapse|0
5559372|NCT01190930|19212382|P7|Post Induction Pre-Maintenance|Relapse|0
5559373|NCT01190930|19212383|P6|Post Induction Pre-Maintenance|Relapse|0
5559374|NCT01190930|19212384|P5|Post Induction Pre-Maintenance|Relapse|0
5559375|NCT01190930|19212385|P4|Post Induction Pre-Maintenance|Relapse|0
5559376|NCT01190930|19212386|P3|Post Induction Pre-Maintenance|Relapse|1
5559377|NCT01190930|19212387|P2|Post Induction Pre-Maintenance|Relapse|0
5559378|NCT01190930|19212388|P1|Post Induction Pre-Maintenance|Relapse|0
5559379|NCT01190930|19212379|P10|Post Induction Pre-Maintenance|Progressive disease|0
5559380|NCT01190930|19212380|P9|Post Induction Pre-Maintenance|Progressive disease|0
5559381|NCT01190930|19212381|P8|Post Induction Pre-Maintenance|Progressive disease|0
5559382|NCT01190930|19212382|P7|Post Induction Pre-Maintenance|Progressive disease|0
5559383|NCT01190930|19212383|P6|Post Induction Pre-Maintenance|Progressive disease|0
5559384|NCT01190930|19212384|P5|Post Induction Pre-Maintenance|Progressive disease|0
5559385|NCT01190930|19212385|P4|Post Induction Pre-Maintenance|Progressive disease|0
5559386|NCT01190930|19212386|P3|Post Induction Pre-Maintenance|Progressive disease|1
5559387|NCT01190930|19212387|P2|Post Induction Pre-Maintenance|Progressive disease|0
5559388|NCT01190930|19212388|P1|Post Induction Pre-Maintenance|Progressive disease|0
5559389|NCT01190930|19212379|P10|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5559390|NCT01190930|19212380|P9|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5559391|NCT01190930|19212381|P8|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5559392|NCT01190930|19212382|P7|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5559393|NCT01190930|19212383|P6|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5559394|NCT01190930|19212384|P5|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5559395|NCT01190930|19212385|P4|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5559396|NCT01190930|19212386|P3|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5559397|NCT01190930|19212387|P2|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
5559398|NCT01190930|19212388|P1|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
5559399|NCT01190930|19212379|P10|Post Induction Pre-Maintenance|Inevaluable|0
5559400|NCT01190930|19212380|P9|Post Induction Pre-Maintenance|Inevaluable|0
5559401|NCT01190930|19212381|P8|Post Induction Pre-Maintenance|Inevaluable|0
5559402|NCT01190930|19212382|P7|Post Induction Pre-Maintenance|Inevaluable|0
5559403|NCT01190930|19212383|P6|Post Induction Pre-Maintenance|Inevaluable|0
5559404|NCT01190930|19212384|P5|Post Induction Pre-Maintenance|Inevaluable|0
5559405|NCT01190930|19212385|P4|Post Induction Pre-Maintenance|Inevaluable|0
5559406|NCT01190930|19212386|P3|Post Induction Pre-Maintenance|Inevaluable|6
5559407|NCT01190930|19212387|P2|Post Induction Pre-Maintenance|Inevaluable|0
5559408|NCT01190930|19212388|P1|Post Induction Pre-Maintenance|Inevaluable|0
5559409|NCT01190930|19212379|P10|Post Induction Pre-Maintenance|Refusal|0
5559410|NCT01190930|19212380|P9|Post Induction Pre-Maintenance|Refusal|0
5559411|NCT01190930|19212381|P8|Post Induction Pre-Maintenance|Refusal|0
5559412|NCT01190930|19212382|P7|Post Induction Pre-Maintenance|Refusal|0
5559413|NCT01190930|19212383|P6|Post Induction Pre-Maintenance|Refusal|3
5559414|NCT01190930|19212384|P5|Post Induction Pre-Maintenance|Refusal|0
5559415|NCT01190930|19212385|P4|Post Induction Pre-Maintenance|Refusal|4
5559416|NCT01190930|19212386|P3|Post Induction Pre-Maintenance|Refusal|694
5559417|NCT01190930|19212387|P2|Post Induction Pre-Maintenance|Refusal|2
5559418|NCT01190930|19212388|P1|Post Induction Pre-Maintenance|Refusal|0
5559419|NCT01190930|19212379|P10|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5559420|NCT01190930|19212380|P9|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5559421|NCT01190930|19212381|P8|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5559422|NCT01190930|19212382|P7|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5559423|NCT01190930|19212383|P6|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5559424|NCT01190930|19212384|P5|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5559425|NCT01190930|19212385|P4|Post Induction Pre-Maintenance|Withdrawal by Subject|2
5559426|NCT01190930|19212386|P3|Post Induction Pre-Maintenance|Withdrawal by Subject|5
5559427|NCT01190930|19212387|P2|Post Induction Pre-Maintenance|Withdrawal by Subject|1
5559428|NCT01190930|19212388|P1|Post Induction Pre-Maintenance|Withdrawal by Subject|0
5559429|NCT01190930|19212379|P10|Post Induction Pre-Maintenance|Physician Decision|0
5559430|NCT01190930|19212380|P9|Post Induction Pre-Maintenance|Physician Decision|0
5559431|NCT01190930|19212381|P8|Post Induction Pre-Maintenance|Physician Decision|0
5559432|NCT01190930|19212382|P7|Post Induction Pre-Maintenance|Physician Decision|0
5559433|NCT01190930|19212383|P6|Post Induction Pre-Maintenance|Physician Decision|3
5559434|NCT01190930|19212384|P5|Post Induction Pre-Maintenance|Physician Decision|5
5559435|NCT01190930|19212385|P4|Post Induction Pre-Maintenance|Physician Decision|7
5559436|NCT01190930|19212386|P3|Post Induction Pre-Maintenance|Physician Decision|35
5559437|NCT01190930|19212387|P2|Post Induction Pre-Maintenance|Physician Decision|2
5559438|NCT01190930|19212388|P1|Post Induction Pre-Maintenance|Physician Decision|0
5559439|NCT01190930|19212379|P10|Post Induction Pre-Maintenance|Death|0
5559440|NCT01190930|19212380|P9|Post Induction Pre-Maintenance|Death|0
5559441|NCT01190930|19212381|P8|Post Induction Pre-Maintenance|Death|0
5559442|NCT01190930|19212382|P7|Post Induction Pre-Maintenance|Death|0
5559443|NCT01190930|19212383|P6|Post Induction Pre-Maintenance|Death|0
5559444|NCT01190930|19212384|P5|Post Induction Pre-Maintenance|Death|0
5559445|NCT01190930|19212385|P4|Post Induction Pre-Maintenance|Death|4
5559446|NCT01190930|19212386|P3|Post Induction Pre-Maintenance|Death|8
5559447|NCT01190930|19212387|P2|Post Induction Pre-Maintenance|Death|0
5559448|NCT01190930|19212388|P1|Post Induction Pre-Maintenance|Death|0
5559449|NCT01190930|19212379|P10|Post Induction Pre-Maintenance|Adverse Event|0
5559450|NCT01190930|19212380|P9|Post Induction Pre-Maintenance|Adverse Event|0
5559451|NCT01190930|19212381|P8|Post Induction Pre-Maintenance|Adverse Event|0
5559452|NCT01190930|19212382|P7|Post Induction Pre-Maintenance|Adverse Event|0
5559453|NCT01190930|19212383|P6|Post Induction Pre-Maintenance|Adverse Event|0
5559454|NCT01190930|19212384|P5|Post Induction Pre-Maintenance|Adverse Event|0
5559455|NCT01190930|19212385|P4|Post Induction Pre-Maintenance|Adverse Event|0
5559456|NCT01190930|19212386|P3|Post Induction Pre-Maintenance|Adverse Event|8
5559457|NCT01190930|19212387|P2|Post Induction Pre-Maintenance|Adverse Event|0
5559458|NCT01190930|19212388|P1|Post Induction Pre-Maintenance|Adverse Event|0
5559459|NCT01190930|19212379|P10|Induction|Ineligible|0
5559460|NCT01190930|19212380|P9|Induction|Ineligible|0
5559461|NCT01190930|19212381|P8|Induction|Ineligible|0
5559462|NCT01190930|19212382|P7|Induction|Ineligible|0
5559463|NCT01190930|19212383|P6|Induction|Ineligible|0
5559464|NCT01190930|19212384|P5|Induction|Ineligible|0
5559465|NCT01190930|19212385|P4|Induction|Ineligible|0
5559466|NCT01190930|19212386|P3|Induction|Ineligible|0
5559467|NCT01190930|19212387|P2|Induction|Ineligible|4
5559468|NCT01190930|19212388|P1|Induction|Ineligible|69
5559469|NCT01190930|19212379|P10|Induction|No treatment|0
5559470|NCT01190930|19212380|P9|Induction|No treatment|0
5559471|NCT01190930|19212381|P8|Induction|No treatment|0
5559472|NCT01190930|19212382|P7|Induction|No treatment|0
5559473|NCT01190930|19212383|P6|Induction|No treatment|0
5559474|NCT01190930|19212384|P5|Induction|No treatment|0
5559475|NCT01190930|19212385|P4|Induction|No treatment|0
5559476|NCT01190930|19212386|P3|Induction|No treatment|0
5559477|NCT01190930|19212387|P2|Induction|No treatment|0
5559478|NCT01190930|19212388|P1|Induction|No treatment|3
5559479|NCT01190930|19212379|P10|Induction|Progressive disease|0
5559480|NCT01190930|19212380|P9|Induction|Progressive disease|0
5559481|NCT01190930|19212381|P8|Induction|Progressive disease|0
5559482|NCT01190930|19212382|P7|Induction|Progressive disease|0
5559483|NCT01190930|19212383|P6|Induction|Progressive disease|0
5559484|NCT01190930|19212384|P5|Induction|Progressive disease|0
5559485|NCT01190930|19212385|P4|Induction|Progressive disease|0
5559486|NCT01190930|19212386|P3|Induction|Progressive disease|0
5559487|NCT01190930|19212387|P2|Induction|Progressive disease|1
5559488|NCT01190930|19212388|P1|Induction|Progressive disease|0
5559489|NCT01190930|19212379|P10|Induction|Incomplete Induction data|0
5559490|NCT01190930|19212380|P9|Induction|Incomplete Induction data|0
5559491|NCT01190930|19212381|P8|Induction|Incomplete Induction data|0
5559492|NCT01190930|19212382|P7|Induction|Incomplete Induction data|0
5559493|NCT01190930|19212383|P6|Induction|Incomplete Induction data|0
5559494|NCT01190930|19212384|P5|Induction|Incomplete Induction data|0
5559495|NCT01190930|19212385|P4|Induction|Incomplete Induction data|0
5559496|NCT01190930|19212386|P3|Induction|Incomplete Induction data|0
5559497|NCT01190930|19212387|P2|Induction|Incomplete Induction data|0
5559498|NCT01190930|19212388|P1|Induction|Incomplete Induction data|63
5559499|NCT01190930|19212379|P10|Induction|Philadelphia chromosome-positive|0
5559500|NCT01190930|19212380|P9|Induction|Philadelphia chromosome-positive|0
5559501|NCT01190930|19212381|P8|Induction|Philadelphia chromosome-positive|0
5559502|NCT01190930|19212382|P7|Induction|Philadelphia chromosome-positive|0
5559503|NCT01190930|19212383|P6|Induction|Philadelphia chromosome-positive|0
5559504|NCT01190930|19212384|P5|Induction|Philadelphia chromosome-positive|0
5559505|NCT01190930|19212385|P4|Induction|Philadelphia chromosome-positive|0
5559506|NCT01190930|19212386|P3|Induction|Philadelphia chromosome-positive|0
5559507|NCT01190930|19212387|P2|Induction|Philadelphia chromosome-positive|0
5559508|NCT01190930|19212388|P1|Induction|Philadelphia chromosome-positive|99
5559509|NCT01190930|19212379|P10|Induction|Very High Risk|0
5559510|NCT01190930|19212380|P9|Induction|Very High Risk|0
5559511|NCT01190930|19212381|P8|Induction|Very High Risk|0
5559512|NCT01190930|19212382|P7|Induction|Very High Risk|0
5559513|NCT01190930|19212383|P6|Induction|Very High Risk|0
5559514|NCT01190930|19212384|P5|Induction|Very High Risk|0
5559515|NCT01190930|19212385|P4|Induction|Very High Risk|0
5559516|NCT01190930|19212386|P3|Induction|Very High Risk|0
5559517|NCT01190930|19212387|P2|Induction|Very High Risk|0
5559518|NCT01190930|19212388|P1|Induction|Very High Risk|1012
5559519|NCT01190930|19212379|P10|Induction|Low Risk|0
5559520|NCT01190930|19212380|P9|Induction|Low Risk|0
5559521|NCT01190930|19212381|P8|Induction|Low Risk|0
5559522|NCT01190930|19212382|P7|Induction|Low Risk|0
5559523|NCT01190930|19212383|P6|Induction|Low Risk|0
5559524|NCT01190930|19212384|P5|Induction|Low Risk|0
5559525|NCT01190930|19212385|P4|Induction|Low Risk|0
5559526|NCT01190930|19212386|P3|Induction|Low Risk|0
5559527|NCT01190930|19212387|P2|Induction|Low Risk|0
5559528|NCT01190930|19212388|P1|Induction|Low Risk|443
5559529|NCT01190930|19212379|P10|Induction|High Risk|0
5559530|NCT01190930|19212380|P9|Induction|High Risk|0
5559531|NCT01190930|19212381|P8|Induction|High Risk|0
5559532|NCT01190930|19212382|P7|Induction|High Risk|0
5559533|NCT01190930|19212383|P6|Induction|High Risk|0
5559534|NCT01190930|19212384|P5|Induction|High Risk|0
5559535|NCT01190930|19212385|P4|Induction|High Risk|0
5559536|NCT01190930|19212386|P3|Induction|High Risk|0
5559537|NCT01190930|19212387|P2|Induction|High Risk|0
5559538|NCT01190930|19212388|P1|Induction|High Risk|1227
5559539|NCT01190930|19212379|P10|Induction|Average Risk|0
5559540|NCT01190930|19212380|P9|Induction|Average Risk|0
5559541|NCT01190930|19212381|P8|Induction|Average Risk|0
5559542|NCT01190930|19212382|P7|Induction|Average Risk|0
5559543|NCT01190930|19212383|P6|Induction|Average Risk|0
5559544|NCT01190930|19212384|P5|Induction|Average Risk|0
5559545|NCT01190930|19212385|P4|Induction|Average Risk|0
5559546|NCT01190930|19212386|P3|Induction|Average Risk|0
5559547|NCT01190930|19212387|P2|Induction|Average Risk|0
5559548|NCT01190930|19212388|P1|Induction|Average Risk|1847
5559549|NCT01190930|19212379|P10|Induction|Enrollment onto another COG Protocol|0
5559550|NCT01190930|19212380|P9|Induction|Enrollment onto another COG Protocol|0
5559551|NCT01190930|19212381|P8|Induction|Enrollment onto another COG Protocol|0
5559552|NCT01190930|19212382|P7|Induction|Enrollment onto another COG Protocol|0
5559553|NCT01190930|19212383|P6|Induction|Enrollment onto another COG Protocol|0
5559554|NCT01190930|19212384|P5|Induction|Enrollment onto another COG Protocol|0
5559555|NCT01190930|19212385|P4|Induction|Enrollment onto another COG Protocol|0
5559556|NCT01190930|19212386|P3|Induction|Enrollment onto another COG Protocol|0
5559557|NCT01190930|19212387|P2|Induction|Enrollment onto another COG Protocol|0
5559558|NCT01190930|19212388|P1|Induction|Enrollment onto another COG Protocol|1
5559559|NCT01190930|19212379|P10|Induction|High Risk Downs|0
5559560|NCT01190930|19212380|P9|Induction|High Risk Downs|0
5559561|NCT01190930|19212381|P8|Induction|High Risk Downs|0
5559562|NCT01190930|19212382|P7|Induction|High Risk Downs|0
5559563|NCT01190930|19212383|P6|Induction|High Risk Downs|0
5559564|NCT01190930|19212384|P5|Induction|High Risk Downs|0
5559565|NCT01190930|19212385|P4|Induction|High Risk Downs|0
5559566|NCT01190930|19212386|P3|Induction|High Risk Downs|0
5559567|NCT01190930|19212387|P2|Induction|High Risk Downs|0
5559568|NCT01190930|19212388|P1|Induction|High Risk Downs|80
5559569|NCT01190930|19212379|P10|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5559570|NCT01190930|19212380|P9|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5559571|NCT01190930|19212381|P8|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5559572|NCT01190930|19212382|P7|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5559573|NCT01190930|19212383|P6|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5559574|NCT01190930|19212384|P5|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5559575|NCT01190930|19212385|P4|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5559576|NCT01190930|19212386|P3|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5559577|NCT01190930|19212387|P2|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
5559578|NCT01190930|19212388|P1|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
5559579|NCT01190930|19212379|P10|Induction|Inevaluable|0
5559580|NCT01190930|19212380|P9|Induction|Inevaluable|0
5559581|NCT01190930|19212381|P8|Induction|Inevaluable|0
5559582|NCT01190930|19212382|P7|Induction|Inevaluable|0
5559583|NCT01190930|19212383|P6|Induction|Inevaluable|0
5559584|NCT01190930|19212384|P5|Induction|Inevaluable|0
5559585|NCT01190930|19212385|P4|Induction|Inevaluable|0
5559586|NCT01190930|19212386|P3|Induction|Inevaluable|0
5559587|NCT01190930|19212387|P2|Induction|Inevaluable|1
5559588|NCT01190930|19212388|P1|Induction|Inevaluable|23
5559589|NCT01190930|19212379|P10|Induction|Refusal|0
5559590|NCT01190930|19212380|P9|Induction|Refusal|0
5559591|NCT01190930|19212381|P8|Induction|Refusal|0
5559592|NCT01190930|19212382|P7|Induction|Refusal|0
5559593|NCT01190930|19212383|P6|Induction|Refusal|0
5559594|NCT01190930|19212384|P5|Induction|Refusal|0
5559595|NCT01190930|19212385|P4|Induction|Refusal|0
5559596|NCT01190930|19212386|P3|Induction|Refusal|0
5559597|NCT01190930|19212387|P2|Induction|Refusal|0
5559598|NCT01190930|19212388|P1|Induction|Refusal|235
5559599|NCT01190930|19212379|P10|Induction|Withdrawal by Subject|0
5559600|NCT01190930|19212380|P9|Induction|Withdrawal by Subject|0
5559601|NCT01190930|19212381|P8|Induction|Withdrawal by Subject|0
5559602|NCT01190930|19212382|P7|Induction|Withdrawal by Subject|0
5559603|NCT01190930|19212383|P6|Induction|Withdrawal by Subject|0
5559604|NCT01190930|19212384|P5|Induction|Withdrawal by Subject|0
5559605|NCT01190930|19212385|P4|Induction|Withdrawal by Subject|0
5559606|NCT01190930|19212386|P3|Induction|Withdrawal by Subject|0
5559607|NCT01190930|19212387|P2|Induction|Withdrawal by Subject|0
5559608|NCT01190930|19212388|P1|Induction|Withdrawal by Subject|9
5559609|NCT01190930|19212379|P10|Induction|Physician Decision|0
5559610|NCT01190930|19212380|P9|Induction|Physician Decision|0
5559611|NCT01190930|19212381|P8|Induction|Physician Decision|0
5559612|NCT01190930|19212382|P7|Induction|Physician Decision|0
5559613|NCT01190930|19212383|P6|Induction|Physician Decision|0
5559614|NCT01190930|19212384|P5|Induction|Physician Decision|0
5559615|NCT01190930|19212385|P4|Induction|Physician Decision|0
5559616|NCT01190930|19212386|P3|Induction|Physician Decision|0
5559617|NCT01190930|19212387|P2|Induction|Physician Decision|3
5559618|NCT01190930|19212388|P1|Induction|Physician Decision|125
5559619|NCT01190930|19212379|P10|Induction|Lost to Follow-up|0
5559620|NCT01190930|19212380|P9|Induction|Lost to Follow-up|0
5559621|NCT01190930|19212381|P8|Induction|Lost to Follow-up|0
5559622|NCT01190930|19212382|P7|Induction|Lost to Follow-up|0
5559623|NCT01190930|19212383|P6|Induction|Lost to Follow-up|0
5559624|NCT01190930|19212384|P5|Induction|Lost to Follow-up|0
5559625|NCT01190930|19212385|P4|Induction|Lost to Follow-up|0
5559626|NCT01190930|19212386|P3|Induction|Lost to Follow-up|0
5559627|NCT01190930|19212387|P2|Induction|Lost to Follow-up|0
5559628|NCT01190930|19212388|P1|Induction|Lost to Follow-up|1
5559629|NCT01190930|19212379|P10|Induction|Death|0
5559630|NCT01190930|19212380|P9|Induction|Death|0
5559631|NCT01190930|19212381|P8|Induction|Death|0
5559632|NCT01190930|19212382|P7|Induction|Death|0
5559633|NCT01190930|19212383|P6|Induction|Death|0
5559634|NCT01190930|19212384|P5|Induction|Death|0
5559635|NCT01190930|19212385|P4|Induction|Death|0
5559636|NCT01190930|19212386|P3|Induction|Death|0
5559637|NCT01190930|19212387|P2|Induction|Death|0
5559638|NCT01190930|19212388|P1|Induction|Death|34
5559639|NCT01190930|19212379|P10|Induction|Adverse Event|0
5559640|NCT01190930|19212380|P9|Induction|Adverse Event|0
5559641|NCT01190930|19212381|P8|Induction|Adverse Event|0
5559642|NCT01190930|19212382|P7|Induction|Adverse Event|0
5559643|NCT01190930|19212383|P6|Induction|Adverse Event|0
5559644|NCT01190930|19212384|P5|Induction|Adverse Event|0
5559645|NCT01190930|19212385|P4|Induction|Adverse Event|0
5559646|NCT01190930|19212386|P3|Induction|Adverse Event|0
5559647|NCT01190930|19212387|P2|Induction|Adverse Event|0
5559648|NCT01190930|19212388|P1|Induction|Adverse Event|17
5559649|NCT01190891|19212412|P2|Overall Study|Withdrawal by Subject|0
5559650|NCT01190891|19212413|P1|Overall Study|Withdrawal by Subject|5
5559651|NCT01190891|19212412|P2|Overall Study|Protocol Violation|0
5559652|NCT01190891|19212413|P1|Overall Study|Protocol Violation|1
5559653|NCT01190865|19212438|P1|Overall Study|Non-compliance|2
5559654|NCT01190865|19212438|P1|Overall Study|Withdrawal by Subject|1
5559655|NCT01190839|19212445|P2|Overall Study|Randomized but not treated|4
5559656|NCT01190839|19212446|P1|Overall Study|Randomized but not treated|2
5559657|NCT01190839|19212445|P2|Overall Study|Undefined|31
5559658|NCT01190839|19212446|P1|Overall Study|Undefined|35
5559659|NCT01190839|19212445|P2|Overall Study|Trial stopped by Sponsor|68
5559660|NCT01190839|19212446|P1|Overall Study|Trial stopped by Sponsor|71
5559661|NCT01190839|19212445|P2|Overall Study|Death|0
5559662|NCT01190839|19212446|P1|Overall Study|Death|1
5559663|NCT01190839|19212445|P2|Overall Study|Lost to Follow-up|1
5559664|NCT01190839|19212446|P1|Overall Study|Lost to Follow-up|7
5559665|NCT01190839|19212445|P2|Overall Study|Protocol Violation|2
5559666|NCT01190839|19212446|P1|Overall Study|Protocol Violation|2
5559667|NCT01190839|19212445|P2|Overall Study|Adverse Event|41
5559668|NCT01190839|19212446|P1|Overall Study|Adverse Event|32
5559669|NCT01190813|19212460|P2|Overall Study|Adverse Event|1
5559670|NCT01190813|19212461|P1|Overall Study|Adverse Event|0
5559671|NCT01190813|19212460|P2|Overall Study|Refused study treatment after randomized|0
5559672|NCT01190813|19212461|P1|Overall Study|Refused study treatment after randomized|1
5559673|NCT01190813|19212460|P2|Overall Study|Withdrawal by Subject|1
5559674|NCT01190813|19212461|P1|Overall Study|Withdrawal by Subject|2
5559675|NCT01190813|19212460|P2|Overall Study|Lost to Follow-up|2
5559676|NCT01190813|19212461|P1|Overall Study|Lost to Follow-up|1
5559677|NCT01190514|19212582|P4|Third Intervention (Period 3)|Adverse Event|0
5559678|NCT01190514|19212583|P3|Third Intervention (Period 3)|Adverse Event|0
5559679|NCT01190514|19212584|P2|Third Intervention (Period 3)|Adverse Event|0
5559680|NCT01190514|19212585|P1|Third Intervention (Period 3)|Adverse Event|1
5559681|NCT01190514|19212582|P4|First Intervention (Period 1)|Adverse Event|0
5559682|NCT01190514|19212583|P3|First Intervention (Period 1)|Adverse Event|0
5559683|NCT01190514|19212584|P2|First Intervention (Period 1)|Adverse Event|0
5559684|NCT01190514|19212585|P1|First Intervention (Period 1)|Adverse Event|1
5559685|NCT01190475|19212618|P3|Overall Study|Withdrawal by Subject|1
5559686|NCT01190475|19212619|P2|Overall Study|Withdrawal by Subject|0
5559687|NCT01190475|19212620|P1|Overall Study|Withdrawal by Subject|0
5559688|NCT01190449|19212636|P2|Overall Study|Ineligible|4
5559689|NCT01190449|19212637|P1|Overall Study|Ineligible|0
5559690|NCT01190436|19212645|P1|Overall Study|Other|4
5559691|NCT01190436|19212645|P1|Overall Study|Lost to Follow-up|35
5559692|NCT01190410|19212661|P2|Overall Study|PI discretion|2
5559693|NCT01190410|19212662|P1|Overall Study|PI discretion|0
5559694|NCT01190410|19212661|P2|Overall Study|Administrative decision|0
5559695|NCT01190410|19212662|P1|Overall Study|Administrative decision|1
5559696|NCT01190410|19212661|P2|Overall Study|Withdrawal by Subject|2
5559697|NCT01190410|19212662|P1|Overall Study|Withdrawal by Subject|0
5559698|NCT01190410|19212661|P2|Overall Study|Lack of Efficacy|2
5559699|NCT01190410|19212662|P1|Overall Study|Lack of Efficacy|0
5559700|NCT01190410|19212661|P2|Overall Study|Adverse Event|3
5559701|NCT01190410|19212662|P1|Overall Study|Adverse Event|0
5559702|NCT01190267|19212690|P2|Overall Study|Protocol Violation|1
5559703|NCT01190267|19212691|P1|Overall Study|Protocol Violation|8
5559704|NCT01190267|19212690|P2|Overall Study|Withdrawal by Subject|1
5559705|NCT01190267|19212691|P1|Overall Study|Withdrawal by Subject|13
5559706|NCT01190267|19212690|P2|Overall Study|Lost to Follow-up|0
5559707|NCT01190267|19212691|P1|Overall Study|Lost to Follow-up|2
5559708|NCT01190267|19212690|P2|Overall Study|Treatment Failure|2
5559709|NCT01190267|19212691|P1|Overall Study|Treatment Failure|8
5559710|NCT01190267|19212690|P2|Overall Study|Adverse Event|0
5559711|NCT01190267|19212691|P1|Overall Study|Adverse Event|10
5559712|NCT01190254|19212702|P3|Overall Study|Did not meet protocol eligibility|0
5559713|NCT01190254|19212703|P2|Overall Study|Did not meet protocol eligibility|0
5559714|NCT01190254|19212704|P1|Overall Study|Did not meet protocol eligibility|1
5559715|NCT01190254|19212702|P3|Overall Study|Protocol Violation|2
5559716|NCT01190254|19212703|P2|Overall Study|Protocol Violation|0
5559717|NCT01190254|19212704|P1|Overall Study|Protocol Violation|2
5559718|NCT01190254|19212702|P3|Overall Study|Withdrawal by Subject|7
5559719|NCT01190254|19212703|P2|Overall Study|Withdrawal by Subject|5
5559720|NCT01190254|19212704|P1|Overall Study|Withdrawal by Subject|4
5559721|NCT01190254|19212702|P3|Overall Study|Lost to Follow-up|0
5559722|NCT01190254|19212703|P2|Overall Study|Lost to Follow-up|2
5559723|NCT01190254|19212704|P1|Overall Study|Lost to Follow-up|4
5559724|NCT01190254|19212702|P3|Overall Study|Lack of Efficacy|5
5559725|NCT01190254|19212703|P2|Overall Study|Lack of Efficacy|4
5559726|NCT01190254|19212704|P1|Overall Study|Lack of Efficacy|7
5559727|NCT01190254|19212702|P3|Overall Study|Adverse Event|8
5559728|NCT01190254|19212703|P2|Overall Study|Adverse Event|6
5559729|NCT01190254|19212704|P1|Overall Study|Adverse Event|3
5559730|NCT01190228|19212769|P3|Overall Study|Withdrawal by Subject|0
5559731|NCT01190228|19212770|P2|Overall Study|Withdrawal by Subject|0
5559732|NCT01190228|19212771|P1|Overall Study|Withdrawal by Subject|1
5559733|NCT01190228|19212769|P3|Overall Study|Protocol Violation|0
5559734|NCT01190228|19212770|P2|Overall Study|Protocol Violation|0
5559735|NCT01190228|19212771|P1|Overall Study|Protocol Violation|4
5559736|NCT01190215|19212794|P2|Up to Month 6|Lost to Follow-up|0
5559737|NCT01190215|19212795|P1|Up to Month 6|Lost to Follow-up|2
5559738|NCT01190189|19213128|P1|Overall Study|Migrated/moved from study area|1
5559739|NCT01190189|19213128|P1|Overall Study|Withdrawal by Subject|1
5559740|NCT01190189|19213128|P1|Overall Study|Lost to Follow-up|4
5559741|NCT01190176|19213135|P1|Overall Study|Lost to Follow-up|1
5559742|NCT01190176|19213135|P1|Overall Study|Withdrawal by Subject|1
5559743|NCT01190150|19213156|P2|Washout|Difficulty in adherence|1
5559744|NCT01190150|19213157|P1|Washout|Difficulty in adherence|0
5559745|NCT01190150|19213156|P2|Washout|Withdrawal by Subject|1
5559746|NCT01190150|19213157|P1|Washout|Withdrawal by Subject|0
5559747|NCT01190150|19213156|P2|First Treatment|Withdrawal by Subject|0
5559748|NCT01190150|19213157|P1|First Treatment|Withdrawal by Subject|1
5559749|NCT01190124|19213184|P3|Overall Study|Lost to Follow-up|0
5559750|NCT01190124|19213185|P2|Overall Study|Lost to Follow-up|0
5559751|NCT01190124|19213186|P1|Overall Study|Lost to Follow-up|2
5559752|NCT01190124|19213184|P3|Overall Study|Therapeutic Failure|1
5559753|NCT01190124|19213185|P2|Overall Study|Therapeutic Failure|0
5559754|NCT01190124|19213186|P1|Overall Study|Therapeutic Failure|12
5559755|NCT01190124|19213184|P3|Overall Study|Death|0
5559756|NCT01190124|19213185|P2|Overall Study|Death|0
5559757|NCT01190124|19213186|P1|Overall Study|Death|3
5559758|NCT01190098|19213224|P2|Overall Study|Other|1
5559759|NCT01190098|19213225|P1|Overall Study|Other|0
5559760|NCT01190098|19213224|P2|Overall Study|Lack of transportation|0
5559761|NCT01190098|19213225|P1|Overall Study|Lack of transportation|1
5559762|NCT01190098|19213224|P2|Overall Study|Patient coomorbidity|1
5559763|NCT01190098|19213225|P1|Overall Study|Patient coomorbidity|0
5559764|NCT01190098|19213224|P2|Overall Study|Adverse Event|0
5559765|NCT01190098|19213225|P1|Overall Study|Adverse Event|2
5559766|NCT01190020|19213266|P2|Overall Study|Withdrawal by Subject|0
5559767|NCT01190020|19213267|P1|Overall Study|Withdrawal by Subject|3
5559768|NCT01190020|19213266|P2|Overall Study|Lost to Follow-up|0
5559769|NCT01190020|19213267|P1|Overall Study|Lost to Follow-up|2
5559770|NCT01190020|19213266|P2|Overall Study|Adverse Event|0
5559771|NCT01190020|19213267|P1|Overall Study|Adverse Event|2
5559772|NCT01190007|19213279|P1|Overall Study|Participant was arrested|1
5559773|NCT01190007|19213279|P1|Overall Study|Difficulty of visit for complications|1
5559774|NCT01190007|19213279|P1|Overall Study|Adverse Event|8
5559775|NCT01190007|19213279|P1|Overall Study|Withdrawal by Subject|4
5559776|NCT01189890|19213296|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
5559777|NCT01189890|19213297|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
5559778|NCT01189890|19213296|P2|Overall Study|Physician Decision|4
5559779|NCT01189890|19213297|P1|Overall Study|Physician Decision|5
5559780|NCT01189890|19213296|P2|Overall Study|Non Compliance|1
5559781|NCT01189890|19213297|P1|Overall Study|Non Compliance|0
5559782|NCT01189890|19213296|P2|Overall Study|Withdrawal by Subject|11
5559783|NCT01189890|19213297|P1|Overall Study|Withdrawal by Subject|15
5559784|NCT01189890|19213296|P2|Overall Study|Protocol Violation|5
5559785|NCT01189890|19213297|P1|Overall Study|Protocol Violation|1
5559786|NCT01189890|19213296|P2|Overall Study|Lost to Follow-up|7
5559787|NCT01189890|19213297|P1|Overall Study|Lost to Follow-up|1
5559788|NCT01189890|19213296|P2|Overall Study|Lack of Efficacy|2
5559789|NCT01189890|19213297|P1|Overall Study|Lack of Efficacy|7
5559790|NCT01189890|19213296|P2|Overall Study|Adverse Event|4
5559791|NCT01189890|19213297|P1|Overall Study|Adverse Event|3
5559792|NCT01189812|19213319|P2|Overall Study|Moved out of State|2
5559793|NCT01189812|19213320|P1|Overall Study|Moved out of State|1
5559794|NCT01189812|19213319|P2|Overall Study|Out of Window|3
5559795|NCT01189812|19213320|P1|Overall Study|Out of Window|4
5559796|NCT01189812|19213319|P2|Overall Study|Adverse Event|0
5559797|NCT01189812|19213320|P1|Overall Study|Adverse Event|1
5559798|NCT01189812|19213319|P2|Overall Study|Withdrawal by Subject|3
5559799|NCT01189812|19213320|P1|Overall Study|Withdrawal by Subject|2
5559800|NCT01189604|19213404|P7|Overall Study|Withdrawal by Subject|0
5559801|NCT01189604|19213405|P6|Overall Study|Withdrawal by Subject|0
5559802|NCT01189604|19213406|P5|Overall Study|Withdrawal by Subject|0
5559803|NCT01189604|19213407|P4|Overall Study|Withdrawal by Subject|0
5559804|NCT01189604|19213408|P3|Overall Study|Withdrawal by Subject|0
5559805|NCT01189604|19213409|P2|Overall Study|Withdrawal by Subject|0
5559806|NCT01189604|19213410|P1|Overall Study|Withdrawal by Subject|1
5559807|NCT01189604|19213404|P7|Overall Study|Adverse Event|1
5559808|NCT01189604|19213405|P6|Overall Study|Adverse Event|0
5559809|NCT01189604|19213406|P5|Overall Study|Adverse Event|2
5559810|NCT01189604|19213407|P4|Overall Study|Adverse Event|0
5559811|NCT01189604|19213408|P3|Overall Study|Adverse Event|0
5559812|NCT01189604|19213409|P2|Overall Study|Adverse Event|1
5559813|NCT01189604|19213410|P1|Overall Study|Adverse Event|0
5559814|NCT01189604|19213404|P7|Overall Study|Impossible to visit|0
5559815|NCT01189604|19213405|P6|Overall Study|Impossible to visit|1
5559816|NCT01189604|19213406|P5|Overall Study|Impossible to visit|0
5559817|NCT01189604|19213407|P4|Overall Study|Impossible to visit|0
5559818|NCT01189604|19213408|P3|Overall Study|Impossible to visit|0
5559819|NCT01189604|19213409|P2|Overall Study|Impossible to visit|0
5559820|NCT01189604|19213410|P1|Overall Study|Impossible to visit|0
5559821|NCT01189500|19213454|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
5559822|NCT01189500|19213454|P1|Period 1: TAMOX Alone|Adverse Event|1
5559823|NCT01189487|19213515|P1|Overall Study|Adverse Event|1
5559824|NCT01189487|19213515|P1|Overall Study|Lack of Efficacy|2
5559825|NCT01189461|19213523|P1|Overall Study|Other|8
5559826|NCT01189461|19213523|P1|Overall Study|Did not meet entrance criteria|3
5559827|NCT01189461|19213523|P1|Overall Study|Adverse Event|2
5559828|NCT01189461|19213523|P1|Overall Study|Protocol Violation|1
5559829|NCT01189461|19213523|P1|Overall Study|Withdrawal by Subject|6
5559830|NCT01189461|19213523|P1|Overall Study|Lost to Follow-up|1
5559831|NCT01189461|19213523|P1|Overall Study|Lack of Efficacy|13
5559832|NCT01189435|19213530|P1|Overall Study|Physician Decision|1
5559833|NCT01189435|19213530|P1|Overall Study|Withdrawal by Subject|1
5559834|NCT01189266|19213610|P3|Overall Study|No treatment|1
5559835|NCT01189266|19213611|P2|Overall Study|No treatment|0
5559836|NCT01189266|19213612|P1|Overall Study|No treatment|0
5559837|NCT01189266|19213610|P3|Overall Study|Patient refuses further therapy|7
5559838|NCT01189266|19213611|P2|Overall Study|Patient refuses further therapy|0
5559839|NCT01189266|19213612|P1|Overall Study|Patient refuses further therapy|1
5559840|NCT01189266|19213610|P3|Overall Study|Withdrawal by Subject|1
5559841|NCT01189266|19213611|P2|Overall Study|Withdrawal by Subject|0
5559842|NCT01189266|19213612|P1|Overall Study|Withdrawal by Subject|0
5559843|NCT01189266|19213610|P3|Overall Study|Protocol Violation|1
5559844|NCT01189266|19213611|P2|Overall Study|Protocol Violation|1
5559845|NCT01189266|19213612|P1|Overall Study|Protocol Violation|0
5559846|NCT01189266|19213610|P3|Overall Study|Physician Decision|1
5559847|NCT01189266|19213611|P2|Overall Study|Physician Decision|0
5559848|NCT01189266|19213612|P1|Overall Study|Physician Decision|0
5559849|NCT01189266|19213610|P3|Overall Study|Lack of Efficacy|44
5559850|NCT01189266|19213611|P2|Overall Study|Lack of Efficacy|5
5559851|NCT01189266|19213612|P1|Overall Study|Lack of Efficacy|4
5559852|NCT01189266|19213610|P3|Overall Study|Death|5
5559853|NCT01189266|19213611|P2|Overall Study|Death|0
5559854|NCT01189266|19213612|P1|Overall Study|Death|0
5559855|NCT01189266|19213610|P3|Overall Study|Adverse Event|5
5559856|NCT01189266|19213611|P2|Overall Study|Adverse Event|0
5559857|NCT01189266|19213612|P1|Overall Study|Adverse Event|1
5559858|NCT01189227|19213662|P2|Overall Study|Study terminated due to low accrual|3
5559859|NCT01189227|19213663|P1|Overall Study|Study terminated due to low accrual|6
5559860|NCT01189201|19213669|P1|Overall Study|Adverse Event|1
5559861|NCT01189032|19213772|P3|Overall Study|Protocol Violation|1
5559862|NCT01189032|19213773|P2|Overall Study|Protocol Violation|1
5559863|NCT01189032|19213774|P1|Overall Study|Protocol Violation|1
5559864|NCT01189032|19213772|P3|Overall Study|Withdrawal by Subject|1
5559865|NCT01189032|19213773|P2|Overall Study|Withdrawal by Subject|0
5559866|NCT01189032|19213774|P1|Overall Study|Withdrawal by Subject|1
5559867|NCT01189032|19213772|P3|Overall Study|Lack of Efficacy|0
5559868|NCT01189032|19213773|P2|Overall Study|Lack of Efficacy|3
5559869|NCT01189032|19213774|P1|Overall Study|Lack of Efficacy|2
5559870|NCT01189032|19213772|P3|Overall Study|Adverse Event|4
5559871|NCT01189032|19213773|P2|Overall Study|Adverse Event|3
5559872|NCT01189032|19213774|P1|Overall Study|Adverse Event|1
5559873|NCT01188967|19213784|P2|Overall Study|Lost to Follow-up|2
5559874|NCT01188967|19213785|P1|Overall Study|Lost to Follow-up|3
5559875|NCT01188967|19213784|P2|Overall Study|Physician Decision|1
5559876|NCT01188967|19213785|P1|Overall Study|Physician Decision|1
5559877|NCT01188967|19213784|P2|Overall Study|Withdrawal by Subject|1
5559878|NCT01188967|19213785|P1|Overall Study|Withdrawal by Subject|1
5559879|NCT01188811|19213838|P2|Overall Study|Adverse Event|0
5559880|NCT01188811|19213839|P1|Overall Study|Adverse Event|6
5559881|NCT01188811|19213838|P2|Overall Study|Withdrawal by Subject|2
5559882|NCT01188811|19213839|P1|Overall Study|Withdrawal by Subject|0
5559883|NCT01188798|19213851|P2|Overall Study|Protocol closure|1
5559884|NCT01188798|19213852|P1|Overall Study|Protocol closure|1
5559885|NCT01188798|19213851|P2|Overall Study|Required additional transplant|1
5559886|NCT01188798|19213852|P1|Overall Study|Required additional transplant|1
5559887|NCT01188798|19213851|P2|Overall Study|Death|1
5559888|NCT01188798|19213852|P1|Overall Study|Death|0
5559889|NCT01188772|19213864|P4|Overall Study|Withdrawal by Subject|0
5559890|NCT01188772|19213865|P3|Overall Study|Withdrawal by Subject|2
5559891|NCT01188772|19213866|P2|Overall Study|Withdrawal by Subject|0
5559892|NCT01188772|19213867|P1|Overall Study|Withdrawal by Subject|0
5559893|NCT01188772|19213864|P4|Overall Study|Virologic Failure|0
5559894|NCT01188772|19213865|P3|Overall Study|Virologic Failure|0
5559895|NCT01188772|19213866|P2|Overall Study|Virologic Failure|0
5559896|NCT01188772|19213867|P1|Overall Study|Virologic Failure|1
5559897|NCT01188772|19213864|P4|Overall Study|Treatment Failure|0
5559898|NCT01188772|19213865|P3|Overall Study|Treatment Failure|1
5559899|NCT01188772|19213866|P2|Overall Study|Treatment Failure|0
5559900|NCT01188772|19213867|P1|Overall Study|Treatment Failure|0
5559901|NCT01188772|19213864|P4|Overall Study|Terminated by Sponsor|0
5559902|NCT01188772|19213865|P3|Overall Study|Terminated by Sponsor|1
5559903|NCT01188772|19213866|P2|Overall Study|Terminated by Sponsor|0
5559904|NCT01188772|19213867|P1|Overall Study|Terminated by Sponsor|0
5559905|NCT01188772|19213864|P4|Overall Study|Physician Decision|0
5559906|NCT01188772|19213865|P3|Overall Study|Physician Decision|1
5559907|NCT01188772|19213866|P2|Overall Study|Physician Decision|0
5559908|NCT01188772|19213867|P1|Overall Study|Physician Decision|0
5559909|NCT01188772|19213864|P4|Overall Study|Non-responder|0
5559910|NCT01188772|19213865|P3|Overall Study|Non-responder|3
5559911|NCT01188772|19213866|P2|Overall Study|Non-responder|0
5559912|NCT01188772|19213867|P1|Overall Study|Non-responder|0
5559913|NCT01188772|19213864|P4|Overall Study|Lost to Follow-up|1
5559914|NCT01188772|19213865|P3|Overall Study|Lost to Follow-up|1
5559915|NCT01188772|19213866|P2|Overall Study|Lost to Follow-up|1
5559916|NCT01188772|19213867|P1|Overall Study|Lost to Follow-up|4
5559917|NCT01188772|19213864|P4|Overall Study|Adverse Event|0
5559918|NCT01188772|19213865|P3|Overall Study|Adverse Event|2
5559919|NCT01188772|19213866|P2|Overall Study|Adverse Event|1
5559920|NCT01188772|19213867|P1|Overall Study|Adverse Event|0
5559921|NCT01188772|19213864|P4|Overall Study|Randomized but Not Treated|0
5559922|NCT01188772|19213865|P3|Overall Study|Randomized but Not Treated|0
5559923|NCT01188772|19213866|P2|Overall Study|Randomized but Not Treated|1
5559924|NCT01188772|19213867|P1|Overall Study|Randomized but Not Treated|0
5559925|NCT01188681|19213939|P4|Overall Study|Withdrawal by Subject|1
5559926|NCT01188681|19213940|P3|Overall Study|Withdrawal by Subject|0
5559927|NCT01188681|19213941|P2|Overall Study|Withdrawal by Subject|0
5559928|NCT01188681|19213942|P1|Overall Study|Withdrawal by Subject|0
5559929|NCT01188681|19213939|P4|Overall Study|bladder cancer|0
5559930|NCT01188681|19213940|P3|Overall Study|bladder cancer|1
5559931|NCT01188681|19213941|P2|Overall Study|bladder cancer|0
5559932|NCT01188681|19213942|P1|Overall Study|bladder cancer|0
5559933|NCT01188668|19213956|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
5559934|NCT01188668|19213956|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
5559935|NCT01188668|19213956|P1|Period 1: ARIP Alone|Protocol Violation|2
5559936|NCT01188655|19213989|P1|Overall Study|Other|11
5559937|NCT01188655|19213989|P1|Overall Study|Lost to Follow-up|1
5559938|NCT01188655|19213989|P1|Overall Study|Lack of Efficacy|1
5559939|NCT01188564|19214033|P2|Double-blind Phase|randomized not treated|0
5559940|NCT01188564|19214034|P1|Double-blind Phase|randomized not treated|1
5559941|NCT01188551|19214046|P4|Overall Study|Pharmacy issues|0
5559942|NCT01188551|19214047|P3|Overall Study|Pharmacy issues|0
5559943|NCT01188551|19214048|P2|Overall Study|Pharmacy issues|0
5559944|NCT01188551|19214049|P1|Overall Study|Pharmacy issues|1
5559945|NCT01188538|19214065|P2|Overall Study|Lost to Follow-up|1
5559946|NCT01188538|19214066|P1|Overall Study|Lost to Follow-up|0
5559947|NCT01188343|19214162|P3|Overall Study|Withdrawal by Subject|0
5559948|NCT01188343|19214163|P2|Overall Study|Withdrawal by Subject|24
5559949|NCT01188343|19214164|P1|Overall Study|Withdrawal by Subject|1
5559950|NCT01188343|19214162|P3|Overall Study|Not vaccinated|1
5559951|NCT01188343|19214163|P2|Overall Study|Not vaccinated|2
5559952|NCT01188343|19214164|P1|Overall Study|Not vaccinated|0
5559953|NCT01188226|19214190|P1|Overall Study|Withdrawal by Subject|4
5559954|NCT01187953|19214236|P2|Overall Study|Withdrawal by Subject|3
5559955|NCT01187953|19214237|P1|Overall Study|Withdrawal by Subject|3
5559956|NCT01187953|19214236|P2|Overall Study|Lost to Follow-up|3
5559957|NCT01187953|19214237|P1|Overall Study|Lost to Follow-up|0
5559958|NCT01187953|19214236|P2|Overall Study|Adverse Event|2
5559959|NCT01187953|19214237|P1|Overall Study|Adverse Event|1
5559960|NCT01187953|19214236|P2|Overall Study|Death|13
5559961|NCT01187953|19214237|P1|Overall Study|Death|11
5559962|NCT01187901|19214251|P2|Overall Study|Pregnancy|2
5559963|NCT01187901|19214252|P1|Overall Study|Pregnancy|0
5559964|NCT01187901|19214251|P2|Overall Study|No Endpoint due to Early Study Halt|3
5559965|NCT01187901|19214252|P1|Overall Study|No Endpoint due to Early Study Halt|2
5559966|NCT01187901|19214251|P2|Overall Study|Adverse Event|0
5559967|NCT01187901|19214252|P1|Overall Study|Adverse Event|3
5559968|NCT01187901|19214251|P2|Overall Study|Suspected Allergic Reaction|1
5559969|NCT01187901|19214252|P1|Overall Study|Suspected Allergic Reaction|1
5559970|NCT01187901|19214251|P2|Overall Study|Unrelated Health Reasons|2
5559971|NCT01187901|19214252|P1|Overall Study|Unrelated Health Reasons|1
5559972|NCT01187901|19214251|P2|Overall Study|Lost to Follow-up|2
5559973|NCT01187901|19214252|P1|Overall Study|Lost to Follow-up|1
5559974|NCT01187901|19214251|P2|Overall Study|Protocol Violation|0
5559975|NCT01187901|19214252|P1|Overall Study|Protocol Violation|1
5559976|NCT01187550|19214293|P2|Overall Study|Randomized but not treated|0
5559977|NCT01187550|19214294|P1|Overall Study|Randomized but not treated|8
5559978|NCT01187550|19214293|P2|Overall Study|Other|0
5559979|NCT01187550|19214294|P1|Overall Study|Other|3
5559980|NCT01187550|19214293|P2|Overall Study|Protocol Violation|1
5559981|NCT01187550|19214294|P1|Overall Study|Protocol Violation|3
5559982|NCT01187446|19214450|P2|Overall Study|Patient started non-protocol therapy|1
5559983|NCT01187446|19214451|P1|Overall Study|Patient started non-protocol therapy|0
5559984|NCT01187433|19214467|P2|Overall Study|Withdrawal by Subject|2
5559985|NCT01187433|19214468|P1|Overall Study|Withdrawal by Subject|5
5559986|NCT01187433|19214467|P2|Overall Study|Protocol Violation|2
5559987|NCT01187433|19214468|P1|Overall Study|Protocol Violation|6
5559988|NCT01187407|19214498|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
5559989|NCT01187407|19214499|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5559990|NCT01187407|19214500|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5559991|NCT01187407|19214501|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5559992|NCT01187407|19214502|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5559993|NCT01187407|19214498|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
5559994|NCT01187407|19214499|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
5559995|NCT01187407|19214500|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
5559996|NCT01187407|19214501|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
5559997|NCT01187407|19214502|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
5559998|NCT01187407|19214498|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
5559999|NCT01187407|19214499|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
5560000|NCT01187407|19214500|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5560001|NCT01187407|19214501|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
5560002|NCT01187407|19214502|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
5560003|NCT01187407|19214498|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
5560004|NCT01187407|19214499|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5560005|NCT01187407|19214500|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5560006|NCT01187407|19214501|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5560007|NCT01187407|19214502|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5560008|NCT01187407|19214498|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
5560009|NCT01187407|19214499|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
5560010|NCT01187407|19214500|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
5560011|NCT01187407|19214501|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
5560012|NCT01187407|19214502|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5560013|NCT01187407|19214498|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
5560014|NCT01187407|19214499|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
5560015|NCT01187407|19214500|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
5560016|NCT01187407|19214501|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
5560017|NCT01187407|19214502|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
5560018|NCT01187407|19214498|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
5560019|NCT01187407|19214499|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
5560020|NCT01187407|19214500|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
5560021|NCT01187407|19214501|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
5560022|NCT01187407|19214502|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
5560023|NCT01187407|19214498|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5560024|NCT01187407|19214499|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5560025|NCT01187407|19214500|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5560026|NCT01187407|19214501|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5560027|NCT01187407|19214502|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
5560028|NCT01187407|19214498|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5560029|NCT01187407|19214499|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5560030|NCT01187407|19214500|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5560031|NCT01187407|19214501|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5560032|NCT01187407|19214502|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
5560033|NCT01187407|19214498|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5560034|NCT01187407|19214499|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5560035|NCT01187407|19214500|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5560036|NCT01187407|19214501|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5560037|NCT01187407|19214502|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
5560038|NCT01187407|19214498|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5560039|NCT01187407|19214499|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5560040|NCT01187407|19214500|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5560041|NCT01187407|19214501|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5560042|NCT01187407|19214502|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
5560043|NCT01187407|19214498|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5560044|NCT01187407|19214499|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5560045|NCT01187407|19214500|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5560046|NCT01187407|19214501|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5560047|NCT01187407|19214502|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
5560048|NCT01187407|19214498|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5560049|NCT01187407|19214499|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5560050|NCT01187407|19214500|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5560051|NCT01187407|19214501|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5560052|NCT01187407|19214502|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
5560053|NCT01187407|19214498|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5560054|NCT01187407|19214499|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5560055|NCT01187407|19214500|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5560056|NCT01187407|19214501|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5560057|NCT01187407|19214502|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
5560058|NCT01187043|19214615|P5|Overall Study|Unable to make scheduled visits|1
5560059|NCT01187043|19214616|P4|Overall Study|Unable to make scheduled visits|0
5560060|NCT01187043|19214617|P3|Overall Study|Unable to make scheduled visits|4
5560061|NCT01187043|19214618|P2|Overall Study|Unable to make scheduled visits|0
5560062|NCT01187043|19214619|P1|Overall Study|Unable to make scheduled visits|1
5560063|NCT01187043|19214615|P5|Overall Study|Adverse Event|1
5560064|NCT01187043|19214616|P4|Overall Study|Adverse Event|0
5560065|NCT01187043|19214617|P3|Overall Study|Adverse Event|0
5560066|NCT01187043|19214618|P2|Overall Study|Adverse Event|0
5560067|NCT01187043|19214619|P1|Overall Study|Adverse Event|0
5560068|NCT01186978|19214645|P1|Overall Study|Withdrawal by Subject|1
5560069|NCT01186939|19214652|P1|Overall Study|Transformation to AML|1
5560070|NCT01186939|19214652|P1|Overall Study|Bone marrow transplant|1
5560071|NCT01186939|19214652|P1|Overall Study|Myocardial infarction|1
5560072|NCT01186939|19214652|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
5560073|NCT01186939|19214652|P1|Overall Study|Started additional treatment|1
5560074|NCT01186939|19214652|P1|Overall Study|Sponsor decision|4
5560075|NCT01186939|19214652|P1|Overall Study|Program closed|5
5560076|NCT01186939|19214652|P1|Overall Study|No longer receiving clinical benefit|17
5560077|NCT01186939|19214652|P1|Overall Study|Withdrawal by Subject|2
5560078|NCT01186939|19214652|P1|Overall Study|Death|7
5560079|NCT01186848|19214656|P1|Overall Study|Adverse Event|2
5560080|NCT01186848|19214656|P1|Overall Study|Withdrawal by Subject|2
5560081|NCT01186848|19214656|P1|Overall Study|Lost to Follow-up|4
5560082|NCT01186809|19214662|P1|Overall Study|Death|30
5560083|NCT01186796|19214668|P2|Overall Study|Protocol Violation|1
5560084|NCT01186796|19214669|P1|Overall Study|Protocol Violation|0
5560085|NCT01186796|19214668|P2|Overall Study|Withdrawal by Subject|1
5560086|NCT01186796|19214669|P1|Overall Study|Withdrawal by Subject|1
5560087|NCT01186796|19214668|P2|Overall Study|Adverse Event|0
5560088|NCT01186796|19214669|P1|Overall Study|Adverse Event|3
5560089|NCT01186770|19214687|P4|Overall Study|Other than specified|2
5560090|NCT01186770|19214688|P3|Overall Study|Other than specified|1
5560091|NCT01186770|19214689|P2|Overall Study|Other than specified|1
5560092|NCT01186770|19214690|P1|Overall Study|Other than specified|0
5560093|NCT01186770|19214687|P4|Overall Study|Insufficient response to treatment|7
5560094|NCT01186770|19214688|P3|Overall Study|Insufficient response to treatment|5
5560095|NCT01186770|19214689|P2|Overall Study|Insufficient response to treatment|8
5560096|NCT01186770|19214690|P1|Overall Study|Insufficient response to treatment|7
5560097|NCT01186770|19214687|P4|Overall Study|Lost to Follow-up|9
5560098|NCT01186770|19214688|P3|Overall Study|Lost to Follow-up|14
5560099|NCT01186770|19214689|P2|Overall Study|Lost to Follow-up|6
5560100|NCT01186770|19214690|P1|Overall Study|Lost to Follow-up|10
5560101|NCT01186770|19214687|P4|Overall Study|Withdrawal by Subject|17
5560102|NCT01186770|19214688|P3|Overall Study|Withdrawal by Subject|11
5560103|NCT01186770|19214689|P2|Overall Study|Withdrawal by Subject|13
5560104|NCT01186770|19214690|P1|Overall Study|Withdrawal by Subject|15
5560105|NCT01186770|19214687|P4|Overall Study|Adverse Event|9
5560106|NCT01186770|19214688|P3|Overall Study|Adverse Event|7
5560107|NCT01186770|19214689|P2|Overall Study|Adverse Event|9
5560108|NCT01186770|19214690|P1|Overall Study|Adverse Event|2
5560109|NCT01186770|19214687|P4|Overall Study|Protocol Violation|14
5560110|NCT01186770|19214688|P3|Overall Study|Protocol Violation|12
5560111|NCT01186770|19214689|P2|Overall Study|Protocol Violation|9
5560112|NCT01186770|19214690|P1|Overall Study|Protocol Violation|7
5560113|NCT01186770|19214687|P4|Overall Study|Ineligibility|0
5560114|NCT01186770|19214688|P3|Overall Study|Ineligibility|2
5560115|NCT01186770|19214689|P2|Overall Study|Ineligibility|0
5560116|NCT01186770|19214690|P1|Overall Study|Ineligibility|0
5560117|NCT01186744|19214714|P6|Overall Study|Death|0
5560118|NCT01186744|19214715|P5|Overall Study|Death|0
5560119|NCT01186744|19214716|P4|Overall Study|Death|0
5560120|NCT01186744|19214717|P3|Overall Study|Death|0
5560121|NCT01186744|19214718|P2|Overall Study|Death|0
5560122|NCT01186744|19214719|P1|Overall Study|Death|1
5560123|NCT01186744|19214714|P6|Overall Study|Adverse Event|4
5560124|NCT01186744|19214715|P5|Overall Study|Adverse Event|1
5560125|NCT01186744|19214716|P4|Overall Study|Adverse Event|0
5560126|NCT01186744|19214717|P3|Overall Study|Adverse Event|1
5560127|NCT01186744|19214718|P2|Overall Study|Adverse Event|14
5560128|NCT01186744|19214719|P1|Overall Study|Adverse Event|10
5560129|NCT01186744|19214714|P6|Overall Study|Other|5
5560130|NCT01186744|19214715|P5|Overall Study|Other|1
5560131|NCT01186744|19214716|P4|Overall Study|Other|2
5560132|NCT01186744|19214717|P3|Overall Study|Other|1
5560133|NCT01186744|19214718|P2|Overall Study|Other|10
5560134|NCT01186744|19214719|P1|Overall Study|Other|9
5560135|NCT01186744|19214714|P6|Overall Study|Study terminated by Sponsor|0
5560136|NCT01186744|19214715|P5|Overall Study|Study terminated by Sponsor|0
5560137|NCT01186744|19214716|P4|Overall Study|Study terminated by Sponsor|0
5560138|NCT01186744|19214717|P3|Overall Study|Study terminated by Sponsor|0
5560139|NCT01186744|19214718|P2|Overall Study|Study terminated by Sponsor|0
5560140|NCT01186744|19214719|P1|Overall Study|Study terminated by Sponsor|1
5560141|NCT01186744|19214714|P6|Overall Study|Withdrawal by Subject|6
5560142|NCT01186744|19214715|P5|Overall Study|Withdrawal by Subject|0
5560143|NCT01186744|19214716|P4|Overall Study|Withdrawal by Subject|5
5560144|NCT01186744|19214717|P3|Overall Study|Withdrawal by Subject|2
5560145|NCT01186744|19214718|P2|Overall Study|Withdrawal by Subject|10
5560146|NCT01186744|19214719|P1|Overall Study|Withdrawal by Subject|14
5560147|NCT01186744|19214714|P6|Overall Study|Screen failure|0
5560148|NCT01186744|19214715|P5|Overall Study|Screen failure|0
5560149|NCT01186744|19214716|P4|Overall Study|Screen failure|1
5560150|NCT01186744|19214717|P3|Overall Study|Screen failure|0
5560151|NCT01186744|19214718|P2|Overall Study|Screen failure|1
5560152|NCT01186744|19214719|P1|Overall Study|Screen failure|1
5560153|NCT01186744|19214714|P6|Overall Study|Lost to Follow-up|4
5560154|NCT01186744|19214715|P5|Overall Study|Lost to Follow-up|1
5560155|NCT01186744|19214716|P4|Overall Study|Lost to Follow-up|1
5560156|NCT01186744|19214717|P3|Overall Study|Lost to Follow-up|2
5560157|NCT01186744|19214718|P2|Overall Study|Lost to Follow-up|16
5560158|NCT01186744|19214719|P1|Overall Study|Lost to Follow-up|15
5560159|NCT01186744|19214714|P6|Overall Study|Protocol Violation|2
5560160|NCT01186744|19214715|P5|Overall Study|Protocol Violation|1
5560161|NCT01186744|19214716|P4|Overall Study|Protocol Violation|1
5560162|NCT01186744|19214717|P3|Overall Study|Protocol Violation|0
5560163|NCT01186744|19214718|P2|Overall Study|Protocol Violation|2
5560164|NCT01186744|19214719|P1|Overall Study|Protocol Violation|1
5560165|NCT01186744|19214714|P6|Overall Study|Lack of Efficacy|5
5560166|NCT01186744|19214715|P5|Overall Study|Lack of Efficacy|2
5560167|NCT01186744|19214716|P4|Overall Study|Lack of Efficacy|2
5560168|NCT01186744|19214717|P3|Overall Study|Lack of Efficacy|0
5560169|NCT01186744|19214718|P2|Overall Study|Lack of Efficacy|99
5560170|NCT01186744|19214719|P1|Overall Study|Lack of Efficacy|156
5560171|NCT01186692|19215139|P1|Overall Study|Adverse Event|2
5560172|NCT01186692|19215139|P1|Overall Study|Futher testing contraindicated implant|19
5560173|NCT01186692|19215139|P1|Overall Study|Not Catheterized|11
5560174|NCT01186458|19215166|P1|Overall Study|Adverse Event|1
5560175|NCT01186419|19215175|P2|Overall Study|Other|1
5560176|NCT01186419|19215176|P1|Overall Study|Other|1
5560177|NCT01186419|19215175|P2|Overall Study|Physician Decision|3
5560178|NCT01186419|19215176|P1|Overall Study|Physician Decision|0
5560179|NCT01186419|19215175|P2|Overall Study|Adverse Event|2
5560180|NCT01186419|19215176|P1|Overall Study|Adverse Event|1
5560181|NCT01186419|19215175|P2|Overall Study|Withdrawal by Subject|3
5560182|NCT01186419|19215176|P1|Overall Study|Withdrawal by Subject|5
5560183|NCT01186328|19215190|P3|Overall Study|Death|0
5560184|NCT01186328|19215191|P2|Overall Study|Death|0
5560185|NCT01186328|19215192|P1|Overall Study|Death|1
5560186|NCT01185964|19215222|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
5560187|NCT01185964|19215223|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
5560188|NCT01185964|19215224|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
5560189|NCT01185964|19215225|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
5560190|NCT01185964|19215222|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
5560191|NCT01185964|19215223|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
5560192|NCT01185964|19215224|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
5560193|NCT01185964|19215225|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
5560194|NCT01185964|19215222|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
5560195|NCT01185964|19215223|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
5560196|NCT01185964|19215224|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
5560197|NCT01185964|19215225|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
5560198|NCT01185964|19215222|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
5560199|NCT01185964|19215223|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
5560200|NCT01185964|19215224|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
5560201|NCT01185964|19215225|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
5560202|NCT01185964|19215222|P4|Phase 1b and Phase 2|Adverse Event|0
5560203|NCT01185964|19215223|P3|Phase 1b and Phase 2|Adverse Event|2
5560204|NCT01185964|19215224|P2|Phase 1b and Phase 2|Adverse Event|0
5560205|NCT01185964|19215225|P1|Phase 1b and Phase 2|Adverse Event|1
5560206|NCT01185964|19215222|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
5560207|NCT01185964|19215223|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
5560208|NCT01185964|19215224|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
5560209|NCT01185964|19215225|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
5560210|NCT01185964|19215222|P4|Phase 1b and Phase 2|Other Therapy Started|0
5560211|NCT01185964|19215223|P3|Phase 1b and Phase 2|Other Therapy Started|3
5560212|NCT01185964|19215224|P2|Phase 1b and Phase 2|Other Therapy Started|3
5560213|NCT01185964|19215225|P1|Phase 1b and Phase 2|Other Therapy Started|0
5560214|NCT01185964|19215222|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
5560215|NCT01185964|19215223|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
5560216|NCT01185964|19215224|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
5560217|NCT01185964|19215225|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
5560218|NCT01185834|19215251|P1|Overall Study|Early exit - Site error|2
5560219|NCT01185834|19215251|P1|Overall Study|Time/Job Conflict|2
5560220|NCT01185834|19215251|P1|Overall Study|Biomicroscopy|4
5560221|NCT01185834|19215251|P1|Overall Study|Discomfort|4
5560222|NCT01185834|19215251|P1|Overall Study|Lost to Follow-up|2
5560223|NCT01185821|19215261|P5|Overall Study|Administrative problems|2
5560224|NCT01185821|19215262|P4|Overall Study|Administrative problems|1
5560225|NCT01185821|19215263|P3|Overall Study|Administrative problems|1
5560226|NCT01185821|19215264|P2|Overall Study|Administrative problems|0
5560227|NCT01185821|19215265|P1|Overall Study|Administrative problems|0
5560228|NCT01185821|19215261|P5|Overall Study|Lost to Follow-up|2
5560229|NCT01185821|19215262|P4|Overall Study|Lost to Follow-up|1
5560230|NCT01185821|19215263|P3|Overall Study|Lost to Follow-up|2
5560231|NCT01185821|19215264|P2|Overall Study|Lost to Follow-up|1
5560232|NCT01185821|19215265|P1|Overall Study|Lost to Follow-up|1
5560233|NCT01185821|19215261|P5|Overall Study|Withdrawal by Subject|3
5560234|NCT01185821|19215262|P4|Overall Study|Withdrawal by Subject|1
5560235|NCT01185821|19215263|P3|Overall Study|Withdrawal by Subject|2
5560236|NCT01185821|19215264|P2|Overall Study|Withdrawal by Subject|2
5560237|NCT01185821|19215265|P1|Overall Study|Withdrawal by Subject|3
5560238|NCT01185821|19215261|P5|Overall Study|Lack of Efficacy|9
5560239|NCT01185821|19215262|P4|Overall Study|Lack of Efficacy|0
5560240|NCT01185821|19215263|P3|Overall Study|Lack of Efficacy|3
5560241|NCT01185821|19215264|P2|Overall Study|Lack of Efficacy|0
5560242|NCT01185821|19215265|P1|Overall Study|Lack of Efficacy|0
5560243|NCT01185821|19215261|P5|Overall Study|Adverse Event|5
5560244|NCT01185821|19215262|P4|Overall Study|Adverse Event|2
5560245|NCT01185821|19215263|P3|Overall Study|Adverse Event|1
5560246|NCT01185821|19215264|P2|Overall Study|Adverse Event|3
5560247|NCT01185821|19215265|P1|Overall Study|Adverse Event|2
5560248|NCT01185821|19215261|P5|Overall Study|Condition no longer required study drug|1
5560249|NCT01185821|19215262|P4|Overall Study|Condition no longer required study drug|0
5560250|NCT01185821|19215263|P3|Overall Study|Condition no longer required study drug|0
5560251|NCT01185821|19215264|P2|Overall Study|Condition no longer required study drug|0
5560252|NCT01185821|19215265|P1|Overall Study|Condition no longer required study drug|0
5560253|NCT01185821|19215261|P5|Overall Study|Death|0
5560254|NCT01185821|19215262|P4|Overall Study|Death|0
5560255|NCT01185821|19215263|P3|Overall Study|Death|0
5560256|NCT01185821|19215264|P2|Overall Study|Death|1
5560257|NCT01185821|19215265|P1|Overall Study|Death|0
5560258|NCT01185821|19215261|P5|Overall Study|Abnormal test procedure result|1
5560259|NCT01185821|19215262|P4|Overall Study|Abnormal test procedure result|0
5560260|NCT01185821|19215263|P3|Overall Study|Abnormal test procedure result|0
5560261|NCT01185821|19215264|P2|Overall Study|Abnormal test procedure result|0
5560262|NCT01185821|19215265|P1|Overall Study|Abnormal test procedure result|0
5560263|NCT01185821|19215261|P5|Overall Study|Protocol Violation|1
5560264|NCT01185821|19215262|P4|Overall Study|Protocol Violation|1
5560265|NCT01185821|19215263|P3|Overall Study|Protocol Violation|0
5560266|NCT01185821|19215264|P2|Overall Study|Protocol Violation|0
5560267|NCT01185821|19215265|P1|Overall Study|Protocol Violation|0
5560268|NCT01185821|19215261|P5|Overall Study|Abnormal laboratory value(s)|0
5560269|NCT01185821|19215262|P4|Overall Study|Abnormal laboratory value(s)|0
5560270|NCT01185821|19215263|P3|Overall Study|Abnormal laboratory value(s)|1
5560271|NCT01185821|19215264|P2|Overall Study|Abnormal laboratory value(s)|2
5560272|NCT01185821|19215265|P1|Overall Study|Abnormal laboratory value(s)|1
5560273|NCT01185782|19215316|P2|Overall Study|Randomized but not treated|4
5560274|NCT01185782|19215317|P1|Overall Study|Randomized but not treated|0
5560275|NCT01185782|19215316|P2|Overall Study|Other|5
5560276|NCT01185782|19215317|P1|Overall Study|Other|2
5560277|NCT01185782|19215316|P2|Overall Study|Poor Response to Treatment|1
5560278|NCT01185782|19215317|P1|Overall Study|Poor Response to Treatment|3
5560279|NCT01185782|19215316|P2|Overall Study|Protocol Violation|0
5560280|NCT01185782|19215317|P1|Overall Study|Protocol Violation|1
5560281|NCT01185782|19215316|P2|Overall Study|Adverse Event|1
5560282|NCT01185782|19215317|P1|Overall Study|Adverse Event|0
5560283|NCT01185704|19215345|P2|Overall Study|Ectopic pregnancy|1
5560284|NCT01185704|19215346|P1|Overall Study|Ectopic pregnancy|0
5560285|NCT01185704|19215345|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
5560286|NCT01185704|19215346|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
5560287|NCT01185704|19215345|P2|Overall Study|Lack of ovarian response|1
5560288|NCT01185704|19215346|P1|Overall Study|Lack of ovarian response|5
5560289|NCT01185704|19215345|P2|Overall Study|Randomized but not treated|3
5560290|NCT01185704|19215346|P1|Overall Study|Randomized but not treated|3
5560291|NCT01185639|19215380|P1|Overall Study|Progressed and didn't receive therapy|2
5560292|NCT01185600|19215390|P2|Overall Study|Hold by DSMB|2
5560293|NCT01185600|19215391|P1|Overall Study|Hold by DSMB|1
5560294|NCT01185600|19215390|P2|Overall Study|Withdrawal by Subject|1
5560295|NCT01185600|19215391|P1|Overall Study|Withdrawal by Subject|1
5560296|NCT01185600|19215390|P2|Overall Study|Physician Decision|35
5560297|NCT01185600|19215391|P1|Overall Study|Physician Decision|29
5560298|NCT01185600|19215390|P2|Overall Study|Lost to Follow-up|5
5560299|NCT01185600|19215391|P1|Overall Study|Lost to Follow-up|0
5560300|NCT01185600|19215390|P2|Overall Study|Death|1
5560301|NCT01185600|19215391|P1|Overall Study|Death|0
5560302|NCT01185600|19215390|P2|Overall Study|Adverse Event|1
5560303|NCT01185600|19215391|P1|Overall Study|Adverse Event|1
5560304|NCT01185561|19215413|P2|Overall Study|Withdrawal by Subject|8
5560305|NCT01185561|19215414|P1|Overall Study|Withdrawal by Subject|2
5560306|NCT01185561|19215413|P2|Overall Study|Lost to Follow-up|4
5560307|NCT01185561|19215414|P1|Overall Study|Lost to Follow-up|0
5560308|NCT01185548|19215426|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
5560309|NCT01185522|19215439|P1|Overall Study|Other reasons|12
5560310|NCT01185522|19215439|P1|Overall Study|Poor tolerance|39
5560311|NCT01185522|19215439|P1|Overall Study|Withdrawal by Subject|10
5560312|NCT01185522|19215439|P1|Overall Study|Lost to Follow-up|19
5560313|NCT01185522|19215439|P1|Overall Study|Lack of Efficacy|28
5560314|NCT01185509|19215465|P2|Overall Study|Intercurrent Illness|1
5560315|NCT01185509|19215466|P1|Overall Study|Intercurrent Illness|0
5560316|NCT01185509|19215465|P2|Overall Study|Death|1
5560317|NCT01185509|19215466|P1|Overall Study|Death|0
5560318|NCT01185509|19215465|P2|Overall Study|Withdrawal by Subject|1
5560319|NCT01185509|19215466|P1|Overall Study|Withdrawal by Subject|0
5560320|NCT01185509|19215465|P2|Overall Study|Physician Decision|2
5560321|NCT01185509|19215466|P1|Overall Study|Physician Decision|2
5560322|NCT01185509|19215465|P2|Overall Study|Progression/Relapse|15
5560323|NCT01185509|19215466|P1|Overall Study|Progression/Relapse|9
5560324|NCT01185353|19215482|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
5560325|NCT01185353|19215483|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
5560326|NCT01185353|19215484|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
5560327|NCT01185353|19215485|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
5560328|NCT01185353|19215486|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
5560329|NCT01185353|19215487|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
5560330|NCT01185353|19215488|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
5560331|NCT01185353|19215489|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
5560332|NCT01185353|19215490|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
5560333|NCT01185353|19215491|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
5560334|NCT01185353|19215482|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
5560335|NCT01185353|19215483|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
5560336|NCT01185353|19215484|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
5560337|NCT01185353|19215485|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5560338|NCT01185353|19215486|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5560339|NCT01185353|19215487|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5560340|NCT01185353|19215488|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5560341|NCT01185353|19215489|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5560342|NCT01185353|19215490|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5560343|NCT01185353|19215491|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
5560344|NCT01185353|19215482|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5560345|NCT01185353|19215483|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
5560346|NCT01185353|19215484|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
5560347|NCT01185353|19215485|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5560348|NCT01185353|19215486|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5560349|NCT01185353|19215487|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5560350|NCT01185353|19215488|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5560351|NCT01185353|19215489|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5560352|NCT01185353|19215490|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5560353|NCT01185353|19215491|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
5560354|NCT01185353|19215482|P10|Part C (Weeks 24 Through 76)|Reason missing|0
5560355|NCT01185353|19215483|P9|Part C (Weeks 24 Through 76)|Reason missing|1
5560356|NCT01185353|19215484|P8|Part C (Weeks 24 Through 76)|Reason missing|0
5560357|NCT01185353|19215485|P7|Part C (Weeks 24 Through 76)|Reason missing|0
5560358|NCT01185353|19215486|P6|Part C (Weeks 24 Through 76)|Reason missing|0
5560359|NCT01185353|19215487|P5|Part C (Weeks 24 Through 76)|Reason missing|0
5560360|NCT01185353|19215488|P4|Part C (Weeks 24 Through 76)|Reason missing|0
5560361|NCT01185353|19215489|P3|Part C (Weeks 24 Through 76)|Reason missing|0
5560362|NCT01185353|19215490|P2|Part C (Weeks 24 Through 76)|Reason missing|0
5560363|NCT01185353|19215491|P1|Part C (Weeks 24 Through 76)|Reason missing|0
5560364|NCT01185353|19215482|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
5560365|NCT01185353|19215483|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
5560366|NCT01185353|19215484|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
5560367|NCT01185353|19215485|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
5560368|NCT01185353|19215486|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
5560369|NCT01185353|19215487|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
5560370|NCT01185353|19215488|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
5560371|NCT01185353|19215489|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
5560372|NCT01185353|19215490|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
5560373|NCT01185353|19215491|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
5560374|NCT01185353|19215482|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
5560375|NCT01185353|19215483|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5560376|NCT01185353|19215484|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5560377|NCT01185353|19215485|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5560378|NCT01185353|19215486|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5560379|NCT01185353|19215487|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5560380|NCT01185353|19215488|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5560381|NCT01185353|19215489|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5560382|NCT01185353|19215490|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5560383|NCT01185353|19215491|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
5560384|NCT01185353|19215482|P10|Part C (Weeks 24 Through 76)|Death|1
5560385|NCT01185353|19215483|P9|Part C (Weeks 24 Through 76)|Death|0
5560386|NCT01185353|19215484|P8|Part C (Weeks 24 Through 76)|Death|0
5560387|NCT01185353|19215485|P7|Part C (Weeks 24 Through 76)|Death|0
5560388|NCT01185353|19215486|P6|Part C (Weeks 24 Through 76)|Death|0
5560389|NCT01185353|19215487|P5|Part C (Weeks 24 Through 76)|Death|0
5560390|NCT01185353|19215488|P4|Part C (Weeks 24 Through 76)|Death|0
5560391|NCT01185353|19215489|P3|Part C (Weeks 24 Through 76)|Death|0
5560392|NCT01185353|19215490|P2|Part C (Weeks 24 Through 76)|Death|0
5560393|NCT01185353|19215491|P1|Part C (Weeks 24 Through 76)|Death|0
5560394|NCT01185353|19215482|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5560395|NCT01185353|19215483|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
5560396|NCT01185353|19215484|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5560397|NCT01185353|19215485|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5560398|NCT01185353|19215486|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5560399|NCT01185353|19215487|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5560400|NCT01185353|19215488|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5560401|NCT01185353|19215489|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5560402|NCT01185353|19215490|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5560403|NCT01185353|19215491|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
5560404|NCT01185353|19215482|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
5560405|NCT01185353|19215483|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
5560406|NCT01185353|19215484|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
5560407|NCT01185353|19215485|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5560408|NCT01185353|19215486|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5560409|NCT01185353|19215487|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5560410|NCT01185353|19215488|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5560411|NCT01185353|19215489|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5560412|NCT01185353|19215490|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5560413|NCT01185353|19215491|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
5560414|NCT01185353|19215482|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
5560415|NCT01185353|19215483|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
5560416|NCT01185353|19215484|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
5560417|NCT01185353|19215485|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5560418|NCT01185353|19215486|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5560419|NCT01185353|19215487|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5560420|NCT01185353|19215488|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5560421|NCT01185353|19215489|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5560422|NCT01185353|19215490|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5560423|NCT01185353|19215491|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
5560424|NCT01185353|19215482|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
5560425|NCT01185353|19215483|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
5560426|NCT01185353|19215484|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
5560427|NCT01185353|19215485|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
5560428|NCT01185353|19215486|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
5560429|NCT01185353|19215487|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
5560430|NCT01185353|19215488|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
5560431|NCT01185353|19215489|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
5560432|NCT01185353|19215490|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
5560433|NCT01185353|19215491|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
5560434|NCT01185353|19215482|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5560435|NCT01185353|19215483|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5560436|NCT01185353|19215484|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5560437|NCT01185353|19215485|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
5560438|NCT01185353|19215486|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5560439|NCT01185353|19215487|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5560440|NCT01185353|19215488|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5560441|NCT01185353|19215489|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5560442|NCT01185353|19215490|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5560443|NCT01185353|19215491|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
5560444|NCT01185353|19215482|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5560445|NCT01185353|19215483|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5560446|NCT01185353|19215484|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5560447|NCT01185353|19215485|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
5560448|NCT01185353|19215486|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
5560449|NCT01185353|19215487|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5560450|NCT01185353|19215488|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
5560451|NCT01185353|19215489|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
5560452|NCT01185353|19215490|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5560453|NCT01185353|19215491|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
5560454|NCT01185353|19215482|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5560455|NCT01185353|19215483|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5560456|NCT01185353|19215484|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5560457|NCT01185353|19215485|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
5560458|NCT01185353|19215486|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5560459|NCT01185353|19215487|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5560460|NCT01185353|19215488|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
5560461|NCT01185353|19215489|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5560462|NCT01185353|19215490|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5560463|NCT01185353|19215491|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
5560464|NCT01185353|19215482|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5560465|NCT01185353|19215483|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5560466|NCT01185353|19215484|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5560467|NCT01185353|19215485|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5560468|NCT01185353|19215486|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5560469|NCT01185353|19215487|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5560470|NCT01185353|19215488|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
5560471|NCT01185353|19215489|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5560472|NCT01185353|19215490|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
5560473|NCT01185353|19215491|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
5560474|NCT01185353|19215482|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
5560475|NCT01185353|19215483|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
5560476|NCT01185353|19215484|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
5560477|NCT01185353|19215485|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
5560478|NCT01185353|19215486|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
5560479|NCT01185353|19215487|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
5560480|NCT01185353|19215488|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
5560481|NCT01185353|19215489|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
5560482|NCT01185353|19215490|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
5560483|NCT01185353|19215491|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
5560484|NCT01185353|19215482|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5560485|NCT01185353|19215483|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5560486|NCT01185353|19215484|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5560487|NCT01185353|19215485|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5560488|NCT01185353|19215486|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5560489|NCT01185353|19215487|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
5560490|NCT01185353|19215488|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5560491|NCT01185353|19215489|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5560492|NCT01185353|19215490|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
5560493|NCT01185353|19215491|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
5560494|NCT01185353|19215482|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
5560495|NCT01185353|19215483|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
5560496|NCT01185353|19215484|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
5560497|NCT01185353|19215485|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
5560498|NCT01185353|19215486|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
5560499|NCT01185353|19215487|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
5560500|NCT01185353|19215488|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
5560501|NCT01185353|19215489|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
5560502|NCT01185353|19215490|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
5560503|NCT01185353|19215491|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
5560504|NCT01185353|19215482|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
5560505|NCT01185353|19215483|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
5560506|NCT01185353|19215484|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
5560507|NCT01185353|19215485|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
5560508|NCT01185353|19215486|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
5560509|NCT01185353|19215487|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
5560510|NCT01185353|19215488|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
5560511|NCT01185353|19215489|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
5560512|NCT01185353|19215490|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
5560513|NCT01185353|19215491|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
5560514|NCT01185353|19215482|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5560515|NCT01185353|19215483|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5560516|NCT01185353|19215484|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5560517|NCT01185353|19215485|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5560518|NCT01185353|19215486|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5560519|NCT01185353|19215487|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
5560520|NCT01185353|19215488|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5560521|NCT01185353|19215489|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5560522|NCT01185353|19215490|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
5560523|NCT01185353|19215491|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
5560524|NCT01185353|19215482|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5560525|NCT01185353|19215483|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5560526|NCT01185353|19215484|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5560527|NCT01185353|19215485|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5560528|NCT01185353|19215486|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5560529|NCT01185353|19215487|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
5560530|NCT01185353|19215488|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5560531|NCT01185353|19215489|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5560532|NCT01185353|19215490|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5560533|NCT01185353|19215491|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
5560534|NCT01185353|19215482|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
5560535|NCT01185353|19215483|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
5560536|NCT01185353|19215484|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
5560537|NCT01185353|19215485|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
5560538|NCT01185353|19215486|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
5560539|NCT01185353|19215487|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
5560540|NCT01185353|19215488|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
5560541|NCT01185353|19215489|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
5560542|NCT01185353|19215490|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
5560543|NCT01185353|19215491|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
5560544|NCT01185340|19215652|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
5560545|NCT01185340|19215653|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
5560546|NCT01185340|19215654|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5560547|NCT01185340|19215655|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5560548|NCT01185340|19215652|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
5560549|NCT01185340|19215653|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
5560550|NCT01185340|19215654|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
5560551|NCT01185340|19215655|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
5560552|NCT01185340|19215652|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5560553|NCT01185340|19215653|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
5560554|NCT01185340|19215654|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5560555|NCT01185340|19215655|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
5560556|NCT01185340|19215652|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5560557|NCT01185340|19215653|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5560558|NCT01185340|19215654|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5560559|NCT01185340|19215655|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5560560|NCT01185340|19215652|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
5560561|NCT01185340|19215653|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
5560562|NCT01185340|19215654|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
5560563|NCT01185340|19215655|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5560564|NCT01185340|19215652|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
5560565|NCT01185340|19215653|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
5560566|NCT01185340|19215654|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
5560567|NCT01185340|19215655|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
5560568|NCT01185340|19215652|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
5560569|NCT01185340|19215653|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
5560570|NCT01185340|19215654|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
5560571|NCT01185340|19215655|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
5560572|NCT01185340|19215652|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5560573|NCT01185340|19215653|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5560574|NCT01185340|19215654|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5560575|NCT01185340|19215655|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
5560576|NCT01185340|19215652|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5560577|NCT01185340|19215653|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5560578|NCT01185340|19215654|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5560579|NCT01185340|19215655|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
5560580|NCT01185340|19215652|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5560581|NCT01185340|19215653|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5560582|NCT01185340|19215654|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5560583|NCT01185340|19215655|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
5560584|NCT01185340|19215652|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5560585|NCT01185340|19215653|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5560586|NCT01185340|19215654|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5560587|NCT01185340|19215655|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
5560588|NCT01185340|19215652|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5560589|NCT01185340|19215653|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5560590|NCT01185340|19215654|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5560591|NCT01185340|19215655|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
5560592|NCT01185340|19215652|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5560593|NCT01185340|19215653|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5560594|NCT01185340|19215654|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5560595|NCT01185340|19215655|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
5560596|NCT01185340|19215652|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5560597|NCT01185340|19215653|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5560598|NCT01185340|19215654|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5560599|NCT01185340|19215655|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
5560600|NCT01185301|19215707|P4|Overall Study|Other Reason|2
5560601|NCT01185301|19215708|P3|Overall Study|Other Reason|2
5560602|NCT01185301|19215709|P2|Overall Study|Other Reason|2
5560603|NCT01185301|19215710|P1|Overall Study|Other Reason|3
5560604|NCT01185301|19215707|P4|Overall Study|Lost to Follow-up|1
5560605|NCT01185301|19215708|P3|Overall Study|Lost to Follow-up|0
5560606|NCT01185301|19215709|P2|Overall Study|Lost to Follow-up|0
5560607|NCT01185301|19215710|P1|Overall Study|Lost to Follow-up|2
5560608|NCT01185301|19215707|P4|Overall Study|Withdrawal by Subject|3
5560609|NCT01185301|19215708|P3|Overall Study|Withdrawal by Subject|2
5560610|NCT01185301|19215709|P2|Overall Study|Withdrawal by Subject|5
5560611|NCT01185301|19215710|P1|Overall Study|Withdrawal by Subject|7
5560612|NCT01185301|19215707|P4|Overall Study|Adverse Event|3
5560613|NCT01185301|19215708|P3|Overall Study|Adverse Event|2
5560614|NCT01185301|19215709|P2|Overall Study|Adverse Event|0
5560615|NCT01185301|19215710|P1|Overall Study|Adverse Event|3
5560616|NCT01185288|19215770|P2|Overall Study|Noncompliance|1
5560617|NCT01185288|19215771|P1|Overall Study|Noncompliance|0
5560618|NCT01185288|19215770|P2|Overall Study|Did not meet inclusion criteria|0
5560619|NCT01185288|19215771|P1|Overall Study|Did not meet inclusion criteria|1
5560620|NCT01185288|19215770|P2|Overall Study|Investigator discretion|0
5560621|NCT01185288|19215771|P1|Overall Study|Investigator discretion|1
5560622|NCT01185288|19215770|P2|Overall Study|Lack of Efficacy|0
5560623|NCT01185288|19215771|P1|Overall Study|Lack of Efficacy|2
5560624|NCT01185288|19215770|P2|Overall Study|Lost to Follow-up|5
5560625|NCT01185288|19215771|P1|Overall Study|Lost to Follow-up|2
5560626|NCT01185288|19215770|P2|Overall Study|Withdrawal by Subject|4
5560627|NCT01185288|19215771|P1|Overall Study|Withdrawal by Subject|6
5560628|NCT01185288|19215770|P2|Overall Study|Adverse Event|6
5560629|NCT01185288|19215771|P1|Overall Study|Adverse Event|7
5560630|NCT01185249|19215789|P1|Overall Study|Patients discharged or change in status|42
5560631|NCT01185171|19215794|P1|Maintenance|Disease Recurrence|1
5560632|NCT01185171|19215794|P1|Maintenance|Withdrawal by Subject|1
5560633|NCT01185171|19215794|P1|Maintenance|Comorbid Illness|2
5560634|NCT01185171|19215794|P1|Maintenance|Nausea|1
5560635|NCT01185171|19215794|P1|Maintenance|Xerostomia|1
5560636|NCT01185171|19215794|P1|Maintenance|Diarrhea|1
5560637|NCT01185171|19215794|P1|Maintenance|Rush|2
5560638|NCT01185171|19215794|P1|Maintenance|Elevated liver transaminases|3
5560639|NCT01185171|19215794|P1|Concurrent Chemo and Radiation Treatment|Death|3
5560640|NCT01185171|19215794|P1|Induction Chemotherapy|Duodenal Ulcer|1
5560641|NCT01185171|19215794|P1|Induction Chemotherapy|Withdrawal by Subject|1
5560642|NCT01185080|19215804|P3|Overall Study|Personal reasons|1
5560643|NCT01185080|19215805|P2|Overall Study|Personal reasons|0
5560644|NCT01185080|19215806|P1|Overall Study|Personal reasons|0
5560645|NCT01185080|19215804|P3|Overall Study|Adverse Event|0
5560646|NCT01185080|19215805|P2|Overall Study|Adverse Event|1
5560647|NCT01185080|19215806|P1|Overall Study|Adverse Event|1
5560648|NCT01184989|19215858|P1|Overall Study|Withdrawal by Subject|1
5560649|NCT01184989|19215858|P1|Overall Study|Adverse Event|11
5560650|NCT01184872|19215878|P2|Overall Study|Protocol deviation|0
5560651|NCT01184872|19215879|P1|Overall Study|Protocol deviation|1
5560652|NCT01184872|19215878|P2|Overall Study|Administrative problems|1
5560653|NCT01184872|19215879|P1|Overall Study|Administrative problems|1
5560654|NCT01184872|19215878|P2|Overall Study|Lost to Follow-up|1
5560655|NCT01184872|19215879|P1|Overall Study|Lost to Follow-up|0
5560656|NCT01184872|19215878|P2|Overall Study|Withdrawal by Subject|0
5560657|NCT01184872|19215879|P1|Overall Study|Withdrawal by Subject|2
5560658|NCT01184872|19215878|P2|Overall Study|Unsatisfactory therapeutic effect|2
5560659|NCT01184872|19215879|P1|Overall Study|Unsatisfactory therapeutic effect|3
5560660|NCT01184872|19215878|P2|Overall Study|Adverse Event|4
5560661|NCT01184872|19215879|P1|Overall Study|Adverse Event|3
5560662|NCT01184859|19215898|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
5560663|NCT01184859|19215899|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
5560664|NCT01184859|19215900|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
5560665|NCT01184859|19215901|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
5560666|NCT01184859|19215902|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
5560667|NCT01184859|19215898|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
5560668|NCT01184859|19215899|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5560669|NCT01184859|19215900|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5560670|NCT01184859|19215901|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5560671|NCT01184859|19215902|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
5560672|NCT01184859|19215898|P5|Period 1: Single Dose|Adverse Event|1
5560673|NCT01184859|19215899|P4|Period 1: Single Dose|Adverse Event|0
5560674|NCT01184859|19215900|P3|Period 1: Single Dose|Adverse Event|0
5560675|NCT01184859|19215901|P2|Period 1: Single Dose|Adverse Event|0
5560676|NCT01184859|19215902|P1|Period 1: Single Dose|Adverse Event|0
5560677|NCT01184859|19215898|P5|Period 1: Single Dose|Protocol Violation|0
5560678|NCT01184859|19215899|P4|Period 1: Single Dose|Protocol Violation|0
5560679|NCT01184859|19215900|P3|Period 1: Single Dose|Protocol Violation|0
5560680|NCT01184859|19215901|P2|Period 1: Single Dose|Protocol Violation|1
5560681|NCT01184859|19215902|P1|Period 1: Single Dose|Protocol Violation|0
5560682|NCT01184859|19215898|P5|Period 1: Single Dose|Insufficient urine production|0
5560683|NCT01184859|19215899|P4|Period 1: Single Dose|Insufficient urine production|0
5560684|NCT01184859|19215900|P3|Period 1: Single Dose|Insufficient urine production|0
5560685|NCT01184859|19215901|P2|Period 1: Single Dose|Insufficient urine production|1
5560686|NCT01184859|19215902|P1|Period 1: Single Dose|Insufficient urine production|0
5560687|NCT01184846|19215994|P1|Overall Study|Insufficient response|1
5560688|NCT01184846|19215994|P1|Overall Study|Adverse Event|2
5560689|NCT01184508|19216027|P2|Overall Study|Randomized, Not Treated|1
5560690|NCT01184508|19216028|P1|Overall Study|Randomized, Not Treated|0
5560691|NCT01184508|19216027|P2|Overall Study|Withdrawal by Subject|3
5560692|NCT01184508|19216028|P1|Overall Study|Withdrawal by Subject|1
5560693|NCT01184508|19216027|P2|Overall Study|Sponsor Decision|2
5560694|NCT01184508|19216028|P1|Overall Study|Sponsor Decision|5
5560695|NCT01184508|19216027|P2|Overall Study|Protocol Violation|1
5560696|NCT01184508|19216028|P1|Overall Study|Protocol Violation|3
5560697|NCT01184508|19216027|P2|Overall Study|Physician Decision|0
5560698|NCT01184508|19216028|P1|Overall Study|Physician Decision|1
5560699|NCT01184508|19216027|P2|Overall Study|Lost to Follow-up|1
5560700|NCT01184508|19216028|P1|Overall Study|Lost to Follow-up|1
5560701|NCT01184508|19216027|P2|Overall Study|Lack of Efficacy|1
5560702|NCT01184508|19216028|P1|Overall Study|Lack of Efficacy|1
5560703|NCT01184508|19216027|P2|Overall Study|Adverse Event|6
5560704|NCT01184508|19216028|P1|Overall Study|Adverse Event|4
5560705|NCT01184326|19216088|P3|Overall Study|Disease Progression|12
5560706|NCT01184326|19216089|P2|Overall Study|Disease Progression|3
5560707|NCT01184326|19216090|P1|Overall Study|Disease Progression|1
5560708|NCT01184326|19216088|P3|Overall Study|Physician Decision|0
5560709|NCT01184326|19216089|P2|Overall Study|Physician Decision|1
5560710|NCT01184326|19216090|P1|Overall Study|Physician Decision|1
5560711|NCT01184326|19216088|P3|Overall Study|Withdrawal by Subject|1
5560712|NCT01184326|19216089|P2|Overall Study|Withdrawal by Subject|0
5560713|NCT01184326|19216090|P1|Overall Study|Withdrawal by Subject|0
5560714|NCT01184326|19216088|P3|Overall Study|Death|1
5560715|NCT01184326|19216089|P2|Overall Study|Death|0
5560716|NCT01184326|19216090|P1|Overall Study|Death|0
5560717|NCT01184326|19216088|P3|Overall Study|Adverse Event|0
5560718|NCT01184326|19216089|P2|Overall Study|Adverse Event|2
5560719|NCT01184326|19216090|P1|Overall Study|Adverse Event|1
5560720|NCT01184118|19216104|P1|Overall Study|Withdrawal by Subject|5
5560721|NCT01184118|19216104|P1|Overall Study|Exclusionary medical condition|2
5560722|NCT01184118|19216104|P1|Overall Study|FEV1 <60% predicted|2
5560723|NCT01184118|19216104|P1|Overall Study|No physiologic confirmation of asthma|8
5560724|NCT01184118|19216104|P1|Overall Study|Only asthma step 1 - screen fail|1
5560725|NCT01184079|19216112|P2|Overall Study|Lost to Follow-up|2
5560726|NCT01184079|19216113|P1|Overall Study|Lost to Follow-up|14
5560727|NCT01184053|19216123|P1|Overall Study|progression while on treatment|3
5560728|NCT01183975|19216139|P1|Overall Study|Lost to Follow-up|73
5560729|NCT01183884|19216156|P1|Overall Study|Other|4
5560730|NCT01183884|19216156|P1|Overall Study|Not Treated|1
5560731|NCT01183884|19216156|P1|Overall Study|Other Complicating Disease|3
5560732|NCT01183884|19216156|P1|Overall Study|Withdrawal by Subject|1
5560733|NCT01183884|19216156|P1|Overall Study|Adverse Event|3
5560734|NCT01183884|19216156|P1|Overall Study|Progressive Disease|26
5560735|NCT01183858|19216164|P2|Overall Study|Lost to Follow-up|1
5560736|NCT01183858|19216165|P1|Overall Study|Lost to Follow-up|1
5560737|NCT01183858|19216164|P2|Overall Study|Death related to Progressive Disease|5
5560738|NCT01183858|19216165|P1|Overall Study|Death related to Progressive Disease|4
5560739|NCT01183858|19216164|P2|Overall Study|Progressive Disease|115
5560740|NCT01183858|19216165|P1|Overall Study|Progressive Disease|112
5560741|NCT01183858|19216164|P2|Overall Study|Administrative/Other|6
5560742|NCT01183858|19216165|P1|Overall Study|Administrative/Other|6
5560743|NCT01183858|19216164|P2|Overall Study|Protocol Violation|0
5560744|NCT01183858|19216165|P1|Overall Study|Protocol Violation|1
5560745|NCT01183858|19216164|P2|Overall Study|Discontinued Smoking|1
5560746|NCT01183858|19216165|P1|Overall Study|Discontinued Smoking|3
5560747|NCT01183858|19216164|P2|Overall Study|Withdrew Consent|4
5560748|NCT01183858|19216165|P1|Overall Study|Withdrew Consent|4
5560749|NCT01183858|19216164|P2|Overall Study|Refused Treatment|4
5560750|NCT01183858|19216165|P1|Overall Study|Refused Treatment|1
5560751|NCT01183858|19216164|P2|Overall Study|Insufficient Therapeutic Response|0
5560752|NCT01183858|19216165|P1|Overall Study|Insufficient Therapeutic Response|2
5560753|NCT01183858|19216164|P2|Overall Study|Investigator's Decision|3
5560754|NCT01183858|19216165|P1|Overall Study|Investigator's Decision|0
5560755|NCT01183858|19216164|P2|Overall Study|Adverse Event|11
5560756|NCT01183858|19216165|P1|Overall Study|Adverse Event|14
5560757|NCT01183858|19216164|P2|Overall Study|Death not related to Progressive Disease|6
5560758|NCT01183858|19216165|P1|Overall Study|Death not related to Progressive Disease|5
5560759|NCT01183780|19216187|P2|Overall Study|Lost to Follow-up|11
5560760|NCT01183780|19216188|P1|Overall Study|Lost to Follow-up|6
5560761|NCT01183780|19216187|P2|Overall Study|Withdrawal by Subject|14
5560762|NCT01183780|19216188|P1|Overall Study|Withdrawal by Subject|25
5560763|NCT01183468|19216321|P4|Overall Study|Withdrawal by Subject|0
5560764|NCT01183468|19216322|P3|Overall Study|Withdrawal by Subject|0
5560765|NCT01183468|19216323|P2|Overall Study|Withdrawal by Subject|1
5560766|NCT01183468|19216324|P1|Overall Study|Withdrawal by Subject|0
5560767|NCT01183468|19216321|P4|Overall Study|Physician Decision|0
5560768|NCT01183468|19216322|P3|Overall Study|Physician Decision|0
5560769|NCT01183468|19216323|P2|Overall Study|Physician Decision|0
5560770|NCT01183468|19216324|P1|Overall Study|Physician Decision|1
5560771|NCT01183468|19216321|P4|Overall Study|Lost to Follow-up|0
5560772|NCT01183468|19216322|P3|Overall Study|Lost to Follow-up|0
5560773|NCT01183468|19216323|P2|Overall Study|Lost to Follow-up|1
5560774|NCT01183468|19216324|P1|Overall Study|Lost to Follow-up|2
5560775|NCT01183390|19216346|P2|First Intervention|Adverse Event|1
5560776|NCT01183390|19216347|P1|First Intervention|Adverse Event|0
5560777|NCT01183260|19216380|P2|Overall Study|Death|0
5560778|NCT01183260|19216381|P1|Overall Study|Death|1
5560779|NCT01183260|19216380|P2|Overall Study|Revised within 30 days|1
5560780|NCT01183260|19216381|P1|Overall Study|Revised within 30 days|0
5560781|NCT01183260|19216380|P2|Overall Study|Withdrawal by Subject|1
5560782|NCT01183260|19216381|P1|Overall Study|Withdrawal by Subject|1
5560783|NCT01183260|19216380|P2|Overall Study|Intraop screen failure|0
5560784|NCT01183260|19216381|P1|Overall Study|Intraop screen failure|2
5560785|NCT01183234|19216391|P2|First Intervention|Adverse Event|0
5560786|NCT01183234|19216392|P1|First Intervention|Adverse Event|1
5560787|NCT01183143|19216484|P1|Overall Study|Subjects enrolled, but not treated|11
5560788|NCT01183143|19216484|P1|Overall Study|Subject Questionnaires not returned|5
5560789|NCT01183143|19216484|P1|Overall Study|Withdrawal by Subject|19
5560790|NCT01183143|19216484|P1|Overall Study|Protocol Violation|115
5560791|NCT01183104|19216500|P2|Overall Study|Did not receive study drug|9
5560792|NCT01183104|19216501|P1|Overall Study|Did not receive study drug|5
5560793|NCT01183104|19216500|P2|Overall Study|Nonparticipation in Extension Study|50
5560794|NCT01183104|19216501|P1|Overall Study|Nonparticipation in Extension Study|39
5560795|NCT01183104|19216500|P2|Overall Study|Withdrawal by Subject|11
5560796|NCT01183104|19216501|P1|Overall Study|Withdrawal by Subject|6
5560797|NCT01183104|19216500|P2|Overall Study|Physician Decision|8
5560798|NCT01183104|19216501|P1|Overall Study|Physician Decision|5
5560799|NCT01183104|19216500|P2|Overall Study|Lost to Follow-up|7
5560800|NCT01183104|19216501|P1|Overall Study|Lost to Follow-up|14
5560801|NCT01183104|19216500|P2|Overall Study|Death|1
5560802|NCT01183104|19216501|P1|Overall Study|Death|0
5560803|NCT01183104|19216500|P2|Overall Study|Adverse Event|6
5560804|NCT01183104|19216501|P1|Overall Study|Adverse Event|8
5560805|NCT01183065|19216517|P1|Overall Study|Patient no longer fits eligibility crite|1
5560806|NCT01183013|19216528|P7|Overall Study|Reasons other than stated above|13
5560807|NCT01183013|19216529|P6|Overall Study|Reasons other than stated above|15
5560808|NCT01183013|19216530|P5|Overall Study|Reasons other than stated above|12
5560809|NCT01183013|19216531|P4|Overall Study|Reasons other than stated above|12
5560810|NCT01183013|19216532|P3|Overall Study|Reasons other than stated above|17
5560811|NCT01183013|19216533|P2|Overall Study|Reasons other than stated above|11
5560812|NCT01183013|19216534|P1|Overall Study|Reasons other than stated above|15
5560813|NCT01183013|19216528|P7|Overall Study|Withdrawal by Subject|10
5560814|NCT01183013|19216529|P6|Overall Study|Withdrawal by Subject|9
5560815|NCT01183013|19216530|P5|Overall Study|Withdrawal by Subject|7
5560816|NCT01183013|19216531|P4|Overall Study|Withdrawal by Subject|8
5560817|NCT01183013|19216532|P3|Overall Study|Withdrawal by Subject|10
5560818|NCT01183013|19216533|P2|Overall Study|Withdrawal by Subject|13
5560819|NCT01183013|19216534|P1|Overall Study|Withdrawal by Subject|9
5560820|NCT01183013|19216528|P7|Overall Study|Lost to Follow-up|5
5560821|NCT01183013|19216529|P6|Overall Study|Lost to Follow-up|6
5560822|NCT01183013|19216530|P5|Overall Study|Lost to Follow-up|2
5560823|NCT01183013|19216531|P4|Overall Study|Lost to Follow-up|3
5560824|NCT01183013|19216532|P3|Overall Study|Lost to Follow-up|4
5560825|NCT01183013|19216533|P2|Overall Study|Lost to Follow-up|3
5560826|NCT01183013|19216534|P1|Overall Study|Lost to Follow-up|7
5560827|NCT01183013|19216528|P7|Overall Study|Protocol Violation|3
5560828|NCT01183013|19216529|P6|Overall Study|Protocol Violation|3
5560829|NCT01183013|19216530|P5|Overall Study|Protocol Violation|4
5560830|NCT01183013|19216531|P4|Overall Study|Protocol Violation|0
5560831|NCT01183013|19216532|P3|Overall Study|Protocol Violation|4
5560832|NCT01183013|19216533|P2|Overall Study|Protocol Violation|2
5560833|NCT01183013|19216534|P1|Overall Study|Protocol Violation|5
5560834|NCT01183013|19216528|P7|Overall Study|Lack of Efficacy|0
5560835|NCT01183013|19216529|P6|Overall Study|Lack of Efficacy|2
5560836|NCT01183013|19216530|P5|Overall Study|Lack of Efficacy|1
5560837|NCT01183013|19216531|P4|Overall Study|Lack of Efficacy|2
5560838|NCT01183013|19216532|P3|Overall Study|Lack of Efficacy|1
5560839|NCT01183013|19216533|P2|Overall Study|Lack of Efficacy|2
5560840|NCT01183013|19216534|P1|Overall Study|Lack of Efficacy|3
5560841|NCT01183013|19216528|P7|Overall Study|Adverse Event|6
5560842|NCT01183013|19216529|P6|Overall Study|Adverse Event|10
5560843|NCT01183013|19216530|P5|Overall Study|Adverse Event|10
5560844|NCT01183013|19216531|P4|Overall Study|Adverse Event|5
5560845|NCT01183013|19216532|P3|Overall Study|Adverse Event|5
5560846|NCT01183013|19216533|P2|Overall Study|Adverse Event|8
5560847|NCT01183013|19216534|P1|Overall Study|Adverse Event|6
5560848|NCT01182844|19216615|P2|Overall Study|Withdrawal by Subject|2
5560849|NCT01182844|19216616|P1|Overall Study|Withdrawal by Subject|0
5560850|NCT01182441|19216701|P2|Overall Study|Physician Decision|1
5560851|NCT01182441|19216702|P1|Overall Study|Physician Decision|1
5560852|NCT01182441|19216701|P2|Overall Study|Adverse Event|0
5560853|NCT01182441|19216702|P1|Overall Study|Adverse Event|2
5560854|NCT01182441|19216701|P2|Overall Study|Implant Not Attempted|0
5560855|NCT01182441|19216702|P1|Overall Study|Implant Not Attempted|4
5560856|NCT01182441|19216701|P2|Overall Study|Withdrawal by Subject|13
5560857|NCT01182441|19216702|P1|Overall Study|Withdrawal by Subject|6
5560858|NCT01182441|19216701|P2|Overall Study|Lost to Follow-up|8
5560859|NCT01182441|19216702|P1|Overall Study|Lost to Follow-up|5
5560860|NCT01182441|19216701|P2|Overall Study|Implant Attempt Unsuccessful|0
5560861|NCT01182441|19216702|P1|Overall Study|Implant Attempt Unsuccessful|13
5560862|NCT01182441|19216701|P2|Overall Study|Death|25
5560863|NCT01182441|19216702|P1|Overall Study|Death|37
5560864|NCT01182441|19216701|P2|Overall Study|Patient Still in Follow-up|72
5560865|NCT01182441|19216702|P1|Overall Study|Patient Still in Follow-up|152
5560866|NCT01182428|19216713|P2|Overall Study|Withdrawal by Subject|0
5560867|NCT01182428|19216714|P1|Overall Study|Withdrawal by Subject|1
5560868|NCT01182428|19216713|P2|Overall Study|Lost to Follow-up|1
5560869|NCT01182428|19216714|P1|Overall Study|Lost to Follow-up|9
5560870|NCT01182428|19216713|P2|Overall Study|Physician Decision|0
5560871|NCT01182428|19216714|P1|Overall Study|Physician Decision|1
5560872|NCT01182415|19216778|P1|Overall Study|Lost to Follow-up|1
5560873|NCT01182350|19216794|P5|Overall Study|Unevaluable for Biopsy|3
5560874|NCT01182350|19216795|P4|Overall Study|Unevaluable for Biopsy|0
5560875|NCT01182350|19216796|P3|Overall Study|Unevaluable for Biopsy|0
5560876|NCT01182350|19216797|P2|Overall Study|Unevaluable for Biopsy|0
5560877|NCT01182350|19216798|P1|Overall Study|Unevaluable for Biopsy|0
5560878|NCT01182350|19216794|P5|Overall Study|Travel Issue/Prefer Treatment at Home|0
5560879|NCT01182350|19216795|P4|Overall Study|Travel Issue/Prefer Treatment at Home|1
5560880|NCT01182350|19216796|P3|Overall Study|Travel Issue/Prefer Treatment at Home|1
5560881|NCT01182350|19216797|P2|Overall Study|Travel Issue/Prefer Treatment at Home|0
5560882|NCT01182350|19216798|P1|Overall Study|Travel Issue/Prefer Treatment at Home|2
5560883|NCT01182350|19216794|P5|Overall Study|Alternative Therapy|0
5560884|NCT01182350|19216795|P4|Overall Study|Alternative Therapy|0
5560885|NCT01182350|19216796|P3|Overall Study|Alternative Therapy|1
5560886|NCT01182350|19216797|P2|Overall Study|Alternative Therapy|0
5560887|NCT01182350|19216798|P1|Overall Study|Alternative Therapy|2
5560888|NCT01182350|19216794|P5|Overall Study|Withdrawal by Subject|0
5560889|NCT01182350|19216795|P4|Overall Study|Withdrawal by Subject|1
5560890|NCT01182350|19216796|P3|Overall Study|Withdrawal by Subject|0
5560891|NCT01182350|19216797|P2|Overall Study|Withdrawal by Subject|1
5560892|NCT01182350|19216798|P1|Overall Study|Withdrawal by Subject|3
5560893|NCT01182350|19216794|P5|Overall Study|Death|0
5560894|NCT01182350|19216795|P4|Overall Study|Death|0
5560895|NCT01182350|19216796|P3|Overall Study|Death|1
5560896|NCT01182350|19216797|P2|Overall Study|Death|1
5560897|NCT01182350|19216798|P1|Overall Study|Death|0
5560898|NCT01182350|19216794|P5|Overall Study|Disease Progression|0
5560899|NCT01182350|19216795|P4|Overall Study|Disease Progression|1
5560900|NCT01182350|19216796|P3|Overall Study|Disease Progression|0
5560901|NCT01182350|19216797|P2|Overall Study|Disease Progression|12
5560902|NCT01182350|19216798|P1|Overall Study|Disease Progression|15
5560903|NCT01182350|19216794|P5|Overall Study|Adverse Event|0
5560904|NCT01182350|19216795|P4|Overall Study|Adverse Event|0
5560905|NCT01182350|19216796|P3|Overall Study|Adverse Event|0
5560906|NCT01182350|19216797|P2|Overall Study|Adverse Event|0
5560907|NCT01182350|19216798|P1|Overall Study|Adverse Event|5
5560908|NCT01182337|19216820|P2|Overall Study|Lost to Follow-up|1
5560909|NCT01182337|19216821|P1|Overall Study|Lost to Follow-up|0
5560910|NCT01182337|19216820|P2|Overall Study|Withdrawal by Subject|1
5560911|NCT01182337|19216821|P1|Overall Study|Withdrawal by Subject|3
5560912|NCT01182298|19216839|P1|Overall Study|Withdrawal by Subject|2
5560913|NCT01182298|19216839|P1|Overall Study|Lack of Efficacy|4
5560914|NCT01182285|19216843|P3|Third Intervention Week 11-52|Other|2
5560915|NCT01182285|19216844|P2|Third Intervention Week 11-52|Other|0
5560916|NCT01182285|19216845|P1|Third Intervention Week 11-52|Other|0
5560917|NCT01182285|19216843|P3|Third Intervention Week 11-52|Disease Progression|6
5560918|NCT01182285|19216844|P2|Third Intervention Week 11-52|Disease Progression|0
5560919|NCT01182285|19216845|P1|Third Intervention Week 11-52|Disease Progression|0
5560920|NCT01182285|19216843|P3|First Intervention Week 1-10|Non-compliance|0
5560921|NCT01182285|19216844|P2|First Intervention Week 1-10|Non-compliance|0
5560922|NCT01182285|19216845|P1|First Intervention Week 1-10|Non-compliance|1
5560923|NCT01182285|19216843|P3|First Intervention Week 1-10|Adverse Event|0
5560924|NCT01182285|19216844|P2|First Intervention Week 1-10|Adverse Event|0
5560925|NCT01182285|19216845|P1|First Intervention Week 1-10|Adverse Event|1
5560926|NCT01182285|19216843|P3|First Intervention Week 1-10|Disease progression|0
5560927|NCT01182285|19216844|P2|First Intervention Week 1-10|Disease progression|0
5560928|NCT01182285|19216845|P1|First Intervention Week 1-10|Disease progression|1
5560929|NCT01182207|19216855|P2|Second Intervention|Emeses within 1 hour of dosing|0
5560930|NCT01182207|19216856|P1|Second Intervention|Emeses within 1 hour of dosing|1
5560931|NCT01182207|19216855|P2|First Intervention|Positive Hepatitis Results|1
5560932|NCT01182207|19216856|P1|First Intervention|Positive Hepatitis Results|0
5560933|NCT01182194|19216874|P2|Washout of 28 Days|Withdrawal by Subject|0
5560934|NCT01182194|19216875|P1|Washout of 28 Days|Withdrawal by Subject|1
5560935|NCT01182181|19216893|P2|Washout of 21 Days|Withdrawal by Subject|1
5560936|NCT01182181|19216894|P1|Washout of 21 Days|Withdrawal by Subject|0
5560937|NCT01182181|19216893|P2|First Intervention|Adverse Event|0
5560938|NCT01182181|19216894|P1|First Intervention|Adverse Event|1
5560939|NCT01181986|19216919|P3|Phase 2|Medical condition|0
5560940|NCT01181986|19216920|P2|Phase 2|Medical condition|1
5560941|NCT01181986|19216921|P1|Phase 2|Medical condition|0
5560942|NCT01181986|19216919|P3|Phase 2|Adverse Event|0
5560943|NCT01181986|19216920|P2|Phase 2|Adverse Event|3
5560944|NCT01181986|19216921|P1|Phase 2|Adverse Event|0
5560945|NCT01181986|19216919|P3|Phase 1|Protocol Violation|0
5560946|NCT01181986|19216920|P2|Phase 1|Protocol Violation|0
5560947|NCT01181986|19216921|P1|Phase 1|Protocol Violation|1
5560948|NCT01181986|19216919|P3|Phase 1|Adverse Event|1
5560949|NCT01181986|19216920|P2|Phase 1|Adverse Event|0
5560950|NCT01181986|19216921|P1|Phase 1|Adverse Event|0
5560951|NCT01181986|19216919|P3|Phase 1|Lost to Follow-up|1
5560952|NCT01181986|19216920|P2|Phase 1|Lost to Follow-up|1
5560953|NCT01181986|19216921|P1|Phase 1|Lost to Follow-up|0
5560954|NCT01181921|19216942|P1|Overall Study|Lost to Follow-up|1
5560955|NCT01181895|19216949|P3|Overall Study|Withdrawal by Subject|5
5560956|NCT01181895|19216950|P2|Overall Study|Withdrawal by Subject|0
5560957|NCT01181895|19216951|P1|Overall Study|Withdrawal by Subject|3
5560958|NCT01181895|19216949|P3|Overall Study|Investigator Discretion|1
5560959|NCT01181895|19216950|P2|Overall Study|Investigator Discretion|2
5560960|NCT01181895|19216951|P1|Overall Study|Investigator Discretion|1
5560961|NCT01181895|19216949|P3|Overall Study|Lost to Follow-up|2
5560962|NCT01181895|19216950|P2|Overall Study|Lost to Follow-up|1
5560963|NCT01181895|19216951|P1|Overall Study|Lost to Follow-up|0
5560964|NCT01181895|19216949|P3|Overall Study|Protocol Violation|0
5560965|NCT01181895|19216950|P2|Overall Study|Protocol Violation|1
5560966|NCT01181895|19216951|P1|Overall Study|Protocol Violation|2
5560967|NCT01181895|19216949|P3|Overall Study|Lack of Efficacy|9
5560968|NCT01181895|19216950|P2|Overall Study|Lack of Efficacy|9
5560969|NCT01181895|19216951|P1|Overall Study|Lack of Efficacy|8
5560970|NCT01181895|19216949|P3|Overall Study|Adverse Event|1
5560971|NCT01181895|19216950|P2|Overall Study|Adverse Event|1
5560972|NCT01181895|19216951|P1|Overall Study|Adverse Event|3
5560973|NCT01181778|19217009|P1|Overall Study|Physician Decision|48
5560974|NCT01181726|19217017|P2|First Intervention|Adverse Event|0
5560975|NCT01181726|19217018|P1|First Intervention|Adverse Event|1
5560976|NCT01181609|19217098|P1|Overall Study|Death|50
5560977|NCT01181609|19217098|P1|Overall Study|Lost to Follow-up|1
5560978|NCT01181609|19217098|P1|Overall Study|Withdrawal by Subject|1
5560979|NCT01181609|19217098|P1|Overall Study|Adverse Event|1
5560980|NCT01181531|19217116|P2|Overall Study|Adverse Event|1
5560981|NCT01181531|19217117|P1|Overall Study|Adverse Event|0
5560982|NCT01181531|19217116|P2|Overall Study|Death|12
5560983|NCT01181531|19217117|P1|Overall Study|Death|9
5560984|NCT01181531|19217116|P2|Overall Study|Protocol Violation|6
5560985|NCT01181531|19217117|P1|Overall Study|Protocol Violation|6
5560986|NCT01181531|19217116|P2|Overall Study|Withdrawal by Subject|7
5560987|NCT01181531|19217117|P1|Overall Study|Withdrawal by Subject|8
5560988|NCT01181531|19217116|P2|Overall Study|Pregnancy|1
5560989|NCT01181531|19217117|P1|Overall Study|Pregnancy|0
5560990|NCT01181531|19217116|P2|Overall Study|Protocol Specified Criteria|8
5560991|NCT01181531|19217117|P1|Overall Study|Protocol Specified Criteria|15
5560992|NCT01181531|19217116|P2|Overall Study|Ineligibility determined|2
5560993|NCT01181531|19217117|P1|Overall Study|Ineligibility determined|1
5560994|NCT01181531|19217116|P2|Overall Study|Noncompliance|2
5560995|NCT01181531|19217117|P1|Overall Study|Noncompliance|2
5560996|NCT01181531|19217116|P2|Overall Study|Physician Decision|1
5560997|NCT01181531|19217117|P1|Overall Study|Physician Decision|3
5560998|NCT01181531|19217116|P2|Overall Study|Partial consent by subject withdrawn|1
5560999|NCT01181531|19217117|P1|Overall Study|Partial consent by subject withdrawn|0
5561000|NCT01181531|19217116|P2|Overall Study|Other|12
5561001|NCT01181531|19217117|P1|Overall Study|Other|17
5561002|NCT01181271|19217259|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
5561003|NCT01181271|19217259|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
5561004|NCT01181271|19217259|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
5561005|NCT01181271|19217259|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
5561006|NCT01181167|19217283|P2|Overall Study|Withdrawal by Subject|8
5561007|NCT01181167|19217284|P1|Overall Study|Withdrawal by Subject|6
5561008|NCT01181167|19217283|P2|Overall Study|Protocol Violation|0
5561009|NCT01181167|19217284|P1|Overall Study|Protocol Violation|3
5561010|NCT01181167|19217283|P2|Overall Study|Physician Decision|3
5561011|NCT01181167|19217284|P1|Overall Study|Physician Decision|2
5561012|NCT01181167|19217283|P2|Overall Study|Lost to Follow-up|0
5561013|NCT01181167|19217284|P1|Overall Study|Lost to Follow-up|1
5561014|NCT01181167|19217283|P2|Overall Study|Adverse Event|21
5561015|NCT01181167|19217284|P1|Overall Study|Adverse Event|11
5561016|NCT01181141|19217294|P2|Overall Study|Withdrawal by Subject|1
5561017|NCT01181141|19217295|P1|Overall Study|Withdrawal by Subject|3
5561018|NCT01181141|19217294|P2|Overall Study|Protocol Violation|1
5561019|NCT01181141|19217295|P1|Overall Study|Protocol Violation|3
5561020|NCT01181141|19217294|P2|Overall Study|Physician Decision|0
5561021|NCT01181141|19217295|P1|Overall Study|Physician Decision|2
5561022|NCT01181141|19217294|P2|Overall Study|Lost to Follow-up|1
5561023|NCT01181141|19217295|P1|Overall Study|Lost to Follow-up|1
5561024|NCT01181141|19217294|P2|Overall Study|Lack of Efficacy|0
5561025|NCT01181141|19217295|P1|Overall Study|Lack of Efficacy|1
5561026|NCT01181141|19217294|P2|Overall Study|Adverse Event|1
5561027|NCT01181141|19217295|P1|Overall Study|Adverse Event|2
5561028|NCT01181128|19217304|P3|Overall Study|Other|1
5561029|NCT01181128|19217305|P2|Overall Study|Other|1
5561030|NCT01181128|19217306|P1|Overall Study|Other|1
5561031|NCT01181128|19217304|P3|Overall Study|Adverse Event|0
5561032|NCT01181128|19217305|P2|Overall Study|Adverse Event|2
5561033|NCT01181128|19217306|P1|Overall Study|Adverse Event|0
5561034|NCT01181128|19217304|P3|Overall Study|Physician Decision|0
5561035|NCT01181128|19217305|P2|Overall Study|Physician Decision|0
5561036|NCT01181128|19217306|P1|Overall Study|Physician Decision|2
5561037|NCT01181128|19217304|P3|Overall Study|Death|0
5561038|NCT01181128|19217305|P2|Overall Study|Death|0
5561039|NCT01181128|19217306|P1|Overall Study|Death|1
5561040|NCT01181128|19217304|P3|Overall Study|Withdrawal by Subject|0
5561041|NCT01181128|19217305|P2|Overall Study|Withdrawal by Subject|2
5561042|NCT01181128|19217306|P1|Overall Study|Withdrawal by Subject|2
5561043|NCT01181102|19217394|P2|Overall Study|Withdrawal by Subject|12
5561044|NCT01181102|19217395|P1|Overall Study|Withdrawal by Subject|10
5561045|NCT01181102|19217394|P2|Overall Study|Protocol Violation|6
5561046|NCT01181102|19217395|P1|Overall Study|Protocol Violation|5
5561047|NCT01181102|19217394|P2|Overall Study|Physician Decision|1
5561048|NCT01181102|19217395|P1|Overall Study|Physician Decision|3
5561049|NCT01181102|19217394|P2|Overall Study|Lost to Follow-up|0
5561050|NCT01181102|19217395|P1|Overall Study|Lost to Follow-up|2
5561051|NCT01181102|19217394|P2|Overall Study|Lack of Efficacy|1
5561052|NCT01181102|19217395|P1|Overall Study|Lack of Efficacy|3
5561053|NCT01181102|19217394|P2|Overall Study|Adverse Event|26
5561054|NCT01181102|19217395|P1|Overall Study|Adverse Event|28
5561055|NCT01181011|19217439|P1|Overall Study|Lost to Follow-up|1
5561056|NCT01181011|19217439|P1|Overall Study|Adverse Event|2
5561057|NCT01180998|19217489|P3|Overall Study|Poor lens handling|2
5561058|NCT01180998|19217490|P2|Overall Study|Poor lens handling|0
5561059|NCT01180998|19217491|P1|Overall Study|Poor lens handling|0
5561060|NCT01180998|19217489|P3|Overall Study|Poor comfort|4
5561061|NCT01180998|19217490|P2|Overall Study|Poor comfort|0
5561062|NCT01180998|19217491|P1|Overall Study|Poor comfort|3
5561063|NCT01180998|19217489|P3|Overall Study|Withdrawal by Subject|1
5561064|NCT01180998|19217490|P2|Overall Study|Withdrawal by Subject|0
5561065|NCT01180998|19217491|P1|Overall Study|Withdrawal by Subject|0
5561066|NCT01180998|19217489|P3|Overall Study|Protocol Violation|0
5561067|NCT01180998|19217490|P2|Overall Study|Protocol Violation|2
5561068|NCT01180998|19217491|P1|Overall Study|Protocol Violation|1
5561069|NCT01180998|19217489|P3|Overall Study|Lost to Follow-up|1
5561070|NCT01180998|19217490|P2|Overall Study|Lost to Follow-up|0
5561071|NCT01180998|19217491|P1|Overall Study|Lost to Follow-up|0
5561072|NCT01180998|19217489|P3|Overall Study|Poor Vision|2
5561073|NCT01180998|19217490|P2|Overall Study|Poor Vision|2
5561074|NCT01180998|19217491|P1|Overall Study|Poor Vision|0
5561075|NCT01180985|19217505|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
5561076|NCT01180985|19217506|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
5561077|NCT01180790|19217545|P7|Overall Study|Severe coronary atherosclerosis (death)|0
5561078|NCT01180790|19217546|P6|Overall Study|Severe coronary atherosclerosis (death)|0
5561079|NCT01180790|19217547|P5|Overall Study|Severe coronary atherosclerosis (death)|0
5561080|NCT01180790|19217548|P4|Overall Study|Severe coronary atherosclerosis (death)|0
5561081|NCT01180790|19217549|P3|Overall Study|Severe coronary atherosclerosis (death)|1
5561082|NCT01180790|19217550|P2|Overall Study|Severe coronary atherosclerosis (death)|0
5561083|NCT01180790|19217551|P1|Overall Study|Severe coronary atherosclerosis (death)|0
5561084|NCT01180790|19217545|P7|Overall Study|compliance|0
5561085|NCT01180790|19217546|P6|Overall Study|compliance|0
5561086|NCT01180790|19217547|P5|Overall Study|compliance|0
5561087|NCT01180790|19217548|P4|Overall Study|compliance|0
5561088|NCT01180790|19217549|P3|Overall Study|compliance|0
5561089|NCT01180790|19217550|P2|Overall Study|compliance|1
5561090|NCT01180790|19217551|P1|Overall Study|compliance|0
5561091|NCT01180790|19217545|P7|Overall Study|Lack of Efficacy|0
5561092|NCT01180790|19217546|P6|Overall Study|Lack of Efficacy|3
5561093|NCT01180790|19217547|P5|Overall Study|Lack of Efficacy|1
5561094|NCT01180790|19217548|P4|Overall Study|Lack of Efficacy|6
5561095|NCT01180790|19217549|P3|Overall Study|Lack of Efficacy|5
5561096|NCT01180790|19217550|P2|Overall Study|Lack of Efficacy|2
5561097|NCT01180790|19217551|P1|Overall Study|Lack of Efficacy|1
5561098|NCT01180790|19217545|P7|Overall Study|Physician Decision|0
5561099|NCT01180790|19217546|P6|Overall Study|Physician Decision|0
5561100|NCT01180790|19217547|P5|Overall Study|Physician Decision|0
5561101|NCT01180790|19217548|P4|Overall Study|Physician Decision|1
5561102|NCT01180790|19217549|P3|Overall Study|Physician Decision|0
5561103|NCT01180790|19217550|P2|Overall Study|Physician Decision|0
5561104|NCT01180790|19217551|P1|Overall Study|Physician Decision|1
5561105|NCT01180790|19217545|P7|Overall Study|Lost to Follow-up|1
5561106|NCT01180790|19217546|P6|Overall Study|Lost to Follow-up|0
5561107|NCT01180790|19217547|P5|Overall Study|Lost to Follow-up|1
5561108|NCT01180790|19217548|P4|Overall Study|Lost to Follow-up|2
5561109|NCT01180790|19217549|P3|Overall Study|Lost to Follow-up|0
5561110|NCT01180790|19217550|P2|Overall Study|Lost to Follow-up|1
5561111|NCT01180790|19217551|P1|Overall Study|Lost to Follow-up|3
5561112|NCT01180790|19217545|P7|Overall Study|Withdrawal by Subject|0
5561113|NCT01180790|19217546|P6|Overall Study|Withdrawal by Subject|1
5561114|NCT01180790|19217547|P5|Overall Study|Withdrawal by Subject|2
5561115|NCT01180790|19217548|P4|Overall Study|Withdrawal by Subject|0
5561116|NCT01180790|19217549|P3|Overall Study|Withdrawal by Subject|5
5561117|NCT01180790|19217550|P2|Overall Study|Withdrawal by Subject|0
5561118|NCT01180790|19217551|P1|Overall Study|Withdrawal by Subject|3
5561119|NCT01180790|19217545|P7|Overall Study|Adverse Event|0
5561120|NCT01180790|19217546|P6|Overall Study|Adverse Event|3
5561121|NCT01180790|19217547|P5|Overall Study|Adverse Event|1
5561122|NCT01180790|19217548|P4|Overall Study|Adverse Event|0
5561123|NCT01180790|19217549|P3|Overall Study|Adverse Event|2
5561124|NCT01180790|19217550|P2|Overall Study|Adverse Event|1
5561125|NCT01180790|19217551|P1|Overall Study|Adverse Event|1
5561126|NCT01180777|19217616|P1|Overall Study|Adverse Event|1
5561127|NCT01180777|19217616|P1|Overall Study|Lost to Follow-up|1
5561128|NCT01180777|19217616|P1|Overall Study|Poor lens fit|4
5561129|NCT01180777|19217616|P1|Overall Study|Protocol Violation|6
5561130|NCT01180660|19217630|P2|Overall Study|Changed to open surgery|0
5561131|NCT01180660|19217631|P1|Overall Study|Changed to open surgery|1
5561132|NCT01180647|19217641|P2|Overall Study|Lost to Follow-up|6
5561133|NCT01180647|19217642|P1|Overall Study|Lost to Follow-up|5
5561134|NCT01180400|19217677|P2|Overall Study|Other|1
5561135|NCT01180400|19217678|P1|Overall Study|Other|0
5561136|NCT01180400|19217677|P2|Overall Study|Lost to Follow-up|3
5561137|NCT01180400|19217678|P1|Overall Study|Lost to Follow-up|2
5561138|NCT01180400|19217677|P2|Overall Study|Study-specific withdrawal criteria|2
5561139|NCT01180400|19217678|P1|Overall Study|Study-specific withdrawal criteria|1
5561140|NCT01180400|19217677|P2|Overall Study|Lack of Efficacy|0
5561141|NCT01180400|19217678|P1|Overall Study|Lack of Efficacy|2
5561142|NCT01180400|19217677|P2|Overall Study|Condition under investigation worsened|1
5561143|NCT01180400|19217678|P1|Overall Study|Condition under investigation worsened|2
5561144|NCT01180400|19217677|P2|Overall Study|Severe non-compliance to protocol|2
5561145|NCT01180400|19217678|P1|Overall Study|Severe non-compliance to protocol|1
5561146|NCT01180400|19217677|P2|Overall Study|Adverse Event|10
5561147|NCT01180400|19217678|P1|Overall Study|Adverse Event|12
5561148|NCT01180400|19217677|P2|Overall Study|Eligibility criteria not fulfilled|2
5561149|NCT01180400|19217678|P1|Overall Study|Eligibility criteria not fulfilled|0
5561150|NCT01180400|19217677|P2|Overall Study|Withdrawal by Subject|6
5561151|NCT01180400|19217678|P1|Overall Study|Withdrawal by Subject|5
5561152|NCT01180296|19217726|P2|Overall Study|Protocol Violation|2
5561153|NCT01180296|19217727|P1|Overall Study|Protocol Violation|1
5561154|NCT01180244|19217737|P2|Overall Study|Lost to Follow-up|0
5561155|NCT01180244|19217738|P1|Overall Study|Lost to Follow-up|1
5561156|NCT01180244|19217737|P2|Overall Study|Protocol Violation|0
5561157|NCT01180244|19217738|P1|Overall Study|Protocol Violation|1
5561158|NCT01180244|19217737|P2|Overall Study|Withdrawal by Subject|1
5561159|NCT01180244|19217738|P1|Overall Study|Withdrawal by Subject|0
5561160|NCT01180244|19217737|P2|Overall Study|Adverse Event|0
5561161|NCT01180244|19217738|P1|Overall Study|Adverse Event|1
5561162|NCT01180244|19217737|P2|Overall Study|Physician Decision|0
5561163|NCT01180244|19217738|P1|Overall Study|Physician Decision|3
5561164|NCT01180244|19217737|P2|Overall Study|Lack of Efficacy|7
5561165|NCT01180244|19217738|P1|Overall Study|Lack of Efficacy|0
5561166|NCT01180049|19217783|P2|Overall Study|Death|35
5561167|NCT01180049|19217784|P1|Overall Study|Death|36
5561168|NCT01180049|19217783|P2|Overall Study|Lost to Follow-up|6
5561169|NCT01180049|19217784|P1|Overall Study|Lost to Follow-up|8
5561170|NCT01180049|19217783|P2|Overall Study|Other|7
5561171|NCT01180049|19217784|P1|Overall Study|Other|9
5561172|NCT01179919|19217821|P1|Overall Study|Adverse Event|1
5561173|NCT01179919|19217821|P1|Overall Study|Protocol Violation|1
5561174|NCT01179737|19217830|P4|Extension|The study was terminated|0
5561175|NCT01179737|19217831|P3|Extension|The study was terminated|0
5561176|NCT01179737|19217832|P2|Extension|The study was terminated|0
5561177|NCT01179737|19217833|P1|Extension|The study was terminated|3
5561178|NCT01179737|19217830|P4|Cohort 1 & Cohort 2 Expansion|Death|0
5561179|NCT01179737|19217831|P3|Cohort 1 & Cohort 2 Expansion|Death|0
5561180|NCT01179737|19217832|P2|Cohort 1 & Cohort 2 Expansion|Death|0
5561181|NCT01179737|19217833|P1|Cohort 1 & Cohort 2 Expansion|Death|1
5561182|NCT01179737|19217830|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
5561183|NCT01179737|19217831|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
5561184|NCT01179737|19217832|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
5561185|NCT01179737|19217833|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
5561186|NCT01179737|19217830|P4|Cohort 1 & Cohort 2|Death|0
5561187|NCT01179737|19217831|P3|Cohort 1 & Cohort 2|Death|1
5561188|NCT01179737|19217832|P2|Cohort 1 & Cohort 2|Death|0
5561189|NCT01179737|19217833|P1|Cohort 1 & Cohort 2|Death|0
5561190|NCT01179737|19217830|P4|Cohort 1 & Cohort 2|Administrative problems|4
5561191|NCT01179737|19217831|P3|Cohort 1 & Cohort 2|Administrative problems|2
5561192|NCT01179737|19217832|P2|Cohort 1 & Cohort 2|Administrative problems|0
5561193|NCT01179737|19217833|P1|Cohort 1 & Cohort 2|Administrative problems|0
5561194|NCT01179737|19217830|P4|Cohort 1 & Cohort 2|Withdrew consent|0
5561195|NCT01179737|19217831|P3|Cohort 1 & Cohort 2|Withdrew consent|0
5561196|NCT01179737|19217832|P2|Cohort 1 & Cohort 2|Withdrew consent|0
5561197|NCT01179737|19217833|P1|Cohort 1 & Cohort 2|Withdrew consent|2
5561198|NCT01179737|19217830|P4|Cohort 1 & Cohort 2|Adverse Event|0
5561199|NCT01179737|19217831|P3|Cohort 1 & Cohort 2|Adverse Event|1
5561200|NCT01179737|19217832|P2|Cohort 1 & Cohort 2|Adverse Event|1
5561201|NCT01179737|19217833|P1|Cohort 1 & Cohort 2|Adverse Event|3
5561202|NCT01179672|19217844|P2|Overall Study|Physician Decision|1
5561203|NCT01179672|19217845|P1|Overall Study|Physician Decision|1
5561204|NCT01179672|19217844|P2|Overall Study|Protocol Violation|2
5561205|NCT01179672|19217845|P1|Overall Study|Protocol Violation|2
5561206|NCT01179672|19217844|P2|Overall Study|Lost to Follow-up|1
5561207|NCT01179672|19217845|P1|Overall Study|Lost to Follow-up|0
5561208|NCT01179672|19217844|P2|Overall Study|Entry Criteria Not Met|2
5561209|NCT01179672|19217845|P1|Overall Study|Entry Criteria Not Met|0
5561210|NCT01179672|19217844|P2|Overall Study|Withdrawal by Subject|12
5561211|NCT01179672|19217845|P1|Overall Study|Withdrawal by Subject|10
5561212|NCT01179672|19217844|P2|Overall Study|Adverse Event|8
5561213|NCT01179672|19217845|P1|Overall Study|Adverse Event|17
5561214|NCT01179516|19217901|P3|Overall Study|Other|2
5561215|NCT01179516|19217902|P2|Overall Study|Other|0
5561216|NCT01179516|19217903|P1|Overall Study|Other|2
5561217|NCT01179516|19217901|P3|Overall Study|Lost to Follow-up|3
5561218|NCT01179516|19217902|P2|Overall Study|Lost to Follow-up|7
5561219|NCT01179516|19217903|P1|Overall Study|Lost to Follow-up|7
5561220|NCT01179516|19217901|P3|Overall Study|Withdrawal of Consent|10
5561221|NCT01179516|19217902|P2|Overall Study|Withdrawal of Consent|6
5561222|NCT01179516|19217903|P1|Overall Study|Withdrawal of Consent|2
5561223|NCT01179516|19217901|P3|Overall Study|Protocol Deviations|3
5561224|NCT01179516|19217902|P2|Overall Study|Protocol Deviations|3
5561225|NCT01179516|19217903|P1|Overall Study|Protocol Deviations|4
5561226|NCT01179516|19217901|P3|Overall Study|Noncompliance with Study Drug|1
5561227|NCT01179516|19217902|P2|Overall Study|Noncompliance with Study Drug|0
5561228|NCT01179516|19217903|P1|Overall Study|Noncompliance with Study Drug|2
5561229|NCT01179516|19217901|P3|Overall Study|Lack of Efficacy|0
5561230|NCT01179516|19217902|P2|Overall Study|Lack of Efficacy|2
5561231|NCT01179516|19217903|P1|Overall Study|Lack of Efficacy|4
5561232|NCT01179516|19217901|P3|Overall Study|Pretreatment Event or Adverse Event|12
5561233|NCT01179516|19217902|P2|Overall Study|Pretreatment Event or Adverse Event|8
5561234|NCT01179516|19217903|P1|Overall Study|Pretreatment Event or Adverse Event|6
5561235|NCT01179477|19217947|P1|Overall Study|Did not complete final visit|27
5561236|NCT01179477|19217947|P1|Overall Study|Non-death withdrawal|438
5561237|NCT01179477|19217947|P1|Overall Study|Unsuccessful implant|80
5561238|NCT01179477|19217947|P1|Overall Study|Death|542
5561239|NCT01179399|19217952|P1|Overall Study|Withdrawal by Subject|1
5561240|NCT01179399|19217952|P1|Overall Study|Lack of Efficacy|30
5561241|NCT01179399|19217952|P1|Overall Study|Adverse Event|1
5561242|NCT01179347|19217958|P2|Open-label Period (12 Weeks)|Other|4
5561243|NCT01179347|19217959|P1|Open-label Period (12 Weeks)|Other|7
5561244|NCT01179347|19217958|P2|Open-label Period (12 Weeks)|Protocol Violation|0
5561245|NCT01179347|19217959|P1|Open-label Period (12 Weeks)|Protocol Violation|1
5561246|NCT01179347|19217958|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
5561247|NCT01179347|19217959|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
5561248|NCT01179347|19217958|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
5561249|NCT01179347|19217959|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
5561250|NCT01179347|19217958|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
5561251|NCT01179347|19217959|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
5561252|NCT01179347|19217958|P2|Open-label Period (12 Weeks)|Adverse Event|9
5561253|NCT01179347|19217959|P1|Open-label Period (12 Weeks)|Adverse Event|5
5561254|NCT01179347|19217958|P2|Double-blind Period (12 Weeks)|Other|4
5561255|NCT01179347|19217959|P1|Double-blind Period (12 Weeks)|Other|2
5561256|NCT01179347|19217958|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
5561257|NCT01179347|19217959|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
5561258|NCT01179347|19217958|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
5561259|NCT01179347|19217959|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
5561260|NCT01179347|19217958|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
5561261|NCT01179347|19217959|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
5561262|NCT01179347|19217958|P2|Double-blind Period (12 Weeks)|Adverse Event|6
5561263|NCT01179347|19217959|P1|Double-blind Period (12 Weeks)|Adverse Event|2
5561264|NCT01179334|19217981|P2|Long-term Extension (LTE) Period|Adverse Event|4
5561265|NCT01179334|19217982|P1|Long-term Extension (LTE) Period|Adverse Event|2
5561266|NCT01179334|19217981|P2|Long-term Extension (LTE) Period|Death|0
5561267|NCT01179334|19217982|P1|Long-term Extension (LTE) Period|Death|3
5561268|NCT01179334|19217981|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
5561269|NCT01179334|19217982|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
5561270|NCT01179334|19217981|P2|Treatment Period|Adverse Event|0
5561271|NCT01179334|19217982|P1|Treatment Period|Adverse Event|1
5561272|NCT01179191|19218037|P1|Maintenance Phase (8 Weeks)|Other|66
5561273|NCT01179191|19218037|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
5561274|NCT01179191|19218037|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
5561275|NCT01179191|19218037|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
5561276|NCT01179191|19218037|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
5561277|NCT01179191|19218037|P1|Titration Phase (up to 6 Weeks)|Other|62
5561278|NCT01179191|19218037|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
5561279|NCT01179191|19218037|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
5561280|NCT01179191|19218037|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
5561281|NCT01179191|19218037|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
5561282|NCT01179191|19218037|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
5561283|NCT01179048|19218069|P2|Overall Study|Alive|142
5561284|NCT01179048|19218070|P1|Overall Study|Alive|127
5561285|NCT01179048|19218069|P2|Overall Study|Lost to Follow-up|9
5561286|NCT01179048|19218070|P1|Overall Study|Lost to Follow-up|8
5561287|NCT01179048|19218069|P2|Overall Study|Withdrawn - does not allow contact|8
5561288|NCT01179048|19218070|P1|Overall Study|Withdrawn - does not allow contact|4
5561289|NCT01178853|19218097|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
5561290|NCT01178853|19218098|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
5561291|NCT01178853|19218097|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
5561292|NCT01178853|19218098|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
5561293|NCT01178853|19218097|P2|Period 3 (Warfarin Titration)|Adverse Event|0
5561294|NCT01178853|19218098|P1|Period 3 (Warfarin Titration)|Adverse Event|1
5561295|NCT01178853|19218097|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
5561296|NCT01178853|19218098|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
5561297|NCT01178853|19218097|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
5561298|NCT01178853|19218098|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
5561299|NCT01178762|19218138|P1|Overall Study|Lost to Follow-up|15
5561300|NCT01178671|19218144|P2|Overall Study|Physician Decision|6
5561301|NCT01178671|19218145|P1|Overall Study|Physician Decision|4
5561302|NCT01178671|19218144|P2|Overall Study|Lost to Follow-up|1
5561303|NCT01178671|19218145|P1|Overall Study|Lost to Follow-up|3
5561304|NCT01178671|19218144|P2|Overall Study|Lack of Efficacy|1
5561305|NCT01178671|19218145|P1|Overall Study|Lack of Efficacy|0
5561306|NCT01178671|19218144|P2|Overall Study|Protocol Violation|1
5561307|NCT01178671|19218145|P1|Overall Study|Protocol Violation|1
5561308|NCT01178671|19218144|P2|Overall Study|Adverse Event|6
5561309|NCT01178671|19218145|P1|Overall Study|Adverse Event|4
5561310|NCT01178385|19218193|P2|Overall Study|Withdrawal by Subject|0
5561311|NCT01178385|19218194|P1|Overall Study|Withdrawal by Subject|2
5561312|NCT01178294|19218263|P1|Overall Study|Completion status could not be verified|1
5561313|NCT01178294|19218263|P1|Overall Study|Subject status is terminal|1
5561314|NCT01178294|19218263|P1|Overall Study|Development of inhibitors to OBI-1|1
5561315|NCT01178294|19218263|P1|Overall Study|Death|1
5561316|NCT01178294|19218263|P1|Overall Study|Lack of Efficacy|1
5561317|NCT01178294|19218263|P1|Overall Study|Lost to Follow-up|2
5561318|NCT01178294|19218263|P1|Overall Study|Adverse Event|4
5561319|NCT01178138|19218543|P1|Overall Study|Physician Decision|8
5561320|NCT01178138|19218543|P1|Overall Study|Withdrawal by Subject|7
5561321|NCT01178138|19218543|P1|Overall Study|Lost to Follow-up|8
5561322|NCT01178125|19218564|P1|Overall Study|Investigator Decision|5
5561323|NCT01178125|19218564|P1|Overall Study|Protocol Violation|17
5561324|NCT01178125|19218564|P1|Overall Study|Sponsor Decision|28
5561325|NCT01178125|19218564|P1|Overall Study|Other Reason|39
5561326|NCT01178125|19218564|P1|Overall Study|Pregnancy|55
5561327|NCT01178125|19218564|P1|Overall Study|Noncompliance|184
5561328|NCT01178125|19218564|P1|Overall Study|Withdrawal by Subject|209
5561329|NCT01178125|19218564|P1|Overall Study|Adverse Event|244
5561330|NCT01178125|19218564|P1|Overall Study|Lost to Follow-up|397
5561331|NCT01178099|19218595|P2|Overall Study|Physician Decision|1
5561332|NCT01178099|19218596|P1|Overall Study|Physician Decision|0
5561333|NCT01178086|19218636|P1|Overall Study|Excluded from EAS|20
5561334|NCT01178086|19218636|P1|Overall Study|Other unspecified|89
5561335|NCT01178086|19218636|P1|Overall Study|Death|59
5561336|NCT01178086|19218636|P1|Overall Study|Switch to other CLL therapy|113
5561337|NCT01178086|19218636|P1|Overall Study|Physician Decision|44
5561338|NCT01178086|19218636|P1|Overall Study|Participant refusal|7
5561339|NCT01178073|19218663|P3|Overall Study|Missing Completion Status|0
5561340|NCT01178073|19218664|P2|Overall Study|Missing Completion Status|0
5561341|NCT01178073|19218665|P1|Overall Study|Missing Completion Status|1
5561342|NCT01178073|19218663|P3|Overall Study|Withdrawal by Subject|8
5561343|NCT01178073|19218664|P2|Overall Study|Withdrawal by Subject|6
5561344|NCT01178073|19218665|P1|Overall Study|Withdrawal by Subject|10
5561345|NCT01178073|19218663|P3|Overall Study|Physician Decision|10
5561346|NCT01178073|19218664|P2|Overall Study|Physician Decision|10
5561347|NCT01178073|19218665|P1|Overall Study|Physician Decision|14
5561348|NCT01178073|19218663|P3|Overall Study|Lost to Follow-up|3
5561349|NCT01178073|19218664|P2|Overall Study|Lost to Follow-up|0
5561350|NCT01178073|19218665|P1|Overall Study|Lost to Follow-up|2
5561351|NCT01178073|19218663|P3|Overall Study|Protocol Violation|1
5561352|NCT01178073|19218664|P2|Overall Study|Protocol Violation|1
5561353|NCT01178073|19218665|P1|Overall Study|Protocol Violation|1
5561354|NCT01178073|19218663|P3|Overall Study|Adverse Event|24
5561355|NCT01178073|19218664|P2|Overall Study|Adverse Event|27
5561356|NCT01178073|19218665|P1|Overall Study|Adverse Event|34
5561357|NCT01177969|19218696|P2|Overall Study|Withdrawal by Subject|2
5561358|NCT01177969|19218697|P1|Overall Study|Withdrawal by Subject|1
5561359|NCT01177969|19218696|P2|Overall Study|Protocol Violation|1
5561360|NCT01177969|19218697|P1|Overall Study|Protocol Violation|2
5561361|NCT01177943|19218720|P2|First Intervention|Withdrawal by Subject|0
5561362|NCT01177943|19218721|P1|First Intervention|Withdrawal by Subject|2
5561363|NCT01177813|19218734|P5|Overall Study|Other reason not defined above|2
5561364|NCT01177813|19218735|P4|Overall Study|Other reason not defined above|3
5561365|NCT01177813|19218736|P3|Overall Study|Other reason not defined above|2
5561366|NCT01177813|19218737|P2|Overall Study|Other reason not defined above|2
5561367|NCT01177813|19218738|P1|Overall Study|Other reason not defined above|5
5561368|NCT01177813|19218734|P5|Overall Study|Withdrawal by Subject|3
5561369|NCT01177813|19218735|P4|Overall Study|Withdrawal by Subject|5
5561370|NCT01177813|19218736|P3|Overall Study|Withdrawal by Subject|6
5561371|NCT01177813|19218737|P2|Overall Study|Withdrawal by Subject|7
5561372|NCT01177813|19218738|P1|Overall Study|Withdrawal by Subject|12
5561373|NCT01177813|19218734|P5|Overall Study|Lost to Follow-up|0
5561374|NCT01177813|19218735|P4|Overall Study|Lost to Follow-up|3
5561375|NCT01177813|19218736|P3|Overall Study|Lost to Follow-up|6
5561376|NCT01177813|19218737|P2|Overall Study|Lost to Follow-up|5
5561377|NCT01177813|19218738|P1|Overall Study|Lost to Follow-up|12
5561378|NCT01177813|19218734|P5|Overall Study|Protocol Violation|1
5561379|NCT01177813|19218735|P4|Overall Study|Protocol Violation|0
5561380|NCT01177813|19218736|P3|Overall Study|Protocol Violation|2
5561381|NCT01177813|19218737|P2|Overall Study|Protocol Violation|2
5561382|NCT01177813|19218738|P1|Overall Study|Protocol Violation|3
5561383|NCT01177813|19218734|P5|Overall Study|Lack of Efficacy|0
5561384|NCT01177813|19218735|P4|Overall Study|Lack of Efficacy|0
5561385|NCT01177813|19218736|P3|Overall Study|Lack of Efficacy|0
5561386|NCT01177813|19218737|P2|Overall Study|Lack of Efficacy|0
5561387|NCT01177813|19218738|P1|Overall Study|Lack of Efficacy|1
5561388|NCT01177813|19218734|P5|Overall Study|Adverse Event|3
5561389|NCT01177813|19218735|P4|Overall Study|Adverse Event|6
5561390|NCT01177813|19218736|P3|Overall Study|Adverse Event|4
5561391|NCT01177813|19218737|P2|Overall Study|Adverse Event|2
5561392|NCT01177813|19218738|P1|Overall Study|Adverse Event|8
5561393|NCT01177800|19218767|P2|Overall Study|Withdrawal of informed consent|1
5561394|NCT01177800|19218768|P1|Overall Study|Withdrawal of informed consent|0
5561395|NCT01177800|19218767|P2|Overall Study|Physician Decision|0
5561396|NCT01177800|19218768|P1|Overall Study|Physician Decision|1
5561397|NCT01177800|19218767|P2|Overall Study|Protocol Violation|1
5561398|NCT01177800|19218768|P1|Overall Study|Protocol Violation|0
5561399|NCT01177800|19218767|P2|Overall Study|Adverse Event|3
5561400|NCT01177800|19218768|P1|Overall Study|Adverse Event|9
5561401|NCT01177722|19218790|P4|Overall Study|Withdrawal by Subject|6
5561402|NCT01177722|19218791|P3|Overall Study|Withdrawal by Subject|4
5561403|NCT01177722|19218792|P2|Overall Study|Withdrawal by Subject|6
5561404|NCT01177722|19218793|P1|Overall Study|Withdrawal by Subject|10
5561405|NCT01177722|19218790|P4|Overall Study|Lost to Follow-up|1
5561406|NCT01177722|19218791|P3|Overall Study|Lost to Follow-up|3
5561407|NCT01177722|19218792|P2|Overall Study|Lost to Follow-up|4
5561408|NCT01177722|19218793|P1|Overall Study|Lost to Follow-up|3
5561409|NCT01177722|19218790|P4|Overall Study|Protocol Violation|0
5561410|NCT01177722|19218791|P3|Overall Study|Protocol Violation|1
5561411|NCT01177722|19218792|P2|Overall Study|Protocol Violation|0
5561412|NCT01177722|19218793|P1|Overall Study|Protocol Violation|0
5561413|NCT01177722|19218790|P4|Overall Study|Serious Adverse Event|0
5561414|NCT01177722|19218791|P3|Overall Study|Serious Adverse Event|1
5561415|NCT01177722|19218792|P2|Overall Study|Serious Adverse Event|0
5561416|NCT01177722|19218793|P1|Overall Study|Serious Adverse Event|0
5561417|NCT01177670|19218825|P1|Overall Study|Withdrawal by Subject|4
5561418|NCT01177670|19218825|P1|Overall Study|Physician Decision|50
5561419|NCT01177670|19218825|P1|Overall Study|Study Terminated|115
5561420|NCT01177553|19218832|P2|Overall Study|babies not yet 6 months of age|0
5561421|NCT01177553|19218833|P1|Overall Study|babies not yet 6 months of age|1
5561422|NCT01177410|19218842|P3|Overall Study|Lost to Follow-up|0
5561423|NCT01177410|19218843|P2|Overall Study|Lost to Follow-up|1
5561424|NCT01177410|19218844|P1|Overall Study|Lost to Follow-up|0
5561425|NCT01177410|19218842|P3|Overall Study|Withdrawal by Subject|3
5561426|NCT01177410|19218843|P2|Overall Study|Withdrawal by Subject|4
5561427|NCT01177410|19218844|P1|Overall Study|Withdrawal by Subject|1
5561428|NCT01177410|19218842|P3|Overall Study|Adverse Event|2
5561429|NCT01177410|19218843|P2|Overall Study|Adverse Event|2
5561430|NCT01177410|19218844|P1|Overall Study|Adverse Event|0
5561431|NCT01177384|19218857|P2|Overall Study|Withdrawal by Subject|12
5561432|NCT01177384|19218858|P1|Overall Study|Withdrawal by Subject|5
5561433|NCT01177384|19218857|P2|Overall Study|Protocol Violation|2
5561434|NCT01177384|19218858|P1|Overall Study|Protocol Violation|0
5561435|NCT01177384|19218857|P2|Overall Study|Physician Decision|3
5561436|NCT01177384|19218858|P1|Overall Study|Physician Decision|0
5561437|NCT01177384|19218857|P2|Overall Study|Lost to Follow-up|4
5561438|NCT01177384|19218858|P1|Overall Study|Lost to Follow-up|3
5561439|NCT01177384|19218857|P2|Overall Study|Lack of Efficacy|1
5561440|NCT01177384|19218858|P1|Overall Study|Lack of Efficacy|0
5561441|NCT01177384|19218857|P2|Overall Study|Adverse Event|4
5561442|NCT01177384|19218858|P1|Overall Study|Adverse Event|6
5561443|NCT01177293|19218870|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
5561444|NCT01177293|19218871|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
5561445|NCT01177228|19218889|P4|Overall Study|Withdrawal by Subject|0
5561446|NCT01177228|19218890|P3|Overall Study|Withdrawal by Subject|0
5561447|NCT01177228|19218891|P2|Overall Study|Withdrawal by Subject|1
5561448|NCT01177228|19218892|P1|Overall Study|Withdrawal by Subject|0
5561449|NCT01177228|19218889|P4|Overall Study|Worsening disease activity|0
5561450|NCT01177228|19218890|P3|Overall Study|Worsening disease activity|0
5561451|NCT01177228|19218891|P2|Overall Study|Worsening disease activity|0
5561452|NCT01177228|19218892|P1|Overall Study|Worsening disease activity|1
5561453|NCT01177228|19218889|P4|Overall Study|Positive tuberculosis test|0
5561454|NCT01177228|19218890|P3|Overall Study|Positive tuberculosis test|0
5561455|NCT01177228|19218891|P2|Overall Study|Positive tuberculosis test|1
5561456|NCT01177228|19218892|P1|Overall Study|Positive tuberculosis test|0
5561457|NCT01177137|19218946|P3|Overall Study|Withdrawal by Subject|2
5561458|NCT01177137|19218947|P2|Overall Study|Withdrawal by Subject|10
5561459|NCT01177137|19218948|P1|Overall Study|Withdrawal by Subject|10
5561460|NCT01177059|19219032|P1|Overall Study|Lost to Follow-up|18
5561461|NCT01177059|19219032|P1|Overall Study|Withdrew consent|2
5561462|NCT01177059|19219032|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
5561463|NCT01177007|19219038|P1|Overall Study|Change in treatment modality|21
5561464|NCT01177007|19219038|P1|Overall Study|Required additional Y90 treatment|6
5561465|NCT01177007|19219038|P1|Overall Study|Entered hospice care|5
5561466|NCT01177007|19219038|P1|Overall Study|Death|4
5561467|NCT01177007|19219038|P1|Overall Study|Lost to Follow-up|2
5561468|NCT01176968|19219052|P2|Overall Study|Reason not defined|3
5561469|NCT01176968|19219053|P1|Overall Study|Reason not defined|5
5561470|NCT01176968|19219052|P2|Overall Study|Study terminated by sponsor|1
5561471|NCT01176968|19219053|P1|Overall Study|Study terminated by sponsor|0
5561472|NCT01176968|19219052|P2|Overall Study|Did Not Meet Entrance Criteria|0
5561473|NCT01176968|19219053|P1|Overall Study|Did Not Meet Entrance Criteria|1
5561474|NCT01176968|19219052|P2|Overall Study|Protocol Violation|1
5561475|NCT01176968|19219053|P1|Overall Study|Protocol Violation|2
5561476|NCT01176968|19219052|P2|Overall Study|Withdrawal by Subject|48
5561477|NCT01176968|19219053|P1|Overall Study|Withdrawal by Subject|48
5561478|NCT01176968|19219052|P2|Overall Study|Lost to Follow-up|14
5561479|NCT01176968|19219053|P1|Overall Study|Lost to Follow-up|16
5561480|NCT01176968|19219052|P2|Overall Study|Lack of Efficacy|1
5561481|NCT01176968|19219053|P1|Overall Study|Lack of Efficacy|0
5561482|NCT01176968|19219052|P2|Overall Study|Death|3
5561483|NCT01176968|19219053|P1|Overall Study|Death|2
5561484|NCT01176968|19219052|P2|Overall Study|Adverse Event|11
5561485|NCT01176968|19219053|P1|Overall Study|Adverse Event|10
5561486|NCT01176916|19219099|P1|Overall Study|Withdrawal prior to Treatment|6
5561487|NCT01176916|19219099|P1|Overall Study|Other|6
5561488|NCT01176916|19219099|P1|Overall Study|Withdrawal by Subject|37
5561489|NCT01176916|19219099|P1|Overall Study|Protocol Violation|24
5561490|NCT01176916|19219099|P1|Overall Study|Objective progression or relapse|17
5561491|NCT01176916|19219099|P1|Overall Study|Lost to Follow-up|15
5561492|NCT01176916|19219099|P1|Overall Study|Death|1
5561493|NCT01176916|19219099|P1|Overall Study|Adverse Event|61
5561494|NCT01176773|19219114|P1|Overall Study|Withdrew consent|1
5561495|NCT01176773|19219114|P1|Overall Study|Screen Failure|2
5561496|NCT01176565|19219157|P2|Overall Study|Not Analyzed (any other reason)|2
5561497|NCT01176565|19219158|P1|Overall Study|Not Analyzed (any other reason)|1
5561498|NCT01176565|19219157|P2|Overall Study|Withdrawal by Subject|1
5561499|NCT01176565|19219158|P1|Overall Study|Withdrawal by Subject|7
5561500|NCT01176565|19219157|P2|Overall Study|Lost to Follow-up|16
5561501|NCT01176565|19219158|P1|Overall Study|Lost to Follow-up|12
5561502|NCT01176513|19219176|P1|Overall Study|Withdrew subjects prior to dosing|3
5561503|NCT01176292|19219204|P2|Overall Study|Has not scheduled one-year visit yet|2
5561504|NCT01176292|19219205|P1|Overall Study|Has not scheduled one-year visit yet|2
5561505|NCT01176292|19219204|P2|Overall Study|Physician Decision|2
5561506|NCT01176292|19219205|P1|Overall Study|Physician Decision|0
5561507|NCT01176292|19219204|P2|Overall Study|Adverse Event|1
5561508|NCT01176292|19219205|P1|Overall Study|Adverse Event|1
5561509|NCT01176292|19219204|P2|Overall Study|Lost to Follow-up|4
5561510|NCT01176292|19219205|P1|Overall Study|Lost to Follow-up|2
5561511|NCT01176266|19219223|P1|Overall Study|Withdrawal by Subject|3
5561512|NCT01176266|19219223|P1|Overall Study|Death|6
5561513|NCT01176240|19219247|P2|Study 306B|withdrew prior to dosing|1
5561514|NCT01176240|19219248|P1|Study 306B|withdrew prior to dosing|2
5561515|NCT01176240|19219247|P2|Study 306B|Lost to Follow-up|1
5561516|NCT01176240|19219248|P1|Study 306B|Lost to Follow-up|0
5561517|NCT01176240|19219247|P2|Study 306B|Supine Hypertension|2
5561518|NCT01176240|19219248|P1|Study 306B|Supine Hypertension|1
5561519|NCT01176240|19219247|P2|Study 306B|Physician Decision|1
5561520|NCT01176240|19219248|P1|Study 306B|Physician Decision|2
5561521|NCT01176240|19219247|P2|Study 306B|Withdrawal by Subject|1
5561522|NCT01176240|19219248|P1|Study 306B|Withdrawal by Subject|4
5561523|NCT01176240|19219247|P2|Study 306B|Protocol Violation|3
5561524|NCT01176240|19219248|P1|Study 306B|Protocol Violation|2
5561525|NCT01176240|19219247|P2|Study 306B|Adverse Event|5
5561526|NCT01176240|19219248|P1|Study 306B|Adverse Event|10
5561527|NCT01176240|19219247|P2|Study 306B|Lack of Efficacy|3
5561528|NCT01176240|19219248|P1|Study 306B|Lack of Efficacy|5
5561529|NCT01176240|19219247|P2|Study 306A|Stop due to diverse problems|0
5561530|NCT01176240|19219248|P1|Study 306A|Stop due to diverse problems|1
5561531|NCT01176240|19219247|P2|Study 306A|Withdrawal by Subject|1
5561532|NCT01176240|19219248|P1|Study 306A|Withdrawal by Subject|0
5561533|NCT01176240|19219247|P2|Study 306A|Protocol Violation|1
5561534|NCT01176240|19219248|P1|Study 306A|Protocol Violation|0
5561535|NCT01176240|19219247|P2|Study 306A|Lack of Efficacy|1
5561536|NCT01176240|19219248|P1|Study 306A|Lack of Efficacy|2
5561537|NCT01176058|19219274|P2|Overall Study|Withdrawal by Subject|0
5561538|NCT01176058|19219275|P1|Overall Study|Withdrawal by Subject|1
5561539|NCT01176058|19219274|P2|Overall Study|Insufficient mycological response|1
5561540|NCT01176058|19219275|P1|Overall Study|Insufficient mycological response|0
5561541|NCT01176058|19219274|P2|Overall Study|Insufficient clinical response|2
5561542|NCT01176058|19219275|P1|Overall Study|Insufficient clinical response|2
5561543|NCT01176058|19219274|P2|Overall Study|Adverse Event|0
5561544|NCT01176058|19219275|P1|Overall Study|Adverse Event|1
5561545|NCT01176032|19219299|P2|Overall Study|Other|0
5561546|NCT01176032|19219300|P1|Overall Study|Other|1
5561547|NCT01176032|19219299|P2|Overall Study|Informed consent withdrawn|0
5561548|NCT01176032|19219300|P1|Overall Study|Informed consent withdrawn|3
5561549|NCT01176032|19219299|P2|Overall Study|Protocol Violation|0
5561550|NCT01176032|19219300|P1|Overall Study|Protocol Violation|1
5561551|NCT01176032|19219299|P2|Overall Study|Unsatisfactory therapeutic effect|1
5561552|NCT01176032|19219300|P1|Overall Study|Unsatisfactory therapeutic effect|0
5561553|NCT01176032|19219299|P2|Overall Study|Adverse Event|0
5561554|NCT01176032|19219300|P1|Overall Study|Adverse Event|1
5561555|NCT01175824|19219441|P2|Overall Study|Entry Criteria Not Met|4
5561556|NCT01175824|19219442|P1|Overall Study|Entry Criteria Not Met|6
5561557|NCT01175824|19219441|P2|Overall Study|Sponsor Decision|0
5561558|NCT01175824|19219442|P1|Overall Study|Sponsor Decision|1
5561559|NCT01175824|19219441|P2|Overall Study|Withdrawal by Subject|7
5561560|NCT01175824|19219442|P1|Overall Study|Withdrawal by Subject|3
5561561|NCT01175824|19219441|P2|Overall Study|Protocol Violation|5
5561562|NCT01175824|19219442|P1|Overall Study|Protocol Violation|2
5561563|NCT01175824|19219441|P2|Overall Study|Physician Decision|4
5561564|NCT01175824|19219442|P1|Overall Study|Physician Decision|0
5561565|NCT01175824|19219441|P2|Overall Study|Lost to Follow-up|1
5561566|NCT01175824|19219442|P1|Overall Study|Lost to Follow-up|0
5561567|NCT01175824|19219441|P2|Overall Study|Lack of Efficacy|0
5561568|NCT01175824|19219442|P1|Overall Study|Lack of Efficacy|2
5561569|NCT01175824|19219441|P2|Overall Study|Adverse Event|1
5561570|NCT01175824|19219442|P1|Overall Study|Adverse Event|2
5561571|NCT01175811|19219476|P2|Overall Study|Withdrawal by Subject|7
5561572|NCT01175811|19219477|P1|Overall Study|Withdrawal by Subject|6
5561573|NCT01175811|19219476|P2|Overall Study|Protocol Violation|2
5561574|NCT01175811|19219477|P1|Overall Study|Protocol Violation|1
5561575|NCT01175811|19219476|P2|Overall Study|Physician Decision|1
5561576|NCT01175811|19219477|P1|Overall Study|Physician Decision|1
5561577|NCT01175811|19219476|P2|Overall Study|Lost to Follow-up|2
5561578|NCT01175811|19219477|P1|Overall Study|Lost to Follow-up|3
5561579|NCT01175811|19219476|P2|Overall Study|Lack of Efficacy|0
5561580|NCT01175811|19219477|P1|Overall Study|Lack of Efficacy|1
5561581|NCT01175811|19219476|P2|Overall Study|Entry criteria not met|1
5561582|NCT01175811|19219477|P1|Overall Study|Entry criteria not met|3
5561583|NCT01175811|19219476|P2|Overall Study|Adverse Event|1
5561584|NCT01175811|19219477|P1|Overall Study|Adverse Event|1
5561585|NCT01175707|19219512|P2|Overall Study|Adverse Event|6
5561586|NCT01175707|19219513|P1|Overall Study|Adverse Event|4
5561587|NCT01175668|19219549|P2|Overall Study|Withdrawal by Subject|0
5561588|NCT01175668|19219550|P1|Overall Study|Withdrawal by Subject|2
5561589|NCT01175590|19219560|P2|Overall Study|Protocol Violation|1
5561590|NCT01175590|19219561|P1|Overall Study|Protocol Violation|0
5561591|NCT01175590|19219560|P2|Overall Study|Herpes Simplex Dermatitis|0
5561592|NCT01175590|19219561|P1|Overall Study|Herpes Simplex Dermatitis|1
5561593|NCT01175590|19219560|P2|Overall Study|Treated not as randomized|2
5561594|NCT01175590|19219561|P1|Overall Study|Treated not as randomized|3
5561595|NCT01175590|19219560|P2|Overall Study|Residual Bacterial Conjunctivitis|0
5561596|NCT01175590|19219561|P1|Overall Study|Residual Bacterial Conjunctivitis|1
5561597|NCT01175590|19219560|P2|Overall Study|Lack of Efficacy|1
5561598|NCT01175590|19219561|P1|Overall Study|Lack of Efficacy|1
5561599|NCT01175590|19219560|P2|Overall Study|Physician Decision|4
5561600|NCT01175590|19219561|P1|Overall Study|Physician Decision|1
5561601|NCT01175590|19219560|P2|Overall Study|Adverse Event|0
5561602|NCT01175590|19219561|P1|Overall Study|Adverse Event|4
5561603|NCT01175590|19219560|P2|Overall Study|Withdrawal by Subject|2
5561604|NCT01175590|19219561|P1|Overall Study|Withdrawal by Subject|0
5561605|NCT01175590|19219560|P2|Overall Study|Lost to Follow-up|0
5561606|NCT01175590|19219561|P1|Overall Study|Lost to Follow-up|1
5561607|NCT01175473|19219595|P2|Overall Study|Adverse Event|2
5561608|NCT01175473|19219596|P1|Overall Study|Adverse Event|2
5561609|NCT01175382|19219637|P3|Overall Study|Unable to tolerate study meds|1
5561610|NCT01175382|19219638|P2|Overall Study|Unable to tolerate study meds|1
5561611|NCT01175382|19219639|P1|Overall Study|Unable to tolerate study meds|0
5561612|NCT01175382|19219637|P3|Overall Study|Unwilling to follow protocol|0
5561613|NCT01175382|19219638|P2|Overall Study|Unwilling to follow protocol|1
5561614|NCT01175382|19219639|P1|Overall Study|Unwilling to follow protocol|0
5561615|NCT01175382|19219637|P3|Overall Study|Unable/unwilling to attend visits|2
5561616|NCT01175382|19219638|P2|Overall Study|Unable/unwilling to attend visits|1
5561617|NCT01175382|19219639|P1|Overall Study|Unable/unwilling to attend visits|3
5561618|NCT01175382|19219637|P3|Overall Study|No longer having problem|1
5561619|NCT01175382|19219638|P2|Overall Study|No longer having problem|0
5561620|NCT01175382|19219639|P1|Overall Study|No longer having problem|1
5561621|NCT01175382|19219637|P3|Overall Study|Withdrawal by Subject|1
5561622|NCT01175382|19219638|P2|Overall Study|Withdrawal by Subject|0
5561623|NCT01175382|19219639|P1|Overall Study|Withdrawal by Subject|0
5561624|NCT01175382|19219637|P3|Overall Study|Physician Decision|0
5561625|NCT01175382|19219638|P2|Overall Study|Physician Decision|1
5561626|NCT01175382|19219639|P1|Overall Study|Physician Decision|0
5561627|NCT01175382|19219637|P3|Overall Study|Lost to Follow-up|1
5561628|NCT01175382|19219638|P2|Overall Study|Lost to Follow-up|3
5561629|NCT01175382|19219639|P1|Overall Study|Lost to Follow-up|4
5561630|NCT01175356|19219725|P1|Overall Study|Initiation other tx prior to completion|9
5561631|NCT01175356|19219725|P1|Overall Study|Inadequate stem cell for transplant|1
5561632|NCT01175356|19219725|P1|Overall Study|On other COG study w/tumor tx intent|7
5561633|NCT01175356|19219725|P1|Overall Study|Pts MIBG non-avid after enrollment|2
5561634|NCT01175356|19219725|P1|Overall Study|Refusal by patient/parent/guardian|6
5561635|NCT01175356|19219725|P1|Overall Study|Treatment Slot Not Available|18
5561636|NCT01175356|19219725|P1|Overall Study|Ineligible|1
5561637|NCT01175356|19219725|P1|Overall Study|Physician Decision|23
5561638|NCT01175356|19219725|P1|Overall Study|Lost to Follow-up|1
5561639|NCT01175356|19219725|P1|Overall Study|Lack of Efficacy|12
5561640|NCT01175356|19219725|P1|Overall Study|Death|1
5561641|NCT01175213|19219765|P2|Safety Follow-up|Adverse Event|0
5561642|NCT01175213|19219766|P1|Safety Follow-up|Adverse Event|1
5561643|NCT01175213|19219765|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
5561644|NCT01175213|19219766|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
5561645|NCT01175213|19219765|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
5561646|NCT01175213|19219766|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
5561647|NCT01175213|19219765|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
5561648|NCT01175213|19219766|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
5561649|NCT01175213|19219765|P2|IGSC, 10%/rHuPH20|Death|0
5561650|NCT01175213|19219766|P1|IGSC, 10%/rHuPH20|Death|1
5561651|NCT01175213|19219765|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
5561652|NCT01175213|19219766|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
5561653|NCT01175135|19219823|P4|Overall Study|Randomized But Not Treated|0
5561654|NCT01175135|19219824|P3|Overall Study|Randomized But Not Treated|1
5561655|NCT01175135|19219825|P2|Overall Study|Randomized But Not Treated|0
5561656|NCT01175135|19219826|P1|Overall Study|Randomized But Not Treated|0
5561657|NCT01175135|19219823|P4|Overall Study|Other|0
5561658|NCT01175135|19219824|P3|Overall Study|Other|3
5561659|NCT01175135|19219825|P2|Overall Study|Other|1
5561660|NCT01175135|19219826|P1|Overall Study|Other|3
5561661|NCT01175135|19219823|P4|Overall Study|Withdrawal by Subject|5
5561662|NCT01175135|19219824|P3|Overall Study|Withdrawal by Subject|5
5561663|NCT01175135|19219825|P2|Overall Study|Withdrawal by Subject|8
5561664|NCT01175135|19219826|P1|Overall Study|Withdrawal by Subject|4
5561665|NCT01175135|19219823|P4|Overall Study|Protocol Violation|0
5561666|NCT01175135|19219824|P3|Overall Study|Protocol Violation|0
5561667|NCT01175135|19219825|P2|Overall Study|Protocol Violation|1
5561668|NCT01175135|19219826|P1|Overall Study|Protocol Violation|1
5561669|NCT01175135|19219823|P4|Overall Study|Lost to Follow-up|0
5561670|NCT01175135|19219824|P3|Overall Study|Lost to Follow-up|0
5561671|NCT01175135|19219825|P2|Overall Study|Lost to Follow-up|2
5561672|NCT01175135|19219826|P1|Overall Study|Lost to Follow-up|1
5561673|NCT01175135|19219823|P4|Overall Study|Lack of Efficacy|5
5561674|NCT01175135|19219824|P3|Overall Study|Lack of Efficacy|0
5561675|NCT01175135|19219825|P2|Overall Study|Lack of Efficacy|5
5561676|NCT01175135|19219826|P1|Overall Study|Lack of Efficacy|4
5561677|NCT01175135|19219823|P4|Overall Study|Death|0
5561678|NCT01175135|19219824|P3|Overall Study|Death|0
5561679|NCT01175135|19219825|P2|Overall Study|Death|0
5561680|NCT01175135|19219826|P1|Overall Study|Death|1
5561681|NCT01175135|19219823|P4|Overall Study|Adverse Event|4
5561682|NCT01175135|19219824|P3|Overall Study|Adverse Event|3
5561683|NCT01175135|19219825|P2|Overall Study|Adverse Event|5
5561684|NCT01175135|19219826|P1|Overall Study|Adverse Event|2
5561685|NCT01175083|19219914|P6|Booster Epoch|Withdrawal by Subject|0
5561686|NCT01175083|19219915|P5|Booster Epoch|Withdrawal by Subject|0
5561687|NCT01175083|19219916|P4|Booster Epoch|Withdrawal by Subject|1
5561688|NCT01175083|19219917|P3|Booster Epoch|Withdrawal by Subject|0
5561689|NCT01175083|19219918|P2|Booster Epoch|Withdrawal by Subject|0
5561690|NCT01175083|19219919|P1|Booster Epoch|Withdrawal by Subject|0
5561691|NCT01175083|19219914|P6|Booster Epoch|Death|0
5561692|NCT01175083|19219915|P5|Booster Epoch|Death|0
5561693|NCT01175083|19219916|P4|Booster Epoch|Death|0
5561694|NCT01175083|19219917|P3|Booster Epoch|Death|1
5561695|NCT01175083|19219918|P2|Booster Epoch|Death|0
5561696|NCT01175083|19219919|P1|Booster Epoch|Death|0
5561697|NCT01175083|19219914|P6|Primary Epoch|Lost to Follow-up|1
5561698|NCT01175083|19219915|P5|Primary Epoch|Lost to Follow-up|0
5561699|NCT01175083|19219916|P4|Primary Epoch|Lost to Follow-up|0
5561700|NCT01175083|19219917|P3|Primary Epoch|Lost to Follow-up|0
5561701|NCT01175083|19219918|P2|Primary Epoch|Lost to Follow-up|0
5561702|NCT01175083|19219919|P1|Primary Epoch|Lost to Follow-up|0
5561703|NCT01175083|19219914|P6|Primary Epoch|Withdrawal by Subject|2
5561704|NCT01175083|19219915|P5|Primary Epoch|Withdrawal by Subject|0
5561705|NCT01175083|19219916|P4|Primary Epoch|Withdrawal by Subject|0
5561706|NCT01175083|19219917|P3|Primary Epoch|Withdrawal by Subject|0
5561707|NCT01175083|19219918|P2|Primary Epoch|Withdrawal by Subject|0
5561708|NCT01175083|19219919|P1|Primary Epoch|Withdrawal by Subject|0
5561709|NCT01175018|19220011|P2|Overall Study|Adverse Event|1
5561710|NCT01175018|19220012|P1|Overall Study|Adverse Event|3
5561711|NCT01174784|19220074|P1|Overall Study|Screen fails|4
5561712|NCT01174563|19220120|P1|Overall Study|Sponsor's decision|1
5561713|NCT01174563|19220120|P1|Overall Study|Rash Adverse Event|1
5561714|NCT01174563|19220120|P1|Overall Study|Participant Withdrew Consent|3
5561715|NCT01174563|19220120|P1|Overall Study|Investigator's Discretion|5
5561716|NCT01174563|19220120|P1|Overall Study|Death|5
5561717|NCT01174563|19220120|P1|Overall Study|Progressive Disease|45
5561718|NCT01174550|19220128|P2|Overall Study|Withdrawal by Subject|289
5561719|NCT01174550|19220129|P1|Overall Study|Withdrawal by Subject|543
5561720|NCT01174550|19220128|P2|Overall Study|Lost to Follow-up|510
5561721|NCT01174550|19220129|P1|Overall Study|Lost to Follow-up|652
5561722|NCT01174550|19220128|P2|Overall Study|Death|74
5561723|NCT01174550|19220129|P1|Overall Study|Death|75
5561724|NCT01174459|19220157|P1|Overall Study|case report form (CRF) not collected|5
5561725|NCT01174446|19220162|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
5561726|NCT01174446|19220163|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
5561727|NCT01174446|19220164|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
5561728|NCT01174446|19220165|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
5561729|NCT01174446|19220162|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
5561730|NCT01174446|19220163|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
5561731|NCT01174446|19220164|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
5561732|NCT01174446|19220165|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
5561733|NCT01174446|19220162|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
5561734|NCT01174446|19220163|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
5561735|NCT01174446|19220164|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
5561736|NCT01174446|19220165|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
5561737|NCT01174446|19220162|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
5561738|NCT01174446|19220163|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
5561739|NCT01174446|19220164|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
5561740|NCT01174446|19220165|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
5561741|NCT01174368|19220352|P1|Overall Study|Withdrawal by Subject|1
5561742|NCT01174342|19220358|P1|Overall Study|Conversion to cesarean section|4
5561743|NCT01174264|19220365|P3|Steady-state Pharmacokinetics|Not evaluable|2
5561744|NCT01174264|19220366|P2|Steady-state Pharmacokinetics|Not evaluable|0
5561745|NCT01174264|19220367|P1|Steady-state Pharmacokinetics|Not evaluable|6
5561746|NCT01174264|19220365|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
5561747|NCT01174264|19220366|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
5561748|NCT01174264|19220367|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
5561749|NCT01174264|19220365|P3|Single Dose Pharmacokinetics|Early progressive disease|1
5561750|NCT01174264|19220366|P2|Single Dose Pharmacokinetics|Early progressive disease|0
5561751|NCT01174264|19220367|P1|Single Dose Pharmacokinetics|Early progressive disease|1
5561752|NCT01174238|19220399|P1|Overall Study|Lost to Follow-up|2
5561753|NCT01174186|19220410|P2|Overall Study|Withdrawal by Subject|2
5561754|NCT01174186|19220411|P1|Overall Study|Withdrawal by Subject|0
5561755|NCT01174186|19220410|P2|Overall Study|Lost to Follow-up|1
5561756|NCT01174186|19220411|P1|Overall Study|Lost to Follow-up|0
5561757|NCT01174173|19220418|P1|Overall Study|drug-drug interaction|1
5561758|NCT01174160|19220429|P2|Overall Study|Withdrawal by Subject|0
5561759|NCT01174160|19220430|P1|Overall Study|Withdrawal by Subject|1
5561760|NCT01174160|19220429|P2|Overall Study|Protocol Violation|6
5561761|NCT01174160|19220430|P1|Overall Study|Protocol Violation|4
5561762|NCT01174160|19220429|P2|Overall Study|Physician Decision|0
5561763|NCT01174160|19220430|P1|Overall Study|Physician Decision|1
5561764|NCT01174160|19220429|P2|Overall Study|Lost to Follow-up|0
5561765|NCT01174160|19220430|P1|Overall Study|Lost to Follow-up|1
5561766|NCT01174160|19220429|P2|Overall Study|Adverse Event|0
5561767|NCT01174160|19220430|P1|Overall Study|Adverse Event|1
5561768|NCT01174043|19220445|P1|Overall Study|Withdrawal by Subject|2
5561769|NCT01174043|19220445|P1|Overall Study|Death|1
5561770|NCT01174043|19220445|P1|Overall Study|Adverse Event|3
5561771|NCT01174043|19220445|P1|Overall Study|Disease progression|5
5561772|NCT01174004|19220484|P2|Overall Study|Physician Decision|0
5561773|NCT01174004|19220485|P1|Overall Study|Physician Decision|1
5561774|NCT01174004|19220484|P2|Overall Study|Protocol Violation|1
5561775|NCT01174004|19220485|P1|Overall Study|Protocol Violation|0
5561776|NCT01174004|19220484|P2|Overall Study|At Discretion of Sponsor|2
5561777|NCT01174004|19220485|P1|Overall Study|At Discretion of Sponsor|2
5561778|NCT01174004|19220484|P2|Overall Study|Withdrawal by Subject|3
5561779|NCT01174004|19220485|P1|Overall Study|Withdrawal by Subject|2
5561780|NCT01174004|19220484|P2|Overall Study|Adverse Event|10
5561781|NCT01174004|19220485|P1|Overall Study|Adverse Event|2
5561782|NCT01173718|19220516|P1|Overall Study|Abandonment of study graft|27
5561783|NCT01173718|19220516|P1|Overall Study|Death|17
5561784|NCT01173679|19220525|P1|Overall Study|Death|1
5561785|NCT01173653|19220533|P2|Overall Study|Pts unwilling to provide follow-up|41
5561786|NCT01173653|19220534|P1|Overall Study|Pts unwilling to provide follow-up|53
5561787|NCT01173601|19220544|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
5561788|NCT01173601|19220545|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
5561789|NCT01173601|19220546|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5561790|NCT01173601|19220547|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5561791|NCT01173601|19220548|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
5561792|NCT01173601|19220544|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
5561793|NCT01173601|19220545|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
5561794|NCT01173601|19220546|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
5561795|NCT01173601|19220547|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
5561796|NCT01173601|19220548|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
5561797|NCT01173601|19220544|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5561798|NCT01173601|19220545|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
5561799|NCT01173601|19220546|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
5561800|NCT01173601|19220547|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
5561801|NCT01173601|19220548|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
5561802|NCT01173601|19220544|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
5561803|NCT01173601|19220545|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
5561804|NCT01173601|19220546|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5561805|NCT01173601|19220547|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
5561806|NCT01173601|19220548|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
5561807|NCT01173601|19220544|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
5561808|NCT01173601|19220545|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
5561809|NCT01173601|19220546|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5561810|NCT01173601|19220547|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
5561811|NCT01173601|19220548|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
5561812|NCT01173601|19220544|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
5561813|NCT01173601|19220545|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
5561814|NCT01173601|19220546|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
5561815|NCT01173601|19220547|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
5561816|NCT01173601|19220548|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
5561817|NCT01173601|19220544|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
5561818|NCT01173601|19220545|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
5561819|NCT01173601|19220546|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
5561820|NCT01173601|19220547|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
5561821|NCT01173601|19220548|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
5561822|NCT01173601|19220544|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5561823|NCT01173601|19220545|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5561824|NCT01173601|19220546|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5561825|NCT01173601|19220547|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
5561826|NCT01173601|19220548|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
5561827|NCT01173601|19220544|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5561828|NCT01173601|19220545|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5561829|NCT01173601|19220546|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5561830|NCT01173601|19220547|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
5561831|NCT01173601|19220548|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
5561832|NCT01173601|19220544|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5561833|NCT01173601|19220545|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5561834|NCT01173601|19220546|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5561835|NCT01173601|19220547|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
5561836|NCT01173601|19220548|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
5561837|NCT01173601|19220544|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5561838|NCT01173601|19220545|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5561839|NCT01173601|19220546|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5561840|NCT01173601|19220547|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
5561841|NCT01173601|19220548|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
5561842|NCT01173601|19220544|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5561843|NCT01173601|19220545|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5561844|NCT01173601|19220546|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5561845|NCT01173601|19220547|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
5561846|NCT01173601|19220548|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
5561847|NCT01173601|19220544|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5561848|NCT01173601|19220545|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5561849|NCT01173601|19220546|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5561850|NCT01173601|19220547|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
5561851|NCT01173601|19220548|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
5561852|NCT01173601|19220544|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5561853|NCT01173601|19220545|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5561854|NCT01173601|19220546|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5561855|NCT01173601|19220547|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
5561856|NCT01173601|19220548|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
5561857|NCT01173523|19220625|P2|Overall Study|Other|3
5561858|NCT01173523|19220626|P1|Overall Study|Other|2
5561859|NCT01173523|19220625|P2|Overall Study|Progressive Disease|8
5561860|NCT01173523|19220626|P1|Overall Study|Progressive Disease|10
5561861|NCT01173523|19220625|P2|Overall Study|Clinical Progression|1
5561862|NCT01173523|19220626|P1|Overall Study|Clinical Progression|1
5561863|NCT01173471|19220642|P4|Overall Study|Reason given as Other|0
5561864|NCT01173471|19220643|P3|Overall Study|Reason given as Other|1
5561865|NCT01173471|19220644|P2|Overall Study|Reason given as Other|0
5561866|NCT01173471|19220645|P1|Overall Study|Reason given as Other|0
5561867|NCT01173471|19220642|P4|Overall Study|Lost to Follow-up|0
5561868|NCT01173471|19220643|P3|Overall Study|Lost to Follow-up|1
5561869|NCT01173471|19220644|P2|Overall Study|Lost to Follow-up|0
5561870|NCT01173471|19220645|P1|Overall Study|Lost to Follow-up|0
5561871|NCT01173471|19220642|P4|Overall Study|Condition under investigation worsened|0
5561872|NCT01173471|19220643|P3|Overall Study|Condition under investigation worsened|0
5561873|NCT01173471|19220644|P2|Overall Study|Condition under investigation worsened|0
5561874|NCT01173471|19220645|P1|Overall Study|Condition under investigation worsened|2
5561875|NCT01173471|19220642|P4|Overall Study|Eligibility criteria not fulfilled|1
5561876|NCT01173471|19220643|P3|Overall Study|Eligibility criteria not fulfilled|1
5561877|NCT01173471|19220644|P2|Overall Study|Eligibility criteria not fulfilled|0
5561878|NCT01173471|19220645|P1|Overall Study|Eligibility criteria not fulfilled|0
5561879|NCT01173120|19220785|P1|Overall Study|Switch-Difficulty With Device|12
5561880|NCT01173120|19220785|P1|Overall Study|Switch-Participant Decision|12
5561881|NCT01173120|19220785|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
5561882|NCT01173120|19220785|P1|Overall Study|Participant Decision|2
5561883|NCT01173120|19220785|P1|Overall Study|Lost to Follow-up|1
5561884|NCT01173120|19220785|P1|Overall Study|Lack of Efficacy|2
5561885|NCT01173055|19220803|P2|Period 2 - Day 64 to 112|Adverse Event|1
5561886|NCT01173055|19220804|P1|Period 2 - Day 64 to 112|Adverse Event|0
5561887|NCT01173055|19220803|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
5561888|NCT01173055|19220804|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
5561889|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
5561890|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5561891|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5561892|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5561893|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5561894|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5561895|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5561896|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5561897|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
5561898|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5561899|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5561900|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5561901|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5561902|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5561903|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5561904|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
5561905|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5561906|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
5561907|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
5561908|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
5561909|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
5561910|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
5561911|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
5561912|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
5561913|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
5561914|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
5561915|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
5561916|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5561917|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
5561918|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5561919|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5561920|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5561921|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5561922|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
5561923|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
5561924|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
5561925|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5561926|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
5561927|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5561928|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5561929|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5561930|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5561931|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5561932|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
5561933|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
5561934|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5561935|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5561936|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5561937|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5561938|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5561939|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5561940|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
5561941|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5561942|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
5561943|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
5561944|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
5561945|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5561946|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5561947|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5561948|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5561949|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
5561950|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5561951|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
5561952|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5561953|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
5561954|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5561955|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5561956|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5561957|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5561958|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5561959|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5561960|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
5561961|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
5561962|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5561963|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5561964|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5561965|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5561966|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5561967|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
5561968|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5561969|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
5561970|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
5561971|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
5561972|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5561973|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5561974|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5561975|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5561976|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
5561977|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
5561978|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
5561979|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
5561980|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
5561981|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5561982|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5561983|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5561984|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5561985|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
5561986|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
5561987|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
5561988|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5561989|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
5561990|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5561991|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5561992|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5561993|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5561994|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
5561995|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
5561996|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
5561997|NCT01172938|19220855|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5561998|NCT01172938|19220856|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5561999|NCT01172938|19220857|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5562000|NCT01172938|19220858|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5562001|NCT01172938|19220859|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5562002|NCT01172938|19220860|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5562003|NCT01172938|19220861|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
5562004|NCT01172938|19220862|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5562005|NCT01172938|19220863|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
5562006|NCT01172938|19220855|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5562007|NCT01172938|19220856|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5562008|NCT01172938|19220857|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5562009|NCT01172938|19220858|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5562010|NCT01172938|19220859|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5562011|NCT01172938|19220860|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5562012|NCT01172938|19220861|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5562013|NCT01172938|19220862|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
5562014|NCT01172938|19220863|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
5562015|NCT01172938|19220855|P9|Active-Treatment Phase Weeks (104-156)|Death|0
5562016|NCT01172938|19220856|P8|Active-Treatment Phase Weeks (104-156)|Death|1
5562017|NCT01172938|19220857|P7|Active-Treatment Phase Weeks (104-156)|Death|0
5562018|NCT01172938|19220858|P6|Active-Treatment Phase Weeks (104-156)|Death|0
5562019|NCT01172938|19220859|P5|Active-Treatment Phase Weeks (104-156)|Death|0
5562020|NCT01172938|19220860|P4|Active-Treatment Phase Weeks (104-156)|Death|0
5562021|NCT01172938|19220861|P3|Active-Treatment Phase Weeks (104-156)|Death|0
5562022|NCT01172938|19220862|P2|Active-Treatment Phase Weeks (104-156)|Death|0
5562023|NCT01172938|19220863|P1|Active-Treatment Phase Weeks (104-156)|Death|0
5562024|NCT01172938|19220855|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
5562025|NCT01172938|19220856|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
5562026|NCT01172938|19220857|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5562027|NCT01172938|19220858|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5562028|NCT01172938|19220859|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5562029|NCT01172938|19220860|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5562030|NCT01172938|19220861|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
5562031|NCT01172938|19220862|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
5562032|NCT01172938|19220863|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
5562033|NCT01172938|19220855|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
5562034|NCT01172938|19220856|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
5562035|NCT01172938|19220857|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5562036|NCT01172938|19220858|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5562037|NCT01172938|19220859|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5562038|NCT01172938|19220860|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5562039|NCT01172938|19220861|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
5562040|NCT01172938|19220862|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
5562041|NCT01172938|19220863|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
5562042|NCT01172938|19220855|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
5562043|NCT01172938|19220856|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5562044|NCT01172938|19220857|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5562045|NCT01172938|19220858|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5562046|NCT01172938|19220859|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5562047|NCT01172938|19220860|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5562048|NCT01172938|19220861|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5562049|NCT01172938|19220862|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5562050|NCT01172938|19220863|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
5562051|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
5562052|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
5562053|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
5562054|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
5562055|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
5562056|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
5562057|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
5562058|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
5562059|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
5562060|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
5562061|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5562062|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5562063|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5562064|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5562065|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5562066|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5562067|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
5562068|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
5562069|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5562070|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
5562071|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5562072|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5562073|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5562074|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5562075|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
5562076|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
5562077|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
5562078|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
5562079|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
5562080|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
5562081|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
5562082|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
5562083|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
5562084|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
5562085|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
5562086|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
5562087|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
5562088|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
5562089|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5562090|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5562091|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5562092|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5562093|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
5562094|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
5562095|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
5562096|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5562097|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5562098|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5562099|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5562100|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5562101|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5562102|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
5562103|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5562104|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
5562105|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5562106|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
5562107|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5562108|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5562109|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5562110|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5562184|NCT01172938|19220862|P2|Placebo-controlled Phase (Week 0-24)|Other|2
5562111|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
5562112|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
5562113|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
5562114|NCT01172938|19220855|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
5562115|NCT01172938|19220856|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
5562116|NCT01172938|19220857|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5562117|NCT01172938|19220858|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5562118|NCT01172938|19220859|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5562119|NCT01172938|19220860|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5562120|NCT01172938|19220861|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
5562121|NCT01172938|19220862|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
5562122|NCT01172938|19220863|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
5562123|NCT01172938|19220855|P9|Active Treatment Phase (Weeks 25-52)|Other|0
5562124|NCT01172938|19220856|P8|Active Treatment Phase (Weeks 25-52)|Other|0
5562125|NCT01172938|19220857|P7|Active Treatment Phase (Weeks 25-52)|Other|1
5562126|NCT01172938|19220858|P6|Active Treatment Phase (Weeks 25-52)|Other|1
5562127|NCT01172938|19220859|P5|Active Treatment Phase (Weeks 25-52)|Other|0
5562128|NCT01172938|19220860|P4|Active Treatment Phase (Weeks 25-52)|Other|0
5562129|NCT01172938|19220861|P3|Active Treatment Phase (Weeks 25-52)|Other|0
5562130|NCT01172938|19220862|P2|Active Treatment Phase (Weeks 25-52)|Other|0
5562131|NCT01172938|19220863|P1|Active Treatment Phase (Weeks 25-52)|Other|0
5562132|NCT01172938|19220855|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5562133|NCT01172938|19220856|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5562134|NCT01172938|19220857|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5562135|NCT01172938|19220858|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5562136|NCT01172938|19220859|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5562137|NCT01172938|19220860|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
5562138|NCT01172938|19220861|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
5562139|NCT01172938|19220862|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
5562140|NCT01172938|19220863|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
5562141|NCT01172938|19220855|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
5562142|NCT01172938|19220856|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
5562143|NCT01172938|19220857|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
5562144|NCT01172938|19220858|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
5562145|NCT01172938|19220859|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
5562146|NCT01172938|19220860|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
5562147|NCT01172938|19220861|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
5562148|NCT01172938|19220862|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
5562149|NCT01172938|19220863|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
5562150|NCT01172938|19220855|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5562151|NCT01172938|19220856|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5562152|NCT01172938|19220857|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5562153|NCT01172938|19220858|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5562154|NCT01172938|19220859|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5562155|NCT01172938|19220860|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5562156|NCT01172938|19220861|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
5562157|NCT01172938|19220862|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5562158|NCT01172938|19220863|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
5562159|NCT01172938|19220855|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5562160|NCT01172938|19220856|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5562161|NCT01172938|19220857|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5562162|NCT01172938|19220858|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
5562163|NCT01172938|19220859|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
5562164|NCT01172938|19220860|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
5562165|NCT01172938|19220861|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
5562166|NCT01172938|19220862|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
5562167|NCT01172938|19220863|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
5562168|NCT01172938|19220855|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5562169|NCT01172938|19220856|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5562170|NCT01172938|19220857|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5562171|NCT01172938|19220858|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
5562172|NCT01172938|19220859|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
5562173|NCT01172938|19220860|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
5562174|NCT01172938|19220861|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
5562175|NCT01172938|19220862|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
5562176|NCT01172938|19220863|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
5562177|NCT01172938|19220855|P9|Placebo-controlled Phase (Week 0-24)|Other|0
5562178|NCT01172938|19220856|P8|Placebo-controlled Phase (Week 0-24)|Other|0
5562179|NCT01172938|19220857|P7|Placebo-controlled Phase (Week 0-24)|Other|0
5562180|NCT01172938|19220858|P6|Placebo-controlled Phase (Week 0-24)|Other|0
5562181|NCT01172938|19220859|P5|Placebo-controlled Phase (Week 0-24)|Other|0
5562182|NCT01172938|19220860|P4|Placebo-controlled Phase (Week 0-24)|Other|0
5562183|NCT01172938|19220861|P3|Placebo-controlled Phase (Week 0-24)|Other|1
5562185|NCT01172938|19220863|P1|Placebo-controlled Phase (Week 0-24)|Other|0
5562186|NCT01172938|19220855|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5562187|NCT01172938|19220856|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5562188|NCT01172938|19220857|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5562189|NCT01172938|19220858|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5562190|NCT01172938|19220859|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5562191|NCT01172938|19220860|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5562192|NCT01172938|19220861|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5562193|NCT01172938|19220862|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
5562194|NCT01172938|19220863|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
5562195|NCT01172938|19220855|P9|Placebo-controlled Phase (Week 0-24)|Death|0
5562196|NCT01172938|19220856|P8|Placebo-controlled Phase (Week 0-24)|Death|0
5562197|NCT01172938|19220857|P7|Placebo-controlled Phase (Week 0-24)|Death|0
5562198|NCT01172938|19220858|P6|Placebo-controlled Phase (Week 0-24)|Death|0
5562199|NCT01172938|19220859|P5|Placebo-controlled Phase (Week 0-24)|Death|0
5562200|NCT01172938|19220860|P4|Placebo-controlled Phase (Week 0-24)|Death|0
5562201|NCT01172938|19220861|P3|Placebo-controlled Phase (Week 0-24)|Death|0
5562202|NCT01172938|19220862|P2|Placebo-controlled Phase (Week 0-24)|Death|1
5562203|NCT01172938|19220863|P1|Placebo-controlled Phase (Week 0-24)|Death|0
5562204|NCT01172938|19220855|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5562205|NCT01172938|19220856|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5562206|NCT01172938|19220857|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5562207|NCT01172938|19220858|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5562208|NCT01172938|19220859|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5562209|NCT01172938|19220860|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
5562210|NCT01172938|19220861|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
5562211|NCT01172938|19220862|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
5562212|NCT01172938|19220863|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
5562213|NCT01172938|19220855|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5562214|NCT01172938|19220856|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5562215|NCT01172938|19220857|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5562216|NCT01172938|19220858|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5562217|NCT01172938|19220859|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5562218|NCT01172938|19220860|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5562219|NCT01172938|19220861|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
5562220|NCT01172938|19220862|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
5562221|NCT01172938|19220863|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
5562222|NCT01172938|19220855|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5562223|NCT01172938|19220856|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5562224|NCT01172938|19220857|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5562225|NCT01172938|19220858|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5562226|NCT01172938|19220859|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5562227|NCT01172938|19220860|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
5562228|NCT01172938|19220861|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
5562229|NCT01172938|19220862|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
5562230|NCT01172938|19220863|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
5562231|NCT01172938|19220855|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5562232|NCT01172938|19220856|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5562233|NCT01172938|19220857|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5562234|NCT01172938|19220858|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5562235|NCT01172938|19220859|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5562236|NCT01172938|19220860|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
5562237|NCT01172938|19220861|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
5562238|NCT01172938|19220862|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
5562239|NCT01172938|19220863|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
5562240|NCT01172873|19221049|P2|Overall Study|Withdrawal by Subject|2
5562241|NCT01172873|19221050|P1|Overall Study|Withdrawal by Subject|3
5562242|NCT01172847|19221060|P1|Overall Study|Withdrawal by Subject|3
5562243|NCT01172821|19221089|P4|Overall Study|Other|3
5562244|NCT01172821|19221090|P3|Overall Study|Other|5
5562245|NCT01172821|19221091|P2|Overall Study|Other|4
5562246|NCT01172821|19221092|P1|Overall Study|Other|3
5562247|NCT01172821|19221089|P4|Overall Study|Withdrawal by Subject|3
5562248|NCT01172821|19221090|P3|Overall Study|Withdrawal by Subject|3
5562249|NCT01172821|19221091|P2|Overall Study|Withdrawal by Subject|3
5562250|NCT01172821|19221092|P1|Overall Study|Withdrawal by Subject|2
5562251|NCT01172821|19221089|P4|Overall Study|Lost to Follow-up|2
5562252|NCT01172821|19221090|P3|Overall Study|Lost to Follow-up|2
5562253|NCT01172821|19221091|P2|Overall Study|Lost to Follow-up|1
5562254|NCT01172821|19221092|P1|Overall Study|Lost to Follow-up|4
5562255|NCT01172821|19221089|P4|Overall Study|Protocol Violation|2
5562256|NCT01172821|19221090|P3|Overall Study|Protocol Violation|1
5562257|NCT01172821|19221091|P2|Overall Study|Protocol Violation|2
5562258|NCT01172821|19221092|P1|Overall Study|Protocol Violation|0
5562259|NCT01172821|19221089|P4|Overall Study|Adverse Event|7
5562260|NCT01172821|19221090|P3|Overall Study|Adverse Event|2
5562261|NCT01172821|19221091|P2|Overall Study|Adverse Event|2
5562262|NCT01172821|19221092|P1|Overall Study|Adverse Event|5
5562263|NCT01172808|19221182|P4|Overall Study|Other|7
5562264|NCT01172808|19221183|P3|Overall Study|Other|9
5562265|NCT01172808|19221184|P2|Overall Study|Other|5
5562266|NCT01172808|19221185|P1|Overall Study|Other|6
5562267|NCT01172808|19221182|P4|Overall Study|Withdrawal by Subject|2
5562268|NCT01172808|19221183|P3|Overall Study|Withdrawal by Subject|3
5562269|NCT01172808|19221184|P2|Overall Study|Withdrawal by Subject|1
5562270|NCT01172808|19221185|P1|Overall Study|Withdrawal by Subject|4
5562271|NCT01172808|19221182|P4|Overall Study|Lost to Follow-up|3
5562272|NCT01172808|19221183|P3|Overall Study|Lost to Follow-up|1
5562273|NCT01172808|19221184|P2|Overall Study|Lost to Follow-up|1
5562274|NCT01172808|19221185|P1|Overall Study|Lost to Follow-up|0
5562275|NCT01172808|19221182|P4|Overall Study|Protocol Violation|0
5562276|NCT01172808|19221183|P3|Overall Study|Protocol Violation|2
5562277|NCT01172808|19221184|P2|Overall Study|Protocol Violation|2
5562278|NCT01172808|19221185|P1|Overall Study|Protocol Violation|2
5562279|NCT01172808|19221182|P4|Overall Study|Lack of Efficacy|0
5562280|NCT01172808|19221183|P3|Overall Study|Lack of Efficacy|0
5562281|NCT01172808|19221184|P2|Overall Study|Lack of Efficacy|0
5562282|NCT01172808|19221185|P1|Overall Study|Lack of Efficacy|1
5562283|NCT01172808|19221182|P4|Overall Study|Adverse Event|3
5562284|NCT01172808|19221183|P3|Overall Study|Adverse Event|8
5562285|NCT01172808|19221184|P2|Overall Study|Adverse Event|4
5562286|NCT01172808|19221185|P1|Overall Study|Adverse Event|8
5562287|NCT01172639|19221276|P5|Overall Study|Withdrawal by Subject|0
5562288|NCT01172639|19221277|P4|Overall Study|Withdrawal by Subject|5
5562289|NCT01172639|19221278|P3|Overall Study|Withdrawal by Subject|5
5562290|NCT01172639|19221279|P2|Overall Study|Withdrawal by Subject|3
5562291|NCT01172639|19221280|P1|Overall Study|Withdrawal by Subject|3
5562292|NCT01172639|19221276|P5|Overall Study|Lost to Follow-up|6
5562293|NCT01172639|19221277|P4|Overall Study|Lost to Follow-up|6
5562294|NCT01172639|19221278|P3|Overall Study|Lost to Follow-up|11
5562295|NCT01172639|19221279|P2|Overall Study|Lost to Follow-up|7
5562296|NCT01172639|19221280|P1|Overall Study|Lost to Follow-up|9
5562297|NCT01172639|19221276|P5|Overall Study|Death|0
5562298|NCT01172639|19221277|P4|Overall Study|Death|0
5562299|NCT01172639|19221278|P3|Overall Study|Death|0
5562300|NCT01172639|19221279|P2|Overall Study|Death|1
5562301|NCT01172639|19221280|P1|Overall Study|Death|1
5562302|NCT01172535|19221355|P1|Overall Study|Unwilling to adhere to study requirement|1
5562303|NCT01172535|19221355|P1|Overall Study|Ineligible at study entry|1
5562304|NCT01172535|19221355|P1|Overall Study|Lost to Follow-up|1
5562305|NCT01172535|19221355|P1|Overall Study|Withdrawal by Subject|2
5562306|NCT01172535|19221355|P1|Overall Study|Death|3
5562307|NCT01172288|19221408|P2|Overall Study|Protocol Violation|1
5562308|NCT01172288|19221409|P1|Overall Study|Protocol Violation|0
5562309|NCT01172288|19221408|P2|Overall Study|Adverse Event|0
5562310|NCT01172288|19221409|P1|Overall Study|Adverse Event|1
5562311|NCT01172275|19221425|P2|Overall Study|Protocol Violation|0
5562312|NCT01172275|19221426|P1|Overall Study|Protocol Violation|1
5562313|NCT01172275|19221425|P2|Overall Study|Lost to Follow-up|0
5562314|NCT01172275|19221426|P1|Overall Study|Lost to Follow-up|1
5562315|NCT01171989|19221484|P3|Overall Study|Lost to Follow-up|1
5562316|NCT01171989|19221485|P2|Overall Study|Lost to Follow-up|0
5562317|NCT01171989|19221486|P1|Overall Study|Lost to Follow-up|0
5562318|NCT01171976|19221560|P3|Overall Study|Adverse Event|5
5562319|NCT01171976|19221561|P2|Overall Study|Adverse Event|2
5562320|NCT01171976|19221562|P1|Overall Study|Adverse Event|6
5562321|NCT01171976|19221560|P3|Overall Study|Abnormal test result|0
5562322|NCT01171976|19221561|P2|Overall Study|Abnormal test result|0
5562323|NCT01171976|19221562|P1|Overall Study|Abnormal test result|1
5562324|NCT01171976|19221560|P3|Overall Study|Withdrawal by Subject|6
5562325|NCT01171976|19221561|P2|Overall Study|Withdrawal by Subject|5
5562326|NCT01171976|19221562|P1|Overall Study|Withdrawal by Subject|1
5562327|NCT01171976|19221560|P3|Overall Study|Lost to Follow-up|2
5562328|NCT01171976|19221561|P2|Overall Study|Lost to Follow-up|0
5562329|NCT01171976|19221562|P1|Overall Study|Lost to Follow-up|4
5562330|NCT01171976|19221560|P3|Overall Study|Death|1
5562331|NCT01171976|19221561|P2|Overall Study|Death|4
5562332|NCT01171976|19221562|P1|Overall Study|Death|2
5562333|NCT01171976|19221560|P3|Overall Study|Protocol Violation|1
5562334|NCT01171976|19221561|P2|Overall Study|Protocol Violation|0
5562335|NCT01171976|19221562|P1|Overall Study|Protocol Violation|0
5562336|NCT01171963|19221599|P2|Overall Study|Withdrawal by Subject|129
5562337|NCT01171963|19221600|P1|Overall Study|Withdrawal by Subject|114
5562338|NCT01171963|19221599|P2|Overall Study|Other - diarrhoea|0
5562339|NCT01171963|19221600|P1|Overall Study|Other - diarrhoea|1
5562340|NCT01171963|19221599|P2|Overall Study|Lost to Follow-up|24
5562341|NCT01171963|19221600|P1|Overall Study|Lost to Follow-up|23
5562342|NCT01171963|19221599|P2|Overall Study|Adverse Event|15
5562343|NCT01171963|19221600|P1|Overall Study|Adverse Event|10
5562344|NCT01171898|19221669|P4|Overall Study|Other|2
5562345|NCT01171898|19221670|P3|Overall Study|Other|0
5562346|NCT01171898|19221671|P2|Overall Study|Other|5
5562347|NCT01171898|19221672|P1|Overall Study|Other|1
5562348|NCT01171898|19221669|P4|Overall Study|Ongoing|0
5562349|NCT01171898|19221670|P3|Overall Study|Ongoing|3
5562350|NCT01171898|19221671|P2|Overall Study|Ongoing|9
5562351|NCT01171898|19221672|P1|Overall Study|Ongoing|1
5562352|NCT01171898|19221669|P4|Overall Study|Terminated by Sponsor|0
5562353|NCT01171898|19221670|P3|Overall Study|Terminated by Sponsor|0
5562354|NCT01171898|19221671|P2|Overall Study|Terminated by Sponsor|0
5562355|NCT01171898|19221672|P1|Overall Study|Terminated by Sponsor|1
5562356|NCT01171898|19221669|P4|Overall Study|Withdrawal by Subject|3
5562357|NCT01171898|19221670|P3|Overall Study|Withdrawal by Subject|6
5562358|NCT01171898|19221671|P2|Overall Study|Withdrawal by Subject|4
5562359|NCT01171898|19221672|P1|Overall Study|Withdrawal by Subject|1
5562360|NCT01171898|19221669|P4|Overall Study|Lost to Follow-up|1
5562361|NCT01171898|19221670|P3|Overall Study|Lost to Follow-up|1
5562362|NCT01171898|19221671|P2|Overall Study|Lost to Follow-up|1
5562363|NCT01171898|19221672|P1|Overall Study|Lost to Follow-up|0
5562364|NCT01171898|19221669|P4|Overall Study|Death|0
5562365|NCT01171898|19221670|P3|Overall Study|Death|2
5562366|NCT01171898|19221671|P2|Overall Study|Death|0
5562367|NCT01171898|19221672|P1|Overall Study|Death|0
5562368|NCT01171820|19221696|P2|Overall Study|1-Year Missed Visit|1
5562369|NCT01171820|19221697|P1|Overall Study|1-Year Missed Visit|1
5562370|NCT01171820|19221696|P2|Overall Study|Physician Decision|1
5562371|NCT01171820|19221697|P1|Overall Study|Physician Decision|0
5562372|NCT01171820|19221696|P2|Overall Study|Withdrawal by Subject|0
5562373|NCT01171820|19221697|P1|Overall Study|Withdrawal by Subject|2
5562374|NCT01171820|19221696|P2|Overall Study|Lost to Follow-up|1
5562375|NCT01171820|19221697|P1|Overall Study|Lost to Follow-up|0
5562376|NCT01171820|19221696|P2|Overall Study|Death|3
5562377|NCT01171820|19221697|P1|Overall Study|Death|3
5562378|NCT01171677|19221775|P2|Overall Study|completed <70% IntenSati classes|0
5562379|NCT01171677|19221776|P1|Overall Study|completed <70% IntenSati classes|5
5562380|NCT01171677|19221775|P2|Overall Study|Adverse Event|0
5562381|NCT01171677|19221776|P1|Overall Study|Adverse Event|1
5562382|NCT01171677|19221775|P2|Overall Study|Withdrawal by Subject|3
5562383|NCT01171677|19221776|P1|Overall Study|Withdrawal by Subject|0
5562384|NCT01171625|19221808|P1|Overall Study|Consented but did not receive device|25
5562385|NCT01171625|19221808|P1|Overall Study|Other|1
5562386|NCT01171625|19221808|P1|Overall Study|Patient received valve-in-valve|3
5562387|NCT01171625|19221808|P1|Overall Study|Lost to Follow-up|5
5562388|NCT01171625|19221808|P1|Overall Study|Explanted|10
5562389|NCT01171625|19221808|P1|Overall Study|Withdrawal by Subject|31
5562390|NCT01171625|19221808|P1|Overall Study|Death|38
5562391|NCT01171625|19221808|P1|Overall Study|On-Protocol|67
5562392|NCT01171612|19221841|P1|Overall Study|Lost to Follow-up|51
5562393|NCT01171534|19221851|P2|Overall Study|screen failure|1
5562394|NCT01171534|19221852|P1|Overall Study|screen failure|0
5562395|NCT01171534|19221851|P2|Overall Study|Lost to Follow-up|2
5562396|NCT01171534|19221852|P1|Overall Study|Lost to Follow-up|0
5562397|NCT01171521|19221864|P1|Overall Study|screen failure|1
5562398|NCT01171521|19221864|P1|Overall Study|Lost to Follow-up|5
5562399|NCT01171183|19221871|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
5562400|NCT01171183|19221872|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
5562401|NCT01171183|19221871|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
5562402|NCT01171183|19221872|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
5562403|NCT01171183|19221871|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
5562404|NCT01171183|19221872|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
5562405|NCT01171183|19221871|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
5562406|NCT01171183|19221872|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
5562407|NCT01171183|19221871|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
5562408|NCT01171183|19221872|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
5562409|NCT01171183|19221871|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
5562410|NCT01171183|19221872|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
5562411|NCT01170962|19221893|P3|Follow up Period|Others|3
5562412|NCT01170962|19221894|P2|Follow up Period|Others|7
5562413|NCT01170962|19221895|P1|Follow up Period|Others|10
5562414|NCT01170962|19221893|P3|Follow up Period|Death|0
5562415|NCT01170962|19221894|P2|Follow up Period|Death|2
5562416|NCT01170962|19221895|P1|Follow up Period|Death|2
5562417|NCT01170962|19221893|P3|Follow up Period|Lost to Follow-up|1
5562418|NCT01170962|19221894|P2|Follow up Period|Lost to Follow-up|8
5562419|NCT01170962|19221895|P1|Follow up Period|Lost to Follow-up|13
5562420|NCT01170962|19221893|P3|Follow up Period|Withdrawal by Subject|2
5562421|NCT01170962|19221894|P2|Follow up Period|Withdrawal by Subject|10
5562422|NCT01170962|19221895|P1|Follow up Period|Withdrawal by Subject|14
5562423|NCT01170962|19221893|P3|Treatment Period|Completed 24 Week treatment period only|0
5562424|NCT01170962|19221894|P2|Treatment Period|Completed 24 Week treatment period only|2
5562425|NCT01170962|19221895|P1|Treatment Period|Completed 24 Week treatment period only|10
5562426|NCT01170962|19221893|P3|Treatment Period|Request to discontinue treatment|1
5562427|NCT01170962|19221894|P2|Treatment Period|Request to discontinue treatment|3
5562428|NCT01170962|19221895|P1|Treatment Period|Request to discontinue treatment|7
5562429|NCT01170962|19221893|P3|Treatment Period|Participant no longer meets criteria|0
5562430|NCT01170962|19221894|P2|Treatment Period|Participant no longer meets criteria|1
5562431|NCT01170962|19221895|P1|Treatment Period|Participant no longer meets criteria|0
5562432|NCT01170962|19221893|P3|Treatment Period|Lost to Follow-up|1
5562433|NCT01170962|19221894|P2|Treatment Period|Lost to Follow-up|1
5562434|NCT01170962|19221895|P1|Treatment Period|Lost to Follow-up|1
5562435|NCT01170962|19221893|P3|Treatment Period|Withdrawal by Subject|0
5562436|NCT01170962|19221894|P2|Treatment Period|Withdrawal by Subject|1
5562437|NCT01170962|19221895|P1|Treatment Period|Withdrawal by Subject|2
5562438|NCT01170962|19221893|P3|Treatment Period|Adverse Event|3
5562439|NCT01170962|19221894|P2|Treatment Period|Adverse Event|12
5562440|NCT01170962|19221895|P1|Treatment Period|Adverse Event|11
5562441|NCT01170962|19221893|P3|Treatment Period|Lack of Efficacy|7
5562442|NCT01170962|19221894|P2|Treatment Period|Lack of Efficacy|91
5562443|NCT01170962|19221895|P1|Treatment Period|Lack of Efficacy|96
5562444|NCT01170663|19221990|P2|Overall Study|Withdrawal of consent without follow-up|11
5562445|NCT01170663|19221991|P1|Overall Study|Withdrawal of consent without follow-up|11
5562446|NCT01170663|19221990|P2|Overall Study|Lost to Follow-up|9
5562447|NCT01170663|19221991|P1|Overall Study|Lost to Follow-up|3
5562448|NCT01170598|19222019|P1|Overall Study|Refused|1
5562449|NCT01170598|19222019|P1|Overall Study|Lost to Follow-up|1
5562450|NCT01170598|19222019|P1|Overall Study|Death|3
5562451|NCT01170598|19222019|P1|Overall Study|Withdrawal by Subject|1
5562452|NCT01170364|19222082|P2|Overall Study|Protocol Violation|1
5562453|NCT01170364|19222083|P1|Overall Study|Protocol Violation|4
5562454|NCT01170273|19222091|P2|Overall Study|Adverse Event|1
5562455|NCT01170273|19222092|P1|Overall Study|Adverse Event|0
5562456|NCT01170273|19222091|P2|Overall Study|Death|0
5562457|NCT01170273|19222092|P1|Overall Study|Death|1
5562458|NCT01170273|19222091|P2|Overall Study|Protocol Violation|0
5562459|NCT01170273|19222092|P1|Overall Study|Protocol Violation|1
5562460|NCT01170273|19222091|P2|Overall Study|Lost to Follow-up|8
5562461|NCT01170273|19222092|P1|Overall Study|Lost to Follow-up|6
5562462|NCT01170221|19222109|P2|Overall Study|Randomized but not treated|0
5562463|NCT01170221|19222110|P1|Overall Study|Randomized but not treated|1
5562464|NCT01170221|19222109|P2|Overall Study|Subject completed only screening and LFU|0
5562465|NCT01170221|19222110|P1|Overall Study|Subject completed only screening and LFU|1
5562466|NCT01170221|19222109|P2|Overall Study|Withdrawal by Subject|7
5562467|NCT01170221|19222110|P1|Overall Study|Withdrawal by Subject|9
5562468|NCT01170221|19222109|P2|Overall Study|Lost to Follow-up|21
5562469|NCT01170221|19222110|P1|Overall Study|Lost to Follow-up|22
5562470|NCT01170208|19222133|P3|Overall Study|Protocol Violation|1
5562471|NCT01170208|19222134|P2|Overall Study|Protocol Violation|0
5562472|NCT01170208|19222135|P1|Overall Study|Protocol Violation|1
5562473|NCT01170208|19222133|P3|Overall Study|Withdrawal by Subject|1
5562474|NCT01170208|19222134|P2|Overall Study|Withdrawal by Subject|0
5562475|NCT01170208|19222135|P1|Overall Study|Withdrawal by Subject|5
5562476|NCT01170091|19222163|P1|Overall Study|Treatment duration is less than 4 weeks|21
5562477|NCT01170091|19222163|P1|Overall Study|Missing efficacy evaluation|3
5562478|NCT01170065|19222173|P3|Overall Study|Ongoing after planned observation time|10
5562479|NCT01170065|19222174|P2|Overall Study|Ongoing after planned observation time|26
5562480|NCT01170065|19222175|P1|Overall Study|Ongoing after planned observation time|5
5562481|NCT01170065|19222173|P3|Overall Study|Reason other than specified|3
5562482|NCT01170065|19222174|P2|Overall Study|Reason other than specified|8
5562483|NCT01170065|19222175|P1|Overall Study|Reason other than specified|3
5562484|NCT01170065|19222173|P3|Overall Study|Consent withdrawn, not due to AE|2
5562485|NCT01170065|19222174|P2|Overall Study|Consent withdrawn, not due to AE|4
5562486|NCT01170065|19222175|P1|Overall Study|Consent withdrawn, not due to AE|2
5562487|NCT01170065|19222173|P3|Overall Study|Lost to Follow-up|1
5562488|NCT01170065|19222174|P2|Overall Study|Lost to Follow-up|4
5562489|NCT01170065|19222175|P1|Overall Study|Lost to Follow-up|1
5562490|NCT01170065|19222173|P3|Overall Study|Adverse Event|10
5562491|NCT01170065|19222174|P2|Overall Study|Adverse Event|50
5562492|NCT01170065|19222175|P1|Overall Study|Adverse Event|17
5562493|NCT01170039|19222206|P2|Overall Study|Lack of funding, drug not available|3
5562494|NCT01170039|19222207|P1|Overall Study|Lack of funding, drug not available|3
5562495|NCT01170039|19222206|P2|Overall Study|Withdrawal by Subject|3
5562496|NCT01170039|19222207|P1|Overall Study|Withdrawal by Subject|5
5562497|NCT01169987|19222219|P1|Overall Study|Other|4
5562498|NCT01169987|19222219|P1|Overall Study|Lost to Follow-up|24
5562499|NCT01169987|19222219|P1|Overall Study|Withdrawal by Subject|3
5562500|NCT01169779|19222285|P2|Overall Study|Familial and personal reasons|3
5562501|NCT01169779|19222286|P1|Overall Study|Familial and personal reasons|3
5562502|NCT01169779|19222285|P2|Overall Study|Withdrawal by Subject|2
5562503|NCT01169779|19222286|P1|Overall Study|Withdrawal by Subject|3
5562504|NCT01169779|19222285|P2|Overall Study|Protocol Violation|1
5562505|NCT01169779|19222286|P1|Overall Study|Protocol Violation|1
5562506|NCT01169779|19222285|P2|Overall Study|Lack of Efficacy|0
5562507|NCT01169779|19222286|P1|Overall Study|Lack of Efficacy|1
5562508|NCT01169779|19222285|P2|Overall Study|Adverse Event|11
5562509|NCT01169779|19222286|P1|Overall Study|Adverse Event|3
5562510|NCT01169701|19222321|P2|Overall Study|Sponsor decision|1
5562511|NCT01169701|19222322|P1|Overall Study|Sponsor decision|0
5562512|NCT01169701|19222321|P2|Overall Study|Serious adverse event|1
5562513|NCT01169701|19222322|P1|Overall Study|Serious adverse event|0
5562514|NCT01169701|19222321|P2|Overall Study|Administrative problems|1
5562515|NCT01169701|19222322|P1|Overall Study|Administrative problems|0
5562516|NCT01169701|19222321|P2|Overall Study|Death|1
5562517|NCT01169701|19222322|P1|Overall Study|Death|0
5562518|NCT01169701|19222321|P2|Overall Study|Exclusion criteria|0
5562519|NCT01169701|19222322|P1|Overall Study|Exclusion criteria|2
5562520|NCT01169701|19222321|P2|Overall Study|Adverse Event|2
5562521|NCT01169701|19222322|P1|Overall Study|Adverse Event|1
5562522|NCT01169701|19222321|P2|Overall Study|Withdrawal by Subject|3
5562523|NCT01169701|19222322|P1|Overall Study|Withdrawal by Subject|1
5562524|NCT01169701|19222321|P2|Overall Study|Lost to Follow-up|1
5562525|NCT01169701|19222322|P1|Overall Study|Lost to Follow-up|1
5562526|NCT01169675|19222359|P5|Overall Study|Other Reason Not Defined Above|1
5562527|NCT01169675|19222360|P4|Overall Study|Other Reason Not Defined Above|1
5562528|NCT01169675|19222361|P3|Overall Study|Other Reason Not Defined Above|0
5562529|NCT01169675|19222362|P2|Overall Study|Other Reason Not Defined Above|0
5562530|NCT01169675|19222363|P1|Overall Study|Other Reason Not Defined Above|0
5562531|NCT01169675|19222359|P5|Overall Study|Withdrawal by Subject|2
5562532|NCT01169675|19222360|P4|Overall Study|Withdrawal by Subject|1
5562533|NCT01169675|19222361|P3|Overall Study|Withdrawal by Subject|0
5562534|NCT01169675|19222362|P2|Overall Study|Withdrawal by Subject|0
5562535|NCT01169675|19222363|P1|Overall Study|Withdrawal by Subject|1
5562536|NCT01169675|19222359|P5|Overall Study|Adverse Event|0
5562537|NCT01169675|19222360|P4|Overall Study|Adverse Event|0
5562538|NCT01169675|19222361|P3|Overall Study|Adverse Event|2
5562539|NCT01169675|19222362|P2|Overall Study|Adverse Event|1
5562540|NCT01169675|19222363|P1|Overall Study|Adverse Event|5
5562541|NCT01169675|19222359|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
5562542|NCT01169675|19222360|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
5562543|NCT01169675|19222361|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
5562544|NCT01169675|19222362|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
5562545|NCT01169675|19222363|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
5562546|NCT01169675|19222359|P5|Overall Study|Progressive disease|1
5562547|NCT01169675|19222360|P4|Overall Study|Progressive disease|15
5562548|NCT01169675|19222361|P3|Overall Study|Progressive disease|5
5562549|NCT01169675|19222362|P2|Overall Study|Progressive disease|2
5562550|NCT01169675|19222363|P1|Overall Study|Progressive disease|13
5562551|NCT01169649|19222400|P1|Overall Study|Patient Not Treated|3
5562552|NCT01169558|19222412|P1|Overall Study|Partial response|2
5562553|NCT01169558|19222412|P1|Overall Study|Protocol Violation|2
5562554|NCT01169558|19222412|P1|Overall Study|Non-compliance|2
5562555|NCT01169558|19222412|P1|Overall Study|Need for Surgery|4
5562556|NCT01169558|19222412|P1|Overall Study|Lost to Follow-up|4
5562557|NCT01169558|19222412|P1|Overall Study|Stable Disease|4
5562558|NCT01169558|19222412|P1|Overall Study|Medical Decision|7
5562559|NCT01169558|19222412|P1|Overall Study|Withdrawal of Consent|8
5562560|NCT01169558|19222412|P1|Overall Study|Adverse Event|25
5562561|NCT01169558|19222412|P1|Overall Study|Disease progression|98
5562562|NCT01169493|19222437|P6|Period 3 (6 Months)|Physician Decision|0
5562563|NCT01169493|19222438|P5|Period 3 (6 Months)|Physician Decision|0
5562564|NCT01169493|19222439|P4|Period 3 (6 Months)|Physician Decision|0
5562565|NCT01169493|19222440|P3|Period 3 (6 Months)|Physician Decision|1
5562566|NCT01169493|19222441|P2|Period 3 (6 Months)|Physician Decision|1
5562567|NCT01169493|19222442|P1|Period 3 (6 Months)|Physician Decision|0
5562568|NCT01169493|19222437|P6|Period 3 (6 Months)|Adverse Event|0
5562569|NCT01169493|19222438|P5|Period 3 (6 Months)|Adverse Event|0
5562570|NCT01169493|19222439|P4|Period 3 (6 Months)|Adverse Event|0
5562571|NCT01169493|19222440|P3|Period 3 (6 Months)|Adverse Event|0
5562572|NCT01169493|19222441|P2|Period 3 (6 Months)|Adverse Event|1
5562573|NCT01169493|19222442|P1|Period 3 (6 Months)|Adverse Event|0
5562574|NCT01169493|19222437|P6|Period 1 (6 Months)|Withdrawal by Subject|3
5562575|NCT01169493|19222438|P5|Period 1 (6 Months)|Withdrawal by Subject|0
5562576|NCT01169493|19222439|P4|Period 1 (6 Months)|Withdrawal by Subject|0
5562577|NCT01169493|19222440|P3|Period 1 (6 Months)|Withdrawal by Subject|2
5562578|NCT01169493|19222441|P2|Period 1 (6 Months)|Withdrawal by Subject|1
5562579|NCT01169493|19222442|P1|Period 1 (6 Months)|Withdrawal by Subject|0
5562580|NCT01169350|19222488|P1|Overall Study|Lost to Follow-up|2
5562581|NCT01169350|19222488|P1|Overall Study|Physician Decision|3
5562582|NCT01169103|19222626|P2|Overall Study|Withdrawal by Subject|1
5562583|NCT01169103|19222627|P1|Overall Study|Withdrawal by Subject|3
5562584|NCT01169103|19222626|P2|Overall Study|Lost to Follow-up|3
5562585|NCT01169103|19222627|P1|Overall Study|Lost to Follow-up|3
5562586|NCT01169038|19222654|P1|Overall Study|Required antibiotic administration|1
5562587|NCT01169038|19222654|P1|Overall Study|Adverse Event|5
5562588|NCT01169038|19222654|P1|Overall Study|Death|1
5562589|NCT01168999|19222662|P4|Overall Study|Lost to Follow-up|0
5562590|NCT01168999|19222663|P3|Overall Study|Lost to Follow-up|0
5562591|NCT01168999|19222664|P2|Overall Study|Lost to Follow-up|1
5562592|NCT01168999|19222665|P1|Overall Study|Lost to Follow-up|2
5562593|NCT01168973|19222731|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
5562594|NCT01168973|19222732|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
5562595|NCT01168973|19222731|P2|Overall Study|Sponsor Decision|1
5562596|NCT01168973|19222732|P1|Overall Study|Sponsor Decision|2
5562597|NCT01168973|19222731|P2|Overall Study|Physician Decision|19
5562598|NCT01168973|19222732|P1|Overall Study|Physician Decision|37
5562599|NCT01168973|19222731|P2|Overall Study|Death|45
5562600|NCT01168973|19222732|P1|Overall Study|Death|42
5562601|NCT01168973|19222731|P2|Overall Study|Withdrawal by Subject|53
5562602|NCT01168973|19222732|P1|Overall Study|Withdrawal by Subject|90
5562603|NCT01168973|19222731|P2|Overall Study|Adverse Event|55
5562604|NCT01168973|19222732|P1|Overall Study|Adverse Event|94
5562605|NCT01168973|19222731|P2|Overall Study|Progressive Disease|429
5562606|NCT01168973|19222732|P1|Overall Study|Progressive Disease|341
5562607|NCT01168856|19222807|P2|Overall Study|Protocol Violation|6
5562608|NCT01168856|19222808|P1|Overall Study|Protocol Violation|4
5562609|NCT01168856|19222807|P2|Overall Study|Other|291
5562610|NCT01168856|19222808|P1|Overall Study|Other|1
5562611|NCT01168856|19222807|P2|Overall Study|Death|2
5562612|NCT01168856|19222808|P1|Overall Study|Death|0
5562613|NCT01168856|19222807|P2|Overall Study|Participant received anti-HCV treatment|0
5562614|NCT01168856|19222808|P1|Overall Study|Participant received anti-HCV treatment|1
5562615|NCT01168856|19222807|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
5562616|NCT01168856|19222808|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
5562617|NCT01168856|19222807|P2|Overall Study|Physician Decision|1
5562618|NCT01168856|19222808|P1|Overall Study|Physician Decision|2
5562619|NCT01168856|19222807|P2|Overall Study|Withdrawal by Subject|8
5562620|NCT01168856|19222808|P1|Overall Study|Withdrawal by Subject|6
5562621|NCT01168856|19222807|P2|Overall Study|Lost to Follow-up|34
5562622|NCT01168856|19222808|P1|Overall Study|Lost to Follow-up|4
5562623|NCT01168596|19222906|P2|Overall Study|Withdrawal by Subject|1
5562624|NCT01168596|19222907|P1|Overall Study|Withdrawal by Subject|3
5562625|NCT01168427|19222951|P1|Overall Study|Patient exited prior to implant|1
5562626|NCT01168401|19222967|P11|Overall Study|Withdrawal by Subject|0
5562627|NCT01168401|19222968|P10|Overall Study|Withdrawal by Subject|0
5562628|NCT01168401|19222969|P9|Overall Study|Withdrawal by Subject|0
5562629|NCT01168401|19222970|P8|Overall Study|Withdrawal by Subject|0
5562630|NCT01168401|19222971|P7|Overall Study|Withdrawal by Subject|0
5562631|NCT01168401|19222972|P6|Overall Study|Withdrawal by Subject|0
5562632|NCT01168401|19222973|P5|Overall Study|Withdrawal by Subject|0
5562633|NCT01168401|19222974|P4|Overall Study|Withdrawal by Subject|1
5562634|NCT01168401|19222975|P3|Overall Study|Withdrawal by Subject|0
5562635|NCT01168401|19222976|P2|Overall Study|Withdrawal by Subject|0
5562636|NCT01168401|19222977|P1|Overall Study|Withdrawal by Subject|0
5562637|NCT01168401|19222967|P11|Overall Study|Lost to Follow-up|0
5562638|NCT01168401|19222968|P10|Overall Study|Lost to Follow-up|0
5562639|NCT01168401|19222969|P9|Overall Study|Lost to Follow-up|0
5562640|NCT01168401|19222970|P8|Overall Study|Lost to Follow-up|0
5562641|NCT01168401|19222971|P7|Overall Study|Lost to Follow-up|0
5562642|NCT01168401|19222972|P6|Overall Study|Lost to Follow-up|0
5562643|NCT01168401|19222973|P5|Overall Study|Lost to Follow-up|0
5562644|NCT01168401|19222974|P4|Overall Study|Lost to Follow-up|1
5562645|NCT01168401|19222975|P3|Overall Study|Lost to Follow-up|2
5562646|NCT01168401|19222976|P2|Overall Study|Lost to Follow-up|1
5562647|NCT01168401|19222977|P1|Overall Study|Lost to Follow-up|1
5562648|NCT01168349|19223210|P1|Overall Study|Protocol Violation|76
5562649|NCT01168349|19223210|P1|Overall Study|Other|22
5562650|NCT01168349|19223210|P1|Overall Study|Kidney transplantation|3
5562651|NCT01168349|19223210|P1|Overall Study|Withdrawal by Subject|9
5562652|NCT01168349|19223210|P1|Overall Study|Lost to Follow-up|34
5562653|NCT01168349|19223210|P1|Overall Study|Death|157
5562654|NCT01168232|19223316|P1|Overall Study|Ineligible-Inadequate pathology|1
5562655|NCT01168232|19223316|P1|Overall Study|Ineligible- Wrong cell type|6
5562656|NCT01168232|19223316|P1|Overall Study|Ineligible-Second primary cancer site|1
5562657|NCT01168219|19223323|P1|Overall Study|ineligible due to CML|2
5562658|NCT01168219|19223323|P1|Overall Study|withdrew before transplant|1
5562659|NCT01168219|19223323|P1|Overall Study|off study before starting treatment|2
5562660|NCT01167907|19223346|P2|Overall Study|saphenous catheter dislodged before comp|1
5562661|NCT01167907|19223347|P1|Overall Study|saphenous catheter dislodged before comp|1
5562662|NCT01167907|19223346|P2|Overall Study|Protocol Violation|0
5562663|NCT01167907|19223347|P1|Overall Study|Protocol Violation|1
5562664|NCT01167881|19223365|P2|Overall Study|Other not defined above|55
5562665|NCT01167881|19223366|P1|Overall Study|Other not defined above|31
5562666|NCT01167881|19223365|P2|Overall Study|Not treated|0
5562667|NCT01167881|19223366|P1|Overall Study|Not treated|4
5562668|NCT01167881|19223365|P2|Overall Study|Patient refusal to cont., not due to AE|40
5562669|NCT01167881|19223366|P1|Overall Study|Patient refusal to cont., not due to AE|45
5562670|NCT01167881|19223365|P2|Overall Study|Lost to Follow-up|20
5562671|NCT01167881|19223366|P1|Overall Study|Lost to Follow-up|19
5562672|NCT01167881|19223365|P2|Overall Study|Non compliant with protocol|18
5562673|NCT01167881|19223366|P1|Overall Study|Non compliant with protocol|9
5562674|NCT01167881|19223365|P2|Overall Study|Lack of Efficacy|7
5562675|NCT01167881|19223366|P1|Overall Study|Lack of Efficacy|4
5562676|NCT01167881|19223365|P2|Overall Study|Adverse Event|51
5562677|NCT01167881|19223366|P1|Overall Study|Adverse Event|47
5562678|NCT01167634|19223420|P4|Overall Study|Withdrawal by Subject|0
5562679|NCT01167634|19223421|P3|Overall Study|Withdrawal by Subject|0
5562680|NCT01167634|19223422|P2|Overall Study|Withdrawal by Subject|1
5562681|NCT01167634|19223423|P1|Overall Study|Withdrawal by Subject|1
5562682|NCT01167634|19223420|P4|Overall Study|Lost to Follow-up|4
5562683|NCT01167634|19223421|P3|Overall Study|Lost to Follow-up|3
5562684|NCT01167634|19223422|P2|Overall Study|Lost to Follow-up|3
5562685|NCT01167634|19223423|P1|Overall Study|Lost to Follow-up|1
5562686|NCT01167582|19223444|P2|Overall Study|Lost to Follow-up|1
5562687|NCT01167582|19223445|P1|Overall Study|Lost to Follow-up|0
5562688|NCT01167426|19223496|P1|Overall Study|Sponsor Decision|1
5562689|NCT01167426|19223496|P1|Overall Study|Withdrawal by Subject|2
5562690|NCT01167426|19223496|P1|Overall Study|Protocol Violation|1
5562691|NCT01167426|19223496|P1|Overall Study|Lost to Follow-up|6
5562692|NCT01167257|19223504|P2|Overall Study|Withdrew consent|1
5562693|NCT01167257|19223505|P1|Overall Study|Withdrew consent|1
5562694|NCT01167257|19223504|P2|Overall Study|Lost to Follow-up|2
5562695|NCT01167257|19223505|P1|Overall Study|Lost to Follow-up|2
5562696|NCT01167192|19223527|P1|Overall Study|Insurance denial|1
5562697|NCT01167192|19223527|P1|Overall Study|Withdrawal by Subject|1
5562698|NCT01167192|19223527|P1|Overall Study|Death|1
5562699|NCT01167192|19223527|P1|Overall Study|Adverse Event|1
5562700|NCT01167179|19223544|P2|Overall Study|diverse|5
5562701|NCT01167179|19223545|P1|Overall Study|diverse|6
5562702|NCT01167179|19223544|P2|Overall Study|Withdrawal by Subject|2
5562703|NCT01167179|19223545|P1|Overall Study|Withdrawal by Subject|1
5562704|NCT01167179|19223544|P2|Overall Study|Death|10
5562705|NCT01167179|19223545|P1|Overall Study|Death|4
5562706|NCT01167179|19223544|P2|Overall Study|disease recurrence|4
5562707|NCT01167179|19223545|P1|Overall Study|disease recurrence|4
5562708|NCT01167153|19223555|P2|Overall Study|Subject initiation withdrawal, Other|8
5562709|NCT01167153|19223556|P1|Overall Study|Subject initiation withdrawal, Other|5
5562710|NCT01167153|19223555|P2|Overall Study|Withdrawal consent|1
5562711|NCT01167153|19223556|P1|Overall Study|Withdrawal consent|1
5562712|NCT01167153|19223555|P2|Overall Study|Investigator initiation withdrawal,Other|1
5562713|NCT01167153|19223556|P1|Overall Study|Investigator initiation withdrawal,Other|1
5562714|NCT01167153|19223555|P2|Overall Study|Non-compliance to concomitant medication|2
5562715|NCT01167153|19223556|P1|Overall Study|Non-compliance to concomitant medication|0
5562716|NCT01167153|19223555|P2|Overall Study|Lost to Follow-up|9
5562717|NCT01167153|19223556|P1|Overall Study|Lost to Follow-up|7
5562718|NCT01167153|19223555|P2|Overall Study|Hypotension|0
5562719|NCT01167153|19223556|P1|Overall Study|Hypotension|1
5562720|NCT01167153|19223555|P2|Overall Study|AE including clinical laboratory AE|8
5562721|NCT01167153|19223556|P1|Overall Study|AE including clinical laboratory AE|2
5562722|NCT01167153|19223555|P2|Overall Study|Non-effective therapy|4
5562723|NCT01167153|19223556|P1|Overall Study|Non-effective therapy|1
5562724|NCT01167140|19223574|P1|Overall Study|Withdrawal by Subject|1
5562725|NCT01167023|19223582|P3|Overall Study|Withdrawal by Subject|1
5562726|NCT01167023|19223583|P2|Overall Study|Withdrawal by Subject|0
5562727|NCT01167023|19223584|P1|Overall Study|Withdrawal by Subject|0
5562728|NCT01167023|19223582|P3|Overall Study|Sponsor Decision|0
5562729|NCT01167023|19223583|P2|Overall Study|Sponsor Decision|1
5562730|NCT01167023|19223584|P1|Overall Study|Sponsor Decision|0
5562731|NCT01167023|19223582|P3|Overall Study|Screen Failure|0
5562732|NCT01167023|19223583|P2|Overall Study|Screen Failure|1
5562733|NCT01167023|19223584|P1|Overall Study|Screen Failure|0
5562734|NCT01167023|19223582|P3|Overall Study|Lost to Follow-up|1
5562735|NCT01167023|19223583|P2|Overall Study|Lost to Follow-up|1
5562736|NCT01167023|19223584|P1|Overall Study|Lost to Follow-up|0
5562737|NCT01166958|19223624|P2|Overall Study|Withdrawal by Subject|0
5562738|NCT01166958|19223625|P1|Overall Study|Withdrawal by Subject|1
5562739|NCT01166945|19223641|P2|Day 30|Lost to Follow-up|3
5562740|NCT01166945|19223642|P1|Day 30|Lost to Follow-up|4
5562741|NCT01166945|19223641|P2|Day 15|NonCompliance/Lost to Follow Up|1
5562742|NCT01166945|19223642|P1|Day 15|NonCompliance/Lost to Follow Up|2
5562743|NCT01166945|19223641|P2|Day 10|NonCompliance/Lost to Follow Up|2
5562744|NCT01166945|19223642|P1|Day 10|NonCompliance/Lost to Follow Up|3
5562745|NCT01166945|19223641|P2|Randomized|diagnosed with Group A strep|4
5562746|NCT01166945|19223642|P1|Randomized|diagnosed with Group A strep|4
5562747|NCT01166763|19223650|P1|Overall Study|Withdrawal by Subject|3
5562748|NCT01166750|19223658|P2|Overall Study|Lost to Follow-up|0
5562749|NCT01166750|19223659|P1|Overall Study|Lost to Follow-up|1
5562750|NCT01166659|19223676|P1|Overall Study|Study Closed at Site|1
5562751|NCT01166659|19223676|P1|Overall Study|Lost to Follow-up|1
5562752|NCT01166659|19223676|P1|Overall Study|Death|1
5562753|NCT01166659|19223676|P1|Overall Study|Investigator Decision|2
5562754|NCT01166659|19223676|P1|Overall Study|Subject Decision|8
5562755|NCT01166646|19223685|P2|Overall Study|Adverse Event|0
5562756|NCT01166646|19223686|P1|Overall Study|Adverse Event|1
5562757|NCT01166646|19223685|P2|Overall Study|Protocol Violation|1
5562758|NCT01166646|19223686|P1|Overall Study|Protocol Violation|0
5562759|NCT01166568|19223705|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
5562760|NCT01166568|19223706|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
5562761|NCT01166568|19223707|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
5562762|NCT01166568|19223705|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
5562763|NCT01166568|19223706|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
5562764|NCT01166568|19223707|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
5562765|NCT01166568|19223705|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
5562766|NCT01166568|19223706|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
5562767|NCT01166568|19223707|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
5562768|NCT01166438|19223720|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
5562769|NCT01166438|19223721|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
5562770|NCT01166438|19223720|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
5562771|NCT01166438|19223721|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
5562772|NCT01166438|19223720|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
5562773|NCT01166438|19223721|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
5562774|NCT01166438|19223720|P2|Double-blind Phase: 1st 6 Months|Not treated|1
5562775|NCT01166438|19223721|P1|Double-blind Phase: 1st 6 Months|Not treated|1
5562776|NCT01166438|19223720|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
5562777|NCT01166438|19223721|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
5562778|NCT01166438|19223720|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
5562779|NCT01166438|19223721|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
5562780|NCT01166373|19223739|P4|Overall Study|Physician Decision|0
5562781|NCT01166373|19223740|P3|Overall Study|Physician Decision|0
5562782|NCT01166373|19223741|P2|Overall Study|Physician Decision|0
5562783|NCT01166373|19223742|P1|Overall Study|Physician Decision|1
5562784|NCT01166373|19223739|P4|Overall Study|Withdrawal by Subject|3
5562785|NCT01166373|19223740|P3|Overall Study|Withdrawal by Subject|2
5562786|NCT01166373|19223741|P2|Overall Study|Withdrawal by Subject|2
5562787|NCT01166373|19223742|P1|Overall Study|Withdrawal by Subject|1
5562788|NCT01166373|19223739|P4|Overall Study|Lost to Follow-up|2
5562789|NCT01166373|19223740|P3|Overall Study|Lost to Follow-up|2
5562790|NCT01166373|19223741|P2|Overall Study|Lost to Follow-up|2
5562791|NCT01166373|19223742|P1|Overall Study|Lost to Follow-up|3
5562792|NCT01166282|19223875|P3|Open-label Period|Irregular Compliance|1
5562793|NCT01166282|19223876|P2|Open-label Period|Irregular Compliance|0
5562794|NCT01166282|19223877|P1|Open-label Period|Irregular Compliance|0
5562795|NCT01166282|19223875|P3|Open-label Period|Remission|4
5562796|NCT01166282|19223876|P2|Open-label Period|Remission|0
5562797|NCT01166282|19223877|P1|Open-label Period|Remission|0
5562798|NCT01166282|19223875|P3|Open-label Period|Lack of Efficacy|2
5562799|NCT01166282|19223876|P2|Open-label Period|Lack of Efficacy|0
5562800|NCT01166282|19223877|P1|Open-label Period|Lack of Efficacy|0
5562801|NCT01166282|19223875|P3|Open-label Period|Withdrawal by Subject|4
5562802|NCT01166282|19223876|P2|Open-label Period|Withdrawal by Subject|0
5562803|NCT01166282|19223877|P1|Open-label Period|Withdrawal by Subject|0
5562804|NCT01166282|19223875|P3|Open-label Period|Adverse Event|6
5562805|NCT01166282|19223876|P2|Open-label Period|Adverse Event|0
5562806|NCT01166282|19223877|P1|Open-label Period|Adverse Event|0
5562807|NCT01166178|19223916|P2|Overall Study|Study was terminated|8
5562808|NCT01166178|19223917|P1|Overall Study|Study was terminated|20
5562809|NCT01166178|19223916|P2|Overall Study|Withdrawal by Subject|0
5562810|NCT01166178|19223917|P1|Overall Study|Withdrawal by Subject|1
5562811|NCT01165996|19223956|P1|Overall Study|Physician Decision|1
5562812|NCT01165996|19223956|P1|Overall Study|Death|1
5562813|NCT01165684|19224027|P2|Overall Study|Unclassified|22
5562814|NCT01165684|19224028|P1|Overall Study|Unclassified|16
5562815|NCT01165684|19224027|P2|Overall Study|Withdrawal Criteria|13
5562816|NCT01165684|19224028|P1|Overall Study|Withdrawal Criteria|2
5562817|NCT01165684|19224027|P2|Overall Study|Protocol Violation|15
5562818|NCT01165684|19224028|P1|Overall Study|Protocol Violation|7
5562819|NCT01165684|19224027|P2|Overall Study|Lack of Efficacy|1
5562820|NCT01165684|19224028|P1|Overall Study|Lack of Efficacy|2
5562821|NCT01165684|19224027|P2|Overall Study|Adverse Event|1
5562822|NCT01165684|19224028|P1|Overall Study|Adverse Event|1
5562823|NCT01165554|19224062|P1|Overall Study|Withdrawal by Subject|23
5562824|NCT01165424|19224085|P1|Overall Study|Participant moved (relocated)|1
5562825|NCT01165424|19224085|P1|Overall Study|Did not meet entry criteria|1
5562826|NCT01165424|19224085|P1|Overall Study|Laboratory adverse experiences|1
5562827|NCT01165424|19224085|P1|Overall Study|Clinical adverse experiences|1
5562828|NCT01165320|19224092|P3|Overall Study|Reason unknown|0
5562829|NCT01165320|19224093|P2|Overall Study|Reason unknown|1
5562830|NCT01165320|19224094|P1|Overall Study|Reason unknown|0
5562831|NCT01165320|19224092|P3|Overall Study|Lack of Efficacy|0
5562832|NCT01165320|19224093|P2|Overall Study|Lack of Efficacy|2
5562833|NCT01165320|19224094|P1|Overall Study|Lack of Efficacy|0
5562834|NCT01165320|19224092|P3|Overall Study|Laboratory adverse experience|0
5562835|NCT01165320|19224093|P2|Overall Study|Laboratory adverse experience|0
5562836|NCT01165320|19224094|P1|Overall Study|Laboratory adverse experience|1
5562837|NCT01165320|19224092|P3|Overall Study|Clinical adverse experience|0
5562838|NCT01165320|19224093|P2|Overall Study|Clinical adverse experience|1
5562839|NCT01165320|19224094|P1|Overall Study|Clinical adverse experience|2
5562840|NCT01165307|19224104|P2|Overall Study|Subject not available for contact|0
5562841|NCT01165307|19224105|P1|Overall Study|Subject not available for contact|1
5562842|NCT01165307|19224104|P2|Overall Study|Withdrawal by Subject|0
5562843|NCT01165307|19224105|P1|Overall Study|Withdrawal by Subject|2
5562844|NCT01165307|19224104|P2|Overall Study|Lost to Follow-up|3
5562845|NCT01165307|19224105|P1|Overall Study|Lost to Follow-up|11
5562846|NCT01165281|19224135|P2|Overall Study|Other|0
5562847|NCT01165281|19224136|P1|Overall Study|Other|6
5562848|NCT01165281|19224135|P2|Overall Study|Progressive Disease|14
5562849|NCT01165281|19224136|P1|Overall Study|Progressive Disease|10
5562850|NCT01165281|19224135|P2|Overall Study|Noncompliance with Study Drug|4
5562851|NCT01165281|19224136|P1|Overall Study|Noncompliance with Study Drug|1
5562852|NCT01165281|19224135|P2|Overall Study|Withdrawal by Subject|7
5562853|NCT01165281|19224136|P1|Overall Study|Withdrawal by Subject|8
5562854|NCT01165281|19224135|P2|Overall Study|Protocol Violation|5
5562855|NCT01165281|19224136|P1|Overall Study|Protocol Violation|6
5562856|NCT01165281|19224135|P2|Overall Study|Physician Decision|1
5562857|NCT01165281|19224136|P1|Overall Study|Physician Decision|8
5562858|NCT01165281|19224135|P2|Overall Study|Lost to Follow-up|1
5562859|NCT01165281|19224136|P1|Overall Study|Lost to Follow-up|0
5562860|NCT01165281|19224135|P2|Overall Study|Lack of Efficacy|1
5562861|NCT01165281|19224136|P1|Overall Study|Lack of Efficacy|4
5562862|NCT01165281|19224135|P2|Overall Study|Death|4
5562863|NCT01165281|19224136|P1|Overall Study|Death|3
5562864|NCT01165281|19224135|P2|Overall Study|Adverse Event|14
5562865|NCT01165281|19224136|P1|Overall Study|Adverse Event|12
5562866|NCT01165242|19224157|P3|Overall Study|Lost to Follow-up|10
5562867|NCT01165242|19224158|P2|Overall Study|Lost to Follow-up|7
5562868|NCT01165242|19224159|P1|Overall Study|Lost to Follow-up|9
5562869|NCT01165242|19224157|P3|Overall Study|Extended Holiday|1
5562870|NCT01165242|19224158|P2|Overall Study|Extended Holiday|0
5562871|NCT01165242|19224159|P1|Overall Study|Extended Holiday|0
5562872|NCT01165242|19224157|P3|Overall Study|Withdrawal by Subject|2
5562873|NCT01165242|19224158|P2|Overall Study|Withdrawal by Subject|2
5562874|NCT01165242|19224159|P1|Overall Study|Withdrawal by Subject|0
5562875|NCT01165242|19224157|P3|Overall Study|Visit 2 Declined by Subject|1
5562876|NCT01165242|19224158|P2|Overall Study|Visit 2 Declined by Subject|0
5562877|NCT01165242|19224159|P1|Overall Study|Visit 2 Declined by Subject|0
5562878|NCT01165242|19224157|P3|Overall Study|Incarcerated Subjects|0
5562879|NCT01165242|19224158|P2|Overall Study|Incarcerated Subjects|1
5562880|NCT01165242|19224159|P1|Overall Study|Incarcerated Subjects|0
5562881|NCT01165242|19224157|P3|Overall Study|Unreachable Subjects|0
5562882|NCT01165242|19224158|P2|Overall Study|Unreachable Subjects|0
5562883|NCT01165242|19224159|P1|Overall Study|Unreachable Subjects|1
5562884|NCT01165229|19224193|P2|Overall Study|Unknown completion status|1
5562885|NCT01165229|19224194|P1|Overall Study|Unknown completion status|0
5562886|NCT01165229|19224193|P2|Overall Study|No reason from the subject|102
5562887|NCT01165229|19224194|P1|Overall Study|No reason from the subject|108
5562888|NCT01165229|19224193|P2|Overall Study|Suspected HZ Episode|2
5562889|NCT01165229|19224194|P1|Overall Study|Suspected HZ Episode|2
5562890|NCT01165229|19224193|P2|Overall Study|Lost to Follow-up|133
5562891|NCT01165229|19224194|P1|Overall Study|Lost to Follow-up|123
5562892|NCT01165229|19224193|P2|Overall Study|Migrated/moved from study area|46
5562893|NCT01165229|19224194|P1|Overall Study|Migrated/moved from study area|51
5562894|NCT01165229|19224193|P2|Overall Study|Withdrawal by Subject|396
5562895|NCT01165229|19224194|P1|Overall Study|Withdrawal by Subject|387
5562896|NCT01165229|19224193|P2|Overall Study|Protocol Violation|8
5562897|NCT01165229|19224194|P1|Overall Study|Protocol Violation|6
5562898|NCT01165229|19224193|P2|Overall Study|Non-Serious Adverse Event|15
5562899|NCT01165229|19224194|P1|Overall Study|Non-Serious Adverse Event|47
5562900|NCT01165229|19224193|P2|Overall Study|Serious Adverse Event|487
5562901|NCT01165229|19224194|P1|Overall Study|Serious Adverse Event|456
5562902|NCT01165216|19224328|P2|Overall Study|Disease progression|3
5562903|NCT01165216|19224329|P1|Overall Study|Disease progression|1
5562904|NCT01165216|19224328|P2|Overall Study|Withdrawal by Subject|1
5562905|NCT01165216|19224329|P1|Overall Study|Withdrawal by Subject|1
5562906|NCT01165216|19224328|P2|Overall Study|Adverse Event|3
5562907|NCT01165216|19224329|P1|Overall Study|Adverse Event|6
5562908|NCT01165203|19224351|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
5562909|NCT01165203|19224352|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
5562910|NCT01165203|19224351|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
5562911|NCT01165203|19224352|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
5562912|NCT01165203|19224351|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
5562913|NCT01165203|19224352|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
5562914|NCT01165203|19224351|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
5562915|NCT01165203|19224352|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
5562916|NCT01165203|19224351|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
5562917|NCT01165203|19224352|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
5562918|NCT01165203|19224351|P2|Active Phase|Lost to Follow-up|0
5562919|NCT01165203|19224352|P1|Active Phase|Lost to Follow-up|2
5562920|NCT01165203|19224351|P2|Active Phase|Migrated/moved from study area|1
5562921|NCT01165203|19224352|P1|Active Phase|Migrated/moved from study area|0
5562922|NCT01165203|19224351|P2|Active Phase|Withdrawal by Subject|1
5562923|NCT01165203|19224352|P1|Active Phase|Withdrawal by Subject|2
5562924|NCT01165203|19224351|P2|Active Phase|Serious Adverse Event|0
5562925|NCT01165203|19224352|P1|Active Phase|Serious Adverse Event|1
5562926|NCT01165177|19224442|P2|Overall Study|Migrated/ moved from study area|43
5562927|NCT01165177|19224443|P1|Overall Study|Migrated/ moved from study area|48
5562928|NCT01165177|19224442|P2|Overall Study|Lost to Follow-up|194
5562929|NCT01165177|19224443|P1|Overall Study|Lost to Follow-up|183
5562930|NCT01165177|19224442|P2|Overall Study|Suspected HZ episode|2
5562931|NCT01165177|19224443|P1|Overall Study|Suspected HZ episode|0
5562932|NCT01165177|19224442|P2|Overall Study|Other unspecified reasons|35
5562933|NCT01165177|19224443|P1|Overall Study|Other unspecified reasons|47
5562934|NCT01165177|19224442|P2|Overall Study|Non-serious adverse event|18
5562935|NCT01165177|19224443|P1|Overall Study|Non-serious adverse event|30
5562936|NCT01165177|19224442|P2|Overall Study|Protocol Violation|21
5562937|NCT01165177|19224443|P1|Overall Study|Protocol Violation|19
5562938|NCT01165177|19224442|P2|Overall Study|Withdrawal by Subject|354
5562939|NCT01165177|19224443|P1|Overall Study|Withdrawal by Subject|368
5562940|NCT01165177|19224442|P2|Overall Study|Serious Adverse Event|235
5562941|NCT01165177|19224443|P1|Overall Study|Serious Adverse Event|227
5562942|NCT01165138|19224572|P4|Overall Study|Withdrawal by Subject|3
5562943|NCT01165138|19224573|P3|Overall Study|Withdrawal by Subject|6
5562944|NCT01165138|19224574|P2|Overall Study|Withdrawal by Subject|6
5562945|NCT01165138|19224575|P1|Overall Study|Withdrawal by Subject|0
5562946|NCT01165138|19224572|P4|Overall Study|Physician Decision|6
5562947|NCT01165138|19224573|P3|Overall Study|Physician Decision|7
5562948|NCT01165138|19224574|P2|Overall Study|Physician Decision|6
5562949|NCT01165138|19224575|P1|Overall Study|Physician Decision|0
5562950|NCT01165138|19224572|P4|Overall Study|Lost to Follow-up|2
5562951|NCT01165138|19224573|P3|Overall Study|Lost to Follow-up|1
5562952|NCT01165138|19224574|P2|Overall Study|Lost to Follow-up|0
5562953|NCT01165138|19224575|P1|Overall Study|Lost to Follow-up|0
5562954|NCT01165138|19224572|P4|Overall Study|Protocol Violation|2
5562955|NCT01165138|19224573|P3|Overall Study|Protocol Violation|0
5562956|NCT01165138|19224574|P2|Overall Study|Protocol Violation|7
5562957|NCT01165138|19224575|P1|Overall Study|Protocol Violation|0
5562958|NCT01165138|19224572|P4|Overall Study|Lack of Efficacy|7
5562959|NCT01165138|19224573|P3|Overall Study|Lack of Efficacy|6
5562960|NCT01165138|19224574|P2|Overall Study|Lack of Efficacy|32
5562961|NCT01165138|19224575|P1|Overall Study|Lack of Efficacy|0
5562962|NCT01165138|19224572|P4|Overall Study|Adverse Event|2
5562963|NCT01165138|19224573|P3|Overall Study|Adverse Event|0
5562964|NCT01165138|19224574|P2|Overall Study|Adverse Event|1
5562965|NCT01165138|19224575|P1|Overall Study|Adverse Event|0
5562966|NCT01165021|19224645|P1|Overall Study|Death|1
5562967|NCT01164956|19224653|P3|Overall Study|Side Effects|1
5562968|NCT01164956|19224654|P2|Overall Study|Side Effects|0
5562969|NCT01164956|19224655|P1|Overall Study|Side Effects|1
5562970|NCT01164891|19224663|P1|Overall Study|Adverse Event|1
5562971|NCT01164891|19224663|P1|Overall Study|Disease Progression|5
5562972|NCT01164865|19224683|P2|Overall Study|Lost to Follow-up|1
5562973|NCT01164865|19224684|P1|Overall Study|Lost to Follow-up|2
5562974|NCT01164722|19224694|P2|Overall Study|enrolled on other study, concomitant med|3
5562975|NCT01164722|19224695|P1|Overall Study|enrolled on other study, concomitant med|1
5562976|NCT01164722|19224694|P2|Overall Study|met protocol criteria for non-treatment|1
5562977|NCT01164722|19224695|P1|Overall Study|met protocol criteria for non-treatment|11
5562978|NCT01164722|19224694|P2|Overall Study|Lost to Follow-up|6
5562979|NCT01164722|19224695|P1|Overall Study|Lost to Follow-up|3
5562980|NCT01164722|19224694|P2|Overall Study|Withdrawal by Subject|4
5562981|NCT01164722|19224695|P1|Overall Study|Withdrawal by Subject|3
5562982|NCT01164722|19224694|P2|Overall Study|Adverse Event|1
5562983|NCT01164722|19224695|P1|Overall Study|Adverse Event|0
5562984|NCT01164579|19224725|P3|Overall Study|Reason not specified|0
5562985|NCT01164579|19224726|P2|Overall Study|Reason not specified|0
5562986|NCT01164579|19224727|P1|Overall Study|Reason not specified|1
5562987|NCT01164579|19224725|P3|Overall Study|Adverse Event|5
5562988|NCT01164579|19224726|P2|Overall Study|Adverse Event|2
5562989|NCT01164579|19224727|P1|Overall Study|Adverse Event|4
5562990|NCT01164579|19224725|P3|Overall Study|Protocol Violation|2
5562991|NCT01164579|19224726|P2|Overall Study|Protocol Violation|1
5562992|NCT01164579|19224727|P1|Overall Study|Protocol Violation|0
5562993|NCT01164579|19224725|P3|Overall Study|Withdrawal by Subject|3
5562994|NCT01164579|19224726|P2|Overall Study|Withdrawal by Subject|5
5562995|NCT01164579|19224727|P1|Overall Study|Withdrawal by Subject|2
5562996|NCT01164579|19224725|P3|Overall Study|Lost to Follow-up|0
5562997|NCT01164579|19224726|P2|Overall Study|Lost to Follow-up|1
5562998|NCT01164579|19224727|P1|Overall Study|Lost to Follow-up|1
5562999|NCT01164579|19224725|P3|Overall Study|Lack of Efficacy|6
5563000|NCT01164579|19224726|P2|Overall Study|Lack of Efficacy|0
5563001|NCT01164579|19224727|P1|Overall Study|Lack of Efficacy|0
5563002|NCT01164501|19224807|P3|Overall Study|Other reason not defined above|4
5563003|NCT01164501|19224808|P2|Overall Study|Other reason not defined above|1
5563004|NCT01164501|19224809|P1|Overall Study|Other reason not defined above|9
5563005|NCT01164501|19224807|P3|Overall Study|Patient refusal to continue,not due toAE|8
5563006|NCT01164501|19224808|P2|Overall Study|Patient refusal to continue,not due toAE|4
5563007|NCT01164501|19224809|P1|Overall Study|Patient refusal to continue,not due toAE|10
5563008|NCT01164501|19224807|P3|Overall Study|Lost to Follow-up|3
5563009|NCT01164501|19224808|P2|Overall Study|Lost to Follow-up|0
5563010|NCT01164501|19224809|P1|Overall Study|Lost to Follow-up|3
5563011|NCT01164501|19224807|P3|Overall Study|Non compliant with protocol|4
5563012|NCT01164501|19224808|P2|Overall Study|Non compliant with protocol|1
5563013|NCT01164501|19224809|P1|Overall Study|Non compliant with protocol|1
5563014|NCT01164501|19224807|P3|Overall Study|Lack of Efficacy|1
5563015|NCT01164501|19224808|P2|Overall Study|Lack of Efficacy|0
5563016|NCT01164501|19224809|P1|Overall Study|Lack of Efficacy|0
5563017|NCT01164501|19224807|P3|Overall Study|Adverse Event|21
5563018|NCT01164501|19224808|P2|Overall Study|Adverse Event|4
5563019|NCT01164501|19224809|P1|Overall Study|Adverse Event|18
5563020|NCT01164501|19224807|P3|Overall Study|Not treated|1
5563021|NCT01164501|19224808|P2|Overall Study|Not treated|0
5563022|NCT01164501|19224809|P1|Overall Study|Not treated|2
5563023|NCT01164475|19224826|P2|Overall Study|Protocol Violation|0
5563024|NCT01164475|19224827|P1|Overall Study|Protocol Violation|1
5563025|NCT01164475|19224826|P2|Overall Study|Progressive disease|1
5563026|NCT01164475|19224827|P1|Overall Study|Progressive disease|0
5563027|NCT01164475|19224826|P2|Overall Study|Other|1
5563028|NCT01164475|19224827|P1|Overall Study|Other|0
5563029|NCT01164475|19224826|P2|Overall Study|Lack of Efficacy|0
5563030|NCT01164475|19224827|P1|Overall Study|Lack of Efficacy|1
5563031|NCT01164007|19224881|P1|Overall Study|Medical Decision|3
5563032|NCT01164007|19224881|P1|Overall Study|Withdrawal by Subject|1
5563033|NCT01164007|19224881|P1|Overall Study|Protocol Violation|1
5563034|NCT01164007|19224881|P1|Overall Study|Progression of Disease|30
5563035|NCT01164007|19224881|P1|Overall Study|Adverse Event|5
5563036|NCT01163916|19224907|P3|Overall Study|Other|16
5563037|NCT01163916|19224908|P2|Overall Study|Other|4
5563038|NCT01163916|19224909|P1|Overall Study|Other|24
5563039|NCT01163916|19224907|P3|Overall Study|Lack of Efficacy|1
5563040|NCT01163916|19224908|P2|Overall Study|Lack of Efficacy|0
5563041|NCT01163916|19224909|P1|Overall Study|Lack of Efficacy|2
5563042|NCT01163916|19224907|P3|Overall Study|Adverse Event|1
5563043|NCT01163916|19224908|P2|Overall Study|Adverse Event|0
5563044|NCT01163916|19224909|P1|Overall Study|Adverse Event|2
5563045|NCT01163916|19224907|P3|Overall Study|Withdrawal by Subject|2
5563046|NCT01163916|19224908|P2|Overall Study|Withdrawal by Subject|0
5563047|NCT01163916|19224909|P1|Overall Study|Withdrawal by Subject|2
5563048|NCT01163851|19224947|P2|Overall Study|Enrolled but not treated|0
5563049|NCT01163851|19224948|P1|Overall Study|Enrolled but not treated|1
5563050|NCT01163851|19224947|P2|Overall Study|Site Closure|1
5563051|NCT01163851|19224948|P1|Overall Study|Site Closure|0
5563052|NCT01163786|19225026|P1|Completed Follow up (Visit 9 and 10)|Other|1
5563053|NCT01163786|19225026|P1|Treatment With Bortezomib|Adverse Event|2
5563054|NCT01163786|19225026|P1|Treatment With Bortezomib|Withdrawal by Subject|1
5563055|NCT01163747|19225049|P2|Overall Study|Refused Treatment|4
5563056|NCT01163747|19225050|P1|Overall Study|Refused Treatment|6
5563057|NCT01163747|19225049|P2|Overall Study|Protocol Violation|1
5563058|NCT01163747|19225050|P1|Overall Study|Protocol Violation|0
5563059|NCT01163747|19225049|P2|Overall Study|Insufficient Therapeutic Response|1
5563060|NCT01163747|19225050|P1|Overall Study|Insufficient Therapeutic Response|0
5563061|NCT01163747|19225049|P2|Overall Study|Adverse Event|5
5563062|NCT01163747|19225050|P1|Overall Study|Adverse Event|0
5563063|NCT01163721|19225070|P2|Overall Study|Physician Decision|1
5563064|NCT01163721|19225071|P1|Overall Study|Physician Decision|0
5563065|NCT01163721|19225070|P2|Overall Study|Lost to Follow-up|1
5563066|NCT01163721|19225071|P1|Overall Study|Lost to Follow-up|0
5563067|NCT01163721|19225070|P2|Overall Study|Withdrawal by Subject|4
5563068|NCT01163721|19225071|P1|Overall Study|Withdrawal by Subject|3
5563069|NCT01163721|19225070|P2|Overall Study|Adverse Event|6
5563070|NCT01163721|19225071|P1|Overall Study|Adverse Event|5
5563071|NCT01163617|19225121|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5563072|NCT01163617|19225122|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5563073|NCT01163617|19225123|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5563074|NCT01163617|19225124|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5563075|NCT01163617|19225125|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5563076|NCT01163617|19225126|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
5563077|NCT01163617|19225127|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5563078|NCT01163617|19225128|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
5563079|NCT01163617|19225121|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5563080|NCT01163617|19225122|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5563081|NCT01163617|19225123|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5563082|NCT01163617|19225124|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5563083|NCT01163617|19225125|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5563084|NCT01163617|19225126|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5563085|NCT01163617|19225127|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
5563086|NCT01163617|19225128|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
5563087|NCT01163617|19225121|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5563088|NCT01163617|19225122|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5563089|NCT01163617|19225123|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5563090|NCT01163617|19225124|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5563091|NCT01163617|19225125|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5563092|NCT01163617|19225126|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5563093|NCT01163617|19225127|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
5563094|NCT01163617|19225128|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
5563095|NCT01163474|19225157|P1|Overall Study|Lost to Follow-up|3
5563096|NCT01163474|19225157|P1|Overall Study|Tech barriers to videoteleconference vis|12
5563097|NCT01163474|19225157|P1|Overall Study|Withdrawal by Subject|1
5563098|NCT01163318|19225169|P1|Overall Study|Multiple Reasons Per Participant|224
5563099|NCT01163318|19225169|P1|Overall Study|Participants Without Case Report Form|7
5563100|NCT01163318|19225169|P1|Overall Study|History/comorbidity of malignant tumor|3
5563101|NCT01163318|19225169|P1|Overall Study|Did Not Continue Use of Adalimumab|26
5563102|NCT01163318|19225169|P1|Overall Study|Off-Label Use of Adalimumab|8
5563103|NCT01163292|19225178|P2|Overall Study|No further visits|7
5563104|NCT01163292|19225179|P1|Overall Study|No further visits|5
5563105|NCT01163292|19225178|P2|Overall Study|Economic reasons|0
5563106|NCT01163292|19225179|P1|Overall Study|Economic reasons|6
5563107|NCT01163292|19225178|P2|Overall Study|Refusal to receive adalimumab|0
5563108|NCT01163292|19225179|P1|Overall Study|Refusal to receive adalimumab|7
5563109|NCT01163292|19225178|P2|Overall Study|Sufficient response to adalimumab|0
5563110|NCT01163292|19225179|P1|Overall Study|Sufficient response to adalimumab|8
5563111|NCT01163292|19225178|P2|Overall Study|Initiation of biological therapy|15
5563112|NCT01163292|19225179|P1|Overall Study|Initiation of biological therapy|0
5563113|NCT01163292|19225178|P2|Overall Study|Adverse Event|0
5563114|NCT01163292|19225179|P1|Overall Study|Adverse Event|6
5563115|NCT01163292|19225178|P2|Overall Study|Lack of Efficacy|0
5563116|NCT01163292|19225179|P1|Overall Study|Lack of Efficacy|9
5563117|NCT01163279|19225195|P2|Overall Study|Withdrawal by Subject|0
5563118|NCT01163279|19225196|P1|Overall Study|Withdrawal by Subject|2
5563119|NCT01163266|19225225|P3|Overall Study|Other|2
5563120|NCT01163266|19225226|P2|Overall Study|Other|1
5563121|NCT01163266|19225227|P1|Overall Study|Other|1
5563122|NCT01163266|19225225|P3|Overall Study|Lost to Follow-up|10
5563123|NCT01163266|19225226|P2|Overall Study|Lost to Follow-up|7
5563124|NCT01163266|19225227|P1|Overall Study|Lost to Follow-up|7
5563125|NCT01163266|19225225|P3|Overall Study|Withdrawal of Consent|3
5563126|NCT01163266|19225226|P2|Overall Study|Withdrawal of Consent|7
5563127|NCT01163266|19225227|P1|Overall Study|Withdrawal of Consent|5
5563128|NCT01163266|19225225|P3|Overall Study|Protocol Deviations|5
5563129|NCT01163266|19225226|P2|Overall Study|Protocol Deviations|2
5563130|NCT01163266|19225227|P1|Overall Study|Protocol Deviations|2
5563131|NCT01163266|19225225|P3|Overall Study|Noncompliance with Study Drug|0
5563132|NCT01163266|19225226|P2|Overall Study|Noncompliance with Study Drug|2
5563133|NCT01163266|19225227|P1|Overall Study|Noncompliance with Study Drug|0
5563134|NCT01163266|19225225|P3|Overall Study|Lack of Efficacy|1
5563135|NCT01163266|19225226|P2|Overall Study|Lack of Efficacy|3
5563136|NCT01163266|19225227|P1|Overall Study|Lack of Efficacy|1
5563137|NCT01163266|19225225|P3|Overall Study|Pretreatment Event or Adverse Event|7
5563138|NCT01163266|19225226|P2|Overall Study|Pretreatment Event or Adverse Event|9
5563139|NCT01163266|19225227|P1|Overall Study|Pretreatment Event or Adverse Event|2
5563140|NCT01163253|19225252|P2|Overall Study|Other Unspecified|34
5563141|NCT01163253|19225253|P1|Overall Study|Other Unspecified|170
5563142|NCT01163253|19225252|P2|Overall Study|Ongoing|4
5563143|NCT01163253|19225253|P1|Overall Study|Ongoing|13
5563144|NCT01163253|19225252|P2|Overall Study|Death|5
5563145|NCT01163253|19225253|P1|Overall Study|Death|17
5563146|NCT01163253|19225252|P2|Overall Study|Adverse Event|78
5563147|NCT01163253|19225253|P1|Overall Study|Adverse Event|300
5563148|NCT01163253|19225252|P2|Overall Study|Insufficient Clinical Response|29
5563149|NCT01163253|19225253|P1|Overall Study|Insufficient Clinical Response|423
5563150|NCT01163253|19225252|P2|Overall Study|Lost to Follow-up|23
5563151|NCT01163253|19225253|P1|Overall Study|Lost to Follow-up|125
5563152|NCT01163253|19225252|P2|Overall Study|Medication Error|0
5563153|NCT01163253|19225253|P1|Overall Study|Medication Error|1
5563154|NCT01163253|19225252|P2|Overall Study|Withdrawal by Subject|50
5563155|NCT01163253|19225253|P1|Overall Study|Withdrawal by Subject|199
5563156|NCT01163253|19225252|P2|Overall Study|Protocol Violation|12
5563157|NCT01163253|19225253|P1|Overall Study|Protocol Violation|43
5563158|NCT01163253|19225252|P2|Overall Study|Study Terminated by Sponsor|349
5563159|NCT01163253|19225253|P1|Overall Study|Study Terminated by Sponsor|978
5563160|NCT01163253|19225252|P2|Overall Study|Withdrawn Due to Pregnancy|2
5563161|NCT01163253|19225253|P1|Overall Study|Withdrawn Due to Pregnancy|12
5563162|NCT01163149|19225441|P3|Extension Treatment Period|Noncompliance|1
5563163|NCT01163149|19225442|P2|Extension Treatment Period|Noncompliance|0
5563164|NCT01163149|19225443|P1|Extension Treatment Period|Noncompliance|0
5563165|NCT01163149|19225441|P3|Extension Treatment Period|Adverse Event|0
5563166|NCT01163149|19225442|P2|Extension Treatment Period|Adverse Event|1
5563167|NCT01163149|19225443|P1|Extension Treatment Period|Adverse Event|0
5563168|NCT01163149|19225441|P3|Extension Treatment Period|Withdrawal by Subject|1
5563169|NCT01163149|19225442|P2|Extension Treatment Period|Withdrawal by Subject|0
5563170|NCT01163149|19225443|P1|Extension Treatment Period|Withdrawal by Subject|2
5563171|NCT01163032|19225552|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
5563172|NCT01163032|19225553|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
5563173|NCT01163032|19225554|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
5563174|NCT01163032|19225552|P3|Open Label Extension Phase|Study Termination|7
5563175|NCT01163032|19225553|P2|Open Label Extension Phase|Study Termination|0
5563176|NCT01163032|19225554|P1|Open Label Extension Phase|Study Termination|0
5563177|NCT01163032|19225552|P3|Open Label Extension Phase|Protocol Violation|1
5563178|NCT01163032|19225553|P2|Open Label Extension Phase|Protocol Violation|0
5563179|NCT01163032|19225554|P1|Open Label Extension Phase|Protocol Violation|0
5563180|NCT01163032|19225552|P3|Open Label Extension Phase|Withdrawal by Subject|3
5563181|NCT01163032|19225553|P2|Open Label Extension Phase|Withdrawal by Subject|0
5563182|NCT01163032|19225554|P1|Open Label Extension Phase|Withdrawal by Subject|0
5563183|NCT01163032|19225552|P3|Open Label Extension Phase|Adverse Event|3
5563184|NCT01163032|19225553|P2|Open Label Extension Phase|Adverse Event|0
5563185|NCT01163032|19225554|P1|Open Label Extension Phase|Adverse Event|0
5563186|NCT01163032|19225552|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
5563187|NCT01163032|19225553|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
5563188|NCT01163032|19225554|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
5563189|NCT01163032|19225552|P3|Randomization Phase|Various*|0
5563190|NCT01163032|19225553|P2|Randomization Phase|Various*|4
5563191|NCT01163032|19225554|P1|Randomization Phase|Various*|5
5563192|NCT01163032|19225552|P3|Randomization Phase|Protocol Violation|0
5563193|NCT01163032|19225553|P2|Randomization Phase|Protocol Violation|1
5563194|NCT01163032|19225554|P1|Randomization Phase|Protocol Violation|0
5563195|NCT01163032|19225552|P3|Randomization Phase|Adverse Event|0
5563196|NCT01163032|19225553|P2|Randomization Phase|Adverse Event|3
5563197|NCT01163032|19225554|P1|Randomization Phase|Adverse Event|3
5563198|NCT01163032|19225552|P3|Randomization Phase|Withdrawal by Subject|0
5563199|NCT01163032|19225553|P2|Randomization Phase|Withdrawal by Subject|3
5563200|NCT01163032|19225554|P1|Randomization Phase|Withdrawal by Subject|2
5563201|NCT01162863|19225587|P3|Overall Study|Adverse Event|0
5563202|NCT01162863|19225588|P2|Overall Study|Adverse Event|1
5563203|NCT01162863|19225589|P1|Overall Study|Adverse Event|0
5563204|NCT01162863|19225587|P3|Overall Study|Lack of Efficacy|0
5563205|NCT01162863|19225588|P2|Overall Study|Lack of Efficacy|0
5563206|NCT01162863|19225589|P1|Overall Study|Lack of Efficacy|1
5563207|NCT01162499|19225619|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
5563208|NCT01162499|19225620|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
5563209|NCT01162486|19225645|P5|Overall Study|Pregnancy|0
5563210|NCT01162486|19225646|P4|Overall Study|Pregnancy|1
5563211|NCT01162486|19225647|P3|Overall Study|Pregnancy|0
5563212|NCT01162486|19225648|P2|Overall Study|Pregnancy|0
5563213|NCT01162486|19225649|P1|Overall Study|Pregnancy|0
5563214|NCT01162486|19225645|P5|Overall Study|elevated LFTs|0
5563215|NCT01162486|19225646|P4|Overall Study|elevated LFTs|0
5563216|NCT01162486|19225647|P3|Overall Study|elevated LFTs|1
5563217|NCT01162486|19225648|P2|Overall Study|elevated LFTs|0
5563218|NCT01162486|19225649|P1|Overall Study|elevated LFTs|0
5563219|NCT01162486|19225645|P5|Overall Study|vomited Rifampin/ gagged with midazolam|0
5563220|NCT01162486|19225646|P4|Overall Study|vomited Rifampin/ gagged with midazolam|0
5563221|NCT01162486|19225647|P3|Overall Study|vomited Rifampin/ gagged with midazolam|0
5563222|NCT01162486|19225648|P2|Overall Study|vomited Rifampin/ gagged with midazolam|0
5563223|NCT01162486|19225649|P1|Overall Study|vomited Rifampin/ gagged with midazolam|1
5563224|NCT01162486|19225645|P5|Overall Study|low ANC|0
5563225|NCT01162486|19225646|P4|Overall Study|low ANC|0
5563226|NCT01162486|19225647|P3|Overall Study|low ANC|0
5563227|NCT01162486|19225648|P2|Overall Study|low ANC|0
5563228|NCT01162486|19225649|P1|Overall Study|low ANC|1
5563229|NCT01162473|19225682|P2|Overall Study|Withdrawal by Subject|4
5563230|NCT01162473|19225683|P1|Overall Study|Withdrawal by Subject|0
5563231|NCT01162473|19225682|P2|Overall Study|Adverse Event|1
5563232|NCT01162473|19225683|P1|Overall Study|Adverse Event|2
5563233|NCT01162421|19225691|P2|Overall Study|Other|3
5563234|NCT01162421|19225692|P1|Overall Study|Other|2
5563235|NCT01162421|19225691|P2|Overall Study|Lack of Efficacy|2
5563236|NCT01162421|19225692|P1|Overall Study|Lack of Efficacy|2
5563237|NCT01162421|19225691|P2|Overall Study|Lost to Follow-up|2
5563238|NCT01162421|19225692|P1|Overall Study|Lost to Follow-up|0
5563239|NCT01162421|19225691|P2|Overall Study|Adverse Event|5
5563240|NCT01162421|19225692|P1|Overall Study|Adverse Event|2
5563241|NCT01162421|19225691|P2|Overall Study|Did not receive study drug|1
5563242|NCT01162421|19225692|P1|Overall Study|Did not receive study drug|2
5563243|NCT01162343|19225775|P1|Overall Study|Refused psychiatrist assessment|12
5563244|NCT01162343|19225775|P1|Overall Study|Left ED prior to psychiatrist assessment|80
5563245|NCT01162304|19225790|P1|Overall Study|Beck scale to high|11
5563246|NCT01162239|19225808|P4|Extended Follow-up|Lost to Follow-up|6
5563247|NCT01162239|19225809|P3|Extended Follow-up|Lost to Follow-up|8
5563248|NCT01162239|19225810|P2|Extended Follow-up|Lost to Follow-up|13
5563249|NCT01162239|19225811|P1|Extended Follow-up|Lost to Follow-up|8
5563250|NCT01162239|19225808|P4|Treatment Phase|Lost to Follow-up|1
5563251|NCT01162239|19225809|P3|Treatment Phase|Lost to Follow-up|2
5563252|NCT01162239|19225810|P2|Treatment Phase|Lost to Follow-up|4
5563253|NCT01162239|19225811|P1|Treatment Phase|Lost to Follow-up|5
5563254|NCT01162239|19225808|P4|Treatment Phase|Death|1
5563255|NCT01162239|19225809|P3|Treatment Phase|Death|0
5563256|NCT01162239|19225810|P2|Treatment Phase|Death|0
5563257|NCT01162239|19225811|P1|Treatment Phase|Death|0
5563258|NCT01162239|19225808|P4|Treatment Phase|Withdrawal by Subject|3
5563259|NCT01162239|19225809|P3|Treatment Phase|Withdrawal by Subject|2
5563260|NCT01162239|19225810|P2|Treatment Phase|Withdrawal by Subject|3
5563261|NCT01162239|19225811|P1|Treatment Phase|Withdrawal by Subject|1
5563262|NCT01162135|19225841|P1|Overall Study|Ineligible|1
5563263|NCT01162135|19225841|P1|Overall Study|Severe back pain|1
5563264|NCT01162135|19225841|P1|Overall Study|Withdrawal by Subject|1
5563265|NCT01162122|19225847|P2|Overall Study|Missing primary reason|0
5563266|NCT01162122|19225848|P1|Overall Study|Missing primary reason|1
5563267|NCT01162122|19225847|P2|Overall Study|Unable to classify|7
5563268|NCT01162122|19225848|P1|Overall Study|Unable to classify|3
5563269|NCT01162122|19225847|P2|Overall Study|Administrative reason|1
5563270|NCT01162122|19225848|P1|Overall Study|Administrative reason|1
5563271|NCT01162122|19225847|P2|Overall Study|Inappropriate enrollment|4
5563272|NCT01162122|19225848|P1|Overall Study|Inappropriate enrollment|5
5563273|NCT01162122|19225847|P2|Overall Study|Protocol Violation|2
5563274|NCT01162122|19225848|P1|Overall Study|Protocol Violation|2
5563275|NCT01162122|19225847|P2|Overall Study|Death|46
5563276|NCT01162122|19225848|P1|Overall Study|Death|51
5563277|NCT01162122|19225847|P2|Overall Study|Adverse Event|2
5563278|NCT01162122|19225848|P1|Overall Study|Adverse Event|3
5563279|NCT01162122|19225847|P2|Overall Study|Lost to Follow-up|91
5563280|NCT01162122|19225848|P1|Overall Study|Lost to Follow-up|73
5563281|NCT01162122|19225847|P2|Overall Study|Withdrawal by Subject|43
5563282|NCT01162122|19225848|P1|Overall Study|Withdrawal by Subject|52
5563283|NCT01161628|19225954|P1|Overall Study|Lack of Efficacy|2
5563284|NCT01161628|19225954|P1|Overall Study|Death|6
5563285|NCT01161537|19225977|P1|Part B|Withdrawal by Subject|2
5563286|NCT01161524|19225995|P3|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
5563287|NCT01161524|19225996|P2|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
5563288|NCT01161524|19225997|P1|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
5563289|NCT01161524|19225995|P3|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
5563290|NCT01161524|19225996|P2|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
5563291|NCT01161524|19225997|P1|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
5563292|NCT01161524|19225995|P3|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
5563293|NCT01161524|19225996|P2|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
5563294|NCT01161524|19225997|P1|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
5563295|NCT01161524|19225995|P3|Extension Phase (Approximately 83 Weeks)|Other|6
5563296|NCT01161524|19225996|P2|Extension Phase (Approximately 83 Weeks)|Other|0
5563297|NCT01161524|19225997|P1|Extension Phase (Approximately 83 Weeks)|Other|0
5563298|NCT01161524|19225995|P3|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
5563299|NCT01161524|19225996|P2|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
5563300|NCT01161524|19225997|P1|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
5563301|NCT01161524|19225995|P3|Core Study (23 Weeks)|Subject Choice|0
5563302|NCT01161524|19225996|P2|Core Study (23 Weeks)|Subject Choice|2
5563303|NCT01161524|19225997|P1|Core Study (23 Weeks)|Subject Choice|3
5563304|NCT01161524|19225995|P3|Core Study (23 Weeks)|Lost to Follow-up|0
5563305|NCT01161524|19225996|P2|Core Study (23 Weeks)|Lost to Follow-up|2
5563306|NCT01161524|19225997|P1|Core Study (23 Weeks)|Lost to Follow-up|1
5563307|NCT01161524|19225995|P3|Core Study (23 Weeks)|Withdrawal of Consent|0
5563308|NCT01161524|19225996|P2|Core Study (23 Weeks)|Withdrawal of Consent|1
5563309|NCT01161524|19225997|P1|Core Study (23 Weeks)|Withdrawal of Consent|1
5563310|NCT01161524|19225995|P3|Core Study (23 Weeks)|Other|0
5563311|NCT01161524|19225996|P2|Core Study (23 Weeks)|Other|0
5563312|NCT01161524|19225997|P1|Core Study (23 Weeks)|Other|1
5563313|NCT01161524|19225995|P3|Core Study (23 Weeks)|Adverse Event|0
5563314|NCT01161524|19225996|P2|Core Study (23 Weeks)|Adverse Event|0
5563315|NCT01161524|19225997|P1|Core Study (23 Weeks)|Adverse Event|3
5563316|NCT01161498|19226036|P2|Overall Study|Disease Progression|1
5563317|NCT01161498|19226037|P1|Overall Study|Disease Progression|0
5563318|NCT01161472|19226061|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
5563319|NCT01161472|19226062|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
5563320|NCT01161472|19226063|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
5563321|NCT01161472|19226064|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
5563322|NCT01161446|19226120|P2|Overall Study|Withdrawal by Subject|1
5563323|NCT01161446|19226121|P1|Overall Study|Withdrawal by Subject|0
5563324|NCT01161446|19226120|P2|Overall Study|Lost to Follow-up|14
5563325|NCT01161446|19226121|P1|Overall Study|Lost to Follow-up|18
5563326|NCT01161407|19226147|P2|Overall Study|Protocol Violation|1
5563327|NCT01161407|19226148|P1|Overall Study|Protocol Violation|3
5563328|NCT01161173|19226203|P1|Overall Study|Reasons Not Specified|23
5563329|NCT01161173|19226203|P1|Overall Study|End of Study|2
5563330|NCT01161173|19226203|P1|Overall Study|Death|194
5563331|NCT01161173|19226203|P1|Overall Study|Unacceptable Toxicity|21
5563332|NCT01161173|19226203|P1|Overall Study|Withdrawal of Consent|5
5563333|NCT01161173|19226203|P1|Overall Study|Progressive Disease|82
5563334|NCT01161173|19226203|P1|Overall Study|Lost to Follow-up|7
5563335|NCT01161173|19226203|P1|Overall Study|Protocol Violation|13
5563336|NCT01161043|19226298|P1|Overall Study|Withdrawal by Subject|3
5563337|NCT01160822|19226335|P7|Overall Study|Protocol deviation|0
5563338|NCT01160822|19226336|P6|Overall Study|Protocol deviation|0
5563339|NCT01160822|19226337|P5|Overall Study|Protocol deviation|2
5563340|NCT01160822|19226338|P4|Overall Study|Protocol deviation|0
5563341|NCT01160822|19226339|P3|Overall Study|Protocol deviation|0
5563342|NCT01160822|19226340|P2|Overall Study|Protocol deviation|0
5563343|NCT01160822|19226341|P1|Overall Study|Protocol deviation|0
5563344|NCT01160822|19226335|P7|Overall Study|Administrative problems|0
5563345|NCT01160822|19226336|P6|Overall Study|Administrative problems|0
5563346|NCT01160822|19226337|P5|Overall Study|Administrative problems|1
5563347|NCT01160822|19226338|P4|Overall Study|Administrative problems|0
5563348|NCT01160822|19226339|P3|Overall Study|Administrative problems|0
5563349|NCT01160822|19226340|P2|Overall Study|Administrative problems|0
5563350|NCT01160822|19226341|P1|Overall Study|Administrative problems|0
5563351|NCT01160822|19226335|P7|Overall Study|Lost to Follow-up|0
5563352|NCT01160822|19226336|P6|Overall Study|Lost to Follow-up|0
5563353|NCT01160822|19226337|P5|Overall Study|Lost to Follow-up|1
5563354|NCT01160822|19226338|P4|Overall Study|Lost to Follow-up|0
5563355|NCT01160822|19226339|P3|Overall Study|Lost to Follow-up|0
5563356|NCT01160822|19226340|P2|Overall Study|Lost to Follow-up|0
5563357|NCT01160822|19226341|P1|Overall Study|Lost to Follow-up|0
5563358|NCT01160822|19226335|P7|Overall Study|Withdrawal by Subject|1
5563359|NCT01160822|19226336|P6|Overall Study|Withdrawal by Subject|0
5563360|NCT01160822|19226337|P5|Overall Study|Withdrawal by Subject|0
5563361|NCT01160822|19226338|P4|Overall Study|Withdrawal by Subject|0
5563362|NCT01160822|19226339|P3|Overall Study|Withdrawal by Subject|0
5563363|NCT01160822|19226340|P2|Overall Study|Withdrawal by Subject|0
5563364|NCT01160822|19226341|P1|Overall Study|Withdrawal by Subject|0
5563365|NCT01160822|19226335|P7|Overall Study|Unsatisfactory therapeutic effect|3
5563366|NCT01160822|19226336|P6|Overall Study|Unsatisfactory therapeutic effect|5
5563367|NCT01160822|19226337|P5|Overall Study|Unsatisfactory therapeutic effect|4
5563368|NCT01160822|19226338|P4|Overall Study|Unsatisfactory therapeutic effect|0
5563369|NCT01160822|19226339|P3|Overall Study|Unsatisfactory therapeutic effect|0
5563370|NCT01160822|19226340|P2|Overall Study|Unsatisfactory therapeutic effect|0
5563371|NCT01160822|19226341|P1|Overall Study|Unsatisfactory therapeutic effect|0
5563372|NCT01160822|19226335|P7|Overall Study|Adverse Event|5
5563373|NCT01160822|19226336|P6|Overall Study|Adverse Event|2
5563374|NCT01160822|19226337|P5|Overall Study|Adverse Event|1
5563375|NCT01160822|19226338|P4|Overall Study|Adverse Event|0
5563376|NCT01160822|19226339|P3|Overall Study|Adverse Event|0
5563377|NCT01160822|19226340|P2|Overall Study|Adverse Event|0
5563378|NCT01160822|19226341|P1|Overall Study|Adverse Event|0
5563379|NCT01160770|19226430|P1|Overall Study|Other Reasons|1
5563380|NCT01160770|19226430|P1|Overall Study|Lack of Efficacy|15
5563381|NCT01160770|19226430|P1|Overall Study|Death|9
5563382|NCT01160770|19226430|P1|Overall Study|Study termination or sponsor request|1
5563383|NCT01160770|19226430|P1|Overall Study|Lost to Follow-up|7
5563384|NCT01160770|19226430|P1|Overall Study|Physician Decision|1
5563385|NCT01160770|19226430|P1|Overall Study|Subject/parent/caregiver request|33
5563386|NCT01160770|19226430|P1|Overall Study|Protocol Violation|2
5563387|NCT01160770|19226430|P1|Overall Study|Adverse Event|10
5563388|NCT01160744|19226443|P4|Overall Study|Not meet inclusion/exclusion criteria|0
5563389|NCT01160744|19226444|P3|Overall Study|Not meet inclusion/exclusion criteria|1
5563390|NCT01160744|19226445|P2|Overall Study|Not meet inclusion/exclusion criteria|0
5563391|NCT01160744|19226446|P1|Overall Study|Not meet inclusion/exclusion criteria|0
5563392|NCT01160744|19226443|P4|Overall Study|Withdrawal by Subject|4
5563393|NCT01160744|19226444|P3|Overall Study|Withdrawal by Subject|6
5563394|NCT01160744|19226445|P2|Overall Study|Withdrawal by Subject|5
5563395|NCT01160744|19226446|P1|Overall Study|Withdrawal by Subject|11
5563396|NCT01160640|19226482|P2|Overall Study|Withdrawal by Subject|3
5563397|NCT01160640|19226483|P1|Overall Study|Withdrawal by Subject|0
5563398|NCT01160640|19226482|P2|Overall Study|Incarceration|0
5563399|NCT01160640|19226483|P1|Overall Study|Incarceration|1
5563400|NCT01160640|19226482|P2|Overall Study|Physician Decision|3
5563401|NCT01160640|19226483|P1|Overall Study|Physician Decision|3
5563402|NCT01160614|19226499|P2|Overall Study|Withdrawal by Subject|2
5563403|NCT01160614|19226500|P1|Overall Study|Withdrawal by Subject|0
5563404|NCT01160484|19226548|P1|Overall Study|inclusion/exclusion criteria failure|1
5563405|NCT01160484|19226548|P1|Overall Study|Withdrawal by Subject|2
5563406|NCT01160484|19226548|P1|Overall Study|Adverse Event|6
5563407|NCT01160484|19226548|P1|Overall Study|Lack of Efficacy|9
5563408|NCT01160354|19226601|P3|Overall Study|Death|1
5563409|NCT01160354|19226602|P2|Overall Study|Death|1
5563410|NCT01160354|19226603|P1|Overall Study|Death|0
5563411|NCT01160289|19226622|P6|Post-Randomization Period|Sponsor Decision|0
5563412|NCT01160289|19226623|P5|Post-Randomization Period|Sponsor Decision|0
5563413|NCT01160289|19226624|P4|Post-Randomization Period|Sponsor Decision|0
5563414|NCT01160289|19226625|P3|Post-Randomization Period|Sponsor Decision|0
5563415|NCT01160289|19226626|P2|Post-Randomization Period|Sponsor Decision|1
5563416|NCT01160289|19226627|P1|Post-Randomization Period|Sponsor Decision|0
5563417|NCT01160289|19226622|P6|Post-Randomization Period|Entry Criteria Not Met|0
5563418|NCT01160289|19226623|P5|Post-Randomization Period|Entry Criteria Not Met|0
5563419|NCT01160289|19226624|P4|Post-Randomization Period|Entry Criteria Not Met|2
5563420|NCT01160289|19226625|P3|Post-Randomization Period|Entry Criteria Not Met|2
5563421|NCT01160289|19226626|P2|Post-Randomization Period|Entry Criteria Not Met|2
5563422|NCT01160289|19226627|P1|Post-Randomization Period|Entry Criteria Not Met|0
5563423|NCT01160289|19226622|P6|Post-Randomization Period|Withdrawal by Subject|7
5563424|NCT01160289|19226623|P5|Post-Randomization Period|Withdrawal by Subject|5
5563425|NCT01160289|19226624|P4|Post-Randomization Period|Withdrawal by Subject|8
5563426|NCT01160289|19226625|P3|Post-Randomization Period|Withdrawal by Subject|13
5563427|NCT01160289|19226626|P2|Post-Randomization Period|Withdrawal by Subject|5
5563428|NCT01160289|19226627|P1|Post-Randomization Period|Withdrawal by Subject|0
5563429|NCT01160289|19226622|P6|Post-Randomization Period|Protocol Violation|3
5563430|NCT01160289|19226623|P5|Post-Randomization Period|Protocol Violation|1
5563431|NCT01160289|19226624|P4|Post-Randomization Period|Protocol Violation|0
5563432|NCT01160289|19226625|P3|Post-Randomization Period|Protocol Violation|2
5563433|NCT01160289|19226626|P2|Post-Randomization Period|Protocol Violation|4
5563434|NCT01160289|19226627|P1|Post-Randomization Period|Protocol Violation|0
5563435|NCT01160289|19226622|P6|Post-Randomization Period|Physician Decision|0
5563436|NCT01160289|19226623|P5|Post-Randomization Period|Physician Decision|0
5563437|NCT01160289|19226624|P4|Post-Randomization Period|Physician Decision|0
5563438|NCT01160289|19226625|P3|Post-Randomization Period|Physician Decision|1
5563439|NCT01160289|19226626|P2|Post-Randomization Period|Physician Decision|0
5563440|NCT01160289|19226627|P1|Post-Randomization Period|Physician Decision|0
5563441|NCT01160289|19226622|P6|Post-Randomization Period|Lost to Follow-up|4
5563442|NCT01160289|19226623|P5|Post-Randomization Period|Lost to Follow-up|3
5563443|NCT01160289|19226624|P4|Post-Randomization Period|Lost to Follow-up|5
5563444|NCT01160289|19226625|P3|Post-Randomization Period|Lost to Follow-up|2
5563445|NCT01160289|19226626|P2|Post-Randomization Period|Lost to Follow-up|3
5563446|NCT01160289|19226627|P1|Post-Randomization Period|Lost to Follow-up|0
5563447|NCT01160289|19226622|P6|Post-Randomization Period|Lack of Efficacy|0
5563448|NCT01160289|19226623|P5|Post-Randomization Period|Lack of Efficacy|0
5563449|NCT01160289|19226624|P4|Post-Randomization Period|Lack of Efficacy|3
5563450|NCT01160289|19226625|P3|Post-Randomization Period|Lack of Efficacy|0
5563451|NCT01160289|19226626|P2|Post-Randomization Period|Lack of Efficacy|1
5563452|NCT01160289|19226627|P1|Post-Randomization Period|Lack of Efficacy|0
5563453|NCT01160289|19226622|P6|Post-Randomization Period|Death|0
5563454|NCT01160289|19226623|P5|Post-Randomization Period|Death|0
5563455|NCT01160289|19226624|P4|Post-Randomization Period|Death|1
5563456|NCT01160289|19226625|P3|Post-Randomization Period|Death|0
5563457|NCT01160289|19226626|P2|Post-Randomization Period|Death|0
5563458|NCT01160289|19226627|P1|Post-Randomization Period|Death|0
5563459|NCT01160289|19226622|P6|Post-Randomization Period|Adverse Event|0
5563460|NCT01160289|19226623|P5|Post-Randomization Period|Adverse Event|0
5563461|NCT01160289|19226624|P4|Post-Randomization Period|Adverse Event|2
5563462|NCT01160289|19226625|P3|Post-Randomization Period|Adverse Event|4
5563463|NCT01160289|19226626|P2|Post-Randomization Period|Adverse Event|4
5563464|NCT01160289|19226627|P1|Post-Randomization Period|Adverse Event|0
5563465|NCT01160289|19226622|P6|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5563466|NCT01160289|19226623|P5|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5563467|NCT01160289|19226624|P4|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5563468|NCT01160289|19226625|P3|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5563469|NCT01160289|19226626|P2|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
5563470|NCT01160289|19226627|P1|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
5563471|NCT01160289|19226622|P6|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5563472|NCT01160289|19226623|P5|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5563473|NCT01160289|19226624|P4|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5563474|NCT01160289|19226625|P3|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5563475|NCT01160289|19226626|P2|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
5563476|NCT01160289|19226627|P1|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
5563477|NCT01160289|19226622|P6|Screening, Washout, and Lead-In Period|Protocol Violation|0
5563478|NCT01160289|19226623|P5|Screening, Washout, and Lead-In Period|Protocol Violation|0
5563479|NCT01160289|19226624|P4|Screening, Washout, and Lead-In Period|Protocol Violation|0
5563480|NCT01160289|19226625|P3|Screening, Washout, and Lead-In Period|Protocol Violation|0
5563481|NCT01160289|19226626|P2|Screening, Washout, and Lead-In Period|Protocol Violation|0
5563482|NCT01160289|19226627|P1|Screening, Washout, and Lead-In Period|Protocol Violation|1
5563483|NCT01160289|19226622|P6|Screening, Washout, and Lead-In Period|Physician Decision|0
5563484|NCT01160289|19226623|P5|Screening, Washout, and Lead-In Period|Physician Decision|0
5563485|NCT01160289|19226624|P4|Screening, Washout, and Lead-In Period|Physician Decision|0
5563486|NCT01160289|19226625|P3|Screening, Washout, and Lead-In Period|Physician Decision|0
5563487|NCT01160289|19226626|P2|Screening, Washout, and Lead-In Period|Physician Decision|0
5563488|NCT01160289|19226627|P1|Screening, Washout, and Lead-In Period|Physician Decision|26
5563489|NCT01160289|19226622|P6|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5563490|NCT01160289|19226623|P5|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5563491|NCT01160289|19226624|P4|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5563492|NCT01160289|19226625|P3|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5563493|NCT01160289|19226626|P2|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
5563494|NCT01160289|19226627|P1|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
5563495|NCT01160289|19226622|P6|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5563496|NCT01160289|19226623|P5|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5563497|NCT01160289|19226624|P4|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5563498|NCT01160289|19226625|P3|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5563499|NCT01160289|19226626|P2|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
5563500|NCT01160289|19226627|P1|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
5563501|NCT01160289|19226622|P6|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5563502|NCT01160289|19226623|P5|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5563503|NCT01160289|19226624|P4|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5563504|NCT01160289|19226625|P3|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5563505|NCT01160289|19226626|P2|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
5563506|NCT01160289|19226627|P1|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
5563507|NCT01160289|19226622|P6|Screening, Washout, and Lead-In Period|Adverse Event|0
5563508|NCT01160289|19226623|P5|Screening, Washout, and Lead-In Period|Adverse Event|0
5563509|NCT01160289|19226624|P4|Screening, Washout, and Lead-In Period|Adverse Event|0
5563510|NCT01160289|19226625|P3|Screening, Washout, and Lead-In Period|Adverse Event|0
5563511|NCT01160289|19226626|P2|Screening, Washout, and Lead-In Period|Adverse Event|0
5563512|NCT01160289|19226627|P1|Screening, Washout, and Lead-In Period|Adverse Event|8
5563513|NCT01160211|19226716|P3|Overall Study|Lost to Follow-up|5
5563514|NCT01160211|19226717|P2|Overall Study|Lost to Follow-up|7
5563515|NCT01160211|19226718|P1|Overall Study|Lost to Follow-up|4
5563516|NCT01160211|19226716|P3|Overall Study|Physician Decision|0
5563517|NCT01160211|19226717|P2|Overall Study|Physician Decision|0
5563518|NCT01160211|19226718|P1|Overall Study|Physician Decision|2
5563519|NCT01160211|19226716|P3|Overall Study|Withdrawal by Subject|3
5563520|NCT01160211|19226717|P2|Overall Study|Withdrawal by Subject|5
5563521|NCT01160211|19226718|P1|Overall Study|Withdrawal by Subject|3
5563522|NCT01160211|19226716|P3|Overall Study|ongoing|79
5563523|NCT01160211|19226717|P2|Overall Study|ongoing|75
5563524|NCT01160211|19226718|P1|Overall Study|ongoing|90
5563525|NCT01160198|19226751|P3|Overall Study|Participant lost drug; withdrew consent|1
5563526|NCT01160198|19226752|P2|Overall Study|Participant lost drug; withdrew consent|0
5563527|NCT01160198|19226753|P1|Overall Study|Participant lost drug; withdrew consent|0
5563528|NCT01160198|19226751|P3|Overall Study|Lost to Follow-up|0
5563529|NCT01160198|19226752|P2|Overall Study|Lost to Follow-up|1
5563530|NCT01160198|19226753|P1|Overall Study|Lost to Follow-up|0
5563531|NCT01160198|19226751|P3|Overall Study|Adverse Event|0
5563532|NCT01160198|19226752|P2|Overall Study|Adverse Event|1
5563533|NCT01160198|19226753|P1|Overall Study|Adverse Event|0
5563534|NCT01160198|19226751|P3|Overall Study|Withdrawal by Subject|0
5563535|NCT01160198|19226752|P2|Overall Study|Withdrawal by Subject|1
5563536|NCT01160198|19226753|P1|Overall Study|Withdrawal by Subject|2
5563537|NCT01159938|19226775|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
5563538|NCT01159938|19226776|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
5563539|NCT01159938|19226777|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
5563540|NCT01159938|19226778|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
5563541|NCT01159938|19226779|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
5563542|NCT01159912|19226842|P3|Overall Study|Withdrawal by Subject|3
5563543|NCT01159912|19226843|P2|Overall Study|Withdrawal by Subject|3
5563544|NCT01159912|19226844|P1|Overall Study|Withdrawal by Subject|10
5563545|NCT01159912|19226842|P3|Overall Study|Physician Decision|3
5563546|NCT01159912|19226843|P2|Overall Study|Physician Decision|0
5563547|NCT01159912|19226844|P1|Overall Study|Physician Decision|0
5563548|NCT01159912|19226842|P3|Overall Study|Lost to Follow-up|0
5563549|NCT01159912|19226843|P2|Overall Study|Lost to Follow-up|0
5563550|NCT01159912|19226844|P1|Overall Study|Lost to Follow-up|4
5563551|NCT01159912|19226842|P3|Overall Study|Protocol Violation|3
5563552|NCT01159912|19226843|P2|Overall Study|Protocol Violation|2
5563553|NCT01159912|19226844|P1|Overall Study|Protocol Violation|1
5563554|NCT01159912|19226842|P3|Overall Study|Lack of Efficacy|14
5563555|NCT01159912|19226843|P2|Overall Study|Lack of Efficacy|15
5563556|NCT01159912|19226844|P1|Overall Study|Lack of Efficacy|23
5563557|NCT01159912|19226842|P3|Overall Study|Adverse Event|3
5563558|NCT01159912|19226843|P2|Overall Study|Adverse Event|2
5563559|NCT01159912|19226844|P1|Overall Study|Adverse Event|2
5563560|NCT01159769|19226867|P1|Overall Study|Adverse Event|1
5563561|NCT01159691|19226887|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
5563562|NCT01159691|19226887|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
5563563|NCT01159691|19226887|P1|Overall Study|Disc. Neupro other & unknown reasons|7
5563564|NCT01159691|19226887|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
5563565|NCT01159691|19226887|P1|Overall Study|Discontinued Neupro due to other reasons|1
5563566|NCT01159691|19226887|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
5563567|NCT01159691|19226887|P1|Overall Study|Unknown reasons|1
5563568|NCT01159691|19226887|P1|Overall Study|Lost to Follow-up|2
5563569|NCT01159665|19226900|P6|Overall Study|Withdrawal by Subject|0
5563570|NCT01159665|19226901|P5|Overall Study|Withdrawal by Subject|0
5563571|NCT01159665|19226902|P4|Overall Study|Withdrawal by Subject|0
5563572|NCT01159665|19226903|P3|Overall Study|Withdrawal by Subject|0
5563573|NCT01159665|19226904|P2|Overall Study|Withdrawal by Subject|1
5563574|NCT01159665|19226905|P1|Overall Study|Withdrawal by Subject|0
5563575|NCT01159600|19226933|P8|Overall Study|Other reason not defined above|3
5563576|NCT01159600|19226934|P7|Overall Study|Other reason not defined above|3
5563577|NCT01159600|19226935|P6|Overall Study|Other reason not defined above|7
5563578|NCT01159600|19226936|P5|Overall Study|Other reason not defined above|5
5563579|NCT01159600|19226937|P4|Overall Study|Other reason not defined above|2
5563580|NCT01159600|19226938|P3|Overall Study|Other reason not defined above|4
5563581|NCT01159600|19226939|P2|Overall Study|Other reason not defined above|0
5563582|NCT01159600|19226940|P1|Overall Study|Other reason not defined above|3
5563583|NCT01159600|19226933|P8|Overall Study|Patient refusal to continue,not due toAE|5
5563584|NCT01159600|19226934|P7|Overall Study|Patient refusal to continue,not due toAE|2
5563585|NCT01159600|19226935|P6|Overall Study|Patient refusal to continue,not due toAE|4
5563586|NCT01159600|19226936|P5|Overall Study|Patient refusal to continue,not due toAE|4
5563587|NCT01159600|19226937|P4|Overall Study|Patient refusal to continue,not due toAE|5
5563588|NCT01159600|19226938|P3|Overall Study|Patient refusal to continue,not due toAE|4
5563589|NCT01159600|19226939|P2|Overall Study|Patient refusal to continue,not due toAE|2
5563590|NCT01159600|19226940|P1|Overall Study|Patient refusal to continue,not due toAE|7
5563591|NCT01159600|19226933|P8|Overall Study|Lost to Follow-up|2
5563592|NCT01159600|19226934|P7|Overall Study|Lost to Follow-up|3
5563593|NCT01159600|19226935|P6|Overall Study|Lost to Follow-up|0
5563594|NCT01159600|19226936|P5|Overall Study|Lost to Follow-up|3
5563595|NCT01159600|19226937|P4|Overall Study|Lost to Follow-up|3
5563596|NCT01159600|19226938|P3|Overall Study|Lost to Follow-up|4
5563597|NCT01159600|19226939|P2|Overall Study|Lost to Follow-up|3
5563598|NCT01159600|19226940|P1|Overall Study|Lost to Follow-up|2
5563599|NCT01159600|19226933|P8|Overall Study|Non compliant with protocol|0
5563600|NCT01159600|19226934|P7|Overall Study|Non compliant with protocol|2
5563601|NCT01159600|19226935|P6|Overall Study|Non compliant with protocol|0
5563602|NCT01159600|19226936|P5|Overall Study|Non compliant with protocol|2
5563603|NCT01159600|19226937|P4|Overall Study|Non compliant with protocol|0
5563604|NCT01159600|19226938|P3|Overall Study|Non compliant with protocol|0
5563605|NCT01159600|19226939|P2|Overall Study|Non compliant with protocol|1
5563606|NCT01159600|19226940|P1|Overall Study|Non compliant with protocol|2
5563607|NCT01159600|19226933|P8|Overall Study|Lack of Efficacy|1
5563608|NCT01159600|19226934|P7|Overall Study|Lack of Efficacy|0
5563609|NCT01159600|19226935|P6|Overall Study|Lack of Efficacy|0
5563610|NCT01159600|19226936|P5|Overall Study|Lack of Efficacy|2
5563611|NCT01159600|19226937|P4|Overall Study|Lack of Efficacy|0
5563612|NCT01159600|19226938|P3|Overall Study|Lack of Efficacy|0
5563613|NCT01159600|19226939|P2|Overall Study|Lack of Efficacy|0
5563614|NCT01159600|19226940|P1|Overall Study|Lack of Efficacy|0
5563615|NCT01159600|19226933|P8|Overall Study|Adverse Event|5
5563616|NCT01159600|19226934|P7|Overall Study|Adverse Event|7
5563617|NCT01159600|19226935|P6|Overall Study|Adverse Event|6
5563618|NCT01159600|19226936|P5|Overall Study|Adverse Event|8
5563619|NCT01159600|19226937|P4|Overall Study|Adverse Event|1
5563620|NCT01159600|19226938|P3|Overall Study|Adverse Event|5
5563621|NCT01159600|19226939|P2|Overall Study|Adverse Event|2
5563622|NCT01159600|19226940|P1|Overall Study|Adverse Event|7
5563623|NCT01159600|19226933|P8|Overall Study|Not treated|2
5563624|NCT01159600|19226934|P7|Overall Study|Not treated|2
5563625|NCT01159600|19226935|P6|Overall Study|Not treated|1
5563626|NCT01159600|19226936|P5|Overall Study|Not treated|0
5563627|NCT01159600|19226937|P4|Overall Study|Not treated|0
5563628|NCT01159600|19226938|P3|Overall Study|Not treated|1
5563629|NCT01159600|19226939|P2|Overall Study|Not treated|0
5563630|NCT01159600|19226940|P1|Overall Study|Not treated|0
5563631|NCT01159574|19226982|P1|Follow Up Phase|still being followed for overall surviva|18
5563632|NCT01159574|19226982|P1|Follow Up Phase|Lost to Follow-up|2
5563633|NCT01159574|19226982|P1|Treatment Phase|still on treatment|2
5563634|NCT01159574|19226982|P1|Treatment Phase|Withdrawal by Subject|7
5563635|NCT01159574|19226982|P1|Treatment Phase|Physician Decision|2
5563636|NCT01159574|19226982|P1|Treatment Phase|Death|6
5563637|NCT01159574|19226982|P1|Treatment Phase|Adverse Event|3
5563638|NCT01159574|19226982|P1|Treatment Phase|non-evaluable/not included in analysis|1
5563639|NCT01159431|19227003|P2|Overall Study|Lack of Efficacy|3
5563640|NCT01159431|19227004|P1|Overall Study|Lack of Efficacy|0
5563641|NCT01159431|19227003|P2|Overall Study|non-compliance|1
5563642|NCT01159431|19227004|P1|Overall Study|non-compliance|1
5563643|NCT01159431|19227003|P2|Overall Study|Adverse Event|2
5563644|NCT01159431|19227004|P1|Overall Study|Adverse Event|1
5563645|NCT01159171|19227057|P1|Overall Study|Death|1
5563646|NCT01159171|19227057|P1|Overall Study|Medical Decision|4
5563647|NCT01159171|19227057|P1|Overall Study|Need for Surgery|5
5563648|NCT01159171|19227057|P1|Overall Study|Protocol Violation|1
5563649|NCT01159171|19227057|P1|Overall Study|Progression of Disease|28
5563650|NCT01159171|19227057|P1|Overall Study|Adverse Event|11
5563651|NCT01158950|19227145|P2|1st Intervention (1 Day)|Physician Decision|2
5563652|NCT01158950|19227146|P1|1st Intervention (1 Day)|Physician Decision|1
5563653|NCT01158924|19227154|P2|Overall Study|Lost to Follow-up|1
5563654|NCT01158924|19227155|P1|Overall Study|Lost to Follow-up|0
5563655|NCT01158924|19227154|P2|Overall Study|Withdrawal by Subject|2
5563656|NCT01158924|19227155|P1|Overall Study|Withdrawal by Subject|1
5563657|NCT01158534|19227260|P1|Overall Study|Other|1
5563658|NCT01158534|19227260|P1|Overall Study|Death|1
5563659|NCT01158534|19227260|P1|Overall Study|Withdrawal by Subject|1
5563660|NCT01158404|19227285|P8|Overall Study|Progressive Disease|0
5563661|NCT01158404|19227286|P7|Overall Study|Progressive Disease|1
5563662|NCT01158404|19227287|P6|Overall Study|Progressive Disease|0
5563663|NCT01158404|19227288|P5|Overall Study|Progressive Disease|0
5563664|NCT01158404|19227289|P4|Overall Study|Progressive Disease|0
5563665|NCT01158404|19227290|P3|Overall Study|Progressive Disease|0
5563666|NCT01158404|19227291|P2|Overall Study|Progressive Disease|0
5563667|NCT01158404|19227292|P1|Overall Study|Progressive Disease|0
5563668|NCT01158404|19227285|P8|Overall Study|Physician Decision|1
5563669|NCT01158404|19227286|P7|Overall Study|Physician Decision|0
5563670|NCT01158404|19227287|P6|Overall Study|Physician Decision|0
5563671|NCT01158404|19227288|P5|Overall Study|Physician Decision|0
5563672|NCT01158404|19227289|P4|Overall Study|Physician Decision|0
5563673|NCT01158404|19227290|P3|Overall Study|Physician Decision|0
5563674|NCT01158404|19227291|P2|Overall Study|Physician Decision|0
5563675|NCT01158404|19227292|P1|Overall Study|Physician Decision|0
5563676|NCT01158404|19227285|P8|Overall Study|Withdrawal by Subject|1
5563677|NCT01158404|19227286|P7|Overall Study|Withdrawal by Subject|0
5563678|NCT01158404|19227287|P6|Overall Study|Withdrawal by Subject|1
5563679|NCT01158404|19227288|P5|Overall Study|Withdrawal by Subject|3
5563680|NCT01158404|19227289|P4|Overall Study|Withdrawal by Subject|0
5563681|NCT01158404|19227290|P3|Overall Study|Withdrawal by Subject|0
5563682|NCT01158404|19227291|P2|Overall Study|Withdrawal by Subject|1
5563683|NCT01158404|19227292|P1|Overall Study|Withdrawal by Subject|0
5563684|NCT01158378|19227334|P2|Overall Study|Withdrawal by Subject|0
5563685|NCT01158378|19227335|P1|Overall Study|Withdrawal by Subject|4
5563686|NCT01158378|19227334|P2|Overall Study|Lost to Follow-up|4
5563687|NCT01158378|19227335|P1|Overall Study|Lost to Follow-up|2
5563688|NCT01158378|19227334|P2|Overall Study|Death|5
5563689|NCT01158378|19227335|P1|Overall Study|Death|4
5563690|NCT01158261|19227347|P1|Overall Study|Withdrawal by Subject|1
5563691|NCT01158261|19227347|P1|Overall Study|Death|7
5563692|NCT01158261|19227347|P1|Overall Study|Lost to Follow-up|9
5563693|NCT01158222|19227351|P1|Overall Study|Not eligible for intermediate phase|17
5563694|NCT01158118|19227363|P2|Overall Study|Death|1
5563695|NCT01158118|19227364|P1|Overall Study|Death|0
5563696|NCT01158118|19227363|P2|Overall Study|Suffered stroke prior to transplant|1
5563697|NCT01158118|19227364|P1|Overall Study|Suffered stroke prior to transplant|0
5563698|NCT01158118|19227363|P2|Overall Study|Donor match was a screen failure|1
5563699|NCT01158118|19227364|P1|Overall Study|Donor match was a screen failure|0
5563700|NCT01158118|19227363|P2|Overall Study|Screen failure|0
5563701|NCT01158118|19227364|P1|Overall Study|Screen failure|1
5563702|NCT01157897|19227384|P4|Overall Study|Relocated|0
5563703|NCT01157897|19227385|P3|Overall Study|Relocated|0
5563704|NCT01157897|19227386|P2|Overall Study|Relocated|2
5563705|NCT01157897|19227387|P1|Overall Study|Relocated|0
5563706|NCT01157897|19227384|P4|Overall Study|Lost to Follow-up|1
5563707|NCT01157897|19227385|P3|Overall Study|Lost to Follow-up|0
5563708|NCT01157897|19227386|P2|Overall Study|Lost to Follow-up|0
5563709|NCT01157897|19227387|P1|Overall Study|Lost to Follow-up|2
5563710|NCT01157845|19227412|P1|Overall Study|Device malfunction|1
5563711|NCT01157845|19227412|P1|Overall Study|Study was ended|1
5563712|NCT01157845|19227412|P1|Overall Study|Protocol Violation|13
5563713|NCT01157845|19227412|P1|Overall Study|Physician Decision|3
5563714|NCT01157845|19227412|P1|Overall Study|Withdrawal by Subject|12
5563715|NCT01157845|19227412|P1|Overall Study|Lost to Follow-up|5
5563716|NCT01157676|19227419|P2|Surgery|underwent robotic cystectomy|0
5563717|NCT01157676|19227420|P1|Surgery|underwent robotic cystectomy|1
5563718|NCT01157676|19227419|P2|Surgery|converted to open procedure|5
5563719|NCT01157676|19227420|P1|Surgery|converted to open procedure|0
5563720|NCT01157676|19227419|P2|Surgery|underwent open cystectomy|4
5563721|NCT01157676|19227420|P1|Surgery|underwent open cystectomy|0
5563722|NCT01157676|19227419|P2|Randomization|Physician Decision|0
5563723|NCT01157676|19227420|P1|Randomization|Physician Decision|1
5563724|NCT01157676|19227419|P2|Randomization|Withdrawal by Subject|13
5563725|NCT01157676|19227420|P1|Randomization|Withdrawal by Subject|17
5563726|NCT01157676|19227419|P2|Randomization|unresectable|3
5563727|NCT01157676|19227420|P1|Randomization|unresectable|2
5563728|NCT01157676|19227419|P2|Randomization|Death|1
5563729|NCT01157676|19227420|P1|Randomization|Death|1
5563730|NCT01157377|19227495|P7|Overall Study|Other Miscellaneous Reasons|1
5563731|NCT01157377|19227496|P6|Overall Study|Other Miscellaneous Reasons|1
5563732|NCT01157377|19227497|P5|Overall Study|Other Miscellaneous Reasons|1
5563733|NCT01157377|19227498|P4|Overall Study|Other Miscellaneous Reasons|0
5563734|NCT01157377|19227499|P3|Overall Study|Other Miscellaneous Reasons|0
5563735|NCT01157377|19227500|P2|Overall Study|Other Miscellaneous Reasons|2
5563736|NCT01157377|19227501|P1|Overall Study|Other Miscellaneous Reasons|0
5563737|NCT01157377|19227495|P7|Overall Study|Lack of Efficacy|1
5563738|NCT01157377|19227496|P6|Overall Study|Lack of Efficacy|0
5563739|NCT01157377|19227497|P5|Overall Study|Lack of Efficacy|0
5563740|NCT01157377|19227498|P4|Overall Study|Lack of Efficacy|0
5563741|NCT01157377|19227499|P3|Overall Study|Lack of Efficacy|0
5563742|NCT01157377|19227500|P2|Overall Study|Lack of Efficacy|0
5563743|NCT01157377|19227501|P1|Overall Study|Lack of Efficacy|0
5563744|NCT01157377|19227495|P7|Overall Study|Protocol Violation|0
5563745|NCT01157377|19227496|P6|Overall Study|Protocol Violation|1
5563746|NCT01157377|19227497|P5|Overall Study|Protocol Violation|0
5563747|NCT01157377|19227498|P4|Overall Study|Protocol Violation|0
5563748|NCT01157377|19227499|P3|Overall Study|Protocol Violation|0
5563749|NCT01157377|19227500|P2|Overall Study|Protocol Violation|0
5563750|NCT01157377|19227501|P1|Overall Study|Protocol Violation|0
5563751|NCT01157377|19227495|P7|Overall Study|Personal Reasons|0
5563752|NCT01157377|19227496|P6|Overall Study|Personal Reasons|0
5563753|NCT01157377|19227497|P5|Overall Study|Personal Reasons|0
5563754|NCT01157377|19227498|P4|Overall Study|Personal Reasons|1
5563755|NCT01157377|19227499|P3|Overall Study|Personal Reasons|0
5563756|NCT01157377|19227500|P2|Overall Study|Personal Reasons|1
5563757|NCT01157377|19227501|P1|Overall Study|Personal Reasons|2
5563758|NCT01157377|19227495|P7|Overall Study|Lost to Follow-up|0
5563759|NCT01157377|19227496|P6|Overall Study|Lost to Follow-up|1
5563760|NCT01157377|19227497|P5|Overall Study|Lost to Follow-up|1
5563761|NCT01157377|19227498|P4|Overall Study|Lost to Follow-up|0
5563762|NCT01157377|19227499|P3|Overall Study|Lost to Follow-up|1
5563763|NCT01157377|19227500|P2|Overall Study|Lost to Follow-up|0
5563764|NCT01157377|19227501|P1|Overall Study|Lost to Follow-up|0
5563765|NCT01157364|19227523|P6|Overall Study|Adverse Event|0
5563766|NCT01157364|19227524|P5|Overall Study|Adverse Event|1
5563767|NCT01157364|19227525|P4|Overall Study|Adverse Event|0
5563768|NCT01157364|19227526|P3|Overall Study|Adverse Event|1
5563769|NCT01157364|19227527|P2|Overall Study|Adverse Event|1
5563770|NCT01157364|19227528|P1|Overall Study|Adverse Event|0
5563771|NCT01157364|19227523|P6|Overall Study|Lack of Efficacy|0
5563772|NCT01157364|19227524|P5|Overall Study|Lack of Efficacy|0
5563773|NCT01157364|19227525|P4|Overall Study|Lack of Efficacy|1
5563774|NCT01157364|19227526|P3|Overall Study|Lack of Efficacy|0
5563775|NCT01157364|19227527|P2|Overall Study|Lack of Efficacy|0
5563776|NCT01157364|19227528|P1|Overall Study|Lack of Efficacy|0
5563777|NCT01157364|19227523|P6|Overall Study|Lost to Follow-up|0
5563778|NCT01157364|19227524|P5|Overall Study|Lost to Follow-up|0
5563779|NCT01157364|19227525|P4|Overall Study|Lost to Follow-up|0
5563780|NCT01157364|19227526|P3|Overall Study|Lost to Follow-up|1
5563781|NCT01157364|19227527|P2|Overall Study|Lost to Follow-up|0
5563782|NCT01157364|19227528|P1|Overall Study|Lost to Follow-up|1
5563783|NCT01157364|19227523|P6|Overall Study|Personal Reasons|1
5563784|NCT01157364|19227524|P5|Overall Study|Personal Reasons|1
5563785|NCT01157364|19227525|P4|Overall Study|Personal Reasons|0
5563786|NCT01157364|19227526|P3|Overall Study|Personal Reasons|0
5563787|NCT01157364|19227527|P2|Overall Study|Personal Reasons|2
5563788|NCT01157364|19227528|P1|Overall Study|Personal Reasons|0
5563789|NCT01157364|19227523|P6|Overall Study|Other Reasons|0
5563790|NCT01157364|19227524|P5|Overall Study|Other Reasons|0
5563791|NCT01157364|19227525|P4|Overall Study|Other Reasons|1
5563792|NCT01157364|19227526|P3|Overall Study|Other Reasons|2
5563793|NCT01157364|19227527|P2|Overall Study|Other Reasons|1
5563794|NCT01157364|19227528|P1|Overall Study|Other Reasons|1
5563795|NCT01157351|19227562|P2|Overall Study|Randomized but not Treated|2
5563796|NCT01157351|19227563|P1|Overall Study|Randomized but not Treated|4
5563797|NCT01157351|19227562|P2|Overall Study|Noncompliance with Study Drug|3
5563798|NCT01157351|19227563|P1|Overall Study|Noncompliance with Study Drug|0
5563799|NCT01157351|19227562|P2|Overall Study|Other|36
5563800|NCT01157351|19227563|P1|Overall Study|Other|32
5563801|NCT01157351|19227562|P2|Overall Study|Protocol Violation|1
5563802|NCT01157351|19227563|P1|Overall Study|Protocol Violation|0
5563803|NCT01157351|19227562|P2|Overall Study|Physician Decision|4
5563804|NCT01157351|19227563|P1|Overall Study|Physician Decision|5
5563805|NCT01157351|19227562|P2|Overall Study|Withdrawal by Subject|27
5563806|NCT01157351|19227563|P1|Overall Study|Withdrawal by Subject|37
5563807|NCT01157351|19227562|P2|Overall Study|Lost to Follow-up|55
5563808|NCT01157351|19227563|P1|Overall Study|Lost to Follow-up|53
5563809|NCT01157351|19227562|P2|Overall Study|Death|0
5563810|NCT01157351|19227563|P1|Overall Study|Death|1
5563811|NCT01157351|19227562|P2|Overall Study|Adverse Event|4
5563812|NCT01157351|19227563|P1|Overall Study|Adverse Event|5
5563813|NCT01157234|19227581|P2|Overall Study|Withdrawal by Subject|0
5563814|NCT01157234|19227582|P1|Overall Study|Withdrawal by Subject|1
5563815|NCT01157182|19227614|P2|Washout of 28 Days|Adverse Event|0
5563816|NCT01157182|19227615|P1|Washout of 28 Days|Adverse Event|2
5563817|NCT01157169|19227663|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
5563818|NCT01157169|19227664|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
5563819|NCT01157169|19227663|P2|First Intervention|Emesis Within 4 hrs of Administration|2
5563820|NCT01157169|19227664|P1|First Intervention|Emesis Within 4 hrs of Administration|4
5563821|NCT01157117|19227683|P3|Overall Study|Unknown (Pending Final Form Submission)|13
5563822|NCT01157117|19227684|P2|Overall Study|Unknown (Pending Final Form Submission)|5
5563823|NCT01157117|19227685|P1|Overall Study|Unknown (Pending Final Form Submission)|4
5563824|NCT01157117|19227683|P3|Overall Study|Lost to Follow-up|1
5563825|NCT01157117|19227684|P2|Overall Study|Lost to Follow-up|0
5563826|NCT01157117|19227685|P1|Overall Study|Lost to Follow-up|0
5563827|NCT01157117|19227683|P3|Overall Study|Lack of Efficacy|0
5563828|NCT01157117|19227684|P2|Overall Study|Lack of Efficacy|1
5563829|NCT01157117|19227685|P1|Overall Study|Lack of Efficacy|1
5563830|NCT01157117|19227683|P3|Overall Study|Withdrawal by Subject|1
5563831|NCT01157117|19227684|P2|Overall Study|Withdrawal by Subject|1
5563832|NCT01157117|19227685|P1|Overall Study|Withdrawal by Subject|4
5563833|NCT01157117|19227683|P3|Overall Study|Dosing Symptoms|0
5563834|NCT01157117|19227684|P2|Overall Study|Dosing Symptoms|4
5563835|NCT01157117|19227685|P1|Overall Study|Dosing Symptoms|0
5563836|NCT01157078|19227726|P2|Overall Study|Other|4
5563837|NCT01157078|19227727|P1|Overall Study|Other|2
5563838|NCT01157078|19227726|P2|Overall Study|Lost to Follow-up|5
5563839|NCT01157078|19227727|P1|Overall Study|Lost to Follow-up|7
5563840|NCT01157078|19227726|P2|Overall Study|Study-specific withdrawal criteria|2
5563841|NCT01157078|19227727|P1|Overall Study|Study-specific withdrawal criteria|2
5563842|NCT01157078|19227726|P2|Overall Study|Lack of Efficacy|0
5563843|NCT01157078|19227727|P1|Overall Study|Lack of Efficacy|2
5563844|NCT01157078|19227726|P2|Overall Study|Condition under investigation worsened|1
5563845|NCT01157078|19227727|P1|Overall Study|Condition under investigation worsened|0
5563846|NCT01157078|19227726|P2|Overall Study|Severe non-compliance to protocol|4
5563847|NCT01157078|19227727|P1|Overall Study|Severe non-compliance to protocol|2
5563848|NCT01157078|19227726|P2|Overall Study|Adverse Event|6
5563849|NCT01157078|19227727|P1|Overall Study|Adverse Event|6
5563850|NCT01157078|19227726|P2|Overall Study|Eligibility criteria not fulfilled|0
5563851|NCT01157078|19227727|P1|Overall Study|Eligibility criteria not fulfilled|2
5563852|NCT01157078|19227726|P2|Overall Study|Withdrawal by Subject|14
5563853|NCT01157078|19227727|P1|Overall Study|Withdrawal by Subject|12
5563854|NCT01157065|19227777|P2|Overall Study|Death|1
5563855|NCT01157065|19227778|P1|Overall Study|Death|0
5563856|NCT01156844|19227799|P4|Overall Study|Protocol deviation|0
5563857|NCT01156844|19227800|P3|Overall Study|Protocol deviation|0
5563858|NCT01156844|19227801|P2|Overall Study|Protocol deviation|0
5563859|NCT01156844|19227802|P1|Overall Study|Protocol deviation|2
5563860|NCT01156844|19227799|P4|Overall Study|Administrative problems|1
5563861|NCT01156844|19227800|P3|Overall Study|Administrative problems|0
5563862|NCT01156844|19227801|P2|Overall Study|Administrative problems|1
5563863|NCT01156844|19227802|P1|Overall Study|Administrative problems|0
5563864|NCT01156844|19227799|P4|Overall Study|Lost to Follow-up|0
5563865|NCT01156844|19227800|P3|Overall Study|Lost to Follow-up|1
5563866|NCT01156844|19227801|P2|Overall Study|Lost to Follow-up|0
5563867|NCT01156844|19227802|P1|Overall Study|Lost to Follow-up|0
5563868|NCT01156844|19227799|P4|Overall Study|Withdrawal by Subject|2
5563869|NCT01156844|19227800|P3|Overall Study|Withdrawal by Subject|2
5563870|NCT01156844|19227801|P2|Overall Study|Withdrawal by Subject|0
5563871|NCT01156844|19227802|P1|Overall Study|Withdrawal by Subject|0
5563872|NCT01156844|19227799|P4|Overall Study|Abnormal test procedure result(s)|2
5563873|NCT01156844|19227800|P3|Overall Study|Abnormal test procedure result(s)|2
5563874|NCT01156844|19227801|P2|Overall Study|Abnormal test procedure result(s)|1
5563875|NCT01156844|19227802|P1|Overall Study|Abnormal test procedure result(s)|0
5563876|NCT01156844|19227799|P4|Overall Study|Adverse Event|1
5563877|NCT01156844|19227800|P3|Overall Study|Adverse Event|1
5563878|NCT01156844|19227801|P2|Overall Study|Adverse Event|0
5563879|NCT01156844|19227802|P1|Overall Study|Adverse Event|0
5563880|NCT01156792|19227836|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
5563881|NCT01156792|19227836|P1|Overall Study|Withdrawal by Subject|9
5563882|NCT01156792|19227836|P1|Overall Study|Physician Decision|3
5563883|NCT01156792|19227836|P1|Overall Study|Lost to Follow-up|3
5563884|NCT01156792|19227836|P1|Overall Study|Protocol Violation|6
5563885|NCT01156792|19227836|P1|Overall Study|Lack of Efficacy|36
5563886|NCT01156792|19227836|P1|Overall Study|Adverse Event|1
5563887|NCT01156714|19227904|P3|Overall Study|Withdrawal by Subject|3
5563888|NCT01156714|19227905|P2|Overall Study|Withdrawal by Subject|4
5563889|NCT01156714|19227906|P1|Overall Study|Withdrawal by Subject|9
5563890|NCT01156675|19227969|P3|Overall Study|No data|2
5563891|NCT01156675|19227970|P2|Overall Study|No data|22
5563892|NCT01156675|19227971|P1|Overall Study|No data|29
5563893|NCT01156675|19227969|P3|Overall Study|Death|0
5563894|NCT01156675|19227970|P2|Overall Study|Death|3
5563895|NCT01156675|19227971|P1|Overall Study|Death|5
5563896|NCT01156532|19228029|P1|Overall Study|Lost to Follow-up|1
5563897|NCT01156532|19228029|P1|Overall Study|Family Reasons|1
5563898|NCT01156480|19228041|P2|Overall Study|change in diagnosis|1
5563899|NCT01156480|19228042|P1|Overall Study|change in diagnosis|0
5563900|NCT01156376|19228071|P3|Overall Study|Withdrawal by Subject|3
5563901|NCT01156376|19228072|P2|Overall Study|Withdrawal by Subject|0
5563902|NCT01156376|19228073|P1|Overall Study|Withdrawal by Subject|0
5563903|NCT01156376|19228071|P3|Overall Study|Adverse Event|1
5563904|NCT01156376|19228072|P2|Overall Study|Adverse Event|0
5563905|NCT01156376|19228073|P1|Overall Study|Adverse Event|1
5563906|NCT01156363|19228294|P1|Overall Study|Other|6
5563907|NCT01156363|19228294|P1|Overall Study|Refused Treatment|4
5563908|NCT01156363|19228294|P1|Overall Study|Failure to Return|1
5563909|NCT01156363|19228294|P1|Overall Study|Insufficient Therapeutic Response|5
5563910|NCT01156363|19228294|P1|Overall Study|Adverse Event|6
5563911|NCT01156311|19228316|P4|6-month Add-on Therapy Period|Other|2
5563912|NCT01156311|19228317|P3|6-month Add-on Therapy Period|Other|1
5563913|NCT01156311|19228318|P2|6-month Add-on Therapy Period|Other|0
5563914|NCT01156311|19228319|P1|6-month Add-on Therapy Period|Other|0
5563915|NCT01156311|19228316|P4|6-month Add-on Therapy Period|Physician Decision|0
5563916|NCT01156311|19228317|P3|6-month Add-on Therapy Period|Physician Decision|1
5563917|NCT01156311|19228318|P2|6-month Add-on Therapy Period|Physician Decision|0
5563918|NCT01156311|19228319|P1|6-month Add-on Therapy Period|Physician Decision|0
5563919|NCT01156311|19228316|P4|6-month Add-on Therapy Period|Disease Activity|2
5563920|NCT01156311|19228317|P3|6-month Add-on Therapy Period|Disease Activity|1
5563921|NCT01156311|19228318|P2|6-month Add-on Therapy Period|Disease Activity|0
5563922|NCT01156311|19228319|P1|6-month Add-on Therapy Period|Disease Activity|0
5563923|NCT01156311|19228316|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
5563924|NCT01156311|19228317|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
5563925|NCT01156311|19228318|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
5563926|NCT01156311|19228319|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
5563927|NCT01156311|19228316|P4|6-month Add-on Therapy Period|Adverse Event|6
5563928|NCT01156311|19228317|P3|6-month Add-on Therapy Period|Adverse Event|7
5563929|NCT01156311|19228318|P2|6-month Add-on Therapy Period|Adverse Event|0
5563930|NCT01156311|19228319|P1|6-month Add-on Therapy Period|Adverse Event|0
5563931|NCT01156311|19228316|P4|2-Month Monotherapy Period|Other|0
5563932|NCT01156311|19228317|P3|2-Month Monotherapy Period|Other|0
5563933|NCT01156311|19228318|P2|2-Month Monotherapy Period|Other|0
5563934|NCT01156311|19228319|P1|2-Month Monotherapy Period|Other|1
5563935|NCT01156311|19228316|P4|2-Month Monotherapy Period|Physician Decision|0
5563936|NCT01156311|19228317|P3|2-Month Monotherapy Period|Physician Decision|0
5563937|NCT01156311|19228318|P2|2-Month Monotherapy Period|Physician Decision|1
5563938|NCT01156311|19228319|P1|2-Month Monotherapy Period|Physician Decision|0
5563939|NCT01156311|19228316|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
5563940|NCT01156311|19228317|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
5563941|NCT01156311|19228318|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
5563942|NCT01156311|19228319|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
5563943|NCT01156142|19228343|P2|Overall Study|Ineligible|1
5563944|NCT01156142|19228344|P1|Overall Study|Ineligible|0
5563945|NCT01156142|19228343|P2|Overall Study|Withdrawal by Subject|6
5563946|NCT01156142|19228344|P1|Overall Study|Withdrawal by Subject|8
5563947|NCT01156116|19228362|P2|Overall Study|CPAP intolerance|0
5563948|NCT01156116|19228363|P1|Overall Study|CPAP intolerance|2
5563949|NCT01156116|19228362|P2|Overall Study|Withdrawal by Subject|1
5563950|NCT01156116|19228363|P1|Overall Study|Withdrawal by Subject|3
5563951|NCT01156051|19228377|P2|Overall Study|patient not compliant with protocol|1
5563952|NCT01156051|19228378|P1|Overall Study|patient not compliant with protocol|0
5563953|NCT01156051|19228377|P2|Overall Study|Lost to Follow-up|0
5563954|NCT01156051|19228378|P1|Overall Study|Lost to Follow-up|1
5563955|NCT01156012|19228392|P2|Overall Study|Non respect of one of inclusion criteria|1
5563956|NCT01156012|19228393|P1|Overall Study|Non respect of one of inclusion criteria|2
5563957|NCT01156012|19228392|P2|Overall Study|use of commercial drug instead of study|1
5563958|NCT01156012|19228393|P1|Overall Study|use of commercial drug instead of study|0
5563959|NCT01156012|19228392|P2|Overall Study|Withdrawal by Subject|0
5563960|NCT01156012|19228393|P1|Overall Study|Withdrawal by Subject|1
5563961|NCT01156012|19228392|P2|Overall Study|Lost to Follow-up|0
5563962|NCT01156012|19228393|P1|Overall Study|Lost to Follow-up|1
5563963|NCT01156012|19228392|P2|Overall Study|Adverse Event|1
5563964|NCT01156012|19228393|P1|Overall Study|Adverse Event|3
5563965|NCT01155869|19228410|P2|Overall Study|Lost to Follow-up|1
5563966|NCT01155869|19228411|P1|Overall Study|Lost to Follow-up|3
5563967|NCT01155726|19228520|P4|Period 1, 3 Days (Masked)|Inconvenience|0
5563968|NCT01155726|19228521|P3|Period 1, 3 Days (Masked)|Inconvenience|2
5563969|NCT01155726|19228522|P2|Period 1, 3 Days (Masked)|Inconvenience|0
5563970|NCT01155726|19228523|P1|Period 1, 3 Days (Masked)|Inconvenience|1
5563971|NCT01155661|19228545|P1|Overall Study|Sponsor Decision|13
5563972|NCT01155661|19228545|P1|Overall Study|Withdrawal by Subject|73
5563973|NCT01155661|19228545|P1|Overall Study|Protocol Violation|35
5563974|NCT01155661|19228545|P1|Overall Study|Physician Decision|3
5563975|NCT01155661|19228545|P1|Overall Study|Lost to Follow-up|22
5563976|NCT01155661|19228545|P1|Overall Study|Lack of Efficacy|32
5563977|NCT01155661|19228545|P1|Overall Study|Death|1
5563978|NCT01155661|19228545|P1|Overall Study|Adverse Event|101
5563979|NCT01155583|19228580|P9|Phase I|Withdrawal by Subject|0
5563980|NCT01155583|19228581|P8|Phase I|Withdrawal by Subject|1
5563981|NCT01155583|19228582|P7|Phase I|Withdrawal by Subject|0
5563982|NCT01155583|19228583|P6|Phase I|Withdrawal by Subject|0
5563983|NCT01155583|19228584|P5|Phase I|Withdrawal by Subject|0
5563984|NCT01155583|19228585|P4|Phase I|Withdrawal by Subject|0
5563985|NCT01155583|19228586|P3|Phase I|Withdrawal by Subject|0
5563986|NCT01155583|19228587|P2|Phase I|Withdrawal by Subject|0
5563987|NCT01155583|19228588|P1|Phase I|Withdrawal by Subject|0
5563988|NCT01155583|19228580|P9|Phase I|Screen failure - did not start treatment|0
5563989|NCT01155583|19228581|P8|Phase I|Screen failure - did not start treatment|2
5563990|NCT01155583|19228582|P7|Phase I|Screen failure - did not start treatment|0
5563991|NCT01155583|19228583|P6|Phase I|Screen failure - did not start treatment|0
5563992|NCT01155583|19228584|P5|Phase I|Screen failure - did not start treatment|1
5563993|NCT01155583|19228585|P4|Phase I|Screen failure - did not start treatment|0
5563994|NCT01155583|19228586|P3|Phase I|Screen failure - did not start treatment|0
5563995|NCT01155583|19228587|P2|Phase I|Screen failure - did not start treatment|0
5563996|NCT01155583|19228588|P1|Phase I|Screen failure - did not start treatment|0
5563997|NCT01155570|19228607|P1|Overall Study|Other Reasons|23
5563998|NCT01155570|19228607|P1|Overall Study|Participant's Economic Reasons + Other|1
5563999|NCT01155570|19228607|P1|Overall Study|Adverse Event + Other Reasons|7
5564000|NCT01155570|19228607|P1|Overall Study|Adverse Event + Lack of Efficacy|2
5564001|NCT01155570|19228607|P1|Overall Study|No Hospital Visits|7
5564002|NCT01155570|19228607|P1|Overall Study|Participant's Economic Reasons|17
5564003|NCT01155570|19228607|P1|Overall Study|Lack of Efficacy|46
5564004|NCT01155570|19228607|P1|Overall Study|Adverse Event|39
5564005|NCT01155531|19228641|P4|Overall Study|Withdrawal by Subject|0
5564006|NCT01155531|19228642|P3|Overall Study|Withdrawal by Subject|1
5564007|NCT01155531|19228643|P2|Overall Study|Withdrawal by Subject|0
5564008|NCT01155531|19228644|P1|Overall Study|Withdrawal by Subject|1
5564009|NCT01155531|19228641|P4|Overall Study|Lost to Follow-up|1
5564010|NCT01155531|19228642|P3|Overall Study|Lost to Follow-up|0
5564011|NCT01155531|19228643|P2|Overall Study|Lost to Follow-up|0
5564012|NCT01155531|19228644|P1|Overall Study|Lost to Follow-up|0
5564013|NCT01155531|19228641|P4|Overall Study|Adverse Event|0
5564014|NCT01155531|19228642|P3|Overall Study|Adverse Event|1
5564015|NCT01155531|19228643|P2|Overall Study|Adverse Event|0
5564016|NCT01155531|19228644|P1|Overall Study|Adverse Event|0
5564017|NCT01155479|19228692|P5|Part II|Non-Compliance with Protocol|0
5564018|NCT01155479|19228693|P4|Part II|Non-Compliance with Protocol|2
5564019|NCT01155479|19228694|P3|Part II|Non-Compliance with Protocol|0
5564020|NCT01155479|19228695|P2|Part II|Non-Compliance with Protocol|1
5564021|NCT01155479|19228696|P1|Part II|Non-Compliance with Protocol|0
5564022|NCT01155479|19228692|P5|Part II|Treatment Failure|1
5564023|NCT01155479|19228693|P4|Part II|Treatment Failure|0
5564024|NCT01155479|19228694|P3|Part II|Treatment Failure|2
5564025|NCT01155479|19228695|P2|Part II|Treatment Failure|1
5564026|NCT01155479|19228696|P1|Part II|Treatment Failure|0
5564027|NCT01155479|19228692|P5|Part II|Lost to Follow-up|1
5564028|NCT01155479|19228693|P4|Part II|Lost to Follow-up|0
5564029|NCT01155479|19228694|P3|Part II|Lost to Follow-up|0
5564030|NCT01155479|19228695|P2|Part II|Lost to Follow-up|0
5564031|NCT01155479|19228696|P1|Part II|Lost to Follow-up|1
5564032|NCT01155479|19228692|P5|Part II|Withdrawal by Subject|3
5564033|NCT01155479|19228693|P4|Part II|Withdrawal by Subject|7
5564034|NCT01155479|19228694|P3|Part II|Withdrawal by Subject|12
5564035|NCT01155479|19228695|P2|Part II|Withdrawal by Subject|4
5564036|NCT01155479|19228696|P1|Part II|Withdrawal by Subject|8
5564037|NCT01155479|19228692|P5|Part II|Administrative|46
5564038|NCT01155479|19228693|P4|Part II|Administrative|38
5564039|NCT01155479|19228694|P3|Part II|Administrative|36
5564040|NCT01155479|19228695|P2|Part II|Administrative|49
5564041|NCT01155479|19228696|P1|Part II|Administrative|43
5564042|NCT01155479|19228692|P5|Part II|Adverse Event|4
5564043|NCT01155479|19228693|P4|Part II|Adverse Event|3
5564044|NCT01155479|19228694|P3|Part II|Adverse Event|8
5564045|NCT01155479|19228695|P2|Part II|Adverse Event|6
5564046|NCT01155479|19228696|P1|Part II|Adverse Event|7
5564047|NCT01155479|19228692|P5|Part I|Non-Compliance with Protocol|2
5564048|NCT01155479|19228693|P4|Part I|Non-Compliance with Protocol|3
5564049|NCT01155479|19228694|P3|Part I|Non-Compliance with Protocol|3
5564050|NCT01155479|19228695|P2|Part I|Non-Compliance with Protocol|1
5564051|NCT01155479|19228696|P1|Part I|Non-Compliance with Protocol|2
5564052|NCT01155479|19228692|P5|Part I|Did Not Receive Treatment|1
5564053|NCT01155479|19228693|P4|Part I|Did Not Receive Treatment|6
5564054|NCT01155479|19228694|P3|Part I|Did Not Receive Treatment|2
5564055|NCT01155479|19228695|P2|Part I|Did Not Receive Treatment|2
5564056|NCT01155479|19228696|P1|Part I|Did Not Receive Treatment|4
5564057|NCT01155479|19228692|P5|Part I|Treatment Failure|2
5564058|NCT01155479|19228693|P4|Part I|Treatment Failure|1
5564059|NCT01155479|19228694|P3|Part I|Treatment Failure|3
5564060|NCT01155479|19228695|P2|Part I|Treatment Failure|0
5564061|NCT01155479|19228696|P1|Part I|Treatment Failure|3
5564062|NCT01155479|19228692|P5|Part I|Lost to Follow-up|0
5564063|NCT01155479|19228693|P4|Part I|Lost to Follow-up|1
5564064|NCT01155479|19228694|P3|Part I|Lost to Follow-up|1
5564065|NCT01155479|19228695|P2|Part I|Lost to Follow-up|0
5564066|NCT01155479|19228696|P1|Part I|Lost to Follow-up|0
5564067|NCT01155479|19228692|P5|Part I|Withdrawal by Subject|9
5564068|NCT01155479|19228693|P4|Part I|Withdrawal by Subject|8
5564069|NCT01155479|19228694|P3|Part I|Withdrawal by Subject|8
5564070|NCT01155479|19228695|P2|Part I|Withdrawal by Subject|13
5564071|NCT01155479|19228696|P1|Part I|Withdrawal by Subject|11
5564072|NCT01155479|19228692|P5|Part I|Did Not Meet Protocol Eligibility|3
5564073|NCT01155479|19228693|P4|Part I|Did Not Meet Protocol Eligibility|1
5564074|NCT01155479|19228694|P3|Part I|Did Not Meet Protocol Eligibility|2
5564075|NCT01155479|19228695|P2|Part I|Did Not Meet Protocol Eligibility|1
5564076|NCT01155479|19228696|P1|Part I|Did Not Meet Protocol Eligibility|3
5564077|NCT01155479|19228692|P5|Part I|Administrative|0
5564078|NCT01155479|19228693|P4|Part I|Administrative|0
5564079|NCT01155479|19228694|P3|Part I|Administrative|2
5564080|NCT01155479|19228695|P2|Part I|Administrative|2
5564081|NCT01155479|19228696|P1|Part I|Administrative|2
5564082|NCT01155479|19228692|P5|Part I|Adverse Event|6
5564083|NCT01155479|19228693|P4|Part I|Adverse Event|7
5564084|NCT01155479|19228694|P3|Part I|Adverse Event|18
5564085|NCT01155479|19228695|P2|Part I|Adverse Event|8
5564086|NCT01155479|19228696|P1|Part I|Adverse Event|13
5564087|NCT01155466|19228748|P5|Overall Study|Randomized not treated|2
5564088|NCT01155466|19228749|P4|Overall Study|Randomized not treated|0
5564089|NCT01155466|19228750|P3|Overall Study|Randomized not treated|3
5564090|NCT01155466|19228751|P2|Overall Study|Randomized not treated|2
5564091|NCT01155466|19228752|P1|Overall Study|Randomized not treated|2
5564092|NCT01155466|19228748|P5|Overall Study|Administrative|0
5564093|NCT01155466|19228749|P4|Overall Study|Administrative|0
5564094|NCT01155466|19228750|P3|Overall Study|Administrative|0
5564095|NCT01155466|19228751|P2|Overall Study|Administrative|3
5564096|NCT01155466|19228752|P1|Overall Study|Administrative|0
5564097|NCT01155466|19228748|P5|Overall Study|Protocol Violation|1
5564098|NCT01155466|19228749|P4|Overall Study|Protocol Violation|0
5564099|NCT01155466|19228750|P3|Overall Study|Protocol Violation|2
5564100|NCT01155466|19228751|P2|Overall Study|Protocol Violation|0
5564101|NCT01155466|19228752|P1|Overall Study|Protocol Violation|0
5564102|NCT01155466|19228748|P5|Overall Study|Withdrawal by Subject|4
5564103|NCT01155466|19228749|P4|Overall Study|Withdrawal by Subject|4
5564104|NCT01155466|19228750|P3|Overall Study|Withdrawal by Subject|9
5564105|NCT01155466|19228751|P2|Overall Study|Withdrawal by Subject|5
5564106|NCT01155466|19228752|P1|Overall Study|Withdrawal by Subject|7
5564107|NCT01155466|19228748|P5|Overall Study|Lost to Follow-up|2
5564108|NCT01155466|19228749|P4|Overall Study|Lost to Follow-up|0
5564109|NCT01155466|19228750|P3|Overall Study|Lost to Follow-up|0
5564110|NCT01155466|19228751|P2|Overall Study|Lost to Follow-up|0
5564111|NCT01155466|19228752|P1|Overall Study|Lost to Follow-up|0
5564112|NCT01155466|19228748|P5|Overall Study|Adverse Event|18
5564113|NCT01155466|19228749|P4|Overall Study|Adverse Event|17
5564114|NCT01155466|19228750|P3|Overall Study|Adverse Event|6
5564115|NCT01155466|19228751|P2|Overall Study|Adverse Event|15
5564116|NCT01155466|19228752|P1|Overall Study|Adverse Event|13
5564117|NCT01155388|19228806|P2|Overall Study|Adverse Event|0
5564118|NCT01155388|19228807|P1|Overall Study|Adverse Event|1
5564119|NCT01155375|19228817|P2|Overall Study|Adverse Event|0
5564120|NCT01155375|19228818|P1|Overall Study|Adverse Event|1
5564121|NCT01155323|19228837|P2|Second Intervention|Lost to Follow-up|1
5564122|NCT01155323|19228838|P1|Second Intervention|Lost to Follow-up|1
5564123|NCT01155323|19228837|P2|First Intervention|exclusion criteria|1
5564124|NCT01155323|19228838|P1|First Intervention|exclusion criteria|1
5564125|NCT01155284|19228856|P2|Overall Study|Adverse Event|0
5564126|NCT01155284|19228857|P1|Overall Study|Adverse Event|1
5564127|NCT01155284|19228856|P2|Overall Study|Physician Decision|0
5564128|NCT01155284|19228857|P1|Overall Study|Physician Decision|1
5564129|NCT01155284|19228856|P2|Overall Study|Lost to Follow-up|2
5564130|NCT01155284|19228857|P1|Overall Study|Lost to Follow-up|1
5564131|NCT01155284|19228856|P2|Overall Study|Withdrawal by Subject|3
5564132|NCT01155284|19228857|P1|Overall Study|Withdrawal by Subject|4
5564133|NCT01155219|19228867|P2|Overall Study|non-medical reason|2
5564134|NCT01155219|19228868|P1|Overall Study|non-medical reason|1
5564135|NCT01155219|19228867|P2|Overall Study|Adverse Event|1
5564136|NCT01155219|19228868|P1|Overall Study|Adverse Event|3
5564137|NCT01155167|19228917|P2|Overall Study|Access site changed to femoral artery|0
5564138|NCT01155167|19228918|P1|Overall Study|Access site changed to femoral artery|1
5564139|NCT01155167|19228917|P2|Overall Study|Insufficient ultrasound data|0
5564140|NCT01155167|19228918|P1|Overall Study|Insufficient ultrasound data|2
5564141|NCT01155141|19228941|P1|Overall Study|Screen Failure|1
5564142|NCT01155141|19228941|P1|Overall Study|Withdrawal by Subject|1
5564143|NCT01155063|19228953|P1|Overall Study|Study terminated by sponsor|87
5564144|NCT01155063|19228953|P1|Overall Study|Withdrawal by Subject|1
5564145|NCT01155063|19228953|P1|Overall Study|Adverse Event|1
5564146|NCT01155050|19228967|P4|Overall Study|Lost to Follow-up|22
5564147|NCT01155050|19228968|P3|Overall Study|Lost to Follow-up|19
5564148|NCT01155050|19228969|P2|Overall Study|Lost to Follow-up|20
5564149|NCT01155050|19228970|P1|Overall Study|Lost to Follow-up|15
5564150|NCT01155024|19229008|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
5564151|NCT01155024|19229009|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
5564152|NCT01155024|19229008|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
5564153|NCT01155024|19229009|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
5564154|NCT01155024|19229008|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
5564155|NCT01155024|19229009|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
5564156|NCT01155011|19229019|P2|6 to 12 Months|Death|5
5564157|NCT01155011|19229020|P1|6 to 12 Months|Death|1
5564158|NCT01155011|19229019|P2|6 to 12 Months|Withdrawal by Subject|5
5564159|NCT01155011|19229020|P1|6 to 12 Months|Withdrawal by Subject|8
5564160|NCT01155011|19229019|P2|Baseline to 6 Months|Death|1
5564161|NCT01155011|19229020|P1|Baseline to 6 Months|Death|0
5564162|NCT01155011|19229019|P2|Baseline to 6 Months|investigator decision, moved|5
5564163|NCT01155011|19229020|P1|Baseline to 6 Months|investigator decision, moved|4
5564164|NCT01155011|19229019|P2|Baseline to 6 Months|Withdrawal by Subject|19
5564165|NCT01155011|19229020|P1|Baseline to 6 Months|Withdrawal by Subject|18
5564166|NCT01154816|19229061|P12|Overall Study|Adverse Event|0
5564167|NCT01154816|19229062|P11|Overall Study|Adverse Event|0
5564168|NCT01154816|19229063|P10|Overall Study|Adverse Event|0
5564169|NCT01154816|19229064|P9|Overall Study|Adverse Event|0
5564170|NCT01154816|19229065|P8|Overall Study|Adverse Event|1
5564171|NCT01154816|19229066|P7|Overall Study|Adverse Event|1
5564172|NCT01154816|19229067|P6|Overall Study|Adverse Event|0
5564173|NCT01154816|19229068|P5|Overall Study|Adverse Event|0
5564174|NCT01154816|19229069|P4|Overall Study|Adverse Event|0
5564175|NCT01154816|19229070|P3|Overall Study|Adverse Event|0
5564176|NCT01154816|19229071|P2|Overall Study|Adverse Event|2
5564177|NCT01154816|19229072|P1|Overall Study|Adverse Event|5
5564178|NCT01154816|19229061|P12|Overall Study|Physician Decision|1
5564179|NCT01154816|19229062|P11|Overall Study|Physician Decision|1
5564180|NCT01154816|19229063|P10|Overall Study|Physician Decision|1
5564181|NCT01154816|19229064|P9|Overall Study|Physician Decision|0
5564182|NCT01154816|19229065|P8|Overall Study|Physician Decision|0
5564183|NCT01154816|19229066|P7|Overall Study|Physician Decision|0
5564184|NCT01154816|19229067|P6|Overall Study|Physician Decision|0
5564185|NCT01154816|19229068|P5|Overall Study|Physician Decision|2
5564186|NCT01154816|19229069|P4|Overall Study|Physician Decision|0
5564187|NCT01154816|19229070|P3|Overall Study|Physician Decision|1
5564188|NCT01154816|19229071|P2|Overall Study|Physician Decision|0
5564189|NCT01154816|19229072|P1|Overall Study|Physician Decision|1
5564190|NCT01154816|19229061|P12|Overall Study|Progressive Disease|3
5564191|NCT01154816|19229062|P11|Overall Study|Progressive Disease|10
5564192|NCT01154816|19229063|P10|Overall Study|Progressive Disease|6
5564193|NCT01154816|19229064|P9|Overall Study|Progressive Disease|8
5564194|NCT01154816|19229065|P8|Overall Study|Progressive Disease|6
5564195|NCT01154816|19229066|P7|Overall Study|Progressive Disease|5
5564196|NCT01154816|19229067|P6|Overall Study|Progressive Disease|8
5564197|NCT01154816|19229068|P5|Overall Study|Progressive Disease|8
5564198|NCT01154816|19229069|P4|Overall Study|Progressive Disease|9
5564199|NCT01154816|19229070|P3|Overall Study|Progressive Disease|9
5564200|NCT01154816|19229071|P2|Overall Study|Progressive Disease|8
5564201|NCT01154816|19229072|P1|Overall Study|Progressive Disease|13
5564202|NCT01154816|19229061|P12|Overall Study|Withdrawal by Subject|0
5564203|NCT01154816|19229062|P11|Overall Study|Withdrawal by Subject|0
5564204|NCT01154816|19229063|P10|Overall Study|Withdrawal by Subject|3
5564205|NCT01154816|19229064|P9|Overall Study|Withdrawal by Subject|1
5564206|NCT01154816|19229065|P8|Overall Study|Withdrawal by Subject|0
5564207|NCT01154816|19229066|P7|Overall Study|Withdrawal by Subject|0
5564208|NCT01154816|19229067|P6|Overall Study|Withdrawal by Subject|0
5564209|NCT01154816|19229068|P5|Overall Study|Withdrawal by Subject|0
5564210|NCT01154816|19229069|P4|Overall Study|Withdrawal by Subject|1
5564211|NCT01154816|19229070|P3|Overall Study|Withdrawal by Subject|0
5564212|NCT01154816|19229071|P2|Overall Study|Withdrawal by Subject|0
5564213|NCT01154816|19229072|P1|Overall Study|Withdrawal by Subject|1
5564214|NCT01154673|19229149|P2|Overall Study|moved out of province|0
5564215|NCT01154673|19229150|P1|Overall Study|moved out of province|1
5564216|NCT01154673|19229149|P2|Overall Study|Lost to Follow-up|0
5564217|NCT01154673|19229150|P1|Overall Study|Lost to Follow-up|1
5564218|NCT01154452|19229205|P4|Phase II|Adverse Event|4
5564219|NCT01154452|19229206|P3|Phase II|Adverse Event|4
5564220|NCT01154452|19229207|P2|Phase II|Adverse Event|0
5564221|NCT01154452|19229208|P1|Phase II|Adverse Event|0
5564222|NCT01154452|19229205|P4|Phase II|Withdrawal by Subject|2
5564223|NCT01154452|19229206|P3|Phase II|Withdrawal by Subject|1
5564224|NCT01154452|19229207|P2|Phase II|Withdrawal by Subject|0
5564225|NCT01154452|19229208|P1|Phase II|Withdrawal by Subject|0
5564226|NCT01154452|19229205|P4|Phase Ib|Adverse Event|0
5564227|NCT01154452|19229206|P3|Phase Ib|Adverse Event|0
5564228|NCT01154452|19229207|P2|Phase Ib|Adverse Event|1
5564229|NCT01154452|19229208|P1|Phase Ib|Adverse Event|2
5564230|NCT01154452|19229205|P4|Phase Ib|Not Treated|0
5564231|NCT01154452|19229206|P3|Phase Ib|Not Treated|0
5564232|NCT01154452|19229207|P2|Phase Ib|Not Treated|0
5564233|NCT01154452|19229208|P1|Phase Ib|Not Treated|1
5564234|NCT01154296|19229240|P2|6-month Follow-up|Declined by Study Coordinator|4
5564235|NCT01154296|19229241|P1|6-month Follow-up|Declined by Study Coordinator|5
5564236|NCT01154296|19229240|P2|6-month Follow-up|Death|2
5564237|NCT01154296|19229241|P1|6-month Follow-up|Death|3
5564238|NCT01154296|19229240|P2|6-month Follow-up|Withdrew consent|15
5564239|NCT01154296|19229241|P1|6-month Follow-up|Withdrew consent|14
5564240|NCT01154296|19229240|P2|6-month Follow-up|Incarcerated|32
5564241|NCT01154296|19229241|P1|6-month Follow-up|Incarcerated|37
5564242|NCT01154296|19229240|P2|6-month Follow-up|Lost contact|275
5564243|NCT01154296|19229241|P1|6-month Follow-up|Lost contact|269
5564244|NCT01154296|19229240|P2|Randomization and Intervention|Left clinic early|0
5564245|NCT01154296|19229241|P1|Randomization and Intervention|Left clinic early|2
5564246|NCT01154296|19229240|P2|Randomization and Intervention|Left before test|1
5564247|NCT01154296|19229241|P1|Randomization and Intervention|Left before test|0
5564248|NCT01154296|19229240|P2|Randomization and Intervention|Did not return|0
5564249|NCT01154296|19229241|P1|Randomization and Intervention|Did not return|1
5564250|NCT01154296|19229240|P2|Randomization and Intervention|Declined by staff|0
5564251|NCT01154296|19229241|P1|Randomization and Intervention|Declined by staff|1
5564252|NCT01154296|19229240|P2|Randomization and Intervention|Decided to decline|1
5564253|NCT01154296|19229241|P1|Randomization and Intervention|Decided to decline|1
5564254|NCT01154283|19229259|P2|7-12 Weeks|Withdrawal by Subject|1
5564255|NCT01154283|19229260|P1|7-12 Weeks|Withdrawal by Subject|0
5564256|NCT01154283|19229259|P2|7-12 Weeks|Death|0
5564257|NCT01154283|19229260|P1|7-12 Weeks|Death|1
5564258|NCT01154283|19229259|P2|0-6 Weeks|Death|1
5564259|NCT01154283|19229260|P1|0-6 Weeks|Death|0
5564260|NCT01154283|19229259|P2|0-6 Weeks|Withdrawal by Subject|2
5564261|NCT01154283|19229260|P1|0-6 Weeks|Withdrawal by Subject|7
5564262|NCT01154231|19229272|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
5564263|NCT01154231|19229272|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
5564264|NCT01154218|19229278|P4|Fourth Intervention Period|Withdrawal by Subject|0
5564265|NCT01154218|19229279|P3|Fourth Intervention Period|Withdrawal by Subject|0
5564266|NCT01154218|19229280|P2|Fourth Intervention Period|Withdrawal by Subject|0
5564267|NCT01154218|19229281|P1|Fourth Intervention Period|Withdrawal by Subject|1
5564268|NCT01154218|19229278|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
5564269|NCT01154218|19229279|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5564270|NCT01154218|19229280|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5564271|NCT01154218|19229281|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
5564272|NCT01154218|19229278|P4|Third Intervention Period|Adverse Event|0
5564273|NCT01154218|19229279|P3|Third Intervention Period|Adverse Event|0
5564274|NCT01154218|19229280|P2|Third Intervention Period|Adverse Event|1
5564275|NCT01154218|19229281|P1|Third Intervention Period|Adverse Event|0
5564276|NCT01154166|19229355|P2|Overall Study|Poor Compliance|0
5564277|NCT01154166|19229356|P1|Overall Study|Poor Compliance|1
5564278|NCT01154166|19229355|P2|Overall Study|Disease Progression|0
5564279|NCT01154166|19229356|P1|Overall Study|Disease Progression|1
5564280|NCT01154166|19229355|P2|Overall Study|Lack of Efficacy|0
5564281|NCT01154166|19229356|P1|Overall Study|Lack of Efficacy|3
5564282|NCT01154166|19229355|P2|Overall Study|Withdrawal by Subject|1
5564283|NCT01154166|19229356|P1|Overall Study|Withdrawal by Subject|10
5564284|NCT01154166|19229355|P2|Overall Study|Protocol Violation|1
5564285|NCT01154166|19229356|P1|Overall Study|Protocol Violation|4
5564286|NCT01154166|19229355|P2|Overall Study|Lost to Follow-up|1
5564287|NCT01154166|19229356|P1|Overall Study|Lost to Follow-up|1
5564288|NCT01154166|19229355|P2|Overall Study|Adverse Event|9
5564289|NCT01154166|19229356|P1|Overall Study|Adverse Event|14
5564290|NCT01154153|19229388|P2|Overall Study|Withdrew consent|0
5564291|NCT01154153|19229389|P1|Overall Study|Withdrew consent|1
5564292|NCT01154153|19229388|P2|Overall Study|Unable to use labs|3
5564293|NCT01154153|19229389|P1|Overall Study|Unable to use labs|2
5564294|NCT01154153|19229388|P2|Overall Study|Poor compliance to protocol|0
5564295|NCT01154153|19229389|P1|Overall Study|Poor compliance to protocol|2
5564296|NCT01154140|19229407|P2|Overall Study|Randomized but not treated|2
5564297|NCT01154140|19229408|P1|Overall Study|Randomized but not treated|1
5564298|NCT01154140|19229407|P2|Overall Study|Other|1
5564299|NCT01154140|19229408|P1|Overall Study|Other|3
5564300|NCT01154140|19229407|P2|Overall Study|Withdrawal by Subject|13
5564301|NCT01154140|19229408|P1|Overall Study|Withdrawal by Subject|12
5564302|NCT01154140|19229407|P2|Overall Study|Lost to Follow-up|5
5564303|NCT01154140|19229408|P1|Overall Study|Lost to Follow-up|4
5564304|NCT01154140|19229407|P2|Overall Study|Death|81
5564305|NCT01154140|19229408|P1|Overall Study|Death|71
5564306|NCT01154127|19229461|P2|Period 2 (21 Days)|Protocol Deviation|1
5564307|NCT01154127|19229462|P1|Period 2 (21 Days)|Protocol Deviation|0
5564308|NCT01154127|19229461|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
5564309|NCT01154127|19229462|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
5564310|NCT01154127|19229461|P2|Washout (14 - 28 Days)|Adverse Event|0
5564311|NCT01154127|19229462|P1|Washout (14 - 28 Days)|Adverse Event|2
5564312|NCT01154127|19229461|P2|Period 1 (21 Days)|Withdrawal by Subject|2
5564313|NCT01154127|19229462|P1|Period 1 (21 Days)|Withdrawal by Subject|0
5564314|NCT01154127|19229461|P2|Period 1 (21 Days)|Adverse Event|4
5564315|NCT01154127|19229462|P1|Period 1 (21 Days)|Adverse Event|3
5564316|NCT01154101|19229489|P5|Overall Study|Withdrawal by Subject|1
5564317|NCT01154101|19229490|P4|Overall Study|Withdrawal by Subject|0
5564318|NCT01154101|19229491|P3|Overall Study|Withdrawal by Subject|2
5564319|NCT01154101|19229492|P2|Overall Study|Withdrawal by Subject|1
5564320|NCT01154101|19229493|P1|Overall Study|Withdrawal by Subject|0
5564321|NCT01154101|19229489|P5|Overall Study|Lost to Follow-up|0
5564322|NCT01154101|19229490|P4|Overall Study|Lost to Follow-up|1
5564323|NCT01154101|19229491|P3|Overall Study|Lost to Follow-up|0
5564324|NCT01154101|19229492|P2|Overall Study|Lost to Follow-up|1
5564325|NCT01154101|19229493|P1|Overall Study|Lost to Follow-up|0
5564326|NCT01154101|19229489|P5|Overall Study|Adverse Event|0
5564327|NCT01154101|19229490|P4|Overall Study|Adverse Event|1
5564328|NCT01154101|19229491|P3|Overall Study|Adverse Event|1
5564329|NCT01154101|19229492|P2|Overall Study|Adverse Event|2
5564330|NCT01154101|19229493|P1|Overall Study|Adverse Event|0
5564331|NCT01154088|19229548|P3|Overall Study|Lost to Follow-up|7
5564332|NCT01154088|19229549|P2|Overall Study|Lost to Follow-up|6
5564333|NCT01154088|19229550|P1|Overall Study|Lost to Follow-up|4
5564334|NCT01154036|19229590|P8|Phase II|Withdrawal by Subject|4
5564335|NCT01154036|19229591|P7|Phase II|Withdrawal by Subject|5
5564336|NCT01154036|19229592|P6|Phase II|Withdrawal by Subject|2
5564337|NCT01154036|19229593|P5|Phase II|Withdrawal by Subject|4
5564338|NCT01154036|19229594|P4|Phase II|Withdrawal by Subject|0
5564339|NCT01154036|19229595|P3|Phase II|Withdrawal by Subject|0
5564340|NCT01154036|19229596|P2|Phase II|Withdrawal by Subject|0
5564341|NCT01154036|19229597|P1|Phase II|Withdrawal by Subject|0
5564342|NCT01154036|19229590|P8|Phase II|Protocol Violation|0
5564343|NCT01154036|19229591|P7|Phase II|Protocol Violation|0
5564344|NCT01154036|19229592|P6|Phase II|Protocol Violation|2
5564345|NCT01154036|19229593|P5|Phase II|Protocol Violation|1
5564346|NCT01154036|19229594|P4|Phase II|Protocol Violation|0
5564347|NCT01154036|19229595|P3|Phase II|Protocol Violation|0
5564348|NCT01154036|19229596|P2|Phase II|Protocol Violation|0
5564349|NCT01154036|19229597|P1|Phase II|Protocol Violation|0
5564350|NCT01154036|19229590|P8|Phase II|Lost to Follow-up|1
5564351|NCT01154036|19229591|P7|Phase II|Lost to Follow-up|2
5564352|NCT01154036|19229592|P6|Phase II|Lost to Follow-up|0
5564353|NCT01154036|19229593|P5|Phase II|Lost to Follow-up|2
5564354|NCT01154036|19229594|P4|Phase II|Lost to Follow-up|1
5564355|NCT01154036|19229595|P3|Phase II|Lost to Follow-up|0
5564356|NCT01154036|19229596|P2|Phase II|Lost to Follow-up|0
5564357|NCT01154036|19229597|P1|Phase II|Lost to Follow-up|0
5564358|NCT01154036|19229590|P8|Phase II|Physician Decision|0
5564359|NCT01154036|19229591|P7|Phase II|Physician Decision|1
5564360|NCT01154036|19229592|P6|Phase II|Physician Decision|0
5564361|NCT01154036|19229593|P5|Phase II|Physician Decision|0
5564362|NCT01154036|19229594|P4|Phase II|Physician Decision|0
5564363|NCT01154036|19229595|P3|Phase II|Physician Decision|0
5564364|NCT01154036|19229596|P2|Phase II|Physician Decision|0
5564365|NCT01154036|19229597|P1|Phase II|Physician Decision|0
5564366|NCT01154036|19229590|P8|Phase II|Adverse Event|1
5564367|NCT01154036|19229591|P7|Phase II|Adverse Event|1
5564368|NCT01154036|19229592|P6|Phase II|Adverse Event|1
5564369|NCT01154036|19229593|P5|Phase II|Adverse Event|1
5564370|NCT01154036|19229594|P4|Phase II|Adverse Event|0
5564371|NCT01154036|19229595|P3|Phase II|Adverse Event|0
5564372|NCT01154036|19229596|P2|Phase II|Adverse Event|0
5564373|NCT01154036|19229597|P1|Phase II|Adverse Event|0
5564374|NCT01154036|19229590|P8|Phase I|Adverse Event|0
5564375|NCT01154036|19229591|P7|Phase I|Adverse Event|0
5564376|NCT01154036|19229592|P6|Phase I|Adverse Event|0
5564377|NCT01154036|19229593|P5|Phase I|Adverse Event|0
5564378|NCT01154036|19229594|P4|Phase I|Adverse Event|0
5564379|NCT01154036|19229595|P3|Phase I|Adverse Event|12
5564380|NCT01154036|19229596|P2|Phase I|Adverse Event|11
5564381|NCT01154036|19229597|P1|Phase I|Adverse Event|1
5564382|NCT01154036|19229590|P8|Phase I|Withdrawal by Subject|0
5564383|NCT01154036|19229591|P7|Phase I|Withdrawal by Subject|0
5564384|NCT01154036|19229592|P6|Phase I|Withdrawal by Subject|0
5564385|NCT01154036|19229593|P5|Phase I|Withdrawal by Subject|0
5564386|NCT01154036|19229594|P4|Phase I|Withdrawal by Subject|0
5564387|NCT01154036|19229595|P3|Phase I|Withdrawal by Subject|29
5564388|NCT01154036|19229596|P2|Phase I|Withdrawal by Subject|10
5564389|NCT01154036|19229597|P1|Phase I|Withdrawal by Subject|2
5564390|NCT01154036|19229590|P8|Phase I|Protocol Violation|0
5564391|NCT01154036|19229591|P7|Phase I|Protocol Violation|0
5564392|NCT01154036|19229592|P6|Phase I|Protocol Violation|0
5564393|NCT01154036|19229593|P5|Phase I|Protocol Violation|0
5564394|NCT01154036|19229594|P4|Phase I|Protocol Violation|0
5564395|NCT01154036|19229595|P3|Phase I|Protocol Violation|9
5564396|NCT01154036|19229596|P2|Phase I|Protocol Violation|3
5564397|NCT01154036|19229597|P1|Phase I|Protocol Violation|0
5564398|NCT01154036|19229590|P8|Phase I|Lost to Follow-up|0
5564399|NCT01154036|19229591|P7|Phase I|Lost to Follow-up|0
5564400|NCT01154036|19229592|P6|Phase I|Lost to Follow-up|0
5564401|NCT01154036|19229593|P5|Phase I|Lost to Follow-up|0
5564402|NCT01154036|19229594|P4|Phase I|Lost to Follow-up|0
5564403|NCT01154036|19229595|P3|Phase I|Lost to Follow-up|6
5564404|NCT01154036|19229596|P2|Phase I|Lost to Follow-up|3
5564405|NCT01154036|19229597|P1|Phase I|Lost to Follow-up|0
5564406|NCT01154036|19229590|P8|Phase I|Physician Decision|0
5564407|NCT01154036|19229591|P7|Phase I|Physician Decision|0
5564408|NCT01154036|19229592|P6|Phase I|Physician Decision|0
5564409|NCT01154036|19229593|P5|Phase I|Physician Decision|0
5564410|NCT01154036|19229594|P4|Phase I|Physician Decision|0
5564411|NCT01154036|19229595|P3|Phase I|Physician Decision|0
5564412|NCT01154036|19229596|P2|Phase I|Physician Decision|1
5564413|NCT01154036|19229597|P1|Phase I|Physician Decision|0
5564414|NCT01154010|19229721|P2|Overall Study|Lost to Follow-up|1
5564415|NCT01154010|19229722|P1|Overall Study|Lost to Follow-up|0
5564416|NCT01153984|19229728|P1|Overall Study|Adverse Event|1
5564417|NCT01153984|19229728|P1|Overall Study|Withdrawal by Subject|1
5564418|NCT01153971|19229739|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
5564419|NCT01153971|19229739|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
5564420|NCT01153971|19229739|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
5564421|NCT01153971|19229739|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
5564422|NCT01153971|19229739|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
5564423|NCT01153971|19229739|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
5564424|NCT01153971|19229739|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
5564425|NCT01153958|19229762|P2|Overall Study|Study Terminated|32
5564426|NCT01153958|19229763|P1|Overall Study|Study Terminated|36
5564427|NCT01153893|19229781|P2|Overall Study|Adverse Event|0
5564428|NCT01153893|19229782|P1|Overall Study|Adverse Event|1
5564429|NCT01153841|19229808|P2|Overall Study|Lost to Follow-up|0
5564430|NCT01153841|19229809|P1|Overall Study|Lost to Follow-up|2
5564431|NCT01153841|19229808|P2|Overall Study|Protocol Violation|0
5564432|NCT01153841|19229809|P1|Overall Study|Protocol Violation|2
5564433|NCT01153841|19229808|P2|Overall Study|Withdrawal by Subject|0
5564434|NCT01153841|19229809|P1|Overall Study|Withdrawal by Subject|1
5564435|NCT01153841|19229808|P2|Overall Study|Adverse Event|0
5564436|NCT01153841|19229809|P1|Overall Study|Adverse Event|1
5564437|NCT01153815|19229825|P2|Overall Study|Withdrawal by Subject|4
5564438|NCT01153815|19229826|P1|Overall Study|Withdrawal by Subject|6
5564439|NCT01153815|19229825|P2|Overall Study|Adverse Event|1
5564440|NCT01153815|19229826|P1|Overall Study|Adverse Event|3
5564441|NCT01153763|19229848|P1|Overall Study|Withdrawal by Subject|2
5564442|NCT01153763|19229848|P1|Overall Study|Physician Decision|2
5564443|NCT01153763|19229848|P1|Overall Study|Lost to Follow-up|1
5564444|NCT01153763|19229848|P1|Overall Study|Study Closed|16
5564445|NCT01153724|19229864|P1|Treatment Period 2|Other reason not defined above|1
5564446|NCT01153724|19229864|P1|Treatment Period 2|Adverse Event|1
5564447|NCT01153724|19229864|P1|Treatment Period 1|Withdrawal by Subject|1
5564448|NCT01153698|19229904|P1|Overall Study|Not treated with Pradaxa|5
5564449|NCT01153698|19229904|P1|Overall Study|Other|2
5564450|NCT01153698|19229904|P1|Overall Study|Switch to other anticoagulants|4
5564451|NCT01153698|19229904|P1|Overall Study|Withdrawal by Subject|2
5564452|NCT01153698|19229904|P1|Overall Study|Lost to Follow-up|4
5564453|NCT01153698|19229904|P1|Overall Study|Adverse Event|12
5564454|NCT01153633|19229955|P2|Overall Study|Therapeutic failure|3
5564455|NCT01153633|19229956|P1|Overall Study|Therapeutic failure|3
5564456|NCT01153633|19229955|P2|Overall Study|Protocol Violation|1
5564457|NCT01153633|19229956|P1|Overall Study|Protocol Violation|1
5564458|NCT01153516|19229993|P2|Overall Study|Both subjects refused surgery|0
5564459|NCT01153516|19229994|P1|Overall Study|Both subjects refused surgery|2
5564460|NCT01153425|19230019|P2|Overall Study|Withdrawal by Subject|3
5564461|NCT01153425|19230020|P1|Overall Study|Withdrawal by Subject|3
5564462|NCT01153347|19230032|P4|Overall Study|Death|0
5564463|NCT01153347|19230033|P3|Overall Study|Death|0
5564464|NCT01153347|19230034|P2|Overall Study|Death|0
5564465|NCT01153347|19230035|P1|Overall Study|Death|1
5564466|NCT01153347|19230032|P4|Overall Study|Other|0
5564467|NCT01153347|19230033|P3|Overall Study|Other|4
5564468|NCT01153347|19230034|P2|Overall Study|Other|5
5564469|NCT01153347|19230035|P1|Overall Study|Other|5
5564470|NCT01153347|19230032|P4|Overall Study|Lost to Follow-up|8
5564471|NCT01153347|19230033|P3|Overall Study|Lost to Follow-up|11
5564472|NCT01153347|19230034|P2|Overall Study|Lost to Follow-up|9
5564473|NCT01153347|19230035|P1|Overall Study|Lost to Follow-up|4
5564474|NCT01153347|19230032|P4|Overall Study|Study-specific withdrawal criteria|2
5564475|NCT01153347|19230033|P3|Overall Study|Study-specific withdrawal criteria|1
5564476|NCT01153347|19230034|P2|Overall Study|Study-specific withdrawal criteria|3
5564477|NCT01153347|19230035|P1|Overall Study|Study-specific withdrawal criteria|4
5564478|NCT01153347|19230032|P4|Overall Study|Lack of Efficacy|4
5564479|NCT01153347|19230033|P3|Overall Study|Lack of Efficacy|0
5564480|NCT01153347|19230034|P2|Overall Study|Lack of Efficacy|2
5564481|NCT01153347|19230035|P1|Overall Study|Lack of Efficacy|2
5564482|NCT01153347|19230032|P4|Overall Study|Condition under investigation worsened|0
5564483|NCT01153347|19230033|P3|Overall Study|Condition under investigation worsened|0
5564484|NCT01153347|19230034|P2|Overall Study|Condition under investigation worsened|1
5564485|NCT01153347|19230035|P1|Overall Study|Condition under investigation worsened|1
5564486|NCT01153347|19230032|P4|Overall Study|Severe non-compliance to protocol|3
5564487|NCT01153347|19230033|P3|Overall Study|Severe non-compliance to protocol|4
5564488|NCT01153347|19230034|P2|Overall Study|Severe non-compliance to protocol|7
5564489|NCT01153347|19230035|P1|Overall Study|Severe non-compliance to protocol|6
5564490|NCT01153347|19230032|P4|Overall Study|Adverse Event|7
5564491|NCT01153347|19230033|P3|Overall Study|Adverse Event|21
5564492|NCT01153347|19230034|P2|Overall Study|Adverse Event|9
5564493|NCT01153347|19230035|P1|Overall Study|Adverse Event|3
5564494|NCT01153347|19230032|P4|Overall Study|Eligibility criteria not fulfilled|1
5564495|NCT01153347|19230033|P3|Overall Study|Eligibility criteria not fulfilled|2
5564496|NCT01153347|19230034|P2|Overall Study|Eligibility criteria not fulfilled|1
5564497|NCT01153347|19230035|P1|Overall Study|Eligibility criteria not fulfilled|0
5564498|NCT01153347|19230032|P4|Overall Study|Withdrawal by Subject|7
5564499|NCT01153347|19230033|P3|Overall Study|Withdrawal by Subject|7
5564500|NCT01153347|19230034|P2|Overall Study|Withdrawal by Subject|7
5564501|NCT01153347|19230035|P1|Overall Study|Withdrawal by Subject|7
5564502|NCT01153321|19230135|P2|Overall Study|Adverse Event|1
5564503|NCT01153321|19230136|P1|Overall Study|Adverse Event|1
5564504|NCT01153321|19230135|P2|Overall Study|Withdrawal by Subject|1
5564505|NCT01153321|19230136|P1|Overall Study|Withdrawal by Subject|0
5564506|NCT01153321|19230135|P2|Overall Study|Development of study withdrawal criteria|1
5564507|NCT01153321|19230136|P1|Overall Study|Development of study withdrawal criteria|0
5564508|NCT01153269|19230248|P1|Overall Study|Antiretroviral therapy break|1
5564509|NCT01153269|19230248|P1|Overall Study|Withdrawal by Subject|1
5564510|NCT01153009|19230311|P4|Overall Study|Other|2
5564511|NCT01153009|19230312|P3|Overall Study|Other|3
5564512|NCT01153009|19230313|P2|Overall Study|Other|1
5564513|NCT01153009|19230314|P1|Overall Study|Other|1
5564514|NCT01153009|19230311|P4|Overall Study|Lost to Follow-up|15
5564515|NCT01153009|19230312|P3|Overall Study|Lost to Follow-up|11
5564516|NCT01153009|19230313|P2|Overall Study|Lost to Follow-up|8
5564517|NCT01153009|19230314|P1|Overall Study|Lost to Follow-up|8
5564518|NCT01153009|19230311|P4|Overall Study|Withdrawal of Consent|6
5564519|NCT01153009|19230312|P3|Overall Study|Withdrawal of Consent|4
5564520|NCT01153009|19230313|P2|Overall Study|Withdrawal of Consent|5
5564521|NCT01153009|19230314|P1|Overall Study|Withdrawal of Consent|5
5564522|NCT01153009|19230311|P4|Overall Study|Protocol Deviations|2
5564523|NCT01153009|19230312|P3|Overall Study|Protocol Deviations|3
5564524|NCT01153009|19230313|P2|Overall Study|Protocol Deviations|3
5564525|NCT01153009|19230314|P1|Overall Study|Protocol Deviations|4
5564526|NCT01153009|19230311|P4|Overall Study|Noncompliance with Study Medication|1
5564527|NCT01153009|19230312|P3|Overall Study|Noncompliance with Study Medication|4
5564528|NCT01153009|19230313|P2|Overall Study|Noncompliance with Study Medication|3
5564529|NCT01153009|19230314|P1|Overall Study|Noncompliance with Study Medication|1
5564530|NCT01153009|19230311|P4|Overall Study|Lack of Efficacy|1
5564531|NCT01153009|19230312|P3|Overall Study|Lack of Efficacy|2
5564532|NCT01153009|19230313|P2|Overall Study|Lack of Efficacy|0
5564533|NCT01153009|19230314|P1|Overall Study|Lack of Efficacy|9
5564534|NCT01153009|19230311|P4|Overall Study|Adverse Event|10
5564535|NCT01153009|19230312|P3|Overall Study|Adverse Event|14
5564536|NCT01153009|19230313|P2|Overall Study|Adverse Event|14
5564537|NCT01153009|19230314|P1|Overall Study|Adverse Event|4
5564538|NCT01152996|19230344|P1|Overall Study|Elevated liver enzymes|1
5564539|NCT01152996|19230344|P1|Overall Study|Protocol Violation|22
5564540|NCT01152996|19230344|P1|Overall Study|Other|36
5564541|NCT01152996|19230344|P1|Overall Study|Noncompliance|41
5564542|NCT01152996|19230344|P1|Overall Study|Lack of Efficacy|68
5564543|NCT01152996|19230344|P1|Overall Study|Lost to Follow-up|112
5564544|NCT01152996|19230344|P1|Overall Study|Adverse Event|115
5564545|NCT01152996|19230344|P1|Overall Study|Withdrawal by Subject|142
5564546|NCT01152814|19230357|P1|Overall Study|Lost to Follow-up|2
5564547|NCT01152788|19230366|P2|Overall Study|No treatment|1
5564548|NCT01152788|19230367|P1|Overall Study|No treatment|0
5564549|NCT01152788|19230366|P2|Overall Study|Withdrawal by Subject|3
5564550|NCT01152788|19230367|P1|Overall Study|Withdrawal by Subject|0
5564551|NCT01152580|19230404|P2|Overall Study|Withdrawal by Subject|1
5564552|NCT01152580|19230405|P1|Overall Study|Withdrawal by Subject|0
5564553|NCT01152554|19230427|P2|Overall Study|Death|1
5564554|NCT01152554|19230428|P1|Overall Study|Death|1
5564555|NCT01152554|19230427|P2|Overall Study|Other|8
5564556|NCT01152554|19230428|P1|Overall Study|Other|28
5564557|NCT01152554|19230427|P2|Overall Study|Lost to Follow-up|32
5564558|NCT01152554|19230428|P1|Overall Study|Lost to Follow-up|87
5564559|NCT01152554|19230427|P2|Overall Study|Study-specific withdrawal criteria|8
5564560|NCT01152554|19230428|P1|Overall Study|Study-specific withdrawal criteria|17
5564561|NCT01152554|19230427|P2|Overall Study|Lack of Efficacy|3
5564562|NCT01152554|19230428|P1|Overall Study|Lack of Efficacy|20
5564563|NCT01152554|19230427|P2|Overall Study|Condition under investigation worsened|2
5564564|NCT01152554|19230428|P1|Overall Study|Condition under investigation worsened|5
5564565|NCT01152554|19230427|P2|Overall Study|Severe non-compliance to protocol|14
5564566|NCT01152554|19230428|P1|Overall Study|Severe non-compliance to protocol|36
5564567|NCT01152554|19230427|P2|Overall Study|Adverse Event|14
5564568|NCT01152554|19230428|P1|Overall Study|Adverse Event|67
5564569|NCT01152554|19230427|P2|Overall Study|Eligiblity criteria not fulfilled|1
5564570|NCT01152554|19230428|P1|Overall Study|Eligiblity criteria not fulfilled|0
5564571|NCT01152554|19230427|P2|Overall Study|Withdrawal by Subject|28
5564572|NCT01152554|19230428|P1|Overall Study|Withdrawal by Subject|73
5564573|NCT01152450|19230467|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
5564574|NCT01152450|19230468|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
5564575|NCT01152450|19230469|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
5564576|NCT01152450|19230470|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
5564577|NCT01152450|19230471|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
5564578|NCT01152450|19230472|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
5564579|NCT01152450|19230467|P6|Period 1 (4 Weeks)|Protocol Violation|0
5564580|NCT01152450|19230468|P5|Period 1 (4 Weeks)|Protocol Violation|1
5564581|NCT01152450|19230469|P4|Period 1 (4 Weeks)|Protocol Violation|0
5564582|NCT01152450|19230470|P3|Period 1 (4 Weeks)|Protocol Violation|0
5564583|NCT01152450|19230471|P2|Period 1 (4 Weeks)|Protocol Violation|0
5564584|NCT01152450|19230472|P1|Period 1 (4 Weeks)|Protocol Violation|0
5564585|NCT01152450|19230467|P6|Period 1 (4 Weeks)|Adverse Event|1
5564586|NCT01152450|19230468|P5|Period 1 (4 Weeks)|Adverse Event|1
5564587|NCT01152450|19230469|P4|Period 1 (4 Weeks)|Adverse Event|0
5564588|NCT01152450|19230470|P3|Period 1 (4 Weeks)|Adverse Event|0
5564589|NCT01152450|19230471|P2|Period 1 (4 Weeks)|Adverse Event|0
5564590|NCT01152450|19230472|P1|Period 1 (4 Weeks)|Adverse Event|0
5564591|NCT01152437|19230543|P3|Overall Study|Refusal to continue taking trial medicat|2
5564592|NCT01152437|19230544|P2|Overall Study|Refusal to continue taking trial medicat|0
5564593|NCT01152437|19230545|P1|Overall Study|Refusal to continue taking trial medicat|1
5564594|NCT01152437|19230543|P3|Overall Study|Progressive disease|32
5564595|NCT01152437|19230544|P2|Overall Study|Progressive disease|13
5564596|NCT01152437|19230545|P1|Overall Study|Progressive disease|27
5564597|NCT01152437|19230543|P3|Overall Study|Not treated|2
5564598|NCT01152437|19230544|P2|Overall Study|Not treated|1
5564599|NCT01152437|19230545|P1|Overall Study|Not treated|0
5564600|NCT01152437|19230543|P3|Overall Study|Other Adverse Event|7
5564601|NCT01152437|19230544|P2|Overall Study|Other Adverse Event|1
5564602|NCT01152437|19230545|P1|Overall Study|Other Adverse Event|8
5564603|NCT01152385|19230565|P4|Overall Study|Other|3
5564604|NCT01152385|19230566|P3|Overall Study|Other|2
5564605|NCT01152385|19230567|P2|Overall Study|Other|3
5564606|NCT01152385|19230568|P1|Overall Study|Other|4
5564607|NCT01152385|19230565|P4|Overall Study|Study-specific withdrawal criteria|0
5564608|NCT01152385|19230566|P3|Overall Study|Study-specific withdrawal criteria|2
5564609|NCT01152385|19230567|P2|Overall Study|Study-specific withdrawal criteria|1
5564610|NCT01152385|19230568|P1|Overall Study|Study-specific withdrawal criteria|1
5564611|NCT01152385|19230565|P4|Overall Study|Adverse Event|0
5564612|NCT01152385|19230566|P3|Overall Study|Adverse Event|0
5564613|NCT01152385|19230567|P2|Overall Study|Adverse Event|1
5564614|NCT01152385|19230568|P1|Overall Study|Adverse Event|1
5564615|NCT01152385|19230565|P4|Overall Study|Protocol Violation|1
5564616|NCT01152385|19230566|P3|Overall Study|Protocol Violation|0
5564617|NCT01152385|19230567|P2|Overall Study|Protocol Violation|0
5564618|NCT01152385|19230568|P1|Overall Study|Protocol Violation|0
5564619|NCT01152385|19230565|P4|Overall Study|Withdrawal by Subject|1
5564620|NCT01152385|19230566|P3|Overall Study|Withdrawal by Subject|1
5564621|NCT01152385|19230567|P2|Overall Study|Withdrawal by Subject|1
5564622|NCT01152385|19230568|P1|Overall Study|Withdrawal by Subject|3
5564623|NCT01152190|19230639|P2|Overall Study|Withdrawal by Subject|3
5564624|NCT01152190|19230640|P1|Overall Study|Withdrawal by Subject|1
5564625|NCT01152190|19230639|P2|Overall Study|Protocol Violation|1
5564626|NCT01152190|19230640|P1|Overall Study|Protocol Violation|1
5564627|NCT01152190|19230639|P2|Overall Study|Death|0
5564628|NCT01152190|19230640|P1|Overall Study|Death|1
5564629|NCT01152190|19230639|P2|Overall Study|Adverse Event|4
5564630|NCT01152190|19230640|P1|Overall Study|Adverse Event|2
5564631|NCT01152021|19230663|P2|Overall Study|No access to study drug in Pharmacy|1
5564632|NCT01152021|19230664|P1|Overall Study|No access to study drug in Pharmacy|0
5564633|NCT01152021|19230663|P2|Overall Study|Physician Decision|1
5564634|NCT01152021|19230664|P1|Overall Study|Physician Decision|1
5564635|NCT01152021|19230663|P2|Overall Study|Study drug had expired|0
5564636|NCT01152021|19230664|P1|Overall Study|Study drug had expired|1
5564637|NCT01152021|19230663|P2|Overall Study|Adverse Event|4
5564638|NCT01152021|19230664|P1|Overall Study|Adverse Event|4
5564639|NCT01151618|19230721|P1|Overall Study|Withdrawal by Subject|7
5564640|NCT01151618|19230721|P1|Overall Study|Adverse Event|2
5564641|NCT01151579|19230729|P2|Overall Study|Not meet inclusion criteria|4
5564642|NCT01151579|19230730|P1|Overall Study|Not meet inclusion criteria|6
5564643|NCT01151579|19230729|P2|Overall Study|Withdrawal by Subject|2
5564644|NCT01151579|19230730|P1|Overall Study|Withdrawal by Subject|3
5564645|NCT01151579|19230729|P2|Overall Study|Physician Decision|1
5564646|NCT01151579|19230730|P1|Overall Study|Physician Decision|3
5564647|NCT01151540|19230744|P1|Overall Study|Withdrawal by Subject|7
5564648|NCT01151540|19230744|P1|Overall Study|Adverse event, non-fatal|4
5564649|NCT01151540|19230744|P1|Overall Study|Other|2
5564650|NCT01151423|19230793|P2|Overall Study|Participated in other clinical trial|0
5564651|NCT01151423|19230794|P1|Overall Study|Participated in other clinical trial|1
5564652|NCT01151423|19230793|P2|Overall Study|Diagnosed as non-TTP patient|1
5564653|NCT01151423|19230794|P1|Overall Study|Diagnosed as non-TTP patient|0
5564654|NCT01151423|19230793|P2|Overall Study|Lost to Follow-up|0
5564655|NCT01151423|19230794|P1|Overall Study|Lost to Follow-up|1
5564656|NCT01151423|19230793|P2|Overall Study|Withdrawal by Subject|3
5564657|NCT01151423|19230794|P1|Overall Study|Withdrawal by Subject|1
5564658|NCT01151423|19230793|P2|Overall Study|Adverse Event|0
5564659|NCT01151423|19230794|P1|Overall Study|Adverse Event|3
5564660|NCT01151423|19230793|P2|Overall Study|Death|1
5564661|NCT01151423|19230794|P1|Overall Study|Death|0
5564662|NCT01151423|19230793|P2|Overall Study|Pregnancy|1
5564663|NCT01151423|19230794|P1|Overall Study|Pregnancy|0
5564664|NCT01151423|19230793|P2|Overall Study|Physician Decision|1
5564665|NCT01151423|19230794|P1|Overall Study|Physician Decision|1
5564666|NCT01151423|19230793|P2|Overall Study|Protocol Violation|1
5564667|NCT01151423|19230794|P1|Overall Study|Protocol Violation|0
5564668|NCT01151423|19230793|P2|Overall Study|Study terminated by Sponsor|10
5564669|NCT01151423|19230794|P1|Overall Study|Study terminated by Sponsor|9
5564670|NCT01151410|19230842|P2|Overall Study|Abnormal laboratory value(s)|1
5564671|NCT01151410|19230843|P1|Overall Study|Abnormal laboratory value(s)|0
5564672|NCT01151410|19230842|P2|Overall Study|Unsatisfactory therapeutic effect|1
5564673|NCT01151410|19230843|P1|Overall Study|Unsatisfactory therapeutic effect|1
5564674|NCT01151410|19230842|P2|Overall Study|Administrative problems|1
5564675|NCT01151410|19230843|P1|Overall Study|Administrative problems|1
5564676|NCT01151410|19230842|P2|Overall Study|Protocol deviation|1
5564677|NCT01151410|19230843|P1|Overall Study|Protocol deviation|2
5564678|NCT01151410|19230842|P2|Overall Study|Adverse Event|2
5564679|NCT01151410|19230843|P1|Overall Study|Adverse Event|1
5564680|NCT01151410|19230842|P2|Overall Study|Lost to Follow-up|4
5564681|NCT01151410|19230843|P1|Overall Study|Lost to Follow-up|3
5564682|NCT01151410|19230842|P2|Overall Study|Withdrawal by Subject|5
5564683|NCT01151410|19230843|P1|Overall Study|Withdrawal by Subject|3
5564684|NCT01151345|19230887|P2|First Intervention Period|Protocol Violation|1
5564685|NCT01151345|19230888|P1|First Intervention Period|Protocol Violation|0
5564686|NCT01151280|19230902|P1|Overall Study|Lack of Efficacy|3
5564687|NCT01151280|19230902|P1|Overall Study|Adverse Event|1
5564688|NCT01151215|19230915|P3|Overall Study|Safety as judged by the investigator|1
5564689|NCT01151215|19230916|P2|Overall Study|Safety as judged by the investigator|0
5564690|NCT01151215|19230917|P1|Overall Study|Safety as judged by the investigator|0
5564691|NCT01151215|19230915|P3|Overall Study|Disease progression|1
5564692|NCT01151215|19230916|P2|Overall Study|Disease progression|1
5564693|NCT01151215|19230917|P1|Overall Study|Disease progression|0
5564694|NCT01151215|19230915|P3|Overall Study|Withdrawal by Subject|2
5564695|NCT01151215|19230916|P2|Overall Study|Withdrawal by Subject|1
5564696|NCT01151215|19230917|P1|Overall Study|Withdrawal by Subject|3
5564697|NCT01151215|19230915|P3|Overall Study|Lost to Follow-up|3
5564698|NCT01151215|19230916|P2|Overall Study|Lost to Follow-up|0
5564699|NCT01151215|19230917|P1|Overall Study|Lost to Follow-up|0
5564700|NCT01151215|19230915|P3|Overall Study|Death|11
5564701|NCT01151215|19230916|P2|Overall Study|Death|20
5564702|NCT01151215|19230917|P1|Overall Study|Death|16
5564703|NCT01151215|19230915|P3|Overall Study|Worsening of condition under study|1
5564704|NCT01151215|19230916|P2|Overall Study|Worsening of condition under study|1
5564705|NCT01151215|19230917|P1|Overall Study|Worsening of condition under study|1
5564706|NCT01151137|19230955|P2|Overall Study|Lost to Follow-up|1
5564707|NCT01151137|19230956|P1|Overall Study|Lost to Follow-up|1
5564708|NCT01151137|19230955|P2|Overall Study|Death|27
5564709|NCT01151137|19230956|P1|Overall Study|Death|15
5564710|NCT01151098|19230974|P1|Overall Study|Miscellaneous|13
5564711|NCT01151098|19230974|P1|Overall Study|Protocol Violation|1
5564712|NCT01151098|19230974|P1|Overall Study|Lack of Efficacy|15
5564713|NCT01151098|19230974|P1|Overall Study|Lost to Follow-up|6
5564714|NCT01151098|19230974|P1|Overall Study|Adverse Event|82
5564715|NCT01151085|19230978|P1|Overall Study|Protocol Violation|25
5564716|NCT01151085|19230978|P1|Overall Study|Lost to Follow-up|31
5564717|NCT01151020|19231009|P1|Overall Study|Still be eligible for follow-up|79
5564718|NCT01151020|19231009|P1|Overall Study|Patients did not receive the device|2
5564719|NCT01151020|19231009|P1|Overall Study|Withdrawal by Subject|12
5564720|NCT01151020|19231009|P1|Overall Study|Lost to Follow-up|1
5564721|NCT01151020|19231009|P1|Overall Study|Conversion to open repair|1
5564722|NCT01151020|19231009|P1|Overall Study|Death|15
5564723|NCT01150474|19231088|P2|Overall Study|Surgery Changed|0
5564724|NCT01150474|19231089|P1|Overall Study|Surgery Changed|1
5564725|NCT01150474|19231088|P2|Overall Study|Drug not administered|0
5564726|NCT01150474|19231089|P1|Overall Study|Drug not administered|1
5564727|NCT01150474|19231088|P2|Overall Study|Drug did not arrive in time|0
5564728|NCT01150474|19231089|P1|Overall Study|Drug did not arrive in time|1
5564729|NCT01150474|19231088|P2|Overall Study|Rectotomy|0
5564730|NCT01150474|19231089|P1|Overall Study|Rectotomy|1
5564731|NCT01150474|19231088|P2|Overall Study|Multiple Studies|1
5564732|NCT01150474|19231089|P1|Overall Study|Multiple Studies|0
5564733|NCT01150474|19231088|P2|Overall Study|Cancer found|0
5564734|NCT01150474|19231089|P1|Overall Study|Cancer found|1
5564735|NCT01150474|19231088|P2|Overall Study|Withdrawal by Subject|2
5564736|NCT01150474|19231089|P1|Overall Study|Withdrawal by Subject|5
5564737|NCT01150357|19231134|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
5564738|NCT01150357|19231135|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
5564739|NCT01150357|19231136|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
5564740|NCT01150357|19231134|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
5564741|NCT01150357|19231135|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
5564742|NCT01150357|19231136|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
5564743|NCT01150357|19231134|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
5564744|NCT01150357|19231135|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
5564745|NCT01150357|19231136|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
5564746|NCT01150357|19231134|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
5564747|NCT01150357|19231135|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
5564748|NCT01150357|19231136|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
5564749|NCT01150357|19231134|P3|Dose Response Phase (Phase 1)|Adverse Event|1
5564750|NCT01150357|19231135|P2|Dose Response Phase (Phase 1)|Adverse Event|0
5564751|NCT01150357|19231136|P1|Dose Response Phase (Phase 1)|Adverse Event|0
5564752|NCT01150357|19231134|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
5564753|NCT01150357|19231135|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
5564754|NCT01150357|19231136|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
5564755|NCT01150357|19231134|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
5564756|NCT01150357|19231135|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
5564757|NCT01150357|19231136|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
5564758|NCT01150123|19231216|P18|Overall Study|Lost to Follow-up|0
5564759|NCT01150123|19231217|P17|Overall Study|Lost to Follow-up|0
5564760|NCT01150123|19231218|P16|Overall Study|Lost to Follow-up|0
5564761|NCT01150123|19231219|P15|Overall Study|Lost to Follow-up|0
5564762|NCT01150123|19231220|P14|Overall Study|Lost to Follow-up|0
5564763|NCT01150123|19231221|P13|Overall Study|Lost to Follow-up|2
5564764|NCT01150123|19231222|P12|Overall Study|Lost to Follow-up|1
5564765|NCT01150123|19231223|P11|Overall Study|Lost to Follow-up|1
5564766|NCT01150123|19231224|P10|Overall Study|Lost to Follow-up|1
5564767|NCT01150123|19231225|P9|Overall Study|Lost to Follow-up|3
5564768|NCT01150123|19231226|P8|Overall Study|Lost to Follow-up|0
5564769|NCT01150123|19231227|P7|Overall Study|Lost to Follow-up|0
5564770|NCT01150123|19231228|P6|Overall Study|Lost to Follow-up|5
5564771|NCT01150123|19231229|P5|Overall Study|Lost to Follow-up|2
5564772|NCT01150123|19231230|P4|Overall Study|Lost to Follow-up|2
5564773|NCT01150123|19231231|P3|Overall Study|Lost to Follow-up|2
5564774|NCT01150123|19231232|P2|Overall Study|Lost to Follow-up|1
5564775|NCT01150123|19231233|P1|Overall Study|Lost to Follow-up|2
5564776|NCT01150123|19231216|P18|Overall Study|Withdrawal by Subject|1
5564777|NCT01150123|19231217|P17|Overall Study|Withdrawal by Subject|0
5564778|NCT01150123|19231218|P16|Overall Study|Withdrawal by Subject|1
5564779|NCT01150123|19231219|P15|Overall Study|Withdrawal by Subject|0
5564780|NCT01150123|19231220|P14|Overall Study|Withdrawal by Subject|0
5564781|NCT01150123|19231221|P13|Overall Study|Withdrawal by Subject|1
5564782|NCT01150123|19231222|P12|Overall Study|Withdrawal by Subject|0
5564783|NCT01150123|19231223|P11|Overall Study|Withdrawal by Subject|1
5564784|NCT01150123|19231224|P10|Overall Study|Withdrawal by Subject|0
5564785|NCT01150123|19231225|P9|Overall Study|Withdrawal by Subject|2
5564786|NCT01150123|19231226|P8|Overall Study|Withdrawal by Subject|3
5564787|NCT01150123|19231227|P7|Overall Study|Withdrawal by Subject|0
5564788|NCT01150123|19231228|P6|Overall Study|Withdrawal by Subject|1
5564789|NCT01150123|19231229|P5|Overall Study|Withdrawal by Subject|1
5564790|NCT01150123|19231230|P4|Overall Study|Withdrawal by Subject|1
5564791|NCT01150123|19231231|P3|Overall Study|Withdrawal by Subject|2
5564792|NCT01150123|19231232|P2|Overall Study|Withdrawal by Subject|1
5564793|NCT01150123|19231233|P1|Overall Study|Withdrawal by Subject|1
5564794|NCT01150097|19231409|P3|Months 24 to 48 Post-transplantation|Death|0
5564795|NCT01150097|19231410|P2|Months 24 to 48 Post-transplantation|Death|0
5564796|NCT01150097|19231411|P1|Months 24 to 48 Post-transplantation|Death|2
5564797|NCT01150097|19231409|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
5564798|NCT01150097|19231410|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
5564799|NCT01150097|19231411|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
5564800|NCT01150097|19231409|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
5564801|NCT01150097|19231410|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
5564802|NCT01150097|19231411|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
5564803|NCT01150097|19231409|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
5564804|NCT01150097|19231410|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
5564805|NCT01150097|19231411|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
5564806|NCT01150097|19231409|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
5564807|NCT01150097|19231410|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
5564808|NCT01150097|19231411|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
5564809|NCT01150097|19231409|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
5564810|NCT01150097|19231410|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
5564811|NCT01150097|19231411|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
5564812|NCT01150097|19231409|P3|Months 24 to 36 Post-transplantation|Death|0
5564813|NCT01150097|19231410|P2|Months 24 to 36 Post-transplantation|Death|0
5564814|NCT01150097|19231411|P1|Months 24 to 36 Post-transplantation|Death|2
5564815|NCT01149863|19231455|P1|Overall Study|Missing data or Not receiveing studydrug|3
5564816|NCT01149681|19231530|P1|Overall Study|adverse events nonrelated study drug|2
5564817|NCT01149681|19231530|P1|Overall Study|Physician Decision|2
5564818|NCT01149681|19231530|P1|Overall Study|Progressive disease|1
5564819|NCT01149681|19231530|P1|Overall Study|Withdrawal by Subject|7
5564820|NCT01149655|19231538|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
5564821|NCT01149655|19231539|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
5564822|NCT01149655|19231540|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
5564823|NCT01149655|19231541|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
5564824|NCT01149655|19231538|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
5564825|NCT01149655|19231539|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
5564826|NCT01149655|19231540|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
5564827|NCT01149655|19231541|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
5564828|NCT01149655|19231538|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
5564829|NCT01149655|19231539|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
5564830|NCT01149655|19231540|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
5564831|NCT01149655|19231541|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
5564832|NCT01149655|19231538|P4|Period 3-DB Maintenance Phase|Physician Decision|0
5564833|NCT01149655|19231539|P3|Period 3-DB Maintenance Phase|Physician Decision|1
5564834|NCT01149655|19231540|P2|Period 3-DB Maintenance Phase|Physician Decision|0
5564835|NCT01149655|19231541|P1|Period 3-DB Maintenance Phase|Physician Decision|0
5564836|NCT01149655|19231538|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
5564837|NCT01149655|19231539|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
5564838|NCT01149655|19231540|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
5564839|NCT01149655|19231541|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
5564840|NCT01149655|19231538|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
5564841|NCT01149655|19231539|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
5564842|NCT01149655|19231540|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
5564843|NCT01149655|19231541|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
5564844|NCT01149655|19231538|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
5564845|NCT01149655|19231539|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
5564846|NCT01149655|19231540|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
5564847|NCT01149655|19231541|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
5564848|NCT01149655|19231538|P4|Period 2-Stabilization Phase|Physician Decision|0
5564849|NCT01149655|19231539|P3|Period 2-Stabilization Phase|Physician Decision|0
5564850|NCT01149655|19231540|P2|Period 2-Stabilization Phase|Physician Decision|3
5564851|NCT01149655|19231541|P1|Period 2-Stabilization Phase|Physician Decision|0
5564852|NCT01149655|19231538|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
5564853|NCT01149655|19231539|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
5564854|NCT01149655|19231540|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
5564855|NCT01149655|19231541|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
5564856|NCT01149655|19231538|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
5564857|NCT01149655|19231539|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
5564858|NCT01149655|19231540|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
5564859|NCT01149655|19231541|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
5564860|NCT01149655|19231538|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
5564861|NCT01149655|19231539|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
5564862|NCT01149655|19231540|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
5564863|NCT01149655|19231541|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
5564864|NCT01149655|19231538|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
5564865|NCT01149655|19231539|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
5564866|NCT01149655|19231540|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
5564867|NCT01149655|19231541|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
5564868|NCT01149655|19231538|P4|Period 1 - Conversion Phase|Physician Decision|0
5564869|NCT01149655|19231539|P3|Period 1 - Conversion Phase|Physician Decision|0
5564870|NCT01149655|19231540|P2|Period 1 - Conversion Phase|Physician Decision|0
5564871|NCT01149655|19231541|P1|Period 1 - Conversion Phase|Physician Decision|2
5564872|NCT01149655|19231538|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5564873|NCT01149655|19231539|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5564874|NCT01149655|19231540|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5564875|NCT01149655|19231541|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
5564876|NCT01149655|19231538|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
5564877|NCT01149655|19231539|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
5564878|NCT01149655|19231540|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
5564879|NCT01149655|19231541|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
5564880|NCT01149655|19231538|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
5564881|NCT01149655|19231539|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
5564882|NCT01149655|19231540|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
5564883|NCT01149655|19231541|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
5564884|NCT01149538|19231584|P2|Overall Study|Withdrawal by Subject|3
5564885|NCT01149538|19231585|P1|Overall Study|Withdrawal by Subject|5
5564886|NCT01149538|19231584|P2|Overall Study|Lost to Follow-up|1
5564887|NCT01149538|19231585|P1|Overall Study|Lost to Follow-up|0
5564888|NCT01149486|19231606|P2|First Intervention|Adverse Event|1
5564889|NCT01149486|19231607|P1|First Intervention|Adverse Event|0
5564890|NCT01149473|19231631|P2|Washout of 7 Days|Withdrawal by Subject|1
5564891|NCT01149473|19231632|P1|Washout of 7 Days|Withdrawal by Subject|1
5564892|NCT01149473|19231631|P2|First Intervention|Adverse Event|1
5564893|NCT01149473|19231632|P1|First Intervention|Adverse Event|1
5564894|NCT01149460|19231650|P2|Overall Study|Withdrawal by Subject|2
5564895|NCT01149460|19231651|P1|Overall Study|Withdrawal by Subject|0
5564896|NCT01149421|19231684|P3|Overall Study|Protocol Violation|6
5564897|NCT01149421|19231685|P2|Overall Study|Protocol Violation|2
5564898|NCT01149421|19231686|P1|Overall Study|Protocol Violation|2
5564899|NCT01149421|19231684|P3|Overall Study|Entry Criteria Not Met|2
5564900|NCT01149421|19231685|P2|Overall Study|Entry Criteria Not Met|1
5564901|NCT01149421|19231686|P1|Overall Study|Entry Criteria Not Met|1
5564902|NCT01149421|19231684|P3|Overall Study|Physician Decision|6
5564903|NCT01149421|19231685|P2|Overall Study|Physician Decision|3
5564904|NCT01149421|19231686|P1|Overall Study|Physician Decision|5
5564905|NCT01149421|19231684|P3|Overall Study|Lost to Follow-up|5
5564906|NCT01149421|19231685|P2|Overall Study|Lost to Follow-up|4
5564907|NCT01149421|19231686|P1|Overall Study|Lost to Follow-up|2
5564908|NCT01149421|19231684|P3|Overall Study|Sponsor Decision|1
5564909|NCT01149421|19231685|P2|Overall Study|Sponsor Decision|1
5564910|NCT01149421|19231686|P1|Overall Study|Sponsor Decision|0
5564911|NCT01149421|19231684|P3|Overall Study|Withdrawal by Subject|13
5564912|NCT01149421|19231685|P2|Overall Study|Withdrawal by Subject|12
5564913|NCT01149421|19231686|P1|Overall Study|Withdrawal by Subject|20
5564914|NCT01149421|19231684|P3|Overall Study|Adverse Event|11
5564915|NCT01149421|19231685|P2|Overall Study|Adverse Event|6
5564916|NCT01149421|19231686|P1|Overall Study|Adverse Event|22
5564917|NCT01149369|19231767|P2|Overall Study|Adverse Event|3
5564918|NCT01149369|19231768|P1|Overall Study|Adverse Event|6
5564919|NCT01149343|19231936|P4|Overall Study|Recurrence / Progressive disease|0
5564920|NCT01149343|19231937|P3|Overall Study|Recurrence / Progressive disease|1
5564921|NCT01149343|19231938|P2|Overall Study|Recurrence / Progressive disease|0
5564922|NCT01149343|19231939|P1|Overall Study|Recurrence / Progressive disease|0
5564923|NCT01149343|19231936|P4|Overall Study|Sponsor study termination|2
5564924|NCT01149343|19231937|P3|Overall Study|Sponsor study termination|0
5564925|NCT01149343|19231938|P2|Overall Study|Sponsor study termination|0
5564926|NCT01149343|19231939|P1|Overall Study|Sponsor study termination|0
5564927|NCT01149343|19231936|P4|Overall Study|Other|14
5564928|NCT01149343|19231937|P3|Overall Study|Other|2
5564929|NCT01149343|19231938|P2|Overall Study|Other|10
5564930|NCT01149343|19231939|P1|Overall Study|Other|8
5564931|NCT01149343|19231936|P4|Overall Study|Lost to Follow-up|1
5564932|NCT01149343|19231937|P3|Overall Study|Lost to Follow-up|0
5564933|NCT01149343|19231938|P2|Overall Study|Lost to Follow-up|0
5564934|NCT01149343|19231939|P1|Overall Study|Lost to Follow-up|1
5564935|NCT01149343|19231936|P4|Overall Study|Death|18
5564936|NCT01149343|19231937|P3|Overall Study|Death|18
5564937|NCT01149343|19231938|P2|Overall Study|Death|13
5564938|NCT01149343|19231939|P1|Overall Study|Death|10
5564939|NCT01149343|19231936|P4|Overall Study|Withdrawal by Subject|5
5564940|NCT01149343|19231937|P3|Overall Study|Withdrawal by Subject|1
5564941|NCT01149343|19231938|P2|Overall Study|Withdrawal by Subject|1
5564942|NCT01149343|19231939|P1|Overall Study|Withdrawal by Subject|1
5564943|NCT01149148|19232024|P2|Overall Study|Death|0
5564944|NCT01149148|19232025|P1|Overall Study|Death|1
5564945|NCT01149148|19232024|P2|Overall Study|Lost to Follow-up|2
5564946|NCT01149148|19232025|P1|Overall Study|Lost to Follow-up|1
5564947|NCT01149096|19232035|P2|Overall Study|Lost to Follow-up|1
5564948|NCT01149096|19232036|P1|Overall Study|Lost to Follow-up|0
5564949|NCT01149057|19232060|P1|Overall Study|Other|6
5564950|NCT01149057|19232060|P1|Overall Study|High Parathyroid Hormone Value|1
5564951|NCT01149057|19232060|P1|Overall Study|Lost to Follow-up|1
5564952|NCT01149057|19232060|P1|Overall Study|Participant Non-Compliance|2
5564953|NCT01149057|19232060|P1|Overall Study|B Cell Depletion|4
5564954|NCT01149057|19232060|P1|Overall Study|Positive Hepatitis B Core Antibody|5
5564955|NCT01149057|19232060|P1|Overall Study|Withdrawal by Subject|9
5564956|NCT01149057|19232060|P1|Overall Study|Adverse Event|13
5564957|NCT01149057|19232060|P1|Overall Study|Lack of Efficacy|16
5564958|NCT01148979|19232087|P2|Overall Study|Lost to Follow-up|1
5564959|NCT01148979|19232088|P1|Overall Study|Lost to Follow-up|0
5564960|NCT01148862|19232106|P2|Second Intervention|Withdrawal by Subject|2
5564961|NCT01148862|19232107|P1|Second Intervention|Withdrawal by Subject|0
5564962|NCT01148810|19232139|P2|Overall Study|Protocol Violation|0
5564963|NCT01148810|19232140|P1|Overall Study|Protocol Violation|1
5564964|NCT01148810|19232139|P2|Overall Study|Withdrawal by Subject|2
5564965|NCT01148810|19232140|P1|Overall Study|Withdrawal by Subject|0
5564966|NCT01148810|19232139|P2|Overall Study|Lack of Efficacy|1
5564967|NCT01148810|19232140|P1|Overall Study|Lack of Efficacy|0
5564968|NCT01148810|19232139|P2|Overall Study|Adverse Event|2
5564969|NCT01148810|19232140|P1|Overall Study|Adverse Event|0
5564970|NCT01148771|19232167|P2|Washout Period|Withdrawal by Subject|1
5564971|NCT01148771|19232168|P1|Washout Period|Withdrawal by Subject|0
5564972|NCT01148693|19232188|P2|Overall Study|Attempts for cannulation were failed|10
5564973|NCT01148693|19232189|P1|Overall Study|Attempts for cannulation were failed|13
5564974|NCT01148537|19232209|P3|Overall Study|Adverse Event|1
5564975|NCT01148537|19232210|P2|Overall Study|Adverse Event|0
5564976|NCT01148537|19232211|P1|Overall Study|Adverse Event|2
5564977|NCT01148537|19232209|P3|Overall Study|Withdrawal by Subject|2
5564978|NCT01148537|19232210|P2|Overall Study|Withdrawal by Subject|0
5564979|NCT01148537|19232211|P1|Overall Study|Withdrawal by Subject|1
5564980|NCT01148511|19232297|P3|Randomized|Other|1
5564981|NCT01148511|19232298|P2|Randomized|Other|1
5564982|NCT01148511|19232299|P1|Randomized|Other|0
5564983|NCT01148511|19232297|P3|Randomized|Consent withdrawal|3
5564984|NCT01148511|19232298|P2|Randomized|Consent withdrawal|5
5564985|NCT01148511|19232299|P1|Randomized|Consent withdrawal|0
5564986|NCT01148511|19232297|P3|Randomized|Lost to Follow-up|1
5564987|NCT01148511|19232298|P2|Randomized|Lost to Follow-up|1
5564988|NCT01148511|19232299|P1|Randomized|Lost to Follow-up|0
5564989|NCT01148511|19232297|P3|Randomized|Protocol Violation|1
5564990|NCT01148511|19232298|P2|Randomized|Protocol Violation|2
5564991|NCT01148511|19232299|P1|Randomized|Protocol Violation|0
5564992|NCT01148511|19232297|P3|Randomized|Adverse Event|0
5564993|NCT01148511|19232298|P2|Randomized|Adverse Event|1
5564994|NCT01148511|19232299|P1|Randomized|Adverse Event|0
5564995|NCT01148511|19232297|P3|Exposed to Study Drug|Lost to Follow-up|0
5564996|NCT01148511|19232298|P2|Exposed to Study Drug|Lost to Follow-up|0
5564997|NCT01148511|19232299|P1|Exposed to Study Drug|Lost to Follow-up|4
5564998|NCT01148511|19232297|P3|Exposed to Study Drug|Protocol Violation|0
5564999|NCT01148511|19232298|P2|Exposed to Study Drug|Protocol Violation|0
5565000|NCT01148511|19232299|P1|Exposed to Study Drug|Protocol Violation|2
5565001|NCT01148459|19232320|P2|Overall Study|Failure to comply with study procedures|1
5565002|NCT01148459|19232321|P1|Overall Study|Failure to comply with study procedures|0
5565003|NCT01148459|19232320|P2|Overall Study|Refusal|0
5565004|NCT01148459|19232321|P1|Overall Study|Refusal|1
5565005|NCT01148459|19232320|P2|Overall Study|Lost to Follow-up|0
5565006|NCT01148459|19232321|P1|Overall Study|Lost to Follow-up|2
5565007|NCT01148459|19232320|P2|Overall Study|Migrated/moved from study area|6
5565008|NCT01148459|19232321|P1|Overall Study|Migrated/moved from study area|3
5565009|NCT01148459|19232320|P2|Overall Study|Withdrawal by Subject|0
5565010|NCT01148459|19232321|P1|Overall Study|Withdrawal by Subject|1
5565011|NCT01148459|19232320|P2|Overall Study|Serious Adverse Event|4
5565012|NCT01148459|19232321|P1|Overall Study|Serious Adverse Event|5
5565013|NCT01148225|19232369|P1|Overall Study|Other|185
5565014|NCT01148017|19232420|P4|Overall Study|Unable to classify|0
5565015|NCT01148017|19232421|P3|Overall Study|Unable to classify|0
5565016|NCT01148017|19232422|P2|Overall Study|Unable to classify|1
5565017|NCT01148017|19232423|P1|Overall Study|Unable to classify|3
5565018|NCT01148017|19232420|P4|Overall Study|Administrative reason|0
5565019|NCT01148017|19232421|P3|Overall Study|Administrative reason|0
5565020|NCT01148017|19232422|P2|Overall Study|Administrative reason|9
5565021|NCT01148017|19232423|P1|Overall Study|Administrative reason|22
5565022|NCT01148017|19232420|P4|Overall Study|Inappropriate enrollment|0
5565023|NCT01148017|19232421|P3|Overall Study|Inappropriate enrollment|0
5565024|NCT01148017|19232422|P2|Overall Study|Inappropriate enrollment|0
5565025|NCT01148017|19232423|P1|Overall Study|Inappropriate enrollment|1
5565026|NCT01148017|19232420|P4|Overall Study|Lost to Follow-up|0
5565027|NCT01148017|19232421|P3|Overall Study|Lost to Follow-up|0
5565028|NCT01148017|19232422|P2|Overall Study|Lost to Follow-up|10
5565029|NCT01148017|19232423|P1|Overall Study|Lost to Follow-up|23
5565030|NCT01148017|19232420|P4|Overall Study|Withdrawal by Subject|0
5565031|NCT01148017|19232421|P3|Overall Study|Withdrawal by Subject|0
5565032|NCT01148017|19232422|P2|Overall Study|Withdrawal by Subject|14
5565033|NCT01148017|19232423|P1|Overall Study|Withdrawal by Subject|31
5565034|NCT01147926|19232462|P2|Overall Study|Colonoscopy result|1
5565035|NCT01147926|19232463|P1|Overall Study|Colonoscopy result|0
5565036|NCT01147926|19232462|P2|Overall Study|Went on holiday|1
5565037|NCT01147926|19232463|P1|Overall Study|Went on holiday|0
5565038|NCT01147926|19232462|P2|Overall Study|Too busy, no time for study|0
5565039|NCT01147926|19232463|P1|Overall Study|Too busy, no time for study|1
5565040|NCT01147926|19232462|P2|Overall Study|Lack of Efficacy|0
5565041|NCT01147926|19232463|P1|Overall Study|Lack of Efficacy|1
5565042|NCT01147926|19232462|P2|Overall Study|Sponsor's Decision|1
5565043|NCT01147926|19232463|P1|Overall Study|Sponsor's Decision|0
5565044|NCT01147926|19232462|P2|Overall Study|Lost to Follow-up|2
5565045|NCT01147926|19232463|P1|Overall Study|Lost to Follow-up|0
5565046|NCT01147926|19232462|P2|Overall Study|Selection criteria not met|1
5565047|NCT01147926|19232463|P1|Overall Study|Selection criteria not met|3
5565048|NCT01147926|19232462|P2|Overall Study|Principal investigator left hospital|3
5565049|NCT01147926|19232463|P1|Overall Study|Principal investigator left hospital|1
5565050|NCT01147926|19232462|P2|Overall Study|Subject Non-Compliant|4
5565051|NCT01147926|19232463|P1|Overall Study|Subject Non-Compliant|5
5565052|NCT01147926|19232462|P2|Overall Study|Adverse Event|6
5565053|NCT01147926|19232463|P1|Overall Study|Adverse Event|7
5565054|NCT01147926|19232462|P2|Overall Study|Subject Withdrew Consent|10
5565055|NCT01147926|19232463|P1|Overall Study|Subject Withdrew Consent|9
5565056|NCT01147900|19232498|P3|At Year 10|Lost to Follow-up|0
5565057|NCT01147900|19232499|P2|At Year 10|Lost to Follow-up|1
5565058|NCT01147900|19232500|P1|At Year 10|Lost to Follow-up|0
5565059|NCT01147874|19232559|P1|Overall Study|Withdrawal by Subject|24
5565060|NCT01147874|19232559|P1|Overall Study|Sponsor's Decision|2
5565061|NCT01147874|19232559|P1|Overall Study|Protocol Violation|5
5565062|NCT01147874|19232559|P1|Overall Study|Other|5
5565063|NCT01147874|19232559|P1|Overall Study|Lost to Follow-up|25
5565064|NCT01147874|19232559|P1|Overall Study|Investigator's Request|1
5565065|NCT01147874|19232559|P1|Overall Study|Adverse Event|5
5565066|NCT01147848|19232567|P3|Randomized Phase|Withdrawal by Subject|9
5565067|NCT01147848|19232568|P2|Randomized Phase|Withdrawal by Subject|7
5565068|NCT01147848|19232569|P1|Randomized Phase|Withdrawal by Subject|0
5565069|NCT01147848|19232567|P3|Randomized Phase|Physician Decision|1
5565070|NCT01147848|19232568|P2|Randomized Phase|Physician Decision|0
5565071|NCT01147848|19232569|P1|Randomized Phase|Physician Decision|0
5565072|NCT01147848|19232567|P3|Randomized Phase|Lost to Follow-up|7
5565073|NCT01147848|19232568|P2|Randomized Phase|Lost to Follow-up|5
5565074|NCT01147848|19232569|P1|Randomized Phase|Lost to Follow-up|0
5565075|NCT01147848|19232567|P3|Randomized Phase|Protocol Violation|10
5565076|NCT01147848|19232568|P2|Randomized Phase|Protocol Violation|7
5565077|NCT01147848|19232569|P1|Randomized Phase|Protocol Violation|0
5565078|NCT01147848|19232567|P3|Randomized Phase|Lack of Efficacy|11
5565079|NCT01147848|19232568|P2|Randomized Phase|Lack of Efficacy|20
5565080|NCT01147848|19232569|P1|Randomized Phase|Lack of Efficacy|0
5565081|NCT01147848|19232567|P3|Randomized Phase|Adverse Event|8
5565082|NCT01147848|19232568|P2|Randomized Phase|Adverse Event|6
5565083|NCT01147848|19232569|P1|Randomized Phase|Adverse Event|0
5565084|NCT01147848|19232567|P3|Run-in Period|Run-in Failure|0
5565085|NCT01147848|19232568|P2|Run-in Period|Run-in Failure|0
5565086|NCT01147848|19232569|P1|Run-in Period|Run-in Failure|135
5565087|NCT01147848|19232567|P3|Run-in Period|Screen Failure|0
5565088|NCT01147848|19232568|P2|Run-in Period|Screen Failure|0
5565089|NCT01147848|19232569|P1|Run-in Period|Screen Failure|623
5565090|NCT01147822|19232601|P2|Overall Study|Not Completed/Ongoing|102
5565091|NCT01147822|19232602|P1|Overall Study|Not Completed/Ongoing|111
5565092|NCT01147822|19232601|P2|Overall Study|Withdrawal by Subject|13
5565093|NCT01147822|19232602|P1|Overall Study|Withdrawal by Subject|8
5565094|NCT01147822|19232601|P2|Overall Study|Physician Decision|2
5565095|NCT01147822|19232602|P1|Overall Study|Physician Decision|0
5565096|NCT01147822|19232601|P2|Overall Study|Lost to Follow-up|2
5565097|NCT01147822|19232602|P1|Overall Study|Lost to Follow-up|3
5565098|NCT01147822|19232601|P2|Overall Study|Protocol Violation|1
5565099|NCT01147822|19232602|P1|Overall Study|Protocol Violation|0
5565100|NCT01147822|19232601|P2|Overall Study|Death|59
5565101|NCT01147822|19232602|P1|Overall Study|Death|66
5565102|NCT01147809|19232622|P6|Phase II (168 Days)|Ongoing|0
5565103|NCT01147809|19232623|P5|Phase II (168 Days)|Ongoing|1
5565104|NCT01147809|19232624|P4|Phase II (168 Days)|Ongoing|0
5565105|NCT01147809|19232625|P3|Phase II (168 Days)|Ongoing|0
5565106|NCT01147809|19232626|P2|Phase II (168 Days)|Ongoing|0
5565107|NCT01147809|19232627|P1|Phase II (168 Days)|Ongoing|0
5565108|NCT01147809|19232622|P6|Phase II (168 Days)|Withdrawal by Subject|15
5565109|NCT01147809|19232623|P5|Phase II (168 Days)|Withdrawal by Subject|7
5565110|NCT01147809|19232624|P4|Phase II (168 Days)|Withdrawal by Subject|0
5565111|NCT01147809|19232625|P3|Phase II (168 Days)|Withdrawal by Subject|0
5565112|NCT01147809|19232626|P2|Phase II (168 Days)|Withdrawal by Subject|0
5565113|NCT01147809|19232627|P1|Phase II (168 Days)|Withdrawal by Subject|0
5565114|NCT01147809|19232622|P6|Phase II (168 Days)|Physician Decision|11
5565115|NCT01147809|19232623|P5|Phase II (168 Days)|Physician Decision|5
5565116|NCT01147809|19232624|P4|Phase II (168 Days)|Physician Decision|0
5565117|NCT01147809|19232625|P3|Phase II (168 Days)|Physician Decision|0
5565118|NCT01147809|19232626|P2|Phase II (168 Days)|Physician Decision|0
5565119|NCT01147809|19232627|P1|Phase II (168 Days)|Physician Decision|0
5565120|NCT01147809|19232622|P6|Phase II (168 Days)|Protocol Violation|1
5565121|NCT01147809|19232623|P5|Phase II (168 Days)|Protocol Violation|0
5565122|NCT01147809|19232624|P4|Phase II (168 Days)|Protocol Violation|0
5565123|NCT01147809|19232625|P3|Phase II (168 Days)|Protocol Violation|0
5565124|NCT01147809|19232626|P2|Phase II (168 Days)|Protocol Violation|0
5565125|NCT01147809|19232627|P1|Phase II (168 Days)|Protocol Violation|0
5565126|NCT01147809|19232622|P6|Phase II (168 Days)|Adverse Event|6
5565127|NCT01147809|19232623|P5|Phase II (168 Days)|Adverse Event|3
5565128|NCT01147809|19232624|P4|Phase II (168 Days)|Adverse Event|0
5565129|NCT01147809|19232625|P3|Phase II (168 Days)|Adverse Event|0
5565130|NCT01147809|19232626|P2|Phase II (168 Days)|Adverse Event|0
5565131|NCT01147809|19232627|P1|Phase II (168 Days)|Adverse Event|0
5565132|NCT01147809|19232622|P6|Phase I (168 Days)|Withdrawal by Subject|0
5565133|NCT01147809|19232623|P5|Phase I (168 Days)|Withdrawal by Subject|0
5565134|NCT01147809|19232624|P4|Phase I (168 Days)|Withdrawal by Subject|3
5565135|NCT01147809|19232625|P3|Phase I (168 Days)|Withdrawal by Subject|0
5565136|NCT01147809|19232626|P2|Phase I (168 Days)|Withdrawal by Subject|0
5565137|NCT01147809|19232627|P1|Phase I (168 Days)|Withdrawal by Subject|0
5565138|NCT01147809|19232622|P6|Phase I (168 Days)|Physician Decision|0
5565139|NCT01147809|19232623|P5|Phase I (168 Days)|Physician Decision|0
5565140|NCT01147809|19232624|P4|Phase I (168 Days)|Physician Decision|0
5565141|NCT01147809|19232625|P3|Phase I (168 Days)|Physician Decision|2
5565142|NCT01147809|19232626|P2|Phase I (168 Days)|Physician Decision|1
5565143|NCT01147809|19232627|P1|Phase I (168 Days)|Physician Decision|0
5565144|NCT01147809|19232622|P6|Phase I (168 Days)|Lost to Follow-up|0
5565145|NCT01147809|19232623|P5|Phase I (168 Days)|Lost to Follow-up|0
5565146|NCT01147809|19232624|P4|Phase I (168 Days)|Lost to Follow-up|1
5565147|NCT01147809|19232625|P3|Phase I (168 Days)|Lost to Follow-up|0
5565148|NCT01147809|19232626|P2|Phase I (168 Days)|Lost to Follow-up|0
5565149|NCT01147809|19232627|P1|Phase I (168 Days)|Lost to Follow-up|1
5565150|NCT01147809|19232622|P6|Phase I (168 Days)|Adverse Event|0
5565151|NCT01147809|19232623|P5|Phase I (168 Days)|Adverse Event|0
5565152|NCT01147809|19232624|P4|Phase I (168 Days)|Adverse Event|1
5565153|NCT01147809|19232625|P3|Phase I (168 Days)|Adverse Event|0
5565154|NCT01147809|19232626|P2|Phase I (168 Days)|Adverse Event|0
5565155|NCT01147809|19232627|P1|Phase I (168 Days)|Adverse Event|0
5565156|NCT01147744|19232748|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
5565157|NCT01147744|19232749|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
5565158|NCT01147744|19232750|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
5565159|NCT01147744|19232751|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
5565160|NCT01147744|19232752|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
5565161|NCT01147744|19232753|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
5565162|NCT01147744|19232754|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
5565163|NCT01147744|19232748|P7|Overall Study|Sponsor decision to amend protocol|6
5565164|NCT01147744|19232749|P6|Overall Study|Sponsor decision to amend protocol|2
5565165|NCT01147744|19232750|P5|Overall Study|Sponsor decision to amend protocol|7
5565166|NCT01147744|19232751|P4|Overall Study|Sponsor decision to amend protocol|5
5565167|NCT01147744|19232752|P3|Overall Study|Sponsor decision to amend protocol|2
5565168|NCT01147744|19232753|P2|Overall Study|Sponsor decision to amend protocol|4
5565169|NCT01147744|19232754|P1|Overall Study|Sponsor decision to amend protocol|7
5565170|NCT01147744|19232748|P7|Overall Study|Lost to Follow-up|0
5565171|NCT01147744|19232749|P6|Overall Study|Lost to Follow-up|0
5565172|NCT01147744|19232750|P5|Overall Study|Lost to Follow-up|0
5565173|NCT01147744|19232751|P4|Overall Study|Lost to Follow-up|0
5565174|NCT01147744|19232752|P3|Overall Study|Lost to Follow-up|0
5565175|NCT01147744|19232753|P2|Overall Study|Lost to Follow-up|1
5565176|NCT01147744|19232754|P1|Overall Study|Lost to Follow-up|0
5565177|NCT01147744|19232748|P7|Overall Study|Withdrawal by Subject|2
5565178|NCT01147744|19232749|P6|Overall Study|Withdrawal by Subject|5
5565179|NCT01147744|19232750|P5|Overall Study|Withdrawal by Subject|2
5565180|NCT01147744|19232751|P4|Overall Study|Withdrawal by Subject|2
5565181|NCT01147744|19232752|P3|Overall Study|Withdrawal by Subject|2
5565182|NCT01147744|19232753|P2|Overall Study|Withdrawal by Subject|4
5565183|NCT01147744|19232754|P1|Overall Study|Withdrawal by Subject|8
5565184|NCT01147744|19232748|P7|Overall Study|Adverse Event|2
5565185|NCT01147744|19232749|P6|Overall Study|Adverse Event|1
5565186|NCT01147744|19232750|P5|Overall Study|Adverse Event|2
5565187|NCT01147744|19232751|P4|Overall Study|Adverse Event|0
5565188|NCT01147744|19232752|P3|Overall Study|Adverse Event|3
5565189|NCT01147744|19232753|P2|Overall Study|Adverse Event|2
5565190|NCT01147744|19232754|P1|Overall Study|Adverse Event|1
5565191|NCT01147744|19232748|P7|Overall Study|Lack of Efficacy|7
5565192|NCT01147744|19232749|P6|Overall Study|Lack of Efficacy|8
5565193|NCT01147744|19232750|P5|Overall Study|Lack of Efficacy|13
5565194|NCT01147744|19232751|P4|Overall Study|Lack of Efficacy|11
5565195|NCT01147744|19232752|P3|Overall Study|Lack of Efficacy|9
5565196|NCT01147744|19232753|P2|Overall Study|Lack of Efficacy|11
5565197|NCT01147744|19232754|P1|Overall Study|Lack of Efficacy|11
5565198|NCT01147744|19232748|P7|Overall Study|Physician Decision|1
5565199|NCT01147744|19232749|P6|Overall Study|Physician Decision|0
5565200|NCT01147744|19232750|P5|Overall Study|Physician Decision|0
5565201|NCT01147744|19232751|P4|Overall Study|Physician Decision|0
5565202|NCT01147744|19232752|P3|Overall Study|Physician Decision|1
5565203|NCT01147744|19232753|P2|Overall Study|Physician Decision|1
5565204|NCT01147744|19232754|P1|Overall Study|Physician Decision|0
5565205|NCT01147744|19232748|P7|Overall Study|Protocol Violation|1
5565206|NCT01147744|19232749|P6|Overall Study|Protocol Violation|3
5565207|NCT01147744|19232750|P5|Overall Study|Protocol Violation|1
5565208|NCT01147744|19232751|P4|Overall Study|Protocol Violation|0
5565209|NCT01147744|19232752|P3|Overall Study|Protocol Violation|1
5565210|NCT01147744|19232753|P2|Overall Study|Protocol Violation|0
5565211|NCT01147744|19232754|P1|Overall Study|Protocol Violation|1
5565212|NCT01147653|19232849|P2|Year 2|Withdrawal by Subject|3
5565213|NCT01147653|19232850|P1|Year 2|Withdrawal by Subject|2
5565214|NCT01147640|19232911|P2|Overall Study|Didn't meet eligibility criteria|0
5565215|NCT01147640|19232912|P1|Overall Study|Didn't meet eligibility criteria|1
5565216|NCT01147640|19232911|P2|Overall Study|Lost to Follow-up|1
5565217|NCT01147640|19232912|P1|Overall Study|Lost to Follow-up|0
5565218|NCT01147640|19232911|P2|Overall Study|Withdrawal by Subject|0
5565219|NCT01147640|19232912|P1|Overall Study|Withdrawal by Subject|1
5565220|NCT01147640|19232911|P2|Overall Study|Physician Decision|0
5565221|NCT01147640|19232912|P1|Overall Study|Physician Decision|1
5565222|NCT01147640|19232911|P2|Overall Study|Adverse Event|0
5565223|NCT01147640|19232912|P1|Overall Study|Adverse Event|2
5565224|NCT01147497|19232944|P2|Overall Study|failed insertion|0
5565225|NCT01147497|19232945|P1|Overall Study|failed insertion|2
5565226|NCT01147471|19232965|P2|6 Month Follow Up|Lost to Follow-up|2
5565227|NCT01147471|19232966|P1|6 Month Follow Up|Lost to Follow-up|4
5565228|NCT01147471|19232965|P2|3 Month Follow Up|Physician Decision|1
5565229|NCT01147471|19232966|P1|3 Month Follow Up|Physician Decision|0
5565230|NCT01147471|19232965|P2|3 Month Follow Up|Lost to Follow-up|1
5565231|NCT01147471|19232966|P1|3 Month Follow Up|Lost to Follow-up|1
5565232|NCT01147471|19232965|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
5565233|NCT01147471|19232966|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
5565234|NCT01147471|19232965|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
5565235|NCT01147471|19232966|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
5565236|NCT01147471|19232965|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
5565237|NCT01147471|19232966|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
5565238|NCT01147458|19232980|P4|Second Intervention|Other|0
5565239|NCT01147458|19232981|P3|Second Intervention|Other|1
5565240|NCT01147458|19232982|P2|Second Intervention|Other|0
5565241|NCT01147458|19232983|P1|Second Intervention|Other|0
5565242|NCT01147458|19232980|P4|Second Intervention|Adverse Event|1
5565243|NCT01147458|19232981|P3|Second Intervention|Adverse Event|1
5565244|NCT01147458|19232982|P2|Second Intervention|Adverse Event|0
5565245|NCT01147458|19232983|P1|Second Intervention|Adverse Event|2
5565246|NCT01147458|19232980|P4|Second Intervention|Withdrawal by Subject|0
5565247|NCT01147458|19232981|P3|Second Intervention|Withdrawal by Subject|0
5565248|NCT01147458|19232982|P2|Second Intervention|Withdrawal by Subject|1
5565249|NCT01147458|19232983|P1|Second Intervention|Withdrawal by Subject|0
5565250|NCT01147458|19232980|P4|Second Intervention|Protocol Violation|0
5565251|NCT01147458|19232981|P3|Second Intervention|Protocol Violation|1
5565252|NCT01147458|19232982|P2|Second Intervention|Protocol Violation|1
5565253|NCT01147458|19232983|P1|Second Intervention|Protocol Violation|0
5565254|NCT01147458|19232980|P4|Second Intervention|Study terminated by sponsor|3
5565255|NCT01147458|19232981|P3|Second Intervention|Study terminated by sponsor|5
5565256|NCT01147458|19232982|P2|Second Intervention|Study terminated by sponsor|5
5565257|NCT01147458|19232983|P1|Second Intervention|Study terminated by sponsor|7
5565258|NCT01147458|19232980|P4|First Intervention|Other|0
5565259|NCT01147458|19232981|P3|First Intervention|Other|0
5565260|NCT01147458|19232982|P2|First Intervention|Other|2
5565261|NCT01147458|19232983|P1|First Intervention|Other|1
5565262|NCT01147458|19232980|P4|First Intervention|Adverse Event|3
5565263|NCT01147458|19232981|P3|First Intervention|Adverse Event|2
5565264|NCT01147458|19232982|P2|First Intervention|Adverse Event|3
5565265|NCT01147458|19232983|P1|First Intervention|Adverse Event|0
5565266|NCT01147458|19232980|P4|First Intervention|Withdrawal by Subject|0
5565267|NCT01147458|19232981|P3|First Intervention|Withdrawal by Subject|1
5565268|NCT01147458|19232982|P2|First Intervention|Withdrawal by Subject|0
5565269|NCT01147458|19232983|P1|First Intervention|Withdrawal by Subject|3
5565270|NCT01147458|19232980|P4|First Intervention|Protocol Violation|3
5565271|NCT01147458|19232981|P3|First Intervention|Protocol Violation|2
5565272|NCT01147458|19232982|P2|First Intervention|Protocol Violation|3
5565273|NCT01147458|19232983|P1|First Intervention|Protocol Violation|2
5565274|NCT01147458|19232980|P4|First Intervention|Study terminated by sponsor|8
5565275|NCT01147458|19232981|P3|First Intervention|Study terminated by sponsor|7
5565276|NCT01147458|19232982|P2|First Intervention|Study terminated by sponsor|8
5565277|NCT01147458|19232983|P1|First Intervention|Study terminated by sponsor|8
5565278|NCT01147393|19233062|P1|Dose Level -1|Dose Limited Toxicity|1
5565279|NCT01147393|19233062|P1|Dose Level 1|Dose limiting Toxicity|2
5565280|NCT01147341|19233083|P2|Open Label Period|Subject moved|0
5565281|NCT01147341|19233084|P1|Open Label Period|Subject moved|1
5565282|NCT01147341|19233083|P2|Open Label Period|Lack of Efficacy|0
5565283|NCT01147341|19233084|P1|Open Label Period|Lack of Efficacy|3
5565284|NCT01147341|19233083|P2|Double Blind Period|Withdrawal by Subject|1
5565285|NCT01147341|19233084|P1|Double Blind Period|Withdrawal by Subject|0
5565286|NCT01147341|19233083|P2|Double Blind Period|Lack of Efficacy|1
5565287|NCT01147341|19233084|P1|Double Blind Period|Lack of Efficacy|1
5565288|NCT01147250|19233147|P2|Overall Study|Other than specified|1
5565289|NCT01147250|19233148|P1|Overall Study|Other than specified|0
5565290|NCT01147250|19233147|P2|Overall Study|Site termination by sponsor|5
5565291|NCT01147250|19233148|P1|Overall Study|Site termination by sponsor|13
5565292|NCT01147250|19233147|P2|Overall Study|Withdrawal by Subject|88
5565293|NCT01147250|19233148|P1|Overall Study|Withdrawal by Subject|83
5565294|NCT01147250|19233147|P2|Overall Study|Lost to Follow-up|11
5565295|NCT01147250|19233148|P1|Overall Study|Lost to Follow-up|14
5565296|NCT01147172|19233160|P1|Overall Study|Lost to Follow-up|2
5565297|NCT01147172|19233160|P1|Overall Study|Withdrawal by Subject|2
5565298|NCT01147068|19233178|P7|Subjects That Completed Safety Follow-up|Ineligible|0
5565299|NCT01147068|19233179|P6|Subjects That Completed Safety Follow-up|Ineligible|0
5565300|NCT01147068|19233180|P5|Subjects That Completed Safety Follow-up|Ineligible|0
5565301|NCT01147068|19233181|P4|Subjects That Completed Safety Follow-up|Ineligible|0
5565302|NCT01147068|19233182|P3|Subjects That Completed Safety Follow-up|Ineligible|0
5565303|NCT01147068|19233183|P2|Subjects That Completed Safety Follow-up|Ineligible|1
5565304|NCT01147068|19233184|P1|Subjects That Completed Safety Follow-up|Ineligible|0
5565305|NCT01147068|19233178|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5565306|NCT01147068|19233179|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5565307|NCT01147068|19233180|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5565308|NCT01147068|19233181|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
5565309|NCT01147068|19233182|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5565310|NCT01147068|19233183|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5565311|NCT01147068|19233184|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
5565312|NCT01147068|19233178|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
5565313|NCT01147068|19233179|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
5565314|NCT01147068|19233180|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5565315|NCT01147068|19233181|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5565316|NCT01147068|19233182|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5565317|NCT01147068|19233183|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
5565318|NCT01147068|19233184|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
5565319|NCT01147068|19233178|P7|Subjects That Received 2nd Dose|Other|0
5565320|NCT01147068|19233179|P6|Subjects That Received 2nd Dose|Other|0
5565321|NCT01147068|19233180|P5|Subjects That Received 2nd Dose|Other|1
5565322|NCT01147068|19233181|P4|Subjects That Received 2nd Dose|Other|0
5565323|NCT01147068|19233182|P3|Subjects That Received 2nd Dose|Other|3
5565324|NCT01147068|19233183|P2|Subjects That Received 2nd Dose|Other|3
5565325|NCT01147068|19233184|P1|Subjects That Received 2nd Dose|Other|0
5565326|NCT01147068|19233178|P7|Subjects That Received 2nd Dose|Did not complete the study|0
5565327|NCT01147068|19233179|P6|Subjects That Received 2nd Dose|Did not complete the study|1
5565328|NCT01147068|19233180|P5|Subjects That Received 2nd Dose|Did not complete the study|0
5565329|NCT01147068|19233181|P4|Subjects That Received 2nd Dose|Did not complete the study|0
5565330|NCT01147068|19233182|P3|Subjects That Received 2nd Dose|Did not complete the study|0
5565331|NCT01147068|19233183|P2|Subjects That Received 2nd Dose|Did not complete the study|1
5565332|NCT01147068|19233184|P1|Subjects That Received 2nd Dose|Did not complete the study|0
5565333|NCT01147068|19233178|P7|Subjects That Received 2nd Dose|Ineligible|0
5565334|NCT01147068|19233179|P6|Subjects That Received 2nd Dose|Ineligible|0
5565335|NCT01147068|19233180|P5|Subjects That Received 2nd Dose|Ineligible|0
5565336|NCT01147068|19233181|P4|Subjects That Received 2nd Dose|Ineligible|0
5565337|NCT01147068|19233182|P3|Subjects That Received 2nd Dose|Ineligible|0
5565338|NCT01147068|19233183|P2|Subjects That Received 2nd Dose|Ineligible|1
5565339|NCT01147068|19233184|P1|Subjects That Received 2nd Dose|Ineligible|0
5565340|NCT01147068|19233178|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
5565341|NCT01147068|19233179|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
5565342|NCT01147068|19233180|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
5565343|NCT01147068|19233181|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
5565344|NCT01147068|19233182|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
5565345|NCT01147068|19233183|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
5565346|NCT01147068|19233184|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
5565347|NCT01147055|19233214|P2|First Intervention Period|Lost to Follow-up|0
5565348|NCT01147055|19233215|P1|First Intervention Period|Lost to Follow-up|1
5565349|NCT01146951|19233257|P2|Overall Study|Adverse Event|1
5565350|NCT01146951|19233258|P1|Overall Study|Adverse Event|4
5565351|NCT01146912|19233279|P8|Overall Study|Duplicate patient|0
5565352|NCT01146912|19233280|P7|Overall Study|Duplicate patient|0
5565353|NCT01146912|19233281|P6|Overall Study|Duplicate patient|0
5565354|NCT01146912|19233282|P5|Overall Study|Duplicate patient|0
5565355|NCT01146912|19233283|P4|Overall Study|Duplicate patient|0
5565356|NCT01146912|19233284|P3|Overall Study|Duplicate patient|1
5565357|NCT01146912|19233285|P2|Overall Study|Duplicate patient|0
5565358|NCT01146912|19233286|P1|Overall Study|Duplicate patient|0
5565359|NCT01146912|19233279|P8|Overall Study|< 14 weeks gestational age|0
5565360|NCT01146912|19233280|P7|Overall Study|< 14 weeks gestational age|0
5565361|NCT01146912|19233281|P6|Overall Study|< 14 weeks gestational age|0
5565362|NCT01146912|19233282|P5|Overall Study|< 14 weeks gestational age|0
5565363|NCT01146912|19233283|P4|Overall Study|< 14 weeks gestational age|2
5565364|NCT01146912|19233284|P3|Overall Study|< 14 weeks gestational age|3
5565365|NCT01146912|19233285|P2|Overall Study|< 14 weeks gestational age|0
5565366|NCT01146912|19233286|P1|Overall Study|< 14 weeks gestational age|0
5565367|NCT01146912|19233279|P8|Overall Study|Already received influenza vaccination|0
5565368|NCT01146912|19233280|P7|Overall Study|Already received influenza vaccination|56
5565369|NCT01146912|19233281|P6|Overall Study|Already received influenza vaccination|61
5565370|NCT01146912|19233282|P5|Overall Study|Already received influenza vaccination|41
5565371|NCT01146912|19233283|P4|Overall Study|Already received influenza vaccination|15
5565372|NCT01146912|19233284|P3|Overall Study|Already received influenza vaccination|13
5565373|NCT01146912|19233285|P2|Overall Study|Already received influenza vaccination|822
5565374|NCT01146912|19233286|P1|Overall Study|Already received influenza vaccination|817
5565375|NCT01146873|19233308|P2|Overall Study|Transfer out|6
5565376|NCT01146873|19233309|P1|Overall Study|Transfer out|0
5565377|NCT01146860|19233325|P2|Overall Study|Withdrawal by Subject|1
5565378|NCT01146860|19233326|P1|Overall Study|Withdrawal by Subject|0
5565379|NCT01146782|19233377|P1|Primary Endpoint Cohort|Physician Decision|1
5565380|NCT01146782|19233377|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
5565381|NCT01146782|19233377|P1|Safety Cohort|TST <4 hrs|14
5565382|NCT01146782|19233377|P1|Safety Cohort|Control AHI <5|4
5565383|NCT01146782|19233377|P1|Safety Cohort|Withdrawal by Subject|4
5565384|NCT01146782|19233377|P1|Safety Cohort|Screen Failure|61
5565385|NCT01146782|19233377|P1|Screening Cohort|Withdrawal by Subject|29
5565386|NCT01146782|19233377|P1|Screening Cohort|Physician Decision|1
5565387|NCT01146782|19233377|P1|Screening Cohort|Lost to Follow-up|4
5565388|NCT01146782|19233377|P1|Screening Cohort|Screen Failure|187
5565389|NCT01146665|19233395|P2|Overall Study|Withdrawal by Subject|16
5565390|NCT01146665|19233396|P1|Overall Study|Withdrawal by Subject|10
5565391|NCT01146613|19233428|P2|Overall Study|Outpatient detox|0
5565392|NCT01146613|19233429|P1|Overall Study|Outpatient detox|1
5565393|NCT01146613|19233428|P2|Overall Study|schedule conflict|0
5565394|NCT01146613|19233429|P1|Overall Study|schedule conflict|1
5565395|NCT01146613|19233428|P2|Overall Study|Withdrawal by Subject|3
5565396|NCT01146613|19233429|P1|Overall Study|Withdrawal by Subject|0
5565397|NCT01146613|19233428|P2|Overall Study|Physician Decision|0
5565398|NCT01146613|19233429|P1|Overall Study|Physician Decision|1
5565399|NCT01146613|19233428|P2|Overall Study|Death|0
5565400|NCT01146613|19233429|P1|Overall Study|Death|1
5565401|NCT01146613|19233428|P2|Overall Study|Lack of Efficacy|1
5565402|NCT01146613|19233429|P1|Overall Study|Lack of Efficacy|0
5565403|NCT01146613|19233428|P2|Overall Study|Lost to Follow-up|8
5565404|NCT01146613|19233429|P1|Overall Study|Lost to Follow-up|3
5565405|NCT01146288|19233539|P2|First Intervention(1 Day)|Adverse Event|1
5565406|NCT01146288|19233540|P1|First Intervention(1 Day)|Adverse Event|0
5565407|NCT01146054|19233554|P1|Overall Study|Lost to Follow-up|1
5565408|NCT01146054|19233554|P1|Overall Study|Other illness precluded treatment|2
5565409|NCT01146054|19233554|P1|Overall Study|Rapid tumor progression|2
5565410|NCT01146054|19233554|P1|Overall Study|Did not meet dose constraints for SBRT|5
5565411|NCT01145898|19233564|P2|3-year Treatment|medication change by treating physician|16
5565412|NCT01145898|19233565|P1|3-year Treatment|medication change by treating physician|3
5565413|NCT01145885|19233596|P1|Overall Study|Progressive Disease|7
5565414|NCT01145755|19233642|P3|Overall Study|Positive urine ethanol|0
5565415|NCT01145755|19233643|P2|Overall Study|Positive urine ethanol|1
5565416|NCT01145755|19233644|P1|Overall Study|Positive urine ethanol|0
5565417|NCT01145755|19233642|P3|Overall Study|Withdrawal by Subject|1
5565418|NCT01145755|19233643|P2|Overall Study|Withdrawal by Subject|0
5565419|NCT01145755|19233644|P1|Overall Study|Withdrawal by Subject|0
5565420|NCT01145755|19233642|P3|Overall Study|Patient could not swollow medication|1
5565421|NCT01145755|19233643|P2|Overall Study|Patient could not swollow medication|0
5565422|NCT01145755|19233644|P1|Overall Study|Patient could not swollow medication|0
5565423|NCT01145755|19233642|P3|Overall Study|Lack of Efficacy|0
5565424|NCT01145755|19233643|P2|Overall Study|Lack of Efficacy|1
5565425|NCT01145755|19233644|P1|Overall Study|Lack of Efficacy|0
5565426|NCT01145755|19233642|P3|Overall Study|Study Closure|17
5565427|NCT01145755|19233643|P2|Overall Study|Study Closure|14
5565428|NCT01145755|19233644|P1|Overall Study|Study Closure|14
5565429|NCT01145755|19233642|P3|Overall Study|Protocol Violation|1
5565430|NCT01145755|19233643|P2|Overall Study|Protocol Violation|3
5565431|NCT01145755|19233644|P1|Overall Study|Protocol Violation|0
5565432|NCT01145755|19233642|P3|Overall Study|Lost to Follow-up|1
5565433|NCT01145755|19233643|P2|Overall Study|Lost to Follow-up|3
5565434|NCT01145755|19233644|P1|Overall Study|Lost to Follow-up|2
5565435|NCT01145755|19233642|P3|Overall Study|Withdrawal by Subject|2
5565436|NCT01145755|19233643|P2|Overall Study|Withdrawal by Subject|2
5565437|NCT01145755|19233644|P1|Overall Study|Withdrawal by Subject|2
5565438|NCT01145755|19233642|P3|Overall Study|Adverse Event|2
5565439|NCT01145755|19233643|P2|Overall Study|Adverse Event|4
5565440|NCT01145755|19233644|P1|Overall Study|Adverse Event|2
5565441|NCT01145625|19233671|P2|Overall Study|Pregnancy|1
5565442|NCT01145625|19233672|P1|Overall Study|Pregnancy|0
5565443|NCT01145625|19233671|P2|Overall Study|Withdrawal by Subject|16
5565444|NCT01145625|19233672|P1|Overall Study|Withdrawal by Subject|7
5565445|NCT01145625|19233671|P2|Overall Study|Protocol Violation|1
5565446|NCT01145625|19233672|P1|Overall Study|Protocol Violation|3
5565447|NCT01145625|19233671|P2|Overall Study|Adverse Event|4
5565448|NCT01145625|19233672|P1|Overall Study|Adverse Event|6
5565449|NCT01145625|19233671|P2|Overall Study|Lost to Follow-up|9
5565450|NCT01145625|19233672|P1|Overall Study|Lost to Follow-up|8
5565451|NCT01145560|19233685|P3|Overall Study|Withdrawal of therapy|1
5565452|NCT01145560|19233686|P2|Overall Study|Withdrawal of therapy|0
5565453|NCT01145560|19233687|P1|Overall Study|Withdrawal of therapy|0
5565454|NCT01145560|19233685|P3|Overall Study|False insurance information|0
5565455|NCT01145560|19233686|P2|Overall Study|False insurance information|1
5565456|NCT01145560|19233687|P1|Overall Study|False insurance information|0
5565457|NCT01145560|19233685|P3|Overall Study|Accidental unblinding of study treatment|0
5565458|NCT01145560|19233686|P2|Overall Study|Accidental unblinding of study treatment|1
5565459|NCT01145560|19233687|P1|Overall Study|Accidental unblinding of study treatment|0
5565460|NCT01145560|19233685|P3|Overall Study|No study drug by 24h after organ failure|0
5565461|NCT01145560|19233686|P2|Overall Study|No study drug by 24h after organ failure|0
5565462|NCT01145560|19233687|P1|Overall Study|No study drug by 24h after organ failure|1
5565463|NCT01145560|19233685|P3|Overall Study|Lost to Follow-up|1
5565464|NCT01145560|19233686|P2|Overall Study|Lost to Follow-up|1
5565465|NCT01145560|19233687|P1|Overall Study|Lost to Follow-up|1
5565466|NCT01145560|19233685|P3|Overall Study|Withdrawal by Subject|0
5565467|NCT01145560|19233686|P2|Overall Study|Withdrawal by Subject|1
5565468|NCT01145560|19233687|P1|Overall Study|Withdrawal by Subject|2
5565469|NCT01145508|19233713|P2|Overall Study|Never started treatment|1
5565470|NCT01145508|19233714|P1|Overall Study|Never started treatment|1
5565471|NCT01145508|19233713|P2|Overall Study|Physician Decision|1
5565472|NCT01145508|19233714|P1|Overall Study|Physician Decision|2
5565473|NCT01145508|19233713|P2|Overall Study|Death|0
5565474|NCT01145508|19233714|P1|Overall Study|Death|1
5565475|NCT01145508|19233713|P2|Overall Study|Adverse Event|0
5565476|NCT01145508|19233714|P1|Overall Study|Adverse Event|1
5565477|NCT01145495|19233720|P1|Overall Study|Disease progression after respone|1
5565478|NCT01145495|19233720|P1|Overall Study|Withdrawal by Subject|5
5565479|NCT01145495|19233720|P1|Overall Study|Adverse Event|6
5565480|NCT01145482|19233726|P2|First Intervention (1 Day)|Withdrawal by Subject|1
5565481|NCT01145482|19233727|P1|First Intervention (1 Day)|Withdrawal by Subject|0
5565482|NCT01145417|19233737|P2|Overall Study|Other|0
5565483|NCT01145417|19233738|P1|Overall Study|Other|1
5565484|NCT01145417|19233737|P2|Overall Study|Study terminated by sponsor|43
5565485|NCT01145417|19233738|P1|Overall Study|Study terminated by sponsor|35
5565486|NCT01145417|19233737|P2|Overall Study|Adverse Event|1
5565487|NCT01145417|19233738|P1|Overall Study|Adverse Event|0
5565488|NCT01145417|19233737|P2|Overall Study|Pregnancy|0
5565489|NCT01145417|19233738|P1|Overall Study|Pregnancy|1
5565490|NCT01145417|19233737|P2|Overall Study|Withdrawal by Subject|2
5565491|NCT01145417|19233738|P1|Overall Study|Withdrawal by Subject|1
5565492|NCT01145417|19233737|P2|Overall Study|Lost to Follow-up|1
5565493|NCT01145417|19233738|P1|Overall Study|Lost to Follow-up|2
5565494|NCT01145417|19233737|P2|Overall Study|Death|0
5565495|NCT01145417|19233738|P1|Overall Study|Death|1
5565496|NCT01145352|19233771|P1|Overall Study|Syringe formulation was used|1
5565497|NCT01145352|19233771|P1|Overall Study|Treated before marketing approval|4
5565498|NCT01145352|19233771|P1|Overall Study|Found to have been registered twice|6
5565499|NCT01145222|19233783|P4|Overall Study|Poor bowel preparation|1
5565500|NCT01145222|19233784|P3|Overall Study|Poor bowel preparation|0
5565501|NCT01145222|19233785|P2|Overall Study|Poor bowel preparation|0
5565502|NCT01145222|19233786|P1|Overall Study|Poor bowel preparation|0
5565503|NCT01145222|19233783|P4|Overall Study|Procedure not done (no anesthesiologist)|0
5565504|NCT01145222|19233784|P3|Overall Study|Procedure not done (no anesthesiologist)|1
5565505|NCT01145222|19233785|P2|Overall Study|Procedure not done (no anesthesiologist)|0
5565506|NCT01145222|19233786|P1|Overall Study|Procedure not done (no anesthesiologist)|0
5565507|NCT01145066|19233833|P3|Overall Study|Low platelet count|0
5565508|NCT01145066|19233834|P2|Overall Study|Low platelet count|1
5565509|NCT01145066|19233835|P1|Overall Study|Low platelet count|0
5565510|NCT01145066|19233833|P3|Overall Study|Abdominal discomfort|0
5565511|NCT01145066|19233834|P2|Overall Study|Abdominal discomfort|1
5565512|NCT01145066|19233835|P1|Overall Study|Abdominal discomfort|0
5565513|NCT01145066|19233833|P3|Overall Study|problems swallowing capsule|0
5565514|NCT01145066|19233834|P2|Overall Study|problems swallowing capsule|0
5565515|NCT01145066|19233835|P1|Overall Study|problems swallowing capsule|1
5565516|NCT01145066|19233833|P3|Overall Study|To start new med|0
5565517|NCT01145066|19233834|P2|Overall Study|To start new med|0
5565518|NCT01145066|19233835|P1|Overall Study|To start new med|1
5565519|NCT01145066|19233833|P3|Overall Study|Withdrawal by Subject|2
5565520|NCT01145066|19233834|P2|Overall Study|Withdrawal by Subject|0
5565521|NCT01145066|19233835|P1|Overall Study|Withdrawal by Subject|0
5565522|NCT01145066|19233833|P3|Overall Study|Non-related surgery|1
5565523|NCT01145066|19233834|P2|Overall Study|Non-related surgery|0
5565524|NCT01145066|19233835|P1|Overall Study|Non-related surgery|0
5565525|NCT01145066|19233833|P3|Overall Study|To resume NSAIDs|1
5565526|NCT01145066|19233834|P2|Overall Study|To resume NSAIDs|2
5565527|NCT01145066|19233835|P1|Overall Study|To resume NSAIDs|2
5565528|NCT01145053|19233903|P1|Overall Study|Other|18
5565529|NCT01145053|19233903|P1|Overall Study|Withdrawal by Subject|25
5565530|NCT01145053|19233903|P1|Overall Study|Lost to Follow-up|28
5565531|NCT01145053|19233903|P1|Overall Study|Adverse Event|22
5565532|NCT01144715|19233955|P2|Overall Study|Adverse Event|1
5565533|NCT01144715|19233956|P1|Overall Study|Adverse Event|0
5565534|NCT01144715|19233955|P2|Overall Study|Withdrawal by Subject|1
5565535|NCT01144715|19233956|P1|Overall Study|Withdrawal by Subject|2
5565536|NCT01144715|19233955|P2|Overall Study|Lost to Follow-up|1
5565537|NCT01144715|19233956|P1|Overall Study|Lost to Follow-up|2
5565538|NCT01144663|19233972|P4|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
5565539|NCT01144663|19233973|P3|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
5565540|NCT01144663|19233974|P2|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
5565541|NCT01144663|19233975|P1|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
5565542|NCT01144663|19233972|P4|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
5565543|NCT01144663|19233973|P3|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
5565544|NCT01144663|19233974|P2|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
5565545|NCT01144663|19233975|P1|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
5565546|NCT01144663|19233972|P4|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
5565547|NCT01144663|19233973|P3|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
5565548|NCT01144663|19233974|P2|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
5565549|NCT01144663|19233975|P1|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
5565550|NCT01144663|19233972|P4|Booster Vaccination Phase|Lost to Follow-up|0
5565551|NCT01144663|19233973|P3|Booster Vaccination Phase|Lost to Follow-up|3
5565552|NCT01144663|19233974|P2|Booster Vaccination Phase|Lost to Follow-up|1
5565553|NCT01144663|19233975|P1|Booster Vaccination Phase|Lost to Follow-up|2
5565554|NCT01144663|19233972|P4|Booster Vaccination Phase|Migrated/moved from study area|0
5565555|NCT01144663|19233973|P3|Booster Vaccination Phase|Migrated/moved from study area|1
5565556|NCT01144663|19233974|P2|Booster Vaccination Phase|Migrated/moved from study area|1
5565557|NCT01144663|19233975|P1|Booster Vaccination Phase|Migrated/moved from study area|1
5565558|NCT01144663|19233972|P4|Booster Vaccination Phase|Withdrawal by Subject|1
5565559|NCT01144663|19233973|P3|Booster Vaccination Phase|Withdrawal by Subject|1
5565560|NCT01144663|19233974|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5565561|NCT01144663|19233975|P1|Booster Vaccination Phase|Withdrawal by Subject|0
5565562|NCT01144663|19233972|P4|Primary Vaccination Phase|Other|2
5565563|NCT01144663|19233973|P3|Primary Vaccination Phase|Other|0
5565564|NCT01144663|19233974|P2|Primary Vaccination Phase|Other|1
5565565|NCT01144663|19233975|P1|Primary Vaccination Phase|Other|0
5565566|NCT01144663|19233972|P4|Primary Vaccination Phase|Lost to Follow-up|2
5565567|NCT01144663|19233973|P3|Primary Vaccination Phase|Lost to Follow-up|1
5565568|NCT01144663|19233974|P2|Primary Vaccination Phase|Lost to Follow-up|0
5565569|NCT01144663|19233975|P1|Primary Vaccination Phase|Lost to Follow-up|2
5565570|NCT01144663|19233972|P4|Primary Vaccination Phase|Migrated/moved from study area|3
5565571|NCT01144663|19233973|P3|Primary Vaccination Phase|Migrated/moved from study area|2
5565572|NCT01144663|19233974|P2|Primary Vaccination Phase|Migrated/moved from study area|1
5565573|NCT01144663|19233975|P1|Primary Vaccination Phase|Migrated/moved from study area|4
5565574|NCT01144663|19233972|P4|Primary Vaccination Phase|Withdrawal by Subject|10
5565575|NCT01144663|19233973|P3|Primary Vaccination Phase|Withdrawal by Subject|3
5565576|NCT01144663|19233974|P2|Primary Vaccination Phase|Withdrawal by Subject|5
5565577|NCT01144663|19233975|P1|Primary Vaccination Phase|Withdrawal by Subject|9
5565578|NCT01144663|19233972|P4|Primary Vaccination Phase|Protocol Violation|0
5565579|NCT01144663|19233973|P3|Primary Vaccination Phase|Protocol Violation|1
5565580|NCT01144663|19233974|P2|Primary Vaccination Phase|Protocol Violation|0
5565581|NCT01144663|19233975|P1|Primary Vaccination Phase|Protocol Violation|2
5565582|NCT01144663|19233972|P4|Primary Vaccination Phase|Adverse Event|1
5565583|NCT01144663|19233973|P3|Primary Vaccination Phase|Adverse Event|0
5565584|NCT01144663|19233974|P2|Primary Vaccination Phase|Adverse Event|0
5565585|NCT01144663|19233975|P1|Primary Vaccination Phase|Adverse Event|1
5565586|NCT01144663|19233972|P4|Primary Vaccination Phase|Serious adverse event, fatal|0
5565587|NCT01144663|19233973|P3|Primary Vaccination Phase|Serious adverse event, fatal|1
5565588|NCT01144663|19233974|P2|Primary Vaccination Phase|Serious adverse event, fatal|0
5565667|NCT01144364|19234396|P2|Follow-Up/Maintenance Phase|Death|2
5565589|NCT01144663|19233975|P1|Primary Vaccination Phase|Serious adverse event, fatal|2
5565590|NCT01144416|19234313|P2|Intervention Period|Other|5
5565591|NCT01144416|19234314|P1|Intervention Period|Other|7
5565592|NCT01144416|19234313|P2|Intervention Period|No/too few/bad quality embryos|3
5565593|NCT01144416|19234314|P1|Intervention Period|No/too few/bad quality embryos|3
5565594|NCT01144416|19234313|P2|Intervention Period|No or abnormal fertilization|10
5565595|NCT01144416|19234314|P1|Intervention Period|No or abnormal fertilization|25
5565596|NCT01144416|19234313|P2|Intervention Period|No/too few/bad oocytes|5
5565597|NCT01144416|19234314|P1|Intervention Period|No/too few/bad oocytes|7
5565598|NCT01144416|19234313|P2|Intervention Period|Too high ovarian response|2
5565599|NCT01144416|19234314|P1|Intervention Period|Too high ovarian response|4
5565600|NCT01144416|19234313|P2|Intervention Period|Risk of OHSS|1
5565601|NCT01144416|19234314|P1|Intervention Period|Risk of OHSS|0
5565602|NCT01144416|19234313|P2|Intervention Period|Insufficient ovarian response|17
5565603|NCT01144416|19234314|P1|Intervention Period|Insufficient ovarian response|11
5565604|NCT01144416|19234313|P2|Intervention Period|Adverse Event|6
5565605|NCT01144416|19234314|P1|Intervention Period|Adverse Event|5
5565606|NCT01144403|19234330|P1|Overall Study|Adverse Event|1
5565607|NCT01144403|19234330|P1|Overall Study|Death|1
5565608|NCT01144403|19234330|P1|Overall Study|Lost to Follow-up|3
5565609|NCT01144377|19234342|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5565610|NCT01144377|19234343|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5565611|NCT01144377|19234344|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5565612|NCT01144377|19234345|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
5565613|NCT01144377|19234346|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
5565614|NCT01144377|19234342|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
5565615|NCT01144377|19234343|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5565616|NCT01144377|19234344|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5565617|NCT01144377|19234345|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5565618|NCT01144377|19234346|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
5565619|NCT01144377|19234342|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
5565620|NCT01144377|19234343|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
5565621|NCT01144377|19234344|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
5565622|NCT01144377|19234345|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
5565623|NCT01144377|19234346|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
5565624|NCT01144377|19234342|P5|52 Week Treatment Period|Sponsor Decision|1
5565625|NCT01144377|19234343|P4|52 Week Treatment Period|Sponsor Decision|0
5565626|NCT01144377|19234344|P3|52 Week Treatment Period|Sponsor Decision|0
5565627|NCT01144377|19234345|P2|52 Week Treatment Period|Sponsor Decision|0
5565628|NCT01144377|19234346|P1|52 Week Treatment Period|Sponsor Decision|0
5565629|NCT01144377|19234342|P5|52 Week Treatment Period|Withdrawal by Subject|0
5565630|NCT01144377|19234343|P4|52 Week Treatment Period|Withdrawal by Subject|1
5565631|NCT01144377|19234344|P3|52 Week Treatment Period|Withdrawal by Subject|1
5565632|NCT01144377|19234345|P2|52 Week Treatment Period|Withdrawal by Subject|1
5565633|NCT01144377|19234346|P1|52 Week Treatment Period|Withdrawal by Subject|4
5565634|NCT01144377|19234342|P5|52 Week Treatment Period|Lost to Follow-up|0
5565635|NCT01144377|19234343|P4|52 Week Treatment Period|Lost to Follow-up|0
5565636|NCT01144377|19234344|P3|52 Week Treatment Period|Lost to Follow-up|0
5565637|NCT01144377|19234345|P2|52 Week Treatment Period|Lost to Follow-up|0
5565638|NCT01144377|19234346|P1|52 Week Treatment Period|Lost to Follow-up|1
5565639|NCT01144377|19234342|P5|52 Week Treatment Period|Protocol Violation|1
5565640|NCT01144377|19234343|P4|52 Week Treatment Period|Protocol Violation|0
5565641|NCT01144377|19234344|P3|52 Week Treatment Period|Protocol Violation|0
5565642|NCT01144377|19234345|P2|52 Week Treatment Period|Protocol Violation|0
5565643|NCT01144377|19234346|P1|52 Week Treatment Period|Protocol Violation|0
5565644|NCT01144377|19234342|P5|52 Week Treatment Period|Entry Criteria Not Met|0
5565645|NCT01144377|19234343|P4|52 Week Treatment Period|Entry Criteria Not Met|1
5565646|NCT01144377|19234344|P3|52 Week Treatment Period|Entry Criteria Not Met|1
5565647|NCT01144377|19234345|P2|52 Week Treatment Period|Entry Criteria Not Met|0
5565648|NCT01144377|19234346|P1|52 Week Treatment Period|Entry Criteria Not Met|0
5565649|NCT01144377|19234342|P5|52 Week Treatment Period|Adverse Event|1
5565650|NCT01144377|19234343|P4|52 Week Treatment Period|Adverse Event|2
5565651|NCT01144377|19234344|P3|52 Week Treatment Period|Adverse Event|3
5565652|NCT01144377|19234345|P2|52 Week Treatment Period|Adverse Event|0
5565653|NCT01144377|19234346|P1|52 Week Treatment Period|Adverse Event|0
5565654|NCT01144364|19234395|P3|Follow-Up/Maintenance Phase|Physician Decision|1
5565655|NCT01144364|19234396|P2|Follow-Up/Maintenance Phase|Physician Decision|0
5565656|NCT01144364|19234397|P1|Follow-Up/Maintenance Phase|Physician Decision|0
5565657|NCT01144364|19234395|P3|Follow-Up/Maintenance Phase|Relapse|5
5565658|NCT01144364|19234396|P2|Follow-Up/Maintenance Phase|Relapse|5
5565659|NCT01144364|19234397|P1|Follow-Up/Maintenance Phase|Relapse|0
5565660|NCT01144364|19234395|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
5565661|NCT01144364|19234396|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
5565662|NCT01144364|19234397|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
5565663|NCT01144364|19234395|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
5565664|NCT01144364|19234396|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
5565665|NCT01144364|19234397|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
5565666|NCT01144364|19234395|P3|Follow-Up/Maintenance Phase|Death|0
5565668|NCT01144364|19234397|P1|Follow-Up/Maintenance Phase|Death|0
5565669|NCT01144364|19234395|P3|Follow-Up/Maintenance Phase|Adverse Event|1
5565670|NCT01144364|19234396|P2|Follow-Up/Maintenance Phase|Adverse Event|3
5565671|NCT01144364|19234397|P1|Follow-Up/Maintenance Phase|Adverse Event|0
5565672|NCT01144364|19234395|P3|Follow-Up/Maintenance Phase|Disease progression|29
5565673|NCT01144364|19234396|P2|Follow-Up/Maintenance Phase|Disease progression|23
5565674|NCT01144364|19234397|P1|Follow-Up/Maintenance Phase|Disease progression|0
5565675|NCT01144364|19234395|P3|Induction Phase|Protocol Violation|0
5565676|NCT01144364|19234396|P2|Induction Phase|Protocol Violation|0
5565677|NCT01144364|19234397|P1|Induction Phase|Protocol Violation|1
5565678|NCT01144364|19234395|P3|Induction Phase|Secondary neoplasia|0
5565679|NCT01144364|19234396|P2|Induction Phase|Secondary neoplasia|0
5565680|NCT01144364|19234397|P1|Induction Phase|Secondary neoplasia|1
5565681|NCT01144364|19234395|P3|Induction Phase|Stable disease|0
5565682|NCT01144364|19234396|P2|Induction Phase|Stable disease|0
5565683|NCT01144364|19234397|P1|Induction Phase|Stable disease|2
5565684|NCT01144364|19234395|P3|Induction Phase|Physician Decision|0
5565685|NCT01144364|19234396|P2|Induction Phase|Physician Decision|0
5565686|NCT01144364|19234397|P1|Induction Phase|Physician Decision|1
5565687|NCT01144364|19234395|P3|Induction Phase|Lost to Follow-up|0
5565688|NCT01144364|19234396|P2|Induction Phase|Lost to Follow-up|0
5565689|NCT01144364|19234397|P1|Induction Phase|Lost to Follow-up|2
5565690|NCT01144364|19234395|P3|Induction Phase|Withdrawal by Subject|0
5565691|NCT01144364|19234396|P2|Induction Phase|Withdrawal by Subject|0
5565692|NCT01144364|19234397|P1|Induction Phase|Withdrawal by Subject|1
5565693|NCT01144364|19234395|P3|Induction Phase|Death|0
5565694|NCT01144364|19234396|P2|Induction Phase|Death|0
5565695|NCT01144364|19234397|P1|Induction Phase|Death|1
5565696|NCT01144364|19234395|P3|Induction Phase|Adverse Event|0
5565697|NCT01144364|19234396|P2|Induction Phase|Adverse Event|0
5565698|NCT01144364|19234397|P1|Induction Phase|Adverse Event|9
5565699|NCT01144364|19234395|P3|Induction Phase|Disease progression|0
5565700|NCT01144364|19234396|P2|Induction Phase|Disease progression|0
5565701|NCT01144364|19234397|P1|Induction Phase|Disease progression|14
5565702|NCT01144299|19234446|P2|Overall Study|Withdrawal by Subject|0
5565703|NCT01144299|19234447|P1|Overall Study|Withdrawal by Subject|1
5565704|NCT01144299|19234446|P2|Overall Study|Lost to Follow-up|0
5565705|NCT01144299|19234447|P1|Overall Study|Lost to Follow-up|1
5565706|NCT01144182|19234492|P2|Overall Study|Lost to Follow-up|9
5565707|NCT01144182|19234493|P1|Overall Study|Lost to Follow-up|9
5565708|NCT01144182|19234492|P2|Overall Study|Withdrawal by Subject|6
5565709|NCT01144182|19234493|P1|Overall Study|Withdrawal by Subject|3
5565710|NCT01144182|19234492|P2|Overall Study|Death|6
5565711|NCT01144182|19234493|P1|Overall Study|Death|5
5565712|NCT01144052|19234553|P2|Overall Study|Withdrawal by Subject|1
5565713|NCT01144052|19234554|P1|Overall Study|Withdrawal by Subject|1
5565714|NCT01143896|19234585|P2|Overall Study|Death|3
5565715|NCT01143896|19234586|P1|Overall Study|Death|6
5565716|NCT01143896|19234585|P2|Overall Study|Withdrawal by Subject|5
5565717|NCT01143896|19234586|P1|Overall Study|Withdrawal by Subject|13
5565718|NCT01143896|19234585|P2|Overall Study|Lost to Follow-up|13
5565719|NCT01143896|19234586|P1|Overall Study|Lost to Follow-up|18
5565720|NCT01143896|19234585|P2|Overall Study|Did not complete Baseline Interview|4
5565721|NCT01143896|19234586|P1|Overall Study|Did not complete Baseline Interview|5
5565722|NCT01143714|19234698|P2|Overall Study|wound size increased|0
5565723|NCT01143714|19234699|P1|Overall Study|wound size increased|1
5565724|NCT01143714|19234698|P2|Overall Study|wound closed = deemed healed|0
5565725|NCT01143714|19234699|P1|Overall Study|wound closed = deemed healed|1
5565726|NCT01143714|19234698|P2|Overall Study|Subject non-compliance|1
5565727|NCT01143714|19234699|P1|Overall Study|Subject non-compliance|0
5565728|NCT01143714|19234698|P2|Overall Study|Withdrawal by Subject|0
5565729|NCT01143714|19234699|P1|Overall Study|Withdrawal by Subject|1
5565730|NCT01143714|19234698|P2|Overall Study|Adverse Event|2
5565731|NCT01143714|19234699|P1|Overall Study|Adverse Event|4
5565732|NCT01143402|19234804|P3|Overall Study|Not Treated|1
5565733|NCT01143402|19234805|P2|Overall Study|Not Treated|0
5565734|NCT01143402|19234806|P1|Overall Study|Not Treated|0
5565735|NCT01143402|19234804|P3|Overall Study|Rapid clinical decline|0
5565736|NCT01143402|19234805|P2|Overall Study|Rapid clinical decline|1
5565737|NCT01143402|19234806|P1|Overall Study|Rapid clinical decline|1
5565738|NCT01143389|19234817|P2|Overall Study|Lost to Follow-up|25
5565739|NCT01143389|19234818|P1|Overall Study|Lost to Follow-up|26
5565740|NCT01143337|19234832|P3|Overall Study|Other reason|5
5565741|NCT01143337|19234833|P2|Overall Study|Other reason|0
5565742|NCT01143337|19234834|P1|Overall Study|Other reason|0
5565743|NCT01143337|19234832|P3|Overall Study|Withdrawal by Subject|1
5565744|NCT01143337|19234833|P2|Overall Study|Withdrawal by Subject|0
5565745|NCT01143337|19234834|P1|Overall Study|Withdrawal by Subject|0
5565746|NCT01143337|19234832|P3|Overall Study|Protocol Violation|0
5565747|NCT01143337|19234833|P2|Overall Study|Protocol Violation|0
5565748|NCT01143337|19234834|P1|Overall Study|Protocol Violation|1
5565749|NCT01143337|19234832|P3|Overall Study|Lack of Efficacy|1
5565750|NCT01143337|19234833|P2|Overall Study|Lack of Efficacy|2
5565751|NCT01143337|19234834|P1|Overall Study|Lack of Efficacy|6
5565752|NCT01143337|19234832|P3|Overall Study|Adverse Event|5
5565753|NCT01143337|19234833|P2|Overall Study|Adverse Event|9
5565754|NCT01143337|19234834|P1|Overall Study|Adverse Event|3
5565755|NCT01143324|19234848|P1|Overall Study|Explant of the device|4
5565756|NCT01143324|19234848|P1|Overall Study|Withdrawal by Subject|4
5565757|NCT01143324|19234848|P1|Overall Study|Lost to Follow-up|11
5565758|NCT01143259|19234887|P2|Overall Study|Screen Failure|9
5565759|NCT01143259|19234888|P1|Overall Study|Screen Failure|7
5565760|NCT01143259|19234887|P2|Overall Study|Protocol Violation|9
5565761|NCT01143259|19234888|P1|Overall Study|Protocol Violation|13
5565762|NCT01143259|19234887|P2|Overall Study|Withdrawal by Subject|2
5565763|NCT01143259|19234888|P1|Overall Study|Withdrawal by Subject|3
5565764|NCT01143207|19234896|P1|Overall Study|Lost to Follow-up|2
5565765|NCT01143090|19234916|P1|Overall Study|Administrative|1
5565766|NCT01143090|19234916|P1|Overall Study|Failure to meet eligibility criteria|1
5565767|NCT01143090|19234916|P1|Overall Study|Non-compliance with study drug|1
5565768|NCT01143090|19234916|P1|Overall Study|Withdrawal by Subject|18
5565769|NCT01143090|19234916|P1|Overall Study|Protocol Violation|2
5565770|NCT01143090|19234916|P1|Overall Study|Lost to Follow-up|9
5565771|NCT01143090|19234916|P1|Overall Study|Adverse Event|17
5565772|NCT01143090|19234916|P1|Overall Study|Lack of Efficacy|2
5565773|NCT01143077|19234923|P3|Overall Study|Principal Investigator Decision|1
5565774|NCT01143077|19234924|P2|Overall Study|Principal Investigator Decision|0
5565775|NCT01143077|19234925|P1|Overall Study|Principal Investigator Decision|2
5565776|NCT01143077|19234923|P3|Overall Study|Administrative|0
5565777|NCT01143077|19234924|P2|Overall Study|Administrative|0
5565778|NCT01143077|19234925|P1|Overall Study|Administrative|1
5565779|NCT01143077|19234923|P3|Overall Study|Non-compliance with study drug|1
5565780|NCT01143077|19234924|P2|Overall Study|Non-compliance with study drug|1
5565781|NCT01143077|19234925|P1|Overall Study|Non-compliance with study drug|0
5565782|NCT01143077|19234923|P3|Overall Study|Withdrawal by Subject|3
5565783|NCT01143077|19234924|P2|Overall Study|Withdrawal by Subject|3
5565784|NCT01143077|19234925|P1|Overall Study|Withdrawal by Subject|4
5565785|NCT01143077|19234923|P3|Overall Study|Protocol Violation|0
5565786|NCT01143077|19234924|P2|Overall Study|Protocol Violation|0
5565787|NCT01143077|19234925|P1|Overall Study|Protocol Violation|2
5565788|NCT01143077|19234923|P3|Overall Study|Lost to Follow-up|4
5565789|NCT01143077|19234924|P2|Overall Study|Lost to Follow-up|3
5565790|NCT01143077|19234925|P1|Overall Study|Lost to Follow-up|2
5565791|NCT01143077|19234923|P3|Overall Study|Adverse Event|5
5565792|NCT01143077|19234924|P2|Overall Study|Adverse Event|6
5565793|NCT01143077|19234925|P1|Overall Study|Adverse Event|5
5565794|NCT01143077|19234923|P3|Overall Study|Lack of Efficacy|1
5565795|NCT01143077|19234924|P2|Overall Study|Lack of Efficacy|2
5565796|NCT01143077|19234925|P1|Overall Study|Lack of Efficacy|0
5565797|NCT01143051|19234942|P6|3-14 Day Washout|Withdrawal by Subject|1
5565798|NCT01143051|19234943|P5|3-14 Day Washout|Withdrawal by Subject|0
5565799|NCT01143051|19234944|P4|3-14 Day Washout|Withdrawal by Subject|0
5565800|NCT01143051|19234945|P3|3-14 Day Washout|Withdrawal by Subject|0
5565801|NCT01143051|19234946|P2|3-14 Day Washout|Withdrawal by Subject|0
5565802|NCT01143051|19234947|P1|3-14 Day Washout|Withdrawal by Subject|0
5565803|NCT01143051|19234942|P6|3-14 Day Washout|Withdrawal by Subject|0
5565804|NCT01143051|19234943|P5|3-14 Day Washout|Withdrawal by Subject|0
5565805|NCT01143051|19234944|P4|3-14 Day Washout|Withdrawal by Subject|0
5565806|NCT01143051|19234945|P3|3-14 Day Washout|Withdrawal by Subject|1
5565807|NCT01143051|19234946|P2|3-14 Day Washout|Withdrawal by Subject|0
5565808|NCT01143051|19234947|P1|3-14 Day Washout|Withdrawal by Subject|0
5565809|NCT01143038|19234996|P1|Overall Study|Death|1
5565810|NCT01143038|19234996|P1|Overall Study|Protocol Deviation|1
5565811|NCT01143038|19234996|P1|Overall Study|Lost to Follow-up|2
5565812|NCT01143038|19234996|P1|Overall Study|Adverse Event|3
5565813|NCT01143038|19234996|P1|Overall Study|Requirement for alternative therapy|5
5565814|NCT01143038|19234996|P1|Overall Study|Withdrawal by Subject|4
5565815|NCT01142908|19235010|P2|Overall Study|Withdrawal by Subject|0
5565816|NCT01142908|19235011|P1|Overall Study|Withdrawal by Subject|3
5565817|NCT01142908|19235010|P2|Overall Study|Excluded - did not meet criteria|5
5565818|NCT01142908|19235011|P1|Overall Study|Excluded - did not meet criteria|9
5565819|NCT01142908|19235010|P2|Overall Study|Death|4
5565820|NCT01142908|19235011|P1|Overall Study|Death|1
5565821|NCT01142908|19235010|P2|Overall Study|Lost to Follow-up|13
5565822|NCT01142908|19235011|P1|Overall Study|Lost to Follow-up|19
5565823|NCT01142791|19235057|P2|Overall Study|Received only 1 sonication|6
5565824|NCT01142791|19235058|P1|Overall Study|Received only 1 sonication|0
5565825|NCT01142791|19235057|P2|Overall Study|Withdrawal by Subject|0
5565826|NCT01142791|19235058|P1|Overall Study|Withdrawal by Subject|5
5565827|NCT01142791|19235057|P2|Overall Study|Lost to Follow-up|0
5565828|NCT01142791|19235058|P1|Overall Study|Lost to Follow-up|1
5565829|NCT01142791|19235057|P2|Overall Study|Alternative Treatment|0
5565830|NCT01142791|19235058|P1|Overall Study|Alternative Treatment|1
5565831|NCT01142726|19235065|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
5565832|NCT01142726|19235066|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
5565833|NCT01142726|19235067|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
5565834|NCT01142726|19235065|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
5565835|NCT01142726|19235066|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
5565836|NCT01142726|19235067|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
5565837|NCT01142726|19235065|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
5565838|NCT01142726|19235066|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
5565839|NCT01142726|19235067|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
5565840|NCT01142726|19235065|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
5565841|NCT01142726|19235066|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
5565842|NCT01142726|19235067|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
5565843|NCT01142726|19235065|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
5565844|NCT01142726|19235066|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
5565845|NCT01142726|19235067|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
5565846|NCT01142726|19235065|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
5565847|NCT01142726|19235066|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
5565848|NCT01142726|19235067|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
5565849|NCT01142726|19235065|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
5565850|NCT01142726|19235066|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
5565851|NCT01142726|19235067|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
5565852|NCT01142726|19235065|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
5565853|NCT01142726|19235066|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
5565854|NCT01142726|19235067|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
5565855|NCT01142726|19235065|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
5565856|NCT01142726|19235066|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
5565857|NCT01142726|19235067|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
5565858|NCT01142726|19235065|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
5565859|NCT01142726|19235066|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
5565860|NCT01142726|19235067|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
5565861|NCT01142726|19235065|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
5565862|NCT01142726|19235066|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
5565863|NCT01142726|19235067|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
5565864|NCT01142726|19235065|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
5565865|NCT01142726|19235066|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
5565866|NCT01142726|19235067|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
5565867|NCT01142726|19235065|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
5565868|NCT01142726|19235066|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
5565869|NCT01142726|19235067|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
5565870|NCT01142726|19235065|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
5565871|NCT01142726|19235066|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
5565872|NCT01142726|19235067|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
5565873|NCT01142726|19235065|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
5565874|NCT01142726|19235066|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
5565875|NCT01142726|19235067|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
5565876|NCT01142726|19235065|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
5565877|NCT01142726|19235066|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
5565878|NCT01142726|19235067|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
5565879|NCT01142661|19235130|P1|Overall Study|Physician Decision|1
5565880|NCT01142661|19235130|P1|Overall Study|Withdrawal by Subject|1
5565881|NCT01142661|19235130|P1|Overall Study|Adverse Event|2
5565882|NCT01142596|19235137|P2|Overall Study|Other reason (not specified)|4
5565883|NCT01142596|19235138|P1|Overall Study|Other reason (not specified)|5
5565884|NCT01142596|19235137|P2|Overall Study|Lost to Follow-up|3
5565885|NCT01142596|19235138|P1|Overall Study|Lost to Follow-up|2
5565886|NCT01142596|19235137|P2|Overall Study|Lack of Efficacy|9
5565887|NCT01142596|19235138|P1|Overall Study|Lack of Efficacy|5
5565888|NCT01142596|19235137|P2|Overall Study|Adverse Event|35
5565889|NCT01142596|19235138|P1|Overall Study|Adverse Event|8
5565890|NCT01142596|19235137|P2|Overall Study|Withdrawal by Subject|35
5565891|NCT01142596|19235138|P1|Overall Study|Withdrawal by Subject|9
5565892|NCT01142466|19235190|P2|Overall Study|Withdrawal by Subject|1
5565893|NCT01142466|19235191|P1|Overall Study|Withdrawal by Subject|1
5565894|NCT01142466|19235190|P2|Overall Study|Adverse Event|1
5565895|NCT01142466|19235191|P1|Overall Study|Adverse Event|2
5565896|NCT01142388|19235211|P2|Overall Study|Never started therapy|3
5565897|NCT01142388|19235212|P1|Overall Study|Never started therapy|7
5565898|NCT01142388|19235211|P2|Overall Study|Other|1
5565899|NCT01142388|19235212|P1|Overall Study|Other|1
5565900|NCT01142388|19235211|P2|Overall Study|Other complications|2
5565901|NCT01142388|19235212|P1|Overall Study|Other complications|0
5565902|NCT01142388|19235211|P2|Overall Study|Alternative therapy|0
5565903|NCT01142388|19235212|P1|Overall Study|Alternative therapy|1
5565904|NCT01142388|19235211|P2|Overall Study|Withdrawal by Subject|3
5565905|NCT01142388|19235212|P1|Overall Study|Withdrawal by Subject|5
5565906|NCT01142388|19235211|P2|Overall Study|Death|2
5565907|NCT01142388|19235212|P1|Overall Study|Death|3
5565908|NCT01142388|19235211|P2|Overall Study|Adverse Event|5
5565909|NCT01142388|19235212|P1|Overall Study|Adverse Event|9
5565910|NCT01142388|19235211|P2|Overall Study|Lack of Efficacy|31
5565911|NCT01142388|19235212|P1|Overall Study|Lack of Efficacy|21
5565912|NCT01142336|19235224|P2|Overall Study|Lost to Follow-up|1
5565913|NCT01142336|19235225|P1|Overall Study|Lost to Follow-up|0
5565914|NCT01142336|19235224|P2|Overall Study|Adverse Event|1
5565915|NCT01142336|19235225|P1|Overall Study|Adverse Event|1
5565916|NCT01142232|19235262|P5|Overall Study|Noncompliance|2
5565917|NCT01142232|19235263|P4|Overall Study|Noncompliance|0
5565918|NCT01142232|19235264|P3|Overall Study|Noncompliance|0
5565919|NCT01142232|19235265|P2|Overall Study|Noncompliance|0
5565920|NCT01142232|19235266|P1|Overall Study|Noncompliance|0
5565921|NCT01142232|19235262|P5|Overall Study|Off Trt for other complicating disease|1
5565922|NCT01142232|19235263|P4|Overall Study|Off Trt for other complicating disease|0
5565923|NCT01142232|19235264|P3|Overall Study|Off Trt for other complicating disease|0
5565924|NCT01142232|19235265|P2|Overall Study|Off Trt for other complicating disease|0
5565925|NCT01142232|19235266|P1|Overall Study|Off Trt for other complicating disease|0
5565926|NCT01142232|19235262|P5|Overall Study|Alternative Therapy|1
5565927|NCT01142232|19235263|P4|Overall Study|Alternative Therapy|0
5565928|NCT01142232|19235264|P3|Overall Study|Alternative Therapy|1
5565929|NCT01142232|19235265|P2|Overall Study|Alternative Therapy|1
5565930|NCT01142232|19235266|P1|Overall Study|Alternative Therapy|0
5565931|NCT01142232|19235262|P5|Overall Study|Physician Decision|10
5565932|NCT01142232|19235263|P4|Overall Study|Physician Decision|2
5565933|NCT01142232|19235264|P3|Overall Study|Physician Decision|0
5565934|NCT01142232|19235265|P2|Overall Study|Physician Decision|1
5565935|NCT01142232|19235266|P1|Overall Study|Physician Decision|0
5565936|NCT01142232|19235262|P5|Overall Study|Withdrawal by Subject|3
5565937|NCT01142232|19235263|P4|Overall Study|Withdrawal by Subject|1
5565938|NCT01142232|19235264|P3|Overall Study|Withdrawal by Subject|0
5565939|NCT01142232|19235265|P2|Overall Study|Withdrawal by Subject|0
5565940|NCT01142232|19235266|P1|Overall Study|Withdrawal by Subject|0
5565941|NCT01142232|19235262|P5|Overall Study|Disease Progression|12
5565942|NCT01142232|19235263|P4|Overall Study|Disease Progression|2
5565943|NCT01142232|19235264|P3|Overall Study|Disease Progression|1
5565944|NCT01142232|19235265|P2|Overall Study|Disease Progression|0
5565945|NCT01142232|19235266|P1|Overall Study|Disease Progression|2
5565946|NCT01142232|19235262|P5|Overall Study|Death|1
5565947|NCT01142232|19235263|P4|Overall Study|Death|0
5565948|NCT01142232|19235264|P3|Overall Study|Death|0
5565949|NCT01142232|19235265|P2|Overall Study|Death|0
5565950|NCT01142232|19235266|P1|Overall Study|Death|0
5565951|NCT01142232|19235262|P5|Overall Study|Adverse Event|4
5565952|NCT01142232|19235263|P4|Overall Study|Adverse Event|0
5565953|NCT01142232|19235264|P3|Overall Study|Adverse Event|1
5565954|NCT01142232|19235265|P2|Overall Study|Adverse Event|2
5565955|NCT01142232|19235266|P1|Overall Study|Adverse Event|1
5565956|NCT01142193|19235281|P2|Overall Study|Other|2
5565957|NCT01142193|19235282|P1|Overall Study|Other|1
5565958|NCT01142193|19235281|P2|Overall Study|Protocol Discontinuation Criterion Met|0
5565959|NCT01142193|19235282|P1|Overall Study|Protocol Discontinuation Criterion Met|1
5565960|NCT01142193|19235281|P2|Overall Study|Withdrawal by Subject|3
5565961|NCT01142193|19235282|P1|Overall Study|Withdrawal by Subject|4
5565962|NCT01142193|19235281|P2|Overall Study|Physician Decision|1
5565963|NCT01142193|19235282|P1|Overall Study|Physician Decision|1
5565964|NCT01142193|19235281|P2|Overall Study|Lack of Efficacy|1
5565965|NCT01142193|19235282|P1|Overall Study|Lack of Efficacy|2
5565966|NCT01142193|19235281|P2|Overall Study|Adverse Event|4
5565967|NCT01142193|19235282|P1|Overall Study|Adverse Event|12
5565968|NCT01142128|19235310|P1|Overall Study|Withdrawal by Subject|2
5565969|NCT01142128|19235310|P1|Overall Study|Lost to Follow-up|1
5565970|NCT01142128|19235310|P1|Overall Study|Physician Decision|1
5565971|NCT01142115|19235320|P2|First Intervention|Adverse Event|0
5565972|NCT01142115|19235321|P1|First Intervention|Adverse Event|1
5565973|NCT01142115|19235320|P2|First Intervention|Lack of Efficacy|1
5565974|NCT01142115|19235321|P1|First Intervention|Lack of Efficacy|1
5565975|NCT01142089|19235338|P2|Overall Study|Patient required rescue medication|17
5565976|NCT01142089|19235339|P1|Overall Study|Patient required rescue medication|8
5565977|NCT01142089|19235338|P2|Overall Study|Noncompliance with study procedures|1
5565978|NCT01142089|19235339|P1|Overall Study|Noncompliance with study procedures|2
5565979|NCT01142089|19235338|P2|Overall Study|Use of prohibited medications|1
5565980|NCT01142089|19235339|P1|Overall Study|Use of prohibited medications|0
5565981|NCT01142089|19235338|P2|Overall Study|Withdrawal by Subject|2
5565982|NCT01142089|19235339|P1|Overall Study|Withdrawal by Subject|1
5565983|NCT01142089|19235338|P2|Overall Study|Physician Decision|0
5565984|NCT01142089|19235339|P1|Overall Study|Physician Decision|1
5565985|NCT01141712|19235370|P1|Overall Study|Disease progression|3
5565986|NCT01141660|19235391|P2|Overall Study|Physician Decision|12
5565987|NCT01141660|19235392|P1|Overall Study|Physician Decision|0
5565988|NCT01141283|19235460|P1|Overall Study|Lack of Efficacy|10
5565989|NCT01141283|19235460|P1|Overall Study|Administrative|4
5565990|NCT01141283|19235460|P1|Overall Study|Withdrawal by Subject|14
5565991|NCT01141283|19235460|P1|Overall Study|Lost to Follow-up|4
5565992|NCT01141283|19235460|P1|Overall Study|Adverse Event|56
5565993|NCT01141205|19235466|P2|Overall Study|Withdrawal by Subject|1
5565994|NCT01141205|19235467|P1|Overall Study|Withdrawal by Subject|1
5565995|NCT01141205|19235466|P2|Overall Study|Lost to Follow-up|0
5565996|NCT01141205|19235467|P1|Overall Study|Lost to Follow-up|1
5565997|NCT01141205|19235466|P2|Overall Study|Physician Decision|1
5565998|NCT01141205|19235467|P1|Overall Study|Physician Decision|1
5565999|NCT01140906|19235506|P4|Overall Study|Administrative or other reason|2
5566000|NCT01140906|19235507|P3|Overall Study|Administrative or other reason|3
5566001|NCT01140906|19235508|P2|Overall Study|Administrative or other reason|5
5566002|NCT01140906|19235509|P1|Overall Study|Administrative or other reason|0
5566003|NCT01140906|19235506|P4|Overall Study|Lost to Follow-up|2
5566004|NCT01140906|19235507|P3|Overall Study|Lost to Follow-up|0
5566005|NCT01140906|19235508|P2|Overall Study|Lost to Follow-up|1
5566006|NCT01140906|19235509|P1|Overall Study|Lost to Follow-up|1
5566007|NCT01140906|19235506|P4|Overall Study|Withdrawal of consent|2
5566008|NCT01140906|19235507|P3|Overall Study|Withdrawal of consent|2
5566009|NCT01140906|19235508|P2|Overall Study|Withdrawal of consent|6
5566010|NCT01140906|19235509|P1|Overall Study|Withdrawal of consent|6
5566011|NCT01140906|19235506|P4|Overall Study|Protocol Violation|1
5566012|NCT01140906|19235507|P3|Overall Study|Protocol Violation|2
5566013|NCT01140906|19235508|P2|Overall Study|Protocol Violation|3
5566014|NCT01140906|19235509|P1|Overall Study|Protocol Violation|5
5566015|NCT01140906|19235506|P4|Overall Study|Non-compliance|1
5566016|NCT01140906|19235507|P3|Overall Study|Non-compliance|0
5566017|NCT01140906|19235508|P2|Overall Study|Non-compliance|1
5566018|NCT01140906|19235509|P1|Overall Study|Non-compliance|0
5566019|NCT01140906|19235506|P4|Overall Study|Lack of Efficacy|1
5566020|NCT01140906|19235507|P3|Overall Study|Lack of Efficacy|2
5566021|NCT01140906|19235508|P2|Overall Study|Lack of Efficacy|8
5566022|NCT01140906|19235509|P1|Overall Study|Lack of Efficacy|6
5566023|NCT01140906|19235506|P4|Overall Study|Adverse Event|7
5566024|NCT01140906|19235507|P3|Overall Study|Adverse Event|17
5566025|NCT01140906|19235508|P2|Overall Study|Adverse Event|10
5566026|NCT01140906|19235509|P1|Overall Study|Adverse Event|7
5566027|NCT01140880|19235549|P2|Overall Study|Protocol Violation|30
5566028|NCT01140880|19235550|P1|Overall Study|Protocol Violation|0
5566029|NCT01140880|19235549|P2|Overall Study|Lost to Follow-up|10
5566030|NCT01140880|19235550|P1|Overall Study|Lost to Follow-up|8
5566031|NCT01140880|19235549|P2|Overall Study|Withdrawal by Subject|3
5566032|NCT01140880|19235550|P1|Overall Study|Withdrawal by Subject|6
5566033|NCT01140880|19235549|P2|Overall Study|Death|1
5566034|NCT01140880|19235550|P1|Overall Study|Death|0
5566035|NCT01140867|19235562|P1|Overall Study|Medication Noncompliance|2
5566036|NCT01140867|19235562|P1|Overall Study|Uncooperative patient|2
5566037|NCT01140867|19235562|P1|Overall Study|Protocol Violation|1
5566038|NCT01140867|19235562|P1|Overall Study|Withdrawal by Subject|1
5566039|NCT01140867|19235562|P1|Overall Study|Lost to Follow-up|2
5566040|NCT01140867|19235562|P1|Overall Study|Lack of Efficacy|3
5566041|NCT01140867|19235562|P1|Overall Study|Adverse Event|22
5566042|NCT01140646|19235602|P1|Overall Study|Refused Further Treatment|5
5566043|NCT01140646|19235602|P1|Overall Study|Adverse Event|4
5566044|NCT01140568|19235610|P1|Overall Study|Screen Fail|4
5566045|NCT01140568|19235610|P1|Overall Study|Withdrawal by Subject|1
5566046|NCT01140568|19235610|P1|Overall Study|disease progression|31
5566047|NCT01140503|19235615|P1|Overall Study|Withdrawal by Subject|1
5566048|NCT01140477|19235623|P2|Overall Study|Subject explanted|1
5566049|NCT01140477|19235624|P1|Overall Study|Subject explanted|0
5566050|NCT01140477|19235623|P2|Overall Study|Death|1
5566051|NCT01140477|19235624|P1|Overall Study|Death|1
5566052|NCT01140477|19235623|P2|Overall Study|Surgical complication preventing implant|0
5566053|NCT01140477|19235624|P1|Overall Study|Surgical complication preventing implant|2
5566054|NCT01140477|19235623|P2|Overall Study|Withdrawal by Subject|4
5566055|NCT01140477|19235624|P1|Overall Study|Withdrawal by Subject|1
5566056|NCT01140477|19235623|P2|Overall Study|Lost to Follow-up|0
5566057|NCT01140477|19235624|P1|Overall Study|Lost to Follow-up|4
5566058|NCT01140451|19235635|P2|Overall Study|Participants Planning Pregnancy|0
5566059|NCT01140451|19235636|P1|Overall Study|Participants Planning Pregnancy|3
5566060|NCT01140451|19235635|P2|Overall Study|Lost to Follow-up|0
5566061|NCT01140451|19235636|P1|Overall Study|Lost to Follow-up|2
5566062|NCT01140451|19235635|P2|Overall Study|Physician Decision|3
5566063|NCT01140451|19235636|P1|Overall Study|Physician Decision|5
5566064|NCT01140451|19235635|P2|Overall Study|Adverse Event|6
5566065|NCT01140451|19235636|P1|Overall Study|Adverse Event|2
5566066|NCT01140451|19235635|P2|Overall Study|Withdrawal by Subject|33
5566067|NCT01140451|19235636|P1|Overall Study|Withdrawal by Subject|26
5566068|NCT01140347|19235701|P2|Overall Study|Withdrawal by Subject|8
5566069|NCT01140347|19235702|P1|Overall Study|Withdrawal by Subject|13
5566070|NCT01140347|19235701|P2|Overall Study|Lost to Follow-up|6
5566071|NCT01140347|19235702|P1|Overall Study|Lost to Follow-up|5
5566072|NCT01140061|19235755|P10|Extension|Laboratory Adverse Event|1
5566073|NCT01140061|19235756|P9|Extension|Laboratory Adverse Event|0
5566074|NCT01140061|19235757|P8|Extension|Laboratory Adverse Event|0
5566075|NCT01140061|19235758|P7|Extension|Laboratory Adverse Event|0
5566076|NCT01140061|19235759|P6|Extension|Laboratory Adverse Event|0
5566077|NCT01140061|19235760|P5|Extension|Laboratory Adverse Event|0
5566078|NCT01140061|19235761|P4|Extension|Laboratory Adverse Event|0
5566079|NCT01140061|19235762|P3|Extension|Laboratory Adverse Event|0
5566080|NCT01140061|19235763|P2|Extension|Laboratory Adverse Event|0
5566081|NCT01140061|19235764|P1|Extension|Laboratory Adverse Event|0
5566082|NCT01140061|19235755|P10|Part I|Adverse Event|0
5566083|NCT01140061|19235756|P9|Part I|Adverse Event|0
5566084|NCT01140061|19235757|P8|Part I|Adverse Event|0
5566085|NCT01140061|19235758|P7|Part I|Adverse Event|0
5566086|NCT01140061|19235759|P6|Part I|Adverse Event|0
5566087|NCT01140061|19235760|P5|Part I|Adverse Event|0
5566088|NCT01140061|19235761|P4|Part I|Adverse Event|0
5566089|NCT01140061|19235762|P3|Part I|Adverse Event|0
5566090|NCT01140061|19235763|P2|Part I|Adverse Event|0
5566091|NCT01140061|19235764|P1|Part I|Adverse Event|1
5566092|NCT01140048|19235791|P1|Overall Study|Lost to Follow-up|31
5566093|NCT01140048|19235791|P1|Overall Study|Withdrawal by Subject|13
5566094|NCT01140048|19235791|P1|Overall Study|Physician Decision|1
5566095|NCT01139775|19235831|P3|Overall Study|Physician Decision|2
5566096|NCT01139775|19235832|P2|Overall Study|Physician Decision|2
5566097|NCT01139775|19235833|P1|Overall Study|Physician Decision|0
5566098|NCT01139775|19235831|P3|Overall Study|Withdrawal by Subject|2
5566099|NCT01139775|19235832|P2|Overall Study|Withdrawal by Subject|0
5566100|NCT01139775|19235833|P1|Overall Study|Withdrawal by Subject|1
5566101|NCT01139775|19235831|P3|Overall Study|Protocol Violation|0
5566102|NCT01139775|19235832|P2|Overall Study|Protocol Violation|5
5566103|NCT01139775|19235833|P1|Overall Study|Protocol Violation|0
5566104|NCT01139775|19235831|P3|Overall Study|Adverse Event|2
5566105|NCT01139775|19235832|P2|Overall Study|Adverse Event|6
5566106|NCT01139775|19235833|P1|Overall Study|Adverse Event|0
5566107|NCT01139762|19235865|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
5566108|NCT01139762|19235866|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
5566109|NCT01139762|19235867|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
5566110|NCT01139762|19235865|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
5566111|NCT01139762|19235866|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
5566112|NCT01139762|19235867|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
5566113|NCT01139762|19235865|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
5566114|NCT01139762|19235866|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
5566115|NCT01139762|19235867|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
5566116|NCT01139762|19235865|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
5566117|NCT01139762|19235866|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
5566118|NCT01139762|19235867|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
5566119|NCT01139762|19235865|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
5566120|NCT01139762|19235866|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
5566121|NCT01139762|19235867|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
5566122|NCT01139762|19235865|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
5566123|NCT01139762|19235866|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
5566124|NCT01139762|19235867|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
5566125|NCT01139762|19235865|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
5566126|NCT01139762|19235866|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
5566127|NCT01139762|19235867|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
5566128|NCT01139762|19235865|P3|Double-Blind Randomized Active Treatment|Death|1
5566129|NCT01139762|19235866|P2|Double-Blind Randomized Active Treatment|Death|1
5566130|NCT01139762|19235867|P1|Double-Blind Randomized Active Treatment|Death|0
5566131|NCT01139762|19235865|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
5566132|NCT01139762|19235866|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
5566133|NCT01139762|19235867|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
5566134|NCT01139762|19235865|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
5566135|NCT01139762|19235866|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
5566136|NCT01139762|19235867|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
5566137|NCT01139762|19235865|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
5566138|NCT01139762|19235866|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
5566139|NCT01139762|19235867|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
5566140|NCT01139762|19235865|P3|Washout and Placebo Lead-In Period|Physician Decision|0
5566141|NCT01139762|19235866|P2|Washout and Placebo Lead-In Period|Physician Decision|0
5566142|NCT01139762|19235867|P1|Washout and Placebo Lead-In Period|Physician Decision|12
5566143|NCT01139762|19235865|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
5566144|NCT01139762|19235866|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
5566145|NCT01139762|19235867|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
5566146|NCT01139762|19235865|P3|Washout and Placebo Lead-In Period|Adverse Event|0
5566147|NCT01139762|19235866|P2|Washout and Placebo Lead-In Period|Adverse Event|0
5566148|NCT01139762|19235867|P1|Washout and Placebo Lead-In Period|Adverse Event|1
5566149|NCT01139762|19235865|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
5566150|NCT01139762|19235866|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
5566151|NCT01139762|19235867|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
5566152|NCT01139658|19235902|P2|Overall Study|Other|75
5566153|NCT01139658|19235903|P1|Overall Study|Other|28
5566154|NCT01139658|19235902|P2|Overall Study|No documentation of treatment|0
5566155|NCT01139658|19235903|P1|Overall Study|No documentation of treatment|1
5566156|NCT01139658|19235902|P2|Overall Study|Withdrawal by Subject|4
5566157|NCT01139658|19235903|P1|Overall Study|Withdrawal by Subject|2
5566158|NCT01139658|19235902|P2|Overall Study|Lack of Efficacy|7
5566159|NCT01139658|19235903|P1|Overall Study|Lack of Efficacy|15
5566160|NCT01139658|19235902|P2|Overall Study|Adverse Event|27
5566161|NCT01139658|19235903|P1|Overall Study|Adverse Event|10
5566162|NCT01139580|19235941|P2|Overall Study|Participant Randomization in Error|1
5566163|NCT01139580|19235942|P1|Overall Study|Participant Randomization in Error|0
5566164|NCT01139580|19235941|P2|Overall Study|Beginning Study Exclusion Treatment|1
5566165|NCT01139580|19235942|P1|Overall Study|Beginning Study Exclusion Treatment|0
5566166|NCT01139580|19235941|P2|Overall Study|Misrandomized|0
5566167|NCT01139580|19235942|P1|Overall Study|Misrandomized|1
5566168|NCT01139580|19235941|P2|Overall Study|Did Not Meet Exclusion Criteria|0
5566169|NCT01139580|19235942|P1|Overall Study|Did Not Meet Exclusion Criteria|1
5566170|NCT01139580|19235941|P2|Overall Study|Used Excluded Medicine After Enrollment|0
5566171|NCT01139580|19235942|P1|Overall Study|Used Excluded Medicine After Enrollment|1
5566172|NCT01139580|19235941|P2|Overall Study|Withdrawal by Subject|9
5566173|NCT01139580|19235942|P1|Overall Study|Withdrawal by Subject|6
5566174|NCT01139580|19235941|P2|Overall Study|Lack of Efficacy|2
5566175|NCT01139580|19235942|P1|Overall Study|Lack of Efficacy|0
5566176|NCT01139580|19235941|P2|Overall Study|Lost to Follow-up|1
5566177|NCT01139580|19235942|P1|Overall Study|Lost to Follow-up|9
5566178|NCT01139580|19235941|P2|Overall Study|Adverse Event|4
5566179|NCT01139580|19235942|P1|Overall Study|Adverse Event|5
5566180|NCT01139450|19235990|P3|Overall Study|Adverse Event|3
5566181|NCT01139450|19235991|P2|Overall Study|Adverse Event|2
5566182|NCT01139450|19235992|P1|Overall Study|Adverse Event|2
5566183|NCT01139450|19235990|P3|Overall Study|Administrative|1
5566184|NCT01139450|19235991|P2|Overall Study|Administrative|0
5566185|NCT01139450|19235992|P1|Overall Study|Administrative|0
5566186|NCT01139450|19235990|P3|Overall Study|Lost to Follow-up|11
5566187|NCT01139450|19235991|P2|Overall Study|Lost to Follow-up|7
5566188|NCT01139450|19235992|P1|Overall Study|Lost to Follow-up|9
5566189|NCT01139450|19235990|P3|Overall Study|Protocol Violation|2
5566190|NCT01139450|19235991|P2|Overall Study|Protocol Violation|5
5566191|NCT01139450|19235992|P1|Overall Study|Protocol Violation|6
5566192|NCT01139450|19235990|P3|Overall Study|Lack of Efficacy|8
5566193|NCT01139450|19235991|P2|Overall Study|Lack of Efficacy|1
5566194|NCT01139450|19235992|P1|Overall Study|Lack of Efficacy|3
5566195|NCT01139450|19235990|P3|Overall Study|Withdrawal by Subject|13
5566196|NCT01139450|19235991|P2|Overall Study|Withdrawal by Subject|10
5566197|NCT01139450|19235992|P1|Overall Study|Withdrawal by Subject|7
5566198|NCT01139164|19236044|P3|Overall Study|Withdrawn prior to study start|0
5566199|NCT01139164|19236045|P2|Overall Study|Withdrawn prior to study start|2
5566200|NCT01139164|19236046|P1|Overall Study|Withdrawn prior to study start|0
5566201|NCT01139125|19236060|P1|Overall Study|Withdrawal by Subject|1
5566202|NCT01139047|19236064|P1|Overall Study|Withdrawal by Subject|1
5566203|NCT01139021|19236079|P6|Overall Study|Withdrawal by Subject|0
5566204|NCT01139021|19236080|P5|Overall Study|Withdrawal by Subject|4
5566205|NCT01139021|19236081|P4|Overall Study|Withdrawal by Subject|1
5566206|NCT01139021|19236082|P3|Overall Study|Withdrawal by Subject|0
5566207|NCT01139021|19236083|P2|Overall Study|Withdrawal by Subject|0
5566208|NCT01139021|19236084|P1|Overall Study|Withdrawal by Subject|0
5566209|NCT01139021|19236079|P6|Overall Study|Protocol Violation|0
5566210|NCT01139021|19236080|P5|Overall Study|Protocol Violation|2
5566211|NCT01139021|19236081|P4|Overall Study|Protocol Violation|0
5566212|NCT01139021|19236082|P3|Overall Study|Protocol Violation|0
5566213|NCT01139021|19236083|P2|Overall Study|Protocol Violation|0
5566214|NCT01139021|19236084|P1|Overall Study|Protocol Violation|1
5566215|NCT01139021|19236079|P6|Overall Study|Lost to Follow-up|0
5566216|NCT01139021|19236080|P5|Overall Study|Lost to Follow-up|2
5566217|NCT01139021|19236081|P4|Overall Study|Lost to Follow-up|0
5566218|NCT01139021|19236082|P3|Overall Study|Lost to Follow-up|0
5566219|NCT01139021|19236083|P2|Overall Study|Lost to Follow-up|0
5566220|NCT01139021|19236084|P1|Overall Study|Lost to Follow-up|0
5566221|NCT01139021|19236079|P6|Overall Study|Adverse Event|0
5566222|NCT01139021|19236080|P5|Overall Study|Adverse Event|1
5566223|NCT01139021|19236081|P4|Overall Study|Adverse Event|0
5566224|NCT01139021|19236082|P3|Overall Study|Adverse Event|0
5566225|NCT01139021|19236083|P2|Overall Study|Adverse Event|0
5566226|NCT01139021|19236084|P1|Overall Study|Adverse Event|0
5566227|NCT01139008|19236120|P1|Overall Study|Non-compliant, lost product|1
5566228|NCT01139008|19236120|P1|Overall Study|Withdrawal by Subject|5
5566229|NCT01138826|19236167|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
5566230|NCT01138826|19236168|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
5566231|NCT01138826|19236169|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
5566232|NCT01138826|19236170|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
5566233|NCT01138826|19236171|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
5566234|NCT01138826|19236172|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
5566235|NCT01138657|19236209|P2|Overall Study|Miscellaneous Reasons|4
5566236|NCT01138657|19236210|P1|Overall Study|Miscellaneous Reasons|3
5566237|NCT01138657|19236209|P2|Overall Study|Lost to Follow-up|3
5566238|NCT01138657|19236210|P1|Overall Study|Lost to Follow-up|0
5566239|NCT01138657|19236209|P2|Overall Study|Lack of Efficacy|1
5566240|NCT01138657|19236210|P1|Overall Study|Lack of Efficacy|2
5566241|NCT01138657|19236209|P2|Overall Study|Adverse Event|10
5566242|NCT01138657|19236210|P1|Overall Study|Adverse Event|3
5566243|NCT01138501|19236273|P1|Overall Study|Withdrawal by Subject|3
5566244|NCT01138501|19236273|P1|Overall Study|Protocol Violation|2
5566245|NCT01138150|19236317|P2|Overall Study|Physician Decision|0
5566246|NCT01138150|19236318|P1|Overall Study|Physician Decision|1
5566247|NCT01138150|19236317|P2|Overall Study|blood unable to be processed|1
5566248|NCT01138150|19236318|P1|Overall Study|blood unable to be processed|0
5566249|NCT01138111|19236399|P1|Overall Study|Lost to Follow-up|2
5566250|NCT01138111|19236399|P1|Overall Study|Death|1
5566251|NCT01138111|19236399|P1|Overall Study|Adverse Event|1
5566252|NCT01138111|19236399|P1|Overall Study|Withdrawal by Subject|5
5566253|NCT01138046|19236453|P1|Overall Study|Withdrawal due to death|6
5566254|NCT01138007|19236473|P3|Overall Study|Withdrawal by Subject|15
5566255|NCT01138007|19236474|P2|Overall Study|Withdrawal by Subject|6
5566256|NCT01138007|19236475|P1|Overall Study|Withdrawal by Subject|5
5566257|NCT01138007|19236473|P3|Overall Study|Physician Decision|3
5566258|NCT01138007|19236474|P2|Overall Study|Physician Decision|5
5566259|NCT01138007|19236475|P1|Overall Study|Physician Decision|0
5566260|NCT01138007|19236473|P3|Overall Study|Lost to Follow-up|5
5566261|NCT01138007|19236474|P2|Overall Study|Lost to Follow-up|3
5566262|NCT01138007|19236475|P1|Overall Study|Lost to Follow-up|3
5566263|NCT01138007|19236473|P3|Overall Study|Protocol-Defined Stopping Criteria|8
5566264|NCT01138007|19236474|P2|Overall Study|Protocol-Defined Stopping Criteria|1
5566265|NCT01138007|19236475|P1|Overall Study|Protocol-Defined Stopping Criteria|6
5566266|NCT01138007|19236473|P3|Overall Study|Protocol Violation|2
5566267|NCT01138007|19236474|P2|Overall Study|Protocol Violation|3
5566268|NCT01138007|19236475|P1|Overall Study|Protocol Violation|2
5566269|NCT01138007|19236473|P3|Overall Study|Lack of Efficacy|6
5566270|NCT01138007|19236474|P2|Overall Study|Lack of Efficacy|0
5566271|NCT01138007|19236475|P1|Overall Study|Lack of Efficacy|2
5566272|NCT01138007|19236473|P3|Overall Study|Adverse Event|9
5566273|NCT01138007|19236474|P2|Overall Study|Adverse Event|12
5566274|NCT01138007|19236475|P1|Overall Study|Adverse Event|4
5566275|NCT01137812|19236582|P2|Overall Study|Other|27
5566276|NCT01137812|19236583|P1|Overall Study|Other|19
5566277|NCT01137812|19236582|P2|Overall Study|Patient met glycemic withdrawal criteria|85
5566278|NCT01137812|19236583|P1|Overall Study|Patient met glycemic withdrawal criteria|40
5566279|NCT01137812|19236582|P2|Overall Study|Death|0
5566280|NCT01137812|19236583|P1|Overall Study|Death|2
5566281|NCT01137812|19236582|P2|Overall Study|Withdrawal by Subject|13
5566282|NCT01137812|19236583|P1|Overall Study|Withdrawal by Subject|5
5566283|NCT01137812|19236582|P2|Overall Study|Protocol Violation|4
5566284|NCT01137812|19236583|P1|Overall Study|Protocol Violation|5
5566285|NCT01137812|19236582|P2|Overall Study|Physician Decision|17
5566286|NCT01137812|19236583|P1|Overall Study|Physician Decision|25
5566287|NCT01137812|19236582|P2|Overall Study|Lost to Follow-up|8
5566288|NCT01137812|19236583|P1|Overall Study|Lost to Follow-up|6
5566289|NCT01137812|19236582|P2|Overall Study|Adverse Event|14
5566290|NCT01137812|19236583|P1|Overall Study|Adverse Event|21
5566291|NCT01137786|19236603|P2|Overall Study|Withdrawal by Subject|1
5566292|NCT01137786|19236604|P1|Overall Study|Withdrawal by Subject|1
5566293|NCT01137786|19236603|P2|Overall Study|Lost to Follow-up|2
5566294|NCT01137786|19236604|P1|Overall Study|Lost to Follow-up|0
5566295|NCT01137773|19236614|P2|Overall Study|Lost to Follow-up|0
5566296|NCT01137773|19236615|P1|Overall Study|Lost to Follow-up|6
5566297|NCT01137773|19236614|P2|Overall Study|Death|3
5566298|NCT01137773|19236615|P1|Overall Study|Death|3
5566299|NCT01137682|19236626|P3|Overall Study|Did not receive treatment in extension|1
5566300|NCT01137682|19236627|P2|Overall Study|Did not receive treatment in extension|0
5566301|NCT01137682|19236628|P1|Overall Study|Did not receive treatment in extension|0
5566302|NCT01137682|19236626|P3|Overall Study|Did not enter extension|2
5566303|NCT01137682|19236627|P2|Overall Study|Did not enter extension|3
5566304|NCT01137682|19236628|P1|Overall Study|Did not enter extension|2
5566305|NCT01137682|19236626|P3|Overall Study|Protocol Violation-Extension|0
5566306|NCT01137682|19236627|P2|Overall Study|Protocol Violation-Extension|1
5566307|NCT01137682|19236628|P1|Overall Study|Protocol Violation-Extension|2
5566308|NCT01137682|19236626|P3|Overall Study|Death-Extension|0
5566309|NCT01137682|19236627|P2|Overall Study|Death-Extension|0
5566310|NCT01137682|19236628|P1|Overall Study|Death-Extension|2
5566311|NCT01137682|19236626|P3|Overall Study|Administrative problems-Extension|0
5566312|NCT01137682|19236627|P2|Overall Study|Administrative problems-Extension|2
5566313|NCT01137682|19236628|P1|Overall Study|Administrative problems-Extension|0
5566314|NCT01137682|19236626|P3|Overall Study|Lost to Follow Up-Extension|0
5566315|NCT01137682|19236627|P2|Overall Study|Lost to Follow Up-Extension|1
5566316|NCT01137682|19236628|P1|Overall Study|Lost to Follow Up-Extension|0
5566317|NCT01137682|19236626|P3|Overall Study|Withdrawal by Subject-Extension|8
5566318|NCT01137682|19236627|P2|Overall Study|Withdrawal by Subject-Extension|8
5566319|NCT01137682|19236628|P1|Overall Study|Withdrawal by Subject-Extension|6
5566320|NCT01137682|19236626|P3|Overall Study|Lack of Efficacy-Extension|13
5566321|NCT01137682|19236627|P2|Overall Study|Lack of Efficacy-Extension|9
5566322|NCT01137682|19236628|P1|Overall Study|Lack of Efficacy-Extension|15
5566323|NCT01137682|19236626|P3|Overall Study|Adverse Event-Extension|7
5566324|NCT01137682|19236627|P2|Overall Study|Adverse Event-Extension|8
5566325|NCT01137682|19236628|P1|Overall Study|Adverse Event-Extension|4
5566326|NCT01137682|19236626|P3|Overall Study|Protocol Violation-CORE|1
5566327|NCT01137682|19236627|P2|Overall Study|Protocol Violation-CORE|1
5566328|NCT01137682|19236628|P1|Overall Study|Protocol Violation-CORE|0
5566329|NCT01137682|19236626|P3|Overall Study|Administrative problems-CORE|0
5566330|NCT01137682|19236627|P2|Overall Study|Administrative problems-CORE|1
5566331|NCT01137682|19236628|P1|Overall Study|Administrative problems-CORE|2
5566332|NCT01137682|19236626|P3|Overall Study|Withdrawal by Subject-CORE|2
5566333|NCT01137682|19236627|P2|Overall Study|Withdrawal by Subject-CORE|2
5566334|NCT01137682|19236628|P1|Overall Study|Withdrawal by Subject-CORE|2
5566335|NCT01137682|19236626|P3|Overall Study|Adverse Event-CORE|0
5566336|NCT01137682|19236627|P2|Overall Study|Adverse Event-CORE|4
5566337|NCT01137682|19236628|P1|Overall Study|Adverse Event-CORE|2
5566338|NCT01137604|19236678|P4|Overall Study|Clinical Decline|1
5566339|NCT01137604|19236679|P3|Overall Study|Clinical Decline|1
5566340|NCT01137604|19236680|P2|Overall Study|Clinical Decline|0
5566341|NCT01137604|19236681|P1|Overall Study|Clinical Decline|0
5566342|NCT01137604|19236678|P4|Overall Study|Participant's Decision|0
5566343|NCT01137604|19236679|P3|Overall Study|Participant's Decision|0
5566344|NCT01137604|19236680|P2|Overall Study|Participant's Decision|0
5566345|NCT01137604|19236681|P1|Overall Study|Participant's Decision|1
5566346|NCT01137604|19236678|P4|Overall Study|Clinical Progression|0
5566347|NCT01137604|19236679|P3|Overall Study|Clinical Progression|1
5566348|NCT01137604|19236680|P2|Overall Study|Clinical Progression|2
5566349|NCT01137604|19236681|P1|Overall Study|Clinical Progression|0
5566350|NCT01137604|19236678|P4|Overall Study|Withdrawal by Subject|1
5566351|NCT01137604|19236679|P3|Overall Study|Withdrawal by Subject|2
5566352|NCT01137604|19236680|P2|Overall Study|Withdrawal by Subject|2
5566353|NCT01137604|19236681|P1|Overall Study|Withdrawal by Subject|0
5566354|NCT01137604|19236678|P4|Overall Study|Adverse Event|9
5566355|NCT01137604|19236679|P3|Overall Study|Adverse Event|9
5566356|NCT01137604|19236680|P2|Overall Study|Adverse Event|6
5566357|NCT01137604|19236681|P1|Overall Study|Adverse Event|1
5566358|NCT01137578|19236715|P3|Overall Study|Other|6
5566359|NCT01137578|19236716|P2|Overall Study|Other|2
5566360|NCT01137578|19236717|P1|Overall Study|Other|12
5566361|NCT01137578|19236715|P3|Overall Study|Withdrawal by Subject|0
5566362|NCT01137578|19236716|P2|Overall Study|Withdrawal by Subject|0
5566363|NCT01137578|19236717|P1|Overall Study|Withdrawal by Subject|1
5566364|NCT01137578|19236715|P3|Overall Study|Participant requested to Discontinue|0
5566365|NCT01137578|19236716|P2|Overall Study|Participant requested to Discontinue|0
5566366|NCT01137578|19236717|P1|Overall Study|Participant requested to Discontinue|3
5566367|NCT01137474|19236766|P4|Overall Study|Administrative reason by sponsor|0
5566368|NCT01137474|19236767|P3|Overall Study|Administrative reason by sponsor|0
5566369|NCT01137474|19236768|P2|Overall Study|Administrative reason by sponsor|1
5566370|NCT01137474|19236769|P1|Overall Study|Administrative reason by sponsor|0
5566371|NCT01137474|19236766|P4|Overall Study|Pregnancy|0
5566372|NCT01137474|19236767|P3|Overall Study|Pregnancy|0
5566373|NCT01137474|19236768|P2|Overall Study|Pregnancy|1
5566374|NCT01137474|19236769|P1|Overall Study|Pregnancy|0
5566375|NCT01137474|19236766|P4|Overall Study|Other|0
5566376|NCT01137474|19236767|P3|Overall Study|Other|0
5566377|NCT01137474|19236768|P2|Overall Study|Other|1
5566378|NCT01137474|19236769|P1|Overall Study|Other|3
5566379|NCT01137474|19236766|P4|Overall Study|Lack of Efficacy|2
5566380|NCT01137474|19236767|P3|Overall Study|Lack of Efficacy|0
5566381|NCT01137474|19236768|P2|Overall Study|Lack of Efficacy|0
5566382|NCT01137474|19236769|P1|Overall Study|Lack of Efficacy|0
5566383|NCT01137474|19236766|P4|Overall Study|Lost to Follow-up|2
5566384|NCT01137474|19236767|P3|Overall Study|Lost to Follow-up|0
5566385|NCT01137474|19236768|P2|Overall Study|Lost to Follow-up|1
5566386|NCT01137474|19236769|P1|Overall Study|Lost to Follow-up|5
5566387|NCT01137474|19236766|P4|Overall Study|No longer met study criteria|5
5566388|NCT01137474|19236767|P3|Overall Study|No longer met study criteria|0
5566389|NCT01137474|19236768|P2|Overall Study|No longer met study criteria|1
5566390|NCT01137474|19236769|P1|Overall Study|No longer met study criteria|6
5566391|NCT01137474|19236766|P4|Overall Study|Withdrawal by Subject|9
5566392|NCT01137474|19236767|P3|Overall Study|Withdrawal by Subject|6
5566393|NCT01137474|19236768|P2|Overall Study|Withdrawal by Subject|2
5566394|NCT01137474|19236769|P1|Overall Study|Withdrawal by Subject|7
5566395|NCT01137474|19236766|P4|Overall Study|Adverse Event|3
5566396|NCT01137474|19236767|P3|Overall Study|Adverse Event|1
5566397|NCT01137474|19236768|P2|Overall Study|Adverse Event|5
5566398|NCT01137474|19236769|P1|Overall Study|Adverse Event|3
5566399|NCT01137435|19236787|P1|Overall Study|Off label usage|4
5566400|NCT01137435|19236787|P1|Overall Study|Lost to Follow-up|24
5566401|NCT01137292|19236814|P1|Overall Study|Other|7
5566402|NCT01137292|19236814|P1|Overall Study|Lost to Follow-up|1
5566403|NCT01137292|19236814|P1|Overall Study|Lack of Efficacy|13
5566404|NCT01137292|19236814|P1|Overall Study|Adverse Event|3
5566405|NCT01137292|19236814|P1|Overall Study|Death|30
5566406|NCT01137110|19236823|P2|Overall Study|Protocol Violation|0
5566407|NCT01137110|19236824|P1|Overall Study|Protocol Violation|1
5566408|NCT01137071|19236830|P1|Overall Study|Wrongly Included|1
5566409|NCT01137071|19236830|P1|Overall Study|Withdrawal by Subject|2
5566410|NCT01137071|19236830|P1|Overall Study|Disease Progression|11
5566411|NCT01136967|19236986|P2|Overall Study|Diagnosis of Second Primary Cancer|1
5566412|NCT01136967|19236987|P1|Overall Study|Diagnosis of Second Primary Cancer|0
5566413|NCT01136967|19236986|P2|Overall Study|Increase in Lesion Size|2
5566414|NCT01136967|19236987|P1|Overall Study|Increase in Lesion Size|0
5566415|NCT01136967|19236986|P2|Overall Study|Investigator's Choice|1
5566416|NCT01136967|19236987|P1|Overall Study|Investigator's Choice|1
5566417|NCT01136967|19236986|P2|Overall Study|Non-compliance|0
5566418|NCT01136967|19236987|P1|Overall Study|Non-compliance|1
5566419|NCT01136967|19236986|P2|Overall Study|Radiation|0
5566420|NCT01136967|19236987|P1|Overall Study|Radiation|1
5566421|NCT01136967|19236986|P2|Overall Study|Clinical Progression|5
5566422|NCT01136967|19236987|P1|Overall Study|Clinical Progression|3
5566423|NCT01136967|19236986|P2|Overall Study|Withdrawal by Subject|2
5566424|NCT01136967|19236987|P1|Overall Study|Withdrawal by Subject|1
5566425|NCT01136967|19236986|P2|Overall Study|Lost to Follow-up|1
5566426|NCT01136967|19236987|P1|Overall Study|Lost to Follow-up|0
5566427|NCT01136967|19236986|P2|Overall Study|Participant Choice|3
5566428|NCT01136967|19236987|P1|Overall Study|Participant Choice|8
5566429|NCT01136967|19236986|P2|Overall Study|Adverse Event|12
5566430|NCT01136967|19236987|P1|Overall Study|Adverse Event|9
5566431|NCT01136954|19237009|P2|Overall Study|Other|3
5566432|NCT01136954|19237010|P1|Overall Study|Other|1
5566433|NCT01136954|19237009|P2|Overall Study|Physician Decision|1
5566434|NCT01136954|19237010|P1|Overall Study|Physician Decision|0
5566435|NCT01136954|19237009|P2|Overall Study|Lack of Efficacy|13
5566436|NCT01136954|19237010|P1|Overall Study|Lack of Efficacy|14
5566437|NCT01136954|19237009|P2|Overall Study|Withdrawal by Subject|2
5566438|NCT01136954|19237010|P1|Overall Study|Withdrawal by Subject|6
5566439|NCT01136954|19237009|P2|Overall Study|Adverse Event|2
5566440|NCT01136954|19237010|P1|Overall Study|Adverse Event|3
5566441|NCT01136915|19237024|P2|Overall Study|Exclusion criterion met|1
5566442|NCT01136915|19237025|P1|Overall Study|Exclusion criterion met|0
5566443|NCT01136915|19237024|P2|Overall Study|Lost to Follow-up|0
5566444|NCT01136915|19237025|P1|Overall Study|Lost to Follow-up|2
5566445|NCT01136876|19237035|P2|Overall Study|Missing NGAL measurement|5
5566446|NCT01136876|19237036|P1|Overall Study|Missing NGAL measurement|2
5566447|NCT01136876|19237035|P2|Overall Study|Physician Decision|5
5566448|NCT01136876|19237036|P1|Overall Study|Physician Decision|3
5566449|NCT01136876|19237035|P2|Overall Study|Lost to Follow-up|1
5566450|NCT01136876|19237036|P1|Overall Study|Lost to Follow-up|0
5566451|NCT01136785|19237065|P2|Overall Study|Protocol Violation|1
5566452|NCT01136785|19237066|P1|Overall Study|Protocol Violation|2
5566453|NCT01136772|19237081|P2|Overall Study|Did not follow up after first injection|2
5566454|NCT01136772|19237082|P1|Overall Study|Did not follow up after first injection|2
5566455|NCT01136772|19237081|P2|Overall Study|Did not receive injection|7
5566456|NCT01136772|19237082|P1|Overall Study|Did not receive injection|10
5566457|NCT01136772|19237081|P2|Overall Study|Withdrawal by Subject|36
5566458|NCT01136772|19237082|P1|Overall Study|Withdrawal by Subject|33
5566459|NCT01136772|19237081|P2|Overall Study|Administrative|12
5566460|NCT01136772|19237082|P1|Overall Study|Administrative|14
5566461|NCT01136772|19237081|P2|Overall Study|Lack of Efficacy|39
5566462|NCT01136772|19237082|P1|Overall Study|Lack of Efficacy|42
5566463|NCT01136772|19237081|P2|Overall Study|Adverse Event|14
5566464|NCT01136772|19237082|P1|Overall Study|Adverse Event|15
5566465|NCT01136746|19237092|P2|Overall Study|Death|0
5566466|NCT01136746|19237093|P1|Overall Study|Death|1
5566467|NCT01136746|19237092|P2|Overall Study|Protocol Violation|1
5566468|NCT01136746|19237093|P1|Overall Study|Protocol Violation|2
5566469|NCT01136746|19237092|P2|Overall Study|Lost to Follow-up|2
5566470|NCT01136746|19237093|P1|Overall Study|Lost to Follow-up|0
5566471|NCT01136733|19237160|P7|Phase 2|Other|6
5566472|NCT01136733|19237161|P6|Phase 2|Other|7
5566473|NCT01136733|19237162|P5|Phase 2|Other|6
5566474|NCT01136733|19237163|P4|Phase 2|Other|0
5566475|NCT01136733|19237164|P3|Phase 2|Other|0
5566476|NCT01136733|19237165|P2|Phase 2|Other|0
5566477|NCT01136733|19237166|P1|Phase 2|Other|0
5566478|NCT01136733|19237160|P7|Phase 2|Administrative-Withdrew Consent|0
5566479|NCT01136733|19237161|P6|Phase 2|Administrative-Withdrew Consent|0
5566480|NCT01136733|19237162|P5|Phase 2|Administrative-Withdrew Consent|1
5566481|NCT01136733|19237163|P4|Phase 2|Administrative-Withdrew Consent|0
5566482|NCT01136733|19237164|P3|Phase 2|Administrative-Withdrew Consent|0
5566483|NCT01136733|19237165|P2|Phase 2|Administrative-Withdrew Consent|0
5566484|NCT01136733|19237166|P1|Phase 2|Administrative-Withdrew Consent|0
5566485|NCT01136733|19237160|P7|Phase 2|Participant Choice|1
5566486|NCT01136733|19237161|P6|Phase 2|Participant Choice|0
5566487|NCT01136733|19237162|P5|Phase 2|Participant Choice|3
5566488|NCT01136733|19237163|P4|Phase 2|Participant Choice|0
5566489|NCT01136733|19237164|P3|Phase 2|Participant Choice|0
5566490|NCT01136733|19237165|P2|Phase 2|Participant Choice|0
5566491|NCT01136733|19237166|P1|Phase 2|Participant Choice|0
5566492|NCT01136733|19237160|P7|Phase 2|Adverse Event|5
5566493|NCT01136733|19237161|P6|Phase 2|Adverse Event|13
5566494|NCT01136733|19237162|P5|Phase 2|Adverse Event|11
5566495|NCT01136733|19237163|P4|Phase 2|Adverse Event|0
5566496|NCT01136733|19237164|P3|Phase 2|Adverse Event|0
5566497|NCT01136733|19237165|P2|Phase 2|Adverse Event|0
5566498|NCT01136733|19237166|P1|Phase 2|Adverse Event|0
5566499|NCT01136733|19237160|P7|Phase 2|Disease Progression|38
5566500|NCT01136733|19237161|P6|Phase 2|Disease Progression|32
5566501|NCT01136733|19237162|P5|Phase 2|Disease Progression|30
5566502|NCT01136733|19237163|P4|Phase 2|Disease Progression|0
5566503|NCT01136733|19237164|P3|Phase 2|Disease Progression|0
5566504|NCT01136733|19237165|P2|Phase 2|Disease Progression|0
5566505|NCT01136733|19237166|P1|Phase 2|Disease Progression|0
5566506|NCT01136733|19237160|P7|Phase 1b|Clinical Progression|0
5566507|NCT01136733|19237161|P6|Phase 1b|Clinical Progression|0
5566508|NCT01136733|19237162|P5|Phase 1b|Clinical Progression|0
5566509|NCT01136733|19237163|P4|Phase 1b|Clinical Progression|0
5566510|NCT01136733|19237164|P3|Phase 1b|Clinical Progression|0
5566511|NCT01136733|19237165|P2|Phase 1b|Clinical Progression|1
5566512|NCT01136733|19237166|P1|Phase 1b|Clinical Progression|1
5566513|NCT01136733|19237160|P7|Phase 1b|Administrative-Withdrew Consent|0
5566514|NCT01136733|19237161|P6|Phase 1b|Administrative-Withdrew Consent|0
5566515|NCT01136733|19237162|P5|Phase 1b|Administrative-Withdrew Consent|0
5566516|NCT01136733|19237163|P4|Phase 1b|Administrative-Withdrew Consent|0
5566517|NCT01136733|19237164|P3|Phase 1b|Administrative-Withdrew Consent|0
5566518|NCT01136733|19237165|P2|Phase 1b|Administrative-Withdrew Consent|1
5566519|NCT01136733|19237166|P1|Phase 1b|Administrative-Withdrew Consent|0
5566520|NCT01136733|19237160|P7|Phase 1b|Participant Choice|0
5566521|NCT01136733|19237161|P6|Phase 1b|Participant Choice|0
5566522|NCT01136733|19237162|P5|Phase 1b|Participant Choice|0
5566523|NCT01136733|19237163|P4|Phase 1b|Participant Choice|0
5566524|NCT01136733|19237164|P3|Phase 1b|Participant Choice|1
5566525|NCT01136733|19237165|P2|Phase 1b|Participant Choice|0
5566526|NCT01136733|19237166|P1|Phase 1b|Participant Choice|0
5566527|NCT01136733|19237160|P7|Phase 1b|Adverse Event|0
5566528|NCT01136733|19237161|P6|Phase 1b|Adverse Event|0
5566529|NCT01136733|19237162|P5|Phase 1b|Adverse Event|0
5566530|NCT01136733|19237163|P4|Phase 1b|Adverse Event|0
5566531|NCT01136733|19237164|P3|Phase 1b|Adverse Event|1
5566532|NCT01136733|19237165|P2|Phase 1b|Adverse Event|3
5566533|NCT01136733|19237166|P1|Phase 1b|Adverse Event|0
5566534|NCT01136655|19237249|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
5566535|NCT01136655|19237249|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
5566536|NCT01136655|19237249|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
5566537|NCT01136655|19237249|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
5566538|NCT01136408|19237282|P3|Overall Study|Protocol Violation|1
5566539|NCT01136408|19237283|P2|Overall Study|Protocol Violation|1
5566540|NCT01136408|19237284|P1|Overall Study|Protocol Violation|1
5566541|NCT01136408|19237282|P3|Overall Study|Adverse Event|4
5566542|NCT01136408|19237283|P2|Overall Study|Adverse Event|8
5566543|NCT01136408|19237284|P1|Overall Study|Adverse Event|4
5566544|NCT01136382|19237341|P2|Overall Study|Withdrawal by Subject|1
5566545|NCT01136382|19237342|P1|Overall Study|Withdrawal by Subject|4
5566546|NCT01136382|19237341|P2|Overall Study|Severe Non-Compliance to Protocol|2
5566547|NCT01136382|19237342|P1|Overall Study|Severe Non-Compliance to Protocol|0
5566548|NCT01136382|19237341|P2|Overall Study|Study-Specific Withdrawal Criteria|25
5566549|NCT01136382|19237342|P1|Overall Study|Study-Specific Withdrawal Criteria|48
5566550|NCT01136382|19237341|P2|Overall Study|Other|3
5566551|NCT01136382|19237342|P1|Overall Study|Other|8
5566552|NCT01136356|19237368|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
5566553|NCT01136356|19237369|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
5566554|NCT01136356|19237368|P2|First 18-day Withdrawal|Physician Decision|0
5566555|NCT01136356|19237369|P1|First 18-day Withdrawal|Physician Decision|1
5566556|NCT01136356|19237368|P2|First 18-day Withdrawal|Withdrawal by Subject|0
5566557|NCT01136356|19237369|P1|First 18-day Withdrawal|Withdrawal by Subject|3
5566558|NCT01136291|19237380|P2|Overall Study|Lost to Follow-up|1
5566559|NCT01136291|19237381|P1|Overall Study|Lost to Follow-up|1
5566560|NCT01136174|19237400|P4|Overall Study|Adverse Event|4
5566561|NCT01136174|19237401|P3|Overall Study|Adverse Event|0
5566562|NCT01136174|19237402|P2|Overall Study|Adverse Event|0
5566563|NCT01136174|19237403|P1|Overall Study|Adverse Event|0
5566564|NCT01135992|19237483|P1|Overall Study|Unclassified|7
5566565|NCT01135992|19237483|P1|Overall Study|Withdrawal criteria|10
5566566|NCT01135992|19237483|P1|Overall Study|Protocol Violation|2
5566567|NCT01135992|19237483|P1|Overall Study|Lack of Efficacy|1
5566568|NCT01135992|19237483|P1|Overall Study|Adverse Event|1
5566569|NCT01135914|19237495|P3|Overall Study|Adverse Event|2
5566570|NCT01135914|19237496|P2|Overall Study|Adverse Event|1
5566571|NCT01135914|19237497|P1|Overall Study|Adverse Event|0
5566572|NCT01135914|19237495|P3|Overall Study|Lack of Efficacy|10
5566573|NCT01135914|19237496|P2|Overall Study|Lack of Efficacy|1
5566574|NCT01135914|19237497|P1|Overall Study|Lack of Efficacy|2
5566575|NCT01135914|19237495|P3|Overall Study|Protocol Violation|3
5566576|NCT01135914|19237496|P2|Overall Study|Protocol Violation|0
5566577|NCT01135914|19237497|P1|Overall Study|Protocol Violation|0
5566578|NCT01135914|19237495|P3|Overall Study|Lost to Follow-up|1
5566579|NCT01135914|19237496|P2|Overall Study|Lost to Follow-up|0
5566580|NCT01135914|19237497|P1|Overall Study|Lost to Follow-up|1
5566581|NCT01135914|19237495|P3|Overall Study|Withdrawal by Subject|6
5566582|NCT01135914|19237496|P2|Overall Study|Withdrawal by Subject|3
5566583|NCT01135914|19237497|P1|Overall Study|Withdrawal by Subject|1
5566584|NCT01135524|19237530|P1|Overall Study|Lack of Efficacy|8
5566585|NCT01135524|19237530|P1|Overall Study|Administrative|151
5566586|NCT01135524|19237530|P1|Overall Study|Lost to Follow-up|3
5566587|NCT01135524|19237530|P1|Overall Study|Adverse Event|20
5566588|NCT01135524|19237530|P1|Overall Study|Withdrawal by Subject|14
5566589|NCT01135511|19237543|P9|Overall Study|Withdrawal by Subject|1
5566590|NCT01135511|19237544|P8|Overall Study|Withdrawal by Subject|0
5566591|NCT01135511|19237545|P7|Overall Study|Withdrawal by Subject|1
5566592|NCT01135511|19237546|P6|Overall Study|Withdrawal by Subject|0
5566593|NCT01135511|19237547|P5|Overall Study|Withdrawal by Subject|0
5566594|NCT01135511|19237548|P4|Overall Study|Withdrawal by Subject|0
5566595|NCT01135511|19237549|P3|Overall Study|Withdrawal by Subject|0
5566596|NCT01135511|19237550|P2|Overall Study|Withdrawal by Subject|0
5566597|NCT01135511|19237551|P1|Overall Study|Withdrawal by Subject|0
5566598|NCT01135511|19237543|P9|Overall Study|noncompliance with study drug taken|0
5566599|NCT01135511|19237544|P8|Overall Study|noncompliance with study drug taken|0
5566600|NCT01135511|19237545|P7|Overall Study|noncompliance with study drug taken|0
5566601|NCT01135511|19237546|P6|Overall Study|noncompliance with study drug taken|0
5566602|NCT01135511|19237547|P5|Overall Study|noncompliance with study drug taken|1
5566603|NCT01135511|19237548|P4|Overall Study|noncompliance with study drug taken|0
5566604|NCT01135511|19237549|P3|Overall Study|noncompliance with study drug taken|0
5566605|NCT01135511|19237550|P2|Overall Study|noncompliance with study drug taken|0
5566606|NCT01135511|19237551|P1|Overall Study|noncompliance with study drug taken|0
5566607|NCT01135511|19237543|P9|Overall Study|could not visit the clinic|0
5566608|NCT01135511|19237544|P8|Overall Study|could not visit the clinic|0
5566609|NCT01135511|19237545|P7|Overall Study|could not visit the clinic|0
5566610|NCT01135511|19237546|P6|Overall Study|could not visit the clinic|0
5566611|NCT01135511|19237547|P5|Overall Study|could not visit the clinic|0
5566612|NCT01135511|19237548|P4|Overall Study|could not visit the clinic|0
5566613|NCT01135511|19237549|P3|Overall Study|could not visit the clinic|2
5566614|NCT01135511|19237550|P2|Overall Study|could not visit the clinic|1
5566615|NCT01135511|19237551|P1|Overall Study|could not visit the clinic|0
5566616|NCT01135511|19237543|P9|Overall Study|Pregnancy|0
5566617|NCT01135511|19237544|P8|Overall Study|Pregnancy|0
5566618|NCT01135511|19237545|P7|Overall Study|Pregnancy|0
5566619|NCT01135511|19237546|P6|Overall Study|Pregnancy|0
5566620|NCT01135511|19237547|P5|Overall Study|Pregnancy|0
5566621|NCT01135511|19237548|P4|Overall Study|Pregnancy|1
5566622|NCT01135511|19237549|P3|Overall Study|Pregnancy|0
5566623|NCT01135511|19237550|P2|Overall Study|Pregnancy|0
5566624|NCT01135511|19237551|P1|Overall Study|Pregnancy|0
5566625|NCT01135511|19237543|P9|Overall Study|Protocol Violation|0
5566626|NCT01135511|19237544|P8|Overall Study|Protocol Violation|0
5566627|NCT01135511|19237545|P7|Overall Study|Protocol Violation|0
5566628|NCT01135511|19237546|P6|Overall Study|Protocol Violation|0
5566629|NCT01135511|19237547|P5|Overall Study|Protocol Violation|0
5566630|NCT01135511|19237548|P4|Overall Study|Protocol Violation|0
5566631|NCT01135511|19237549|P3|Overall Study|Protocol Violation|3
5566632|NCT01135511|19237550|P2|Overall Study|Protocol Violation|0
5566633|NCT01135511|19237551|P1|Overall Study|Protocol Violation|0
5566634|NCT01135511|19237543|P9|Overall Study|Lack of Efficacy|0
5566635|NCT01135511|19237544|P8|Overall Study|Lack of Efficacy|0
5566636|NCT01135511|19237545|P7|Overall Study|Lack of Efficacy|0
5566637|NCT01135511|19237546|P6|Overall Study|Lack of Efficacy|0
5566638|NCT01135511|19237547|P5|Overall Study|Lack of Efficacy|0
5566639|NCT01135511|19237548|P4|Overall Study|Lack of Efficacy|2
5566640|NCT01135511|19237549|P3|Overall Study|Lack of Efficacy|1
5566641|NCT01135511|19237550|P2|Overall Study|Lack of Efficacy|1
5566642|NCT01135511|19237551|P1|Overall Study|Lack of Efficacy|0
5566643|NCT01135511|19237543|P9|Overall Study|Adverse Event|0
5566644|NCT01135511|19237544|P8|Overall Study|Adverse Event|1
5566645|NCT01135511|19237545|P7|Overall Study|Adverse Event|0
5566646|NCT01135511|19237546|P6|Overall Study|Adverse Event|1
5566647|NCT01135511|19237547|P5|Overall Study|Adverse Event|0
5566648|NCT01135511|19237548|P4|Overall Study|Adverse Event|0
5566649|NCT01135511|19237549|P3|Overall Study|Adverse Event|2
5566650|NCT01135511|19237550|P2|Overall Study|Adverse Event|1
5566651|NCT01135511|19237551|P1|Overall Study|Adverse Event|0
5566652|NCT01135498|19237833|P1|Overall Study|Ongoing at time of analysis|2
5566653|NCT01135498|19237833|P1|Overall Study|Death|1
5566654|NCT01135498|19237833|P1|Overall Study|Withdrawal by Subject|4
5566655|NCT01135498|19237833|P1|Overall Study|Investigator judgement|25
5566656|NCT01135498|19237833|P1|Overall Study|Progressive disease|38
5566657|NCT01135498|19237833|P1|Overall Study|Adverse Event|20
5566658|NCT01135134|19238012|P2|Overall Study|Did not meet protocol eligibility|0
5566659|NCT01135134|19238013|P1|Overall Study|Did not meet protocol eligibility|1
5566660|NCT01135134|19238012|P2|Overall Study|Adverse Event|1
5566661|NCT01135134|19238013|P1|Overall Study|Adverse Event|1
5566662|NCT01135017|19238036|P2|Overall Study|Other than above|4
5566663|NCT01135017|19238037|P1|Overall Study|Other than above|3
5566664|NCT01135017|19238036|P2|Overall Study|Adverse Event|8
5566665|NCT01135017|19238037|P1|Overall Study|Adverse Event|3
5566666|NCT01134939|19238075|P8|Overall Study|Termination page not available|0
5566667|NCT01134939|19238076|P7|Overall Study|Termination page not available|7
5566668|NCT01134939|19238077|P6|Overall Study|Termination page not available|3
5566669|NCT01134939|19238078|P5|Overall Study|Termination page not available|0
5566670|NCT01134939|19238079|P4|Overall Study|Termination page not available|8
5566671|NCT01134939|19238080|P3|Overall Study|Termination page not available|5
5566672|NCT01134939|19238081|P2|Overall Study|Termination page not available|6
5566673|NCT01134939|19238082|P1|Overall Study|Termination page not available|4
5566674|NCT01134939|19238075|P8|Overall Study|Death|0
5566675|NCT01134939|19238076|P7|Overall Study|Death|0
5566676|NCT01134939|19238077|P6|Overall Study|Death|0
5566677|NCT01134939|19238078|P5|Overall Study|Death|0
5566678|NCT01134939|19238079|P4|Overall Study|Death|0
5566679|NCT01134939|19238080|P3|Overall Study|Death|0
5566680|NCT01134939|19238081|P2|Overall Study|Death|1
5566681|NCT01134939|19238082|P1|Overall Study|Death|0
5566682|NCT01134939|19238075|P8|Overall Study|Lost to Follow-up|0
5566683|NCT01134939|19238076|P7|Overall Study|Lost to Follow-up|0
5566684|NCT01134939|19238077|P6|Overall Study|Lost to Follow-up|1
5566685|NCT01134939|19238078|P5|Overall Study|Lost to Follow-up|2
5566686|NCT01134939|19238079|P4|Overall Study|Lost to Follow-up|1
5566687|NCT01134939|19238080|P3|Overall Study|Lost to Follow-up|0
5566688|NCT01134939|19238081|P2|Overall Study|Lost to Follow-up|3
5566689|NCT01134939|19238082|P1|Overall Study|Lost to Follow-up|2
5566690|NCT01134939|19238075|P8|Overall Study|Lack of Efficacy|0
5566691|NCT01134939|19238076|P7|Overall Study|Lack of Efficacy|1
5566692|NCT01134939|19238077|P6|Overall Study|Lack of Efficacy|0
5566693|NCT01134939|19238078|P5|Overall Study|Lack of Efficacy|3
5566694|NCT01134939|19238079|P4|Overall Study|Lack of Efficacy|0
5566695|NCT01134939|19238080|P3|Overall Study|Lack of Efficacy|1
5566696|NCT01134939|19238081|P2|Overall Study|Lack of Efficacy|5
5566697|NCT01134939|19238082|P1|Overall Study|Lack of Efficacy|2
5566698|NCT01134939|19238075|P8|Overall Study|Adverse Event|0
5566699|NCT01134939|19238076|P7|Overall Study|Adverse Event|1
5566700|NCT01134939|19238077|P6|Overall Study|Adverse Event|5
5566701|NCT01134939|19238078|P5|Overall Study|Adverse Event|5
5566702|NCT01134939|19238079|P4|Overall Study|Adverse Event|5
5566703|NCT01134939|19238080|P3|Overall Study|Adverse Event|4
5566704|NCT01134939|19238081|P2|Overall Study|Adverse Event|3
5566705|NCT01134939|19238082|P1|Overall Study|Adverse Event|9
5566706|NCT01134783|19238220|P2|Overall Study|Lost to Follow-up|20
5566707|NCT01134783|19238221|P1|Overall Study|Lost to Follow-up|5
5566708|NCT01134783|19238220|P2|Overall Study|Withdrawal by Subject|9
5566709|NCT01134783|19238221|P1|Overall Study|Withdrawal by Subject|15
5566710|NCT01134783|19238220|P2|Overall Study|Pregnancy|8
5566711|NCT01134783|19238221|P1|Overall Study|Pregnancy|16
5566712|NCT01134731|19238240|P3|Overall Study|Lost to Follow-up|3
5566713|NCT01134731|19238241|P2|Overall Study|Lost to Follow-up|4
5566714|NCT01134731|19238242|P1|Overall Study|Lost to Follow-up|5
5566715|NCT01134731|19238240|P3|Overall Study|Withdrawal by Subject|1
5566716|NCT01134731|19238241|P2|Overall Study|Withdrawal by Subject|3
5566717|NCT01134731|19238242|P1|Overall Study|Withdrawal by Subject|3
5566718|NCT01134731|19238240|P3|Overall Study|Lack of Efficacy|1
5566719|NCT01134731|19238241|P2|Overall Study|Lack of Efficacy|0
5566720|NCT01134731|19238242|P1|Overall Study|Lack of Efficacy|0
5566721|NCT01134731|19238240|P3|Overall Study|Physician Decision|2
5566722|NCT01134731|19238241|P2|Overall Study|Physician Decision|2
5566723|NCT01134731|19238242|P1|Overall Study|Physician Decision|2
5566724|NCT01134731|19238240|P3|Overall Study|Adverse Event|1
5566725|NCT01134731|19238241|P2|Overall Study|Adverse Event|2
5566726|NCT01134731|19238242|P1|Overall Study|Adverse Event|3
5566727|NCT01134705|19238255|P2|Overall Study|Other|6
5566728|NCT01134705|19238256|P1|Overall Study|Other|1
5566729|NCT01134705|19238255|P2|Overall Study|Protocol Violation|1
5566730|NCT01134705|19238256|P1|Overall Study|Protocol Violation|1
5566731|NCT01134705|19238255|P2|Overall Study|Lost to Follow-up|2
5566732|NCT01134705|19238256|P1|Overall Study|Lost to Follow-up|5
5566733|NCT01134705|19238255|P2|Overall Study|Pregnancy|0
5566734|NCT01134705|19238256|P1|Overall Study|Pregnancy|1
5566735|NCT01134705|19238255|P2|Overall Study|Withdrawal by Subject|6
5566736|NCT01134705|19238256|P1|Overall Study|Withdrawal by Subject|6
5566737|NCT01134705|19238255|P2|Overall Study|Adverse Event|7
5566738|NCT01134705|19238256|P1|Overall Study|Adverse Event|1
5566739|NCT01134627|19238268|P2|Overall Study|Other|14
5566740|NCT01134627|19238269|P1|Overall Study|Other|11
5566741|NCT01134627|19238268|P2|Overall Study|Planning to become pregnant/pregnancy|0
5566742|NCT01134627|19238269|P1|Overall Study|Planning to become pregnant/pregnancy|1
5566743|NCT01134627|19238268|P2|Overall Study|Withdrawal by Subject|3
5566744|NCT01134627|19238269|P1|Overall Study|Withdrawal by Subject|4
5566745|NCT01134627|19238268|P2|Overall Study|Lack of Efficacy|12
5566746|NCT01134627|19238269|P1|Overall Study|Lack of Efficacy|2
5566747|NCT01134627|19238268|P2|Overall Study|Protocol Violation|5
5566748|NCT01134627|19238269|P1|Overall Study|Protocol Violation|3
5566749|NCT01134627|19238268|P2|Overall Study|Lost to Follow-up|2
5566750|NCT01134627|19238269|P1|Overall Study|Lost to Follow-up|1
5566751|NCT01134627|19238268|P2|Overall Study|Adverse Event|31
5566752|NCT01134627|19238269|P1|Overall Study|Adverse Event|47
5566753|NCT01134614|19238299|P2|Overall Study|Patient in hospice care|1
5566754|NCT01134614|19238300|P1|Overall Study|Patient in hospice care|0
5566755|NCT01134614|19238299|P2|Overall Study|Symptomatic deterioration|1
5566756|NCT01134614|19238300|P1|Overall Study|Symptomatic deterioration|0
5566757|NCT01134614|19238299|P2|Overall Study|Pt received tx not allowed on study|1
5566758|NCT01134614|19238300|P1|Overall Study|Pt received tx not allowed on study|0
5566759|NCT01134614|19238299|P2|Overall Study|Never started treatment|1
5566760|NCT01134614|19238300|P1|Overall Study|Never started treatment|4
5566761|NCT01134614|19238299|P2|Overall Study|Physician's decision|1
5566762|NCT01134614|19238300|P1|Overall Study|Physician's decision|0
5566763|NCT01134614|19238299|P2|Overall Study|Complicating disease|1
5566764|NCT01134614|19238300|P1|Overall Study|Complicating disease|2
5566765|NCT01134614|19238299|P2|Overall Study|Alternative therapy|0
5566766|NCT01134614|19238300|P1|Overall Study|Alternative therapy|2
5566767|NCT01134614|19238299|P2|Overall Study|Withdrawal by Subject|2
5566768|NCT01134614|19238300|P1|Overall Study|Withdrawal by Subject|3
5566769|NCT01134614|19238299|P2|Overall Study|Death|8
5566770|NCT01134614|19238300|P1|Overall Study|Death|5
5566771|NCT01134614|19238299|P2|Overall Study|Adverse Event|39
5566772|NCT01134614|19238300|P1|Overall Study|Adverse Event|26
5566773|NCT01134614|19238299|P2|Overall Study|Progressive disease|54
5566774|NCT01134614|19238300|P1|Overall Study|Progressive disease|60
5566775|NCT01134614|19238299|P2|Overall Study|Still on treatment as of March 2013|13
5566776|NCT01134614|19238300|P1|Overall Study|Still on treatment as of March 2013|21
5566777|NCT01134562|19238328|P5|Overall Study|Adverse Event|0
5566778|NCT01134562|19238329|P4|Overall Study|Adverse Event|0
5566779|NCT01134562|19238330|P3|Overall Study|Adverse Event|0
5566780|NCT01134562|19238331|P2|Overall Study|Adverse Event|1
5566781|NCT01134562|19238332|P1|Overall Study|Adverse Event|0
5566782|NCT01134393|19238504|P1|Overall Study|Other|6
5566783|NCT01134393|19238504|P1|Overall Study|Withdrawal by Subject|11
5566784|NCT01134393|19238504|P1|Overall Study|Lost to Follow-up|3
5566785|NCT01134393|19238504|P1|Overall Study|Protocol Violation|12
5566786|NCT01134393|19238504|P1|Overall Study|Lack of Efficacy|2
5566787|NCT01134393|19238504|P1|Overall Study|Adverse Event|18
5566788|NCT01134315|19238625|P2|Overall Study|Other Reason|17
5566789|NCT01134315|19238626|P1|Overall Study|Other Reason|8
5566790|NCT01134315|19238625|P2|Overall Study|Adverse Event|2
5566791|NCT01134315|19238626|P1|Overall Study|Adverse Event|1
5566792|NCT01134263|19238664|P5|Overall Study|Enrolled, but not treated|0
5566793|NCT01134263|19238665|P4|Overall Study|Enrolled, but not treated|1
5566794|NCT01134263|19238666|P3|Overall Study|Enrolled, but not treated|0
5566795|NCT01134263|19238667|P2|Overall Study|Enrolled, but not treated|1
5566796|NCT01134263|19238668|P1|Overall Study|Enrolled, but not treated|1
5566797|NCT01134263|19238664|P5|Overall Study|Withdrawal by Subject|5
5566798|NCT01134263|19238665|P4|Overall Study|Withdrawal by Subject|7
5566799|NCT01134263|19238666|P3|Overall Study|Withdrawal by Subject|16
5566800|NCT01134263|19238667|P2|Overall Study|Withdrawal by Subject|6
5566801|NCT01134263|19238668|P1|Overall Study|Withdrawal by Subject|8
5566802|NCT01134263|19238664|P5|Overall Study|Lost to Follow-up|1
5566803|NCT01134263|19238665|P4|Overall Study|Lost to Follow-up|3
5566804|NCT01134263|19238666|P3|Overall Study|Lost to Follow-up|5
5566805|NCT01134263|19238667|P2|Overall Study|Lost to Follow-up|3
5566806|NCT01134263|19238668|P1|Overall Study|Lost to Follow-up|4
5566807|NCT01134263|19238664|P5|Overall Study|Protocol Violation|2
5566808|NCT01134263|19238665|P4|Overall Study|Protocol Violation|4
5566809|NCT01134263|19238666|P3|Overall Study|Protocol Violation|2
5566810|NCT01134263|19238667|P2|Overall Study|Protocol Violation|7
5566811|NCT01134263|19238668|P1|Overall Study|Protocol Violation|8
5566812|NCT01134263|19238664|P5|Overall Study|Other adverse event|0
5566813|NCT01134263|19238665|P4|Overall Study|Other adverse event|3
5566814|NCT01134263|19238666|P3|Overall Study|Other adverse event|5
5566815|NCT01134263|19238667|P2|Overall Study|Other adverse event|2
5566816|NCT01134263|19238668|P1|Overall Study|Other adverse event|1
5566817|NCT01134263|19238664|P5|Overall Study|Serious adverse event|1
5566818|NCT01134263|19238665|P4|Overall Study|Serious adverse event|1
5566819|NCT01134263|19238666|P3|Overall Study|Serious adverse event|1
5566820|NCT01134263|19238667|P2|Overall Study|Serious adverse event|1
5566821|NCT01134263|19238668|P1|Overall Study|Serious adverse event|2
5566822|NCT01134107|19238701|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
5566823|NCT01134107|19238702|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
5566824|NCT01134107|19238701|P2|Period 2-Second Treatment Intervention|Physician Decision|0
5566825|NCT01134107|19238702|P1|Period 2-Second Treatment Intervention|Physician Decision|1
5566826|NCT01134107|19238701|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
5566827|NCT01134107|19238702|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
5566828|NCT01134107|19238701|P2|Period 1-First Treatment Intervention|Physician Decision|0
5566829|NCT01134107|19238702|P1|Period 1-First Treatment Intervention|Physician Decision|1
5566830|NCT01134107|19238701|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
5566831|NCT01134107|19238702|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
5566832|NCT01134107|19238701|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
5566833|NCT01134107|19238702|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
5566834|NCT01134107|19238701|P2|Period 1-First Treatment Intervention|Adverse Event|0
5566835|NCT01134107|19238702|P1|Period 1-First Treatment Intervention|Adverse Event|1
5566836|NCT01134055|19238749|P7|Overall Study|Physician Decision|1
5566837|NCT01134055|19238750|P6|Overall Study|Physician Decision|0
5566838|NCT01134055|19238751|P5|Overall Study|Physician Decision|0
5566839|NCT01134055|19238752|P4|Overall Study|Physician Decision|0
5566840|NCT01134055|19238753|P3|Overall Study|Physician Decision|0
5566841|NCT01134055|19238754|P2|Overall Study|Physician Decision|0
5566842|NCT01134055|19238755|P1|Overall Study|Physician Decision|0
5566843|NCT01134055|19238749|P7|Overall Study|Protocol Violation|0
5566844|NCT01134055|19238750|P6|Overall Study|Protocol Violation|0
5566845|NCT01134055|19238751|P5|Overall Study|Protocol Violation|1
5566846|NCT01134055|19238752|P4|Overall Study|Protocol Violation|1
5566847|NCT01134055|19238753|P3|Overall Study|Protocol Violation|0
5566848|NCT01134055|19238754|P2|Overall Study|Protocol Violation|0
5566849|NCT01134055|19238755|P1|Overall Study|Protocol Violation|0
5566850|NCT01134055|19238749|P7|Overall Study|Withdrawal by Subject|8
5566851|NCT01134055|19238750|P6|Overall Study|Withdrawal by Subject|0
5566852|NCT01134055|19238751|P5|Overall Study|Withdrawal by Subject|0
5566853|NCT01134055|19238752|P4|Overall Study|Withdrawal by Subject|2
5566854|NCT01134055|19238753|P3|Overall Study|Withdrawal by Subject|1
5566855|NCT01134055|19238754|P2|Overall Study|Withdrawal by Subject|3
5566856|NCT01134055|19238755|P1|Overall Study|Withdrawal by Subject|3
5566857|NCT01134055|19238749|P7|Overall Study|Lost to Follow-up|0
5566858|NCT01134055|19238750|P6|Overall Study|Lost to Follow-up|0
5566859|NCT01134055|19238751|P5|Overall Study|Lost to Follow-up|0
5566860|NCT01134055|19238752|P4|Overall Study|Lost to Follow-up|1
5566861|NCT01134055|19238753|P3|Overall Study|Lost to Follow-up|0
5566862|NCT01134055|19238754|P2|Overall Study|Lost to Follow-up|1
5566863|NCT01134055|19238755|P1|Overall Study|Lost to Follow-up|0
5566864|NCT01134055|19238749|P7|Overall Study|Adverse Event|2
5566865|NCT01134055|19238750|P6|Overall Study|Adverse Event|7
5566866|NCT01134055|19238751|P5|Overall Study|Adverse Event|5
5566867|NCT01134055|19238752|P4|Overall Study|Adverse Event|2
5566868|NCT01134055|19238753|P3|Overall Study|Adverse Event|2
5566869|NCT01134055|19238754|P2|Overall Study|Adverse Event|2
5566870|NCT01134055|19238755|P1|Overall Study|Adverse Event|5
5566871|NCT01134042|19238889|P3|Overall Study|Withdrawal by Subject|7
5566872|NCT01134042|19238890|P2|Overall Study|Withdrawal by Subject|4
5566873|NCT01134042|19238891|P1|Overall Study|Withdrawal by Subject|13
5566874|NCT01134042|19238889|P3|Overall Study|Physician Decision|1
5566875|NCT01134042|19238890|P2|Overall Study|Physician Decision|8
5566876|NCT01134042|19238891|P1|Overall Study|Physician Decision|4
5566877|NCT01134042|19238889|P3|Overall Study|Lost to Follow-up|1
5566878|NCT01134042|19238890|P2|Overall Study|Lost to Follow-up|0
5566879|NCT01134042|19238891|P1|Overall Study|Lost to Follow-up|2
5566880|NCT01134042|19238889|P3|Overall Study|Protocol Violation|5
5566881|NCT01134042|19238890|P2|Overall Study|Protocol Violation|3
5566882|NCT01134042|19238891|P1|Overall Study|Protocol Violation|5
5566883|NCT01134042|19238889|P3|Overall Study|Lack of Efficacy|18
5566884|NCT01134042|19238890|P2|Overall Study|Lack of Efficacy|6
5566885|NCT01134042|19238891|P1|Overall Study|Lack of Efficacy|21
5566886|NCT01134042|19238889|P3|Overall Study|Adverse Event|2
5566887|NCT01134042|19238890|P2|Overall Study|Adverse Event|7
5566888|NCT01134042|19238891|P1|Overall Study|Adverse Event|3
5566889|NCT01133977|19238967|P5|Overall Study|Withdrawal by Subject|1
5566890|NCT01133977|19238968|P4|Overall Study|Withdrawal by Subject|5
5566891|NCT01133977|19238969|P3|Overall Study|Withdrawal by Subject|0
5566892|NCT01133977|19238970|P2|Overall Study|Withdrawal by Subject|0
5566893|NCT01133977|19238971|P1|Overall Study|Withdrawal by Subject|0
5566894|NCT01133977|19238967|P5|Overall Study|Lost to Follow-up|1
5566895|NCT01133977|19238968|P4|Overall Study|Lost to Follow-up|2
5566896|NCT01133977|19238969|P3|Overall Study|Lost to Follow-up|0
5566897|NCT01133977|19238970|P2|Overall Study|Lost to Follow-up|0
5566898|NCT01133977|19238971|P1|Overall Study|Lost to Follow-up|0
5566899|NCT01133977|19238967|P5|Overall Study|Started a New Line of Therapy|33
5566900|NCT01133977|19238968|P4|Overall Study|Started a New Line of Therapy|25
5566901|NCT01133977|19238969|P3|Overall Study|Started a New Line of Therapy|4
5566902|NCT01133977|19238970|P2|Overall Study|Started a New Line of Therapy|6
5566903|NCT01133977|19238971|P1|Overall Study|Started a New Line of Therapy|2
5566904|NCT01133977|19238967|P5|Overall Study|Death|3
5566905|NCT01133977|19238968|P4|Overall Study|Death|7
5566906|NCT01133977|19238969|P3|Overall Study|Death|1
5566907|NCT01133977|19238970|P2|Overall Study|Death|1
5566908|NCT01133977|19238971|P1|Overall Study|Death|1
5566909|NCT01133977|19238967|P5|Overall Study|Adverse Event|0
5566910|NCT01133977|19238968|P4|Overall Study|Adverse Event|0
5566911|NCT01133977|19238969|P3|Overall Study|Adverse Event|1
5566912|NCT01133977|19238970|P2|Overall Study|Adverse Event|0
5566913|NCT01133977|19238971|P1|Overall Study|Adverse Event|0
5566914|NCT01133847|19238998|P3|Follow-Up Phase|Lost to Follow-up|7
5566915|NCT01133847|19238999|P2|Follow-Up Phase|Lost to Follow-up|3
5566916|NCT01133847|19239000|P1|Follow-Up Phase|Lost to Follow-up|1
5566917|NCT01133847|19238998|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
5566918|NCT01133847|19238999|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
5566919|NCT01133847|19239000|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
5566920|NCT01133821|19239040|P2|Overall Study|Refused participation|3
5566921|NCT01133821|19239041|P1|Overall Study|Refused participation|1
5566922|NCT01133821|19239040|P2|Overall Study|Protocol Violation|1
5566923|NCT01133821|19239041|P1|Overall Study|Protocol Violation|0
5566924|NCT01133821|19239040|P2|Overall Study|preferred other treatment|1
5566925|NCT01133821|19239041|P1|Overall Study|preferred other treatment|1
5566926|NCT01133821|19239040|P2|Overall Study|Withdrawal by Subject|3
5566927|NCT01133821|19239041|P1|Overall Study|Withdrawal by Subject|8
5566928|NCT01133821|19239040|P2|Overall Study|Lost to Follow-up|11
5566929|NCT01133821|19239041|P1|Overall Study|Lost to Follow-up|8
5566930|NCT01133756|19239052|P3|Overall Study|Progression of Disease|1
5566931|NCT01133756|19239053|P2|Overall Study|Progression of Disease|0
5566932|NCT01133756|19239054|P1|Overall Study|Progression of Disease|0
5566933|NCT01133756|19239052|P3|Overall Study|Withdrawal by Subject|0
5566934|NCT01133756|19239053|P2|Overall Study|Withdrawal by Subject|1
5566935|NCT01133756|19239054|P1|Overall Study|Withdrawal by Subject|0
5566936|NCT01133756|19239052|P3|Overall Study|Investigator Decision|0
5566937|NCT01133756|19239053|P2|Overall Study|Investigator Decision|0
5566938|NCT01133756|19239054|P1|Overall Study|Investigator Decision|1
5566939|NCT01133756|19239052|P3|Overall Study|Adverse Event|1
5566940|NCT01133756|19239053|P2|Overall Study|Adverse Event|2
5566941|NCT01133756|19239054|P1|Overall Study|Adverse Event|1
5566942|NCT01133704|19239070|P2|Overall Study|Study Closure|0
5566943|NCT01133704|19239071|P1|Overall Study|Study Closure|1
5566944|NCT01133704|19239070|P2|Overall Study|Patient refused to continue|0
5566945|NCT01133704|19239071|P1|Overall Study|Patient refused to continue|4
5566946|NCT01133704|19239070|P2|Overall Study|Death|26
5566947|NCT01133704|19239071|P1|Overall Study|Death|44
5566948|NCT01133678|19239081|P2|Overall Study|Death|1
5566949|NCT01133678|19239082|P1|Overall Study|Death|1
5566950|NCT01133665|19239088|P1|Overall Study|Physician Decision|2
5566951|NCT01133626|19239148|P3|Overall Study|Other|0
5566952|NCT01133626|19239149|P2|Overall Study|Other|2
5566953|NCT01133626|19239150|P1|Overall Study|Other|0
5566954|NCT01133626|19239148|P3|Overall Study|Withdrawal by Subject|2
5566955|NCT01133626|19239149|P2|Overall Study|Withdrawal by Subject|2
5566956|NCT01133626|19239150|P1|Overall Study|Withdrawal by Subject|1
5566957|NCT01133626|19239148|P3|Overall Study|Adverse Event|0
5566958|NCT01133626|19239149|P2|Overall Study|Adverse Event|1
5566959|NCT01133626|19239150|P1|Overall Study|Adverse Event|0
5566960|NCT01133522|19239168|P10|Overall Study|Physician Decision|0
5566961|NCT01133522|19239169|P9|Overall Study|Physician Decision|0
5566962|NCT01133522|19239170|P8|Overall Study|Physician Decision|0
5566963|NCT01133522|19239171|P7|Overall Study|Physician Decision|0
5566964|NCT01133522|19239172|P6|Overall Study|Physician Decision|0
5566965|NCT01133522|19239173|P5|Overall Study|Physician Decision|1
5566966|NCT01133522|19239174|P4|Overall Study|Physician Decision|0
5566967|NCT01133522|19239175|P3|Overall Study|Physician Decision|0
5566968|NCT01133522|19239176|P2|Overall Study|Physician Decision|0
5566969|NCT01133522|19239177|P1|Overall Study|Physician Decision|0
5566970|NCT01133522|19239168|P10|Overall Study|Withdrawal by Subject|0
5566971|NCT01133522|19239169|P9|Overall Study|Withdrawal by Subject|0
5566972|NCT01133522|19239170|P8|Overall Study|Withdrawal by Subject|0
5566973|NCT01133522|19239171|P7|Overall Study|Withdrawal by Subject|0
5566974|NCT01133522|19239172|P6|Overall Study|Withdrawal by Subject|0
5566975|NCT01133522|19239173|P5|Overall Study|Withdrawal by Subject|0
5566976|NCT01133522|19239174|P4|Overall Study|Withdrawal by Subject|1
5566977|NCT01133522|19239175|P3|Overall Study|Withdrawal by Subject|0
5566978|NCT01133522|19239176|P2|Overall Study|Withdrawal by Subject|1
5566979|NCT01133522|19239177|P1|Overall Study|Withdrawal by Subject|0
5566980|NCT01133418|19239245|P2|Overall Study|Lost to Follow-up|6
5566981|NCT01133418|19239246|P1|Overall Study|Lost to Follow-up|5
5566982|NCT01133405|19239268|P10|Period 2|Physician Decision|0
5566983|NCT01133405|19239269|P9|Period 2|Physician Decision|0
5566984|NCT01133405|19239270|P8|Period 2|Physician Decision|0
5566985|NCT01133405|19239271|P7|Period 2|Physician Decision|0
5566986|NCT01133405|19239272|P6|Period 2|Physician Decision|1
5566987|NCT01133405|19239273|P5|Period 2|Physician Decision|0
5566988|NCT01133405|19239274|P4|Period 2|Physician Decision|0
5566989|NCT01133405|19239275|P3|Period 2|Physician Decision|0
5566990|NCT01133405|19239276|P2|Period 2|Physician Decision|0
5566991|NCT01133405|19239277|P1|Period 2|Physician Decision|0
5566992|NCT01133405|19239268|P10|Period 2|Entry Criteria Not Met|0
5566993|NCT01133405|19239269|P9|Period 2|Entry Criteria Not Met|0
5566994|NCT01133405|19239270|P8|Period 2|Entry Criteria Not Met|0
5566995|NCT01133405|19239271|P7|Period 2|Entry Criteria Not Met|0
5566996|NCT01133405|19239272|P6|Period 2|Entry Criteria Not Met|0
5566997|NCT01133405|19239273|P5|Period 2|Entry Criteria Not Met|0
5566998|NCT01133405|19239274|P4|Period 2|Entry Criteria Not Met|0
5566999|NCT01133405|19239275|P3|Period 2|Entry Criteria Not Met|0
5567000|NCT01133405|19239276|P2|Period 2|Entry Criteria Not Met|1
5567001|NCT01133405|19239277|P1|Period 2|Entry Criteria Not Met|0
5567002|NCT01133405|19239268|P10|Period 2|Withdrawal by Subject|0
5567003|NCT01133405|19239269|P9|Period 2|Withdrawal by Subject|0
5567004|NCT01133405|19239270|P8|Period 2|Withdrawal by Subject|0
5567005|NCT01133405|19239271|P7|Period 2|Withdrawal by Subject|0
5567006|NCT01133405|19239272|P6|Period 2|Withdrawal by Subject|1
5567007|NCT01133405|19239273|P5|Period 2|Withdrawal by Subject|0
5567008|NCT01133405|19239274|P4|Period 2|Withdrawal by Subject|1
5567009|NCT01133405|19239275|P3|Period 2|Withdrawal by Subject|0
5567010|NCT01133405|19239276|P2|Period 2|Withdrawal by Subject|0
5567011|NCT01133405|19239277|P1|Period 2|Withdrawal by Subject|0
5567012|NCT01133405|19239268|P10|Period 2|Adverse Event|0
5567013|NCT01133405|19239269|P9|Period 2|Adverse Event|0
5567014|NCT01133405|19239270|P8|Period 2|Adverse Event|0
5567015|NCT01133405|19239271|P7|Period 2|Adverse Event|0
5567016|NCT01133405|19239272|P6|Period 2|Adverse Event|0
5567017|NCT01133405|19239273|P5|Period 2|Adverse Event|0
5567018|NCT01133405|19239274|P4|Period 2|Adverse Event|0
5567019|NCT01133405|19239275|P3|Period 2|Adverse Event|1
5567020|NCT01133405|19239276|P2|Period 2|Adverse Event|0
5567021|NCT01133405|19239277|P1|Period 2|Adverse Event|0
5567022|NCT01133405|19239268|P10|Period 1|Received drug only in period 3|0
5567023|NCT01133405|19239269|P9|Period 1|Received drug only in period 3|0
5567024|NCT01133405|19239270|P8|Period 1|Received drug only in period 3|0
5567025|NCT01133405|19239271|P7|Period 1|Received drug only in period 3|0
5567026|NCT01133405|19239272|P6|Period 1|Received drug only in period 3|0
5567027|NCT01133405|19239273|P5|Period 1|Received drug only in period 3|0
5567028|NCT01133405|19239274|P4|Period 1|Received drug only in period 3|0
5567029|NCT01133405|19239275|P3|Period 1|Received drug only in period 3|1
5567030|NCT01133405|19239276|P2|Period 1|Received drug only in period 3|1
5567031|NCT01133405|19239277|P1|Period 1|Received drug only in period 3|0
5567032|NCT01133405|19239268|P10|Period 1|Received drug only in period 2|0
5567033|NCT01133405|19239269|P9|Period 1|Received drug only in period 2|0
5567034|NCT01133405|19239270|P8|Period 1|Received drug only in period 2|0
5567035|NCT01133405|19239271|P7|Period 1|Received drug only in period 2|0
5567036|NCT01133405|19239272|P6|Period 1|Received drug only in period 2|1
5567037|NCT01133405|19239273|P5|Period 1|Received drug only in period 2|0
5567038|NCT01133405|19239274|P4|Period 1|Received drug only in period 2|2
5567039|NCT01133405|19239275|P3|Period 1|Received drug only in period 2|0
5567040|NCT01133405|19239276|P2|Period 1|Received drug only in period 2|1
5567041|NCT01133405|19239277|P1|Period 1|Received drug only in period 2|0
5567042|NCT01133405|19239268|P10|Period 1|Discontinued after randomization|0
5567043|NCT01133405|19239269|P9|Period 1|Discontinued after randomization|0
5567044|NCT01133405|19239270|P8|Period 1|Discontinued after randomization|0
5567045|NCT01133405|19239271|P7|Period 1|Discontinued after randomization|1
5567046|NCT01133405|19239272|P6|Period 1|Discontinued after randomization|0
5567047|NCT01133405|19239273|P5|Period 1|Discontinued after randomization|0
5567048|NCT01133405|19239274|P4|Period 1|Discontinued after randomization|0
5567049|NCT01133405|19239275|P3|Period 1|Discontinued after randomization|0
5567050|NCT01133405|19239276|P2|Period 1|Discontinued after randomization|0
5567051|NCT01133405|19239277|P1|Period 1|Discontinued after randomization|1
5567052|NCT01133405|19239268|P10|Period 1|Physician Decision|0
5567053|NCT01133405|19239269|P9|Period 1|Physician Decision|0
5567054|NCT01133405|19239270|P8|Period 1|Physician Decision|0
5567055|NCT01133405|19239271|P7|Period 1|Physician Decision|0
5567056|NCT01133405|19239272|P6|Period 1|Physician Decision|0
5567057|NCT01133405|19239273|P5|Period 1|Physician Decision|0
5567058|NCT01133405|19239274|P4|Period 1|Physician Decision|1
5567059|NCT01133405|19239275|P3|Period 1|Physician Decision|0
5567060|NCT01133405|19239276|P2|Period 1|Physician Decision|0
5567061|NCT01133405|19239277|P1|Period 1|Physician Decision|0
5567062|NCT01133405|19239268|P10|Period 1|Withdrawal by Subject|0
5567063|NCT01133405|19239269|P9|Period 1|Withdrawal by Subject|0
5567064|NCT01133405|19239270|P8|Period 1|Withdrawal by Subject|0
5567065|NCT01133405|19239271|P7|Period 1|Withdrawal by Subject|0
5567066|NCT01133405|19239272|P6|Period 1|Withdrawal by Subject|1
5567067|NCT01133405|19239273|P5|Period 1|Withdrawal by Subject|0
5567068|NCT01133405|19239274|P4|Period 1|Withdrawal by Subject|1
5567069|NCT01133405|19239275|P3|Period 1|Withdrawal by Subject|0
5567070|NCT01133405|19239276|P2|Period 1|Withdrawal by Subject|1
5567071|NCT01133405|19239277|P1|Period 1|Withdrawal by Subject|0
5567072|NCT01133392|19239328|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
5567073|NCT01133392|19239329|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
5567074|NCT01133392|19239328|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
5567075|NCT01133392|19239329|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
5567076|NCT01133379|19239346|P3|Overall Study|Lost to Follow-up|1
5567077|NCT01133379|19239347|P2|Overall Study|Lost to Follow-up|1
5567078|NCT01133379|19239348|P1|Overall Study|Lost to Follow-up|1
5567079|NCT01133379|19239346|P3|Overall Study|Withdrawal by Subject|1
5567080|NCT01133379|19239347|P2|Overall Study|Withdrawal by Subject|1
5567081|NCT01133379|19239348|P1|Overall Study|Withdrawal by Subject|0
5567082|NCT01133288|19239401|P1|Intervention Allocation|study terminated|2
5567083|NCT01133288|19239401|P1|Eligibility Assessment|met exclusion criteria|5
5567084|NCT01133275|19239406|P1|Overall Study|Cerebrovascular accident (CVA)|1
5567085|NCT01133275|19239406|P1|Overall Study|Withdrawal by Subject|1
5567086|NCT01133171|19239414|P3|Overall Study|Withdrawal by Subject|0
5567087|NCT01133171|19239415|P2|Overall Study|Withdrawal by Subject|2
5567088|NCT01133171|19239416|P1|Overall Study|Withdrawal by Subject|1
5567089|NCT01133067|19239432|P1|Overall Study|Lost to Follow-up|3
5567090|NCT01133067|19239432|P1|Overall Study|Death|136
5567091|NCT01132820|19239492|P1|Overall Study|Inadequate data|1
5567092|NCT01132820|19239492|P1|Overall Study|Never treated|1
5567093|NCT01132820|19239492|P1|Overall Study|Ineligible:Inadequate pathology|1
5567094|NCT01132820|19239492|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
5567095|NCT01132820|19239492|P1|Overall Study|Ineligible: wrong cell type|1
5567096|NCT01132755|19239501|P1|Overall Study|Withdrawal by Subject|4
5567097|NCT01132755|19239501|P1|Overall Study|Protocol Violation|15
5567098|NCT01132755|19239501|P1|Overall Study|Procedure not done due to medical reason|23
5567099|NCT01132664|19239530|P5|BM Cohort|Withdrawal by Subject|1
5567100|NCT01132664|19239531|P4|BM Cohort|Withdrawal by Subject|0
5567101|NCT01132664|19239532|P3|BM Cohort|Withdrawal by Subject|0
5567102|NCT01132664|19239533|P2|BM Cohort|Withdrawal by Subject|0
5567103|NCT01132664|19239534|P1|BM Cohort|Withdrawal by Subject|0
5567104|NCT01132664|19239530|P5|BM Cohort|Adverse Event|1
5567105|NCT01132664|19239531|P4|BM Cohort|Adverse Event|0
5567106|NCT01132664|19239532|P3|BM Cohort|Adverse Event|0
5567107|NCT01132664|19239533|P2|BM Cohort|Adverse Event|0
5567108|NCT01132664|19239534|P1|BM Cohort|Adverse Event|0
5567109|NCT01132664|19239530|P5|BM Cohort|Disease progression|4
5567110|NCT01132664|19239531|P4|BM Cohort|Disease progression|3
5567111|NCT01132664|19239532|P3|BM Cohort|Disease progression|0
5567112|NCT01132664|19239533|P2|BM Cohort|Disease progression|0
5567113|NCT01132664|19239534|P1|BM Cohort|Disease progression|0
5567114|NCT01132664|19239530|P5|Phase ll|Disease progression|0
5567115|NCT01132664|19239531|P4|Phase ll|Disease progression|0
5567116|NCT01132664|19239532|P3|Phase ll|Disease progression|35
5567117|NCT01132664|19239533|P2|Phase ll|Disease progression|0
5567118|NCT01132664|19239534|P1|Phase ll|Disease progression|0
5567119|NCT01132664|19239530|P5|Phase ll|Withdrawal by Subject|0
5567120|NCT01132664|19239531|P4|Phase ll|Withdrawal by Subject|0
5567121|NCT01132664|19239532|P3|Phase ll|Withdrawal by Subject|3
5567122|NCT01132664|19239533|P2|Phase ll|Withdrawal by Subject|0
5567123|NCT01132664|19239534|P1|Phase ll|Withdrawal by Subject|0
5567124|NCT01132664|19239530|P5|Phase ll|Adverse Event|0
5567125|NCT01132664|19239531|P4|Phase ll|Adverse Event|0
5567126|NCT01132664|19239532|P3|Phase ll|Adverse Event|10
5567127|NCT01132664|19239533|P2|Phase ll|Adverse Event|0
5567128|NCT01132664|19239534|P1|Phase ll|Adverse Event|0
5567129|NCT01132664|19239530|P5|Phase ll|Death|0
5567130|NCT01132664|19239531|P4|Phase ll|Death|0
5567131|NCT01132664|19239532|P3|Phase ll|Death|2
5567132|NCT01132664|19239533|P2|Phase ll|Death|0
5567133|NCT01132664|19239534|P1|Phase ll|Death|0
5567134|NCT01132664|19239530|P5|Phase lb|Disease Progression|0
5567135|NCT01132664|19239531|P4|Phase lb|Disease Progression|0
5567136|NCT01132664|19239532|P3|Phase lb|Disease Progression|0
5567137|NCT01132664|19239533|P2|Phase lb|Disease Progression|9
5567138|NCT01132664|19239534|P1|Phase lb|Disease Progression|4
5567139|NCT01132664|19239530|P5|Phase lb|Withdrawal by Subject|0
5567140|NCT01132664|19239531|P4|Phase lb|Withdrawal by Subject|0
5567141|NCT01132664|19239532|P3|Phase lb|Withdrawal by Subject|0
5567142|NCT01132664|19239533|P2|Phase lb|Withdrawal by Subject|2
5567143|NCT01132664|19239534|P1|Phase lb|Withdrawal by Subject|1
5567144|NCT01132664|19239530|P5|Phase lb|Adverse Event|0
5567145|NCT01132664|19239531|P4|Phase lb|Adverse Event|0
5567146|NCT01132664|19239532|P3|Phase lb|Adverse Event|0
5567147|NCT01132664|19239533|P2|Phase lb|Adverse Event|1
5567148|NCT01132664|19239534|P1|Phase lb|Adverse Event|0
5567149|NCT01132651|19239568|P2|Overall Study|Lost to Follow-up|1
5567150|NCT01132651|19239569|P1|Overall Study|Lost to Follow-up|1
5567151|NCT01132612|19239580|P3|Overall Study|Lack of Efficacy|73
5567152|NCT01132612|19239581|P2|Overall Study|Lack of Efficacy|22
5567153|NCT01132612|19239582|P1|Overall Study|Lack of Efficacy|23
5567154|NCT01132612|19239580|P3|Overall Study|Administrative problems|52
5567155|NCT01132612|19239581|P2|Overall Study|Administrative problems|1
5567156|NCT01132612|19239582|P1|Overall Study|Administrative problems|5
5567157|NCT01132612|19239580|P3|Overall Study|Withdrawal by Subject|19
5567158|NCT01132612|19239581|P2|Overall Study|Withdrawal by Subject|8
5567159|NCT01132612|19239582|P1|Overall Study|Withdrawal by Subject|5
5567160|NCT01132612|19239580|P3|Overall Study|Adverse Event|15
5567161|NCT01132612|19239581|P2|Overall Study|Adverse Event|2
5567162|NCT01132612|19239582|P1|Overall Study|Adverse Event|5
5567163|NCT01132612|19239580|P3|Overall Study|Lost to Follow-up|7
5567164|NCT01132612|19239581|P2|Overall Study|Lost to Follow-up|2
5567165|NCT01132612|19239582|P1|Overall Study|Lost to Follow-up|2
5567166|NCT01132612|19239580|P3|Overall Study|Protocol deviation|3
5567167|NCT01132612|19239581|P2|Overall Study|Protocol deviation|0
5567168|NCT01132612|19239582|P1|Overall Study|Protocol deviation|0
5567169|NCT01132612|19239580|P3|Overall Study|Death|1
5567170|NCT01132612|19239581|P2|Overall Study|Death|0
5567171|NCT01132612|19239582|P1|Overall Study|Death|0
5567172|NCT01132547|19239598|P2|Overall Study|Death|0
5567173|NCT01132547|19239599|P1|Overall Study|Death|1
5567174|NCT01132547|19239598|P2|Overall Study|Withdrawal by Subject|1
5567175|NCT01132547|19239599|P1|Overall Study|Withdrawal by Subject|3
5567176|NCT01132495|19239669|P4|Overall Study|Various reasons|12
5567177|NCT01132495|19239670|P3|Overall Study|Various reasons|20
5567178|NCT01132495|19239671|P2|Overall Study|Various reasons|38
5567179|NCT01132495|19239672|P1|Overall Study|Various reasons|40
5567180|NCT01132482|19239685|P2|Overall Study|Adverse Event|0
5567181|NCT01132482|19239686|P1|Overall Study|Adverse Event|1
5567182|NCT01132326|19239709|P1|Overall Study|Subject Unable to Come To Visits|1
5567183|NCT01132326|19239709|P1|Overall Study|Death|5
5567184|NCT01132326|19239709|P1|Overall Study|Caregiver Withdrew Consent|1
5567185|NCT01132326|19239709|P1|Overall Study|Pregnancy|1
5567186|NCT01132326|19239709|P1|Overall Study|Declining Health|1
5567187|NCT01132326|19239709|P1|Overall Study|Study Termination|80
5567188|NCT01132326|19239709|P1|Overall Study|Physician Decision|10
5567189|NCT01132326|19239709|P1|Overall Study|Withdrawal by Subject|40
5567190|NCT01132326|19239709|P1|Overall Study|Lost to Follow-up|16
5567191|NCT01132326|19239709|P1|Overall Study|Protocol Violation|1
5567192|NCT01132326|19239709|P1|Overall Study|Adverse Event|37
5567193|NCT01132326|19239709|P1|Overall Study|Lack of Efficacy|25
5567194|NCT01132313|19239725|P12|Overall Study|Other reason not defined above|0
5567195|NCT01132313|19239726|P11|Overall Study|Other reason not defined above|0
5567196|NCT01132313|19239727|P10|Overall Study|Other reason not defined above|0
5567197|NCT01132313|19239728|P9|Overall Study|Other reason not defined above|0
5567198|NCT01132313|19239729|P8|Overall Study|Other reason not defined above|1
5567199|NCT01132313|19239730|P7|Overall Study|Other reason not defined above|0
5567200|NCT01132313|19239731|P6|Overall Study|Other reason not defined above|0
5567201|NCT01132313|19239732|P5|Overall Study|Other reason not defined above|0
5567202|NCT01132313|19239733|P4|Overall Study|Other reason not defined above|0
5567203|NCT01132313|19239734|P3|Overall Study|Other reason not defined above|0
5567204|NCT01132313|19239735|P2|Overall Study|Other reason not defined above|0
5567205|NCT01132313|19239736|P1|Overall Study|Other reason not defined above|0
5567206|NCT01132313|19239725|P12|Overall Study|Lack of antiviral response|0
5567207|NCT01132313|19239726|P11|Overall Study|Lack of antiviral response|1
5567208|NCT01132313|19239727|P10|Overall Study|Lack of antiviral response|0
5567209|NCT01132313|19239728|P9|Overall Study|Lack of antiviral response|0
5567210|NCT01132313|19239729|P8|Overall Study|Lack of antiviral response|0
5567211|NCT01132313|19239730|P7|Overall Study|Lack of antiviral response|21
5567212|NCT01132313|19239731|P6|Overall Study|Lack of antiviral response|18
5567213|NCT01132313|19239732|P5|Overall Study|Lack of antiviral response|18
5567214|NCT01132313|19239733|P4|Overall Study|Lack of antiviral response|18
5567215|NCT01132313|19239734|P3|Overall Study|Lack of antiviral response|12
5567216|NCT01132313|19239735|P2|Overall Study|Lack of antiviral response|0
5567217|NCT01132313|19239736|P1|Overall Study|Lack of antiviral response|0
5567218|NCT01132313|19239725|P12|Overall Study|Withdrawal by Subject|0
5567219|NCT01132313|19239726|P11|Overall Study|Withdrawal by Subject|0
5567220|NCT01132313|19239727|P10|Overall Study|Withdrawal by Subject|2
5567221|NCT01132313|19239728|P9|Overall Study|Withdrawal by Subject|0
5567222|NCT01132313|19239729|P8|Overall Study|Withdrawal by Subject|0
5567223|NCT01132313|19239730|P7|Overall Study|Withdrawal by Subject|1
5567224|NCT01132313|19239731|P6|Overall Study|Withdrawal by Subject|0
5567225|NCT01132313|19239732|P5|Overall Study|Withdrawal by Subject|6
5567226|NCT01132313|19239733|P4|Overall Study|Withdrawal by Subject|3
5567227|NCT01132313|19239734|P3|Overall Study|Withdrawal by Subject|3
5567228|NCT01132313|19239735|P2|Overall Study|Withdrawal by Subject|0
5567229|NCT01132313|19239736|P1|Overall Study|Withdrawal by Subject|0
5567230|NCT01132313|19239725|P12|Overall Study|Lost to Follow-up|0
5567231|NCT01132313|19239726|P11|Overall Study|Lost to Follow-up|0
5567232|NCT01132313|19239727|P10|Overall Study|Lost to Follow-up|0
5567233|NCT01132313|19239728|P9|Overall Study|Lost to Follow-up|0
5567234|NCT01132313|19239729|P8|Overall Study|Lost to Follow-up|1
5567235|NCT01132313|19239730|P7|Overall Study|Lost to Follow-up|0
5567236|NCT01132313|19239731|P6|Overall Study|Lost to Follow-up|0
5567237|NCT01132313|19239732|P5|Overall Study|Lost to Follow-up|0
5567238|NCT01132313|19239733|P4|Overall Study|Lost to Follow-up|0
5567239|NCT01132313|19239734|P3|Overall Study|Lost to Follow-up|1
5567240|NCT01132313|19239735|P2|Overall Study|Lost to Follow-up|0
5567241|NCT01132313|19239736|P1|Overall Study|Lost to Follow-up|0
5567242|NCT01132313|19239725|P12|Overall Study|Protocol Violation|0
5567243|NCT01132313|19239726|P11|Overall Study|Protocol Violation|0
5567244|NCT01132313|19239727|P10|Overall Study|Protocol Violation|0
5567245|NCT01132313|19239728|P9|Overall Study|Protocol Violation|0
5567246|NCT01132313|19239729|P8|Overall Study|Protocol Violation|0
5567247|NCT01132313|19239730|P7|Overall Study|Protocol Violation|0
5567248|NCT01132313|19239731|P6|Overall Study|Protocol Violation|0
5567249|NCT01132313|19239732|P5|Overall Study|Protocol Violation|0
5567250|NCT01132313|19239733|P4|Overall Study|Protocol Violation|1
5567251|NCT01132313|19239734|P3|Overall Study|Protocol Violation|0
5567252|NCT01132313|19239735|P2|Overall Study|Protocol Violation|0
5567253|NCT01132313|19239736|P1|Overall Study|Protocol Violation|0
5567254|NCT01132313|19239725|P12|Overall Study|Adverse Event|0
5567255|NCT01132313|19239726|P11|Overall Study|Adverse Event|0
5567256|NCT01132313|19239727|P10|Overall Study|Adverse Event|2
5567257|NCT01132313|19239728|P9|Overall Study|Adverse Event|7
5567258|NCT01132313|19239729|P8|Overall Study|Adverse Event|3
5567259|NCT01132313|19239730|P7|Overall Study|Adverse Event|5
5567260|NCT01132313|19239731|P6|Overall Study|Adverse Event|6
5567261|NCT01132313|19239732|P5|Overall Study|Adverse Event|19
5567262|NCT01132313|19239733|P4|Overall Study|Adverse Event|10
5567263|NCT01132313|19239734|P3|Overall Study|Adverse Event|4
5567264|NCT01132313|19239735|P2|Overall Study|Adverse Event|0
5567265|NCT01132313|19239736|P1|Overall Study|Adverse Event|0
5567266|NCT01132313|19239725|P12|Overall Study|Not treated|0
5567267|NCT01132313|19239726|P11|Overall Study|Not treated|0
5567268|NCT01132313|19239727|P10|Overall Study|Not treated|0
5567269|NCT01132313|19239728|P9|Overall Study|Not treated|0
5567270|NCT01132313|19239729|P8|Overall Study|Not treated|0
5567271|NCT01132313|19239730|P7|Overall Study|Not treated|3
5567272|NCT01132313|19239731|P6|Overall Study|Not treated|1
5567273|NCT01132313|19239732|P5|Overall Study|Not treated|2
5567274|NCT01132313|19239733|P4|Overall Study|Not treated|0
5567275|NCT01132313|19239734|P3|Overall Study|Not treated|0
5567276|NCT01132313|19239735|P2|Overall Study|Not treated|0
5567277|NCT01132313|19239736|P1|Overall Study|Not treated|2
5567278|NCT01132313|19239725|P12|Overall Study|Lack of Efficacy|0
5567279|NCT01132313|19239726|P11|Overall Study|Lack of Efficacy|0
5567280|NCT01132313|19239727|P10|Overall Study|Lack of Efficacy|16
5567281|NCT01132313|19239728|P9|Overall Study|Lack of Efficacy|14
5567282|NCT01132313|19239729|P8|Overall Study|Lack of Efficacy|3
5567283|NCT01132313|19239730|P7|Overall Study|Lack of Efficacy|0
5567284|NCT01132313|19239731|P6|Overall Study|Lack of Efficacy|0
5567285|NCT01132313|19239732|P5|Overall Study|Lack of Efficacy|0
5567286|NCT01132313|19239733|P4|Overall Study|Lack of Efficacy|0
5567287|NCT01132313|19239734|P3|Overall Study|Lack of Efficacy|0
5567288|NCT01132313|19239735|P2|Overall Study|Lack of Efficacy|0
5567289|NCT01132313|19239736|P1|Overall Study|Lack of Efficacy|1
5567290|NCT01132118|19239816|P2|Second Intervention (8 Weeks)|Adverse Event|1
5567291|NCT01132118|19239817|P1|Second Intervention (8 Weeks)|Adverse Event|0
5567292|NCT01132118|19239816|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
5567293|NCT01132118|19239817|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
5567294|NCT01132118|19239816|P2|First Intervention (8 Weeks)|Adverse Event|0
5567295|NCT01132118|19239817|P1|First Intervention (8 Weeks)|Adverse Event|1
5567296|NCT01131676|19239847|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
5567297|NCT01131676|19239848|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
5567298|NCT01131676|19239849|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
5567299|NCT01131676|19239847|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
5567300|NCT01131676|19239848|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
5567301|NCT01131676|19239849|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
5567302|NCT01131676|19239847|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
5567303|NCT01131676|19239848|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
5567304|NCT01131676|19239849|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
5567305|NCT01131676|19239847|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
5567306|NCT01131676|19239848|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
5567307|NCT01131676|19239849|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
5567308|NCT01131676|19239847|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
5567309|NCT01131676|19239848|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
5567310|NCT01131676|19239849|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
5567311|NCT01131676|19239847|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
5567312|NCT01131676|19239848|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
5567313|NCT01131676|19239849|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
5567314|NCT01131676|19239847|P3|Discontinuation From Treatment|Adverse Event|273
5567315|NCT01131676|19239848|P2|Discontinuation From Treatment|Adverse Event|267
5567316|NCT01131676|19239849|P1|Discontinuation From Treatment|Adverse Event|303
5567317|NCT01131676|19239847|P3|Discontinuation From Treatment|Other than those specified|125
5567318|NCT01131676|19239848|P2|Discontinuation From Treatment|Other than those specified|142
5567319|NCT01131676|19239849|P1|Discontinuation From Treatment|Other than those specified|162
5567320|NCT01131676|19239847|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
5567321|NCT01131676|19239848|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
5567322|NCT01131676|19239849|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
5567323|NCT01131676|19239847|P3|Discontinuation From Treatment|Lost to Follow-up|6
5567324|NCT01131676|19239848|P2|Discontinuation From Treatment|Lost to Follow-up|9
5567325|NCT01131676|19239849|P1|Discontinuation From Treatment|Lost to Follow-up|15
5567326|NCT01131676|19239847|P3|Discontinuation From Treatment|Non compliant with protocol|12
5567327|NCT01131676|19239848|P2|Discontinuation From Treatment|Non compliant with protocol|15
5567328|NCT01131676|19239849|P1|Discontinuation From Treatment|Non compliant with protocol|15
5567329|NCT01131676|19239847|P3|Discontinuation From Treatment|Lack of Efficacy|0
5567330|NCT01131676|19239848|P2|Discontinuation From Treatment|Lack of Efficacy|1
5567331|NCT01131676|19239849|P1|Discontinuation From Treatment|Lack of Efficacy|11
5567332|NCT01131676|19239847|P3|Discontinuation From Treatment|Not treated|2
5567333|NCT01131676|19239848|P2|Discontinuation From Treatment|Not treated|2
5567334|NCT01131676|19239849|P1|Discontinuation From Treatment|Not treated|4
5567335|NCT01131676|19239847|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
5567336|NCT01131676|19239848|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
5567337|NCT01131676|19239849|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
5567338|NCT01131585|19239884|P2|Overall Study|Study termination|32
5567339|NCT01131585|19239885|P1|Overall Study|Study termination|78
5567340|NCT01131585|19239884|P2|Overall Study|Administrative problems|1
5567341|NCT01131585|19239885|P1|Overall Study|Administrative problems|1
5567342|NCT01131585|19239884|P2|Overall Study|Lost to Follow-up|1
5567343|NCT01131585|19239885|P1|Overall Study|Lost to Follow-up|0
5567344|NCT01131585|19239884|P2|Overall Study|Withdrawal by Subject|3
5567345|NCT01131585|19239885|P1|Overall Study|Withdrawal by Subject|3
5567346|NCT01131585|19239884|P2|Overall Study|Protocol Violation|1
5567347|NCT01131585|19239885|P1|Overall Study|Protocol Violation|2
5567348|NCT01131585|19239884|P2|Overall Study|Unsatisfactory therapeutic effect|3
5567349|NCT01131585|19239885|P1|Overall Study|Unsatisfactory therapeutic effect|0
5567350|NCT01131585|19239884|P2|Overall Study|Abnormal laboratory value|0
5567351|NCT01131585|19239885|P1|Overall Study|Abnormal laboratory value|1
5567352|NCT01131585|19239884|P2|Overall Study|Adverse Event|2
5567353|NCT01131585|19239885|P1|Overall Study|Adverse Event|0
5567354|NCT01131520|19239893|P2|Overall Study|Subject changed history after enrollment|1
5567355|NCT01131520|19239894|P1|Overall Study|Subject changed history after enrollment|0
5567356|NCT01131520|19239893|P2|Overall Study|Counselor not available|3
5567357|NCT01131520|19239894|P1|Overall Study|Counselor not available|0
5567358|NCT01131520|19239893|P2|Overall Study|Computer problem|0
5567359|NCT01131520|19239894|P1|Overall Study|Computer problem|1
5567360|NCT01131507|19239916|P1|Overall Study|Withdrawal by Subject|1
5567361|NCT01131507|19239916|P1|Overall Study|Lost to Follow-up|1
5567362|NCT01131507|19239916|P1|Overall Study|Adverse Event|1
5567363|NCT01131494|19239921|P1|Overall Study|Withdrawal by Subject|2
5567364|NCT01131455|19239931|P3|Overall Study|Death of PI|0
5567365|NCT01131455|19239932|P2|Overall Study|Death of PI|4
5567366|NCT01131455|19239933|P1|Overall Study|Death of PI|6
5567367|NCT01131312|19239944|P3|Overall Study|Lost to Follow-up|351
5567368|NCT01131312|19239945|P2|Overall Study|Lost to Follow-up|229
5567369|NCT01131312|19239946|P1|Overall Study|Lost to Follow-up|425
5567370|NCT01131299|19239957|P2|Overall Study|Withdrawal by Subject|7
5567371|NCT01131299|19239958|P1|Overall Study|Withdrawal by Subject|4
5567372|NCT01131260|19239971|P2|Overall Study|Ineligible|2
5567373|NCT01131260|19239972|P1|Overall Study|Ineligible|0
5567374|NCT01131260|19239971|P2|Overall Study|Staff error|1
5567375|NCT01131260|19239972|P1|Overall Study|Staff error|2
5567376|NCT01131260|19239971|P2|Overall Study|Technical problems|6
5567377|NCT01131260|19239972|P1|Overall Study|Technical problems|7
5567378|NCT01131260|19239971|P2|Overall Study|Physician Decision|24
5567379|NCT01131260|19239972|P1|Overall Study|Physician Decision|22
5567380|NCT01131260|19239971|P2|Overall Study|Declined to continue participation|13
5567381|NCT01131260|19239972|P1|Overall Study|Declined to continue participation|8
5567382|NCT01131260|19239971|P2|Overall Study|Randomization error|1
5567383|NCT01131260|19239972|P1|Overall Study|Randomization error|5
5567384|NCT01131182|19240020|P2|Overall Study|Other Reason|0
5567385|NCT01131182|19240021|P1|Overall Study|Other Reason|1
5567386|NCT01131182|19240020|P2|Overall Study|Lost to Follow-up|15
5567387|NCT01131182|19240021|P1|Overall Study|Lost to Follow-up|14
5567388|NCT01131182|19240020|P2|Overall Study|Withdrawal by Subject|1
5567389|NCT01131182|19240021|P1|Overall Study|Withdrawal by Subject|1
5567390|NCT01131130|19240029|P1|Period 3- Crossover|+ Slit lamp finding|1
5567391|NCT01131130|19240029|P1|Period 1 - Baseline|Pregnancy|1
5567392|NCT01131104|19240042|P1|Overall Study|No Information on Index Date of Onset|1
5567393|NCT01131104|19240042|P1|Overall Study|Information Not Available|5
5567394|NCT01131104|19240042|P1|Overall Study|Physician Decision|4
5567395|NCT01131104|19240042|P1|Overall Study|Withdrawal by Subject|3
5567396|NCT01131078|19240049|P3|Overall Study|Other|0
5567397|NCT01131078|19240050|P2|Overall Study|Other|1
5567398|NCT01131078|19240051|P1|Overall Study|Other|0
5567399|NCT01131078|19240049|P3|Overall Study|Death|2
5567400|NCT01131078|19240050|P2|Overall Study|Death|0
5567401|NCT01131078|19240051|P1|Overall Study|Death|4
5567402|NCT01131078|19240049|P3|Overall Study|Physician Decision|8
5567403|NCT01131078|19240050|P2|Overall Study|Physician Decision|6
5567404|NCT01131078|19240051|P1|Overall Study|Physician Decision|10
5567405|NCT01131078|19240049|P3|Overall Study|Non-compliance|0
5567406|NCT01131078|19240050|P2|Overall Study|Non-compliance|0
5567407|NCT01131078|19240051|P1|Overall Study|Non-compliance|3
5567408|NCT01131078|19240049|P3|Overall Study|Withdrawal by Subject|3
5567409|NCT01131078|19240050|P2|Overall Study|Withdrawal by Subject|4
5567410|NCT01131078|19240051|P1|Overall Study|Withdrawal by Subject|2
5567411|NCT01131078|19240049|P3|Overall Study|Lost to Follow-up|1
5567412|NCT01131078|19240050|P2|Overall Study|Lost to Follow-up|1
5567413|NCT01131078|19240051|P1|Overall Study|Lost to Follow-up|1
5567414|NCT01131078|19240049|P3|Overall Study|Protocol Violation|0
5567415|NCT01131078|19240050|P2|Overall Study|Protocol Violation|0
5567416|NCT01131078|19240051|P1|Overall Study|Protocol Violation|1
5567417|NCT01131078|19240049|P3|Overall Study|Progressive Disease|71
5567418|NCT01131078|19240050|P2|Overall Study|Progressive Disease|77
5567419|NCT01131078|19240051|P1|Overall Study|Progressive Disease|58
5567420|NCT01131078|19240049|P3|Overall Study|Adverse Event|17
5567421|NCT01131078|19240050|P2|Overall Study|Adverse Event|12
5567422|NCT01131078|19240051|P1|Overall Study|Adverse Event|22
5567423|NCT01130974|19240138|P2|Overall Study|Ineligibility criteria|2
5567424|NCT01130974|19240139|P1|Overall Study|Ineligibility criteria|5
5567425|NCT01130974|19240138|P2|Overall Study|Withdrawal by Subject|1
5567426|NCT01130974|19240139|P1|Overall Study|Withdrawal by Subject|0
5567427|NCT01130974|19240138|P2|Overall Study|Protocol Violation|10
5567428|NCT01130974|19240139|P1|Overall Study|Protocol Violation|10
5567429|NCT01130883|19240165|P1|Overall Study|Adverse Event|3
5567430|NCT01130883|19240165|P1|Overall Study|Reason Unknown|1
5567431|NCT01130883|19240165|P1|Overall Study|Patient Noncompliance|6
5567432|NCT01130831|19240222|P1|Overall Study|Information was missing|3
5567433|NCT01130831|19240222|P1|Overall Study|Death|4
5567434|NCT01130831|19240222|P1|Overall Study|Withdrawal by Subject|7
5567435|NCT01130597|19240261|P1|Overall Study|Protocol Violation|1
5567436|NCT01130597|19240261|P1|Overall Study|Death|1
5567437|NCT01130597|19240261|P1|Overall Study|Adverse Event|4
5567438|NCT01130597|19240261|P1|Overall Study|Protocol-specified (High K+)|1
5567439|NCT01130532|19240286|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
5567440|NCT01130532|19240287|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
5567441|NCT01130532|19240288|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
5567442|NCT01130532|19240289|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
5567443|NCT01130532|19240286|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
5567444|NCT01130532|19240287|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
5567445|NCT01130532|19240288|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
5567446|NCT01130532|19240289|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
5567447|NCT01130532|19240286|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
5567448|NCT01130532|19240287|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
5567449|NCT01130532|19240288|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
5567450|NCT01130532|19240289|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
5567451|NCT01130532|19240286|P4|Period IV (Weeks 13-16)|Adverse Event|1
5567452|NCT01130532|19240287|P3|Period IV (Weeks 13-16)|Adverse Event|0
5567453|NCT01130532|19240288|P2|Period IV (Weeks 13-16)|Adverse Event|0
5567454|NCT01130532|19240289|P1|Period IV (Weeks 13-16)|Adverse Event|0
5567455|NCT01130532|19240286|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
5567456|NCT01130532|19240287|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
5567457|NCT01130532|19240288|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
5567458|NCT01130532|19240289|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
5567459|NCT01130532|19240286|P4|Period III (Weeks 0-12)|Sponsor Decision|0
5567460|NCT01130532|19240287|P3|Period III (Weeks 0-12)|Sponsor Decision|2
5567461|NCT01130532|19240288|P2|Period III (Weeks 0-12)|Sponsor Decision|4
5567462|NCT01130532|19240289|P1|Period III (Weeks 0-12)|Sponsor Decision|3
5567463|NCT01130532|19240286|P4|Period III (Weeks 0-12)|Protocol Violation|0
5567464|NCT01130532|19240287|P3|Period III (Weeks 0-12)|Protocol Violation|1
5567465|NCT01130532|19240288|P2|Period III (Weeks 0-12)|Protocol Violation|0
5567466|NCT01130532|19240289|P1|Period III (Weeks 0-12)|Protocol Violation|0
5567467|NCT01130532|19240286|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
5567468|NCT01130532|19240287|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
5567469|NCT01130532|19240288|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
5567470|NCT01130532|19240289|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
5567471|NCT01130532|19240286|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
5567472|NCT01130532|19240287|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
5567473|NCT01130532|19240288|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
5567474|NCT01130532|19240289|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
5567475|NCT01130532|19240286|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
5567476|NCT01130532|19240287|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
5567477|NCT01130532|19240288|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
5567478|NCT01130532|19240289|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
5567479|NCT01130532|19240286|P4|Period III (Weeks 0-12)|Adverse Event|0
5567480|NCT01130532|19240287|P3|Period III (Weeks 0-12)|Adverse Event|2
5567481|NCT01130532|19240288|P2|Period III (Weeks 0-12)|Adverse Event|3
5567482|NCT01130532|19240289|P1|Period III (Weeks 0-12)|Adverse Event|3
5567483|NCT01130493|19240334|P3|Part 2: OLE|Withdrawal by Subject|4
5567484|NCT01130493|19240335|P2|Part 2: OLE|Withdrawal by Subject|1
5567485|NCT01130493|19240336|P1|Part 2: OLE|Withdrawal by Subject|0
5567486|NCT01130493|19240334|P3|Part 2: OLE|Adverse Event|1
5567487|NCT01130493|19240335|P2|Part 2: OLE|Adverse Event|2
5567488|NCT01130493|19240336|P1|Part 2: OLE|Adverse Event|0
5567489|NCT01130493|19240334|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
5567490|NCT01130493|19240335|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
5567491|NCT01130493|19240336|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
5567492|NCT01130493|19240334|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
5567493|NCT01130493|19240335|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
5567494|NCT01130493|19240336|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
5567495|NCT01130493|19240334|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
5567496|NCT01130493|19240335|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
5567497|NCT01130493|19240336|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
5567498|NCT01130493|19240334|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
5567499|NCT01130493|19240335|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
5567500|NCT01130493|19240336|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
5567501|NCT01130493|19240334|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
5567502|NCT01130493|19240335|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
5567503|NCT01130493|19240336|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
5567504|NCT01130493|19240334|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
5567505|NCT01130493|19240335|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
5567506|NCT01130493|19240336|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
5567507|NCT01130493|19240334|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
5567508|NCT01130493|19240335|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
5567509|NCT01130493|19240336|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
5567510|NCT01130493|19240334|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
5567511|NCT01130493|19240335|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
5567512|NCT01130493|19240336|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
5567513|NCT01130493|19240334|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
5567514|NCT01130493|19240335|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
5567515|NCT01130493|19240336|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
5567516|NCT01130493|19240334|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
5567517|NCT01130493|19240335|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
5567518|NCT01130493|19240336|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
5567519|NCT01130493|19240334|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
5567520|NCT01130493|19240335|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
5567521|NCT01130493|19240336|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
5567522|NCT01130493|19240334|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
5567523|NCT01130493|19240335|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
5567524|NCT01130493|19240336|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
5567525|NCT01130337|19240353|P1|Overall Study|Surgical resection (R2)|1
5567526|NCT01130337|19240353|P1|Overall Study|Toxicity, AE/intercurrent disease|7
5567527|NCT01130337|19240353|P1|Overall Study|Disease progression|1
5567528|NCT01130337|19240353|P1|Overall Study|Death|1
5567529|NCT01130337|19240353|P1|Overall Study|Principal investigator decision|1
5567530|NCT01130337|19240353|P1|Overall Study|Withdrawal by Subject|3
5567531|NCT01130272|19240365|P5|Overall Study|Study arm discontinued|0
5567532|NCT01130272|19240366|P4|Overall Study|Study arm discontinued|0
5567533|NCT01130272|19240367|P3|Overall Study|Study arm discontinued|0
5567534|NCT01130272|19240368|P2|Overall Study|Study arm discontinued|0
5567535|NCT01130272|19240369|P1|Overall Study|Study arm discontinued|38
5567536|NCT01130272|19240365|P5|Overall Study|Sponsor decision|16
5567537|NCT01130272|19240366|P4|Overall Study|Sponsor decision|13
5567538|NCT01130272|19240367|P3|Overall Study|Sponsor decision|16
5567539|NCT01130272|19240368|P2|Overall Study|Sponsor decision|15
5567540|NCT01130272|19240369|P1|Overall Study|Sponsor decision|6
5567541|NCT01130272|19240365|P5|Overall Study|Physician Decision|2
5567542|NCT01130272|19240366|P4|Overall Study|Physician Decision|1
5567543|NCT01130272|19240367|P3|Overall Study|Physician Decision|0
5567544|NCT01130272|19240368|P2|Overall Study|Physician Decision|1
5567545|NCT01130272|19240369|P1|Overall Study|Physician Decision|1
5567546|NCT01130272|19240365|P5|Overall Study|Withdrawal by Subject|8
5567547|NCT01130272|19240366|P4|Overall Study|Withdrawal by Subject|9
5567548|NCT01130272|19240367|P3|Overall Study|Withdrawal by Subject|10
5567549|NCT01130272|19240368|P2|Overall Study|Withdrawal by Subject|11
5567550|NCT01130272|19240369|P1|Overall Study|Withdrawal by Subject|4
5567551|NCT01130272|19240365|P5|Overall Study|Lost to Follow-up|6
5567552|NCT01130272|19240366|P4|Overall Study|Lost to Follow-up|7
5567553|NCT01130272|19240367|P3|Overall Study|Lost to Follow-up|4
5567554|NCT01130272|19240368|P2|Overall Study|Lost to Follow-up|3
5567555|NCT01130272|19240369|P1|Overall Study|Lost to Follow-up|4
5567556|NCT01130272|19240365|P5|Overall Study|Protocol Violation|5
5567557|NCT01130272|19240366|P4|Overall Study|Protocol Violation|5
5567558|NCT01130272|19240367|P3|Overall Study|Protocol Violation|3
5567559|NCT01130272|19240368|P2|Overall Study|Protocol Violation|0
5567560|NCT01130272|19240369|P1|Overall Study|Protocol Violation|0
5567561|NCT01130272|19240365|P5|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5567562|NCT01130272|19240366|P4|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
5567563|NCT01130272|19240367|P3|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5567564|NCT01130272|19240368|P2|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5567565|NCT01130272|19240369|P1|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
5567566|NCT01130272|19240365|P5|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
5567567|NCT01130272|19240366|P4|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
5567568|NCT01130272|19240367|P3|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
5567569|NCT01130272|19240368|P2|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
5567570|NCT01130272|19240369|P1|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
5567571|NCT01130272|19240365|P5|Overall Study|Rescue medications due to diarrhea|6
5567572|NCT01130272|19240366|P4|Overall Study|Rescue medications due to diarrhea|8
5567573|NCT01130272|19240367|P3|Overall Study|Rescue medications due to diarrhea|8
5567574|NCT01130272|19240368|P2|Overall Study|Rescue medications due to diarrhea|5
5567575|NCT01130272|19240369|P1|Overall Study|Rescue medications due to diarrhea|3
5567576|NCT01130272|19240365|P5|Overall Study|IVRS-confirmed constipation|0
5567577|NCT01130272|19240366|P4|Overall Study|IVRS-confirmed constipation|2
5567578|NCT01130272|19240367|P3|Overall Study|IVRS-confirmed constipation|1
5567579|NCT01130272|19240368|P2|Overall Study|IVRS-confirmed constipation|1
5567580|NCT01130272|19240369|P1|Overall Study|IVRS-confirmed constipation|0
5567581|NCT01130272|19240365|P5|Overall Study|Adverse Event|7
5567582|NCT01130272|19240366|P4|Overall Study|Adverse Event|22
5567583|NCT01130272|19240367|P3|Overall Study|Adverse Event|6
5567584|NCT01130272|19240368|P2|Overall Study|Adverse Event|5
5567585|NCT01130272|19240369|P1|Overall Study|Adverse Event|2
5567586|NCT01130168|19240406|P6|Period 1|Adverse Event|0
5567587|NCT01130168|19240407|P5|Period 1|Adverse Event|0
5567588|NCT01130168|19240408|P4|Period 1|Adverse Event|1
5567589|NCT01130168|19240409|P3|Period 1|Adverse Event|0
5567590|NCT01130168|19240410|P2|Period 1|Adverse Event|0
5567591|NCT01130168|19240411|P1|Period 1|Adverse Event|0
5567592|NCT01130168|19240406|P6|Period 1|Discontinued For Other Reason|0
5567593|NCT01130168|19240407|P5|Period 1|Discontinued For Other Reason|0
5567594|NCT01130168|19240408|P4|Period 1|Discontinued For Other Reason|1
5567595|NCT01130168|19240409|P3|Period 1|Discontinued For Other Reason|1
5567596|NCT01130168|19240410|P2|Period 1|Discontinued For Other Reason|0
5567597|NCT01130168|19240411|P1|Period 1|Discontinued For Other Reason|0
5567598|NCT01130168|19240406|P6|Period 1|Withdrawal by Subject|0
5567599|NCT01130168|19240407|P5|Period 1|Withdrawal by Subject|0
5567600|NCT01130168|19240408|P4|Period 1|Withdrawal by Subject|1
5567601|NCT01130168|19240409|P3|Period 1|Withdrawal by Subject|0
5567602|NCT01130168|19240410|P2|Period 1|Withdrawal by Subject|1
5567603|NCT01130168|19240411|P1|Period 1|Withdrawal by Subject|0
5567604|NCT01130103|19240448|P2|Maintenance Treatment|Withdrawal by Subject|0
5567605|NCT01130103|19240449|P1|Maintenance Treatment|Withdrawal by Subject|1
5567606|NCT01130103|19240448|P2|Maintenance Treatment|Lost to Follow-up|1
5567607|NCT01130103|19240449|P1|Maintenance Treatment|Lost to Follow-up|1
5567608|NCT01130103|19240448|P2|Maintenance Treatment|Lack of Efficacy|1
5567609|NCT01130103|19240449|P1|Maintenance Treatment|Lack of Efficacy|0
5567610|NCT01130103|19240448|P2|Randomized Treatment|Withdrawal by Subject|2
5567611|NCT01130103|19240449|P1|Randomized Treatment|Withdrawal by Subject|1
5567612|NCT01130103|19240448|P2|Randomized Treatment|Protocol Violation|2
5567613|NCT01130103|19240449|P1|Randomized Treatment|Protocol Violation|3
5567614|NCT01130103|19240448|P2|Randomized Treatment|Lost to Follow-up|0
5567615|NCT01130103|19240449|P1|Randomized Treatment|Lost to Follow-up|1
5567616|NCT01130103|19240448|P2|Randomized Treatment|Adverse Event|1
5567617|NCT01130103|19240449|P1|Randomized Treatment|Adverse Event|1
5567618|NCT01130051|19240463|P2|Washout Period of 14 Days|Protocol Violation|1
5567619|NCT01130051|19240464|P1|Washout Period of 14 Days|Protocol Violation|1
5567620|NCT01130051|19240463|P2|Washout Period of 14 Days|Withdrawal by Subject|1
5567621|NCT01130051|19240464|P1|Washout Period of 14 Days|Withdrawal by Subject|0
5567622|NCT01129960|19240478|P4|Overall Study|Pregnancy|0
5567623|NCT01129960|19240479|P3|Overall Study|Pregnancy|0
5567624|NCT01129960|19240480|P2|Overall Study|Pregnancy|0
5567625|NCT01129960|19240481|P1|Overall Study|Pregnancy|1
5567626|NCT01129960|19240478|P4|Overall Study|Physician Decision|0
5567627|NCT01129960|19240479|P3|Overall Study|Physician Decision|0
5567628|NCT01129960|19240480|P2|Overall Study|Physician Decision|0
5567629|NCT01129960|19240481|P1|Overall Study|Physician Decision|1
5567630|NCT01129960|19240478|P4|Overall Study|Discontinuation of the study by Sponsor|0
5567631|NCT01129960|19240479|P3|Overall Study|Discontinuation of the study by Sponsor|0
5567632|NCT01129960|19240480|P2|Overall Study|Discontinuation of the study by Sponsor|1
5567633|NCT01129960|19240481|P1|Overall Study|Discontinuation of the study by Sponsor|0
5567634|NCT01129960|19240478|P4|Overall Study|Lost to Follow-up|3
5567635|NCT01129960|19240479|P3|Overall Study|Lost to Follow-up|3
5567636|NCT01129960|19240480|P2|Overall Study|Lost to Follow-up|2
5567637|NCT01129960|19240481|P1|Overall Study|Lost to Follow-up|0
5567638|NCT01129960|19240478|P4|Overall Study|Protocol Violation|0
5567639|NCT01129960|19240479|P3|Overall Study|Protocol Violation|3
5567640|NCT01129960|19240480|P2|Overall Study|Protocol Violation|2
5567641|NCT01129960|19240481|P1|Overall Study|Protocol Violation|1
5567642|NCT01129960|19240478|P4|Overall Study|Adverse Event|7
5567643|NCT01129960|19240479|P3|Overall Study|Adverse Event|16
5567644|NCT01129960|19240480|P2|Overall Study|Adverse Event|16
5567645|NCT01129960|19240481|P1|Overall Study|Adverse Event|23
5567646|NCT01129960|19240478|P4|Overall Study|Lack of Efficacy|1
5567647|NCT01129960|19240479|P3|Overall Study|Lack of Efficacy|1
5567648|NCT01129960|19240480|P2|Overall Study|Lack of Efficacy|1
5567649|NCT01129960|19240481|P1|Overall Study|Lack of Efficacy|1
5567650|NCT01129960|19240478|P4|Overall Study|Withdrawal by Subject|2
5567651|NCT01129960|19240479|P3|Overall Study|Withdrawal by Subject|3
5567652|NCT01129960|19240480|P2|Overall Study|Withdrawal by Subject|0
5567653|NCT01129960|19240481|P1|Overall Study|Withdrawal by Subject|3
5567654|NCT01129921|19240493|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
5567655|NCT01129921|19240494|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
5567656|NCT01129921|19240493|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
5567657|NCT01129921|19240494|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
5567658|NCT01129921|19240493|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
5567659|NCT01129921|19240494|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
5567660|NCT01129921|19240493|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
5567661|NCT01129921|19240494|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
5567662|NCT01129882|19240504|P1|Overall Study|Withdrawal by Subject|160
5567663|NCT01129882|19240504|P1|Overall Study|Trial Termination by Sponsor|6
5567664|NCT01129882|19240504|P1|Overall Study|Withdrawal Criteria Met|19
5567665|NCT01129882|19240504|P1|Overall Study|Protocol Deviation|3
5567666|NCT01129882|19240504|P1|Overall Study|Physician Decision|27
5567667|NCT01129882|19240504|P1|Overall Study|Lost to Follow-up|13
5567668|NCT01129882|19240504|P1|Overall Study|Lack of Efficacy|5
5567669|NCT01129882|19240504|P1|Overall Study|Death|6
5567670|NCT01129882|19240504|P1|Overall Study|Adverse Event|39
5567671|NCT01129622|19240523|P1|Overall Study|Withdrawal by Subject|2
5567672|NCT01129583|19240534|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
5567673|NCT01129583|19240535|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
5567674|NCT01129583|19240534|P2|Overall Study|Lost to Follow-up|1
5567675|NCT01129583|19240535|P1|Overall Study|Lost to Follow-up|1
5567676|NCT01129583|19240534|P2|Overall Study|Death|0
5567677|NCT01129583|19240535|P1|Overall Study|Death|1
5567678|NCT01129557|19240548|P3|Overall Study|Novartis terminated study early|2
5567679|NCT01129557|19240549|P2|Overall Study|Novartis terminated study early|3
5567680|NCT01129557|19240550|P1|Overall Study|Novartis terminated study early|3
5567681|NCT01129557|19240548|P3|Overall Study|Adverse Event|2
5567682|NCT01129557|19240549|P2|Overall Study|Adverse Event|2
5567683|NCT01129557|19240550|P1|Overall Study|Adverse Event|1
5567684|NCT01129336|19240663|P2|Overall Study|Death|4
5567685|NCT01129336|19240664|P1|Overall Study|Death|0
5567686|NCT01129336|19240663|P2|Overall Study|Missing Study Completion Status|3
5567687|NCT01129336|19240664|P1|Overall Study|Missing Study Completion Status|2
5567688|NCT01129336|19240663|P2|Overall Study|Adverse Event|1
5567689|NCT01129336|19240664|P1|Overall Study|Adverse Event|0
5567690|NCT01129336|19240663|P2|Overall Study|Withdrawal by Subject|4
5567691|NCT01129336|19240664|P1|Overall Study|Withdrawal by Subject|7
5567692|NCT01129336|19240663|P2|Overall Study|Lost to Follow-up|0
5567693|NCT01129336|19240664|P1|Overall Study|Lost to Follow-up|1
5567694|NCT01129336|19240663|P2|Overall Study|Disease Progression|4
5567695|NCT01129336|19240664|P1|Overall Study|Disease Progression|1
5567696|NCT01129336|19240663|P2|Overall Study|Protocol Violation|0
5567697|NCT01129336|19240664|P1|Overall Study|Protocol Violation|1
5567698|NCT01129284|19240679|P3|Overall Study|Adverse Event|1
5567699|NCT01129284|19240680|P2|Overall Study|Adverse Event|0
5567700|NCT01129284|19240681|P1|Overall Study|Adverse Event|2
5567701|NCT01129128|19240729|P3|Overall Study|Physician Decision|0
5567702|NCT01129128|19240730|P2|Overall Study|Physician Decision|0
5567703|NCT01129128|19240731|P1|Overall Study|Physician Decision|1
5567704|NCT01129128|19240729|P3|Overall Study|Withdrawal by Subject|3
5567705|NCT01129128|19240730|P2|Overall Study|Withdrawal by Subject|1
5567706|NCT01129128|19240731|P1|Overall Study|Withdrawal by Subject|0
5567707|NCT01129128|19240729|P3|Overall Study|Protocol Violation|0
5567708|NCT01129128|19240730|P2|Overall Study|Protocol Violation|1
5567709|NCT01129128|19240731|P1|Overall Study|Protocol Violation|0
5567710|NCT01129128|19240729|P3|Overall Study|Lost to Follow-up|1
5567711|NCT01129128|19240730|P2|Overall Study|Lost to Follow-up|2
5567712|NCT01129128|19240731|P1|Overall Study|Lost to Follow-up|2
5567713|NCT01129115|19240755|P4|Overall Study|Protocol Violation|2
5567714|NCT01129115|19240756|P3|Overall Study|Protocol Violation|2
5567715|NCT01129115|19240757|P2|Overall Study|Protocol Violation|2
5567716|NCT01129115|19240758|P1|Overall Study|Protocol Violation|0
5567717|NCT01129115|19240755|P4|Overall Study|Withdrawal by Subject|4
5567718|NCT01129115|19240756|P3|Overall Study|Withdrawal by Subject|1
5567719|NCT01129115|19240757|P2|Overall Study|Withdrawal by Subject|3
5567720|NCT01129115|19240758|P1|Overall Study|Withdrawal by Subject|1
5567721|NCT01129115|19240755|P4|Overall Study|Adverse Event|3
5567722|NCT01129115|19240756|P3|Overall Study|Adverse Event|3
5567723|NCT01129115|19240757|P2|Overall Study|Adverse Event|2
5567724|NCT01129115|19240758|P1|Overall Study|Adverse Event|1
5567725|NCT01129102|19240795|P3|Overall Study|Lost to Follow-up|0
5567726|NCT01129102|19240796|P2|Overall Study|Lost to Follow-up|0
5567727|NCT01129102|19240797|P1|Overall Study|Lost to Follow-up|2
5567728|NCT01129102|19240795|P3|Overall Study|Adverse Event|1
5567729|NCT01129102|19240796|P2|Overall Study|Adverse Event|2
5567730|NCT01129102|19240797|P1|Overall Study|Adverse Event|2
5567731|NCT01129102|19240795|P3|Overall Study|Pregnancy|1
5567732|NCT01129102|19240796|P2|Overall Study|Pregnancy|0
5567733|NCT01129102|19240797|P1|Overall Study|Pregnancy|0
5567734|NCT01129102|19240795|P3|Overall Study|Protocol Violation|1
5567735|NCT01129102|19240796|P2|Overall Study|Protocol Violation|1
5567736|NCT01129102|19240797|P1|Overall Study|Protocol Violation|0
5567737|NCT01129102|19240795|P3|Overall Study|Withdrawal by Subject|3
5567738|NCT01129102|19240796|P2|Overall Study|Withdrawal by Subject|0
5567739|NCT01129102|19240797|P1|Overall Study|Withdrawal by Subject|2
5567740|NCT01129102|19240795|P3|Overall Study|No study drug treatment|1
5567741|NCT01129102|19240796|P2|Overall Study|No study drug treatment|3
5567742|NCT01129102|19240797|P1|Overall Study|No study drug treatment|2
5567743|NCT01129011|19240808|P2|Overall Study|misc|4
5567744|NCT01129011|19240809|P1|Overall Study|misc|7
5567745|NCT01129011|19240808|P2|Overall Study|Duodenal Ulcer|8
5567746|NCT01129011|19240809|P1|Overall Study|Duodenal Ulcer|2
5567747|NCT01129011|19240808|P2|Overall Study|Lost to Follow-up|7
5567748|NCT01129011|19240809|P1|Overall Study|Lost to Follow-up|6
5567749|NCT01129011|19240808|P2|Overall Study|Withdrawal by Subject|8
5567750|NCT01129011|19240809|P1|Overall Study|Withdrawal by Subject|24
5567751|NCT01129011|19240808|P2|Overall Study|Adverse Event|30
5567752|NCT01129011|19240809|P1|Overall Study|Adverse Event|20
5567753|NCT01128959|19240864|P1|Treatment Period|Withdrawal by Subject|1
5567754|NCT01128959|19240864|P1|Treatment Period|Adverse Event|3
5567755|NCT01128959|19240864|P1|Lead in Period|Adverse Event|3
5567756|NCT01128946|19240870|P4|Period III|Protocol Violation|0
5567757|NCT01128946|19240871|P3|Period III|Protocol Violation|0
5567758|NCT01128946|19240872|P2|Period III|Protocol Violation|0
5567759|NCT01128946|19240873|P1|Period III|Protocol Violation|1
5567760|NCT01128946|19240870|P4|Period II|Withdrawal by Subject|1
5567761|NCT01128946|19240871|P3|Period II|Withdrawal by Subject|0
5567762|NCT01128946|19240872|P2|Period II|Withdrawal by Subject|0
5567763|NCT01128946|19240873|P1|Period II|Withdrawal by Subject|0
5567764|NCT01128946|19240870|P4|Period II|Protocol Violation|0
5567765|NCT01128946|19240871|P3|Period II|Protocol Violation|0
5567766|NCT01128946|19240872|P2|Period II|Protocol Violation|1
5567767|NCT01128946|19240873|P1|Period II|Protocol Violation|0
5567768|NCT01128946|19240870|P4|Period I|Withdrawal by Subject|1
5567769|NCT01128946|19240871|P3|Period I|Withdrawal by Subject|1
5567770|NCT01128946|19240872|P2|Period I|Withdrawal by Subject|0
5567771|NCT01128946|19240873|P1|Period I|Withdrawal by Subject|0
5567772|NCT01128946|19240870|P4|Period I|Protocol Violation|0
5567773|NCT01128946|19240871|P3|Period I|Protocol Violation|0
5567774|NCT01128946|19240872|P2|Period I|Protocol Violation|1
5567775|NCT01128946|19240873|P1|Period I|Protocol Violation|0
5567776|NCT01128894|19240891|P2|Overall Study|Conflicting HbA1c Results at Screening|0
5567777|NCT01128894|19240892|P1|Overall Study|Conflicting HbA1c Results at Screening|1
5567778|NCT01128894|19240891|P2|Overall Study|Physician Decision|1
5567779|NCT01128894|19240892|P1|Overall Study|Physician Decision|2
5567780|NCT01128894|19240891|P2|Overall Study|Withdrawal by Subject|12
5567781|NCT01128894|19240892|P1|Overall Study|Withdrawal by Subject|10
5567782|NCT01128894|19240891|P2|Overall Study|Lost to Follow-up|8
5567783|NCT01128894|19240892|P1|Overall Study|Lost to Follow-up|8
5567784|NCT01128894|19240891|P2|Overall Study|Noncompliance|5
5567785|NCT01128894|19240892|P1|Overall Study|Noncompliance|4
5567786|NCT01128894|19240891|P2|Overall Study|Protocol Violation|1
5567787|NCT01128894|19240892|P1|Overall Study|Protocol Violation|2
5567788|NCT01128894|19240891|P2|Overall Study|Adverse Event|41
5567789|NCT01128894|19240892|P1|Overall Study|Adverse Event|31
5567790|NCT01128842|19240910|P1|Overall Study|Disease Progression|6
5567791|NCT01128842|19240910|P1|Overall Study|Adverse Event|1
5567792|NCT01128738|19240927|P2|Second TP|Withdrawal by Subject|2
5567793|NCT01128738|19240928|P1|Second TP|Withdrawal by Subject|0
5567794|NCT01128738|19240927|P2|Second TP|Lost to Follow-up|1
5567795|NCT01128738|19240928|P1|Second TP|Lost to Follow-up|0
5567796|NCT01128738|19240927|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
5567797|NCT01128738|19240928|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
5567798|NCT01128738|19240927|P2|First Treatment Phase (TP)|Lost to Follow-up|0
5567799|NCT01128738|19240928|P1|First Treatment Phase (TP)|Lost to Follow-up|1
5567800|NCT01128621|19241053|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
5567801|NCT01128621|19241054|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
5567802|NCT01128595|19241175|P4|Treatment Period 3|Withdrawal by Subject|0
5567803|NCT01128595|19241176|P3|Treatment Period 3|Withdrawal by Subject|0
5567804|NCT01128595|19241177|P2|Treatment Period 3|Withdrawal by Subject|1
5567805|NCT01128595|19241178|P1|Treatment Period 3|Withdrawal by Subject|0
5567806|NCT01128569|19241208|P6|Treatment Period 2|Withdrawal by Subject|0
5567807|NCT01128569|19241209|P5|Treatment Period 2|Withdrawal by Subject|0
5567808|NCT01128569|19241210|P4|Treatment Period 2|Withdrawal by Subject|0
5567809|NCT01128569|19241211|P3|Treatment Period 2|Withdrawal by Subject|0
5567810|NCT01128569|19241212|P2|Treatment Period 2|Withdrawal by Subject|1
5567811|NCT01128569|19241213|P1|Treatment Period 2|Withdrawal by Subject|0
5567812|NCT01128569|19241208|P6|Washout Period 1|Adverse Event|0
5567813|NCT01128569|19241209|P5|Washout Period 1|Adverse Event|0
5567814|NCT01128569|19241210|P4|Washout Period 1|Adverse Event|0
5567815|NCT01128569|19241211|P3|Washout Period 1|Adverse Event|1
5567816|NCT01128569|19241212|P2|Washout Period 1|Adverse Event|0
5567817|NCT01128569|19241213|P1|Washout Period 1|Adverse Event|0
5567818|NCT01128543|19241230|P1|Overall Study|Protocol Violation|1
5567819|NCT01128543|19241230|P1|Overall Study|Withdrawal by Subject|3
5567820|NCT01128413|19241256|P2|Overall Study|Pt made DNR|0
5567821|NCT01128413|19241257|P1|Overall Study|Pt made DNR|1
5567822|NCT01128413|19241256|P2|Overall Study|NICOM Monitor Problems|1
5567823|NCT01128413|19241257|P1|Overall Study|NICOM Monitor Problems|2
5567824|NCT01128413|19241256|P2|Overall Study|Withdrawal by Subject|0
5567825|NCT01128413|19241257|P1|Overall Study|Withdrawal by Subject|1
5567826|NCT01128400|19241266|P3|Overall Study|Excluded due to sinus problems|0
5567827|NCT01128400|19241267|P2|Overall Study|Excluded due to sinus problems|1
5567828|NCT01128400|19241268|P1|Overall Study|Excluded due to sinus problems|0
5567829|NCT01128400|19241266|P3|Overall Study|were not invited to participate on taste|15
5567830|NCT01128400|19241267|P2|Overall Study|were not invited to participate on taste|0
5567831|NCT01128400|19241268|P1|Overall Study|were not invited to participate on taste|0
5567832|NCT01128400|19241266|P3|Overall Study|Screening failure|0
5567833|NCT01128400|19241267|P2|Overall Study|Screening failure|0
5567834|NCT01128400|19241268|P1|Overall Study|Screening failure|1
5567835|NCT01128400|19241266|P3|Overall Study|Lost to Follow-up|1
5567836|NCT01128400|19241267|P2|Overall Study|Lost to Follow-up|0
5567837|NCT01128400|19241268|P1|Overall Study|Lost to Follow-up|1
5567838|NCT01128387|19241281|P2|Overall Study|Physician Decision|1
5567839|NCT01128387|19241282|P1|Overall Study|Physician Decision|0
5567840|NCT01128361|19241292|P2|Overall Study|Withdrawal by Subject|2
5567841|NCT01128361|19241293|P1|Overall Study|Withdrawal by Subject|5
5567842|NCT01128361|19241292|P2|Overall Study|Lost to Follow-up|1
5567843|NCT01128361|19241293|P1|Overall Study|Lost to Follow-up|0
5567844|NCT01128296|19241305|P6|Overall Study|Withdrawal by Subject|2
5567845|NCT01128296|19241306|P5|Overall Study|Withdrawal by Subject|0
5567846|NCT01128296|19241307|P4|Overall Study|Withdrawal by Subject|0
5567847|NCT01128296|19241308|P3|Overall Study|Withdrawal by Subject|0
5567848|NCT01128296|19241309|P2|Overall Study|Withdrawal by Subject|0
5567849|NCT01128296|19241310|P1|Overall Study|Withdrawal by Subject|0
5567850|NCT01128296|19241305|P6|Overall Study|Physician Decision|3
5567851|NCT01128296|19241306|P5|Overall Study|Physician Decision|0
5567852|NCT01128296|19241307|P4|Overall Study|Physician Decision|0
5567853|NCT01128296|19241308|P3|Overall Study|Physician Decision|0
5567854|NCT01128296|19241309|P2|Overall Study|Physician Decision|0
5567855|NCT01128296|19241310|P1|Overall Study|Physician Decision|0
5567856|NCT01128244|19241341|P1|Overall Study|Scheduling conflict|2
5567857|NCT01128244|19241341|P1|Overall Study|Adverse Event|1
5567858|NCT01128179|19241382|P2|Overall Study|Protocol Violation|0
5567859|NCT01128179|19241383|P1|Overall Study|Protocol Violation|1
5567860|NCT01128179|19241382|P2|Overall Study|Death|0
5567861|NCT01128179|19241383|P1|Overall Study|Death|1
5567862|NCT01128153|19241403|P2|Overall Study|Developed discontinuation criteria|1
5567863|NCT01128153|19241404|P1|Overall Study|Developed discontinuation criteria|1
5567864|NCT01128153|19241403|P2|Overall Study|Protocol Violation|0
5567865|NCT01128153|19241404|P1|Overall Study|Protocol Violation|2
5567866|NCT01128153|19241403|P2|Overall Study|Incorrect enrolment to study|1
5567867|NCT01128153|19241404|P1|Overall Study|Incorrect enrolment to study|2
5567868|NCT01128153|19241403|P2|Overall Study|Withdrawal by Subject|3
5567869|NCT01128153|19241404|P1|Overall Study|Withdrawal by Subject|2
5567870|NCT01128153|19241403|P2|Overall Study|Condition under investigation worsened|7
5567871|NCT01128153|19241404|P1|Overall Study|Condition under investigation worsened|8
5567872|NCT01128153|19241403|P2|Overall Study|Adverse Event|3
5567873|NCT01128153|19241404|P1|Overall Study|Adverse Event|1
5567874|NCT01128114|19241420|P1|Overall Study|Screening Failed|2
5567875|NCT01128114|19241420|P1|Overall Study|Treatment Withdrawn|6
5567876|NCT01127763|19241437|P1|Overall Study|Physician Decision|2
5567877|NCT01127763|19241437|P1|Overall Study|Withdrawal by Subject|1
5567878|NCT01127763|19241437|P1|Overall Study|Adverse Event|2
5567879|NCT01127646|19241482|P2|Overall Study|Protocol Violation|1
5567880|NCT01127646|19241483|P1|Overall Study|Protocol Violation|0
5567881|NCT01127646|19241482|P2|Overall Study|Entry Criteria Not Met|0
5567882|NCT01127646|19241483|P1|Overall Study|Entry Criteria Not Met|1
5567883|NCT01127633|19241517|P2|Overall Study|Not treated|0
5567884|NCT01127633|19241518|P1|Overall Study|Not treated|1
5567885|NCT01127633|19241517|P2|Overall Study|Abnormal Lab/ECG Result|1
5567886|NCT01127633|19241518|P1|Overall Study|Abnormal Lab/ECG Result|0
5567887|NCT01127633|19241517|P2|Overall Study|Protocol Violation|16
5567888|NCT01127633|19241518|P1|Overall Study|Protocol Violation|8
5567889|NCT01127633|19241517|P2|Overall Study|Sponsor Decision|195
5567890|NCT01127633|19241518|P1|Overall Study|Sponsor Decision|163
5567891|NCT01127633|19241517|P2|Overall Study|Withdrawal by Subject|72
5567892|NCT01127633|19241518|P1|Overall Study|Withdrawal by Subject|57
5567893|NCT01127633|19241517|P2|Overall Study|Physician Decision|45
5567894|NCT01127633|19241518|P1|Overall Study|Physician Decision|60
5567895|NCT01127633|19241517|P2|Overall Study|Parent/Caregiver Decision|228
5567896|NCT01127633|19241518|P1|Overall Study|Parent/Caregiver Decision|246
5567897|NCT01127633|19241517|P2|Overall Study|Lost to Follow-up|0
5567898|NCT01127633|19241518|P1|Overall Study|Lost to Follow-up|4
5567899|NCT01127633|19241517|P2|Overall Study|Death|43
5567900|NCT01127633|19241518|P1|Overall Study|Death|40
5567901|NCT01127633|19241517|P2|Overall Study|Adverse Event|73
5567902|NCT01127633|19241518|P1|Overall Study|Adverse Event|74
5567903|NCT01127607|19241550|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
5567904|NCT01127607|19241551|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
5567905|NCT01127607|19241550|P2|Phase II (Between Subjects)|Lost to Follow-up|2
5567906|NCT01127607|19241551|P1|Phase II (Between Subjects)|Lost to Follow-up|0
5567907|NCT01127256|19241728|P2|Overall Study|Protocol Violation|0
5567908|NCT01127256|19241729|P1|Overall Study|Protocol Violation|1
5567909|NCT01127256|19241728|P2|Overall Study|Withdrawal by Subject|9
5567910|NCT01127256|19241729|P1|Overall Study|Withdrawal by Subject|5
5567911|NCT01127256|19241728|P2|Overall Study|Lost to Follow-up|17
5567912|NCT01127256|19241729|P1|Overall Study|Lost to Follow-up|16
5567913|NCT01127256|19241728|P2|Overall Study|Lack of Efficacy|0
5567914|NCT01127256|19241729|P1|Overall Study|Lack of Efficacy|4
5567915|NCT01127256|19241728|P2|Overall Study|Adverse Event|13
5567916|NCT01127256|19241729|P1|Overall Study|Adverse Event|13
5567917|NCT01127165|19241741|P2|Overall Study|Protocol Violation|1
5567918|NCT01127165|19241742|P1|Overall Study|Protocol Violation|0
5567919|NCT01127165|19241741|P2|Overall Study|Withdrawal by Subject|3
5567920|NCT01127165|19241742|P1|Overall Study|Withdrawal by Subject|1
5567921|NCT01127165|19241741|P2|Overall Study|Lost to Follow-up|5
5567922|NCT01127165|19241742|P1|Overall Study|Lost to Follow-up|3
5567923|NCT01127165|19241741|P2|Overall Study|Lack of Efficacy|8
5567924|NCT01127165|19241742|P1|Overall Study|Lack of Efficacy|10
5567925|NCT01127165|19241741|P2|Overall Study|Adverse Event|2
5567926|NCT01127165|19241742|P1|Overall Study|Adverse Event|2
5567927|NCT01127139|19241754|P1|Overall Study|Reason not specified|1
5567928|NCT01127139|19241754|P1|Overall Study|Lack of Efficacy|4
5567929|NCT01127139|19241754|P1|Overall Study|Incompliance|12
5567930|NCT01127139|19241754|P1|Overall Study|Adverse Event|40
5567931|NCT01127061|19241782|P2|Overall Study|Physician Decision|3
5567932|NCT01127061|19241783|P1|Overall Study|Physician Decision|3
5567933|NCT01127061|19241782|P2|Overall Study|Lost to Follow-up|10
5567934|NCT01127061|19241783|P1|Overall Study|Lost to Follow-up|7
5567935|NCT01126879|19241820|P2|Overall Study|Physician Decision|0
5567936|NCT01126879|19241821|P1|Overall Study|Physician Decision|1
5567937|NCT01126879|19241820|P2|Overall Study|Adverse Event|1
5567938|NCT01126879|19241821|P1|Overall Study|Adverse Event|0
5567939|NCT01126879|19241820|P2|Overall Study|Withdrawal by Subject|0
5567940|NCT01126879|19241821|P1|Overall Study|Withdrawal by Subject|1
5567941|NCT01126879|19241820|P2|Overall Study|Progressive Disease|1
5567942|NCT01126879|19241821|P1|Overall Study|Progressive Disease|3
5567943|NCT01126619|19241868|P1|Overall Study|Non-compliance|1
5567944|NCT01126619|19241868|P1|Overall Study|Withdrawal by Subject|9
5567945|NCT01126619|19241868|P1|Overall Study|Serious adverse event|1
5567946|NCT01126619|19241868|P1|Overall Study|Investigator decision|4
5567947|NCT01126619|19241868|P1|Overall Study|Not eligible for the study|2
5567948|NCT01126580|19241896|P3|Overall Study|Treatment Non-compliance|3
5567949|NCT01126580|19241897|P2|Overall Study|Treatment Non-compliance|2
5567950|NCT01126580|19241898|P1|Overall Study|Treatment Non-compliance|0
5567951|NCT01126580|19241896|P3|Overall Study|Lost to Follow-up|9
5567952|NCT01126580|19241897|P2|Overall Study|Lost to Follow-up|13
5567953|NCT01126580|19241898|P1|Overall Study|Lost to Follow-up|15
5567954|NCT01126580|19241896|P3|Overall Study|Protocol Violation|2
5567955|NCT01126580|19241897|P2|Overall Study|Protocol Violation|1
5567956|NCT01126580|19241898|P1|Overall Study|Protocol Violation|0
5567957|NCT01126580|19241896|P3|Overall Study|Lack of Efficacy|4
5567958|NCT01126580|19241897|P2|Overall Study|Lack of Efficacy|3
5567959|NCT01126580|19241898|P1|Overall Study|Lack of Efficacy|2
5567960|NCT01126580|19241896|P3|Overall Study|Entry Criteria Not Met|2
5567961|NCT01126580|19241897|P2|Overall Study|Entry Criteria Not Met|1
5567962|NCT01126580|19241898|P1|Overall Study|Entry Criteria Not Met|1
5567963|NCT01126580|19241896|P3|Overall Study|Physician Decision|2
5567964|NCT01126580|19241897|P2|Overall Study|Physician Decision|1
5567965|NCT01126580|19241898|P1|Overall Study|Physician Decision|1
5567966|NCT01126580|19241896|P3|Overall Study|Sponsor Decision|7
5567967|NCT01126580|19241897|P2|Overall Study|Sponsor Decision|4
5567968|NCT01126580|19241898|P1|Overall Study|Sponsor Decision|5
5567969|NCT01126580|19241896|P3|Overall Study|Withdrawal by Subject|14
5567970|NCT01126580|19241897|P2|Overall Study|Withdrawal by Subject|19
5567971|NCT01126580|19241898|P1|Overall Study|Withdrawal by Subject|11
5567972|NCT01126580|19241896|P3|Overall Study|Adverse Event|12
5567973|NCT01126580|19241897|P2|Overall Study|Adverse Event|8
5567974|NCT01126580|19241898|P1|Overall Study|Adverse Event|14
5567975|NCT01126541|19241993|P3|Overall Study|Administrative reason or other|2
5567976|NCT01126541|19241994|P2|Overall Study|Administrative reason or other|1
5567977|NCT01126541|19241995|P1|Overall Study|Administrative reason or other|1
5567978|NCT01126541|19241993|P3|Overall Study|Protocol Violation|1
5567979|NCT01126541|19241994|P2|Overall Study|Protocol Violation|0
5567980|NCT01126541|19241995|P1|Overall Study|Protocol Violation|0
5567981|NCT01126541|19241993|P3|Overall Study|Withdrawal by Subject|6
5567982|NCT01126541|19241994|P2|Overall Study|Withdrawal by Subject|5
5567983|NCT01126541|19241995|P1|Overall Study|Withdrawal by Subject|2
5567984|NCT01126541|19241993|P3|Overall Study|Lost to Follow-up|2
5567985|NCT01126541|19241994|P2|Overall Study|Lost to Follow-up|2
5567986|NCT01126541|19241995|P1|Overall Study|Lost to Follow-up|1
5567987|NCT01126541|19241993|P3|Overall Study|Lack of Efficacy|11
5567988|NCT01126541|19241994|P2|Overall Study|Lack of Efficacy|1
5567989|NCT01126541|19241995|P1|Overall Study|Lack of Efficacy|6
5567990|NCT01126541|19241993|P3|Overall Study|Death|0
5567991|NCT01126541|19241994|P2|Overall Study|Death|1
5567992|NCT01126541|19241995|P1|Overall Study|Death|0
5567993|NCT01126541|19241993|P3|Overall Study|Adverse Event|4
5567994|NCT01126541|19241994|P2|Overall Study|Adverse Event|2
5567995|NCT01126541|19241995|P1|Overall Study|Adverse Event|0
5567996|NCT01126437|19242079|P3|Overall Study|Other reason not specified|178
5567997|NCT01126437|19242080|P2|Overall Study|Other reason not specified|176
5567998|NCT01126437|19242081|P1|Overall Study|Other reason not specified|210
5567999|NCT01126437|19242079|P3|Overall Study|Withdrawal by Subject|319
5568000|NCT01126437|19242080|P2|Overall Study|Withdrawal by Subject|335
5568001|NCT01126437|19242081|P1|Overall Study|Withdrawal by Subject|331
5568002|NCT01126437|19242079|P3|Overall Study|Lost to Follow-up|55
5568003|NCT01126437|19242080|P2|Overall Study|Lost to Follow-up|63
5568004|NCT01126437|19242081|P1|Overall Study|Lost to Follow-up|52
5568005|NCT01126437|19242079|P3|Overall Study|Protocol Violation|41
5568006|NCT01126437|19242080|P2|Overall Study|Protocol Violation|66
5568007|NCT01126437|19242081|P1|Overall Study|Protocol Violation|64
5568008|NCT01126437|19242079|P3|Overall Study|Lack of Efficacy|59
5568009|NCT01126437|19242080|P2|Overall Study|Lack of Efficacy|60
5568010|NCT01126437|19242081|P1|Overall Study|Lack of Efficacy|65
5568011|NCT01126437|19242079|P3|Overall Study|Adverse Event|635
5568012|NCT01126437|19242080|P2|Overall Study|Adverse Event|606
5568013|NCT01126437|19242081|P1|Overall Study|Adverse Event|602
5568014|NCT01126437|19242079|P3|Overall Study|Sites with data irregularities/fraud|7
5568015|NCT01126437|19242080|P2|Overall Study|Sites with data irregularities/fraud|6
5568016|NCT01126437|19242081|P1|Overall Study|Sites with data irregularities/fraud|6
5568017|NCT01126437|19242079|P3|Overall Study|Not treated|19
5568018|NCT01126437|19242080|P2|Overall Study|Not treated|18
5568019|NCT01126437|19242081|P1|Overall Study|Not treated|11
5568020|NCT01126424|19242119|P6|Overall Study|Withdrawal by Subject|0
5568021|NCT01126424|19242120|P5|Overall Study|Withdrawal by Subject|1
5568022|NCT01126424|19242121|P4|Overall Study|Withdrawal by Subject|3
5568023|NCT01126424|19242122|P3|Overall Study|Withdrawal by Subject|1
5568024|NCT01126424|19242123|P2|Overall Study|Withdrawal by Subject|0
5568025|NCT01126424|19242124|P1|Overall Study|Withdrawal by Subject|0
5568026|NCT01126424|19242119|P6|Overall Study|Adverse Event|0
5568027|NCT01126424|19242120|P5|Overall Study|Adverse Event|1
5568028|NCT01126424|19242121|P4|Overall Study|Adverse Event|0
5568029|NCT01126424|19242122|P3|Overall Study|Adverse Event|0
5568030|NCT01126424|19242123|P2|Overall Study|Adverse Event|0
5568031|NCT01126424|19242124|P1|Overall Study|Adverse Event|0
5568032|NCT01126359|19242147|P2|First Intervention (20-minutes)|Physician Decision|1
5568033|NCT01126359|19242148|P1|First Intervention (20-minutes)|Physician Decision|0
5568034|NCT01126268|19242160|P1|Overall Study|Adverse Event|1
5568035|NCT01126060|19242199|P2|Overall Study|Protocol Violation|2
5568036|NCT01126060|19242200|P1|Overall Study|Protocol Violation|0
5568037|NCT01125930|19242208|P2|Overall Study|Lost to Follow-up|2
5568038|NCT01125930|19242209|P1|Overall Study|Lost to Follow-up|0
5568039|NCT01125930|19242208|P2|Overall Study|Protocol Violation|1
5568040|NCT01125930|19242209|P1|Overall Study|Protocol Violation|0
5568041|NCT01125930|19242208|P2|Overall Study|Withdrawal by Subject|6
5568042|NCT01125930|19242209|P1|Overall Study|Withdrawal by Subject|1
5568043|NCT01125930|19242208|P2|Overall Study|Adverse Event|1
5568044|NCT01125930|19242209|P1|Overall Study|Adverse Event|0
5568045|NCT01125917|19242363|P1|Overall Study|Lack of Efficacy|19
5568046|NCT01125917|19242363|P1|Overall Study|Administrative|223
5568047|NCT01125917|19242363|P1|Overall Study|Withdrawal by Subject|31
5568048|NCT01125917|19242363|P1|Overall Study|Lost to Follow-up|23
5568049|NCT01125917|19242363|P1|Overall Study|Adverse Event|43
5568050|NCT01125813|19242367|P1|Overall Study|Screen Failures|4
5568051|NCT01125813|19242367|P1|Overall Study|Withdrawal by Subject|1
5568052|NCT01125813|19242367|P1|Overall Study|Death|1
5568053|NCT01125800|19242377|P5|Phase II|Disease progression|8
5568054|NCT01125800|19242378|P4|Phase II|Disease progression|1
5568055|NCT01125800|19242379|P3|Phase II|Disease progression|0
5568056|NCT01125800|19242380|P2|Phase II|Disease progression|0
5568057|NCT01125800|19242381|P1|Phase II|Disease progression|0
5568058|NCT01125800|19242377|P5|Phase II|Adverse Event|2
5568059|NCT01125800|19242378|P4|Phase II|Adverse Event|0
5568060|NCT01125800|19242379|P3|Phase II|Adverse Event|0
5568061|NCT01125800|19242380|P2|Phase II|Adverse Event|0
5568062|NCT01125800|19242381|P1|Phase II|Adverse Event|0
5568063|NCT01125800|19242377|P5|Phase II|Protocol Violation|1
5568064|NCT01125800|19242378|P4|Phase II|Protocol Violation|0
5568065|NCT01125800|19242379|P3|Phase II|Protocol Violation|0
5568066|NCT01125800|19242380|P2|Phase II|Protocol Violation|0
5568067|NCT01125800|19242381|P1|Phase II|Protocol Violation|0
5568068|NCT01125800|19242377|P5|Phase I|Disease progression|0
5568069|NCT01125800|19242378|P4|Phase I|Disease progression|3
5568070|NCT01125800|19242379|P3|Phase I|Disease progression|1
5568071|NCT01125800|19242380|P2|Phase I|Disease progression|4
5568072|NCT01125800|19242381|P1|Phase I|Disease progression|5
5568073|NCT01125800|19242377|P5|Phase I|Withdrawal by Subject|0
5568074|NCT01125800|19242378|P4|Phase I|Withdrawal by Subject|0
5568075|NCT01125800|19242379|P3|Phase I|Withdrawal by Subject|1
5568076|NCT01125800|19242380|P2|Phase I|Withdrawal by Subject|0
5568077|NCT01125800|19242381|P1|Phase I|Withdrawal by Subject|0
5568078|NCT01125800|19242377|P5|Phase I|Administrative problems|0
5568079|NCT01125800|19242378|P4|Phase I|Administrative problems|0
5568080|NCT01125800|19242379|P3|Phase I|Administrative problems|0
5568081|NCT01125800|19242380|P2|Phase I|Administrative problems|0
5568082|NCT01125800|19242381|P1|Phase I|Administrative problems|1
5568083|NCT01125800|19242377|P5|Phase I|Adverse Event|0
5568084|NCT01125800|19242378|P4|Phase I|Adverse Event|7
5568085|NCT01125800|19242379|P3|Phase I|Adverse Event|1
5568086|NCT01125800|19242380|P2|Phase I|Adverse Event|2
5568087|NCT01125800|19242381|P1|Phase I|Adverse Event|2
5568088|NCT01125800|19242377|P5|Phase I|Protocol Violation|0
5568089|NCT01125800|19242378|P4|Phase I|Protocol Violation|1
5568090|NCT01125800|19242379|P3|Phase I|Protocol Violation|1
5568091|NCT01125800|19242380|P2|Phase I|Protocol Violation|3
5568092|NCT01125800|19242381|P1|Phase I|Protocol Violation|0
5568093|NCT01125748|19242447|P2|Overall Study|Patient Decision to Withdraw|4
5568094|NCT01125748|19242448|P1|Overall Study|Patient Decision to Withdraw|2
5568095|NCT01125748|19242447|P2|Overall Study|Physician Decision|7
5568096|NCT01125748|19242448|P1|Overall Study|Physician Decision|8
5568097|NCT01125748|19242447|P2|Overall Study|Lost to Follow-up|1
5568098|NCT01125748|19242448|P1|Overall Study|Lost to Follow-up|0
5568099|NCT01125748|19242447|P2|Overall Study|Adverse Event|2
5568100|NCT01125748|19242448|P1|Overall Study|Adverse Event|0
5568101|NCT01125722|19242458|P2|Overall Study|Lost to Follow-up|0
5568102|NCT01125722|19242459|P1|Overall Study|Lost to Follow-up|1
5568103|NCT01125722|19242458|P2|Overall Study|Withdrawal by Subject|1
5568104|NCT01125722|19242459|P1|Overall Study|Withdrawal by Subject|2
5568105|NCT01125566|19242506|P3|Patients Who Switched From AV to TV|Other than listed above|4
5568106|NCT01125566|19242507|P2|Patients Who Switched From AV to TV|Other than listed above|0
5568107|NCT01125566|19242508|P1|Patients Who Switched From AV to TV|Other than listed above|0
5568108|NCT01125566|19242506|P3|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
5568109|NCT01125566|19242507|P2|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
5568110|NCT01125566|19242508|P1|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
5568111|NCT01125566|19242506|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|7
5568112|NCT01125566|19242507|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
5568113|NCT01125566|19242508|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
5568114|NCT01125566|19242506|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
5568115|NCT01125566|19242507|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
5568116|NCT01125566|19242508|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
5568117|NCT01125566|19242506|P3|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
5568118|NCT01125566|19242507|P2|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
5568119|NCT01125566|19242508|P1|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
5568120|NCT01125566|19242506|P3|Patients Before the Switch (26Apr2013)|Other than listed above|0
5568121|NCT01125566|19242507|P2|Patients Before the Switch (26Apr2013)|Other than listed above|13
5568122|NCT01125566|19242508|P1|Patients Before the Switch (26Apr2013)|Other than listed above|25
5568123|NCT01125566|19242506|P3|Patients Before the Switch (26Apr2013)|Not treated|0
5568124|NCT01125566|19242507|P2|Patients Before the Switch (26Apr2013)|Not treated|0
5568125|NCT01125566|19242508|P1|Patients Before the Switch (26Apr2013)|Not treated|2
5568126|NCT01125566|19242506|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
5568127|NCT01125566|19242507|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
5568128|NCT01125566|19242508|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
5568129|NCT01125566|19242506|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
5568130|NCT01125566|19242507|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|2
5568131|NCT01125566|19242508|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
5568132|NCT01125566|19242506|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
5568133|NCT01125566|19242507|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
5568134|NCT01125566|19242508|P1|Patients Before the Switch (26Apr2013)|Adverse Event|25
5568135|NCT01125566|19242506|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
5568136|NCT01125566|19242507|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
5568137|NCT01125566|19242508|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
5568138|NCT01125566|19242506|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
5568139|NCT01125566|19242507|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
5568140|NCT01125566|19242508|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
5568141|NCT01125514|19242521|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
5568142|NCT01125514|19242521|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
5568143|NCT01125514|19242521|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
5568144|NCT01125514|19242521|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
5568145|NCT01125514|19242521|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
5568146|NCT01125514|19242521|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
5568147|NCT01125189|19242621|P3|Follow up Period|Other reasons|5
5568148|NCT01125189|19242622|P2|Follow up Period|Other reasons|4
5568149|NCT01125189|19242623|P1|Follow up Period|Other reasons|4
5568150|NCT01125189|19242621|P3|Follow up Period|Lost to Follow-up|6
5568151|NCT01125189|19242622|P2|Follow up Period|Lost to Follow-up|9
5568152|NCT01125189|19242623|P1|Follow up Period|Lost to Follow-up|12
5568153|NCT01125189|19242621|P3|Follow up Period|Death|0
5568154|NCT01125189|19242622|P2|Follow up Period|Death|0
5568155|NCT01125189|19242623|P1|Follow up Period|Death|1
5568156|NCT01125189|19242621|P3|Follow up Period|Withdrawal by Subject|5
5568157|NCT01125189|19242622|P2|Follow up Period|Withdrawal by Subject|2
5568158|NCT01125189|19242623|P1|Follow up Period|Withdrawal by Subject|3
5568159|NCT01125189|19242621|P3|Treatment Period|Completed 24 week treatment period only|2
5568160|NCT01125189|19242622|P2|Treatment Period|Completed 24 week treatment period only|1
5568161|NCT01125189|19242623|P1|Treatment Period|Completed 24 week treatment period only|2
5568162|NCT01125189|19242621|P3|Treatment Period|Other reasons|0
5568163|NCT01125189|19242622|P2|Treatment Period|Other reasons|1
5568164|NCT01125189|19242623|P1|Treatment Period|Other reasons|1
5568165|NCT01125189|19242621|P3|Treatment Period|Participants requested to discontinue|4
5568166|NCT01125189|19242622|P2|Treatment Period|Participants requested to discontinue|3
5568167|NCT01125189|19242623|P1|Treatment Period|Participants requested to discontinue|1
5568168|NCT01125189|19242621|P3|Treatment Period|Poor compliance/noncompliance|0
5568169|NCT01125189|19242622|P2|Treatment Period|Poor compliance/noncompliance|1
5568170|NCT01125189|19242623|P1|Treatment Period|Poor compliance/noncompliance|0
5568171|NCT01125189|19242621|P3|Treatment Period|Lost to Follow-up|1
5568172|NCT01125189|19242622|P2|Treatment Period|Lost to Follow-up|2
5568173|NCT01125189|19242623|P1|Treatment Period|Lost to Follow-up|1
5568174|NCT01125189|19242621|P3|Treatment Period|Death|0
5568175|NCT01125189|19242622|P2|Treatment Period|Death|0
5568176|NCT01125189|19242623|P1|Treatment Period|Death|1
5568177|NCT01125189|19242621|P3|Treatment Period|Withdrawal by Subject|1
5568178|NCT01125189|19242622|P2|Treatment Period|Withdrawal by Subject|1
5568179|NCT01125189|19242623|P1|Treatment Period|Withdrawal by Subject|3
5568180|NCT01125189|19242621|P3|Treatment Period|Adverse Event|8
5568181|NCT01125189|19242622|P2|Treatment Period|Adverse Event|8
5568182|NCT01125189|19242623|P1|Treatment Period|Adverse Event|7
5568183|NCT01125189|19242621|P3|Treatment Period|Lack of Efficacy|25
5568184|NCT01125189|19242622|P2|Treatment Period|Lack of Efficacy|18
5568185|NCT01125189|19242623|P1|Treatment Period|Lack of Efficacy|15
5568186|NCT01124916|19242692|P2|Overall Study|Lost to Follow-up|2
5568187|NCT01124916|19242693|P1|Overall Study|Lost to Follow-up|3
5568188|NCT01124864|19242707|P6|Overall Study|Protocol Violation|0
5568189|NCT01124864|19242708|P5|Overall Study|Protocol Violation|1
5568190|NCT01124864|19242709|P4|Overall Study|Protocol Violation|0
5568191|NCT01124864|19242710|P3|Overall Study|Protocol Violation|0
5568192|NCT01124864|19242711|P2|Overall Study|Protocol Violation|0
5568193|NCT01124864|19242712|P1|Overall Study|Protocol Violation|1
5568194|NCT01124864|19242707|P6|Overall Study|Lost to Follow-up|0
5568195|NCT01124864|19242708|P5|Overall Study|Lost to Follow-up|0
5568196|NCT01124864|19242709|P4|Overall Study|Lost to Follow-up|1
5568197|NCT01124864|19242710|P3|Overall Study|Lost to Follow-up|0
5568198|NCT01124864|19242711|P2|Overall Study|Lost to Follow-up|1
5568199|NCT01124864|19242712|P1|Overall Study|Lost to Follow-up|1
5568200|NCT01124864|19242707|P6|Overall Study|Withdrawal by Subject|1
5568201|NCT01124864|19242708|P5|Overall Study|Withdrawal by Subject|2
5568202|NCT01124864|19242709|P4|Overall Study|Withdrawal by Subject|0
5568203|NCT01124864|19242710|P3|Overall Study|Withdrawal by Subject|4
5568204|NCT01124864|19242711|P2|Overall Study|Withdrawal by Subject|3
5568205|NCT01124864|19242712|P1|Overall Study|Withdrawal by Subject|2
5568206|NCT01124864|19242707|P6|Overall Study|Death|0
5568207|NCT01124864|19242708|P5|Overall Study|Death|1
5568208|NCT01124864|19242709|P4|Overall Study|Death|2
5568209|NCT01124864|19242710|P3|Overall Study|Death|6
5568210|NCT01124864|19242711|P2|Overall Study|Death|9
5568211|NCT01124864|19242712|P1|Overall Study|Death|6
5568212|NCT01124864|19242707|P6|Overall Study|Follow up phase competed as per protocol|2
5568213|NCT01124864|19242708|P5|Overall Study|Follow up phase competed as per protocol|26
5568214|NCT01124864|19242709|P4|Overall Study|Follow up phase competed as per protocol|18
5568215|NCT01124864|19242710|P3|Overall Study|Follow up phase competed as per protocol|24
5568216|NCT01124864|19242711|P2|Overall Study|Follow up phase competed as per protocol|22
5568217|NCT01124864|19242712|P1|Overall Study|Follow up phase competed as per protocol|18
5568218|NCT01124838|19242746|P2|Overall Study|Lost to Follow-up|0
5568219|NCT01124838|19242747|P1|Overall Study|Lost to Follow-up|2
5568220|NCT01124838|19242746|P2|Overall Study|Withdrawal by Subject|2
5568221|NCT01124838|19242747|P1|Overall Study|Withdrawal by Subject|3
5568222|NCT01124838|19242746|P2|Overall Study|Lack of Efficacy|0
5568223|NCT01124838|19242747|P1|Overall Study|Lack of Efficacy|2
5568224|NCT01124838|19242746|P2|Overall Study|Adverse Event|11
5568225|NCT01124838|19242747|P1|Overall Study|Adverse Event|7
5568226|NCT01124838|19242746|P2|Overall Study|Miscellaneous|2
5568227|NCT01124838|19242747|P1|Overall Study|Miscellaneous|4
5568228|NCT01124734|19242814|P1|Overall Study|Elected for alternative treatment|2
5568229|NCT01124734|19242814|P1|Overall Study|Withdrawal by Subject|1
5568230|NCT01124734|19242814|P1|Overall Study|Adverse Event|1
5568231|NCT01124734|19242814|P1|Overall Study|Disease progression|13
5568232|NCT01124643|19242825|P1|Overall Study|Death|1
5568233|NCT01124617|19242839|P2|Overall Study|Other|1
5568234|NCT01124617|19242840|P1|Overall Study|Other|2
5568235|NCT01124617|19242839|P2|Overall Study|Withdrawal by Subject|1
5568236|NCT01124617|19242840|P1|Overall Study|Withdrawal by Subject|9
5568237|NCT01124617|19242839|P2|Overall Study|Protocol Violation|1
5568238|NCT01124617|19242840|P1|Overall Study|Protocol Violation|1
5568239|NCT01124617|19242839|P2|Overall Study|Lack of Efficacy|1
5568240|NCT01124617|19242840|P1|Overall Study|Lack of Efficacy|2
5568241|NCT01124617|19242839|P2|Overall Study|Adverse Event|2
5568242|NCT01124617|19242840|P1|Overall Study|Adverse Event|5
5568243|NCT01124604|19242872|P2|Overall Study|Disease Progression|1
5568244|NCT01124604|19242873|P1|Overall Study|Disease Progression|0
5568245|NCT01124604|19242872|P2|Overall Study|Withdrawal by Subject|0
5568246|NCT01124604|19242873|P1|Overall Study|Withdrawal by Subject|4
5568247|NCT01124604|19242872|P2|Overall Study|Lack of Efficacy|0
5568248|NCT01124604|19242873|P1|Overall Study|Lack of Efficacy|1
5568249|NCT01124604|19242872|P2|Overall Study|Adverse Event|1
5568250|NCT01124604|19242873|P1|Overall Study|Adverse Event|10
5568251|NCT01124448|19242912|P2|Overall Study|Protocol Violation|0
5568252|NCT01124448|19242913|P1|Overall Study|Protocol Violation|2
5568253|NCT01124448|19242912|P2|Overall Study|Lost to Follow-up|3
5568254|NCT01124448|19242913|P1|Overall Study|Lost to Follow-up|0
5568255|NCT01124422|19242921|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
5568256|NCT01124422|19242922|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
5568257|NCT01124422|19242923|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
5568258|NCT01124422|19242921|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
5568259|NCT01124422|19242922|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
5568260|NCT01124422|19242923|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
5568261|NCT01124422|19242921|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
5568262|NCT01124422|19242922|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
5568263|NCT01124422|19242923|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
5568264|NCT01124422|19242921|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
5568265|NCT01124422|19242922|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
5568266|NCT01124422|19242923|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
5568267|NCT01124422|19242921|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
5568268|NCT01124422|19242922|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
5568269|NCT01124422|19242923|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
5568270|NCT01124422|19242921|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
5568271|NCT01124422|19242922|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
5568272|NCT01124422|19242923|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
5568273|NCT01124422|19242921|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
5568274|NCT01124422|19242922|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
5568275|NCT01124422|19242923|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
5568276|NCT01124422|19242921|P3|4-Week Open-label Run-in Phase|Physician Decision|0
5568277|NCT01124422|19242922|P2|4-Week Open-label Run-in Phase|Physician Decision|0
5568278|NCT01124422|19242923|P1|4-Week Open-label Run-in Phase|Physician Decision|4
5568279|NCT01124422|19242921|P3|4-Week Open-label Run-in Phase|Adverse Event|0
5568280|NCT01124422|19242922|P2|4-Week Open-label Run-in Phase|Adverse Event|0
5568281|NCT01124422|19242923|P1|4-Week Open-label Run-in Phase|Adverse Event|7
5568282|NCT01124422|19242921|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
5568283|NCT01124422|19242922|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
5568284|NCT01124422|19242923|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
5568285|NCT01124292|19242993|P3|Overall Study|piercing track closed|1
5568286|NCT01124292|19242994|P2|Overall Study|piercing track closed|2
5568287|NCT01124292|19242995|P1|Overall Study|piercing track closed|0
5568288|NCT01124292|19242993|P3|Overall Study|medical issue unrelated to the study|2
5568289|NCT01124292|19242994|P2|Overall Study|medical issue unrelated to the study|0
5568290|NCT01124292|19242995|P1|Overall Study|medical issue unrelated to the study|0
5568291|NCT01124292|19242993|P3|Overall Study|Withdrawal by Subject|2
5568292|NCT01124292|19242994|P2|Overall Study|Withdrawal by Subject|6
5568293|NCT01124292|19242995|P1|Overall Study|Withdrawal by Subject|0
5568294|NCT01124292|19242993|P3|Overall Study|Physician Decision|2
5568295|NCT01124292|19242994|P2|Overall Study|Physician Decision|3
5568296|NCT01124292|19242995|P1|Overall Study|Physician Decision|0
5568297|NCT01124292|19242993|P3|Overall Study|Lost to Follow-up|3
5568298|NCT01124292|19242994|P2|Overall Study|Lost to Follow-up|4
5568299|NCT01124292|19242995|P1|Overall Study|Lost to Follow-up|2
5568300|NCT01124175|19243066|P2|Washout of 7 Days|Withdrawal by Subject|2
5568301|NCT01124175|19243067|P1|Washout of 7 Days|Withdrawal by Subject|0
5568302|NCT01124162|19243085|P2|Washout of 7 Days|Withdrawal by Subject|0
5568303|NCT01124162|19243086|P1|Washout of 7 Days|Withdrawal by Subject|1
5568304|NCT01124162|19243085|P2|First Intervention|Adverse Event|0
5568305|NCT01124162|19243086|P1|First Intervention|Adverse Event|2
5568306|NCT01124149|19243102|P1|Maintenance Phase|Non-compliance|1
5568307|NCT01124149|19243102|P1|Maintenance Phase|Coordinator error|1
5568308|NCT01124149|19243102|P1|Maintenance Phase|Protocol Violation|5
5568309|NCT01124149|19243102|P1|Maintenance Phase|Withdrawal by Subject|10
5568310|NCT01124149|19243102|P1|Maintenance Phase|Lost to Follow-up|15
5568311|NCT01124149|19243102|P1|Maintenance Phase|Adverse Event|24
5568312|NCT01124149|19243102|P1|Maintenance Phase|Lack of Efficacy|40
5568313|NCT01124149|19243102|P1|Acute Phase|Sponsor decision|1
5568314|NCT01124149|19243102|P1|Acute Phase|Travelling to another country|1
5568315|NCT01124149|19243102|P1|Acute Phase|Low hemoglobin|1
5568316|NCT01124149|19243102|P1|Acute Phase|Non-compliance|1
5568317|NCT01124149|19243102|P1|Acute Phase|UC symptoms not ameliorated|1
5568318|NCT01124149|19243102|P1|Acute Phase|Sponsor request|1
5568319|NCT01124149|19243102|P1|Acute Phase|Prolonged antibiotic therapy|1
5568320|NCT01124149|19243102|P1|Acute Phase|Lost to Follow-up|2
5568321|NCT01124149|19243102|P1|Acute Phase|Protocol Violation|14
5568322|NCT01124149|19243102|P1|Acute Phase|Lack of Efficacy|17
5568323|NCT01124149|19243102|P1|Acute Phase|Adverse Event|21
5568324|NCT01124149|19243102|P1|Acute Phase|Withdrawal by Subject|22
5568325|NCT01124097|19243122|P4|Overall Study|Physician Decision|0
5568326|NCT01124097|19243123|P3|Overall Study|Physician Decision|0
5568327|NCT01124097|19243124|P2|Overall Study|Physician Decision|1
5568328|NCT01124097|19243125|P1|Overall Study|Physician Decision|2
5568329|NCT01124097|19243122|P4|Overall Study|Protocol Violation|1
5568330|NCT01124097|19243123|P3|Overall Study|Protocol Violation|2
5568331|NCT01124097|19243124|P2|Overall Study|Protocol Violation|0
5568332|NCT01124097|19243125|P1|Overall Study|Protocol Violation|2
5568333|NCT01124097|19243122|P4|Overall Study|Adverse Event|7
5568334|NCT01124097|19243123|P3|Overall Study|Adverse Event|15
5568335|NCT01124097|19243124|P2|Overall Study|Adverse Event|15
5568336|NCT01124097|19243125|P1|Overall Study|Adverse Event|24
5568337|NCT01124097|19243122|P4|Overall Study|Lack of Efficacy|3
5568338|NCT01124097|19243123|P3|Overall Study|Lack of Efficacy|1
5568339|NCT01124097|19243124|P2|Overall Study|Lack of Efficacy|3
5568340|NCT01124097|19243125|P1|Overall Study|Lack of Efficacy|2
5568341|NCT01124097|19243122|P4|Overall Study|Withdrawal by Subject|3
5568342|NCT01124097|19243123|P3|Overall Study|Withdrawal by Subject|2
5568343|NCT01124097|19243124|P2|Overall Study|Withdrawal by Subject|3
5568344|NCT01124097|19243125|P1|Overall Study|Withdrawal by Subject|4
5568345|NCT01124045|19243137|P2|Overall Study|Physician Decision|2
5568346|NCT01124045|19243138|P1|Overall Study|Physician Decision|0
5568347|NCT01124045|19243137|P2|Overall Study|Lost to Follow-up|1
5568348|NCT01124045|19243138|P1|Overall Study|Lost to Follow-up|0
5568349|NCT01124006|19243171|P3|Overall Study|Other|1
5568350|NCT01124006|19243172|P2|Overall Study|Other|0
5568351|NCT01124006|19243173|P1|Overall Study|Other|0
5568352|NCT01124006|19243171|P3|Overall Study|Lost to Follow-up|1
5568353|NCT01124006|19243172|P2|Overall Study|Lost to Follow-up|0
5568354|NCT01124006|19243173|P1|Overall Study|Lost to Follow-up|1
5568355|NCT01124006|19243171|P3|Overall Study|Withdrawal by Subject|0
5568356|NCT01124006|19243172|P2|Overall Study|Withdrawal by Subject|2
5568357|NCT01124006|19243173|P1|Overall Study|Withdrawal by Subject|2
5568358|NCT01123980|19243201|P2|Overall Study|Unclassified|7
5568359|NCT01123980|19243202|P1|Overall Study|Unclassified|6
5568360|NCT01123980|19243201|P2|Overall Study|Withdrawal by Subject|3
5568361|NCT01123980|19243202|P1|Overall Study|Withdrawal by Subject|5
5568362|NCT01123980|19243201|P2|Overall Study|Protocol Violation|6
5568363|NCT01123980|19243202|P1|Overall Study|Protocol Violation|6
5568364|NCT01123980|19243201|P2|Overall Study|Lost to Follow-up|6
5568365|NCT01123980|19243202|P1|Overall Study|Lost to Follow-up|0
5568366|NCT01123980|19243201|P2|Overall Study|Physician Decision|1
5568367|NCT01123980|19243202|P1|Overall Study|Physician Decision|0
5568368|NCT01123980|19243201|P2|Overall Study|Lack of Efficacy|0
5568369|NCT01123980|19243202|P1|Overall Study|Lack of Efficacy|1
5568370|NCT01123980|19243201|P2|Overall Study|Adverse Event|1
5568371|NCT01123980|19243202|P1|Overall Study|Adverse Event|1
5568372|NCT01123941|19243222|P2|Overall Study|Lost to Follow-up|1
5568373|NCT01123941|19243223|P1|Overall Study|Lost to Follow-up|2
5568374|NCT01123889|19243258|P2|Overall Study|Lost to Follow-up|1
5568375|NCT01123889|19243259|P1|Overall Study|Lost to Follow-up|3
5568376|NCT01123850|19243269|P1|Overall Study|Slow enrollment|45
5568377|NCT01123655|19243276|P3|Overall Study|began prohibitive drug|1
5568378|NCT01123655|19243277|P2|Overall Study|began prohibitive drug|0
5568379|NCT01123655|19243278|P1|Overall Study|began prohibitive drug|0
5568380|NCT01123655|19243276|P3|Overall Study|new illness|0
5568381|NCT01123655|19243277|P2|Overall Study|new illness|1
5568382|NCT01123655|19243278|P1|Overall Study|new illness|0
5568383|NCT01123655|19243276|P3|Overall Study|Medication for RA had to be changed|0
5568384|NCT01123655|19243277|P2|Overall Study|Medication for RA had to be changed|0
5568385|NCT01123655|19243278|P1|Overall Study|Medication for RA had to be changed|1
5568386|NCT01123642|19243350|P1|Overall Study|ineligible at baseline assessment|36
5568387|NCT01123642|19243350|P1|Overall Study|Withdrawal by Subject|9
5568388|NCT01123642|19243350|P1|Overall Study|Lost to Follow-up|23
5568389|NCT01123395|19243366|P2|Washout Period of 14 Days|Withdrawal by Subject|1
5568390|NCT01123395|19243367|P1|Washout Period of 14 Days|Withdrawal by Subject|0
5568391|NCT01123382|19243379|P2|Overall Study|Lost to Follow-up|2
5568392|NCT01123382|19243380|P1|Overall Study|Lost to Follow-up|1
5568393|NCT01123382|19243379|P2|Overall Study|Withdrawal by Subject|4
5568394|NCT01123382|19243380|P1|Overall Study|Withdrawal by Subject|1
5568395|NCT01123356|19243402|P1|Overall Study|Withdrawal by Subject|1
5568396|NCT01123356|19243402|P1|Overall Study|Lack of Efficacy|4
5568397|NCT01123356|19243402|P1|Overall Study|Adverse Event|2
5568398|NCT01123200|19243410|P1|Overall Study|Withdrawal by Subject|1
5568399|NCT01123161|19243417|P2|Overall Study|Withdrawal by Subject|0
5568400|NCT01123161|19243418|P1|Overall Study|Withdrawal by Subject|1
5568401|NCT01123161|19243417|P2|Overall Study|Lost to Follow-up|0
5568402|NCT01123161|19243418|P1|Overall Study|Lost to Follow-up|1
5568403|NCT01123148|19243436|P1|Overall Study|Didn't meet milestone criteria|1
5568404|NCT01123148|19243436|P1|Overall Study|Coughing caused unacceptable EEG quality|1
5568405|NCT01123083|19243442|P2|Overall Study|Participant/legal representative request|3
5568406|NCT01123083|19243443|P1|Overall Study|Participant/legal representative request|7
5568407|NCT01123083|19243442|P2|Overall Study|Withdrew for another reason not covered|1
5568408|NCT01123083|19243443|P1|Overall Study|Withdrew for another reason not covered|0
5568409|NCT01123083|19243442|P2|Overall Study|Adverse Event|0
5568410|NCT01123083|19243443|P1|Overall Study|Adverse Event|1
5568411|NCT01123083|19243442|P2|Overall Study|Lost to Follow-up|6
5568412|NCT01123083|19243443|P1|Overall Study|Lost to Follow-up|2
5568413|NCT01123083|19243442|P2|Overall Study|Administrative reasons|4
5568414|NCT01123083|19243443|P1|Overall Study|Administrative reasons|0
5568415|NCT01123083|19243442|P2|Overall Study|Investigator recommendation|1
5568416|NCT01123083|19243443|P1|Overall Study|Investigator recommendation|1
5568417|NCT01122927|19243467|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
5568418|NCT01122927|19243468|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
5568419|NCT01122927|19243467|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
5568420|NCT01122927|19243468|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
5568421|NCT01122927|19243467|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
5568422|NCT01122927|19243468|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
5568423|NCT01122927|19243467|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
5568424|NCT01122927|19243468|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
5568425|NCT01122927|19243467|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
5568426|NCT01122927|19243468|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
5568427|NCT01122927|19243467|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
5568428|NCT01122927|19243468|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
5568429|NCT01122927|19243467|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
5568430|NCT01122927|19243468|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
5568431|NCT01122927|19243467|P2|Period 1 - Conversion Phase|Protocol Deviation|0
5568432|NCT01122927|19243468|P1|Period 1 - Conversion Phase|Protocol Deviation|1
5568433|NCT01122927|19243467|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
5568434|NCT01122927|19243468|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
5568435|NCT01122927|19243467|P2|Period 1 - Conversion Phase|Physician Decision|0
5568436|NCT01122927|19243468|P1|Period 1 - Conversion Phase|Physician Decision|2
5568437|NCT01122927|19243467|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
5568438|NCT01122927|19243468|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
5568439|NCT01122927|19243467|P2|Period 1 - Conversion Phase|Adverse Event|0
5568440|NCT01122927|19243468|P1|Period 1 - Conversion Phase|Adverse Event|3
5568441|NCT01122862|19243520|P3|Period 2|Adverse Event|1
5568442|NCT01122862|19243521|P2|Period 2|Adverse Event|0
5568443|NCT01122862|19243522|P1|Period 2|Adverse Event|0
5568444|NCT01122862|19243520|P3|Period 1|Protocol Violation|0
5568445|NCT01122862|19243521|P2|Period 1|Protocol Violation|1
5568446|NCT01122862|19243522|P1|Period 1|Protocol Violation|0
5568447|NCT01122680|19243628|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
5568448|NCT01122680|19243629|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
5568449|NCT01122680|19243630|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
5568450|NCT01122680|19243631|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
5568451|NCT01122680|19243628|P4|Period 3 (4 Weeks)|Adverse Event|0
5568452|NCT01122680|19243629|P3|Period 3 (4 Weeks)|Adverse Event|0
5568453|NCT01122680|19243630|P2|Period 3 (4 Weeks)|Adverse Event|0
5568454|NCT01122680|19243631|P1|Period 3 (4 Weeks)|Adverse Event|1
5568455|NCT01122680|19243628|P4|Period 2 (4 Weeks)|Other|0
5568456|NCT01122680|19243629|P3|Period 2 (4 Weeks)|Other|0
5568457|NCT01122680|19243630|P2|Period 2 (4 Weeks)|Other|0
5568458|NCT01122680|19243631|P1|Period 2 (4 Weeks)|Other|1
5568459|NCT01122680|19243628|P4|Period 2 (4 Weeks)|Protocol Violation|1
5568460|NCT01122680|19243629|P3|Period 2 (4 Weeks)|Protocol Violation|0
5568461|NCT01122680|19243630|P2|Period 2 (4 Weeks)|Protocol Violation|0
5568462|NCT01122680|19243631|P1|Period 2 (4 Weeks)|Protocol Violation|0
5568463|NCT01122680|19243628|P4|Period 1 (4 Weeks)|Other|0
5568464|NCT01122680|19243629|P3|Period 1 (4 Weeks)|Other|0
5568465|NCT01122680|19243630|P2|Period 1 (4 Weeks)|Other|1
5568466|NCT01122680|19243631|P1|Period 1 (4 Weeks)|Other|1
5568467|NCT01122680|19243628|P4|Period 1 (4 Weeks)|Protocol Violation|0
5568468|NCT01122680|19243629|P3|Period 1 (4 Weeks)|Protocol Violation|0
5568469|NCT01122680|19243630|P2|Period 1 (4 Weeks)|Protocol Violation|0
5568470|NCT01122680|19243631|P1|Period 1 (4 Weeks)|Protocol Violation|1
5568471|NCT01122680|19243628|P4|Period 1 (4 Weeks)|Adverse Event|0
5568472|NCT01122680|19243629|P3|Period 1 (4 Weeks)|Adverse Event|0
5568473|NCT01122680|19243630|P2|Period 1 (4 Weeks)|Adverse Event|0
5568474|NCT01122680|19243631|P1|Period 1 (4 Weeks)|Adverse Event|1
5568475|NCT01122576|19243696|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
5568476|NCT01122576|19243697|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
5568477|NCT01122576|19243698|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
5568478|NCT01122576|19243696|P3|Post-Cataract Surgery|Central Macular Edema|1
5568479|NCT01122576|19243697|P2|Post-Cataract Surgery|Central Macular Edema|0
5568480|NCT01122576|19243698|P1|Post-Cataract Surgery|Central Macular Edema|0
5568481|NCT01122576|19243696|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
5568482|NCT01122576|19243697|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
5568483|NCT01122576|19243698|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
5568484|NCT01122394|19243879|P2|Overall Study|Adverse Event|1
5568485|NCT01122394|19243880|P1|Overall Study|Adverse Event|0
5568486|NCT01122394|19243879|P2|Overall Study|Lost to Follow-up|2
5568487|NCT01122394|19243880|P1|Overall Study|Lost to Follow-up|2
5568488|NCT01122394|19243879|P2|Overall Study|Withdrawal by Subject|1
5568489|NCT01122394|19243880|P1|Overall Study|Withdrawal by Subject|1
5568490|NCT01122381|19243896|P2|Overall Study|study terminated early|1
5568491|NCT01122381|19243897|P1|Overall Study|study terminated early|0
5568492|NCT01122264|19243913|P3|Overall Study|Lack of Efficacy|1
5568493|NCT01122264|19243914|P2|Overall Study|Lack of Efficacy|1
5568494|NCT01122264|19243915|P1|Overall Study|Lack of Efficacy|3
5568495|NCT01122264|19243913|P3|Overall Study|Physician Decision|1
5568496|NCT01122264|19243914|P2|Overall Study|Physician Decision|1
5568497|NCT01122264|19243915|P1|Overall Study|Physician Decision|3
5568498|NCT01122264|19243913|P3|Overall Study|Withdrawal by Subject|16
5568499|NCT01122264|19243914|P2|Overall Study|Withdrawal by Subject|6
5568500|NCT01122264|19243915|P1|Overall Study|Withdrawal by Subject|6
5568501|NCT01122264|19243913|P3|Overall Study|Protocol Violation|9
5568502|NCT01122264|19243914|P2|Overall Study|Protocol Violation|7
5568503|NCT01122264|19243915|P1|Overall Study|Protocol Violation|7
5568504|NCT01122264|19243913|P3|Overall Study|Entry Criteria Not Met|0
5568505|NCT01122264|19243914|P2|Overall Study|Entry Criteria Not Met|0
5568506|NCT01122264|19243915|P1|Overall Study|Entry Criteria Not Met|1
5568507|NCT01122264|19243913|P3|Overall Study|Lost to Follow-up|13
5568508|NCT01122264|19243914|P2|Overall Study|Lost to Follow-up|9
5568509|NCT01122264|19243915|P1|Overall Study|Lost to Follow-up|5
5568510|NCT01122264|19243913|P3|Overall Study|Death|0
5568511|NCT01122264|19243914|P2|Overall Study|Death|0
5568512|NCT01122264|19243915|P1|Overall Study|Death|1
5568513|NCT01122264|19243913|P3|Overall Study|Adverse Event|7
5568514|NCT01122264|19243914|P2|Overall Study|Adverse Event|5
5568515|NCT01122264|19243915|P1|Overall Study|Adverse Event|6
5568516|NCT01122173|19244025|P1|Overall Study|Left study for other reasons|3
5568517|NCT01122173|19244025|P1|Overall Study|Withdrawal by Subject|3
5568518|NCT01122173|19244025|P1|Overall Study|Lost to Follow-up|3
5568519|NCT01121991|19244248|P1|Overall Study|No Fertilization|1
5568520|NCT01121991|19244248|P1|Overall Study|No Oocytes Retrieved|3
5568521|NCT01121991|19244248|P1|Overall Study|Lack of Ovarian Response|2
5568522|NCT01121926|19244273|P2|Washout Period|Positive pregnancy test|1
5568523|NCT01121926|19244274|P1|Washout Period|Positive pregnancy test|0
5568524|NCT01121926|19244273|P2|Washout Period|Adverse Event|1
5568525|NCT01121926|19244274|P1|Washout Period|Adverse Event|0
5568526|NCT01121926|19244273|P2|First Intervention Period|Adverse Event|0
5568527|NCT01121926|19244274|P1|First Intervention Period|Adverse Event|1
5568528|NCT01121913|19244292|P4|Third Washout Period|Adverse Event|0
5568529|NCT01121913|19244293|P3|Third Washout Period|Adverse Event|0
5568530|NCT01121913|19244294|P2|Third Washout Period|Adverse Event|0
5568531|NCT01121913|19244295|P1|Third Washout Period|Adverse Event|1
5568532|NCT01121913|19244292|P4|Second Washout Period|Withdrawal by Subject|0
5568533|NCT01121913|19244293|P3|Second Washout Period|Withdrawal by Subject|1
5568534|NCT01121913|19244294|P2|Second Washout Period|Withdrawal by Subject|0
5568535|NCT01121913|19244295|P1|Second Washout Period|Withdrawal by Subject|0
5568536|NCT01121913|19244292|P4|Second Intervention Period|Adverse Event|0
5568537|NCT01121913|19244293|P3|Second Intervention Period|Adverse Event|1
5568538|NCT01121913|19244294|P2|Second Intervention Period|Adverse Event|0
5568539|NCT01121913|19244295|P1|Second Intervention Period|Adverse Event|0
5568540|NCT01121913|19244292|P4|First Washout Period|Withdrawal by Subject|0
5568541|NCT01121913|19244293|P3|First Washout Period|Withdrawal by Subject|0
5568542|NCT01121913|19244294|P2|First Washout Period|Withdrawal by Subject|0
5568543|NCT01121913|19244295|P1|First Washout Period|Withdrawal by Subject|1
5568544|NCT01121913|19244292|P4|First Intervention Period|Adverse Event|0
5568545|NCT01121913|19244293|P3|First Intervention Period|Adverse Event|1
5568546|NCT01121913|19244294|P2|First Intervention Period|Adverse Event|0
5568547|NCT01121913|19244295|P1|First Intervention Period|Adverse Event|0
5568548|NCT01121900|19244325|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5568549|NCT01121900|19244326|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5568550|NCT01121900|19244325|P2|First Intervention Period|Adverse Event|1
5568551|NCT01121900|19244326|P1|First Intervention Period|Adverse Event|1
5568552|NCT01121757|19244346|P2|Combination|Disease Progression|0
5568553|NCT01121757|19244347|P1|Combination|Disease Progression|2
5568554|NCT01121757|19244346|P2|Combination|Physician Decision|1
5568555|NCT01121757|19244347|P1|Combination|Physician Decision|0
5568556|NCT01121757|19244346|P2|First Drug|Disease Progression|2
5568557|NCT01121757|19244347|P1|First Drug|Disease Progression|0
5568558|NCT01121757|19244346|P2|First Drug|Death|0
5568559|NCT01121757|19244347|P1|First Drug|Death|1
5568560|NCT01121666|19244363|P2|Overall Study|Protocol Violation|10
5568561|NCT01121666|19244364|P1|Overall Study|Protocol Violation|29
5568562|NCT01121575|19244420|P6|Overall Study|Death|1
5568563|NCT01121575|19244421|P5|Overall Study|Death|7
5568564|NCT01121575|19244422|P4|Overall Study|Death|1
5568565|NCT01121575|19244423|P3|Overall Study|Death|0
5568566|NCT01121575|19244424|P2|Overall Study|Death|0
5568567|NCT01121575|19244425|P1|Overall Study|Death|6
5568568|NCT01121575|19244420|P6|Overall Study|Unspecified Reasons|10
5568569|NCT01121575|19244421|P5|Overall Study|Unspecified Reasons|13
5568570|NCT01121575|19244422|P4|Overall Study|Unspecified Reasons|5
5568571|NCT01121575|19244423|P3|Overall Study|Unspecified Reasons|7
5568572|NCT01121575|19244424|P2|Overall Study|Unspecified Reasons|6
5568573|NCT01121575|19244425|P1|Overall Study|Unspecified Reasons|8
5568574|NCT01121575|19244420|P6|Overall Study|Participant Refused Further Follow-Up|1
5568575|NCT01121575|19244421|P5|Overall Study|Participant Refused Further Follow-Up|5
5568576|NCT01121575|19244422|P4|Overall Study|Participant Refused Further Follow-Up|0
5568577|NCT01121575|19244423|P3|Overall Study|Participant Refused Further Follow-Up|0
5568578|NCT01121575|19244424|P2|Overall Study|Participant Refused Further Follow-Up|0
5568579|NCT01121575|19244425|P1|Overall Study|Participant Refused Further Follow-Up|0
5568580|NCT01121562|19244549|P1|Overall Study|Met study discontinuation criteria|1
5568581|NCT01121562|19244549|P1|Overall Study|Sponsor Decision|1
5568582|NCT01121562|19244549|P1|Overall Study|Adverse Event|1
5568583|NCT01121562|19244549|P1|Overall Study|Withdrawal by Subject|1
5568584|NCT01121562|19244549|P1|Overall Study|Objective progression or relapse|8
5568585|NCT01121549|19244558|P1|Overall Study|Other|58
5568586|NCT01121549|19244558|P1|Overall Study|Withdrawal by Subject|16
5568587|NCT01121549|19244558|P1|Overall Study|Protocol Violation|33
5568588|NCT01121549|19244558|P1|Overall Study|Pregnancy|1
5568589|NCT01121549|19244558|P1|Overall Study|Study terminated by sponsor|197
5568590|NCT01121549|19244558|P1|Overall Study|Did not meet entrance criteria|9
5568591|NCT01121549|19244558|P1|Overall Study|Lost to Follow-up|12
5568592|NCT01121549|19244558|P1|Overall Study|Lack of Efficacy|11
5568593|NCT01121549|19244558|P1|Overall Study|Adverse Event|10
5568594|NCT01121536|19244569|P1|Overall Study|Other|118
5568595|NCT01121536|19244569|P1|Overall Study|Lost to Follow-up|39
5568596|NCT01121536|19244569|P1|Overall Study|Noncompliance with study procedures|9
5568597|NCT01121536|19244569|P1|Overall Study|Noncompliance with study medication|12
5568598|NCT01121536|19244569|P1|Overall Study|Protocol Violation|20
5568599|NCT01121536|19244569|P1|Overall Study|Withdrawal by Subject|65
5568600|NCT01121536|19244569|P1|Overall Study|Lack of Efficacy|35
5568601|NCT01121536|19244569|P1|Overall Study|Adverse Event|63
5568602|NCT01121484|19244590|P2|Overall Study|Randomized, not treated|4
5568603|NCT01121484|19244591|P1|Overall Study|Randomized, not treated|1
5568604|NCT01121484|19244590|P2|Overall Study|Other|3
5568605|NCT01121484|19244591|P1|Overall Study|Other|3
5568606|NCT01121484|19244590|P2|Overall Study|Discontinuation of study by sponsor|1
5568607|NCT01121484|19244591|P1|Overall Study|Discontinuation of study by sponsor|0
5568608|NCT01121484|19244590|P2|Overall Study|Withdrawal by Subject|7
5568609|NCT01121484|19244591|P1|Overall Study|Withdrawal by Subject|8
5568610|NCT01121484|19244590|P2|Overall Study|Protocol Violation|0
5568611|NCT01121484|19244591|P1|Overall Study|Protocol Violation|1
5568612|NCT01121484|19244590|P2|Overall Study|Physician Decision|3
5568613|NCT01121484|19244591|P1|Overall Study|Physician Decision|0
5568614|NCT01121484|19244590|P2|Overall Study|Lost to Follow-up|9
5568615|NCT01121484|19244591|P1|Overall Study|Lost to Follow-up|5
5568616|NCT01121484|19244590|P2|Overall Study|Lack of Efficacy|11
5568617|NCT01121484|19244591|P1|Overall Study|Lack of Efficacy|3
5568618|NCT01121484|19244590|P2|Overall Study|Adverse Event|5
5568619|NCT01121484|19244591|P1|Overall Study|Adverse Event|12
5568620|NCT01121406|19244609|P2|Overall Study|Not treated|0
5568621|NCT01121406|19244610|P1|Overall Study|Not treated|1
5568622|NCT01121406|19244609|P2|Overall Study|Reason other than specified above|6
5568623|NCT01121406|19244610|P1|Overall Study|Reason other than specified above|2
5568624|NCT01121406|19244609|P2|Overall Study|Refused continuation of study med.|2
5568625|NCT01121406|19244610|P1|Overall Study|Refused continuation of study med.|1
5568626|NCT01121406|19244609|P2|Overall Study|Lost to Follow-up|1
5568627|NCT01121406|19244610|P1|Overall Study|Lost to Follow-up|0
5568628|NCT01121406|19244609|P2|Overall Study|Non-compliant with protocol|2
5568629|NCT01121406|19244610|P1|Overall Study|Non-compliant with protocol|0
5568630|NCT01121406|19244609|P2|Overall Study|Other AE|10
5568631|NCT01121406|19244610|P1|Overall Study|Other AE|3
5568632|NCT01121406|19244609|P2|Overall Study|Wors. or AE of underlying cancer disease|6
5568633|NCT01121406|19244610|P1|Overall Study|Wors. or AE of underlying cancer disease|4
5568634|NCT01121406|19244609|P2|Overall Study|Progressive disease RECIST|28
5568635|NCT01121406|19244610|P1|Overall Study|Progressive disease RECIST|44
5568636|NCT01121393|19244660|P2|Overall Study|Other than listed|0
5568637|NCT01121393|19244661|P1|Overall Study|Other than listed|6
5568638|NCT01121393|19244660|P2|Overall Study|Not treated|9
5568639|NCT01121393|19244661|P1|Overall Study|Not treated|3
5568640|NCT01121393|19244660|P2|Overall Study|Refused cont. medication|7
5568641|NCT01121393|19244661|P1|Overall Study|Refused cont. medication|7
5568642|NCT01121393|19244660|P2|Overall Study|Lost to Follow-up|0
5568643|NCT01121393|19244661|P1|Overall Study|Lost to Follow-up|1
5568644|NCT01121393|19244660|P2|Overall Study|Non-compliant with protocol|3
5568645|NCT01121393|19244661|P1|Overall Study|Non-compliant with protocol|0
5568646|NCT01121393|19244660|P2|Overall Study|Other Adverse events|45
5568647|NCT01121393|19244661|P1|Overall Study|Other Adverse events|24
5568648|NCT01121393|19244660|P2|Overall Study|Progressive disease|20
5568649|NCT01121393|19244661|P1|Overall Study|Progressive disease|201
5568650|NCT01121263|19244706|P2|Overall Study|Withdrawal by Subject|1
5568651|NCT01121263|19244707|P1|Overall Study|Withdrawal by Subject|0
5568652|NCT01121263|19244706|P2|Overall Study|Lost to Follow-up|12
5568653|NCT01121263|19244707|P1|Overall Study|Lost to Follow-up|22
5568654|NCT01121263|19244706|P2|Overall Study|Death|2
5568655|NCT01121263|19244707|P1|Overall Study|Death|3
5568656|NCT01121185|19244798|P2|Overall Study|Not transplanted|0
5568657|NCT01121185|19244799|P1|Overall Study|Not transplanted|1
5568658|NCT01121185|19244798|P2|Overall Study|Not infused|1
5568659|NCT01121185|19244799|P1|Overall Study|Not infused|0
5568660|NCT01121146|19244833|P2|Overall Study|Lost to Follow-up|16
5568661|NCT01121146|19244834|P1|Overall Study|Lost to Follow-up|7
5568662|NCT01121146|19244833|P2|Overall Study|Adverse Event|11
5568663|NCT01121146|19244834|P1|Overall Study|Adverse Event|2
5568664|NCT01121146|19244833|P2|Overall Study|Death|15
5568665|NCT01121146|19244834|P1|Overall Study|Death|17
5568666|NCT01120899|19244855|P1|Overall Study|Withdrawal by Subject|3
5568667|NCT01120782|19244883|P1|Overall Study|Test article shipping error|11
5568668|NCT01120756|19244889|P2|Overall Study|Withdrawal by Subject|1
5568669|NCT01120756|19244890|P1|Overall Study|Withdrawal by Subject|1
5568670|NCT01120717|19244900|P2|Overall Study|Abnormal Test Procedure Result(s)|0
5568671|NCT01120717|19244901|P1|Overall Study|Abnormal Test Procedure Result(s)|1
5568672|NCT01120717|19244900|P2|Overall Study|Death|1
5568673|NCT01120717|19244901|P1|Overall Study|Death|3
5568674|NCT01120717|19244900|P2|Overall Study|Lost to Follow-up|3
5568675|NCT01120717|19244901|P1|Overall Study|Lost to Follow-up|2
5568676|NCT01120717|19244900|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
5568677|NCT01120717|19244901|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
5568678|NCT01120717|19244900|P2|Overall Study|Protocol Deviation|5
5568679|NCT01120717|19244901|P1|Overall Study|Protocol Deviation|2
5568680|NCT01120717|19244900|P2|Overall Study|Adverse Event|6
5568681|NCT01120717|19244901|P1|Overall Study|Adverse Event|10
5568682|NCT01120717|19244900|P2|Overall Study|Withdrawal by Subject|6
5568683|NCT01120717|19244901|P1|Overall Study|Withdrawal by Subject|11
5568684|NCT01120691|19245007|P3|Overall Study|Abnormal laboratory value(s)|4
5568685|NCT01120691|19245008|P2|Overall Study|Abnormal laboratory value(s)|3
5568686|NCT01120691|19245009|P1|Overall Study|Abnormal laboratory value(s)|1
5568687|NCT01120691|19245007|P3|Overall Study|Patient's inability to use the device|0
5568688|NCT01120691|19245008|P2|Overall Study|Patient's inability to use the device|1
5568689|NCT01120691|19245009|P1|Overall Study|Patient's inability to use the device|3
5568690|NCT01120691|19245007|P3|Overall Study|Abnormal test procedure result(s)|1
5568691|NCT01120691|19245008|P2|Overall Study|Abnormal test procedure result(s)|2
5568692|NCT01120691|19245009|P1|Overall Study|Abnormal test procedure result(s)|3
5568693|NCT01120691|19245007|P3|Overall Study|Lost to Follow-up|4
5568694|NCT01120691|19245008|P2|Overall Study|Lost to Follow-up|6
5568695|NCT01120691|19245009|P1|Overall Study|Lost to Follow-up|5
5568696|NCT01120691|19245007|P3|Overall Study|Protocol deviation|12
5568697|NCT01120691|19245008|P2|Overall Study|Protocol deviation|12
5568698|NCT01120691|19245009|P1|Overall Study|Protocol deviation|13
5568699|NCT01120691|19245007|P3|Overall Study|Administrative problems|9
5568700|NCT01120691|19245008|P2|Overall Study|Administrative problems|8
5568701|NCT01120691|19245009|P1|Overall Study|Administrative problems|15
5568702|NCT01120691|19245007|P3|Overall Study|Unsatisfactory therapeutic effect|38
5568703|NCT01120691|19245008|P2|Overall Study|Unsatisfactory therapeutic effect|32
5568704|NCT01120691|19245009|P1|Overall Study|Unsatisfactory therapeutic effect|18
5568705|NCT01120691|19245007|P3|Overall Study|Death|24
5568706|NCT01120691|19245008|P2|Overall Study|Death|22
5568707|NCT01120691|19245009|P1|Overall Study|Death|21
5568708|NCT01120691|19245007|P3|Overall Study|Subject withdrew consent|44
5568709|NCT01120691|19245008|P2|Overall Study|Subject withdrew consent|50
5568710|NCT01120691|19245009|P1|Overall Study|Subject withdrew consent|33
5568711|NCT01120691|19245007|P3|Overall Study|Adverse Event|47
5568712|NCT01120691|19245008|P2|Overall Study|Adverse Event|67
5568713|NCT01120691|19245009|P1|Overall Study|Adverse Event|59
5568714|NCT01120626|19245106|P2|Overall Study|Withdrawal by Subject|0
5568715|NCT01120626|19245107|P1|Overall Study|Withdrawal by Subject|1
5568716|NCT01120600|19245117|P2|Overall Study|Withdrawal by Subject|11
5568717|NCT01120600|19245118|P1|Overall Study|Withdrawal by Subject|10
5568718|NCT01120600|19245117|P2|Overall Study|Protocol Violation|4
5568719|NCT01120600|19245118|P1|Overall Study|Protocol Violation|0
5568720|NCT01120600|19245117|P2|Overall Study|Physician Decision|3
5568721|NCT01120600|19245118|P1|Overall Study|Physician Decision|1
5568722|NCT01120600|19245117|P2|Overall Study|Lost to Follow-up|3
5568723|NCT01120600|19245118|P1|Overall Study|Lost to Follow-up|1
5568724|NCT01120600|19245117|P2|Overall Study|Excessive Bone Loss|4
5568725|NCT01120600|19245118|P1|Overall Study|Excessive Bone Loss|0
5568726|NCT01120600|19245117|P2|Overall Study|Adverse Event|7
5568727|NCT01120600|19245118|P1|Overall Study|Adverse Event|7
5568728|NCT01120379|19245173|P1|Four Year Timepoint|Any other reason for early termination|217
5568729|NCT01120379|19245173|P1|Four Year Timepoint|Physician Decision|5
5568730|NCT01120379|19245173|P1|Four Year Timepoint|Death|131
5568731|NCT01120379|19245173|P1|Four Year Timepoint|Lost to Follow-up|10
5568732|NCT01120379|19245173|P1|Four Year Timepoint|Withdrawal by Subject|5
5568733|NCT01120379|19245173|P1|Three Year Timepoint|Any other reason for early termination|17
5568734|NCT01120379|19245173|P1|Three Year Timepoint|Physician Decision|9
5568735|NCT01120379|19245173|P1|Three Year Timepoint|Death|120
5568736|NCT01120379|19245173|P1|Three Year Timepoint|Lost to Follow-up|43
5568737|NCT01120379|19245173|P1|Three Year Timepoint|Withdrawal by Subject|25
5568738|NCT01120379|19245173|P1|Two Year Timepoint|Any other reason for early termination|4
5568739|NCT01120379|19245173|P1|Two Year Timepoint|Physician Decision|12
5568740|NCT01120379|19245173|P1|Two Year Timepoint|Death|123
5568741|NCT01120379|19245173|P1|Two Year Timepoint|Lost to Follow-up|87
5568742|NCT01120379|19245173|P1|Two Year Timepoint|Withdrawal by Subject|11
5568743|NCT01120379|19245173|P1|One Year Timepoint|Any other reason for early termination|5
5568744|NCT01120379|19245173|P1|One Year Timepoint|Physician Decision|9
5568745|NCT01120379|19245173|P1|One Year Timepoint|Death|108
5568746|NCT01120379|19245173|P1|One Year Timepoint|Lost to Follow-up|115
5568747|NCT01120379|19245173|P1|One Year Timepoint|Withdrawal by Subject|41
5568748|NCT01120275|19245209|P1|Overall Study|Not specific|1
5568749|NCT01120275|19245209|P1|Overall Study|Refusal|1
5568750|NCT01120275|19245209|P1|Overall Study|Withdrawal by Subject|1
5568751|NCT01120275|19245209|P1|Overall Study|Ineligible|3
5568752|NCT01120275|19245209|P1|Overall Study|Progression|27
5568753|NCT01120275|19245209|P1|Overall Study|Adverse Event|3
5568754|NCT01120210|19245276|P2|MAIN INFUSION|Withdrawal by Subject|1
5568755|NCT01120210|19245277|P1|MAIN INFUSION|Withdrawal by Subject|0
5568756|NCT01120210|19245276|P2|MAIN INFUSION|Adverse Event|0
5568757|NCT01120210|19245277|P1|MAIN INFUSION|Adverse Event|1
5568758|NCT01120184|19245327|P3|Overall Study|Death|169
5568759|NCT01120184|19245328|P2|Overall Study|Death|176
5568760|NCT01120184|19245329|P1|Overall Study|Death|170
5568761|NCT01120184|19245327|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
5568762|NCT01120184|19245328|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
5568763|NCT01120184|19245329|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
5568764|NCT01120184|19245327|P3|Overall Study|Sponsor Decision to Terminate Study|143
5568765|NCT01120184|19245328|P2|Overall Study|Sponsor Decision to Terminate Study|144
5568766|NCT01120184|19245329|P1|Overall Study|Sponsor Decision to Terminate Study|133
5568767|NCT01120184|19245327|P3|Overall Study|Reason not Specified|12
5568768|NCT01120184|19245328|P2|Overall Study|Reason not Specified|3
5568769|NCT01120184|19245329|P1|Overall Study|Reason not Specified|8
5568770|NCT01120184|19245327|P3|Overall Study|Physician Decision|3
5568771|NCT01120184|19245328|P2|Overall Study|Physician Decision|1
5568772|NCT01120184|19245329|P1|Overall Study|Physician Decision|9
5568773|NCT01120184|19245327|P3|Overall Study|Lost to Follow-up|11
5568774|NCT01120184|19245328|P2|Overall Study|Lost to Follow-up|13
5568775|NCT01120184|19245329|P1|Overall Study|Lost to Follow-up|13
5568776|NCT01120184|19245327|P3|Overall Study|Adverse Event|0
5568777|NCT01120184|19245328|P2|Overall Study|Adverse Event|1
5568778|NCT01120184|19245329|P1|Overall Study|Adverse Event|0
5568779|NCT01120093|19245451|P5|Treatment Period 5|Adverse Event|0
5568780|NCT01120093|19245452|P4|Treatment Period 5|Adverse Event|1
5568781|NCT01120093|19245453|P3|Treatment Period 5|Adverse Event|0
5568782|NCT01120093|19245454|P2|Treatment Period 5|Adverse Event|1
5568783|NCT01120093|19245455|P1|Treatment Period 5|Adverse Event|0
5568784|NCT01120093|19245451|P5|Treatment Period 4|Adverse Event|0
5568785|NCT01120093|19245452|P4|Treatment Period 4|Adverse Event|0
5568786|NCT01120093|19245453|P3|Treatment Period 4|Adverse Event|0
5568787|NCT01120093|19245454|P2|Treatment Period 4|Adverse Event|0
5568788|NCT01120093|19245455|P1|Treatment Period 4|Adverse Event|1
5568789|NCT01120093|19245451|P5|Treatment Period 3|Withdrawal by Subject|0
5568790|NCT01120093|19245452|P4|Treatment Period 3|Withdrawal by Subject|0
5568791|NCT01120093|19245453|P3|Treatment Period 3|Withdrawal by Subject|1
5568792|NCT01120093|19245454|P2|Treatment Period 3|Withdrawal by Subject|0
5568793|NCT01120093|19245455|P1|Treatment Period 3|Withdrawal by Subject|0
5568794|NCT01120093|19245451|P5|Treatment Period 3|Adverse Event|1
5568795|NCT01120093|19245452|P4|Treatment Period 3|Adverse Event|0
5568796|NCT01120093|19245453|P3|Treatment Period 3|Adverse Event|0
5568797|NCT01120093|19245454|P2|Treatment Period 3|Adverse Event|0
5568798|NCT01120093|19245455|P1|Treatment Period 3|Adverse Event|0
5568799|NCT01120093|19245451|P5|Treatment Period 3|Lack of Efficacy|0
5568800|NCT01120093|19245452|P4|Treatment Period 3|Lack of Efficacy|1
5568801|NCT01120093|19245453|P3|Treatment Period 3|Lack of Efficacy|0
5568802|NCT01120093|19245454|P2|Treatment Period 3|Lack of Efficacy|0
5568803|NCT01120093|19245455|P1|Treatment Period 3|Lack of Efficacy|0
5568804|NCT01120093|19245451|P5|Treatment Period 2|Withdrawal by Subject|1
5568805|NCT01120093|19245452|P4|Treatment Period 2|Withdrawal by Subject|0
5568806|NCT01120093|19245453|P3|Treatment Period 2|Withdrawal by Subject|0
5568807|NCT01120093|19245454|P2|Treatment Period 2|Withdrawal by Subject|0
5568808|NCT01120093|19245455|P1|Treatment Period 2|Withdrawal by Subject|0
5568809|NCT01120093|19245451|P5|Treatment Period 2|Adverse Event|0
5568810|NCT01120093|19245452|P4|Treatment Period 2|Adverse Event|1
5568811|NCT01120093|19245453|P3|Treatment Period 2|Adverse Event|0
5568812|NCT01120093|19245454|P2|Treatment Period 2|Adverse Event|0
5568813|NCT01120093|19245455|P1|Treatment Period 2|Adverse Event|0
5568814|NCT01120093|19245451|P5|Treatment Period 1|Withdrawal by Subject|0
5568815|NCT01120093|19245452|P4|Treatment Period 1|Withdrawal by Subject|0
5568816|NCT01120093|19245453|P3|Treatment Period 1|Withdrawal by Subject|0
5568817|NCT01120093|19245454|P2|Treatment Period 1|Withdrawal by Subject|1
5568818|NCT01120093|19245455|P1|Treatment Period 1|Withdrawal by Subject|0
5568819|NCT01120093|19245451|P5|Treatment Period 1|Adverse Event|1
5568820|NCT01120093|19245452|P4|Treatment Period 1|Adverse Event|0
5568821|NCT01120093|19245453|P3|Treatment Period 1|Adverse Event|1
5568822|NCT01120093|19245454|P2|Treatment Period 1|Adverse Event|0
5568823|NCT01120093|19245455|P1|Treatment Period 1|Adverse Event|0
5568824|NCT01120067|19245484|P2|Overall Study|fail to engage >3 sessions|0
5568825|NCT01120067|19245485|P1|Overall Study|fail to engage >3 sessions|2
5568826|NCT01120067|19245484|P2|Overall Study|Lost to Follow-up|1
5568827|NCT01120067|19245485|P1|Overall Study|Lost to Follow-up|3
5568828|NCT01120028|19245495|P4|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
5568829|NCT01120028|19245496|P3|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
5568830|NCT01120028|19245497|P2|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
5568831|NCT01120028|19245498|P1|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
5568832|NCT01120028|19245495|P4|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
5568833|NCT01120028|19245496|P3|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
5568834|NCT01120028|19245497|P2|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
5568835|NCT01120028|19245498|P1|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
5568836|NCT01119963|19245522|P2|Overall Study|Lost to Follow-up|1
5568837|NCT01119963|19245523|P1|Overall Study|Lost to Follow-up|1
5568838|NCT01119950|19245533|P1|Overall Study|Death|1
5568839|NCT01119950|19245533|P1|Overall Study|Abnormal lab value|1
5568840|NCT01119950|19245533|P1|Overall Study|Administrative|2
5568841|NCT01119950|19245533|P1|Overall Study|Lost to Follow-up|4
5568842|NCT01119950|19245533|P1|Overall Study|Protocol Violation|5
5568843|NCT01119950|19245533|P1|Overall Study|Withdrawal by Subject|9
5568844|NCT01119950|19245533|P1|Overall Study|Adverse Event|25
5568845|NCT01119937|19245780|P2|Overall Study|Withdrawal by Subject|1
5568846|NCT01119937|19245781|P1|Overall Study|Withdrawal by Subject|2
5568847|NCT01119937|19245780|P2|Overall Study|Unsatisfactory therapeutic effect|0
5568848|NCT01119937|19245781|P1|Overall Study|Unsatisfactory therapeutic effect|3
5568849|NCT01119937|19245780|P2|Overall Study|Protocol deviation|1
5568850|NCT01119937|19245781|P1|Overall Study|Protocol deviation|3
5568851|NCT01119937|19245780|P2|Overall Study|Adverse Event|5
5568852|NCT01119937|19245781|P1|Overall Study|Adverse Event|11
5568853|NCT01119898|19245809|P2|Overall Study|Randomized in error did not participate|0
5568854|NCT01119898|19245810|P1|Overall Study|Randomized in error did not participate|1
5568855|NCT01119898|19245809|P2|Overall Study|Medical procedure|0
5568856|NCT01119898|19245810|P1|Overall Study|Medical procedure|1
5568857|NCT01119898|19245809|P2|Overall Study|Protocol Violation|1
5568858|NCT01119898|19245810|P1|Overall Study|Protocol Violation|1
5568859|NCT01119898|19245809|P2|Overall Study|Lack of Efficacy|2
5568860|NCT01119898|19245810|P1|Overall Study|Lack of Efficacy|0
5568861|NCT01119898|19245809|P2|Overall Study|Withdrawal by Subject|4
5568862|NCT01119898|19245810|P1|Overall Study|Withdrawal by Subject|1
5568863|NCT01119898|19245809|P2|Overall Study|Adverse Event|5
5568864|NCT01119898|19245810|P1|Overall Study|Adverse Event|4
5568865|NCT01119859|19245836|P2|Overall Study|Failure to return|0
5568866|NCT01119859|19245837|P1|Overall Study|Failure to return|3
5568867|NCT01119859|19245836|P2|Overall Study|Refused treatment|6
5568868|NCT01119859|19245837|P1|Overall Study|Refused treatment|3
5568869|NCT01119859|19245836|P2|Overall Study|Insufficient therapeutic response|14
5568870|NCT01119859|19245837|P1|Overall Study|Insufficient therapeutic response|7
5568871|NCT01119859|19245836|P2|Overall Study|Death|0
5568872|NCT01119859|19245837|P1|Overall Study|Death|2
5568873|NCT01119859|19245836|P2|Overall Study|Adverse Event|10
5568874|NCT01119859|19245837|P1|Overall Study|Adverse Event|9
5568875|NCT01119846|19245856|P3|Overall Study|Withdrawal by Subject|4
5568876|NCT01119846|19245857|P2|Overall Study|Withdrawal by Subject|0
5568877|NCT01119846|19245858|P1|Overall Study|Withdrawal by Subject|0
5568878|NCT01119846|19245856|P3|Overall Study|Protocol Violation|1
5568879|NCT01119846|19245857|P2|Overall Study|Protocol Violation|0
5568880|NCT01119846|19245858|P1|Overall Study|Protocol Violation|0
5568881|NCT01119846|19245856|P3|Overall Study|Physician Decision|0
5568882|NCT01119846|19245857|P2|Overall Study|Physician Decision|0
5568883|NCT01119846|19245858|P1|Overall Study|Physician Decision|1
5568884|NCT01119846|19245856|P3|Overall Study|Adverse Event|6
5568885|NCT01119846|19245857|P2|Overall Study|Adverse Event|0
5568886|NCT01119846|19245858|P1|Overall Study|Adverse Event|1
5568887|NCT01119768|19246072|P2|Treatment Period|Lack of Efficacy|25
5568888|NCT01119768|19246073|P1|Treatment Period|Lack of Efficacy|18
5568889|NCT01119703|19246129|P2|Overall Study|Adverse Event|1
5568890|NCT01119703|19246130|P1|Overall Study|Adverse Event|0
5568891|NCT01119625|19246144|P2|Overall Study|Other|1
5568892|NCT01119625|19246145|P1|Overall Study|Other|0
5568893|NCT01119625|19246144|P2|Overall Study|Withdrawal by Subject|1
5568894|NCT01119625|19246145|P1|Overall Study|Withdrawal by Subject|2
5568895|NCT01119625|19246144|P2|Overall Study|Lost to Follow-up|2
5568896|NCT01119625|19246145|P1|Overall Study|Lost to Follow-up|1
5568897|NCT01119508|19246185|P1|Overall Study|Died before tumor response evaluation|1
5568898|NCT01119508|19246185|P1|Overall Study|Withdrawal by Subject|2
5568899|NCT01119508|19246185|P1|Overall Study|Adverse Event|56
5568900|NCT01119443|19246265|P2|Crossover Period 1 (5 Days)|Adverse Event|1
5568901|NCT01119443|19246266|P1|Crossover Period 1 (5 Days)|Adverse Event|0
5568902|NCT01119287|19246309|P6|Overall Study|Patient Decision, not related to AE|0
5568903|NCT01119287|19246310|P5|Overall Study|Patient Decision, not related to AE|1
5568904|NCT01119287|19246311|P4|Overall Study|Patient Decision, not related to AE|2
5568905|NCT01119287|19246312|P3|Overall Study|Patient Decision, not related to AE|2
5568906|NCT01119287|19246313|P2|Overall Study|Patient Decision, not related to AE|0
5568907|NCT01119287|19246314|P1|Overall Study|Patient Decision, not related to AE|0
5568908|NCT01119248|19246327|P1|Overall Study|Physician Decision|5
5568909|NCT01119131|19246377|P3|Overall Study|Physician Decision|1
5568910|NCT01119131|19246378|P2|Overall Study|Physician Decision|0
5568911|NCT01119131|19246379|P1|Overall Study|Physician Decision|0
5568912|NCT01119131|19246377|P3|Overall Study|Non-Compliance|4
5568913|NCT01119131|19246378|P2|Overall Study|Non-Compliance|0
5568914|NCT01119131|19246379|P1|Overall Study|Non-Compliance|1
5568915|NCT01119131|19246377|P3|Overall Study|Adverse Event|1
5568916|NCT01119131|19246378|P2|Overall Study|Adverse Event|1
5568917|NCT01119131|19246379|P1|Overall Study|Adverse Event|1
5568918|NCT01119118|19246408|P1|Overall Study|Adverse Event|1
5568919|NCT01119105|19246419|P3|Overall Study|Other|0
5568920|NCT01119105|19246420|P2|Overall Study|Other|1
5568921|NCT01119105|19246421|P1|Overall Study|Other|1
5568922|NCT01119105|19246419|P3|Overall Study|study drug missed on 2 consecutive days|1
5568923|NCT01119105|19246420|P2|Overall Study|study drug missed on 2 consecutive days|2
5568924|NCT01119105|19246421|P1|Overall Study|study drug missed on 2 consecutive days|1
5568925|NCT01119105|19246419|P3|Overall Study|Adverse Event|1
5568926|NCT01119105|19246420|P2|Overall Study|Adverse Event|0
5568927|NCT01119105|19246421|P1|Overall Study|Adverse Event|1
5568928|NCT01119105|19246419|P3|Overall Study|Lost to Follow-up|5
5568929|NCT01119105|19246420|P2|Overall Study|Lost to Follow-up|2
5568930|NCT01119105|19246421|P1|Overall Study|Lost to Follow-up|0
5568931|NCT01119105|19246419|P3|Overall Study|Withdrawal by Subject|1
5568932|NCT01119105|19246420|P2|Overall Study|Withdrawal by Subject|1
5568933|NCT01119105|19246421|P1|Overall Study|Withdrawal by Subject|1
5568934|NCT01119001|19246436|P1|Overall Study|Withdrawal by Subject|2
5568935|NCT01118975|19246480|P2|Overall Study|Adverse Event|1
5568936|NCT01118975|19246481|P1|Overall Study|Adverse Event|0
5568937|NCT01118962|19246487|P1|Overall Study|Non-compliance with Medicinal Product|1
5568938|NCT01118962|19246487|P1|Overall Study|Pregnancy|1
5568939|NCT01118962|19246487|P1|Overall Study|Withdrawal by Subject|4
5568940|NCT01118962|19246487|P1|Overall Study|Protocol Violation|1
5568941|NCT01118962|19246487|P1|Overall Study|Lack of Efficacy|1
5568942|NCT01118962|19246487|P1|Overall Study|Adverse Event|2
5568943|NCT01118949|19246492|P1|Overall Study|Withdrawal by Subject|4
5568944|NCT01118949|19246492|P1|Overall Study|Adverse Event|5
5568945|NCT01118780|19246522|P2|Overall Study|Withdrawal by Subject|8
5568946|NCT01118780|19246523|P1|Overall Study|Withdrawal by Subject|13
5568947|NCT01118780|19246522|P2|Overall Study|Protocol Violation|6
5568948|NCT01118780|19246523|P1|Overall Study|Protocol Violation|3
5568949|NCT01118780|19246522|P2|Overall Study|Physician Decision|0
5568950|NCT01118780|19246523|P1|Overall Study|Physician Decision|2
5568951|NCT01118780|19246522|P2|Overall Study|Lack of Efficacy|6
5568952|NCT01118780|19246523|P1|Overall Study|Lack of Efficacy|2
5568953|NCT01118780|19246522|P2|Overall Study|Death|0
5568954|NCT01118780|19246523|P1|Overall Study|Death|1
5568955|NCT01118780|19246522|P2|Overall Study|Adverse Event|15
5568956|NCT01118780|19246523|P1|Overall Study|Adverse Event|15
5568957|NCT01118728|19246581|P1|Overall Study|Lost to Follow-up|4
5568958|NCT01118728|19246581|P1|Overall Study|Withdrawal by Subject|3
5568959|NCT01118728|19246581|P1|Overall Study|Sponsor's decision to discontinue study|172
5568960|NCT01118728|19246581|P1|Overall Study|Lack of Efficacy|27
5568961|NCT01118728|19246581|P1|Overall Study|Adverse Event|17
5568962|NCT01118663|19246618|P2|Overall Study|Withdrawal by Subject|1
5568963|NCT01118663|19246619|P1|Overall Study|Withdrawal by Subject|0
5568964|NCT01118663|19246618|P2|Overall Study|Adverse Event|1
5568965|NCT01118663|19246619|P1|Overall Study|Adverse Event|2
5568966|NCT01118455|19246642|P2|Baseline [Visits 1 & 2]|Adverse Event|0
5568967|NCT01118455|19246643|P1|Baseline [Visits 1 & 2]|Adverse Event|1
5568968|NCT01118377|19246671|P1|Overall Study|Failure to Return|3
5568969|NCT01118377|19246671|P1|Overall Study|Death|38
5568970|NCT01118377|19246671|P1|Overall Study|Did Not Receive Study Medication|1
5568971|NCT01118351|19246677|P1|Overall Study|Withdrawal by Subject|1
5568972|NCT01118351|19246677|P1|Overall Study|Adverse Event|3
5568973|NCT01118325|19246701|P3|Overall Study|Adverse Event|1
5568974|NCT01118325|19246702|P2|Overall Study|Adverse Event|0
5568975|NCT01118325|19246703|P1|Overall Study|Adverse Event|1
5568976|NCT01118312|19246749|P2|Overall Study|Withdrawal by Subject|3
5568977|NCT01118312|19246750|P1|Overall Study|Withdrawal by Subject|1
5568978|NCT01118312|19246749|P2|Overall Study|Lost to Follow-up|32
5568979|NCT01118312|19246750|P1|Overall Study|Lost to Follow-up|33
5568980|NCT01118299|19246760|P2|Overall Study|Enrollment Closure, Protocol Amendment|15
5568981|NCT01118299|19246761|P1|Overall Study|Enrollment Closure, Protocol Amendment|6
5568982|NCT01118299|19246760|P2|Overall Study|Lost to Follow-up|1
5568983|NCT01118299|19246761|P1|Overall Study|Lost to Follow-up|2
5568984|NCT01118299|19246760|P2|Overall Study|Withdrawal by Subject|8
5568985|NCT01118299|19246761|P1|Overall Study|Withdrawal by Subject|8
5568986|NCT01118299|19246760|P2|Overall Study|Death|5
5568987|NCT01118299|19246761|P1|Overall Study|Death|7
5568988|NCT01118143|19246958|P2|Overall Study|Withdrawal by Subject|5
5568989|NCT01118143|19246959|P1|Overall Study|Withdrawal by Subject|2
5568990|NCT01118117|19246969|P2|Overall Study|Missed 12 Month Visit|0
5568991|NCT01118117|19246970|P1|Overall Study|Missed 12 Month Visit|7
5568992|NCT01118117|19246969|P2|Overall Study|Lost to Follow-up|0
5568993|NCT01118117|19246970|P1|Overall Study|Lost to Follow-up|6
5568994|NCT01118117|19246969|P2|Overall Study|Death|0
5568995|NCT01118117|19246970|P1|Overall Study|Death|8
5568996|NCT01118052|19247002|P1|Overall Study|Never treated|2
5568997|NCT01117987|19247025|P2|Overall Study|Administrative problems|22
5568998|NCT01117987|19247026|P1|Overall Study|Administrative problems|25
5568999|NCT01117987|19247025|P2|Overall Study|Adverse Event|26
5569000|NCT01117987|19247026|P1|Overall Study|Adverse Event|19
5569001|NCT01117987|19247025|P2|Overall Study|Withdrawal by Subject|10
5569002|NCT01117987|19247026|P1|Overall Study|Withdrawal by Subject|5
5569003|NCT01117987|19247025|P2|Overall Study|Death|10
5569004|NCT01117987|19247026|P1|Overall Study|Death|5
5569005|NCT01117987|19247025|P2|Overall Study|Lack of Efficacy|4
5569006|NCT01117987|19247026|P1|Overall Study|Lack of Efficacy|3
5569007|NCT01117987|19247025|P2|Overall Study|Abnormal test procedure result|0
5569008|NCT01117987|19247026|P1|Overall Study|Abnormal test procedure result|2
5569009|NCT01117987|19247025|P2|Overall Study|Lost to Follow-up|1
5569010|NCT01117987|19247026|P1|Overall Study|Lost to Follow-up|1
5569011|NCT01117987|19247025|P2|Overall Study|Subject no longer requires study drug|0
5569012|NCT01117987|19247026|P1|Overall Study|Subject no longer requires study drug|1
5569013|NCT01117987|19247025|P2|Overall Study|Protocol deviation|1
5569014|NCT01117987|19247026|P1|Overall Study|Protocol deviation|0
5569015|NCT01117870|19247047|P2|Overall Study|Inability to place needle|0
5569016|NCT01117870|19247048|P1|Overall Study|Inability to place needle|1
5569017|NCT01117857|19247062|P1|Overall Study|Physician Decision|1
5569018|NCT01117857|19247062|P1|Overall Study|Withdrawal by Subject|4
5569019|NCT01117857|19247062|P1|Overall Study|Lost to Follow-up|4
5569020|NCT01117766|19247070|P2|Second Intervention|Withdrawal by Subject|1
5569021|NCT01117766|19247071|P1|Second Intervention|Withdrawal by Subject|0
5569022|NCT01117766|19247070|P2|Second Intervention|Adverse Event|2
5569023|NCT01117766|19247071|P1|Second Intervention|Adverse Event|0
5569024|NCT01117766|19247070|P2|Second Intervention|Other|2
5569025|NCT01117766|19247071|P1|Second Intervention|Other|1
5569026|NCT01117766|19247070|P2|Second Intervention|Lost to Follow-up|0
5569027|NCT01117766|19247071|P1|Second Intervention|Lost to Follow-up|1
5569028|NCT01117766|19247070|P2|Washout Period|Protocol Violation|2
5569029|NCT01117766|19247071|P1|Washout Period|Protocol Violation|0
5569030|NCT01117766|19247070|P2|First Intervention|Protocol Violation|0
5569031|NCT01117766|19247071|P1|First Intervention|Protocol Violation|1
5569032|NCT01117766|19247070|P2|First Intervention|Adverse Event|1
5569033|NCT01117766|19247071|P1|First Intervention|Adverse Event|0
5569034|NCT01117623|19247108|P8|Overall Study|Invest. text: completed all planned txs|0
5569035|NCT01117623|19247109|P7|Overall Study|Invest. text: completed all planned txs|0
5569036|NCT01117623|19247110|P6|Overall Study|Invest. text: completed all planned txs|1
5569037|NCT01117623|19247111|P5|Overall Study|Invest. text: completed all planned txs|0
5569038|NCT01117623|19247112|P4|Overall Study|Invest. text: completed all planned txs|0
5569039|NCT01117623|19247113|P3|Overall Study|Invest. text: completed all planned txs|0
5569040|NCT01117623|19247114|P2|Overall Study|Invest. text: completed all planned txs|0
5569041|NCT01117623|19247115|P1|Overall Study|Invest. text: completed all planned txs|0
5569042|NCT01117623|19247108|P8|Overall Study|Non-compliance with study medication|1
5569043|NCT01117623|19247109|P7|Overall Study|Non-compliance with study medication|0
5569044|NCT01117623|19247110|P6|Overall Study|Non-compliance with study medication|0
5569045|NCT01117623|19247111|P5|Overall Study|Non-compliance with study medication|0
5569046|NCT01117623|19247112|P4|Overall Study|Non-compliance with study medication|0
5569047|NCT01117623|19247113|P3|Overall Study|Non-compliance with study medication|0
5569048|NCT01117623|19247114|P2|Overall Study|Non-compliance with study medication|0
5569049|NCT01117623|19247115|P1|Overall Study|Non-compliance with study medication|0
5569050|NCT01117623|19247108|P8|Overall Study|Withdrawal by Subject|1
5569051|NCT01117623|19247109|P7|Overall Study|Withdrawal by Subject|1
5569052|NCT01117623|19247110|P6|Overall Study|Withdrawal by Subject|1
5569053|NCT01117623|19247111|P5|Overall Study|Withdrawal by Subject|0
5569054|NCT01117623|19247112|P4|Overall Study|Withdrawal by Subject|0
5569055|NCT01117623|19247113|P3|Overall Study|Withdrawal by Subject|2
5569056|NCT01117623|19247114|P2|Overall Study|Withdrawal by Subject|0
5569057|NCT01117623|19247115|P1|Overall Study|Withdrawal by Subject|0
5569058|NCT01117623|19247108|P8|Overall Study|Disease progression, recurrence, relapse|22
5569059|NCT01117623|19247109|P7|Overall Study|Disease progression, recurrence, relapse|5
5569060|NCT01117623|19247110|P6|Overall Study|Disease progression, recurrence, relapse|14
5569061|NCT01117623|19247111|P5|Overall Study|Disease progression, recurrence, relapse|8
5569062|NCT01117623|19247112|P4|Overall Study|Disease progression, recurrence, relapse|6
5569063|NCT01117623|19247113|P3|Overall Study|Disease progression, recurrence, relapse|5
5569064|NCT01117623|19247114|P2|Overall Study|Disease progression, recurrence, relapse|6
5569065|NCT01117623|19247115|P1|Overall Study|Disease progression, recurrence, relapse|3
5569066|NCT01117623|19247108|P8|Overall Study|Adverse Event|2
5569067|NCT01117623|19247109|P7|Overall Study|Adverse Event|0
5569068|NCT01117623|19247110|P6|Overall Study|Adverse Event|0
5569069|NCT01117623|19247111|P5|Overall Study|Adverse Event|2
5569070|NCT01117623|19247112|P4|Overall Study|Adverse Event|0
5569071|NCT01117623|19247113|P3|Overall Study|Adverse Event|4
5569072|NCT01117623|19247114|P2|Overall Study|Adverse Event|2
5569073|NCT01117623|19247115|P1|Overall Study|Adverse Event|0
5569074|NCT01117480|19247267|P1|Overall Study|Did Not Start Adalimumab Therapy|20
5569075|NCT01117480|19247267|P1|Overall Study|Protocol Violation|8
5569076|NCT01117454|19247275|P2|Overall Study|Pregnancy|1
5569077|NCT01117454|19247276|P1|Overall Study|Pregnancy|0
5569078|NCT01117428|19247288|P6|Overall Study|Progressive disease|17
5569079|NCT01117428|19247289|P5|Overall Study|Progressive disease|16
5569080|NCT01117428|19247290|P4|Overall Study|Progressive disease|12
5569081|NCT01117428|19247291|P3|Overall Study|Progressive disease|10
5569082|NCT01117428|19247292|P2|Overall Study|Progressive disease|27
5569083|NCT01117428|19247293|P1|Overall Study|Progressive disease|15
5569084|NCT01117428|19247288|P6|Overall Study|Withdrawal by Subject|0
5569085|NCT01117428|19247289|P5|Overall Study|Withdrawal by Subject|0
5569086|NCT01117428|19247290|P4|Overall Study|Withdrawal by Subject|0
5569087|NCT01117428|19247291|P3|Overall Study|Withdrawal by Subject|1
5569088|NCT01117428|19247292|P2|Overall Study|Withdrawal by Subject|0
5569089|NCT01117428|19247293|P1|Overall Study|Withdrawal by Subject|0
5569090|NCT01117428|19247288|P6|Overall Study|Physician Decision|0
5569091|NCT01117428|19247289|P5|Overall Study|Physician Decision|0
5569092|NCT01117428|19247290|P4|Overall Study|Physician Decision|0
5569093|NCT01117428|19247291|P3|Overall Study|Physician Decision|0
5569094|NCT01117428|19247292|P2|Overall Study|Physician Decision|1
5569095|NCT01117428|19247293|P1|Overall Study|Physician Decision|0
5569096|NCT01117428|19247288|P6|Overall Study|Death|1
5569097|NCT01117428|19247289|P5|Overall Study|Death|0
5569098|NCT01117428|19247290|P4|Overall Study|Death|0
5569099|NCT01117428|19247291|P3|Overall Study|Death|2
5569100|NCT01117428|19247292|P2|Overall Study|Death|1
5569101|NCT01117428|19247293|P1|Overall Study|Death|0
5569102|NCT01117428|19247288|P6|Overall Study|Adverse Event|2
5569103|NCT01117428|19247289|P5|Overall Study|Adverse Event|1
5569104|NCT01117428|19247290|P4|Overall Study|Adverse Event|0
5569105|NCT01117428|19247291|P3|Overall Study|Adverse Event|0
5569106|NCT01117428|19247292|P2|Overall Study|Adverse Event|0
5569107|NCT01117428|19247293|P1|Overall Study|Adverse Event|4
5569108|NCT01117428|19247288|P6|Overall Study|Lack of Efficacy|0
5569109|NCT01117428|19247289|P5|Overall Study|Lack of Efficacy|0
5569110|NCT01117428|19247290|P4|Overall Study|Lack of Efficacy|0
5569111|NCT01117428|19247291|P3|Overall Study|Lack of Efficacy|0
5569112|NCT01117428|19247292|P2|Overall Study|Lack of Efficacy|0
5569113|NCT01117428|19247293|P1|Overall Study|Lack of Efficacy|1
5569114|NCT01117350|19247327|P2|Extension Period|Prohibited medication|1
5569115|NCT01117350|19247328|P1|Extension Period|Prohibited medication|0
5569116|NCT01117350|19247327|P2|Extension Period|Inclusion criteria not respected|1
5569117|NCT01117350|19247328|P1|Extension Period|Inclusion criteria not respected|0
5569118|NCT01117350|19247327|P2|Extension Period|Lack of Efficacy|2
5569119|NCT01117350|19247328|P1|Extension Period|Lack of Efficacy|0
5569120|NCT01117350|19247327|P2|Extension Period|Withdrawal by Subject|3
5569121|NCT01117350|19247328|P1|Extension Period|Withdrawal by Subject|0
5569122|NCT01117350|19247327|P2|Extension Period|Lost to Follow-up|2
5569123|NCT01117350|19247328|P1|Extension Period|Lost to Follow-up|0
5569124|NCT01117350|19247327|P2|Extension Period|Protocol Violation|2
5569125|NCT01117350|19247328|P1|Extension Period|Protocol Violation|0
5569126|NCT01117350|19247327|P2|Extension Period|Adverse Event|2
5569127|NCT01117350|19247328|P1|Extension Period|Adverse Event|0
5569128|NCT01117350|19247327|P2|Extension Period|Not included in extension, not treated|50
5569129|NCT01117350|19247328|P1|Extension Period|Not included in extension, not treated|0
5569130|NCT01117350|19247327|P2|Comparative Period|Move to another city/country|1
5569131|NCT01117350|19247328|P1|Comparative Period|Move to another city/country|2
5569132|NCT01117350|19247327|P2|Comparative Period|Physician Decision|1
5569133|NCT01117350|19247328|P1|Comparative Period|Physician Decision|0
5569134|NCT01117350|19247327|P2|Comparative Period|Lack of Efficacy|0
5569135|NCT01117350|19247328|P1|Comparative Period|Lack of Efficacy|1
5569136|NCT01117350|19247327|P2|Comparative Period|Protocol Violation|12
5569137|NCT01117350|19247328|P1|Comparative Period|Protocol Violation|8
5569138|NCT01117350|19247327|P2|Comparative Period|Withdrawal by Subject|13
5569139|NCT01117350|19247328|P1|Comparative Period|Withdrawal by Subject|9
5569140|NCT01117350|19247327|P2|Comparative Period|Lost to Follow-up|7
5569141|NCT01117350|19247328|P1|Comparative Period|Lost to Follow-up|11
5569142|NCT01117350|19247327|P2|Comparative Period|Adverse Event|33
5569143|NCT01117350|19247328|P1|Comparative Period|Adverse Event|6
5569144|NCT01117350|19247327|P2|Comparative Period|Not Treated|8
5569145|NCT01117350|19247328|P1|Comparative Period|Not Treated|5
5569146|NCT01117337|19247360|P2|Overall Study|Lost to Follow-up|0
5569147|NCT01117337|19247361|P1|Overall Study|Lost to Follow-up|4
5569148|NCT01117181|19247382|P2|Overall Study|Withdrawal by Subject|2
5569149|NCT01117181|19247383|P1|Overall Study|Withdrawal by Subject|0
5569150|NCT01117181|19247382|P2|Overall Study|Lost to Follow-up|0
5569151|NCT01117181|19247383|P1|Overall Study|Lost to Follow-up|1
5569152|NCT01117051|19247416|P2|Overall Study|Convenience issue|0
5569153|NCT01117051|19247417|P1|Overall Study|Convenience issue|1
5569154|NCT01117051|19247416|P2|Overall Study|Randomized by mistake|1
5569155|NCT01117051|19247417|P1|Overall Study|Randomized by mistake|0
5569156|NCT01117051|19247416|P2|Overall Study|Surgical procedure|1
5569157|NCT01117051|19247417|P1|Overall Study|Surgical procedure|0
5569158|NCT01117051|19247416|P2|Overall Study|Sponsor's decision|1
5569159|NCT01117051|19247417|P1|Overall Study|Sponsor's decision|3
5569160|NCT01117051|19247416|P2|Overall Study|Did not meet in-/exclusion criteria|1
5569161|NCT01117051|19247417|P1|Overall Study|Did not meet in-/exclusion criteria|0
5569162|NCT01117051|19247416|P2|Overall Study|Lost to Follow-up|1
5569163|NCT01117051|19247417|P1|Overall Study|Lost to Follow-up|0
5569164|NCT01117051|19247416|P2|Overall Study|Adverse Event|3
5569165|NCT01117051|19247417|P1|Overall Study|Adverse Event|4
5569166|NCT01117051|19247416|P2|Overall Study|Withdrawal by Subject|3
5569167|NCT01117051|19247417|P1|Overall Study|Withdrawal by Subject|5
5569168|NCT01117012|19247427|P2|Overall Study|Undefined|3
5569169|NCT01117012|19247428|P1|Overall Study|Undefined|4
5569170|NCT01117012|19247427|P2|Overall Study|Withdrawal by Subject|0
5569171|NCT01117012|19247428|P1|Overall Study|Withdrawal by Subject|3
5569172|NCT01117012|19247427|P2|Overall Study|Death|1
5569173|NCT01117012|19247428|P1|Overall Study|Death|1
5569174|NCT01117012|19247427|P2|Overall Study|Adverse Event|1
5569175|NCT01117012|19247428|P1|Overall Study|Adverse Event|0
5569176|NCT01116882|19247602|P2|12-month|Withdrawal by Subject|8
5569177|NCT01116882|19247603|P1|12-month|Withdrawal by Subject|5
5569178|NCT01116882|19247602|P2|12-month|Other Reasons|49
5569179|NCT01116882|19247603|P1|12-month|Other Reasons|151
5569180|NCT01116882|19247602|P2|12-month|Lost to Follow-up|42
5569181|NCT01116882|19247603|P1|12-month|Lost to Follow-up|111
5569182|NCT01116882|19247602|P2|30-day|Other Reasons|6
5569183|NCT01116882|19247603|P1|30-day|Other Reasons|16
5569184|NCT01116882|19247602|P2|30-day|Withdrawal by Subject|4
5569185|NCT01116882|19247603|P1|30-day|Withdrawal by Subject|2
5569186|NCT01116882|19247602|P2|30-day|Lost to Follow-up|21
5569187|NCT01116882|19247603|P1|30-day|Lost to Follow-up|50
5569188|NCT01116687|19247641|P1|Overall Study|Withdrawal by Subject|4
5569189|NCT01116648|19247668|P15|Phase 1 Dose Level 3|Adverse Event|0
5569190|NCT01116648|19247669|P14|Phase 1 Dose Level 3|Adverse Event|0
5569191|NCT01116648|19247670|P13|Phase 1 Dose Level 3|Adverse Event|0
5569192|NCT01116648|19247671|P12|Phase 1 Dose Level 3|Adverse Event|0
5569193|NCT01116648|19247672|P11|Phase 1 Dose Level 3|Adverse Event|0
5569194|NCT01116648|19247673|P10|Phase 1 Dose Level 3|Adverse Event|0
5569195|NCT01116648|19247674|P9|Phase 1 Dose Level 3|Adverse Event|0
5569196|NCT01116648|19247675|P8|Phase 1 Dose Level 3|Adverse Event|0
5569197|NCT01116648|19247676|P7|Phase 1 Dose Level 3|Adverse Event|0
5569198|NCT01116648|19247677|P6|Phase 1 Dose Level 3|Adverse Event|0
5569199|NCT01116648|19247678|P5|Phase 1 Dose Level 3|Adverse Event|0
5569200|NCT01116648|19247679|P4|Phase 1 Dose Level 3|Adverse Event|2
5569201|NCT01116648|19247680|P3|Phase 1 Dose Level 3|Adverse Event|0
5569202|NCT01116648|19247681|P2|Phase 1 Dose Level 3|Adverse Event|0
5569203|NCT01116648|19247682|P1|Phase 1 Dose Level 3|Adverse Event|0
5569204|NCT01116544|19247709|P2|Overall Study|Withdrawal by Subject|1
5569205|NCT01116544|19247710|P1|Overall Study|Withdrawal by Subject|1
5569206|NCT01116544|19247709|P2|Overall Study|Protocol Violation|0
5569207|NCT01116544|19247710|P1|Overall Study|Protocol Violation|1
5569208|NCT01116440|19247736|P2|Follow-up|Withdrawal by Subject|1
5569209|NCT01116440|19247737|P1|Follow-up|Withdrawal by Subject|0
5569210|NCT01116440|19247736|P2|Follow-up|Lost to Follow-up|1
5569211|NCT01116440|19247737|P1|Follow-up|Lost to Follow-up|0
5569212|NCT01116440|19247736|P2|Withdrawal|Lost to Follow-up|1
5569213|NCT01116440|19247737|P1|Withdrawal|Lost to Follow-up|0
5569214|NCT01116440|19247736|P2|Withdrawal|Withdrawal by Subject|1
5569215|NCT01116440|19247737|P1|Withdrawal|Withdrawal by Subject|0
5569216|NCT01116440|19247736|P2|Treatment|Adverse Event|1
5569217|NCT01116440|19247737|P1|Treatment|Adverse Event|0
5569218|NCT01116440|19247736|P2|Treatment|Lack of Efficacy|1
5569219|NCT01116440|19247737|P1|Treatment|Lack of Efficacy|0
5569220|NCT01116440|19247736|P2|Treatment|Protocol Violation|2
5569221|NCT01116440|19247737|P1|Treatment|Protocol Violation|0
5569222|NCT01116440|19247736|P2|Treatment|Lost to Follow-up|1
5569223|NCT01116440|19247737|P1|Treatment|Lost to Follow-up|1
5569224|NCT01116440|19247736|P2|Treatment|Withdrawal by Subject|2
5569225|NCT01116440|19247737|P1|Treatment|Withdrawal by Subject|2
5569226|NCT01116427|19247753|P2|Extension Phase|Not using appropriate birth control|0
5569227|NCT01116427|19247754|P1|Extension Phase|Not using appropriate birth control|1
5569228|NCT01116427|19247753|P2|Extension Phase|Withdrawal by Subject|1
5569229|NCT01116427|19247754|P1|Extension Phase|Withdrawal by Subject|5
5569230|NCT01116427|19247753|P2|Extension Phase|Lost to Follow-up|0
5569231|NCT01116427|19247754|P1|Extension Phase|Lost to Follow-up|2
5569232|NCT01116427|19247753|P2|Extension Phase|Adverse Event|1
5569233|NCT01116427|19247754|P1|Extension Phase|Adverse Event|1
5569234|NCT01116427|19247753|P2|Core Phase|Worsening Multiple Sclerosis|0
5569235|NCT01116427|19247754|P1|Core Phase|Worsening Multiple Sclerosis|1
5569236|NCT01116427|19247753|P2|Core Phase|Withdrawal by Subject|0
5569237|NCT01116427|19247754|P1|Core Phase|Withdrawal by Subject|3
5569238|NCT01116427|19247753|P2|Core Phase|Lost to Follow-up|0
5569239|NCT01116427|19247754|P1|Core Phase|Lost to Follow-up|1
5569240|NCT01116427|19247753|P2|Core Phase|Adverse Event|1
5569241|NCT01116427|19247754|P1|Core Phase|Adverse Event|0
5569242|NCT01116232|19247795|P1|Overall Study|Progressive diease|4
5569243|NCT01115998|19247909|P2|Overall Study|Lost to Follow-up|6
5569244|NCT01115998|19247910|P1|Overall Study|Lost to Follow-up|6
5569245|NCT01115933|19247920|P1|Overall Study|Did not receive XIENCE PRIME SV|1
5569246|NCT01115855|19248017|P2|Overall Study|Other|6
5569247|NCT01115855|19248018|P1|Overall Study|Other|8
5569248|NCT01115855|19248017|P2|Overall Study|Withdrawal by Subject|5
5569249|NCT01115855|19248018|P1|Overall Study|Withdrawal by Subject|5
5569250|NCT01115855|19248017|P2|Overall Study|Protocol Violation|1
5569251|NCT01115855|19248018|P1|Overall Study|Protocol Violation|0
5569252|NCT01115855|19248017|P2|Overall Study|Lab Abnormality|1
5569253|NCT01115855|19248018|P1|Overall Study|Lab Abnormality|1
5569254|NCT01115855|19248017|P2|Overall Study|Death|5
5569255|NCT01115855|19248018|P1|Overall Study|Death|6
5569256|NCT01115855|19248017|P2|Overall Study|Adverse Event|18
5569257|NCT01115855|19248018|P1|Overall Study|Adverse Event|16
5569258|NCT01115803|19248073|P7|Overall Study|Progressive Disease during Cycle1|1
5569259|NCT01115803|19248074|P6|Overall Study|Progressive Disease during Cycle1|0
5569260|NCT01115803|19248075|P5|Overall Study|Progressive Disease during Cycle1|0
5569261|NCT01115803|19248076|P4|Overall Study|Progressive Disease during Cycle1|0
5569262|NCT01115803|19248077|P3|Overall Study|Progressive Disease during Cycle1|0
5569263|NCT01115803|19248078|P2|Overall Study|Progressive Disease during Cycle1|0
5569264|NCT01115803|19248079|P1|Overall Study|Progressive Disease during Cycle1|0
5569265|NCT01115803|19248073|P7|Overall Study|Lost to Follow-up|0
5569266|NCT01115803|19248074|P6|Overall Study|Lost to Follow-up|0
5569267|NCT01115803|19248075|P5|Overall Study|Lost to Follow-up|0
5569268|NCT01115803|19248076|P4|Overall Study|Lost to Follow-up|0
5569269|NCT01115803|19248077|P3|Overall Study|Lost to Follow-up|1
5569270|NCT01115803|19248078|P2|Overall Study|Lost to Follow-up|0
5569271|NCT01115803|19248079|P1|Overall Study|Lost to Follow-up|0
5569272|NCT01115803|19248073|P7|Overall Study|Withdrawal by Subject|1
5569273|NCT01115803|19248074|P6|Overall Study|Withdrawal by Subject|0
5569274|NCT01115803|19248075|P5|Overall Study|Withdrawal by Subject|0
5569275|NCT01115803|19248076|P4|Overall Study|Withdrawal by Subject|0
5569276|NCT01115803|19248077|P3|Overall Study|Withdrawal by Subject|0
5569277|NCT01115803|19248078|P2|Overall Study|Withdrawal by Subject|0
5569278|NCT01115803|19248079|P1|Overall Study|Withdrawal by Subject|0
5569279|NCT01115738|19248142|P3|Overall Study|Withdrawal by Subject|9
5569280|NCT01115738|19248143|P2|Overall Study|Withdrawal by Subject|6
5569281|NCT01115738|19248144|P1|Overall Study|Withdrawal by Subject|6
5569282|NCT01115738|19248142|P3|Overall Study|Physician Decision|17
5569283|NCT01115738|19248143|P2|Overall Study|Physician Decision|15
5569284|NCT01115738|19248144|P1|Overall Study|Physician Decision|18
5569285|NCT01115738|19248142|P3|Overall Study|Lost to Follow-up|1
5569286|NCT01115738|19248143|P2|Overall Study|Lost to Follow-up|0
5569287|NCT01115738|19248144|P1|Overall Study|Lost to Follow-up|0
5569288|NCT01115738|19248142|P3|Overall Study|Death|0
5569289|NCT01115738|19248143|P2|Overall Study|Death|0
5569290|NCT01115738|19248144|P1|Overall Study|Death|1
5569291|NCT01115569|19248342|P2|Maintenance Phase|Administrative|1
5569292|NCT01115569|19248343|P1|Maintenance Phase|Administrative|0
5569293|NCT01115569|19248342|P2|Maintenance Phase|Non-Compliance with Study Drug|48
5569294|NCT01115569|19248343|P1|Maintenance Phase|Non-Compliance with Study Drug|0
5569295|NCT01115569|19248342|P2|Maintenance Phase|Withdrawal by Subject|27
5569296|NCT01115569|19248343|P1|Maintenance Phase|Withdrawal by Subject|0
5569297|NCT01115569|19248342|P2|Maintenance Phase|Protocol Violation|9
5569298|NCT01115569|19248343|P1|Maintenance Phase|Protocol Violation|0
5569299|NCT01115569|19248342|P2|Maintenance Phase|Physician Decision|3
5569300|NCT01115569|19248343|P1|Maintenance Phase|Physician Decision|0
5569301|NCT01115569|19248342|P2|Maintenance Phase|Lost to Follow-up|8
5569302|NCT01115569|19248343|P1|Maintenance Phase|Lost to Follow-up|0
5569303|NCT01115569|19248342|P2|Maintenance Phase|Adverse Event|43
5569304|NCT01115569|19248343|P1|Maintenance Phase|Adverse Event|0
5569305|NCT01115569|19248342|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
5569306|NCT01115569|19248343|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
5569307|NCT01115569|19248342|P2|Conversion/Titration Phase|Withdrawal by Subject|0
5569308|NCT01115569|19248343|P1|Conversion/Titration Phase|Withdrawal by Subject|26
5569309|NCT01115569|19248342|P2|Conversion/Titration Phase|Protocol Violation|0
5569310|NCT01115569|19248343|P1|Conversion/Titration Phase|Protocol Violation|68
5569311|NCT01115569|19248342|P2|Conversion/Titration Phase|Physician Decision|0
5569312|NCT01115569|19248343|P1|Conversion/Titration Phase|Physician Decision|5
5569313|NCT01115569|19248342|P2|Conversion/Titration Phase|Lost to Follow-up|0
5569314|NCT01115569|19248343|P1|Conversion/Titration Phase|Lost to Follow-up|3
5569315|NCT01115569|19248342|P2|Conversion/Titration Phase|Adverse Event|0
5569316|NCT01115569|19248343|P1|Conversion/Titration Phase|Adverse Event|59
5569317|NCT01115491|19248372|P1|Overall Study|Physician Decision|1
5569318|NCT01115491|19248372|P1|Overall Study|Withdrawal by Subject|1
5569319|NCT01115491|19248372|P1|Overall Study|Lost to Follow-up|3
5569320|NCT01115491|19248372|P1|Overall Study|Adverse Event|3
5569321|NCT01115491|19248372|P1|Overall Study|Death|22
5569322|NCT01115309|19248431|P1|Long-term Follow-up|Lost to Follow-up|6
5569323|NCT01115309|19248431|P1|Procedure Safety (1-Month)|Withdrawal by Subject|1
5569324|NCT01115309|19248431|P1|Procedure Safety (1-Month)|Lost to Follow-up|2
5569325|NCT01114880|19248598|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
5569326|NCT01114880|19248599|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
5569327|NCT01114880|19248598|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
5569328|NCT01114880|19248599|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
5569329|NCT01114880|19248598|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
5569330|NCT01114880|19248599|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
5569331|NCT01114880|19248598|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
5569332|NCT01114880|19248599|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
5569333|NCT01114880|19248598|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
5569334|NCT01114880|19248599|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
5569335|NCT01114880|19248598|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
5569336|NCT01114880|19248599|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
5569337|NCT01114828|19248651|P2|Overall Study|Withdrawal by Subject|1
5569338|NCT01114828|19248652|P1|Overall Study|Withdrawal by Subject|0
5569339|NCT01114828|19248651|P2|Overall Study|Protocol Violation|0
5569340|NCT01114828|19248652|P1|Overall Study|Protocol Violation|2
5569341|NCT01114828|19248651|P2|Overall Study|Lack of Efficacy|2
5569342|NCT01114828|19248652|P1|Overall Study|Lack of Efficacy|0
5569343|NCT01114828|19248651|P2|Overall Study|Adverse Event|1
5569344|NCT01114828|19248652|P1|Overall Study|Adverse Event|1
5569345|NCT01114737|19248662|P2|Open-Label Treatment Period|Difficult Personal Events|0
5569346|NCT01114737|19248663|P1|Open-Label Treatment Period|Difficult Personal Events|1
5569347|NCT01114737|19248662|P2|Open-Label Treatment Period|Lost to Follow-up|1
5569348|NCT01114737|19248663|P1|Open-Label Treatment Period|Lost to Follow-up|3
5569349|NCT01114737|19248662|P2|Open-Label Treatment Period|Withdrawal by Subject|1
5569350|NCT01114737|19248663|P1|Open-Label Treatment Period|Withdrawal by Subject|1
5569351|NCT01114737|19248662|P2|Randomized Treatment Period|Pregnancy|0
5569352|NCT01114737|19248663|P1|Randomized Treatment Period|Pregnancy|1
5569353|NCT01114737|19248662|P2|Randomized Treatment Period|Lost to Follow-up|1
5569354|NCT01114737|19248663|P1|Randomized Treatment Period|Lost to Follow-up|1
5569355|NCT01114737|19248662|P2|Randomized Treatment Period|Withdrawal by Subject|0
5569356|NCT01114737|19248663|P1|Randomized Treatment Period|Withdrawal by Subject|1
5569357|NCT01114724|19248711|P1|Overall Study|Withdrawal by Subject|1
5569358|NCT01114724|19248711|P1|Overall Study|Lost to Follow-up|1
5569359|NCT01114724|19248711|P1|Overall Study|Death|8
5569360|NCT01114672|19248731|P2|Overall Study|transplanted|0
5569361|NCT01114672|19248732|P1|Overall Study|transplanted|1
5569362|NCT01114672|19248731|P2|Overall Study|Lost to Follow-up|0
5569363|NCT01114672|19248732|P1|Overall Study|Lost to Follow-up|1
5569364|NCT01114672|19248731|P2|Overall Study|Withdrawal by Subject|1
5569365|NCT01114672|19248732|P1|Overall Study|Withdrawal by Subject|2
5569366|NCT01114672|19248731|P2|Overall Study|Death|1
5569367|NCT01114672|19248732|P1|Overall Study|Death|0
5569368|NCT01114646|19248740|P2|Overall Study|Withdrawal by Subject|2
5569369|NCT01114646|19248741|P1|Overall Study|Withdrawal by Subject|3
5569370|NCT01114529|19248801|P3|Completed Study Phase at Month 24|Missing|0
5569371|NCT01114529|19248802|P2|Completed Study Phase at Month 24|Missing|0
5569372|NCT01114529|19248803|P1|Completed Study Phase at Month 24|Missing|2
5569373|NCT01114529|19248801|P3|Completed Study Phase at Month 24|Other|0
5569374|NCT01114529|19248802|P2|Completed Study Phase at Month 24|Other|0
5569375|NCT01114529|19248803|P1|Completed Study Phase at Month 24|Other|2
5569376|NCT01114529|19248801|P3|Completed Study Phase at Month 24|Death|4
5569377|NCT01114529|19248802|P2|Completed Study Phase at Month 24|Death|5
5569378|NCT01114529|19248803|P1|Completed Study Phase at Month 24|Death|8
5569379|NCT01114529|19248801|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
5569380|NCT01114529|19248802|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
5569381|NCT01114529|19248803|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
5569382|NCT01114529|19248801|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
5569383|NCT01114529|19248802|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
5569384|NCT01114529|19248803|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
5569385|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Missing|0
5569386|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Missing|0
5569387|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Missing|2
5569388|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Protocol Violation|2
5569389|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Protocol Violation|5
5569390|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Protocol Violation|0
5569391|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Graft loss|0
5569392|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Graft loss|2
5569393|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Graft loss|0
5569394|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Death|2
5569395|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Death|1
5569396|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Death|2
5569397|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Administrative problems|2
5569398|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Administrative problems|1
5569399|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Administrative problems|2
5569400|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
5569401|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
5569402|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
5569403|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
5569404|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
5569405|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
5569406|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
5569407|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
5569408|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
5569409|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
5569410|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
5569411|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
5569412|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
5569413|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
5569414|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
5569415|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
5569416|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
5569417|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
5569418|NCT01114529|19248801|P3|Completed Study Medication at Month 24|Adverse Event|17
5569419|NCT01114529|19248802|P2|Completed Study Medication at Month 24|Adverse Event|18
5569420|NCT01114529|19248803|P1|Completed Study Medication at Month 24|Adverse Event|87
5569421|NCT01114516|19248822|P2|Overall Study|Lost to Follow-up|1
5569422|NCT01114516|19248823|P1|Overall Study|Lost to Follow-up|2
5569423|NCT01114438|19248858|P1|Overall Study|Withdrawal by Subject|2
5569424|NCT01114438|19248858|P1|Overall Study|Physician Decision|1
5569425|NCT01114438|19248858|P1|Overall Study|concomitant medication|1
5569426|NCT01114438|19248858|P1|Overall Study|Adverse Event|10
5569427|NCT01114373|19248868|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
5569428|NCT01114373|19248869|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
5569429|NCT01114373|19248868|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
5569430|NCT01114373|19248869|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
5569431|NCT01114373|19248868|P2|Intervention 1 (4 Weeks)|Incarceration|0
5569432|NCT01114373|19248869|P1|Intervention 1 (4 Weeks)|Incarceration|1
5569433|NCT01114373|19248868|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
5569434|NCT01114373|19248869|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
5569435|NCT01114360|19248901|P2|Intervention 1 (4 Weeks)|Physician Decision|1
5569436|NCT01114360|19248902|P1|Intervention 1 (4 Weeks)|Physician Decision|0
5569437|NCT01114217|19248953|P2|Overall Study|Other-Withdrawal by Subject|1
5569438|NCT01114217|19248954|P1|Overall Study|Other-Withdrawal by Subject|1
5569439|NCT01114217|19248953|P2|Overall Study|Other-Lost to Follow-up|0
5569440|NCT01114217|19248954|P1|Overall Study|Other-Lost to Follow-up|1
5569441|NCT01114217|19248953|P2|Overall Study|Other-Site Stopped Communicating|0
5569442|NCT01114217|19248954|P1|Overall Study|Other-Site Stopped Communicating|2
5569443|NCT01114217|19248953|P2|Overall Study|Other-Study Withdrawn|1
5569444|NCT01114217|19248954|P1|Overall Study|Other-Study Withdrawn|1
5569445|NCT01114217|19248953|P2|Overall Study|Other-Study Termination|1
5569446|NCT01114217|19248954|P1|Overall Study|Other-Study Termination|0
5569447|NCT01114217|19248953|P2|Overall Study|Other-Sponsor Decision|12
5569448|NCT01114217|19248954|P1|Overall Study|Other-Sponsor Decision|10
5569449|NCT01114217|19248953|P2|Overall Study|Other-Physician Decision|1
5569450|NCT01114217|19248954|P1|Overall Study|Other-Physician Decision|1
5569451|NCT01114217|19248953|P2|Overall Study|Other-Non Compliance|0
5569452|NCT01114217|19248954|P1|Overall Study|Other-Non Compliance|2
5569453|NCT01114217|19248953|P2|Overall Study|Other-Lack of Efficacy|0
5569454|NCT01114217|19248954|P1|Overall Study|Other-Lack of Efficacy|1
5569455|NCT01114217|19248953|P2|Overall Study|Other-Protocol Violation|3
5569456|NCT01114217|19248954|P1|Overall Study|Other-Protocol Violation|1
5569457|NCT01114217|19248953|P2|Overall Study|Other-Pregnancy|4
5569458|NCT01114217|19248954|P1|Overall Study|Other-Pregnancy|2
5569459|NCT01114217|19248953|P2|Overall Study|Other-Procedure|1
5569460|NCT01114217|19248954|P1|Overall Study|Other-Procedure|1
5569461|NCT01114217|19248953|P2|Overall Study|Other-Early termination|10
5569462|NCT01114217|19248954|P1|Overall Study|Other-Early termination|6
5569463|NCT01114217|19248953|P2|Overall Study|Other-Clerical Error|0
5569464|NCT01114217|19248954|P1|Overall Study|Other-Clerical Error|3
5569465|NCT01114217|19248953|P2|Overall Study|Withdrawal by Subject|28
5569466|NCT01114217|19248954|P1|Overall Study|Withdrawal by Subject|21
5569467|NCT01114217|19248953|P2|Overall Study|Lost to Follow-up|33
5569468|NCT01114217|19248954|P1|Overall Study|Lost to Follow-up|17
5569469|NCT01114217|19248953|P2|Overall Study|Adverse Event|3
5569470|NCT01114217|19248954|P1|Overall Study|Adverse Event|5
5569471|NCT01114204|19248966|P2|Overall Study|Other-Protocol Violation|0
5569472|NCT01114204|19248967|P1|Overall Study|Other-Protocol Violation|1
5569473|NCT01114204|19248966|P2|Overall Study|Other-Participant request|0
5569474|NCT01114204|19248967|P1|Overall Study|Other-Participant request|2
5569475|NCT01114204|19248966|P2|Overall Study|Other-Medical monitor request|0
5569476|NCT01114204|19248967|P1|Overall Study|Other-Medical monitor request|1
5569477|NCT01114204|19248966|P2|Overall Study|Other-Personal reasons|0
5569478|NCT01114204|19248967|P1|Overall Study|Other-Personal reasons|2
5569479|NCT01114204|19248966|P2|Overall Study|Death|0
5569480|NCT01114204|19248967|P1|Overall Study|Death|1
5569481|NCT01114204|19248966|P2|Overall Study|Withdrawal by Subject|6
5569482|NCT01114204|19248967|P1|Overall Study|Withdrawal by Subject|10
5569483|NCT01114204|19248966|P2|Overall Study|Lost to Follow-up|0
5569484|NCT01114204|19248967|P1|Overall Study|Lost to Follow-up|1
5569485|NCT01114204|19248966|P2|Overall Study|Adverse Event|2
5569486|NCT01114204|19248967|P1|Overall Study|Adverse Event|3
5569487|NCT01114139|19248985|P2|Overall Study|Other-Withdrew prior to receiving dose|3
5569488|NCT01114139|19248986|P1|Overall Study|Other-Withdrew prior to receiving dose|1
5569489|NCT01114139|19248985|P2|Overall Study|Other-Physician changed treatment|0
5569490|NCT01114139|19248986|P1|Overall Study|Other-Physician changed treatment|1
5569491|NCT01114139|19248985|P2|Overall Study|Other-Participant went on hospice|1
5569492|NCT01114139|19248986|P1|Overall Study|Other-Participant went on hospice|0
5569493|NCT01114139|19248985|P2|Overall Study|Other-Participant falsified records|1
5569494|NCT01114139|19248986|P1|Overall Study|Other-Participant falsified records|0
5569495|NCT01114139|19248985|P2|Overall Study|Other-Out of window for study drug dose|0
5569496|NCT01114139|19248986|P1|Overall Study|Other-Out of window for study drug dose|1
5569497|NCT01114139|19248985|P2|Overall Study|Other-Protocol Violation|0
5569498|NCT01114139|19248986|P1|Overall Study|Other-Protocol Violation|1
5569499|NCT01114139|19248985|P2|Overall Study|Other-Missed 1 visit|0
5569500|NCT01114139|19248986|P1|Overall Study|Other-Missed 1 visit|1
5569501|NCT01114139|19248985|P2|Overall Study|Withdrawal by Subject|6
5569502|NCT01114139|19248986|P1|Overall Study|Withdrawal by Subject|17
5569503|NCT01114139|19248985|P2|Overall Study|Lost to Follow-up|3
5569504|NCT01114139|19248986|P1|Overall Study|Lost to Follow-up|15
5569505|NCT01114139|19248985|P2|Overall Study|Adverse Event|2
5569506|NCT01114139|19248986|P1|Overall Study|Adverse Event|3
5569507|NCT01113931|19249015|P2|Overall Study|Withdrawal by Subject|0
5569508|NCT01113931|19249016|P1|Overall Study|Withdrawal by Subject|3
5569509|NCT01113931|19249015|P2|Overall Study|Various|4
5569510|NCT01113931|19249016|P1|Overall Study|Various|2
5569511|NCT01113931|19249015|P2|Overall Study|Lost to Follow-up|9
5569512|NCT01113931|19249016|P1|Overall Study|Lost to Follow-up|12
5569513|NCT01113931|19249015|P2|Overall Study|Physician Decision|2
5569514|NCT01113931|19249016|P1|Overall Study|Physician Decision|0
5569515|NCT01113931|19249015|P2|Overall Study|Adverse Event|2
5569516|NCT01113931|19249016|P1|Overall Study|Adverse Event|2
5569517|NCT01113892|19249030|P2|Overall Study|Graft no longer evaluable|9
5569518|NCT01113892|19249031|P1|Overall Study|Graft no longer evaluable|9
5569519|NCT01113892|19249030|P2|Overall Study|Death|4
5569520|NCT01113892|19249031|P1|Overall Study|Death|2
5569521|NCT01113892|19249030|P2|Overall Study|Withdrawal by Subject|1
5569522|NCT01113892|19249031|P1|Overall Study|Withdrawal by Subject|1
5569523|NCT01113892|19249030|P2|Overall Study|Lost to Follow-up|2
5569524|NCT01113892|19249031|P1|Overall Study|Lost to Follow-up|2
5569525|NCT01113879|19249059|P2|Period 1: Block 1|Withdrawal by Subject|0
5569526|NCT01113879|19249060|P1|Period 1: Block 1|Withdrawal by Subject|2
5569527|NCT01113801|19249072|P4|Overall Study|Clinical Endpoint (ESRD)|5
5569528|NCT01113801|19249073|P3|Overall Study|Clinical Endpoint (ESRD)|2
5569529|NCT01113801|19249074|P2|Overall Study|Clinical Endpoint (ESRD)|4
5569530|NCT01113801|19249075|P1|Overall Study|Clinical Endpoint (ESRD)|7
5569531|NCT01113801|19249072|P4|Overall Study|Sponsor Decision|15
5569532|NCT01113801|19249073|P3|Overall Study|Sponsor Decision|20
5569533|NCT01113801|19249074|P2|Overall Study|Sponsor Decision|21
5569534|NCT01113801|19249075|P1|Overall Study|Sponsor Decision|15
5569535|NCT01113801|19249072|P4|Overall Study|Physician Decision|3
5569536|NCT01113801|19249073|P3|Overall Study|Physician Decision|3
5569537|NCT01113801|19249074|P2|Overall Study|Physician Decision|2
5569538|NCT01113801|19249075|P1|Overall Study|Physician Decision|2
5569539|NCT01113801|19249072|P4|Overall Study|Withdrawal by Subject|8
5569540|NCT01113801|19249073|P3|Overall Study|Withdrawal by Subject|7
5569541|NCT01113801|19249074|P2|Overall Study|Withdrawal by Subject|7
5569542|NCT01113801|19249075|P1|Overall Study|Withdrawal by Subject|9
5569543|NCT01113801|19249072|P4|Overall Study|Protocol Violation|0
5569544|NCT01113801|19249073|P3|Overall Study|Protocol Violation|0
5569545|NCT01113801|19249074|P2|Overall Study|Protocol Violation|1
5569546|NCT01113801|19249075|P1|Overall Study|Protocol Violation|0
5569547|NCT01113801|19249072|P4|Overall Study|Death|4
5569548|NCT01113801|19249073|P3|Overall Study|Death|3
5569549|NCT01113801|19249074|P2|Overall Study|Death|5
5569550|NCT01113801|19249075|P1|Overall Study|Death|4
5569551|NCT01113801|19249072|P4|Overall Study|Adverse Event|6
5569552|NCT01113801|19249073|P3|Overall Study|Adverse Event|2
5569553|NCT01113801|19249074|P2|Overall Study|Adverse Event|0
5569554|NCT01113801|19249075|P1|Overall Study|Adverse Event|4
5569555|NCT01113749|19249103|P2|Overall Study|Lost to Follow-up|2
5569556|NCT01113749|19249104|P1|Overall Study|Lost to Follow-up|1
5569557|NCT01113710|19249127|P1|Overall Study|Subject Did Not Receive Neupro|3
5569558|NCT01113710|19249127|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
5569559|NCT01113710|19249127|P1|Overall Study|Lack of Patient's Compliance/Other|1
5569560|NCT01113710|19249127|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
5569561|NCT01113710|19249127|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
5569562|NCT01113710|19249127|P1|Overall Study|Compliance/Efficacy/AE/Other|1
5569563|NCT01113710|19249127|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
5569564|NCT01113710|19249127|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
5569565|NCT01113710|19249127|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
5569566|NCT01113710|19249127|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
5569567|NCT01113710|19249127|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
5569568|NCT01113710|19249127|P1|Overall Study|Lack of Efficacy/Adverse Event|3
5569569|NCT01113710|19249127|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
5569570|NCT01113710|19249127|P1|Overall Study|Lack of Efficacy/Other|4
5569571|NCT01113710|19249127|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
5569572|NCT01113710|19249127|P1|Overall Study|Adverse Event/Other|5
5569573|NCT01113710|19249127|P1|Overall Study|Other|7
5569574|NCT01113710|19249127|P1|Overall Study|Lack of Patient's Compliance|8
5569575|NCT01113710|19249127|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
5569576|NCT01113710|19249127|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
5569577|NCT01113710|19249127|P1|Overall Study|Lost to Follow-up|20
5569578|NCT01113710|19249127|P1|Overall Study|Withdrawal by Subject|28
5569579|NCT01113710|19249127|P1|Overall Study|No Information Available|40
5569580|NCT01113710|19249127|P1|Overall Study|Lack of Efficacy|41
5569581|NCT01113710|19249127|P1|Overall Study|Adverse Event|64
5569582|NCT01113580|19249155|P2|Overall Study|Protocol Violation|0
5569583|NCT01113580|19249156|P1|Overall Study|Protocol Violation|1
5569584|NCT01113541|19249170|P1|Overall Study|Adverse Event|4
5569585|NCT01113541|19249170|P1|Overall Study|Study Terminated by Sponsor|7
5569586|NCT01113541|19249170|P1|Overall Study|Protocol Violation|1
5569587|NCT01113541|19249170|P1|Overall Study|Withdrawal by Subject|1
5569588|NCT01113463|19249203|P1|Overall Study|Physician Decision|5
5569589|NCT01112982|19249233|P1|Overall Study|exceeded weight limit to complete MRI|1
5569590|NCT01112982|19249233|P1|Overall Study|Withdrawal by Subject|1
5569591|NCT01112917|19249245|P2|Overall Study|Unable to Convert Filter|0
5569592|NCT01112917|19249246|P1|Overall Study|Unable to Convert Filter|3
5569593|NCT01112917|19249245|P2|Overall Study|Withdrawal by Subject|3
5569594|NCT01112917|19249246|P1|Overall Study|Withdrawal by Subject|1
5569595|NCT01112917|19249245|P2|Overall Study|Lost to Follow-up|1
5569596|NCT01112917|19249246|P1|Overall Study|Lost to Follow-up|1
5569597|NCT01112917|19249245|P2|Overall Study|Death|11
5569598|NCT01112917|19249246|P1|Overall Study|Death|2
5569599|NCT01112579|19249350|P2|Overall Study|Death|2
5569600|NCT01112579|19249351|P1|Overall Study|Death|0
5569601|NCT01112579|19249350|P2|Overall Study|Missed Visit|1
5569602|NCT01112579|19249351|P1|Overall Study|Missed Visit|1
5569603|NCT01112514|19249361|P1|Overall Study|Lost to Follow-up|1
5569604|NCT01112267|19249417|P2|Overall Study|Participants not receive any study drug|2
5569605|NCT01112267|19249418|P1|Overall Study|Participants not receive any study drug|1
5569606|NCT01112267|19249417|P2|Overall Study|Participants not compliant|2
5569607|NCT01112267|19249418|P1|Overall Study|Participants not compliant|1
5569608|NCT01112267|19249417|P2|Overall Study|Protocol Violation|3
5569609|NCT01112267|19249418|P1|Overall Study|Protocol Violation|5
5569610|NCT01112267|19249417|P2|Overall Study|Withdrawal by Subject|5
5569611|NCT01112267|19249418|P1|Overall Study|Withdrawal by Subject|3
5569612|NCT01112267|19249417|P2|Overall Study|Adverse Event|6
5569613|NCT01112267|19249418|P1|Overall Study|Adverse Event|24
5569614|NCT01112059|19249457|P2|Overall Study|Withdrawal by Subject|0
5569615|NCT01112059|19249458|P1|Overall Study|Withdrawal by Subject|1
5569616|NCT01111851|19249472|P2|Overall Study|All planned PET scans were not obtained.|0
5569617|NCT01111851|19249473|P1|Overall Study|All planned PET scans were not obtained.|2
5569618|NCT01111838|19249485|P1|Overall Study|Other Complicating Disease|1
5569619|NCT01111838|19249485|P1|Overall Study|Clinical deterioration|1
5569620|NCT01111838|19249485|P1|Overall Study|Not Treated|3
5569621|NCT01111838|19249485|P1|Overall Study|Patient Ineligible|2
5569622|NCT01111825|19249493|P4|Overall Study|Discontinuation by Sponsor|20
5569623|NCT01111825|19249494|P3|Overall Study|Discontinuation by Sponsor|0
5569624|NCT01111825|19249495|P2|Overall Study|Discontinuation by Sponsor|0
5569625|NCT01111825|19249496|P1|Overall Study|Discontinuation by Sponsor|0
5569626|NCT01111825|19249493|P4|Overall Study|Disease Progression|0
5569627|NCT01111825|19249494|P3|Overall Study|Disease Progression|0
5569628|NCT01111825|19249495|P2|Overall Study|Disease Progression|0
5569629|NCT01111825|19249496|P1|Overall Study|Disease Progression|1
5569630|NCT01111825|19249493|P4|Overall Study|Adverse Event|0
5569631|NCT01111825|19249494|P3|Overall Study|Adverse Event|4
5569632|NCT01111825|19249495|P2|Overall Study|Adverse Event|1
5569633|NCT01111825|19249496|P1|Overall Study|Adverse Event|2
5569634|NCT01111825|19249493|P4|Overall Study|Lost to Follow-up|1
5569635|NCT01111825|19249494|P3|Overall Study|Lost to Follow-up|3
5569636|NCT01111825|19249495|P2|Overall Study|Lost to Follow-up|0
5569637|NCT01111825|19249496|P1|Overall Study|Lost to Follow-up|0
5569638|NCT01111825|19249493|P4|Overall Study|Withdrawal by Subject|0
5569639|NCT01111825|19249494|P3|Overall Study|Withdrawal by Subject|1
5569640|NCT01111825|19249495|P2|Overall Study|Withdrawal by Subject|0
5569641|NCT01111825|19249496|P1|Overall Study|Withdrawal by Subject|0
5569642|NCT01111604|19249518|P3|Overall Study|Met Exclusion Criteria|0
5569643|NCT01111604|19249519|P2|Overall Study|Met Exclusion Criteria|0
5569644|NCT01111604|19249520|P1|Overall Study|Met Exclusion Criteria|2
5569645|NCT01111604|19249518|P3|Overall Study|Death|0
5569646|NCT01111604|19249519|P2|Overall Study|Death|0
5569647|NCT01111604|19249520|P1|Overall Study|Death|1
5569648|NCT01111604|19249518|P3|Overall Study|Withdrawal by Subject|0
5569649|NCT01111604|19249519|P2|Overall Study|Withdrawal by Subject|0
5569650|NCT01111604|19249520|P1|Overall Study|Withdrawal by Subject|2
5569651|NCT01111604|19249518|P3|Overall Study|Withdrew Consent|2
5569652|NCT01111604|19249519|P2|Overall Study|Withdrew Consent|0
5569653|NCT01111604|19249520|P1|Overall Study|Withdrew Consent|3
5569654|NCT01111604|19249518|P3|Overall Study|Lost to Follow-up|1
5569655|NCT01111604|19249519|P2|Overall Study|Lost to Follow-up|0
5569656|NCT01111604|19249520|P1|Overall Study|Lost to Follow-up|0
5569657|NCT01111526|19249558|P3|Overall Study|GVHD Disease Progression|2
5569658|NCT01111526|19249559|P2|Overall Study|GVHD Disease Progression|1
5569659|NCT01111526|19249560|P1|Overall Study|GVHD Disease Progression|0
5569660|NCT01111474|19249572|P1|Overall Study|Lost to Follow-up|12
5569661|NCT01111461|19249580|P1|Overall Study|Other|6
5569662|NCT01111461|19249580|P1|Overall Study|Withdrawal by Subject|1
5569663|NCT01111461|19249580|P1|Overall Study|Lost to Follow-up|1
5569664|NCT01111461|19249580|P1|Overall Study|Participant choice|11
5569665|NCT01111461|19249580|P1|Overall Study|Adverse Event|32
5569666|NCT01111292|19249760|P2|Treatment|Physician Decision|1
5569667|NCT01111292|19249761|P1|Treatment|Physician Decision|1
5569668|NCT01111240|19249767|P1|Overall Study|Other|312
5569669|NCT01111240|19249767|P1|Overall Study|Lack of Efficacy and Adverse Event|19
5569670|NCT01111240|19249767|P1|Overall Study|Lack of Efficacy|545
5569671|NCT01111240|19249767|P1|Overall Study|Adverse Event|190
5569672|NCT01111149|19249797|P3|Overall Study|Withdrawal by Subject|2
5569673|NCT01111149|19249798|P2|Overall Study|Withdrawal by Subject|0
5569674|NCT01111149|19249799|P1|Overall Study|Withdrawal by Subject|1
5569675|NCT01111149|19249797|P3|Overall Study|Protocol Violation|2
5569676|NCT01111149|19249798|P2|Overall Study|Protocol Violation|1
5569677|NCT01111149|19249799|P1|Overall Study|Protocol Violation|1
5569678|NCT01111123|19249875|P2|Maintenance Phase|Lost to Follow-up|2
5569679|NCT01111123|19249876|P1|Maintenance Phase|Lost to Follow-up|0
5569680|NCT01111123|19249875|P2|Open- Label Phase|Failed to be clear or almost cleared|0
5569681|NCT01111123|19249876|P1|Open- Label Phase|Failed to be clear or almost cleared|14
5569682|NCT01111019|19249922|P1|Overall Study|Other|1
5569683|NCT01111019|19249922|P1|Overall Study|Withdrew Prematurely|2
5569684|NCT01110915|19249954|P2|Overall Study|Withdrawal by Subject|1
5569685|NCT01110915|19249955|P1|Overall Study|Withdrawal by Subject|7
5569686|NCT01110915|19249954|P2|Overall Study|Lost to Follow-up|0
5569687|NCT01110915|19249955|P1|Overall Study|Lost to Follow-up|1
5569688|NCT01110915|19249954|P2|Overall Study|Death|1
5569689|NCT01110915|19249955|P1|Overall Study|Death|2
5569690|NCT01110707|19249972|P2|Overall Study|Protocol Violation|3
5569691|NCT01110707|19249973|P1|Overall Study|Protocol Violation|0
5569692|NCT01110408|19250074|P2|Overall Study|Protocol Violation|0
5569693|NCT01110408|19250075|P1|Overall Study|Protocol Violation|1
5569694|NCT01110382|19250099|P2|Overall Study|Protocol Violation|1
5569695|NCT01110382|19250100|P1|Overall Study|Protocol Violation|0
5569696|NCT01110382|19250099|P2|Overall Study|Withdrawal by Subject|1
5569697|NCT01110382|19250100|P1|Overall Study|Withdrawal by Subject|0
5569698|NCT01110330|19250121|P3|Overall Study|Other|1
5569699|NCT01110330|19250122|P2|Overall Study|Other|1
5569700|NCT01110330|19250123|P1|Overall Study|Other|1
5569701|NCT01110330|19250121|P3|Overall Study|Withdrawal by Subject|2
5569702|NCT01110330|19250122|P2|Overall Study|Withdrawal by Subject|6
5569703|NCT01110330|19250123|P1|Overall Study|Withdrawal by Subject|0
5569704|NCT01110330|19250121|P3|Overall Study|Protocol Violation|4
5569705|NCT01110330|19250122|P2|Overall Study|Protocol Violation|0
5569706|NCT01110330|19250123|P1|Overall Study|Protocol Violation|2
5569707|NCT01110330|19250121|P3|Overall Study|Physician Decision|0
5569708|NCT01110330|19250122|P2|Overall Study|Physician Decision|1
5569709|NCT01110330|19250123|P1|Overall Study|Physician Decision|0
5569710|NCT01110330|19250121|P3|Overall Study|Lost to Follow-up|15
5569711|NCT01110330|19250122|P2|Overall Study|Lost to Follow-up|10
5569712|NCT01110330|19250123|P1|Overall Study|Lost to Follow-up|9
5569713|NCT01110330|19250121|P3|Overall Study|Lack of Efficacy|1
5569714|NCT01110330|19250122|P2|Overall Study|Lack of Efficacy|1
5569715|NCT01110330|19250123|P1|Overall Study|Lack of Efficacy|3
5569716|NCT01110330|19250121|P3|Overall Study|Adverse Event|3
5569717|NCT01110330|19250122|P2|Overall Study|Adverse Event|4
5569718|NCT01110330|19250123|P1|Overall Study|Adverse Event|0
5569719|NCT01110239|19250151|P4|7.5 Min Ischemia|Withdrawal by Subject|0
5569720|NCT01110239|19250152|P3|7.5 Min Ischemia|Withdrawal by Subject|1
5569721|NCT01110239|19250153|P2|7.5 Min Ischemia|Withdrawal by Subject|0
5569722|NCT01110239|19250154|P1|7.5 Min Ischemia|Withdrawal by Subject|0
5569723|NCT01110239|19250151|P4|Sham Preconditioning|Withdrawal by Subject|0
5569724|NCT01110239|19250152|P3|Sham Preconditioning|Withdrawal by Subject|1
5569725|NCT01110239|19250153|P2|Sham Preconditioning|Withdrawal by Subject|0
5569726|NCT01110239|19250154|P1|Sham Preconditioning|Withdrawal by Subject|0
5569727|NCT01110200|19250170|P2|Overall Study|Lost to Follow-up|7
5569728|NCT01110200|19250171|P1|Overall Study|Lost to Follow-up|10
5569729|NCT01110200|19250170|P2|Overall Study|Physician Decision|17
5569730|NCT01110200|19250171|P1|Overall Study|Physician Decision|13
5569731|NCT01110200|19250170|P2|Overall Study|Protocol Violation|12
5569732|NCT01110200|19250171|P1|Overall Study|Protocol Violation|14
5569733|NCT01110200|19250170|P2|Overall Study|Lack of Efficacy|25
5569734|NCT01110200|19250171|P1|Overall Study|Lack of Efficacy|16
5569735|NCT01110200|19250170|P2|Overall Study|Withdrawal by Subject|32
5569736|NCT01110200|19250171|P1|Overall Study|Withdrawal by Subject|25
5569737|NCT01110200|19250170|P2|Overall Study|Adverse Event|28
5569738|NCT01110200|19250171|P1|Overall Study|Adverse Event|28
5569739|NCT01110005|19250207|P2|Overall Study|Withdrawal by Subject|1
5569740|NCT01110005|19250208|P1|Overall Study|Withdrawal by Subject|0
5569741|NCT01110005|19250207|P2|Overall Study|missing consent|2
5569742|NCT01110005|19250208|P1|Overall Study|missing consent|3
5569743|NCT01110005|19250207|P2|Overall Study|ineligible|2
5569744|NCT01110005|19250208|P1|Overall Study|ineligible|1
5569745|NCT01109992|19250220|P2|Overall Study|Movement during rest scan.|1
5569746|NCT01109992|19250221|P1|Overall Study|Movement during rest scan.|0
5569747|NCT01109992|19250220|P2|Overall Study|Withdrawal by Subject|1
5569748|NCT01109992|19250221|P1|Overall Study|Withdrawal by Subject|0
5569749|NCT01109979|19250235|P2|Overall Study|Withdrawal by Subject|1
5569750|NCT01109979|19250236|P1|Overall Study|Withdrawal by Subject|0
5569751|NCT01109979|19250235|P2|Overall Study|Physician Decision|0
5569752|NCT01109979|19250236|P1|Overall Study|Physician Decision|2
5569753|NCT01109849|19250244|P5|Adaptive Randomization: Weight Recovery|moved away|0
5569754|NCT01109849|19250245|P4|Adaptive Randomization: Weight Recovery|moved away|2
5569755|NCT01109849|19250246|P3|Adaptive Randomization: Weight Recovery|moved away|0
5569756|NCT01109849|19250247|P2|Adaptive Randomization: Weight Recovery|moved away|0
5569757|NCT01109849|19250248|P1|Adaptive Randomization: Weight Recovery|moved away|0
5569758|NCT01109849|19250244|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
5569759|NCT01109849|19250245|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
5569760|NCT01109849|19250246|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
5569761|NCT01109849|19250247|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
5569762|NCT01109849|19250248|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
5569763|NCT01109849|19250244|P5|Initial Randomization: ADHD Treatment|move away|0
5569764|NCT01109849|19250245|P4|Initial Randomization: ADHD Treatment|move away|0
5569765|NCT01109849|19250246|P3|Initial Randomization: ADHD Treatment|move away|0
5569766|NCT01109849|19250247|P2|Initial Randomization: ADHD Treatment|move away|7
5569767|NCT01109849|19250248|P1|Initial Randomization: ADHD Treatment|move away|2
5569768|NCT01109849|19250244|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
5569769|NCT01109849|19250245|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
5569770|NCT01109849|19250246|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
5569771|NCT01109849|19250247|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
5569772|NCT01109849|19250248|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
5569773|NCT01109849|19250244|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
5569774|NCT01109849|19250245|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
5569775|NCT01109849|19250246|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
5569776|NCT01109849|19250247|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
5569777|NCT01109849|19250248|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
5569778|NCT01109849|19250244|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
5569779|NCT01109849|19250245|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
5569780|NCT01109849|19250246|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
5569781|NCT01109849|19250247|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
5569782|NCT01109849|19250248|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
5569783|NCT01109524|19250317|P1|Overall Study|Other|5
5569784|NCT01109524|19250317|P1|Overall Study|Participant requested to end treatment|4
5569785|NCT01109524|19250317|P1|Overall Study|No longer meets criteria|2
5569786|NCT01109524|19250317|P1|Overall Study|Death|2
5569787|NCT01109524|19250317|P1|Overall Study|Maximum clinical benefit|3
5569788|NCT01109524|19250317|P1|Overall Study|Withdrawal by Subject|2
5569789|NCT01109524|19250317|P1|Overall Study|Adverse Event|4
5569790|NCT01109524|19250317|P1|Overall Study|Study Drug toxicity|6
5569791|NCT01109524|19250317|P1|Overall Study|Disease Progression|29
5569792|NCT01109316|19250339|P6|Study Period 3|Withdrawal by Subject|0
5569793|NCT01109316|19250340|P5|Study Period 3|Withdrawal by Subject|1
5569794|NCT01109316|19250341|P4|Study Period 3|Withdrawal by Subject|0
5569795|NCT01109316|19250342|P3|Study Period 3|Withdrawal by Subject|0
5569796|NCT01109316|19250343|P2|Study Period 3|Withdrawal by Subject|0
5569797|NCT01109316|19250344|P1|Study Period 3|Withdrawal by Subject|1
5569798|NCT01109316|19250339|P6|Study Period 3|Lost to Follow-up|0
5569799|NCT01109316|19250340|P5|Study Period 3|Lost to Follow-up|1
5569800|NCT01109316|19250341|P4|Study Period 3|Lost to Follow-up|0
5569801|NCT01109316|19250342|P3|Study Period 3|Lost to Follow-up|0
5569802|NCT01109316|19250343|P2|Study Period 3|Lost to Follow-up|0
5569803|NCT01109316|19250344|P1|Study Period 3|Lost to Follow-up|0
5569804|NCT01109316|19250339|P6|Study Period 2|Withdrawal by Subject|1
5569805|NCT01109316|19250340|P5|Study Period 2|Withdrawal by Subject|0
5569806|NCT01109316|19250341|P4|Study Period 2|Withdrawal by Subject|0
5569807|NCT01109316|19250342|P3|Study Period 2|Withdrawal by Subject|1
5569808|NCT01109316|19250343|P2|Study Period 2|Withdrawal by Subject|0
5569809|NCT01109316|19250344|P1|Study Period 2|Withdrawal by Subject|0
5569810|NCT01109316|19250339|P6|Study Period 2|Protocol Violation|0
5569811|NCT01109316|19250340|P5|Study Period 2|Protocol Violation|0
5569812|NCT01109316|19250341|P4|Study Period 2|Protocol Violation|0
5569813|NCT01109316|19250342|P3|Study Period 2|Protocol Violation|0
5569814|NCT01109316|19250343|P2|Study Period 2|Protocol Violation|0
5569815|NCT01109316|19250344|P1|Study Period 2|Protocol Violation|1
5569816|NCT01109316|19250339|P6|Study Period 2|Physician Decision|0
5569817|NCT01109316|19250340|P5|Study Period 2|Physician Decision|0
5569818|NCT01109316|19250341|P4|Study Period 2|Physician Decision|1
5569819|NCT01109316|19250342|P3|Study Period 2|Physician Decision|0
5569820|NCT01109316|19250343|P2|Study Period 2|Physician Decision|0
5569821|NCT01109316|19250344|P1|Study Period 2|Physician Decision|0
5569822|NCT01109316|19250339|P6|Study Period 2|Entry Criteria Not Met|0
5569823|NCT01109316|19250340|P5|Study Period 2|Entry Criteria Not Met|0
5569824|NCT01109316|19250341|P4|Study Period 2|Entry Criteria Not Met|0
5569825|NCT01109316|19250342|P3|Study Period 2|Entry Criteria Not Met|0
5569826|NCT01109316|19250343|P2|Study Period 2|Entry Criteria Not Met|1
5569827|NCT01109316|19250344|P1|Study Period 2|Entry Criteria Not Met|0
5569828|NCT01109316|19250339|P6|Study Period 1|Sponsor Decision|2
5569829|NCT01109316|19250340|P5|Study Period 1|Sponsor Decision|0
5569830|NCT01109316|19250341|P4|Study Period 1|Sponsor Decision|0
5569831|NCT01109316|19250342|P3|Study Period 1|Sponsor Decision|0
5569832|NCT01109316|19250343|P2|Study Period 1|Sponsor Decision|0
5569833|NCT01109316|19250344|P1|Study Period 1|Sponsor Decision|0
5569834|NCT01109316|19250339|P6|Study Period 1|Withdrawal by Subject|0
5569835|NCT01109316|19250340|P5|Study Period 1|Withdrawal by Subject|2
5569836|NCT01109316|19250341|P4|Study Period 1|Withdrawal by Subject|0
5569837|NCT01109316|19250342|P3|Study Period 1|Withdrawal by Subject|1
5569838|NCT01109316|19250343|P2|Study Period 1|Withdrawal by Subject|0
5569839|NCT01109316|19250344|P1|Study Period 1|Withdrawal by Subject|0
5569840|NCT01109316|19250339|P6|Study Period 1|Lost to Follow-up|0
5569841|NCT01109316|19250340|P5|Study Period 1|Lost to Follow-up|0
5569842|NCT01109316|19250341|P4|Study Period 1|Lost to Follow-up|1
5569843|NCT01109316|19250342|P3|Study Period 1|Lost to Follow-up|1
5569844|NCT01109316|19250343|P2|Study Period 1|Lost to Follow-up|0
5569845|NCT01109316|19250344|P1|Study Period 1|Lost to Follow-up|0
5569846|NCT01109316|19250339|P6|Study Period 1|Adverse Event|0
5569847|NCT01109316|19250340|P5|Study Period 1|Adverse Event|0
5569848|NCT01109316|19250341|P4|Study Period 1|Adverse Event|0
5569849|NCT01109316|19250342|P3|Study Period 1|Adverse Event|1
5569850|NCT01109316|19250343|P2|Study Period 1|Adverse Event|0
5569851|NCT01109316|19250344|P1|Study Period 1|Adverse Event|0
5569852|NCT01109173|19250392|P4|Overall Study|Not Specifiied|14
5569853|NCT01109173|19250393|P3|Overall Study|Not Specifiied|9
5569854|NCT01109173|19250394|P2|Overall Study|Not Specifiied|4
5569855|NCT01109173|19250395|P1|Overall Study|Not Specifiied|5
5569856|NCT01109173|19250392|P4|Overall Study|Patient Did Not Use Study Medication|7
5569857|NCT01109173|19250393|P3|Overall Study|Patient Did Not Use Study Medication|11
5569858|NCT01109173|19250394|P2|Overall Study|Patient Did Not Use Study Medication|26
5569859|NCT01109173|19250395|P1|Overall Study|Patient Did Not Use Study Medication|34
5569860|NCT01109173|19250392|P4|Overall Study|Protocol Violation|2
5569861|NCT01109173|19250393|P3|Overall Study|Protocol Violation|1
5569862|NCT01109173|19250394|P2|Overall Study|Protocol Violation|5
5569863|NCT01109173|19250395|P1|Overall Study|Protocol Violation|4
5569864|NCT01109173|19250392|P4|Overall Study|Treatment Failure|64
5569865|NCT01109173|19250393|P3|Overall Study|Treatment Failure|69
5569866|NCT01109173|19250394|P2|Overall Study|Treatment Failure|32
5569867|NCT01109173|19250395|P1|Overall Study|Treatment Failure|25
5569868|NCT01109173|19250392|P4|Overall Study|Noncompliance|0
5569869|NCT01109173|19250393|P3|Overall Study|Noncompliance|0
5569870|NCT01109173|19250394|P2|Overall Study|Noncompliance|1
5569871|NCT01109173|19250395|P1|Overall Study|Noncompliance|0
5569872|NCT01109173|19250392|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
5569873|NCT01109173|19250393|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
5569874|NCT01109173|19250394|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
5569875|NCT01109173|19250395|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
5569876|NCT01109173|19250392|P4|Overall Study|Lost to Follow-up|0
5569877|NCT01109173|19250393|P3|Overall Study|Lost to Follow-up|0
5569878|NCT01109173|19250394|P2|Overall Study|Lost to Follow-up|1
5569879|NCT01109173|19250395|P1|Overall Study|Lost to Follow-up|0
5569880|NCT01109173|19250392|P4|Overall Study|Adverse Event|6
5569881|NCT01109173|19250393|P3|Overall Study|Adverse Event|9
5569882|NCT01109173|19250394|P2|Overall Study|Adverse Event|17
5569883|NCT01109173|19250395|P1|Overall Study|Adverse Event|15
5569884|NCT01108809|19250508|P1|Overall Study|Lost to Follow-up|1
5569885|NCT01108809|19250508|P1|Overall Study|Adverse Event|3
5569886|NCT01108796|19250525|P2|Overall Study|Lost to Follow-up|6
5569887|NCT01108796|19250526|P1|Overall Study|Lost to Follow-up|7
5569888|NCT01108796|19250525|P2|Overall Study|Adverse Event|1
5569889|NCT01108796|19250526|P1|Overall Study|Adverse Event|0
5569890|NCT01108731|19250569|P2|Overall Study|Adverse Event|3
5569891|NCT01108731|19250570|P1|Overall Study|Adverse Event|3
5569892|NCT01108731|19250569|P2|Overall Study|Withdrawal by Subject|1
5569893|NCT01108731|19250570|P1|Overall Study|Withdrawal by Subject|1
5569894|NCT01108718|19250582|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
5569895|NCT01108718|19250583|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
5569896|NCT01108523|19250595|P1|Overall Study|Protocol Violation|4
5569897|NCT01108510|19250602|P2|Overall Study|Death|1
5569898|NCT01108510|19250603|P1|Overall Study|Death|1
5569899|NCT01108510|19250602|P2|Overall Study|Pregnancy|3
5569900|NCT01108510|19250603|P1|Overall Study|Pregnancy|0
5569901|NCT01108510|19250602|P2|Overall Study|Lack of Efficacy|0
5569902|NCT01108510|19250603|P1|Overall Study|Lack of Efficacy|3
5569903|NCT01108510|19250602|P2|Overall Study|Participant Noncompliance|7
5569904|NCT01108510|19250603|P1|Overall Study|Participant Noncompliance|5
5569905|NCT01108510|19250602|P2|Overall Study|Investigator's Discretion|10
5569906|NCT01108510|19250603|P1|Overall Study|Investigator's Discretion|12
5569907|NCT01108510|19250602|P2|Overall Study|Withdrew Consent|15
5569908|NCT01108510|19250603|P1|Overall Study|Withdrew Consent|21
5569909|NCT01108510|19250602|P2|Overall Study|Lost to Follow-up|17
5569910|NCT01108510|19250603|P1|Overall Study|Lost to Follow-up|20
5569911|NCT01108510|19250602|P2|Overall Study|Adverse Event|19
5569912|NCT01108510|19250603|P1|Overall Study|Adverse Event|26
5569913|NCT01108510|19250602|P2|Overall Study|Joined Another Gilead-sponsored Study|195
5569914|NCT01108510|19250603|P1|Overall Study|Joined Another Gilead-sponsored Study|186
5569915|NCT01108510|19250602|P2|Overall Study|Randomized but Not Treated|1
5569916|NCT01108510|19250603|P1|Overall Study|Randomized but Not Treated|5
5569917|NCT01108458|19250623|P1|Overall Study|Withdrawal by Subject|1
5569918|NCT01108341|19250675|P1|Overall Study|Other|1
5569919|NCT01108341|19250675|P1|Overall Study|Lost to Follow-up|1
5569920|NCT01108341|19250675|P1|Overall Study|Withdrawal by Subject|1
5569921|NCT01108341|19250675|P1|Overall Study|Death|2
5569922|NCT01108263|19250682|P2|Overall Study|Adverse Event|1
5569923|NCT01108263|19250683|P1|Overall Study|Adverse Event|0
5569924|NCT01108237|19250693|P2|Overall Study|Did not meet criteria for analysis|0
5569925|NCT01108237|19250694|P1|Overall Study|Did not meet criteria for analysis|7
5569926|NCT01108237|19250693|P2|Overall Study|No alignment data|17
5569927|NCT01108237|19250694|P1|Overall Study|No alignment data|2
5569928|NCT01108185|19250700|P1|Overall Study|Lost to Follow-up|12
5569929|NCT01108185|19250700|P1|Overall Study|Non-compliance|15
5569930|NCT01108094|19250717|P4|Overall Study|Withdrawal by Subject|0
5569931|NCT01108094|19250718|P3|Overall Study|Withdrawal by Subject|0
5569932|NCT01108094|19250719|P2|Overall Study|Withdrawal by Subject|0
5569933|NCT01108094|19250720|P1|Overall Study|Withdrawal by Subject|1
5569934|NCT01108094|19250717|P4|Overall Study|Adverse Event|0
5569935|NCT01108094|19250718|P3|Overall Study|Adverse Event|0
5569936|NCT01108094|19250719|P2|Overall Study|Adverse Event|0
5569937|NCT01108094|19250720|P1|Overall Study|Adverse Event|2
5569938|NCT01108068|19250764|P2|Overall Study|5 not started, 1 stop due to side effect|0
5569939|NCT01108068|19250765|P1|Overall Study|5 not started, 1 stop due to side effect|6
5569940|NCT01108055|19250772|P1|Overall Study|Not evaluable- didn't complete treatment|4
5569941|NCT01108055|19250772|P1|Overall Study|Ineligible|11
5569942|NCT01107925|19250810|P6|Period 2|Withdrawal by Subject|1
5569943|NCT01107925|19250811|P5|Period 2|Withdrawal by Subject|0
5569944|NCT01107925|19250812|P4|Period 2|Withdrawal by Subject|0
5569945|NCT01107925|19250813|P3|Period 2|Withdrawal by Subject|0
5569946|NCT01107925|19250814|P2|Period 2|Withdrawal by Subject|1
5569947|NCT01107925|19250815|P1|Period 2|Withdrawal by Subject|0
5569948|NCT01107925|19250810|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5569949|NCT01107925|19250811|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
5569950|NCT01107925|19250812|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5569951|NCT01107925|19250813|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5569952|NCT01107925|19250814|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
5569953|NCT01107925|19250815|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
5569954|NCT01107912|19250853|P6|Period 3|Withdrawal by Subject|0
5569955|NCT01107912|19250854|P5|Period 3|Withdrawal by Subject|0
5569956|NCT01107912|19250855|P4|Period 3|Withdrawal by Subject|1
5569957|NCT01107912|19250856|P3|Period 3|Withdrawal by Subject|0
5569958|NCT01107912|19250857|P2|Period 3|Withdrawal by Subject|0
5569959|NCT01107912|19250858|P1|Period 3|Withdrawal by Subject|0
5569960|NCT01107912|19250853|P6|Period 3|Adverse Event|0
5569961|NCT01107912|19250854|P5|Period 3|Adverse Event|0
5569962|NCT01107912|19250855|P4|Period 3|Adverse Event|0
5569963|NCT01107912|19250856|P3|Period 3|Adverse Event|1
5569964|NCT01107912|19250857|P2|Period 3|Adverse Event|1
5569965|NCT01107912|19250858|P1|Period 3|Adverse Event|0
5569966|NCT01107912|19250853|P6|Period 2|Physician Decision|0
5569967|NCT01107912|19250854|P5|Period 2|Physician Decision|0
5569968|NCT01107912|19250855|P4|Period 2|Physician Decision|0
5569969|NCT01107912|19250856|P3|Period 2|Physician Decision|1
5569970|NCT01107912|19250857|P2|Period 2|Physician Decision|0
5569971|NCT01107912|19250858|P1|Period 2|Physician Decision|0
5569972|NCT01107912|19250853|P6|Period 1|Withdrawal by Subject|0
5569973|NCT01107912|19250854|P5|Period 1|Withdrawal by Subject|0
5569974|NCT01107912|19250855|P4|Period 1|Withdrawal by Subject|0
5569975|NCT01107912|19250856|P3|Period 1|Withdrawal by Subject|0
5569976|NCT01107912|19250857|P2|Period 1|Withdrawal by Subject|0
5569977|NCT01107912|19250858|P1|Period 1|Withdrawal by Subject|1
5569978|NCT01107912|19250853|P6|Period 1|Physician Decision|0
5569979|NCT01107912|19250854|P5|Period 1|Physician Decision|1
5569980|NCT01107912|19250855|P4|Period 1|Physician Decision|0
5569981|NCT01107912|19250856|P3|Period 1|Physician Decision|0
5569982|NCT01107912|19250857|P2|Period 1|Physician Decision|0
5569983|NCT01107912|19250858|P1|Period 1|Physician Decision|0
5569984|NCT01107912|19250853|P6|Period 1|Adverse Event|0
5569985|NCT01107912|19250854|P5|Period 1|Adverse Event|2
5569986|NCT01107912|19250855|P4|Period 1|Adverse Event|0
5569987|NCT01107912|19250856|P3|Period 1|Adverse Event|0
5569988|NCT01107912|19250857|P2|Period 1|Adverse Event|0
5569989|NCT01107912|19250858|P1|Period 1|Adverse Event|0
5569990|NCT01107899|19250895|P3|Overall Study|Withdrawal by Subject|1
5569991|NCT01107899|19250896|P2|Overall Study|Withdrawal by Subject|0
5569992|NCT01107899|19250897|P1|Overall Study|Withdrawal by Subject|0
5569993|NCT01107899|19250895|P3|Overall Study|Physician Decision|3
5569994|NCT01107899|19250896|P2|Overall Study|Physician Decision|0
5569995|NCT01107899|19250897|P1|Overall Study|Physician Decision|5
5569996|NCT01107886|19250943|P2|Overall Study|Administrative withdrawal of consent|5
5569997|NCT01107886|19250944|P1|Overall Study|Administrative withdrawal of consent|7
5569998|NCT01107886|19250943|P2|Overall Study|Withdrawal by Subject|196
5569999|NCT01107886|19250944|P1|Overall Study|Withdrawal by Subject|180
5570000|NCT01107886|19250943|P2|Overall Study|Lost to Follow-up|13
5570001|NCT01107886|19250944|P1|Overall Study|Lost to Follow-up|15
5570002|NCT01107743|19250977|P1|Overall Study|Protocol Violation|46
5570003|NCT01107535|19251091|P1|Overall Study|Death|5
5570004|NCT01107457|19251104|P6|Part B and C|Clinical Relapse|4
5570005|NCT01107457|19251105|P5|Part B and C|Clinical Relapse|0
5570006|NCT01107457|19251106|P4|Part B and C|Clinical Relapse|0
5570007|NCT01107457|19251107|P3|Part B and C|Clinical Relapse|0
5570008|NCT01107457|19251108|P2|Part B and C|Clinical Relapse|0
5570009|NCT01107457|19251109|P1|Part B and C|Clinical Relapse|0
5570010|NCT01107457|19251104|P6|Part B and C|Withdrawal by Subject|16
5570011|NCT01107457|19251105|P5|Part B and C|Withdrawal by Subject|0
5570012|NCT01107457|19251106|P4|Part B and C|Withdrawal by Subject|0
5570013|NCT01107457|19251107|P3|Part B and C|Withdrawal by Subject|0
5570014|NCT01107457|19251108|P2|Part B and C|Withdrawal by Subject|0
5570015|NCT01107457|19251109|P1|Part B and C|Withdrawal by Subject|0
5570016|NCT01107457|19251104|P6|Part B and C|Sponsor Decision|66
5570017|NCT01107457|19251105|P5|Part B and C|Sponsor Decision|0
5570018|NCT01107457|19251106|P4|Part B and C|Sponsor Decision|0
5570019|NCT01107457|19251107|P3|Part B and C|Sponsor Decision|0
5570020|NCT01107457|19251108|P2|Part B and C|Sponsor Decision|0
5570021|NCT01107457|19251109|P1|Part B and C|Sponsor Decision|0
5570022|NCT01107457|19251104|P6|Part B and C|Protocol Violation|1
5570023|NCT01107457|19251105|P5|Part B and C|Protocol Violation|0
5570024|NCT01107457|19251106|P4|Part B and C|Protocol Violation|0
5570025|NCT01107457|19251107|P3|Part B and C|Protocol Violation|0
5570026|NCT01107457|19251108|P2|Part B and C|Protocol Violation|0
5570027|NCT01107457|19251109|P1|Part B and C|Protocol Violation|0
5570028|NCT01107457|19251104|P6|Part B and C|Lost to Follow-up|10
5570029|NCT01107457|19251105|P5|Part B and C|Lost to Follow-up|0
5570030|NCT01107457|19251106|P4|Part B and C|Lost to Follow-up|0
5570031|NCT01107457|19251107|P3|Part B and C|Lost to Follow-up|0
5570032|NCT01107457|19251108|P2|Part B and C|Lost to Follow-up|0
5570033|NCT01107457|19251109|P1|Part B and C|Lost to Follow-up|0
5570034|NCT01107457|19251104|P6|Part B and C|Lack of Efficacy|7
5570035|NCT01107457|19251105|P5|Part B and C|Lack of Efficacy|0
5570036|NCT01107457|19251106|P4|Part B and C|Lack of Efficacy|0
5570037|NCT01107457|19251107|P3|Part B and C|Lack of Efficacy|0
5570038|NCT01107457|19251108|P2|Part B and C|Lack of Efficacy|0
5570039|NCT01107457|19251109|P1|Part B and C|Lack of Efficacy|0
5570040|NCT01107457|19251104|P6|Part B and C|Physician Decision|3
5570041|NCT01107457|19251105|P5|Part B and C|Physician Decision|0
5570042|NCT01107457|19251106|P4|Part B and C|Physician Decision|0
5570043|NCT01107457|19251107|P3|Part B and C|Physician Decision|0
5570044|NCT01107457|19251108|P2|Part B and C|Physician Decision|0
5570045|NCT01107457|19251109|P1|Part B and C|Physician Decision|0
5570046|NCT01107457|19251104|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
5570047|NCT01107457|19251105|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5570048|NCT01107457|19251106|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5570049|NCT01107457|19251107|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5570050|NCT01107457|19251108|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5570051|NCT01107457|19251109|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
5570052|NCT01107457|19251104|P6|Part B and C|Adverse Event|12
5570053|NCT01107457|19251105|P5|Part B and C|Adverse Event|0
5570054|NCT01107457|19251106|P4|Part B and C|Adverse Event|0
5570055|NCT01107457|19251107|P3|Part B and C|Adverse Event|0
5570056|NCT01107457|19251108|P2|Part B and C|Adverse Event|0
5570057|NCT01107457|19251109|P1|Part B and C|Adverse Event|0
5570058|NCT01107457|19251104|P6|Part A|Protocol Violation|0
5570059|NCT01107457|19251105|P5|Part A|Protocol Violation|0
5570060|NCT01107457|19251106|P4|Part A|Protocol Violation|0
5570061|NCT01107457|19251107|P3|Part A|Protocol Violation|0
5570062|NCT01107457|19251108|P2|Part A|Protocol Violation|1
5570063|NCT01107457|19251109|P1|Part A|Protocol Violation|0
5570064|NCT01107457|19251104|P6|Part A|Lack of Efficacy|0
5570065|NCT01107457|19251105|P5|Part A|Lack of Efficacy|0
5570066|NCT01107457|19251106|P4|Part A|Lack of Efficacy|0
5570067|NCT01107457|19251107|P3|Part A|Lack of Efficacy|0
5570068|NCT01107457|19251108|P2|Part A|Lack of Efficacy|0
5570069|NCT01107457|19251109|P1|Part A|Lack of Efficacy|1
5570070|NCT01107457|19251104|P6|Part A|Lost to Follow-up|0
5570071|NCT01107457|19251105|P5|Part A|Lost to Follow-up|0
5570072|NCT01107457|19251106|P4|Part A|Lost to Follow-up|0
5570073|NCT01107457|19251107|P3|Part A|Lost to Follow-up|0
5570074|NCT01107457|19251108|P2|Part A|Lost to Follow-up|1
5570075|NCT01107457|19251109|P1|Part A|Lost to Follow-up|0
5570076|NCT01107457|19251104|P6|Part A|Withdrawal by Subject|0
5570077|NCT01107457|19251105|P5|Part A|Withdrawal by Subject|1
5570078|NCT01107457|19251106|P4|Part A|Withdrawal by Subject|3
5570079|NCT01107457|19251107|P3|Part A|Withdrawal by Subject|0
5570080|NCT01107457|19251108|P2|Part A|Withdrawal by Subject|3
5570081|NCT01107457|19251109|P1|Part A|Withdrawal by Subject|3
5570082|NCT01107457|19251104|P6|Part A|Adverse Event|0
5570083|NCT01107457|19251105|P5|Part A|Adverse Event|0
5570084|NCT01107457|19251106|P4|Part A|Adverse Event|0
5570085|NCT01107457|19251107|P3|Part A|Adverse Event|1
5570086|NCT01107457|19251108|P2|Part A|Adverse Event|2
5570087|NCT01107457|19251109|P1|Part A|Adverse Event|1
5570088|NCT01107444|19251237|P2|Overall Study|Protocol Entry Criteria Not Met|1
5570089|NCT01107444|19251238|P1|Overall Study|Protocol Entry Criteria Not Met|0
5570090|NCT01107444|19251237|P2|Overall Study|Withdrawal by Subject|12
5570091|NCT01107444|19251238|P1|Overall Study|Withdrawal by Subject|8
5570092|NCT01107418|19251272|P1|Overall Study|Entered Extension Study|1
5570093|NCT01107418|19251272|P1|Overall Study|Started Other Therapy|1
5570094|NCT01107418|19251272|P1|Overall Study|Study Closing|1
5570095|NCT01107418|19251272|P1|Overall Study|Withdrawal by Subject|1
5570096|NCT01107418|19251272|P1|Overall Study|Adverse Event|3
5570097|NCT01107418|19251272|P1|Overall Study|Disease Progression|45
5570098|NCT01107405|19251345|P5|Overall Study|Protocol Violation|0
5570099|NCT01107405|19251346|P4|Overall Study|Protocol Violation|1
5570100|NCT01107405|19251347|P3|Overall Study|Protocol Violation|1
5570101|NCT01107405|19251348|P2|Overall Study|Protocol Violation|0
5570102|NCT01107405|19251349|P1|Overall Study|Protocol Violation|0
5570103|NCT01107405|19251345|P5|Overall Study|Withdrawal by Subject|1
5570104|NCT01107405|19251346|P4|Overall Study|Withdrawal by Subject|2
5570105|NCT01107405|19251347|P3|Overall Study|Withdrawal by Subject|1
5570106|NCT01107405|19251348|P2|Overall Study|Withdrawal by Subject|0
5570107|NCT01107405|19251349|P1|Overall Study|Withdrawal by Subject|1
5570108|NCT01107405|19251345|P5|Overall Study|Adverse Event|2
5570109|NCT01107405|19251346|P4|Overall Study|Adverse Event|0
5570110|NCT01107405|19251347|P3|Overall Study|Adverse Event|0
5570111|NCT01107405|19251348|P2|Overall Study|Adverse Event|1
5570112|NCT01107405|19251349|P1|Overall Study|Adverse Event|1
5570113|NCT01107392|19251388|P2|Overall Study|Administrative decision|0
5570114|NCT01107392|19251389|P1|Overall Study|Administrative decision|1
5570115|NCT01107392|19251388|P2|Overall Study|Personal Reasons|3
5570116|NCT01107392|19251389|P1|Overall Study|Personal Reasons|2
5570117|NCT01107392|19251388|P2|Overall Study|Adverse Event|0
5570118|NCT01107392|19251389|P1|Overall Study|Adverse Event|2
5570119|NCT01107379|19251401|P1|Overall Study|Lost to Follow-up|3
5570120|NCT01107379|19251401|P1|Overall Study|Withdrawal by Subject|18
5570121|NCT01107353|19251412|P2|Overall Study|Positive Drug Screen|0
5570122|NCT01107353|19251413|P1|Overall Study|Positive Drug Screen|1
5570123|NCT01107197|19251421|P2|Overall Study|Withdrawal by Subject|5
5570124|NCT01107197|19251422|P1|Overall Study|Withdrawal by Subject|3
5570125|NCT01107197|19251421|P2|Overall Study|Lost to Follow-up|8
5570126|NCT01107197|19251422|P1|Overall Study|Lost to Follow-up|5
5570127|NCT01107197|19251421|P2|Overall Study|Death|10
5570128|NCT01107197|19251422|P1|Overall Study|Death|12
5570129|NCT01106976|19251457|P1|Overall Study|Lost to Follow-up|8
5570130|NCT01106911|19251471|P1|Overall Study|deemed ineligible after screening|3
5570131|NCT01106911|19251471|P1|Overall Study|Physician Decision|2
5570132|NCT01106898|19251475|P1|Overall Study|Adverse Event|6
5570133|NCT01106846|19251520|P2|Overall Study|Change in surgical procedure|1
5570134|NCT01106846|19251521|P1|Overall Study|Change in surgical procedure|0
5570135|NCT01106690|19251571|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5570136|NCT01106690|19251572|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5570137|NCT01106690|19251573|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
5570138|NCT01106690|19251571|P3|Extension Period: Week 26 to Week 52|Other|4
5570139|NCT01106690|19251572|P2|Extension Period: Week 26 to Week 52|Other|3
5570140|NCT01106690|19251573|P1|Extension Period: Week 26 to Week 52|Other|8
5570141|NCT01106690|19251571|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5570142|NCT01106690|19251572|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5570143|NCT01106690|19251573|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5570144|NCT01106690|19251571|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
5570145|NCT01106690|19251572|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5570146|NCT01106690|19251573|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5570147|NCT01106690|19251571|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
5570148|NCT01106690|19251572|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
5570149|NCT01106690|19251573|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
5570150|NCT01106690|19251571|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5570151|NCT01106690|19251572|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5570152|NCT01106690|19251573|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5570153|NCT01106690|19251571|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
5570154|NCT01106690|19251572|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
5570155|NCT01106690|19251573|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
5570156|NCT01106690|19251571|P3|Core Period: Baseline to Week 26|Other|6
5570157|NCT01106690|19251572|P2|Core Period: Baseline to Week 26|Other|2
5570158|NCT01106690|19251573|P1|Core Period: Baseline to Week 26|Other|10
5570159|NCT01106690|19251571|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5570160|NCT01106690|19251572|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5570161|NCT01106690|19251573|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
5570162|NCT01106690|19251571|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5570163|NCT01106690|19251572|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5570164|NCT01106690|19251573|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
5570165|NCT01106690|19251571|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5570166|NCT01106690|19251572|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5570167|NCT01106690|19251573|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5570168|NCT01106690|19251571|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
5570169|NCT01106690|19251572|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
5570170|NCT01106690|19251573|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
5570171|NCT01106690|19251571|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
5570172|NCT01106690|19251572|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
5570173|NCT01106690|19251573|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
5570174|NCT01106690|19251571|P3|Core Period: Baseline to Week 26|Protocol Violation|0
5570175|NCT01106690|19251572|P2|Core Period: Baseline to Week 26|Protocol Violation|0
5570176|NCT01106690|19251573|P1|Core Period: Baseline to Week 26|Protocol Violation|1
5570177|NCT01106690|19251571|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
5570178|NCT01106690|19251572|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
5570179|NCT01106690|19251573|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
5570180|NCT01106690|19251571|P3|Core Period: Baseline to Week 26|Adverse Event|4
5570181|NCT01106690|19251572|P2|Core Period: Baseline to Week 26|Adverse Event|1
5570182|NCT01106690|19251573|P1|Core Period: Baseline to Week 26|Adverse Event|6
5570183|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Other|5
5570184|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Other|8
5570185|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Other|5
5570186|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Other|6
5570187|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5570188|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5570189|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5570190|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5570191|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
5570192|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
5570193|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
5570194|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
5570195|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5570196|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
5570197|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
5570198|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5570199|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
5570200|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
5570201|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
5570202|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
5570203|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
5570204|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
5570205|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
5570206|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
5570207|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5570208|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5570209|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5570210|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5570211|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
5570212|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
5570213|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
5570214|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
5570215|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Death|1
5570216|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Death|0
5570217|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Death|0
5570218|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Death|0
5570219|NCT01106677|19251609|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
5570220|NCT01106677|19251610|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
5570221|NCT01106677|19251611|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
5570222|NCT01106677|19251612|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
5570223|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Pregnancy|0
5570224|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Pregnancy|0
5570225|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Pregnancy|1
5570226|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Pregnancy|0
5570227|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Other|23
5570228|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Other|8
5570229|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Other|14
5570230|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Other|8
5570231|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Product quality complaint|0
5570232|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Product quality complaint|1
5570233|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Product quality complaint|1
5570234|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Product quality complaint|0
5570235|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
5570236|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
5570237|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
5570238|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
5570239|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5570240|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5570241|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
5570242|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5570243|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
5570244|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
5570245|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
5570246|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
5570247|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
5570248|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
5570249|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
5570250|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
5570251|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Protocol Violation|3
5570252|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Protocol Violation|0
5570253|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Protocol Violation|1
5570254|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Protocol Violation|0
5570255|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Physician Decision|1
5570256|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Physician Decision|3
5570257|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Physician Decision|1
5570258|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Physician Decision|2
5570259|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
5570260|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
5570261|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
5570262|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
5570263|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
5570264|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
5570265|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
5570266|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
5570267|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Death|0
5570268|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Death|1
5570269|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Death|0
5570270|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Death|0
5570271|NCT01106677|19251609|P4|Core Period: Baseline to Week 26|Adverse Event|8
5570272|NCT01106677|19251610|P3|Core Period: Baseline to Week 26|Adverse Event|6
5570273|NCT01106677|19251611|P2|Core Period: Baseline to Week 26|Adverse Event|18
5570274|NCT01106677|19251612|P1|Core Period: Baseline to Week 26|Adverse Event|7
5570275|NCT01106651|19251675|P3|Overall Study|Death|0
5570276|NCT01106651|19251676|P2|Overall Study|Death|3
5570277|NCT01106651|19251677|P1|Overall Study|Death|0
5570278|NCT01106651|19251675|P3|Overall Study|Other|21
5570279|NCT01106651|19251676|P2|Overall Study|Other|31
5570280|NCT01106651|19251677|P1|Overall Study|Other|34
5570281|NCT01106651|19251675|P3|Overall Study|Noncompliance with study drug|2
5570282|NCT01106651|19251676|P2|Overall Study|Noncompliance with study drug|0
5570283|NCT01106651|19251677|P1|Overall Study|Noncompliance with study drug|1
5570284|NCT01106651|19251675|P3|Overall Study|Withdrawal by Subject|4
5570285|NCT01106651|19251676|P2|Overall Study|Withdrawal by Subject|7
5570286|NCT01106651|19251677|P1|Overall Study|Withdrawal by Subject|14
5570287|NCT01106651|19251675|P3|Overall Study|Protocol Violation|1
5570288|NCT01106651|19251676|P2|Overall Study|Protocol Violation|2
5570289|NCT01106651|19251677|P1|Overall Study|Protocol Violation|1
5570290|NCT01106651|19251675|P3|Overall Study|Physician Decision|1
5570291|NCT01106651|19251676|P2|Overall Study|Physician Decision|3
5570292|NCT01106651|19251677|P1|Overall Study|Physician Decision|4
5570293|NCT01106651|19251675|P3|Overall Study|Lost to Follow-up|6
5570294|NCT01106651|19251676|P2|Overall Study|Lost to Follow-up|2
5570295|NCT01106651|19251677|P1|Overall Study|Lost to Follow-up|8
5570296|NCT01106651|19251675|P3|Overall Study|Adverse Event|23
5570297|NCT01106651|19251676|P2|Overall Study|Adverse Event|9
5570298|NCT01106651|19251677|P1|Overall Study|Adverse Event|17
5570299|NCT01106625|19251730|P3|Extension Period: Week 26 to Week 52|Other|4
5570300|NCT01106625|19251731|P2|Extension Period: Week 26 to Week 52|Other|5
5570301|NCT01106625|19251732|P1|Extension Period: Week 26 to Week 52|Other|5
5570302|NCT01106625|19251730|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
5570303|NCT01106625|19251731|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
5570304|NCT01106625|19251732|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
5570305|NCT01106625|19251730|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
5570306|NCT01106625|19251731|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
5570307|NCT01106625|19251732|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
5570308|NCT01106625|19251730|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5570309|NCT01106625|19251731|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5570310|NCT01106625|19251732|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
5570311|NCT01106625|19251730|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
5570312|NCT01106625|19251731|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
5570313|NCT01106625|19251732|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
5570314|NCT01106625|19251730|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
5570315|NCT01106625|19251731|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
5570316|NCT01106625|19251732|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
5570317|NCT01106625|19251730|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
5570318|NCT01106625|19251731|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
5570319|NCT01106625|19251732|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
5570320|NCT01106625|19251730|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
5570321|NCT01106625|19251731|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
5570322|NCT01106625|19251732|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
5570323|NCT01106625|19251730|P3|Core Period: Baseline to Week 26|Other|4
5570324|NCT01106625|19251731|P2|Core Period: Baseline to Week 26|Other|7
5570325|NCT01106625|19251732|P1|Core Period: Baseline to Week 26|Other|8
5570326|NCT01106625|19251730|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5570327|NCT01106625|19251731|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5570328|NCT01106625|19251732|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5570329|NCT01106625|19251730|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
5570330|NCT01106625|19251731|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
5570331|NCT01106625|19251732|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
5570332|NCT01106625|19251730|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5570333|NCT01106625|19251731|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
5570334|NCT01106625|19251732|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
5570335|NCT01106625|19251730|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
5570336|NCT01106625|19251731|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
5570337|NCT01106625|19251732|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
5570338|NCT01106625|19251730|P3|Core Period: Baseline to Week 26|Protocol Violation|3
5570339|NCT01106625|19251731|P2|Core Period: Baseline to Week 26|Protocol Violation|1
5570340|NCT01106625|19251732|P1|Core Period: Baseline to Week 26|Protocol Violation|2
5570341|NCT01106625|19251730|P3|Core Period: Baseline to Week 26|Physician Decision|0
5570342|NCT01106625|19251731|P2|Core Period: Baseline to Week 26|Physician Decision|0
5570343|NCT01106625|19251732|P1|Core Period: Baseline to Week 26|Physician Decision|1
5570344|NCT01106625|19251730|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
5570345|NCT01106625|19251731|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
5570346|NCT01106625|19251732|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
5570347|NCT01106625|19251730|P3|Core Period: Baseline to Week 26|Adverse Event|8
5570348|NCT01106625|19251731|P2|Core Period: Baseline to Week 26|Adverse Event|8
5570349|NCT01106625|19251732|P1|Core Period: Baseline to Week 26|Adverse Event|6
5570350|NCT01106586|19251763|P2|Overall Study|Participant Transferred to Another Study|197
5570351|NCT01106586|19251764|P1|Overall Study|Participant Transferred to Another Study|212
5570352|NCT01106586|19251763|P2|Overall Study|Protocol Violation|0
5570353|NCT01106586|19251764|P1|Overall Study|Protocol Violation|1
5570354|NCT01106586|19251763|P2|Overall Study|Participant Noncompliance|10
5570355|NCT01106586|19251764|P1|Overall Study|Participant Noncompliance|12
5570356|NCT01106586|19251763|P2|Overall Study|Lost to Follow-up|20
5570357|NCT01106586|19251764|P1|Overall Study|Lost to Follow-up|24
5570358|NCT01106586|19251763|P2|Overall Study|Withdrew Consent|30
5570359|NCT01106586|19251764|P1|Overall Study|Withdrew Consent|18
5570360|NCT01106586|19251763|P2|Overall Study|Investigator's Discretion|8
5570361|NCT01106586|19251764|P1|Overall Study|Investigator's Discretion|5
5570362|NCT01106586|19251763|P2|Overall Study|Lack of Efficacy|0
5570363|NCT01106586|19251764|P1|Overall Study|Lack of Efficacy|1
5570364|NCT01106586|19251763|P2|Overall Study|Pregnancy|2
5570365|NCT01106586|19251764|P1|Overall Study|Pregnancy|2
5570366|NCT01106586|19251763|P2|Overall Study|Death|3
5570367|NCT01106586|19251764|P1|Overall Study|Death|1
5570368|NCT01106586|19251763|P2|Overall Study|Adverse Event|15
5570369|NCT01106586|19251764|P1|Overall Study|Adverse Event|9
5570370|NCT01106534|19251782|P1|Overall Study|Physician Decision|1
5570371|NCT01106534|19251782|P1|Overall Study|Death|16
5570372|NCT01106534|19251782|P1|Overall Study|Lost to Follow-up|2
5570373|NCT01106534|19251782|P1|Overall Study|Withdrawal by Subject|18
5570374|NCT01106430|19251814|P2|Overall Study|Withdrawal by Subject|4
5570375|NCT01106430|19251815|P1|Overall Study|Withdrawal by Subject|8
5570376|NCT01106430|19251814|P2|Overall Study|Protocol Violation|2
5570377|NCT01106430|19251815|P1|Overall Study|Protocol Violation|7
5570378|NCT01106430|19251814|P2|Overall Study|Previous Use Of Marijuana|0
5570379|NCT01106430|19251815|P1|Overall Study|Previous Use Of Marijuana|1
5570380|NCT01106430|19251814|P2|Overall Study|Hard Time Swallowing The Pills|0
5570381|NCT01106430|19251815|P1|Overall Study|Hard Time Swallowing The Pills|1
5570382|NCT01106430|19251814|P2|Overall Study|Noncompliance|1
5570383|NCT01106430|19251815|P1|Overall Study|Noncompliance|0
5570384|NCT01106430|19251814|P2|Overall Study|Refused To Take Medication|1
5570385|NCT01106430|19251815|P1|Overall Study|Refused To Take Medication|0
5570386|NCT01106430|19251814|P2|Overall Study|Moved Out Of State|1
5570387|NCT01106430|19251815|P1|Overall Study|Moved Out Of State|0
5570388|NCT01106430|19251814|P2|Overall Study|Early Termination Requested By Sponsor|0
5570389|NCT01106430|19251815|P1|Overall Study|Early Termination Requested By Sponsor|1
5570390|NCT01106430|19251814|P2|Overall Study|Lost to Follow-up|1
5570391|NCT01106430|19251815|P1|Overall Study|Lost to Follow-up|5
5570392|NCT01106430|19251814|P2|Overall Study|Lack of Efficacy|13
5570393|NCT01106430|19251815|P1|Overall Study|Lack of Efficacy|2
5570394|NCT01106430|19251814|P2|Overall Study|Adverse Event|10
5570395|NCT01106430|19251815|P1|Overall Study|Adverse Event|8
5570396|NCT01106404|19251837|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
5570397|NCT01106404|19251838|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
5570398|NCT01106404|19251837|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
5570399|NCT01106404|19251838|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
5570400|NCT01106404|19251837|P2|Period I (First 6 Weeks)|Physician Decision|0
5570401|NCT01106404|19251838|P1|Period I (First 6 Weeks)|Physician Decision|1
5570402|NCT01106404|19251837|P2|Period I (First 6 Weeks)|Adverse Event|0
5570403|NCT01106404|19251838|P1|Period I (First 6 Weeks)|Adverse Event|2
5570404|NCT01106352|19251861|P5|Overall Study|Home hospice since July 2013|0
5570405|NCT01106352|19251862|P4|Overall Study|Home hospice since July 2013|1
5570406|NCT01106352|19251863|P3|Overall Study|Home hospice since July 2013|0
5570407|NCT01106352|19251864|P2|Overall Study|Home hospice since July 2013|0
5570408|NCT01106352|19251865|P1|Overall Study|Home hospice since July 2013|0
5570409|NCT01106352|19251861|P5|Overall Study|Subject entered hospice|0
5570410|NCT01106352|19251862|P4|Overall Study|Subject entered hospice|1
5570411|NCT01106352|19251863|P3|Overall Study|Subject entered hospice|0
5570412|NCT01106352|19251864|P2|Overall Study|Subject entered hospice|0
5570413|NCT01106352|19251865|P1|Overall Study|Subject entered hospice|0
5570414|NCT01106352|19251861|P5|Overall Study|Went on hospice|0
5570415|NCT01106352|19251862|P4|Overall Study|Went on hospice|1
5570416|NCT01106352|19251863|P3|Overall Study|Went on hospice|0
5570417|NCT01106352|19251864|P2|Overall Study|Went on hospice|0
5570418|NCT01106352|19251865|P1|Overall Study|Went on hospice|0
5570419|NCT01106352|19251861|P5|Overall Study|Withdrawal by Subject|2
5570420|NCT01106352|19251862|P4|Overall Study|Withdrawal by Subject|3
5570421|NCT01106352|19251863|P3|Overall Study|Withdrawal by Subject|0
5570422|NCT01106352|19251864|P2|Overall Study|Withdrawal by Subject|0
5570423|NCT01106352|19251865|P1|Overall Study|Withdrawal by Subject|0
5570424|NCT01106352|19251861|P5|Overall Study|Disease progression|0
5570425|NCT01106352|19251862|P4|Overall Study|Disease progression|1
5570426|NCT01106352|19251863|P3|Overall Study|Disease progression|0
5570427|NCT01106352|19251864|P2|Overall Study|Disease progression|0
5570428|NCT01106352|19251865|P1|Overall Study|Disease progression|0
5570429|NCT01106352|19251861|P5|Overall Study|Death|1
5570430|NCT01106352|19251862|P4|Overall Study|Death|3
5570431|NCT01106352|19251863|P3|Overall Study|Death|1
5570432|NCT01106352|19251864|P2|Overall Study|Death|0
5570433|NCT01106352|19251865|P1|Overall Study|Death|0
5570434|NCT01106352|19251861|P5|Overall Study|Lost to Follow-up|1
5570435|NCT01106352|19251862|P4|Overall Study|Lost to Follow-up|0
5570436|NCT01106352|19251863|P3|Overall Study|Lost to Follow-up|0
5570437|NCT01106352|19251864|P2|Overall Study|Lost to Follow-up|0
5570438|NCT01106352|19251865|P1|Overall Study|Lost to Follow-up|0
5570439|NCT01106352|19251861|P5|Overall Study|Too ill to come in for the visit|0
5570440|NCT01106352|19251862|P4|Overall Study|Too ill to come in for the visit|0
5570441|NCT01106352|19251863|P3|Overall Study|Too ill to come in for the visit|1
5570442|NCT01106352|19251864|P2|Overall Study|Too ill to come in for the visit|0
5570443|NCT01106352|19251865|P1|Overall Study|Too ill to come in for the visit|0
5570444|NCT01106352|19251861|P5|Overall Study|Sponsor Decision|0
5570445|NCT01106352|19251862|P4|Overall Study|Sponsor Decision|0
5570446|NCT01106352|19251863|P3|Overall Study|Sponsor Decision|0
5570447|NCT01106352|19251864|P2|Overall Study|Sponsor Decision|0
5570448|NCT01106352|19251865|P1|Overall Study|Sponsor Decision|1
5570449|NCT01106352|19251861|P5|Overall Study|Subjects untreated|4
5570450|NCT01106352|19251862|P4|Overall Study|Subjects untreated|3
5570451|NCT01106352|19251863|P3|Overall Study|Subjects untreated|0
5570452|NCT01106352|19251864|P2|Overall Study|Subjects untreated|0
5570453|NCT01106352|19251865|P1|Overall Study|Subjects untreated|0
5570454|NCT01106287|19251961|P4|Overall Study|Adverse Event|0
5570455|NCT01106287|19251962|P3|Overall Study|Adverse Event|0
5570456|NCT01106287|19251963|P2|Overall Study|Adverse Event|0
5570457|NCT01106287|19251964|P1|Overall Study|Adverse Event|1
5570458|NCT01106248|19251984|P1|Overall Study|Administrative|2
5570459|NCT01106248|19251984|P1|Overall Study|Adverse Event|1
5570460|NCT01106157|19251992|P2|Overall Study|Withdrawal by Subject|0
5570461|NCT01106157|19251993|P1|Overall Study|Withdrawal by Subject|1
5570462|NCT01106092|19252021|P4|Overall Study|Withdrawal by Subject|1
5570463|NCT01106092|19252022|P3|Overall Study|Withdrawal by Subject|0
5570464|NCT01106092|19252023|P2|Overall Study|Withdrawal by Subject|0
5570465|NCT01106092|19252024|P1|Overall Study|Withdrawal by Subject|0
5570466|NCT01106027|19252107|P1|Overall Study|Lost graft early, discontinued|1
5570467|NCT01106014|19252113|P2|Overall Study|Lost to Follow-up|3
5570468|NCT01106014|19252114|P1|Overall Study|Lost to Follow-up|2
5570469|NCT01106014|19252113|P2|Overall Study|Administrative reason|6
5570470|NCT01106014|19252114|P1|Overall Study|Administrative reason|7
5570471|NCT01106014|19252113|P2|Overall Study|Withdrawal by Subject|37
5570472|NCT01106014|19252114|P1|Overall Study|Withdrawal by Subject|43
5570473|NCT01106014|19252113|P2|Overall Study|Adverse Event|42
5570474|NCT01106014|19252114|P1|Overall Study|Adverse Event|78
5570475|NCT01106014|19252113|P2|Overall Study|Morbidity or Mortality primary endpoint|242
5570476|NCT01106014|19252114|P1|Overall Study|Morbidity or Mortality primary endpoint|155
5570477|NCT01105975|19252134|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5570478|NCT01105975|19252135|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
5570479|NCT01105975|19252136|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5570480|NCT01105975|19252137|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5570481|NCT01105975|19252138|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
5570482|NCT01105975|19252139|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5570483|NCT01105975|19252140|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5570484|NCT01105975|19252141|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5570485|NCT01105975|19252142|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5570486|NCT01105975|19252143|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5570487|NCT01105975|19252134|P10|Overall Study|Protocol Violation|2
5570488|NCT01105975|19252135|P9|Overall Study|Protocol Violation|2
5570489|NCT01105975|19252136|P8|Overall Study|Protocol Violation|1
5570490|NCT01105975|19252137|P7|Overall Study|Protocol Violation|1
5570491|NCT01105975|19252138|P6|Overall Study|Protocol Violation|1
5570492|NCT01105975|19252139|P5|Overall Study|Protocol Violation|1
5570493|NCT01105975|19252140|P4|Overall Study|Protocol Violation|0
5570494|NCT01105975|19252141|P3|Overall Study|Protocol Violation|2
5570495|NCT01105975|19252142|P2|Overall Study|Protocol Violation|2
5570496|NCT01105975|19252143|P1|Overall Study|Protocol Violation|0
5570497|NCT01105975|19252134|P10|Overall Study|Physician Decision|0
5570498|NCT01105975|19252135|P9|Overall Study|Physician Decision|0
5570499|NCT01105975|19252136|P8|Overall Study|Physician Decision|0
5570500|NCT01105975|19252137|P7|Overall Study|Physician Decision|2
5570501|NCT01105975|19252138|P6|Overall Study|Physician Decision|0
5570502|NCT01105975|19252139|P5|Overall Study|Physician Decision|0
5570503|NCT01105975|19252140|P4|Overall Study|Physician Decision|0
5570504|NCT01105975|19252141|P3|Overall Study|Physician Decision|0
5570505|NCT01105975|19252142|P2|Overall Study|Physician Decision|0
5570506|NCT01105975|19252143|P1|Overall Study|Physician Decision|0
5570507|NCT01105975|19252134|P10|Overall Study|Lost to Follow-up|0
5570508|NCT01105975|19252135|P9|Overall Study|Lost to Follow-up|1
5570509|NCT01105975|19252136|P8|Overall Study|Lost to Follow-up|0
5570510|NCT01105975|19252137|P7|Overall Study|Lost to Follow-up|0
5570511|NCT01105975|19252138|P6|Overall Study|Lost to Follow-up|0
5570512|NCT01105975|19252139|P5|Overall Study|Lost to Follow-up|1
5570513|NCT01105975|19252140|P4|Overall Study|Lost to Follow-up|1
5570514|NCT01105975|19252141|P3|Overall Study|Lost to Follow-up|0
5570515|NCT01105975|19252142|P2|Overall Study|Lost to Follow-up|0
5570516|NCT01105975|19252143|P1|Overall Study|Lost to Follow-up|1
5570517|NCT01105975|19252134|P10|Overall Study|Withdrawal by Subject|3
5570518|NCT01105975|19252135|P9|Overall Study|Withdrawal by Subject|0
5570519|NCT01105975|19252136|P8|Overall Study|Withdrawal by Subject|1
5570520|NCT01105975|19252137|P7|Overall Study|Withdrawal by Subject|2
5570521|NCT01105975|19252138|P6|Overall Study|Withdrawal by Subject|1
5570522|NCT01105975|19252139|P5|Overall Study|Withdrawal by Subject|4
5570523|NCT01105975|19252140|P4|Overall Study|Withdrawal by Subject|0
5570524|NCT01105975|19252141|P3|Overall Study|Withdrawal by Subject|2
5570525|NCT01105975|19252142|P2|Overall Study|Withdrawal by Subject|2
5570526|NCT01105975|19252143|P1|Overall Study|Withdrawal by Subject|2
5570527|NCT01105975|19252134|P10|Overall Study|Adverse Event|4
5570528|NCT01105975|19252135|P9|Overall Study|Adverse Event|1
5570529|NCT01105975|19252136|P8|Overall Study|Adverse Event|4
5570530|NCT01105975|19252137|P7|Overall Study|Adverse Event|2
5570531|NCT01105975|19252138|P6|Overall Study|Adverse Event|1
5570532|NCT01105975|19252139|P5|Overall Study|Adverse Event|0
5570533|NCT01105975|19252140|P4|Overall Study|Adverse Event|1
5570534|NCT01105975|19252141|P3|Overall Study|Adverse Event|5
5570535|NCT01105975|19252142|P2|Overall Study|Adverse Event|1
5570536|NCT01105975|19252143|P1|Overall Study|Adverse Event|2
5570537|NCT01105936|19252291|P4|Period 3|Protocol Violation|0
5570538|NCT01105936|19252292|P3|Period 3|Protocol Violation|0
5570539|NCT01105936|19252293|P2|Period 3|Protocol Violation|2
5570540|NCT01105936|19252294|P1|Period 3|Protocol Violation|0
5570541|NCT01105936|19252291|P4|Period 2|Adverse Event|0
5570542|NCT01105936|19252292|P3|Period 2|Adverse Event|0
5570543|NCT01105936|19252293|P2|Period 2|Adverse Event|0
5570544|NCT01105936|19252294|P1|Period 2|Adverse Event|1
5570545|NCT01105936|19252291|P4|Period 1|Adverse Event|1
5570546|NCT01105936|19252292|P3|Period 1|Adverse Event|0
5570547|NCT01105936|19252293|P2|Period 1|Adverse Event|0
5570548|NCT01105936|19252294|P1|Period 1|Adverse Event|0
5570549|NCT01105767|19252323|P3|Overall Study|Lost to Follow-up|1184
5570550|NCT01105767|19252324|P2|Overall Study|Lost to Follow-up|1614
5570551|NCT01105767|19252325|P1|Overall Study|Lost to Follow-up|1160
5570552|NCT01105533|19252377|P9|Overall Study|Physician Decision|0
5570553|NCT01105533|19252378|P8|Overall Study|Physician Decision|1
5570554|NCT01105533|19252379|P7|Overall Study|Physician Decision|0
5570555|NCT01105533|19252380|P6|Overall Study|Physician Decision|0
5570556|NCT01105533|19252381|P5|Overall Study|Physician Decision|0
5570557|NCT01105533|19252382|P4|Overall Study|Physician Decision|0
5570558|NCT01105533|19252383|P3|Overall Study|Physician Decision|0
5570559|NCT01105533|19252384|P2|Overall Study|Physician Decision|0
5570560|NCT01105533|19252385|P1|Overall Study|Physician Decision|0
5570561|NCT01105533|19252377|P9|Overall Study|Other|2
5570562|NCT01105533|19252378|P8|Overall Study|Other|1
5570563|NCT01105533|19252379|P7|Overall Study|Other|3
5570564|NCT01105533|19252380|P6|Overall Study|Other|0
5570565|NCT01105533|19252381|P5|Overall Study|Other|1
5570566|NCT01105533|19252382|P4|Overall Study|Other|0
5570567|NCT01105533|19252383|P3|Overall Study|Other|0
5570568|NCT01105533|19252384|P2|Overall Study|Other|0
5570569|NCT01105533|19252385|P1|Overall Study|Other|0
5570570|NCT01105533|19252377|P9|Overall Study|Adverse Event|1
5570571|NCT01105533|19252378|P8|Overall Study|Adverse Event|0
5570572|NCT01105533|19252379|P7|Overall Study|Adverse Event|2
5570573|NCT01105533|19252380|P6|Overall Study|Adverse Event|2
5570574|NCT01105533|19252381|P5|Overall Study|Adverse Event|1
5570575|NCT01105533|19252382|P4|Overall Study|Adverse Event|0
5570576|NCT01105533|19252383|P3|Overall Study|Adverse Event|0
5570577|NCT01105533|19252384|P2|Overall Study|Adverse Event|0
5570578|NCT01105533|19252385|P1|Overall Study|Adverse Event|0
5570579|NCT01105533|19252377|P9|Overall Study|Lack of Efficacy|9
5570580|NCT01105533|19252378|P8|Overall Study|Lack of Efficacy|2
5570581|NCT01105533|19252379|P7|Overall Study|Lack of Efficacy|3
5570582|NCT01105533|19252380|P6|Overall Study|Lack of Efficacy|5
5570583|NCT01105533|19252381|P5|Overall Study|Lack of Efficacy|4
5570584|NCT01105533|19252382|P4|Overall Study|Lack of Efficacy|3
5570585|NCT01105533|19252383|P3|Overall Study|Lack of Efficacy|3
5570586|NCT01105533|19252384|P2|Overall Study|Lack of Efficacy|1
5570587|NCT01105533|19252385|P1|Overall Study|Lack of Efficacy|1
5570588|NCT01105533|19252377|P9|Overall Study|Death|0
5570589|NCT01105533|19252378|P8|Overall Study|Death|0
5570590|NCT01105533|19252379|P7|Overall Study|Death|0
5570591|NCT01105533|19252380|P6|Overall Study|Death|0
5570592|NCT01105533|19252381|P5|Overall Study|Death|1
5570593|NCT01105533|19252382|P4|Overall Study|Death|0
5570594|NCT01105533|19252383|P3|Overall Study|Death|0
5570595|NCT01105533|19252384|P2|Overall Study|Death|0
5570596|NCT01105533|19252385|P1|Overall Study|Death|0
5570597|NCT01105377|19252475|P2|Overall Study|Withdrawal by Subject|1
5570598|NCT01105377|19252476|P1|Overall Study|Withdrawal by Subject|0
5570599|NCT01105130|19252524|P3|Overall Study|Multiple Reasons|2
5570600|NCT01105130|19252525|P2|Overall Study|Multiple Reasons|0
5570601|NCT01105130|19252526|P1|Overall Study|Multiple Reasons|3
5570602|NCT01105130|19252524|P3|Overall Study|Toxicity|2
5570603|NCT01105130|19252525|P2|Overall Study|Toxicity|3
5570604|NCT01105130|19252526|P1|Overall Study|Toxicity|1
5570605|NCT01105130|19252524|P3|Overall Study|Never Started|4
5570606|NCT01105130|19252525|P2|Overall Study|Never Started|2
5570607|NCT01105130|19252526|P1|Overall Study|Never Started|2
5570608|NCT01105130|19252524|P3|Overall Study|Withdrawal by Subject|2
5570609|NCT01105130|19252525|P2|Overall Study|Withdrawal by Subject|6
5570610|NCT01105130|19252526|P1|Overall Study|Withdrawal by Subject|4
5570611|NCT01105091|19252556|P2|Overall Study|Death|0
5570612|NCT01105091|19252557|P1|Overall Study|Death|2
5570613|NCT01105065|19252581|P1|Overall Study|Technical Problems|1
5570614|NCT01105065|19252581|P1|Overall Study|Adverse Event|5
5570615|NCT01104870|19252590|P3|Overall Study|Withdrawal by Subject|1
5570616|NCT01104870|19252591|P2|Overall Study|Withdrawal by Subject|0
5570617|NCT01104870|19252592|P1|Overall Study|Withdrawal by Subject|0
5570618|NCT01104870|19252590|P3|Overall Study|Death|1
5570619|NCT01104870|19252591|P2|Overall Study|Death|0
5570620|NCT01104870|19252592|P1|Overall Study|Death|0
5570621|NCT01104870|19252590|P3|Overall Study|Adverse Event|0
5570622|NCT01104870|19252591|P2|Overall Study|Adverse Event|1
5570623|NCT01104870|19252592|P1|Overall Study|Adverse Event|1
5570624|NCT01104792|19252621|P1|Overall Study|Did Not Meet Eligibility Criteria|133
5570625|NCT01104792|19252621|P1|Overall Study|Reasons Not Specified|27
5570626|NCT01104792|19252621|P1|Overall Study|Lost to Follow-up|43
5570627|NCT01104792|19252621|P1|Overall Study|Withdrawal of Consent|179
5570628|NCT01104792|19252621|P1|Overall Study|Protocol Violation|45
5570629|NCT01104792|19252621|P1|Overall Study|Insufficient Therapeutic Response|22
5570630|NCT01104792|19252621|P1|Overall Study|Adverse Event|77
5570631|NCT01104779|19252629|P3|Overall Study|Withdrawal by Subject|32
5570632|NCT01104779|19252630|P2|Overall Study|Withdrawal by Subject|25
5570633|NCT01104779|19252631|P1|Overall Study|Withdrawal by Subject|16
5570634|NCT01104779|19252629|P3|Overall Study|Lost to Follow-up|1
5570635|NCT01104779|19252630|P2|Overall Study|Lost to Follow-up|0
5570636|NCT01104779|19252631|P1|Overall Study|Lost to Follow-up|2
5570637|NCT01104779|19252629|P3|Overall Study|Other reasons|0
5570638|NCT01104779|19252630|P2|Overall Study|Other reasons|1
5570639|NCT01104779|19252631|P1|Overall Study|Other reasons|0
5570640|NCT01104779|19252629|P3|Overall Study|Did not meet inc/exc criteria|1
5570641|NCT01104779|19252630|P2|Overall Study|Did not meet inc/exc criteria|1
5570642|NCT01104779|19252631|P1|Overall Study|Did not meet inc/exc criteria|1
5570643|NCT01104779|19252629|P3|Overall Study|Adverse Event|13
5570644|NCT01104779|19252630|P2|Overall Study|Adverse Event|14
5570645|NCT01104779|19252631|P1|Overall Study|Adverse Event|13
5570646|NCT01104779|19252629|P3|Overall Study|Lack of Efficacy|13
5570647|NCT01104779|19252630|P2|Overall Study|Lack of Efficacy|12
5570648|NCT01104779|19252631|P1|Overall Study|Lack of Efficacy|26
5570649|NCT01104779|19252629|P3|Overall Study|Protocol Violation|2
5570650|NCT01104779|19252630|P2|Overall Study|Protocol Violation|2
5570651|NCT01104779|19252631|P1|Overall Study|Protocol Violation|1
5570652|NCT01104766|19252646|P4|Overall Study|Lost to Follow-up|1
5570653|NCT01104766|19252647|P3|Overall Study|Lost to Follow-up|1
5570654|NCT01104766|19252648|P2|Overall Study|Lost to Follow-up|2
5570655|NCT01104766|19252649|P1|Overall Study|Lost to Follow-up|1
5570656|NCT01104766|19252646|P4|Overall Study|Withdrawal by Subject|15
5570657|NCT01104766|19252647|P3|Overall Study|Withdrawal by Subject|25
5570658|NCT01104766|19252648|P2|Overall Study|Withdrawal by Subject|19
5570659|NCT01104766|19252649|P1|Overall Study|Withdrawal by Subject|17
5570660|NCT01104766|19252646|P4|Overall Study|Protocol Violation|0
5570661|NCT01104766|19252647|P3|Overall Study|Protocol Violation|0
5570662|NCT01104766|19252648|P2|Overall Study|Protocol Violation|0
5570663|NCT01104766|19252649|P1|Overall Study|Protocol Violation|2
5570664|NCT01104766|19252646|P4|Overall Study|Lack of Efficacy|8
5570665|NCT01104766|19252647|P3|Overall Study|Lack of Efficacy|14
5570666|NCT01104766|19252648|P2|Overall Study|Lack of Efficacy|15
5570667|NCT01104766|19252649|P1|Overall Study|Lack of Efficacy|20
5570668|NCT01104766|19252646|P4|Overall Study|Adverse Event|14
5570669|NCT01104766|19252647|P3|Overall Study|Adverse Event|20
5570670|NCT01104766|19252648|P2|Overall Study|Adverse Event|15
5570671|NCT01104766|19252649|P1|Overall Study|Adverse Event|17
5570672|NCT01104766|19252646|P4|Overall Study|Did not meet inc/exc criteria|0
5570673|NCT01104766|19252647|P3|Overall Study|Did not meet inc/exc criteria|0
5570674|NCT01104766|19252648|P2|Overall Study|Did not meet inc/exc criteria|0
5570675|NCT01104766|19252649|P1|Overall Study|Did not meet inc/exc criteria|1
5570676|NCT01104701|19252667|P4|Overall Study|Physician Decision|0
5570677|NCT01104701|19252668|P3|Overall Study|Physician Decision|0
5570678|NCT01104701|19252669|P2|Overall Study|Physician Decision|2
5570679|NCT01104701|19252670|P1|Overall Study|Physician Decision|0
5570680|NCT01104701|19252667|P4|Overall Study|Adverse Event|1
5570681|NCT01104701|19252668|P3|Overall Study|Adverse Event|0
5570682|NCT01104701|19252669|P2|Overall Study|Adverse Event|0
5570683|NCT01104701|19252670|P1|Overall Study|Adverse Event|0
5570684|NCT01104701|19252667|P4|Overall Study|Withdrawal by Subject|1
5570685|NCT01104701|19252668|P3|Overall Study|Withdrawal by Subject|2
5570686|NCT01104701|19252669|P2|Overall Study|Withdrawal by Subject|1
5570687|NCT01104701|19252670|P1|Overall Study|Withdrawal by Subject|0
5570688|NCT01104662|19252732|P8|Overall Study|Randomized but not treated|0
5570689|NCT01104662|19252733|P7|Overall Study|Randomized but not treated|0
5570690|NCT01104662|19252734|P6|Overall Study|Randomized but not treated|1
5570691|NCT01104662|19252735|P5|Overall Study|Randomized but not treated|0
5570692|NCT01104662|19252736|P4|Overall Study|Randomized but not treated|0
5570693|NCT01104662|19252737|P3|Overall Study|Randomized but not treated|1
5570694|NCT01104662|19252738|P2|Overall Study|Randomized but not treated|4
5570695|NCT01104662|19252739|P1|Overall Study|Randomized but not treated|3
5570696|NCT01104662|19252732|P8|Overall Study|Reason not specified|0
5570697|NCT01104662|19252733|P7|Overall Study|Reason not specified|0
5570698|NCT01104662|19252734|P6|Overall Study|Reason not specified|1
5570699|NCT01104662|19252735|P5|Overall Study|Reason not specified|0
5570700|NCT01104662|19252736|P4|Overall Study|Reason not specified|0
5570701|NCT01104662|19252737|P3|Overall Study|Reason not specified|0
5570702|NCT01104662|19252738|P2|Overall Study|Reason not specified|3
5570703|NCT01104662|19252739|P1|Overall Study|Reason not specified|3
5570704|NCT01104662|19252732|P8|Overall Study|Participant left investigator's care|0
5570705|NCT01104662|19252733|P7|Overall Study|Participant left investigator's care|0
5570706|NCT01104662|19252734|P6|Overall Study|Participant left investigator's care|0
5570707|NCT01104662|19252735|P5|Overall Study|Participant left investigator's care|0
5570708|NCT01104662|19252736|P4|Overall Study|Participant left investigator's care|0
5570709|NCT01104662|19252737|P3|Overall Study|Participant left investigator's care|0
5570710|NCT01104662|19252738|P2|Overall Study|Participant left investigator's care|1
5570711|NCT01104662|19252739|P1|Overall Study|Participant left investigator's care|1
5570712|NCT01104662|19252732|P8|Overall Study|Clinical Failure|0
5570713|NCT01104662|19252733|P7|Overall Study|Clinical Failure|0
5570714|NCT01104662|19252734|P6|Overall Study|Clinical Failure|1
5570715|NCT01104662|19252735|P5|Overall Study|Clinical Failure|0
5570716|NCT01104662|19252736|P4|Overall Study|Clinical Failure|0
5570717|NCT01104662|19252737|P3|Overall Study|Clinical Failure|0
5570718|NCT01104662|19252738|P2|Overall Study|Clinical Failure|0
5570719|NCT01104662|19252739|P1|Overall Study|Clinical Failure|1
5570720|NCT01104662|19252732|P8|Overall Study|Adverse Event|0
5570721|NCT01104662|19252733|P7|Overall Study|Adverse Event|0
5570722|NCT01104662|19252734|P6|Overall Study|Adverse Event|1
5570723|NCT01104662|19252735|P5|Overall Study|Adverse Event|1
5570724|NCT01104662|19252736|P4|Overall Study|Adverse Event|1
5570725|NCT01104662|19252737|P3|Overall Study|Adverse Event|0
5570726|NCT01104662|19252738|P2|Overall Study|Adverse Event|2
5570727|NCT01104662|19252739|P1|Overall Study|Adverse Event|2
5570728|NCT01104636|19252765|P1|Overall Study|Ongoing|21
5570729|NCT01104636|19252765|P1|Overall Study|Adverse Event|40
5570730|NCT01104636|19252765|P1|Overall Study|Pregnancy|2
5570731|NCT01104636|19252765|P1|Overall Study|Study terminated by sponsor|1
5570732|NCT01104636|19252765|P1|Overall Study|Other|43
5570733|NCT01104636|19252765|P1|Overall Study|Withdrawal by Subject|4
5570734|NCT01104636|19252765|P1|Overall Study|Lost to Follow-up|24
5570735|NCT01104636|19252765|P1|Overall Study|Lack of Efficacy|43
5570736|NCT01104584|19252770|P1|Overall Study|Study prematurely discontinued|2
5570737|NCT01104584|19252770|P1|Overall Study|Study drug never administered|21
5570738|NCT01104558|19252840|P1|Overall Study|Missing of genetic analysis results|1
5570739|NCT01104558|19252840|P1|Overall Study|Missing of primary efficacy assessment|10
5570740|NCT01104558|19252840|P1|Overall Study|Protocol Violation|6
5570741|NCT01104545|19252884|P3|Overall Study|Adverse Event|2
5570742|NCT01104545|19252885|P2|Overall Study|Adverse Event|1
5570743|NCT01104545|19252886|P1|Overall Study|Adverse Event|0
5570744|NCT01104493|19253043|P2|Overall Study|Lost to Follow-up|2
5570745|NCT01104493|19253044|P1|Overall Study|Lost to Follow-up|0
5570746|NCT01104415|19253062|P2|Extension Period|Heart surgery/feeling miserable|1
5570747|NCT01104415|19253063|P1|Extension Period|Heart surgery/feeling miserable|0
5570748|NCT01104415|19253062|P2|Extension Period|Transition to Study LX1606.302|4
5570749|NCT01104415|19253063|P1|Extension Period|Transition to Study LX1606.302|0
5570750|NCT01104415|19253062|P2|Extension Period|Physician Decision|1
5570751|NCT01104415|19253063|P1|Extension Period|Physician Decision|0
5570752|NCT01104415|19253062|P2|Extension Period|Death|1
5570753|NCT01104415|19253063|P1|Extension Period|Death|0
5570754|NCT01104415|19253062|P2|Extension Period|Progressive disease|4
5570755|NCT01104415|19253063|P1|Extension Period|Progressive disease|0
5570756|NCT01104415|19253062|P2|Core Phase|Consent withdrawn by subjects|0
5570757|NCT01104415|19253063|P1|Core Phase|Consent withdrawn by subjects|1
5570758|NCT01104376|19253107|P1|Overall Study|Consented but excluded after labs|13
5570759|NCT01104376|19253107|P1|Overall Study|Withdrawal by Subject|15
5570760|NCT01104311|19253113|P2|Overall Study|Adverse Event|2
5570761|NCT01104311|19253114|P1|Overall Study|Adverse Event|1
5570762|NCT01104311|19253113|P2|Overall Study|low compliance|1
5570763|NCT01104311|19253114|P1|Overall Study|low compliance|1
5570764|NCT01104311|19253113|P2|Overall Study|Physician Decision|2
5570765|NCT01104311|19253114|P1|Overall Study|Physician Decision|2
5570766|NCT01104311|19253113|P2|Overall Study|Protocol Violation|1
5570767|NCT01104311|19253114|P1|Overall Study|Protocol Violation|0
5570768|NCT01104311|19253113|P2|Overall Study|Withdrawal by Subject|6
5570769|NCT01104311|19253114|P1|Overall Study|Withdrawal by Subject|6
5570770|NCT01104246|19253141|P1|Overall Study|did not meet inclusion criteria|4
5570771|NCT01104246|19253141|P1|Overall Study|Withdrawal by Subject|1
5570772|NCT01104155|19253156|P2|Overall Study|Other|4
5570773|NCT01104155|19253157|P1|Overall Study|Other|3
5570774|NCT01104155|19253156|P2|Overall Study|Withdrawal of consent|1
5570775|NCT01104155|19253157|P1|Overall Study|Withdrawal of consent|1
5570776|NCT01104155|19253156|P2|Overall Study|Participant choice|5
5570777|NCT01104155|19253157|P1|Overall Study|Participant choice|6
5570778|NCT01104155|19253156|P2|Overall Study|Adverse Event|8
5570779|NCT01104155|19253157|P1|Overall Study|Adverse Event|15
5570780|NCT01103960|19253209|P2|Overall Study|Other|0
5570781|NCT01103960|19253210|P1|Overall Study|Other|1
5570782|NCT01103960|19253209|P2|Overall Study|Withdrawal by Subject|1
5570783|NCT01103960|19253210|P1|Overall Study|Withdrawal by Subject|2
5570784|NCT01103960|19253209|P2|Overall Study|Adverse Event|1
5570785|NCT01103960|19253210|P1|Overall Study|Adverse Event|2
5570786|NCT01103778|19253245|P1|Overall Study|Screen failure|1
5570787|NCT01103778|19253245|P1|Overall Study|Proteinuria improved prior to enrollment|1
5570788|NCT01103778|19253245|P1|Overall Study|Lost to Follow-up|1
5570789|NCT01103713|19253252|P1|Overall Study|Other|1
5570790|NCT01103713|19253252|P1|Overall Study|Study terminated by sponsor|2
5570791|NCT01103713|19253252|P1|Overall Study|Withdrawal by Subject|8
5570792|NCT01103713|19253252|P1|Overall Study|Lost to Follow-up|2
5570793|NCT01103479|19253302|P3|Overall Study|Saw non-study physician|0
5570794|NCT01103479|19253303|P2|Overall Study|Saw non-study physician|0
5570795|NCT01103479|19253304|P1|Overall Study|Saw non-study physician|2
5570796|NCT01103479|19253302|P3|Overall Study|Active cancer|0
5570797|NCT01103479|19253303|P2|Overall Study|Active cancer|0
5570798|NCT01103479|19253304|P1|Overall Study|Active cancer|1
5570799|NCT01103479|19253302|P3|Overall Study|Family history of CRC|2
5570800|NCT01103479|19253303|P2|Overall Study|Family history of CRC|0
5570801|NCT01103479|19253304|P1|Overall Study|Family history of CRC|1
5570802|NCT01103479|19253302|P3|Overall Study|Up to date with CRC screening|12
5570803|NCT01103479|19253303|P2|Overall Study|Up to date with CRC screening|9
5570804|NCT01103479|19253304|P1|Overall Study|Up to date with CRC screening|1
5570805|NCT01103466|19253317|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
5570806|NCT01103466|19253318|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
5570807|NCT01103466|19253319|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
5570808|NCT01103466|19253317|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
5570809|NCT01103466|19253318|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
5570810|NCT01103466|19253319|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
5570811|NCT01103466|19253317|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
5570812|NCT01103466|19253318|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
5570813|NCT01103466|19253319|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
5570814|NCT01103466|19253317|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
5570815|NCT01103466|19253318|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
5570816|NCT01103466|19253319|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
5570817|NCT01103466|19253317|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
5570818|NCT01103466|19253318|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
5570819|NCT01103466|19253319|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
5570820|NCT01103466|19253317|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
5570821|NCT01103466|19253318|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
5570822|NCT01103466|19253319|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
5570823|NCT01103362|19253409|P1|Overall Study|study terminated|596
5570824|NCT01103323|19253415|P2|Switched From Placebo to Regorafenib|Adverse Event|1
5570825|NCT01103323|19253416|P1|Switched From Placebo to Regorafenib|Adverse Event|0
5570826|NCT01103323|19253415|P2|Without/Before Drug Switch|Switch to Regorafenib|4
5570827|NCT01103323|19253416|P1|Without/Before Drug Switch|Switch to Regorafenib|0
5570828|NCT01103323|19253415|P2|Without/Before Drug Switch|did not receive study treatment|2
5570829|NCT01103323|19253416|P1|Without/Before Drug Switch|did not receive study treatment|5
5570830|NCT01103323|19253415|P2|Without/Before Drug Switch|Physician Decision|0
5570831|NCT01103323|19253416|P1|Without/Before Drug Switch|Physician Decision|2
5570832|NCT01103323|19253415|P2|Without/Before Drug Switch|Protocol Violation|0
5570833|NCT01103323|19253416|P1|Without/Before Drug Switch|Protocol Violation|2
5570834|NCT01103323|19253415|P2|Without/Before Drug Switch|Withdrawal by Subject|5
5570835|NCT01103323|19253416|P1|Without/Before Drug Switch|Withdrawal by Subject|17
5570836|NCT01103323|19253415|P2|Without/Before Drug Switch|Adverse Event|7
5570837|NCT01103323|19253416|P1|Without/Before Drug Switch|Adverse Event|50
5570838|NCT01103284|19253433|P2|Overall Study|Missing CRF entries for study completion|2
5570839|NCT01103284|19253434|P1|Overall Study|Missing CRF entries for study completion|0
5570840|NCT01103284|19253433|P2|Overall Study|Not described|1
5570841|NCT01103284|19253434|P1|Overall Study|Not described|2
5570842|NCT01103284|19253433|P2|Overall Study|Termination by the Sponsor|1
5570843|NCT01103284|19253434|P1|Overall Study|Termination by the Sponsor|0
5570844|NCT01103284|19253433|P2|Overall Study|Dermal Hypersensitivity|1
5570845|NCT01103284|19253434|P1|Overall Study|Dermal Hypersensitivity|0
5570846|NCT01103284|19253433|P2|Overall Study|Withdrawal by Subject|18
5570847|NCT01103284|19253434|P1|Overall Study|Withdrawal by Subject|14
5570848|NCT01103284|19253433|P2|Overall Study|Adverse Event|5
5570849|NCT01103284|19253434|P1|Overall Study|Adverse Event|0
5570850|NCT01103284|19253433|P2|Overall Study|Protocol Violation|5
5570851|NCT01103284|19253434|P1|Overall Study|Protocol Violation|12
5570852|NCT01103284|19253433|P2|Overall Study|Pregnancy|1
5570853|NCT01103284|19253434|P1|Overall Study|Pregnancy|3
5570854|NCT01103284|19253433|P2|Overall Study|Lost to Follow-up|10
5570855|NCT01103284|19253434|P1|Overall Study|Lost to Follow-up|9
5570856|NCT01103284|19253433|P2|Overall Study|Death|0
5570857|NCT01103284|19253434|P1|Overall Study|Death|2
5570858|NCT01103245|19253462|P4|Overall Study|Physician Decision|0
5570859|NCT01103245|19253463|P3|Overall Study|Physician Decision|0
5570860|NCT01103245|19253464|P2|Overall Study|Physician Decision|0
5570861|NCT01103245|19253465|P1|Overall Study|Physician Decision|1
5570862|NCT01103245|19253462|P4|Overall Study|Adverse Event|0
5570863|NCT01103245|19253463|P3|Overall Study|Adverse Event|1
5570864|NCT01103245|19253464|P2|Overall Study|Adverse Event|2
5570865|NCT01103245|19253465|P1|Overall Study|Adverse Event|0
5570866|NCT01103245|19253462|P4|Overall Study|Inadequate IV access|0
5570867|NCT01103245|19253463|P3|Overall Study|Inadequate IV access|0
5570868|NCT01103245|19253464|P2|Overall Study|Inadequate IV access|0
5570869|NCT01103245|19253465|P1|Overall Study|Inadequate IV access|1
5570870|NCT01103245|19253462|P4|Overall Study|Withdrawal by Subject|0
5570871|NCT01103245|19253463|P3|Overall Study|Withdrawal by Subject|3
5570872|NCT01103245|19253464|P2|Overall Study|Withdrawal by Subject|0
5570873|NCT01103245|19253465|P1|Overall Study|Withdrawal by Subject|1
5570874|NCT01103232|19253481|P2|Overall Study|Protocol Violation|1
5570875|NCT01103232|19253482|P1|Overall Study|Protocol Violation|0
5570876|NCT01103232|19253481|P2|Overall Study|Withdrawal by Subject|1
5570877|NCT01103232|19253482|P1|Overall Study|Withdrawal by Subject|1
5570878|NCT01103180|19253490|P2|Overall Study|Protocol Violation|1
5570879|NCT01103180|19253491|P1|Overall Study|Protocol Violation|0
5570880|NCT01103180|19253490|P2|Overall Study|Physician Decision|0
5570881|NCT01103180|19253491|P1|Overall Study|Physician Decision|1
5570882|NCT01103180|19253490|P2|Overall Study|Lost to Follow-up|7
5570883|NCT01103180|19253491|P1|Overall Study|Lost to Follow-up|13
5570884|NCT01103180|19253490|P2|Overall Study|Withdrawal by Subject|13
5570885|NCT01103180|19253491|P1|Overall Study|Withdrawal by Subject|8
5570886|NCT01103141|19253501|P2|Overall Study|Lost to Follow-up|1
5570887|NCT01103141|19253502|P1|Overall Study|Lost to Follow-up|2
5570888|NCT01103141|19253501|P2|Overall Study|Death|1
5570889|NCT01103141|19253502|P1|Overall Study|Death|0
5570890|NCT01103063|19253510|P2|Overall Study|Death|1
5570891|NCT01103063|19253511|P1|Overall Study|Death|3
5570892|NCT01103063|19253510|P2|Overall Study|Study terminated by Sponsor|342
5570893|NCT01103063|19253511|P1|Overall Study|Study terminated by Sponsor|326
5570894|NCT01103063|19253510|P2|Overall Study|Protocol Violation|0
5570895|NCT01103063|19253511|P1|Overall Study|Protocol Violation|1
5570896|NCT01103063|19253510|P2|Overall Study|Other|11
5570897|NCT01103063|19253511|P1|Overall Study|Other|16
5570898|NCT01103063|19253510|P2|Overall Study|Withdrawal by Subject|15
5570899|NCT01103063|19253511|P1|Overall Study|Withdrawal by Subject|60
5570900|NCT01103063|19253510|P2|Overall Study|Lost to Follow-up|51
5570901|NCT01103063|19253511|P1|Overall Study|Lost to Follow-up|68
5570902|NCT01103063|19253510|P2|Overall Study|Adverse Event|1
5570903|NCT01103063|19253511|P1|Overall Study|Adverse Event|3
5570904|NCT01102972|19253579|P2|Overall Study|Withdrawal by Subject|6
5570905|NCT01102972|19253580|P1|Overall Study|Withdrawal by Subject|6
5570906|NCT01102972|19253579|P2|Overall Study|Investigator Discretion|0
5570907|NCT01102972|19253580|P1|Overall Study|Investigator Discretion|2
5570908|NCT01102972|19253579|P2|Overall Study|Lost to Follow-up|5
5570909|NCT01102972|19253580|P1|Overall Study|Lost to Follow-up|10
5570910|NCT01102972|19253579|P2|Overall Study|Protocol Violation|0
5570911|NCT01102972|19253580|P1|Overall Study|Protocol Violation|1
5570912|NCT01102972|19253579|P2|Overall Study|Lack of Efficacy|1
5570913|NCT01102972|19253580|P1|Overall Study|Lack of Efficacy|2
5570914|NCT01102972|19253579|P2|Overall Study|Adverse Event|2
5570915|NCT01102972|19253580|P1|Overall Study|Adverse Event|8
5570916|NCT01102803|19253644|P2|Post to Follow-Up|Lost to Follow-up|3
5570917|NCT01102803|19253645|P1|Post to Follow-Up|Lost to Follow-up|1
5570918|NCT01102803|19253644|P2|Baseline to Post-Treatment|Lost to Follow-up|0
5570919|NCT01102803|19253645|P1|Baseline to Post-Treatment|Lost to Follow-up|3
5570920|NCT01102777|19253659|P2|Overall Study|Lost to Follow-up|10
5570921|NCT01102777|19253660|P1|Overall Study|Lost to Follow-up|7
5570922|NCT01102777|19253659|P2|Overall Study|Death|6
5570923|NCT01102777|19253660|P1|Overall Study|Death|2
5570924|NCT01102491|19253719|P2|Overall Study|Protocol Violation|12
5570925|NCT01102491|19253720|P1|Overall Study|Protocol Violation|11
5570926|NCT01102426|19253728|P2|Overall Study|Death (non-related to the study|8
5570927|NCT01102426|19253729|P1|Overall Study|Death (non-related to the study|19
5570928|NCT01102426|19253728|P2|Overall Study|Death (due to adverse events|1
5570929|NCT01102426|19253729|P1|Overall Study|Death (due to adverse events|0
5570930|NCT01102426|19253728|P2|Overall Study|Patient Refusal|12
5570931|NCT01102426|19253729|P1|Overall Study|Patient Refusal|24
5570932|NCT01102426|19253728|P2|Overall Study|Adverse Events (unrelated to|1
5570933|NCT01102426|19253729|P1|Overall Study|Adverse Events (unrelated to|9
5570934|NCT01102426|19253728|P2|Overall Study|Progressive Disease|44
5570935|NCT01102426|19253729|P1|Overall Study|Progressive Disease|85
5570936|NCT01102426|19253728|P2|Overall Study|Physician Decision|6
5570937|NCT01102426|19253729|P1|Overall Study|Physician Decision|9
5570938|NCT01102426|19253728|P2|Overall Study|Adverse Events (treatment-related)|8
5570939|NCT01102426|19253729|P1|Overall Study|Adverse Events (treatment-related)|15
5570940|NCT01102426|19253728|P2|Overall Study|Randomized but not treated|1
5570941|NCT01102426|19253729|P1|Overall Study|Randomized but not treated|4
5570942|NCT01102374|19253780|P2|Overall Study|Lost to Follow-up|6
5570943|NCT01102374|19253781|P1|Overall Study|Lost to Follow-up|7
5570944|NCT01102374|19253780|P2|Overall Study|Death|13
5570945|NCT01102374|19253781|P1|Overall Study|Death|9
5570946|NCT01102257|19253830|P2|Overall Study|Adverse Event|0
5570947|NCT01102257|19253831|P1|Overall Study|Adverse Event|1
5570948|NCT01102257|19253830|P2|Overall Study|Adverse Event|0
5570949|NCT01102257|19253831|P1|Overall Study|Adverse Event|1
5570950|NCT01102140|19253848|P2|Overall Study|Investigator terminated study|2
5570951|NCT01102140|19253849|P1|Overall Study|Investigator terminated study|2
5570952|NCT01102140|19253848|P2|Overall Study|Lost to Follow-up|0
5570953|NCT01102140|19253849|P1|Overall Study|Lost to Follow-up|1
5570954|NCT01101997|19253861|P1|Overall Study|Withdrawal by Subject|2
5570955|NCT01101841|19253910|P2|Overall Study|Eligibility Criteria|2
5570956|NCT01101841|19253911|P1|Overall Study|Eligibility Criteria|1
5570957|NCT01101841|19253910|P2|Overall Study|Suicidality Tracking Scale|1
5570958|NCT01101841|19253911|P1|Overall Study|Suicidality Tracking Scale|3
5570959|NCT01101841|19253910|P2|Overall Study|Other|1
5570960|NCT01101841|19253911|P1|Overall Study|Other|0
5570961|NCT01101841|19253910|P2|Overall Study|Lack of Efficacy|2
5570962|NCT01101841|19253911|P1|Overall Study|Lack of Efficacy|0
5570963|NCT01101841|19253910|P2|Overall Study|Physician Decision|2
5570964|NCT01101841|19253911|P1|Overall Study|Physician Decision|0
5570965|NCT01101841|19253910|P2|Overall Study|Protocol Violation|1
5570966|NCT01101841|19253911|P1|Overall Study|Protocol Violation|1
5570967|NCT01101841|19253910|P2|Overall Study|Withdrawal by Subject|40
5570968|NCT01101841|19253911|P1|Overall Study|Withdrawal by Subject|21
5570969|NCT01101841|19253910|P2|Overall Study|Lost to Follow-up|3
5570970|NCT01101841|19253911|P1|Overall Study|Lost to Follow-up|9
5570971|NCT01101841|19253910|P2|Overall Study|Adverse Event|15
5570972|NCT01101841|19253911|P1|Overall Study|Adverse Event|15
5570973|NCT01101542|19253953|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
5570974|NCT01101542|19253953|P1|Year 6 Surveillance Period|Pregnancy|1
5570975|NCT01101542|19253953|P1|Year 6 Surveillance Period|Lost to Follow-up|986
5570976|NCT01101542|19253953|P1|Year 5 Surveillance Period|Pregnancy|1
5570977|NCT01101542|19253953|P1|Year 5 Surveillance Period|Lost to Follow-up|140
5570978|NCT01101542|19253953|P1|Year 4 Surveillance Period|Other|287
5570979|NCT01101542|19253953|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
5570980|NCT01101542|19253953|P1|Year 3 Surveillance Period|Lost to Follow-up|7
5570981|NCT01101477|19253969|P3|Overall Study|Protocol Violation|1
5570982|NCT01101477|19253970|P2|Overall Study|Protocol Violation|3
5570983|NCT01101477|19253971|P1|Overall Study|Protocol Violation|5
5570984|NCT01101334|19253994|P2|Overall Study|Other|1
5570985|NCT01101334|19253995|P1|Overall Study|Other|2
5570986|NCT01101334|19253994|P2|Overall Study|Progressive Disease|35
5570987|NCT01101334|19253995|P1|Overall Study|Progressive Disease|22
5570988|NCT01101334|19253994|P2|Overall Study|Withdrawal by Sponsor|1
5570989|NCT01101334|19253995|P1|Overall Study|Withdrawal by Sponsor|1
5570990|NCT01101334|19253994|P2|Overall Study|Withdrawal by Subject|3
5570991|NCT01101334|19253995|P1|Overall Study|Withdrawal by Subject|4
5570992|NCT01101334|19253994|P2|Overall Study|Death|1
5570993|NCT01101334|19253995|P1|Overall Study|Death|7
5570994|NCT01101334|19253994|P2|Overall Study|Adverse Event|4
5570995|NCT01101334|19253995|P1|Overall Study|Adverse Event|9
5570996|NCT01101321|19254007|P2|Period 1|Adverse Event|3
5570997|NCT01101321|19254008|P1|Period 1|Adverse Event|3
5570998|NCT01101321|19254007|P2|Period 1|Withdrawal by Subject|1
5570999|NCT01101321|19254008|P1|Period 1|Withdrawal by Subject|1
5571000|NCT01101308|19254018|P2|Period 1|Positive for cotinine|0
5571001|NCT01101308|19254019|P1|Period 1|Positive for cotinine|1
5571002|NCT01101308|19254018|P2|Period 1|Adverse Event|1
5571003|NCT01101308|19254019|P1|Period 1|Adverse Event|2
5571004|NCT01101191|19254030|P2|Period 1|Adverse Event|2
5571005|NCT01101191|19254031|P1|Period 1|Adverse Event|1
5571006|NCT01101191|19254030|P2|Period 1|Withdrawal by Subject|0
5571007|NCT01101191|19254031|P1|Period 1|Withdrawal by Subject|1
5571008|NCT01101178|19254042|P2|Period 2|Withdrawal by Subject|1
5571009|NCT01101178|19254043|P1|Period 2|Withdrawal by Subject|0
5571010|NCT01101178|19254042|P2|Period 1|Adverse Event|1
5571011|NCT01101178|19254043|P1|Period 1|Adverse Event|2
5571012|NCT01101178|19254042|P2|Period 1|Positive drug screen|1
5571013|NCT01101178|19254043|P1|Period 1|Positive drug screen|1
5571014|NCT01101178|19254042|P2|Period 1|Withdrawal by Subject|2
5571015|NCT01101178|19254043|P1|Period 1|Withdrawal by Subject|1
5571016|NCT01101165|19254054|P2|Period 2|Adverse Event|0
5571017|NCT01101165|19254055|P1|Period 2|Adverse Event|1
5571018|NCT01101165|19254054|P2|Period 2|Withdrawal by Subject|1
5571019|NCT01101165|19254055|P1|Period 2|Withdrawal by Subject|3
5571020|NCT01101165|19254054|P2|Period 1|Lost to Follow-up|0
5571021|NCT01101165|19254055|P1|Period 1|Lost to Follow-up|1
5571022|NCT01101165|19254054|P2|Period 1|Positive Drug Screen|1
5571023|NCT01101165|19254055|P1|Period 1|Positive Drug Screen|0
5571024|NCT01101165|19254054|P2|Period 1|Withdrawal by Subject|2
5571025|NCT01101165|19254055|P1|Period 1|Withdrawal by Subject|0
5571026|NCT01101165|19254054|P2|Period 1|Adverse Event|2
5571027|NCT01101165|19254055|P1|Period 1|Adverse Event|1
5571028|NCT01101061|19254076|P6|Overall Study|Adverse Event|0
5571029|NCT01101061|19254077|P5|Overall Study|Adverse Event|0
5571030|NCT01101061|19254078|P4|Overall Study|Adverse Event|0
5571031|NCT01101061|19254079|P3|Overall Study|Adverse Event|1
5571032|NCT01101061|19254080|P2|Overall Study|Adverse Event|0
5571033|NCT01101061|19254081|P1|Overall Study|Adverse Event|0
5571034|NCT01101035|19254161|P2|Overall Study|Reason not Specified|363
5571035|NCT01101035|19254162|P1|Overall Study|Reason not Specified|333
5571036|NCT01101035|19254161|P2|Overall Study|Voluntary Withdrawal|587
5571037|NCT01101035|19254162|P1|Overall Study|Voluntary Withdrawal|595
5571038|NCT01101035|19254161|P2|Overall Study|Lost to Follow-up|223
5571039|NCT01101035|19254162|P1|Overall Study|Lost to Follow-up|226
5571040|NCT01101035|19254161|P2|Overall Study|Major Protocol Deviation|46
5571041|NCT01101035|19254162|P1|Overall Study|Major Protocol Deviation|52
5571042|NCT01101035|19254161|P2|Overall Study|Adverse Event|172
5571043|NCT01101035|19254162|P1|Overall Study|Adverse Event|191
5571044|NCT01101022|19254182|P2|Overall Study|Vacation|1
5571045|NCT01101022|19254183|P1|Overall Study|Vacation|0
5571046|NCT01101022|19254182|P2|Overall Study|Work schedule|1
5571047|NCT01101022|19254183|P1|Overall Study|Work schedule|1
5571048|NCT01101022|19254182|P2|Overall Study|Non-compliance|0
5571049|NCT01101022|19254183|P1|Overall Study|Non-compliance|1
5571050|NCT01101022|19254182|P2|Overall Study|Sponsor decision|1
5571051|NCT01101022|19254183|P1|Overall Study|Sponsor decision|1
5571052|NCT01101022|19254182|P2|Overall Study|Lack of Efficacy|7
5571053|NCT01101022|19254183|P1|Overall Study|Lack of Efficacy|0
5571054|NCT01101022|19254182|P2|Overall Study|Lost to Follow-up|4
5571055|NCT01101022|19254183|P1|Overall Study|Lost to Follow-up|1
5571056|NCT01101022|19254182|P2|Overall Study|Withdrawal by Subject|8
5571057|NCT01101022|19254183|P1|Overall Study|Withdrawal by Subject|3
5571058|NCT01101022|19254182|P2|Overall Study|Protocol Violation|3
5571059|NCT01101022|19254183|P1|Overall Study|Protocol Violation|4
5571060|NCT01101022|19254182|P2|Overall Study|Adverse Event|2
5571061|NCT01101022|19254183|P1|Overall Study|Adverse Event|6
5571062|NCT01100944|19254217|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
5571063|NCT01100944|19254218|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
5571064|NCT01100944|19254219|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
5571229|NCT01098539|19255011|P2|Overall Study|Protocol Violation|4
5571065|NCT01100944|19254217|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
5571066|NCT01100944|19254218|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
5571067|NCT01100944|19254219|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
5571068|NCT01100944|19254217|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
5571069|NCT01100944|19254218|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
5571070|NCT01100944|19254219|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
5571071|NCT01100944|19254217|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
5571072|NCT01100944|19254218|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
5571073|NCT01100944|19254219|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
5571074|NCT01100853|19254277|P2|Overall Study|Withdrawal by Subject|4
5571075|NCT01100853|19254278|P1|Overall Study|Withdrawal by Subject|6
5571076|NCT01100853|19254277|P2|Overall Study|Received <4 study injections|13
5571077|NCT01100853|19254278|P1|Overall Study|Received <4 study injections|10
5571078|NCT01100853|19254277|P2|Overall Study|Lost to Follow-up|6
5571079|NCT01100853|19254278|P1|Overall Study|Lost to Follow-up|11
5571080|NCT01100658|19254324|P1|Overall Study|Withdrawal by Subject|1
5571081|NCT01100567|19254356|P2|Overall Study|Deemed ineligible after consent|1
5571082|NCT01100567|19254357|P1|Overall Study|Deemed ineligible after consent|0
5571083|NCT01100567|19254356|P2|Overall Study|Physician Decision|1
5571084|NCT01100567|19254357|P1|Overall Study|Physician Decision|0
5571085|NCT01100567|19254356|P2|Overall Study|Lost to Follow-up|2
5571086|NCT01100567|19254357|P1|Overall Study|Lost to Follow-up|1
5571087|NCT01100567|19254356|P2|Overall Study|Early Hospital Discharge|4
5571088|NCT01100567|19254357|P1|Overall Study|Early Hospital Discharge|6
5571089|NCT01100567|19254356|P2|Overall Study|Withdrawal by Subject|8
5571090|NCT01100567|19254357|P1|Overall Study|Withdrawal by Subject|5
5571091|NCT01100528|19254365|P1|Overall Study|Withdrawal by Subject|2
5571092|NCT01100528|19254365|P1|Overall Study|Death|1
5571093|NCT01100502|19254373|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
5571094|NCT01100502|19254374|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
5571095|NCT01100502|19254373|P2|Long-Term Follow-up|Lost to Follow-up|2
5571096|NCT01100502|19254374|P1|Long-Term Follow-up|Lost to Follow-up|5
5571097|NCT01100502|19254373|P2|Long-Term Follow-up|Withdrawal by Subject|8
5571098|NCT01100502|19254374|P1|Long-Term Follow-up|Withdrawal by Subject|10
5571099|NCT01100502|19254373|P2|Treatment Period|Progressive Disease|69
5571100|NCT01100502|19254374|P1|Treatment Period|Progressive Disease|24
5571101|NCT01100502|19254373|P2|Treatment Period|Withdrawal by Subject|4
5571102|NCT01100502|19254374|P1|Treatment Period|Withdrawal by Subject|9
5571103|NCT01100502|19254373|P2|Treatment Period|Adverse Event|10
5571104|NCT01100502|19254374|P1|Treatment Period|Adverse Event|54
5571105|NCT01100437|19254384|P3|Maintenance|Sponsor termination of study|1
5571106|NCT01100437|19254385|P2|Maintenance|Sponsor termination of study|0
5571107|NCT01100437|19254386|P1|Maintenance|Sponsor termination of study|0
5571108|NCT01100437|19254384|P3|Maintenance|Withdrawal by Subject|1
5571109|NCT01100437|19254385|P2|Maintenance|Withdrawal by Subject|0
5571110|NCT01100437|19254386|P1|Maintenance|Withdrawal by Subject|0
5571111|NCT01100437|19254384|P3|Titration/Stabilization|Sponsor canceled study|1
5571112|NCT01100437|19254385|P2|Titration/Stabilization|Sponsor canceled study|0
5571113|NCT01100437|19254386|P1|Titration/Stabilization|Sponsor canceled study|0
5571114|NCT01100437|19254384|P3|Titration/Stabilization|Non-compliance|1
5571115|NCT01100437|19254385|P2|Titration/Stabilization|Non-compliance|0
5571116|NCT01100437|19254386|P1|Titration/Stabilization|Non-compliance|0
5571117|NCT01100437|19254384|P3|Titration/Stabilization|Adverse Event|4
5571118|NCT01100437|19254385|P2|Titration/Stabilization|Adverse Event|0
5571119|NCT01100437|19254386|P1|Titration/Stabilization|Adverse Event|0
5571120|NCT01100320|19254423|P2|Period 2|Withdrawal by Subject|1
5571121|NCT01100320|19254424|P1|Period 2|Withdrawal by Subject|1
5571122|NCT01100320|19254423|P2|Period 1|Adverse Event|2
5571123|NCT01100320|19254424|P1|Period 1|Adverse Event|2
5571124|NCT01100320|19254423|P2|Period 1|Positive Drug Screen|1
5571125|NCT01100320|19254424|P1|Period 1|Positive Drug Screen|1
5571126|NCT01100320|19254423|P2|Period 1|Withdrawal by Subject|4
5571127|NCT01100320|19254424|P1|Period 1|Withdrawal by Subject|2
5571128|NCT01100307|19254436|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
5571129|NCT01100307|19254437|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
5571130|NCT01100307|19254436|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
5571131|NCT01100307|19254437|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
5571132|NCT01100307|19254436|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
5571133|NCT01100307|19254437|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
5571134|NCT01100307|19254436|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
5571135|NCT01100307|19254437|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
5571136|NCT01100307|19254436|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
5571137|NCT01100307|19254437|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
5571138|NCT01100307|19254436|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
5571139|NCT01100307|19254437|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
5571140|NCT01100086|19254506|P2|Period 1|Withdrawal by Subject|0
5571141|NCT01100086|19254507|P1|Period 1|Withdrawal by Subject|1
5571142|NCT01100073|19254517|P1|Overall Study|Missing|5
5571143|NCT01100073|19254517|P1|Overall Study|Other|8
5571144|NCT01100073|19254517|P1|Overall Study|Insufficient tolerability +patients wish|8
5571145|NCT01100073|19254517|P1|Overall Study|Lack of effect + patient's wish|2
5571146|NCT01100073|19254517|P1|Overall Study|Lost to Follow-up|39
5571147|NCT01100073|19254517|P1|Overall Study|Withdrawal by Subject|13
5571148|NCT01100073|19254517|P1|Overall Study|Insufficient Tolerability|21
5571149|NCT01100073|19254517|P1|Overall Study|Lack of Efficacy|4
5571150|NCT01100034|19254532|P1|Overall Study|Site closed due to non-responsiveness|1
5571151|NCT01100034|19254532|P1|Overall Study|Participants moved to another hospital|4
5571152|NCT01100034|19254532|P1|Overall Study|Participated in another clinical trial|1
5571153|NCT01100034|19254532|P1|Overall Study|Sponsor decision|21
5571154|NCT01100034|19254532|P1|Overall Study|Withdrawal by Subject|4
5571155|NCT01100034|19254532|P1|Overall Study|Withdrawal of parent/guardian consent|1
5571156|NCT01100034|19254532|P1|Overall Study|Lost to Follow-up|11
5571157|NCT01099917|19254570|P1|Overall Study|Not Treated|24
5571158|NCT01099917|19254570|P1|Overall Study|Adverse Event|3
5571159|NCT01099709|19254632|P2|Period 1|Adverse Event|0
5571160|NCT01099709|19254633|P1|Period 1|Adverse Event|1
5571161|NCT01099709|19254632|P2|Period 1|Positive cotinine test|1
5571162|NCT01099709|19254633|P1|Period 1|Positive cotinine test|0
5571163|NCT01099709|19254632|P2|Period 1|Withdrawal by Subject|1
5571164|NCT01099709|19254633|P1|Period 1|Withdrawal by Subject|0
5571165|NCT01099579|19254702|P3|Stage 2 (ATV Capsule)|Adverse Event|0
5571166|NCT01099579|19254703|P2|Stage 2 (ATV Capsule)|Adverse Event|1
5571167|NCT01099579|19254704|P1|Stage 2 (ATV Capsule)|Adverse Event|0
5571168|NCT01099579|19254702|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
5571169|NCT01099579|19254703|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
5571170|NCT01099579|19254704|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
5571171|NCT01099579|19254702|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
5571172|NCT01099579|19254703|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
5571173|NCT01099579|19254704|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
5571174|NCT01099579|19254702|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
5571175|NCT01099579|19254703|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
5571176|NCT01099579|19254704|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
5571177|NCT01099579|19254702|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
5571178|NCT01099579|19254703|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
5571179|NCT01099579|19254704|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
5571180|NCT01099579|19254702|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
5571181|NCT01099579|19254703|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
5571182|NCT01099579|19254704|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
5571183|NCT01099579|19254702|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
5571184|NCT01099579|19254703|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
5571185|NCT01099579|19254704|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
5571186|NCT01099579|19254702|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
5571187|NCT01099579|19254703|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
5571188|NCT01099579|19254704|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
5571189|NCT01099579|19254702|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
5571190|NCT01099579|19254703|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
5571191|NCT01099579|19254704|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
5571192|NCT01099579|19254702|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
5571193|NCT01099579|19254703|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
5571194|NCT01099579|19254704|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
5571195|NCT01099397|19254813|P1|Overall Study|Withdrawal by Subject|5
5571196|NCT01099397|19254813|P1|Overall Study|Protocol Violation|4
5571197|NCT01099397|19254813|P1|Overall Study|Lost to Follow-up|4
5571198|NCT01099267|19254840|P1|MDS-003 Study|Secondary Malign Disease|1
5571199|NCT01099267|19254840|P1|MDS-003 Study|Loss of Response|1
5571200|NCT01099267|19254840|P1|MDS-003 Study|Non-Compliance|2
5571201|NCT01099267|19254840|P1|MDS-003 Study|Investigator Decision|2
5571202|NCT01099267|19254840|P1|MDS-003 Study|Disease Progression|7
5571203|NCT01099267|19254840|P1|MDS-003 Study|Study Closed by Sponsor|2
5571204|NCT01099267|19254840|P1|MDS-003 Study|Death|11
5571205|NCT01099267|19254840|P1|MDS-003 Study|Lost to Follow-up|1
5571206|NCT01099267|19254840|P1|MDS-003 Study|Withdrawal by Subject|8
5571207|NCT01099267|19254840|P1|MDS-003 Study|Lack of Efficacy|52
5571208|NCT01099267|19254840|P1|MDS-003 Study|Adverse Event|37
5571209|NCT01099215|19254850|P2|Overall Study|Adverse Event|1
5571210|NCT01099215|19254851|P1|Overall Study|Adverse Event|0
5571211|NCT01099215|19254850|P2|Overall Study|Withdrawal by Subject|0
5571212|NCT01099215|19254851|P1|Overall Study|Withdrawal by Subject|1
5571213|NCT01098851|19254921|P2|Overall Study|Equipment failure|0
5571214|NCT01098851|19254922|P1|Overall Study|Equipment failure|1
5571215|NCT01098812|19254933|P3|Overall Study|Lost to Follow-up|0
5571216|NCT01098812|19254934|P2|Overall Study|Lost to Follow-up|1
5571217|NCT01098812|19254935|P1|Overall Study|Lost to Follow-up|0
5571218|NCT01098812|19254933|P3|Overall Study|Death|1
5571219|NCT01098812|19254934|P2|Overall Study|Death|0
5571220|NCT01098812|19254935|P1|Overall Study|Death|2
5571221|NCT01098539|19255011|P2|Overall Study|Physician Decision|3
5571222|NCT01098539|19255012|P1|Overall Study|Physician Decision|5
5571223|NCT01098539|19255011|P2|Overall Study|Withdrawal by Subject|26
5571224|NCT01098539|19255012|P1|Overall Study|Withdrawal by Subject|12
5571225|NCT01098539|19255011|P2|Overall Study|Lost to Follow-up|4
5571226|NCT01098539|19255012|P1|Overall Study|Lost to Follow-up|4
5571227|NCT01098539|19255011|P2|Overall Study|Noncompliance|5
5571228|NCT01098539|19255012|P1|Overall Study|Noncompliance|3
5571230|NCT01098539|19255012|P1|Overall Study|Protocol Violation|1
5571231|NCT01098539|19255011|P2|Overall Study|Adverse Event|26
5571232|NCT01098539|19255012|P1|Overall Study|Adverse Event|26
5571233|NCT01098487|19255063|P1|Overall Study|Physician Decision|1
5571234|NCT01098487|19255063|P1|Overall Study|Lost to Follow-up|3
5571235|NCT01098487|19255063|P1|Overall Study|Withdrawal by Subject|7
5571236|NCT01098487|19255063|P1|Overall Study|Lack of Efficacy|11
5571237|NCT01098487|19255063|P1|Overall Study|Adverse Event|22
5571238|NCT01098474|19255081|P6|Follow Up Phase|Lost to Follow-up|0
5571239|NCT01098474|19255082|P5|Follow Up Phase|Lost to Follow-up|1
5571240|NCT01098474|19255083|P4|Follow Up Phase|Lost to Follow-up|0
5571241|NCT01098474|19255084|P3|Follow Up Phase|Lost to Follow-up|0
5571242|NCT01098474|19255085|P2|Follow Up Phase|Lost to Follow-up|0
5571243|NCT01098474|19255086|P1|Follow Up Phase|Lost to Follow-up|0
5571244|NCT01098474|19255081|P6|Follow Up Phase|Withdrawal by Subject|1
5571245|NCT01098474|19255082|P5|Follow Up Phase|Withdrawal by Subject|0
5571246|NCT01098474|19255083|P4|Follow Up Phase|Withdrawal by Subject|2
5571247|NCT01098474|19255084|P3|Follow Up Phase|Withdrawal by Subject|0
5571248|NCT01098474|19255085|P2|Follow Up Phase|Withdrawal by Subject|0
5571249|NCT01098474|19255086|P1|Follow Up Phase|Withdrawal by Subject|0
5571250|NCT01098474|19255081|P6|Follow Up Phase|Other|4
5571251|NCT01098474|19255082|P5|Follow Up Phase|Other|0
5571252|NCT01098474|19255083|P4|Follow Up Phase|Other|0
5571253|NCT01098474|19255084|P3|Follow Up Phase|Other|0
5571254|NCT01098474|19255085|P2|Follow Up Phase|Other|0
5571255|NCT01098474|19255086|P1|Follow Up Phase|Other|0
5571256|NCT01098474|19255081|P6|Follow Up Phase|Travelled out of study area|0
5571257|NCT01098474|19255082|P5|Follow Up Phase|Travelled out of study area|1
5571258|NCT01098474|19255083|P4|Follow Up Phase|Travelled out of study area|0
5571259|NCT01098474|19255084|P3|Follow Up Phase|Travelled out of study area|0
5571260|NCT01098474|19255085|P2|Follow Up Phase|Travelled out of study area|0
5571261|NCT01098474|19255086|P1|Follow Up Phase|Travelled out of study area|0
5571262|NCT01098474|19255081|P6|Active Phase|Lost to Follow-up|0
5571263|NCT01098474|19255082|P5|Active Phase|Lost to Follow-up|0
5571264|NCT01098474|19255083|P4|Active Phase|Lost to Follow-up|0
5571265|NCT01098474|19255084|P3|Active Phase|Lost to Follow-up|0
5571266|NCT01098474|19255085|P2|Active Phase|Lost to Follow-up|0
5571267|NCT01098474|19255086|P1|Active Phase|Lost to Follow-up|1
5571268|NCT01098474|19255081|P6|Active Phase|Withdrawal by Subject|0
5571269|NCT01098474|19255082|P5|Active Phase|Withdrawal by Subject|0
5571270|NCT01098474|19255083|P4|Active Phase|Withdrawal by Subject|0
5571271|NCT01098474|19255084|P3|Active Phase|Withdrawal by Subject|2
5571272|NCT01098474|19255085|P2|Active Phase|Withdrawal by Subject|1
5571273|NCT01098474|19255086|P1|Active Phase|Withdrawal by Subject|1
5571274|NCT01098474|19255081|P6|Active Phase|Other|0
5571275|NCT01098474|19255082|P5|Active Phase|Other|0
5571276|NCT01098474|19255083|P4|Active Phase|Other|0
5571277|NCT01098474|19255084|P3|Active Phase|Other|3
5571278|NCT01098474|19255085|P2|Active Phase|Other|0
5571279|NCT01098474|19255086|P1|Active Phase|Other|0
5571280|NCT01098461|19255320|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
5571281|NCT01098461|19255321|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
5571282|NCT01098461|19255322|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
5571283|NCT01098461|19255323|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
5571284|NCT01098461|19255320|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
5571285|NCT01098461|19255321|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
5571286|NCT01098461|19255322|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
5571287|NCT01098461|19255323|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
5571288|NCT01098461|19255320|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
5571289|NCT01098461|19255321|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
5571290|NCT01098461|19255322|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
5571291|NCT01098461|19255323|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
5571292|NCT01098461|19255320|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
5571293|NCT01098461|19255321|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
5571294|NCT01098461|19255322|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
5571295|NCT01098461|19255323|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
5571296|NCT01098461|19255320|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
5571297|NCT01098461|19255321|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
5571298|NCT01098461|19255322|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
5571299|NCT01098461|19255323|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
5571300|NCT01098461|19255320|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
5571301|NCT01098461|19255321|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
5571302|NCT01098461|19255322|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
5571303|NCT01098461|19255323|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
5571304|NCT01098461|19255320|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
5571305|NCT01098461|19255321|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
5571306|NCT01098461|19255322|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
5571307|NCT01098461|19255323|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
5571308|NCT01098305|19255383|P2|Overall Study|Lost to Follow-up|33
5571309|NCT01098305|19255384|P1|Overall Study|Lost to Follow-up|31
5571310|NCT01098266|19255394|P2|Overall Study|Withdrawal by Subject|5
5571311|NCT01098266|19255395|P1|Overall Study|Withdrawal by Subject|3
5571312|NCT01098266|19255394|P2|Overall Study|Death|2
5571313|NCT01098266|19255395|P1|Overall Study|Death|3
5571314|NCT01098266|19255394|P2|Overall Study|Physician Decision|0
5571315|NCT01098266|19255395|P1|Overall Study|Physician Decision|1
5571316|NCT01098240|19255424|P3|Double-Blind Phase|Adverse Event|3
5571317|NCT01098240|19255425|P2|Double-Blind Phase|Adverse Event|3
5571318|NCT01098240|19255426|P1|Double-Blind Phase|Adverse Event|0
5571319|NCT01098240|19255424|P3|Double-Blind Phase|Withdrawal by Subject|3
5571320|NCT01098240|19255425|P2|Double-Blind Phase|Withdrawal by Subject|1
5571321|NCT01098240|19255426|P1|Double-Blind Phase|Withdrawal by Subject|0
5571322|NCT01098240|19255424|P3|Double-Blind Phase|Insufficient Clinical Response|2
5571323|NCT01098240|19255425|P2|Double-Blind Phase|Insufficient Clinical Response|1
5571324|NCT01098240|19255426|P1|Double-Blind Phase|Insufficient Clinical Response|0
5571325|NCT01098240|19255424|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
5571326|NCT01098240|19255425|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
5571327|NCT01098240|19255426|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
5571328|NCT01098240|19255424|P3|Double-Blind Phase|Other|2
5571329|NCT01098240|19255425|P2|Double-Blind Phase|Other|2
5571330|NCT01098240|19255426|P1|Double-Blind Phase|Other|0
5571331|NCT01098240|19255424|P3|Double-Blind Phase|Lost to Follow-up|0
5571332|NCT01098240|19255425|P2|Double-Blind Phase|Lost to Follow-up|2
5571333|NCT01098240|19255426|P1|Double-Blind Phase|Lost to Follow-up|0
5571334|NCT01098240|19255424|P3|Double-Blind Phase|Protocol Violation|4
5571335|NCT01098240|19255425|P2|Double-Blind Phase|Protocol Violation|2
5571336|NCT01098240|19255426|P1|Double-Blind Phase|Protocol Violation|0
5571337|NCT01098240|19255424|P3|Double-Blind Phase|Study Terminated by Sponsor|8
5571338|NCT01098240|19255425|P2|Double-Blind Phase|Study Terminated by Sponsor|5
5571339|NCT01098240|19255426|P1|Double-Blind Phase|Study Terminated by Sponsor|0
5571340|NCT01098240|19255424|P3|Open-Label Phase|Adverse Event|0
5571341|NCT01098240|19255425|P2|Open-Label Phase|Adverse Event|0
5571342|NCT01098240|19255426|P1|Open-Label Phase|Adverse Event|12
5571343|NCT01098240|19255424|P3|Open-Label Phase|Withdrawal by Subject|0
5571344|NCT01098240|19255425|P2|Open-Label Phase|Withdrawal by Subject|0
5571345|NCT01098240|19255426|P1|Open-Label Phase|Withdrawal by Subject|9
5571346|NCT01098240|19255424|P3|Open-Label Phase|Pregnancy|0
5571347|NCT01098240|19255425|P2|Open-Label Phase|Pregnancy|0
5571348|NCT01098240|19255426|P1|Open-Label Phase|Pregnancy|1
5571349|NCT01098240|19255424|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
5571350|NCT01098240|19255425|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
5571351|NCT01098240|19255426|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
5571352|NCT01098240|19255424|P3|Open-Label Phase|Other|0
5571353|NCT01098240|19255425|P2|Open-Label Phase|Other|0
5571354|NCT01098240|19255426|P1|Open-Label Phase|Other|19
5571355|NCT01098240|19255424|P3|Open-Label Phase|Lost to Follow-up|0
5571356|NCT01098240|19255425|P2|Open-Label Phase|Lost to Follow-up|0
5571357|NCT01098240|19255426|P1|Open-Label Phase|Lost to Follow-up|13
5571358|NCT01098240|19255424|P3|Open-Label Phase|Protocol Violation|0
5571359|NCT01098240|19255425|P2|Open-Label Phase|Protocol Violation|0
5571360|NCT01098240|19255426|P1|Open-Label Phase|Protocol Violation|4
5571361|NCT01098240|19255424|P3|Open-Label Phase|Study Terminated by Sponsor|0
5571362|NCT01098240|19255425|P2|Open-Label Phase|Study Terminated by Sponsor|0
5571363|NCT01098240|19255426|P1|Open-Label Phase|Study Terminated by Sponsor|27
5571364|NCT01098162|19255456|P1|Overall Study|Reason Unknown|26
5571365|NCT01098162|19255456|P1|Overall Study|Other Reason|1
5571366|NCT01098162|19255456|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
5571367|NCT01098162|19255456|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
5571368|NCT01098162|19255456|P1|Overall Study|Adverse Event & Lost to Follow-up|2
5571369|NCT01098162|19255456|P1|Overall Study|Adverse Event & Wish of Patient|13
5571370|NCT01098162|19255456|P1|Overall Study|Adverse Event & Lack of Efficacy|6
5571371|NCT01098162|19255456|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
5571372|NCT01098162|19255456|P1|Overall Study|Lost to Follow-up|9
5571373|NCT01098162|19255456|P1|Overall Study|Wish of Patient|7
5571374|NCT01098162|19255456|P1|Overall Study|Lack of Efficacy|4
5571375|NCT01098162|19255456|P1|Overall Study|Adverse Event|37
5571376|NCT01098110|19255468|P3|Overall Study|Untreated|0
5571377|NCT01098110|19255469|P2|Overall Study|Untreated|1
5571378|NCT01098110|19255470|P1|Overall Study|Untreated|1
5571379|NCT01098110|19255468|P3|Overall Study|Other|5
5571380|NCT01098110|19255469|P2|Overall Study|Other|7
5571381|NCT01098110|19255470|P1|Overall Study|Other|4
5571382|NCT01098110|19255468|P3|Overall Study|Lack of Efficacy|27
5571383|NCT01098110|19255469|P2|Overall Study|Lack of Efficacy|9
5571384|NCT01098110|19255470|P1|Overall Study|Lack of Efficacy|13
5571385|NCT01098110|19255468|P3|Overall Study|Adverse Event|43
5571386|NCT01098110|19255469|P2|Overall Study|Adverse Event|32
5571387|NCT01098110|19255470|P1|Overall Study|Adverse Event|30
5571388|NCT01098110|19255468|P3|Overall Study|Withdrawal by Subject|19
5571389|NCT01098110|19255469|P2|Overall Study|Withdrawal by Subject|24
5571390|NCT01098110|19255470|P1|Overall Study|Withdrawal by Subject|14
5571391|NCT01098097|19255511|P1|Overall Study|No reason reported|31
5571392|NCT01098097|19255511|P1|Overall Study|Status unknown|16
5571393|NCT01098097|19255511|P1|Overall Study|Lost to Follow-up|18
5571394|NCT01098097|19255511|P1|Overall Study|Adverse Event|17
5571395|NCT01098071|19255520|P1|Overall Study|Lost to Follow-up|13
5571396|NCT01098071|19255520|P1|Overall Study|Surgery (adenoidectomy)|2
5571397|NCT01098032|19255533|P2|Overall Study|Withdrawal by Subject|1
5571398|NCT01098032|19255534|P1|Overall Study|Withdrawal by Subject|1
5571399|NCT01097863|19255651|P3|Overall Study|Did not return for final visit|1
5571400|NCT01097863|19255652|P2|Overall Study|Did not return for final visit|0
5571401|NCT01097863|19255653|P1|Overall Study|Did not return for final visit|0
5571402|NCT01097863|19255651|P3|Overall Study|Discomfort|1
5571403|NCT01097863|19255652|P2|Overall Study|Discomfort|0
5571404|NCT01097863|19255653|P1|Overall Study|Discomfort|1
5571405|NCT01097707|19255677|P5|Overall Study|Reason unknown|1
5571406|NCT01097707|19255678|P4|Overall Study|Reason unknown|0
5571407|NCT01097707|19255679|P3|Overall Study|Reason unknown|0
5571408|NCT01097707|19255680|P2|Overall Study|Reason unknown|0
5571409|NCT01097707|19255681|P1|Overall Study|Reason unknown|0
5571410|NCT01097707|19255677|P5|Overall Study|Withdrawal by Subject|3
5571411|NCT01097707|19255678|P4|Overall Study|Withdrawal by Subject|4
5571412|NCT01097707|19255679|P3|Overall Study|Withdrawal by Subject|1
5571413|NCT01097707|19255680|P2|Overall Study|Withdrawal by Subject|6
5571414|NCT01097707|19255681|P1|Overall Study|Withdrawal by Subject|3
5571415|NCT01097707|19255677|P5|Overall Study|Sponsor Decision|36
5571416|NCT01097707|19255678|P4|Overall Study|Sponsor Decision|35
5571417|NCT01097707|19255679|P3|Overall Study|Sponsor Decision|34
5571418|NCT01097707|19255680|P2|Overall Study|Sponsor Decision|31
5571419|NCT01097707|19255681|P1|Overall Study|Sponsor Decision|31
5571420|NCT01097707|19255677|P5|Overall Study|Protocol Violation|2
5571421|NCT01097707|19255678|P4|Overall Study|Protocol Violation|2
5571422|NCT01097707|19255679|P3|Overall Study|Protocol Violation|3
5571423|NCT01097707|19255680|P2|Overall Study|Protocol Violation|2
5571424|NCT01097707|19255681|P1|Overall Study|Protocol Violation|2
5571425|NCT01097707|19255677|P5|Overall Study|Lost to Follow-up|3
5571426|NCT01097707|19255678|P4|Overall Study|Lost to Follow-up|0
5571427|NCT01097707|19255679|P3|Overall Study|Lost to Follow-up|2
5571428|NCT01097707|19255680|P2|Overall Study|Lost to Follow-up|1
5571429|NCT01097707|19255681|P1|Overall Study|Lost to Follow-up|1
5571430|NCT01097707|19255677|P5|Overall Study|Lack of Efficacy|0
5571431|NCT01097707|19255678|P4|Overall Study|Lack of Efficacy|1
5571432|NCT01097707|19255679|P3|Overall Study|Lack of Efficacy|0
5571433|NCT01097707|19255680|P2|Overall Study|Lack of Efficacy|0
5571434|NCT01097707|19255681|P1|Overall Study|Lack of Efficacy|1
5571435|NCT01097707|19255677|P5|Overall Study|Entry Criteria Not Met|1
5571436|NCT01097707|19255678|P4|Overall Study|Entry Criteria Not Met|0
5571437|NCT01097707|19255679|P3|Overall Study|Entry Criteria Not Met|1
5571438|NCT01097707|19255680|P2|Overall Study|Entry Criteria Not Met|1
5571439|NCT01097707|19255681|P1|Overall Study|Entry Criteria Not Met|2
5571440|NCT01097707|19255677|P5|Overall Study|Adverse Event|3
5571441|NCT01097707|19255678|P4|Overall Study|Adverse Event|1
5571442|NCT01097707|19255679|P3|Overall Study|Adverse Event|3
5571443|NCT01097707|19255680|P2|Overall Study|Adverse Event|2
5571444|NCT01097707|19255681|P1|Overall Study|Adverse Event|4
5571445|NCT01097707|19255677|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5571446|NCT01097707|19255678|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5571447|NCT01097707|19255679|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
5571448|NCT01097707|19255680|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5571449|NCT01097707|19255681|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
5571450|NCT01097694|19255730|P2|Overall Study|Withdrawal by Subject|1
5571451|NCT01097694|19255731|P1|Overall Study|Withdrawal by Subject|3
5571452|NCT01097694|19255730|P2|Overall Study|Lost to Follow-up|3
5571453|NCT01097694|19255731|P1|Overall Study|Lost to Follow-up|0
5571454|NCT01097694|19255730|P2|Overall Study|Adverse Event|0
5571455|NCT01097694|19255731|P1|Overall Study|Adverse Event|5
5571456|NCT01097668|19255793|P2|Overall Study|Lost to Follow-up|0
5571457|NCT01097668|19255794|P1|Overall Study|Lost to Follow-up|1
5571458|NCT01097668|19255793|P2|Overall Study|Withdrawal by Subject|2
5571459|NCT01097668|19255794|P1|Overall Study|Withdrawal by Subject|1
5571460|NCT01097655|19255804|P1|Overall Study|Did Not Meet Inclusion Criteria|8
5571461|NCT01097655|19255804|P1|Overall Study|Subject Documented Twice|1
5571462|NCT01097655|19255804|P1|Overall Study|Withdrawal by Subject|1
5571463|NCT01097629|19255814|P8|DB RO Phase|Lost to Follow-up|0
5571464|NCT01097629|19255815|P7|DB RO Phase|Lost to Follow-up|2
5571465|NCT01097629|19255816|P6|DB RO Phase|Lost to Follow-up|0
5571466|NCT01097629|19255817|P5|DB RO Phase|Lost to Follow-up|0
5571467|NCT01097629|19255818|P4|DB RO Phase|Lost to Follow-up|0
5571468|NCT01097629|19255819|P3|DB RO Phase|Lost to Follow-up|0
5571469|NCT01097629|19255820|P2|DB RO Phase|Lost to Follow-up|0
5571470|NCT01097629|19255821|P1|DB RO Phase|Lost to Follow-up|0
5571471|NCT01097629|19255814|P8|DB RO Phase|Protocol Violation|0
5571472|NCT01097629|19255815|P7|DB RO Phase|Protocol Violation|1
5571473|NCT01097629|19255816|P6|DB RO Phase|Protocol Violation|1
5571474|NCT01097629|19255817|P5|DB RO Phase|Protocol Violation|0
5571475|NCT01097629|19255818|P4|DB RO Phase|Protocol Violation|1
5571476|NCT01097629|19255819|P3|DB RO Phase|Protocol Violation|0
5571477|NCT01097629|19255820|P2|DB RO Phase|Protocol Violation|0
5571478|NCT01097629|19255821|P1|DB RO Phase|Protocol Violation|0
5571479|NCT01097629|19255814|P8|DB RO Phase|Withdrawal by Subject|1
5571480|NCT01097629|19255815|P7|DB RO Phase|Withdrawal by Subject|0
5571481|NCT01097629|19255816|P6|DB RO Phase|Withdrawal by Subject|0
5571482|NCT01097629|19255817|P5|DB RO Phase|Withdrawal by Subject|0
5571483|NCT01097629|19255818|P4|DB RO Phase|Withdrawal by Subject|0
5571484|NCT01097629|19255819|P3|DB RO Phase|Withdrawal by Subject|0
5571485|NCT01097629|19255820|P2|DB RO Phase|Withdrawal by Subject|0
5571486|NCT01097629|19255821|P1|DB RO Phase|Withdrawal by Subject|0
5571487|NCT01097629|19255814|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571488|NCT01097629|19255815|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571489|NCT01097629|19255816|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571490|NCT01097629|19255817|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571491|NCT01097629|19255818|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571492|NCT01097629|19255819|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
5571493|NCT01097629|19255820|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
5571494|NCT01097629|19255821|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
5571495|NCT01097629|19255814|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571496|NCT01097629|19255815|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571497|NCT01097629|19255816|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571498|NCT01097629|19255817|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571499|NCT01097629|19255818|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571500|NCT01097629|19255819|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571501|NCT01097629|19255820|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
5571502|NCT01097629|19255821|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
5571503|NCT01097629|19255814|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571504|NCT01097629|19255815|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571505|NCT01097629|19255816|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571506|NCT01097629|19255817|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571507|NCT01097629|19255818|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571508|NCT01097629|19255819|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
5571509|NCT01097629|19255820|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
5571510|NCT01097629|19255821|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
5571511|NCT01097629|19255814|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571512|NCT01097629|19255815|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571513|NCT01097629|19255816|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571514|NCT01097629|19255817|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571515|NCT01097629|19255818|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571516|NCT01097629|19255819|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
5571517|NCT01097629|19255820|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
5571518|NCT01097629|19255821|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
5571519|NCT01097629|19255814|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571520|NCT01097629|19255815|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571521|NCT01097629|19255816|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571522|NCT01097629|19255817|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571523|NCT01097629|19255818|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571524|NCT01097629|19255819|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
5571525|NCT01097629|19255820|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
5571526|NCT01097629|19255821|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
5571527|NCT01097629|19255814|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571528|NCT01097629|19255815|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571529|NCT01097629|19255816|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571530|NCT01097629|19255817|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571531|NCT01097629|19255818|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571532|NCT01097629|19255819|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
5571533|NCT01097629|19255820|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
5571534|NCT01097629|19255821|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
5571535|NCT01097629|19255814|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571536|NCT01097629|19255815|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571537|NCT01097629|19255816|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571538|NCT01097629|19255817|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571539|NCT01097629|19255818|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571540|NCT01097629|19255819|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
5571541|NCT01097629|19255820|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
5571542|NCT01097629|19255821|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
5571543|NCT01097616|19255872|P8|DB RO Phase|Not Treated in RO|0
5571544|NCT01097616|19255873|P7|DB RO Phase|Not Treated in RO|0
5571545|NCT01097616|19255874|P6|DB RO Phase|Not Treated in RO|1
5571546|NCT01097616|19255875|P5|DB RO Phase|Not Treated in RO|0
5571547|NCT01097616|19255876|P4|DB RO Phase|Not Treated in RO|0
5571548|NCT01097616|19255877|P3|DB RO Phase|Not Treated in RO|0
5571549|NCT01097616|19255878|P2|DB RO Phase|Not Treated in RO|0
5571550|NCT01097616|19255879|P1|DB RO Phase|Not Treated in RO|0
5571551|NCT01097616|19255872|P8|DB RO Phase|Lost to Follow-up|1
5571552|NCT01097616|19255873|P7|DB RO Phase|Lost to Follow-up|0
5571553|NCT01097616|19255874|P6|DB RO Phase|Lost to Follow-up|0
5571554|NCT01097616|19255875|P5|DB RO Phase|Lost to Follow-up|1
5571555|NCT01097616|19255876|P4|DB RO Phase|Lost to Follow-up|1
5571556|NCT01097616|19255877|P3|DB RO Phase|Lost to Follow-up|0
5571557|NCT01097616|19255878|P2|DB RO Phase|Lost to Follow-up|0
5571558|NCT01097616|19255879|P1|DB RO Phase|Lost to Follow-up|0
5571559|NCT01097616|19255872|P8|DB RO Phase|Withdrawal by Subject|0
5571560|NCT01097616|19255873|P7|DB RO Phase|Withdrawal by Subject|0
5571561|NCT01097616|19255874|P6|DB RO Phase|Withdrawal by Subject|1
5571562|NCT01097616|19255875|P5|DB RO Phase|Withdrawal by Subject|0
5571563|NCT01097616|19255876|P4|DB RO Phase|Withdrawal by Subject|0
5571564|NCT01097616|19255877|P3|DB RO Phase|Withdrawal by Subject|0
5571565|NCT01097616|19255878|P2|DB RO Phase|Withdrawal by Subject|0
5571566|NCT01097616|19255879|P1|DB RO Phase|Withdrawal by Subject|0
5571567|NCT01097616|19255872|P8|DB RO Phase|Adverse Event|0
5571568|NCT01097616|19255873|P7|DB RO Phase|Adverse Event|1
5571569|NCT01097616|19255874|P6|DB RO Phase|Adverse Event|0
5571570|NCT01097616|19255875|P5|DB RO Phase|Adverse Event|0
5571571|NCT01097616|19255876|P4|DB RO Phase|Adverse Event|0
5571572|NCT01097616|19255877|P3|DB RO Phase|Adverse Event|0
5571573|NCT01097616|19255878|P2|DB RO Phase|Adverse Event|0
5571574|NCT01097616|19255879|P1|DB RO Phase|Adverse Event|0
5571575|NCT01097616|19255872|P8|Optional DB EXT Phase|Physician Decision|0
5571576|NCT01097616|19255873|P7|Optional DB EXT Phase|Physician Decision|0
5571577|NCT01097616|19255874|P6|Optional DB EXT Phase|Physician Decision|0
5571578|NCT01097616|19255875|P5|Optional DB EXT Phase|Physician Decision|0
5571579|NCT01097616|19255876|P4|Optional DB EXT Phase|Physician Decision|0
5571580|NCT01097616|19255877|P3|Optional DB EXT Phase|Physician Decision|0
5571581|NCT01097616|19255878|P2|Optional DB EXT Phase|Physician Decision|0
5571582|NCT01097616|19255879|P1|Optional DB EXT Phase|Physician Decision|1
5571583|NCT01097616|19255872|P8|Optional DB EXT Phase|Lack of Efficacy|0
5571584|NCT01097616|19255873|P7|Optional DB EXT Phase|Lack of Efficacy|0
5571585|NCT01097616|19255874|P6|Optional DB EXT Phase|Lack of Efficacy|0
5571586|NCT01097616|19255875|P5|Optional DB EXT Phase|Lack of Efficacy|0
5571587|NCT01097616|19255876|P4|Optional DB EXT Phase|Lack of Efficacy|0
5571588|NCT01097616|19255877|P3|Optional DB EXT Phase|Lack of Efficacy|1
5571589|NCT01097616|19255878|P2|Optional DB EXT Phase|Lack of Efficacy|1
5571590|NCT01097616|19255879|P1|Optional DB EXT Phase|Lack of Efficacy|1
5571591|NCT01097616|19255872|P8|Optional DB EXT Phase|Lost to Follow-up|0
5571592|NCT01097616|19255873|P7|Optional DB EXT Phase|Lost to Follow-up|0
5571593|NCT01097616|19255874|P6|Optional DB EXT Phase|Lost to Follow-up|0
5571594|NCT01097616|19255875|P5|Optional DB EXT Phase|Lost to Follow-up|0
5571595|NCT01097616|19255876|P4|Optional DB EXT Phase|Lost to Follow-up|0
5571596|NCT01097616|19255877|P3|Optional DB EXT Phase|Lost to Follow-up|1
5571597|NCT01097616|19255878|P2|Optional DB EXT Phase|Lost to Follow-up|5
5571598|NCT01097616|19255879|P1|Optional DB EXT Phase|Lost to Follow-up|1
5571599|NCT01097616|19255872|P8|Optional DB EXT Phase|Protocol Violation|0
5571600|NCT01097616|19255873|P7|Optional DB EXT Phase|Protocol Violation|0
5571601|NCT01097616|19255874|P6|Optional DB EXT Phase|Protocol Violation|0
5571602|NCT01097616|19255875|P5|Optional DB EXT Phase|Protocol Violation|0
5571603|NCT01097616|19255876|P4|Optional DB EXT Phase|Protocol Violation|0
5571604|NCT01097616|19255877|P3|Optional DB EXT Phase|Protocol Violation|3
5571605|NCT01097616|19255878|P2|Optional DB EXT Phase|Protocol Violation|2
5571606|NCT01097616|19255879|P1|Optional DB EXT Phase|Protocol Violation|0
5571607|NCT01097616|19255872|P8|Optional DB EXT Phase|Withdrawal by Subject|0
5571608|NCT01097616|19255873|P7|Optional DB EXT Phase|Withdrawal by Subject|0
5571609|NCT01097616|19255874|P6|Optional DB EXT Phase|Withdrawal by Subject|0
5571610|NCT01097616|19255875|P5|Optional DB EXT Phase|Withdrawal by Subject|0
5571611|NCT01097616|19255876|P4|Optional DB EXT Phase|Withdrawal by Subject|0
5571612|NCT01097616|19255877|P3|Optional DB EXT Phase|Withdrawal by Subject|3
5571613|NCT01097616|19255878|P2|Optional DB EXT Phase|Withdrawal by Subject|6
5571614|NCT01097616|19255879|P1|Optional DB EXT Phase|Withdrawal by Subject|12
5571615|NCT01097616|19255872|P8|Optional DB EXT Phase|Adverse Event|0
5571616|NCT01097616|19255873|P7|Optional DB EXT Phase|Adverse Event|0
5571617|NCT01097616|19255874|P6|Optional DB EXT Phase|Adverse Event|0
5571618|NCT01097616|19255875|P5|Optional DB EXT Phase|Adverse Event|0
5571619|NCT01097616|19255876|P4|Optional DB EXT Phase|Adverse Event|0
5571620|NCT01097616|19255877|P3|Optional DB EXT Phase|Adverse Event|2
5571621|NCT01097616|19255878|P2|Optional DB EXT Phase|Adverse Event|7
5571622|NCT01097616|19255879|P1|Optional DB EXT Phase|Adverse Event|0
5571623|NCT01097616|19255872|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571624|NCT01097616|19255873|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571625|NCT01097616|19255874|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571626|NCT01097616|19255875|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571627|NCT01097616|19255876|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571628|NCT01097616|19255877|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
5571629|NCT01097616|19255878|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571630|NCT01097616|19255879|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
5571631|NCT01097616|19255872|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571632|NCT01097616|19255873|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571633|NCT01097616|19255874|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571634|NCT01097616|19255875|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571635|NCT01097616|19255876|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571636|NCT01097616|19255877|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
5571637|NCT01097616|19255878|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
5571638|NCT01097616|19255879|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
5571639|NCT01097616|19255872|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5571640|NCT01097616|19255873|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5571641|NCT01097616|19255874|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5571642|NCT01097616|19255875|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5571643|NCT01097616|19255876|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5571644|NCT01097616|19255877|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
5571645|NCT01097616|19255878|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
5571646|NCT01097616|19255879|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
5571647|NCT01097616|19255872|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571648|NCT01097616|19255873|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571649|NCT01097616|19255874|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571650|NCT01097616|19255875|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571651|NCT01097616|19255876|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
5571652|NCT01097616|19255877|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
5571653|NCT01097616|19255878|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
5571654|NCT01097616|19255879|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
5571655|NCT01097616|19255872|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571656|NCT01097616|19255873|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571657|NCT01097616|19255874|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571658|NCT01097616|19255875|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571659|NCT01097616|19255876|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571660|NCT01097616|19255877|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
5571661|NCT01097616|19255878|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
5571662|NCT01097616|19255879|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
5571663|NCT01097616|19255872|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571664|NCT01097616|19255873|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571665|NCT01097616|19255874|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571666|NCT01097616|19255875|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571667|NCT01097616|19255876|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
5571668|NCT01097616|19255877|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
5571669|NCT01097616|19255878|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
5571670|NCT01097616|19255879|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
5571671|NCT01097616|19255872|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571672|NCT01097616|19255873|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571673|NCT01097616|19255874|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571674|NCT01097616|19255875|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571675|NCT01097616|19255876|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
5571676|NCT01097616|19255877|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
5571677|NCT01097616|19255878|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
5571678|NCT01097616|19255879|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
5571679|NCT01097616|19255872|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571680|NCT01097616|19255873|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571681|NCT01097616|19255874|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571682|NCT01097616|19255875|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571683|NCT01097616|19255876|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
5571684|NCT01097616|19255877|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
5571685|NCT01097616|19255878|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
5571686|NCT01097616|19255879|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
5571687|NCT01097577|19255952|P2|Overall Study|Adverse Event|1
5571688|NCT01097577|19255953|P1|Overall Study|Adverse Event|0
5571689|NCT01097421|19255973|P1|Overall Study|Withdrawal by Subject|3
5571690|NCT01097421|19255973|P1|Overall Study|Lost to Follow-up|1
5571691|NCT01097421|19255973|P1|Overall Study|Protocol Violation|2
5571692|NCT01097421|19255973|P1|Overall Study|Adverse Event|8
5571693|NCT01097330|19255992|P2|Overall Study|Study terminated early|5
5571694|NCT01097330|19255993|P1|Overall Study|Study terminated early|7
5571695|NCT01097057|19256010|P1|Overall Study|Physician Decision|3
5571696|NCT01097044|19256019|P2|Overall Study|Withdrawal by Sponsor|1
5571697|NCT01097044|19256020|P1|Overall Study|Withdrawal by Sponsor|0
5571698|NCT01097044|19256019|P2|Overall Study|Lost to Follow-up|0
5571699|NCT01097044|19256020|P1|Overall Study|Lost to Follow-up|1
5571700|NCT01097044|19256019|P2|Overall Study|Withdrawal by Subject|4
5571701|NCT01097044|19256020|P1|Overall Study|Withdrawal by Subject|4
5571702|NCT01097005|19256038|P1|Overall Study|Discontinuance by complication|50
5571703|NCT01097005|19256038|P1|Overall Study|Adverse Event|14
5571704|NCT01097005|19256038|P1|Overall Study|Deviation from exclusion criteria|37
5571705|NCT01097005|19256038|P1|Overall Study|No examination data available|244
5571706|NCT01097005|19256038|P1|Overall Study|Poor medication compliance|1
5571707|NCT01097005|19256038|P1|Overall Study|Subjects cannot visit the hospital|1
5571708|NCT01097005|19256038|P1|Overall Study|Case Report Form not collected|18
5571709|NCT01096849|19256084|P3|Overall Study|Lost to Follow-up|1
5571710|NCT01096849|19256085|P2|Overall Study|Lost to Follow-up|3
5571711|NCT01096849|19256086|P1|Overall Study|Lost to Follow-up|1
5571712|NCT01096849|19256084|P3|Overall Study|Administrative Reasons|2
5571713|NCT01096849|19256085|P2|Overall Study|Administrative Reasons|1
5571714|NCT01096849|19256086|P1|Overall Study|Administrative Reasons|0
5571715|NCT01096849|19256084|P3|Overall Study|Investigator or Medical Monitor Decision|0
5571716|NCT01096849|19256085|P2|Overall Study|Investigator or Medical Monitor Decision|1
5571717|NCT01096849|19256086|P1|Overall Study|Investigator or Medical Monitor Decision|0
5571718|NCT01096849|19256084|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
5571719|NCT01096849|19256085|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
5571720|NCT01096849|19256086|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
5571721|NCT01096849|19256084|P3|Overall Study|Lack of Efficacy|0
5571722|NCT01096849|19256085|P2|Overall Study|Lack of Efficacy|2
5571723|NCT01096849|19256086|P1|Overall Study|Lack of Efficacy|0
5571724|NCT01096849|19256084|P3|Overall Study|Consent Withdrawn|2
5571725|NCT01096849|19256085|P2|Overall Study|Consent Withdrawn|4
5571726|NCT01096849|19256086|P1|Overall Study|Consent Withdrawn|1
5571727|NCT01096784|19256162|P2|Overall Study|Other Unspecified|1
5571728|NCT01096784|19256163|P1|Overall Study|Other Unspecified|0
5571729|NCT01096784|19256162|P2|Overall Study|Administrative Decision|1
5571730|NCT01096784|19256163|P1|Overall Study|Administrative Decision|0
5571731|NCT01096784|19256162|P2|Overall Study|Protocol Deviation|2
5571732|NCT01096784|19256163|P1|Overall Study|Protocol Deviation|2
5571733|NCT01096784|19256162|P2|Overall Study|Adverse Event|9
5571734|NCT01096784|19256163|P1|Overall Study|Adverse Event|11
5571735|NCT01096784|19256162|P2|Overall Study|Withdrawal by Subject|1
5571736|NCT01096784|19256163|P1|Overall Study|Withdrawal by Subject|2
5571737|NCT01096667|19256268|P5|Overall Study|Not treated|0
5571738|NCT01096667|19256269|P4|Overall Study|Not treated|0
5571739|NCT01096667|19256270|P3|Overall Study|Not treated|0
5571740|NCT01096667|19256271|P2|Overall Study|Not treated|0
5571741|NCT01096667|19256272|P1|Overall Study|Not treated|1
5571742|NCT01096667|19256268|P5|Overall Study|Protocol Violation|0
5571743|NCT01096667|19256269|P4|Overall Study|Protocol Violation|1
5571744|NCT01096667|19256270|P3|Overall Study|Protocol Violation|0
5571745|NCT01096667|19256271|P2|Overall Study|Protocol Violation|0
5571746|NCT01096667|19256272|P1|Overall Study|Protocol Violation|0
5571747|NCT01096667|19256268|P5|Overall Study|Reason not available|0
5571748|NCT01096667|19256269|P4|Overall Study|Reason not available|1
5571749|NCT01096667|19256270|P3|Overall Study|Reason not available|1
5571750|NCT01096667|19256271|P2|Overall Study|Reason not available|1
5571751|NCT01096667|19256272|P1|Overall Study|Reason not available|0
5571752|NCT01096667|19256268|P5|Overall Study|Withdrawal by Subject|0
5571753|NCT01096667|19256269|P4|Overall Study|Withdrawal by Subject|1
5571754|NCT01096667|19256270|P3|Overall Study|Withdrawal by Subject|0
5571755|NCT01096667|19256271|P2|Overall Study|Withdrawal by Subject|0
5571756|NCT01096667|19256272|P1|Overall Study|Withdrawal by Subject|1
5571757|NCT01096667|19256268|P5|Overall Study|Lost to Follow-up|0
5571758|NCT01096667|19256269|P4|Overall Study|Lost to Follow-up|0
5571759|NCT01096667|19256270|P3|Overall Study|Lost to Follow-up|1
5571760|NCT01096667|19256271|P2|Overall Study|Lost to Follow-up|1
5571761|NCT01096667|19256272|P1|Overall Study|Lost to Follow-up|1
5571762|NCT01096589|19256414|P4|Overall Study|found treatment exhausting|1
5571763|NCT01096589|19256415|P3|Overall Study|found treatment exhausting|0
5571764|NCT01096589|19256416|P2|Overall Study|found treatment exhausting|0
5571765|NCT01096589|19256417|P1|Overall Study|found treatment exhausting|0
5571766|NCT01096589|19256414|P4|Overall Study|Compliance with protocol|0
5571767|NCT01096589|19256415|P3|Overall Study|Compliance with protocol|1
5571768|NCT01096589|19256416|P2|Overall Study|Compliance with protocol|0
5571769|NCT01096589|19256417|P1|Overall Study|Compliance with protocol|0
5571770|NCT01096589|19256414|P4|Overall Study|Withdrawal by Subject|1
5571771|NCT01096589|19256415|P3|Overall Study|Withdrawal by Subject|1
5571772|NCT01096589|19256416|P2|Overall Study|Withdrawal by Subject|1
5571773|NCT01096589|19256417|P1|Overall Study|Withdrawal by Subject|2
5571774|NCT01096589|19256414|P4|Overall Study|Adverse Event|1
5571775|NCT01096589|19256415|P3|Overall Study|Adverse Event|2
5571776|NCT01096589|19256416|P2|Overall Study|Adverse Event|1
5571777|NCT01096589|19256417|P1|Overall Study|Adverse Event|2
5571778|NCT01096550|19256433|P2|Overall Study|Lost to Follow-up|9
5571779|NCT01096550|19256434|P1|Overall Study|Lost to Follow-up|12
5571780|NCT01096550|19256433|P2|Overall Study|non-African American participant|6
5571781|NCT01096550|19256434|P1|Overall Study|non-African American participant|13
5571782|NCT01096550|19256433|P2|Overall Study|Withdrawal by Subject|1
5571783|NCT01096550|19256434|P1|Overall Study|Withdrawal by Subject|0
5571784|NCT01096550|19256433|P2|Overall Study|clinic readmission|1
5571785|NCT01096550|19256434|P1|Overall Study|clinic readmission|1
5571786|NCT01096550|19256433|P2|Overall Study|non-regular treatment track at clinic|1
5571787|NCT01096550|19256434|P1|Overall Study|non-regular treatment track at clinic|1
5571788|NCT01096550|19256433|P2|Overall Study|discontinued site|11
5571789|NCT01096550|19256434|P1|Overall Study|discontinued site|10
5571790|NCT01096446|19256442|P2|Overall Study|Protocol Violation|0
5571791|NCT01096446|19256443|P1|Overall Study|Protocol Violation|2
5571792|NCT01096446|19256442|P2|Overall Study|Death|0
5571793|NCT01096446|19256443|P1|Overall Study|Death|1
5571794|NCT01096342|19256448|P1|Overall Study|Protocol Violation|1
5571795|NCT01096316|19256456|P2|Overall Study|Lost to Follow-up|9
5571796|NCT01096316|19256457|P1|Overall Study|Lost to Follow-up|15
5571797|NCT01096186|19256478|P1|Overall Study|Noncompliance with study drug|1
5571798|NCT01096186|19256478|P1|Overall Study|Physician Decision|1
5571799|NCT01096186|19256478|P1|Overall Study|Withdrawal by Subject|22
5571800|NCT01096186|19256478|P1|Overall Study|Lost to Follow-up|2
5571801|NCT01096186|19256478|P1|Overall Study|Lack of Efficacy|4
5571802|NCT01096186|19256478|P1|Overall Study|Death|4
5571803|NCT01096186|19256478|P1|Overall Study|Adverse Event|16
5571804|NCT01096160|19256494|P10|Overall Study|Met stopping criteria per protocol|0
5571805|NCT01096160|19256495|P9|Overall Study|Met stopping criteria per protocol|2
5571806|NCT01096160|19256496|P8|Overall Study|Met stopping criteria per protocol|0
5571807|NCT01096160|19256497|P7|Overall Study|Met stopping criteria per protocol|2
5571808|NCT01096160|19256498|P6|Overall Study|Met stopping criteria per protocol|0
5571809|NCT01096160|19256499|P5|Overall Study|Met stopping criteria per protocol|1
5571810|NCT01096160|19256500|P4|Overall Study|Met stopping criteria per protocol|0
5571811|NCT01096160|19256501|P3|Overall Study|Met stopping criteria per protocol|0
5571812|NCT01096160|19256502|P2|Overall Study|Met stopping criteria per protocol|0
5571813|NCT01096160|19256503|P1|Overall Study|Met stopping criteria per protocol|0
5571814|NCT01096160|19256494|P10|Overall Study|Adverse Event|1
5571815|NCT01096160|19256495|P9|Overall Study|Adverse Event|0
5571816|NCT01096160|19256496|P8|Overall Study|Adverse Event|0
5571817|NCT01096160|19256497|P7|Overall Study|Adverse Event|0
5571818|NCT01096160|19256498|P6|Overall Study|Adverse Event|0
5571819|NCT01096160|19256499|P5|Overall Study|Adverse Event|0
5571820|NCT01096160|19256500|P4|Overall Study|Adverse Event|0
5571821|NCT01096160|19256501|P3|Overall Study|Adverse Event|1
5571822|NCT01096160|19256502|P2|Overall Study|Adverse Event|0
5571823|NCT01096160|19256503|P1|Overall Study|Adverse Event|0
5571824|NCT01096056|19256561|P2|Overall Study|Lost to Follow-up|1
5571825|NCT01096056|19256562|P1|Overall Study|Lost to Follow-up|0
5571826|NCT01096017|19256594|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
5571827|NCT01096017|19256595|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
5571828|NCT01095978|19256623|P1|Overall Study|Adverse Event|1
5571829|NCT01095978|19256623|P1|Overall Study|Did not take Klacid SR|2
5571830|NCT01095835|19256657|P3|Overall Study|Protocol Violation|0
5571831|NCT01095835|19256658|P2|Overall Study|Protocol Violation|2
5571832|NCT01095835|19256659|P1|Overall Study|Protocol Violation|1
5571833|NCT01095835|19256657|P3|Overall Study|Non study compliance|1
5571834|NCT01095835|19256658|P2|Overall Study|Non study compliance|0
5571835|NCT01095835|19256659|P1|Overall Study|Non study compliance|0
5571836|NCT01095835|19256657|P3|Overall Study|Withdrawal by Subject|0
5571837|NCT01095835|19256658|P2|Overall Study|Withdrawal by Subject|3
5571838|NCT01095835|19256659|P1|Overall Study|Withdrawal by Subject|1
5571839|NCT01095835|19256657|P3|Overall Study|Physician Decision|1
5571840|NCT01095835|19256658|P2|Overall Study|Physician Decision|0
5571841|NCT01095835|19256659|P1|Overall Study|Physician Decision|0
5571842|NCT01095835|19256657|P3|Overall Study|Lack of Efficacy|0
5571843|NCT01095835|19256658|P2|Overall Study|Lack of Efficacy|1
5571844|NCT01095835|19256659|P1|Overall Study|Lack of Efficacy|0
5571845|NCT01095835|19256657|P3|Overall Study|Adverse Event|6
5571846|NCT01095835|19256658|P2|Overall Study|Adverse Event|6
5571847|NCT01095835|19256659|P1|Overall Study|Adverse Event|8
5571848|NCT01095796|19256697|P2|Overall Study|Participant Transferred to Another Study|200
5571849|NCT01095796|19256698|P1|Overall Study|Participant Transferred to Another Study|215
5571850|NCT01095796|19256697|P2|Overall Study|Protocol Violation|0
5571851|NCT01095796|19256698|P1|Overall Study|Protocol Violation|1
5571852|NCT01095796|19256697|P2|Overall Study|Participant Noncompliance|10
5571853|NCT01095796|19256698|P1|Overall Study|Participant Noncompliance|5
5571854|NCT01095796|19256697|P2|Overall Study|Lost to Follow-up|29
5571855|NCT01095796|19256698|P1|Overall Study|Lost to Follow-up|27
5571856|NCT01095796|19256697|P2|Overall Study|Withdrew Consent|22
5571857|NCT01095796|19256698|P1|Overall Study|Withdrew Consent|16
5571858|NCT01095796|19256697|P2|Overall Study|Investigator's Discretion|2
5571859|NCT01095796|19256698|P1|Overall Study|Investigator's Discretion|7
5571860|NCT01095796|19256697|P2|Overall Study|Lack of Efficacy|3
5571861|NCT01095796|19256698|P1|Overall Study|Lack of Efficacy|5
5571862|NCT01095796|19256697|P2|Overall Study|Pregnancy|0
5571863|NCT01095796|19256698|P1|Overall Study|Pregnancy|2
5571864|NCT01095796|19256697|P2|Overall Study|Death|2
5571865|NCT01095796|19256698|P1|Overall Study|Death|3
5571866|NCT01095796|19256697|P2|Overall Study|Adverse Event|19
5571867|NCT01095796|19256698|P1|Overall Study|Adverse Event|9
5571868|NCT01095796|19256697|P2|Overall Study|Randomized but Not Treated|2
5571869|NCT01095796|19256698|P1|Overall Study|Randomized but Not Treated|5
5571870|NCT01095666|19256728|P3|Overall Study|Non-compliance, not met criteria etc.|2
5571871|NCT01095666|19256729|P2|Overall Study|Non-compliance, not met criteria etc.|2
5571872|NCT01095666|19256730|P1|Overall Study|Non-compliance, not met criteria etc.|7
5571873|NCT01095666|19256728|P3|Overall Study|Withdrawal by Subject|1
5571874|NCT01095666|19256729|P2|Overall Study|Withdrawal by Subject|6
5571875|NCT01095666|19256730|P1|Overall Study|Withdrawal by Subject|6
5571876|NCT01095666|19256728|P3|Overall Study|Lost to Follow-up|0
5571877|NCT01095666|19256729|P2|Overall Study|Lost to Follow-up|2
5571878|NCT01095666|19256730|P1|Overall Study|Lost to Follow-up|2
5571879|NCT01095666|19256728|P3|Overall Study|Adverse Event|3
5571880|NCT01095666|19256729|P2|Overall Study|Adverse Event|1
5571881|NCT01095666|19256730|P1|Overall Study|Adverse Event|2
5571882|NCT01095666|19256728|P3|Overall Study|Lack of Efficacy|1
5571883|NCT01095666|19256729|P2|Overall Study|Lack of Efficacy|0
5571884|NCT01095666|19256730|P1|Overall Study|Lack of Efficacy|0
5571885|NCT01095653|19256753|P3|Overall Study|non-compliance, not met criteria, etc.|5
5571886|NCT01095653|19256754|P2|Overall Study|non-compliance, not met criteria, etc.|6
5571887|NCT01095653|19256755|P1|Overall Study|non-compliance, not met criteria, etc.|10
5571888|NCT01095653|19256753|P3|Overall Study|Withdrawal by Subject|3
5571889|NCT01095653|19256754|P2|Overall Study|Withdrawal by Subject|5
5571890|NCT01095653|19256755|P1|Overall Study|Withdrawal by Subject|4
5571891|NCT01095653|19256753|P3|Overall Study|Lost to Follow-up|4
5571892|NCT01095653|19256754|P2|Overall Study|Lost to Follow-up|0
5571893|NCT01095653|19256755|P1|Overall Study|Lost to Follow-up|1
5571894|NCT01095653|19256753|P3|Overall Study|Adverse Event|4
5571895|NCT01095653|19256754|P2|Overall Study|Adverse Event|4
5571896|NCT01095653|19256755|P1|Overall Study|Adverse Event|1
5571897|NCT01095653|19256753|P3|Overall Study|Lack of Efficacy|0
5571898|NCT01095653|19256754|P2|Overall Study|Lack of Efficacy|0
5571899|NCT01095653|19256755|P1|Overall Study|Lack of Efficacy|3
5571900|NCT01095250|19256813|P4|Overall Study|Withdrawal by Subject|0
5571901|NCT01095250|19256814|P3|Overall Study|Withdrawal by Subject|1
5571902|NCT01095250|19256815|P2|Overall Study|Withdrawal by Subject|0
5571903|NCT01095250|19256816|P1|Overall Study|Withdrawal by Subject|0
5571904|NCT01095250|19256813|P4|Overall Study|administrative reasons|5
5571905|NCT01095250|19256814|P3|Overall Study|administrative reasons|7
5571906|NCT01095250|19256815|P2|Overall Study|administrative reasons|10
5571907|NCT01095250|19256816|P1|Overall Study|administrative reasons|8
5571908|NCT01095094|19256846|P1|Overall Study|Physician Decision|1
5571909|NCT01095094|19256846|P1|Overall Study|Death|1
5571910|NCT01095094|19256846|P1|Overall Study|Withdrawal by Subject|1
5571911|NCT01094886|19256868|P1|Overall Study|Withdrawal by Subject|5
5571912|NCT01094886|19256868|P1|Overall Study|Adverse Event|2
5571913|NCT01094808|19256878|P3|Overall Study|Withdrawal by Subject|0
5571914|NCT01094808|19256879|P2|Overall Study|Withdrawal by Subject|1
5571915|NCT01094808|19256880|P1|Overall Study|Withdrawal by Subject|1
5571916|NCT01094782|19256921|P6|Overall Study|Noncompliance With Study Schedule|0
5571917|NCT01094782|19256922|P5|Overall Study|Noncompliance With Study Schedule|0
5571918|NCT01094782|19256923|P4|Overall Study|Noncompliance With Study Schedule|1
5571919|NCT01094782|19256924|P3|Overall Study|Noncompliance With Study Schedule|0
5571920|NCT01094782|19256925|P2|Overall Study|Noncompliance With Study Schedule|0
5571921|NCT01094782|19256926|P1|Overall Study|Noncompliance With Study Schedule|0
5571922|NCT01094782|19256921|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
5571923|NCT01094782|19256922|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
5571924|NCT01094782|19256923|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
5571925|NCT01094782|19256924|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
5571926|NCT01094782|19256925|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
5571927|NCT01094782|19256926|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
5571928|NCT01094782|19256921|P6|Overall Study|Recent Interventional Injection|1
5571929|NCT01094782|19256922|P5|Overall Study|Recent Interventional Injection|0
5571930|NCT01094782|19256923|P4|Overall Study|Recent Interventional Injection|0
5571931|NCT01094782|19256924|P3|Overall Study|Recent Interventional Injection|0
5571932|NCT01094782|19256925|P2|Overall Study|Recent Interventional Injection|0
5571933|NCT01094782|19256926|P1|Overall Study|Recent Interventional Injection|0
5571934|NCT01094782|19256921|P6|Overall Study|Wrong Pain Condition|1
5571935|NCT01094782|19256922|P5|Overall Study|Wrong Pain Condition|1
5571936|NCT01094782|19256923|P4|Overall Study|Wrong Pain Condition|2
5571937|NCT01094782|19256924|P3|Overall Study|Wrong Pain Condition|0
5571938|NCT01094782|19256925|P2|Overall Study|Wrong Pain Condition|0
5571939|NCT01094782|19256926|P1|Overall Study|Wrong Pain Condition|0
5571940|NCT01094782|19256921|P6|Overall Study|Hypertension|0
5571941|NCT01094782|19256922|P5|Overall Study|Hypertension|0
5571942|NCT01094782|19256923|P4|Overall Study|Hypertension|0
5571943|NCT01094782|19256924|P3|Overall Study|Hypertension|1
5571944|NCT01094782|19256925|P2|Overall Study|Hypertension|0
5571945|NCT01094782|19256926|P1|Overall Study|Hypertension|0
5571946|NCT01094782|19256921|P6|Overall Study|Healthy Subject Had Pain|0
5571947|NCT01094782|19256922|P5|Overall Study|Healthy Subject Had Pain|0
5571948|NCT01094782|19256923|P4|Overall Study|Healthy Subject Had Pain|0
5571949|NCT01094782|19256924|P3|Overall Study|Healthy Subject Had Pain|0
5571950|NCT01094782|19256925|P2|Overall Study|Healthy Subject Had Pain|1
5571951|NCT01094782|19256926|P1|Overall Study|Healthy Subject Had Pain|0
5571952|NCT01094782|19256921|P6|Overall Study|Unable to Complete Questionnaires|0
5571953|NCT01094782|19256922|P5|Overall Study|Unable to Complete Questionnaires|0
5571954|NCT01094782|19256923|P4|Overall Study|Unable to Complete Questionnaires|0
5571955|NCT01094782|19256924|P3|Overall Study|Unable to Complete Questionnaires|0
5571956|NCT01094782|19256925|P2|Overall Study|Unable to Complete Questionnaires|1
5571957|NCT01094782|19256926|P1|Overall Study|Unable to Complete Questionnaires|0
5571958|NCT01094782|19256921|P6|Overall Study|Sensory Deficit at Site of QST|0
5571959|NCT01094782|19256922|P5|Overall Study|Sensory Deficit at Site of QST|0
5571960|NCT01094782|19256923|P4|Overall Study|Sensory Deficit at Site of QST|0
5571961|NCT01094782|19256924|P3|Overall Study|Sensory Deficit at Site of QST|0
5571962|NCT01094782|19256925|P2|Overall Study|Sensory Deficit at Site of QST|1
5571963|NCT01094782|19256926|P1|Overall Study|Sensory Deficit at Site of QST|0
5571964|NCT01094782|19256921|P6|Overall Study|Positive Drug Screen|2
5571965|NCT01094782|19256922|P5|Overall Study|Positive Drug Screen|3
5571966|NCT01094782|19256923|P4|Overall Study|Positive Drug Screen|1
5571967|NCT01094782|19256924|P3|Overall Study|Positive Drug Screen|1
5571968|NCT01094782|19256925|P2|Overall Study|Positive Drug Screen|2
5571969|NCT01094782|19256926|P1|Overall Study|Positive Drug Screen|2
5571970|NCT01094782|19256921|P6|Overall Study|Lost to Follow-up|4
5571971|NCT01094782|19256922|P5|Overall Study|Lost to Follow-up|1
5571972|NCT01094782|19256923|P4|Overall Study|Lost to Follow-up|2
5571973|NCT01094782|19256924|P3|Overall Study|Lost to Follow-up|0
5571974|NCT01094782|19256925|P2|Overall Study|Lost to Follow-up|0
5571975|NCT01094782|19256926|P1|Overall Study|Lost to Follow-up|1
5571976|NCT01094782|19256921|P6|Overall Study|Withdrawal by Subject|0
5571977|NCT01094782|19256922|P5|Overall Study|Withdrawal by Subject|5
5571978|NCT01094782|19256923|P4|Overall Study|Withdrawal by Subject|5
5571979|NCT01094782|19256924|P3|Overall Study|Withdrawal by Subject|1
5571980|NCT01094782|19256925|P2|Overall Study|Withdrawal by Subject|5
5571981|NCT01094782|19256926|P1|Overall Study|Withdrawal by Subject|5
5571982|NCT01094743|19256970|P1|Period 1|Unsatisfactory comfort at lens fitting|2
5571983|NCT01094730|19256987|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
5571984|NCT01094730|19256988|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
5571985|NCT01094730|19256987|P2|Period 2 (14 Days)|Adverse Event|1
5571986|NCT01094730|19256988|P1|Period 2 (14 Days)|Adverse Event|0
5571987|NCT01094730|19256987|P2|Period 2 (14 Days)|No time for the follow-up visit|0
5571988|NCT01094730|19256988|P1|Period 2 (14 Days)|No time for the follow-up visit|1
5571989|NCT01094730|19256987|P2|Period 2 (14 Days)|Protocol Violation|0
5571990|NCT01094730|19256988|P1|Period 2 (14 Days)|Protocol Violation|2
5571991|NCT01094730|19256987|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
5571992|NCT01094730|19256988|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
5571993|NCT01094730|19256987|P2|Period 1 (14 Days)|No time for the follow-up visit|0
5571994|NCT01094730|19256988|P1|Period 1 (14 Days)|No time for the follow-up visit|1
5571995|NCT01094730|19256987|P2|Period 1 (14 Days)|Withdrawal by Subject|1
5571996|NCT01094730|19256988|P1|Period 1 (14 Days)|Withdrawal by Subject|0
5571997|NCT01094730|19256987|P2|Period 1 (14 Days)|Lost to Follow-up|1
5571998|NCT01094730|19256988|P1|Period 1 (14 Days)|Lost to Follow-up|0
5571999|NCT01094301|19257124|P1|Implant Stage|No return of pain|4
5572000|NCT01094301|19257124|P1|Implant Stage|Withdrawal by Subject|2
5572001|NCT01094301|19257124|P1|Implant Stage|Protocol Violation|1
5572002|NCT01094301|19257124|P1|Implant Stage|Adverse Event|1
5572003|NCT01094301|19257124|P1|Trial Stage|Withdrawal by Subject|1
5572004|NCT01094288|19257154|P8|Overall Study|Ongoing Participants|0
5572005|NCT01094288|19257155|P7|Overall Study|Ongoing Participants|0
5572006|NCT01094288|19257156|P6|Overall Study|Ongoing Participants|0
5572007|NCT01094288|19257157|P5|Overall Study|Ongoing Participants|0
5572008|NCT01094288|19257158|P4|Overall Study|Ongoing Participants|0
5572009|NCT01094288|19257159|P3|Overall Study|Ongoing Participants|0
5572010|NCT01094288|19257160|P2|Overall Study|Ongoing Participants|3
5572011|NCT01094288|19257161|P1|Overall Study|Ongoing Participants|0
5572012|NCT01094288|19257154|P8|Overall Study|Reason not Specified|0
5572013|NCT01094288|19257155|P7|Overall Study|Reason not Specified|0
5572014|NCT01094288|19257156|P6|Overall Study|Reason not Specified|0
5572015|NCT01094288|19257157|P5|Overall Study|Reason not Specified|0
5572016|NCT01094288|19257158|P4|Overall Study|Reason not Specified|1
5572017|NCT01094288|19257159|P3|Overall Study|Reason not Specified|0
5572018|NCT01094288|19257160|P2|Overall Study|Reason not Specified|3
5572019|NCT01094288|19257161|P1|Overall Study|Reason not Specified|2
5572020|NCT01094288|19257154|P8|Overall Study|Initiation of Alternative Therapy|0
5572021|NCT01094288|19257155|P7|Overall Study|Initiation of Alternative Therapy|0
5572022|NCT01094288|19257156|P6|Overall Study|Initiation of Alternative Therapy|0
5572023|NCT01094288|19257157|P5|Overall Study|Initiation of Alternative Therapy|0
5572024|NCT01094288|19257158|P4|Overall Study|Initiation of Alternative Therapy|0
5572025|NCT01094288|19257159|P3|Overall Study|Initiation of Alternative Therapy|1
5572026|NCT01094288|19257160|P2|Overall Study|Initiation of Alternative Therapy|0
5572027|NCT01094288|19257161|P1|Overall Study|Initiation of Alternative Therapy|0
5572028|NCT01094288|19257154|P8|Overall Study|Withdrawal by Subject|2
5572029|NCT01094288|19257155|P7|Overall Study|Withdrawal by Subject|0
5572030|NCT01094288|19257156|P6|Overall Study|Withdrawal by Subject|0
5572031|NCT01094288|19257157|P5|Overall Study|Withdrawal by Subject|0
5572032|NCT01094288|19257158|P4|Overall Study|Withdrawal by Subject|0
5572033|NCT01094288|19257159|P3|Overall Study|Withdrawal by Subject|2
5572034|NCT01094288|19257160|P2|Overall Study|Withdrawal by Subject|1
5572035|NCT01094288|19257161|P1|Overall Study|Withdrawal by Subject|0
5572036|NCT01094288|19257154|P8|Overall Study|Adverse Event|0
5572037|NCT01094288|19257155|P7|Overall Study|Adverse Event|0
5572038|NCT01094288|19257156|P6|Overall Study|Adverse Event|0
5572039|NCT01094288|19257157|P5|Overall Study|Adverse Event|0
5572040|NCT01094288|19257158|P4|Overall Study|Adverse Event|1
5572041|NCT01094288|19257159|P3|Overall Study|Adverse Event|1
5572042|NCT01094288|19257160|P2|Overall Study|Adverse Event|3
5572043|NCT01094288|19257161|P1|Overall Study|Adverse Event|0
5572044|NCT01094184|19257273|P2|Overall Study|Death|11
5572045|NCT01094184|19257274|P1|Overall Study|Death|35
5572046|NCT01094171|19257508|P1|Overall Study|Other|1
5572047|NCT01094171|19257508|P1|Overall Study|Migration from the study area|3
5572048|NCT01094171|19257508|P1|Overall Study|Informed consent withdrawal|4
5572049|NCT01094171|19257508|P1|Overall Study|Lost to Follow-up|2
5572050|NCT01094119|19257517|P2|Overall Study|Lack of Efficacy|4
5572051|NCT01094119|19257518|P1|Overall Study|Lack of Efficacy|2
5572052|NCT01093885|19257543|P1|Overall Study|Lost to Follow-up|1
5572053|NCT01093885|19257543|P1|Overall Study|Adverse Event|4
5572054|NCT01093846|19257551|P3|Overall Study|Administrative Problems|15
5572055|NCT01093846|19257552|P2|Overall Study|Administrative Problems|17
5572056|NCT01093846|19257553|P1|Overall Study|Administrative Problems|18
5572057|NCT01093846|19257551|P3|Overall Study|Condition no longer required study drug|1
5572058|NCT01093846|19257552|P2|Overall Study|Condition no longer required study drug|1
5572059|NCT01093846|19257553|P1|Overall Study|Condition no longer required study drug|1
5572060|NCT01093846|19257551|P3|Overall Study|Lack of Efficacy|4
5572061|NCT01093846|19257552|P2|Overall Study|Lack of Efficacy|0
5572062|NCT01093846|19257553|P1|Overall Study|Lack of Efficacy|0
5572063|NCT01093846|19257551|P3|Overall Study|Adverse Event|1
5572064|NCT01093846|19257552|P2|Overall Study|Adverse Event|0
5572065|NCT01093846|19257553|P1|Overall Study|Adverse Event|0
5572066|NCT01093755|19257578|P2|Overall Study|Withdrawal by Subject|4
5572067|NCT01093755|19257579|P1|Overall Study|Withdrawal by Subject|3
5572068|NCT01093625|19257619|P2|1-Year Visit|Lost to Follow-up|3
5572069|NCT01093625|19257620|P1|1-Year Visit|Lost to Follow-up|5
5572070|NCT01093625|19257619|P2|6-Month Visit|Lost to Follow-up|2
5572071|NCT01093625|19257620|P1|6-Month Visit|Lost to Follow-up|2
5572072|NCT01093625|19257619|P2|6-Month Visit|Withdrawal by Subject|7
5572073|NCT01093625|19257620|P1|6-Month Visit|Withdrawal by Subject|6
5572074|NCT01093625|19257619|P2|3-Month Visit|Lost to Follow-up|0
5572075|NCT01093625|19257620|P1|3-Month Visit|Lost to Follow-up|2
5572076|NCT01093625|19257619|P2|1-Month Visit|Lost to Follow-up|0
5572077|NCT01093625|19257620|P1|1-Month Visit|Lost to Follow-up|2
5572078|NCT01093625|19257619|P2|2-Week Visit|Withdrawal by Subject|0
5572079|NCT01093625|19257620|P1|2-Week Visit|Withdrawal by Subject|1
5572080|NCT01093625|19257619|P2|Baseline and Dispensed|Withdrawal by Subject|0
5572081|NCT01093625|19257620|P1|Baseline and Dispensed|Withdrawal by Subject|2
5572082|NCT01093599|19257640|P2|Overall Study|Lost to Follow-up|46
5572083|NCT01093599|19257641|P1|Overall Study|Lost to Follow-up|32
5572084|NCT01093586|19257647|P1|Overall Study|Failed to engraft|3
5572085|NCT01093573|19257668|P3|Overall Study|Insurance Denied|1
5572086|NCT01093573|19257669|P2|Overall Study|Insurance Denied|0
5572087|NCT01093573|19257670|P1|Overall Study|Insurance Denied|0
5572088|NCT01093573|19257668|P3|Overall Study|Physician Decision|1
5572089|NCT01093573|19257669|P2|Overall Study|Physician Decision|0
5572090|NCT01093573|19257670|P1|Overall Study|Physician Decision|0
5572091|NCT01093534|19257687|P3|Overall Study|Other|4
5572092|NCT01093534|19257688|P2|Overall Study|Other|3
5572093|NCT01093534|19257689|P1|Overall Study|Other|1
5572094|NCT01093534|19257687|P3|Overall Study|Withdrawal by Subject|2
5572095|NCT01093534|19257688|P2|Overall Study|Withdrawal by Subject|7
5572096|NCT01093534|19257689|P1|Overall Study|Withdrawal by Subject|5
5572097|NCT01093534|19257687|P3|Overall Study|Lack of Efficacy|1
5572098|NCT01093534|19257688|P2|Overall Study|Lack of Efficacy|1
5572099|NCT01093534|19257689|P1|Overall Study|Lack of Efficacy|2
5572100|NCT01093534|19257687|P3|Overall Study|Adverse Event|2
5572101|NCT01093534|19257688|P2|Overall Study|Adverse Event|5
5572102|NCT01093534|19257689|P1|Overall Study|Adverse Event|2
5572103|NCT01093222|19257837|P1|Overall Study|Not protocol specified|1
5572104|NCT01093222|19257837|P1|Overall Study|Death|2
5572105|NCT01093222|19257837|P1|Overall Study|Progression/relapse|24
5572106|NCT01093222|19257837|P1|Overall Study|Adverse Event|7
5572107|NCT01093222|19257837|P1|Overall Study|Ineligible|6
5572108|NCT01092832|19257913|P2|Overall Study|Other|0
5572109|NCT01092832|19257914|P1|Overall Study|Other|1
5572110|NCT01092780|19257926|P4|Washout Period 2|Adverse Event|0
5572111|NCT01092780|19257927|P3|Washout Period 2|Adverse Event|1
5572112|NCT01092780|19257928|P2|Washout Period 2|Adverse Event|1
5572113|NCT01092780|19257929|P1|Washout Period 2|Adverse Event|0
5572114|NCT01092780|19257926|P4|Washout Period 1|Noncompliance with nCPAP|0
5572115|NCT01092780|19257927|P3|Washout Period 1|Noncompliance with nCPAP|0
5572116|NCT01092780|19257928|P2|Washout Period 1|Noncompliance with nCPAP|0
5572117|NCT01092780|19257929|P1|Washout Period 1|Noncompliance with nCPAP|1
5572118|NCT01092780|19257926|P4|Washout Period 1|Adverse Event|0
5572119|NCT01092780|19257927|P3|Washout Period 1|Adverse Event|0
5572120|NCT01092780|19257928|P2|Washout Period 1|Adverse Event|1
5572121|NCT01092780|19257929|P1|Washout Period 1|Adverse Event|0
5572122|NCT01092728|19257965|P2|Overall Study|Prohibited Concomitant Medications|0
5572123|NCT01092728|19257966|P1|Overall Study|Prohibited Concomitant Medications|1
5572124|NCT01092728|19257965|P2|Overall Study|Disease Progression|13
5572125|NCT01092728|19257966|P1|Overall Study|Disease Progression|1
5572126|NCT01092728|19257965|P2|Overall Study|Adverse Event|1
5572127|NCT01092728|19257966|P1|Overall Study|Adverse Event|0
5572128|NCT01092728|19257965|P2|Overall Study|Withdrawal by Subject|0
5572129|NCT01092728|19257966|P1|Overall Study|Withdrawal by Subject|2
5572130|NCT01092702|19257974|P1|Overall Study|Lost to Follow-up|2
5572131|NCT01092702|19257974|P1|Overall Study|Withdrawal by Subject|7
5572132|NCT01092663|19257991|P2|Overall Study|Protocol Violation|1
5572133|NCT01092663|19257992|P1|Overall Study|Protocol Violation|0
5572134|NCT01092663|19257991|P2|Overall Study|Adverse Event|1
5572135|NCT01092663|19257992|P1|Overall Study|Adverse Event|1
5572136|NCT01092663|19257991|P2|Overall Study|High fasting triglyceride|0
5572137|NCT01092663|19257992|P1|Overall Study|High fasting triglyceride|2
5572138|NCT01092663|19257991|P2|Overall Study|Glucose >300mg/dL|0
5572139|NCT01092663|19257992|P1|Overall Study|Glucose >300mg/dL|1
5572140|NCT01092663|19257991|P2|Overall Study|Withdrawal by Subject|2
5572141|NCT01092663|19257992|P1|Overall Study|Withdrawal by Subject|3
5572142|NCT01092637|19258040|P2|Overall Study|Death|49
5572143|NCT01092637|19258041|P1|Overall Study|Death|47
5572144|NCT01092546|19258056|P1|Overall Study|Subjects withdrawn prior to dosing|4
5572145|NCT01092507|19258063|P2|Overall Study|Withdrawal by Subject|0
5572146|NCT01092507|19258064|P1|Overall Study|Withdrawal by Subject|2
5572147|NCT01092416|19258099|P1|12-Month Follow-up|Data collected after close of 1Y window|2
5572148|NCT01092416|19258099|P1|12-Month Follow-up|Missed 1-year follow-up|1
5572149|NCT01092416|19258099|P1|12-Month Follow-up|Withdrawal by Subject|2
5572150|NCT01092416|19258099|P1|12-Month Follow-up|Lost to Follow-up|4
5572151|NCT01092416|19258099|P1|12-Month Follow-up|Death|16
5572152|NCT01092416|19258099|P1|30-Day Follow-up|Data collected after close of 30D window|5
5572153|NCT01092416|19258099|P1|30-Day Follow-up|Missed 30-day follow-up|3
5572154|NCT01092416|19258099|P1|30-Day Follow-up|Death|2
5572155|NCT01092416|19258099|P1|Enrollment|Atherectomy device not inserted|3
5572156|NCT01091974|19258149|P4|Overall Study|side-effects|2
5572157|NCT01091974|19258150|P3|Overall Study|side-effects|0
5572158|NCT01091974|19258151|P2|Overall Study|side-effects|1
5572159|NCT01091974|19258152|P1|Overall Study|side-effects|1
5572160|NCT01091974|19258149|P4|Overall Study|Withdrawal by Subject|2
5572161|NCT01091974|19258150|P3|Overall Study|Withdrawal by Subject|2
5572162|NCT01091974|19258151|P2|Overall Study|Withdrawal by Subject|3
5572163|NCT01091974|19258152|P1|Overall Study|Withdrawal by Subject|1
5572164|NCT01091974|19258149|P4|Overall Study|resumed sleep medication|2
5572165|NCT01091974|19258150|P3|Overall Study|resumed sleep medication|1
5572166|NCT01091974|19258151|P2|Overall Study|resumed sleep medication|0
5572167|NCT01091974|19258152|P1|Overall Study|resumed sleep medication|0
5572168|NCT01091974|19258149|P4|Overall Study|Did not start intervention|1
5572169|NCT01091974|19258150|P3|Overall Study|Did not start intervention|3
5572170|NCT01091974|19258151|P2|Overall Study|Did not start intervention|1
5572171|NCT01091974|19258152|P1|Overall Study|Did not start intervention|3
5572172|NCT01091675|19258187|P1|Overall Study|Lack of Efficacy|27
5572173|NCT01091675|19258187|P1|Overall Study|Adverse Event|7
5572174|NCT01091662|19258193|P2|Overall Study|unable to swallow capsule|1
5572175|NCT01091662|19258194|P1|Overall Study|unable to swallow capsule|0
5572176|NCT01091662|19258193|P2|Overall Study|Protocol Violation|2
5572177|NCT01091662|19258194|P1|Overall Study|Protocol Violation|0
5572178|NCT01091662|19258193|P2|Overall Study|Pregnancy|1
5572179|NCT01091662|19258194|P1|Overall Study|Pregnancy|0
5572180|NCT01091662|19258193|P2|Overall Study|Lost to Follow-up|1
5572181|NCT01091662|19258194|P1|Overall Study|Lost to Follow-up|0
5572182|NCT01091662|19258193|P2|Overall Study|met exclusion criteria|0
5572183|NCT01091662|19258194|P1|Overall Study|met exclusion criteria|1
5572184|NCT01091662|19258193|P2|Overall Study|met exit criteria|13
5572185|NCT01091662|19258194|P1|Overall Study|met exit criteria|7
5572186|NCT01091662|19258193|P2|Overall Study|Withdrawal by Subject|6
5572187|NCT01091662|19258194|P1|Overall Study|Withdrawal by Subject|7
5572188|NCT01091662|19258193|P2|Overall Study|Physician Decision|1
5572189|NCT01091662|19258194|P1|Overall Study|Physician Decision|1
5572190|NCT01091662|19258193|P2|Overall Study|Adverse Event|9
5572191|NCT01091662|19258194|P1|Overall Study|Adverse Event|1
5572192|NCT01091519|19258232|P2|Overall Study|Randomized not treated|4
5572193|NCT01091519|19258233|P1|Overall Study|Randomized not treated|4
5572194|NCT01091519|19258232|P2|Overall Study|Other|8
5572195|NCT01091519|19258233|P1|Overall Study|Other|6
5572196|NCT01091519|19258232|P2|Overall Study|Withdrawal by Subject|2
5572197|NCT01091519|19258233|P1|Overall Study|Withdrawal by Subject|2
5572198|NCT01091519|19258232|P2|Overall Study|Lost to Follow-up|24
5572199|NCT01091519|19258233|P1|Overall Study|Lost to Follow-up|14
5572200|NCT01091519|19258232|P2|Overall Study|Lack of Efficacy|19
5572201|NCT01091519|19258233|P1|Overall Study|Lack of Efficacy|16
5572202|NCT01091519|19258232|P2|Overall Study|Death|0
5572203|NCT01091519|19258233|P1|Overall Study|Death|1
5572204|NCT01091519|19258232|P2|Overall Study|Adverse Event|16
5572205|NCT01091519|19258233|P1|Overall Study|Adverse Event|12
5572206|NCT01091454|19258245|P1|Overall Study|Ineligible|1
5572207|NCT01091428|19258258|P4|Phase 2|Physician Decision|0
5572208|NCT01091428|19258259|P3|Phase 2|Physician Decision|2
5572209|NCT01091428|19258260|P2|Phase 2|Physician Decision|0
5572210|NCT01091428|19258261|P1|Phase 2|Physician Decision|0
5572211|NCT01091428|19258258|P4|Phase 2|Reason not specified|3
5572212|NCT01091428|19258259|P3|Phase 2|Reason not specified|4
5572213|NCT01091428|19258260|P2|Phase 2|Reason not specified|0
5572214|NCT01091428|19258261|P1|Phase 2|Reason not specified|0
5572215|NCT01091428|19258258|P4|Phase 2|Unsatisfactory Therapeutic Response|1
5572216|NCT01091428|19258259|P3|Phase 2|Unsatisfactory Therapeutic Response|1
5572217|NCT01091428|19258260|P2|Phase 2|Unsatisfactory Therapeutic Response|0
5572218|NCT01091428|19258261|P1|Phase 2|Unsatisfactory Therapeutic Response|0
5572219|NCT01091428|19258258|P4|Phase 2|Withdrawal by Subject|8
5572220|NCT01091428|19258259|P3|Phase 2|Withdrawal by Subject|9
5572221|NCT01091428|19258260|P2|Phase 2|Withdrawal by Subject|0
5572222|NCT01091428|19258261|P1|Phase 2|Withdrawal by Subject|0
5572223|NCT01091428|19258258|P4|Phase 2|Adverse Event|5
5572224|NCT01091428|19258259|P3|Phase 2|Adverse Event|12
5572225|NCT01091428|19258260|P2|Phase 2|Adverse Event|0
5572226|NCT01091428|19258261|P1|Phase 2|Adverse Event|0
5572227|NCT01091428|19258258|P4|Phase 2|Symptomatic Deterioration|6
5572228|NCT01091428|19258259|P3|Phase 2|Symptomatic Deterioration|1
5572229|NCT01091428|19258260|P2|Phase 2|Symptomatic Deterioration|0
5572230|NCT01091428|19258261|P1|Phase 2|Symptomatic Deterioration|0
5572231|NCT01091428|19258258|P4|Phase 2|Progressive Disease|46
5572232|NCT01091428|19258259|P3|Phase 2|Progressive Disease|44
5572233|NCT01091428|19258260|P2|Phase 2|Progressive Disease|0
5572234|NCT01091428|19258261|P1|Phase 2|Progressive Disease|0
5572235|NCT01091428|19258258|P4|Phase 1|Single-Patient IND|0
5572236|NCT01091428|19258259|P3|Phase 1|Single-Patient IND|0
5572237|NCT01091428|19258260|P2|Phase 1|Single-Patient IND|0
5572238|NCT01091428|19258261|P1|Phase 1|Single-Patient IND|2
5572239|NCT01091428|19258258|P4|Phase 1|Reason not specified|0
5572240|NCT01091428|19258259|P3|Phase 1|Reason not specified|0
5572241|NCT01091428|19258260|P2|Phase 1|Reason not specified|1
5572242|NCT01091428|19258261|P1|Phase 1|Reason not specified|0
5572243|NCT01091428|19258258|P4|Phase 1|Withdrawal by Subject|0
5572244|NCT01091428|19258259|P3|Phase 1|Withdrawal by Subject|0
5572245|NCT01091428|19258260|P2|Phase 1|Withdrawal by Subject|0
5572246|NCT01091428|19258261|P1|Phase 1|Withdrawal by Subject|7
5572247|NCT01091428|19258258|P4|Phase 1|Adverse Event|0
5572248|NCT01091428|19258259|P3|Phase 1|Adverse Event|0
5572249|NCT01091428|19258260|P2|Phase 1|Adverse Event|0
5572250|NCT01091428|19258261|P1|Phase 1|Adverse Event|2
5572251|NCT01091428|19258258|P4|Phase 1|Symptomatic Deterioration|0
5572252|NCT01091428|19258259|P3|Phase 1|Symptomatic Deterioration|0
5572253|NCT01091428|19258260|P2|Phase 1|Symptomatic Deterioration|2
5572254|NCT01091428|19258261|P1|Phase 1|Symptomatic Deterioration|3
5572255|NCT01091428|19258258|P4|Phase 1|Progressive Disease|0
5572256|NCT01091428|19258259|P3|Phase 1|Progressive Disease|0
5572257|NCT01091428|19258260|P2|Phase 1|Progressive Disease|8
5572258|NCT01091428|19258261|P1|Phase 1|Progressive Disease|24
5572259|NCT01091363|19258364|P2|Overall Study|Lost to Follow-up|2
5572260|NCT01091363|19258365|P1|Overall Study|Lost to Follow-up|2
5572261|NCT01091363|19258364|P2|Overall Study|Withdrawal by Subject|15
5572262|NCT01091363|19258365|P1|Overall Study|Withdrawal by Subject|11
5572263|NCT01091259|19258375|P1|Overall Study|Lack of Efficacy|2
5572264|NCT01091259|19258375|P1|Overall Study|Adverse Event|3
5572265|NCT01091246|19258386|P3|Overall Study|Subject not dosed|1
5572266|NCT01091246|19258387|P2|Overall Study|Subject not dosed|0
5572267|NCT01091246|19258388|P1|Overall Study|Subject not dosed|2
5572268|NCT01091246|19258386|P3|Overall Study|Withdrawal by Subject|4
5572269|NCT01091246|19258387|P2|Overall Study|Withdrawal by Subject|5
5572270|NCT01091246|19258388|P1|Overall Study|Withdrawal by Subject|9
5572271|NCT01091246|19258386|P3|Overall Study|Adverse Event|1
5572272|NCT01091246|19258387|P2|Overall Study|Adverse Event|0
5572273|NCT01091246|19258388|P1|Overall Study|Adverse Event|1
5572274|NCT01091246|19258386|P3|Overall Study|Lost to Follow-up|7
5572275|NCT01091246|19258387|P2|Overall Study|Lost to Follow-up|11
5572276|NCT01091246|19258388|P1|Overall Study|Lost to Follow-up|23
5572277|NCT01091168|19258464|P2|Overall Study|Physician, patient's decision, other|37
5572278|NCT01091168|19258465|P1|Overall Study|Physician, patient's decision, other|27
5572279|NCT01091168|19258464|P2|Overall Study|Lost to Follow-up|1
5572280|NCT01091168|19258465|P1|Overall Study|Lost to Follow-up|0
5572281|NCT01091168|19258464|P2|Overall Study|Adverse Event|24
5572282|NCT01091168|19258465|P1|Overall Study|Adverse Event|21
5572283|NCT01091168|19258464|P2|Overall Study|Progressive disease|234
5572284|NCT01091168|19258465|P1|Overall Study|Progressive disease|250
5572285|NCT01091103|19258540|P1|Overall Study|Progressive Disease|3
5572286|NCT01091103|19258540|P1|Overall Study|Adverse Event|1
5572287|NCT01090973|19258560|P1|Overall Study|Disease progression|1
5572288|NCT01090765|19258581|P6|Overall Study|Vasovagal reaction with first infusion|0
5572289|NCT01090765|19258582|P5|Overall Study|Vasovagal reaction with first infusion|1
5572290|NCT01090765|19258583|P4|Overall Study|Vasovagal reaction with first infusion|0
5572291|NCT01090765|19258584|P3|Overall Study|Vasovagal reaction with first infusion|0
5572292|NCT01090765|19258585|P2|Overall Study|Vasovagal reaction with first infusion|0
5572293|NCT01090765|19258586|P1|Overall Study|Vasovagal reaction with first infusion|0
5572294|NCT01090765|19258581|P6|Overall Study|Developed a DVT, needed anticoagulation|0
5572295|NCT01090765|19258582|P5|Overall Study|Developed a DVT, needed anticoagulation|0
5572296|NCT01090765|19258583|P4|Overall Study|Developed a DVT, needed anticoagulation|1
5572297|NCT01090765|19258584|P3|Overall Study|Developed a DVT, needed anticoagulation|0
5572298|NCT01090765|19258585|P2|Overall Study|Developed a DVT, needed anticoagulation|0
5572299|NCT01090765|19258586|P1|Overall Study|Developed a DVT, needed anticoagulation|0
5572300|NCT01090765|19258581|P6|Overall Study|Patient withdrew consent|1
5572301|NCT01090765|19258582|P5|Overall Study|Patient withdrew consent|1
5572302|NCT01090765|19258583|P4|Overall Study|Patient withdrew consent|0
5572303|NCT01090765|19258584|P3|Overall Study|Patient withdrew consent|0
5572304|NCT01090765|19258585|P2|Overall Study|Patient withdrew consent|0
5572305|NCT01090765|19258586|P1|Overall Study|Patient withdrew consent|0
5572306|NCT01090739|19258632|P1|36 Month Follow-up|Visit still pending|17
5572307|NCT01090739|19258632|P1|36 Month Follow-up|Withdrawal by Subject|6
5572308|NCT01090739|19258632|P1|24 Month Follow-up|Death|1
5572309|NCT01090739|19258632|P1|24 Month Follow-up|Lost to Follow-up|1
5572310|NCT01090739|19258632|P1|24 Month Follow-up|Withdrawal by Subject|7
5572311|NCT01090739|19258632|P1|12 Month Follow-up|Death|1
5572312|NCT01090739|19258632|P1|12 Month Follow-up|Physician Decision|1
5572313|NCT01090739|19258632|P1|12 Month Follow-up|Lost to Follow-up|1
5572314|NCT01090739|19258632|P1|12 Month Follow-up|Withdrawal by Subject|2
5572315|NCT01090739|19258632|P1|Enrollment|Adverse Event|1
5572316|NCT01090739|19258632|P1|Enrollment|Study implant limit reached|2
5572317|NCT01090739|19258632|P1|Enrollment|Sponsor termination of site|4
5572318|NCT01090739|19258632|P1|Enrollment|Physician Decision|5
5572319|NCT01090739|19258632|P1|Enrollment|Lost to Follow-up|5
5572320|NCT01090739|19258632|P1|Enrollment|Protocol Violation|14
5572321|NCT01090739|19258632|P1|Enrollment|Withdrawal by Subject|24
5572322|NCT01090492|19258657|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5572323|NCT01090492|19258658|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
5572324|NCT01090492|19258659|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5572325|NCT01090492|19258660|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5572326|NCT01090492|19258661|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5572327|NCT01090492|19258662|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5572328|NCT01090492|19258663|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5572329|NCT01090492|19258664|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
5572330|NCT01090492|19258657|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
5572331|NCT01090492|19258658|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
5572332|NCT01090492|19258659|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
5572333|NCT01090492|19258660|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
5572334|NCT01090492|19258661|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
5572335|NCT01090492|19258662|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
5572336|NCT01090492|19258663|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
5572337|NCT01090492|19258664|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
5572338|NCT01090492|19258657|P8|Second Intervention Period (4 Weeks)|Other|0
5572339|NCT01090492|19258658|P7|Second Intervention Period (4 Weeks)|Other|0
5572340|NCT01090492|19258659|P6|Second Intervention Period (4 Weeks)|Other|0
5572341|NCT01090492|19258660|P5|Second Intervention Period (4 Weeks)|Other|0
5572342|NCT01090492|19258661|P4|Second Intervention Period (4 Weeks)|Other|0
5572343|NCT01090492|19258662|P3|Second Intervention Period (4 Weeks)|Other|1
5572344|NCT01090492|19258663|P2|Second Intervention Period (4 Weeks)|Other|1
5572345|NCT01090492|19258664|P1|Second Intervention Period (4 Weeks)|Other|0
5572346|NCT01090492|19258657|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
5572347|NCT01090492|19258658|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
5572348|NCT01090492|19258659|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
5572349|NCT01090492|19258660|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
5572350|NCT01090492|19258661|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
5572351|NCT01090492|19258662|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
5572352|NCT01090492|19258663|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
5572353|NCT01090492|19258664|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
5572354|NCT01090492|19258657|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
5572355|NCT01090492|19258658|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
5572356|NCT01090492|19258659|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
5572357|NCT01090492|19258660|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
5572358|NCT01090492|19258661|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
5572359|NCT01090492|19258662|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
5572360|NCT01090492|19258663|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
5572361|NCT01090492|19258664|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
5572362|NCT01090492|19258657|P8|First Intervention Period (4 Weeks)|Adverse Event|5
5572363|NCT01090492|19258658|P7|First Intervention Period (4 Weeks)|Adverse Event|0
5572364|NCT01090492|19258659|P6|First Intervention Period (4 Weeks)|Adverse Event|2
5572365|NCT01090492|19258660|P5|First Intervention Period (4 Weeks)|Adverse Event|1
5572366|NCT01090492|19258661|P4|First Intervention Period (4 Weeks)|Adverse Event|3
5572367|NCT01090492|19258662|P3|First Intervention Period (4 Weeks)|Adverse Event|0
5572368|NCT01090492|19258663|P2|First Intervention Period (4 Weeks)|Adverse Event|2
5572369|NCT01090492|19258664|P1|First Intervention Period (4 Weeks)|Adverse Event|0
5572370|NCT01090492|19258657|P8|First Intervention Period (4 Weeks)|Pregnancy|0
5572371|NCT01090492|19258658|P7|First Intervention Period (4 Weeks)|Pregnancy|0
5572372|NCT01090492|19258659|P6|First Intervention Period (4 Weeks)|Pregnancy|0
5572373|NCT01090492|19258660|P5|First Intervention Period (4 Weeks)|Pregnancy|1
5572374|NCT01090492|19258661|P4|First Intervention Period (4 Weeks)|Pregnancy|0
5572375|NCT01090492|19258662|P3|First Intervention Period (4 Weeks)|Pregnancy|0
5572376|NCT01090492|19258663|P2|First Intervention Period (4 Weeks)|Pregnancy|0
5572377|NCT01090492|19258664|P1|First Intervention Period (4 Weeks)|Pregnancy|0
5572378|NCT01090492|19258657|P8|First Intervention Period (4 Weeks)|Other|0
5572379|NCT01090492|19258658|P7|First Intervention Period (4 Weeks)|Other|0
5572380|NCT01090492|19258659|P6|First Intervention Period (4 Weeks)|Other|0
5572381|NCT01090492|19258660|P5|First Intervention Period (4 Weeks)|Other|2
5572382|NCT01090492|19258661|P4|First Intervention Period (4 Weeks)|Other|1
5572383|NCT01090492|19258662|P3|First Intervention Period (4 Weeks)|Other|1
5572384|NCT01090492|19258663|P2|First Intervention Period (4 Weeks)|Other|0
5572385|NCT01090492|19258664|P1|First Intervention Period (4 Weeks)|Other|0
5572386|NCT01090492|19258657|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5572387|NCT01090492|19258658|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5572388|NCT01090492|19258659|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5572389|NCT01090492|19258660|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5572390|NCT01090492|19258661|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5572391|NCT01090492|19258662|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
5572392|NCT01090492|19258663|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5572393|NCT01090492|19258664|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
5572394|NCT01090492|19258657|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
5572395|NCT01090492|19258658|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5572396|NCT01090492|19258659|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5572397|NCT01090492|19258660|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5572398|NCT01090492|19258661|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5572399|NCT01090492|19258662|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5572400|NCT01090492|19258663|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
5572401|NCT01090492|19258664|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
5572402|NCT01090492|19258657|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
5572403|NCT01090492|19258658|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
5572404|NCT01090492|19258659|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
5572405|NCT01090492|19258660|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
5572406|NCT01090492|19258661|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
5572407|NCT01090492|19258662|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
5572408|NCT01090492|19258663|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
5572409|NCT01090492|19258664|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
5572410|NCT01090453|19258732|P2|Overall Study|Eligibility Criteria|1
5572411|NCT01090453|19258733|P1|Overall Study|Eligibility Criteria|0
5572412|NCT01090453|19258732|P2|Overall Study|Other|4
5572413|NCT01090453|19258733|P1|Overall Study|Other|2
5572414|NCT01090453|19258732|P2|Overall Study|Protocol Violation|0
5572415|NCT01090453|19258733|P1|Overall Study|Protocol Violation|2
5572416|NCT01090453|19258732|P2|Overall Study|Non serious AEs|0
5572417|NCT01090453|19258733|P1|Overall Study|Non serious AEs|1
5572418|NCT01090453|19258732|P2|Overall Study|Lost to Follow-up|7
5572419|NCT01090453|19258733|P1|Overall Study|Lost to Follow-up|7
5572420|NCT01090453|19258732|P2|Overall Study|Withdrawal by Subject|2
5572421|NCT01090453|19258733|P1|Overall Study|Withdrawal by Subject|1
5572422|NCT01090427|19258784|P7|After Controlled Period|Adverse Event|0
5572423|NCT01090427|19258785|P6|After Controlled Period|Adverse Event|1
5572424|NCT01090427|19258786|P5|After Controlled Period|Adverse Event|0
5572425|NCT01090427|19258787|P4|After Controlled Period|Adverse Event|2
5572426|NCT01090427|19258788|P3|After Controlled Period|Adverse Event|0
5572427|NCT01090427|19258789|P2|After Controlled Period|Adverse Event|0
5572428|NCT01090427|19258790|P1|After Controlled Period|Adverse Event|0
5572429|NCT01090427|19258784|P7|After Controlled Period|Lack of Efficacy|2
5572430|NCT01090427|19258785|P6|After Controlled Period|Lack of Efficacy|3
5572431|NCT01090427|19258786|P5|After Controlled Period|Lack of Efficacy|0
5572432|NCT01090427|19258787|P4|After Controlled Period|Lack of Efficacy|0
5572433|NCT01090427|19258788|P3|After Controlled Period|Lack of Efficacy|0
5572434|NCT01090427|19258789|P2|After Controlled Period|Lack of Efficacy|0
5572435|NCT01090427|19258790|P1|After Controlled Period|Lack of Efficacy|0
5572436|NCT01090427|19258784|P7|After Controlled Period|Death|0
5572437|NCT01090427|19258785|P6|After Controlled Period|Death|1
5572438|NCT01090427|19258786|P5|After Controlled Period|Death|0
5572439|NCT01090427|19258787|P4|After Controlled Period|Death|0
5572440|NCT01090427|19258788|P3|After Controlled Period|Death|0
5572441|NCT01090427|19258789|P2|After Controlled Period|Death|0
5572442|NCT01090427|19258790|P1|After Controlled Period|Death|0
5572443|NCT01090414|19258827|P4|Study 101-99|Participant Request|0
5572444|NCT01090414|19258828|P3|Study 101-99|Participant Request|0
5572445|NCT01090414|19258829|P2|Study 101-99|Participant Request|1
5572446|NCT01090414|19258830|P1|Study 101-99|Participant Request|3
5572447|NCT01090414|19258827|P4|Study 101-99|Withdrew Consent|1
5572448|NCT01090414|19258828|P3|Study 101-99|Withdrew Consent|3
5572449|NCT01090414|19258829|P2|Study 101-99|Withdrew Consent|2
5572450|NCT01090414|19258830|P1|Study 101-99|Withdrew Consent|0
5572451|NCT01090414|19258827|P4|Study 101-99|Other (Unknown Reasons)|0
5572452|NCT01090414|19258828|P3|Study 101-99|Other (Unknown Reasons)|0
5572453|NCT01090414|19258829|P2|Study 101-99|Other (Unknown Reasons)|3
5572454|NCT01090414|19258830|P1|Study 101-99|Other (Unknown Reasons)|3
5572455|NCT01090414|19258827|P4|Study 101-99|Sponsor Discontinued Study|0
5572456|NCT01090414|19258828|P3|Study 101-99|Sponsor Discontinued Study|5
5572457|NCT01090414|19258829|P2|Study 101-99|Sponsor Discontinued Study|7
5572458|NCT01090414|19258830|P1|Study 101-99|Sponsor Discontinued Study|0
5572459|NCT01090414|19258827|P4|Study 101-99|Death|0
5572460|NCT01090414|19258828|P3|Study 101-99|Death|1
5572461|NCT01090414|19258829|P2|Study 101-99|Death|8
5572462|NCT01090414|19258830|P1|Study 101-99|Death|3
5572463|NCT01090414|19258827|P4|Study 101-99|Investigator Request|0
5572464|NCT01090414|19258828|P3|Study 101-99|Investigator Request|4
5572465|NCT01090414|19258829|P2|Study 101-99|Investigator Request|11
5572466|NCT01090414|19258830|P1|Study 101-99|Investigator Request|1
5572467|NCT01090414|19258827|P4|Study 101-99|Adverse Event|0
5572468|NCT01090414|19258828|P3|Study 101-99|Adverse Event|18
5572469|NCT01090414|19258829|P2|Study 101-99|Adverse Event|28
5572470|NCT01090414|19258830|P1|Study 101-99|Adverse Event|10
5572471|NCT01090414|19258827|P4|Study 101-99|Progressive Disease|4
5572472|NCT01090414|19258828|P3|Study 101-99|Progressive Disease|10
5572473|NCT01090414|19258829|P2|Study 101-99|Progressive Disease|48
5572474|NCT01090414|19258830|P1|Study 101-99|Progressive Disease|28
5572475|NCT01090323|19258897|P2|Overall Study|Stopped end of extension 1#|1
5572476|NCT01090323|19258898|P1|Overall Study|Stopped end of extension 1#|3
5572477|NCT01090323|19258897|P2|Overall Study|Stopped end of core|0
5572478|NCT01090323|19258898|P1|Overall Study|Stopped end of core|7
5572479|NCT01090323|19258897|P2|Overall Study|Death|2
5572480|NCT01090323|19258898|P1|Overall Study|Death|1
5572481|NCT01090323|19258897|P2|Overall Study|Administrative problems|4
5572482|NCT01090323|19258898|P1|Overall Study|Administrative problems|6
5572483|NCT01090323|19258897|P2|Overall Study|Lost to Follow-up|6
5572484|NCT01090323|19258898|P1|Overall Study|Lost to Follow-up|11
5572485|NCT01090323|19258897|P2|Overall Study|Withdrew consent|11
5572486|NCT01090323|19258898|P1|Overall Study|Withdrew consent|33
5572487|NCT01090323|19258897|P2|Overall Study|Protocol Violation|1
5572488|NCT01090323|19258898|P1|Overall Study|Protocol Violation|2
5572489|NCT01090323|19258897|P2|Overall Study|Condition no longer requires drug|4
5572490|NCT01090323|19258898|P1|Overall Study|Condition no longer requires drug|5
5572491|NCT01090323|19258897|P2|Overall Study|Unsatisfactory therapeutic effect|2
5572492|NCT01090323|19258898|P1|Overall Study|Unsatisfactory therapeutic effect|4
5572493|NCT01090323|19258897|P2|Overall Study|Abnormal Test Procedure Results|0
5572494|NCT01090323|19258898|P1|Overall Study|Abnormal Test Procedure Results|2
5572495|NCT01090323|19258897|P2|Overall Study|Abnormal Lab Values|1
5572496|NCT01090323|19258898|P1|Overall Study|Abnormal Lab Values|3
5572497|NCT01090323|19258897|P2|Overall Study|Adverse Event|2
5572498|NCT01090323|19258898|P1|Overall Study|Adverse Event|12
5572499|NCT01090310|19258910|P4|Extension Study|Subject withdrew consent|0
5572500|NCT01090310|19258911|P3|Extension Study|Subject withdrew consent|0
5572501|NCT01090310|19258912|P2|Extension Study|Subject withdrew consent|1
5572502|NCT01090310|19258913|P1|Extension Study|Subject withdrew consent|0
5572503|NCT01090310|19258910|P4|Extension Study|Unsatisfactory therapeutic effect|1
5572504|NCT01090310|19258911|P3|Extension Study|Unsatisfactory therapeutic effect|1
5572505|NCT01090310|19258912|P2|Extension Study|Unsatisfactory therapeutic effect|0
5572506|NCT01090310|19258913|P1|Extension Study|Unsatisfactory therapeutic effect|1
5572507|NCT01090310|19258910|P4|Extension Study|Adverse Event|1
5572508|NCT01090310|19258911|P3|Extension Study|Adverse Event|0
5572509|NCT01090310|19258912|P2|Extension Study|Adverse Event|0
5572510|NCT01090310|19258913|P1|Extension Study|Adverse Event|0
5572511|NCT01090310|19258910|P4|Extension Study|Aministrative problems|18
5572512|NCT01090310|19258911|P3|Extension Study|Aministrative problems|14
5572513|NCT01090310|19258912|P2|Extension Study|Aministrative problems|15
5572514|NCT01090310|19258913|P1|Extension Study|Aministrative problems|13
5572515|NCT01090310|19258910|P4|Core Study|Protocol deviation|1
5572516|NCT01090310|19258911|P3|Core Study|Protocol deviation|0
5572517|NCT01090310|19258912|P2|Core Study|Protocol deviation|0
5572518|NCT01090310|19258913|P1|Core Study|Protocol deviation|1
5572519|NCT01090310|19258910|P4|Core Study|Administrative reasons|4
5572520|NCT01090310|19258911|P3|Core Study|Administrative reasons|4
5572521|NCT01090310|19258912|P2|Core Study|Administrative reasons|6
5572522|NCT01090310|19258913|P1|Core Study|Administrative reasons|5
5572523|NCT01090310|19258910|P4|Core Study|Abnormal test procedure result|0
5572524|NCT01090310|19258911|P3|Core Study|Abnormal test procedure result|1
5572525|NCT01090310|19258912|P2|Core Study|Abnormal test procedure result|0
5572526|NCT01090310|19258913|P1|Core Study|Abnormal test procedure result|0
5572527|NCT01090310|19258910|P4|Core Study|Subject withdrew consent|1
5572528|NCT01090310|19258911|P3|Core Study|Subject withdrew consent|1
5572529|NCT01090310|19258912|P2|Core Study|Subject withdrew consent|3
5572530|NCT01090310|19258913|P1|Core Study|Subject withdrew consent|0
5572531|NCT01090310|19258910|P4|Core Study|Adverse Event|1
5572532|NCT01090310|19258911|P3|Core Study|Adverse Event|1
5572533|NCT01090310|19258912|P2|Core Study|Adverse Event|2
5572534|NCT01090310|19258913|P1|Core Study|Adverse Event|2
5572535|NCT01090102|19258961|P2|Second 12 Weeks|Withdrawal by Subject|1
5572536|NCT01090102|19258962|P1|Second 12 Weeks|Withdrawal by Subject|0
5572537|NCT01090102|19258961|P2|First 12 Weeks|Death|1
5572538|NCT01090102|19258962|P1|First 12 Weeks|Death|1
5572539|NCT01090102|19258961|P2|First 12 Weeks|Adverse Event|0
5572540|NCT01090102|19258962|P1|First 12 Weeks|Adverse Event|2
5572541|NCT01090102|19258961|P2|First 12 Weeks|Withdrawal by Subject|1
5572542|NCT01090102|19258962|P1|First 12 Weeks|Withdrawal by Subject|1
5572543|NCT01090076|19258972|P2|Overall Study|Withdrawal by Subject|1
5572544|NCT01090076|19258973|P1|Overall Study|Withdrawal by Subject|0
5572545|NCT01090076|19258972|P2|Overall Study|Death|1
5572546|NCT01090076|19258973|P1|Overall Study|Death|1
5572547|NCT01090063|19258983|P1|Treatment|Withdrawal by Subject|4
5572548|NCT01090063|19258983|P1|Screen|Screen Failed|4
5572549|NCT01090050|19258999|P2|Overall Study|Physician Decision|1
5572550|NCT01090050|19259000|P1|Overall Study|Physician Decision|0
5572551|NCT01090050|19258999|P2|Overall Study|Lack of Efficacy|5
5572552|NCT01090050|19259000|P1|Overall Study|Lack of Efficacy|1
5572553|NCT01090050|19258999|P2|Overall Study|Lost to Follow-up|1
5572554|NCT01090050|19259000|P1|Overall Study|Lost to Follow-up|0
5572555|NCT01090011|19259020|P1|Overall Study|Other reason not defined above|5
5572556|NCT01090011|19259020|P1|Overall Study|Refusal to start/continue medication|5
5572557|NCT01090011|19259020|P1|Overall Study|Protocol Violation|1
5572558|NCT01090011|19259020|P1|Overall Study|Adverse Event|32
5572559|NCT01090011|19259020|P1|Overall Study|Progressive disease|128
5572560|NCT01089647|19259113|P2|Overall Study|Adverse Event|1
5572561|NCT01089647|19259114|P1|Overall Study|Adverse Event|0
5572562|NCT01089647|19259113|P2|Overall Study|Withdrawal by Subject|1
5572563|NCT01089647|19259114|P1|Overall Study|Withdrawal by Subject|2
5572564|NCT01089647|19259113|P2|Overall Study|Lost to Follow-up|2
5572565|NCT01089647|19259114|P1|Overall Study|Lost to Follow-up|2
5572566|NCT01089608|19259122|P2|Overall Study|Lost to Follow-up|2
5572567|NCT01089608|19259123|P1|Overall Study|Lost to Follow-up|0
5572568|NCT01089608|19259122|P2|Overall Study|Adverse Event|4
5572569|NCT01089608|19259123|P1|Overall Study|Adverse Event|0
5572570|NCT01089582|19259140|P1|Overall Study|Withdrawal by Subject|1
5572571|NCT01089582|19259140|P1|Overall Study|Other|4
5572572|NCT01089582|19259140|P1|Overall Study|Lost to Follow-up|8
5572573|NCT01089582|19259140|P1|Overall Study|Adverse Event|15
5572574|NCT01089582|19259140|P1|Overall Study|Death|2
5572575|NCT01089556|19259183|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
5572576|NCT01089556|19259184|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
5572577|NCT01089556|19259185|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
5572578|NCT01089556|19259186|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
5572579|NCT01089556|19259187|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
5572580|NCT01089556|19259188|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
5572581|NCT01089556|19259183|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
5572582|NCT01089556|19259184|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
5572583|NCT01089556|19259185|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
5572584|NCT01089556|19259186|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
5572585|NCT01089556|19259187|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
5572586|NCT01089556|19259188|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
5572587|NCT01089556|19259183|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
5572588|NCT01089556|19259184|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
5572589|NCT01089556|19259185|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
5572590|NCT01089556|19259186|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
5572591|NCT01089556|19259187|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
5572592|NCT01089556|19259188|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
5572593|NCT01089556|19259183|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5572594|NCT01089556|19259184|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5572595|NCT01089556|19259185|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5572596|NCT01089556|19259186|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
5572597|NCT01089556|19259187|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5572598|NCT01089556|19259188|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
5572599|NCT01089556|19259183|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5572600|NCT01089556|19259184|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
5572601|NCT01089556|19259185|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
5572602|NCT01089556|19259186|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5572603|NCT01089556|19259187|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5572604|NCT01089556|19259188|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
5572605|NCT01089556|19259183|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5572606|NCT01089556|19259184|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5572607|NCT01089556|19259185|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5572608|NCT01089556|19259186|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
5572609|NCT01089556|19259187|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
5572610|NCT01089556|19259188|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
5572611|NCT01089556|19259183|P6|Study Period III (Weeks 9-16)|Adverse Event|3
5572612|NCT01089556|19259184|P5|Study Period III (Weeks 9-16)|Adverse Event|4
5572613|NCT01089556|19259185|P4|Study Period III (Weeks 9-16)|Adverse Event|2
5572614|NCT01089556|19259186|P3|Study Period III (Weeks 9-16)|Adverse Event|4
5572615|NCT01089556|19259187|P2|Study Period III (Weeks 9-16)|Adverse Event|0
5572616|NCT01089556|19259188|P1|Study Period III (Weeks 9-16)|Adverse Event|0
5572617|NCT01089556|19259183|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
5572618|NCT01089556|19259184|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
5572619|NCT01089556|19259185|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
5572620|NCT01089556|19259186|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
5572621|NCT01089556|19259187|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
5572622|NCT01089556|19259188|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
5572623|NCT01089556|19259183|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5572624|NCT01089556|19259184|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5572625|NCT01089556|19259185|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5572626|NCT01089556|19259186|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
5572627|NCT01089556|19259187|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
5572628|NCT01089556|19259188|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
5572629|NCT01089556|19259183|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
5572630|NCT01089556|19259184|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
5572631|NCT01089556|19259185|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
5572632|NCT01089556|19259186|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
5572633|NCT01089556|19259187|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
5572634|NCT01089556|19259188|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
5572635|NCT01089556|19259183|P6|Study Period II (Weeks 1-8)|Physician Decision|0
5572636|NCT01089556|19259184|P5|Study Period II (Weeks 1-8)|Physician Decision|0
5572637|NCT01089556|19259185|P4|Study Period II (Weeks 1-8)|Physician Decision|0
5572638|NCT01089556|19259186|P3|Study Period II (Weeks 1-8)|Physician Decision|0
5572639|NCT01089556|19259187|P2|Study Period II (Weeks 1-8)|Physician Decision|0
5572640|NCT01089556|19259188|P1|Study Period II (Weeks 1-8)|Physician Decision|4
5572641|NCT01089556|19259183|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5572642|NCT01089556|19259184|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5572643|NCT01089556|19259185|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5572644|NCT01089556|19259186|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5572645|NCT01089556|19259187|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
5572646|NCT01089556|19259188|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
5572647|NCT01089556|19259183|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5572648|NCT01089556|19259184|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5572649|NCT01089556|19259185|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5572650|NCT01089556|19259186|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
5572651|NCT01089556|19259187|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
5572652|NCT01089556|19259188|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
5572653|NCT01089556|19259183|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5572654|NCT01089556|19259184|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5572655|NCT01089556|19259185|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5572656|NCT01089556|19259186|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
5572657|NCT01089556|19259187|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
5572658|NCT01089556|19259188|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
5572659|NCT01089556|19259183|P6|Study Period II (Weeks 1-8)|Adverse Event|0
5572660|NCT01089556|19259184|P5|Study Period II (Weeks 1-8)|Adverse Event|0
5572661|NCT01089556|19259185|P4|Study Period II (Weeks 1-8)|Adverse Event|0
5572662|NCT01089556|19259186|P3|Study Period II (Weeks 1-8)|Adverse Event|0
5572663|NCT01089556|19259187|P2|Study Period II (Weeks 1-8)|Adverse Event|39
5572664|NCT01089556|19259188|P1|Study Period II (Weeks 1-8)|Adverse Event|35
5572665|NCT01089543|19259262|P4|Overall Study|Adverse Event|0
5572666|NCT01089543|19259263|P3|Overall Study|Adverse Event|0
5572667|NCT01089543|19259264|P2|Overall Study|Adverse Event|1
5572668|NCT01089543|19259265|P1|Overall Study|Adverse Event|0
5572669|NCT01089543|19259262|P4|Overall Study|Physician Decision|1
5572670|NCT01089543|19259263|P3|Overall Study|Physician Decision|0
5572671|NCT01089543|19259264|P2|Overall Study|Physician Decision|0
5572672|NCT01089543|19259265|P1|Overall Study|Physician Decision|1
5572673|NCT01089543|19259262|P4|Overall Study|Withdrawal by Subject|1
5572674|NCT01089543|19259263|P3|Overall Study|Withdrawal by Subject|3
5572675|NCT01089543|19259264|P2|Overall Study|Withdrawal by Subject|3
5572676|NCT01089543|19259265|P1|Overall Study|Withdrawal by Subject|2
5572677|NCT01089504|19259300|P2|Overall Study|Withdrawal by Subject|0
5572678|NCT01089504|19259301|P1|Overall Study|Withdrawal by Subject|2
5572679|NCT01089504|19259300|P2|Overall Study|Lost to Follow-up|1
5572680|NCT01089504|19259301|P1|Overall Study|Lost to Follow-up|1
5572681|NCT01089413|19259314|P1|Overall Study|Other|71
5572682|NCT01089413|19259314|P1|Overall Study|Metastasectomy|13
5572683|NCT01089413|19259314|P1|Overall Study|Death|10
5572684|NCT01089413|19259314|P1|Overall Study|Unacceptable Toxicity|12
5572685|NCT01089413|19259314|P1|Overall Study|Participant Withdrew Consent|1
5572686|NCT01089413|19259314|P1|Overall Study|Progressive Disease|93
5572687|NCT01089413|19259314|P1|Overall Study|Lost to Follow-up|1
5572688|NCT01089361|19259333|P2|Overall Study|Death|0
5572689|NCT01089361|19259334|P1|Overall Study|Death|1
5572690|NCT01089127|19259383|P6|Overall Study|Protocol deviation|0
5572691|NCT01089127|19259384|P5|Overall Study|Protocol deviation|1
5572692|NCT01089127|19259385|P4|Overall Study|Protocol deviation|0
5572693|NCT01089127|19259386|P3|Overall Study|Protocol deviation|0
5572694|NCT01089127|19259387|P2|Overall Study|Protocol deviation|1
5572695|NCT01089127|19259388|P1|Overall Study|Protocol deviation|0
5572696|NCT01089127|19259383|P6|Overall Study|Lost to Follow-up|0
5572697|NCT01089127|19259384|P5|Overall Study|Lost to Follow-up|1
5572698|NCT01089127|19259385|P4|Overall Study|Lost to Follow-up|0
5572699|NCT01089127|19259386|P3|Overall Study|Lost to Follow-up|0
5572700|NCT01089127|19259387|P2|Overall Study|Lost to Follow-up|1
5572701|NCT01089127|19259388|P1|Overall Study|Lost to Follow-up|1
5572702|NCT01089127|19259383|P6|Overall Study|Abnormal test procedure result(s)|0
5572703|NCT01089127|19259384|P5|Overall Study|Abnormal test procedure result(s)|0
5572704|NCT01089127|19259385|P4|Overall Study|Abnormal test procedure result(s)|0
5572705|NCT01089127|19259386|P3|Overall Study|Abnormal test procedure result(s)|0
5572706|NCT01089127|19259387|P2|Overall Study|Abnormal test procedure result(s)|1
5572707|NCT01089127|19259388|P1|Overall Study|Abnormal test procedure result(s)|2
5572708|NCT01089127|19259383|P6|Overall Study|Subject withdrew consent|2
5572709|NCT01089127|19259384|P5|Overall Study|Subject withdrew consent|0
5572710|NCT01089127|19259385|P4|Overall Study|Subject withdrew consent|1
5572711|NCT01089127|19259386|P3|Overall Study|Subject withdrew consent|1
5572712|NCT01089127|19259387|P2|Overall Study|Subject withdrew consent|1
5572713|NCT01089127|19259388|P1|Overall Study|Subject withdrew consent|0
5572714|NCT01089127|19259383|P6|Overall Study|Adverse Event|1
5572715|NCT01089127|19259384|P5|Overall Study|Adverse Event|0
5572716|NCT01089127|19259385|P4|Overall Study|Adverse Event|0
5572717|NCT01089127|19259386|P3|Overall Study|Adverse Event|1
5572718|NCT01089127|19259387|P2|Overall Study|Adverse Event|1
5572719|NCT01089127|19259388|P1|Overall Study|Adverse Event|5
5572720|NCT01089023|19259442|P1|Overall Study|Lack of Efficacy|1
5572721|NCT01089023|19259442|P1|Overall Study|Protocol Violation|1
5572722|NCT01089023|19259442|P1|Overall Study|Withdrawal by Subject|1
5572723|NCT01089023|19259442|P1|Overall Study|Adverse Event|1
5572724|NCT01089023|19259442|P1|Overall Study|Lost to Follow-up|3
5572725|NCT01088997|19259456|P2|Overall Study|Excluded prior to receiving drug|1
5572726|NCT01088997|19259457|P1|Overall Study|Excluded prior to receiving drug|1
5572727|NCT01088997|19259456|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
5572728|NCT01088997|19259457|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
5572729|NCT01088997|19259456|P2|Overall Study|Physician Decision|1
5572730|NCT01088997|19259457|P1|Overall Study|Physician Decision|1
5572731|NCT01088984|19259468|P2|Phase 2|Other|1
5572732|NCT01088984|19259469|P1|Phase 2|Other|0
5572733|NCT01088984|19259468|P2|Phase 2|DIsease Progression|25
5572734|NCT01088984|19259469|P1|Phase 2|DIsease Progression|0
5572735|NCT01088984|19259468|P2|Phase 2|Withdrawal by Subject|1
5572736|NCT01088984|19259469|P1|Phase 2|Withdrawal by Subject|0
5572737|NCT01088984|19259468|P2|Phase 2|Death|5
5572738|NCT01088984|19259469|P1|Phase 2|Death|0
5572739|NCT01088984|19259468|P2|Phase 1|Other|1
5572740|NCT01088984|19259469|P1|Phase 1|Other|1
5572741|NCT01088984|19259468|P2|Phase 1|Disease Progression|4
5572742|NCT01088984|19259469|P1|Phase 1|Disease Progression|2
5572743|NCT01088984|19259468|P2|Phase 1|Death|1
5572744|NCT01088984|19259469|P1|Phase 1|Death|2
5572745|NCT01088529|19259540|P2|Overall Study|Did not receive study treatment|1
5572746|NCT01088529|19259541|P1|Overall Study|Did not receive study treatment|0
5572747|NCT01088503|19259554|P3|Overall Study|Death|7
5572748|NCT01088503|19259555|P2|Overall Study|Death|358
5572749|NCT01088503|19259556|P1|Overall Study|Death|64
5572750|NCT01088503|19259554|P3|Overall Study|Withdrawal by Subject|10
5572751|NCT01088503|19259555|P2|Overall Study|Withdrawal by Subject|327
5572752|NCT01088503|19259556|P1|Overall Study|Withdrawal by Subject|118
5572753|NCT01088438|19259634|P2|Overall Study|Lost to Follow-up|30
5572754|NCT01088438|19259635|P1|Overall Study|Lost to Follow-up|18
5572755|NCT01088438|19259634|P2|Overall Study|Withdrawal by Subject|6
5572756|NCT01088438|19259635|P1|Overall Study|Withdrawal by Subject|11
5572757|NCT01088412|19259648|P3|Overall Study|Study Summary Not Completed|22
5572758|NCT01088412|19259649|P2|Overall Study|Study Summary Not Completed|64
5572759|NCT01088412|19259650|P1|Overall Study|Study Summary Not Completed|4360
5572760|NCT01088412|19259648|P3|Overall Study|Lost to Follow-up|11
5572761|NCT01088412|19259649|P2|Overall Study|Lost to Follow-up|130
5572762|NCT01088412|19259650|P1|Overall Study|Lost to Follow-up|3052
5572763|NCT01088412|19259648|P3|Overall Study|Third Party Required to Change Brand|0
5572764|NCT01088412|19259649|P2|Overall Study|Third Party Required to Change Brand|0
5572765|NCT01088412|19259650|P1|Overall Study|Third Party Required to Change Brand|487
5572766|NCT01088412|19259648|P3|Overall Study|Sponsor Decision|23
5572767|NCT01088412|19259649|P2|Overall Study|Sponsor Decision|79
5572768|NCT01088412|19259650|P1|Overall Study|Sponsor Decision|4467
5572769|NCT01088412|19259648|P3|Overall Study|Physician Decision|4
5572770|NCT01088412|19259649|P2|Overall Study|Physician Decision|8
5572771|NCT01088412|19259650|P1|Overall Study|Physician Decision|1041
5572772|NCT01088412|19259648|P3|Overall Study|Participant Moved|2
5572773|NCT01088412|19259649|P2|Overall Study|Participant Moved|21
5572774|NCT01088412|19259650|P1|Overall Study|Participant Moved|601
5572775|NCT01088412|19259648|P3|Overall Study|Received Another GH Product|0
5572776|NCT01088412|19259649|P2|Overall Study|Received Another GH Product|0
5572777|NCT01088412|19259650|P1|Overall Study|Received Another GH Product|79
5572778|NCT01088412|19259648|P3|Overall Study|Withdrawal by Subject|1
5572779|NCT01088412|19259649|P2|Overall Study|Withdrawal by Subject|25
5572780|NCT01088412|19259650|P1|Overall Study|Withdrawal by Subject|1761
5572781|NCT01088412|19259648|P3|Overall Study|Other Reason per Case Report Form|9
5572782|NCT01088412|19259649|P2|Overall Study|Other Reason per Case Report Form|103
5572783|NCT01088412|19259650|P1|Overall Study|Other Reason per Case Report Form|2089
5572784|NCT01088412|19259648|P3|Overall Study|Death|0
5572785|NCT01088412|19259649|P2|Overall Study|Death|6
5572786|NCT01088412|19259650|P1|Overall Study|Death|42
5572787|NCT01088412|19259648|P3|Overall Study|Adverse Event|0
5572788|NCT01088412|19259649|P2|Overall Study|Adverse Event|0
5572789|NCT01088412|19259650|P1|Overall Study|Adverse Event|38
5572790|NCT01088399|19259669|P3|Overall Study|Study summary visit not completed|80
5572791|NCT01088399|19259670|P2|Overall Study|Study summary visit not completed|283
5572792|NCT01088399|19259671|P1|Overall Study|Study summary visit not completed|2398
5572793|NCT01088399|19259669|P3|Overall Study|Enrollment criteria not met|70
5572794|NCT01088399|19259670|P2|Overall Study|Enrollment criteria not met|119
5572795|NCT01088399|19259671|P1|Overall Study|Enrollment criteria not met|48
5572796|NCT01088399|19259669|P3|Overall Study|Protocol Violation|0
5572797|NCT01088399|19259670|P2|Overall Study|Protocol Violation|1
5572798|NCT01088399|19259671|P1|Overall Study|Protocol Violation|10
5572799|NCT01088399|19259669|P3|Overall Study|Sponsor decision|7
5572800|NCT01088399|19259670|P2|Overall Study|Sponsor decision|298
5572801|NCT01088399|19259671|P1|Overall Study|Sponsor decision|1573
5572802|NCT01088399|19259669|P3|Overall Study|Change to or start of somatropin therapy|12
5572803|NCT01088399|19259670|P2|Overall Study|Change to or start of somatropin therapy|17
5572804|NCT01088399|19259671|P1|Overall Study|Change to or start of somatropin therapy|234
5572805|NCT01088399|19259669|P3|Overall Study|Withdrawal by Subject|33
5572806|NCT01088399|19259670|P2|Overall Study|Withdrawal by Subject|195
5572807|NCT01088399|19259671|P1|Overall Study|Withdrawal by Subject|544
5572808|NCT01088399|19259669|P3|Overall Study|Physician Decision|16
5572809|NCT01088399|19259670|P2|Overall Study|Physician Decision|88
5572810|NCT01088399|19259671|P1|Overall Study|Physician Decision|531
5572811|NCT01088399|19259669|P3|Overall Study|Lost to Follow-up|58
5572812|NCT01088399|19259670|P2|Overall Study|Lost to Follow-up|278
5572813|NCT01088399|19259671|P1|Overall Study|Lost to Follow-up|1070
5572814|NCT01088399|19259669|P3|Overall Study|Lack of Efficacy|5
5572815|NCT01088399|19259670|P2|Overall Study|Lack of Efficacy|7
5572816|NCT01088399|19259671|P1|Overall Study|Lack of Efficacy|298
5572817|NCT01088399|19259669|P3|Overall Study|Death|0
5572818|NCT01088399|19259670|P2|Overall Study|Death|45
5572819|NCT01088399|19259671|P1|Overall Study|Death|204
5572820|NCT01088399|19259669|P3|Overall Study|Adverse Event|0
5572821|NCT01088399|19259670|P2|Overall Study|Adverse Event|16
5572822|NCT01088399|19259671|P1|Overall Study|Adverse Event|211
5572823|NCT01088243|19259700|P2|Overall Study|Adverse Event|0
5572824|NCT01088243|19259701|P1|Overall Study|Adverse Event|1
5572825|NCT01087970|19259742|P1|Overall Study|Protocol Violation|2
5572826|NCT01087957|19259754|P2|Overall Study|Physician Decision|9
5572827|NCT01087957|19259755|P1|Overall Study|Physician Decision|5
5572828|NCT01087957|19259754|P2|Overall Study|Withdrawal by Subject|15
5572829|NCT01087957|19259755|P1|Overall Study|Withdrawal by Subject|18
5572830|NCT01087957|19259754|P2|Overall Study|Protocol Violation|25
5572831|NCT01087957|19259755|P1|Overall Study|Protocol Violation|13
5572832|NCT01087957|19259754|P2|Overall Study|Lost to Follow-up|4
5572833|NCT01087957|19259755|P1|Overall Study|Lost to Follow-up|3
5572834|NCT01087957|19259754|P2|Overall Study|Death|2
5572835|NCT01087957|19259755|P1|Overall Study|Death|2
5572836|NCT01087944|19259781|P2|Period 2 (Week 4-6)|Adverse Event|2
5572837|NCT01087944|19259782|P1|Period 2 (Week 4-6)|Adverse Event|0
5572838|NCT01087944|19259781|P2|Period 1 (Week 1-3)|Adverse Event|0
5572839|NCT01087944|19259782|P1|Period 1 (Week 1-3)|Adverse Event|1
5572840|NCT01087905|19259862|P8|Overall Study|Withdrawal by Subject|5
5572841|NCT01087905|19259863|P7|Overall Study|Withdrawal by Subject|3
5572842|NCT01087905|19259864|P6|Overall Study|Withdrawal by Subject|3
5572843|NCT01087905|19259865|P5|Overall Study|Withdrawal by Subject|4
5572844|NCT01087905|19259866|P4|Overall Study|Withdrawal by Subject|5
5572845|NCT01087905|19259867|P3|Overall Study|Withdrawal by Subject|4
5572846|NCT01087905|19259868|P2|Overall Study|Withdrawal by Subject|4
5572847|NCT01087905|19259869|P1|Overall Study|Withdrawal by Subject|5
5572848|NCT01087905|19259862|P8|Overall Study|Lost to Follow-up|24
5572849|NCT01087905|19259863|P7|Overall Study|Lost to Follow-up|20
5572850|NCT01087905|19259864|P6|Overall Study|Lost to Follow-up|25
5572851|NCT01087905|19259865|P5|Overall Study|Lost to Follow-up|27
5572852|NCT01087905|19259866|P4|Overall Study|Lost to Follow-up|31
5572853|NCT01087905|19259867|P3|Overall Study|Lost to Follow-up|18
5572854|NCT01087905|19259868|P2|Overall Study|Lost to Follow-up|28
5572855|NCT01087905|19259869|P1|Overall Study|Lost to Follow-up|24
5572856|NCT01087814|19259891|P2|Second Intervention (5 Days)|Physician Decision|0
5572857|NCT01087814|19259892|P1|Second Intervention (5 Days)|Physician Decision|1
5572858|NCT01087814|19259891|P2|First Intervention (5 Days)|Withdrawal by Subject|1
5572859|NCT01087814|19259892|P1|First Intervention (5 Days)|Withdrawal by Subject|3
5572860|NCT01087788|19259910|P3|Open-Label Period (OL-P)|Personal reasons|1
5572861|NCT01087788|19259911|P2|Open-Label Period (OL-P)|Personal reasons|0
5572862|NCT01087788|19259912|P1|Open-Label Period (OL-P)|Personal reasons|0
5572863|NCT01087788|19259910|P3|Open-Label Period (OL-P)|No participation in study extension|1
5572864|NCT01087788|19259911|P2|Open-Label Period (OL-P)|No participation in study extension|0
5572865|NCT01087788|19259912|P1|Open-Label Period (OL-P)|No participation in study extension|0
5572866|NCT01087788|19259910|P3|Open-Label Period (OL-P)|Principal investigator decision|2
5572867|NCT01087788|19259911|P2|Open-Label Period (OL-P)|Principal investigator decision|1
5572868|NCT01087788|19259912|P1|Open-Label Period (OL-P)|Principal investigator decision|0
5572869|NCT01087788|19259910|P3|Open-Label Period (OL-P)|Sponsor request|0
5572870|NCT01087788|19259911|P2|Open-Label Period (OL-P)|Sponsor request|0
5572871|NCT01087788|19259912|P1|Open-Label Period (OL-P)|Sponsor request|1
5572872|NCT01087788|19259910|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
5572873|NCT01087788|19259911|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
5572874|NCT01087788|19259912|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
5572875|NCT01087788|19259910|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
5572876|NCT01087788|19259911|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
5572877|NCT01087788|19259912|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
5572878|NCT01087788|19259910|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
5572879|NCT01087788|19259911|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
5572880|NCT01087788|19259912|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
5572881|NCT01087788|19259910|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
5572882|NCT01087788|19259911|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
5572883|NCT01087788|19259912|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
5572884|NCT01087788|19259910|P3|Open-Label Period (OL-P)|AE, serious fatal|1
5572885|NCT01087788|19259911|P2|Open-Label Period (OL-P)|AE, serious fatal|0
5572886|NCT01087788|19259912|P1|Open-Label Period (OL-P)|AE, serious fatal|2
5572887|NCT01087788|19259910|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
5572888|NCT01087788|19259911|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
5572889|NCT01087788|19259912|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
5572890|NCT01087788|19259910|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
5572891|NCT01087788|19259911|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
5572892|NCT01087788|19259912|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
5572893|NCT01087788|19259910|P3|Open-Label Period (OL-P)|Protocol Violation|0
5572894|NCT01087788|19259911|P2|Open-Label Period (OL-P)|Protocol Violation|1
5572895|NCT01087788|19259912|P1|Open-Label Period (OL-P)|Protocol Violation|2
5572896|NCT01087788|19259910|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
5572897|NCT01087788|19259911|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
5572898|NCT01087788|19259912|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
5572899|NCT01087788|19259910|P3|24-weeks Dose-blind Period|Patient moved|1
5572900|NCT01087788|19259911|P2|24-weeks Dose-blind Period|Patient moved|0
5572901|NCT01087788|19259912|P1|24-weeks Dose-blind Period|Patient moved|0
5572902|NCT01087788|19259910|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
5572903|NCT01087788|19259911|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
5572904|NCT01087788|19259912|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
5572905|NCT01087788|19259910|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
5572906|NCT01087788|19259911|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
5572907|NCT01087788|19259912|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
5572908|NCT01087788|19259910|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
5572909|NCT01087788|19259911|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
5572910|NCT01087788|19259912|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
5572911|NCT01087788|19259910|P3|24-weeks Dose-blind Period|AE, serious fatal|0
5572912|NCT01087788|19259911|P2|24-weeks Dose-blind Period|AE, serious fatal|1
5572913|NCT01087788|19259912|P1|24-weeks Dose-blind Period|AE, serious fatal|0
5572914|NCT01087788|19259910|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
5572915|NCT01087788|19259911|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
5572916|NCT01087788|19259912|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
5572917|NCT01087788|19259910|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
5572918|NCT01087788|19259911|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
5572919|NCT01087788|19259912|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
5572920|NCT01087788|19259910|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
5572921|NCT01087788|19259911|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
5572922|NCT01087788|19259912|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
5572923|NCT01087788|19259910|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
5572924|NCT01087788|19259911|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
5572925|NCT01087788|19259912|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
5572926|NCT01087788|19259910|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
5572927|NCT01087788|19259911|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
5572928|NCT01087788|19259912|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
5572929|NCT01087788|19259910|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
5572930|NCT01087788|19259911|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
5572931|NCT01087788|19259912|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
5572932|NCT01087788|19259910|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
5572933|NCT01087788|19259911|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
5572934|NCT01087788|19259912|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
5572935|NCT01087788|19259910|P3|24-weeks Double-blind Period|AE, unknown type|1
5572936|NCT01087788|19259911|P2|24-weeks Double-blind Period|AE, unknown type|0
5572937|NCT01087788|19259912|P1|24-weeks Double-blind Period|AE, unknown type|0
5572938|NCT01087788|19259910|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
5572939|NCT01087788|19259911|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
5572940|NCT01087788|19259912|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
5572941|NCT01087788|19259910|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
5572942|NCT01087788|19259911|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
5572943|NCT01087788|19259912|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
5572944|NCT01087788|19259910|P3|24-weeks Double-blind Period|AE, serious fatal|1
5572945|NCT01087788|19259911|P2|24-weeks Double-blind Period|AE, serious fatal|1
5572946|NCT01087788|19259912|P1|24-weeks Double-blind Period|AE, serious fatal|0
5572947|NCT01087788|19259910|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
5572948|NCT01087788|19259911|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
5572949|NCT01087788|19259912|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
5572950|NCT01087788|19259910|P3|24-weeks Double-blind Period|Lost to Follow-up|1
5572951|NCT01087788|19259911|P2|24-weeks Double-blind Period|Lost to Follow-up|1
5572952|NCT01087788|19259912|P1|24-weeks Double-blind Period|Lost to Follow-up|4
5572953|NCT01087788|19259910|P3|24-weeks Double-blind Period|Protocol Violation|0
5572954|NCT01087788|19259911|P2|24-weeks Double-blind Period|Protocol Violation|1
5572955|NCT01087788|19259912|P1|24-weeks Double-blind Period|Protocol Violation|0
5572956|NCT01087788|19259910|P3|24-weeks Double-blind Period|Lack of Efficacy|1
5572957|NCT01087788|19259911|P2|24-weeks Double-blind Period|Lack of Efficacy|0
5572958|NCT01087788|19259912|P1|24-weeks Double-blind Period|Lack of Efficacy|2
5572959|NCT01087775|19259939|P1|Overall Study|failed inclusion criteria|2
5572960|NCT01087762|19259947|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
5572961|NCT01087762|19259948|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
5572962|NCT01087762|19259949|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
5572963|NCT01087762|19259950|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
5572964|NCT01087762|19259951|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
5572965|NCT01087762|19259947|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
5572966|NCT01087762|19259948|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
5572967|NCT01087762|19259949|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
5572968|NCT01087762|19259950|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
5572969|NCT01087762|19259951|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
5572970|NCT01087762|19259947|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
5572971|NCT01087762|19259948|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
5572972|NCT01087762|19259949|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
5572973|NCT01087762|19259950|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
5572974|NCT01087762|19259951|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
5572975|NCT01087762|19259947|P5|Open-Label Period (Weeks 48-204)|Other|4
5572976|NCT01087762|19259948|P4|Open-Label Period (Weeks 48-204)|Other|2
5572977|NCT01087762|19259949|P3|Open-Label Period (Weeks 48-204)|Other|0
5572978|NCT01087762|19259950|P2|Open-Label Period (Weeks 48-204)|Other|0
5572979|NCT01087762|19259951|P1|Open-Label Period (Weeks 48-204)|Other|0
5572980|NCT01087762|19259947|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
5572981|NCT01087762|19259948|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
5572982|NCT01087762|19259949|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
5572983|NCT01087762|19259950|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
5572984|NCT01087762|19259951|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
5572985|NCT01087762|19259947|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
5572986|NCT01087762|19259948|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
5572987|NCT01087762|19259949|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
5572988|NCT01087762|19259950|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
5572989|NCT01087762|19259951|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
5572990|NCT01087762|19259947|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
5572991|NCT01087762|19259948|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
5572992|NCT01087762|19259949|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
5572993|NCT01087762|19259950|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
5572994|NCT01087762|19259951|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
5572995|NCT01087762|19259947|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
5572996|NCT01087762|19259948|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
5572997|NCT01087762|19259949|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
5572998|NCT01087762|19259950|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
5572999|NCT01087762|19259951|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
5573000|NCT01087762|19259947|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
5573001|NCT01087762|19259948|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
5573002|NCT01087762|19259949|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
5573003|NCT01087762|19259950|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
5573004|NCT01087762|19259951|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
5573005|NCT01087762|19259947|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
5573006|NCT01087762|19259948|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
5573007|NCT01087762|19259949|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
5573008|NCT01087762|19259950|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
5573009|NCT01087762|19259951|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
5573010|NCT01087762|19259947|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
5573011|NCT01087762|19259948|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
5573012|NCT01087762|19259949|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
5573013|NCT01087762|19259950|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
5573014|NCT01087762|19259951|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
5573015|NCT01087762|19259947|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
5573016|NCT01087762|19259948|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
5573017|NCT01087762|19259949|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
5573018|NCT01087762|19259950|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
5573019|NCT01087762|19259951|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
5573020|NCT01087762|19259947|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
5573021|NCT01087762|19259948|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
5573022|NCT01087762|19259949|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
5573023|NCT01087762|19259950|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
5573024|NCT01087762|19259951|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
5573025|NCT01087736|19259999|P2|Overall Study|Withdrawal by Subject|1
5573026|NCT01087736|19260000|P1|Overall Study|Withdrawal by Subject|0
5573027|NCT01087736|19259999|P2|Overall Study|Death|1
5573028|NCT01087736|19260000|P1|Overall Study|Death|0
5573029|NCT01087736|19259999|P2|Overall Study|Lost to Follow-up|0
5573030|NCT01087736|19260000|P1|Overall Study|Lost to Follow-up|1
5573031|NCT01087723|19260010|P2|Overall Study|Reason Not Specified|2
5573032|NCT01087723|19260011|P1|Overall Study|Reason Not Specified|1
5573033|NCT01087723|19260010|P2|Overall Study|Lost to Follow-up|4
5573034|NCT01087723|19260011|P1|Overall Study|Lost to Follow-up|1
5573035|NCT01087723|19260010|P2|Overall Study|Physician Decision|0
5573036|NCT01087723|19260011|P1|Overall Study|Physician Decision|2
5573037|NCT01087723|19260010|P2|Overall Study|Withdrawal by Subject|13
5573038|NCT01087723|19260011|P1|Overall Study|Withdrawal by Subject|10
5573039|NCT01087723|19260010|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
5573040|NCT01087723|19260011|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
5573041|NCT01087528|19260052|P1|Overall Study|Incomplete CE procedure|6
5573042|NCT01087528|19260052|P1|Overall Study|Withdrawal by Subject|1
5573043|NCT01087502|19260064|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
5573044|NCT01087502|19260065|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
5573045|NCT01087502|19260064|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
5573046|NCT01087502|19260065|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
5573047|NCT01087502|19260064|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
5573048|NCT01087502|19260065|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
5573049|NCT01087502|19260064|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
5573050|NCT01087502|19260065|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
5573051|NCT01087502|19260064|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
5573052|NCT01087502|19260065|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
5573053|NCT01087502|19260064|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
5573054|NCT01087502|19260065|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
5573055|NCT01087502|19260064|P2|Up to Final Analysis (Week 52)|Adverse Event|10
5573056|NCT01087502|19260065|P1|Up to Final Analysis (Week 52)|Adverse Event|17
5573057|NCT01087502|19260064|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
5573058|NCT01087502|19260065|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
5573059|NCT01087502|19260064|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
5573060|NCT01087502|19260065|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
5573061|NCT01087502|19260064|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
5573062|NCT01087502|19260065|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
5573063|NCT01087502|19260064|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
5573064|NCT01087502|19260065|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
5573065|NCT01087502|19260064|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
5573066|NCT01087502|19260065|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
5573067|NCT01087489|19260084|P2|Overall Study|unable to survey by telephone|1
5573068|NCT01087489|19260085|P1|Overall Study|unable to survey by telephone|0
5573069|NCT01087489|19260084|P2|Overall Study|Death|1
5573070|NCT01087489|19260085|P1|Overall Study|Death|0
5573071|NCT01087489|19260084|P2|Overall Study|enrolled in another VA study|1
5573072|NCT01087489|19260085|P1|Overall Study|enrolled in another VA study|0
5573073|NCT01086969|19260098|P3|Overall Study|Withdrawal by Subject|0
5573074|NCT01086969|19260099|P2|Overall Study|Withdrawal by Subject|2
5573075|NCT01086969|19260100|P1|Overall Study|Withdrawal by Subject|1
5573076|NCT01086540|19260196|P2|Overall Study|Addition of new therapy for PAH|0
5573077|NCT01086540|19260197|P1|Overall Study|Addition of new therapy for PAH|1
5573078|NCT01086540|19260196|P2|Overall Study|Physician Decision|1
5573079|NCT01086540|19260197|P1|Overall Study|Physician Decision|2
5573080|NCT01086540|19260196|P2|Overall Study|Death|1
5573081|NCT01086540|19260197|P1|Overall Study|Death|3
5573082|NCT01086423|19260255|P3|Overall Study|Lost to Follow-up|1
5573083|NCT01086423|19260256|P2|Overall Study|Lost to Follow-up|0
5573084|NCT01086423|19260257|P1|Overall Study|Lost to Follow-up|0
5573085|NCT01086423|19260255|P3|Overall Study|Withdrawal by Subject|3
5573086|NCT01086423|19260256|P2|Overall Study|Withdrawal by Subject|1
5573087|NCT01086423|19260257|P1|Overall Study|Withdrawal by Subject|5
5573088|NCT01086423|19260255|P3|Overall Study|Adverse event, non-fatal|0
5573089|NCT01086423|19260256|P2|Overall Study|Adverse event, non-fatal|1
5573090|NCT01086423|19260257|P1|Overall Study|Adverse event, non-fatal|2
5573091|NCT01086423|19260255|P3|Overall Study|Adverse event, fatal|0
5573092|NCT01086423|19260256|P2|Overall Study|Adverse event, fatal|1
5573093|NCT01086423|19260257|P1|Overall Study|Adverse event, fatal|1
5573094|NCT01086423|19260255|P3|Overall Study|Migrated/moved from study area|4
5573095|NCT01086423|19260256|P2|Overall Study|Migrated/moved from study area|0
5573096|NCT01086423|19260257|P1|Overall Study|Migrated/moved from study area|2
5573097|NCT01086423|19260255|P3|Overall Study|Protocol Violation|1
5573098|NCT01086423|19260256|P2|Overall Study|Protocol Violation|0
5573099|NCT01086423|19260257|P1|Overall Study|Protocol Violation|0
5573100|NCT01086410|19260302|P4|Overall Study|Lost to Follow-up|0
5573101|NCT01086410|19260303|P3|Overall Study|Lost to Follow-up|1
5573102|NCT01086410|19260304|P2|Overall Study|Lost to Follow-up|0
5573103|NCT01086410|19260305|P1|Overall Study|Lost to Follow-up|0
5573104|NCT01086410|19260302|P4|Overall Study|Protocol Violation|0
5573105|NCT01086410|19260303|P3|Overall Study|Protocol Violation|0
5573106|NCT01086410|19260304|P2|Overall Study|Protocol Violation|1
5573107|NCT01086410|19260305|P1|Overall Study|Protocol Violation|1
5573108|NCT01086410|19260302|P4|Overall Study|Lack of Efficacy|0
5573109|NCT01086410|19260303|P3|Overall Study|Lack of Efficacy|0
5573110|NCT01086410|19260304|P2|Overall Study|Lack of Efficacy|1
5573111|NCT01086410|19260305|P1|Overall Study|Lack of Efficacy|1
5573112|NCT01086410|19260302|P4|Overall Study|Adverse Event|2
5573113|NCT01086410|19260303|P3|Overall Study|Adverse Event|0
5573114|NCT01086410|19260304|P2|Overall Study|Adverse Event|0
5573115|NCT01086410|19260305|P1|Overall Study|Adverse Event|1
5573116|NCT01086384|19260401|P3|Treatment Period|Received Treatment in Error|0
5573117|NCT01086384|19260402|P2|Treatment Period|Received Treatment in Error|1
5573118|NCT01086384|19260403|P1|Treatment Period|Received Treatment in Error|0
5573119|NCT01086384|19260401|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
5573120|NCT01086384|19260402|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
5573121|NCT01086384|19260403|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
5573122|NCT01086384|19260401|P3|Treatment Period|Study Closed/Terminated|8
5573123|NCT01086384|19260402|P2|Treatment Period|Study Closed/Terminated|7
5573124|NCT01086384|19260403|P1|Treatment Period|Study Closed/Terminated|0
5573125|NCT01086384|19260401|P3|Treatment Period|Physician Decision|6
5573126|NCT01086384|19260402|P2|Treatment Period|Physician Decision|9
5573127|NCT01086384|19260403|P1|Treatment Period|Physician Decision|0
5573128|NCT01086384|19260401|P3|Treatment Period|Lost to Follow-up|9
5573129|NCT01086384|19260402|P2|Treatment Period|Lost to Follow-up|11
5573130|NCT01086384|19260403|P1|Treatment Period|Lost to Follow-up|0
5573131|NCT01086384|19260401|P3|Treatment Period|Adverse Event|15
5573132|NCT01086384|19260402|P2|Treatment Period|Adverse Event|19
5573133|NCT01086384|19260403|P1|Treatment Period|Adverse Event|0
5573134|NCT01086384|19260401|P3|Treatment Period|Lack of Efficacy|13
5573135|NCT01086384|19260402|P2|Treatment Period|Lack of Efficacy|22
5573136|NCT01086384|19260403|P1|Treatment Period|Lack of Efficacy|0
5573137|NCT01086384|19260401|P3|Treatment Period|Protocol Violation|17
5573138|NCT01086384|19260402|P2|Treatment Period|Protocol Violation|26
5573139|NCT01086384|19260403|P1|Treatment Period|Protocol Violation|0
5573140|NCT01086384|19260401|P3|Treatment Period|Withdrawal by Subject|55
5573141|NCT01086384|19260402|P2|Treatment Period|Withdrawal by Subject|53
5573142|NCT01086384|19260403|P1|Treatment Period|Withdrawal by Subject|0
5573143|NCT01086384|19260401|P3|2-week Run-in Period|Randomized in Error|0
5573144|NCT01086384|19260402|P2|2-week Run-in Period|Randomized in Error|0
5573145|NCT01086384|19260403|P1|2-week Run-in Period|Randomized in Error|1
5573146|NCT01086384|19260401|P3|2-week Run-in Period|Continuation Criteria Not Met|0
5573147|NCT01086384|19260402|P2|2-week Run-in Period|Continuation Criteria Not Met|0
5573148|NCT01086384|19260403|P1|2-week Run-in Period|Continuation Criteria Not Met|92
5573149|NCT01086384|19260401|P3|2-week Run-in Period|Study Closed/Terminated|0
5573150|NCT01086384|19260402|P2|2-week Run-in Period|Study Closed/Terminated|0
5573151|NCT01086384|19260403|P1|2-week Run-in Period|Study Closed/Terminated|42
5573152|NCT01086384|19260401|P3|2-week Run-in Period|Withdrawal by Subject|0
5573153|NCT01086384|19260402|P2|2-week Run-in Period|Withdrawal by Subject|0
5573154|NCT01086384|19260403|P1|2-week Run-in Period|Withdrawal by Subject|19
5573155|NCT01086384|19260401|P3|2-week Run-in Period|Physician Decision|0
5573156|NCT01086384|19260402|P2|2-week Run-in Period|Physician Decision|0
5573157|NCT01086384|19260403|P1|2-week Run-in Period|Physician Decision|6
5573158|NCT01086384|19260401|P3|2-week Run-in Period|Lost to Follow-up|0
5573159|NCT01086384|19260402|P2|2-week Run-in Period|Lost to Follow-up|0
5573160|NCT01086384|19260403|P1|2-week Run-in Period|Lost to Follow-up|1
5573161|NCT01086384|19260401|P3|2-week Run-in Period|Protocol Violation|0
5573162|NCT01086384|19260402|P2|2-week Run-in Period|Protocol Violation|0
5573163|NCT01086384|19260403|P1|2-week Run-in Period|Protocol Violation|1
5573164|NCT01086384|19260401|P3|2-week Run-in Period|Adverse Event|0
5573165|NCT01086384|19260402|P2|2-week Run-in Period|Adverse Event|0
5573166|NCT01086384|19260403|P1|2-week Run-in Period|Adverse Event|1
5573167|NCT01086358|19260413|P2|Second Intervention|Lost to Follow-up|4
5573168|NCT01086358|19260414|P1|Second Intervention|Lost to Follow-up|4
5573169|NCT01086358|19260413|P2|First Intervention|Withdrawal by Subject|1
5573170|NCT01086358|19260414|P1|First Intervention|Withdrawal by Subject|0
5573171|NCT01086358|19260413|P2|First Intervention|Lost to Follow-up|4
5573172|NCT01086358|19260414|P1|First Intervention|Lost to Follow-up|9
5573173|NCT01086215|19260484|P4|Overall Study|Lost to Follow-up|2
5573174|NCT01086215|19260485|P3|Overall Study|Lost to Follow-up|18
5573175|NCT01086215|19260486|P2|Overall Study|Lost to Follow-up|39
5573176|NCT01086215|19260487|P1|Overall Study|Lost to Follow-up|22
5573177|NCT01086215|19260484|P4|Overall Study|Death|1
5573178|NCT01086215|19260485|P3|Overall Study|Death|8
5573179|NCT01086215|19260486|P2|Overall Study|Death|8
5573180|NCT01086215|19260487|P1|Overall Study|Death|14
5573181|NCT01086150|19260508|P3|Overall Study|Screen Failure|0
5573182|NCT01086150|19260509|P2|Overall Study|Screen Failure|1
5573183|NCT01086150|19260510|P1|Overall Study|Screen Failure|0
5573184|NCT01086150|19260508|P3|Overall Study|Lost to Follow-up|0
5573185|NCT01086150|19260509|P2|Overall Study|Lost to Follow-up|1
5573186|NCT01086150|19260510|P1|Overall Study|Lost to Follow-up|0
5573187|NCT01086150|19260508|P3|Overall Study|Withdrawal by Subject|1
5573188|NCT01086150|19260509|P2|Overall Study|Withdrawal by Subject|4
5573189|NCT01086150|19260510|P1|Overall Study|Withdrawal by Subject|0
5573190|NCT01086033|19260521|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
5573191|NCT01086033|19260521|P1|Overall Study|AE and Other Reason|1
5573192|NCT01086033|19260521|P1|Overall Study|AE and Lost to Follow-up|1
5573193|NCT01086033|19260521|P1|Overall Study|Death|1
5573194|NCT01086033|19260521|P1|Overall Study|AE and Lack of Efficacy|4
5573195|NCT01086033|19260521|P1|Overall Study|Withdrew consent and Other Reason|4
5573196|NCT01086033|19260521|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
5573197|NCT01086033|19260521|P1|Overall Study|AE and Withdrew Consent|5
5573198|NCT01086033|19260521|P1|Overall Study|Other|13
5573199|NCT01086033|19260521|P1|Overall Study|Other|14
5573200|NCT01086033|19260521|P1|Overall Study|Withdrawal by Subject|41
5573201|NCT01086033|19260521|P1|Overall Study|Adverse Event|42
5573202|NCT01086033|19260521|P1|Overall Study|Lost to Follow-up|86
5573203|NCT01086033|19260521|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
5573204|NCT01085812|19260587|P2|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
5573205|NCT01085812|19260588|P1|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
5573206|NCT01085812|19260587|P2|Double-blind Intent-to-treat Population|Lost to Follow-up|17
5573207|NCT01085812|19260588|P1|Double-blind Intent-to-treat Population|Lost to Follow-up|4
5573208|NCT01085812|19260587|P2|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
5573209|NCT01085812|19260588|P1|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
5573210|NCT01085812|19260587|P2|Double-blind Intent-to-treat Population|Protocol Violation|7
5573211|NCT01085812|19260588|P1|Double-blind Intent-to-treat Population|Protocol Violation|2
5573212|NCT01085812|19260587|P2|Double-blind Intent-to-treat Population|Adverse Event|8
5573213|NCT01085812|19260588|P1|Double-blind Intent-to-treat Population|Adverse Event|3
5573214|NCT01085812|19260587|P2|Double-Blind Period|Other Reasons|2
5573215|NCT01085812|19260588|P1|Double-Blind Period|Other Reasons|0
5573216|NCT01085812|19260587|P2|Double-Blind Period|Lost to Follow-up|17
5573217|NCT01085812|19260588|P1|Double-Blind Period|Lost to Follow-up|5
5573218|NCT01085812|19260587|P2|Double-Blind Period|Withdrawal by Subject|24
5573219|NCT01085812|19260588|P1|Double-Blind Period|Withdrawal by Subject|11
5573220|NCT01085812|19260587|P2|Double-Blind Period|Protocol Violation|7
5573221|NCT01085812|19260588|P1|Double-Blind Period|Protocol Violation|2
5573222|NCT01085812|19260587|P2|Double-Blind Period|Adverse Event|8
5573223|NCT01085812|19260588|P1|Double-Blind Period|Adverse Event|3
5573224|NCT01085812|19260587|P2|Open-Label Period|Lost to Follow-up|42
5573225|NCT01085812|19260588|P1|Open-Label Period|Lost to Follow-up|0
5573226|NCT01085812|19260587|P2|Open-Label Period|Withdrawal by Subject|53
5573227|NCT01085812|19260588|P1|Open-Label Period|Withdrawal by Subject|0
5573228|NCT01085812|19260587|P2|Open-Label Period|Protocol Violation|39
5573229|NCT01085812|19260588|P1|Open-Label Period|Protocol Violation|0
5573230|NCT01085812|19260587|P2|Open-Label Period|Lack of Efficacy|26
5573231|NCT01085812|19260588|P1|Open-Label Period|Lack of Efficacy|0
5573232|NCT01085812|19260587|P2|Open-Label Period|Adverse Event|80
5573233|NCT01085812|19260588|P1|Open-Label Period|Adverse Event|0
5573234|NCT01085734|19260635|P2|Overall Study|Withdrawal by Subject|1
5573235|NCT01085734|19260636|P1|Overall Study|Withdrawal by Subject|0
5573236|NCT01085734|19260635|P2|Overall Study|Lost to Follow-up|1
5573237|NCT01085734|19260636|P1|Overall Study|Lost to Follow-up|0
5573238|NCT01085734|19260635|P2|Overall Study|Death|0
5573239|NCT01085734|19260636|P1|Overall Study|Death|1
5573240|NCT01085734|19260635|P2|Overall Study|Adverse Event|2
5573241|NCT01085734|19260636|P1|Overall Study|Adverse Event|0
5573242|NCT01085682|19260648|P2|Overall Study|Withdrawal by Subject|25
5573243|NCT01085682|19260649|P1|Overall Study|Withdrawal by Subject|25
5573244|NCT01085630|19260666|P2|Overall Study|Ineligible|0
5573245|NCT01085630|19260667|P1|Overall Study|Ineligible|3
5573246|NCT01085630|19260666|P2|Overall Study|Insufficient data|0
5573247|NCT01085630|19260667|P1|Overall Study|Insufficient data|1
5573248|NCT01085591|19260680|P3|Overall Study|Not Properly Consented|0
5573249|NCT01085591|19260681|P2|Overall Study|Not Properly Consented|0
5573250|NCT01085591|19260682|P1|Overall Study|Not Properly Consented|1
5573251|NCT01085591|19260680|P3|Overall Study|Other|0
5573252|NCT01085591|19260681|P2|Overall Study|Other|1
5573253|NCT01085591|19260682|P1|Overall Study|Other|0
5573254|NCT01085591|19260680|P3|Overall Study|Protocol Violation|1
5573255|NCT01085591|19260681|P2|Overall Study|Protocol Violation|1
5573256|NCT01085591|19260682|P1|Overall Study|Protocol Violation|1
5573257|NCT01085591|19260680|P3|Overall Study|Lost to Follow-up|1
5573258|NCT01085591|19260681|P2|Overall Study|Lost to Follow-up|1
5573259|NCT01085591|19260682|P1|Overall Study|Lost to Follow-up|0
5573260|NCT01085591|19260680|P3|Overall Study|Withdrawal by Subject|1
5573261|NCT01085591|19260681|P2|Overall Study|Withdrawal by Subject|2
5573262|NCT01085591|19260682|P1|Overall Study|Withdrawal by Subject|0
5573263|NCT01085591|19260680|P3|Overall Study|Physician Decision|1
5573264|NCT01085591|19260681|P2|Overall Study|Physician Decision|0
5573265|NCT01085591|19260682|P1|Overall Study|Physician Decision|1
5573266|NCT01085591|19260680|P3|Overall Study|Adverse Event|3
5573267|NCT01085591|19260681|P2|Overall Study|Adverse Event|1
5573268|NCT01085591|19260682|P1|Overall Study|Adverse Event|0
5573269|NCT01085357|19260735|P2|Overall Study|Lost to Follow-up|0
5573270|NCT01085357|19260736|P1|Overall Study|Lost to Follow-up|2
5573271|NCT01085357|19260735|P2|Overall Study|Death|1
5573272|NCT01085357|19260736|P1|Overall Study|Death|11
5573273|NCT01085357|19260735|P2|Overall Study|Investigator Decision|1
5573274|NCT01085357|19260736|P1|Overall Study|Investigator Decision|1
5573275|NCT01085357|19260735|P2|Overall Study|Subject Decision|3
5573276|NCT01085357|19260736|P1|Overall Study|Subject Decision|4
5573277|NCT01085357|19260735|P2|Overall Study|Adverse Event|1
5573278|NCT01085357|19260736|P1|Overall Study|Adverse Event|1
5573279|NCT01085214|19260809|P1|Overall Study|Alternate treatment required|1
5573280|NCT01085201|19260821|P5|Overall Study|Fond ineligible after consent|0
5573281|NCT01085201|19260822|P4|Overall Study|Fond ineligible after consent|0
5573282|NCT01085201|19260823|P3|Overall Study|Fond ineligible after consent|1
5573283|NCT01085201|19260824|P2|Overall Study|Fond ineligible after consent|1
5573284|NCT01085201|19260825|P1|Overall Study|Fond ineligible after consent|0
5573285|NCT01085201|19260821|P5|Overall Study|Unknown- no study drug|0
5573286|NCT01085201|19260822|P4|Overall Study|Unknown- no study drug|0
5573287|NCT01085201|19260823|P3|Overall Study|Unknown- no study drug|0
5573288|NCT01085201|19260824|P2|Overall Study|Unknown- no study drug|0
5573289|NCT01085201|19260825|P1|Overall Study|Unknown- no study drug|2
5573290|NCT01085201|19260821|P5|Overall Study|Scheduling conflict|0
5573291|NCT01085201|19260822|P4|Overall Study|Scheduling conflict|0
5573292|NCT01085201|19260823|P3|Overall Study|Scheduling conflict|1
5573293|NCT01085201|19260824|P2|Overall Study|Scheduling conflict|0
5573294|NCT01085201|19260825|P1|Overall Study|Scheduling conflict|1
5573295|NCT01085136|19260847|P3|Part B|Other reason not defined above|3
5573296|NCT01085136|19260848|P2|Part B|Other reason not defined above|6
5573297|NCT01085136|19260849|P1|Part B|Other reason not defined above|0
5573298|NCT01085136|19260847|P3|Part B|Not treated|8
5573299|NCT01085136|19260848|P2|Part B|Not treated|4
5573300|NCT01085136|19260849|P1|Part B|Not treated|0
5573301|NCT01085136|19260847|P3|Part B|Refusal to continue trial medication|7
5573302|NCT01085136|19260848|P2|Part B|Refusal to continue trial medication|12
5573303|NCT01085136|19260849|P1|Part B|Refusal to continue trial medication|0
5573304|NCT01085136|19260847|P3|Part B|Other AE|8
5573305|NCT01085136|19260848|P2|Part B|Other AE|29
5573306|NCT01085136|19260849|P1|Part B|Other AE|0
5573307|NCT01085136|19260847|P3|Part A|Other reason not defined above|0
5573308|NCT01085136|19260848|P2|Part A|Other reason not defined above|0
5573309|NCT01085136|19260849|P1|Part A|Other reason not defined above|30
5573310|NCT01085136|19260847|P3|Part A|Refusal to continue trial medication|0
5573311|NCT01085136|19260848|P2|Part A|Refusal to continue trial medication|0
5573312|NCT01085136|19260849|P1|Part A|Refusal to continue trial medication|64
5573313|NCT01085136|19260847|P3|Part A|Lost to Follow-up|0
5573314|NCT01085136|19260848|P2|Part A|Lost to Follow-up|0
5573315|NCT01085136|19260849|P1|Part A|Lost to Follow-up|3
5573316|NCT01085136|19260847|P3|Part A|Protocol Violation|0
5573317|NCT01085136|19260848|P2|Part A|Protocol Violation|0
5573318|NCT01085136|19260849|P1|Part A|Protocol Violation|3
5573319|NCT01085136|19260847|P3|Part A|Other Adverse event|0
5573320|NCT01085136|19260848|P2|Part A|Other Adverse event|0
5573321|NCT01085136|19260849|P1|Part A|Other Adverse event|223
5573322|NCT01085045|19260865|P1|Part B|Adverse Event|6
5573323|NCT01085045|19260865|P1|Part B|Lost to Follow-up|1
5573324|NCT01085045|19260865|P1|Part B|Protocol Specified Criteria|6
5573325|NCT01085045|19260865|P1|Part B|Withdrawal by Subject|2
5573326|NCT01085045|19260865|P1|Part A|Protocol Specified Criteria|7
5573327|NCT01085045|19260865|P1|Part A|Protocol Violation|1
5573328|NCT01085045|19260865|P1|Part A|Adverse Event|6
5573329|NCT01085045|19260865|P1|Part A|Withdrawal by Subject|4
5573330|NCT01084772|19260976|P2|2 Years|Study Termination|2
5573331|NCT01084772|19260977|P1|2 Years|Study Termination|3
5573332|NCT01084772|19260976|P2|2 Years|Lost to Follow-up|2
5573333|NCT01084772|19260977|P1|2 Years|Lost to Follow-up|5
5573334|NCT01084772|19260976|P2|2 Years|Withdrawal by Subject|0
5573335|NCT01084772|19260977|P1|2 Years|Withdrawal by Subject|1
5573336|NCT01084772|19260976|P2|1 Year|Study Termination|7
5573337|NCT01084772|19260977|P1|1 Year|Study Termination|0
5573338|NCT01084772|19260976|P2|1 Year|Lost to Follow-up|0
5573339|NCT01084772|19260977|P1|1 Year|Lost to Follow-up|3
5573340|NCT01084772|19260976|P2|1 Year|Withdrawal by Subject|1
5573341|NCT01084772|19260977|P1|1 Year|Withdrawal by Subject|0
5573342|NCT01084772|19260976|P2|3 Months|Study Termination|2
5573343|NCT01084772|19260977|P1|3 Months|Study Termination|2
5573344|NCT01084772|19260976|P2|3 Months|Death|0
5573345|NCT01084772|19260977|P1|3 Months|Death|1
5573346|NCT01084772|19260976|P2|Baseline|Withdrawal by Subject|6
5573347|NCT01084772|19260977|P1|Baseline|Withdrawal by Subject|7
5573348|NCT01084707|19261013|P1|Overall Study|Withdrawal by Subject|6
5573349|NCT01084694|19261049|P2|Overall Study|eligibility not maintained|7
5573350|NCT01084694|19261050|P1|Overall Study|eligibility not maintained|2
5573351|NCT01084694|19261049|P2|Overall Study|Death|12
5573352|NCT01084694|19261050|P1|Overall Study|Death|2
5573353|NCT01084694|19261049|P2|Overall Study|Withdrawal by Subject|1
5573354|NCT01084694|19261050|P1|Overall Study|Withdrawal by Subject|2
5573355|NCT01084668|19261066|P1|Overall Study|Non-compliance|1
5573356|NCT01084668|19261066|P1|Overall Study|Pregnancy|1
5573357|NCT01084668|19261066|P1|Overall Study|Withdrawal by Subject|2
5573358|NCT01084668|19261066|P1|Overall Study|Lack of Efficacy|5
5573359|NCT01084655|19261078|P3|Overall Study|Prostate-specificAntigen(PSA)progression|1
5573360|NCT01084655|19261079|P2|Overall Study|Prostate-specificAntigen(PSA)progression|0
5573361|NCT01084655|19261080|P1|Overall Study|Prostate-specificAntigen(PSA)progression|0
5573362|NCT01084655|19261078|P3|Overall Study|Symptomatic deterioration|2
5573363|NCT01084655|19261079|P2|Overall Study|Symptomatic deterioration|0
5573364|NCT01084655|19261080|P1|Overall Study|Symptomatic deterioration|0
5573365|NCT01084655|19261078|P3|Overall Study|Other|2
5573366|NCT01084655|19261079|P2|Overall Study|Other|3
5573367|NCT01084655|19261080|P1|Overall Study|Other|0
5573368|NCT01084655|19261078|P3|Overall Study|Adverse Event|2
5573369|NCT01084655|19261079|P2|Overall Study|Adverse Event|1
5573370|NCT01084655|19261080|P1|Overall Study|Adverse Event|2
5573371|NCT01084655|19261078|P3|Overall Study|Withdrawal by Subject|4
5573372|NCT01084655|19261079|P2|Overall Study|Withdrawal by Subject|0
5573373|NCT01084655|19261080|P1|Overall Study|Withdrawal by Subject|1
5573374|NCT01084655|19261078|P3|Overall Study|Radiographic disease progression|8
5573375|NCT01084655|19261079|P2|Overall Study|Radiographic disease progression|2
5573376|NCT01084655|19261080|P1|Overall Study|Radiographic disease progression|3
5573377|NCT01084603|19261115|P1|Washout Period 4|Adverse Event|1
5573378|NCT01084603|19261115|P1|Oral Nicotine 1|Withdrawal by Subject|1
5573379|NCT01084603|19261115|P1|Nicorette® Gum|Withdrawal by Subject|1
5573380|NCT01084603|19261115|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
5573381|NCT01084603|19261115|P1|Baseline|Withdrawal by Subject|2
5573382|NCT01084551|19261151|P3|Overall Study|Physician Decision|0
5573383|NCT01084551|19261152|P2|Overall Study|Physician Decision|0
5573384|NCT01084551|19261153|P1|Overall Study|Physician Decision|1
5573385|NCT01084551|19261151|P3|Overall Study|Lost to Follow-up|3
5573386|NCT01084551|19261152|P2|Overall Study|Lost to Follow-up|0
5573387|NCT01084551|19261153|P1|Overall Study|Lost to Follow-up|0
5573388|NCT01084551|19261151|P3|Overall Study|Protocol Violation|0
5573389|NCT01084551|19261152|P2|Overall Study|Protocol Violation|4
5573390|NCT01084551|19261153|P1|Overall Study|Protocol Violation|2
5573391|NCT01084551|19261151|P3|Overall Study|Withdrawal by Subject|0
5573392|NCT01084551|19261152|P2|Overall Study|Withdrawal by Subject|1
5573393|NCT01084551|19261153|P1|Overall Study|Withdrawal by Subject|2
5573394|NCT01084551|19261151|P3|Overall Study|Lack of Efficacy|1
5573395|NCT01084551|19261152|P2|Overall Study|Lack of Efficacy|0
5573396|NCT01084551|19261153|P1|Overall Study|Lack of Efficacy|2
5573397|NCT01084551|19261151|P3|Overall Study|Adverse Event|4
5573398|NCT01084551|19261152|P2|Overall Study|Adverse Event|9
5573399|NCT01084551|19261153|P1|Overall Study|Adverse Event|2
5573400|NCT01084538|19261191|P1|Overall Study|Reason unknown|8
5573401|NCT01084538|19261191|P1|Overall Study|Over-suppression of parathyroid gland|2
5573402|NCT01084538|19261191|P1|Overall Study|Change of residence|2
5573403|NCT01084538|19261191|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
5573404|NCT01084538|19261191|P1|Overall Study|Hyperphosphatemia|2
5573405|NCT01084538|19261191|P1|Overall Study|Patient noncompliance|2
5573406|NCT01084538|19261191|P1|Overall Study|Lack of effectiveness|2
5573407|NCT01084538|19261191|P1|Overall Study|Serious Adverse Event|3
5573408|NCT01084538|19261191|P1|Overall Study|Kidney transplant|6
5573409|NCT01084538|19261191|P1|Overall Study|Adverse Event|9
5573410|NCT01084538|19261191|P1|Overall Study|Drug not available|30
5573411|NCT01084252|19261325|P14|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573412|NCT01084252|19261326|P13|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
5573413|NCT01084252|19261327|P12|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573414|NCT01084252|19261328|P11|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573415|NCT01084252|19261329|P10|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573416|NCT01084252|19261330|P9|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573417|NCT01084252|19261331|P8|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573418|NCT01084252|19261332|P7|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573419|NCT01084252|19261333|P6|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573420|NCT01084252|19261334|P5|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573421|NCT01084252|19261335|P4|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573422|NCT01084252|19261336|P3|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573423|NCT01084252|19261337|P2|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573424|NCT01084252|19261338|P1|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
5573425|NCT01084252|19261325|P14|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
5573426|NCT01084252|19261326|P13|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
5573427|NCT01084252|19261327|P12|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573428|NCT01084252|19261328|P11|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573429|NCT01084252|19261329|P10|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573430|NCT01084252|19261330|P9|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573431|NCT01084252|19261331|P8|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573432|NCT01084252|19261332|P7|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573433|NCT01084252|19261333|P6|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573434|NCT01084252|19261334|P5|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573435|NCT01084252|19261335|P4|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573436|NCT01084252|19261336|P3|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573437|NCT01084252|19261337|P2|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573438|NCT01084252|19261338|P1|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
5573439|NCT01084252|19261325|P14|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
5573440|NCT01084252|19261326|P13|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
5573441|NCT01084252|19261327|P12|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573442|NCT01084252|19261328|P11|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573443|NCT01084252|19261329|P10|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573444|NCT01084252|19261330|P9|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573445|NCT01084252|19261331|P8|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573446|NCT01084252|19261332|P7|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573447|NCT01084252|19261333|P6|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573448|NCT01084252|19261334|P5|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573449|NCT01084252|19261335|P4|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573450|NCT01084252|19261336|P3|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573451|NCT01084252|19261337|P2|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573452|NCT01084252|19261338|P1|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
5573453|NCT01084252|19261325|P14|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573454|NCT01084252|19261326|P13|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
5573455|NCT01084252|19261327|P12|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573456|NCT01084252|19261328|P11|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573457|NCT01084252|19261329|P10|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573458|NCT01084252|19261330|P9|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573459|NCT01084252|19261331|P8|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573460|NCT01084252|19261332|P7|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573461|NCT01084252|19261333|P6|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573462|NCT01084252|19261334|P5|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573463|NCT01084252|19261335|P4|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573464|NCT01084252|19261336|P3|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573465|NCT01084252|19261337|P2|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573466|NCT01084252|19261338|P1|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
5573467|NCT01084252|19261325|P14|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
5573468|NCT01084252|19261326|P13|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
5573469|NCT01084252|19261327|P12|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573470|NCT01084252|19261328|P11|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573471|NCT01084252|19261329|P10|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573626|NCT01083810|19261676|P3|Overall Study|Co-morbidities|0
5573472|NCT01084252|19261330|P9|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573473|NCT01084252|19261331|P8|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573474|NCT01084252|19261332|P7|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573475|NCT01084252|19261333|P6|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573476|NCT01084252|19261334|P5|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573477|NCT01084252|19261335|P4|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573478|NCT01084252|19261336|P3|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573479|NCT01084252|19261337|P2|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573480|NCT01084252|19261338|P1|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
5573481|NCT01084252|19261325|P14|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
5573482|NCT01084252|19261326|P13|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
5573483|NCT01084252|19261327|P12|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573484|NCT01084252|19261328|P11|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573485|NCT01084252|19261329|P10|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573486|NCT01084252|19261330|P9|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573487|NCT01084252|19261331|P8|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573488|NCT01084252|19261332|P7|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573489|NCT01084252|19261333|P6|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573490|NCT01084252|19261334|P5|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573491|NCT01084252|19261335|P4|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573492|NCT01084252|19261336|P3|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573493|NCT01084252|19261337|P2|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573494|NCT01084252|19261338|P1|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
5573495|NCT01084252|19261325|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573496|NCT01084252|19261326|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573497|NCT01084252|19261327|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
5573498|NCT01084252|19261328|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
5573499|NCT01084252|19261329|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
5573500|NCT01084252|19261330|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
5573501|NCT01084252|19261331|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573502|NCT01084252|19261332|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573503|NCT01084252|19261333|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573504|NCT01084252|19261334|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573505|NCT01084252|19261335|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573506|NCT01084252|19261336|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573507|NCT01084252|19261337|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573508|NCT01084252|19261338|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
5573509|NCT01084252|19261325|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573510|NCT01084252|19261326|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573511|NCT01084252|19261327|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
5573512|NCT01084252|19261328|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
5573513|NCT01084252|19261329|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573514|NCT01084252|19261330|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
5573515|NCT01084252|19261331|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573516|NCT01084252|19261332|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573517|NCT01084252|19261333|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573518|NCT01084252|19261334|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573519|NCT01084252|19261335|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573520|NCT01084252|19261336|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573521|NCT01084252|19261337|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573522|NCT01084252|19261338|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
5573523|NCT01084252|19261325|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573524|NCT01084252|19261326|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573525|NCT01084252|19261327|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
5573526|NCT01084252|19261328|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
5573527|NCT01084252|19261329|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
5573528|NCT01084252|19261330|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
5573529|NCT01084252|19261331|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573530|NCT01084252|19261332|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573531|NCT01084252|19261333|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573532|NCT01084252|19261334|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573533|NCT01084252|19261335|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573534|NCT01084252|19261336|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573535|NCT01084252|19261337|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573536|NCT01084252|19261338|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
5573537|NCT01084252|19261325|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573538|NCT01084252|19261326|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573539|NCT01084252|19261327|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
5573540|NCT01084252|19261328|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
5573541|NCT01084252|19261329|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
5573542|NCT01084252|19261330|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573543|NCT01084252|19261331|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573544|NCT01084252|19261332|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573545|NCT01084252|19261333|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573546|NCT01084252|19261334|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573547|NCT01084252|19261335|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573548|NCT01084252|19261336|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573549|NCT01084252|19261337|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573550|NCT01084252|19261338|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
5573551|NCT01084252|19261325|P14|Phase 1 (120 Weeks)|Other than specified above|0
5573552|NCT01084252|19261326|P13|Phase 1 (120 Weeks)|Other than specified above|0
5573553|NCT01084252|19261327|P12|Phase 1 (120 Weeks)|Other than specified above|0
5573554|NCT01084252|19261328|P11|Phase 1 (120 Weeks)|Other than specified above|0
5573555|NCT01084252|19261329|P10|Phase 1 (120 Weeks)|Other than specified above|0
5573556|NCT01084252|19261330|P9|Phase 1 (120 Weeks)|Other than specified above|0
5573557|NCT01084252|19261331|P8|Phase 1 (120 Weeks)|Other than specified above|1
5573558|NCT01084252|19261332|P7|Phase 1 (120 Weeks)|Other than specified above|1
5573559|NCT01084252|19261333|P6|Phase 1 (120 Weeks)|Other than specified above|0
5573560|NCT01084252|19261334|P5|Phase 1 (120 Weeks)|Other than specified above|1
5573561|NCT01084252|19261335|P4|Phase 1 (120 Weeks)|Other than specified above|3
5573562|NCT01084252|19261336|P3|Phase 1 (120 Weeks)|Other than specified above|0
5573563|NCT01084252|19261337|P2|Phase 1 (120 Weeks)|Other than specified above|1
5573564|NCT01084252|19261338|P1|Phase 1 (120 Weeks)|Other than specified above|1
5573565|NCT01084252|19261325|P14|Phase 1 (120 Weeks)|Progressive disease|0
5573566|NCT01084252|19261326|P13|Phase 1 (120 Weeks)|Progressive disease|0
5573567|NCT01084252|19261327|P12|Phase 1 (120 Weeks)|Progressive disease|0
5573568|NCT01084252|19261328|P11|Phase 1 (120 Weeks)|Progressive disease|0
5573569|NCT01084252|19261329|P10|Phase 1 (120 Weeks)|Progressive disease|0
5573570|NCT01084252|19261330|P9|Phase 1 (120 Weeks)|Progressive disease|0
5573571|NCT01084252|19261331|P8|Phase 1 (120 Weeks)|Progressive disease|6
5573572|NCT01084252|19261332|P7|Phase 1 (120 Weeks)|Progressive disease|5
5573573|NCT01084252|19261333|P6|Phase 1 (120 Weeks)|Progressive disease|6
5573574|NCT01084252|19261334|P5|Phase 1 (120 Weeks)|Progressive disease|16
5573575|NCT01084252|19261335|P4|Phase 1 (120 Weeks)|Progressive disease|22
5573576|NCT01084252|19261336|P3|Phase 1 (120 Weeks)|Progressive disease|2
5573577|NCT01084252|19261337|P2|Phase 1 (120 Weeks)|Progressive disease|5
5573578|NCT01084252|19261338|P1|Phase 1 (120 Weeks)|Progressive disease|15
5573579|NCT01084252|19261325|P14|Phase 1 (120 Weeks)|Adverse Event|0
5573580|NCT01084252|19261326|P13|Phase 1 (120 Weeks)|Adverse Event|0
5573581|NCT01084252|19261327|P12|Phase 1 (120 Weeks)|Adverse Event|0
5573582|NCT01084252|19261328|P11|Phase 1 (120 Weeks)|Adverse Event|0
5573583|NCT01084252|19261329|P10|Phase 1 (120 Weeks)|Adverse Event|0
5573584|NCT01084252|19261330|P9|Phase 1 (120 Weeks)|Adverse Event|0
5573585|NCT01084252|19261331|P8|Phase 1 (120 Weeks)|Adverse Event|0
5573586|NCT01084252|19261332|P7|Phase 1 (120 Weeks)|Adverse Event|1
5573587|NCT01084252|19261333|P6|Phase 1 (120 Weeks)|Adverse Event|0
5573588|NCT01084252|19261334|P5|Phase 1 (120 Weeks)|Adverse Event|1
5573589|NCT01084252|19261335|P4|Phase 1 (120 Weeks)|Adverse Event|1
5573590|NCT01084252|19261336|P3|Phase 1 (120 Weeks)|Adverse Event|1
5573591|NCT01084252|19261337|P2|Phase 1 (120 Weeks)|Adverse Event|0
5573592|NCT01084252|19261338|P1|Phase 1 (120 Weeks)|Adverse Event|0
5573593|NCT01084239|19261522|P2|28-Day Follow-up|Lost to Follow-up|9
5573594|NCT01084239|19261523|P1|28-Day Follow-up|Lost to Follow-up|4
5573595|NCT01084174|19261541|P2|Overall Study|Participant noncompliance|1
5573596|NCT01084174|19261542|P1|Overall Study|Participant noncompliance|0
5573597|NCT01084174|19261541|P2|Overall Study|Anaphylaxis|1
5573598|NCT01084174|19261542|P1|Overall Study|Anaphylaxis|0
5573599|NCT01084174|19261541|P2|Overall Study|Eosinophilic esophagitis|1
5573600|NCT01084174|19261542|P1|Overall Study|Eosinophilic esophagitis|0
5573601|NCT01084174|19261541|P2|Overall Study|gastrointestinal symptoms|1
5573602|NCT01084174|19261542|P1|Overall Study|gastrointestinal symptoms|1
5573603|NCT01084135|19261575|P2|20 Week|Physician Decision|1
5573604|NCT01084135|19261576|P1|20 Week|Physician Decision|0
5573605|NCT01084083|19261586|P1|Overall Study|Never started assigned therapy|1
5573606|NCT01084083|19261586|P1|Overall Study|Other|2
5573607|NCT01084083|19261586|P1|Overall Study|Complicating disease|1
5573608|NCT01084083|19261586|P1|Overall Study|Withdrawal by Subject|2
5573609|NCT01084083|19261586|P1|Overall Study|Death|1
5573610|NCT01084083|19261586|P1|Overall Study|Adverse Event|5
5573611|NCT01084005|19261594|P2|Overall Study|Withdrawal by Subject|1
5573612|NCT01084005|19261595|P1|Overall Study|Withdrawal by Subject|1
5573613|NCT01084005|19261594|P2|Overall Study|Protocol Violation|7
5573614|NCT01084005|19261595|P1|Overall Study|Protocol Violation|3
5573615|NCT01084005|19261594|P2|Overall Study|Adverse Event|8
5573616|NCT01084005|19261595|P1|Overall Study|Adverse Event|1
5573617|NCT01083810|19261676|P3|Overall Study|Virologic failure|0
5573618|NCT01083810|19261677|P2|Overall Study|Virologic failure|8
5573619|NCT01083810|19261678|P1|Overall Study|Virologic failure|1
5573620|NCT01083810|19261676|P3|Overall Study|Therapy break|2
5573621|NCT01083810|19261677|P2|Overall Study|Therapy break|2
5573622|NCT01083810|19261678|P1|Overall Study|Therapy break|1
5573623|NCT01083810|19261676|P3|Overall Study|Participation in study|0
5573624|NCT01083810|19261677|P2|Overall Study|Participation in study|0
5573625|NCT01083810|19261678|P1|Overall Study|Participation in study|1
5573627|NCT01083810|19261677|P2|Overall Study|Co-morbidities|0
5573628|NCT01083810|19261678|P1|Overall Study|Co-morbidities|1
5573629|NCT01083810|19261676|P3|Overall Study|Death|3
5573630|NCT01083810|19261677|P2|Overall Study|Death|2
5573631|NCT01083810|19261678|P1|Overall Study|Death|2
5573632|NCT01083810|19261676|P3|Overall Study|Simplification|0
5573633|NCT01083810|19261677|P2|Overall Study|Simplification|1
5573634|NCT01083810|19261678|P1|Overall Study|Simplification|4
5573635|NCT01083810|19261676|P3|Overall Study|Non-compliance|2
5573636|NCT01083810|19261677|P2|Overall Study|Non-compliance|7
5573637|NCT01083810|19261678|P1|Overall Study|Non-compliance|4
5573638|NCT01083810|19261676|P3|Overall Study|Reason not reported|1
5573639|NCT01083810|19261677|P2|Overall Study|Reason not reported|1
5573640|NCT01083810|19261678|P1|Overall Study|Reason not reported|6
5573641|NCT01083810|19261676|P3|Overall Study|Withdrawal by Subject|4
5573642|NCT01083810|19261677|P2|Overall Study|Withdrawal by Subject|2
5573643|NCT01083810|19261678|P1|Overall Study|Withdrawal by Subject|7
5573644|NCT01083810|19261676|P3|Overall Study|Adverse Event|4
5573645|NCT01083810|19261677|P2|Overall Study|Adverse Event|11
5573646|NCT01083810|19261678|P1|Overall Study|Adverse Event|15
5573647|NCT01083810|19261676|P3|Overall Study|Lost to Follow-up|4
5573648|NCT01083810|19261677|P2|Overall Study|Lost to Follow-up|11
5573649|NCT01083810|19261678|P1|Overall Study|Lost to Follow-up|23
5573650|NCT01083771|19261699|P1|Overall Study|Withdrawal by Subject|3
5573651|NCT01083771|19261699|P1|Overall Study|non-compliant|2
5573652|NCT01083693|19261800|P3|Overall Study|Reason unknown|1
5573653|NCT01083693|19261801|P2|Overall Study|Reason unknown|0
5573654|NCT01083693|19261802|P1|Overall Study|Reason unknown|0
5573655|NCT01083693|19261800|P3|Overall Study|Withdrawal by Subject|2
5573656|NCT01083693|19261801|P2|Overall Study|Withdrawal by Subject|0
5573657|NCT01083693|19261802|P1|Overall Study|Withdrawal by Subject|3
5573658|NCT01083693|19261800|P3|Overall Study|Other medical condition/surgery|0
5573659|NCT01083693|19261801|P2|Overall Study|Other medical condition/surgery|1
5573660|NCT01083693|19261802|P1|Overall Study|Other medical condition/surgery|1
5573661|NCT01083693|19261800|P3|Overall Study|Complete remission|0
5573662|NCT01083693|19261801|P2|Overall Study|Complete remission|1
5573663|NCT01083693|19261802|P1|Overall Study|Complete remission|0
5573664|NCT01083693|19261800|P3|Overall Study|Patient Moved|0
5573665|NCT01083693|19261801|P2|Overall Study|Patient Moved|1
5573666|NCT01083693|19261802|P1|Overall Study|Patient Moved|0
5573667|NCT01083693|19261800|P3|Overall Study|Lack of effectiveness|2
5573668|NCT01083693|19261801|P2|Overall Study|Lack of effectiveness|2
5573669|NCT01083693|19261802|P1|Overall Study|Lack of effectiveness|13
5573670|NCT01083693|19261800|P3|Overall Study|Lost to Follow-up|2
5573671|NCT01083693|19261801|P2|Overall Study|Lost to Follow-up|0
5573672|NCT01083693|19261802|P1|Overall Study|Lost to Follow-up|2
5573673|NCT01083693|19261800|P3|Overall Study|Adverse Event|0
5573674|NCT01083693|19261801|P2|Overall Study|Adverse Event|1
5573675|NCT01083693|19261802|P1|Overall Study|Adverse Event|1
5573676|NCT01083680|19261837|P1|Overall Study|Withdrawal by Subject|1086
5573677|NCT01083680|19261837|P1|Overall Study|Lost to Follow-up|2758
5573678|NCT01083641|19261860|P1|Overall Study|Withdrawal by Subject|2
5573679|NCT01083602|19261880|P1|Overall Study|Lack of Efficacy|36
5573680|NCT01083602|19261880|P1|Overall Study|Withdrawal by Subject|5
5573681|NCT01083602|19261880|P1|Overall Study|Death|1
5573682|NCT01083602|19261880|P1|Overall Study|New Cancer Therapy|2
5573683|NCT01083602|19261880|P1|Overall Study|Adverse Event|11
5573684|NCT01083576|19261891|P2|Overall Study|Treatment Failure|1
5573685|NCT01083576|19261892|P1|Overall Study|Treatment Failure|6
5573686|NCT01083485|19261922|P2|Overall Study|Other|0
5573687|NCT01083485|19261923|P1|Overall Study|Other|1
5573688|NCT01083485|19261922|P2|Overall Study|Withdrawal by Subject|2
5573689|NCT01083485|19261923|P1|Overall Study|Withdrawal by Subject|5
5573690|NCT01083485|19261922|P2|Overall Study|Protocol Violation|0
5573691|NCT01083485|19261923|P1|Overall Study|Protocol Violation|1
5573692|NCT01083485|19261922|P2|Overall Study|Adverse Event|1
5573693|NCT01083485|19261923|P1|Overall Study|Adverse Event|0
5573694|NCT01083316|19261955|P1|Overall Study|Withdrawal by Subject|1
5573695|NCT01083316|19261955|P1|Overall Study|Adverse Event|2
5573696|NCT01083186|19261967|P1|Overall Study|Non-compliance to Study Treatment|1
5573697|NCT01083186|19261967|P1|Overall Study|Administrative Reasons|2
5573698|NCT01083186|19261967|P1|Overall Study|Hemodialysis Initiation|28
5573699|NCT01083186|19261967|P1|Overall Study|Lack of Efficacy|2
5573700|NCT01083186|19261967|P1|Overall Study|Adverse Event|3
5573701|NCT01083186|19261967|P1|Overall Study|Death|3
5573702|NCT01083186|19261967|P1|Overall Study|Consent Withdrawal|7
5573703|NCT01083186|19261967|P1|Overall Study|Lost to Follow-up|48
5573704|NCT01083173|19262008|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
5573705|NCT01083173|19262009|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
5573706|NCT01083173|19262008|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
5573707|NCT01083173|19262009|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
5573708|NCT01083173|19262008|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
5573709|NCT01083173|19262009|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
5573710|NCT01083173|19262008|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
5573711|NCT01083173|19262009|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
5573712|NCT01083173|19262008|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
5573713|NCT01083173|19262009|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
5573714|NCT01083173|19262008|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
5573715|NCT01083173|19262009|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
5573716|NCT01083173|19262008|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
5573717|NCT01083173|19262009|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
5573718|NCT01083173|19262008|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
5573719|NCT01083173|19262009|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
5573720|NCT01083173|19262008|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
5573721|NCT01083173|19262009|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
5573722|NCT01083173|19262008|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
5573723|NCT01083173|19262009|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
5573724|NCT01083173|19262008|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
5573725|NCT01083173|19262009|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
5573726|NCT01083160|19262027|P1|Overall Study|Adverse Event|1
5573727|NCT01083121|19262034|P1|Overall Study|Use of Humira outside the approved label|81
5573728|NCT01082965|19262044|P2|Overall Study|Other|1
5573729|NCT01082965|19262045|P1|Overall Study|Other|1
5573730|NCT01082965|19262044|P2|Overall Study|Protocol Violation|1
5573731|NCT01082965|19262045|P1|Overall Study|Protocol Violation|0
5573732|NCT01082874|19262082|P4|Overall Study|Withdrawal by Subject|3
5573733|NCT01082874|19262083|P3|Overall Study|Withdrawal by Subject|5
5573734|NCT01082874|19262084|P2|Overall Study|Withdrawal by Subject|2
5573735|NCT01082874|19262085|P1|Overall Study|Withdrawal by Subject|1
5573736|NCT01082874|19262082|P4|Overall Study|Lost to Follow-up|10
5573737|NCT01082874|19262083|P3|Overall Study|Lost to Follow-up|6
5573738|NCT01082874|19262084|P2|Overall Study|Lost to Follow-up|10
5573739|NCT01082874|19262085|P1|Overall Study|Lost to Follow-up|10
5573740|NCT01082640|19262098|P3|Overall Study|Other|3
5573741|NCT01082640|19262099|P2|Overall Study|Other|1
5573742|NCT01082640|19262100|P1|Overall Study|Other|2
5573743|NCT01082640|19262098|P3|Overall Study|Lost to Follow-up|0
5573744|NCT01082640|19262099|P2|Overall Study|Lost to Follow-up|3
5573745|NCT01082640|19262100|P1|Overall Study|Lost to Follow-up|0
5573746|NCT01082640|19262098|P3|Overall Study|Major protocol deviation|0
5573747|NCT01082640|19262099|P2|Overall Study|Major protocol deviation|3
5573748|NCT01082640|19262100|P1|Overall Study|Major protocol deviation|3
5573749|NCT01082640|19262098|P3|Overall Study|Withdrawal by Subject|2
5573750|NCT01082640|19262099|P2|Overall Study|Withdrawal by Subject|3
5573751|NCT01082640|19262100|P1|Overall Study|Withdrawal by Subject|3
5573752|NCT01082640|19262098|P3|Overall Study|Adverse Event|3
5573753|NCT01082640|19262099|P2|Overall Study|Adverse Event|5
5573754|NCT01082640|19262100|P1|Overall Study|Adverse Event|9
5573755|NCT01082614|19262122|P2|Overall Study|Physician Decision|0
5573756|NCT01082614|19262123|P1|Overall Study|Physician Decision|2
5573757|NCT01082614|19262122|P2|Overall Study|Equipment Malfunction|1
5573758|NCT01082614|19262123|P1|Overall Study|Equipment Malfunction|0
5573759|NCT01082614|19262122|P2|Overall Study|Adverse Event|4
5573760|NCT01082614|19262123|P1|Overall Study|Adverse Event|1
5573761|NCT01082367|19262194|P2|Follow-up (F-U) Period|Adverse Event|1
5573762|NCT01082367|19262195|P1|Follow-up (F-U) Period|Adverse Event|0
5573763|NCT01082367|19262194|P2|Follow-up (F-U) Period|Abnormal lab values|0
5573764|NCT01082367|19262195|P1|Follow-up (F-U) Period|Abnormal lab values|1
5573765|NCT01082367|19262194|P2|Follow-up (F-U) Period|Administrative problems|0
5573766|NCT01082367|19262195|P1|Follow-up (F-U) Period|Administrative problems|1
5573767|NCT01082367|19262194|P2|Double-blind Period|Adverse Event|1
5573768|NCT01082367|19262195|P1|Double-blind Period|Adverse Event|0
5573769|NCT01082367|19262194|P2|Double-blind Period|Lack of Efficacy|11
5573770|NCT01082367|19262195|P1|Double-blind Period|Lack of Efficacy|5
5573771|NCT01082367|19262194|P2|Double-blind Period|Administrative problems|1
5573772|NCT01082367|19262195|P1|Double-blind Period|Administrative problems|0
5573773|NCT01082328|19262209|P1|Overall Study|Adverse Event|1
5573774|NCT01082211|19262218|P1|Overall Study|No protocol treatment received|3
5573775|NCT01082211|19262218|P1|Overall Study|Protocol Violation|4
5573776|NCT01082081|19262245|P3|Overall Study|Other Reason|0
5573777|NCT01082081|19262246|P2|Overall Study|Other Reason|1
5573778|NCT01082081|19262247|P1|Overall Study|Other Reason|0
5573779|NCT01082081|19262245|P3|Overall Study|Withdrawal by Subject|1
5573780|NCT01082081|19262246|P2|Overall Study|Withdrawal by Subject|0
5573781|NCT01082081|19262247|P1|Overall Study|Withdrawal by Subject|0
5573782|NCT01082081|19262245|P3|Overall Study|Lost to Follow-up|1
5573783|NCT01082081|19262246|P2|Overall Study|Lost to Follow-up|0
5573784|NCT01082081|19262247|P1|Overall Study|Lost to Follow-up|0
5573785|NCT01081951|19262299|P2|Overall Study|Lost to Follow-up|1
5573786|NCT01081951|19262300|P1|Overall Study|Lost to Follow-up|0
5573787|NCT01081951|19262299|P2|Overall Study|Allocated treatment but did not take it|1
5573788|NCT01081951|19262300|P1|Overall Study|Allocated treatment but did not take it|0
5573789|NCT01081951|19262299|P2|Overall Study|Withdrawal by Subject|6
5573790|NCT01081951|19262300|P1|Overall Study|Withdrawal by Subject|2
5573791|NCT01081951|19262299|P2|Overall Study|Death|47
5573792|NCT01081951|19262300|P1|Overall Study|Death|54
5573793|NCT01081912|19262310|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
5573794|NCT01081912|19262311|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
5573795|NCT01081912|19262312|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
5573796|NCT01081912|19262310|P3|Maintenance Treatment|Non-Compliance|7
5573797|NCT01081912|19262311|P2|Maintenance Treatment|Non-Compliance|4
5573798|NCT01081912|19262312|P1|Maintenance Treatment|Non-Compliance|0
5573799|NCT01081912|19262310|P3|Maintenance Treatment|Withdrawal by Subject|5
5573800|NCT01081912|19262311|P2|Maintenance Treatment|Withdrawal by Subject|5
5573801|NCT01081912|19262312|P1|Maintenance Treatment|Withdrawal by Subject|0
5573802|NCT01081912|19262310|P3|Maintenance Treatment|Protocol Violation|2
5573803|NCT01081912|19262311|P2|Maintenance Treatment|Protocol Violation|1
5573804|NCT01081912|19262312|P1|Maintenance Treatment|Protocol Violation|0
5573805|NCT01081912|19262310|P3|Maintenance Treatment|Physician Decision|1
5573806|NCT01081912|19262311|P2|Maintenance Treatment|Physician Decision|0
5573807|NCT01081912|19262312|P1|Maintenance Treatment|Physician Decision|0
5573808|NCT01081912|19262310|P3|Maintenance Treatment|Lost to Follow-up|0
5573809|NCT01081912|19262311|P2|Maintenance Treatment|Lost to Follow-up|1
5573810|NCT01081912|19262312|P1|Maintenance Treatment|Lost to Follow-up|0
5573811|NCT01081912|19262310|P3|Maintenance Treatment|Lack of Efficacy|64
5573812|NCT01081912|19262311|P2|Maintenance Treatment|Lack of Efficacy|14
5573813|NCT01081912|19262312|P1|Maintenance Treatment|Lack of Efficacy|0
5573814|NCT01081912|19262310|P3|Maintenance Treatment|Adverse Event|12
5573815|NCT01081912|19262311|P2|Maintenance Treatment|Adverse Event|2
5573816|NCT01081912|19262312|P1|Maintenance Treatment|Adverse Event|0
5573817|NCT01081912|19262310|P3|Conversion/Titration|Non-Compliance|0
5573818|NCT01081912|19262311|P2|Conversion/Titration|Non-Compliance|0
5573819|NCT01081912|19262312|P1|Conversion/Titration|Non-Compliance|47
5573820|NCT01081912|19262310|P3|Conversion/Titration|Withdrawal by Subject|0
5573821|NCT01081912|19262311|P2|Conversion/Titration|Withdrawal by Subject|0
5573822|NCT01081912|19262312|P1|Conversion/Titration|Withdrawal by Subject|23
5573823|NCT01081912|19262310|P3|Conversion/Titration|Protocol Violation|0
5573824|NCT01081912|19262311|P2|Conversion/Titration|Protocol Violation|0
5573825|NCT01081912|19262312|P1|Conversion/Titration|Protocol Violation|67
5573826|NCT01081912|19262310|P3|Conversion/Titration|Physician Decision|0
5573827|NCT01081912|19262311|P2|Conversion/Titration|Physician Decision|0
5573828|NCT01081912|19262312|P1|Conversion/Titration|Physician Decision|2
5573829|NCT01081912|19262310|P3|Conversion/Titration|Lost to Follow-up|0
5573830|NCT01081912|19262311|P2|Conversion/Titration|Lost to Follow-up|0
5573831|NCT01081912|19262312|P1|Conversion/Titration|Lost to Follow-up|5
5573832|NCT01081912|19262310|P3|Conversion/Titration|Lack of Efficacy|0
5573833|NCT01081912|19262311|P2|Conversion/Titration|Lack of Efficacy|0
5573834|NCT01081912|19262312|P1|Conversion/Titration|Lack of Efficacy|17
5573835|NCT01081912|19262310|P3|Conversion/Titration|Adverse Event|0
5573836|NCT01081912|19262311|P2|Conversion/Titration|Adverse Event|0
5573837|NCT01081912|19262312|P1|Conversion/Titration|Adverse Event|47
5573838|NCT01081886|19262321|P2|Overall Study|Study termination|13
5573839|NCT01081886|19262322|P1|Overall Study|Study termination|11
5573840|NCT01081873|19262330|P1|Overall Study|Other|47
5573841|NCT01081873|19262330|P1|Overall Study|Progression of prostate cancer|13
5573842|NCT01081873|19262330|P1|Overall Study|Lost to Follow-up|142
5573843|NCT01081873|19262330|P1|Overall Study|Withdrawal by Subject|10
5573844|NCT01081873|19262330|P1|Overall Study|Death|86
5573845|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
5573846|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
5573847|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
5573848|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
5573849|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
5573850|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
5573851|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
5573852|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
5573853|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
5573854|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
5573855|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Other|0
5573856|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Other|0
5573857|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Other|4
5573858|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Other|5
5573859|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Other|4
5573860|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
5573861|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
5573862|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
5573863|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
5573864|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
5573865|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5573866|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5573867|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5573868|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
5573869|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
5573870|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5573871|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5573872|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5573873|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
5573874|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5573875|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
5573876|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
5573877|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
5573878|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
5573879|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
5573880|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5573881|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5573882|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5573883|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
5573884|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
5573885|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Death|0
5573886|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Death|0
5573887|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Death|0
5573888|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Death|0
5573889|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Death|1
5573890|NCT01081834|19262402|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
5573891|NCT01081834|19262403|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
5573892|NCT01081834|19262404|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
5573893|NCT01081834|19262405|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
5573894|NCT01081834|19262406|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
5573895|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5573896|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5573897|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
5573898|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
5573899|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
5573900|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Other|0
5573901|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Other|1
5573902|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Other|3
5573903|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Other|4
5573904|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Other|4
5573905|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5573906|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5573907|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5573908|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
5573909|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
5573910|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5573911|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
5573912|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
5573913|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
5573914|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
5573915|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
5573916|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
5573917|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
5573918|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
5573919|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
5573920|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Protocol Violation|2
5573921|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Protocol Violation|0
5573922|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Protocol Violation|0
5573923|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Protocol Violation|4
5573924|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Protocol Violation|0
5573925|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
5573926|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
5573927|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
5573928|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
5573929|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
5573930|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Death|0
5573931|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Death|0
5573932|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Death|0
5573933|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Death|0
5573934|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Death|1
5573935|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Adverse Event|1
5573936|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Adverse Event|1
5573937|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Adverse Event|3
5573938|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Adverse Event|5
5573939|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Adverse Event|2
5573940|NCT01081834|19262402|P5|Core Period: Baseline to Week 26|Pregnancy|0
5573941|NCT01081834|19262403|P4|Core Period: Baseline to Week 26|Pregnancy|0
5573942|NCT01081834|19262404|P3|Core Period: Baseline to Week 26|Pregnancy|0
5573943|NCT01081834|19262405|P2|Core Period: Baseline to Week 26|Pregnancy|0
5573944|NCT01081834|19262406|P1|Core Period: Baseline to Week 26|Pregnancy|1
5573945|NCT01081795|19262467|P3|Overall Study|Other|0
5573946|NCT01081795|19262468|P2|Overall Study|Other|2
5573947|NCT01081795|19262469|P1|Overall Study|Other|1
5573948|NCT01081795|19262467|P3|Overall Study|Using drug with restricted days of use|2
5573949|NCT01081795|19262468|P2|Overall Study|Using drug with restricted days of use|3
5573950|NCT01081795|19262469|P1|Overall Study|Using drug with restricted days of use|2
5573951|NCT01081795|19262467|P3|Overall Study|Use of a prohibited concomitant drug|1
5573952|NCT01081795|19262468|P2|Overall Study|Use of a prohibited concomitant drug|1
5573953|NCT01081795|19262469|P1|Overall Study|Use of a prohibited concomitant drug|1
5573954|NCT01081795|19262467|P3|Overall Study|Ineligible for participation|0
5573955|NCT01081795|19262468|P2|Overall Study|Ineligible for participation|0
5573956|NCT01081795|19262469|P1|Overall Study|Ineligible for participation|1
5573957|NCT01081795|19262467|P3|Overall Study|Revocation of informed consent|0
5573958|NCT01081795|19262468|P2|Overall Study|Revocation of informed consent|0
5573959|NCT01081795|19262469|P1|Overall Study|Revocation of informed consent|2
5573960|NCT01081795|19262467|P3|Overall Study|Subject's schedule|2
5573961|NCT01081795|19262468|P2|Overall Study|Subject's schedule|1
5573962|NCT01081795|19262469|P1|Overall Study|Subject's schedule|1
5573963|NCT01081795|19262467|P3|Overall Study|Lack of Efficacy|19
5573964|NCT01081795|19262468|P2|Overall Study|Lack of Efficacy|5
5573965|NCT01081795|19262469|P1|Overall Study|Lack of Efficacy|7
5573966|NCT01081795|19262467|P3|Overall Study|Adverse Event|6
5573967|NCT01081795|19262468|P2|Overall Study|Adverse Event|23
5573968|NCT01081795|19262469|P1|Overall Study|Adverse Event|18
5573969|NCT01081769|19262506|P2|CORE Intent-To-Treat|Patient Moved|2
5573970|NCT01081769|19262507|P1|CORE Intent-To-Treat|Patient Moved|2
5573971|NCT01081769|19262506|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
5573972|NCT01081769|19262507|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
5573973|NCT01081769|19262506|P2|CORE Intent-To-Treat|Ineligibility|4
5573974|NCT01081769|19262507|P1|CORE Intent-To-Treat|Ineligibility|3
5573975|NCT01081769|19262506|P2|CORE Intent-To-Treat|Other|1
5573976|NCT01081769|19262507|P1|CORE Intent-To-Treat|Other|0
5573977|NCT01081769|19262506|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
5573978|NCT01081769|19262507|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
5573979|NCT01081769|19262506|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
5573980|NCT01081769|19262507|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
5573981|NCT01081769|19262506|P2|CORE Intent-To-Treat|Pregnancy|0
5573982|NCT01081769|19262507|P1|CORE Intent-To-Treat|Pregnancy|1
5573983|NCT01081769|19262506|P2|CORE Intent-To-Treat|Lost to Follow-up|5
5573984|NCT01081769|19262507|P1|CORE Intent-To-Treat|Lost to Follow-up|4
5573985|NCT01081769|19262506|P2|CORE Intent-To-Treat|Lack of Efficacy|6
5573986|NCT01081769|19262507|P1|CORE Intent-To-Treat|Lack of Efficacy|2
5573987|NCT01081769|19262506|P2|CORE Intent-To-Treat|Death|1
5573988|NCT01081769|19262507|P1|CORE Intent-To-Treat|Death|1
5573989|NCT01081769|19262506|P2|CORE Intent-To-Treat|Adverse Event|11
5573990|NCT01081769|19262507|P1|CORE Intent-To-Treat|Adverse Event|14
5573991|NCT01081769|19262506|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
5573992|NCT01081769|19262507|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
5573993|NCT01081769|19262506|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
5573994|NCT01081769|19262507|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
5573995|NCT01081769|19262506|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
5573996|NCT01081769|19262507|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
5573997|NCT01081769|19262506|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
5573998|NCT01081769|19262507|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
5573999|NCT01081678|19262545|P4|Overall Study|Other|0
5574000|NCT01081678|19262546|P3|Overall Study|Other|0
5574001|NCT01081678|19262547|P2|Overall Study|Other|1
5574002|NCT01081678|19262548|P1|Overall Study|Other|0
5574003|NCT01081678|19262545|P4|Overall Study|Death|6
5574004|NCT01081678|19262546|P3|Overall Study|Death|2
5574005|NCT01081678|19262547|P2|Overall Study|Death|2
5574006|NCT01081678|19262548|P1|Overall Study|Death|2
5574007|NCT01081678|19262545|P4|Overall Study|Lost to Follow-up|3
5574008|NCT01081678|19262546|P3|Overall Study|Lost to Follow-up|4
5574009|NCT01081678|19262547|P2|Overall Study|Lost to Follow-up|1
5574010|NCT01081678|19262548|P1|Overall Study|Lost to Follow-up|4
5574011|NCT01081678|19262545|P4|Overall Study|Administrative Decision|1
5574012|NCT01081678|19262546|P3|Overall Study|Administrative Decision|0
5574013|NCT01081678|19262547|P2|Overall Study|Administrative Decision|0
5574014|NCT01081678|19262548|P1|Overall Study|Administrative Decision|1
5574015|NCT01081678|19262545|P4|Overall Study|Withdrawal by Subject|14
5574016|NCT01081678|19262546|P3|Overall Study|Withdrawal by Subject|17
5574017|NCT01081678|19262547|P2|Overall Study|Withdrawal by Subject|7
5574018|NCT01081678|19262548|P1|Overall Study|Withdrawal by Subject|15
5574019|NCT01081678|19262545|P4|Overall Study|Adverse Event|2
5574020|NCT01081678|19262546|P3|Overall Study|Adverse Event|2
5574021|NCT01081678|19262547|P2|Overall Study|Adverse Event|1
5574022|NCT01081678|19262548|P1|Overall Study|Adverse Event|2
5574023|NCT01081678|19262545|P4|Overall Study|Noncompliance|2
5574024|NCT01081678|19262546|P3|Overall Study|Noncompliance|5
5574025|NCT01081678|19262547|P2|Overall Study|Noncompliance|4
5574026|NCT01081678|19262548|P1|Overall Study|Noncompliance|3
5574027|NCT01081678|19262545|P4|Overall Study|Ineligibility Determined|1
5574028|NCT01081678|19262546|P3|Overall Study|Ineligibility Determined|1
5574029|NCT01081678|19262547|P2|Overall Study|Ineligibility Determined|0
5574030|NCT01081678|19262548|P1|Overall Study|Ineligibility Determined|0
5574031|NCT01081665|19262578|P1|Overall Study|Lack of Efficacy|1
5574032|NCT01081665|19262578|P1|Overall Study|Adverse Event|1
5574033|NCT01081665|19262578|P1|Overall Study|Change in renal replacement therapy|2
5574034|NCT01081665|19262578|P1|Overall Study|Regulation of iPTH|5
5574035|NCT01081665|19262578|P1|Overall Study|Change of dialysis unit|10
5574036|NCT01081665|19262578|P1|Overall Study|Withdrawal by Subject|17
5574037|NCT01081665|19262578|P1|Overall Study|Lost to Follow-up|18
5574038|NCT01081665|19262578|P1|Overall Study|Death|41
5574039|NCT01081626|19262590|P2|Overall Study|Other|30
5574040|NCT01081626|19262591|P1|Overall Study|Other|33
5574041|NCT01081626|19262590|P2|Overall Study|Lost to Follow-up|1
5574042|NCT01081626|19262591|P1|Overall Study|Lost to Follow-up|0
5574043|NCT01081626|19262590|P2|Overall Study|Overstimulation|1
5574044|NCT01081626|19262591|P1|Overall Study|Overstimulation|0
5574045|NCT01081626|19262590|P2|Overall Study|Low antral follicle count|0
5574046|NCT01081626|19262591|P1|Overall Study|Low antral follicle count|1
5574047|NCT01081626|19262590|P2|Overall Study|Missing Estradiol|28
5574048|NCT01081626|19262591|P1|Overall Study|Missing Estradiol|25
5574049|NCT01081626|19262590|P2|Overall Study|Dosing error|1
5574050|NCT01081626|19262591|P1|Overall Study|Dosing error|1
5574051|NCT01081301|19262617|P1|Overall Study|Lost to Follow-up|4
5574052|NCT01081301|19262617|P1|Overall Study|Patient too ill|2
5574053|NCT01081301|19262617|P1|Overall Study|Too busy|5
5574054|NCT01081301|19262617|P1|Overall Study|Bereaved|3
5574055|NCT01081249|19262692|P2|Overall Study|Diagnosed with Bipolar Disorder|1
5574056|NCT01081249|19262693|P1|Overall Study|Diagnosed with Bipolar Disorder|0
5574057|NCT01081145|19262699|P2|Double-Blind Randomized-Withdrawal Phase|Other|3
5574058|NCT01081145|19262700|P1|Double-Blind Randomized-Withdrawal Phase|Other|4
5574059|NCT01081145|19262699|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
5574060|NCT01081145|19262700|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
5574061|NCT01081145|19262699|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
5574062|NCT01081145|19262700|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
5574063|NCT01081145|19262699|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
5574064|NCT01081145|19262700|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
5574065|NCT01081145|19262699|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
5574066|NCT01081145|19262700|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
5574067|NCT01081145|19262699|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
5574068|NCT01081145|19262700|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
5574069|NCT01081145|19262699|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
5574070|NCT01081145|19262700|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
5574071|NCT01081145|19262699|P2|Open-Label Phase|Protocol Violation|0
5574072|NCT01081145|19262700|P1|Open-Label Phase|Protocol Violation|4
5574073|NCT01081145|19262699|P2|Open-Label Phase|Lost to Follow-up|0
5574074|NCT01081145|19262700|P1|Open-Label Phase|Lost to Follow-up|11
5574075|NCT01081145|19262699|P2|Open-Label Phase|Other|0
5574076|NCT01081145|19262700|P1|Open-Label Phase|Other|12
5574077|NCT01081145|19262699|P2|Open-Label Phase|Withdrawal by Subject|0
5574078|NCT01081145|19262700|P1|Open-Label Phase|Withdrawal by Subject|41
5574079|NCT01081145|19262699|P2|Open-Label Phase|Adverse Event|0
5574080|NCT01081145|19262700|P1|Open-Label Phase|Adverse Event|42
5574081|NCT01081145|19262699|P2|Open-Label Phase|Response criteria not met|0
5574082|NCT01081145|19262700|P1|Open-Label Phase|Response criteria not met|46
5574083|NCT01081145|19262699|P2|Open-Label Phase|Lack of Efficacy|0
5574084|NCT01081145|19262700|P1|Open-Label Phase|Lack of Efficacy|56
5574085|NCT01081132|19262728|P2|Overall Study|Protocol Violation|1
5574086|NCT01081132|19262729|P1|Overall Study|Protocol Violation|3
5574087|NCT01081132|19262728|P2|Overall Study|Declined Taper Phase|1
5574088|NCT01081132|19262729|P1|Overall Study|Declined Taper Phase|0
5574089|NCT01081132|19262728|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
5574090|NCT01081132|19262729|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
5574091|NCT01081132|19262728|P2|Overall Study|Stopped Taking Meds|0
5574092|NCT01081132|19262729|P1|Overall Study|Stopped Taking Meds|2
5574093|NCT01081132|19262728|P2|Overall Study|Missed Visits|1
5574094|NCT01081132|19262729|P1|Overall Study|Missed Visits|1
5574095|NCT01081132|19262728|P2|Overall Study|Lack Of Compliance|1
5574096|NCT01081132|19262729|P1|Overall Study|Lack Of Compliance|0
5574097|NCT01081132|19262728|P2|Overall Study|Non Compliance|2
5574098|NCT01081132|19262729|P1|Overall Study|Non Compliance|4
5574099|NCT01081132|19262728|P2|Overall Study|Adverse Event|9
5574100|NCT01081132|19262729|P1|Overall Study|Adverse Event|3
5574101|NCT01081132|19262728|P2|Overall Study|Lost to Follow-up|11
5574102|NCT01081132|19262729|P1|Overall Study|Lost to Follow-up|4
5574103|NCT01081132|19262728|P2|Overall Study|Withdrawal by Subject|16
5574104|NCT01081132|19262729|P1|Overall Study|Withdrawal by Subject|13
5574105|NCT01081132|19262728|P2|Overall Study|Lack of Efficacy|9
5574106|NCT01081132|19262729|P1|Overall Study|Lack of Efficacy|25
5574107|NCT01080807|19262813|P2|Overall Study|Moved away without notifying center|0
5574108|NCT01080807|19262814|P1|Overall Study|Moved away without notifying center|1
5574109|NCT01080807|19262813|P2|Overall Study|Switched to first shift|0
5574110|NCT01080807|19262814|P1|Overall Study|Switched to first shift|1
5574111|NCT01080807|19262813|P2|Overall Study|Work schedule and travel|1
5574112|NCT01080807|19262814|P1|Overall Study|Work schedule and travel|0
5574113|NCT01080807|19262813|P2|Overall Study|Work schedule changing|1
5574114|NCT01080807|19262814|P1|Overall Study|Work schedule changing|1
5574115|NCT01080807|19262813|P2|Overall Study|Stopped working consistent night shifts|1
5574116|NCT01080807|19262814|P1|Overall Study|Stopped working consistent night shifts|0
5574117|NCT01080807|19262813|P2|Overall Study|Laid off or terminated from job|2
5574118|NCT01080807|19262814|P1|Overall Study|Laid off or terminated from job|1
5574119|NCT01080807|19262813|P2|Overall Study|Began working day shift|2
5574120|NCT01080807|19262814|P1|Overall Study|Began working day shift|0
5574121|NCT01080807|19262813|P2|Overall Study|Noncompliance to study procedures|1
5574122|NCT01080807|19262814|P1|Overall Study|Noncompliance to study procedures|1
5574123|NCT01080807|19262813|P2|Overall Study|Noncompliance with drug administration|1
5574124|NCT01080807|19262814|P1|Overall Study|Noncompliance with drug administration|1
5574125|NCT01080807|19262813|P2|Overall Study|Lost to Follow-up|4
5574126|NCT01080807|19262814|P1|Overall Study|Lost to Follow-up|6
5574127|NCT01080807|19262813|P2|Overall Study|Protocol Violation|6
5574128|NCT01080807|19262814|P1|Overall Study|Protocol Violation|7
5574129|NCT01080807|19262813|P2|Overall Study|Withdrawal by Subject|2
5574130|NCT01080807|19262814|P1|Overall Study|Withdrawal by Subject|7
5574131|NCT01080807|19262813|P2|Overall Study|Lack of Efficacy|1
5574132|NCT01080807|19262814|P1|Overall Study|Lack of Efficacy|0
5574133|NCT01080807|19262813|P2|Overall Study|Adverse Event|1
5574134|NCT01080807|19262814|P1|Overall Study|Adverse Event|9
5574135|NCT01080768|19262923|P2|Overall Study|Protocol Deviation|1
5574136|NCT01080768|19262924|P1|Overall Study|Protocol Deviation|2
5574137|NCT01080716|19262934|P4|Part 1|Physician Decision|0
5574138|NCT01080716|19262935|P3|Part 1|Physician Decision|0
5574139|NCT01080716|19262936|P2|Part 1|Physician Decision|0
5574140|NCT01080716|19262937|P1|Part 1|Physician Decision|1
5574141|NCT01080625|19262976|P3|Overall Study|Physician Decision|1
5574142|NCT01080625|19262977|P2|Overall Study|Physician Decision|2
5574143|NCT01080625|19262978|P1|Overall Study|Physician Decision|0
5574144|NCT01080391|19262988|P2|Overall Study|Randomized but not treated|4
5574145|NCT01080391|19262989|P1|Overall Study|Randomized but not treated|7
5574146|NCT01080326|19263007|P1|Overall Study|Surgeon decision|1
5574147|NCT01080326|19263007|P1|Overall Study|Patient deterioration prior to procedure|3
5574148|NCT01080300|19263013|P2|Overall Study|Reasons not specified|6
5574149|NCT01080300|19263014|P1|Overall Study|Reasons not specified|4
5574150|NCT01080300|19263013|P2|Overall Study|Withdrawal by Subject|28
5574151|NCT01080300|19263014|P1|Overall Study|Withdrawal by Subject|12
5574152|NCT01080300|19263013|P2|Overall Study|Death|1
5574153|NCT01080300|19263014|P1|Overall Study|Death|0
5574154|NCT01080300|19263013|P2|Overall Study|Lost to Follow-up|6
5574155|NCT01080300|19263014|P1|Overall Study|Lost to Follow-up|10
5574156|NCT01080300|19263013|P2|Overall Study|Protocol Violation|13
5574157|NCT01080300|19263014|P1|Overall Study|Protocol Violation|7
5574158|NCT01080300|19263013|P2|Overall Study|Lack of Efficacy|15
5574159|NCT01080300|19263014|P1|Overall Study|Lack of Efficacy|12
5574160|NCT01080300|19263013|P2|Overall Study|Adverse Event|35
5574161|NCT01080300|19263014|P1|Overall Study|Adverse Event|49
5574162|NCT01080131|19263119|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
5574163|NCT01080131|19263120|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
5574164|NCT01080131|19263119|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
5574165|NCT01080131|19263120|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
5574166|NCT01080131|19263119|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
5574167|NCT01080131|19263120|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
5574168|NCT01080131|19263119|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
5574169|NCT01080131|19263120|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
5574170|NCT01080131|19263119|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
5574171|NCT01080131|19263120|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
5574172|NCT01080131|19263119|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
5574173|NCT01080131|19263120|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
5574174|NCT01080131|19263119|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
5574175|NCT01080131|19263120|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
5574176|NCT01080131|19263119|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
5574177|NCT01080131|19263120|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
5574178|NCT01080131|19263119|P2|Core Study (0- 12 Weeks)|Death|0
5574179|NCT01080131|19263120|P1|Core Study (0- 12 Weeks)|Death|1
5574180|NCT01080131|19263119|P2|Core Study (0- 12 Weeks)|Administrative problems|1
5574181|NCT01080131|19263120|P1|Core Study (0- 12 Weeks)|Administrative problems|0
5574182|NCT01080131|19263119|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
5574183|NCT01080131|19263120|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
5574184|NCT01080131|19263119|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
5574185|NCT01080131|19263120|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
5574186|NCT01080131|19263119|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
5574187|NCT01080131|19263120|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
5574188|NCT01079988|19263215|P5|Overall Study|Other|1
5574189|NCT01079988|19263216|P4|Overall Study|Other|2
5574190|NCT01079988|19263217|P3|Overall Study|Other|0
5574191|NCT01079988|19263218|P2|Overall Study|Other|0
5574192|NCT01079988|19263219|P1|Overall Study|Other|0
5574193|NCT01079988|19263215|P5|Overall Study|Lack of Efficacy|0
5574194|NCT01079988|19263216|P4|Overall Study|Lack of Efficacy|0
5574195|NCT01079988|19263217|P3|Overall Study|Lack of Efficacy|0
5574196|NCT01079988|19263218|P2|Overall Study|Lack of Efficacy|0
5574197|NCT01079988|19263219|P1|Overall Study|Lack of Efficacy|1
5574198|NCT01079988|19263215|P5|Overall Study|Lost to Follow-up|0
5574199|NCT01079988|19263216|P4|Overall Study|Lost to Follow-up|1
5574200|NCT01079988|19263217|P3|Overall Study|Lost to Follow-up|0
5574201|NCT01079988|19263218|P2|Overall Study|Lost to Follow-up|0
5574202|NCT01079988|19263219|P1|Overall Study|Lost to Follow-up|0
5574203|NCT01079962|19263238|P2|Overall Study|Due to arrhythmia/bradycardia|1
5574204|NCT01079962|19263239|P1|Overall Study|Due to arrhythmia/bradycardia|1
5574205|NCT01079962|19263238|P2|Overall Study|Participant not returning for next visit|0
5574206|NCT01079962|19263239|P1|Overall Study|Participant not returning for next visit|1
5574207|NCT01079962|19263238|P2|Overall Study|Inclusion/exclusion criteria|3
5574208|NCT01079962|19263239|P1|Overall Study|Inclusion/exclusion criteria|1
5574209|NCT01079962|19263238|P2|Overall Study|No blood pressure (BP) control|0
5574210|NCT01079962|19263239|P1|Overall Study|No blood pressure (BP) control|3
5574211|NCT01079962|19263238|P2|Overall Study|Protocol Violation|2
5574212|NCT01079962|19263239|P1|Overall Study|Protocol Violation|2
5574213|NCT01079962|19263238|P2|Overall Study|Withdrawal by Subject|7
5574214|NCT01079962|19263239|P1|Overall Study|Withdrawal by Subject|5
5574215|NCT01079962|19263238|P2|Overall Study|Adverse Event|2
5574216|NCT01079962|19263239|P1|Overall Study|Adverse Event|2
5574217|NCT01079949|19263267|P2|Overall Study|Randomized but not treated|0
5574218|NCT01079949|19263268|P1|Overall Study|Randomized but not treated|1
5574219|NCT01079949|19263267|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
5574220|NCT01079949|19263268|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
5574221|NCT01079949|19263267|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
5574222|NCT01079949|19263268|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
5574223|NCT01079949|19263267|P2|Overall Study|Withdrawal before r-hCG administration|3
5574224|NCT01079949|19263268|P1|Overall Study|Withdrawal before r-hCG administration|2
5574225|NCT01079936|19263314|P5|Phase II|Insurance Issue|1
5574226|NCT01079936|19263315|P4|Phase II|Insurance Issue|0
5574227|NCT01079936|19263316|P3|Phase II|Insurance Issue|0
5574228|NCT01079936|19263317|P2|Phase II|Insurance Issue|0
5574229|NCT01079936|19263318|P1|Phase II|Insurance Issue|0
5574230|NCT01079936|19263314|P5|Phase II|Adverse Event|0
5574231|NCT01079936|19263315|P4|Phase II|Adverse Event|0
5574232|NCT01079936|19263316|P3|Phase II|Adverse Event|1
5574233|NCT01079936|19263317|P2|Phase II|Adverse Event|0
5574234|NCT01079936|19263318|P1|Phase II|Adverse Event|0
5574235|NCT01079936|19263314|P5|Phase I: MTD|No Stem Cell Transplantation|0
5574236|NCT01079936|19263315|P4|Phase I: MTD|No Stem Cell Transplantation|0
5574237|NCT01079936|19263316|P3|Phase I: MTD|No Stem Cell Transplantation|0
5574238|NCT01079936|19263317|P2|Phase I: MTD|No Stem Cell Transplantation|0
5574239|NCT01079936|19263318|P1|Phase I: MTD|No Stem Cell Transplantation|2
5574240|NCT01079936|19263314|P5|Phase I: MTD|First Remission Status|0
5574241|NCT01079936|19263315|P4|Phase I: MTD|First Remission Status|0
5574242|NCT01079936|19263316|P3|Phase I: MTD|First Remission Status|0
5574243|NCT01079936|19263317|P2|Phase I: MTD|First Remission Status|0
5574244|NCT01079936|19263318|P1|Phase I: MTD|First Remission Status|2
5574245|NCT01079832|19263337|P1|Overall Study|Withdrawal by Subject|1
5574246|NCT01079806|19263347|P2|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
5574247|NCT01079806|19263348|P1|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
5574248|NCT01079806|19263347|P2|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
5574249|NCT01079806|19263348|P1|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
5574250|NCT01079806|19263347|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
5574251|NCT01079806|19263348|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
5574252|NCT01079806|19263347|P2|Day 1 to Week 96|Removal by Medical Monitor|1
5574253|NCT01079806|19263348|P1|Day 1 to Week 96|Removal by Medical Monitor|0
5574254|NCT01079806|19263347|P2|Day 1 to Week 96|Subject request to stop study treatment|0
5574255|NCT01079806|19263348|P1|Day 1 to Week 96|Subject request to stop study treatment|1
5574256|NCT01079806|19263347|P2|Day 1 to Week 96|Lost to Follow-up|0
5574257|NCT01079806|19263348|P1|Day 1 to Week 96|Lost to Follow-up|1
5574258|NCT01079806|19263347|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
5574259|NCT01079806|19263348|P1|Day 1 to Week 96|Poor compliance or noncompliance|2
5574260|NCT01079806|19263347|P2|Day 1 to Week 96|Pregnancy|1
5574261|NCT01079806|19263348|P1|Day 1 to Week 96|Pregnancy|0
5574262|NCT01079806|19263347|P2|Day 1 to Week 96|Withdrawal by Subject|2
5574263|NCT01079806|19263348|P1|Day 1 to Week 96|Withdrawal by Subject|3
5574264|NCT01079806|19263347|P2|Day 1 to Week 96|Adverse Event|3
5574265|NCT01079806|19263348|P1|Day 1 to Week 96|Adverse Event|0
5574266|NCT01079741|19263383|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
5574267|NCT01079741|19263384|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5574268|NCT01079741|19263385|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5574269|NCT01079741|19263386|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5574270|NCT01079741|19263387|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
5574271|NCT01079741|19263383|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5574272|NCT01079741|19263384|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5574273|NCT01079741|19263385|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5574274|NCT01079741|19263386|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
5574275|NCT01079741|19263387|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
5574276|NCT01079234|19263435|P4|Extension: Week 27 to 52|Unclassified|7
5574277|NCT01079234|19263436|P3|Extension: Week 27 to 52|Unclassified|4
5574278|NCT01079234|19263437|P2|Extension: Week 27 to 52|Unclassified|0
5574279|NCT01079234|19263438|P1|Extension: Week 27 to 52|Unclassified|0
5574280|NCT01079234|19263435|P4|Extension: Week 27 to 52|Withdrawal criteria|2
5574281|NCT01079234|19263436|P3|Extension: Week 27 to 52|Withdrawal criteria|4
5574282|NCT01079234|19263437|P2|Extension: Week 27 to 52|Withdrawal criteria|0
5574283|NCT01079234|19263438|P1|Extension: Week 27 to 52|Withdrawal criteria|0
5574284|NCT01079234|19263435|P4|Extension: Week 27 to 52|Protocol Violation|5
5574285|NCT01079234|19263436|P3|Extension: Week 27 to 52|Protocol Violation|2
5574286|NCT01079234|19263437|P2|Extension: Week 27 to 52|Protocol Violation|0
5574287|NCT01079234|19263438|P1|Extension: Week 27 to 52|Protocol Violation|0
5574288|NCT01079234|19263435|P4|Extension: Week 27 to 52|Lack of Efficacy|2
5574289|NCT01079234|19263436|P3|Extension: Week 27 to 52|Lack of Efficacy|0
5574290|NCT01079234|19263437|P2|Extension: Week 27 to 52|Lack of Efficacy|0
5574291|NCT01079234|19263438|P1|Extension: Week 27 to 52|Lack of Efficacy|0
5574292|NCT01079234|19263435|P4|Extension: Week 27 to 52|Adverse Event|0
5574293|NCT01079234|19263436|P3|Extension: Week 27 to 52|Adverse Event|1
5574294|NCT01079234|19263437|P2|Extension: Week 27 to 52|Adverse Event|0
5574295|NCT01079234|19263438|P1|Extension: Week 27 to 52|Adverse Event|0
5574296|NCT01079234|19263435|P4|Main: Week 0 to 26|Unclassified|0
5574297|NCT01079234|19263436|P3|Main: Week 0 to 26|Unclassified|4
5574298|NCT01079234|19263437|P2|Main: Week 0 to 26|Unclassified|13
5574299|NCT01079234|19263438|P1|Main: Week 0 to 26|Unclassified|7
5574300|NCT01079234|19263435|P4|Main: Week 0 to 26|Withdrawal criteria|0
5574301|NCT01079234|19263436|P3|Main: Week 0 to 26|Withdrawal criteria|2
5574302|NCT01079234|19263437|P2|Main: Week 0 to 26|Withdrawal criteria|6
5574303|NCT01079234|19263438|P1|Main: Week 0 to 26|Withdrawal criteria|6
5574304|NCT01079234|19263435|P4|Main: Week 0 to 26|Protocol Violation|0
5574305|NCT01079234|19263436|P3|Main: Week 0 to 26|Protocol Violation|4
5574306|NCT01079234|19263437|P2|Main: Week 0 to 26|Protocol Violation|2
5574307|NCT01079234|19263438|P1|Main: Week 0 to 26|Protocol Violation|6
5574308|NCT01079234|19263435|P4|Main: Week 0 to 26|Lack of Efficacy|0
5574309|NCT01079234|19263436|P3|Main: Week 0 to 26|Lack of Efficacy|1
5574310|NCT01079234|19263437|P2|Main: Week 0 to 26|Lack of Efficacy|1
5574311|NCT01079234|19263438|P1|Main: Week 0 to 26|Lack of Efficacy|2
5574312|NCT01079234|19263435|P4|Main: Week 0 to 26|Adverse Event|0
5574313|NCT01079234|19263436|P3|Main: Week 0 to 26|Adverse Event|1
5574314|NCT01079234|19263437|P2|Main: Week 0 to 26|Adverse Event|4
5574315|NCT01079234|19263438|P1|Main: Week 0 to 26|Adverse Event|5
5574316|NCT01079195|19263456|P1|Overall Study|Non-compliance|2
5574317|NCT01079195|19263456|P1|Overall Study|No Follow-up Documentation Available|4
5574318|NCT01079195|19263456|P1|Overall Study|Improved Status of Participant|4
5574319|NCT01079195|19263456|P1|Overall Study|Physician Decision|4
5574320|NCT01079195|19263456|P1|Overall Study|Lack of Effectiveness|12
5574321|NCT01079195|19263456|P1|Overall Study|Financial Reasons|15
5574322|NCT01079195|19263456|P1|Overall Study|Withdrawal by Subject|18
5574323|NCT01079195|19263456|P1|Overall Study|Reason Unknown|39
5574324|NCT01079195|19263456|P1|Overall Study|Adverse Event|157
5574325|NCT01079195|19263456|P1|Overall Study|No Documentation Available|437
5574326|NCT01079195|19263456|P1|Overall Study|No Documentation of Tarka Therapy|739
5574327|NCT01079182|19263462|P1|Overall Study|Reasons not Evaluated|271
5574328|NCT01079182|19263462|P1|Overall Study|ADR and Lack of Effectiveness|39
5574329|NCT01079182|19263462|P1|Overall Study|Lack of Efficacy|514
5574330|NCT01079182|19263462|P1|Overall Study|Adverse Drug Reaction (ADR)|261
5574331|NCT01079182|19263462|P1|Overall Study|Lost to Follow-up|1634
5574332|NCT01079130|19263570|P6|Overall Study|Lost to Follow-up|0
5574333|NCT01079130|19263571|P5|Overall Study|Lost to Follow-up|1
5574334|NCT01079130|19263572|P4|Overall Study|Lost to Follow-up|0
5574335|NCT01079130|19263573|P3|Overall Study|Lost to Follow-up|0
5574336|NCT01079130|19263574|P2|Overall Study|Lost to Follow-up|0
5574337|NCT01079130|19263575|P1|Overall Study|Lost to Follow-up|0
5574338|NCT01079130|19263570|P6|Overall Study|Unsatisfactory therapeutic effect|0
5574339|NCT01079130|19263571|P5|Overall Study|Unsatisfactory therapeutic effect|0
5574340|NCT01079130|19263572|P4|Overall Study|Unsatisfactory therapeutic effect|2
5574341|NCT01079130|19263573|P3|Overall Study|Unsatisfactory therapeutic effect|0
5574342|NCT01079130|19263574|P2|Overall Study|Unsatisfactory therapeutic effect|0
5574343|NCT01079130|19263575|P1|Overall Study|Unsatisfactory therapeutic effect|0
5574344|NCT01079130|19263570|P6|Overall Study|Abnormal test procedure result(s)|0
5574345|NCT01079130|19263571|P5|Overall Study|Abnormal test procedure result(s)|1
5574346|NCT01079130|19263572|P4|Overall Study|Abnormal test procedure result(s)|0
5574347|NCT01079130|19263573|P3|Overall Study|Abnormal test procedure result(s)|0
5574348|NCT01079130|19263574|P2|Overall Study|Abnormal test procedure result(s)|0
5574349|NCT01079130|19263575|P1|Overall Study|Abnormal test procedure result(s)|0
5574350|NCT01079130|19263570|P6|Overall Study|Protocol deviation|0
5574351|NCT01079130|19263571|P5|Overall Study|Protocol deviation|0
5574352|NCT01079130|19263572|P4|Overall Study|Protocol deviation|2
5574353|NCT01079130|19263573|P3|Overall Study|Protocol deviation|1
5574354|NCT01079130|19263574|P2|Overall Study|Protocol deviation|2
5574355|NCT01079130|19263575|P1|Overall Study|Protocol deviation|0
5574356|NCT01079130|19263570|P6|Overall Study|Withdrawal by Subject|3
5574357|NCT01079130|19263571|P5|Overall Study|Withdrawal by Subject|1
5574358|NCT01079130|19263572|P4|Overall Study|Withdrawal by Subject|0
5574359|NCT01079130|19263573|P3|Overall Study|Withdrawal by Subject|0
5574360|NCT01079130|19263574|P2|Overall Study|Withdrawal by Subject|1
5574361|NCT01079130|19263575|P1|Overall Study|Withdrawal by Subject|0
5574362|NCT01079130|19263570|P6|Overall Study|Administrative problems|1
5574363|NCT01079130|19263571|P5|Overall Study|Administrative problems|0
5574364|NCT01079130|19263572|P4|Overall Study|Administrative problems|0
5574365|NCT01079130|19263573|P3|Overall Study|Administrative problems|0
5574366|NCT01079130|19263574|P2|Overall Study|Administrative problems|3
5574367|NCT01079130|19263575|P1|Overall Study|Administrative problems|1
5574368|NCT01079130|19263570|P6|Overall Study|Adverse Event|1
5574369|NCT01079130|19263571|P5|Overall Study|Adverse Event|5
5574370|NCT01079130|19263572|P4|Overall Study|Adverse Event|1
5574371|NCT01079130|19263573|P3|Overall Study|Adverse Event|0
5574372|NCT01079130|19263574|P2|Overall Study|Adverse Event|1
5574373|NCT01079130|19263575|P1|Overall Study|Adverse Event|1
5574374|NCT01078974|19263595|P1|Overall Study|Adverse Event|3
5574375|NCT01078922|19263600|P1|Overall Study|Adverse Event|1
5574376|NCT01078805|19263641|P1|Overall Study|Didn't take study drug|82
5574377|NCT01078805|19263641|P1|Overall Study|Other|173
5574378|NCT01078805|19263641|P1|Overall Study|Withdrawal by Subject|739
5574379|NCT01078805|19263641|P1|Overall Study|Sponsor decision|46
5574380|NCT01078805|19263641|P1|Overall Study|Serious adverse event|26
5574381|NCT01078805|19263641|P1|Overall Study|Physician Decision|169
5574382|NCT01078805|19263641|P1|Overall Study|Lost to Follow-up|676
5574383|NCT01078805|19263641|P1|Overall Study|Death|134
5574384|NCT01078805|19263641|P1|Overall Study|Clinically significant abnormal lab|5
5574385|NCT01078675|19263668|P2|Overall Study|Adverse Event|0
5574386|NCT01078675|19263669|P1|Overall Study|Adverse Event|3
5574387|NCT01078675|19263668|P2|Overall Study|Provided in CRF for specific reasons|3
5574388|NCT01078675|19263669|P1|Overall Study|Provided in CRF for specific reasons|2
5574389|NCT01078675|19263668|P2|Overall Study|Protocol Violation|0
5574390|NCT01078675|19263669|P1|Overall Study|Protocol Violation|56
5574391|NCT01078675|19263668|P2|Overall Study|Withdrawal by Subject|3
5574392|NCT01078675|19263669|P1|Overall Study|Withdrawal by Subject|7
5574393|NCT01078662|19263691|P5|Overall Study|Lost to Follow-up|0
5574394|NCT01078662|19263692|P4|Overall Study|Lost to Follow-up|0
5574395|NCT01078662|19263693|P3|Overall Study|Lost to Follow-up|0
5574396|NCT01078662|19263694|P2|Overall Study|Lost to Follow-up|0
5574397|NCT01078662|19263695|P1|Overall Study|Lost to Follow-up|1
5574398|NCT01078662|19263691|P5|Overall Study|Protocol Violation|0
5574399|NCT01078662|19263692|P4|Overall Study|Protocol Violation|0
5574400|NCT01078662|19263693|P3|Overall Study|Protocol Violation|0
5574401|NCT01078662|19263694|P2|Overall Study|Protocol Violation|1
5574402|NCT01078662|19263695|P1|Overall Study|Protocol Violation|0
5574403|NCT01078662|19263691|P5|Overall Study|Withdrawal by Subject|0
5574404|NCT01078662|19263692|P4|Overall Study|Withdrawal by Subject|0
5574405|NCT01078662|19263693|P3|Overall Study|Withdrawal by Subject|1
5574406|NCT01078662|19263694|P2|Overall Study|Withdrawal by Subject|11
5574407|NCT01078662|19263695|P1|Overall Study|Withdrawal by Subject|4
5574408|NCT01078662|19263691|P5|Overall Study|Patients reached data cut-off|3
5574409|NCT01078662|19263692|P4|Overall Study|Patients reached data cut-off|2
5574410|NCT01078662|19263693|P3|Overall Study|Patients reached data cut-off|2
5574411|NCT01078662|19263694|P2|Overall Study|Patients reached data cut-off|53
5574412|NCT01078662|19263695|P1|Overall Study|Patients reached data cut-off|12
5574413|NCT01078662|19263691|P5|Overall Study|Death|8
5574414|NCT01078662|19263692|P4|Overall Study|Death|5
5574415|NCT01078662|19263693|P3|Overall Study|Death|18
5574416|NCT01078662|19263694|P2|Overall Study|Death|103
5574417|NCT01078662|19263695|P1|Overall Study|Death|41
5574418|NCT01078623|19263734|P20|Treatment Period 4|Withdrawal by Subject|0
5574419|NCT01078623|19263735|P19|Treatment Period 4|Withdrawal by Subject|0
5574420|NCT01078623|19263736|P18|Treatment Period 4|Withdrawal by Subject|0
5574421|NCT01078623|19263737|P17|Treatment Period 4|Withdrawal by Subject|0
5574422|NCT01078623|19263738|P16|Treatment Period 4|Withdrawal by Subject|1
5574423|NCT01078623|19263739|P15|Treatment Period 4|Withdrawal by Subject|0
5574424|NCT01078623|19263740|P14|Treatment Period 4|Withdrawal by Subject|0
5574425|NCT01078623|19263741|P13|Treatment Period 4|Withdrawal by Subject|0
5574426|NCT01078623|19263742|P12|Treatment Period 4|Withdrawal by Subject|0
5574427|NCT01078623|19263743|P11|Treatment Period 4|Withdrawal by Subject|0
5574428|NCT01078623|19263744|P10|Treatment Period 4|Withdrawal by Subject|0
5574429|NCT01078623|19263745|P9|Treatment Period 4|Withdrawal by Subject|0
5574430|NCT01078623|19263746|P8|Treatment Period 4|Withdrawal by Subject|0
5574431|NCT01078623|19263747|P7|Treatment Period 4|Withdrawal by Subject|0
5574432|NCT01078623|19263748|P6|Treatment Period 4|Withdrawal by Subject|0
5574433|NCT01078623|19263749|P5|Treatment Period 4|Withdrawal by Subject|0
5574434|NCT01078623|19263750|P4|Treatment Period 4|Withdrawal by Subject|0
5574435|NCT01078623|19263751|P3|Treatment Period 4|Withdrawal by Subject|0
5574436|NCT01078623|19263752|P2|Treatment Period 4|Withdrawal by Subject|0
5574437|NCT01078623|19263753|P1|Treatment Period 4|Withdrawal by Subject|0
5574438|NCT01078623|19263734|P20|Treatment Period 4|Adverse Event|0
5574439|NCT01078623|19263735|P19|Treatment Period 4|Adverse Event|0
5574440|NCT01078623|19263736|P18|Treatment Period 4|Adverse Event|0
5574441|NCT01078623|19263737|P17|Treatment Period 4|Adverse Event|0
5574442|NCT01078623|19263738|P16|Treatment Period 4|Adverse Event|0
5574443|NCT01078623|19263739|P15|Treatment Period 4|Adverse Event|0
5574444|NCT01078623|19263740|P14|Treatment Period 4|Adverse Event|0
5574445|NCT01078623|19263741|P13|Treatment Period 4|Adverse Event|0
5574446|NCT01078623|19263742|P12|Treatment Period 4|Adverse Event|0
5574447|NCT01078623|19263743|P11|Treatment Period 4|Adverse Event|0
5574448|NCT01078623|19263744|P10|Treatment Period 4|Adverse Event|0
5574449|NCT01078623|19263745|P9|Treatment Period 4|Adverse Event|0
5574450|NCT01078623|19263746|P8|Treatment Period 4|Adverse Event|0
5574451|NCT01078623|19263747|P7|Treatment Period 4|Adverse Event|0
5574452|NCT01078623|19263748|P6|Treatment Period 4|Adverse Event|0
5574453|NCT01078623|19263749|P5|Treatment Period 4|Adverse Event|0
5574454|NCT01078623|19263750|P4|Treatment Period 4|Adverse Event|0
5574455|NCT01078623|19263751|P3|Treatment Period 4|Adverse Event|1
5574456|NCT01078623|19263752|P2|Treatment Period 4|Adverse Event|0
5574457|NCT01078623|19263753|P1|Treatment Period 4|Adverse Event|0
5574458|NCT01078623|19263734|P20|Treatment Period 3|Adverse Event|0
5574459|NCT01078623|19263735|P19|Treatment Period 3|Adverse Event|0
5574460|NCT01078623|19263736|P18|Treatment Period 3|Adverse Event|0
5574461|NCT01078623|19263737|P17|Treatment Period 3|Adverse Event|0
5574462|NCT01078623|19263738|P16|Treatment Period 3|Adverse Event|0
5574463|NCT01078623|19263739|P15|Treatment Period 3|Adverse Event|0
5574464|NCT01078623|19263740|P14|Treatment Period 3|Adverse Event|1
5574465|NCT01078623|19263741|P13|Treatment Period 3|Adverse Event|0
5574466|NCT01078623|19263742|P12|Treatment Period 3|Adverse Event|0
5574467|NCT01078623|19263743|P11|Treatment Period 3|Adverse Event|0
5574468|NCT01078623|19263744|P10|Treatment Period 3|Adverse Event|0
5574469|NCT01078623|19263745|P9|Treatment Period 3|Adverse Event|0
5574470|NCT01078623|19263746|P8|Treatment Period 3|Adverse Event|0
5574471|NCT01078623|19263747|P7|Treatment Period 3|Adverse Event|0
5574472|NCT01078623|19263748|P6|Treatment Period 3|Adverse Event|0
5574473|NCT01078623|19263749|P5|Treatment Period 3|Adverse Event|1
5574474|NCT01078623|19263750|P4|Treatment Period 3|Adverse Event|0
5574475|NCT01078623|19263751|P3|Treatment Period 3|Adverse Event|0
5574476|NCT01078623|19263752|P2|Treatment Period 3|Adverse Event|0
5574477|NCT01078623|19263753|P1|Treatment Period 3|Adverse Event|0
5574478|NCT01078623|19263734|P20|Treatment Period 2|Withdrawal by Subject|0
5574479|NCT01078623|19263735|P19|Treatment Period 2|Withdrawal by Subject|0
5574480|NCT01078623|19263736|P18|Treatment Period 2|Withdrawal by Subject|0
5574481|NCT01078623|19263737|P17|Treatment Period 2|Withdrawal by Subject|0
5574482|NCT01078623|19263738|P16|Treatment Period 2|Withdrawal by Subject|0
5574483|NCT01078623|19263739|P15|Treatment Period 2|Withdrawal by Subject|0
5574484|NCT01078623|19263740|P14|Treatment Period 2|Withdrawal by Subject|0
5574485|NCT01078623|19263741|P13|Treatment Period 2|Withdrawal by Subject|0
5574486|NCT01078623|19263742|P12|Treatment Period 2|Withdrawal by Subject|0
5574487|NCT01078623|19263743|P11|Treatment Period 2|Withdrawal by Subject|0
5574488|NCT01078623|19263744|P10|Treatment Period 2|Withdrawal by Subject|0
5574489|NCT01078623|19263745|P9|Treatment Period 2|Withdrawal by Subject|0
5574490|NCT01078623|19263746|P8|Treatment Period 2|Withdrawal by Subject|0
5574491|NCT01078623|19263747|P7|Treatment Period 2|Withdrawal by Subject|0
5574492|NCT01078623|19263748|P6|Treatment Period 2|Withdrawal by Subject|1
5574493|NCT01078623|19263749|P5|Treatment Period 2|Withdrawal by Subject|0
5574494|NCT01078623|19263750|P4|Treatment Period 2|Withdrawal by Subject|0
5574495|NCT01078623|19263751|P3|Treatment Period 2|Withdrawal by Subject|0
5574496|NCT01078623|19263752|P2|Treatment Period 2|Withdrawal by Subject|0
5574497|NCT01078623|19263753|P1|Treatment Period 2|Withdrawal by Subject|0
5574498|NCT01078623|19263734|P20|Treatment Period 2|Adverse Event|0
5574499|NCT01078623|19263735|P19|Treatment Period 2|Adverse Event|1
5574500|NCT01078623|19263736|P18|Treatment Period 2|Adverse Event|0
5574501|NCT01078623|19263737|P17|Treatment Period 2|Adverse Event|0
5574502|NCT01078623|19263738|P16|Treatment Period 2|Adverse Event|0
5574503|NCT01078623|19263739|P15|Treatment Period 2|Adverse Event|0
5574504|NCT01078623|19263740|P14|Treatment Period 2|Adverse Event|0
5574505|NCT01078623|19263741|P13|Treatment Period 2|Adverse Event|0
5574506|NCT01078623|19263742|P12|Treatment Period 2|Adverse Event|0
5574507|NCT01078623|19263743|P11|Treatment Period 2|Adverse Event|0
5574508|NCT01078623|19263744|P10|Treatment Period 2|Adverse Event|0
5574509|NCT01078623|19263745|P9|Treatment Period 2|Adverse Event|0
5574510|NCT01078623|19263746|P8|Treatment Period 2|Adverse Event|0
5574511|NCT01078623|19263747|P7|Treatment Period 2|Adverse Event|1
5574512|NCT01078623|19263748|P6|Treatment Period 2|Adverse Event|0
5574513|NCT01078623|19263749|P5|Treatment Period 2|Adverse Event|0
5574514|NCT01078623|19263750|P4|Treatment Period 2|Adverse Event|0
5574515|NCT01078623|19263751|P3|Treatment Period 2|Adverse Event|0
5574516|NCT01078623|19263752|P2|Treatment Period 2|Adverse Event|0
5574517|NCT01078623|19263753|P1|Treatment Period 2|Adverse Event|0
5574518|NCT01078623|19263734|P20|Treatment Period 1|Protocol Violation|0
5574519|NCT01078623|19263735|P19|Treatment Period 1|Protocol Violation|0
5574520|NCT01078623|19263736|P18|Treatment Period 1|Protocol Violation|0
5574521|NCT01078623|19263737|P17|Treatment Period 1|Protocol Violation|0
5574522|NCT01078623|19263738|P16|Treatment Period 1|Protocol Violation|0
5574523|NCT01078623|19263739|P15|Treatment Period 1|Protocol Violation|0
5574524|NCT01078623|19263740|P14|Treatment Period 1|Protocol Violation|0
5574525|NCT01078623|19263741|P13|Treatment Period 1|Protocol Violation|0
5574526|NCT01078623|19263742|P12|Treatment Period 1|Protocol Violation|0
5574527|NCT01078623|19263743|P11|Treatment Period 1|Protocol Violation|0
5574528|NCT01078623|19263744|P10|Treatment Period 1|Protocol Violation|0
5574529|NCT01078623|19263745|P9|Treatment Period 1|Protocol Violation|0
5574530|NCT01078623|19263746|P8|Treatment Period 1|Protocol Violation|0
5574531|NCT01078623|19263747|P7|Treatment Period 1|Protocol Violation|0
5574532|NCT01078623|19263748|P6|Treatment Period 1|Protocol Violation|1
5574533|NCT01078623|19263749|P5|Treatment Period 1|Protocol Violation|0
5574534|NCT01078623|19263750|P4|Treatment Period 1|Protocol Violation|0
5574535|NCT01078623|19263751|P3|Treatment Period 1|Protocol Violation|0
5574536|NCT01078623|19263752|P2|Treatment Period 1|Protocol Violation|0
5574537|NCT01078623|19263753|P1|Treatment Period 1|Protocol Violation|0
5574538|NCT01078623|19263734|P20|Treatment Period 1|Withdrawal by Subject|0
5574539|NCT01078623|19263735|P19|Treatment Period 1|Withdrawal by Subject|0
5574540|NCT01078623|19263736|P18|Treatment Period 1|Withdrawal by Subject|0
5574541|NCT01078623|19263737|P17|Treatment Period 1|Withdrawal by Subject|0
5574542|NCT01078623|19263738|P16|Treatment Period 1|Withdrawal by Subject|0
5574543|NCT01078623|19263739|P15|Treatment Period 1|Withdrawal by Subject|0
5574544|NCT01078623|19263740|P14|Treatment Period 1|Withdrawal by Subject|0
5574545|NCT01078623|19263741|P13|Treatment Period 1|Withdrawal by Subject|0
5574546|NCT01078623|19263742|P12|Treatment Period 1|Withdrawal by Subject|0
5574547|NCT01078623|19263743|P11|Treatment Period 1|Withdrawal by Subject|1
5574548|NCT01078623|19263744|P10|Treatment Period 1|Withdrawal by Subject|0
5574549|NCT01078623|19263745|P9|Treatment Period 1|Withdrawal by Subject|0
5574550|NCT01078623|19263746|P8|Treatment Period 1|Withdrawal by Subject|1
5574551|NCT01078623|19263747|P7|Treatment Period 1|Withdrawal by Subject|0
5574552|NCT01078623|19263748|P6|Treatment Period 1|Withdrawal by Subject|0
5574553|NCT01078623|19263749|P5|Treatment Period 1|Withdrawal by Subject|0
5574554|NCT01078623|19263750|P4|Treatment Period 1|Withdrawal by Subject|0
5574555|NCT01078623|19263751|P3|Treatment Period 1|Withdrawal by Subject|0
5574556|NCT01078623|19263752|P2|Treatment Period 1|Withdrawal by Subject|0
5574557|NCT01078623|19263753|P1|Treatment Period 1|Withdrawal by Subject|0
5574558|NCT01078623|19263734|P20|Treatment Period 1|Adverse Event|0
5574559|NCT01078623|19263735|P19|Treatment Period 1|Adverse Event|0
5574560|NCT01078623|19263736|P18|Treatment Period 1|Adverse Event|0
5574561|NCT01078623|19263737|P17|Treatment Period 1|Adverse Event|0
5574562|NCT01078623|19263738|P16|Treatment Period 1|Adverse Event|0
5574563|NCT01078623|19263739|P15|Treatment Period 1|Adverse Event|0
5574564|NCT01078623|19263740|P14|Treatment Period 1|Adverse Event|0
5574565|NCT01078623|19263741|P13|Treatment Period 1|Adverse Event|0
5574566|NCT01078623|19263742|P12|Treatment Period 1|Adverse Event|0
5574567|NCT01078623|19263743|P11|Treatment Period 1|Adverse Event|0
5574568|NCT01078623|19263744|P10|Treatment Period 1|Adverse Event|1
5574569|NCT01078623|19263745|P9|Treatment Period 1|Adverse Event|1
5574570|NCT01078623|19263746|P8|Treatment Period 1|Adverse Event|0
5574571|NCT01078623|19263747|P7|Treatment Period 1|Adverse Event|1
5574572|NCT01078623|19263748|P6|Treatment Period 1|Adverse Event|0
5574573|NCT01078623|19263749|P5|Treatment Period 1|Adverse Event|0
5574574|NCT01078623|19263750|P4|Treatment Period 1|Adverse Event|0
5574575|NCT01078623|19263751|P3|Treatment Period 1|Adverse Event|1
5574576|NCT01078623|19263752|P2|Treatment Period 1|Adverse Event|1
5574577|NCT01078623|19263753|P1|Treatment Period 1|Adverse Event|1
5574578|NCT01078584|19263775|P1|Overall Study|Multiple Reasons|2
5574579|NCT01078584|19263775|P1|Overall Study|Serious Adverse Event|27
5574580|NCT01078584|19263775|P1|Overall Study|Protocol Violation|75
5574581|NCT01078584|19263775|P1|Overall Study|Lack of Efficacy|98
5574582|NCT01078584|19263775|P1|Overall Study|Physician Discontinued Patient|12
5574583|NCT01078584|19263775|P1|Overall Study|Physician Switched Medication|26
5574584|NCT01078584|19263775|P1|Overall Study|Blood Pressure Controlled|49
5574585|NCT01078584|19263775|P1|Overall Study|Non-compliance|67
5574586|NCT01078584|19263775|P1|Overall Study|Physician Withdrew from Study|90
5574587|NCT01078584|19263775|P1|Overall Study|Withdrawal of Consent|244
5574588|NCT01078584|19263775|P1|Overall Study|Non-serious Adverse Event|577
5574589|NCT01078584|19263775|P1|Overall Study|Lost to Follow-up|670
5574590|NCT01078584|19263775|P1|Overall Study|Final Status Unknown|1073
5574591|NCT01078571|19263856|P1|Overall Study|Protocol Violation|2
5574592|NCT01078571|19263856|P1|Overall Study|Lost to Follow-up|8
5574593|NCT01078571|19263856|P1|Overall Study|Withdrawal by Subject|12
5574594|NCT01078571|19263856|P1|Overall Study|Reason not reported|21
5574595|NCT01078571|19263856|P1|Overall Study|Lack of effectiveness|36
5574596|NCT01078571|19263856|P1|Overall Study|Adverse Event|36
5574597|NCT01078545|19263907|P1|Overall Study|Participant moved to another physician|1
5574598|NCT01078545|19263907|P1|Overall Study|Death|3
5574599|NCT01078545|19263907|P1|Overall Study|Withdrawal by Subject|3
5574600|NCT01078545|19263907|P1|Overall Study|Physician Decision|6
5574601|NCT01078545|19263907|P1|Overall Study|Lost to Follow-up|13
5574602|NCT01078454|19263917|P2|Overall Study|Death|1
5574603|NCT01078454|19263918|P1|Overall Study|Death|0
5574604|NCT01078454|19263917|P2|Overall Study|Adverse Event|1
5574605|NCT01078454|19263918|P1|Overall Study|Adverse Event|1
5574606|NCT01078441|19263924|P1|Overall Study|Withdrawal by Subject|1
5574607|NCT01078389|19263964|P2|Overall Study|Other|2
5574608|NCT01078389|19263965|P1|Overall Study|Other|9
5574609|NCT01078389|19263964|P2|Overall Study|Voluntary Withdrawal|36
5574610|NCT01078389|19263965|P1|Overall Study|Voluntary Withdrawal|20
5574611|NCT01078389|19263964|P2|Overall Study|Lost to Follow-up|23
5574612|NCT01078389|19263965|P1|Overall Study|Lost to Follow-up|23
5574613|NCT01078389|19263964|P2|Overall Study|Major Protocol Deviation|0
5574614|NCT01078389|19263965|P1|Overall Study|Major Protocol Deviation|2
5574615|NCT01078389|19263964|P2|Overall Study|Adverse Event|6
5574616|NCT01078389|19263965|P1|Overall Study|Adverse Event|10
5574617|NCT01078298|19264126|P2|Overall Study|Other|32
5574618|NCT01078298|19264127|P1|Overall Study|Other|24
5574619|NCT01078298|19264126|P2|Overall Study|Did not meet entrance criteria|1
5574620|NCT01078298|19264127|P1|Overall Study|Did not meet entrance criteria|0
5574621|NCT01078298|19264126|P2|Overall Study|Death|0
5574622|NCT01078298|19264127|P1|Overall Study|Death|2
5574623|NCT01078298|19264126|P2|Overall Study|Adverse Event|5
5574624|NCT01078298|19264127|P1|Overall Study|Adverse Event|6
5574625|NCT01078298|19264126|P2|Overall Study|Protocol Violation|6
5574626|NCT01078298|19264127|P1|Overall Study|Protocol Violation|6
5574627|NCT01078298|19264126|P2|Overall Study|Withdrawal by Subject|33
5574628|NCT01078298|19264127|P1|Overall Study|Withdrawal by Subject|31
5574629|NCT01078298|19264126|P2|Overall Study|Lost to Follow-up|13
5574630|NCT01078298|19264127|P1|Overall Study|Lost to Follow-up|12
5574631|NCT01078168|19264237|P2|Overall Study|Physician Decision|1
5574632|NCT01078168|19264238|P1|Overall Study|Physician Decision|0
5574633|NCT01078155|19264244|P1|Overall Study|Lost to Follow-up|15
5574634|NCT01078155|19264244|P1|Overall Study|Participant's Decision|6
5574635|NCT01078155|19264244|P1|Overall Study|Lack of Efficacy|16
5574636|NCT01078155|19264244|P1|Overall Study|Adverse Event|7
5574637|NCT01078116|19264260|P1|Overall Study|Case report form not completed|3
5574638|NCT01078116|19264260|P1|Overall Study|Lack of effectiveness|15
5574639|NCT01078116|19264260|P1|Overall Study|Withdrawal by Subject|8
5574640|NCT01078116|19264260|P1|Overall Study|Adverse Event|5
5574641|NCT01078116|19264260|P1|Overall Study|Lost to Follow-up|17
5574642|NCT01078090|19264268|P1|Overall Study|Other|523
5574643|NCT01078090|19264268|P1|Overall Study|ADR and lack of efficacy|61
5574644|NCT01078090|19264268|P1|Overall Study|Lack of Efficacy|1193
5574645|NCT01078090|19264268|P1|Overall Study|Adverse drug reaction (ADR)|453
5574646|NCT01078090|19264268|P1|Overall Study|Lost to Follow-up|2363
5574647|NCT01077960|19264362|P1|Overall Study|Reason unspecified|1
5574648|NCT01077960|19264362|P1|Overall Study|Subject decision|1
5574649|NCT01077960|19264362|P1|Overall Study|Lost to Follow-up|5
5574650|NCT01077960|19264362|P1|Overall Study|Protocol Violation|3
5574651|NCT01077960|19264362|P1|Overall Study|Adverse Event|6
5574652|NCT01077804|19264612|P1|Overall Study|Other|18
5574653|NCT01077804|19264612|P1|Overall Study|Refused to continue|79
5574654|NCT01077804|19264612|P1|Overall Study|Unreachable|102
5574655|NCT01077739|19264621|P2|Overall Study|Other|2
5574656|NCT01077739|19264622|P1|Overall Study|Other|2
5574657|NCT01077739|19264621|P2|Overall Study|Unacceptable toxicity|2
5574658|NCT01077739|19264622|P1|Overall Study|Unacceptable toxicity|1
5574659|NCT01077739|19264621|P2|Overall Study|Death|3
5574660|NCT01077739|19264622|P1|Overall Study|Death|0
5574661|NCT01077739|19264621|P2|Overall Study|Withdrawal by Subject|0
5574662|NCT01077739|19264622|P1|Overall Study|Withdrawal by Subject|1
5574663|NCT01077739|19264621|P2|Overall Study|Premature withdrawal|3
5574664|NCT01077739|19264622|P1|Overall Study|Premature withdrawal|1
5574665|NCT01077713|19264636|P2|Overall Study|Other|2
5574666|NCT01077713|19264637|P1|Overall Study|Other|4
5574667|NCT01077713|19264636|P2|Overall Study|Adverse Event|1
5574668|NCT01077713|19264637|P1|Overall Study|Adverse Event|2
5574669|NCT01077713|19264636|P2|Overall Study|Lost to Follow-up|1
5574670|NCT01077713|19264637|P1|Overall Study|Lost to Follow-up|1
5574671|NCT01077713|19264636|P2|Overall Study|Death|29
5574672|NCT01077713|19264637|P1|Overall Study|Death|28
5574673|NCT01077713|19264636|P2|Overall Study|Progressive Disease (PD)|1
5574674|NCT01077713|19264637|P1|Overall Study|Progressive Disease (PD)|0
5574675|NCT01077713|19264636|P2|Overall Study|Withdrawal by Subject|2
5574676|NCT01077713|19264637|P1|Overall Study|Withdrawal by Subject|1
5574677|NCT01077622|19264661|P1|Overall Study|Withdrawal by Subject|1
5574678|NCT01077622|19264661|P1|Overall Study|Physician Decision|2
5574679|NCT01077544|19264781|P2|Overall Study|Disease Progression|1
5574680|NCT01077544|19264782|P1|Overall Study|Disease Progression|0
5574681|NCT01077544|19264781|P2|Overall Study|Adverse Event|1
5574682|NCT01077544|19264782|P1|Overall Study|Adverse Event|0
5574683|NCT01077544|19264781|P2|Overall Study|New Cancer Therapy|3
5574684|NCT01077544|19264782|P1|Overall Study|New Cancer Therapy|3
5574685|NCT01077518|19264810|P3|Optional Ofa Phase|Withdrawal by Subject|3
5574686|NCT01077518|19264811|P2|Optional Ofa Phase|Withdrawal by Subject|0
5574687|NCT01077518|19264812|P1|Optional Ofa Phase|Withdrawal by Subject|0
5574688|NCT01077518|19264810|P3|Optional Ofa Phase|Study Terminated by Sponsor|12
5574689|NCT01077518|19264811|P2|Optional Ofa Phase|Study Terminated by Sponsor|0
5574690|NCT01077518|19264812|P1|Optional Ofa Phase|Study Terminated by Sponsor|0
5574691|NCT01077518|19264810|P3|Optional Ofa Phase|Physician Decision|1
5574692|NCT01077518|19264811|P2|Optional Ofa Phase|Physician Decision|0
5574693|NCT01077518|19264812|P1|Optional Ofa Phase|Physician Decision|0
5574694|NCT01077518|19264810|P3|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
5574695|NCT01077518|19264811|P2|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
5574696|NCT01077518|19264812|P1|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
5574697|NCT01077518|19264810|P3|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
5574698|NCT01077518|19264811|P2|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
5574699|NCT01077518|19264812|P1|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
5574700|NCT01077518|19264810|P3|Treatment Phase - no Optional Ofa|Physician Decision|0
5574701|NCT01077518|19264811|P2|Treatment Phase - no Optional Ofa|Physician Decision|11
5574702|NCT01077518|19264812|P1|Treatment Phase - no Optional Ofa|Physician Decision|10
5574703|NCT01077518|19264810|P3|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
5574704|NCT01077518|19264811|P2|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
5574705|NCT01077518|19264812|P1|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
5574706|NCT01077375|19264885|P2|Overall Study|Other Reason|1
5574707|NCT01077375|19264886|P1|Overall Study|Other Reason|0
5574708|NCT01077375|19264885|P2|Overall Study|Lost to Follow-up|5
5574709|NCT01077375|19264886|P1|Overall Study|Lost to Follow-up|2
5574710|NCT01077375|19264885|P2|Overall Study|Withdrawal by Subject|6
5574711|NCT01077375|19264886|P1|Overall Study|Withdrawal by Subject|0
5574712|NCT01077375|19264885|P2|Overall Study|Lack of Efficacy|8
5574713|NCT01077375|19264886|P1|Overall Study|Lack of Efficacy|6
5574714|NCT01077375|19264885|P2|Overall Study|Adverse Event|15
5574715|NCT01077375|19264886|P1|Overall Study|Adverse Event|2
5574716|NCT01077362|19264897|P3|Overall Study|Other|2
5574717|NCT01077362|19264898|P2|Overall Study|Other|1
5574718|NCT01077362|19264899|P1|Overall Study|Other|0
5574719|NCT01077362|19264897|P3|Overall Study|Withdrawal by Subject|5
5574720|NCT01077362|19264898|P2|Overall Study|Withdrawal by Subject|3
5574721|NCT01077362|19264899|P1|Overall Study|Withdrawal by Subject|5
5574722|NCT01077362|19264897|P3|Overall Study|Adverse Event|4
5574723|NCT01077362|19264898|P2|Overall Study|Adverse Event|7
5574724|NCT01077362|19264899|P1|Overall Study|Adverse Event|12
5574725|NCT01077362|19264897|P3|Overall Study|Lost to Follow-up|3
5574726|NCT01077362|19264898|P2|Overall Study|Lost to Follow-up|0
5574727|NCT01077362|19264899|P1|Overall Study|Lost to Follow-up|1
5574728|NCT01077362|19264897|P3|Overall Study|Lack of Efficacy|10
5574729|NCT01077362|19264898|P2|Overall Study|Lack of Efficacy|8
5574730|NCT01077362|19264899|P1|Overall Study|Lack of Efficacy|13
5574731|NCT01077323|19264935|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
5574732|NCT01077323|19264936|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
5574733|NCT01077323|19264937|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
5574734|NCT01077323|19264935|P3|Overall Study|Dispensing of drug in baseline period|256446
5574735|NCT01077323|19264936|P2|Overall Study|Dispensing of drug in baseline period|120229
5574736|NCT01077323|19264937|P1|Overall Study|Dispensing of drug in baseline period|0
5574737|NCT01077323|19264935|P3|Overall Study|<9 months enroll before drug dispensed|11655523
5574738|NCT01077323|19264936|P2|Overall Study|<9 months enroll before drug dispensed|263954
5574739|NCT01077323|19264937|P1|Overall Study|<9 months enroll before drug dispensed|11226
5574740|NCT01077284|19264980|P3|Overall Study|Other|1
5574741|NCT01077284|19264981|P2|Overall Study|Other|0
5574742|NCT01077284|19264982|P1|Overall Study|Other|0
5574743|NCT01077284|19264980|P3|Overall Study|Withdrawal by Subject|1
5574744|NCT01077284|19264981|P2|Overall Study|Withdrawal by Subject|3
5574745|NCT01077284|19264982|P1|Overall Study|Withdrawal by Subject|2
5574746|NCT01077284|19264980|P3|Overall Study|Lost to Follow-up|0
5574747|NCT01077284|19264981|P2|Overall Study|Lost to Follow-up|2
5574748|NCT01077284|19264982|P1|Overall Study|Lost to Follow-up|1
5574749|NCT01077284|19264980|P3|Overall Study|Adverse Event|1
5574750|NCT01077284|19264981|P2|Overall Study|Adverse Event|0
5574751|NCT01077284|19264982|P1|Overall Study|Adverse Event|2
5574752|NCT01077271|19265003|P1|Overall Study|Mother unconvinced of the necessity|1
5574753|NCT01077271|19265003|P1|Overall Study|End of RSV season nearly reached|1
5574754|NCT01077271|19265003|P1|Overall Study|Parents thought too many injections|2
5574755|NCT01077271|19265003|P1|Overall Study|Changed doctors|2
5574756|NCT01077271|19265003|P1|Overall Study|Quota used up (insurance reimb issue)|2
5574757|NCT01077271|19265003|P1|Overall Study|Noncompliance|2
5574758|NCT01077271|19265003|P1|Overall Study|Screen failure, did not take palivizumab|4
5574759|NCT01077271|19265003|P1|Overall Study|Parental desire|8
5574760|NCT01077258|19265041|P1|Overall Study|Other reasons|260
5574761|NCT01077258|19265041|P1|Overall Study|Clinical remission|37
5574762|NCT01077258|19265041|P1|Overall Study|Lack of Efficacy|663
5574763|NCT01077258|19265041|P1|Overall Study|Adverse drug reaction|218
5574764|NCT01077258|19265041|P1|Overall Study|Lost to Follow-up|1390
5574765|NCT01077193|19265077|P1|Overall Study|Study Terminated by Sponsor|40
5574766|NCT01077193|19265077|P1|Overall Study|Lack of Efficacy|1
5574767|NCT01077193|19265077|P1|Overall Study|Withdrawal by Subject|2
5574768|NCT01077193|19265077|P1|Overall Study|Lost to Follow-up|1
5574769|NCT01077154|19265083|P2|Overall Study|Protocol Deviation|0
5574770|NCT01077154|19265084|P1|Overall Study|Protocol Deviation|1
5574771|NCT01077154|19265083|P2|Overall Study|Administrative Decision|6
5574772|NCT01077154|19265084|P1|Overall Study|Administrative Decision|1
5574773|NCT01077154|19265083|P2|Overall Study|Adverse Event|9
5574774|NCT01077154|19265084|P1|Overall Study|Adverse Event|9
5574775|NCT01077154|19265083|P2|Overall Study|Other|11
5574776|NCT01077154|19265084|P1|Overall Study|Other|14
5574777|NCT01077154|19265083|P2|Overall Study|Ineligibility Determined|14
5574778|NCT01077154|19265084|P1|Overall Study|Ineligibility Determined|10
5574779|NCT01077154|19265083|P2|Overall Study|Disease Progression|20
5574780|NCT01077154|19265084|P1|Overall Study|Disease Progression|18
5574781|NCT01077154|19265083|P2|Overall Study|Noncompliance|20
5574782|NCT01077154|19265084|P1|Overall Study|Noncompliance|22
5574783|NCT01077154|19265083|P2|Overall Study|Lost to Follow-up|35
5574784|NCT01077154|19265084|P1|Overall Study|Lost to Follow-up|43
5574785|NCT01077154|19265083|P2|Overall Study|Death|214
5574786|NCT01077154|19265084|P1|Overall Study|Death|215
5574787|NCT01077154|19265083|P2|Overall Study|Withdrawal by Subject|385
5574788|NCT01077154|19265084|P1|Overall Study|Withdrawal by Subject|369
5574789|NCT01077154|19265083|P2|Overall Study|Protocol-specified Criteria: Study Ended|1514
5574790|NCT01077154|19265084|P1|Overall Study|Protocol-specified Criteria: Study Ended|1524
5574791|NCT01077128|19265098|P1|Overall Study|Other|54
5574792|NCT01077128|19265098|P1|Overall Study|Lack of efficacy/disease exacerbation|1
5574793|NCT01077128|19265098|P1|Overall Study|Adverse event and disease exacerbation|1
5574794|NCT01077128|19265098|P1|Overall Study|Adverse event and consent withdrawal|1
5574795|NCT01077128|19265098|P1|Overall Study|Disease exacerbation|1
5574796|NCT01077128|19265098|P1|Overall Study|Lack of Efficacy|1
5574797|NCT01077128|19265098|P1|Overall Study|Adverse Event|8
5574798|NCT01077076|19265156|P6|Third Intervention|Death in the participant's family|1
5574799|NCT01077076|19265157|P5|Third Intervention|Death in the participant's family|0
5574800|NCT01077076|19265158|P4|Third Intervention|Death in the participant's family|0
5574801|NCT01077076|19265159|P3|Third Intervention|Death in the participant's family|0
5574802|NCT01077076|19265160|P2|Third Intervention|Death in the participant's family|0
5574803|NCT01077076|19265161|P1|Third Intervention|Death in the participant's family|0
5574804|NCT01077076|19265156|P6|First Intervention|Withdrawal by Subject|0
5574805|NCT01077076|19265157|P5|First Intervention|Withdrawal by Subject|0
5574806|NCT01077076|19265158|P4|First Intervention|Withdrawal by Subject|0
5574807|NCT01077076|19265159|P3|First Intervention|Withdrawal by Subject|0
5574808|NCT01077076|19265160|P2|First Intervention|Withdrawal by Subject|0
5574809|NCT01077076|19265161|P1|First Intervention|Withdrawal by Subject|1
5574810|NCT01077063|19265171|P2|Overall Study|Withdrawal by Subject|2
5574811|NCT01077063|19265172|P1|Overall Study|Withdrawal by Subject|0
5574812|NCT01077063|19265171|P2|Overall Study|Death|1
5574813|NCT01077063|19265172|P1|Overall Study|Death|1
5574814|NCT01077063|19265171|P2|Overall Study|Adverse Event|0
5574815|NCT01077063|19265172|P1|Overall Study|Adverse Event|3
5574816|NCT01077050|19265178|P1|Overall Study|Screen failure|8
5574817|NCT01077050|19265178|P1|Overall Study|Subjects signed ICF could not be located|1
5574818|NCT01077024|19265184|P2|Overall Study|Other|4
5574819|NCT01077024|19265185|P1|Overall Study|Other|4
5574820|NCT01077024|19265184|P2|Overall Study|Incarcerated|8
5574821|NCT01077024|19265185|P1|Overall Study|Incarcerated|7
5574822|NCT01077024|19265184|P2|Overall Study|Withdrawal by Subject|2
5574823|NCT01077024|19265185|P1|Overall Study|Withdrawal by Subject|0
5574824|NCT01077024|19265184|P2|Overall Study|Lost to Follow-up|14
5574825|NCT01077024|19265185|P1|Overall Study|Lost to Follow-up|20
5574826|NCT01076959|19265224|P1|Overall Study|Other|119
5574827|NCT01076959|19265224|P1|Overall Study|Lost to Follow-up|241
5574828|NCT01076959|19265224|P1|Overall Study|Non-compliance|274
5574829|NCT01076959|19265224|P1|Overall Study|Lack of Efficacy|849
5574830|NCT01076959|19265224|P1|Overall Study|Adverse Event|767
5574831|NCT01076647|19265260|P2|Overall Study|Unclassified|12
5574832|NCT01076647|19265261|P1|Overall Study|Unclassified|12
5574833|NCT01076647|19265260|P2|Overall Study|Withdrawal criteria|2
5574834|NCT01076647|19265261|P1|Overall Study|Withdrawal criteria|2
5574835|NCT01076647|19265260|P2|Overall Study|Protocol Violation|9
5574836|NCT01076647|19265261|P1|Overall Study|Protocol Violation|7
5574837|NCT01076647|19265260|P2|Overall Study|Lack of Efficacy|1
5574838|NCT01076647|19265261|P1|Overall Study|Lack of Efficacy|0
5574839|NCT01076647|19265260|P2|Overall Study|Adverse Event|1
5574840|NCT01076647|19265261|P1|Overall Study|Adverse Event|4
5574841|NCT01076543|19265275|P6|Overall Study|Withdrawal by Subject|0
5574842|NCT01076543|19265276|P5|Overall Study|Withdrawal by Subject|0
5574843|NCT01076543|19265277|P4|Overall Study|Withdrawal by Subject|0
5574844|NCT01076543|19265278|P3|Overall Study|Withdrawal by Subject|0
5574845|NCT01076543|19265279|P2|Overall Study|Withdrawal by Subject|0
5574846|NCT01076543|19265280|P1|Overall Study|Withdrawal by Subject|2
5574847|NCT01076400|19265341|P3|Overall Study|Progressive Disease|0
5574848|NCT01076400|19265342|P2|Overall Study|Progressive Disease|0
5574849|NCT01076400|19265343|P1|Overall Study|Progressive Disease|5
5574850|NCT01076400|19265341|P3|Overall Study|Adverse Event|0
5574851|NCT01076400|19265342|P2|Overall Study|Adverse Event|0
5574852|NCT01076400|19265343|P1|Overall Study|Adverse Event|2
5574853|NCT01076361|19265349|P1|Overall Study|22 leads were excluded from analysis|21
5574854|NCT01076335|19265357|P1|Overall Study|Withdrawal without treatment|1
5574855|NCT01076335|19265357|P1|Overall Study|Withdrawal by Subject|3
5574856|NCT01076205|19265409|P1|Overall Study|Lost to Follow-up|3151
5574857|NCT01076205|19265409|P1|Overall Study|Unknown Reason|71
5574858|NCT01076205|19265409|P1|Overall Study|Other Reason|1075
5574859|NCT01076205|19265409|P1|Overall Study|Lack of Effectiveness|1423
5574860|NCT01076205|19265409|P1|Overall Study|Adverse Drug Reaction|299
5574861|NCT01076192|19265462|P1|Overall Study|Other|197
5574862|NCT01076179|19265477|P1|Overall Study|Withdrawal by Subject|1
5574863|NCT01076166|19265500|P1|Overall Study|Symptoms improved/resolved|6
5574864|NCT01076166|19265500|P1|Overall Study|Adverse Event|3
5574865|NCT01076153|19265507|P1|Overall Study|Adverse Event|1
5574866|NCT01076153|19265507|P1|Overall Study|Symptoms improved/resolved|10
5574867|NCT01076088|19265521|P6|Overall Study|Other protocol specified criteria|1
5574868|NCT01076088|19265522|P5|Overall Study|Other protocol specified criteria|0
5574869|NCT01076088|19265523|P4|Overall Study|Other protocol specified criteria|0
5574870|NCT01076088|19265524|P3|Overall Study|Other protocol specified criteria|0
5574871|NCT01076088|19265525|P2|Overall Study|Other protocol specified criteria|0
5574872|NCT01076088|19265526|P1|Overall Study|Other protocol specified criteria|0
5574873|NCT01076088|19265521|P6|Overall Study|Withdrawal by Subject|17
5574874|NCT01076088|19265522|P5|Overall Study|Withdrawal by Subject|11
5574875|NCT01076088|19265523|P4|Overall Study|Withdrawal by Subject|10
5574876|NCT01076088|19265524|P3|Overall Study|Withdrawal by Subject|14
5574877|NCT01076088|19265525|P2|Overall Study|Withdrawal by Subject|8
5574878|NCT01076088|19265526|P1|Overall Study|Withdrawal by Subject|8
5574879|NCT01076088|19265521|P6|Overall Study|Physician Decision|0
5574880|NCT01076088|19265522|P5|Overall Study|Physician Decision|1
5574881|NCT01076088|19265523|P4|Overall Study|Physician Decision|1
5574882|NCT01076088|19265524|P3|Overall Study|Physician Decision|0
5574883|NCT01076088|19265525|P2|Overall Study|Physician Decision|3
5574884|NCT01076088|19265526|P1|Overall Study|Physician Decision|1
5574885|NCT01076088|19265521|P6|Overall Study|Non-compliance with study drug|0
5574886|NCT01076088|19265522|P5|Overall Study|Non-compliance with study drug|0
5574887|NCT01076088|19265523|P4|Overall Study|Non-compliance with study drug|1
5574888|NCT01076088|19265524|P3|Overall Study|Non-compliance with study drug|0
5574889|NCT01076088|19265525|P2|Overall Study|Non-compliance with study drug|0
5574890|NCT01076088|19265526|P1|Overall Study|Non-compliance with study drug|0
5574891|NCT01076088|19265521|P6|Overall Study|Lost to Follow-up|2
5574892|NCT01076088|19265522|P5|Overall Study|Lost to Follow-up|1
5574893|NCT01076088|19265523|P4|Overall Study|Lost to Follow-up|1
5574894|NCT01076088|19265524|P3|Overall Study|Lost to Follow-up|0
5574895|NCT01076088|19265525|P2|Overall Study|Lost to Follow-up|1
5574896|NCT01076088|19265526|P1|Overall Study|Lost to Follow-up|1
5574897|NCT01076088|19265521|P6|Overall Study|Adverse Event|3
5574898|NCT01076088|19265522|P5|Overall Study|Adverse Event|3
5574899|NCT01076088|19265523|P4|Overall Study|Adverse Event|2
5574900|NCT01076088|19265524|P3|Overall Study|Adverse Event|3
5574901|NCT01076088|19265525|P2|Overall Study|Adverse Event|6
5574902|NCT01076088|19265526|P1|Overall Study|Adverse Event|1
5574903|NCT01076075|19265554|P2|Overall Study|Withdrawal by Subject|19
5574904|NCT01076075|19265555|P1|Overall Study|Withdrawal by Subject|8
5574905|NCT01076075|19265554|P2|Overall Study|Protocol Violation|1
5574906|NCT01076075|19265555|P1|Overall Study|Protocol Violation|0
5574907|NCT01076075|19265554|P2|Overall Study|other|9
5574908|NCT01076075|19265555|P1|Overall Study|other|19
5574909|NCT01076075|19265554|P2|Overall Study|Lost to Follow-up|5
5574910|NCT01076075|19265555|P1|Overall Study|Lost to Follow-up|6
5574911|NCT01076075|19265554|P2|Overall Study|Lack of Efficacy|4
5574912|NCT01076075|19265555|P1|Overall Study|Lack of Efficacy|5
5574913|NCT01076075|19265554|P2|Overall Study|Adverse Event|9
5574914|NCT01076075|19265555|P1|Overall Study|Adverse Event|3
5574915|NCT01076036|19265569|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
5574916|NCT01076010|19265577|P3|Overall Study|Other|0
5574917|NCT01076010|19265578|P2|Overall Study|Other|2
5574918|NCT01076010|19265579|P1|Overall Study|Other|5
5574919|NCT01076010|19265577|P3|Overall Study|Withdrawal by Subject|1
5574920|NCT01076010|19265578|P2|Overall Study|Withdrawal by Subject|0
5574921|NCT01076010|19265579|P1|Overall Study|Withdrawal by Subject|3
5574922|NCT01076010|19265577|P3|Overall Study|Noncompliance|0
5574923|NCT01076010|19265578|P2|Overall Study|Noncompliance|1
5574924|NCT01076010|19265579|P1|Overall Study|Noncompliance|1
5574925|NCT01076010|19265577|P3|Overall Study|Protocol Violation|0
5574926|NCT01076010|19265578|P2|Overall Study|Protocol Violation|1
5574927|NCT01076010|19265579|P1|Overall Study|Protocol Violation|0
5574928|NCT01076010|19265577|P3|Overall Study|Significant Surgical Procedure|0
5574929|NCT01076010|19265578|P2|Overall Study|Significant Surgical Procedure|1
5574930|NCT01076010|19265579|P1|Overall Study|Significant Surgical Procedure|0
5574931|NCT01076010|19265577|P3|Overall Study|Treatment Interruption for > 2 Weeks|0
5574932|NCT01076010|19265578|P2|Overall Study|Treatment Interruption for > 2 Weeks|1
5574933|NCT01076010|19265579|P1|Overall Study|Treatment Interruption for > 2 Weeks|0
5574934|NCT01076010|19265577|P3|Overall Study|Lack of Efficacy|0
5574935|NCT01076010|19265578|P2|Overall Study|Lack of Efficacy|0
5574936|NCT01076010|19265579|P1|Overall Study|Lack of Efficacy|4
5574937|NCT01076010|19265577|P3|Overall Study|Progressive disease|1
5574938|NCT01076010|19265578|P2|Overall Study|Progressive disease|30
5574939|NCT01076010|19265579|P1|Overall Study|Progressive disease|90
5574940|NCT01076010|19265577|P3|Overall Study|Adverse Event|0
5574941|NCT01076010|19265578|P2|Overall Study|Adverse Event|2
5574942|NCT01076010|19265579|P1|Overall Study|Adverse Event|7
5574943|NCT01076010|19265577|P3|Overall Study|Death|0
5574944|NCT01076010|19265578|P2|Overall Study|Death|1
5574945|NCT01076010|19265579|P1|Overall Study|Death|15
5574946|NCT01075984|19265619|P5|Follow-up Phase|Treatment failure|4
5574947|NCT01075984|19265620|P4|Follow-up Phase|Treatment failure|0
5574948|NCT01075984|19265621|P3|Follow-up Phase|Treatment failure|0
5574949|NCT01075984|19265622|P2|Follow-up Phase|Treatment failure|0
5574950|NCT01075984|19265623|P1|Follow-up Phase|Treatment failure|0
5574951|NCT01075984|19265619|P5|Follow-up Phase|Progression of disease|2
5574952|NCT01075984|19265620|P4|Follow-up Phase|Progression of disease|0
5574953|NCT01075984|19265621|P3|Follow-up Phase|Progression of disease|0
5574954|NCT01075984|19265622|P2|Follow-up Phase|Progression of disease|0
5574955|NCT01075984|19265623|P1|Follow-up Phase|Progression of disease|0
5574956|NCT01075984|19265619|P5|Follow-up Phase|Withdrawal by Subject|10
5574957|NCT01075984|19265620|P4|Follow-up Phase|Withdrawal by Subject|0
5574958|NCT01075984|19265621|P3|Follow-up Phase|Withdrawal by Subject|0
5574959|NCT01075984|19265622|P2|Follow-up Phase|Withdrawal by Subject|0
5574960|NCT01075984|19265623|P1|Follow-up Phase|Withdrawal by Subject|0
5574961|NCT01075984|19265619|P5|Follow-up Phase|Administrative|1
5574962|NCT01075984|19265620|P4|Follow-up Phase|Administrative|0
5574963|NCT01075984|19265621|P3|Follow-up Phase|Administrative|0
5574964|NCT01075984|19265622|P2|Follow-up Phase|Administrative|0
5574965|NCT01075984|19265623|P1|Follow-up Phase|Administrative|0
5574966|NCT01075984|19265619|P5|Follow-up Phase|Adverse Event|27
5574967|NCT01075984|19265620|P4|Follow-up Phase|Adverse Event|2
5574968|NCT01075984|19265621|P3|Follow-up Phase|Adverse Event|0
5574969|NCT01075984|19265622|P2|Follow-up Phase|Adverse Event|0
5574970|NCT01075984|19265623|P1|Follow-up Phase|Adverse Event|0
5574971|NCT01075984|19265619|P5|Follow-up Phase|Protocol Violation|3
5574972|NCT01075984|19265620|P4|Follow-up Phase|Protocol Violation|0
5574973|NCT01075984|19265621|P3|Follow-up Phase|Protocol Violation|1
5574974|NCT01075984|19265622|P2|Follow-up Phase|Protocol Violation|0
5574975|NCT01075984|19265623|P1|Follow-up Phase|Protocol Violation|0
5574976|NCT01075984|19265619|P5|Treatment Phase|Progression of disease|2
5574977|NCT01075984|19265620|P4|Treatment Phase|Progression of disease|0
5574978|NCT01075984|19265621|P3|Treatment Phase|Progression of disease|0
5574979|NCT01075984|19265622|P2|Treatment Phase|Progression of disease|0
5574980|NCT01075984|19265623|P1|Treatment Phase|Progression of disease|0
5574981|NCT01075984|19265619|P5|Treatment Phase|Treatment Failure|5
5574982|NCT01075984|19265620|P4|Treatment Phase|Treatment Failure|0
5574983|NCT01075984|19265621|P3|Treatment Phase|Treatment Failure|1
5574984|NCT01075984|19265622|P2|Treatment Phase|Treatment Failure|0
5574985|NCT01075984|19265623|P1|Treatment Phase|Treatment Failure|0
5574986|NCT01075984|19265619|P5|Treatment Phase|Withdrawal by Subject|15
5574987|NCT01075984|19265620|P4|Treatment Phase|Withdrawal by Subject|0
5574988|NCT01075984|19265621|P3|Treatment Phase|Withdrawal by Subject|2
5574989|NCT01075984|19265622|P2|Treatment Phase|Withdrawal by Subject|0
5574990|NCT01075984|19265623|P1|Treatment Phase|Withdrawal by Subject|0
5574991|NCT01075984|19265619|P5|Treatment Phase|Protocol Violation|3
5574992|NCT01075984|19265620|P4|Treatment Phase|Protocol Violation|0
5574993|NCT01075984|19265621|P3|Treatment Phase|Protocol Violation|1
5574994|NCT01075984|19265622|P2|Treatment Phase|Protocol Violation|0
5574995|NCT01075984|19265623|P1|Treatment Phase|Protocol Violation|0
5574996|NCT01075984|19265619|P5|Treatment Phase|Adverse Event|35
5574997|NCT01075984|19265620|P4|Treatment Phase|Adverse Event|7
5574998|NCT01075984|19265621|P3|Treatment Phase|Adverse Event|3
5574999|NCT01075984|19265622|P2|Treatment Phase|Adverse Event|1
5575000|NCT01075984|19265623|P1|Treatment Phase|Adverse Event|0
5575001|NCT01075958|19265681|P1|Overall Study|Blood sample could not be obtained|44
5575002|NCT01075815|19265697|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
5575003|NCT01075815|19265698|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
5575004|NCT01075815|19265697|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
5575005|NCT01075815|19265698|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
5575006|NCT01075815|19265697|P2|Overall Study|Withdrawal before r-hCG administration|1
5575007|NCT01075815|19265698|P1|Overall Study|Withdrawal before r-hCG administration|6
5575008|NCT01075763|19265736|P2|Overall Study|Withdrawal by Subject|2
5575009|NCT01075763|19265737|P1|Overall Study|Withdrawal by Subject|2
5575010|NCT01075763|19265736|P2|Overall Study|Lack of Efficacy|1
5575011|NCT01075763|19265737|P1|Overall Study|Lack of Efficacy|0
5575012|NCT01075763|19265736|P2|Overall Study|Lost to Follow-up|1
5575013|NCT01075763|19265737|P1|Overall Study|Lost to Follow-up|2
5575014|NCT01075685|19265761|P2|Overall Study|Lost to Follow-up|220
5575015|NCT01075685|19265762|P1|Overall Study|Lost to Follow-up|563
5575016|NCT01075685|19265761|P2|Overall Study|Withdrawal by Subject|5
5575017|NCT01075685|19265762|P1|Overall Study|Withdrawal by Subject|20
5575018|NCT01075685|19265761|P2|Overall Study|Protocol Violation|1
5575019|NCT01075685|19265762|P1|Overall Study|Protocol Violation|9
5575020|NCT01075646|19265778|P4|Overall Study|Lost to Follow-up|2
5575021|NCT01075646|19265779|P3|Overall Study|Lost to Follow-up|1
5575022|NCT01075646|19265780|P2|Overall Study|Lost to Follow-up|3
5575023|NCT01075646|19265781|P1|Overall Study|Lost to Follow-up|4
5575024|NCT01075412|19265813|P2|Overall Study|Withdrawal by Subject|1
5575025|NCT01075412|19265814|P1|Overall Study|Withdrawal by Subject|0
5575026|NCT01075321|19265839|P4|Overall Study|Ineligible (miscalculated lab value)|1
5575027|NCT01075321|19265840|P3|Overall Study|Ineligible (miscalculated lab value)|0
5575028|NCT01075321|19265841|P2|Overall Study|Ineligible (miscalculated lab value)|0
5575029|NCT01075321|19265842|P1|Overall Study|Ineligible (miscalculated lab value)|0
5575030|NCT01075321|19265839|P4|Overall Study|Treatment Incomplete due to progression|0
5575031|NCT01075321|19265840|P3|Overall Study|Treatment Incomplete due to progression|0
5575032|NCT01075321|19265841|P2|Overall Study|Treatment Incomplete due to progression|0
5575033|NCT01075321|19265842|P1|Overall Study|Treatment Incomplete due to progression|1
5575034|NCT01075321|19265839|P4|Overall Study|Protocol Violation|0
5575035|NCT01075321|19265840|P3|Overall Study|Protocol Violation|1
5575036|NCT01075321|19265841|P2|Overall Study|Protocol Violation|0
5575037|NCT01075321|19265842|P1|Overall Study|Protocol Violation|0
5575038|NCT01075321|19265839|P4|Overall Study|Withdrawal by Subject|1
5575039|NCT01075321|19265840|P3|Overall Study|Withdrawal by Subject|1
5575040|NCT01075321|19265841|P2|Overall Study|Withdrawal by Subject|0
5575041|NCT01075321|19265842|P1|Overall Study|Withdrawal by Subject|0
5575042|NCT01075282|19265860|P3|Overall Study|Death|2
5575043|NCT01075282|19265861|P2|Overall Study|Death|1
5575044|NCT01075282|19265862|P1|Overall Study|Death|0
5575045|NCT01075282|19265860|P3|Overall Study|Protocol Violation|1
5575046|NCT01075282|19265861|P2|Overall Study|Protocol Violation|2
5575047|NCT01075282|19265862|P1|Overall Study|Protocol Violation|0
5575048|NCT01075282|19265860|P3|Overall Study|Treatment Non-compliance|2
5575049|NCT01075282|19265861|P2|Overall Study|Treatment Non-compliance|2
5575050|NCT01075282|19265862|P1|Overall Study|Treatment Non-compliance|1
5575051|NCT01075282|19265860|P3|Overall Study|Lack of Efficacy|0
5575052|NCT01075282|19265861|P2|Overall Study|Lack of Efficacy|1
5575053|NCT01075282|19265862|P1|Overall Study|Lack of Efficacy|1
5575054|NCT01075282|19265860|P3|Overall Study|Physician Decision|3
5575055|NCT01075282|19265861|P2|Overall Study|Physician Decision|3
5575056|NCT01075282|19265862|P1|Overall Study|Physician Decision|3
5575057|NCT01075282|19265860|P3|Overall Study|Lost to Follow-up|3
5575058|NCT01075282|19265861|P2|Overall Study|Lost to Follow-up|3
5575059|NCT01075282|19265862|P1|Overall Study|Lost to Follow-up|3
5575060|NCT01075282|19265860|P3|Overall Study|Entry Criteria Not Met|0
5575061|NCT01075282|19265861|P2|Overall Study|Entry Criteria Not Met|2
5575062|NCT01075282|19265862|P1|Overall Study|Entry Criteria Not Met|3
5575063|NCT01075282|19265860|P3|Overall Study|Adverse Event|5
5575064|NCT01075282|19265861|P2|Overall Study|Adverse Event|8
5575065|NCT01075282|19265862|P1|Overall Study|Adverse Event|9
5575066|NCT01075282|19265860|P3|Overall Study|Withdrawal by Subject|11
5575067|NCT01075282|19265861|P2|Overall Study|Withdrawal by Subject|7
5575068|NCT01075282|19265862|P1|Overall Study|Withdrawal by Subject|11
5575069|NCT01075256|19265945|P3|Overall Study|Withdrawal by Subject|0
5575070|NCT01075256|19265946|P2|Overall Study|Withdrawal by Subject|0
5575071|NCT01075256|19265947|P1|Overall Study|Withdrawal by Subject|1
5575072|NCT01075243|19265979|P3|Overall Study|Withdrawal by Subject|0
5575073|NCT01075243|19265980|P2|Overall Study|Withdrawal by Subject|1
5575074|NCT01075243|19265981|P1|Overall Study|Withdrawal by Subject|1
5575075|NCT01075243|19265979|P3|Overall Study|Lost to Follow-up|0
5575076|NCT01075243|19265980|P2|Overall Study|Lost to Follow-up|2
5575077|NCT01075243|19265981|P1|Overall Study|Lost to Follow-up|5
5575078|NCT01075217|19266033|P2|Overall Study|Physician Decision|0
5575079|NCT01075217|19266034|P1|Overall Study|Physician Decision|1
5575080|NCT01075217|19266033|P2|Overall Study|Adverse Event|1
5575081|NCT01075217|19266034|P1|Overall Study|Adverse Event|1
5575082|NCT01075191|19266067|P1|Overall Study|Unknown Reasons|1
5575083|NCT01075191|19266067|P1|Overall Study|Patient's Wish|2
5575084|NCT01075191|19266067|P1|Overall Study|Therapy Break|3
5575085|NCT01075191|19266067|P1|Overall Study|Noncompliance|3
5575086|NCT01075191|19266067|P1|Overall Study|Adverse Event|4
5575087|NCT01075191|19266067|P1|Overall Study|Co-morbidities|1
5575088|NCT01075191|19266067|P1|Overall Study|Intensification|3
5575089|NCT01075191|19266067|P1|Overall Study|Death|1
5575090|NCT01075178|19266078|P2|Subject Chart Review|matched partner excluded (reasons above)|3
5575091|NCT01075178|19266079|P1|Subject Chart Review|matched partner excluded (reasons above)|6
5575092|NCT01075178|19266078|P2|Subject Chart Review|no data collected due to site closure|4
5575093|NCT01075178|19266079|P1|Subject Chart Review|no data collected due to site closure|3
5575094|NCT01075178|19266078|P2|Subject Chart Review|died before chart review period|2
5575095|NCT01075178|19266079|P1|Subject Chart Review|died before chart review period|0
5575096|NCT01075178|19266078|P2|Subject Matching|eligible but not matched|403
5575097|NCT01075178|19266079|P1|Subject Matching|eligible but not matched|130
5575098|NCT01075152|19266093|P2|Overall Study|Withdrawal by Subject|0
5575099|NCT01075152|19266094|P1|Overall Study|Withdrawal by Subject|1
5575100|NCT01075100|19266120|P2|Overall Study|Other|1
5575101|NCT01075100|19266121|P1|Overall Study|Other|3
5575102|NCT01075100|19266120|P2|Overall Study|Disease Progression|29
5575103|NCT01075100|19266121|P1|Overall Study|Disease Progression|25
5575104|NCT01075100|19266120|P2|Overall Study|Investigator Request|1
5575105|NCT01075100|19266121|P1|Overall Study|Investigator Request|2
5575106|NCT01075100|19266120|P2|Overall Study|Patient Request|4
5575107|NCT01075100|19266121|P1|Overall Study|Patient Request|4
5575108|NCT01075100|19266120|P2|Overall Study|Adverse Event|18
5575109|NCT01075100|19266121|P1|Overall Study|Adverse Event|15
5575110|NCT01075074|19266151|P3|Overall Study|Surgeon changed to open incisional case|2
5575111|NCT01075074|19266152|P2|Overall Study|Surgeon changed to open incisional case|2
5575112|NCT01075074|19266153|P1|Overall Study|Surgeon changed to open incisional case|1
5575113|NCT01075048|19266173|P3|Overall Study|Lost to Follow-up|1
5575114|NCT01075048|19266174|P2|Overall Study|Lost to Follow-up|1
5575115|NCT01075048|19266175|P1|Overall Study|Lost to Follow-up|0
5575116|NCT01075048|19266173|P3|Overall Study|Withdrawal by Subject|3
5575117|NCT01075048|19266174|P2|Overall Study|Withdrawal by Subject|6
5575118|NCT01075048|19266175|P1|Overall Study|Withdrawal by Subject|1
5575119|NCT01075048|19266173|P3|Overall Study|Start of other or new therapy|46
5575120|NCT01075048|19266174|P2|Overall Study|Start of other or new therapy|36
5575121|NCT01075048|19266175|P1|Overall Study|Start of other or new therapy|4
5575122|NCT01075048|19266173|P3|Overall Study|Death|12
5575123|NCT01075048|19266174|P2|Overall Study|Death|17
5575124|NCT01075048|19266175|P1|Overall Study|Death|4
5575125|NCT01074944|19266198|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
5575126|NCT01074944|19266199|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5575127|NCT01074944|19266200|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5575128|NCT01074944|19266201|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5575129|NCT01074944|19266202|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
5575130|NCT01074944|19266198|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
5575131|NCT01074944|19266199|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
5575132|NCT01074944|19266200|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
5575133|NCT01074944|19266201|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
5575134|NCT01074944|19266202|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
5575135|NCT01074944|19266198|P5|Long Term Treatment|Withdrawal by Subject|0
5575136|NCT01074944|19266199|P4|Long Term Treatment|Withdrawal by Subject|2
5575137|NCT01074944|19266200|P3|Long Term Treatment|Withdrawal by Subject|0
5575138|NCT01074944|19266201|P2|Long Term Treatment|Withdrawal by Subject|0
5575139|NCT01074944|19266202|P1|Long Term Treatment|Withdrawal by Subject|0
5575140|NCT01074944|19266198|P5|Long Term Treatment|Entered in Period, But Not Treated|0
5575141|NCT01074944|19266199|P4|Long Term Treatment|Entered in Period, But Not Treated|1
5575142|NCT01074944|19266200|P3|Long Term Treatment|Entered in Period, But Not Treated|0
5575143|NCT01074944|19266201|P2|Long Term Treatment|Entered in Period, But Not Treated|0
5575144|NCT01074944|19266202|P1|Long Term Treatment|Entered in Period, But Not Treated|0
5575145|NCT01074944|19266198|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5575146|NCT01074944|19266199|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
5575147|NCT01074944|19266200|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5575148|NCT01074944|19266201|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5575149|NCT01074944|19266202|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
5575150|NCT01074944|19266198|P5|Long Term Treatment|Lost to Follow-up|0
5575151|NCT01074944|19266199|P4|Long Term Treatment|Lost to Follow-up|2
5575152|NCT01074944|19266200|P3|Long Term Treatment|Lost to Follow-up|0
5575153|NCT01074944|19266201|P2|Long Term Treatment|Lost to Follow-up|0
5575154|NCT01074944|19266202|P1|Long Term Treatment|Lost to Follow-up|0
5575155|NCT01074944|19266198|P5|Long Term Treatment|Adverse Event|0
5575156|NCT01074944|19266199|P4|Long Term Treatment|Adverse Event|3
5575157|NCT01074944|19266200|P3|Long Term Treatment|Adverse Event|0
5575158|NCT01074944|19266201|P2|Long Term Treatment|Adverse Event|0
5575159|NCT01074944|19266202|P1|Long Term Treatment|Adverse Event|0
5575160|NCT01074944|19266198|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
5575161|NCT01074944|19266199|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
5575162|NCT01074944|19266200|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
5575163|NCT01074944|19266201|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
5575164|NCT01074944|19266202|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
5575165|NCT01074944|19266198|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5575166|NCT01074944|19266199|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5575167|NCT01074944|19266200|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5575168|NCT01074944|19266201|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
5575169|NCT01074944|19266202|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
5575170|NCT01074944|19266198|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
5575171|NCT01074944|19266199|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
5575172|NCT01074944|19266200|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
5575173|NCT01074944|19266201|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
5575174|NCT01074944|19266202|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
5575175|NCT01074944|19266198|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
5575176|NCT01074944|19266199|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
5575177|NCT01074944|19266200|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
5575178|NCT01074944|19266201|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
5575179|NCT01074944|19266202|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
5575180|NCT01074944|19266198|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
5575181|NCT01074944|19266199|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
5575182|NCT01074944|19266200|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
5575183|NCT01074944|19266201|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
5575184|NCT01074944|19266202|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
5575185|NCT01074944|19266198|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5575186|NCT01074944|19266199|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5575187|NCT01074944|19266200|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5575188|NCT01074944|19266201|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
5575189|NCT01074944|19266202|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
5575190|NCT01074944|19266198|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5575191|NCT01074944|19266199|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5575192|NCT01074944|19266200|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5575193|NCT01074944|19266201|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
5575194|NCT01074944|19266202|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
5575195|NCT01074944|19266198|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5575196|NCT01074944|19266199|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5575197|NCT01074944|19266200|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5575198|NCT01074944|19266201|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
5575199|NCT01074944|19266202|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
5575200|NCT01074944|19266198|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5575201|NCT01074944|19266199|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5575202|NCT01074944|19266200|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5575203|NCT01074944|19266201|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
5575204|NCT01074944|19266202|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
5575205|NCT01074931|19266256|P1|Overall Study|Death|5
5575206|NCT01074931|19266256|P1|Overall Study|Economic reasons|1
5575207|NCT01074658|19266268|P1|Overall Study|No implant attempted|19
5575208|NCT01074554|19266276|P2|Overall Study|Lost to Follow-up|1
5575209|NCT01074554|19266277|P1|Overall Study|Lost to Follow-up|0
5575210|NCT01074554|19266276|P2|Overall Study|Adverse Event|3
5575211|NCT01074554|19266277|P1|Overall Study|Adverse Event|3
5575212|NCT01074502|19266287|P1|Overall Study|Withdrawal by Subject|1
5575213|NCT01074450|19266311|P2|Second Intervention|Physician Decision|1
5575214|NCT01074450|19266312|P1|Second Intervention|Physician Decision|0
5575215|NCT01074450|19266311|P2|Second Intervention|Protocol Violation|0
5575216|NCT01074450|19266312|P1|Second Intervention|Protocol Violation|1
5575217|NCT01074450|19266311|P2|First Intervention|Emesis in Dosing Interval|2
5575218|NCT01074450|19266312|P1|First Intervention|Emesis in Dosing Interval|0
5575219|NCT01074307|19266341|P2|Overall Study|Protocol Violation|5
5575220|NCT01074307|19266342|P1|Overall Study|Protocol Violation|8
5575221|NCT01074307|19266341|P2|Overall Study|Exclusion criterion|1
5575222|NCT01074307|19266342|P1|Overall Study|Exclusion criterion|0
5575223|NCT01074307|19266341|P2|Overall Study|No primary endpoint evaluation|6
5575224|NCT01074307|19266342|P1|Overall Study|No primary endpoint evaluation|14
5575225|NCT01074268|19266364|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
5575226|NCT01074268|19266365|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
5575227|NCT01074268|19266364|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
5575228|NCT01074268|19266365|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
5575229|NCT01074268|19266364|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
5575230|NCT01074268|19266365|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
5575231|NCT01074268|19266364|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
5575232|NCT01074268|19266365|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
5575233|NCT01074268|19266364|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
5575234|NCT01074268|19266365|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
5575235|NCT01074268|19266364|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
5575236|NCT01074268|19266365|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
5575237|NCT01074268|19266364|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
5575238|NCT01074268|19266365|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
5575239|NCT01074268|19266364|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
5575240|NCT01074268|19266365|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
5575241|NCT01074268|19266364|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
5575242|NCT01074268|19266365|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
5575243|NCT01074255|19266391|P1|Overall Study|Did not receive EMEND|2
5575244|NCT01074242|19266395|P1|Overall Study|Duplicate Case Report Form|5
5575245|NCT01074242|19266395|P1|Overall Study|Violation of vaccine dose or dosage|351
5575246|NCT01074242|19266395|P1|Overall Study|Case report unclear|6
5575247|NCT01074242|19266395|P1|Overall Study|Lost to Follow-up|1
5575248|NCT01074242|19266395|P1|Overall Study|Case report before date of contract|40
5575249|NCT01074229|19266403|P3|Overall Study|Change to open surgical procedure|4
5575250|NCT01074229|19266404|P2|Overall Study|Change to open surgical procedure|3
5575251|NCT01074229|19266405|P1|Overall Study|Change to open surgical procedure|1
5575252|NCT01074229|19266403|P3|Overall Study|Lost to Follow-up|0
5575253|NCT01074229|19266404|P2|Overall Study|Lost to Follow-up|0
5575254|NCT01074229|19266405|P1|Overall Study|Lost to Follow-up|1
5575255|NCT01074216|19266416|P1|Overall Study|Not Treated|12
5575256|NCT01074216|19266416|P1|Overall Study|Physician Decision|1
5575257|NCT01074047|19266480|P2|Extension Phase|Death|0
5575258|NCT01074047|19266481|P1|Extension Phase|Death|5
5575259|NCT01074047|19266480|P2|Extension Phase|Withdrawal by Subject|0
5575260|NCT01074047|19266481|P1|Extension Phase|Withdrawal by Subject|2
5575261|NCT01074047|19266480|P2|Extension Phase|Disease Progression|0
5575262|NCT01074047|19266481|P1|Extension Phase|Disease Progression|9
5575263|NCT01074047|19266480|P2|Extension Phase|Adverse Event|0
5575264|NCT01074047|19266481|P1|Extension Phase|Adverse Event|5
5575265|NCT01074047|19266480|P2|Extension Phase|Physician Decision|0
5575266|NCT01074047|19266481|P1|Extension Phase|Physician Decision|1
5575267|NCT01074047|19266480|P2|Survival Follow-Up Phase|Alive at study closure|3
5575268|NCT01074047|19266481|P1|Survival Follow-Up Phase|Alive at study closure|1
5575269|NCT01074047|19266480|P2|Survival Follow-Up Phase|Death|124
5575270|NCT01074047|19266481|P1|Survival Follow-Up Phase|Death|116
5575271|NCT01074047|19266480|P2|Survival Follow-Up Phase|Lost to Follow-up|1
5575272|NCT01074047|19266481|P1|Survival Follow-Up Phase|Lost to Follow-up|2
5575273|NCT01074047|19266480|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
5575274|NCT01074047|19266481|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
5575275|NCT01074047|19266480|P2|Treatment Phase|Miscellaneous|39
5575276|NCT01074047|19266481|P1|Treatment Phase|Miscellaneous|32
5575277|NCT01074047|19266480|P2|Treatment Phase|Protocol Violation|1
5575278|NCT01074047|19266481|P1|Treatment Phase|Protocol Violation|0
5575279|NCT01074047|19266480|P2|Treatment Phase|Lost to Follow-up|1
5575280|NCT01074047|19266481|P1|Treatment Phase|Lost to Follow-up|0
5575281|NCT01074047|19266480|P2|Treatment Phase|Death|58
5575282|NCT01074047|19266481|P1|Treatment Phase|Death|53
5575283|NCT01074047|19266480|P2|Treatment Phase|Withdrawal by Subject|48
5575284|NCT01074047|19266481|P1|Treatment Phase|Withdrawal by Subject|27
5575285|NCT01074047|19266480|P2|Treatment Phase|Disease Progression|21
5575286|NCT01074047|19266481|P1|Treatment Phase|Disease Progression|16
5575287|NCT01074047|19266480|P2|Treatment Phase|Adverse Event|66
5575288|NCT01074047|19266481|P1|Treatment Phase|Adverse Event|89
5575289|NCT01074008|19266569|P9|Overall Study|Lost to Follow-up|4
5575290|NCT01074008|19266570|P8|Overall Study|Lost to Follow-up|0
5575291|NCT01074008|19266571|P7|Overall Study|Lost to Follow-up|1
5575292|NCT01074008|19266572|P6|Overall Study|Lost to Follow-up|0
5575293|NCT01074008|19266573|P5|Overall Study|Lost to Follow-up|1
5575294|NCT01074008|19266574|P4|Overall Study|Lost to Follow-up|1
5575295|NCT01074008|19266575|P3|Overall Study|Lost to Follow-up|1
5575296|NCT01074008|19266576|P2|Overall Study|Lost to Follow-up|1
5575297|NCT01074008|19266577|P1|Overall Study|Lost to Follow-up|0
5575298|NCT01074008|19266569|P9|Overall Study|Withdrawal by Subject|0
5575299|NCT01074008|19266570|P8|Overall Study|Withdrawal by Subject|0
5575300|NCT01074008|19266571|P7|Overall Study|Withdrawal by Subject|0
5575301|NCT01074008|19266572|P6|Overall Study|Withdrawal by Subject|0
5575302|NCT01074008|19266573|P5|Overall Study|Withdrawal by Subject|1
5575303|NCT01074008|19266574|P4|Overall Study|Withdrawal by Subject|0
5575304|NCT01074008|19266575|P3|Overall Study|Withdrawal by Subject|1
5575305|NCT01074008|19266576|P2|Overall Study|Withdrawal by Subject|1
5575306|NCT01074008|19266577|P1|Overall Study|Withdrawal by Subject|1
5575307|NCT01074008|19266569|P9|Overall Study|Adverse Event|0
5575308|NCT01074008|19266570|P8|Overall Study|Adverse Event|0
5575309|NCT01074008|19266571|P7|Overall Study|Adverse Event|0
5575310|NCT01074008|19266572|P6|Overall Study|Adverse Event|0
5575311|NCT01074008|19266573|P5|Overall Study|Adverse Event|0
5575312|NCT01074008|19266574|P4|Overall Study|Adverse Event|0
5575313|NCT01074008|19266575|P3|Overall Study|Adverse Event|0
5575314|NCT01074008|19266576|P2|Overall Study|Adverse Event|1
5575315|NCT01074008|19266577|P1|Overall Study|Adverse Event|0
5575316|NCT01073943|19266687|P2|Overall Study|Could not tolerate prep|0
5575317|NCT01073943|19266688|P1|Overall Study|Could not tolerate prep|1
5575318|NCT01073943|19266687|P2|Overall Study|Unable to return for follow-up|1
5575319|NCT01073943|19266688|P1|Overall Study|Unable to return for follow-up|0
5575320|NCT01073943|19266687|P2|Overall Study|Subject forgot|1
5575321|NCT01073943|19266688|P1|Overall Study|Subject forgot|0
5575322|NCT01073943|19266687|P2|Overall Study|Power outage; colonoscopy not done|0
5575323|NCT01073943|19266688|P1|Overall Study|Power outage; colonoscopy not done|1
5575324|NCT01073943|19266687|P2|Overall Study|Lost to Follow-up|2
5575325|NCT01073943|19266688|P1|Overall Study|Lost to Follow-up|0
5575326|NCT01073943|19266687|P2|Overall Study|Adverse Event|1
5575327|NCT01073943|19266688|P1|Overall Study|Adverse Event|1
5575328|NCT01073943|19266687|P2|Overall Study|Protocol Violation|1
5575329|NCT01073943|19266688|P1|Overall Study|Protocol Violation|2
5575330|NCT01073943|19266687|P2|Overall Study|Withdrawal by Subject|2
5575331|NCT01073943|19266688|P1|Overall Study|Withdrawal by Subject|8
5575332|NCT01073930|19266714|P2|Overall Study|Inadequate prep; unable to do procedure|1
5575333|NCT01073930|19266715|P1|Overall Study|Inadequate prep; unable to do procedure|0
5575334|NCT01073930|19266714|P2|Overall Study|Noncompliance with study drug|1
5575335|NCT01073930|19266715|P1|Overall Study|Noncompliance with study drug|0
5575336|NCT01073930|19266714|P2|Overall Study|Adverse Event|1
5575337|NCT01073930|19266715|P1|Overall Study|Adverse Event|0
5575338|NCT01073930|19266714|P2|Overall Study|Lost to Follow-up|1
5575339|NCT01073930|19266715|P1|Overall Study|Lost to Follow-up|0
5575340|NCT01073930|19266714|P2|Overall Study|Withdrawal by Subject|2
5575341|NCT01073930|19266715|P1|Overall Study|Withdrawal by Subject|3
5575342|NCT01073865|19266739|P2|Overall Study|Withdrawal by Subject|5
5575343|NCT01073865|19266740|P1|Overall Study|Withdrawal by Subject|5
5575344|NCT01073865|19266739|P2|Overall Study|Death|2
5575345|NCT01073865|19266740|P1|Overall Study|Death|3
5575346|NCT01073865|19266739|P2|Overall Study|Lost to Follow-up|1
5575347|NCT01073865|19266740|P1|Overall Study|Lost to Follow-up|1
5575348|NCT01073865|19266739|P2|Overall Study|Reasons other than below|31
5575349|NCT01073865|19266740|P1|Overall Study|Reasons other than below|19
5575350|NCT01073631|19266759|P1|Overall Study|Other|63
5575351|NCT01073631|19266759|P1|Overall Study|Adverse Event|24
5575352|NCT01073631|19266759|P1|Overall Study|Death|82
5575353|NCT01073618|19266764|P1|Overall Study|Other|80
5575354|NCT01073618|19266764|P1|Overall Study|Adverse Event|19
5575355|NCT01073618|19266764|P1|Overall Study|Death|208
5575356|NCT01073605|19266772|P3|Overall Study|Randomized But Not Treated|1
5575357|NCT01073605|19266773|P2|Overall Study|Randomized But Not Treated|1
5575358|NCT01073605|19266774|P1|Overall Study|Randomized But Not Treated|0
5575359|NCT01073605|19266772|P3|Overall Study|Withdrawal by Subject|22
5575360|NCT01073605|19266773|P2|Overall Study|Withdrawal by Subject|39
5575361|NCT01073605|19266774|P1|Overall Study|Withdrawal by Subject|31
5575362|NCT01073605|19266772|P3|Overall Study|Other|29
5575363|NCT01073605|19266773|P2|Overall Study|Other|21
5575364|NCT01073605|19266774|P1|Overall Study|Other|25
5575365|NCT01073605|19266772|P3|Overall Study|Lost to Follow-up|9
5575366|NCT01073605|19266773|P2|Overall Study|Lost to Follow-up|4
5575367|NCT01073605|19266774|P1|Overall Study|Lost to Follow-up|3
5575368|NCT01073605|19266772|P3|Overall Study|Adverse Event|0
5575369|NCT01073605|19266773|P2|Overall Study|Adverse Event|1
5575370|NCT01073605|19266774|P1|Overall Study|Adverse Event|2
5575371|NCT01073605|19266772|P3|Overall Study|Ongoing at Cutoff Date|0
5575372|NCT01073605|19266773|P2|Overall Study|Ongoing at Cutoff Date|1
5575373|NCT01073605|19266774|P1|Overall Study|Ongoing at Cutoff Date|1
5575374|NCT01073566|19266820|P2|Period 2 (6 Weeks)|Adverse Event|0
5575375|NCT01073566|19266821|P1|Period 2 (6 Weeks)|Adverse Event|1
5575376|NCT01073462|19266833|P1|Overall Study|Lost to Follow-up|7
5575377|NCT01073462|19266833|P1|Overall Study|Serious adverse event|2
5575378|NCT01073462|19266833|P1|Overall Study|Low parathyroid hormone levels|8
5575379|NCT01073462|19266833|P1|Overall Study|Kidney transplant|10
5575380|NCT01073462|19266833|P1|Overall Study|Death|14
5575381|NCT01073293|19266852|P2|Overall Study|Withdrawal by Subject|10
5575382|NCT01073293|19266853|P1|Overall Study|Withdrawal by Subject|5
5575383|NCT01073293|19266852|P2|Overall Study|Lost to Follow-up|1
5575384|NCT01073293|19266853|P1|Overall Study|Lost to Follow-up|0
5575385|NCT01073267|19266875|P1|Overall Study|Disease Progression|3
5575386|NCT01073163|19266879|P1|Overall Study|Early termination|1
5575387|NCT01073163|19266879|P1|Overall Study|Disease Progression|1
5575388|NCT01073163|19266879|P1|Overall Study|Adverse Event|1
5575389|NCT01072929|19266902|P3|Overall Study|Other|0
5575390|NCT01072929|19266903|P2|Overall Study|Other|3
5575391|NCT01072929|19266904|P1|Overall Study|Other|0
5575392|NCT01072929|19266902|P3|Overall Study|Noncompliance with study procedures|1
5575393|NCT01072929|19266903|P2|Overall Study|Noncompliance with study procedures|0
5575394|NCT01072929|19266904|P1|Overall Study|Noncompliance with study procedures|1
5575395|NCT01072929|19266902|P3|Overall Study|Noncompliance with study medication|0
5575396|NCT01072929|19266903|P2|Overall Study|Noncompliance with study medication|3
5575397|NCT01072929|19266904|P1|Overall Study|Noncompliance with study medication|0
5575398|NCT01072929|19266902|P3|Overall Study|Lost to Follow-up|1
5575399|NCT01072929|19266903|P2|Overall Study|Lost to Follow-up|4
5575400|NCT01072929|19266904|P1|Overall Study|Lost to Follow-up|8
5575401|NCT01072929|19266902|P3|Overall Study|Protocol Violation|2
5575402|NCT01072929|19266903|P2|Overall Study|Protocol Violation|11
5575403|NCT01072929|19266904|P1|Overall Study|Protocol Violation|13
5575404|NCT01072929|19266902|P3|Overall Study|Withdrawal by Subject|3
5575405|NCT01072929|19266903|P2|Overall Study|Withdrawal by Subject|15
5575406|NCT01072929|19266904|P1|Overall Study|Withdrawal by Subject|7
5575407|NCT01072929|19266902|P3|Overall Study|Lack of Efficacy|0
5575408|NCT01072929|19266903|P2|Overall Study|Lack of Efficacy|4
5575409|NCT01072929|19266904|P1|Overall Study|Lack of Efficacy|7
5575410|NCT01072929|19266902|P3|Overall Study|Adverse Event|2
5575411|NCT01072929|19266903|P2|Overall Study|Adverse Event|11
5575412|NCT01072929|19266904|P1|Overall Study|Adverse Event|8
5575413|NCT01072877|19266983|P5|Overall Study|Lost to Follow-up|0
5575414|NCT01072877|19266984|P4|Overall Study|Lost to Follow-up|2
5575415|NCT01072877|19266985|P3|Overall Study|Lost to Follow-up|0
5575416|NCT01072877|19266986|P2|Overall Study|Lost to Follow-up|1
5575417|NCT01072877|19266987|P1|Overall Study|Lost to Follow-up|1
5575418|NCT01072630|19267066|P3|Overall Study|Other|1
5575419|NCT01072630|19267067|P2|Overall Study|Other|2
5575420|NCT01072630|19267068|P1|Overall Study|Other|3
5575421|NCT01072630|19267066|P3|Overall Study|Noncompliance with study procedures|1
5575422|NCT01072630|19267067|P2|Overall Study|Noncompliance with study procedures|2
5575423|NCT01072630|19267068|P1|Overall Study|Noncompliance with study procedures|1
5575424|NCT01072630|19267066|P3|Overall Study|Noncompliance with study medication|1
5575425|NCT01072630|19267067|P2|Overall Study|Noncompliance with study medication|1
5575426|NCT01072630|19267068|P1|Overall Study|Noncompliance with study medication|1
5575427|NCT01072630|19267066|P3|Overall Study|Lost to Follow-up|1
5575428|NCT01072630|19267067|P2|Overall Study|Lost to Follow-up|11
5575429|NCT01072630|19267068|P1|Overall Study|Lost to Follow-up|11
5575430|NCT01072630|19267066|P3|Overall Study|Protocol Violation|4
5575431|NCT01072630|19267067|P2|Overall Study|Protocol Violation|8
5575432|NCT01072630|19267068|P1|Overall Study|Protocol Violation|10
5575433|NCT01072630|19267066|P3|Overall Study|Withdrawal by Subject|2
5575434|NCT01072630|19267067|P2|Overall Study|Withdrawal by Subject|7
5575435|NCT01072630|19267068|P1|Overall Study|Withdrawal by Subject|8
5575436|NCT01072630|19267066|P3|Overall Study|Lack of Efficacy|1
5575437|NCT01072630|19267067|P2|Overall Study|Lack of Efficacy|10
5575438|NCT01072630|19267068|P1|Overall Study|Lack of Efficacy|10
5575439|NCT01072630|19267066|P3|Overall Study|Adverse Event|2
5575440|NCT01072630|19267067|P2|Overall Study|Adverse Event|19
5575441|NCT01072630|19267068|P1|Overall Study|Adverse Event|11
5575442|NCT01072539|19267149|P1|Overall Study|Protocol Violation|2
5575443|NCT01072539|19267149|P1|Overall Study|Treated prior to the Site Initiation|1
5575444|NCT01072500|19267173|P2|Overall Study|Withdrawal by Subject|10
5575445|NCT01072500|19267174|P1|Overall Study|Withdrawal by Subject|17
5575446|NCT01072500|19267173|P2|Overall Study|Lost to Follow-up|2
5575447|NCT01072500|19267174|P1|Overall Study|Lost to Follow-up|5
5575448|NCT01072500|19267173|P2|Overall Study|Death|2
5575449|NCT01072500|19267174|P1|Overall Study|Death|2
5575450|NCT01072448|19267184|P2|Overall Study|Death|2
5575451|NCT01072448|19267185|P1|Overall Study|Death|0
5575452|NCT01072448|19267184|P2|Overall Study|Abnormal laboratory value(s)|1
5575453|NCT01072448|19267185|P1|Overall Study|Abnormal laboratory value(s)|0
5575454|NCT01072448|19267184|P2|Overall Study|Lost to Follow-up|1
5575455|NCT01072448|19267185|P1|Overall Study|Lost to Follow-up|1
5575456|NCT01072448|19267184|P2|Overall Study|Unsatisfactory therapeutic effect|3
5575457|NCT01072448|19267185|P1|Overall Study|Unsatisfactory therapeutic effect|1
5575458|NCT01072448|19267184|P2|Overall Study|Abnormal test procedure result(s)|0
5575459|NCT01072448|19267185|P1|Overall Study|Abnormal test procedure result(s)|1
5575460|NCT01072448|19267184|P2|Overall Study|Protocol deviation|4
5575461|NCT01072448|19267185|P1|Overall Study|Protocol deviation|3
5575462|NCT01072448|19267184|P2|Overall Study|Subject withdrew consent|9
5575463|NCT01072448|19267185|P1|Overall Study|Subject withdrew consent|4
5575464|NCT01072448|19267184|P2|Overall Study|Adverse Event|10
5575465|NCT01072448|19267185|P1|Overall Study|Adverse Event|9
5575466|NCT01072396|19267199|P2|Period Two|Lost to Follow-up|0
5575467|NCT01072396|19267200|P1|Period Two|Lost to Follow-up|1
5575468|NCT01072396|19267199|P2|Period Two|Adverse Event|3
5575469|NCT01072396|19267200|P1|Period Two|Adverse Event|0
5575470|NCT01072396|19267199|P2|Washout Period|Missing termination information|1
5575471|NCT01072396|19267200|P1|Washout Period|Missing termination information|0
5575472|NCT01072396|19267199|P2|Period One|Withdrawal by Subject|0
5575473|NCT01072396|19267200|P1|Period One|Withdrawal by Subject|2
5575474|NCT01072396|19267199|P2|Period One|Protocol Violation|1
5575475|NCT01072396|19267200|P1|Period One|Protocol Violation|2
5575476|NCT01072396|19267199|P2|Period One|Adverse Event|1
5575477|NCT01072396|19267200|P1|Period One|Adverse Event|1
5575478|NCT01072357|19267212|P2|Overall Study|Lost to Follow-up|1
5575479|NCT01072357|19267213|P1|Overall Study|Lost to Follow-up|0
5575480|NCT01072344|19267223|P2|Overall Study|Lost to Follow-up|4
5575481|NCT01072344|19267224|P1|Overall Study|Lost to Follow-up|3
5575482|NCT01072344|19267223|P2|Overall Study|Protocol Violation|2
5575483|NCT01072344|19267224|P1|Overall Study|Protocol Violation|1
5575484|NCT01072344|19267223|P2|Overall Study|Relasped-reached end point|12
5575485|NCT01072344|19267224|P1|Overall Study|Relasped-reached end point|7
5575486|NCT01072201|19267262|P2|Overall Study|Lost to Follow-up|1
5575487|NCT01072201|19267263|P1|Overall Study|Lost to Follow-up|0
5575488|NCT01072175|19267296|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575489|NCT01072175|19267297|P12|Part D (HPMC Capsules)|Withdrawal by Subject|3
5575490|NCT01072175|19267298|P11|Part D (HPMC Capsules)|Withdrawal by Subject|1
5575491|NCT01072175|19267299|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575492|NCT01072175|19267300|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575493|NCT01072175|19267301|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575494|NCT01072175|19267302|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575495|NCT01072175|19267303|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575496|NCT01072175|19267304|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575497|NCT01072175|19267305|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575498|NCT01072175|19267306|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575499|NCT01072175|19267307|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575500|NCT01072175|19267308|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
5575501|NCT01072175|19267296|P13|Part D (HPMC Capsules)|Study closed/terminated|9
5575502|NCT01072175|19267297|P12|Part D (HPMC Capsules)|Study closed/terminated|10
5575503|NCT01072175|19267298|P11|Part D (HPMC Capsules)|Study closed/terminated|1
5575504|NCT01072175|19267299|P10|Part D (HPMC Capsules)|Study closed/terminated|2
5575505|NCT01072175|19267300|P9|Part D (HPMC Capsules)|Study closed/terminated|0
5575506|NCT01072175|19267301|P8|Part D (HPMC Capsules)|Study closed/terminated|0
5575507|NCT01072175|19267302|P7|Part D (HPMC Capsules)|Study closed/terminated|0
5575508|NCT01072175|19267303|P6|Part D (HPMC Capsules)|Study closed/terminated|0
5575509|NCT01072175|19267304|P5|Part D (HPMC Capsules)|Study closed/terminated|0
5575510|NCT01072175|19267305|P4|Part D (HPMC Capsules)|Study closed/terminated|0
5575511|NCT01072175|19267306|P3|Part D (HPMC Capsules)|Study closed/terminated|0
5575512|NCT01072175|19267307|P2|Part D (HPMC Capsules)|Study closed/terminated|0
5575513|NCT01072175|19267308|P1|Part D (HPMC Capsules)|Study closed/terminated|0
5575514|NCT01072175|19267296|P13|Part D (HPMC Capsules)|Lost to Follow-up|3
5575515|NCT01072175|19267297|P12|Part D (HPMC Capsules)|Lost to Follow-up|1
5575516|NCT01072175|19267298|P11|Part D (HPMC Capsules)|Lost to Follow-up|1
5575517|NCT01072175|19267299|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
5575518|NCT01072175|19267300|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
5575519|NCT01072175|19267301|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
5575520|NCT01072175|19267302|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
5575521|NCT01072175|19267303|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
5575522|NCT01072175|19267304|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
5575523|NCT01072175|19267305|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
5575524|NCT01072175|19267306|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
5575525|NCT01072175|19267307|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
5575526|NCT01072175|19267308|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
5575527|NCT01072175|19267296|P13|Part D (HPMC Capsules)|Physician Decision|1
5575528|NCT01072175|19267297|P12|Part D (HPMC Capsules)|Physician Decision|1
5575529|NCT01072175|19267298|P11|Part D (HPMC Capsules)|Physician Decision|1
5575530|NCT01072175|19267299|P10|Part D (HPMC Capsules)|Physician Decision|0
5575531|NCT01072175|19267300|P9|Part D (HPMC Capsules)|Physician Decision|0
5575532|NCT01072175|19267301|P8|Part D (HPMC Capsules)|Physician Decision|0
5575533|NCT01072175|19267302|P7|Part D (HPMC Capsules)|Physician Decision|0
5575534|NCT01072175|19267303|P6|Part D (HPMC Capsules)|Physician Decision|0
5575535|NCT01072175|19267304|P5|Part D (HPMC Capsules)|Physician Decision|0
5575536|NCT01072175|19267305|P4|Part D (HPMC Capsules)|Physician Decision|0
5575537|NCT01072175|19267306|P3|Part D (HPMC Capsules)|Physician Decision|0
5575538|NCT01072175|19267307|P2|Part D (HPMC Capsules)|Physician Decision|0
5575539|NCT01072175|19267308|P1|Part D (HPMC Capsules)|Physician Decision|0
5575540|NCT01072175|19267296|P13|Part D (HPMC Capsules)|Death|26
5575541|NCT01072175|19267297|P12|Part D (HPMC Capsules)|Death|28
5575542|NCT01072175|19267298|P11|Part D (HPMC Capsules)|Death|12
5575543|NCT01072175|19267299|P10|Part D (HPMC Capsules)|Death|10
5575544|NCT01072175|19267300|P9|Part D (HPMC Capsules)|Death|0
5575545|NCT01072175|19267301|P8|Part D (HPMC Capsules)|Death|0
5575546|NCT01072175|19267302|P7|Part D (HPMC Capsules)|Death|0
5575547|NCT01072175|19267303|P6|Part D (HPMC Capsules)|Death|0
5575548|NCT01072175|19267304|P5|Part D (HPMC Capsules)|Death|0
5575549|NCT01072175|19267305|P4|Part D (HPMC Capsules)|Death|0
5575550|NCT01072175|19267306|P3|Part D (HPMC Capsules)|Death|0
5575551|NCT01072175|19267307|P2|Part D (HPMC Capsules)|Death|0
5575552|NCT01072175|19267308|P1|Part D (HPMC Capsules)|Death|0
5575553|NCT01072175|19267296|P13|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575554|NCT01072175|19267297|P12|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575555|NCT01072175|19267298|P11|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575556|NCT01072175|19267299|P10|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575557|NCT01072175|19267300|P9|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
5575558|NCT01072175|19267301|P8|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575559|NCT01072175|19267302|P7|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575560|NCT01072175|19267303|P6|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575561|NCT01072175|19267304|P5|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5576012|NCT01071252|19267730|P1|Overall Study|Adverse Event|1
5575562|NCT01072175|19267305|P4|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575563|NCT01072175|19267306|P3|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575564|NCT01072175|19267307|P2|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575565|NCT01072175|19267308|P1|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
5575566|NCT01072175|19267296|P13|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575567|NCT01072175|19267297|P12|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575568|NCT01072175|19267298|P11|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575569|NCT01072175|19267299|P10|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575570|NCT01072175|19267300|P9|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
5575571|NCT01072175|19267301|P8|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575572|NCT01072175|19267302|P7|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575573|NCT01072175|19267303|P6|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575574|NCT01072175|19267304|P5|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575575|NCT01072175|19267305|P4|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575576|NCT01072175|19267306|P3|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575577|NCT01072175|19267307|P2|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575578|NCT01072175|19267308|P1|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
5575579|NCT01072175|19267296|P13|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575580|NCT01072175|19267297|P12|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575581|NCT01072175|19267298|P11|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575582|NCT01072175|19267299|P10|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575583|NCT01072175|19267300|P9|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
5575584|NCT01072175|19267301|P8|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575585|NCT01072175|19267302|P7|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575586|NCT01072175|19267303|P6|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575587|NCT01072175|19267304|P5|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575588|NCT01072175|19267305|P4|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575589|NCT01072175|19267306|P3|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575590|NCT01072175|19267307|P2|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575591|NCT01072175|19267308|P1|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
5575592|NCT01072175|19267296|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
5575593|NCT01072175|19267297|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
5575594|NCT01072175|19267298|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
5575595|NCT01072175|19267299|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
5575596|NCT01072175|19267300|P9|Part C (Phase II: Crossover Phase [CP])|Death|37
5575597|NCT01072175|19267301|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
5575598|NCT01072175|19267302|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
5575599|NCT01072175|19267303|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
5575600|NCT01072175|19267304|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
5575601|NCT01072175|19267305|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
5575602|NCT01072175|19267306|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
5575603|NCT01072175|19267307|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
5575604|NCT01072175|19267308|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
5575605|NCT01072175|19267296|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575606|NCT01072175|19267297|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575607|NCT01072175|19267298|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575608|NCT01072175|19267299|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575609|NCT01072175|19267300|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575610|NCT01072175|19267301|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575611|NCT01072175|19267302|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
5575612|NCT01072175|19267303|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
5575613|NCT01072175|19267304|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575614|NCT01072175|19267305|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575615|NCT01072175|19267306|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575616|NCT01072175|19267307|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575617|NCT01072175|19267308|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
5575618|NCT01072175|19267296|P13|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575619|NCT01072175|19267297|P12|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575620|NCT01072175|19267298|P11|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575621|NCT01072175|19267299|P10|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575622|NCT01072175|19267300|P9|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575623|NCT01072175|19267301|P8|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
5575624|NCT01072175|19267302|P7|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
5575625|NCT01072175|19267303|P6|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
5575626|NCT01072175|19267304|P5|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575627|NCT01072175|19267305|P4|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575628|NCT01072175|19267306|P3|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575629|NCT01072175|19267307|P2|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575630|NCT01072175|19267308|P1|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
5575631|NCT01072175|19267296|P13|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575632|NCT01072175|19267297|P12|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575633|NCT01072175|19267298|P11|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575634|NCT01072175|19267299|P10|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575635|NCT01072175|19267300|P9|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575636|NCT01072175|19267301|P8|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
5575637|NCT01072175|19267302|P7|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
5575638|NCT01072175|19267303|P6|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575639|NCT01072175|19267304|P5|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575640|NCT01072175|19267305|P4|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575641|NCT01072175|19267306|P3|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575642|NCT01072175|19267307|P2|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575643|NCT01072175|19267308|P1|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
5575644|NCT01072175|19267296|P13|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575645|NCT01072175|19267297|P12|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575646|NCT01072175|19267298|P11|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575647|NCT01072175|19267299|P10|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575648|NCT01072175|19267300|P9|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575649|NCT01072175|19267301|P8|Part C (Phase II: Randomized Phase)|Physician Decision|1
5575650|NCT01072175|19267302|P7|Part C (Phase II: Randomized Phase)|Physician Decision|1
5575651|NCT01072175|19267303|P6|Part C (Phase II: Randomized Phase)|Physician Decision|1
5575652|NCT01072175|19267304|P5|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575653|NCT01072175|19267305|P4|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575654|NCT01072175|19267306|P3|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575655|NCT01072175|19267307|P2|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575656|NCT01072175|19267308|P1|Part C (Phase II: Randomized Phase)|Physician Decision|0
5575657|NCT01072175|19267296|P13|Part C (Phase II: Randomized Phase)|Death|0
5575658|NCT01072175|19267297|P12|Part C (Phase II: Randomized Phase)|Death|0
5575659|NCT01072175|19267298|P11|Part C (Phase II: Randomized Phase)|Death|0
5575660|NCT01072175|19267299|P10|Part C (Phase II: Randomized Phase)|Death|0
5575661|NCT01072175|19267300|P9|Part C (Phase II: Randomized Phase)|Death|0
5575662|NCT01072175|19267301|P8|Part C (Phase II: Randomized Phase)|Death|39
5575663|NCT01072175|19267302|P7|Part C (Phase II: Randomized Phase)|Death|34
5575664|NCT01072175|19267303|P6|Part C (Phase II: Randomized Phase)|Death|44
5575665|NCT01072175|19267304|P5|Part C (Phase II: Randomized Phase)|Death|0
5575666|NCT01072175|19267305|P4|Part C (Phase II: Randomized Phase)|Death|0
5575667|NCT01072175|19267306|P3|Part C (Phase II: Randomized Phase)|Death|0
5575668|NCT01072175|19267307|P2|Part C (Phase II: Randomized Phase)|Death|0
5575669|NCT01072175|19267308|P1|Part C (Phase II: Randomized Phase)|Death|0
5575670|NCT01072175|19267296|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575671|NCT01072175|19267297|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575672|NCT01072175|19267298|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575673|NCT01072175|19267299|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575674|NCT01072175|19267300|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575675|NCT01072175|19267301|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575676|NCT01072175|19267302|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575677|NCT01072175|19267303|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575678|NCT01072175|19267304|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
5575679|NCT01072175|19267305|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
5575680|NCT01072175|19267306|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575681|NCT01072175|19267307|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
5575682|NCT01072175|19267308|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
5575683|NCT01072175|19267296|P13|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575684|NCT01072175|19267297|P12|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575685|NCT01072175|19267298|P11|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575686|NCT01072175|19267299|P10|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575687|NCT01072175|19267300|P9|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575688|NCT01072175|19267301|P8|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575689|NCT01072175|19267302|P7|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575690|NCT01072175|19267303|P6|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575691|NCT01072175|19267304|P5|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
5575692|NCT01072175|19267305|P4|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
5575693|NCT01072175|19267306|P3|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
5575694|NCT01072175|19267307|P2|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575695|NCT01072175|19267308|P1|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
5575696|NCT01072175|19267296|P13|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575697|NCT01072175|19267297|P12|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575698|NCT01072175|19267298|P11|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575699|NCT01072175|19267299|P10|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575700|NCT01072175|19267300|P9|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575701|NCT01072175|19267301|P8|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575702|NCT01072175|19267302|P7|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575703|NCT01072175|19267303|P6|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575704|NCT01072175|19267304|P5|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
5575705|NCT01072175|19267305|P4|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
5575706|NCT01072175|19267306|P3|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575707|NCT01072175|19267307|P2|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
5575708|NCT01072175|19267308|P1|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
5575709|NCT01072175|19267296|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575710|NCT01072175|19267297|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575711|NCT01072175|19267298|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575712|NCT01072175|19267299|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575713|NCT01072175|19267300|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575714|NCT01072175|19267301|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575715|NCT01072175|19267302|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575716|NCT01072175|19267303|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575717|NCT01072175|19267304|P5|Part B (Dose Escalation and Expansion)|Physician Decision|4
5575718|NCT01072175|19267305|P4|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575719|NCT01072175|19267306|P3|Part B (Dose Escalation and Expansion)|Physician Decision|2
5575720|NCT01072175|19267307|P2|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575721|NCT01072175|19267308|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
5575722|NCT01072175|19267296|P13|Part B (Dose Escalation and Expansion)|Death|0
5575723|NCT01072175|19267297|P12|Part B (Dose Escalation and Expansion)|Death|0
5575724|NCT01072175|19267298|P11|Part B (Dose Escalation and Expansion)|Death|0
5575725|NCT01072175|19267299|P10|Part B (Dose Escalation and Expansion)|Death|0
5575726|NCT01072175|19267300|P9|Part B (Dose Escalation and Expansion)|Death|0
5575727|NCT01072175|19267301|P8|Part B (Dose Escalation and Expansion)|Death|0
5575728|NCT01072175|19267302|P7|Part B (Dose Escalation and Expansion)|Death|0
5575729|NCT01072175|19267303|P6|Part B (Dose Escalation and Expansion)|Death|0
5575730|NCT01072175|19267304|P5|Part B (Dose Escalation and Expansion)|Death|68
5575731|NCT01072175|19267305|P4|Part B (Dose Escalation and Expansion)|Death|21
5575732|NCT01072175|19267306|P3|Part B (Dose Escalation and Expansion)|Death|18
5575733|NCT01072175|19267307|P2|Part B (Dose Escalation and Expansion)|Death|4
5575734|NCT01072175|19267308|P1|Part B (Dose Escalation and Expansion)|Death|0
5575735|NCT01072175|19267296|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575736|NCT01072175|19267297|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575737|NCT01072175|19267298|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575738|NCT01072175|19267299|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575739|NCT01072175|19267300|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575740|NCT01072175|19267301|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575741|NCT01072175|19267302|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575742|NCT01072175|19267303|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575743|NCT01072175|19267304|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575744|NCT01072175|19267305|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575745|NCT01072175|19267306|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575746|NCT01072175|19267307|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
5575747|NCT01072175|19267308|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
5575748|NCT01072175|19267296|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
5575749|NCT01072175|19267297|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
5575750|NCT01072175|19267298|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
5575751|NCT01072175|19267299|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
5575752|NCT01072175|19267300|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
5575753|NCT01072175|19267301|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
5575754|NCT01072175|19267302|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
5575755|NCT01072175|19267303|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
5575756|NCT01072175|19267304|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
5575757|NCT01072175|19267305|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
5575758|NCT01072175|19267306|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
5575759|NCT01072175|19267307|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
5575760|NCT01072175|19267308|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
5575761|NCT01072175|19267296|P13|Part A (Drug-Drug Interaction)|Death|0
5575762|NCT01072175|19267297|P12|Part A (Drug-Drug Interaction)|Death|0
5575763|NCT01072175|19267298|P11|Part A (Drug-Drug Interaction)|Death|0
5575764|NCT01072175|19267299|P10|Part A (Drug-Drug Interaction)|Death|0
5575765|NCT01072175|19267300|P9|Part A (Drug-Drug Interaction)|Death|0
5575766|NCT01072175|19267301|P8|Part A (Drug-Drug Interaction)|Death|0
5575767|NCT01072175|19267302|P7|Part A (Drug-Drug Interaction)|Death|0
5575768|NCT01072175|19267303|P6|Part A (Drug-Drug Interaction)|Death|0
5575769|NCT01072175|19267304|P5|Part A (Drug-Drug Interaction)|Death|0
5575770|NCT01072175|19267305|P4|Part A (Drug-Drug Interaction)|Death|0
5575771|NCT01072175|19267306|P3|Part A (Drug-Drug Interaction)|Death|0
5575772|NCT01072175|19267307|P2|Part A (Drug-Drug Interaction)|Death|0
5575773|NCT01072175|19267308|P1|Part A (Drug-Drug Interaction)|Death|1
5575774|NCT01072149|19267517|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575775|NCT01072149|19267518|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575776|NCT01072149|19267519|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575777|NCT01072149|19267520|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575778|NCT01072149|19267521|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
5575779|NCT01072149|19267522|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575780|NCT01072149|19267523|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575781|NCT01072149|19267524|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575782|NCT01072149|19267525|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575783|NCT01072149|19267526|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575784|NCT01072149|19267527|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575785|NCT01072149|19267528|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575786|NCT01072149|19267529|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575787|NCT01072149|19267530|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575788|NCT01072149|19267531|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575789|NCT01072149|19267532|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
5575790|NCT01072149|19267533|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575791|NCT01072149|19267534|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
5575792|NCT01072149|19267517|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575793|NCT01072149|19267518|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575794|NCT01072149|19267519|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575795|NCT01072149|19267520|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575796|NCT01072149|19267521|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575797|NCT01072149|19267522|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
5575798|NCT01072149|19267523|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575799|NCT01072149|19267524|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575800|NCT01072149|19267525|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575801|NCT01072149|19267526|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575802|NCT01072149|19267527|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575803|NCT01072149|19267528|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575804|NCT01072149|19267529|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575805|NCT01072149|19267530|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575806|NCT01072149|19267531|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575807|NCT01072149|19267532|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575808|NCT01072149|19267533|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575809|NCT01072149|19267534|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
5575810|NCT01072149|19267517|P18|Washout Period 2 (14 Days)|Adverse Event|0
5575811|NCT01072149|19267518|P17|Washout Period 2 (14 Days)|Adverse Event|0
5575812|NCT01072149|19267519|P16|Washout Period 2 (14 Days)|Adverse Event|1
5575813|NCT01072149|19267520|P15|Washout Period 2 (14 Days)|Adverse Event|0
5575814|NCT01072149|19267521|P14|Washout Period 2 (14 Days)|Adverse Event|0
5575815|NCT01072149|19267522|P13|Washout Period 2 (14 Days)|Adverse Event|0
5575816|NCT01072149|19267523|P12|Washout Period 2 (14 Days)|Adverse Event|0
5575817|NCT01072149|19267524|P11|Washout Period 2 (14 Days)|Adverse Event|0
5575818|NCT01072149|19267525|P10|Washout Period 2 (14 Days)|Adverse Event|0
5575819|NCT01072149|19267526|P9|Washout Period 2 (14 Days)|Adverse Event|0
5575820|NCT01072149|19267527|P8|Washout Period 2 (14 Days)|Adverse Event|0
5575821|NCT01072149|19267528|P7|Washout Period 2 (14 Days)|Adverse Event|0
5575822|NCT01072149|19267529|P6|Washout Period 2 (14 Days)|Adverse Event|0
5575823|NCT01072149|19267530|P5|Washout Period 2 (14 Days)|Adverse Event|0
5575824|NCT01072149|19267531|P4|Washout Period 2 (14 Days)|Adverse Event|0
5575825|NCT01072149|19267532|P3|Washout Period 2 (14 Days)|Adverse Event|0
5575826|NCT01072149|19267533|P2|Washout Period 2 (14 Days)|Adverse Event|0
5575827|NCT01072149|19267534|P1|Washout Period 2 (14 Days)|Adverse Event|0
5575828|NCT01072149|19267517|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575829|NCT01072149|19267518|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575830|NCT01072149|19267519|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
5575831|NCT01072149|19267520|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575832|NCT01072149|19267521|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575833|NCT01072149|19267522|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575834|NCT01072149|19267523|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575835|NCT01072149|19267524|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575836|NCT01072149|19267525|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575837|NCT01072149|19267526|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575838|NCT01072149|19267527|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575839|NCT01072149|19267528|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575840|NCT01072149|19267529|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575841|NCT01072149|19267530|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575842|NCT01072149|19267531|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575843|NCT01072149|19267532|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575844|NCT01072149|19267533|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575845|NCT01072149|19267534|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
5575846|NCT01072149|19267517|P18|Washout Period 2 (14 Days)|Physician Decision|0
5575847|NCT01072149|19267518|P17|Washout Period 2 (14 Days)|Physician Decision|0
5575848|NCT01072149|19267519|P16|Washout Period 2 (14 Days)|Physician Decision|0
5575849|NCT01072149|19267520|P15|Washout Period 2 (14 Days)|Physician Decision|0
5575850|NCT01072149|19267521|P14|Washout Period 2 (14 Days)|Physician Decision|0
5575851|NCT01072149|19267522|P13|Washout Period 2 (14 Days)|Physician Decision|0
5575852|NCT01072149|19267523|P12|Washout Period 2 (14 Days)|Physician Decision|0
5575853|NCT01072149|19267524|P11|Washout Period 2 (14 Days)|Physician Decision|0
5575854|NCT01072149|19267525|P10|Washout Period 2 (14 Days)|Physician Decision|0
5575855|NCT01072149|19267526|P9|Washout Period 2 (14 Days)|Physician Decision|0
5575856|NCT01072149|19267527|P8|Washout Period 2 (14 Days)|Physician Decision|0
5575857|NCT01072149|19267528|P7|Washout Period 2 (14 Days)|Physician Decision|0
5575858|NCT01072149|19267529|P6|Washout Period 2 (14 Days)|Physician Decision|0
5575859|NCT01072149|19267530|P5|Washout Period 2 (14 Days)|Physician Decision|0
5575860|NCT01072149|19267531|P4|Washout Period 2 (14 Days)|Physician Decision|0
5575861|NCT01072149|19267532|P3|Washout Period 2 (14 Days)|Physician Decision|0
5575862|NCT01072149|19267533|P2|Washout Period 2 (14 Days)|Physician Decision|0
5575863|NCT01072149|19267534|P1|Washout Period 2 (14 Days)|Physician Decision|1
5575864|NCT01072149|19267517|P18|Treatment Period 2 (28 Days)|Physician Decision|0
5575865|NCT01072149|19267518|P17|Treatment Period 2 (28 Days)|Physician Decision|0
5575866|NCT01072149|19267519|P16|Treatment Period 2 (28 Days)|Physician Decision|0
5575867|NCT01072149|19267520|P15|Treatment Period 2 (28 Days)|Physician Decision|0
5575868|NCT01072149|19267521|P14|Treatment Period 2 (28 Days)|Physician Decision|0
5575869|NCT01072149|19267522|P13|Treatment Period 2 (28 Days)|Physician Decision|0
5575870|NCT01072149|19267523|P12|Treatment Period 2 (28 Days)|Physician Decision|0
5575871|NCT01072149|19267524|P11|Treatment Period 2 (28 Days)|Physician Decision|0
5575872|NCT01072149|19267525|P10|Treatment Period 2 (28 Days)|Physician Decision|0
5575873|NCT01072149|19267526|P9|Treatment Period 2 (28 Days)|Physician Decision|0
5575874|NCT01072149|19267527|P8|Treatment Period 2 (28 Days)|Physician Decision|1
5575875|NCT01072149|19267528|P7|Treatment Period 2 (28 Days)|Physician Decision|0
5575876|NCT01072149|19267529|P6|Treatment Period 2 (28 Days)|Physician Decision|0
5575877|NCT01072149|19267530|P5|Treatment Period 2 (28 Days)|Physician Decision|0
5575878|NCT01072149|19267531|P4|Treatment Period 2 (28 Days)|Physician Decision|0
5575879|NCT01072149|19267532|P3|Treatment Period 2 (28 Days)|Physician Decision|0
5575880|NCT01072149|19267533|P2|Treatment Period 2 (28 Days)|Physician Decision|0
5575881|NCT01072149|19267534|P1|Treatment Period 2 (28 Days)|Physician Decision|0
5575882|NCT01072149|19267517|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575883|NCT01072149|19267518|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575884|NCT01072149|19267519|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575885|NCT01072149|19267520|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575886|NCT01072149|19267521|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575887|NCT01072149|19267522|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575888|NCT01072149|19267523|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575889|NCT01072149|19267524|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575890|NCT01072149|19267525|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575891|NCT01072149|19267526|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575892|NCT01072149|19267527|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575893|NCT01072149|19267528|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575894|NCT01072149|19267529|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575895|NCT01072149|19267530|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575896|NCT01072149|19267531|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575897|NCT01072149|19267532|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
5575898|NCT01072149|19267533|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575899|NCT01072149|19267534|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
5575900|NCT01072149|19267517|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575901|NCT01072149|19267518|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575902|NCT01072149|19267519|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575903|NCT01072149|19267520|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575904|NCT01072149|19267521|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575905|NCT01072149|19267522|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575906|NCT01072149|19267523|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575907|NCT01072149|19267524|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575908|NCT01072149|19267525|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575909|NCT01072149|19267526|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575910|NCT01072149|19267527|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575911|NCT01072149|19267528|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575912|NCT01072149|19267529|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575913|NCT01072149|19267530|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575914|NCT01072149|19267531|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575915|NCT01072149|19267532|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575916|NCT01072149|19267533|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
5575917|NCT01072149|19267534|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5575918|NCT01072149|19267517|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575919|NCT01072149|19267518|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575920|NCT01072149|19267519|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575921|NCT01072149|19267520|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575922|NCT01072149|19267521|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575923|NCT01072149|19267522|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575924|NCT01072149|19267523|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575925|NCT01072149|19267524|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
5575926|NCT01072149|19267525|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575927|NCT01072149|19267526|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575928|NCT01072149|19267527|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575929|NCT01072149|19267528|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575930|NCT01072149|19267529|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575931|NCT01072149|19267530|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575932|NCT01072149|19267531|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575933|NCT01072149|19267532|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575934|NCT01072149|19267533|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575935|NCT01072149|19267534|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5575936|NCT01072149|19267517|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
5575937|NCT01072149|19267518|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
5575938|NCT01072149|19267519|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
5575939|NCT01072149|19267520|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
5575940|NCT01072149|19267521|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
5575941|NCT01072149|19267522|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
5575942|NCT01072149|19267523|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
5575943|NCT01072149|19267524|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
5575944|NCT01072149|19267525|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
5575945|NCT01072149|19267526|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
5575946|NCT01072149|19267527|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
5575947|NCT01072149|19267528|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
5575948|NCT01072149|19267529|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
5575949|NCT01072149|19267530|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
5575950|NCT01072149|19267531|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
5575951|NCT01072149|19267532|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
5575952|NCT01072149|19267533|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
5575953|NCT01072149|19267534|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
5575954|NCT01072149|19267517|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575955|NCT01072149|19267518|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575956|NCT01072149|19267519|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575957|NCT01072149|19267520|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575958|NCT01072149|19267521|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575959|NCT01072149|19267522|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575960|NCT01072149|19267523|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575961|NCT01072149|19267524|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575962|NCT01072149|19267525|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575963|NCT01072149|19267526|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575964|NCT01072149|19267527|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575965|NCT01072149|19267528|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575966|NCT01072149|19267529|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575967|NCT01072149|19267530|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575968|NCT01072149|19267531|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575969|NCT01072149|19267532|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5575970|NCT01072149|19267533|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575971|NCT01072149|19267534|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5575972|NCT01071954|19267623|P1|Overall Study|Protocol Specified Criteria|1
5575973|NCT01071954|19267623|P1|Overall Study|Administrative Decision|5
5575974|NCT01071954|19267623|P1|Overall Study|Requirement for Alternative Therapy|5
5575975|NCT01071954|19267623|P1|Overall Study|Withdrawal by Subject|11
5575976|NCT01071954|19267623|P1|Overall Study|Adverse Event|1
5575977|NCT01071954|19267623|P1|Overall Study|Noncompliance|4
5575978|NCT01071915|19267632|P1|Overall Study|Miscellaneous Reasons|2
5575979|NCT01071915|19267632|P1|Overall Study|Withdrawal by Subject|2
5575980|NCT01071915|19267632|P1|Overall Study|Physician Decision|2
5575981|NCT01071915|19267632|P1|Overall Study|Adverse Event|3
5575982|NCT01071798|19267642|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
5575983|NCT01071798|19267642|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
5575984|NCT01071798|19267642|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
5575985|NCT01071798|19267642|P1|Subpopulation Who Received Two Cycles|Remission|1
5575986|NCT01071798|19267642|P1|Participants Who Received One Cycle|Severe concomitant disease|2
5575987|NCT01071798|19267642|P1|Participants Who Received One Cycle|Change of therapy|6
5575988|NCT01071798|19267642|P1|Participants Who Received One Cycle|Death|5
5575989|NCT01071798|19267642|P1|Participants Who Received One Cycle|Patient requirement|20
5575990|NCT01071798|19267642|P1|Participants Who Received One Cycle|Lack of tolerability|14
5575991|NCT01071798|19267642|P1|Participants Who Received One Cycle|Lack of Efficacy|18
5575992|NCT01071512|19267672|P1|Overall Study|positive anti-JC virus antibody test|2
5575993|NCT01071512|19267672|P1|Overall Study|Development of antibodies to drug|2
5575994|NCT01071512|19267672|P1|Overall Study|Adverse Event|1
5575995|NCT01071395|19267682|P2|Overall Study|Adverse Event|1
5575996|NCT01071395|19267683|P1|Overall Study|Adverse Event|3
5575997|NCT01071395|19267682|P2|Overall Study|Withdrawal by Subject|1
5575998|NCT01071395|19267683|P1|Overall Study|Withdrawal by Subject|2
5575999|NCT01071317|19267702|P2|Overall Study|Lost to Follow-up|2
5576000|NCT01071317|19267703|P1|Overall Study|Lost to Follow-up|2
5576001|NCT01071278|19267715|P1|Overall Study|Completion Status Unknown|459
5576002|NCT01071278|19267715|P1|Overall Study|Premature Discontinuation|254
5576003|NCT01071252|19267726|P5|Overall Study|Death|1
5576004|NCT01071252|19267727|P4|Overall Study|Death|0
5576005|NCT01071252|19267728|P3|Overall Study|Death|0
5576006|NCT01071252|19267729|P2|Overall Study|Death|0
5576007|NCT01071252|19267730|P1|Overall Study|Death|0
5576008|NCT01071252|19267726|P5|Overall Study|Adverse Event|0
5576009|NCT01071252|19267727|P4|Overall Study|Adverse Event|1
5576010|NCT01071252|19267728|P3|Overall Study|Adverse Event|0
5576011|NCT01071252|19267729|P2|Overall Study|Adverse Event|1
5576013|NCT01071252|19267726|P5|Overall Study|Lost to Follow-up|0
5576014|NCT01071252|19267727|P4|Overall Study|Lost to Follow-up|2
5576015|NCT01071252|19267728|P3|Overall Study|Lost to Follow-up|1
5576016|NCT01071252|19267729|P2|Overall Study|Lost to Follow-up|0
5576017|NCT01071252|19267730|P1|Overall Study|Lost to Follow-up|1
5576018|NCT01071252|19267726|P5|Overall Study|administrative problems|1
5576019|NCT01071252|19267727|P4|Overall Study|administrative problems|2
5576020|NCT01071252|19267728|P3|Overall Study|administrative problems|0
5576021|NCT01071252|19267729|P2|Overall Study|administrative problems|1
5576022|NCT01071252|19267730|P1|Overall Study|administrative problems|1
5576023|NCT01071252|19267726|P5|Overall Study|Withdrawal by Subject|3
5576024|NCT01071252|19267727|P4|Overall Study|Withdrawal by Subject|2
5576025|NCT01071252|19267728|P3|Overall Study|Withdrawal by Subject|1
5576026|NCT01071252|19267729|P2|Overall Study|Withdrawal by Subject|2
5576027|NCT01071252|19267730|P1|Overall Study|Withdrawal by Subject|8
5576028|NCT01071252|19267726|P5|Overall Study|unsatisfactory therapeutic effect|6
5576029|NCT01071252|19267727|P4|Overall Study|unsatisfactory therapeutic effect|0
5576030|NCT01071252|19267728|P3|Overall Study|unsatisfactory therapeutic effect|2
5576031|NCT01071252|19267729|P2|Overall Study|unsatisfactory therapeutic effect|6
5576032|NCT01071252|19267730|P1|Overall Study|unsatisfactory therapeutic effect|4
5576033|NCT01071200|19267758|P2|Overall Study|No viable embryos|1
5576034|NCT01071200|19267759|P1|Overall Study|No viable embryos|0
5576035|NCT01071200|19267758|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
5576036|NCT01071200|19267759|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
5576037|NCT01071200|19267758|P2|Overall Study|No oocytes retrieved|1
5576038|NCT01071200|19267759|P1|Overall Study|No oocytes retrieved|1
5576039|NCT01071200|19267758|P2|Overall Study|No fertilization|0
5576040|NCT01071200|19267759|P1|Overall Study|No fertilization|4
5576041|NCT01071200|19267758|P2|Overall Study|Lack of ovarian response|1
5576042|NCT01071200|19267759|P1|Overall Study|Lack of ovarian response|1
5576043|NCT01071096|19267791|P2|First Intervention (90 Days)|Lost to Follow-up|0
5576044|NCT01071096|19267792|P1|First Intervention (90 Days)|Lost to Follow-up|1
5576045|NCT01071083|19267816|P5|Overall Study|Subject Refused to Continue|0
5576046|NCT01071083|19267817|P4|Overall Study|Subject Refused to Continue|0
5576047|NCT01071083|19267818|P3|Overall Study|Subject Refused to Continue|0
5576048|NCT01071083|19267819|P2|Overall Study|Subject Refused to Continue|0
5576049|NCT01071083|19267820|P1|Overall Study|Subject Refused to Continue|1
5576050|NCT01071083|19267816|P5|Overall Study|Did Not Want Per Protocol Treatment|1
5576051|NCT01071083|19267817|P4|Overall Study|Did Not Want Per Protocol Treatment|0
5576052|NCT01071083|19267818|P3|Overall Study|Did Not Want Per Protocol Treatment|1
5576053|NCT01071083|19267819|P2|Overall Study|Did Not Want Per Protocol Treatment|0
5576054|NCT01071083|19267820|P1|Overall Study|Did Not Want Per Protocol Treatment|0
5576055|NCT01071083|19267816|P5|Overall Study|Did Not Meet Eligibility Criteria|1
5576056|NCT01071083|19267817|P4|Overall Study|Did Not Meet Eligibility Criteria|1
5576057|NCT01071083|19267818|P3|Overall Study|Did Not Meet Eligibility Criteria|1
5576058|NCT01071083|19267819|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5576059|NCT01071083|19267820|P1|Overall Study|Did Not Meet Eligibility Criteria|0
5576060|NCT01071083|19267816|P5|Overall Study|Images Not Usable (Motion)|0
5576061|NCT01071083|19267817|P4|Overall Study|Images Not Usable (Motion)|0
5576062|NCT01071083|19267818|P3|Overall Study|Images Not Usable (Motion)|0
5576063|NCT01071083|19267819|P2|Overall Study|Images Not Usable (Motion)|1
5576064|NCT01071083|19267820|P1|Overall Study|Images Not Usable (Motion)|0
5576065|NCT01071083|19267816|P5|Overall Study|Subject Moved|0
5576066|NCT01071083|19267817|P4|Overall Study|Subject Moved|0
5576067|NCT01071083|19267818|P3|Overall Study|Subject Moved|0
5576068|NCT01071083|19267819|P2|Overall Study|Subject Moved|1
5576069|NCT01071083|19267820|P1|Overall Study|Subject Moved|0
5576070|NCT01071083|19267816|P5|Overall Study|Early Rescue|1
5576071|NCT01071083|19267817|P4|Overall Study|Early Rescue|0
5576072|NCT01071083|19267818|P3|Overall Study|Early Rescue|0
5576073|NCT01071083|19267819|P2|Overall Study|Early Rescue|0
5576074|NCT01071083|19267820|P1|Overall Study|Early Rescue|1
5576075|NCT01071083|19267816|P5|Overall Study|Physician Decision|1
5576076|NCT01071083|19267817|P4|Overall Study|Physician Decision|1
5576077|NCT01071083|19267818|P3|Overall Study|Physician Decision|0
5576078|NCT01071083|19267819|P2|Overall Study|Physician Decision|0
5576079|NCT01071083|19267820|P1|Overall Study|Physician Decision|1
5576080|NCT01071083|19267816|P5|Overall Study|Withdrawal by Subject|3
5576081|NCT01071083|19267817|P4|Overall Study|Withdrawal by Subject|0
5576082|NCT01071083|19267818|P3|Overall Study|Withdrawal by Subject|2
5576083|NCT01071083|19267819|P2|Overall Study|Withdrawal by Subject|0
5576084|NCT01071083|19267820|P1|Overall Study|Withdrawal by Subject|3
5576085|NCT01071083|19267816|P5|Overall Study|Adverse Event|1
5576086|NCT01071083|19267817|P4|Overall Study|Adverse Event|0
5576087|NCT01071083|19267818|P3|Overall Study|Adverse Event|1
5576088|NCT01071083|19267819|P2|Overall Study|Adverse Event|0
5576089|NCT01071083|19267820|P1|Overall Study|Adverse Event|1
5576090|NCT01071070|19267839|P2|Overall Study|Hypercalcemia|0
5576091|NCT01071070|19267840|P1|Overall Study|Hypercalcemia|1
5576092|NCT01071070|19267839|P2|Overall Study|Missed 3 consecutive doses of study drug|0
5576093|NCT01071070|19267840|P1|Overall Study|Missed 3 consecutive doses of study drug|2
5576094|NCT01071070|19267839|P2|Overall Study|Withdrawal by Subject|0
5576095|NCT01071070|19267840|P1|Overall Study|Withdrawal by Subject|1
5576096|NCT01071070|19267839|P2|Overall Study|Adverse Event|3
5576097|NCT01071070|19267840|P1|Overall Study|Adverse Event|0
5576098|NCT01070979|19267886|P3|Overall Study|No study drug taken|0
5576099|NCT01070979|19267887|P2|Overall Study|No study drug taken|1
5576100|NCT01070979|19267888|P1|Overall Study|No study drug taken|0
5576101|NCT01070979|19267886|P3|Overall Study|Withdrawal by Subject|1
5576102|NCT01070979|19267887|P2|Overall Study|Withdrawal by Subject|1
5576103|NCT01070979|19267888|P1|Overall Study|Withdrawal by Subject|3
5576104|NCT01070979|19267886|P3|Overall Study|Surgery, moving, personal, abn. labs|2
5576105|NCT01070979|19267887|P2|Overall Study|Surgery, moving, personal, abn. labs|4
5576106|NCT01070979|19267888|P1|Overall Study|Surgery, moving, personal, abn. labs|4
5576107|NCT01070979|19267886|P3|Overall Study|Protocol Violation|6
5576108|NCT01070979|19267887|P2|Overall Study|Protocol Violation|2
5576109|NCT01070979|19267888|P1|Overall Study|Protocol Violation|0
5576110|NCT01070979|19267886|P3|Overall Study|Lost to Follow-up|1
5576111|NCT01070979|19267887|P2|Overall Study|Lost to Follow-up|1
5576112|NCT01070979|19267888|P1|Overall Study|Lost to Follow-up|2
5576113|NCT01070979|19267886|P3|Overall Study|Adverse Event|3
5576114|NCT01070979|19267887|P2|Overall Study|Adverse Event|3
5576115|NCT01070979|19267888|P1|Overall Study|Adverse Event|2
5576116|NCT01070966|19267914|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
5576117|NCT01070966|19267914|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
5576118|NCT01070966|19267914|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
5576119|NCT01070966|19267914|P1|Participants for Safety Evaluation|TMT given before date of contract|3
5576120|NCT01070966|19267914|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
5576121|NCT01070966|19267914|P1|Participants for Safety Evaluation|Duplicate Participants|4
5576122|NCT01070966|19267914|P1|Participants for Safety Evaluation|Off-label use|9
5576123|NCT01070966|19267914|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
5576124|NCT01070953|19267925|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
5576125|NCT01070953|19267925|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
5576126|NCT01070953|19267925|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
5576127|NCT01070953|19267925|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
5576128|NCT01070953|19267925|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
5576129|NCT01070953|19267925|P1|Participants for Safety Evaluation|Uncontracted participants|4
5576130|NCT01070953|19267925|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
5576131|NCT01070953|19267925|P1|Participants for Safety Evaluation|Duplicated participants|22
5576132|NCT01070953|19267925|P1|Participants for Safety Evaluation|Off-label use|283
5576133|NCT01070953|19267925|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
5576134|NCT01070888|19267938|P2|Washout (14 Days)|Physician Decision|0
5576135|NCT01070888|19267939|P1|Washout (14 Days)|Physician Decision|1
5576136|NCT01070888|19267938|P2|First Intervention (14 Days)|Lost to Follow-up|1
5576137|NCT01070888|19267939|P1|First Intervention (14 Days)|Lost to Follow-up|0
5576138|NCT01070888|19267938|P2|First Intervention (14 Days)|Adverse Event|1
5576139|NCT01070888|19267939|P1|First Intervention (14 Days)|Adverse Event|0
5576140|NCT01070784|19267964|P2|Overall Study|Adverse Event|9
5576141|NCT01070784|19267965|P1|Overall Study|Adverse Event|14
5576142|NCT01070784|19267964|P2|Overall Study|Withdrawal by Subject|9
5576143|NCT01070784|19267965|P1|Overall Study|Withdrawal by Subject|6
5576144|NCT01070771|19268053|P1|Overall Study|Protocol Violation|1
5576145|NCT01070771|19268053|P1|Overall Study|Adverse Event|2
5576146|NCT01070550|19268073|P6|Overall Study|Withdrawal by Subject|0
5576147|NCT01070550|19268074|P5|Overall Study|Withdrawal by Subject|0
5576148|NCT01070550|19268075|P4|Overall Study|Withdrawal by Subject|0
5576149|NCT01070550|19268076|P3|Overall Study|Withdrawal by Subject|3
5576150|NCT01070550|19268077|P2|Overall Study|Withdrawal by Subject|0
5576151|NCT01070550|19268078|P1|Overall Study|Withdrawal by Subject|35
5576152|NCT01070550|19268073|P6|Overall Study|Other|0
5576153|NCT01070550|19268074|P5|Overall Study|Other|0
5576154|NCT01070550|19268075|P4|Overall Study|Other|1
5576155|NCT01070550|19268076|P3|Overall Study|Other|0
5576156|NCT01070550|19268077|P2|Overall Study|Other|0
5576157|NCT01070550|19268078|P1|Overall Study|Other|5
5576158|NCT01070550|19268073|P6|Overall Study|Treatment was stopped early|0
5576159|NCT01070550|19268074|P5|Overall Study|Treatment was stopped early|0
5576160|NCT01070550|19268075|P4|Overall Study|Treatment was stopped early|0
5576161|NCT01070550|19268076|P3|Overall Study|Treatment was stopped early|0
5576162|NCT01070550|19268077|P2|Overall Study|Treatment was stopped early|0
5576163|NCT01070550|19268078|P1|Overall Study|Treatment was stopped early|7
5576164|NCT01070550|19268073|P6|Overall Study|Treatment unavailable|0
5576165|NCT01070550|19268074|P5|Overall Study|Treatment unavailable|0
5576166|NCT01070550|19268075|P4|Overall Study|Treatment unavailable|0
5576167|NCT01070550|19268076|P3|Overall Study|Treatment unavailable|0
5576168|NCT01070550|19268077|P2|Overall Study|Treatment unavailable|0
5576169|NCT01070550|19268078|P1|Overall Study|Treatment unavailable|1
5576170|NCT01070550|19268073|P6|Overall Study|Treatment stopped|0
5576171|NCT01070550|19268074|P5|Overall Study|Treatment stopped|0
5576172|NCT01070550|19268075|P4|Overall Study|Treatment stopped|0
5576173|NCT01070550|19268076|P3|Overall Study|Treatment stopped|0
5576174|NCT01070550|19268077|P2|Overall Study|Treatment stopped|0
5576175|NCT01070550|19268078|P1|Overall Study|Treatment stopped|3
5576176|NCT01070550|19268073|P6|Overall Study|Treatment restarted|0
5576177|NCT01070550|19268074|P5|Overall Study|Treatment restarted|0
5576178|NCT01070550|19268075|P4|Overall Study|Treatment restarted|0
5576179|NCT01070550|19268076|P3|Overall Study|Treatment restarted|0
5576180|NCT01070550|19268077|P2|Overall Study|Treatment restarted|1
5576181|NCT01070550|19268078|P1|Overall Study|Treatment restarted|0
5576182|NCT01070550|19268073|P6|Overall Study|Treatment not started|0
5576183|NCT01070550|19268074|P5|Overall Study|Treatment not started|0
5576184|NCT01070550|19268075|P4|Overall Study|Treatment not started|0
5576185|NCT01070550|19268076|P3|Overall Study|Treatment not started|4
5576186|NCT01070550|19268077|P2|Overall Study|Treatment not started|2
5576187|NCT01070550|19268078|P1|Overall Study|Treatment not started|14
5576188|NCT01070550|19268073|P6|Overall Study|Treatment interrupted|0
5576189|NCT01070550|19268074|P5|Overall Study|Treatment interrupted|0
5576190|NCT01070550|19268075|P4|Overall Study|Treatment interrupted|1
5576191|NCT01070550|19268076|P3|Overall Study|Treatment interrupted|1
5576192|NCT01070550|19268077|P2|Overall Study|Treatment interrupted|0
5576193|NCT01070550|19268078|P1|Overall Study|Treatment interrupted|7
5576194|NCT01070550|19268073|P6|Overall Study|Treatment duration shortened|0
5576195|NCT01070550|19268074|P5|Overall Study|Treatment duration shortened|0
5576196|NCT01070550|19268075|P4|Overall Study|Treatment duration shortened|0
5576197|NCT01070550|19268076|P3|Overall Study|Treatment duration shortened|0
5576198|NCT01070550|19268077|P2|Overall Study|Treatment duration shortened|0
5576199|NCT01070550|19268078|P1|Overall Study|Treatment duration shortened|1
5576200|NCT01070550|19268073|P6|Overall Study|Sponsor decision|0
5576201|NCT01070550|19268074|P5|Overall Study|Sponsor decision|0
5576202|NCT01070550|19268075|P4|Overall Study|Sponsor decision|0
5576203|NCT01070550|19268076|P3|Overall Study|Sponsor decision|0
5576204|NCT01070550|19268077|P2|Overall Study|Sponsor decision|0
5576205|NCT01070550|19268078|P1|Overall Study|Sponsor decision|1
5576206|NCT01070550|19268073|P6|Overall Study|Screen failure|0
5576207|NCT01070550|19268074|P5|Overall Study|Screen failure|0
5576208|NCT01070550|19268075|P4|Overall Study|Screen failure|0
5576209|NCT01070550|19268076|P3|Overall Study|Screen failure|0
5576210|NCT01070550|19268077|P2|Overall Study|Screen failure|0
5576211|NCT01070550|19268078|P1|Overall Study|Screen failure|1
5576212|NCT01070550|19268073|P6|Overall Study|Result not available|0
5576213|NCT01070550|19268074|P5|Overall Study|Result not available|0
5576214|NCT01070550|19268075|P4|Overall Study|Result not available|0
5576215|NCT01070550|19268076|P3|Overall Study|Result not available|3
5576216|NCT01070550|19268077|P2|Overall Study|Result not available|1
5576217|NCT01070550|19268078|P1|Overall Study|Result not available|3
5576218|NCT01070550|19268073|P6|Overall Study|Relapse|0
5576219|NCT01070550|19268074|P5|Overall Study|Relapse|0
5576220|NCT01070550|19268075|P4|Overall Study|Relapse|4
5576221|NCT01070550|19268076|P3|Overall Study|Relapse|14
5576222|NCT01070550|19268077|P2|Overall Study|Relapse|5
5576223|NCT01070550|19268078|P1|Overall Study|Relapse|44
5576224|NCT01070550|19268073|P6|Overall Study|Protocol Violation|0
5576225|NCT01070550|19268074|P5|Overall Study|Protocol Violation|0
5576226|NCT01070550|19268075|P4|Overall Study|Protocol Violation|1
5576227|NCT01070550|19268076|P3|Overall Study|Protocol Violation|1
5576228|NCT01070550|19268077|P2|Overall Study|Protocol Violation|1
5576229|NCT01070550|19268078|P1|Overall Study|Protocol Violation|15
5576230|NCT01070550|19268073|P6|Overall Study|Not categorized|1
5576231|NCT01070550|19268074|P5|Overall Study|Not categorized|0
5576232|NCT01070550|19268075|P4|Overall Study|Not categorized|1
5576233|NCT01070550|19268076|P3|Overall Study|Not categorized|6
5576234|NCT01070550|19268077|P2|Overall Study|Not categorized|2
5576235|NCT01070550|19268078|P1|Overall Study|Not categorized|33
5576236|NCT01070550|19268073|P6|Overall Study|Non-responders|2
5576237|NCT01070550|19268074|P5|Overall Study|Non-responders|0
5576238|NCT01070550|19268075|P4|Overall Study|Non-responders|20
5576239|NCT01070550|19268076|P3|Overall Study|Non-responders|21
5576240|NCT01070550|19268077|P2|Overall Study|Non-responders|4
5576241|NCT01070550|19268078|P1|Overall Study|Non-responders|493
5576242|NCT01070550|19268073|P6|Overall Study|New treatment started|0
5576243|NCT01070550|19268074|P5|Overall Study|New treatment started|0
5576244|NCT01070550|19268075|P4|Overall Study|New treatment started|2
5576245|NCT01070550|19268076|P3|Overall Study|New treatment started|0
5576246|NCT01070550|19268077|P2|Overall Study|New treatment started|1
5576247|NCT01070550|19268078|P1|Overall Study|New treatment started|3
5576248|NCT01070550|19268073|P6|Overall Study|Miscellaneous|0
5576249|NCT01070550|19268074|P5|Overall Study|Miscellaneous|0
5576250|NCT01070550|19268075|P4|Overall Study|Miscellaneous|1
5576251|NCT01070550|19268076|P3|Overall Study|Miscellaneous|3
5576252|NCT01070550|19268077|P2|Overall Study|Miscellaneous|2
5576253|NCT01070550|19268078|P1|Overall Study|Miscellaneous|12
5576254|NCT01070550|19268073|P6|Overall Study|Lack of Efficacy|1
5576255|NCT01070550|19268074|P5|Overall Study|Lack of Efficacy|0
5576256|NCT01070550|19268075|P4|Overall Study|Lack of Efficacy|5
5576257|NCT01070550|19268076|P3|Overall Study|Lack of Efficacy|5
5576258|NCT01070550|19268077|P2|Overall Study|Lack of Efficacy|1
5576259|NCT01070550|19268078|P1|Overall Study|Lack of Efficacy|65
5576260|NCT01070550|19268073|P6|Overall Study|Lab test not done|1
5576261|NCT01070550|19268074|P5|Overall Study|Lab test not done|0
5576262|NCT01070550|19268075|P4|Overall Study|Lab test not done|1
5576263|NCT01070550|19268076|P3|Overall Study|Lab test not done|4
5576264|NCT01070550|19268077|P2|Overall Study|Lab test not done|3
5576265|NCT01070550|19268078|P1|Overall Study|Lab test not done|22
5576266|NCT01070550|19268073|P6|Overall Study|Incomplete treatment|0
5576267|NCT01070550|19268074|P5|Overall Study|Incomplete treatment|0
5576268|NCT01070550|19268075|P4|Overall Study|Incomplete treatment|0
5576269|NCT01070550|19268076|P3|Overall Study|Incomplete treatment|0
5576270|NCT01070550|19268077|P2|Overall Study|Incomplete treatment|0
5576271|NCT01070550|19268078|P1|Overall Study|Incomplete treatment|2
5576272|NCT01070550|19268073|P6|Overall Study|Failed to return|2
5576273|NCT01070550|19268074|P5|Overall Study|Failed to return|1
5576274|NCT01070550|19268075|P4|Overall Study|Failed to return|40
5576275|NCT01070550|19268076|P3|Overall Study|Failed to return|144
5576276|NCT01070550|19268077|P2|Overall Study|Failed to return|33
5576277|NCT01070550|19268078|P1|Overall Study|Failed to return|450
5576278|NCT01070550|19268073|P6|Overall Study|Early termination|0
5576279|NCT01070550|19268074|P5|Overall Study|Early termination|0
5576280|NCT01070550|19268075|P4|Overall Study|Early termination|0
5576281|NCT01070550|19268076|P3|Overall Study|Early termination|0
5576282|NCT01070550|19268077|P2|Overall Study|Early termination|0
5576283|NCT01070550|19268078|P1|Overall Study|Early termination|3
5576284|NCT01070550|19268073|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
5576285|NCT01070550|19268074|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
5576286|NCT01070550|19268075|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
5576287|NCT01070550|19268076|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
5576288|NCT01070550|19268077|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
5576289|NCT01070550|19268078|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
5576290|NCT01070550|19268073|P6|Overall Study|Death|0
5576291|NCT01070550|19268074|P5|Overall Study|Death|0
5576292|NCT01070550|19268075|P4|Overall Study|Death|0
5576293|NCT01070550|19268076|P3|Overall Study|Death|3
5576294|NCT01070550|19268077|P2|Overall Study|Death|4
5576295|NCT01070550|19268078|P1|Overall Study|Death|20
5576296|NCT01070550|19268073|P6|Overall Study|Adverse Event|0
5576297|NCT01070550|19268074|P5|Overall Study|Adverse Event|0
5576298|NCT01070550|19268075|P4|Overall Study|Adverse Event|0
5576299|NCT01070550|19268076|P3|Overall Study|Adverse Event|3
5576300|NCT01070550|19268077|P2|Overall Study|Adverse Event|1
5576301|NCT01070550|19268078|P1|Overall Study|Adverse Event|43
5576302|NCT01070394|19268218|P1|Overall Study|Withdrawal by Subject|1
5576303|NCT01070394|19268218|P1|Overall Study|Adverse Event|6
5576304|NCT01070381|19268229|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
5576305|NCT01070381|19268230|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
5576306|NCT01070381|19268229|P2|Period 2, 1 Week of Wear|Handling|1
5576307|NCT01070381|19268230|P1|Period 2, 1 Week of Wear|Handling|0
5576308|NCT01070329|19268238|P2|Overall Study|Sponsor Decision|1
5576309|NCT01070329|19268239|P1|Overall Study|Sponsor Decision|0
5576310|NCT01070329|19268238|P2|Overall Study|Entry Criteria Not Met|0
5576311|NCT01070329|19268239|P1|Overall Study|Entry Criteria Not Met|1
5576312|NCT01070329|19268238|P2|Overall Study|Physician Decision|1
5576313|NCT01070329|19268239|P1|Overall Study|Physician Decision|2
5576314|NCT01070329|19268238|P2|Overall Study|Lack of Efficacy|6
5576315|NCT01070329|19268239|P1|Overall Study|Lack of Efficacy|2
5576316|NCT01070329|19268238|P2|Overall Study|Protocol Violation|8
5576317|NCT01070329|19268239|P1|Overall Study|Protocol Violation|3
5576318|NCT01070329|19268238|P2|Overall Study|Withdrawal by Subject|11
5576319|NCT01070329|19268239|P1|Overall Study|Withdrawal by Subject|9
5576320|NCT01070329|19268238|P2|Overall Study|Lost to Follow-up|12
5576321|NCT01070329|19268239|P1|Overall Study|Lost to Follow-up|22
5576322|NCT01070329|19268238|P2|Overall Study|Adverse Event|10
5576323|NCT01070329|19268239|P1|Overall Study|Adverse Event|13
5576324|NCT01070316|19268271|P1|Extension Phase|Withdrawal by Subject|1
5576325|NCT01070316|19268271|P1|Extension Phase|Lack of Efficacy|3
5576326|NCT01070303|19268278|P1|Overall Study|Other|18
5576327|NCT01070303|19268278|P1|Overall Study|Administrative Reason|1
5576328|NCT01070303|19268278|P1|Overall Study|Lack of Efficacy|2
5576329|NCT01070303|19268278|P1|Overall Study|Protocol Violation|0
5576330|NCT01070303|19268278|P1|Overall Study|Lost to Follow-up|9
5576331|NCT01070303|19268278|P1|Overall Study|Withdrawal by Subject|20
5576332|NCT01070303|19268278|P1|Overall Study|Adverse Event|39
5576333|NCT01070043|19268373|P3|Double-Blind Treatment|Adverse Event|2
5576334|NCT01070043|19268374|P2|Double-Blind Treatment|Adverse Event|0
5576335|NCT01070043|19268375|P1|Double-Blind Treatment|Adverse Event|0
5576336|NCT01070043|19268373|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
5576337|NCT01070043|19268374|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
5576338|NCT01070043|19268375|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
5576339|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Removal|0
5576340|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Removal|1
5576341|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Physician Decision|2
5576342|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Physician Decision|0
5576343|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
5576344|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
5576345|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
5576346|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
5576347|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
5576348|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
5576349|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
5576350|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
5576351|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Protocol Violation|1
5576352|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Protocol Violation|0
5576353|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
5576354|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
5576355|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
5576356|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
5576357|NCT01069939|19268391|P2|Randomised and Included in the Analyses|Adverse Event|22
5576358|NCT01069939|19268392|P1|Randomised and Included in the Analyses|Adverse Event|17
5576359|NCT01069900|19268418|P2|Overall Study|Insufficient Therapeutic effect|0
5576360|NCT01069900|19268419|P1|Overall Study|Insufficient Therapeutic effect|1
5576361|NCT01069900|19268418|P2|Overall Study|Protocol Violation|1
5576362|NCT01069900|19268419|P1|Overall Study|Protocol Violation|4
5576363|NCT01069900|19268418|P2|Overall Study|Withdrawal by Subject|1
5576364|NCT01069900|19268419|P1|Overall Study|Withdrawal by Subject|6
5576365|NCT01069900|19268418|P2|Overall Study|Lost to Follow-up|1
5576366|NCT01069900|19268419|P1|Overall Study|Lost to Follow-up|7
5576367|NCT01069900|19268418|P2|Overall Study|Technical problems|1
5576368|NCT01069900|19268419|P1|Overall Study|Technical problems|0
5576369|NCT01069861|19268463|P1|Overall Study|Did not meet entrance criteria|1
5576370|NCT01069861|19268463|P1|Overall Study|Adverse Event|1
5576371|NCT01069861|19268463|P1|Overall Study|Death|1
5576372|NCT01069627|19268476|P1|Overall Study|Protocol Violation|1
5576373|NCT01069627|19268476|P1|Overall Study|Adverse Event|12
5576374|NCT01069627|19268476|P1|Overall Study|Disease progression|7
5576375|NCT01069523|19268526|P2|Overall Study|Withdrawal by Subject|7
5576376|NCT01069523|19268527|P1|Overall Study|Withdrawal by Subject|4
5576377|NCT01069484|19268550|P2|Overall Study|Illness mother or child|1
5576378|NCT01069484|19268551|P1|Overall Study|Illness mother or child|3
5576379|NCT01069484|19268550|P2|Overall Study|No specific reason|2
5576380|NCT01069484|19268551|P1|Overall Study|No specific reason|8
5576381|NCT01069484|19268550|P2|Overall Study|Death-in-near-family|0
5576382|NCT01069484|19268551|P1|Overall Study|Death-in-near-family|1
5576383|NCT01069419|19268559|P1|Overall Study|Missing termination information|13
5576384|NCT01069419|19268559|P1|Overall Study|Other Reason|43
5576385|NCT01069419|19268559|P1|Overall Study|Withdrawal by Subject|34
5576386|NCT01069419|19268559|P1|Overall Study|Remission of disease|11
5576387|NCT01069419|19268559|P1|Overall Study|Lost to Follow-up|49
5576388|NCT01069419|19268559|P1|Overall Study|Lack of Efficacy|332
5576389|NCT01069419|19268559|P1|Overall Study|Adverse Event|233
5576390|NCT01069341|19268588|P1|Overall Study|Lost to Follow-up|1
5576391|NCT01069289|19268630|P2|Overall Study|Due to deteriorating health condition|0
5576392|NCT01069289|19268631|P1|Overall Study|Due to deteriorating health condition|1
5576393|NCT01069289|19268630|P2|Overall Study|Severe non-compliance to protocol|2
5576394|NCT01069289|19268631|P1|Overall Study|Severe non-compliance to protocol|3
5576395|NCT01069289|19268630|P2|Overall Study|Eligibility criteria not fulfilled|0
5576396|NCT01069289|19268631|P1|Overall Study|Eligibility criteria not fulfilled|2
5576397|NCT01069289|19268630|P2|Overall Study|Adverse Event|28
5576398|NCT01069289|19268631|P1|Overall Study|Adverse Event|21
5576399|NCT01069289|19268630|P2|Overall Study|Withdrawal by Subject|26
5576400|NCT01069289|19268631|P1|Overall Study|Withdrawal by Subject|15
5576401|NCT01069172|19268680|P2|Overall Study|Withdrawal by Subject|0
5576402|NCT01069172|19268681|P1|Overall Study|Withdrawal by Subject|1
5576403|NCT01069120|19268691|P1|Overall Study|Study prematurely terminated|27
5576404|NCT01068912|19268728|P3|Overall Study|other underlying illness|3
5576405|NCT01068912|19268729|P2|Overall Study|other underlying illness|3
5576406|NCT01068912|19268730|P1|Overall Study|other underlying illness|0
5576407|NCT01068912|19268728|P3|Overall Study|aggravation influenza|1
5576408|NCT01068912|19268729|P2|Overall Study|aggravation influenza|1
5576409|NCT01068912|19268730|P1|Overall Study|aggravation influenza|1
5576410|NCT01068912|19268728|P3|Overall Study|Protocol Violation|0
5576411|NCT01068912|19268729|P2|Overall Study|Protocol Violation|2
5576412|NCT01068912|19268730|P1|Overall Study|Protocol Violation|0
5576413|NCT01068912|19268728|P3|Overall Study|Lost to Follow-up|3
5576414|NCT01068912|19268729|P2|Overall Study|Lost to Follow-up|7
5576415|NCT01068912|19268730|P1|Overall Study|Lost to Follow-up|3
5576416|NCT01068912|19268728|P3|Overall Study|Withdrawal by Subject|6
5576417|NCT01068912|19268729|P2|Overall Study|Withdrawal by Subject|6
5576418|NCT01068912|19268730|P1|Overall Study|Withdrawal by Subject|5
5576419|NCT01068912|19268728|P3|Overall Study|Adverse Event|2
5576420|NCT01068912|19268729|P2|Overall Study|Adverse Event|3
5576421|NCT01068912|19268730|P1|Overall Study|Adverse Event|2
5576422|NCT01068860|19268758|P10|Overall Study|Lost to Follow-up|0
5576423|NCT01068860|19268759|P9|Overall Study|Lost to Follow-up|0
5576424|NCT01068860|19268760|P8|Overall Study|Lost to Follow-up|0
5576425|NCT01068860|19268761|P7|Overall Study|Lost to Follow-up|0
5576426|NCT01068860|19268762|P6|Overall Study|Lost to Follow-up|0
5576427|NCT01068860|19268763|P5|Overall Study|Lost to Follow-up|0
5576428|NCT01068860|19268764|P4|Overall Study|Lost to Follow-up|0
5576429|NCT01068860|19268765|P3|Overall Study|Lost to Follow-up|0
5576430|NCT01068860|19268766|P2|Overall Study|Lost to Follow-up|1
5576431|NCT01068860|19268767|P1|Overall Study|Lost to Follow-up|0
5576432|NCT01068860|19268758|P10|Overall Study|Administrative problems; misrandomized|1
5576433|NCT01068860|19268759|P9|Overall Study|Administrative problems; misrandomized|0
5576434|NCT01068860|19268760|P8|Overall Study|Administrative problems; misrandomized|0
5576435|NCT01068860|19268761|P7|Overall Study|Administrative problems; misrandomized|0
5576436|NCT01068860|19268762|P6|Overall Study|Administrative problems; misrandomized|0
5576437|NCT01068860|19268763|P5|Overall Study|Administrative problems; misrandomized|0
5576438|NCT01068860|19268764|P4|Overall Study|Administrative problems; misrandomized|1
5576439|NCT01068860|19268765|P3|Overall Study|Administrative problems; misrandomized|0
5576440|NCT01068860|19268766|P2|Overall Study|Administrative problems; misrandomized|0
5576441|NCT01068860|19268767|P1|Overall Study|Administrative problems; misrandomized|0
5576442|NCT01068860|19268758|P10|Overall Study|Withdrawal by Subject|3
5576443|NCT01068860|19268759|P9|Overall Study|Withdrawal by Subject|0
5576444|NCT01068860|19268760|P8|Overall Study|Withdrawal by Subject|0
5576445|NCT01068860|19268761|P7|Overall Study|Withdrawal by Subject|0
5576446|NCT01068860|19268762|P6|Overall Study|Withdrawal by Subject|2
5576447|NCT01068860|19268763|P5|Overall Study|Withdrawal by Subject|0
5576448|NCT01068860|19268764|P4|Overall Study|Withdrawal by Subject|0
5576449|NCT01068860|19268765|P3|Overall Study|Withdrawal by Subject|0
5576450|NCT01068860|19268766|P2|Overall Study|Withdrawal by Subject|0
5576451|NCT01068860|19268767|P1|Overall Study|Withdrawal by Subject|0
5576452|NCT01068769|19268950|P1|Overall Study|Ineligible|1
5576453|NCT01068743|19268955|P4|Period 3|Adverse Event|0
5576454|NCT01068743|19268956|P3|Period 3|Adverse Event|0
5576455|NCT01068743|19268957|P2|Period 3|Adverse Event|1
5576456|NCT01068743|19268958|P1|Period 3|Adverse Event|0
5576457|NCT01068730|19269032|P4|Period 4|Family emergency|0
5576458|NCT01068730|19269033|P3|Period 4|Family emergency|0
5576459|NCT01068730|19269034|P2|Period 4|Family emergency|1
5576460|NCT01068730|19269035|P1|Period 4|Family emergency|0
5576461|NCT01068730|19269032|P4|Period 3|Personal reason|0
5576462|NCT01068730|19269033|P3|Period 3|Personal reason|0
5576463|NCT01068730|19269034|P2|Period 3|Personal reason|0
5576464|NCT01068730|19269035|P1|Period 3|Personal reason|1
5576465|NCT01068717|19269089|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
5576466|NCT01068717|19269090|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
5576467|NCT01068717|19269091|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
5576468|NCT01068717|19269092|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
5576469|NCT01068678|19269148|P2|Overall Study|Unclassified|15
5576470|NCT01068678|19269149|P1|Overall Study|Unclassified|18
5576471|NCT01068678|19269148|P2|Overall Study|Withdrawal criteria|6
5576472|NCT01068678|19269149|P1|Overall Study|Withdrawal criteria|12
5576473|NCT01068678|19269148|P2|Overall Study|Protocol Violation|1
5576474|NCT01068678|19269149|P1|Overall Study|Protocol Violation|5
5576475|NCT01068678|19269148|P2|Overall Study|Lack of Efficacy|2
5576476|NCT01068678|19269149|P1|Overall Study|Lack of Efficacy|3
5576477|NCT01068665|19269159|P2|Overall Study|Other|12
5576478|NCT01068665|19269160|P1|Overall Study|Other|17
5576479|NCT01068665|19269159|P2|Overall Study|Withdrawal Criteria|9
5576480|NCT01068665|19269160|P1|Overall Study|Withdrawal Criteria|3
5576481|NCT01068665|19269159|P2|Overall Study|Protocol Violation|2
5576482|NCT01068665|19269160|P1|Overall Study|Protocol Violation|5
5576483|NCT01068665|19269159|P2|Overall Study|Lack of Efficacy|2
5576484|NCT01068665|19269160|P1|Overall Study|Lack of Efficacy|0
5576485|NCT01068665|19269159|P2|Overall Study|Adverse Event|4
5576486|NCT01068665|19269160|P1|Overall Study|Adverse Event|5
5576487|NCT01068652|19269170|P2|Overall Study|Unclassified|4
5576488|NCT01068652|19269171|P1|Overall Study|Unclassified|7
5576489|NCT01068652|19269170|P2|Overall Study|Patient was not eligible|0
5576490|NCT01068652|19269171|P1|Overall Study|Patient was not eligible|1
5576491|NCT01068652|19269170|P2|Overall Study|Withdrawal criteria|2
5576492|NCT01068652|19269171|P1|Overall Study|Withdrawal criteria|1
5576493|NCT01068652|19269170|P2|Overall Study|Protocol Violation|6
5576494|NCT01068652|19269171|P1|Overall Study|Protocol Violation|3
5576495|NCT01068652|19269170|P2|Overall Study|Lost to Follow-up|1
5576496|NCT01068652|19269171|P1|Overall Study|Lost to Follow-up|2
5576497|NCT01068652|19269170|P2|Overall Study|Lack of Efficacy|2
5576498|NCT01068652|19269171|P1|Overall Study|Lack of Efficacy|0
5576499|NCT01068652|19269170|P2|Overall Study|Adverse Event|0
5576500|NCT01068652|19269171|P1|Overall Study|Adverse Event|4
5576501|NCT01068626|19269211|P2|Overall Study|Withdrawal by Subject|2
5576502|NCT01068626|19269212|P1|Overall Study|Withdrawal by Subject|0
5576503|NCT01068626|19269211|P2|Overall Study|Adverse Event|0
5576504|NCT01068626|19269212|P1|Overall Study|Adverse Event|3
5576505|NCT01068600|19269230|P2|Overall Study|Administrative problems|1
5576506|NCT01068600|19269231|P1|Overall Study|Administrative problems|0
5576507|NCT01068600|19269230|P2|Overall Study|Unsatisfactory therapeutic effect|4
5576508|NCT01068600|19269231|P1|Overall Study|Unsatisfactory therapeutic effect|0
5576509|NCT01068600|19269230|P2|Overall Study|Protocol deviation|1
5576510|NCT01068600|19269231|P1|Overall Study|Protocol deviation|1
5576511|NCT01068600|19269230|P2|Overall Study|Lost to Follow-up|2
5576512|NCT01068600|19269231|P1|Overall Study|Lost to Follow-up|1
5576513|NCT01068600|19269230|P2|Overall Study|Abnormal laboratory value(s)|0
5576514|NCT01068600|19269231|P1|Overall Study|Abnormal laboratory value(s)|1
5576515|NCT01068600|19269230|P2|Overall Study|Adverse Event|3
5576516|NCT01068600|19269231|P1|Overall Study|Adverse Event|3
5576517|NCT01068600|19269230|P2|Overall Study|Withdrawal by Subject|6
5576518|NCT01068600|19269231|P1|Overall Study|Withdrawal by Subject|5
5576519|NCT01068509|19269253|P3|Overall Study|Reason Not Specified|0
5576520|NCT01068509|19269254|P2|Overall Study|Reason Not Specified|1
5576521|NCT01068509|19269255|P1|Overall Study|Reason Not Specified|0
5576522|NCT01068509|19269253|P3|Overall Study|Withdrew Consent|2
5576523|NCT01068509|19269254|P2|Overall Study|Withdrew Consent|1
5576524|NCT01068509|19269255|P1|Overall Study|Withdrew Consent|0
5576525|NCT01068509|19269253|P3|Overall Study|Lost to Follow-up|0
5576526|NCT01068509|19269254|P2|Overall Study|Lost to Follow-up|0
5576527|NCT01068509|19269255|P1|Overall Study|Lost to Follow-up|1
5576528|NCT01068509|19269253|P3|Overall Study|Disease Progression|18
5576529|NCT01068509|19269254|P2|Overall Study|Disease Progression|20
5576530|NCT01068509|19269255|P1|Overall Study|Disease Progression|5
5576531|NCT01068509|19269253|P3|Overall Study|Death|1
5576532|NCT01068509|19269254|P2|Overall Study|Death|0
5576533|NCT01068509|19269255|P1|Overall Study|Death|0
5576534|NCT01068418|19269268|P1|Overall Study|Physician Decision|12
5576535|NCT01068262|19269277|P4|Overall Study|Withdrawal by Subject|0
5576536|NCT01068262|19269278|P3|Overall Study|Withdrawal by Subject|0
5576537|NCT01068262|19269279|P2|Overall Study|Withdrawal by Subject|1
5576538|NCT01068262|19269280|P1|Overall Study|Withdrawal by Subject|0
5576539|NCT01068262|19269277|P4|Overall Study|Protocol Violation|0
5576540|NCT01068262|19269278|P3|Overall Study|Protocol Violation|0
5576541|NCT01068262|19269279|P2|Overall Study|Protocol Violation|0
5576542|NCT01068262|19269280|P1|Overall Study|Protocol Violation|1
5576543|NCT01068262|19269277|P4|Overall Study|Adverse Event|0
5576544|NCT01068262|19269278|P3|Overall Study|Adverse Event|1
5576545|NCT01068262|19269279|P2|Overall Study|Adverse Event|0
5576546|NCT01068262|19269280|P1|Overall Study|Adverse Event|2
5576547|NCT01068158|19269310|P2|Overall Study|Protocol Violation|2
5576548|NCT01068158|19269311|P1|Overall Study|Protocol Violation|0
5576549|NCT01068158|19269310|P2|Overall Study|Lost to Follow-up|0
5576550|NCT01068158|19269311|P1|Overall Study|Lost to Follow-up|7
5576551|NCT01068158|19269310|P2|Overall Study|Withdrawal by Subject|2
5576552|NCT01068158|19269311|P1|Overall Study|Withdrawal by Subject|1
5576553|NCT01067976|19269323|P1|Overall Study|Study prematurely discontinued|2
5576554|NCT01067976|19269323|P1|Overall Study|Study drug never administered|20
5576555|NCT01067846|19269384|P2|Overall Study|participation in other tx study|0
5576556|NCT01067846|19269385|P1|Overall Study|participation in other tx study|1
5576557|NCT01067846|19269384|P2|Overall Study|Withdrawal by Subject|0
5576558|NCT01067846|19269385|P1|Overall Study|Withdrawal by Subject|1
5576559|NCT01067846|19269384|P2|Overall Study|Lost to Follow-up|19
5576560|NCT01067846|19269385|P1|Overall Study|Lost to Follow-up|17
5576561|NCT01067521|19269455|P2|Open-Label Period|Lost to Follow-up|20
5576562|NCT01067521|19269456|P1|Open-Label Period|Lost to Follow-up|21
5576563|NCT01067521|19269455|P2|Open-Label Period|Teva requested subject to be withdrawn|2
5576564|NCT01067521|19269456|P1|Open-Label Period|Teva requested subject to be withdrawn|5
5576565|NCT01067521|19269455|P2|Open-Label Period|Pregnancy|8
5576566|NCT01067521|19269456|P1|Open-Label Period|Pregnancy|14
5576567|NCT01067521|19269455|P2|Open-Label Period|Protocol Violation|0
5576568|NCT01067521|19269456|P1|Open-Label Period|Protocol Violation|3
5576569|NCT01067521|19269455|P2|Open-Label Period|Non-compliance with study drug|0
5576570|NCT01067521|19269456|P1|Open-Label Period|Non-compliance with study drug|5
5576571|NCT01067521|19269455|P2|Open-Label Period|Physician Decision|11
5576572|NCT01067521|19269456|P1|Open-Label Period|Physician Decision|13
5576573|NCT01067521|19269455|P2|Open-Label Period|Withdrawal by Subject|88
5576574|NCT01067521|19269456|P1|Open-Label Period|Withdrawal by Subject|160
5576575|NCT01067521|19269455|P2|Open-Label Period|Adverse Event|28
5576576|NCT01067521|19269456|P1|Open-Label Period|Adverse Event|30
5576577|NCT01067521|19269455|P2|Open-Label Period|Death|1
5576578|NCT01067521|19269456|P1|Open-Label Period|Death|3
5576579|NCT01067521|19269455|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
5576580|NCT01067521|19269456|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
5576581|NCT01067521|19269455|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
5576582|NCT01067521|19269456|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
5576583|NCT01067521|19269455|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
5576584|NCT01067521|19269456|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
5576585|NCT01067521|19269455|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
5576586|NCT01067521|19269456|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
5576587|NCT01067521|19269455|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
5576588|NCT01067521|19269456|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
5576589|NCT01067521|19269455|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
5576590|NCT01067521|19269456|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
5576591|NCT01067521|19269455|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
5576592|NCT01067521|19269456|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
5576593|NCT01067521|19269455|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
5576594|NCT01067521|19269456|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
5576595|NCT01067521|19269455|P2|Double-Blind Placebo-Controlled Period|Death|1
5576596|NCT01067521|19269456|P1|Double-Blind Placebo-Controlled Period|Death|0
5576597|NCT01067508|19269482|P2|Overall Study|Withdrawal by Subject|1
5576598|NCT01067508|19269483|P1|Overall Study|Withdrawal by Subject|0
5576599|NCT01067508|19269482|P2|Overall Study|Physician Decision|1
5576600|NCT01067508|19269483|P1|Overall Study|Physician Decision|0
5576601|NCT01067469|19269491|P2|Overall Study|Disease Progression|1
5576602|NCT01067469|19269492|P1|Overall Study|Disease Progression|0
5576603|NCT01067469|19269491|P2|Overall Study|Withdrawal by Subject|1
5576604|NCT01067469|19269492|P1|Overall Study|Withdrawal by Subject|0
5576605|NCT01067352|19269524|P3|Overall Study|Physician Decision|0
5576606|NCT01067352|19269525|P2|Overall Study|Physician Decision|1
5576607|NCT01067352|19269526|P1|Overall Study|Physician Decision|0
5576608|NCT01067352|19269524|P3|Overall Study|Withdrawal by Subject|1
5576609|NCT01067352|19269525|P2|Overall Study|Withdrawal by Subject|2
5576610|NCT01067352|19269526|P1|Overall Study|Withdrawal by Subject|1
5576611|NCT01067339|19269542|P2|Overall Study|Withdrawal by Subject|5
5576612|NCT01067339|19269543|P1|Overall Study|Withdrawal by Subject|6
5576613|NCT01067326|19269553|P2|Overall Study|Early Study Termination|1
5576614|NCT01067326|19269554|P1|Overall Study|Early Study Termination|1
5576615|NCT01067326|19269553|P2|Overall Study|Withdrawal by Subject|0
5576616|NCT01067326|19269554|P1|Overall Study|Withdrawal by Subject|1
5576617|NCT01067326|19269553|P2|Overall Study|Adverse Event|2
5576618|NCT01067326|19269554|P1|Overall Study|Adverse Event|0
5576619|NCT01067144|19269568|P2|Follow-up|Death|1
5576620|NCT01067144|19269569|P1|Follow-up|Death|0
5576621|NCT01067144|19269568|P2|Follow-up|Surgery cancelled|1
5576622|NCT01067144|19269569|P1|Follow-up|Surgery cancelled|0
5576623|NCT01067144|19269568|P2|Follow-up|Withdrawal by Subject|14
5576624|NCT01067144|19269569|P1|Follow-up|Withdrawal by Subject|18
5576625|NCT01067144|19269568|P2|Follow-up|Censored owing to second surgery|28
5576626|NCT01067144|19269569|P1|Follow-up|Censored owing to second surgery|19
5576627|NCT01067144|19269568|P2|Follow-up|Lost to Follow-up|12
5576628|NCT01067144|19269569|P1|Follow-up|Lost to Follow-up|22
5576629|NCT01067144|19269568|P2|Treatment|Did not receive allocated intervention|7
5576630|NCT01067144|19269569|P1|Treatment|Did not receive allocated intervention|4
5576631|NCT01067105|19269585|P1|Overall Study|Other|31
5576632|NCT01067105|19269585|P1|Overall Study|Physician Decision|6
5576633|NCT01067105|19269585|P1|Overall Study|Lost to Follow-up|6
5576634|NCT01067105|19269585|P1|Overall Study|Withdrawal by Subject|36
5576635|NCT01067105|19269585|P1|Overall Study|Protocol Violation|48
5576636|NCT01067105|19269585|P1|Overall Study|Adverse Event|14
5576637|NCT01066936|19269602|P1|Overall Study|Withdrawal by Subject|4
5576638|NCT01066936|19269602|P1|Overall Study|Lost to Follow-up|3
5576639|NCT01066936|19269602|P1|Overall Study|Device revised/removed|1
5576640|NCT01066936|19269602|P1|Overall Study|Death|2
5576641|NCT01066923|19269638|P4|Overall Study|Withdrawal by Subject|8
5576642|NCT01066923|19269639|P3|Overall Study|Withdrawal by Subject|8
5576643|NCT01066923|19269640|P2|Overall Study|Withdrawal by Subject|3
5576644|NCT01066923|19269641|P1|Overall Study|Withdrawal by Subject|3
5576645|NCT01066897|19269665|P2|Overall Study|stopped study after developing the flu.|0
5576646|NCT01066897|19269666|P1|Overall Study|stopped study after developing the flu.|1
5576647|NCT01066897|19269665|P2|Overall Study|Withdrawal by Subject|0
5576648|NCT01066897|19269666|P1|Overall Study|Withdrawal by Subject|1
5576649|NCT01066871|19269680|P4|Overall Study|Other|2
5576650|NCT01066871|19269681|P3|Overall Study|Other|1
5576651|NCT01066871|19269682|P2|Overall Study|Other|2
5576652|NCT01066871|19269683|P1|Overall Study|Other|0
5576653|NCT01066871|19269680|P4|Overall Study|Withdrawal by Subject|0
5576654|NCT01066871|19269681|P3|Overall Study|Withdrawal by Subject|0
5576655|NCT01066871|19269682|P2|Overall Study|Withdrawal by Subject|1
5576656|NCT01066871|19269683|P1|Overall Study|Withdrawal by Subject|3
5576657|NCT01066871|19269680|P4|Overall Study|Lack of Efficacy|1
5576658|NCT01066871|19269681|P3|Overall Study|Lack of Efficacy|0
5576659|NCT01066871|19269682|P2|Overall Study|Lack of Efficacy|0
5576660|NCT01066871|19269683|P1|Overall Study|Lack of Efficacy|0
5576661|NCT01066871|19269680|P4|Overall Study|Protocol Violation|2
5576662|NCT01066871|19269681|P3|Overall Study|Protocol Violation|3
5576663|NCT01066871|19269682|P2|Overall Study|Protocol Violation|0
5576664|NCT01066871|19269683|P1|Overall Study|Protocol Violation|1
5576665|NCT01066871|19269680|P4|Overall Study|Lost to Follow-up|0
5576666|NCT01066871|19269681|P3|Overall Study|Lost to Follow-up|2
5576667|NCT01066871|19269682|P2|Overall Study|Lost to Follow-up|2
5576668|NCT01066871|19269683|P1|Overall Study|Lost to Follow-up|0
5576669|NCT01066819|19269747|P6|Overall Study|Other|0
5576670|NCT01066819|19269748|P5|Overall Study|Other|0
5576671|NCT01066819|19269749|P4|Overall Study|Other|0
5576672|NCT01066819|19269750|P3|Overall Study|Other|1
5576673|NCT01066819|19269751|P2|Overall Study|Other|1
5576674|NCT01066819|19269752|P1|Overall Study|Other|5
5576675|NCT01066819|19269747|P6|Overall Study|Treatment stopped|0
5576676|NCT01066819|19269748|P5|Overall Study|Treatment stopped|0
5576677|NCT01066819|19269749|P4|Overall Study|Treatment stopped|1
5576678|NCT01066819|19269750|P3|Overall Study|Treatment stopped|2
5576679|NCT01066819|19269751|P2|Overall Study|Treatment stopped|1
5576680|NCT01066819|19269752|P1|Overall Study|Treatment stopped|12
5576681|NCT01066819|19269747|P6|Overall Study|Treatment never started|2
5576682|NCT01066819|19269748|P5|Overall Study|Treatment never started|2
5576683|NCT01066819|19269749|P4|Overall Study|Treatment never started|3
5576684|NCT01066819|19269750|P3|Overall Study|Treatment never started|19
5576685|NCT01066819|19269751|P2|Overall Study|Treatment never started|19
5576686|NCT01066819|19269752|P1|Overall Study|Treatment never started|85
5576687|NCT01066819|19269747|P6|Overall Study|Spontaneous cure|0
5576688|NCT01066819|19269748|P5|Overall Study|Spontaneous cure|0
5576689|NCT01066819|19269749|P4|Overall Study|Spontaneous cure|0
5576690|NCT01066819|19269750|P3|Overall Study|Spontaneous cure|0
5576691|NCT01066819|19269751|P2|Overall Study|Spontaneous cure|0
5576692|NCT01066819|19269752|P1|Overall Study|Spontaneous cure|1
5576693|NCT01066819|19269747|P6|Overall Study|Screen failure|0
5576694|NCT01066819|19269748|P5|Overall Study|Screen failure|0
5576695|NCT01066819|19269749|P4|Overall Study|Screen failure|0
5576696|NCT01066819|19269750|P3|Overall Study|Screen failure|0
5576697|NCT01066819|19269751|P2|Overall Study|Screen failure|0
5576698|NCT01066819|19269752|P1|Overall Study|Screen failure|1
5576699|NCT01066819|19269747|P6|Overall Study|Results not available|0
5576700|NCT01066819|19269748|P5|Overall Study|Results not available|0
5576701|NCT01066819|19269749|P4|Overall Study|Results not available|0
5576702|NCT01066819|19269750|P3|Overall Study|Results not available|0
5576703|NCT01066819|19269751|P2|Overall Study|Results not available|0
5576704|NCT01066819|19269752|P1|Overall Study|Results not available|1
5576705|NCT01066819|19269747|P6|Overall Study|Relapse|0
5576706|NCT01066819|19269748|P5|Overall Study|Relapse|0
5576707|NCT01066819|19269749|P4|Overall Study|Relapse|0
5576708|NCT01066819|19269750|P3|Overall Study|Relapse|3
5576709|NCT01066819|19269751|P2|Overall Study|Relapse|4
5576710|NCT01066819|19269752|P1|Overall Study|Relapse|16
5576711|NCT01066819|19269747|P6|Overall Study|Not categorised|0
5576712|NCT01066819|19269748|P5|Overall Study|Not categorised|0
5576713|NCT01066819|19269749|P4|Overall Study|Not categorised|1
5576714|NCT01066819|19269750|P3|Overall Study|Not categorised|6
5576715|NCT01066819|19269751|P2|Overall Study|Not categorised|2
5576716|NCT01066819|19269752|P1|Overall Study|Not categorised|9
5576717|NCT01066819|19269747|P6|Overall Study|Non responders|1
5576718|NCT01066819|19269748|P5|Overall Study|Non responders|0
5576719|NCT01066819|19269749|P4|Overall Study|Non responders|2
5576720|NCT01066819|19269750|P3|Overall Study|Non responders|7
5576721|NCT01066819|19269751|P2|Overall Study|Non responders|2
5576722|NCT01066819|19269752|P1|Overall Study|Non responders|123
5576723|NCT01066819|19269747|P6|Overall Study|Miscellaneous|0
5576724|NCT01066819|19269748|P5|Overall Study|Miscellaneous|0
5576725|NCT01066819|19269749|P4|Overall Study|Miscellaneous|1
5576726|NCT01066819|19269750|P3|Overall Study|Miscellaneous|18
5576727|NCT01066819|19269751|P2|Overall Study|Miscellaneous|10
5576728|NCT01066819|19269752|P1|Overall Study|Miscellaneous|28
5576729|NCT01066819|19269747|P6|Overall Study|Lab test not done|0
5576730|NCT01066819|19269748|P5|Overall Study|Lab test not done|0
5576731|NCT01066819|19269749|P4|Overall Study|Lab test not done|1
5576732|NCT01066819|19269750|P3|Overall Study|Lab test not done|2
5576733|NCT01066819|19269751|P2|Overall Study|Lab test not done|0
5576734|NCT01066819|19269752|P1|Overall Study|Lab test not done|9
5576735|NCT01066819|19269747|P6|Overall Study|Failed to return|3
5576736|NCT01066819|19269748|P5|Overall Study|Failed to return|2
5576737|NCT01066819|19269749|P4|Overall Study|Failed to return|7
5576738|NCT01066819|19269750|P3|Overall Study|Failed to return|68
5576739|NCT01066819|19269751|P2|Overall Study|Failed to return|107
5576740|NCT01066819|19269752|P1|Overall Study|Failed to return|298
5576741|NCT01066819|19269747|P6|Overall Study|Early termination|0
5576742|NCT01066819|19269748|P5|Overall Study|Early termination|0
5576743|NCT01066819|19269749|P4|Overall Study|Early termination|0
5576744|NCT01066819|19269750|P3|Overall Study|Early termination|0
5576745|NCT01066819|19269751|P2|Overall Study|Early termination|0
5576746|NCT01066819|19269752|P1|Overall Study|Early termination|2
5576747|NCT01066819|19269747|P6|Overall Study|Not met inclusion/exclusion criteria|0
5576748|NCT01066819|19269748|P5|Overall Study|Not met inclusion/exclusion criteria|0
5576749|NCT01066819|19269749|P4|Overall Study|Not met inclusion/exclusion criteria|0
5576750|NCT01066819|19269750|P3|Overall Study|Not met inclusion/exclusion criteria|0
5576751|NCT01066819|19269751|P2|Overall Study|Not met inclusion/exclusion criteria|0
5576752|NCT01066819|19269752|P1|Overall Study|Not met inclusion/exclusion criteria|1
5576753|NCT01066819|19269747|P6|Overall Study|Administrative|0
5576754|NCT01066819|19269748|P5|Overall Study|Administrative|0
5576755|NCT01066819|19269749|P4|Overall Study|Administrative|0
5576756|NCT01066819|19269750|P3|Overall Study|Administrative|2
5576757|NCT01066819|19269751|P2|Overall Study|Administrative|4
5576758|NCT01066819|19269752|P1|Overall Study|Administrative|6
5576759|NCT01066819|19269747|P6|Overall Study|Withdrawal by Subject|0
5576760|NCT01066819|19269748|P5|Overall Study|Withdrawal by Subject|0
5576761|NCT01066819|19269749|P4|Overall Study|Withdrawal by Subject|0
5576762|NCT01066819|19269750|P3|Overall Study|Withdrawal by Subject|6
5576763|NCT01066819|19269751|P2|Overall Study|Withdrawal by Subject|11
5576764|NCT01066819|19269752|P1|Overall Study|Withdrawal by Subject|29
5576765|NCT01066819|19269747|P6|Overall Study|Protocol Violation|0
5576766|NCT01066819|19269748|P5|Overall Study|Protocol Violation|0
5576767|NCT01066819|19269749|P4|Overall Study|Protocol Violation|0
5576768|NCT01066819|19269750|P3|Overall Study|Protocol Violation|0
5576769|NCT01066819|19269751|P2|Overall Study|Protocol Violation|6
5576770|NCT01066819|19269752|P1|Overall Study|Protocol Violation|12
5576771|NCT01066819|19269747|P6|Overall Study|Physician Decision|0
5576772|NCT01066819|19269748|P5|Overall Study|Physician Decision|0
5576773|NCT01066819|19269749|P4|Overall Study|Physician Decision|0
5576774|NCT01066819|19269750|P3|Overall Study|Physician Decision|3
5576775|NCT01066819|19269751|P2|Overall Study|Physician Decision|2
5576776|NCT01066819|19269752|P1|Overall Study|Physician Decision|6
5576777|NCT01066819|19269747|P6|Overall Study|Lack of Efficacy|0
5576778|NCT01066819|19269748|P5|Overall Study|Lack of Efficacy|0
5576779|NCT01066819|19269749|P4|Overall Study|Lack of Efficacy|1
5576780|NCT01066819|19269750|P3|Overall Study|Lack of Efficacy|2
5576781|NCT01066819|19269751|P2|Overall Study|Lack of Efficacy|1
5576782|NCT01066819|19269752|P1|Overall Study|Lack of Efficacy|22
5576783|NCT01066819|19269747|P6|Overall Study|Death|0
5576784|NCT01066819|19269748|P5|Overall Study|Death|0
5576785|NCT01066819|19269749|P4|Overall Study|Death|0
5576786|NCT01066819|19269750|P3|Overall Study|Death|1
5576787|NCT01066819|19269751|P2|Overall Study|Death|0
5576788|NCT01066819|19269752|P1|Overall Study|Death|5
5576789|NCT01066819|19269747|P6|Overall Study|Adverse Event|0
5576790|NCT01066819|19269748|P5|Overall Study|Adverse Event|0
5576791|NCT01066819|19269749|P4|Overall Study|Adverse Event|0
5576792|NCT01066819|19269750|P3|Overall Study|Adverse Event|6
5576793|NCT01066819|19269751|P2|Overall Study|Adverse Event|1
5576794|NCT01066819|19269752|P1|Overall Study|Adverse Event|18
5576795|NCT01066793|19269893|P6|Overall Study|Treatment Stopped|0
5576796|NCT01066793|19269894|P5|Overall Study|Treatment Stopped|0
5576797|NCT01066793|19269895|P4|Overall Study|Treatment Stopped|1
5576798|NCT01066793|19269896|P3|Overall Study|Treatment Stopped|0
5576799|NCT01066793|19269897|P2|Overall Study|Treatment Stopped|1
5576800|NCT01066793|19269898|P1|Overall Study|Treatment Stopped|2
5576801|NCT01066793|19269893|P6|Overall Study|Treatment Never Started|0
5576802|NCT01066793|19269894|P5|Overall Study|Treatment Never Started|0
5576803|NCT01066793|19269895|P4|Overall Study|Treatment Never Started|1
5576804|NCT01066793|19269896|P3|Overall Study|Treatment Never Started|4
5576805|NCT01066793|19269897|P2|Overall Study|Treatment Never Started|5
5576806|NCT01066793|19269898|P1|Overall Study|Treatment Never Started|18
5576807|NCT01066793|19269893|P6|Overall Study|Treatment Interrupted|0
5576808|NCT01066793|19269894|P5|Overall Study|Treatment Interrupted|0
5576809|NCT01066793|19269895|P4|Overall Study|Treatment Interrupted|0
5576810|NCT01066793|19269896|P3|Overall Study|Treatment Interrupted|0
5576811|NCT01066793|19269897|P2|Overall Study|Treatment Interrupted|1
5576812|NCT01066793|19269898|P1|Overall Study|Treatment Interrupted|1
5576813|NCT01066793|19269893|P6|Overall Study|Result Not Available|0
5576814|NCT01066793|19269894|P5|Overall Study|Result Not Available|0
5576815|NCT01066793|19269895|P4|Overall Study|Result Not Available|0
5576816|NCT01066793|19269896|P3|Overall Study|Result Not Available|0
5576817|NCT01066793|19269897|P2|Overall Study|Result Not Available|0
5576818|NCT01066793|19269898|P1|Overall Study|Result Not Available|1
5576819|NCT01066793|19269893|P6|Overall Study|Relapse|0
5576820|NCT01066793|19269894|P5|Overall Study|Relapse|0
5576821|NCT01066793|19269895|P4|Overall Study|Relapse|3
5576822|NCT01066793|19269896|P3|Overall Study|Relapse|2
5576823|NCT01066793|19269897|P2|Overall Study|Relapse|8
5576824|NCT01066793|19269898|P1|Overall Study|Relapse|20
5576825|NCT01066793|19269893|P6|Overall Study|Other|0
5576826|NCT01066793|19269894|P5|Overall Study|Other|0
5576827|NCT01066793|19269895|P4|Overall Study|Other|2
5576828|NCT01066793|19269896|P3|Overall Study|Other|6
5576829|NCT01066793|19269897|P2|Overall Study|Other|5
5576830|NCT01066793|19269898|P1|Overall Study|Other|15
5576831|NCT01066793|19269893|P6|Overall Study|Non-responders|0
5576832|NCT01066793|19269894|P5|Overall Study|Non-responders|0
5576833|NCT01066793|19269895|P4|Overall Study|Non-responders|25
5576834|NCT01066793|19269896|P3|Overall Study|Non-responders|11
5576835|NCT01066793|19269897|P2|Overall Study|Non-responders|5
5576836|NCT01066793|19269898|P1|Overall Study|Non-responders|104
5576837|NCT01066793|19269893|P6|Overall Study|Miscellaneous|0
5576838|NCT01066793|19269894|P5|Overall Study|Miscellaneous|0
5576839|NCT01066793|19269895|P4|Overall Study|Miscellaneous|0
5576840|NCT01066793|19269896|P3|Overall Study|Miscellaneous|6
5576841|NCT01066793|19269897|P2|Overall Study|Miscellaneous|5
5576842|NCT01066793|19269898|P1|Overall Study|Miscellaneous|4
5576843|NCT01066793|19269893|P6|Overall Study|Lab test not done|0
5576844|NCT01066793|19269894|P5|Overall Study|Lab test not done|0
5576845|NCT01066793|19269895|P4|Overall Study|Lab test not done|1
5576846|NCT01066793|19269896|P3|Overall Study|Lab test not done|0
5576847|NCT01066793|19269897|P2|Overall Study|Lab test not done|0
5576848|NCT01066793|19269898|P1|Overall Study|Lab test not done|7
5576849|NCT01066793|19269893|P6|Overall Study|Early Termination|0
5576850|NCT01066793|19269894|P5|Overall Study|Early Termination|0
5576851|NCT01066793|19269895|P4|Overall Study|Early Termination|0
5576852|NCT01066793|19269896|P3|Overall Study|Early Termination|0
5576853|NCT01066793|19269897|P2|Overall Study|Early Termination|0
5576854|NCT01066793|19269898|P1|Overall Study|Early Termination|3
5576855|NCT01066793|19269893|P6|Overall Study|Withdrawal by Subject|0
5576856|NCT01066793|19269894|P5|Overall Study|Withdrawal by Subject|0
5576857|NCT01066793|19269895|P4|Overall Study|Withdrawal by Subject|0
5576858|NCT01066793|19269896|P3|Overall Study|Withdrawal by Subject|1
5576859|NCT01066793|19269897|P2|Overall Study|Withdrawal by Subject|4
5576860|NCT01066793|19269898|P1|Overall Study|Withdrawal by Subject|7
5576861|NCT01066793|19269893|P6|Overall Study|Protocol Violation|0
5576862|NCT01066793|19269894|P5|Overall Study|Protocol Violation|0
5576863|NCT01066793|19269895|P4|Overall Study|Protocol Violation|0
5576864|NCT01066793|19269896|P3|Overall Study|Protocol Violation|2
5576865|NCT01066793|19269897|P2|Overall Study|Protocol Violation|2
5576866|NCT01066793|19269898|P1|Overall Study|Protocol Violation|3
5576867|NCT01066793|19269893|P6|Overall Study|Physician Decision|0
5576868|NCT01066793|19269894|P5|Overall Study|Physician Decision|0
5576869|NCT01066793|19269895|P4|Overall Study|Physician Decision|0
5576870|NCT01066793|19269896|P3|Overall Study|Physician Decision|0
5576871|NCT01066793|19269897|P2|Overall Study|Physician Decision|0
5576872|NCT01066793|19269898|P1|Overall Study|Physician Decision|3
5576873|NCT01066793|19269893|P6|Overall Study|Lost to Follow-up|1
5576874|NCT01066793|19269894|P5|Overall Study|Lost to Follow-up|0
5576875|NCT01066793|19269895|P4|Overall Study|Lost to Follow-up|16
5576876|NCT01066793|19269896|P3|Overall Study|Lost to Follow-up|82
5576877|NCT01066793|19269897|P2|Overall Study|Lost to Follow-up|39
5576878|NCT01066793|19269898|P1|Overall Study|Lost to Follow-up|180
5576879|NCT01066793|19269893|P6|Overall Study|Lack of Efficacy|0
5576880|NCT01066793|19269894|P5|Overall Study|Lack of Efficacy|0
5576881|NCT01066793|19269895|P4|Overall Study|Lack of Efficacy|0
5576882|NCT01066793|19269896|P3|Overall Study|Lack of Efficacy|0
5576883|NCT01066793|19269897|P2|Overall Study|Lack of Efficacy|1
5576884|NCT01066793|19269898|P1|Overall Study|Lack of Efficacy|2
5576885|NCT01066793|19269893|P6|Overall Study|Death|0
5576886|NCT01066793|19269894|P5|Overall Study|Death|0
5576887|NCT01066793|19269895|P4|Overall Study|Death|0
5576888|NCT01066793|19269896|P3|Overall Study|Death|1
5576889|NCT01066793|19269897|P2|Overall Study|Death|1
5576890|NCT01066793|19269898|P1|Overall Study|Death|4
5576891|NCT01066780|19270038|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
5576892|NCT01066780|19270039|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
5576893|NCT01066585|19270069|P2|Overall Study|Withdrawal by Subject|3
5576894|NCT01066585|19270070|P1|Overall Study|Withdrawal by Subject|0
5576895|NCT01066585|19270069|P2|Overall Study|Protocol Violation|0
5576896|NCT01066585|19270070|P1|Overall Study|Protocol Violation|1
5576897|NCT01066546|19270082|P1|Overall Study|Study terminated by sponsor|5
5576898|NCT01066156|19270127|P1|Overall Study|Withdrawal by Subject|1
5576899|NCT01066156|19270127|P1|Overall Study|Lost to Follow-up|7
5576900|NCT01066156|19270127|P1|Overall Study|ineligible|2
5576901|NCT01066143|19270131|P1|Overall Study|ineligible for the study|8
5576902|NCT01066104|19270137|P2|Overall Study|Protocol Violation|0
5576903|NCT01066104|19270138|P1|Overall Study|Protocol Violation|1
5576904|NCT01066104|19270137|P2|Overall Study|Adverse Event|1
5576905|NCT01066104|19270138|P1|Overall Study|Adverse Event|1
5576906|NCT01066052|19270148|P2|Overall Study|Enrolled But Not Treated|0
5576907|NCT01066052|19270149|P1|Overall Study|Enrolled But Not Treated|3
5576908|NCT01066039|19270160|P1|Overall Study|Drug/Dose Adjustment Required|1
5576909|NCT01066039|19270160|P1|Overall Study|Failure to Control Blood Pressure|1
5576910|NCT01066039|19270160|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
5576911|NCT01066039|19270160|P1|Overall Study|Additional Antihypertensive Required|4
5576912|NCT01066039|19270160|P1|Overall Study|Dropout due to Insulin Administration|1
5576913|NCT01066039|19270160|P1|Overall Study|Investigator's Request|1
5576914|NCT01066039|19270160|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
5576915|NCT01066039|19270160|P1|Overall Study|Protocol Violation|2
5576916|NCT01066039|19270160|P1|Overall Study|Withdrawal by Subject|17
5576917|NCT01066039|19270160|P1|Overall Study|Adverse Event|6
5576918|NCT01066000|19270185|P1|Overall Study|Adverse Event|1
5576919|NCT01066000|19270185|P1|Overall Study|Withdrawal by Subject|1
5576920|NCT01066000|19270185|P1|Overall Study|Death|3
5576921|NCT01066000|19270185|P1|Overall Study|Protocol Violation|4
5576922|NCT01065844|19270196|P1|Overall Study|Adverse Event|5
5576923|NCT01065818|19270200|P1|Overall Study|Not a candidate for surgery|1
5576924|NCT01065818|19270200|P1|Overall Study|Withdrawal by Subject|1
5576925|NCT01065779|19270204|P1|Overall Study|Inclusion Criteria Violation|7
5576926|NCT01065779|19270204|P1|Overall Study|Failed to Follow-up|10
5576927|NCT01065779|19270204|P1|Overall Study|Not Administered With Study Drug|17
5576928|NCT01065779|19270204|P1|Overall Study|Non-enrollment Period Administration|10
5576929|NCT01065779|19270204|P1|Overall Study|Investigation Before Contract Date|37
5576930|NCT01065779|19270204|P1|Overall Study|Duplicate Investigation|1
5576931|NCT01065766|19270215|P1|Overall Study|Violated dosage/administration|25
5576932|NCT01065766|19270215|P1|Overall Study|Contraindication to administration|6
5576933|NCT01065766|19270215|P1|Overall Study|Assessed before the contracted date|1
5576934|NCT01065597|19270234|P1|Overall Study|Adverse Event|1
5576935|NCT01065454|19270281|P4|Follow up|study ongoing|41
5576936|NCT01065454|19270282|P3|Follow up|study ongoing|15
5576937|NCT01065454|19270283|P2|Follow up|study ongoing|22
5576938|NCT01065454|19270284|P1|Follow up|study ongoing|37
5576939|NCT01065454|19270281|P4|Follow up|Withdrawal by Subject|0
5576940|NCT01065454|19270282|P3|Follow up|Withdrawal by Subject|1
5576941|NCT01065454|19270283|P2|Follow up|Withdrawal by Subject|1
5576942|NCT01065454|19270284|P1|Follow up|Withdrawal by Subject|1
5576943|NCT01065454|19270281|P4|Follow up|Progressive disease|1
5576944|NCT01065454|19270282|P3|Follow up|Progressive disease|0
5576945|NCT01065454|19270283|P2|Follow up|Progressive disease|0
5576946|NCT01065454|19270284|P1|Follow up|Progressive disease|0
5576947|NCT01065454|19270281|P4|Follow up|Lost to Follow-up|1
5576948|NCT01065454|19270282|P3|Follow up|Lost to Follow-up|0
5576949|NCT01065454|19270283|P2|Follow up|Lost to Follow-up|0
5576950|NCT01065454|19270284|P1|Follow up|Lost to Follow-up|0
5576951|NCT01065454|19270281|P4|Follow up|Death|0
5576952|NCT01065454|19270282|P3|Follow up|Death|1
5576953|NCT01065454|19270283|P2|Follow up|Death|1
5576954|NCT01065454|19270284|P1|Follow up|Death|0
5576955|NCT01065454|19270281|P4|Follow up|Adverse Event|1
5576956|NCT01065454|19270282|P3|Follow up|Adverse Event|0
5576957|NCT01065454|19270283|P2|Follow up|Adverse Event|0
5576958|NCT01065454|19270284|P1|Follow up|Adverse Event|1
5576959|NCT01065454|19270281|P4|Treatment|Withdrawal by Subject|3
5576960|NCT01065454|19270282|P3|Treatment|Withdrawal by Subject|2
5576961|NCT01065454|19270283|P2|Treatment|Withdrawal by Subject|1
5576962|NCT01065454|19270284|P1|Treatment|Withdrawal by Subject|3
5576963|NCT01065454|19270281|P4|Treatment|Protocol Violation|0
5576964|NCT01065454|19270282|P3|Treatment|Protocol Violation|1
5576965|NCT01065454|19270283|P2|Treatment|Protocol Violation|0
5576966|NCT01065454|19270284|P1|Treatment|Protocol Violation|1
5576967|NCT01065454|19270281|P4|Treatment|Protocol Decision|2
5576968|NCT01065454|19270282|P3|Treatment|Protocol Decision|3
5576969|NCT01065454|19270283|P2|Treatment|Protocol Decision|0
5576970|NCT01065454|19270284|P1|Treatment|Protocol Decision|0
5576971|NCT01065454|19270281|P4|Treatment|Non-compliance|1
5576972|NCT01065454|19270282|P3|Treatment|Non-compliance|0
5576973|NCT01065454|19270283|P2|Treatment|Non-compliance|0
5576974|NCT01065454|19270284|P1|Treatment|Non-compliance|1
5576975|NCT01065454|19270281|P4|Treatment|Death|0
5576976|NCT01065454|19270282|P3|Treatment|Death|0
5576977|NCT01065454|19270283|P2|Treatment|Death|0
5576978|NCT01065454|19270284|P1|Treatment|Death|1
5576979|NCT01065454|19270281|P4|Treatment|Adverse Event|6
5576980|NCT01065454|19270282|P3|Treatment|Adverse Event|3
5576981|NCT01065454|19270283|P2|Treatment|Adverse Event|4
5576982|NCT01065454|19270284|P1|Treatment|Adverse Event|7
5576983|NCT01065350|19270407|P2|Overall Study|Received incorrect drug allocation|1
5576984|NCT01065350|19270408|P1|Overall Study|Received incorrect drug allocation|0
5576985|NCT01064947|19270469|P1|Overall Study|negative culture|41
5576986|NCT01064856|19270510|P4|Open-label (OL) Period|Other|7
5576987|NCT01064856|19270511|P3|Open-label (OL) Period|Other|7
5576988|NCT01064856|19270512|P2|Open-label (OL) Period|Other|0
5576989|NCT01064856|19270513|P1|Open-label (OL) Period|Other|0
5576990|NCT01064856|19270510|P4|Open-label (OL) Period|Lost to Follow-up|1
5576991|NCT01064856|19270511|P3|Open-label (OL) Period|Lost to Follow-up|2
5576992|NCT01064856|19270512|P2|Open-label (OL) Period|Lost to Follow-up|0
5576993|NCT01064856|19270513|P1|Open-label (OL) Period|Lost to Follow-up|0
5576994|NCT01064856|19270510|P4|Open-label (OL) Period|Consent withdrawn by participant|6
5576995|NCT01064856|19270511|P3|Open-label (OL) Period|Consent withdrawn by participant|5
5576996|NCT01064856|19270512|P2|Open-label (OL) Period|Consent withdrawn by participant|0
5576997|NCT01064856|19270513|P1|Open-label (OL) Period|Consent withdrawn by participant|0
5576998|NCT01064856|19270510|P4|Open-label (OL) Period|Adverse Event|6
5576999|NCT01064856|19270511|P3|Open-label (OL) Period|Adverse Event|12
5577000|NCT01064856|19270512|P2|Open-label (OL) Period|Adverse Event|0
5577001|NCT01064856|19270513|P1|Open-label (OL) Period|Adverse Event|0
5577002|NCT01064856|19270510|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
5577003|NCT01064856|19270511|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
5577004|NCT01064856|19270512|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
5577005|NCT01064856|19270513|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
5577006|NCT01064856|19270510|P4|Double-blind (DB) Period|Adverse Event|0
5577007|NCT01064856|19270511|P3|Double-blind (DB) Period|Adverse Event|0
5577008|NCT01064856|19270512|P2|Double-blind (DB) Period|Adverse Event|0
5577009|NCT01064856|19270513|P1|Double-blind (DB) Period|Adverse Event|1
5577010|NCT01064817|19270557|P2|Study Completion|Withdrawal by Subject|0
5577011|NCT01064817|19270558|P1|Study Completion|Withdrawal by Subject|1
5577012|NCT01064817|19270557|P2|Study Completion|Physician Decision|0
5577013|NCT01064817|19270558|P1|Study Completion|Physician Decision|1
5577014|NCT01064739|19270570|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
5577015|NCT01064687|19270641|P4|Overall Study|Treatment Noncompliance|0
5577016|NCT01064687|19270642|P3|Overall Study|Treatment Noncompliance|1
5577017|NCT01064687|19270643|P2|Overall Study|Treatment Noncompliance|1
5577018|NCT01064687|19270644|P1|Overall Study|Treatment Noncompliance|1
5577019|NCT01064687|19270641|P4|Overall Study|Withdrawal by Subject|5
5577020|NCT01064687|19270642|P3|Overall Study|Withdrawal by Subject|12
5577021|NCT01064687|19270643|P2|Overall Study|Withdrawal by Subject|7
5577022|NCT01064687|19270644|P1|Overall Study|Withdrawal by Subject|9
5577023|NCT01064687|19270641|P4|Overall Study|Sponsor Decision|0
5577024|NCT01064687|19270642|P3|Overall Study|Sponsor Decision|3
5577025|NCT01064687|19270643|P2|Overall Study|Sponsor Decision|0
5577026|NCT01064687|19270644|P1|Overall Study|Sponsor Decision|0
5577027|NCT01064687|19270641|P4|Overall Study|Protocol Violation|1
5577028|NCT01064687|19270642|P3|Overall Study|Protocol Violation|0
5577029|NCT01064687|19270643|P2|Overall Study|Protocol Violation|1
5577030|NCT01064687|19270644|P1|Overall Study|Protocol Violation|1
5577031|NCT01064687|19270641|P4|Overall Study|Physician Decision|0
5577032|NCT01064687|19270642|P3|Overall Study|Physician Decision|0
5577033|NCT01064687|19270643|P2|Overall Study|Physician Decision|2
5577034|NCT01064687|19270644|P1|Overall Study|Physician Decision|2
5577035|NCT01064687|19270641|P4|Overall Study|Lost to Follow-up|5
5577036|NCT01064687|19270642|P3|Overall Study|Lost to Follow-up|13
5577037|NCT01064687|19270643|P2|Overall Study|Lost to Follow-up|10
5577038|NCT01064687|19270644|P1|Overall Study|Lost to Follow-up|7
5577039|NCT01064687|19270641|P4|Overall Study|Lack of Efficacy|3
5577040|NCT01064687|19270642|P3|Overall Study|Lack of Efficacy|2
5577041|NCT01064687|19270643|P2|Overall Study|Lack of Efficacy|0
5577042|NCT01064687|19270644|P1|Overall Study|Lack of Efficacy|1
5577043|NCT01064687|19270641|P4|Overall Study|Entry Criteria Not Met|0
5577044|NCT01064687|19270642|P3|Overall Study|Entry Criteria Not Met|0
5577045|NCT01064687|19270643|P2|Overall Study|Entry Criteria Not Met|0
5577046|NCT01064687|19270644|P1|Overall Study|Entry Criteria Not Met|3
5577047|NCT01064687|19270641|P4|Overall Study|Death|0
5577048|NCT01064687|19270642|P3|Overall Study|Death|0
5577049|NCT01064687|19270643|P2|Overall Study|Death|1
5577050|NCT01064687|19270644|P1|Overall Study|Death|1
5577051|NCT01064687|19270641|P4|Overall Study|Adverse Event|3
5577052|NCT01064687|19270642|P3|Overall Study|Adverse Event|10
5577053|NCT01064687|19270643|P2|Overall Study|Adverse Event|4
5577054|NCT01064687|19270644|P1|Overall Study|Adverse Event|9
5577055|NCT01064648|19270824|P4|Phase II|Under Review|0
5577056|NCT01064648|19270825|P3|Phase II|Under Review|2
5577057|NCT01064648|19270826|P2|Phase II|Under Review|0
5577058|NCT01064648|19270827|P1|Phase II|Under Review|0
5577059|NCT01064648|19270824|P4|Phase II|Non-protocol specified|3
5577060|NCT01064648|19270825|P3|Phase II|Non-protocol specified|5
5577061|NCT01064648|19270826|P2|Phase II|Non-protocol specified|0
5577062|NCT01064648|19270827|P1|Phase II|Non-protocol specified|0
5577063|NCT01064648|19270824|P4|Phase II|Progression|27
5577064|NCT01064648|19270825|P3|Phase II|Progression|21
5577065|NCT01064648|19270826|P2|Phase II|Progression|0
5577066|NCT01064648|19270827|P1|Phase II|Progression|0
5577067|NCT01064648|19270824|P4|Phase II|Withdrawal by Subject|5
5577068|NCT01064648|19270825|P3|Phase II|Withdrawal by Subject|2
5577069|NCT01064648|19270826|P2|Phase II|Withdrawal by Subject|0
5577070|NCT01064648|19270827|P1|Phase II|Withdrawal by Subject|0
5577071|NCT01064648|19270824|P4|Phase II|Death|5
5577072|NCT01064648|19270825|P3|Phase II|Death|4
5577073|NCT01064648|19270826|P2|Phase II|Death|0
5577074|NCT01064648|19270827|P1|Phase II|Death|0
5577075|NCT01064648|19270824|P4|Phase II|Adverse Event|8
5577076|NCT01064648|19270825|P3|Phase II|Adverse Event|15
5577077|NCT01064648|19270826|P2|Phase II|Adverse Event|0
5577078|NCT01064648|19270827|P1|Phase II|Adverse Event|0
5577079|NCT01064648|19270824|P4|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
5577080|NCT01064648|19270825|P3|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
5577081|NCT01064648|19270826|P2|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
5577082|NCT01064648|19270827|P1|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
5577083|NCT01064648|19270824|P4|Phase I Cohort 2: Dose Level 2|Progression|0
5577084|NCT01064648|19270825|P3|Phase I Cohort 2: Dose Level 2|Progression|0
5577085|NCT01064648|19270826|P2|Phase I Cohort 2: Dose Level 2|Progression|5
5577086|NCT01064648|19270827|P1|Phase I Cohort 2: Dose Level 2|Progression|0
5577087|NCT01064648|19270824|P4|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
5577088|NCT01064648|19270825|P3|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
5577089|NCT01064648|19270826|P2|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
5577090|NCT01064648|19270827|P1|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
5577091|NCT01064648|19270824|P4|Phase I Cohort 2: Dose Level 2|Adverse Event|0
5577092|NCT01064648|19270825|P3|Phase I Cohort 2: Dose Level 2|Adverse Event|0
5577093|NCT01064648|19270826|P2|Phase I Cohort 2: Dose Level 2|Adverse Event|3
5577094|NCT01064648|19270827|P1|Phase I Cohort 2: Dose Level 2|Adverse Event|0
5577095|NCT01064648|19270824|P4|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
5577096|NCT01064648|19270825|P3|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
5577097|NCT01064648|19270826|P2|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
5577098|NCT01064648|19270827|P1|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
5577099|NCT01064648|19270824|P4|Phase I Cohort1: Dose Level 1|Progression|0
5577100|NCT01064648|19270825|P3|Phase I Cohort1: Dose Level 1|Progression|0
5577101|NCT01064648|19270826|P2|Phase I Cohort1: Dose Level 1|Progression|0
5577102|NCT01064648|19270827|P1|Phase I Cohort1: Dose Level 1|Progression|5
5577103|NCT01064622|19270853|P2|Randomized Phase II|Protocol Violation|1
5577104|NCT01064622|19270854|P1|Randomized Phase II|Protocol Violation|0
5577105|NCT01064622|19270853|P2|Randomized Phase II|Withdrawal by Subject|2
5577106|NCT01064622|19270854|P1|Randomized Phase II|Withdrawal by Subject|2
5577107|NCT01064531|19270877|P2|Overall Study|Death|1
5577108|NCT01064531|19270878|P1|Overall Study|Death|0
5577109|NCT01064531|19270877|P2|Overall Study|Revision due to dislocation|1
5577110|NCT01064531|19270878|P1|Overall Study|Revision due to dislocation|0
5577111|NCT01064531|19270877|P2|Overall Study|Revision due to femoral stem loosening|0
5577112|NCT01064531|19270878|P1|Overall Study|Revision due to femoral stem loosening|1
5577113|NCT01064531|19270877|P2|Overall Study|Withdrawal by Subject|2
5577114|NCT01064531|19270878|P1|Overall Study|Withdrawal by Subject|2
5577115|NCT01064531|19270877|P2|Overall Study|Physician Decision|1
5577116|NCT01064531|19270878|P1|Overall Study|Physician Decision|0
5577117|NCT01064531|19270877|P2|Overall Study|Lost to Follow-up|2
5577118|NCT01064531|19270878|P1|Overall Study|Lost to Follow-up|0
5577119|NCT01064414|19270925|P3|Extension Period: Week 26 to Week 52|Other|1
5577120|NCT01064414|19270926|P2|Extension Period: Week 26 to Week 52|Other|2
5577121|NCT01064414|19270927|P1|Extension Period: Week 26 to Week 52|Other|5
5577122|NCT01064414|19270925|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
5577123|NCT01064414|19270926|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
5577124|NCT01064414|19270927|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
5577125|NCT01064414|19270925|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5577126|NCT01064414|19270926|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
5577127|NCT01064414|19270927|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
5577128|NCT01064414|19270925|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5577129|NCT01064414|19270926|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
5577130|NCT01064414|19270927|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
5577131|NCT01064414|19270925|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
5577132|NCT01064414|19270926|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
5577133|NCT01064414|19270927|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
5577134|NCT01064414|19270925|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5577135|NCT01064414|19270926|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
5577136|NCT01064414|19270927|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
5577137|NCT01064414|19270925|P3|Extension Period: Week 26 to Week 52|Death|0
5577138|NCT01064414|19270926|P2|Extension Period: Week 26 to Week 52|Death|1
5577139|NCT01064414|19270927|P1|Extension Period: Week 26 to Week 52|Death|0
5577140|NCT01064414|19270925|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
5577141|NCT01064414|19270926|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
5577142|NCT01064414|19270927|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
5577143|NCT01064414|19270925|P3|Core Period: Baseline to Week 26|Other|2
5577144|NCT01064414|19270926|P2|Core Period: Baseline to Week 26|Other|7
5577145|NCT01064414|19270927|P1|Core Period: Baseline to Week 26|Other|4
5577146|NCT01064414|19270925|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5577147|NCT01064414|19270926|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
5577148|NCT01064414|19270927|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
5577149|NCT01064414|19270925|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
5577150|NCT01064414|19270926|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
5577151|NCT01064414|19270927|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
5577152|NCT01064414|19270925|P3|Core Period: Baseline to Week 26|Protocol Violation|1
5577153|NCT01064414|19270926|P2|Core Period: Baseline to Week 26|Protocol Violation|0
5577154|NCT01064414|19270927|P1|Core Period: Baseline to Week 26|Protocol Violation|1
5577155|NCT01064414|19270925|P3|Core Period: Baseline to Week 26|Death|0
5577156|NCT01064414|19270926|P2|Core Period: Baseline to Week 26|Death|1
5577157|NCT01064414|19270927|P1|Core Period: Baseline to Week 26|Death|0
5577158|NCT01064414|19270925|P3|Core Period: Baseline to Week 26|Adverse Event|2
5577159|NCT01064414|19270926|P2|Core Period: Baseline to Week 26|Adverse Event|4
5577160|NCT01064414|19270927|P1|Core Period: Baseline to Week 26|Adverse Event|4
5577161|NCT01064401|19270946|P2|Overall Study|Other|1
5577162|NCT01064401|19270947|P1|Overall Study|Other|2
5577163|NCT01064401|19270946|P2|Overall Study|Site Closure|5
5577164|NCT01064401|19270947|P1|Overall Study|Site Closure|4
5577165|NCT01064401|19270946|P2|Overall Study|Noncompliance|8
5577166|NCT01064401|19270947|P1|Overall Study|Noncompliance|7
5577167|NCT01064401|19270946|P2|Overall Study|Pregnancy|7
5577168|NCT01064401|19270947|P1|Overall Study|Pregnancy|4
5577169|NCT01064401|19270946|P2|Overall Study|Death|0
5577170|NCT01064401|19270947|P1|Overall Study|Death|4
5577171|NCT01064401|19270946|P2|Overall Study|Investigator Decision|6
5577172|NCT01064401|19270947|P1|Overall Study|Investigator Decision|4
5577173|NCT01064401|19270946|P2|Overall Study|Consent Withdrawn|80
5577174|NCT01064401|19270947|P1|Overall Study|Consent Withdrawn|98
5577175|NCT01064401|19270946|P2|Overall Study|Lost to Follow-up|9
5577176|NCT01064401|19270947|P1|Overall Study|Lost to Follow-up|12
5577177|NCT01064401|19270946|P2|Overall Study|Lack of Efficacy|23
5577178|NCT01064401|19270947|P1|Overall Study|Lack of Efficacy|46
5577179|NCT01064401|19270946|P2|Overall Study|Adverse Event|56
5577180|NCT01064401|19270947|P1|Overall Study|Adverse Event|47
5577181|NCT01064310|19270996|P3|Open Label Pazopinib|Physician Decision|20
5577182|NCT01064310|19270997|P2|Open Label Pazopinib|Physician Decision|0
5577183|NCT01064310|19270998|P1|Open Label Pazopinib|Physician Decision|0
5577184|NCT01064310|19270996|P3|Open Label Pazopinib|Lack of Efficacy|51
5577185|NCT01064310|19270997|P2|Open Label Pazopinib|Lack of Efficacy|0
5577186|NCT01064310|19270998|P1|Open Label Pazopinib|Lack of Efficacy|0
5577187|NCT01064310|19270996|P3|Open Label Pazopinib|Adverse Event|12
5577188|NCT01064310|19270997|P2|Open Label Pazopinib|Adverse Event|0
5577189|NCT01064310|19270998|P1|Open Label Pazopinib|Adverse Event|0
5577190|NCT01064310|19270996|P3|Open Label Pazopinib|Withdrawal by Subject|1
5577191|NCT01064310|19270997|P2|Open Label Pazopinib|Withdrawal by Subject|0
5577192|NCT01064310|19270998|P1|Open Label Pazopinib|Withdrawal by Subject|0
5577193|NCT01064310|19270996|P3|Period 2|Lack of Efficacy|0
5577194|NCT01064310|19270997|P2|Period 2|Lack of Efficacy|4
5577195|NCT01064310|19270998|P1|Period 2|Lack of Efficacy|1
5577196|NCT01064310|19270996|P3|Period 2|Entered Open-label Period|0
5577197|NCT01064310|19270997|P2|Period 2|Entered Open-label Period|0
5577198|NCT01064310|19270998|P1|Period 2|Entered Open-label Period|1
5577199|NCT01064310|19270996|P3|Period 2|Physician Decision|0
5577200|NCT01064310|19270997|P2|Period 2|Physician Decision|1
5577201|NCT01064310|19270998|P1|Period 2|Physician Decision|0
5577202|NCT01064310|19270996|P3|Period 2|Adverse Event|0
5577203|NCT01064310|19270997|P2|Period 2|Adverse Event|1
5577204|NCT01064310|19270998|P1|Period 2|Adverse Event|2
5577205|NCT01064310|19270996|P3|Period 1|Entered Open-label Period|0
5577206|NCT01064310|19270997|P2|Period 1|Entered Open-label Period|1
5577207|NCT01064310|19270998|P1|Period 1|Entered Open-label Period|1
5577208|NCT01064310|19270996|P3|Period 1|Lack of Efficacy|0
5577209|NCT01064310|19270997|P2|Period 1|Lack of Efficacy|5
5577210|NCT01064310|19270998|P1|Period 1|Lack of Efficacy|3
5577211|NCT01064310|19270996|P3|Period 1|Withdrawal by Subject|0
5577212|NCT01064310|19270997|P2|Period 1|Withdrawal by Subject|2
5577213|NCT01064310|19270998|P1|Period 1|Withdrawal by Subject|2
5577214|NCT01064310|19270996|P3|Period 1|Physician Decision|0
5577215|NCT01064310|19270997|P2|Period 1|Physician Decision|0
5577216|NCT01064310|19270998|P1|Period 1|Physician Decision|1
5577217|NCT01064310|19270996|P3|Period 1|Adverse Event|0
5577218|NCT01064310|19270997|P2|Period 1|Adverse Event|10
5577219|NCT01064310|19270998|P1|Period 1|Adverse Event|7
5577220|NCT01064297|19271028|P3|Overall Study|Lost to Follow-up|133
5577221|NCT01064297|19271029|P2|Overall Study|Lost to Follow-up|48
5577222|NCT01064297|19271030|P1|Overall Study|Lost to Follow-up|791
5577223|NCT01064167|19271099|P2|Overall Study|Protocol Violation|15
5577224|NCT01064167|19271100|P1|Overall Study|Protocol Violation|14
5577225|NCT01063972|19271115|P2|Overall Study|Incarcerated|1
5577226|NCT01063972|19271116|P1|Overall Study|Incarcerated|2
5577227|NCT01063972|19271115|P2|Overall Study|Death|11
5577228|NCT01063972|19271116|P1|Overall Study|Death|12
5577229|NCT01063881|19271166|P3|Overall Study|Reason for not completed not specified|0
5577230|NCT01063881|19271167|P2|Overall Study|Reason for not completed not specified|1
5577231|NCT01063881|19271168|P1|Overall Study|Reason for not completed not specified|5
5577232|NCT01063881|19271166|P3|Overall Study|Withdrawal by Subject|0
5577233|NCT01063881|19271167|P2|Overall Study|Withdrawal by Subject|1
5577234|NCT01063881|19271168|P1|Overall Study|Withdrawal by Subject|25
5577235|NCT01063881|19271166|P3|Overall Study|Lost to Follow-up|1
5577236|NCT01063881|19271167|P2|Overall Study|Lost to Follow-up|7
5577237|NCT01063881|19271168|P1|Overall Study|Lost to Follow-up|13
5577238|NCT01063881|19271166|P3|Overall Study|Adverse Event|0
5577239|NCT01063881|19271167|P2|Overall Study|Adverse Event|2
5577240|NCT01063881|19271168|P1|Overall Study|Adverse Event|12
5577241|NCT01063868|19271192|P2|Overall Study|Study Terminated By Sponsor|4
5577242|NCT01063868|19271193|P1|Overall Study|Study Terminated By Sponsor|23
5577243|NCT01063868|19271192|P2|Overall Study|Withdrawal by Subject|1
5577244|NCT01063868|19271193|P1|Overall Study|Withdrawal by Subject|3
5577245|NCT01063868|19271192|P2|Overall Study|Adverse Event|7
5577246|NCT01063868|19271193|P1|Overall Study|Adverse Event|9
5577247|NCT01063855|19271201|P2|Overall Study|Reason not specified|11
5577248|NCT01063855|19271202|P1|Overall Study|Reason not specified|13
5577249|NCT01063855|19271201|P2|Overall Study|Withdrawal by Subject|8
5577250|NCT01063855|19271202|P1|Overall Study|Withdrawal by Subject|11
5577251|NCT01063855|19271201|P2|Overall Study|Lack of Efficacy|1
5577252|NCT01063855|19271202|P1|Overall Study|Lack of Efficacy|0
5577253|NCT01063855|19271201|P2|Overall Study|Pregnancy|0
5577254|NCT01063855|19271202|P1|Overall Study|Pregnancy|1
5577255|NCT01063855|19271201|P2|Overall Study|Lost to Follow-up|4
5577256|NCT01063855|19271202|P1|Overall Study|Lost to Follow-up|8
5577257|NCT01063855|19271201|P2|Overall Study|Death|1
5577258|NCT01063855|19271202|P1|Overall Study|Death|0
5577259|NCT01063855|19271201|P2|Overall Study|Adverse Event|4
5577260|NCT01063855|19271202|P1|Overall Study|Adverse Event|4
5577261|NCT01063764|19271249|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
5577262|NCT01063764|19271249|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
5577263|NCT01063764|19271249|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
5577264|NCT01063764|19271249|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
5577265|NCT01063764|19271249|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
5577266|NCT01063764|19271249|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
5577267|NCT01063764|19271249|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
5577268|NCT01063595|19271268|P2|First Intervention|Reason not Specified|1
5577269|NCT01063595|19271269|P1|First Intervention|Reason not Specified|0
5577270|NCT01063595|19271268|P2|First Intervention|Withdrawal by Subject|0
5577271|NCT01063595|19271269|P1|First Intervention|Withdrawal by Subject|1
5577272|NCT01063595|19271268|P2|First Intervention|Adverse Event|4
5577273|NCT01063595|19271269|P1|First Intervention|Adverse Event|1
5577274|NCT01063595|19271268|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
5577275|NCT01063595|19271269|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
5577276|NCT01063595|19271268|P2|Enrolled in Study and Randomized|Adverse Event|1
5577277|NCT01063595|19271269|P1|Enrolled in Study and Randomized|Adverse Event|0
5577278|NCT01063595|19271268|P2|Enrolled in Study and Randomized|Reason not Specified|0
5577279|NCT01063595|19271269|P1|Enrolled in Study and Randomized|Reason not Specified|1
5577280|NCT01063517|19271281|P2|Overall Study|Death|48
5577281|NCT01063517|19271282|P1|Overall Study|Death|33
5577282|NCT01063517|19271281|P2|Overall Study|Withdrawal by Subject|2
5577283|NCT01063517|19271282|P1|Overall Study|Withdrawal by Subject|1
5577284|NCT01063517|19271281|P2|Overall Study|Lost to Follow-up|3
5577285|NCT01063517|19271282|P1|Overall Study|Lost to Follow-up|4
5577286|NCT01063517|19271281|P2|Overall Study|Study reached data cut-off|7
5577287|NCT01063517|19271282|P1|Overall Study|Study reached data cut-off|19
5577288|NCT01063517|19271281|P2|Overall Study|Consent withdrawal|0
5577289|NCT01063517|19271282|P1|Overall Study|Consent withdrawal|1
5577290|NCT01063348|19271322|P2|Overall Study|Lost to Follow-up|10
5577291|NCT01063348|19271323|P1|Overall Study|Lost to Follow-up|3
5577292|NCT01063283|19271333|P3|Cycle 1|Technical failure in data collection|0
5577293|NCT01063283|19271334|P2|Cycle 1|Technical failure in data collection|0
5577294|NCT01063283|19271335|P1|Cycle 1|Technical failure in data collection|1
5577295|NCT01063283|19271333|P3|Cycle 1|Adverse Event|0
5577296|NCT01063283|19271334|P2|Cycle 1|Adverse Event|0
5577297|NCT01063283|19271335|P1|Cycle 1|Adverse Event|2
5577298|NCT01063153|19271349|P2|Overall Study|Physician Decision|4
5577299|NCT01063153|19271350|P1|Overall Study|Physician Decision|0
5577300|NCT01063153|19271349|P2|Overall Study|Withdrawal by Subject|1
5577301|NCT01063153|19271350|P1|Overall Study|Withdrawal by Subject|0
5577302|NCT01063153|19271349|P2|Overall Study|Lost to Follow-up|7
5577303|NCT01063153|19271350|P1|Overall Study|Lost to Follow-up|0
5577304|NCT01063153|19271349|P2|Overall Study|Found Ineligible During Screening|0
5577305|NCT01063153|19271350|P1|Overall Study|Found Ineligible During Screening|2
5577306|NCT01063062|19271381|P2|Overall Study|Miscellaneous reason|1
5577307|NCT01063062|19271382|P1|Overall Study|Miscellaneous reason|0
5577308|NCT01063062|19271381|P2|Overall Study|Lost to Follow-up|2
5577309|NCT01063062|19271382|P1|Overall Study|Lost to Follow-up|0
5577310|NCT01063062|19271381|P2|Overall Study|Investigator's request|0
5577311|NCT01063062|19271382|P1|Overall Study|Investigator's request|1
5577312|NCT01063062|19271381|P2|Overall Study|Protocol Violation|4
5577313|NCT01063062|19271382|P1|Overall Study|Protocol Violation|5
5577314|NCT01063062|19271381|P2|Overall Study|Adverse Event|4
5577315|NCT01063062|19271382|P1|Overall Study|Adverse Event|2
5577316|NCT01063062|19271381|P2|Overall Study|Patient withdrew consent|1
5577317|NCT01063062|19271382|P1|Overall Study|Patient withdrew consent|0
5577318|NCT01063036|19271436|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
5577319|NCT01063036|19271436|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
5577320|NCT01063036|19271436|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
5577321|NCT01063036|19271436|P1|Participants Treated With Study Drug|Pregnancy|1
5577322|NCT01063036|19271436|P1|Participants Treated With Study Drug|Lost to Follow-up|1
5577323|NCT01063036|19271436|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
5577324|NCT01063036|19271436|P1|Participants Treated With Study Drug|Protocol Violation|1
5577325|NCT01063036|19271436|P1|Participants Treated With Study Drug|Adverse Event|1
5577326|NCT01062971|19271452|P2|Overall Study|Lost to Follow-up|4
5577327|NCT01062971|19271453|P1|Overall Study|Lost to Follow-up|3
5577328|NCT01062971|19271452|P2|Overall Study|Protocol Violation|3
5577329|NCT01062971|19271453|P1|Overall Study|Protocol Violation|1
5577330|NCT01062841|19271492|P2|Overall Study|Withdrawal by Study|0
5577331|NCT01062841|19271493|P1|Overall Study|Withdrawal by Study|3
5577332|NCT01062841|19271492|P2|Overall Study|Withdrawal by Subject|0
5577333|NCT01062841|19271493|P1|Overall Study|Withdrawal by Subject|2
5577334|NCT01062841|19271492|P2|Overall Study|Death|5
5577335|NCT01062841|19271493|P1|Overall Study|Death|3
5577336|NCT01062841|19271492|P2|Overall Study|Indwelling Device Removed|48
5577337|NCT01062841|19271493|P1|Overall Study|Indwelling Device Removed|41
5577338|NCT01062763|19271523|P2|Overall Study|Adverse Event|4
5577339|NCT01062763|19271524|P1|Overall Study|Adverse Event|3
5577340|NCT01062555|19271550|P4|Phase 2|Physician Decision|17
5577341|NCT01062555|19271551|P3|Phase 2|Physician Decision|0
5577342|NCT01062555|19271552|P2|Phase 2|Physician Decision|0
5577343|NCT01062555|19271553|P1|Phase 2|Physician Decision|0
5577344|NCT01062555|19271550|P4|Phase 2|Protocol Violation|3
5577345|NCT01062555|19271551|P3|Phase 2|Protocol Violation|0
5577346|NCT01062555|19271552|P2|Phase 2|Protocol Violation|0
5577347|NCT01062555|19271553|P1|Phase 2|Protocol Violation|0
5577348|NCT01062555|19271550|P4|Phase 2|Withdrawal by Subject|7
5577349|NCT01062555|19271551|P3|Phase 2|Withdrawal by Subject|0
5577350|NCT01062555|19271552|P2|Phase 2|Withdrawal by Subject|0
5577351|NCT01062555|19271553|P1|Phase 2|Withdrawal by Subject|0
5577352|NCT01062555|19271550|P4|Phase 2|Graft failure|4
5577353|NCT01062555|19271551|P3|Phase 2|Graft failure|7
5577354|NCT01062555|19271552|P2|Phase 2|Graft failure|0
5577355|NCT01062555|19271553|P1|Phase 2|Graft failure|0
5577356|NCT01062555|19271550|P4|Phase 2|Death|3
5577357|NCT01062555|19271551|P3|Phase 2|Death|8
5577358|NCT01062555|19271552|P2|Phase 2|Death|0
5577359|NCT01062555|19271553|P1|Phase 2|Death|0
5577360|NCT01062555|19271550|P4|Phase 1|Withdrawal by Subject|0
5577361|NCT01062555|19271551|P3|Phase 1|Withdrawal by Subject|0
5577362|NCT01062555|19271552|P2|Phase 1|Withdrawal by Subject|1
5577363|NCT01062555|19271553|P1|Phase 1|Withdrawal by Subject|1
5577364|NCT01062555|19271550|P4|Phase 1|Graft Failure|0
5577365|NCT01062555|19271551|P3|Phase 1|Graft Failure|0
5577366|NCT01062555|19271552|P2|Phase 1|Graft Failure|8
5577367|NCT01062555|19271553|P1|Phase 1|Graft Failure|12
5577368|NCT01062555|19271550|P4|Phase 1|Death|0
5577369|NCT01062555|19271551|P3|Phase 1|Death|0
5577370|NCT01062555|19271552|P2|Phase 1|Death|17
5577371|NCT01062555|19271553|P1|Phase 1|Death|10
5577372|NCT01062425|19271573|P2|Overall Study|Protocol Violation|6
5577373|NCT01062425|19271574|P1|Overall Study|Protocol Violation|3
5577374|NCT01062399|19271591|P5|Overall Study|Protocol Violation|4
5577375|NCT01062399|19271592|P4|Overall Study|Protocol Violation|6
5577376|NCT01062399|19271593|P3|Overall Study|Protocol Violation|0
5577377|NCT01062399|19271594|P2|Overall Study|Protocol Violation|1
5577378|NCT01062399|19271595|P1|Overall Study|Protocol Violation|0
5577379|NCT01062256|19271639|P3|Overall Study|Administrative|0
5577380|NCT01062256|19271640|P2|Overall Study|Administrative|2
5577381|NCT01062256|19271641|P1|Overall Study|Administrative|0
5577382|NCT01062256|19271639|P3|Overall Study|Ineligible|3
5577383|NCT01062256|19271640|P2|Overall Study|Ineligible|4
5577384|NCT01062256|19271641|P1|Overall Study|Ineligible|1
5577385|NCT01062256|19271639|P3|Overall Study|Withdrawal by Subject|1
5577386|NCT01062256|19271640|P2|Overall Study|Withdrawal by Subject|1
5577387|NCT01062256|19271641|P1|Overall Study|Withdrawal by Subject|1
5577388|NCT01062256|19271639|P3|Overall Study|Adverse Event|0
5577389|NCT01062256|19271640|P2|Overall Study|Adverse Event|0
5577390|NCT01062256|19271641|P1|Overall Study|Adverse Event|1
5577391|NCT01062126|19271672|P1|Overall Study|All Withdrawals|324
5577392|NCT01062126|19271672|P1|Overall Study|Death|209
5577393|NCT01062113|19271679|P3|Overall Study|Withdrawal by Subject|0
5577394|NCT01062113|19271680|P2|Overall Study|Withdrawal by Subject|0
5577395|NCT01062113|19271681|P1|Overall Study|Withdrawal by Subject|1
5577396|NCT01062113|19271679|P3|Overall Study|Lack of Efficacy|31
5577397|NCT01062113|19271680|P2|Overall Study|Lack of Efficacy|22
5577398|NCT01062113|19271681|P1|Overall Study|Lack of Efficacy|38
5577399|NCT01062113|19271679|P3|Overall Study|Adverse Event|0
5577400|NCT01062113|19271680|P2|Overall Study|Adverse Event|0
5577401|NCT01062113|19271681|P1|Overall Study|Adverse Event|1
5577402|NCT01062061|19271699|P1|Overall Study|Failed to meet inclusion criteria|2
5577403|NCT01062061|19271699|P1|Overall Study|Outside chief indications|10
5577404|NCT01062061|19271699|P1|Overall Study|Investigated before study start|13
5577405|NCT01062061|19271699|P1|Overall Study|Enrolled more than once|2
5577406|NCT01061866|19271738|P1|Overall Study|Adverse Event|2
5577407|NCT01061775|19271742|P1|Overall Study|Lost to Follow-up|1
5577408|NCT01061775|19271742|P1|Overall Study|Physician Decision|2
5577409|NCT01061736|19271759|P10|Overall Study|Other than specified above|21
5577410|NCT01061736|19271760|P9|Overall Study|Other than specified above|15
5577411|NCT01061736|19271761|P8|Overall Study|Other than specified above|18
5577412|NCT01061736|19271762|P7|Overall Study|Other than specified above|0
5577413|NCT01061736|19271763|P6|Overall Study|Other than specified above|0
5577414|NCT01061736|19271764|P5|Overall Study|Other than specified above|1
5577415|NCT01061736|19271765|P4|Overall Study|Other than specified above|0
5577416|NCT01061736|19271766|P3|Overall Study|Other than specified above|2
5577417|NCT01061736|19271767|P2|Overall Study|Other than specified above|1
5577418|NCT01061736|19271768|P1|Overall Study|Other than specified above|0
5577419|NCT01061736|19271759|P10|Overall Study|Not treated|0
5577420|NCT01061736|19271760|P9|Overall Study|Not treated|1
5577421|NCT01061736|19271761|P8|Overall Study|Not treated|2
5577422|NCT01061736|19271762|P7|Overall Study|Not treated|0
5577423|NCT01061736|19271763|P6|Overall Study|Not treated|0
5577424|NCT01061736|19271764|P5|Overall Study|Not treated|1
5577425|NCT01061736|19271765|P4|Overall Study|Not treated|0
5577426|NCT01061736|19271766|P3|Overall Study|Not treated|0
5577427|NCT01061736|19271767|P2|Overall Study|Not treated|0
5577428|NCT01061736|19271768|P1|Overall Study|Not treated|0
5577429|NCT01061736|19271759|P10|Overall Study|Poor compliance to protocol|9
5577430|NCT01061736|19271760|P9|Overall Study|Poor compliance to protocol|5
5577431|NCT01061736|19271761|P8|Overall Study|Poor compliance to protocol|2
5577432|NCT01061736|19271762|P7|Overall Study|Poor compliance to protocol|0
5577433|NCT01061736|19271763|P6|Overall Study|Poor compliance to protocol|0
5577434|NCT01061736|19271764|P5|Overall Study|Poor compliance to protocol|0
5577435|NCT01061736|19271765|P4|Overall Study|Poor compliance to protocol|0
5577436|NCT01061736|19271766|P3|Overall Study|Poor compliance to protocol|0
5577437|NCT01061736|19271767|P2|Overall Study|Poor compliance to protocol|0
5577438|NCT01061736|19271768|P1|Overall Study|Poor compliance to protocol|0
5577439|NCT01061736|19271759|P10|Overall Study|Lack of Efficacy|10
5577440|NCT01061736|19271760|P9|Overall Study|Lack of Efficacy|9
5577441|NCT01061736|19271761|P8|Overall Study|Lack of Efficacy|9
5577442|NCT01061736|19271762|P7|Overall Study|Lack of Efficacy|1
5577443|NCT01061736|19271763|P6|Overall Study|Lack of Efficacy|2
5577444|NCT01061736|19271764|P5|Overall Study|Lack of Efficacy|1
5577445|NCT01061736|19271765|P4|Overall Study|Lack of Efficacy|1
5577446|NCT01061736|19271766|P3|Overall Study|Lack of Efficacy|1
5577447|NCT01061736|19271767|P2|Overall Study|Lack of Efficacy|2
5577448|NCT01061736|19271768|P1|Overall Study|Lack of Efficacy|0
5577449|NCT01061736|19271759|P10|Overall Study|Adverse Event|34
5577450|NCT01061736|19271760|P9|Overall Study|Adverse Event|67
5577451|NCT01061736|19271761|P8|Overall Study|Adverse Event|63
5577452|NCT01061736|19271762|P7|Overall Study|Adverse Event|4
5577453|NCT01061736|19271763|P6|Overall Study|Adverse Event|1
5577454|NCT01061736|19271764|P5|Overall Study|Adverse Event|4
5577455|NCT01061736|19271765|P4|Overall Study|Adverse Event|2
5577456|NCT01061736|19271766|P3|Overall Study|Adverse Event|3
5577457|NCT01061736|19271767|P2|Overall Study|Adverse Event|1
5577458|NCT01061736|19271768|P1|Overall Study|Adverse Event|13
5577459|NCT01061736|19271759|P10|Overall Study|Dose regimen not selected|0
5577460|NCT01061736|19271760|P9|Overall Study|Dose regimen not selected|0
5577461|NCT01061736|19271761|P8|Overall Study|Dose regimen not selected|0
5577462|NCT01061736|19271762|P7|Overall Study|Dose regimen not selected|79
5577463|NCT01061736|19271763|P6|Overall Study|Dose regimen not selected|0
5577464|NCT01061736|19271764|P5|Overall Study|Dose regimen not selected|0
5577465|NCT01061736|19271765|P4|Overall Study|Dose regimen not selected|0
5577466|NCT01061736|19271766|P3|Overall Study|Dose regimen not selected|0
5577467|NCT01061736|19271767|P2|Overall Study|Dose regimen not selected|0
5577468|NCT01061736|19271768|P1|Overall Study|Dose regimen not selected|0
5577469|NCT01061723|19271807|P6|Overall Study|Other than specified above|1
5577470|NCT01061723|19271808|P5|Overall Study|Other than specified above|0
5577471|NCT01061723|19271809|P4|Overall Study|Other than specified above|1
5577472|NCT01061723|19271810|P3|Overall Study|Other than specified above|1
5577473|NCT01061723|19271811|P2|Overall Study|Other than specified above|1
5577474|NCT01061723|19271812|P1|Overall Study|Other than specified above|2
5577475|NCT01061723|19271807|P6|Overall Study|Randomized but not treated|1
5577476|NCT01061723|19271808|P5|Overall Study|Randomized but not treated|0
5577477|NCT01061723|19271809|P4|Overall Study|Randomized but not treated|0
5577478|NCT01061723|19271810|P3|Overall Study|Randomized but not treated|0
5577479|NCT01061723|19271811|P2|Overall Study|Randomized but not treated|0
5577480|NCT01061723|19271812|P1|Overall Study|Randomized but not treated|0
5577481|NCT01061723|19271807|P6|Overall Study|Lack of Efficacy|1
5577482|NCT01061723|19271808|P5|Overall Study|Lack of Efficacy|1
5577483|NCT01061723|19271809|P4|Overall Study|Lack of Efficacy|2
5577484|NCT01061723|19271810|P3|Overall Study|Lack of Efficacy|4
5577485|NCT01061723|19271811|P2|Overall Study|Lack of Efficacy|3
5577486|NCT01061723|19271812|P1|Overall Study|Lack of Efficacy|2
5577487|NCT01061723|19271807|P6|Overall Study|Adverse Event|6
5577488|NCT01061723|19271808|P5|Overall Study|Adverse Event|2
5577489|NCT01061723|19271809|P4|Overall Study|Adverse Event|5
5577490|NCT01061723|19271810|P3|Overall Study|Adverse Event|5
5577491|NCT01061723|19271811|P2|Overall Study|Adverse Event|2
5577492|NCT01061723|19271812|P1|Overall Study|Adverse Event|0
5577493|NCT01061710|19271892|P1|Overall Study|Protocol Violation|14
5577494|NCT01061671|19271902|P2|Overall Study|Death|30
5577495|NCT01061671|19271903|P1|Overall Study|Death|28
5577496|NCT01061671|19271902|P2|Overall Study|Lost to Follow-up|5
5577497|NCT01061671|19271903|P1|Overall Study|Lost to Follow-up|3
5577498|NCT01061671|19271902|P2|Overall Study|Withdrawal by Subject|20
5577499|NCT01061671|19271903|P1|Overall Study|Withdrawal by Subject|16
5577500|NCT01061606|19271915|P1|Overall Study|alternative therapy|2
5577501|NCT01061606|19271915|P1|Overall Study|Disease Progression|4
5577502|NCT01061606|19271915|P1|Overall Study|Death|1
5577503|NCT01061606|19271915|P1|Overall Study|Adverse Event|1
5577504|NCT01061567|19271924|P1|Overall Study|Other reason than stated above|3
5577505|NCT01061567|19271924|P1|Overall Study|Withdrawal by Subject|11
5577506|NCT01061567|19271924|P1|Overall Study|Protocol Violation|1
5577507|NCT01061567|19271924|P1|Overall Study|Lost to Follow-up|24
5577508|NCT01061567|19271924|P1|Overall Study|Lack of Efficacy|3
5577509|NCT01061567|19271924|P1|Overall Study|Death|2
5577510|NCT01061567|19271924|P1|Overall Study|Adverse Event|32
5577511|NCT01061385|19271948|P2|Overall Study|subject decision not related to AE|1
5577512|NCT01061385|19271949|P1|Overall Study|subject decision not related to AE|0
5577513|NCT01061385|19271948|P2|Overall Study|Lost to Follow-up|0
5577514|NCT01061385|19271949|P1|Overall Study|Lost to Follow-up|1
5577515|NCT01061359|19271957|P1|Overall Study|Secondary neoplasm|11
5577516|NCT01061359|19271957|P1|Overall Study|Relapse|187
5577517|NCT01061359|19271957|P1|Overall Study|Lost to Follow-up|1072
5577518|NCT01061359|19271957|P1|Overall Study|Death|32
5577519|NCT01061333|19271963|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
5577520|NCT01061333|19271964|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
5577521|NCT01061177|19272002|P1|Overall Study|Death|4
5577522|NCT01061177|19272002|P1|Overall Study|Administratie problems|4
5577523|NCT01061177|19272002|P1|Overall Study|Abnormal test procedure results|4
5577524|NCT01061177|19272002|P1|Overall Study|Abnormal laboratory values|6
5577525|NCT01061177|19272002|P1|Overall Study|New cancer therapy|9
5577526|NCT01061177|19272002|P1|Overall Study|Lost to Follow-up|9
5577527|NCT01061177|19272002|P1|Overall Study|Protocol Violation|11
5577528|NCT01061177|19272002|P1|Overall Study|Disease progression|17
5577529|NCT01061177|19272002|P1|Overall Study|Withdrawal by Subject|27
5577530|NCT01061177|19272002|P1|Overall Study|Adverse Event|117
5577531|NCT01061151|19272025|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
5577532|NCT01061151|19272026|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
5577533|NCT01061151|19272027|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
5577534|NCT01061151|19272028|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
5577535|NCT01061151|19272025|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
5577536|NCT01061151|19272026|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
5577537|NCT01061151|19272027|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
5577538|NCT01061151|19272028|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
5577539|NCT01061151|19272025|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
5577540|NCT01061151|19272026|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
5577541|NCT01061151|19272027|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
5577542|NCT01061151|19272028|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
5577543|NCT01061151|19272025|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
5577544|NCT01061151|19272026|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
5577545|NCT01061151|19272027|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
5577546|NCT01061151|19272028|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
5577547|NCT01061151|19272025|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
5577548|NCT01061151|19272026|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
5577549|NCT01061151|19272027|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
5577550|NCT01061151|19272028|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
5577551|NCT01061151|19272025|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
5577552|NCT01061151|19272026|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
5577553|NCT01061151|19272027|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
5577554|NCT01061151|19272028|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
5577555|NCT01061151|19272025|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
5577556|NCT01061151|19272026|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
5577557|NCT01061151|19272027|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
5577558|NCT01061151|19272028|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
5577559|NCT01061151|19272025|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
5577560|NCT01061151|19272026|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
5577561|NCT01061151|19272027|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
5577562|NCT01061151|19272028|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
5577563|NCT01061151|19272025|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
5577564|NCT01061151|19272026|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
5577565|NCT01061151|19272027|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
5577566|NCT01061151|19272028|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
5577567|NCT01061151|19272025|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
5577733|NCT01059825|19272504|P5|Treatment Period|Protocol Violation|1
5577568|NCT01061151|19272026|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
5577569|NCT01061151|19272027|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
5577570|NCT01061151|19272028|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
5577571|NCT01061151|19272025|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
5577572|NCT01061151|19272026|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
5577573|NCT01061151|19272027|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
5577574|NCT01061151|19272028|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
5577575|NCT01061151|19272025|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
5577576|NCT01061151|19272026|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
5577577|NCT01061151|19272027|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
5577578|NCT01061151|19272028|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
5577579|NCT01061151|19272025|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
5577580|NCT01061151|19272026|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
5577581|NCT01061151|19272027|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
5577582|NCT01061151|19272028|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
5577583|NCT01061151|19272025|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
5577584|NCT01061151|19272026|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
5577585|NCT01061151|19272027|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
5577586|NCT01061151|19272028|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
5577587|NCT01061151|19272025|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
5577588|NCT01061151|19272026|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
5577589|NCT01061151|19272027|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
5577590|NCT01061151|19272028|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
5577591|NCT01061008|19272087|P2|Overall Study|Adverse Event|1
5577592|NCT01061008|19272088|P1|Overall Study|Adverse Event|0
5577593|NCT01061008|19272087|P2|Overall Study|Unable to exercise following surgery|0
5577594|NCT01061008|19272088|P1|Overall Study|Unable to exercise following surgery|1
5577595|NCT01061008|19272087|P2|Overall Study|Withdrawal by Subject|3
5577596|NCT01061008|19272088|P1|Overall Study|Withdrawal by Subject|1
5577597|NCT01061008|19272087|P2|Overall Study|Death|0
5577598|NCT01061008|19272088|P1|Overall Study|Death|1
5577599|NCT01061008|19272087|P2|Overall Study|Badiocephalic fistula failed|2
5577600|NCT01061008|19272088|P1|Overall Study|Badiocephalic fistula failed|3
5577601|NCT01060670|19272096|P2|Run In|screen failure|238
5577602|NCT01060670|19272097|P1|Run In|screen failure|0
5577603|NCT01060553|19272132|P2|Overall Study|Lack of Efficacy|0
5577604|NCT01060553|19272133|P1|Overall Study|Lack of Efficacy|1
5577605|NCT01060553|19272132|P2|Overall Study|Withdrawal by Subject|5
5577606|NCT01060553|19272133|P1|Overall Study|Withdrawal by Subject|5
5577607|NCT01060553|19272132|P2|Overall Study|Lost to Follow-up|5
5577608|NCT01060553|19272133|P1|Overall Study|Lost to Follow-up|3
5577609|NCT01060540|19272140|P2|Overall Study|Physician Decision|1
5577610|NCT01060540|19272141|P1|Overall Study|Physician Decision|0
5577611|NCT01060540|19272140|P2|Overall Study|Death|1
5577612|NCT01060540|19272141|P1|Overall Study|Death|2
5577613|NCT01060540|19272140|P2|Overall Study|Lost to Follow-up|43
5577614|NCT01060540|19272141|P1|Overall Study|Lost to Follow-up|52
5577615|NCT01060540|19272140|P2|Overall Study|Withdrawal by Subject|20
5577616|NCT01060540|19272141|P1|Overall Study|Withdrawal by Subject|10
5577617|NCT01060384|19272155|P5|Overall Study|Intercurrent illness|1
5577618|NCT01060384|19272156|P4|Overall Study|Intercurrent illness|0
5577619|NCT01060384|19272157|P3|Overall Study|Intercurrent illness|0
5577620|NCT01060384|19272158|P2|Overall Study|Intercurrent illness|0
5577621|NCT01060384|19272159|P1|Overall Study|Intercurrent illness|0
5577622|NCT01060384|19272155|P5|Overall Study|Death|1
5577623|NCT01060384|19272156|P4|Overall Study|Death|0
5577624|NCT01060384|19272157|P3|Overall Study|Death|0
5577625|NCT01060384|19272158|P2|Overall Study|Death|0
5577626|NCT01060384|19272159|P1|Overall Study|Death|0
5577627|NCT01060384|19272155|P5|Overall Study|Withdrawal by Subject|0
5577628|NCT01060384|19272156|P4|Overall Study|Withdrawal by Subject|0
5577629|NCT01060384|19272157|P3|Overall Study|Withdrawal by Subject|0
5577630|NCT01060384|19272158|P2|Overall Study|Withdrawal by Subject|1
5577631|NCT01060384|19272159|P1|Overall Study|Withdrawal by Subject|0
5577632|NCT01060150|19272178|P1|Overall Study|Enrolled, but not treated|2
5577633|NCT01060150|19272178|P1|Overall Study|Withdrawal by Subject|8
5577634|NCT01060150|19272178|P1|Overall Study|Protocol Violation|6
5577635|NCT01060150|19272178|P1|Overall Study|Lost to Follow-up|1
5577636|NCT01060150|19272178|P1|Overall Study|Adverse Event|6
5577637|NCT01060124|19272193|P1|Overall Study|Withdrawal by Subject|7
5577638|NCT01060124|19272193|P1|Overall Study|Adverse Event|14
5577639|NCT01060124|19272193|P1|Overall Study|Other|16
5577640|NCT01060111|19272204|P3|Overall Study|Other|4
5577641|NCT01060111|19272205|P2|Overall Study|Other|3
5577642|NCT01060111|19272206|P1|Overall Study|Other|2
5577643|NCT01060111|19272204|P3|Overall Study|Participants' non-cooperation|0
5577644|NCT01060111|19272205|P2|Overall Study|Participants' non-cooperation|0
5577645|NCT01060111|19272206|P1|Overall Study|Participants' non-cooperation|1
5577646|NCT01060111|19272204|P3|Overall Study|Adverse event and insufficient effect|0
5577647|NCT01060111|19272205|P2|Overall Study|Adverse event and insufficient effect|1
5577648|NCT01060111|19272206|P1|Overall Study|Adverse event and insufficient effect|0
5577649|NCT01060111|19272204|P3|Overall Study|Participants' non-cooperation|6
5577650|NCT01060111|19272205|P2|Overall Study|Participants' non-cooperation|6
5577651|NCT01060111|19272206|P1|Overall Study|Participants' non-cooperation|8
5577652|NCT01060111|19272204|P3|Overall Study|Participants' evasion for hospital visit|2
5577653|NCT01060111|19272205|P2|Overall Study|Participants' evasion for hospital visit|3
5577654|NCT01060111|19272206|P1|Overall Study|Participants' evasion for hospital visit|0
5577655|NCT01060111|19272204|P3|Overall Study|Inappropriate participant|5
5577656|NCT01060111|19272205|P2|Overall Study|Inappropriate participant|4
5577657|NCT01060111|19272206|P1|Overall Study|Inappropriate participant|5
5577658|NCT01060111|19272204|P3|Overall Study|Lack of Efficacy|0
5577659|NCT01060111|19272205|P2|Overall Study|Lack of Efficacy|1
5577660|NCT01060111|19272206|P1|Overall Study|Lack of Efficacy|2
5577661|NCT01060111|19272204|P3|Overall Study|Adverse Event|18
5577662|NCT01060111|19272205|P2|Overall Study|Adverse Event|5
5577663|NCT01060111|19272206|P1|Overall Study|Adverse Event|9
5577664|NCT01060072|19272238|P2|Overall Study|Excluded Medications|1
5577665|NCT01060072|19272239|P1|Overall Study|Excluded Medications|0
5577666|NCT01060072|19272238|P2|Overall Study|Acute cholecystitis|0
5577667|NCT01060072|19272239|P1|Overall Study|Acute cholecystitis|1
5577668|NCT01060072|19272238|P2|Overall Study|Protocol Violation|1
5577669|NCT01060072|19272239|P1|Overall Study|Protocol Violation|0
5577670|NCT01060072|19272238|P2|Overall Study|Physician Decision|2
5577671|NCT01060072|19272239|P1|Overall Study|Physician Decision|0
5577672|NCT01060072|19272238|P2|Overall Study|Adverse Event|1
5577673|NCT01060072|19272239|P1|Overall Study|Adverse Event|1
5577674|NCT01060059|19272255|P2|Overall Study|lack of compliance|2
5577675|NCT01060059|19272256|P1|Overall Study|lack of compliance|5
5577676|NCT01060059|19272255|P2|Overall Study|lack of glycemic control|1
5577677|NCT01060059|19272256|P1|Overall Study|lack of glycemic control|2
5577678|NCT01060059|19272255|P2|Overall Study|Withdrawal by Subject|23
5577679|NCT01060059|19272256|P1|Overall Study|Withdrawal by Subject|35
5577680|NCT01060059|19272255|P2|Overall Study|entry criteria not met|3
5577681|NCT01060059|19272256|P1|Overall Study|entry criteria not met|4
5577682|NCT01060059|19272255|P2|Overall Study|Lost to Follow-up|34
5577683|NCT01060059|19272256|P1|Overall Study|Lost to Follow-up|18
5577684|NCT01060059|19272255|P2|Overall Study|Death|3
5577685|NCT01060059|19272256|P1|Overall Study|Death|2
5577686|NCT01060059|19272255|P2|Overall Study|Adverse Event|1
5577687|NCT01060059|19272256|P1|Overall Study|Adverse Event|1
5577688|NCT01060007|19272314|P1|Overall Study|Inevaluable for response at surgery|3
5577689|NCT01060007|19272314|P1|Overall Study|Withdrawal by Subject|1
5577690|NCT01059903|19272382|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
5577691|NCT01059903|19272383|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
5577692|NCT01059864|19272426|P3|Double-Blind Treatment Phase|Adverse Event|3
5577693|NCT01059864|19272427|P2|Double-Blind Treatment Phase|Adverse Event|3
5577694|NCT01059864|19272428|P1|Double-Blind Treatment Phase|Adverse Event|0
5577695|NCT01059864|19272426|P3|Open-Label Run-In Phase|Protocol Violation|0
5577696|NCT01059864|19272427|P2|Open-Label Run-In Phase|Protocol Violation|0
5577697|NCT01059864|19272428|P1|Open-Label Run-In Phase|Protocol Violation|2
5577698|NCT01059864|19272426|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
5577699|NCT01059864|19272427|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
5577700|NCT01059864|19272428|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
5577701|NCT01059864|19272426|P3|Open-Label Run-In Phase|Lost to Follow-up|0
5577702|NCT01059864|19272427|P2|Open-Label Run-In Phase|Lost to Follow-up|0
5577703|NCT01059864|19272428|P1|Open-Label Run-In Phase|Lost to Follow-up|2
5577704|NCT01059864|19272426|P3|Open-Label Run-In Phase|Lack of Efficacy|0
5577705|NCT01059864|19272427|P2|Open-Label Run-In Phase|Lack of Efficacy|0
5577706|NCT01059864|19272428|P1|Open-Label Run-In Phase|Lack of Efficacy|1
5577707|NCT01059864|19272426|P3|Open-Label Run-In Phase|Adverse Event|0
5577708|NCT01059864|19272427|P2|Open-Label Run-In Phase|Adverse Event|0
5577709|NCT01059864|19272428|P1|Open-Label Run-In Phase|Adverse Event|7
5577710|NCT01059825|19272502|P7|Treatment Period|Adverse event not related to study drug|0
5577711|NCT01059825|19272503|P6|Treatment Period|Adverse event not related to study drug|1
5577712|NCT01059825|19272504|P5|Treatment Period|Adverse event not related to study drug|1
5577713|NCT01059825|19272505|P4|Treatment Period|Adverse event not related to study drug|1
5577714|NCT01059825|19272506|P3|Treatment Period|Adverse event not related to study drug|2
5577715|NCT01059825|19272507|P2|Treatment Period|Adverse event not related to study drug|1
5577716|NCT01059825|19272508|P1|Treatment Period|Adverse event not related to study drug|0
5577717|NCT01059825|19272502|P7|Treatment Period|Insufficient clinical response|0
5577718|NCT01059825|19272503|P6|Treatment Period|Insufficient clinical response|0
5577719|NCT01059825|19272504|P5|Treatment Period|Insufficient clinical response|0
5577720|NCT01059825|19272505|P4|Treatment Period|Insufficient clinical response|0
5577721|NCT01059825|19272506|P3|Treatment Period|Insufficient clinical response|0
5577722|NCT01059825|19272507|P2|Treatment Period|Insufficient clinical response|0
5577723|NCT01059825|19272508|P1|Treatment Period|Insufficient clinical response|3
5577724|NCT01059825|19272502|P7|Treatment Period|Adverse event related to study drug|0
5577725|NCT01059825|19272503|P6|Treatment Period|Adverse event related to study drug|0
5577726|NCT01059825|19272504|P5|Treatment Period|Adverse event related to study drug|0
5577727|NCT01059825|19272505|P4|Treatment Period|Adverse event related to study drug|1
5577728|NCT01059825|19272506|P3|Treatment Period|Adverse event related to study drug|1
5577729|NCT01059825|19272507|P2|Treatment Period|Adverse event related to study drug|0
5577730|NCT01059825|19272508|P1|Treatment Period|Adverse event related to study drug|1
5577731|NCT01059825|19272502|P7|Treatment Period|Protocol Violation|0
5577732|NCT01059825|19272503|P6|Treatment Period|Protocol Violation|1
5577734|NCT01059825|19272505|P4|Treatment Period|Protocol Violation|1
5577735|NCT01059825|19272506|P3|Treatment Period|Protocol Violation|1
5577736|NCT01059825|19272507|P2|Treatment Period|Protocol Violation|0
5577737|NCT01059825|19272508|P1|Treatment Period|Protocol Violation|0
5577738|NCT01059825|19272502|P7|Treatment Period|Other reason not specified|0
5577739|NCT01059825|19272503|P6|Treatment Period|Other reason not specified|0
5577740|NCT01059825|19272504|P5|Treatment Period|Other reason not specified|0
5577741|NCT01059825|19272505|P4|Treatment Period|Other reason not specified|2
5577742|NCT01059825|19272506|P3|Treatment Period|Other reason not specified|1
5577743|NCT01059825|19272507|P2|Treatment Period|Other reason not specified|2
5577744|NCT01059825|19272508|P1|Treatment Period|Other reason not specified|1
5577745|NCT01059825|19272502|P7|Treatment Period|Withdrawal by Subject|0
5577746|NCT01059825|19272503|P6|Treatment Period|Withdrawal by Subject|1
5577747|NCT01059825|19272504|P5|Treatment Period|Withdrawal by Subject|4
5577748|NCT01059825|19272505|P4|Treatment Period|Withdrawal by Subject|5
5577749|NCT01059825|19272506|P3|Treatment Period|Withdrawal by Subject|1
5577750|NCT01059825|19272507|P2|Treatment Period|Withdrawal by Subject|0
5577751|NCT01059825|19272508|P1|Treatment Period|Withdrawal by Subject|3
5577752|NCT01059825|19272502|P7|Treatment Period|Lost to Follow-up|0
5577753|NCT01059825|19272503|P6|Treatment Period|Lost to Follow-up|0
5577754|NCT01059825|19272504|P5|Treatment Period|Lost to Follow-up|2
5577755|NCT01059825|19272505|P4|Treatment Period|Lost to Follow-up|1
5577756|NCT01059825|19272506|P3|Treatment Period|Lost to Follow-up|0
5577757|NCT01059825|19272507|P2|Treatment Period|Lost to Follow-up|1
5577758|NCT01059825|19272508|P1|Treatment Period|Lost to Follow-up|2
5577759|NCT01059825|19272502|P7|Enrolled, Run-in Period|Protocol Violation|5
5577760|NCT01059825|19272503|P6|Enrolled, Run-in Period|Protocol Violation|0
5577761|NCT01059825|19272504|P5|Enrolled, Run-in Period|Protocol Violation|0
5577762|NCT01059825|19272505|P4|Enrolled, Run-in Period|Protocol Violation|0
5577763|NCT01059825|19272506|P3|Enrolled, Run-in Period|Protocol Violation|0
5577764|NCT01059825|19272507|P2|Enrolled, Run-in Period|Protocol Violation|0
5577765|NCT01059825|19272508|P1|Enrolled, Run-in Period|Protocol Violation|0
5577766|NCT01059825|19272502|P7|Enrolled, Run-in Period|Other reason not specified|7
5577767|NCT01059825|19272503|P6|Enrolled, Run-in Period|Other reason not specified|0
5577768|NCT01059825|19272504|P5|Enrolled, Run-in Period|Other reason not specified|0
5577769|NCT01059825|19272505|P4|Enrolled, Run-in Period|Other reason not specified|0
5577770|NCT01059825|19272506|P3|Enrolled, Run-in Period|Other reason not specified|0
5577771|NCT01059825|19272507|P2|Enrolled, Run-in Period|Other reason not specified|0
5577772|NCT01059825|19272508|P1|Enrolled, Run-in Period|Other reason not specified|0
5577773|NCT01059825|19272502|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
5577774|NCT01059825|19272503|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
5577775|NCT01059825|19272504|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
5577776|NCT01059825|19272505|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
5577777|NCT01059825|19272506|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
5577778|NCT01059825|19272507|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
5577779|NCT01059825|19272508|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
5577780|NCT01059825|19272502|P7|Enrolled, Run-in Period|Lost to Follow-up|5
5577781|NCT01059825|19272503|P6|Enrolled, Run-in Period|Lost to Follow-up|0
5577782|NCT01059825|19272504|P5|Enrolled, Run-in Period|Lost to Follow-up|0
5577783|NCT01059825|19272505|P4|Enrolled, Run-in Period|Lost to Follow-up|0
5577784|NCT01059825|19272506|P3|Enrolled, Run-in Period|Lost to Follow-up|0
5577785|NCT01059825|19272507|P2|Enrolled, Run-in Period|Lost to Follow-up|0
5577786|NCT01059825|19272508|P1|Enrolled, Run-in Period|Lost to Follow-up|0
5577787|NCT01059825|19272502|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
5577788|NCT01059825|19272503|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
5577789|NCT01059825|19272504|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
5577790|NCT01059825|19272505|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
5577791|NCT01059825|19272506|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
5577792|NCT01059825|19272507|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
5577793|NCT01059825|19272508|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
5577794|NCT01059825|19272502|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
5577795|NCT01059825|19272503|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
5577796|NCT01059825|19272504|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
5577797|NCT01059825|19272505|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
5577798|NCT01059825|19272506|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
5577799|NCT01059825|19272507|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
5577800|NCT01059825|19272508|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
5577801|NCT01059812|19272695|P2|Overall Study|Unclassified|4
5577802|NCT01059812|19272696|P1|Overall Study|Unclassified|14
5577803|NCT01059812|19272695|P2|Overall Study|Withdrawal Criteria|4
5577804|NCT01059812|19272696|P1|Overall Study|Withdrawal Criteria|9
5577805|NCT01059812|19272695|P2|Overall Study|Protocol Violation|1
5577806|NCT01059812|19272696|P1|Overall Study|Protocol Violation|3
5577807|NCT01059812|19272695|P2|Overall Study|Lack of Efficacy|2
5577808|NCT01059812|19272696|P1|Overall Study|Lack of Efficacy|2
5577809|NCT01059812|19272695|P2|Overall Study|Adverse Event|5
5577810|NCT01059812|19272696|P1|Overall Study|Adverse Event|9
5577811|NCT01059799|19272712|P2|Overall Study|Other|3
5577812|NCT01059799|19272713|P1|Overall Study|Other|12
5577813|NCT01059799|19272712|P2|Overall Study|Withdrawal criteria|2
5577814|NCT01059799|19272713|P1|Overall Study|Withdrawal criteria|13
5577815|NCT01059799|19272712|P2|Overall Study|Protocol Violation|2
5577816|NCT01059799|19272713|P1|Overall Study|Protocol Violation|3
5577817|NCT01059799|19272712|P2|Overall Study|Lack of Efficacy|0
5577818|NCT01059799|19272713|P1|Overall Study|Lack of Efficacy|1
5577819|NCT01059799|19272712|P2|Overall Study|Adverse Event|3
5577820|NCT01059799|19272713|P1|Overall Study|Adverse Event|2
5577821|NCT01059773|19272727|P2|Overall Study|Other|3
5577822|NCT01059773|19272728|P1|Overall Study|Other|1
5577823|NCT01059773|19272727|P2|Overall Study|Ineligible follow TB screening criteria|1
5577824|NCT01059773|19272728|P1|Overall Study|Ineligible follow TB screening criteria|0
5577825|NCT01059773|19272727|P2|Overall Study|Malignancy including squamous cell skin|1
5577826|NCT01059773|19272728|P1|Overall Study|Malignancy including squamous cell skin|0
5577827|NCT01059773|19272727|P2|Overall Study|Death|1
5577828|NCT01059773|19272728|P1|Overall Study|Death|0
5577829|NCT01059773|19272727|P2|Overall Study|Lack of Efficacy|3
5577830|NCT01059773|19272728|P1|Overall Study|Lack of Efficacy|3
5577831|NCT01059773|19272727|P2|Overall Study|Physician Decision|4
5577832|NCT01059773|19272728|P1|Overall Study|Physician Decision|5
5577833|NCT01059773|19272727|P2|Overall Study|Protocol Violation|2
5577834|NCT01059773|19272728|P1|Overall Study|Protocol Violation|6
5577835|NCT01059773|19272727|P2|Overall Study|Pregnancy|1
5577836|NCT01059773|19272728|P1|Overall Study|Pregnancy|1
5577837|NCT01059773|19272727|P2|Overall Study|Lost to Follow-up|1
5577838|NCT01059773|19272728|P1|Overall Study|Lost to Follow-up|1
5577839|NCT01059773|19272727|P2|Overall Study|Withdrawal by Subject|5
5577840|NCT01059773|19272728|P1|Overall Study|Withdrawal by Subject|1
5577841|NCT01059773|19272727|P2|Overall Study|Adverse Event|2
5577842|NCT01059773|19272728|P1|Overall Study|Adverse Event|2
5577843|NCT01059643|19272884|P1|Overall Study|Physician Decision|1
5577844|NCT01059643|19272884|P1|Overall Study|Withdrawal by Subject|2
5577845|NCT01059643|19272884|P1|Overall Study|Adverse Event|3
5577846|NCT01059630|19272899|P2|Overall Study|Withdrawal by Subject|14
5577847|NCT01059630|19272900|P1|Overall Study|Withdrawal by Subject|21
5577848|NCT01059630|19272899|P2|Overall Study|Physician Decision|4
5577849|NCT01059630|19272900|P1|Overall Study|Physician Decision|2
5577850|NCT01059630|19272899|P2|Overall Study|Lost to Follow-up|1
5577851|NCT01059630|19272900|P1|Overall Study|Lost to Follow-up|4
5577852|NCT01059630|19272899|P2|Overall Study|Death|84
5577853|NCT01059630|19272900|P1|Overall Study|Death|100
5577854|NCT01059617|19272974|P4|Overall Study|Other|6
5577855|NCT01059617|19272975|P3|Overall Study|Other|8
5577856|NCT01059617|19272976|P2|Overall Study|Other|1
5577857|NCT01059617|19272977|P1|Overall Study|Other|7
5577858|NCT01059565|19273147|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
5577859|NCT01059565|19273148|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
5577860|NCT01059565|19273147|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
5577861|NCT01059565|19273148|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
5577862|NCT01059565|19273147|P2|24-Week Open-Label Phase|Subject noncompliance|0
5577863|NCT01059565|19273148|P1|24-Week Open-Label Phase|Subject noncompliance|1
5577864|NCT01059565|19273147|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
5577865|NCT01059565|19273148|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
5577866|NCT01059565|19273147|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
5577867|NCT01059565|19273148|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
5577868|NCT01059565|19273147|P2|24-Week Open-Label Phase|Adverse Event|0
5577869|NCT01059565|19273148|P1|24-Week Open-Label Phase|Adverse Event|2
5577870|NCT01059565|19273147|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
5577871|NCT01059565|19273148|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
5577872|NCT01059565|19273147|P2|24-Week Randomized Phase|Lost to Follow-up|1
5577873|NCT01059565|19273148|P1|24-Week Randomized Phase|Lost to Follow-up|0
5577874|NCT01059565|19273147|P2|24-Week Randomized Phase|Withdrawal by Subject|1
5577875|NCT01059565|19273148|P1|24-Week Randomized Phase|Withdrawal by Subject|3
5577876|NCT01059565|19273147|P2|24-Week Randomized Phase|Adverse Event|0
5577877|NCT01059565|19273148|P1|24-Week Randomized Phase|Adverse Event|5
5577878|NCT01059565|19273147|P2|24-Week Randomized Phase|Randomized but not treated|0
5577879|NCT01059565|19273148|P1|24-Week Randomized Phase|Randomized but not treated|1
5577880|NCT01059539|19273182|P1|Overall Study|Reason Not Specified|2
5577881|NCT01059539|19273182|P1|Overall Study|Lost to Follow-up|42
5577882|NCT01059539|19273182|P1|Overall Study|Withdrawal of Consent|80
5577883|NCT01059539|19273182|P1|Overall Study|Protocol Violation|55
5577884|NCT01059539|19273182|P1|Overall Study|Insufficient Therapeutic Response|26
5577885|NCT01059539|19273182|P1|Overall Study|Adverse Event|66
5577886|NCT01059526|19273189|P2|Overall Study|Patient found to be dermatographic|0
5577887|NCT01059526|19273190|P1|Overall Study|Patient found to be dermatographic|1
5577888|NCT01059526|19273189|P2|Overall Study|Lost to Follow-up|1
5577889|NCT01059526|19273190|P1|Overall Study|Lost to Follow-up|4
5577890|NCT01059526|19273189|P2|Overall Study|Withdrawal by Subject|1
5577891|NCT01059526|19273190|P1|Overall Study|Withdrawal by Subject|3
5577892|NCT01059526|19273189|P2|Overall Study|Protocol Violation|1
5577893|NCT01059526|19273190|P1|Overall Study|Protocol Violation|0
5577894|NCT01059526|19273189|P2|Overall Study|Adverse Event|2
5577895|NCT01059526|19273190|P1|Overall Study|Adverse Event|2
5577896|NCT01059526|19273189|P2|Overall Study|Patient enrolled but not treated|17
5577897|NCT01059526|19273190|P1|Overall Study|Patient enrolled but not treated|20
5577898|NCT01059344|19273536|P2|Overall Study|Other|6
5577899|NCT01059344|19273537|P1|Overall Study|Other|3
5577900|NCT01059344|19273536|P2|Overall Study|Lost to Follow-up|1
5577901|NCT01059344|19273537|P1|Overall Study|Lost to Follow-up|1
5577902|NCT01059344|19273536|P2|Overall Study|Withdrawal by Subject|9
5577903|NCT01059344|19273537|P1|Overall Study|Withdrawal by Subject|6
5577904|NCT01059344|19273536|P2|Overall Study|Adverse Event|30
5577905|NCT01059344|19273537|P1|Overall Study|Adverse Event|12
5577906|NCT01059318|19273555|P1|Extension (36 Week)|Adverse Event|3
5577907|NCT01059318|19273555|P1|Core Study (26 Week)|Withdrawal by Subject|1
5577908|NCT01059318|19273555|P1|Core Study (26 Week)|Adverse Event|3
5577909|NCT01059175|19273576|P2|Overall Study|Lost to Follow-up|1
5577910|NCT01059175|19273577|P1|Overall Study|Lost to Follow-up|0
5577911|NCT01059175|19273576|P2|Overall Study|Adverse Event|2
5577912|NCT01059175|19273577|P1|Overall Study|Adverse Event|4
5577913|NCT01059175|19273576|P2|Overall Study|Death|17
5577914|NCT01059175|19273577|P1|Overall Study|Death|17
5577915|NCT01059071|19273599|P4|Overall Study|Physician Decision|1
5577916|NCT01059071|19273600|P3|Overall Study|Physician Decision|0
5577917|NCT01059071|19273601|P2|Overall Study|Physician Decision|0
5577918|NCT01059071|19273602|P1|Overall Study|Physician Decision|0
5577919|NCT01059071|19273599|P4|Overall Study|Withdrawal by Subject|2
5577920|NCT01059071|19273600|P3|Overall Study|Withdrawal by Subject|0
5577921|NCT01059071|19273601|P2|Overall Study|Withdrawal by Subject|0
5577922|NCT01059071|19273602|P1|Overall Study|Withdrawal by Subject|1
5577923|NCT01059071|19273599|P4|Overall Study|Lack of Efficacy|3
5577924|NCT01059071|19273600|P3|Overall Study|Lack of Efficacy|2
5577925|NCT01059071|19273601|P2|Overall Study|Lack of Efficacy|4
5577926|NCT01059071|19273602|P1|Overall Study|Lack of Efficacy|1
5577927|NCT01058863|19273629|P1|Overall Study|Randomized in error|1
5577928|NCT01058863|19273629|P1|Overall Study|Sponsor requested withdrawal|1
5577929|NCT01058863|19273629|P1|Overall Study|Withdrawal by Subject|1
5577930|NCT01058863|19273629|P1|Overall Study|Lost to Follow-up|1
5577931|NCT01058707|19273654|P7|Overall Study|Reason Not Specified|7
5577932|NCT01058707|19273655|P6|Overall Study|Reason Not Specified|1
5577933|NCT01058707|19273656|P5|Overall Study|Reason Not Specified|7
5577934|NCT01058707|19273657|P4|Overall Study|Reason Not Specified|0
5577935|NCT01058707|19273658|P3|Overall Study|Reason Not Specified|2
5577936|NCT01058707|19273659|P2|Overall Study|Reason Not Specified|3
5577937|NCT01058707|19273660|P1|Overall Study|Reason Not Specified|0
5577938|NCT01058707|19273654|P7|Overall Study|Lost to Follow-up|0
5577939|NCT01058707|19273655|P6|Overall Study|Lost to Follow-up|0
5577940|NCT01058707|19273656|P5|Overall Study|Lost to Follow-up|0
5577941|NCT01058707|19273657|P4|Overall Study|Lost to Follow-up|0
5577942|NCT01058707|19273658|P3|Overall Study|Lost to Follow-up|1
5577943|NCT01058707|19273659|P2|Overall Study|Lost to Follow-up|0
5577944|NCT01058707|19273660|P1|Overall Study|Lost to Follow-up|0
5577945|NCT01058707|19273654|P7|Overall Study|Subject Decision|6
5577946|NCT01058707|19273655|P6|Overall Study|Subject Decision|3
5577947|NCT01058707|19273656|P5|Overall Study|Subject Decision|2
5577948|NCT01058707|19273657|P4|Overall Study|Subject Decision|1
5577949|NCT01058707|19273658|P3|Overall Study|Subject Decision|3
5577950|NCT01058707|19273659|P2|Overall Study|Subject Decision|3
5577951|NCT01058707|19273660|P1|Overall Study|Subject Decision|5
5577952|NCT01058707|19273654|P7|Overall Study|Adverse Event|1
5577953|NCT01058707|19273655|P6|Overall Study|Adverse Event|3
5577954|NCT01058707|19273656|P5|Overall Study|Adverse Event|7
5577955|NCT01058707|19273657|P4|Overall Study|Adverse Event|6
5577956|NCT01058707|19273658|P3|Overall Study|Adverse Event|7
5577957|NCT01058707|19273659|P2|Overall Study|Adverse Event|4
5577958|NCT01058707|19273660|P1|Overall Study|Adverse Event|11
5577959|NCT01058707|19273654|P7|Overall Study|Disease Progression|12
5577960|NCT01058707|19273655|P6|Overall Study|Disease Progression|10
5577961|NCT01058707|19273656|P5|Overall Study|Disease Progression|23
5577962|NCT01058707|19273657|P4|Overall Study|Disease Progression|15
5577963|NCT01058707|19273658|P3|Overall Study|Disease Progression|20
5577964|NCT01058707|19273659|P2|Overall Study|Disease Progression|20
5577965|NCT01058707|19273660|P1|Overall Study|Disease Progression|15
5577966|NCT01058668|19273826|P3|Double-blind Treatment Phase|Other Unspecified|0
5577967|NCT01058668|19273827|P2|Double-blind Treatment Phase|Other Unspecified|1
5577968|NCT01058668|19273828|P1|Double-blind Treatment Phase|Other Unspecified|1
5577969|NCT01058668|19273826|P3|Double-blind Treatment Phase|Lost to Follow-up|1
5577970|NCT01058668|19273827|P2|Double-blind Treatment Phase|Lost to Follow-up|1
5577971|NCT01058668|19273828|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5577972|NCT01058668|19273826|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
5577973|NCT01058668|19273827|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
5577974|NCT01058668|19273828|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
5577975|NCT01058668|19273826|P3|Double-blind Treatment Phase|Protocol Violation|2
5577976|NCT01058668|19273827|P2|Double-blind Treatment Phase|Protocol Violation|1
5577977|NCT01058668|19273828|P1|Double-blind Treatment Phase|Protocol Violation|1
5577978|NCT01058668|19273826|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
5577979|NCT01058668|19273827|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
5577980|NCT01058668|19273828|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
5577981|NCT01058668|19273826|P3|Double-blind Treatment Phase|Adverse Event|25
5577982|NCT01058668|19273827|P2|Double-blind Treatment Phase|Adverse Event|15
5577983|NCT01058668|19273828|P1|Double-blind Treatment Phase|Adverse Event|8
5577984|NCT01058655|19273843|P4|Overall Study|Other|4
5577985|NCT01058655|19273844|P3|Overall Study|Other|0
5577986|NCT01058655|19273845|P2|Overall Study|Other|0
5577987|NCT01058655|19273846|P1|Overall Study|Other|0
5577988|NCT01058655|19273843|P4|Overall Study|Disease Progression|24
5577989|NCT01058655|19273844|P3|Overall Study|Disease Progression|4
5577990|NCT01058655|19273845|P2|Overall Study|Disease Progression|2
5577991|NCT01058655|19273846|P1|Overall Study|Disease Progression|1
5577992|NCT01058655|19273843|P4|Overall Study|Death|0
5577993|NCT01058655|19273844|P3|Overall Study|Death|1
5577994|NCT01058655|19273845|P2|Overall Study|Death|1
5577995|NCT01058655|19273846|P1|Overall Study|Death|0
5577996|NCT01058655|19273843|P4|Overall Study|Clinical Progression (non-RECIST)|7
5577997|NCT01058655|19273844|P3|Overall Study|Clinical Progression (non-RECIST)|0
5577998|NCT01058655|19273845|P2|Overall Study|Clinical Progression (non-RECIST)|0
5577999|NCT01058655|19273846|P1|Overall Study|Clinical Progression (non-RECIST)|1
5578000|NCT01058655|19273843|P4|Overall Study|Symptomatic Deterioration|1
5578001|NCT01058655|19273844|P3|Overall Study|Symptomatic Deterioration|0
5578002|NCT01058655|19273845|P2|Overall Study|Symptomatic Deterioration|0
5578003|NCT01058655|19273846|P1|Overall Study|Symptomatic Deterioration|0
5578004|NCT01058655|19273843|P4|Overall Study|Prolonged Treatment Delay|2
5578005|NCT01058655|19273844|P3|Overall Study|Prolonged Treatment Delay|0
5578006|NCT01058655|19273845|P2|Overall Study|Prolonged Treatment Delay|0
5578007|NCT01058655|19273846|P1|Overall Study|Prolonged Treatment Delay|0
5578008|NCT01058655|19273843|P4|Overall Study|Withdrawal by Subject|4
5578009|NCT01058655|19273844|P3|Overall Study|Withdrawal by Subject|3
5578010|NCT01058655|19273845|P2|Overall Study|Withdrawal by Subject|0
5578011|NCT01058655|19273846|P1|Overall Study|Withdrawal by Subject|1
5578012|NCT01058642|19273864|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
5578013|NCT01058642|19273865|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
5578014|NCT01058642|19273866|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
5578015|NCT01058642|19273867|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
5578016|NCT01058642|19273864|P4|Treatment Period 1|Protocol Violation|1
5578017|NCT01058642|19273865|P3|Treatment Period 1|Protocol Violation|0
5578018|NCT01058642|19273866|P2|Treatment Period 1|Protocol Violation|0
5578019|NCT01058642|19273867|P1|Treatment Period 1|Protocol Violation|0
5578020|NCT01058642|19273864|P4|Treatment Period 1|Lack of Efficacy|1
5578021|NCT01058642|19273865|P3|Treatment Period 1|Lack of Efficacy|0
5578022|NCT01058642|19273866|P2|Treatment Period 1|Lack of Efficacy|0
5578023|NCT01058642|19273867|P1|Treatment Period 1|Lack of Efficacy|0
5578024|NCT01058642|19273864|P4|Treatment Period 1|Withdrawal by Subject|0
5578025|NCT01058642|19273865|P3|Treatment Period 1|Withdrawal by Subject|0
5578026|NCT01058642|19273866|P2|Treatment Period 1|Withdrawal by Subject|0
5578027|NCT01058642|19273867|P1|Treatment Period 1|Withdrawal by Subject|1
5578028|NCT01058642|19273864|P4|Treatment Period 1|Physician Decision|0
5578029|NCT01058642|19273865|P3|Treatment Period 1|Physician Decision|1
5578030|NCT01058642|19273866|P2|Treatment Period 1|Physician Decision|0
5578031|NCT01058642|19273867|P1|Treatment Period 1|Physician Decision|0
5578032|NCT01058642|19273864|P4|Treatment Period 1|Adverse Event|0
5578033|NCT01058642|19273865|P3|Treatment Period 1|Adverse Event|1
5578034|NCT01058642|19273866|P2|Treatment Period 1|Adverse Event|1
5578035|NCT01058642|19273867|P1|Treatment Period 1|Adverse Event|0
5578036|NCT01058421|19273877|P2|6 Month Outcomes|Remained in Other Facility|3
5578037|NCT01058421|19273878|P1|6 Month Outcomes|Remained in Other Facility|1
5578038|NCT01058421|19273877|P2|6 Month Outcomes|Lost to Follow-up|21
5578039|NCT01058421|19273878|P1|6 Month Outcomes|Lost to Follow-up|16
5578040|NCT01058421|19273877|P2|6 Month Outcomes|Death|2
5578041|NCT01058421|19273878|P1|6 Month Outcomes|Death|2
5578042|NCT01058421|19273877|P2|3 Month Outcomes|Remained in Other Facility|8
5578043|NCT01058421|19273878|P1|3 Month Outcomes|Remained in Other Facility|5
5578044|NCT01058421|19273877|P2|3 Month Outcomes|Remained in Hospital|2
5578045|NCT01058421|19273878|P1|3 Month Outcomes|Remained in Hospital|0
5578046|NCT01058421|19273877|P2|3 Month Outcomes|Lost to Follow-up|11
5578047|NCT01058421|19273878|P1|3 Month Outcomes|Lost to Follow-up|12
5578048|NCT01058421|19273877|P2|3 Month Outcomes|Death|5
5578049|NCT01058421|19273878|P1|3 Month Outcomes|Death|3
5578050|NCT01058421|19273877|P2|1 Month Outcomes|Remained in Other Facility|17
5578051|NCT01058421|19273878|P1|1 Month Outcomes|Remained in Other Facility|16
5578052|NCT01058421|19273877|P2|1 Month Outcomes|Remained in Hospital|12
5578053|NCT01058421|19273878|P1|1 Month Outcomes|Remained in Hospital|5
5578054|NCT01058421|19273877|P2|1 Month Outcomes|Lost to Follow-up|7
5578055|NCT01058421|19273878|P1|1 Month Outcomes|Lost to Follow-up|8
5578056|NCT01058421|19273877|P2|1 Month Outcomes|Death|6
5578057|NCT01058421|19273878|P1|1 Month Outcomes|Death|10
5578058|NCT01058395|19273902|P2|Overall Study|Lost to Follow-up|0
5578059|NCT01058395|19273903|P1|Overall Study|Lost to Follow-up|1
5578060|NCT01058395|19273902|P2|Overall Study|Death|1
5578061|NCT01058395|19273903|P1|Overall Study|Death|2
5578062|NCT01058369|19273912|P1|Overall Study|Early termination study|1
5578063|NCT01058369|19273912|P1|Overall Study|Adverse Event|1
5578064|NCT01058356|19273916|P1|Overall Study|Lost to Follow-up|4
5578065|NCT01058356|19273916|P1|Overall Study|Withdrawal by Subject|21
5578066|NCT01058356|19273916|P1|Overall Study|Administration of contraindicated drugs|12
5578067|NCT01058356|19273916|P1|Overall Study|Adverse Event|5
5578068|NCT01058304|19273923|P2|Overall Study|Developed exclusion criterion|12
5578069|NCT01058304|19273924|P1|Overall Study|Developed exclusion criterion|6
5578070|NCT01058304|19273923|P2|Overall Study|Lost to Follow-up|16
5578071|NCT01058304|19273924|P1|Overall Study|Lost to Follow-up|13
5578072|NCT01058304|19273923|P2|Overall Study|Withdrawal by Subject|5
5578073|NCT01058304|19273924|P1|Overall Study|Withdrawal by Subject|8
5578074|NCT01058265|19273934|P2|Overall Study|Lost to Follow-up|12
5578075|NCT01058265|19273935|P1|Overall Study|Lost to Follow-up|11
5578076|NCT01058096|19273954|P2|Double-blind Treatment Phase|Other Unspecified|0
5578077|NCT01058096|19273955|P1|Double-blind Treatment Phase|Other Unspecified|2
5578078|NCT01058096|19273954|P2|Double-blind Treatment Phase|Lost to Follow-up|1
5578079|NCT01058096|19273955|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5578080|NCT01058096|19273954|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
5578081|NCT01058096|19273955|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
5578082|NCT01058096|19273954|P2|Double-blind Treatment Phase|Protocol Violation|1
5578083|NCT01058096|19273955|P1|Double-blind Treatment Phase|Protocol Violation|2
5578084|NCT01058096|19273954|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
5578085|NCT01058096|19273955|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
5578086|NCT01058096|19273954|P2|Double-blind Treatment Phase|Adverse Event|15
5578087|NCT01058096|19273955|P1|Double-blind Treatment Phase|Adverse Event|11
5578088|NCT01058005|19273971|P3|Overall Study|Reason Missing|1
5578089|NCT01058005|19273972|P2|Overall Study|Reason Missing|3
5578090|NCT01058005|19273973|P1|Overall Study|Reason Missing|5
5578091|NCT01058005|19273971|P3|Overall Study|Withdrawn Due to Study Termination|7
5578092|NCT01058005|19273972|P2|Overall Study|Withdrawn Due to Study Termination|13
5578093|NCT01058005|19273973|P1|Overall Study|Withdrawn Due to Study Termination|27
5578094|NCT01058005|19273971|P3|Overall Study|Withdrawal by Subject|11
5578095|NCT01058005|19273972|P2|Overall Study|Withdrawal by Subject|5
5578096|NCT01058005|19273973|P1|Overall Study|Withdrawal by Subject|4
5578097|NCT01058005|19273971|P3|Overall Study|Physician Decision|0
5578098|NCT01058005|19273972|P2|Overall Study|Physician Decision|2
5578099|NCT01058005|19273973|P1|Overall Study|Physician Decision|2
5578100|NCT01058005|19273971|P3|Overall Study|Adverse Event|1
5578101|NCT01058005|19273972|P2|Overall Study|Adverse Event|2
5578102|NCT01058005|19273973|P1|Overall Study|Adverse Event|0
5578103|NCT01057862|19274008|P2|Overall Study|Withdrawal by Subject|2
5578104|NCT01057862|19274009|P1|Overall Study|Withdrawal by Subject|1
5578105|NCT01057810|19274019|P2|Overall Study|Other|14
5578106|NCT01057810|19274020|P1|Overall Study|Other|7
5578107|NCT01057810|19274019|P2|Overall Study|No longer met study criteria|1
5578108|NCT01057810|19274020|P1|Overall Study|No longer met study criteria|0
5578109|NCT01057810|19274019|P2|Overall Study|Poor/non-compliance|1
5578110|NCT01057810|19274020|P1|Overall Study|Poor/non-compliance|0
5578111|NCT01057810|19274019|P2|Overall Study|Maximum clinical benefit|5
5578112|NCT01057810|19274020|P1|Overall Study|Maximum clinical benefit|5
5578113|NCT01057810|19274019|P2|Overall Study|Death|12
5578114|NCT01057810|19274020|P1|Overall Study|Death|2
5578115|NCT01057810|19274019|P2|Overall Study|Withdrawal by Subject|25
5578116|NCT01057810|19274020|P1|Overall Study|Withdrawal by Subject|10
5578117|NCT01057810|19274019|P2|Overall Study|Adverse event unrelated to study drug|29
5578118|NCT01057810|19274020|P1|Overall Study|Adverse event unrelated to study drug|13
5578119|NCT01057810|19274019|P2|Overall Study|Study drug toxicity|114
5578120|NCT01057810|19274020|P1|Overall Study|Study drug toxicity|5
5578121|NCT01057810|19274019|P2|Overall Study|Disease progression|197
5578122|NCT01057810|19274020|P1|Overall Study|Disease progression|156
5578123|NCT01057693|19274036|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
5578124|NCT01057693|19274037|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
5578125|NCT01057693|19274038|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
5578126|NCT01057693|19274036|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
5578127|NCT01057693|19274037|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
5578128|NCT01057693|19274038|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
5578129|NCT01057693|19274036|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
5578130|NCT01057693|19274037|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
5578131|NCT01057693|19274038|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
5578132|NCT01057693|19274036|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
5578133|NCT01057693|19274037|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
5578134|NCT01057693|19274038|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
5578135|NCT01057693|19274036|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
5578136|NCT01057693|19274037|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
5578137|NCT01057693|19274038|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
5578138|NCT01057693|19274036|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
5578139|NCT01057693|19274037|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
5578140|NCT01057693|19274038|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
5578141|NCT01057693|19274036|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
5578142|NCT01057693|19274037|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
5578143|NCT01057693|19274038|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
5578144|NCT01057693|19274036|P3|Between Single-Blind and Double-Blind|Other|0
5578145|NCT01057693|19274037|P2|Between Single-Blind and Double-Blind|Other|0
5578146|NCT01057693|19274038|P1|Between Single-Blind and Double-Blind|Other|6
5578147|NCT01057693|19274036|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
5578148|NCT01057693|19274037|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
5578149|NCT01057693|19274038|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
5578150|NCT01057693|19274036|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
5578151|NCT01057693|19274037|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
5578152|NCT01057693|19274038|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
5578153|NCT01057693|19274036|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
5578154|NCT01057693|19274037|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
5578155|NCT01057693|19274038|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
5578156|NCT01057693|19274036|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
5578157|NCT01057693|19274037|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
5578158|NCT01057693|19274038|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
5578159|NCT01057693|19274036|P3|Between Single-Blind and Double-Blind|Adverse Event|0
5578160|NCT01057693|19274037|P2|Between Single-Blind and Double-Blind|Adverse Event|0
5578161|NCT01057693|19274038|P1|Between Single-Blind and Double-Blind|Adverse Event|5
5578162|NCT01057693|19274036|P3|Single-Blind Phase (Up to Week 6)|Other|0
5578163|NCT01057693|19274037|P2|Single-Blind Phase (Up to Week 6)|Other|0
5578164|NCT01057693|19274038|P1|Single-Blind Phase (Up to Week 6)|Other|2
5578165|NCT01057693|19274036|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
5578166|NCT01057693|19274037|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
5578167|NCT01057693|19274038|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
5578168|NCT01057693|19274036|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
5578169|NCT01057693|19274037|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
5578170|NCT01057693|19274038|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
5578171|NCT01057693|19274036|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
5578172|NCT01057693|19274037|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
5578173|NCT01057693|19274038|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
5578174|NCT01057693|19274036|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
5578175|NCT01057693|19274037|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
5578176|NCT01057693|19274038|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
5578177|NCT01057693|19274036|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
5578178|NCT01057693|19274037|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
5578179|NCT01057693|19274038|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
5578180|NCT01057589|19274084|P1|Overall Study|Lost to Follow-up|1
5578181|NCT01057589|19274084|P1|Overall Study|Death|8
5578182|NCT01057589|19274084|P1|Overall Study|Sponsor Decision|1
5578183|NCT01057589|19274084|P1|Overall Study|Withdrawal by Subject|3
5578184|NCT01057589|19274084|P1|Overall Study|Physician Decision|8
5578185|NCT01057589|19274084|P1|Overall Study|Adverse Event|10
5578186|NCT01057589|19274084|P1|Overall Study|Disease Progression|35
5578187|NCT01057433|19274093|P1|Overall Study|Adverse Event|1
5578188|NCT01057394|19274097|P2|Overall Study|Not eligible|2
5578189|NCT01057394|19274098|P1|Overall Study|Not eligible|0
5578190|NCT01057251|19274108|P2|Overall Study|Other Reason|1
5578191|NCT01057251|19274109|P1|Overall Study|Other Reason|1
5578192|NCT01057251|19274108|P2|Overall Study|Lost to Follow-up|6
5578193|NCT01057251|19274109|P1|Overall Study|Lost to Follow-up|7
5578194|NCT01057251|19274108|P2|Overall Study|Withdrawal by Subject|5
5578195|NCT01057251|19274109|P1|Overall Study|Withdrawal by Subject|4
5578196|NCT01057251|19274108|P2|Overall Study|Protocol Violation|2
5578197|NCT01057251|19274109|P1|Overall Study|Protocol Violation|6
5578198|NCT01057251|19274108|P2|Overall Study|Lack of Efficacy|11
5578199|NCT01057251|19274109|P1|Overall Study|Lack of Efficacy|2
5578200|NCT01057251|19274108|P2|Overall Study|Adverse Event|2
5578201|NCT01057251|19274109|P1|Overall Study|Adverse Event|4
5578202|NCT01057251|19274108|P2|Overall Study|Did not meet InclusionExclusion criteria|2
5578203|NCT01057251|19274109|P1|Overall Study|Did not meet InclusionExclusion criteria|4
5578204|NCT01056822|19274187|P2|Overall Study|Lost to Follow-up|0
5578205|NCT01056822|19274188|P1|Overall Study|Lost to Follow-up|1
5578206|NCT01056822|19274187|P2|Overall Study|Withdrawal by Subject|1
5578207|NCT01056822|19274188|P1|Overall Study|Withdrawal by Subject|1
5578208|NCT01056822|19274187|P2|Overall Study|Protocol Violation|5
5578209|NCT01056822|19274188|P1|Overall Study|Protocol Violation|6
5578210|NCT01056822|19274187|P2|Overall Study|Adverse Event|1
5578211|NCT01056822|19274188|P1|Overall Study|Adverse Event|0
5578212|NCT01056718|19274237|P1|Overall Study|Ischemia on baseline stress test|1
5578213|NCT01056718|19274237|P1|Overall Study|Withdrawal by Subject|2
5578214|NCT01056653|19274270|P3|Overall Study|Lost to Follow-up|2
5578215|NCT01056653|19274271|P2|Overall Study|Lost to Follow-up|0
5578216|NCT01056653|19274272|P1|Overall Study|Lost to Follow-up|0
5578217|NCT01056640|19274288|P2|Overall Study|Death|4
5578218|NCT01056640|19274289|P1|Overall Study|Death|15
5578219|NCT01056640|19274288|P2|Overall Study|Withdrawal by Subject|8
5578220|NCT01056640|19274289|P1|Overall Study|Withdrawal by Subject|11
5578221|NCT01056536|19274304|P3|Overall Study|Lost to Follow-up|248
5578222|NCT01056536|19274305|P2|Overall Study|Lost to Follow-up|116
5578223|NCT01056536|19274306|P1|Overall Study|Lost to Follow-up|202
5578224|NCT01056523|19274317|P7|Overall Study|Death|1
5578225|NCT01056523|19274318|P6|Overall Study|Death|0
5578226|NCT01056523|19274319|P5|Overall Study|Death|0
5578227|NCT01056523|19274320|P4|Overall Study|Death|3
5578228|NCT01056523|19274321|P3|Overall Study|Death|2
5578229|NCT01056523|19274322|P2|Overall Study|Death|0
5578230|NCT01056523|19274323|P1|Overall Study|Death|1
5578231|NCT01056510|19274333|P2|Overall Study|Missing|1
5578232|NCT01056510|19274334|P1|Overall Study|Missing|0
5578233|NCT01056510|19274333|P2|Overall Study|Other|12
5578234|NCT01056510|19274334|P1|Overall Study|Other|10
5578235|NCT01056510|19274333|P2|Overall Study|Lost to Follow-up|6
5578236|NCT01056510|19274334|P1|Overall Study|Lost to Follow-up|5
5578237|NCT01056510|19274333|P2|Overall Study|Physician Decision|5
5578238|NCT01056510|19274334|P1|Overall Study|Physician Decision|4
5578239|NCT01056510|19274333|P2|Overall Study|Noncompliance|3
5578240|NCT01056510|19274334|P1|Overall Study|Noncompliance|1
5578241|NCT01056510|19274333|P2|Overall Study|Death|34
5578242|NCT01056510|19274334|P1|Overall Study|Death|29
5578243|NCT01056510|19274333|P2|Overall Study|Withdrawal by Subject|2
5578244|NCT01056510|19274334|P1|Overall Study|Withdrawal by Subject|4
5578245|NCT01056510|19274333|P2|Overall Study|Dropout Before Start of Treatment|1
5578246|NCT01056510|19274334|P1|Overall Study|Dropout Before Start of Treatment|1
5578247|NCT01056484|19274380|P2|Follow up - Non-randomized|Withdrawal by Subject|2
5578248|NCT01056484|19274381|P1|Follow up - Non-randomized|Withdrawal by Subject|0
5578249|NCT01056484|19274380|P2|Randomized Controlled Trial|Physician Decision|0
5578250|NCT01056484|19274381|P1|Randomized Controlled Trial|Physician Decision|1
5578251|NCT01056484|19274380|P2|Randomized Controlled Trial|Withdrawal by Subject|1
5578252|NCT01056484|19274381|P1|Randomized Controlled Trial|Withdrawal by Subject|6
5578253|NCT01056380|19274397|P2|Overall Study|Lost to Follow-up|3
5578254|NCT01056380|19274398|P1|Overall Study|Lost to Follow-up|2
5578255|NCT01056341|19274425|P5|Overall Study|Other reasons|5
5578256|NCT01056341|19274426|P4|Overall Study|Other reasons|9
5578257|NCT01056341|19274427|P3|Overall Study|Other reasons|8
5578258|NCT01056341|19274428|P2|Overall Study|Other reasons|4
5578259|NCT01056341|19274429|P1|Overall Study|Other reasons|4
5578260|NCT01056341|19274425|P5|Overall Study|Lack of Efficacy|9
5578261|NCT01056341|19274426|P4|Overall Study|Lack of Efficacy|25
5578262|NCT01056341|19274427|P3|Overall Study|Lack of Efficacy|7
5578263|NCT01056341|19274428|P2|Overall Study|Lack of Efficacy|30
5578264|NCT01056341|19274429|P1|Overall Study|Lack of Efficacy|32
5578265|NCT01056341|19274425|P5|Overall Study|Treatment Intolerance|0
5578266|NCT01056341|19274426|P4|Overall Study|Treatment Intolerance|2
5578267|NCT01056341|19274427|P3|Overall Study|Treatment Intolerance|0
5578268|NCT01056341|19274428|P2|Overall Study|Treatment Intolerance|2
5578269|NCT01056341|19274429|P1|Overall Study|Treatment Intolerance|0
5578270|NCT01056289|19274508|P4|Double-blind Phase|Physician Decision|0
5578271|NCT01056289|19274509|P3|Double-blind Phase|Physician Decision|1
5578272|NCT01056289|19274510|P2|Double-blind Phase|Physician Decision|0
5578273|NCT01056289|19274511|P1|Double-blind Phase|Physician Decision|0
5578274|NCT01056289|19274508|P4|Double-blind Phase|Discontinuation symptom|2
5578275|NCT01056289|19274509|P3|Double-blind Phase|Discontinuation symptom|2
5578276|NCT01056289|19274510|P2|Double-blind Phase|Discontinuation symptom|1
5578277|NCT01056289|19274511|P1|Double-blind Phase|Discontinuation symptom|0
5578278|NCT01056289|19274508|P4|Double-blind Phase|Withdrawal by Subject|2
5578279|NCT01056289|19274509|P3|Double-blind Phase|Withdrawal by Subject|4
5578280|NCT01056289|19274510|P2|Double-blind Phase|Withdrawal by Subject|0
5578281|NCT01056289|19274511|P1|Double-blind Phase|Withdrawal by Subject|0
5578282|NCT01056289|19274508|P4|Double-blind Phase|Protocol Violation|1
5578283|NCT01056289|19274509|P3|Double-blind Phase|Protocol Violation|1
5578284|NCT01056289|19274510|P2|Double-blind Phase|Protocol Violation|0
5578285|NCT01056289|19274511|P1|Double-blind Phase|Protocol Violation|0
5578286|NCT01056289|19274508|P4|Double-blind Phase|Other|2
5578287|NCT01056289|19274509|P3|Double-blind Phase|Other|1
5578288|NCT01056289|19274510|P2|Double-blind Phase|Other|0
5578289|NCT01056289|19274511|P1|Double-blind Phase|Other|0
5578290|NCT01056289|19274508|P4|Double-blind Phase|Lost to Follow-up|2
5578291|NCT01056289|19274509|P3|Double-blind Phase|Lost to Follow-up|2
5578292|NCT01056289|19274510|P2|Double-blind Phase|Lost to Follow-up|2
5578293|NCT01056289|19274511|P1|Double-blind Phase|Lost to Follow-up|0
5578294|NCT01056289|19274508|P4|Double-blind Phase|Adverse Event|1
5578295|NCT01056289|19274509|P3|Double-blind Phase|Adverse Event|2
5578296|NCT01056289|19274510|P2|Double-blind Phase|Adverse Event|1
5578297|NCT01056289|19274511|P1|Double-blind Phase|Adverse Event|0
5578298|NCT01056289|19274508|P4|Open-label Phase|Not randomized to Double-blind phase|0
5578299|NCT01056289|19274509|P3|Open-label Phase|Not randomized to Double-blind phase|0
5578300|NCT01056289|19274510|P2|Open-label Phase|Not randomized to Double-blind phase|0
5578301|NCT01056289|19274511|P1|Open-label Phase|Not randomized to Double-blind phase|1
5578302|NCT01056289|19274508|P4|Open-label Phase|Lack of Efficacy|0
5578303|NCT01056289|19274509|P3|Open-label Phase|Lack of Efficacy|0
5578304|NCT01056289|19274510|P2|Open-label Phase|Lack of Efficacy|0
5578305|NCT01056289|19274511|P1|Open-label Phase|Lack of Efficacy|18
5578306|NCT01056289|19274508|P4|Open-label Phase|Withdrawal by Subject|0
5578307|NCT01056289|19274509|P3|Open-label Phase|Withdrawal by Subject|0
5578308|NCT01056289|19274510|P2|Open-label Phase|Withdrawal by Subject|0
5578309|NCT01056289|19274511|P1|Open-label Phase|Withdrawal by Subject|26
5578310|NCT01056289|19274508|P4|Open-label Phase|Protocol Violation|0
5578311|NCT01056289|19274509|P3|Open-label Phase|Protocol Violation|0
5578312|NCT01056289|19274510|P2|Open-label Phase|Protocol Violation|0
5578313|NCT01056289|19274511|P1|Open-label Phase|Protocol Violation|6
5578314|NCT01056289|19274508|P4|Open-label Phase|Other|0
5578315|NCT01056289|19274509|P3|Open-label Phase|Other|0
5578316|NCT01056289|19274510|P2|Open-label Phase|Other|0
5578317|NCT01056289|19274511|P1|Open-label Phase|Other|9
5578318|NCT01056289|19274508|P4|Open-label Phase|Lost to Follow-up|0
5578319|NCT01056289|19274509|P3|Open-label Phase|Lost to Follow-up|0
5578320|NCT01056289|19274510|P2|Open-label Phase|Lost to Follow-up|0
5578321|NCT01056289|19274511|P1|Open-label Phase|Lost to Follow-up|30
5578322|NCT01056289|19274508|P4|Open-label Phase|Adverse Event|0
5578323|NCT01056289|19274509|P3|Open-label Phase|Adverse Event|0
5578324|NCT01056289|19274510|P2|Open-label Phase|Adverse Event|0
5578325|NCT01056289|19274511|P1|Open-label Phase|Adverse Event|29
5578326|NCT01056276|19274528|P2|Maintenance Therapy|Continuing maintenance therapy|14
5578327|NCT01056276|19274529|P1|Maintenance Therapy|Continuing maintenance therapy|0
5578328|NCT01056276|19274528|P2|Maintenance Therapy|Intercurrent Illness|1
5578329|NCT01056276|19274529|P1|Maintenance Therapy|Intercurrent Illness|0
5578330|NCT01056276|19274528|P2|Maintenance Therapy|Withdrawal by Subject|1
5578331|NCT01056276|19274529|P1|Maintenance Therapy|Withdrawal by Subject|0
5578332|NCT01056276|19274528|P2|Maintenance Therapy|Physician Decision|1
5578333|NCT01056276|19274529|P1|Maintenance Therapy|Physician Decision|0
5578334|NCT01056276|19274528|P2|Maintenance Therapy|Progressive Disease|9
5578335|NCT01056276|19274529|P1|Maintenance Therapy|Progressive Disease|0
5578336|NCT01056276|19274528|P2|Maintenance Therapy|Toxicity|2
5578337|NCT01056276|19274529|P1|Maintenance Therapy|Toxicity|0
5578338|NCT01056276|19274528|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
5578339|NCT01056276|19274529|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
5578340|NCT01056276|19274528|P2|Treatment Period-Cycles 1-8|Death|1
5578341|NCT01056276|19274529|P1|Treatment Period-Cycles 1-8|Death|3
5578342|NCT01056276|19274528|P2|Treatment Period-Cycles 1-8|Physician Decision|0
5578343|NCT01056276|19274529|P1|Treatment Period-Cycles 1-8|Physician Decision|3
5578344|NCT01056276|19274528|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
5578345|NCT01056276|19274529|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
5578346|NCT01056276|19274528|P2|Treatment Period-Cycles 1-8|Disease Progression|2
5578347|NCT01056276|19274529|P1|Treatment Period-Cycles 1-8|Disease Progression|2
5578348|NCT01056276|19274528|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
5578349|NCT01056276|19274529|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
5578350|NCT01056276|19274528|P2|Treatment Period-Cycles 1-8|Toxicity|1
5578351|NCT01056276|19274529|P1|Treatment Period-Cycles 1-8|Toxicity|2
5578352|NCT01056263|19274543|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
5578353|NCT01056263|19274543|P1|Overall Study|Objective progression or relapse|1
5578354|NCT01056263|19274543|P1|Overall Study|Neoplasm progression|1
5578355|NCT01056263|19274543|P1|Overall Study|Progressive disease|2
5578356|NCT01056263|19274543|P1|Overall Study|Lack of Efficacy|29
5578357|NCT01056263|19274543|P1|Overall Study|Withdrawal by Subject|1
5578358|NCT01056263|19274543|P1|Overall Study|Death|1
5578359|NCT01056263|19274543|P1|Overall Study|Adverse Event|12
5578360|NCT01056107|19274566|P4|Overall Study|Withdrawal by Subject|0
5578361|NCT01056107|19274567|P3|Overall Study|Withdrawal by Subject|3
5578362|NCT01056107|19274568|P2|Overall Study|Withdrawal by Subject|1
5578363|NCT01056107|19274569|P1|Overall Study|Withdrawal by Subject|0
5578364|NCT01055886|19274626|P2|Overall Study|Withdrawal by PI|1
5578365|NCT01055886|19274627|P1|Overall Study|Withdrawal by PI|0
5578366|NCT01055886|19274626|P2|Overall Study|Lost to Follow-up|1
5578367|NCT01055886|19274627|P1|Overall Study|Lost to Follow-up|1
5578368|NCT01055886|19274626|P2|Overall Study|Withdrawal by Subject|9
5578369|NCT01055886|19274627|P1|Overall Study|Withdrawal by Subject|4
5578370|NCT01055834|19274639|P2|Treatment Period I|Adverse Event|0
5578371|NCT01055834|19274640|P1|Treatment Period I|Adverse Event|1
5578372|NCT01055639|19274725|P2|Overall Study|Withdrawal by Subject|11
5578373|NCT01055639|19274726|P1|Overall Study|Withdrawal by Subject|8
5578374|NCT01055639|19274725|P2|Overall Study|Protocol Violation|5
5578375|NCT01055639|19274726|P1|Overall Study|Protocol Violation|5
5578376|NCT01055639|19274725|P2|Overall Study|Lost to Follow-up|11
5578377|NCT01055639|19274726|P1|Overall Study|Lost to Follow-up|8
5578378|NCT01055639|19274725|P2|Overall Study|Lack of Efficacy|1
5578379|NCT01055639|19274726|P1|Overall Study|Lack of Efficacy|0
5578380|NCT01055639|19274725|P2|Overall Study|Adverse Event|1
5578381|NCT01055639|19274726|P1|Overall Study|Adverse Event|0
5578382|NCT01055613|19274750|P2|Overall Study|Subject Disinterest|1
5578383|NCT01055613|19274751|P1|Overall Study|Subject Disinterest|1
5578384|NCT01055613|19274750|P2|Overall Study|Protocol Violation|1
5578385|NCT01055613|19274751|P1|Overall Study|Protocol Violation|1
5578386|NCT01055613|19274750|P2|Overall Study|Lost to Follow-up|1
5578387|NCT01055613|19274751|P1|Overall Study|Lost to Follow-up|1
5578388|NCT01055613|19274750|P2|Overall Study|Discomfort|1
5578389|NCT01055613|19274751|P1|Overall Study|Discomfort|2
5578390|NCT01055613|19274750|P2|Overall Study|Unacceptable lens fit|0
5578391|NCT01055613|19274751|P1|Overall Study|Unacceptable lens fit|1
5578392|NCT01055613|19274750|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5578393|NCT01055613|19274751|P1|Overall Study|No Longer Meets Eligibility Criteria|3
5578394|NCT01055496|19274761|P2|Overall Study|Other - Unspecified|1
5578395|NCT01055496|19274762|P1|Overall Study|Other - Unspecified|0
5578396|NCT01055496|19274761|P2|Overall Study|Lost to Follow-up|2
5578397|NCT01055496|19274762|P1|Overall Study|Lost to Follow-up|0
5578398|NCT01055496|19274761|P2|Overall Study|Death|23
5578399|NCT01055496|19274762|P1|Overall Study|Death|13
5578400|NCT01055496|19274761|P2|Overall Study|Withdrawal by Subject|4
5578401|NCT01055496|19274762|P1|Overall Study|Withdrawal by Subject|2
5578402|NCT01055457|19274819|P10|Overall Study|Adverse Event|0
5578403|NCT01055457|19274820|P9|Overall Study|Adverse Event|0
5578404|NCT01055457|19274821|P8|Overall Study|Adverse Event|0
5578405|NCT01055457|19274822|P7|Overall Study|Adverse Event|0
5578406|NCT01055457|19274823|P6|Overall Study|Adverse Event|0
5578407|NCT01055457|19274824|P5|Overall Study|Adverse Event|0
5578408|NCT01055457|19274825|P4|Overall Study|Adverse Event|1
5578409|NCT01055457|19274826|P3|Overall Study|Adverse Event|0
5578410|NCT01055457|19274827|P2|Overall Study|Adverse Event|0
5578411|NCT01055457|19274828|P1|Overall Study|Adverse Event|0
5578412|NCT01055457|19274819|P10|Overall Study|Pregnancy|0
5578413|NCT01055457|19274820|P9|Overall Study|Pregnancy|0
5578414|NCT01055457|19274821|P8|Overall Study|Pregnancy|0
5578415|NCT01055457|19274822|P7|Overall Study|Pregnancy|0
5578416|NCT01055457|19274823|P6|Overall Study|Pregnancy|0
5578417|NCT01055457|19274824|P5|Overall Study|Pregnancy|0
5578418|NCT01055457|19274825|P4|Overall Study|Pregnancy|1
5578419|NCT01055457|19274826|P3|Overall Study|Pregnancy|0
5578420|NCT01055457|19274827|P2|Overall Study|Pregnancy|0
5578421|NCT01055457|19274828|P1|Overall Study|Pregnancy|0
5578422|NCT01055457|19274819|P10|Overall Study|Discomfort|0
5578423|NCT01055457|19274820|P9|Overall Study|Discomfort|0
5578424|NCT01055457|19274821|P8|Overall Study|Discomfort|0
5578425|NCT01055457|19274822|P7|Overall Study|Discomfort|0
5578426|NCT01055457|19274823|P6|Overall Study|Discomfort|0
5578427|NCT01055457|19274824|P5|Overall Study|Discomfort|1
5578428|NCT01055457|19274825|P4|Overall Study|Discomfort|0
5578429|NCT01055457|19274826|P3|Overall Study|Discomfort|0
5578430|NCT01055457|19274827|P2|Overall Study|Discomfort|0
5578431|NCT01055457|19274828|P1|Overall Study|Discomfort|0
5578432|NCT01055457|19274819|P10|Overall Study|Subject Ineligible|0
5578433|NCT01055457|19274820|P9|Overall Study|Subject Ineligible|0
5578434|NCT01055457|19274821|P8|Overall Study|Subject Ineligible|0
5578435|NCT01055457|19274822|P7|Overall Study|Subject Ineligible|0
5578436|NCT01055457|19274823|P6|Overall Study|Subject Ineligible|0
5578437|NCT01055457|19274824|P5|Overall Study|Subject Ineligible|1
5578438|NCT01055457|19274825|P4|Overall Study|Subject Ineligible|0
5578439|NCT01055457|19274826|P3|Overall Study|Subject Ineligible|1
5578440|NCT01055457|19274827|P2|Overall Study|Subject Ineligible|0
5578441|NCT01055457|19274828|P1|Overall Study|Subject Ineligible|1
5578442|NCT01055457|19274819|P10|Overall Study|Subject Disinterest|0
5578443|NCT01055457|19274820|P9|Overall Study|Subject Disinterest|0
5578444|NCT01055457|19274821|P8|Overall Study|Subject Disinterest|1
5578445|NCT01055457|19274822|P7|Overall Study|Subject Disinterest|0
5578446|NCT01055457|19274823|P6|Overall Study|Subject Disinterest|0
5578447|NCT01055457|19274824|P5|Overall Study|Subject Disinterest|0
5578448|NCT01055457|19274825|P4|Overall Study|Subject Disinterest|0
5578449|NCT01055457|19274826|P3|Overall Study|Subject Disinterest|0
5578450|NCT01055457|19274827|P2|Overall Study|Subject Disinterest|0
5578451|NCT01055457|19274828|P1|Overall Study|Subject Disinterest|0
5578452|NCT01055457|19274819|P10|Overall Study|Protocol Violation|1
5578453|NCT01055457|19274820|P9|Overall Study|Protocol Violation|0
5578454|NCT01055457|19274821|P8|Overall Study|Protocol Violation|0
5578455|NCT01055457|19274822|P7|Overall Study|Protocol Violation|1
5578456|NCT01055457|19274823|P6|Overall Study|Protocol Violation|2
5578457|NCT01055457|19274824|P5|Overall Study|Protocol Violation|1
5578458|NCT01055457|19274825|P4|Overall Study|Protocol Violation|1
5578459|NCT01055457|19274826|P3|Overall Study|Protocol Violation|1
5578460|NCT01055457|19274827|P2|Overall Study|Protocol Violation|0
5578461|NCT01055457|19274828|P1|Overall Study|Protocol Violation|0
5578462|NCT01055457|19274819|P10|Overall Study|Lost to Follow-up|0
5578463|NCT01055457|19274820|P9|Overall Study|Lost to Follow-up|0
5578464|NCT01055457|19274821|P8|Overall Study|Lost to Follow-up|0
5578465|NCT01055457|19274822|P7|Overall Study|Lost to Follow-up|0
5578466|NCT01055457|19274823|P6|Overall Study|Lost to Follow-up|1
5578467|NCT01055457|19274824|P5|Overall Study|Lost to Follow-up|0
5578468|NCT01055457|19274825|P4|Overall Study|Lost to Follow-up|0
5578469|NCT01055457|19274826|P3|Overall Study|Lost to Follow-up|0
5578470|NCT01055457|19274827|P2|Overall Study|Lost to Follow-up|1
5578471|NCT01055457|19274828|P1|Overall Study|Lost to Follow-up|0
5578472|NCT01055314|19274862|P2|Overall Study|No treatment|0
5578473|NCT01055314|19274863|P1|Overall Study|No treatment|1
5578474|NCT01055314|19274862|P2|Overall Study|Refusal of further protocol therapy|4
5578475|NCT01055314|19274863|P1|Overall Study|Refusal of further protocol therapy|10
5578476|NCT01055314|19274862|P2|Overall Study|Ineligible|5
5578477|NCT01055314|19274863|P1|Overall Study|Ineligible|3
5578478|NCT01055314|19274862|P2|Overall Study|Withdrawal by Subject|0
5578479|NCT01055314|19274863|P1|Overall Study|Withdrawal by Subject|1
5578480|NCT01055314|19274862|P2|Overall Study|Physician Decision|5
5578481|NCT01055314|19274863|P1|Overall Study|Physician Decision|10
5578482|NCT01055314|19274862|P2|Overall Study|Lack of Efficacy|19
5578483|NCT01055314|19274863|P1|Overall Study|Lack of Efficacy|11
5578484|NCT01055314|19274862|P2|Overall Study|Death|1
5578485|NCT01055314|19274863|P1|Overall Study|Death|2
5578486|NCT01055314|19274862|P2|Overall Study|Adverse Event|4
5578487|NCT01055314|19274863|P1|Overall Study|Adverse Event|7
5578488|NCT01055262|19274875|P1|Overall Study|Uncooperativeness|1
5578489|NCT01055262|19274875|P1|Overall Study|Protocol Violation|3
5578490|NCT01055262|19274875|P1|Overall Study|Adverse Event|5
5578491|NCT01055197|19274916|P2|Overall Study|Withdrawal by Subject|0
5578492|NCT01055197|19274917|P1|Overall Study|Withdrawal by Subject|2
5578493|NCT01055197|19274916|P2|Overall Study|Protocol Violation|2
5578494|NCT01055197|19274917|P1|Overall Study|Protocol Violation|7
5578495|NCT01055132|19274952|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
5578496|NCT01055132|19274953|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
5578497|NCT01055132|19274952|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
5578498|NCT01055132|19274953|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
5578499|NCT01055028|19274978|P2|Inter-treatment Period|Did not start Cycle 4|3
5578500|NCT01055028|19274979|P1|Inter-treatment Period|Did not start Cycle 4|0
5578501|NCT01055028|19274978|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
5578502|NCT01055028|19274979|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
5578503|NCT01055028|19274978|P2|Treatment Cycles 1 to 3|Adverse Event|1
5578504|NCT01055028|19274979|P1|Treatment Cycles 1 to 3|Adverse Event|0
5578505|NCT01055028|19274978|P2|Screening|Screen Failure|1
5578506|NCT01055028|19274979|P1|Screening|Screen Failure|1
5578507|NCT01054976|19274993|P1|Overall Study|Other|8
5578508|NCT01054976|19274993|P1|Overall Study|Withdrawal by Subject|4
5578509|NCT01054976|19274993|P1|Overall Study|Uncooperative participations to study|7
5578510|NCT01054976|19274993|P1|Overall Study|Adverse Event|16
5578511|NCT01054885|19275014|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
5578512|NCT01054885|19275015|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5578513|NCT01054885|19275016|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
5578514|NCT01054885|19275017|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
5578515|NCT01054885|19275018|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5578516|NCT01054885|19275019|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
5578517|NCT01054885|19275020|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5578518|NCT01054885|19275014|P7|24-week, Double-blind Treatment Period|Physician Decision|1
5578519|NCT01054885|19275015|P6|24-week, Double-blind Treatment Period|Physician Decision|1
5578520|NCT01054885|19275016|P5|24-week, Double-blind Treatment Period|Physician Decision|3
5578521|NCT01054885|19275017|P4|24-week, Double-blind Treatment Period|Physician Decision|6
5578522|NCT01054885|19275018|P3|24-week, Double-blind Treatment Period|Physician Decision|1
5578523|NCT01054885|19275019|P2|24-week, Double-blind Treatment Period|Physician Decision|4
5578524|NCT01054885|19275020|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5578525|NCT01054885|19275014|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5578526|NCT01054885|19275015|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5578527|NCT01054885|19275016|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5578528|NCT01054885|19275017|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5578529|NCT01054885|19275018|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5578530|NCT01054885|19275019|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
5578531|NCT01054885|19275020|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5578532|NCT01054885|19275014|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
5578533|NCT01054885|19275015|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5578534|NCT01054885|19275016|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5578535|NCT01054885|19275017|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5578536|NCT01054885|19275018|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
5578537|NCT01054885|19275019|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5578538|NCT01054885|19275020|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
5578539|NCT01054885|19275014|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
5578540|NCT01054885|19275015|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
5578541|NCT01054885|19275016|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
5578542|NCT01054885|19275017|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
5578543|NCT01054885|19275018|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
5578544|NCT01054885|19275019|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
5578545|NCT01054885|19275020|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
5578546|NCT01054885|19275014|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
5578547|NCT01054885|19275015|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
5578548|NCT01054885|19275016|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
5578549|NCT01054885|19275017|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
5578550|NCT01054885|19275018|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
5578551|NCT01054885|19275019|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
5578552|NCT01054885|19275020|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5578553|NCT01054885|19275014|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
5578554|NCT01054885|19275015|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
5578555|NCT01054885|19275016|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
5578556|NCT01054885|19275017|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
5578557|NCT01054885|19275018|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
5578558|NCT01054885|19275019|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
5578559|NCT01054885|19275020|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
5578560|NCT01054885|19275014|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5578561|NCT01054885|19275015|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
5578562|NCT01054885|19275016|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5578563|NCT01054885|19275017|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
5578564|NCT01054885|19275018|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
5578565|NCT01054885|19275019|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5578566|NCT01054885|19275020|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5578567|NCT01054885|19275014|P7|24-week, Double-blind Treatment Period|Adverse Event|19
5578568|NCT01054885|19275015|P6|24-week, Double-blind Treatment Period|Adverse Event|17
5578569|NCT01054885|19275016|P5|24-week, Double-blind Treatment Period|Adverse Event|15
5578570|NCT01054885|19275017|P4|24-week, Double-blind Treatment Period|Adverse Event|15
5578571|NCT01054885|19275018|P3|24-week, Double-blind Treatment Period|Adverse Event|12
5578572|NCT01054885|19275019|P2|24-week, Double-blind Treatment Period|Adverse Event|18
5578573|NCT01054885|19275020|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5578574|NCT01054885|19275014|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578575|NCT01054885|19275015|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578576|NCT01054885|19275016|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578577|NCT01054885|19275017|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578578|NCT01054885|19275018|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578579|NCT01054885|19275019|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578580|NCT01054885|19275020|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
5578581|NCT01054885|19275014|P7|2-week, Single-blind Run-In Period|Adverse Event|0
5578582|NCT01054885|19275015|P6|2-week, Single-blind Run-In Period|Adverse Event|0
5578583|NCT01054885|19275016|P5|2-week, Single-blind Run-In Period|Adverse Event|0
5578584|NCT01054885|19275017|P4|2-week, Single-blind Run-In Period|Adverse Event|0
5578585|NCT01054885|19275018|P3|2-week, Single-blind Run-In Period|Adverse Event|0
5578586|NCT01054885|19275019|P2|2-week, Single-blind Run-In Period|Adverse Event|0
5578587|NCT01054885|19275020|P1|2-week, Single-blind Run-In Period|Adverse Event|7
5578588|NCT01054885|19275014|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578589|NCT01054885|19275015|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578590|NCT01054885|19275016|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578591|NCT01054885|19275017|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578592|NCT01054885|19275018|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578593|NCT01054885|19275019|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578594|NCT01054885|19275020|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
5578595|NCT01054885|19275014|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578596|NCT01054885|19275015|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578597|NCT01054885|19275016|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578598|NCT01054885|19275017|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578599|NCT01054885|19275018|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578600|NCT01054885|19275019|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578601|NCT01054885|19275020|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
5578602|NCT01054885|19275014|P7|2-week, Single-blind Run-In Period|Physician Decision|0
5578603|NCT01054885|19275015|P6|2-week, Single-blind Run-In Period|Physician Decision|0
5578604|NCT01054885|19275016|P5|2-week, Single-blind Run-In Period|Physician Decision|0
5578605|NCT01054885|19275017|P4|2-week, Single-blind Run-In Period|Physician Decision|0
5578606|NCT01054885|19275018|P3|2-week, Single-blind Run-In Period|Physician Decision|0
5578607|NCT01054885|19275019|P2|2-week, Single-blind Run-In Period|Physician Decision|0
5578608|NCT01054885|19275020|P1|2-week, Single-blind Run-In Period|Physician Decision|6
5578609|NCT01054885|19275014|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578610|NCT01054885|19275015|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578611|NCT01054885|19275016|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578612|NCT01054885|19275017|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578613|NCT01054885|19275018|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578614|NCT01054885|19275019|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578615|NCT01054885|19275020|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
5578616|NCT01054846|19275060|P2|Overall Study|Lost to Follow-up|17
5578617|NCT01054846|19275061|P1|Overall Study|Lost to Follow-up|76
5578618|NCT01054820|19275068|P1|Overall Study|Withdrawal by Subject|2
5578619|NCT01054729|19275090|P4|Overall Study|Lack of Efficacy|1
5578620|NCT01054729|19275091|P3|Overall Study|Lack of Efficacy|0
5578621|NCT01054729|19275092|P2|Overall Study|Lack of Efficacy|0
5578622|NCT01054729|19275093|P1|Overall Study|Lack of Efficacy|0
5578623|NCT01054729|19275090|P4|Overall Study|Subject moved|0
5578624|NCT01054729|19275091|P3|Overall Study|Subject moved|1
5578625|NCT01054729|19275092|P2|Overall Study|Subject moved|0
5578626|NCT01054729|19275093|P1|Overall Study|Subject moved|0
5578627|NCT01054729|19275090|P4|Overall Study|Personal/Obligations|0
5578628|NCT01054729|19275091|P3|Overall Study|Personal/Obligations|0
5578629|NCT01054729|19275092|P2|Overall Study|Personal/Obligations|1
5578630|NCT01054729|19275093|P1|Overall Study|Personal/Obligations|0
5578631|NCT01054729|19275090|P4|Overall Study|PEG/RBV Non-responder|0
5578632|NCT01054729|19275091|P3|Overall Study|PEG/RBV Non-responder|1
5578633|NCT01054729|19275092|P2|Overall Study|PEG/RBV Non-responder|0
5578634|NCT01054729|19275093|P1|Overall Study|PEG/RBV Non-responder|1
5578635|NCT01054729|19275090|P4|Overall Study|Non-responder|1
5578636|NCT01054729|19275091|P3|Overall Study|Non-responder|1
5578637|NCT01054729|19275092|P2|Overall Study|Non-responder|0
5578638|NCT01054729|19275093|P1|Overall Study|Non-responder|1
5578639|NCT01054729|19275090|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
5578640|NCT01054729|19275091|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
5578641|NCT01054729|19275092|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
5578642|NCT01054729|19275093|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
5578643|NCT01054729|19275090|P4|Overall Study|Lost to Follow-up|0
5578644|NCT01054729|19275091|P3|Overall Study|Lost to Follow-up|0
5578645|NCT01054729|19275092|P2|Overall Study|Lost to Follow-up|1
5578646|NCT01054729|19275093|P1|Overall Study|Lost to Follow-up|0
5578647|NCT01054729|19275090|P4|Overall Study|Withdrawal by Subject|0
5578648|NCT01054729|19275091|P3|Overall Study|Withdrawal by Subject|1
5578649|NCT01054729|19275092|P2|Overall Study|Withdrawal by Subject|0
5578650|NCT01054729|19275093|P1|Overall Study|Withdrawal by Subject|1
5578651|NCT01054729|19275090|P4|Overall Study|Adverse Event|1
5578652|NCT01054729|19275091|P3|Overall Study|Adverse Event|2
5578653|NCT01054729|19275092|P2|Overall Study|Adverse Event|1
5578654|NCT01054729|19275093|P1|Overall Study|Adverse Event|1
5578655|NCT01054729|19275090|P4|Overall Study|Randomized but Not Treated|0
5578656|NCT01054729|19275091|P3|Overall Study|Randomized but Not Treated|0
5578657|NCT01054729|19275092|P2|Overall Study|Randomized but Not Treated|1
5578658|NCT01054729|19275093|P1|Overall Study|Randomized but Not Treated|0
5578659|NCT01054599|19275191|P2|Overall Study|Withdrawal by Subject|1
5578660|NCT01054599|19275192|P1|Overall Study|Withdrawal by Subject|0
5578661|NCT01054599|19275191|P2|Overall Study|Adverse Event|1
5578662|NCT01054599|19275192|P1|Overall Study|Adverse Event|0
5578663|NCT01054599|19275191|P2|Overall Study|Lost to Follow-up|2
5578664|NCT01054599|19275192|P1|Overall Study|Lost to Follow-up|0
5578665|NCT01054599|19275191|P2|Overall Study|Visual impairment, WTAR <80|1
5578666|NCT01054599|19275192|P1|Overall Study|Visual impairment, WTAR <80|0
5578667|NCT01054599|19275191|P2|Overall Study|Timing/scheduling difficulties|1
5578668|NCT01054599|19275192|P1|Overall Study|Timing/scheduling difficulties|1
5578669|NCT01054599|19275191|P2|Overall Study|Spells/seizure-like episodes|1
5578670|NCT01054599|19275192|P1|Overall Study|Spells/seizure-like episodes|1
5578671|NCT01054599|19275191|P2|Overall Study|Protocol Violation|0
5578672|NCT01054599|19275192|P1|Overall Study|Protocol Violation|1
5578673|NCT01054599|19275191|P2|Overall Study|Dizziness due to phenytoin toxicity|0
5578674|NCT01054599|19275192|P1|Overall Study|Dizziness due to phenytoin toxicity|1
5578675|NCT01054573|19275299|P4|Overall Study|Withdrawal by Subject|1
5578676|NCT01054573|19275300|P3|Overall Study|Withdrawal by Subject|2
5578677|NCT01054573|19275301|P2|Overall Study|Withdrawal by Subject|2
5578678|NCT01054573|19275302|P1|Overall Study|Withdrawal by Subject|0
5578679|NCT01054573|19275299|P4|Overall Study|Lost to Follow-up|0
5578680|NCT01054573|19275300|P3|Overall Study|Lost to Follow-up|0
5578681|NCT01054573|19275301|P2|Overall Study|Lost to Follow-up|2
5578682|NCT01054573|19275302|P1|Overall Study|Lost to Follow-up|0
5578683|NCT01054573|19275299|P4|Overall Study|Adverse Event|1
5578684|NCT01054573|19275300|P3|Overall Study|Adverse Event|1
5578685|NCT01054573|19275301|P2|Overall Study|Adverse Event|0
5578686|NCT01054573|19275302|P1|Overall Study|Adverse Event|1
5578687|NCT01054560|19275348|P2|Overall Study|Physician Decision|0
5578688|NCT01054560|19275349|P1|Overall Study|Physician Decision|1
5578689|NCT01054560|19275348|P2|Overall Study|Withdrawal by Subject|2
5578690|NCT01054560|19275349|P1|Overall Study|Withdrawal by Subject|0
5578691|NCT01054560|19275348|P2|Overall Study|Lost to Follow-up|5
5578692|NCT01054560|19275349|P1|Overall Study|Lost to Follow-up|2
5578693|NCT01054560|19275348|P2|Overall Study|Death|21
5578694|NCT01054560|19275349|P1|Overall Study|Death|10
5578695|NCT01054456|19275371|P1|Overall Study|Other|1
5578696|NCT01054300|19275419|P4|Period 2|Withdrawal by Subject|0
5578697|NCT01054300|19275420|P3|Period 2|Withdrawal by Subject|1
5578698|NCT01054300|19275421|P2|Period 2|Withdrawal by Subject|0
5578699|NCT01054300|19275422|P1|Period 2|Withdrawal by Subject|0
5578700|NCT01054300|19275419|P4|Period 1|Adverse Event|0
5578701|NCT01054300|19275420|P3|Period 1|Adverse Event|0
5578702|NCT01054300|19275421|P2|Period 1|Adverse Event|0
5578703|NCT01054300|19275422|P1|Period 1|Adverse Event|1
5578704|NCT01054222|19275472|P1|Overall Study|Withdrawal by Subject|6
5578705|NCT01054222|19275472|P1|Overall Study|Lost to Follow-up|4
5578706|NCT01054222|19275472|P1|Overall Study|Lack of Efficacy|1
5578707|NCT01054170|19275513|P2|Overall Study|Adverse Event|4
5578708|NCT01054170|19275514|P1|Overall Study|Adverse Event|0
5578709|NCT01054170|19275513|P2|Overall Study|Withdrawal by Subject|2
5578710|NCT01054170|19275514|P1|Overall Study|Withdrawal by Subject|3
5578711|NCT01054170|19275513|P2|Overall Study|Protocol Violation|0
5578712|NCT01054170|19275514|P1|Overall Study|Protocol Violation|1
5578713|NCT01053988|19275579|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5578714|NCT01053988|19275580|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
5578715|NCT01053988|19275581|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
5578716|NCT01053988|19275582|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
5578717|NCT01053988|19275583|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
5578718|NCT01053988|19275584|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
5578719|NCT01053988|19275579|P6|24-week, Double-blind Treatment Period|Physician Decision|4
5578720|NCT01053988|19275580|P5|24-week, Double-blind Treatment Period|Physician Decision|5
5578721|NCT01053988|19275581|P4|24-week, Double-blind Treatment Period|Physician Decision|5
5578722|NCT01053988|19275582|P3|24-week, Double-blind Treatment Period|Physician Decision|2
5578723|NCT01053988|19275583|P2|24-week, Double-blind Treatment Period|Physician Decision|5
5578724|NCT01053988|19275584|P1|24-week, Double-blind Treatment Period|Physician Decision|0
5578725|NCT01053988|19275579|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
5578726|NCT01053988|19275580|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
5578727|NCT01053988|19275581|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
5578728|NCT01053988|19275582|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5578729|NCT01053988|19275583|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
5578730|NCT01053988|19275584|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
5578731|NCT01053988|19275579|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
5578732|NCT01053988|19275580|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
5578733|NCT01053988|19275581|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
5578734|NCT01053988|19275582|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
5578735|NCT01053988|19275583|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
5578736|NCT01053988|19275584|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5578737|NCT01053988|19275579|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
5578738|NCT01053988|19275580|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
5578739|NCT01053988|19275581|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
5578740|NCT01053988|19275582|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
5578741|NCT01053988|19275583|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
5578742|NCT01053988|19275584|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
5578743|NCT01053988|19275579|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
5578744|NCT01053988|19275580|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
5578745|NCT01053988|19275581|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
5578746|NCT01053988|19275582|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
5578747|NCT01053988|19275583|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
5578748|NCT01053988|19275584|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
5578749|NCT01053988|19275579|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5578750|NCT01053988|19275580|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
5578751|NCT01053988|19275581|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
5578752|NCT01053988|19275582|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
5578753|NCT01053988|19275583|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
5578754|NCT01053988|19275584|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
5578755|NCT01053988|19275579|P6|24-week, Double-blind Treatment Period|Adverse Event|14
5578756|NCT01053988|19275580|P5|24-week, Double-blind Treatment Period|Adverse Event|17
5578757|NCT01053988|19275581|P4|24-week, Double-blind Treatment Period|Adverse Event|24
5578758|NCT01053988|19275582|P3|24-week, Double-blind Treatment Period|Adverse Event|23
5578759|NCT01053988|19275583|P2|24-week, Double-blind Treatment Period|Adverse Event|15
5578760|NCT01053988|19275584|P1|24-week, Double-blind Treatment Period|Adverse Event|0
5578761|NCT01053988|19275579|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578762|NCT01053988|19275580|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578763|NCT01053988|19275581|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578764|NCT01053988|19275582|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578765|NCT01053988|19275583|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
5578766|NCT01053988|19275584|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
5578767|NCT01053988|19275579|P6|2-week, Single-blind Run-In Period|Physician Decision|0
5578768|NCT01053988|19275580|P5|2-week, Single-blind Run-In Period|Physician Decision|0
5578769|NCT01053988|19275581|P4|2-week, Single-blind Run-In Period|Physician Decision|0
5578770|NCT01053988|19275582|P3|2-week, Single-blind Run-In Period|Physician Decision|0
5578771|NCT01053988|19275583|P2|2-week, Single-blind Run-In Period|Physician Decision|0
5578772|NCT01053988|19275584|P1|2-week, Single-blind Run-In Period|Physician Decision|5
5578773|NCT01053988|19275579|P6|2-week, Single-blind Run-In Period|Adverse Event|0
5578774|NCT01053988|19275580|P5|2-week, Single-blind Run-In Period|Adverse Event|0
5578775|NCT01053988|19275581|P4|2-week, Single-blind Run-In Period|Adverse Event|0
5578776|NCT01053988|19275582|P3|2-week, Single-blind Run-In Period|Adverse Event|0
5578777|NCT01053988|19275583|P2|2-week, Single-blind Run-In Period|Adverse Event|0
5578778|NCT01053988|19275584|P1|2-week, Single-blind Run-In Period|Adverse Event|6
5578779|NCT01053988|19275579|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578780|NCT01053988|19275580|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578781|NCT01053988|19275581|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578782|NCT01053988|19275582|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578783|NCT01053988|19275583|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
5578784|NCT01053988|19275584|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
5578785|NCT01053988|19275579|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578786|NCT01053988|19275580|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578787|NCT01053988|19275581|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578788|NCT01053988|19275582|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578789|NCT01053988|19275583|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
5578790|NCT01053988|19275584|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
5578791|NCT01053988|19275579|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578792|NCT01053988|19275580|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578793|NCT01053988|19275581|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578794|NCT01053988|19275582|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578795|NCT01053988|19275583|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
5578796|NCT01053988|19275584|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
5578797|NCT01053962|19275621|P5|Treatment Period|Noncompliance with protocol|0
5578798|NCT01053962|19275622|P4|Treatment Period|Noncompliance with protocol|0
5578799|NCT01053962|19275623|P3|Treatment Period|Noncompliance with protocol|0
5578800|NCT01053962|19275624|P2|Treatment Period|Noncompliance with protocol|0
5578801|NCT01053962|19275625|P1|Treatment Period|Noncompliance with protocol|1
5578802|NCT01053962|19275621|P5|Treatment Period|Withdrawal by Subject|1
5578803|NCT01053962|19275622|P4|Treatment Period|Withdrawal by Subject|0
5578804|NCT01053962|19275623|P3|Treatment Period|Withdrawal by Subject|0
5578805|NCT01053962|19275624|P2|Treatment Period|Withdrawal by Subject|0
5578806|NCT01053962|19275625|P1|Treatment Period|Withdrawal by Subject|0
5578807|NCT01053962|19275621|P5|Treatment Period|Adverse Event|1
5578808|NCT01053962|19275622|P4|Treatment Period|Adverse Event|0
5578809|NCT01053962|19275623|P3|Treatment Period|Adverse Event|0
5578810|NCT01053962|19275624|P2|Treatment Period|Adverse Event|0
5578811|NCT01053962|19275625|P1|Treatment Period|Adverse Event|0
5578812|NCT01053962|19275621|P5|Treatment Period|Lack of Efficacy|1
5578813|NCT01053962|19275622|P4|Treatment Period|Lack of Efficacy|0
5578814|NCT01053962|19275623|P3|Treatment Period|Lack of Efficacy|0
5578815|NCT01053962|19275624|P2|Treatment Period|Lack of Efficacy|0
5578816|NCT01053962|19275625|P1|Treatment Period|Lack of Efficacy|0
5578817|NCT01053962|19275621|P5|Pretreatment Period|Abnormal Lab values Exl 16|0
5578818|NCT01053962|19275622|P4|Pretreatment Period|Abnormal Lab values Exl 16|1
5578819|NCT01053962|19275623|P3|Pretreatment Period|Abnormal Lab values Exl 16|0
5578820|NCT01053962|19275624|P2|Pretreatment Period|Abnormal Lab values Exl 16|0
5578821|NCT01053962|19275625|P1|Pretreatment Period|Abnormal Lab values Exl 16|0
5578822|NCT01053962|19275621|P5|Pretreatment Period|Failed Urine drug screen Day 1|0
5578823|NCT01053962|19275622|P4|Pretreatment Period|Failed Urine drug screen Day 1|0
5578824|NCT01053962|19275623|P3|Pretreatment Period|Failed Urine drug screen Day 1|0
5578825|NCT01053962|19275624|P2|Pretreatment Period|Failed Urine drug screen Day 1|1
5578826|NCT01053962|19275625|P1|Pretreatment Period|Failed Urine drug screen Day 1|0
5578827|NCT01053962|19275621|P5|Pretreatment Period|Venipuncture Failure|0
5578828|NCT01053962|19275622|P4|Pretreatment Period|Venipuncture Failure|0
5578829|NCT01053962|19275623|P3|Pretreatment Period|Venipuncture Failure|1
5578830|NCT01053962|19275624|P2|Pretreatment Period|Venipuncture Failure|0
5578831|NCT01053962|19275625|P1|Pretreatment Period|Venipuncture Failure|0
5578832|NCT01053962|19275621|P5|Pretreatment Period|Withdrew Consent (Patient/PI)|2
5578833|NCT01053962|19275622|P4|Pretreatment Period|Withdrew Consent (Patient/PI)|1
5578834|NCT01053962|19275623|P3|Pretreatment Period|Withdrew Consent (Patient/PI)|0
5578835|NCT01053962|19275624|P2|Pretreatment Period|Withdrew Consent (Patient/PI)|0
5578836|NCT01053962|19275625|P1|Pretreatment Period|Withdrew Consent (Patient/PI)|0
5578837|NCT01053741|19275676|P2|2nd Study Intervention|Physician Decision|1
5578838|NCT01053741|19275677|P1|2nd Study Intervention|Physician Decision|0
5578839|NCT01053663|19275686|P1|Overall Study|Negative Influenza Diagnosis|1
5578840|NCT01053663|19275686|P1|Overall Study|Transferred to Another Hospital|1
5578841|NCT01053663|19275686|P1|Overall Study|Poor IV Access|1
5578842|NCT01053663|19275686|P1|Overall Study|Lost to Follow-up|1
5578843|NCT01053663|19275686|P1|Overall Study|Death|2
5578844|NCT01053429|19275744|P1|Overall Study|Other|309
5578845|NCT01053429|19275744|P1|Overall Study|Adverse Event|64
5578846|NCT01053247|19275774|P3|Overall Study|Adverse Event|3
5578847|NCT01053247|19275775|P2|Overall Study|Adverse Event|9
5578848|NCT01053247|19275776|P1|Overall Study|Adverse Event|0
5578849|NCT01053247|19275774|P3|Overall Study|Lost to Follow-up|7
5578850|NCT01053247|19275775|P2|Overall Study|Lost to Follow-up|5
5578851|NCT01053247|19275776|P1|Overall Study|Lost to Follow-up|8
5578852|NCT01053247|19275774|P3|Overall Study|Protocol Violation|2
5578853|NCT01053247|19275775|P2|Overall Study|Protocol Violation|1
5578854|NCT01053247|19275776|P1|Overall Study|Protocol Violation|2
5578855|NCT01053247|19275774|P3|Overall Study|Lack of Efficacy|1
5578856|NCT01053247|19275775|P2|Overall Study|Lack of Efficacy|0
5578857|NCT01053247|19275776|P1|Overall Study|Lack of Efficacy|1
5578858|NCT01053247|19275774|P3|Overall Study|Withdrawal by Subject|15
5578859|NCT01053247|19275775|P2|Overall Study|Withdrawal by Subject|4
5578860|NCT01053247|19275776|P1|Overall Study|Withdrawal by Subject|9
5578861|NCT01053221|19275786|P2|Overall Study|The study was closed prematurely|9
5578862|NCT01053221|19275787|P1|Overall Study|The study was closed prematurely|5
5578863|NCT01052844|19275889|P2|Overall Study|Adverse Event|1
5578864|NCT01052844|19275890|P1|Overall Study|Adverse Event|0
5578865|NCT01052779|19275911|P2|Overall Study|Other-Missed Week 5 Visit|0
5578866|NCT01052779|19275912|P1|Overall Study|Other-Missed Week 5 Visit|2
5578867|NCT01052779|19275911|P2|Overall Study|Other-Surgery|2
5578868|NCT01052779|19275912|P1|Overall Study|Other-Surgery|0
5578869|NCT01052779|19275911|P2|Overall Study|Other-Protocol Violation|1
5578870|NCT01052779|19275912|P1|Overall Study|Other-Protocol Violation|1
5578871|NCT01052779|19275911|P2|Overall Study|Withdrawal by Subject|2
5578872|NCT01052779|19275912|P1|Overall Study|Withdrawal by Subject|1
5578873|NCT01052779|19275911|P2|Overall Study|Adverse Event|4
5578874|NCT01052779|19275912|P1|Overall Study|Adverse Event|1
5578875|NCT01052714|19275922|P3|Overall Study|Withdrawal by Subject|1
5578876|NCT01052714|19275923|P2|Overall Study|Withdrawal by Subject|12
5578877|NCT01052714|19275924|P1|Overall Study|Withdrawal by Subject|7
5578878|NCT01052714|19275922|P3|Overall Study|Physician Decision|1
5578879|NCT01052714|19275923|P2|Overall Study|Physician Decision|9
5578880|NCT01052714|19275924|P1|Overall Study|Physician Decision|9
5578881|NCT01052714|19275922|P3|Overall Study|Lost to Follow-up|0
5578882|NCT01052714|19275923|P2|Overall Study|Lost to Follow-up|3
5578883|NCT01052714|19275924|P1|Overall Study|Lost to Follow-up|2
5578884|NCT01052714|19275922|P3|Overall Study|Death|0
5578885|NCT01052714|19275923|P2|Overall Study|Death|2
5578886|NCT01052714|19275924|P1|Overall Study|Death|1
5578887|NCT01052714|19275922|P3|Overall Study|Adverse Event|0
5578888|NCT01052714|19275923|P2|Overall Study|Adverse Event|3
5578889|NCT01052714|19275924|P1|Overall Study|Adverse Event|6
5578890|NCT01052662|19275978|P3|Overall Study|Administrative|0
5578891|NCT01052662|19275979|P2|Overall Study|Administrative|3
5578892|NCT01052662|19275980|P1|Overall Study|Administrative|0
5578893|NCT01052662|19275978|P3|Overall Study|Legal Problem|0
5578894|NCT01052662|19275979|P2|Overall Study|Legal Problem|0
5578895|NCT01052662|19275980|P1|Overall Study|Legal Problem|2
5578896|NCT01052662|19275978|P3|Overall Study|Adverse Event|0
5578897|NCT01052662|19275979|P2|Overall Study|Adverse Event|1
5578898|NCT01052662|19275980|P1|Overall Study|Adverse Event|1
5578899|NCT01052662|19275978|P3|Overall Study|Pharmacy issue|3
5578900|NCT01052662|19275979|P2|Overall Study|Pharmacy issue|3
5578901|NCT01052662|19275980|P1|Overall Study|Pharmacy issue|1
5578902|NCT01052662|19275978|P3|Overall Study|Withdrawal by Subject|1
5578903|NCT01052662|19275979|P2|Overall Study|Withdrawal by Subject|2
5578904|NCT01052662|19275980|P1|Overall Study|Withdrawal by Subject|3
5578905|NCT01052662|19275978|P3|Overall Study|Lost to Follow-up|18
5578906|NCT01052662|19275979|P2|Overall Study|Lost to Follow-up|13
5578907|NCT01052662|19275980|P1|Overall Study|Lost to Follow-up|15
5578908|NCT01052480|19276021|P2|Overall Study|Death|5
5578909|NCT01052480|19276022|P1|Overall Study|Death|1
5578910|NCT01052480|19276021|P2|Overall Study|Physician Decision|2
5578911|NCT01052480|19276022|P1|Overall Study|Physician Decision|0
5578912|NCT01052480|19276021|P2|Overall Study|Withdrawal by Subject|7
5578913|NCT01052480|19276022|P1|Overall Study|Withdrawal by Subject|3
5578914|NCT01052480|19276021|P2|Overall Study|Protocol Violation|0
5578915|NCT01052480|19276022|P1|Overall Study|Protocol Violation|1
5578916|NCT01052480|19276021|P2|Overall Study|Lost to Follow-up|3
5578917|NCT01052480|19276022|P1|Overall Study|Lost to Follow-up|3
5578918|NCT01052428|19276072|P2|Overall Study|Withdrawal by Subject|1
5578919|NCT01052428|19276073|P1|Overall Study|Withdrawal by Subject|0
5578920|NCT01052428|19276072|P2|Overall Study|Death|0
5578921|NCT01052428|19276073|P1|Overall Study|Death|1
5578922|NCT01052272|19276095|P4|Overall Study|decline in health|0
5578923|NCT01052272|19276096|P3|Overall Study|decline in health|1
5578924|NCT01052272|19276097|P2|Overall Study|decline in health|0
5578925|NCT01052272|19276098|P1|Overall Study|decline in health|0
5578926|NCT01052272|19276095|P4|Overall Study|placed in long-term care|0
5578927|NCT01052272|19276096|P3|Overall Study|placed in long-term care|1
5578928|NCT01052272|19276097|P2|Overall Study|placed in long-term care|0
5578929|NCT01052272|19276098|P1|Overall Study|placed in long-term care|0
5578930|NCT01052272|19276095|P4|Overall Study|Withdrawal by Subject|2
5578931|NCT01052272|19276096|P3|Overall Study|Withdrawal by Subject|3
5578932|NCT01052272|19276097|P2|Overall Study|Withdrawal by Subject|2
5578933|NCT01052272|19276098|P1|Overall Study|Withdrawal by Subject|0
5578934|NCT01052272|19276095|P4|Overall Study|patient refuses follow-up|4
5578935|NCT01052272|19276096|P3|Overall Study|patient refuses follow-up|2
5578936|NCT01052272|19276097|P2|Overall Study|patient refuses follow-up|4
5578937|NCT01052272|19276098|P1|Overall Study|patient refuses follow-up|5
5578938|NCT01052272|19276095|P4|Overall Study|Physician Decision|0
5578939|NCT01052272|19276096|P3|Overall Study|Physician Decision|0
5578940|NCT01052272|19276097|P2|Overall Study|Physician Decision|1
5578941|NCT01052272|19276098|P1|Overall Study|Physician Decision|0
5578942|NCT01052272|19276095|P4|Overall Study|Death|1
5578943|NCT01052272|19276096|P3|Overall Study|Death|1
5578944|NCT01052272|19276097|P2|Overall Study|Death|0
5578945|NCT01052272|19276098|P1|Overall Study|Death|0
5578946|NCT01052116|19276143|P2|Overall Study|Spirometry not performed|4
5578947|NCT01052116|19276144|P1|Overall Study|Spirometry not performed|0
5578948|NCT01052116|19276143|P2|Overall Study|Withdrawal by Subject|6
5578949|NCT01052116|19276144|P1|Overall Study|Withdrawal by Subject|3
5578950|NCT01052116|19276143|P2|Overall Study|Lost to Follow-up|17
5578951|NCT01052116|19276144|P1|Overall Study|Lost to Follow-up|11
5578952|NCT01052077|19276152|P4|Phase A+|Withdrawal by Subject|7
5578953|NCT01052077|19276153|P3|Phase A+|Withdrawal by Subject|0
5578954|NCT01052077|19276154|P2|Phase A+|Withdrawal by Subject|0
5578955|NCT01052077|19276155|P1|Phase A+|Withdrawal by Subject|0
5578956|NCT01052077|19276152|P4|Phase A+|Met Withdrawal Criteria|2
5578957|NCT01052077|19276153|P3|Phase A+|Met Withdrawal Criteria|0
5578958|NCT01052077|19276154|P2|Phase A+|Met Withdrawal Criteria|0
5578959|NCT01052077|19276155|P1|Phase A+|Met Withdrawal Criteria|0
5578960|NCT01052077|19276152|P4|Phase A+|Adverse Event|4
5578961|NCT01052077|19276153|P3|Phase A+|Adverse Event|0
5578962|NCT01052077|19276154|P2|Phase A+|Adverse Event|0
5578963|NCT01052077|19276155|P1|Phase A+|Adverse Event|0
5578964|NCT01052077|19276152|P4|Phase A+|Lost to Follow-up|8
5578965|NCT01052077|19276153|P3|Phase A+|Lost to Follow-up|0
5578966|NCT01052077|19276154|P2|Phase A+|Lost to Follow-up|0
5578967|NCT01052077|19276155|P1|Phase A+|Lost to Follow-up|0
5578968|NCT01052077|19276152|P4|Phase B|Lack of Efficacy|0
5578969|NCT01052077|19276153|P3|Phase B|Lack of Efficacy|0
5578970|NCT01052077|19276154|P2|Phase B|Lack of Efficacy|1
5578971|NCT01052077|19276155|P1|Phase B|Lack of Efficacy|0
5578972|NCT01052077|19276152|P4|Phase B|Protocol Deviation|0
5578973|NCT01052077|19276153|P3|Phase B|Protocol Deviation|4
5578974|NCT01052077|19276154|P2|Phase B|Protocol Deviation|3
5578975|NCT01052077|19276155|P1|Phase B|Protocol Deviation|0
5578976|NCT01052077|19276152|P4|Phase B|Withdrawal by Subject|0
5578977|NCT01052077|19276153|P3|Phase B|Withdrawal by Subject|5
5578978|NCT01052077|19276154|P2|Phase B|Withdrawal by Subject|0
5578979|NCT01052077|19276155|P1|Phase B|Withdrawal by Subject|0
5578980|NCT01052077|19276152|P4|Phase B|Physician Decision|0
5578981|NCT01052077|19276153|P3|Phase B|Physician Decision|1
5578982|NCT01052077|19276154|P2|Phase B|Physician Decision|1
5578983|NCT01052077|19276155|P1|Phase B|Physician Decision|0
5578984|NCT01052077|19276152|P4|Phase B|Met Withdrawal Criteria|0
5578985|NCT01052077|19276153|P3|Phase B|Met Withdrawal Criteria|1
5578986|NCT01052077|19276154|P2|Phase B|Met Withdrawal Criteria|2
5578987|NCT01052077|19276155|P1|Phase B|Met Withdrawal Criteria|0
5578988|NCT01052077|19276152|P4|Phase B|Adverse Event|0
5578989|NCT01052077|19276153|P3|Phase B|Adverse Event|2
5578990|NCT01052077|19276154|P2|Phase B|Adverse Event|9
5578991|NCT01052077|19276155|P1|Phase B|Adverse Event|0
5578992|NCT01052077|19276152|P4|Phase B|Lost to Follow-up|0
5578993|NCT01052077|19276153|P3|Phase B|Lost to Follow-up|3
5578994|NCT01052077|19276154|P2|Phase B|Lost to Follow-up|2
5578995|NCT01052077|19276155|P1|Phase B|Lost to Follow-up|0
5578996|NCT01052077|19276152|P4|Phase A|Protocol Deviation|0
5578997|NCT01052077|19276153|P3|Phase A|Protocol Deviation|0
5578998|NCT01052077|19276154|P2|Phase A|Protocol Deviation|0
5578999|NCT01052077|19276155|P1|Phase A|Protocol Deviation|27
5579000|NCT01052077|19276152|P4|Phase A|Withdrawal by Subject|0
5579001|NCT01052077|19276153|P3|Phase A|Withdrawal by Subject|0
5579002|NCT01052077|19276154|P2|Phase A|Withdrawal by Subject|0
5579003|NCT01052077|19276155|P1|Phase A|Withdrawal by Subject|29
5579004|NCT01052077|19276152|P4|Phase A|Physician Decision|0
5579005|NCT01052077|19276153|P3|Phase A|Physician Decision|0
5579006|NCT01052077|19276154|P2|Phase A|Physician Decision|0
5579007|NCT01052077|19276155|P1|Phase A|Physician Decision|10
5579008|NCT01052077|19276152|P4|Phase A|Met Withdrawal Criteria|0
5579009|NCT01052077|19276153|P3|Phase A|Met Withdrawal Criteria|0
5579010|NCT01052077|19276154|P2|Phase A|Met Withdrawal Criteria|0
5579011|NCT01052077|19276155|P1|Phase A|Met Withdrawal Criteria|26
5579012|NCT01052077|19276152|P4|Phase A|Adverse Event|0
5579013|NCT01052077|19276153|P3|Phase A|Adverse Event|0
5579014|NCT01052077|19276154|P2|Phase A|Adverse Event|0
5579015|NCT01052077|19276155|P1|Phase A|Adverse Event|32
5579016|NCT01052077|19276152|P4|Phase A|Lost to Follow-up|0
5579017|NCT01052077|19276153|P3|Phase A|Lost to Follow-up|0
5579018|NCT01052077|19276154|P2|Phase A|Lost to Follow-up|0
5579019|NCT01052077|19276155|P1|Phase A|Lost to Follow-up|22
5579020|NCT01052038|19276182|P3|Overall Study|Protocol Violation|3
5579021|NCT01052038|19276183|P2|Overall Study|Protocol Violation|3
5579022|NCT01052038|19276184|P1|Overall Study|Protocol Violation|2
5579023|NCT01052038|19276182|P3|Overall Study|Lost to Follow-up|1
5579024|NCT01052038|19276183|P2|Overall Study|Lost to Follow-up|3
5579025|NCT01052038|19276184|P1|Overall Study|Lost to Follow-up|2
5579026|NCT01051986|19276206|P2|Overall Study|Protocol Violation|3
5579027|NCT01051986|19276207|P1|Overall Study|Protocol Violation|2
5579028|NCT01051986|19276206|P2|Overall Study|Withdrawal by Subject|1
5579029|NCT01051986|19276207|P1|Overall Study|Withdrawal by Subject|2
5579030|NCT01051986|19276206|P2|Overall Study|Death|0
5579031|NCT01051986|19276207|P1|Overall Study|Death|1
5579032|NCT01051960|19276221|P1|Overall Study|Adverse Event|1
5579033|NCT01051921|19276229|P1|Overall Study|patient moved|1
5579034|NCT01051921|19276229|P1|Overall Study|virological failure|1
5579035|NCT01051921|19276229|P1|Overall Study|Lost to Follow-up|4
5579036|NCT01051921|19276229|P1|Overall Study|Withdrawal by Subject|7
5579037|NCT01051921|19276229|P1|Overall Study|Adverse Event|8
5579038|NCT01051921|19276229|P1|Overall Study|Physician Decision|9
5579039|NCT01051856|19276236|P2|Overall Study|Withdrawal by Subject|0
5579040|NCT01051856|19276237|P1|Overall Study|Withdrawal by Subject|1
5579041|NCT01051817|19276247|P2|Overall Study|Protocol Violation|1
5579042|NCT01051817|19276248|P1|Overall Study|Protocol Violation|0
5579043|NCT01051817|19276247|P2|Overall Study|Withdrawal by Subject|5
5579044|NCT01051817|19276248|P1|Overall Study|Withdrawal by Subject|3
5579045|NCT01051817|19276247|P2|Overall Study|Abnormal Test Proceedure reults|1
5579046|NCT01051817|19276248|P1|Overall Study|Abnormal Test Proceedure reults|0
5579047|NCT01051817|19276247|P2|Overall Study|Adverse Event|2
5579048|NCT01051817|19276248|P1|Overall Study|Adverse Event|0
5579049|NCT01051791|19276258|P1|Overall Study|Withdrawal by Subject|1
5579050|NCT01051791|19276258|P1|Overall Study|Failed screening|3
5579051|NCT01051739|19276276|P2|Overall Study|Withdrawal by Subject|10
5579052|NCT01051739|19276277|P1|Overall Study|Withdrawal by Subject|25
5579053|NCT01051739|19276276|P2|Overall Study|Death|3
5579054|NCT01051739|19276277|P1|Overall Study|Death|3
5579055|NCT01051661|19276289|P6|Overall Study|Withdrawal by Subject|34
5579056|NCT01051661|19276290|P5|Overall Study|Withdrawal by Subject|12
5579057|NCT01051661|19276291|P4|Overall Study|Withdrawal by Subject|28
5579058|NCT01051661|19276292|P3|Overall Study|Withdrawal by Subject|13
5579059|NCT01051661|19276293|P2|Overall Study|Withdrawal by Subject|30
5579060|NCT01051661|19276294|P1|Overall Study|Withdrawal by Subject|16
5579061|NCT01051661|19276289|P6|Overall Study|Protocol Violation|1
5579062|NCT01051661|19276290|P5|Overall Study|Protocol Violation|2
5579063|NCT01051661|19276291|P4|Overall Study|Protocol Violation|1
5579064|NCT01051661|19276292|P3|Overall Study|Protocol Violation|0
5579065|NCT01051661|19276293|P2|Overall Study|Protocol Violation|0
5579066|NCT01051661|19276294|P1|Overall Study|Protocol Violation|0
5579067|NCT01051661|19276289|P6|Overall Study|Subject lost legal representation|0
5579068|NCT01051661|19276290|P5|Overall Study|Subject lost legal representation|1
5579069|NCT01051661|19276291|P4|Overall Study|Subject lost legal representation|0
5579070|NCT01051661|19276292|P3|Overall Study|Subject lost legal representation|0
5579071|NCT01051661|19276293|P2|Overall Study|Subject lost legal representation|0
5579072|NCT01051661|19276294|P1|Overall Study|Subject lost legal representation|0
5579073|NCT01051661|19276289|P6|Overall Study|Failure to comply with protocol|0
5579074|NCT01051661|19276290|P5|Overall Study|Failure to comply with protocol|0
5579075|NCT01051661|19276291|P4|Overall Study|Failure to comply with protocol|0
5579076|NCT01051661|19276292|P3|Overall Study|Failure to comply with protocol|2
5579077|NCT01051661|19276293|P2|Overall Study|Failure to comply with protocol|0
5579078|NCT01051661|19276294|P1|Overall Study|Failure to comply with protocol|0
5579079|NCT01051661|19276289|P6|Overall Study|Consent not received from both parents|1
5579080|NCT01051661|19276290|P5|Overall Study|Consent not received from both parents|0
5579081|NCT01051661|19276291|P4|Overall Study|Consent not received from both parents|0
5579082|NCT01051661|19276292|P3|Overall Study|Consent not received from both parents|0
5579083|NCT01051661|19276293|P2|Overall Study|Consent not received from both parents|0
5579084|NCT01051661|19276294|P1|Overall Study|Consent not received from both parents|0
5579085|NCT01051661|19276289|P6|Overall Study|Unable to attend visit(s)|2
5579086|NCT01051661|19276290|P5|Overall Study|Unable to attend visit(s)|3
5579087|NCT01051661|19276291|P4|Overall Study|Unable to attend visit(s)|1
5579088|NCT01051661|19276292|P3|Overall Study|Unable to attend visit(s)|2
5579089|NCT01051661|19276293|P2|Overall Study|Unable to attend visit(s)|4
5579090|NCT01051661|19276294|P1|Overall Study|Unable to attend visit(s)|2
5579091|NCT01051661|19276289|P6|Overall Study|Data not reliable|1
5579092|NCT01051661|19276290|P5|Overall Study|Data not reliable|0
5579093|NCT01051661|19276291|P4|Overall Study|Data not reliable|0
5579094|NCT01051661|19276292|P3|Overall Study|Data not reliable|0
5579095|NCT01051661|19276293|P2|Overall Study|Data not reliable|0
5579096|NCT01051661|19276294|P1|Overall Study|Data not reliable|1
5579097|NCT01051661|19276289|P6|Overall Study|Refused blood sampling|1
5579098|NCT01051661|19276290|P5|Overall Study|Refused blood sampling|0
5579099|NCT01051661|19276291|P4|Overall Study|Refused blood sampling|0
5579100|NCT01051661|19276292|P3|Overall Study|Refused blood sampling|0
5579101|NCT01051661|19276293|P2|Overall Study|Refused blood sampling|0
5579102|NCT01051661|19276294|P1|Overall Study|Refused blood sampling|0
5579103|NCT01051661|19276289|P6|Overall Study|Migrated/moved from study area|3
5579104|NCT01051661|19276290|P5|Overall Study|Migrated/moved from study area|7
5579105|NCT01051661|19276291|P4|Overall Study|Migrated/moved from study area|8
5579106|NCT01051661|19276292|P3|Overall Study|Migrated/moved from study area|6
5579107|NCT01051661|19276293|P2|Overall Study|Migrated/moved from study area|6
5579108|NCT01051661|19276294|P1|Overall Study|Migrated/moved from study area|1
5579109|NCT01051661|19276289|P6|Overall Study|Lost to Follow-up|24
5579110|NCT01051661|19276290|P5|Overall Study|Lost to Follow-up|10
5579111|NCT01051661|19276291|P4|Overall Study|Lost to Follow-up|17
5579112|NCT01051661|19276292|P3|Overall Study|Lost to Follow-up|15
5579113|NCT01051661|19276293|P2|Overall Study|Lost to Follow-up|22
5579114|NCT01051661|19276294|P1|Overall Study|Lost to Follow-up|13
5579115|NCT01051661|19276289|P6|Overall Study|Adverse Event|0
5579116|NCT01051661|19276290|P5|Overall Study|Adverse Event|0
5579117|NCT01051661|19276291|P4|Overall Study|Adverse Event|1
5579118|NCT01051661|19276292|P3|Overall Study|Adverse Event|1
5579119|NCT01051661|19276293|P2|Overall Study|Adverse Event|1
5579120|NCT01051661|19276294|P1|Overall Study|Adverse Event|1
5579121|NCT01051557|19276496|P7|Overall Study|Adverse Event|4
5579122|NCT01051557|19276497|P6|Overall Study|Adverse Event|3
5579123|NCT01051557|19276498|P5|Overall Study|Adverse Event|1
5579124|NCT01051557|19276499|P4|Overall Study|Adverse Event|1
5579125|NCT01051557|19276500|P3|Overall Study|Adverse Event|0
5579126|NCT01051557|19276501|P2|Overall Study|Adverse Event|0
5579127|NCT01051557|19276502|P1|Overall Study|Adverse Event|0
5579128|NCT01051557|19276496|P7|Overall Study|Withdrawal by Subject|1
5579129|NCT01051557|19276497|P6|Overall Study|Withdrawal by Subject|0
5579130|NCT01051557|19276498|P5|Overall Study|Withdrawal by Subject|2
5579131|NCT01051557|19276499|P4|Overall Study|Withdrawal by Subject|0
5579132|NCT01051557|19276500|P3|Overall Study|Withdrawal by Subject|1
5579133|NCT01051557|19276501|P2|Overall Study|Withdrawal by Subject|0
5579134|NCT01051557|19276502|P1|Overall Study|Withdrawal by Subject|0
5579135|NCT01051557|19276496|P7|Overall Study|disease progression|1
5579136|NCT01051557|19276497|P6|Overall Study|disease progression|3
5579137|NCT01051557|19276498|P5|Overall Study|disease progression|4
5579138|NCT01051557|19276499|P4|Overall Study|disease progression|2
5579139|NCT01051557|19276500|P3|Overall Study|disease progression|5
5579140|NCT01051557|19276501|P2|Overall Study|disease progression|3
5579141|NCT01051557|19276502|P1|Overall Study|disease progression|3
5579142|NCT01051557|19276496|P7|Overall Study|Physician Decision|0
5579143|NCT01051557|19276497|P6|Overall Study|Physician Decision|0
5579144|NCT01051557|19276498|P5|Overall Study|Physician Decision|0
5579145|NCT01051557|19276499|P4|Overall Study|Physician Decision|0
5579146|NCT01051557|19276500|P3|Overall Study|Physician Decision|0
5579147|NCT01051557|19276501|P2|Overall Study|Physician Decision|0
5579148|NCT01051557|19276502|P1|Overall Study|Physician Decision|1
5579149|NCT01051466|19276533|P2|Overall Study|Physician Decision|0
5579150|NCT01051466|19276534|P1|Overall Study|Physician Decision|1
5579151|NCT01051466|19276533|P2|Overall Study|Entry Criteria Not Met|3
5579152|NCT01051466|19276534|P1|Overall Study|Entry Criteria Not Met|0
5579153|NCT01051466|19276533|P2|Overall Study|Withdrawal by Subject|1
5579154|NCT01051466|19276534|P1|Overall Study|Withdrawal by Subject|5
5579155|NCT01051466|19276533|P2|Overall Study|Lost to Follow-up|1
5579156|NCT01051466|19276534|P1|Overall Study|Lost to Follow-up|1
5579157|NCT01051466|19276533|P2|Overall Study|Adverse Event|0
5579158|NCT01051466|19276534|P1|Overall Study|Adverse Event|1
5579159|NCT01051349|19276579|P1|Overall Study|Reason not Specified|12
5579160|NCT01051349|19276579|P1|Overall Study|Subject non-compliance|7
5579161|NCT01051349|19276579|P1|Overall Study|Lost to Follow-up|6
5579162|NCT01051349|19276579|P1|Overall Study|Investigator Decision|6
5579163|NCT01051349|19276579|P1|Overall Study|Consent Withdrawn|54
5579164|NCT01051349|19276579|P1|Overall Study|Adverse Event|88
5579165|NCT01051323|19276608|P1|Overall Study|Missing|37
5579166|NCT01051323|19276608|P1|Overall Study|Other|148
5579167|NCT01051323|19276608|P1|Overall Study|Hospitalization|28
5579168|NCT01051323|19276608|P1|Overall Study|Death|129
5579169|NCT01051323|19276608|P1|Overall Study|Lost to Follow-up|31
5579170|NCT01051323|19276608|P1|Overall Study|Withdrawal by Subject|13
5579171|NCT01051323|19276608|P1|Overall Study|Dialysis dependency|22
5579172|NCT01051323|19276608|P1|Overall Study|Transplantation|28
5579173|NCT01051323|19276608|P1|Overall Study|Discontinuation of treatment|103
5579174|NCT01051063|19276637|P2|Overall Study|Lost to Follow-up|1
5579175|NCT01051063|19276638|P1|Overall Study|Lost to Follow-up|0
5579176|NCT01051063|19276637|P2|Overall Study|Other|0
5579177|NCT01051063|19276638|P1|Overall Study|Other|1
5579178|NCT01051063|19276637|P2|Overall Study|Moved from the study site area|0
5579179|NCT01051063|19276638|P1|Overall Study|Moved from the study site area|1
5579180|NCT01051063|19276637|P2|Overall Study|Termination of the study|0
5579181|NCT01051063|19276638|P1|Overall Study|Termination of the study|5
5579182|NCT01051063|19276637|P2|Overall Study|Withdrawal by Subject|1
5579183|NCT01051063|19276638|P1|Overall Study|Withdrawal by Subject|1
5579184|NCT01051063|19276637|P2|Overall Study|Death|2
5579185|NCT01051063|19276638|P1|Overall Study|Death|2
5579186|NCT01050998|19276658|P5|Overall Study|Data integrity issues|4
5579187|NCT01050998|19276659|P4|Overall Study|Data integrity issues|1
5579188|NCT01050998|19276660|P3|Overall Study|Data integrity issues|1
5579189|NCT01050998|19276661|P2|Overall Study|Data integrity issues|0
5579190|NCT01050998|19276662|P1|Overall Study|Data integrity issues|0
5579191|NCT01050998|19276658|P5|Overall Study|Other|5
5579192|NCT01050998|19276659|P4|Overall Study|Other|1
5579193|NCT01050998|19276660|P3|Overall Study|Other|1
5579194|NCT01050998|19276661|P2|Overall Study|Other|2
5579195|NCT01050998|19276662|P1|Overall Study|Other|3
5579196|NCT01050998|19276658|P5|Overall Study|Withdrawal by Subject|3
5579197|NCT01050998|19276659|P4|Overall Study|Withdrawal by Subject|1
5579198|NCT01050998|19276660|P3|Overall Study|Withdrawal by Subject|0
5579199|NCT01050998|19276661|P2|Overall Study|Withdrawal by Subject|0
5579200|NCT01050998|19276662|P1|Overall Study|Withdrawal by Subject|0
5579201|NCT01050998|19276658|P5|Overall Study|Adverse Event|2
5579202|NCT01050998|19276659|P4|Overall Study|Adverse Event|0
5579203|NCT01050998|19276660|P3|Overall Study|Adverse Event|1
5579204|NCT01050998|19276661|P2|Overall Study|Adverse Event|0
5579205|NCT01050998|19276662|P1|Overall Study|Adverse Event|1
5579206|NCT01050816|19277001|P1|Overall Study|patient's refusal|2
5579207|NCT01050816|19277001|P1|Overall Study|Lost to Follow-up|2
5579208|NCT01050790|19277007|P1|Overall Study|Adverse Event|1
5579209|NCT01050764|19277017|P1|Overall Study|Death after HSCT, before T-cell infusion|1
5579210|NCT01050764|19277017|P1|Overall Study|Donor mobilization failure, death|1
5579211|NCT01050764|19277017|P1|Overall Study|Death, before HSCT|1
5579212|NCT01050673|19277028|P2|Overall Study|Physician Decision|5
5579213|NCT01050673|19277029|P1|Overall Study|Physician Decision|4
5579214|NCT01050634|19277097|P1|Overall Study|Ongoing at Date of Cut-Off|5
5579215|NCT01050634|19277097|P1|Overall Study|Other|21
5579216|NCT01050634|19277097|P1|Overall Study|Lost to Follow-up|2
5579217|NCT01050634|19277097|P1|Overall Study|Adverse Event|42
5579218|NCT01050634|19277097|P1|Overall Study|Death|2
5579219|NCT01050634|19277097|P1|Overall Study|Enrolled, but Not Treated|56
5579220|NCT01050569|19277121|P3|Overall Study|Physician Decision|3
5579221|NCT01050569|19277122|P2|Overall Study|Physician Decision|3
5579222|NCT01050569|19277123|P1|Overall Study|Physician Decision|3
5579223|NCT01050569|19277121|P3|Overall Study|Adverse Event|0
5579224|NCT01050569|19277122|P2|Overall Study|Adverse Event|0
5579225|NCT01050569|19277123|P1|Overall Study|Adverse Event|1
5579226|NCT01050569|19277121|P3|Overall Study|Lack of Efficacy|3
5579227|NCT01050569|19277122|P2|Overall Study|Lack of Efficacy|4
5579228|NCT01050569|19277123|P1|Overall Study|Lack of Efficacy|5
5579229|NCT01050569|19277121|P3|Overall Study|Withdrawal by Subject|11
5579230|NCT01050569|19277122|P2|Overall Study|Withdrawal by Subject|3
5579231|NCT01050569|19277123|P1|Overall Study|Withdrawal by Subject|9
5579232|NCT01050569|19277121|P3|Overall Study|Lost to Follow-up|16
5579233|NCT01050569|19277122|P2|Overall Study|Lost to Follow-up|14
5579234|NCT01050569|19277123|P1|Overall Study|Lost to Follow-up|20
5579235|NCT01050543|19277142|P2|Overall Study|Administrative|1
5579236|NCT01050543|19277143|P1|Overall Study|Administrative|4
5579237|NCT01050543|19277142|P2|Overall Study|Protocol Violation|1
5579238|NCT01050543|19277143|P1|Overall Study|Protocol Violation|0
5579239|NCT01050543|19277142|P2|Overall Study|Withdrawal by Subject|2
5579240|NCT01050543|19277143|P1|Overall Study|Withdrawal by Subject|0
5579241|NCT01050530|19277151|P2|Overall Study|Protocol Violation|0
5579242|NCT01050530|19277152|P1|Overall Study|Protocol Violation|1
5579243|NCT01050530|19277151|P2|Overall Study|Withdrawal by Subject|3
5579244|NCT01050530|19277152|P1|Overall Study|Withdrawal by Subject|0
5579245|NCT01050530|19277151|P2|Overall Study|Lack of Efficacy|4
5579246|NCT01050530|19277152|P1|Overall Study|Lack of Efficacy|1
5579247|NCT01050530|19277151|P2|Overall Study|Adverse Event|3
5579248|NCT01050530|19277152|P1|Overall Study|Adverse Event|6
5579249|NCT01050257|19277163|P3|Overall Study|Death|1
5579250|NCT01050257|19277164|P2|Overall Study|Death|0
5579251|NCT01050257|19277165|P1|Overall Study|Death|0
5579252|NCT01050257|19277163|P3|Overall Study|Failure to return|0
5579253|NCT01050257|19277164|P2|Overall Study|Failure to return|2
5579254|NCT01050257|19277165|P1|Overall Study|Failure to return|0
5579255|NCT01050257|19277163|P3|Overall Study|Violation criteria|0
5579256|NCT01050257|19277164|P2|Overall Study|Violation criteria|1
5579257|NCT01050257|19277165|P1|Overall Study|Violation criteria|0
5579258|NCT01050257|19277163|P3|Overall Study|Refused treatment/ Did not Cooperate|0
5579259|NCT01050257|19277164|P2|Overall Study|Refused treatment/ Did not Cooperate|1
5579260|NCT01050257|19277165|P1|Overall Study|Refused treatment/ Did not Cooperate|1
5579261|NCT01050257|19277163|P3|Overall Study|No reason specified|2
5579262|NCT01050257|19277164|P2|Overall Study|No reason specified|0
5579263|NCT01050257|19277165|P1|Overall Study|No reason specified|0
5579264|NCT01050257|19277163|P3|Overall Study|Withdrawal by Subject|0
5579265|NCT01050257|19277164|P2|Overall Study|Withdrawal by Subject|3
5579266|NCT01050257|19277165|P1|Overall Study|Withdrawal by Subject|0
5579267|NCT01050257|19277163|P3|Overall Study|Admin/Other (did not switch to oral)|2
5579268|NCT01050257|19277164|P2|Overall Study|Admin/Other (did not switch to oral)|2
5579269|NCT01050257|19277165|P1|Overall Study|Admin/Other (did not switch to oral)|6
5579270|NCT01050257|19277163|P3|Overall Study|Adverse Event|2
5579271|NCT01050257|19277164|P2|Overall Study|Adverse Event|4
5579272|NCT01050257|19277165|P1|Overall Study|Adverse Event|4
5579273|NCT01050218|19277200|P1|Overall Study|Family emergency|1
5579274|NCT01050218|19277200|P1|Overall Study|Serious Adverse Event|1
5579275|NCT01050218|19277200|P1|Overall Study|Failed to return|7
5579276|NCT01050218|19277200|P1|Overall Study|Compliance|2
5579277|NCT01050218|19277200|P1|Overall Study|Discontinued by sponsor|18
5579278|NCT01050218|19277200|P1|Overall Study|Withdrawal by Subject|18
5579279|NCT01050218|19277200|P1|Overall Study|Protocol Violation|3
5579280|NCT01050218|19277200|P1|Overall Study|Lack of Efficacy|8
5579281|NCT01050218|19277200|P1|Overall Study|Adverse Event|37
5579282|NCT01050205|19277206|P2|Overall Study|Discontinued Intervention|0
5579283|NCT01050205|19277207|P1|Overall Study|Discontinued Intervention|2
5579284|NCT01050205|19277206|P2|Overall Study|Relocated from area|2
5579285|NCT01050205|19277207|P1|Overall Study|Relocated from area|1
5579286|NCT01050205|19277206|P2|Overall Study|Withdrawal by Subject|1
5579287|NCT01050205|19277207|P1|Overall Study|Withdrawal by Subject|1
5579288|NCT01050205|19277206|P2|Overall Study|Lost to Follow-up|1
5579289|NCT01050205|19277207|P1|Overall Study|Lost to Follow-up|7
5579290|NCT01050062|19277264|P2|Overall Study|Others|11
5579291|NCT01050062|19277265|P1|Overall Study|Others|17
5579292|NCT01050062|19277264|P2|Overall Study|Physician Decision|9
5579293|NCT01050062|19277265|P1|Overall Study|Physician Decision|74
5579294|NCT01050062|19277264|P2|Overall Study|Lack of Efficacy|35
5579295|NCT01050062|19277265|P1|Overall Study|Lack of Efficacy|22
5579296|NCT01050062|19277264|P2|Overall Study|Lost to Follow-up|35
5579297|NCT01050062|19277265|P1|Overall Study|Lost to Follow-up|83
5579298|NCT01050062|19277264|P2|Overall Study|Adverse Event|22
5579299|NCT01050062|19277265|P1|Overall Study|Adverse Event|75
5579300|NCT01049984|19277287|P2|Overall Study|Treatment failure|2
5579301|NCT01049984|19277288|P1|Overall Study|Treatment failure|0
5579302|NCT01049984|19277287|P2|Overall Study|Adverse Event|7
5579303|NCT01049984|19277288|P1|Overall Study|Adverse Event|13
5579304|NCT01049984|19277287|P2|Overall Study|Lost to Follow-up|1
5579305|NCT01049984|19277288|P1|Overall Study|Lost to Follow-up|2
5579306|NCT01049984|19277287|P2|Overall Study|Protocol Violation|4
5579307|NCT01049984|19277288|P1|Overall Study|Protocol Violation|3
5579308|NCT01049984|19277287|P2|Overall Study|Withdrawal by Subject|5
5579309|NCT01049984|19277288|P1|Overall Study|Withdrawal by Subject|1
5579310|NCT01049581|19277352|P2|Overall Study|Lost to Follow-up|1
5579311|NCT01049581|19277353|P1|Overall Study|Lost to Follow-up|2
5579312|NCT01049503|19277368|P6|Overall Study|Lost to Follow-up|8
5579313|NCT01049503|19277369|P5|Overall Study|Lost to Follow-up|27
5579314|NCT01049503|19277370|P4|Overall Study|Lost to Follow-up|26
5579315|NCT01049503|19277371|P3|Overall Study|Lost to Follow-up|24
5579316|NCT01049503|19277372|P2|Overall Study|Lost to Follow-up|12
5579317|NCT01049503|19277373|P1|Overall Study|Lost to Follow-up|11
5579318|NCT01049412|19277404|P2|Period II|Lost to Follow-up|0
5579319|NCT01049412|19277405|P1|Period II|Lost to Follow-up|1
5579320|NCT01049412|19277404|P2|Period II|Adverse Event|0
5579321|NCT01049412|19277405|P1|Period II|Adverse Event|1
5579322|NCT01049412|19277404|P2|Period II|Withdrawal by Subject|3
5579323|NCT01049412|19277405|P1|Period II|Withdrawal by Subject|2
5579324|NCT01049412|19277404|P2|Period I|Adverse Event|0
5579325|NCT01049412|19277405|P1|Period I|Adverse Event|1
5579326|NCT01049412|19277404|P2|Period I|Protocol Violation|2
5579327|NCT01049412|19277405|P1|Period I|Protocol Violation|1
5579328|NCT01049412|19277404|P2|Period I|Physician Decision|3
5579329|NCT01049412|19277405|P1|Period I|Physician Decision|0
5579330|NCT01049412|19277404|P2|Period I|Lost to Follow-up|2
5579331|NCT01049412|19277405|P1|Period I|Lost to Follow-up|2
5579332|NCT01049412|19277404|P2|Period I|Withdrawal by Subject|6
5579333|NCT01049412|19277405|P1|Period I|Withdrawal by Subject|4
5579334|NCT01049373|19277434|P2|Overall Study|Non-cooperation|1
5579335|NCT01049373|19277435|P1|Overall Study|Non-cooperation|0
5579336|NCT01049373|19277434|P2|Overall Study|Other|1
5579337|NCT01049373|19277435|P1|Overall Study|Other|1
5579338|NCT01049373|19277434|P2|Overall Study|no evaluable study values|21
5579339|NCT01049373|19277435|P1|Overall Study|no evaluable study values|9
5579340|NCT01049373|19277434|P2|Overall Study|Lost to Follow-up|4
5579341|NCT01049373|19277435|P1|Overall Study|Lost to Follow-up|9
5579342|NCT01049373|19277434|P2|Overall Study|Adverse Event|3
5579343|NCT01049373|19277435|P1|Overall Study|Adverse Event|3
5579344|NCT01049373|19277434|P2|Overall Study|Withdrawal by Subject|5
5579345|NCT01049373|19277435|P1|Overall Study|Withdrawal by Subject|8
5579346|NCT01049373|19277434|P2|Overall Study|Protocol Violation|9
5579347|NCT01049373|19277435|P1|Overall Study|Protocol Violation|9
5579348|NCT01049360|19277449|P20|Period 4|Withdrawal by Subject|0
5579349|NCT01049360|19277450|P19|Period 4|Withdrawal by Subject|0
5579350|NCT01049360|19277451|P18|Period 4|Withdrawal by Subject|0
5579351|NCT01049360|19277452|P17|Period 4|Withdrawal by Subject|0
5579352|NCT01049360|19277453|P16|Period 4|Withdrawal by Subject|0
5579353|NCT01049360|19277454|P15|Period 4|Withdrawal by Subject|0
5579354|NCT01049360|19277455|P14|Period 4|Withdrawal by Subject|0
5579355|NCT01049360|19277456|P13|Period 4|Withdrawal by Subject|0
5579356|NCT01049360|19277457|P12|Period 4|Withdrawal by Subject|0
5579357|NCT01049360|19277458|P11|Period 4|Withdrawal by Subject|0
5579358|NCT01049360|19277459|P10|Period 4|Withdrawal by Subject|0
5579359|NCT01049360|19277460|P9|Period 4|Withdrawal by Subject|0
5579360|NCT01049360|19277461|P8|Period 4|Withdrawal by Subject|0
5579361|NCT01049360|19277462|P7|Period 4|Withdrawal by Subject|0
5579362|NCT01049360|19277463|P6|Period 4|Withdrawal by Subject|0
5579363|NCT01049360|19277464|P5|Period 4|Withdrawal by Subject|0
5579364|NCT01049360|19277465|P4|Period 4|Withdrawal by Subject|1
5579365|NCT01049360|19277466|P3|Period 4|Withdrawal by Subject|0
5579366|NCT01049360|19277467|P2|Period 4|Withdrawal by Subject|0
5579367|NCT01049360|19277468|P1|Period 4|Withdrawal by Subject|0
5579368|NCT01049360|19277449|P20|Period 4|Protocol Violation|0
5579369|NCT01049360|19277450|P19|Period 4|Protocol Violation|0
5579370|NCT01049360|19277451|P18|Period 4|Protocol Violation|1
5579371|NCT01049360|19277452|P17|Period 4|Protocol Violation|0
5579372|NCT01049360|19277453|P16|Period 4|Protocol Violation|0
5579373|NCT01049360|19277454|P15|Period 4|Protocol Violation|0
5579374|NCT01049360|19277455|P14|Period 4|Protocol Violation|0
5579375|NCT01049360|19277456|P13|Period 4|Protocol Violation|0
5579376|NCT01049360|19277457|P12|Period 4|Protocol Violation|0
5579377|NCT01049360|19277458|P11|Period 4|Protocol Violation|0
5579378|NCT01049360|19277459|P10|Period 4|Protocol Violation|0
5579379|NCT01049360|19277460|P9|Period 4|Protocol Violation|0
5579380|NCT01049360|19277461|P8|Period 4|Protocol Violation|0
5579381|NCT01049360|19277462|P7|Period 4|Protocol Violation|0
5579382|NCT01049360|19277463|P6|Period 4|Protocol Violation|0
5579383|NCT01049360|19277464|P5|Period 4|Protocol Violation|0
5579384|NCT01049360|19277465|P4|Period 4|Protocol Violation|0
5579385|NCT01049360|19277466|P3|Period 4|Protocol Violation|0
5579386|NCT01049360|19277467|P2|Period 4|Protocol Violation|0
5579387|NCT01049360|19277468|P1|Period 4|Protocol Violation|0
5579388|NCT01049360|19277449|P20|Period 2|Lack of Efficacy|0
5579389|NCT01049360|19277450|P19|Period 2|Lack of Efficacy|0
5579390|NCT01049360|19277451|P18|Period 2|Lack of Efficacy|0
5579391|NCT01049360|19277452|P17|Period 2|Lack of Efficacy|0
5579392|NCT01049360|19277453|P16|Period 2|Lack of Efficacy|0
5579393|NCT01049360|19277454|P15|Period 2|Lack of Efficacy|0
5579394|NCT01049360|19277455|P14|Period 2|Lack of Efficacy|0
5579395|NCT01049360|19277456|P13|Period 2|Lack of Efficacy|0
5579396|NCT01049360|19277457|P12|Period 2|Lack of Efficacy|0
5579397|NCT01049360|19277458|P11|Period 2|Lack of Efficacy|0
5579398|NCT01049360|19277459|P10|Period 2|Lack of Efficacy|0
5579399|NCT01049360|19277460|P9|Period 2|Lack of Efficacy|0
5579400|NCT01049360|19277461|P8|Period 2|Lack of Efficacy|0
5579401|NCT01049360|19277462|P7|Period 2|Lack of Efficacy|0
5579402|NCT01049360|19277463|P6|Period 2|Lack of Efficacy|1
5579403|NCT01049360|19277464|P5|Period 2|Lack of Efficacy|0
5579404|NCT01049360|19277465|P4|Period 2|Lack of Efficacy|0
5579405|NCT01049360|19277466|P3|Period 2|Lack of Efficacy|0
5579406|NCT01049360|19277467|P2|Period 2|Lack of Efficacy|0
5579407|NCT01049360|19277468|P1|Period 2|Lack of Efficacy|0
5579408|NCT01049360|19277449|P20|Period 2|Withdrawal by Subject|1
5579409|NCT01049360|19277450|P19|Period 2|Withdrawal by Subject|0
5579410|NCT01049360|19277451|P18|Period 2|Withdrawal by Subject|0
5579411|NCT01049360|19277452|P17|Period 2|Withdrawal by Subject|0
5579412|NCT01049360|19277453|P16|Period 2|Withdrawal by Subject|0
5579413|NCT01049360|19277454|P15|Period 2|Withdrawal by Subject|1
5579414|NCT01049360|19277455|P14|Period 2|Withdrawal by Subject|0
5579415|NCT01049360|19277456|P13|Period 2|Withdrawal by Subject|0
5579416|NCT01049360|19277457|P12|Period 2|Withdrawal by Subject|0
5579417|NCT01049360|19277458|P11|Period 2|Withdrawal by Subject|0
5579418|NCT01049360|19277459|P10|Period 2|Withdrawal by Subject|0
5579419|NCT01049360|19277460|P9|Period 2|Withdrawal by Subject|0
5579420|NCT01049360|19277461|P8|Period 2|Withdrawal by Subject|0
5579421|NCT01049360|19277462|P7|Period 2|Withdrawal by Subject|0
5579422|NCT01049360|19277463|P6|Period 2|Withdrawal by Subject|0
5579423|NCT01049360|19277464|P5|Period 2|Withdrawal by Subject|0
5579424|NCT01049360|19277465|P4|Period 2|Withdrawal by Subject|1
5579425|NCT01049360|19277466|P3|Period 2|Withdrawal by Subject|0
5579426|NCT01049360|19277467|P2|Period 2|Withdrawal by Subject|0
5579427|NCT01049360|19277468|P1|Period 2|Withdrawal by Subject|0
5579428|NCT01049360|19277449|P20|Period 2|Adverse Event|1
5579429|NCT01049360|19277450|P19|Period 2|Adverse Event|0
5579430|NCT01049360|19277451|P18|Period 2|Adverse Event|0
5579431|NCT01049360|19277452|P17|Period 2|Adverse Event|0
5579432|NCT01049360|19277453|P16|Period 2|Adverse Event|0
5579433|NCT01049360|19277454|P15|Period 2|Adverse Event|0
5579434|NCT01049360|19277455|P14|Period 2|Adverse Event|0
5579435|NCT01049360|19277456|P13|Period 2|Adverse Event|0
5579436|NCT01049360|19277457|P12|Period 2|Adverse Event|0
5579437|NCT01049360|19277458|P11|Period 2|Adverse Event|0
5579438|NCT01049360|19277459|P10|Period 2|Adverse Event|0
5579439|NCT01049360|19277460|P9|Period 2|Adverse Event|1
5579440|NCT01049360|19277461|P8|Period 2|Adverse Event|0
5579441|NCT01049360|19277462|P7|Period 2|Adverse Event|0
5579442|NCT01049360|19277463|P6|Period 2|Adverse Event|0
5579443|NCT01049360|19277464|P5|Period 2|Adverse Event|0
5579444|NCT01049360|19277465|P4|Period 2|Adverse Event|0
5579445|NCT01049360|19277466|P3|Period 2|Adverse Event|0
5579446|NCT01049360|19277467|P2|Period 2|Adverse Event|1
5579447|NCT01049360|19277468|P1|Period 2|Adverse Event|0
5579448|NCT01049360|19277449|P20|Period 2|Protocol Violation|0
5579449|NCT01049360|19277450|P19|Period 2|Protocol Violation|0
5579450|NCT01049360|19277451|P18|Period 2|Protocol Violation|0
5579451|NCT01049360|19277452|P17|Period 2|Protocol Violation|0
5579452|NCT01049360|19277453|P16|Period 2|Protocol Violation|1
5579453|NCT01049360|19277454|P15|Period 2|Protocol Violation|1
5579454|NCT01049360|19277455|P14|Period 2|Protocol Violation|0
5579455|NCT01049360|19277456|P13|Period 2|Protocol Violation|0
5579456|NCT01049360|19277457|P12|Period 2|Protocol Violation|0
5579457|NCT01049360|19277458|P11|Period 2|Protocol Violation|0
5579458|NCT01049360|19277459|P10|Period 2|Protocol Violation|0
5579459|NCT01049360|19277460|P9|Period 2|Protocol Violation|0
5579460|NCT01049360|19277461|P8|Period 2|Protocol Violation|0
5579461|NCT01049360|19277462|P7|Period 2|Protocol Violation|0
5579462|NCT01049360|19277463|P6|Period 2|Protocol Violation|0
5579463|NCT01049360|19277464|P5|Period 2|Protocol Violation|0
5579464|NCT01049360|19277465|P4|Period 2|Protocol Violation|1
5579465|NCT01049360|19277466|P3|Period 2|Protocol Violation|0
5579466|NCT01049360|19277467|P2|Period 2|Protocol Violation|0
5579467|NCT01049360|19277468|P1|Period 2|Protocol Violation|0
5579468|NCT01049360|19277449|P20|Period 1|Withdrawal by Subject|0
5579469|NCT01049360|19277450|P19|Period 1|Withdrawal by Subject|0
5579470|NCT01049360|19277451|P18|Period 1|Withdrawal by Subject|0
5579471|NCT01049360|19277452|P17|Period 1|Withdrawal by Subject|0
5579472|NCT01049360|19277453|P16|Period 1|Withdrawal by Subject|0
5579473|NCT01049360|19277454|P15|Period 1|Withdrawal by Subject|0
5579474|NCT01049360|19277455|P14|Period 1|Withdrawal by Subject|0
5579475|NCT01049360|19277456|P13|Period 1|Withdrawal by Subject|1
5579476|NCT01049360|19277457|P12|Period 1|Withdrawal by Subject|0
5579477|NCT01049360|19277458|P11|Period 1|Withdrawal by Subject|1
5579478|NCT01049360|19277459|P10|Period 1|Withdrawal by Subject|0
5579479|NCT01049360|19277460|P9|Period 1|Withdrawal by Subject|1
5579480|NCT01049360|19277461|P8|Period 1|Withdrawal by Subject|0
5579481|NCT01049360|19277462|P7|Period 1|Withdrawal by Subject|0
5579482|NCT01049360|19277463|P6|Period 1|Withdrawal by Subject|0
5579483|NCT01049360|19277464|P5|Period 1|Withdrawal by Subject|0
5579484|NCT01049360|19277465|P4|Period 1|Withdrawal by Subject|0
5579485|NCT01049360|19277466|P3|Period 1|Withdrawal by Subject|0
5579486|NCT01049360|19277467|P2|Period 1|Withdrawal by Subject|0
5579487|NCT01049360|19277468|P1|Period 1|Withdrawal by Subject|0
5579488|NCT01049360|19277449|P20|Period 1|Did not meet inc/exc criteria|0
5579489|NCT01049360|19277450|P19|Period 1|Did not meet inc/exc criteria|0
5579490|NCT01049360|19277451|P18|Period 1|Did not meet inc/exc criteria|0
5579491|NCT01049360|19277452|P17|Period 1|Did not meet inc/exc criteria|0
5579492|NCT01049360|19277453|P16|Period 1|Did not meet inc/exc criteria|0
5579493|NCT01049360|19277454|P15|Period 1|Did not meet inc/exc criteria|0
5579494|NCT01049360|19277455|P14|Period 1|Did not meet inc/exc criteria|0
5579495|NCT01049360|19277456|P13|Period 1|Did not meet inc/exc criteria|0
5579496|NCT01049360|19277457|P12|Period 1|Did not meet inc/exc criteria|0
5579497|NCT01049360|19277458|P11|Period 1|Did not meet inc/exc criteria|0
5579498|NCT01049360|19277459|P10|Period 1|Did not meet inc/exc criteria|0
5579499|NCT01049360|19277460|P9|Period 1|Did not meet inc/exc criteria|1
5579500|NCT01049360|19277461|P8|Period 1|Did not meet inc/exc criteria|1
5579501|NCT01049360|19277462|P7|Period 1|Did not meet inc/exc criteria|0
5579502|NCT01049360|19277463|P6|Period 1|Did not meet inc/exc criteria|0
5579503|NCT01049360|19277464|P5|Period 1|Did not meet inc/exc criteria|0
5579504|NCT01049360|19277465|P4|Period 1|Did not meet inc/exc criteria|0
5579505|NCT01049360|19277466|P3|Period 1|Did not meet inc/exc criteria|0
5579506|NCT01049360|19277467|P2|Period 1|Did not meet inc/exc criteria|0
5579507|NCT01049360|19277468|P1|Period 1|Did not meet inc/exc criteria|0
5579508|NCT01049360|19277449|P20|Period 1|Adverse Event|0
5579509|NCT01049360|19277450|P19|Period 1|Adverse Event|1
5579510|NCT01049360|19277451|P18|Period 1|Adverse Event|0
5579511|NCT01049360|19277452|P17|Period 1|Adverse Event|1
5579512|NCT01049360|19277453|P16|Period 1|Adverse Event|0
5579513|NCT01049360|19277454|P15|Period 1|Adverse Event|0
5579514|NCT01049360|19277455|P14|Period 1|Adverse Event|1
5579515|NCT01049360|19277456|P13|Period 1|Adverse Event|1
5579516|NCT01049360|19277457|P12|Period 1|Adverse Event|0
5579517|NCT01049360|19277458|P11|Period 1|Adverse Event|0
5579518|NCT01049360|19277459|P10|Period 1|Adverse Event|0
5579519|NCT01049360|19277460|P9|Period 1|Adverse Event|0
5579520|NCT01049360|19277461|P8|Period 1|Adverse Event|1
5579521|NCT01049360|19277462|P7|Period 1|Adverse Event|0
5579522|NCT01049360|19277463|P6|Period 1|Adverse Event|0
5579523|NCT01049360|19277464|P5|Period 1|Adverse Event|0
5579524|NCT01049360|19277465|P4|Period 1|Adverse Event|1
5579525|NCT01049360|19277466|P3|Period 1|Adverse Event|0
5579526|NCT01049360|19277467|P2|Period 1|Adverse Event|1
5579527|NCT01049360|19277468|P1|Period 1|Adverse Event|0
5579528|NCT01049334|19277492|P2|Overall Study|Protocol Violation|1
5579529|NCT01049334|19277493|P1|Overall Study|Protocol Violation|0
5579530|NCT01049334|19277492|P2|Overall Study|Physician Decision|0
5579531|NCT01049334|19277493|P1|Overall Study|Physician Decision|2
5579532|NCT01049334|19277492|P2|Overall Study|Adverse Event|3
5579533|NCT01049334|19277493|P1|Overall Study|Adverse Event|2
5579534|NCT01049334|19277492|P2|Overall Study|Withdrawal by Subject|3
5579535|NCT01049334|19277493|P1|Overall Study|Withdrawal by Subject|5
5579536|NCT01049308|19277529|P1|Pill Counts|Withdrawal by Subject|83
5579537|NCT01049217|19277543|P2|Overall Study|Randomized but not Treated|2
5579538|NCT01049217|19277544|P1|Overall Study|Randomized but not Treated|0
5579539|NCT01049217|19277543|P2|Overall Study|Other|2
5579540|NCT01049217|19277544|P1|Overall Study|Other|1
5579541|NCT01049217|19277543|P2|Overall Study|Study Terminated by Sponsor|43
5579542|NCT01049217|19277544|P1|Overall Study|Study Terminated by Sponsor|43
5579543|NCT01049217|19277543|P2|Overall Study|Pregnancy|0
5579544|NCT01049217|19277544|P1|Overall Study|Pregnancy|1
5579545|NCT01049217|19277543|P2|Overall Study|Protocol Violation|3
5579546|NCT01049217|19277544|P1|Overall Study|Protocol Violation|1
5579547|NCT01049217|19277543|P2|Overall Study|Withdrawal by Subject|3
5579548|NCT01049217|19277544|P1|Overall Study|Withdrawal by Subject|4
5579549|NCT01049217|19277543|P2|Overall Study|Lost to Follow-up|8
5579550|NCT01049217|19277544|P1|Overall Study|Lost to Follow-up|3
5579551|NCT01049217|19277543|P2|Overall Study|Lack of Efficacy|1
5579552|NCT01049217|19277544|P1|Overall Study|Lack of Efficacy|1
5579553|NCT01049217|19277543|P2|Overall Study|Adverse Event|1
5579554|NCT01049217|19277544|P1|Overall Study|Adverse Event|2
5579555|NCT01049035|19277621|P7|Overall Study|Voluntary withdrawal not due to an AE|2
5579556|NCT01049035|19277622|P6|Overall Study|Voluntary withdrawal not due to an AE|5
5579557|NCT01049035|19277623|P5|Overall Study|Voluntary withdrawal not due to an AE|1
5579558|NCT01049035|19277624|P4|Overall Study|Voluntary withdrawal not due to an AE|2
5579559|NCT01049035|19277625|P3|Overall Study|Voluntary withdrawal not due to an AE|8
5579560|NCT01049035|19277626|P2|Overall Study|Voluntary withdrawal not due to an AE|10
5579561|NCT01049035|19277627|P1|Overall Study|Voluntary withdrawal not due to an AE|16
5579562|NCT01049035|19277621|P7|Overall Study|Lost to Follow-up|3
5579563|NCT01049035|19277622|P6|Overall Study|Lost to Follow-up|3
5579564|NCT01049035|19277623|P5|Overall Study|Lost to Follow-up|0
5579565|NCT01049035|19277624|P4|Overall Study|Lost to Follow-up|1
5579566|NCT01049035|19277625|P3|Overall Study|Lost to Follow-up|4
5579567|NCT01049035|19277626|P2|Overall Study|Lost to Follow-up|4
5579568|NCT01049035|19277627|P1|Overall Study|Lost to Follow-up|5
5579569|NCT01049035|19277621|P7|Overall Study|Non-compliance with the protocol|10
5579570|NCT01049035|19277622|P6|Overall Study|Non-compliance with the protocol|4
5579571|NCT01049035|19277623|P5|Overall Study|Non-compliance with the protocol|3
5579572|NCT01049035|19277624|P4|Overall Study|Non-compliance with the protocol|5
5579573|NCT01049035|19277625|P3|Overall Study|Non-compliance with the protocol|14
5579574|NCT01049035|19277626|P2|Overall Study|Non-compliance with the protocol|6
5579575|NCT01049035|19277627|P1|Overall Study|Non-compliance with the protocol|12
5579576|NCT01049035|19277621|P7|Overall Study|Other adverse event (AE)|0
5579577|NCT01049035|19277622|P6|Overall Study|Other adverse event (AE)|0
5579578|NCT01049035|19277623|P5|Overall Study|Other adverse event (AE)|0
5579579|NCT01049035|19277624|P4|Overall Study|Other adverse event (AE)|1
5579580|NCT01049035|19277625|P3|Overall Study|Other adverse event (AE)|0
5579581|NCT01049035|19277626|P2|Overall Study|Other adverse event (AE)|0
5579582|NCT01049035|19277627|P1|Overall Study|Other adverse event (AE)|0
5579583|NCT01049035|19277621|P7|Overall Study|Serious adverse event|0
5579584|NCT01049035|19277622|P6|Overall Study|Serious adverse event|0
5579585|NCT01049035|19277623|P5|Overall Study|Serious adverse event|0
5579586|NCT01049035|19277624|P4|Overall Study|Serious adverse event|2
5579587|NCT01049035|19277625|P3|Overall Study|Serious adverse event|1
5579588|NCT01049035|19277626|P2|Overall Study|Serious adverse event|1
5579589|NCT01049035|19277627|P1|Overall Study|Serious adverse event|0
5579590|NCT01049009|19277786|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
5579591|NCT01049009|19277787|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
5579592|NCT01049009|19277786|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
5579593|NCT01049009|19277787|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
5579594|NCT01049009|19277786|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
5579595|NCT01049009|19277787|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
5579596|NCT01049009|19277786|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5579597|NCT01049009|19277787|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
5579598|NCT01048944|19277799|P4|Overall Study|Protocol Violation|2
5579599|NCT01048944|19277800|P3|Overall Study|Protocol Violation|10
5579600|NCT01048944|19277801|P2|Overall Study|Protocol Violation|10
5579601|NCT01048944|19277802|P1|Overall Study|Protocol Violation|8
5579602|NCT01048866|19277834|P2|Overall Study|Other|1
5579603|NCT01048866|19277835|P1|Overall Study|Other|1
5579604|NCT01048866|19277834|P2|Overall Study|Lost to Follow-up|2
5579605|NCT01048866|19277835|P1|Overall Study|Lost to Follow-up|0
5579606|NCT01048866|19277834|P2|Overall Study|Withdrawal by Subject|2
5579607|NCT01048866|19277835|P1|Overall Study|Withdrawal by Subject|0
5579608|NCT01048866|19277834|P2|Overall Study|Physician Decision|0
5579609|NCT01048866|19277835|P1|Overall Study|Physician Decision|1
5579610|NCT01048866|19277834|P2|Overall Study|Protocol Violation|0
5579611|NCT01048866|19277835|P1|Overall Study|Protocol Violation|1
5579612|NCT01048866|19277834|P2|Overall Study|Adverse Event|0
5579613|NCT01048866|19277835|P1|Overall Study|Adverse Event|1
5579614|NCT01048788|19277880|P3|Overall Study|Withdrawal by Subject|0
5579615|NCT01048788|19277881|P2|Overall Study|Withdrawal by Subject|1
5579616|NCT01048788|19277882|P1|Overall Study|Withdrawal by Subject|0
5579617|NCT01048788|19277880|P3|Overall Study|Lack of Efficacy|1
5579618|NCT01048788|19277881|P2|Overall Study|Lack of Efficacy|0
5579619|NCT01048788|19277882|P1|Overall Study|Lack of Efficacy|0
5579620|NCT01048788|19277880|P3|Overall Study|Adverse Event|1
5579621|NCT01048788|19277881|P2|Overall Study|Adverse Event|1
5579622|NCT01048788|19277882|P1|Overall Study|Adverse Event|5
5579623|NCT01048671|19277904|P3|Overall Study|Protocol Violation|1
5579624|NCT01048671|19277905|P2|Overall Study|Protocol Violation|1
5579625|NCT01048671|19277906|P1|Overall Study|Protocol Violation|0
5579626|NCT01048541|19277986|P2|Overall Study|Withdrawal by Subject|0
5579627|NCT01048541|19277987|P1|Overall Study|Withdrawal by Subject|1
5579628|NCT01048502|19277997|P4|Overall Study|Physician Decision|1
5579629|NCT01048502|19277998|P3|Overall Study|Physician Decision|0
5579630|NCT01048502|19277999|P2|Overall Study|Physician Decision|3
5579631|NCT01048502|19278000|P1|Overall Study|Physician Decision|0
5579632|NCT01048502|19277997|P4|Overall Study|Withdrawal by Subject|3
5579633|NCT01048502|19277998|P3|Overall Study|Withdrawal by Subject|5
5579634|NCT01048502|19277999|P2|Overall Study|Withdrawal by Subject|4
5579635|NCT01048502|19278000|P1|Overall Study|Withdrawal by Subject|1
5579636|NCT01048502|19277997|P4|Overall Study|Adverse Event|0
5579637|NCT01048502|19277998|P3|Overall Study|Adverse Event|0
5579638|NCT01048502|19277999|P2|Overall Study|Adverse Event|0
5579639|NCT01048502|19278000|P1|Overall Study|Adverse Event|1
5579640|NCT01048502|19277997|P4|Overall Study|Lost to Follow-up|0
5579641|NCT01048502|19277998|P3|Overall Study|Lost to Follow-up|0
5579642|NCT01048502|19277999|P2|Overall Study|Lost to Follow-up|0
5579643|NCT01048502|19278000|P1|Overall Study|Lost to Follow-up|2
5579644|NCT01048333|19278036|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5579645|NCT01048333|19278037|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5579646|NCT01048333|19278038|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5579647|NCT01048333|19278039|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5579648|NCT01048333|19278040|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
5579649|NCT01048333|19278041|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
5579650|NCT01048242|19278063|P2|Overall Study|See study flow chart|2
5579651|NCT01048242|19278064|P1|Overall Study|See study flow chart|4
5579652|NCT01048099|19278079|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
5579653|NCT01048099|19278079|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
5579654|NCT01047553|19278127|P2|Overall Study|PI's decision|1
5579655|NCT01047553|19278128|P1|Overall Study|PI's decision|0
5579656|NCT01047553|19278127|P2|Overall Study|Sever Non-Compliance to Protocol|0
5579657|NCT01047553|19278128|P1|Overall Study|Sever Non-Compliance to Protocol|1
5579658|NCT01047553|19278127|P2|Overall Study|Lost to Follow-up|0
5579659|NCT01047553|19278128|P1|Overall Study|Lost to Follow-up|1
5579660|NCT01047553|19278127|P2|Overall Study|Development of Study-Specific Withdrawal|1
5579661|NCT01047553|19278128|P1|Overall Study|Development of Study-Specific Withdrawal|1
5579662|NCT01047553|19278127|P2|Overall Study|Withdrawal by Subject|2
5579663|NCT01047553|19278128|P1|Overall Study|Withdrawal by Subject|4
5579664|NCT01047553|19278127|P2|Overall Study|Adverse Event|5
5579665|NCT01047553|19278128|P1|Overall Study|Adverse Event|10
5579666|NCT01047436|19278235|P2|Overall Study|Protocol Violation|0
5579667|NCT01047436|19278236|P1|Overall Study|Protocol Violation|1
5579668|NCT01047345|19278261|P3|Extension|Lost to Follow-up|5
5579669|NCT01047345|19278262|P2|Extension|Lost to Follow-up|0
5579670|NCT01047345|19278263|P1|Extension|Lost to Follow-up|0
5579671|NCT01047345|19278261|P3|Extension|Withdrawal by Subject|1
5579672|NCT01047345|19278262|P2|Extension|Withdrawal by Subject|0
5579673|NCT01047345|19278263|P1|Extension|Withdrawal by Subject|0
5579674|NCT01047345|19278261|P3|Base Study|Withdrawal by Subject|0
5579675|NCT01047345|19278262|P2|Base Study|Withdrawal by Subject|4
5579676|NCT01047345|19278263|P1|Base Study|Withdrawal by Subject|12
5579677|NCT01047345|19278261|P3|Base Study|Protocol Violation|0
5579678|NCT01047345|19278262|P2|Base Study|Protocol Violation|1
5579679|NCT01047345|19278263|P1|Base Study|Protocol Violation|3
5579680|NCT01047345|19278261|P3|Base Study|Lost to Follow-up|0
5579681|NCT01047345|19278262|P2|Base Study|Lost to Follow-up|1
5579682|NCT01047345|19278263|P1|Base Study|Lost to Follow-up|4
5579683|NCT01047345|19278261|P3|Base Study|Adverse Event|0
5579684|NCT01047345|19278262|P2|Base Study|Adverse Event|0
5579685|NCT01047345|19278263|P1|Base Study|Adverse Event|3
5579686|NCT01047332|19278285|P2|Overall Study|Lost to Follow-up|3
5579687|NCT01047332|19278286|P1|Overall Study|Lost to Follow-up|8
5579688|NCT01047332|19278285|P2|Overall Study|Died Unobstructed|41
5579689|NCT01047332|19278286|P1|Overall Study|Died Unobstructed|38
5579690|NCT01047332|19278285|P2|Overall Study|SEMS Obstruction|20
5579691|NCT01047332|19278286|P1|Overall Study|SEMS Obstruction|11
5579692|NCT01047319|19278301|P3|Overall Study|Study terminated by Sponsor|203
5579693|NCT01047319|19278302|P2|Overall Study|Study terminated by Sponsor|215
5579694|NCT01047319|19278303|P1|Overall Study|Study terminated by Sponsor|198
5579695|NCT01047319|19278301|P3|Overall Study|Withdrawal by Subject|87
5579696|NCT01047319|19278302|P2|Overall Study|Withdrawal by Subject|75
5579697|NCT01047319|19278303|P1|Overall Study|Withdrawal by Subject|77
5579698|NCT01047319|19278301|P3|Overall Study|Adverse Event|21
5579699|NCT01047319|19278302|P2|Overall Study|Adverse Event|27
5579700|NCT01047319|19278303|P1|Overall Study|Adverse Event|16
5579701|NCT01047319|19278301|P3|Overall Study|Lost to Follow-up|10
5579702|NCT01047319|19278302|P2|Overall Study|Lost to Follow-up|10
5579703|NCT01047319|19278303|P1|Overall Study|Lost to Follow-up|14
5579704|NCT01047319|19278301|P3|Overall Study|Physician Decision|10
5579705|NCT01047319|19278302|P2|Overall Study|Physician Decision|9
5579706|NCT01047319|19278303|P1|Overall Study|Physician Decision|12
5579707|NCT01047319|19278301|P3|Overall Study|Pregnancy|8
5579708|NCT01047319|19278302|P2|Overall Study|Pregnancy|8
5579709|NCT01047319|19278303|P1|Overall Study|Pregnancy|13
5579710|NCT01047319|19278301|P3|Overall Study|Death|5
5579711|NCT01047319|19278302|P2|Overall Study|Death|1
5579712|NCT01047319|19278303|P1|Overall Study|Death|5
5579713|NCT01047319|19278301|P3|Overall Study|Lack of Efficacy|3
5579714|NCT01047319|19278302|P2|Overall Study|Lack of Efficacy|3
5579715|NCT01047319|19278303|P1|Overall Study|Lack of Efficacy|4
5579716|NCT01047319|19278301|P3|Overall Study|Protocol Violation|4
5579717|NCT01047319|19278302|P2|Overall Study|Protocol Violation|2
5579718|NCT01047319|19278303|P1|Overall Study|Protocol Violation|3
5579719|NCT01047319|19278301|P3|Overall Study|Teva requested participant withdrawal|1
5579720|NCT01047319|19278302|P2|Overall Study|Teva requested participant withdrawal|0
5579721|NCT01047319|19278303|P1|Overall Study|Teva requested participant withdrawal|3
5579722|NCT01047306|19278325|P2|Overall Study|Lost to Follow-up|0
5579723|NCT01047306|19278326|P1|Overall Study|Lost to Follow-up|1
5579724|NCT01047306|19278325|P2|Overall Study|Withdrawal by Subject|0
5579725|NCT01047306|19278326|P1|Overall Study|Withdrawal by Subject|2
5579726|NCT01047293|19278400|P4|Overall Study|DLT criteria not fulfilled|0
5579727|NCT01047293|19278401|P3|Overall Study|DLT criteria not fulfilled|0
5579728|NCT01047293|19278402|P2|Overall Study|DLT criteria not fulfilled|1
5579729|NCT01047293|19278403|P1|Overall Study|DLT criteria not fulfilled|1
5579730|NCT01047007|19278434|P4|Overall Study|Progressive Disease|0
5579731|NCT01047007|19278435|P3|Overall Study|Progressive Disease|1
5579732|NCT01047007|19278436|P2|Overall Study|Progressive Disease|4
5579733|NCT01047007|19278437|P1|Overall Study|Progressive Disease|2
5579734|NCT01047007|19278434|P4|Overall Study|Adverse Event|0
5579735|NCT01047007|19278435|P3|Overall Study|Adverse Event|1
5579736|NCT01047007|19278436|P2|Overall Study|Adverse Event|2
5579737|NCT01047007|19278437|P1|Overall Study|Adverse Event|0
5579738|NCT01046903|19278448|P1|Overall Study|Other|5
5579739|NCT01046903|19278448|P1|Overall Study|Withdrawal by Subject|3
5579740|NCT01046903|19278448|P1|Overall Study|Adverse Event|4
5579741|NCT01046903|19278448|P1|Overall Study|Lost to Follow-up|16
5579742|NCT01046877|19278461|P1|Overall Study|Exited voluntarily after tube extrusion|11
5579743|NCT01046877|19278461|P1|Overall Study|Exited voluntarily before tube extrusion|7
5579744|NCT01046695|19278477|P2|Overall Study|TENS interfered with the cardiac monitor|1
5579745|NCT01046695|19278478|P1|Overall Study|TENS interfered with the cardiac monitor|0
5579746|NCT01046695|19278477|P2|Overall Study|Subject had a pacemaker|1
5579747|NCT01046695|19278478|P1|Overall Study|Subject had a pacemaker|0
5579748|NCT01046682|19278490|P2|Overall Study|Adverse Event|0
5579749|NCT01046682|19278491|P1|Overall Study|Adverse Event|2
5579750|NCT01046643|19278508|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
5579751|NCT01046643|19278509|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
5579752|NCT01046643|19278510|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
5579753|NCT01046643|19278511|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
5579754|NCT01046565|19278533|P1|Overall Study|Withdrawal by Subject|7
5579755|NCT01046565|19278533|P1|Overall Study|Adverse Event|2
5579756|NCT01046396|19278542|P1|Overall Study|Withdrawal by Subject|5
5579757|NCT01046253|19278553|P2|Second Intervention|Protocol Violation|1
5579758|NCT01046253|19278554|P1|Second Intervention|Protocol Violation|0
5579759|NCT01046253|19278553|P2|Second Intervention|Adverse Event|1
5579760|NCT01046253|19278554|P1|Second Intervention|Adverse Event|0
5579761|NCT01046136|19278566|P2|Overall Study|Lost to Follow-up|3
5579762|NCT01046136|19278567|P1|Overall Study|Lost to Follow-up|3
5579763|NCT01046136|19278566|P2|Overall Study|Physician Decision|1
5579764|NCT01046136|19278567|P1|Overall Study|Physician Decision|1
5579765|NCT01046136|19278566|P2|Overall Study|Withdrawal by Subject|4
5579766|NCT01046136|19278567|P1|Overall Study|Withdrawal by Subject|0
5579767|NCT01046110|19278579|P2|Overall Study|Unclassified|35
5579768|NCT01046110|19278580|P1|Overall Study|Unclassified|36
5579769|NCT01046110|19278579|P2|Overall Study|Withdrawal Criteria|5
5579770|NCT01046110|19278580|P1|Overall Study|Withdrawal Criteria|3
5579771|NCT01046110|19278579|P2|Overall Study|Protocol Violation|12
5579772|NCT01046110|19278580|P1|Overall Study|Protocol Violation|7
5579773|NCT01046110|19278579|P2|Overall Study|Lack of Efficacy|1
5579774|NCT01046110|19278580|P1|Overall Study|Lack of Efficacy|0
5579775|NCT01046110|19278579|P2|Overall Study|Adverse Event|2
5579776|NCT01046110|19278580|P1|Overall Study|Adverse Event|9
5579777|NCT01046084|19278590|P2|Third Washout of 7 Days|Withdrawal by Subject|0
5579778|NCT01046084|19278591|P1|Third Washout of 7 Days|Withdrawal by Subject|2
5579779|NCT01045993|19278605|P4|Overall Study|Treated-later found eligibility not met|0
5579780|NCT01045993|19278606|P3|Overall Study|Treated-later found eligibility not met|0
5579781|NCT01045993|19278607|P2|Overall Study|Treated-later found eligibility not met|1
5579782|NCT01045993|19278608|P1|Overall Study|Treated-later found eligibility not met|0
5579783|NCT01045967|19278684|P2|Second Intervention|Protocol Violation|1
5579784|NCT01045967|19278685|P1|Second Intervention|Protocol Violation|0
5579785|NCT01045798|19278697|P2|Overall Study|Received Systemic Antifungal Prestudy|1
5579786|NCT01045798|19278698|P1|Overall Study|Received Systemic Antifungal Prestudy|0
5579787|NCT01045798|19278697|P2|Overall Study|Changed to Other Antifungal Therapy|2
5579788|NCT01045798|19278698|P1|Overall Study|Changed to Other Antifungal Therapy|1
5579789|NCT01045798|19278697|P2|Overall Study|Invasive Fungal Infection at Baseline|1
5579790|NCT01045798|19278698|P1|Overall Study|Invasive Fungal Infection at Baseline|0
5579791|NCT01045798|19278697|P2|Overall Study|Changed to Open-Label Caspofungin|0
5579792|NCT01045798|19278698|P1|Overall Study|Changed to Open-Label Caspofungin|1
5579793|NCT01045707|19278706|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
5579794|NCT01045707|19278707|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
5579795|NCT01045707|19278706|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
5579796|NCT01045707|19278707|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
5579797|NCT01045707|19278706|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
5579798|NCT01045707|19278707|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
5579799|NCT01045707|19278706|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
5579800|NCT01045707|19278707|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
5579801|NCT01045707|19278706|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
5579802|NCT01045707|19278707|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
5579803|NCT01045707|19278706|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
5579804|NCT01045707|19278707|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
5579805|NCT01045707|19278706|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
5579806|NCT01045707|19278707|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
5579807|NCT01045707|19278706|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
5579808|NCT01045707|19278707|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
5579809|NCT01045707|19278706|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
5579810|NCT01045707|19278707|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
5579811|NCT01045694|19278723|P1|Overall Study|Withdrawal by Subject|2
5579812|NCT01045460|19278744|P2|Overall Study|Lack of Efficacy|0
5579813|NCT01045460|19278745|P1|Overall Study|Lack of Efficacy|3
5579814|NCT01045460|19278744|P2|Overall Study|Lost to Follow-up|1
5579815|NCT01045460|19278745|P1|Overall Study|Lost to Follow-up|0
5579816|NCT01045460|19278744|P2|Overall Study|Physician Decision|2
5579817|NCT01045460|19278745|P1|Overall Study|Physician Decision|3
5579818|NCT01045447|19278757|P2|Overall Study|Unclassified|13
5579819|NCT01045447|19278758|P1|Overall Study|Unclassified|17
5579820|NCT01045447|19278757|P2|Overall Study|Withdrawal Criteria|10
5579821|NCT01045447|19278758|P1|Overall Study|Withdrawal Criteria|10
5579822|NCT01045447|19278757|P2|Overall Study|Protocol Violation|3
5579823|NCT01045447|19278758|P1|Overall Study|Protocol Violation|6
5579824|NCT01045447|19278757|P2|Overall Study|Lack of Efficacy|1
5579825|NCT01045447|19278758|P1|Overall Study|Lack of Efficacy|3
5579826|NCT01045447|19278757|P2|Overall Study|Adverse Event|1
5579827|NCT01045447|19278758|P1|Overall Study|Adverse Event|0
5579828|NCT01045421|19278772|P11|Phase 2|Other|1
5579829|NCT01045421|19278773|P10|Phase 2|Other|0
5579830|NCT01045421|19278774|P9|Phase 2|Other|0
5579831|NCT01045421|19278775|P8|Phase 2|Other|3
5579832|NCT01045421|19278776|P7|Phase 2|Other|0
5579833|NCT01045421|19278777|P6|Phase 2|Other|0
5579834|NCT01045421|19278778|P5|Phase 2|Other|0
5579835|NCT01045421|19278779|P4|Phase 2|Other|0
5579836|NCT01045421|19278780|P3|Phase 2|Other|0
5579837|NCT01045421|19278781|P2|Phase 2|Other|0
5579838|NCT01045421|19278782|P1|Phase 2|Other|0
5579839|NCT01045421|19278772|P11|Phase 2|Death|0
5579840|NCT01045421|19278773|P10|Phase 2|Death|2
5579841|NCT01045421|19278774|P9|Phase 2|Death|1
5579842|NCT01045421|19278775|P8|Phase 2|Death|1
5579843|NCT01045421|19278776|P7|Phase 2|Death|0
5579844|NCT01045421|19278777|P6|Phase 2|Death|0
5579845|NCT01045421|19278778|P5|Phase 2|Death|0
5579846|NCT01045421|19278779|P4|Phase 2|Death|0
5579847|NCT01045421|19278780|P3|Phase 2|Death|0
5579848|NCT01045421|19278781|P2|Phase 2|Death|0
5579849|NCT01045421|19278782|P1|Phase 2|Death|0
5579850|NCT01045421|19278772|P11|Phase 2|Progressive Disease|1
5579851|NCT01045421|19278773|P10|Phase 2|Progressive Disease|1
5579852|NCT01045421|19278774|P9|Phase 2|Progressive Disease|1
5579853|NCT01045421|19278775|P8|Phase 2|Progressive Disease|1
5579854|NCT01045421|19278776|P7|Phase 2|Progressive Disease|0
5579855|NCT01045421|19278777|P6|Phase 2|Progressive Disease|0
5579856|NCT01045421|19278778|P5|Phase 2|Progressive Disease|0
5579857|NCT01045421|19278779|P4|Phase 2|Progressive Disease|0
5579858|NCT01045421|19278780|P3|Phase 2|Progressive Disease|0
5579859|NCT01045421|19278781|P2|Phase 2|Progressive Disease|0
5579860|NCT01045421|19278782|P1|Phase 2|Progressive Disease|0
5579861|NCT01045421|19278772|P11|Phase 1|Withdrawal by Subject|0
5579862|NCT01045421|19278773|P10|Phase 1|Withdrawal by Subject|0
5579863|NCT01045421|19278774|P9|Phase 1|Withdrawal by Subject|0
5579864|NCT01045421|19278775|P8|Phase 1|Withdrawal by Subject|0
5579865|NCT01045421|19278776|P7|Phase 1|Withdrawal by Subject|0
5579866|NCT01045421|19278777|P6|Phase 1|Withdrawal by Subject|0
5579867|NCT01045421|19278778|P5|Phase 1|Withdrawal by Subject|0
5579868|NCT01045421|19278779|P4|Phase 1|Withdrawal by Subject|1
5579869|NCT01045421|19278780|P3|Phase 1|Withdrawal by Subject|0
5579870|NCT01045421|19278781|P2|Phase 1|Withdrawal by Subject|0
5579871|NCT01045421|19278782|P1|Phase 1|Withdrawal by Subject|0
5579872|NCT01045421|19278772|P11|Phase 1|Progressive Disease|0
5579873|NCT01045421|19278773|P10|Phase 1|Progressive Disease|0
5579874|NCT01045421|19278774|P9|Phase 1|Progressive Disease|0
5579875|NCT01045421|19278775|P8|Phase 1|Progressive Disease|0
5579876|NCT01045421|19278776|P7|Phase 1|Progressive Disease|0
5579877|NCT01045421|19278777|P6|Phase 1|Progressive Disease|0
5579878|NCT01045421|19278778|P5|Phase 1|Progressive Disease|1
5579879|NCT01045421|19278779|P4|Phase 1|Progressive Disease|0
5579880|NCT01045421|19278780|P3|Phase 1|Progressive Disease|0
5579881|NCT01045421|19278781|P2|Phase 1|Progressive Disease|0
5579882|NCT01045421|19278782|P1|Phase 1|Progressive Disease|0
5579883|NCT01045161|19278891|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
5579884|NCT01045161|19278892|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
5579885|NCT01045161|19278893|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
5579886|NCT01045161|19278891|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
5579887|NCT01045161|19278892|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
5579888|NCT01045161|19278893|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
5579889|NCT01045161|19278891|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
5579890|NCT01045161|19278892|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
5579891|NCT01045161|19278893|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
5579892|NCT01045161|19278891|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
5579893|NCT01045161|19278892|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
5579894|NCT01045161|19278893|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
5579895|NCT01045161|19278891|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
5579896|NCT01045161|19278892|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
5579897|NCT01045161|19278893|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
5579898|NCT01045161|19278891|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
5579899|NCT01045161|19278892|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
5579900|NCT01045161|19278893|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
5579901|NCT01045161|19278891|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
5579902|NCT01045161|19278892|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
5579903|NCT01045161|19278893|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
5579904|NCT01045161|19278891|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
5579905|NCT01045161|19278892|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
5579906|NCT01045161|19278893|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
5579907|NCT01045161|19278891|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
5579908|NCT01045161|19278892|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
5579909|NCT01045161|19278893|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
5579910|NCT01045161|19278891|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
5579911|NCT01045161|19278892|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
5579912|NCT01045161|19278893|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
5579913|NCT01045161|19278891|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
5579914|NCT01045161|19278892|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
5579915|NCT01045161|19278893|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
5579916|NCT01045161|19278891|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
5579917|NCT01045161|19278892|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
5579918|NCT01045161|19278893|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
5579919|NCT01045161|19278891|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
5579920|NCT01045161|19278892|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
5579921|NCT01045161|19278893|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
5579922|NCT01045161|19278891|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
5579923|NCT01045161|19278892|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
5579924|NCT01045161|19278893|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
5579925|NCT01045096|19278930|P3|Overall Study|Other|0
5579926|NCT01045096|19278931|P2|Overall Study|Other|0
5579927|NCT01045096|19278932|P1|Overall Study|Other|1
5579928|NCT01045096|19278930|P3|Overall Study|Withdrawal by Subject|0
5579929|NCT01045096|19278931|P2|Overall Study|Withdrawal by Subject|0
5579930|NCT01045096|19278932|P1|Overall Study|Withdrawal by Subject|2
5579931|NCT01044745|19279049|P1|Overall Study|Ineiligible|2
5579932|NCT01044732|19279058|P2|Overall Study|Technical error or malfunction|14
5579933|NCT01044732|19279059|P1|Overall Study|Technical error or malfunction|15
5579934|NCT01044732|19279058|P2|Overall Study|Inability to reach cecum|2
5579935|NCT01044732|19279059|P1|Overall Study|Inability to reach cecum|5
5579936|NCT01044732|19279058|P2|Overall Study|Inadequate bowel preparation|17
5579937|NCT01044732|19279059|P1|Overall Study|Inadequate bowel preparation|11
5579938|NCT01044732|19279058|P2|Overall Study|Withdrawal by Subject|1
5579939|NCT01044732|19279059|P1|Overall Study|Withdrawal by Subject|0
5579940|NCT01044732|19279058|P2|Overall Study|Protocol Violation|12
5579941|NCT01044732|19279059|P1|Overall Study|Protocol Violation|11
5579942|NCT01044732|19279058|P2|Overall Study|Physician Decision|3
5579943|NCT01044732|19279059|P1|Overall Study|Physician Decision|5
5579944|NCT01044732|19279058|P2|Overall Study|Lost to Follow-up|1
5579945|NCT01044732|19279059|P1|Overall Study|Lost to Follow-up|2
5579946|NCT01044498|19279248|P2|Overall Study|Other|0
5579947|NCT01044498|19279249|P1|Overall Study|Other|1
5579948|NCT01044498|19279248|P2|Overall Study|Adverse Event|1
5579949|NCT01044498|19279249|P1|Overall Study|Adverse Event|1
5579950|NCT01044498|19279248|P2|Overall Study|Withdrew consent|1
5579951|NCT01044498|19279249|P1|Overall Study|Withdrew consent|1
5579952|NCT01044459|19279275|P2|Overall Study|Lost to Follow-up|12
5579953|NCT01044459|19279276|P1|Overall Study|Lost to Follow-up|18
5579954|NCT01044459|19279275|P2|Overall Study|COPD exacerbation|8
5579955|NCT01044459|19279276|P1|Overall Study|COPD exacerbation|9
5579956|NCT01044459|19279275|P2|Overall Study|Other Reason|14
5579957|NCT01044459|19279276|P1|Overall Study|Other Reason|7
5579958|NCT01044459|19279275|P2|Overall Study|Protocol Violation|16
5579959|NCT01044459|19279276|P1|Overall Study|Protocol Violation|11
5579960|NCT01044459|19279275|P2|Overall Study|Lack of Efficacy|12
5579961|NCT01044459|19279276|P1|Overall Study|Lack of Efficacy|23
5579962|NCT01044459|19279275|P2|Overall Study|Adverse Event|20
5579963|NCT01044459|19279276|P1|Overall Study|Adverse Event|22
5579964|NCT01044459|19279275|P2|Overall Study|Terminated by Sponsor|21
5579965|NCT01044459|19279276|P1|Overall Study|Terminated by Sponsor|22
5579966|NCT01044459|19279275|P2|Overall Study|Withdrawal by Subject|28
5579967|NCT01044459|19279276|P1|Overall Study|Withdrawal by Subject|21
5579968|NCT01044433|19279284|P1|Overall Study|Withdrawal by Subject|3
5579969|NCT01044433|19279284|P1|Overall Study|Lost to Follow-up|3
5579970|NCT01044303|19279292|P1|Overall Study|Lost to Follow-up|2
5579971|NCT01044290|19279302|P3|Follow-Up 2|Withdrawal by Subject|1
5579972|NCT01044290|19279303|P2|Follow-Up 2|Withdrawal by Subject|1
5579973|NCT01044290|19279304|P1|Follow-Up 2|Withdrawal by Subject|0
5579974|NCT01044290|19279302|P3|Follow-Up 2|Death|1
5579975|NCT01044290|19279303|P2|Follow-Up 2|Death|1
5579976|NCT01044290|19279304|P1|Follow-Up 2|Death|0
5579977|NCT01044290|19279302|P3|Follow-up 1|Withdrawal by Subject|0
5579978|NCT01044290|19279303|P2|Follow-up 1|Withdrawal by Subject|2
5579979|NCT01044290|19279304|P1|Follow-up 1|Withdrawal by Subject|2
5579980|NCT01044290|19279302|P3|Follow-up 1|Death|1
5579981|NCT01044290|19279303|P2|Follow-up 1|Death|3
5579982|NCT01044290|19279304|P1|Follow-up 1|Death|3
5579983|NCT01043874|19279424|P1|Overall Study|Administrative Problems|1
5579984|NCT01043874|19279424|P1|Overall Study|Lack of Efficacy|1
5579985|NCT01043874|19279424|P1|Overall Study|Withdrawal by Subject|1
5579986|NCT01043874|19279424|P1|Overall Study|Adverse Event|3
5579987|NCT01043705|19279434|P3|Overall Study|Other|25
5579988|NCT01043705|19279435|P2|Overall Study|Other|19
5579989|NCT01043705|19279436|P1|Overall Study|Other|0
5579990|NCT01043705|19279434|P3|Overall Study|Screen Fail|0
5579991|NCT01043705|19279435|P2|Overall Study|Screen Fail|0
5579992|NCT01043705|19279436|P1|Overall Study|Screen Fail|21
5579993|NCT01043705|19279434|P3|Overall Study|Adverse Event|0
5579994|NCT01043705|19279435|P2|Overall Study|Adverse Event|2
5579995|NCT01043705|19279436|P1|Overall Study|Adverse Event|0
5579996|NCT01043705|19279434|P3|Overall Study|Subsequent Procedure|29
5579997|NCT01043705|19279435|P2|Overall Study|Subsequent Procedure|24
5579998|NCT01043705|19279436|P1|Overall Study|Subsequent Procedure|9
5579999|NCT01043705|19279434|P3|Overall Study|Site Closure|0
5580000|NCT01043705|19279435|P2|Overall Study|Site Closure|0
5580001|NCT01043705|19279436|P1|Overall Study|Site Closure|8
5580002|NCT01043705|19279434|P3|Overall Study|Withdrawal by Subject|0
5580003|NCT01043705|19279435|P2|Overall Study|Withdrawal by Subject|6
5580004|NCT01043705|19279436|P1|Overall Study|Withdrawal by Subject|8
5580005|NCT01043705|19279434|P3|Overall Study|Protocol Violation|0
5580006|NCT01043705|19279435|P2|Overall Study|Protocol Violation|1
5580007|NCT01043705|19279436|P1|Overall Study|Protocol Violation|2
5580008|NCT01043705|19279434|P3|Overall Study|Multiple Reasons|0
5580009|NCT01043705|19279435|P2|Overall Study|Multiple Reasons|7
5580010|NCT01043705|19279436|P1|Overall Study|Multiple Reasons|4
5580011|NCT01043705|19279434|P3|Overall Study|Lost to Follow-up|0
5580012|NCT01043705|19279435|P2|Overall Study|Lost to Follow-up|12
5580013|NCT01043705|19279436|P1|Overall Study|Lost to Follow-up|27
5580014|NCT01043705|19279434|P3|Overall Study|Death|26
5580015|NCT01043705|19279435|P2|Overall Study|Death|60
5580016|NCT01043705|19279436|P1|Overall Study|Death|28
5580017|NCT01043185|19279525|P10|Period 6 - Third Washout Period|Protocol Violation|0
5580018|NCT01043185|19279526|P9|Period 6 - Third Washout Period|Protocol Violation|1
5580019|NCT01043185|19279527|P8|Period 6 - Third Washout Period|Protocol Violation|0
5580020|NCT01043185|19279528|P7|Period 6 - Third Washout Period|Protocol Violation|0
5580021|NCT01043185|19279529|P6|Period 6 - Third Washout Period|Protocol Violation|0
5580022|NCT01043185|19279530|P5|Period 6 - Third Washout Period|Protocol Violation|0
5580023|NCT01043185|19279531|P4|Period 6 - Third Washout Period|Protocol Violation|0
5580024|NCT01043185|19279532|P3|Period 6 - Third Washout Period|Protocol Violation|0
5580025|NCT01043185|19279533|P2|Period 6 - Third Washout Period|Protocol Violation|0
5580026|NCT01043185|19279534|P1|Period 6 - Third Washout Period|Protocol Violation|0
5580027|NCT01042977|19279610|P2|Overall Study|Various|0
5580028|NCT01042977|19279611|P1|Overall Study|Various|3
5580029|NCT01042977|19279610|P2|Overall Study|Administrative reason by sponsor|1
5580030|NCT01042977|19279611|P1|Overall Study|Administrative reason by sponsor|0
5580031|NCT01042977|19279610|P2|Overall Study|Safety|2
5580032|NCT01042977|19279611|P1|Overall Study|Safety|0
5580033|NCT01042977|19279610|P2|Overall Study|Incorrect enrollment|4
5580034|NCT01042977|19279611|P1|Overall Study|Incorrect enrollment|6
5580035|NCT01042977|19279610|P2|Overall Study|Subject no longer meets study criteria|13
5580036|NCT01042977|19279611|P1|Overall Study|Subject no longer meets study criteria|15
5580037|NCT01042977|19279610|P2|Overall Study|Poor/non-compliance|4
5580038|NCT01042977|19279611|P1|Overall Study|Poor/non-compliance|3
5580039|NCT01042977|19279610|P2|Overall Study|Lost to Follow-up|2
5580040|NCT01042977|19279611|P1|Overall Study|Lost to Follow-up|0
5580041|NCT01042977|19279610|P2|Overall Study|Withdrawal by Subject|16
5580042|NCT01042977|19279611|P1|Overall Study|Withdrawal by Subject|8
5580043|NCT01042977|19279610|P2|Overall Study|Death|1
5580044|NCT01042977|19279611|P1|Overall Study|Death|2
5580045|NCT01042977|19279610|P2|Overall Study|Adverse Event|12
5580046|NCT01042977|19279611|P1|Overall Study|Adverse Event|4
5580047|NCT01042938|19279631|P2|Overall Study|Ineligible: RTOG study conflict|0
5580048|NCT01042938|19279632|P1|Overall Study|Ineligible: RTOG study conflict|1
5580049|NCT01042938|19279631|P2|Overall Study|Protocol Violation|1
5580050|NCT01042938|19279632|P1|Overall Study|Protocol Violation|1
5580051|NCT01042938|19279631|P2|Overall Study|Withdrawal by Subject|1
5580052|NCT01042938|19279632|P1|Overall Study|Withdrawal by Subject|1
5580053|NCT01042678|19279651|P6|Overall Study|Physician Decision|0
5580054|NCT01042678|19279652|P5|Overall Study|Physician Decision|0
5580055|NCT01042678|19279653|P4|Overall Study|Physician Decision|0
5580056|NCT01042678|19279654|P3|Overall Study|Physician Decision|0
5580057|NCT01042678|19279655|P2|Overall Study|Physician Decision|0
5580058|NCT01042678|19279656|P1|Overall Study|Physician Decision|1
5580059|NCT01042600|19279694|P2|Overall Study|Ineligible|0
5580060|NCT01042600|19279695|P1|Overall Study|Ineligible|1
5580061|NCT01042535|19279715|P1|Overall Study|complications from other disease|2
5580062|NCT01042535|19279715|P1|Overall Study|disease progression during treatment|3
5580063|NCT01042535|19279715|P1|Overall Study|disease progression prior to treatment|3
5580064|NCT01042392|19279749|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
5580065|NCT01042392|19279750|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
5580066|NCT01042392|19279751|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
5580067|NCT01042392|19279752|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
5580068|NCT01042392|19279749|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
5580069|NCT01042392|19279750|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
5580070|NCT01042392|19279751|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
5580071|NCT01042392|19279752|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
5580072|NCT01042392|19279749|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
5580073|NCT01042392|19279750|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
5580074|NCT01042392|19279751|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
5580075|NCT01042392|19279752|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
5580076|NCT01042392|19279749|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
5580077|NCT01042392|19279750|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
5580078|NCT01042392|19279751|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
5580079|NCT01042392|19279752|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
5580080|NCT01042392|19279749|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
5580081|NCT01042392|19279750|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
5580082|NCT01042392|19279751|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
5580083|NCT01042392|19279752|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
5580084|NCT01042392|19279749|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
5580085|NCT01042392|19279750|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
5580086|NCT01042392|19279751|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
5580087|NCT01042392|19279752|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
5580088|NCT01042392|19279749|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
5580089|NCT01042392|19279750|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
5580090|NCT01042392|19279751|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
5580091|NCT01042392|19279752|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
5580092|NCT01042392|19279749|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
5580093|NCT01042392|19279750|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
5580094|NCT01042392|19279751|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
5580095|NCT01042392|19279752|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
5580096|NCT01042392|19279749|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
5580097|NCT01042392|19279750|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
5580098|NCT01042392|19279751|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
5580099|NCT01042392|19279752|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
5580100|NCT01042236|19279800|P6|Treatment Period 3|Protocol Violation|0
5580101|NCT01042236|19279801|P5|Treatment Period 3|Protocol Violation|0
5580102|NCT01042236|19279802|P4|Treatment Period 3|Protocol Violation|1
5580103|NCT01042236|19279803|P3|Treatment Period 3|Protocol Violation|0
5580104|NCT01042236|19279804|P2|Treatment Period 3|Protocol Violation|0
5580105|NCT01042236|19279805|P1|Treatment Period 3|Protocol Violation|0
5580106|NCT01042236|19279800|P6|Treatment Period 3|Adverse Event|0
5580107|NCT01042236|19279801|P5|Treatment Period 3|Adverse Event|0
5580108|NCT01042236|19279802|P4|Treatment Period 3|Adverse Event|1
5580109|NCT01042236|19279803|P3|Treatment Period 3|Adverse Event|0
5580110|NCT01042236|19279804|P2|Treatment Period 3|Adverse Event|0
5580111|NCT01042236|19279805|P1|Treatment Period 3|Adverse Event|0
5580112|NCT01042236|19279800|P6|Treatment Period 1|Adverse Event|0
5580113|NCT01042236|19279801|P5|Treatment Period 1|Adverse Event|1
5580114|NCT01042236|19279802|P4|Treatment Period 1|Adverse Event|0
5580115|NCT01042236|19279803|P3|Treatment Period 1|Adverse Event|0
5580116|NCT01042236|19279804|P2|Treatment Period 1|Adverse Event|1
5580117|NCT01042236|19279805|P1|Treatment Period 1|Adverse Event|0
5580118|NCT01042158|19279842|P1|Overall Study|Physician Decision|1
5580119|NCT01042093|19279872|P4|Overall Study|Withdrawal by Subject|1
5580120|NCT01042093|19279873|P3|Overall Study|Withdrawal by Subject|0
5580121|NCT01042093|19279874|P2|Overall Study|Withdrawal by Subject|0
5580122|NCT01042093|19279875|P1|Overall Study|Withdrawal by Subject|0
5580123|NCT01042093|19279872|P4|Overall Study|Protocol Violation|3
5580124|NCT01042093|19279873|P3|Overall Study|Protocol Violation|2
5580125|NCT01042093|19279874|P2|Overall Study|Protocol Violation|2
5580126|NCT01042093|19279875|P1|Overall Study|Protocol Violation|2
5580127|NCT01041976|19279895|P2|Overall Study|Death|4
5580128|NCT01041976|19279896|P1|Overall Study|Death|0
5580129|NCT01041976|19279895|P2|Overall Study|Incarceration|0
5580130|NCT01041976|19279896|P1|Overall Study|Incarceration|2
5580131|NCT01041976|19279895|P2|Overall Study|Withdrawal by Subject|0
5580132|NCT01041976|19279896|P1|Overall Study|Withdrawal by Subject|3
5580133|NCT01041859|19279906|P3|Double-Blind Maintenance|Withdrawal by Subject|9
5580134|NCT01041859|19279907|P2|Double-Blind Maintenance|Withdrawal by Subject|8
5580135|NCT01041859|19279908|P1|Double-Blind Maintenance|Withdrawal by Subject|0
5580136|NCT01041859|19279906|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
5580137|NCT01041859|19279907|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
5580138|NCT01041859|19279908|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
5580139|NCT01041859|19279906|P3|Double-Blind Maintenance|Other|2
5580140|NCT01041859|19279907|P2|Double-Blind Maintenance|Other|6
5580141|NCT01041859|19279908|P1|Double-Blind Maintenance|Other|0
5580142|NCT01041859|19279906|P3|Double-Blind Maintenance|Protocol Violation|3
5580143|NCT01041859|19279907|P2|Double-Blind Maintenance|Protocol Violation|1
5580144|NCT01041859|19279908|P1|Double-Blind Maintenance|Protocol Violation|0
5580145|NCT01041859|19279906|P3|Double-Blind Maintenance|Physician Decision|1
5580146|NCT01041859|19279907|P2|Double-Blind Maintenance|Physician Decision|2
5580147|NCT01041859|19279908|P1|Double-Blind Maintenance|Physician Decision|0
5580148|NCT01041859|19279906|P3|Double-Blind Maintenance|Lost to Follow-up|0
5580149|NCT01041859|19279907|P2|Double-Blind Maintenance|Lost to Follow-up|1
5580150|NCT01041859|19279908|P1|Double-Blind Maintenance|Lost to Follow-up|0
5580151|NCT01041859|19279906|P3|Double-Blind Maintenance|Lack of Efficacy|11
5580152|NCT01041859|19279907|P2|Double-Blind Maintenance|Lack of Efficacy|3
5580153|NCT01041859|19279908|P1|Double-Blind Maintenance|Lack of Efficacy|0
5580154|NCT01041859|19279906|P3|Double-Blind Maintenance|Adverse Event|13
5580155|NCT01041859|19279907|P2|Double-Blind Maintenance|Adverse Event|23
5580156|NCT01041859|19279908|P1|Double-Blind Maintenance|Adverse Event|0
5580157|NCT01041859|19279906|P3|Open-Label Titration|Withdrawal by Subject|0
5580158|NCT01041859|19279907|P2|Open-Label Titration|Withdrawal by Subject|0
5580159|NCT01041859|19279908|P1|Open-Label Titration|Withdrawal by Subject|11
5580160|NCT01041859|19279906|P3|Open-Label Titration|Noncompliance With Study Drug|0
5580161|NCT01041859|19279907|P2|Open-Label Titration|Noncompliance With Study Drug|0
5580162|NCT01041859|19279908|P1|Open-Label Titration|Noncompliance With Study Drug|8
5580163|NCT01041859|19279906|P3|Open-Label Titration|Other|0
5580164|NCT01041859|19279907|P2|Open-Label Titration|Other|0
5580165|NCT01041859|19279908|P1|Open-Label Titration|Other|7
5580166|NCT01041859|19279906|P3|Open-Label Titration|Protocol Violation|0
5580167|NCT01041859|19279907|P2|Open-Label Titration|Protocol Violation|0
5580168|NCT01041859|19279908|P1|Open-Label Titration|Protocol Violation|1
5580169|NCT01041859|19279906|P3|Open-Label Titration|Physician Decision|0
5580170|NCT01041859|19279907|P2|Open-Label Titration|Physician Decision|0
5580171|NCT01041859|19279908|P1|Open-Label Titration|Physician Decision|1
5580172|NCT01041859|19279906|P3|Open-Label Titration|Lost to Follow-up|0
5580173|NCT01041859|19279907|P2|Open-Label Titration|Lost to Follow-up|0
5580174|NCT01041859|19279908|P1|Open-Label Titration|Lost to Follow-up|1
5580175|NCT01041859|19279906|P3|Open-Label Titration|Lack of Efficacy|0
5580176|NCT01041859|19279907|P2|Open-Label Titration|Lack of Efficacy|0
5580177|NCT01041859|19279908|P1|Open-Label Titration|Lack of Efficacy|3
5580178|NCT01041859|19279906|P3|Open-Label Titration|Adverse Event|0
5580179|NCT01041859|19279907|P2|Open-Label Titration|Adverse Event|0
5580180|NCT01041859|19279908|P1|Open-Label Titration|Adverse Event|69
5580181|NCT01041638|19279944|P1|Overall Study|Withdrawal by Subject|11
5580182|NCT01041638|19279944|P1|Overall Study|Physician Decision|4
5580183|NCT01041638|19279944|P1|Overall Study|Lack of Efficacy|7
5580184|NCT01041638|19279944|P1|Overall Study|Death|1
5580185|NCT01041638|19279944|P1|Overall Study|Adverse Event|4
5580186|NCT01041573|19279954|P4|Overall Study|positive to anti-HCV|0
5580187|NCT01041573|19279955|P3|Overall Study|positive to anti-HCV|0
5580188|NCT01041573|19279956|P2|Overall Study|positive to anti-HCV|0
5580189|NCT01041573|19279957|P1|Overall Study|positive to anti-HCV|1
5580190|NCT01041573|19279954|P4|Overall Study|further blood extraction|0
5580191|NCT01041573|19279955|P3|Overall Study|further blood extraction|0
5580192|NCT01041573|19279956|P2|Overall Study|further blood extraction|1
5580193|NCT01041573|19279957|P1|Overall Study|further blood extraction|0
5580194|NCT01041573|19279954|P4|Overall Study|relocation|1
5580195|NCT01041573|19279955|P3|Overall Study|relocation|3
5580196|NCT01041573|19279956|P2|Overall Study|relocation|4
5580197|NCT01041573|19279957|P1|Overall Study|relocation|1
5580198|NCT01041573|19279954|P4|Overall Study|Adverse Event|0
5580199|NCT01041573|19279955|P3|Overall Study|Adverse Event|0
5580200|NCT01041573|19279956|P2|Overall Study|Adverse Event|2
5580201|NCT01041573|19279957|P1|Overall Study|Adverse Event|0
5580202|NCT01041573|19279954|P4|Overall Study|Lost to Follow-up|1
5580203|NCT01041573|19279955|P3|Overall Study|Lost to Follow-up|2
5580204|NCT01041573|19279956|P2|Overall Study|Lost to Follow-up|1
5580205|NCT01041573|19279957|P1|Overall Study|Lost to Follow-up|0
5580206|NCT01041573|19279954|P4|Overall Study|Death|0
5580207|NCT01041573|19279955|P3|Overall Study|Death|0
5580208|NCT01041573|19279956|P2|Overall Study|Death|0
5580209|NCT01041573|19279957|P1|Overall Study|Death|1
5580210|NCT01041573|19279954|P4|Overall Study|Withdrawal by Subject|0
5580211|NCT01041573|19279955|P3|Overall Study|Withdrawal by Subject|2
5580212|NCT01041573|19279956|P2|Overall Study|Withdrawal by Subject|5
5580213|NCT01041573|19279957|P1|Overall Study|Withdrawal by Subject|2
5580214|NCT01041417|19279980|P2|Overall Study|Death|0
5580215|NCT01041417|19279981|P1|Overall Study|Death|1
5580216|NCT01041417|19279980|P2|Overall Study|Lost to Follow-up|1
5580217|NCT01041417|19279981|P1|Overall Study|Lost to Follow-up|1
5580218|NCT01041417|19279980|P2|Overall Study|Adverse Event|2
5580219|NCT01041417|19279981|P1|Overall Study|Adverse Event|5
5580220|NCT01041404|19280019|P2|Overall Study|Other|23
5580221|NCT01041404|19280020|P1|Overall Study|Other|11
5580222|NCT01041404|19280019|P2|Overall Study|Failure to Return|2
5580223|NCT01041404|19280020|P1|Overall Study|Failure to Return|1
5580224|NCT01041404|19280019|P2|Overall Study|Withdrawal by Subject|23
5580225|NCT01041404|19280020|P1|Overall Study|Withdrawal by Subject|29
5580226|NCT01041404|19280019|P2|Overall Study|Protocol Violation|0
5580227|NCT01041404|19280020|P1|Overall Study|Protocol Violation|4
5580228|NCT01041404|19280019|P2|Overall Study|Violation of Selection Criteria|1
5580229|NCT01041404|19280020|P1|Overall Study|Violation of Selection Criteria|0
5580230|NCT01041404|19280019|P2|Overall Study|Lack of Efficacy|210
5580231|NCT01041404|19280020|P1|Overall Study|Lack of Efficacy|200
5580232|NCT01041404|19280019|P2|Overall Study|Adverse Event|35
5580233|NCT01041404|19280020|P1|Overall Study|Adverse Event|45
5580234|NCT01041287|19280061|P2|Treatment Period 2 (3 Months)|Adverse Event|2
5580235|NCT01041287|19280062|P1|Treatment Period 2 (3 Months)|Adverse Event|0
5580236|NCT01041287|19280061|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
5580237|NCT01041287|19280062|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
5580238|NCT01040871|19280102|P2|Overall Study|Randomized and Not Treated|1
5580239|NCT01040871|19280103|P1|Overall Study|Randomized and Not Treated|2
5580240|NCT01040871|19280102|P2|Overall Study|drug supply issue|0
5580241|NCT01040871|19280103|P1|Overall Study|drug supply issue|1
5580242|NCT01040871|19280102|P2|Overall Study|Lack of Efficacy|1
5580243|NCT01040871|19280103|P1|Overall Study|Lack of Efficacy|1
5580244|NCT01040871|19280102|P2|Overall Study|Death|3
5580245|NCT01040871|19280103|P1|Overall Study|Death|1
5580246|NCT01040871|19280102|P2|Overall Study|Withdrawal by Subject|0
5580247|NCT01040871|19280103|P1|Overall Study|Withdrawal by Subject|2
5580248|NCT01040871|19280102|P2|Overall Study|Adverse Event|2
5580249|NCT01040871|19280103|P1|Overall Study|Adverse Event|6
5580250|NCT01040845|19280154|P2|Overall Study|Physician Decision|0
5580251|NCT01040845|19280155|P1|Overall Study|Physician Decision|1
5580252|NCT01040845|19280154|P2|Overall Study|Withdrawal by Subject|1
5580253|NCT01040845|19280155|P1|Overall Study|Withdrawal by Subject|1
5580254|NCT01040832|19280170|P2|Overall Study|Other|1
5580255|NCT01040832|19280171|P1|Overall Study|Other|2
5580256|NCT01040832|19280170|P2|Overall Study|Symptomatic deterioration|5
5580257|NCT01040832|19280171|P1|Overall Study|Symptomatic deterioration|2
5580258|NCT01040832|19280170|P2|Overall Study|Progressive disease|17
5580259|NCT01040832|19280171|P1|Overall Study|Progressive disease|32
5580260|NCT01040832|19280170|P2|Overall Study|Withdrawal by Subject|3
5580261|NCT01040832|19280171|P1|Overall Study|Withdrawal by Subject|2
5580262|NCT01040832|19280170|P2|Overall Study|Death|6
5580263|NCT01040832|19280171|P1|Overall Study|Death|4
5580264|NCT01040832|19280170|P2|Overall Study|Adverse Event|5
5580265|NCT01040832|19280171|P1|Overall Study|Adverse Event|4
5580266|NCT01040793|19280194|P6|Overall Study|Other reasons not listed above|0
5580267|NCT01040793|19280195|P5|Overall Study|Other reasons not listed above|1
5580268|NCT01040793|19280196|P4|Overall Study|Other reasons not listed above|0
5580269|NCT01040793|19280197|P3|Overall Study|Other reasons not listed above|1
5580270|NCT01040793|19280198|P2|Overall Study|Other reasons not listed above|0
5580271|NCT01040793|19280199|P1|Overall Study|Other reasons not listed above|0
5580272|NCT01040793|19280194|P6|Overall Study|Withdrawal by Subject|0
5580273|NCT01040793|19280195|P5|Overall Study|Withdrawal by Subject|0
5580274|NCT01040793|19280196|P4|Overall Study|Withdrawal by Subject|2
5580275|NCT01040793|19280197|P3|Overall Study|Withdrawal by Subject|0
5580276|NCT01040793|19280198|P2|Overall Study|Withdrawal by Subject|0
5580277|NCT01040793|19280199|P1|Overall Study|Withdrawal by Subject|0
5580278|NCT01040793|19280194|P6|Overall Study|Lost to Follow-up|0
5580279|NCT01040793|19280195|P5|Overall Study|Lost to Follow-up|0
5580280|NCT01040793|19280196|P4|Overall Study|Lost to Follow-up|0
5580281|NCT01040793|19280197|P3|Overall Study|Lost to Follow-up|1
5580282|NCT01040793|19280198|P2|Overall Study|Lost to Follow-up|1
5580283|NCT01040793|19280199|P1|Overall Study|Lost to Follow-up|0
5580284|NCT01040793|19280194|P6|Overall Study|Protocol Violation|0
5580285|NCT01040793|19280195|P5|Overall Study|Protocol Violation|1
5580286|NCT01040793|19280196|P4|Overall Study|Protocol Violation|0
5580287|NCT01040793|19280197|P3|Overall Study|Protocol Violation|1
5580288|NCT01040793|19280198|P2|Overall Study|Protocol Violation|1
5580289|NCT01040793|19280199|P1|Overall Study|Protocol Violation|1
5580290|NCT01040793|19280194|P6|Overall Study|Adverse Event|1
5580291|NCT01040793|19280195|P5|Overall Study|Adverse Event|2
5580292|NCT01040793|19280196|P4|Overall Study|Adverse Event|2
5580293|NCT01040793|19280197|P3|Overall Study|Adverse Event|0
5580294|NCT01040793|19280198|P2|Overall Study|Adverse Event|3
5580295|NCT01040793|19280199|P1|Overall Study|Adverse Event|5
5580296|NCT01040780|19280278|P2|Overall Study|Protocol Violation|3
5580297|NCT01040780|19280279|P1|Overall Study|Protocol Violation|1
5580298|NCT01040728|19280293|P4|Overall Study|Other reasons not listed above|0
5580299|NCT01040728|19280294|P3|Overall Study|Other reasons not listed above|0
5580300|NCT01040728|19280295|P2|Overall Study|Other reasons not listed above|1
5580301|NCT01040728|19280296|P1|Overall Study|Other reasons not listed above|0
5580302|NCT01040728|19280293|P4|Overall Study|Lack of Efficacy|1
5580303|NCT01040728|19280294|P3|Overall Study|Lack of Efficacy|0
5580304|NCT01040728|19280295|P2|Overall Study|Lack of Efficacy|1
5580305|NCT01040728|19280296|P1|Overall Study|Lack of Efficacy|0
5580306|NCT01040728|19280293|P4|Overall Study|Protocol Violation|1
5580307|NCT01040728|19280294|P3|Overall Study|Protocol Violation|0
5580308|NCT01040728|19280295|P2|Overall Study|Protocol Violation|0
5580309|NCT01040728|19280296|P1|Overall Study|Protocol Violation|0
5580310|NCT01040728|19280293|P4|Overall Study|Withdrawal by Subject|0
5580311|NCT01040728|19280294|P3|Overall Study|Withdrawal by Subject|1
5580312|NCT01040728|19280295|P2|Overall Study|Withdrawal by Subject|1
5580313|NCT01040728|19280296|P1|Overall Study|Withdrawal by Subject|0
5580314|NCT01040728|19280293|P4|Overall Study|Adverse Event|4
5580315|NCT01040728|19280294|P3|Overall Study|Adverse Event|0
5580316|NCT01040728|19280295|P2|Overall Study|Adverse Event|8
5580317|NCT01040728|19280296|P1|Overall Study|Adverse Event|4
5580318|NCT01040689|19280366|P4|Overall Study|Other reasons not listed above|0
5580319|NCT01040689|19280367|P3|Overall Study|Other reasons not listed above|0
5580320|NCT01040689|19280368|P2|Overall Study|Other reasons not listed above|1
5580321|NCT01040689|19280369|P1|Overall Study|Other reasons not listed above|0
5580322|NCT01040689|19280366|P4|Overall Study|Withdrawal by Subject|0
5580323|NCT01040689|19280367|P3|Overall Study|Withdrawal by Subject|1
5580324|NCT01040689|19280368|P2|Overall Study|Withdrawal by Subject|1
5580325|NCT01040689|19280369|P1|Overall Study|Withdrawal by Subject|2
5580326|NCT01040689|19280366|P4|Overall Study|Lost to Follow-up|0
5580327|NCT01040689|19280367|P3|Overall Study|Lost to Follow-up|0
5580328|NCT01040689|19280368|P2|Overall Study|Lost to Follow-up|0
5580329|NCT01040689|19280369|P1|Overall Study|Lost to Follow-up|1
5580330|NCT01040689|19280366|P4|Overall Study|Lack of Efficacy|0
5580331|NCT01040689|19280367|P3|Overall Study|Lack of Efficacy|1
5580332|NCT01040689|19280368|P2|Overall Study|Lack of Efficacy|0
5580333|NCT01040689|19280369|P1|Overall Study|Lack of Efficacy|0
5580334|NCT01040689|19280366|P4|Overall Study|Adverse Event|4
5580335|NCT01040689|19280367|P3|Overall Study|Adverse Event|2
5580336|NCT01040689|19280368|P2|Overall Study|Adverse Event|0
5580337|NCT01040689|19280369|P1|Overall Study|Adverse Event|0
5580338|NCT01040403|19280448|P1|Overall Study|Other reason not defined above|6
5580339|NCT01040403|19280448|P1|Overall Study|Not treated|1
5580340|NCT01040403|19280448|P1|Overall Study|Lost to Follow-up|1
5580341|NCT01040403|19280448|P1|Overall Study|Protocol Violation|2
5580342|NCT01040403|19280448|P1|Overall Study|Adverse Event|10
5580343|NCT01040351|19280636|P2|Overall Study|poor ovarian response|2
5580344|NCT01040351|19280637|P1|Overall Study|poor ovarian response|1
5580345|NCT01040260|19280647|P2|Overall Study|Lost to Follow-up|5
5580346|NCT01040260|19280648|P1|Overall Study|Lost to Follow-up|3
5580347|NCT01040260|19280647|P2|Overall Study|Withdrawal by Subject|6
5580348|NCT01040260|19280648|P1|Overall Study|Withdrawal by Subject|12
5580349|NCT01040169|19280675|P2|Overall Study|Lost to Follow-up|8
5580350|NCT01040169|19280676|P1|Overall Study|Lost to Follow-up|3
5580351|NCT01040130|19280684|P6|Overall Study|Other reasons not listed above|0
5580352|NCT01040130|19280685|P5|Overall Study|Other reasons not listed above|0
5580353|NCT01040130|19280686|P4|Overall Study|Other reasons not listed above|0
5580354|NCT01040130|19280687|P3|Overall Study|Other reasons not listed above|0
5580355|NCT01040130|19280688|P2|Overall Study|Other reasons not listed above|0
5580356|NCT01040130|19280689|P1|Overall Study|Other reasons not listed above|2
5580357|NCT01040130|19280684|P6|Overall Study|Withdrawal by Subject|1
5580358|NCT01040130|19280685|P5|Overall Study|Withdrawal by Subject|0
5580359|NCT01040130|19280686|P4|Overall Study|Withdrawal by Subject|0
5580360|NCT01040130|19280687|P3|Overall Study|Withdrawal by Subject|0
5580361|NCT01040130|19280688|P2|Overall Study|Withdrawal by Subject|2
5580362|NCT01040130|19280689|P1|Overall Study|Withdrawal by Subject|0
5580363|NCT01040130|19280684|P6|Overall Study|Protocol Violation|0
5580364|NCT01040130|19280685|P5|Overall Study|Protocol Violation|0
5580365|NCT01040130|19280686|P4|Overall Study|Protocol Violation|0
5580366|NCT01040130|19280687|P3|Overall Study|Protocol Violation|2
5580367|NCT01040130|19280688|P2|Overall Study|Protocol Violation|0
5580368|NCT01040130|19280689|P1|Overall Study|Protocol Violation|0
5580369|NCT01040130|19280684|P6|Overall Study|Adverse Event|3
5580370|NCT01040130|19280685|P5|Overall Study|Adverse Event|0
5580371|NCT01040130|19280686|P4|Overall Study|Adverse Event|5
5580372|NCT01040130|19280687|P3|Overall Study|Adverse Event|0
5580373|NCT01040130|19280688|P2|Overall Study|Adverse Event|1
5580374|NCT01040130|19280689|P1|Overall Study|Adverse Event|1
5580375|NCT01039688|19280782|P3|Overall Study|Death|0
5580376|NCT01039688|19280783|P2|Overall Study|Death|0
5580377|NCT01039688|19280784|P1|Overall Study|Death|2
5580378|NCT01039688|19280782|P3|Overall Study|Withdrawal by Subject|13
5580379|NCT01039688|19280783|P2|Overall Study|Withdrawal by Subject|27
5580380|NCT01039688|19280784|P1|Overall Study|Withdrawal by Subject|23
5580381|NCT01039688|19280782|P3|Overall Study|Other|12
5580382|NCT01039688|19280783|P2|Overall Study|Other|25
5580383|NCT01039688|19280784|P1|Overall Study|Other|13
5580384|NCT01039688|19280782|P3|Overall Study|Lost to Follow-up|5
5580385|NCT01039688|19280783|P2|Overall Study|Lost to Follow-up|9
5580386|NCT01039688|19280784|P1|Overall Study|Lost to Follow-up|11
5580387|NCT01039688|19280782|P3|Overall Study|Lack of Efficacy|26
5580388|NCT01039688|19280783|P2|Overall Study|Lack of Efficacy|11
5580389|NCT01039688|19280784|P1|Overall Study|Lack of Efficacy|20
5580390|NCT01039688|19280782|P3|Overall Study|Adverse Event|24
5580391|NCT01039688|19280783|P2|Overall Study|Adverse Event|39
5580392|NCT01039688|19280784|P1|Overall Study|Adverse Event|38
5580393|NCT01039675|19281055|P2|Overall Study|Physician Decision|1
5580394|NCT01039675|19281056|P1|Overall Study|Physician Decision|0
5580395|NCT01039675|19281055|P2|Overall Study|Lost to Follow-up|1
5580396|NCT01039675|19281056|P1|Overall Study|Lost to Follow-up|0
5580397|NCT01039675|19281055|P2|Overall Study|Withdrawal by Subject|1
5580398|NCT01039675|19281056|P1|Overall Study|Withdrawal by Subject|0
5580399|NCT01039675|19281055|P2|Overall Study|Lack of Efficacy|2
5580400|NCT01039675|19281056|P1|Overall Study|Lack of Efficacy|0
5580401|NCT01039675|19281055|P2|Overall Study|Adverse Event|2
5580402|NCT01039675|19281056|P1|Overall Study|Adverse Event|0
5580403|NCT01039584|19281069|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
5580404|NCT01039584|19281070|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
5580405|NCT01039584|19281071|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
5580406|NCT01039584|19281069|P3|Overall Study|Pap smear with significant pathology|3
5580407|NCT01039584|19281070|P2|Overall Study|Pap smear with significant pathology|10
5580408|NCT01039584|19281071|P1|Overall Study|Pap smear with significant pathology|10
5580409|NCT01039584|19281069|P3|Overall Study|other|1
5580410|NCT01039584|19281070|P2|Overall Study|other|3
5580411|NCT01039584|19281071|P1|Overall Study|other|1
5580412|NCT01039584|19281069|P3|Overall Study|Lack of Efficacy|10
5580413|NCT01039584|19281070|P2|Overall Study|Lack of Efficacy|6
5580414|NCT01039584|19281071|P1|Overall Study|Lack of Efficacy|7
5580415|NCT01039584|19281069|P3|Overall Study|Negative Baseline culture for Candida|24
5580416|NCT01039584|19281070|P2|Overall Study|Negative Baseline culture for Candida|59
5580417|NCT01039584|19281071|P1|Overall Study|Negative Baseline culture for Candida|59
5580418|NCT01039584|19281069|P3|Overall Study|Lost to Follow-up|4
5580419|NCT01039584|19281070|P2|Overall Study|Lost to Follow-up|3
5580420|NCT01039584|19281071|P1|Overall Study|Lost to Follow-up|5
5580421|NCT01039584|19281069|P3|Overall Study|Protocol Violation|6
5580422|NCT01039584|19281070|P2|Overall Study|Protocol Violation|4
5580423|NCT01039584|19281071|P1|Overall Study|Protocol Violation|10
5580424|NCT01039584|19281069|P3|Overall Study|Withdrawal by Subject|1
5580425|NCT01039584|19281070|P2|Overall Study|Withdrawal by Subject|2
5580426|NCT01039584|19281071|P1|Overall Study|Withdrawal by Subject|4
5580427|NCT01039519|19281085|P1|Survival Follow-up|Sponsor decision|4
5580428|NCT01039519|19281085|P1|Survival Follow-up|Death|23
5580429|NCT01039519|19281085|P1|Treatment|Physician Decision|2
5580430|NCT01039519|19281085|P1|Treatment|Adverse Event|3
5580431|NCT01039519|19281085|P1|Treatment|Treatment failure|2
5580432|NCT01039519|19281085|P1|Treatment|Progressive disease|20
5580433|NCT01039428|19281121|P2|Overall Study|Withdrawal by Subject|0
5580434|NCT01039428|19281122|P1|Overall Study|Withdrawal by Subject|1
5580435|NCT01039428|19281121|P2|Overall Study|Protocol Violation|0
5580436|NCT01039428|19281122|P1|Overall Study|Protocol Violation|1
5580437|NCT01039376|19281146|P2|Overall Study|Study terminated by Sponsor|72
5580438|NCT01039376|19281147|P1|Overall Study|Study terminated by Sponsor|90
5580439|NCT01039376|19281146|P2|Overall Study|Withdrawal by Subject|32
5580440|NCT01039376|19281147|P1|Overall Study|Withdrawal by Subject|20
5580441|NCT01039376|19281146|P2|Overall Study|Physician Decision|10
5580442|NCT01039376|19281147|P1|Overall Study|Physician Decision|15
5580443|NCT01039376|19281146|P2|Overall Study|Lost to Follow-up|12
5580444|NCT01039376|19281147|P1|Overall Study|Lost to Follow-up|5
5580445|NCT01038921|19281216|P2|Overall Study|Physician Decision|0
5580446|NCT01038921|19281217|P1|Overall Study|Physician Decision|1
5580447|NCT01038921|19281216|P2|Overall Study|Withdrawal by Subject|0
5580448|NCT01038921|19281217|P1|Overall Study|Withdrawal by Subject|1
5580449|NCT01038869|19281223|P1|Overall Study|Lost to Follow-up|6
5580450|NCT01038869|19281223|P1|Overall Study|Withdrawal by Subject|1
5580451|NCT01038856|19281231|P1|Overall Study|Adverse Event|2
5580452|NCT01038752|19281240|P2|Overall Study|Lost to Follow-up|3
5580453|NCT01038752|19281241|P1|Overall Study|Lost to Follow-up|3
5580454|NCT01038752|19281240|P2|Overall Study|Tumor Progression|2
5580455|NCT01038752|19281241|P1|Overall Study|Tumor Progression|2
5580456|NCT01038713|19281264|P3|Overall Study|Autoimmune Pancreatitis|0
5580457|NCT01038713|19281265|P2|Overall Study|Autoimmune Pancreatitis|0
5580458|NCT01038713|19281266|P1|Overall Study|Autoimmune Pancreatitis|1
5580459|NCT01038713|19281264|P3|Overall Study|died from PEP|0
5580460|NCT01038713|19281265|P2|Overall Study|died from PEP|1
5580461|NCT01038713|19281266|P1|Overall Study|died from PEP|0
5580462|NCT01038713|19281264|P3|Overall Study|Neuroendocrine Tumor|0
5580463|NCT01038713|19281265|P2|Overall Study|Neuroendocrine Tumor|1
5580464|NCT01038713|19281266|P1|Overall Study|Neuroendocrine Tumor|0
5580465|NCT01038713|19281264|P3|Overall Study|Lost to Follow-up|0
5580466|NCT01038713|19281265|P2|Overall Study|Lost to Follow-up|0
5580467|NCT01038713|19281266|P1|Overall Study|Lost to Follow-up|3
5580468|NCT01038713|19281264|P3|Overall Study|Patient to hospice|1
5580469|NCT01038713|19281265|P2|Overall Study|Patient to hospice|1
5580470|NCT01038713|19281266|P1|Overall Study|Patient to hospice|1
5580471|NCT01038687|19281289|P3|Overall Study|Adverse Event|1
5580472|NCT01038687|19281290|P2|Overall Study|Adverse Event|2
5580473|NCT01038687|19281291|P1|Overall Study|Adverse Event|0
5580474|NCT01038635|19281332|P9|Overall Study|Death|2
5580475|NCT01038635|19281333|P8|Overall Study|Death|1
5580476|NCT01038635|19281334|P7|Overall Study|Death|1
5580477|NCT01038635|19281335|P6|Overall Study|Death|0
5580478|NCT01038635|19281336|P5|Overall Study|Death|1
5580479|NCT01038635|19281337|P4|Overall Study|Death|0
5580480|NCT01038635|19281338|P3|Overall Study|Death|0
5580481|NCT01038635|19281339|P2|Overall Study|Death|0
5580482|NCT01038635|19281340|P1|Overall Study|Death|0
5580483|NCT01038635|19281332|P9|Overall Study|Disease Progression|0
5580484|NCT01038635|19281333|P8|Overall Study|Disease Progression|4
5580485|NCT01038635|19281334|P7|Overall Study|Disease Progression|1
5580486|NCT01038635|19281335|P6|Overall Study|Disease Progression|0
5580487|NCT01038635|19281336|P5|Overall Study|Disease Progression|0
5580488|NCT01038635|19281337|P4|Overall Study|Disease Progression|0
5580489|NCT01038635|19281338|P3|Overall Study|Disease Progression|0
5580490|NCT01038635|19281339|P2|Overall Study|Disease Progression|0
5580491|NCT01038635|19281340|P1|Overall Study|Disease Progression|2
5580492|NCT01038609|19281366|P5|Overall Study|Refusal of Blood Draws|0
5580493|NCT01038609|19281367|P4|Overall Study|Refusal of Blood Draws|0
5580494|NCT01038609|19281368|P3|Overall Study|Refusal of Blood Draws|0
5580495|NCT01038609|19281369|P2|Overall Study|Refusal of Blood Draws|1
5580496|NCT01038609|19281370|P1|Overall Study|Refusal of Blood Draws|0
5580497|NCT01038609|19281366|P5|Overall Study|Death in the Family|0
5580498|NCT01038609|19281367|P4|Overall Study|Death in the Family|0
5580499|NCT01038609|19281368|P3|Overall Study|Death in the Family|0
5580500|NCT01038609|19281369|P2|Overall Study|Death in the Family|0
5580501|NCT01038609|19281370|P1|Overall Study|Death in the Family|1
5580502|NCT01038609|19281366|P5|Overall Study|Dosing Error|1
5580503|NCT01038609|19281367|P4|Overall Study|Dosing Error|1
5580504|NCT01038609|19281368|P3|Overall Study|Dosing Error|0
5580505|NCT01038609|19281369|P2|Overall Study|Dosing Error|0
5580506|NCT01038609|19281370|P1|Overall Study|Dosing Error|0
5580507|NCT01038609|19281366|P5|Overall Study|Adverse Event|0
5580508|NCT01038609|19281367|P4|Overall Study|Adverse Event|0
5580509|NCT01038609|19281368|P3|Overall Study|Adverse Event|1
5580510|NCT01038609|19281369|P2|Overall Study|Adverse Event|0
5580511|NCT01038609|19281370|P1|Overall Study|Adverse Event|0
5580512|NCT01038323|19281489|P3|Overall Study|Withdrawal by Subject|4
5580513|NCT01038323|19281490|P2|Overall Study|Withdrawal by Subject|2
5580514|NCT01038323|19281491|P1|Overall Study|Withdrawal by Subject|3
5580515|NCT01038128|19281505|P1|Overall Study|Withdrawal by Subject|2
5580516|NCT01038128|19281505|P1|Overall Study|Lost to Follow-up|1
5580517|NCT01038128|19281505|P1|Overall Study|Lack of Efficacy|1
5580518|NCT01037244|19281669|P4|Overall Study|Various|1
5580519|NCT01037244|19281670|P3|Overall Study|Various|1
5580520|NCT01037244|19281671|P2|Overall Study|Various|2
5580521|NCT01037244|19281672|P1|Overall Study|Various|3
5580522|NCT01037244|19281669|P4|Overall Study|Partner Withdrew Consent|0
5580523|NCT01037244|19281670|P3|Overall Study|Partner Withdrew Consent|0
5580524|NCT01037244|19281671|P2|Overall Study|Partner Withdrew Consent|1
5580525|NCT01037244|19281672|P1|Overall Study|Partner Withdrew Consent|2
5580526|NCT01037244|19281669|P4|Overall Study|Withdrawal by Subject|5
5580527|NCT01037244|19281670|P3|Overall Study|Withdrawal by Subject|3
5580528|NCT01037244|19281671|P2|Overall Study|Withdrawal by Subject|5
5580529|NCT01037244|19281672|P1|Overall Study|Withdrawal by Subject|1
5580530|NCT01037244|19281669|P4|Overall Study|Lost to Follow-up|4
5580531|NCT01037244|19281670|P3|Overall Study|Lost to Follow-up|4
5580532|NCT01037244|19281671|P2|Overall Study|Lost to Follow-up|3
5580533|NCT01037244|19281672|P1|Overall Study|Lost to Follow-up|3
5580534|NCT01037244|19281669|P4|Overall Study|Lack of Efficacy|1
5580535|NCT01037244|19281670|P3|Overall Study|Lack of Efficacy|0
5580536|NCT01037244|19281671|P2|Overall Study|Lack of Efficacy|1
5580537|NCT01037244|19281672|P1|Overall Study|Lack of Efficacy|1
5580538|NCT01037244|19281669|P4|Overall Study|Adverse Event|3
5580539|NCT01037244|19281670|P3|Overall Study|Adverse Event|6
5580540|NCT01037244|19281671|P2|Overall Study|Adverse Event|2
5580541|NCT01037244|19281672|P1|Overall Study|Adverse Event|3
5580542|NCT01037218|19281734|P4|Overall Study|Various|1
5580543|NCT01037218|19281735|P3|Overall Study|Various|3
5580544|NCT01037218|19281736|P2|Overall Study|Various|2
5580545|NCT01037218|19281737|P1|Overall Study|Various|3
5580546|NCT01037218|19281734|P4|Overall Study|Protocol Violation|2
5580547|NCT01037218|19281735|P3|Overall Study|Protocol Violation|2
5580548|NCT01037218|19281736|P2|Overall Study|Protocol Violation|0
5580549|NCT01037218|19281737|P1|Overall Study|Protocol Violation|0
5580550|NCT01037218|19281734|P4|Overall Study|Partner Withdrew Consent|1
5580551|NCT01037218|19281735|P3|Overall Study|Partner Withdrew Consent|2
5580552|NCT01037218|19281736|P2|Overall Study|Partner Withdrew Consent|3
5580553|NCT01037218|19281737|P1|Overall Study|Partner Withdrew Consent|0
5580554|NCT01037218|19281734|P4|Overall Study|Withdrawal by Subject|4
5580555|NCT01037218|19281735|P3|Overall Study|Withdrawal by Subject|7
5580556|NCT01037218|19281736|P2|Overall Study|Withdrawal by Subject|7
5580557|NCT01037218|19281737|P1|Overall Study|Withdrawal by Subject|6
5580558|NCT01037218|19281734|P4|Overall Study|Lost to Follow-up|2
5580559|NCT01037218|19281735|P3|Overall Study|Lost to Follow-up|4
5580560|NCT01037218|19281736|P2|Overall Study|Lost to Follow-up|5
5580561|NCT01037218|19281737|P1|Overall Study|Lost to Follow-up|3
5580562|NCT01037218|19281734|P4|Overall Study|Lack of Efficacy|5
5580563|NCT01037218|19281735|P3|Overall Study|Lack of Efficacy|1
5580564|NCT01037218|19281736|P2|Overall Study|Lack of Efficacy|2
5580565|NCT01037218|19281737|P1|Overall Study|Lack of Efficacy|0
5580566|NCT01037218|19281734|P4|Overall Study|Adverse Event|1
5580567|NCT01037218|19281735|P3|Overall Study|Adverse Event|2
5580568|NCT01037218|19281736|P2|Overall Study|Adverse Event|2
5580569|NCT01037218|19281737|P1|Overall Study|Adverse Event|4
5580570|NCT01037127|19281808|P2|Overall Study|Study Closed Terminated|17
5580571|NCT01037127|19281809|P1|Overall Study|Study Closed Terminated|2
5580572|NCT01037127|19281808|P2|Overall Study|Physician Decision|0
5580573|NCT01037127|19281809|P1|Overall Study|Physician Decision|1
5580574|NCT01037127|19281808|P2|Overall Study|Lost to Follow-up|4
5580575|NCT01037127|19281809|P1|Overall Study|Lost to Follow-up|2
5580576|NCT01037114|19281841|P1|Year 20|Others|1
5580577|NCT01037088|19281854|P1|Overall Study|Withdrawal by Subject|3
5580578|NCT01036763|19281886|P1|Overall Study|Other reason (not specified)|40
5580579|NCT01036763|19281886|P1|Overall Study|Lost to Follow-up|28
5580580|NCT01036763|19281886|P1|Overall Study|Adverse Event|25
5580581|NCT01036724|19281898|P2|Overall Study|Protocol Violation|5
5580582|NCT01036724|19281899|P1|Overall Study|Protocol Violation|4
5580583|NCT01036724|19281898|P2|Overall Study|Lack of Efficacy|1
5580584|NCT01036724|19281899|P1|Overall Study|Lack of Efficacy|1
5580585|NCT01036724|19281898|P2|Overall Study|Adverse Event|2
5580586|NCT01036724|19281899|P1|Overall Study|Adverse Event|1
5580587|NCT01036594|19281907|P2|Treatment Regiments Post Week 12|Lack of Efficacy|1
5580588|NCT01036594|19281908|P1|Treatment Regiments Post Week 12|Lack of Efficacy|0
5580589|NCT01036594|19281907|P2|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
5580590|NCT01036594|19281908|P1|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
5580591|NCT01036594|19281907|P2|Treatment Regiments Post Week 12|Adverse Event|1
5580592|NCT01036594|19281908|P1|Treatment Regiments Post Week 12|Adverse Event|0
5580593|NCT01036594|19281907|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
5580594|NCT01036594|19281908|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|1
5580595|NCT01036594|19281907|P2|Treatment Regiments Post Week 12|Physician Decision|1
5580596|NCT01036594|19281908|P1|Treatment Regiments Post Week 12|Physician Decision|1
5580597|NCT01036594|19281907|P2|Week 12 Evaluation|Physician Decision|0
5580598|NCT01036594|19281908|P1|Week 12 Evaluation|Physician Decision|1
5580599|NCT01036594|19281907|P2|Week 12 Evaluation|Adverse Event|0
5580600|NCT01036594|19281908|P1|Week 12 Evaluation|Adverse Event|5
5580601|NCT01036594|19281907|P2|First Treatment Regimen|Withdrawal by Subject|0
5580602|NCT01036594|19281908|P1|First Treatment Regimen|Withdrawal by Subject|1
5580603|NCT01036594|19281907|P2|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
5580604|NCT01036594|19281908|P1|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
5580605|NCT01036529|19281932|P2|Overall Study|Sponsor study termination|12
5580606|NCT01036529|19281933|P1|Overall Study|Sponsor study termination|11
5580607|NCT01036529|19281932|P2|Overall Study|Withdrawal by Subject|1
5580608|NCT01036529|19281933|P1|Overall Study|Withdrawal by Subject|1
5580609|NCT01036529|19281932|P2|Overall Study|Physician Decision|0
5580610|NCT01036529|19281933|P1|Overall Study|Physician Decision|1
5580611|NCT01036529|19281932|P2|Overall Study|Lost to Follow-up|1
5580612|NCT01036529|19281933|P1|Overall Study|Lost to Follow-up|0
5580613|NCT01036529|19281932|P2|Overall Study|Adverse Event|1
5580614|NCT01036529|19281933|P1|Overall Study|Adverse Event|0
5580615|NCT01036438|19281960|P2|Overall Study|No effect of study treatment|1
5580616|NCT01036438|19281961|P1|Overall Study|No effect of study treatment|3
5580617|NCT01036438|19281960|P2|Overall Study|Death|1
5580618|NCT01036438|19281961|P1|Overall Study|Death|0
5580619|NCT01036438|19281960|P2|Overall Study|Adverse Event|8
5580620|NCT01036438|19281961|P1|Overall Study|Adverse Event|7
5580621|NCT01036321|19281969|P2|Overall Study|Adverse Event|1
5580622|NCT01036321|19281970|P1|Overall Study|Adverse Event|2
5580623|NCT01036321|19281969|P2|Overall Study|Withdrawal by Subject|2
5580624|NCT01036321|19281970|P1|Overall Study|Withdrawal by Subject|3
5580625|NCT01036321|19281969|P2|Overall Study|Ineligible after randomization|1
5580626|NCT01036321|19281970|P1|Overall Study|Ineligible after randomization|0
5580627|NCT01036165|19281994|P1|Overall Study|Problems finding proper area to inject|1
5580628|NCT01036165|19281994|P1|Overall Study|Device Related Issues|3
5580629|NCT01036165|19281994|P1|Overall Study|Withdrawal by Subject|3
5580630|NCT01036165|19281994|P1|Overall Study|Lost to Follow-up|2
5580631|NCT01036165|19281994|P1|Overall Study|Adverse Event|6
5580632|NCT01036022|19282005|P6|Overall Study|Withdrawal by Subject|0
5580633|NCT01036022|19282006|P5|Overall Study|Withdrawal by Subject|2
5580634|NCT01036022|19282007|P4|Overall Study|Withdrawal by Subject|1
5580635|NCT01036022|19282008|P3|Overall Study|Withdrawal by Subject|0
5580636|NCT01036022|19282009|P2|Overall Study|Withdrawal by Subject|0
5580637|NCT01036022|19282010|P1|Overall Study|Withdrawal by Subject|0
5580638|NCT01036022|19282005|P6|Overall Study|Physician Decision|0
5580639|NCT01036022|19282006|P5|Overall Study|Physician Decision|0
5580640|NCT01036022|19282007|P4|Overall Study|Physician Decision|0
5580641|NCT01036022|19282008|P3|Overall Study|Physician Decision|1
5580642|NCT01036022|19282009|P2|Overall Study|Physician Decision|0
5580643|NCT01036022|19282010|P1|Overall Study|Physician Decision|0
5580644|NCT01036022|19282005|P6|Overall Study|Lack of Efficacy|1
5580645|NCT01036022|19282006|P5|Overall Study|Lack of Efficacy|1
5580646|NCT01036022|19282007|P4|Overall Study|Lack of Efficacy|0
5580647|NCT01036022|19282008|P3|Overall Study|Lack of Efficacy|1
5580648|NCT01036022|19282009|P2|Overall Study|Lack of Efficacy|1
5580649|NCT01036022|19282010|P1|Overall Study|Lack of Efficacy|1
5580650|NCT01036022|19282005|P6|Overall Study|Adverse Event|2
5580651|NCT01036022|19282006|P5|Overall Study|Adverse Event|0
5580652|NCT01036022|19282007|P4|Overall Study|Adverse Event|1
5580653|NCT01036022|19282008|P3|Overall Study|Adverse Event|2
5580654|NCT01036022|19282009|P2|Overall Study|Adverse Event|3
5580655|NCT01036022|19282010|P1|Overall Study|Adverse Event|1
5580656|NCT01035905|19282146|P2|Overall Study|Lack of Efficacy|1
5580657|NCT01035905|19282147|P1|Overall Study|Lack of Efficacy|1
5580658|NCT01035606|19282320|P3|Overall Study|change in health, job demands,family|4
5580659|NCT01035606|19282321|P2|Overall Study|change in health, job demands,family|3
5580660|NCT01035606|19282322|P1|Overall Study|change in health, job demands,family|3
5580661|NCT01035463|19282338|P6|Overall Study|Other|2
5580662|NCT01035463|19282339|P5|Overall Study|Other|0
5580663|NCT01035463|19282340|P4|Overall Study|Other|1
5580664|NCT01035463|19282341|P3|Overall Study|Other|0
5580665|NCT01035463|19282342|P2|Overall Study|Other|0
5580666|NCT01035463|19282343|P1|Overall Study|Other|0
5580667|NCT01035463|19282338|P6|Overall Study|Other Malignancy|2
5580668|NCT01035463|19282339|P5|Overall Study|Other Malignancy|0
5580669|NCT01035463|19282340|P4|Overall Study|Other Malignancy|0
5580670|NCT01035463|19282341|P3|Overall Study|Other Malignancy|0
5580671|NCT01035463|19282342|P2|Overall Study|Other Malignancy|0
5580672|NCT01035463|19282343|P1|Overall Study|Other Malignancy|0
5580673|NCT01035463|19282338|P6|Overall Study|Disease progression|3
5580674|NCT01035463|19282339|P5|Overall Study|Disease progression|0
5580675|NCT01035463|19282340|P4|Overall Study|Disease progression|0
5580676|NCT01035463|19282341|P3|Overall Study|Disease progression|0
5580677|NCT01035463|19282342|P2|Overall Study|Disease progression|0
5580678|NCT01035463|19282343|P1|Overall Study|Disease progression|0
5580679|NCT01035463|19282338|P6|Overall Study|Withdrawal by Subject|4
5580680|NCT01035463|19282339|P5|Overall Study|Withdrawal by Subject|1
5580681|NCT01035463|19282340|P4|Overall Study|Withdrawal by Subject|0
5580682|NCT01035463|19282341|P3|Overall Study|Withdrawal by Subject|1
5580683|NCT01035463|19282342|P2|Overall Study|Withdrawal by Subject|2
5580684|NCT01035463|19282343|P1|Overall Study|Withdrawal by Subject|0
5580685|NCT01035463|19282338|P6|Overall Study|Adverse Event|7
5580686|NCT01035463|19282339|P5|Overall Study|Adverse Event|5
5580687|NCT01035463|19282340|P4|Overall Study|Adverse Event|1
5580688|NCT01035463|19282341|P3|Overall Study|Adverse Event|4
5580689|NCT01035463|19282342|P2|Overall Study|Adverse Event|0
5580690|NCT01035463|19282343|P1|Overall Study|Adverse Event|0
5580691|NCT01035255|19282380|P2|Overall Study|patient's request|13
5580692|NCT01035255|19282381|P1|Overall Study|patient's request|15
5580693|NCT01035255|19282380|P2|Overall Study|Lost to Follow-up|5
5580694|NCT01035255|19282381|P1|Overall Study|Lost to Follow-up|2
5580695|NCT01035255|19282380|P2|Overall Study|Death|844
5580696|NCT01035255|19282381|P1|Overall Study|Death|724
5580697|NCT01035229|19282399|P2|Overall Study|Disease Progression|152
5580698|NCT01035229|19282400|P1|Overall Study|Disease Progression|261
5580699|NCT01035229|19282399|P2|Overall Study|Sponsor's decision to end study|3
5580700|NCT01035229|19282400|P1|Overall Study|Sponsor's decision to end study|3
5580701|NCT01035229|19282399|P2|Overall Study|Protocol Violation|2
5580702|NCT01035229|19282400|P1|Overall Study|Protocol Violation|0
5580703|NCT01035229|19282399|P2|Overall Study|New cancer therapy|0
5580704|NCT01035229|19282400|P1|Overall Study|New cancer therapy|2
5580705|NCT01035229|19282399|P2|Overall Study|Death|5
5580706|NCT01035229|19282400|P1|Overall Study|Death|13
5580707|NCT01035229|19282399|P2|Overall Study|Administrative problems|1
5580708|NCT01035229|19282400|P1|Overall Study|Administrative problems|1
5580709|NCT01035229|19282399|P2|Overall Study|Lost to Follow-up|0
5580710|NCT01035229|19282400|P1|Overall Study|Lost to Follow-up|1
5580711|NCT01035229|19282399|P2|Overall Study|Withdrawal by Subject|7
5580712|NCT01035229|19282400|P1|Overall Study|Withdrawal by Subject|20
5580713|NCT01035229|19282399|P2|Overall Study|Adverse Event|14
5580714|NCT01035229|19282400|P1|Overall Study|Adverse Event|61
5580715|NCT01035138|19282430|P3|Overall Study|Lost to Follow-up|1
5580716|NCT01035138|19282431|P2|Overall Study|Lost to Follow-up|0
5580717|NCT01035138|19282432|P1|Overall Study|Lost to Follow-up|0
5580718|NCT01035138|19282430|P3|Overall Study|Sponsor Decision|42
5580719|NCT01035138|19282431|P2|Overall Study|Sponsor Decision|60
5580720|NCT01035138|19282432|P1|Overall Study|Sponsor Decision|66
5580721|NCT01035138|19282430|P3|Overall Study|Physician Decision|1
5580722|NCT01035138|19282431|P2|Overall Study|Physician Decision|0
5580723|NCT01035138|19282432|P1|Overall Study|Physician Decision|0
5580724|NCT01035138|19282430|P3|Overall Study|Withdrawal by Subject|0
5580725|NCT01035138|19282431|P2|Overall Study|Withdrawal by Subject|0
5580726|NCT01035138|19282432|P1|Overall Study|Withdrawal by Subject|1
5580727|NCT01035138|19282430|P3|Overall Study|Caregiver Decision|1
5580728|NCT01035138|19282431|P2|Overall Study|Caregiver Decision|0
5580729|NCT01035138|19282432|P1|Overall Study|Caregiver Decision|2
5580730|NCT01035138|19282430|P3|Overall Study|Adverse Event|2
5580731|NCT01035138|19282431|P2|Overall Study|Adverse Event|0
5580732|NCT01035138|19282432|P1|Overall Study|Adverse Event|4
5580733|NCT01035060|19282532|P2|Overall Study|Physician Decision|0
5580734|NCT01035060|19282533|P1|Overall Study|Physician Decision|2
5580735|NCT01035060|19282532|P2|Overall Study|Withdrawal by Subject|6
5580736|NCT01035060|19282533|P1|Overall Study|Withdrawal by Subject|8
5580737|NCT01035060|19282532|P2|Overall Study|Did not quality after 2nd screening|1
5580738|NCT01035060|19282533|P1|Overall Study|Did not quality after 2nd screening|14
5580739|NCT01035060|19282532|P2|Overall Study|Lost to Follow-up|7
5580740|NCT01035060|19282533|P1|Overall Study|Lost to Follow-up|0
5580741|NCT01034709|19282558|P2|Overall Study|Protocol Violation|16
5580742|NCT01034709|19282559|P1|Overall Study|Protocol Violation|9
5580743|NCT01034657|19282565|P3|Randomized Phase|Adverse Event|1
5580744|NCT01034657|19282566|P2|Randomized Phase|Adverse Event|2
5580745|NCT01034657|19282567|P1|Randomized Phase|Adverse Event|0
5580746|NCT01034657|19282565|P3|Randomized Phase|Abnormal laboratory value|0
5580747|NCT01034657|19282566|P2|Randomized Phase|Abnormal laboratory value|1
5580748|NCT01034657|19282567|P1|Randomized Phase|Abnormal laboratory value|0
5580749|NCT01034657|19282565|P3|Randomized Phase|Lack of Efficacy|0
5580750|NCT01034657|19282566|P2|Randomized Phase|Lack of Efficacy|1
5580751|NCT01034657|19282567|P1|Randomized Phase|Lack of Efficacy|5
5580752|NCT01034657|19282565|P3|Randomized Phase|Withdrawal by Subject|0
5580753|NCT01034657|19282566|P2|Randomized Phase|Withdrawal by Subject|2
5580754|NCT01034657|19282567|P1|Randomized Phase|Withdrawal by Subject|0
5580755|NCT01034657|19282565|P3|Core Phase|Protocol Violation|0
5580756|NCT01034657|19282566|P2|Core Phase|Protocol Violation|0
5580757|NCT01034657|19282567|P1|Core Phase|Protocol Violation|2
5580758|NCT01034657|19282565|P3|Core Phase|Adverse Event|0
5580759|NCT01034657|19282566|P2|Core Phase|Adverse Event|0
5580760|NCT01034657|19282567|P1|Core Phase|Adverse Event|8
5580761|NCT01034657|19282565|P3|Core Phase|Abnormal laboratory value|0
5580762|NCT01034657|19282566|P2|Core Phase|Abnormal laboratory value|0
5580763|NCT01034657|19282567|P1|Core Phase|Abnormal laboratory value|1
5580764|NCT01034657|19282565|P3|Core Phase|Lack of Efficacy|0
5580765|NCT01034657|19282566|P2|Core Phase|Lack of Efficacy|0
5580766|NCT01034657|19282567|P1|Core Phase|Lack of Efficacy|2
5580767|NCT01034657|19282565|P3|Core Phase|Withdrawal by Subject|0
5580768|NCT01034657|19282566|P2|Core Phase|Withdrawal by Subject|0
5580769|NCT01034657|19282567|P1|Core Phase|Withdrawal by Subject|1
5580770|NCT01034631|19282608|P3|Phase II|Determined Ineligible per protocol|0
5580771|NCT01034631|19282609|P2|Phase II|Determined Ineligible per protocol|1
5580772|NCT01034631|19282610|P1|Phase II|Determined Ineligible per protocol|0
5580773|NCT01034631|19282608|P3|Phase II|Not Evaluable per protocol|2
5580774|NCT01034631|19282609|P2|Phase II|Not Evaluable per protocol|0
5580775|NCT01034631|19282610|P1|Phase II|Not Evaluable per protocol|0
5580776|NCT01034631|19282608|P3|Phase I|Symptomatic Deterioration before Treatme|0
5580777|NCT01034631|19282609|P2|Phase I|Symptomatic Deterioration before Treatme|0
5580778|NCT01034631|19282610|P1|Phase I|Symptomatic Deterioration before Treatme|3
5580779|NCT01034540|19282677|P2|Overall Study|Adverse Event|1
5580780|NCT01034540|19282678|P1|Overall Study|Adverse Event|0
5580781|NCT01034462|19282697|P2|Overall Study|Other reasons|2
5580782|NCT01034462|19282698|P1|Overall Study|Other reasons|1
5580783|NCT01034462|19282697|P2|Overall Study|Lost to Follow-up|16
5580784|NCT01034462|19282698|P1|Overall Study|Lost to Follow-up|14
5580785|NCT01034462|19282697|P2|Overall Study|Withdrawal by Subject|8
5580786|NCT01034462|19282698|P1|Overall Study|Withdrawal by Subject|9
5580787|NCT01034462|19282697|P2|Overall Study|Protocol Violation|7
5580788|NCT01034462|19282698|P1|Overall Study|Protocol Violation|10
5580789|NCT01034462|19282697|P2|Overall Study|Lack of Efficacy|4
5580790|NCT01034462|19282698|P1|Overall Study|Lack of Efficacy|4
5580791|NCT01034462|19282697|P2|Overall Study|Adverse Event|17
5580792|NCT01034462|19282698|P1|Overall Study|Adverse Event|7
5580793|NCT01034397|19282708|P2|Overall Study|Other|1
5580794|NCT01034397|19282709|P1|Overall Study|Other|0
5580795|NCT01034397|19282708|P2|Overall Study|Adverse Event|0
5580796|NCT01034397|19282709|P1|Overall Study|Adverse Event|4
5580797|NCT01034397|19282708|P2|Overall Study|Lack of Efficacy|0
5580798|NCT01034397|19282709|P1|Overall Study|Lack of Efficacy|3
5580799|NCT01034397|19282708|P2|Overall Study|Lack of compliance|1
5580800|NCT01034397|19282709|P1|Overall Study|Lack of compliance|0
5580801|NCT01034358|19282858|P1|Overall Study|Protocol Violation|1
5580802|NCT01034358|19282858|P1|Overall Study|Withdrawal by Subject|1
5580803|NCT01034306|19282864|P2|Overall Study|Noncomplience|0
5580804|NCT01034306|19282865|P1|Overall Study|Noncomplience|1
5580805|NCT01034306|19282864|P2|Overall Study|hospitalized and decided to stop|0
5580806|NCT01034306|19282865|P1|Overall Study|hospitalized and decided to stop|1
5580807|NCT01034306|19282864|P2|Overall Study|Withdrawal by Subject|2
5580808|NCT01034306|19282865|P1|Overall Study|Withdrawal by Subject|2
5580809|NCT01034306|19282864|P2|Overall Study|Lost to Follow-up|1
5580810|NCT01034306|19282865|P1|Overall Study|Lost to Follow-up|0
5580811|NCT01034306|19282864|P2|Overall Study|Adverse Event|0
5580812|NCT01034306|19282865|P1|Overall Study|Adverse Event|1
5580813|NCT01034176|19282873|P2|Overall Study|Lost to Follow-up|1
5580814|NCT01034176|19282874|P1|Overall Study|Lost to Follow-up|0
5580815|NCT01034176|19282873|P2|Overall Study|Withdrawal by Subject|1
5580816|NCT01034176|19282874|P1|Overall Study|Withdrawal by Subject|0
5580817|NCT01034176|19282873|P2|Overall Study|Physician Decision|0
5580818|NCT01034176|19282874|P1|Overall Study|Physician Decision|2
5580819|NCT01034163|19282884|P2|Overall Study|Abnormal laboratory value|0
5580820|NCT01034163|19282885|P1|Overall Study|Abnormal laboratory value|1
5580821|NCT01034163|19282884|P2|Overall Study|Administrative problems|1
5580822|NCT01034163|19282885|P1|Overall Study|Administrative problems|0
5580823|NCT01034163|19282884|P2|Overall Study|Adverse Event|0
5580824|NCT01034163|19282885|P1|Overall Study|Adverse Event|6
5580825|NCT01034163|19282884|P2|Overall Study|Disease progression|4
5580826|NCT01034163|19282885|P1|Overall Study|Disease progression|3
5580827|NCT01034163|19282884|P2|Overall Study|Protocol deviation|0
5580828|NCT01034163|19282885|P1|Overall Study|Protocol deviation|1
5580829|NCT01034163|19282884|P2|Overall Study|Withdrawal by Subject|2
5580830|NCT01034163|19282885|P1|Overall Study|Withdrawal by Subject|8
5580831|NCT01034163|19282884|P2|Overall Study|Treatment completed as per protocol|7
5580832|NCT01034163|19282885|P1|Overall Study|Treatment completed as per protocol|8
5580833|NCT01034137|19282894|P3|Overall Study|Administrative or other|4
5580834|NCT01034137|19282895|P2|Overall Study|Administrative or other|3
5580835|NCT01034137|19282896|P1|Overall Study|Administrative or other|2
5580836|NCT01034137|19282894|P3|Overall Study|Refused treatment or did not cooperate|1
5580837|NCT01034137|19282895|P2|Overall Study|Refused treatment or did not cooperate|0
5580838|NCT01034137|19282896|P1|Overall Study|Refused treatment or did not cooperate|2
5580839|NCT01034137|19282894|P3|Overall Study|Protocol Violation|1
5580840|NCT01034137|19282895|P2|Overall Study|Protocol Violation|2
5580841|NCT01034137|19282896|P1|Overall Study|Protocol Violation|2
5580842|NCT01034137|19282894|P3|Overall Study|Lack of Efficacy|13
5580843|NCT01034137|19282895|P2|Overall Study|Lack of Efficacy|4
5580844|NCT01034137|19282896|P1|Overall Study|Lack of Efficacy|9
5580845|NCT01034137|19282894|P3|Overall Study|Withdrawal by Subject|3
5580846|NCT01034137|19282895|P2|Overall Study|Withdrawal by Subject|3
5580847|NCT01034137|19282896|P1|Overall Study|Withdrawal by Subject|4
5580848|NCT01034137|19282894|P3|Overall Study|Adverse Event|8
5580849|NCT01034137|19282895|P2|Overall Study|Adverse Event|10
5580850|NCT01034137|19282896|P1|Overall Study|Adverse Event|9
5580851|NCT01033942|19283035|P3|Overall Study|Enrolled in Extension Study|0
5580852|NCT01033942|19283036|P2|Overall Study|Enrolled in Extension Study|3
5580853|NCT01033942|19283037|P1|Overall Study|Enrolled in Extension Study|0
5580854|NCT01033942|19283035|P3|Overall Study|Lost to Follow-up|0
5580855|NCT01033942|19283036|P2|Overall Study|Lost to Follow-up|0
5580856|NCT01033942|19283037|P1|Overall Study|Lost to Follow-up|1
5580857|NCT01033942|19283035|P3|Overall Study|Withdrawal by Subject|1
5580858|NCT01033942|19283036|P2|Overall Study|Withdrawal by Subject|1
5580859|NCT01033942|19283037|P1|Overall Study|Withdrawal by Subject|1
5580860|NCT01033851|19283335|P2|Overall Study|Withdrawal by Subject|7
5580861|NCT01033851|19283336|P1|Overall Study|Withdrawal by Subject|3
5580862|NCT01033825|19283351|P7|Overall Study|Other|0
5580863|NCT01033825|19283352|P6|Overall Study|Other|0
5580864|NCT01033825|19283353|P5|Overall Study|Other|1
5580865|NCT01033825|19283354|P4|Overall Study|Other|0
5580866|NCT01033825|19283355|P3|Overall Study|Other|0
5580867|NCT01033825|19283356|P2|Overall Study|Other|0
5580868|NCT01033825|19283357|P1|Overall Study|Other|0
5580869|NCT01033825|19283351|P7|Overall Study|Protocol Violation|0
5580870|NCT01033825|19283352|P6|Overall Study|Protocol Violation|0
5580871|NCT01033825|19283353|P5|Overall Study|Protocol Violation|0
5580872|NCT01033825|19283354|P4|Overall Study|Protocol Violation|0
5580873|NCT01033825|19283355|P3|Overall Study|Protocol Violation|0
5580874|NCT01033825|19283356|P2|Overall Study|Protocol Violation|0
5580875|NCT01033825|19283357|P1|Overall Study|Protocol Violation|1
5580876|NCT01033825|19283351|P7|Overall Study|Adverse Event|0
5580877|NCT01033825|19283352|P6|Overall Study|Adverse Event|0
5580878|NCT01033825|19283353|P5|Overall Study|Adverse Event|0
5580879|NCT01033825|19283354|P4|Overall Study|Adverse Event|1
5580880|NCT01033825|19283355|P3|Overall Study|Adverse Event|0
5580881|NCT01033825|19283356|P2|Overall Study|Adverse Event|0
5580882|NCT01033825|19283357|P1|Overall Study|Adverse Event|0
5580883|NCT01033825|19283351|P7|Overall Study|Withdrawal by Subject|0
5580884|NCT01033825|19283352|P6|Overall Study|Withdrawal by Subject|0
5580885|NCT01033825|19283353|P5|Overall Study|Withdrawal by Subject|1
5580886|NCT01033825|19283354|P4|Overall Study|Withdrawal by Subject|1
5580887|NCT01033825|19283355|P3|Overall Study|Withdrawal by Subject|2
5580888|NCT01033825|19283356|P2|Overall Study|Withdrawal by Subject|3
5580889|NCT01033825|19283357|P1|Overall Study|Withdrawal by Subject|2
5580890|NCT01033747|19283584|P2|Overall Study|Stopped at end of Extension 1|0
5580891|NCT01033747|19283585|P1|Overall Study|Stopped at end of Extension 1|2
5580892|NCT01033747|19283584|P2|Overall Study|Stopped at end of prolongation visit 1|0
5580893|NCT01033747|19283585|P1|Overall Study|Stopped at end of prolongation visit 1|1
5580894|NCT01033747|19283584|P2|Overall Study|Withdrawal by Subject|6
5580895|NCT01033747|19283585|P1|Overall Study|Withdrawal by Subject|9
5580896|NCT01033747|19283584|P2|Overall Study|Protocol Violation|0
5580897|NCT01033747|19283585|P1|Overall Study|Protocol Violation|1
5580898|NCT01033747|19283584|P2|Overall Study|Unsatisfactory therapeutic effect|4
5580899|NCT01033747|19283585|P1|Overall Study|Unsatisfactory therapeutic effect|14
5580900|NCT01033747|19283584|P2|Overall Study|Abnormal test procedure|1
5580901|NCT01033747|19283585|P1|Overall Study|Abnormal test procedure|0
5580902|NCT01033747|19283584|P2|Overall Study|Abnormal Laboratory Value|0
5580903|NCT01033747|19283585|P1|Overall Study|Abnormal Laboratory Value|1
5580904|NCT01033747|19283584|P2|Overall Study|Adverse Event|4
5580905|NCT01033747|19283585|P1|Overall Study|Adverse Event|9
5580906|NCT01033734|19283593|P1|Overall Study|Withdrawal by Subject|1
5580907|NCT01033487|19283649|P10|Fourth Intervention Period|Adverse Event|0
5580908|NCT01033487|19283650|P9|Fourth Intervention Period|Adverse Event|1
5580909|NCT01033487|19283651|P8|Fourth Intervention Period|Adverse Event|0
5580910|NCT01033487|19283652|P7|Fourth Intervention Period|Adverse Event|0
5580911|NCT01033487|19283653|P6|Fourth Intervention Period|Adverse Event|0
5580912|NCT01033487|19283654|P5|Fourth Intervention Period|Adverse Event|0
5580913|NCT01033487|19283655|P4|Fourth Intervention Period|Adverse Event|0
5580914|NCT01033487|19283656|P3|Fourth Intervention Period|Adverse Event|0
5580915|NCT01033487|19283657|P2|Fourth Intervention Period|Adverse Event|0
5580916|NCT01033487|19283658|P1|Fourth Intervention Period|Adverse Event|0
5580917|NCT01033448|19283712|P1|Overall Study|Unknown disposition|1
5580918|NCT01033448|19283712|P1|Overall Study|Withdrew due to other reasons|3
5580919|NCT01033448|19283712|P1|Overall Study|Lost to Follow-up|3
5580920|NCT01033448|19283712|P1|Overall Study|Positive HCV-RNA at week 48|1
5580921|NCT01033448|19283712|P1|Overall Study|Withdrawal by Subject|4
5580922|NCT01033136|19283771|P2|Follow-Up (3 Month)|Lost to Follow-up|2
5580923|NCT01033136|19283772|P1|Follow-Up (3 Month)|Lost to Follow-up|2
5580924|NCT01033071|19283783|P3|Overall Study|Other|3
5580925|NCT01033071|19283784|P2|Overall Study|Other|4
5580926|NCT01033071|19283785|P1|Overall Study|Other|6
5580927|NCT01033071|19283783|P3|Overall Study|Lack of Efficacy|1
5580928|NCT01033071|19283784|P2|Overall Study|Lack of Efficacy|1
5580929|NCT01033071|19283785|P1|Overall Study|Lack of Efficacy|0
5580930|NCT01033071|19283783|P3|Overall Study|Withdrawal by Subject|11
5580931|NCT01033071|19283784|P2|Overall Study|Withdrawal by Subject|14
5580932|NCT01033071|19283785|P1|Overall Study|Withdrawal by Subject|17
5580933|NCT01033071|19283783|P3|Overall Study|Lost to Follow-up|5
5580934|NCT01033071|19283784|P2|Overall Study|Lost to Follow-up|5
5580935|NCT01033071|19283785|P1|Overall Study|Lost to Follow-up|4
5580936|NCT01033071|19283783|P3|Overall Study|Protocol Violation|1
5580937|NCT01033071|19283784|P2|Overall Study|Protocol Violation|2
5580938|NCT01033071|19283785|P1|Overall Study|Protocol Violation|0
5580939|NCT01033071|19283783|P3|Overall Study|Adverse Event|26
5580940|NCT01033071|19283784|P2|Overall Study|Adverse Event|51
5580941|NCT01033071|19283785|P1|Overall Study|Adverse Event|28
5580942|NCT01033019|19283856|P2|Overall Study|Withdrawal by Subject|0
5580943|NCT01033019|19283857|P1|Overall Study|Withdrawal by Subject|1
5580944|NCT01032915|19283914|P4|Overall Study|Protocol Violation|1
5580945|NCT01032915|19283915|P3|Overall Study|Protocol Violation|0
5580946|NCT01032915|19283916|P2|Overall Study|Protocol Violation|0
5580947|NCT01032915|19283917|P1|Overall Study|Protocol Violation|1
5580948|NCT01032915|19283914|P4|Overall Study|Administrative reasons|4
5580949|NCT01032915|19283915|P3|Overall Study|Administrative reasons|4
5580950|NCT01032915|19283916|P2|Overall Study|Administrative reasons|6
5580951|NCT01032915|19283917|P1|Overall Study|Administrative reasons|5
5580952|NCT01032915|19283914|P4|Overall Study|Withdrawal by Subject|1
5580953|NCT01032915|19283915|P3|Overall Study|Withdrawal by Subject|1
5580954|NCT01032915|19283916|P2|Overall Study|Withdrawal by Subject|3
5580955|NCT01032915|19283917|P1|Overall Study|Withdrawal by Subject|0
5580956|NCT01032915|19283914|P4|Overall Study|Abnormal test procedure result|0
5580957|NCT01032915|19283915|P3|Overall Study|Abnormal test procedure result|1
5580958|NCT01032915|19283916|P2|Overall Study|Abnormal test procedure result|0
5580959|NCT01032915|19283917|P1|Overall Study|Abnormal test procedure result|0
5580960|NCT01032915|19283914|P4|Overall Study|Adverse Event|1
5580961|NCT01032915|19283915|P3|Overall Study|Adverse Event|1
5580962|NCT01032915|19283916|P2|Overall Study|Adverse Event|2
5580963|NCT01032915|19283917|P1|Overall Study|Adverse Event|2
5580964|NCT01032889|19283942|P3|Overall Study|Miscellaneous Reasons|1
5580965|NCT01032889|19283943|P2|Overall Study|Miscellaneous Reasons|1
5580966|NCT01032889|19283944|P1|Overall Study|Miscellaneous Reasons|2
5580967|NCT01032889|19283942|P3|Overall Study|Lack of Submental Fat|1
5580968|NCT01032889|19283943|P2|Overall Study|Lack of Submental Fat|8
5580969|NCT01032889|19283944|P1|Overall Study|Lack of Submental Fat|2
5580970|NCT01032889|19283942|P3|Overall Study|Lost to Follow-up|0
5580971|NCT01032889|19283943|P2|Overall Study|Lost to Follow-up|1
5580972|NCT01032889|19283944|P1|Overall Study|Lost to Follow-up|1
5580973|NCT01032889|19283942|P3|Overall Study|Patient Request|0
5580974|NCT01032889|19283943|P2|Overall Study|Patient Request|1
5580975|NCT01032889|19283944|P1|Overall Study|Patient Request|0
5580976|NCT01032889|19283942|P3|Overall Study|Withdrawal of Consent|1
5580977|NCT01032889|19283943|P2|Overall Study|Withdrawal of Consent|2
5580978|NCT01032889|19283944|P1|Overall Study|Withdrawal of Consent|1
5580979|NCT01032889|19283942|P3|Overall Study|Adverse Event|0
5580980|NCT01032889|19283943|P2|Overall Study|Adverse Event|2
5580981|NCT01032889|19283944|P1|Overall Study|Adverse Event|2
5580982|NCT01032837|19283975|P4|Overall Study|Refused treatment|1
5580983|NCT01032837|19283976|P3|Overall Study|Refused treatment|0
5580984|NCT01032837|19283977|P2|Overall Study|Refused treatment|0
5580985|NCT01032837|19283978|P1|Overall Study|Refused treatment|0
5580986|NCT01032837|19283975|P4|Overall Study|Failed to return|0
5580987|NCT01032837|19283976|P3|Overall Study|Failed to return|1
5580988|NCT01032837|19283977|P2|Overall Study|Failed to return|0
5580989|NCT01032837|19283978|P1|Overall Study|Failed to return|0
5580990|NCT01032837|19283975|P4|Overall Study|Withdrew consent|1
5580991|NCT01032837|19283976|P3|Overall Study|Withdrew consent|0
5580992|NCT01032837|19283977|P2|Overall Study|Withdrew consent|2
5580993|NCT01032837|19283978|P1|Overall Study|Withdrew consent|0
5580994|NCT01032837|19283975|P4|Overall Study|Adverse event/internal illness|1
5580995|NCT01032837|19283976|P3|Overall Study|Adverse event/internal illness|0
5580996|NCT01032837|19283977|P2|Overall Study|Adverse event/internal illness|1
5580997|NCT01032837|19283978|P1|Overall Study|Adverse event/internal illness|0
5580998|NCT01032629|19284078|P3|Overall Study|Lost to Follow-up|37
5580999|NCT01032629|19284079|P2|Overall Study|Lost to Follow-up|47
5581000|NCT01032629|19284080|P1|Overall Study|Lost to Follow-up|74
5581001|NCT01032629|19284078|P3|Overall Study|Withdrawal by Subject|35
5581002|NCT01032629|19284079|P2|Overall Study|Withdrawal by Subject|36
5581003|NCT01032629|19284080|P1|Overall Study|Withdrawal by Subject|50
5581004|NCT01032629|19284078|P3|Overall Study|Closed Site|16
5581005|NCT01032629|19284079|P2|Overall Study|Closed Site|18
5581006|NCT01032629|19284080|P1|Overall Study|Closed Site|21
5581007|NCT01032382|19284192|P2|Overall Study|Index lesion relapse|3
5581008|NCT01032382|19284193|P1|Overall Study|Index lesion relapse|1
5581009|NCT01032382|19284192|P2|Overall Study|Treatment failure|1
5581010|NCT01032382|19284193|P1|Overall Study|Treatment failure|3
5581011|NCT01032382|19284192|P2|Overall Study|Disease dissemination|1
5581012|NCT01032382|19284193|P1|Overall Study|Disease dissemination|1
5581013|NCT01032291|19284281|P3|Proof of Concept|Never Received Study Drug|0
5581014|NCT01032291|19284282|P2|Proof of Concept|Never Received Study Drug|1
5581015|NCT01032291|19284283|P1|Proof of Concept|Never Received Study Drug|0
5581016|NCT01032291|19284281|P3|Proof of Concept|Lack of Efficacy|0
5581017|NCT01032291|19284282|P2|Proof of Concept|Lack of Efficacy|1
5581018|NCT01032291|19284283|P1|Proof of Concept|Lack of Efficacy|0
5581019|NCT01032291|19284281|P3|Proof of Concept|Death|2
5581020|NCT01032291|19284282|P2|Proof of Concept|Death|1
5581021|NCT01032291|19284283|P1|Proof of Concept|Death|0
5581022|NCT01032291|19284281|P3|Proof of Concept|Adverse Event|1
5581023|NCT01032291|19284282|P2|Proof of Concept|Adverse Event|5
5581024|NCT01032291|19284283|P1|Proof of Concept|Adverse Event|0
5581025|NCT01032291|19284281|P3|Safety Lead-in|Death|0
5581026|NCT01032291|19284282|P2|Safety Lead-in|Death|0
5581027|NCT01032291|19284283|P1|Safety Lead-in|Death|1
5581028|NCT01032291|19284281|P3|Safety Lead-in|Adverse Event|0
5581029|NCT01032291|19284282|P2|Safety Lead-in|Adverse Event|0
5581030|NCT01032291|19284283|P1|Safety Lead-in|Adverse Event|1
5581031|NCT01032239|19284330|P2|Overall Study|Protocol Violation|0
5581032|NCT01032239|19284331|P1|Overall Study|Protocol Violation|1
5581033|NCT01032239|19284330|P2|Overall Study|Death|0
5581034|NCT01032239|19284331|P1|Overall Study|Death|1
5581035|NCT01032239|19284330|P2|Overall Study|Withdrawal by Subject|3
5581036|NCT01032239|19284331|P1|Overall Study|Withdrawal by Subject|2
5581037|NCT01032239|19284330|P2|Overall Study|Lost to Follow-up|2
5581038|NCT01032239|19284331|P1|Overall Study|Lost to Follow-up|3
5581039|NCT01032200|19284361|P2|Overall Study|Multiple|1
5581040|NCT01032200|19284362|P1|Overall Study|Multiple|1
5581041|NCT01032200|19284361|P2|Overall Study|Progression|0
5581042|NCT01032200|19284362|P1|Overall Study|Progression|1
5581043|NCT01032200|19284361|P2|Overall Study|Toxicity|2
5581044|NCT01032200|19284362|P1|Overall Study|Toxicity|0
5581045|NCT01032200|19284361|P2|Overall Study|Withdrawal by Subject|3
5581046|NCT01032200|19284362|P1|Overall Study|Withdrawal by Subject|1
5581047|NCT01032200|19284361|P2|Overall Study|Death|1
5581048|NCT01032200|19284362|P1|Overall Study|Death|1
5581049|NCT01032174|19284378|P2|Overall Study|Adverse Event|1
5581050|NCT01032174|19284379|P1|Overall Study|Adverse Event|0
5581051|NCT01032070|19284619|P2|Overall Study|Withdrawal by Subject|2
5581052|NCT01032070|19284620|P1|Overall Study|Withdrawal by Subject|0
5581053|NCT01032070|19284619|P2|Overall Study|Medical or ethical reasons|2
5581054|NCT01032070|19284620|P1|Overall Study|Medical or ethical reasons|0
5581055|NCT01032070|19284619|P2|Overall Study|Disease progression|8
5581056|NCT01032070|19284620|P1|Overall Study|Disease progression|13
5581057|NCT01032044|19284649|P2|Overall Study|Lost to Follow-up|11
5581058|NCT01032044|19284650|P1|Overall Study|Lost to Follow-up|11
5581059|NCT01032044|19284649|P2|Overall Study|Adverse Event|1
5581060|NCT01032044|19284650|P1|Overall Study|Adverse Event|0
5581061|NCT01032044|19284649|P2|Overall Study|Protocol Violation|8
5581062|NCT01032044|19284650|P1|Overall Study|Protocol Violation|14
5581063|NCT01032018|19284658|P2|Overall Study|Death|1
5581064|NCT01032018|19284659|P1|Overall Study|Death|0
5581065|NCT01032018|19284658|P2|Overall Study|Lost to Follow-up|5
5581066|NCT01032018|19284659|P1|Overall Study|Lost to Follow-up|6
5581067|NCT01031979|19284669|P2|Overall Study|Lost to Follow-up|4
5581068|NCT01031979|19284670|P1|Overall Study|Lost to Follow-up|5
5581069|NCT01031836|19284703|P6|Stage II|Other|0
5581070|NCT01031836|19284704|P5|Stage II|Other|1
5581071|NCT01031836|19284705|P4|Stage II|Other|1
5581072|NCT01031836|19284706|P3|Stage II|Other|0
5581073|NCT01031836|19284707|P2|Stage II|Other|0
5581074|NCT01031836|19284708|P1|Stage II|Other|2
5581075|NCT01031836|19284703|P6|Stage II|Adverse Event|1
5581076|NCT01031836|19284704|P5|Stage II|Adverse Event|1
5581077|NCT01031836|19284705|P4|Stage II|Adverse Event|2
5581078|NCT01031836|19284706|P3|Stage II|Adverse Event|2
5581079|NCT01031836|19284707|P2|Stage II|Adverse Event|0
5581080|NCT01031836|19284708|P1|Stage II|Adverse Event|0
5581081|NCT01031836|19284703|P6|Stage I|Other|1
5581082|NCT01031836|19284704|P5|Stage I|Other|0
5581083|NCT01031836|19284705|P4|Stage I|Other|0
5581084|NCT01031836|19284706|P3|Stage I|Other|0
5581085|NCT01031836|19284707|P2|Stage I|Other|1
5581086|NCT01031836|19284708|P1|Stage I|Other|0
5581087|NCT01031836|19284703|P6|Stage I|Adverse Event|0
5581088|NCT01031836|19284704|P5|Stage I|Adverse Event|0
5581089|NCT01031836|19284705|P4|Stage I|Adverse Event|0
5581090|NCT01031836|19284706|P3|Stage I|Adverse Event|0
5581091|NCT01031836|19284707|P2|Stage I|Adverse Event|1
5581092|NCT01031836|19284708|P1|Stage I|Adverse Event|1
5581093|NCT01031706|19284769|P2|Overall Study|Withdrawal by Subject|1
5581094|NCT01031706|19284770|P1|Overall Study|Withdrawal by Subject|1
5581095|NCT01031706|19284769|P2|Overall Study|Adverse Event|0
5581096|NCT01031706|19284770|P1|Overall Study|Adverse Event|1
5581097|NCT01031680|19284780|P2|Overall Study|Various|2
5581098|NCT01031680|19284781|P1|Overall Study|Various|0
5581099|NCT01031680|19284780|P2|Overall Study|Administrative Reason by Sponsor|1
5581100|NCT01031680|19284781|P1|Overall Study|Administrative Reason by Sponsor|0
5581101|NCT01031680|19284780|P2|Overall Study|Incorrect Enrolment|2
5581102|NCT01031680|19284781|P1|Overall Study|Incorrect Enrolment|1
5581103|NCT01031680|19284780|P2|Overall Study|Safety|0
5581104|NCT01031680|19284781|P1|Overall Study|Safety|1
5581105|NCT01031680|19284780|P2|Overall Study|Poor/Non-compliance|6
5581106|NCT01031680|19284781|P1|Overall Study|Poor/Non-compliance|5
5581107|NCT01031680|19284780|P2|Overall Study|Subject No Longer Meets Study Criteria|17
5581108|NCT01031680|19284781|P1|Overall Study|Subject No Longer Meets Study Criteria|26
5581109|NCT01031680|19284780|P2|Overall Study|Death|1
5581110|NCT01031680|19284781|P1|Overall Study|Death|2
5581111|NCT01031680|19284780|P2|Overall Study|Withdrawal by Subject|16
5581112|NCT01031680|19284781|P1|Overall Study|Withdrawal by Subject|12
5581113|NCT01031680|19284780|P2|Overall Study|Lost to Follow-up|10
5581114|NCT01031680|19284781|P1|Overall Study|Lost to Follow-up|2
5581115|NCT01031680|19284780|P2|Overall Study|Adverse Event|3
5581116|NCT01031680|19284781|P1|Overall Study|Adverse Event|8
5581117|NCT01031628|19284801|P4|Overall Study|Study terminated early|0
5581118|NCT01031628|19284802|P3|Overall Study|Study terminated early|3
5581119|NCT01031628|19284803|P2|Overall Study|Study terminated early|1
5581120|NCT01031628|19284804|P1|Overall Study|Study terminated early|0
5581121|NCT01031537|19284829|P1|Overall Study|PI removal, no longer met eligibility|12
5581122|NCT01031537|19284829|P1|Overall Study|Withdrawal by Subject|5
5581123|NCT01031537|19284829|P1|Overall Study|moved, met exclusion criteria|10
5581124|NCT01031537|19284829|P1|Overall Study|retired from NIH, met exclusion criteria|1
5581125|NCT01031537|19284829|P1|Overall Study|Lack of Efficacy|1
5581126|NCT01031537|19284829|P1|Overall Study|medical reasons not related to study|3
5581127|NCT01031446|19284847|P1|Overall Study|Still on treatment|1
5581128|NCT01031446|19284847|P1|Overall Study|Withdrawal by Subject|3
5581129|NCT01031446|19284847|P1|Overall Study|Physician Decision|4
5581130|NCT01031446|19284847|P1|Overall Study|Adverse Event|9
5581131|NCT01031446|19284847|P1|Overall Study|Disease Progression|38
5581132|NCT01031381|19284861|P1|Overall Study|Withdrawal by Subject|6
5581133|NCT01031381|19284861|P1|Overall Study|Physician Decision|3
5581134|NCT01031069|19284890|P4|Overall Study|Other|0
5581135|NCT01031069|19284891|P3|Overall Study|Other|1
5581136|NCT01031069|19284892|P2|Overall Study|Other|0
5581137|NCT01031069|19284893|P1|Overall Study|Other|0
5581138|NCT01031069|19284890|P4|Overall Study|Lost to Follow-up|15
5581139|NCT01031069|19284891|P3|Overall Study|Lost to Follow-up|21
5581140|NCT01031069|19284892|P2|Overall Study|Lost to Follow-up|5
5581141|NCT01031069|19284893|P1|Overall Study|Lost to Follow-up|9
5581142|NCT01031069|19284890|P4|Overall Study|Migrated/moved from study area|1
5581143|NCT01031069|19284891|P3|Overall Study|Migrated/moved from study area|1
5581144|NCT01031069|19284892|P2|Overall Study|Migrated/moved from study area|2
5581145|NCT01031069|19284893|P1|Overall Study|Migrated/moved from study area|1
5581146|NCT01031069|19284890|P4|Overall Study|Withdrawal by Subject|18
5581147|NCT01031069|19284891|P3|Overall Study|Withdrawal by Subject|18
5581148|NCT01031069|19284892|P2|Overall Study|Withdrawal by Subject|3
5581149|NCT01031069|19284893|P1|Overall Study|Withdrawal by Subject|2
5581150|NCT01031069|19284890|P4|Overall Study|Serious Adverse Event|0
5581151|NCT01031069|19284891|P3|Overall Study|Serious Adverse Event|0
5581152|NCT01031069|19284892|P2|Overall Study|Serious Adverse Event|1
5581153|NCT01031069|19284893|P1|Overall Study|Serious Adverse Event|0
5581154|NCT01031004|19284995|P2|Overall Study|Lost to Follow-up|0
5581155|NCT01031004|19284996|P1|Overall Study|Lost to Follow-up|1
5581156|NCT01031004|19284995|P2|Overall Study|Protocol Violation|1
5581157|NCT01031004|19284996|P1|Overall Study|Protocol Violation|0
5581158|NCT01030965|19285040|P4|Overall Study|Withdrawal by Subject|2
5581159|NCT01030965|19285041|P3|Overall Study|Withdrawal by Subject|0
5581160|NCT01030965|19285042|P2|Overall Study|Withdrawal by Subject|1
5581161|NCT01030965|19285043|P1|Overall Study|Withdrawal by Subject|0
5581162|NCT01030965|19285040|P4|Overall Study|Protocol-defined Stopping Criteria|0
5581163|NCT01030965|19285041|P3|Overall Study|Protocol-defined Stopping Criteria|1
5581164|NCT01030965|19285042|P2|Overall Study|Protocol-defined Stopping Criteria|1
5581165|NCT01030965|19285043|P1|Overall Study|Protocol-defined Stopping Criteria|0
5581166|NCT01030965|19285040|P4|Overall Study|Adverse Event|1
5581167|NCT01030965|19285041|P3|Overall Study|Adverse Event|2
5581168|NCT01030965|19285042|P2|Overall Study|Adverse Event|1
5581169|NCT01030965|19285043|P1|Overall Study|Adverse Event|0
5581170|NCT01030965|19285040|P4|Overall Study|Protocol Violation|1
5581171|NCT01030965|19285041|P3|Overall Study|Protocol Violation|1
5581172|NCT01030965|19285042|P2|Overall Study|Protocol Violation|1
5581173|NCT01030965|19285043|P1|Overall Study|Protocol Violation|1
5581174|NCT01030965|19285040|P4|Overall Study|Lack of Efficacy|3
5581175|NCT01030965|19285041|P3|Overall Study|Lack of Efficacy|0
5581176|NCT01030965|19285042|P2|Overall Study|Lack of Efficacy|2
5581177|NCT01030965|19285043|P1|Overall Study|Lack of Efficacy|3
5581178|NCT01030952|19285063|P2|Overall Study|Unexplained|1
5581179|NCT01030952|19285064|P1|Overall Study|Unexplained|1
5581180|NCT01030952|19285063|P2|Overall Study|Lost to Follow-up|1
5581181|NCT01030952|19285064|P1|Overall Study|Lost to Follow-up|0
5581182|NCT01030952|19285063|P2|Overall Study|Informed consent withdrawal|0
5581183|NCT01030952|19285064|P1|Overall Study|Informed consent withdrawal|1
5581184|NCT01030952|19285063|P2|Overall Study|Protocol Violation|1
5581185|NCT01030952|19285064|P1|Overall Study|Protocol Violation|0
5581186|NCT01030822|19285112|P3|Overall Study|Lost to Follow-up|7
5581187|NCT01030822|19285113|P2|Overall Study|Lost to Follow-up|4
5581188|NCT01030822|19285114|P1|Overall Study|Lost to Follow-up|9
5581189|NCT01030822|19285112|P3|Overall Study|Withdrawal by Subject|16
5581190|NCT01030822|19285113|P2|Overall Study|Withdrawal by Subject|13
5581191|NCT01030822|19285114|P1|Overall Study|Withdrawal by Subject|16
5581192|NCT01030822|19285112|P3|Overall Study|Moved/migrated from study area|3
5581193|NCT01030822|19285113|P2|Overall Study|Moved/migrated from study area|7
5581194|NCT01030822|19285114|P1|Overall Study|Moved/migrated from study area|6
5581195|NCT01030718|19285189|P3|Study CA180-036 Only|Other Reasons|0
5581196|NCT01030718|19285190|P2|Study CA180-036 Only|Other Reasons|2
5581197|NCT01030718|19285191|P1|Study CA180-036 Only|Other Reasons|0
5581198|NCT01030718|19285189|P3|Study CA180-036 Only|Death|0
5581199|NCT01030718|19285190|P2|Study CA180-036 Only|Death|1
5581200|NCT01030718|19285191|P1|Study CA180-036 Only|Death|0
5581201|NCT01030718|19285189|P3|Study CA180-036 Only|Adverse Event|0
5581202|NCT01030718|19285190|P2|Study CA180-036 Only|Adverse Event|3
5581203|NCT01030718|19285191|P1|Study CA180-036 Only|Adverse Event|2
5581204|NCT01030718|19285189|P3|Study CA180-036 Only|insufficient effect|5
5581205|NCT01030718|19285190|P2|Study CA180-036 Only|insufficient effect|1
5581206|NCT01030718|19285191|P1|Study CA180-036 Only|insufficient effect|1
5581207|NCT01030718|19285189|P3|Studies CA180-031 and -036 Combined|other reasons|0
5581208|NCT01030718|19285190|P2|Studies CA180-031 and -036 Combined|other reasons|2
5581209|NCT01030718|19285191|P1|Studies CA180-031 and -036 Combined|other reasons|0
5581210|NCT01030718|19285189|P3|Studies CA180-031 and -036 Combined|Death|0
5581211|NCT01030718|19285190|P2|Studies CA180-031 and -036 Combined|Death|1
5581212|NCT01030718|19285191|P1|Studies CA180-031 and -036 Combined|Death|0
5581213|NCT01030718|19285189|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
5581214|NCT01030718|19285190|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
5581215|NCT01030718|19285191|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
5581216|NCT01030718|19285189|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
5581217|NCT01030718|19285190|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
5581218|NCT01030718|19285191|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
5581219|NCT01030666|19285252|P2|Overall Study|Lost to Follow-up|2
5581220|NCT01030666|19285253|P1|Overall Study|Lost to Follow-up|3
5581221|NCT01030536|19285278|P5|Overall Study|Death|0
5581222|NCT01030536|19285279|P4|Overall Study|Death|0
5581223|NCT01030536|19285280|P3|Overall Study|Death|0
5581224|NCT01030536|19285281|P2|Overall Study|Death|1
5581225|NCT01030536|19285282|P1|Overall Study|Death|0
5581226|NCT01030536|19285278|P5|Overall Study|Progressive disease|0
5581227|NCT01030536|19285279|P4|Overall Study|Progressive disease|2
5581228|NCT01030536|19285280|P3|Overall Study|Progressive disease|3
5581229|NCT01030536|19285281|P2|Overall Study|Progressive disease|2
5581230|NCT01030536|19285282|P1|Overall Study|Progressive disease|6
5581231|NCT01030536|19285278|P5|Overall Study|Adverse Event|1
5581232|NCT01030536|19285279|P4|Overall Study|Adverse Event|0
5581233|NCT01030536|19285280|P3|Overall Study|Adverse Event|1
5581234|NCT01030536|19285281|P2|Overall Study|Adverse Event|3
5581235|NCT01030536|19285282|P1|Overall Study|Adverse Event|0
5581236|NCT01030536|19285278|P5|Overall Study|undefined|0
5581237|NCT01030536|19285279|P4|Overall Study|undefined|1
5581238|NCT01030536|19285280|P3|Overall Study|undefined|1
5581239|NCT01030536|19285281|P2|Overall Study|undefined|0
5581240|NCT01030536|19285282|P1|Overall Study|undefined|1
5581241|NCT01030536|19285278|P5|Overall Study|Withdrawal by Subject|0
5581242|NCT01030536|19285279|P4|Overall Study|Withdrawal by Subject|0
5581243|NCT01030536|19285280|P3|Overall Study|Withdrawal by Subject|1
5581244|NCT01030536|19285281|P2|Overall Study|Withdrawal by Subject|0
5581245|NCT01030536|19285282|P1|Overall Study|Withdrawal by Subject|0
5581246|NCT01030523|19285387|P2|Overall Study|Withdrawal by Subject|1
5581247|NCT01030523|19285388|P1|Overall Study|Withdrawal by Subject|0
5581248|NCT01030523|19285387|P2|Overall Study|Implant failure|0
5581249|NCT01030523|19285388|P1|Overall Study|Implant failure|1
5581250|NCT01030523|19285387|P2|Overall Study|Lost to Follow-up|4
5581251|NCT01030523|19285388|P1|Overall Study|Lost to Follow-up|4
5581252|NCT01030523|19285387|P2|Overall Study|Death|0
5581253|NCT01030523|19285388|P1|Overall Study|Death|1
5581254|NCT01030458|19285402|P2|Overall Study|Side effect of medication|1
5581255|NCT01030458|19285403|P1|Overall Study|Side effect of medication|1
5581256|NCT01030458|19285402|P2|Overall Study|Moved or changed job|13
5581257|NCT01030458|19285403|P1|Overall Study|Moved or changed job|6
5581258|NCT01030458|19285402|P2|Overall Study|Logistical reasons|5
5581259|NCT01030458|19285403|P1|Overall Study|Logistical reasons|9
5581260|NCT01030458|19285402|P2|Overall Study|Withdrawal by Subject|3
5581261|NCT01030458|19285403|P1|Overall Study|Withdrawal by Subject|2
5581262|NCT01030458|19285402|P2|Overall Study|Lost to Follow-up|10
5581263|NCT01030458|19285403|P1|Overall Study|Lost to Follow-up|9
5581264|NCT01030341|19285436|P1|Overall Study|Lost to Follow-up|2
5581265|NCT01030341|19285436|P1|Overall Study|Withdrawal by Subject|1
5581266|NCT01030198|19285459|P2|Overall Study|Could not measure efficacy accurately|7
5581267|NCT01030198|19285460|P1|Overall Study|Could not measure efficacy accurately|0
5581268|NCT01030133|19285468|P2|Overall Study|failed to experience pain at level 7/10|2
5581269|NCT01030133|19285469|P1|Overall Study|failed to experience pain at level 7/10|2
5581270|NCT01029925|19285481|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
5581271|NCT01029925|19285481|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
5581272|NCT01029925|19285481|P1|Completion of Cycle 1 (28 Days)|Death|2
5581273|NCT01029886|19285500|P2|Overall Study|Loss Glucose Control|1
5581274|NCT01029886|19285501|P1|Overall Study|Loss Glucose Control|7
5581275|NCT01029886|19285500|P2|Overall Study|Sponsor Decision|0
5581276|NCT01029886|19285501|P1|Overall Study|Sponsor Decision|1
5581277|NCT01029886|19285500|P2|Overall Study|Entry Criteria Not Met|5
5581278|NCT01029886|19285501|P1|Overall Study|Entry Criteria Not Met|13
5581279|NCT01029886|19285500|P2|Overall Study|Withdrawal by Subject|18
5581280|NCT01029886|19285501|P1|Overall Study|Withdrawal by Subject|8
5581281|NCT01029886|19285500|P2|Overall Study|Protocol Violation|5
5581282|NCT01029886|19285501|P1|Overall Study|Protocol Violation|17
5581283|NCT01029886|19285500|P2|Overall Study|Physician Decision|6
5581284|NCT01029886|19285501|P1|Overall Study|Physician Decision|2
5581285|NCT01029886|19285500|P2|Overall Study|Lost to Follow-up|0
5581286|NCT01029886|19285501|P1|Overall Study|Lost to Follow-up|1
5581287|NCT01029886|19285500|P2|Overall Study|Adverse Event|25
5581288|NCT01029886|19285501|P1|Overall Study|Adverse Event|12
5581289|NCT01029795|19285529|P2|Overall Study|Withdrawal by Subject|3
5581290|NCT01029795|19285530|P1|Overall Study|Withdrawal by Subject|1
5581291|NCT01029795|19285529|P2|Overall Study|Sponsor Decision|17
5581292|NCT01029795|19285530|P1|Overall Study|Sponsor Decision|11
5581293|NCT01029795|19285529|P2|Overall Study|Physician Decision|1
5581294|NCT01029795|19285530|P1|Overall Study|Physician Decision|2
5581295|NCT01029795|19285529|P2|Overall Study|Entry Criteria Not Met|1
5581296|NCT01029795|19285530|P1|Overall Study|Entry Criteria Not Met|2
5581297|NCT01029782|19285584|P2|Overall Study|Withdrawal by Subject|1
5581298|NCT01029782|19285585|P1|Overall Study|Withdrawal by Subject|0
5581299|NCT01029782|19285584|P2|Overall Study|Protocol Violation|2
5581300|NCT01029782|19285585|P1|Overall Study|Protocol Violation|0
5581301|NCT01029782|19285584|P2|Overall Study|Physician Decision|1
5581302|NCT01029782|19285585|P1|Overall Study|Physician Decision|0
5581303|NCT01029782|19285584|P2|Overall Study|Adverse Event|1
5581304|NCT01029782|19285585|P1|Overall Study|Adverse Event|0
5581305|NCT01029782|19285584|P2|Overall Study|Diagnosis changed|1
5581306|NCT01029782|19285585|P1|Overall Study|Diagnosis changed|1
5581307|NCT01029782|19285584|P2|Overall Study|Lost to Follow-up|2
5581308|NCT01029782|19285585|P1|Overall Study|Lost to Follow-up|2
5581309|NCT01029691|19285637|P3|Continued APAP to Delivery|Death|1
5581310|NCT01029691|19285638|P2|Continued APAP to Delivery|Death|0
5581311|NCT01029691|19285639|P1|Continued APAP to Delivery|Death|0
5581312|NCT01029652|19285664|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
5581313|NCT01029652|19285665|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
5581314|NCT01029652|19285664|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
5581315|NCT01029652|19285665|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
5581316|NCT01029652|19285664|P2|Extension Study 2 (25-72 Weeks)|Death|1
5581317|NCT01029652|19285665|P1|Extension Study 2 (25-72 Weeks)|Death|1
5581318|NCT01029652|19285664|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
5581319|NCT01029652|19285665|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
5581320|NCT01029652|19285664|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
5581321|NCT01029652|19285665|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
5581322|NCT01029652|19285664|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
5581323|NCT01029652|19285665|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
5581324|NCT01029652|19285664|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
5581325|NCT01029652|19285665|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
5581326|NCT01029652|19285664|P2|Core Study (0-12 Weeks)|Death|1
5581327|NCT01029652|19285665|P1|Core Study (0-12 Weeks)|Death|0
5581328|NCT01029652|19285664|P2|Core Study (0-12 Weeks)|Administrative problems|1
5581329|NCT01029652|19285665|P1|Core Study (0-12 Weeks)|Administrative problems|2
5581330|NCT01029652|19285664|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
5581331|NCT01029652|19285665|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
5581332|NCT01029652|19285664|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
5581333|NCT01029652|19285665|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
5581334|NCT01029652|19285664|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
5581335|NCT01029652|19285665|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
5581336|NCT01029535|19285749|P1|Overall Study|Death|1
5581337|NCT01029535|19285749|P1|Overall Study|Use of Another Treatment|1
5581338|NCT01029535|19285749|P1|Overall Study|Adverse Event|1
5581339|NCT01029535|19285749|P1|Overall Study|Participant Withdrew Consent|2
5581340|NCT01029535|19285749|P1|Overall Study|Protocol Violation|2
5581341|NCT01029535|19285749|P1|Overall Study|Lost to Follow-up|24
5581342|NCT01029405|19285778|P4|Overall Study|Other|1
5581343|NCT01029405|19285779|P3|Overall Study|Other|0
5581344|NCT01029405|19285780|P2|Overall Study|Other|1
5581345|NCT01029405|19285781|P1|Overall Study|Other|0
5581346|NCT01029405|19285778|P4|Overall Study|Lost to Follow-up|2
5581347|NCT01029405|19285779|P3|Overall Study|Lost to Follow-up|1
5581348|NCT01029405|19285780|P2|Overall Study|Lost to Follow-up|1
5581349|NCT01029405|19285781|P1|Overall Study|Lost to Follow-up|2
5581350|NCT01029405|19285778|P4|Overall Study|Adverse Event|1
5581351|NCT01029405|19285779|P3|Overall Study|Adverse Event|1
5581352|NCT01029405|19285780|P2|Overall Study|Adverse Event|0
5581353|NCT01029405|19285781|P1|Overall Study|Adverse Event|0
5581354|NCT01029405|19285778|P4|Overall Study|Protocol Violation|1
5581355|NCT01029405|19285779|P3|Overall Study|Protocol Violation|0
5581356|NCT01029405|19285780|P2|Overall Study|Protocol Violation|0
5581357|NCT01029405|19285781|P1|Overall Study|Protocol Violation|0
5581358|NCT01029405|19285778|P4|Overall Study|Withdrawal by Subject|0
5581359|NCT01029405|19285779|P3|Overall Study|Withdrawal by Subject|2
5581360|NCT01029405|19285780|P2|Overall Study|Withdrawal by Subject|1
5581361|NCT01029405|19285781|P1|Overall Study|Withdrawal by Subject|0
5581362|NCT01029392|19285793|P2|Overall Study|Physician Decision|0
5581363|NCT01029392|19285794|P1|Overall Study|Physician Decision|2
5581364|NCT01029392|19285793|P2|Overall Study|Withdrawal by Subject|11
5581365|NCT01029392|19285794|P1|Overall Study|Withdrawal by Subject|18
5581366|NCT01029366|19285804|P2|Overall Study|manufacturing failure|1
5581367|NCT01029366|19285805|P1|Overall Study|manufacturing failure|0
5581368|NCT01029366|19285804|P2|Overall Study|disease progression|0
5581369|NCT01029366|19285805|P1|Overall Study|disease progression|2
5581370|NCT01029366|19285804|P2|Overall Study|Death|1
5581371|NCT01029366|19285805|P1|Overall Study|Death|1
5581372|NCT01029366|19285804|P2|Overall Study|Withdrawal by Subject|0
5581373|NCT01029366|19285805|P1|Overall Study|Withdrawal by Subject|1
5581374|NCT01029340|19285817|P6|Extension Period|Physician Decision|1
5581375|NCT01029340|19285818|P5|Extension Period|Physician Decision|0
5581376|NCT01029340|19285819|P4|Extension Period|Physician Decision|0
5581377|NCT01029340|19285820|P3|Extension Period|Physician Decision|0
5581378|NCT01029340|19285821|P2|Extension Period|Physician Decision|0
5581379|NCT01029340|19285822|P1|Extension Period|Physician Decision|0
5581380|NCT01029340|19285817|P6|Extension Period|Withdrawal by Subject|1
5581381|NCT01029340|19285818|P5|Extension Period|Withdrawal by Subject|0
5581382|NCT01029340|19285819|P4|Extension Period|Withdrawal by Subject|0
5581383|NCT01029340|19285820|P3|Extension Period|Withdrawal by Subject|0
5581384|NCT01029340|19285821|P2|Extension Period|Withdrawal by Subject|0
5581385|NCT01029340|19285822|P1|Extension Period|Withdrawal by Subject|0
5581386|NCT01029340|19285817|P6|Extension Period|non-compliance|1
5581387|NCT01029340|19285818|P5|Extension Period|non-compliance|0
5581388|NCT01029340|19285819|P4|Extension Period|non-compliance|0
5581389|NCT01029340|19285820|P3|Extension Period|non-compliance|0
5581390|NCT01029340|19285821|P2|Extension Period|non-compliance|0
5581391|NCT01029340|19285822|P1|Extension Period|non-compliance|0
5581392|NCT01029340|19285817|P6|Extension Period|starting another study|8
5581393|NCT01029340|19285818|P5|Extension Period|starting another study|0
5581394|NCT01029340|19285819|P4|Extension Period|starting another study|0
5581395|NCT01029340|19285820|P3|Extension Period|starting another study|0
5581396|NCT01029340|19285821|P2|Extension Period|starting another study|0
5581397|NCT01029340|19285822|P1|Extension Period|starting another study|0
5581398|NCT01029340|19285817|P6|Extension Period|Adverse Event|1
5581399|NCT01029340|19285818|P5|Extension Period|Adverse Event|0
5581400|NCT01029340|19285819|P4|Extension Period|Adverse Event|0
5581401|NCT01029340|19285820|P3|Extension Period|Adverse Event|0
5581402|NCT01029340|19285821|P2|Extension Period|Adverse Event|0
5581403|NCT01029340|19285822|P1|Extension Period|Adverse Event|0
5581404|NCT01029340|19285817|P6|Part B Treatment Period|Protocol Violation|0
5581405|NCT01029340|19285818|P5|Part B Treatment Period|Protocol Violation|0
5581406|NCT01029340|19285819|P4|Part B Treatment Period|Protocol Violation|0
5581407|NCT01029340|19285820|P3|Part B Treatment Period|Protocol Violation|1
5581408|NCT01029340|19285821|P2|Part B Treatment Period|Protocol Violation|0
5581409|NCT01029340|19285822|P1|Part B Treatment Period|Protocol Violation|0
5581410|NCT01029340|19285817|P6|Part B Treatment Period|Withdrawal by Subject|0
5581411|NCT01029340|19285818|P5|Part B Treatment Period|Withdrawal by Subject|0
5581412|NCT01029340|19285819|P4|Part B Treatment Period|Withdrawal by Subject|0
5581413|NCT01029340|19285820|P3|Part B Treatment Period|Withdrawal by Subject|1
5581414|NCT01029340|19285821|P2|Part B Treatment Period|Withdrawal by Subject|0
5581415|NCT01029340|19285822|P1|Part B Treatment Period|Withdrawal by Subject|0
5581416|NCT01029262|19285853|P2|Overall Study|Death|3
5581417|NCT01029262|19285854|P1|Overall Study|Death|0
5581418|NCT01029262|19285853|P2|Overall Study|Miscellaneous|9
5581419|NCT01029262|19285854|P1|Overall Study|Miscellaneous|1
5581420|NCT01029262|19285853|P2|Overall Study|Protocol Violation|3
5581421|NCT01029262|19285854|P1|Overall Study|Protocol Violation|2
5581422|NCT01029262|19285853|P2|Overall Study|Withdrawal by Subject|17
5581423|NCT01029262|19285854|P1|Overall Study|Withdrawal by Subject|10
5581424|NCT01029262|19285853|P2|Overall Study|Lack of therapeutic effect|76
5581425|NCT01029262|19285854|P1|Overall Study|Lack of therapeutic effect|57
5581426|NCT01029262|19285853|P2|Overall Study|Adverse Event|52
5581427|NCT01029262|19285854|P1|Overall Study|Adverse Event|9
5581428|NCT01028651|19286023|P1|Overall Study|Adverse Event|1
5581429|NCT01028651|19286023|P1|Overall Study|Death|2
5581430|NCT01028560|19286046|P2|Overall Study|Withdrawal by Subject|12
5581431|NCT01028560|19286047|P1|Overall Study|Withdrawal by Subject|7
5581432|NCT01028560|19286046|P2|Overall Study|Lack of Efficacy|6
5581433|NCT01028560|19286047|P1|Overall Study|Lack of Efficacy|3
5581434|NCT01028391|19286061|P2|Overall Study|Needed excluded medication|1
5581435|NCT01028391|19286062|P1|Overall Study|Needed excluded medication|1
5581436|NCT01028391|19286061|P2|Overall Study|Withdrawal by Subject|3
5581437|NCT01028391|19286062|P1|Overall Study|Withdrawal by Subject|6
5581438|NCT01028391|19286061|P2|Overall Study|Physician Decision|1
5581439|NCT01028391|19286062|P1|Overall Study|Physician Decision|0
5581440|NCT01028391|19286061|P2|Overall Study|Lost to Follow-up|4
5581441|NCT01028391|19286062|P1|Overall Study|Lost to Follow-up|3
5581442|NCT01028391|19286061|P2|Overall Study|Lack of Efficacy|2
5581443|NCT01028391|19286062|P1|Overall Study|Lack of Efficacy|0
5581444|NCT01028391|19286061|P2|Overall Study|Adverse Event|0
5581445|NCT01028391|19286062|P1|Overall Study|Adverse Event|4
5581446|NCT01028378|19286070|P1|Overall Study|Adminstrative Reasons|4
5581447|NCT01028378|19286070|P1|Overall Study|Withdrawal by Subject|1
5581448|NCT01028378|19286070|P1|Overall Study|Lost to Follow-up|12
5581449|NCT01028352|19286082|P1|Overall Study|Withdrawal by Subject|1
5581450|NCT01028352|19286082|P1|Overall Study|Ineligible due to baseline average pain|5
5581451|NCT01028300|19286087|P1|Overall Study|Study Terminated|4
5581452|NCT01028222|19286096|P2|Overall Study|Adverse Event|0
5581453|NCT01028222|19286097|P1|Overall Study|Adverse Event|2
5581454|NCT01028222|19286096|P2|Overall Study|Crossover to nilotinib w/out progression|2
5581455|NCT01028222|19286097|P1|Overall Study|Crossover to nilotinib w/out progression|0
5581456|NCT01028222|19286096|P2|Overall Study|Withdrawal by Subject|0
5581457|NCT01028222|19286097|P1|Overall Study|Withdrawal by Subject|1
5581458|NCT01028222|19286096|P2|Overall Study|Lost to Follow-up|1
5581459|NCT01028222|19286097|P1|Overall Study|Lost to Follow-up|0
5581460|NCT01028222|19286096|P2|Overall Study|Administrative problems|1
5581461|NCT01028222|19286097|P1|Overall Study|Administrative problems|1
5581462|NCT01028222|19286096|P2|Overall Study|Disease progression|9
5581463|NCT01028222|19286097|P1|Overall Study|Disease progression|33
5581464|NCT01028222|19286096|P2|Overall Study|Protocol deviation|0
5581465|NCT01028222|19286097|P1|Overall Study|Protocol deviation|1
5581466|NCT01028053|19286139|P1|Overall Study|Various reasons|4
5581467|NCT01028053|19286139|P1|Overall Study|Terminated by Sponsor|1
5581468|NCT01028053|19286139|P1|Overall Study|Technical Problem|1
5581469|NCT01028053|19286139|P1|Overall Study|Physician Decision|2
5581470|NCT01028053|19286139|P1|Overall Study|Protocol Violation|1
5581471|NCT01028053|19286139|P1|Overall Study|Patient Request|11
5581472|NCT01028053|19286139|P1|Overall Study|Screen Failure|113
5581473|NCT01028027|19286147|P2|Overall Study|Lack of Efficacy|1
5581474|NCT01028027|19286148|P1|Overall Study|Lack of Efficacy|0
5581475|NCT01028027|19286147|P2|Overall Study|Protocol Violation|1
5581476|NCT01028027|19286148|P1|Overall Study|Protocol Violation|3
5581477|NCT01028027|19286147|P2|Overall Study|Adverse Event|7
5581478|NCT01028027|19286148|P1|Overall Study|Adverse Event|4
5581479|NCT01028027|19286147|P2|Overall Study|Withdrawal by Subject|3
5581480|NCT01028027|19286148|P1|Overall Study|Withdrawal by Subject|5
5581481|NCT01028027|19286147|P2|Overall Study|Lost to Follow-up|1
5581482|NCT01028027|19286148|P1|Overall Study|Lost to Follow-up|4
5581483|NCT01028014|19286170|P6|Overall Study|Lost to Follow-up|2
5581484|NCT01028014|19286171|P5|Overall Study|Lost to Follow-up|1
5581485|NCT01028014|19286172|P4|Overall Study|Lost to Follow-up|1
5581486|NCT01028014|19286173|P3|Overall Study|Lost to Follow-up|0
5581487|NCT01028014|19286174|P2|Overall Study|Lost to Follow-up|2
5581488|NCT01028014|19286175|P1|Overall Study|Lost to Follow-up|1
5581489|NCT01027897|19286216|P1|Overall Study|Withdrawal by Subject|1
5581490|NCT01027897|19286216|P1|Overall Study|Protocol Violation|1
5581491|NCT01027884|19286224|P2|Overall Study|Spinal fixation surgery|3
5581492|NCT01027884|19286225|P1|Overall Study|Spinal fixation surgery|0
5581493|NCT01027884|19286224|P2|Overall Study|Lost to Follow-up|1
5581494|NCT01027884|19286225|P1|Overall Study|Lost to Follow-up|0
5581495|NCT01027884|19286224|P2|Overall Study|Withdrawal by Subject|1
5581496|NCT01027884|19286225|P1|Overall Study|Withdrawal by Subject|0
5581497|NCT01027884|19286224|P2|Overall Study|Non-compliance|1
5581498|NCT01027884|19286225|P1|Overall Study|Non-compliance|1
5581499|NCT01027884|19286224|P2|Overall Study|Protocol Violation|0
5581500|NCT01027884|19286225|P1|Overall Study|Protocol Violation|1
5581501|NCT01027884|19286224|P2|Overall Study|Adverse Event|1
5581502|NCT01027884|19286225|P1|Overall Study|Adverse Event|2
5581503|NCT01027871|19286242|P3|Overall Study|Discontinued Prior to Treatment|1
5581504|NCT01027871|19286243|P2|Overall Study|Discontinued Prior to Treatment|0
5581505|NCT01027871|19286244|P1|Overall Study|Discontinued Prior to Treatment|0
5581506|NCT01027871|19286242|P3|Overall Study|Sponsor Decision|0
5581507|NCT01027871|19286243|P2|Overall Study|Sponsor Decision|2
5581508|NCT01027871|19286244|P1|Overall Study|Sponsor Decision|0
5581509|NCT01027871|19286242|P3|Overall Study|Adverse Event|2
5581510|NCT01027871|19286243|P2|Overall Study|Adverse Event|2
5581511|NCT01027871|19286244|P1|Overall Study|Adverse Event|0
5581512|NCT01027871|19286242|P3|Overall Study|Withdrawal by Subject|2
5581513|NCT01027871|19286243|P2|Overall Study|Withdrawal by Subject|2
5581514|NCT01027871|19286244|P1|Overall Study|Withdrawal by Subject|1
5581515|NCT01027871|19286242|P3|Overall Study|Protocol Violation|2
5581516|NCT01027871|19286243|P2|Overall Study|Protocol Violation|2
5581517|NCT01027871|19286244|P1|Overall Study|Protocol Violation|0
5581518|NCT01027871|19286242|P3|Overall Study|Physician Decision|0
5581519|NCT01027871|19286243|P2|Overall Study|Physician Decision|5
5581520|NCT01027871|19286244|P1|Overall Study|Physician Decision|1
5581521|NCT01027845|19286303|P4|Booster Vaccination Phase|Migrated/moved from study area|0
5581522|NCT01027845|19286304|P3|Booster Vaccination Phase|Migrated/moved from study area|0
5581523|NCT01027845|19286305|P2|Booster Vaccination Phase|Migrated/moved from study area|0
5581524|NCT01027845|19286306|P1|Booster Vaccination Phase|Migrated/moved from study area|1
5581525|NCT01027845|19286303|P4|Booster Vaccination Phase|Withdrawal by Subject|0
5581526|NCT01027845|19286304|P3|Booster Vaccination Phase|Withdrawal by Subject|0
5581527|NCT01027845|19286305|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5581528|NCT01027845|19286306|P1|Booster Vaccination Phase|Withdrawal by Subject|1
5581529|NCT01027845|19286303|P4|Primary Vaccination Phase|Migrated/moved from study area|0
5581530|NCT01027845|19286304|P3|Primary Vaccination Phase|Migrated/moved from study area|0
5581531|NCT01027845|19286305|P2|Primary Vaccination Phase|Migrated/moved from study area|1
5581532|NCT01027845|19286306|P1|Primary Vaccination Phase|Migrated/moved from study area|0
5581533|NCT01027845|19286303|P4|Primary Vaccination Phase|Protocol Violation|0
5581534|NCT01027845|19286304|P3|Primary Vaccination Phase|Protocol Violation|0
5581535|NCT01027845|19286305|P2|Primary Vaccination Phase|Protocol Violation|0
5581536|NCT01027845|19286306|P1|Primary Vaccination Phase|Protocol Violation|1
5581537|NCT01027845|19286303|P4|Primary Vaccination Phase|Adverse Event|0
5581538|NCT01027845|19286304|P3|Primary Vaccination Phase|Adverse Event|0
5581539|NCT01027845|19286305|P2|Primary Vaccination Phase|Adverse Event|0
5581540|NCT01027845|19286306|P1|Primary Vaccination Phase|Adverse Event|1
5581541|NCT01027845|19286303|P4|Primary Vaccination Phase|Serious Adverse Event|0
5581542|NCT01027845|19286304|P3|Primary Vaccination Phase|Serious Adverse Event|0
5581543|NCT01027845|19286305|P2|Primary Vaccination Phase|Serious Adverse Event|0
5581544|NCT01027845|19286306|P1|Primary Vaccination Phase|Serious Adverse Event|2
5581545|NCT01027754|19286389|P2|Overall Study|Withdrawal by Subject|5
5581546|NCT01027754|19286390|P1|Overall Study|Withdrawal by Subject|0
5581547|NCT01027754|19286389|P2|Overall Study|withdrew/lost to follow-up after interve|3
5581548|NCT01027754|19286390|P1|Overall Study|withdrew/lost to follow-up after interve|2
5581549|NCT01027702|19286424|P7|Overall Study|Death|0
5581550|NCT01027702|19286425|P6|Overall Study|Death|0
5581551|NCT01027702|19286426|P5|Overall Study|Death|0
5581552|NCT01027702|19286427|P4|Overall Study|Death|0
5581553|NCT01027702|19286428|P3|Overall Study|Death|1
5581554|NCT01027702|19286429|P2|Overall Study|Death|0
5581555|NCT01027702|19286430|P1|Overall Study|Death|0
5581556|NCT01027702|19286424|P7|Overall Study|Received subsequent therapy|1
5581557|NCT01027702|19286425|P6|Overall Study|Received subsequent therapy|0
5581558|NCT01027702|19286426|P5|Overall Study|Received subsequent therapy|1
5581559|NCT01027702|19286427|P4|Overall Study|Received subsequent therapy|4
5581560|NCT01027702|19286428|P3|Overall Study|Received subsequent therapy|0
5581561|NCT01027702|19286429|P2|Overall Study|Received subsequent therapy|2
5581562|NCT01027702|19286430|P1|Overall Study|Received subsequent therapy|1
5581563|NCT01027650|19286456|P8|Overall Study|Lack of Efficacy|0
5581564|NCT01027650|19286457|P7|Overall Study|Lack of Efficacy|0
5581565|NCT01027650|19286458|P6|Overall Study|Lack of Efficacy|1
5581566|NCT01027650|19286459|P5|Overall Study|Lack of Efficacy|0
5581567|NCT01027650|19286460|P4|Overall Study|Lack of Efficacy|0
5581568|NCT01027650|19286461|P3|Overall Study|Lack of Efficacy|0
5581569|NCT01027650|19286462|P2|Overall Study|Lack of Efficacy|0
5581570|NCT01027650|19286463|P1|Overall Study|Lack of Efficacy|0
5581571|NCT01027650|19286456|P8|Overall Study|Lost to Follow-up|0
5581572|NCT01027650|19286457|P7|Overall Study|Lost to Follow-up|1
5581573|NCT01027650|19286458|P6|Overall Study|Lost to Follow-up|0
5581574|NCT01027650|19286459|P5|Overall Study|Lost to Follow-up|0
5581575|NCT01027650|19286460|P4|Overall Study|Lost to Follow-up|0
5581576|NCT01027650|19286461|P3|Overall Study|Lost to Follow-up|0
5581577|NCT01027650|19286462|P2|Overall Study|Lost to Follow-up|0
5581578|NCT01027650|19286463|P1|Overall Study|Lost to Follow-up|0
5581579|NCT01027650|19286456|P8|Overall Study|Personal Reasons|0
5581580|NCT01027650|19286457|P7|Overall Study|Personal Reasons|0
5581581|NCT01027650|19286458|P6|Overall Study|Personal Reasons|1
5581582|NCT01027650|19286459|P5|Overall Study|Personal Reasons|2
5581583|NCT01027650|19286460|P4|Overall Study|Personal Reasons|0
5581584|NCT01027650|19286461|P3|Overall Study|Personal Reasons|0
5581585|NCT01027650|19286462|P2|Overall Study|Personal Reasons|0
5581586|NCT01027650|19286463|P1|Overall Study|Personal Reasons|0
5581587|NCT01027416|19286541|P2|Overall Study|Physician Decision|4
5581588|NCT01027416|19286542|P1|Overall Study|Physician Decision|1
5581589|NCT01027416|19286541|P2|Overall Study|Withdrawal by Subject|1
5581590|NCT01027416|19286542|P1|Overall Study|Withdrawal by Subject|0
5581591|NCT01027364|19286554|P4|Overall Study|Withdrawal by Subject|0
5581592|NCT01027364|19286555|P3|Overall Study|Withdrawal by Subject|0
5581593|NCT01027364|19286556|P2|Overall Study|Withdrawal by Subject|2
5581594|NCT01027364|19286557|P1|Overall Study|Withdrawal by Subject|1
5581595|NCT01027364|19286554|P4|Overall Study|Protocol Violation|1
5581596|NCT01027364|19286555|P3|Overall Study|Protocol Violation|0
5581597|NCT01027364|19286556|P2|Overall Study|Protocol Violation|0
5581598|NCT01027364|19286557|P1|Overall Study|Protocol Violation|1
5581599|NCT01027364|19286554|P4|Overall Study|Lost to Follow-up|0
5581600|NCT01027364|19286555|P3|Overall Study|Lost to Follow-up|0
5581601|NCT01027364|19286556|P2|Overall Study|Lost to Follow-up|0
5581602|NCT01027364|19286557|P1|Overall Study|Lost to Follow-up|1
5581603|NCT01027364|19286554|P4|Overall Study|Adverse Event|0
5581604|NCT01027364|19286555|P3|Overall Study|Adverse Event|1
5581605|NCT01027364|19286556|P2|Overall Study|Adverse Event|0
5581606|NCT01027364|19286557|P1|Overall Study|Adverse Event|1
5581607|NCT01027351|19286652|P6|Overall Study|Protocol Violation|0
5581608|NCT01027351|19286653|P5|Overall Study|Protocol Violation|1
5581609|NCT01027351|19286654|P4|Overall Study|Protocol Violation|1
5581610|NCT01027351|19286655|P3|Overall Study|Protocol Violation|0
5581611|NCT01027351|19286656|P2|Overall Study|Protocol Violation|0
5581612|NCT01027351|19286657|P1|Overall Study|Protocol Violation|1
5581613|NCT01027351|19286652|P6|Overall Study|Inappropriate enrollment|0
5581614|NCT01027351|19286653|P5|Overall Study|Inappropriate enrollment|1
5581615|NCT01027351|19286654|P4|Overall Study|Inappropriate enrollment|0
5581616|NCT01027351|19286655|P3|Overall Study|Inappropriate enrollment|0
5581617|NCT01027351|19286656|P2|Overall Study|Inappropriate enrollment|0
5581618|NCT01027351|19286657|P1|Overall Study|Inappropriate enrollment|0
5581619|NCT01027351|19286652|P6|Overall Study|Lost to Follow-up|0
5581620|NCT01027351|19286653|P5|Overall Study|Lost to Follow-up|6
5581621|NCT01027351|19286654|P4|Overall Study|Lost to Follow-up|1
5581622|NCT01027351|19286655|P3|Overall Study|Lost to Follow-up|0
5581623|NCT01027351|19286656|P2|Overall Study|Lost to Follow-up|1
5581624|NCT01027351|19286657|P1|Overall Study|Lost to Follow-up|1
5581625|NCT01027351|19286652|P6|Overall Study|Withdrawal by Subject|5
5581626|NCT01027351|19286653|P5|Overall Study|Withdrawal by Subject|3
5581627|NCT01027351|19286654|P4|Overall Study|Withdrawal by Subject|0
5581628|NCT01027351|19286655|P3|Overall Study|Withdrawal by Subject|1
5581629|NCT01027351|19286656|P2|Overall Study|Withdrawal by Subject|0
5581630|NCT01027351|19286657|P1|Overall Study|Withdrawal by Subject|1
5581631|NCT01027286|19286741|P2|Overall Study|Lost to Follow-up|1
5581632|NCT01027286|19286742|P1|Overall Study|Lost to Follow-up|0
5581633|NCT01027286|19286741|P2|Overall Study|Unable to Obtain Required Blood Volume|0
5581634|NCT01027286|19286742|P1|Overall Study|Unable to Obtain Required Blood Volume|1
5581635|NCT01027273|19286762|P2|Overall Study|Death|2
5581636|NCT01027273|19286763|P1|Overall Study|Death|2
5581637|NCT01027273|19286762|P2|Overall Study|Lost to Follow-up|31
5581638|NCT01027273|19286763|P1|Overall Study|Lost to Follow-up|57
5581639|NCT01026974|19286810|P4|Overall Study|Inappropriate enrollment|0
5581640|NCT01026974|19286811|P3|Overall Study|Inappropriate enrollment|1
5581641|NCT01026974|19286812|P2|Overall Study|Inappropriate enrollment|0
5581642|NCT01026974|19286813|P1|Overall Study|Inappropriate enrollment|0
5581643|NCT01026974|19286810|P4|Overall Study|Adverse Event|1
5581644|NCT01026974|19286811|P3|Overall Study|Adverse Event|0
5581645|NCT01026974|19286812|P2|Overall Study|Adverse Event|0
5581646|NCT01026974|19286813|P1|Overall Study|Adverse Event|0
5581647|NCT01026974|19286810|P4|Overall Study|Lost to Follow-up|0
5581648|NCT01026974|19286811|P3|Overall Study|Lost to Follow-up|4
5581649|NCT01026974|19286812|P2|Overall Study|Lost to Follow-up|1
5581650|NCT01026974|19286813|P1|Overall Study|Lost to Follow-up|1
5581651|NCT01026974|19286810|P4|Overall Study|Withdrawal by Subject|2
5581652|NCT01026974|19286811|P3|Overall Study|Withdrawal by Subject|7
5581653|NCT01026974|19286812|P2|Overall Study|Withdrawal by Subject|1
5581654|NCT01026974|19286813|P1|Overall Study|Withdrawal by Subject|0
5581655|NCT01026948|19286870|P1|Overall Study|Physician Decision|8
5581656|NCT01026831|19286903|P2|Overall Study|Withdrawal by Subject|5
5581657|NCT01026831|19286904|P1|Overall Study|Withdrawal by Subject|7
5581658|NCT01026831|19286903|P2|Overall Study|Protocol Violation|2
5581659|NCT01026831|19286904|P1|Overall Study|Protocol Violation|0
5581660|NCT01026831|19286903|P2|Overall Study|Physician Decision|1
5581661|NCT01026831|19286904|P1|Overall Study|Physician Decision|1
5581662|NCT01026831|19286903|P2|Overall Study|Lost to Follow-up|0
5581663|NCT01026831|19286904|P1|Overall Study|Lost to Follow-up|2
5581664|NCT01026831|19286903|P2|Overall Study|Adverse Event|3
5581665|NCT01026831|19286904|P1|Overall Study|Adverse Event|4
5581666|NCT01026818|19286915|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
5581667|NCT01026818|19286916|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
5581668|NCT01026818|19286917|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
5581669|NCT01026818|19286918|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
5581670|NCT01026818|19286915|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
5581671|NCT01026818|19286916|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
5581672|NCT01026818|19286917|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
5581673|NCT01026818|19286918|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
5581674|NCT01026818|19286915|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
5581675|NCT01026818|19286916|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
5581676|NCT01026818|19286917|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
5581677|NCT01026818|19286918|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
5581678|NCT01026818|19286915|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
5581679|NCT01026818|19286916|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
5581680|NCT01026818|19286917|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
5581681|NCT01026818|19286918|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
5581682|NCT01026818|19286915|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
5581683|NCT01026818|19286916|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
5581684|NCT01026818|19286917|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
5581685|NCT01026818|19286918|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
5581686|NCT01026818|19286915|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
5581687|NCT01026818|19286916|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
5581688|NCT01026818|19286917|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
5581689|NCT01026818|19286918|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
5581690|NCT01026818|19286915|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
5581691|NCT01026818|19286916|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
5581692|NCT01026818|19286917|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
5581693|NCT01026818|19286918|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
5581694|NCT01026818|19286915|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
5581695|NCT01026818|19286916|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
5581696|NCT01026818|19286917|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
5581697|NCT01026818|19286918|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
5581698|NCT01026818|19286915|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
5581699|NCT01026818|19286916|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
5581700|NCT01026818|19286917|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
5581701|NCT01026818|19286918|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
5581702|NCT01026818|19286915|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
5581703|NCT01026818|19286916|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
5581704|NCT01026818|19286917|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
5581705|NCT01026818|19286918|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
5581706|NCT01026818|19286915|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
5581707|NCT01026818|19286916|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
5581708|NCT01026818|19286917|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
5581709|NCT01026818|19286918|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
5581710|NCT01026818|19286915|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
5581711|NCT01026818|19286916|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
5581712|NCT01026818|19286917|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
5581713|NCT01026818|19286918|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
5581714|NCT01026818|19286915|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
5581715|NCT01026818|19286916|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
5581716|NCT01026818|19286917|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
5581717|NCT01026818|19286918|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
5581718|NCT01026818|19286915|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
5581719|NCT01026818|19286916|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
5581720|NCT01026818|19286917|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
5581721|NCT01026818|19286918|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
5581722|NCT01026818|19286915|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
5581723|NCT01026818|19286916|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
5581724|NCT01026818|19286917|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
5581725|NCT01026818|19286918|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
5581726|NCT01026818|19286915|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
5581727|NCT01026818|19286916|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
5581728|NCT01026818|19286917|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
5581729|NCT01026818|19286918|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
5581730|NCT01026818|19286915|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
5581731|NCT01026818|19286916|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
5581732|NCT01026818|19286917|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
5581733|NCT01026818|19286918|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
5581734|NCT01026818|19286915|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
5581735|NCT01026818|19286916|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
5581736|NCT01026818|19286917|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
5581737|NCT01026818|19286918|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
5581738|NCT01026818|19286915|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
5581739|NCT01026818|19286916|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
5581740|NCT01026818|19286917|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
5581741|NCT01026818|19286918|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
5581742|NCT01026818|19286915|P4|Screening Period|Physician Decision|0
5581743|NCT01026818|19286916|P3|Screening Period|Physician Decision|0
5581744|NCT01026818|19286917|P2|Screening Period|Physician Decision|0
5581745|NCT01026818|19286918|P1|Screening Period|Physician Decision|1
5581746|NCT01026818|19286915|P4|Screening Period|Adverse Event|0
5581747|NCT01026818|19286916|P3|Screening Period|Adverse Event|0
5581748|NCT01026818|19286917|P2|Screening Period|Adverse Event|0
5581749|NCT01026818|19286918|P1|Screening Period|Adverse Event|2
5581750|NCT01026818|19286915|P4|Screening Period|Protocol Deviation|0
5581751|NCT01026818|19286916|P3|Screening Period|Protocol Deviation|0
5581752|NCT01026818|19286917|P2|Screening Period|Protocol Deviation|0
5581753|NCT01026818|19286918|P1|Screening Period|Protocol Deviation|3
5581754|NCT01026818|19286915|P4|Screening Period|Withdrawal by Subject|0
5581755|NCT01026818|19286916|P3|Screening Period|Withdrawal by Subject|0
5581756|NCT01026818|19286917|P2|Screening Period|Withdrawal by Subject|0
5581757|NCT01026818|19286918|P1|Screening Period|Withdrawal by Subject|49
5581758|NCT01026818|19286915|P4|Screening Period|Entry Criteria Not Met|0
5581759|NCT01026818|19286916|P3|Screening Period|Entry Criteria Not Met|0
5581760|NCT01026818|19286917|P2|Screening Period|Entry Criteria Not Met|0
5581761|NCT01026818|19286918|P1|Screening Period|Entry Criteria Not Met|105
5581762|NCT01026792|19287006|P1|Overall Study|Protocol Violation|1
5581763|NCT01026493|19287049|P8|Overall Study|Protocol Violation|1
5581764|NCT01026493|19287050|P7|Overall Study|Protocol Violation|4
5581765|NCT01026493|19287051|P6|Overall Study|Protocol Violation|3
5581766|NCT01026493|19287052|P5|Overall Study|Protocol Violation|2
5581767|NCT01026493|19287053|P4|Overall Study|Protocol Violation|0
5581768|NCT01026493|19287054|P3|Overall Study|Protocol Violation|0
5581769|NCT01026493|19287055|P2|Overall Study|Protocol Violation|1
5581770|NCT01026493|19287056|P1|Overall Study|Protocol Violation|0
5581771|NCT01026454|19287084|P2|Second Intervention|Pregnancy|1
5581772|NCT01026454|19287085|P1|Second Intervention|Pregnancy|1
5581773|NCT01026389|19287434|P2|Overall Study|change of treatment, patient moved|2
5581774|NCT01026389|19287435|P1|Overall Study|change of treatment, patient moved|4
5581775|NCT01026389|19287434|P2|Overall Study|Withdrawal by Subject|3
5581776|NCT01026389|19287435|P1|Overall Study|Withdrawal by Subject|1
5581777|NCT01026324|19287450|P3|Follow up/Survival|Withdrawal by Subject|0
5581778|NCT01026324|19287451|P2|Follow up/Survival|Withdrawal by Subject|0
5581779|NCT01026324|19287452|P1|Follow up/Survival|Withdrawal by Subject|1
5581780|NCT01026220|19287462|P3|Consolidation Maintenance|Withdrawal by Subject|6
5581781|NCT01026220|19287463|P2|Consolidation Maintenance|Withdrawal by Subject|2
5581782|NCT01026220|19287464|P1|Consolidation Maintenance|Withdrawal by Subject|0
5581783|NCT01026220|19287462|P3|Consolidation Maintenance|Physician Decision|7
5581784|NCT01026220|19287463|P2|Consolidation Maintenance|Physician Decision|2
5581785|NCT01026220|19287464|P1|Consolidation Maintenance|Physician Decision|0
5581786|NCT01026220|19287462|P3|Consolidation Maintenance|Lack of Efficacy|1
5581787|NCT01026220|19287463|P2|Consolidation Maintenance|Lack of Efficacy|1
5581788|NCT01026220|19287464|P1|Consolidation Maintenance|Lack of Efficacy|0
5581789|NCT01026220|19287462|P3|Consolidation Maintenance|Death|0
5581790|NCT01026220|19287463|P2|Consolidation Maintenance|Death|1
5581791|NCT01026220|19287464|P1|Consolidation Maintenance|Death|0
5581792|NCT01026220|19287462|P3|Induction|Ineligible|0
5581793|NCT01026220|19287463|P2|Induction|Ineligible|0
5581794|NCT01026220|19287464|P1|Induction|Ineligible|1
5581795|NCT01026220|19287462|P3|Induction|Withdrawal by Subject|0
5581796|NCT01026220|19287463|P2|Induction|Withdrawal by Subject|0
5581797|NCT01026220|19287464|P1|Induction|Withdrawal by Subject|9
5581798|NCT01026220|19287462|P3|Induction|Physician Decision|0
5581799|NCT01026220|19287463|P2|Induction|Physician Decision|0
5581800|NCT01026220|19287464|P1|Induction|Physician Decision|12
5581801|NCT01026220|19287462|P3|Induction|Lack of Efficacy|0
5581802|NCT01026220|19287463|P2|Induction|Lack of Efficacy|0
5581803|NCT01026220|19287464|P1|Induction|Lack of Efficacy|2
5581804|NCT01026220|19287462|P3|Induction|Death|0
5581805|NCT01026220|19287463|P2|Induction|Death|0
5581806|NCT01026220|19287464|P1|Induction|Death|1
5581807|NCT01026194|19287488|P2|Period 2：Open-label Period|Withdrawal by Subject|4
5581808|NCT01026194|19287489|P1|Period 2：Open-label Period|Withdrawal by Subject|0
5581809|NCT01026194|19287488|P2|Period 2：Open-label Period|Physician Decision|1
5581810|NCT01026194|19287489|P1|Period 2：Open-label Period|Physician Decision|3
5581811|NCT01026194|19287488|P2|Period 2：Open-label Period|Adverse Event|5
5581812|NCT01026194|19287489|P1|Period 2：Open-label Period|Adverse Event|4
5581813|NCT01026194|19287488|P2|Period 1：Double Blind Period|Physician Decision|4
5581814|NCT01026194|19287489|P1|Period 1：Double Blind Period|Physician Decision|0
5581815|NCT01026194|19287488|P2|Period 1：Double Blind Period|Lack of Efficacy|0
5581816|NCT01026194|19287489|P1|Period 1：Double Blind Period|Lack of Efficacy|1
5581817|NCT01026194|19287488|P2|Period 1：Double Blind Period|Adverse Event|1
5581818|NCT01026194|19287489|P1|Period 1：Double Blind Period|Adverse Event|2
5581819|NCT01026142|19287521|P2|Overall Study|Withdrew consent or lost to follow-up|29
5581820|NCT01026142|19287522|P1|Overall Study|Withdrew consent or lost to follow-up|36
5581821|NCT01026142|19287521|P2|Overall Study|Death|134
5581822|NCT01026142|19287522|P1|Overall Study|Death|136
5581823|NCT01026103|19287544|P1|Overall Study|did not receive study device bc of error|1
5581824|NCT01026103|19287544|P1|Overall Study|Physician Decision|1
5581825|NCT01026038|19287554|P3|Overall Study|Lost to Follow-up|0
5581826|NCT01026038|19287555|P2|Overall Study|Lost to Follow-up|1
5581827|NCT01026038|19287556|P1|Overall Study|Lost to Follow-up|1
5581828|NCT01025843|19287605|P10|Washout 4|Withdrawal by Subject|0
5581829|NCT01025843|19287606|P9|Washout 4|Withdrawal by Subject|0
5581830|NCT01025843|19287607|P8|Washout 4|Withdrawal by Subject|0
5581831|NCT01025843|19287608|P7|Washout 4|Withdrawal by Subject|0
5581832|NCT01025843|19287609|P6|Washout 4|Withdrawal by Subject|0
5581833|NCT01025843|19287610|P5|Washout 4|Withdrawal by Subject|0
5581834|NCT01025843|19287611|P4|Washout 4|Withdrawal by Subject|1
5581835|NCT01025843|19287612|P3|Washout 4|Withdrawal by Subject|1
5581836|NCT01025843|19287613|P2|Washout 4|Withdrawal by Subject|0
5581837|NCT01025843|19287614|P1|Washout 4|Withdrawal by Subject|0
5581838|NCT01025817|19287708|P2|Completed Study|Lost to Follow-up|1
5581839|NCT01025817|19287709|P1|Completed Study|Lost to Follow-up|0
5581840|NCT01025817|19287708|P2|Completed Study|Missing|0
5581841|NCT01025817|19287709|P1|Completed Study|Missing|2
5581842|NCT01025817|19287708|P2|Completed Study|Death|5
5581843|NCT01025817|19287709|P1|Completed Study|Death|6
5581844|NCT01025817|19287708|P2|Completed Study|Withdrawal by Subject|16
5581845|NCT01025817|19287709|P1|Completed Study|Withdrawal by Subject|8
5581846|NCT01025817|19287708|P2|Completed Study Medication|Lost to Follow-up|1
5581847|NCT01025817|19287709|P1|Completed Study Medication|Lost to Follow-up|0
5581848|NCT01025817|19287708|P2|Completed Study Medication|Subject no longer required study drug|1
5581849|NCT01025817|19287709|P1|Completed Study Medication|Subject no longer required study drug|0
5581850|NCT01025817|19287708|P2|Completed Study Medication|Abnormal lab values|2
5581851|NCT01025817|19287709|P1|Completed Study Medication|Abnormal lab values|0
5581852|NCT01025817|19287708|P2|Completed Study Medication|Death|2
5581853|NCT01025817|19287709|P1|Completed Study Medication|Death|2
5581854|NCT01025817|19287708|P2|Completed Study Medication|Graft loss|5
5581855|NCT01025817|19287709|P1|Completed Study Medication|Graft loss|2
5581856|NCT01025817|19287708|P2|Completed Study Medication|Abnormal test procedure|0
5581857|NCT01025817|19287709|P1|Completed Study Medication|Abnormal test procedure|4
5581858|NCT01025817|19287708|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
5581859|NCT01025817|19287709|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
5581860|NCT01025817|19287708|P2|Completed Study Medication|Administrative problems|5
5581861|NCT01025817|19287709|P1|Completed Study Medication|Administrative problems|7
5581862|NCT01025817|19287708|P2|Completed Study Medication|Withdrawal by Subject|9
5581863|NCT01025817|19287709|P1|Completed Study Medication|Withdrawal by Subject|8
5581864|NCT01025817|19287708|P2|Completed Study Medication|Protocol Deviation|8
5581865|NCT01025817|19287709|P1|Completed Study Medication|Protocol Deviation|9
5581866|NCT01025817|19287708|P2|Completed Study Medication|Adverse Event|39
5581867|NCT01025817|19287709|P1|Completed Study Medication|Adverse Event|66
5581868|NCT01025752|19287875|P2|Overall Study|Physician Decision|3
5581869|NCT01025752|19287876|P1|Overall Study|Physician Decision|1
5581870|NCT01025752|19287875|P2|Overall Study|Lost to Follow-up|10
5581871|NCT01025752|19287876|P1|Overall Study|Lost to Follow-up|7
5581872|NCT01025635|19287896|P2|Overall Study|Reason not known|2
5581873|NCT01025635|19287897|P1|Overall Study|Reason not known|4
5581874|NCT01025635|19287896|P2|Overall Study|Lost to Follow-up|13
5581875|NCT01025635|19287897|P1|Overall Study|Lost to Follow-up|9
5581876|NCT01025635|19287896|P2|Overall Study|Lack of Efficacy|1
5581877|NCT01025635|19287897|P1|Overall Study|Lack of Efficacy|0
5581878|NCT01025635|19287896|P2|Overall Study|Protocol Violation|2
5581879|NCT01025635|19287897|P1|Overall Study|Protocol Violation|4
5581880|NCT01025635|19287896|P2|Overall Study|Withdrawal by Subject|7
5581881|NCT01025635|19287897|P1|Overall Study|Withdrawal by Subject|6
5581882|NCT01025336|19287929|P5|Overall Study|Protocol Violation|0
5581883|NCT01025336|19287930|P4|Overall Study|Protocol Violation|2
5581884|NCT01025336|19287931|P3|Overall Study|Protocol Violation|0
5581885|NCT01025336|19287932|P2|Overall Study|Protocol Violation|0
5581886|NCT01025336|19287933|P1|Overall Study|Protocol Violation|0
5581887|NCT01025284|19287988|P3|Overall Study|Withdrawal by Subject|0
5581888|NCT01025284|19287989|P2|Overall Study|Withdrawal by Subject|1
5581889|NCT01025284|19287990|P1|Overall Study|Withdrawal by Subject|0
5581890|NCT01025284|19287988|P3|Overall Study|Investigator Decision|0
5581891|NCT01025284|19287989|P2|Overall Study|Investigator Decision|1
5581892|NCT01025284|19287990|P1|Overall Study|Investigator Decision|0
5581893|NCT01025232|19288015|P2|Overall Study|Study drug no longer available|6
5581894|NCT01025232|19288016|P1|Overall Study|Study drug no longer available|3
5581895|NCT01025193|19288034|P1|Overall Study|Adverse Event|3
5581896|NCT01025193|19288034|P1|Overall Study|Protocol Violation|1
5581897|NCT01025154|19288044|P1|Overall Study|Withdrawal by Subject|1
5581898|NCT01025154|19288044|P1|Overall Study|Lost to Follow-up|1
5581899|NCT01025037|19288053|P1|Overall Study|Withdrawal by Subject|1
5581900|NCT01025037|19288053|P1|Overall Study|Lost to Follow-up|7
5581901|NCT01025037|19288053|P1|Overall Study|Adverse Event|3
5581902|NCT01024959|19288075|P1|Overall Study|missing results required for analysis|17
5581903|NCT01024959|19288075|P1|Overall Study|results not evaluable|12
5581904|NCT01024959|19288075|P1|Overall Study|ineligible|12
5581905|NCT01024946|19288084|P1|Overall Study|Adverse Event|1
5581906|NCT01024946|19288084|P1|Overall Study|Withdrawal by Subject|1
5581907|NCT01024946|19288084|P1|Overall Study|Screen Failure|3
5581908|NCT01024920|19288090|P2|Overall Study|Not treated|0
5581909|NCT01024920|19288091|P1|Overall Study|Not treated|3
5581910|NCT01024920|19288090|P2|Overall Study|Other reason|13
5581911|NCT01024920|19288091|P1|Overall Study|Other reason|21
5581912|NCT01024920|19288090|P2|Overall Study|Withdrawal by Subject|0
5581913|NCT01024920|19288091|P1|Overall Study|Withdrawal by Subject|2
5581914|NCT01024920|19288090|P2|Overall Study|Lost to Follow-up|4
5581915|NCT01024920|19288091|P1|Overall Study|Lost to Follow-up|4
5581916|NCT01024920|19288090|P2|Overall Study|Adverse Event|2
5581917|NCT01024920|19288091|P1|Overall Study|Adverse Event|4
5581918|NCT01024920|19288090|P2|Overall Study|Progressive disease|3
5581919|NCT01024920|19288091|P1|Overall Study|Progressive disease|11
5581920|NCT01024855|19288109|P1|Overall Study|Inclusion/exclusion criteria|1
5581921|NCT01024751|19288116|P2|Eligible Participants|Ineligible|1
5581922|NCT01024751|19288117|P1|Eligible Participants|Ineligible|0
5581923|NCT01024751|19288116|P2|Eligible Participants|Lost to Follow-up|1
5581924|NCT01024751|19288117|P1|Eligible Participants|Lost to Follow-up|0
5581925|NCT01024751|19288116|P2|Eligible Participants|Withdrawal by Subject|1
5581926|NCT01024751|19288117|P1|Eligible Participants|Withdrawal by Subject|0
5581927|NCT01024751|19288116|P2|Enrolled Participants|Ineligible at baseline|4
5581928|NCT01024751|19288117|P1|Enrolled Participants|Ineligible at baseline|3
5581929|NCT01024608|19288174|P2|Overall Study|Never received study treatment|0
5581930|NCT01024608|19288175|P1|Overall Study|Never received study treatment|2
5581931|NCT01024608|19288174|P2|Overall Study|Protocol Violation|3
5581932|NCT01024608|19288175|P1|Overall Study|Protocol Violation|0
5581933|NCT01024608|19288174|P2|Overall Study|Lost to Follow-up|1
5581934|NCT01024608|19288175|P1|Overall Study|Lost to Follow-up|0
5581935|NCT01024608|19288174|P2|Overall Study|Withdrawal by Subject|0
5581936|NCT01024608|19288175|P1|Overall Study|Withdrawal by Subject|1
5581937|NCT01024608|19288174|P2|Overall Study|Adverse Event|0
5581938|NCT01024608|19288175|P1|Overall Study|Adverse Event|1
5581939|NCT01024465|19288204|P1|Overall Study|Physician Decision|1
5581940|NCT01024465|19288204|P1|Overall Study|Adverse Event|2
5581941|NCT01024387|19288208|P1|Overall Study|Other|5
5581942|NCT01024387|19288208|P1|Overall Study|Adverse Event|3
5581943|NCT01024387|19288208|P1|Overall Study|Prolonged Treatment Delay|1
5581944|NCT01024387|19288208|P1|Overall Study|Death|2
5581945|NCT01024387|19288208|P1|Overall Study|Withdrawal by Subject|5
5581946|NCT01024387|19288208|P1|Overall Study|Physician Decision|5
5581947|NCT01024387|19288208|P1|Overall Study|Symptomatic Progression|10
5581948|NCT01024387|19288208|P1|Overall Study|Radiographic Progression|29
5581949|NCT01024309|19288229|P2|Overall Study|Withdrawal by Subject|4
5581950|NCT01024309|19288230|P1|Overall Study|Withdrawal by Subject|4
5581951|NCT01024309|19288229|P2|Overall Study|Physician Decision|0
5581952|NCT01024309|19288230|P1|Overall Study|Physician Decision|4
5581953|NCT01024244|19288262|P5|Overall Study|Withdrawal by Subject|0
5581954|NCT01024244|19288263|P4|Overall Study|Withdrawal by Subject|0
5581955|NCT01024244|19288264|P3|Overall Study|Withdrawal by Subject|0
5581956|NCT01024244|19288265|P2|Overall Study|Withdrawal by Subject|1
5581957|NCT01024244|19288266|P1|Overall Study|Withdrawal by Subject|0
5581958|NCT01024244|19288262|P5|Overall Study|Sponsor Decision|10
5581959|NCT01024244|19288263|P4|Overall Study|Sponsor Decision|12
5581960|NCT01024244|19288264|P3|Overall Study|Sponsor Decision|14
5581961|NCT01024244|19288265|P2|Overall Study|Sponsor Decision|7
5581962|NCT01024244|19288266|P1|Overall Study|Sponsor Decision|14
5581963|NCT01024244|19288262|P5|Overall Study|Protocol Violation|2
5581964|NCT01024244|19288263|P4|Overall Study|Protocol Violation|0
5581965|NCT01024244|19288264|P3|Overall Study|Protocol Violation|0
5581966|NCT01024244|19288265|P2|Overall Study|Protocol Violation|0
5581967|NCT01024244|19288266|P1|Overall Study|Protocol Violation|1
5581968|NCT01024244|19288262|P5|Overall Study|Lack of Efficacy|0
5581969|NCT01024244|19288263|P4|Overall Study|Lack of Efficacy|0
5581970|NCT01024244|19288264|P3|Overall Study|Lack of Efficacy|0
5581971|NCT01024244|19288265|P2|Overall Study|Lack of Efficacy|0
5581972|NCT01024244|19288266|P1|Overall Study|Lack of Efficacy|1
5581973|NCT01024244|19288262|P5|Overall Study|Entry Criteria Not Met|0
5581974|NCT01024244|19288263|P4|Overall Study|Entry Criteria Not Met|0
5581975|NCT01024244|19288264|P3|Overall Study|Entry Criteria Not Met|0
5581976|NCT01024244|19288265|P2|Overall Study|Entry Criteria Not Met|1
5581977|NCT01024244|19288266|P1|Overall Study|Entry Criteria Not Met|0
5581978|NCT01024244|19288262|P5|Overall Study|Adverse Event|2
5581979|NCT01024244|19288263|P4|Overall Study|Adverse Event|1
5581980|NCT01024244|19288264|P3|Overall Study|Adverse Event|0
5581981|NCT01024244|19288265|P2|Overall Study|Adverse Event|2
5581982|NCT01024244|19288266|P1|Overall Study|Adverse Event|1
5581983|NCT01024036|19288380|P2|Follow-Up Period|Adverse Event|1
5581984|NCT01024036|19288381|P1|Follow-Up Period|Adverse Event|4
5581985|NCT01024036|19288380|P2|Follow-Up Period|Withdrawal by Subject|1
5581986|NCT01024036|19288381|P1|Follow-Up Period|Withdrawal by Subject|0
5581987|NCT01024036|19288380|P2|Follow-Up Period|Lost to Follow-up|1
5581988|NCT01024036|19288381|P1|Follow-Up Period|Lost to Follow-up|1
5581989|NCT01024036|19288380|P2|Unblinded Treatment|Lack of Efficacy|2
5581990|NCT01024036|19288381|P1|Unblinded Treatment|Lack of Efficacy|0
5581991|NCT01024036|19288380|P2|Unblinded Treatment|Adverse Event|1
5581992|NCT01024036|19288381|P1|Unblinded Treatment|Adverse Event|0
5581993|NCT01024036|19288380|P2|Blinded Treatment|Withdrawal by Subject|3
5581994|NCT01024036|19288381|P1|Blinded Treatment|Withdrawal by Subject|4
5581995|NCT01024036|19288380|P2|Blinded Treatment|Death|2
5581996|NCT01024036|19288381|P1|Blinded Treatment|Death|0
5581997|NCT01024036|19288380|P2|Blinded Treatment|Physician Decision|0
5581998|NCT01024036|19288381|P1|Blinded Treatment|Physician Decision|1
5581999|NCT01024036|19288380|P2|Blinded Treatment|Lack of Efficacy|14
5582000|NCT01024036|19288381|P1|Blinded Treatment|Lack of Efficacy|16
5582001|NCT01024036|19288380|P2|Blinded Treatment|Adverse Event|1
5582002|NCT01024036|19288381|P1|Blinded Treatment|Adverse Event|1
5582003|NCT01023958|19288428|P1|Overall Study|Refused to continue medication|1
5582004|NCT01023958|19288428|P1|Overall Study|Other adverse event|1
5582005|NCT01023958|19288428|P1|Overall Study|Progressive disease|48
5582006|NCT01023815|19288476|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
5582007|NCT01023815|19288477|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
5582008|NCT01023815|19288478|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
5582009|NCT01023815|19288479|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
5582010|NCT01023815|19288476|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
5582011|NCT01023815|19288477|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
5582012|NCT01023815|19288478|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
5582013|NCT01023815|19288479|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
5582014|NCT01023815|19288476|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
5582015|NCT01023815|19288477|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
5582016|NCT01023815|19288478|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
5582017|NCT01023815|19288479|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
5582018|NCT01023815|19288476|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
5582019|NCT01023815|19288477|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
5582020|NCT01023815|19288478|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
5582021|NCT01023815|19288479|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
5582022|NCT01023815|19288476|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
5582023|NCT01023815|19288477|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
5582024|NCT01023815|19288478|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
5582025|NCT01023815|19288479|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
5582026|NCT01023789|19288498|P1|3 - Year Visit|Lost to Follow-up|13
5582027|NCT01023789|19288498|P1|3 - Year Visit|Withdrawal of consent|1
5582028|NCT01023789|19288498|P1|3 - Year Visit|Death|29
5582029|NCT01023672|19288584|P1|Overall Study|Death|1
5582030|NCT01023672|19288584|P1|Overall Study|Worsening disease|2
5582031|NCT01023659|19288591|P3|Overall Study|Lost to Follow-up|99
5582032|NCT01023659|19288592|P2|Overall Study|Lost to Follow-up|228
5582033|NCT01023659|19288593|P1|Overall Study|Lost to Follow-up|73
5582034|NCT01023581|19288620|P7|Overall Study|Other|0
5582035|NCT01023581|19288621|P6|Overall Study|Other|0
5582036|NCT01023581|19288622|P5|Overall Study|Other|1
5582037|NCT01023581|19288623|P4|Overall Study|Other|0
5582038|NCT01023581|19288624|P3|Overall Study|Other|1
5582039|NCT01023581|19288625|P2|Overall Study|Other|0
5582040|NCT01023581|19288626|P1|Overall Study|Other|1
5582041|NCT01023581|19288620|P7|Overall Study|Physician Decision|1
5582042|NCT01023581|19288621|P6|Overall Study|Physician Decision|1
5582043|NCT01023581|19288622|P5|Overall Study|Physician Decision|1
5582044|NCT01023581|19288623|P4|Overall Study|Physician Decision|1
5582045|NCT01023581|19288624|P3|Overall Study|Physician Decision|2
5582046|NCT01023581|19288625|P2|Overall Study|Physician Decision|0
5582047|NCT01023581|19288626|P1|Overall Study|Physician Decision|2
5582048|NCT01023581|19288620|P7|Overall Study|Lack of Efficacy|1
5582049|NCT01023581|19288621|P6|Overall Study|Lack of Efficacy|2
5582050|NCT01023581|19288622|P5|Overall Study|Lack of Efficacy|1
5582051|NCT01023581|19288623|P4|Overall Study|Lack of Efficacy|2
5582052|NCT01023581|19288624|P3|Overall Study|Lack of Efficacy|6
5582053|NCT01023581|19288625|P2|Overall Study|Lack of Efficacy|3
5582054|NCT01023581|19288626|P1|Overall Study|Lack of Efficacy|9
5582055|NCT01023581|19288620|P7|Overall Study|Pregnancy|0
5582056|NCT01023581|19288621|P6|Overall Study|Pregnancy|1
5582057|NCT01023581|19288622|P5|Overall Study|Pregnancy|0
5582058|NCT01023581|19288623|P4|Overall Study|Pregnancy|2
5582059|NCT01023581|19288624|P3|Overall Study|Pregnancy|0
5582060|NCT01023581|19288625|P2|Overall Study|Pregnancy|0
5582061|NCT01023581|19288626|P1|Overall Study|Pregnancy|0
5582062|NCT01023581|19288620|P7|Overall Study|Withdrawal by Subject|5
5582063|NCT01023581|19288621|P6|Overall Study|Withdrawal by Subject|8
5582064|NCT01023581|19288622|P5|Overall Study|Withdrawal by Subject|6
5582065|NCT01023581|19288623|P4|Overall Study|Withdrawal by Subject|10
5582066|NCT01023581|19288624|P3|Overall Study|Withdrawal by Subject|16
5582067|NCT01023581|19288625|P2|Overall Study|Withdrawal by Subject|8
5582068|NCT01023581|19288626|P1|Overall Study|Withdrawal by Subject|13
5582069|NCT01023581|19288620|P7|Overall Study|Lost to Follow-up|2
5582070|NCT01023581|19288621|P6|Overall Study|Lost to Follow-up|2
5582071|NCT01023581|19288622|P5|Overall Study|Lost to Follow-up|5
5582072|NCT01023581|19288623|P4|Overall Study|Lost to Follow-up|2
5582073|NCT01023581|19288624|P3|Overall Study|Lost to Follow-up|7
5582074|NCT01023581|19288625|P2|Overall Study|Lost to Follow-up|8
5582075|NCT01023581|19288626|P1|Overall Study|Lost to Follow-up|4
5582076|NCT01023581|19288620|P7|Overall Study|Major protocol deviation|0
5582077|NCT01023581|19288621|P6|Overall Study|Major protocol deviation|0
5582078|NCT01023581|19288622|P5|Overall Study|Major protocol deviation|0
5582079|NCT01023581|19288623|P4|Overall Study|Major protocol deviation|0
5582080|NCT01023581|19288624|P3|Overall Study|Major protocol deviation|3
5582081|NCT01023581|19288625|P2|Overall Study|Major protocol deviation|0
5582082|NCT01023581|19288626|P1|Overall Study|Major protocol deviation|2
5582083|NCT01023581|19288620|P7|Overall Study|Adverse Event|11
5582084|NCT01023581|19288621|P6|Overall Study|Adverse Event|5
5582085|NCT01023581|19288622|P5|Overall Study|Adverse Event|2
5582086|NCT01023581|19288623|P4|Overall Study|Adverse Event|3
5582087|NCT01023581|19288624|P3|Overall Study|Adverse Event|7
5582088|NCT01023581|19288625|P2|Overall Study|Adverse Event|4
5582089|NCT01023581|19288626|P1|Overall Study|Adverse Event|4
5582090|NCT01023516|19288683|P2|Overall Study|Incorrect enrolment|2
5582091|NCT01023516|19288684|P1|Overall Study|Incorrect enrolment|4
5582092|NCT01023516|19288683|P2|Overall Study|Study-specific criteria|2
5582093|NCT01023516|19288684|P1|Overall Study|Study-specific criteria|4
5582094|NCT01023516|19288683|P2|Overall Study|Safety reason|3
5582095|NCT01023516|19288684|P1|Overall Study|Safety reason|0
5582096|NCT01023516|19288683|P2|Overall Study|Adverse Event|6
5582097|NCT01023516|19288684|P1|Overall Study|Adverse Event|9
5582098|NCT01023516|19288683|P2|Overall Study|Voluntary discontinuation|5
5582099|NCT01023516|19288684|P1|Overall Study|Voluntary discontinuation|7
5582100|NCT01023308|19288766|P2|Overall Study|Withdrawal by Subject|18
5582101|NCT01023308|19288767|P1|Overall Study|Withdrawal by Subject|34
5582102|NCT01023308|19288766|P2|Overall Study|Lost to Follow-up|0
5582103|NCT01023308|19288767|P1|Overall Study|Lost to Follow-up|1
5582104|NCT01023308|19288766|P2|Overall Study|Untreated|5
5582105|NCT01023308|19288767|P1|Overall Study|Untreated|5
5582106|NCT01023308|19288766|P2|Overall Study|Protocol Violation|4
5582107|NCT01023308|19288767|P1|Overall Study|Protocol Violation|3
5582108|NCT01023308|19288766|P2|Overall Study|New Cancer therapy|7
5582109|NCT01023308|19288767|P1|Overall Study|New Cancer therapy|4
5582110|NCT01023308|19288766|P2|Overall Study|Disease progression|153
5582111|NCT01023308|19288767|P1|Overall Study|Disease progression|82
5582112|NCT01023308|19288766|P2|Overall Study|Death|17
5582113|NCT01023308|19288767|P1|Overall Study|Death|21
5582114|NCT01023308|19288766|P2|Overall Study|Adverse Event|66
5582115|NCT01023308|19288767|P1|Overall Study|Adverse Event|130
5582116|NCT01023308|19288766|P2|Overall Study|Administrative problems|1
5582117|NCT01023308|19288767|P1|Overall Study|Administrative problems|2
5582118|NCT01023308|19288766|P2|Overall Study|Abnormal test proceedure results|8
5582119|NCT01023308|19288767|P1|Overall Study|Abnormal test proceedure results|3
5582120|NCT01023269|19288793|P2|Overall Study|early termination of the study|0
5582121|NCT01023269|19288794|P1|Overall Study|early termination of the study|2
5582122|NCT01023256|19288802|P4|Overall Study|Withdrawal by Subject|2
5582123|NCT01023256|19288803|P3|Overall Study|Withdrawal by Subject|0
5582124|NCT01023256|19288804|P2|Overall Study|Withdrawal by Subject|0
5582125|NCT01023256|19288805|P1|Overall Study|Withdrawal by Subject|0
5582126|NCT01023256|19288802|P4|Overall Study|Adverse Event|1
5582127|NCT01023256|19288803|P3|Overall Study|Adverse Event|0
5582128|NCT01023256|19288804|P2|Overall Study|Adverse Event|0
5582129|NCT01023256|19288805|P1|Overall Study|Adverse Event|0
5582130|NCT01023256|19288802|P4|Overall Study|Other|2
5582131|NCT01023256|19288803|P3|Overall Study|Other|0
5582132|NCT01023256|19288804|P2|Overall Study|Other|0
5582133|NCT01023256|19288805|P1|Overall Study|Other|1
5582134|NCT01023256|19288802|P4|Overall Study|Randomized but not treated|0
5582135|NCT01023256|19288803|P3|Overall Study|Randomized but not treated|1
5582136|NCT01023256|19288804|P2|Overall Study|Randomized but not treated|0
5582137|NCT01023256|19288805|P1|Overall Study|Randomized but not treated|1
5582138|NCT01023256|19288802|P4|Overall Study|Protocol Violation|0
5582139|NCT01023256|19288803|P3|Overall Study|Protocol Violation|0
5582140|NCT01023256|19288804|P2|Overall Study|Protocol Violation|3
5582141|NCT01023256|19288805|P1|Overall Study|Protocol Violation|2
5582142|NCT01023217|19288847|P2|Overall Study|Withdrawal by Subject|0
5582143|NCT01023217|19288848|P1|Overall Study|Withdrawal by Subject|1
5582144|NCT01023061|19288886|P1|Overall Study|Withdrawal prior to treatment|2
5582145|NCT01023035|19288895|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
5582146|NCT01023035|19288896|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
5582147|NCT01023035|19288897|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
5582148|NCT01023035|19288895|P3|Follow-up Period (up to Week 72)|Adverse Event|1
5582149|NCT01023035|19288896|P2|Follow-up Period (up to Week 72)|Adverse Event|0
5582150|NCT01023035|19288897|P1|Follow-up Period (up to Week 72)|Adverse Event|2
5582151|NCT01023035|19288895|P3|Treatment Period|Treatment Failure|24
5582152|NCT01023035|19288896|P2|Treatment Period|Treatment Failure|31
5582153|NCT01023035|19288897|P1|Treatment Period|Treatment Failure|26
5582154|NCT01023035|19288895|P3|Treatment Period|Non-Medical Reasons|44
5582155|NCT01023035|19288896|P2|Treatment Period|Non-Medical Reasons|22
5582156|NCT01023035|19288897|P1|Treatment Period|Non-Medical Reasons|19
5582157|NCT01023035|19288895|P3|Treatment Period|Adverse Event|50
5582158|NCT01023035|19288896|P2|Treatment Period|Adverse Event|32
5582159|NCT01023035|19288897|P1|Treatment Period|Adverse Event|27
5582160|NCT01023022|19288907|P1|Overall Study|due to technical issues|2
5582161|NCT01023022|19288907|P1|Overall Study|Lost to Follow-up|7
5582162|NCT01023022|19288907|P1|Overall Study|Death|5
5582163|NCT01022996|19288913|P1|Overall Study|Protocol Violation|1
5582164|NCT01022996|19288913|P1|Overall Study|Disease Progression|32
5582165|NCT01022996|19288913|P1|Overall Study|Administrative problems|6
5582166|NCT01022996|19288913|P1|Overall Study|Lost to Follow-up|1
5582167|NCT01022996|19288913|P1|Overall Study|Withdrawal by Subject|3
5582168|NCT01022996|19288913|P1|Overall Study|Adverse Event|14
5582169|NCT01022853|19288927|P5|Overall Study|Other not stated above|0
5582170|NCT01022853|19288928|P4|Overall Study|Other not stated above|0
5582171|NCT01022853|19288929|P3|Overall Study|Other not stated above|1
5582172|NCT01022853|19288930|P2|Overall Study|Other not stated above|0
5582173|NCT01022853|19288931|P1|Overall Study|Other not stated above|1
5582174|NCT01022853|19288927|P5|Overall Study|Withdrawal by Subject|0
5582175|NCT01022853|19288928|P4|Overall Study|Withdrawal by Subject|1
5582176|NCT01022853|19288929|P3|Overall Study|Withdrawal by Subject|1
5582177|NCT01022853|19288930|P2|Overall Study|Withdrawal by Subject|1
5582178|NCT01022853|19288931|P1|Overall Study|Withdrawal by Subject|0
5582179|NCT01022853|19288927|P5|Overall Study|Dose-limiting toxicity|1
5582180|NCT01022853|19288928|P4|Overall Study|Dose-limiting toxicity|0
5582181|NCT01022853|19288929|P3|Overall Study|Dose-limiting toxicity|0
5582182|NCT01022853|19288930|P2|Overall Study|Dose-limiting toxicity|0
5582183|NCT01022853|19288931|P1|Overall Study|Dose-limiting toxicity|0
5582184|NCT01022853|19288927|P5|Overall Study|Progressive disease|1
5582185|NCT01022853|19288928|P4|Overall Study|Progressive disease|7
5582186|NCT01022853|19288929|P3|Overall Study|Progressive disease|11
5582187|NCT01022853|19288930|P2|Overall Study|Progressive disease|3
5582188|NCT01022853|19288931|P1|Overall Study|Progressive disease|2
5582189|NCT01022762|19289010|P2|Overall Study|Unclassified|20
5582190|NCT01022762|19289011|P1|Overall Study|Unclassified|12
5582191|NCT01022762|19289010|P2|Overall Study|Protocol Violation|6
5582192|NCT01022762|19289011|P1|Overall Study|Protocol Violation|7
5582193|NCT01022762|19289010|P2|Overall Study|Lack of Efficacy|1
5582194|NCT01022762|19289011|P1|Overall Study|Lack of Efficacy|0
5582195|NCT01022762|19289010|P2|Overall Study|Adverse Event|1
5582196|NCT01022762|19289011|P1|Overall Study|Adverse Event|3
5582197|NCT01022502|19289046|P1|Overall Study|Withdrawal by Subject|1
5582198|NCT01022502|19289046|P1|Overall Study|employment related reasons|1
5582199|NCT01022502|19289046|P1|Overall Study|Adverse Event|1
5582200|NCT01022424|19289060|P1|Overall Study|eGFR under the withdrawal criteria|2
5582201|NCT01022424|19289060|P1|Overall Study|Physician Decision|1
5582202|NCT01022424|19289060|P1|Overall Study|Adverse Event|1
5582203|NCT01022398|19289075|P2|Overall Study|Study terminated|2
5582204|NCT01022398|19289076|P1|Overall Study|Study terminated|2
5582205|NCT01022203|19289101|P2|Follow-Up Assessment|Lost to Follow-up|2
5582206|NCT01022203|19289102|P1|Follow-Up Assessment|Lost to Follow-up|2
5582207|NCT01022203|19289101|P2|Post Treatment Assessment|Adverse Event|2
5582208|NCT01022203|19289102|P1|Post Treatment Assessment|Adverse Event|0
5582209|NCT01022203|19289101|P2|Post Treatment Assessment|Physician Decision|0
5582210|NCT01022203|19289102|P1|Post Treatment Assessment|Physician Decision|2
5582211|NCT01022203|19289101|P2|Post Treatment Assessment|Withdrawal by Subject|12
5582212|NCT01022203|19289102|P1|Post Treatment Assessment|Withdrawal by Subject|12
5582213|NCT01022112|19289121|P5|Overall Study|Fasting plasma glucose level increased|7
5582214|NCT01022112|19289122|P4|Overall Study|Fasting plasma glucose level increased|0
5582215|NCT01022112|19289123|P3|Overall Study|Fasting plasma glucose level increased|0
5582216|NCT01022112|19289124|P2|Overall Study|Fasting plasma glucose level increased|0
5582217|NCT01022112|19289125|P1|Overall Study|Fasting plasma glucose level increased|1
5582218|NCT01022112|19289121|P5|Overall Study|Withdrawal by Subject|1
5582219|NCT01022112|19289122|P4|Overall Study|Withdrawal by Subject|2
5582220|NCT01022112|19289123|P3|Overall Study|Withdrawal by Subject|2
5582221|NCT01022112|19289124|P2|Overall Study|Withdrawal by Subject|1
5582222|NCT01022112|19289125|P1|Overall Study|Withdrawal by Subject|0
5582223|NCT01022112|19289121|P5|Overall Study|Physician Decision|1
5582224|NCT01022112|19289122|P4|Overall Study|Physician Decision|0
5582225|NCT01022112|19289123|P3|Overall Study|Physician Decision|1
5582226|NCT01022112|19289124|P2|Overall Study|Physician Decision|0
5582227|NCT01022112|19289125|P1|Overall Study|Physician Decision|0
5582228|NCT01022112|19289121|P5|Overall Study|Lack of Efficacy|1
5582229|NCT01022112|19289122|P4|Overall Study|Lack of Efficacy|0
5582230|NCT01022112|19289123|P3|Overall Study|Lack of Efficacy|0
5582231|NCT01022112|19289124|P2|Overall Study|Lack of Efficacy|0
5582232|NCT01022112|19289125|P1|Overall Study|Lack of Efficacy|1
5582233|NCT01022112|19289121|P5|Overall Study|Adverse Event|0
5582234|NCT01022112|19289122|P4|Overall Study|Adverse Event|1
5582235|NCT01022112|19289123|P3|Overall Study|Adverse Event|0
5582236|NCT01022112|19289124|P2|Overall Study|Adverse Event|2
5582237|NCT01022112|19289125|P1|Overall Study|Adverse Event|1
5582238|NCT01021878|19289174|P2|Overall Study|Transplantation|1
5582239|NCT01021878|19289175|P1|Overall Study|Transplantation|6
5582240|NCT01021878|19289174|P2|Overall Study|Adverse Event|5
5582241|NCT01021878|19289175|P1|Overall Study|Adverse Event|6
5582242|NCT01021878|19289174|P2|Overall Study|Death|1
5582243|NCT01021878|19289175|P1|Overall Study|Death|0
5582244|NCT01021878|19289174|P2|Overall Study|Lost to Follow-up|3
5582245|NCT01021878|19289175|P1|Overall Study|Lost to Follow-up|4
5582246|NCT01021852|19289197|P8|Treatment Period 2|Withdrawal by Subject|2
5582247|NCT01021852|19289198|P7|Treatment Period 2|Withdrawal by Subject|1
5582248|NCT01021852|19289199|P6|Treatment Period 2|Withdrawal by Subject|0
5582249|NCT01021852|19289200|P5|Treatment Period 2|Withdrawal by Subject|0
5582250|NCT01021852|19289201|P4|Treatment Period 2|Withdrawal by Subject|0
5582251|NCT01021852|19289202|P3|Treatment Period 2|Withdrawal by Subject|0
5582252|NCT01021852|19289203|P2|Treatment Period 2|Withdrawal by Subject|0
5582253|NCT01021852|19289204|P1|Treatment Period 2|Withdrawal by Subject|0
5582254|NCT01021852|19289197|P8|Treatment Period 2|Protocol Violation|0
5582255|NCT01021852|19289198|P7|Treatment Period 2|Protocol Violation|1
5582256|NCT01021852|19289199|P6|Treatment Period 2|Protocol Violation|0
5582257|NCT01021852|19289200|P5|Treatment Period 2|Protocol Violation|1
5582258|NCT01021852|19289201|P4|Treatment Period 2|Protocol Violation|0
5582259|NCT01021852|19289202|P3|Treatment Period 2|Protocol Violation|0
5582260|NCT01021852|19289203|P2|Treatment Period 2|Protocol Violation|0
5582261|NCT01021852|19289204|P1|Treatment Period 2|Protocol Violation|0
5582262|NCT01021852|19289197|P8|Treatment Period 2|Physician Decision|0
5582263|NCT01021852|19289198|P7|Treatment Period 2|Physician Decision|0
5582264|NCT01021852|19289199|P6|Treatment Period 2|Physician Decision|0
5582265|NCT01021852|19289200|P5|Treatment Period 2|Physician Decision|0
5582266|NCT01021852|19289201|P4|Treatment Period 2|Physician Decision|0
5582267|NCT01021852|19289202|P3|Treatment Period 2|Physician Decision|1
5582268|NCT01021852|19289203|P2|Treatment Period 2|Physician Decision|0
5582269|NCT01021852|19289204|P1|Treatment Period 2|Physician Decision|0
5582270|NCT01021852|19289197|P8|Treatment Period 2|Lack of Efficacy|0
5582271|NCT01021852|19289198|P7|Treatment Period 2|Lack of Efficacy|0
5582272|NCT01021852|19289199|P6|Treatment Period 2|Lack of Efficacy|1
5582273|NCT01021852|19289200|P5|Treatment Period 2|Lack of Efficacy|0
5582274|NCT01021852|19289201|P4|Treatment Period 2|Lack of Efficacy|0
5582275|NCT01021852|19289202|P3|Treatment Period 2|Lack of Efficacy|0
5582276|NCT01021852|19289203|P2|Treatment Period 2|Lack of Efficacy|0
5582277|NCT01021852|19289204|P1|Treatment Period 2|Lack of Efficacy|0
5582278|NCT01021852|19289197|P8|Treatment Period 2|Adverse Event|0
5582279|NCT01021852|19289198|P7|Treatment Period 2|Adverse Event|1
5582280|NCT01021852|19289199|P6|Treatment Period 2|Adverse Event|0
5582281|NCT01021852|19289200|P5|Treatment Period 2|Adverse Event|1
5582282|NCT01021852|19289201|P4|Treatment Period 2|Adverse Event|0
5582283|NCT01021852|19289202|P3|Treatment Period 2|Adverse Event|0
5582284|NCT01021852|19289203|P2|Treatment Period 2|Adverse Event|1
5582285|NCT01021852|19289204|P1|Treatment Period 2|Adverse Event|0
5582286|NCT01021852|19289197|P8|Washout Period-No Drug|Adverse Event|0
5582287|NCT01021852|19289198|P7|Washout Period-No Drug|Adverse Event|0
5582288|NCT01021852|19289199|P6|Washout Period-No Drug|Adverse Event|1
5582289|NCT01021852|19289200|P5|Washout Period-No Drug|Adverse Event|0
5582290|NCT01021852|19289201|P4|Washout Period-No Drug|Adverse Event|0
5582291|NCT01021852|19289202|P3|Washout Period-No Drug|Adverse Event|0
5582292|NCT01021852|19289203|P2|Washout Period-No Drug|Adverse Event|0
5582293|NCT01021852|19289204|P1|Washout Period-No Drug|Adverse Event|1
5582294|NCT01021852|19289197|P8|Washout Period-Placebo|Protocol Violation|0
5582295|NCT01021852|19289198|P7|Washout Period-Placebo|Protocol Violation|1
5582296|NCT01021852|19289199|P6|Washout Period-Placebo|Protocol Violation|0
5582297|NCT01021852|19289200|P5|Washout Period-Placebo|Protocol Violation|0
5582298|NCT01021852|19289201|P4|Washout Period-Placebo|Protocol Violation|0
5582299|NCT01021852|19289202|P3|Washout Period-Placebo|Protocol Violation|0
5582300|NCT01021852|19289203|P2|Washout Period-Placebo|Protocol Violation|0
5582301|NCT01021852|19289204|P1|Washout Period-Placebo|Protocol Violation|0
5582302|NCT01021852|19289197|P8|Washout Period-Placebo|Lost to Follow-up|0
5582303|NCT01021852|19289198|P7|Washout Period-Placebo|Lost to Follow-up|0
5582304|NCT01021852|19289199|P6|Washout Period-Placebo|Lost to Follow-up|0
5582305|NCT01021852|19289200|P5|Washout Period-Placebo|Lost to Follow-up|1
5582306|NCT01021852|19289201|P4|Washout Period-Placebo|Lost to Follow-up|0
5582307|NCT01021852|19289202|P3|Washout Period-Placebo|Lost to Follow-up|0
5582308|NCT01021852|19289203|P2|Washout Period-Placebo|Lost to Follow-up|0
5582309|NCT01021852|19289204|P1|Washout Period-Placebo|Lost to Follow-up|0
5582310|NCT01021852|19289197|P8|Washout Period-Placebo|Adverse Event|0
5582311|NCT01021852|19289198|P7|Washout Period-Placebo|Adverse Event|0
5582312|NCT01021852|19289199|P6|Washout Period-Placebo|Adverse Event|1
5582313|NCT01021852|19289200|P5|Washout Period-Placebo|Adverse Event|0
5582314|NCT01021852|19289201|P4|Washout Period-Placebo|Adverse Event|1
5582315|NCT01021852|19289202|P3|Washout Period-Placebo|Adverse Event|0
5582316|NCT01021852|19289203|P2|Washout Period-Placebo|Adverse Event|0
5582317|NCT01021852|19289204|P1|Washout Period-Placebo|Adverse Event|0
5582318|NCT01021852|19289197|P8|Treatment Period 1|Not Treated|0
5582319|NCT01021852|19289198|P7|Treatment Period 1|Not Treated|0
5582320|NCT01021852|19289199|P6|Treatment Period 1|Not Treated|0
5582321|NCT01021852|19289200|P5|Treatment Period 1|Not Treated|0
5582322|NCT01021852|19289201|P4|Treatment Period 1|Not Treated|2
5582323|NCT01021852|19289202|P3|Treatment Period 1|Not Treated|0
5582324|NCT01021852|19289203|P2|Treatment Period 1|Not Treated|0
5582325|NCT01021852|19289204|P1|Treatment Period 1|Not Treated|0
5582326|NCT01021852|19289197|P8|Treatment Period 1|Withdrawal by Subject|1
5582327|NCT01021852|19289198|P7|Treatment Period 1|Withdrawal by Subject|0
5582328|NCT01021852|19289199|P6|Treatment Period 1|Withdrawal by Subject|0
5582329|NCT01021852|19289200|P5|Treatment Period 1|Withdrawal by Subject|1
5582330|NCT01021852|19289201|P4|Treatment Period 1|Withdrawal by Subject|0
5582331|NCT01021852|19289202|P3|Treatment Period 1|Withdrawal by Subject|0
5582332|NCT01021852|19289203|P2|Treatment Period 1|Withdrawal by Subject|0
5582333|NCT01021852|19289204|P1|Treatment Period 1|Withdrawal by Subject|0
5582334|NCT01021852|19289197|P8|Treatment Period 1|Pregnancy|0
5582335|NCT01021852|19289198|P7|Treatment Period 1|Pregnancy|0
5582336|NCT01021852|19289199|P6|Treatment Period 1|Pregnancy|0
5582337|NCT01021852|19289200|P5|Treatment Period 1|Pregnancy|0
5582338|NCT01021852|19289201|P4|Treatment Period 1|Pregnancy|0
5582339|NCT01021852|19289202|P3|Treatment Period 1|Pregnancy|1
5582340|NCT01021852|19289203|P2|Treatment Period 1|Pregnancy|0
5582341|NCT01021852|19289204|P1|Treatment Period 1|Pregnancy|0
5582342|NCT01021852|19289197|P8|Treatment Period 1|Adverse Event|0
5582343|NCT01021852|19289198|P7|Treatment Period 1|Adverse Event|0
5582344|NCT01021852|19289199|P6|Treatment Period 1|Adverse Event|2
5582345|NCT01021852|19289200|P5|Treatment Period 1|Adverse Event|2
5582346|NCT01021852|19289201|P4|Treatment Period 1|Adverse Event|0
5582347|NCT01021852|19289202|P3|Treatment Period 1|Adverse Event|1
5582348|NCT01021852|19289203|P2|Treatment Period 1|Adverse Event|1
5582349|NCT01021852|19289204|P1|Treatment Period 1|Adverse Event|3
5582350|NCT01021813|19289240|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
5582351|NCT01021813|19289241|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
5582352|NCT01021813|19289242|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
5582353|NCT01021813|19289243|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
5582354|NCT01021813|19289244|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
5582355|NCT01021813|19289240|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
5582356|NCT01021813|19289241|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
5582357|NCT01021813|19289242|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
5582358|NCT01021813|19289243|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
5582359|NCT01021813|19289244|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
5582360|NCT01021813|19289240|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
5582361|NCT01021813|19289241|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5582362|NCT01021813|19289242|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5582363|NCT01021813|19289243|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5582364|NCT01021813|19289244|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
5582365|NCT01021813|19289240|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5582366|NCT01021813|19289241|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
5582367|NCT01021813|19289242|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5582368|NCT01021813|19289243|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5582369|NCT01021813|19289244|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
5582370|NCT01021813|19289240|P5|DB Randomized Discontinuation Phase|Adverse Event|1
5582371|NCT01021813|19289241|P4|DB Randomized Discontinuation Phase|Adverse Event|3
5582372|NCT01021813|19289242|P3|DB Randomized Discontinuation Phase|Adverse Event|0
5582373|NCT01021813|19289243|P2|DB Randomized Discontinuation Phase|Adverse Event|0
5582374|NCT01021813|19289244|P1|DB Randomized Discontinuation Phase|Adverse Event|0
5582375|NCT01021813|19289240|P5|DB Treatment Phase|Withdrawal by Subject|0
5582376|NCT01021813|19289241|P4|DB Treatment Phase|Withdrawal by Subject|0
5582377|NCT01021813|19289242|P3|DB Treatment Phase|Withdrawal by Subject|0
5582378|NCT01021813|19289243|P2|DB Treatment Phase|Withdrawal by Subject|24
5582379|NCT01021813|19289244|P1|DB Treatment Phase|Withdrawal by Subject|60
5582380|NCT01021813|19289240|P5|DB Treatment Phase|Protocol Violation|0
5582381|NCT01021813|19289241|P4|DB Treatment Phase|Protocol Violation|0
5582382|NCT01021813|19289242|P3|DB Treatment Phase|Protocol Violation|0
5582383|NCT01021813|19289243|P2|DB Treatment Phase|Protocol Violation|3
5582384|NCT01021813|19289244|P1|DB Treatment Phase|Protocol Violation|4
5582385|NCT01021813|19289240|P5|DB Treatment Phase|Pregnancy|0
5582386|NCT01021813|19289241|P4|DB Treatment Phase|Pregnancy|0
5582387|NCT01021813|19289242|P3|DB Treatment Phase|Pregnancy|0
5582388|NCT01021813|19289243|P2|DB Treatment Phase|Pregnancy|0
5582389|NCT01021813|19289244|P1|DB Treatment Phase|Pregnancy|1
5582390|NCT01021813|19289240|P5|DB Treatment Phase|Physician Decision|0
5582391|NCT01021813|19289241|P4|DB Treatment Phase|Physician Decision|0
5582392|NCT01021813|19289242|P3|DB Treatment Phase|Physician Decision|0
5582393|NCT01021813|19289243|P2|DB Treatment Phase|Physician Decision|8
5582394|NCT01021813|19289244|P1|DB Treatment Phase|Physician Decision|17
5582395|NCT01021813|19289240|P5|DB Treatment Phase|Lost to Follow-up|0
5582396|NCT01021813|19289241|P4|DB Treatment Phase|Lost to Follow-up|0
5582397|NCT01021813|19289242|P3|DB Treatment Phase|Lost to Follow-up|0
5582398|NCT01021813|19289243|P2|DB Treatment Phase|Lost to Follow-up|12
5582399|NCT01021813|19289244|P1|DB Treatment Phase|Lost to Follow-up|14
5582400|NCT01021813|19289240|P5|DB Treatment Phase|Lack of Efficacy|0
5582401|NCT01021813|19289241|P4|DB Treatment Phase|Lack of Efficacy|0
5582402|NCT01021813|19289242|P3|DB Treatment Phase|Lack of Efficacy|0
5582403|NCT01021813|19289243|P2|DB Treatment Phase|Lack of Efficacy|28
5582404|NCT01021813|19289244|P1|DB Treatment Phase|Lack of Efficacy|44
5582405|NCT01021813|19289240|P5|DB Treatment Phase|Adverse Event|0
5582406|NCT01021813|19289241|P4|DB Treatment Phase|Adverse Event|0
5582407|NCT01021813|19289242|P3|DB Treatment Phase|Adverse Event|0
5582408|NCT01021813|19289243|P2|DB Treatment Phase|Adverse Event|22
5582409|NCT01021813|19289244|P1|DB Treatment Phase|Adverse Event|60
5582410|NCT01021748|19289305|P9|Overall Study|Not Treated|0
5582411|NCT01021748|19289306|P8|Overall Study|Not Treated|0
5582412|NCT01021748|19289307|P7|Overall Study|Not Treated|0
5582413|NCT01021748|19289308|P6|Overall Study|Not Treated|0
5582414|NCT01021748|19289309|P5|Overall Study|Not Treated|0
5582415|NCT01021748|19289310|P4|Overall Study|Not Treated|0
5582416|NCT01021748|19289311|P3|Overall Study|Not Treated|0
5582417|NCT01021748|19289312|P2|Overall Study|Not Treated|1
5582418|NCT01021748|19289313|P1|Overall Study|Not Treated|0
5582419|NCT01021748|19289305|P9|Overall Study|Withdrawal by Subject|1
5582420|NCT01021748|19289306|P8|Overall Study|Withdrawal by Subject|0
5582421|NCT01021748|19289307|P7|Overall Study|Withdrawal by Subject|1
5582422|NCT01021748|19289308|P6|Overall Study|Withdrawal by Subject|0
5582423|NCT01021748|19289309|P5|Overall Study|Withdrawal by Subject|0
5582424|NCT01021748|19289310|P4|Overall Study|Withdrawal by Subject|0
5582425|NCT01021748|19289311|P3|Overall Study|Withdrawal by Subject|0
5582426|NCT01021748|19289312|P2|Overall Study|Withdrawal by Subject|0
5582427|NCT01021748|19289313|P1|Overall Study|Withdrawal by Subject|0
5582428|NCT01021748|19289305|P9|Overall Study|Progressive Disease|6
5582429|NCT01021748|19289306|P8|Overall Study|Progressive Disease|5
5582430|NCT01021748|19289307|P7|Overall Study|Progressive Disease|0
5582431|NCT01021748|19289308|P6|Overall Study|Progressive Disease|3
5582432|NCT01021748|19289309|P5|Overall Study|Progressive Disease|7
5582433|NCT01021748|19289310|P4|Overall Study|Progressive Disease|6
5582434|NCT01021748|19289311|P3|Overall Study|Progressive Disease|4
5582435|NCT01021748|19289312|P2|Overall Study|Progressive Disease|3
5582436|NCT01021748|19289313|P1|Overall Study|Progressive Disease|3
5582437|NCT01021748|19289305|P9|Overall Study|Physician Decision|2
5582438|NCT01021748|19289306|P8|Overall Study|Physician Decision|1
5582439|NCT01021748|19289307|P7|Overall Study|Physician Decision|1
5582440|NCT01021748|19289308|P6|Overall Study|Physician Decision|0
5582441|NCT01021748|19289309|P5|Overall Study|Physician Decision|0
5582442|NCT01021748|19289310|P4|Overall Study|Physician Decision|1
5582443|NCT01021748|19289311|P3|Overall Study|Physician Decision|1
5582444|NCT01021748|19289312|P2|Overall Study|Physician Decision|0
5582445|NCT01021748|19289313|P1|Overall Study|Physician Decision|1
5582446|NCT01021748|19289305|P9|Overall Study|Adverse Event|7
5582447|NCT01021748|19289306|P8|Overall Study|Adverse Event|0
5582448|NCT01021748|19289307|P7|Overall Study|Adverse Event|1
5582449|NCT01021748|19289308|P6|Overall Study|Adverse Event|0
5582450|NCT01021748|19289309|P5|Overall Study|Adverse Event|2
5582451|NCT01021748|19289310|P4|Overall Study|Adverse Event|0
5582452|NCT01021748|19289311|P3|Overall Study|Adverse Event|2
5582453|NCT01021748|19289312|P2|Overall Study|Adverse Event|1
5582454|NCT01021748|19289313|P1|Overall Study|Adverse Event|2
5582455|NCT01021683|19289360|P1|Overall Study|Other|8
5582456|NCT01021683|19289360|P1|Overall Study|Recovery of neutrophil count|51
5582457|NCT01021683|19289360|P1|Overall Study|Lack of Efficacy|12
5582458|NCT01021553|19289386|P3|Overall Study|Withdrawal by Subject|0
5582459|NCT01021553|19289387|P2|Overall Study|Withdrawal by Subject|1
5582460|NCT01021553|19289388|P1|Overall Study|Withdrawal by Subject|1
5582461|NCT01021553|19289386|P3|Overall Study|Lost to Follow-up|1
5582462|NCT01021553|19289387|P2|Overall Study|Lost to Follow-up|0
5582463|NCT01021553|19289388|P1|Overall Study|Lost to Follow-up|0
5582464|NCT01021553|19289386|P3|Overall Study|Protocol Violation|2
5582465|NCT01021553|19289387|P2|Overall Study|Protocol Violation|2
5582466|NCT01021553|19289388|P1|Overall Study|Protocol Violation|0
5582467|NCT01021553|19289386|P3|Overall Study|Lack of Efficacy|0
5582468|NCT01021553|19289387|P2|Overall Study|Lack of Efficacy|2
5582469|NCT01021553|19289388|P1|Overall Study|Lack of Efficacy|2
5582470|NCT01021553|19289386|P3|Overall Study|Adverse Event|0
5582471|NCT01021553|19289387|P2|Overall Study|Adverse Event|0
5582472|NCT01021553|19289388|P1|Overall Study|Adverse Event|1
5582473|NCT01021423|19289442|P2|Overall Study|Study terminated|5
5582474|NCT01021423|19289443|P1|Overall Study|Study terminated|4
5582475|NCT01021332|19289459|P1|Overall Study|Miscellaneous|3
5582476|NCT01021332|19289459|P1|Overall Study|Protocol Violation|9
5582477|NCT01021332|19289459|P1|Overall Study|Lost to Follow-up|4
5582478|NCT01021332|19289459|P1|Overall Study|Withdrawal of Consent|23
5582479|NCT01021332|19289459|P1|Overall Study|Lack of Efficacy|19
5582480|NCT01021332|19289459|P1|Overall Study|Adverse Event|43
5582481|NCT01021332|19289459|P1|Overall Study|Not fulfilling incl./excl.criteria|5
5582482|NCT01021293|19289520|P2|Overall Study|Lost to Follow-up|1
5582483|NCT01021293|19289521|P1|Overall Study|Lost to Follow-up|1
5582484|NCT01021293|19289520|P2|Overall Study|Migrated/moved from study area|18
5582485|NCT01021293|19289521|P1|Overall Study|Migrated/moved from study area|6
5582486|NCT01021293|19289520|P2|Overall Study|Withdrawal by Subject|3
5582487|NCT01021293|19289521|P1|Overall Study|Withdrawal by Subject|1
5582488|NCT01021293|19289520|P2|Overall Study|Adverse Event|1
5582489|NCT01021293|19289521|P1|Overall Study|Adverse Event|2
5582490|NCT01021293|19289520|P2|Overall Study|Serious Adverse Event|1
5582491|NCT01021293|19289521|P1|Overall Study|Serious Adverse Event|2
5582492|NCT01021215|19289540|P2|Overall Study|Lost to Follow-up|0
5582493|NCT01021215|19289541|P1|Overall Study|Lost to Follow-up|3
5582494|NCT01021137|19289555|P4|Overall Study|Withdrawal by Subject|3
5582495|NCT01021137|19289556|P3|Overall Study|Withdrawal by Subject|0
5582496|NCT01021137|19289557|P2|Overall Study|Withdrawal by Subject|0
5582497|NCT01021137|19289558|P1|Overall Study|Withdrawal by Subject|1
5582498|NCT01021137|19289555|P4|Overall Study|Lost to Follow-up|6
5582499|NCT01021137|19289556|P3|Overall Study|Lost to Follow-up|2
5582500|NCT01021137|19289557|P2|Overall Study|Lost to Follow-up|4
5582501|NCT01021137|19289558|P1|Overall Study|Lost to Follow-up|9
5582502|NCT01021020|19289601|P1|14 Day Washout Period A|Physician Decision|1
5582503|NCT01021020|19289601|P1|Period I|Withdrawal by Subject|1
5582504|NCT01021020|19289601|P1|Period I|Protocol Violation|1
5582505|NCT01021007|19289617|P2|Overall Study|Adverse Event|3
5582506|NCT01021007|19289618|P1|Overall Study|Adverse Event|1
5582507|NCT01021007|19289617|P2|Overall Study|Lost to Follow-up|1
5582508|NCT01021007|19289618|P1|Overall Study|Lost to Follow-up|1
5582509|NCT01020981|19289630|P2|Overall Study|Participant declined to complete survey|0
5582510|NCT01020981|19289631|P1|Overall Study|Participant declined to complete survey|2
5582511|NCT01020981|19289630|P2|Overall Study|Survey returned undeliverable|32
5582512|NCT01020981|19289631|P1|Overall Study|Survey returned undeliverable|8
5582513|NCT01020981|19289630|P2|Overall Study|Did not return mailed survey|58
5582514|NCT01020981|19289631|P1|Overall Study|Did not return mailed survey|74
5582515|NCT01020877|19289652|P2|Second Intervention|Withdrawal by Subject|0
5582516|NCT01020877|19289653|P1|Second Intervention|Withdrawal by Subject|1
5582517|NCT01020838|19289663|P1|Overall Study|Most common: Study ended by sponsor|77
5582518|NCT01020838|19289663|P1|Overall Study|Lost to Follow-up|6
5582519|NCT01020838|19289663|P1|Overall Study|Withdrawal by Subject|9
5582520|NCT01020838|19289663|P1|Overall Study|Adverse Event|1
5582521|NCT01020838|19289663|P1|Overall Study|Death|90
5582522|NCT01020812|19289678|P1|Overall Study|Protocol Violation|1
5582523|NCT01020812|19289678|P1|Overall Study|Withdrawal by Subject|1
5582524|NCT01020812|19289678|P1|Overall Study|Physician Decision|1
5582525|NCT01020799|19289688|P3|Overall Study|Lost to Follow-up|2
5582526|NCT01020799|19289689|P2|Overall Study|Lost to Follow-up|4
5582527|NCT01020799|19289690|P1|Overall Study|Lost to Follow-up|6
5582528|NCT01020799|19289688|P3|Overall Study|Withdrawal by Subject|3
5582529|NCT01020799|19289689|P2|Overall Study|Withdrawal by Subject|2
5582530|NCT01020799|19289690|P1|Overall Study|Withdrawal by Subject|2
5582531|NCT01020799|19289688|P3|Overall Study|Protocol Violation|0
5582532|NCT01020799|19289689|P2|Overall Study|Protocol Violation|2
5582533|NCT01020799|19289690|P1|Overall Study|Protocol Violation|3
5582534|NCT01020799|19289688|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
5582535|NCT01020799|19289689|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
5582536|NCT01020799|19289690|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
5582537|NCT01020799|19289688|P3|Overall Study|Adverse Event|2
5582538|NCT01020799|19289689|P2|Overall Study|Adverse Event|3
5582539|NCT01020799|19289690|P1|Overall Study|Adverse Event|4
5582540|NCT01020786|19289713|P1|Maintenance Period|Sponsor Decision|1
5582541|NCT01020786|19289713|P1|Maintenance Period|Withdrawal by Subject|8
5582542|NCT01020786|19289713|P1|Maintenance Period|Progressive Disease|43
5582543|NCT01020786|19289713|P1|Maintenance Period|Adverse Event|8
5582544|NCT01020786|19289713|P1|Induction Period|Withdrawal by Subject|3
5582545|NCT01020786|19289713|P1|Induction Period|Investigator Decision|3
5582546|NCT01020786|19289713|P1|Induction Period|Progressive Disease|31
5582547|NCT01020786|19289713|P1|Induction Period|Adverse Event|10
5582548|NCT01020786|19289713|P1|Induction Period|Entry Criteria Not Met|2
5582549|NCT01020773|19289727|P2|Overall Study|Withdrawal by Subject|3
5582550|NCT01020773|19289728|P1|Overall Study|Withdrawal by Subject|4
5582551|NCT01020747|19289734|P1|Overall Study|Withdrawal by Subject|1
5582552|NCT01020526|19289750|P1|Overall Study|Adverse Event|2
5582553|NCT01020526|19289750|P1|Overall Study|Lost to Follow-up|1
5582554|NCT01020526|19289750|P1|Overall Study|Insufficient clinical response|3
5582555|NCT01020526|19289750|P1|Overall Study|Other reasons|3
5582556|NCT01020526|19289750|P1|Overall Study|Withdrawal by Subject|5
5582557|NCT01020474|19289756|P2|Overall Study|Insufficient Clinical Response|3
5582558|NCT01020474|19289757|P1|Overall Study|Insufficient Clinical Response|0
5582559|NCT01020474|19289756|P2|Overall Study|Other Reasons|1
5582560|NCT01020474|19289757|P1|Overall Study|Other Reasons|1
5582561|NCT01020474|19289756|P2|Overall Study|Withdrawal by Subject|7
5582562|NCT01020474|19289757|P1|Overall Study|Withdrawal by Subject|5
5582563|NCT01020474|19289756|P2|Overall Study|Protocol Violation|2
5582564|NCT01020474|19289757|P1|Overall Study|Protocol Violation|0
5582565|NCT01020474|19289756|P2|Overall Study|Adverse Event|4
5582566|NCT01020474|19289757|P1|Overall Study|Adverse Event|4
5582567|NCT01020448|19289777|P1|Treatment|Lost to Follow-up|2
5582568|NCT01020448|19289777|P1|Treatment|Lack of Efficacy|8
5582569|NCT01020448|19289777|P1|Treatment|Disease Progression|2
5582570|NCT01020448|19289777|P1|Treatment|Consent Withdrawn|3
5582571|NCT01020448|19289777|P1|Treatment|Adverse Event|11
5582572|NCT01020448|19289777|P1|Pre-assignment|Does Not Meet Entry Criteria|2
5582573|NCT01020448|19289777|P1|Pre-assignment|Withdrawal by Subject|5
5582574|NCT01020448|19289777|P1|Pre-assignment|Adverse Event|6
5582575|NCT01020435|19289788|P2|Overall Study|Lost to Follow-up|1
5582576|NCT01020435|19289789|P1|Overall Study|Lost to Follow-up|0
5582577|NCT01020305|19289797|P1|Overall Study|Adverse Event|2
5582578|NCT01020123|19289808|P7|Extention Period|Lost to Follow-up|0
5582579|NCT01020123|19289809|P6|Extention Period|Lost to Follow-up|2
5582580|NCT01020123|19289810|P5|Extention Period|Lost to Follow-up|0
5582581|NCT01020123|19289811|P4|Extention Period|Lost to Follow-up|0
5582582|NCT01020123|19289812|P3|Extention Period|Lost to Follow-up|0
5582583|NCT01020123|19289813|P2|Extention Period|Lost to Follow-up|0
5582584|NCT01020123|19289814|P1|Extention Period|Lost to Follow-up|0
5582585|NCT01020123|19289808|P7|Extention Period|Protocol Violation|1
5582586|NCT01020123|19289809|P6|Extention Period|Protocol Violation|0
5582587|NCT01020123|19289810|P5|Extention Period|Protocol Violation|0
5582588|NCT01020123|19289811|P4|Extention Period|Protocol Violation|0
5582589|NCT01020123|19289812|P3|Extention Period|Protocol Violation|1
5582590|NCT01020123|19289813|P2|Extention Period|Protocol Violation|1
5582591|NCT01020123|19289814|P1|Extention Period|Protocol Violation|1
5582592|NCT01020123|19289808|P7|Extention Period|Adverse Event|0
5582593|NCT01020123|19289809|P6|Extention Period|Adverse Event|0
5582594|NCT01020123|19289810|P5|Extention Period|Adverse Event|0
5582595|NCT01020123|19289811|P4|Extention Period|Adverse Event|1
5582596|NCT01020123|19289812|P3|Extention Period|Adverse Event|0
5582597|NCT01020123|19289813|P2|Extention Period|Adverse Event|0
5582598|NCT01020123|19289814|P1|Extention Period|Adverse Event|0
5582599|NCT01020123|19289808|P7|Extention Period|Withdrawal by Subject|0
5582600|NCT01020123|19289809|P6|Extention Period|Withdrawal by Subject|0
5582601|NCT01020123|19289810|P5|Extention Period|Withdrawal by Subject|0
5582602|NCT01020123|19289811|P4|Extention Period|Withdrawal by Subject|0
5582603|NCT01020123|19289812|P3|Extention Period|Withdrawal by Subject|1
5582604|NCT01020123|19289813|P2|Extention Period|Withdrawal by Subject|1
5582605|NCT01020123|19289814|P1|Extention Period|Withdrawal by Subject|2
5582606|NCT01020123|19289808|P7|Main Period|Unclasified|6
5582607|NCT01020123|19289809|P6|Main Period|Unclasified|3
5582608|NCT01020123|19289810|P5|Main Period|Unclasified|1
5582609|NCT01020123|19289811|P4|Main Period|Unclasified|0
5582610|NCT01020123|19289812|P3|Main Period|Unclasified|1
5582611|NCT01020123|19289813|P2|Main Period|Unclasified|0
5582612|NCT01020123|19289814|P1|Main Period|Unclasified|2
5582613|NCT01020123|19289808|P7|Main Period|Lost to Follow-up|0
5582614|NCT01020123|19289809|P6|Main Period|Lost to Follow-up|0
5582615|NCT01020123|19289810|P5|Main Period|Lost to Follow-up|0
5582616|NCT01020123|19289811|P4|Main Period|Lost to Follow-up|0
5582617|NCT01020123|19289812|P3|Main Period|Lost to Follow-up|0
5582618|NCT01020123|19289813|P2|Main Period|Lost to Follow-up|2
5582619|NCT01020123|19289814|P1|Main Period|Lost to Follow-up|0
5582620|NCT01020123|19289808|P7|Main Period|Protocol Violation|2
5582621|NCT01020123|19289809|P6|Main Period|Protocol Violation|3
5582622|NCT01020123|19289810|P5|Main Period|Protocol Violation|2
5582623|NCT01020123|19289811|P4|Main Period|Protocol Violation|5
5582624|NCT01020123|19289812|P3|Main Period|Protocol Violation|2
5582625|NCT01020123|19289813|P2|Main Period|Protocol Violation|4
5582626|NCT01020123|19289814|P1|Main Period|Protocol Violation|4
5582627|NCT01020123|19289808|P7|Main Period|Adverse Event|1
5582628|NCT01020123|19289809|P6|Main Period|Adverse Event|2
5582629|NCT01020123|19289810|P5|Main Period|Adverse Event|1
5582630|NCT01020123|19289811|P4|Main Period|Adverse Event|1
5582631|NCT01020123|19289812|P3|Main Period|Adverse Event|2
5582632|NCT01020123|19289813|P2|Main Period|Adverse Event|2
5582633|NCT01020123|19289814|P1|Main Period|Adverse Event|5
5582634|NCT01020123|19289808|P7|Main Period|Eligibility Criteria not fullfilled|0
5582635|NCT01020123|19289809|P6|Main Period|Eligibility Criteria not fullfilled|0
5582636|NCT01020123|19289810|P5|Main Period|Eligibility Criteria not fullfilled|1
5582637|NCT01020123|19289811|P4|Main Period|Eligibility Criteria not fullfilled|0
5582638|NCT01020123|19289812|P3|Main Period|Eligibility Criteria not fullfilled|0
5582639|NCT01020123|19289813|P2|Main Period|Eligibility Criteria not fullfilled|1
5582640|NCT01020123|19289814|P1|Main Period|Eligibility Criteria not fullfilled|0
5582641|NCT01020123|19289808|P7|Main Period|Withdrawal by Subject|2
5582642|NCT01020123|19289809|P6|Main Period|Withdrawal by Subject|3
5582643|NCT01020123|19289810|P5|Main Period|Withdrawal by Subject|6
5582644|NCT01020123|19289811|P4|Main Period|Withdrawal by Subject|1
5582645|NCT01020123|19289812|P3|Main Period|Withdrawal by Subject|3
5582646|NCT01020123|19289813|P2|Main Period|Withdrawal by Subject|5
5582647|NCT01020123|19289814|P1|Main Period|Withdrawal by Subject|6
5582648|NCT01020019|19290009|P2|Overall Study|moving|2
5582649|NCT01020019|19290010|P1|Overall Study|moving|0
5582650|NCT01020019|19290009|P2|Overall Study|not interested in treatment|4
5582651|NCT01020019|19290010|P1|Overall Study|not interested in treatment|4
5582652|NCT01020019|19290009|P2|Overall Study|Adverse Event|5
5582653|NCT01020019|19290010|P1|Overall Study|Adverse Event|1
5582654|NCT01020019|19290009|P2|Overall Study|Lost to Follow-up|18
5582655|NCT01020019|19290010|P1|Overall Study|Lost to Follow-up|21
5582656|NCT01019980|19290031|P2|Overall Study|Drug not available.|0
5582657|NCT01019980|19290032|P1|Overall Study|Drug not available.|2
5582658|NCT01019694|19290095|P3|Overall Study|Other reason (not specified)|6
5582659|NCT01019694|19290096|P2|Overall Study|Other reason (not specified)|5
5582660|NCT01019694|19290097|P1|Overall Study|Other reason (not specified)|1
5582661|NCT01019694|19290095|P3|Overall Study|Not treated|3
5582662|NCT01019694|19290096|P2|Overall Study|Not treated|2
5582663|NCT01019694|19290097|P1|Overall Study|Not treated|0
5582664|NCT01019694|19290095|P3|Overall Study|Withdrawal by Subject|12
5582665|NCT01019694|19290096|P2|Overall Study|Withdrawal by Subject|6
5582666|NCT01019694|19290097|P1|Overall Study|Withdrawal by Subject|4
5582667|NCT01019694|19290095|P3|Overall Study|Lost to Follow-up|3
5582668|NCT01019694|19290096|P2|Overall Study|Lost to Follow-up|3
5582669|NCT01019694|19290097|P1|Overall Study|Lost to Follow-up|5
5582670|NCT01019694|19290095|P3|Overall Study|Protocol Violation|4
5582671|NCT01019694|19290096|P2|Overall Study|Protocol Violation|6
5582672|NCT01019694|19290097|P1|Overall Study|Protocol Violation|2
5582673|NCT01019694|19290095|P3|Overall Study|Adverse Event|19
5582674|NCT01019694|19290096|P2|Overall Study|Adverse Event|16
5582675|NCT01019694|19290097|P1|Overall Study|Adverse Event|12
5582676|NCT01019486|19290222|P3|Overall Study|Withdrawal by Subject|1
5582677|NCT01019486|19290223|P2|Overall Study|Withdrawal by Subject|1
5582678|NCT01019486|19290224|P1|Overall Study|Withdrawal by Subject|1
5582679|NCT01019369|19290238|P2|Overall Study|Withdrawal by Subject|1
5582680|NCT01019369|19290239|P1|Overall Study|Withdrawal by Subject|0
5582681|NCT01019369|19290238|P2|Overall Study|Lost to Follow-up|6
5582682|NCT01019369|19290239|P1|Overall Study|Lost to Follow-up|10
5582683|NCT01019317|19290255|P1|Overall Study|Not Eligible|4
5582684|NCT01019252|19290261|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
5582685|NCT01019252|19290262|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
5582686|NCT01019252|19290261|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
5582687|NCT01019252|19290262|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
5582688|NCT01019252|19290261|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
5582689|NCT01019252|19290262|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
5582690|NCT01019252|19290261|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
5582691|NCT01019252|19290262|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
5582692|NCT01019135|19290275|P3|Overall Study|Did not attend CR|6
5582693|NCT01019135|19290276|P2|Overall Study|Did not attend CR|13
5582694|NCT01019135|19290277|P1|Overall Study|Did not attend CR|8
5582695|NCT01019135|19290275|P3|Overall Study|Did not receive allocated intervention|25
5582696|NCT01019135|19290276|P2|Overall Study|Did not receive allocated intervention|6
5582697|NCT01019135|19290277|P1|Overall Study|Did not receive allocated intervention|12
5582698|NCT01018992|19290305|P2|Overall Study|Lost to Follow-up|1
5582699|NCT01018992|19290306|P1|Overall Study|Lost to Follow-up|5
5582700|NCT01018992|19290305|P2|Overall Study|Protocol Violation|4
5582701|NCT01018992|19290306|P1|Overall Study|Protocol Violation|0
5582702|NCT01018992|19290305|P2|Overall Study|Withdrawal by Subject|8
5582703|NCT01018992|19290306|P1|Overall Study|Withdrawal by Subject|3
5582704|NCT01018992|19290305|P2|Overall Study|Adverse Event|3
5582705|NCT01018992|19290306|P1|Overall Study|Adverse Event|8
5582706|NCT01018979|19290320|P2|Overall Study|Not received at least one dose|1
5582707|NCT01018979|19290321|P1|Overall Study|Not received at least one dose|0
5582708|NCT01018979|19290320|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
5582709|NCT01018979|19290321|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
5582710|NCT01018953|19290351|P1|Overall Study|Study termination by sponsor|5
5582711|NCT01018953|19290351|P1|Overall Study|Withdrawal by Subject|1
5582712|NCT01018953|19290351|P1|Overall Study|Adverse Event|2
5582713|NCT01018862|19290364|P3|Overall Study|administrative problems|4
5582714|NCT01018862|19290365|P2|Overall Study|administrative problems|4
5582715|NCT01018862|19290366|P1|Overall Study|administrative problems|5
5582716|NCT01018862|19290364|P3|Overall Study|Withdrawal by Subject|1
5582717|NCT01018862|19290365|P2|Overall Study|Withdrawal by Subject|2
5582718|NCT01018862|19290366|P1|Overall Study|Withdrawal by Subject|1
5582719|NCT01018862|19290364|P3|Overall Study|Protocol Violation|3
5582720|NCT01018862|19290365|P2|Overall Study|Protocol Violation|3
5582721|NCT01018862|19290366|P1|Overall Study|Protocol Violation|1
5582722|NCT01018862|19290364|P3|Overall Study|Lost to Follow-up|0
5582723|NCT01018862|19290365|P2|Overall Study|Lost to Follow-up|1
5582724|NCT01018862|19290366|P1|Overall Study|Lost to Follow-up|3
5582725|NCT01018862|19290364|P3|Overall Study|Lack of Efficacy|2
5582726|NCT01018862|19290365|P2|Overall Study|Lack of Efficacy|0
5582727|NCT01018862|19290366|P1|Overall Study|Lack of Efficacy|1
5582728|NCT01018862|19290364|P3|Overall Study|Adverse Event|6
5582729|NCT01018862|19290365|P2|Overall Study|Adverse Event|0
5582730|NCT01018862|19290366|P1|Overall Study|Adverse Event|2
5582731|NCT01018810|19290388|P5|Overall Study|Sponsor Decision|1
5582732|NCT01018810|19290389|P4|Overall Study|Sponsor Decision|1
5582733|NCT01018810|19290390|P3|Overall Study|Sponsor Decision|1
5582734|NCT01018810|19290391|P2|Overall Study|Sponsor Decision|0
5582735|NCT01018810|19290392|P1|Overall Study|Sponsor Decision|2
5582736|NCT01018810|19290388|P5|Overall Study|Withdrawal by Subject|0
5582737|NCT01018810|19290389|P4|Overall Study|Withdrawal by Subject|0
5582738|NCT01018810|19290390|P3|Overall Study|Withdrawal by Subject|0
5582739|NCT01018810|19290391|P2|Overall Study|Withdrawal by Subject|1
5582740|NCT01018810|19290392|P1|Overall Study|Withdrawal by Subject|0
5582741|NCT01018732|19290452|P3|Overall Study|Unable to Classify|1
5582742|NCT01018732|19290453|P2|Overall Study|Unable to Classify|0
5582743|NCT01018732|19290454|P1|Overall Study|Unable to Classify|0
5582744|NCT01018732|19290452|P3|Overall Study|Inappropriate Enrollment|0
5582745|NCT01018732|19290453|P2|Overall Study|Inappropriate Enrollment|1
5582746|NCT01018732|19290454|P1|Overall Study|Inappropriate Enrollment|0
5582747|NCT01018732|19290452|P3|Overall Study|Protocol Violation|0
5582748|NCT01018732|19290453|P2|Overall Study|Protocol Violation|1
5582749|NCT01018732|19290454|P1|Overall Study|Protocol Violation|1
5582750|NCT01018732|19290452|P3|Overall Study|Lost to Follow-up|3
5582751|NCT01018732|19290453|P2|Overall Study|Lost to Follow-up|0
5582752|NCT01018732|19290454|P1|Overall Study|Lost to Follow-up|0
5582753|NCT01018680|19290488|P2|Overall Study|Physician Decision|1
5582754|NCT01018680|19290489|P1|Overall Study|Physician Decision|3
5582755|NCT01018680|19290488|P2|Overall Study|Entry Criteria Not Met|4
5582756|NCT01018680|19290489|P1|Overall Study|Entry Criteria Not Met|1
5582757|NCT01018680|19290488|P2|Overall Study|Lost to Follow-up|3
5582758|NCT01018680|19290489|P1|Overall Study|Lost to Follow-up|5
5582759|NCT01018680|19290488|P2|Overall Study|Lack of Efficacy|2
5582760|NCT01018680|19290489|P1|Overall Study|Lack of Efficacy|8
5582761|NCT01018680|19290488|P2|Overall Study|Sponsor Decision|7
5582762|NCT01018680|19290489|P1|Overall Study|Sponsor Decision|6
5582763|NCT01018680|19290488|P2|Overall Study|Protocol Violation|8
5582764|NCT01018680|19290489|P1|Overall Study|Protocol Violation|5
5582765|NCT01018680|19290488|P2|Overall Study|Withdrawal by Subject|10
5582766|NCT01018680|19290489|P1|Overall Study|Withdrawal by Subject|10
5582767|NCT01018680|19290488|P2|Overall Study|Adverse Event|40
5582768|NCT01018680|19290489|P1|Overall Study|Adverse Event|23
5582769|NCT01020487|19290532|P3|Part 2 Open-label Period|Adverse Event|1
5582770|NCT01020487|19290533|P2|Part 2 Open-label Period|Adverse Event|4
5582771|NCT01020487|19290534|P1|Part 2 Open-label Period|Adverse Event|0
5582772|NCT01020487|19290532|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
5582773|NCT01020487|19290533|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
5582774|NCT01020487|19290534|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
5582775|NCT01020487|19290532|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
5582776|NCT01020487|19290533|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
5582777|NCT01020487|19290534|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
5582778|NCT01020487|19290532|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
5582779|NCT01020487|19290533|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
5582780|NCT01020487|19290534|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
5582781|NCT01020487|19290532|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
5582782|NCT01020487|19290533|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
5582783|NCT01020487|19290534|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
5582784|NCT01018511|19290559|P4|Overall Study|Miscellaneous|0
5582785|NCT01018511|19290560|P3|Overall Study|Miscellaneous|0
5582786|NCT01018511|19290561|P2|Overall Study|Miscellaneous|2
5582787|NCT01018511|19290562|P1|Overall Study|Miscellaneous|0
5582788|NCT01018511|19290559|P4|Overall Study|Protocol Violation|9
5582789|NCT01018511|19290560|P3|Overall Study|Protocol Violation|7
5582790|NCT01018511|19290561|P2|Overall Study|Protocol Violation|8
5582791|NCT01018511|19290562|P1|Overall Study|Protocol Violation|5
5582792|NCT01018511|19290559|P4|Overall Study|Lost to Follow-up|0
5582793|NCT01018511|19290560|P3|Overall Study|Lost to Follow-up|1
5582794|NCT01018511|19290561|P2|Overall Study|Lost to Follow-up|0
5582795|NCT01018511|19290562|P1|Overall Study|Lost to Follow-up|0
5582796|NCT01018511|19290559|P4|Overall Study|Withdrawal by Subject|9
5582797|NCT01018511|19290560|P3|Overall Study|Withdrawal by Subject|11
5582798|NCT01018511|19290561|P2|Overall Study|Withdrawal by Subject|5
5582799|NCT01018511|19290562|P1|Overall Study|Withdrawal by Subject|6
5582800|NCT01018511|19290559|P4|Overall Study|Lack of Efficacy|2
5582801|NCT01018511|19290560|P3|Overall Study|Lack of Efficacy|1
5582802|NCT01018511|19290561|P2|Overall Study|Lack of Efficacy|1
5582803|NCT01018511|19290562|P1|Overall Study|Lack of Efficacy|4
5582804|NCT01018511|19290559|P4|Overall Study|Adverse Event|10
5582805|NCT01018511|19290560|P3|Overall Study|Adverse Event|13
5582806|NCT01018511|19290561|P2|Overall Study|Adverse Event|9
5582807|NCT01018511|19290562|P1|Overall Study|Adverse Event|5
5582808|NCT01018511|19290559|P4|Overall Study|Not fulfilling eligibility criteria|3
5582809|NCT01018511|19290560|P3|Overall Study|Not fulfilling eligibility criteria|7
5582810|NCT01018511|19290561|P2|Overall Study|Not fulfilling eligibility criteria|7
5582811|NCT01018511|19290562|P1|Overall Study|Not fulfilling eligibility criteria|6
5582812|NCT01018394|19290759|P2|Overall Study|Lost to Follow-up|3
5582813|NCT01018394|19290760|P1|Overall Study|Lost to Follow-up|4
5582814|NCT01018394|19290759|P2|Overall Study|Withdrawal by Subject|5
5582815|NCT01018394|19290760|P1|Overall Study|Withdrawal by Subject|5
5582816|NCT01018264|19290770|P2|Overall Study|Lost to Follow-up|1
5582817|NCT01018264|19290771|P1|Overall Study|Lost to Follow-up|0
5582818|NCT01018264|19290770|P2|Overall Study|Withdrawal by Subject|0
5582819|NCT01018264|19290771|P1|Overall Study|Withdrawal by Subject|1
5582820|NCT01018186|19290788|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
5582821|NCT01018186|19290789|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
5582822|NCT01018186|19290790|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
5582823|NCT01018186|19290791|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
5582824|NCT01018186|19290788|P4|52-week Double-blind Treatment Period|Physician Decision|3
5582825|NCT01018186|19290789|P3|52-week Double-blind Treatment Period|Physician Decision|0
5582826|NCT01018186|19290790|P2|52-week Double-blind Treatment Period|Physician Decision|1
5582827|NCT01018186|19290791|P1|52-week Double-blind Treatment Period|Physician Decision|0
5582828|NCT01018186|19290788|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
5582829|NCT01018186|19290789|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
5582830|NCT01018186|19290790|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
5582831|NCT01018186|19290791|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
5582832|NCT01018186|19290788|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
5582833|NCT01018186|19290789|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
5582834|NCT01018186|19290790|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
5582835|NCT01018186|19290791|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
5582836|NCT01018186|19290788|P4|52-week Double-blind Treatment Period|Protocol Violation|2
5582837|NCT01018186|19290789|P3|52-week Double-blind Treatment Period|Protocol Violation|8
5582838|NCT01018186|19290790|P2|52-week Double-blind Treatment Period|Protocol Violation|8
5582839|NCT01018186|19290791|P1|52-week Double-blind Treatment Period|Protocol Violation|0
5582840|NCT01018186|19290788|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
5582841|NCT01018186|19290789|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
5582842|NCT01018186|19290790|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
5582843|NCT01018186|19290791|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
5582844|NCT01018186|19290788|P4|52-week Double-blind Treatment Period|Adverse Event|6
5582845|NCT01018186|19290789|P3|52-week Double-blind Treatment Period|Adverse Event|3
5582846|NCT01018186|19290790|P2|52-week Double-blind Treatment Period|Adverse Event|5
5582847|NCT01018186|19290791|P1|52-week Double-blind Treatment Period|Adverse Event|0
5582848|NCT01018186|19290788|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5582849|NCT01018186|19290789|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5582850|NCT01018186|19290790|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5582851|NCT01018186|19290791|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
5582852|NCT01018186|19290788|P4|2-week Run-in Period|Withdrawal by Subject|0
5582853|NCT01018186|19290789|P3|2-week Run-in Period|Withdrawal by Subject|0
5582854|NCT01018186|19290790|P2|2-week Run-in Period|Withdrawal by Subject|0
5582855|NCT01018186|19290791|P1|2-week Run-in Period|Withdrawal by Subject|11
5582856|NCT01018186|19290788|P4|2-week Run-in Period|Physician Decision|0
5582857|NCT01018186|19290789|P3|2-week Run-in Period|Physician Decision|0
5582858|NCT01018186|19290790|P2|2-week Run-in Period|Physician Decision|0
5582859|NCT01018186|19290791|P1|2-week Run-in Period|Physician Decision|3
5582860|NCT01018186|19290788|P4|2-week Run-in Period|Lost to Follow-up|0
5582861|NCT01018186|19290789|P3|2-week Run-in Period|Lost to Follow-up|0
5582862|NCT01018186|19290790|P2|2-week Run-in Period|Lost to Follow-up|0
5582863|NCT01018186|19290791|P1|2-week Run-in Period|Lost to Follow-up|2
5582864|NCT01018186|19290788|P4|2-week Run-in Period|Protocol Violation|0
5582865|NCT01018186|19290789|P3|2-week Run-in Period|Protocol Violation|0
5582866|NCT01018186|19290790|P2|2-week Run-in Period|Protocol Violation|0
5582867|NCT01018186|19290791|P1|2-week Run-in Period|Protocol Violation|1
5582868|NCT01018030|19290992|P3|Overall Study|Did Not Receive Study Drug|0
5582869|NCT01018030|19290993|P2|Overall Study|Did Not Receive Study Drug|3
5582870|NCT01018030|19290994|P1|Overall Study|Did Not Receive Study Drug|1
5582871|NCT01018030|19290992|P3|Overall Study|Lack of Efficacy|0
5582872|NCT01018030|19290993|P2|Overall Study|Lack of Efficacy|0
5582873|NCT01018030|19290994|P1|Overall Study|Lack of Efficacy|1
5582874|NCT01018030|19290992|P3|Overall Study|Physician Decision|1
5582875|NCT01018030|19290993|P2|Overall Study|Physician Decision|0
5582876|NCT01018030|19290994|P1|Overall Study|Physician Decision|1
5582877|NCT01018030|19290992|P3|Overall Study|Protocol Violation|0
5582878|NCT01018030|19290993|P2|Overall Study|Protocol Violation|1
5582879|NCT01018030|19290994|P1|Overall Study|Protocol Violation|2
5582880|NCT01018030|19290992|P3|Overall Study|Lost to Follow-up|3
5582881|NCT01018030|19290993|P2|Overall Study|Lost to Follow-up|0
5582882|NCT01018030|19290994|P1|Overall Study|Lost to Follow-up|2
5582883|NCT01018030|19290992|P3|Overall Study|Withdrawal by Subject|4
5582884|NCT01018030|19290993|P2|Overall Study|Withdrawal by Subject|2
5582885|NCT01018030|19290994|P1|Overall Study|Withdrawal by Subject|2
5582886|NCT01018030|19290992|P3|Overall Study|Adverse Event|5
5582887|NCT01018030|19290993|P2|Overall Study|Adverse Event|5
5582888|NCT01018030|19290994|P1|Overall Study|Adverse Event|10
5582889|NCT01017952|19291045|P5|52-week, Double-blind Treatment Period|Physician Decision|7
5582890|NCT01017952|19291046|P4|52-week, Double-blind Treatment Period|Physician Decision|9
5582891|NCT01017952|19291047|P3|52-week, Double-blind Treatment Period|Physician Decision|8
5582892|NCT01017952|19291048|P2|52-week, Double-blind Treatment Period|Physician Decision|10
5582893|NCT01017952|19291049|P1|52-week, Double-blind Treatment Period|Physician Decision|0
5582894|NCT01017952|19291045|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
5582895|NCT01017952|19291046|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
5582896|NCT01017952|19291047|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
5582897|NCT01017952|19291048|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
5582898|NCT01017952|19291049|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
5582899|NCT01017952|19291045|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5582900|NCT01017952|19291046|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5582901|NCT01017952|19291047|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
5582902|NCT01017952|19291048|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
5582903|NCT01017952|19291049|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5582904|NCT01017952|19291045|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
5582905|NCT01017952|19291046|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
5582906|NCT01017952|19291047|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
5582907|NCT01017952|19291048|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
5582908|NCT01017952|19291049|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5582909|NCT01017952|19291045|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
5582910|NCT01017952|19291046|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
5582911|NCT01017952|19291047|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
5582912|NCT01017952|19291048|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
5582913|NCT01017952|19291049|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
5582914|NCT01017952|19291045|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
5582915|NCT01017952|19291046|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
5582916|NCT01017952|19291047|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
5582917|NCT01017952|19291048|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
5582918|NCT01017952|19291049|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
5582919|NCT01017952|19291045|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
5582920|NCT01017952|19291046|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
5582921|NCT01017952|19291047|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
5582922|NCT01017952|19291048|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
5582923|NCT01017952|19291049|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
5582924|NCT01017952|19291045|P5|52-week, Double-blind Treatment Period|Adverse Event|30
5582925|NCT01017952|19291046|P4|52-week, Double-blind Treatment Period|Adverse Event|35
5582926|NCT01017952|19291047|P3|52-week, Double-blind Treatment Period|Adverse Event|32
5582927|NCT01017952|19291048|P2|52-week, Double-blind Treatment Period|Adverse Event|25
5582928|NCT01017952|19291049|P1|52-week, Double-blind Treatment Period|Adverse Event|0
5582929|NCT01017952|19291045|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5582930|NCT01017952|19291046|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5582931|NCT01017952|19291047|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5582932|NCT01017952|19291048|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5582933|NCT01017952|19291049|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
5582934|NCT01017952|19291045|P5|4-week, Open-label Run-In Period|Physician Decision|0
5582935|NCT01017952|19291046|P4|4-week, Open-label Run-In Period|Physician Decision|0
5582936|NCT01017952|19291047|P3|4-week, Open-label Run-In Period|Physician Decision|0
5582937|NCT01017952|19291048|P2|4-week, Open-label Run-In Period|Physician Decision|0
5582938|NCT01017952|19291049|P1|4-week, Open-label Run-In Period|Physician Decision|10
5582939|NCT01017952|19291045|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
5582940|NCT01017952|19291046|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
5582941|NCT01017952|19291047|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
5582942|NCT01017952|19291048|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
5582943|NCT01017952|19291049|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
5582944|NCT01017952|19291045|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5582945|NCT01017952|19291046|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5582946|NCT01017952|19291047|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5582947|NCT01017952|19291048|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
5582948|NCT01017952|19291049|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
5582949|NCT01017952|19291045|P5|4-week, Open-label Run-In Period|Adverse Event|0
5582950|NCT01017952|19291046|P4|4-week, Open-label Run-In Period|Adverse Event|0
5582951|NCT01017952|19291047|P3|4-week, Open-label Run-In Period|Adverse Event|0
5582952|NCT01017952|19291048|P2|4-week, Open-label Run-In Period|Adverse Event|0
5582953|NCT01017952|19291049|P1|4-week, Open-label Run-In Period|Adverse Event|23
5582954|NCT01017952|19291045|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5582955|NCT01017952|19291046|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5582956|NCT01017952|19291047|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5582957|NCT01017952|19291048|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5582958|NCT01017952|19291049|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
5582959|NCT01017874|19291073|P2|Overall Study|Physician Decision|3
5582960|NCT01017874|19291074|P1|Overall Study|Physician Decision|1
5582961|NCT01017874|19291073|P2|Overall Study|Lost to Follow-up|2
5582962|NCT01017874|19291074|P1|Overall Study|Lost to Follow-up|3
5582963|NCT01017874|19291073|P2|Overall Study|Sponsor decision|1
5582964|NCT01017874|19291074|P1|Overall Study|Sponsor decision|3
5582965|NCT01017874|19291073|P2|Overall Study|Withdrawal by Subject|20
5582966|NCT01017874|19291074|P1|Overall Study|Withdrawal by Subject|23
5582967|NCT01017731|19291092|P1|Overall Study|Adverse Event|1
5582968|NCT01017731|19291092|P1|Overall Study|Physician Decision|2
5582969|NCT01017731|19291092|P1|Overall Study|Withdrawal by Subject|3
5582970|NCT01017731|19291092|P1|Overall Study|Lost to Follow-up|2
5582971|NCT01017601|19291121|P2|Overall Study|Withdrawal by Subject|1
5582972|NCT01017601|19291122|P1|Overall Study|Withdrawal by Subject|0
5582973|NCT01017601|19291121|P2|Overall Study|Disease Progression|12
5582974|NCT01017601|19291122|P1|Overall Study|Disease Progression|12
5582975|NCT01017575|19291149|P5|Overall Study|Withdrawal by Subject|0
5582976|NCT01017575|19291150|P4|Overall Study|Withdrawal by Subject|0
5582977|NCT01017575|19291151|P3|Overall Study|Withdrawal by Subject|0
5582978|NCT01017575|19291152|P2|Overall Study|Withdrawal by Subject|0
5582979|NCT01017575|19291153|P1|Overall Study|Withdrawal by Subject|1
5582980|NCT01017575|19291149|P5|Overall Study|Adverse Event|2
5582981|NCT01017575|19291150|P4|Overall Study|Adverse Event|0
5582982|NCT01017575|19291151|P3|Overall Study|Adverse Event|0
5582983|NCT01017575|19291152|P2|Overall Study|Adverse Event|1
5582984|NCT01017575|19291153|P1|Overall Study|Adverse Event|0
5582985|NCT01017575|19291149|P5|Overall Study|Lack of Efficacy|1
5582986|NCT01017575|19291150|P4|Overall Study|Lack of Efficacy|1
5582987|NCT01017575|19291151|P3|Overall Study|Lack of Efficacy|0
5582988|NCT01017575|19291152|P2|Overall Study|Lack of Efficacy|1
5582989|NCT01017575|19291153|P1|Overall Study|Lack of Efficacy|0
5582990|NCT01017549|19291190|P1|5 Year Follow-up|Mastectomy|3
5582991|NCT01017549|19291190|P1|5 Year Follow-up|Lost to Follow-up|9
5582992|NCT01017549|19291190|P1|One-year Follow-up|Withdrawal by Subject|5
5582993|NCT01017549|19291190|P1|One-year Follow-up|Lost to Follow-up|2
5582994|NCT01017549|19291190|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
5582995|NCT01017263|19291221|P1|Overall Study|not eligible|12
5582996|NCT01017146|19291302|P2|Overall Study|Change in Work Situation|0
5582997|NCT01017146|19291303|P1|Overall Study|Change in Work Situation|1
5582998|NCT01017146|19291302|P2|Overall Study|Did Not Meet Eligibility Criteria|2
5582999|NCT01017146|19291303|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5583000|NCT01017146|19291302|P2|Overall Study|Took Excluded Medication|0
5583001|NCT01017146|19291303|P1|Overall Study|Took Excluded Medication|2
5583002|NCT01017146|19291302|P2|Overall Study|Protocol Violation|0
5583003|NCT01017146|19291303|P1|Overall Study|Protocol Violation|2
5583004|NCT01017146|19291302|P2|Overall Study|Pregnancy|1
5583005|NCT01017146|19291303|P1|Overall Study|Pregnancy|2
5583006|NCT01017146|19291302|P2|Overall Study|Relocation|4
5583007|NCT01017146|19291303|P1|Overall Study|Relocation|0
5583008|NCT01017146|19291302|P2|Overall Study|Withdrawal by Subject|16
5583009|NCT01017146|19291303|P1|Overall Study|Withdrawal by Subject|32
5583010|NCT01017146|19291302|P2|Overall Study|Noncompliance with Study Product|1
5583011|NCT01017146|19291303|P1|Overall Study|Noncompliance with Study Product|1
5583012|NCT01017146|19291302|P2|Overall Study|Lost to Follow-up|14
5583013|NCT01017146|19291303|P1|Overall Study|Lost to Follow-up|14
5583014|NCT01017146|19291302|P2|Overall Study|Adverse Event|1
5583015|NCT01017146|19291303|P1|Overall Study|Adverse Event|11
5583016|NCT01017120|19291341|P2|Overall Study|Parent Unable to Provide Transportation|0
5583017|NCT01017120|19291342|P1|Overall Study|Parent Unable to Provide Transportation|1
5583018|NCT01017120|19291341|P2|Overall Study|Protocol Violation|0
5583019|NCT01017120|19291342|P1|Overall Study|Protocol Violation|1
5583020|NCT01017120|19291341|P2|Overall Study|Relocated Out of Town|2
5583021|NCT01017120|19291342|P1|Overall Study|Relocated Out of Town|0
5583022|NCT01017120|19291341|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5583023|NCT01017120|19291342|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5583024|NCT01017120|19291341|P2|Overall Study|Pregnancy|1
5583025|NCT01017120|19291342|P1|Overall Study|Pregnancy|1
5583026|NCT01017120|19291341|P2|Overall Study|Withdrawal by Subject|21
5583027|NCT01017120|19291342|P1|Overall Study|Withdrawal by Subject|39
5583028|NCT01017120|19291341|P2|Overall Study|Lack of Efficacy|0
5583029|NCT01017120|19291342|P1|Overall Study|Lack of Efficacy|1
5583030|NCT01017120|19291341|P2|Overall Study|Lost to Follow-up|11
5583031|NCT01017120|19291342|P1|Overall Study|Lost to Follow-up|13
5583032|NCT01017120|19291341|P2|Overall Study|Adverse Event|0
5583033|NCT01017120|19291342|P1|Overall Study|Adverse Event|9
5583034|NCT01017029|19291403|P2|Overall Study|Death|1
5583035|NCT01017029|19291404|P1|Overall Study|Death|3
5583036|NCT01017029|19291403|P2|Overall Study|Administrative problem|1
5583037|NCT01017029|19291404|P1|Overall Study|Administrative problem|0
5583038|NCT01017029|19291403|P2|Overall Study|Lost to Follow-up|0
5583039|NCT01017029|19291404|P1|Overall Study|Lost to Follow-up|1
5583040|NCT01016977|19291432|P2|Overall Study|Withdrawal by Subject|2
5583041|NCT01016977|19291433|P1|Overall Study|Withdrawal by Subject|2
5583042|NCT01016977|19291432|P2|Overall Study|Lost to Follow-up|0
5583043|NCT01016977|19291433|P1|Overall Study|Lost to Follow-up|1
5583044|NCT01016964|19291469|P2|Overall Study|Lost to Follow-up|3
5583045|NCT01016964|19291470|P1|Overall Study|Lost to Follow-up|3
5583046|NCT01016912|19291486|P5|Follow-up Period|Other reason|0
5583047|NCT01016912|19291487|P4|Follow-up Period|Other reason|1
5583048|NCT01016912|19291488|P3|Follow-up Period|Other reason|1
5583049|NCT01016912|19291489|P2|Follow-up Period|Other reason|0
5583050|NCT01016912|19291490|P1|Follow-up Period|Other reason|0
5583051|NCT01016912|19291486|P5|End of Treatment Period|Completed double-blind period only|0
5583052|NCT01016912|19291487|P4|End of Treatment Period|Completed double-blind period only|0
5583053|NCT01016912|19291488|P3|End of Treatment Period|Completed double-blind period only|0
5583054|NCT01016912|19291489|P2|End of Treatment Period|Completed double-blind period only|1
5583055|NCT01016912|19291490|P1|End of Treatment Period|Completed double-blind period only|0
5583056|NCT01016912|19291486|P5|End of Treatment Period|Adverse Event|0
5583057|NCT01016912|19291487|P4|End of Treatment Period|Adverse Event|0
5583058|NCT01016912|19291488|P3|End of Treatment Period|Adverse Event|1
5583059|NCT01016912|19291489|P2|End of Treatment Period|Adverse Event|1
5583060|NCT01016912|19291490|P1|End of Treatment Period|Adverse Event|0
5583061|NCT01016912|19291486|P5|End of Treatment Period|Lack of Efficacy|4
5583062|NCT01016912|19291487|P4|End of Treatment Period|Lack of Efficacy|4
5583063|NCT01016912|19291488|P3|End of Treatment Period|Lack of Efficacy|0
5583064|NCT01016912|19291489|P2|End of Treatment Period|Lack of Efficacy|1
5583065|NCT01016912|19291490|P1|End of Treatment Period|Lack of Efficacy|0
5583066|NCT01016600|19291669|P4|Overall Study|Did not start treatment|0
5583067|NCT01016600|19291670|P3|Overall Study|Did not start treatment|0
5583068|NCT01016600|19291671|P2|Overall Study|Did not start treatment|0
5583069|NCT01016600|19291672|P1|Overall Study|Did not start treatment|1
5583070|NCT01016262|19291860|P6|Open-Label Phase|Withdrawal of Informed Consent|0
5583071|NCT01016262|19291861|P5|Open-Label Phase|Withdrawal of Informed Consent|1
5583072|NCT01016262|19291862|P4|Open-Label Phase|Withdrawal of Informed Consent|0
5583073|NCT01016262|19291863|P3|Open-Label Phase|Withdrawal of Informed Consent|0
5583074|NCT01016262|19291864|P2|Open-Label Phase|Withdrawal of Informed Consent|0
5583075|NCT01016262|19291865|P1|Open-Label Phase|Withdrawal of Informed Consent|0
5583076|NCT01016262|19291860|P6|Open-Label Phase|Lack of Efficacy|0
5583077|NCT01016262|19291861|P5|Open-Label Phase|Lack of Efficacy|0
5583078|NCT01016262|19291862|P4|Open-Label Phase|Lack of Efficacy|1
5583079|NCT01016262|19291863|P3|Open-Label Phase|Lack of Efficacy|0
5583080|NCT01016262|19291864|P2|Open-Label Phase|Lack of Efficacy|0
5583081|NCT01016262|19291865|P1|Open-Label Phase|Lack of Efficacy|0
5583082|NCT01016262|19291860|P6|Open-Label Phase|Lost to Follow-up|0
5583083|NCT01016262|19291861|P5|Open-Label Phase|Lost to Follow-up|1
5583084|NCT01016262|19291862|P4|Open-Label Phase|Lost to Follow-up|0
5583085|NCT01016262|19291863|P3|Open-Label Phase|Lost to Follow-up|0
5583086|NCT01016262|19291864|P2|Open-Label Phase|Lost to Follow-up|0
5583087|NCT01016262|19291865|P1|Open-Label Phase|Lost to Follow-up|0
5583088|NCT01016262|19291860|P6|Open-Label Phase|Adverse Event|0
5583089|NCT01016262|19291861|P5|Open-Label Phase|Adverse Event|0
5583090|NCT01016262|19291862|P4|Open-Label Phase|Adverse Event|1
5583091|NCT01016262|19291863|P3|Open-Label Phase|Adverse Event|0
5583092|NCT01016262|19291864|P2|Open-Label Phase|Adverse Event|0
5583093|NCT01016262|19291865|P1|Open-Label Phase|Adverse Event|0
5583094|NCT01016262|19291860|P6|Double-blind Phase|Withdrawal of Informed Consent|0
5583095|NCT01016262|19291861|P5|Double-blind Phase|Withdrawal of Informed Consent|0
5583096|NCT01016262|19291862|P4|Double-blind Phase|Withdrawal of Informed Consent|0
5583097|NCT01016262|19291863|P3|Double-blind Phase|Withdrawal of Informed Consent|1
5583098|NCT01016262|19291864|P2|Double-blind Phase|Withdrawal of Informed Consent|0
5583099|NCT01016262|19291865|P1|Double-blind Phase|Withdrawal of Informed Consent|0
5583100|NCT01016262|19291860|P6|Double-blind Phase|Disease Progression|0
5583101|NCT01016262|19291861|P5|Double-blind Phase|Disease Progression|0
5583102|NCT01016262|19291862|P4|Double-blind Phase|Disease Progression|0
5583103|NCT01016262|19291863|P3|Double-blind Phase|Disease Progression|2
5583104|NCT01016262|19291864|P2|Double-blind Phase|Disease Progression|1
5583105|NCT01016262|19291865|P1|Double-blind Phase|Disease Progression|0
5583106|NCT01016262|19291860|P6|Double-blind Phase|Lack of Efficacy|0
5583107|NCT01016262|19291861|P5|Double-blind Phase|Lack of Efficacy|0
5583108|NCT01016262|19291862|P4|Double-blind Phase|Lack of Efficacy|0
5583109|NCT01016262|19291863|P3|Double-blind Phase|Lack of Efficacy|5
5583110|NCT01016262|19291864|P2|Double-blind Phase|Lack of Efficacy|0
5583111|NCT01016262|19291865|P1|Double-blind Phase|Lack of Efficacy|1
5583112|NCT01016262|19291860|P6|Double-blind Phase|Adverse Event|0
5583113|NCT01016262|19291861|P5|Double-blind Phase|Adverse Event|0
5583114|NCT01016262|19291862|P4|Double-blind Phase|Adverse Event|0
5583115|NCT01016262|19291863|P3|Double-blind Phase|Adverse Event|1
5583116|NCT01016262|19291864|P2|Double-blind Phase|Adverse Event|0
5583117|NCT01016262|19291865|P1|Double-blind Phase|Adverse Event|0
5583118|NCT01016132|19291888|P1|Overall Study|Discomfort|1
5583119|NCT01016067|19291903|P2|Overall Study|Withdrew due to Relocation|1
5583120|NCT01016067|19291904|P1|Overall Study|Withdrew due to Relocation|0
5583121|NCT01016067|19291903|P2|Overall Study|Physician Decision|1
5583122|NCT01016067|19291904|P1|Overall Study|Physician Decision|1
5583123|NCT01016067|19291903|P2|Overall Study|Lost to Follow-up|2
5583124|NCT01016067|19291904|P1|Overall Study|Lost to Follow-up|1
5583125|NCT01016015|19291922|P1|Overall Study|Adverse Event|15
5583126|NCT01016015|19291922|P1|Overall Study|Withdrawal by Subject|1
5583127|NCT01016015|19291922|P1|Overall Study|Not Treated|3
5583128|NCT01015833|19291933|P2|Overall Study|Did not start treatment|0
5583129|NCT01015833|19291934|P1|Overall Study|Did not start treatment|1
5583130|NCT01015833|19291933|P2|Overall Study|Motor Vehicle Accidents|0
5583131|NCT01015833|19291934|P1|Overall Study|Motor Vehicle Accidents|1
5583132|NCT01015833|19291933|P2|Overall Study|Other|1
5583133|NCT01015833|19291934|P1|Overall Study|Other|5
5583134|NCT01015833|19291933|P2|Overall Study|Symptomatic deterioration|1
5583135|NCT01015833|19291934|P1|Overall Study|Symptomatic deterioration|0
5583136|NCT01015833|19291933|P2|Overall Study|Physician Decision|0
5583137|NCT01015833|19291934|P1|Overall Study|Physician Decision|2
5583138|NCT01015833|19291933|P2|Overall Study|Adverse Event|1
5583139|NCT01015833|19291934|P1|Overall Study|Adverse Event|0
5583140|NCT01015833|19291933|P2|Overall Study|Withdrawal by Subject|2
5583141|NCT01015833|19291934|P1|Overall Study|Withdrawal by Subject|3
5583142|NCT01015833|19291933|P2|Overall Study|Death|0
5583143|NCT01015833|19291934|P1|Overall Study|Death|1
5583144|NCT01015820|19291950|P2|Overall Study|Suboptimal measurements|0
5583145|NCT01015820|19291951|P1|Overall Study|Suboptimal measurements|1
5583146|NCT01015768|19291981|P2|Overall Study|Some subject data unuseable|4
5583147|NCT01015768|19291982|P1|Overall Study|Some subject data unuseable|4
5583148|NCT01015703|19291997|P5|Overall Study|Protocol Violation|0
5583149|NCT01015703|19291998|P4|Overall Study|Protocol Violation|0
5583150|NCT01015703|19291999|P3|Overall Study|Protocol Violation|0
5583151|NCT01015703|19292000|P2|Overall Study|Protocol Violation|0
5583152|NCT01015703|19292001|P1|Overall Study|Protocol Violation|1
5583153|NCT01015703|19291997|P5|Overall Study|Adverse Event|0
5583154|NCT01015703|19291998|P4|Overall Study|Adverse Event|0
5583155|NCT01015703|19291999|P3|Overall Study|Adverse Event|0
5583156|NCT01015703|19292000|P2|Overall Study|Adverse Event|0
5583157|NCT01015703|19292001|P1|Overall Study|Adverse Event|1
5583158|NCT01015703|19291997|P5|Overall Study|Withdrawal by Subject|0
5583159|NCT01015703|19291998|P4|Overall Study|Withdrawal by Subject|0
5583160|NCT01015703|19291999|P3|Overall Study|Withdrawal by Subject|0
5583161|NCT01015703|19292000|P2|Overall Study|Withdrawal by Subject|1
5583162|NCT01015703|19292001|P1|Overall Study|Withdrawal by Subject|0
5583163|NCT01015677|19292016|P3|Overall Study|Withdrawal by Subject|0
5583164|NCT01015677|19292017|P2|Overall Study|Withdrawal by Subject|1
5583165|NCT01015677|19292018|P1|Overall Study|Withdrawal by Subject|1
5583166|NCT01015677|19292016|P3|Overall Study|Protocol Violation|0
5583167|NCT01015677|19292017|P2|Overall Study|Protocol Violation|1
5583168|NCT01015677|19292018|P1|Overall Study|Protocol Violation|0
5583169|NCT01015677|19292016|P3|Overall Study|Lack of Efficacy|0
5583170|NCT01015677|19292017|P2|Overall Study|Lack of Efficacy|1
5583171|NCT01015677|19292018|P1|Overall Study|Lack of Efficacy|0
5583172|NCT01015677|19292016|P3|Overall Study|Adverse Event|0
5583173|NCT01015677|19292017|P2|Overall Study|Adverse Event|1
5583174|NCT01015677|19292018|P1|Overall Study|Adverse Event|0
5583175|NCT01015638|19292040|P2|Overall Study|Withdrawal by Subject|0
5583176|NCT01015638|19292041|P1|Overall Study|Withdrawal by Subject|1
5583177|NCT01015612|19292069|P1|Overall Study|Withdrawal by Subject|40
5583178|NCT01015612|19292069|P1|Overall Study|Death|113
5583179|NCT01015560|19292100|P1|Overall Study|Withdrawal by Subject|1
5583180|NCT01015560|19292100|P1|Overall Study|Not protocol specified|1
5583181|NCT01015560|19292100|P1|Overall Study|Adverse Event|1
5583182|NCT01015287|19292149|P2|Overall Study|Protocol Violation|1
5583183|NCT01015287|19292150|P1|Overall Study|Protocol Violation|1
5583184|NCT01015287|19292149|P2|Overall Study|Lost to Follow-up|1
5583185|NCT01015287|19292150|P1|Overall Study|Lost to Follow-up|2
5583186|NCT01015287|19292149|P2|Overall Study|Entry Criteria not Met|14
5583187|NCT01015287|19292150|P1|Overall Study|Entry Criteria not Met|11
5583188|NCT01015287|19292149|P2|Overall Study|Withdrawal by Subject|19
5583189|NCT01015287|19292150|P1|Overall Study|Withdrawal by Subject|14
5583190|NCT01015287|19292149|P2|Overall Study|Physician Decision|21
5583191|NCT01015287|19292150|P1|Overall Study|Physician Decision|19
5583192|NCT01015287|19292149|P2|Overall Study|Sponsor Decision|7
5583193|NCT01015287|19292150|P1|Overall Study|Sponsor Decision|3
5583194|NCT01015287|19292149|P2|Overall Study|Adverse Event|0
5583195|NCT01015287|19292150|P1|Overall Study|Adverse Event|1
5583196|NCT01015287|19292149|P2|Overall Study|Death|16
5583197|NCT01015287|19292150|P1|Overall Study|Death|21
5583198|NCT01015131|19292182|P1|Overall Study|Other Protocol Specified Criteria|4
5583199|NCT01015131|19292182|P1|Overall Study|Withdrawal by Subject|2
5583200|NCT01015131|19292182|P1|Overall Study|Protocol Violation|1
5583201|NCT01015131|19292182|P1|Overall Study|Physician Decision|1
5583202|NCT01015118|19292198|P2|Overall Study|Other than stated above|23
5583203|NCT01015118|19292199|P1|Overall Study|Other than stated above|42
5583204|NCT01015118|19292198|P2|Overall Study|Not treated|5
5583205|NCT01015118|19292199|P1|Overall Study|Not treated|9
5583206|NCT01015118|19292198|P2|Overall Study|Progressive disease|229
5583207|NCT01015118|19292199|P1|Overall Study|Progressive disease|364
5583208|NCT01015118|19292198|P2|Overall Study|Worsening or AE of underlying disease|4
5583209|NCT01015118|19292199|P1|Overall Study|Worsening or AE of underlying disease|5
5583210|NCT01015118|19292198|P2|Overall Study|Other Adverse Event (AE)|33
5583211|NCT01015118|19292199|P1|Overall Study|Other Adverse Event (AE)|141
5583212|NCT01015118|19292198|P2|Overall Study|Withdrawal by Subject|27
5583213|NCT01015118|19292199|P1|Overall Study|Withdrawal by Subject|103
5583214|NCT01015118|19292198|P2|Overall Study|Protocol Violation|6
5583215|NCT01015118|19292199|P1|Overall Study|Protocol Violation|5
5583216|NCT01014988|19292227|P6|Overall Study|Withdrawal by Subject|0
5583217|NCT01014988|19292228|P5|Overall Study|Withdrawal by Subject|0
5583218|NCT01014988|19292229|P4|Overall Study|Withdrawal by Subject|0
5583219|NCT01014988|19292230|P3|Overall Study|Withdrawal by Subject|0
5583220|NCT01014988|19292231|P2|Overall Study|Withdrawal by Subject|0
5583221|NCT01014988|19292232|P1|Overall Study|Withdrawal by Subject|1
5583222|NCT01014988|19292227|P6|Overall Study|Physician Decision|0
5583223|NCT01014988|19292228|P5|Overall Study|Physician Decision|0
5583224|NCT01014988|19292229|P4|Overall Study|Physician Decision|0
5583225|NCT01014988|19292230|P3|Overall Study|Physician Decision|0
5583226|NCT01014988|19292231|P2|Overall Study|Physician Decision|0
5583227|NCT01014988|19292232|P1|Overall Study|Physician Decision|1
5583228|NCT01014988|19292227|P6|Overall Study|Lost to Follow-up|0
5583229|NCT01014988|19292228|P5|Overall Study|Lost to Follow-up|0
5583230|NCT01014988|19292229|P4|Overall Study|Lost to Follow-up|0
5583231|NCT01014988|19292230|P3|Overall Study|Lost to Follow-up|1
5583232|NCT01014988|19292231|P2|Overall Study|Lost to Follow-up|0
5583233|NCT01014988|19292232|P1|Overall Study|Lost to Follow-up|1
5583234|NCT01014988|19292227|P6|Overall Study|Adverse Event|3
5583235|NCT01014988|19292228|P5|Overall Study|Adverse Event|1
5583236|NCT01014988|19292229|P4|Overall Study|Adverse Event|0
5583237|NCT01014988|19292230|P3|Overall Study|Adverse Event|1
5583238|NCT01014988|19292231|P2|Overall Study|Adverse Event|0
5583239|NCT01014988|19292232|P1|Overall Study|Adverse Event|20
5583240|NCT01014975|19292404|P3|Overall Study|Lost to Follow-up|1
5583241|NCT01014975|19292405|P2|Overall Study|Lost to Follow-up|0
5583242|NCT01014975|19292406|P1|Overall Study|Lost to Follow-up|0
5583243|NCT01014975|19292404|P3|Overall Study|Death|4
5583244|NCT01014975|19292405|P2|Overall Study|Death|3
5583245|NCT01014975|19292406|P1|Overall Study|Death|3
5583246|NCT01014975|19292404|P3|Overall Study|Withdrawal by Subject|1
5583247|NCT01014975|19292405|P2|Overall Study|Withdrawal by Subject|0
5583248|NCT01014975|19292406|P1|Overall Study|Withdrawal by Subject|1
5583249|NCT01014910|19292911|P2|Overall Study|Withdrawal by Subject|2
5583250|NCT01014910|19292912|P1|Overall Study|Withdrawal by Subject|0
5583251|NCT01014767|19292930|P4|Overall Study|PI left institution, data unavailable|1
5583252|NCT01014767|19292931|P3|Overall Study|PI left institution, data unavailable|4
5583253|NCT01014767|19292932|P2|Overall Study|PI left institution, data unavailable|1
5583254|NCT01014767|19292933|P1|Overall Study|PI left institution, data unavailable|12
5583255|NCT01014689|19292977|P2|Overall Study|Pregnancy|0
5583256|NCT01014689|19292978|P1|Overall Study|Pregnancy|1
5583257|NCT01014689|19292977|P2|Overall Study|Lost to Follow-up|7
5583258|NCT01014689|19292978|P1|Overall Study|Lost to Follow-up|3
5583259|NCT01014689|19292977|P2|Overall Study|Protocol Violation|1
5583260|NCT01014689|19292978|P1|Overall Study|Protocol Violation|1
5583261|NCT01014689|19292977|P2|Overall Study|Withdrawal by Subject|4
5583262|NCT01014689|19292978|P1|Overall Study|Withdrawal by Subject|5
5583263|NCT01014689|19292977|P2|Overall Study|Adverse Event|0
5583264|NCT01014689|19292978|P1|Overall Study|Adverse Event|3
5583265|NCT01014689|19292977|P2|Overall Study|Lack of Efficacy|1
5583266|NCT01014689|19292978|P1|Overall Study|Lack of Efficacy|0
5583267|NCT01014585|19293013|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
5583268|NCT01014585|19293014|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
5583269|NCT01014585|19293015|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
5583270|NCT01014585|19293016|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
5583271|NCT01014585|19293013|P4|Overall Study|Lost to Follow-up|2
5583272|NCT01014585|19293014|P3|Overall Study|Lost to Follow-up|0
5583273|NCT01014585|19293015|P2|Overall Study|Lost to Follow-up|0
5583274|NCT01014585|19293016|P1|Overall Study|Lost to Follow-up|0
5583275|NCT01014585|19293013|P4|Overall Study|Withdrawal by Subject|3
5583276|NCT01014585|19293014|P3|Overall Study|Withdrawal by Subject|1
5583277|NCT01014585|19293015|P2|Overall Study|Withdrawal by Subject|0
5583278|NCT01014585|19293016|P1|Overall Study|Withdrawal by Subject|2
5583279|NCT01014585|19293013|P4|Overall Study|Adverse Event|3
5583280|NCT01014585|19293014|P3|Overall Study|Adverse Event|0
5583281|NCT01014585|19293015|P2|Overall Study|Adverse Event|2
5583282|NCT01014585|19293016|P1|Overall Study|Adverse Event|0
5583283|NCT01014533|19293036|P2|Overall Study|unable to come to appointment|3
5583284|NCT01014533|19293037|P1|Overall Study|unable to come to appointment|0
5583285|NCT01014533|19293036|P2|Overall Study|Withdrawal by Subject|0
5583286|NCT01014533|19293037|P1|Overall Study|Withdrawal by Subject|2
5583287|NCT01014533|19293036|P2|Overall Study|Protocol Violation|2
5583288|NCT01014533|19293037|P1|Overall Study|Protocol Violation|3
5583289|NCT01014442|19293058|P2|Overall Study|Unspecified Reason|1
5583290|NCT01014442|19293059|P1|Overall Study|Unspecified Reason|1
5583291|NCT01014442|19293058|P2|Overall Study|Lack of Compliance|1
5583292|NCT01014442|19293059|P1|Overall Study|Lack of Compliance|0
5583293|NCT01014442|19293058|P2|Overall Study|Protocol Violation|5
5583294|NCT01014442|19293059|P1|Overall Study|Protocol Violation|2
5583295|NCT01014442|19293058|P2|Overall Study|Withdrawal by Subject|4
5583296|NCT01014442|19293059|P1|Overall Study|Withdrawal by Subject|4
5583297|NCT01014442|19293058|P2|Overall Study|Adverse Event|8
5583298|NCT01014442|19293059|P1|Overall Study|Adverse Event|0
5583299|NCT01014208|19293183|P2|Overall Study|Study Closed/terminated|83
5583300|NCT01014208|19293184|P1|Overall Study|Study Closed/terminated|78
5583301|NCT01014208|19293183|P2|Overall Study|Did Not Receive Study Drug|0
5583302|NCT01014208|19293184|P1|Overall Study|Did Not Receive Study Drug|2
5583303|NCT01014208|19293183|P2|Overall Study|Participant Withdrew Consent|12
5583304|NCT01014208|19293184|P1|Overall Study|Participant Withdrew Consent|12
5583305|NCT01014208|19293183|P2|Overall Study|Lost to Follow-up|5
5583306|NCT01014208|19293184|P1|Overall Study|Lost to Follow-up|2
5583307|NCT01014143|19293226|P3|Second Intervention|Lost to Follow-up|0
5583308|NCT01014143|19293227|P2|Second Intervention|Lost to Follow-up|0
5583309|NCT01014143|19293228|P1|Second Intervention|Lost to Follow-up|2
5583310|NCT01014013|19293323|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
5583311|NCT01014013|19293324|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
5583312|NCT01014013|19293323|P2|Overall Study|Appendectomy|0
5583313|NCT01014013|19293324|P1|Overall Study|Appendectomy|1
5583314|NCT01014013|19293323|P2|Overall Study|Another antibiotic therapy required|1
5583315|NCT01014013|19293324|P1|Overall Study|Another antibiotic therapy required|0
5583316|NCT01014013|19293323|P2|Overall Study|Physician Decision|1
5583317|NCT01014013|19293324|P1|Overall Study|Physician Decision|0
5583318|NCT01014013|19293323|P2|Overall Study|Pathogen resistant|4
5583319|NCT01014013|19293324|P1|Overall Study|Pathogen resistant|7
5583320|NCT01014013|19293323|P2|Overall Study|Negative urine culture|0
5583321|NCT01014013|19293324|P1|Overall Study|Negative urine culture|2
5583322|NCT01014013|19293323|P2|Overall Study|Pathogen culture = no growth|34
5583323|NCT01014013|19293324|P1|Overall Study|Pathogen culture = no growth|26
5583324|NCT01014013|19293323|P2|Overall Study|Clinical/microbiologic failure|2
5583325|NCT01014013|19293324|P1|Overall Study|Clinical/microbiologic failure|1
5583326|NCT01014013|19293323|P2|Overall Study|Withdrawal by Subject|4
5583327|NCT01014013|19293324|P1|Overall Study|Withdrawal by Subject|7
5583328|NCT01014013|19293323|P2|Overall Study|Protocol Violation|3
5583329|NCT01014013|19293324|P1|Overall Study|Protocol Violation|1
5583330|NCT01014013|19293323|P2|Overall Study|Laboratory adverse experience|1
5583331|NCT01014013|19293324|P1|Overall Study|Laboratory adverse experience|1
5583332|NCT01014013|19293323|P2|Overall Study|Clinical adverse experience|2
5583333|NCT01014013|19293324|P1|Overall Study|Clinical adverse experience|4
5583334|NCT01014013|19293323|P2|Overall Study|Inclusion/Exclusion criteria not met|3
5583335|NCT01014013|19293324|P1|Overall Study|Inclusion/Exclusion criteria not met|1
5583336|NCT01013961|19293336|P2|Overall Study|Physician Decision|1
5583337|NCT01013961|19293337|P1|Overall Study|Physician Decision|0
5583338|NCT01013961|19293336|P2|Overall Study|Withdrawal by Subject|0
5583339|NCT01013961|19293337|P1|Overall Study|Withdrawal by Subject|1
5583340|NCT01013961|19293336|P2|Overall Study|Adverse Event|2
5583341|NCT01013961|19293337|P1|Overall Study|Adverse Event|2
5583342|NCT01013883|19293355|P2|Overall Study|Lost to Follow-up|2
5583343|NCT01013883|19293356|P1|Overall Study|Lost to Follow-up|2
5583344|NCT01013870|19293368|P2|Overall Study|Lost to Follow-up|3
5583345|NCT01013870|19293369|P1|Overall Study|Lost to Follow-up|1
5583346|NCT01013792|19293418|P2|Overall Study|Lost to Follow-up|1
5583347|NCT01013792|19293419|P1|Overall Study|Lost to Follow-up|0
5583348|NCT01013792|19293418|P2|Overall Study|Adverse Event|3
5583349|NCT01013792|19293419|P1|Overall Study|Adverse Event|0
5583350|NCT01013792|19293418|P2|Overall Study|Study suspended|1
5583351|NCT01013792|19293419|P1|Overall Study|Study suspended|2
5583352|NCT01013753|19293425|P1|Overall Study|Other|2
5583353|NCT01013753|19293425|P1|Overall Study|Withdrawal by Subject|2
5583354|NCT01013753|19293425|P1|Overall Study|Lost to Follow-up|1
5583355|NCT01013753|19293425|P1|Overall Study|Protocol Violation|3
5583356|NCT01013753|19293425|P1|Overall Study|Adverse Event|8
5583357|NCT01013740|19293621|P2|Overall Study|Ongoing: Study records not completed|2
5583358|NCT01013740|19293622|P1|Overall Study|Ongoing: Study records not completed|0
5583359|NCT01013740|19293621|P2|Overall Study|Missing|1
5583360|NCT01013740|19293622|P1|Overall Study|Missing|2
5583361|NCT01013740|19293621|P2|Overall Study|study close / terminated : done in error|1
5583362|NCT01013740|19293622|P1|Overall Study|study close / terminated : done in error|2
5583363|NCT01013740|19293621|P2|Overall Study|Withdrawal by Subject|10
5583364|NCT01013740|19293622|P1|Overall Study|Withdrawal by Subject|2
5583365|NCT01013740|19293621|P2|Overall Study|Physician Decision|0
5583366|NCT01013740|19293622|P1|Overall Study|Physician Decision|2
5583367|NCT01013740|19293621|P2|Overall Study|Lost to Follow-up|5
5583368|NCT01013740|19293622|P1|Overall Study|Lost to Follow-up|3
5583369|NCT01013701|19293646|P1|Overall Study|study prematurely terminated|7
5583370|NCT01013597|19293653|P1|Overall Study|Withdrawal by Subject|1
5583371|NCT01013350|19293665|P2|Overall Study|Other|25
5583372|NCT01013350|19293666|P1|Overall Study|Other|1
5583373|NCT01013350|19293665|P2|Overall Study|Participant entered interventional study|8
5583374|NCT01013350|19293666|P1|Overall Study|Participant entered interventional study|0
5583375|NCT01013350|19293665|P2|Overall Study|Death|5
5583376|NCT01013350|19293666|P1|Overall Study|Death|3
5583377|NCT01013350|19293665|P2|Overall Study|Withdrawal by Subject|38
5583378|NCT01013350|19293666|P1|Overall Study|Withdrawal by Subject|15
5583379|NCT01013350|19293665|P2|Overall Study|Physician Decision|20
5583380|NCT01013350|19293666|P1|Overall Study|Physician Decision|4
5583381|NCT01013350|19293665|P2|Overall Study|Adverse Event|1
5583382|NCT01013350|19293666|P1|Overall Study|Adverse Event|0
5583383|NCT01013350|19293665|P2|Overall Study|Lost to Follow-up|95
5583384|NCT01013350|19293666|P1|Overall Study|Lost to Follow-up|15
5583385|NCT01013285|19293679|P2|Overall Study|Death|89
5583386|NCT01013285|19293680|P1|Overall Study|Death|48
5583387|NCT01013207|19293693|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
5583388|NCT01012999|19293711|P1|Overall Study|Protocol Violation|1
5583389|NCT01012973|19293717|P2|Overall Study|Withdrawal by Subject|6
5583390|NCT01012973|19293718|P1|Overall Study|Withdrawal by Subject|4
5583391|NCT01012973|19293717|P2|Overall Study|Protocol Violation|2
5583392|NCT01012973|19293718|P1|Overall Study|Protocol Violation|5
5583393|NCT01012973|19293717|P2|Overall Study|Increase in vis. acuity, never injected|1
5583394|NCT01012973|19293718|P1|Overall Study|Increase in vis. acuity, never injected|0
5583395|NCT01012973|19293717|P2|Overall Study|(Overseas travel - indefinite period)|0
5583396|NCT01012973|19293718|P1|Overall Study|(Overseas travel - indefinite period)|1
5583397|NCT01012973|19293717|P2|Overall Study|Lost to Follow-up|0
5583398|NCT01012973|19293718|P1|Overall Study|Lost to Follow-up|1
5583399|NCT01012973|19293717|P2|Overall Study|Lack of Efficacy|5
5583400|NCT01012973|19293718|P1|Overall Study|Lack of Efficacy|0
5583401|NCT01012973|19293717|P2|Overall Study|Adverse Event|5
5583402|NCT01012973|19293718|P1|Overall Study|Adverse Event|5
5583403|NCT01012947|19293743|P5|Overall Study|Lost to Follow-up|142
5583404|NCT01012947|19293744|P4|Overall Study|Lost to Follow-up|118
5583405|NCT01012947|19293745|P3|Overall Study|Lost to Follow-up|130
5583406|NCT01012947|19293746|P2|Overall Study|Lost to Follow-up|135
5583407|NCT01012947|19293747|P1|Overall Study|Lost to Follow-up|131
5583408|NCT01012765|19293768|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
5583409|NCT01012765|19293769|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
5583410|NCT01012765|19293770|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
5583411|NCT01012765|19293771|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
5583412|NCT01012765|19293772|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
5583413|NCT01012765|19293773|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
5583414|NCT01012765|19293768|P6|Treatment Period 2|Adverse Event|0
5583415|NCT01012765|19293769|P5|Treatment Period 2|Adverse Event|0
5583416|NCT01012765|19293770|P4|Treatment Period 2|Adverse Event|0
5583417|NCT01012765|19293771|P3|Treatment Period 2|Adverse Event|1
5583418|NCT01012765|19293772|P2|Treatment Period 2|Adverse Event|1
5583419|NCT01012765|19293773|P1|Treatment Period 2|Adverse Event|0
5583420|NCT01012765|19293768|P6|Treatment Period 2|Abnormal laboratory value(s)|1
5583421|NCT01012765|19293769|P5|Treatment Period 2|Abnormal laboratory value(s)|0
5583422|NCT01012765|19293770|P4|Treatment Period 2|Abnormal laboratory value(s)|0
5583423|NCT01012765|19293771|P3|Treatment Period 2|Abnormal laboratory value(s)|0
5583424|NCT01012765|19293772|P2|Treatment Period 2|Abnormal laboratory value(s)|0
5583425|NCT01012765|19293773|P1|Treatment Period 2|Abnormal laboratory value(s)|0
5583426|NCT01012765|19293768|P6|Treatment Period 2|Withdrawal by Subject|0
5583427|NCT01012765|19293769|P5|Treatment Period 2|Withdrawal by Subject|1
5583428|NCT01012765|19293770|P4|Treatment Period 2|Withdrawal by Subject|0
5583429|NCT01012765|19293771|P3|Treatment Period 2|Withdrawal by Subject|1
5583430|NCT01012765|19293772|P2|Treatment Period 2|Withdrawal by Subject|0
5583431|NCT01012765|19293773|P1|Treatment Period 2|Withdrawal by Subject|1
5583432|NCT01012765|19293768|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
5583433|NCT01012765|19293769|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
5583434|NCT01012765|19293770|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
5583435|NCT01012765|19293771|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
5583436|NCT01012765|19293772|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
5583437|NCT01012765|19293773|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
5583438|NCT01012765|19293768|P6|Treatment Period 1|Protocol Violation|0
5583439|NCT01012765|19293769|P5|Treatment Period 1|Protocol Violation|1
5583440|NCT01012765|19293770|P4|Treatment Period 1|Protocol Violation|2
5583441|NCT01012765|19293771|P3|Treatment Period 1|Protocol Violation|0
5583442|NCT01012765|19293772|P2|Treatment Period 1|Protocol Violation|0
5583443|NCT01012765|19293773|P1|Treatment Period 1|Protocol Violation|0
5583444|NCT01012765|19293768|P6|Treatment Period 1|Administrative problems|0
5583445|NCT01012765|19293769|P5|Treatment Period 1|Administrative problems|1
5583446|NCT01012765|19293770|P4|Treatment Period 1|Administrative problems|1
5583447|NCT01012765|19293771|P3|Treatment Period 1|Administrative problems|1
5583448|NCT01012765|19293772|P2|Treatment Period 1|Administrative problems|0
5583449|NCT01012765|19293773|P1|Treatment Period 1|Administrative problems|0
5583450|NCT01012765|19293768|P6|Treatment Period 1|Withdrawal by Subject|0
5583451|NCT01012765|19293769|P5|Treatment Period 1|Withdrawal by Subject|0
5583452|NCT01012765|19293770|P4|Treatment Period 1|Withdrawal by Subject|0
5583453|NCT01012765|19293771|P3|Treatment Period 1|Withdrawal by Subject|0
5583454|NCT01012765|19293772|P2|Treatment Period 1|Withdrawal by Subject|0
5583455|NCT01012765|19293773|P1|Treatment Period 1|Withdrawal by Subject|2
5583456|NCT01012765|19293768|P6|Treatment Period 1|Adverse Event|0
5583457|NCT01012765|19293769|P5|Treatment Period 1|Adverse Event|0
5583458|NCT01012765|19293770|P4|Treatment Period 1|Adverse Event|0
5583459|NCT01012765|19293771|P3|Treatment Period 1|Adverse Event|1
5583460|NCT01012765|19293772|P2|Treatment Period 1|Adverse Event|0
5583461|NCT01012765|19293773|P1|Treatment Period 1|Adverse Event|1
5583462|NCT01012739|19293802|P4|Treatment Period 2|Abnormal test procedure results|1
5583463|NCT01012739|19293803|P3|Treatment Period 2|Abnormal test procedure results|0
5583464|NCT01012739|19293804|P2|Treatment Period 2|Abnormal test procedure results|0
5583465|NCT01012739|19293805|P1|Treatment Period 2|Abnormal test procedure results|0
5583466|NCT01012739|19293802|P4|Treatment Period 1|Adverse Event|1
5583467|NCT01012739|19293803|P3|Treatment Period 1|Adverse Event|0
5583468|NCT01012739|19293804|P2|Treatment Period 1|Adverse Event|0
5583469|NCT01012739|19293805|P1|Treatment Period 1|Adverse Event|0
5583470|NCT01012713|19293833|P1|Overall Study|Lack of Efficacy|3
5583471|NCT01012622|19293859|P1|Overall Study|withdrawal of consent by a parent|2
5583472|NCT01012622|19293859|P1|Overall Study|screening failure|1
5583473|NCT01012622|19293859|P1|Overall Study|Other|1
5583474|NCT01012622|19293859|P1|Overall Study|non-compliance with the drug|9
5583475|NCT01012622|19293859|P1|Overall Study|Adverse Event|7
5583476|NCT01012622|19293859|P1|Overall Study|Lost to Follow-up|5
5583477|NCT01012622|19293859|P1|Overall Study|Withdrawal by Subject|6
5583478|NCT01012440|19293885|P1|Overall Study|Withdrawal by Subject|2
5583479|NCT01012414|19293889|P1|Overall Study|Trial was stopped before completed|7
5583480|NCT01012414|19293889|P1|Overall Study|Lost to Follow-up|1
5583481|NCT01012414|19293889|P1|Overall Study|Withdrawal by Subject|2
5583482|NCT01012323|19293930|P1|Overall Study|Investigator Judgment|1
5583483|NCT01012258|19293967|P1|Overall Study|Ongoing|29
5583484|NCT01012258|19293967|P1|Overall Study|Another Tumor Discovered|1
5583485|NCT01012258|19293967|P1|Overall Study|Another Anti-cancer Drug Received|1
5583486|NCT01012258|19293967|P1|Overall Study|Symptomatic Deterioration|1
5583487|NCT01012258|19293967|P1|Overall Study|Progressive Disease (PD)|18
5583488|NCT01012258|19293967|P1|Overall Study|Adverse Event|1
5583489|NCT01012258|19293967|P1|Overall Study|Lost to Follow-up|1
5583490|NCT01012258|19293967|P1|Overall Study|Death|14
5583491|NCT01012219|19294014|P1|Period 2|Withdrawal by Subject|1
5583492|NCT01012219|19294014|P1|Period 1|Withdrawal by Subject|1
5583493|NCT01012037|19294305|P3|Overall Study|Other reason (not specified)|1
5583494|NCT01012037|19294306|P2|Overall Study|Other reason (not specified)|1
5583495|NCT01012037|19294307|P1|Overall Study|Other reason (not specified)|1
5583496|NCT01012037|19294305|P3|Overall Study|Withdrawal by Subject|1
5583497|NCT01012037|19294306|P2|Overall Study|Withdrawal by Subject|4
5583498|NCT01012037|19294307|P1|Overall Study|Withdrawal by Subject|0
5583499|NCT01012037|19294305|P3|Overall Study|Protocol Violation|5
5583500|NCT01012037|19294306|P2|Overall Study|Protocol Violation|3
5583501|NCT01012037|19294307|P1|Overall Study|Protocol Violation|0
5583502|NCT01012037|19294305|P3|Overall Study|Adverse Event|3
5583503|NCT01012037|19294306|P2|Overall Study|Adverse Event|8
5583504|NCT01012037|19294307|P1|Overall Study|Adverse Event|0
5583505|NCT01011946|19294342|P1|Overall Study|No pathological lab value|1
5583506|NCT01011946|19294342|P1|Overall Study|Transferred to another hospital|2
5583507|NCT01011933|19294346|P1|Overall Study|Never treated|1
5583508|NCT01011933|19294346|P1|Overall Study|Inadequate pathology|1
5583509|NCT01011933|19294346|P1|Overall Study|Improper pre-protocol Rx|1
5583510|NCT01011933|19294346|P1|Overall Study|Wrong cell type|1
5583511|NCT01011907|19294363|P2|Overall Study|Adverse Event|4
5583512|NCT01011907|19294364|P1|Overall Study|Adverse Event|1
5583513|NCT01011907|19294363|P2|Overall Study|Withdrawal by Subject|11
5583514|NCT01011907|19294364|P1|Overall Study|Withdrawal by Subject|13
5583515|NCT01011868|19294381|P3|After Week 78 Follow-up|Other reason not defined above|16
5583516|NCT01011868|19294382|P2|After Week 78 Follow-up|Other reason not defined above|5
5583517|NCT01011868|19294383|P1|After Week 78 Follow-up|Other reason not defined above|5
5583518|NCT01011868|19294381|P3|After Week 78 Follow-up|Withdrawal by Subject|1
5583519|NCT01011868|19294382|P2|After Week 78 Follow-up|Withdrawal by Subject|8
5583520|NCT01011868|19294383|P1|After Week 78 Follow-up|Withdrawal by Subject|9
5583521|NCT01011868|19294381|P3|After Week 78 Follow-up|Lost to Follow-up|4
5583522|NCT01011868|19294382|P2|After Week 78 Follow-up|Lost to Follow-up|6
5583523|NCT01011868|19294383|P1|After Week 78 Follow-up|Lost to Follow-up|11
5583524|NCT01011868|19294381|P3|After Week 78 Follow-up|Protocol Violation|2
5583525|NCT01011868|19294382|P2|After Week 78 Follow-up|Protocol Violation|1
5583526|NCT01011868|19294383|P1|After Week 78 Follow-up|Protocol Violation|9
5583527|NCT01011868|19294381|P3|After Week 78 Follow-up|Lack of Efficacy|0
5583528|NCT01011868|19294382|P2|After Week 78 Follow-up|Lack of Efficacy|0
5583529|NCT01011868|19294383|P1|After Week 78 Follow-up|Lack of Efficacy|4
5583530|NCT01011868|19294381|P3|After Week 78 Follow-up|Adverse Event|21
5583531|NCT01011868|19294382|P2|After Week 78 Follow-up|Adverse Event|18
5583532|NCT01011868|19294383|P1|After Week 78 Follow-up|Adverse Event|14
5583533|NCT01011868|19294381|P3|After Week 18 Follow-up|Other reason not defined above|12
5583534|NCT01011868|19294382|P2|After Week 18 Follow-up|Other reason not defined above|3
5583535|NCT01011868|19294383|P1|After Week 18 Follow-up|Other reason not defined above|2
5583536|NCT01011868|19294381|P3|After Week 18 Follow-up|Withdrawal by Subject|0
5583537|NCT01011868|19294382|P2|After Week 18 Follow-up|Withdrawal by Subject|3
5583538|NCT01011868|19294383|P1|After Week 18 Follow-up|Withdrawal by Subject|6
5583539|NCT01011868|19294381|P3|After Week 18 Follow-up|Lost to Follow-up|0
5583540|NCT01011868|19294382|P2|After Week 18 Follow-up|Lost to Follow-up|3
5583541|NCT01011868|19294383|P1|After Week 18 Follow-up|Lost to Follow-up|5
5583542|NCT01011868|19294381|P3|After Week 18 Follow-up|Protocol Violation|1
5583543|NCT01011868|19294382|P2|After Week 18 Follow-up|Protocol Violation|1
5583544|NCT01011868|19294383|P1|After Week 18 Follow-up|Protocol Violation|1
5583545|NCT01011868|19294381|P3|After Week 18 Follow-up|Lack of Efficacy|0
5583546|NCT01011868|19294382|P2|After Week 18 Follow-up|Lack of Efficacy|0
5583547|NCT01011868|19294383|P1|After Week 18 Follow-up|Lack of Efficacy|1
5583548|NCT01011868|19294381|P3|After Week 18 Follow-up|Adverse Event|13
5583549|NCT01011868|19294382|P2|After Week 18 Follow-up|Adverse Event|6
5583550|NCT01011868|19294383|P1|After Week 18 Follow-up|Adverse Event|8
5583551|NCT01011738|19294445|P3|Overall Study|Unknown reasons|17
5583552|NCT01011738|19294446|P2|Overall Study|Unknown reasons|291
5583553|NCT01011738|19294447|P1|Overall Study|Unknown reasons|312
5583554|NCT01011738|19294445|P3|Overall Study|Death|0
5583555|NCT01011738|19294446|P2|Overall Study|Death|3
5583556|NCT01011738|19294447|P1|Overall Study|Death|12
5583557|NCT01011673|19294487|P2|24 Hour Follow-up|Lost to Follow-up|3
5583558|NCT01011673|19294488|P1|24 Hour Follow-up|Lost to Follow-up|3
5583559|NCT01011673|19294487|P2|Randomized|Secondary headache|1
5583560|NCT01011673|19294488|P1|Randomized|Secondary headache|2
5583561|NCT01011556|19294511|P4|Overall Study|Inclusion/exclusion criteria not met|5
5583562|NCT01011556|19294512|P3|Overall Study|Inclusion/exclusion criteria not met|3
5583563|NCT01011556|19294513|P2|Overall Study|Inclusion/exclusion criteria not met|1
5583564|NCT01011556|19294514|P1|Overall Study|Inclusion/exclusion criteria not met|2
5583565|NCT01011556|19294511|P4|Overall Study|Sponsor decision|2
5583566|NCT01011556|19294512|P3|Overall Study|Sponsor decision|1
5583567|NCT01011556|19294513|P2|Overall Study|Sponsor decision|1
5583568|NCT01011556|19294514|P1|Overall Study|Sponsor decision|0
5583569|NCT01011556|19294511|P4|Overall Study|Withdrawal by Subject|4
5583570|NCT01011556|19294512|P3|Overall Study|Withdrawal by Subject|4
5583571|NCT01011556|19294513|P2|Overall Study|Withdrawal by Subject|2
5583572|NCT01011556|19294514|P1|Overall Study|Withdrawal by Subject|1
5583573|NCT01011556|19294511|P4|Overall Study|Protocol Violation|0
5583574|NCT01011556|19294512|P3|Overall Study|Protocol Violation|0
5583575|NCT01011556|19294513|P2|Overall Study|Protocol Violation|1
5583576|NCT01011556|19294514|P1|Overall Study|Protocol Violation|0
5583577|NCT01011556|19294511|P4|Overall Study|Physician Decision|1
5583578|NCT01011556|19294512|P3|Overall Study|Physician Decision|0
5583579|NCT01011556|19294513|P2|Overall Study|Physician Decision|0
5583580|NCT01011556|19294514|P1|Overall Study|Physician Decision|1
5583581|NCT01011556|19294511|P4|Overall Study|Lost to Follow-up|0
5583582|NCT01011556|19294512|P3|Overall Study|Lost to Follow-up|0
5583583|NCT01011556|19294513|P2|Overall Study|Lost to Follow-up|0
5583584|NCT01011556|19294514|P1|Overall Study|Lost to Follow-up|1
5583585|NCT01011556|19294511|P4|Overall Study|Adverse Event|1
5583586|NCT01011556|19294512|P3|Overall Study|Adverse Event|2
5583587|NCT01011556|19294513|P2|Overall Study|Adverse Event|3
5583588|NCT01011556|19294514|P1|Overall Study|Adverse Event|1
5583589|NCT01011465|19294592|P8|Overall Study|Withdrawal by Subject|0
5583590|NCT01011465|19294593|P7|Overall Study|Withdrawal by Subject|1
5583591|NCT01011465|19294594|P6|Overall Study|Withdrawal by Subject|0
5583592|NCT01011465|19294595|P5|Overall Study|Withdrawal by Subject|1
5583593|NCT01011465|19294596|P4|Overall Study|Withdrawal by Subject|0
5583594|NCT01011465|19294597|P3|Overall Study|Withdrawal by Subject|0
5583595|NCT01011465|19294598|P2|Overall Study|Withdrawal by Subject|1
5583596|NCT01011465|19294599|P1|Overall Study|Withdrawal by Subject|2
5583597|NCT01011439|19294627|P1|Overall Study|Sponsor's decision|15
5583598|NCT01011439|19294627|P1|Overall Study|Withdrawal by Subject|1
5583599|NCT01011439|19294627|P1|Overall Study|Lost to Follow-up|4
5583600|NCT01011439|19294627|P1|Overall Study|Death|37
5583601|NCT01011387|19294664|P1|Overall Study|Protocol Violation|1
5583602|NCT01011387|19294664|P1|Overall Study|Adverse Event|2
5583603|NCT01011387|19294664|P1|Overall Study|Withdrawal by Subject|3
5583604|NCT01011335|19294672|P13|Overall Study|Adverse Event|1
5583605|NCT01011335|19294673|P12|Overall Study|Adverse Event|0
5583606|NCT01011335|19294674|P11|Overall Study|Adverse Event|4
5583607|NCT01011335|19294675|P10|Overall Study|Adverse Event|0
5583608|NCT01011335|19294676|P9|Overall Study|Adverse Event|0
5583609|NCT01011335|19294677|P8|Overall Study|Adverse Event|0
5583610|NCT01011335|19294678|P7|Overall Study|Adverse Event|0
5583611|NCT01011335|19294679|P6|Overall Study|Adverse Event|0
5583612|NCT01011335|19294680|P5|Overall Study|Adverse Event|0
5583613|NCT01011335|19294681|P4|Overall Study|Adverse Event|0
5583614|NCT01011335|19294682|P3|Overall Study|Adverse Event|0
5583615|NCT01011335|19294683|P2|Overall Study|Adverse Event|0
5583616|NCT01011335|19294684|P1|Overall Study|Adverse Event|0
5583617|NCT01011335|19294672|P13|Overall Study|Moved/deployed or no booster|0
5583618|NCT01011335|19294673|P12|Overall Study|Moved/deployed or no booster|0
5583619|NCT01011335|19294674|P11|Overall Study|Moved/deployed or no booster|2
5583620|NCT01011335|19294675|P10|Overall Study|Moved/deployed or no booster|0
5583621|NCT01011335|19294676|P9|Overall Study|Moved/deployed or no booster|1
5583622|NCT01011335|19294677|P8|Overall Study|Moved/deployed or no booster|0
5583623|NCT01011335|19294678|P7|Overall Study|Moved/deployed or no booster|1
5583624|NCT01011335|19294679|P6|Overall Study|Moved/deployed or no booster|0
5583625|NCT01011335|19294680|P5|Overall Study|Moved/deployed or no booster|0
5583626|NCT01011335|19294681|P4|Overall Study|Moved/deployed or no booster|1
5583627|NCT01011335|19294682|P3|Overall Study|Moved/deployed or no booster|0
5583628|NCT01011335|19294683|P2|Overall Study|Moved/deployed or no booster|0
5583629|NCT01011335|19294684|P1|Overall Study|Moved/deployed or no booster|1
5583630|NCT01011335|19294672|P13|Overall Study|Protocol Violation|0
5583631|NCT01011335|19294673|P12|Overall Study|Protocol Violation|0
5583632|NCT01011335|19294674|P11|Overall Study|Protocol Violation|0
5583633|NCT01011335|19294675|P10|Overall Study|Protocol Violation|0
5583634|NCT01011335|19294676|P9|Overall Study|Protocol Violation|0
5583635|NCT01011335|19294677|P8|Overall Study|Protocol Violation|0
5583636|NCT01011335|19294678|P7|Overall Study|Protocol Violation|0
5583637|NCT01011335|19294679|P6|Overall Study|Protocol Violation|0
5583638|NCT01011335|19294680|P5|Overall Study|Protocol Violation|0
5583639|NCT01011335|19294681|P4|Overall Study|Protocol Violation|0
5583640|NCT01011335|19294682|P3|Overall Study|Protocol Violation|0
5583641|NCT01011335|19294683|P2|Overall Study|Protocol Violation|1
5583642|NCT01011335|19294684|P1|Overall Study|Protocol Violation|0
5583643|NCT01011335|19294672|P13|Overall Study|Lost to Follow-up|2
5583644|NCT01011335|19294673|P12|Overall Study|Lost to Follow-up|1
5583645|NCT01011335|19294674|P11|Overall Study|Lost to Follow-up|0
5583646|NCT01011335|19294675|P10|Overall Study|Lost to Follow-up|0
5583647|NCT01011335|19294676|P9|Overall Study|Lost to Follow-up|1
5583648|NCT01011335|19294677|P8|Overall Study|Lost to Follow-up|2
5583649|NCT01011335|19294678|P7|Overall Study|Lost to Follow-up|2
5583650|NCT01011335|19294679|P6|Overall Study|Lost to Follow-up|1
5583651|NCT01011335|19294680|P5|Overall Study|Lost to Follow-up|1
5583652|NCT01011335|19294681|P4|Overall Study|Lost to Follow-up|1
5583653|NCT01011335|19294682|P3|Overall Study|Lost to Follow-up|1
5583654|NCT01011335|19294683|P2|Overall Study|Lost to Follow-up|0
5583655|NCT01011335|19294684|P1|Overall Study|Lost to Follow-up|0
5583656|NCT01011309|19294724|P3|Overall Study|Protocol Violation|3
5583657|NCT01011309|19294725|P2|Overall Study|Protocol Violation|1
5583658|NCT01011309|19294726|P1|Overall Study|Protocol Violation|0
5583659|NCT01011309|19294724|P3|Overall Study|Lack of Efficacy|0
5583660|NCT01011309|19294725|P2|Overall Study|Lack of Efficacy|1
5583661|NCT01011309|19294726|P1|Overall Study|Lack of Efficacy|0
5583662|NCT01011309|19294724|P3|Overall Study|Adverse Event|2
5583663|NCT01011309|19294725|P2|Overall Study|Adverse Event|1
5583664|NCT01011309|19294726|P1|Overall Study|Adverse Event|2
5583665|NCT01011283|19294742|P2|Overall Study|Other|2
5583666|NCT01011283|19294743|P1|Overall Study|Other|2
5583667|NCT01011283|19294742|P2|Overall Study|Terminated by Sponsor|5
5583668|NCT01011283|19294743|P1|Overall Study|Terminated by Sponsor|5
5583669|NCT01011283|19294742|P2|Overall Study|Progressive Disease|2
5583670|NCT01011283|19294743|P1|Overall Study|Progressive Disease|0
5583671|NCT01011283|19294742|P2|Overall Study|Adverse Event|2
5583672|NCT01011283|19294743|P1|Overall Study|Adverse Event|4
5583673|NCT01011153|19294792|P3|Overall Study|Less than 78 cases completed|9
5583674|NCT01011153|19294793|P2|Overall Study|Less than 78 cases completed|11
5583675|NCT01011153|19294794|P1|Overall Study|Less than 78 cases completed|8
5583676|NCT01011049|19294823|P4|Overall Study|Withdrawal by Subject|0
5583677|NCT01011049|19294824|P3|Overall Study|Withdrawal by Subject|1
5583678|NCT01011049|19294825|P2|Overall Study|Withdrawal by Subject|0
5583679|NCT01011049|19294826|P1|Overall Study|Withdrawal by Subject|0
5583680|NCT01011049|19294823|P4|Overall Study|Lost to Follow-up|0
5583681|NCT01011049|19294824|P3|Overall Study|Lost to Follow-up|1
5583682|NCT01011049|19294825|P2|Overall Study|Lost to Follow-up|2
5583683|NCT01011049|19294826|P1|Overall Study|Lost to Follow-up|1
5583684|NCT01011049|19294823|P4|Overall Study|Protocol Violation|0
5583685|NCT01011049|19294824|P3|Overall Study|Protocol Violation|2
5583686|NCT01011049|19294825|P2|Overall Study|Protocol Violation|0
5583687|NCT01011049|19294826|P1|Overall Study|Protocol Violation|0
5583688|NCT01010971|19294856|P3|Overall Study|Other|2
5583689|NCT01010971|19294857|P2|Overall Study|Other|0
5583690|NCT01010971|19294858|P1|Overall Study|Other|1
5583691|NCT01010971|19294856|P3|Overall Study|Lost to Follow-up|3
5583692|NCT01010971|19294857|P2|Overall Study|Lost to Follow-up|2
5583693|NCT01010971|19294858|P1|Overall Study|Lost to Follow-up|0
5583694|NCT01010971|19294856|P3|Overall Study|Withdrawal by Subject|5
5583695|NCT01010971|19294857|P2|Overall Study|Withdrawal by Subject|2
5583696|NCT01010971|19294858|P1|Overall Study|Withdrawal by Subject|0
5583697|NCT01010971|19294856|P3|Overall Study|Adverse Event|3
5583698|NCT01010971|19294857|P2|Overall Study|Adverse Event|4
5583699|NCT01010971|19294858|P1|Overall Study|Adverse Event|2
5583700|NCT01010867|19294986|P1|Overall Study|< 50% adherence to probiotic|1
5583701|NCT01010776|19294998|P1|Extension Phase|Other|3
5583702|NCT01010776|19294998|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
5583703|NCT01010776|19294998|P1|Main Phase|Did not received study medication|5
5583704|NCT01010776|19294998|P1|Main Phase|Other|1
5583705|NCT01010776|19294998|P1|Main Phase|Inform consent withdrawal|1
5583706|NCT01010776|19294998|P1|Main Phase|Selection failure|2
5583707|NCT01010776|19294998|P1|Main Phase|Non-compliance to study medication|5
5583708|NCT01010776|19294998|P1|Main Phase|Lost to Follow-up|6
5583709|NCT01010776|19294998|P1|Main Phase|Adverse Event|7
5583710|NCT01010776|19294998|P1|Main Phase|Lack of Efficacy|8
5583711|NCT01010776|19294998|P1|Main Phase|Withdrawal by Subject|14
5583712|NCT01010750|19295055|P6|Second Intervention|Adverse Event|0
5583713|NCT01010750|19295056|P5|Second Intervention|Adverse Event|0
5583714|NCT01010750|19295057|P4|Second Intervention|Adverse Event|0
5583715|NCT01010750|19295058|P3|Second Intervention|Adverse Event|0
5583716|NCT01010750|19295059|P2|Second Intervention|Adverse Event|1
5583717|NCT01010750|19295060|P1|Second Intervention|Adverse Event|0
5583718|NCT01010633|19295085|P2|Overall Study|Investigator decision|1
5583719|NCT01010633|19295086|P1|Overall Study|Investigator decision|0
5583720|NCT01010633|19295085|P2|Overall Study|Withdrawal by Subject|1
5583721|NCT01010633|19295086|P1|Overall Study|Withdrawal by Subject|2
5583722|NCT01010633|19295085|P2|Overall Study|Protocol Violation|2
5583723|NCT01010633|19295086|P1|Overall Study|Protocol Violation|1
5583724|NCT01010633|19295085|P2|Overall Study|Adverse Event|1
5583725|NCT01010633|19295086|P1|Overall Study|Adverse Event|1
5583726|NCT01010503|19295113|P1|Overall Study|Death|1
5583727|NCT01010503|19295113|P1|Overall Study|Adverse Event|1
5583728|NCT01010230|19295172|P2|Overall Study|Lost to Follow-up|2
5583729|NCT01010230|19295173|P1|Overall Study|Lost to Follow-up|4
5583730|NCT01010230|19295172|P2|Overall Study|Withdrawal by Subject|5
5583731|NCT01010230|19295173|P1|Overall Study|Withdrawal by Subject|6
5583732|NCT01010217|19295208|P5|Overall Study|Physician Decision|3
5583733|NCT01010217|19295209|P4|Overall Study|Physician Decision|6
5583734|NCT01010217|19295210|P3|Overall Study|Physician Decision|0
5583735|NCT01010217|19295211|P2|Overall Study|Physician Decision|0
5583736|NCT01010217|19295212|P1|Overall Study|Physician Decision|0
5583737|NCT01010217|19295208|P5|Overall Study|Withdrawal by Subject|0
5583738|NCT01010217|19295209|P4|Overall Study|Withdrawal by Subject|0
5583739|NCT01010217|19295210|P3|Overall Study|Withdrawal by Subject|0
5583740|NCT01010217|19295211|P2|Overall Study|Withdrawal by Subject|0
5583741|NCT01010217|19295212|P1|Overall Study|Withdrawal by Subject|1
5583742|NCT01010217|19295208|P5|Overall Study|Lost to Follow-up|0
5583743|NCT01010217|19295209|P4|Overall Study|Lost to Follow-up|0
5583744|NCT01010217|19295210|P3|Overall Study|Lost to Follow-up|1
5583745|NCT01010217|19295211|P2|Overall Study|Lost to Follow-up|5
5583746|NCT01010217|19295212|P1|Overall Study|Lost to Follow-up|4
5583747|NCT01010204|19295251|P2|Overall Study|psychiatric hospitalization|1
5583748|NCT01010204|19295252|P1|Overall Study|psychiatric hospitalization|2
5583749|NCT01010204|19295251|P2|Overall Study|Withdrawal by Subject|3
5583750|NCT01010204|19295252|P1|Overall Study|Withdrawal by Subject|2
5583751|NCT01010204|19295251|P2|Overall Study|Adverse Event|3
5583752|NCT01010204|19295252|P1|Overall Study|Adverse Event|1
5583753|NCT01010204|19295251|P2|Overall Study|Lost to Follow-up|2
5583754|NCT01010204|19295252|P1|Overall Study|Lost to Follow-up|2
5583755|NCT01010126|19295268|P6|Overall Study|Withdrawal by Subject|0
5583756|NCT01010126|19295269|P5|Overall Study|Withdrawal by Subject|3
5583757|NCT01010126|19295270|P4|Overall Study|Withdrawal by Subject|0
5583758|NCT01010126|19295271|P3|Overall Study|Withdrawal by Subject|1
5583759|NCT01010126|19295272|P2|Overall Study|Withdrawal by Subject|0
5583760|NCT01010126|19295273|P1|Overall Study|Withdrawal by Subject|1
5583761|NCT01010061|19295325|P2|Overall Study|Did Not Receive Treatment|2
5583762|NCT01010061|19295326|P1|Overall Study|Did Not Receive Treatment|2
5583763|NCT01010061|19295325|P2|Overall Study|Violation of Selection Criteria|1
5583764|NCT01010061|19295326|P1|Overall Study|Violation of Selection Criteria|0
5583765|NCT01010061|19295325|P2|Overall Study|Insufficient Therapeutic Response|5
5583766|NCT01010061|19295326|P1|Overall Study|Insufficient Therapeutic Response|1
5583767|NCT01010061|19295325|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
5583768|NCT01010061|19295326|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
5583769|NCT01010061|19295325|P2|Overall Study|Administrative/Other|1
5583770|NCT01010061|19295326|P1|Overall Study|Administrative/Other|0
5583771|NCT01010061|19295325|P2|Overall Study|Death|6
5583772|NCT01010061|19295326|P1|Overall Study|Death|3
5583773|NCT01010061|19295325|P2|Overall Study|Withdrew Consent|1
5583774|NCT01010061|19295326|P1|Overall Study|Withdrew Consent|5
5583775|NCT01010061|19295325|P2|Overall Study|Disease Progression|8
5583776|NCT01010061|19295326|P1|Overall Study|Disease Progression|2
5583777|NCT01010061|19295325|P2|Overall Study|Adverse Events or Intercurrent Illness|16
5583778|NCT01010061|19295326|P1|Overall Study|Adverse Events or Intercurrent Illness|33
5583779|NCT01009983|19295377|P1|Overall Study|necessary scans not completed|1
5583780|NCT01009840|19295390|P1|Overall Study|Subject Withdrew Consent to Participate|1
5583781|NCT01009840|19295390|P1|Overall Study|Subject was Withdrawn by Investigator|1
5583782|NCT01009840|19295390|P1|Overall Study|Subject Met Withdrawal Criteria|7
5583783|NCT01009840|19295390|P1|Overall Study|Adverse Event|4
5583784|NCT01009840|19295390|P1|Overall Study|Lost to Follow-up|1
5583785|NCT01009814|19295408|P5|Overall Study|No longer met study criteria|0
5583786|NCT01009814|19295409|P4|Overall Study|No longer met study criteria|0
5583787|NCT01009814|19295410|P3|Overall Study|No longer met study criteria|0
5583788|NCT01009814|19295411|P2|Overall Study|No longer met study criteria|1
5583789|NCT01009814|19295412|P1|Overall Study|No longer met study criteria|1
5583790|NCT01009645|19295536|P4|Overall Study|Lost to Follow-up|5
5583791|NCT01009645|19295537|P3|Overall Study|Lost to Follow-up|4
5583792|NCT01009645|19295538|P2|Overall Study|Lost to Follow-up|8
5583793|NCT01009645|19295539|P1|Overall Study|Lost to Follow-up|2
5583794|NCT01009580|19295576|P2|Overall Study|Unclassified|21
5583795|NCT01009580|19295577|P1|Overall Study|Unclassified|17
5583796|NCT01009580|19295576|P2|Overall Study|Withdrawal Criteria|6
5583797|NCT01009580|19295577|P1|Overall Study|Withdrawal Criteria|4
5583798|NCT01009580|19295576|P2|Overall Study|Protocol Violation|3
5583799|NCT01009580|19295577|P1|Overall Study|Protocol Violation|2
5583800|NCT01009580|19295576|P2|Overall Study|Lack of Efficacy|1
5583801|NCT01009580|19295577|P1|Overall Study|Lack of Efficacy|0
5583802|NCT01009580|19295576|P2|Overall Study|Adverse Event|4
5583803|NCT01009580|19295577|P1|Overall Study|Adverse Event|4
5583804|NCT01009554|19295591|P2|Overall Study|Noncompliant with Study Product|3
5583805|NCT01009554|19295592|P1|Overall Study|Noncompliant with Study Product|0
5583806|NCT01009554|19295591|P2|Overall Study|Withdrawal by Subject|3
5583807|NCT01009554|19295592|P1|Overall Study|Withdrawal by Subject|1
5583808|NCT01009554|19295591|P2|Overall Study|Adverse Event|1
5583809|NCT01009554|19295592|P1|Overall Study|Adverse Event|1
5583810|NCT01009515|19295724|P1|Overall Study|Withdrawal by Subject|3
5583811|NCT01009463|19295735|P5|52-week, Double-blind Treatment Period|Physician Decision|8
5583812|NCT01009463|19295736|P4|52-week, Double-blind Treatment Period|Physician Decision|6
5583813|NCT01009463|19295737|P3|52-week, Double-blind Treatment Period|Physician Decision|6
5583814|NCT01009463|19295738|P2|52-week, Double-blind Treatment Period|Physician Decision|4
5583815|NCT01009463|19295739|P1|52-week, Double-blind Treatment Period|Physician Decision|0
5583816|NCT01009463|19295735|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
5583817|NCT01009463|19295736|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
5583818|NCT01009463|19295737|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
5583819|NCT01009463|19295738|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
5583820|NCT01009463|19295739|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
5583821|NCT01009463|19295735|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5583822|NCT01009463|19295736|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
5583823|NCT01009463|19295737|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5583824|NCT01009463|19295738|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
5583825|NCT01009463|19295739|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
5583826|NCT01009463|19295735|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
5583827|NCT01009463|19295736|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
5583828|NCT01009463|19295737|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
5583829|NCT01009463|19295738|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
5583830|NCT01009463|19295739|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
5583831|NCT01009463|19295735|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
5583832|NCT01009463|19295736|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
5583833|NCT01009463|19295737|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
5583834|NCT01009463|19295738|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
5583835|NCT01009463|19295739|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
5583836|NCT01009463|19295735|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
5583837|NCT01009463|19295736|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
5583838|NCT01009463|19295737|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
5583839|NCT01009463|19295738|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
5583840|NCT01009463|19295739|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
5583841|NCT01009463|19295735|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
5583842|NCT01009463|19295736|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
5583843|NCT01009463|19295737|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
5583844|NCT01009463|19295738|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
5583845|NCT01009463|19295739|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
5583846|NCT01009463|19295735|P5|52-week, Double-blind Treatment Period|Adverse Event|31
5583847|NCT01009463|19295736|P4|52-week, Double-blind Treatment Period|Adverse Event|29
5583848|NCT01009463|19295737|P3|52-week, Double-blind Treatment Period|Adverse Event|25
5583849|NCT01009463|19295738|P2|52-week, Double-blind Treatment Period|Adverse Event|22
5583850|NCT01009463|19295739|P1|52-week, Double-blind Treatment Period|Adverse Event|0
5583851|NCT01009463|19295735|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5583852|NCT01009463|19295736|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5583853|NCT01009463|19295737|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5583854|NCT01009463|19295738|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
5583855|NCT01009463|19295739|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
5583856|NCT01009463|19295735|P5|4-week, Open-label Run-In Period|Physician Decision|0
5583857|NCT01009463|19295736|P4|4-week, Open-label Run-In Period|Physician Decision|0
5583858|NCT01009463|19295737|P3|4-week, Open-label Run-In Period|Physician Decision|0
5583859|NCT01009463|19295738|P2|4-week, Open-label Run-In Period|Physician Decision|0
5583860|NCT01009463|19295739|P1|4-week, Open-label Run-In Period|Physician Decision|10
5583861|NCT01009463|19295735|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
5583862|NCT01009463|19295736|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
5583863|NCT01009463|19295737|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
5583864|NCT01009463|19295738|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
5583865|NCT01009463|19295739|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
5583866|NCT01009463|19295735|P5|4-week, Open-label Run-In Period|Adverse Event|0
5583867|NCT01009463|19295736|P4|4-week, Open-label Run-In Period|Adverse Event|0
5583868|NCT01009463|19295737|P3|4-week, Open-label Run-In Period|Adverse Event|0
5583869|NCT01009463|19295738|P2|4-week, Open-label Run-In Period|Adverse Event|0
5583870|NCT01009463|19295739|P1|4-week, Open-label Run-In Period|Adverse Event|10
5583871|NCT01009463|19295735|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5583872|NCT01009463|19295736|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5583873|NCT01009463|19295737|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5583874|NCT01009463|19295738|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
5583875|NCT01009463|19295739|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
5583876|NCT01009346|19295761|P1|Overall Study|Adverse Event|4
5583877|NCT01009294|19295785|P1|Overall Study|Study discontinued by Sponsor|6
5583878|NCT01009203|19295806|P1|Overall Study|Treatment-unrelated death|1
5583879|NCT01009203|19295806|P1|Overall Study|Adverse Event|5
5583880|NCT01009203|19295806|P1|Overall Study|Withdrawal by Subject|1
5583881|NCT01009099|19295846|P2|Overall Study|Death|1
5583882|NCT01009099|19295847|P1|Overall Study|Death|0
5583883|NCT01009099|19295846|P2|Overall Study|Withdrawal by Subject|1
5583884|NCT01009099|19295847|P1|Overall Study|Withdrawal by Subject|1
5583885|NCT01009099|19295846|P2|Overall Study|Physician Decision|2
5583886|NCT01009099|19295847|P1|Overall Study|Physician Decision|3
5583887|NCT01009099|19295846|P2|Overall Study|Lost to Follow-up|0
5583888|NCT01009099|19295847|P1|Overall Study|Lost to Follow-up|1
5583889|NCT01009086|19295856|P3|Overall Study|Other|1
5583890|NCT01009086|19295857|P2|Overall Study|Other|5
5583891|NCT01009086|19295858|P1|Overall Study|Other|3
5583892|NCT01009086|19295856|P3|Overall Study|Withdrawal by Subject|13
5583893|NCT01009086|19295857|P2|Overall Study|Withdrawal by Subject|11
5583894|NCT01009086|19295858|P1|Overall Study|Withdrawal by Subject|9
5583895|NCT01009086|19295856|P3|Overall Study|Adverse Event|8
5583896|NCT01009086|19295857|P2|Overall Study|Adverse Event|11
5583897|NCT01009086|19295858|P1|Overall Study|Adverse Event|12
5583898|NCT01009086|19295856|P3|Overall Study|Lost to Follow-up|3
5583899|NCT01009086|19295857|P2|Overall Study|Lost to Follow-up|5
5583900|NCT01009086|19295858|P1|Overall Study|Lost to Follow-up|4
5583901|NCT01009086|19295856|P3|Overall Study|Lack of Efficacy|9
5583902|NCT01009086|19295857|P2|Overall Study|Lack of Efficacy|15
5583903|NCT01009086|19295858|P1|Overall Study|Lack of Efficacy|16
5583904|NCT01009060|19295893|P2|Overall Study|Withdrawal by Subject|1
5583905|NCT01009060|19295894|P1|Overall Study|Withdrawal by Subject|1
5583906|NCT01009060|19295893|P2|Overall Study|Physician Decision|1
5583907|NCT01009060|19295894|P1|Overall Study|Physician Decision|1
5583908|NCT01009060|19295893|P2|Overall Study|Lost to Follow-up|0
5583909|NCT01009060|19295894|P1|Overall Study|Lost to Follow-up|1
5583910|NCT01009060|19295893|P2|Overall Study|Protocol Violation|1
5583911|NCT01009060|19295894|P1|Overall Study|Protocol Violation|0
5583912|NCT01009060|19295893|P2|Overall Study|Adverse Event|2
5583913|NCT01009060|19295894|P1|Overall Study|Adverse Event|1
5583914|NCT01009047|19295932|P2|Overall Study|Other|2
5583915|NCT01009047|19295933|P1|Overall Study|Other|3
5583916|NCT01009047|19295932|P2|Overall Study|Withdrawal by consent|11
5583917|NCT01009047|19295933|P1|Overall Study|Withdrawal by consent|16
5583918|NCT01009047|19295932|P2|Overall Study|Lack of Efficacy|11
5583919|NCT01009047|19295933|P1|Overall Study|Lack of Efficacy|4
5583920|NCT01009047|19295932|P2|Overall Study|Lost to Follow-up|2
5583921|NCT01009047|19295933|P1|Overall Study|Lost to Follow-up|0
5583922|NCT01009047|19295932|P2|Overall Study|Adverse Event|0
5583923|NCT01009047|19295933|P1|Overall Study|Adverse Event|5
5583924|NCT01009034|19295955|P1|Overall Study|Withdrawal by Subject|2
5583925|NCT01009034|19295955|P1|Overall Study|Lost to Follow-up|2
5583926|NCT01008995|19295963|P4|After Controlled Period|Other|0
5583927|NCT01008995|19295964|P3|After Controlled Period|Other|1
5583928|NCT01008995|19295965|P2|After Controlled Period|Other|0
5583929|NCT01008995|19295966|P1|After Controlled Period|Other|0
5583930|NCT01008995|19295963|P4|After Controlled Period|Adverse Event|1
5583931|NCT01008995|19295964|P3|After Controlled Period|Adverse Event|1
5583932|NCT01008995|19295965|P2|After Controlled Period|Adverse Event|0
5583933|NCT01008995|19295966|P1|After Controlled Period|Adverse Event|0
5583934|NCT01008995|19295963|P4|Controlled Period|Other|0
5583935|NCT01008995|19295964|P3|Controlled Period|Other|0
5583936|NCT01008995|19295965|P2|Controlled Period|Other|1
5583937|NCT01008995|19295966|P1|Controlled Period|Other|2
5583938|NCT01008995|19295963|P4|Controlled Period|Adverse Event|0
5583939|NCT01008995|19295964|P3|Controlled Period|Adverse Event|0
5583940|NCT01008995|19295965|P2|Controlled Period|Adverse Event|2
5583941|NCT01008995|19295966|P1|Controlled Period|Adverse Event|1
5583942|NCT01008943|19295983|P1|Overall Study|Withdrawal by Subject|1
5583943|NCT01008904|19295990|P1|Overall Study|unexpected unrelated surgery|1
5583944|NCT01008904|19295990|P1|Overall Study|Adverse Event|2
5583945|NCT01008904|19295990|P1|Overall Study|Lost to Follow-up|1
5583946|NCT01008748|19295995|P1|Overall Study|Other|1
5583947|NCT01008748|19295995|P1|Overall Study|Lost to Follow-up|80
5583948|NCT01008696|19296020|P2|Overall Study|Other|2
5583949|NCT01008696|19296021|P1|Overall Study|Other|0
5583950|NCT01008696|19296020|P2|Overall Study|Other|3
5583951|NCT01008696|19296021|P1|Overall Study|Other|2
5583952|NCT01008696|19296020|P2|Overall Study|Participants' non-cooperation|3
5583953|NCT01008696|19296021|P1|Overall Study|Participants' non-cooperation|2
5583954|NCT01008696|19296020|P2|Overall Study|Adverse Event|0
5583955|NCT01008696|19296021|P1|Overall Study|Adverse Event|1
5583956|NCT01008696|19296020|P2|Overall Study|Physician Decision|1
5583957|NCT01008696|19296021|P1|Overall Study|Physician Decision|5
5583958|NCT01008696|19296020|P2|Overall Study|Withdrawal by Subject|4
5583959|NCT01008696|19296021|P1|Overall Study|Withdrawal by Subject|2
5583960|NCT01008696|19296020|P2|Overall Study|Participant's evasion of hospital visit|4
5583961|NCT01008696|19296021|P1|Overall Study|Participant's evasion of hospital visit|5
5583962|NCT01008618|19296031|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
5583963|NCT01008618|19296032|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
5583964|NCT01008618|19296033|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
5583965|NCT01008618|19296031|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
5583966|NCT01008618|19296032|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
5583967|NCT01008618|19296033|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
5583968|NCT01008618|19296031|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
5583969|NCT01008618|19296032|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5583970|NCT01008618|19296033|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5583971|NCT01008618|19296031|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
5583972|NCT01008618|19296032|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
5583973|NCT01008618|19296033|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
5583974|NCT01008618|19296031|P3|Period 2 (Double-Blind Period)|Physician Decision|0
5583975|NCT01008618|19296032|P2|Period 2 (Double-Blind Period)|Physician Decision|1
5583976|NCT01008618|19296033|P1|Period 2 (Double-Blind Period)|Physician Decision|0
5583977|NCT01008618|19296031|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
5583978|NCT01008618|19296032|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
5583979|NCT01008618|19296033|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
5583980|NCT01008618|19296031|P3|Period 2 (Double-Blind Period)|Adverse Event|2
5583981|NCT01008618|19296032|P2|Period 2 (Double-Blind Period)|Adverse Event|11
5583982|NCT01008618|19296033|P1|Period 2 (Double-Blind Period)|Adverse Event|0
5583983|NCT01008618|19296031|P3|Period 1 (Titration Period)|Aggravated symptom|0
5583984|NCT01008618|19296032|P2|Period 1 (Titration Period)|Aggravated symptom|0
5583985|NCT01008618|19296033|P1|Period 1 (Titration Period)|Aggravated symptom|2
5583986|NCT01008618|19296031|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5583987|NCT01008618|19296032|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5583988|NCT01008618|19296033|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
5583989|NCT01008618|19296031|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
5583990|NCT01008618|19296032|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
5583991|NCT01008618|19296033|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
5583992|NCT01008618|19296031|P3|Period 1 (Titration Period)|Adverse Event|0
5583993|NCT01008618|19296032|P2|Period 1 (Titration Period)|Adverse Event|0
5583994|NCT01008618|19296033|P1|Period 1 (Titration Period)|Adverse Event|33
5583995|NCT01008618|19296031|P3|Period 1 (Titration Period)|Physician Decision|0
5583996|NCT01008618|19296032|P2|Period 1 (Titration Period)|Physician Decision|0
5583997|NCT01008618|19296033|P1|Period 1 (Titration Period)|Physician Decision|2
5583998|NCT01008553|19296082|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
5583999|NCT01008553|19296083|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
5584000|NCT01008553|19296084|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
5584001|NCT01008553|19296082|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
5584002|NCT01008553|19296083|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5584003|NCT01008553|19296084|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
5584004|NCT01008553|19296082|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
5584005|NCT01008553|19296083|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
5584006|NCT01008553|19296084|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
5584007|NCT01008553|19296082|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
5584008|NCT01008553|19296083|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
5584009|NCT01008553|19296084|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
5584010|NCT01008553|19296082|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
5584011|NCT01008553|19296083|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
5584012|NCT01008553|19296084|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
5584013|NCT01008553|19296082|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
5584014|NCT01008553|19296083|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
5584015|NCT01008553|19296084|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
5584016|NCT01008553|19296082|P3|Period 2 (Double-Blind Period)|Adverse Event|4
5584017|NCT01008553|19296083|P2|Period 2 (Double-Blind Period)|Adverse Event|14
5584018|NCT01008553|19296084|P1|Period 2 (Double-Blind Period)|Adverse Event|0
5584019|NCT01008553|19296082|P3|Period 2 (Double-Blind Period)|Physician Decision|2
5584020|NCT01008553|19296083|P2|Period 2 (Double-Blind Period)|Physician Decision|1
5584021|NCT01008553|19296084|P1|Period 2 (Double-Blind Period)|Physician Decision|0
5584022|NCT01008553|19296082|P3|Period 1 (Titration Period)|Not appropriate for this study|0
5584023|NCT01008553|19296083|P2|Period 1 (Titration Period)|Not appropriate for this study|0
5584024|NCT01008553|19296084|P1|Period 1 (Titration Period)|Not appropriate for this study|1
5584025|NCT01008553|19296082|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5584026|NCT01008553|19296083|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
5584027|NCT01008553|19296084|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
5584028|NCT01008553|19296082|P3|Period 1 (Titration Period)|Determined to increase dosage|0
5584029|NCT01008553|19296083|P2|Period 1 (Titration Period)|Determined to increase dosage|0
5584030|NCT01008553|19296084|P1|Period 1 (Titration Period)|Determined to increase dosage|3
5584031|NCT01008553|19296082|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
5584032|NCT01008553|19296083|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
5584033|NCT01008553|19296084|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
5584034|NCT01008553|19296082|P3|Period 1 (Titration Period)|Adverse Event|0
5584035|NCT01008553|19296083|P2|Period 1 (Titration Period)|Adverse Event|0
5584036|NCT01008553|19296084|P1|Period 1 (Titration Period)|Adverse Event|33
5584037|NCT01008553|19296082|P3|Period 1 (Titration Period)|Physician Decision|0
5584038|NCT01008553|19296083|P2|Period 1 (Titration Period)|Physician Decision|0
5584039|NCT01008553|19296084|P1|Period 1 (Titration Period)|Physician Decision|2
5584040|NCT01008475|19296116|P7|Overall Study|Ongoing treatment at data cut-off date|4
5584041|NCT01008475|19296117|P6|Overall Study|Ongoing treatment at data cut-off date|6
5584042|NCT01008475|19296118|P5|Overall Study|Ongoing treatment at data cut-off date|5
5584043|NCT01008475|19296119|P4|Overall Study|Ongoing treatment at data cut-off date|0
5584044|NCT01008475|19296120|P3|Overall Study|Ongoing treatment at data cut-off date|0
5584045|NCT01008475|19296121|P2|Overall Study|Ongoing treatment at data cut-off date|0
5584046|NCT01008475|19296122|P1|Overall Study|Ongoing treatment at data cut-off date|0
5584047|NCT01008449|19296162|P2|Overall Study|Lost to Follow-up|19
5584048|NCT01008449|19296163|P1|Overall Study|Lost to Follow-up|29
5584049|NCT01008423|19296185|P2|Overall Study|Other|1
5584050|NCT01008423|19296186|P1|Overall Study|Other|0
5584051|NCT01008423|19296185|P2|Overall Study|Personal Conflict|0
5584052|NCT01008423|19296186|P1|Overall Study|Personal Conflict|1
5584053|NCT01008423|19296185|P2|Overall Study|Disease Extent 70 centimeters (cm)|0
5584054|NCT01008423|19296186|P1|Overall Study|Disease Extent 70 centimeters (cm)|1
5584055|NCT01008423|19296185|P2|Overall Study|Lack of Efficacy|5
5584056|NCT01008423|19296186|P1|Overall Study|Lack of Efficacy|0
5584057|NCT01008423|19296185|P2|Overall Study|Low Cortisol|1
5584058|NCT01008423|19296186|P1|Overall Study|Low Cortisol|0
5584059|NCT01008423|19296185|P2|Overall Study|Lost to Follow-up|2
5584060|NCT01008423|19296186|P1|Overall Study|Lost to Follow-up|0
5584061|NCT01008423|19296185|P2|Overall Study|Withdrawal by Subject|7
5584062|NCT01008423|19296186|P1|Overall Study|Withdrawal by Subject|4
5584063|NCT01008423|19296185|P2|Overall Study|Adverse Event|6
5584064|NCT01008423|19296186|P1|Overall Study|Adverse Event|13
5584065|NCT01008410|19296212|P2|Overall Study|Met Exclusion Criterion|1
5584066|NCT01008410|19296213|P1|Overall Study|Met Exclusion Criterion|0
5584067|NCT01008410|19296212|P2|Overall Study|Lack of Efficacy|6
5584068|NCT01008410|19296213|P1|Overall Study|Lack of Efficacy|2
5584069|NCT01008410|19296212|P2|Overall Study|Low Cortisol|0
5584070|NCT01008410|19296213|P1|Overall Study|Low Cortisol|2
5584071|NCT01008410|19296212|P2|Overall Study|Noncompliance|0
5584072|NCT01008410|19296213|P1|Overall Study|Noncompliance|1
5584073|NCT01008410|19296212|P2|Overall Study|Lost to Follow-up|0
5584074|NCT01008410|19296213|P1|Overall Study|Lost to Follow-up|1
5584075|NCT01008410|19296212|P2|Overall Study|Withdrawal by Subject|2
5584076|NCT01008410|19296213|P1|Overall Study|Withdrawal by Subject|6
5584077|NCT01008410|19296212|P2|Overall Study|Adverse Event|7
5584078|NCT01008410|19296213|P1|Overall Study|Adverse Event|13
5584079|NCT01008150|19296267|P4|Overall Study|did not receive study drug|0
5584080|NCT01008150|19296268|P3|Overall Study|did not receive study drug|1
5584081|NCT01008150|19296269|P2|Overall Study|did not receive study drug|1
5584082|NCT01008150|19296270|P1|Overall Study|did not receive study drug|1
5584083|NCT01007916|19296318|P2|Period 2, 4 Weeks of Wear|Relocation|0
5584084|NCT01007916|19296319|P1|Period 2, 4 Weeks of Wear|Relocation|1
5584085|NCT01007916|19296318|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
5584086|NCT01007916|19296319|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
5584087|NCT01007942|19296327|P2|Overall Study|Patients untreated|3
5584088|NCT01007942|19296328|P1|Overall Study|Patients untreated|4
5584089|NCT01007942|19296327|P2|Overall Study|Death|2
5584090|NCT01007942|19296328|P1|Overall Study|Death|3
5584091|NCT01007942|19296327|P2|Overall Study|Administrative problems|0
5584092|NCT01007942|19296328|P1|Overall Study|Administrative problems|2
5584093|NCT01007942|19296327|P2|Overall Study|Lost to Follow-up|0
5584094|NCT01007942|19296328|P1|Overall Study|Lost to Follow-up|1
5584095|NCT01007942|19296327|P2|Overall Study|Withdrawal by Subject|14
5584096|NCT01007942|19296328|P1|Overall Study|Withdrawal by Subject|19
5584097|NCT01007942|19296327|P2|Overall Study|Protocol Violation|1
5584098|NCT01007942|19296328|P1|Overall Study|Protocol Violation|1
5584099|NCT01007942|19296327|P2|Overall Study|New cancer therapy|1
5584100|NCT01007942|19296328|P1|Overall Study|New cancer therapy|5
5584101|NCT01007942|19296327|P2|Overall Study|Disease progression|242
5584102|NCT01007942|19296328|P1|Overall Study|Disease progression|217
5584103|NCT01007942|19296327|P2|Overall Study|Abnormal test procedure|1
5584104|NCT01007942|19296328|P1|Overall Study|Abnormal test procedure|0
5584105|NCT01007942|19296327|P2|Overall Study|Adverse Event|14
5584106|NCT01007942|19296328|P1|Overall Study|Adverse Event|29
5584107|NCT01007838|19296354|P4|Overall Study|Started home haemodialysis|0
5584108|NCT01007838|19296355|P3|Overall Study|Started home haemodialysis|0
5584109|NCT01007838|19296356|P2|Overall Study|Started home haemodialysis|0
5584110|NCT01007838|19296357|P1|Overall Study|Started home haemodialysis|1
5584111|NCT01007838|19296354|P4|Overall Study|Physician Decision|0
5584112|NCT01007838|19296355|P3|Overall Study|Physician Decision|0
5584113|NCT01007838|19296356|P2|Overall Study|Physician Decision|0
5584114|NCT01007838|19296357|P1|Overall Study|Physician Decision|1
5584115|NCT01007838|19296354|P4|Overall Study|Withdrawal by Subject|0
5584116|NCT01007838|19296355|P3|Overall Study|Withdrawal by Subject|0
5584117|NCT01007838|19296356|P2|Overall Study|Withdrawal by Subject|0
5584118|NCT01007838|19296357|P1|Overall Study|Withdrawal by Subject|1
5584119|NCT01007812|19296367|P2|Period 1, One Week|Discomfort|0
5584120|NCT01007812|19296368|P1|Period 1, One Week|Discomfort|1
5584121|NCT01007812|19296367|P2|Period 1, One Week|Lost to Follow-up|1
5584122|NCT01007812|19296368|P1|Period 1, One Week|Lost to Follow-up|0
5584123|NCT01007552|19296418|P1|Overall Study|Withdrawal by Subject|1
5584124|NCT01007448|19296434|P2|Overall Study|Adverse Event|4
5584125|NCT01007448|19296435|P1|Overall Study|Adverse Event|1
5584126|NCT01007448|19296434|P2|Overall Study|Withdrawal by Subject|3
5584127|NCT01007448|19296435|P1|Overall Study|Withdrawal by Subject|2
5584128|NCT01007448|19296434|P2|Overall Study|Lack of Efficacy|0
5584129|NCT01007448|19296435|P1|Overall Study|Lack of Efficacy|2
5584130|NCT01007448|19296434|P2|Overall Study|Progressive Disease|2
5584131|NCT01007448|19296435|P1|Overall Study|Progressive Disease|1
5584132|NCT01007448|19296434|P2|Overall Study|Participant Given Prohibited Medication|0
5584133|NCT01007448|19296435|P1|Overall Study|Participant Given Prohibited Medication|1
5584134|NCT01007448|19296434|P2|Overall Study|Participant Leaving the Country|0
5584135|NCT01007448|19296435|P1|Overall Study|Participant Leaving the Country|1
5584136|NCT01007448|19296434|P2|Overall Study|Staph Skin Infection Flare|0
5584137|NCT01007448|19296435|P1|Overall Study|Staph Skin Infection Flare|1
5584138|NCT01007448|19296434|P2|Overall Study|Continuing Prohibited Systemic Drugs|0
5584139|NCT01007448|19296435|P1|Overall Study|Continuing Prohibited Systemic Drugs|1
5584140|NCT01007435|19296467|P4|Overall Study|Reason not Specified|1
5584141|NCT01007435|19296468|P3|Overall Study|Reason not Specified|2
5584142|NCT01007435|19296469|P2|Overall Study|Reason not Specified|1
5584143|NCT01007435|19296470|P1|Overall Study|Reason not Specified|1
5584144|NCT01007435|19296467|P4|Overall Study|Failure to Return|6
5584145|NCT01007435|19296468|P3|Overall Study|Failure to Return|3
5584146|NCT01007435|19296469|P2|Overall Study|Failure to Return|4
5584147|NCT01007435|19296470|P1|Overall Study|Failure to Return|5
5584148|NCT01007435|19296467|P4|Overall Study|Refused Treatment|8
5584149|NCT01007435|19296468|P3|Overall Study|Refused Treatment|5
5584150|NCT01007435|19296469|P2|Overall Study|Refused Treatment|13
5584151|NCT01007435|19296470|P1|Overall Study|Refused Treatment|13
5584152|NCT01007435|19296467|P4|Overall Study|Other Protocol Violation|0
5584153|NCT01007435|19296468|P3|Overall Study|Other Protocol Violation|1
5584154|NCT01007435|19296469|P2|Overall Study|Other Protocol Violation|0
5584155|NCT01007435|19296470|P1|Overall Study|Other Protocol Violation|2
5584156|NCT01007435|19296467|P4|Overall Study|Violation of Selection Criteria at Entry|0
5584157|NCT01007435|19296468|P3|Overall Study|Violation of Selection Criteria at Entry|2
5584158|NCT01007435|19296469|P2|Overall Study|Violation of Selection Criteria at Entry|5
5584159|NCT01007435|19296470|P1|Overall Study|Violation of Selection Criteria at Entry|3
5584160|NCT01007435|19296467|P4|Overall Study|Insufficient Therapeutic Response|9
5584161|NCT01007435|19296468|P3|Overall Study|Insufficient Therapeutic Response|2
5584162|NCT01007435|19296469|P2|Overall Study|Insufficient Therapeutic Response|7
5584163|NCT01007435|19296470|P1|Overall Study|Insufficient Therapeutic Response|21
5584164|NCT01007435|19296467|P4|Overall Study|Death|1
5584165|NCT01007435|19296468|P3|Overall Study|Death|2
5584166|NCT01007435|19296469|P2|Overall Study|Death|4
5584167|NCT01007435|19296470|P1|Overall Study|Death|2
5584168|NCT01007435|19296467|P4|Overall Study|Adverse Event|31
5584169|NCT01007435|19296468|P3|Overall Study|Adverse Event|47
5584170|NCT01007435|19296469|P2|Overall Study|Adverse Event|25
5584171|NCT01007435|19296470|P1|Overall Study|Adverse Event|16
5584172|NCT01007396|19296512|P1|Overall Study|Lost to Follow-up|47
5584173|NCT01007253|19296517|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
5584174|NCT01007253|19296518|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
5584175|NCT01007253|19296519|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
5584176|NCT01007253|19296520|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
5584177|NCT01007149|19296552|P2|Overall Study|Administrative problems|1
5584178|NCT01007149|19296553|P1|Overall Study|Administrative problems|0
5584179|NCT01007123|19296627|P4|Overall Study|Lost to Follow-up|0
5584180|NCT01007123|19296628|P3|Overall Study|Lost to Follow-up|0
5584181|NCT01007123|19296629|P2|Overall Study|Lost to Follow-up|1
5584182|NCT01007123|19296630|P1|Overall Study|Lost to Follow-up|0
5584183|NCT01007123|19296627|P4|Overall Study|Withdrawal by Subject|0
5584184|NCT01007123|19296628|P3|Overall Study|Withdrawal by Subject|1
5584185|NCT01007123|19296629|P2|Overall Study|Withdrawal by Subject|0
5584186|NCT01007123|19296630|P1|Overall Study|Withdrawal by Subject|1
5584187|NCT01007123|19296627|P4|Overall Study|Protocol Violation|1
5584188|NCT01007123|19296628|P3|Overall Study|Protocol Violation|2
5584189|NCT01007123|19296629|P2|Overall Study|Protocol Violation|1
5584190|NCT01007123|19296630|P1|Overall Study|Protocol Violation|1
5584191|NCT01007123|19296627|P4|Overall Study|Lack of Efficacy|4
5584192|NCT01007123|19296628|P3|Overall Study|Lack of Efficacy|1
5584193|NCT01007123|19296629|P2|Overall Study|Lack of Efficacy|0
5584194|NCT01007123|19296630|P1|Overall Study|Lack of Efficacy|1
5584195|NCT01007123|19296627|P4|Overall Study|Adverse Event|1
5584196|NCT01007123|19296628|P3|Overall Study|Adverse Event|7
5584197|NCT01007123|19296629|P2|Overall Study|Adverse Event|4
5584198|NCT01007123|19296630|P1|Overall Study|Adverse Event|3
5584199|NCT01007032|19296691|P4|Overall Study|Withdrawal by Subject|1
5584200|NCT01007032|19296692|P3|Overall Study|Withdrawal by Subject|0
5584201|NCT01007032|19296693|P2|Overall Study|Withdrawal by Subject|0
5584202|NCT01007032|19296694|P1|Overall Study|Withdrawal by Subject|0
5584203|NCT01007032|19296691|P4|Overall Study|On Study Treatment at Cut-off Date|0
5584204|NCT01007032|19296692|P3|Overall Study|On Study Treatment at Cut-off Date|1
5584205|NCT01007032|19296693|P2|Overall Study|On Study Treatment at Cut-off Date|1
5584206|NCT01007032|19296694|P1|Overall Study|On Study Treatment at Cut-off Date|0
5584207|NCT01006980|19296738|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
5584208|NCT01006980|19296739|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
5584209|NCT01006980|19296738|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
5584210|NCT01006980|19296739|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
5584211|NCT01006980|19296738|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
5584212|NCT01006980|19296739|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
5584213|NCT01006980|19296738|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
5584214|NCT01006980|19296739|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
5584215|NCT01006980|19296738|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
5584216|NCT01006980|19296739|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
5584217|NCT01006980|19296738|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
5584218|NCT01006980|19296739|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
5584219|NCT01006980|19296738|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
5584220|NCT01006980|19296739|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
5584221|NCT01006980|19296738|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
5584222|NCT01006980|19296739|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
5584223|NCT01006980|19296738|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
5584224|NCT01006980|19296739|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
5584225|NCT01006980|19296738|P2|Vemurafenib and Dacarbazine|Progression|218
5584226|NCT01006980|19296739|P1|Vemurafenib and Dacarbazine|Progression|257
5584227|NCT01006980|19296738|P2|Vemurafenib and Dacarbazine|Death|12
5584228|NCT01006980|19296739|P1|Vemurafenib and Dacarbazine|Death|13
5584229|NCT01006980|19296738|P2|Vemurafenib and Dacarbazine|Adverse Event|5
5584230|NCT01006980|19296739|P1|Vemurafenib and Dacarbazine|Adverse Event|25
5584231|NCT01006980|19296738|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
5584232|NCT01006980|19296739|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
5584233|NCT01006889|19296778|P1|Overall Study|Withdrawal by Subject|3
5584234|NCT01006707|19296789|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
5584235|NCT01006707|19296790|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
5584236|NCT01006707|19296791|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
5584237|NCT01006707|19296789|P3|Study Session 1|Lost to Follow-up|0
5584238|NCT01006707|19296790|P2|Study Session 1|Lost to Follow-up|0
5584239|NCT01006707|19296791|P1|Study Session 1|Lost to Follow-up|2
5584240|NCT01006629|19296811|P1|Overall Study|Parent unable to perform site visit|4
5584241|NCT01006629|19296811|P1|Overall Study|Parent refused to continue participation|1
5584242|NCT01006629|19296811|P1|Overall Study|Adverse Event|1
5584243|NCT01006616|19296826|P4|Period 2 (18 Months)|Study Terminated|70
5584244|NCT01006616|19296827|P3|Period 2 (18 Months)|Study Terminated|44
5584245|NCT01006616|19296828|P2|Period 2 (18 Months)|Study Terminated|46
5584246|NCT01006616|19296829|P1|Period 2 (18 Months)|Study Terminated|63
5584247|NCT01006616|19296826|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
5584248|NCT01006616|19296827|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
5584249|NCT01006616|19296828|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
5584250|NCT01006616|19296829|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
5584251|NCT01006616|19296826|P4|Period 2 (18 Months)|Withdrawal by Subject|1
5584252|NCT01006616|19296827|P3|Period 2 (18 Months)|Withdrawal by Subject|0
5584253|NCT01006616|19296828|P2|Period 2 (18 Months)|Withdrawal by Subject|4
5584254|NCT01006616|19296829|P1|Period 2 (18 Months)|Withdrawal by Subject|1
5584255|NCT01006616|19296826|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
5584256|NCT01006616|19296827|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
5584257|NCT01006616|19296828|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
5584258|NCT01006616|19296829|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
5584259|NCT01006616|19296826|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
5584260|NCT01006616|19296827|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
5584261|NCT01006616|19296828|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
5584262|NCT01006616|19296829|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
5584263|NCT01006616|19296826|P4|Period 2 (18 Months)|Lost to Follow-up|0
5584264|NCT01006616|19296827|P3|Period 2 (18 Months)|Lost to Follow-up|0
5584265|NCT01006616|19296828|P2|Period 2 (18 Months)|Lost to Follow-up|0
5584266|NCT01006616|19296829|P1|Period 2 (18 Months)|Lost to Follow-up|2
5584267|NCT01006616|19296826|P4|Period 2 (18 Months)|Lack of Efficacy|2
5584268|NCT01006616|19296827|P3|Period 2 (18 Months)|Lack of Efficacy|1
5584269|NCT01006616|19296828|P2|Period 2 (18 Months)|Lack of Efficacy|0
5584270|NCT01006616|19296829|P1|Period 2 (18 Months)|Lack of Efficacy|0
5584271|NCT01006616|19296826|P4|Period 2 (18 Months)|Adverse Event|4
5584272|NCT01006616|19296827|P3|Period 2 (18 Months)|Adverse Event|6
5584273|NCT01006616|19296828|P2|Period 2 (18 Months)|Adverse Event|6
5584274|NCT01006616|19296829|P1|Period 2 (18 Months)|Adverse Event|6
5584275|NCT01006616|19296826|P4|Period 1 (6 Months)|Not Treated|1
5584276|NCT01006616|19296827|P3|Period 1 (6 Months)|Not Treated|1
5584277|NCT01006616|19296828|P2|Period 1 (6 Months)|Not Treated|0
5584278|NCT01006616|19296829|P1|Period 1 (6 Months)|Not Treated|0
5584279|NCT01006616|19296826|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
5584280|NCT01006616|19296827|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
5584281|NCT01006616|19296828|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
5584282|NCT01006616|19296829|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
5584283|NCT01006616|19296826|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
5584284|NCT01006616|19296827|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
5584285|NCT01006616|19296828|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
5584286|NCT01006616|19296829|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
5584287|NCT01006616|19296826|P4|Period 1 (6 Months)|Withdrawal by Subject|0
5584288|NCT01006616|19296827|P3|Period 1 (6 Months)|Withdrawal by Subject|2
5584289|NCT01006616|19296828|P2|Period 1 (6 Months)|Withdrawal by Subject|2
5584290|NCT01006616|19296829|P1|Period 1 (6 Months)|Withdrawal by Subject|2
5584291|NCT01006616|19296826|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
5584292|NCT01006616|19296827|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
5584293|NCT01006616|19296828|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
5584294|NCT01006616|19296829|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
5584295|NCT01006616|19296826|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
5584296|NCT01006616|19296827|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
5584297|NCT01006616|19296828|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
5584298|NCT01006616|19296829|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
5584299|NCT01006616|19296826|P4|Period 1 (6 Months)|Lost to Follow-up|0
5584300|NCT01006616|19296827|P3|Period 1 (6 Months)|Lost to Follow-up|1
5584301|NCT01006616|19296828|P2|Period 1 (6 Months)|Lost to Follow-up|0
5584302|NCT01006616|19296829|P1|Period 1 (6 Months)|Lost to Follow-up|0
5584303|NCT01006616|19296826|P4|Period 1 (6 Months)|Lack of Efficacy|4
5584304|NCT01006616|19296827|P3|Period 1 (6 Months)|Lack of Efficacy|0
5584305|NCT01006616|19296828|P2|Period 1 (6 Months)|Lack of Efficacy|4
5584306|NCT01006616|19296829|P1|Period 1 (6 Months)|Lack of Efficacy|3
5584307|NCT01006616|19296826|P4|Period 1 (6 Months)|Adverse Event|9
5584308|NCT01006616|19296827|P3|Period 1 (6 Months)|Adverse Event|37
5584309|NCT01006616|19296828|P2|Period 1 (6 Months)|Adverse Event|31
5584310|NCT01006616|19296829|P1|Period 1 (6 Months)|Adverse Event|10
5584311|NCT01006603|19296965|P2|Overall Study|Other|7
5584312|NCT01006603|19296966|P1|Overall Study|Other|3
5584313|NCT01006603|19296965|P2|Overall Study|Study specific discontinuation criteria|34
5584314|NCT01006603|19296966|P1|Overall Study|Study specific discontinuation criteria|33
5584315|NCT01006603|19296965|P2|Overall Study|Death|1
5584316|NCT01006603|19296966|P1|Overall Study|Death|1
5584317|NCT01006603|19296965|P2|Overall Study|Adverse Event|7
5584318|NCT01006603|19296966|P1|Overall Study|Adverse Event|15
5584319|NCT01006603|19296965|P2|Overall Study|Incorrect enrolment|2
5584320|NCT01006603|19296966|P1|Overall Study|Incorrect enrolment|0
5584321|NCT01006603|19296965|P2|Overall Study|Protocol Violation|3
5584322|NCT01006603|19296966|P1|Overall Study|Protocol Violation|1
5584323|NCT01006603|19296965|P2|Overall Study|Safety reason|1
5584324|NCT01006603|19296966|P1|Overall Study|Safety reason|1
5584325|NCT01006603|19296965|P2|Overall Study|Lost to Follow-up|1
5584326|NCT01006603|19296966|P1|Overall Study|Lost to Follow-up|0
5584327|NCT01006603|19296965|P2|Overall Study|Withdrawal by Subject|19
5584328|NCT01006603|19296966|P1|Overall Study|Withdrawal by Subject|17
5584329|NCT01006590|19296986|P2|Overall Study|Other|2
5584330|NCT01006590|19296987|P1|Overall Study|Other|3
5584331|NCT01006590|19296986|P2|Overall Study|Study specific discontinuation criteria|23
5584332|NCT01006590|19296987|P1|Overall Study|Study specific discontinuation criteria|16
5584333|NCT01006590|19296986|P2|Overall Study|Withdrawal by Subject|2
5584334|NCT01006590|19296987|P1|Overall Study|Withdrawal by Subject|4
5584335|NCT01006590|19296986|P2|Overall Study|Protocol Violation|0
5584336|NCT01006590|19296987|P1|Overall Study|Protocol Violation|1
5584337|NCT01006590|19296986|P2|Overall Study|Lost to Follow-up|1
5584338|NCT01006590|19296987|P1|Overall Study|Lost to Follow-up|1
5584339|NCT01006590|19296986|P2|Overall Study|Death|1
5584340|NCT01006590|19296987|P1|Overall Study|Death|1
5584341|NCT01006590|19296986|P2|Overall Study|Adverse Event|3
5584342|NCT01006590|19296987|P1|Overall Study|Adverse Event|2
5584343|NCT01006356|19297026|P1|Overall Study|Other|23
5584344|NCT01006356|19297026|P1|Overall Study|Protocol Violation|3
5584345|NCT01006356|19297026|P1|Overall Study|Choice by participants|2
5584346|NCT01006356|19297026|P1|Overall Study|Withdrawal by Subject|1
5584347|NCT01006356|19297026|P1|Overall Study|Paticipants did not cooperate|6
5584348|NCT01006356|19297026|P1|Overall Study|Physician Decision|1
5584349|NCT01006356|19297026|P1|Overall Study|Adverse Event|6
5584350|NCT01006291|19297041|P3|Overall Study|Other|17
5584351|NCT01006291|19297042|P2|Overall Study|Other|14
5584352|NCT01006291|19297043|P1|Overall Study|Other|14
5584353|NCT01006291|19297041|P3|Overall Study|Withdrawal criteria|4
5584354|NCT01006291|19297042|P2|Overall Study|Withdrawal criteria|4
5584355|NCT01006291|19297043|P1|Overall Study|Withdrawal criteria|5
5584356|NCT01006291|19297041|P3|Overall Study|Protocol Violation|3
5584357|NCT01006291|19297042|P2|Overall Study|Protocol Violation|3
5584358|NCT01006291|19297043|P1|Overall Study|Protocol Violation|3
5584359|NCT01006291|19297041|P3|Overall Study|Lack of Efficacy|1
5584360|NCT01006291|19297042|P2|Overall Study|Lack of Efficacy|2
5584361|NCT01006291|19297043|P1|Overall Study|Lack of Efficacy|2
5584362|NCT01006291|19297041|P3|Overall Study|Adverse Event|2
5584363|NCT01006291|19297042|P2|Overall Study|Adverse Event|1
5584364|NCT01006291|19297043|P1|Overall Study|Adverse Event|2
5584365|NCT01006135|19297093|P1|Overall Study|Other|72
5584366|NCT01006135|19297093|P1|Overall Study|Lost to Follow-up|32
5584367|NCT01006135|19297093|P1|Overall Study|Protocol Violation|14
5584368|NCT01006135|19297093|P1|Overall Study|Adverse Event|22
5584369|NCT01006122|19297100|P2|Second Double-blind Intervention Period|Death|1
5584370|NCT01006122|19297101|P1|Second Double-blind Intervention Period|Death|0
5584371|NCT01006122|19297100|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
5584372|NCT01006122|19297101|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
5584373|NCT01006122|19297100|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
5584374|NCT01006122|19297101|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
5584375|NCT01006122|19297100|P2|Second Double-blind Intervention Period|Protocol Violation|0
5584376|NCT01006122|19297101|P1|Second Double-blind Intervention Period|Protocol Violation|1
5584377|NCT01006122|19297100|P2|Second Double-blind Intervention Period|Adverse Event|1
5584378|NCT01006122|19297101|P1|Second Double-blind Intervention Period|Adverse Event|1
5584379|NCT01006122|19297100|P2|First Double-blind Intervention Period|Adverse Event|4
5584380|NCT01006122|19297101|P1|First Double-blind Intervention Period|Adverse Event|0
5584381|NCT01006122|19297100|P2|First Double-blind Intervention Period|Other|0
5584382|NCT01006122|19297101|P1|First Double-blind Intervention Period|Other|3
5584383|NCT01006122|19297100|P2|First Double-blind Intervention Period|Lack of Efficacy|1
5584384|NCT01006122|19297101|P1|First Double-blind Intervention Period|Lack of Efficacy|2
5584385|NCT01006122|19297100|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
5584386|NCT01006122|19297101|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
5584387|NCT01006122|19297100|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
5584388|NCT01006122|19297101|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
5584389|NCT01006122|19297100|P2|First Double-blind Intervention Period|Pregnancy|1
5584390|NCT01006122|19297101|P1|First Double-blind Intervention Period|Pregnancy|0
5584391|NCT01006122|19297100|P2|First Double-blind Intervention Period|Protocol Violation|1
5584392|NCT01006122|19297101|P1|First Double-blind Intervention Period|Protocol Violation|1
5584393|NCT01006122|19297100|P2|First Double-blind Intervention Period|Lost to Follow-up|2
5584394|NCT01006122|19297101|P1|First Double-blind Intervention Period|Lost to Follow-up|0
5584395|NCT01005966|19297152|P5|Treatment Period 4 (14 Days)|Other Reason|1
5584396|NCT01005966|19297153|P4|Treatment Period 4 (14 Days)|Other Reason|0
5584397|NCT01005966|19297154|P3|Treatment Period 4 (14 Days)|Other Reason|0
5584398|NCT01005966|19297155|P2|Treatment Period 4 (14 Days)|Other Reason|0
5584399|NCT01005966|19297156|P1|Treatment Period 4 (14 Days)|Other Reason|0
5584400|NCT01005966|19297152|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
5584401|NCT01005966|19297153|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
5584402|NCT01005966|19297154|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
5584403|NCT01005966|19297155|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
5584404|NCT01005966|19297156|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
5584405|NCT01005966|19297152|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
5584406|NCT01005966|19297153|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
5584407|NCT01005966|19297154|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
5584408|NCT01005966|19297155|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
5584409|NCT01005966|19297156|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
5584410|NCT01005966|19297152|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5584411|NCT01005966|19297153|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5584412|NCT01005966|19297154|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
5584413|NCT01005966|19297155|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5584414|NCT01005966|19297156|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
5584415|NCT01005966|19297152|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
5584416|NCT01005966|19297153|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
5584417|NCT01005966|19297154|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
5584418|NCT01005966|19297155|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
5584419|NCT01005966|19297156|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
5584420|NCT01005966|19297152|P5|Treatment Period 2 (14 Days)|Adverse Event|0
5584421|NCT01005966|19297153|P4|Treatment Period 2 (14 Days)|Adverse Event|0
5584422|NCT01005966|19297154|P3|Treatment Period 2 (14 Days)|Adverse Event|1
5584423|NCT01005966|19297155|P2|Treatment Period 2 (14 Days)|Adverse Event|1
5584424|NCT01005966|19297156|P1|Treatment Period 2 (14 Days)|Adverse Event|0
5584425|NCT01005966|19297152|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5584426|NCT01005966|19297153|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
5584427|NCT01005966|19297154|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5584428|NCT01005966|19297155|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5584429|NCT01005966|19297156|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
5584430|NCT01005966|19297152|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
5584431|NCT01005966|19297153|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
5584432|NCT01005966|19297154|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
5584433|NCT01005966|19297155|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
5584434|NCT01005966|19297156|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
5584435|NCT01005966|19297152|P5|Treatment Period 1 (14 Days)|Adverse Event|0
5584436|NCT01005966|19297153|P4|Treatment Period 1 (14 Days)|Adverse Event|0
5584437|NCT01005966|19297154|P3|Treatment Period 1 (14 Days)|Adverse Event|0
5584438|NCT01005966|19297155|P2|Treatment Period 1 (14 Days)|Adverse Event|0
5584439|NCT01005966|19297156|P1|Treatment Period 1 (14 Days)|Adverse Event|1
5584440|NCT01005914|19297176|P1|Overall Study|Withdrawal by Subject|1
5584441|NCT01005914|19297176|P1|Overall Study|Lack of Efficacy|1
5584442|NCT01005914|19297176|P1|Overall Study|Death|4
5584443|NCT01005914|19297176|P1|Overall Study|Adverse Event|4
5584444|NCT01005901|19297182|P2|Overall Study|No longer requires study drug|1
5584445|NCT01005901|19297183|P1|Overall Study|No longer requires study drug|0
5584446|NCT01005901|19297182|P2|Overall Study|Patient's inability to use the device|1
5584447|NCT01005901|19297183|P1|Overall Study|Patient's inability to use the device|1
5584448|NCT01005901|19297182|P2|Overall Study|Lost to Follow-up|2
5584449|NCT01005901|19297183|P1|Overall Study|Lost to Follow-up|1
5584450|NCT01005901|19297182|P2|Overall Study|Death|3
5584451|NCT01005901|19297183|P1|Overall Study|Death|2
5584452|NCT01005901|19297182|P2|Overall Study|Protocol Violation|3
5584453|NCT01005901|19297183|P1|Overall Study|Protocol Violation|4
5584454|NCT01005901|19297182|P2|Overall Study|Unsatisfactory therapeutic effect|5
5584455|NCT01005901|19297183|P1|Overall Study|Unsatisfactory therapeutic effect|5
5584456|NCT01005901|19297182|P2|Overall Study|Administrative problems|13
5584457|NCT01005901|19297183|P1|Overall Study|Administrative problems|21
5584458|NCT01005901|19297182|P2|Overall Study|Adverse Event|16
5584459|NCT01005901|19297183|P1|Overall Study|Adverse Event|30
5584460|NCT01005901|19297182|P2|Overall Study|Withdrawal by Subject|14
5584461|NCT01005901|19297183|P1|Overall Study|Withdrawal by Subject|38
5584462|NCT01005875|19297246|P1|Overall Study|Death|3
5584463|NCT01005745|19297263|P1|Overall Study|Inappropriate antidiuretic hormone|1
5584464|NCT01005745|19297263|P1|Overall Study|Death prior to treatment|1
5584465|NCT01005745|19297263|P1|Overall Study|Disease progressed during TIL growth|3
5584466|NCT01005745|19297263|P1|Overall Study|No TIL growth|1
5584467|NCT01005732|19297268|P1|Overall Study|Death|1
5584468|NCT01005732|19297268|P1|Overall Study|Lost to Follow-up|10
5584469|NCT01005719|19297284|P6|Period 2|Adverse Event|1
5584470|NCT01005719|19297285|P5|Period 2|Adverse Event|1
5584471|NCT01005719|19297286|P4|Period 2|Adverse Event|0
5584472|NCT01005719|19297287|P3|Period 2|Adverse Event|0
5584473|NCT01005719|19297288|P2|Period 2|Adverse Event|0
5584474|NCT01005719|19297289|P1|Period 2|Adverse Event|0
5584475|NCT01005719|19297284|P6|Period 1|Delay in completing study procedures|1
5584476|NCT01005719|19297285|P5|Period 1|Delay in completing study procedures|0
5584477|NCT01005719|19297286|P4|Period 1|Delay in completing study procedures|0
5584478|NCT01005719|19297287|P3|Period 1|Delay in completing study procedures|0
5584479|NCT01005719|19297288|P2|Period 1|Delay in completing study procedures|0
5584480|NCT01005719|19297289|P1|Period 1|Delay in completing study procedures|0
5584481|NCT01005719|19297284|P6|Period 1|Adverse Event|0
5584482|NCT01005719|19297285|P5|Period 1|Adverse Event|0
5584483|NCT01005719|19297286|P4|Period 1|Adverse Event|1
5584484|NCT01005719|19297287|P3|Period 1|Adverse Event|0
5584485|NCT01005719|19297288|P2|Period 1|Adverse Event|0
5584486|NCT01005719|19297289|P1|Period 1|Adverse Event|0
5584487|NCT01005680|19297356|P2|Overall Study|Physician Decision|1
5584488|NCT01005680|19297357|P1|Overall Study|Physician Decision|1
5584489|NCT01005680|19297356|P2|Overall Study|Withdrawal by Subject|4
5584490|NCT01005680|19297357|P1|Overall Study|Withdrawal by Subject|1
5584491|NCT01005680|19297356|P2|Overall Study|Lost to Follow-up|6
5584492|NCT01005680|19297357|P1|Overall Study|Lost to Follow-up|4
5584493|NCT01005602|19297381|P2|Overall Study|Excluded due to unreliable clinical data|0
5584494|NCT01005602|19297382|P1|Overall Study|Excluded due to unreliable clinical data|1
5584495|NCT01005329|19297470|P1|Overall Study|Ineligible or received no protocol trt.|4
5584496|NCT01005316|19297483|P4|Overall Study|Retransplanted|0
5584497|NCT01005316|19297484|P3|Overall Study|Retransplanted|0
5584498|NCT01005316|19297485|P2|Overall Study|Retransplanted|1
5584499|NCT01005316|19297486|P1|Overall Study|Retransplanted|0
5584500|NCT01005316|19297483|P4|Overall Study|Transferred Care|3
5584501|NCT01005316|19297484|P3|Overall Study|Transferred Care|1
5584502|NCT01005316|19297485|P2|Overall Study|Transferred Care|0
5584503|NCT01005316|19297486|P1|Overall Study|Transferred Care|1
5584504|NCT01005316|19297483|P4|Overall Study|Delisted|0
5584505|NCT01005316|19297484|P3|Overall Study|Delisted|0
5584506|NCT01005316|19297485|P2|Overall Study|Delisted|0
5584507|NCT01005316|19297486|P1|Overall Study|Delisted|8
5584508|NCT01005316|19297483|P4|Overall Study|Consented to Another Study|0
5584509|NCT01005316|19297484|P3|Overall Study|Consented to Another Study|0
5584510|NCT01005316|19297485|P2|Overall Study|Consented to Another Study|0
5584511|NCT01005316|19297486|P1|Overall Study|Consented to Another Study|2
5584512|NCT01005316|19297483|P4|Overall Study|Withdrawal by Subject|2
5584513|NCT01005316|19297484|P3|Overall Study|Withdrawal by Subject|0
5584514|NCT01005316|19297485|P2|Overall Study|Withdrawal by Subject|1
5584515|NCT01005316|19297486|P1|Overall Study|Withdrawal by Subject|1
5584516|NCT01005316|19297483|P4|Overall Study|Sponsor Decision|0
5584517|NCT01005316|19297484|P3|Overall Study|Sponsor Decision|0
5584518|NCT01005316|19297485|P2|Overall Study|Sponsor Decision|3
5584519|NCT01005316|19297486|P1|Overall Study|Sponsor Decision|6
5584520|NCT01005316|19297483|P4|Overall Study|Physician Decision|0
5584521|NCT01005316|19297484|P3|Overall Study|Physician Decision|0
5584522|NCT01005316|19297485|P2|Overall Study|Physician Decision|0
5584523|NCT01005316|19297486|P1|Overall Study|Physician Decision|6
5584524|NCT01005316|19297483|P4|Overall Study|Lost to Follow-up|2
5584525|NCT01005316|19297484|P3|Overall Study|Lost to Follow-up|0
5584526|NCT01005316|19297485|P2|Overall Study|Lost to Follow-up|3
5584527|NCT01005316|19297486|P1|Overall Study|Lost to Follow-up|1
5584528|NCT01005316|19297483|P4|Overall Study|Study Termination|85
5584529|NCT01005316|19297484|P3|Overall Study|Study Termination|9
5584530|NCT01005316|19297485|P2|Overall Study|Study Termination|63
5584531|NCT01005316|19297486|P1|Overall Study|Study Termination|5
5584532|NCT01005316|19297483|P4|Overall Study|Death|15
5584533|NCT01005316|19297484|P3|Overall Study|Death|1
5584534|NCT01005316|19297485|P2|Overall Study|Death|5
5584535|NCT01005316|19297486|P1|Overall Study|Death|20
5584536|NCT01005316|19297483|P4|Overall Study|Adverse Event|1
5584537|NCT01005316|19297484|P3|Overall Study|Adverse Event|0
5584538|NCT01005316|19297485|P2|Overall Study|Adverse Event|0
5584539|NCT01005316|19297486|P1|Overall Study|Adverse Event|0
5584540|NCT01005251|19297553|P5|Overall Study|Lack of Efficacy|0
5584541|NCT01005251|19297554|P4|Overall Study|Lack of Efficacy|1
5584542|NCT01005251|19297555|P3|Overall Study|Lack of Efficacy|1
5584543|NCT01005251|19297556|P2|Overall Study|Lack of Efficacy|0
5584544|NCT01005251|19297557|P1|Overall Study|Lack of Efficacy|0
5584545|NCT01005251|19297553|P5|Overall Study|Randomized in error|0
5584546|NCT01005251|19297554|P4|Overall Study|Randomized in error|1
5584547|NCT01005251|19297555|P3|Overall Study|Randomized in error|1
5584548|NCT01005251|19297556|P2|Overall Study|Randomized in error|0
5584549|NCT01005251|19297557|P1|Overall Study|Randomized in error|0
5584550|NCT01005251|19297553|P5|Overall Study|Wrong drug dispensed|0
5584551|NCT01005251|19297554|P4|Overall Study|Wrong drug dispensed|0
5584552|NCT01005251|19297555|P3|Overall Study|Wrong drug dispensed|0
5584553|NCT01005251|19297556|P2|Overall Study|Wrong drug dispensed|1
5584554|NCT01005251|19297557|P1|Overall Study|Wrong drug dispensed|0
5584555|NCT01005251|19297553|P5|Overall Study|Patient moved|0
5584556|NCT01005251|19297554|P4|Overall Study|Patient moved|0
5584557|NCT01005251|19297555|P3|Overall Study|Patient moved|0
5584558|NCT01005251|19297556|P2|Overall Study|Patient moved|0
5584559|NCT01005251|19297557|P1|Overall Study|Patient moved|1
5584560|NCT01005251|19297553|P5|Overall Study|Physician Decision|2
5584561|NCT01005251|19297554|P4|Overall Study|Physician Decision|0
5584562|NCT01005251|19297555|P3|Overall Study|Physician Decision|0
5584563|NCT01005251|19297556|P2|Overall Study|Physician Decision|0
5584564|NCT01005251|19297557|P1|Overall Study|Physician Decision|0
5584565|NCT01005251|19297553|P5|Overall Study|Lost to Follow-up|0
5584566|NCT01005251|19297554|P4|Overall Study|Lost to Follow-up|0
5584567|NCT01005251|19297555|P3|Overall Study|Lost to Follow-up|2
5584568|NCT01005251|19297556|P2|Overall Study|Lost to Follow-up|4
5584569|NCT01005251|19297557|P1|Overall Study|Lost to Follow-up|1
5584570|NCT01005251|19297553|P5|Overall Study|Developed study-specific withdrawal crit|1
5584571|NCT01005251|19297554|P4|Overall Study|Developed study-specific withdrawal crit|0
5584572|NCT01005251|19297555|P3|Overall Study|Developed study-specific withdrawal crit|3
5584573|NCT01005251|19297556|P2|Overall Study|Developed study-specific withdrawal crit|0
5584574|NCT01005251|19297557|P1|Overall Study|Developed study-specific withdrawal crit|2
5584575|NCT01005251|19297553|P5|Overall Study|Protocol Violation|2
5584576|NCT01005251|19297554|P4|Overall Study|Protocol Violation|0
5584577|NCT01005251|19297555|P3|Overall Study|Protocol Violation|0
5584578|NCT01005251|19297556|P2|Overall Study|Protocol Violation|0
5584579|NCT01005251|19297557|P1|Overall Study|Protocol Violation|1
5584580|NCT01005251|19297553|P5|Overall Study|Adverse Event|4
5584581|NCT01005251|19297554|P4|Overall Study|Adverse Event|5
5584582|NCT01005251|19297555|P3|Overall Study|Adverse Event|8
5584583|NCT01005251|19297556|P2|Overall Study|Adverse Event|6
5584584|NCT01005251|19297557|P1|Overall Study|Adverse Event|2
5584585|NCT01005251|19297553|P5|Overall Study|Eligibility criteria not fulfilled|0
5584586|NCT01005251|19297554|P4|Overall Study|Eligibility criteria not fulfilled|1
5584587|NCT01005251|19297555|P3|Overall Study|Eligibility criteria not fulfilled|4
5584588|NCT01005251|19297556|P2|Overall Study|Eligibility criteria not fulfilled|0
5584589|NCT01005251|19297557|P1|Overall Study|Eligibility criteria not fulfilled|4
5584590|NCT01005251|19297553|P5|Overall Study|Withdrawal by Subject|9
5584591|NCT01005251|19297554|P4|Overall Study|Withdrawal by Subject|4
5584592|NCT01005251|19297555|P3|Overall Study|Withdrawal by Subject|3
5584593|NCT01005251|19297556|P2|Overall Study|Withdrawal by Subject|5
5584594|NCT01005251|19297557|P1|Overall Study|Withdrawal by Subject|2
5584595|NCT01004861|19297641|P13|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584596|NCT01004861|19297642|P12|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584597|NCT01004861|19297643|P11|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584598|NCT01004861|19297644|P10|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584599|NCT01004861|19297645|P9|Overall Study|Ongoing (as of 31 Jan 2018)|13
5584600|NCT01004861|19297646|P8|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584601|NCT01004861|19297647|P7|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584602|NCT01004861|19297648|P6|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584603|NCT01004861|19297649|P5|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584604|NCT01004861|19297650|P4|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584605|NCT01004861|19297651|P3|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584606|NCT01004861|19297652|P2|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584607|NCT01004861|19297653|P1|Overall Study|Ongoing (as of 31 Jan 2018)|0
5584608|NCT01004861|19297641|P13|Overall Study|Other|3
5584609|NCT01004861|19297642|P12|Overall Study|Other|2
5584610|NCT01004861|19297643|P11|Overall Study|Other|1
5584611|NCT01004861|19297644|P10|Overall Study|Other|2
5584612|NCT01004861|19297645|P9|Overall Study|Other|1
5584613|NCT01004861|19297646|P8|Overall Study|Other|0
5584614|NCT01004861|19297647|P7|Overall Study|Other|0
5584615|NCT01004861|19297648|P6|Overall Study|Other|0
5584616|NCT01004861|19297649|P5|Overall Study|Other|0
5584617|NCT01004861|19297650|P4|Overall Study|Other|0
5584618|NCT01004861|19297651|P3|Overall Study|Other|0
5584619|NCT01004861|19297652|P2|Overall Study|Other|0
5584620|NCT01004861|19297653|P1|Overall Study|Other|0
5584621|NCT01004861|19297641|P13|Overall Study|Non-compliance|1
5584622|NCT01004861|19297642|P12|Overall Study|Non-compliance|0
5584623|NCT01004861|19297643|P11|Overall Study|Non-compliance|0
5584624|NCT01004861|19297644|P10|Overall Study|Non-compliance|0
5584625|NCT01004861|19297645|P9|Overall Study|Non-compliance|5
5584626|NCT01004861|19297646|P8|Overall Study|Non-compliance|0
5584627|NCT01004861|19297647|P7|Overall Study|Non-compliance|0
5584628|NCT01004861|19297648|P6|Overall Study|Non-compliance|0
5584629|NCT01004861|19297649|P5|Overall Study|Non-compliance|0
5584630|NCT01004861|19297650|P4|Overall Study|Non-compliance|0
5584631|NCT01004861|19297651|P3|Overall Study|Non-compliance|0
5584632|NCT01004861|19297652|P2|Overall Study|Non-compliance|0
5584633|NCT01004861|19297653|P1|Overall Study|Non-compliance|0
5584634|NCT01004861|19297641|P13|Overall Study|Lost to Follow-up|0
5584635|NCT01004861|19297642|P12|Overall Study|Lost to Follow-up|1
5584636|NCT01004861|19297643|P11|Overall Study|Lost to Follow-up|0
5584637|NCT01004861|19297644|P10|Overall Study|Lost to Follow-up|0
5584638|NCT01004861|19297645|P9|Overall Study|Lost to Follow-up|1
5584639|NCT01004861|19297646|P8|Overall Study|Lost to Follow-up|1
5584640|NCT01004861|19297647|P7|Overall Study|Lost to Follow-up|0
5584641|NCT01004861|19297648|P6|Overall Study|Lost to Follow-up|0
5584642|NCT01004861|19297649|P5|Overall Study|Lost to Follow-up|0
5584643|NCT01004861|19297650|P4|Overall Study|Lost to Follow-up|0
5584644|NCT01004861|19297651|P3|Overall Study|Lost to Follow-up|0
5584645|NCT01004861|19297652|P2|Overall Study|Lost to Follow-up|0
5584646|NCT01004861|19297653|P1|Overall Study|Lost to Follow-up|0
5584647|NCT01004861|19297641|P13|Overall Study|Withdrawal by Subject|3
5584648|NCT01004861|19297642|P12|Overall Study|Withdrawal by Subject|2
5584649|NCT01004861|19297643|P11|Overall Study|Withdrawal by Subject|1
5584650|NCT01004861|19297644|P10|Overall Study|Withdrawal by Subject|1
5584651|NCT01004861|19297645|P9|Overall Study|Withdrawal by Subject|2
5584652|NCT01004861|19297646|P8|Overall Study|Withdrawal by Subject|0
5584653|NCT01004861|19297647|P7|Overall Study|Withdrawal by Subject|1
5584654|NCT01004861|19297648|P6|Overall Study|Withdrawal by Subject|0
5584655|NCT01004861|19297649|P5|Overall Study|Withdrawal by Subject|1
5584656|NCT01004861|19297650|P4|Overall Study|Withdrawal by Subject|0
5584657|NCT01004861|19297651|P3|Overall Study|Withdrawal by Subject|0
5584658|NCT01004861|19297652|P2|Overall Study|Withdrawal by Subject|0
5584659|NCT01004861|19297653|P1|Overall Study|Withdrawal by Subject|0
5584660|NCT01004861|19297641|P13|Overall Study|Protocol Violation|0
5584661|NCT01004861|19297642|P12|Overall Study|Protocol Violation|0
5584662|NCT01004861|19297643|P11|Overall Study|Protocol Violation|0
5584663|NCT01004861|19297644|P10|Overall Study|Protocol Violation|0
5584664|NCT01004861|19297645|P9|Overall Study|Protocol Violation|0
5584665|NCT01004861|19297646|P8|Overall Study|Protocol Violation|0
5584666|NCT01004861|19297647|P7|Overall Study|Protocol Violation|0
5584667|NCT01004861|19297648|P6|Overall Study|Protocol Violation|0
5584668|NCT01004861|19297649|P5|Overall Study|Protocol Violation|1
5584669|NCT01004861|19297650|P4|Overall Study|Protocol Violation|0
5584670|NCT01004861|19297651|P3|Overall Study|Protocol Violation|0
5584671|NCT01004861|19297652|P2|Overall Study|Protocol Violation|0
5584672|NCT01004861|19297653|P1|Overall Study|Protocol Violation|0
5584673|NCT01004861|19297641|P13|Overall Study|Adverse Event|2
5584674|NCT01004861|19297642|P12|Overall Study|Adverse Event|0
5584675|NCT01004861|19297643|P11|Overall Study|Adverse Event|1
5584676|NCT01004861|19297644|P10|Overall Study|Adverse Event|1
5584677|NCT01004861|19297645|P9|Overall Study|Adverse Event|13
5584678|NCT01004861|19297646|P8|Overall Study|Adverse Event|1
5584679|NCT01004861|19297647|P7|Overall Study|Adverse Event|1
5584680|NCT01004861|19297648|P6|Overall Study|Adverse Event|2
5584681|NCT01004861|19297649|P5|Overall Study|Adverse Event|0
5584682|NCT01004861|19297650|P4|Overall Study|Adverse Event|1
5584683|NCT01004861|19297651|P3|Overall Study|Adverse Event|0
5584684|NCT01004861|19297652|P2|Overall Study|Adverse Event|0
5584685|NCT01004861|19297653|P1|Overall Study|Adverse Event|0
5584686|NCT01004861|19297641|P13|Overall Study|Physician Decision|3
5584687|NCT01004861|19297642|P12|Overall Study|Physician Decision|0
5584688|NCT01004861|19297643|P11|Overall Study|Physician Decision|0
5584689|NCT01004861|19297644|P10|Overall Study|Physician Decision|0
5584690|NCT01004861|19297645|P9|Overall Study|Physician Decision|0
5584691|NCT01004861|19297646|P8|Overall Study|Physician Decision|1
5584692|NCT01004861|19297647|P7|Overall Study|Physician Decision|0
5584693|NCT01004861|19297648|P6|Overall Study|Physician Decision|0
5584694|NCT01004861|19297649|P5|Overall Study|Physician Decision|1
5584695|NCT01004861|19297650|P4|Overall Study|Physician Decision|1
5584696|NCT01004861|19297651|P3|Overall Study|Physician Decision|1
5584697|NCT01004861|19297652|P2|Overall Study|Physician Decision|2
5584698|NCT01004861|19297653|P1|Overall Study|Physician Decision|0
5584699|NCT01004861|19297641|P13|Overall Study|Disease progression|8
5584700|NCT01004861|19297642|P12|Overall Study|Disease progression|3
5584701|NCT01004861|19297643|P11|Overall Study|Disease progression|6
5584702|NCT01004861|19297644|P10|Overall Study|Disease progression|7
5584703|NCT01004861|19297645|P9|Overall Study|Disease progression|4
5584704|NCT01004861|19297646|P8|Overall Study|Disease progression|1
5584705|NCT01004861|19297647|P7|Overall Study|Disease progression|5
5584706|NCT01004861|19297648|P6|Overall Study|Disease progression|4
5584707|NCT01004861|19297649|P5|Overall Study|Disease progression|4
5584708|NCT01004861|19297650|P4|Overall Study|Disease progression|4
5584709|NCT01004861|19297651|P3|Overall Study|Disease progression|5
5584710|NCT01004861|19297652|P2|Overall Study|Disease progression|4
5584711|NCT01004861|19297653|P1|Overall Study|Disease progression|3
5584712|NCT01004848|19297719|P2|Overall Study|Lost to Follow-up|45
5584713|NCT01004848|19297720|P1|Overall Study|Lost to Follow-up|55
5584714|NCT01004822|19297758|P8|Overall Study|Other|0
5584715|NCT01004822|19297759|P7|Overall Study|Other|0
5584716|NCT01004822|19297760|P6|Overall Study|Other|1
5584717|NCT01004822|19297761|P5|Overall Study|Other|0
5584718|NCT01004822|19297762|P4|Overall Study|Other|1
5584719|NCT01004822|19297763|P3|Overall Study|Other|4
5584720|NCT01004822|19297764|P2|Overall Study|Other|0
5584721|NCT01004822|19297765|P1|Overall Study|Other|0
5584722|NCT01004822|19297758|P8|Overall Study|Adverse Event|1
5584723|NCT01004822|19297759|P7|Overall Study|Adverse Event|1
5584724|NCT01004822|19297760|P6|Overall Study|Adverse Event|0
5584725|NCT01004822|19297761|P5|Overall Study|Adverse Event|0
5584726|NCT01004822|19297762|P4|Overall Study|Adverse Event|0
5584727|NCT01004822|19297763|P3|Overall Study|Adverse Event|0
5584728|NCT01004822|19297764|P2|Overall Study|Adverse Event|0
5584729|NCT01004822|19297765|P1|Overall Study|Adverse Event|0
5584730|NCT01004822|19297758|P8|Overall Study|No longer willing to continue|0
5584731|NCT01004822|19297759|P7|Overall Study|No longer willing to continue|1
5584732|NCT01004822|19297760|P6|Overall Study|No longer willing to continue|1
5584733|NCT01004822|19297761|P5|Overall Study|No longer willing to continue|2
5584734|NCT01004822|19297762|P4|Overall Study|No longer willing to continue|1
5584735|NCT01004822|19297763|P3|Overall Study|No longer willing to continue|0
5584736|NCT01004822|19297764|P2|Overall Study|No longer willing to continue|0
5584737|NCT01004822|19297765|P1|Overall Study|No longer willing to continue|0
5584738|NCT01004822|19297758|P8|Overall Study|Global deterioration of health status|0
5584739|NCT01004822|19297759|P7|Overall Study|Global deterioration of health status|1
5584740|NCT01004822|19297760|P6|Overall Study|Global deterioration of health status|0
5584741|NCT01004822|19297761|P5|Overall Study|Global deterioration of health status|0
5584742|NCT01004822|19297762|P4|Overall Study|Global deterioration of health status|1
5584743|NCT01004822|19297763|P3|Overall Study|Global deterioration of health status|0
5584744|NCT01004822|19297764|P2|Overall Study|Global deterioration of health status|0
5584745|NCT01004822|19297765|P1|Overall Study|Global deterioration of health status|0
5584746|NCT01004822|19297758|P8|Overall Study|Objective progression or relapse|4
5584747|NCT01004822|19297759|P7|Overall Study|Objective progression or relapse|1
5584748|NCT01004822|19297760|P6|Overall Study|Objective progression or relapse|2
5584749|NCT01004822|19297761|P5|Overall Study|Objective progression or relapse|2
5584750|NCT01004822|19297762|P4|Overall Study|Objective progression or relapse|1
5584751|NCT01004822|19297763|P3|Overall Study|Objective progression or relapse|0
5584752|NCT01004822|19297764|P2|Overall Study|Objective progression or relapse|3
5584753|NCT01004822|19297765|P1|Overall Study|Objective progression or relapse|3
5584754|NCT01004614|19297930|P4|Washout|Withdrawal by Subject|0
5584755|NCT01004614|19297931|P3|Washout|Withdrawal by Subject|0
5584756|NCT01004614|19297932|P2|Washout|Withdrawal by Subject|1
5584757|NCT01004614|19297933|P1|Washout|Withdrawal by Subject|0
5584758|NCT01004510|19297967|P1|Overall Study|Adverse Event|1
5584759|NCT01004432|19297971|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
5584760|NCT01004432|19297972|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5584761|NCT01004432|19297973|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5584762|NCT01004432|19297974|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5584763|NCT01004432|19297975|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
5584764|NCT01004432|19297971|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
5584765|NCT01004432|19297972|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5584766|NCT01004432|19297973|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5584767|NCT01004432|19297974|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5584768|NCT01004432|19297975|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
5584769|NCT01004432|19297971|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
5584770|NCT01004432|19297972|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5584771|NCT01004432|19297973|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5584772|NCT01004432|19297974|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5584773|NCT01004432|19297975|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
5584774|NCT01004432|19297971|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
5584775|NCT01004432|19297972|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
5584776|NCT01004432|19297973|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
5584777|NCT01004432|19297974|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
5584778|NCT01004432|19297975|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
5584779|NCT01004432|19297971|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
5584780|NCT01004432|19297972|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
5584781|NCT01004432|19297973|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
5584782|NCT01004432|19297974|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
5584783|NCT01004432|19297975|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
5584784|NCT01004432|19297971|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
5584785|NCT01004432|19297972|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
5584786|NCT01004432|19297973|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
5584787|NCT01004432|19297974|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
5584788|NCT01004432|19297975|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
5584789|NCT01004432|19297971|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5584790|NCT01004432|19297972|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
5584791|NCT01004432|19297973|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5584792|NCT01004432|19297974|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5584793|NCT01004432|19297975|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
5584794|NCT01004432|19297971|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
5584961|NCT01003249|19298318|P1|Second Intervention (4 Weeks)|Adverse Event|1
5584795|NCT01004432|19297972|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
5584796|NCT01004432|19297973|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
5584797|NCT01004432|19297974|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
5584798|NCT01004432|19297975|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
5584799|NCT01004432|19297971|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
5584800|NCT01004432|19297972|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
5584801|NCT01004432|19297973|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
5584802|NCT01004432|19297974|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
5584803|NCT01004432|19297975|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
5584804|NCT01004432|19297971|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
5584805|NCT01004432|19297972|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
5584806|NCT01004432|19297973|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
5584807|NCT01004432|19297974|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
5584808|NCT01004432|19297975|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
5584809|NCT01004432|19297971|P5|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5584810|NCT01004432|19297972|P4|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5584811|NCT01004432|19297973|P3|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5584812|NCT01004432|19297974|P2|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
5584813|NCT01004432|19297975|P1|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
5584814|NCT01004432|19297971|P5|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5584815|NCT01004432|19297972|P4|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5584816|NCT01004432|19297973|P3|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5584817|NCT01004432|19297974|P2|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
5584818|NCT01004432|19297975|P1|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
5584819|NCT01004432|19297971|P5|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5584820|NCT01004432|19297972|P4|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5584821|NCT01004432|19297973|P3|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5584822|NCT01004432|19297974|P2|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
5584823|NCT01004432|19297975|P1|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
5584824|NCT01004432|19297971|P5|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5584825|NCT01004432|19297972|P4|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5584826|NCT01004432|19297973|P3|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5584827|NCT01004432|19297974|P2|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
5584828|NCT01004432|19297975|P1|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
5584829|NCT01004432|19297971|P5|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5584830|NCT01004432|19297972|P4|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5584831|NCT01004432|19297973|P3|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5584832|NCT01004432|19297974|P2|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
5584833|NCT01004432|19297975|P1|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
5584834|NCT01004406|19297997|P2|Overall Study|Lost to Follow-up|0
5584835|NCT01004406|19297998|P1|Overall Study|Lost to Follow-up|1
5584836|NCT01004406|19297997|P2|Overall Study|Withdrawal by Subject|0
5584837|NCT01004406|19297998|P1|Overall Study|Withdrawal by Subject|2
5584838|NCT01004263|19298033|P1|Overall Study|Lack of Qualifying Event|2
5584839|NCT01004263|19298033|P1|Overall Study|Physician Decision|15
5584840|NCT01004263|19298033|P1|Overall Study|Pregnancy|2
5584841|NCT01004263|19298033|P1|Overall Study|Lack of Efficacy|13
5584842|NCT01004263|19298033|P1|Overall Study|Lost to Follow-up|64
5584843|NCT01004263|19298033|P1|Overall Study|Protocol Violation|10
5584844|NCT01004263|19298033|P1|Overall Study|Withdrawal by Subject|58
5584845|NCT01004263|19298033|P1|Overall Study|Adverse Event|15
5584846|NCT01004250|19298041|P1|Follow-Up (FU) Period|Lost to Follow-up|1
5584847|NCT01004250|19298041|P1|Maintenance Therapy Period|Physician Decision|4
5584848|NCT01004250|19298041|P1|Maintenance Therapy Period|Withdrawal by Subject|5
5584849|NCT01004250|19298041|P1|Maintenance Therapy Period|Protocol Violation|1
5584850|NCT01004250|19298041|P1|Maintenance Therapy Period|Lost to Follow-up|1
5584851|NCT01004250|19298041|P1|Maintenance Therapy Period|Adverse Event|15
5584852|NCT01004250|19298041|P1|Induction Therapy Period|Physician Decision|2
5584853|NCT01004250|19298041|P1|Induction Therapy Period|Withdrawal by Subject|2
5584854|NCT01004250|19298041|P1|Induction Therapy Period|Entry Criteria Not Met|1
5584855|NCT01004250|19298041|P1|Induction Therapy Period|Adverse Event|10
5584856|NCT01004185|19298053|P2|Overall Study|Withdrawal by Subject|1
5584857|NCT01004185|19298054|P1|Overall Study|Withdrawal by Subject|2
5584858|NCT01004185|19298053|P2|Overall Study|Sponsor Terminated Study|5
5584859|NCT01004185|19298054|P1|Overall Study|Sponsor Terminated Study|4
5584860|NCT01004185|19298053|P2|Overall Study|Lack of Efficacy|1
5584861|NCT01004185|19298054|P1|Overall Study|Lack of Efficacy|2
5584862|NCT01004185|19298053|P2|Overall Study|Lost to Follow-up|1
5584863|NCT01004185|19298054|P1|Overall Study|Lost to Follow-up|0
5584864|NCT01004185|19298053|P2|Overall Study|Adverse Event|1
5584865|NCT01004185|19298054|P1|Overall Study|Adverse Event|1
5584866|NCT01004172|19298062|P1|Overall Study|Symptomatic Deterioration|2
5584867|NCT01004172|19298062|P1|Overall Study|Physician Decision|1
5584868|NCT01004172|19298062|P1|Overall Study|Adverse Event|1
5584869|NCT01004172|19298062|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
5584870|NCT01004172|19298062|P1|Overall Study|Progressive Disease in Non-CNS Only|16
5585048|NCT01001767|19298774|P2|Overall Study|Lost to Follow-up|0
5584871|NCT01004172|19298062|P1|Overall Study|Progressive Disease in CNS Only|16
5584872|NCT01004159|19298070|P1|Overall Study|Disease Progression|18
5584873|NCT01004159|19298070|P1|Overall Study|Adverse Event|2
5584874|NCT01004146|19298077|P2|Overall Study|Withdrawal by Subject|5
5584875|NCT01004146|19298078|P1|Overall Study|Withdrawal by Subject|4
5584876|NCT01004003|19298172|P9|Overall Study|Other|0
5584877|NCT01004003|19298173|P8|Overall Study|Other|0
5584878|NCT01004003|19298174|P7|Overall Study|Other|0
5584879|NCT01004003|19298175|P6|Overall Study|Other|1
5584880|NCT01004003|19298176|P5|Overall Study|Other|0
5584881|NCT01004003|19298177|P4|Overall Study|Other|0
5584882|NCT01004003|19298178|P3|Overall Study|Other|0
5584883|NCT01004003|19298179|P2|Overall Study|Other|0
5584884|NCT01004003|19298180|P1|Overall Study|Other|0
5584885|NCT01004003|19298172|P9|Overall Study|Refused to continue taking trial med.|2
5584886|NCT01004003|19298173|P8|Overall Study|Refused to continue taking trial med.|0
5584887|NCT01004003|19298174|P7|Overall Study|Refused to continue taking trial med.|0
5584888|NCT01004003|19298175|P6|Overall Study|Refused to continue taking trial med.|0
5584889|NCT01004003|19298176|P5|Overall Study|Refused to continue taking trial med.|0
5584890|NCT01004003|19298177|P4|Overall Study|Refused to continue taking trial med.|0
5584891|NCT01004003|19298178|P3|Overall Study|Refused to continue taking trial med.|0
5584892|NCT01004003|19298179|P2|Overall Study|Refused to continue taking trial med.|0
5584893|NCT01004003|19298180|P1|Overall Study|Refused to continue taking trial med.|0
5584894|NCT01004003|19298172|P9|Overall Study|Adverse Event|6
5584895|NCT01004003|19298173|P8|Overall Study|Adverse Event|21
5584896|NCT01004003|19298174|P7|Overall Study|Adverse Event|7
5584897|NCT01004003|19298175|P6|Overall Study|Adverse Event|2
5584898|NCT01004003|19298176|P5|Overall Study|Adverse Event|2
5584899|NCT01004003|19298177|P4|Overall Study|Adverse Event|3
5584900|NCT01004003|19298178|P3|Overall Study|Adverse Event|3
5584901|NCT01004003|19298179|P2|Overall Study|Adverse Event|2
5584902|NCT01004003|19298180|P1|Overall Study|Adverse Event|4
5584903|NCT01004003|19298172|P9|Overall Study|Progressive disease|22
5584904|NCT01004003|19298173|P8|Overall Study|Progressive disease|39
5584905|NCT01004003|19298174|P7|Overall Study|Progressive disease|1
5584906|NCT01004003|19298175|P6|Overall Study|Progressive disease|1
5584907|NCT01004003|19298176|P5|Overall Study|Progressive disease|2
5584908|NCT01004003|19298177|P4|Overall Study|Progressive disease|0
5584909|NCT01004003|19298178|P3|Overall Study|Progressive disease|1
5584910|NCT01004003|19298179|P2|Overall Study|Progressive disease|1
5584911|NCT01004003|19298180|P1|Overall Study|Progressive disease|2
5584912|NCT01003990|19298211|P3|Overall Study|Subject Withdrew Consent|7
5584913|NCT01003990|19298212|P2|Overall Study|Subject Withdrew Consent|5
5584914|NCT01003990|19298213|P1|Overall Study|Subject Withdrew Consent|12
5584915|NCT01003990|19298211|P3|Overall Study|No Longer Met Study Criteria|0
5584916|NCT01003990|19298212|P2|Overall Study|No Longer Met Study Criteria|1
5584917|NCT01003990|19298213|P1|Overall Study|No Longer Met Study Criteria|4
5584918|NCT01003990|19298211|P3|Overall Study|Pregnancy|4
5584919|NCT01003990|19298212|P2|Overall Study|Pregnancy|2
5584920|NCT01003990|19298213|P1|Overall Study|Pregnancy|10
5584921|NCT01003990|19298211|P3|Overall Study|Poor/Non-compliance|2
5584922|NCT01003990|19298212|P2|Overall Study|Poor/Non-compliance|3
5584923|NCT01003990|19298213|P1|Overall Study|Poor/Non-compliance|4
5584924|NCT01003990|19298211|P3|Overall Study|Reasons Not Identified|8
5584925|NCT01003990|19298212|P2|Overall Study|Reasons Not Identified|13
5584926|NCT01003990|19298213|P1|Overall Study|Reasons Not Identified|14
5584927|NCT01003990|19298211|P3|Overall Study|Lost to Follow-up|7
5584928|NCT01003990|19298212|P2|Overall Study|Lost to Follow-up|12
5584929|NCT01003990|19298213|P1|Overall Study|Lost to Follow-up|30
5584930|NCT01003990|19298211|P3|Overall Study|Lack of Efficacy|3
5584931|NCT01003990|19298212|P2|Overall Study|Lack of Efficacy|2
5584932|NCT01003990|19298213|P1|Overall Study|Lack of Efficacy|10
5584933|NCT01003990|19298211|P3|Overall Study|Death|1
5584934|NCT01003990|19298212|P2|Overall Study|Death|8
5584935|NCT01003990|19298213|P1|Overall Study|Death|0
5584936|NCT01003990|19298211|P3|Overall Study|Adverse Event|11
5584937|NCT01003990|19298212|P2|Overall Study|Adverse Event|5
5584938|NCT01003990|19298213|P1|Overall Study|Adverse Event|8
5584939|NCT01003899|19298230|P1|Overall Study|Progressive disease|34
5584940|NCT01003899|19298230|P1|Overall Study|Not treated|1
5584941|NCT01003899|19298230|P1|Overall Study|Not entered|4
5584942|NCT01003899|19298230|P1|Overall Study|Other Adverse Event|8
5584943|NCT01003886|19298239|P1|Overall Study|Adverse Event|3
5584944|NCT01003886|19298239|P1|Overall Study|Other|14
5584945|NCT01003886|19298239|P1|Overall Study|Withdrawal by Subject|39
5584946|NCT01003886|19298239|P1|Overall Study|Lost to Follow-up|169
5584947|NCT01003886|19298239|P1|Overall Study|Lack of Efficacy|5
5584948|NCT01003639|19298260|P2|Overall Study|Physician Decision|0
5584949|NCT01003639|19298261|P1|Overall Study|Physician Decision|1
5584950|NCT01003639|19298260|P2|Overall Study|Protocol Violation|1
5584951|NCT01003639|19298261|P1|Overall Study|Protocol Violation|0
5584952|NCT01003639|19298260|P2|Overall Study|Adverse Event|1
5584953|NCT01003639|19298261|P1|Overall Study|Adverse Event|0
5584954|NCT01003639|19298260|P2|Overall Study|Lack of Efficacy|6
5584955|NCT01003639|19298261|P1|Overall Study|Lack of Efficacy|1
5584956|NCT01003639|19298260|P2|Overall Study|Withdrawal by Subject|5
5584957|NCT01003639|19298261|P1|Overall Study|Withdrawal by Subject|9
5584958|NCT01003639|19298260|P2|Overall Study|Lost to Follow-up|9
5584959|NCT01003639|19298261|P1|Overall Study|Lost to Follow-up|6
5584960|NCT01003249|19298317|P2|Second Intervention (4 Weeks)|Adverse Event|0
5584962|NCT01003249|19298317|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
5584963|NCT01003249|19298318|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
5584964|NCT01003249|19298317|P2|First Intervention (4 Weeks)|Non-Serious Event|1
5584965|NCT01003249|19298318|P1|First Intervention (4 Weeks)|Non-Serious Event|1
5584966|NCT01003249|19298317|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
5584967|NCT01003249|19298318|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
5584968|NCT01003210|19298336|P2|Overall Study|Lost to Follow-up|3
5584969|NCT01003210|19298337|P1|Overall Study|Lost to Follow-up|1
5584970|NCT01003184|19298349|P2|Overall Study|Physician Decision|0
5584971|NCT01003184|19298350|P1|Overall Study|Physician Decision|1
5584972|NCT01003184|19298349|P2|Overall Study|Withdrawal by Subject|6
5584973|NCT01003184|19298350|P1|Overall Study|Withdrawal by Subject|1
5584974|NCT01003184|19298349|P2|Overall Study|Protocol Violation|0
5584975|NCT01003184|19298350|P1|Overall Study|Protocol Violation|3
5584976|NCT01003184|19298349|P2|Overall Study|Loss of glucose control|1
5584977|NCT01003184|19298350|P1|Overall Study|Loss of glucose control|1
5584978|NCT01003184|19298349|P2|Overall Study|Lost to Follow-up|0
5584979|NCT01003184|19298350|P1|Overall Study|Lost to Follow-up|1
5584980|NCT01003184|19298349|P2|Overall Study|Adverse Event|5
5584981|NCT01003184|19298350|P1|Overall Study|Adverse Event|12
5584982|NCT01002989|19298433|P1|Overall Study|exclusion criteria, no consent|5
5584983|NCT01002742|19298448|P2|Overall Study|Determined to be ineligible|1
5584984|NCT01002742|19298449|P1|Overall Study|Determined to be ineligible|0
5584985|NCT01002573|19298485|P2|Overall Study|Subject did not receive at least 1 dose|7
5584986|NCT01002573|19298486|P1|Overall Study|Subject did not receive at least 1 dose|11
5584987|NCT01002547|19298507|P3|Overall Study|Adverse Event|0
5584988|NCT01002547|19298508|P2|Overall Study|Adverse Event|0
5584989|NCT01002547|19298509|P1|Overall Study|Adverse Event|1
5584990|NCT01002547|19298507|P3|Overall Study|Death|2
5584991|NCT01002547|19298508|P2|Overall Study|Death|2
5584992|NCT01002547|19298509|P1|Overall Study|Death|0
5584993|NCT01002547|19298507|P3|Overall Study|Physician Decision|0
5584994|NCT01002547|19298508|P2|Overall Study|Physician Decision|0
5584995|NCT01002547|19298509|P1|Overall Study|Physician Decision|1
5584996|NCT01002547|19298507|P3|Overall Study|Lost to Follow-up|1
5584997|NCT01002547|19298508|P2|Overall Study|Lost to Follow-up|1
5584998|NCT01002547|19298509|P1|Overall Study|Lost to Follow-up|2
5584999|NCT01002547|19298507|P3|Overall Study|Withdrawal by Subject|5
5585000|NCT01002547|19298508|P2|Overall Study|Withdrawal by Subject|0
5585001|NCT01002547|19298509|P1|Overall Study|Withdrawal by Subject|4
5585002|NCT01002482|19298567|P2|Overall Study|Included twice|0
5585003|NCT01002482|19298568|P1|Overall Study|Included twice|1
5585004|NCT01002482|19298567|P2|Overall Study|Withdrawal by Subject|21
5585005|NCT01002482|19298568|P1|Overall Study|Withdrawal by Subject|14
5585006|NCT01002339|19298602|P3|Overall Study|Randomized. Not transplanted|1
5585007|NCT01002339|19298603|P2|Overall Study|Randomized. Not transplanted|0
5585008|NCT01002339|19298604|P1|Overall Study|Randomized. Not transplanted|0
5585009|NCT01002339|19298602|P3|Overall Study|Lung cancer detected before transplant|1
5585010|NCT01002339|19298603|P2|Overall Study|Lung cancer detected before transplant|0
5585011|NCT01002339|19298604|P1|Overall Study|Lung cancer detected before transplant|0
5585012|NCT01002339|19298602|P3|Overall Study|Protocol Violation|2
5585013|NCT01002339|19298603|P2|Overall Study|Protocol Violation|0
5585014|NCT01002339|19298604|P1|Overall Study|Protocol Violation|0
5585015|NCT01002339|19298602|P3|Overall Study|Incorrect treatment assignment|1
5585016|NCT01002339|19298603|P2|Overall Study|Incorrect treatment assignment|0
5585017|NCT01002339|19298604|P1|Overall Study|Incorrect treatment assignment|0
5585018|NCT01002339|19298602|P3|Overall Study|Withdrawal by Subject|0
5585019|NCT01002339|19298603|P2|Overall Study|Withdrawal by Subject|1
5585020|NCT01002339|19298604|P1|Overall Study|Withdrawal by Subject|0
5585021|NCT01002105|19298680|P2|Overall Study|condition worsened|2
5585022|NCT01002105|19298681|P1|Overall Study|condition worsened|4
5585023|NCT01002105|19298680|P2|Overall Study|non compliance|3
5585024|NCT01002105|19298681|P1|Overall Study|non compliance|5
5585025|NCT01002105|19298680|P2|Overall Study|Lost to Follow-up|16
5585026|NCT01002105|19298681|P1|Overall Study|Lost to Follow-up|10
5585027|NCT01001988|19298697|P1|Overall Study|Lost to Follow-up|15
5585028|NCT01001988|19298697|P1|Overall Study|Withdrawal by Subject|18
5585029|NCT01001988|19298697|P1|Overall Study|Protocol Violation|84
5585030|NCT01001832|19298715|P2|Follow-up Period|Other|1
5585031|NCT01001832|19298716|P1|Follow-up Period|Other|2
5585032|NCT01001832|19298715|P2|Follow-up Period|Follow-up no longer required /protocol|20
5585033|NCT01001832|19298716|P1|Follow-up Period|Follow-up no longer required /protocol|15
5585034|NCT01001832|19298715|P2|Follow-up Period|Withdrawal by Subject|0
5585035|NCT01001832|19298716|P1|Follow-up Period|Withdrawal by Subject|1
5585036|NCT01001832|19298715|P2|Long-term Period|Other|2
5585037|NCT01001832|19298716|P1|Long-term Period|Other|1
5585038|NCT01001832|19298715|P2|Long-term Period|Lack of Efficacy|2
5585039|NCT01001832|19298716|P1|Long-term Period|Lack of Efficacy|0
5585040|NCT01001832|19298715|P2|Long-term Period|Withdrawal by Subject|0
5585041|NCT01001832|19298716|P1|Long-term Period|Withdrawal by Subject|1
5585042|NCT01001832|19298715|P2|Long-term Period|Adverse Event|1
5585043|NCT01001832|19298716|P1|Long-term Period|Adverse Event|2
5585044|NCT01001832|19298715|P2|Short-term Period|Adverse Event|3
5585045|NCT01001832|19298716|P1|Short-term Period|Adverse Event|2
5585046|NCT01001767|19298774|P2|Overall Study|Physician Decision|0
5585047|NCT01001767|19298775|P1|Overall Study|Physician Decision|1
5585049|NCT01001767|19298775|P1|Overall Study|Lost to Follow-up|1
5585050|NCT01001767|19298774|P2|Overall Study|Protocol Violation|0
5585051|NCT01001767|19298775|P1|Overall Study|Protocol Violation|1
5585052|NCT01001767|19298774|P2|Overall Study|no baseline study performed|0
5585053|NCT01001767|19298775|P1|Overall Study|no baseline study performed|1
5585054|NCT01001702|19298781|P1|Overall Study|Lack of Efficacy per Investigator|3
5585055|NCT01001702|19298781|P1|Overall Study|Withdrawal by Subject|19
5585056|NCT01001702|19298781|P1|Overall Study|Investigator withdrew Subject|10
5585057|NCT01001702|19298781|P1|Overall Study|Subject met Withdrawal Criteria|22
5585058|NCT01001702|19298781|P1|Overall Study|Sponsor Discontinued Study|4
5585059|NCT01001702|19298781|P1|Overall Study|Adverse Event|7
5585060|NCT01001702|19298781|P1|Overall Study|Lost to Follow-up|7
5585061|NCT01001598|19298792|P1|Overall Study|Adverse Event|1
5585062|NCT01001598|19298792|P1|Overall Study|Hematopoietic Stem Cell Transplant|1
5585063|NCT01001572|19298800|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
5585064|NCT01001572|19298801|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
5585065|NCT01001572|19298802|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
5585066|NCT01001572|19298800|P3|Double-Blind Treatment Phase|Protocol deviation|1
5585067|NCT01001572|19298801|P2|Double-Blind Treatment Phase|Protocol deviation|0
5585068|NCT01001572|19298802|P1|Double-Blind Treatment Phase|Protocol deviation|0
5585069|NCT01001572|19298800|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
5585070|NCT01001572|19298801|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
5585071|NCT01001572|19298802|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
5585072|NCT01001572|19298800|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
5585073|NCT01001572|19298801|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
5585074|NCT01001572|19298802|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
5585075|NCT01001572|19298800|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
5585076|NCT01001572|19298801|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
5585077|NCT01001572|19298802|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
5585078|NCT01001572|19298800|P3|Double-Blind Treatment Phase|Adverse Event|2
5585079|NCT01001572|19298801|P2|Double-Blind Treatment Phase|Adverse Event|2
5585080|NCT01001572|19298802|P1|Double-Blind Treatment Phase|Adverse Event|0
5585081|NCT01001572|19298800|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
5585082|NCT01001572|19298801|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
5585083|NCT01001572|19298802|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
5585084|NCT01001572|19298800|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
5585085|NCT01001572|19298801|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
5585086|NCT01001572|19298802|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
5585087|NCT01001572|19298800|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
5585088|NCT01001572|19298801|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
5585089|NCT01001572|19298802|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
5585090|NCT01001572|19298800|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
5585091|NCT01001572|19298801|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
5585092|NCT01001572|19298802|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
5585093|NCT01001572|19298800|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
5585094|NCT01001572|19298801|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
5585095|NCT01001572|19298802|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
5585096|NCT01001572|19298800|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
5585097|NCT01001572|19298801|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
5585098|NCT01001572|19298802|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
5585099|NCT01001572|19298800|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
5585100|NCT01001572|19298801|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
5585101|NCT01001572|19298802|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
5585102|NCT01001572|19298800|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
5585103|NCT01001572|19298801|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
5585104|NCT01001572|19298802|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
5585105|NCT01001520|19298840|P2|Medication Period 2|Withdrawal by Subject|3
5585106|NCT01001520|19298841|P1|Medication Period 2|Withdrawal by Subject|0
5585107|NCT01001520|19298840|P2|Washout Period|Withdrawal by Subject|1
5585108|NCT01001520|19298841|P1|Washout Period|Withdrawal by Subject|2
5585109|NCT01001520|19298840|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
5585110|NCT01001520|19298841|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
5585111|NCT01001520|19298840|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
5585112|NCT01001520|19298841|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
5585113|NCT01001520|19298840|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
5585114|NCT01001520|19298841|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
5585115|NCT01001520|19298840|P2|Medication Period 1|Withdrawal by Subject|2
5585116|NCT01001520|19298841|P1|Medication Period 1|Withdrawal by Subject|2
5585117|NCT01001494|19298868|P3|Overall Study|Other|3
5585118|NCT01001494|19298869|P2|Overall Study|Other|1
5585119|NCT01001494|19298870|P1|Overall Study|Other|0
5585120|NCT01001494|19298868|P3|Overall Study|Lack of Efficacy|8
5585121|NCT01001494|19298869|P2|Overall Study|Lack of Efficacy|0
5585122|NCT01001494|19298870|P1|Overall Study|Lack of Efficacy|2
5585123|NCT01001494|19298868|P3|Overall Study|COPD exacerbation|5
5585124|NCT01001494|19298869|P2|Overall Study|COPD exacerbation|4
5585125|NCT01001494|19298870|P1|Overall Study|COPD exacerbation|3
5585126|NCT01001494|19298868|P3|Overall Study|Withdrawal by Subject|17
5585127|NCT01001494|19298869|P2|Overall Study|Withdrawal by Subject|7
5585128|NCT01001494|19298870|P1|Overall Study|Withdrawal by Subject|9
5585129|NCT01001494|19298868|P3|Overall Study|Lost to Follow-up|1
5585130|NCT01001494|19298869|P2|Overall Study|Lost to Follow-up|0
5585131|NCT01001494|19298870|P1|Overall Study|Lost to Follow-up|2
5585132|NCT01001494|19298868|P3|Overall Study|Protocol Violation|1
5585133|NCT01001494|19298869|P2|Overall Study|Protocol Violation|1
5585134|NCT01001494|19298870|P1|Overall Study|Protocol Violation|0
5585135|NCT01001494|19298868|P3|Overall Study|Adverse Event|6
5585136|NCT01001494|19298869|P2|Overall Study|Adverse Event|4
5585137|NCT01001494|19298870|P1|Overall Study|Adverse Event|8
5585138|NCT01001429|19298955|P2|Overall Study|surgery cancelled|1
5585139|NCT01001429|19298956|P1|Overall Study|surgery cancelled|0
5585140|NCT01001390|19298995|P2|Overall Study|Failure to wear AFO device|0
5585141|NCT01001390|19298996|P1|Overall Study|Failure to wear AFO device|2
5585142|NCT01001377|19299004|P2|Overall Study|Death|384
5585143|NCT01001377|19299005|P1|Overall Study|Death|391
5585144|NCT01001377|19299004|P2|Overall Study|Lost to Follow-up|17
5585145|NCT01001377|19299005|P1|Overall Study|Lost to Follow-up|14
5585146|NCT01001377|19299004|P2|Overall Study|Withdrawal by Subject|20
5585147|NCT01001377|19299005|P1|Overall Study|Withdrawal by Subject|19
5585148|NCT01001377|19299004|P2|Overall Study|Ineligibility determined|0
5585149|NCT01001377|19299005|P1|Overall Study|Ineligibility determined|2
5585150|NCT01001325|19299035|P2|Overall Study|Protocol Violation|0
5585151|NCT01001325|19299036|P1|Overall Study|Protocol Violation|2
5585152|NCT01001325|19299035|P2|Overall Study|Lost to Follow-up|10
5585153|NCT01001325|19299036|P1|Overall Study|Lost to Follow-up|16
5585154|NCT01001299|19299042|P1|Overall Study|Withdrew Consent|1
5585155|NCT01001299|19299042|P1|Overall Study|Began Taking Commercially Available Drug|2
5585156|NCT01001299|19299042|P1|Overall Study|Death|1
5585157|NCT01001299|19299042|P1|Overall Study|Adverse event or Intercurrent Illness|1
5585158|NCT01001299|19299042|P1|Overall Study|Insufficient Therapeutic Response|20
5585159|NCT01001234|19299071|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
5585160|NCT01001234|19299072|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
5585161|NCT01001234|19299073|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
5585162|NCT01001234|19299074|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
5585163|NCT01001234|19299075|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
5585164|NCT01001234|19299071|P5|Overall Study|Not Treated: Physician Decision|0
5585165|NCT01001234|19299072|P4|Overall Study|Not Treated: Physician Decision|0
5585166|NCT01001234|19299073|P3|Overall Study|Not Treated: Physician Decision|0
5585167|NCT01001234|19299074|P2|Overall Study|Not Treated: Physician Decision|4
5585168|NCT01001234|19299075|P1|Overall Study|Not Treated: Physician Decision|37
5585169|NCT01001234|19299071|P5|Overall Study|Not Treated: Pregnancy|0
5585170|NCT01001234|19299072|P4|Overall Study|Not Treated: Pregnancy|0
5585171|NCT01001234|19299073|P3|Overall Study|Not Treated: Pregnancy|0
5585172|NCT01001234|19299074|P2|Overall Study|Not Treated: Pregnancy|0
5585173|NCT01001234|19299075|P1|Overall Study|Not Treated: Pregnancy|3
5585174|NCT01001234|19299071|P5|Overall Study|Not Treated: Lost to Follow-up|0
5585175|NCT01001234|19299072|P4|Overall Study|Not Treated: Lost to Follow-up|5
5585176|NCT01001234|19299073|P3|Overall Study|Not Treated: Lost to Follow-up|7
5585177|NCT01001234|19299074|P2|Overall Study|Not Treated: Lost to Follow-up|4
5585178|NCT01001234|19299075|P1|Overall Study|Not Treated: Lost to Follow-up|53
5585179|NCT01001234|19299071|P5|Overall Study|Not Treated: Protocol Violation|0
5585180|NCT01001234|19299072|P4|Overall Study|Not Treated: Protocol Violation|0
5585181|NCT01001234|19299073|P3|Overall Study|Not Treated: Protocol Violation|0
5585182|NCT01001234|19299074|P2|Overall Study|Not Treated: Protocol Violation|0
5585183|NCT01001234|19299075|P1|Overall Study|Not Treated: Protocol Violation|3
5585184|NCT01001234|19299071|P5|Overall Study|Not Treated: Withdrawal by Subject|0
5585185|NCT01001234|19299072|P4|Overall Study|Not Treated: Withdrawal by Subject|0
5585186|NCT01001234|19299073|P3|Overall Study|Not Treated: Withdrawal by Subject|2
5585187|NCT01001234|19299074|P2|Overall Study|Not Treated: Withdrawal by Subject|2
5585188|NCT01001234|19299075|P1|Overall Study|Not Treated: Withdrawal by Subject|23
5585189|NCT01001234|19299071|P5|Overall Study|Not Treated: Adverse Event|0
5585190|NCT01001234|19299072|P4|Overall Study|Not Treated: Adverse Event|0
5585191|NCT01001234|19299073|P3|Overall Study|Not Treated: Adverse Event|0
5585192|NCT01001234|19299074|P2|Overall Study|Not Treated: Adverse Event|0
5585193|NCT01001234|19299075|P1|Overall Study|Not Treated: Adverse Event|1
5585194|NCT01001234|19299071|P5|Overall Study|Physician Decision|0
5585195|NCT01001234|19299072|P4|Overall Study|Physician Decision|0
5585196|NCT01001234|19299073|P3|Overall Study|Physician Decision|0
5585197|NCT01001234|19299074|P2|Overall Study|Physician Decision|0
5585198|NCT01001234|19299075|P1|Overall Study|Physician Decision|1
5585199|NCT01001234|19299071|P5|Overall Study|Lost to Follow-up|0
5585200|NCT01001234|19299072|P4|Overall Study|Lost to Follow-up|2
5585201|NCT01001234|19299073|P3|Overall Study|Lost to Follow-up|1
5585202|NCT01001234|19299074|P2|Overall Study|Lost to Follow-up|0
5585203|NCT01001234|19299075|P1|Overall Study|Lost to Follow-up|0
5585204|NCT01001234|19299071|P5|Overall Study|Protocol Violation|0
5585205|NCT01001234|19299072|P4|Overall Study|Protocol Violation|18
5585206|NCT01001234|19299073|P3|Overall Study|Protocol Violation|19
5585207|NCT01001234|19299074|P2|Overall Study|Protocol Violation|3
5585208|NCT01001234|19299075|P1|Overall Study|Protocol Violation|34
5585209|NCT01001234|19299071|P5|Overall Study|Withdrawal by Subject|0
5585210|NCT01001234|19299072|P4|Overall Study|Withdrawal by Subject|0
5585211|NCT01001234|19299073|P3|Overall Study|Withdrawal by Subject|3
5585212|NCT01001234|19299074|P2|Overall Study|Withdrawal by Subject|0
5585213|NCT01001234|19299075|P1|Overall Study|Withdrawal by Subject|2
5585214|NCT01001221|19299091|P5|Overall Study|Not treated; protocol exclusion|0
5585215|NCT01001221|19299092|P4|Overall Study|Not treated; protocol exclusion|0
5585216|NCT01001221|19299093|P3|Overall Study|Not treated; protocol exclusion|1
5585217|NCT01001221|19299094|P2|Overall Study|Not treated; protocol exclusion|0
5585218|NCT01001221|19299095|P1|Overall Study|Not treated; protocol exclusion|0
5585219|NCT01001221|19299091|P5|Overall Study|Other|0
5585220|NCT01001221|19299092|P4|Overall Study|Other|0
5585221|NCT01001221|19299093|P3|Overall Study|Other|0
5585222|NCT01001221|19299094|P2|Overall Study|Other|1
5585223|NCT01001221|19299095|P1|Overall Study|Other|1
5585224|NCT01001221|19299091|P5|Overall Study|Disease progression|0
5585225|NCT01001221|19299092|P4|Overall Study|Disease progression|4
5585226|NCT01001221|19299093|P3|Overall Study|Disease progression|2
5585227|NCT01001221|19299094|P2|Overall Study|Disease progression|2
5585228|NCT01001221|19299095|P1|Overall Study|Disease progression|3
5585229|NCT01001221|19299091|P5|Overall Study|Adverse Event|0
5585230|NCT01001221|19299092|P4|Overall Study|Adverse Event|2
5585231|NCT01001221|19299093|P3|Overall Study|Adverse Event|0
5585232|NCT01001221|19299094|P2|Overall Study|Adverse Event|2
5585233|NCT01001221|19299095|P1|Overall Study|Adverse Event|1
5585234|NCT01001208|19299270|P2|Overall Study|Other|2
5585235|NCT01001208|19299271|P1|Overall Study|Other|0
5585236|NCT01001208|19299270|P2|Overall Study|Disease Progression|3
5585237|NCT01001208|19299271|P1|Overall Study|Disease Progression|0
5585238|NCT01001208|19299270|P2|Overall Study|Noncompliance|7
5585239|NCT01001208|19299271|P1|Overall Study|Noncompliance|4
5585240|NCT01001208|19299270|P2|Overall Study|Ineligibility Determined|2
5585241|NCT01001208|19299271|P1|Overall Study|Ineligibility Determined|4
5585242|NCT01001208|19299270|P2|Overall Study|Withdrawal by Subject|5
5585243|NCT01001208|19299271|P1|Overall Study|Withdrawal by Subject|4
5585244|NCT01001208|19299270|P2|Overall Study|Physician Decision|0
5585245|NCT01001208|19299271|P1|Overall Study|Physician Decision|1
5585246|NCT01001208|19299270|P2|Overall Study|Lost to Follow-up|9
5585247|NCT01001208|19299271|P1|Overall Study|Lost to Follow-up|5
5585248|NCT01001208|19299270|P2|Overall Study|Adverse Event|5
5585249|NCT01001208|19299271|P1|Overall Study|Adverse Event|10
5585250|NCT01001169|19299314|P2|Overall Study|Withdrawal by Subject|1
5585251|NCT01001169|19299315|P1|Overall Study|Withdrawal by Subject|2
5585252|NCT01001104|19299423|P4|Overall Study|Withdrawal by Subject|2
5585253|NCT01001104|19299424|P3|Overall Study|Withdrawal by Subject|0
5585254|NCT01001104|19299425|P2|Overall Study|Withdrawal by Subject|0
5585255|NCT01001104|19299426|P1|Overall Study|Withdrawal by Subject|0
5585256|NCT01001104|19299423|P4|Overall Study|Entry Criteria Not Met|1
5585257|NCT01001104|19299424|P3|Overall Study|Entry Criteria Not Met|0
5585258|NCT01001104|19299425|P2|Overall Study|Entry Criteria Not Met|0
5585259|NCT01001104|19299426|P1|Overall Study|Entry Criteria Not Met|0
5585260|NCT01001104|19299423|P4|Overall Study|Lost to Follow-up|0
5585261|NCT01001104|19299424|P3|Overall Study|Lost to Follow-up|1
5585262|NCT01001104|19299425|P2|Overall Study|Lost to Follow-up|0
5585263|NCT01001104|19299426|P1|Overall Study|Lost to Follow-up|0
5585264|NCT01001104|19299423|P4|Overall Study|Adverse Event|0
5585265|NCT01001104|19299424|P3|Overall Study|Adverse Event|0
5585266|NCT01001104|19299425|P2|Overall Study|Adverse Event|1
5585267|NCT01001104|19299426|P1|Overall Study|Adverse Event|2
5585268|NCT01000974|19299517|P3|Booster Vaccination Phase|Other|4
5585269|NCT01000974|19299518|P2|Booster Vaccination Phase|Other|6
5585270|NCT01000974|19299519|P1|Booster Vaccination Phase|Other|24
5585271|NCT01000974|19299517|P3|Booster Vaccination Phase|Lost to Follow-up|7
5585272|NCT01000974|19299518|P2|Booster Vaccination Phase|Lost to Follow-up|5
5585273|NCT01000974|19299519|P1|Booster Vaccination Phase|Lost to Follow-up|40
5585274|NCT01000974|19299517|P3|Booster Vaccination Phase|Withdrawal by Subject|1
5585275|NCT01000974|19299518|P2|Booster Vaccination Phase|Withdrawal by Subject|1
5585276|NCT01000974|19299519|P1|Booster Vaccination Phase|Withdrawal by Subject|3
5585277|NCT01000974|19299517|P3|Booster Vaccination Phase|Protocol Violation|2
5585278|NCT01000974|19299518|P2|Booster Vaccination Phase|Protocol Violation|0
5585279|NCT01000974|19299519|P1|Booster Vaccination Phase|Protocol Violation|0
5585280|NCT01000974|19299517|P3|Primary Vaccination Phase|Other|12
5585281|NCT01000974|19299518|P2|Primary Vaccination Phase|Other|9
5585282|NCT01000974|19299519|P1|Primary Vaccination Phase|Other|4
5585283|NCT01000974|19299517|P3|Primary Vaccination Phase|Adverse Event|2
5585284|NCT01000974|19299518|P2|Primary Vaccination Phase|Adverse Event|2
5585285|NCT01000974|19299519|P1|Primary Vaccination Phase|Adverse Event|14
5585286|NCT01000974|19299517|P3|Primary Vaccination Phase|Protocol Violation|2
5585287|NCT01000974|19299518|P2|Primary Vaccination Phase|Protocol Violation|3
5585288|NCT01000974|19299519|P1|Primary Vaccination Phase|Protocol Violation|40
5585289|NCT01000974|19299517|P3|Primary Vaccination Phase|Lost to Follow-up|26
5585290|NCT01000974|19299518|P2|Primary Vaccination Phase|Lost to Follow-up|19
5585291|NCT01000974|19299519|P1|Primary Vaccination Phase|Lost to Follow-up|171
5585292|NCT01000974|19299517|P3|Primary Vaccination Phase|Withdrawal by Subject|21
5585293|NCT01000974|19299518|P2|Primary Vaccination Phase|Withdrawal by Subject|17
5585294|NCT01000974|19299519|P1|Primary Vaccination Phase|Withdrawal by Subject|109
5585295|NCT01000961|19299626|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
5585296|NCT01000961|19299627|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
5585297|NCT01000961|19299626|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
5585298|NCT01000961|19299627|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
5585299|NCT01000805|19299650|P2|Overall Study|Sponsor Decision|1
5585300|NCT01000805|19299651|P1|Overall Study|Sponsor Decision|0
5585301|NCT01000805|19299650|P2|Overall Study|Withdrawal by Subject|6
5585302|NCT01000805|19299651|P1|Overall Study|Withdrawal by Subject|16
5585303|NCT01000805|19299650|P2|Overall Study|Protocol Violation|8
5585304|NCT01000805|19299651|P1|Overall Study|Protocol Violation|12
5585305|NCT01000805|19299650|P2|Overall Study|Physician Decision|1
5585306|NCT01000805|19299651|P1|Overall Study|Physician Decision|0
5585307|NCT01000805|19299650|P2|Overall Study|Lost to Follow-up|21
5585308|NCT01000805|19299651|P1|Overall Study|Lost to Follow-up|16
5585309|NCT01000805|19299650|P2|Overall Study|Lack of Efficacy|16
5585310|NCT01000805|19299651|P1|Overall Study|Lack of Efficacy|5
5585311|NCT01000805|19299650|P2|Overall Study|Adverse Event|9
5585312|NCT01000805|19299651|P1|Overall Study|Adverse Event|21
5585313|NCT01000727|19299685|P2|Overall Study|Study closed/terminated|24
5585314|NCT01000727|19299686|P1|Overall Study|Study closed/terminated|23
5585315|NCT01000727|19299685|P2|Overall Study|Withdrawal by Subject|109
5585316|NCT01000727|19299686|P1|Overall Study|Withdrawal by Subject|111
5585317|NCT01000727|19299685|P2|Overall Study|Lost to Follow-up|43
5585318|NCT01000727|19299686|P1|Overall Study|Lost to Follow-up|41
5585319|NCT01000649|19299751|P4|Overall Study|Lost to Follow-up|2
5585320|NCT01000649|19299752|P3|Overall Study|Lost to Follow-up|0
5585321|NCT01000649|19299753|P2|Overall Study|Lost to Follow-up|2
5585322|NCT01000649|19299754|P1|Overall Study|Lost to Follow-up|0
5585323|NCT01000649|19299751|P4|Overall Study|Adverse Event|4
5585324|NCT01000649|19299752|P3|Overall Study|Adverse Event|2
5585325|NCT01000649|19299753|P2|Overall Study|Adverse Event|1
5585326|NCT01000649|19299754|P1|Overall Study|Adverse Event|5
5585327|NCT01000610|19299835|P1|Overall Study|Treatment failure|1
5585328|NCT01000610|19299835|P1|Overall Study|Lost to Follow-up|4
5585329|NCT01000610|19299835|P1|Overall Study|Adverse Event|1
5585330|NCT01000506|19299846|P4|Overall Study|Withdrawal by Subject|7
5585331|NCT01000506|19299847|P3|Overall Study|Withdrawal by Subject|2
5585332|NCT01000506|19299848|P2|Overall Study|Withdrawal by Subject|8
5585333|NCT01000506|19299849|P1|Overall Study|Withdrawal by Subject|11
5585334|NCT01000506|19299846|P4|Overall Study|Physician Decision|3
5585335|NCT01000506|19299847|P3|Overall Study|Physician Decision|3
5585336|NCT01000506|19299848|P2|Overall Study|Physician Decision|3
5585337|NCT01000506|19299849|P1|Overall Study|Physician Decision|1
5585338|NCT01000506|19299846|P4|Overall Study|Lost to Follow-up|0
5585339|NCT01000506|19299847|P3|Overall Study|Lost to Follow-up|4
5585340|NCT01000506|19299848|P2|Overall Study|Lost to Follow-up|1
5585341|NCT01000506|19299849|P1|Overall Study|Lost to Follow-up|1
5585342|NCT01000506|19299846|P4|Overall Study|Protocol Violation|0
5585343|NCT01000506|19299847|P3|Overall Study|Protocol Violation|0
5585344|NCT01000506|19299848|P2|Overall Study|Protocol Violation|1
5585345|NCT01000506|19299849|P1|Overall Study|Protocol Violation|1
5585346|NCT01000506|19299846|P4|Overall Study|Lack of Efficacy|4
5585347|NCT01000506|19299847|P3|Overall Study|Lack of Efficacy|4
5585348|NCT01000506|19299848|P2|Overall Study|Lack of Efficacy|6
5585349|NCT01000506|19299849|P1|Overall Study|Lack of Efficacy|8
5585350|NCT01000506|19299846|P4|Overall Study|Adverse Event|9
5585351|NCT01000506|19299847|P3|Overall Study|Adverse Event|8
5585352|NCT01000506|19299848|P2|Overall Study|Adverse Event|5
5585353|NCT01000506|19299849|P1|Overall Study|Adverse Event|6
5585354|NCT01000493|19299893|P2|Overall Study|Withdrawal by Subject|7
5585355|NCT01000493|19299894|P1|Overall Study|Withdrawal by Subject|3
5585356|NCT01000493|19299893|P2|Overall Study|Physician Decision|1
5585357|NCT01000493|19299894|P1|Overall Study|Physician Decision|1
5585358|NCT01000493|19299893|P2|Overall Study|Lost to Follow-up|9
5585359|NCT01000493|19299894|P1|Overall Study|Lost to Follow-up|5
5585360|NCT01000493|19299893|P2|Overall Study|Study closed/terminated|23
5585361|NCT01000493|19299894|P1|Overall Study|Study closed/terminated|25
5585362|NCT01000493|19299893|P2|Overall Study|Protocol Violation|8
5585363|NCT01000493|19299894|P1|Overall Study|Protocol Violation|1
5585364|NCT01000493|19299893|P2|Overall Study|Lack of Efficacy|1
5585365|NCT01000493|19299894|P1|Overall Study|Lack of Efficacy|1
5585366|NCT01000493|19299893|P2|Overall Study|Adverse Event|6
5585367|NCT01000493|19299894|P1|Overall Study|Adverse Event|3
5585368|NCT01000480|19299944|P1|Concurrent Therapy Phase|Physician Decision|1
5585369|NCT01000480|19299944|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
5585370|NCT01000480|19299944|P1|Concurrent Therapy Phase|Protocol Violation|2
5585371|NCT01000480|19299944|P1|Concurrent Therapy Phase|Adverse Event|4
5585372|NCT01000480|19299944|P1|Induction Phase|Entry Criteria Not Met|3
5585373|NCT01000480|19299944|P1|Induction Phase|Physician Decision|1
5585374|NCT01000480|19299944|P1|Induction Phase|Lost to Follow-up|1
5585375|NCT01000480|19299944|P1|Induction Phase|Adverse Event|2
5585376|NCT01000376|19299952|P2|Cycle 1 Day 1|Progressive Disease|0
5585377|NCT01000376|19299953|P1|Cycle 1 Day 1|Progressive Disease|1
5585378|NCT01000376|19299952|P2|Cycle 1 Day 1|Adverse Event|0
5585379|NCT01000376|19299953|P1|Cycle 1 Day 1|Adverse Event|1
5585380|NCT01000337|19299963|P2|Overall Study|Lost to Follow-up|3
5585381|NCT01000337|19299964|P1|Overall Study|Lost to Follow-up|4
5585382|NCT01000311|19299982|P2|Overall Study|Administrative reason|15
5585383|NCT01000311|19299983|P1|Overall Study|Administrative reason|9
5585384|NCT01000311|19299982|P2|Overall Study|Inappropriate enrollment|0
5585385|NCT01000311|19299983|P1|Overall Study|Inappropriate enrollment|2
5585386|NCT01000311|19299982|P2|Overall Study|Protocol Violation|2
5585387|NCT01000311|19299983|P1|Overall Study|Protocol Violation|1
5585388|NCT01000311|19299982|P2|Overall Study|Lost to Follow-up|24
5585389|NCT01000311|19299983|P1|Overall Study|Lost to Follow-up|15
5585390|NCT01000311|19299982|P2|Overall Study|Withdrawal by Subject|24
5585391|NCT01000311|19299983|P1|Overall Study|Withdrawal by Subject|16
5585392|NCT01000311|19299982|P2|Overall Study|Adverse Event|5
5585393|NCT01000311|19299983|P1|Overall Study|Adverse Event|2
5585394|NCT01000155|19300033|P1|Overall Study|Adverse Event|1
5585395|NCT01000155|19300033|P1|Overall Study|Withdrawal by Subject|1
5585396|NCT01000064|19300039|P2|Overall Study|Withdrawal by Subject|1
5585397|NCT01000064|19300040|P1|Overall Study|Withdrawal by Subject|1
5585398|NCT01000051|19300063|P2|Overall Study|Serious noncompliance|0
5585399|NCT01000051|19300064|P1|Overall Study|Serious noncompliance|1
5585400|NCT01000051|19300063|P2|Overall Study|Disease Progression|0
5585401|NCT01000051|19300064|P1|Overall Study|Disease Progression|1
5585402|NCT01000051|19300063|P2|Overall Study|Withdrawal by Subject|1
5585403|NCT01000051|19300064|P1|Overall Study|Withdrawal by Subject|1
5585404|NCT01000025|19300072|P2|Overall Study|Intercurrent Illness|7
5585405|NCT01000025|19300073|P1|Overall Study|Intercurrent Illness|26
5585406|NCT01000025|19300072|P2|Overall Study|Lack of Efficacy|208
5585407|NCT01000025|19300073|P1|Overall Study|Lack of Efficacy|363
5585408|NCT01000025|19300072|P2|Overall Study|Death|13
5585409|NCT01000025|19300073|P1|Overall Study|Death|23
5585410|NCT01000025|19300072|P2|Overall Study|Withdrawal by Subject|8
5585411|NCT01000025|19300073|P1|Overall Study|Withdrawal by Subject|13
5585412|NCT01000025|19300072|P2|Overall Study|Adverse Event|2
5585413|NCT01000025|19300073|P1|Overall Study|Adverse Event|43
5585414|NCT00999921|19300091|P2|Overall Study|Lost to Follow-up|19
5585415|NCT00999921|19300092|P1|Overall Study|Lost to Follow-up|10
5585416|NCT00999908|19300102|P3|Treatment Period 2|Protocol Violation|0
5585417|NCT00999908|19300103|P2|Treatment Period 2|Protocol Violation|0
5585418|NCT00999908|19300104|P1|Treatment Period 2|Protocol Violation|1
5585419|NCT00999908|19300102|P3|Treatment Period 1|Subject withdrew consent|0
5585420|NCT00999908|19300103|P2|Treatment Period 1|Subject withdrew consent|0
5585421|NCT00999908|19300104|P1|Treatment Period 1|Subject withdrew consent|2
5585422|NCT00999804|19300133|P2|Overall Study|Ineligible|0
5585423|NCT00999804|19300134|P1|Overall Study|Ineligible|3
5585424|NCT00999804|19300133|P2|Overall Study|Death|0
5585425|NCT00999804|19300134|P1|Overall Study|Death|1
5585426|NCT00999804|19300133|P2|Overall Study|Withdrawal by Subject|0
5585427|NCT00999804|19300134|P1|Overall Study|Withdrawal by Subject|4
5585428|NCT00999804|19300133|P2|Overall Study|Adverse Event|3
5585429|NCT00999804|19300134|P1|Overall Study|Adverse Event|4
5585430|NCT00999804|19300133|P2|Overall Study|Lack of Efficacy|2
5585431|NCT00999804|19300134|P1|Overall Study|Lack of Efficacy|9
5585432|NCT00999713|19300148|P2|Overall Study|Physician Decision|0
5585433|NCT00999713|19300149|P1|Overall Study|Physician Decision|2
5585434|NCT00999687|19300163|P1|Second Intervention|Lack of Efficacy|1
5585435|NCT00999687|19300163|P1|Second Intervention|Withdrawal by Subject|2
5585436|NCT00999687|19300163|P1|First Intervention|Withdrawal by Subject|1
5585437|NCT00999661|19300170|P1|Overall Study|Not meeting eligibility criteria|9
5585438|NCT00999661|19300170|P1|Overall Study|Withdrawal by Subject|1
5585439|NCT00999661|19300170|P1|Overall Study|Adverse Event|1
5585440|NCT00999661|19300170|P1|Overall Study|Lost to Follow-up|59
5585441|NCT00999596|19300191|P1|Overall Study|Statistical population not required|101
5585442|NCT00999544|19300196|P1|Overall Study|Withdrawal by Subject|1
5585443|NCT00999466|19300232|P3|Main Part|Adverse Event|2
5585444|NCT00999466|19300233|P2|Main Part|Adverse Event|4
5585445|NCT00999466|19300234|P1|Main Part|Adverse Event|0
5585446|NCT00999466|19300232|P3|Main Part|Withdrawal by Subject|2
5585447|NCT00999466|19300233|P2|Main Part|Withdrawal by Subject|0
5585448|NCT00999466|19300234|P1|Main Part|Withdrawal by Subject|0
5585449|NCT00999167|19300511|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
5585450|NCT00999167|19300512|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
5585451|NCT00999167|19300513|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
5585452|NCT00999167|19300511|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
5585453|NCT00999167|19300512|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
5585454|NCT00999167|19300513|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
5585455|NCT00999167|19300511|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
5585456|NCT00999167|19300512|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
5585457|NCT00999167|19300513|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
5585458|NCT00999167|19300511|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
5585459|NCT00999167|19300512|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
5585460|NCT00999167|19300513|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
5585461|NCT00999167|19300511|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
5585462|NCT00999167|19300512|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
5585463|NCT00999167|19300513|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
5585464|NCT00999167|19300511|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
5585465|NCT00999167|19300512|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
5585466|NCT00999167|19300513|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
5585467|NCT00999167|19300511|P3|Part A: Open Label Safety run-in|Adverse Event|0
5585468|NCT00999167|19300512|P2|Part A: Open Label Safety run-in|Adverse Event|0
5585469|NCT00999167|19300513|P1|Part A: Open Label Safety run-in|Adverse Event|3
5585470|NCT00999167|19300511|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
5585471|NCT00999167|19300512|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
5585472|NCT00999167|19300513|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
5585473|NCT00998985|19300651|P14|Overall Study|Protocol Violation|0
5585474|NCT00998985|19300652|P13|Overall Study|Protocol Violation|0
5585475|NCT00998985|19300653|P12|Overall Study|Protocol Violation|0
5585476|NCT00998985|19300654|P11|Overall Study|Protocol Violation|0
5585477|NCT00998985|19300655|P10|Overall Study|Protocol Violation|0
5585478|NCT00998985|19300656|P9|Overall Study|Protocol Violation|0
5585479|NCT00998985|19300657|P8|Overall Study|Protocol Violation|0
5585480|NCT00998985|19300658|P7|Overall Study|Protocol Violation|0
5585481|NCT00998985|19300659|P6|Overall Study|Protocol Violation|1
5585482|NCT00998985|19300660|P5|Overall Study|Protocol Violation|0
5585483|NCT00998985|19300661|P4|Overall Study|Protocol Violation|0
5585484|NCT00998985|19300662|P3|Overall Study|Protocol Violation|0
5585485|NCT00998985|19300663|P2|Overall Study|Protocol Violation|0
5585486|NCT00998985|19300664|P1|Overall Study|Protocol Violation|0
5585487|NCT00998985|19300651|P14|Overall Study|Withdrawal by Subject|0
5585488|NCT00998985|19300652|P13|Overall Study|Withdrawal by Subject|0
5585489|NCT00998985|19300653|P12|Overall Study|Withdrawal by Subject|0
5585490|NCT00998985|19300654|P11|Overall Study|Withdrawal by Subject|0
5585491|NCT00998985|19300655|P10|Overall Study|Withdrawal by Subject|0
5585492|NCT00998985|19300656|P9|Overall Study|Withdrawal by Subject|1
5585493|NCT00998985|19300657|P8|Overall Study|Withdrawal by Subject|0
5585494|NCT00998985|19300658|P7|Overall Study|Withdrawal by Subject|0
5585495|NCT00998985|19300659|P6|Overall Study|Withdrawal by Subject|0
5585496|NCT00998985|19300660|P5|Overall Study|Withdrawal by Subject|0
5585497|NCT00998985|19300661|P4|Overall Study|Withdrawal by Subject|0
5585498|NCT00998985|19300662|P3|Overall Study|Withdrawal by Subject|0
5585499|NCT00998985|19300663|P2|Overall Study|Withdrawal by Subject|0
5585500|NCT00998985|19300664|P1|Overall Study|Withdrawal by Subject|0
5585501|NCT00998881|19300732|P2|Overall Study|Personal matter|0
5585502|NCT00998881|19300733|P1|Overall Study|Personal matter|1
5585503|NCT00998881|19300732|P2|Overall Study|Withdrawal by Subject|0
5585504|NCT00998881|19300733|P1|Overall Study|Withdrawal by Subject|1
5585505|NCT00998881|19300732|P2|Overall Study|Physician Decision|0
5585506|NCT00998881|19300733|P1|Overall Study|Physician Decision|3
5585507|NCT00998881|19300732|P2|Overall Study|Lack of Efficacy|0
5585508|NCT00998881|19300733|P1|Overall Study|Lack of Efficacy|1
5585509|NCT00998881|19300732|P2|Overall Study|Adverse Event|2
5585510|NCT00998881|19300733|P1|Overall Study|Adverse Event|2
5585511|NCT00998790|19300752|P1|Overall Study|Withdrawal by Subject|21
5585512|NCT00998764|19300762|P2|Overall Study|Recurrent Episode of vasogenic edema|0
5585513|NCT00998764|19300763|P1|Overall Study|Recurrent Episode of vasogenic edema|1
5585514|NCT00998764|19300762|P2|Overall Study|Other|4
5585515|NCT00998764|19300763|P1|Overall Study|Other|4
5585516|NCT00998764|19300762|P2|Overall Study|Loss of Caregiver|3
5585517|NCT00998764|19300763|P1|Overall Study|Loss of Caregiver|0
5585518|NCT00998764|19300762|P2|Overall Study|Lost to Follow-up|1
5585519|NCT00998764|19300763|P1|Overall Study|Lost to Follow-up|1
5585520|NCT00998764|19300762|P2|Overall Study|Failed to Return|1
5585521|NCT00998764|19300763|P1|Overall Study|Failed to Return|1
5585522|NCT00998764|19300762|P2|Overall Study|Protocol Violation|1
5585523|NCT00998764|19300763|P1|Overall Study|Protocol Violation|0
5585524|NCT00998764|19300762|P2|Overall Study|Discontinuation of Study by Sponsor|217
5585525|NCT00998764|19300763|P1|Overall Study|Discontinuation of Study by Sponsor|164
5585526|NCT00998764|19300762|P2|Overall Study|Death|1
5585527|NCT00998764|19300763|P1|Overall Study|Death|3
5585528|NCT00998764|19300762|P2|Overall Study|Physician Decision|3
5585529|NCT00998764|19300763|P1|Overall Study|Physician Decision|3
5585530|NCT00998764|19300762|P2|Overall Study|Withdrawal by Subject|25
5585531|NCT00998764|19300763|P1|Overall Study|Withdrawal by Subject|19
5585532|NCT00998764|19300762|P2|Overall Study|Adverse Event|12
5585533|NCT00998764|19300763|P1|Overall Study|Adverse Event|17
5585534|NCT00998764|19300762|P2|Overall Study|Lack of Efficacy|6
5585535|NCT00998764|19300763|P1|Overall Study|Lack of Efficacy|3
5585536|NCT00998738|19300785|P1|Overall Study|Uknown|1
5585537|NCT00998400|19300853|P2|Overall Study|Logistical problems|0
5585538|NCT00998400|19300854|P1|Overall Study|Logistical problems|1
5585539|NCT00998400|19300853|P2|Overall Study|Lack of interest/motivation|2
5585540|NCT00998400|19300854|P1|Overall Study|Lack of interest/motivation|1
5585541|NCT00998335|19300899|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
5585542|NCT00998335|19300900|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
5585543|NCT00998309|19300928|P1|Overall Study|Protocol Violation|4
5585544|NCT00998296|19300995|P11|Overall Study|Reason other than those specified above|0
5585545|NCT00998296|19300996|P10|Overall Study|Reason other than those specified above|1
5585546|NCT00998296|19300997|P9|Overall Study|Reason other than those specified above|0
5585547|NCT00998296|19300998|P8|Overall Study|Reason other than those specified above|0
5585548|NCT00998296|19300999|P7|Overall Study|Reason other than those specified above|0
5585549|NCT00998296|19301000|P6|Overall Study|Reason other than those specified above|0
5585550|NCT00998296|19301001|P5|Overall Study|Reason other than those specified above|0
5585551|NCT00998296|19301002|P4|Overall Study|Reason other than those specified above|0
5585635|NCT00997893|19301184|P3|Overall Study|Adverse Event|0
5585552|NCT00998296|19301003|P3|Overall Study|Reason other than those specified above|0
5585553|NCT00998296|19301004|P2|Overall Study|Reason other than those specified above|0
5585554|NCT00998296|19301005|P1|Overall Study|Reason other than those specified above|0
5585555|NCT00998296|19300995|P11|Overall Study|Refused to continue taking trial med.|0
5585556|NCT00998296|19300996|P10|Overall Study|Refused to continue taking trial med.|2
5585557|NCT00998296|19300997|P9|Overall Study|Refused to continue taking trial med.|0
5585558|NCT00998296|19300998|P8|Overall Study|Refused to continue taking trial med.|0
5585559|NCT00998296|19300999|P7|Overall Study|Refused to continue taking trial med.|0
5585560|NCT00998296|19301000|P6|Overall Study|Refused to continue taking trial med.|0
5585561|NCT00998296|19301001|P5|Overall Study|Refused to continue taking trial med.|0
5585562|NCT00998296|19301002|P4|Overall Study|Refused to continue taking trial med.|0
5585563|NCT00998296|19301003|P3|Overall Study|Refused to continue taking trial med.|0
5585564|NCT00998296|19301004|P2|Overall Study|Refused to continue taking trial med.|0
5585565|NCT00998296|19301005|P1|Overall Study|Refused to continue taking trial med.|0
5585566|NCT00998296|19300995|P11|Overall Study|Other adverse event|2
5585567|NCT00998296|19300996|P10|Overall Study|Other adverse event|1
5585568|NCT00998296|19300997|P9|Overall Study|Other adverse event|0
5585569|NCT00998296|19300998|P8|Overall Study|Other adverse event|0
5585570|NCT00998296|19300999|P7|Overall Study|Other adverse event|0
5585571|NCT00998296|19301000|P6|Overall Study|Other adverse event|0
5585572|NCT00998296|19301001|P5|Overall Study|Other adverse event|1
5585573|NCT00998296|19301002|P4|Overall Study|Other adverse event|0
5585574|NCT00998296|19301003|P3|Overall Study|Other adverse event|0
5585575|NCT00998296|19301004|P2|Overall Study|Other adverse event|0
5585576|NCT00998296|19301005|P1|Overall Study|Other adverse event|0
5585577|NCT00998296|19300995|P11|Overall Study|Dose limiting or dose reducing toxicity|0
5585578|NCT00998296|19300996|P10|Overall Study|Dose limiting or dose reducing toxicity|0
5585579|NCT00998296|19300997|P9|Overall Study|Dose limiting or dose reducing toxicity|2
5585580|NCT00998296|19300998|P8|Overall Study|Dose limiting or dose reducing toxicity|2
5585581|NCT00998296|19300999|P7|Overall Study|Dose limiting or dose reducing toxicity|0
5585582|NCT00998296|19301000|P6|Overall Study|Dose limiting or dose reducing toxicity|0
5585583|NCT00998296|19301001|P5|Overall Study|Dose limiting or dose reducing toxicity|1
5585584|NCT00998296|19301002|P4|Overall Study|Dose limiting or dose reducing toxicity|0
5585585|NCT00998296|19301003|P3|Overall Study|Dose limiting or dose reducing toxicity|0
5585586|NCT00998296|19301004|P2|Overall Study|Dose limiting or dose reducing toxicity|0
5585587|NCT00998296|19301005|P1|Overall Study|Dose limiting or dose reducing toxicity|0
5585588|NCT00998296|19300995|P11|Overall Study|Progressive disease|5
5585589|NCT00998296|19300996|P10|Overall Study|Progressive disease|14
5585590|NCT00998296|19300997|P9|Overall Study|Progressive disease|0
5585591|NCT00998296|19300998|P8|Overall Study|Progressive disease|0
5585592|NCT00998296|19300999|P7|Overall Study|Progressive disease|1
5585593|NCT00998296|19301000|P6|Overall Study|Progressive disease|0
5585594|NCT00998296|19301001|P5|Overall Study|Progressive disease|0
5585595|NCT00998296|19301002|P4|Overall Study|Progressive disease|0
5585596|NCT00998296|19301003|P3|Overall Study|Progressive disease|0
5585597|NCT00998296|19301004|P2|Overall Study|Progressive disease|1
5585598|NCT00998296|19301005|P1|Overall Study|Progressive disease|0
5585599|NCT00997984|19301108|P3|Overall Study|Work schedule|2
5585600|NCT00997984|19301109|P2|Overall Study|Work schedule|0
5585601|NCT00997984|19301110|P1|Overall Study|Work schedule|0
5585602|NCT00997984|19301108|P3|Overall Study|Suicidal ideation|1
5585603|NCT00997984|19301109|P2|Overall Study|Suicidal ideation|0
5585604|NCT00997984|19301110|P1|Overall Study|Suicidal ideation|0
5585605|NCT00997984|19301108|P3|Overall Study|Wrong medication dispensed|0
5585606|NCT00997984|19301109|P2|Overall Study|Wrong medication dispensed|1
5585607|NCT00997984|19301110|P1|Overall Study|Wrong medication dispensed|0
5585608|NCT00997984|19301108|P3|Overall Study|non-compliance|3
5585609|NCT00997984|19301109|P2|Overall Study|non-compliance|2
5585610|NCT00997984|19301110|P1|Overall Study|non-compliance|0
5585611|NCT00997984|19301108|P3|Overall Study|Met exclusion criteria|0
5585612|NCT00997984|19301109|P2|Overall Study|Met exclusion criteria|0
5585613|NCT00997984|19301110|P1|Overall Study|Met exclusion criteria|1
5585614|NCT00997984|19301108|P3|Overall Study|Lack of Efficacy|3
5585615|NCT00997984|19301109|P2|Overall Study|Lack of Efficacy|6
5585616|NCT00997984|19301110|P1|Overall Study|Lack of Efficacy|20
5585617|NCT00997984|19301108|P3|Overall Study|Lost to Follow-up|4
5585618|NCT00997984|19301109|P2|Overall Study|Lost to Follow-up|5
5585619|NCT00997984|19301110|P1|Overall Study|Lost to Follow-up|8
5585620|NCT00997984|19301108|P3|Overall Study|Withdrawal by Subject|5
5585621|NCT00997984|19301109|P2|Overall Study|Withdrawal by Subject|9
5585622|NCT00997984|19301110|P1|Overall Study|Withdrawal by Subject|6
5585623|NCT00997984|19301108|P3|Overall Study|Protocol Violation|0
5585624|NCT00997984|19301109|P2|Overall Study|Protocol Violation|3
5585625|NCT00997984|19301110|P1|Overall Study|Protocol Violation|1
5585626|NCT00997984|19301108|P3|Overall Study|Adverse Event|8
5585627|NCT00997984|19301109|P2|Overall Study|Adverse Event|8
5585628|NCT00997984|19301110|P1|Overall Study|Adverse Event|1
5585629|NCT00997893|19301184|P3|Overall Study|Pain/pain meds during Visit 4|0
5585630|NCT00997893|19301185|P2|Overall Study|Pain/pain meds during Visit 4|1
5585631|NCT00997893|19301186|P1|Overall Study|Pain/pain meds during Visit 4|0
5585632|NCT00997893|19301184|P3|Overall Study|Unable to meet study timelines|0
5585633|NCT00997893|19301185|P2|Overall Study|Unable to meet study timelines|0
5585634|NCT00997893|19301186|P1|Overall Study|Unable to meet study timelines|1
5585636|NCT00997893|19301185|P2|Overall Study|Adverse Event|0
5585637|NCT00997893|19301186|P1|Overall Study|Adverse Event|1
5585638|NCT00997503|19301293|P1|Overall Study|Other reason|13
5585639|NCT00997503|19301293|P1|Overall Study|Missed 12-month follow-up|85
5585640|NCT00997503|19301293|P1|Overall Study|Physician Decision|10
5585641|NCT00997503|19301293|P1|Overall Study|Adverse Event|3
5585642|NCT00997503|19301293|P1|Overall Study|Lost to Follow-up|33
5585643|NCT00997503|19301293|P1|Overall Study|Withdrawal by Subject|76
5585644|NCT00997503|19301293|P1|Overall Study|Death|53
5585645|NCT00997438|19301336|P3|Overall Study|Exclusion criteria at visit 1|3
5585646|NCT00997438|19301337|P2|Overall Study|Exclusion criteria at visit 1|2
5585647|NCT00997438|19301338|P1|Overall Study|Exclusion criteria at visit 1|2
5585648|NCT00997438|19301336|P3|Overall Study|Withdrawal by Subject|0
5585649|NCT00997438|19301337|P2|Overall Study|Withdrawal by Subject|1
5585650|NCT00997438|19301338|P1|Overall Study|Withdrawal by Subject|1
5585651|NCT00997438|19301336|P3|Overall Study|Blood draw difficulty|1
5585652|NCT00997438|19301337|P2|Overall Study|Blood draw difficulty|0
5585653|NCT00997438|19301338|P1|Overall Study|Blood draw difficulty|2
5585654|NCT00997386|19301378|P1|Overall Study|Death|7
5585655|NCT00997373|19301387|P2|Overall Study|could not have hysterectomy|0
5585656|NCT00997373|19301388|P1|Overall Study|could not have hysterectomy|6
5585657|NCT00997373|19301387|P2|Overall Study|wrong tumor type|0
5585658|NCT00997373|19301388|P1|Overall Study|wrong tumor type|4
5585659|NCT00997373|19301387|P2|Overall Study|Withdrawal by Subject|0
5585660|NCT00997373|19301388|P1|Overall Study|Withdrawal by Subject|5
5585661|NCT00997334|19301394|P1|Overall Study|Ineligible|1
5585662|NCT00997334|19301394|P1|Overall Study|No lesion amenable|1
5585663|NCT00997334|19301394|P1|Overall Study|Urgent Palliative Care|2
5585664|NCT00997334|19301394|P1|Overall Study|Death|2
5585665|NCT00997334|19301394|P1|Overall Study|Withdrawal by Subject|3
5585666|NCT00997334|19301394|P1|Overall Study|Patient non-compliance|1
5585667|NCT00997334|19301394|P1|Overall Study|Adverse Event|3
5585668|NCT00997334|19301394|P1|Overall Study|still on therapy|12
5585669|NCT00997321|19301403|P2|Overall Study|did not undergo sedation after enrollmen|3
5585670|NCT00997321|19301404|P1|Overall Study|did not undergo sedation after enrollmen|0
5585671|NCT00997243|19301416|P1|Overall Study|Early termination of study by sponsor|7
5585672|NCT00997126|19301448|P2|Overall Study|Physician Decision|11
5585673|NCT00997126|19301449|P1|Overall Study|Physician Decision|7
5585674|NCT00997035|19301478|P2|3-month Follow-up Visit|Lost to Follow-up|6
5585675|NCT00997035|19301479|P1|3-month Follow-up Visit|Lost to Follow-up|12
5585676|NCT00997035|19301478|P2|3-week Followup Visit|Lost to Follow-up|6
5585677|NCT00997035|19301479|P1|3-week Followup Visit|Lost to Follow-up|9
5585678|NCT00996996|19301503|P1|Overall Study|Did Not Receive Study Medications|1
5585679|NCT00996996|19301503|P1|Overall Study|Death|5
5585680|NCT00996996|19301503|P1|Overall Study|Lost to Follow-up|9
5585681|NCT00996996|19301503|P1|Overall Study|Non-compliance|8
5585682|NCT00996996|19301503|P1|Overall Study|Progressive Disease|10
5585683|NCT00996944|19301537|P2|Long-term Treatment Period|Study Closed/Terminated|5
5585684|NCT00996944|19301538|P1|Long-term Treatment Period|Study Closed/Terminated|12
5585685|NCT00996944|19301537|P2|Double-blind Treatment Period|Withdrawal by Subject|1
5585686|NCT00996944|19301538|P1|Double-blind Treatment Period|Withdrawal by Subject|1
5585687|NCT00996944|19301537|P2|Double-blind Treatment Period|Study Closed/Terminated|5
5585688|NCT00996944|19301538|P1|Double-blind Treatment Period|Study Closed/Terminated|6
5585689|NCT00996944|19301537|P2|Double-blind Treatment Period|Protocol Violation|0
5585690|NCT00996944|19301538|P1|Double-blind Treatment Period|Protocol Violation|1
5585691|NCT00996944|19301537|P2|Double-blind Treatment Period|Adverse Event|1
5585692|NCT00996944|19301538|P1|Double-blind Treatment Period|Adverse Event|2
5585693|NCT00996918|19301590|P5|Overall Study|Other|0
5585694|NCT00996918|19301591|P4|Overall Study|Other|0
5585695|NCT00996918|19301592|P3|Overall Study|Other|0
5585696|NCT00996918|19301593|P2|Overall Study|Other|1
5585697|NCT00996918|19301594|P1|Overall Study|Other|3
5585698|NCT00996918|19301590|P5|Overall Study|Loss of Caregiver|0
5585699|NCT00996918|19301591|P4|Overall Study|Loss of Caregiver|0
5585700|NCT00996918|19301592|P3|Overall Study|Loss of Caregiver|0
5585701|NCT00996918|19301593|P2|Overall Study|Loss of Caregiver|1
5585702|NCT00996918|19301594|P1|Overall Study|Loss of Caregiver|0
5585703|NCT00996918|19301590|P5|Overall Study|Discontinuation of Study by Sponsor|2
5585704|NCT00996918|19301591|P4|Overall Study|Discontinuation of Study by Sponsor|45
5585705|NCT00996918|19301592|P3|Overall Study|Discontinuation of Study by Sponsor|30
5585706|NCT00996918|19301593|P2|Overall Study|Discontinuation of Study by Sponsor|54
5585707|NCT00996918|19301594|P1|Overall Study|Discontinuation of Study by Sponsor|31
5585708|NCT00996918|19301590|P5|Overall Study|Physician Decision|0
5585709|NCT00996918|19301591|P4|Overall Study|Physician Decision|0
5585710|NCT00996918|19301592|P3|Overall Study|Physician Decision|0
5585711|NCT00996918|19301593|P2|Overall Study|Physician Decision|0
5585712|NCT00996918|19301594|P1|Overall Study|Physician Decision|1
5585713|NCT00996918|19301590|P5|Overall Study|Withdrawal by Subject|2
5585714|NCT00996918|19301591|P4|Overall Study|Withdrawal by Subject|3
5585715|NCT00996918|19301592|P3|Overall Study|Withdrawal by Subject|3
5585716|NCT00996918|19301593|P2|Overall Study|Withdrawal by Subject|4
5585717|NCT00996918|19301594|P1|Overall Study|Withdrawal by Subject|1
5585718|NCT00996918|19301590|P5|Overall Study|Adverse Event|0
5585719|NCT00996918|19301591|P4|Overall Study|Adverse Event|6
5585720|NCT00996918|19301592|P3|Overall Study|Adverse Event|2
5585721|NCT00996918|19301593|P2|Overall Study|Adverse Event|5
5585722|NCT00996918|19301594|P1|Overall Study|Adverse Event|2
5585723|NCT00996918|19301590|P5|Overall Study|Lack of Efficacy|0
5585724|NCT00996918|19301591|P4|Overall Study|Lack of Efficacy|2
5585725|NCT00996918|19301592|P3|Overall Study|Lack of Efficacy|2
5585726|NCT00996918|19301593|P2|Overall Study|Lack of Efficacy|1
5585727|NCT00996918|19301594|P1|Overall Study|Lack of Efficacy|1
5585728|NCT00996892|19301638|P20|Expansion Stage 2A|Disease Progression|31
5585729|NCT00996892|19301639|P19|Expansion Stage 2A|Disease Progression|0
5585730|NCT00996892|19301640|P18|Expansion Stage 2A|Disease Progression|0
5585731|NCT00996892|19301641|P17|Expansion Stage 2A|Disease Progression|0
5585732|NCT00996892|19301642|P16|Expansion Stage 2A|Disease Progression|0
5585733|NCT00996892|19301643|P15|Expansion Stage 2A|Disease Progression|0
5585734|NCT00996892|19301644|P14|Expansion Stage 2A|Disease Progression|0
5585735|NCT00996892|19301645|P13|Expansion Stage 2A|Disease Progression|0
5585736|NCT00996892|19301646|P12|Expansion Stage 2A|Disease Progression|0
5585737|NCT00996892|19301647|P11|Expansion Stage 2A|Disease Progression|0
5585738|NCT00996892|19301648|P10|Expansion Stage 2A|Disease Progression|0
5585739|NCT00996892|19301649|P9|Expansion Stage 2A|Disease Progression|0
5585740|NCT00996892|19301650|P8|Expansion Stage 2A|Disease Progression|0
5585741|NCT00996892|19301651|P7|Expansion Stage 2A|Disease Progression|0
5585742|NCT00996892|19301652|P6|Expansion Stage 2A|Disease Progression|0
5585743|NCT00996892|19301653|P5|Expansion Stage 2A|Disease Progression|0
5585744|NCT00996892|19301654|P4|Expansion Stage 2A|Disease Progression|0
5585745|NCT00996892|19301655|P3|Expansion Stage 2A|Disease Progression|0
5585746|NCT00996892|19301656|P2|Expansion Stage 2A|Disease Progression|0
5585747|NCT00996892|19301657|P1|Expansion Stage 2A|Disease Progression|0
5585748|NCT00996892|19301638|P20|Expansion Stage 2A|Withdrawal by Subject|4
5585749|NCT00996892|19301639|P19|Expansion Stage 2A|Withdrawal by Subject|0
5585750|NCT00996892|19301640|P18|Expansion Stage 2A|Withdrawal by Subject|0
5585751|NCT00996892|19301641|P17|Expansion Stage 2A|Withdrawal by Subject|0
5585752|NCT00996892|19301642|P16|Expansion Stage 2A|Withdrawal by Subject|0
5585753|NCT00996892|19301643|P15|Expansion Stage 2A|Withdrawal by Subject|0
5585754|NCT00996892|19301644|P14|Expansion Stage 2A|Withdrawal by Subject|0
5585755|NCT00996892|19301645|P13|Expansion Stage 2A|Withdrawal by Subject|0
5585756|NCT00996892|19301646|P12|Expansion Stage 2A|Withdrawal by Subject|0
5585757|NCT00996892|19301647|P11|Expansion Stage 2A|Withdrawal by Subject|0
5585758|NCT00996892|19301648|P10|Expansion Stage 2A|Withdrawal by Subject|0
5585759|NCT00996892|19301649|P9|Expansion Stage 2A|Withdrawal by Subject|0
5585760|NCT00996892|19301650|P8|Expansion Stage 2A|Withdrawal by Subject|0
5585761|NCT00996892|19301651|P7|Expansion Stage 2A|Withdrawal by Subject|0
5585762|NCT00996892|19301652|P6|Expansion Stage 2A|Withdrawal by Subject|0
5585763|NCT00996892|19301653|P5|Expansion Stage 2A|Withdrawal by Subject|0
5585764|NCT00996892|19301654|P4|Expansion Stage 2A|Withdrawal by Subject|0
5585765|NCT00996892|19301655|P3|Expansion Stage 2A|Withdrawal by Subject|0
5585766|NCT00996892|19301656|P2|Expansion Stage 2A|Withdrawal by Subject|0
5585767|NCT00996892|19301657|P1|Expansion Stage 2A|Withdrawal by Subject|0
5585768|NCT00996892|19301638|P20|Expansion Stage 2A|Physician Decision|2
5585769|NCT00996892|19301639|P19|Expansion Stage 2A|Physician Decision|0
5585770|NCT00996892|19301640|P18|Expansion Stage 2A|Physician Decision|0
5585771|NCT00996892|19301641|P17|Expansion Stage 2A|Physician Decision|0
5585772|NCT00996892|19301642|P16|Expansion Stage 2A|Physician Decision|0
5585773|NCT00996892|19301643|P15|Expansion Stage 2A|Physician Decision|0
5585774|NCT00996892|19301644|P14|Expansion Stage 2A|Physician Decision|0
5585775|NCT00996892|19301645|P13|Expansion Stage 2A|Physician Decision|0
5585776|NCT00996892|19301646|P12|Expansion Stage 2A|Physician Decision|0
5585777|NCT00996892|19301647|P11|Expansion Stage 2A|Physician Decision|0
5585778|NCT00996892|19301648|P10|Expansion Stage 2A|Physician Decision|0
5585779|NCT00996892|19301649|P9|Expansion Stage 2A|Physician Decision|0
5585780|NCT00996892|19301650|P8|Expansion Stage 2A|Physician Decision|0
5585781|NCT00996892|19301651|P7|Expansion Stage 2A|Physician Decision|0
5585782|NCT00996892|19301652|P6|Expansion Stage 2A|Physician Decision|0
5585783|NCT00996892|19301653|P5|Expansion Stage 2A|Physician Decision|0
5585784|NCT00996892|19301654|P4|Expansion Stage 2A|Physician Decision|0
5585785|NCT00996892|19301655|P3|Expansion Stage 2A|Physician Decision|0
5585786|NCT00996892|19301656|P2|Expansion Stage 2A|Physician Decision|0
5585787|NCT00996892|19301657|P1|Expansion Stage 2A|Physician Decision|0
5585788|NCT00996892|19301638|P20|Expansion Stage 2A|Adverse Event|8
5585789|NCT00996892|19301639|P19|Expansion Stage 2A|Adverse Event|0
5585790|NCT00996892|19301640|P18|Expansion Stage 2A|Adverse Event|0
5585791|NCT00996892|19301641|P17|Expansion Stage 2A|Adverse Event|0
5585792|NCT00996892|19301642|P16|Expansion Stage 2A|Adverse Event|0
5585793|NCT00996892|19301643|P15|Expansion Stage 2A|Adverse Event|0
5585794|NCT00996892|19301644|P14|Expansion Stage 2A|Adverse Event|0
5585795|NCT00996892|19301645|P13|Expansion Stage 2A|Adverse Event|0
5585796|NCT00996892|19301646|P12|Expansion Stage 2A|Adverse Event|0
5585797|NCT00996892|19301647|P11|Expansion Stage 2A|Adverse Event|0
5585798|NCT00996892|19301648|P10|Expansion Stage 2A|Adverse Event|0
5585799|NCT00996892|19301649|P9|Expansion Stage 2A|Adverse Event|0
5585800|NCT00996892|19301650|P8|Expansion Stage 2A|Adverse Event|0
5585801|NCT00996892|19301651|P7|Expansion Stage 2A|Adverse Event|0
5585802|NCT00996892|19301652|P6|Expansion Stage 2A|Adverse Event|0
5585803|NCT00996892|19301653|P5|Expansion Stage 2A|Adverse Event|0
5585804|NCT00996892|19301654|P4|Expansion Stage 2A|Adverse Event|0
5585805|NCT00996892|19301655|P3|Expansion Stage 2A|Adverse Event|0
5585806|NCT00996892|19301656|P2|Expansion Stage 2A|Adverse Event|0
5585807|NCT00996892|19301657|P1|Expansion Stage 2A|Adverse Event|0
5585808|NCT00996892|19301638|P20|Expansion Stage 2|Disease Progression|0
5585809|NCT00996892|19301639|P19|Expansion Stage 2|Disease Progression|28
5585810|NCT00996892|19301640|P18|Expansion Stage 2|Disease Progression|0
5585811|NCT00996892|19301641|P17|Expansion Stage 2|Disease Progression|0
5585812|NCT00996892|19301642|P16|Expansion Stage 2|Disease Progression|0
5585813|NCT00996892|19301643|P15|Expansion Stage 2|Disease Progression|0
5585814|NCT00996892|19301644|P14|Expansion Stage 2|Disease Progression|0
5585815|NCT00996892|19301645|P13|Expansion Stage 2|Disease Progression|0
5585816|NCT00996892|19301646|P12|Expansion Stage 2|Disease Progression|0
5585817|NCT00996892|19301647|P11|Expansion Stage 2|Disease Progression|0
5585818|NCT00996892|19301648|P10|Expansion Stage 2|Disease Progression|0
5585819|NCT00996892|19301649|P9|Expansion Stage 2|Disease Progression|0
5585820|NCT00996892|19301650|P8|Expansion Stage 2|Disease Progression|0
5585821|NCT00996892|19301651|P7|Expansion Stage 2|Disease Progression|0
5585822|NCT00996892|19301652|P6|Expansion Stage 2|Disease Progression|0
5585823|NCT00996892|19301653|P5|Expansion Stage 2|Disease Progression|0
5585824|NCT00996892|19301654|P4|Expansion Stage 2|Disease Progression|0
5585825|NCT00996892|19301655|P3|Expansion Stage 2|Disease Progression|0
5585826|NCT00996892|19301656|P2|Expansion Stage 2|Disease Progression|0
5585827|NCT00996892|19301657|P1|Expansion Stage 2|Disease Progression|0
5585828|NCT00996892|19301638|P20|Expansion Stage 2|Withdrawal by Subject|0
5585829|NCT00996892|19301639|P19|Expansion Stage 2|Withdrawal by Subject|1
5585830|NCT00996892|19301640|P18|Expansion Stage 2|Withdrawal by Subject|0
5585831|NCT00996892|19301641|P17|Expansion Stage 2|Withdrawal by Subject|0
5585832|NCT00996892|19301642|P16|Expansion Stage 2|Withdrawal by Subject|0
5585833|NCT00996892|19301643|P15|Expansion Stage 2|Withdrawal by Subject|0
5585834|NCT00996892|19301644|P14|Expansion Stage 2|Withdrawal by Subject|0
5585835|NCT00996892|19301645|P13|Expansion Stage 2|Withdrawal by Subject|0
5585836|NCT00996892|19301646|P12|Expansion Stage 2|Withdrawal by Subject|0
5585837|NCT00996892|19301647|P11|Expansion Stage 2|Withdrawal by Subject|0
5585838|NCT00996892|19301648|P10|Expansion Stage 2|Withdrawal by Subject|0
5585839|NCT00996892|19301649|P9|Expansion Stage 2|Withdrawal by Subject|0
5585840|NCT00996892|19301650|P8|Expansion Stage 2|Withdrawal by Subject|0
5585841|NCT00996892|19301651|P7|Expansion Stage 2|Withdrawal by Subject|0
5585842|NCT00996892|19301652|P6|Expansion Stage 2|Withdrawal by Subject|0
5585843|NCT00996892|19301653|P5|Expansion Stage 2|Withdrawal by Subject|0
5585844|NCT00996892|19301654|P4|Expansion Stage 2|Withdrawal by Subject|0
5585845|NCT00996892|19301655|P3|Expansion Stage 2|Withdrawal by Subject|0
5585846|NCT00996892|19301656|P2|Expansion Stage 2|Withdrawal by Subject|0
5585847|NCT00996892|19301657|P1|Expansion Stage 2|Withdrawal by Subject|0
5585848|NCT00996892|19301638|P20|Expansion Stage 2|Physician Decision|0
5585849|NCT00996892|19301639|P19|Expansion Stage 2|Physician Decision|1
5585850|NCT00996892|19301640|P18|Expansion Stage 2|Physician Decision|0
5585851|NCT00996892|19301641|P17|Expansion Stage 2|Physician Decision|0
5585852|NCT00996892|19301642|P16|Expansion Stage 2|Physician Decision|0
5585853|NCT00996892|19301643|P15|Expansion Stage 2|Physician Decision|0
5585854|NCT00996892|19301644|P14|Expansion Stage 2|Physician Decision|0
5585855|NCT00996892|19301645|P13|Expansion Stage 2|Physician Decision|0
5585856|NCT00996892|19301646|P12|Expansion Stage 2|Physician Decision|0
5585857|NCT00996892|19301647|P11|Expansion Stage 2|Physician Decision|0
5585858|NCT00996892|19301648|P10|Expansion Stage 2|Physician Decision|0
5585859|NCT00996892|19301649|P9|Expansion Stage 2|Physician Decision|0
5585860|NCT00996892|19301650|P8|Expansion Stage 2|Physician Decision|0
5585861|NCT00996892|19301651|P7|Expansion Stage 2|Physician Decision|0
5585862|NCT00996892|19301652|P6|Expansion Stage 2|Physician Decision|0
5585863|NCT00996892|19301653|P5|Expansion Stage 2|Physician Decision|0
5585864|NCT00996892|19301654|P4|Expansion Stage 2|Physician Decision|0
5585865|NCT00996892|19301655|P3|Expansion Stage 2|Physician Decision|0
5585866|NCT00996892|19301656|P2|Expansion Stage 2|Physician Decision|0
5585867|NCT00996892|19301657|P1|Expansion Stage 2|Physician Decision|0
5585868|NCT00996892|19301638|P20|Expansion Stage 2|Death|0
5585869|NCT00996892|19301639|P19|Expansion Stage 2|Death|2
5585870|NCT00996892|19301640|P18|Expansion Stage 2|Death|0
5585871|NCT00996892|19301641|P17|Expansion Stage 2|Death|0
5585872|NCT00996892|19301642|P16|Expansion Stage 2|Death|0
5585873|NCT00996892|19301643|P15|Expansion Stage 2|Death|0
5585874|NCT00996892|19301644|P14|Expansion Stage 2|Death|0
5585875|NCT00996892|19301645|P13|Expansion Stage 2|Death|0
5585876|NCT00996892|19301646|P12|Expansion Stage 2|Death|0
5585877|NCT00996892|19301647|P11|Expansion Stage 2|Death|0
5585878|NCT00996892|19301648|P10|Expansion Stage 2|Death|0
5585879|NCT00996892|19301649|P9|Expansion Stage 2|Death|0
5585880|NCT00996892|19301650|P8|Expansion Stage 2|Death|0
5585881|NCT00996892|19301651|P7|Expansion Stage 2|Death|0
5585882|NCT00996892|19301652|P6|Expansion Stage 2|Death|0
5585883|NCT00996892|19301653|P5|Expansion Stage 2|Death|0
5585884|NCT00996892|19301654|P4|Expansion Stage 2|Death|0
5585885|NCT00996892|19301655|P3|Expansion Stage 2|Death|0
5585886|NCT00996892|19301656|P2|Expansion Stage 2|Death|0
5585887|NCT00996892|19301657|P1|Expansion Stage 2|Death|0
5585888|NCT00996892|19301638|P20|Expansion Stage 2|Adverse Event|0
5585889|NCT00996892|19301639|P19|Expansion Stage 2|Adverse Event|3
5585890|NCT00996892|19301640|P18|Expansion Stage 2|Adverse Event|0
5585891|NCT00996892|19301641|P17|Expansion Stage 2|Adverse Event|0
5585892|NCT00996892|19301642|P16|Expansion Stage 2|Adverse Event|0
5585893|NCT00996892|19301643|P15|Expansion Stage 2|Adverse Event|0
5585894|NCT00996892|19301644|P14|Expansion Stage 2|Adverse Event|0
5585895|NCT00996892|19301645|P13|Expansion Stage 2|Adverse Event|0
5585896|NCT00996892|19301646|P12|Expansion Stage 2|Adverse Event|0
5585897|NCT00996892|19301647|P11|Expansion Stage 2|Adverse Event|0
5585898|NCT00996892|19301648|P10|Expansion Stage 2|Adverse Event|0
5585899|NCT00996892|19301649|P9|Expansion Stage 2|Adverse Event|0
5585900|NCT00996892|19301650|P8|Expansion Stage 2|Adverse Event|0
5585901|NCT00996892|19301651|P7|Expansion Stage 2|Adverse Event|0
5585902|NCT00996892|19301652|P6|Expansion Stage 2|Adverse Event|0
5585903|NCT00996892|19301653|P5|Expansion Stage 2|Adverse Event|0
5585904|NCT00996892|19301654|P4|Expansion Stage 2|Adverse Event|0
5585905|NCT00996892|19301655|P3|Expansion Stage 2|Adverse Event|0
5585906|NCT00996892|19301656|P2|Expansion Stage 2|Adverse Event|0
5585907|NCT00996892|19301657|P1|Expansion Stage 2|Adverse Event|0
5585908|NCT00996892|19301638|P20|Dose-Escalation Stage 1B|Disease Progression|0
5585909|NCT00996892|19301639|P19|Dose-Escalation Stage 1B|Disease Progression|0
5585910|NCT00996892|19301640|P18|Dose-Escalation Stage 1B|Disease Progression|3
5585911|NCT00996892|19301641|P17|Dose-Escalation Stage 1B|Disease Progression|3
5585912|NCT00996892|19301642|P16|Dose-Escalation Stage 1B|Disease Progression|3
5585913|NCT00996892|19301643|P15|Dose-Escalation Stage 1B|Disease Progression|4
5585914|NCT00996892|19301644|P14|Dose-Escalation Stage 1B|Disease Progression|0
5585915|NCT00996892|19301645|P13|Dose-Escalation Stage 1B|Disease Progression|0
5585916|NCT00996892|19301646|P12|Dose-Escalation Stage 1B|Disease Progression|0
5585917|NCT00996892|19301647|P11|Dose-Escalation Stage 1B|Disease Progression|0
5585918|NCT00996892|19301648|P10|Dose-Escalation Stage 1B|Disease Progression|0
5585919|NCT00996892|19301649|P9|Dose-Escalation Stage 1B|Disease Progression|0
5585920|NCT00996892|19301650|P8|Dose-Escalation Stage 1B|Disease Progression|0
5585921|NCT00996892|19301651|P7|Dose-Escalation Stage 1B|Disease Progression|0
5585922|NCT00996892|19301652|P6|Dose-Escalation Stage 1B|Disease Progression|0
5585923|NCT00996892|19301653|P5|Dose-Escalation Stage 1B|Disease Progression|0
5585924|NCT00996892|19301654|P4|Dose-Escalation Stage 1B|Disease Progression|0
5585925|NCT00996892|19301655|P3|Dose-Escalation Stage 1B|Disease Progression|0
5585926|NCT00996892|19301656|P2|Dose-Escalation Stage 1B|Disease Progression|0
5585927|NCT00996892|19301657|P1|Dose-Escalation Stage 1B|Disease Progression|0
5585928|NCT00996892|19301638|P20|Dose-Escalation Stage 1B|Physician Decision|0
5585929|NCT00996892|19301639|P19|Dose-Escalation Stage 1B|Physician Decision|0
5585930|NCT00996892|19301640|P18|Dose-Escalation Stage 1B|Physician Decision|2
5585931|NCT00996892|19301641|P17|Dose-Escalation Stage 1B|Physician Decision|0
5585932|NCT00996892|19301642|P16|Dose-Escalation Stage 1B|Physician Decision|0
5585933|NCT00996892|19301643|P15|Dose-Escalation Stage 1B|Physician Decision|0
5585934|NCT00996892|19301644|P14|Dose-Escalation Stage 1B|Physician Decision|0
5585935|NCT00996892|19301645|P13|Dose-Escalation Stage 1B|Physician Decision|0
5585936|NCT00996892|19301646|P12|Dose-Escalation Stage 1B|Physician Decision|0
5585937|NCT00996892|19301647|P11|Dose-Escalation Stage 1B|Physician Decision|0
5585938|NCT00996892|19301648|P10|Dose-Escalation Stage 1B|Physician Decision|0
5585939|NCT00996892|19301649|P9|Dose-Escalation Stage 1B|Physician Decision|0
5585940|NCT00996892|19301650|P8|Dose-Escalation Stage 1B|Physician Decision|0
5585941|NCT00996892|19301651|P7|Dose-Escalation Stage 1B|Physician Decision|0
5585942|NCT00996892|19301652|P6|Dose-Escalation Stage 1B|Physician Decision|0
5585943|NCT00996892|19301653|P5|Dose-Escalation Stage 1B|Physician Decision|0
5585944|NCT00996892|19301654|P4|Dose-Escalation Stage 1B|Physician Decision|0
5585945|NCT00996892|19301655|P3|Dose-Escalation Stage 1B|Physician Decision|0
5585946|NCT00996892|19301656|P2|Dose-Escalation Stage 1B|Physician Decision|0
5585947|NCT00996892|19301657|P1|Dose-Escalation Stage 1B|Physician Decision|0
5585948|NCT00996892|19301638|P20|Dose-Escalation Stage 1A|Disease Progression|0
5585949|NCT00996892|19301639|P19|Dose-Escalation Stage 1A|Disease Progression|0
5585950|NCT00996892|19301640|P18|Dose-Escalation Stage 1A|Disease Progression|0
5585951|NCT00996892|19301641|P17|Dose-Escalation Stage 1A|Disease Progression|0
5585952|NCT00996892|19301642|P16|Dose-Escalation Stage 1A|Disease Progression|0
5585953|NCT00996892|19301643|P15|Dose-Escalation Stage 1A|Disease Progression|0
5585954|NCT00996892|19301644|P14|Dose-Escalation Stage 1A|Disease Progression|4
5585955|NCT00996892|19301645|P13|Dose-Escalation Stage 1A|Disease Progression|6
5585956|NCT00996892|19301646|P12|Dose-Escalation Stage 1A|Disease Progression|7
5585957|NCT00996892|19301647|P11|Dose-Escalation Stage 1A|Disease Progression|5
5585958|NCT00996892|19301648|P10|Dose-Escalation Stage 1A|Disease Progression|1
5585959|NCT00996892|19301649|P9|Dose-Escalation Stage 1A|Disease Progression|3
5585960|NCT00996892|19301650|P8|Dose-Escalation Stage 1A|Disease Progression|2
5585961|NCT00996892|19301651|P7|Dose-Escalation Stage 1A|Disease Progression|0
5585962|NCT00996892|19301652|P6|Dose-Escalation Stage 1A|Disease Progression|0
5585963|NCT00996892|19301653|P5|Dose-Escalation Stage 1A|Disease Progression|0
5585964|NCT00996892|19301654|P4|Dose-Escalation Stage 1A|Disease Progression|0
5585965|NCT00996892|19301655|P3|Dose-Escalation Stage 1A|Disease Progression|0
5585966|NCT00996892|19301656|P2|Dose-Escalation Stage 1A|Disease Progression|0
5585967|NCT00996892|19301657|P1|Dose-Escalation Stage 1A|Disease Progression|0
5585968|NCT00996892|19301638|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585969|NCT00996892|19301639|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585970|NCT00996892|19301640|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585971|NCT00996892|19301641|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585972|NCT00996892|19301642|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585973|NCT00996892|19301643|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585974|NCT00996892|19301644|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585975|NCT00996892|19301645|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5585976|NCT00996892|19301646|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5585977|NCT00996892|19301647|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5585978|NCT00996892|19301648|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
5585979|NCT00996892|19301649|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585980|NCT00996892|19301650|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585981|NCT00996892|19301651|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585982|NCT00996892|19301652|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585983|NCT00996892|19301653|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585984|NCT00996892|19301654|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585985|NCT00996892|19301655|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585986|NCT00996892|19301656|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585987|NCT00996892|19301657|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
5585988|NCT00996892|19301638|P20|Dose-Escalation Stage 1A|Physician Decision|0
5585989|NCT00996892|19301639|P19|Dose-Escalation Stage 1A|Physician Decision|0
5585990|NCT00996892|19301640|P18|Dose-Escalation Stage 1A|Physician Decision|0
5585991|NCT00996892|19301641|P17|Dose-Escalation Stage 1A|Physician Decision|0
5585992|NCT00996892|19301642|P16|Dose-Escalation Stage 1A|Physician Decision|0
5585993|NCT00996892|19301643|P15|Dose-Escalation Stage 1A|Physician Decision|0
5585994|NCT00996892|19301644|P14|Dose-Escalation Stage 1A|Physician Decision|0
5585995|NCT00996892|19301645|P13|Dose-Escalation Stage 1A|Physician Decision|0
5585996|NCT00996892|19301646|P12|Dose-Escalation Stage 1A|Physician Decision|0
5585997|NCT00996892|19301647|P11|Dose-Escalation Stage 1A|Physician Decision|0
5585998|NCT00996892|19301648|P10|Dose-Escalation Stage 1A|Physician Decision|0
5585999|NCT00996892|19301649|P9|Dose-Escalation Stage 1A|Physician Decision|0
5586000|NCT00996892|19301650|P8|Dose-Escalation Stage 1A|Physician Decision|1
5586001|NCT00996892|19301651|P7|Dose-Escalation Stage 1A|Physician Decision|0
5586002|NCT00996892|19301652|P6|Dose-Escalation Stage 1A|Physician Decision|0
5586003|NCT00996892|19301653|P5|Dose-Escalation Stage 1A|Physician Decision|0
5586004|NCT00996892|19301654|P4|Dose-Escalation Stage 1A|Physician Decision|0
5586005|NCT00996892|19301655|P3|Dose-Escalation Stage 1A|Physician Decision|0
5586006|NCT00996892|19301656|P2|Dose-Escalation Stage 1A|Physician Decision|0
5586007|NCT00996892|19301657|P1|Dose-Escalation Stage 1A|Physician Decision|0
5586008|NCT00996892|19301638|P20|Dose-Escalation Stage 1A|Death|0
5586009|NCT00996892|19301639|P19|Dose-Escalation Stage 1A|Death|0
5586010|NCT00996892|19301640|P18|Dose-Escalation Stage 1A|Death|0
5586011|NCT00996892|19301641|P17|Dose-Escalation Stage 1A|Death|0
5586012|NCT00996892|19301642|P16|Dose-Escalation Stage 1A|Death|0
5586013|NCT00996892|19301643|P15|Dose-Escalation Stage 1A|Death|0
5586014|NCT00996892|19301644|P14|Dose-Escalation Stage 1A|Death|0
5586015|NCT00996892|19301645|P13|Dose-Escalation Stage 1A|Death|1
5586016|NCT00996892|19301646|P12|Dose-Escalation Stage 1A|Death|1
5586017|NCT00996892|19301647|P11|Dose-Escalation Stage 1A|Death|0
5586018|NCT00996892|19301648|P10|Dose-Escalation Stage 1A|Death|2
5586019|NCT00996892|19301649|P9|Dose-Escalation Stage 1A|Death|0
5586020|NCT00996892|19301650|P8|Dose-Escalation Stage 1A|Death|0
5586021|NCT00996892|19301651|P7|Dose-Escalation Stage 1A|Death|0
5586022|NCT00996892|19301652|P6|Dose-Escalation Stage 1A|Death|0
5586023|NCT00996892|19301653|P5|Dose-Escalation Stage 1A|Death|0
5586024|NCT00996892|19301654|P4|Dose-Escalation Stage 1A|Death|0
5586025|NCT00996892|19301655|P3|Dose-Escalation Stage 1A|Death|0
5586026|NCT00996892|19301656|P2|Dose-Escalation Stage 1A|Death|0
5586027|NCT00996892|19301657|P1|Dose-Escalation Stage 1A|Death|0
5586028|NCT00996892|19301638|P20|Dose-Escalation Stage 1A|Adverse Event|0
5586029|NCT00996892|19301639|P19|Dose-Escalation Stage 1A|Adverse Event|0
5586030|NCT00996892|19301640|P18|Dose-Escalation Stage 1A|Adverse Event|0
5586031|NCT00996892|19301641|P17|Dose-Escalation Stage 1A|Adverse Event|0
5586032|NCT00996892|19301642|P16|Dose-Escalation Stage 1A|Adverse Event|0
5586033|NCT00996892|19301643|P15|Dose-Escalation Stage 1A|Adverse Event|0
5586034|NCT00996892|19301644|P14|Dose-Escalation Stage 1A|Adverse Event|1
5586035|NCT00996892|19301645|P13|Dose-Escalation Stage 1A|Adverse Event|0
5586036|NCT00996892|19301646|P12|Dose-Escalation Stage 1A|Adverse Event|0
5586037|NCT00996892|19301647|P11|Dose-Escalation Stage 1A|Adverse Event|1
5586038|NCT00996892|19301648|P10|Dose-Escalation Stage 1A|Adverse Event|0
5586039|NCT00996892|19301649|P9|Dose-Escalation Stage 1A|Adverse Event|0
5586040|NCT00996892|19301650|P8|Dose-Escalation Stage 1A|Adverse Event|0
5586041|NCT00996892|19301651|P7|Dose-Escalation Stage 1A|Adverse Event|0
5586042|NCT00996892|19301652|P6|Dose-Escalation Stage 1A|Adverse Event|0
5586043|NCT00996892|19301653|P5|Dose-Escalation Stage 1A|Adverse Event|0
5586044|NCT00996892|19301654|P4|Dose-Escalation Stage 1A|Adverse Event|0
5586045|NCT00996892|19301655|P3|Dose-Escalation Stage 1A|Adverse Event|0
5586046|NCT00996892|19301656|P2|Dose-Escalation Stage 1A|Adverse Event|0
5586047|NCT00996892|19301657|P1|Dose-Escalation Stage 1A|Adverse Event|0
5586048|NCT00996892|19301638|P20|Dose-Escalation Stage 1|Disease Progression|0
5586049|NCT00996892|19301639|P19|Dose-Escalation Stage 1|Disease Progression|0
5586050|NCT00996892|19301640|P18|Dose-Escalation Stage 1|Disease Progression|0
5586051|NCT00996892|19301641|P17|Dose-Escalation Stage 1|Disease Progression|0
5586052|NCT00996892|19301642|P16|Dose-Escalation Stage 1|Disease Progression|0
5586053|NCT00996892|19301643|P15|Dose-Escalation Stage 1|Disease Progression|0
5586054|NCT00996892|19301644|P14|Dose-Escalation Stage 1|Disease Progression|0
5586055|NCT00996892|19301645|P13|Dose-Escalation Stage 1|Disease Progression|0
5586056|NCT00996892|19301646|P12|Dose-Escalation Stage 1|Disease Progression|0
5586057|NCT00996892|19301647|P11|Dose-Escalation Stage 1|Disease Progression|0
5586058|NCT00996892|19301648|P10|Dose-Escalation Stage 1|Disease Progression|0
5586059|NCT00996892|19301649|P9|Dose-Escalation Stage 1|Disease Progression|0
5586060|NCT00996892|19301650|P8|Dose-Escalation Stage 1|Disease Progression|0
5586061|NCT00996892|19301651|P7|Dose-Escalation Stage 1|Disease Progression|0
5586062|NCT00996892|19301652|P6|Dose-Escalation Stage 1|Disease Progression|7
5586063|NCT00996892|19301653|P5|Dose-Escalation Stage 1|Disease Progression|10
5586064|NCT00996892|19301654|P4|Dose-Escalation Stage 1|Disease Progression|4
5586065|NCT00996892|19301655|P3|Dose-Escalation Stage 1|Disease Progression|3
5586066|NCT00996892|19301656|P2|Dose-Escalation Stage 1|Disease Progression|2
5586067|NCT00996892|19301657|P1|Dose-Escalation Stage 1|Disease Progression|2
5586068|NCT00996892|19301638|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586069|NCT00996892|19301639|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586070|NCT00996892|19301640|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586071|NCT00996892|19301641|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586072|NCT00996892|19301642|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586073|NCT00996892|19301643|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586074|NCT00996892|19301644|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586075|NCT00996892|19301645|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586076|NCT00996892|19301646|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586077|NCT00996892|19301647|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586078|NCT00996892|19301648|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586079|NCT00996892|19301649|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586080|NCT00996892|19301650|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586081|NCT00996892|19301651|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
5586082|NCT00996892|19301652|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
5586083|NCT00996892|19301653|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
5586084|NCT00996892|19301654|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
5586085|NCT00996892|19301655|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586086|NCT00996892|19301656|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
5586087|NCT00996892|19301657|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
5586088|NCT00996892|19301638|P20|Dose-Escalation Stage 1|Physician Decision|0
5586089|NCT00996892|19301639|P19|Dose-Escalation Stage 1|Physician Decision|0
5586090|NCT00996892|19301640|P18|Dose-Escalation Stage 1|Physician Decision|0
5586091|NCT00996892|19301641|P17|Dose-Escalation Stage 1|Physician Decision|0
5586092|NCT00996892|19301642|P16|Dose-Escalation Stage 1|Physician Decision|0
5586093|NCT00996892|19301643|P15|Dose-Escalation Stage 1|Physician Decision|0
5586094|NCT00996892|19301644|P14|Dose-Escalation Stage 1|Physician Decision|0
5586095|NCT00996892|19301645|P13|Dose-Escalation Stage 1|Physician Decision|0
5586096|NCT00996892|19301646|P12|Dose-Escalation Stage 1|Physician Decision|0
5586097|NCT00996892|19301647|P11|Dose-Escalation Stage 1|Physician Decision|0
5586098|NCT00996892|19301648|P10|Dose-Escalation Stage 1|Physician Decision|0
5586099|NCT00996892|19301649|P9|Dose-Escalation Stage 1|Physician Decision|0
5586100|NCT00996892|19301650|P8|Dose-Escalation Stage 1|Physician Decision|0
5586101|NCT00996892|19301651|P7|Dose-Escalation Stage 1|Physician Decision|2
5586102|NCT00996892|19301652|P6|Dose-Escalation Stage 1|Physician Decision|1
5586103|NCT00996892|19301653|P5|Dose-Escalation Stage 1|Physician Decision|0
5586104|NCT00996892|19301654|P4|Dose-Escalation Stage 1|Physician Decision|1
5586105|NCT00996892|19301655|P3|Dose-Escalation Stage 1|Physician Decision|0
5586106|NCT00996892|19301656|P2|Dose-Escalation Stage 1|Physician Decision|0
5586107|NCT00996892|19301657|P1|Dose-Escalation Stage 1|Physician Decision|1
5586108|NCT00996892|19301638|P20|Dose-Escalation Stage 1|Death|0
5586109|NCT00996892|19301639|P19|Dose-Escalation Stage 1|Death|0
5586110|NCT00996892|19301640|P18|Dose-Escalation Stage 1|Death|0
5586111|NCT00996892|19301641|P17|Dose-Escalation Stage 1|Death|0
5586112|NCT00996892|19301642|P16|Dose-Escalation Stage 1|Death|0
5586113|NCT00996892|19301643|P15|Dose-Escalation Stage 1|Death|0
5586114|NCT00996892|19301644|P14|Dose-Escalation Stage 1|Death|0
5586115|NCT00996892|19301645|P13|Dose-Escalation Stage 1|Death|0
5586116|NCT00996892|19301646|P12|Dose-Escalation Stage 1|Death|0
5586117|NCT00996892|19301647|P11|Dose-Escalation Stage 1|Death|0
5586118|NCT00996892|19301648|P10|Dose-Escalation Stage 1|Death|0
5586119|NCT00996892|19301649|P9|Dose-Escalation Stage 1|Death|0
5586120|NCT00996892|19301650|P8|Dose-Escalation Stage 1|Death|0
5586121|NCT00996892|19301651|P7|Dose-Escalation Stage 1|Death|0
5586122|NCT00996892|19301652|P6|Dose-Escalation Stage 1|Death|1
5586123|NCT00996892|19301653|P5|Dose-Escalation Stage 1|Death|0
5586124|NCT00996892|19301654|P4|Dose-Escalation Stage 1|Death|0
5586125|NCT00996892|19301655|P3|Dose-Escalation Stage 1|Death|0
5586126|NCT00996892|19301656|P2|Dose-Escalation Stage 1|Death|0
5586127|NCT00996892|19301657|P1|Dose-Escalation Stage 1|Death|1
5586128|NCT00996892|19301638|P20|Dose-Escalation Stage 1|Adverse Event|0
5586129|NCT00996892|19301639|P19|Dose-Escalation Stage 1|Adverse Event|0
5586130|NCT00996892|19301640|P18|Dose-Escalation Stage 1|Adverse Event|0
5586131|NCT00996892|19301641|P17|Dose-Escalation Stage 1|Adverse Event|0
5586132|NCT00996892|19301642|P16|Dose-Escalation Stage 1|Adverse Event|0
5586133|NCT00996892|19301643|P15|Dose-Escalation Stage 1|Adverse Event|0
5586134|NCT00996892|19301644|P14|Dose-Escalation Stage 1|Adverse Event|0
5586135|NCT00996892|19301645|P13|Dose-Escalation Stage 1|Adverse Event|0
5586136|NCT00996892|19301646|P12|Dose-Escalation Stage 1|Adverse Event|0
5586137|NCT00996892|19301647|P11|Dose-Escalation Stage 1|Adverse Event|0
5586138|NCT00996892|19301648|P10|Dose-Escalation Stage 1|Adverse Event|0
5586139|NCT00996892|19301649|P9|Dose-Escalation Stage 1|Adverse Event|0
5586140|NCT00996892|19301650|P8|Dose-Escalation Stage 1|Adverse Event|0
5586141|NCT00996892|19301651|P7|Dose-Escalation Stage 1|Adverse Event|1
5586142|NCT00996892|19301652|P6|Dose-Escalation Stage 1|Adverse Event|0
5586143|NCT00996892|19301653|P5|Dose-Escalation Stage 1|Adverse Event|0
5586144|NCT00996892|19301654|P4|Dose-Escalation Stage 1|Adverse Event|2
5586145|NCT00996892|19301655|P3|Dose-Escalation Stage 1|Adverse Event|0
5586146|NCT00996892|19301656|P2|Dose-Escalation Stage 1|Adverse Event|0
5586147|NCT00996892|19301657|P1|Dose-Escalation Stage 1|Adverse Event|0
5586148|NCT00996840|19302251|P5|Overall Study|Withdrawal by Subject|0
5586149|NCT00996840|19302252|P4|Overall Study|Withdrawal by Subject|0
5586150|NCT00996840|19302253|P3|Overall Study|Withdrawal by Subject|0
5586151|NCT00996840|19302254|P2|Overall Study|Withdrawal by Subject|1
5586152|NCT00996840|19302255|P1|Overall Study|Withdrawal by Subject|1
5586153|NCT00996840|19302251|P5|Overall Study|Physician Decision|2
5586154|NCT00996840|19302252|P4|Overall Study|Physician Decision|1
5586155|NCT00996840|19302253|P3|Overall Study|Physician Decision|1
5586156|NCT00996840|19302254|P2|Overall Study|Physician Decision|0
5586157|NCT00996840|19302255|P1|Overall Study|Physician Decision|0
5586158|NCT00996840|19302251|P5|Overall Study|Adverse Event|0
5586159|NCT00996840|19302252|P4|Overall Study|Adverse Event|0
5586160|NCT00996840|19302253|P3|Overall Study|Adverse Event|0
5586161|NCT00996840|19302254|P2|Overall Study|Adverse Event|1
5586162|NCT00996840|19302255|P1|Overall Study|Adverse Event|0
5586163|NCT00996801|19302405|P6|Overall Study|Withdrawal by Subject|9
5586164|NCT00996801|19302406|P5|Overall Study|Withdrawal by Subject|5
5586165|NCT00996801|19302407|P4|Overall Study|Withdrawal by Subject|5
5586166|NCT00996801|19302408|P3|Overall Study|Withdrawal by Subject|9
5586167|NCT00996801|19302409|P2|Overall Study|Withdrawal by Subject|6
5586168|NCT00996801|19302410|P1|Overall Study|Withdrawal by Subject|8
5586169|NCT00996801|19302405|P6|Overall Study|Study Terminated by Sponsor|0
5586170|NCT00996801|19302406|P5|Overall Study|Study Terminated by Sponsor|46
5586171|NCT00996801|19302407|P4|Overall Study|Study Terminated by Sponsor|0
5586172|NCT00996801|19302408|P3|Overall Study|Study Terminated by Sponsor|0
5586173|NCT00996801|19302409|P2|Overall Study|Study Terminated by Sponsor|1
5586174|NCT00996801|19302410|P1|Overall Study|Study Terminated by Sponsor|0
5586175|NCT00996801|19302405|P6|Overall Study|Protocol Violation|4
5586176|NCT00996801|19302406|P5|Overall Study|Protocol Violation|3
5586177|NCT00996801|19302407|P4|Overall Study|Protocol Violation|2
5586178|NCT00996801|19302408|P3|Overall Study|Protocol Violation|1
5586179|NCT00996801|19302409|P2|Overall Study|Protocol Violation|4
5586180|NCT00996801|19302410|P1|Overall Study|Protocol Violation|3
5586181|NCT00996801|19302405|P6|Overall Study|Progressive Disease|0
5586182|NCT00996801|19302406|P5|Overall Study|Progressive Disease|0
5586183|NCT00996801|19302407|P4|Overall Study|Progressive Disease|0
5586184|NCT00996801|19302408|P3|Overall Study|Progressive Disease|0
5586185|NCT00996801|19302409|P2|Overall Study|Progressive Disease|1
5586186|NCT00996801|19302410|P1|Overall Study|Progressive Disease|0
5586187|NCT00996801|19302405|P6|Overall Study|Physician Decision|0
5586188|NCT00996801|19302406|P5|Overall Study|Physician Decision|0
5586189|NCT00996801|19302407|P4|Overall Study|Physician Decision|1
5586190|NCT00996801|19302408|P3|Overall Study|Physician Decision|0
5586191|NCT00996801|19302409|P2|Overall Study|Physician Decision|0
5586192|NCT00996801|19302410|P1|Overall Study|Physician Decision|0
5586193|NCT00996801|19302405|P6|Overall Study|Lost to Follow-up|2
5586194|NCT00996801|19302406|P5|Overall Study|Lost to Follow-up|3
5586195|NCT00996801|19302407|P4|Overall Study|Lost to Follow-up|3
5586196|NCT00996801|19302408|P3|Overall Study|Lost to Follow-up|0
5586197|NCT00996801|19302409|P2|Overall Study|Lost to Follow-up|0
5586198|NCT00996801|19302410|P1|Overall Study|Lost to Follow-up|0
5586199|NCT00996801|19302405|P6|Overall Study|Lack of Efficacy|1
5586200|NCT00996801|19302406|P5|Overall Study|Lack of Efficacy|0
5586201|NCT00996801|19302407|P4|Overall Study|Lack of Efficacy|3
5586202|NCT00996801|19302408|P3|Overall Study|Lack of Efficacy|1
5586203|NCT00996801|19302409|P2|Overall Study|Lack of Efficacy|0
5586204|NCT00996801|19302410|P1|Overall Study|Lack of Efficacy|3
5586205|NCT00996801|19302405|P6|Overall Study|Adverse Event|3
5586206|NCT00996801|19302406|P5|Overall Study|Adverse Event|31
5586207|NCT00996801|19302407|P4|Overall Study|Adverse Event|17
5586208|NCT00996801|19302408|P3|Overall Study|Adverse Event|12
5586209|NCT00996801|19302409|P2|Overall Study|Adverse Event|4
5586210|NCT00996801|19302410|P1|Overall Study|Adverse Event|6
5586211|NCT00996736|19302522|P2|Overall Study|Visit not within 3-month window|3
5586212|NCT00996736|19302523|P1|Overall Study|Visit not within 3-month window|5
5586213|NCT00996736|19302522|P2|Overall Study|Lost to Follow-up|14
5586214|NCT00996736|19302523|P1|Overall Study|Lost to Follow-up|15
5586215|NCT00996736|19302522|P2|Overall Study|Death|1
5586216|NCT00996736|19302523|P1|Overall Study|Death|1
5586217|NCT00996658|19302543|P2|Overall Study|Other|7
5586218|NCT00996658|19302544|P1|Overall Study|Other|9
5586219|NCT00996658|19302543|P2|Overall Study|Non-compliance issues|3
5586220|NCT00996658|19302544|P1|Overall Study|Non-compliance issues|3
5586221|NCT00996658|19302543|P2|Overall Study|Lost to Follow-up|5
5586222|NCT00996658|19302544|P1|Overall Study|Lost to Follow-up|2
5586223|NCT00996658|19302543|P2|Overall Study|Protocol Violation|1
5586224|NCT00996658|19302544|P1|Overall Study|Protocol Violation|0
5586225|NCT00996658|19302543|P2|Overall Study|Adverse Event|5
5586226|NCT00996658|19302544|P1|Overall Study|Adverse Event|2
5586227|NCT00996632|19302572|P2|Overall Study|Physician Decision|0
5586228|NCT00996632|19302573|P1|Overall Study|Physician Decision|0
5586229|NCT00996606|19302581|P1|Overall Study|Withdrawal by Subject|3
5586230|NCT00996606|19302581|P1|Overall Study|Protocol Violation|1
5586231|NCT00996606|19302581|P1|Overall Study|Insufficient Therapeutic Response|2
5586232|NCT00996606|19302581|P1|Overall Study|Adverse Event or Intercurrent Illness|2
5586233|NCT00996593|19302675|P1|Long-Term Follow-Up|Site Closed|1
5586234|NCT00996593|19302675|P1|Long-Term Follow-Up|Withdrawal by Subject|2
5586235|NCT00996593|19302675|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
5586236|NCT00996593|19302675|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
5586237|NCT00996593|19302675|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
5586238|NCT00996593|19302675|P1|Dosimetric and Therapeutic Treatment|Death|1
5586239|NCT00996593|19302675|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
5586240|NCT00996593|19302675|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
5586241|NCT00996593|19302675|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
5586242|NCT00996580|19302703|P1|Overall Study|Other|29
5586243|NCT00996580|19302703|P1|Overall Study|Withdrawal by Subject|217
5586244|NCT00996580|19302703|P1|Overall Study|Sponsor requested participant withdrawal|35
5586245|NCT00996580|19302703|P1|Overall Study|Protocol Violation|16
5586246|NCT00996580|19302703|P1|Overall Study|Pregnancy|68
5586247|NCT00996580|19302703|P1|Overall Study|Physician Decision|5
5586248|NCT00996580|19302703|P1|Overall Study|Noncompliance with the protocol|137
5586249|NCT00996580|19302703|P1|Overall Study|Lost to Follow-up|480
5586250|NCT00996580|19302703|P1|Overall Study|Adverse Event|466
5586251|NCT00996489|19302738|P1|Overall Study|Discontinued|116
5586252|NCT00996489|19302738|P1|Overall Study|Device failure|45
5586253|NCT00996476|19302758|P5|Overall Study|Adverse Event|1
5586254|NCT00996476|19302759|P4|Overall Study|Adverse Event|0
5586255|NCT00996476|19302760|P3|Overall Study|Adverse Event|0
5586256|NCT00996476|19302761|P2|Overall Study|Adverse Event|1
5586257|NCT00996476|19302762|P1|Overall Study|Adverse Event|0
5586258|NCT00996476|19302758|P5|Overall Study|Withdrawal by Subject|1
5586259|NCT00996476|19302759|P4|Overall Study|Withdrawal by Subject|0
5586260|NCT00996476|19302760|P3|Overall Study|Withdrawal by Subject|1
5586261|NCT00996476|19302761|P2|Overall Study|Withdrawal by Subject|2
5586262|NCT00996476|19302762|P1|Overall Study|Withdrawal by Subject|1
5586263|NCT00996437|19302830|P2|Overall Study|Missed|5
5586264|NCT00996437|19302831|P1|Overall Study|Missed|2
5586265|NCT00996437|19302830|P2|Overall Study|Dropped|2
5586266|NCT00996437|19302831|P1|Overall Study|Dropped|2
5586267|NCT00996437|19302830|P2|Overall Study|Death|0
5586268|NCT00996437|19302831|P1|Overall Study|Death|1
5586269|NCT00996333|19302876|P1|Overall Study|Other|5
5586270|NCT00996333|19302876|P1|Overall Study|Physician Decision|1
5586271|NCT00996333|19302876|P1|Overall Study|Adverse Event|1
5586272|NCT00996333|19302876|P1|Overall Study|Death|4
5586273|NCT00996333|19302876|P1|Overall Study|Withdrawal by Subject|1
5586274|NCT00996333|19302876|P1|Overall Study|Screen failure|1
5586275|NCT00996307|19302886|P4|Overall Study|Unable to classify|1
5586276|NCT00996307|19302887|P3|Overall Study|Unable to classify|2
5586277|NCT00996307|19302888|P2|Overall Study|Unable to classify|0
5586278|NCT00996307|19302889|P1|Overall Study|Unable to classify|4
5586279|NCT00996307|19302886|P4|Overall Study|Administrative reason|0
5586280|NCT00996307|19302887|P3|Overall Study|Administrative reason|0
5586281|NCT00996307|19302888|P2|Overall Study|Administrative reason|1
5586282|NCT00996307|19302889|P1|Overall Study|Administrative reason|0
5586283|NCT00996307|19302886|P4|Overall Study|Lost to Follow-up|15
5586284|NCT00996307|19302887|P3|Overall Study|Lost to Follow-up|7
5586285|NCT00996307|19302888|P2|Overall Study|Lost to Follow-up|13
5586286|NCT00996307|19302889|P1|Overall Study|Lost to Follow-up|13
5586287|NCT00996307|19302886|P4|Overall Study|Withdrawal by Subject|5
5586288|NCT00996307|19302887|P3|Overall Study|Withdrawal by Subject|5
5586289|NCT00996307|19302888|P2|Overall Study|Withdrawal by Subject|2
5586290|NCT00996307|19302889|P1|Overall Study|Withdrawal by Subject|3
5586291|NCT00996307|19302886|P4|Overall Study|Adverse Event|0
5586292|NCT00996307|19302887|P3|Overall Study|Adverse Event|0
5586293|NCT00996307|19302888|P2|Overall Study|Adverse Event|1
5586294|NCT00996307|19302889|P1|Overall Study|Adverse Event|0
5586295|NCT00996281|19302949|P2|Overall Study|Other|7
5586296|NCT00996281|19302950|P1|Overall Study|Other|5
5586297|NCT00996281|19302949|P2|Overall Study|Lack of Efficacy|2
5586298|NCT00996281|19302950|P1|Overall Study|Lack of Efficacy|0
5586299|NCT00996281|19302949|P2|Overall Study|Withdrawal by Subject|20
5586300|NCT00996281|19302950|P1|Overall Study|Withdrawal by Subject|31
5586301|NCT00996281|19302949|P2|Overall Study|Lost to Follow-up|16
5586302|NCT00996281|19302950|P1|Overall Study|Lost to Follow-up|14
5586303|NCT00996281|19302949|P2|Overall Study|Major Protocol Deviation|7
5586304|NCT00996281|19302950|P1|Overall Study|Major Protocol Deviation|6
5586305|NCT00996281|19302949|P2|Overall Study|Adverse Event|37
5586306|NCT00996281|19302950|P1|Overall Study|Adverse Event|75
5586307|NCT00996216|19302958|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
5586308|NCT00996216|19302958|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
5586309|NCT00996216|19302958|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
5586310|NCT00996203|19302974|P1|Overall Study|Protocol Violation|2
5586311|NCT00996203|19302974|P1|Overall Study|Lack of Efficacy|1
5586312|NCT00996203|19302974|P1|Overall Study|Lost to Follow-up|1
5586313|NCT00996203|19302974|P1|Overall Study|Adverse Event|3
5586314|NCT00996125|19303006|P2|Overall Study|Withdrawal by Subject|3
5586315|NCT00996125|19303007|P1|Overall Study|Withdrawal by Subject|4
5586316|NCT00996125|19303006|P2|Overall Study|Lost to Follow-up|6
5586317|NCT00996125|19303007|P1|Overall Study|Lost to Follow-up|1
5586318|NCT00996125|19303006|P2|Overall Study|Adverse Event|2
5586319|NCT00996125|19303007|P1|Overall Study|Adverse Event|0
5586320|NCT00996034|19303027|P1|Overall Study|withdrawn by PI|1
5586321|NCT00996034|19303027|P1|Overall Study|Lost to Follow-up|2
5586322|NCT00995930|19303033|P2|Overall Study|Adverse Event|14
5586323|NCT00995930|19303034|P1|Overall Study|Adverse Event|11
5586324|NCT00995930|19303033|P2|Overall Study|Withdrawal by Subject|4
5586325|NCT00995930|19303034|P1|Overall Study|Withdrawal by Subject|3
5586326|NCT00995930|19303033|P2|Overall Study|Lost to Follow-up|2
5586327|NCT00995930|19303034|P1|Overall Study|Lost to Follow-up|1
5586328|NCT00995930|19303033|P2|Overall Study|Administrative problems|2
5586329|NCT00995930|19303034|P1|Overall Study|Administrative problems|4
5586330|NCT00995930|19303033|P2|Overall Study|Death|1
5586331|NCT00995930|19303034|P1|Overall Study|Death|0
5586332|NCT00995930|19303033|P2|Overall Study|Protocol deviation|5
5586333|NCT00995930|19303034|P1|Overall Study|Protocol deviation|2
5586334|NCT00995865|19303085|P3|Overall Study|Lost to Follow-up|1
5586335|NCT00995865|19303086|P2|Overall Study|Lost to Follow-up|0
5586336|NCT00995865|19303087|P1|Overall Study|Lost to Follow-up|0
5586337|NCT00995865|19303085|P3|Overall Study|Protocol Violation|0
5586338|NCT00995865|19303086|P2|Overall Study|Protocol Violation|0
5586339|NCT00995865|19303087|P1|Overall Study|Protocol Violation|2
5586340|NCT00995774|19303109|P2|Training Period 2|Withdrawal by Subject|0
5586341|NCT00995774|19303110|P1|Training Period 2|Withdrawal by Subject|2
5586342|NCT00995709|19303144|P3|Overall Study|Protocol Violation|0
5586343|NCT00995709|19303145|P2|Overall Study|Protocol Violation|1
5586344|NCT00995709|19303146|P1|Overall Study|Protocol Violation|2
5586345|NCT00995709|19303144|P3|Overall Study|Death|0
5586346|NCT00995709|19303145|P2|Overall Study|Death|1
5586347|NCT00995709|19303146|P1|Overall Study|Death|0
5586348|NCT00995709|19303144|P3|Overall Study|Lost to Follow-up|0
5586349|NCT00995709|19303145|P2|Overall Study|Lost to Follow-up|0
5586350|NCT00995709|19303146|P1|Overall Study|Lost to Follow-up|1
5586351|NCT00995709|19303144|P3|Overall Study|Withdrawal by Subject|1
5586352|NCT00995709|19303145|P2|Overall Study|Withdrawal by Subject|4
5586353|NCT00995709|19303146|P1|Overall Study|Withdrawal by Subject|0
5586354|NCT00995709|19303144|P3|Overall Study|Lack of Efficacy|4
5586355|NCT00995709|19303145|P2|Overall Study|Lack of Efficacy|1
5586356|NCT00995709|19303146|P1|Overall Study|Lack of Efficacy|0
5586357|NCT00995709|19303144|P3|Overall Study|Adverse Event|0
5586358|NCT00995709|19303145|P2|Overall Study|Adverse Event|2
5586359|NCT00995709|19303146|P1|Overall Study|Adverse Event|4
5586360|NCT00995670|19303172|P3|Overall Study|Failed arterial cannulation|3
5586361|NCT00995670|19303173|P2|Overall Study|Failed arterial cannulation|0
5586362|NCT00995670|19303174|P1|Overall Study|Failed arterial cannulation|1
5586363|NCT00995566|19303182|P1|Overall Study|Early study termination|52
5586364|NCT00995566|19303182|P1|Overall Study|Adverse Event|2
5586365|NCT00995553|19303196|P2|Overall Study|Withdrawal by Subject|6
5586366|NCT00995553|19303197|P1|Overall Study|Withdrawal by Subject|2
5586367|NCT00995488|19303246|P1|Overall Study|Withdrawal by Subject|1
5586368|NCT00995436|19303280|P3|Overall Study|Withdrawal by Subject|0
5586369|NCT00995436|19303281|P2|Overall Study|Withdrawal by Subject|5
5586370|NCT00995436|19303282|P1|Overall Study|Withdrawal by Subject|2
5586371|NCT00995410|19303290|P1|Overall Study|Misc|28
5586372|NCT00995410|19303290|P1|Overall Study|Lost to Follow-up|2
5586373|NCT00995410|19303290|P1|Overall Study|Withdrawal by Subject|7
5586374|NCT00995410|19303290|P1|Overall Study|Adverse Event|51
5586375|NCT00995371|19303297|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
5586376|NCT00995371|19303298|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
5586377|NCT00995345|19303316|P5|Overall Study|all other reasons combined|3
5586378|NCT00995345|19303317|P4|Overall Study|all other reasons combined|1
5586379|NCT00995345|19303318|P3|Overall Study|all other reasons combined|2
5586380|NCT00995345|19303319|P2|Overall Study|all other reasons combined|2
5586381|NCT00995345|19303320|P1|Overall Study|all other reasons combined|2
5586382|NCT00995345|19303316|P5|Overall Study|Lost to Follow-up|0
5586383|NCT00995345|19303317|P4|Overall Study|Lost to Follow-up|1
5586384|NCT00995345|19303318|P3|Overall Study|Lost to Follow-up|2
5586385|NCT00995345|19303319|P2|Overall Study|Lost to Follow-up|2
5586386|NCT00995345|19303320|P1|Overall Study|Lost to Follow-up|2
5586387|NCT00995345|19303316|P5|Overall Study|Adverse Event|1
5586388|NCT00995345|19303317|P4|Overall Study|Adverse Event|0
5586389|NCT00995345|19303318|P3|Overall Study|Adverse Event|2
5586390|NCT00995345|19303319|P2|Overall Study|Adverse Event|1
5586391|NCT00995345|19303320|P1|Overall Study|Adverse Event|3
5586392|NCT00995345|19303316|P5|Overall Study|Withdrawal by Subject|1
5586393|NCT00995345|19303317|P4|Overall Study|Withdrawal by Subject|3
5586394|NCT00995345|19303318|P3|Overall Study|Withdrawal by Subject|1
5586395|NCT00995345|19303319|P2|Overall Study|Withdrawal by Subject|2
5586396|NCT00995345|19303320|P1|Overall Study|Withdrawal by Subject|4
5586397|NCT00995085|19303352|P1|Overall Study|Withdrawal by Subject|5
5586398|NCT00995020|19303369|P2|Overall Study|specimen fragmentation, thermal damage|2
5586399|NCT00995020|19303370|P1|Overall Study|specimen fragmentation, thermal damage|1
5586400|NCT00995020|19303369|P2|Overall Study|margin analysis not performed|5
5586401|NCT00995020|19303370|P1|Overall Study|margin analysis not performed|2
5586402|NCT00995007|19303380|P2|Overall Study|Toxicity|0
5586403|NCT00995007|19303381|P1|Overall Study|Toxicity|8
5586404|NCT00995007|19303380|P2|Overall Study|Refused further treatment|2
5586405|NCT00995007|19303381|P1|Overall Study|Refused further treatment|8
5586406|NCT00995007|19303380|P2|Overall Study|Withdrew consent|0
5586407|NCT00995007|19303381|P1|Overall Study|Withdrew consent|1
5586408|NCT00994682|19303444|P2|Pioglitazone Open Label|Physician Decision|1
5586409|NCT00994682|19303445|P1|Pioglitazone Open Label|Physician Decision|6
5586410|NCT00994682|19303444|P2|Pioglitazone Open Label|Lost to Follow-up|2
5586411|NCT00994682|19303445|P1|Pioglitazone Open Label|Lost to Follow-up|3
5586412|NCT00994682|19303444|P2|Pioglitazone Open Label|Withdrawal by Subject|4
5586413|NCT00994682|19303445|P1|Pioglitazone Open Label|Withdrawal by Subject|4
5586414|NCT00994682|19303444|P2|Double Bilnd|Adverse Event|0
5586415|NCT00994682|19303445|P1|Double Bilnd|Adverse Event|1
5586416|NCT00994682|19303444|P2|Double Bilnd|Lost to Follow-up|3
5586417|NCT00994682|19303445|P1|Double Bilnd|Lost to Follow-up|3
5586418|NCT00994682|19303444|P2|Double Bilnd|Withdrawal by Subject|6
5586419|NCT00994682|19303445|P1|Double Bilnd|Withdrawal by Subject|5
5586420|NCT00994643|19303489|P1|Overall Study|Withdrawal by Subject|1
5586421|NCT00994461|19303503|P3|Overall Study|Adverse Event|0
5586422|NCT00994461|19303504|P2|Overall Study|Adverse Event|1
5586423|NCT00994461|19303505|P1|Overall Study|Adverse Event|2
5586424|NCT00994448|19303533|P2|Overall Study|Physician Decision|0
5586425|NCT00994448|19303534|P1|Overall Study|Physician Decision|1
5586426|NCT00994448|19303533|P2|Overall Study|Withdrawal by Subject|1
5586427|NCT00994448|19303534|P1|Overall Study|Withdrawal by Subject|1
5586428|NCT00994448|19303533|P2|Overall Study|Lost to Follow-up|1
5586429|NCT00994448|19303534|P1|Overall Study|Lost to Follow-up|5
5586430|NCT00994448|19303533|P2|Overall Study|Adverse Event|0
5586431|NCT00994448|19303534|P1|Overall Study|Adverse Event|1
5586432|NCT00994422|19303542|P2|Overall Study|Lost to Follow-up|1
5586433|NCT00994422|19303543|P1|Overall Study|Lost to Follow-up|7
5586434|NCT00994279|19303568|P2|Overall Study|Multiple reasons|3
5586435|NCT00994279|19303569|P1|Overall Study|Multiple reasons|1
5586436|NCT00994279|19303568|P2|Overall Study|Toxicity|0
5586437|NCT00994279|19303569|P1|Overall Study|Toxicity|1
5586438|NCT00994279|19303568|P2|Overall Study|Withdrawal by Subject|2
5586439|NCT00994279|19303569|P1|Overall Study|Withdrawal by Subject|2
5586440|NCT00994240|19303579|P2|Overall Study|study termination|3
5586441|NCT00994240|19303580|P1|Overall Study|study termination|2
5586442|NCT00994240|19303579|P2|Overall Study|Withdrawal by Subject|0
5586443|NCT00994240|19303580|P1|Overall Study|Withdrawal by Subject|1
5586444|NCT00994240|19303579|P2|Overall Study|Lost to Follow-up|2
5586445|NCT00994240|19303580|P1|Overall Study|Lost to Follow-up|3
5586446|NCT00994214|19303590|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
5586447|NCT00994214|19303591|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
5586448|NCT00994214|19303592|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
5586449|NCT00994214|19303593|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
5586450|NCT00994214|19303590|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
5586451|NCT00994214|19303591|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
5586452|NCT00994214|19303592|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
5586453|NCT00994214|19303593|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
5586454|NCT00994214|19303590|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
5586455|NCT00994214|19303591|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
5586456|NCT00994214|19303592|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
5586457|NCT00994214|19303593|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
5586458|NCT00994214|19303590|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
5586459|NCT00994214|19303591|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
5586460|NCT00994214|19303592|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
5586461|NCT00994214|19303593|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
5586462|NCT00994214|19303590|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
5586463|NCT00994214|19303591|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
5586464|NCT00994214|19303592|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
5586465|NCT00994214|19303593|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
5586466|NCT00994214|19303590|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
5586467|NCT00994214|19303591|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
5586468|NCT00994214|19303592|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
5586469|NCT00994214|19303593|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
5586470|NCT00994110|19303672|P2|Overall Study|Pt not eligible|5
5586471|NCT00994110|19303673|P1|Overall Study|Pt not eligible|10
5586472|NCT00994110|19303672|P2|Overall Study|Patient not resected|52
5586473|NCT00994110|19303673|P1|Overall Study|Patient not resected|41
5586474|NCT00994110|19303672|P2|Overall Study|Adverse Event|0
5586475|NCT00994110|19303673|P1|Overall Study|Adverse Event|1
5586476|NCT00994110|19303672|P2|Overall Study|Not Treated|8
5586477|NCT00994110|19303673|P1|Overall Study|Not Treated|4
5586478|NCT00994110|19303672|P2|Overall Study|Withdrawal by Subject|9
5586479|NCT00994110|19303673|P1|Overall Study|Withdrawal by Subject|9
5586480|NCT00993967|19303679|P1|Overall Study|Protocol Violation|2
5586481|NCT00993967|19303679|P1|Overall Study|Withdrawal by Subject|36
5586482|NCT00993967|19303679|P1|Overall Study|Lost to Follow-up|14
5586483|NCT00993967|19303679|P1|Overall Study|Death|1
5586484|NCT00993967|19303679|P1|Overall Study|Adverse Event|8
5586485|NCT00993954|19303686|P2|Overall Study|Protocol Violation|2
5586486|NCT00993954|19303687|P1|Overall Study|Protocol Violation|21
5586487|NCT00993928|19303700|P2|Overall Study|ineligible|0
5586488|NCT00993928|19303701|P1|Overall Study|ineligible|1
5586489|NCT00993928|19303700|P2|Overall Study|Withdrawal by Subject|7
5586490|NCT00993928|19303701|P1|Overall Study|Withdrawal by Subject|4
5586491|NCT00993915|19303715|P1|Overall Study|Ongoing|3
5586492|NCT00993915|19303715|P1|Overall Study|Other|1
5586493|NCT00993915|19303715|P1|Overall Study|Withdrawal by Subject|2
5586494|NCT00993915|19303715|P1|Overall Study|Insufficient clinical response|3
5586495|NCT00993668|19303741|P2|Open-Label Period|Lost to Follow-up|1
5586496|NCT00993668|19303742|P1|Open-Label Period|Lost to Follow-up|6
5586497|NCT00993668|19303741|P2|Open-Label Period|Withdrawal by Subject|3
5586498|NCT00993668|19303742|P1|Open-Label Period|Withdrawal by Subject|4
5586499|NCT00993668|19303741|P2|Open-Label Period|Lack of Efficacy|3
5586500|NCT00993668|19303742|P1|Open-Label Period|Lack of Efficacy|4
5586501|NCT00993668|19303741|P2|Open-Label Period|Adverse Event|8
5586502|NCT00993668|19303742|P1|Open-Label Period|Adverse Event|9
5586503|NCT00993668|19303741|P2|Single-Blind Period|Lost to Follow-up|1
5586504|NCT00993668|19303742|P1|Single-Blind Period|Lost to Follow-up|3
5586505|NCT00993668|19303741|P2|Single-Blind Period|Lack of Efficacy|1
5586506|NCT00993668|19303742|P1|Single-Blind Period|Lack of Efficacy|0
5586507|NCT00993668|19303741|P2|Single-Blind Period|Adverse Event|1
5586508|NCT00993668|19303742|P1|Single-Blind Period|Adverse Event|1
5586509|NCT00993616|19303786|P1|Overall Study|Never treated|1
5586510|NCT00993616|19303786|P1|Overall Study|No tumor at entry|1
5586511|NCT00993499|19303804|P6|Discontinued After Starting Course 3|Other adverse event|0
5586512|NCT00993499|19303805|P5|Discontinued After Starting Course 3|Other adverse event|0
5586513|NCT00993499|19303806|P4|Discontinued After Starting Course 3|Other adverse event|0
5586514|NCT00993499|19303807|P3|Discontinued After Starting Course 3|Other adverse event|1
5586515|NCT00993499|19303808|P2|Discontinued After Starting Course 3|Other adverse event|0
5586516|NCT00993499|19303809|P1|Discontinued After Starting Course 3|Other adverse event|1
5586517|NCT00993499|19303804|P6|Discontinued After Starting Course 3|DLT|0
5586518|NCT00993499|19303805|P5|Discontinued After Starting Course 3|DLT|0
5586519|NCT00993499|19303806|P4|Discontinued After Starting Course 3|DLT|1
5586520|NCT00993499|19303807|P3|Discontinued After Starting Course 3|DLT|2
5586521|NCT00993499|19303808|P2|Discontinued After Starting Course 3|DLT|0
5586522|NCT00993499|19303809|P1|Discontinued After Starting Course 3|DLT|1
5586523|NCT00993499|19303804|P6|Discontinued After Starting Course 3|Progressive Disease|3
5586524|NCT00993499|19303805|P5|Discontinued After Starting Course 3|Progressive Disease|3
5586525|NCT00993499|19303806|P4|Discontinued After Starting Course 3|Progressive Disease|1
5586526|NCT00993499|19303807|P3|Discontinued After Starting Course 3|Progressive Disease|3
5586527|NCT00993499|19303808|P2|Discontinued After Starting Course 3|Progressive Disease|4
5586528|NCT00993499|19303809|P1|Discontinued After Starting Course 3|Progressive Disease|6
5586529|NCT00993499|19303804|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
5586530|NCT00993499|19303805|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
5586531|NCT00993499|19303806|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
5586532|NCT00993499|19303807|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
5586533|NCT00993499|19303808|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
5586534|NCT00993499|19303809|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
5586535|NCT00993499|19303804|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5586536|NCT00993499|19303805|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5586537|NCT00993499|19303806|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5586538|NCT00993499|19303807|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
5586539|NCT00993499|19303808|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5586540|NCT00993499|19303809|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
5586541|NCT00993499|19303804|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5586542|NCT00993499|19303805|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5586543|NCT00993499|19303806|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
5586544|NCT00993499|19303807|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
5586545|NCT00993499|19303808|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5586546|NCT00993499|19303809|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
5586547|NCT00993499|19303804|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5586548|NCT00993499|19303805|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5586549|NCT00993499|19303806|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5586550|NCT00993499|19303807|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
5586551|NCT00993499|19303808|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
5586552|NCT00993499|19303809|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
5586553|NCT00993499|19303804|P6|Discontinued Before Starting Course 3|Progressive Disease|0
5586554|NCT00993499|19303805|P5|Discontinued Before Starting Course 3|Progressive Disease|0
5586555|NCT00993499|19303806|P4|Discontinued Before Starting Course 3|Progressive Disease|0
5586556|NCT00993499|19303807|P3|Discontinued Before Starting Course 3|Progressive Disease|0
5586557|NCT00993499|19303808|P2|Discontinued Before Starting Course 3|Progressive Disease|2
5586558|NCT00993499|19303809|P1|Discontinued Before Starting Course 3|Progressive Disease|2
5586559|NCT00993499|19303804|P6|Run-in Period (8 Days)|Progressive disease|0
5586560|NCT00993499|19303805|P5|Run-in Period (8 Days)|Progressive disease|0
5586561|NCT00993499|19303806|P4|Run-in Period (8 Days)|Progressive disease|0
5586562|NCT00993499|19303807|P3|Run-in Period (8 Days)|Progressive disease|1
5586563|NCT00993499|19303808|P2|Run-in Period (8 Days)|Progressive disease|1
5586564|NCT00993499|19303809|P1|Run-in Period (8 Days)|Progressive disease|0
5586565|NCT00993499|19303804|P6|Run-in Period (8 Days)|Consent withdrawn|0
5586566|NCT00993499|19303805|P5|Run-in Period (8 Days)|Consent withdrawn|0
5586567|NCT00993499|19303806|P4|Run-in Period (8 Days)|Consent withdrawn|0
5586568|NCT00993499|19303807|P3|Run-in Period (8 Days)|Consent withdrawn|0
5586569|NCT00993499|19303808|P2|Run-in Period (8 Days)|Consent withdrawn|1
5586570|NCT00993499|19303809|P1|Run-in Period (8 Days)|Consent withdrawn|0
5586571|NCT00993499|19303804|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5586572|NCT00993499|19303805|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5586573|NCT00993499|19303806|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5586574|NCT00993499|19303807|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5586575|NCT00993499|19303808|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
5586576|NCT00993499|19303809|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
5586577|NCT00993499|19303804|P6|Run-in Period (8 Days)|Adverse Event|0
5586578|NCT00993499|19303805|P5|Run-in Period (8 Days)|Adverse Event|0
5586579|NCT00993499|19303806|P4|Run-in Period (8 Days)|Adverse Event|0
5586580|NCT00993499|19303807|P3|Run-in Period (8 Days)|Adverse Event|0
5586581|NCT00993499|19303808|P2|Run-in Period (8 Days)|Adverse Event|1
5586582|NCT00993499|19303809|P1|Run-in Period (8 Days)|Adverse Event|0
5586583|NCT00993473|19303891|P2|Overall Study|Family event|0
5586584|NCT00993473|19303892|P1|Overall Study|Family event|1
5586585|NCT00993473|19303891|P2|Overall Study|Technical problem with CGM device|1
5586586|NCT00993473|19303892|P1|Overall Study|Technical problem with CGM device|0
5586587|NCT00993473|19303891|P2|Overall Study|Withdrawal by Subject|5
5586588|NCT00993473|19303892|P1|Overall Study|Withdrawal by Subject|1
5586589|NCT00993473|19303891|P2|Overall Study|Lost to Follow-up|0
5586590|NCT00993473|19303892|P1|Overall Study|Lost to Follow-up|1
5586591|NCT00993473|19303891|P2|Overall Study|Protocol Violation|2
5586592|NCT00993473|19303892|P1|Overall Study|Protocol Violation|1
5586593|NCT00993473|19303891|P2|Overall Study|Adverse Event|2
5586594|NCT00993473|19303892|P1|Overall Study|Adverse Event|0
5586595|NCT00993447|19303930|P2|Overall Study|Adverse Event|0
5586596|NCT00993447|19303931|P1|Overall Study|Adverse Event|1
5586597|NCT00993447|19303930|P2|Overall Study|Lost to Follow-up|3
5586598|NCT00993447|19303931|P1|Overall Study|Lost to Follow-up|1
5586599|NCT00993447|19303930|P2|Overall Study|Protocol Violation|8
5586600|NCT00993447|19303931|P1|Overall Study|Protocol Violation|12
5586601|NCT00993447|19303930|P2|Overall Study|Withdrawal by Subject|8
5586602|NCT00993447|19303931|P1|Overall Study|Withdrawal by Subject|23
5586603|NCT00993421|19303968|P7|Overall Study|Protocol Violation|1
5586604|NCT00993421|19303969|P6|Overall Study|Protocol Violation|2
5586605|NCT00993421|19303970|P5|Overall Study|Protocol Violation|0
5586606|NCT00993421|19303971|P4|Overall Study|Protocol Violation|0
5586607|NCT00993421|19303972|P3|Overall Study|Protocol Violation|0
5586608|NCT00993421|19303973|P2|Overall Study|Protocol Violation|0
5586609|NCT00993421|19303974|P1|Overall Study|Protocol Violation|0
5586610|NCT00993421|19303968|P7|Overall Study|Physician Decision|1
5586611|NCT00993421|19303969|P6|Overall Study|Physician Decision|1
5586612|NCT00993421|19303970|P5|Overall Study|Physician Decision|0
5586613|NCT00993421|19303971|P4|Overall Study|Physician Decision|0
5586614|NCT00993421|19303972|P3|Overall Study|Physician Decision|0
5586615|NCT00993421|19303973|P2|Overall Study|Physician Decision|0
5586616|NCT00993421|19303974|P1|Overall Study|Physician Decision|0
5586617|NCT00993421|19303968|P7|Overall Study|Entry Criteria Exclusion|0
5586618|NCT00993421|19303969|P6|Overall Study|Entry Criteria Exclusion|1
5586619|NCT00993421|19303970|P5|Overall Study|Entry Criteria Exclusion|0
5586620|NCT00993421|19303971|P4|Overall Study|Entry Criteria Exclusion|3
5586621|NCT00993421|19303972|P3|Overall Study|Entry Criteria Exclusion|1
5586622|NCT00993421|19303973|P2|Overall Study|Entry Criteria Exclusion|0
5586623|NCT00993421|19303974|P1|Overall Study|Entry Criteria Exclusion|0
5586624|NCT00993421|19303968|P7|Overall Study|Death|1
5586625|NCT00993421|19303969|P6|Overall Study|Death|0
5586626|NCT00993421|19303970|P5|Overall Study|Death|0
5586627|NCT00993421|19303971|P4|Overall Study|Death|0
5586628|NCT00993421|19303972|P3|Overall Study|Death|0
5586629|NCT00993421|19303973|P2|Overall Study|Death|0
5586630|NCT00993421|19303974|P1|Overall Study|Death|0
5586631|NCT00993421|19303968|P7|Overall Study|Withdrawal by Subject|3
5586632|NCT00993421|19303969|P6|Overall Study|Withdrawal by Subject|5
5586633|NCT00993421|19303970|P5|Overall Study|Withdrawal by Subject|3
5586634|NCT00993421|19303971|P4|Overall Study|Withdrawal by Subject|3
5586635|NCT00993421|19303972|P3|Overall Study|Withdrawal by Subject|3
5586636|NCT00993421|19303973|P2|Overall Study|Withdrawal by Subject|2
5586637|NCT00993421|19303974|P1|Overall Study|Withdrawal by Subject|3
5586638|NCT00993421|19303968|P7|Overall Study|Lost to Follow-up|6
5586639|NCT00993421|19303969|P6|Overall Study|Lost to Follow-up|0
5586640|NCT00993421|19303970|P5|Overall Study|Lost to Follow-up|0
5586641|NCT00993421|19303971|P4|Overall Study|Lost to Follow-up|0
5586642|NCT00993421|19303972|P3|Overall Study|Lost to Follow-up|5
5586643|NCT00993421|19303973|P2|Overall Study|Lost to Follow-up|5
5586644|NCT00993421|19303974|P1|Overall Study|Lost to Follow-up|3
5586645|NCT00993421|19303968|P7|Overall Study|Sponsor Decision|29
5586646|NCT00993421|19303969|P6|Overall Study|Sponsor Decision|30
5586647|NCT00993421|19303970|P5|Overall Study|Sponsor Decision|38
5586648|NCT00993421|19303971|P4|Overall Study|Sponsor Decision|30
5586649|NCT00993421|19303972|P3|Overall Study|Sponsor Decision|28
5586650|NCT00993421|19303973|P2|Overall Study|Sponsor Decision|31
5586651|NCT00993421|19303974|P1|Overall Study|Sponsor Decision|36
5586652|NCT00993421|19303968|P7|Overall Study|Adverse Event|1
5586653|NCT00993421|19303969|P6|Overall Study|Adverse Event|7
5586654|NCT00993421|19303970|P5|Overall Study|Adverse Event|5
5586655|NCT00993421|19303971|P4|Overall Study|Adverse Event|9
5586656|NCT00993421|19303972|P3|Overall Study|Adverse Event|6
5586657|NCT00993421|19303973|P2|Overall Study|Adverse Event|7
5586658|NCT00993421|19303974|P1|Overall Study|Adverse Event|2
5586659|NCT00993317|19304125|P2|Overall Study|Early study termination at the site|0
5586660|NCT00993317|19304126|P1|Overall Study|Early study termination at the site|1
5586661|NCT00993317|19304125|P2|Overall Study|Investigator's opinion|1
5586662|NCT00993317|19304126|P1|Overall Study|Investigator's opinion|0
5586663|NCT00993317|19304125|P2|Overall Study|Withdrawal by Subject|2
5586664|NCT00993317|19304126|P1|Overall Study|Withdrawal by Subject|0
5586665|NCT00993317|19304125|P2|Overall Study|Lack of Efficacy|18
5586666|NCT00993317|19304126|P1|Overall Study|Lack of Efficacy|18
5586667|NCT00993317|19304125|P2|Overall Study|Adverse Event|4
5586668|NCT00993317|19304126|P1|Overall Study|Adverse Event|2
5586669|NCT00993291|19304144|P1|Overall Study|Withdrawal by Subject|1
5586670|NCT00993265|19304150|P2|Overall Study|Non-compliant with study medication|0
5586671|NCT00993265|19304151|P1|Overall Study|Non-compliant with study medication|1
5586672|NCT00993265|19304150|P2|Overall Study|Changed dose of concomitant drug|0
5586673|NCT00993265|19304151|P1|Overall Study|Changed dose of concomitant drug|2
5586674|NCT00993265|19304150|P2|Overall Study|Adverse Event|0
5586675|NCT00993265|19304151|P1|Overall Study|Adverse Event|1
5586676|NCT00993148|19304203|P1|Overall Study|never initiated treatment|1
5586677|NCT00993148|19304203|P1|Overall Study|Lost to Follow-up|2
5586678|NCT00993044|19304215|P1|Irinotecan 50 mg|Physician Decision|1
5586679|NCT00993031|19304222|P2|Overall Study|Lost to Follow-up|13
5586680|NCT00993031|19304223|P1|Overall Study|Lost to Follow-up|19
5586681|NCT00993031|19304222|P2|Overall Study|Withdrawal by Subject|3
5586682|NCT00993031|19304223|P1|Overall Study|Withdrawal by Subject|3
5586683|NCT00993031|19304222|P2|Overall Study|Physician Decision|2
5586684|NCT00993031|19304223|P1|Overall Study|Physician Decision|0
5586685|NCT00993031|19304222|P2|Overall Study|Death|1
5586686|NCT00993031|19304223|P1|Overall Study|Death|0
5586687|NCT00992992|19304255|P1|Overall Study|Sponsor Closed the Study|4
5586688|NCT00992992|19304255|P1|Overall Study|GlaxoSmithKline Closed the Study|2
5586689|NCT00992992|19304255|P1|Overall Study|Death|16
5586690|NCT00992992|19304255|P1|Overall Study|Lost to Follow-up|3
5586691|NCT00992836|19304286|P1|Overall Study|Protocol Violation|2
5586692|NCT00992836|19304286|P1|Overall Study|Withdrawal by Subject|2
5586693|NCT00992836|19304286|P1|Overall Study|Lost to Follow-up|1
5586694|NCT00992784|19304301|P3|Overall Study|Withdrawal by Subject|1
5586695|NCT00992784|19304302|P2|Overall Study|Withdrawal by Subject|1
5586696|NCT00992784|19304303|P1|Overall Study|Withdrawal by Subject|1
5586697|NCT00992784|19304301|P3|Overall Study|Adverse Event|0
5586698|NCT00992784|19304302|P2|Overall Study|Adverse Event|1
5586699|NCT00992784|19304303|P1|Overall Study|Adverse Event|2
5586700|NCT00992589|19304415|P4|Double-Blind Phase|Other|3
5586701|NCT00992589|19304416|P3|Double-Blind Phase|Other|6
5586702|NCT00992589|19304417|P2|Double-Blind Phase|Other|1
5586703|NCT00992589|19304418|P1|Double-Blind Phase|Other|0
5586704|NCT00992589|19304415|P4|Double-Blind Phase|Lost to Follow-up|2
5586705|NCT00992589|19304416|P3|Double-Blind Phase|Lost to Follow-up|0
5586706|NCT00992589|19304417|P2|Double-Blind Phase|Lost to Follow-up|0
5586707|NCT00992589|19304418|P1|Double-Blind Phase|Lost to Follow-up|0
5586708|NCT00992589|19304415|P4|Double-Blind Phase|Withdrawal by Subject|2
5586709|NCT00992589|19304416|P3|Double-Blind Phase|Withdrawal by Subject|5
5586710|NCT00992589|19304417|P2|Double-Blind Phase|Withdrawal by Subject|6
5586711|NCT00992589|19304418|P1|Double-Blind Phase|Withdrawal by Subject|0
5586712|NCT00992589|19304415|P4|Double-Blind Phase|Adverse Event|3
5586713|NCT00992589|19304416|P3|Double-Blind Phase|Adverse Event|2
5586714|NCT00992589|19304417|P2|Double-Blind Phase|Adverse Event|6
5586715|NCT00992589|19304418|P1|Double-Blind Phase|Adverse Event|0
5586716|NCT00992589|19304415|P4|Open-Label Phase|Other|0
5586717|NCT00992589|19304416|P3|Open-Label Phase|Other|0
5586718|NCT00992589|19304417|P2|Open-Label Phase|Other|0
5586719|NCT00992589|19304418|P1|Open-Label Phase|Other|45
5586720|NCT00992589|19304415|P4|Open-Label Phase|Physician Decision|0
5586721|NCT00992589|19304416|P3|Open-Label Phase|Physician Decision|0
5586722|NCT00992589|19304417|P2|Open-Label Phase|Physician Decision|0
5586723|NCT00992589|19304418|P1|Open-Label Phase|Physician Decision|4
5586724|NCT00992589|19304415|P4|Open-Label Phase|Protocol Violation|0
5586725|NCT00992589|19304416|P3|Open-Label Phase|Protocol Violation|0
5586726|NCT00992589|19304417|P2|Open-Label Phase|Protocol Violation|0
5586727|NCT00992589|19304418|P1|Open-Label Phase|Protocol Violation|3
5586728|NCT00992589|19304415|P4|Open-Label Phase|Lost to Follow-up|0
5586729|NCT00992589|19304416|P3|Open-Label Phase|Lost to Follow-up|0
5586730|NCT00992589|19304417|P2|Open-Label Phase|Lost to Follow-up|0
5586731|NCT00992589|19304418|P1|Open-Label Phase|Lost to Follow-up|1
5586732|NCT00992589|19304415|P4|Open-Label Phase|Withdrawal by Subject|0
5586733|NCT00992589|19304416|P3|Open-Label Phase|Withdrawal by Subject|0
5586734|NCT00992589|19304417|P2|Open-Label Phase|Withdrawal by Subject|0
5586735|NCT00992589|19304418|P1|Open-Label Phase|Withdrawal by Subject|20
5586736|NCT00992589|19304415|P4|Open-Label Phase|Adverse Event|0
5586737|NCT00992589|19304416|P3|Open-Label Phase|Adverse Event|0
5586738|NCT00992589|19304417|P2|Open-Label Phase|Adverse Event|0
5586739|NCT00992589|19304418|P1|Open-Label Phase|Adverse Event|4
5586740|NCT00992511|19304464|P4|Overall Study|Withdrawal by Subject|1
5586741|NCT00992511|19304465|P3|Overall Study|Withdrawal by Subject|1
5586742|NCT00992511|19304466|P2|Overall Study|Withdrawal by Subject|0
5586743|NCT00992511|19304467|P1|Overall Study|Withdrawal by Subject|0
5586744|NCT00992511|19304464|P4|Overall Study|Lost to Follow-up|2
5586745|NCT00992511|19304465|P3|Overall Study|Lost to Follow-up|0
5586746|NCT00992511|19304466|P2|Overall Study|Lost to Follow-up|0
5586747|NCT00992511|19304467|P1|Overall Study|Lost to Follow-up|1
5586748|NCT00992511|19304464|P4|Overall Study|Migrated/moved from study area|2
5586749|NCT00992511|19304465|P3|Overall Study|Migrated/moved from study area|1
5586750|NCT00992511|19304466|P2|Overall Study|Migrated/moved from study area|0
5586751|NCT00992511|19304467|P1|Overall Study|Migrated/moved from study area|1
5586752|NCT00992459|19304551|P2|Overall Study|Adverse Event|0
5586753|NCT00992459|19304552|P1|Overall Study|Adverse Event|1
5586754|NCT00992459|19304551|P2|Overall Study|Withdrawal by Subject|1
5586755|NCT00992459|19304552|P1|Overall Study|Withdrawal by Subject|0
5586756|NCT00992446|19304576|P1|Overall Study|Maintenance Therapy Screen Fail|5
5586757|NCT00992446|19304576|P1|Overall Study|Withdrawal by Subject|2
5586758|NCT00992446|19304576|P1|Overall Study|Disease Progression|1
5586759|NCT00992407|19304651|P2|Overall Study|Study medication not administered|13
5586760|NCT00992407|19304652|P1|Overall Study|Study medication not administered|17
5586761|NCT00992407|19304651|P2|Overall Study|Loss of follow-up & Adverse events|1
5586762|NCT00992407|19304652|P1|Overall Study|Loss of follow-up & Adverse events|2
5586763|NCT00992407|19304651|P2|Overall Study|Other|0
5586764|NCT00992407|19304652|P1|Overall Study|Other|2
5586765|NCT00992407|19304651|P2|Overall Study|protocol Violation & Adverse events|4
5586766|NCT00992407|19304652|P1|Overall Study|protocol Violation & Adverse events|2
5586767|NCT00992407|19304651|P2|Overall Study|Adverse Event|2
5586768|NCT00992407|19304652|P1|Overall Study|Adverse Event|3
5586769|NCT00992407|19304651|P2|Overall Study|Lost to Follow-up|3
5586770|NCT00992407|19304652|P1|Overall Study|Lost to Follow-up|3
5586771|NCT00992407|19304651|P2|Overall Study|Protocol Violation|1
5586772|NCT00992407|19304652|P1|Overall Study|Protocol Violation|2
5586773|NCT00992394|19304702|P2|Overall Study|Other event|0
5586774|NCT00992394|19304703|P1|Overall Study|Other event|1
5586775|NCT00992394|19304702|P2|Overall Study|Lost to Follow-up|0
5586776|NCT00992394|19304703|P1|Overall Study|Lost to Follow-up|2
5586777|NCT00992394|19304702|P2|Overall Study|Protocol Violation|4
5586778|NCT00992394|19304703|P1|Overall Study|Protocol Violation|2
5586779|NCT00992394|19304702|P2|Overall Study|Physician Decision|0
5586780|NCT00992394|19304703|P1|Overall Study|Physician Decision|1
5586781|NCT00992394|19304702|P2|Overall Study|Withdrawal by Subject|2
5586782|NCT00992394|19304703|P1|Overall Study|Withdrawal by Subject|8
5586783|NCT00992394|19304702|P2|Overall Study|Adverse Event|5
5586784|NCT00992394|19304703|P1|Overall Study|Adverse Event|4
5586785|NCT00992394|19304702|P2|Overall Study|Lack of Efficacy|3
5586786|NCT00992394|19304703|P1|Overall Study|Lack of Efficacy|6
5586787|NCT00992225|19304790|P1|Overall Study|Adverse Event|2
5586788|NCT00992225|19304790|P1|Overall Study|Entry Criteria Not Met|8
5586789|NCT00992186|19304800|P1|Overall Study|Refusal To Receive Study Agent|3
5586790|NCT00992186|19304800|P1|Overall Study|Progressive Disease|30
5586791|NCT00992186|19304800|P1|Overall Study|Adverse Event|9
5586792|NCT00992186|19304800|P1|Overall Study|Physician Decision|1
5586793|NCT00992186|19304800|P1|Overall Study|Protocol Violation|1
5586794|NCT00992186|19304800|P1|Overall Study|Withdrawal by Subject|2
5586795|NCT00992108|19304819|P2|Overall Study|Lost to Follow-up|1
5586796|NCT00992108|19304820|P1|Overall Study|Lost to Follow-up|0
5586797|NCT00992056|19304834|P2|Washout Period (2 Weeks)|Physician Decision|0
5586798|NCT00992056|19304835|P1|Washout Period (2 Weeks)|Physician Decision|1
5586799|NCT00992056|19304834|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
5586800|NCT00992056|19304835|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
5586801|NCT00992017|19304841|P1|Overall Study|Not adhere to study requirements|1
5586802|NCT00992017|19304841|P1|Overall Study|Unable to get to clinic|5
5586803|NCT00992017|19304841|P1|Overall Study|Withdrawal by Subject|2
5586804|NCT00992017|19304841|P1|Overall Study|Lost to Follow-up|2
5586805|NCT00991952|19304856|P2|Overall Study|Adverse Event|1
5586806|NCT00991952|19304857|P1|Overall Study|Adverse Event|0
5586807|NCT00991939|19304865|P2|Overall Study|Entire study terminated|1
5586808|NCT00991939|19304866|P1|Overall Study|Entire study terminated|4
5586809|NCT00991939|19304865|P2|Overall Study|Withdrawal by Subject|0
5586810|NCT00991939|19304866|P1|Overall Study|Withdrawal by Subject|1
5586811|NCT00991939|19304865|P2|Overall Study|Lost to Follow-up|1
5586812|NCT00991939|19304866|P1|Overall Study|Lost to Follow-up|0
5586813|NCT00991887|19304900|P2|Overall Study|Lost to Follow-up|1
5586814|NCT00991887|19304901|P1|Overall Study|Lost to Follow-up|2
5586815|NCT00991510|19304920|P2|Period III (Days 29-112)|Adverse Event|1
5586816|NCT00991510|19304921|P1|Period III (Days 29-112)|Adverse Event|1
5586817|NCT00991510|19304920|P2|Period I (Days 1-14)|Adverse Event|0
5586818|NCT00991510|19304921|P1|Period I (Days 1-14)|Adverse Event|1
5587073|NCT00988884|19306021|P1|Overall Study|Protocol Violation|0
5586819|NCT00991406|19304965|P1|Overall Study|One participant did not respond to FES.|1
5586820|NCT00991341|19304974|P2|Overall Study|Withdrawal by Subject|4
5586821|NCT00991341|19304975|P1|Overall Study|Withdrawal by Subject|3
5586822|NCT00991341|19304974|P2|Overall Study|Physician Decision|2
5586823|NCT00991341|19304975|P1|Overall Study|Physician Decision|1
5586824|NCT00991341|19304974|P2|Overall Study|no RBCs received 96hrs after randomized|155
5586825|NCT00991341|19304975|P1|Overall Study|no RBCs received 96hrs after randomized|186
5586826|NCT00991341|19304974|P2|Overall Study|Death|0
5586827|NCT00991341|19304975|P1|Overall Study|Death|3
5586828|NCT00991341|19304974|P2|Overall Study|no surgery w/in 30 days of randomization|18
5586829|NCT00991341|19304975|P1|Overall Study|no surgery w/in 30 days of randomization|11
5586830|NCT00991302|19305013|P2|Overall Study|Lost to Follow-up|12
5586831|NCT00991302|19305014|P1|Overall Study|Lost to Follow-up|14
5586832|NCT00991302|19305013|P2|Overall Study|Death|1
5586833|NCT00991302|19305014|P1|Overall Study|Death|0
5586834|NCT00991289|19305030|P1|Overall Study|Protocol Violation|2
5586835|NCT00991289|19305030|P1|Overall Study|Lost to Follow-up|4
5586836|NCT00991289|19305030|P1|Overall Study|Withdrawal by Subject|3
5586837|NCT00991289|19305030|P1|Overall Study|Physician Decision|2
5586838|NCT00991289|19305030|P1|Overall Study|Adverse Event|1
5586839|NCT00991276|19305050|P6|Third Intervention Period|Withdrawal by Subject|0
5586840|NCT00991276|19305051|P5|Third Intervention Period|Withdrawal by Subject|0
5586841|NCT00991276|19305052|P4|Third Intervention Period|Withdrawal by Subject|1
5586842|NCT00991276|19305053|P3|Third Intervention Period|Withdrawal by Subject|0
5586843|NCT00991276|19305054|P2|Third Intervention Period|Withdrawal by Subject|0
5586844|NCT00991276|19305055|P1|Third Intervention Period|Withdrawal by Subject|0
5586845|NCT00991276|19305050|P6|Third Intervention Period|Adverse Event|0
5586846|NCT00991276|19305051|P5|Third Intervention Period|Adverse Event|0
5586847|NCT00991276|19305052|P4|Third Intervention Period|Adverse Event|0
5586848|NCT00991276|19305053|P3|Third Intervention Period|Adverse Event|1
5586849|NCT00991276|19305054|P2|Third Intervention Period|Adverse Event|0
5586850|NCT00991276|19305055|P1|Third Intervention Period|Adverse Event|0
5586851|NCT00991276|19305050|P6|Third Intervention Period|Other|1
5586852|NCT00991276|19305051|P5|Third Intervention Period|Other|0
5586853|NCT00991276|19305052|P4|Third Intervention Period|Other|0
5586854|NCT00991276|19305053|P3|Third Intervention Period|Other|0
5586855|NCT00991276|19305054|P2|Third Intervention Period|Other|0
5586856|NCT00991276|19305055|P1|Third Intervention Period|Other|0
5586857|NCT00991276|19305050|P6|Third Intervention Period|Protocol Violation|0
5586858|NCT00991276|19305051|P5|Third Intervention Period|Protocol Violation|0
5586859|NCT00991276|19305052|P4|Third Intervention Period|Protocol Violation|0
5586860|NCT00991276|19305053|P3|Third Intervention Period|Protocol Violation|0
5586861|NCT00991276|19305054|P2|Third Intervention Period|Protocol Violation|0
5586862|NCT00991276|19305055|P1|Third Intervention Period|Protocol Violation|1
5586863|NCT00991276|19305050|P6|Second Intervention Period|Other|1
5586864|NCT00991276|19305051|P5|Second Intervention Period|Other|0
5586865|NCT00991276|19305052|P4|Second Intervention Period|Other|1
5586866|NCT00991276|19305053|P3|Second Intervention Period|Other|0
5586867|NCT00991276|19305054|P2|Second Intervention Period|Other|0
5586868|NCT00991276|19305055|P1|Second Intervention Period|Other|0
5586869|NCT00991276|19305050|P6|Second Intervention Period|Protocol Violation|0
5586870|NCT00991276|19305051|P5|Second Intervention Period|Protocol Violation|0
5586871|NCT00991276|19305052|P4|Second Intervention Period|Protocol Violation|0
5586872|NCT00991276|19305053|P3|Second Intervention Period|Protocol Violation|0
5586873|NCT00991276|19305054|P2|Second Intervention Period|Protocol Violation|0
5586874|NCT00991276|19305055|P1|Second Intervention Period|Protocol Violation|1
5586875|NCT00991276|19305050|P6|Second Intervention Period|Adverse Event|0
5586876|NCT00991276|19305051|P5|Second Intervention Period|Adverse Event|1
5586877|NCT00991276|19305052|P4|Second Intervention Period|Adverse Event|1
5586878|NCT00991276|19305053|P3|Second Intervention Period|Adverse Event|0
5586879|NCT00991276|19305054|P2|Second Intervention Period|Adverse Event|2
5586880|NCT00991276|19305055|P1|Second Intervention Period|Adverse Event|0
5586881|NCT00991276|19305050|P6|First Intervention Period|Lost to Follow-up|0
5586882|NCT00991276|19305051|P5|First Intervention Period|Lost to Follow-up|0
5586883|NCT00991276|19305052|P4|First Intervention Period|Lost to Follow-up|1
5586884|NCT00991276|19305053|P3|First Intervention Period|Lost to Follow-up|0
5586885|NCT00991276|19305054|P2|First Intervention Period|Lost to Follow-up|1
5586886|NCT00991276|19305055|P1|First Intervention Period|Lost to Follow-up|0
5586887|NCT00991276|19305050|P6|First Intervention Period|Withdrawal by Subject|1
5586888|NCT00991276|19305051|P5|First Intervention Period|Withdrawal by Subject|0
5586889|NCT00991276|19305052|P4|First Intervention Period|Withdrawal by Subject|1
5586890|NCT00991276|19305053|P3|First Intervention Period|Withdrawal by Subject|0
5586891|NCT00991276|19305054|P2|First Intervention Period|Withdrawal by Subject|1
5586892|NCT00991276|19305055|P1|First Intervention Period|Withdrawal by Subject|0
5586893|NCT00991276|19305050|P6|First Intervention Period|Other|0
5586894|NCT00991276|19305051|P5|First Intervention Period|Other|1
5586895|NCT00991276|19305052|P4|First Intervention Period|Other|1
5586896|NCT00991276|19305053|P3|First Intervention Period|Other|0
5586897|NCT00991276|19305054|P2|First Intervention Period|Other|0
5586898|NCT00991276|19305055|P1|First Intervention Period|Other|0
5586899|NCT00991276|19305050|P6|First Intervention Period|Insufficient clinical response|0
5586900|NCT00991276|19305051|P5|First Intervention Period|Insufficient clinical response|1
5586901|NCT00991276|19305052|P4|First Intervention Period|Insufficient clinical response|0
5586902|NCT00991276|19305053|P3|First Intervention Period|Insufficient clinical response|0
5586903|NCT00991276|19305054|P2|First Intervention Period|Insufficient clinical response|0
5586904|NCT00991276|19305055|P1|First Intervention Period|Insufficient clinical response|0
5586905|NCT00991276|19305050|P6|First Intervention Period|Protocol Violation|0
5586906|NCT00991276|19305051|P5|First Intervention Period|Protocol Violation|2
5586907|NCT00991276|19305052|P4|First Intervention Period|Protocol Violation|0
5586908|NCT00991276|19305053|P3|First Intervention Period|Protocol Violation|0
5586909|NCT00991276|19305054|P2|First Intervention Period|Protocol Violation|0
5586910|NCT00991276|19305055|P1|First Intervention Period|Protocol Violation|0
5586911|NCT00991276|19305050|P6|First Intervention Period|Adverse Event|0
5586912|NCT00991276|19305051|P5|First Intervention Period|Adverse Event|0
5586913|NCT00991276|19305052|P4|First Intervention Period|Adverse Event|1
5586914|NCT00991276|19305053|P3|First Intervention Period|Adverse Event|0
5586915|NCT00991276|19305054|P2|First Intervention Period|Adverse Event|1
5586916|NCT00991276|19305055|P1|First Intervention Period|Adverse Event|0
5586917|NCT00990821|19305270|P14|Overall Study|Withdrawal by Subject|1
5586918|NCT00990821|19305271|P13|Overall Study|Withdrawal by Subject|2
5586919|NCT00990821|19305272|P12|Overall Study|Withdrawal by Subject|5
5586920|NCT00990821|19305273|P11|Overall Study|Withdrawal by Subject|3
5586921|NCT00990821|19305274|P10|Overall Study|Withdrawal by Subject|1
5586922|NCT00990821|19305275|P9|Overall Study|Withdrawal by Subject|0
5586923|NCT00990821|19305276|P8|Overall Study|Withdrawal by Subject|0
5586924|NCT00990821|19305277|P7|Overall Study|Withdrawal by Subject|1
5586925|NCT00990821|19305278|P6|Overall Study|Withdrawal by Subject|3
5586926|NCT00990821|19305279|P5|Overall Study|Withdrawal by Subject|3
5586927|NCT00990821|19305280|P4|Overall Study|Withdrawal by Subject|0
5586928|NCT00990821|19305281|P3|Overall Study|Withdrawal by Subject|0
5586929|NCT00990821|19305282|P2|Overall Study|Withdrawal by Subject|2
5586930|NCT00990821|19305283|P1|Overall Study|Withdrawal by Subject|0
5586931|NCT00990704|19305320|P2|Overall Study|Physician Decision|1
5586932|NCT00990704|19305321|P1|Overall Study|Physician Decision|0
5586933|NCT00990704|19305320|P2|Overall Study|Adverse Event|1
5586934|NCT00990704|19305321|P1|Overall Study|Adverse Event|1
5586935|NCT00990665|19305341|P1|Overall Study|System Explant|3
5586936|NCT00990665|19305341|P1|Overall Study|Lost to Follow-up|1
5586937|NCT00990665|19305341|P1|Overall Study|Withdrawal by Subject|6
5586938|NCT00990665|19305341|P1|Overall Study|Heart Transplant|1
5586939|NCT00990665|19305341|P1|Overall Study|Death|29
5586940|NCT00990665|19305341|P1|Overall Study|Unsuccessful Implant|8
5586941|NCT00990652|19305348|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
5586942|NCT00990652|19305348|P1|Pre-surgical Bortezomib|Adverse Event|1
5586943|NCT00990340|19305382|P2|First 14-day Treatment|Protocol Violation|2
5586944|NCT00990340|19305383|P1|First 14-day Treatment|Protocol Violation|2
5586945|NCT00990340|19305382|P2|First 14-day Treatment|Lost to Follow-up|1
5586946|NCT00990340|19305383|P1|First 14-day Treatment|Lost to Follow-up|2
5586947|NCT00990340|19305382|P2|First 14-day Treatment|Not Compliant|1
5586948|NCT00990340|19305383|P1|First 14-day Treatment|Not Compliant|2
5586949|NCT00990314|19305397|P1|Overall Study|Lack of Efficacy|1
5586950|NCT00990314|19305397|P1|Overall Study|Physician Decision|3
5586951|NCT00990314|19305397|P1|Overall Study|Non-Compliance|1
5586952|NCT00990314|19305397|P1|Overall Study|Withdrawal by Subject|3
5586953|NCT00990314|19305397|P1|Overall Study|Adverse Event|2
5586954|NCT00990314|19305397|P1|Overall Study|Death|2
5586955|NCT00990249|19305439|P1|Overall Study|Not treated|2
5586956|NCT00990249|19305439|P1|Overall Study|Death|2
5586957|NCT00990249|19305439|P1|Overall Study|Non-Compliance|1
5586958|NCT00990249|19305439|P1|Overall Study|Disease Progression|8
5586959|NCT00990184|19305454|P1|Overall Study|Physician Decision|1
5586960|NCT00990106|19305462|P2|Overall Study|scheduling conflicts|2
5586961|NCT00990106|19305463|P1|Overall Study|scheduling conflicts|0
5586962|NCT00990106|19305462|P2|Overall Study|planned major surgery|1
5586963|NCT00990106|19305463|P1|Overall Study|planned major surgery|0
5586964|NCT00990106|19305462|P2|Overall Study|started exclusionary medication|1
5586965|NCT00990106|19305463|P1|Overall Study|started exclusionary medication|0
5586966|NCT00990106|19305462|P2|Overall Study|relocation/deployment|1
5586967|NCT00990106|19305463|P1|Overall Study|relocation/deployment|4
5586968|NCT00990106|19305462|P2|Overall Study|opted for open label prazosin|1
5586969|NCT00990106|19305463|P1|Overall Study|opted for open label prazosin|1
5586970|NCT00990106|19305462|P2|Overall Study|Withdrawal by Subject|1
5586971|NCT00990106|19305463|P1|Overall Study|Withdrawal by Subject|2
5586972|NCT00990106|19305462|P2|Overall Study|Lost to Follow-up|3
5586973|NCT00990106|19305463|P1|Overall Study|Lost to Follow-up|1
5586974|NCT00990106|19305462|P2|Overall Study|"too busy to continue"|2
5586975|NCT00990106|19305463|P1|Overall Study|"too busy to continue"|1
5586976|NCT00990093|19305473|P2|Test Period 2 (15-28 Days)|Other|1
5586977|NCT00990093|19305474|P1|Test Period 2 (15-28 Days)|Other|0
5586978|NCT00990093|19305473|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
5586979|NCT00990093|19305474|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
5586980|NCT00990093|19305473|P2|Test Period 2 (15-28 Days)|Adverse Event|0
5586981|NCT00990093|19305474|P1|Test Period 2 (15-28 Days)|Adverse Event|1
5586982|NCT00990093|19305473|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
5586983|NCT00990093|19305474|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
5586984|NCT00990093|19305473|P2|Test Period 1 (1-14 Days)|Other|0
5586985|NCT00990093|19305474|P1|Test Period 1 (1-14 Days)|Other|1
5587074|NCT00988884|19306020|P2|Overall Study|Lost to Follow-up|16
5586986|NCT00990093|19305473|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
5586987|NCT00990093|19305474|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
5586988|NCT00990093|19305473|P2|Test Period 1 (1-14 Days)|Adverse Event|0
5586989|NCT00990093|19305474|P1|Test Period 1 (1-14 Days)|Adverse Event|1
5586990|NCT00989963|19305526|P3|Overall Study|Adverse Event|1
5586991|NCT00989963|19305527|P2|Overall Study|Adverse Event|1
5586992|NCT00989963|19305528|P1|Overall Study|Adverse Event|1
5586993|NCT00989950|19305564|P4|Randomized Phase|Adverse Event|0
5586994|NCT00989950|19305565|P3|Randomized Phase|Adverse Event|0
5586995|NCT00989950|19305566|P2|Randomized Phase|Adverse Event|1
5586996|NCT00989950|19305567|P1|Randomized Phase|Adverse Event|0
5586997|NCT00989950|19305564|P4|Randomized Phase|Protocol Violation|0
5586998|NCT00989950|19305565|P3|Randomized Phase|Protocol Violation|0
5586999|NCT00989950|19305566|P2|Randomized Phase|Protocol Violation|0
5587000|NCT00989950|19305567|P1|Randomized Phase|Protocol Violation|1
5587001|NCT00989833|19305599|P3|Overall Study|Incorrectly randomized|0
5587002|NCT00989833|19305600|P2|Overall Study|Incorrectly randomized|0
5587003|NCT00989833|19305601|P1|Overall Study|Incorrectly randomized|1
5587004|NCT00989833|19305599|P3|Overall Study|Withdrawal by Subject|1
5587005|NCT00989833|19305600|P2|Overall Study|Withdrawal by Subject|0
5587006|NCT00989833|19305601|P1|Overall Study|Withdrawal by Subject|0
5587007|NCT00989833|19305599|P3|Overall Study|Protocol Violation|1
5587008|NCT00989833|19305600|P2|Overall Study|Protocol Violation|2
5587009|NCT00989833|19305601|P1|Overall Study|Protocol Violation|1
5587010|NCT00989833|19305599|P3|Overall Study|Lost to Follow-up|0
5587011|NCT00989833|19305600|P2|Overall Study|Lost to Follow-up|1
5587012|NCT00989833|19305601|P1|Overall Study|Lost to Follow-up|0
5587013|NCT00989781|19305632|P2|Ovarian Response to hCG|Lost to Follow-up|2
5587014|NCT00989781|19305633|P1|Ovarian Response to hCG|Lost to Follow-up|3
5587015|NCT00989664|19305663|P1|Long-Term Follow-Up|Death|3
5587016|NCT00989664|19305663|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
5587017|NCT00989664|19305663|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
5587018|NCT00989664|19305663|P1|Dosimetric and Therapeutic Treatment|Death|1
5587019|NCT00989664|19305663|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
5587020|NCT00989664|19305663|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
5587021|NCT00989664|19305663|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
5587022|NCT00989287|19305748|P2|Overall Study|Lost to Follow-up|1
5587023|NCT00989287|19305749|P1|Overall Study|Lost to Follow-up|0
5587024|NCT00989287|19305748|P2|Overall Study|Adverse Event|0
5587025|NCT00989287|19305749|P1|Overall Study|Adverse Event|1
5587026|NCT00989261|19305851|P2|Overall Study|Lost to Follow-up|0
5587027|NCT00989261|19305852|P1|Overall Study|Lost to Follow-up|3
5587028|NCT00989261|19305851|P2|Overall Study|Withdrawal by Subject|1
5587029|NCT00989261|19305852|P1|Overall Study|Withdrawal by Subject|0
5587030|NCT00989261|19305851|P2|Overall Study|Still in follow up|21
5587031|NCT00989261|19305852|P1|Overall Study|Still in follow up|12
5587032|NCT00989235|19305882|P2|Overall Study|Lost to Follow-up|1
5587033|NCT00989235|19305883|P1|Overall Study|Lost to Follow-up|0
5587034|NCT00989235|19305882|P2|Overall Study|Randomized by Mistake|2
5587035|NCT00989235|19305883|P1|Overall Study|Randomized by Mistake|0
5587036|NCT00989235|19305882|P2|Overall Study|Desire to Become Pregnant|0
5587037|NCT00989235|19305883|P1|Overall Study|Desire to Become Pregnant|1
5587038|NCT00989235|19305882|P2|Overall Study|Withdrawal of Consent|1
5587039|NCT00989235|19305883|P1|Overall Study|Withdrawal of Consent|1
5587040|NCT00989235|19305882|P2|Overall Study|Lack of Efficacy|0
5587041|NCT00989235|19305883|P1|Overall Study|Lack of Efficacy|1
5587042|NCT00989235|19305882|P2|Overall Study|Adverse Event|1
5587043|NCT00989235|19305883|P1|Overall Study|Adverse Event|0
5587044|NCT00989235|19305882|P2|Overall Study|Death|1
5587045|NCT00989235|19305883|P1|Overall Study|Death|0
5587046|NCT00989196|19305928|P2|Treatment Period|Lost to Follow-up|0
5587047|NCT00989196|19305929|P1|Treatment Period|Lost to Follow-up|1
5587048|NCT00989092|19305967|P2|Overall Study|Did not receive study drug|0
5587049|NCT00989092|19305968|P1|Overall Study|Did not receive study drug|2
5587050|NCT00989092|19305967|P2|Overall Study|Erythropoietin therapy initiated|0
5587051|NCT00989092|19305968|P1|Overall Study|Erythropoietin therapy initiated|2
5587052|NCT00989092|19305967|P2|Overall Study|Protocol deviation|0
5587053|NCT00989092|19305968|P1|Overall Study|Protocol deviation|2
5587054|NCT00989092|19305967|P2|Overall Study|Other|1
5587055|NCT00989092|19305968|P1|Overall Study|Other|3
5587056|NCT00989092|19305967|P2|Overall Study|Lost to Follow-up|2
5587057|NCT00989092|19305968|P1|Overall Study|Lost to Follow-up|6
5587058|NCT00989092|19305967|P2|Overall Study|Ineligibility determined|3
5587059|NCT00989092|19305968|P1|Overall Study|Ineligibility determined|3
5587060|NCT00989092|19305967|P2|Overall Study|Death|2
5587061|NCT00989092|19305968|P1|Overall Study|Death|14
5587062|NCT00989092|19305967|P2|Overall Study|Withdrawal by Subject|9
5587063|NCT00989092|19305968|P1|Overall Study|Withdrawal by Subject|17
5587064|NCT00989092|19305967|P2|Overall Study|Chemotherapy initiated|4
5587065|NCT00989092|19305968|P1|Overall Study|Chemotherapy initiated|12
5587066|NCT00989092|19305967|P2|Overall Study|Adverse Event|1
5587067|NCT00989092|19305968|P1|Overall Study|Adverse Event|20
5587068|NCT00989092|19305967|P2|Overall Study|Physician Decision|6
5587069|NCT00989092|19305968|P1|Overall Study|Physician Decision|9
5587070|NCT00988884|19306020|P2|Overall Study|Withdrawal by Subject|18
5587071|NCT00988884|19306021|P1|Overall Study|Withdrawal by Subject|15
5587072|NCT00988884|19306020|P2|Overall Study|Protocol Violation|1
5587075|NCT00988884|19306021|P1|Overall Study|Lost to Follow-up|20
5587076|NCT00988884|19306020|P2|Overall Study|Adverse Event|1
5587077|NCT00988884|19306021|P1|Overall Study|Adverse Event|0
5587078|NCT00988858|19306043|P1|Overall Study|Sponsor Decision|1
5587079|NCT00988858|19306043|P1|Overall Study|Physician Decision|1
5587080|NCT00988858|19306043|P1|Overall Study|Death|1
5587081|NCT00988858|19306043|P1|Overall Study|Adverse Event|7
5587082|NCT00988637|19306092|P2|Overall Study|non-compliance with study drug|1
5587083|NCT00988637|19306093|P1|Overall Study|non-compliance with study drug|0
5587084|NCT00988637|19306092|P2|Overall Study|Withdrawal by Subject|1
5587085|NCT00988637|19306093|P1|Overall Study|Withdrawal by Subject|1
5587086|NCT00988637|19306092|P2|Overall Study|Lost to Follow-up|1
5587087|NCT00988637|19306093|P1|Overall Study|Lost to Follow-up|2
5587088|NCT00988598|19306125|P2|Overall Study|Withdrawal by Subject|0
5587089|NCT00988598|19306126|P1|Overall Study|Withdrawal by Subject|2
5587090|NCT00988559|19306154|P4|Overall Study|Lost to Follow-up|0
5587091|NCT00988559|19306155|P3|Overall Study|Lost to Follow-up|1
5587092|NCT00988559|19306156|P2|Overall Study|Lost to Follow-up|0
5587093|NCT00988559|19306157|P1|Overall Study|Lost to Follow-up|0
5587094|NCT00988559|19306154|P4|Overall Study|Pregnancy|0
5587095|NCT00988559|19306155|P3|Overall Study|Pregnancy|1
5587096|NCT00988559|19306156|P2|Overall Study|Pregnancy|1
5587097|NCT00988559|19306157|P1|Overall Study|Pregnancy|0
5587098|NCT00988559|19306154|P4|Overall Study|Withdrawal by Subject|1
5587099|NCT00988559|19306155|P3|Overall Study|Withdrawal by Subject|0
5587100|NCT00988559|19306156|P2|Overall Study|Withdrawal by Subject|1
5587101|NCT00988559|19306157|P1|Overall Study|Withdrawal by Subject|1
5587102|NCT00988533|19306171|P1|Overall Study|Lost to Follow-up|3
5587103|NCT00988442|19306185|P2|Overall Study|Early Study Closure|25
5587104|NCT00988442|19306186|P1|Overall Study|Early Study Closure|29
5587105|NCT00988442|19306185|P2|Overall Study|Lost to Follow-up|1
5587106|NCT00988442|19306186|P1|Overall Study|Lost to Follow-up|0
5587107|NCT00988442|19306185|P2|Overall Study|Death|2
5587108|NCT00988442|19306186|P1|Overall Study|Death|1
5587109|NCT00988429|19306249|P3|Overall Study|other reasons|1
5587110|NCT00988429|19306250|P2|Overall Study|other reasons|8
5587111|NCT00988429|19306251|P1|Overall Study|other reasons|8
5587112|NCT00988429|19306249|P3|Overall Study|Administrative Reasons|1
5587113|NCT00988429|19306250|P2|Overall Study|Administrative Reasons|2
5587114|NCT00988429|19306251|P1|Overall Study|Administrative Reasons|1
5587115|NCT00988429|19306249|P3|Overall Study|Withdrawal by Subject|12
5587116|NCT00988429|19306250|P2|Overall Study|Withdrawal by Subject|7
5587117|NCT00988429|19306251|P1|Overall Study|Withdrawal by Subject|7
5587118|NCT00988429|19306249|P3|Overall Study|Protocol Violation|3
5587119|NCT00988429|19306250|P2|Overall Study|Protocol Violation|3
5587120|NCT00988429|19306251|P1|Overall Study|Protocol Violation|4
5587121|NCT00988429|19306249|P3|Overall Study|Pregnancy|0
5587122|NCT00988429|19306250|P2|Overall Study|Pregnancy|1
5587123|NCT00988429|19306251|P1|Overall Study|Pregnancy|2
5587124|NCT00988429|19306249|P3|Overall Study|Physician Decision|3
5587125|NCT00988429|19306250|P2|Overall Study|Physician Decision|0
5587126|NCT00988429|19306251|P1|Overall Study|Physician Decision|1
5587127|NCT00988429|19306249|P3|Overall Study|Non-Compliance with Study Drug|3
5587128|NCT00988429|19306250|P2|Overall Study|Non-Compliance with Study Drug|1
5587129|NCT00988429|19306251|P1|Overall Study|Non-Compliance with Study Drug|5
5587130|NCT00988429|19306249|P3|Overall Study|Lack of Efficacy|1
5587131|NCT00988429|19306250|P2|Overall Study|Lack of Efficacy|0
5587132|NCT00988429|19306251|P1|Overall Study|Lack of Efficacy|0
5587133|NCT00988429|19306249|P3|Overall Study|Adverse Event|45
5587134|NCT00988429|19306250|P2|Overall Study|Adverse Event|21
5587135|NCT00988429|19306251|P1|Overall Study|Adverse Event|9
5587136|NCT00988351|19306264|P2|Overall Study|not using CPAP|3
5587137|NCT00988351|19306265|P1|Overall Study|not using CPAP|5
5587138|NCT00988351|19306264|P2|Overall Study|Lost to Follow-up|9
5587139|NCT00988351|19306265|P1|Overall Study|Lost to Follow-up|6
5587140|NCT00988351|19306264|P2|Overall Study|Withdrawal by Subject|0
5587141|NCT00988351|19306265|P1|Overall Study|Withdrawal by Subject|8
5587142|NCT00988247|19306342|P2|Overall Study|Other|0
5587143|NCT00988247|19306343|P1|Overall Study|Other|3
5587144|NCT00988247|19306342|P2|Overall Study|Sponsor requested withdrawal|1
5587145|NCT00988247|19306343|P1|Overall Study|Sponsor requested withdrawal|3
5587146|NCT00988247|19306342|P2|Overall Study|Protocol Violation|5
5587147|NCT00988247|19306343|P1|Overall Study|Protocol Violation|4
5587148|NCT00988247|19306342|P2|Overall Study|Lost to Follow-up|2
5587149|NCT00988247|19306343|P1|Overall Study|Lost to Follow-up|11
5587150|NCT00988247|19306342|P2|Overall Study|Pregnancy|2
5587151|NCT00988247|19306343|P1|Overall Study|Pregnancy|1
5587152|NCT00988247|19306342|P2|Overall Study|Withdrawal by Subject|13
5587153|NCT00988247|19306343|P1|Overall Study|Withdrawal by Subject|44
5587154|NCT00988247|19306342|P2|Overall Study|Adverse Event|3
5587155|NCT00988247|19306343|P1|Overall Study|Adverse Event|17
5587156|NCT00988221|19306362|P4|Part III|Refused Treatment|0
5587157|NCT00988221|19306363|P3|Part III|Refused Treatment|1
5587158|NCT00988221|19306364|P2|Part III|Refused Treatment|0
5587159|NCT00988221|19306365|P1|Part III|Refused Treatment|0
5587160|NCT00988221|19306362|P4|Part III|Insufficient Therapeutic Response|0
5587161|NCT00988221|19306363|P3|Part III|Insufficient Therapeutic Response|1
5587162|NCT00988221|19306364|P2|Part III|Insufficient Therapeutic Response|1
5587163|NCT00988221|19306365|P1|Part III|Insufficient Therapeutic Response|0
5587164|NCT00988221|19306362|P4|Part III|Adverse Event|0
5587165|NCT00988221|19306363|P3|Part III|Adverse Event|1
5587166|NCT00988221|19306364|P2|Part III|Adverse Event|0
5587167|NCT00988221|19306365|P1|Part III|Adverse Event|1
5587168|NCT00988221|19306362|P4|Part II|Reason not Specified|0
5587169|NCT00988221|19306363|P3|Part II|Reason not Specified|1
5587170|NCT00988221|19306364|P2|Part II|Reason not Specified|0
5587171|NCT00988221|19306365|P1|Part II|Reason not Specified|0
5587172|NCT00988221|19306362|P4|Part II|Withdrawal by Subject|2
5587173|NCT00988221|19306363|P3|Part II|Withdrawal by Subject|2
5587174|NCT00988221|19306364|P2|Part II|Withdrawal by Subject|0
5587175|NCT00988221|19306365|P1|Part II|Withdrawal by Subject|0
5587176|NCT00988221|19306362|P4|Part II|Adverse Event|1
5587177|NCT00988221|19306363|P3|Part II|Adverse Event|0
5587178|NCT00988221|19306364|P2|Part II|Adverse Event|0
5587179|NCT00988221|19306365|P1|Part II|Adverse Event|1
5587180|NCT00988221|19306362|P4|Part I|Lost to Follow-up|0
5587181|NCT00988221|19306363|P3|Part I|Lost to Follow-up|0
5587182|NCT00988221|19306364|P2|Part I|Lost to Follow-up|1
5587183|NCT00988221|19306365|P1|Part I|Lost to Follow-up|0
5587184|NCT00988221|19306362|P4|Part I|Refused Treatment|0
5587185|NCT00988221|19306363|P3|Part I|Refused Treatment|1
5587186|NCT00988221|19306364|P2|Part I|Refused Treatment|2
5587187|NCT00988221|19306365|P1|Part I|Refused Treatment|0
5587188|NCT00988221|19306362|P4|Part I|Insufficient Therapeutic Response|0
5587189|NCT00988221|19306363|P3|Part I|Insufficient Therapeutic Response|5
5587190|NCT00988221|19306364|P2|Part I|Insufficient Therapeutic Response|6
5587191|NCT00988221|19306365|P1|Part I|Insufficient Therapeutic Response|4
5587192|NCT00988221|19306362|P4|Part I|Adverse Event|0
5587193|NCT00988221|19306363|P3|Part I|Adverse Event|2
5587194|NCT00988221|19306364|P2|Part I|Adverse Event|1
5587195|NCT00988221|19306365|P1|Part I|Adverse Event|0
5587196|NCT00988208|19306538|P2|Overall Study|Other|3
5587197|NCT00988208|19306539|P1|Overall Study|Other|8
5587198|NCT00988208|19306538|P2|Overall Study|Subject Decision/Investigator Discretion|32
5587199|NCT00988208|19306539|P1|Overall Study|Subject Decision/Investigator Discretion|32
5587200|NCT00988208|19306538|P2|Overall Study|Clinical Deterioration|14
5587201|NCT00988208|19306539|P1|Overall Study|Clinical Deterioration|7
5587202|NCT00988208|19306538|P2|Overall Study|Biochemical Progression|7
5587203|NCT00988208|19306539|P1|Overall Study|Biochemical Progression|21
5587204|NCT00988208|19306538|P2|Overall Study|Clinical Progression|16
5587205|NCT00988208|19306539|P1|Overall Study|Clinical Progression|17
5587206|NCT00988208|19306538|P2|Overall Study|Sponsor Decision|78
5587207|NCT00988208|19306539|P1|Overall Study|Sponsor Decision|102
5587208|NCT00988208|19306538|P2|Overall Study|Protocol Violation|2
5587209|NCT00988208|19306539|P1|Overall Study|Protocol Violation|9
5587210|NCT00988208|19306538|P2|Overall Study|Lost to Follow-up|3
5587211|NCT00988208|19306539|P1|Overall Study|Lost to Follow-up|2
5587212|NCT00988208|19306538|P2|Overall Study|Death|15
5587213|NCT00988208|19306539|P1|Overall Study|Death|9
5587214|NCT00988208|19306538|P2|Overall Study|Withdrawal by Subject|57
5587215|NCT00988208|19306539|P1|Overall Study|Withdrawal by Subject|50
5587216|NCT00988208|19306538|P2|Overall Study|Disease Progression|89
5587217|NCT00988208|19306539|P1|Overall Study|Disease Progression|103
5587218|NCT00988208|19306538|P2|Overall Study|Adverse Event|122
5587219|NCT00988208|19306539|P1|Overall Study|Adverse Event|71
5587220|NCT00988169|19306557|P1|Overall Study|Withdrawal by Subject|1
5587221|NCT00988117|19306609|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
5587222|NCT00988117|19306609|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
5587223|NCT00988091|19306618|P2|Open-label Period|Other|3
5587224|NCT00988091|19306619|P1|Open-label Period|Other|2
5587225|NCT00988091|19306618|P2|Open-label Period|Lost to Follow-up|5
5587226|NCT00988091|19306619|P1|Open-label Period|Lost to Follow-up|3
5587227|NCT00988091|19306618|P2|Open-label Period|Withdrawal by Subject|16
5587228|NCT00988091|19306619|P1|Open-label Period|Withdrawal by Subject|10
5587229|NCT00988091|19306618|P2|Open-label Period|Protocol Violation|1
5587230|NCT00988091|19306619|P1|Open-label Period|Protocol Violation|1
5587231|NCT00988091|19306618|P2|Open-label Period|Use of exclusionary medication|1
5587232|NCT00988091|19306619|P1|Open-label Period|Use of exclusionary medication|1
5587233|NCT00988091|19306618|P2|Open-label Period|Adverse Event|7
5587234|NCT00988091|19306619|P1|Open-label Period|Adverse Event|4
5587235|NCT00988091|19306618|P2|Double-blind Period|Use of exclusionary medication|3
5587236|NCT00988091|19306619|P1|Double-blind Period|Use of exclusionary medication|2
5587237|NCT00988091|19306618|P2|Double-blind Period|Adverse Event|9
5587238|NCT00988091|19306619|P1|Double-blind Period|Adverse Event|6
5587239|NCT00988091|19306618|P2|Double-blind Period|Other|8
5587240|NCT00988091|19306619|P1|Double-blind Period|Other|8
5587241|NCT00988091|19306618|P2|Double-blind Period|Lost to Follow-up|14
5587242|NCT00988091|19306619|P1|Double-blind Period|Lost to Follow-up|12
5587243|NCT00988091|19306618|P2|Double-blind Period|Withdrawal by Subject|13
5587244|NCT00988091|19306619|P1|Double-blind Period|Withdrawal by Subject|15
5587245|NCT00988065|19306641|P3|Overall Study|Noncompliance with protocol|9
5587246|NCT00988065|19306642|P2|Overall Study|Noncompliance with protocol|6
5587247|NCT00988065|19306643|P1|Overall Study|Noncompliance with protocol|5
5587248|NCT00988065|19306641|P3|Overall Study|Subject withdrew consent|2
5587249|NCT00988065|19306642|P2|Overall Study|Subject withdrew consent|5
5587250|NCT00988065|19306643|P1|Overall Study|Subject withdrew consent|3
5587251|NCT00988065|19306641|P3|Overall Study|Lost to Follow-up|2
5587252|NCT00988065|19306642|P2|Overall Study|Lost to Follow-up|2
5587253|NCT00988065|19306643|P1|Overall Study|Lost to Follow-up|1
5587254|NCT00988065|19306641|P3|Overall Study|Adverse Event|2
5587255|NCT00988065|19306642|P2|Overall Study|Adverse Event|10
5587256|NCT00988065|19306643|P1|Overall Study|Adverse Event|4
5587257|NCT00988052|19306665|P2|Overall Study|Study terminated by sponsor|236
5587258|NCT00988052|19306666|P1|Overall Study|Study terminated by sponsor|240
5587259|NCT00988052|19306665|P2|Overall Study|Withdrawal by Subject|91
5587260|NCT00988052|19306666|P1|Overall Study|Withdrawal by Subject|90
5587261|NCT00988052|19306665|P2|Overall Study|Adverse Event|28
5587262|NCT00988052|19306666|P1|Overall Study|Adverse Event|35
5587263|NCT00988052|19306665|P2|Overall Study|Physician Decision|28
5587264|NCT00988052|19306666|P1|Overall Study|Physician Decision|27
5587265|NCT00988052|19306665|P2|Overall Study|Lost to Follow-up|11
5587266|NCT00988052|19306666|P1|Overall Study|Lost to Follow-up|6
5587267|NCT00988052|19306665|P2|Overall Study|Lack of Efficacy|7
5587268|NCT00988052|19306666|P1|Overall Study|Lack of Efficacy|8
5587269|NCT00988052|19306665|P2|Overall Study|Pregnancy|6
5587270|NCT00988052|19306666|P1|Overall Study|Pregnancy|6
5587271|NCT00988052|19306665|P2|Overall Study|Protocol Violation|5
5587272|NCT00988052|19306666|P1|Overall Study|Protocol Violation|6
5587273|NCT00988052|19306665|P2|Overall Study|Death|3
5587274|NCT00988052|19306666|P1|Overall Study|Death|1
5587275|NCT00988052|19306665|P2|Overall Study|Teva requested subject withdrawal|1
5587276|NCT00988052|19306666|P1|Overall Study|Teva requested subject withdrawal|3
5587277|NCT00988052|19306665|P2|Overall Study|Missing|0
5587278|NCT00988052|19306666|P1|Overall Study|Missing|1
5587279|NCT00987935|19306710|P9|Overall Study|Reason other than those specified above|1
5587280|NCT00987935|19306711|P8|Overall Study|Reason other than those specified above|0
5587281|NCT00987935|19306712|P7|Overall Study|Reason other than those specified above|0
5587282|NCT00987935|19306713|P6|Overall Study|Reason other than those specified above|0
5587283|NCT00987935|19306714|P5|Overall Study|Reason other than those specified above|0
5587284|NCT00987935|19306715|P4|Overall Study|Reason other than those specified above|0
5587285|NCT00987935|19306716|P3|Overall Study|Reason other than those specified above|0
5587286|NCT00987935|19306717|P2|Overall Study|Reason other than those specified above|0
5587287|NCT00987935|19306718|P1|Overall Study|Reason other than those specified above|0
5587288|NCT00987935|19306710|P9|Overall Study|Refused to continue taking trial med.|2
5587289|NCT00987935|19306711|P8|Overall Study|Refused to continue taking trial med.|4
5587290|NCT00987935|19306712|P7|Overall Study|Refused to continue taking trial med.|4
5587291|NCT00987935|19306713|P6|Overall Study|Refused to continue taking trial med.|0
5587292|NCT00987935|19306714|P5|Overall Study|Refused to continue taking trial med.|1
5587293|NCT00987935|19306715|P4|Overall Study|Refused to continue taking trial med.|0
5587294|NCT00987935|19306716|P3|Overall Study|Refused to continue taking trial med.|0
5587295|NCT00987935|19306717|P2|Overall Study|Refused to continue taking trial med.|0
5587296|NCT00987935|19306718|P1|Overall Study|Refused to continue taking trial med.|1
5587297|NCT00987935|19306710|P9|Overall Study|Adverse Event|6
5587298|NCT00987935|19306711|P8|Overall Study|Adverse Event|10
5587299|NCT00987935|19306712|P7|Overall Study|Adverse Event|2
5587300|NCT00987935|19306713|P6|Overall Study|Adverse Event|0
5587301|NCT00987935|19306714|P5|Overall Study|Adverse Event|1
5587302|NCT00987935|19306715|P4|Overall Study|Adverse Event|1
5587303|NCT00987935|19306716|P3|Overall Study|Adverse Event|0
5587304|NCT00987935|19306717|P2|Overall Study|Adverse Event|1
5587305|NCT00987935|19306718|P1|Overall Study|Adverse Event|0
5587306|NCT00987935|19306710|P9|Overall Study|Progressive disease|23
5587307|NCT00987935|19306711|P8|Overall Study|Progressive disease|48
5587308|NCT00987935|19306712|P7|Overall Study|Progressive disease|9
5587309|NCT00987935|19306713|P6|Overall Study|Progressive disease|3
5587310|NCT00987935|19306714|P5|Overall Study|Progressive disease|5
5587311|NCT00987935|19306715|P4|Overall Study|Progressive disease|2
5587312|NCT00987935|19306716|P3|Overall Study|Progressive disease|3
5587313|NCT00987935|19306717|P2|Overall Study|Progressive disease|2
5587314|NCT00987935|19306718|P1|Overall Study|Progressive disease|3
5587315|NCT00987831|19306774|P3|Overall Study|Lost to Follow-up|0
5587316|NCT00987831|19306775|P2|Overall Study|Lost to Follow-up|3
5587317|NCT00987831|19306776|P1|Overall Study|Lost to Follow-up|0
5587318|NCT00987831|19306774|P3|Overall Study|Never flared in 12 months|0
5587319|NCT00987831|19306775|P2|Overall Study|Never flared in 12 months|0
5587320|NCT00987831|19306776|P1|Overall Study|Never flared in 12 months|1
5587321|NCT00987623|19306798|P2|Overall Study|Influenza|1
5587322|NCT00987623|19306799|P1|Overall Study|Influenza|0
5587323|NCT00987623|19306798|P2|Overall Study|Biomicroscopy|1
5587324|NCT00987623|19306799|P1|Overall Study|Biomicroscopy|0
5587325|NCT00987623|19306798|P2|Overall Study|Discomfort|0
5587326|NCT00987623|19306799|P1|Overall Study|Discomfort|1
5587327|NCT00987623|19306798|P2|Overall Study|Time/job conflict|0
5587328|NCT00987623|19306799|P1|Overall Study|Time/job conflict|2
5587329|NCT00987623|19306798|P2|Overall Study|Lost to Follow-up|1
5587330|NCT00987623|19306799|P1|Overall Study|Lost to Follow-up|2
5587331|NCT00987467|19306828|P1|Overall Study|Lost to Follow-up|2
5587332|NCT00987402|19306852|P2|Overall Study|Insufficient data entry|98
5587333|NCT00987402|19306853|P1|Overall Study|Insufficient data entry|86
5587334|NCT00987389|19306861|P4|Overall Study|Multiple different reasons|1
5587335|NCT00987389|19306862|P3|Overall Study|Multiple different reasons|3
5587336|NCT00987389|19306863|P2|Overall Study|Multiple different reasons|0
5587337|NCT00987389|19306864|P1|Overall Study|Multiple different reasons|1
5587338|NCT00987389|19306861|P4|Overall Study|Withdrawn from Treatment|0
5587339|NCT00987389|19306862|P3|Overall Study|Withdrawn from Treatment|0
5587340|NCT00987389|19306863|P2|Overall Study|Withdrawn from Treatment|1
5587341|NCT00987389|19306864|P1|Overall Study|Withdrawn from Treatment|0
5587342|NCT00987389|19306861|P4|Overall Study|Withdrawal by Subject|1
5587343|NCT00987389|19306862|P3|Overall Study|Withdrawal by Subject|2
5587344|NCT00987389|19306863|P2|Overall Study|Withdrawal by Subject|3
5587345|NCT00987389|19306864|P1|Overall Study|Withdrawal by Subject|4
5587346|NCT00987389|19306861|P4|Overall Study|Lost to Follow-up|1
5587347|NCT00987389|19306862|P3|Overall Study|Lost to Follow-up|3
5587348|NCT00987389|19306863|P2|Overall Study|Lost to Follow-up|1
5587349|NCT00987389|19306864|P1|Overall Study|Lost to Follow-up|4
5587350|NCT00987389|19306861|P4|Overall Study|Ineligible|0
5587351|NCT00987389|19306862|P3|Overall Study|Ineligible|0
5587352|NCT00987389|19306863|P2|Overall Study|Ineligible|3
5587353|NCT00987389|19306864|P1|Overall Study|Ineligible|0
5587354|NCT00987337|19306883|P3|Overall Study|Participant Relapsed|5
5587355|NCT00987337|19306884|P2|Overall Study|Participant Relapsed|20
5587356|NCT00987337|19306885|P1|Overall Study|Participant Relapsed|18
5587357|NCT00987337|19306883|P3|Overall Study|Protocol Violation|2
5587358|NCT00987337|19306884|P2|Overall Study|Protocol Violation|0
5587359|NCT00987337|19306885|P1|Overall Study|Protocol Violation|1
5587360|NCT00987337|19306883|P3|Overall Study|Other|5
5587361|NCT00987337|19306884|P2|Overall Study|Other|2
5587362|NCT00987337|19306885|P1|Overall Study|Other|0
5587363|NCT00987337|19306883|P3|Overall Study|Withdrawal by Subject|9
5587364|NCT00987337|19306884|P2|Overall Study|Withdrawal by Subject|9
5587365|NCT00987337|19306885|P1|Overall Study|Withdrawal by Subject|6
5587366|NCT00987337|19306883|P3|Overall Study|Lost to Follow-up|2
5587367|NCT00987337|19306884|P2|Overall Study|Lost to Follow-up|6
5587368|NCT00987337|19306885|P1|Overall Study|Lost to Follow-up|10
5587369|NCT00987337|19306883|P3|Overall Study|Virologic Breakthrough|8
5587370|NCT00987337|19306884|P2|Overall Study|Virologic Breakthrough|2
5587371|NCT00987337|19306885|P1|Overall Study|Virologic Breakthrough|2
5587372|NCT00987337|19306883|P3|Overall Study|Insufficient Virologic Response|12
5587373|NCT00987337|19306884|P2|Overall Study|Insufficient Virologic Response|7
5587374|NCT00987337|19306885|P1|Overall Study|Insufficient Virologic Response|10
5587375|NCT00987337|19306883|P3|Overall Study|Adverse Event|8
5587376|NCT00987337|19306884|P2|Overall Study|Adverse Event|9
5587377|NCT00987337|19306885|P1|Overall Study|Adverse Event|10
5587378|NCT00986986|19306940|P2|Overall Study|Lost to Follow-up|1
5587379|NCT00986986|19306941|P1|Overall Study|Lost to Follow-up|0
5587380|NCT00986973|19306951|P1|Overall Study|Withdrawn by study team|1
5587381|NCT00986921|19306977|P2|Overall Study|Physician Decision|0
5587382|NCT00986921|19306978|P1|Overall Study|Physician Decision|1
5587383|NCT00986830|19307011|P1|Overall Study|Unable to access sinus with device|5
5587384|NCT00986830|19307011|P1|Overall Study|Lack of Efficacy|1
5587385|NCT00986830|19307011|P1|Overall Study|Lost to Follow-up|1
5587386|NCT00986830|19307011|P1|Overall Study|Death|1
5587387|NCT00986674|19307026|P3|Overall Study|unknown/not specify|9
5587388|NCT00986674|19307027|P2|Overall Study|unknown/not specify|7
5587389|NCT00986674|19307028|P1|Overall Study|unknown/not specify|0
5587390|NCT00986674|19307026|P3|Overall Study|not start protocol therapy|1
5587391|NCT00986674|19307027|P2|Overall Study|not start protocol therapy|3
5587392|NCT00986674|19307028|P1|Overall Study|not start protocol therapy|4
5587393|NCT00986674|19307026|P3|Overall Study|alternative therapy|1
5587394|NCT00986674|19307027|P2|Overall Study|alternative therapy|0
5587395|NCT00986674|19307028|P1|Overall Study|alternative therapy|0
5587396|NCT00986674|19307026|P3|Overall Study|Withdrawal by Subject|1
5587397|NCT00986674|19307027|P2|Overall Study|Withdrawal by Subject|2
5587398|NCT00986674|19307028|P1|Overall Study|Withdrawal by Subject|6
5587399|NCT00986674|19307026|P3|Overall Study|Death|4
5587400|NCT00986674|19307027|P2|Overall Study|Death|0
5587401|NCT00986674|19307028|P1|Overall Study|Death|5
5587402|NCT00986674|19307026|P3|Overall Study|Adverse Event|9
5587403|NCT00986674|19307027|P2|Overall Study|Adverse Event|8
5587404|NCT00986674|19307028|P1|Overall Study|Adverse Event|4
5587405|NCT00986674|19307026|P3|Overall Study|Lack of Efficacy|23
5587406|NCT00986674|19307027|P2|Overall Study|Lack of Efficacy|25
5587407|NCT00986674|19307028|P1|Overall Study|Lack of Efficacy|28
5587408|NCT00986570|19307061|P1|Overall Study|Potential bias for objective assessment|1
5587409|NCT00986570|19307061|P1|Overall Study|Lost to Follow-up|6
5587410|NCT00986479|19307078|P2|Period 1|Administrative reasons|0
5587411|NCT00986479|19307079|P1|Period 1|Administrative reasons|1
5587412|NCT00986479|19307078|P2|Period 1|Improved mood|0
5587413|NCT00986479|19307079|P1|Period 1|Improved mood|1
5587414|NCT00986440|19307125|P2|Overall Study|Screen failure (not dosed)|2
5587415|NCT00986440|19307126|P1|Overall Study|Screen failure (not dosed)|4
5587416|NCT00986440|19307125|P2|Overall Study|Withdrawal by Subject|2
5587417|NCT00986440|19307126|P1|Overall Study|Withdrawal by Subject|1
5587418|NCT00986440|19307125|P2|Overall Study|Serious adverse event or adverse event|2
5587419|NCT00986440|19307126|P1|Overall Study|Serious adverse event or adverse event|9
5587420|NCT00986440|19307125|P2|Overall Study|Progressive disease|37
5587421|NCT00986440|19307126|P1|Overall Study|Progressive disease|27
5587422|NCT00986427|19307144|P2|Overall Study|Withdrawal by Subject|0
5587423|NCT00986427|19307145|P1|Overall Study|Withdrawal by Subject|1
5587424|NCT00986427|19307144|P2|Overall Study|Lack of Efficacy|0
5587425|NCT00986427|19307145|P1|Overall Study|Lack of Efficacy|1
5587426|NCT00986427|19307144|P2|Overall Study|Lost to Follow-up|0
5587427|NCT00986427|19307145|P1|Overall Study|Lost to Follow-up|2
5587428|NCT00986362|19307173|P2|Overall Study|Lost to Follow-up|1
5587429|NCT00986362|19307174|P1|Overall Study|Lost to Follow-up|0
5587430|NCT00986362|19307173|P2|Overall Study|Death|0
5587431|NCT00986362|19307174|P1|Overall Study|Death|2
5587432|NCT00986349|19307180|P1|Overall Study|device migration|1
5587433|NCT00986349|19307180|P1|Overall Study|Physician Decision|1
5587434|NCT00986349|19307180|P1|Overall Study|Adverse Event|2
5587435|NCT00986349|19307180|P1|Overall Study|Unsuccessful implant procedure|3
5587436|NCT00986258|19307204|P1|Maintenance Period|Withdrawal by Subject|2
5587437|NCT00986258|19307204|P1|Maintenance Period|Lack of Efficacy|2
5587438|NCT00986258|19307204|P1|Maintenance Period|Adverse Event|5
5587439|NCT00986258|19307204|P1|Titration and Optimal Dose Period|Other|1
5587440|NCT00986258|19307204|P1|Titration and Optimal Dose Period|Non-Compliance|1
5587441|NCT00986258|19307204|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
5587442|NCT00986258|19307204|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
5587443|NCT00986258|19307204|P1|Titration and Optimal Dose Period|Adverse Event|15
5587444|NCT00986258|19307204|P1|Observation Period|Not eligible to be dosed|11
5587445|NCT00986245|19307232|P2|Second Intervention|Protocol Violation|1
5587446|NCT00986245|19307233|P1|Second Intervention|Protocol Violation|0
5587447|NCT00986245|19307232|P2|Second Intervention|Lost to Follow-up|0
5587448|NCT00986245|19307233|P1|Second Intervention|Lost to Follow-up|1
5587449|NCT00986245|19307232|P2|Second Intervention|Poor compliance|0
5587450|NCT00986245|19307233|P1|Second Intervention|Poor compliance|1
5587451|NCT00986245|19307232|P2|First Intervention|Out of indication|0
5587452|NCT00986245|19307233|P1|First Intervention|Out of indication|1
5587453|NCT00986245|19307232|P2|First Intervention|Protocol Violation|1
5587454|NCT00986245|19307233|P1|First Intervention|Protocol Violation|0
5587455|NCT00986245|19307232|P2|First Intervention|Withdrawal by Subject|1
5587456|NCT00986245|19307233|P1|First Intervention|Withdrawal by Subject|0
5587457|NCT00986245|19307232|P2|First Intervention|Lack of Efficacy|2
5587458|NCT00986245|19307233|P1|First Intervention|Lack of Efficacy|1
5587459|NCT00986245|19307232|P2|First Intervention|Poor compliance|4
5587460|NCT00986245|19307233|P1|First Intervention|Poor compliance|8
5587461|NCT00986232|19307270|P4|Overall Study|Incomplete safety follow-up|2
5587462|NCT00986232|19307271|P3|Overall Study|Incomplete safety follow-up|2
5587463|NCT00986232|19307272|P2|Overall Study|Incomplete safety follow-up|7
5587464|NCT00986232|19307273|P1|Overall Study|Incomplete safety follow-up|3
5587465|NCT00986232|19307270|P4|Overall Study|Missed one or more bleeds|7
5587466|NCT00986232|19307271|P3|Overall Study|Missed one or more bleeds|6
5587467|NCT00986232|19307272|P2|Overall Study|Missed one or more bleeds|10
5587468|NCT00986232|19307273|P1|Overall Study|Missed one or more bleeds|13
5587469|NCT00986232|19307270|P4|Overall Study|Withdrawal by Subject|3
5587470|NCT00986232|19307271|P3|Overall Study|Withdrawal by Subject|12
5587471|NCT00986232|19307272|P2|Overall Study|Withdrawal by Subject|16
5587472|NCT00986232|19307273|P1|Overall Study|Withdrawal by Subject|13
5587473|NCT00986232|19307270|P4|Overall Study|Protocol Violation|1
5587474|NCT00986232|19307271|P3|Overall Study|Protocol Violation|0
5587475|NCT00986232|19307272|P2|Overall Study|Protocol Violation|3
5587476|NCT00986232|19307273|P1|Overall Study|Protocol Violation|2
5587477|NCT00986232|19307270|P4|Overall Study|Lost to Follow-up|7
5587478|NCT00986232|19307271|P3|Overall Study|Lost to Follow-up|12
5587479|NCT00986232|19307272|P2|Overall Study|Lost to Follow-up|12
5587480|NCT00986232|19307273|P1|Overall Study|Lost to Follow-up|19
5587481|NCT00986232|19307270|P4|Overall Study|Adverse Event|0
5587482|NCT00986232|19307271|P3|Overall Study|Adverse Event|3
5587483|NCT00986232|19307272|P2|Overall Study|Adverse Event|2
5587484|NCT00986232|19307273|P1|Overall Study|Adverse Event|1
5587485|NCT00986180|19307347|P2|Overall Study|Miscellanies|11
5587486|NCT00986180|19307348|P1|Overall Study|Miscellanies|10
5587487|NCT00986180|19307347|P2|Overall Study|Withdrawal by Subject|9
5587488|NCT00986180|19307348|P1|Overall Study|Withdrawal by Subject|1
5587489|NCT00986180|19307347|P2|Overall Study|Protocol Violation|0
5587490|NCT00986180|19307348|P1|Overall Study|Protocol Violation|2
5587491|NCT00986180|19307347|P2|Overall Study|Physician Decision|3
5587492|NCT00986180|19307348|P1|Overall Study|Physician Decision|1
5587493|NCT00986180|19307347|P2|Overall Study|Lost to Follow-up|7
5587494|NCT00986180|19307348|P1|Overall Study|Lost to Follow-up|5
5587495|NCT00986180|19307347|P2|Overall Study|Lack of Efficacy|3
5587496|NCT00986180|19307348|P1|Overall Study|Lack of Efficacy|4
5587497|NCT00986180|19307347|P2|Overall Study|Adverse Event|23
5587498|NCT00986180|19307348|P1|Overall Study|Adverse Event|21
5587499|NCT00986154|19307426|P2|Overall Study|never received study drug|27
5587500|NCT00986154|19307427|P1|Overall Study|never received study drug|25
5587501|NCT00986154|19307426|P2|Overall Study|investigator/subject decide not continue|3
5587502|NCT00986154|19307427|P1|Overall Study|investigator/subject decide not continue|6
5587503|NCT00986154|19307426|P2|Overall Study|Withdrawal by Subject|33
5587504|NCT00986154|19307427|P1|Overall Study|Withdrawal by Subject|32
5587505|NCT00986154|19307426|P2|Overall Study|Lost to Follow-up|4
5587506|NCT00986154|19307427|P1|Overall Study|Lost to Follow-up|7
5587507|NCT00986154|19307426|P2|Overall Study|Death|127
5587508|NCT00986154|19307427|P1|Overall Study|Death|136
5587509|NCT00986102|19307441|P4|Overall Study|Withdrawal by Subject|0
5587510|NCT00986102|19307442|P3|Overall Study|Withdrawal by Subject|0
5587511|NCT00986102|19307443|P2|Overall Study|Withdrawal by Subject|1
5587512|NCT00986102|19307444|P1|Overall Study|Withdrawal by Subject|1
5587513|NCT00986102|19307441|P4|Overall Study|Lost to Follow-up|1
5587514|NCT00986102|19307442|P3|Overall Study|Lost to Follow-up|0
5587515|NCT00986102|19307443|P2|Overall Study|Lost to Follow-up|1
5587516|NCT00986102|19307444|P1|Overall Study|Lost to Follow-up|0
5587517|NCT00985985|19307494|P4|Overall Study|Other Reason|2
5587518|NCT00985985|19307495|P3|Overall Study|Other Reason|4
5587519|NCT00985985|19307496|P2|Overall Study|Other Reason|1
5587520|NCT00985985|19307497|P1|Overall Study|Other Reason|6
5587521|NCT00985985|19307494|P4|Overall Study|Withdrawal by Subject|2
5587522|NCT00985985|19307495|P3|Overall Study|Withdrawal by Subject|2
5587523|NCT00985985|19307496|P2|Overall Study|Withdrawal by Subject|2
5587524|NCT00985985|19307497|P1|Overall Study|Withdrawal by Subject|4
5587525|NCT00985985|19307494|P4|Overall Study|Lack of Efficacy|3
5587526|NCT00985985|19307495|P3|Overall Study|Lack of Efficacy|1
5587527|NCT00985985|19307496|P2|Overall Study|Lack of Efficacy|6
5587528|NCT00985985|19307497|P1|Overall Study|Lack of Efficacy|5
5587529|NCT00985985|19307494|P4|Overall Study|Protocol Violation|1
5587530|NCT00985985|19307495|P3|Overall Study|Protocol Violation|0
5587531|NCT00985985|19307496|P2|Overall Study|Protocol Violation|2
5587532|NCT00985985|19307497|P1|Overall Study|Protocol Violation|1
5587533|NCT00985985|19307494|P4|Overall Study|Lost to Follow-up|3
5587534|NCT00985985|19307495|P3|Overall Study|Lost to Follow-up|2
5587535|NCT00985985|19307496|P2|Overall Study|Lost to Follow-up|11
5587536|NCT00985985|19307497|P1|Overall Study|Lost to Follow-up|4
5587537|NCT00985985|19307494|P4|Overall Study|Adverse Event|2
5587538|NCT00985985|19307495|P3|Overall Study|Adverse Event|2
5587539|NCT00985985|19307496|P2|Overall Study|Adverse Event|2
5587540|NCT00985985|19307497|P1|Overall Study|Adverse Event|4
5587541|NCT00985959|19307538|P3|Overall Study|Other|11
5587542|NCT00985959|19307539|P2|Overall Study|Other|0
5587543|NCT00985959|19307540|P1|Overall Study|Other|0
5587544|NCT00985959|19307538|P3|Overall Study|Complete response observed over 2 cycles|4
5587545|NCT00985959|19307539|P2|Overall Study|Complete response observed over 2 cycles|1
5587546|NCT00985959|19307540|P1|Overall Study|Complete response observed over 2 cycles|0
5587547|NCT00985959|19307538|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
5587548|NCT00985959|19307539|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
5587549|NCT00985959|19307540|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
5587550|NCT00985959|19307538|P3|Overall Study|Unrecovered toxicity|7
5587551|NCT00985959|19307539|P2|Overall Study|Unrecovered toxicity|0
5587552|NCT00985959|19307540|P1|Overall Study|Unrecovered toxicity|0
5587553|NCT00985959|19307538|P3|Overall Study|Progressive disease|8
5587554|NCT00985959|19307539|P2|Overall Study|Progressive disease|2
5587555|NCT00985959|19307540|P1|Overall Study|Progressive disease|1
5587556|NCT00985959|19307538|P3|Overall Study|Withdrawal by Subject|8
5587557|NCT00985959|19307539|P2|Overall Study|Withdrawal by Subject|0
5587558|NCT00985959|19307540|P1|Overall Study|Withdrawal by Subject|0
5587559|NCT00985959|19307538|P3|Overall Study|Adverse Event|19
5587560|NCT00985959|19307539|P2|Overall Study|Adverse Event|0
5587561|NCT00985959|19307540|P1|Overall Study|Adverse Event|0
5587562|NCT00985946|19307563|P1|Overall Study|Withdrawal by Subject|1
5587563|NCT00985946|19307563|P1|Overall Study|Lost to Follow-up|6
5587564|NCT00985790|19307592|P2|Overall Study|Lost to Follow-up|7
5587565|NCT00985790|19307593|P1|Overall Study|Lost to Follow-up|6
5587566|NCT00985790|19307592|P2|Overall Study|Withdrawal by Subject|1
5587567|NCT00985790|19307593|P1|Overall Study|Withdrawal by Subject|1
5587568|NCT00985751|19307634|P5|Overall Study|Adverse Event|1
5587569|NCT00985751|19307635|P4|Overall Study|Adverse Event|0
5587570|NCT00985751|19307636|P3|Overall Study|Adverse Event|0
5587571|NCT00985751|19307637|P2|Overall Study|Adverse Event|0
5587572|NCT00985751|19307638|P1|Overall Study|Adverse Event|0
5587573|NCT00985738|19307701|P2|Overall Study|Study closed prematurely|8
5587574|NCT00985738|19307702|P1|Overall Study|Study closed prematurely|8
5587575|NCT00985725|19307710|P2|Overall Study|Out-of-window visits|1
5587576|NCT00985725|19307711|P1|Overall Study|Out-of-window visits|0
5587577|NCT00985725|19307710|P2|Overall Study|Non-compliance|2
5587578|NCT00985725|19307711|P1|Overall Study|Non-compliance|1
5587579|NCT00985725|19307710|P2|Overall Study|Lack of Efficacy|1
5587580|NCT00985725|19307711|P1|Overall Study|Lack of Efficacy|0
5587581|NCT00985725|19307710|P2|Overall Study|Lost to Follow-up|1
5587582|NCT00985725|19307711|P1|Overall Study|Lost to Follow-up|1
5587583|NCT00985725|19307710|P2|Overall Study|Withdrawal by Subject|4
5587584|NCT00985725|19307711|P1|Overall Study|Withdrawal by Subject|4
5587585|NCT00985725|19307710|P2|Overall Study|Protocol Violation|3
5587586|NCT00985725|19307711|P1|Overall Study|Protocol Violation|1
5587587|NCT00985725|19307710|P2|Overall Study|Adverse Event|1
5587588|NCT00985725|19307711|P1|Overall Study|Adverse Event|4
5587589|NCT00985712|19307747|P2|Overall Study|Sponsor decision|2
5587590|NCT00985712|19307748|P1|Overall Study|Sponsor decision|0
5587591|NCT00985712|19307747|P2|Overall Study|Withdrawal by Subject|1
5587592|NCT00985712|19307748|P1|Overall Study|Withdrawal by Subject|4
5587593|NCT00985712|19307747|P2|Overall Study|Protocol Violation|1
5587594|NCT00985712|19307748|P1|Overall Study|Protocol Violation|0
5587595|NCT00985712|19307747|P2|Overall Study|Lost to Follow-up|2
5587596|NCT00985712|19307748|P1|Overall Study|Lost to Follow-up|2
5587597|NCT00985712|19307747|P2|Overall Study|Adverse Event|1
5587598|NCT00985712|19307748|P1|Overall Study|Adverse Event|0
5587599|NCT00985686|19307766|P4|Overall Study|Lost to Follow-up|2
5587600|NCT00985686|19307767|P3|Overall Study|Lost to Follow-up|0
5587601|NCT00985686|19307768|P2|Overall Study|Lost to Follow-up|1
5587602|NCT00985686|19307769|P1|Overall Study|Lost to Follow-up|1
5587603|NCT00985673|19307783|P6|Overall Study|Other|0
5587604|NCT00985673|19307784|P5|Overall Study|Other|1
5587605|NCT00985673|19307785|P4|Overall Study|Other|0
5587606|NCT00985673|19307786|P3|Overall Study|Other|1
5587607|NCT00985673|19307787|P2|Overall Study|Other|0
5587608|NCT00985673|19307788|P1|Overall Study|Other|1
5587609|NCT00985673|19307783|P6|Overall Study|Withdrawal by Subject|3
5587610|NCT00985673|19307784|P5|Overall Study|Withdrawal by Subject|2
5587611|NCT00985673|19307785|P4|Overall Study|Withdrawal by Subject|2
5587612|NCT00985673|19307786|P3|Overall Study|Withdrawal by Subject|5
5587613|NCT00985673|19307787|P2|Overall Study|Withdrawal by Subject|4
5587614|NCT00985673|19307788|P1|Overall Study|Withdrawal by Subject|0
5587615|NCT00985673|19307783|P6|Overall Study|Lost to Follow-up|3
5587616|NCT00985673|19307784|P5|Overall Study|Lost to Follow-up|5
5587617|NCT00985673|19307785|P4|Overall Study|Lost to Follow-up|10
5587618|NCT00985673|19307786|P3|Overall Study|Lost to Follow-up|6
5587619|NCT00985673|19307787|P2|Overall Study|Lost to Follow-up|7
5587620|NCT00985673|19307788|P1|Overall Study|Lost to Follow-up|6
5587621|NCT00985504|19308071|P2|Optimization Period|Withdrawal by Subject|8
5587622|NCT00985504|19308072|P1|Optimization Period|Withdrawal by Subject|10
5587623|NCT00985504|19308071|P2|Optimization Period|Protocol Violation|1
5587624|NCT00985504|19308072|P1|Optimization Period|Protocol Violation|3
5587625|NCT00985504|19308071|P2|Optimization Period|Physician Decision|0
5587626|NCT00985504|19308072|P1|Optimization Period|Physician Decision|1
5587627|NCT00985504|19308071|P2|Optimization Period|Lost to Follow-up|1
5587628|NCT00985504|19308072|P1|Optimization Period|Lost to Follow-up|0
5587629|NCT00985504|19308071|P2|Optimization Period|Lack of Efficacy|3
5587630|NCT00985504|19308072|P1|Optimization Period|Lack of Efficacy|5
5587631|NCT00985504|19308071|P2|Optimization Period|Death|1
5587632|NCT00985504|19308072|P1|Optimization Period|Death|0
5587633|NCT00985504|19308071|P2|Optimization Period|Adverse Event|9
5587634|NCT00985504|19308072|P1|Optimization Period|Adverse Event|7
5587635|NCT00985504|19308071|P2|Acute Treatment Period|Withdrawal by Subject|5
5587636|NCT00985504|19308072|P1|Acute Treatment Period|Withdrawal by Subject|9
5587637|NCT00985504|19308071|P2|Acute Treatment Period|Sponsor Decision|1
5587638|NCT00985504|19308072|P1|Acute Treatment Period|Sponsor Decision|0
5587639|NCT00985504|19308071|P2|Acute Treatment Period|Protocol Violation|0
5587640|NCT00985504|19308072|P1|Acute Treatment Period|Protocol Violation|2
5587641|NCT00985504|19308071|P2|Acute Treatment Period|Entry Criteria Not Met|2
5587642|NCT00985504|19308072|P1|Acute Treatment Period|Entry Criteria Not Met|1
5587643|NCT00985504|19308071|P2|Acute Treatment Period|Adverse Event|4
5587644|NCT00985504|19308072|P1|Acute Treatment Period|Adverse Event|3
5587645|NCT00985491|19308098|P1|Overall Study|implant failure|3
5587646|NCT00985491|19308098|P1|Overall Study|Withdrawal by Subject|1
5587647|NCT00985491|19308098|P1|Overall Study|device migration|7
5587648|NCT00985491|19308098|P1|Overall Study|Adverse Event|8
5587649|NCT00985465|19308105|P2|Overall Study|Considered to be part of the other group|1
5587650|NCT00985465|19308106|P1|Overall Study|Considered to be part of the other group|0
5587651|NCT00985465|19308105|P2|Overall Study|Withdrawal by Subject|2
5587652|NCT00985465|19308106|P1|Overall Study|Withdrawal by Subject|1
5587653|NCT00985439|19308133|P4|Overall Study|Adverse Event|0
5587654|NCT00985439|19308134|P3|Overall Study|Adverse Event|1
5587655|NCT00985439|19308135|P2|Overall Study|Adverse Event|0
5587656|NCT00985439|19308136|P1|Overall Study|Adverse Event|0
5587657|NCT00985426|19308148|P2|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
5587658|NCT00985426|19308149|P1|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
5587659|NCT00985426|19308148|P2|Overall Study|Protocol Violation|0
5587660|NCT00985426|19308149|P1|Overall Study|Protocol Violation|2
5587661|NCT00985426|19308148|P2|Overall Study|Death|3
5587662|NCT00985426|19308149|P1|Overall Study|Death|7
5587663|NCT00985426|19308148|P2|Overall Study|Lost to Follow-up|10
5587664|NCT00985426|19308149|P1|Overall Study|Lost to Follow-up|8
5587665|NCT00985426|19308148|P2|Overall Study|Withdrawal by Subject|16
5587666|NCT00985426|19308149|P1|Overall Study|Withdrawal by Subject|12
5587667|NCT00985426|19308148|P2|Overall Study|Subject Non-Compliance|3
5587668|NCT00985426|19308149|P1|Overall Study|Subject Non-Compliance|3
5587669|NCT00985426|19308148|P2|Overall Study|Adverse Event|1
5587670|NCT00985426|19308149|P1|Overall Study|Adverse Event|0
5587671|NCT00985231|19308171|P2|Overall Study|Study related symptoms & complaints|2
5587672|NCT00985231|19308172|P1|Overall Study|Study related symptoms & complaints|0
5587673|NCT00985231|19308171|P2|Overall Study|Lost to Follow-up|1
5587674|NCT00985231|19308172|P1|Overall Study|Lost to Follow-up|0
5587675|NCT00985231|19308171|P2|Overall Study|Withdrawal by Subject|0
5587676|NCT00985231|19308172|P1|Overall Study|Withdrawal by Subject|1
5587677|NCT00985231|19308171|P2|Overall Study|Protocol Violation|0
5587678|NCT00985231|19308172|P1|Overall Study|Protocol Violation|1
5587679|NCT00985231|19308171|P2|Overall Study|ineligible|0
5587680|NCT00985231|19308172|P1|Overall Study|ineligible|1
5587681|NCT00985192|19308180|P1|Overall Study|Determined to be Ineligible During Trial|2
5587682|NCT00985192|19308180|P1|Overall Study|Disease Progression|1
5587683|NCT00985192|19308180|P1|Overall Study|Withdrawal by Subject|1
5587684|NCT00985166|19308192|P3|Overall Study|Other|1
5587685|NCT00985166|19308193|P2|Overall Study|Other|0
5587686|NCT00985166|19308194|P1|Overall Study|Other|1
5587687|NCT00985166|19308192|P3|Overall Study|Test not done|4
5587688|NCT00985166|19308193|P2|Overall Study|Test not done|0
5587689|NCT00985166|19308194|P1|Overall Study|Test not done|2
5587690|NCT00985166|19308192|P3|Overall Study|Withdrawal by Subject|0
5587691|NCT00985166|19308193|P2|Overall Study|Withdrawal by Subject|2
5587692|NCT00985166|19308194|P1|Overall Study|Withdrawal by Subject|3
5587693|NCT00985166|19308192|P3|Overall Study|Lost to Follow-up|2
5587694|NCT00985166|19308193|P2|Overall Study|Lost to Follow-up|2
5587695|NCT00985166|19308194|P1|Overall Study|Lost to Follow-up|3
5587696|NCT00985153|19308214|P4|Overall Study|Incomplete Safety Follow-up|4
5587697|NCT00985153|19308215|P3|Overall Study|Incomplete Safety Follow-up|4
5587698|NCT00985153|19308216|P2|Overall Study|Incomplete Safety Follow-up|5
5587699|NCT00985153|19308217|P1|Overall Study|Incomplete Safety Follow-up|3
5587700|NCT00985153|19308214|P4|Overall Study|Missed One or More Bleeds|10
5587701|NCT00985153|19308215|P3|Overall Study|Missed One or More Bleeds|8
5587702|NCT00985153|19308216|P2|Overall Study|Missed One or More Bleeds|7
5587703|NCT00985153|19308217|P1|Overall Study|Missed One or More Bleeds|7
5587704|NCT00985153|19308214|P4|Overall Study|Withdrawal by Subject|10
5587705|NCT00985153|19308215|P3|Overall Study|Withdrawal by Subject|11
5587706|NCT00985153|19308216|P2|Overall Study|Withdrawal by Subject|11
5587707|NCT00985153|19308217|P1|Overall Study|Withdrawal by Subject|6
5587708|NCT00985153|19308214|P4|Overall Study|Protocol Violation|3
5587709|NCT00985153|19308215|P3|Overall Study|Protocol Violation|4
5587710|NCT00985153|19308216|P2|Overall Study|Protocol Violation|2
5587711|NCT00985153|19308217|P1|Overall Study|Protocol Violation|3
5587712|NCT00985153|19308214|P4|Overall Study|Lost to Follow-up|20
5587713|NCT00985153|19308215|P3|Overall Study|Lost to Follow-up|17
5587714|NCT00985153|19308216|P2|Overall Study|Lost to Follow-up|19
5587715|NCT00985153|19308217|P1|Overall Study|Lost to Follow-up|16
5587716|NCT00985114|19308265|P2|Overall Study|Withdrawal by Subject|2
5587717|NCT00985114|19308266|P1|Overall Study|Withdrawal by Subject|0
5587718|NCT00985114|19308265|P2|Overall Study|Adverse Event|0
5587719|NCT00985114|19308266|P1|Overall Study|Adverse Event|1
5587720|NCT00985088|19308280|P8|Overall Study|Lost to Follow-up|2
5587721|NCT00985088|19308281|P7|Overall Study|Lost to Follow-up|3
5587722|NCT00985088|19308282|P6|Overall Study|Lost to Follow-up|5
5587723|NCT00985088|19308283|P5|Overall Study|Lost to Follow-up|6
5587724|NCT00985088|19308284|P4|Overall Study|Lost to Follow-up|6
5587725|NCT00985088|19308285|P3|Overall Study|Lost to Follow-up|2
5587726|NCT00985088|19308286|P2|Overall Study|Lost to Follow-up|1
5587727|NCT00985088|19308287|P1|Overall Study|Lost to Follow-up|6
5587728|NCT00985088|19308280|P8|Overall Study|Migrated/moved from study area|1
5587729|NCT00985088|19308281|P7|Overall Study|Migrated/moved from study area|0
5587730|NCT00985088|19308282|P6|Overall Study|Migrated/moved from study area|0
5587731|NCT00985088|19308283|P5|Overall Study|Migrated/moved from study area|0
5587732|NCT00985088|19308284|P4|Overall Study|Migrated/moved from study area|0
5587733|NCT00985088|19308285|P3|Overall Study|Migrated/moved from study area|1
5587734|NCT00985088|19308286|P2|Overall Study|Migrated/moved from study area|0
5587735|NCT00985088|19308287|P1|Overall Study|Migrated/moved from study area|0
5587736|NCT00985088|19308280|P8|Overall Study|Withdrawal by Subject|2
5587737|NCT00985088|19308281|P7|Overall Study|Withdrawal by Subject|1
5587738|NCT00985088|19308282|P6|Overall Study|Withdrawal by Subject|2
5587739|NCT00985088|19308283|P5|Overall Study|Withdrawal by Subject|3
5587740|NCT00985088|19308284|P4|Overall Study|Withdrawal by Subject|1
5587741|NCT00985088|19308285|P3|Overall Study|Withdrawal by Subject|0
5587742|NCT00985088|19308286|P2|Overall Study|Withdrawal by Subject|0
5587743|NCT00985088|19308287|P1|Overall Study|Withdrawal by Subject|4
5587744|NCT00985088|19308280|P8|Overall Study|Adverse Event|0
5587745|NCT00985088|19308281|P7|Overall Study|Adverse Event|0
5587746|NCT00985088|19308282|P6|Overall Study|Adverse Event|0
5587747|NCT00985088|19308283|P5|Overall Study|Adverse Event|0
5587748|NCT00985088|19308284|P4|Overall Study|Adverse Event|0
5587749|NCT00985088|19308285|P3|Overall Study|Adverse Event|1
5587750|NCT00985088|19308286|P2|Overall Study|Adverse Event|0
5587751|NCT00985088|19308287|P1|Overall Study|Adverse Event|0
5587752|NCT00985088|19308280|P8|Overall Study|Serious Adverse Event|1
5587753|NCT00985088|19308281|P7|Overall Study|Serious Adverse Event|0
5587754|NCT00985088|19308282|P6|Overall Study|Serious Adverse Event|0
5587755|NCT00985088|19308283|P5|Overall Study|Serious Adverse Event|0
5587756|NCT00985088|19308284|P4|Overall Study|Serious Adverse Event|0
5587757|NCT00985088|19308285|P3|Overall Study|Serious Adverse Event|0
5587758|NCT00985088|19308286|P2|Overall Study|Serious Adverse Event|1
5587759|NCT00985088|19308287|P1|Overall Study|Serious Adverse Event|1
5587760|NCT00984867|19308556|P2|Overall Study|lack of efficacy and subject compliance|0
5587761|NCT00984867|19308557|P1|Overall Study|lack of efficacy and subject compliance|1
5587762|NCT00984867|19308556|P2|Overall Study|site closing|0
5587763|NCT00984867|19308557|P1|Overall Study|site closing|1
5587764|NCT00984867|19308556|P2|Overall Study|Subject no longer meets study criteria|1
5587765|NCT00984867|19308557|P1|Overall Study|Subject no longer meets study criteria|1
5587766|NCT00984867|19308556|P2|Overall Study|Poor/non-compliance|1
5587767|NCT00984867|19308557|P1|Overall Study|Poor/non-compliance|0
5587768|NCT00984867|19308556|P2|Overall Study|Lost to Follow-up|4
5587769|NCT00984867|19308557|P1|Overall Study|Lost to Follow-up|3
5587770|NCT00984867|19308556|P2|Overall Study|Withdrawal by Subject|4
5587771|NCT00984867|19308557|P1|Overall Study|Withdrawal by Subject|13
5587772|NCT00984867|19308556|P2|Overall Study|Death|0
5587773|NCT00984867|19308557|P1|Overall Study|Death|1
5587774|NCT00984867|19308556|P2|Overall Study|Adverse Event|7
5587775|NCT00984867|19308557|P1|Overall Study|Adverse Event|3
5587776|NCT00984659|19308597|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
5587777|NCT00984659|19308598|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
5587778|NCT00984659|19308599|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
5587779|NCT00984659|19308600|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
5587780|NCT00984659|19308597|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
5587781|NCT00984659|19308598|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
5587782|NCT00984659|19308599|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
5587783|NCT00984659|19308600|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
5587784|NCT00984659|19308597|P4|6-week Double-blind Treatment Period|Protocol Violation|4
5587785|NCT00984659|19308598|P3|6-week Double-blind Treatment Period|Protocol Violation|0
5587786|NCT00984659|19308599|P2|6-week Double-blind Treatment Period|Protocol Violation|0
5587787|NCT00984659|19308600|P1|6-week Double-blind Treatment Period|Protocol Violation|0
5587788|NCT00984659|19308597|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
5587789|NCT00984659|19308598|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
5587790|NCT00984659|19308599|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
5587791|NCT00984659|19308600|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
5587792|NCT00984659|19308597|P4|6-week Double-blind Treatment Period|Adverse Event|7
5587793|NCT00984659|19308598|P3|6-week Double-blind Treatment Period|Adverse Event|3
5587794|NCT00984659|19308599|P2|6-week Double-blind Treatment Period|Adverse Event|3
5587795|NCT00984659|19308600|P1|6-week Double-blind Treatment Period|Adverse Event|0
5587796|NCT00984659|19308597|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5587797|NCT00984659|19308598|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5587798|NCT00984659|19308599|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
5587799|NCT00984659|19308600|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
5587800|NCT00984659|19308597|P4|2-week Run-in Period|Withdrawal by Subject|0
5587801|NCT00984659|19308598|P3|2-week Run-in Period|Withdrawal by Subject|0
5587802|NCT00984659|19308599|P2|2-week Run-in Period|Withdrawal by Subject|0
5587803|NCT00984659|19308600|P1|2-week Run-in Period|Withdrawal by Subject|10
5587804|NCT00984659|19308597|P4|2-week Run-in Period|Physician Decision|0
5587805|NCT00984659|19308598|P3|2-week Run-in Period|Physician Decision|0
5587806|NCT00984659|19308599|P2|2-week Run-in Period|Physician Decision|0
5587807|NCT00984659|19308600|P1|2-week Run-in Period|Physician Decision|10
5587808|NCT00984659|19308597|P4|2-week Run-in Period|Lost to Follow-up|0
5587809|NCT00984659|19308598|P3|2-week Run-in Period|Lost to Follow-up|0
5587810|NCT00984659|19308599|P2|2-week Run-in Period|Lost to Follow-up|0
5587811|NCT00984659|19308600|P1|2-week Run-in Period|Lost to Follow-up|3
5587812|NCT00984659|19308597|P4|2-week Run-in Period|Study Closed/Terminated|0
5587813|NCT00984659|19308598|P3|2-week Run-in Period|Study Closed/Terminated|0
5587814|NCT00984659|19308599|P2|2-week Run-in Period|Study Closed/Terminated|0
5587815|NCT00984659|19308600|P1|2-week Run-in Period|Study Closed/Terminated|2
5587816|NCT00984659|19308597|P4|2-week Run-in Period|Protocol Violation|0
5587817|NCT00984659|19308598|P3|2-week Run-in Period|Protocol Violation|0
5587818|NCT00984659|19308599|P2|2-week Run-in Period|Protocol Violation|0
5587819|NCT00984659|19308600|P1|2-week Run-in Period|Protocol Violation|5
5587820|NCT00984659|19308597|P4|2-week Run-in Period|Adverse Event|0
5587821|NCT00984659|19308598|P3|2-week Run-in Period|Adverse Event|0
5587822|NCT00984659|19308599|P2|2-week Run-in Period|Adverse Event|0
5587823|NCT00984659|19308600|P1|2-week Run-in Period|Adverse Event|8
5587824|NCT00984620|19308627|P2|Overall Study|reason other than listed above|4
5587825|NCT00984620|19308628|P1|Overall Study|reason other than listed above|0
5587826|NCT00984620|19308627|P2|Overall Study|Withdrawal by Subject|2
5587827|NCT00984620|19308628|P1|Overall Study|Withdrawal by Subject|0
5587828|NCT00984620|19308627|P2|Overall Study|Lost to Follow-up|1
5587829|NCT00984620|19308628|P1|Overall Study|Lost to Follow-up|1
5587830|NCT00984620|19308627|P2|Overall Study|Adverse Event|5
5587831|NCT00984620|19308628|P1|Overall Study|Adverse Event|5
5587832|NCT00984594|19308666|P2|Overall Study|Withdrawal by Subject|1
5587833|NCT00984594|19308667|P1|Overall Study|Withdrawal by Subject|0
5587834|NCT00984594|19308666|P2|Overall Study|Lost to Follow-up|0
5587835|NCT00984594|19308667|P1|Overall Study|Lost to Follow-up|1
5587836|NCT00984568|19308683|P2|Overall Study|Unknown Reason|3
5587837|NCT00984568|19308684|P1|Overall Study|Unknown Reason|1
5587838|NCT00984568|19308683|P2|Overall Study|Opportunistic Infection|0
5587839|NCT00984568|19308684|P1|Overall Study|Opportunistic Infection|1
5587840|NCT00984568|19308683|P2|Overall Study|Lost to Follow-up|1
5587841|NCT00984568|19308684|P1|Overall Study|Lost to Follow-up|0
5587842|NCT00984568|19308683|P2|Overall Study|Did Not Meet Randomization Criteria|0
5587843|NCT00984568|19308684|P1|Overall Study|Did Not Meet Randomization Criteria|1
5587844|NCT00984568|19308683|P2|Overall Study|Adverse Event|0
5587845|NCT00984568|19308684|P1|Overall Study|Adverse Event|2
5587846|NCT00984568|19308683|P2|Overall Study|Lack of Efficacy|0
5587847|NCT00984568|19308684|P1|Overall Study|Lack of Efficacy|2
5587848|NCT00984568|19308683|P2|Overall Study|Withdrawal by Subject|2
5587849|NCT00984568|19308684|P1|Overall Study|Withdrawal by Subject|1
5587850|NCT00984542|19308692|P1|Overall Study|clinical deterioration|2
5587851|NCT00984542|19308692|P1|Overall Study|Withdrawal by Subject|3
5587852|NCT00984542|19308692|P1|Overall Study|complicating disease|3
5587853|NCT00984542|19308692|P1|Overall Study|Death|7
5587854|NCT00984542|19308692|P1|Overall Study|toxicity|7
5587855|NCT00984542|19308692|P1|Overall Study|disease progression|19
5587856|NCT00984295|19308742|P3|Overall Study|Incomplete safety follow-up|3
5587857|NCT00984295|19308743|P2|Overall Study|Incomplete safety follow-up|2
5587858|NCT00984295|19308744|P1|Overall Study|Incomplete safety follow-up|11
5587859|NCT00984295|19308742|P3|Overall Study|Missed one or more blood samplings|2
5587860|NCT00984295|19308743|P2|Overall Study|Missed one or more blood samplings|7
5587861|NCT00984295|19308744|P1|Overall Study|Missed one or more blood samplings|3
5587862|NCT00984295|19308742|P3|Overall Study|CAE - discontinued test vaccine|3
5587863|NCT00984295|19308743|P2|Overall Study|CAE - discontinued test vaccine|1
5587864|NCT00984295|19308744|P1|Overall Study|CAE - discontinued test vaccine|0
5587865|NCT00984295|19308742|P3|Overall Study|Withdrawal by Subject|12
5587866|NCT00984295|19308743|P2|Overall Study|Withdrawal by Subject|9
5587867|NCT00984295|19308744|P1|Overall Study|Withdrawal by Subject|18
5587868|NCT00984295|19308742|P3|Overall Study|Protocol Violation|4
5587869|NCT00984295|19308743|P2|Overall Study|Protocol Violation|1
5587870|NCT00984295|19308744|P1|Overall Study|Protocol Violation|2
5587871|NCT00984295|19308742|P3|Overall Study|Lost to Follow-up|13
5587872|NCT00984295|19308743|P2|Overall Study|Lost to Follow-up|12
5587873|NCT00984295|19308744|P1|Overall Study|Lost to Follow-up|31
5587874|NCT00984282|19308811|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
5587875|NCT00984282|19308812|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
5587876|NCT00984282|19308811|P2|Long Term Follow-up|Switched to commercial drug|2
5587877|NCT00984282|19308812|P1|Long Term Follow-up|Switched to commercial drug|4
5587878|NCT00984282|19308811|P2|Long Term Follow-up|Transferred to treat. continuation study|3
5587879|NCT00984282|19308812|P1|Long Term Follow-up|Transferred to treat. continuation study|2
5587880|NCT00984282|19308811|P2|Long Term Follow-up|Protocol driven decision point|26
5587881|NCT00984282|19308812|P1|Long Term Follow-up|Protocol driven decision point|25
5587882|NCT00984282|19308811|P2|Long Term Follow-up|Lost to Follow-up|6
5587883|NCT00984282|19308812|P1|Long Term Follow-up|Lost to Follow-up|3
5587884|NCT00984282|19308811|P2|Long Term Follow-up|Death|68
5587885|NCT00984282|19308812|P1|Long Term Follow-up|Death|27
5587886|NCT00984282|19308811|P2|Long Term Follow-up|Withdrawal by Subject|14
5587887|NCT00984282|19308812|P1|Long Term Follow-up|Withdrawal by Subject|8
5587888|NCT00984282|19308811|P2|Open-label Treatment|Physician Decision|0
5587889|NCT00984282|19308812|P1|Open-label Treatment|Physician Decision|1
5587890|NCT00984282|19308811|P2|Open-label Treatment|Switched to commercial drug|7
5587891|NCT00984282|19308812|P1|Open-label Treatment|Switched to commercial drug|6
5587892|NCT00984282|19308811|P2|Open-label Treatment|Transferred to treat. continuation study|3
5587893|NCT00984282|19308812|P1|Open-label Treatment|Transferred to treat. continuation study|2
5587894|NCT00984282|19308811|P2|Open-label Treatment|Protocol driven decision point|1
5587895|NCT00984282|19308812|P1|Open-label Treatment|Protocol driven decision point|1
5587896|NCT00984282|19308811|P2|Open-label Treatment|Target lesion removed|1
5587897|NCT00984282|19308812|P1|Open-label Treatment|Target lesion removed|0
5587898|NCT00984282|19308811|P2|Open-label Treatment|Non-compliant with study medication|0
5587899|NCT00984282|19308812|P1|Open-label Treatment|Non-compliant with study medication|1
5587900|NCT00984282|19308811|P2|Open-label Treatment|Patient convenience|0
5587901|NCT00984282|19308812|P1|Open-label Treatment|Patient convenience|1
5587902|NCT00984282|19308811|P2|Open-label Treatment|Lost to Follow-up|1
5587903|NCT00984282|19308812|P1|Open-label Treatment|Lost to Follow-up|1
5587904|NCT00984282|19308811|P2|Open-label Treatment|Progression, recurrence or relapse|82
5587905|NCT00984282|19308812|P1|Open-label Treatment|Progression, recurrence or relapse|40
5587906|NCT00984282|19308811|P2|Open-label Treatment|Death|15
5587907|NCT00984282|19308812|P1|Open-label Treatment|Death|7
5587908|NCT00984282|19308811|P2|Open-label Treatment|Withdrawal by Subject|21
5587909|NCT00984282|19308812|P1|Open-label Treatment|Withdrawal by Subject|6
5587910|NCT00984282|19308811|P2|Open-label Treatment|Adverse Event|30
5587911|NCT00984282|19308812|P1|Open-label Treatment|Adverse Event|20
5587912|NCT00984282|19308811|P2|Double Blind Treatment|Transferred to treat. continuation study|1
5587913|NCT00984282|19308812|P1|Double Blind Treatment|Transferred to treat. continuation study|2
5587914|NCT00984282|19308811|P2|Double Blind Treatment|Radiological and clinical progression|1
5587915|NCT00984282|19308812|P1|Double Blind Treatment|Radiological and clinical progression|0
5587916|NCT00984282|19308811|P2|Double Blind Treatment|protocol driven decision point|1
5587917|NCT00984282|19308812|P1|Double Blind Treatment|protocol driven decision point|1
5587918|NCT00984282|19308811|P2|Double Blind Treatment|Switched to commercial drug|1
5587919|NCT00984282|19308812|P1|Double Blind Treatment|Switched to commercial drug|6
5587920|NCT00984282|19308811|P2|Double Blind Treatment|Not treated|1
5587921|NCT00984282|19308812|P1|Double Blind Treatment|Not treated|0
5587922|NCT00984282|19308811|P2|Double Blind Treatment|Death|4
5587923|NCT00984282|19308812|P1|Double Blind Treatment|Death|8
5587924|NCT00984282|19308811|P2|Double Blind Treatment|Lost to Follow-up|0
5587925|NCT00984282|19308812|P1|Double Blind Treatment|Lost to Follow-up|3
5587926|NCT00984282|19308811|P2|Double Blind Treatment|Withdrawal by Subject|18
5587927|NCT00984282|19308812|P1|Double Blind Treatment|Withdrawal by Subject|13
5587928|NCT00984282|19308811|P2|Double Blind Treatment|Progression by clinical judgment|0
5587929|NCT00984282|19308812|P1|Double Blind Treatment|Progression by clinical judgment|2
5587930|NCT00984282|19308811|P2|Double Blind Treatment|Noncompliance with study medication|0
5587931|NCT00984282|19308812|P1|Double Blind Treatment|Noncompliance with study medication|3
5587932|NCT00984282|19308811|P2|Double Blind Treatment|Physician Decision|2
5587933|NCT00984282|19308812|P1|Double Blind Treatment|Physician Decision|1
5587934|NCT00984282|19308811|P2|Double Blind Treatment|Progression, recurrence or relapse|3
5587935|NCT00984282|19308812|P1|Double Blind Treatment|Progression, recurrence or relapse|25
5587936|NCT00984282|19308811|P2|Double Blind Treatment|Adverse Event|6
5587937|NCT00984282|19308812|P1|Double Blind Treatment|Adverse Event|40
5587938|NCT00984256|19308835|P2|Overall Study|Withdrawal by Subject|1
5587939|NCT00984256|19308836|P1|Overall Study|Withdrawal by Subject|0
5587940|NCT00984204|19308856|P1|Overall Study|Lack of Efficacy|10
5587941|NCT00984204|19308856|P1|Overall Study|Lost to Follow-up|4
5587942|NCT00984204|19308856|P1|Overall Study|Death|1
5587943|NCT00984165|19308866|P4|Overall Study|removed with a pair recipient|1
5587944|NCT00984165|19308867|P3|Overall Study|removed with a pair recipient|0
5587945|NCT00984165|19308868|P2|Overall Study|removed with a pair recipient|0
5587946|NCT00984165|19308869|P1|Overall Study|removed with a pair recipient|0
5587947|NCT00984165|19308866|P4|Overall Study|P+/donor pair removed from protocol|1
5587948|NCT00984165|19308867|P3|Overall Study|P+/donor pair removed from protocol|0
5587949|NCT00984165|19308868|P2|Overall Study|P+/donor pair removed from protocol|0
5587950|NCT00984165|19308869|P1|Overall Study|P+/donor pair removed from protocol|0
5587951|NCT00984165|19308866|P4|Overall Study|New protocol|1
5587952|NCT00984165|19308867|P3|Overall Study|New protocol|0
5587953|NCT00984165|19308868|P2|Overall Study|New protocol|0
5587954|NCT00984165|19308869|P1|Overall Study|New protocol|0
5587955|NCT00984165|19308866|P4|Overall Study|Death of recipient|1
5587956|NCT00984165|19308867|P3|Overall Study|Death of recipient|0
5587957|NCT00984165|19308868|P2|Overall Study|Death of recipient|0
5587958|NCT00984165|19308869|P1|Overall Study|Death of recipient|0
5587959|NCT00984165|19308866|P4|Overall Study|Disease progression on study|0
5587960|NCT00984165|19308867|P3|Overall Study|Disease progression on study|0
5587961|NCT00984165|19308868|P2|Overall Study|Disease progression on study|1
5587962|NCT00984165|19308869|P1|Overall Study|Disease progression on study|5
5587963|NCT00984165|19308866|P4|Overall Study|Death on study|0
5587964|NCT00984165|19308867|P3|Overall Study|Death on study|0
5587965|NCT00984165|19308868|P2|Overall Study|Death on study|0
5587966|NCT00984165|19308869|P1|Overall Study|Death on study|2
5587967|NCT00984126|19308898|P4|Overall Study|Withdrawal criteria|9
5587968|NCT00984126|19308899|P3|Overall Study|Withdrawal criteria|3
5587969|NCT00984126|19308900|P2|Overall Study|Withdrawal criteria|1
5587970|NCT00984126|19308901|P1|Overall Study|Withdrawal criteria|0
5587971|NCT00984126|19308898|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
5587972|NCT00984126|19308899|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
5587973|NCT00984126|19308900|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
5587974|NCT00984126|19308901|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
5587975|NCT00984126|19308898|P4|Overall Study|Adverse Event|2
5587976|NCT00984126|19308899|P3|Overall Study|Adverse Event|0
5587977|NCT00984126|19308900|P2|Overall Study|Adverse Event|0
5587978|NCT00984126|19308901|P1|Overall Study|Adverse Event|0
5587979|NCT00984126|19308898|P4|Overall Study|Protocol Violation|2
5587980|NCT00984126|19308899|P3|Overall Study|Protocol Violation|1
5587981|NCT00984126|19308900|P2|Overall Study|Protocol Violation|0
5587982|NCT00984126|19308901|P1|Overall Study|Protocol Violation|0
5587983|NCT00984061|19308926|P1|Clarithromycin Alone|Protocol Violation|1
5587984|NCT00984022|19308939|P2|Overall Study|Lost to Follow-up|14
5587985|NCT00984022|19308940|P1|Overall Study|Lost to Follow-up|10
5587986|NCT00984009|19308950|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
5587987|NCT00983957|19308983|P1|Overall Study|Personal Reasons|1
5587988|NCT00983957|19308983|P1|Overall Study|Adverse Event|1
5587989|NCT00983931|19309017|P1|14 Day Washout Period|Physician Decision|1
5587990|NCT00983918|19309031|P4|Overall Study|conversion to open cholecystectomy|2
5587991|NCT00983918|19309032|P3|Overall Study|conversion to open cholecystectomy|2
5587992|NCT00983918|19309033|P2|Overall Study|conversion to open cholecystectomy|2
5587993|NCT00983918|19309034|P1|Overall Study|conversion to open cholecystectomy|0
5587994|NCT00983905|19309044|P1|Colchicine Alone|Adverse Event|2
5587995|NCT00983905|19309044|P1|Theophylline Alone|Adverse Event|1
5587996|NCT00983892|19309057|P2|Overall Study|Withdrawal by Subject|12
5587997|NCT00983892|19309058|P1|Overall Study|Withdrawal by Subject|10
5587998|NCT00983853|19309070|P6|Overall Study|Unable to come to study follow-up visits|0
5587999|NCT00983853|19309071|P5|Overall Study|Unable to come to study follow-up visits|0
5588000|NCT00983853|19309072|P4|Overall Study|Unable to come to study follow-up visits|0
5588001|NCT00983853|19309073|P3|Overall Study|Unable to come to study follow-up visits|0
5588002|NCT00983853|19309074|P2|Overall Study|Unable to come to study follow-up visits|1
5588003|NCT00983853|19309075|P1|Overall Study|Unable to come to study follow-up visits|0
5588004|NCT00983853|19309070|P6|Overall Study|Withdrawal by Subject|0
5588005|NCT00983853|19309071|P5|Overall Study|Withdrawal by Subject|1
5588006|NCT00983853|19309072|P4|Overall Study|Withdrawal by Subject|0
5588007|NCT00983853|19309073|P3|Overall Study|Withdrawal by Subject|1
5588008|NCT00983853|19309074|P2|Overall Study|Withdrawal by Subject|0
5588009|NCT00983853|19309075|P1|Overall Study|Withdrawal by Subject|0
5588010|NCT00983853|19309070|P6|Overall Study|Lost to Follow-up|1
5588011|NCT00983853|19309071|P5|Overall Study|Lost to Follow-up|2
5588012|NCT00983853|19309072|P4|Overall Study|Lost to Follow-up|2
5588013|NCT00983853|19309073|P3|Overall Study|Lost to Follow-up|2
5588014|NCT00983853|19309074|P2|Overall Study|Lost to Follow-up|1
5588015|NCT00983853|19309075|P1|Overall Study|Lost to Follow-up|1
5588016|NCT00983827|19309103|P1|Overall Study|Withdrawal by Subject|1
5588017|NCT00983749|19309121|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
5588018|NCT00983749|19309122|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
5588019|NCT00983619|19309157|P12|Overall Study|Other|0
5588020|NCT00983619|19309158|P11|Overall Study|Other|1
5588021|NCT00983619|19309159|P10|Overall Study|Other|1
5588022|NCT00983619|19309160|P9|Overall Study|Other|0
5588023|NCT00983619|19309161|P8|Overall Study|Other|2
5588024|NCT00983619|19309162|P7|Overall Study|Other|2
5588025|NCT00983619|19309163|P6|Overall Study|Other|12
5588026|NCT00983619|19309164|P5|Overall Study|Other|0
5588027|NCT00983619|19309165|P4|Overall Study|Other|1
5588028|NCT00983619|19309166|P3|Overall Study|Other|0
5588029|NCT00983619|19309167|P2|Overall Study|Other|0
5588030|NCT00983619|19309168|P1|Overall Study|Other|1
5588031|NCT00983619|19309157|P12|Overall Study|Death|8
5588032|NCT00983619|19309158|P11|Overall Study|Death|9
5588033|NCT00983619|19309159|P10|Overall Study|Death|2
5588034|NCT00983619|19309160|P9|Overall Study|Death|1
5588035|NCT00983619|19309161|P8|Overall Study|Death|0
5588036|NCT00983619|19309162|P7|Overall Study|Death|1
5588037|NCT00983619|19309163|P6|Overall Study|Death|30
5588038|NCT00983619|19309164|P5|Overall Study|Death|2
5588039|NCT00983619|19309165|P4|Overall Study|Death|1
5588040|NCT00983619|19309166|P3|Overall Study|Death|2
5588041|NCT00983619|19309167|P2|Overall Study|Death|2
5588042|NCT00983619|19309168|P1|Overall Study|Death|0
5588043|NCT00983619|19309157|P12|Overall Study|Withdrawal by Subject|1
5588044|NCT00983619|19309158|P11|Overall Study|Withdrawal by Subject|1
5588045|NCT00983619|19309159|P10|Overall Study|Withdrawal by Subject|0
5588046|NCT00983619|19309160|P9|Overall Study|Withdrawal by Subject|0
5588047|NCT00983619|19309161|P8|Overall Study|Withdrawal by Subject|0
5588048|NCT00983619|19309162|P7|Overall Study|Withdrawal by Subject|0
5588049|NCT00983619|19309163|P6|Overall Study|Withdrawal by Subject|23
5588050|NCT00983619|19309164|P5|Overall Study|Withdrawal by Subject|1
5588051|NCT00983619|19309165|P4|Overall Study|Withdrawal by Subject|3
5588052|NCT00983619|19309166|P3|Overall Study|Withdrawal by Subject|1
5588053|NCT00983619|19309167|P2|Overall Study|Withdrawal by Subject|1
5588054|NCT00983619|19309168|P1|Overall Study|Withdrawal by Subject|2
5588055|NCT00983619|19309157|P12|Overall Study|Lost to Follow-up|2
5588056|NCT00983619|19309158|P11|Overall Study|Lost to Follow-up|0
5588057|NCT00983619|19309159|P10|Overall Study|Lost to Follow-up|0
5588058|NCT00983619|19309160|P9|Overall Study|Lost to Follow-up|0
5588059|NCT00983619|19309161|P8|Overall Study|Lost to Follow-up|0
5588060|NCT00983619|19309162|P7|Overall Study|Lost to Follow-up|0
5588061|NCT00983619|19309163|P6|Overall Study|Lost to Follow-up|2
5588062|NCT00983619|19309164|P5|Overall Study|Lost to Follow-up|0
5588063|NCT00983619|19309165|P4|Overall Study|Lost to Follow-up|0
5588064|NCT00983619|19309166|P3|Overall Study|Lost to Follow-up|0
5588065|NCT00983619|19309167|P2|Overall Study|Lost to Follow-up|1
5588066|NCT00983619|19309168|P1|Overall Study|Lost to Follow-up|0
5588067|NCT00983580|19309473|P2|Overall Study|Ineligible|0
5588068|NCT00983580|19309474|P1|Overall Study|Ineligible|3
5588069|NCT00983580|19309473|P2|Overall Study|Protocol Violation|1
5588070|NCT00983580|19309474|P1|Overall Study|Protocol Violation|1
5588071|NCT00983580|19309473|P2|Overall Study|Cancel Prior to treatment|3
5588072|NCT00983580|19309474|P1|Overall Study|Cancel Prior to treatment|1
5588073|NCT00983528|19309500|P1|Overall Study|Study Terminated|1
5588074|NCT00983528|19309500|P1|Overall Study|Lost to Follow-up|1
5588075|NCT00983528|19309500|P1|Overall Study|Death|4
5588076|NCT00983515|19309505|P1|Colchicine With Ritonavir|Lost to Follow-up|1
5588077|NCT00983515|19309505|P1|Ritonavir Alone|liver panel out of range|6
5588078|NCT00983476|19309532|P3|Overall Study|Did not receive intervention|0
5588079|NCT00983476|19309533|P2|Overall Study|Did not receive intervention|22
5588080|NCT00983476|19309534|P1|Overall Study|Did not receive intervention|17
5588081|NCT00983437|19309566|P1|Overall Study|Other Reason|26
5588082|NCT00983437|19309566|P1|Overall Study|Lost to Follow-up|2
5588083|NCT00983437|19309566|P1|Overall Study|Noncompliance to Study Procedures|1
5588084|NCT00983437|19309566|P1|Overall Study|Withdrawal by Subject|8
5588085|NCT00983437|19309566|P1|Overall Study|Lack of Efficacy|1
5588086|NCT00983437|19309566|P1|Overall Study|Adverse Event|9
5588087|NCT00983385|19309585|P1|Observation Period|Not Evaluable due to Non Compliance|12
5588088|NCT00983385|19309585|P1|Observation Period|Not eligible to be dosed|20
5588089|NCT00983372|19309630|P1|Diltiazem ER Alone|Adverse Event|1
5588090|NCT00983372|19309630|P1|Diltiazem ER Alone|missed diltiazem dose|2
5588091|NCT00983372|19309630|P1|14 Day Washout Period|Withdrawal by Subject|1
5588092|NCT00983294|19309657|P1|Colchicine With Azithromycin|Adverse Event|1
5588093|NCT00983294|19309657|P1|14 Day Washout Period|Withdrawal by Subject|2
5588094|NCT00983073|19309699|P1|Maintenance Period|Other Reason|7
5588095|NCT00983073|19309699|P1|Maintenance Period|Lack of Efficacy|2
5588096|NCT00983073|19309699|P1|Maintenance Period|Withdrawal by Subject|2
5588097|NCT00983073|19309699|P1|Maintenance Period|Adverse Event|5
5588098|NCT00983073|19309699|P1|Titration and Optimal Dose Period|Other reason|4
5588099|NCT00983073|19309699|P1|Titration and Optimal Dose Period|Non-Compliance|1
5588100|NCT00983073|19309699|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
5588101|NCT00983073|19309699|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
5588102|NCT00983073|19309699|P1|Titration and Optimal Dose Period|Adverse Event|19
5588103|NCT00982878|19309725|P1|Overall Study|Physician Decision|1
5588104|NCT00982735|19310023|P1|Overall Study|Patient ineligible for trial|224
5588105|NCT00982735|19310023|P1|Overall Study|Lost to Follow-up|6
5588106|NCT00982657|19310033|P4|Overall Study|On going at date of cut-off|1
5588107|NCT00982657|19310034|P3|Overall Study|On going at date of cut-off|0
5588108|NCT00982657|19310035|P2|Overall Study|On going at date of cut-off|0
5588109|NCT00982657|19310036|P1|Overall Study|On going at date of cut-off|0
5588110|NCT00982657|19310033|P4|Overall Study|Other|4
5588111|NCT00982657|19310034|P3|Overall Study|Other|0
5588112|NCT00982657|19310035|P2|Overall Study|Other|0
5588113|NCT00982657|19310036|P1|Overall Study|Other|0
5588114|NCT00982657|19310033|P4|Overall Study|Withdrawal by Subject|3
5588115|NCT00982657|19310034|P3|Overall Study|Withdrawal by Subject|1
5588116|NCT00982657|19310035|P2|Overall Study|Withdrawal by Subject|0
5588117|NCT00982657|19310036|P1|Overall Study|Withdrawal by Subject|0
5588118|NCT00982657|19310033|P4|Overall Study|Death|1
5588119|NCT00982657|19310034|P3|Overall Study|Death|1
5588120|NCT00982657|19310035|P2|Overall Study|Death|0
5588121|NCT00982657|19310036|P1|Overall Study|Death|1
5588122|NCT00982644|19310077|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
5588123|NCT00982644|19310078|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
5588124|NCT00982644|19310077|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
5588125|NCT00982644|19310078|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
5588126|NCT00982644|19310077|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
5588127|NCT00982644|19310078|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
5588128|NCT00982644|19310077|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
5588129|NCT00982644|19310078|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
5588130|NCT00982644|19310077|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
5588131|NCT00982644|19310078|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
5588132|NCT00982644|19310077|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
5588133|NCT00982644|19310078|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
5588134|NCT00982644|19310077|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
5588135|NCT00982644|19310078|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
5588136|NCT00982644|19310077|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
5588137|NCT00982644|19310078|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
5588138|NCT00982644|19310077|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
5588139|NCT00982644|19310078|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
5588140|NCT00982644|19310077|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
5588141|NCT00982644|19310078|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
5588142|NCT00982488|19310133|P5|Overall Study|Withdrawal by Subject|0
5588143|NCT00982488|19310134|P4|Overall Study|Withdrawal by Subject|0
5588144|NCT00982488|19310135|P3|Overall Study|Withdrawal by Subject|1
5588145|NCT00982488|19310136|P2|Overall Study|Withdrawal by Subject|1
5588146|NCT00982488|19310137|P1|Overall Study|Withdrawal by Subject|5
5588147|NCT00982488|19310133|P5|Overall Study|Study drug toxicity|0
5588148|NCT00982488|19310134|P4|Overall Study|Study drug toxicity|0
5588149|NCT00982488|19310135|P3|Overall Study|Study drug toxicity|6
5588150|NCT00982488|19310136|P2|Overall Study|Study drug toxicity|1
5588151|NCT00982488|19310137|P1|Overall Study|Study drug toxicity|34
5588152|NCT00982488|19310133|P5|Overall Study|Stem cell transplant|0
5588153|NCT00982488|19310134|P4|Overall Study|Stem cell transplant|1
5588154|NCT00982488|19310135|P3|Overall Study|Stem cell transplant|0
5588155|NCT00982488|19310136|P2|Overall Study|Stem cell transplant|0
5588156|NCT00982488|19310137|P1|Overall Study|Stem cell transplant|2
5588157|NCT00982488|19310133|P5|Overall Study|Poor compliance/noncompliance|0
5588158|NCT00982488|19310134|P4|Overall Study|Poor compliance/noncompliance|0
5588159|NCT00982488|19310135|P3|Overall Study|Poor compliance/noncompliance|0
5588160|NCT00982488|19310136|P2|Overall Study|Poor compliance/noncompliance|1
5588161|NCT00982488|19310137|P1|Overall Study|Poor compliance/noncompliance|0
5588162|NCT00982488|19310133|P5|Overall Study|Other|0
5588163|NCT00982488|19310134|P4|Overall Study|Other|1
5588164|NCT00982488|19310135|P3|Overall Study|Other|3
5588165|NCT00982488|19310136|P2|Overall Study|Other|1
5588166|NCT00982488|19310137|P1|Overall Study|Other|15
5588167|NCT00982488|19310133|P5|Overall Study|Maximum clinical benefit|0
5588168|NCT00982488|19310134|P4|Overall Study|Maximum clinical benefit|0
5588169|NCT00982488|19310135|P3|Overall Study|Maximum clinical benefit|1
5588170|NCT00982488|19310136|P2|Overall Study|Maximum clinical benefit|1
5588171|NCT00982488|19310137|P1|Overall Study|Maximum clinical benefit|1
5588172|NCT00982488|19310133|P5|Overall Study|Lost to Follow-up|0
5588173|NCT00982488|19310134|P4|Overall Study|Lost to Follow-up|0
5588174|NCT00982488|19310135|P3|Overall Study|Lost to Follow-up|0
5588175|NCT00982488|19310136|P2|Overall Study|Lost to Follow-up|0
5588176|NCT00982488|19310137|P1|Overall Study|Lost to Follow-up|1
5588177|NCT00982488|19310133|P5|Overall Study|Disease progression|1
5588178|NCT00982488|19310134|P4|Overall Study|Disease progression|1
5588179|NCT00982488|19310135|P3|Overall Study|Disease progression|10
5588180|NCT00982488|19310136|P2|Overall Study|Disease progression|5
5588181|NCT00982488|19310137|P1|Overall Study|Disease progression|30
5588182|NCT00982488|19310133|P5|Overall Study|Death|0
5588183|NCT00982488|19310134|P4|Overall Study|Death|0
5588184|NCT00982488|19310135|P3|Overall Study|Death|2
5588185|NCT00982488|19310136|P2|Overall Study|Death|0
5588186|NCT00982488|19310137|P1|Overall Study|Death|11
5588187|NCT00982488|19310133|P5|Overall Study|Adverse event unrelated to study drug|0
5588188|NCT00982488|19310134|P4|Overall Study|Adverse event unrelated to study drug|0
5588189|NCT00982488|19310135|P3|Overall Study|Adverse event unrelated to study drug|0
5588190|NCT00982488|19310136|P2|Overall Study|Adverse event unrelated to study drug|1
5588191|NCT00982488|19310137|P1|Overall Study|Adverse event unrelated to study drug|5
5588192|NCT00982488|19310133|P5|Overall Study|Administrative reason by sponsor|0
5588193|NCT00982488|19310134|P4|Overall Study|Administrative reason by sponsor|0
5588194|NCT00982488|19310135|P3|Overall Study|Administrative reason by sponsor|11
5588195|NCT00982488|19310136|P2|Overall Study|Administrative reason by sponsor|3
5588196|NCT00982488|19310137|P1|Overall Study|Administrative reason by sponsor|81
5588197|NCT00982410|19310170|P2|12-month Follow-up Assessment|scheduled, no-show|0
5588198|NCT00982410|19310171|P1|12-month Follow-up Assessment|scheduled, no-show|1
5588199|NCT00982410|19310170|P2|12-month Follow-up Assessment|incarceration|1
5588200|NCT00982410|19310171|P1|12-month Follow-up Assessment|incarceration|2
5588201|NCT00982410|19310170|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
5588202|NCT00982410|19310171|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
5588203|NCT00982410|19310170|P2|12-month Follow-up Assessment|could not reach to schedule|5
5588204|NCT00982410|19310171|P1|12-month Follow-up Assessment|could not reach to schedule|6
5588205|NCT00982410|19310170|P2|12-month Follow-up Assessment|Death|2
5588206|NCT00982410|19310171|P1|12-month Follow-up Assessment|Death|0
5588207|NCT00982410|19310170|P2|6-month Follow-up Assessment|scheduled, no-show|1
5588208|NCT00982410|19310171|P1|6-month Follow-up Assessment|scheduled, no-show|0
5588209|NCT00982410|19310170|P2|6-month Follow-up Assessment|patent surgery|1
5588210|NCT00982410|19310171|P1|6-month Follow-up Assessment|patent surgery|0
5588211|NCT00982410|19310170|P2|6-month Follow-up Assessment|incarceration|2
5588212|NCT00982410|19310171|P1|6-month Follow-up Assessment|incarceration|0
5588213|NCT00982410|19310170|P2|6-month Follow-up Assessment|participant no transportation|0
5588214|NCT00982410|19310171|P1|6-month Follow-up Assessment|participant no transportation|1
5588215|NCT00982410|19310170|P2|6-month Follow-up Assessment|Could not reach to schedule|7
5588216|NCT00982410|19310171|P1|6-month Follow-up Assessment|Could not reach to schedule|5
5588217|NCT00982410|19310170|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
5588218|NCT00982410|19310171|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
5588219|NCT00982410|19310170|P2|3-month Follow-up Assessment|Scheduled, no-show|2
5588220|NCT00982410|19310171|P1|3-month Follow-up Assessment|Scheduled, no-show|1
5588221|NCT00982410|19310170|P2|3-month Follow-up Assessment|Could not reach to schedule|9
5588222|NCT00982410|19310171|P1|3-month Follow-up Assessment|Could not reach to schedule|8
5588223|NCT00982319|19310212|P2|Overall Study|Pregnancy|1
5588224|NCT00982319|19310213|P1|Overall Study|Pregnancy|0
5588225|NCT00982319|19310212|P2|Overall Study|Preop values out of acceptable range|1
5588226|NCT00982319|19310213|P1|Overall Study|Preop values out of acceptable range|1
5588227|NCT00982319|19310212|P2|Overall Study|Surgery date change|0
5588228|NCT00982319|19310213|P1|Overall Study|Surgery date change|1
5588229|NCT00982280|19310221|P1|Maintenance Period|Adverse Event|1
5588230|NCT00982280|19310221|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
5588231|NCT00982280|19310221|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
5588232|NCT00982280|19310221|P1|Titration and Optimal Dose Period|Adverse Event|5
5588233|NCT00982280|19310221|P1|Observation Period|Not eligible to be dosed|19
5588234|NCT00982228|19310246|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
5588235|NCT00982228|19310247|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
5588236|NCT00982228|19310246|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
5588237|NCT00982228|19310247|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
5588238|NCT00982228|19310246|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
5588239|NCT00982228|19310247|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
5588240|NCT00982228|19310246|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
5588241|NCT00982228|19310247|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
5588242|NCT00982228|19310246|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
5588243|NCT00982228|19310247|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
5588244|NCT00982228|19310246|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
5588245|NCT00982228|19310247|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
5588246|NCT00982228|19310246|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
5588247|NCT00982228|19310247|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
5588248|NCT00982228|19310246|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
5588249|NCT00982228|19310247|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
5588250|NCT00982228|19310246|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
5588251|NCT00982228|19310247|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
5588252|NCT00982228|19310246|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
5588253|NCT00982228|19310247|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
5588254|NCT00982137|19310306|P4|Overall Study|Withdrawal by Subject|0
5588255|NCT00982137|19310307|P3|Overall Study|Withdrawal by Subject|0
5588256|NCT00982137|19310308|P2|Overall Study|Withdrawal by Subject|1
5588257|NCT00982137|19310309|P1|Overall Study|Withdrawal by Subject|0
5588258|NCT00982137|19310306|P4|Overall Study|Lost to Follow-up|1
5588259|NCT00982137|19310307|P3|Overall Study|Lost to Follow-up|0
5588260|NCT00982137|19310308|P2|Overall Study|Lost to Follow-up|0
5588261|NCT00982137|19310309|P1|Overall Study|Lost to Follow-up|0
5588262|NCT00982111|19310341|P2|Overall Study|Withdrawal by Subject|17
5588263|NCT00982111|19310342|P1|Overall Study|Withdrawal by Subject|16
5588264|NCT00982111|19310341|P2|Overall Study|On Study Treatment at Conclusion|0
5588265|NCT00982111|19310342|P1|Overall Study|On Study Treatment at Conclusion|7
5588266|NCT00982111|19310341|P2|Overall Study|New Anti-Cancer Therapy|5
5588267|NCT00982111|19310342|P1|Overall Study|New Anti-Cancer Therapy|5
5588268|NCT00982111|19310341|P2|Overall Study|Lost to Follow-up|6
5588269|NCT00982111|19310342|P1|Overall Study|Lost to Follow-up|9
5588270|NCT00982111|19310341|P2|Overall Study|Progressive Disease|37
5588271|NCT00982111|19310342|P1|Overall Study|Progressive Disease|37
5588272|NCT00982111|19310341|P2|Overall Study|Adverse Event|1
5588273|NCT00982111|19310342|P1|Overall Study|Adverse Event|1
5588274|NCT00982020|19310375|P2|Overall Study|Clinical Relapse|1
5588275|NCT00982020|19310376|P1|Overall Study|Clinical Relapse|0
5588276|NCT00982020|19310375|P2|Overall Study|Protocol Violation|2
5588277|NCT00982020|19310376|P1|Overall Study|Protocol Violation|0
5588278|NCT00982020|19310375|P2|Overall Study|Entry Criteria Not Met|1
5588279|NCT00982020|19310376|P1|Overall Study|Entry Criteria Not Met|2
5588280|NCT00982020|19310375|P2|Overall Study|Physician Decision|5
5588281|NCT00982020|19310376|P1|Overall Study|Physician Decision|2
5588282|NCT00982020|19310375|P2|Overall Study|Treatment Non-compliance|6
5588283|NCT00982020|19310376|P1|Overall Study|Treatment Non-compliance|3
5588284|NCT00982020|19310375|P2|Overall Study|Parent/Caregiver Decision|5
5588285|NCT00982020|19310376|P1|Overall Study|Parent/Caregiver Decision|5
5588286|NCT00982020|19310375|P2|Overall Study|Lack of Efficacy|4
5588287|NCT00982020|19310376|P1|Overall Study|Lack of Efficacy|10
5588288|NCT00982020|19310375|P2|Overall Study|Lost to Follow-up|11
5588289|NCT00982020|19310376|P1|Overall Study|Lost to Follow-up|5
5588290|NCT00982020|19310375|P2|Overall Study|Withdrawal by Subject|14
5588291|NCT00982020|19310376|P1|Overall Study|Withdrawal by Subject|11
5588292|NCT00982020|19310375|P2|Overall Study|Adverse Event|15
5588293|NCT00982020|19310376|P1|Overall Study|Adverse Event|19
5588294|NCT00981799|19310430|P4|Overall Study|Adverse Event|0
5588295|NCT00981799|19310431|P3|Overall Study|Adverse Event|0
5588296|NCT00981799|19310432|P2|Overall Study|Adverse Event|1
5588297|NCT00981799|19310433|P1|Overall Study|Adverse Event|1
5588298|NCT00981747|19310447|P1|Placebo Oral Tablet|Withdrawal by Subject|1
5588299|NCT00981747|19310447|P1|Losartan|Death|1
5588300|NCT00981747|19310447|P1|Losartan|Withdrawal by Subject|1
5588301|NCT00981578|19310513|P1|Overall Study|Withdrawal by Subject|2
5588302|NCT00981578|19310513|P1|Overall Study|Death|1
5588303|NCT00981526|19310521|P2|Overall Study|Physician Decision|4
5588304|NCT00981526|19310522|P1|Overall Study|Physician Decision|4
5588305|NCT00981526|19310521|P2|Overall Study|Withdrawal by Subject|2
5588306|NCT00981526|19310522|P1|Overall Study|Withdrawal by Subject|0
5588307|NCT00981461|19310540|P2|Overall Study|Lost to Follow-up|2
5588308|NCT00981461|19310541|P1|Overall Study|Lost to Follow-up|5
5588309|NCT00981409|19310565|P2|Overall Study|Prostate Cancer Treatment before Trial|0
5588310|NCT00981409|19310566|P1|Overall Study|Prostate Cancer Treatment before Trial|2
5588311|NCT00981409|19310565|P2|Overall Study|Protocol Violation|1
5588312|NCT00981409|19310566|P1|Overall Study|Protocol Violation|0
5588313|NCT00981409|19310565|P2|Overall Study|Adverse Event|0
5588314|NCT00981409|19310566|P1|Overall Study|Adverse Event|4
5588315|NCT00981292|19310605|P6|Day 3|Protocol Violation|1
5588316|NCT00981292|19310606|P5|Day 3|Protocol Violation|0
5588317|NCT00981292|19310607|P4|Day 3|Protocol Violation|0
5588318|NCT00981292|19310608|P3|Day 3|Protocol Violation|0
5588319|NCT00981292|19310609|P2|Day 3|Protocol Violation|0
5588320|NCT00981292|19310610|P1|Day 3|Protocol Violation|0
5588321|NCT00981292|19310605|P6|Day 2|Protocol Violation|0
5588322|NCT00981292|19310606|P5|Day 2|Protocol Violation|0
5588323|NCT00981292|19310607|P4|Day 2|Protocol Violation|0
5588324|NCT00981292|19310608|P3|Day 2|Protocol Violation|0
5588325|NCT00981292|19310609|P2|Day 2|Protocol Violation|0
5588326|NCT00981292|19310610|P1|Day 2|Protocol Violation|2
5588327|NCT00981292|19310605|P6|Day 1|Protocol Violation|2
5588328|NCT00981292|19310606|P5|Day 1|Protocol Violation|0
5588329|NCT00981292|19310607|P4|Day 1|Protocol Violation|0
5588330|NCT00981292|19310608|P3|Day 1|Protocol Violation|0
5588331|NCT00981292|19310609|P2|Day 1|Protocol Violation|0
5588332|NCT00981292|19310610|P1|Day 1|Protocol Violation|1
5588333|NCT00981175|19310694|P2|Booster Dose Vaccination|Lost to Follow-up|3
5588334|NCT00981175|19310695|P1|Booster Dose Vaccination|Lost to Follow-up|2
5588335|NCT00981175|19310694|P2|Primary Dose Vaccination|Lost to Follow-up|1
5588336|NCT00981175|19310695|P1|Primary Dose Vaccination|Lost to Follow-up|2
5588337|NCT00981175|19310694|P2|Primary Dose Vaccination|Protocol Violation|1
5588338|NCT00981175|19310695|P1|Primary Dose Vaccination|Protocol Violation|0
5588339|NCT00981175|19310694|P2|Primary Dose Vaccination|Adverse Event|0
5588340|NCT00981175|19310695|P1|Primary Dose Vaccination|Adverse Event|1
5588341|NCT00981149|19310720|P2|Overall Study|Withdrawal by Subject|1
5588342|NCT00981149|19310721|P1|Overall Study|Withdrawal by Subject|1
5588343|NCT00981149|19310720|P2|Overall Study|Lost to Follow-up|2
5588344|NCT00981149|19310721|P1|Overall Study|Lost to Follow-up|1
5588345|NCT00981084|19310731|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
5588346|NCT00981084|19310732|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
5588347|NCT00981084|19310731|P2|Post Intervention (Data Analysis)|poor effort|1
5588348|NCT00981084|19310732|P1|Post Intervention (Data Analysis)|poor effort|1
5588349|NCT00981058|19310748|P2|Overall Study|On study treatment at conclusion|0
5588350|NCT00981058|19310749|P1|Overall Study|On study treatment at conclusion|9
5588351|NCT00981058|19310748|P2|Overall Study|Withdrawal by Subject|23
5588352|NCT00981058|19310749|P1|Overall Study|Withdrawal by Subject|25
5588353|NCT00981058|19310748|P2|Overall Study|Randomization Error|2
5588354|NCT00981058|19310749|P1|Overall Study|Randomization Error|1
5588355|NCT00981058|19310748|P2|Overall Study|Radiologist Error|1
5588356|NCT00981058|19310749|P1|Overall Study|Radiologist Error|0
5588357|NCT00981058|19310748|P2|Overall Study|Noncompliance|0
5588358|NCT00981058|19310749|P1|Overall Study|Noncompliance|1
5588359|NCT00981058|19310748|P2|Overall Study|New Anticancer Therapy|6
5588360|NCT00981058|19310749|P1|Overall Study|New Anticancer Therapy|6
5588361|NCT00981058|19310748|P2|Overall Study|Lost to Follow-up|15
5588362|NCT00981058|19310749|P1|Overall Study|Lost to Follow-up|16
5588363|NCT00981058|19310748|P2|Overall Study|Progressive Disease|49
5588364|NCT00981058|19310749|P1|Overall Study|Progressive Disease|61
5588365|NCT00981058|19310748|P2|Overall Study|Adverse Event|1
5588366|NCT00981058|19310749|P1|Overall Study|Adverse Event|1
5588367|NCT00981019|19310780|P1|Overall Study|Hit the survey after closure|79
5588368|NCT00981019|19310780|P1|Overall Study|Inadvertent exclusion|239
5588369|NCT00981019|19310780|P1|Overall Study|Did not match target population|94
5588370|NCT00981019|19310780|P1|Overall Study|Did not respond|65
5588371|NCT00980980|19310787|P3|Overall Study|Withdrawal by Hospital|0
5588372|NCT00980980|19310788|P2|Overall Study|Withdrawal by Hospital|1
5588373|NCT00980980|19310789|P1|Overall Study|Withdrawal by Hospital|0
5588374|NCT00980798|19310820|P2|Overall Study|Other|1
5588375|NCT00980798|19310821|P1|Overall Study|Other|0
5588376|NCT00980798|19310820|P2|Overall Study|Withdrawal by Subject|11
5588377|NCT00980798|19310821|P1|Overall Study|Withdrawal by Subject|8
5588378|NCT00980798|19310820|P2|Overall Study|Physician Decision|1
5588379|NCT00980798|19310821|P1|Overall Study|Physician Decision|2
5588380|NCT00980798|19310820|P2|Overall Study|Lost to Follow-up|1
5588381|NCT00980798|19310821|P1|Overall Study|Lost to Follow-up|0
5588382|NCT00980798|19310820|P2|Overall Study|Lack of Efficacy|5
5588383|NCT00980798|19310821|P1|Overall Study|Lack of Efficacy|16
5588384|NCT00980798|19310820|P2|Overall Study|Adverse Event|36
5588385|NCT00980798|19310821|P1|Overall Study|Adverse Event|7
5588386|NCT00980655|19310877|P2|Overall Study|Other|1
5588387|NCT00980655|19310878|P1|Overall Study|Other|0
5588388|NCT00980655|19310877|P2|Overall Study|Parent/legal guardian request|0
5588389|NCT00980655|19310878|P1|Overall Study|Parent/legal guardian request|1
5588390|NCT00980655|19310877|P2|Overall Study|Lost to Follow-up|1
5588391|NCT00980655|19310878|P1|Overall Study|Lost to Follow-up|0
5588392|NCT00980655|19310877|P2|Overall Study|Withdrawal by Subject|4
5588393|NCT00980655|19310878|P1|Overall Study|Withdrawal by Subject|0
5588394|NCT00980655|19310877|P2|Overall Study|Protocol Violation|7
5588395|NCT00980655|19310878|P1|Overall Study|Protocol Violation|2
5588396|NCT00980655|19310877|P2|Overall Study|Death|7
5588397|NCT00980655|19310878|P1|Overall Study|Death|0
5588398|NCT00980655|19310877|P2|Overall Study|Adverse Event|31
5588399|NCT00980655|19310878|P1|Overall Study|Adverse Event|13
5588400|NCT00980343|19310961|P2|Overall Study|no tumor at surgery - treatment effect|3
5588401|NCT00980343|19310962|P1|Overall Study|no tumor at surgery - treatment effect|1
5588402|NCT00980330|19310986|P7|Overall Study|(not specified)|0
5588403|NCT00980330|19310987|P6|Overall Study|(not specified)|1
5588404|NCT00980330|19310988|P5|Overall Study|(not specified)|1
5588405|NCT00980330|19310989|P4|Overall Study|(not specified)|1
5588406|NCT00980330|19310990|P3|Overall Study|(not specified)|0
5588407|NCT00980330|19310991|P2|Overall Study|(not specified)|0
5588408|NCT00980330|19310992|P1|Overall Study|(not specified)|2
5588409|NCT00980330|19310986|P7|Overall Study|Withdrawal by Subject|5
5588410|NCT00980330|19310987|P6|Overall Study|Withdrawal by Subject|2
5588411|NCT00980330|19310988|P5|Overall Study|Withdrawal by Subject|3
5588412|NCT00980330|19310989|P4|Overall Study|Withdrawal by Subject|1
5588413|NCT00980330|19310990|P3|Overall Study|Withdrawal by Subject|4
5588414|NCT00980330|19310991|P2|Overall Study|Withdrawal by Subject|4
5588415|NCT00980330|19310992|P1|Overall Study|Withdrawal by Subject|2
5588416|NCT00980330|19310986|P7|Overall Study|Lost to Follow-up|2
5588417|NCT00980330|19310987|P6|Overall Study|Lost to Follow-up|1
5588418|NCT00980330|19310988|P5|Overall Study|Lost to Follow-up|1
5588419|NCT00980330|19310989|P4|Overall Study|Lost to Follow-up|2
5588420|NCT00980330|19310990|P3|Overall Study|Lost to Follow-up|4
5588421|NCT00980330|19310991|P2|Overall Study|Lost to Follow-up|1
5588422|NCT00980330|19310992|P1|Overall Study|Lost to Follow-up|1
5588423|NCT00980330|19310986|P7|Overall Study|Adverse Event|0
5588424|NCT00980330|19310987|P6|Overall Study|Adverse Event|0
5588425|NCT00980330|19310988|P5|Overall Study|Adverse Event|0
5588426|NCT00980330|19310989|P4|Overall Study|Adverse Event|1
5588427|NCT00980330|19310990|P3|Overall Study|Adverse Event|0
5588428|NCT00980330|19310991|P2|Overall Study|Adverse Event|0
5588429|NCT00980330|19310992|P1|Overall Study|Adverse Event|0
5588430|NCT00980200|19311107|P5|7-day Treatment Period 3|Lack of Efficacy|1
5588431|NCT00980200|19311108|P4|7-day Treatment Period 3|Lack of Efficacy|0
5588432|NCT00980200|19311109|P3|7-day Treatment Period 3|Lack of Efficacy|0
5588433|NCT00980200|19311110|P2|7-day Treatment Period 3|Lack of Efficacy|1
5588434|NCT00980200|19311111|P1|7-day Treatment Period 3|Lack of Efficacy|0
5588435|NCT00980200|19311107|P5|7-day Treatment Period 1|Withdrawal by Subject|0
5588436|NCT00980200|19311108|P4|7-day Treatment Period 1|Withdrawal by Subject|0
5588437|NCT00980200|19311109|P3|7-day Treatment Period 1|Withdrawal by Subject|0
5588438|NCT00980200|19311110|P2|7-day Treatment Period 1|Withdrawal by Subject|1
5588439|NCT00980200|19311111|P1|7-day Treatment Period 1|Withdrawal by Subject|0
5588440|NCT00980174|19311130|P2|Overall Study|Other|1
5588441|NCT00980174|19311131|P1|Overall Study|Other|0
5588442|NCT00980174|19311130|P2|Overall Study|Death|1
5588443|NCT00980174|19311131|P1|Overall Study|Death|1
5588444|NCT00980174|19311130|P2|Overall Study|Ineligibility determined|1
5588445|NCT00980174|19311131|P1|Overall Study|Ineligibility determined|2
5588446|NCT00980174|19311130|P2|Overall Study|Adverse Event|3
5588447|NCT00980174|19311131|P1|Overall Study|Adverse Event|0
5588448|NCT00980174|19311130|P2|Overall Study|Withdrawal by Subject|4
5588449|NCT00980174|19311131|P1|Overall Study|Withdrawal by Subject|1
5588450|NCT00980148|19311149|P2|Overall Study|Various other reasons|9
5588451|NCT00980148|19311150|P1|Overall Study|Various other reasons|8
5588452|NCT00980148|19311149|P2|Overall Study|Negative for chlamydia at enrollment|9
5588453|NCT00980148|19311150|P1|Overall Study|Negative for chlamydia at enrollment|12
5588543|NCT00979901|19311282|P4|Overall Study|Lack of Efficacy|0
5588454|NCT00980148|19311149|P2|Overall Study|Received other antichlamydia treatment|14
5588455|NCT00980148|19311150|P1|Overall Study|Received other antichlamydia treatment|20
5588456|NCT00980148|19311149|P2|Overall Study|Discharged from facility|96
5588457|NCT00980148|19311150|P1|Overall Study|Discharged from facility|89
5588458|NCT00980057|19311158|P2|Overall Study|Withdrawal by Subject|1
5588459|NCT00980057|19311159|P1|Overall Study|Withdrawal by Subject|1
5588460|NCT00980057|19311158|P2|Overall Study|Lost to Follow-up|0
5588461|NCT00980057|19311159|P1|Overall Study|Lost to Follow-up|1
5588462|NCT00980057|19311158|P2|Overall Study|Physician Decision|0
5588463|NCT00980057|19311159|P1|Overall Study|Physician Decision|4
5588464|NCT00980057|19311158|P2|Overall Study|Adverse Event|1
5588465|NCT00980057|19311159|P1|Overall Study|Adverse Event|0
5588466|NCT00980057|19311158|P2|Overall Study|Death|3
5588467|NCT00980057|19311159|P1|Overall Study|Death|13
5588468|NCT00980044|19311182|P3|Overall Study|Protocol Violation|2
5588469|NCT00980044|19311183|P2|Overall Study|Protocol Violation|0
5588470|NCT00980044|19311184|P1|Overall Study|Protocol Violation|0
5588471|NCT00980044|19311182|P3|Overall Study|Withdrawal by Subject|3
5588472|NCT00980044|19311183|P2|Overall Study|Withdrawal by Subject|7
5588473|NCT00980044|19311184|P1|Overall Study|Withdrawal by Subject|5
5588474|NCT00980005|19311203|P2|Overall Study|Other|3
5588475|NCT00980005|19311204|P1|Overall Study|Other|4
5588476|NCT00980005|19311203|P2|Overall Study|Lost to Follow-up|43
5588477|NCT00980005|19311204|P1|Overall Study|Lost to Follow-up|37
5588478|NCT00980005|19311203|P2|Overall Study|Withdrawal by Subject|17
5588479|NCT00980005|19311204|P1|Overall Study|Withdrawal by Subject|6
5588480|NCT00979992|19311244|P1|Overall Study|Refused - Never Treated|2
5588481|NCT00979992|19311244|P1|Overall Study|Ineligible - wrong cell type|2
5588482|NCT00979992|19311244|P1|Overall Study|Ineligible - inadequate pathology|1
5588483|NCT00979953|19311256|P4|Overall Study|Protocol Violation|2
5588484|NCT00979953|19311257|P3|Overall Study|Protocol Violation|2
5588485|NCT00979953|19311258|P2|Overall Study|Protocol Violation|0
5588486|NCT00979953|19311259|P1|Overall Study|Protocol Violation|1
5588487|NCT00979953|19311256|P4|Overall Study|Withdrawal by Subject|1
5588488|NCT00979953|19311257|P3|Overall Study|Withdrawal by Subject|2
5588489|NCT00979953|19311258|P2|Overall Study|Withdrawal by Subject|0
5588490|NCT00979953|19311259|P1|Overall Study|Withdrawal by Subject|0
5588491|NCT00979953|19311256|P4|Overall Study|Lost to Follow-up|0
5588492|NCT00979953|19311257|P3|Overall Study|Lost to Follow-up|1
5588493|NCT00979953|19311258|P2|Overall Study|Lost to Follow-up|1
5588494|NCT00979953|19311259|P1|Overall Study|Lost to Follow-up|1
5588495|NCT00979953|19311256|P4|Overall Study|Lack of Efficacy|0
5588496|NCT00979953|19311257|P3|Overall Study|Lack of Efficacy|0
5588497|NCT00979953|19311258|P2|Overall Study|Lack of Efficacy|2
5588498|NCT00979953|19311259|P1|Overall Study|Lack of Efficacy|1
5588499|NCT00979953|19311256|P4|Overall Study|Adverse Event|4
5588500|NCT00979953|19311257|P3|Overall Study|Adverse Event|17
5588501|NCT00979953|19311258|P2|Overall Study|Adverse Event|2
5588502|NCT00979953|19311259|P1|Overall Study|Adverse Event|5
5588503|NCT00979901|19311282|P4|Overall Study|Treatment Group Terminated by Sponsor|112
5588504|NCT00979901|19311283|P3|Overall Study|Treatment Group Terminated by Sponsor|0
5588505|NCT00979901|19311284|P2|Overall Study|Treatment Group Terminated by Sponsor|0
5588506|NCT00979901|19311285|P1|Overall Study|Treatment Group Terminated by Sponsor|0
5588507|NCT00979901|19311282|P4|Overall Study|Left Country|0
5588508|NCT00979901|19311283|P3|Overall Study|Left Country|1
5588509|NCT00979901|19311284|P2|Overall Study|Left Country|0
5588510|NCT00979901|19311285|P1|Overall Study|Left Country|0
5588511|NCT00979901|19311282|P4|Overall Study|Discontinued in Error|0
5588512|NCT00979901|19311283|P3|Overall Study|Discontinued in Error|0
5588513|NCT00979901|19311284|P2|Overall Study|Discontinued in Error|1
5588514|NCT00979901|19311285|P1|Overall Study|Discontinued in Error|0
5588515|NCT00979901|19311282|P4|Overall Study|elevated lab values pre-randomization|0
5588516|NCT00979901|19311283|P3|Overall Study|elevated lab values pre-randomization|0
5588517|NCT00979901|19311284|P2|Overall Study|elevated lab values pre-randomization|0
5588518|NCT00979901|19311285|P1|Overall Study|elevated lab values pre-randomization|1
5588519|NCT00979901|19311282|P4|Overall Study|vacation|0
5588520|NCT00979901|19311283|P3|Overall Study|vacation|0
5588521|NCT00979901|19311284|P2|Overall Study|vacation|0
5588522|NCT00979901|19311285|P1|Overall Study|vacation|1
5588523|NCT00979901|19311282|P4|Overall Study|out-of-state|0
5588524|NCT00979901|19311283|P3|Overall Study|out-of-state|0
5588525|NCT00979901|19311284|P2|Overall Study|out-of-state|0
5588526|NCT00979901|19311285|P1|Overall Study|out-of-state|1
5588527|NCT00979901|19311282|P4|Overall Study|Noncompliance|0
5588528|NCT00979901|19311283|P3|Overall Study|Noncompliance|0
5588529|NCT00979901|19311284|P2|Overall Study|Noncompliance|0
5588530|NCT00979901|19311285|P1|Overall Study|Noncompliance|1
5588531|NCT00979901|19311282|P4|Overall Study|Withdrawal by Subject|1
5588532|NCT00979901|19311283|P3|Overall Study|Withdrawal by Subject|1
5588533|NCT00979901|19311284|P2|Overall Study|Withdrawal by Subject|1
5588534|NCT00979901|19311285|P1|Overall Study|Withdrawal by Subject|2
5588535|NCT00979901|19311282|P4|Overall Study|Protocol Violation|1
5588536|NCT00979901|19311283|P3|Overall Study|Protocol Violation|7
5588537|NCT00979901|19311284|P2|Overall Study|Protocol Violation|2
5588538|NCT00979901|19311285|P1|Overall Study|Protocol Violation|2
5588539|NCT00979901|19311282|P4|Overall Study|Lost to Follow-up|0
5588540|NCT00979901|19311283|P3|Overall Study|Lost to Follow-up|2
5588541|NCT00979901|19311284|P2|Overall Study|Lost to Follow-up|1
5588542|NCT00979901|19311285|P1|Overall Study|Lost to Follow-up|1
5588544|NCT00979901|19311283|P3|Overall Study|Lack of Efficacy|9
5588545|NCT00979901|19311284|P2|Overall Study|Lack of Efficacy|4
5588546|NCT00979901|19311285|P1|Overall Study|Lack of Efficacy|8
5588547|NCT00979901|19311282|P4|Overall Study|Adverse Event|2
5588548|NCT00979901|19311283|P3|Overall Study|Adverse Event|9
5588549|NCT00979901|19311284|P2|Overall Study|Adverse Event|3
5588550|NCT00979901|19311285|P1|Overall Study|Adverse Event|1
5588551|NCT00979654|19311365|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
5588552|NCT00979654|19311365|P1|Overall Study|Serious Adverse Event|1
5588553|NCT00979654|19311365|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
5588554|NCT00979654|19311365|P1|Overall Study|Per Principal Investigator's Discretion|1
5588555|NCT00979654|19311365|P1|Overall Study|Adverse Event of Diverticulitis|1
5588556|NCT00979654|19311365|P1|Overall Study|Adverse Event|1
5588557|NCT00979654|19311365|P1|Overall Study|Lack of Efficacy|6
5588558|NCT00979654|19311365|P1|Overall Study|Death|1
5588559|NCT00979654|19311365|P1|Overall Study|Withdrawal by Subject|22
5588560|NCT00979654|19311365|P1|Overall Study|Lost to Follow-up|1
5588561|NCT00979628|19311380|P3|Overall Study|transferred to ICU|1
5588562|NCT00979628|19311381|P2|Overall Study|transferred to ICU|2
5588563|NCT00979628|19311382|P1|Overall Study|transferred to ICU|1
5588564|NCT00979628|19311380|P3|Overall Study|received steroids|0
5588565|NCT00979628|19311381|P2|Overall Study|received steroids|1
5588566|NCT00979628|19311382|P1|Overall Study|received steroids|1
5588567|NCT00979628|19311380|P3|Overall Study|received regimen < 24 hours|5
5588568|NCT00979628|19311381|P2|Overall Study|received regimen < 24 hours|6
5588569|NCT00979628|19311382|P1|Overall Study|received regimen < 24 hours|7
5588570|NCT00979602|19311412|P2|Overall Study|Others|3
5588571|NCT00979602|19311413|P1|Overall Study|Others|3
5588572|NCT00979602|19311412|P2|Overall Study|Migrated/moved from study area|6
5588573|NCT00979602|19311413|P1|Overall Study|Migrated/moved from study area|3
5588574|NCT00979602|19311412|P2|Overall Study|Lost to Follow-up|96
5588575|NCT00979602|19311413|P1|Overall Study|Lost to Follow-up|100
5588576|NCT00979602|19311412|P2|Overall Study|Withdrawal by Subject|25
5588577|NCT00979602|19311413|P1|Overall Study|Withdrawal by Subject|31
5588578|NCT00979602|19311412|P2|Overall Study|Protocol Violation|0
5588579|NCT00979602|19311413|P1|Overall Study|Protocol Violation|3
5588580|NCT00979602|19311412|P2|Overall Study|Serious Adverse Event|3
5588581|NCT00979602|19311413|P1|Overall Study|Serious Adverse Event|5
5588582|NCT00979576|19311584|P3|Combination Followed by Monotherapy|Progressive Disease|1
5588583|NCT00979576|19311585|P2|Combination Followed by Monotherapy|Progressive Disease|2
5588584|NCT00979576|19311586|P1|Combination Followed by Monotherapy|Progressive Disease|0
5588585|NCT00979576|19311584|P3|Combination Treatment Phase|Adverse Event|2
5588586|NCT00979576|19311585|P2|Combination Treatment Phase|Adverse Event|2
5588587|NCT00979576|19311586|P1|Combination Treatment Phase|Adverse Event|0
5588588|NCT00979576|19311584|P3|Combination Treatment Phase|Dose limiting toxicity|2
5588589|NCT00979576|19311585|P2|Combination Treatment Phase|Dose limiting toxicity|3
5588590|NCT00979576|19311586|P1|Combination Treatment Phase|Dose limiting toxicity|0
5588591|NCT00979576|19311584|P3|Combination Treatment Phase|Progressive disease|5
5588592|NCT00979576|19311585|P2|Combination Treatment Phase|Progressive disease|1
5588593|NCT00979576|19311586|P1|Combination Treatment Phase|Progressive disease|3
5588594|NCT00979420|19311643|P4|Overall Study|Other reasons not related to Viramune|1
5588595|NCT00979420|19311644|P3|Overall Study|Other reasons not related to Viramune|0
5588596|NCT00979420|19311645|P2|Overall Study|Other reasons not related to Viramune|0
5588597|NCT00979420|19311646|P1|Overall Study|Other reasons not related to Viramune|3
5588598|NCT00979420|19311643|P4|Overall Study|Lack of Efficacy|1
5588599|NCT00979420|19311644|P3|Overall Study|Lack of Efficacy|1
5588600|NCT00979420|19311645|P2|Overall Study|Lack of Efficacy|0
5588601|NCT00979420|19311646|P1|Overall Study|Lack of Efficacy|3
5588602|NCT00979420|19311643|P4|Overall Study|Adverse Event|0
5588603|NCT00979420|19311644|P3|Overall Study|Adverse Event|0
5588604|NCT00979420|19311645|P2|Overall Study|Adverse Event|0
5588605|NCT00979420|19311646|P1|Overall Study|Adverse Event|1
5588606|NCT00979407|19311716|P2|Overall Study|Lost to Follow-up|3
5588607|NCT00979407|19311717|P1|Overall Study|Lost to Follow-up|3
5588608|NCT00979407|19311716|P2|Overall Study|Withdrawal by Subject|4
5588609|NCT00979407|19311717|P1|Overall Study|Withdrawal by Subject|3
5588610|NCT00979212|19311770|P2|Overall Study|No protocol therapy received|0
5588611|NCT00979212|19311771|P1|Overall Study|No protocol therapy received|1
5588612|NCT00979212|19311770|P2|Overall Study|Protocol Violation|8
5588613|NCT00979212|19311771|P1|Overall Study|Protocol Violation|1
5588614|NCT00979134|19311808|P3|Overall Study|Other|5
5588615|NCT00979134|19311809|P2|Overall Study|Other|1
5588616|NCT00979134|19311810|P1|Overall Study|Other|8
5588617|NCT00979134|19311808|P3|Overall Study|Death|26
5588618|NCT00979134|19311809|P2|Overall Study|Death|0
5588619|NCT00979134|19311810|P1|Overall Study|Death|4
5588620|NCT00979134|19311808|P3|Overall Study|Lost to Follow-up|0
5588621|NCT00979134|19311809|P2|Overall Study|Lost to Follow-up|2
5588622|NCT00979134|19311810|P1|Overall Study|Lost to Follow-up|2
5588623|NCT00979134|19311808|P3|Overall Study|Withdrawal by Subject|2
5588624|NCT00979134|19311809|P2|Overall Study|Withdrawal by Subject|1
5588625|NCT00979134|19311810|P1|Overall Study|Withdrawal by Subject|1
5588626|NCT00979134|19311808|P3|Overall Study|Adverse Event|2
5588627|NCT00979134|19311809|P2|Overall Study|Adverse Event|0
5588628|NCT00979134|19311810|P1|Overall Study|Adverse Event|0
5588629|NCT00979134|19311808|P3|Overall Study|Disease progression|5
5588630|NCT00979134|19311809|P2|Overall Study|Disease progression|2
5588631|NCT00979134|19311810|P1|Overall Study|Disease progression|18
5588632|NCT00978757|19311898|P2|Overall Study|Physician Decision|3
5588633|NCT00978757|19311899|P1|Overall Study|Physician Decision|1
5588634|NCT00978731|19311909|P4|Overall Study|No response|0
5588635|NCT00978731|19311910|P3|Overall Study|No response|0
5588636|NCT00978731|19311911|P2|Overall Study|No response|0
5588637|NCT00978731|19311912|P1|Overall Study|No response|1
5588638|NCT00978731|19311909|P4|Overall Study|Study closure|1
5588639|NCT00978731|19311910|P3|Overall Study|Study closure|1
5588640|NCT00978731|19311911|P2|Overall Study|Study closure|4
5588641|NCT00978731|19311912|P1|Overall Study|Study closure|3
5588642|NCT00978731|19311909|P4|Overall Study|Disease progression/relapse|2
5588643|NCT00978731|19311910|P3|Overall Study|Disease progression/relapse|2
5588644|NCT00978731|19311911|P2|Overall Study|Disease progression/relapse|4
5588645|NCT00978731|19311912|P1|Overall Study|Disease progression/relapse|5
5588646|NCT00978731|19311909|P4|Overall Study|Deterioration without progression|0
5588647|NCT00978731|19311910|P3|Overall Study|Deterioration without progression|0
5588648|NCT00978731|19311911|P2|Overall Study|Deterioration without progression|1
5588649|NCT00978731|19311912|P1|Overall Study|Deterioration without progression|0
5588650|NCT00978731|19311909|P4|Overall Study|Administrative reason|0
5588651|NCT00978731|19311910|P3|Overall Study|Administrative reason|1
5588652|NCT00978731|19311911|P2|Overall Study|Administrative reason|3
5588653|NCT00978731|19311912|P1|Overall Study|Administrative reason|3
5588654|NCT00978731|19311909|P4|Overall Study|Participant's request|0
5588655|NCT00978731|19311910|P3|Overall Study|Participant's request|0
5588656|NCT00978731|19311911|P2|Overall Study|Participant's request|0
5588657|NCT00978731|19311912|P1|Overall Study|Participant's request|1
5588658|NCT00978731|19311909|P4|Overall Study|Adverse Event|0
5588659|NCT00978731|19311910|P3|Overall Study|Adverse Event|0
5588660|NCT00978731|19311911|P2|Overall Study|Adverse Event|2
5588661|NCT00978731|19311912|P1|Overall Study|Adverse Event|5
5588662|NCT00978731|19311909|P4|Overall Study|Lost to Follow-up|1
5588663|NCT00978731|19311910|P3|Overall Study|Lost to Follow-up|0
5588664|NCT00978731|19311911|P2|Overall Study|Lost to Follow-up|0
5588665|NCT00978731|19311912|P1|Overall Study|Lost to Follow-up|0
5588666|NCT00978731|19311909|P4|Overall Study|Death|0
5588667|NCT00978731|19311910|P3|Overall Study|Death|1
5588668|NCT00978731|19311911|P2|Overall Study|Death|1
5588669|NCT00978731|19311912|P1|Overall Study|Death|4
5588670|NCT00978627|19311952|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
5588671|NCT00978627|19311953|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
5588672|NCT00978627|19311952|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
5588673|NCT00978627|19311953|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
5588674|NCT00978627|19311952|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
5588675|NCT00978627|19311953|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
5588676|NCT00978627|19311952|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
5588677|NCT00978627|19311953|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
5588678|NCT00978627|19311952|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
5588679|NCT00978627|19311953|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
5588680|NCT00978627|19311952|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
5588681|NCT00978627|19311953|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
5588682|NCT00978627|19311952|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
5588683|NCT00978627|19311953|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
5588684|NCT00978627|19311952|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
5588685|NCT00978627|19311953|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
5588686|NCT00978627|19311952|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
5588687|NCT00978627|19311953|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
5588688|NCT00978432|19311991|P3|Overall Study|Adverse Event|1
5588689|NCT00978432|19311992|P2|Overall Study|Adverse Event|0
5588690|NCT00978432|19311993|P1|Overall Study|Adverse Event|2
5588691|NCT00978432|19311991|P3|Overall Study|Lack of Efficacy|3
5588692|NCT00978432|19311992|P2|Overall Study|Lack of Efficacy|1
5588693|NCT00978432|19311993|P1|Overall Study|Lack of Efficacy|1
5588694|NCT00978432|19311991|P3|Overall Study|Withdrawal by Subject|1
5588695|NCT00978432|19311992|P2|Overall Study|Withdrawal by Subject|0
5588696|NCT00978432|19311993|P1|Overall Study|Withdrawal by Subject|0
5588697|NCT00978380|19312044|P1|Overall Study|Unclassified|8
5588698|NCT00978380|19312044|P1|Overall Study|Withdrawal criteria|9
5588699|NCT00978380|19312044|P1|Overall Study|Protocol Violation|2
5588700|NCT00978341|19312050|P2|Washout Period of 2 Weeks|Adverse Event|0
5588701|NCT00978341|19312051|P1|Washout Period of 2 Weeks|Adverse Event|1
5588702|NCT00978250|19312073|P4|Overall Study|Late determination of ineligibility|1
5588703|NCT00978250|19312074|P3|Overall Study|Late determination of ineligibility|0
5588704|NCT00978250|19312075|P2|Overall Study|Late determination of ineligibility|1
5588705|NCT00978250|19312076|P1|Overall Study|Late determination of ineligibility|0
5588706|NCT00978120|19312092|P4|Overall Study|Moved out of state|1
5588707|NCT00978120|19312093|P3|Overall Study|Moved out of state|0
5588708|NCT00978120|19312094|P2|Overall Study|Moved out of state|0
5588709|NCT00978120|19312095|P1|Overall Study|Moved out of state|0
5588710|NCT00978120|19312092|P4|Overall Study|Withdrawal by Subject|0
5588711|NCT00978120|19312093|P3|Overall Study|Withdrawal by Subject|0
5588712|NCT00978120|19312094|P2|Overall Study|Withdrawal by Subject|0
5588713|NCT00978120|19312095|P1|Overall Study|Withdrawal by Subject|2
5588714|NCT00978120|19312092|P4|Overall Study|Lost to Follow-up|0
5588715|NCT00978120|19312093|P3|Overall Study|Lost to Follow-up|3
5588716|NCT00978120|19312094|P2|Overall Study|Lost to Follow-up|0
5588717|NCT00978120|19312095|P1|Overall Study|Lost to Follow-up|0
5588718|NCT00978120|19312092|P4|Overall Study|Death|1
5588719|NCT00978120|19312093|P3|Overall Study|Death|0
5588720|NCT00978120|19312094|P2|Overall Study|Death|0
5588721|NCT00978120|19312095|P1|Overall Study|Death|0
5588722|NCT00978068|19312147|P2|Overall Study|Unable to Comply with Study|2
5588723|NCT00978068|19312148|P1|Overall Study|Unable to Comply with Study|0
5588724|NCT00978068|19312147|P2|Overall Study|Physician Decision|1
5588725|NCT00978068|19312148|P1|Overall Study|Physician Decision|0
5588726|NCT00978068|19312147|P2|Overall Study|Lost to Follow-up|2
5588727|NCT00978068|19312148|P1|Overall Study|Lost to Follow-up|1
5588728|NCT00978068|19312147|P2|Overall Study|Death|2
5588729|NCT00978068|19312148|P1|Overall Study|Death|1
5588730|NCT00978068|19312147|P2|Overall Study|Were Awaiting Initiation of ART|2
5588731|NCT00978068|19312148|P1|Overall Study|Were Awaiting Initiation of ART|2
5588732|NCT00978042|19312166|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
5588733|NCT00978042|19312167|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
5588734|NCT00978042|19312166|P2|Initial Treatment Period|Consent withdrawn|9
5588735|NCT00978042|19312167|P1|Initial Treatment Period|Consent withdrawn|22
5588736|NCT00978042|19312166|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
5588737|NCT00978042|19312167|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
5588738|NCT00978042|19312166|P2|Initial Treatment Period|Adverse Event|0
5588739|NCT00978042|19312167|P1|Initial Treatment Period|Adverse Event|2
5588740|NCT00978042|19312166|P2|Initial Treatment Period|Lost to Follow-up|3
5588741|NCT00978042|19312167|P1|Initial Treatment Period|Lost to Follow-up|21
5588742|NCT00978042|19312166|P2|Initial Treatment Period|Ineligibility|0
5588743|NCT00978042|19312167|P1|Initial Treatment Period|Ineligibility|1
5588744|NCT00978042|19312166|P2|Initial Treatment Period|Treated in Error|3
5588745|NCT00978042|19312167|P1|Initial Treatment Period|Treated in Error|0
5588746|NCT00978029|19312180|P3|Overall Study|Protocol Violation|0
5588747|NCT00978029|19312181|P2|Overall Study|Protocol Violation|1
5588748|NCT00978029|19312182|P1|Overall Study|Protocol Violation|0
5588749|NCT00978029|19312180|P3|Overall Study|Withdrawal by Subject|1
5588750|NCT00978029|19312181|P2|Overall Study|Withdrawal by Subject|0
5588751|NCT00978029|19312182|P1|Overall Study|Withdrawal by Subject|0
5588752|NCT00978029|19312180|P3|Overall Study|Adverse Event|5
5588753|NCT00978029|19312181|P2|Overall Study|Adverse Event|2
5588754|NCT00978029|19312182|P1|Overall Study|Adverse Event|1
5588755|NCT00977938|19312209|P4|Observation (30-33 mo. Post Procedure)|Other|0
5588756|NCT00977938|19312210|P3|Observation (30-33 mo. Post Procedure)|Other|0
5588757|NCT00977938|19312211|P2|Observation (30-33 mo. Post Procedure)|Other|4
5588758|NCT00977938|19312212|P1|Observation (30-33 mo. Post Procedure)|Other|8
5588759|NCT00977938|19312209|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
5588760|NCT00977938|19312210|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
5588761|NCT00977938|19312211|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
5588762|NCT00977938|19312212|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
5588763|NCT00977938|19312209|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
5588764|NCT00977938|19312210|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
5588765|NCT00977938|19312211|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
5588766|NCT00977938|19312212|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
5588767|NCT00977938|19312209|P4|Treatment (12-30 mo. Post Procedure)|Other|4
5588768|NCT00977938|19312210|P3|Treatment (12-30 mo. Post Procedure)|Other|3
5588769|NCT00977938|19312211|P2|Treatment (12-30 mo. Post Procedure)|Other|18
5588770|NCT00977938|19312212|P1|Treatment (12-30 mo. Post Procedure)|Other|17
5588771|NCT00977938|19312209|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
5588772|NCT00977938|19312210|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
5588773|NCT00977938|19312211|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
5588774|NCT00977938|19312212|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
5588775|NCT00977938|19312209|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
5588776|NCT00977938|19312210|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
5588777|NCT00977938|19312211|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
5588778|NCT00977938|19312212|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
5588779|NCT00977665|19312289|P2|Overall Study|Treatment failure|1
5588780|NCT00977665|19312290|P1|Overall Study|Treatment failure|0
5588781|NCT00977665|19312289|P2|Overall Study|Adverse Event|7
5588782|NCT00977665|19312290|P1|Overall Study|Adverse Event|14
5588783|NCT00977665|19312289|P2|Overall Study|Death|2
5588784|NCT00977665|19312290|P1|Overall Study|Death|3
5588785|NCT00977665|19312289|P2|Overall Study|Lost to Follow-up|0
5588786|NCT00977665|19312290|P1|Overall Study|Lost to Follow-up|1
5588787|NCT00977665|19312289|P2|Overall Study|Sponsor requested withdrawal|1
5588788|NCT00977665|19312290|P1|Overall Study|Sponsor requested withdrawal|0
5588789|NCT00977665|19312289|P2|Overall Study|Physician Decision|1
5588790|NCT00977665|19312290|P1|Overall Study|Physician Decision|2
5588791|NCT00977665|19312289|P2|Overall Study|Withdrawal by Subject|3
5588792|NCT00977665|19312290|P1|Overall Study|Withdrawal by Subject|1
5588793|NCT00977613|19312322|P1|Overall Study|Lost to Follow-up|16
5588794|NCT00977574|19312329|P3|Overall Study|Never Treated|4
5588795|NCT00977574|19312330|P2|Overall Study|Never Treated|2
5588796|NCT00977574|19312331|P1|Overall Study|Never Treated|4
5588797|NCT00977561|19312350|P2|Overall Study|Other|0
5588798|NCT00977561|19312351|P1|Overall Study|Other|2
5588799|NCT00977561|19312350|P2|Overall Study|Study terminated|2
5588800|NCT00977561|19312351|P1|Overall Study|Study terminated|0
5588801|NCT00977561|19312350|P2|Overall Study|Death|2
5588802|NCT00977561|19312351|P1|Overall Study|Death|3
5588803|NCT00977548|19312378|P1|Overall Study|Withdrawal by Subject|1
5588804|NCT00977548|19312378|P1|Overall Study|Adverse Event|8
5588805|NCT00977548|19312378|P1|Overall Study|Ineligible|4
5588806|NCT00977470|19312387|P2|Overall Study|Still on-study|0
5588807|NCT00977470|19312388|P1|Overall Study|Still on-study|2
5588808|NCT00977470|19312387|P2|Overall Study|prolonged recovery post-surgery|1
5588809|NCT00977470|19312388|P1|Overall Study|prolonged recovery post-surgery|0
5588810|NCT00977470|19312387|P2|Overall Study|clinical decline|1
5588811|NCT00977470|19312388|P1|Overall Study|clinical decline|0
5588812|NCT00977470|19312387|P2|Overall Study|Death|2
5588813|NCT00977470|19312388|P1|Overall Study|Death|0
5588814|NCT00977470|19312387|P2|Overall Study|Withdrawal by Subject|2
5588815|NCT00977470|19312388|P1|Overall Study|Withdrawal by Subject|0
5588816|NCT00977470|19312387|P2|Overall Study|Protocol Violation|0
5588817|NCT00977470|19312388|P1|Overall Study|Protocol Violation|1
5588818|NCT00977470|19312387|P2|Overall Study|Adverse Event|2
5588819|NCT00977470|19312388|P1|Overall Study|Adverse Event|1
5588820|NCT00977470|19312387|P2|Overall Study|Physician Decision|0
5588821|NCT00977470|19312388|P1|Overall Study|Physician Decision|2
5588822|NCT00977470|19312387|P2|Overall Study|Lack of Efficacy|30
5588823|NCT00977470|19312388|P1|Overall Study|Lack of Efficacy|32
5588824|NCT00977431|19312411|P5|Overall Study|Progressive disease|5
5588825|NCT00977431|19312412|P4|Overall Study|Progressive disease|3
5588826|NCT00977431|19312413|P3|Overall Study|Progressive disease|1
5588827|NCT00977431|19312414|P2|Overall Study|Progressive disease|6
5588828|NCT00977431|19312415|P1|Overall Study|Progressive disease|2
5588829|NCT00977431|19312411|P5|Overall Study|Dose-limiting toxicity (DLT)|0
5588830|NCT00977431|19312412|P4|Overall Study|Dose-limiting toxicity (DLT)|0
5588831|NCT00977431|19312413|P3|Overall Study|Dose-limiting toxicity (DLT)|1
5588832|NCT00977431|19312414|P2|Overall Study|Dose-limiting toxicity (DLT)|0
5588833|NCT00977431|19312415|P1|Overall Study|Dose-limiting toxicity (DLT)|1
5588834|NCT00977431|19312411|P5|Overall Study|Adverse Event|6
5588835|NCT00977431|19312412|P4|Overall Study|Adverse Event|0
5588836|NCT00977431|19312413|P3|Overall Study|Adverse Event|4
5588837|NCT00977431|19312414|P2|Overall Study|Adverse Event|0
5588838|NCT00977431|19312415|P1|Overall Study|Adverse Event|3
5588839|NCT00977431|19312411|P5|Overall Study|Protocol Violation|0
5588840|NCT00977431|19312412|P4|Overall Study|Protocol Violation|0
5588841|NCT00977431|19312413|P3|Overall Study|Protocol Violation|1
5588842|NCT00977431|19312414|P2|Overall Study|Protocol Violation|0
5588843|NCT00977431|19312415|P1|Overall Study|Protocol Violation|0
5588844|NCT00977431|19312411|P5|Overall Study|Other than listed|2
5588845|NCT00977431|19312412|P4|Overall Study|Other than listed|0
5588846|NCT00977431|19312413|P3|Overall Study|Other than listed|0
5588847|NCT00977431|19312414|P2|Overall Study|Other than listed|0
5588848|NCT00977431|19312415|P1|Overall Study|Other than listed|1
5588849|NCT00977379|19312448|P2|Overall Study|Randomization Error|1
5588850|NCT00977379|19312449|P1|Overall Study|Randomization Error|0
5588851|NCT00977379|19312448|P2|Overall Study|Participant Moving House|1
5588852|NCT00977379|19312449|P1|Overall Study|Participant Moving House|0
5588853|NCT00977379|19312448|P2|Overall Study|Premature Study Termination|0
5588854|NCT00977379|19312449|P1|Overall Study|Premature Study Termination|4
5588855|NCT00977379|19312448|P2|Overall Study|Death|9
5588856|NCT00977379|19312449|P1|Overall Study|Death|7
5588857|NCT00977379|19312448|P2|Overall Study|Withdrawal by Subject|1
5588858|NCT00977379|19312449|P1|Overall Study|Withdrawal by Subject|1
5588859|NCT00977314|19312485|P2|Overall Study|Physician Decision|0
5588860|NCT00977314|19312486|P1|Overall Study|Physician Decision|1
5588861|NCT00977314|19312485|P2|Overall Study|Withdrawal by Subject|0
5588862|NCT00977314|19312486|P1|Overall Study|Withdrawal by Subject|1
5588863|NCT00977197|19312494|P2|Overall Study|Nonadherence|1
5588864|NCT00977197|19312495|P1|Overall Study|Nonadherence|1
5588865|NCT00977197|19312494|P2|Overall Study|Lost to Follow-up|3
5588866|NCT00977197|19312495|P1|Overall Study|Lost to Follow-up|1
5588867|NCT00977197|19312494|P2|Overall Study|Lack of Efficacy|0
5588868|NCT00977197|19312495|P1|Overall Study|Lack of Efficacy|1
5588869|NCT00977197|19312494|P2|Overall Study|Adverse Event|1
5588870|NCT00977197|19312495|P1|Overall Study|Adverse Event|3
5588871|NCT00977197|19312494|P2|Overall Study|Withdrawal by Subject|4
5588872|NCT00977197|19312495|P1|Overall Study|Withdrawal by Subject|3
5588873|NCT00977106|19312558|P2|Overall Study|Other|0
5588874|NCT00977106|19312559|P1|Overall Study|Other|1
5588875|NCT00977106|19312558|P2|Overall Study|Protocol Violation|1
5588876|NCT00977106|19312559|P1|Overall Study|Protocol Violation|0
5588877|NCT00977106|19312558|P2|Overall Study|Lack of Efficacy|2
5588878|NCT00977106|19312559|P1|Overall Study|Lack of Efficacy|2
5588879|NCT00977106|19312558|P2|Overall Study|Withdrawal by Subject|2
5588880|NCT00977106|19312559|P1|Overall Study|Withdrawal by Subject|2
5588881|NCT00977106|19312558|P2|Overall Study|Adverse Event|6
5588882|NCT00977106|19312559|P1|Overall Study|Adverse Event|5
5588883|NCT00977080|19312651|P4|Overall Study|Travel for family reasons|0
5588884|NCT00977080|19312652|P3|Overall Study|Travel for family reasons|0
5588885|NCT00977080|19312653|P2|Overall Study|Travel for family reasons|0
5588886|NCT00977080|19312654|P1|Overall Study|Travel for family reasons|1
5588887|NCT00977080|19312651|P4|Overall Study|Required kidney transplantation|1
5588888|NCT00977080|19312652|P3|Overall Study|Required kidney transplantation|3
5588889|NCT00977080|19312653|P2|Overall Study|Required kidney transplantation|3
5588890|NCT00977080|19312654|P1|Overall Study|Required kidney transplantation|1
5588891|NCT00977080|19312651|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
5588892|NCT00977080|19312652|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
5588893|NCT00977080|19312653|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
5588894|NCT00977080|19312654|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
5588895|NCT00977080|19312651|P4|Overall Study|Noncompliance|0
5588896|NCT00977080|19312652|P3|Overall Study|Noncompliance|1
5588897|NCT00977080|19312653|P2|Overall Study|Noncompliance|2
5588898|NCT00977080|19312654|P1|Overall Study|Noncompliance|0
5588899|NCT00977080|19312651|P4|Overall Study|Protocol Violation|3
5588900|NCT00977080|19312652|P3|Overall Study|Protocol Violation|4
5588901|NCT00977080|19312653|P2|Overall Study|Protocol Violation|3
5588902|NCT00977080|19312654|P1|Overall Study|Protocol Violation|7
5588903|NCT00977080|19312651|P4|Overall Study|Withdrawal by Subject|5
5588904|NCT00977080|19312652|P3|Overall Study|Withdrawal by Subject|1
5588905|NCT00977080|19312653|P2|Overall Study|Withdrawal by Subject|5
5588906|NCT00977080|19312654|P1|Overall Study|Withdrawal by Subject|1
5588907|NCT00977080|19312651|P4|Overall Study|Adverse Event|7
5588908|NCT00977080|19312652|P3|Overall Study|Adverse Event|7
5588909|NCT00977080|19312653|P2|Overall Study|Adverse Event|7
5588910|NCT00977080|19312654|P1|Overall Study|Adverse Event|2
5588911|NCT00976989|19312687|P3|Overall Study|Other|1
5588912|NCT00976989|19312688|P2|Overall Study|Other|0
5588913|NCT00976989|19312689|P1|Overall Study|Other|1
5588914|NCT00976989|19312687|P3|Overall Study|Recurrence of Disease|0
5588915|NCT00976989|19312688|P2|Overall Study|Recurrence of Disease|1
5588916|NCT00976989|19312689|P1|Overall Study|Recurrence of Disease|0
5588917|NCT00976989|19312687|P3|Overall Study|Failure to Return|0
5588918|NCT00976989|19312688|P2|Overall Study|Failure to Return|1
5588919|NCT00976989|19312689|P1|Overall Study|Failure to Return|2
5588920|NCT00976989|19312687|P3|Overall Study|Refused Treatment|5
5588921|NCT00976989|19312688|P2|Overall Study|Refused Treatment|3
5588922|NCT00976989|19312689|P1|Overall Study|Refused Treatment|4
5588923|NCT00976989|19312687|P3|Overall Study|Death|10
5588924|NCT00976989|19312688|P2|Overall Study|Death|7
5588925|NCT00976989|19312689|P1|Overall Study|Death|5
5588926|NCT00976989|19312687|P3|Overall Study|Violation of Selection Criteria at Entry|1
5588927|NCT00976989|19312688|P2|Overall Study|Violation of Selection Criteria at Entry|0
5588928|NCT00976989|19312689|P1|Overall Study|Violation of Selection Criteria at Entry|1
5588929|NCT00976950|19312730|P1|Overall Study|Events with no relationship to Aptivus|3
5588930|NCT00976950|19312730|P1|Overall Study|Adverse Event|3
5588931|NCT00976937|19312738|P2|Overall Study|Personal and Familial Reason|2
5588932|NCT00976937|19312739|P1|Overall Study|Personal and Familial Reason|2
5588933|NCT00976937|19312738|P2|Overall Study|Poor compliance to protocol|0
5588934|NCT00976937|19312739|P1|Overall Study|Poor compliance to protocol|3
5588935|NCT00976937|19312738|P2|Overall Study|Withdrawal by Subject|3
5588936|NCT00976937|19312739|P1|Overall Study|Withdrawal by Subject|5
5588937|NCT00976937|19312738|P2|Overall Study|Lost to Follow-up|1
5588938|NCT00976937|19312739|P1|Overall Study|Lost to Follow-up|2
5588939|NCT00976937|19312738|P2|Overall Study|Adverse Event|5
5588940|NCT00976937|19312739|P1|Overall Study|Adverse Event|4
5588941|NCT00976911|19312781|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
5588942|NCT00976911|19312782|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
5588943|NCT00976911|19312781|P2|Overall Study|Other|9
5588944|NCT00976911|19312782|P1|Overall Study|Other|8
5588945|NCT00976911|19312781|P2|Overall Study|Protocol Violation|0
5588946|NCT00976911|19312782|P1|Overall Study|Protocol Violation|2
5588947|NCT00976911|19312781|P2|Overall Study|Adverse Event|1
5588948|NCT00976911|19312782|P1|Overall Study|Adverse Event|0
5588949|NCT00976911|19312781|P2|Overall Study|Death|126
5588950|NCT00976911|19312782|P1|Overall Study|Death|138
5588951|NCT00976911|19312781|P2|Overall Study|Withdrawal by Subject|6
5588952|NCT00976911|19312782|P1|Overall Study|Withdrawal by Subject|4
5588953|NCT00976898|19312800|P1|Overall Study|Progressive Disease|1
5588954|NCT00976898|19312800|P1|Overall Study|Liver Transplant|1
5588955|NCT00976898|19312800|P1|Overall Study|Physician Decision|1
5588956|NCT00976898|19312800|P1|Overall Study|Adverse Event|1
5588957|NCT00976898|19312800|P1|Overall Study|Protocol Violation|1
5588958|NCT00976820|19312811|P4|Overall Study|Withdrawal by Subject|4
5588959|NCT00976820|19312812|P3|Overall Study|Withdrawal by Subject|1
5588960|NCT00976820|19312813|P2|Overall Study|Withdrawal by Subject|4
5588961|NCT00976820|19312814|P1|Overall Study|Withdrawal by Subject|2
5588962|NCT00976820|19312811|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
5588963|NCT00976820|19312812|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
5588964|NCT00976820|19312813|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
5588965|NCT00976820|19312814|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
5588966|NCT00976820|19312811|P4|Overall Study|Lost to Follow-up|3
5588967|NCT00976820|19312812|P3|Overall Study|Lost to Follow-up|2
5588968|NCT00976820|19312813|P2|Overall Study|Lost to Follow-up|16
5588969|NCT00976820|19312814|P1|Overall Study|Lost to Follow-up|5
5588970|NCT00976716|19313150|P1|Overall Study|Adverse Event|1
5588971|NCT00976703|19313168|P2|Overall Study|ineligible for study|2
5588972|NCT00976703|19313169|P1|Overall Study|ineligible for study|2
5588973|NCT00976703|19313168|P2|Overall Study|Physician Decision|1
5588974|NCT00976703|19313169|P1|Overall Study|Physician Decision|1
5588975|NCT00976677|19313183|P2|Overall Study|Unknown/Missing|0
5588976|NCT00976677|19313184|P1|Overall Study|Unknown/Missing|1
5588977|NCT00976677|19313183|P2|Overall Study|Trial unblinded|2
5588978|NCT00976677|19313184|P1|Overall Study|Trial unblinded|2
5588979|NCT00976677|19313183|P2|Overall Study|Disease progression|1
5588980|NCT00976677|19313184|P1|Overall Study|Disease progression|1
5588981|NCT00976677|19313183|P2|Overall Study|Withdrawal by Subject|2
5588982|NCT00976677|19313184|P1|Overall Study|Withdrawal by Subject|0
5588983|NCT00976677|19313183|P2|Overall Study|Adverse Event|0
5588984|NCT00976677|19313184|P1|Overall Study|Adverse Event|1
5588985|NCT00976573|19313392|P2|Overall Study|Cancel prior to receiving treatment|2
5588986|NCT00976573|19313393|P1|Overall Study|Cancel prior to receiving treatment|4
5588987|NCT00976573|19313392|P2|Overall Study|Ineligible|1
5588988|NCT00976573|19313393|P1|Overall Study|Ineligible|0
5588989|NCT00976560|19313407|P2|Overall Study|Withdrawal by Subject|3
5588990|NCT00976560|19313408|P1|Overall Study|Withdrawal by Subject|2
5588991|NCT00976560|19313407|P2|Overall Study|Physician Decision|0
5588992|NCT00976560|19313408|P1|Overall Study|Physician Decision|2
5588993|NCT00976560|19313407|P2|Overall Study|Lost to Follow-up|0
5588994|NCT00976560|19313408|P1|Overall Study|Lost to Follow-up|1
5588995|NCT00976560|19313407|P2|Overall Study|Protocol Violation|0
5588996|NCT00976560|19313408|P1|Overall Study|Protocol Violation|1
5588997|NCT00976560|19313407|P2|Overall Study|Lack of Efficacy|5
5588998|NCT00976560|19313408|P1|Overall Study|Lack of Efficacy|3
5588999|NCT00976560|19313407|P2|Overall Study|Adverse Event|5
5589000|NCT00976560|19313408|P1|Overall Study|Adverse Event|5
5589001|NCT00976508|19313477|P2|Overall Study|Terminated by the Sponsor|1
5589002|NCT00976508|19313478|P1|Overall Study|Terminated by the Sponsor|0
5589003|NCT00976508|19313477|P2|Overall Study|Subject Enrolled in Hospice|0
5589004|NCT00976508|19313478|P1|Overall Study|Subject Enrolled in Hospice|1
5589005|NCT00976508|19313477|P2|Overall Study|Disease Progression|4
5589006|NCT00976508|19313478|P1|Overall Study|Disease Progression|4
5589007|NCT00976508|19313477|P2|Overall Study|Withdrawal by Subject|0
5589008|NCT00976508|19313478|P1|Overall Study|Withdrawal by Subject|1
5589009|NCT00976508|19313477|P2|Overall Study|Lost to Follow-up|0
5589010|NCT00976508|19313478|P1|Overall Study|Lost to Follow-up|1
5589011|NCT00976508|19313477|P2|Overall Study|Death|1
5589012|NCT00976508|19313478|P1|Overall Study|Death|7
5589013|NCT00976495|19313511|P3|Overall Study|Withdrawal by Subject|0
5589014|NCT00976495|19313512|P2|Overall Study|Withdrawal by Subject|1
5589015|NCT00976495|19313513|P1|Overall Study|Withdrawal by Subject|0
5589016|NCT00976482|19313530|P1|Overall Study|Protocol Violation|5
5589017|NCT00976482|19313530|P1|Overall Study|Center terminated|1
5589018|NCT00976482|19313530|P1|Overall Study|Withdrawal by Subject|45
5589019|NCT00976482|19313530|P1|Overall Study|Death|208
5589020|NCT00976456|19313536|P2|Overall Study|screening failure, unknown|4
5589021|NCT00976456|19313537|P1|Overall Study|screening failure, unknown|11
5589022|NCT00976456|19313536|P2|Overall Study|Withdrawal by Subject|1
5589023|NCT00976456|19313537|P1|Overall Study|Withdrawal by Subject|3
5589024|NCT00976456|19313536|P2|Overall Study|Lack of Efficacy|2
5589025|NCT00976456|19313537|P1|Overall Study|Lack of Efficacy|5
5589026|NCT00976456|19313536|P2|Overall Study|Death|9
5589027|NCT00976456|19313537|P1|Overall Study|Death|7
5589028|NCT00976456|19313536|P2|Overall Study|Adverse Event|22
5589029|NCT00976456|19313537|P1|Overall Study|Adverse Event|17
5589030|NCT00976391|19313564|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
5589031|NCT00976391|19313565|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
5589032|NCT00976391|19313564|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
5589033|NCT00976391|19313565|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
5589034|NCT00976391|19313564|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
5589035|NCT00976391|19313565|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
5589036|NCT00976391|19313564|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
5589037|NCT00976391|19313565|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
5589038|NCT00976391|19313564|P2|Follow-up Period (8 Weeks)|Noncompliance|2
5589039|NCT00976391|19313565|P1|Follow-up Period (8 Weeks)|Noncompliance|2
5589040|NCT00976391|19313564|P2|Follow-up Period (8 Weeks)|Adverse Event|1
5589041|NCT00976391|19313565|P1|Follow-up Period (8 Weeks)|Adverse Event|3
5589042|NCT00976391|19313564|P2|Treatment Period (52 Weeks)|Pregnancy|0
5589043|NCT00976391|19313565|P1|Treatment Period (52 Weeks)|Pregnancy|1
5589044|NCT00976391|19313564|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
5589045|NCT00976391|19313565|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
5589046|NCT00976391|19313564|P2|Treatment Period (52 Weeks)|Physician Decision|1
5589047|NCT00976391|19313565|P1|Treatment Period (52 Weeks)|Physician Decision|1
5589048|NCT00976391|19313564|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
5589049|NCT00976391|19313565|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
5589050|NCT00976391|19313564|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
5589051|NCT00976391|19313565|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
5589052|NCT00976391|19313564|P2|Treatment Period (52 Weeks)|Noncompliance|4
5589053|NCT00976391|19313565|P1|Treatment Period (52 Weeks)|Noncompliance|4
5589054|NCT00976391|19313564|P2|Treatment Period (52 Weeks)|Protocol Violation|1
5589055|NCT00976391|19313565|P1|Treatment Period (52 Weeks)|Protocol Violation|1
5589056|NCT00976391|19313564|P2|Treatment Period (52 Weeks)|Adverse Event|2
5589057|NCT00976391|19313565|P1|Treatment Period (52 Weeks)|Adverse Event|16
5589058|NCT00976274|19313613|P2|Overall Study|Physician Decision|2
5589059|NCT00976274|19313614|P1|Overall Study|Physician Decision|1
5589060|NCT00976274|19313613|P2|Overall Study|Withdrawal by Subject|1
5589061|NCT00976274|19313614|P1|Overall Study|Withdrawal by Subject|1
5589062|NCT00976274|19313613|P2|Overall Study|Lost to Follow-up|5
5589063|NCT00976274|19313614|P1|Overall Study|Lost to Follow-up|5
5589064|NCT00976209|19313630|P2|Treatment Period 2|Lost to Follow-up|1
5589065|NCT00976209|19313631|P1|Treatment Period 2|Lost to Follow-up|0
5589066|NCT00976209|19313630|P2|Treatment Period 2|Withdrawal by Subject|1
5589067|NCT00976209|19313631|P1|Treatment Period 2|Withdrawal by Subject|0
5589068|NCT00976209|19313630|P2|Wash-out Period|Other|0
5589069|NCT00976209|19313631|P1|Wash-out Period|Other|1
5589070|NCT00976209|19313630|P2|Wash-out Period|Protocol Violation|0
5589071|NCT00976209|19313631|P1|Wash-out Period|Protocol Violation|1
5589072|NCT00976209|19313630|P2|Wash-out Period|Lost to Follow-up|0
5589073|NCT00976209|19313631|P1|Wash-out Period|Lost to Follow-up|1
5589074|NCT00976209|19313630|P2|Wash-out Period|Adverse Event|2
5589075|NCT00976209|19313631|P1|Wash-out Period|Adverse Event|1
5589076|NCT00976209|19313630|P2|Treatment Period 1|Other|1
5589077|NCT00976209|19313631|P1|Treatment Period 1|Other|0
5589078|NCT00976209|19313630|P2|Treatment Period 1|Lost to Follow-up|0
5589079|NCT00976209|19313631|P1|Treatment Period 1|Lost to Follow-up|2
5589080|NCT00976209|19313630|P2|Treatment Period 1|Protocol Violation|0
5589081|NCT00976209|19313631|P1|Treatment Period 1|Protocol Violation|1
5589082|NCT00976027|19313644|P2|Overall Study|Withdrawal by Subject|66
5589083|NCT00976027|19313645|P1|Overall Study|Withdrawal by Subject|107
5589084|NCT00976027|19313644|P2|Overall Study|Lost to Follow-up|103
5589085|NCT00976027|19313645|P1|Overall Study|Lost to Follow-up|208
5589086|NCT00976027|19313644|P2|Overall Study|Protocol Violation|27
5589087|NCT00976027|19313645|P1|Overall Study|Protocol Violation|60
5589088|NCT00976027|19313644|P2|Overall Study|Adverse Event|2
5589089|NCT00976027|19313645|P1|Overall Study|Adverse Event|0
5589090|NCT00976027|19313644|P2|Overall Study|Serious Adverse Event|17
5589091|NCT00976027|19313645|P1|Overall Study|Serious Adverse Event|36
5589092|NCT00975975|19313657|P1|Overall Study|Death|6
5589093|NCT00975923|19313665|P2|Overall Study|Withdrawal by Subject|1
5589094|NCT00975923|19313666|P1|Overall Study|Withdrawal by Subject|0
5589095|NCT00975884|19313676|P2|Overall Study|Other|3
5589096|NCT00975884|19313677|P1|Overall Study|Other|1
5589097|NCT00975884|19313676|P2|Overall Study|Withdrawal by Subject|9
5589098|NCT00975884|19313677|P1|Overall Study|Withdrawal by Subject|9
5589099|NCT00975884|19313676|P2|Overall Study|Lost to Follow-up|3
5589100|NCT00975884|19313677|P1|Overall Study|Lost to Follow-up|5
5589101|NCT00975884|19313676|P2|Overall Study|Adverse Event|0
5589102|NCT00975884|19313677|P1|Overall Study|Adverse Event|1
5589103|NCT00975806|19313834|P3|Overall Study|Physician decision and disease related|1
5589104|NCT00975806|19313835|P2|Overall Study|Physician decision and disease related|0
5589105|NCT00975806|19313836|P1|Overall Study|Physician decision and disease related|1
5589106|NCT00975806|19313834|P3|Overall Study|Death|0
5589107|NCT00975806|19313835|P2|Overall Study|Death|1
5589108|NCT00975806|19313836|P1|Overall Study|Death|0
5589109|NCT00975806|19313834|P3|Overall Study|Withdrawal by Subject|0
5589110|NCT00975806|19313835|P2|Overall Study|Withdrawal by Subject|0
5589111|NCT00975806|19313836|P1|Overall Study|Withdrawal by Subject|1
5589112|NCT00975806|19313834|P3|Overall Study|Disease Progression|1
5589113|NCT00975806|19313835|P2|Overall Study|Disease Progression|5
5589114|NCT00975806|19313836|P1|Overall Study|Disease Progression|1
5589115|NCT00975806|19313834|P3|Overall Study|Adverse Event|2
5589116|NCT00975806|19313835|P2|Overall Study|Adverse Event|1
5589117|NCT00975806|19313836|P1|Overall Study|Adverse Event|2
5589118|NCT00975780|19313860|P2|Follow Up|Discharged from Facility|12
5589119|NCT00975780|19313861|P1|Follow Up|Discharged from Facility|7
5589120|NCT00975780|19313860|P2|Follow Up|Facility Withdrawal|23
5589121|NCT00975780|19313861|P1|Follow Up|Facility Withdrawal|7
5589122|NCT00975780|19313860|P2|Follow Up|Death|122
5589123|NCT00975780|19313861|P1|Follow Up|Death|88
5589124|NCT00975715|19313871|P2|Maintenance Period|Adverse Event|1
5589125|NCT00975715|19313872|P1|Maintenance Period|Adverse Event|2
5589126|NCT00975715|19313871|P2|Titration Period|Protocol Violation|0
5589127|NCT00975715|19313872|P1|Titration Period|Protocol Violation|1
5589128|NCT00975715|19313871|P2|Titration Period|Adverse Event|0
5589129|NCT00975715|19313872|P1|Titration Period|Adverse Event|6
5589130|NCT00975689|19313888|P2|Overall Study|Physician Decision|0
5589131|NCT00975689|19313889|P1|Overall Study|Physician Decision|1
5589132|NCT00975689|19313888|P2|Overall Study|Withdrawal by Subject|0
5589133|NCT00975689|19313889|P1|Overall Study|Withdrawal by Subject|1
5589134|NCT00975689|19313888|P2|Overall Study|Adverse Event|3
5589135|NCT00975689|19313889|P1|Overall Study|Adverse Event|0
5589136|NCT00975611|19313958|P1|Overall Study|Physician Decision|1
5589137|NCT00975611|19313958|P1|Overall Study|Screen Fail|16
5589138|NCT00975585|19313964|P2|Overall Study|Lens issue|2
5589139|NCT00975585|19313965|P1|Overall Study|Lens issue|2
5589140|NCT00975585|19313964|P2|Overall Study|Withdrawal by Subject|1
5589141|NCT00975585|19313965|P1|Overall Study|Withdrawal by Subject|2
5589142|NCT00975585|19313964|P2|Overall Study|Lost to Follow-up|5
5589143|NCT00975585|19313965|P1|Overall Study|Lost to Follow-up|3
5589144|NCT00975585|19313964|P2|Overall Study|Adverse Event|4
5589145|NCT00975585|19313965|P1|Overall Study|Adverse Event|0
5589146|NCT00975507|19313985|P2|Overall Study|Withdrawal by Subject|3
5589147|NCT00975507|19313986|P1|Overall Study|Withdrawal by Subject|10
5589148|NCT00975507|19313985|P2|Overall Study|Protocol Violation|0
5589149|NCT00975507|19313986|P1|Overall Study|Protocol Violation|2
5589150|NCT00975507|19313985|P2|Overall Study|Lost to Follow-up|1
5589151|NCT00975507|19313986|P1|Overall Study|Lost to Follow-up|7
5589152|NCT00975507|19313985|P2|Overall Study|Adverse Event|0
5589153|NCT00975507|19313986|P1|Overall Study|Adverse Event|1
5589154|NCT00975481|19314006|P6|Fifth Intervention Period|Withdrawal by Subject|0
5589155|NCT00975481|19314007|P5|Fifth Intervention Period|Withdrawal by Subject|1
5589156|NCT00975481|19314008|P4|Fifth Intervention Period|Withdrawal by Subject|0
5589157|NCT00975481|19314009|P3|Fifth Intervention Period|Withdrawal by Subject|0
5589158|NCT00975481|19314010|P2|Fifth Intervention Period|Withdrawal by Subject|0
5589159|NCT00975481|19314011|P1|Fifth Intervention Period|Withdrawal by Subject|0
5589160|NCT00975481|19314006|P6|Fourth Intervention Period|Withdrawal by Subject|0
5589161|NCT00975481|19314007|P5|Fourth Intervention Period|Withdrawal by Subject|0
5589162|NCT00975481|19314008|P4|Fourth Intervention Period|Withdrawal by Subject|1
5589163|NCT00975481|19314009|P3|Fourth Intervention Period|Withdrawal by Subject|1
5589164|NCT00975481|19314010|P2|Fourth Intervention Period|Withdrawal by Subject|0
5589165|NCT00975481|19314011|P1|Fourth Intervention Period|Withdrawal by Subject|0
5589166|NCT00975481|19314006|P6|Second Intervention Period|Withdrawal by Subject|0
5589167|NCT00975481|19314007|P5|Second Intervention Period|Withdrawal by Subject|0
5589168|NCT00975481|19314008|P4|Second Intervention Period|Withdrawal by Subject|0
5589169|NCT00975481|19314009|P3|Second Intervention Period|Withdrawal by Subject|1
5589170|NCT00975481|19314010|P2|Second Intervention Period|Withdrawal by Subject|0
5589171|NCT00975481|19314011|P1|Second Intervention Period|Withdrawal by Subject|0
5589172|NCT00975481|19314006|P6|Second Intervention Period|Adverse Event|0
5589173|NCT00975481|19314007|P5|Second Intervention Period|Adverse Event|0
5589174|NCT00975481|19314008|P4|Second Intervention Period|Adverse Event|0
5589175|NCT00975481|19314009|P3|Second Intervention Period|Adverse Event|0
5589176|NCT00975481|19314010|P2|Second Intervention Period|Adverse Event|1
5589177|NCT00975481|19314011|P1|Second Intervention Period|Adverse Event|2
5589178|NCT00975416|19314111|P2|Overall Study|early discharge from tx|5
5589179|NCT00975416|19314112|P1|Overall Study|early discharge from tx|3
5589180|NCT00975286|19314121|P2|Overall Study|Sponsor Decision|2
5589181|NCT00975286|19314122|P1|Overall Study|Sponsor Decision|0
5589182|NCT00975286|19314121|P2|Overall Study|Poor Compliance to Protocol|2
5589183|NCT00975286|19314122|P1|Overall Study|Poor Compliance to Protocol|0
5589184|NCT00975286|19314121|P2|Overall Study|Familial and Personal Reasons|2
5589185|NCT00975286|19314122|P1|Overall Study|Familial and Personal Reasons|2
5589186|NCT00975286|19314121|P2|Overall Study|Withdrawal by Subject|2
5589187|NCT00975286|19314122|P1|Overall Study|Withdrawal by Subject|0
5589188|NCT00975286|19314121|P2|Overall Study|Protocol Violation|2
5589189|NCT00975286|19314122|P1|Overall Study|Protocol Violation|1
5589190|NCT00975286|19314121|P2|Overall Study|Adverse Event|19
5589191|NCT00975286|19314122|P1|Overall Study|Adverse Event|9
5589192|NCT00975221|19314154|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
5589193|NCT00975221|19314155|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
5589194|NCT00975221|19314154|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
5589195|NCT00975221|19314155|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
5589196|NCT00975221|19314154|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
5589197|NCT00975221|19314155|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
5589198|NCT00975221|19314154|P2|Titration Phase (Weeks 1-12)|Other|1
5589199|NCT00975221|19314155|P1|Titration Phase (Weeks 1-12)|Other|0
5589200|NCT00975221|19314154|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
5589201|NCT00975221|19314155|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
5589202|NCT00975221|19314154|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
5589203|NCT00975221|19314155|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
5589204|NCT00975195|19314171|P2|Overall Study|Not treated|2
5589205|NCT00975195|19314172|P1|Overall Study|Not treated|1
5589206|NCT00975195|19314171|P2|Overall Study|Other reason not defined above|33
5589207|NCT00975195|19314172|P1|Overall Study|Other reason not defined above|29
5589208|NCT00975195|19314171|P2|Overall Study|Withdrawal by Subject|61
5589209|NCT00975195|19314172|P1|Overall Study|Withdrawal by Subject|48
5589210|NCT00975195|19314171|P2|Overall Study|Lost to Follow-up|7
5589211|NCT00975195|19314172|P1|Overall Study|Lost to Follow-up|9
5589212|NCT00975195|19314171|P2|Overall Study|Protocol Violation|23
5589213|NCT00975195|19314172|P1|Overall Study|Protocol Violation|27
5589214|NCT00975195|19314171|P2|Overall Study|Lack of Efficacy|6
5589215|NCT00975195|19314172|P1|Overall Study|Lack of Efficacy|6
5589216|NCT00975195|19314171|P2|Overall Study|Adverse Event|101
5589217|NCT00975195|19314172|P1|Overall Study|Adverse Event|108
5589218|NCT00975156|19314232|P2|Overall Study|Protocol Violation|1
5589219|NCT00975156|19314233|P1|Overall Study|Protocol Violation|0
5589220|NCT00975143|19314245|P2|Overall Study|Details not available|4
5589221|NCT00975143|19314246|P1|Overall Study|Details not available|10
5589222|NCT00975143|19314245|P2|Overall Study|Physician Decision|2
5589223|NCT00975143|19314246|P1|Overall Study|Physician Decision|1
5589224|NCT00975143|19314245|P2|Overall Study|Non-compliance|8
5589225|NCT00975143|19314246|P1|Overall Study|Non-compliance|5
5589226|NCT00975143|19314245|P2|Overall Study|Lost to Follow-up|16
5589227|NCT00975143|19314246|P1|Overall Study|Lost to Follow-up|20
5589228|NCT00975143|19314245|P2|Overall Study|Withdrawal by Subject|15
5589229|NCT00975143|19314246|P1|Overall Study|Withdrawal by Subject|15
5589230|NCT00975143|19314245|P2|Overall Study|Adverse Event|15
5589231|NCT00975143|19314246|P1|Overall Study|Adverse Event|19
5589232|NCT00975130|19314256|P3|Study Part 2|Protocol Violation|1
5589233|NCT00975130|19314257|P2|Study Part 2|Protocol Violation|0
5589234|NCT00975130|19314258|P1|Study Part 2|Protocol Violation|0
5589235|NCT00975130|19314256|P3|Study Part 2|Administrative|0
5589236|NCT00975130|19314257|P2|Study Part 2|Administrative|1
5589237|NCT00975130|19314258|P1|Study Part 2|Administrative|0
5589238|NCT00975130|19314256|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
5589239|NCT00975130|19314257|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
5589240|NCT00975130|19314258|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
5589241|NCT00975130|19314256|P3|Study Part 2|Withdrew Consent|2
5589242|NCT00975130|19314257|P2|Study Part 2|Withdrew Consent|6
5589243|NCT00975130|19314258|P1|Study Part 2|Withdrew Consent|0
5589244|NCT00975130|19314256|P3|Study Part 2|Withdrawal by Subject|5
5589245|NCT00975130|19314257|P2|Study Part 2|Withdrawal by Subject|13
5589246|NCT00975130|19314258|P1|Study Part 2|Withdrawal by Subject|0
5589247|NCT00975130|19314256|P3|Study Part 2|Lost to Follow-up|1
5589248|NCT00975130|19314257|P2|Study Part 2|Lost to Follow-up|0
5589249|NCT00975130|19314258|P1|Study Part 2|Lost to Follow-up|0
5589250|NCT00975130|19314256|P3|Study Part 2|Adverse Event|7
5589251|NCT00975130|19314257|P2|Study Part 2|Adverse Event|14
5589252|NCT00975130|19314258|P1|Study Part 2|Adverse Event|0
5589253|NCT00975130|19314256|P3|Study Part 1|Withdrew Consent|0
5589254|NCT00975130|19314257|P2|Study Part 1|Withdrew Consent|0
5589255|NCT00975130|19314258|P1|Study Part 1|Withdrew Consent|24
5589256|NCT00975130|19314256|P3|Study Part 1|Administrative|0
5589257|NCT00975130|19314257|P2|Study Part 1|Administrative|0
5589258|NCT00975130|19314258|P1|Study Part 1|Administrative|4
5589259|NCT00975130|19314256|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
5589260|NCT00975130|19314257|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
5589261|NCT00975130|19314258|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
5589262|NCT00975130|19314256|P3|Study Part 1|Protocol Violation|0
5589263|NCT00975130|19314257|P2|Study Part 1|Protocol Violation|0
5589264|NCT00975130|19314258|P1|Study Part 1|Protocol Violation|13
5589265|NCT00975130|19314256|P3|Study Part 1|Withdrawal by Subject|0
5589266|NCT00975130|19314257|P2|Study Part 1|Withdrawal by Subject|0
5589267|NCT00975130|19314258|P1|Study Part 1|Withdrawal by Subject|61
5589268|NCT00975130|19314256|P3|Study Part 1|Lost to Follow-up|0
5589269|NCT00975130|19314257|P2|Study Part 1|Lost to Follow-up|0
5589270|NCT00975130|19314258|P1|Study Part 1|Lost to Follow-up|19
5589271|NCT00975130|19314256|P3|Study Part 1|Adverse Event|0
5589272|NCT00975130|19314257|P2|Study Part 1|Adverse Event|0
5589273|NCT00975130|19314258|P1|Study Part 1|Adverse Event|150
5589274|NCT00975000|19314442|P2|Overall Study|Non-compliance|1
5589275|NCT00975000|19314443|P1|Overall Study|Non-compliance|0
5589276|NCT00975000|19314442|P2|Overall Study|Protocol-specified Criteria|0
5589277|NCT00975000|19314443|P1|Overall Study|Protocol-specified Criteria|1
5589278|NCT00975000|19314442|P2|Overall Study|Lost to Follow-up|1
5589279|NCT00975000|19314443|P1|Overall Study|Lost to Follow-up|0
5589280|NCT00975000|19314442|P2|Overall Study|Withdrawal by Subject|2
5589281|NCT00975000|19314443|P1|Overall Study|Withdrawal by Subject|2
5589282|NCT00975000|19314442|P2|Overall Study|Adverse Event|1
5589283|NCT00975000|19314443|P1|Overall Study|Adverse Event|1
5589284|NCT00975000|19314442|P2|Overall Study|Other|0
5589285|NCT00975000|19314443|P1|Overall Study|Other|1
5589286|NCT00974974|19314467|P2|Maintenance - Double Blind Treatment|Various|0
5589287|NCT00974974|19314468|P1|Maintenance - Double Blind Treatment|Various|4
5589288|NCT00974974|19314467|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
5589289|NCT00974974|19314468|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
5589290|NCT00974974|19314467|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
5589291|NCT00974974|19314468|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
5589292|NCT00974974|19314467|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
5589293|NCT00974974|19314468|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
5589294|NCT00974974|19314467|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
5589295|NCT00974974|19314468|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
5589296|NCT00974974|19314467|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
5589297|NCT00974974|19314468|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
5589298|NCT00974974|19314467|P2|Maintenance - Double Blind Treatment|Adverse Event|3
5589299|NCT00974974|19314468|P1|Maintenance - Double Blind Treatment|Adverse Event|3
5589300|NCT00974974|19314467|P2|IPX066 Dose Conversion|Protocol Violation|0
5589301|NCT00974974|19314468|P1|IPX066 Dose Conversion|Protocol Violation|4
5589302|NCT00974974|19314467|P2|IPX066 Dose Conversion|Various|0
5589303|NCT00974974|19314468|P1|IPX066 Dose Conversion|Various|3
5589304|NCT00974974|19314467|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
5589305|NCT00974974|19314468|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
5589306|NCT00974974|19314467|P2|IPX066 Dose Conversion|Lack of Efficacy|0
5589307|NCT00974974|19314468|P1|IPX066 Dose Conversion|Lack of Efficacy|13
5589308|NCT00974974|19314467|P2|IPX066 Dose Conversion|Death|0
5589309|NCT00974974|19314468|P1|IPX066 Dose Conversion|Death|2
5589310|NCT00974974|19314467|P2|IPX066 Dose Conversion|Adverse Event|0
5589311|NCT00974974|19314468|P1|IPX066 Dose Conversion|Adverse Event|23
5589312|NCT00974974|19314467|P2|IR CD-LD Dose Adjustment|Various|9
5589313|NCT00974974|19314468|P1|IR CD-LD Dose Adjustment|Various|0
5589314|NCT00974974|19314467|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
5589315|NCT00974974|19314468|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
5589316|NCT00974974|19314467|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
5589317|NCT00974974|19314468|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
5589318|NCT00974974|19314467|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
5589319|NCT00974974|19314468|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
5589320|NCT00974974|19314467|P2|IR CD-LD Dose Adjustment|Adverse Event|3
5589321|NCT00974974|19314468|P1|IR CD-LD Dose Adjustment|Adverse Event|0
5589322|NCT00974922|19314478|P1|Overall Study|study terminated|24
5589323|NCT00974675|19314496|P4|Overall Study|Participant on holiday; unable to attend|1
5589324|NCT00974675|19314497|P3|Overall Study|Participant on holiday; unable to attend|0
5589325|NCT00974675|19314498|P2|Overall Study|Participant on holiday; unable to attend|0
5589326|NCT00974675|19314499|P1|Overall Study|Participant on holiday; unable to attend|0
5589327|NCT00974675|19314496|P4|Overall Study|Physician Decision|0
5589328|NCT00974675|19314497|P3|Overall Study|Physician Decision|1
5589329|NCT00974675|19314498|P2|Overall Study|Physician Decision|0
5589330|NCT00974675|19314499|P1|Overall Study|Physician Decision|0
5589331|NCT00974675|19314496|P4|Overall Study|Adverse Event|1
5589332|NCT00974675|19314497|P3|Overall Study|Adverse Event|1
5589333|NCT00974675|19314498|P2|Overall Study|Adverse Event|1
5589334|NCT00974675|19314499|P1|Overall Study|Adverse Event|2
5589335|NCT00974571|19314548|P3|Overall Study|Other|10
5589336|NCT00974571|19314549|P2|Overall Study|Other|0
5589337|NCT00974571|19314550|P1|Overall Study|Other|4
5589338|NCT00974571|19314548|P3|Overall Study|Patient Moved|1
5589339|NCT00974571|19314549|P2|Overall Study|Patient Moved|0
5589340|NCT00974571|19314550|P1|Overall Study|Patient Moved|1
5589341|NCT00974571|19314548|P3|Overall Study|Withdrawal by Subject|16
5589342|NCT00974571|19314549|P2|Overall Study|Withdrawal by Subject|5
5589343|NCT00974571|19314550|P1|Overall Study|Withdrawal by Subject|14
5589344|NCT00974571|19314548|P3|Overall Study|Protocol Violation|18
5589345|NCT00974571|19314549|P2|Overall Study|Protocol Violation|4
5589346|NCT00974571|19314550|P1|Overall Study|Protocol Violation|13
5589347|NCT00974571|19314548|P3|Overall Study|Lost to Follow-up|2
5589348|NCT00974571|19314549|P2|Overall Study|Lost to Follow-up|1
5589349|NCT00974571|19314550|P1|Overall Study|Lost to Follow-up|2
5589350|NCT00974571|19314548|P3|Overall Study|Lack of Efficacy|9
5589351|NCT00974571|19314549|P2|Overall Study|Lack of Efficacy|2
5589352|NCT00974571|19314550|P1|Overall Study|Lack of Efficacy|3
5589353|NCT00974571|19314548|P3|Overall Study|Adverse Event|27
5589354|NCT00974571|19314549|P2|Overall Study|Adverse Event|4
5589355|NCT00974571|19314550|P1|Overall Study|Adverse Event|31
5589356|NCT00974311|19314656|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
5589357|NCT00974311|19314657|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
5589358|NCT00974311|19314656|P2|OLE Phase (up to 77 Months)|Other|2
5589359|NCT00974311|19314657|P1|OLE Phase (up to 77 Months)|Other|15
5589360|NCT00974311|19314656|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
5589361|NCT00974311|19314657|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
5589362|NCT00974311|19314656|P2|OLE Phase (up to 77 Months)|Death|21
5589363|NCT00974311|19314657|P1|OLE Phase (up to 77 Months)|Death|14
5589364|NCT00974311|19314656|P2|DB Phase (up to 24 Months)|Other|0
5589365|NCT00974311|19314657|P1|DB Phase (up to 24 Months)|Other|1
5589366|NCT00974311|19314656|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
5589367|NCT00974311|19314657|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
5589368|NCT00974311|19314656|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
5589369|NCT00974311|19314657|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
5589370|NCT00974311|19314656|P2|DB Phase (up to 24 Months)|Death|298
5589371|NCT00974311|19314657|P1|DB Phase (up to 24 Months)|Death|561
5589372|NCT00974311|19314656|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
5589373|NCT00974311|19314657|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
5589374|NCT00974259|19314695|P2|Overall Study|Technically inadequate PbtO2 recordings|1
5589375|NCT00974259|19314696|P1|Overall Study|Technically inadequate PbtO2 recordings|2
5589376|NCT00974233|19314714|P1|Maintenance Lenalidomide|Adverse Event|8
5589377|NCT00974233|19314714|P1|Maintenance Lenalidomide|Lack of Efficacy|5
5589378|NCT00974233|19314714|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
5589379|NCT00974233|19314714|P1|Induction Chemoimmunotherapy|Adverse Event|7
5589380|NCT00974233|19314714|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
5589381|NCT00974233|19314714|P1|Induction Chemoimmunotherapy|Death|2
5589382|NCT00974220|19314729|P2|Treatment Period 1|noncompliant subjects|1
5589383|NCT00974220|19314730|P1|Treatment Period 1|noncompliant subjects|0
5589384|NCT00974220|19314729|P2|Treatment Period 1|Adverse Event|1
5589385|NCT00974220|19314730|P1|Treatment Period 1|Adverse Event|2
5589386|NCT00974090|19314775|P2|Period 2: Open-label Period|Withdrawal by Subject|0
5589387|NCT00974090|19314776|P1|Period 2: Open-label Period|Withdrawal by Subject|1
5589388|NCT00974090|19314775|P2|Period 2: Open-label Period|Physician Decision|3
5589389|NCT00974090|19314776|P1|Period 2: Open-label Period|Physician Decision|0
5589390|NCT00974090|19314775|P2|Period 2: Open-label Period|Lack of Efficacy|1
5589391|NCT00974090|19314776|P1|Period 2: Open-label Period|Lack of Efficacy|3
5589392|NCT00974090|19314775|P2|Period 2: Open-label Period|Adverse Event|6
5589393|NCT00974090|19314776|P1|Period 2: Open-label Period|Adverse Event|4
5589394|NCT00974090|19314775|P2|Period 1: Double Blind Period|Physician Decision|0
5589395|NCT00974090|19314776|P1|Period 1: Double Blind Period|Physician Decision|1
5589396|NCT00974090|19314775|P2|Period 1: Double Blind Period|Adverse Event|1
5589397|NCT00974090|19314776|P1|Period 1: Double Blind Period|Adverse Event|2
5589398|NCT00973973|19314812|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
5589480|NCT00973349|19315040|P11|Overall Study|Unable to classify|0
5589399|NCT00973973|19314813|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
5589400|NCT00973973|19314812|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
5589401|NCT00973973|19314813|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
5589402|NCT00973973|19314812|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
5589403|NCT00973973|19314813|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
5589404|NCT00973973|19314812|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
5589405|NCT00973973|19314813|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
5589406|NCT00973973|19314812|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
5589407|NCT00973973|19314813|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
5589408|NCT00973973|19314812|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
5589409|NCT00973973|19314813|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
5589410|NCT00973973|19314812|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
5589411|NCT00973973|19314813|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
5589412|NCT00973973|19314812|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
5589413|NCT00973973|19314813|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
5589414|NCT00973973|19314812|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
5589415|NCT00973973|19314813|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
5589416|NCT00973973|19314812|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
5589417|NCT00973973|19314813|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
5589418|NCT00973973|19314812|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
5589419|NCT00973973|19314813|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
5589420|NCT00973973|19314812|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
5589421|NCT00973973|19314813|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
5589422|NCT00973921|19314873|P1|Overall Study|IVUS results were not available|9
5589423|NCT00973765|19314890|P2|Overall Study|Lost to Follow-up|14
5589424|NCT00973765|19314891|P1|Overall Study|Lost to Follow-up|8
5589425|NCT00973700|19314913|P5|Overall Study|Unable to Classify|1
5589426|NCT00973700|19314914|P4|Overall Study|Unable to Classify|2
5589427|NCT00973700|19314915|P3|Overall Study|Unable to Classify|1
5589428|NCT00973700|19314916|P2|Overall Study|Unable to Classify|0
5589429|NCT00973700|19314917|P1|Overall Study|Unable to Classify|0
5589430|NCT00973700|19314913|P5|Overall Study|Inappropriate enrolment|0
5589431|NCT00973700|19314914|P4|Overall Study|Inappropriate enrolment|4
5589432|NCT00973700|19314915|P3|Overall Study|Inappropriate enrolment|0
5589433|NCT00973700|19314916|P2|Overall Study|Inappropriate enrolment|0
5589434|NCT00973700|19314917|P1|Overall Study|Inappropriate enrolment|0
5589435|NCT00973700|19314913|P5|Overall Study|Lost to Follow-up|5
5589436|NCT00973700|19314914|P4|Overall Study|Lost to Follow-up|8
5589437|NCT00973700|19314915|P3|Overall Study|Lost to Follow-up|1
5589438|NCT00973700|19314916|P2|Overall Study|Lost to Follow-up|0
5589439|NCT00973700|19314917|P1|Overall Study|Lost to Follow-up|5
5589440|NCT00973700|19314913|P5|Overall Study|Withdrawal by Subject|4
5589441|NCT00973700|19314914|P4|Overall Study|Withdrawal by Subject|4
5589442|NCT00973700|19314915|P3|Overall Study|Withdrawal by Subject|8
5589443|NCT00973700|19314916|P2|Overall Study|Withdrawal by Subject|2
5589444|NCT00973700|19314917|P1|Overall Study|Withdrawal by Subject|2
5589445|NCT00973674|19314966|P2|Overall Study|Protocol Violation|0
5589446|NCT00973674|19314967|P1|Overall Study|Protocol Violation|2
5589447|NCT00973622|19314981|P2|Overall Study|did not complete rTMS sessions|2
5589448|NCT00973622|19314982|P1|Overall Study|did not complete rTMS sessions|11
5589449|NCT00973622|19314981|P2|Overall Study|did not pass MRI screen|0
5589450|NCT00973622|19314982|P1|Overall Study|did not pass MRI screen|6
5589451|NCT00973622|19314981|P2|Overall Study|did not attend MRI|3
5589452|NCT00973622|19314982|P1|Overall Study|did not attend MRI|14
5589453|NCT00973479|19314990|P2|Overall Study|Other|7
5589454|NCT00973479|19314991|P1|Overall Study|Other|1
5589455|NCT00973479|19314990|P2|Overall Study|Protocol Violation|2
5589456|NCT00973479|19314991|P1|Overall Study|Protocol Violation|2
5589457|NCT00973479|19314990|P2|Overall Study|Adverse Event|32
5589458|NCT00973479|19314991|P1|Overall Study|Adverse Event|12
5589459|NCT00973479|19314990|P2|Overall Study|Lack of Efficacy|7
5589460|NCT00973479|19314991|P1|Overall Study|Lack of Efficacy|5
5589461|NCT00973479|19314990|P2|Overall Study|Withdrawal by Subject|16
5589462|NCT00973479|19314991|P1|Overall Study|Withdrawal by Subject|15
5589463|NCT00973479|19314990|P2|Overall Study|Death|2
5589464|NCT00973479|19314991|P1|Overall Study|Death|2
5589465|NCT00973479|19314990|P2|Overall Study|Lost to Follow-up|3
5589466|NCT00973479|19314991|P1|Overall Study|Lost to Follow-up|0
5589467|NCT00973362|19315009|P2|3-Year Follow-up|Lost to Follow-up|0
5589468|NCT00973362|19315010|P1|3-Year Follow-up|Lost to Follow-up|17
5589469|NCT00973362|19315009|P2|Baseline Evaluation|Inevaluable|223
5589470|NCT00973362|19315010|P1|Baseline Evaluation|Inevaluable|686
5589471|NCT00973362|19315009|P2|Baseline Evaluation|No colposcopy visit|0
5589472|NCT00973362|19315010|P1|Baseline Evaluation|No colposcopy visit|62
5589473|NCT00973362|19315009|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
5589474|NCT00973362|19315010|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
5589475|NCT00973349|19315035|P16|Overall Study|Unable to classify|0
5589476|NCT00973349|19315036|P15|Overall Study|Unable to classify|0
5589477|NCT00973349|19315037|P14|Overall Study|Unable to classify|0
5589478|NCT00973349|19315038|P13|Overall Study|Unable to classify|0
5589479|NCT00973349|19315039|P12|Overall Study|Unable to classify|0
5589481|NCT00973349|19315041|P10|Overall Study|Unable to classify|1
5589482|NCT00973349|19315042|P9|Overall Study|Unable to classify|0
5589483|NCT00973349|19315043|P8|Overall Study|Unable to classify|0
5589484|NCT00973349|19315044|P7|Overall Study|Unable to classify|0
5589485|NCT00973349|19315045|P6|Overall Study|Unable to classify|1
5589486|NCT00973349|19315046|P5|Overall Study|Unable to classify|1
5589487|NCT00973349|19315047|P4|Overall Study|Unable to classify|0
5589488|NCT00973349|19315048|P3|Overall Study|Unable to classify|0
5589489|NCT00973349|19315049|P2|Overall Study|Unable to classify|0
5589490|NCT00973349|19315050|P1|Overall Study|Unable to classify|0
5589491|NCT00973349|19315035|P16|Overall Study|Protocol Violation|0
5589492|NCT00973349|19315036|P15|Overall Study|Protocol Violation|0
5589493|NCT00973349|19315037|P14|Overall Study|Protocol Violation|0
5589494|NCT00973349|19315038|P13|Overall Study|Protocol Violation|0
5589495|NCT00973349|19315039|P12|Overall Study|Protocol Violation|0
5589496|NCT00973349|19315040|P11|Overall Study|Protocol Violation|0
5589497|NCT00973349|19315041|P10|Overall Study|Protocol Violation|0
5589498|NCT00973349|19315042|P9|Overall Study|Protocol Violation|1
5589499|NCT00973349|19315043|P8|Overall Study|Protocol Violation|0
5589500|NCT00973349|19315044|P7|Overall Study|Protocol Violation|0
5589501|NCT00973349|19315045|P6|Overall Study|Protocol Violation|0
5589502|NCT00973349|19315046|P5|Overall Study|Protocol Violation|0
5589503|NCT00973349|19315047|P4|Overall Study|Protocol Violation|0
5589504|NCT00973349|19315048|P3|Overall Study|Protocol Violation|0
5589505|NCT00973349|19315049|P2|Overall Study|Protocol Violation|0
5589506|NCT00973349|19315050|P1|Overall Study|Protocol Violation|0
5589507|NCT00973349|19315035|P16|Overall Study|Inappropriate enrolment|1
5589508|NCT00973349|19315036|P15|Overall Study|Inappropriate enrolment|1
5589509|NCT00973349|19315037|P14|Overall Study|Inappropriate enrolment|0
5589510|NCT00973349|19315038|P13|Overall Study|Inappropriate enrolment|1
5589511|NCT00973349|19315039|P12|Overall Study|Inappropriate enrolment|0
5589512|NCT00973349|19315040|P11|Overall Study|Inappropriate enrolment|0
5589513|NCT00973349|19315041|P10|Overall Study|Inappropriate enrolment|2
5589514|NCT00973349|19315042|P9|Overall Study|Inappropriate enrolment|0
5589515|NCT00973349|19315043|P8|Overall Study|Inappropriate enrolment|0
5589516|NCT00973349|19315044|P7|Overall Study|Inappropriate enrolment|0
5589517|NCT00973349|19315045|P6|Overall Study|Inappropriate enrolment|0
5589518|NCT00973349|19315046|P5|Overall Study|Inappropriate enrolment|0
5589519|NCT00973349|19315047|P4|Overall Study|Inappropriate enrolment|0
5589520|NCT00973349|19315048|P3|Overall Study|Inappropriate enrolment|1
5589521|NCT00973349|19315049|P2|Overall Study|Inappropriate enrolment|0
5589522|NCT00973349|19315050|P1|Overall Study|Inappropriate enrolment|0
5589523|NCT00973349|19315035|P16|Overall Study|Lost to Follow-up|1
5589524|NCT00973349|19315036|P15|Overall Study|Lost to Follow-up|0
5589525|NCT00973349|19315037|P14|Overall Study|Lost to Follow-up|0
5589526|NCT00973349|19315038|P13|Overall Study|Lost to Follow-up|0
5589527|NCT00973349|19315039|P12|Overall Study|Lost to Follow-up|1
5589528|NCT00973349|19315040|P11|Overall Study|Lost to Follow-up|0
5589529|NCT00973349|19315041|P10|Overall Study|Lost to Follow-up|1
5589530|NCT00973349|19315042|P9|Overall Study|Lost to Follow-up|2
5589531|NCT00973349|19315043|P8|Overall Study|Lost to Follow-up|1
5589532|NCT00973349|19315044|P7|Overall Study|Lost to Follow-up|0
5589533|NCT00973349|19315045|P6|Overall Study|Lost to Follow-up|3
5589534|NCT00973349|19315046|P5|Overall Study|Lost to Follow-up|1
5589535|NCT00973349|19315047|P4|Overall Study|Lost to Follow-up|2
5589536|NCT00973349|19315048|P3|Overall Study|Lost to Follow-up|2
5589537|NCT00973349|19315049|P2|Overall Study|Lost to Follow-up|1
5589538|NCT00973349|19315050|P1|Overall Study|Lost to Follow-up|3
5589539|NCT00973349|19315035|P16|Overall Study|Withdrawal by Subject|0
5589540|NCT00973349|19315036|P15|Overall Study|Withdrawal by Subject|0
5589541|NCT00973349|19315037|P14|Overall Study|Withdrawal by Subject|0
5589542|NCT00973349|19315038|P13|Overall Study|Withdrawal by Subject|0
5589543|NCT00973349|19315039|P12|Overall Study|Withdrawal by Subject|1
5589544|NCT00973349|19315040|P11|Overall Study|Withdrawal by Subject|0
5589545|NCT00973349|19315041|P10|Overall Study|Withdrawal by Subject|2
5589546|NCT00973349|19315042|P9|Overall Study|Withdrawal by Subject|0
5589547|NCT00973349|19315043|P8|Overall Study|Withdrawal by Subject|2
5589548|NCT00973349|19315044|P7|Overall Study|Withdrawal by Subject|2
5589549|NCT00973349|19315045|P6|Overall Study|Withdrawal by Subject|0
5589550|NCT00973349|19315046|P5|Overall Study|Withdrawal by Subject|2
5589551|NCT00973349|19315047|P4|Overall Study|Withdrawal by Subject|3
5589552|NCT00973349|19315048|P3|Overall Study|Withdrawal by Subject|2
5589553|NCT00973349|19315049|P2|Overall Study|Withdrawal by Subject|2
5589554|NCT00973349|19315050|P1|Overall Study|Withdrawal by Subject|1
5589555|NCT00973349|19315035|P16|Overall Study|Adverse Event|0
5589556|NCT00973349|19315036|P15|Overall Study|Adverse Event|1
5589557|NCT00973349|19315037|P14|Overall Study|Adverse Event|0
5589558|NCT00973349|19315038|P13|Overall Study|Adverse Event|0
5589559|NCT00973349|19315039|P12|Overall Study|Adverse Event|0
5589560|NCT00973349|19315040|P11|Overall Study|Adverse Event|0
5589561|NCT00973349|19315041|P10|Overall Study|Adverse Event|0
5589562|NCT00973349|19315042|P9|Overall Study|Adverse Event|1
5589563|NCT00973349|19315043|P8|Overall Study|Adverse Event|0
5589564|NCT00973349|19315044|P7|Overall Study|Adverse Event|0
5589565|NCT00973349|19315045|P6|Overall Study|Adverse Event|0
5589566|NCT00973349|19315046|P5|Overall Study|Adverse Event|1
5589567|NCT00973349|19315047|P4|Overall Study|Adverse Event|0
5589568|NCT00973349|19315048|P3|Overall Study|Adverse Event|0
5589569|NCT00973349|19315049|P2|Overall Study|Adverse Event|0
5589570|NCT00973349|19315050|P1|Overall Study|Adverse Event|0
5589571|NCT00973102|19315150|P2|Overall Study|Prisoner|1
5589572|NCT00973102|19315151|P1|Overall Study|Prisoner|0
5589573|NCT00973102|19315150|P2|Overall Study|Protocol Violation|0
5589574|NCT00973102|19315151|P1|Overall Study|Protocol Violation|1
5589575|NCT00972816|19315182|P8|Overall Study|Unable to classify|0
5589576|NCT00972816|19315183|P7|Overall Study|Unable to classify|0
5589577|NCT00972816|19315184|P6|Overall Study|Unable to classify|0
5589578|NCT00972816|19315185|P5|Overall Study|Unable to classify|1
5589579|NCT00972816|19315186|P4|Overall Study|Unable to classify|0
5589580|NCT00972816|19315187|P3|Overall Study|Unable to classify|0
5589581|NCT00972816|19315188|P2|Overall Study|Unable to classify|0
5589582|NCT00972816|19315189|P1|Overall Study|Unable to classify|2
5589583|NCT00972816|19315182|P8|Overall Study|Inappropriate enrolment|0
5589584|NCT00972816|19315183|P7|Overall Study|Inappropriate enrolment|2
5589585|NCT00972816|19315184|P6|Overall Study|Inappropriate enrolment|0
5589586|NCT00972816|19315185|P5|Overall Study|Inappropriate enrolment|0
5589587|NCT00972816|19315186|P4|Overall Study|Inappropriate enrolment|0
5589588|NCT00972816|19315187|P3|Overall Study|Inappropriate enrolment|0
5589589|NCT00972816|19315188|P2|Overall Study|Inappropriate enrolment|0
5589590|NCT00972816|19315189|P1|Overall Study|Inappropriate enrolment|0
5589591|NCT00972816|19315182|P8|Overall Study|Lost to Follow-up|7
5589592|NCT00972816|19315183|P7|Overall Study|Lost to Follow-up|7
5589593|NCT00972816|19315184|P6|Overall Study|Lost to Follow-up|10
5589594|NCT00972816|19315185|P5|Overall Study|Lost to Follow-up|11
5589595|NCT00972816|19315186|P4|Overall Study|Lost to Follow-up|5
5589596|NCT00972816|19315187|P3|Overall Study|Lost to Follow-up|7
5589597|NCT00972816|19315188|P2|Overall Study|Lost to Follow-up|9
5589598|NCT00972816|19315189|P1|Overall Study|Lost to Follow-up|11
5589599|NCT00972816|19315182|P8|Overall Study|Withdrawal by Subject|2
5589600|NCT00972816|19315183|P7|Overall Study|Withdrawal by Subject|1
5589601|NCT00972816|19315184|P6|Overall Study|Withdrawal by Subject|1
5589602|NCT00972816|19315185|P5|Overall Study|Withdrawal by Subject|0
5589603|NCT00972816|19315186|P4|Overall Study|Withdrawal by Subject|3
5589604|NCT00972816|19315187|P3|Overall Study|Withdrawal by Subject|1
5589605|NCT00972816|19315188|P2|Overall Study|Withdrawal by Subject|2
5589606|NCT00972816|19315189|P1|Overall Study|Withdrawal by Subject|4
5589607|NCT00972816|19315182|P8|Overall Study|Adverse Event|0
5589608|NCT00972816|19315183|P7|Overall Study|Adverse Event|0
5589609|NCT00972816|19315184|P6|Overall Study|Adverse Event|0
5589610|NCT00972816|19315185|P5|Overall Study|Adverse Event|0
5589611|NCT00972816|19315186|P4|Overall Study|Adverse Event|0
5589612|NCT00972816|19315187|P3|Overall Study|Adverse Event|1
5589613|NCT00972816|19315188|P2|Overall Study|Adverse Event|0
5589614|NCT00972816|19315189|P1|Overall Study|Adverse Event|0
5589615|NCT00972777|19315273|P2|Overall Study|Missed visit|0
5589616|NCT00972777|19315274|P1|Overall Study|Missed visit|1
5589617|NCT00972777|19315273|P2|Overall Study|Screening Failure|1
5589618|NCT00972777|19315274|P1|Overall Study|Screening Failure|2
5589619|NCT00972777|19315273|P2|Overall Study|Protocol Violation|2
5589620|NCT00972777|19315274|P1|Overall Study|Protocol Violation|0
5589621|NCT00972777|19315273|P2|Overall Study|Physician Decision|0
5589622|NCT00972777|19315274|P1|Overall Study|Physician Decision|4
5589623|NCT00972777|19315273|P2|Overall Study|Withdrawal by Subject|5
5589624|NCT00972777|19315274|P1|Overall Study|Withdrawal by Subject|4
5589625|NCT00972777|19315273|P2|Overall Study|Lost to Follow-up|4
5589626|NCT00972777|19315274|P1|Overall Study|Lost to Follow-up|0
5589627|NCT00972777|19315273|P2|Overall Study|Adverse Event|2
5589628|NCT00972777|19315274|P1|Overall Study|Adverse Event|3
5589629|NCT00972738|19315289|P3|Overall Study|Other|1
5589630|NCT00972738|19315290|P2|Overall Study|Other|2
5589631|NCT00972738|19315291|P1|Overall Study|Other|1
5589632|NCT00972738|19315289|P3|Overall Study|Moved|1
5589633|NCT00972738|19315290|P2|Overall Study|Moved|0
5589634|NCT00972738|19315291|P1|Overall Study|Moved|0
5589635|NCT00972738|19315289|P3|Overall Study|Withdrawal by Subject|4
5589636|NCT00972738|19315290|P2|Overall Study|Withdrawal by Subject|1
5589637|NCT00972738|19315291|P1|Overall Study|Withdrawal by Subject|5
5589638|NCT00972738|19315289|P3|Overall Study|Lack of Efficacy|11
5589639|NCT00972738|19315290|P2|Overall Study|Lack of Efficacy|1
5589640|NCT00972738|19315291|P1|Overall Study|Lack of Efficacy|5
5589641|NCT00972738|19315289|P3|Overall Study|Lost to Follow-up|1
5589642|NCT00972738|19315290|P2|Overall Study|Lost to Follow-up|0
5589643|NCT00972738|19315291|P1|Overall Study|Lost to Follow-up|1
5589644|NCT00972738|19315289|P3|Overall Study|Protocol Violation|3
5589645|NCT00972738|19315290|P2|Overall Study|Protocol Violation|1
5589646|NCT00972738|19315291|P1|Overall Study|Protocol Violation|2
5589647|NCT00972738|19315289|P3|Overall Study|Adverse Event|8
5589648|NCT00972738|19315290|P2|Overall Study|Adverse Event|1
5589649|NCT00972738|19315291|P1|Overall Study|Adverse Event|7
5589650|NCT00972595|19315408|P2|Period 1|Adverse Event|0
5589651|NCT00972595|19315409|P1|Period 1|Adverse Event|1
5589652|NCT00972543|19315419|P2|Overall Study|Early study termination by sponsor|1
5589653|NCT00972543|19315420|P1|Overall Study|Early study termination by sponsor|4
5589654|NCT00972543|19315419|P2|Overall Study|Adverse Event|0
5589655|NCT00972543|19315420|P1|Overall Study|Adverse Event|1
5589656|NCT00972517|19315503|P6|Overall Study|Withdrawal by Subject|0
5589657|NCT00972517|19315504|P5|Overall Study|Withdrawal by Subject|1
5589658|NCT00972517|19315505|P4|Overall Study|Withdrawal by Subject|2
5589659|NCT00972517|19315506|P3|Overall Study|Withdrawal by Subject|0
5589660|NCT00972517|19315507|P2|Overall Study|Withdrawal by Subject|1
5589661|NCT00972517|19315508|P1|Overall Study|Withdrawal by Subject|0
5589662|NCT00972517|19315503|P6|Overall Study|Adverse Event|0
5589663|NCT00972517|19315504|P5|Overall Study|Adverse Event|0
5589664|NCT00972517|19315505|P4|Overall Study|Adverse Event|1
5589665|NCT00972517|19315506|P3|Overall Study|Adverse Event|0
5589666|NCT00972517|19315507|P2|Overall Study|Adverse Event|0
5589667|NCT00972517|19315508|P1|Overall Study|Adverse Event|0
5589668|NCT00972504|19315603|P1|Overall Study|Investigator discretion|1
5589669|NCT00972504|19315603|P1|Overall Study|Adverse Event|2
5589670|NCT00972478|19315635|P2|Overall Study|Not start protocol treatment|2
5589671|NCT00972478|19315636|P1|Overall Study|Not start protocol treatment|1
5589672|NCT00972478|19315635|P2|Overall Study|Ineligible|7
5589673|NCT00972478|19315636|P1|Overall Study|Ineligible|1
5589674|NCT00972478|19315635|P2|Overall Study|Not protocol specified|1
5589675|NCT00972478|19315636|P1|Overall Study|Not protocol specified|1
5589676|NCT00972478|19315635|P2|Overall Study|Death|2
5589677|NCT00972478|19315636|P1|Overall Study|Death|0
5589678|NCT00972478|19315635|P2|Overall Study|Progression/Relapse|2
5589679|NCT00972478|19315636|P1|Overall Study|Progression/Relapse|0
5589680|NCT00972478|19315635|P2|Overall Study|Withdrawal by Subject|8
5589681|NCT00972478|19315636|P1|Overall Study|Withdrawal by Subject|1
5589682|NCT00972478|19315635|P2|Overall Study|Adverse Event|16
5589683|NCT00972478|19315636|P1|Overall Study|Adverse Event|3
5589684|NCT00972322|19315681|P2|Overall Study|Consistently high glucose values|0
5589685|NCT00972322|19315682|P1|Overall Study|Consistently high glucose values|1
5589686|NCT00972322|19315681|P2|Overall Study|Lost to Follow-up|1
5589687|NCT00972322|19315682|P1|Overall Study|Lost to Follow-up|0
5589688|NCT00972322|19315681|P2|Overall Study|Positive drug screen|1
5589689|NCT00972322|19315682|P1|Overall Study|Positive drug screen|0
5589690|NCT00972322|19315681|P2|Overall Study|Adverse Event|1
5589691|NCT00972322|19315682|P1|Overall Study|Adverse Event|2
5589692|NCT00972283|19315694|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
5589693|NCT00972283|19315695|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
5589694|NCT00972283|19315694|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
5589695|NCT00972283|19315695|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
5589696|NCT00972283|19315694|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
5589697|NCT00972283|19315695|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
5589698|NCT00972283|19315694|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
5589699|NCT00972283|19315695|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
5589700|NCT00972283|19315694|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
5589701|NCT00972283|19315695|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
5589702|NCT00972283|19315694|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
5589703|NCT00972283|19315695|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
5589704|NCT00972283|19315694|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
5589705|NCT00972283|19315695|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
5589706|NCT00972283|19315694|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
5589707|NCT00972283|19315695|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
5589708|NCT00972283|19315694|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
5589709|NCT00972283|19315695|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
5589710|NCT00972283|19315694|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
5589711|NCT00972283|19315695|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
5589712|NCT00972244|19315722|P5|Overall Study|Various|2
5589713|NCT00972244|19315723|P4|Overall Study|Various|0
5589714|NCT00972244|19315724|P3|Overall Study|Various|0
5589715|NCT00972244|19315725|P2|Overall Study|Various|0
5589716|NCT00972244|19315726|P1|Overall Study|Various|0
5589717|NCT00972244|19315722|P5|Overall Study|Death|0
5589718|NCT00972244|19315723|P4|Overall Study|Death|0
5589719|NCT00972244|19315724|P3|Overall Study|Death|0
5589720|NCT00972244|19315725|P2|Overall Study|Death|0
5589721|NCT00972244|19315726|P1|Overall Study|Death|1
5589722|NCT00972244|19315722|P5|Overall Study|Safety|1
5589723|NCT00972244|19315723|P4|Overall Study|Safety|0
5589724|NCT00972244|19315724|P3|Overall Study|Safety|0
5589725|NCT00972244|19315725|P2|Overall Study|Safety|0
5589726|NCT00972244|19315726|P1|Overall Study|Safety|0
5589727|NCT00972244|19315722|P5|Overall Study|Withdrawal by Subject|1
5589728|NCT00972244|19315723|P4|Overall Study|Withdrawal by Subject|0
5589729|NCT00972244|19315724|P3|Overall Study|Withdrawal by Subject|1
5589730|NCT00972244|19315725|P2|Overall Study|Withdrawal by Subject|2
5589731|NCT00972244|19315726|P1|Overall Study|Withdrawal by Subject|1
5589732|NCT00972244|19315722|P5|Overall Study|Subject No Longer Meets Study Criteria|5
5589733|NCT00972244|19315723|P4|Overall Study|Subject No Longer Meets Study Criteria|0
5589734|NCT00972244|19315724|P3|Overall Study|Subject No Longer Meets Study Criteria|0
5589735|NCT00972244|19315725|P2|Overall Study|Subject No Longer Meets Study Criteria|2
5589736|NCT00972244|19315726|P1|Overall Study|Subject No Longer Meets Study Criteria|2
5589737|NCT00972244|19315722|P5|Overall Study|Adverse Event|0
5589738|NCT00972244|19315723|P4|Overall Study|Adverse Event|0
5589739|NCT00972244|19315724|P3|Overall Study|Adverse Event|1
5589740|NCT00972244|19315725|P2|Overall Study|Adverse Event|1
5589741|NCT00972244|19315726|P1|Overall Study|Adverse Event|0
5589742|NCT00972244|19315722|P5|Overall Study|Incorrect Enrolment|0
5589743|NCT00972244|19315723|P4|Overall Study|Incorrect Enrolment|0
5589744|NCT00972244|19315724|P3|Overall Study|Incorrect Enrolment|0
5589745|NCT00972244|19315725|P2|Overall Study|Incorrect Enrolment|0
5589746|NCT00972244|19315726|P1|Overall Study|Incorrect Enrolment|1
5589747|NCT00972153|19315758|P3|Overall Study|Equipment malfunction during case|0
5589748|NCT00972153|19315759|P2|Overall Study|Equipment malfunction during case|1
5589749|NCT00972153|19315760|P1|Overall Study|Equipment malfunction during case|0
5589750|NCT00972023|19315775|P1|Overall Study|Withdrawal by Subject|1
5589751|NCT00971997|19315782|P1|Overall Study|Physician Decision|7
5589752|NCT00971997|19315782|P1|Overall Study|Withdrawal by Subject|5
5589753|NCT00971997|19315782|P1|Overall Study|Protocol Violation|4
5589754|NCT00971997|19315782|P1|Overall Study|Death|1
5589755|NCT00971997|19315782|P1|Overall Study|Adverse Event|2
5589756|NCT00971932|19315800|P1|Overall Study|Ongoing|4
5589757|NCT00971932|19315800|P1|Overall Study|Investigator's decision|2
5589758|NCT00971932|19315800|P1|Overall Study|Withdrawal by Subject|1
5589759|NCT00971425|19315901|P2|Overall Study|Withdrawal by Subject|1
5589760|NCT00971425|19315902|P1|Overall Study|Withdrawal by Subject|0
5589761|NCT00971425|19315901|P2|Overall Study|Adverse Event|1
5589762|NCT00971425|19315902|P1|Overall Study|Adverse Event|1
5589763|NCT00971321|19315938|P2|Up to Month 11-12|Lost to Follow-up|0
5589764|NCT00971321|19315939|P1|Up to Month 11-12|Lost to Follow-up|1
5589765|NCT00971321|19315938|P2|Up to Month 11-12|Migrated/moved from study area|2
5589766|NCT00971321|19315939|P1|Up to Month 11-12|Migrated/moved from study area|2
5589767|NCT00971321|19315938|P2|Up to Month 11-12|Withdrawal by Subject|1
5589768|NCT00971321|19315939|P1|Up to Month 11-12|Withdrawal by Subject|2
5589769|NCT00971321|19315938|P2|Up to Month 7|Migrated/moved from study area|2
5589770|NCT00971321|19315939|P1|Up to Month 7|Migrated/moved from study area|3
5589771|NCT00971321|19315938|P2|Up to Month 7|Withdrawal by Subject|0
5589772|NCT00971321|19315939|P1|Up to Month 7|Withdrawal by Subject|1
5589773|NCT00971243|19316019|P5|Open-label Period|Other reason|2
5589774|NCT00971243|19316020|P4|Open-label Period|Other reason|0
5589775|NCT00971243|19316021|P3|Open-label Period|Other reason|0
5589776|NCT00971243|19316022|P2|Open-label Period|Other reason|0
5589777|NCT00971243|19316023|P1|Open-label Period|Other reason|0
5589778|NCT00971243|19316019|P5|Open-label Period|Withdrawal by Subject|1
5589779|NCT00971243|19316020|P4|Open-label Period|Withdrawal by Subject|2
5589780|NCT00971243|19316021|P3|Open-label Period|Withdrawal by Subject|0
5589781|NCT00971243|19316022|P2|Open-label Period|Withdrawal by Subject|0
5589782|NCT00971243|19316023|P1|Open-label Period|Withdrawal by Subject|1
5589783|NCT00971243|19316019|P5|Open-label Period|Protocol Violation|1
5589784|NCT00971243|19316020|P4|Open-label Period|Protocol Violation|0
5589785|NCT00971243|19316021|P3|Open-label Period|Protocol Violation|1
5589786|NCT00971243|19316022|P2|Open-label Period|Protocol Violation|1
5589787|NCT00971243|19316023|P1|Open-label Period|Protocol Violation|1
5589788|NCT00971243|19316019|P5|Open-label Period|Physician Decision|2
5589789|NCT00971243|19316020|P4|Open-label Period|Physician Decision|7
5589790|NCT00971243|19316021|P3|Open-label Period|Physician Decision|3
5589791|NCT00971243|19316022|P2|Open-label Period|Physician Decision|9
5589792|NCT00971243|19316023|P1|Open-label Period|Physician Decision|5
5589793|NCT00971243|19316019|P5|Open-label Period|Adverse Event|0
5589794|NCT00971243|19316020|P4|Open-label Period|Adverse Event|1
5589795|NCT00971243|19316021|P3|Open-label Period|Adverse Event|1
5589796|NCT00971243|19316022|P2|Open-label Period|Adverse Event|0
5589797|NCT00971243|19316023|P1|Open-label Period|Adverse Event|1
5589798|NCT00971243|19316019|P5|Double Blind Period|Other reasons|1
5589799|NCT00971243|19316020|P4|Double Blind Period|Other reasons|0
5589800|NCT00971243|19316021|P3|Double Blind Period|Other reasons|2
5589801|NCT00971243|19316022|P2|Double Blind Period|Other reasons|0
5589802|NCT00971243|19316023|P1|Double Blind Period|Other reasons|1
5589803|NCT00971243|19316019|P5|Double Blind Period|Withdrawal by Subject|4
5589804|NCT00971243|19316020|P4|Double Blind Period|Withdrawal by Subject|4
5589805|NCT00971243|19316021|P3|Double Blind Period|Withdrawal by Subject|4
5589806|NCT00971243|19316022|P2|Double Blind Period|Withdrawal by Subject|1
5589807|NCT00971243|19316023|P1|Double Blind Period|Withdrawal by Subject|4
5589808|NCT00971243|19316019|P5|Double Blind Period|Protocol Violation|2
5589809|NCT00971243|19316020|P4|Double Blind Period|Protocol Violation|2
5589810|NCT00971243|19316021|P3|Double Blind Period|Protocol Violation|3
5589811|NCT00971243|19316022|P2|Double Blind Period|Protocol Violation|0
5589812|NCT00971243|19316023|P1|Double Blind Period|Protocol Violation|2
5589813|NCT00971243|19316019|P5|Double Blind Period|Physician Decision|7
5589814|NCT00971243|19316020|P4|Double Blind Period|Physician Decision|6
5589815|NCT00971243|19316021|P3|Double Blind Period|Physician Decision|7
5589816|NCT00971243|19316022|P2|Double Blind Period|Physician Decision|6
5589817|NCT00971243|19316023|P1|Double Blind Period|Physician Decision|10
5589818|NCT00971243|19316019|P5|Double Blind Period|Lost to Follow-up|1
5589819|NCT00971243|19316020|P4|Double Blind Period|Lost to Follow-up|0
5589820|NCT00971243|19316021|P3|Double Blind Period|Lost to Follow-up|1
5589821|NCT00971243|19316022|P2|Double Blind Period|Lost to Follow-up|1
5589822|NCT00971243|19316023|P1|Double Blind Period|Lost to Follow-up|0
5589823|NCT00971243|19316019|P5|Double Blind Period|Adverse Event|3
5589824|NCT00971243|19316020|P4|Double Blind Period|Adverse Event|2
5589825|NCT00971243|19316021|P3|Double Blind Period|Adverse Event|2
5589826|NCT00971243|19316022|P2|Double Blind Period|Adverse Event|3
5589827|NCT00971243|19316023|P1|Double Blind Period|Adverse Event|2
5589828|NCT00971204|19316040|P1|Overall Study|Lost to Follow-up|10
5589829|NCT00971204|19316040|P1|Overall Study|Did not meet all criteria-not treated|14
5589830|NCT00971178|19316047|P3|Overall Study|Lost to Follow-up|2
5589831|NCT00971178|19316048|P2|Overall Study|Lost to Follow-up|2
5589832|NCT00971178|19316049|P1|Overall Study|Lost to Follow-up|2
5589833|NCT00971048|19316061|P4|Overall Study|Physician Decision|1
5589834|NCT00971048|19316062|P3|Overall Study|Physician Decision|0
5589835|NCT00971048|19316063|P2|Overall Study|Physician Decision|0
5589836|NCT00971048|19316064|P1|Overall Study|Physician Decision|0
5589837|NCT00971048|19316061|P4|Overall Study|Adverse Event|0
5589838|NCT00971048|19316062|P3|Overall Study|Adverse Event|1
5589839|NCT00971048|19316063|P2|Overall Study|Adverse Event|0
5589840|NCT00971048|19316064|P1|Overall Study|Adverse Event|0
5589841|NCT00971048|19316061|P4|Overall Study|Protocol Violation|1
5589842|NCT00971048|19316062|P3|Overall Study|Protocol Violation|0
5589843|NCT00971048|19316063|P2|Overall Study|Protocol Violation|2
5589844|NCT00971048|19316064|P1|Overall Study|Protocol Violation|1
5589845|NCT00970944|19316088|P2|Overall Study|Physician Decision|2
5589846|NCT00970944|19316089|P1|Overall Study|Physician Decision|0
5589847|NCT00970944|19316088|P2|Overall Study|Death|0
5589848|NCT00970944|19316089|P1|Overall Study|Death|1
5589849|NCT00970684|19316141|P1|Overall Study|Withdrawal by Subject|1
5589850|NCT00970684|19316141|P1|Overall Study|Adverse Event|4
5589851|NCT00970684|19316141|P1|Overall Study|Lack of Efficacy|5
5589852|NCT00970632|19316150|P3|Overall Study|Sponsor decision|1
5589853|NCT00970632|19316151|P2|Overall Study|Sponsor decision|0
5589854|NCT00970632|19316152|P1|Overall Study|Sponsor decision|1
5589855|NCT00970632|19316150|P3|Overall Study|Entry criteria not met|2
5589856|NCT00970632|19316151|P2|Overall Study|Entry criteria not met|2
5589857|NCT00970632|19316152|P1|Overall Study|Entry criteria not met|0
5589858|NCT00970632|19316150|P3|Overall Study|Withdrawal by Subject|4
5589859|NCT00970632|19316151|P2|Overall Study|Withdrawal by Subject|6
5589860|NCT00970632|19316152|P1|Overall Study|Withdrawal by Subject|7
5589861|NCT00970632|19316150|P3|Overall Study|Protocol Violation|8
5589862|NCT00970632|19316151|P2|Overall Study|Protocol Violation|5
5589863|NCT00970632|19316152|P1|Overall Study|Protocol Violation|8
5589864|NCT00970632|19316150|P3|Overall Study|Lost to Follow-up|2
5589865|NCT00970632|19316151|P2|Overall Study|Lost to Follow-up|0
5589866|NCT00970632|19316152|P1|Overall Study|Lost to Follow-up|3
5589867|NCT00970632|19316150|P3|Overall Study|Lack of Efficacy|0
5589868|NCT00970632|19316151|P2|Overall Study|Lack of Efficacy|0
5589869|NCT00970632|19316152|P1|Overall Study|Lack of Efficacy|3
5589870|NCT00970632|19316150|P3|Overall Study|Adverse Event|1
5589871|NCT00970632|19316151|P2|Overall Study|Adverse Event|2
5589872|NCT00970632|19316152|P1|Overall Study|Adverse Event|2
5589873|NCT00970593|19316224|P7|Overall Study|Withdrawal by Subject|0
5589874|NCT00970593|19316225|P6|Overall Study|Withdrawal by Subject|0
5589875|NCT00970593|19316226|P5|Overall Study|Withdrawal by Subject|0
5589876|NCT00970593|19316227|P4|Overall Study|Withdrawal by Subject|0
5589877|NCT00970593|19316228|P3|Overall Study|Withdrawal by Subject|1
5589878|NCT00970593|19316229|P2|Overall Study|Withdrawal by Subject|0
5589879|NCT00970593|19316230|P1|Overall Study|Withdrawal by Subject|0
5589880|NCT00970593|19316224|P7|Overall Study|Discontinuation of study by sponsor|2
5589881|NCT00970593|19316225|P6|Overall Study|Discontinuation of study by sponsor|0
5589882|NCT00970593|19316226|P5|Overall Study|Discontinuation of study by sponsor|0
5589883|NCT00970593|19316227|P4|Overall Study|Discontinuation of study by sponsor|0
5589884|NCT00970593|19316228|P3|Overall Study|Discontinuation of study by sponsor|5
5589885|NCT00970593|19316229|P2|Overall Study|Discontinuation of study by sponsor|0
5589886|NCT00970593|19316230|P1|Overall Study|Discontinuation of study by sponsor|0
5589887|NCT00970593|19316224|P7|Overall Study|Adverse Event|0
5589888|NCT00970593|19316225|P6|Overall Study|Adverse Event|0
5589889|NCT00970593|19316226|P5|Overall Study|Adverse Event|0
5589890|NCT00970593|19316227|P4|Overall Study|Adverse Event|0
5589891|NCT00970593|19316228|P3|Overall Study|Adverse Event|0
5589892|NCT00970593|19316229|P2|Overall Study|Adverse Event|1
5589893|NCT00970593|19316230|P1|Overall Study|Adverse Event|1
5589894|NCT00970502|19316312|P1|Overall Study|Withdrawal by Subject|1
5589895|NCT00970489|19316323|P2|Overall Study|Death/Withdrew/Criteria Violation|41
5589896|NCT00970489|19316324|P1|Overall Study|Death/Withdrew/Criteria Violation|54
5589897|NCT00970359|19316336|P1|Overall Study|Not Treated|4
5589898|NCT00970307|19316366|P3|Overall Study|Withdrawal by Subject|2
5589899|NCT00970307|19316367|P2|Overall Study|Withdrawal by Subject|3
5589900|NCT00970307|19316368|P1|Overall Study|Withdrawal by Subject|2
5589901|NCT00970307|19316366|P3|Overall Study|Serious Adverse Event|0
5589902|NCT00970307|19316367|P2|Overall Study|Serious Adverse Event|0
5589903|NCT00970307|19316368|P1|Overall Study|Serious Adverse Event|1
5589904|NCT00970294|19316442|P1|Overall Study|Withdrawal by Subject|1
5589905|NCT00970294|19316442|P1|Overall Study|Physician Decision|4
5589906|NCT00970281|19316450|P2|Overall Study|Physician Decision|1
5589907|NCT00970281|19316451|P1|Overall Study|Physician Decision|1
5589908|NCT00970281|19316450|P2|Overall Study|Withdrawal by Subject|1
5589909|NCT00970281|19316451|P1|Overall Study|Withdrawal by Subject|0
5589910|NCT00970281|19316450|P2|Overall Study|Lack of Efficacy|14
5589911|NCT00970281|19316451|P1|Overall Study|Lack of Efficacy|1
5589912|NCT00970268|19316469|P2|Overall Study|Inclusion/Exclusion Criteria|0
5589913|NCT00970268|19316470|P1|Overall Study|Inclusion/Exclusion Criteria|1
5589914|NCT00970268|19316469|P2|Overall Study|Lost to Follow-up|2
5589915|NCT00970268|19316470|P1|Overall Study|Lost to Follow-up|1
5589916|NCT00970268|19316469|P2|Overall Study|COPD Exacerbation|2
5589917|NCT00970268|19316470|P1|Overall Study|COPD Exacerbation|4
5589918|NCT00970268|19316469|P2|Overall Study|Other Reason|1
5589919|NCT00970268|19316470|P1|Overall Study|Other Reason|3
5589920|NCT00970268|19316469|P2|Overall Study|Protocol Violation|7
5589921|NCT00970268|19316470|P1|Overall Study|Protocol Violation|4
5589922|NCT00970268|19316469|P2|Overall Study|Lack of Efficacy|6
5589923|NCT00970268|19316470|P1|Overall Study|Lack of Efficacy|3
5589924|NCT00970268|19316469|P2|Overall Study|Adverse Event|12
5589925|NCT00970268|19316470|P1|Overall Study|Adverse Event|15
5589926|NCT00970268|19316469|P2|Overall Study|Withdrawal by Subject|19
5589927|NCT00970268|19316470|P1|Overall Study|Withdrawal by Subject|12
5589928|NCT00969761|19316556|P12|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5589929|NCT00969761|19316557|P11|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5589930|NCT00969761|19316558|P10|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5589931|NCT00969761|19316559|P9|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
5589932|NCT00969761|19316560|P8|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5589933|NCT00969761|19316561|P7|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5589934|NCT00969761|19316562|P6|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5589935|NCT00969761|19316563|P5|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
5589936|NCT00969761|19316564|P4|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
5589937|NCT00969761|19316565|P3|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5589938|NCT00969761|19316566|P2|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5589939|NCT00969761|19316567|P1|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
5589940|NCT00969761|19316556|P12|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5589941|NCT00969761|19316557|P11|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5589942|NCT00969761|19316558|P10|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
5589943|NCT00969761|19316559|P9|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
5589944|NCT00969761|19316560|P8|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
5589945|NCT00969761|19316561|P7|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5589946|NCT00969761|19316562|P6|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5589947|NCT00969761|19316563|P5|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
5589948|NCT00969761|19316564|P4|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5589949|NCT00969761|19316565|P3|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
5589950|NCT00969761|19316566|P2|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
5589951|NCT00969761|19316567|P1|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
5589952|NCT00969761|19316556|P12|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589953|NCT00969761|19316557|P11|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589954|NCT00969761|19316558|P10|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589955|NCT00969761|19316559|P9|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
5589956|NCT00969761|19316560|P8|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589957|NCT00969761|19316561|P7|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589958|NCT00969761|19316562|P6|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589959|NCT00969761|19316563|P5|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589960|NCT00969761|19316564|P4|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589961|NCT00969761|19316565|P3|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589962|NCT00969761|19316566|P2|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589963|NCT00969761|19316567|P1|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
5589964|NCT00969761|19316556|P12|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589965|NCT00969761|19316557|P11|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589966|NCT00969761|19316558|P10|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589967|NCT00969761|19316559|P9|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589968|NCT00969761|19316560|P8|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589969|NCT00969761|19316561|P7|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589970|NCT00969761|19316562|P6|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589971|NCT00969761|19316563|P5|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589972|NCT00969761|19316564|P4|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589973|NCT00969761|19316565|P3|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
5589974|NCT00969761|19316566|P2|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589975|NCT00969761|19316567|P1|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
5589976|NCT00969761|19316556|P12|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589977|NCT00969761|19316557|P11|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589978|NCT00969761|19316558|P10|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589979|NCT00969761|19316559|P9|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589980|NCT00969761|19316560|P8|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589981|NCT00969761|19316561|P7|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589982|NCT00969761|19316562|P6|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589983|NCT00969761|19316563|P5|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589984|NCT00969761|19316564|P4|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589985|NCT00969761|19316565|P3|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
5589986|NCT00969761|19316566|P2|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589987|NCT00969761|19316567|P1|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
5589988|NCT00969761|19316556|P12|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5589989|NCT00969761|19316557|P11|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5589990|NCT00969761|19316558|P10|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5589991|NCT00969761|19316559|P9|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5589992|NCT00969761|19316560|P8|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5589993|NCT00969761|19316561|P7|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5589994|NCT00969761|19316562|P6|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5589995|NCT00969761|19316563|P5|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5589996|NCT00969761|19316564|P4|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5589997|NCT00969761|19316565|P3|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5589998|NCT00969761|19316566|P2|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
5589999|NCT00969761|19316567|P1|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
5590000|NCT00969709|19316873|P4|Overall Study|Other reasons|0
5590001|NCT00969709|19316874|P3|Overall Study|Other reasons|3
5590002|NCT00969709|19316875|P2|Overall Study|Other reasons|0
5590003|NCT00969709|19316876|P1|Overall Study|Other reasons|0
5590004|NCT00969709|19316873|P4|Overall Study|Lost to Follow-up|15
5590005|NCT00969709|19316874|P3|Overall Study|Lost to Follow-up|8
5590006|NCT00969709|19316875|P2|Overall Study|Lost to Follow-up|14
5590007|NCT00969709|19316876|P1|Overall Study|Lost to Follow-up|10
5590008|NCT00969709|19316873|P4|Overall Study|Withdrawal by Subject|23
5590009|NCT00969709|19316874|P3|Overall Study|Withdrawal by Subject|11
5590010|NCT00969709|19316875|P2|Overall Study|Withdrawal by Subject|12
5590011|NCT00969709|19316876|P1|Overall Study|Withdrawal by Subject|9
5590012|NCT00969709|19316873|P4|Overall Study|Protocol Violation|10
5590013|NCT00969709|19316874|P3|Overall Study|Protocol Violation|9
5590014|NCT00969709|19316875|P2|Overall Study|Protocol Violation|5
5590015|NCT00969709|19316876|P1|Overall Study|Protocol Violation|9
5590016|NCT00969709|19316873|P4|Overall Study|Lack of Efficacy|3
5590017|NCT00969709|19316874|P3|Overall Study|Lack of Efficacy|1
5590018|NCT00969709|19316875|P2|Overall Study|Lack of Efficacy|4
5590019|NCT00969709|19316876|P1|Overall Study|Lack of Efficacy|7
5590020|NCT00969709|19316873|P4|Overall Study|Adverse Event|12
5590021|NCT00969709|19316874|P3|Overall Study|Adverse Event|26
5590022|NCT00969709|19316875|P2|Overall Study|Adverse Event|13
5590023|NCT00969709|19316876|P1|Overall Study|Adverse Event|3
5590024|NCT00969618|19316890|P1|Overall Study|Withdrawal by Subject|27
5590025|NCT00969618|19316890|P1|Overall Study|Protocol Violation|9
5590026|NCT00969618|19316890|P1|Overall Study|Physician Decision|1
5590027|NCT00969618|19316890|P1|Overall Study|Lost to Follow-up|7
5590028|NCT00969618|19316890|P1|Overall Study|Lack of Efficacy|2
5590029|NCT00969618|19316890|P1|Overall Study|Entry Criteria Not Met|3
5590030|NCT00969618|19316890|P1|Overall Study|Adverse Event|29
5590031|NCT00969553|19316910|P9|Overall Study|Not specified above|0
5590032|NCT00969553|19316911|P8|Overall Study|Not specified above|1
5590033|NCT00969553|19316912|P7|Overall Study|Not specified above|1
5590034|NCT00969553|19316913|P6|Overall Study|Not specified above|0
5590035|NCT00969553|19316914|P5|Overall Study|Not specified above|0
5590036|NCT00969553|19316915|P4|Overall Study|Not specified above|4
5590037|NCT00969553|19316916|P3|Overall Study|Not specified above|0
5590038|NCT00969553|19316917|P2|Overall Study|Not specified above|0
5590039|NCT00969553|19316918|P1|Overall Study|Not specified above|0
5590040|NCT00969553|19316910|P9|Overall Study|Refused cont. medication|0
5590041|NCT00969553|19316911|P8|Overall Study|Refused cont. medication|1
5590042|NCT00969553|19316912|P7|Overall Study|Refused cont. medication|0
5590043|NCT00969553|19316913|P6|Overall Study|Refused cont. medication|0
5590044|NCT00969553|19316914|P5|Overall Study|Refused cont. medication|0
5590045|NCT00969553|19316915|P4|Overall Study|Refused cont. medication|2
5590046|NCT00969553|19316916|P3|Overall Study|Refused cont. medication|0
5590047|NCT00969553|19316917|P2|Overall Study|Refused cont. medication|1
5590048|NCT00969553|19316918|P1|Overall Study|Refused cont. medication|1
5590049|NCT00969553|19316910|P9|Overall Study|Other Adverse Event|0
5590050|NCT00969553|19316911|P8|Overall Study|Other Adverse Event|0
5590051|NCT00969553|19316912|P7|Overall Study|Other Adverse Event|1
5590052|NCT00969553|19316913|P6|Overall Study|Other Adverse Event|0
5590053|NCT00969553|19316914|P5|Overall Study|Other Adverse Event|0
5590054|NCT00969553|19316915|P4|Overall Study|Other Adverse Event|1
5590055|NCT00969553|19316916|P3|Overall Study|Other Adverse Event|0
5590056|NCT00969553|19316917|P2|Overall Study|Other Adverse Event|0
5590057|NCT00969553|19316918|P1|Overall Study|Other Adverse Event|0
5590058|NCT00969553|19316910|P9|Overall Study|Dose limiting Toxicity (DLT)|0
5590059|NCT00969553|19316911|P8|Overall Study|Dose limiting Toxicity (DLT)|0
5590060|NCT00969553|19316912|P7|Overall Study|Dose limiting Toxicity (DLT)|0
5590061|NCT00969553|19316913|P6|Overall Study|Dose limiting Toxicity (DLT)|0
5590062|NCT00969553|19316914|P5|Overall Study|Dose limiting Toxicity (DLT)|1
5590063|NCT00969553|19316915|P4|Overall Study|Dose limiting Toxicity (DLT)|0
5590064|NCT00969553|19316916|P3|Overall Study|Dose limiting Toxicity (DLT)|0
5590065|NCT00969553|19316917|P2|Overall Study|Dose limiting Toxicity (DLT)|0
5590066|NCT00969553|19316918|P1|Overall Study|Dose limiting Toxicity (DLT)|0
5590067|NCT00969553|19316910|P9|Overall Study|Progressive disease (PD)|3
5590068|NCT00969553|19316911|P8|Overall Study|Progressive disease (PD)|12
5590069|NCT00969553|19316912|P7|Overall Study|Progressive disease (PD)|2
5590070|NCT00969553|19316913|P6|Overall Study|Progressive disease (PD)|4
5590071|NCT00969553|19316914|P5|Overall Study|Progressive disease (PD)|2
5590072|NCT00969553|19316915|P4|Overall Study|Progressive disease (PD)|9
5590073|NCT00969553|19316916|P3|Overall Study|Progressive disease (PD)|6
5590074|NCT00969553|19316917|P2|Overall Study|Progressive disease (PD)|2
5590075|NCT00969553|19316918|P1|Overall Study|Progressive disease (PD)|2
5590076|NCT00969540|19317061|P2|Overall Study|Lost to Follow-up|1
5590077|NCT00969540|19317062|P1|Overall Study|Lost to Follow-up|1
5590078|NCT00969436|19317087|P3|Overall Study|Lost to Follow-up|5
5590079|NCT00969436|19317088|P2|Overall Study|Lost to Follow-up|8
5590080|NCT00969436|19317089|P1|Overall Study|Lost to Follow-up|8
5590081|NCT00969436|19317087|P3|Overall Study|Withdrawal by Subject|2
5590082|NCT00969436|19317088|P2|Overall Study|Withdrawal by Subject|0
5590083|NCT00969436|19317089|P1|Overall Study|Withdrawal by Subject|3
5590084|NCT00969436|19317087|P3|Overall Study|Subject eliminated (other vaccine)|0
5590085|NCT00969436|19317088|P2|Overall Study|Subject eliminated (other vaccine)|0
5590086|NCT00969436|19317089|P1|Overall Study|Subject eliminated (other vaccine)|1
5590087|NCT00969436|19317087|P3|Overall Study|Parents personal problem|1
5590088|NCT00969436|19317088|P2|Overall Study|Parents personal problem|0
5590089|NCT00969436|19317089|P1|Overall Study|Parents personal problem|0
5590090|NCT00969436|19317087|P3|Overall Study|Father - serious health problem|1
5590091|NCT00969436|19317088|P2|Overall Study|Father - serious health problem|0
5590092|NCT00969436|19317089|P1|Overall Study|Father - serious health problem|0
5590093|NCT00969436|19317087|P3|Overall Study|Migrated/moved from study area|2
5590094|NCT00969436|19317088|P2|Overall Study|Migrated/moved from study area|10
5590095|NCT00969436|19317089|P1|Overall Study|Migrated/moved from study area|12
5590096|NCT00969436|19317087|P3|Overall Study|Protocol Violation|0
5590097|NCT00969436|19317088|P2|Overall Study|Protocol Violation|3
5590098|NCT00969436|19317089|P1|Overall Study|Protocol Violation|1
5590099|NCT00969332|19317121|P1|Overall Study|Withdrawal by Subject|3
5590100|NCT00969332|19317121|P1|Overall Study|Physician Decision|8
5590101|NCT00969280|19317137|P2|Overall Study|infection of influenza A(H1N1)|1
5590102|NCT00969280|19317138|P1|Overall Study|infection of influenza A(H1N1)|0
5590103|NCT00969280|19317137|P2|Overall Study|Withdrawal by Subject|1
5590104|NCT00969280|19317138|P1|Overall Study|Withdrawal by Subject|0
5590105|NCT00969280|19317137|P2|Overall Study|Protocol Violation|1
5590106|NCT00969280|19317138|P1|Overall Study|Protocol Violation|2
5590107|NCT00969228|19317146|P2|Overall Study|Porcine circovirus detection in vaccine|14
5590108|NCT00969228|19317147|P1|Overall Study|Porcine circovirus detection in vaccine|38
5590109|NCT00969228|19317146|P2|Overall Study|Withdrawal by Subject|0
5590110|NCT00969228|19317147|P1|Overall Study|Withdrawal by Subject|4
5590111|NCT00969228|19317146|P2|Overall Study|Adverse Event|0
5590112|NCT00969228|19317147|P1|Overall Study|Adverse Event|1
5590113|NCT00969150|19317165|P2|Overall Study|Other reasons|0
5590114|NCT00969150|19317166|P1|Overall Study|Other reasons|1
5590115|NCT00969150|19317165|P2|Overall Study|Lost to Follow-up|4
5590116|NCT00969150|19317166|P1|Overall Study|Lost to Follow-up|5
5590117|NCT00969150|19317165|P2|Overall Study|Withdrawal by Subject|9
5590118|NCT00969150|19317166|P1|Overall Study|Withdrawal by Subject|13
5590119|NCT00969150|19317165|P2|Overall Study|Protocol Violation|12
5590120|NCT00969150|19317166|P1|Overall Study|Protocol Violation|9
5590121|NCT00969150|19317165|P2|Overall Study|Lack of Efficacy|1
5590122|NCT00969150|19317166|P1|Overall Study|Lack of Efficacy|1
5590123|NCT00969150|19317165|P2|Overall Study|Adverse Event|14
5590124|NCT00969150|19317166|P1|Overall Study|Adverse Event|4
5590125|NCT00969124|19317174|P1|Overall Study|Technical error|1
5590126|NCT00969124|19317174|P1|Overall Study|Previously unrecognized disease|3
5590127|NCT00969124|19317174|P1|Overall Study|Inability to reach cecum|9
5590128|NCT00969124|19317174|P1|Overall Study|Inadequate bowel preparation|15
5590129|NCT00969124|19317174|P1|Overall Study|Protocol Violation|2
5590130|NCT00968981|19317183|P3|Overall Study|Withdrawal by Subject|3
5590131|NCT00968981|19317184|P2|Overall Study|Withdrawal by Subject|3
5590132|NCT00968981|19317185|P1|Overall Study|Withdrawal by Subject|1
5590133|NCT00968981|19317183|P3|Overall Study|Physician Decision|5
5590134|NCT00968981|19317184|P2|Overall Study|Physician Decision|3
5590135|NCT00968981|19317185|P1|Overall Study|Physician Decision|5
5590136|NCT00968981|19317183|P3|Overall Study|Lost to Follow-up|1
5590137|NCT00968981|19317184|P2|Overall Study|Lost to Follow-up|0
5590138|NCT00968981|19317185|P1|Overall Study|Lost to Follow-up|0
5590139|NCT00968981|19317183|P3|Overall Study|Disease Progression|13
5590140|NCT00968981|19317184|P2|Overall Study|Disease Progression|16
5590141|NCT00968981|19317185|P1|Overall Study|Disease Progression|14
5590142|NCT00968981|19317183|P3|Overall Study|Adverse Event|0
5590143|NCT00968981|19317184|P2|Overall Study|Adverse Event|0
5590144|NCT00968981|19317185|P1|Overall Study|Adverse Event|2
5590145|NCT00968968|19317223|P2|Overall Study|Lost to Follow-up|1
5590146|NCT00968968|19317224|P1|Overall Study|Lost to Follow-up|0
5590147|NCT00968968|19317223|P2|Overall Study|Physician Decision|2
5590148|NCT00968968|19317224|P1|Overall Study|Physician Decision|1
5590149|NCT00968968|19317223|P2|Overall Study|Withdrawal by Subject|0
5590150|NCT00968968|19317224|P1|Overall Study|Withdrawal by Subject|2
5590151|NCT00968968|19317223|P2|Overall Study|Protocol defined stopping criteria|1
5590152|NCT00968968|19317224|P1|Overall Study|Protocol defined stopping criteria|3
5590153|NCT00968968|19317223|P2|Overall Study|Study closed/terminated|10
5590154|NCT00968968|19317224|P1|Overall Study|Study closed/terminated|10
5590155|NCT00968864|19317270|P1|Overall Study|Protocol exception/ not evaluable|1
5590156|NCT00968812|19317298|P3|Overall Study|Other|40
5590157|NCT00968812|19317299|P2|Overall Study|Other|37
5590158|NCT00968812|19317300|P1|Overall Study|Other|25
5590159|NCT00968812|19317298|P3|Overall Study|Unable to take rescue therapy|17
5590160|NCT00968812|19317299|P2|Overall Study|Unable to take rescue therapy|12
5590161|NCT00968812|19317300|P1|Overall Study|Unable to take rescue therapy|12
5590162|NCT00968812|19317298|P3|Overall Study|Noncompliance with study drug|6
5590163|NCT00968812|19317299|P2|Overall Study|Noncompliance with study drug|1
5590164|NCT00968812|19317300|P1|Overall Study|Noncompliance with study drug|4
5590165|NCT00968812|19317298|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
5590166|NCT00968812|19317299|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
5590167|NCT00968812|19317300|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
5590168|NCT00968812|19317298|P3|Overall Study|Withdrawal by Subject|25
5590169|NCT00968812|19317299|P2|Overall Study|Withdrawal by Subject|23
5590170|NCT00968812|19317300|P1|Overall Study|Withdrawal by Subject|17
5590171|NCT00968812|19317298|P3|Overall Study|Protocol Violation|3
5590172|NCT00968812|19317299|P2|Overall Study|Protocol Violation|4
5590173|NCT00968812|19317300|P1|Overall Study|Protocol Violation|7
5590174|NCT00968812|19317298|P3|Overall Study|Physician Decision|9
5590175|NCT00968812|19317299|P2|Overall Study|Physician Decision|5
5590176|NCT00968812|19317300|P1|Overall Study|Physician Decision|8
5590177|NCT00968812|19317298|P3|Overall Study|Lost to Follow-up|11
5590178|NCT00968812|19317299|P2|Overall Study|Lost to Follow-up|12
5590179|NCT00968812|19317300|P1|Overall Study|Lost to Follow-up|17
5590180|NCT00968812|19317298|P3|Overall Study|Lack of Efficacy|16
5590181|NCT00968812|19317299|P2|Overall Study|Lack of Efficacy|7
5590182|NCT00968812|19317300|P1|Overall Study|Lack of Efficacy|9
5590183|NCT00968812|19317298|P3|Overall Study|Death|1
5590184|NCT00968812|19317299|P2|Overall Study|Death|2
5590185|NCT00968812|19317300|P1|Overall Study|Death|2
5590186|NCT00968812|19317298|P3|Overall Study|Adverse Event|33
5590187|NCT00968812|19317299|P2|Overall Study|Adverse Event|46
5590188|NCT00968812|19317300|P1|Overall Study|Adverse Event|30
5590189|NCT00968799|19317320|P1|Overall Study|Advanced disease, HIPEC not applicable|2
5590190|NCT00968708|19317330|P2|Overall Study|Other|34
5590191|NCT00968708|19317331|P1|Overall Study|Other|26
5590192|NCT00968708|19317330|P2|Overall Study|Investigator Discretion|1
5590193|NCT00968708|19317331|P1|Overall Study|Investigator Discretion|0
5590194|NCT00968708|19317330|P2|Overall Study|Voluntary Withdrawal|101
5590195|NCT00968708|19317331|P1|Overall Study|Voluntary Withdrawal|104
5590196|NCT00968708|19317330|P2|Overall Study|Lost to Follow-up|11
5590197|NCT00968708|19317331|P1|Overall Study|Lost to Follow-up|19
5590198|NCT00968708|19317330|P2|Overall Study|Major Protocol Deviation|1
5590199|NCT00968708|19317331|P1|Overall Study|Major Protocol Deviation|0
5590200|NCT00968708|19317330|P2|Overall Study|Adverse Event|150
5590201|NCT00968708|19317331|P1|Overall Study|Adverse Event|169
5590202|NCT00968669|19317343|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
5590203|NCT00968669|19317344|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
5590204|NCT00968669|19317345|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
5590205|NCT00968669|19317346|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
5590206|NCT00968669|19317343|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
5590207|NCT00968669|19317344|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
5590208|NCT00968669|19317345|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
5590209|NCT00968669|19317346|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
5590210|NCT00968669|19317343|P4|Overall Study|SUBJECT INCARCERATED|0
5590211|NCT00968669|19317344|P3|Overall Study|SUBJECT INCARCERATED|0
5590212|NCT00968669|19317345|P2|Overall Study|SUBJECT INCARCERATED|1
5590213|NCT00968669|19317346|P1|Overall Study|SUBJECT INCARCERATED|0
5590214|NCT00968669|19317343|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
5590215|NCT00968669|19317344|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
5590216|NCT00968669|19317345|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
5590217|NCT00968669|19317346|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
5590218|NCT00968669|19317343|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
5590219|NCT00968669|19317344|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
5590220|NCT00968669|19317345|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
5590221|NCT00968669|19317346|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
5590222|NCT00968669|19317343|P4|Overall Study|SPONSOR DECISION|0
5590223|NCT00968669|19317344|P3|Overall Study|SPONSOR DECISION|0
5590224|NCT00968669|19317345|P2|Overall Study|SPONSOR DECISION|1
5590225|NCT00968669|19317346|P1|Overall Study|SPONSOR DECISION|0
5590226|NCT00968669|19317343|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
5590227|NCT00968669|19317344|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
5590228|NCT00968669|19317345|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
5590229|NCT00968669|19317346|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
5590230|NCT00968669|19317343|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
5590231|NCT00968669|19317344|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
5590232|NCT00968669|19317345|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
5590233|NCT00968669|19317346|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
5590234|NCT00968669|19317343|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
5590235|NCT00968669|19317344|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
5590236|NCT00968669|19317345|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
5590237|NCT00968669|19317346|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
5590238|NCT00968669|19317343|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
5590239|NCT00968669|19317344|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
5590240|NCT00968669|19317345|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
5590241|NCT00968669|19317346|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
5590242|NCT00968669|19317343|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
5590243|NCT00968669|19317344|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
5590244|NCT00968669|19317345|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
5590245|NCT00968669|19317346|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
5590246|NCT00968669|19317343|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
5590247|NCT00968669|19317344|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
5590248|NCT00968669|19317345|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
5590249|NCT00968669|19317346|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
5590250|NCT00968669|19317343|P4|Overall Study|EARLY WITHDRAWAL|0
5590251|NCT00968669|19317344|P3|Overall Study|EARLY WITHDRAWAL|0
5590252|NCT00968669|19317345|P2|Overall Study|EARLY WITHDRAWAL|1
5590253|NCT00968669|19317346|P1|Overall Study|EARLY WITHDRAWAL|0
5590254|NCT00968669|19317343|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
5590255|NCT00968669|19317344|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
5590256|NCT00968669|19317345|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
5590257|NCT00968669|19317346|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
5590258|NCT00968669|19317343|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
5590259|NCT00968669|19317344|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
5590260|NCT00968669|19317345|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
5590261|NCT00968669|19317346|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
5590262|NCT00968669|19317343|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
5590263|NCT00968669|19317344|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
5590264|NCT00968669|19317345|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
5590265|NCT00968669|19317346|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
5590266|NCT00968669|19317343|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
5590267|NCT00968669|19317344|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
5590268|NCT00968669|19317345|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
5590269|NCT00968669|19317346|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
5590270|NCT00968669|19317343|P4|Overall Study|AE|0
5590271|NCT00968669|19317344|P3|Overall Study|AE|0
5590272|NCT00968669|19317345|P2|Overall Study|AE|0
5590273|NCT00968669|19317346|P1|Overall Study|AE|1
5590274|NCT00968669|19317343|P4|Overall Study|Pregnancy|0
5590275|NCT00968669|19317344|P3|Overall Study|Pregnancy|2
5590276|NCT00968669|19317345|P2|Overall Study|Pregnancy|0
5590277|NCT00968669|19317346|P1|Overall Study|Pregnancy|0
5590278|NCT00968669|19317343|P4|Overall Study|Withdrawal by Subject|3
5590279|NCT00968669|19317344|P3|Overall Study|Withdrawal by Subject|5
5590280|NCT00968669|19317345|P2|Overall Study|Withdrawal by Subject|7
5590281|NCT00968669|19317346|P1|Overall Study|Withdrawal by Subject|9
5590282|NCT00968669|19317343|P4|Overall Study|Lost to Follow-up|4
5590283|NCT00968669|19317344|P3|Overall Study|Lost to Follow-up|1
5590284|NCT00968669|19317345|P2|Overall Study|Lost to Follow-up|2
5590285|NCT00968669|19317346|P1|Overall Study|Lost to Follow-up|5
5590286|NCT00968617|19317436|P1|Overall Study|Study terminated by sponsor|6
5590287|NCT00968539|19317450|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
5590288|NCT00968539|19317451|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
5590289|NCT00968526|19317511|P2|Overall Study|Migrated/moved from study area|0
5590290|NCT00968526|19317512|P1|Overall Study|Migrated/moved from study area|1
5590291|NCT00968526|19317511|P2|Overall Study|Adverse Event|0
5590292|NCT00968526|19317512|P1|Overall Study|Adverse Event|2
5590293|NCT00968253|19317614|P3|Overall Study|Adverse Event|1
5590294|NCT00968253|19317615|P2|Overall Study|Adverse Event|0
5590295|NCT00968253|19317616|P1|Overall Study|Adverse Event|0
5590296|NCT00968253|19317614|P3|Overall Study|Disease Progression|3
5590297|NCT00968253|19317615|P2|Overall Study|Disease Progression|3
5590298|NCT00968253|19317616|P1|Overall Study|Disease Progression|0
5590299|NCT00968253|19317614|P3|Overall Study|Withdrawal by Subject|1
5590300|NCT00968253|19317615|P2|Overall Study|Withdrawal by Subject|0
5590301|NCT00968253|19317616|P1|Overall Study|Withdrawal by Subject|0
5590302|NCT00968253|19317614|P3|Overall Study|Death|2
5590303|NCT00968253|19317615|P2|Overall Study|Death|0
5590304|NCT00968253|19317616|P1|Overall Study|Death|0
5590305|NCT00968201|19317637|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
5590306|NCT00968201|19317638|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
5590307|NCT00968201|19317639|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
5590308|NCT00968201|19317637|P3|Extension Study - (Period III)|Other|2
5590309|NCT00968201|19317638|P2|Extension Study - (Period III)|Other|0
5590310|NCT00968201|19317639|P1|Extension Study - (Period III)|Other|0
5590311|NCT00968201|19317637|P3|Extension Study - (Period III)|Noncompliance|3
5590312|NCT00968201|19317638|P2|Extension Study - (Period III)|Noncompliance|0
5590313|NCT00968201|19317639|P1|Extension Study - (Period III)|Noncompliance|0
5590314|NCT00968201|19317637|P3|Extension Study - (Period III)|Patient Relocated|1
5590315|NCT00968201|19317638|P2|Extension Study - (Period III)|Patient Relocated|1
5590316|NCT00968201|19317639|P1|Extension Study - (Period III)|Patient Relocated|0
5590317|NCT00968201|19317637|P3|Extension Study - (Period III)|Withdrawal by Subject|40
5590318|NCT00968201|19317638|P2|Extension Study - (Period III)|Withdrawal by Subject|20
5590319|NCT00968201|19317639|P1|Extension Study - (Period III)|Withdrawal by Subject|0
5590320|NCT00968201|19317637|P3|Extension Study - (Period III)|Protocol Violation|14
5590321|NCT00968201|19317638|P2|Extension Study - (Period III)|Protocol Violation|17
5590322|NCT00968201|19317639|P1|Extension Study - (Period III)|Protocol Violation|0
5590323|NCT00968201|19317637|P3|Extension Study - (Period III)|Lost to Follow-up|13
5590324|NCT00968201|19317638|P2|Extension Study - (Period III)|Lost to Follow-up|7
5590325|NCT00968201|19317639|P1|Extension Study - (Period III)|Lost to Follow-up|0
5590326|NCT00968201|19317637|P3|Extension Study - (Period III)|Adverse Event|22
5590327|NCT00968201|19317638|P2|Extension Study - (Period III)|Adverse Event|5
5590328|NCT00968201|19317639|P1|Extension Study - (Period III)|Adverse Event|0
5590329|NCT00968201|19317637|P3|Base Study - (Period II)|Site Error|1
5590330|NCT00968201|19317638|P2|Base Study - (Period II)|Site Error|0
5590331|NCT00968201|19317639|P1|Base Study - (Period II)|Site Error|0
5590332|NCT00968201|19317637|P3|Base Study - (Period II)|Withdrawal by Subject|8
5590333|NCT00968201|19317638|P2|Base Study - (Period II)|Withdrawal by Subject|0
5590334|NCT00968201|19317639|P1|Base Study - (Period II)|Withdrawal by Subject|4
5590335|NCT00968201|19317637|P3|Base Study - (Period II)|Protocol Violation|12
5590336|NCT00968201|19317638|P2|Base Study - (Period II)|Protocol Violation|0
5590337|NCT00968201|19317639|P1|Base Study - (Period II)|Protocol Violation|12
5590338|NCT00968201|19317637|P3|Base Study - (Period II)|Lost to Follow-up|7
5590339|NCT00968201|19317638|P2|Base Study - (Period II)|Lost to Follow-up|0
5590340|NCT00968201|19317639|P1|Base Study - (Period II)|Lost to Follow-up|2
5590341|NCT00968201|19317637|P3|Base Study - (Period II)|Lack of Efficacy|1
5590342|NCT00968201|19317638|P2|Base Study - (Period II)|Lack of Efficacy|0
5590343|NCT00968201|19317639|P1|Base Study - (Period II)|Lack of Efficacy|0
5590344|NCT00968201|19317637|P3|Base Study - (Period II)|Adverse Event|16
5590345|NCT00968201|19317638|P2|Base Study - (Period II)|Adverse Event|0
5590346|NCT00968201|19317639|P1|Base Study - (Period II)|Adverse Event|8
5590347|NCT00968149|19317700|P2|Overall Study|Withdrawal by Subject|0
5590348|NCT00968149|19317701|P1|Overall Study|Withdrawal by Subject|2
5590349|NCT00968149|19317700|P2|Overall Study|Protocol Violation|0
5590350|NCT00968149|19317701|P1|Overall Study|Protocol Violation|4
5590351|NCT00968149|19317700|P2|Overall Study|Lost to Follow-up|1
5590352|NCT00968149|19317701|P1|Overall Study|Lost to Follow-up|0
5590353|NCT00968149|19317700|P2|Overall Study|Lack of Efficacy|4
5590354|NCT00968149|19317701|P1|Overall Study|Lack of Efficacy|0
5590355|NCT00968149|19317700|P2|Overall Study|Adverse Event|1
5590356|NCT00968149|19317701|P1|Overall Study|Adverse Event|5
5590357|NCT00967798|19317769|P2|Overall Study|Lost to Follow-up|1
5590358|NCT00967798|19317770|P1|Overall Study|Lost to Follow-up|4
5590359|NCT00967798|19317769|P2|Overall Study|Withdrawal by Subject|2
5590360|NCT00967798|19317770|P1|Overall Study|Withdrawal by Subject|5
5590361|NCT00967694|19317784|P1|Overall Study|Withdrawal by Subject|6
5590362|NCT00967668|19317791|P3|Overall Study|Pregnancy|0
5590363|NCT00967668|19317792|P2|Overall Study|Pregnancy|0
5590364|NCT00967668|19317793|P1|Overall Study|Pregnancy|1
5590365|NCT00967668|19317791|P3|Overall Study|Refused 12-mo assessment|9
5590366|NCT00967668|19317792|P2|Overall Study|Refused 12-mo assessment|1
5590367|NCT00967668|19317793|P1|Overall Study|Refused 12-mo assessment|3
5590368|NCT00967668|19317791|P3|Overall Study|Lost to Follow-up|16
5590369|NCT00967668|19317792|P2|Overall Study|Lost to Follow-up|9
5590370|NCT00967668|19317793|P1|Overall Study|Lost to Follow-up|15
5590371|NCT00967668|19317791|P3|Overall Study|Lost to follow-up at 12-mo|26
5590372|NCT00967668|19317792|P2|Overall Study|Lost to follow-up at 12-mo|29
5590373|NCT00967668|19317793|P1|Overall Study|Lost to follow-up at 12-mo|27
5590374|NCT00967668|19317791|P3|Overall Study|Refused Year 2|4
5590375|NCT00967668|19317792|P2|Overall Study|Refused Year 2|6
5590376|NCT00967668|19317793|P1|Overall Study|Refused Year 2|11
5590377|NCT00967668|19317791|P3|Overall Study|Removed due to behavior|2
5590378|NCT00967668|19317792|P2|Overall Study|Removed due to behavior|1
5590379|NCT00967668|19317793|P1|Overall Study|Removed due to behavior|1
5590380|NCT00967668|19317791|P3|Overall Study|Death|4
5590381|NCT00967668|19317792|P2|Overall Study|Death|2
5590382|NCT00967668|19317793|P1|Overall Study|Death|0
5590383|NCT00967668|19317791|P3|Overall Study|Withdrawal by Subject|8
5590384|NCT00967668|19317792|P2|Overall Study|Withdrawal by Subject|8
5590385|NCT00967668|19317793|P1|Overall Study|Withdrawal by Subject|13
5590386|NCT00967616|19317806|P2|Overall Study|Protocol Violation|0
5590387|NCT00967616|19317807|P1|Overall Study|Protocol Violation|1
5590388|NCT00967616|19317806|P2|Overall Study|Other|8
5590389|NCT00967616|19317807|P1|Overall Study|Other|8
5590390|NCT00967616|19317806|P2|Overall Study|Progressive Disease|18
5590391|NCT00967616|19317807|P1|Overall Study|Progressive Disease|31
5590392|NCT00967616|19317806|P2|Overall Study|Withdrawal by Subject|4
5590393|NCT00967616|19317807|P1|Overall Study|Withdrawal by Subject|8
5590394|NCT00967616|19317806|P2|Overall Study|Death|3
5590395|NCT00967616|19317807|P1|Overall Study|Death|0
5590396|NCT00967616|19317806|P2|Overall Study|Adverse Event or Serious Adverse Event|17
5590397|NCT00967616|19317807|P1|Overall Study|Adverse Event or Serious Adverse Event|2
5590398|NCT00967330|19317875|P2|Overall Study|Severe protocol deviation|1
5590399|NCT00967330|19317876|P1|Overall Study|Severe protocol deviation|0
5590400|NCT00967330|19317875|P2|Overall Study|Death|51
5590401|NCT00967330|19317876|P1|Overall Study|Death|102
5590402|NCT00967330|19317875|P2|Overall Study|Lost to Follow-up|1
5590403|NCT00967330|19317876|P1|Overall Study|Lost to Follow-up|1
5590404|NCT00967330|19317875|P2|Overall Study|Withdrawal by Subject|0
5590405|NCT00967330|19317876|P1|Overall Study|Withdrawal by Subject|6
5590406|NCT00967330|19317875|P2|Overall Study|Regular|3
5590407|NCT00967330|19317876|P1|Overall Study|Regular|10
5590408|NCT00967330|19317875|P2|Overall Study|Protocol Violation|4
5590409|NCT00967330|19317876|P1|Overall Study|Protocol Violation|3
5590410|NCT00967226|19317906|P2|Overall Study|Physician Decision|1
5590411|NCT00967226|19317907|P1|Overall Study|Physician Decision|0
5590412|NCT00967226|19317906|P2|Overall Study|Protocol Violation|0
5590413|NCT00967226|19317907|P1|Overall Study|Protocol Violation|2
5590414|NCT00967226|19317906|P2|Overall Study|Adverse Event|5
5590415|NCT00967226|19317907|P1|Overall Study|Adverse Event|0
5590416|NCT00967018|19317941|P1|Overall Study|Miscellaneous Reasons|9
5590417|NCT00967018|19317941|P1|Overall Study|Withdrawal by Subject|1
5590418|NCT00967018|19317941|P1|Overall Study|Lost to Follow-up|2
5590419|NCT00967018|19317941|P1|Overall Study|Physician Decision|7
5590420|NCT00967018|19317941|P1|Overall Study|Adverse Event|2
5590421|NCT00967005|19317950|P2|Overall Study|Lost to Follow-up|10
5590422|NCT00967005|19317951|P1|Overall Study|Lost to Follow-up|7
5590423|NCT00966940|19318037|P2|Period 1, First 6 Weeks|Protocol Violation|0
5590424|NCT00966940|19318038|P1|Period 1, First 6 Weeks|Protocol Violation|1
5590425|NCT00966940|19318037|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
5590426|NCT00966940|19318038|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
5590427|NCT00966875|19318065|P9|Part B|Entry Criteria|1
5590428|NCT00966875|19318066|P8|Part B|Entry Criteria|0
5590429|NCT00966875|19318067|P7|Part B|Entry Criteria|1
5590430|NCT00966875|19318068|P6|Part B|Entry Criteria|0
5590431|NCT00966875|19318069|P5|Part B|Entry Criteria|0
5590432|NCT00966875|19318070|P4|Part B|Entry Criteria|0
5590433|NCT00966875|19318071|P3|Part B|Entry Criteria|0
5590434|NCT00966875|19318072|P2|Part B|Entry Criteria|0
5590435|NCT00966875|19318073|P1|Part B|Entry Criteria|0
5590436|NCT00966875|19318065|P9|Part B|Withdrawal by Subject|5
5590437|NCT00966875|19318066|P8|Part B|Withdrawal by Subject|5
5590438|NCT00966875|19318067|P7|Part B|Withdrawal by Subject|4
5590439|NCT00966875|19318068|P6|Part B|Withdrawal by Subject|1
5590440|NCT00966875|19318069|P5|Part B|Withdrawal by Subject|2
5590441|NCT00966875|19318070|P4|Part B|Withdrawal by Subject|1
5590442|NCT00966875|19318071|P3|Part B|Withdrawal by Subject|2
5590443|NCT00966875|19318072|P2|Part B|Withdrawal by Subject|1
5590444|NCT00966875|19318073|P1|Part B|Withdrawal by Subject|2
5590445|NCT00966875|19318065|P9|Part B|Sponsor Decision|1
5590446|NCT00966875|19318066|P8|Part B|Sponsor Decision|2
5590447|NCT00966875|19318067|P7|Part B|Sponsor Decision|0
5590448|NCT00966875|19318068|P6|Part B|Sponsor Decision|1
5590449|NCT00966875|19318069|P5|Part B|Sponsor Decision|0
5590450|NCT00966875|19318070|P4|Part B|Sponsor Decision|0
5590451|NCT00966875|19318071|P3|Part B|Sponsor Decision|0
5590452|NCT00966875|19318072|P2|Part B|Sponsor Decision|0
5590453|NCT00966875|19318073|P1|Part B|Sponsor Decision|1
5590454|NCT00966875|19318065|P9|Part B|Physician Decision|2
5590455|NCT00966875|19318066|P8|Part B|Physician Decision|0
5590456|NCT00966875|19318067|P7|Part B|Physician Decision|0
5590457|NCT00966875|19318068|P6|Part B|Physician Decision|1
5590458|NCT00966875|19318069|P5|Part B|Physician Decision|2
5590459|NCT00966875|19318070|P4|Part B|Physician Decision|0
5590460|NCT00966875|19318071|P3|Part B|Physician Decision|1
5590461|NCT00966875|19318072|P2|Part B|Physician Decision|0
5590462|NCT00966875|19318073|P1|Part B|Physician Decision|0
5590463|NCT00966875|19318065|P9|Part B|Lost to Follow-up|1
5590464|NCT00966875|19318066|P8|Part B|Lost to Follow-up|0
5590465|NCT00966875|19318067|P7|Part B|Lost to Follow-up|0
5590466|NCT00966875|19318068|P6|Part B|Lost to Follow-up|0
5590467|NCT00966875|19318069|P5|Part B|Lost to Follow-up|0
5590468|NCT00966875|19318070|P4|Part B|Lost to Follow-up|1
5590469|NCT00966875|19318071|P3|Part B|Lost to Follow-up|0
5590470|NCT00966875|19318072|P2|Part B|Lost to Follow-up|0
5590471|NCT00966875|19318073|P1|Part B|Lost to Follow-up|0
5590472|NCT00966875|19318065|P9|Part B|Lack of Efficacy|6
5590473|NCT00966875|19318066|P8|Part B|Lack of Efficacy|9
5590474|NCT00966875|19318067|P7|Part B|Lack of Efficacy|12
5590475|NCT00966875|19318068|P6|Part B|Lack of Efficacy|3
5590476|NCT00966875|19318069|P5|Part B|Lack of Efficacy|2
5590477|NCT00966875|19318070|P4|Part B|Lack of Efficacy|1
5590478|NCT00966875|19318071|P3|Part B|Lack of Efficacy|1
5590479|NCT00966875|19318072|P2|Part B|Lack of Efficacy|1
5590480|NCT00966875|19318073|P1|Part B|Lack of Efficacy|2
5590481|NCT00966875|19318065|P9|Part B|Death|0
5590482|NCT00966875|19318066|P8|Part B|Death|1
5590483|NCT00966875|19318067|P7|Part B|Death|0
5590484|NCT00966875|19318068|P6|Part B|Death|0
5590485|NCT00966875|19318069|P5|Part B|Death|0
5590486|NCT00966875|19318070|P4|Part B|Death|0
5590487|NCT00966875|19318071|P3|Part B|Death|1
5590488|NCT00966875|19318072|P2|Part B|Death|0
5590489|NCT00966875|19318073|P1|Part B|Death|0
5590490|NCT00966875|19318065|P9|Part B|Adverse Event|2
5590491|NCT00966875|19318066|P8|Part B|Adverse Event|2
5590492|NCT00966875|19318067|P7|Part B|Adverse Event|5
5590493|NCT00966875|19318068|P6|Part B|Adverse Event|0
5590494|NCT00966875|19318069|P5|Part B|Adverse Event|1
5590495|NCT00966875|19318070|P4|Part B|Adverse Event|0
5590496|NCT00966875|19318071|P3|Part B|Adverse Event|1
5590497|NCT00966875|19318072|P2|Part B|Adverse Event|1
5590498|NCT00966875|19318073|P1|Part B|Adverse Event|0
5590499|NCT00966875|19318065|P9|Part A|Protocol Violation|1
5590500|NCT00966875|19318066|P8|Part A|Protocol Violation|1
5590501|NCT00966875|19318067|P7|Part A|Protocol Violation|2
5590502|NCT00966875|19318068|P6|Part A|Protocol Violation|0
5590503|NCT00966875|19318069|P5|Part A|Protocol Violation|0
5590504|NCT00966875|19318070|P4|Part A|Protocol Violation|0
5590505|NCT00966875|19318071|P3|Part A|Protocol Violation|0
5590506|NCT00966875|19318072|P2|Part A|Protocol Violation|0
5590507|NCT00966875|19318073|P1|Part A|Protocol Violation|0
5590508|NCT00966875|19318065|P9|Part A|Withdrawal by Subject|1
5590509|NCT00966875|19318066|P8|Part A|Withdrawal by Subject|1
5590510|NCT00966875|19318067|P7|Part A|Withdrawal by Subject|5
5590511|NCT00966875|19318068|P6|Part A|Withdrawal by Subject|0
5590512|NCT00966875|19318069|P5|Part A|Withdrawal by Subject|3
5590513|NCT00966875|19318070|P4|Part A|Withdrawal by Subject|1
5590514|NCT00966875|19318071|P3|Part A|Withdrawal by Subject|1
5590515|NCT00966875|19318072|P2|Part A|Withdrawal by Subject|2
5590516|NCT00966875|19318073|P1|Part A|Withdrawal by Subject|2
5590517|NCT00966875|19318065|P9|Part A|Sponsor Decision|1
5590518|NCT00966875|19318066|P8|Part A|Sponsor Decision|2
5590519|NCT00966875|19318067|P7|Part A|Sponsor Decision|0
5590520|NCT00966875|19318068|P6|Part A|Sponsor Decision|0
5590521|NCT00966875|19318069|P5|Part A|Sponsor Decision|1
5590522|NCT00966875|19318070|P4|Part A|Sponsor Decision|0
5590523|NCT00966875|19318071|P3|Part A|Sponsor Decision|1
5590524|NCT00966875|19318072|P2|Part A|Sponsor Decision|0
5590525|NCT00966875|19318073|P1|Part A|Sponsor Decision|0
5590526|NCT00966875|19318065|P9|Part A|Physician Decision|2
5590527|NCT00966875|19318066|P8|Part A|Physician Decision|0
5590528|NCT00966875|19318067|P7|Part A|Physician Decision|1
5590529|NCT00966875|19318068|P6|Part A|Physician Decision|0
5590530|NCT00966875|19318069|P5|Part A|Physician Decision|1
5590531|NCT00966875|19318070|P4|Part A|Physician Decision|0
5590532|NCT00966875|19318071|P3|Part A|Physician Decision|0
5590533|NCT00966875|19318072|P2|Part A|Physician Decision|0
5590534|NCT00966875|19318073|P1|Part A|Physician Decision|0
5590535|NCT00966875|19318065|P9|Part A|Parent/Caregiver Decision|0
5590536|NCT00966875|19318066|P8|Part A|Parent/Caregiver Decision|0
5590537|NCT00966875|19318067|P7|Part A|Parent/Caregiver Decision|0
5590538|NCT00966875|19318068|P6|Part A|Parent/Caregiver Decision|0
5590539|NCT00966875|19318069|P5|Part A|Parent/Caregiver Decision|0
5590540|NCT00966875|19318070|P4|Part A|Parent/Caregiver Decision|1
5590541|NCT00966875|19318071|P3|Part A|Parent/Caregiver Decision|0
5590542|NCT00966875|19318072|P2|Part A|Parent/Caregiver Decision|0
5590543|NCT00966875|19318073|P1|Part A|Parent/Caregiver Decision|0
5590544|NCT00966875|19318065|P9|Part A|Lost to Follow-up|0
5590545|NCT00966875|19318066|P8|Part A|Lost to Follow-up|0
5590546|NCT00966875|19318067|P7|Part A|Lost to Follow-up|0
5590547|NCT00966875|19318068|P6|Part A|Lost to Follow-up|1
5590548|NCT00966875|19318069|P5|Part A|Lost to Follow-up|0
5590549|NCT00966875|19318070|P4|Part A|Lost to Follow-up|0
5590550|NCT00966875|19318071|P3|Part A|Lost to Follow-up|0
5590551|NCT00966875|19318072|P2|Part A|Lost to Follow-up|0
5590552|NCT00966875|19318073|P1|Part A|Lost to Follow-up|2
5590553|NCT00966875|19318065|P9|Part A|Lack of Efficacy|0
5590554|NCT00966875|19318066|P8|Part A|Lack of Efficacy|0
5590555|NCT00966875|19318067|P7|Part A|Lack of Efficacy|4
5590556|NCT00966875|19318068|P6|Part A|Lack of Efficacy|0
5590557|NCT00966875|19318069|P5|Part A|Lack of Efficacy|0
5590558|NCT00966875|19318070|P4|Part A|Lack of Efficacy|0
5590559|NCT00966875|19318071|P3|Part A|Lack of Efficacy|0
5590560|NCT00966875|19318072|P2|Part A|Lack of Efficacy|1
5590561|NCT00966875|19318073|P1|Part A|Lack of Efficacy|0
5590562|NCT00966875|19318065|P9|Part A|Entry Criteria|0
5590563|NCT00966875|19318066|P8|Part A|Entry Criteria|0
5590564|NCT00966875|19318067|P7|Part A|Entry Criteria|0
5590565|NCT00966875|19318068|P6|Part A|Entry Criteria|2
5590566|NCT00966875|19318069|P5|Part A|Entry Criteria|0
5590567|NCT00966875|19318070|P4|Part A|Entry Criteria|0
5590568|NCT00966875|19318071|P3|Part A|Entry Criteria|0
5590569|NCT00966875|19318072|P2|Part A|Entry Criteria|0
5590570|NCT00966875|19318073|P1|Part A|Entry Criteria|0
5590571|NCT00966875|19318065|P9|Part A|Adverse Event|3
5590572|NCT00966875|19318066|P8|Part A|Adverse Event|3
5590573|NCT00966875|19318067|P7|Part A|Adverse Event|0
5590574|NCT00966875|19318068|P6|Part A|Adverse Event|1
5590575|NCT00966875|19318069|P5|Part A|Adverse Event|0
5590576|NCT00966875|19318070|P4|Part A|Adverse Event|1
5590577|NCT00966875|19318071|P3|Part A|Adverse Event|0
5590578|NCT00966875|19318072|P2|Part A|Adverse Event|1
5590579|NCT00966875|19318073|P1|Part A|Adverse Event|2
5590580|NCT00966719|19318424|P2|Overall Study|Lost to Follow-up|11
5590581|NCT00966719|19318425|P1|Overall Study|Lost to Follow-up|6
5590582|NCT00966693|19318449|P4|Overall Study|Disease Progression|16
5590583|NCT00966693|19318450|P3|Overall Study|Disease Progression|1
5590584|NCT00966693|19318451|P2|Overall Study|Disease Progression|0
5590585|NCT00966693|19318452|P1|Overall Study|Disease Progression|0
5590586|NCT00966693|19318449|P4|Overall Study|Withdrawal by Subject|5
5590587|NCT00966693|19318450|P3|Overall Study|Withdrawal by Subject|0
5590588|NCT00966693|19318451|P2|Overall Study|Withdrawal by Subject|0
5590589|NCT00966693|19318452|P1|Overall Study|Withdrawal by Subject|1
5590590|NCT00966693|19318449|P4|Overall Study|Death|0
5590591|NCT00966693|19318450|P3|Overall Study|Death|1
5590592|NCT00966693|19318451|P2|Overall Study|Death|0
5590593|NCT00966693|19318452|P1|Overall Study|Death|0
5590594|NCT00966693|19318449|P4|Overall Study|Adverse Event|2
5590595|NCT00966693|19318450|P3|Overall Study|Adverse Event|1
5590596|NCT00966693|19318451|P2|Overall Study|Adverse Event|0
5590597|NCT00966693|19318452|P1|Overall Study|Adverse Event|0
5590598|NCT00966654|19318486|P1|Overall Study|Study was terminated,PI left institution|12
5590599|NCT00966355|19318560|P3|Overall Study|Lost to Follow-up|3
5590600|NCT00966355|19318561|P2|Overall Study|Lost to Follow-up|4
5590601|NCT00966355|19318562|P1|Overall Study|Lost to Follow-up|5
5590602|NCT00966355|19318560|P3|Overall Study|newly diagnosed advanced HCC|10
5590603|NCT00966355|19318561|P2|Overall Study|newly diagnosed advanced HCC|12
5590604|NCT00966355|19318562|P1|Overall Study|newly diagnosed advanced HCC|11
5590605|NCT00966355|19318560|P3|Overall Study|non-variceal bleeding on endoscopy|71
5590606|NCT00966355|19318561|P2|Overall Study|non-variceal bleeding on endoscopy|70
5590607|NCT00966355|19318562|P1|Overall Study|non-variceal bleeding on endoscopy|68
5590608|NCT00966277|19318575|P2|Overall Study|Treatment Plan Changed|1
5590609|NCT00966277|19318576|P1|Overall Study|Treatment Plan Changed|0
5590610|NCT00966277|19318575|P2|Overall Study|Ineligible|3
5590611|NCT00966277|19318576|P1|Overall Study|Ineligible|1
5590612|NCT00966277|19318575|P2|Overall Study|Withdrawal by Subject|0
5590613|NCT00966277|19318576|P1|Overall Study|Withdrawal by Subject|3
5590614|NCT00966264|19318584|P2|Overall Study|Lost to Follow-up|3
5590615|NCT00966264|19318585|P1|Overall Study|Lost to Follow-up|4
5590616|NCT00965848|19318631|P3|Overall Study|Other|1
5590617|NCT00965848|19318632|P2|Overall Study|Other|0
5590618|NCT00965848|19318633|P1|Overall Study|Other|5
5590619|NCT00965848|19318631|P3|Overall Study|Not Clinically Evaluable|1
5590620|NCT00965848|19318632|P2|Overall Study|Not Clinically Evaluable|1
5590621|NCT00965848|19318633|P1|Overall Study|Not Clinically Evaluable|7
5590622|NCT00965848|19318631|P3|Overall Study|Indeterminate Clinical Outcome|1
5590623|NCT00965848|19318632|P2|Overall Study|Indeterminate Clinical Outcome|0
5590624|NCT00965848|19318633|P1|Overall Study|Indeterminate Clinical Outcome|2
5590625|NCT00965848|19318631|P3|Overall Study|Withdrawal by Subject|0
5590626|NCT00965848|19318632|P2|Overall Study|Withdrawal by Subject|0
5590627|NCT00965848|19318633|P1|Overall Study|Withdrawal by Subject|1
5590628|NCT00965848|19318631|P3|Overall Study|Lost to Follow-up|1
5590629|NCT00965848|19318632|P2|Overall Study|Lost to Follow-up|0
5590630|NCT00965848|19318633|P1|Overall Study|Lost to Follow-up|0
5590631|NCT00965848|19318631|P3|Overall Study|Death|5
5590632|NCT00965848|19318632|P2|Overall Study|Death|1
5590633|NCT00965848|19318633|P1|Overall Study|Death|11
5590634|NCT00965848|19318631|P3|Overall Study|Protocol Violation|1
5590635|NCT00965848|19318632|P2|Overall Study|Protocol Violation|0
5590636|NCT00965848|19318633|P1|Overall Study|Protocol Violation|3
5590637|NCT00965757|19318652|P4|Extension Phase|Other|1
5590638|NCT00965757|19318653|P3|Extension Phase|Other|2
5590639|NCT00965757|19318654|P2|Extension Phase|Other|0
5590640|NCT00965757|19318655|P1|Extension Phase|Other|0
5590641|NCT00965757|19318652|P4|Extension Phase|Protocol Violation|1
5590642|NCT00965757|19318653|P3|Extension Phase|Protocol Violation|0
5590643|NCT00965757|19318654|P2|Extension Phase|Protocol Violation|0
5590644|NCT00965757|19318655|P1|Extension Phase|Protocol Violation|0
5590645|NCT00965757|19318652|P4|Extension Phase|Ineligible after Taking Study Drug|3
5590646|NCT00965757|19318653|P3|Extension Phase|Ineligible after Taking Study Drug|3
5590647|NCT00965757|19318654|P2|Extension Phase|Ineligible after Taking Study Drug|0
5590648|NCT00965757|19318655|P1|Extension Phase|Ineligible after Taking Study Drug|0
5590649|NCT00965757|19318652|P4|Extension Phase|Lost to Follow-up|1
5590650|NCT00965757|19318653|P3|Extension Phase|Lost to Follow-up|0
5590651|NCT00965757|19318654|P2|Extension Phase|Lost to Follow-up|0
5590652|NCT00965757|19318655|P1|Extension Phase|Lost to Follow-up|0
5590653|NCT00965757|19318652|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
5590654|NCT00965757|19318653|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
5590655|NCT00965757|19318654|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
5590656|NCT00965757|19318655|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
5590657|NCT00965757|19318652|P4|Extension Phase|Lack of Efficacy|12
5590658|NCT00965757|19318653|P3|Extension Phase|Lack of Efficacy|8
5590659|NCT00965757|19318654|P2|Extension Phase|Lack of Efficacy|0
5590660|NCT00965757|19318655|P1|Extension Phase|Lack of Efficacy|0
5590661|NCT00965757|19318652|P4|Extension Phase|Abnormal Laboratory Value|1
5590662|NCT00965757|19318653|P3|Extension Phase|Abnormal Laboratory Value|6
5590663|NCT00965757|19318654|P2|Extension Phase|Abnormal Laboratory Value|0
5590664|NCT00965757|19318655|P1|Extension Phase|Abnormal Laboratory Value|0
5590665|NCT00965757|19318652|P4|Extension Phase|Adverse drug reaction|3
5590666|NCT00965757|19318653|P3|Extension Phase|Adverse drug reaction|6
5590667|NCT00965757|19318654|P2|Extension Phase|Adverse drug reaction|0
5590668|NCT00965757|19318655|P1|Extension Phase|Adverse drug reaction|0
5590669|NCT00965757|19318652|P4|Extension Phase|Progression of concomitant disease|2
5590670|NCT00965757|19318653|P3|Extension Phase|Progression of concomitant disease|4
5590671|NCT00965757|19318654|P2|Extension Phase|Progression of concomitant disease|0
5590672|NCT00965757|19318655|P1|Extension Phase|Progression of concomitant disease|0
5590673|NCT00965757|19318652|P4|Double-blind Phase|Other|0
5590674|NCT00965757|19318653|P3|Double-blind Phase|Other|0
5590675|NCT00965757|19318654|P2|Double-blind Phase|Other|0
5590676|NCT00965757|19318655|P1|Double-blind Phase|Other|1
5590677|NCT00965757|19318652|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
5590678|NCT00965757|19318653|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
5590679|NCT00965757|19318654|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
5590680|NCT00965757|19318655|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
5590681|NCT00965757|19318652|P4|Double-blind Phase|Lost to Follow-up|0
5590682|NCT00965757|19318653|P3|Double-blind Phase|Lost to Follow-up|0
5590683|NCT00965757|19318654|P2|Double-blind Phase|Lost to Follow-up|1
5590684|NCT00965757|19318655|P1|Double-blind Phase|Lost to Follow-up|0
5590685|NCT00965757|19318652|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
5590686|NCT00965757|19318653|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
5590687|NCT00965757|19318654|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
5590688|NCT00965757|19318655|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
5590689|NCT00965757|19318652|P4|Double-blind Phase|Lack of Efficacy|0
5590690|NCT00965757|19318653|P3|Double-blind Phase|Lack of Efficacy|0
5590691|NCT00965757|19318654|P2|Double-blind Phase|Lack of Efficacy|11
5590692|NCT00965757|19318655|P1|Double-blind Phase|Lack of Efficacy|7
5590693|NCT00965757|19318652|P4|Double-blind Phase|Abnormal Laboratory Value|0
5590694|NCT00965757|19318653|P3|Double-blind Phase|Abnormal Laboratory Value|0
5590695|NCT00965757|19318654|P2|Double-blind Phase|Abnormal Laboratory Value|0
5590696|NCT00965757|19318655|P1|Double-blind Phase|Abnormal Laboratory Value|2
5590697|NCT00965757|19318652|P4|Double-blind Phase|Adverse drug reaction|0
5590698|NCT00965757|19318653|P3|Double-blind Phase|Adverse drug reaction|0
5590699|NCT00965757|19318654|P2|Double-blind Phase|Adverse drug reaction|1
5590700|NCT00965757|19318655|P1|Double-blind Phase|Adverse drug reaction|2
5590701|NCT00965757|19318652|P4|Double-blind Phase|Progression of concomitant disease|0
5590702|NCT00965757|19318653|P3|Double-blind Phase|Progression of concomitant disease|0
5590703|NCT00965757|19318654|P2|Double-blind Phase|Progression of concomitant disease|2
5590704|NCT00965757|19318655|P1|Double-blind Phase|Progression of concomitant disease|1
5590705|NCT00965731|19318689|P2|Overall Study|Other|15
5590706|NCT00965731|19318690|P1|Overall Study|Other|7
5590707|NCT00965731|19318689|P2|Overall Study|Withdrawal by Subject|1
5590708|NCT00965731|19318690|P1|Overall Study|Withdrawal by Subject|0
5590709|NCT00965731|19318689|P2|Overall Study|Death|4
5590710|NCT00965731|19318690|P1|Overall Study|Death|0
5590711|NCT00965718|19318754|P1|Overall Study|Withdrawal by Subject|4
5590712|NCT00965575|19318766|P2|Overall Study|subject unwillingness to swallow study c|0
5590713|NCT00965575|19318767|P1|Overall Study|subject unwillingness to swallow study c|1
5590714|NCT00965562|19318778|P3|Overall Study|Withdrawal by Subject|0
5590715|NCT00965562|19318779|P2|Overall Study|Withdrawal by Subject|2
5590716|NCT00965562|19318780|P1|Overall Study|Withdrawal by Subject|2
5590717|NCT00965562|19318778|P3|Overall Study|Lost to Follow-up|3
5590718|NCT00965562|19318779|P2|Overall Study|Lost to Follow-up|2
5590719|NCT00965562|19318780|P1|Overall Study|Lost to Follow-up|1
5590720|NCT00965523|19318818|P1|Study 224|Physician Decision|1
5590721|NCT00965523|19318818|P1|Study 224|Progressive Disease|5
5590722|NCT00965523|19318818|P1|Study 221|Physician Decision|3
5590723|NCT00965523|19318818|P1|Study 221|Progressive Disease|4
5590724|NCT00965497|19318823|P1|Overall Study|Physician Decision|1
5590725|NCT00965484|19318828|P1|Overall Study|Withdrawal by Subject|1
5590726|NCT00965484|19318828|P1|Overall Study|Protocol Violation|1
5590727|NCT00965458|19318837|P2|Overall Study|Withdrawal by Subject|1
5590728|NCT00965458|19318838|P1|Overall Study|Withdrawal by Subject|0
5590729|NCT00965458|19318837|P2|Overall Study|Lost to Follow-up|3
5590730|NCT00965458|19318838|P1|Overall Study|Lost to Follow-up|1
5590731|NCT00965458|19318837|P2|Overall Study|Adverse Event|0
5590732|NCT00965458|19318838|P1|Overall Study|Adverse Event|1
5590733|NCT00965419|19318854|P1|Follow-up Phase|Lack of Efficacy|28
5590734|NCT00965419|19318854|P1|Follow-up Phase|Parent/Caregiver Decision|9
5590735|NCT00965419|19318854|P1|Follow-up Phase|Physician Decision|4
5590736|NCT00965419|19318854|P1|Follow-up Phase|Withdrawal by Subject|8
5590737|NCT00965419|19318854|P1|Follow-up Phase|Protocol Violation|4
5590738|NCT00965419|19318854|P1|Follow-up Phase|Adverse Event|9
5590739|NCT00965419|19318854|P1|Open Label Treatment for Responders|Lost to Follow-up|46
5590740|NCT00965419|19318854|P1|Open Label Treatment for Responders|Lack of Efficacy|67
5590741|NCT00965419|19318854|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
5590742|NCT00965419|19318854|P1|Open Label Treatment for Responders|Sponsor Decision|5
5590743|NCT00965419|19318854|P1|Open Label Treatment for Responders|Physician Decision|6
5590744|NCT00965419|19318854|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
5590745|NCT00965419|19318854|P1|Open Label Treatment for Responders|Protocol Violation|21
5590746|NCT00965419|19318854|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
5590747|NCT00965419|19318854|P1|Open Label Treatment for Responders|Adverse Event|33
5590748|NCT00965341|19318900|P2|Overall Study|Transportation issues|3
5590749|NCT00965341|19318901|P1|Overall Study|Transportation issues|4
5590750|NCT00965341|19318900|P2|Overall Study|Lost to Follow-up|0
5590751|NCT00965341|19318901|P1|Overall Study|Lost to Follow-up|1
5590752|NCT00965341|19318900|P2|Overall Study|Withdrew consent|5
5590753|NCT00965341|19318901|P1|Overall Study|Withdrew consent|1
5590754|NCT00965263|19318911|P2|Overall Study|Protocol Violation|2
5590755|NCT00965263|19318912|P1|Overall Study|Protocol Violation|0
5590756|NCT00965263|19318911|P2|Overall Study|Family emergency|1
5590757|NCT00965263|19318912|P1|Overall Study|Family emergency|0
5590758|NCT00965263|19318911|P2|Overall Study|Physician Decision|0
5590759|NCT00965263|19318912|P1|Overall Study|Physician Decision|2
5590760|NCT00965185|19318972|P2|Overall Study|Withdrawal by Subject|1
5590761|NCT00965185|19318973|P1|Overall Study|Withdrawal by Subject|0
5590762|NCT00965185|19318972|P2|Overall Study|Lost to Follow-up|0
5590763|NCT00965185|19318973|P1|Overall Study|Lost to Follow-up|2
5590764|NCT00965146|19318993|P1|Overall Study|Overall Study Termination|145
5590765|NCT00965146|19318993|P1|Overall Study|Revision / Removal of Study Implant|6
5590766|NCT00965146|19318993|P1|Overall Study|Intercurrent illness|1
5590767|NCT00965146|19318993|P1|Overall Study|Unwilling to return|11
5590768|NCT00965146|19318993|P1|Overall Study|Unable to return|1
5590769|NCT00965146|19318993|P1|Overall Study|Withdrawal by Subject|17
5590770|NCT00965146|19318993|P1|Overall Study|Lost to Follow-up|22
5590771|NCT00965146|19318993|P1|Overall Study|Death|7
5590772|NCT00965094|19319000|P2|Overall Study|Lost to Follow-up|1
5590773|NCT00965094|19319001|P1|Overall Study|Lost to Follow-up|0
5590774|NCT00965094|19319000|P2|Overall Study|Adverse Event|0
5590775|NCT00965094|19319001|P1|Overall Study|Adverse Event|5
5590776|NCT00965081|19319017|P2|Overall Study|Switched to Rescue Arm|12
5590777|NCT00965081|19319018|P1|Overall Study|Switched to Rescue Arm|5
5590778|NCT00965081|19319017|P2|Overall Study|Withdrawal by Subject|7
5590779|NCT00965081|19319018|P1|Overall Study|Withdrawal by Subject|4
5590780|NCT00965081|19319017|P2|Overall Study|Sponsor Decision|0
5590781|NCT00965081|19319018|P1|Overall Study|Sponsor Decision|1
5590782|NCT00965081|19319017|P2|Overall Study|Protocol Violation|5
5590783|NCT00965081|19319018|P1|Overall Study|Protocol Violation|2
5590784|NCT00965081|19319017|P2|Overall Study|Physician Decision|0
5590785|NCT00965081|19319018|P1|Overall Study|Physician Decision|2
5590786|NCT00965081|19319017|P2|Overall Study|Lost to Follow-up|5
5590787|NCT00965081|19319018|P1|Overall Study|Lost to Follow-up|4
5590788|NCT00965081|19319017|P2|Overall Study|Lack of Efficacy|5
5590789|NCT00965081|19319018|P1|Overall Study|Lack of Efficacy|2
5590790|NCT00965081|19319017|P2|Overall Study|Adverse Event|9
5590791|NCT00965081|19319018|P1|Overall Study|Adverse Event|14
5590792|NCT00964886|19319050|P4|Overall Study|Protocol Violation|0
5590793|NCT00964886|19319051|P3|Overall Study|Protocol Violation|0
5590794|NCT00964886|19319052|P2|Overall Study|Protocol Violation|2
5590795|NCT00964886|19319053|P1|Overall Study|Protocol Violation|0
5590796|NCT00964886|19319050|P4|Overall Study|Adverse Event|2
5590797|NCT00964886|19319051|P3|Overall Study|Adverse Event|5
5590798|NCT00964886|19319052|P2|Overall Study|Adverse Event|1
5590799|NCT00964886|19319053|P1|Overall Study|Adverse Event|3
5590800|NCT00964886|19319050|P4|Overall Study|Withdrawal by Subject|3
5590801|NCT00964886|19319051|P3|Overall Study|Withdrawal by Subject|5
5590802|NCT00964886|19319052|P2|Overall Study|Withdrawal by Subject|2
5590803|NCT00964886|19319053|P1|Overall Study|Withdrawal by Subject|6
5590804|NCT00964886|19319050|P4|Overall Study|Lost to Follow-up|4
5590805|NCT00964886|19319051|P3|Overall Study|Lost to Follow-up|6
5590806|NCT00964886|19319052|P2|Overall Study|Lost to Follow-up|2
5590807|NCT00964886|19319053|P1|Overall Study|Lost to Follow-up|2
5590808|NCT00964860|19319069|P2|Overall Study|Withdrawal by Subject|1
5590809|NCT00964860|19319070|P1|Overall Study|Withdrawal by Subject|0
5590810|NCT00964795|19319078|P1|Overall Study|Other|23
5590811|NCT00964795|19319078|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
5590812|NCT00964795|19319078|P1|Overall Study|Termination of Study by Sponsor|169
5590813|NCT00964795|19319078|P1|Overall Study|Lost to Follow-up|7
5590814|NCT00964795|19319078|P1|Overall Study|Death|14
5590815|NCT00964795|19319078|P1|Overall Study|Adverse Event|12
5590816|NCT00964795|19319078|P1|Overall Study|Withdrawal by Subject|79
5590817|NCT00964782|19319087|P2|Overall Study|Lost to Follow-up|0
5590818|NCT00964782|19319088|P1|Overall Study|Lost to Follow-up|1
5590819|NCT00964743|19319102|P1|Overall Study|Neither patient completed 8 weeks of tre|2
5590820|NCT00964678|19319110|P1|Overall Study|Physician Decision|4
5590821|NCT00964392|19319174|P2|Overall Study|Not completed|168
5590822|NCT00964392|19319175|P1|Overall Study|Not completed|44
5590823|NCT00964392|19319174|P2|Overall Study|Early Termination, non-study arrhythmia|6
5590824|NCT00964392|19319175|P1|Overall Study|Early Termination, non-study arrhythmia|1
5590825|NCT00964392|19319174|P2|Overall Study|Lost to Follow-up|10
5590826|NCT00964392|19319175|P1|Overall Study|Lost to Follow-up|4
5590827|NCT00964392|19319174|P2|Overall Study|Withdrawal by Subject|6
5590828|NCT00964392|19319175|P1|Overall Study|Withdrawal by Subject|4
5590829|NCT00964366|19319185|P2|Overall Study|Withdrawal by Subject|1
5590830|NCT00964366|19319186|P1|Overall Study|Withdrawal by Subject|0
5590831|NCT00964366|19319185|P2|Overall Study|Did not qualify at Day 1|0
5590832|NCT00964366|19319186|P1|Overall Study|Did not qualify at Day 1|1
5590833|NCT00964223|19319211|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
5590834|NCT00964158|19319279|P3|Overall Study|Withdrawal by Subject|6
5590835|NCT00964158|19319280|P2|Overall Study|Withdrawal by Subject|0
5590836|NCT00964158|19319281|P1|Overall Study|Withdrawal by Subject|0
5590837|NCT00964158|19319279|P3|Overall Study|Lost to Follow-up|2
5590838|NCT00964158|19319280|P2|Overall Study|Lost to Follow-up|1
5590839|NCT00964158|19319281|P1|Overall Study|Lost to Follow-up|0
5590840|NCT00964028|19319356|P2|Overall Study|Withdrawal by Subject|1
5590841|NCT00964028|19319357|P1|Overall Study|Withdrawal by Subject|0
5590842|NCT00963937|19319372|P3|Overall Study|Physician Decision|4
5590843|NCT00963937|19319373|P2|Overall Study|Physician Decision|10
5590844|NCT00963937|19319374|P1|Overall Study|Physician Decision|18
5590845|NCT00963937|19319372|P3|Overall Study|Protocol Violation|0
5590846|NCT00963937|19319373|P2|Overall Study|Protocol Violation|1
5590847|NCT00963937|19319374|P1|Overall Study|Protocol Violation|1
5590848|NCT00963924|19319412|P2|Overall Study|Lost to Follow-up|1
5590849|NCT00963924|19319413|P1|Overall Study|Lost to Follow-up|0
5590850|NCT00963924|19319412|P2|Overall Study|Changed antipsychotic|1
5590851|NCT00963924|19319413|P1|Overall Study|Changed antipsychotic|0
5590852|NCT00963924|19319412|P2|Overall Study|Withdrawal by Subject|1
5590853|NCT00963924|19319413|P1|Overall Study|Withdrawal by Subject|0
5590854|NCT00963924|19319412|P2|Overall Study|Adverse Event|0
5590855|NCT00963924|19319413|P1|Overall Study|Adverse Event|1
5590856|NCT00963820|19319487|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
5590857|NCT00963820|19319488|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590858|NCT00963820|19319489|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590859|NCT00963820|19319490|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590860|NCT00963820|19319491|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590861|NCT00963820|19319492|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590862|NCT00963820|19319493|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590863|NCT00963820|19319494|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590864|NCT00963820|19319495|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590865|NCT00963820|19319496|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590866|NCT00963820|19319497|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590867|NCT00963820|19319498|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
5590868|NCT00963820|19319487|P12|Expansion Phase|Withdrawal by Subject|1
5590869|NCT00963820|19319488|P11|Expansion Phase|Withdrawal by Subject|1
5590870|NCT00963820|19319489|P10|Expansion Phase|Withdrawal by Subject|0
5590871|NCT00963820|19319490|P9|Expansion Phase|Withdrawal by Subject|1
5590872|NCT00963820|19319491|P8|Expansion Phase|Withdrawal by Subject|0
5590873|NCT00963820|19319492|P7|Expansion Phase|Withdrawal by Subject|0
5590874|NCT00963820|19319493|P6|Expansion Phase|Withdrawal by Subject|0
5590875|NCT00963820|19319494|P5|Expansion Phase|Withdrawal by Subject|0
5590876|NCT00963820|19319495|P4|Expansion Phase|Withdrawal by Subject|0
5590877|NCT00963820|19319496|P3|Expansion Phase|Withdrawal by Subject|0
5590878|NCT00963820|19319497|P2|Expansion Phase|Withdrawal by Subject|0
5590879|NCT00963820|19319498|P1|Expansion Phase|Withdrawal by Subject|0
5590880|NCT00963820|19319487|P12|Expansion Phase|Adverse Event|0
5590881|NCT00963820|19319488|P11|Expansion Phase|Adverse Event|0
5590882|NCT00963820|19319489|P10|Expansion Phase|Adverse Event|3
5590883|NCT00963820|19319490|P9|Expansion Phase|Adverse Event|1
5590884|NCT00963820|19319491|P8|Expansion Phase|Adverse Event|0
5590885|NCT00963820|19319492|P7|Expansion Phase|Adverse Event|0
5590886|NCT00963820|19319493|P6|Expansion Phase|Adverse Event|0
5590887|NCT00963820|19319494|P5|Expansion Phase|Adverse Event|0
5590888|NCT00963820|19319495|P4|Expansion Phase|Adverse Event|0
5590889|NCT00963820|19319496|P3|Expansion Phase|Adverse Event|0
5590890|NCT00963820|19319497|P2|Expansion Phase|Adverse Event|0
5590891|NCT00963820|19319498|P1|Expansion Phase|Adverse Event|0
5590892|NCT00963820|19319487|P12|Expansion Phase|Progressive Disease|2
5590893|NCT00963820|19319488|P11|Expansion Phase|Progressive Disease|4
5590894|NCT00963820|19319489|P10|Expansion Phase|Progressive Disease|6
5590895|NCT00963820|19319490|P9|Expansion Phase|Progressive Disease|8
5590896|NCT00963820|19319491|P8|Expansion Phase|Progressive Disease|0
5590897|NCT00963820|19319492|P7|Expansion Phase|Progressive Disease|0
5590898|NCT00963820|19319493|P6|Expansion Phase|Progressive Disease|0
5590899|NCT00963820|19319494|P5|Expansion Phase|Progressive Disease|0
5590900|NCT00963820|19319495|P4|Expansion Phase|Progressive Disease|0
5590901|NCT00963820|19319496|P3|Expansion Phase|Progressive Disease|0
5590902|NCT00963820|19319497|P2|Expansion Phase|Progressive Disease|0
5590903|NCT00963820|19319498|P1|Expansion Phase|Progressive Disease|0
5590904|NCT00963820|19319487|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590905|NCT00963820|19319488|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590906|NCT00963820|19319489|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590907|NCT00963820|19319490|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590908|NCT00963820|19319491|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590909|NCT00963820|19319492|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
5590910|NCT00963820|19319493|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590911|NCT00963820|19319494|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590912|NCT00963820|19319495|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590913|NCT00963820|19319496|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590914|NCT00963820|19319497|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590915|NCT00963820|19319498|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
5590916|NCT00963820|19319487|P12|Dose Escalation Phase|Withdrawal by Subject|0
5590917|NCT00963820|19319488|P11|Dose Escalation Phase|Withdrawal by Subject|0
5590918|NCT00963820|19319489|P10|Dose Escalation Phase|Withdrawal by Subject|0
5590919|NCT00963820|19319490|P9|Dose Escalation Phase|Withdrawal by Subject|0
5590920|NCT00963820|19319491|P8|Dose Escalation Phase|Withdrawal by Subject|2
5590921|NCT00963820|19319492|P7|Dose Escalation Phase|Withdrawal by Subject|1
5590922|NCT00963820|19319493|P6|Dose Escalation Phase|Withdrawal by Subject|0
5590923|NCT00963820|19319494|P5|Dose Escalation Phase|Withdrawal by Subject|0
5590924|NCT00963820|19319495|P4|Dose Escalation Phase|Withdrawal by Subject|0
5590925|NCT00963820|19319496|P3|Dose Escalation Phase|Withdrawal by Subject|0
5590926|NCT00963820|19319497|P2|Dose Escalation Phase|Withdrawal by Subject|0
5590927|NCT00963820|19319498|P1|Dose Escalation Phase|Withdrawal by Subject|0
5590928|NCT00963820|19319487|P12|Dose Escalation Phase|Adverse Event|0
5590929|NCT00963820|19319488|P11|Dose Escalation Phase|Adverse Event|0
5590930|NCT00963820|19319489|P10|Dose Escalation Phase|Adverse Event|0
5590931|NCT00963820|19319490|P9|Dose Escalation Phase|Adverse Event|0
5590932|NCT00963820|19319491|P8|Dose Escalation Phase|Adverse Event|1
5590933|NCT00963820|19319492|P7|Dose Escalation Phase|Adverse Event|3
5590934|NCT00963820|19319493|P6|Dose Escalation Phase|Adverse Event|0
5590935|NCT00963820|19319494|P5|Dose Escalation Phase|Adverse Event|0
5590936|NCT00963820|19319495|P4|Dose Escalation Phase|Adverse Event|0
5590937|NCT00963820|19319496|P3|Dose Escalation Phase|Adverse Event|0
5590938|NCT00963820|19319497|P2|Dose Escalation Phase|Adverse Event|0
5590939|NCT00963820|19319498|P1|Dose Escalation Phase|Adverse Event|0
5590940|NCT00963820|19319487|P12|Dose Escalation Phase|Progressive Disease|0
5590941|NCT00963820|19319488|P11|Dose Escalation Phase|Progressive Disease|0
5590942|NCT00963820|19319489|P10|Dose Escalation Phase|Progressive Disease|0
5590943|NCT00963820|19319490|P9|Dose Escalation Phase|Progressive Disease|0
5590944|NCT00963820|19319491|P8|Dose Escalation Phase|Progressive Disease|2
5590945|NCT00963820|19319492|P7|Dose Escalation Phase|Progressive Disease|3
5590946|NCT00963820|19319493|P6|Dose Escalation Phase|Progressive Disease|3
5590947|NCT00963820|19319494|P5|Dose Escalation Phase|Progressive Disease|4
5590948|NCT00963820|19319495|P4|Dose Escalation Phase|Progressive Disease|3
5590949|NCT00963820|19319496|P3|Dose Escalation Phase|Progressive Disease|3
5590950|NCT00963820|19319497|P2|Dose Escalation Phase|Progressive Disease|3
5590951|NCT00963820|19319498|P1|Dose Escalation Phase|Progressive Disease|3
5590952|NCT00963807|19319634|P1|Overall Study|Disease progression|15
5590953|NCT00963807|19319634|P1|Overall Study|Reaction to study chemotherapy regimen|1
5590954|NCT00963807|19319634|P1|Overall Study|Physician Decision|2
5590955|NCT00963599|19319667|P4|Overall Study|Withdrawal by Subject|3
5590956|NCT00963599|19319668|P3|Overall Study|Withdrawal by Subject|3
5590957|NCT00963599|19319669|P2|Overall Study|Withdrawal by Subject|1
5590958|NCT00963599|19319670|P1|Overall Study|Withdrawal by Subject|2
5590959|NCT00963599|19319667|P4|Overall Study|Protocol Violation|4
5590960|NCT00963599|19319668|P3|Overall Study|Protocol Violation|3
5590961|NCT00963599|19319669|P2|Overall Study|Protocol Violation|2
5590962|NCT00963599|19319670|P1|Overall Study|Protocol Violation|2
5590963|NCT00963599|19319667|P4|Overall Study|Lost to Follow-up|1
5590964|NCT00963599|19319668|P3|Overall Study|Lost to Follow-up|1
5590965|NCT00963599|19319669|P2|Overall Study|Lost to Follow-up|1
5590966|NCT00963599|19319670|P1|Overall Study|Lost to Follow-up|0
5590967|NCT00963599|19319667|P4|Overall Study|Lack of Efficacy|4
5590968|NCT00963599|19319668|P3|Overall Study|Lack of Efficacy|1
5590969|NCT00963599|19319669|P2|Overall Study|Lack of Efficacy|2
5590970|NCT00963599|19319670|P1|Overall Study|Lack of Efficacy|0
5590971|NCT00963599|19319667|P4|Overall Study|Adverse Event|2
5590972|NCT00963599|19319668|P3|Overall Study|Adverse Event|1
5590973|NCT00963599|19319669|P2|Overall Study|Adverse Event|0
5590974|NCT00963599|19319670|P1|Overall Study|Adverse Event|2
5590975|NCT00963547|19319741|P7|Overall Study|Reason Unknown|0
5590976|NCT00963547|19319742|P6|Overall Study|Reason Unknown|0
5590977|NCT00963547|19319743|P5|Overall Study|Reason Unknown|0
5590978|NCT00963547|19319744|P4|Overall Study|Reason Unknown|0
5590979|NCT00963547|19319745|P3|Overall Study|Reason Unknown|0
5590980|NCT00963547|19319746|P2|Overall Study|Reason Unknown|1
5590981|NCT00963547|19319747|P1|Overall Study|Reason Unknown|0
5590982|NCT00963547|19319741|P7|Overall Study|Withdrawal by Subject|0
5590983|NCT00963547|19319742|P6|Overall Study|Withdrawal by Subject|0
5590984|NCT00963547|19319743|P5|Overall Study|Withdrawal by Subject|0
5590985|NCT00963547|19319744|P4|Overall Study|Withdrawal by Subject|0
5590986|NCT00963547|19319745|P3|Overall Study|Withdrawal by Subject|3
5590987|NCT00963547|19319746|P2|Overall Study|Withdrawal by Subject|0
5590988|NCT00963547|19319747|P1|Overall Study|Withdrawal by Subject|0
5590989|NCT00963547|19319741|P7|Overall Study|Progressive Disease|0
5590990|NCT00963547|19319742|P6|Overall Study|Progressive Disease|0
5590991|NCT00963547|19319743|P5|Overall Study|Progressive Disease|0
5590992|NCT00963547|19319744|P4|Overall Study|Progressive Disease|5
5590993|NCT00963547|19319745|P3|Overall Study|Progressive Disease|9
5590994|NCT00963547|19319746|P2|Overall Study|Progressive Disease|8
5590995|NCT00963547|19319747|P1|Overall Study|Progressive Disease|3
5590996|NCT00963547|19319741|P7|Overall Study|Physician Decision|0
5590997|NCT00963547|19319742|P6|Overall Study|Physician Decision|0
5590998|NCT00963547|19319743|P5|Overall Study|Physician Decision|0
5590999|NCT00963547|19319744|P4|Overall Study|Physician Decision|0
5591000|NCT00963547|19319745|P3|Overall Study|Physician Decision|0
5591001|NCT00963547|19319746|P2|Overall Study|Physician Decision|1
5591002|NCT00963547|19319747|P1|Overall Study|Physician Decision|1
5591003|NCT00963547|19319741|P7|Overall Study|Adverse Event|0
5591004|NCT00963547|19319742|P6|Overall Study|Adverse Event|0
5591005|NCT00963547|19319743|P5|Overall Study|Adverse Event|0
5591006|NCT00963547|19319744|P4|Overall Study|Adverse Event|1
5591007|NCT00963547|19319745|P3|Overall Study|Adverse Event|0
5591008|NCT00963547|19319746|P2|Overall Study|Adverse Event|1
5591009|NCT00963547|19319747|P1|Overall Study|Adverse Event|0
5591010|NCT00963469|19319794|P3|Overall Study|Site closed (local pollen Season ended)|3
5591011|NCT00963469|19319795|P2|Overall Study|Site closed (local pollen Season ended)|1
5591012|NCT00963469|19319796|P1|Overall Study|Site closed (local pollen Season ended)|4
5591013|NCT00963469|19319794|P3|Overall Study|Moved|0
5591014|NCT00963469|19319795|P2|Overall Study|Moved|0
5591015|NCT00963469|19319796|P1|Overall Study|Moved|1
5591016|NCT00963469|19319794|P3|Overall Study|Pre-randomization Adverse Event|0
5591017|NCT00963469|19319795|P2|Overall Study|Pre-randomization Adverse Event|2
5591018|NCT00963469|19319796|P1|Overall Study|Pre-randomization Adverse Event|1
5591019|NCT00963469|19319794|P3|Overall Study|Withdrawal by Subject|1
5591020|NCT00963469|19319795|P2|Overall Study|Withdrawal by Subject|1
5591021|NCT00963469|19319796|P1|Overall Study|Withdrawal by Subject|4
5591022|NCT00963469|19319794|P3|Overall Study|Protocol Violation|3
5591023|NCT00963469|19319795|P2|Overall Study|Protocol Violation|5
5591024|NCT00963469|19319796|P1|Overall Study|Protocol Violation|5
5591025|NCT00963469|19319794|P3|Overall Study|Lost to Follow-up|0
5591026|NCT00963469|19319795|P2|Overall Study|Lost to Follow-up|1
5591027|NCT00963469|19319796|P1|Overall Study|Lost to Follow-up|1
5591028|NCT00963469|19319794|P3|Overall Study|Lack of Efficacy|2
5591029|NCT00963469|19319795|P2|Overall Study|Lack of Efficacy|7
5591030|NCT00963469|19319796|P1|Overall Study|Lack of Efficacy|10
5591031|NCT00963469|19319794|P3|Overall Study|Adverse Event|1
5591032|NCT00963469|19319795|P2|Overall Study|Adverse Event|11
5591033|NCT00963469|19319796|P1|Overall Study|Adverse Event|15
5591034|NCT00963235|19319863|P1|Overall Study|Other|1
5591035|NCT00963235|19319863|P1|Overall Study|Physician Decision|2
5591036|NCT00963235|19319863|P1|Overall Study|Adverse Event|5
5591037|NCT00963235|19319863|P1|Overall Study|Protocol Violation|7
5591038|NCT00963235|19319863|P1|Overall Study|Failed to return|9
5591039|NCT00963235|19319863|P1|Overall Study|Lost to Follow-up|14
5591040|NCT00963235|19319863|P1|Overall Study|Withdrawal by Subject|22
5591041|NCT00962780|19320155|P2|Overall Study|Other|1
5591042|NCT00962780|19320156|P1|Overall Study|Other|0
5591043|NCT00962780|19320155|P2|Overall Study|Withdrawal by Subject|8
5591044|NCT00962780|19320156|P1|Overall Study|Withdrawal by Subject|1
5591045|NCT00962780|19320155|P2|Overall Study|Protocol Violation|4
5591046|NCT00962780|19320156|P1|Overall Study|Protocol Violation|9
5591047|NCT00962780|19320155|P2|Overall Study|Death|1
5591048|NCT00962780|19320156|P1|Overall Study|Death|0
5591049|NCT00962741|19320231|P1|Overall Study|drug ineffective+prohibited drug taken|1
5591050|NCT00962741|19320231|P1|Overall Study|Lack of Efficacy|1
5591051|NCT00962741|19320231|P1|Overall Study|Withdrawal by Subject|1
5591052|NCT00962741|19320231|P1|Overall Study|Lost to Follow-up|2
5591053|NCT00962741|19320231|P1|Overall Study|Failed to return|3
5591054|NCT00962650|19320322|P1|Overall Study|Transgastric DP was not completed|2
5591055|NCT00962585|19320341|P4|Overall Study|Withdrew Consent|0
5591056|NCT00962585|19320342|P3|Overall Study|Withdrew Consent|0
5591057|NCT00962585|19320343|P2|Overall Study|Withdrew Consent|0
5591058|NCT00962585|19320344|P1|Overall Study|Withdrew Consent|2
5591059|NCT00962585|19320341|P4|Overall Study|Withdrawal by Subject|0
5591060|NCT00962585|19320342|P3|Overall Study|Withdrawal by Subject|0
5591061|NCT00962585|19320343|P2|Overall Study|Withdrawal by Subject|0
5591062|NCT00962585|19320344|P1|Overall Study|Withdrawal by Subject|1
5591063|NCT00962585|19320341|P4|Overall Study|Protocol Violation|0
5591064|NCT00962585|19320342|P3|Overall Study|Protocol Violation|1
5591065|NCT00962585|19320343|P2|Overall Study|Protocol Violation|0
5591066|NCT00962585|19320344|P1|Overall Study|Protocol Violation|0
5591067|NCT00962585|19320341|P4|Overall Study|Lost to Follow-up|0
5591068|NCT00962585|19320342|P3|Overall Study|Lost to Follow-up|1
5591069|NCT00962585|19320343|P2|Overall Study|Lost to Follow-up|0
5591070|NCT00962585|19320344|P1|Overall Study|Lost to Follow-up|3
5591071|NCT00962585|19320341|P4|Overall Study|Adverse Event|0
5591072|NCT00962585|19320342|P3|Overall Study|Adverse Event|1
5591073|NCT00962585|19320343|P2|Overall Study|Adverse Event|2
5591074|NCT00962585|19320344|P1|Overall Study|Adverse Event|0
5591075|NCT00962390|19320421|P4|Overall Study|Withdrawal by Subject|0
5591076|NCT00962390|19320422|P3|Overall Study|Withdrawal by Subject|1
5591077|NCT00962390|19320423|P2|Overall Study|Withdrawal by Subject|1
5591078|NCT00962390|19320424|P1|Overall Study|Withdrawal by Subject|1
5591079|NCT00962390|19320421|P4|Overall Study|Protocol Violation|0
5591080|NCT00962390|19320422|P3|Overall Study|Protocol Violation|0
5591081|NCT00962390|19320423|P2|Overall Study|Protocol Violation|0
5591082|NCT00962390|19320424|P1|Overall Study|Protocol Violation|1
5591083|NCT00962390|19320421|P4|Overall Study|Lost to Follow-up|0
5591084|NCT00962390|19320422|P3|Overall Study|Lost to Follow-up|0
5591085|NCT00962390|19320423|P2|Overall Study|Lost to Follow-up|2
5591086|NCT00962390|19320424|P1|Overall Study|Lost to Follow-up|2
5591087|NCT00962390|19320421|P4|Overall Study|Adverse Event|1
5591088|NCT00962390|19320422|P3|Overall Study|Adverse Event|3
5591089|NCT00962390|19320423|P2|Overall Study|Adverse Event|0
5591090|NCT00962390|19320424|P1|Overall Study|Adverse Event|0
5591091|NCT00962247|19320486|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
5591092|NCT00962247|19320486|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
5591093|NCT00962208|19320497|P2|Overall Study|Lost to Follow-up|9
5591094|NCT00962208|19320498|P1|Overall Study|Lost to Follow-up|0
5591095|NCT00962208|19320497|P2|Overall Study|Contraindicated to continue study|1
5591096|NCT00962208|19320498|P1|Overall Study|Contraindicated to continue study|5
5591097|NCT00962208|19320497|P2|Overall Study|Could not achieve good vision|0
5591098|NCT00962208|19320498|P1|Overall Study|Could not achieve good vision|9
5591099|NCT00962104|19320506|P2|Overall Study|Other|0
5591100|NCT00962104|19320507|P1|Overall Study|Other|2
5591101|NCT00962104|19320506|P2|Overall Study|Withdrawal by Subject|6
5591102|NCT00962104|19320507|P1|Overall Study|Withdrawal by Subject|10
5591103|NCT00962104|19320506|P2|Overall Study|Sponsor Decision|1
5591104|NCT00962104|19320507|P1|Overall Study|Sponsor Decision|0
5591105|NCT00962104|19320506|P2|Overall Study|Protocol Violation|8
5591106|NCT00962104|19320507|P1|Overall Study|Protocol Violation|6
5591107|NCT00962104|19320506|P2|Overall Study|Physician Decision|0
5591108|NCT00962104|19320507|P1|Overall Study|Physician Decision|1
5591109|NCT00962104|19320506|P2|Overall Study|Lost to Follow-up|4
5591110|NCT00962104|19320507|P1|Overall Study|Lost to Follow-up|10
5591111|NCT00962104|19320506|P2|Overall Study|Lack of Efficacy|1
5591112|NCT00962104|19320507|P1|Overall Study|Lack of Efficacy|0
5591113|NCT00962104|19320506|P2|Overall Study|Entry Criteria Not Met|2
5591114|NCT00962104|19320507|P1|Overall Study|Entry Criteria Not Met|1
5591115|NCT00962104|19320506|P2|Overall Study|Adverse Event|3
5591116|NCT00962104|19320507|P1|Overall Study|Adverse Event|10
5591117|NCT00962091|19320540|P7|Overall Study|Adverse Event|1
5591118|NCT00962091|19320541|P6|Overall Study|Adverse Event|0
5591119|NCT00962091|19320542|P5|Overall Study|Adverse Event|0
5591120|NCT00962091|19320543|P4|Overall Study|Adverse Event|0
5591121|NCT00962091|19320544|P3|Overall Study|Adverse Event|0
5591122|NCT00962091|19320545|P2|Overall Study|Adverse Event|0
5591123|NCT00962091|19320546|P1|Overall Study|Adverse Event|0
5591124|NCT00962091|19320540|P7|Overall Study|Withdrawal by Subject|0
5591125|NCT00962091|19320541|P6|Overall Study|Withdrawal by Subject|1
5591126|NCT00962091|19320542|P5|Overall Study|Withdrawal by Subject|0
5591127|NCT00962091|19320543|P4|Overall Study|Withdrawal by Subject|1
5591128|NCT00962091|19320544|P3|Overall Study|Withdrawal by Subject|1
5591129|NCT00962091|19320545|P2|Overall Study|Withdrawal by Subject|2
5591130|NCT00962091|19320546|P1|Overall Study|Withdrawal by Subject|1
5591131|NCT00962013|19320649|P1|Overall Study|No 5 year evaluation|6
5591132|NCT00962013|19320649|P1|Overall Study|Site Termination|24
5591133|NCT00962013|19320649|P1|Overall Study|Removal of study device|3
5591134|NCT00962013|19320649|P1|Overall Study|Withdrawal by Subject|8
5591135|NCT00962013|19320649|P1|Overall Study|Unable/Unwilling to return|6
5591136|NCT00962013|19320649|P1|Overall Study|Lost to Follow-up|12
5591137|NCT00962013|19320649|P1|Overall Study|Death|8
5591138|NCT00962013|19320649|P1|Overall Study|Did not have surgery|1
5591139|NCT00961961|19320673|P4|Phase II|Withdrawal by Subject|0
5591140|NCT00961961|19320674|P3|Phase II|Withdrawal by Subject|1
5591141|NCT00961961|19320675|P2|Phase II|Withdrawal by Subject|0
5591142|NCT00961961|19320676|P1|Phase II|Withdrawal by Subject|0
5591143|NCT00961961|19320673|P4|Phase II|Physician Decision|0
5591144|NCT00961961|19320674|P3|Phase II|Physician Decision|1
5591145|NCT00961961|19320675|P2|Phase II|Physician Decision|0
5591146|NCT00961961|19320676|P1|Phase II|Physician Decision|0
5591147|NCT00961961|19320673|P4|Phase II|Adverse Event|1
5591148|NCT00961961|19320674|P3|Phase II|Adverse Event|0
5591149|NCT00961961|19320675|P2|Phase II|Adverse Event|0
5591150|NCT00961961|19320676|P1|Phase II|Adverse Event|0
5591151|NCT00961961|19320673|P4|Phase II|Lost to Follow-up|7
5591152|NCT00961961|19320674|P3|Phase II|Lost to Follow-up|10
5591153|NCT00961961|19320675|P2|Phase II|Lost to Follow-up|0
5591154|NCT00961961|19320676|P1|Phase II|Lost to Follow-up|0
5591155|NCT00961961|19320673|P4|Phase I|Physician Decision|0
5591156|NCT00961961|19320674|P3|Phase I|Physician Decision|0
5591157|NCT00961961|19320675|P2|Phase I|Physician Decision|0
5591158|NCT00961961|19320676|P1|Phase I|Physician Decision|8
5591159|NCT00961961|19320673|P4|Phase I|Adverse Event|0
5591160|NCT00961961|19320674|P3|Phase I|Adverse Event|0
5591161|NCT00961961|19320675|P2|Phase I|Adverse Event|0
5591162|NCT00961961|19320676|P1|Phase I|Adverse Event|7
5591163|NCT00961961|19320673|P4|Phase I|Lack of Efficacy|0
5591164|NCT00961961|19320674|P3|Phase I|Lack of Efficacy|0
5591165|NCT00961961|19320675|P2|Phase I|Lack of Efficacy|0
5591166|NCT00961961|19320676|P1|Phase I|Lack of Efficacy|94
5591167|NCT00961961|19320673|P4|Phase I|Lost to Follow-up|0
5591168|NCT00961961|19320674|P3|Phase I|Lost to Follow-up|0
5591169|NCT00961961|19320675|P2|Phase I|Lost to Follow-up|0
5591170|NCT00961961|19320676|P1|Phase I|Lost to Follow-up|10
5591171|NCT00961961|19320673|P4|Phase I|Withdrawal by Subject|0
5591172|NCT00961961|19320674|P3|Phase I|Withdrawal by Subject|0
5591173|NCT00961961|19320675|P2|Phase I|Withdrawal by Subject|0
5591174|NCT00961961|19320676|P1|Phase I|Withdrawal by Subject|7
5591175|NCT00961896|19320701|P3|Overall Study|Abnormal laboratory value|1
5591176|NCT00961896|19320702|P2|Overall Study|Abnormal laboratory value|0
5591177|NCT00961896|19320703|P1|Overall Study|Abnormal laboratory value|0
5591178|NCT00961649|19320770|P4|Overall Study|Study terminated by sponsor|1
5591179|NCT00961649|19320771|P3|Overall Study|Study terminated by sponsor|4
5591180|NCT00961649|19320772|P2|Overall Study|Study terminated by sponsor|4
5591181|NCT00961649|19320773|P1|Overall Study|Study terminated by sponsor|4
5591182|NCT00961649|19320770|P4|Overall Study|Patient left to Mexico-family emergency|0
5591183|NCT00961649|19320771|P3|Overall Study|Patient left to Mexico-family emergency|0
5591184|NCT00961649|19320772|P2|Overall Study|Patient left to Mexico-family emergency|0
5591185|NCT00961649|19320773|P1|Overall Study|Patient left to Mexico-family emergency|1
5591186|NCT00961649|19320770|P4|Overall Study|Patient has travel plans during holidays|0
5591187|NCT00961649|19320771|P3|Overall Study|Patient has travel plans during holidays|1
5591188|NCT00961649|19320772|P2|Overall Study|Patient has travel plans during holidays|0
5591189|NCT00961649|19320773|P1|Overall Study|Patient has travel plans during holidays|0
5591190|NCT00961649|19320770|P4|Overall Study|Inadequate control of IOP|1
5591191|NCT00961649|19320771|P3|Overall Study|Inadequate control of IOP|0
5591192|NCT00961649|19320772|P2|Overall Study|Inadequate control of IOP|0
5591193|NCT00961649|19320773|P1|Overall Study|Inadequate control of IOP|0
5591194|NCT00961649|19320770|P4|Overall Study|Adverse Event|2
5591195|NCT00961649|19320771|P3|Overall Study|Adverse Event|0
5591196|NCT00961649|19320772|P2|Overall Study|Adverse Event|0
5591197|NCT00961649|19320773|P1|Overall Study|Adverse Event|4
5591198|NCT00961636|19320787|P3|Overall Study|Withdrawal by Subject|13
5591199|NCT00961636|19320788|P2|Overall Study|Withdrawal by Subject|22
5591200|NCT00961636|19320789|P1|Overall Study|Withdrawal by Subject|29
5591201|NCT00961636|19320787|P3|Overall Study|Protocol Violation|1
5591202|NCT00961636|19320788|P2|Overall Study|Protocol Violation|5
5591203|NCT00961636|19320789|P1|Overall Study|Protocol Violation|9
5591204|NCT00961636|19320787|P3|Overall Study|Physician Decision|1
5591205|NCT00961636|19320788|P2|Overall Study|Physician Decision|1
5591206|NCT00961636|19320789|P1|Overall Study|Physician Decision|3
5591207|NCT00961636|19320787|P3|Overall Study|Lost to Follow-up|1
5591208|NCT00961636|19320788|P2|Overall Study|Lost to Follow-up|3
5591209|NCT00961636|19320789|P1|Overall Study|Lost to Follow-up|2
5591210|NCT00961636|19320787|P3|Overall Study|Flushing Symptoms|3
5591211|NCT00961636|19320788|P2|Overall Study|Flushing Symptoms|46
5591212|NCT00961636|19320789|P1|Overall Study|Flushing Symptoms|29
5591213|NCT00961636|19320787|P3|Overall Study|Adverse Event|13
5591214|NCT00961636|19320788|P2|Overall Study|Adverse Event|54
5591215|NCT00961636|19320789|P1|Overall Study|Adverse Event|35
5591216|NCT00961571|19320800|P1|Overall Study|Physician Decision|39
5591217|NCT00961415|19320828|P3|Maintenance Treatment Phase|Other reason|3
5591218|NCT00961415|19320829|P2|Maintenance Treatment Phase|Other reason|1
5591219|NCT00961415|19320830|P1|Maintenance Treatment Phase|Other reason|0
5591220|NCT00961415|19320828|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
5591221|NCT00961415|19320829|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
5591222|NCT00961415|19320830|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
5591223|NCT00961415|19320828|P3|Maintenance Treatment Phase|Investigators decision|0
5591224|NCT00961415|19320829|P2|Maintenance Treatment Phase|Investigators decision|2
5591225|NCT00961415|19320830|P1|Maintenance Treatment Phase|Investigators decision|0
5591226|NCT00961415|19320828|P3|Maintenance Treatment Phase|Death|34
5591227|NCT00961415|19320829|P2|Maintenance Treatment Phase|Death|42
5591228|NCT00961415|19320830|P1|Maintenance Treatment Phase|Death|0
5591229|NCT00961415|19320828|P3|Induction Treatment Phase|Other Reason|0
5591230|NCT00961415|19320829|P2|Induction Treatment Phase|Other Reason|0
5591231|NCT00961415|19320830|P1|Induction Treatment Phase|Other Reason|5
5591232|NCT00961415|19320828|P3|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
5591233|NCT00961415|19320829|P2|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
5591234|NCT00961415|19320830|P1|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
5591235|NCT00961415|19320828|P3|Induction Treatment Phase|Physician Decision|0
5591236|NCT00961415|19320829|P2|Induction Treatment Phase|Physician Decision|0
5591237|NCT00961415|19320830|P1|Induction Treatment Phase|Physician Decision|2
5591238|NCT00961415|19320828|P3|Induction Treatment Phase|Protocol Violation|0
5591239|NCT00961415|19320829|P2|Induction Treatment Phase|Protocol Violation|0
5591240|NCT00961415|19320830|P1|Induction Treatment Phase|Protocol Violation|1
5591241|NCT00961415|19320828|P3|Induction Treatment Phase|Death|0
5591242|NCT00961415|19320829|P2|Induction Treatment Phase|Death|0
5591243|NCT00961415|19320830|P1|Induction Treatment Phase|Death|77
5591244|NCT00961415|19320828|P3|Induction Treatment Phase|Withdrawal by Subject|0
5591245|NCT00961415|19320829|P2|Induction Treatment Phase|Withdrawal by Subject|0
5591246|NCT00961415|19320830|P1|Induction Treatment Phase|Withdrawal by Subject|11
5591247|NCT00961350|19320870|P2|Overall Study|Misc|21
5591248|NCT00961350|19320871|P1|Overall Study|Misc|16
5591249|NCT00961350|19320870|P2|Overall Study|Lost to Follow-up|3
5591250|NCT00961350|19320871|P1|Overall Study|Lost to Follow-up|3
5591251|NCT00961350|19320870|P2|Overall Study|Withdrawal by Subject|10
5591252|NCT00961350|19320871|P1|Overall Study|Withdrawal by Subject|10
5591253|NCT00961350|19320870|P2|Overall Study|Adverse Event|33
5591254|NCT00961350|19320871|P1|Overall Study|Adverse Event|18
5591255|NCT00961298|19320892|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
5591256|NCT00961298|19320892|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
5591257|NCT00961298|19320892|P1|Two Week Placebo Run in|Withdrawal by Subject|1
5591258|NCT00961259|19320899|P3|Washout Period of 7 Days|due to concomitant medication used|0
5591259|NCT00961259|19320900|P2|Washout Period of 7 Days|due to concomitant medication used|1
5591260|NCT00961259|19320901|P1|Washout Period of 7 Days|due to concomitant medication used|0
5591261|NCT00961220|19320929|P1|Overall Study|Complete Response prior to 12 courses|1
5591262|NCT00961220|19320929|P1|Overall Study|O6BG no longer supplied|1
5591263|NCT00961220|19320929|P1|Overall Study|No IV access for O6BG|1
5591264|NCT00961220|19320929|P1|Overall Study|Lack of Efficacy|1
5591265|NCT00961220|19320929|P1|Overall Study|Adverse Event|3
5591266|NCT00961181|19320945|P1|Overall Study|Lost to Follow-up|1
5591267|NCT00961181|19320945|P1|Overall Study|Withdrawal by Subject|2
5591268|NCT00961181|19320945|P1|Overall Study|Death|2
5591269|NCT00961116|19320958|P2|Washout Period of 7 Days|Protocol Violation|1
5591270|NCT00961116|19320959|P1|Washout Period of 7 Days|Protocol Violation|0
5591271|NCT00961116|19320958|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5591272|NCT00961116|19320959|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5591273|NCT00961116|19320958|P2|Washout Period of 7 Days|Adverse Event|1
5591274|NCT00961116|19320959|P1|Washout Period of 7 Days|Adverse Event|1
5591275|NCT00960999|19320986|P2|Overall Study|RT dose constraints not met|0
5591276|NCT00960999|19320987|P1|Overall Study|RT dose constraints not met|2
5591277|NCT00960999|19320986|P2|Overall Study|Protocol Violation|2
5591278|NCT00960999|19320987|P1|Overall Study|Protocol Violation|5
5591279|NCT00960999|19320986|P2|Overall Study|Withdrawal by Subject|0
5591280|NCT00960999|19320987|P1|Overall Study|Withdrawal by Subject|1
5591281|NCT00960986|19321019|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
5591282|NCT00960986|19321020|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
5591283|NCT00960986|19321021|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
5591284|NCT00960986|19321022|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
5591285|NCT00960986|19321019|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
5591286|NCT00960986|19321020|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
5591287|NCT00960986|19321021|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
5591288|NCT00960986|19321022|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
5591289|NCT00960986|19321019|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
5591290|NCT00960986|19321020|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
5591291|NCT00960986|19321021|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
5591292|NCT00960986|19321022|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
5591293|NCT00960986|19321019|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
5591294|NCT00960986|19321020|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
5591295|NCT00960986|19321021|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
5591296|NCT00960986|19321022|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
5591297|NCT00960986|19321019|P4|Period 3 (7-week Therapy Period)|Death|0
5591298|NCT00960986|19321020|P3|Period 3 (7-week Therapy Period)|Death|1
5591299|NCT00960986|19321021|P2|Period 3 (7-week Therapy Period)|Death|0
5591300|NCT00960986|19321022|P1|Period 3 (7-week Therapy Period)|Death|0
5591301|NCT00960986|19321019|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
5591302|NCT00960986|19321020|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
5591303|NCT00960986|19321021|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
5591304|NCT00960986|19321022|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
5591305|NCT00960986|19321019|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
5591306|NCT00960986|19321020|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
5591307|NCT00960986|19321021|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
5591308|NCT00960986|19321022|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
5591309|NCT00960986|19321019|P4|Period 1 (Screening and Washout)|Protocol Violation|0
5591310|NCT00960986|19321020|P3|Period 1 (Screening and Washout)|Protocol Violation|0
5591311|NCT00960986|19321021|P2|Period 1 (Screening and Washout)|Protocol Violation|0
5591312|NCT00960986|19321022|P1|Period 1 (Screening and Washout)|Protocol Violation|1
5591313|NCT00960986|19321019|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
5591314|NCT00960986|19321020|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
5591315|NCT00960986|19321021|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
5591316|NCT00960986|19321022|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
5591317|NCT00960986|19321019|P4|Period 1 (Screening and Washout)|Adverse Event|1
5591318|NCT00960986|19321020|P3|Period 1 (Screening and Washout)|Adverse Event|1
5591319|NCT00960986|19321021|P2|Period 1 (Screening and Washout)|Adverse Event|2
5591320|NCT00960986|19321022|P1|Period 1 (Screening and Washout)|Adverse Event|1
5591321|NCT00960934|19321098|P6|Overall Study|Study Terminated by Sponsor|49
5591322|NCT00960934|19321099|P5|Overall Study|Study Terminated by Sponsor|49
5591323|NCT00960934|19321100|P4|Overall Study|Study Terminated by Sponsor|50
5591324|NCT00960934|19321101|P3|Overall Study|Study Terminated by Sponsor|52
5591325|NCT00960934|19321102|P2|Overall Study|Study Terminated by Sponsor|46
5591326|NCT00960934|19321103|P1|Overall Study|Study Terminated by Sponsor|50
5591327|NCT00960934|19321098|P6|Overall Study|Withdrawal by Subject|7
5591328|NCT00960934|19321099|P5|Overall Study|Withdrawal by Subject|5
5591329|NCT00960934|19321100|P4|Overall Study|Withdrawal by Subject|5
5591330|NCT00960934|19321101|P3|Overall Study|Withdrawal by Subject|4
5591331|NCT00960934|19321102|P2|Overall Study|Withdrawal by Subject|6
5591332|NCT00960934|19321103|P1|Overall Study|Withdrawal by Subject|5
5591333|NCT00960934|19321098|P6|Overall Study|Protocol Violation|2
5591334|NCT00960934|19321099|P5|Overall Study|Protocol Violation|3
5591335|NCT00960934|19321100|P4|Overall Study|Protocol Violation|3
5591336|NCT00960934|19321101|P3|Overall Study|Protocol Violation|0
5591337|NCT00960934|19321102|P2|Overall Study|Protocol Violation|4
5591338|NCT00960934|19321103|P1|Overall Study|Protocol Violation|3
5591339|NCT00960934|19321098|P6|Overall Study|Progressive Disease|1
5591340|NCT00960934|19321099|P5|Overall Study|Progressive Disease|1
5591341|NCT00960934|19321100|P4|Overall Study|Progressive Disease|0
5591342|NCT00960934|19321101|P3|Overall Study|Progressive Disease|0
5591343|NCT00960934|19321102|P2|Overall Study|Progressive Disease|1
5591344|NCT00960934|19321103|P1|Overall Study|Progressive Disease|1
5591345|NCT00960934|19321098|P6|Overall Study|Physician Decision|0
5591346|NCT00960934|19321099|P5|Overall Study|Physician Decision|0
5591347|NCT00960934|19321100|P4|Overall Study|Physician Decision|0
5591348|NCT00960934|19321101|P3|Overall Study|Physician Decision|0
5591349|NCT00960934|19321102|P2|Overall Study|Physician Decision|1
5591350|NCT00960934|19321103|P1|Overall Study|Physician Decision|0
5591351|NCT00960934|19321098|P6|Overall Study|Other|2
5591352|NCT00960934|19321099|P5|Overall Study|Other|2
5591353|NCT00960934|19321100|P4|Overall Study|Other|4
5591354|NCT00960934|19321101|P3|Overall Study|Other|5
5591355|NCT00960934|19321102|P2|Overall Study|Other|1
5591356|NCT00960934|19321103|P1|Overall Study|Other|2
5591357|NCT00960934|19321098|P6|Overall Study|Lost to Follow-up|0
5591358|NCT00960934|19321099|P5|Overall Study|Lost to Follow-up|0
5591359|NCT00960934|19321100|P4|Overall Study|Lost to Follow-up|0
5591360|NCT00960934|19321101|P3|Overall Study|Lost to Follow-up|0
5591361|NCT00960934|19321102|P2|Overall Study|Lost to Follow-up|1
5591362|NCT00960934|19321103|P1|Overall Study|Lost to Follow-up|0
5591363|NCT00960934|19321098|P6|Overall Study|Lack of Efficacy|0
5591364|NCT00960934|19321099|P5|Overall Study|Lack of Efficacy|0
5591365|NCT00960934|19321100|P4|Overall Study|Lack of Efficacy|0
5591366|NCT00960934|19321101|P3|Overall Study|Lack of Efficacy|0
5591367|NCT00960934|19321102|P2|Overall Study|Lack of Efficacy|0
5591368|NCT00960934|19321103|P1|Overall Study|Lack of Efficacy|1
5591369|NCT00960934|19321098|P6|Overall Study|Adverse Event|3
5591370|NCT00960934|19321099|P5|Overall Study|Adverse Event|4
5591371|NCT00960934|19321100|P4|Overall Study|Adverse Event|2
5591372|NCT00960934|19321101|P3|Overall Study|Adverse Event|3
5591373|NCT00960934|19321102|P2|Overall Study|Adverse Event|3
5591374|NCT00960934|19321103|P1|Overall Study|Adverse Event|2
5591375|NCT00960869|19321215|P2|Overall Study|Misc|18
5591376|NCT00960869|19321216|P1|Overall Study|Misc|19
5591377|NCT00960869|19321215|P2|Overall Study|Lost to Follow-up|4
5591378|NCT00960869|19321216|P1|Overall Study|Lost to Follow-up|1
5591379|NCT00960869|19321215|P2|Overall Study|Withdrawal by Subject|14
5591380|NCT00960869|19321216|P1|Overall Study|Withdrawal by Subject|16
5591381|NCT00960869|19321215|P2|Overall Study|Adverse Event|26
5591382|NCT00960869|19321216|P1|Overall Study|Adverse Event|17
5591383|NCT00960856|19321230|P4|Washout Period of 7 Days|Adverse Event|0
5591384|NCT00960856|19321231|P3|Washout Period of 7 Days|Adverse Event|1
5591385|NCT00960856|19321232|P2|Washout Period of 7 Days|Adverse Event|0
5591386|NCT00960856|19321233|P1|Washout Period of 7 Days|Adverse Event|0
5591387|NCT00960856|19321230|P4|Washout Period of 7 Days|Withdrawal by Subject|0
5591388|NCT00960856|19321231|P3|Washout Period of 7 Days|Withdrawal by Subject|0
5591389|NCT00960856|19321232|P2|Washout Period of 7 Days|Withdrawal by Subject|2
5591390|NCT00960856|19321233|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5591391|NCT00960843|19321253|P2|Overall Study|Repeated needle dislodgment|1
5591392|NCT00960843|19321254|P1|Overall Study|Repeated needle dislodgment|0
5591393|NCT00960843|19321253|P2|Overall Study|Protocol Violation|4
5591394|NCT00960843|19321254|P1|Overall Study|Protocol Violation|0
5591395|NCT00960843|19321253|P2|Overall Study|Lost to Follow-up|0
5591396|NCT00960843|19321254|P1|Overall Study|Lost to Follow-up|2
5591397|NCT00960687|19321275|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5591398|NCT00960687|19321276|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5591399|NCT00960687|19321275|P2|Washout Period of 7 Days|Adverse Event|2
5591400|NCT00960687|19321276|P1|Washout Period of 7 Days|Adverse Event|3
5591401|NCT00960661|19321288|P3|Interventional Phase|Lack of Efficacy|0
5591402|NCT00960661|19321289|P2|Interventional Phase|Lack of Efficacy|2
5591403|NCT00960661|19321290|P1|Interventional Phase|Lack of Efficacy|0
5591404|NCT00960661|19321288|P3|Interventional Phase|sponsor decision|0
5591405|NCT00960661|19321289|P2|Interventional Phase|sponsor decision|1
5591406|NCT00960661|19321290|P1|Interventional Phase|sponsor decision|0
5591407|NCT00960661|19321288|P3|Interventional Phase|Physician Decision|5
5591408|NCT00960661|19321289|P2|Interventional Phase|Physician Decision|3
5591409|NCT00960661|19321290|P1|Interventional Phase|Physician Decision|0
5591410|NCT00960661|19321288|P3|Interventional Phase|Withdrawal by Subject|29
5591411|NCT00960661|19321289|P2|Interventional Phase|Withdrawal by Subject|18
5591412|NCT00960661|19321290|P1|Interventional Phase|Withdrawal by Subject|0
5591413|NCT00960661|19321288|P3|Interventional Phase|Protocol Violation|2
5591414|NCT00960661|19321289|P2|Interventional Phase|Protocol Violation|7
5591415|NCT00960661|19321290|P1|Interventional Phase|Protocol Violation|0
5591416|NCT00960661|19321288|P3|Interventional Phase|entry criteria not met|0
5591417|NCT00960661|19321289|P2|Interventional Phase|entry criteria not met|3
5591418|NCT00960661|19321290|P1|Interventional Phase|entry criteria not met|0
5591419|NCT00960661|19321288|P3|Interventional Phase|Lost to Follow-up|2
5591420|NCT00960661|19321289|P2|Interventional Phase|Lost to Follow-up|0
5591421|NCT00960661|19321290|P1|Interventional Phase|Lost to Follow-up|0
5591422|NCT00960661|19321288|P3|Interventional Phase|Death|0
5591423|NCT00960661|19321289|P2|Interventional Phase|Death|1
5591424|NCT00960661|19321290|P1|Interventional Phase|Death|0
5591425|NCT00960661|19321288|P3|Interventional Phase|Adverse Event|8
5591426|NCT00960661|19321289|P2|Interventional Phase|Adverse Event|17
5591427|NCT00960661|19321290|P1|Interventional Phase|Adverse Event|0
5591428|NCT00960661|19321288|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
5591429|NCT00960661|19321289|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
5591430|NCT00960661|19321290|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
5591431|NCT00960661|19321288|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
5591432|NCT00960661|19321289|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
5591433|NCT00960661|19321290|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
5591434|NCT00960661|19321288|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
5591435|NCT00960661|19321289|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
5591436|NCT00960661|19321290|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
5591437|NCT00960661|19321288|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
5591438|NCT00960661|19321289|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
5591439|NCT00960661|19321290|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
5591440|NCT00960661|19321288|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
5591441|NCT00960661|19321289|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
5591442|NCT00960661|19321290|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
5591443|NCT00960661|19321288|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
5591444|NCT00960661|19321289|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
5591445|NCT00960661|19321290|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
5591446|NCT00960570|19321329|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
5591447|NCT00960570|19321329|P1|1 Day Period Between Dosing|Adverse Event|2
5591448|NCT00960570|19321329|P1|21 Day Washout Period|Withdrawal by Subject|1
5591449|NCT00960570|19321329|P1|21 Day Washout Period|Adverse Event|1
5591450|NCT00960531|19321350|P10|Overall Study|Reason not Specified|1
5591451|NCT00960531|19321351|P9|Overall Study|Reason not Specified|8
5591452|NCT00960531|19321352|P8|Overall Study|Reason not Specified|0
5591453|NCT00960531|19321353|P7|Overall Study|Reason not Specified|16
5591454|NCT00960531|19321354|P6|Overall Study|Reason not Specified|0
5591455|NCT00960531|19321355|P5|Overall Study|Reason not Specified|2
5591456|NCT00960531|19321356|P4|Overall Study|Reason not Specified|1
5591457|NCT00960531|19321357|P3|Overall Study|Reason not Specified|13
5591458|NCT00960531|19321358|P2|Overall Study|Reason not Specified|1
5591459|NCT00960531|19321359|P1|Overall Study|Reason not Specified|2
5591460|NCT00960531|19321350|P10|Overall Study|Adverse Event (AE)|0
5591461|NCT00960531|19321351|P9|Overall Study|Adverse Event (AE)|2
5591462|NCT00960531|19321352|P8|Overall Study|Adverse Event (AE)|0
5591463|NCT00960531|19321353|P7|Overall Study|Adverse Event (AE)|2
5591464|NCT00960531|19321354|P6|Overall Study|Adverse Event (AE)|1
5591465|NCT00960531|19321355|P5|Overall Study|Adverse Event (AE)|0
5591466|NCT00960531|19321356|P4|Overall Study|Adverse Event (AE)|0
5591467|NCT00960531|19321357|P3|Overall Study|Adverse Event (AE)|0
5591468|NCT00960531|19321358|P2|Overall Study|Adverse Event (AE)|0
5591469|NCT00960531|19321359|P1|Overall Study|Adverse Event (AE)|2
5591470|NCT00960531|19321350|P10|Overall Study|Failed to Return|0
5591471|NCT00960531|19321351|P9|Overall Study|Failed to Return|0
5591472|NCT00960531|19321352|P8|Overall Study|Failed to Return|2
5591473|NCT00960531|19321353|P7|Overall Study|Failed to Return|0
5591474|NCT00960531|19321354|P6|Overall Study|Failed to Return|0
5591475|NCT00960531|19321355|P5|Overall Study|Failed to Return|0
5591476|NCT00960531|19321356|P4|Overall Study|Failed to Return|0
5591477|NCT00960531|19321357|P3|Overall Study|Failed to Return|0
5591478|NCT00960531|19321358|P2|Overall Study|Failed to Return|0
5591479|NCT00960531|19321359|P1|Overall Study|Failed to Return|2
5591480|NCT00960531|19321350|P10|Overall Study|Lost to Follow-up|0
5591481|NCT00960531|19321351|P9|Overall Study|Lost to Follow-up|0
5591482|NCT00960531|19321352|P8|Overall Study|Lost to Follow-up|0
5591483|NCT00960531|19321353|P7|Overall Study|Lost to Follow-up|1
5591484|NCT00960531|19321354|P6|Overall Study|Lost to Follow-up|0
5591485|NCT00960531|19321355|P5|Overall Study|Lost to Follow-up|0
5591486|NCT00960531|19321356|P4|Overall Study|Lost to Follow-up|0
5591487|NCT00960531|19321357|P3|Overall Study|Lost to Follow-up|1
5591488|NCT00960531|19321358|P2|Overall Study|Lost to Follow-up|0
5591489|NCT00960531|19321359|P1|Overall Study|Lost to Follow-up|0
5591490|NCT00960531|19321350|P10|Overall Study|Discontinuation of Study by Sponsor|0
5591491|NCT00960531|19321351|P9|Overall Study|Discontinuation of Study by Sponsor|0
5591492|NCT00960531|19321352|P8|Overall Study|Discontinuation of Study by Sponsor|1
5591493|NCT00960531|19321353|P7|Overall Study|Discontinuation of Study by Sponsor|0
5591494|NCT00960531|19321354|P6|Overall Study|Discontinuation of Study by Sponsor|0
5591495|NCT00960531|19321355|P5|Overall Study|Discontinuation of Study by Sponsor|0
5591496|NCT00960531|19321356|P4|Overall Study|Discontinuation of Study by Sponsor|0
5591497|NCT00960531|19321357|P3|Overall Study|Discontinuation of Study by Sponsor|0
5591498|NCT00960531|19321358|P2|Overall Study|Discontinuation of Study by Sponsor|0
5591499|NCT00960531|19321359|P1|Overall Study|Discontinuation of Study by Sponsor|0
5591500|NCT00960531|19321350|P10|Overall Study|Investigator Request|0
5591501|NCT00960531|19321351|P9|Overall Study|Investigator Request|0
5591502|NCT00960531|19321352|P8|Overall Study|Investigator Request|0
5591503|NCT00960531|19321353|P7|Overall Study|Investigator Request|0
5591504|NCT00960531|19321354|P6|Overall Study|Investigator Request|0
5591505|NCT00960531|19321355|P5|Overall Study|Investigator Request|0
5591506|NCT00960531|19321356|P4|Overall Study|Investigator Request|0
5591507|NCT00960531|19321357|P3|Overall Study|Investigator Request|1
5591508|NCT00960531|19321358|P2|Overall Study|Investigator Request|0
5591509|NCT00960531|19321359|P1|Overall Study|Investigator Request|0
5591510|NCT00960531|19321350|P10|Overall Study|Caregiver Request|0
5591511|NCT00960531|19321351|P9|Overall Study|Caregiver Request|3
5591512|NCT00960531|19321352|P8|Overall Study|Caregiver Request|1
5591513|NCT00960531|19321353|P7|Overall Study|Caregiver Request|3
5591514|NCT00960531|19321354|P6|Overall Study|Caregiver Request|2
5591515|NCT00960531|19321355|P5|Overall Study|Caregiver Request|0
5591516|NCT00960531|19321356|P4|Overall Study|Caregiver Request|5
5591517|NCT00960531|19321357|P3|Overall Study|Caregiver Request|6
5591518|NCT00960531|19321358|P2|Overall Study|Caregiver Request|0
5591519|NCT00960531|19321359|P1|Overall Study|Caregiver Request|2
5591520|NCT00960531|19321350|P10|Overall Study|Withdrawal by Subject|0
5591521|NCT00960531|19321351|P9|Overall Study|Withdrawal by Subject|1
5591522|NCT00960531|19321352|P8|Overall Study|Withdrawal by Subject|0
5591523|NCT00960531|19321353|P7|Overall Study|Withdrawal by Subject|2
5591524|NCT00960531|19321354|P6|Overall Study|Withdrawal by Subject|0
5591525|NCT00960531|19321355|P5|Overall Study|Withdrawal by Subject|0
5591526|NCT00960531|19321356|P4|Overall Study|Withdrawal by Subject|2
5591527|NCT00960531|19321357|P3|Overall Study|Withdrawal by Subject|5
5591528|NCT00960531|19321358|P2|Overall Study|Withdrawal by Subject|0
5591529|NCT00960531|19321359|P1|Overall Study|Withdrawal by Subject|1
5591530|NCT00960531|19321350|P10|Overall Study|Lack of Efficacy|0
5591531|NCT00960531|19321351|P9|Overall Study|Lack of Efficacy|0
5591532|NCT00960531|19321352|P8|Overall Study|Lack of Efficacy|0
5591533|NCT00960531|19321353|P7|Overall Study|Lack of Efficacy|0
5591534|NCT00960531|19321354|P6|Overall Study|Lack of Efficacy|0
5591535|NCT00960531|19321355|P5|Overall Study|Lack of Efficacy|0
5591536|NCT00960531|19321356|P4|Overall Study|Lack of Efficacy|0
5591537|NCT00960531|19321357|P3|Overall Study|Lack of Efficacy|0
5591538|NCT00960531|19321358|P2|Overall Study|Lack of Efficacy|0
5591539|NCT00960531|19321359|P1|Overall Study|Lack of Efficacy|1
5591540|NCT00960440|19321441|P4|Overall Study|Other|0
5591541|NCT00960440|19321442|P3|Overall Study|Other|1
5591542|NCT00960440|19321443|P2|Overall Study|Other|1
5591543|NCT00960440|19321444|P1|Overall Study|Other|1
5591544|NCT00960440|19321441|P4|Overall Study|Withdrawal by Subject|1
5591545|NCT00960440|19321442|P3|Overall Study|Withdrawal by Subject|2
5591546|NCT00960440|19321443|P2|Overall Study|Withdrawal by Subject|5
5591547|NCT00960440|19321444|P1|Overall Study|Withdrawal by Subject|9
5591548|NCT00960440|19321441|P4|Overall Study|Protocol Violation|4
5591549|NCT00960440|19321442|P3|Overall Study|Protocol Violation|3
5591550|NCT00960440|19321443|P2|Overall Study|Protocol Violation|8
5591551|NCT00960440|19321444|P1|Overall Study|Protocol Violation|2
5591552|NCT00960440|19321441|P4|Overall Study|Lack of Efficacy|8
5591553|NCT00960440|19321442|P3|Overall Study|Lack of Efficacy|3
5591554|NCT00960440|19321443|P2|Overall Study|Lack of Efficacy|5
5591555|NCT00960440|19321444|P1|Overall Study|Lack of Efficacy|2
5591556|NCT00960440|19321441|P4|Overall Study|Adverse Event|4
5591557|NCT00960440|19321442|P3|Overall Study|Adverse Event|4
5591558|NCT00960440|19321443|P2|Overall Study|Adverse Event|12
5591559|NCT00960440|19321444|P1|Overall Study|Adverse Event|12
5591560|NCT00960440|19321441|P4|Overall Study|Death|1
5591561|NCT00960440|19321442|P3|Overall Study|Death|0
5591562|NCT00960440|19321443|P2|Overall Study|Death|0
5591563|NCT00960440|19321444|P1|Overall Study|Death|0
5591564|NCT00960375|19321616|P2|Overall Study|Lost to Follow-up|22
5591565|NCT00960375|19321617|P1|Overall Study|Lost to Follow-up|20
5591566|NCT00960323|19321625|P1|Atorvastatin Alone|Withdrawal by Subject|1
5591567|NCT00960297|19321636|P1|Overall Study|Disease progression|1
5591568|NCT00960297|19321636|P1|Overall Study|Venous port infection|1
5591569|NCT00960297|19321636|P1|Overall Study|Physician Decision|1
5591570|NCT00960206|19321643|P3|Overall Study|Missing 10 year data|1
5591571|NCT00960206|19321644|P2|Overall Study|Missing 10 year data|1
5591572|NCT00960206|19321645|P1|Overall Study|Missing 10 year data|20
5591573|NCT00960206|19321643|P3|Overall Study|Revision of study component|2
5591574|NCT00960206|19321644|P2|Overall Study|Revision of study component|2
5591575|NCT00960206|19321645|P1|Overall Study|Revision of study component|2
5591576|NCT00960206|19321643|P3|Overall Study|Withdrawal by Subject|0
5591577|NCT00960206|19321644|P2|Overall Study|Withdrawal by Subject|4
5591578|NCT00960206|19321645|P1|Overall Study|Withdrawal by Subject|2
5591579|NCT00960206|19321643|P3|Overall Study|Lost to Follow-up|8
5591580|NCT00960206|19321644|P2|Overall Study|Lost to Follow-up|14
5591581|NCT00960206|19321645|P1|Overall Study|Lost to Follow-up|8
5591582|NCT00960206|19321643|P3|Overall Study|Unwilling/Unable to return|0
5591583|NCT00960206|19321644|P2|Overall Study|Unwilling/Unable to return|2
5591584|NCT00960206|19321645|P1|Overall Study|Unwilling/Unable to return|1
5591585|NCT00960206|19321643|P3|Overall Study|Death|1
5591586|NCT00960206|19321644|P2|Overall Study|Death|4
5591587|NCT00960206|19321645|P1|Overall Study|Death|7
5591588|NCT00960193|19321663|P1|14 Day Washout Period|Withdrawal by Subject|1
5591589|NCT00960154|19321676|P2|Overall Study|Study termination|25
5591590|NCT00960154|19321677|P1|Overall Study|Study termination|25
5591591|NCT00960141|19321688|P3|Overall Study|Withdrawal by Subject|1
5591592|NCT00960141|19321689|P2|Overall Study|Withdrawal by Subject|2
5591593|NCT00960141|19321690|P1|Overall Study|Withdrawal by Subject|1
5591594|NCT00960141|19321688|P3|Overall Study|Protocol Violation|2
5591595|NCT00960141|19321689|P2|Overall Study|Protocol Violation|3
5591596|NCT00960141|19321690|P1|Overall Study|Protocol Violation|1
5591597|NCT00960141|19321688|P3|Overall Study|Lost to Follow-up|0
5591598|NCT00960141|19321689|P2|Overall Study|Lost to Follow-up|0
5591599|NCT00960141|19321690|P1|Overall Study|Lost to Follow-up|1
5591600|NCT00960141|19321688|P3|Overall Study|Lack of Efficacy|2
5591601|NCT00960141|19321689|P2|Overall Study|Lack of Efficacy|4
5591602|NCT00960141|19321690|P1|Overall Study|Lack of Efficacy|3
5591603|NCT00960141|19321688|P3|Overall Study|Adverse Event|2
5591604|NCT00960141|19321689|P2|Overall Study|Adverse Event|8
5591605|NCT00960141|19321690|P1|Overall Study|Adverse Event|4
5591606|NCT00960115|19321715|P2|Overall Study|Ongoing treatment at data cut-off date|15
5591607|NCT00960115|19321716|P1|Overall Study|Ongoing treatment at data cut-off date|19
5591608|NCT00960076|19321730|P2|Overall Study|Did not attend the termination visit|1
5591609|NCT00960076|19321731|P1|Overall Study|Did not attend the termination visit|0
5591610|NCT00960076|19321730|P2|Overall Study|Hyperglycemia|5
5591611|NCT00960076|19321731|P1|Overall Study|Hyperglycemia|1
5591612|NCT00960076|19321730|P2|Overall Study|Severe non-compliance to protocol|2
5591613|NCT00960076|19321731|P1|Overall Study|Severe non-compliance to protocol|1
5591614|NCT00960076|19321730|P2|Overall Study|Lost to Follow-up|3
5591615|NCT00960076|19321731|P1|Overall Study|Lost to Follow-up|3
5591616|NCT00960076|19321730|P2|Overall Study|Withdrawal by Subject|2
5591617|NCT00960076|19321731|P1|Overall Study|Withdrawal by Subject|1
5591618|NCT00960076|19321730|P2|Overall Study|No longer met study criteria|5
5591619|NCT00960076|19321731|P1|Overall Study|No longer met study criteria|1
5591620|NCT00960076|19321730|P2|Overall Study|Adverse Event|7
5591621|NCT00960076|19321731|P1|Overall Study|Adverse Event|1
5591622|NCT00960063|19321746|P3|Overall Study|Progression of Disease|3
5591623|NCT00960063|19321747|P2|Overall Study|Progression of Disease|0
5591624|NCT00960063|19321748|P1|Overall Study|Progression of Disease|0
5591625|NCT00960063|19321746|P3|Overall Study|Adverse Event|0
5591626|NCT00960063|19321747|P2|Overall Study|Adverse Event|0
5591627|NCT00960063|19321748|P1|Overall Study|Adverse Event|1
5591628|NCT00960011|19321788|P2|Overall Study|Lost to Follow-up|2
5591629|NCT00960011|19321789|P1|Overall Study|Lost to Follow-up|6
5591630|NCT00960011|19321788|P2|Overall Study|Death|0
5591631|NCT00960011|19321789|P1|Overall Study|Death|5
5591632|NCT00959946|19321882|P8|Overall Study|Withdrawal by Subject|0
5591633|NCT00959946|19321883|P7|Overall Study|Withdrawal by Subject|0
5591634|NCT00959946|19321884|P6|Overall Study|Withdrawal by Subject|1
5591635|NCT00959946|19321885|P5|Overall Study|Withdrawal by Subject|0
5591636|NCT00959946|19321886|P4|Overall Study|Withdrawal by Subject|0
5591637|NCT00959946|19321887|P3|Overall Study|Withdrawal by Subject|0
5591638|NCT00959946|19321888|P2|Overall Study|Withdrawal by Subject|0
5591639|NCT00959946|19321889|P1|Overall Study|Withdrawal by Subject|0
5591640|NCT00959946|19321882|P8|Overall Study|Disease Progression|2
5591641|NCT00959946|19321883|P7|Overall Study|Disease Progression|2
5591642|NCT00959946|19321884|P6|Overall Study|Disease Progression|6
5591643|NCT00959946|19321885|P5|Overall Study|Disease Progression|4
5591644|NCT00959946|19321886|P4|Overall Study|Disease Progression|4
5591645|NCT00959946|19321887|P3|Overall Study|Disease Progression|2
5591646|NCT00959946|19321888|P2|Overall Study|Disease Progression|4
5591647|NCT00959946|19321889|P1|Overall Study|Disease Progression|2
5591648|NCT00959946|19321882|P8|Overall Study|Death|0
5591649|NCT00959946|19321883|P7|Overall Study|Death|0
5591650|NCT00959946|19321884|P6|Overall Study|Death|1
5591651|NCT00959946|19321885|P5|Overall Study|Death|0
5591652|NCT00959946|19321886|P4|Overall Study|Death|0
5591653|NCT00959946|19321887|P3|Overall Study|Death|0
5591654|NCT00959946|19321888|P2|Overall Study|Death|0
5591655|NCT00959946|19321889|P1|Overall Study|Death|0
5591656|NCT00959946|19321882|P8|Overall Study|Adverse Event|0
5591657|NCT00959946|19321883|P7|Overall Study|Adverse Event|0
5591658|NCT00959946|19321884|P6|Overall Study|Adverse Event|1
5591659|NCT00959946|19321885|P5|Overall Study|Adverse Event|0
5591660|NCT00959946|19321886|P4|Overall Study|Adverse Event|1
5591661|NCT00959946|19321887|P3|Overall Study|Adverse Event|2
5591662|NCT00959946|19321888|P2|Overall Study|Adverse Event|0
5591663|NCT00959946|19321889|P1|Overall Study|Adverse Event|0
5591664|NCT00959907|19321953|P2|Overall Study|Withdrawal by Subject|0
5591665|NCT00959907|19321954|P1|Overall Study|Withdrawal by Subject|2
5591666|NCT00959907|19321953|P2|Overall Study|Adverse Event|0
5591667|NCT00959907|19321954|P1|Overall Study|Adverse Event|1
5591668|NCT00959907|19321953|P2|Overall Study|Protocol Violation|1
5591669|NCT00959907|19321954|P1|Overall Study|Protocol Violation|0
5591670|NCT00959894|19321964|P1|Overall Study|Subject moved out of town|1
5591671|NCT00959894|19321964|P1|Overall Study|Need for contraindicated medication|1
5591672|NCT00959894|19321964|P1|Overall Study|Withdrawal by Subject|1
5591673|NCT00959894|19321964|P1|Overall Study|Adverse Event|3
5591674|NCT00959894|19321964|P1|Overall Study|Lost to Follow-up|10
5591675|NCT00959751|19322013|P2|Overall Study|No migraine headache without aura|7
5591676|NCT00959751|19322014|P1|Overall Study|No migraine headache without aura|7
5591677|NCT00959751|19322013|P2|Overall Study|Non-compliance to Study Procedures|1
5591678|NCT00959751|19322014|P1|Overall Study|Non-compliance to Study Procedures|0
5591679|NCT00959751|19322013|P2|Overall Study|Consent Withdrawn|1
5591680|NCT00959751|19322014|P1|Overall Study|Consent Withdrawn|0
5591681|NCT00959751|19322013|P2|Overall Study|Lost to Follow-up|3
5591682|NCT00959751|19322014|P1|Overall Study|Lost to Follow-up|2
5591683|NCT00959699|19322036|P2|Follow-up Period|Withdrawal by Subject|4
5591684|NCT00959699|19322037|P1|Follow-up Period|Withdrawal by Subject|3
5591685|NCT00959699|19322036|P2|Follow-up Period|Lost to Follow-up|2
5591686|NCT00959699|19322037|P1|Follow-up Period|Lost to Follow-up|3
5591687|NCT00959699|19322036|P2|Treatment Period|Futility/crossover to boceprevir|0
5591688|NCT00959699|19322037|P1|Treatment Period|Futility/crossover to boceprevir|4
5591689|NCT00959699|19322036|P2|Treatment Period|Did not receive treatment|1
5591690|NCT00959699|19322037|P1|Treatment Period|Did not receive treatment|0
5591691|NCT00959699|19322036|P2|Treatment Period|Non-Compliance with Protocol|1
5591692|NCT00959699|19322037|P1|Treatment Period|Non-Compliance with Protocol|0
5591693|NCT00959699|19322036|P2|Treatment Period|Withdrawal by Subject|3
5591694|NCT00959699|19322037|P1|Treatment Period|Withdrawal by Subject|1
5591695|NCT00959699|19322036|P2|Treatment Period|Lost to Follow-up|1
5591696|NCT00959699|19322037|P1|Treatment Period|Lost to Follow-up|0
5591697|NCT00959699|19322036|P2|Treatment Period|Lack of Efficacy|6
5591698|NCT00959699|19322037|P1|Treatment Period|Lack of Efficacy|15
5591699|NCT00959699|19322036|P2|Treatment Period|Adverse Event|13
5591700|NCT00959699|19322037|P1|Treatment Period|Adverse Event|3
5591701|NCT00959647|19322083|P1|Overall Study|Withdrawal by Subject|7
5591702|NCT00959647|19322083|P1|Overall Study|Study terminated by sponsor|4
5591703|NCT00959647|19322083|P1|Overall Study|Progressive disease|6
5591704|NCT00959647|19322083|P1|Overall Study|Adverse Event|2
5591705|NCT00959374|19322088|P1|Overall Study|Physician Decision|1
5591706|NCT00959374|19322088|P1|Overall Study|Implant Removed/Not Replaced|4
5591707|NCT00959374|19322088|P1|Overall Study|Protocol Violation|1
5591708|NCT00959374|19322088|P1|Overall Study|Death|1
5591709|NCT00959374|19322088|P1|Overall Study|Lost to Follow-up|14
5591710|NCT00959374|19322088|P1|Overall Study|Withdrawal by Subject|2
5591711|NCT00959192|19322102|P4|Overall Study|Caregiver Request|1
5591712|NCT00959192|19322103|P3|Overall Study|Caregiver Request|2
5591713|NCT00959192|19322104|P2|Overall Study|Caregiver Request|0
5591714|NCT00959192|19322105|P1|Overall Study|Caregiver Request|0
5591715|NCT00959192|19322102|P4|Overall Study|Investigator Request|0
5591716|NCT00959192|19322103|P3|Overall Study|Investigator Request|0
5591717|NCT00959192|19322104|P2|Overall Study|Investigator Request|0
5591718|NCT00959192|19322105|P1|Overall Study|Investigator Request|1
5591719|NCT00959192|19322102|P4|Overall Study|Adverse Event|0
5591720|NCT00959192|19322103|P3|Overall Study|Adverse Event|1
5591721|NCT00959192|19322104|P2|Overall Study|Adverse Event|1
5591722|NCT00959192|19322105|P1|Overall Study|Adverse Event|1
5591723|NCT00959049|19322164|P6|Overall Study|Withdrawal by Subject|0
5591724|NCT00959049|19322165|P5|Overall Study|Withdrawal by Subject|0
5591725|NCT00959049|19322166|P4|Overall Study|Withdrawal by Subject|0
5591726|NCT00959049|19322167|P3|Overall Study|Withdrawal by Subject|0
5591727|NCT00959049|19322168|P2|Overall Study|Withdrawal by Subject|2
5591728|NCT00959049|19322169|P1|Overall Study|Withdrawal by Subject|0
5591729|NCT00959049|19322164|P6|Overall Study|Contraindicated medication|0
5591730|NCT00959049|19322165|P5|Overall Study|Contraindicated medication|0
5591731|NCT00959049|19322166|P4|Overall Study|Contraindicated medication|1
5591732|NCT00959049|19322167|P3|Overall Study|Contraindicated medication|0
5591733|NCT00959049|19322168|P2|Overall Study|Contraindicated medication|0
5591734|NCT00959049|19322169|P1|Overall Study|Contraindicated medication|0
5591735|NCT00959049|19322164|P6|Overall Study|Lost to Follow-up|1
5591736|NCT00959049|19322165|P5|Overall Study|Lost to Follow-up|9
5591737|NCT00959049|19322166|P4|Overall Study|Lost to Follow-up|10
5591738|NCT00959049|19322167|P3|Overall Study|Lost to Follow-up|1
5591739|NCT00959049|19322168|P2|Overall Study|Lost to Follow-up|5
5591740|NCT00959049|19322169|P1|Overall Study|Lost to Follow-up|17
5591741|NCT00959049|19322164|P6|Overall Study|Adverse Event|0
5591742|NCT00959049|19322165|P5|Overall Study|Adverse Event|0
5591743|NCT00959049|19322166|P4|Overall Study|Adverse Event|0
5591744|NCT00959049|19322167|P3|Overall Study|Adverse Event|0
5591745|NCT00959049|19322168|P2|Overall Study|Adverse Event|0
5591746|NCT00959049|19322169|P1|Overall Study|Adverse Event|1
5591747|NCT00958893|19322234|P1|Overall Study|Study prematurely terminated|4
5591748|NCT00958880|19322240|P2|Overall Study|Lost to Follow-up|2
5591749|NCT00958880|19322241|P1|Overall Study|Lost to Follow-up|2
5591750|NCT00958841|19322249|P1|Overall Study|Discontinued prior to M*|28
5591751|NCT00958841|19322249|P1|Overall Study|Completed M6/did not enter extension|27
5591752|NCT00958841|19322249|P1|Overall Study|Unsatisfactory therapeutic effect|22
5591753|NCT00958841|19322249|P1|Overall Study|Withdrawal by Subject|1
5591754|NCT00958841|19322249|P1|Overall Study|New cancer therapy|5
5591755|NCT00958841|19322249|P1|Overall Study|Adverse Event|8
5591756|NCT00958841|19322249|P1|Overall Study|Administrative problems|1
5591757|NCT00958841|19322249|P1|Overall Study|Abnormal test procedure result(s)|3
5591758|NCT00958841|19322249|P1|Overall Study|Abnormal laboratory value(s)|1
5591759|NCT00958828|19322267|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
5591760|NCT00958828|19322268|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
5591761|NCT00958828|19322267|P2|Period 1, 1 Week of Wear|Randomization break|1
5591762|NCT00958828|19322268|P1|Period 1, 1 Week of Wear|Randomization break|0
5591763|NCT00958789|19322274|P1|Overall Study|Revision|7
5591764|NCT00958789|19322274|P1|Overall Study|Subject terminated|2
5591765|NCT00958789|19322274|P1|Overall Study|2 yr. Knee Society Score not calculable|1
5591766|NCT00958789|19322274|P1|Overall Study|No 2 yr. Knee Society Score data|4
5591767|NCT00958789|19322274|P1|Overall Study|Withdrawal by Subject|17
5591768|NCT00958789|19322274|P1|Overall Study|Lost to Follow-up|14
5591769|NCT00958789|19322274|P1|Overall Study|Death|5
5591770|NCT00958776|19322294|P2|Overall Study|Missing|1
5591771|NCT00958776|19322295|P1|Overall Study|Missing|1
5591772|NCT00958776|19322294|P2|Overall Study|Noncompliance; Protocol Deviations|3
5591773|NCT00958776|19322295|P1|Overall Study|Noncompliance; Protocol Deviations|2
5591774|NCT00958776|19322294|P2|Overall Study|Death|1
5591775|NCT00958776|19322295|P1|Overall Study|Death|2
5591776|NCT00958776|19322294|P2|Overall Study|Protocol Violation|1
5591777|NCT00958776|19322295|P1|Overall Study|Protocol Violation|1
5591778|NCT00958776|19322294|P2|Overall Study|Withdrawal by Subject|16
5591779|NCT00958776|19322295|P1|Overall Study|Withdrawal by Subject|7
5591780|NCT00958776|19322294|P2|Overall Study|Lost to Follow-up|6
5591781|NCT00958776|19322295|P1|Overall Study|Lost to Follow-up|2
5591782|NCT00958776|19322294|P2|Overall Study|Physician Decision|0
5591783|NCT00958776|19322295|P1|Overall Study|Physician Decision|1
5591784|NCT00958776|19322294|P2|Overall Study|Adverse Event|1
5591785|NCT00958776|19322295|P1|Overall Study|Adverse Event|0
5591786|NCT00958724|19322325|P1|Overall Study|Disease Progression|6
5591787|NCT00958711|19322337|P2|Overall Study|Adverse Event|2
5591788|NCT00958711|19322338|P1|Overall Study|Adverse Event|1
5591789|NCT00958711|19322337|P2|Overall Study|Death|2
5591790|NCT00958711|19322338|P1|Overall Study|Death|1
5591791|NCT00958711|19322337|P2|Overall Study|Other|5
5591792|NCT00958711|19322338|P1|Overall Study|Other|2
5591793|NCT00958711|19322337|P2|Overall Study|Lost to Follow-up|1
5591794|NCT00958711|19322338|P1|Overall Study|Lost to Follow-up|4
5591795|NCT00958711|19322337|P2|Overall Study|Physician Decision|7
5591796|NCT00958711|19322338|P1|Overall Study|Physician Decision|5
5591797|NCT00958711|19322337|P2|Overall Study|Withdrawal by Subject|4
5591798|NCT00958711|19322338|P1|Overall Study|Withdrawal by Subject|0
5591799|NCT00958568|19322383|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
5591800|NCT00958568|19322384|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
5591801|NCT00958568|19322385|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
5591802|NCT00958568|19322386|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
5591803|NCT00958568|19322383|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
5591804|NCT00958568|19322384|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
5591805|NCT00958568|19322385|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
5591806|NCT00958568|19322386|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
5591954|NCT00958243|19322726|P3|Overall Study|Withdrawal by Subject|3
5591807|NCT00958568|19322383|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
5591808|NCT00958568|19322384|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
5591809|NCT00958568|19322385|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
5591810|NCT00958568|19322386|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
5591811|NCT00958568|19322383|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
5591812|NCT00958568|19322384|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
5591813|NCT00958568|19322385|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
5591814|NCT00958568|19322386|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
5591815|NCT00958568|19322383|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
5591816|NCT00958568|19322384|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
5591817|NCT00958568|19322385|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
5591818|NCT00958568|19322386|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
5591819|NCT00958568|19322383|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
5591820|NCT00958568|19322384|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
5591821|NCT00958568|19322385|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
5591822|NCT00958568|19322386|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
5591823|NCT00958568|19322383|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
5591824|NCT00958568|19322384|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
5591825|NCT00958568|19322385|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
5591826|NCT00958568|19322386|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
5591827|NCT00958568|19322383|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
5591828|NCT00958568|19322384|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
5591829|NCT00958568|19322385|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
5591830|NCT00958568|19322386|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
5591831|NCT00958568|19322383|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
5591832|NCT00958568|19322384|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
5591833|NCT00958568|19322385|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
5591834|NCT00958568|19322386|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
5591835|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
5591836|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
5591837|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
5591838|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
5591839|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
5591840|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
5591841|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
5591842|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
5591843|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
5591844|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
5591845|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
5591846|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
5591847|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
5591848|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
5591849|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
5591850|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
5591851|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
5591852|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
5591853|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
5591854|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
5591855|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
5591856|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
5591857|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
5591858|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
5591859|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
5591860|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
5591861|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
5591862|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
5591863|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
5591864|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
5591865|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
5591866|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
5591867|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
5591868|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
5591869|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
5591870|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
5591871|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
5591872|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
5591873|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
5591874|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
5591875|NCT00958568|19322383|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
5591876|NCT00958568|19322384|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
5591877|NCT00958568|19322385|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
5591878|NCT00958568|19322386|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
5591879|NCT00958568|19322383|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
5591880|NCT00958568|19322384|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
5591881|NCT00958568|19322385|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
5591882|NCT00958568|19322386|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
5591883|NCT00958568|19322383|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
5591884|NCT00958568|19322384|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
5591885|NCT00958568|19322385|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
5591886|NCT00958568|19322386|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
5591887|NCT00958568|19322383|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
5591888|NCT00958568|19322384|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
5591889|NCT00958568|19322385|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
5591890|NCT00958568|19322386|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
5591891|NCT00958568|19322383|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
5591892|NCT00958568|19322384|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
5591893|NCT00958568|19322385|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
5591894|NCT00958568|19322386|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
5591895|NCT00958568|19322383|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
5591896|NCT00958568|19322384|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
5591897|NCT00958568|19322385|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
5591898|NCT00958568|19322386|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
5591899|NCT00958568|19322383|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
5591900|NCT00958568|19322384|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
5591901|NCT00958568|19322385|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
5591902|NCT00958568|19322386|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
5591903|NCT00958568|19322383|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
5591904|NCT00958568|19322384|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
5591905|NCT00958568|19322385|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
5591906|NCT00958568|19322386|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
5591907|NCT00958568|19322383|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
5591908|NCT00958568|19322384|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
5591909|NCT00958568|19322385|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
5591910|NCT00958568|19322386|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
5591911|NCT00958568|19322383|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
5591912|NCT00958568|19322384|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
5591913|NCT00958568|19322385|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
5591914|NCT00958568|19322386|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
5591915|NCT00958438|19322623|P3|Overall Study|Other than specified above|2
5591916|NCT00958438|19322624|P2|Overall Study|Other than specified above|3
5591917|NCT00958438|19322625|P1|Overall Study|Other than specified above|2
5591918|NCT00958438|19322623|P3|Overall Study|Physician Decision|1
5591919|NCT00958438|19322624|P2|Overall Study|Physician Decision|0
5591920|NCT00958438|19322625|P1|Overall Study|Physician Decision|1
5591921|NCT00958438|19322623|P3|Overall Study|Adverse Event|0
5591922|NCT00958438|19322624|P2|Overall Study|Adverse Event|3
5591923|NCT00958438|19322625|P1|Overall Study|Adverse Event|0
5591924|NCT00958438|19322623|P3|Overall Study|Withdrawal by Subject|1
5591925|NCT00958438|19322624|P2|Overall Study|Withdrawal by Subject|2
5591926|NCT00958438|19322625|P1|Overall Study|Withdrawal by Subject|4
5591927|NCT00958438|19322623|P3|Overall Study|Protocol Violation|2
5591928|NCT00958438|19322624|P2|Overall Study|Protocol Violation|2
5591929|NCT00958438|19322625|P1|Overall Study|Protocol Violation|3
5591930|NCT00958412|19322648|P1|Overall Study|Study prematurely terminated|18
5591931|NCT00958360|19322654|P2|Overall Study|Lost to Follow-up|1
5591932|NCT00958360|19322655|P1|Overall Study|Lost to Follow-up|0
5591933|NCT00958360|19322654|P2|Overall Study|Physician Decision|1
5591934|NCT00958360|19322655|P1|Overall Study|Physician Decision|2
5591935|NCT00958360|19322654|P2|Overall Study|Death|7
5591936|NCT00958360|19322655|P1|Overall Study|Death|6
5591937|NCT00958360|19322654|P2|Overall Study|Withdrawal by Subject|1
5591938|NCT00958360|19322655|P1|Overall Study|Withdrawal by Subject|3
5591939|NCT00958347|19322669|P1|Overall Study|study termination|135
5591940|NCT00958347|19322669|P1|Overall Study|revision/removal|10
5591941|NCT00958347|19322669|P1|Overall Study|Lost to Follow-up|15
5591942|NCT00958347|19322669|P1|Overall Study|Withdrawal by Subject|23
5591943|NCT00958347|19322669|P1|Overall Study|Death|43
5591944|NCT00958256|19322713|P1|Overall Study|Adverse Event|3
5591945|NCT00958243|19322723|P6|Overall Study|Lost to Follow-up|5
5591946|NCT00958243|19322724|P5|Overall Study|Lost to Follow-up|8
5591947|NCT00958243|19322725|P4|Overall Study|Lost to Follow-up|2
5591948|NCT00958243|19322726|P3|Overall Study|Lost to Follow-up|11
5591949|NCT00958243|19322727|P2|Overall Study|Lost to Follow-up|5
5591950|NCT00958243|19322728|P1|Overall Study|Lost to Follow-up|2
5591951|NCT00958243|19322723|P6|Overall Study|Withdrawal by Subject|5
5591952|NCT00958243|19322724|P5|Overall Study|Withdrawal by Subject|1
5591953|NCT00958243|19322725|P4|Overall Study|Withdrawal by Subject|1
5591955|NCT00958243|19322727|P2|Overall Study|Withdrawal by Subject|1
5591956|NCT00958243|19322728|P1|Overall Study|Withdrawal by Subject|0
5591957|NCT00958217|19322786|P2|Overall Study|Inpatient hospitalization|1
5591958|NCT00958217|19322787|P1|Overall Study|Inpatient hospitalization|0
5591959|NCT00958217|19322786|P2|Overall Study|Moved out of area|1
5591960|NCT00958217|19322787|P1|Overall Study|Moved out of area|1
5591961|NCT00958217|19322786|P2|Overall Study|Lost to Follow-up|19
5591962|NCT00958217|19322787|P1|Overall Study|Lost to Follow-up|17
5591963|NCT00958217|19322786|P2|Overall Study|Withdrawal by Subject|3
5591964|NCT00958217|19322787|P1|Overall Study|Withdrawal by Subject|4
5591965|NCT00958217|19322786|P2|Overall Study|Death|1
5591966|NCT00958217|19322787|P1|Overall Study|Death|2
5591967|NCT00958191|19322798|P1|Overall Study|No 5 yr x-rays|56
5591968|NCT00958191|19322798|P1|Overall Study|Site termination|11
5591969|NCT00958191|19322798|P1|Overall Study|Revision of study device|4
5591970|NCT00958191|19322798|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
5591971|NCT00958191|19322798|P1|Overall Study|Inadequate 5 yr x-ray quality|10
5591972|NCT00958191|19322798|P1|Overall Study|Lost to Follow-up|5
5591973|NCT00958191|19322798|P1|Overall Study|Death|4
5591974|NCT00958165|19322813|P1|Overall Study|Not eligible|9
5591975|NCT00958165|19322813|P1|Overall Study|Lost to Follow-up|5
5591976|NCT00958126|19322825|P8|Overall Study|Other Reason|0
5591977|NCT00958126|19322826|P7|Overall Study|Other Reason|0
5591978|NCT00958126|19322827|P6|Overall Study|Other Reason|1
5591979|NCT00958126|19322828|P5|Overall Study|Other Reason|0
5591980|NCT00958126|19322829|P4|Overall Study|Other Reason|1
5591981|NCT00958126|19322830|P3|Overall Study|Other Reason|0
5591982|NCT00958126|19322831|P2|Overall Study|Other Reason|0
5591983|NCT00958126|19322832|P1|Overall Study|Other Reason|0
5591984|NCT00958126|19322825|P8|Overall Study|Sponsor/Investigator decision|0
5591985|NCT00958126|19322826|P7|Overall Study|Sponsor/Investigator decision|0
5591986|NCT00958126|19322827|P6|Overall Study|Sponsor/Investigator decision|0
5591987|NCT00958126|19322828|P5|Overall Study|Sponsor/Investigator decision|0
5591988|NCT00958126|19322829|P4|Overall Study|Sponsor/Investigator decision|1
5591989|NCT00958126|19322830|P3|Overall Study|Sponsor/Investigator decision|0
5591990|NCT00958126|19322831|P2|Overall Study|Sponsor/Investigator decision|0
5591991|NCT00958126|19322832|P1|Overall Study|Sponsor/Investigator decision|0
5591992|NCT00958126|19322825|P8|Overall Study|Lost to Follow-up|0
5591993|NCT00958126|19322826|P7|Overall Study|Lost to Follow-up|0
5591994|NCT00958126|19322827|P6|Overall Study|Lost to Follow-up|0
5591995|NCT00958126|19322828|P5|Overall Study|Lost to Follow-up|0
5591996|NCT00958126|19322829|P4|Overall Study|Lost to Follow-up|8
5591997|NCT00958126|19322830|P3|Overall Study|Lost to Follow-up|9
5591998|NCT00958126|19322831|P2|Overall Study|Lost to Follow-up|5
5591999|NCT00958126|19322832|P1|Overall Study|Lost to Follow-up|1
5592000|NCT00958126|19322825|P8|Overall Study|Moved away from study area|0
5592001|NCT00958126|19322826|P7|Overall Study|Moved away from study area|0
5592002|NCT00958126|19322827|P6|Overall Study|Moved away from study area|0
5592003|NCT00958126|19322828|P5|Overall Study|Moved away from study area|0
5592004|NCT00958126|19322829|P4|Overall Study|Moved away from study area|1
5592005|NCT00958126|19322830|P3|Overall Study|Moved away from study area|1
5592006|NCT00958126|19322831|P2|Overall Study|Moved away from study area|0
5592007|NCT00958126|19322832|P1|Overall Study|Moved away from study area|0
5592008|NCT00958126|19322825|P8|Overall Study|Withdrawal by Subject|0
5592009|NCT00958126|19322826|P7|Overall Study|Withdrawal by Subject|0
5592010|NCT00958126|19322827|P6|Overall Study|Withdrawal by Subject|0
5592011|NCT00958126|19322828|P5|Overall Study|Withdrawal by Subject|0
5592012|NCT00958126|19322829|P4|Overall Study|Withdrawal by Subject|0
5592013|NCT00958126|19322830|P3|Overall Study|Withdrawal by Subject|0
5592014|NCT00958126|19322831|P2|Overall Study|Withdrawal by Subject|2
5592015|NCT00958126|19322832|P1|Overall Study|Withdrawal by Subject|0
5592016|NCT00958126|19322825|P8|Overall Study|Serious Adverse Event|0
5592017|NCT00958126|19322826|P7|Overall Study|Serious Adverse Event|1
5592018|NCT00958126|19322827|P6|Overall Study|Serious Adverse Event|0
5592019|NCT00958126|19322828|P5|Overall Study|Serious Adverse Event|0
5592020|NCT00958126|19322829|P4|Overall Study|Serious Adverse Event|0
5592021|NCT00958126|19322830|P3|Overall Study|Serious Adverse Event|0
5592022|NCT00958126|19322831|P2|Overall Study|Serious Adverse Event|2
5592023|NCT00958126|19322832|P1|Overall Study|Serious Adverse Event|0
5592024|NCT00958074|19322904|P2|Overall Study|Withdrawal by Subject|1
5592025|NCT00958074|19322905|P1|Overall Study|Withdrawal by Subject|0
5592026|NCT00958009|19322928|P1|Overall Study|Subject found device difficult to use|1
5592027|NCT00958009|19322928|P1|Overall Study|Adverse Event|1
5592028|NCT00957996|19322935|P2|Overall Study|Noncompliance; Protocol Deviations|6
5592029|NCT00957996|19322936|P1|Overall Study|Noncompliance; Protocol Deviations|5
5592030|NCT00957996|19322935|P2|Overall Study|Missing|0
5592031|NCT00957996|19322936|P1|Overall Study|Missing|1
5592032|NCT00957996|19322935|P2|Overall Study|Influenza-related complication|1
5592033|NCT00957996|19322936|P1|Overall Study|Influenza-related complication|0
5592034|NCT00957996|19322935|P2|Overall Study|Physician Decision|1
5592035|NCT00957996|19322936|P1|Overall Study|Physician Decision|1
5592036|NCT00957996|19322935|P2|Overall Study|Adverse Event|1
5592037|NCT00957996|19322936|P1|Overall Study|Adverse Event|2
5592038|NCT00957996|19322935|P2|Overall Study|Withdrawal by Subject|2
5592039|NCT00957996|19322936|P1|Overall Study|Withdrawal by Subject|9
5592040|NCT00957996|19322935|P2|Overall Study|Lost to Follow-up|7
5592041|NCT00957996|19322936|P1|Overall Study|Lost to Follow-up|4
5592042|NCT00957996|19322935|P2|Overall Study|Death|10
5592043|NCT00957996|19322936|P1|Overall Study|Death|4
5592044|NCT00957944|19322968|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
5592045|NCT00957944|19322969|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
5592046|NCT00957931|19323003|P1|Overall Study|Death|4
5592047|NCT00957905|19323013|P2|Part B|Protocol Violation|1
5592048|NCT00957905|19323014|P1|Part B|Protocol Violation|0
5592049|NCT00957905|19323013|P2|Part B|Death|1
5592050|NCT00957905|19323014|P1|Part B|Death|0
5592051|NCT00957905|19323013|P2|Part B|Physician Decision|1
5592052|NCT00957905|19323014|P1|Part B|Physician Decision|0
5592053|NCT00957905|19323013|P2|Part B|Not Treated|1
5592054|NCT00957905|19323014|P1|Part B|Not Treated|0
5592055|NCT00957853|19323023|P3|Overall Study|Withdrawal by Subject|0
5592056|NCT00957853|19323024|P2|Overall Study|Withdrawal by Subject|0
5592057|NCT00957853|19323025|P1|Overall Study|Withdrawal by Subject|1
5592058|NCT00957801|19323049|P4|Overall Study|Withdrawal by Subject|1
5592059|NCT00957801|19323050|P3|Overall Study|Withdrawal by Subject|0
5592060|NCT00957801|19323051|P2|Overall Study|Withdrawal by Subject|0
5592061|NCT00957801|19323052|P1|Overall Study|Withdrawal by Subject|0
5592062|NCT00957723|19323218|P1|Overall Study|2yr ROM Data Not Evaluable|12
5592063|NCT00957723|19323218|P1|Overall Study|Intercurrent Illness|2
5592064|NCT00957723|19323218|P1|Overall Study|Investigative Site Terminated|61
5592065|NCT00957723|19323218|P1|Overall Study|Withdrawal by Subject|24
5592066|NCT00957723|19323218|P1|Overall Study|Lost to Follow-up|8
5592067|NCT00957723|19323218|P1|Overall Study|Revision/ Removal of Study Implant|3
5592068|NCT00957723|19323218|P1|Overall Study|Death|3
5592069|NCT00957658|19323307|P1|Overall Study|Protocol Violation|5
5592070|NCT00957658|19323307|P1|Overall Study|surgery cancelled|2
5592071|NCT00957658|19323307|P1|Overall Study|unwilling/unable to return|2
5592072|NCT00957658|19323307|P1|Overall Study|Site termination|10
5592073|NCT00957658|19323307|P1|Overall Study|Incomplete 2 yr data|28
5592074|NCT00957658|19323307|P1|Overall Study|Revision|1
5592075|NCT00957658|19323307|P1|Overall Study|Withdrawal by Subject|12
5592076|NCT00957658|19323307|P1|Overall Study|Lost to Follow-up|4
5592077|NCT00957658|19323307|P1|Overall Study|Death|1
5592078|NCT00957580|19323334|P3|Overall Study|Enrolled but not treated|0
5592079|NCT00957580|19323335|P2|Overall Study|Enrolled but not treated|1
5592080|NCT00957580|19323336|P1|Overall Study|Enrolled but not treated|0
5592081|NCT00957580|19323334|P3|Overall Study|Ongoing at data cut-off|0
5592082|NCT00957580|19323335|P2|Overall Study|Ongoing at data cut-off|1
5592083|NCT00957580|19323336|P1|Overall Study|Ongoing at data cut-off|0
5592084|NCT00957528|19323483|P3|Overall Study|Withdrawal by Subject|1
5592085|NCT00957528|19323484|P2|Overall Study|Withdrawal by Subject|0
5592086|NCT00957528|19323485|P1|Overall Study|Withdrawal by Subject|0
5592087|NCT00957528|19323483|P3|Overall Study|Protocol Violation|0
5592088|NCT00957528|19323484|P2|Overall Study|Protocol Violation|1
5592089|NCT00957528|19323485|P1|Overall Study|Protocol Violation|0
5592090|NCT00957424|19323508|P1|Overall Study|Withdrawal by Subject|1
5592091|NCT00957424|19323508|P1|Overall Study|Protocol Violation|3
5592092|NCT00957424|19323508|P1|Overall Study|Lost to Follow-up|19
5592093|NCT00957372|19323518|P4|PART II|Patient non-compliance|4
5592094|NCT00957372|19323519|P3|PART II|Patient non-compliance|0
5592095|NCT00957372|19323520|P2|PART II|Patient non-compliance|0
5592096|NCT00957372|19323521|P1|PART II|Patient non-compliance|0
5592097|NCT00957372|19323518|P4|PART II|Adverse Event|10
5592098|NCT00957372|19323519|P3|PART II|Adverse Event|0
5592099|NCT00957372|19323520|P2|PART II|Adverse Event|0
5592100|NCT00957372|19323521|P1|PART II|Adverse Event|0
5592101|NCT00957372|19323518|P4|PART II|Not Know|20
5592102|NCT00957372|19323519|P3|PART II|Not Know|0
5592103|NCT00957372|19323520|P2|PART II|Not Know|0
5592104|NCT00957372|19323521|P1|PART II|Not Know|0
5592105|NCT00957372|19323518|P4|PART II|Pregnancy|1
5592106|NCT00957372|19323519|P3|PART II|Pregnancy|0
5592107|NCT00957372|19323520|P2|PART II|Pregnancy|0
5592108|NCT00957372|19323521|P1|PART II|Pregnancy|0
5592109|NCT00957372|19323518|P4|PART II|Physician Decision|1
5592110|NCT00957372|19323519|P3|PART II|Physician Decision|0
5592111|NCT00957372|19323520|P2|PART II|Physician Decision|0
5592112|NCT00957372|19323521|P1|PART II|Physician Decision|0
5592113|NCT00957372|19323518|P4|PART II|Withdrawal by Subject|8
5592114|NCT00957372|19323519|P3|PART II|Withdrawal by Subject|0
5592115|NCT00957372|19323520|P2|PART II|Withdrawal by Subject|0
5592116|NCT00957372|19323521|P1|PART II|Withdrawal by Subject|0
5592117|NCT00957372|19323518|P4|PART I|Lost to Follow-up|0
5592118|NCT00957372|19323519|P3|PART I|Lost to Follow-up|1
5592119|NCT00957372|19323520|P2|PART I|Lost to Follow-up|0
5592120|NCT00957372|19323521|P1|PART I|Lost to Follow-up|0
5592121|NCT00957268|19323661|P5|Overall Study|Voluntary Withdrawal|0
5592122|NCT00957268|19323662|P4|Overall Study|Voluntary Withdrawal|0
5592123|NCT00957268|19323663|P3|Overall Study|Voluntary Withdrawal|1
5592124|NCT00957268|19323664|P2|Overall Study|Voluntary Withdrawal|0
5592125|NCT00957268|19323665|P1|Overall Study|Voluntary Withdrawal|0
5592126|NCT00957034|19323787|P3|Overall Study|Withdrawal by Subject|0
5592127|NCT00957034|19323788|P2|Overall Study|Withdrawal by Subject|2
5592128|NCT00957034|19323789|P1|Overall Study|Withdrawal by Subject|0
5592129|NCT00957034|19323787|P3|Overall Study|Sponsor Terminated Study|5
5592130|NCT00957034|19323788|P2|Overall Study|Sponsor Terminated Study|1
5592131|NCT00957034|19323789|P1|Overall Study|Sponsor Terminated Study|6
5592132|NCT00957034|19323787|P3|Overall Study|Adverse Event|1
5592133|NCT00957034|19323788|P2|Overall Study|Adverse Event|1
5592134|NCT00957034|19323789|P1|Overall Study|Adverse Event|0
5592135|NCT00957021|19323812|P1|Overall Study|Termination due to language issue|2
5592136|NCT00957021|19323812|P1|Overall Study|Surgery Cancelled|9
5592137|NCT00957021|19323812|P1|Overall Study|Site Termination by the 2 yr visit|16
5592138|NCT00957021|19323812|P1|Overall Study|Revised study component by 2 yr visit|8
5592139|NCT00957021|19323812|P1|Overall Study|No 2 yr ROM data|35
5592140|NCT00957021|19323812|P1|Overall Study|Withdrawal by Subject|34
5592141|NCT00957021|19323812|P1|Overall Study|Lost to Follow-up|8
5592142|NCT00957021|19323812|P1|Overall Study|Death|5
5592143|NCT00957008|19323825|P4|Overall Study|Relocated; Family conflict|3
5592144|NCT00957008|19323826|P3|Overall Study|Relocated; Family conflict|1
5592145|NCT00957008|19323827|P2|Overall Study|Relocated; Family conflict|1
5592146|NCT00957008|19323828|P1|Overall Study|Relocated; Family conflict|4
5592147|NCT00957008|19323825|P4|Overall Study|Physician Decision|1
5592148|NCT00957008|19323826|P3|Overall Study|Physician Decision|1
5592149|NCT00957008|19323827|P2|Overall Study|Physician Decision|0
5592150|NCT00957008|19323828|P1|Overall Study|Physician Decision|1
5592151|NCT00957008|19323825|P4|Overall Study|Lost to Follow-up|4
5592152|NCT00957008|19323826|P3|Overall Study|Lost to Follow-up|3
5592153|NCT00957008|19323827|P2|Overall Study|Lost to Follow-up|1
5592154|NCT00957008|19323828|P1|Overall Study|Lost to Follow-up|3
5592155|NCT00957008|19323825|P4|Overall Study|Withdrawal by Subject|16
5592156|NCT00957008|19323826|P3|Overall Study|Withdrawal by Subject|12
5592157|NCT00957008|19323827|P2|Overall Study|Withdrawal by Subject|10
5592158|NCT00957008|19323828|P1|Overall Study|Withdrawal by Subject|13
5592159|NCT00956943|19323856|P2|Overall Study|Lost to Follow-up|10
5592160|NCT00956943|19323857|P1|Overall Study|Lost to Follow-up|9
5592161|NCT00956839|19323881|P3|Overall Study|Lost to Follow-up|3
5592162|NCT00956839|19323882|P2|Overall Study|Lost to Follow-up|0
5592163|NCT00956839|19323883|P1|Overall Study|Lost to Follow-up|3
5592164|NCT00956813|19323896|P2|Flaxseed and Placebo|Ineligible|1
5592165|NCT00956813|19323897|P1|Flaxseed and Placebo|Ineligible|3
5592166|NCT00956813|19323896|P2|Flaxseed and Placebo|Withdrawal by Subject|4
5592167|NCT00956813|19323897|P1|Flaxseed and Placebo|Withdrawal by Subject|5
5592168|NCT00956592|19323949|P2|Overall Study|Protocol Violation|3
5592169|NCT00956592|19323950|P1|Overall Study|Protocol Violation|1
5592170|NCT00956293|19323985|P3|Follow-up Period|Follow-up period was terminated.|0
5592171|NCT00956293|19323986|P2|Follow-up Period|Follow-up period was terminated.|32
5592172|NCT00956293|19323987|P1|Follow-up Period|Follow-up period was terminated.|20
5592173|NCT00956293|19323985|P3|Main Period (Randomization)|Adverse Event|0
5592174|NCT00956293|19323986|P2|Main Period (Randomization)|Adverse Event|15
5592175|NCT00956293|19323987|P1|Main Period (Randomization)|Adverse Event|0
5592176|NCT00956293|19323985|P3|Main Period (Randomization)|Lack of Efficacy|0
5592177|NCT00956293|19323986|P2|Main Period (Randomization)|Lack of Efficacy|10
5592178|NCT00956293|19323987|P1|Main Period (Randomization)|Lack of Efficacy|1
5592179|NCT00956293|19323985|P3|Main Period (Randomization)|Abnormal laboratory value|0
5592180|NCT00956293|19323986|P2|Main Period (Randomization)|Abnormal laboratory value|2
5592181|NCT00956293|19323987|P1|Main Period (Randomization)|Abnormal laboratory value|0
5592182|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
5592183|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
5592184|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
5592185|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Adverse Event|36
5592186|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Adverse Event|0
5592187|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Adverse Event|0
5592188|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
5592189|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
5592190|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
5592191|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
5592192|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
5592193|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
5592194|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Graft loss|7
5592195|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Graft loss|0
5592196|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Graft loss|0
5592197|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Administrative problems|6
5592198|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Administrative problems|0
5592199|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Administrative problems|0
5592200|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
5592201|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
5592202|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
5592203|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Protocol Violation|1
5592204|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Protocol Violation|0
5592205|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Protocol Violation|0
5592206|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Death|1
5592207|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Death|0
5592208|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Death|0
5592209|NCT00956293|19323985|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
5592210|NCT00956293|19323986|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
5592211|NCT00956293|19323987|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
5592212|NCT00955968|19324042|P2|Overall Study|Site closed|52
5592213|NCT00955968|19324043|P1|Overall Study|Site closed|55
5592214|NCT00955968|19324042|P2|Overall Study|Lost to Follow-up|39
5592215|NCT00955968|19324043|P1|Overall Study|Lost to Follow-up|45
5592216|NCT00955968|19324042|P2|Overall Study|Withdrawal by Subject|31
5592217|NCT00955968|19324043|P1|Overall Study|Withdrawal by Subject|35
5592218|NCT00955968|19324042|P2|Overall Study|Death|4
5592219|NCT00955968|19324043|P1|Overall Study|Death|2
5592220|NCT00955955|19324085|P3|Overall Study|Lost to Follow-up|0
5592221|NCT00955955|19324086|P2|Overall Study|Lost to Follow-up|0
5592222|NCT00955955|19324087|P1|Overall Study|Lost to Follow-up|2
5592223|NCT00955825|19324171|P2|Overall Study|Any other reason not above-mentioned|9
5592224|NCT00955825|19324172|P1|Overall Study|Any other reason not above-mentioned|7
5592225|NCT00955825|19324171|P2|Overall Study|Withdrawal by Subject|6
5592226|NCT00955825|19324172|P1|Overall Study|Withdrawal by Subject|4
5592227|NCT00955825|19324171|P2|Overall Study|Adverse Event|2
5592228|NCT00955825|19324172|P1|Overall Study|Adverse Event|15
5592229|NCT00955721|19324189|P2|Overall Study|Withdrawal by Subject|0
5592230|NCT00955721|19324190|P1|Overall Study|Withdrawal by Subject|1
5592231|NCT00955721|19324189|P2|Overall Study|Death|0
5592232|NCT00955721|19324190|P1|Overall Study|Death|1
5592233|NCT00955721|19324189|P2|Overall Study|Physician Decision|0
5592234|NCT00955721|19324190|P1|Overall Study|Physician Decision|1
5592235|NCT00955708|19324200|P1|Overall Study|Patient changed care provider/moved|91
5592236|NCT00955708|19324200|P1|Overall Study|Closure of study location|60
5592237|NCT00955708|19324200|P1|Overall Study|Patient Refused to participate further|116
5592238|NCT00955708|19324200|P1|Overall Study|Product removed from service|94
5592239|NCT00955708|19324200|P1|Overall Study|Registry Conclusion|186
5592240|NCT00955708|19324200|P1|Overall Study|Protocol Violation|134
5592241|NCT00955708|19324200|P1|Overall Study|Physician Decision|36
5592242|NCT00955708|19324200|P1|Overall Study|Lost to Follow-up|72
5592243|NCT00955708|19324200|P1|Overall Study|Death|269
5592244|NCT00955682|19324206|P2|Booster Period (Month 49)|Lost to Follow-up|1
5592245|NCT00955682|19324207|P1|Booster Period (Month 49)|Lost to Follow-up|1
5592246|NCT00955617|19324317|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
5592247|NCT00955617|19324318|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
5592248|NCT00955617|19324317|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
5592249|NCT00955617|19324318|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
5592250|NCT00955617|19324317|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
5592251|NCT00955617|19324318|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
5592252|NCT00955617|19324317|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
5592253|NCT00955617|19324318|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
5592254|NCT00955474|19324382|P2|Overall Study|Physician Decision|5
5592255|NCT00955474|19324383|P1|Overall Study|Physician Decision|7
5592256|NCT00955357|19324419|P2|Maintenance Phase|Non compliance to study procedures|0
5592257|NCT00955357|19324420|P1|Maintenance Phase|Non compliance to study procedures|1
5592258|NCT00955357|19324419|P2|Maintenance Phase|Patient moving out of area|1
5592259|NCT00955357|19324420|P1|Maintenance Phase|Patient moving out of area|0
5592260|NCT00955357|19324419|P2|Maintenance Phase|Withdrawal by Subject|4
5592261|NCT00955357|19324420|P1|Maintenance Phase|Withdrawal by Subject|4
5592262|NCT00955357|19324419|P2|Maintenance Phase|Lost to Follow-up|7
5592263|NCT00955357|19324420|P1|Maintenance Phase|Lost to Follow-up|2
5592264|NCT00955357|19324419|P2|Maintenance Phase|Protocol Violation|6
5592265|NCT00955357|19324420|P1|Maintenance Phase|Protocol Violation|2
5592266|NCT00955357|19324419|P2|Maintenance Phase|Lack of Efficacy|4
5592267|NCT00955357|19324420|P1|Maintenance Phase|Lack of Efficacy|0
5592268|NCT00955357|19324419|P2|Maintenance Phase|Adverse Event|23
5592269|NCT00955357|19324420|P1|Maintenance Phase|Adverse Event|3
5592270|NCT00955357|19324419|P2|Titration Phase|Non compliance to study procedures|1
5592271|NCT00955357|19324420|P1|Titration Phase|Non compliance to study procedures|0
5592272|NCT00955357|19324419|P2|Titration Phase|Study medication not tolerated|1
5592273|NCT00955357|19324420|P1|Titration Phase|Study medication not tolerated|0
5592274|NCT00955357|19324419|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
5592275|NCT00955357|19324420|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
5592276|NCT00955357|19324419|P2|Titration Phase|Withdrawal by Subject|5
5592277|NCT00955357|19324420|P1|Titration Phase|Withdrawal by Subject|3
5592278|NCT00955357|19324419|P2|Titration Phase|Lost to Follow-up|3
5592279|NCT00955357|19324420|P1|Titration Phase|Lost to Follow-up|1
5592280|NCT00955357|19324419|P2|Titration Phase|Protocol Violation|7
5592281|NCT00955357|19324420|P1|Titration Phase|Protocol Violation|3
5592282|NCT00955357|19324419|P2|Titration Phase|Lack of Efficacy|2
5592283|NCT00955357|19324420|P1|Titration Phase|Lack of Efficacy|0
5592284|NCT00955357|19324419|P2|Titration Phase|Adverse Event|46
5592285|NCT00955357|19324420|P1|Titration Phase|Adverse Event|9
5592286|NCT00955305|19324428|P2|Overall Study|Ineligible|7
5592287|NCT00955305|19324429|P1|Overall Study|Ineligible|5
5592288|NCT00955305|19324428|P2|Overall Study|Never started protocol treatment|5
5592289|NCT00955305|19324429|P1|Overall Study|Never started protocol treatment|5
5592290|NCT00955305|19324428|P2|Overall Study|No off-treatment reason submitted|0
5592291|NCT00955305|19324429|P1|Overall Study|No off-treatment reason submitted|1
5592292|NCT00955305|19324428|P2|Overall Study|Lost to Follow-up|1
5592293|NCT00955305|19324429|P1|Overall Study|Lost to Follow-up|0
5592294|NCT00955305|19324428|P2|Overall Study|Maximum response achieved|1
5592295|NCT00955305|19324429|P1|Overall Study|Maximum response achieved|0
5592296|NCT00955305|19324428|P2|Overall Study|Functional decline|0
5592297|NCT00955305|19324429|P1|Overall Study|Functional decline|2
5592298|NCT00955305|19324428|P2|Overall Study|Continued presence of residual disease|1
5592299|NCT00955305|19324429|P1|Overall Study|Continued presence of residual disease|0
5592300|NCT00955305|19324428|P2|Overall Study|Physician Decision|0
5592301|NCT00955305|19324429|P1|Overall Study|Physician Decision|1
5592302|NCT00955305|19324428|P2|Overall Study|Other complicating disease|4
5592303|NCT00955305|19324429|P1|Overall Study|Other complicating disease|2
5592304|NCT00955305|19324428|P2|Overall Study|Alternative therapy|0
5592305|NCT00955305|19324429|P1|Overall Study|Alternative therapy|4
5592306|NCT00955305|19324428|P2|Overall Study|Withdrawal by Subject|4
5592307|NCT00955305|19324429|P1|Overall Study|Withdrawal by Subject|5
5592308|NCT00955305|19324428|P2|Overall Study|Death|1
5592309|NCT00955305|19324429|P1|Overall Study|Death|2
5592310|NCT00955305|19324428|P2|Overall Study|Adverse Event|22
5592311|NCT00955305|19324429|P1|Overall Study|Adverse Event|22
5592312|NCT00955305|19324428|P2|Overall Study|Disease progression|41
5592313|NCT00955305|19324429|P1|Overall Study|Disease progression|39
5592314|NCT00955279|19324442|P3|Overall Study|Withdrawal by Subject|3
5592315|NCT00955279|19324443|P2|Overall Study|Withdrawal by Subject|0
5592316|NCT00955279|19324444|P1|Overall Study|Withdrawal by Subject|2
5592317|NCT00955279|19324442|P3|Overall Study|Lost to Follow-up|1
5592318|NCT00955279|19324443|P2|Overall Study|Lost to Follow-up|3
5592319|NCT00955279|19324444|P1|Overall Study|Lost to Follow-up|0
5592320|NCT00955279|19324442|P3|Overall Study|Death|1
5592321|NCT00955279|19324443|P2|Overall Study|Death|1
5592322|NCT00955279|19324444|P1|Overall Study|Death|1
5592323|NCT00955279|19324442|P3|Overall Study|Other|3
5592324|NCT00955279|19324443|P2|Overall Study|Other|0
5592325|NCT00955279|19324444|P1|Overall Study|Other|0
5592326|NCT00955110|19324652|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
5592327|NCT00955110|19324652|P1|Treatment Phase|Non-compliance with study restrictions|1
5592328|NCT00955110|19324652|P1|Treatment Phase|Administrative reasons|2
5592329|NCT00955110|19324652|P1|Treatment Phase|Adverse Event|2
5592330|NCT00955110|19324652|P1|Qualification Phase|Did not meet eligibility criteria|24
5592331|NCT00954941|19324699|P2|Overall Study|Adverse Event|1
5592332|NCT00954941|19324700|P1|Overall Study|Adverse Event|0
5592333|NCT00954941|19324699|P2|Overall Study|Ineligible|2
5592334|NCT00954941|19324700|P1|Overall Study|Ineligible|2
5592335|NCT00954941|19324699|P2|Overall Study|Physician Decision|2
5592336|NCT00954941|19324700|P1|Overall Study|Physician Decision|2
5592337|NCT00954941|19324699|P2|Overall Study|Insurance Denial|2
5592338|NCT00954941|19324700|P1|Overall Study|Insurance Denial|2
5592339|NCT00954941|19324699|P2|Overall Study|Withdrawal by Subject|0
5592340|NCT00954941|19324700|P1|Overall Study|Withdrawal by Subject|1
5592341|NCT00954941|19324699|P2|Overall Study|Received treatment at home|0
5592342|NCT00954941|19324700|P1|Overall Study|Received treatment at home|1
5592343|NCT00954733|19324716|P1|Overall Study|blood gas machine did not work|1
5592344|NCT00954707|19324720|P1|Overall Study|Lost to Follow-up|33
5592345|NCT00954707|19324720|P1|Overall Study|Withdrawal by Subject|100
5592346|NCT00954707|19324720|P1|Overall Study|Death|34
5592347|NCT00954538|19324742|P6|Part III|Withdrawal by Subject|0
5592348|NCT00954538|19324743|P5|Part III|Withdrawal by Subject|1
5592349|NCT00954538|19324744|P4|Part III|Withdrawal by Subject|0
5592350|NCT00954538|19324745|P3|Part III|Withdrawal by Subject|0
5592351|NCT00954538|19324746|P2|Part III|Withdrawal by Subject|0
5592352|NCT00954538|19324747|P1|Part III|Withdrawal by Subject|0
5592353|NCT00954512|19324764|P6|Overall Study|Progression of Disease|1
5592354|NCT00954512|19324765|P5|Overall Study|Progression of Disease|1
5592355|NCT00954512|19324766|P4|Overall Study|Progression of Disease|1
5592356|NCT00954512|19324767|P3|Overall Study|Progression of Disease|0
5592357|NCT00954512|19324768|P2|Overall Study|Progression of Disease|1
5592358|NCT00954512|19324769|P1|Overall Study|Progression of Disease|2
5592359|NCT00954512|19324764|P6|Overall Study|Symptomatic Deterioration|0
5592360|NCT00954512|19324765|P5|Overall Study|Symptomatic Deterioration|2
5592361|NCT00954512|19324766|P4|Overall Study|Symptomatic Deterioration|0
5592362|NCT00954512|19324767|P3|Overall Study|Symptomatic Deterioration|0
5592363|NCT00954512|19324768|P2|Overall Study|Symptomatic Deterioration|1
5592364|NCT00954512|19324769|P1|Overall Study|Symptomatic Deterioration|0
5592365|NCT00954512|19324764|P6|Overall Study|Physician Decision|0
5592366|NCT00954512|19324765|P5|Overall Study|Physician Decision|0
5592367|NCT00954512|19324766|P4|Overall Study|Physician Decision|1
5592368|NCT00954512|19324767|P3|Overall Study|Physician Decision|0
5592369|NCT00954512|19324768|P2|Overall Study|Physician Decision|1
5592370|NCT00954512|19324769|P1|Overall Study|Physician Decision|0
5592371|NCT00954512|19324764|P6|Overall Study|Adverse Event|2
5592372|NCT00954512|19324765|P5|Overall Study|Adverse Event|1
5592373|NCT00954512|19324766|P4|Overall Study|Adverse Event|0
5592374|NCT00954512|19324767|P3|Overall Study|Adverse Event|0
5592375|NCT00954512|19324768|P2|Overall Study|Adverse Event|0
5592376|NCT00954512|19324769|P1|Overall Study|Adverse Event|0
5592377|NCT00954512|19324764|P6|Overall Study|Withdrawal by Subject|1
5592378|NCT00954512|19324765|P5|Overall Study|Withdrawal by Subject|0
5592379|NCT00954512|19324766|P4|Overall Study|Withdrawal by Subject|0
5592380|NCT00954512|19324767|P3|Overall Study|Withdrawal by Subject|0
5592381|NCT00954512|19324768|P2|Overall Study|Withdrawal by Subject|0
5592382|NCT00954512|19324769|P1|Overall Study|Withdrawal by Subject|0
5592383|NCT00954447|19324790|P2|Overall Study|Other|18
5592384|NCT00954447|19324791|P1|Overall Study|Other|21
5592385|NCT00954447|19324790|P2|Overall Study|Withdrawal by Subject|21
5592386|NCT00954447|19324791|P1|Overall Study|Withdrawal by Subject|26
5592387|NCT00954447|19324790|P2|Overall Study|Lost to Follow-up|14
5592388|NCT00954447|19324791|P1|Overall Study|Lost to Follow-up|8
5592389|NCT00954447|19324790|P2|Overall Study|Protocol Violation|7
5592390|NCT00954447|19324791|P1|Overall Study|Protocol Violation|5
5592391|NCT00954447|19324790|P2|Overall Study|Lack of Efficacy|3
5592392|NCT00954447|19324791|P1|Overall Study|Lack of Efficacy|17
5592393|NCT00954447|19324790|P2|Overall Study|Adverse Event|25
5592394|NCT00954447|19324791|P1|Overall Study|Adverse Event|33
5592395|NCT00954421|19324827|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
5592396|NCT00954421|19324827|P1|6 Months of DBS|Withdrawal by Subject|1
5592397|NCT00954421|19324827|P1|Screening|screen failures|3
5592398|NCT00954174|19324877|P4|Overall Study|Never Treated|3
5592399|NCT00954174|19324878|P3|Overall Study|Never Treated|0
5592400|NCT00954174|19324879|P2|Overall Study|Never Treated|17
5592401|NCT00954174|19324880|P1|Overall Study|Never Treated|4
5592402|NCT00954174|19324877|P4|Overall Study|Ineligible|4
5592403|NCT00954174|19324878|P3|Overall Study|Ineligible|7
5592404|NCT00954174|19324879|P2|Overall Study|Ineligible|47
5592405|NCT00954174|19324880|P1|Overall Study|Ineligible|40
5592406|NCT00954174|19324877|P4|Overall Study|Medical Reason|0
5592407|NCT00954174|19324878|P3|Overall Study|Medical Reason|1
5592408|NCT00954174|19324879|P2|Overall Study|Medical Reason|2
5592409|NCT00954174|19324880|P1|Overall Study|Medical Reason|4
5592410|NCT00954174|19324877|P4|Overall Study|Withdrawal by Subject|3
5592411|NCT00954174|19324878|P3|Overall Study|Withdrawal by Subject|4
5592412|NCT00954174|19324879|P2|Overall Study|Withdrawal by Subject|10
5592413|NCT00954174|19324880|P1|Overall Study|Withdrawal by Subject|14
5592414|NCT00954174|19324877|P4|Overall Study|Lack of Efficacy|6
5592415|NCT00954174|19324878|P3|Overall Study|Lack of Efficacy|8
5592416|NCT00954174|19324879|P2|Overall Study|Lack of Efficacy|22
5592417|NCT00954174|19324880|P1|Overall Study|Lack of Efficacy|32
5592418|NCT00954174|19324877|P4|Overall Study|Death|0
5592419|NCT00954174|19324878|P3|Overall Study|Death|0
5592420|NCT00954174|19324879|P2|Overall Study|Death|2
5592421|NCT00954174|19324880|P1|Overall Study|Death|4
5592422|NCT00954174|19324877|P4|Overall Study|Adverse Event|9
5592423|NCT00954174|19324878|P3|Overall Study|Adverse Event|4
5592424|NCT00954174|19324879|P2|Overall Study|Adverse Event|23
5592425|NCT00954174|19324880|P1|Overall Study|Adverse Event|28
5592426|NCT00954122|19324900|P1|Overall Study|Safety Reason|1
5592427|NCT00954122|19324900|P1|Overall Study|Adverse Event|1
5592428|NCT00954122|19324900|P1|Overall Study|Withdrawal by Subject|5
5592429|NCT00953927|19324917|P2|Overall Study|Other study discontinuation|1
5592430|NCT00953927|19324918|P1|Overall Study|Other study discontinuation|1
5592431|NCT00953927|19324917|P2|Overall Study|Death|4
5592432|NCT00953927|19324918|P1|Overall Study|Death|7
5592433|NCT00953927|19324917|P2|Overall Study|Withdrawal by Subject|25
5592434|NCT00953927|19324918|P1|Overall Study|Withdrawal by Subject|36
5592435|NCT00953927|19324917|P2|Overall Study|Lost to Follow-up|65
5592436|NCT00953927|19324918|P1|Overall Study|Lost to Follow-up|61
5592437|NCT00953745|19324973|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
5592438|NCT00953745|19324974|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
5592439|NCT00953745|19324973|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
5592440|NCT00953745|19324974|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
5592441|NCT00953745|19324973|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
5592442|NCT00953745|19324974|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
5592443|NCT00953745|19324973|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
5592444|NCT00953745|19324974|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
5592445|NCT00953745|19324973|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
5592446|NCT00953745|19324974|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
5592447|NCT00953745|19324973|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
5592448|NCT00953745|19324974|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
5592449|NCT00953706|19325007|P4|Part B (96-Week Open-Label Extension)|Other|2
5592450|NCT00953706|19325008|P3|Part B (96-Week Open-Label Extension)|Other|0
5592451|NCT00953706|19325009|P2|Part B (96-Week Open-Label Extension)|Other|0
5592452|NCT00953706|19325010|P1|Part B (96-Week Open-Label Extension)|Other|0
5592453|NCT00953706|19325007|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
5592454|NCT00953706|19325008|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
5592455|NCT00953706|19325009|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
5592456|NCT00953706|19325010|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
5592457|NCT00953706|19325007|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
5592458|NCT00953706|19325008|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
5592459|NCT00953706|19325009|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
5592460|NCT00953706|19325010|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
5592461|NCT00953706|19325007|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
5592462|NCT00953706|19325008|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
5592463|NCT00953706|19325009|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
5592464|NCT00953706|19325010|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
5592465|NCT00953706|19325007|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
5592466|NCT00953706|19325008|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
5592467|NCT00953706|19325009|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
5592468|NCT00953706|19325010|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
5592469|NCT00953706|19325007|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
5592470|NCT00953706|19325008|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
5592471|NCT00953706|19325009|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
5592472|NCT00953706|19325010|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
5592473|NCT00953706|19325007|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
5592474|NCT00953706|19325008|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
5592475|NCT00953706|19325009|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
5592476|NCT00953706|19325010|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
5592477|NCT00953706|19325007|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
5592478|NCT00953706|19325008|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
5592479|NCT00953706|19325009|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
5592480|NCT00953706|19325010|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
5592481|NCT00953706|19325007|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
5592482|NCT00953706|19325008|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
5592483|NCT00953706|19325009|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
5592484|NCT00953706|19325010|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
5592485|NCT00953706|19325007|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
5592486|NCT00953706|19325008|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
5592487|NCT00953706|19325009|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
5592488|NCT00953706|19325010|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
5592489|NCT00953706|19325007|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
5592490|NCT00953706|19325008|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
5592491|NCT00953706|19325009|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
5592492|NCT00953706|19325010|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
5592493|NCT00953680|19325042|P2|Period 1|Withdrawal by Subject|1
5592494|NCT00953680|19325043|P1|Period 1|Withdrawal by Subject|0
5592495|NCT00953667|19325055|P1|Overall Study|poor venous access,unable to draw blood|4
5592496|NCT00953667|19325055|P1|Overall Study|Adverse Event|10
5592497|NCT00953667|19325055|P1|Overall Study|Withdrawal by Subject|63
5592498|NCT00953667|19325055|P1|Overall Study|Physician Decision|35
5592499|NCT00953667|19325055|P1|Overall Study|Lost to Follow-up|11
5592500|NCT00953615|19325076|P1|Overall Study|Adverse Event|1
5592501|NCT00953576|19325085|P2|Overall Study|Ineligible after Consent|0
5592502|NCT00953576|19325086|P1|Overall Study|Ineligible after Consent|2
5592503|NCT00953576|19325085|P2|Overall Study|Adverse Event|1
5592504|NCT00953576|19325086|P1|Overall Study|Adverse Event|0
5592505|NCT00953524|19325101|P4|Overall Study|Withdrawal by Subject|0
5592506|NCT00953524|19325102|P3|Overall Study|Withdrawal by Subject|1
5592507|NCT00953524|19325103|P2|Overall Study|Withdrawal by Subject|4
5592508|NCT00953524|19325104|P1|Overall Study|Withdrawal by Subject|2
5592509|NCT00953524|19325101|P4|Overall Study|Lost to Follow-up|0
5592510|NCT00953524|19325102|P3|Overall Study|Lost to Follow-up|1
5592511|NCT00953524|19325103|P2|Overall Study|Lost to Follow-up|1
5592512|NCT00953524|19325104|P1|Overall Study|Lost to Follow-up|0
5592513|NCT00953524|19325101|P4|Overall Study|Protocol Violation|6
5592514|NCT00953524|19325102|P3|Overall Study|Protocol Violation|11
5592515|NCT00953524|19325103|P2|Overall Study|Protocol Violation|10
5592516|NCT00953524|19325104|P1|Overall Study|Protocol Violation|18
5592517|NCT00953524|19325101|P4|Overall Study|Adverse Event|2
5592518|NCT00953524|19325102|P3|Overall Study|Adverse Event|1
5592519|NCT00953524|19325103|P2|Overall Study|Adverse Event|0
5592520|NCT00953524|19325104|P1|Overall Study|Adverse Event|2
5592521|NCT00953407|19325147|P5|Overall Study|Lost to Follow-up|0
5592522|NCT00953407|19325148|P4|Overall Study|Lost to Follow-up|1
5592523|NCT00953407|19325149|P3|Overall Study|Lost to Follow-up|0
5592524|NCT00953407|19325150|P2|Overall Study|Lost to Follow-up|0
5592525|NCT00953407|19325151|P1|Overall Study|Lost to Follow-up|0
5592526|NCT00953407|19325147|P5|Overall Study|Failed inclusion criteria|1
5592527|NCT00953407|19325148|P4|Overall Study|Failed inclusion criteria|1
5592528|NCT00953407|19325149|P3|Overall Study|Failed inclusion criteria|1
5592529|NCT00953407|19325150|P2|Overall Study|Failed inclusion criteria|1
5592530|NCT00953407|19325151|P1|Overall Study|Failed inclusion criteria|1
5592531|NCT00953329|19325163|P1|Overall Study|Lack of Efficacy|1
5592532|NCT00953225|19325176|P2|Overall Study|Withdrawal by Subject|0
5592533|NCT00953225|19325177|P1|Overall Study|Withdrawal by Subject|2
5592534|NCT00953160|19325261|P1|Overall Study|Withdrawal by Subject|4
5592535|NCT00953160|19325261|P1|Overall Study|Lost to Follow-up|23
5592536|NCT00953147|19325270|P3|Overall Study|Other|13
5592537|NCT00953147|19325271|P2|Overall Study|Other|11
5592538|NCT00953147|19325272|P1|Overall Study|Other|4
5592539|NCT00953147|19325270|P3|Overall Study|Physician Decision|3
5592540|NCT00953147|19325271|P2|Overall Study|Physician Decision|7
5592541|NCT00953147|19325272|P1|Overall Study|Physician Decision|2
5592542|NCT00953147|19325270|P3|Overall Study|Lost to Follow-up|4
5592543|NCT00953147|19325271|P2|Overall Study|Lost to Follow-up|9
5592544|NCT00953147|19325272|P1|Overall Study|Lost to Follow-up|8
5592545|NCT00953147|19325270|P3|Overall Study|Withdrawal by Subject|12
5592546|NCT00953147|19325271|P2|Overall Study|Withdrawal by Subject|15
5592547|NCT00953147|19325272|P1|Overall Study|Withdrawal by Subject|13
5592548|NCT00953147|19325270|P3|Overall Study|Protocol Violation|4
5592549|NCT00953147|19325271|P2|Overall Study|Protocol Violation|8
5592550|NCT00953147|19325272|P1|Overall Study|Protocol Violation|2
5592551|NCT00953147|19325270|P3|Overall Study|Adverse Event|6
5592552|NCT00953147|19325271|P2|Overall Study|Adverse Event|16
5592553|NCT00953147|19325272|P1|Overall Study|Adverse Event|8
5592554|NCT00953056|19325350|P6|Overall Study|Serious Adverse Event|1
5592555|NCT00953056|19325351|P5|Overall Study|Serious Adverse Event|0
5592556|NCT00953056|19325352|P4|Overall Study|Serious Adverse Event|0
5592557|NCT00953056|19325353|P3|Overall Study|Serious Adverse Event|0
5592558|NCT00953056|19325354|P2|Overall Study|Serious Adverse Event|0
5592559|NCT00953056|19325355|P1|Overall Study|Serious Adverse Event|0
5592560|NCT00953056|19325350|P6|Overall Study|Withdrew Consent|3
5592561|NCT00953056|19325351|P5|Overall Study|Withdrew Consent|2
5592562|NCT00953056|19325352|P4|Overall Study|Withdrew Consent|0
5592563|NCT00953056|19325353|P3|Overall Study|Withdrew Consent|0
5592564|NCT00953056|19325354|P2|Overall Study|Withdrew Consent|0
5592565|NCT00953056|19325355|P1|Overall Study|Withdrew Consent|0
5592566|NCT00953043|19325379|P2|Overall Study|Physician Decision|2
5592567|NCT00953043|19325380|P1|Overall Study|Physician Decision|0
5592568|NCT00953043|19325379|P2|Overall Study|Withdrawal by Subject|0
5592569|NCT00953043|19325380|P1|Overall Study|Withdrawal by Subject|4
5592570|NCT00953017|19325404|P4|Overall Study|Brown stool prior to procedure|0
5592571|NCT00953017|19325405|P3|Overall Study|Brown stool prior to procedure|1
5592572|NCT00953017|19325406|P2|Overall Study|Brown stool prior to procedure|0
5592573|NCT00953017|19325407|P1|Overall Study|Brown stool prior to procedure|0
5592574|NCT00953017|19325404|P4|Overall Study|Procedure incomplete due to pain/looping|1
5592575|NCT00953017|19325405|P3|Overall Study|Procedure incomplete due to pain/looping|0
5592576|NCT00953017|19325406|P2|Overall Study|Procedure incomplete due to pain/looping|1
5592577|NCT00953017|19325407|P1|Overall Study|Procedure incomplete due to pain/looping|0
5592578|NCT00953017|19325404|P4|Overall Study|Incomplete data|0
5592579|NCT00953017|19325405|P3|Overall Study|Incomplete data|0
5592580|NCT00953017|19325406|P2|Overall Study|Incomplete data|1
5592581|NCT00953017|19325407|P1|Overall Study|Incomplete data|1
5592582|NCT00953017|19325404|P4|Overall Study|DId not show up for colonoscopy|4
5592583|NCT00953017|19325405|P3|Overall Study|DId not show up for colonoscopy|5
5592584|NCT00953017|19325406|P2|Overall Study|DId not show up for colonoscopy|4
5592585|NCT00953017|19325407|P1|Overall Study|DId not show up for colonoscopy|4
5592586|NCT00952848|19325429|P1|Overall Study|Withdrawal by Subject|4
5592587|NCT00952822|19325436|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
5592588|NCT00952822|19325437|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
5592589|NCT00952822|19325438|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
5592590|NCT00952822|19325439|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
5592591|NCT00952822|19325436|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
5592592|NCT00952822|19325437|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
5592593|NCT00952822|19325438|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
5592594|NCT00952822|19325439|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
5592595|NCT00952731|19325471|P2|Overall Study|Drug supply expired|0
5592596|NCT00952731|19325472|P1|Overall Study|Drug supply expired|1
5592597|NCT00952705|19325504|P3|Overall Study|Exclusion criteria not met pre dose|0
5592598|NCT00952705|19325505|P2|Overall Study|Exclusion criteria not met pre dose|1
5592599|NCT00952705|19325506|P1|Overall Study|Exclusion criteria not met pre dose|0
5592600|NCT00952705|19325504|P3|Overall Study|Incarcerated post dose|0
5592601|NCT00952705|19325505|P2|Overall Study|Incarcerated post dose|0
5592602|NCT00952705|19325506|P1|Overall Study|Incarcerated post dose|5
5592603|NCT00952705|19325504|P3|Overall Study|Death|0
5592604|NCT00952705|19325505|P2|Overall Study|Death|0
5592605|NCT00952705|19325506|P1|Overall Study|Death|2
5592606|NCT00952705|19325504|P3|Overall Study|Withdrawal by Subject|1
5592607|NCT00952705|19325505|P2|Overall Study|Withdrawal by Subject|1
5592608|NCT00952705|19325506|P1|Overall Study|Withdrawal by Subject|2
5592609|NCT00952705|19325504|P3|Overall Study|Lost to Follow-up|9
5592610|NCT00952705|19325505|P2|Overall Study|Lost to Follow-up|8
5592611|NCT00952705|19325506|P1|Overall Study|Lost to Follow-up|24
5592612|NCT00952614|19325593|P1|Overall Study|other reason|1
5592613|NCT00952614|19325593|P1|Overall Study|Lost to Follow-up|3
5592614|NCT00952614|19325593|P1|Overall Study|Death|3
5592615|NCT00952588|19325600|P2|Overall Study|Lack of Efficacy|2
5592616|NCT00952588|19325601|P1|Overall Study|Lack of Efficacy|2
5592617|NCT00952588|19325600|P2|Overall Study|Physician Decision|1
5592618|NCT00952588|19325601|P1|Overall Study|Physician Decision|0
5592619|NCT00952588|19325600|P2|Overall Study|Lost to Follow-up|0
5592620|NCT00952588|19325601|P1|Overall Study|Lost to Follow-up|2
5592621|NCT00952588|19325600|P2|Overall Study|Adverse Event|3
5592622|NCT00952588|19325601|P1|Overall Study|Adverse Event|2
5592623|NCT00952588|19325600|P2|Overall Study|Withdrawal by Subject|5
5592624|NCT00952588|19325601|P1|Overall Study|Withdrawal by Subject|2
5592625|NCT00952588|19325600|P2|Overall Study|Death|13
5592626|NCT00952588|19325601|P1|Overall Study|Death|28
5592627|NCT00952523|19325619|P1|Overall Study|Withdrawal by Subject|7
5592628|NCT00952484|19325628|P3|Overall Study|Withdrawal by Subject|0
5592629|NCT00952484|19325629|P2|Overall Study|Withdrawal by Subject|1
5592630|NCT00952484|19325630|P1|Overall Study|Withdrawal by Subject|0
5592631|NCT00952419|19325657|P3|Overall Study|Withdrawal by Subject|0
5592632|NCT00952419|19325658|P2|Overall Study|Withdrawal by Subject|3
5592633|NCT00952419|19325659|P1|Overall Study|Withdrawal by Subject|1
5592634|NCT00952419|19325657|P3|Overall Study|Protocol Violation|0
5592635|NCT00952419|19325658|P2|Overall Study|Protocol Violation|7
5592636|NCT00952419|19325659|P1|Overall Study|Protocol Violation|3
5592637|NCT00952419|19325657|P3|Overall Study|Adverse Event|0
5592638|NCT00952419|19325658|P2|Overall Study|Adverse Event|0
5592639|NCT00952419|19325659|P1|Overall Study|Adverse Event|2
5592640|NCT00952380|19325700|P5|Overall Study|Non-compliant to protocol|0
5592641|NCT00952380|19325701|P4|Overall Study|Non-compliant to protocol|1
5592642|NCT00952380|19325702|P3|Overall Study|Non-compliant to protocol|0
5592643|NCT00952380|19325703|P2|Overall Study|Non-compliant to protocol|0
5592644|NCT00952380|19325704|P1|Overall Study|Non-compliant to protocol|0
5592645|NCT00952380|19325700|P5|Overall Study|Physician Decision|0
5592646|NCT00952380|19325701|P4|Overall Study|Physician Decision|2
5592647|NCT00952380|19325702|P3|Overall Study|Physician Decision|1
5592648|NCT00952380|19325703|P2|Overall Study|Physician Decision|0
5592649|NCT00952380|19325704|P1|Overall Study|Physician Decision|0
5592650|NCT00952380|19325700|P5|Overall Study|Adverse Event|3
5592651|NCT00952380|19325701|P4|Overall Study|Adverse Event|0
5592652|NCT00952380|19325702|P3|Overall Study|Adverse Event|0
5592653|NCT00952380|19325703|P2|Overall Study|Adverse Event|1
5592654|NCT00952380|19325704|P1|Overall Study|Adverse Event|0
5592655|NCT00952380|19325700|P5|Overall Study|Withdrawal by Subject|2
5592656|NCT00952380|19325701|P4|Overall Study|Withdrawal by Subject|0
5592657|NCT00952380|19325702|P3|Overall Study|Withdrawal by Subject|1
5592658|NCT00952380|19325703|P2|Overall Study|Withdrawal by Subject|0
5592659|NCT00952380|19325704|P1|Overall Study|Withdrawal by Subject|0
5592660|NCT00952380|19325700|P5|Overall Study|Other|1
5592661|NCT00952380|19325701|P4|Overall Study|Other|0
5592662|NCT00952380|19325702|P3|Overall Study|Other|0
5592663|NCT00952380|19325703|P2|Overall Study|Other|0
5592664|NCT00952380|19325704|P1|Overall Study|Other|0
5592665|NCT00952367|19325805|P1|Overall Study|Protocol Violation|3
5592666|NCT00952367|19325805|P1|Overall Study|Noncoordination|1
5592667|NCT00952367|19325805|P1|Overall Study|Withdrawal by Subject|2
5592668|NCT00952341|19325820|P2|Cycle 2|Progressive Disease|1
5592669|NCT00952341|19325821|P1|Cycle 2|Progressive Disease|0
5592670|NCT00952341|19325820|P2|Cycle 2|Physician Decision|1
5592671|NCT00952341|19325821|P1|Cycle 2|Physician Decision|1
5592672|NCT00952341|19325820|P2|Cycle 2|Lost to Follow-up|9
5592673|NCT00952341|19325821|P1|Cycle 2|Lost to Follow-up|6
5592674|NCT00952341|19325820|P2|Cycle 2|Protocol Violation|0
5592675|NCT00952341|19325821|P1|Cycle 2|Protocol Violation|1
5592676|NCT00952341|19325820|P2|Cycle 2|Withdrawal by Subject|1
5592677|NCT00952341|19325821|P1|Cycle 2|Withdrawal by Subject|1
5592678|NCT00952341|19325820|P2|Cycle 1|Physician Decision|1
5592679|NCT00952341|19325821|P1|Cycle 1|Physician Decision|0
5592680|NCT00952341|19325820|P2|Cycle 1|Lost to Follow-up|2
5592681|NCT00952341|19325821|P1|Cycle 1|Lost to Follow-up|11
5592682|NCT00952341|19325820|P2|Cycle 1|Protocol Violation|1
5592683|NCT00952341|19325821|P1|Cycle 1|Protocol Violation|2
5592684|NCT00952341|19325820|P2|Cycle 1|Withdrawal by Subject|8
5592685|NCT00952341|19325821|P1|Cycle 1|Withdrawal by Subject|3
5592686|NCT00952341|19325820|P2|Cycle 1|Adverse Event|1
5592687|NCT00952341|19325821|P1|Cycle 1|Adverse Event|4
5592688|NCT00952289|19325883|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
5592689|NCT00952289|19325884|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
5592690|NCT00952289|19325883|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
5592691|NCT00952289|19325884|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
5592692|NCT00952289|19325883|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
5592693|NCT00952289|19325884|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
5592694|NCT00952289|19325883|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
5592695|NCT00952289|19325884|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
5592696|NCT00952289|19325883|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
5592697|NCT00952289|19325884|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
5592698|NCT00952289|19325883|P2|All Participants|Data lost during site relocation|1
5592699|NCT00952289|19325884|P1|All Participants|Data lost during site relocation|0
5592700|NCT00952289|19325883|P2|All Participants|Withdrawal by Subject|10
5592701|NCT00952289|19325884|P1|All Participants|Withdrawal by Subject|1
5592702|NCT00952289|19325883|P2|All Participants|Disease progression|12
5592703|NCT00952289|19325884|P1|All Participants|Disease progression|3
5592704|NCT00952289|19325883|P2|All Participants|Adverse Event|8
5592705|NCT00952289|19325884|P1|All Participants|Adverse Event|8
5592706|NCT00952289|19325883|P2|All Participants|Death|9
5592707|NCT00952289|19325884|P1|All Participants|Death|9
5592708|NCT00952276|19325913|P5|Overall Study|Withdrawal by Subject|0
5592709|NCT00952276|19325914|P4|Overall Study|Withdrawal by Subject|1
5592710|NCT00952276|19325915|P3|Overall Study|Withdrawal by Subject|0
5592711|NCT00952276|19325916|P2|Overall Study|Withdrawal by Subject|0
5592712|NCT00952276|19325917|P1|Overall Study|Withdrawal by Subject|1
5592713|NCT00952068|19326003|P1|Overall Study|Withdrawal by Subject|4
5592714|NCT00952068|19326003|P1|Overall Study|Adverse Event|3
5592715|NCT00951912|19326014|P3|Overall Study|Other: Stroke|0
5592716|NCT00951912|19326015|P2|Overall Study|Other: Stroke|1
5592717|NCT00951912|19326016|P1|Overall Study|Other: Stroke|0
5592718|NCT00951912|19326014|P3|Overall Study|Other: Colon cancer|0
5592719|NCT00951912|19326015|P2|Overall Study|Other: Colon cancer|0
5592720|NCT00951912|19326016|P1|Overall Study|Other: Colon cancer|1
5592721|NCT00951912|19326014|P3|Overall Study|Other:Depression|0
5592722|NCT00951912|19326015|P2|Overall Study|Other:Depression|0
5592723|NCT00951912|19326016|P1|Overall Study|Other:Depression|1
5592724|NCT00951912|19326014|P3|Overall Study|Withdrawal by Subject|0
5592725|NCT00951912|19326015|P2|Overall Study|Withdrawal by Subject|1
5592726|NCT00951912|19326016|P1|Overall Study|Withdrawal by Subject|1
5592727|NCT00951912|19326014|P3|Overall Study|Physician Decision|1
5592728|NCT00951912|19326015|P2|Overall Study|Physician Decision|0
5592729|NCT00951912|19326016|P1|Overall Study|Physician Decision|1
5592730|NCT00951912|19326014|P3|Overall Study|Lost to Follow-up|0
5592731|NCT00951912|19326015|P2|Overall Study|Lost to Follow-up|2
5592732|NCT00951912|19326016|P1|Overall Study|Lost to Follow-up|2
5592733|NCT00951912|19326014|P3|Overall Study|Adverse Event|1
5592734|NCT00951912|19326015|P2|Overall Study|Adverse Event|1
5592735|NCT00951912|19326016|P1|Overall Study|Adverse Event|0
5592736|NCT00951912|19326014|P3|Overall Study|Lack of Efficacy|0
5592737|NCT00951912|19326015|P2|Overall Study|Lack of Efficacy|0
5592738|NCT00951912|19326016|P1|Overall Study|Lack of Efficacy|1
5592739|NCT00951665|19326116|P6|Phase 2a|Disease Progression|5
5592740|NCT00951665|19326117|P5|Phase 2a|Disease Progression|6
5592741|NCT00951665|19326118|P4|Phase 2a|Disease Progression|0
5592742|NCT00951665|19326119|P3|Phase 2a|Disease Progression|0
5592743|NCT00951665|19326120|P2|Phase 2a|Disease Progression|0
5592744|NCT00951665|19326121|P1|Phase 2a|Disease Progression|0
5592745|NCT00951665|19326116|P6|Phase 2a|Withdrawal by Subject|0
5592746|NCT00951665|19326117|P5|Phase 2a|Withdrawal by Subject|2
5592747|NCT00951665|19326118|P4|Phase 2a|Withdrawal by Subject|0
5592748|NCT00951665|19326119|P3|Phase 2a|Withdrawal by Subject|0
5592749|NCT00951665|19326120|P2|Phase 2a|Withdrawal by Subject|0
5592750|NCT00951665|19326121|P1|Phase 2a|Withdrawal by Subject|0
5592751|NCT00951665|19326116|P6|Phase 2a|Physician Decision|1
5592752|NCT00951665|19326117|P5|Phase 2a|Physician Decision|0
5592753|NCT00951665|19326118|P4|Phase 2a|Physician Decision|0
5592754|NCT00951665|19326119|P3|Phase 2a|Physician Decision|0
5592755|NCT00951665|19326120|P2|Phase 2a|Physician Decision|0
5592756|NCT00951665|19326121|P1|Phase 2a|Physician Decision|0
5592757|NCT00951665|19326116|P6|Phase 2a|Lost to Follow-up|0
5592758|NCT00951665|19326117|P5|Phase 2a|Lost to Follow-up|1
5592759|NCT00951665|19326118|P4|Phase 2a|Lost to Follow-up|0
5592760|NCT00951665|19326119|P3|Phase 2a|Lost to Follow-up|0
5592761|NCT00951665|19326120|P2|Phase 2a|Lost to Follow-up|0
5592762|NCT00951665|19326121|P1|Phase 2a|Lost to Follow-up|0
5592763|NCT00951665|19326116|P6|Phase 2a|Death|1
5592764|NCT00951665|19326117|P5|Phase 2a|Death|1
5592765|NCT00951665|19326118|P4|Phase 2a|Death|0
5592766|NCT00951665|19326119|P3|Phase 2a|Death|0
5592767|NCT00951665|19326120|P2|Phase 2a|Death|0
5592768|NCT00951665|19326121|P1|Phase 2a|Death|0
5592769|NCT00951665|19326116|P6|Phase 2a|Adverse Event|0
5592770|NCT00951665|19326117|P5|Phase 2a|Adverse Event|2
5592771|NCT00951665|19326118|P4|Phase 2a|Adverse Event|0
5592772|NCT00951665|19326119|P3|Phase 2a|Adverse Event|0
5592773|NCT00951665|19326120|P2|Phase 2a|Adverse Event|0
5592774|NCT00951665|19326121|P1|Phase 2a|Adverse Event|0
5592775|NCT00951665|19326116|P6|Phase 1b|Protocol Violation|0
5592776|NCT00951665|19326117|P5|Phase 1b|Protocol Violation|0
5592777|NCT00951665|19326118|P4|Phase 1b|Protocol Violation|0
5592778|NCT00951665|19326119|P3|Phase 1b|Protocol Violation|0
5592779|NCT00951665|19326120|P2|Phase 1b|Protocol Violation|0
5592780|NCT00951665|19326121|P1|Phase 1b|Protocol Violation|2
5592781|NCT00951665|19326116|P6|Phase 1b|Disease Progression|0
5592782|NCT00951665|19326117|P5|Phase 1b|Disease Progression|0
5592783|NCT00951665|19326118|P4|Phase 1b|Disease Progression|0
5592784|NCT00951665|19326119|P3|Phase 1b|Disease Progression|14
5592785|NCT00951665|19326120|P2|Phase 1b|Disease Progression|2
5592786|NCT00951665|19326121|P1|Phase 1b|Disease Progression|13
5592787|NCT00951665|19326116|P6|Phase 1b|Withdrawal by Subject|0
5592788|NCT00951665|19326117|P5|Phase 1b|Withdrawal by Subject|0
5592789|NCT00951665|19326118|P4|Phase 1b|Withdrawal by Subject|0
5592790|NCT00951665|19326119|P3|Phase 1b|Withdrawal by Subject|0
5592791|NCT00951665|19326120|P2|Phase 1b|Withdrawal by Subject|1
5592792|NCT00951665|19326121|P1|Phase 1b|Withdrawal by Subject|0
5592793|NCT00951665|19326116|P6|Phase 1b|Physician Decision|0
5592794|NCT00951665|19326117|P5|Phase 1b|Physician Decision|0
5592795|NCT00951665|19326118|P4|Phase 1b|Physician Decision|0
5592796|NCT00951665|19326119|P3|Phase 1b|Physician Decision|1
5592797|NCT00951665|19326120|P2|Phase 1b|Physician Decision|0
5592798|NCT00951665|19326121|P1|Phase 1b|Physician Decision|4
5592799|NCT00951665|19326116|P6|Phase 1b|Death|0
5592800|NCT00951665|19326117|P5|Phase 1b|Death|0
5592801|NCT00951665|19326118|P4|Phase 1b|Death|0
5592802|NCT00951665|19326119|P3|Phase 1b|Death|2
5592803|NCT00951665|19326120|P2|Phase 1b|Death|0
5592804|NCT00951665|19326121|P1|Phase 1b|Death|1
5592805|NCT00951665|19326116|P6|Phase 1b|Adverse Event|0
5592806|NCT00951665|19326117|P5|Phase 1b|Adverse Event|0
5592807|NCT00951665|19326118|P4|Phase 1b|Adverse Event|1
5592808|NCT00951665|19326119|P3|Phase 1b|Adverse Event|0
5592809|NCT00951665|19326120|P2|Phase 1b|Adverse Event|1
5592810|NCT00951665|19326121|P1|Phase 1b|Adverse Event|2
5592811|NCT00951509|19326230|P1|Overall Study|Withdrawal by Subject|2
5592812|NCT00951496|19326241|P3|Overall Study|Did not initiate study treatment|13
5592813|NCT00951496|19326242|P2|Overall Study|Did not initiate study treatment|8
5592814|NCT00951496|19326243|P1|Overall Study|Did not initiate study treatment|10
5592815|NCT00951483|19326271|P2|Overall Study|Withdrawal by Subject|0
5592816|NCT00951483|19326272|P1|Overall Study|Withdrawal by Subject|15
5592817|NCT00951483|19326271|P2|Overall Study|Physician Decision|0
5592818|NCT00951483|19326272|P1|Overall Study|Physician Decision|4
5592819|NCT00951379|19326292|P2|Overall Study|Disease Progression|1
5592820|NCT00951379|19326293|P1|Overall Study|Disease Progression|0
5592821|NCT00951379|19326292|P2|Overall Study|Noncompliance|0
5592822|NCT00951379|19326293|P1|Overall Study|Noncompliance|1
5592823|NCT00951379|19326292|P2|Overall Study|Withdrawal by Subject|0
5592824|NCT00951379|19326293|P1|Overall Study|Withdrawal by Subject|1
5592825|NCT00951379|19326292|P2|Overall Study|Adverse Event|1
5592826|NCT00951379|19326293|P1|Overall Study|Adverse Event|4
5592827|NCT00951275|19326335|P1|Overall Study|Protocol Violation|1
5592828|NCT00951275|19326335|P1|Overall Study|Withdrawal by Subject|4
5592829|NCT00951275|19326335|P1|Overall Study|Adverse Event|7
5592830|NCT00951275|19326335|P1|Overall Study|Administrative Reason|1
5592831|NCT00951171|19326367|P2|Overall Study|Adverse Event|0
5592832|NCT00951171|19326368|P1|Overall Study|Adverse Event|2
5592833|NCT00951080|19326400|P2|Overall Study|Other|22
5592834|NCT00951080|19326401|P1|Overall Study|Other|19
5592835|NCT00951080|19326400|P2|Overall Study|Physician Decision|1
5592836|NCT00951080|19326401|P1|Overall Study|Physician Decision|4
5592837|NCT00951080|19326400|P2|Overall Study|Lost to Follow-up|1
5592838|NCT00951080|19326401|P1|Overall Study|Lost to Follow-up|0
5592839|NCT00951080|19326400|P2|Overall Study|Adverse Event|3
5592840|NCT00951080|19326401|P1|Overall Study|Adverse Event|3
5592841|NCT00951041|19326409|P2|Overall Study|Other|0
5592842|NCT00951041|19326410|P1|Overall Study|Other|3
5592843|NCT00951041|19326409|P2|Overall Study|Lost to Follow-up|0
5592844|NCT00951041|19326410|P1|Overall Study|Lost to Follow-up|1
5592845|NCT00951041|19326409|P2|Overall Study|Withdrawal by Subject|1
5592846|NCT00951041|19326410|P1|Overall Study|Withdrawal by Subject|1
5592847|NCT00951015|19326465|P5|Open-label Phase|Physician Decision|8
5592848|NCT00951015|19326466|P4|Open-label Phase|Physician Decision|0
5592849|NCT00951015|19326467|P3|Open-label Phase|Physician Decision|0
5592850|NCT00951015|19326468|P2|Open-label Phase|Physician Decision|0
5592851|NCT00951015|19326469|P1|Open-label Phase|Physician Decision|0
5592852|NCT00951015|19326465|P5|Open-label Phase|Withdrawal by Subject|14
5592853|NCT00951015|19326466|P4|Open-label Phase|Withdrawal by Subject|0
5592854|NCT00951015|19326467|P3|Open-label Phase|Withdrawal by Subject|0
5592855|NCT00951015|19326468|P2|Open-label Phase|Withdrawal by Subject|0
5592856|NCT00951015|19326469|P1|Open-label Phase|Withdrawal by Subject|0
5592857|NCT00951015|19326465|P5|Open-label Phase|Lost to Follow-up|12
5592858|NCT00951015|19326466|P4|Open-label Phase|Lost to Follow-up|0
5592859|NCT00951015|19326467|P3|Open-label Phase|Lost to Follow-up|0
5592860|NCT00951015|19326468|P2|Open-label Phase|Lost to Follow-up|0
5592861|NCT00951015|19326469|P1|Open-label Phase|Lost to Follow-up|0
5592862|NCT00951015|19326465|P5|Open-label Phase|Protocol Violation|12
5592863|NCT00951015|19326466|P4|Open-label Phase|Protocol Violation|0
5592864|NCT00951015|19326467|P3|Open-label Phase|Protocol Violation|0
5592865|NCT00951015|19326468|P2|Open-label Phase|Protocol Violation|0
5592866|NCT00951015|19326469|P1|Open-label Phase|Protocol Violation|0
5592867|NCT00951015|19326465|P5|Open-label Phase|Lack of Efficacy|1
5592868|NCT00951015|19326466|P4|Open-label Phase|Lack of Efficacy|0
5592869|NCT00951015|19326467|P3|Open-label Phase|Lack of Efficacy|0
5592870|NCT00951015|19326468|P2|Open-label Phase|Lack of Efficacy|0
5592871|NCT00951015|19326469|P1|Open-label Phase|Lack of Efficacy|0
5592872|NCT00951015|19326465|P5|Open-label Phase|Adverse Event|3
5592873|NCT00951015|19326466|P4|Open-label Phase|Adverse Event|0
5592874|NCT00951015|19326467|P3|Open-label Phase|Adverse Event|0
5592875|NCT00951015|19326468|P2|Open-label Phase|Adverse Event|0
5592876|NCT00951015|19326469|P1|Open-label Phase|Adverse Event|0
5592877|NCT00951015|19326465|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
5592878|NCT00951015|19326466|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
5592879|NCT00951015|19326467|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
5592880|NCT00951015|19326468|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
5592881|NCT00951015|19326469|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
5592882|NCT00951015|19326465|P5|Randomization Phase 96 Week|Lost to Follow-up|0
5592883|NCT00951015|19326466|P4|Randomization Phase 96 Week|Lost to Follow-up|2
5592884|NCT00951015|19326467|P3|Randomization Phase 96 Week|Lost to Follow-up|1
5592885|NCT00951015|19326468|P2|Randomization Phase 96 Week|Lost to Follow-up|3
5592886|NCT00951015|19326469|P1|Randomization Phase 96 Week|Lost to Follow-up|0
5592887|NCT00951015|19326465|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5592888|NCT00951015|19326466|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
5592889|NCT00951015|19326467|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5592890|NCT00951015|19326468|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5592891|NCT00951015|19326469|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
5592892|NCT00951015|19326465|P5|Randomization Phase 96 Week|Protocol Violation|0
5592893|NCT00951015|19326466|P4|Randomization Phase 96 Week|Protocol Violation|0
5592894|NCT00951015|19326467|P3|Randomization Phase 96 Week|Protocol Violation|1
5592895|NCT00951015|19326468|P2|Randomization Phase 96 Week|Protocol Violation|1
5592896|NCT00951015|19326469|P1|Randomization Phase 96 Week|Protocol Violation|1
5592897|NCT00951015|19326465|P5|Randomization Phase 96 Week|Lack of Efficacy|0
5592898|NCT00951015|19326466|P4|Randomization Phase 96 Week|Lack of Efficacy|0
5592899|NCT00951015|19326467|P3|Randomization Phase 96 Week|Lack of Efficacy|0
5592900|NCT00951015|19326468|P2|Randomization Phase 96 Week|Lack of Efficacy|1
5592901|NCT00951015|19326469|P1|Randomization Phase 96 Week|Lack of Efficacy|1
5592902|NCT00951015|19326465|P5|Randomization Phase 96 Week|Adverse Event|0
5592903|NCT00951015|19326466|P4|Randomization Phase 96 Week|Adverse Event|5
5592904|NCT00951015|19326467|P3|Randomization Phase 96 Week|Adverse Event|2
5592905|NCT00951015|19326468|P2|Randomization Phase 96 Week|Adverse Event|1
5592906|NCT00951015|19326469|P1|Randomization Phase 96 Week|Adverse Event|1
5592907|NCT00950963|19326566|P2|Overall Study|Lost to Follow-up|24
5592908|NCT00950963|19326567|P1|Overall Study|Lost to Follow-up|29
5592909|NCT00950950|19326583|P2|Overall Study|Withdrawal by Subject|1
5592910|NCT00950950|19326584|P1|Overall Study|Withdrawal by Subject|0
5592911|NCT00950950|19326583|P2|Overall Study|Adverse Event|0
5592912|NCT00950950|19326584|P1|Overall Study|Adverse Event|1
5592913|NCT00950911|19326666|P2|Overall Study|Poor performance status|1
5592914|NCT00950911|19326667|P1|Overall Study|Poor performance status|0
5592915|NCT00950911|19326666|P2|Overall Study|Noncompliance|0
5592916|NCT00950911|19326667|P1|Overall Study|Noncompliance|1
5592917|NCT00950911|19326666|P2|Overall Study|Ineligibility determined|0
5592918|NCT00950911|19326667|P1|Overall Study|Ineligibility determined|1
5592919|NCT00950911|19326666|P2|Overall Study|Administrative decision|1
5592920|NCT00950911|19326667|P1|Overall Study|Administrative decision|3
5592921|NCT00950911|19326666|P2|Overall Study|Consent withdrawn|3
5592922|NCT00950911|19326667|P1|Overall Study|Consent withdrawn|1
5592923|NCT00950911|19326666|P2|Overall Study|Disease progression|2
5592924|NCT00950911|19326667|P1|Overall Study|Disease progression|2
5592925|NCT00950911|19326666|P2|Overall Study|Death|6
5592926|NCT00950911|19326667|P1|Overall Study|Death|4
5592927|NCT00950911|19326666|P2|Overall Study|Adverse Event|2
5592928|NCT00950911|19326667|P1|Overall Study|Adverse Event|0
5592929|NCT00950872|19326673|P1|Overall Study|Did not have surgery|2
5592930|NCT00950872|19326673|P1|Overall Study|Withdrawal by Subject|1
5592931|NCT00950859|19326682|P2|Overall Study|Lost to Follow-up|3
5592932|NCT00950859|19326683|P1|Overall Study|Lost to Follow-up|0
5592933|NCT00950859|19326682|P2|Overall Study|Protocol Violation|1
5592934|NCT00950859|19326683|P1|Overall Study|Protocol Violation|1
5592935|NCT00950859|19326682|P2|Overall Study|Insufficient Viral Load Response|3
5592936|NCT00950859|19326683|P1|Overall Study|Insufficient Viral Load Response|12
5592937|NCT00950859|19326682|P2|Overall Study|Adverse Event|3
5592938|NCT00950859|19326683|P1|Overall Study|Adverse Event|3
5592939|NCT00950807|19326782|P10|Treatment Period 3|Adverse Event|0
5592940|NCT00950807|19326783|P9|Treatment Period 3|Adverse Event|0
5592941|NCT00950807|19326784|P8|Treatment Period 3|Adverse Event|0
5592942|NCT00950807|19326785|P7|Treatment Period 3|Adverse Event|1
5592943|NCT00950807|19326786|P6|Treatment Period 3|Adverse Event|0
5592944|NCT00950807|19326787|P5|Treatment Period 3|Adverse Event|0
5592945|NCT00950807|19326788|P4|Treatment Period 3|Adverse Event|0
5592946|NCT00950807|19326789|P3|Treatment Period 3|Adverse Event|0
5592947|NCT00950807|19326790|P2|Treatment Period 3|Adverse Event|0
5592948|NCT00950807|19326791|P1|Treatment Period 3|Adverse Event|0
5592949|NCT00950807|19326782|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
5592950|NCT00950807|19326783|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
5592951|NCT00950807|19326784|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
5592952|NCT00950807|19326785|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
5592953|NCT00950807|19326786|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
5592954|NCT00950807|19326787|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
5592955|NCT00950807|19326788|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
5592956|NCT00950807|19326789|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
5592957|NCT00950807|19326790|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
5592958|NCT00950807|19326791|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
5592959|NCT00950807|19326782|P10|Treatment Period 3|Withdrawal by Subject|1
5592960|NCT00950807|19326783|P9|Treatment Period 3|Withdrawal by Subject|0
5592961|NCT00950807|19326784|P8|Treatment Period 3|Withdrawal by Subject|0
5592962|NCT00950807|19326785|P7|Treatment Period 3|Withdrawal by Subject|0
5592963|NCT00950807|19326786|P6|Treatment Period 3|Withdrawal by Subject|0
5592964|NCT00950807|19326787|P5|Treatment Period 3|Withdrawal by Subject|0
5592965|NCT00950807|19326788|P4|Treatment Period 3|Withdrawal by Subject|0
5592966|NCT00950807|19326789|P3|Treatment Period 3|Withdrawal by Subject|0
5592967|NCT00950807|19326790|P2|Treatment Period 3|Withdrawal by Subject|0
5592968|NCT00950807|19326791|P1|Treatment Period 3|Withdrawal by Subject|0
5592969|NCT00950807|19326782|P10|Washout Period 2|Adverse Event|0
5592970|NCT00950807|19326783|P9|Washout Period 2|Adverse Event|0
5592971|NCT00950807|19326784|P8|Washout Period 2|Adverse Event|0
5592972|NCT00950807|19326785|P7|Washout Period 2|Adverse Event|0
5592973|NCT00950807|19326786|P6|Washout Period 2|Adverse Event|0
5592974|NCT00950807|19326787|P5|Washout Period 2|Adverse Event|0
5592975|NCT00950807|19326788|P4|Washout Period 2|Adverse Event|1
5592976|NCT00950807|19326789|P3|Washout Period 2|Adverse Event|0
5592977|NCT00950807|19326790|P2|Washout Period 2|Adverse Event|0
5592978|NCT00950807|19326791|P1|Washout Period 2|Adverse Event|3
5592979|NCT00950807|19326782|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
5592980|NCT00950807|19326783|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
5592981|NCT00950807|19326784|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
5592982|NCT00950807|19326785|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
5592983|NCT00950807|19326786|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
5592984|NCT00950807|19326787|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
5592985|NCT00950807|19326788|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
5592986|NCT00950807|19326789|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
5592987|NCT00950807|19326790|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
5592988|NCT00950807|19326791|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
5592989|NCT00950807|19326782|P10|Washout Period 2|Lack of Efficacy|0
5592990|NCT00950807|19326783|P9|Washout Period 2|Lack of Efficacy|0
5592991|NCT00950807|19326784|P8|Washout Period 2|Lack of Efficacy|0
5592992|NCT00950807|19326785|P7|Washout Period 2|Lack of Efficacy|0
5592993|NCT00950807|19326786|P6|Washout Period 2|Lack of Efficacy|0
5592994|NCT00950807|19326787|P5|Washout Period 2|Lack of Efficacy|0
5592995|NCT00950807|19326788|P4|Washout Period 2|Lack of Efficacy|0
5592996|NCT00950807|19326789|P3|Washout Period 2|Lack of Efficacy|0
5592997|NCT00950807|19326790|P2|Washout Period 2|Lack of Efficacy|0
5592998|NCT00950807|19326791|P1|Washout Period 2|Lack of Efficacy|1
5592999|NCT00950807|19326782|P10|Treatment Period 2|Adverse Event|0
5593000|NCT00950807|19326783|P9|Treatment Period 2|Adverse Event|0
5593001|NCT00950807|19326784|P8|Treatment Period 2|Adverse Event|1
5593002|NCT00950807|19326785|P7|Treatment Period 2|Adverse Event|0
5593003|NCT00950807|19326786|P6|Treatment Period 2|Adverse Event|1
5593004|NCT00950807|19326787|P5|Treatment Period 2|Adverse Event|0
5593005|NCT00950807|19326788|P4|Treatment Period 2|Adverse Event|1
5593006|NCT00950807|19326789|P3|Treatment Period 2|Adverse Event|0
5593007|NCT00950807|19326790|P2|Treatment Period 2|Adverse Event|1
5593008|NCT00950807|19326791|P1|Treatment Period 2|Adverse Event|0
5593009|NCT00950807|19326782|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
5593010|NCT00950807|19326783|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
5593011|NCT00950807|19326784|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
5593012|NCT00950807|19326785|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
5593013|NCT00950807|19326786|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
5593014|NCT00950807|19326787|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
5593015|NCT00950807|19326788|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
5593016|NCT00950807|19326789|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
5593017|NCT00950807|19326790|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
5593018|NCT00950807|19326791|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
5593019|NCT00950807|19326782|P10|Treatment Period 2|Withdrawal by Subject|0
5593020|NCT00950807|19326783|P9|Treatment Period 2|Withdrawal by Subject|0
5593021|NCT00950807|19326784|P8|Treatment Period 2|Withdrawal by Subject|2
5593022|NCT00950807|19326785|P7|Treatment Period 2|Withdrawal by Subject|1
5593023|NCT00950807|19326786|P6|Treatment Period 2|Withdrawal by Subject|0
5593024|NCT00950807|19326787|P5|Treatment Period 2|Withdrawal by Subject|0
5593025|NCT00950807|19326788|P4|Treatment Period 2|Withdrawal by Subject|0
5593026|NCT00950807|19326789|P3|Treatment Period 2|Withdrawal by Subject|0
5593027|NCT00950807|19326790|P2|Treatment Period 2|Withdrawal by Subject|0
5593028|NCT00950807|19326791|P1|Treatment Period 2|Withdrawal by Subject|0
5593029|NCT00950807|19326782|P10|Treatment Period 2|Lack of Efficacy|0
5593030|NCT00950807|19326783|P9|Treatment Period 2|Lack of Efficacy|0
5593031|NCT00950807|19326784|P8|Treatment Period 2|Lack of Efficacy|0
5593032|NCT00950807|19326785|P7|Treatment Period 2|Lack of Efficacy|0
5593033|NCT00950807|19326786|P6|Treatment Period 2|Lack of Efficacy|0
5593034|NCT00950807|19326787|P5|Treatment Period 2|Lack of Efficacy|0
5593035|NCT00950807|19326788|P4|Treatment Period 2|Lack of Efficacy|0
5593036|NCT00950807|19326789|P3|Treatment Period 2|Lack of Efficacy|0
5593037|NCT00950807|19326790|P2|Treatment Period 2|Lack of Efficacy|0
5593038|NCT00950807|19326791|P1|Treatment Period 2|Lack of Efficacy|1
5593039|NCT00950807|19326782|P10|Washout Period 1|Adverse Event|0
5593040|NCT00950807|19326783|P9|Washout Period 1|Adverse Event|0
5593041|NCT00950807|19326784|P8|Washout Period 1|Adverse Event|0
5593042|NCT00950807|19326785|P7|Washout Period 1|Adverse Event|0
5593043|NCT00950807|19326786|P6|Washout Period 1|Adverse Event|0
5593044|NCT00950807|19326787|P5|Washout Period 1|Adverse Event|1
5593045|NCT00950807|19326788|P4|Washout Period 1|Adverse Event|1
5593046|NCT00950807|19326789|P3|Washout Period 1|Adverse Event|0
5593047|NCT00950807|19326790|P2|Washout Period 1|Adverse Event|0
5593048|NCT00950807|19326791|P1|Washout Period 1|Adverse Event|2
5593049|NCT00950807|19326782|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
5593050|NCT00950807|19326783|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
5593051|NCT00950807|19326784|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
5593052|NCT00950807|19326785|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
5593053|NCT00950807|19326786|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
5593054|NCT00950807|19326787|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
5593055|NCT00950807|19326788|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
5593056|NCT00950807|19326789|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
5593057|NCT00950807|19326790|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
5593058|NCT00950807|19326791|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
5593059|NCT00950807|19326782|P10|Washout Period 1|Withdrawal by Subject|0
5593060|NCT00950807|19326783|P9|Washout Period 1|Withdrawal by Subject|1
5593061|NCT00950807|19326784|P8|Washout Period 1|Withdrawal by Subject|0
5593062|NCT00950807|19326785|P7|Washout Period 1|Withdrawal by Subject|0
5593063|NCT00950807|19326786|P6|Washout Period 1|Withdrawal by Subject|0
5593064|NCT00950807|19326787|P5|Washout Period 1|Withdrawal by Subject|0
5593065|NCT00950807|19326788|P4|Washout Period 1|Withdrawal by Subject|0
5593066|NCT00950807|19326789|P3|Washout Period 1|Withdrawal by Subject|0
5593067|NCT00950807|19326790|P2|Washout Period 1|Withdrawal by Subject|0
5593068|NCT00950807|19326791|P1|Washout Period 1|Withdrawal by Subject|0
5593069|NCT00950807|19326782|P10|Washout Period 1|Lack of Efficacy|0
5593070|NCT00950807|19326783|P9|Washout Period 1|Lack of Efficacy|0
5593071|NCT00950807|19326784|P8|Washout Period 1|Lack of Efficacy|0
5593072|NCT00950807|19326785|P7|Washout Period 1|Lack of Efficacy|1
5593073|NCT00950807|19326786|P6|Washout Period 1|Lack of Efficacy|0
5593074|NCT00950807|19326787|P5|Washout Period 1|Lack of Efficacy|0
5593075|NCT00950807|19326788|P4|Washout Period 1|Lack of Efficacy|0
5593076|NCT00950807|19326789|P3|Washout Period 1|Lack of Efficacy|0
5593077|NCT00950807|19326790|P2|Washout Period 1|Lack of Efficacy|0
5593078|NCT00950807|19326791|P1|Washout Period 1|Lack of Efficacy|0
5593079|NCT00950807|19326782|P10|Treatment Period 1|Adverse Event|0
5593080|NCT00950807|19326783|P9|Treatment Period 1|Adverse Event|0
5593081|NCT00950807|19326784|P8|Treatment Period 1|Adverse Event|0
5593082|NCT00950807|19326785|P7|Treatment Period 1|Adverse Event|0
5593083|NCT00950807|19326786|P6|Treatment Period 1|Adverse Event|1
5593084|NCT00950807|19326787|P5|Treatment Period 1|Adverse Event|0
5593085|NCT00950807|19326788|P4|Treatment Period 1|Adverse Event|0
5593086|NCT00950807|19326789|P3|Treatment Period 1|Adverse Event|0
5593087|NCT00950807|19326790|P2|Treatment Period 1|Adverse Event|0
5593088|NCT00950807|19326791|P1|Treatment Period 1|Adverse Event|0
5593089|NCT00950807|19326782|P10|Treatment Period 1|Withdrawal by Subject|0
5593090|NCT00950807|19326783|P9|Treatment Period 1|Withdrawal by Subject|1
5593091|NCT00950807|19326784|P8|Treatment Period 1|Withdrawal by Subject|0
5593092|NCT00950807|19326785|P7|Treatment Period 1|Withdrawal by Subject|0
5593093|NCT00950807|19326786|P6|Treatment Period 1|Withdrawal by Subject|0
5593094|NCT00950807|19326787|P5|Treatment Period 1|Withdrawal by Subject|1
5593095|NCT00950807|19326788|P4|Treatment Period 1|Withdrawal by Subject|0
5593096|NCT00950807|19326789|P3|Treatment Period 1|Withdrawal by Subject|0
5593097|NCT00950807|19326790|P2|Treatment Period 1|Withdrawal by Subject|0
5593098|NCT00950807|19326791|P1|Treatment Period 1|Withdrawal by Subject|1
5593099|NCT00950807|19326782|P10|Treatment Period 1|Lost to Follow-up|0
5593100|NCT00950807|19326783|P9|Treatment Period 1|Lost to Follow-up|0
5593101|NCT00950807|19326784|P8|Treatment Period 1|Lost to Follow-up|0
5593102|NCT00950807|19326785|P7|Treatment Period 1|Lost to Follow-up|0
5593103|NCT00950807|19326786|P6|Treatment Period 1|Lost to Follow-up|0
5593104|NCT00950807|19326787|P5|Treatment Period 1|Lost to Follow-up|0
5593105|NCT00950807|19326788|P4|Treatment Period 1|Lost to Follow-up|0
5593106|NCT00950807|19326789|P3|Treatment Period 1|Lost to Follow-up|1
5593107|NCT00950807|19326790|P2|Treatment Period 1|Lost to Follow-up|0
5593108|NCT00950807|19326791|P1|Treatment Period 1|Lost to Follow-up|0
5593109|NCT00950807|19326782|P10|Treatment Period 1|Protocol Violation|0
5593110|NCT00950807|19326783|P9|Treatment Period 1|Protocol Violation|0
5593111|NCT00950807|19326784|P8|Treatment Period 1|Protocol Violation|0
5593112|NCT00950807|19326785|P7|Treatment Period 1|Protocol Violation|0
5593113|NCT00950807|19326786|P6|Treatment Period 1|Protocol Violation|0
5593114|NCT00950807|19326787|P5|Treatment Period 1|Protocol Violation|0
5593115|NCT00950807|19326788|P4|Treatment Period 1|Protocol Violation|0
5593116|NCT00950807|19326789|P3|Treatment Period 1|Protocol Violation|0
5593117|NCT00950807|19326790|P2|Treatment Period 1|Protocol Violation|0
5593118|NCT00950807|19326791|P1|Treatment Period 1|Protocol Violation|1
5593119|NCT00950807|19326782|P10|Treatment Period 1|Lack of Efficacy|0
5593120|NCT00950807|19326783|P9|Treatment Period 1|Lack of Efficacy|0
5593121|NCT00950807|19326784|P8|Treatment Period 1|Lack of Efficacy|0
5593122|NCT00950807|19326785|P7|Treatment Period 1|Lack of Efficacy|0
5593123|NCT00950807|19326786|P6|Treatment Period 1|Lack of Efficacy|1
5593124|NCT00950807|19326787|P5|Treatment Period 1|Lack of Efficacy|0
5593125|NCT00950807|19326788|P4|Treatment Period 1|Lack of Efficacy|0
5593126|NCT00950807|19326789|P3|Treatment Period 1|Lack of Efficacy|0
5593127|NCT00950807|19326790|P2|Treatment Period 1|Lack of Efficacy|0
5593128|NCT00950807|19326791|P1|Treatment Period 1|Lack of Efficacy|1
5593129|NCT00950755|19326833|P1|Long-Term Follow-Up|Death|8
5593130|NCT00950755|19326833|P1|Long-Term Follow-Up|Lost to Follow-up|1
5593131|NCT00950755|19326833|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
5593132|NCT00950755|19326833|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
5593133|NCT00950755|19326833|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
5593134|NCT00950755|19326833|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
5593135|NCT00950755|19326833|P1|Dosimetric and Therapeutic Treatment|Death|1
5593136|NCT00950755|19326833|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
5593137|NCT00950755|19326833|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
5593138|NCT00950755|19326833|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
5593139|NCT00950742|19326859|P2|Overall Study|Dose limiting toxicity|0
5593140|NCT00950742|19326860|P1|Overall Study|Dose limiting toxicity|6
5593141|NCT00950742|19326859|P2|Overall Study|Progressive Disease|2
5593142|NCT00950742|19326860|P1|Overall Study|Progressive Disease|6
5593143|NCT00950742|19326859|P2|Overall Study|Withdrawal by Subject|0
5593144|NCT00950742|19326860|P1|Overall Study|Withdrawal by Subject|3
5593145|NCT00950742|19326859|P2|Overall Study|Other Adverse Event|0
5593146|NCT00950742|19326860|P1|Overall Study|Other Adverse Event|1
5593147|NCT00950690|19326881|P1|Overall Study|Other|163
5593148|NCT00950690|19326881|P1|Overall Study|Lost to Follow-up|40
5593149|NCT00950690|19326881|P1|Overall Study|Lack of Efficacy|22
5593150|NCT00950690|19326881|P1|Overall Study|Adverse Event|15
5593151|NCT00950690|19326881|P1|Overall Study|Death|4
5593152|NCT00950664|19326888|P2|First Intervention|Withdrawal by Subject|2
5593153|NCT00950664|19326889|P1|First Intervention|Withdrawal by Subject|2
5593154|NCT00950664|19326888|P2|First Intervention|Lost to Follow-up|3
5593155|NCT00950664|19326889|P1|First Intervention|Lost to Follow-up|1
5593156|NCT00950651|19326909|P2|Overall Study|Withdrawal by Subject|9
5593157|NCT00950651|19326910|P1|Overall Study|Withdrawal by Subject|8
5593158|NCT00950651|19326909|P2|Overall Study|Protocol Violation|4
5593159|NCT00950651|19326910|P1|Overall Study|Protocol Violation|3
5593160|NCT00950651|19326909|P2|Overall Study|Lack of Efficacy|2
5593161|NCT00950651|19326910|P1|Overall Study|Lack of Efficacy|2
5593162|NCT00950651|19326909|P2|Overall Study|Death|0
5593163|NCT00950651|19326910|P1|Overall Study|Death|1
5593164|NCT00950651|19326909|P2|Overall Study|Adverse Event|20
5593165|NCT00950651|19326910|P1|Overall Study|Adverse Event|17
5593166|NCT00950599|19327003|P10|Follow-Up Period|Subject withdrew Consent|1
5593167|NCT00950599|19327004|P9|Follow-Up Period|Subject withdrew Consent|2
5593168|NCT00950599|19327005|P8|Follow-Up Period|Subject withdrew Consent|0
5593169|NCT00950599|19327006|P7|Follow-Up Period|Subject withdrew Consent|0
5593170|NCT00950599|19327007|P6|Follow-Up Period|Subject withdrew Consent|0
5593171|NCT00950599|19327008|P5|Follow-Up Period|Subject withdrew Consent|0
5593172|NCT00950599|19327009|P4|Follow-Up Period|Subject withdrew Consent|0
5593173|NCT00950599|19327010|P3|Follow-Up Period|Subject withdrew Consent|0
5593174|NCT00950599|19327011|P2|Follow-Up Period|Subject withdrew Consent|0
5593175|NCT00950599|19327012|P1|Follow-Up Period|Subject withdrew Consent|0
5593176|NCT00950599|19327003|P10|Follow-Up Period|Poor/Noncompliance|0
5593177|NCT00950599|19327004|P9|Follow-Up Period|Poor/Noncompliance|1
5593178|NCT00950599|19327005|P8|Follow-Up Period|Poor/Noncompliance|0
5593179|NCT00950599|19327006|P7|Follow-Up Period|Poor/Noncompliance|0
5593180|NCT00950599|19327007|P6|Follow-Up Period|Poor/Noncompliance|0
5593181|NCT00950599|19327008|P5|Follow-Up Period|Poor/Noncompliance|0
5593182|NCT00950599|19327009|P4|Follow-Up Period|Poor/Noncompliance|0
5593183|NCT00950599|19327010|P3|Follow-Up Period|Poor/Noncompliance|0
5593184|NCT00950599|19327011|P2|Follow-Up Period|Poor/Noncompliance|0
5593185|NCT00950599|19327012|P1|Follow-Up Period|Poor/Noncompliance|0
5593186|NCT00950599|19327003|P10|Follow-Up Period|Physician Decision|0
5593187|NCT00950599|19327004|P9|Follow-Up Period|Physician Decision|1
5593188|NCT00950599|19327005|P8|Follow-Up Period|Physician Decision|0
5593189|NCT00950599|19327006|P7|Follow-Up Period|Physician Decision|0
5593190|NCT00950599|19327007|P6|Follow-Up Period|Physician Decision|0
5593191|NCT00950599|19327008|P5|Follow-Up Period|Physician Decision|0
5593192|NCT00950599|19327009|P4|Follow-Up Period|Physician Decision|0
5593193|NCT00950599|19327010|P3|Follow-Up Period|Physician Decision|0
5593194|NCT00950599|19327011|P2|Follow-Up Period|Physician Decision|0
5593195|NCT00950599|19327012|P1|Follow-Up Period|Physician Decision|0
5593196|NCT00950599|19327003|P10|Follow-Up Period|Lost to Follow-up|1
5593197|NCT00950599|19327004|P9|Follow-Up Period|Lost to Follow-up|5
5593198|NCT00950599|19327005|P8|Follow-Up Period|Lost to Follow-up|0
5593199|NCT00950599|19327006|P7|Follow-Up Period|Lost to Follow-up|0
5593200|NCT00950599|19327007|P6|Follow-Up Period|Lost to Follow-up|0
5593201|NCT00950599|19327008|P5|Follow-Up Period|Lost to Follow-up|0
5593202|NCT00950599|19327009|P4|Follow-Up Period|Lost to Follow-up|0
5593203|NCT00950599|19327010|P3|Follow-Up Period|Lost to Follow-up|0
5593204|NCT00950599|19327011|P2|Follow-Up Period|Lost to Follow-up|0
5593205|NCT00950599|19327012|P1|Follow-Up Period|Lost to Follow-up|0
5593206|NCT00950599|19327003|P10|Follow-Up Period|Lack of Efficacy|0
5593207|NCT00950599|19327004|P9|Follow-Up Period|Lack of Efficacy|3
5593208|NCT00950599|19327005|P8|Follow-Up Period|Lack of Efficacy|0
5593209|NCT00950599|19327006|P7|Follow-Up Period|Lack of Efficacy|0
5593210|NCT00950599|19327007|P6|Follow-Up Period|Lack of Efficacy|0
5593211|NCT00950599|19327008|P5|Follow-Up Period|Lack of Efficacy|0
5593212|NCT00950599|19327009|P4|Follow-Up Period|Lack of Efficacy|0
5593213|NCT00950599|19327010|P3|Follow-Up Period|Lack of Efficacy|0
5593214|NCT00950599|19327011|P2|Follow-Up Period|Lack of Efficacy|0
5593215|NCT00950599|19327012|P1|Follow-Up Period|Lack of Efficacy|0
5593216|NCT00950599|19327003|P10|Follow-Up Period|Adverse Event|0
5593217|NCT00950599|19327004|P9|Follow-Up Period|Adverse Event|1
5593218|NCT00950599|19327005|P8|Follow-Up Period|Adverse Event|0
5593219|NCT00950599|19327006|P7|Follow-Up Period|Adverse Event|0
5593220|NCT00950599|19327007|P6|Follow-Up Period|Adverse Event|0
5593221|NCT00950599|19327008|P5|Follow-Up Period|Adverse Event|0
5593222|NCT00950599|19327009|P4|Follow-Up Period|Adverse Event|0
5593223|NCT00950599|19327010|P3|Follow-Up Period|Adverse Event|0
5593224|NCT00950599|19327011|P2|Follow-Up Period|Adverse Event|0
5593225|NCT00950599|19327012|P1|Follow-Up Period|Adverse Event|0
5593226|NCT00950599|19327003|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
5593227|NCT00950599|19327004|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
5593228|NCT00950599|19327005|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
5593229|NCT00950599|19327006|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
5593230|NCT00950599|19327007|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
5593231|NCT00950599|19327008|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
5593232|NCT00950599|19327009|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
5593233|NCT00950599|19327010|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
5593234|NCT00950599|19327011|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
5593235|NCT00950599|19327012|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
5593236|NCT00950599|19327003|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5593237|NCT00950599|19327004|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5593238|NCT00950599|19327005|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5593239|NCT00950599|19327006|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5593240|NCT00950599|19327007|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
5593241|NCT00950599|19327008|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
5593242|NCT00950599|19327009|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5593243|NCT00950599|19327010|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5593244|NCT00950599|19327011|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5593245|NCT00950599|19327012|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
5593246|NCT00950599|19327003|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
5593247|NCT00950599|19327004|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
5593248|NCT00950599|19327005|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
5593249|NCT00950599|19327006|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
5593250|NCT00950599|19327007|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
5593251|NCT00950599|19327008|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
5593252|NCT00950599|19327009|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
5593253|NCT00950599|19327010|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
5593254|NCT00950599|19327011|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
5593255|NCT00950599|19327012|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
5593256|NCT00950599|19327003|P10|Double-Blind Treatment Period|Lost to Follow-up|0
5593257|NCT00950599|19327004|P9|Double-Blind Treatment Period|Lost to Follow-up|0
5593258|NCT00950599|19327005|P8|Double-Blind Treatment Period|Lost to Follow-up|1
5593259|NCT00950599|19327006|P7|Double-Blind Treatment Period|Lost to Follow-up|0
5593260|NCT00950599|19327007|P6|Double-Blind Treatment Period|Lost to Follow-up|2
5593261|NCT00950599|19327008|P5|Double-Blind Treatment Period|Lost to Follow-up|1
5593262|NCT00950599|19327009|P4|Double-Blind Treatment Period|Lost to Follow-up|1
5593263|NCT00950599|19327010|P3|Double-Blind Treatment Period|Lost to Follow-up|0
5593264|NCT00950599|19327011|P2|Double-Blind Treatment Period|Lost to Follow-up|0
5593265|NCT00950599|19327012|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5593266|NCT00950599|19327003|P10|Double-Blind Treatment Period|Lack of Efficacy|0
5593267|NCT00950599|19327004|P9|Double-Blind Treatment Period|Lack of Efficacy|0
5593268|NCT00950599|19327005|P8|Double-Blind Treatment Period|Lack of Efficacy|1
5593269|NCT00950599|19327006|P7|Double-Blind Treatment Period|Lack of Efficacy|0
5593270|NCT00950599|19327007|P6|Double-Blind Treatment Period|Lack of Efficacy|6
5593271|NCT00950599|19327008|P5|Double-Blind Treatment Period|Lack of Efficacy|3
5593272|NCT00950599|19327009|P4|Double-Blind Treatment Period|Lack of Efficacy|7
5593273|NCT00950599|19327010|P3|Double-Blind Treatment Period|Lack of Efficacy|5
5593274|NCT00950599|19327011|P2|Double-Blind Treatment Period|Lack of Efficacy|5
5593275|NCT00950599|19327012|P1|Double-Blind Treatment Period|Lack of Efficacy|2
5593276|NCT00950599|19327003|P10|Double-Blind Treatment Period|Adverse Event|0
5593277|NCT00950599|19327004|P9|Double-Blind Treatment Period|Adverse Event|0
5593278|NCT00950599|19327005|P8|Double-Blind Treatment Period|Adverse Event|0
5593279|NCT00950599|19327006|P7|Double-Blind Treatment Period|Adverse Event|0
5593280|NCT00950599|19327007|P6|Double-Blind Treatment Period|Adverse Event|1
5593281|NCT00950599|19327008|P5|Double-Blind Treatment Period|Adverse Event|1
5593282|NCT00950599|19327009|P4|Double-Blind Treatment Period|Adverse Event|1
5593283|NCT00950599|19327010|P3|Double-Blind Treatment Period|Adverse Event|1
5593284|NCT00950599|19327011|P2|Double-Blind Treatment Period|Adverse Event|1
5593285|NCT00950599|19327012|P1|Double-Blind Treatment Period|Adverse Event|0
5593286|NCT00950599|19327003|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
5593287|NCT00950599|19327004|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
5593288|NCT00950599|19327005|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
5593289|NCT00950599|19327006|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
5593290|NCT00950599|19327007|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
5593291|NCT00950599|19327008|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
5593292|NCT00950599|19327009|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
5593293|NCT00950599|19327010|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
5593294|NCT00950599|19327011|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
5593295|NCT00950599|19327012|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
5593296|NCT00950300|19327598|P2|SFU Period|Withdrawal by Subject|8
5593297|NCT00950300|19327599|P1|SFU Period|Withdrawal by Subject|4
5593298|NCT00950300|19327598|P2|SFU Period|Lost to Follow-up|28
5593299|NCT00950300|19327599|P1|SFU Period|Lost to Follow-up|30
5593300|NCT00950300|19327598|P2|SFU Period|Death|42
5593301|NCT00950300|19327599|P1|SFU Period|Death|44
5593302|NCT00950300|19327598|P2|TFFU Period|Other|3
5593303|NCT00950300|19327599|P1|TFFU Period|Other|4
5593304|NCT00950300|19327598|P2|TFFU Period|Recurrence of Disease|72
5593305|NCT00950300|19327599|P1|TFFU Period|Recurrence of Disease|63
5593306|NCT00950300|19327598|P2|TFFU Period|Failure to Return|16
5593307|NCT00950300|19327599|P1|TFFU Period|Failure to Return|16
5593308|NCT00950300|19327598|P2|TFFU Period|Refused Treatment|11
5593309|NCT00950300|19327599|P1|TFFU Period|Refused Treatment|10
5593310|NCT00950300|19327598|P2|TFFU Period|Death|1
5593311|NCT00950300|19327599|P1|TFFU Period|Death|4
5593312|NCT00950300|19327598|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
5593313|NCT00950300|19327599|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
5593314|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Other|1
5593315|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Other|1
5593316|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
5593317|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
5593318|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
5593319|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
5593320|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
5593321|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
5593322|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
5593323|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
5593324|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
5593325|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
5593326|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
5593327|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
5593328|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
5593329|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
5593330|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
5593331|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
5593332|NCT00950300|19327598|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
5593333|NCT00950300|19327599|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
5593334|NCT00950248|19327648|P3|Year 2&3 Treatment Randomization|MRI contraindication|0
5593335|NCT00950248|19327649|P2|Year 2&3 Treatment Randomization|MRI contraindication|1
5593336|NCT00950248|19327650|P1|Year 2&3 Treatment Randomization|MRI contraindication|0
5593337|NCT00950248|19327648|P3|Year 2&3 Treatment Randomization|Death|1
5593338|NCT00950248|19327649|P2|Year 2&3 Treatment Randomization|Death|0
5593339|NCT00950248|19327650|P1|Year 2&3 Treatment Randomization|Death|0
5593340|NCT00950248|19327648|P3|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
5593341|NCT00950248|19327649|P2|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
5593342|NCT00950248|19327650|P1|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
5593343|NCT00950248|19327648|P3|Year 2&3 Treatment Randomization|worsening of symptoms|4
5593344|NCT00950248|19327649|P2|Year 2&3 Treatment Randomization|worsening of symptoms|2
5593345|NCT00950248|19327650|P1|Year 2&3 Treatment Randomization|worsening of symptoms|0
5593346|NCT00950248|19327648|P3|Year 1: Baseline|worsening of symptoms|0
5593347|NCT00950248|19327649|P2|Year 1: Baseline|worsening of symptoms|0
5593348|NCT00950248|19327650|P1|Year 1: Baseline|worsening of symptoms|2
5593349|NCT00950248|19327648|P3|Year 1: Baseline|Withdrawal by Subject|0
5593350|NCT00950248|19327649|P2|Year 1: Baseline|Withdrawal by Subject|0
5593351|NCT00950248|19327650|P1|Year 1: Baseline|Withdrawal by Subject|6
5593352|NCT00950170|19327690|P1|Overall Study|Discontinuation of Study by Sponsor|1
5593353|NCT00950170|19327690|P1|Overall Study|Adverse Event|2
5593354|NCT00950170|19327690|P1|Overall Study|Parent/Legal Guardian Request|1
5593355|NCT00949988|19327741|P1|Overall Study|Withdrawal by Subject|3
5593356|NCT00949975|19327756|P4|Overall Study|Other|0
5593357|NCT00949975|19327757|P3|Overall Study|Other|0
5593358|NCT00949975|19327758|P2|Overall Study|Other|0
5593359|NCT00949975|19327759|P1|Overall Study|Other|1
5593360|NCT00949975|19327756|P4|Overall Study|Lost to Follow-up|3
5593361|NCT00949975|19327757|P3|Overall Study|Lost to Follow-up|1
5593362|NCT00949975|19327758|P2|Overall Study|Lost to Follow-up|0
5593363|NCT00949975|19327759|P1|Overall Study|Lost to Follow-up|1
5593364|NCT00949975|19327756|P4|Overall Study|Severe non-compliance|2
5593365|NCT00949975|19327757|P3|Overall Study|Severe non-compliance|0
5593366|NCT00949975|19327758|P2|Overall Study|Severe non-compliance|1
5593367|NCT00949975|19327759|P1|Overall Study|Severe non-compliance|3
5593368|NCT00949975|19327756|P4|Overall Study|Incorrect enrolment|7
5593369|NCT00949975|19327757|P3|Overall Study|Incorrect enrolment|4
5593370|NCT00949975|19327758|P2|Overall Study|Incorrect enrolment|10
5593371|NCT00949975|19327759|P1|Overall Study|Incorrect enrolment|5
5593372|NCT00949975|19327756|P4|Overall Study|Study-specific criteria|0
5593373|NCT00949975|19327757|P3|Overall Study|Study-specific criteria|1
5593374|NCT00949975|19327758|P2|Overall Study|Study-specific criteria|1
5593375|NCT00949975|19327759|P1|Overall Study|Study-specific criteria|0
5593376|NCT00949975|19327756|P4|Overall Study|Safety reason|0
5593377|NCT00949975|19327757|P3|Overall Study|Safety reason|0
5593378|NCT00949975|19327758|P2|Overall Study|Safety reason|1
5593379|NCT00949975|19327759|P1|Overall Study|Safety reason|0
5593380|NCT00949975|19327756|P4|Overall Study|Adverse Event|10
5593381|NCT00949975|19327757|P3|Overall Study|Adverse Event|10
5593382|NCT00949975|19327758|P2|Overall Study|Adverse Event|11
5593383|NCT00949975|19327759|P1|Overall Study|Adverse Event|11
5593384|NCT00949975|19327756|P4|Overall Study|Voluntary discontinuation|6
5593385|NCT00949975|19327757|P3|Overall Study|Voluntary discontinuation|3
5593386|NCT00949975|19327758|P2|Overall Study|Voluntary discontinuation|5
5593387|NCT00949975|19327759|P1|Overall Study|Voluntary discontinuation|6
5593388|NCT00949910|19327877|P1|Overall Study|No Data|9
5593389|NCT00949910|19327877|P1|Overall Study|Other|4
5593390|NCT00949910|19327877|P1|Overall Study|Physician/Participant Decision|7
5593391|NCT00949910|19327877|P1|Overall Study|Serious Adverse Event|6
5593392|NCT00949910|19327877|P1|Overall Study|Adverse Event|83
5593393|NCT00949910|19327877|P1|Overall Study|Prolonged Dosing Interruption|4
5593394|NCT00949910|19327877|P1|Overall Study|Non-Compliance|10
5593395|NCT00949910|19327877|P1|Overall Study|Logistical Reasons|13
5593396|NCT00949910|19327877|P1|Overall Study|Violation of Eligibility|23
5593397|NCT00949910|19327877|P1|Overall Study|Switched to Commercial Treatment|4
5593398|NCT00949910|19327877|P1|Overall Study|Switched to Compassionate/Other Use|174
5593399|NCT00949910|19327877|P1|Overall Study|Unspecified Progression/Deterioration|13
5593400|NCT00949910|19327877|P1|Overall Study|Death from Unknown Cause|5
5593401|NCT00949910|19327877|P1|Overall Study|Death Due to Toxicity|3
5593402|NCT00949910|19327877|P1|Overall Study|Death Due to Adverse Event|115
5593403|NCT00949910|19327877|P1|Overall Study|Death Due to Progression/Deterioration|4
5593404|NCT00949910|19327877|P1|Overall Study|Death Due to Malignant Disease|456
5593405|NCT00949910|19327877|P1|Overall Study|Participant Refusal|390
5593406|NCT00949910|19327877|P1|Overall Study|Study Drug-Related Adverse Event|315
5593407|NCT00949910|19327877|P1|Overall Study|Lost to Follow-up|100
5593408|NCT00949910|19327877|P1|Overall Study|Symptomatic Deterioration|1088
5593409|NCT00949910|19327877|P1|Overall Study|Progressive Disease|3750
5593410|NCT00949884|19327890|P3|Overall Study|Study terminated by sponsor|1
5593411|NCT00949884|19327891|P2|Overall Study|Study terminated by sponsor|0
5593412|NCT00949884|19327892|P1|Overall Study|Study terminated by sponsor|0
5593413|NCT00949884|19327890|P3|Overall Study|Lack of Efficacy|7
5593414|NCT00949884|19327891|P2|Overall Study|Lack of Efficacy|2
5593415|NCT00949884|19327892|P1|Overall Study|Lack of Efficacy|4
5593416|NCT00949884|19327890|P3|Overall Study|Withdrawal by Subject|16
5593417|NCT00949884|19327891|P2|Overall Study|Withdrawal by Subject|4
5593418|NCT00949884|19327892|P1|Overall Study|Withdrawal by Subject|13
5593419|NCT00949884|19327890|P3|Overall Study|Treatment non-compliance|8
5593420|NCT00949884|19327891|P2|Overall Study|Treatment non-compliance|0
5593421|NCT00949884|19327892|P1|Overall Study|Treatment non-compliance|5
5593422|NCT00949884|19327890|P3|Overall Study|Physician Decision|6
5593423|NCT00949884|19327891|P2|Overall Study|Physician Decision|0
5593424|NCT00949884|19327892|P1|Overall Study|Physician Decision|5
5593425|NCT00949884|19327890|P3|Overall Study|Lost to Follow-up|5
5593426|NCT00949884|19327891|P2|Overall Study|Lost to Follow-up|5
5593427|NCT00949884|19327892|P1|Overall Study|Lost to Follow-up|7
5593428|NCT00949884|19327890|P3|Overall Study|Did not meet inclusion/exclusion|3
5593429|NCT00949884|19327891|P2|Overall Study|Did not meet inclusion/exclusion|1
5593430|NCT00949884|19327892|P1|Overall Study|Did not meet inclusion/exclusion|2
5593431|NCT00949884|19327890|P3|Overall Study|Adverse Event|12
5593432|NCT00949884|19327891|P2|Overall Study|Adverse Event|3
5593433|NCT00949884|19327892|P1|Overall Study|Adverse Event|14
5593434|NCT00949715|19327947|P2|Overall Study|Missing 24 month LVEF measurement|0
5593435|NCT00949715|19327948|P1|Overall Study|Missing 24 month LVEF measurement|2
5593436|NCT00949715|19327947|P2|Overall Study|Lost to Follow-up|0
5593437|NCT00949715|19327948|P1|Overall Study|Lost to Follow-up|1
5593438|NCT00949715|19327947|P2|Overall Study|Physician Decision|0
5593439|NCT00949715|19327948|P1|Overall Study|Physician Decision|1
5593440|NCT00949702|19327959|P1|Overall Study|Withdrawal of consent|1
5593441|NCT00949702|19327959|P1|Overall Study|Disease progression|7
5593442|NCT00949702|19327959|P1|Overall Study|Death|40
5593443|NCT00949650|19327976|P2|Overall Study|Other not specified above|0
5593444|NCT00949650|19327977|P1|Overall Study|Other not specified above|5
5593445|NCT00949650|19327976|P2|Overall Study|Not treated|4
5593446|NCT00949650|19327977|P1|Overall Study|Not treated|1
5593447|NCT00949650|19327976|P2|Overall Study|Refusal to continue medication|11
5593448|NCT00949650|19327977|P1|Overall Study|Refusal to continue medication|7
5593449|NCT00949650|19327976|P2|Overall Study|Protocol Violation|4
5593450|NCT00949650|19327977|P1|Overall Study|Protocol Violation|1
5593451|NCT00949650|19327976|P2|Overall Study|Other Adverse Event (AE)|17
5593452|NCT00949650|19327977|P1|Overall Study|Other Adverse Event (AE)|28
5593453|NCT00949650|19327976|P2|Overall Study|Completed 6 courses of chemotherapy|60
5593454|NCT00949650|19327977|P1|Overall Study|Completed 6 courses of chemotherapy|0
5593455|NCT00949650|19327976|P2|Overall Study|Progressive disease|19
5593456|NCT00949650|19327977|P1|Overall Study|Progressive disease|188
5593457|NCT00949533|19328015|P2|Overall Study|Lost to Follow-up|1
5593458|NCT00949533|19328016|P1|Overall Study|Lost to Follow-up|0
5593459|NCT00949325|19328032|P3|Overall Study|Adverse Event|0
5593460|NCT00949325|19328033|P2|Overall Study|Adverse Event|2
5593461|NCT00949325|19328034|P1|Overall Study|Adverse Event|0
5593462|NCT00949117|19328058|P2|Overall Study|Adverse Event|1
5593463|NCT00949117|19328059|P1|Overall Study|Adverse Event|0
5593464|NCT00949117|19328058|P2|Overall Study|Protocol Violation|1
5593465|NCT00949117|19328059|P1|Overall Study|Protocol Violation|1
5593466|NCT00949117|19328058|P2|Overall Study|Lack of Efficacy|3
5593467|NCT00949117|19328059|P1|Overall Study|Lack of Efficacy|2
5593468|NCT00948974|19328100|P2|Overall Study|Lost to Follow-up|20
5593469|NCT00948974|19328101|P1|Overall Study|Lost to Follow-up|23
5593470|NCT00948922|19328119|P3|Overall Study|Not evaluable at time of analysis|0
5593471|NCT00948922|19328120|P2|Overall Study|Not evaluable at time of analysis|3
5593472|NCT00948922|19328121|P1|Overall Study|Not evaluable at time of analysis|0
5593473|NCT00948922|19328119|P3|Overall Study|Transplant eligibility issues|0
5593474|NCT00948922|19328120|P2|Overall Study|Transplant eligibility issues|3
5593475|NCT00948922|19328121|P1|Overall Study|Transplant eligibility issues|2
5593476|NCT00948922|19328119|P3|Overall Study|Insurance issues|0
5593477|NCT00948922|19328120|P2|Overall Study|Insurance issues|0
5593478|NCT00948922|19328121|P1|Overall Study|Insurance issues|1
5593479|NCT00948922|19328119|P3|Overall Study|Disease progression|0
5593480|NCT00948922|19328120|P2|Overall Study|Disease progression|1
5593481|NCT00948922|19328121|P1|Overall Study|Disease progression|0
5593482|NCT00948922|19328119|P3|Overall Study|Death|0
5593483|NCT00948922|19328120|P2|Overall Study|Death|0
5593484|NCT00948922|19328121|P1|Overall Study|Death|3
5593485|NCT00948922|19328119|P3|Overall Study|Withdrawal by Subject|1
5593486|NCT00948922|19328120|P2|Overall Study|Withdrawal by Subject|2
5593487|NCT00948922|19328121|P1|Overall Study|Withdrawal by Subject|0
5593488|NCT00948922|19328119|P3|Overall Study|Did not start study treatment|0
5593489|NCT00948922|19328120|P2|Overall Study|Did not start study treatment|5
5593490|NCT00948922|19328121|P1|Overall Study|Did not start study treatment|2
5593491|NCT00948896|19328144|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5593492|NCT00948896|19328145|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5593493|NCT00948896|19328146|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5593494|NCT00948896|19328147|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5593495|NCT00948896|19328148|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
5593496|NCT00948896|19328149|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5593497|NCT00948896|19328150|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5593498|NCT00948896|19328151|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
5593499|NCT00948896|19328144|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
5593500|NCT00948896|19328145|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
5593501|NCT00948896|19328146|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
5593502|NCT00948896|19328147|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
5593503|NCT00948896|19328148|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
5593504|NCT00948896|19328149|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
5593505|NCT00948896|19328150|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
5593506|NCT00948896|19328151|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
5593507|NCT00948896|19328144|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5593508|NCT00948896|19328145|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5593509|NCT00948896|19328146|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5593510|NCT00948896|19328147|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
5593511|NCT00948896|19328148|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5593512|NCT00948896|19328149|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
5593513|NCT00948896|19328150|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
5593514|NCT00948896|19328151|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
5593515|NCT00948896|19328144|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5593516|NCT00948896|19328145|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5593517|NCT00948896|19328146|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5593518|NCT00948896|19328147|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5593519|NCT00948896|19328148|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
5593520|NCT00948896|19328149|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
5593521|NCT00948896|19328150|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
5593522|NCT00948896|19328151|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
5593523|NCT00948896|19328144|P8|24 Months of Age to 36 Months of Age|Death|0
5593524|NCT00948896|19328145|P7|24 Months of Age to 36 Months of Age|Death|0
5593525|NCT00948896|19328146|P6|24 Months of Age to 36 Months of Age|Death|1
5593526|NCT00948896|19328147|P5|24 Months of Age to 36 Months of Age|Death|0
5593527|NCT00948896|19328148|P4|24 Months of Age to 36 Months of Age|Death|0
5593528|NCT00948896|19328149|P3|24 Months of Age to 36 Months of Age|Death|2
5593529|NCT00948896|19328150|P2|24 Months of Age to 36 Months of Age|Death|2
5593530|NCT00948896|19328151|P1|24 Months of Age to 36 Months of Age|Death|0
5593531|NCT00948896|19328144|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
5593532|NCT00948896|19328145|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
5593533|NCT00948896|19328146|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
5593534|NCT00948896|19328147|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
5593535|NCT00948896|19328148|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
5593536|NCT00948896|19328149|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
5593537|NCT00948896|19328150|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
5593538|NCT00948896|19328151|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
5593539|NCT00948896|19328144|P8|Randomization to 24 Months of Age|Protocol Violation|1
5593540|NCT00948896|19328145|P7|Randomization to 24 Months of Age|Protocol Violation|1
5593541|NCT00948896|19328146|P6|Randomization to 24 Months of Age|Protocol Violation|0
5593542|NCT00948896|19328147|P5|Randomization to 24 Months of Age|Protocol Violation|0
5593543|NCT00948896|19328148|P4|Randomization to 24 Months of Age|Protocol Violation|1
5593544|NCT00948896|19328149|P3|Randomization to 24 Months of Age|Protocol Violation|0
5593545|NCT00948896|19328150|P2|Randomization to 24 Months of Age|Protocol Violation|1
5593546|NCT00948896|19328151|P1|Randomization to 24 Months of Age|Protocol Violation|0
5593547|NCT00948896|19328144|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
5593548|NCT00948896|19328145|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
5593549|NCT00948896|19328146|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
5593550|NCT00948896|19328147|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
5593551|NCT00948896|19328148|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
5593552|NCT00948896|19328149|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
5593553|NCT00948896|19328150|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
5593554|NCT00948896|19328151|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
5593555|NCT00948896|19328144|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
5593556|NCT00948896|19328145|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
5593557|NCT00948896|19328146|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
5593558|NCT00948896|19328147|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
5593559|NCT00948896|19328148|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
5593560|NCT00948896|19328149|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
5593561|NCT00948896|19328150|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
5593562|NCT00948896|19328151|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
5593563|NCT00948896|19328144|P8|Randomization to 24 Months of Age|Death|1
5593564|NCT00948896|19328145|P7|Randomization to 24 Months of Age|Death|2
5593565|NCT00948896|19328146|P6|Randomization to 24 Months of Age|Death|1
5593566|NCT00948896|19328147|P5|Randomization to 24 Months of Age|Death|2
5593567|NCT00948896|19328148|P4|Randomization to 24 Months of Age|Death|0
5593568|NCT00948896|19328149|P3|Randomization to 24 Months of Age|Death|0
5593569|NCT00948896|19328150|P2|Randomization to 24 Months of Age|Death|0
5593570|NCT00948896|19328151|P1|Randomization to 24 Months of Age|Death|1
5593571|NCT00948857|19328187|P2|Overall Study|Lost to Follow-up|0
5593572|NCT00948857|19328188|P1|Overall Study|Lost to Follow-up|1
5593573|NCT00948818|19328196|P2|Overall Study|Other Reason|5
5593574|NCT00948818|19328197|P1|Overall Study|Other Reason|4
5593575|NCT00948818|19328196|P2|Overall Study|Lack of Efficacy|5
5593576|NCT00948818|19328197|P1|Overall Study|Lack of Efficacy|4
5593577|NCT00948818|19328196|P2|Overall Study|Lost to Follow-up|17
5593578|NCT00948818|19328197|P1|Overall Study|Lost to Follow-up|10
5593579|NCT00948818|19328196|P2|Overall Study|Withdrawal by Subject|25
5593580|NCT00948818|19328197|P1|Overall Study|Withdrawal by Subject|25
5593581|NCT00948818|19328196|P2|Overall Study|Protocol Violation|10
5593582|NCT00948818|19328197|P1|Overall Study|Protocol Violation|9
5593583|NCT00948818|19328196|P2|Overall Study|Adverse Event|32
5593584|NCT00948818|19328197|P1|Overall Study|Adverse Event|10
5593585|NCT00948766|19328244|P2|Extension Study|Death|0
5593586|NCT00948766|19328245|P1|Extension Study|Death|4
5593587|NCT00948766|19328244|P2|Extension Study|Administrative Problems|0
5593588|NCT00948766|19328245|P1|Extension Study|Administrative Problems|1
5593589|NCT00948766|19328244|P2|Extension Study|Lost to Follow-up|0
5593590|NCT00948766|19328245|P1|Extension Study|Lost to Follow-up|8
5593591|NCT00948766|19328244|P2|Extension Study|Patient Withdrew Consent|0
5593592|NCT00948766|19328245|P1|Extension Study|Patient Withdrew Consent|32
5593593|NCT00948766|19328244|P2|Extension Study|Study Drug No Longer Required|0
5593594|NCT00948766|19328245|P1|Extension Study|Study Drug No Longer Required|1
5593595|NCT00948766|19328244|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
5593596|NCT00948766|19328245|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
5593597|NCT00948766|19328244|P2|Extension Study|Adverse Event|0
5593598|NCT00948766|19328245|P1|Extension Study|Adverse Event|43
5593599|NCT00948766|19328244|P2|Core Study|Protocol Deviation|10
5593600|NCT00948766|19328245|P1|Core Study|Protocol Deviation|8
5593601|NCT00948766|19328244|P2|Core Study|Death|1
5593602|NCT00948766|19328245|P1|Core Study|Death|1
5593603|NCT00948766|19328244|P2|Core Study|Administrative Problems|2
5593604|NCT00948766|19328245|P1|Core Study|Administrative Problems|2
5593605|NCT00948766|19328244|P2|Core Study|Lost to Follow-up|2
5593606|NCT00948766|19328245|P1|Core Study|Lost to Follow-up|3
5593607|NCT00948766|19328244|P2|Core Study|Patient Withdrew Consent|46
5593608|NCT00948766|19328245|P1|Core Study|Patient Withdrew Consent|27
5593609|NCT00948766|19328244|P2|Core Study|Unsatisfactory Therapeutic Effect|14
5593610|NCT00948766|19328245|P1|Core Study|Unsatisfactory Therapeutic Effect|13
5593611|NCT00948766|19328244|P2|Core Study|Adverse Event|51
5593612|NCT00948766|19328245|P1|Core Study|Adverse Event|73
5593613|NCT00948688|19328261|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
5593614|NCT00948688|19328262|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
5593615|NCT00948688|19328261|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
5593616|NCT00948688|19328262|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
5593617|NCT00948688|19328261|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
5593618|NCT00948688|19328262|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
5593619|NCT00948675|19328276|P2|Overall Study|Treatment ongoing|4
5593620|NCT00948675|19328277|P1|Overall Study|Treatment ongoing|5
5593621|NCT00948675|19328276|P2|Overall Study|Lost to Follow-up|0
5593622|NCT00948675|19328277|P1|Overall Study|Lost to Follow-up|2
5593623|NCT00948506|19328304|P2|Overall Study|Withdrawal by Subject|1
5593624|NCT00948506|19328305|P1|Overall Study|Withdrawal by Subject|3
5593625|NCT00948441|19328316|P2|Overall Study|no longer meet inclusion criteria|4
5593626|NCT00948441|19328317|P1|Overall Study|no longer meet inclusion criteria|1
5593627|NCT00948428|19328328|P3|Overall Study|Non-compliance|0
5593628|NCT00948428|19328329|P2|Overall Study|Non-compliance|2
5593629|NCT00948428|19328330|P1|Overall Study|Non-compliance|1
5593630|NCT00948428|19328328|P3|Overall Study|Intercurrent Illness|0
5593631|NCT00948428|19328329|P2|Overall Study|Intercurrent Illness|0
5593632|NCT00948428|19328330|P1|Overall Study|Intercurrent Illness|1
5593633|NCT00948428|19328328|P3|Overall Study|Death|0
5593634|NCT00948428|19328329|P2|Overall Study|Death|0
5593635|NCT00948428|19328330|P1|Overall Study|Death|2
5593636|NCT00948428|19328328|P3|Overall Study|Lost to Follow-up|1
5593637|NCT00948428|19328329|P2|Overall Study|Lost to Follow-up|1
5593638|NCT00948428|19328330|P1|Overall Study|Lost to Follow-up|2
5593639|NCT00948428|19328328|P3|Overall Study|Adverse Event|0
5593640|NCT00948428|19328329|P2|Overall Study|Adverse Event|3
5593641|NCT00948428|19328330|P1|Overall Study|Adverse Event|6
5593642|NCT00948428|19328328|P3|Overall Study|Withdrawal by Subject|7
5593643|NCT00948428|19328329|P2|Overall Study|Withdrawal by Subject|12
5593644|NCT00948428|19328330|P1|Overall Study|Withdrawal by Subject|6
5593645|NCT00948389|19328349|P5|Overall Study|Both Progression and Toxicity|0
5593646|NCT00948389|19328350|P4|Overall Study|Both Progression and Toxicity|0
5593647|NCT00948389|19328351|P3|Overall Study|Both Progression and Toxicity|0
5593648|NCT00948389|19328352|P2|Overall Study|Both Progression and Toxicity|0
5593649|NCT00948389|19328353|P1|Overall Study|Both Progression and Toxicity|1
5593650|NCT00948389|19328349|P5|Overall Study|Thrombocytopenia, Grade 4|0
5593651|NCT00948389|19328350|P4|Overall Study|Thrombocytopenia, Grade 4|1
5593652|NCT00948389|19328351|P3|Overall Study|Thrombocytopenia, Grade 4|0
5593653|NCT00948389|19328352|P2|Overall Study|Thrombocytopenia, Grade 4|0
5593654|NCT00948389|19328353|P1|Overall Study|Thrombocytopenia, Grade 4|2
5593655|NCT00948389|19328349|P5|Overall Study|Disease Progression/Relapse/Death|1
5593656|NCT00948389|19328350|P4|Overall Study|Disease Progression/Relapse/Death|8
5593657|NCT00948389|19328351|P3|Overall Study|Disease Progression/Relapse/Death|7
5593658|NCT00948389|19328352|P2|Overall Study|Disease Progression/Relapse/Death|3
5593659|NCT00948389|19328353|P1|Overall Study|Disease Progression/Relapse/Death|3
5593660|NCT00948246|19328401|P1|Overall Study|Withdrawal by Subject|1
5593661|NCT00948246|19328401|P1|Overall Study|Death|1
5593662|NCT00948246|19328401|P1|Overall Study|Adverse Event|11
5593663|NCT00948246|19328401|P1|Overall Study|Lost to Follow-up|11
5593664|NCT00948155|19328410|P2|Washout 14 Days|Lost to Follow-up|2
5593665|NCT00948155|19328411|P1|Washout 14 Days|Lost to Follow-up|1
5593666|NCT00948155|19328410|P2|First Intervention 21 Days|Lost to Follow-up|2
5593667|NCT00948155|19328411|P1|First Intervention 21 Days|Lost to Follow-up|2
5593668|NCT00948064|19328458|P3|Phase II|Withdrawal by Subject|0
5593669|NCT00948064|19328459|P2|Phase II|Withdrawal by Subject|1
5593670|NCT00948064|19328460|P1|Phase II|Withdrawal by Subject|0
5593671|NCT00948064|19328458|P3|Phase II|Physician Decision|1
5593672|NCT00948064|19328459|P2|Phase II|Physician Decision|0
5593673|NCT00948064|19328460|P1|Phase II|Physician Decision|0
5593674|NCT00948064|19328458|P3|Phase I|No treatment received|0
5593675|NCT00948064|19328459|P2|Phase I|No treatment received|0
5593676|NCT00948064|19328460|P1|Phase I|No treatment received|1
5593677|NCT00948025|19328473|P2|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
5593678|NCT00948025|19328474|P1|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
5593679|NCT00948025|19328473|P2|Phase 1 (Pilot Phase)|Lost to Follow-up|1
5593680|NCT00948025|19328474|P1|Phase 1 (Pilot Phase)|Lost to Follow-up|7
5593681|NCT00948025|19328473|P2|Phase 1 (Pilot Phase)|Adverse Event|1
5593682|NCT00948025|19328474|P1|Phase 1 (Pilot Phase)|Adverse Event|1
5593683|NCT00947882|19328502|P4|Overall Study|Trial Terminated by Sponsor|70
5593684|NCT00947882|19328503|P3|Overall Study|Trial Terminated by Sponsor|62
5593685|NCT00947882|19328504|P2|Overall Study|Trial Terminated by Sponsor|61
5593686|NCT00947882|19328505|P1|Overall Study|Trial Terminated by Sponsor|62
5593687|NCT00947882|19328502|P4|Overall Study|Other/Unknown|6
5593688|NCT00947882|19328503|P3|Overall Study|Other/Unknown|3
5593689|NCT00947882|19328504|P2|Overall Study|Other/Unknown|13
5593690|NCT00947882|19328505|P1|Overall Study|Other/Unknown|10
5593691|NCT00947882|19328502|P4|Overall Study|Lost to Follow-up|0
5593692|NCT00947882|19328503|P3|Overall Study|Lost to Follow-up|1
5593693|NCT00947882|19328504|P2|Overall Study|Lost to Follow-up|2
5593694|NCT00947882|19328505|P1|Overall Study|Lost to Follow-up|0
5593695|NCT00947882|19328502|P4|Overall Study|Protocol Violation|0
5593696|NCT00947882|19328503|P3|Overall Study|Protocol Violation|1
5593697|NCT00947882|19328504|P2|Overall Study|Protocol Violation|0
5593698|NCT00947882|19328505|P1|Overall Study|Protocol Violation|0
5593699|NCT00947882|19328502|P4|Overall Study|Withdrawal by Subject|2
5593700|NCT00947882|19328503|P3|Overall Study|Withdrawal by Subject|8
5593701|NCT00947882|19328504|P2|Overall Study|Withdrawal by Subject|0
5593702|NCT00947882|19328505|P1|Overall Study|Withdrawal by Subject|2
5593703|NCT00947882|19328502|P4|Overall Study|Adverse Event|4
5593704|NCT00947882|19328503|P3|Overall Study|Adverse Event|4
5593705|NCT00947882|19328504|P2|Overall Study|Adverse Event|1
5593706|NCT00947882|19328505|P1|Overall Study|Adverse Event|0
5593707|NCT00947856|19328533|P2|Follow-up Period|Withdrawal by Subject|0
5593708|NCT00947856|19328534|P1|Follow-up Period|Withdrawal by Subject|1
5593709|NCT00947856|19328533|P2|Follow-up Period|Patient unavailable for site visits|0
5593710|NCT00947856|19328534|P1|Follow-up Period|Patient unavailable for site visits|1
5593711|NCT00947856|19328533|P2|Follow-up Period|Lost to Follow-up|0
5593712|NCT00947856|19328534|P1|Follow-up Period|Lost to Follow-up|7
5593713|NCT00947856|19328533|P2|Follow-up Period|Re-enrolled for Retreatment|3
5593714|NCT00947856|19328534|P1|Follow-up Period|Re-enrolled for Retreatment|2
5593715|NCT00947856|19328533|P2|Follow-up Period|Study Stopped by Sponsor|20
5593716|NCT00947856|19328534|P1|Follow-up Period|Study Stopped by Sponsor|40
5593717|NCT00947856|19328533|P2|Treatment Period|Withdrawal by Subject|1
5593718|NCT00947856|19328534|P1|Treatment Period|Withdrawal by Subject|12
5593719|NCT00947856|19328533|P2|Treatment Period|Study Stopped by Sponsor|4
5593720|NCT00947856|19328534|P1|Treatment Period|Study Stopped by Sponsor|4
5593721|NCT00947856|19328533|P2|Treatment Period|Physician Decision|6
5593722|NCT00947856|19328534|P1|Treatment Period|Physician Decision|14
5593723|NCT00947856|19328533|P2|Treatment Period|Adverse Event|9
5593724|NCT00947856|19328534|P1|Treatment Period|Adverse Event|15
5593725|NCT00947856|19328533|P2|Treatment Period|Progressive Disease|12
5593726|NCT00947856|19328534|P1|Treatment Period|Progressive Disease|33
5593727|NCT00947544|19328623|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
5593728|NCT00947544|19328624|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
5593729|NCT00947531|19328650|P2|Overall Study|Other|1
5593730|NCT00947531|19328651|P1|Overall Study|Other|1
5593731|NCT00947531|19328650|P2|Overall Study|Lack of Efficacy|0
5593732|NCT00947531|19328651|P1|Overall Study|Lack of Efficacy|1
5593733|NCT00947531|19328650|P2|Overall Study|Adverse Event|2
5593734|NCT00947531|19328651|P1|Overall Study|Adverse Event|2
5593735|NCT00947531|19328650|P2|Overall Study|Administrative Reason|1
5593736|NCT00947531|19328651|P1|Overall Study|Administrative Reason|0
5593737|NCT00947531|19328650|P2|Overall Study|Withdrawal by Subject|7
5593738|NCT00947531|19328651|P1|Overall Study|Withdrawal by Subject|10
5593739|NCT00947427|19328689|P2|Overall Study|Protocol Violation|1
5593740|NCT00947427|19328690|P1|Overall Study|Protocol Violation|0
5593741|NCT00947427|19328689|P2|Overall Study|Withdrawal by Subject|3
5593742|NCT00947427|19328690|P1|Overall Study|Withdrawal by Subject|1
5593743|NCT00947349|19328700|P4|Overall Study Standard of Care|Other|1
5593744|NCT00947349|19328701|P3|Overall Study Standard of Care|Other|0
5593745|NCT00947349|19328702|P2|Overall Study Standard of Care|Other|0
5593746|NCT00947349|19328703|P1|Overall Study Standard of Care|Other|0
5593747|NCT00947349|19328700|P4|Overall Study Standard of Care|Withdrawal by Subject|0
5593748|NCT00947349|19328701|P3|Overall Study Standard of Care|Withdrawal by Subject|1
5593749|NCT00947349|19328702|P2|Overall Study Standard of Care|Withdrawal by Subject|0
5593750|NCT00947349|19328703|P1|Overall Study Standard of Care|Withdrawal by Subject|0
5593751|NCT00947349|19328700|P4|Overall Study Standard of Care|Lack of Efficacy|1
5593752|NCT00947349|19328701|P3|Overall Study Standard of Care|Lack of Efficacy|1
5593753|NCT00947349|19328702|P2|Overall Study Standard of Care|Lack of Efficacy|0
5593754|NCT00947349|19328703|P1|Overall Study Standard of Care|Lack of Efficacy|0
5593755|NCT00947349|19328700|P4|Triple Treatment Combination Period|Adverse Event|0
5593756|NCT00947349|19328701|P3|Triple Treatment Combination Period|Adverse Event|0
5593757|NCT00947349|19328702|P2|Triple Treatment Combination Period|Adverse Event|1
5593758|NCT00947349|19328703|P1|Triple Treatment Combination Period|Adverse Event|0
5593759|NCT00947193|19328912|P2|Overall Study|Factor VIII >1%|0
5593760|NCT00947193|19328913|P1|Overall Study|Factor VIII >1%|1
5593761|NCT00947193|19328912|P2|Overall Study|Withdrawal by Subject|0
5593762|NCT00947193|19328913|P1|Overall Study|Withdrawal by Subject|1
5593763|NCT00947193|19328912|P2|Overall Study|Lost to Follow-up|0
5593764|NCT00947193|19328913|P1|Overall Study|Lost to Follow-up|1
5593765|NCT00947154|19328928|P1|Overall Study|Lost to Follow-up|1
5593766|NCT00947115|19328938|P3|Overall Study|Lost to Follow-up|8
5593767|NCT00947115|19328939|P2|Overall Study|Lost to Follow-up|12
5593768|NCT00947115|19328940|P1|Overall Study|Lost to Follow-up|11
5593769|NCT00947115|19328938|P3|Overall Study|Withdrawal by Subject|4
5593770|NCT00947115|19328939|P2|Overall Study|Withdrawal by Subject|3
5593771|NCT00947115|19328940|P1|Overall Study|Withdrawal by Subject|1
5593772|NCT00947115|19328938|P3|Overall Study|Migrated from study area|0
5593773|NCT00947115|19328939|P2|Overall Study|Migrated from study area|0
5593774|NCT00947115|19328940|P1|Overall Study|Migrated from study area|2
5593775|NCT00947115|19328938|P3|Overall Study|Death|1
5593776|NCT00947115|19328939|P2|Overall Study|Death|1
5593777|NCT00947115|19328940|P1|Overall Study|Death|0
5593778|NCT00947115|19328938|P3|Overall Study|Physician Decision|0
5593779|NCT00947115|19328939|P2|Overall Study|Physician Decision|2
5593780|NCT00947115|19328940|P1|Overall Study|Physician Decision|0
5593781|NCT00947115|19328938|P3|Overall Study|Missed reporting interval|2
5593782|NCT00947115|19328939|P2|Overall Study|Missed reporting interval|4
5593783|NCT00947115|19328940|P1|Overall Study|Missed reporting interval|3
5593784|NCT00947011|19329002|P1|Overall Study|Study was terminated,PI left institution|12
5593785|NCT00946998|19329012|P2|Overall Study|Exited prior to first outcome assessment|3
5593786|NCT00946998|19329013|P1|Overall Study|Exited prior to first outcome assessment|5
5593787|NCT00946985|19329027|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
5593788|NCT00946985|19329027|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
5593789|NCT00946985|19329027|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
5593790|NCT00946985|19329027|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
5593791|NCT00946985|19329027|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
5593792|NCT00946985|19329027|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
5593793|NCT00946985|19329027|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
5593794|NCT00946985|19329027|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
5593795|NCT00946985|19329027|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
5593796|NCT00946920|19329033|P2|Overall Study|Miscellaneous reasons|3
5593797|NCT00946920|19329034|P1|Overall Study|Miscellaneous reasons|18
5593798|NCT00946920|19329033|P2|Overall Study|Protocol Violation|8
5593799|NCT00946920|19329034|P1|Overall Study|Protocol Violation|16
5593800|NCT00946920|19329033|P2|Overall Study|Adverse Event|14
5593801|NCT00946920|19329034|P1|Overall Study|Adverse Event|41
5593802|NCT00946920|19329033|P2|Overall Study|Physician Decision|2
5593803|NCT00946920|19329034|P1|Overall Study|Physician Decision|5
5593804|NCT00946920|19329033|P2|Overall Study|Lost to Follow-up|2
5593805|NCT00946920|19329034|P1|Overall Study|Lost to Follow-up|2
5593806|NCT00946920|19329033|P2|Overall Study|Withdrawal by Subject|15
5593807|NCT00946920|19329034|P1|Overall Study|Withdrawal by Subject|28
5593808|NCT00946881|19329049|P1|Retreatment|Withdrawal by Subject|1
5593809|NCT00946881|19329049|P1|First Treatment|Patient relocated to another state|1
5593810|NCT00946881|19329049|P1|First Treatment|Withdrawal by Subject|1
5593811|NCT00946712|19329080|P2|Overall Study|Ineligible|6
5593812|NCT00946712|19329081|P1|Overall Study|Ineligible|14
5593813|NCT00946712|19329080|P2|Overall Study|On Treatment|4
5593814|NCT00946712|19329081|P1|Overall Study|On Treatment|0
5593815|NCT00946712|19329080|P2|Overall Study|Other reasons|73
5593816|NCT00946712|19329081|P1|Overall Study|Other reasons|61
5593817|NCT00946712|19329080|P2|Overall Study|No treatment given|29
5593818|NCT00946712|19329081|P1|Overall Study|No treatment given|25
5593819|NCT00946712|19329080|P2|Overall Study|Death|22
5593820|NCT00946712|19329081|P1|Overall Study|Death|21
5593821|NCT00946712|19329080|P2|Overall Study|Disease progression|404
5593822|NCT00946712|19329081|P1|Overall Study|Disease progression|308
5593823|NCT00946712|19329080|P2|Overall Study|Adverse Event|124
5593824|NCT00946712|19329081|P1|Overall Study|Adverse Event|118
5593825|NCT00946647|19329100|P5|Phase ll Part|Subj cond no longer required study drug|0
5593826|NCT00946647|19329101|P4|Phase ll Part|Subj cond no longer required study drug|2
5593827|NCT00946647|19329102|P3|Phase ll Part|Subj cond no longer required study drug|0
5593828|NCT00946647|19329103|P2|Phase ll Part|Subj cond no longer required study drug|0
5593829|NCT00946647|19329104|P1|Phase ll Part|Subj cond no longer required study drug|0
5593830|NCT00946647|19329100|P5|Phase ll Part|Protocol Violation|2
5593831|NCT00946647|19329101|P4|Phase ll Part|Protocol Violation|4
5593832|NCT00946647|19329102|P3|Phase ll Part|Protocol Violation|0
5593833|NCT00946647|19329103|P2|Phase ll Part|Protocol Violation|0
5593834|NCT00946647|19329104|P1|Phase ll Part|Protocol Violation|0
5593835|NCT00946647|19329100|P5|Phase ll Part|Disease progression|14
5593836|NCT00946647|19329101|P4|Phase ll Part|Disease progression|6
5593837|NCT00946647|19329102|P3|Phase ll Part|Disease progression|0
5593838|NCT00946647|19329103|P2|Phase ll Part|Disease progression|0
5593839|NCT00946647|19329104|P1|Phase ll Part|Disease progression|0
5593840|NCT00946647|19329100|P5|Phase ll Part|Death|4
5593841|NCT00946647|19329101|P4|Phase ll Part|Death|7
5593842|NCT00946647|19329102|P3|Phase ll Part|Death|0
5593843|NCT00946647|19329103|P2|Phase ll Part|Death|0
5593844|NCT00946647|19329104|P1|Phase ll Part|Death|0
5593845|NCT00946647|19329100|P5|Phase ll Part|Administrative problems|8
5593846|NCT00946647|19329101|P4|Phase ll Part|Administrative problems|3
5593847|NCT00946647|19329102|P3|Phase ll Part|Administrative problems|0
5593848|NCT00946647|19329103|P2|Phase ll Part|Administrative problems|0
5593849|NCT00946647|19329104|P1|Phase ll Part|Administrative problems|0
5593850|NCT00946647|19329100|P5|Phase ll Part|Withdrawal by Subject|6
5593851|NCT00946647|19329101|P4|Phase ll Part|Withdrawal by Subject|8
5593852|NCT00946647|19329102|P3|Phase ll Part|Withdrawal by Subject|0
5593853|NCT00946647|19329103|P2|Phase ll Part|Withdrawal by Subject|0
5593854|NCT00946647|19329104|P1|Phase ll Part|Withdrawal by Subject|0
5593855|NCT00946647|19329100|P5|Phase ll Part|Adverse Event|6
5593856|NCT00946647|19329101|P4|Phase ll Part|Adverse Event|10
5593857|NCT00946647|19329102|P3|Phase ll Part|Adverse Event|0
5593858|NCT00946647|19329103|P2|Phase ll Part|Adverse Event|0
5593859|NCT00946647|19329104|P1|Phase ll Part|Adverse Event|0
5593860|NCT00946647|19329100|P5|Phase ll Part|Untreated|2
5593861|NCT00946647|19329101|P4|Phase ll Part|Untreated|0
5593862|NCT00946647|19329102|P3|Phase ll Part|Untreated|0
5593863|NCT00946647|19329103|P2|Phase ll Part|Untreated|0
5593864|NCT00946647|19329104|P1|Phase ll Part|Untreated|0
5593865|NCT00946647|19329100|P5|Phase 1 Part|Reason missing|0
5593866|NCT00946647|19329101|P4|Phase 1 Part|Reason missing|0
5593867|NCT00946647|19329102|P3|Phase 1 Part|Reason missing|0
5593868|NCT00946647|19329103|P2|Phase 1 Part|Reason missing|1
5593869|NCT00946647|19329104|P1|Phase 1 Part|Reason missing|0
5593870|NCT00946647|19329100|P5|Phase 1 Part|Abnormal values|0
5593871|NCT00946647|19329101|P4|Phase 1 Part|Abnormal values|0
5593872|NCT00946647|19329102|P3|Phase 1 Part|Abnormal values|0
5593873|NCT00946647|19329103|P2|Phase 1 Part|Abnormal values|2
5593874|NCT00946647|19329104|P1|Phase 1 Part|Abnormal values|0
5593875|NCT00946647|19329100|P5|Phase 1 Part|Withdrawal by Subject|0
5593876|NCT00946647|19329101|P4|Phase 1 Part|Withdrawal by Subject|0
5593877|NCT00946647|19329102|P3|Phase 1 Part|Withdrawal by Subject|3
5593878|NCT00946647|19329103|P2|Phase 1 Part|Withdrawal by Subject|4
5593879|NCT00946647|19329104|P1|Phase 1 Part|Withdrawal by Subject|1
5593880|NCT00946647|19329100|P5|Phase 1 Part|Disease progression|0
5593881|NCT00946647|19329101|P4|Phase 1 Part|Disease progression|0
5593882|NCT00946647|19329102|P3|Phase 1 Part|Disease progression|1
5593883|NCT00946647|19329103|P2|Phase 1 Part|Disease progression|6
5593884|NCT00946647|19329104|P1|Phase 1 Part|Disease progression|3
5593885|NCT00946647|19329100|P5|Phase 1 Part|Adverse Event|0
5593886|NCT00946647|19329101|P4|Phase 1 Part|Adverse Event|0
5593887|NCT00946647|19329102|P3|Phase 1 Part|Adverse Event|3
5593888|NCT00946647|19329103|P2|Phase 1 Part|Adverse Event|5
5593889|NCT00946647|19329104|P1|Phase 1 Part|Adverse Event|2
5593890|NCT00946530|19329138|P4|Overall Study|Physician Decision|1
5593891|NCT00946530|19329139|P3|Overall Study|Physician Decision|1
5593892|NCT00946530|19329140|P2|Overall Study|Physician Decision|1
5593893|NCT00946530|19329141|P1|Overall Study|Physician Decision|1
5593894|NCT00946530|19329138|P4|Overall Study|Withdrawal by Subject|3
5593895|NCT00946530|19329139|P3|Overall Study|Withdrawal by Subject|0
5593896|NCT00946530|19329140|P2|Overall Study|Withdrawal by Subject|3
5593897|NCT00946530|19329141|P1|Overall Study|Withdrawal by Subject|0
5593898|NCT00946322|19329173|P1|Post-treatment|participant failure to follow up|2
5593899|NCT00946322|19329173|P1|Pre-treatment|participant failure to follow up|1
5593900|NCT00946309|19329186|P2|Overall Study|Procedure cancelled/discontinued|3
5593901|NCT00946309|19329187|P1|Overall Study|Procedure cancelled/discontinued|0
5593902|NCT00946309|19329186|P2|Overall Study|Lost to Follow-up|1
5593903|NCT00946309|19329187|P1|Overall Study|Lost to Follow-up|0
5593904|NCT00946309|19329186|P2|Overall Study|Protocol Violation|0
5593905|NCT00946309|19329187|P1|Overall Study|Protocol Violation|1
5593906|NCT00946296|19329205|P2|Overall Study|Physician Decision|0
5593907|NCT00946296|19329206|P1|Overall Study|Physician Decision|3
5593908|NCT00946192|19329228|P3|Overall Study|Did not start medication|0
5593909|NCT00946192|19329229|P2|Overall Study|Did not start medication|0
5593910|NCT00946192|19329230|P1|Overall Study|Did not start medication|2
5593911|NCT00946192|19329228|P3|Overall Study|Withdrawal by Subject|3
5593912|NCT00946192|19329229|P2|Overall Study|Withdrawal by Subject|7
5593913|NCT00946192|19329230|P1|Overall Study|Withdrawal by Subject|10
5593914|NCT00946192|19329228|P3|Overall Study|Lost to Follow-up|9
5593915|NCT00946192|19329229|P2|Overall Study|Lost to Follow-up|11
5593916|NCT00946192|19329230|P1|Overall Study|Lost to Follow-up|6
5593917|NCT00946153|19329246|P5|Phase 2|14 days washout for recovery due to AE|4
5593918|NCT00946153|19329247|P4|Phase 2|14 days washout for recovery due to AE|0
5593919|NCT00946153|19329248|P3|Phase 2|14 days washout for recovery due to AE|0
5593920|NCT00946153|19329249|P2|Phase 2|14 days washout for recovery due to AE|0
5593921|NCT00946153|19329250|P1|Phase 2|14 days washout for recovery due to AE|0
5593922|NCT00946153|19329246|P5|Phase 2|Physician Decision|1
5593923|NCT00946153|19329247|P4|Phase 2|Physician Decision|0
5593924|NCT00946153|19329248|P3|Phase 2|Physician Decision|0
5593925|NCT00946153|19329249|P2|Phase 2|Physician Decision|0
5593926|NCT00946153|19329250|P1|Phase 2|Physician Decision|0
5593927|NCT00946153|19329246|P5|Phase 2|Need more reduction of dose|2
5593928|NCT00946153|19329247|P4|Phase 2|Need more reduction of dose|0
5593929|NCT00946153|19329248|P3|Phase 2|Need more reduction of dose|0
5593930|NCT00946153|19329249|P2|Phase 2|Need more reduction of dose|0
5593931|NCT00946153|19329250|P1|Phase 2|Need more reduction of dose|0
5593932|NCT00946153|19329246|P5|Phase 2|Adverse Event|6
5593933|NCT00946153|19329247|P4|Phase 2|Adverse Event|0
5593934|NCT00946153|19329248|P3|Phase 2|Adverse Event|0
5593935|NCT00946153|19329249|P2|Phase 2|Adverse Event|0
5593936|NCT00946153|19329250|P1|Phase 2|Adverse Event|0
5593937|NCT00946114|19329278|P2|Overall Study|Withdrawal by Subject|0
5593938|NCT00946114|19329279|P1|Overall Study|Withdrawal by Subject|2
5593939|NCT00946114|19329278|P2|Overall Study|Other|0
5593940|NCT00946114|19329279|P1|Overall Study|Other|1
5593941|NCT00946114|19329278|P2|Overall Study|Death|2
5593942|NCT00946114|19329279|P1|Overall Study|Death|5
5593943|NCT00946101|19329287|P2|Overall Study|Physician Decision|1
5593944|NCT00946101|19329288|P1|Overall Study|Physician Decision|0
5593945|NCT00946101|19329287|P2|Overall Study|Withdrawal of consent|0
5593946|NCT00946101|19329288|P1|Overall Study|Withdrawal of consent|2
5593947|NCT00946101|19329287|P2|Overall Study|Lost to Follow-up|1
5593948|NCT00946101|19329288|P1|Overall Study|Lost to Follow-up|2
5593949|NCT00946088|19329354|P2|Overall Study|Withdrawal by Subject|1
5593950|NCT00946088|19329355|P1|Overall Study|Withdrawal by Subject|0
5593951|NCT00945945|19329399|P2|Overall Study|Entry Criteria Not Met|1
5593952|NCT00945945|19329400|P1|Overall Study|Entry Criteria Not Met|0
5593953|NCT00945945|19329399|P2|Overall Study|Protocol Violation|2
5593954|NCT00945945|19329400|P1|Overall Study|Protocol Violation|4
5593955|NCT00945945|19329399|P2|Overall Study|Lack of Efficacy|2
5593956|NCT00945945|19329400|P1|Overall Study|Lack of Efficacy|6
5593957|NCT00945945|19329399|P2|Overall Study|Lost to Follow-up|5
5593958|NCT00945945|19329400|P1|Overall Study|Lost to Follow-up|4
5593959|NCT00945945|19329399|P2|Overall Study|Withdrawal by Subject|10
5593960|NCT00945945|19329400|P1|Overall Study|Withdrawal by Subject|7
5593961|NCT00945945|19329399|P2|Overall Study|Adverse Event|35
5593962|NCT00945945|19329400|P1|Overall Study|Adverse Event|15
5593963|NCT00945906|19329426|P1|Overall Study|Moved to another country|2
5593964|NCT00945906|19329426|P1|Overall Study|Unable to return for last visit|2
5593965|NCT00945906|19329426|P1|Overall Study|Did not want to return for last visit|2
5593966|NCT00945906|19329426|P1|Overall Study|Withdrawal by Subject|1
5593967|NCT00945893|19329437|P2|Overall Study|Withdrawal of consent|2
5593968|NCT00945893|19329438|P1|Overall Study|Withdrawal of consent|1
5593969|NCT00945893|19329437|P2|Overall Study|Lost to Follow-up|8
5593970|NCT00945893|19329438|P1|Overall Study|Lost to Follow-up|2
5593971|NCT00945815|19329515|P1|Overall Study|Did not begin protocol therapy|1
5593972|NCT00945815|19329515|P1|Overall Study|Ineligible|3
5593973|NCT00945815|19329515|P1|Overall Study|Not protocol specified|1
5593974|NCT00945815|19329515|P1|Overall Study|Death|3
5593975|NCT00945659|19329547|P3|Overall Study|Lost to Follow-up|17
5593976|NCT00945659|19329548|P2|Overall Study|Lost to Follow-up|20
5593977|NCT00945659|19329549|P1|Overall Study|Lost to Follow-up|7
5593978|NCT00945555|19329606|P1|Overall Study|Other|1
5593979|NCT00945555|19329606|P1|Overall Study|Death|18
5593980|NCT00945555|19329606|P1|Overall Study|Participant continued treatment at home|1
5593981|NCT00945555|19329606|P1|Overall Study|Withdrawal by Subject|2
5593982|NCT00945555|19329606|P1|Overall Study|Worsening condition, intensive care unit|1
5593983|NCT00945555|19329606|P1|Overall Study|Referred to another hospital|5
5593984|NCT00945477|19329617|P1|Overall Study|Withdrawal by Subject|1
5593985|NCT00945477|19329617|P1|Overall Study|Lack of Efficacy|2
5593986|NCT00945477|19329617|P1|Overall Study|Adverse Event|3
5593987|NCT00945321|19329633|P6|Period 4|Lost to Follow-up|1
5593988|NCT00945321|19329634|P5|Period 4|Lost to Follow-up|0
5593989|NCT00945321|19329635|P4|Period 4|Lost to Follow-up|0
5593990|NCT00945321|19329636|P3|Period 4|Lost to Follow-up|0
5593991|NCT00945321|19329637|P2|Period 4|Lost to Follow-up|0
5593992|NCT00945321|19329638|P1|Period 4|Lost to Follow-up|0
5593993|NCT00945321|19329633|P6|Period 1|Adverse Event|0
5593994|NCT00945321|19329634|P5|Period 1|Adverse Event|1
5593995|NCT00945321|19329635|P4|Period 1|Adverse Event|0
5593996|NCT00945321|19329636|P3|Period 1|Adverse Event|0
5593997|NCT00945321|19329637|P2|Period 1|Adverse Event|0
5593998|NCT00945321|19329638|P1|Period 1|Adverse Event|0
5593999|NCT00945243|19329771|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
5594000|NCT00945191|19329777|P1|Overall Study|Investigator's discretion|1
5594001|NCT00945191|19329777|P1|Overall Study|Serious adverse event or adverse event|1
5594002|NCT00945191|19329777|P1|Overall Study|Disease progression|3
5594003|NCT00945191|19329777|P1|Overall Study|Participant relocated to another state|1
5594004|NCT00945191|19329777|P1|Overall Study|Did not achieve a complete response|18
5594005|NCT00945009|19329973|P3|Overall Study|Refusal of further protocol|0
5594006|NCT00945009|19329974|P2|Overall Study|Refusal of further protocol|0
5594007|NCT00945009|19329975|P1|Overall Study|Refusal of further protocol|1
5594008|NCT00945009|19329973|P3|Overall Study|Inevaluable|0
5594009|NCT00945009|19329974|P2|Overall Study|Inevaluable|1
5594010|NCT00945009|19329975|P1|Overall Study|Inevaluable|0
5594011|NCT00945009|19329973|P3|Overall Study|Ineligible|0
5594012|NCT00945009|19329974|P2|Overall Study|Ineligible|1
5594013|NCT00945009|19329975|P1|Overall Study|Ineligible|6
5594014|NCT00945009|19329973|P3|Overall Study|Withdrawal by Subject|0
5594015|NCT00945009|19329974|P2|Overall Study|Withdrawal by Subject|0
5594016|NCT00945009|19329975|P1|Overall Study|Withdrawal by Subject|1
5594017|NCT00945009|19329973|P3|Overall Study|Protocol Violation|0
5594018|NCT00945009|19329974|P2|Overall Study|Protocol Violation|1
5594019|NCT00945009|19329975|P1|Overall Study|Protocol Violation|6
5594020|NCT00945009|19329973|P3|Overall Study|Physician Decision|3
5594021|NCT00945009|19329974|P2|Overall Study|Physician Decision|4
5594022|NCT00945009|19329975|P1|Overall Study|Physician Decision|21
5594023|NCT00945009|19329973|P3|Overall Study|Lack of Efficacy|0
5594024|NCT00945009|19329974|P2|Overall Study|Lack of Efficacy|0
5594025|NCT00945009|19329975|P1|Overall Study|Lack of Efficacy|10
5594026|NCT00944697|19330051|P2|Overall Study|Administrative|1
5594027|NCT00944697|19330052|P1|Overall Study|Administrative|1
5594028|NCT00944697|19330051|P2|Overall Study|Adverse Event|3
5594029|NCT00944697|19330052|P1|Overall Study|Adverse Event|0
5594030|NCT00944697|19330051|P2|Overall Study|Withdrawal by Subject|1
5594031|NCT00944697|19330052|P1|Overall Study|Withdrawal by Subject|1
5594032|NCT00944658|19330084|P2|Treatment 12 Weeks|Adverse Event|2
5594033|NCT00944658|19330085|P1|Treatment 12 Weeks|Adverse Event|0
5594034|NCT00944645|19330097|P2|Period 2|Withdrawal by Subject|6
5594035|NCT00944645|19330098|P1|Period 2|Withdrawal by Subject|7
5594036|NCT00944645|19330097|P2|Period 2|Lost to Follow-up|3
5594037|NCT00944645|19330098|P1|Period 2|Lost to Follow-up|0
5594038|NCT00944645|19330097|P2|Period 2|Adverse Event|0
5594039|NCT00944645|19330098|P1|Period 2|Adverse Event|1
5594040|NCT00944229|19330145|P1|Overall Study|Physician Decision|14
5594041|NCT00944229|19330145|P1|Overall Study|Withdrawal by Subject|11
5594042|NCT00944125|19330151|P2|6 Months to Study Completion|Withdrawal by Subject|2
5594043|NCT00944125|19330152|P1|6 Months to Study Completion|Withdrawal by Subject|0
5594044|NCT00944125|19330151|P2|3 to 6 Months|Withdrawal by Subject|2
5594045|NCT00944125|19330152|P1|3 to 6 Months|Withdrawal by Subject|0
5594046|NCT00944034|19330255|P12|Overall Study|Administrative reason|0
5594047|NCT00944034|19330256|P11|Overall Study|Administrative reason|0
5594048|NCT00944034|19330257|P10|Overall Study|Administrative reason|0
5594049|NCT00944034|19330258|P9|Overall Study|Administrative reason|0
5594050|NCT00944034|19330259|P8|Overall Study|Administrative reason|0
5594051|NCT00944034|19330260|P7|Overall Study|Administrative reason|1
5594052|NCT00944034|19330261|P6|Overall Study|Administrative reason|0
5594053|NCT00944034|19330262|P5|Overall Study|Administrative reason|0
5594054|NCT00944034|19330263|P4|Overall Study|Administrative reason|0
5594055|NCT00944034|19330264|P3|Overall Study|Administrative reason|0
5594056|NCT00944034|19330265|P2|Overall Study|Administrative reason|0
5594057|NCT00944034|19330266|P1|Overall Study|Administrative reason|0
5594058|NCT00944034|19330255|P12|Overall Study|Unable to classify|0
5594059|NCT00944034|19330256|P11|Overall Study|Unable to classify|0
5594060|NCT00944034|19330257|P10|Overall Study|Unable to classify|0
5594061|NCT00944034|19330258|P9|Overall Study|Unable to classify|0
5594062|NCT00944034|19330259|P8|Overall Study|Unable to classify|1
5594063|NCT00944034|19330260|P7|Overall Study|Unable to classify|1
5594064|NCT00944034|19330261|P6|Overall Study|Unable to classify|1
5594065|NCT00944034|19330262|P5|Overall Study|Unable to classify|0
5594066|NCT00944034|19330263|P4|Overall Study|Unable to classify|0
5594067|NCT00944034|19330264|P3|Overall Study|Unable to classify|0
5594068|NCT00944034|19330265|P2|Overall Study|Unable to classify|0
5594069|NCT00944034|19330266|P1|Overall Study|Unable to classify|0
5594070|NCT00944034|19330255|P12|Overall Study|Protocol Violation|0
5594071|NCT00944034|19330256|P11|Overall Study|Protocol Violation|0
5594072|NCT00944034|19330257|P10|Overall Study|Protocol Violation|4
5594073|NCT00944034|19330258|P9|Overall Study|Protocol Violation|1
5594074|NCT00944034|19330259|P8|Overall Study|Protocol Violation|1
5594075|NCT00944034|19330260|P7|Overall Study|Protocol Violation|0
5594076|NCT00944034|19330261|P6|Overall Study|Protocol Violation|3
5594077|NCT00944034|19330262|P5|Overall Study|Protocol Violation|2
5594078|NCT00944034|19330263|P4|Overall Study|Protocol Violation|1
5594079|NCT00944034|19330264|P3|Overall Study|Protocol Violation|0
5594080|NCT00944034|19330265|P2|Overall Study|Protocol Violation|0
5594081|NCT00944034|19330266|P1|Overall Study|Protocol Violation|2
5594082|NCT00944034|19330255|P12|Overall Study|Death|0
5594083|NCT00944034|19330256|P11|Overall Study|Death|0
5594084|NCT00944034|19330257|P10|Overall Study|Death|0
5594085|NCT00944034|19330258|P9|Overall Study|Death|0
5594086|NCT00944034|19330259|P8|Overall Study|Death|0
5594087|NCT00944034|19330260|P7|Overall Study|Death|0
5594088|NCT00944034|19330261|P6|Overall Study|Death|0
5594089|NCT00944034|19330262|P5|Overall Study|Death|0
5594090|NCT00944034|19330263|P4|Overall Study|Death|0
5594091|NCT00944034|19330264|P3|Overall Study|Death|1
5594092|NCT00944034|19330265|P2|Overall Study|Death|0
5594093|NCT00944034|19330266|P1|Overall Study|Death|0
5594094|NCT00944034|19330255|P12|Overall Study|Lost to Follow-up|0
5594095|NCT00944034|19330256|P11|Overall Study|Lost to Follow-up|1
5594096|NCT00944034|19330257|P10|Overall Study|Lost to Follow-up|1
5594097|NCT00944034|19330258|P9|Overall Study|Lost to Follow-up|5
5594098|NCT00944034|19330259|P8|Overall Study|Lost to Follow-up|1
5594099|NCT00944034|19330260|P7|Overall Study|Lost to Follow-up|0
5594100|NCT00944034|19330261|P6|Overall Study|Lost to Follow-up|7
5594101|NCT00944034|19330262|P5|Overall Study|Lost to Follow-up|5
5594102|NCT00944034|19330263|P4|Overall Study|Lost to Follow-up|0
5594103|NCT00944034|19330264|P3|Overall Study|Lost to Follow-up|2
5594104|NCT00944034|19330265|P2|Overall Study|Lost to Follow-up|4
5594105|NCT00944034|19330266|P1|Overall Study|Lost to Follow-up|0
5594106|NCT00944034|19330255|P12|Overall Study|Withdrawal by Subject|4
5594107|NCT00944034|19330256|P11|Overall Study|Withdrawal by Subject|0
5594108|NCT00944034|19330257|P10|Overall Study|Withdrawal by Subject|4
5594109|NCT00944034|19330258|P9|Overall Study|Withdrawal by Subject|3
5594110|NCT00944034|19330259|P8|Overall Study|Withdrawal by Subject|2
5594111|NCT00944034|19330260|P7|Overall Study|Withdrawal by Subject|2
5594112|NCT00944034|19330261|P6|Overall Study|Withdrawal by Subject|8
5594113|NCT00944034|19330262|P5|Overall Study|Withdrawal by Subject|5
5594114|NCT00944034|19330263|P4|Overall Study|Withdrawal by Subject|2
5594115|NCT00944034|19330264|P3|Overall Study|Withdrawal by Subject|6
5594116|NCT00944034|19330265|P2|Overall Study|Withdrawal by Subject|2
5594117|NCT00944034|19330266|P1|Overall Study|Withdrawal by Subject|3
5594118|NCT00944034|19330255|P12|Overall Study|Inappropriate enrollment|0
5594119|NCT00944034|19330256|P11|Overall Study|Inappropriate enrollment|0
5594120|NCT00944034|19330257|P10|Overall Study|Inappropriate enrollment|1
5594121|NCT00944034|19330258|P9|Overall Study|Inappropriate enrollment|1
5594122|NCT00944034|19330259|P8|Overall Study|Inappropriate enrollment|0
5594123|NCT00944034|19330260|P7|Overall Study|Inappropriate enrollment|0
5594124|NCT00944034|19330261|P6|Overall Study|Inappropriate enrollment|1
5594125|NCT00944034|19330262|P5|Overall Study|Inappropriate enrollment|2
5594126|NCT00944034|19330263|P4|Overall Study|Inappropriate enrollment|1
5594127|NCT00944034|19330264|P3|Overall Study|Inappropriate enrollment|0
5594128|NCT00944034|19330265|P2|Overall Study|Inappropriate enrollment|1
5594129|NCT00944034|19330266|P1|Overall Study|Inappropriate enrollment|0
5594130|NCT00943917|19330412|P15|Stage II Continuation|A1C elevation|0
5594131|NCT00943917|19330413|P14|Stage II Continuation|A1C elevation|1
5594132|NCT00943917|19330414|P13|Stage II Continuation|A1C elevation|0
5594133|NCT00943917|19330415|P12|Stage II Continuation|A1C elevation|0
5594134|NCT00943917|19330416|P11|Stage II Continuation|A1C elevation|0
5594135|NCT00943917|19330417|P10|Stage II Continuation|A1C elevation|0
5594136|NCT00943917|19330418|P9|Stage II Continuation|A1C elevation|0
5594137|NCT00943917|19330419|P8|Stage II Continuation|A1C elevation|0
5594138|NCT00943917|19330420|P7|Stage II Continuation|A1C elevation|0
5594139|NCT00943917|19330421|P6|Stage II Continuation|A1C elevation|0
5594140|NCT00943917|19330422|P5|Stage II Continuation|A1C elevation|0
5594141|NCT00943917|19330423|P4|Stage II Continuation|A1C elevation|0
5594142|NCT00943917|19330424|P3|Stage II Continuation|A1C elevation|0
5594143|NCT00943917|19330425|P2|Stage II Continuation|A1C elevation|0
5594144|NCT00943917|19330426|P1|Stage II Continuation|A1C elevation|0
5594145|NCT00943917|19330412|P15|Stage II Continuation|hypoglycemia|0
5594146|NCT00943917|19330413|P14|Stage II Continuation|hypoglycemia|0
5594147|NCT00943917|19330414|P13|Stage II Continuation|hypoglycemia|1
5594148|NCT00943917|19330415|P12|Stage II Continuation|hypoglycemia|0
5594149|NCT00943917|19330416|P11|Stage II Continuation|hypoglycemia|0
5594150|NCT00943917|19330417|P10|Stage II Continuation|hypoglycemia|0
5594151|NCT00943917|19330418|P9|Stage II Continuation|hypoglycemia|0
5594152|NCT00943917|19330419|P8|Stage II Continuation|hypoglycemia|0
5594153|NCT00943917|19330420|P7|Stage II Continuation|hypoglycemia|0
5594154|NCT00943917|19330421|P6|Stage II Continuation|hypoglycemia|0
5594155|NCT00943917|19330422|P5|Stage II Continuation|hypoglycemia|0
5594156|NCT00943917|19330423|P4|Stage II Continuation|hypoglycemia|0
5594157|NCT00943917|19330424|P3|Stage II Continuation|hypoglycemia|0
5594158|NCT00943917|19330425|P2|Stage II Continuation|hypoglycemia|0
5594159|NCT00943917|19330426|P1|Stage II Continuation|hypoglycemia|0
5594160|NCT00943917|19330412|P15|Stage II Continuation|Protocol Violation|0
5594161|NCT00943917|19330413|P14|Stage II Continuation|Protocol Violation|0
5594162|NCT00943917|19330414|P13|Stage II Continuation|Protocol Violation|0
5594163|NCT00943917|19330415|P12|Stage II Continuation|Protocol Violation|1
5594164|NCT00943917|19330416|P11|Stage II Continuation|Protocol Violation|0
5594165|NCT00943917|19330417|P10|Stage II Continuation|Protocol Violation|1
5594166|NCT00943917|19330418|P9|Stage II Continuation|Protocol Violation|0
5594167|NCT00943917|19330419|P8|Stage II Continuation|Protocol Violation|0
5594168|NCT00943917|19330420|P7|Stage II Continuation|Protocol Violation|0
5594169|NCT00943917|19330421|P6|Stage II Continuation|Protocol Violation|0
5594170|NCT00943917|19330422|P5|Stage II Continuation|Protocol Violation|0
5594171|NCT00943917|19330423|P4|Stage II Continuation|Protocol Violation|0
5594172|NCT00943917|19330424|P3|Stage II Continuation|Protocol Violation|0
5594173|NCT00943917|19330425|P2|Stage II Continuation|Protocol Violation|0
5594174|NCT00943917|19330426|P1|Stage II Continuation|Protocol Violation|0
5594175|NCT00943917|19330412|P15|Stage II Continuation|Withdrawal by Subject|3
5594176|NCT00943917|19330413|P14|Stage II Continuation|Withdrawal by Subject|1
5594177|NCT00943917|19330414|P13|Stage II Continuation|Withdrawal by Subject|0
5594178|NCT00943917|19330415|P12|Stage II Continuation|Withdrawal by Subject|0
5594179|NCT00943917|19330416|P11|Stage II Continuation|Withdrawal by Subject|0
5594180|NCT00943917|19330417|P10|Stage II Continuation|Withdrawal by Subject|0
5594181|NCT00943917|19330418|P9|Stage II Continuation|Withdrawal by Subject|0
5594182|NCT00943917|19330419|P8|Stage II Continuation|Withdrawal by Subject|0
5594183|NCT00943917|19330420|P7|Stage II Continuation|Withdrawal by Subject|0
5594184|NCT00943917|19330421|P6|Stage II Continuation|Withdrawal by Subject|0
5594185|NCT00943917|19330422|P5|Stage II Continuation|Withdrawal by Subject|0
5594186|NCT00943917|19330423|P4|Stage II Continuation|Withdrawal by Subject|0
5594187|NCT00943917|19330424|P3|Stage II Continuation|Withdrawal by Subject|0
5594188|NCT00943917|19330425|P2|Stage II Continuation|Withdrawal by Subject|0
5594189|NCT00943917|19330426|P1|Stage II Continuation|Withdrawal by Subject|0
5594190|NCT00943917|19330412|P15|Stage II Continuation|Adverse Event|1
5594191|NCT00943917|19330413|P14|Stage II Continuation|Adverse Event|1
5594192|NCT00943917|19330414|P13|Stage II Continuation|Adverse Event|2
5594193|NCT00943917|19330415|P12|Stage II Continuation|Adverse Event|1
5594194|NCT00943917|19330416|P11|Stage II Continuation|Adverse Event|0
5594195|NCT00943917|19330417|P10|Stage II Continuation|Adverse Event|0
5594196|NCT00943917|19330418|P9|Stage II Continuation|Adverse Event|0
5594197|NCT00943917|19330419|P8|Stage II Continuation|Adverse Event|0
5594198|NCT00943917|19330420|P7|Stage II Continuation|Adverse Event|0
5594199|NCT00943917|19330421|P6|Stage II Continuation|Adverse Event|0
5594200|NCT00943917|19330422|P5|Stage II Continuation|Adverse Event|0
5594201|NCT00943917|19330423|P4|Stage II Continuation|Adverse Event|0
5594202|NCT00943917|19330424|P3|Stage II Continuation|Adverse Event|0
5594203|NCT00943917|19330425|P2|Stage II Continuation|Adverse Event|0
5594204|NCT00943917|19330426|P1|Stage II Continuation|Adverse Event|0
5594205|NCT00943917|19330412|P15|Stage II|Pregnancy|0
5594206|NCT00943917|19330413|P14|Stage II|Pregnancy|0
5594207|NCT00943917|19330414|P13|Stage II|Pregnancy|0
5594208|NCT00943917|19330415|P12|Stage II|Pregnancy|0
5594209|NCT00943917|19330416|P11|Stage II|Pregnancy|0
5594210|NCT00943917|19330417|P10|Stage II|Pregnancy|0
5594211|NCT00943917|19330418|P9|Stage II|Pregnancy|0
5594212|NCT00943917|19330419|P8|Stage II|Pregnancy|0
5594213|NCT00943917|19330420|P7|Stage II|Pregnancy|0
5594214|NCT00943917|19330421|P6|Stage II|Pregnancy|1
5594215|NCT00943917|19330422|P5|Stage II|Pregnancy|0
5594216|NCT00943917|19330423|P4|Stage II|Pregnancy|0
5594217|NCT00943917|19330424|P3|Stage II|Pregnancy|0
5594218|NCT00943917|19330425|P2|Stage II|Pregnancy|0
5594219|NCT00943917|19330426|P1|Stage II|Pregnancy|0
5594220|NCT00943917|19330412|P15|Stage II|Withdrawal by Subject|0
5594221|NCT00943917|19330413|P14|Stage II|Withdrawal by Subject|0
5594222|NCT00943917|19330414|P13|Stage II|Withdrawal by Subject|0
5594223|NCT00943917|19330415|P12|Stage II|Withdrawal by Subject|0
5594224|NCT00943917|19330416|P11|Stage II|Withdrawal by Subject|0
5594225|NCT00943917|19330417|P10|Stage II|Withdrawal by Subject|0
5594226|NCT00943917|19330418|P9|Stage II|Withdrawal by Subject|0
5594227|NCT00943917|19330419|P8|Stage II|Withdrawal by Subject|0
5594228|NCT00943917|19330420|P7|Stage II|Withdrawal by Subject|0
5594229|NCT00943917|19330421|P6|Stage II|Withdrawal by Subject|1
5594230|NCT00943917|19330422|P5|Stage II|Withdrawal by Subject|0
5594231|NCT00943917|19330423|P4|Stage II|Withdrawal by Subject|0
5594232|NCT00943917|19330424|P3|Stage II|Withdrawal by Subject|0
5594233|NCT00943917|19330425|P2|Stage II|Withdrawal by Subject|0
5594234|NCT00943917|19330426|P1|Stage II|Withdrawal by Subject|0
5594235|NCT00943917|19330412|P15|Stage II|Adverse Event|0
5594236|NCT00943917|19330413|P14|Stage II|Adverse Event|0
5594237|NCT00943917|19330414|P13|Stage II|Adverse Event|0
5594238|NCT00943917|19330415|P12|Stage II|Adverse Event|0
5594239|NCT00943917|19330416|P11|Stage II|Adverse Event|0
5594240|NCT00943917|19330417|P10|Stage II|Adverse Event|0
5594241|NCT00943917|19330418|P9|Stage II|Adverse Event|1
5594242|NCT00943917|19330419|P8|Stage II|Adverse Event|0
5594243|NCT00943917|19330420|P7|Stage II|Adverse Event|3
5594244|NCT00943917|19330421|P6|Stage II|Adverse Event|1
5594245|NCT00943917|19330422|P5|Stage II|Adverse Event|0
5594246|NCT00943917|19330423|P4|Stage II|Adverse Event|0
5594247|NCT00943917|19330424|P3|Stage II|Adverse Event|0
5594248|NCT00943917|19330425|P2|Stage II|Adverse Event|0
5594249|NCT00943917|19330426|P1|Stage II|Adverse Event|0
5594250|NCT00943917|19330412|P15|Stage I|Withdrawal by Subject|0
5594251|NCT00943917|19330413|P14|Stage I|Withdrawal by Subject|0
5594252|NCT00943917|19330414|P13|Stage I|Withdrawal by Subject|0
5594253|NCT00943917|19330415|P12|Stage I|Withdrawal by Subject|0
5594254|NCT00943917|19330416|P11|Stage I|Withdrawal by Subject|0
5594255|NCT00943917|19330417|P10|Stage I|Withdrawal by Subject|0
5594256|NCT00943917|19330418|P9|Stage I|Withdrawal by Subject|0
5594257|NCT00943917|19330419|P8|Stage I|Withdrawal by Subject|0
5594258|NCT00943917|19330420|P7|Stage I|Withdrawal by Subject|0
5594259|NCT00943917|19330421|P6|Stage I|Withdrawal by Subject|0
5594260|NCT00943917|19330422|P5|Stage I|Withdrawal by Subject|0
5594261|NCT00943917|19330423|P4|Stage I|Withdrawal by Subject|0
5594262|NCT00943917|19330424|P3|Stage I|Withdrawal by Subject|2
5594263|NCT00943917|19330425|P2|Stage I|Withdrawal by Subject|1
5594264|NCT00943917|19330426|P1|Stage I|Withdrawal by Subject|2
5594265|NCT00943917|19330412|P15|Stage I|A1C elevation|0
5594266|NCT00943917|19330413|P14|Stage I|A1C elevation|0
5594267|NCT00943917|19330414|P13|Stage I|A1C elevation|0
5594268|NCT00943917|19330415|P12|Stage I|A1C elevation|0
5594269|NCT00943917|19330416|P11|Stage I|A1C elevation|0
5594270|NCT00943917|19330417|P10|Stage I|A1C elevation|0
5594271|NCT00943917|19330418|P9|Stage I|A1C elevation|0
5594272|NCT00943917|19330419|P8|Stage I|A1C elevation|0
5594273|NCT00943917|19330420|P7|Stage I|A1C elevation|0
5594274|NCT00943917|19330421|P6|Stage I|A1C elevation|0
5594275|NCT00943917|19330422|P5|Stage I|A1C elevation|0
5594276|NCT00943917|19330423|P4|Stage I|A1C elevation|0
5594277|NCT00943917|19330424|P3|Stage I|A1C elevation|0
5594278|NCT00943917|19330425|P2|Stage I|A1C elevation|0
5594279|NCT00943917|19330426|P1|Stage I|A1C elevation|1
5594280|NCT00943917|19330412|P15|Stage I|hyperglycemia|0
5594281|NCT00943917|19330413|P14|Stage I|hyperglycemia|0
5594282|NCT00943917|19330414|P13|Stage I|hyperglycemia|0
5594283|NCT00943917|19330415|P12|Stage I|hyperglycemia|0
5594284|NCT00943917|19330416|P11|Stage I|hyperglycemia|0
5594285|NCT00943917|19330417|P10|Stage I|hyperglycemia|0
5594286|NCT00943917|19330418|P9|Stage I|hyperglycemia|0
5594287|NCT00943917|19330419|P8|Stage I|hyperglycemia|0
5594288|NCT00943917|19330420|P7|Stage I|hyperglycemia|0
5594289|NCT00943917|19330421|P6|Stage I|hyperglycemia|0
5594290|NCT00943917|19330422|P5|Stage I|hyperglycemia|0
5594291|NCT00943917|19330423|P4|Stage I|hyperglycemia|0
5594292|NCT00943917|19330424|P3|Stage I|hyperglycemia|1
5594293|NCT00943917|19330425|P2|Stage I|hyperglycemia|0
5594294|NCT00943917|19330426|P1|Stage I|hyperglycemia|0
5594295|NCT00943917|19330412|P15|Stage I|Lost to Follow-up|0
5594296|NCT00943917|19330413|P14|Stage I|Lost to Follow-up|0
5594297|NCT00943917|19330414|P13|Stage I|Lost to Follow-up|0
5594298|NCT00943917|19330415|P12|Stage I|Lost to Follow-up|0
5594299|NCT00943917|19330416|P11|Stage I|Lost to Follow-up|0
5594300|NCT00943917|19330417|P10|Stage I|Lost to Follow-up|0
5594301|NCT00943917|19330418|P9|Stage I|Lost to Follow-up|0
5594302|NCT00943917|19330419|P8|Stage I|Lost to Follow-up|0
5594303|NCT00943917|19330420|P7|Stage I|Lost to Follow-up|0
5594304|NCT00943917|19330421|P6|Stage I|Lost to Follow-up|0
5594305|NCT00943917|19330422|P5|Stage I|Lost to Follow-up|0
5594306|NCT00943917|19330423|P4|Stage I|Lost to Follow-up|0
5594307|NCT00943917|19330424|P3|Stage I|Lost to Follow-up|1
5594308|NCT00943917|19330425|P2|Stage I|Lost to Follow-up|0
5594309|NCT00943917|19330426|P1|Stage I|Lost to Follow-up|0
5594310|NCT00943917|19330412|P15|Stage I|Adverse Event|0
5594311|NCT00943917|19330413|P14|Stage I|Adverse Event|0
5594312|NCT00943917|19330414|P13|Stage I|Adverse Event|0
5594313|NCT00943917|19330415|P12|Stage I|Adverse Event|0
5594314|NCT00943917|19330416|P11|Stage I|Adverse Event|0
5594315|NCT00943917|19330417|P10|Stage I|Adverse Event|0
5594316|NCT00943917|19330418|P9|Stage I|Adverse Event|0
5594317|NCT00943917|19330419|P8|Stage I|Adverse Event|0
5594318|NCT00943917|19330420|P7|Stage I|Adverse Event|0
5594319|NCT00943917|19330421|P6|Stage I|Adverse Event|0
5594320|NCT00943917|19330422|P5|Stage I|Adverse Event|0
5594321|NCT00943917|19330423|P4|Stage I|Adverse Event|0
5594322|NCT00943917|19330424|P3|Stage I|Adverse Event|2
5594323|NCT00943917|19330425|P2|Stage I|Adverse Event|2
5594324|NCT00943917|19330426|P1|Stage I|Adverse Event|1
5594325|NCT00943852|19330602|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
5594326|NCT00943852|19330603|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
5594327|NCT00943852|19330604|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
5594328|NCT00943852|19330605|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
5594329|NCT00943852|19330606|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
5594330|NCT00943852|19330607|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
5594331|NCT00943852|19330608|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
5594332|NCT00943852|19330609|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
5594333|NCT00943852|19330610|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
5594334|NCT00943852|19330611|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
5594335|NCT00943852|19330602|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5594336|NCT00943852|19330603|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5594337|NCT00943852|19330604|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
5594338|NCT00943852|19330605|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5594339|NCT00943852|19330606|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5594409|NCT00943826|19330624|P2|Concurrent Phase|Withdrew consent|7
5594340|NCT00943852|19330607|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5594341|NCT00943852|19330608|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5594342|NCT00943852|19330609|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5594343|NCT00943852|19330610|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5594344|NCT00943852|19330611|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
5594345|NCT00943852|19330602|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5594346|NCT00943852|19330603|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5594347|NCT00943852|19330604|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5594348|NCT00943852|19330605|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
5594349|NCT00943852|19330606|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5594350|NCT00943852|19330607|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5594351|NCT00943852|19330608|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5594352|NCT00943852|19330609|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5594353|NCT00943852|19330610|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5594354|NCT00943852|19330611|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
5594355|NCT00943852|19330602|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
5594356|NCT00943852|19330603|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
5594357|NCT00943852|19330604|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
5594358|NCT00943852|19330605|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
5594359|NCT00943852|19330606|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
5594360|NCT00943852|19330607|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
5594361|NCT00943852|19330608|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
5594362|NCT00943852|19330609|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
5594363|NCT00943852|19330610|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
5594364|NCT00943852|19330611|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
5594365|NCT00943852|19330602|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5594366|NCT00943852|19330603|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5594367|NCT00943852|19330604|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5594368|NCT00943852|19330605|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5594369|NCT00943852|19330606|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5594370|NCT00943852|19330607|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5594371|NCT00943852|19330608|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
5594372|NCT00943852|19330609|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5594373|NCT00943852|19330610|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5594374|NCT00943852|19330611|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
5594375|NCT00943826|19330624|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
5594376|NCT00943826|19330625|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
5594377|NCT00943826|19330624|P2|After Primary Overall Survival Analysis|Progression of Disease|4
5594378|NCT00943826|19330625|P1|After Primary Overall Survival Analysis|Progression of Disease|2
5594379|NCT00943826|19330624|P2|After Primary Overall Survival Analysis|Administrative reasons|16
5594380|NCT00943826|19330625|P1|After Primary Overall Survival Analysis|Administrative reasons|10
5594381|NCT00943826|19330624|P2|After Primary Overall Survival Analysis|Adverse Event|0
5594382|NCT00943826|19330625|P1|After Primary Overall Survival Analysis|Adverse Event|11
5594383|NCT00943826|19330624|P2|Monotherapy Phase|Failure to return|1
5594384|NCT00943826|19330625|P1|Monotherapy Phase|Failure to return|2
5594385|NCT00943826|19330624|P2|Monotherapy Phase|Withdrew Consent|3
5594386|NCT00943826|19330625|P1|Monotherapy Phase|Withdrew Consent|2
5594387|NCT00943826|19330624|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
5594388|NCT00943826|19330625|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
5594389|NCT00943826|19330624|P2|Monotherapy Phase|Administrative reasons|5
5594390|NCT00943826|19330625|P1|Monotherapy Phase|Administrative reasons|11
5594391|NCT00943826|19330624|P2|Monotherapy Phase|Adverse Event|5
5594392|NCT00943826|19330625|P1|Monotherapy Phase|Adverse Event|42
5594393|NCT00943826|19330624|P2|Maintenance Phase|Failure to return|1
5594394|NCT00943826|19330625|P1|Maintenance Phase|Failure to return|0
5594395|NCT00943826|19330624|P2|Maintenance Phase|Administrative reasons|1
5594396|NCT00943826|19330625|P1|Maintenance Phase|Administrative reasons|4
5594397|NCT00943826|19330624|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
5594398|NCT00943826|19330625|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
5594399|NCT00943826|19330624|P2|Maintenance Phase|Withdrew consent|4
5594400|NCT00943826|19330625|P1|Maintenance Phase|Withdrew consent|2
5594401|NCT00943826|19330624|P2|Maintenance Phase|Adverse Event|30
5594402|NCT00943826|19330625|P1|Maintenance Phase|Adverse Event|31
5594403|NCT00943826|19330624|P2|Concurrent Phase|Protocol Violation|0
5594404|NCT00943826|19330625|P1|Concurrent Phase|Protocol Violation|1
5594405|NCT00943826|19330624|P2|Concurrent Phase|Administrative reasons|1
5594406|NCT00943826|19330625|P1|Concurrent Phase|Administrative reasons|2
5594407|NCT00943826|19330624|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
5594408|NCT00943826|19330625|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
5594410|NCT00943826|19330625|P1|Concurrent Phase|Withdrew consent|3
5594411|NCT00943826|19330624|P2|Concurrent Phase|Adverse Event|27
5594412|NCT00943826|19330625|P1|Concurrent Phase|Adverse Event|50
5594413|NCT00943787|19330649|P1|Overall Study|Withdrawal by Subject|3
5594414|NCT00943787|19330649|P1|Overall Study|Physician Decision|4
5594415|NCT00943761|19330656|P2|Overall Study|Withdrawal by Subject|1
5594416|NCT00943761|19330657|P1|Overall Study|Withdrawal by Subject|2
5594417|NCT00943761|19330656|P2|Overall Study|Lost to Follow-up|0
5594418|NCT00943761|19330657|P1|Overall Study|Lost to Follow-up|2
5594419|NCT00943735|19330669|P1|Overall Study|Other|3
5594420|NCT00943735|19330669|P1|Overall Study|Other|8
5594421|NCT00943735|19330669|P1|Overall Study|Death|1
5594422|NCT00943735|19330669|P1|Overall Study|Withdrawal by Subject|8
5594423|NCT00943735|19330669|P1|Overall Study|Adverse Event|12
5594424|NCT00943722|19330707|P5|Overall Study|Withdrawal by Subject|8
5594425|NCT00943722|19330708|P4|Overall Study|Withdrawal by Subject|13
5594426|NCT00943722|19330709|P3|Overall Study|Withdrawal by Subject|2
5594427|NCT00943722|19330710|P2|Overall Study|Withdrawal by Subject|13
5594428|NCT00943722|19330711|P1|Overall Study|Withdrawal by Subject|12
5594429|NCT00943722|19330707|P5|Overall Study|Protocol Violation|2
5594430|NCT00943722|19330708|P4|Overall Study|Protocol Violation|0
5594431|NCT00943722|19330709|P3|Overall Study|Protocol Violation|0
5594432|NCT00943722|19330710|P2|Overall Study|Protocol Violation|1
5594433|NCT00943722|19330711|P1|Overall Study|Protocol Violation|0
5594434|NCT00943722|19330707|P5|Overall Study|Pregnancy|0
5594435|NCT00943722|19330708|P4|Overall Study|Pregnancy|0
5594436|NCT00943722|19330709|P3|Overall Study|Pregnancy|1
5594437|NCT00943722|19330710|P2|Overall Study|Pregnancy|0
5594438|NCT00943722|19330711|P1|Overall Study|Pregnancy|0
5594439|NCT00943722|19330707|P5|Overall Study|Physician Decision|1
5594440|NCT00943722|19330708|P4|Overall Study|Physician Decision|0
5594441|NCT00943722|19330709|P3|Overall Study|Physician Decision|0
5594442|NCT00943722|19330710|P2|Overall Study|Physician Decision|0
5594443|NCT00943722|19330711|P1|Overall Study|Physician Decision|1
5594444|NCT00943722|19330707|P5|Overall Study|Lost to Follow-up|11
5594445|NCT00943722|19330708|P4|Overall Study|Lost to Follow-up|8
5594446|NCT00943722|19330709|P3|Overall Study|Lost to Follow-up|10
5594447|NCT00943722|19330710|P2|Overall Study|Lost to Follow-up|8
5594448|NCT00943722|19330711|P1|Overall Study|Lost to Follow-up|12
5594449|NCT00943722|19330707|P5|Overall Study|Adverse Event|0
5594450|NCT00943722|19330708|P4|Overall Study|Adverse Event|1
5594451|NCT00943722|19330709|P3|Overall Study|Adverse Event|0
5594452|NCT00943722|19330710|P2|Overall Study|Adverse Event|0
5594453|NCT00943722|19330711|P1|Overall Study|Adverse Event|0
5594454|NCT00943683|19330741|P2|Overall Study|Patient Moved|0
5594455|NCT00943683|19330742|P1|Overall Study|Patient Moved|1
5594456|NCT00943683|19330741|P2|Overall Study|Withdrawal by Subject|0
5594457|NCT00943683|19330742|P1|Overall Study|Withdrawal by Subject|1
5594458|NCT00943683|19330741|P2|Overall Study|Protocol Violation|2
5594459|NCT00943683|19330742|P1|Overall Study|Protocol Violation|1
5594460|NCT00943683|19330741|P2|Overall Study|Lost to Follow-up|1
5594461|NCT00943683|19330742|P1|Overall Study|Lost to Follow-up|1
5594462|NCT00943683|19330741|P2|Overall Study|Adverse Event|3
5594463|NCT00943683|19330742|P1|Overall Study|Adverse Event|3
5594464|NCT00943670|19330748|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
5594465|NCT00943670|19330748|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
5594466|NCT00943670|19330748|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
5594467|NCT00943670|19330748|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
5594468|NCT00943670|19330748|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
5594469|NCT00943670|19330748|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
5594470|NCT00943670|19330748|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
5594471|NCT00943670|19330748|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
5594472|NCT00943670|19330748|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
5594473|NCT00943670|19330748|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
5594474|NCT00943605|19330837|P2|Overall Study|Study termination|30
5594475|NCT00943605|19330838|P1|Overall Study|Study termination|30
5594476|NCT00943592|19330848|P1|Overall Study|Death|3
5594477|NCT00943579|19330861|P2|Overall Study|Lack of Efficacy|2
5594478|NCT00943579|19330862|P1|Overall Study|Lack of Efficacy|2
5594479|NCT00943579|19330861|P2|Overall Study|Adverse Event|3
5594480|NCT00943579|19330862|P1|Overall Study|Adverse Event|4
5594481|NCT00943397|19330963|P2|Overall Study|Site terminated and other|56
5594482|NCT00943397|19330964|P1|Overall Study|Site terminated and other|12
5594483|NCT00943397|19330963|P2|Overall Study|Withdrawal by Subject|1
5594484|NCT00943397|19330964|P1|Overall Study|Withdrawal by Subject|1
5594485|NCT00943397|19330963|P2|Overall Study|Protocol Violation|5
5594486|NCT00943397|19330964|P1|Overall Study|Protocol Violation|2
5594487|NCT00943397|19330963|P2|Overall Study|Lost to Follow-up|4
5594488|NCT00943397|19330964|P1|Overall Study|Lost to Follow-up|0
5594489|NCT00943397|19330963|P2|Overall Study|Adverse Event|6
5594490|NCT00943397|19330964|P1|Overall Study|Adverse Event|0
5594491|NCT00943384|19330970|P1|Overall Study|Withdrawal by Subject|5
5594492|NCT00943384|19330970|P1|Overall Study|Lost to Follow-up|16
5594493|NCT00943384|19330970|P1|Overall Study|Treated off protocol-protocol violation|5
5594494|NCT00943384|19330970|P1|Overall Study|Dispositioned prior to treatment|23
5594495|NCT00943319|19330984|P1|Overall Study|Death|1
5594496|NCT00943306|19330990|P1|Overall Study|Sponsor decision due to non-compliance|1
5594497|NCT00943306|19330990|P1|Overall Study|Death|1
5594498|NCT00943306|19330990|P1|Overall Study|Physician Decision|1
5594499|NCT00943124|19331292|P2|Period 1|Personal Reasons|1
5594500|NCT00943124|19331293|P1|Period 1|Personal Reasons|0
5594501|NCT00943124|19331292|P2|Period 1|Did Not Follow Study Procedures|0
5594502|NCT00943124|19331293|P1|Period 1|Did Not Follow Study Procedures|1
5594503|NCT00943124|19331292|P2|Period 1|Withdrawal by Subject|1
5594504|NCT00943124|19331293|P1|Period 1|Withdrawal by Subject|1
5594505|NCT00943111|19331315|P3|5 Years Long-term Treatment Period|Other than specified above|2
5594506|NCT00943111|19331316|P2|5 Years Long-term Treatment Period|Other than specified above|0
5594507|NCT00943111|19331317|P1|5 Years Long-term Treatment Period|Other than specified above|0
5594508|NCT00943111|19331315|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
5594509|NCT00943111|19331316|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
5594510|NCT00943111|19331317|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
5594511|NCT00943111|19331315|P3|5 Years Long-term Treatment Period|Pregnancy|4
5594512|NCT00943111|19331316|P2|5 Years Long-term Treatment Period|Pregnancy|0
5594513|NCT00943111|19331317|P1|5 Years Long-term Treatment Period|Pregnancy|0
5594514|NCT00943111|19331315|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
5594515|NCT00943111|19331316|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
5594516|NCT00943111|19331317|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
5594517|NCT00943111|19331315|P3|5 Years Long-term Treatment Period|Adverse Event|9
5594518|NCT00943111|19331316|P2|5 Years Long-term Treatment Period|Adverse Event|0
5594519|NCT00943111|19331317|P1|5 Years Long-term Treatment Period|Adverse Event|0
5594520|NCT00943111|19331315|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
5594521|NCT00943111|19331316|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
5594522|NCT00943111|19331317|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
5594523|NCT00943111|19331315|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
5594524|NCT00943111|19331316|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
5594525|NCT00943111|19331317|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
5594526|NCT00943111|19331315|P3|52-Weeks Primary Analysis Period|Adverse Event|0
5594527|NCT00943111|19331316|P2|52-Weeks Primary Analysis Period|Adverse Event|1
5594528|NCT00943111|19331317|P1|52-Weeks Primary Analysis Period|Adverse Event|2
5594529|NCT00943072|19331385|P2|Overall Study|Other|1
5594530|NCT00943072|19331386|P1|Overall Study|Other|1
5594531|NCT00943072|19331385|P2|Overall Study|Lack of Efficacy|4
5594532|NCT00943072|19331386|P1|Overall Study|Lack of Efficacy|0
5594533|NCT00943072|19331385|P2|Overall Study|Lost to Follow-up|2
5594534|NCT00943072|19331386|P1|Overall Study|Lost to Follow-up|1
5594535|NCT00943072|19331385|P2|Overall Study|Protocol Violation|1
5594536|NCT00943072|19331386|P1|Overall Study|Protocol Violation|0
5594537|NCT00943072|19331385|P2|Overall Study|Withdrawal by Subject|1
5594538|NCT00943072|19331386|P1|Overall Study|Withdrawal by Subject|3
5594539|NCT00943072|19331385|P2|Overall Study|Death|2
5594540|NCT00943072|19331386|P1|Overall Study|Death|0
5594541|NCT00943072|19331385|P2|Overall Study|Adverse Event|3
5594542|NCT00943072|19331386|P1|Overall Study|Adverse Event|0
5594543|NCT00942994|19331404|P2|Overall Study|Protocol deviation|2
5594544|NCT00942994|19331405|P1|Overall Study|Protocol deviation|1
5594545|NCT00942994|19331404|P2|Overall Study|Lost to Follow-up|4
5594546|NCT00942994|19331405|P1|Overall Study|Lost to Follow-up|1
5594547|NCT00942994|19331404|P2|Overall Study|Patient withdrew consent|8
5594548|NCT00942994|19331405|P1|Overall Study|Patient withdrew consent|5
5594549|NCT00942994|19331404|P2|Overall Study|Unsatisfactory therapeutic effect|1
5594550|NCT00942994|19331405|P1|Overall Study|Unsatisfactory therapeutic effect|1
5594551|NCT00942994|19331404|P2|Overall Study|Abnormal laboratory value(s)|0
5594552|NCT00942994|19331405|P1|Overall Study|Abnormal laboratory value(s)|1
5594553|NCT00942994|19331404|P2|Overall Study|Adverse Event|4
5594554|NCT00942994|19331405|P1|Overall Study|Adverse Event|7
5594555|NCT00942968|19331421|P1|Overall Study|Deep vein thrombosis (DVT)|2
5594556|NCT00942968|19331421|P1|Overall Study|Participant required pancreatic biopsy|1
5594557|NCT00942968|19331421|P1|Overall Study|Pulmonary embolism (PE)|1
5594558|NCT00942968|19331421|P1|Overall Study|Inferior vena cava filter placement|4
5594559|NCT00942968|19331421|P1|Overall Study|Progression of disease|12
5594560|NCT00942968|19331421|P1|Overall Study|Physician Decision|11
5594561|NCT00942968|19331421|P1|Overall Study|Sponsor request|5
5594562|NCT00942968|19331421|P1|Overall Study|Withdrawal by Subject|44
5594563|NCT00942968|19331421|P1|Overall Study|Lost to Follow-up|4
5594564|NCT00942968|19331421|P1|Overall Study|Protocol Violation|9
5594565|NCT00942968|19331421|P1|Overall Study|Death|76
5594566|NCT00942968|19331421|P1|Overall Study|Adverse Event|60
5594567|NCT00942734|19331499|P1|Overall Study|Physician Decision|1
5594568|NCT00942734|19331499|P1|Overall Study|Disease Progression|2
5594569|NCT00942734|19331499|P1|Overall Study|Protocol Violation|3
5594570|NCT00942734|19331499|P1|Overall Study|Adverse Event|2
5594571|NCT00942708|19331503|P1|Overall Study|Withdrawal by Subject|1
5594572|NCT00942604|19331511|P2|Overall Study|Patient relocation|1
5594573|NCT00942604|19331512|P1|Overall Study|Patient relocation|1
5594574|NCT00942604|19331511|P2|Overall Study|Withdrawal by Subject|1
5594575|NCT00942604|19331512|P1|Overall Study|Withdrawal by Subject|0
5594576|NCT00942604|19331511|P2|Overall Study|Adverse Event|1
5594577|NCT00942604|19331512|P1|Overall Study|Adverse Event|0
5594578|NCT00942604|19331511|P2|Overall Study|Protocol Violation|1
5594579|NCT00942604|19331512|P1|Overall Study|Protocol Violation|1
5594580|NCT00942422|19331620|P1|Overall Study|Progressive diease|1
5594581|NCT00942422|19331620|P1|Overall Study|Death|1
5594582|NCT00942422|19331620|P1|Overall Study|Withdrawal by Subject|1
5594583|NCT00942409|19331624|P1|Overall Study|study drug unavailable|2
5594584|NCT00942409|19331624|P1|Overall Study|Lack of Efficacy|1
5594585|NCT00942357|19331630|P2|Overall Study|Ineligible|40
5594586|NCT00942357|19331631|P1|Overall Study|Ineligible|37
5594587|NCT00942331|19331647|P2|Overall Study|Did not start treatment|22
5594588|NCT00942331|19331648|P1|Overall Study|Did not start treatment|15
5594589|NCT00942266|19331660|P2|Overall Study|medical deterioration (pneumonia)|1
5594590|NCT00942266|19331661|P1|Overall Study|medical deterioration (pneumonia)|0
5594591|NCT00942266|19331660|P2|Overall Study|Physician Decision|0
5594592|NCT00942266|19331661|P1|Overall Study|Physician Decision|2
5594593|NCT00942266|19331660|P2|Overall Study|Intercurrent illness|1
5594594|NCT00942266|19331661|P1|Overall Study|Intercurrent illness|0
5594595|NCT00942266|19331660|P2|Overall Study|Failure to thrive and pt withdrawal|1
5594596|NCT00942266|19331661|P1|Overall Study|Failure to thrive and pt withdrawal|0
5594597|NCT00942266|19331660|P2|Overall Study|Disease Progression|11
5594598|NCT00942266|19331661|P1|Overall Study|Disease Progression|38
5594599|NCT00942266|19331660|P2|Overall Study|Adverse Event|1
5594600|NCT00942266|19331661|P1|Overall Study|Adverse Event|2
5594601|NCT00942266|19331660|P2|Overall Study|Withdrawal by Subject|0
5594602|NCT00942266|19331661|P1|Overall Study|Withdrawal by Subject|1
5594603|NCT00942188|19331683|P4|Overall Study|Sponsor Decision|1
5594604|NCT00942188|19331684|P3|Overall Study|Sponsor Decision|0
5594605|NCT00942188|19331685|P2|Overall Study|Sponsor Decision|2
5594606|NCT00942188|19331686|P1|Overall Study|Sponsor Decision|0
5594607|NCT00942188|19331683|P4|Overall Study|Physician Decision|0
5594608|NCT00942188|19331684|P3|Overall Study|Physician Decision|1
5594609|NCT00942188|19331685|P2|Overall Study|Physician Decision|0
5594610|NCT00942188|19331686|P1|Overall Study|Physician Decision|0
5594611|NCT00942188|19331683|P4|Overall Study|Withdrawal by Subject|2
5594612|NCT00942188|19331684|P3|Overall Study|Withdrawal by Subject|4
5594613|NCT00942188|19331685|P2|Overall Study|Withdrawal by Subject|3
5594614|NCT00942188|19331686|P1|Overall Study|Withdrawal by Subject|1
5594615|NCT00942188|19331683|P4|Overall Study|Lost to Follow-up|0
5594616|NCT00942188|19331684|P3|Overall Study|Lost to Follow-up|2
5594617|NCT00942188|19331685|P2|Overall Study|Lost to Follow-up|1
5594618|NCT00942188|19331686|P1|Overall Study|Lost to Follow-up|2
5594619|NCT00942188|19331683|P4|Overall Study|Protocol Violation|0
5594620|NCT00942188|19331684|P3|Overall Study|Protocol Violation|0
5594621|NCT00942188|19331685|P2|Overall Study|Protocol Violation|1
5594622|NCT00942188|19331686|P1|Overall Study|Protocol Violation|1
5594623|NCT00942188|19331683|P4|Overall Study|Lack of Efficacy|1
5594624|NCT00942188|19331684|P3|Overall Study|Lack of Efficacy|0
5594625|NCT00942188|19331685|P2|Overall Study|Lack of Efficacy|0
5594626|NCT00942188|19331686|P1|Overall Study|Lack of Efficacy|0
5594627|NCT00942188|19331683|P4|Overall Study|Adverse Event|0
5594628|NCT00942188|19331684|P3|Overall Study|Adverse Event|2
5594629|NCT00942188|19331685|P2|Overall Study|Adverse Event|3
5594630|NCT00942188|19331686|P1|Overall Study|Adverse Event|0
5594631|NCT00942175|19331725|P4|Overall Study|Low Platelet Count|0
5594632|NCT00942175|19331726|P3|Overall Study|Low Platelet Count|0
5594633|NCT00942175|19331727|P2|Overall Study|Low Platelet Count|2
5594634|NCT00942175|19331728|P1|Overall Study|Low Platelet Count|0
5594635|NCT00942175|19331725|P4|Overall Study|Elevated Alanine Amino Transferase|1
5594636|NCT00942175|19331726|P3|Overall Study|Elevated Alanine Amino Transferase|0
5594637|NCT00942175|19331727|P2|Overall Study|Elevated Alanine Amino Transferase|0
5594638|NCT00942175|19331728|P1|Overall Study|Elevated Alanine Amino Transferase|0
5594639|NCT00942175|19331725|P4|Overall Study|Pregnancy|1
5594640|NCT00942175|19331726|P3|Overall Study|Pregnancy|0
5594641|NCT00942175|19331727|P2|Overall Study|Pregnancy|0
5594642|NCT00942175|19331728|P1|Overall Study|Pregnancy|0
5594643|NCT00942175|19331725|P4|Overall Study|Protocol Violation|0
5594644|NCT00942175|19331726|P3|Overall Study|Protocol Violation|2
5594645|NCT00942175|19331727|P2|Overall Study|Protocol Violation|1
5594646|NCT00942175|19331728|P1|Overall Study|Protocol Violation|0
5594647|NCT00942175|19331725|P4|Overall Study|Adverse Event|0
5594648|NCT00942175|19331726|P3|Overall Study|Adverse Event|0
5594649|NCT00942175|19331727|P2|Overall Study|Adverse Event|1
5594650|NCT00942175|19331728|P1|Overall Study|Adverse Event|2
5594651|NCT00942162|19331781|P3|Overall Study|Other|2
5594652|NCT00942162|19331782|P2|Overall Study|Other|13
5594653|NCT00942162|19331783|P1|Overall Study|Other|14
5594654|NCT00942162|19331781|P3|Overall Study|Lost to Follow-up|0
5594655|NCT00942162|19331782|P2|Overall Study|Lost to Follow-up|0
5594656|NCT00942162|19331783|P1|Overall Study|Lost to Follow-up|4
5594657|NCT00942162|19331781|P3|Overall Study|Withdrawal by Subject|0
5594658|NCT00942162|19331782|P2|Overall Study|Withdrawal by Subject|2
5594659|NCT00942162|19331783|P1|Overall Study|Withdrawal by Subject|7
5594660|NCT00942162|19331781|P3|Overall Study|Death|0
5594661|NCT00942162|19331782|P2|Overall Study|Death|35
5594662|NCT00942162|19331783|P1|Overall Study|Death|45
5594663|NCT00942084|19331854|P1|Overall Study|Death|2
5594664|NCT00941928|19331871|P1|Overall Study|Disease Progression|1
5594665|NCT00941928|19331871|P1|Overall Study|Withdrawal by Subject|1
5594666|NCT00941863|19331889|P5|Continued After PCD|Disease progression, recurrence, relapse|18
5594667|NCT00941863|19331890|P4|Continued After PCD|Disease progression, recurrence, relapse|0
5594668|NCT00941863|19331891|P3|Continued After PCD|Disease progression, recurrence, relapse|0
5594836|NCT00941031|19332193|P6|Induction Period|Adminstative Problems|0
5594669|NCT00941863|19331892|P2|Continued After PCD|Disease progression, recurrence, relapse|0
5594670|NCT00941863|19331893|P1|Continued After PCD|Disease progression, recurrence, relapse|0
5594671|NCT00941863|19331889|P5|Continued After PCD|Withdrawal by Subject|1
5594672|NCT00941863|19331890|P4|Continued After PCD|Withdrawal by Subject|0
5594673|NCT00941863|19331891|P3|Continued After PCD|Withdrawal by Subject|0
5594674|NCT00941863|19331892|P2|Continued After PCD|Withdrawal by Subject|0
5594675|NCT00941863|19331893|P1|Continued After PCD|Withdrawal by Subject|0
5594676|NCT00941863|19331889|P5|Until Primary Completion Date (PCD)|Disease progression|73
5594677|NCT00941863|19331890|P4|Until Primary Completion Date (PCD)|Disease progression|14
5594678|NCT00941863|19331891|P3|Until Primary Completion Date (PCD)|Disease progression|8
5594679|NCT00941863|19331892|P2|Until Primary Completion Date (PCD)|Disease progression|1
5594680|NCT00941863|19331893|P1|Until Primary Completion Date (PCD)|Disease progression|6
5594681|NCT00941863|19331889|P5|Until Primary Completion Date (PCD)|Death|7
5594682|NCT00941863|19331890|P4|Until Primary Completion Date (PCD)|Death|2
5594683|NCT00941863|19331891|P3|Until Primary Completion Date (PCD)|Death|1
5594684|NCT00941863|19331892|P2|Until Primary Completion Date (PCD)|Death|0
5594685|NCT00941863|19331893|P1|Until Primary Completion Date (PCD)|Death|0
5594686|NCT00941863|19331889|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
5594687|NCT00941863|19331890|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
5594688|NCT00941863|19331891|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
5594689|NCT00941863|19331892|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
5594690|NCT00941863|19331893|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
5594691|NCT00941863|19331889|P5|Until Primary Completion Date (PCD)|Physician Decision|1
5594692|NCT00941863|19331890|P4|Until Primary Completion Date (PCD)|Physician Decision|0
5594693|NCT00941863|19331891|P3|Until Primary Completion Date (PCD)|Physician Decision|0
5594694|NCT00941863|19331892|P2|Until Primary Completion Date (PCD)|Physician Decision|0
5594695|NCT00941863|19331893|P1|Until Primary Completion Date (PCD)|Physician Decision|0
5594696|NCT00941863|19331889|P5|Until Primary Completion Date (PCD)|Adverse Event|5
5594697|NCT00941863|19331890|P4|Until Primary Completion Date (PCD)|Adverse Event|1
5594698|NCT00941863|19331891|P3|Until Primary Completion Date (PCD)|Adverse Event|2
5594699|NCT00941863|19331892|P2|Until Primary Completion Date (PCD)|Adverse Event|2
5594700|NCT00941863|19331893|P1|Until Primary Completion Date (PCD)|Adverse Event|1
5594701|NCT00941798|19331920|P2|Overall Study|Death|1
5594702|NCT00941798|19331921|P1|Overall Study|Death|0
5594703|NCT00941798|19331920|P2|Overall Study|Abnormal laboratory values|2
5594704|NCT00941798|19331921|P1|Overall Study|Abnormal laboratory values|1
5594705|NCT00941798|19331920|P2|Overall Study|Abnormal test procedure results|1
5594706|NCT00941798|19331921|P1|Overall Study|Abnormal test procedure results|3
5594707|NCT00941798|19331920|P2|Overall Study|Patient's inability to use device|1
5594708|NCT00941798|19331921|P1|Overall Study|Patient's inability to use device|6
5594709|NCT00941798|19331920|P2|Overall Study|Lack of Efficacy|17
5594710|NCT00941798|19331921|P1|Overall Study|Lack of Efficacy|10
5594711|NCT00941798|19331920|P2|Overall Study|Administrative problems|23
5594712|NCT00941798|19331921|P1|Overall Study|Administrative problems|13
5594713|NCT00941798|19331920|P2|Overall Study|Protocol Violation|20
5594714|NCT00941798|19331921|P1|Overall Study|Protocol Violation|17
5594715|NCT00941798|19331920|P2|Overall Study|Lost to Follow-up|23
5594716|NCT00941798|19331921|P1|Overall Study|Lost to Follow-up|29
5594717|NCT00941798|19331920|P2|Overall Study|Adverse Event|23
5594718|NCT00941798|19331921|P1|Overall Study|Adverse Event|43
5594719|NCT00941798|19331920|P2|Overall Study|Withdrawal by Subject|74
5594720|NCT00941798|19331921|P1|Overall Study|Withdrawal by Subject|72
5594721|NCT00941733|19331951|P2|Overall Study|Protocol Violation|6
5594722|NCT00941733|19331952|P1|Overall Study|Protocol Violation|15
5594723|NCT00941733|19331951|P2|Overall Study|Lost to Follow-up|2
5594724|NCT00941733|19331952|P1|Overall Study|Lost to Follow-up|1
5594725|NCT00941733|19331951|P2|Overall Study|Adverse Event|4
5594726|NCT00941733|19331952|P1|Overall Study|Adverse Event|20
5594727|NCT00941733|19331951|P2|Overall Study|Withdrawal by Subject|6
5594728|NCT00941733|19331952|P1|Overall Study|Withdrawal by Subject|14
5594729|NCT00941733|19331951|P2|Overall Study|Death|10
5594730|NCT00941733|19331952|P1|Overall Study|Death|24
5594731|NCT00941720|19331992|P1|Overall Study|ineligible|2
5594732|NCT00941720|19331992|P1|Overall Study|Insurance denied participation|11
5594733|NCT00941720|19331992|P1|Overall Study|Withdrawal by Subject|1
5594734|NCT00941655|19332039|P2|Overall Study|non-compliant|1
5594735|NCT00941655|19332040|P1|Overall Study|non-compliant|0
5594736|NCT00941655|19332039|P2|Overall Study|withdrew consent|1
5594737|NCT00941655|19332040|P1|Overall Study|withdrew consent|0
5594738|NCT00941655|19332039|P2|Overall Study|refused further treatment|1
5594739|NCT00941655|19332040|P1|Overall Study|refused further treatment|0
5594740|NCT00941655|19332039|P2|Overall Study|progressed while on chemo|2
5594741|NCT00941655|19332040|P1|Overall Study|progressed while on chemo|0
5594742|NCT00941655|19332039|P2|Overall Study|not meet criteria for chemo foll surgery|0
5594743|NCT00941655|19332040|P1|Overall Study|not meet criteria for chemo foll surgery|4
5594744|NCT00941655|19332039|P2|Overall Study|received some chemo, 4 and 9 cycles|0
5594745|NCT00941655|19332040|P1|Overall Study|received some chemo, 4 and 9 cycles|1
5594746|NCT00941603|19332065|P6|Overall Study|Did not meet protocol eligibility|0
5594747|NCT00941603|19332066|P5|Overall Study|Did not meet protocol eligibility|0
5594748|NCT00941603|19332067|P4|Overall Study|Did not meet protocol eligibility|0
5599599|NCT00906399|19348034|P7|Year 1|Other|0
5594749|NCT00941603|19332068|P3|Overall Study|Did not meet protocol eligibility|0
5594750|NCT00941603|19332069|P2|Overall Study|Did not meet protocol eligibility|0
5594751|NCT00941603|19332070|P1|Overall Study|Did not meet protocol eligibility|1
5594752|NCT00941603|19332065|P6|Overall Study|Protocol Violation|0
5594753|NCT00941603|19332066|P5|Overall Study|Protocol Violation|0
5594754|NCT00941603|19332067|P4|Overall Study|Protocol Violation|0
5594755|NCT00941603|19332068|P3|Overall Study|Protocol Violation|0
5594756|NCT00941603|19332069|P2|Overall Study|Protocol Violation|1
5594757|NCT00941603|19332070|P1|Overall Study|Protocol Violation|0
5594758|NCT00941603|19332065|P6|Overall Study|Withdrawal by Subject|1
5594759|NCT00941603|19332066|P5|Overall Study|Withdrawal by Subject|0
5594760|NCT00941603|19332067|P4|Overall Study|Withdrawal by Subject|2
5594761|NCT00941603|19332068|P3|Overall Study|Withdrawal by Subject|0
5594762|NCT00941603|19332069|P2|Overall Study|Withdrawal by Subject|0
5594763|NCT00941603|19332070|P1|Overall Study|Withdrawal by Subject|0
5594764|NCT00941603|19332065|P6|Overall Study|Lost to Follow-up|2
5594765|NCT00941603|19332066|P5|Overall Study|Lost to Follow-up|0
5594766|NCT00941603|19332067|P4|Overall Study|Lost to Follow-up|1
5594767|NCT00941603|19332068|P3|Overall Study|Lost to Follow-up|0
5594768|NCT00941603|19332069|P2|Overall Study|Lost to Follow-up|0
5594769|NCT00941603|19332070|P1|Overall Study|Lost to Follow-up|0
5594770|NCT00941603|19332065|P6|Overall Study|Adverse Event|0
5594771|NCT00941603|19332066|P5|Overall Study|Adverse Event|4
5594772|NCT00941603|19332067|P4|Overall Study|Adverse Event|1
5594773|NCT00941603|19332068|P3|Overall Study|Adverse Event|5
5594774|NCT00941603|19332069|P2|Overall Study|Adverse Event|15
5594775|NCT00941603|19332070|P1|Overall Study|Adverse Event|10
5594776|NCT00941330|19332092|P2|Overall Study|Physician Decision|2
5594777|NCT00941330|19332093|P1|Overall Study|Physician Decision|0
5594778|NCT00941330|19332092|P2|Overall Study|Other|0
5594779|NCT00941330|19332093|P1|Overall Study|Other|1
5594780|NCT00941304|19332106|P5|Overall Study|Lost to Follow-up|0
5594781|NCT00941304|19332107|P4|Overall Study|Lost to Follow-up|0
5594782|NCT00941304|19332108|P3|Overall Study|Lost to Follow-up|0
5594783|NCT00941304|19332109|P2|Overall Study|Lost to Follow-up|0
5594784|NCT00941304|19332110|P1|Overall Study|Lost to Follow-up|1
5594785|NCT00941070|19332172|P1|Overall Study|Patient non-compliant|1
5594786|NCT00941031|19332192|P7|Maintenance Period|Lack of Efficacy|13
5594787|NCT00941031|19332193|P6|Maintenance Period|Lack of Efficacy|0
5594788|NCT00941031|19332194|P5|Maintenance Period|Lack of Efficacy|0
5594789|NCT00941031|19332195|P4|Maintenance Period|Lack of Efficacy|0
5594790|NCT00941031|19332196|P3|Maintenance Period|Lack of Efficacy|0
5594791|NCT00941031|19332197|P2|Maintenance Period|Lack of Efficacy|0
5594792|NCT00941031|19332198|P1|Maintenance Period|Lack of Efficacy|0
5594793|NCT00941031|19332192|P7|Maintenance Period|Lost to Follow-up|7
5594794|NCT00941031|19332193|P6|Maintenance Period|Lost to Follow-up|2
5594795|NCT00941031|19332194|P5|Maintenance Period|Lost to Follow-up|2
5594796|NCT00941031|19332195|P4|Maintenance Period|Lost to Follow-up|0
5594797|NCT00941031|19332196|P3|Maintenance Period|Lost to Follow-up|0
5594798|NCT00941031|19332197|P2|Maintenance Period|Lost to Follow-up|0
5594799|NCT00941031|19332198|P1|Maintenance Period|Lost to Follow-up|0
5594800|NCT00941031|19332192|P7|Maintenance Period|Adverse Event|8
5594801|NCT00941031|19332193|P6|Maintenance Period|Adverse Event|2
5594802|NCT00941031|19332194|P5|Maintenance Period|Adverse Event|0
5594803|NCT00941031|19332195|P4|Maintenance Period|Adverse Event|0
5594804|NCT00941031|19332196|P3|Maintenance Period|Adverse Event|0
5594805|NCT00941031|19332197|P2|Maintenance Period|Adverse Event|0
5594806|NCT00941031|19332198|P1|Maintenance Period|Adverse Event|0
5594807|NCT00941031|19332192|P7|Maintenance Period|Protocol Violation|1
5594808|NCT00941031|19332193|P6|Maintenance Period|Protocol Violation|0
5594809|NCT00941031|19332194|P5|Maintenance Period|Protocol Violation|0
5594810|NCT00941031|19332195|P4|Maintenance Period|Protocol Violation|0
5594811|NCT00941031|19332196|P3|Maintenance Period|Protocol Violation|0
5594812|NCT00941031|19332197|P2|Maintenance Period|Protocol Violation|0
5594813|NCT00941031|19332198|P1|Maintenance Period|Protocol Violation|0
5594814|NCT00941031|19332192|P7|Maintenance Period|Administrative Problems|1
5594815|NCT00941031|19332193|P6|Maintenance Period|Administrative Problems|0
5594816|NCT00941031|19332194|P5|Maintenance Period|Administrative Problems|1
5594817|NCT00941031|19332195|P4|Maintenance Period|Administrative Problems|0
5594818|NCT00941031|19332196|P3|Maintenance Period|Administrative Problems|0
5594819|NCT00941031|19332197|P2|Maintenance Period|Administrative Problems|0
5594820|NCT00941031|19332198|P1|Maintenance Period|Administrative Problems|0
5594821|NCT00941031|19332192|P7|Maintenance Period|Withdrawal by Subject|13
5594822|NCT00941031|19332193|P6|Maintenance Period|Withdrawal by Subject|2
5594823|NCT00941031|19332194|P5|Maintenance Period|Withdrawal by Subject|6
5594824|NCT00941031|19332195|P4|Maintenance Period|Withdrawal by Subject|0
5594825|NCT00941031|19332196|P3|Maintenance Period|Withdrawal by Subject|0
5594826|NCT00941031|19332197|P2|Maintenance Period|Withdrawal by Subject|0
5594827|NCT00941031|19332198|P1|Maintenance Period|Withdrawal by Subject|0
5594828|NCT00941031|19332192|P7|Induction Period|Adverse Event|0
5594829|NCT00941031|19332193|P6|Induction Period|Adverse Event|0
5594830|NCT00941031|19332194|P5|Induction Period|Adverse Event|0
5594831|NCT00941031|19332195|P4|Induction Period|Adverse Event|2
5594832|NCT00941031|19332196|P3|Induction Period|Adverse Event|3
5594833|NCT00941031|19332197|P2|Induction Period|Adverse Event|0
5594834|NCT00941031|19332198|P1|Induction Period|Adverse Event|1
5594835|NCT00941031|19332192|P7|Induction Period|Adminstative Problems|0
5594837|NCT00941031|19332194|P5|Induction Period|Adminstative Problems|0
5594838|NCT00941031|19332195|P4|Induction Period|Adminstative Problems|0
5594839|NCT00941031|19332196|P3|Induction Period|Adminstative Problems|1
5594840|NCT00941031|19332197|P2|Induction Period|Adminstative Problems|1
5594841|NCT00941031|19332198|P1|Induction Period|Adminstative Problems|1
5594842|NCT00941031|19332192|P7|Induction Period|Withdrawal by Subject|0
5594843|NCT00941031|19332193|P6|Induction Period|Withdrawal by Subject|0
5594844|NCT00941031|19332194|P5|Induction Period|Withdrawal by Subject|0
5594845|NCT00941031|19332195|P4|Induction Period|Withdrawal by Subject|2
5594846|NCT00941031|19332196|P3|Induction Period|Withdrawal by Subject|2
5594847|NCT00941031|19332197|P2|Induction Period|Withdrawal by Subject|2
5594848|NCT00941031|19332198|P1|Induction Period|Withdrawal by Subject|1
5594849|NCT00941031|19332192|P7|Induction Period|Lack of Efficacy|0
5594850|NCT00941031|19332193|P6|Induction Period|Lack of Efficacy|0
5594851|NCT00941031|19332194|P5|Induction Period|Lack of Efficacy|0
5594852|NCT00941031|19332195|P4|Induction Period|Lack of Efficacy|5
5594853|NCT00941031|19332196|P3|Induction Period|Lack of Efficacy|0
5594854|NCT00941031|19332197|P2|Induction Period|Lack of Efficacy|1
5594855|NCT00941031|19332198|P1|Induction Period|Lack of Efficacy|2
5594856|NCT00940992|19332245|P3|Overall Study|Lost to Follow-up|1
5594857|NCT00940992|19332246|P2|Overall Study|Lost to Follow-up|1
5594858|NCT00940992|19332247|P1|Overall Study|Lost to Follow-up|0
5594859|NCT00940992|19332245|P3|Overall Study|subject request|0
5594860|NCT00940992|19332246|P2|Overall Study|subject request|1
5594861|NCT00940992|19332247|P1|Overall Study|subject request|2
5594862|NCT00940992|19332245|P3|Overall Study|Adverse Event|1
5594863|NCT00940992|19332246|P2|Overall Study|Adverse Event|0
5594864|NCT00940992|19332247|P1|Overall Study|Adverse Event|2
5594865|NCT00940888|19332276|P1|Overall Study|Lost to Follow-up|6
5594866|NCT00940888|19332276|P1|Overall Study|Withdrawn - Non-Death|364
5594867|NCT00940888|19332276|P1|Overall Study|Death|461
5594868|NCT00940888|19332276|P1|Overall Study|Unsuccessful Implant|4
5594869|NCT00940875|19332283|P2|Post-Study Treatment|Disease Progression|2
5594870|NCT00940875|19332284|P1|Post-Study Treatment|Disease Progression|0
5594871|NCT00940875|19332283|P2|Post-Study Treatment|Death|1
5594872|NCT00940875|19332284|P1|Post-Study Treatment|Death|0
5594873|NCT00940875|19332283|P2|Treatment Phase|Physician Decision|0
5594874|NCT00940875|19332284|P1|Treatment Phase|Physician Decision|1
5594875|NCT00940875|19332283|P2|Treatment Phase|Disease progression|11
5594876|NCT00940875|19332284|P1|Treatment Phase|Disease progression|9
5594877|NCT00940875|19332283|P2|Treatment Phase|Withdrawal by Subject|0
5594878|NCT00940875|19332284|P1|Treatment Phase|Withdrawal by Subject|3
5594879|NCT00940875|19332283|P2|Treatment Phase|Lack of Efficacy|0
5594880|NCT00940875|19332284|P1|Treatment Phase|Lack of Efficacy|1
5594881|NCT00940875|19332283|P2|Treatment Phase|Death|5
5594882|NCT00940875|19332284|P1|Treatment Phase|Death|3
5594883|NCT00940875|19332283|P2|Treatment Phase|Adverse Event|3
5594884|NCT00940875|19332284|P1|Treatment Phase|Adverse Event|9
5594885|NCT00940823|19332304|P2|Overall Study|Lost to Follow-up|20
5594886|NCT00940823|19332305|P1|Overall Study|Lost to Follow-up|27
5594887|NCT00940823|19332304|P2|Overall Study|Death|12
5594888|NCT00940823|19332305|P1|Overall Study|Death|8
5594889|NCT00940602|19332330|P2|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
5594890|NCT00940602|19332331|P1|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
5594891|NCT00940602|19332330|P2|Overall Study|Adverse Event|2
5594892|NCT00940602|19332331|P1|Overall Study|Adverse Event|7
5594893|NCT00940602|19332330|P2|Overall Study|Patient withdrew consent|13
5594894|NCT00940602|19332331|P1|Overall Study|Patient withdrew consent|26
5594895|NCT00940602|19332330|P2|Overall Study|Lost to Follow-up|1
5594896|NCT00940602|19332331|P1|Overall Study|Lost to Follow-up|3
5594897|NCT00940602|19332330|P2|Overall Study|Death|19
5594898|NCT00940602|19332331|P1|Overall Study|Death|38
5594899|NCT00940602|19332330|P2|Overall Study|Disease progression|2
5594900|NCT00940602|19332331|P1|Overall Study|Disease progression|8
5594901|NCT00940602|19332330|P2|Overall Study|Protocol Deviation (untreated)|0
5594902|NCT00940602|19332331|P1|Overall Study|Protocol Deviation (untreated)|1
5594903|NCT00940602|19332330|P2|Overall Study|Pregnancy|0
5594904|NCT00940602|19332331|P1|Overall Study|Pregnancy|1
5594905|NCT00940602|19332330|P2|Overall Study|Physician Decision|5
5594906|NCT00940602|19332331|P1|Overall Study|Physician Decision|8
5594907|NCT00940602|19332330|P2|Overall Study|Patient/guardian decision|28
5594908|NCT00940602|19332331|P1|Overall Study|Patient/guardian decision|13
5594909|NCT00940602|19332330|P2|Overall Study|Administrative problems|1
5594910|NCT00940602|19332331|P1|Overall Study|Administrative problems|1
5594911|NCT00940498|19332409|P8|Overall Study|Not treated due to disease related pain|0
5594912|NCT00940498|19332410|P7|Overall Study|Not treated due to disease related pain|0
5594913|NCT00940498|19332411|P6|Overall Study|Not treated due to disease related pain|0
5594914|NCT00940498|19332412|P5|Overall Study|Not treated due to disease related pain|1
5594915|NCT00940498|19332413|P4|Overall Study|Not treated due to disease related pain|0
5594916|NCT00940498|19332414|P3|Overall Study|Not treated due to disease related pain|0
5594917|NCT00940498|19332415|P2|Overall Study|Not treated due to disease related pain|0
5594918|NCT00940498|19332416|P1|Overall Study|Not treated due to disease related pain|0
5594919|NCT00940498|19332409|P8|Overall Study|Physician Decision|0
5594920|NCT00940498|19332410|P7|Overall Study|Physician Decision|0
5594921|NCT00940498|19332411|P6|Overall Study|Physician Decision|0
5594922|NCT00940498|19332412|P5|Overall Study|Physician Decision|2
5594923|NCT00940498|19332413|P4|Overall Study|Physician Decision|0
5594924|NCT00940498|19332414|P3|Overall Study|Physician Decision|0
5594925|NCT00940498|19332415|P2|Overall Study|Physician Decision|0
5594926|NCT00940498|19332416|P1|Overall Study|Physician Decision|0
5594927|NCT00940498|19332409|P8|Overall Study|Disease Progression|0
5594928|NCT00940498|19332410|P7|Overall Study|Disease Progression|0
5594929|NCT00940498|19332411|P6|Overall Study|Disease Progression|1
5594930|NCT00940498|19332412|P5|Overall Study|Disease Progression|0
5594931|NCT00940498|19332413|P4|Overall Study|Disease Progression|1
5594932|NCT00940498|19332414|P3|Overall Study|Disease Progression|1
5594933|NCT00940498|19332415|P2|Overall Study|Disease Progression|0
5594934|NCT00940498|19332416|P1|Overall Study|Disease Progression|0
5594935|NCT00940498|19332409|P8|Overall Study|Lost to Follow-up|1
5594936|NCT00940498|19332410|P7|Overall Study|Lost to Follow-up|0
5594937|NCT00940498|19332411|P6|Overall Study|Lost to Follow-up|0
5594938|NCT00940498|19332412|P5|Overall Study|Lost to Follow-up|1
5594939|NCT00940498|19332413|P4|Overall Study|Lost to Follow-up|0
5594940|NCT00940498|19332414|P3|Overall Study|Lost to Follow-up|2
5594941|NCT00940498|19332415|P2|Overall Study|Lost to Follow-up|1
5594942|NCT00940498|19332416|P1|Overall Study|Lost to Follow-up|1
5594943|NCT00940498|19332409|P8|Overall Study|Death|0
5594944|NCT00940498|19332410|P7|Overall Study|Death|1
5594945|NCT00940498|19332411|P6|Overall Study|Death|0
5594946|NCT00940498|19332412|P5|Overall Study|Death|5
5594947|NCT00940498|19332413|P4|Overall Study|Death|1
5594948|NCT00940498|19332414|P3|Overall Study|Death|0
5594949|NCT00940498|19332415|P2|Overall Study|Death|0
5594950|NCT00940498|19332416|P1|Overall Study|Death|2
5594951|NCT00940485|19332534|P2|Overall Study|Others|1
5594952|NCT00940485|19332535|P1|Overall Study|Others|1
5594953|NCT00940485|19332534|P2|Overall Study|Withdrawal by Subject|1
5594954|NCT00940485|19332535|P1|Overall Study|Withdrawal by Subject|1
5594955|NCT00940485|19332534|P2|Overall Study|Adverse Event|0
5594956|NCT00940485|19332535|P1|Overall Study|Adverse Event|8
5594957|NCT00940485|19332534|P2|Overall Study|Lost to Follow-up|3
5594958|NCT00940485|19332535|P1|Overall Study|Lost to Follow-up|2
5594959|NCT00940485|19332534|P2|Overall Study|HBeAb positive at Baseline|2
5594960|NCT00940485|19332535|P1|Overall Study|HBeAb positive at Baseline|3
5594961|NCT00940342|19332573|P3|Overall Study|Adverse Event|1
5594962|NCT00940342|19332574|P2|Overall Study|Adverse Event|2
5594963|NCT00940342|19332575|P1|Overall Study|Adverse Event|0
5594964|NCT00940316|19332586|P3|Treated After Cycle 5|Progressive disease|0
5594965|NCT00940316|19332587|P2|Treated After Cycle 5|Progressive disease|1
5594966|NCT00940316|19332588|P1|Treated After Cycle 5|Progressive disease|0
5594967|NCT00940316|19332586|P3|Treated After Cycle 5|Adverse Event|1
5594968|NCT00940316|19332587|P2|Treated After Cycle 5|Adverse Event|0
5594969|NCT00940316|19332588|P1|Treated After Cycle 5|Adverse Event|0
5594970|NCT00940316|19332586|P3|Moved on to be Treated Cycle 5|Adverse Event|0
5594971|NCT00940316|19332587|P2|Moved on to be Treated Cycle 5|Adverse Event|0
5594972|NCT00940316|19332588|P1|Moved on to be Treated Cycle 5|Adverse Event|2
5594973|NCT00940316|19332586|P3|Reached First Response at 8 Weeks|Progressive disease|0
5594974|NCT00940316|19332587|P2|Reached First Response at 8 Weeks|Progressive disease|3
5594975|NCT00940316|19332588|P1|Reached First Response at 8 Weeks|Progressive disease|1
5594976|NCT00940316|19332586|P3|Reached First Response at 8 Weeks|Adverse Event|0
5594977|NCT00940316|19332587|P2|Reached First Response at 8 Weeks|Adverse Event|1
5594978|NCT00940316|19332588|P1|Reached First Response at 8 Weeks|Adverse Event|2
5594979|NCT00940108|19332631|P4|Overall Study|Diagnosed with H1N1|1
5594980|NCT00940108|19332632|P3|Overall Study|Diagnosed with H1N1|0
5594981|NCT00940108|19332633|P2|Overall Study|Diagnosed with H1N1|0
5594982|NCT00940108|19332634|P1|Overall Study|Diagnosed with H1N1|0
5594983|NCT00940108|19332631|P4|Overall Study|Viral illness after Dose 1|0
5594984|NCT00940108|19332632|P3|Overall Study|Viral illness after Dose 1|0
5594985|NCT00940108|19332633|P2|Overall Study|Viral illness after Dose 1|1
5594986|NCT00940108|19332634|P1|Overall Study|Viral illness after Dose 1|0
5594987|NCT00940108|19332631|P4|Overall Study|Refused - pyrexia after Dose 1|0
5594988|NCT00940108|19332632|P3|Overall Study|Refused - pyrexia after Dose 1|0
5594989|NCT00940108|19332633|P2|Overall Study|Refused - pyrexia after Dose 1|1
5594990|NCT00940108|19332634|P1|Overall Study|Refused - pyrexia after Dose 1|0
5594991|NCT00940108|19332631|P4|Overall Study|Declined further vaccination|0
5594992|NCT00940108|19332632|P3|Overall Study|Declined further vaccination|3
5594993|NCT00940108|19332633|P2|Overall Study|Declined further vaccination|1
5594994|NCT00940108|19332634|P1|Overall Study|Declined further vaccination|0
5594995|NCT00940108|19332631|P4|Overall Study|Dose 2 contraindicated|1
5594996|NCT00940108|19332632|P3|Overall Study|Dose 2 contraindicated|0
5594997|NCT00940108|19332633|P2|Overall Study|Dose 2 contraindicated|1
5594998|NCT00940108|19332634|P1|Overall Study|Dose 2 contraindicated|1
5594999|NCT00940108|19332631|P4|Overall Study|Withdrew Consent|1
5595000|NCT00940108|19332632|P3|Overall Study|Withdrew Consent|0
5595001|NCT00940108|19332633|P2|Overall Study|Withdrew Consent|1
5595002|NCT00940108|19332634|P1|Overall Study|Withdrew Consent|2
5595003|NCT00940108|19332631|P4|Overall Study|Adverse Event|2
5595004|NCT00940108|19332632|P3|Overall Study|Adverse Event|0
5595005|NCT00940108|19332633|P2|Overall Study|Adverse Event|4
5595006|NCT00940108|19332634|P1|Overall Study|Adverse Event|2
5595007|NCT00940017|19332684|P1|Overall Study|Adverse Event|1
5595008|NCT00940017|19332684|P1|Overall Study|did not meet entrance criteria|3
5595009|NCT00939822|19332742|P2|Overall Study|Mental health issues|2
5595010|NCT00939822|19332743|P1|Overall Study|Mental health issues|0
5595011|NCT00939822|19332742|P2|Overall Study|withdrew from study due to busy schedule|1
5595012|NCT00939822|19332743|P1|Overall Study|withdrew from study due to busy schedule|1
5595013|NCT00939822|19332742|P2|Overall Study|Lost to Follow-up|0
5595014|NCT00939822|19332743|P1|Overall Study|Lost to Follow-up|1
5595015|NCT00939809|19332755|P1|Overall Study|Death|1
5595016|NCT00939809|19332755|P1|Overall Study|Adverse Event|2
5595017|NCT00939783|19332770|P1|Overall Study|Enrolled but not treated|1
5595018|NCT00939783|19332770|P1|Overall Study|Protocol Violation|3
5595019|NCT00939783|19332770|P1|Overall Study|Lost to Follow-up|8
5595020|NCT00939783|19332770|P1|Overall Study|Other|16
5595021|NCT00939783|19332770|P1|Overall Study|Withdrawal by Subject|78
5595022|NCT00939783|19332770|P1|Overall Study|Study Terminated by Sponsor|498
5595023|NCT00939783|19332770|P1|Overall Study|Adverse Event|39
5595024|NCT00939783|19332770|P1|Overall Study|Death|6
5595025|NCT00939770|19332785|P8|Overall Study|Withdrawal by Subject|2
5595026|NCT00939770|19332786|P7|Overall Study|Withdrawal by Subject|2
5595027|NCT00939770|19332787|P6|Overall Study|Withdrawal by Subject|0
5595028|NCT00939770|19332788|P5|Overall Study|Withdrawal by Subject|6
5595029|NCT00939770|19332789|P4|Overall Study|Withdrawal by Subject|2
5595030|NCT00939770|19332790|P3|Overall Study|Withdrawal by Subject|5
5595031|NCT00939770|19332791|P2|Overall Study|Withdrawal by Subject|1
5595032|NCT00939770|19332792|P1|Overall Study|Withdrawal by Subject|0
5595033|NCT00939770|19332785|P8|Overall Study|Protocol Violation|0
5595034|NCT00939770|19332786|P7|Overall Study|Protocol Violation|0
5595035|NCT00939770|19332787|P6|Overall Study|Protocol Violation|0
5595036|NCT00939770|19332788|P5|Overall Study|Protocol Violation|1
5595037|NCT00939770|19332789|P4|Overall Study|Protocol Violation|0
5595038|NCT00939770|19332790|P3|Overall Study|Protocol Violation|0
5595039|NCT00939770|19332791|P2|Overall Study|Protocol Violation|0
5595040|NCT00939770|19332792|P1|Overall Study|Protocol Violation|0
5595041|NCT00939770|19332785|P8|Overall Study|Physician Decision|6
5595042|NCT00939770|19332786|P7|Overall Study|Physician Decision|0
5595043|NCT00939770|19332787|P6|Overall Study|Physician Decision|1
5595044|NCT00939770|19332788|P5|Overall Study|Physician Decision|7
5595045|NCT00939770|19332789|P4|Overall Study|Physician Decision|0
5595046|NCT00939770|19332790|P3|Overall Study|Physician Decision|2
5595047|NCT00939770|19332791|P2|Overall Study|Physician Decision|0
5595048|NCT00939770|19332792|P1|Overall Study|Physician Decision|0
5595049|NCT00939770|19332785|P8|Overall Study|Lost to Follow-up|0
5595050|NCT00939770|19332786|P7|Overall Study|Lost to Follow-up|0
5595051|NCT00939770|19332787|P6|Overall Study|Lost to Follow-up|0
5595052|NCT00939770|19332788|P5|Overall Study|Lost to Follow-up|1
5595053|NCT00939770|19332789|P4|Overall Study|Lost to Follow-up|0
5595054|NCT00939770|19332790|P3|Overall Study|Lost to Follow-up|0
5595055|NCT00939770|19332791|P2|Overall Study|Lost to Follow-up|0
5595056|NCT00939770|19332792|P1|Overall Study|Lost to Follow-up|0
5595057|NCT00939770|19332785|P8|Overall Study|Lack of Efficacy|1
5595058|NCT00939770|19332786|P7|Overall Study|Lack of Efficacy|11
5595059|NCT00939770|19332787|P6|Overall Study|Lack of Efficacy|8
5595060|NCT00939770|19332788|P5|Overall Study|Lack of Efficacy|16
5595061|NCT00939770|19332789|P4|Overall Study|Lack of Efficacy|9
5595062|NCT00939770|19332790|P3|Overall Study|Lack of Efficacy|13
5595063|NCT00939770|19332791|P2|Overall Study|Lack of Efficacy|6
5595064|NCT00939770|19332792|P1|Overall Study|Lack of Efficacy|4
5595065|NCT00939770|19332785|P8|Overall Study|Adverse Event|1
5595066|NCT00939770|19332786|P7|Overall Study|Adverse Event|1
5595067|NCT00939770|19332787|P6|Overall Study|Adverse Event|2
5595068|NCT00939770|19332788|P5|Overall Study|Adverse Event|6
5595069|NCT00939770|19332789|P4|Overall Study|Adverse Event|0
5595070|NCT00939770|19332790|P3|Overall Study|Adverse Event|0
5595071|NCT00939770|19332791|P2|Overall Study|Adverse Event|1
5595072|NCT00939770|19332792|P1|Overall Study|Adverse Event|1
5595073|NCT00939692|19332877|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
5595074|NCT00939692|19332878|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
5595075|NCT00939692|19332877|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
5595076|NCT00939692|19332878|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
5595077|NCT00939640|19332893|P1|Overall Study|Physician Decision|1
5595078|NCT00939627|19332914|P3|Overall Study|No off-tx reason given|0
5595079|NCT00939627|19332915|P2|Overall Study|No off-tx reason given|2
5595080|NCT00939627|19332916|P1|Overall Study|No off-tx reason given|0
5595081|NCT00939627|19332914|P3|Overall Study|Not compliant|0
5595082|NCT00939627|19332915|P2|Overall Study|Not compliant|0
5595083|NCT00939627|19332916|P1|Overall Study|Not compliant|2
5595084|NCT00939627|19332914|P3|Overall Study|Other complicating disease|0
5595085|NCT00939627|19332915|P2|Overall Study|Other complicating disease|1
5595086|NCT00939627|19332916|P1|Overall Study|Other complicating disease|1
5595087|NCT00939627|19332914|P3|Overall Study|Withdrawal by Subject|0
5595088|NCT00939627|19332915|P2|Overall Study|Withdrawal by Subject|4
5595089|NCT00939627|19332916|P1|Overall Study|Withdrawal by Subject|2
5595090|NCT00939627|19332914|P3|Overall Study|Death|0
5595091|NCT00939627|19332915|P2|Overall Study|Death|2
5595092|NCT00939627|19332916|P1|Overall Study|Death|0
5595093|NCT00939627|19332914|P3|Overall Study|Adverse Event|0
5595094|NCT00939627|19332915|P2|Overall Study|Adverse Event|7
5595095|NCT00939627|19332916|P1|Overall Study|Adverse Event|6
5595096|NCT00939627|19332914|P3|Overall Study|Disease Progression|0
5595097|NCT00939627|19332915|P2|Overall Study|Disease Progression|12
5595098|NCT00939627|19332916|P1|Overall Study|Disease Progression|16
5595099|NCT00939523|19332956|P1|Overall Study|Physician Decision|2
5595100|NCT00939523|19332956|P1|Overall Study|Lack of Efficacy|1
5595101|NCT00939510|19332963|P1|Overall Study|Withdrawal by Subject|1
5595102|NCT00939484|19332972|P3|Overall Study|Progression/Relapse|3
5595103|NCT00939484|19332973|P2|Overall Study|Progression/Relapse|20
5595104|NCT00939484|19332974|P1|Overall Study|Progression/Relapse|8
5595105|NCT00939393|19333000|P2|Overall Study|Lost to Follow-up|0
5595106|NCT00939393|19333001|P1|Overall Study|Lost to Follow-up|3
5595107|NCT00939393|19333000|P2|Overall Study|Withdrawal by Subject|0
5595108|NCT00939393|19333001|P1|Overall Study|Withdrawal by Subject|1
5595109|NCT00939341|19333032|P1|Overall Study|Incorrect enrolment|8
5595110|NCT00939341|19333032|P1|Overall Study|Protocol Violation|6
5595111|NCT00939341|19333032|P1|Overall Study|Withdrawal by Subject|13
5595112|NCT00939341|19333032|P1|Overall Study|Lost to Follow-up|23
5595113|NCT00939341|19333032|P1|Overall Study|Pregnancy|1
5595114|NCT00939341|19333032|P1|Overall Study|Adverse Event|15
5595115|NCT00939185|19333119|P1|Overall Study|Randomized But Did Not Receive Treatment|10
5595116|NCT00939185|19333119|P1|Overall Study|Withdrawal by Subject|2
5595117|NCT00939185|19333119|P1|Overall Study|Other|3
5595118|NCT00939185|19333119|P1|Overall Study|Lost to Follow-up|6
5595119|NCT00939185|19333119|P1|Overall Study|Lack of Efficacy|1
5595120|NCT00939185|19333119|P1|Overall Study|Adverse Event|3
5595121|NCT00939107|19333157|P2|Overall Study|Lost to Follow-up|12
5595122|NCT00939107|19333158|P1|Overall Study|Lost to Follow-up|14
5595123|NCT00939094|19333172|P2|Overall Study|Abnormal ECG findings|0
5595124|NCT00939094|19333173|P1|Overall Study|Abnormal ECG findings|1
5595125|NCT00939094|19333172|P2|Overall Study|Study stopped by sponsor|2
5595126|NCT00939094|19333173|P1|Overall Study|Study stopped by sponsor|0
5595127|NCT00939094|19333172|P2|Overall Study|Severe non-compliance to protocol|1
5595128|NCT00939094|19333173|P1|Overall Study|Severe non-compliance to protocol|0
5595129|NCT00939094|19333172|P2|Overall Study|Eligibility criteria not fulfilled|0
5595130|NCT00939094|19333173|P1|Overall Study|Eligibility criteria not fulfilled|2
5595131|NCT00939094|19333172|P2|Overall Study|Lost to Follow-up|1
5595132|NCT00939094|19333173|P1|Overall Study|Lost to Follow-up|1
5595133|NCT00939094|19333172|P2|Overall Study|Withdrawal by Subject|6
5595134|NCT00939094|19333173|P1|Overall Study|Withdrawal by Subject|1
5595135|NCT00939094|19333172|P2|Overall Study|Adverse Event|0
5595136|NCT00939094|19333173|P1|Overall Study|Adverse Event|9
5595137|NCT00939055|19333195|P2|Overall Study|Discontinuation prior to procedure|0
5595138|NCT00939055|19333196|P1|Overall Study|Discontinuation prior to procedure|4
5595139|NCT00939029|19333206|P2|Overall Study|Adverse Event|1
5595140|NCT00939029|19333207|P1|Overall Study|Adverse Event|0
5595141|NCT00939029|19333206|P2|Overall Study|Lost to Follow-up|4
5595142|NCT00939029|19333207|P1|Overall Study|Lost to Follow-up|3
5595143|NCT00939029|19333206|P2|Overall Study|Withdrawal by Subject|7
5595144|NCT00939029|19333207|P1|Overall Study|Withdrawal by Subject|3
5595145|NCT00939003|19333219|P2|Open-label Treatment Period|Site Closure|4
5595146|NCT00939003|19333220|P1|Open-label Treatment Period|Site Closure|3
5595147|NCT00939003|19333219|P2|Open-label Treatment Period|Exclusion Criteria|0
5595148|NCT00939003|19333220|P1|Open-label Treatment Period|Exclusion Criteria|1
5595149|NCT00939003|19333219|P2|Open-label Treatment Period|Pregnancy|1
5595150|NCT00939003|19333220|P1|Open-label Treatment Period|Pregnancy|1
5595151|NCT00939003|19333219|P2|Open-label Treatment Period|Lack of Efficacy|9
5595152|NCT00939003|19333220|P1|Open-label Treatment Period|Lack of Efficacy|6
5595153|NCT00939003|19333219|P2|Open-label Treatment Period|Withdrawal by Subject|7
5595154|NCT00939003|19333220|P1|Open-label Treatment Period|Withdrawal by Subject|14
5595155|NCT00939003|19333219|P2|Open-label Treatment Period|Adverse Event|8
5595156|NCT00939003|19333220|P1|Open-label Treatment Period|Adverse Event|4
5595157|NCT00939003|19333219|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
5595158|NCT00939003|19333220|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
5595159|NCT00939003|19333219|P2|Double-blind Treatment Period|Pregnancy|1
5595160|NCT00939003|19333220|P1|Double-blind Treatment Period|Pregnancy|0
5595161|NCT00939003|19333219|P2|Double-blind Treatment Period|Lack of Efficacy|1
5595162|NCT00939003|19333220|P1|Double-blind Treatment Period|Lack of Efficacy|0
5595163|NCT00939003|19333219|P2|Double-blind Treatment Period|Adverse Event|1
5595164|NCT00939003|19333220|P1|Double-blind Treatment Period|Adverse Event|1
5595165|NCT00938964|19333257|P2|Overall Study|Found to Meet Exclusion Criteria|4
5595166|NCT00938964|19333258|P1|Overall Study|Found to Meet Exclusion Criteria|3
5595167|NCT00938964|19333257|P2|Overall Study|Withdrawal by Subject|18
5595168|NCT00938964|19333258|P1|Overall Study|Withdrawal by Subject|22
5595169|NCT00938964|19333257|P2|Overall Study|Lost to Follow-up|3
5595170|NCT00938964|19333258|P1|Overall Study|Lost to Follow-up|2
5595171|NCT00938964|19333257|P2|Overall Study|Death|3
5595172|NCT00938964|19333258|P1|Overall Study|Death|3
5595173|NCT00938886|19333322|P2|Overall Study|Lost to Follow-up|2
5595174|NCT00938886|19333323|P1|Overall Study|Lost to Follow-up|3
5595175|NCT00938886|19333322|P2|Overall Study|Withdrawal by Subject|7
5595176|NCT00938886|19333323|P1|Overall Study|Withdrawal by Subject|4
5595177|NCT00938886|19333322|P2|Overall Study|Death|1
5595178|NCT00938886|19333323|P1|Overall Study|Death|0
5595179|NCT00938860|19333333|P2|Overall Study|Protocol Violation|1
5595180|NCT00938860|19333334|P1|Overall Study|Protocol Violation|3
5595181|NCT00938860|19333333|P2|Overall Study|Death|1
5595182|NCT00938860|19333334|P1|Overall Study|Death|1
5595183|NCT00938860|19333333|P2|Overall Study|Administration problems|0
5595184|NCT00938860|19333334|P1|Overall Study|Administration problems|2
5595185|NCT00938860|19333333|P2|Overall Study|Lost to Follow-up|4
5595186|NCT00938860|19333334|P1|Overall Study|Lost to Follow-up|4
5595187|NCT00938860|19333333|P2|Overall Study|Withdrawal by Subject|8
5595188|NCT00938860|19333334|P1|Overall Study|Withdrawal by Subject|11
5595189|NCT00938860|19333333|P2|Overall Study|Abnormal laboratory values|2
5595190|NCT00938860|19333334|P1|Overall Study|Abnormal laboratory values|2
5595191|NCT00938860|19333333|P2|Overall Study|Adverse Event|1
5595192|NCT00938860|19333334|P1|Overall Study|Adverse Event|2
5595193|NCT00938717|19333367|P2|Overall Study|Other reason|2
5595194|NCT00938717|19333368|P1|Overall Study|Other reason|5
5595195|NCT00938717|19333367|P2|Overall Study|Lack of Efficacy|15
5595196|NCT00938717|19333368|P1|Overall Study|Lack of Efficacy|33
5595197|NCT00938717|19333367|P2|Overall Study|Lost to Follow-up|18
5595198|NCT00938717|19333368|P1|Overall Study|Lost to Follow-up|13
5595199|NCT00938717|19333367|P2|Overall Study|Withdrawal by Subject|24
5595200|NCT00938717|19333368|P1|Overall Study|Withdrawal by Subject|26
5595201|NCT00938717|19333367|P2|Overall Study|Protocol Violation|8
5595202|NCT00938717|19333368|P1|Overall Study|Protocol Violation|11
5595203|NCT00938717|19333367|P2|Overall Study|Adverse Event|41
5595204|NCT00938717|19333368|P1|Overall Study|Adverse Event|10
5595205|NCT00938639|19333419|P2|Overall Study|Participant noncompliance|0
5595206|NCT00938639|19333420|P1|Overall Study|Participant noncompliance|1
5595207|NCT00938639|19333419|P2|Overall Study|Family issues|1
5595208|NCT00938639|19333420|P1|Overall Study|Family issues|1
5595209|NCT00938639|19333419|P2|Overall Study|Lost to Follow-up|2
5595210|NCT00938639|19333420|P1|Overall Study|Lost to Follow-up|1
5595211|NCT00938639|19333419|P2|Overall Study|Moved away from study area|1
5595212|NCT00938639|19333420|P1|Overall Study|Moved away from study area|0
5595213|NCT00938470|19333503|P2|Overall Study|Other Reason|1
5595214|NCT00938470|19333504|P1|Overall Study|Other Reason|0
5595215|NCT00938470|19333503|P2|Overall Study|Death|2
5595216|NCT00938470|19333504|P1|Overall Study|Death|3
5595217|NCT00938470|19333503|P2|Overall Study|Alternate Treatment|0
5595218|NCT00938470|19333504|P1|Overall Study|Alternate Treatment|1
5595219|NCT00938470|19333503|P2|Overall Study|Disease Progression|0
5595220|NCT00938470|19333504|P1|Overall Study|Disease Progression|3
5595221|NCT00938431|19333534|P3|Overall Study|Reached maximum dose early|1
5595222|NCT00938431|19333535|P2|Overall Study|Reached maximum dose early|0
5595223|NCT00938431|19333536|P1|Overall Study|Reached maximum dose early|0
5595224|NCT00938431|19333534|P3|Overall Study|Dosing compliance issue|1
5595225|NCT00938431|19333535|P2|Overall Study|Dosing compliance issue|0
5595226|NCT00938431|19333536|P1|Overall Study|Dosing compliance issue|0
5595227|NCT00938431|19333534|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
5595228|NCT00938431|19333535|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
5595229|NCT00938431|19333536|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
5595230|NCT00938431|19333534|P3|Overall Study|Lack of Efficacy|0
5595231|NCT00938431|19333535|P2|Overall Study|Lack of Efficacy|1
5595232|NCT00938431|19333536|P1|Overall Study|Lack of Efficacy|0
5595233|NCT00938431|19333534|P3|Overall Study|Adverse Event|6
5595234|NCT00938431|19333535|P2|Overall Study|Adverse Event|8
5595235|NCT00938431|19333536|P1|Overall Study|Adverse Event|5
5595236|NCT00938392|19333563|P2|Overall Study|Lost to Follow-up|2
5595237|NCT00938392|19333564|P1|Overall Study|Lost to Follow-up|2
5595238|NCT00938392|19333563|P2|Overall Study|Withdrawal by Subject|1
5595239|NCT00938392|19333564|P1|Overall Study|Withdrawal by Subject|0
5595240|NCT00938392|19333563|P2|Overall Study|Adverse Event|1
5595241|NCT00938392|19333564|P1|Overall Study|Adverse Event|0
5595242|NCT00938366|19333590|P2|Overall Study|Withdrawal by Subject|0
5595243|NCT00938366|19333591|P1|Overall Study|Withdrawal by Subject|1
5595244|NCT00938340|19333611|P1|Overall Study|Adverse Event|1
5595245|NCT00938340|19333611|P1|Overall Study|Protocol Violation|1
5595246|NCT00938340|19333611|P1|Overall Study|Withdrawal by Subject|3
5595247|NCT00938327|19333741|P1|Overall Study|Vaccine not received as out of stock|9
5595248|NCT00938327|19333741|P1|Overall Study|2nd dose received outside of the study|7
5595249|NCT00938327|19333741|P1|Overall Study|Lost to Follow-up|37
5595250|NCT00938327|19333741|P1|Overall Study|Withdrawal by Subject|4
5595251|NCT00938327|19333741|P1|Overall Study|Protocol Violation|1
5595252|NCT00938327|19333741|P1|Overall Study|Adverse Event|2
5595253|NCT00938041|19333809|P1|Overall Study|Adrenal Insufficiency|3
5595254|NCT00938041|19333809|P1|Overall Study|Death|12
5595255|NCT00938041|19333809|P1|Overall Study|Progressive Disease|5
5595256|NCT00938041|19333809|P1|Overall Study|Received Alternative Therapy|1
5595257|NCT00938041|19333809|P1|Overall Study|Lost to Follow-up|6
5595258|NCT00938015|19333818|P1|Overall Study|Reason not related to Etanercept|29
5595259|NCT00938015|19333818|P1|Overall Study|Non-responder|52
5595260|NCT00938015|19333818|P1|Overall Study|Adverse Event|32
5595261|NCT00938015|19333818|P1|Overall Study|Lost to Follow-up|32
5595262|NCT00938015|19333818|P1|Overall Study|Death|2
5595263|NCT00937950|19333834|P1|Overall Study|Other|18
5595264|NCT00937950|19333834|P1|Overall Study|Missing confirmed|4
5595265|NCT00937950|19333834|P1|Overall Study|Lost to Follow-up|144
5595266|NCT00937950|19333834|P1|Overall Study|Migrated/moved from study area|27
5595267|NCT00937950|19333834|P1|Overall Study|Withdrawal by Subject|23
5595268|NCT00937937|19333850|P1|Overall Study|Other|2
5595269|NCT00937937|19333850|P1|Overall Study|Death|1
5595270|NCT00937937|19333850|P1|Overall Study|Progression/relapse|61
5595271|NCT00937937|19333850|P1|Overall Study|Withdrawal by Subject|2
5595272|NCT00937937|19333850|P1|Overall Study|Adverse Event|6
5595273|NCT00937833|19333870|P2|Overall Study|Withdrawal by Subject|6
5595274|NCT00937833|19333871|P1|Overall Study|Withdrawal by Subject|4
5595275|NCT00937833|19333870|P2|Overall Study|Lost to Follow-up|8
5595276|NCT00937833|19333871|P1|Overall Study|Lost to Follow-up|10
5595277|NCT00937833|19333870|P2|Overall Study|Procedure delayed; enrollment closed|1
5595278|NCT00937833|19333871|P1|Overall Study|Procedure delayed; enrollment closed|0
5595279|NCT00937833|19333870|P2|Overall Study|Protocol Violation|2
5595280|NCT00937833|19333871|P1|Overall Study|Protocol Violation|1
5595281|NCT00937768|19333884|P2|Overall Study|No Further Funding|4
5595282|NCT00937768|19333885|P1|Overall Study|No Further Funding|4
5595283|NCT00937768|19333884|P2|Overall Study|Alternate Treatment|1
5595284|NCT00937768|19333885|P1|Overall Study|Alternate Treatment|0
5595285|NCT00937768|19333884|P2|Overall Study|Disease Progression|1
5595286|NCT00937768|19333885|P1|Overall Study|Disease Progression|1
5595287|NCT00937768|19333884|P2|Overall Study|Refused Further Treatment|2
5595288|NCT00937768|19333885|P1|Overall Study|Refused Further Treatment|3
5595289|NCT00937560|19333905|P1|Maintenance Treatment|According to protocol|1
5595290|NCT00937560|19333905|P1|Maintenance Treatment|Withdraw consent|5
5595291|NCT00937560|19333905|P1|Maintenance Treatment|Death|12
5595292|NCT00937560|19333905|P1|Initial Treatment|No end of study page|10
5595293|NCT00937560|19333905|P1|Initial Treatment|Lost to Follow-up|1
5595294|NCT00937560|19333905|P1|Initial Treatment|Adverse Event|1
5595295|NCT00937560|19333905|P1|Initial Treatment|Withdraw consent|3
5595296|NCT00937560|19333905|P1|Initial Treatment|Death|6
5595297|NCT00937547|19333916|P3|Overall Study|misdiagnosis|7
5595298|NCT00937547|19333917|P2|Overall Study|misdiagnosis|6
5595299|NCT00937547|19333918|P1|Overall Study|misdiagnosis|1
5595300|NCT00937521|19333955|P8|Booster Phase|Protocol Deviation|0
5595301|NCT00937521|19333956|P7|Booster Phase|Protocol Deviation|1
5595302|NCT00937521|19333957|P6|Booster Phase|Protocol Deviation|0
5595303|NCT00937521|19333958|P5|Booster Phase|Protocol Deviation|0
5595304|NCT00937521|19333959|P4|Booster Phase|Protocol Deviation|0
5595305|NCT00937521|19333960|P3|Booster Phase|Protocol Deviation|0
5595306|NCT00937521|19333961|P2|Booster Phase|Protocol Deviation|0
5595307|NCT00937521|19333962|P1|Booster Phase|Protocol Deviation|0
5595308|NCT00937521|19333955|P8|Booster Phase|Administrative Reason|0
5595309|NCT00937521|19333956|P7|Booster Phase|Administrative Reason|0
5595310|NCT00937521|19333957|P6|Booster Phase|Administrative Reason|1
5595311|NCT00937521|19333958|P5|Booster Phase|Administrative Reason|1
5595312|NCT00937521|19333959|P4|Booster Phase|Administrative Reason|0
5595313|NCT00937521|19333960|P3|Booster Phase|Administrative Reason|1
5595314|NCT00937521|19333961|P2|Booster Phase|Administrative Reason|0
5595315|NCT00937521|19333962|P1|Booster Phase|Administrative Reason|0
5595316|NCT00937521|19333955|P8|Booster Phase|Lost to Follow-up|0
5595317|NCT00937521|19333956|P7|Booster Phase|Lost to Follow-up|3
5595318|NCT00937521|19333957|P6|Booster Phase|Lost to Follow-up|4
5595319|NCT00937521|19333958|P5|Booster Phase|Lost to Follow-up|4
5595320|NCT00937521|19333959|P4|Booster Phase|Lost to Follow-up|2
5595321|NCT00937521|19333960|P3|Booster Phase|Lost to Follow-up|4
5595322|NCT00937521|19333961|P2|Booster Phase|Lost to Follow-up|2
5595323|NCT00937521|19333962|P1|Booster Phase|Lost to Follow-up|2
5595324|NCT00937521|19333955|P8|Booster Phase|Withdrawal by Subject|2
5595325|NCT00937521|19333956|P7|Booster Phase|Withdrawal by Subject|0
5595326|NCT00937521|19333957|P6|Booster Phase|Withdrawal by Subject|0
5595327|NCT00937521|19333958|P5|Booster Phase|Withdrawal by Subject|0
5595328|NCT00937521|19333959|P4|Booster Phase|Withdrawal by Subject|1
5595329|NCT00937521|19333960|P3|Booster Phase|Withdrawal by Subject|0
5595330|NCT00937521|19333961|P2|Booster Phase|Withdrawal by Subject|0
5595331|NCT00937521|19333962|P1|Booster Phase|Withdrawal by Subject|1
5595332|NCT00937521|19333955|P8|Booster Phase|Adverse Event|0
5595333|NCT00937521|19333956|P7|Booster Phase|Adverse Event|1
5595334|NCT00937521|19333957|P6|Booster Phase|Adverse Event|0
5595335|NCT00937521|19333958|P5|Booster Phase|Adverse Event|0
5595336|NCT00937521|19333959|P4|Booster Phase|Adverse Event|0
5595337|NCT00937521|19333960|P3|Booster Phase|Adverse Event|0
5595338|NCT00937521|19333961|P2|Booster Phase|Adverse Event|0
5595339|NCT00937521|19333962|P1|Booster Phase|Adverse Event|0
5595340|NCT00937521|19333955|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5595341|NCT00937521|19333956|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
5595342|NCT00937521|19333957|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5595343|NCT00937521|19333958|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5595344|NCT00937521|19333959|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5595345|NCT00937521|19333960|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5595346|NCT00937521|19333961|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
5595347|NCT00937521|19333962|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
5595348|NCT00937521|19333955|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5595349|NCT00937521|19333956|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
5595350|NCT00937521|19333957|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
5595351|NCT00937521|19333958|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
5595352|NCT00937521|19333959|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5595353|NCT00937521|19333960|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5595354|NCT00937521|19333961|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
5595355|NCT00937521|19333962|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
5595356|NCT00937521|19333955|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5595357|NCT00937521|19333956|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5595358|NCT00937521|19333957|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5595359|NCT00937521|19333958|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5595360|NCT00937521|19333959|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
5595361|NCT00937521|19333960|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
5595362|NCT00937521|19333961|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5595363|NCT00937521|19333962|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
5595364|NCT00937521|19333955|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
5595365|NCT00937521|19333956|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
5595366|NCT00937521|19333957|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
5595367|NCT00937521|19333958|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
5595368|NCT00937521|19333959|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
5595369|NCT00937521|19333960|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
5595370|NCT00937521|19333961|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
5595371|NCT00937521|19333962|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
5595372|NCT00937521|19333955|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
5595373|NCT00937521|19333956|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
5595374|NCT00937521|19333957|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
5595375|NCT00937521|19333958|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
5595376|NCT00937521|19333959|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
5595377|NCT00937521|19333960|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
5595378|NCT00937521|19333961|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
5595379|NCT00937521|19333962|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
5595380|NCT00937495|19334068|P1|Overall Study|Protocol Violation|2
5595381|NCT00937404|19334074|P1|Overall Study|Withdrawal by Subject|1
5595382|NCT00937404|19334074|P1|Overall Study|Protocol Violation|1
5595383|NCT00937391|19334083|P1|Stage 2|Withdrawal by Subject|1
5595384|NCT00937326|19334150|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
5595385|NCT00937326|19334151|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
5595386|NCT00937326|19334152|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
5595387|NCT00937326|19334153|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
5595388|NCT00937326|19334154|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
5595389|NCT00937326|19334150|P5|Overall Study|Withdrawal by Subject|3
5595390|NCT00937326|19334151|P4|Overall Study|Withdrawal by Subject|4
5595391|NCT00937326|19334152|P3|Overall Study|Withdrawal by Subject|1
5595392|NCT00937326|19334153|P2|Overall Study|Withdrawal by Subject|4
5595393|NCT00937326|19334154|P1|Overall Study|Withdrawal by Subject|3
5595394|NCT00937326|19334150|P5|Overall Study|Death|0
5595395|NCT00937326|19334151|P4|Overall Study|Death|0
5595396|NCT00937326|19334152|P3|Overall Study|Death|1
5595397|NCT00937326|19334153|P2|Overall Study|Death|0
5595398|NCT00937326|19334154|P1|Overall Study|Death|0
5595399|NCT00937326|19334150|P5|Overall Study|Adverse Event|2
5595400|NCT00937326|19334151|P4|Overall Study|Adverse Event|1
5595401|NCT00937326|19334152|P3|Overall Study|Adverse Event|1
5595402|NCT00937326|19334153|P2|Overall Study|Adverse Event|3
5595403|NCT00937326|19334154|P1|Overall Study|Adverse Event|0
5595404|NCT00937157|19334403|P1|Overall Study|Lost to Follow-up|3
5595405|NCT00937157|19334403|P1|Overall Study|Pregnancy|1
5595406|NCT00937040|19334434|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
5595407|NCT00937040|19334435|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
5595408|NCT00937040|19334434|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
5595409|NCT00937040|19334435|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
5595410|NCT00937040|19334434|P2|Overall Study|Withdrawal by Subject|7
5595411|NCT00937040|19334435|P1|Overall Study|Withdrawal by Subject|13
5595412|NCT00937040|19334434|P2|Overall Study|Protocol Violation|0
5595413|NCT00937040|19334435|P1|Overall Study|Protocol Violation|3
5595414|NCT00937040|19334434|P2|Overall Study|Lost to Follow-up|12
5595415|NCT00937040|19334435|P1|Overall Study|Lost to Follow-up|12
5595416|NCT00937040|19334434|P2|Overall Study|Adverse Event|8
5595417|NCT00937040|19334435|P1|Overall Study|Adverse Event|5
5595418|NCT00936975|19334477|P1|Overall Study|Post-Tx scan uninterpretable|2
5595419|NCT00936975|19334477|P1|Overall Study|Disease progression|3
5595420|NCT00936975|19334477|P1|Overall Study|Withdrawal by Subject|1
5595421|NCT00936910|19334486|P1|Overall Study|Lack of Efficacy|3
5595422|NCT00936897|19334495|P2|Overall Study|Death|1
5595423|NCT00936897|19334496|P1|Overall Study|Death|0
5595424|NCT00936897|19334495|P2|Overall Study|Noncompliance|2
5595425|NCT00936897|19334496|P1|Overall Study|Noncompliance|0
5595426|NCT00936897|19334495|P2|Overall Study|Ineligibility Determined|3
5595427|NCT00936897|19334496|P1|Overall Study|Ineligibility Determined|0
5595428|NCT00936897|19334495|P2|Overall Study|Protocol Violation|1
5595429|NCT00936897|19334496|P1|Overall Study|Protocol Violation|1
5595430|NCT00936897|19334495|P2|Overall Study|Administrative Decision|2
5595431|NCT00936897|19334496|P1|Overall Study|Administrative Decision|1
5595432|NCT00936897|19334495|P2|Overall Study|Lost to Follow-up|10
5595433|NCT00936897|19334496|P1|Overall Study|Lost to Follow-up|1
5595434|NCT00936897|19334495|P2|Overall Study|Other|9
5595435|NCT00936897|19334496|P1|Overall Study|Other|3
5595436|NCT00936897|19334495|P2|Overall Study|Adverse Event|13
5595437|NCT00936897|19334496|P1|Overall Study|Adverse Event|4
5595438|NCT00936897|19334495|P2|Overall Study|Withdrawal by Subject|19
5595439|NCT00936897|19334496|P1|Overall Study|Withdrawal by Subject|9
5595440|NCT00936884|19334510|P3|Double-blind|Did not receive study drug|0
5595441|NCT00936884|19334511|P2|Double-blind|Did not receive study drug|1
5595442|NCT00936884|19334512|P1|Double-blind|Did not receive study drug|0
5595443|NCT00936884|19334510|P3|Double-blind|No post baseline diary entry|0
5595444|NCT00936884|19334511|P2|Double-blind|No post baseline diary entry|0
5595445|NCT00936884|19334512|P1|Double-blind|No post baseline diary entry|1
5595446|NCT00936884|19334510|P3|Double-blind|Physician Decision|0
5595447|NCT00936884|19334511|P2|Double-blind|Physician Decision|0
5595448|NCT00936884|19334512|P1|Double-blind|Physician Decision|1
5595449|NCT00936884|19334510|P3|Double-blind|Adverse Event|0
5595450|NCT00936884|19334511|P2|Double-blind|Adverse Event|0
5595451|NCT00936884|19334512|P1|Double-blind|Adverse Event|1
5595452|NCT00936884|19334510|P3|Double-blind|Lack of Efficacy|0
5595453|NCT00936884|19334511|P2|Double-blind|Lack of Efficacy|1
5595454|NCT00936884|19334512|P1|Double-blind|Lack of Efficacy|1
5595455|NCT00936884|19334510|P3|Double-blind|Death|0
5595456|NCT00936884|19334511|P2|Double-blind|Death|1
5595457|NCT00936884|19334512|P1|Double-blind|Death|2
5595458|NCT00936884|19334510|P3|Double-blind|Withdrawal by Subject|0
5595459|NCT00936884|19334511|P2|Double-blind|Withdrawal by Subject|4
5595460|NCT00936884|19334512|P1|Double-blind|Withdrawal by Subject|6
5595461|NCT00936715|19334528|P1|Overall Study|Safety or Tolerability Reasons|4
5595462|NCT00936715|19334528|P1|Overall Study|Protocol Violation|1
5595463|NCT00936715|19334528|P1|Overall Study|Investigators Discretion|1
5595464|NCT00936702|19334532|P1|Overall Study|Other|1
5595465|NCT00936702|19334532|P1|Overall Study|Alternative Treatment|1
5595466|NCT00936702|19334532|P1|Overall Study|Withdrawal by Subject|2
5595467|NCT00936702|19334532|P1|Overall Study|Adverse Event|8
5595468|NCT00936702|19334532|P1|Overall Study|Disease progression|34
5595469|NCT00936598|19334565|P2|Overall Study|Ineligible after consent|0
5595470|NCT00936598|19334566|P1|Overall Study|Ineligible after consent|1
5595471|NCT00936598|19334565|P2|Overall Study|Withdrawal by Subject|0
5595472|NCT00936598|19334566|P1|Overall Study|Withdrawal by Subject|1
5595473|NCT00936221|19334668|P2|Overall Study|Withdrawal by Subject|1
5595474|NCT00936221|19334669|P1|Overall Study|Withdrawal by Subject|1
5595475|NCT00936208|19334683|P2|Overall Study|Protocol Violation|22
5595476|NCT00936208|19334684|P1|Overall Study|Protocol Violation|37
5595477|NCT00936117|19334702|P1|Overall Study|Unable to continue oral medication|3
5595478|NCT00936117|19334702|P1|Overall Study|Adverse Event|7
5595479|NCT00936065|19334710|P3|Overall Study|Withdrawal by Subject|4
5595480|NCT00936065|19334711|P2|Overall Study|Withdrawal by Subject|2
5595481|NCT00936065|19334712|P1|Overall Study|Withdrawal by Subject|0
5595482|NCT00936065|19334710|P3|Overall Study|Protocol Violation|1
5595483|NCT00936065|19334711|P2|Overall Study|Protocol Violation|2
5595484|NCT00936065|19334712|P1|Overall Study|Protocol Violation|1
5595485|NCT00936065|19334710|P3|Overall Study|Lost to Follow-up|0
5595486|NCT00936065|19334711|P2|Overall Study|Lost to Follow-up|0
5595487|NCT00936065|19334712|P1|Overall Study|Lost to Follow-up|1
5595488|NCT00936065|19334710|P3|Overall Study|Lack of Efficacy|1
5595489|NCT00936065|19334711|P2|Overall Study|Lack of Efficacy|0
5595490|NCT00936065|19334712|P1|Overall Study|Lack of Efficacy|1
5595491|NCT00936065|19334710|P3|Overall Study|Adverse Event|1
5595492|NCT00936065|19334711|P2|Overall Study|Adverse Event|0
5595493|NCT00936065|19334712|P1|Overall Study|Adverse Event|1
5595494|NCT00935883|19334818|P2|Treatment Period|Withdrawal by Subject|2
5595495|NCT00935883|19334819|P1|Treatment Period|Withdrawal by Subject|0
5595496|NCT00935883|19334818|P2|Treatment Period|Physician Decision|0
5595497|NCT00935883|19334819|P1|Treatment Period|Physician Decision|1
5595498|NCT00935818|19334846|P2|Overall Study|Physician Decision|1
5595499|NCT00935818|19334847|P1|Overall Study|Physician Decision|0
5595500|NCT00935818|19334846|P2|Overall Study|Adverse Event|7
5595501|NCT00935818|19334847|P1|Overall Study|Adverse Event|6
5595502|NCT00935818|19334846|P2|Overall Study|Lost to Follow-up|42
5595503|NCT00935818|19334847|P1|Overall Study|Lost to Follow-up|40
5595504|NCT00935818|19334846|P2|Overall Study|Withdrawal by Subject|50
5595505|NCT00935818|19334847|P1|Overall Study|Withdrawal by Subject|45
5595506|NCT00935701|19334898|P1|Overall Study|Failure to Transition to Acupuncture|1
5595507|NCT00935584|19334915|P2|Overall Study|Provider dropped out of study|4
5595508|NCT00935584|19334916|P1|Overall Study|Provider dropped out of study|14
5595509|NCT00935584|19334915|P2|Overall Study|Patient changed provider|0
5595510|NCT00935584|19334916|P1|Overall Study|Patient changed provider|3
5595511|NCT00935584|19334915|P2|Overall Study|Relocated|0
5595512|NCT00935584|19334916|P1|Overall Study|Relocated|3
5595513|NCT00935584|19334915|P2|Overall Study|No show|0
5595514|NCT00935584|19334916|P1|Overall Study|No show|9
5595515|NCT00935584|19334915|P2|Overall Study|Lost to Follow-up|0
5595516|NCT00935584|19334916|P1|Overall Study|Lost to Follow-up|8
5595517|NCT00935584|19334915|P2|Overall Study|Death|0
5595518|NCT00935584|19334916|P1|Overall Study|Death|3
5595519|NCT00935584|19334915|P2|Overall Study|Withdrawal by Subject|0
5595520|NCT00935584|19334916|P1|Overall Study|Withdrawal by Subject|9
5595521|NCT00935532|19334928|P2|Overall Study|Loss Glucose Control|0
5595522|NCT00935532|19334929|P1|Overall Study|Loss Glucose Control|4
5595523|NCT00935532|19334928|P2|Overall Study|Sponsor Decision|1
5595524|NCT00935532|19334929|P1|Overall Study|Sponsor Decision|0
5595525|NCT00935532|19334928|P2|Overall Study|Subject Decision|1
5595526|NCT00935532|19334929|P1|Overall Study|Subject Decision|2
5595527|NCT00935532|19334928|P2|Overall Study|Protocol Violation|1
5595528|NCT00935532|19334929|P1|Overall Study|Protocol Violation|2
5595529|NCT00935532|19334928|P2|Overall Study|Physician Decision|2
5595530|NCT00935532|19334929|P1|Overall Study|Physician Decision|1
5595531|NCT00935532|19334928|P2|Overall Study|Lost to Follow-up|0
5595532|NCT00935532|19334929|P1|Overall Study|Lost to Follow-up|1
5595533|NCT00935532|19334928|P2|Overall Study|Death|0
5595534|NCT00935532|19334929|P1|Overall Study|Death|1
5595535|NCT00935532|19334928|P2|Overall Study|Adverse Event|6
5595536|NCT00935532|19334929|P1|Overall Study|Adverse Event|11
5595537|NCT00935493|19334958|P3|Overall Study|Treatment Discontinued|0
5595538|NCT00935493|19334959|P2|Overall Study|Treatment Discontinued|1
5595539|NCT00935493|19334960|P1|Overall Study|Treatment Discontinued|0
5595540|NCT00935493|19334958|P3|Overall Study|Lost to Follow-up|1
5595541|NCT00935493|19334959|P2|Overall Study|Lost to Follow-up|1
5595542|NCT00935493|19334960|P1|Overall Study|Lost to Follow-up|1
5595543|NCT00935272|19335009|P2|Overall Study|Protocol Violation|1
5595544|NCT00935272|19335010|P1|Overall Study|Protocol Violation|0
5595545|NCT00935272|19335009|P2|Overall Study|Physician Decision|0
5595546|NCT00935272|19335010|P1|Overall Study|Physician Decision|1
5595547|NCT00935272|19335009|P2|Overall Study|Withdrawal by Subject|2
5595548|NCT00935272|19335010|P1|Overall Study|Withdrawal by Subject|8
5595549|NCT00935272|19335009|P2|Overall Study|Lost to Follow-up|3
5595550|NCT00935272|19335010|P1|Overall Study|Lost to Follow-up|10
5595551|NCT00935259|19335019|P2|Period 1|Administrative (scheduling conflict)|1
5595552|NCT00935259|19335020|P1|Period 1|Administrative (scheduling conflict)|1
5595553|NCT00935220|19335034|P1|Overall Study|Other reason (not specified)|1
5595554|NCT00935220|19335034|P1|Overall Study|Adverse Event|1
5595555|NCT00934947|19335065|P2|Overall Study|Adverse Event|2
5595556|NCT00934947|19335066|P1|Overall Study|Adverse Event|0
5595557|NCT00934856|19335095|P6|Extension Part|Non-compliance with drug|1
5595558|NCT00934856|19335096|P5|Extension Part|Non-compliance with drug|0
5595559|NCT00934856|19335097|P4|Extension Part|Non-compliance with drug|0
5595560|NCT00934856|19335098|P3|Extension Part|Non-compliance with drug|0
5595561|NCT00934856|19335099|P2|Extension Part|Non-compliance with drug|0
5595562|NCT00934856|19335100|P1|Extension Part|Non-compliance with drug|0
5595563|NCT00934856|19335095|P6|Extension Part|Progressive disease|0
5595564|NCT00934856|19335096|P5|Extension Part|Progressive disease|0
5595565|NCT00934856|19335097|P4|Extension Part|Progressive disease|1
5595566|NCT00934856|19335098|P3|Extension Part|Progressive disease|0
5595567|NCT00934856|19335099|P2|Extension Part|Progressive disease|0
5595568|NCT00934856|19335100|P1|Extension Part|Progressive disease|0
5595569|NCT00934856|19335095|P6|Extension Part|Adverse Event|4
5595570|NCT00934856|19335096|P5|Extension Part|Adverse Event|4
5595571|NCT00934856|19335097|P4|Extension Part|Adverse Event|1
5595572|NCT00934856|19335098|P3|Extension Part|Adverse Event|0
5595573|NCT00934856|19335099|P2|Extension Part|Adverse Event|0
5595574|NCT00934856|19335100|P1|Extension Part|Adverse Event|0
5595575|NCT00934856|19335095|P6|Feasibility Part|Withdrawal by Subject|1
5595576|NCT00934856|19335096|P5|Feasibility Part|Withdrawal by Subject|0
5595577|NCT00934856|19335097|P4|Feasibility Part|Withdrawal by Subject|1
5595578|NCT00934856|19335098|P3|Feasibility Part|Withdrawal by Subject|0
5595579|NCT00934856|19335099|P2|Feasibility Part|Withdrawal by Subject|0
5595580|NCT00934856|19335100|P1|Feasibility Part|Withdrawal by Subject|0
5595581|NCT00934856|19335095|P6|Feasibility Part|Adverse Event|2
5595582|NCT00934856|19335096|P5|Feasibility Part|Adverse Event|0
5595583|NCT00934856|19335097|P4|Feasibility Part|Adverse Event|1
5595584|NCT00934856|19335098|P3|Feasibility Part|Adverse Event|0
5595585|NCT00934856|19335099|P2|Feasibility Part|Adverse Event|1
5595586|NCT00934856|19335100|P1|Feasibility Part|Adverse Event|1
5595587|NCT00934856|19335095|P6|Feasibility Part|Physician Decision|0
5595588|NCT00934856|19335096|P5|Feasibility Part|Physician Decision|0
5595589|NCT00934856|19335097|P4|Feasibility Part|Physician Decision|0
5595590|NCT00934856|19335098|P3|Feasibility Part|Physician Decision|1
5595591|NCT00934856|19335099|P2|Feasibility Part|Physician Decision|0
5595592|NCT00934856|19335100|P1|Feasibility Part|Physician Decision|0
5595593|NCT00934856|19335095|P6|Feasibility Part|Progressive disease|0
5595594|NCT00934856|19335096|P5|Feasibility Part|Progressive disease|0
5595595|NCT00934856|19335097|P4|Feasibility Part|Progressive disease|3
5595596|NCT00934856|19335098|P3|Feasibility Part|Progressive disease|2
5595597|NCT00934856|19335099|P2|Feasibility Part|Progressive disease|4
5595598|NCT00934856|19335100|P1|Feasibility Part|Progressive disease|4
5595599|NCT00934843|19335198|P2|Overall Study|Protocol Violation|1
5595600|NCT00934843|19335199|P1|Overall Study|Protocol Violation|0
5595601|NCT00934791|19335215|P2|Overall Study|Withdrawal by Subject|0
5595602|NCT00934791|19335216|P1|Overall Study|Withdrawal by Subject|1
5595603|NCT00934661|19335224|P2|Overall Study|Failure of Combined/Spinal Epidural|0
5595604|NCT00934661|19335225|P1|Overall Study|Failure of Combined/Spinal Epidural|1
5595605|NCT00934648|19335245|P1|Overall Study|Withdrawal by Subject|1
5595606|NCT00934648|19335245|P1|Overall Study|Failure to return|8
5595607|NCT00934622|19335289|P1|Overall Study|2nd Intraoperative exclusion criteria|1
5595608|NCT00934622|19335289|P1|Overall Study|Lost to Follow-up|7
5595609|NCT00934544|19335327|P3|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
5595610|NCT00934544|19335328|P2|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
5595611|NCT00934544|19335329|P1|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
5595612|NCT00934544|19335327|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
5595613|NCT00934544|19335328|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
5595614|NCT00934544|19335329|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
5599600|NCT00906399|19348035|P6|Year 1|Other|0
5595615|NCT00934544|19335327|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
5595616|NCT00934544|19335328|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
5595617|NCT00934544|19335329|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
5595618|NCT00934544|19335327|P3|Overall Disposition at 5 Year Follow-up|Disease progression|7
5595619|NCT00934544|19335328|P2|Overall Disposition at 5 Year Follow-up|Disease progression|4
5595620|NCT00934544|19335329|P1|Overall Disposition at 5 Year Follow-up|Disease progression|32
5595621|NCT00934544|19335327|P3|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
5595622|NCT00934544|19335328|P2|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
5595623|NCT00934544|19335329|P1|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
5595624|NCT00934544|19335327|P3|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
5595625|NCT00934544|19335328|P2|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
5595626|NCT00934544|19335329|P1|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
5595627|NCT00934544|19335327|P3|Overall Disposition at 5 Year Follow-up|Adverse Event|10
5595628|NCT00934544|19335328|P2|Overall Disposition at 5 Year Follow-up|Adverse Event|5
5595629|NCT00934544|19335329|P1|Overall Disposition at 5 Year Follow-up|Adverse Event|35
5595630|NCT00934544|19335327|P3|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
5595631|NCT00934544|19335328|P2|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
5595632|NCT00934544|19335329|P1|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
5595633|NCT00934544|19335327|P3|Primary Endpoint Analysis (Interim)|Entered extension phase|0
5595634|NCT00934544|19335328|P2|Primary Endpoint Analysis (Interim)|Entered extension phase|18
5595635|NCT00934544|19335329|P1|Primary Endpoint Analysis (Interim)|Entered extension phase|29
5595636|NCT00934544|19335327|P3|Primary Endpoint Analysis (Interim)|Other reasons|0
5595637|NCT00934544|19335328|P2|Primary Endpoint Analysis (Interim)|Other reasons|7
5595638|NCT00934544|19335329|P1|Primary Endpoint Analysis (Interim)|Other reasons|7
5595639|NCT00934544|19335327|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
5595640|NCT00934544|19335328|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
5595641|NCT00934544|19335329|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
5595642|NCT00934544|19335327|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
5595643|NCT00934544|19335328|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
5595644|NCT00934544|19335329|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
5595645|NCT00934544|19335327|P3|Primary Endpoint Analysis (Interim)|Disease Progression|0
5595646|NCT00934544|19335328|P2|Primary Endpoint Analysis (Interim)|Disease Progression|3
5595647|NCT00934544|19335329|P1|Primary Endpoint Analysis (Interim)|Disease Progression|1
5595648|NCT00934544|19335327|P3|Primary Endpoint Analysis (Interim)|Protocol Violation|0
5595649|NCT00934544|19335328|P2|Primary Endpoint Analysis (Interim)|Protocol Violation|0
5595650|NCT00934544|19335329|P1|Primary Endpoint Analysis (Interim)|Protocol Violation|2
5595651|NCT00934544|19335327|P3|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
5595652|NCT00934544|19335328|P2|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
5595653|NCT00934544|19335329|P1|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
5595654|NCT00934544|19335327|P3|Primary Endpoint Analysis (Interim)|Adverse Event|0
5595655|NCT00934544|19335328|P2|Primary Endpoint Analysis (Interim)|Adverse Event|4
5595656|NCT00934544|19335329|P1|Primary Endpoint Analysis (Interim)|Adverse Event|12
5595657|NCT00934440|19335365|P1|Overall Study|Lost to Follow-up|1
5595658|NCT00934362|19335381|P2|Overall Study|Adverse Event|0
5595659|NCT00934362|19335382|P1|Overall Study|Adverse Event|1
5595660|NCT00934128|19335432|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
5595661|NCT00934128|19335433|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
5595662|NCT00934128|19335432|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
5595663|NCT00934128|19335433|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
5595664|NCT00934128|19335432|P2|Washout Period (1 Hour)|Too tired|0
5595665|NCT00934128|19335433|P1|Washout Period (1 Hour)|Too tired|1
5595666|NCT00934128|19335432|P2|Washout Period (1 Hour)|Pain|0
5595667|NCT00934128|19335433|P1|Washout Period (1 Hour)|Pain|1
5595668|NCT00934128|19335432|P2|Washout Period (1 Hour)|Patient preference|3
5595669|NCT00934128|19335433|P1|Washout Period (1 Hour)|Patient preference|1
5595670|NCT00934128|19335432|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
5595671|NCT00934128|19335433|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
5595672|NCT00934128|19335432|P2|First Intervention (2 Hours)|Adverse Event|1
5595673|NCT00934128|19335433|P1|First Intervention (2 Hours)|Adverse Event|4
5595674|NCT00934128|19335432|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
5595675|NCT00934128|19335433|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
5595676|NCT00934102|19335441|P3|Period 1, One Night of Wear|Personal Reasons|0
5595677|NCT00934102|19335442|P2|Period 1, One Night of Wear|Personal Reasons|0
5595678|NCT00934102|19335443|P1|Period 1, One Night of Wear|Personal Reasons|1
5595679|NCT00934050|19335457|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
5595680|NCT00934050|19335458|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
5595681|NCT00934050|19335459|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5595682|NCT00934050|19335460|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5595683|NCT00934050|19335461|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5595684|NCT00934050|19335462|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
5595685|NCT00934050|19335457|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
5595686|NCT00934050|19335458|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5599601|NCT00906399|19348036|P5|Year 1|Other|0
5595687|NCT00934050|19335459|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5595688|NCT00934050|19335460|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5595689|NCT00934050|19335461|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5595690|NCT00934050|19335462|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
5595691|NCT00934050|19335457|P6|Enrolled After 15 Dec 2009|Death|1
5595692|NCT00934050|19335458|P5|Enrolled After 15 Dec 2009|Death|0
5595693|NCT00934050|19335459|P4|Enrolled After 15 Dec 2009|Death|0
5595694|NCT00934050|19335460|P3|Enrolled After 15 Dec 2009|Death|0
5595695|NCT00934050|19335461|P2|Enrolled After 15 Dec 2009|Death|0
5595696|NCT00934050|19335462|P1|Enrolled After 15 Dec 2009|Death|0
5595697|NCT00934050|19335457|P6|Enrolled After 15 Dec 2009|Adverse Event|0
5595698|NCT00934050|19335458|P5|Enrolled After 15 Dec 2009|Adverse Event|3
5595699|NCT00934050|19335459|P4|Enrolled After 15 Dec 2009|Adverse Event|0
5595700|NCT00934050|19335460|P3|Enrolled After 15 Dec 2009|Adverse Event|0
5595701|NCT00934050|19335461|P2|Enrolled After 15 Dec 2009|Adverse Event|0
5595702|NCT00934050|19335462|P1|Enrolled After 15 Dec 2009|Adverse Event|0
5595703|NCT00934050|19335457|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5595704|NCT00934050|19335458|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5595705|NCT00934050|19335459|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5595706|NCT00934050|19335460|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
5595707|NCT00934050|19335461|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5595708|NCT00934050|19335462|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
5595709|NCT00934050|19335457|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
5595710|NCT00934050|19335458|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
5595711|NCT00934050|19335459|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
5595712|NCT00934050|19335460|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
5595713|NCT00934050|19335461|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
5595714|NCT00934050|19335462|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
5595715|NCT00934050|19335457|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5595716|NCT00934050|19335458|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5595717|NCT00934050|19335459|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
5595718|NCT00934050|19335460|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5595719|NCT00934050|19335461|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
5595720|NCT00934050|19335462|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
5595721|NCT00933933|19335485|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
5595722|NCT00933933|19335486|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
5595723|NCT00933933|19335487|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
5595724|NCT00933933|19335485|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
5595725|NCT00933933|19335486|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
5595726|NCT00933933|19335487|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
5595727|NCT00933686|19335505|P2|Overall Study|Failure to show up at endpoint visits|2
5595728|NCT00933686|19335506|P1|Overall Study|Failure to show up at endpoint visits|0
5595729|NCT00933686|19335505|P2|Overall Study|Physician Decision|0
5595730|NCT00933686|19335506|P1|Overall Study|Physician Decision|1
5595731|NCT00933686|19335505|P2|Overall Study|Adverse Event|1
5595732|NCT00933686|19335506|P1|Overall Study|Adverse Event|1
5595733|NCT00933686|19335505|P2|Overall Study|Withdrawal by Subject|5
5595734|NCT00933686|19335506|P1|Overall Study|Withdrawal by Subject|6
5595735|NCT00933686|19335505|P2|Overall Study|Lost to Follow-up|2
5595736|NCT00933686|19335506|P1|Overall Study|Lost to Follow-up|2
5595737|NCT00933686|19335505|P2|Overall Study|Protocol Violation|1
5595738|NCT00933686|19335506|P1|Overall Study|Protocol Violation|0
5595739|NCT00933608|19335526|P2|Overall Study|Physician Decision|0
5595740|NCT00933608|19335527|P1|Overall Study|Physician Decision|1
5595741|NCT00933608|19335526|P2|Overall Study|Adverse Event|2
5595742|NCT00933608|19335527|P1|Overall Study|Adverse Event|4
5595743|NCT00933543|19335535|P2|Overall Study|Other|1
5595744|NCT00933543|19335536|P1|Overall Study|Other|1
5595745|NCT00933543|19335535|P2|Overall Study|Lack of Efficacy|3
5595746|NCT00933543|19335536|P1|Overall Study|Lack of Efficacy|0
5595747|NCT00933543|19335535|P2|Overall Study|Withdrawal by Subject|1
5595748|NCT00933543|19335536|P1|Overall Study|Withdrawal by Subject|0
5595749|NCT00933543|19335535|P2|Overall Study|Lost to Follow-up|1
5595750|NCT00933543|19335536|P1|Overall Study|Lost to Follow-up|0
5595751|NCT00933543|19335535|P2|Overall Study|Adverse Event|1
5595752|NCT00933543|19335536|P1|Overall Study|Adverse Event|2
5595753|NCT00933335|19335605|P2|Overall Study|Co-morbid Illness|0
5595754|NCT00933335|19335606|P1|Overall Study|Co-morbid Illness|1
5595755|NCT00933335|19335605|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
5595756|NCT00933335|19335606|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
5595757|NCT00933335|19335605|P2|Overall Study|Progressive Disease|11
5595758|NCT00933335|19335606|P1|Overall Study|Progressive Disease|0
5595759|NCT00933335|19335605|P2|Overall Study|Withdrawal by Subject|1
5595760|NCT00933335|19335606|P1|Overall Study|Withdrawal by Subject|0
5595761|NCT00933335|19335605|P2|Overall Study|Lost to Follow-up|3
5595762|NCT00933335|19335606|P1|Overall Study|Lost to Follow-up|1
5595763|NCT00933270|19335676|P1|Overall Study|Moved or would not return|10
5595764|NCT00933270|19335676|P1|Overall Study|Death|24
5595765|NCT00933270|19335676|P1|Overall Study|Missed Visit|2
5595766|NCT00933270|19335676|P1|Overall Study|Adverse Event|1
5595767|NCT00933270|19335676|P1|Overall Study|Lost to Follow-up|14
5595768|NCT00933270|19335676|P1|Overall Study|Insufficient Follow-up|10
5595769|NCT00933270|19335676|P1|Overall Study|Withdrawal by Subject|26
5595770|NCT00933244|19335770|P3|Overall Study|Withdrawal by Subject|3
5595771|NCT00933244|19335771|P2|Overall Study|Withdrawal by Subject|1
5595772|NCT00933244|19335772|P1|Overall Study|Withdrawal by Subject|5
5595773|NCT00933166|19335789|P1|Overall Study|Withdrawal by Subject|1
5595774|NCT00933166|19335789|P1|Overall Study|Unavailable|4
5595775|NCT00933166|19335789|P1|Overall Study|Lack of Efficacy|9
5595776|NCT00933166|19335789|P1|Overall Study|Lost to Follow-up|4
5595777|NCT00932893|19335795|P2|Overall Study|Other|144
5595778|NCT00932893|19335796|P1|Overall Study|Other|5
5595779|NCT00932893|19335795|P2|Overall Study|Withdrawal by Subject|2
5595780|NCT00932893|19335796|P1|Overall Study|Withdrawal by Subject|5
5595781|NCT00932893|19335795|P2|Overall Study|Lost to Follow-up|0
5595782|NCT00932893|19335796|P1|Overall Study|Lost to Follow-up|8
5595783|NCT00932893|19335795|P2|Overall Study|Death|24
5595784|NCT00932893|19335796|P1|Overall Study|Death|115
5595785|NCT00932698|19335844|P11|Part 2 (Dose Expansion)|Adverse Event|0
5595786|NCT00932698|19335845|P10|Part 2 (Dose Expansion)|Adverse Event|1
5595787|NCT00932698|19335846|P9|Part 2 (Dose Expansion)|Adverse Event|1
5595788|NCT00932698|19335847|P8|Part 2 (Dose Expansion)|Adverse Event|5
5595789|NCT00932698|19335848|P7|Part 2 (Dose Expansion)|Adverse Event|0
5595790|NCT00932698|19335849|P6|Part 2 (Dose Expansion)|Adverse Event|0
5595791|NCT00932698|19335850|P5|Part 2 (Dose Expansion)|Adverse Event|0
5595792|NCT00932698|19335851|P4|Part 2 (Dose Expansion)|Adverse Event|0
5595793|NCT00932698|19335852|P3|Part 2 (Dose Expansion)|Adverse Event|0
5595794|NCT00932698|19335853|P2|Part 2 (Dose Expansion)|Adverse Event|0
5595795|NCT00932698|19335854|P1|Part 2 (Dose Expansion)|Adverse Event|0
5595796|NCT00932698|19335844|P11|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5595797|NCT00932698|19335845|P10|Part 2 (Dose Expansion)|Withdrawal by Subject|2
5595798|NCT00932698|19335846|P9|Part 2 (Dose Expansion)|Withdrawal by Subject|3
5595799|NCT00932698|19335847|P8|Part 2 (Dose Expansion)|Withdrawal by Subject|1
5595800|NCT00932698|19335848|P7|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5595801|NCT00932698|19335849|P6|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5595802|NCT00932698|19335850|P5|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5595803|NCT00932698|19335851|P4|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5595804|NCT00932698|19335852|P3|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5595805|NCT00932698|19335853|P2|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5595806|NCT00932698|19335854|P1|Part 2 (Dose Expansion)|Withdrawal by Subject|0
5595807|NCT00932698|19335844|P11|Part 2 (Dose Expansion)|Progressive Disease|2
5595808|NCT00932698|19335845|P10|Part 2 (Dose Expansion)|Progressive Disease|3
5595809|NCT00932698|19335846|P9|Part 2 (Dose Expansion)|Progressive Disease|8
5595810|NCT00932698|19335847|P8|Part 2 (Dose Expansion)|Progressive Disease|14
5595811|NCT00932698|19335848|P7|Part 2 (Dose Expansion)|Progressive Disease|0
5595812|NCT00932698|19335849|P6|Part 2 (Dose Expansion)|Progressive Disease|0
5595813|NCT00932698|19335850|P5|Part 2 (Dose Expansion)|Progressive Disease|0
5595814|NCT00932698|19335851|P4|Part 2 (Dose Expansion)|Progressive Disease|0
5595815|NCT00932698|19335852|P3|Part 2 (Dose Expansion)|Progressive Disease|0
5595816|NCT00932698|19335853|P2|Part 2 (Dose Expansion)|Progressive Disease|0
5595817|NCT00932698|19335854|P1|Part 2 (Dose Expansion)|Progressive Disease|0
5595818|NCT00932698|19335844|P11|Part 1 (Dose Escalation)|Other|0
5595819|NCT00932698|19335845|P10|Part 1 (Dose Escalation)|Other|0
5595820|NCT00932698|19335846|P9|Part 1 (Dose Escalation)|Other|0
5595821|NCT00932698|19335847|P8|Part 1 (Dose Escalation)|Other|0
5595822|NCT00932698|19335848|P7|Part 1 (Dose Escalation)|Other|1
5595823|NCT00932698|19335849|P6|Part 1 (Dose Escalation)|Other|0
5595824|NCT00932698|19335850|P5|Part 1 (Dose Escalation)|Other|0
5595825|NCT00932698|19335851|P4|Part 1 (Dose Escalation)|Other|0
5595826|NCT00932698|19335852|P3|Part 1 (Dose Escalation)|Other|1
5595827|NCT00932698|19335853|P2|Part 1 (Dose Escalation)|Other|0
5595828|NCT00932698|19335854|P1|Part 1 (Dose Escalation)|Other|0
5595829|NCT00932698|19335844|P11|Part 1 (Dose Escalation)|Adverse Event|0
5595830|NCT00932698|19335845|P10|Part 1 (Dose Escalation)|Adverse Event|0
5595831|NCT00932698|19335846|P9|Part 1 (Dose Escalation)|Adverse Event|0
5595832|NCT00932698|19335847|P8|Part 1 (Dose Escalation)|Adverse Event|0
5595833|NCT00932698|19335848|P7|Part 1 (Dose Escalation)|Adverse Event|0
5595834|NCT00932698|19335849|P6|Part 1 (Dose Escalation)|Adverse Event|1
5595835|NCT00932698|19335850|P5|Part 1 (Dose Escalation)|Adverse Event|0
5595836|NCT00932698|19335851|P4|Part 1 (Dose Escalation)|Adverse Event|0
5595837|NCT00932698|19335852|P3|Part 1 (Dose Escalation)|Adverse Event|0
5595838|NCT00932698|19335853|P2|Part 1 (Dose Escalation)|Adverse Event|0
5595839|NCT00932698|19335854|P1|Part 1 (Dose Escalation)|Adverse Event|0
5595840|NCT00932698|19335844|P11|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5595841|NCT00932698|19335845|P10|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5595842|NCT00932698|19335846|P9|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5595843|NCT00932698|19335847|P8|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5595844|NCT00932698|19335848|P7|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5595845|NCT00932698|19335849|P6|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5595846|NCT00932698|19335850|P5|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5595847|NCT00932698|19335851|P4|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5595848|NCT00932698|19335852|P3|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5595849|NCT00932698|19335853|P2|Part 1 (Dose Escalation)|Withdrawal by Participant|1
5595850|NCT00932698|19335854|P1|Part 1 (Dose Escalation)|Withdrawal by Participant|0
5595851|NCT00932698|19335844|P11|Part 1 (Dose Escalation)|Progressive Disease|0
5595852|NCT00932698|19335845|P10|Part 1 (Dose Escalation)|Progressive Disease|0
5595853|NCT00932698|19335846|P9|Part 1 (Dose Escalation)|Progressive Disease|0
5595854|NCT00932698|19335847|P8|Part 1 (Dose Escalation)|Progressive Disease|0
5595855|NCT00932698|19335848|P7|Part 1 (Dose Escalation)|Progressive Disease|2
5595856|NCT00932698|19335849|P6|Part 1 (Dose Escalation)|Progressive Disease|5
5595857|NCT00932698|19335850|P5|Part 1 (Dose Escalation)|Progressive Disease|3
5595858|NCT00932698|19335851|P4|Part 1 (Dose Escalation)|Progressive Disease|2
5595859|NCT00932698|19335852|P3|Part 1 (Dose Escalation)|Progressive Disease|2
5595860|NCT00932698|19335853|P2|Part 1 (Dose Escalation)|Progressive Disease|2
5595861|NCT00932698|19335854|P1|Part 1 (Dose Escalation)|Progressive Disease|3
5595862|NCT00932646|19336028|P4|Overall Study|Withdrawal by Subject|0
5595863|NCT00932646|19336029|P3|Overall Study|Withdrawal by Subject|3
5595864|NCT00932646|19336030|P2|Overall Study|Withdrawal by Subject|1
5595865|NCT00932646|19336031|P1|Overall Study|Withdrawal by Subject|1
5595866|NCT00932646|19336028|P4|Overall Study|Lost to Follow-up|0
5595867|NCT00932646|19336029|P3|Overall Study|Lost to Follow-up|0
5595868|NCT00932646|19336030|P2|Overall Study|Lost to Follow-up|1
5595869|NCT00932646|19336031|P1|Overall Study|Lost to Follow-up|2
5595870|NCT00932646|19336028|P4|Overall Study|Adverse Event|1
5595871|NCT00932646|19336029|P3|Overall Study|Adverse Event|1
5595872|NCT00932646|19336030|P2|Overall Study|Adverse Event|1
5595873|NCT00932646|19336031|P1|Overall Study|Adverse Event|2
5595874|NCT00932451|19336118|P1|Overall Study|Other reasons|5
5595875|NCT00932451|19336118|P1|Overall Study|Death|726
5595876|NCT00932451|19336118|P1|Overall Study|Lost to Follow-up|22
5595877|NCT00932451|19336118|P1|Overall Study|Withdrawal by Subject|69
5595878|NCT00932425|19336142|P2|Overall Study|Withdrawal by Subject|1
5595879|NCT00932425|19336143|P1|Overall Study|Withdrawal by Subject|0
5595880|NCT00932425|19336142|P2|Overall Study|Lost to Follow-up|1
5595881|NCT00932425|19336143|P1|Overall Study|Lost to Follow-up|0
5595882|NCT00932373|19336176|P11|Overall Study|Lack of Efficacy|0
5595883|NCT00932373|19336177|P10|Overall Study|Lack of Efficacy|1
5595884|NCT00932373|19336178|P9|Overall Study|Lack of Efficacy|0
5595885|NCT00932373|19336179|P8|Overall Study|Lack of Efficacy|0
5595886|NCT00932373|19336180|P7|Overall Study|Lack of Efficacy|0
5595887|NCT00932373|19336181|P6|Overall Study|Lack of Efficacy|0
5595888|NCT00932373|19336182|P5|Overall Study|Lack of Efficacy|0
5595889|NCT00932373|19336183|P4|Overall Study|Lack of Efficacy|0
5595890|NCT00932373|19336184|P3|Overall Study|Lack of Efficacy|0
5595891|NCT00932373|19336185|P2|Overall Study|Lack of Efficacy|0
5595892|NCT00932373|19336186|P1|Overall Study|Lack of Efficacy|0
5595893|NCT00932373|19336176|P11|Overall Study|Clinical progression|0
5595894|NCT00932373|19336177|P10|Overall Study|Clinical progression|0
5595895|NCT00932373|19336178|P9|Overall Study|Clinical progression|0
5595896|NCT00932373|19336179|P8|Overall Study|Clinical progression|0
5595897|NCT00932373|19336180|P7|Overall Study|Clinical progression|1
5595898|NCT00932373|19336181|P6|Overall Study|Clinical progression|0
5595899|NCT00932373|19336182|P5|Overall Study|Clinical progression|0
5595900|NCT00932373|19336183|P4|Overall Study|Clinical progression|0
5595901|NCT00932373|19336184|P3|Overall Study|Clinical progression|0
5595902|NCT00932373|19336185|P2|Overall Study|Clinical progression|0
5595903|NCT00932373|19336186|P1|Overall Study|Clinical progression|0
5595904|NCT00932373|19336176|P11|Overall Study|Withdrawal by Subject|0
5595905|NCT00932373|19336177|P10|Overall Study|Withdrawal by Subject|0
5595906|NCT00932373|19336178|P9|Overall Study|Withdrawal by Subject|1
5595907|NCT00932373|19336179|P8|Overall Study|Withdrawal by Subject|0
5595908|NCT00932373|19336180|P7|Overall Study|Withdrawal by Subject|0
5595909|NCT00932373|19336181|P6|Overall Study|Withdrawal by Subject|0
5595910|NCT00932373|19336182|P5|Overall Study|Withdrawal by Subject|0
5595911|NCT00932373|19336183|P4|Overall Study|Withdrawal by Subject|0
5595912|NCT00932373|19336184|P3|Overall Study|Withdrawal by Subject|0
5595913|NCT00932373|19336185|P2|Overall Study|Withdrawal by Subject|0
5595914|NCT00932373|19336186|P1|Overall Study|Withdrawal by Subject|0
5595915|NCT00932373|19336176|P11|Overall Study|Dose limiting toxicity|0
5595916|NCT00932373|19336177|P10|Overall Study|Dose limiting toxicity|0
5595917|NCT00932373|19336178|P9|Overall Study|Dose limiting toxicity|0
5595918|NCT00932373|19336179|P8|Overall Study|Dose limiting toxicity|0
5595919|NCT00932373|19336180|P7|Overall Study|Dose limiting toxicity|0
5595920|NCT00932373|19336181|P6|Overall Study|Dose limiting toxicity|1
5595921|NCT00932373|19336182|P5|Overall Study|Dose limiting toxicity|0
5595922|NCT00932373|19336183|P4|Overall Study|Dose limiting toxicity|0
5595923|NCT00932373|19336184|P3|Overall Study|Dose limiting toxicity|0
5595924|NCT00932373|19336185|P2|Overall Study|Dose limiting toxicity|0
5595925|NCT00932373|19336186|P1|Overall Study|Dose limiting toxicity|0
5595926|NCT00932373|19336176|P11|Overall Study|Physician Decision|0
5595927|NCT00932373|19336177|P10|Overall Study|Physician Decision|1
5595928|NCT00932373|19336178|P9|Overall Study|Physician Decision|0
5595929|NCT00932373|19336179|P8|Overall Study|Physician Decision|0
5595930|NCT00932373|19336180|P7|Overall Study|Physician Decision|0
5595931|NCT00932373|19336181|P6|Overall Study|Physician Decision|0
5595932|NCT00932373|19336182|P5|Overall Study|Physician Decision|2
5595933|NCT00932373|19336183|P4|Overall Study|Physician Decision|0
5595934|NCT00932373|19336184|P3|Overall Study|Physician Decision|1
5595935|NCT00932373|19336185|P2|Overall Study|Physician Decision|0
5595936|NCT00932373|19336186|P1|Overall Study|Physician Decision|0
5595937|NCT00932373|19336176|P11|Overall Study|Adverse Event|1
5595938|NCT00932373|19336177|P10|Overall Study|Adverse Event|2
5595939|NCT00932373|19336178|P9|Overall Study|Adverse Event|0
5595940|NCT00932373|19336179|P8|Overall Study|Adverse Event|1
5595941|NCT00932373|19336180|P7|Overall Study|Adverse Event|0
5595942|NCT00932373|19336181|P6|Overall Study|Adverse Event|1
5595943|NCT00932373|19336182|P5|Overall Study|Adverse Event|2
5595944|NCT00932373|19336183|P4|Overall Study|Adverse Event|0
5595945|NCT00932373|19336184|P3|Overall Study|Adverse Event|0
5595946|NCT00932373|19336185|P2|Overall Study|Adverse Event|0
5595947|NCT00932373|19336186|P1|Overall Study|Adverse Event|0
5595948|NCT00932373|19336176|P11|Overall Study|Progressive disease|2
5595949|NCT00932373|19336177|P10|Overall Study|Progressive disease|9
5595950|NCT00932373|19336178|P9|Overall Study|Progressive disease|1
5595951|NCT00932373|19336179|P8|Overall Study|Progressive disease|2
5595952|NCT00932373|19336180|P7|Overall Study|Progressive disease|0
5595953|NCT00932373|19336181|P6|Overall Study|Progressive disease|1
5595954|NCT00932373|19336182|P5|Overall Study|Progressive disease|10
5595955|NCT00932373|19336183|P4|Overall Study|Progressive disease|0
5595956|NCT00932373|19336184|P3|Overall Study|Progressive disease|0
5595957|NCT00932373|19336185|P2|Overall Study|Progressive disease|1
5595958|NCT00932373|19336186|P1|Overall Study|Progressive disease|3
5595959|NCT00932360|19336286|P6|Washout (One Week)|Withdrawal by Subject|0
5595960|NCT00932360|19336287|P5|Washout (One Week)|Withdrawal by Subject|2
5595961|NCT00932360|19336288|P4|Washout (One Week)|Withdrawal by Subject|0
5595962|NCT00932360|19336289|P3|Washout (One Week)|Withdrawal by Subject|0
5595963|NCT00932360|19336290|P2|Washout (One Week)|Withdrawal by Subject|0
5595964|NCT00932360|19336291|P1|Washout (One Week)|Withdrawal by Subject|0
5595965|NCT00932165|19336348|P1|Overall Study|Lost to Follow-up|1
5595966|NCT00932126|19336372|P8|Overall Study|Other|2
5595967|NCT00932126|19336373|P7|Overall Study|Other|1
5595968|NCT00932126|19336374|P6|Overall Study|Other|0
5595969|NCT00932126|19336375|P5|Overall Study|Other|1
5595970|NCT00932126|19336376|P4|Overall Study|Other|0
5595971|NCT00932126|19336377|P3|Overall Study|Other|0
5595972|NCT00932126|19336378|P2|Overall Study|Other|0
5595973|NCT00932126|19336379|P1|Overall Study|Other|0
5595974|NCT00932126|19336372|P8|Overall Study|Objective progression or relapse|5
5595975|NCT00932126|19336373|P7|Overall Study|Objective progression or relapse|3
5595976|NCT00932126|19336374|P6|Overall Study|Objective progression or relapse|3
5595977|NCT00932126|19336375|P5|Overall Study|Objective progression or relapse|3
5595978|NCT00932126|19336376|P4|Overall Study|Objective progression or relapse|3
5595979|NCT00932126|19336377|P3|Overall Study|Objective progression or relapse|2
5595980|NCT00932126|19336378|P2|Overall Study|Objective progression or relapse|3
5595981|NCT00932126|19336379|P1|Overall Study|Objective progression or relapse|3
5595982|NCT00932126|19336372|P8|Overall Study|Withdrawal by Subject|1
5595983|NCT00932126|19336373|P7|Overall Study|Withdrawal by Subject|0
5595984|NCT00932126|19336374|P6|Overall Study|Withdrawal by Subject|0
5595985|NCT00932126|19336375|P5|Overall Study|Withdrawal by Subject|0
5595986|NCT00932126|19336376|P4|Overall Study|Withdrawal by Subject|0
5595987|NCT00932126|19336377|P3|Overall Study|Withdrawal by Subject|1
5595988|NCT00932126|19336378|P2|Overall Study|Withdrawal by Subject|0
5595989|NCT00932126|19336379|P1|Overall Study|Withdrawal by Subject|0
5595990|NCT00932126|19336372|P8|Overall Study|Protocol Violation|0
5595991|NCT00932126|19336373|P7|Overall Study|Protocol Violation|0
5595992|NCT00932126|19336374|P6|Overall Study|Protocol Violation|0
5595993|NCT00932126|19336375|P5|Overall Study|Protocol Violation|1
5595994|NCT00932126|19336376|P4|Overall Study|Protocol Violation|0
5595995|NCT00932126|19336377|P3|Overall Study|Protocol Violation|0
5595996|NCT00932126|19336378|P2|Overall Study|Protocol Violation|0
5595997|NCT00932126|19336379|P1|Overall Study|Protocol Violation|0
5595998|NCT00932126|19336372|P8|Overall Study|Adverse Event|2
5595999|NCT00932126|19336373|P7|Overall Study|Adverse Event|1
5596000|NCT00932126|19336374|P6|Overall Study|Adverse Event|0
5596001|NCT00932126|19336375|P5|Overall Study|Adverse Event|0
5596002|NCT00932126|19336376|P4|Overall Study|Adverse Event|0
5596003|NCT00932126|19336377|P3|Overall Study|Adverse Event|0
5596004|NCT00932126|19336378|P2|Overall Study|Adverse Event|0
5596005|NCT00932126|19336379|P1|Overall Study|Adverse Event|0
5596006|NCT00932113|19336417|P2|Overall Study|Lost to Follow-up|0
5596007|NCT00932113|19336418|P1|Overall Study|Lost to Follow-up|1
5596008|NCT00931918|19336470|P2|Overall Study|Did not receive study drug|2
5596009|NCT00931918|19336471|P1|Overall Study|Did not receive study drug|3
5596010|NCT00931918|19336470|P2|Overall Study|Other Reason not Specified|4
5596011|NCT00931918|19336471|P1|Overall Study|Other Reason not Specified|4
5596012|NCT00931918|19336470|P2|Overall Study|Withdrawal by Patient|4
5596013|NCT00931918|19336471|P1|Overall Study|Withdrawal by Patient|3
5596014|NCT00931918|19336470|P2|Overall Study|Symptomatic Deterioration|0
5596015|NCT00931918|19336471|P1|Overall Study|Symptomatic Deterioration|1
5596016|NCT00931918|19336470|P2|Overall Study|Progressive Disease|1
5596017|NCT00931918|19336471|P1|Overall Study|Progressive Disease|2
5596018|NCT00931918|19336470|P2|Overall Study|Adverse Event|6
5596019|NCT00931918|19336471|P1|Overall Study|Adverse Event|4
5596020|NCT00931801|19336523|P3|Overall Study|Confirmed Virologic Failure|3
5596021|NCT00931801|19336524|P2|Overall Study|Confirmed Virologic Failure|0
5596022|NCT00931801|19336525|P1|Overall Study|Confirmed Virologic Failure|0
5596023|NCT00931801|19336523|P3|Overall Study|Withdrawal by Subject|0
5596024|NCT00931801|19336524|P2|Overall Study|Withdrawal by Subject|0
5596025|NCT00931801|19336525|P1|Overall Study|Withdrawal by Subject|1
5596026|NCT00931801|19336523|P3|Overall Study|Lost to Follow-up|0
5596027|NCT00931801|19336524|P2|Overall Study|Lost to Follow-up|1
5596028|NCT00931801|19336525|P1|Overall Study|Lost to Follow-up|0
5596029|NCT00931801|19336523|P3|Overall Study|Adverse Event|1
5596030|NCT00931801|19336524|P2|Overall Study|Adverse Event|0
5596031|NCT00931801|19336525|P1|Overall Study|Adverse Event|0
5596032|NCT00931723|19336548|P2|Overall Study|Late hospital discharge|0
5596033|NCT00931723|19336549|P1|Overall Study|Late hospital discharge|1
5596034|NCT00931723|19336548|P2|Overall Study|Sponsor decision|0
5596035|NCT00931723|19336549|P1|Overall Study|Sponsor decision|1
5596036|NCT00931723|19336548|P2|Overall Study|Lack or insufficient theraputic response|5
5596037|NCT00931723|19336549|P1|Overall Study|Lack or insufficient theraputic response|2
5596038|NCT00931723|19336548|P2|Overall Study|Took prohibited concomitant medication|1
5596039|NCT00931723|19336549|P1|Overall Study|Took prohibited concomitant medication|0
5596040|NCT00931723|19336548|P2|Overall Study|Safety reasons|1
5596041|NCT00931723|19336549|P1|Overall Study|Safety reasons|0
5596042|NCT00931723|19336548|P2|Overall Study|Severe non-compliance to protocol|0
5596043|NCT00931723|19336549|P1|Overall Study|Severe non-compliance to protocol|2
5596044|NCT00931723|19336548|P2|Overall Study|Study-specific discontinuation criteria|1
5596045|NCT00931723|19336549|P1|Overall Study|Study-specific discontinuation criteria|1
5596046|NCT00931723|19336548|P2|Overall Study|Lost to Follow-up|2
5596047|NCT00931723|19336549|P1|Overall Study|Lost to Follow-up|1
5596048|NCT00931723|19336548|P2|Overall Study|Condition under investigation worsened|2
5596049|NCT00931723|19336549|P1|Overall Study|Condition under investigation worsened|1
5596050|NCT00931723|19336548|P2|Overall Study|Lithium found in blood|1
5596051|NCT00931723|19336549|P1|Overall Study|Lithium found in blood|0
5596052|NCT00931723|19336548|P2|Overall Study|Adverse Event|13
5596053|NCT00931723|19336549|P1|Overall Study|Adverse Event|6
5596054|NCT00931723|19336548|P2|Overall Study|Withdrawal by Subject|13
5596055|NCT00931723|19336549|P1|Overall Study|Withdrawal by Subject|11
5596056|NCT00931710|19336597|P2|Overall Study|Protocol deviation|2
5596057|NCT00931710|19336598|P1|Overall Study|Protocol deviation|1
5596058|NCT00931710|19336597|P2|Overall Study|Lost to Follow-up|5
5596059|NCT00931710|19336598|P1|Overall Study|Lost to Follow-up|6
5596060|NCT00931710|19336597|P2|Overall Study|Patient withdrew consent|9
5596061|NCT00931710|19336598|P1|Overall Study|Patient withdrew consent|4
5596062|NCT00931710|19336597|P2|Overall Study|Unsatisfactory therapeutic effects|12
5596063|NCT00931710|19336598|P1|Overall Study|Unsatisfactory therapeutic effects|5
5596064|NCT00931710|19336597|P2|Overall Study|Abnormal test procedure results|0
5596065|NCT00931710|19336598|P1|Overall Study|Abnormal test procedure results|2
5596066|NCT00931710|19336597|P2|Overall Study|Adverse Event|10
5596067|NCT00931710|19336598|P1|Overall Study|Adverse Event|16
5596068|NCT00931632|19336616|P2|Overall Study|Adverse Event|15
5596069|NCT00931632|19336617|P1|Overall Study|Adverse Event|19
5596070|NCT00931632|19336616|P2|Overall Study|Withdrawal by Subject|3
5596071|NCT00931632|19336617|P1|Overall Study|Withdrawal by Subject|2
5596072|NCT00931528|19336639|P2|Overall Study|Assessment outside of Time Frame|23
5596073|NCT00931528|19336640|P1|Overall Study|Assessment outside of Time Frame|22
5596074|NCT00931528|19336639|P2|Overall Study|Lost to Follow-up|13
5596075|NCT00931528|19336640|P1|Overall Study|Lost to Follow-up|6
5596076|NCT00931528|19336639|P2|Overall Study|Withdrawal by Subject|12
5596077|NCT00931528|19336640|P1|Overall Study|Withdrawal by Subject|4
5596078|NCT00931528|19336639|P2|Overall Study|Protocol Violation|12
5596079|NCT00931528|19336640|P1|Overall Study|Protocol Violation|9
5596080|NCT00931515|19336660|P2|Overall Study|Lost to Follow-up|5
5596081|NCT00931515|19336661|P1|Overall Study|Lost to Follow-up|2
5596082|NCT00931463|19336691|P2|Overall Study|Lost to Follow-up|1
5596083|NCT00931463|19336692|P1|Overall Study|Lost to Follow-up|4
5596084|NCT00931463|19336691|P2|Overall Study|Withdrawal by Subject|0
5596085|NCT00931463|19336692|P1|Overall Study|Withdrawal by Subject|5
5596086|NCT00931463|19336691|P2|Overall Study|Death|4
5596087|NCT00931463|19336692|P1|Overall Study|Death|8
5596088|NCT00931411|19336708|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
5596089|NCT00931411|19336709|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
5596090|NCT00931411|19336708|P2|First Intervention - 42 Days|Lost to Follow-up|0
5596091|NCT00931411|19336709|P1|First Intervention - 42 Days|Lost to Follow-up|2
5596092|NCT00931411|19336708|P2|First Intervention - 42 Days|Adverse Event|3
5596093|NCT00931411|19336709|P1|First Intervention - 42 Days|Adverse Event|2
5596094|NCT00931385|19336730|P4|Overall Study|Lost to Follow-up|1
5596095|NCT00931385|19336731|P3|Overall Study|Lost to Follow-up|0
5596096|NCT00931385|19336732|P2|Overall Study|Lost to Follow-up|0
5596097|NCT00931385|19336733|P1|Overall Study|Lost to Follow-up|0
5596098|NCT00931385|19336730|P4|Overall Study|Withdrawal by Subject|1
5596099|NCT00931385|19336731|P3|Overall Study|Withdrawal by Subject|0
5596100|NCT00931385|19336732|P2|Overall Study|Withdrawal by Subject|1
5596101|NCT00931385|19336733|P1|Overall Study|Withdrawal by Subject|0
5596102|NCT00931385|19336730|P4|Overall Study|Protocol Violation|0
5596103|NCT00931385|19336731|P3|Overall Study|Protocol Violation|1
5596104|NCT00931385|19336732|P2|Overall Study|Protocol Violation|0
5596105|NCT00931385|19336733|P1|Overall Study|Protocol Violation|0
5596106|NCT00931385|19336730|P4|Overall Study|Adverse Event|3
5596107|NCT00931385|19336731|P3|Overall Study|Adverse Event|0
5596108|NCT00931385|19336732|P2|Overall Study|Adverse Event|1
5596109|NCT00931385|19336733|P1|Overall Study|Adverse Event|2
5596110|NCT00931307|19336802|P1|Overall Study|Biomicroscopy|1
5596111|NCT00931307|19336802|P1|Overall Study|Lack of Efficacy|12
5596112|NCT00931268|19336806|P1|Overall Study|Lost to Follow-up|6
5596113|NCT00931255|19336818|P2|Overall Study|Follow up biopsy not done|3
5599602|NCT00906399|19348037|P4|Year 1|Other|0
5596114|NCT00931255|19336819|P1|Overall Study|Follow up biopsy not done|2
5596115|NCT00930982|19336856|P2|Overall Study|Withdrawal by Subject|1
5596116|NCT00930982|19336857|P1|Overall Study|Withdrawal by Subject|1
5596117|NCT00930982|19336856|P2|Overall Study|Protocol Violation|5
5596118|NCT00930982|19336857|P1|Overall Study|Protocol Violation|1
5596119|NCT00930982|19336856|P2|Overall Study|Adverse Event|23
5596120|NCT00930982|19336857|P1|Overall Study|Adverse Event|19
5596121|NCT00930969|19336891|P1|Overall Study|Withdrawal by Subject|19
5596122|NCT00930969|19336891|P1|Overall Study|Physician Decision|13
5596123|NCT00930969|19336891|P1|Overall Study|Lost to Follow-up|1
5596124|NCT00930969|19336891|P1|Overall Study|Death|5
5596125|NCT00930930|19336901|P2|Overall Study|patients not compliant|1
5596126|NCT00930930|19336902|P1|Overall Study|patients not compliant|1
5596127|NCT00930930|19336901|P2|Overall Study|excessive lapse btw txs, not eligible|1
5596128|NCT00930930|19336902|P1|Overall Study|excessive lapse btw txs, not eligible|0
5596129|NCT00930930|19336901|P2|Overall Study|Disease progression|3
5596130|NCT00930930|19336902|P1|Overall Study|Disease progression|2
5596131|NCT00930930|19336901|P2|Overall Study|Withdrawal by Subject|1
5596132|NCT00930930|19336902|P1|Overall Study|Withdrawal by Subject|3
5596133|NCT00930930|19336901|P2|Overall Study|Adverse Event|3
5596134|NCT00930930|19336902|P1|Overall Study|Adverse Event|13
5596135|NCT00930930|19336901|P2|Overall Study|Physician Decision|0
5596136|NCT00930930|19336902|P1|Overall Study|Physician Decision|1
5596137|NCT00930930|19336901|P2|Overall Study|Death|0
5596138|NCT00930930|19336902|P1|Overall Study|Death|1
5596139|NCT00930813|19336916|P2|Overall Study|Lost to Follow-up|4
5596140|NCT00930813|19336917|P1|Overall Study|Lost to Follow-up|2
5596141|NCT00930813|19336916|P2|Overall Study|Withdrawal by Subject|5
5596142|NCT00930813|19336917|P1|Overall Study|Withdrawal by Subject|2
5596143|NCT00930813|19336916|P2|Overall Study|Death|5
5596144|NCT00930813|19336917|P1|Overall Study|Death|4
5596145|NCT00930774|19336938|P4|Overall Study|Withdrawal by Subject|0
5596146|NCT00930774|19336939|P3|Overall Study|Withdrawal by Subject|2
5596147|NCT00930774|19336940|P2|Overall Study|Withdrawal by Subject|9
5596148|NCT00930774|19336941|P1|Overall Study|Withdrawal by Subject|1
5596149|NCT00930761|19336981|P2|Overall Study|less than 3 music therapy sessions|3
5596150|NCT00930761|19336982|P1|Overall Study|less than 3 music therapy sessions|0
5596151|NCT00930761|19336981|P2|Overall Study|3 newborns died; 1 mother quit the study|0
5596152|NCT00930761|19336982|P1|Overall Study|3 newborns died; 1 mother quit the study|4
5596153|NCT00930722|19336994|P1|Overall Study|Study terminated by sponsor|2
5596154|NCT00930722|19336994|P1|Overall Study|No longer willing to participate|9
5596155|NCT00930722|19336994|P1|Overall Study|Lost to Follow-up|16
5596156|NCT00930644|19337009|P1|Overall Study|Adverse Event|16
5596157|NCT00930644|19337009|P1|Overall Study|Death|1
5596158|NCT00930644|19337009|P1|Overall Study|Physician Decision|2
5596159|NCT00930644|19337009|P1|Overall Study|Withdrawal by Subject|4
5596160|NCT00930553|19337022|P1|Overall Study|Other than specified above|28
5596161|NCT00930553|19337022|P1|Overall Study|Study terminated by sponsor|24
5596162|NCT00930553|19337022|P1|Overall Study|Death|9
5596163|NCT00930553|19337022|P1|Overall Study|Lost to Follow-up|25
5596164|NCT00930553|19337022|P1|Overall Study|Withdrawal by Subject|88
5596165|NCT00930553|19337022|P1|Overall Study|Pregnancy|1
5596166|NCT00930553|19337022|P1|Overall Study|Protocol Violation|1
5596167|NCT00930553|19337022|P1|Overall Study|Physician Decision|39
5596168|NCT00930553|19337022|P1|Overall Study|Lack of Efficacy|7
5596169|NCT00930553|19337022|P1|Overall Study|Adverse Event|1
5596170|NCT00930176|19337099|P1|Overall Study|Death|1
5596171|NCT00930059|19337106|P2|Overall Study|Adverse Event|6
5596172|NCT00930059|19337107|P1|Overall Study|Adverse Event|1
5596173|NCT00930059|19337106|P2|Overall Study|1 site terminated by sponsor|1
5596174|NCT00930059|19337107|P1|Overall Study|1 site terminated by sponsor|1
5596175|NCT00930059|19337106|P2|Overall Study|Other|0
5596176|NCT00930059|19337107|P1|Overall Study|Other|1
5596177|NCT00930059|19337106|P2|Overall Study|Withdrawal by Subject|4
5596178|NCT00930059|19337107|P1|Overall Study|Withdrawal by Subject|3
5596179|NCT00930059|19337106|P2|Overall Study|Did not meet entrance criteria|1
5596180|NCT00930059|19337107|P1|Overall Study|Did not meet entrance criteria|1
5596181|NCT00930059|19337106|P2|Overall Study|Death|0
5596182|NCT00930059|19337107|P1|Overall Study|Death|1
5596183|NCT00930046|19337137|P2|Overall Study|Wound catheter malfunctioned|2
5596184|NCT00930046|19337138|P1|Overall Study|Wound catheter malfunctioned|1
5596185|NCT00929994|19337146|P1|Overall Study|employment|1
5596186|NCT00929994|19337146|P1|Overall Study|medical issue unrelated to intervention|4
5596187|NCT00929994|19337146|P1|Overall Study|Withdrawal by Subject|1
5596188|NCT00929864|19337165|P2|Overall Study|Non-specified|7
5596189|NCT00929864|19337166|P1|Overall Study|Non-specified|2
5596190|NCT00929864|19337165|P2|Overall Study|Administrative reason by Sponsor|1
5596191|NCT00929864|19337166|P1|Overall Study|Administrative reason by Sponsor|1
5596192|NCT00929864|19337165|P2|Overall Study|Pregnancy|3
5596193|NCT00929864|19337166|P1|Overall Study|Pregnancy|0
5596194|NCT00929864|19337165|P2|Overall Study|Poor or non-compliance|3
5596195|NCT00929864|19337166|P1|Overall Study|Poor or non-compliance|3
5596196|NCT00929864|19337165|P2|Overall Study|No longer met criteria|1
5596197|NCT00929864|19337166|P1|Overall Study|No longer met criteria|2
5596198|NCT00929864|19337165|P2|Overall Study|Withdrawal by Subject|9
5596199|NCT00929864|19337166|P1|Overall Study|Withdrawal by Subject|20
5596200|NCT00929864|19337165|P2|Overall Study|Lost to Follow-up|12
5596201|NCT00929864|19337166|P1|Overall Study|Lost to Follow-up|7
5596202|NCT00929864|19337165|P2|Overall Study|Lack of Efficacy|16
5596203|NCT00929864|19337166|P1|Overall Study|Lack of Efficacy|19
5596204|NCT00929864|19337165|P2|Overall Study|Adverse Event|30
5596205|NCT00929864|19337166|P1|Overall Study|Adverse Event|11
5596206|NCT00929864|19337165|P2|Overall Study|Death|1
5596207|NCT00929864|19337166|P1|Overall Study|Death|1
5596208|NCT00929734|19337222|P2|Overall Study|Withdrawal by Subject|2
5596209|NCT00929734|19337223|P1|Overall Study|Withdrawal by Subject|0
5596210|NCT00929734|19337222|P2|Overall Study|Lost to Follow-up|1
5596211|NCT00929734|19337223|P1|Overall Study|Lost to Follow-up|2
5596212|NCT00929708|19337240|P5|Overall Study|Lost to Follow-up|0
5596213|NCT00929708|19337241|P4|Overall Study|Lost to Follow-up|1
5596214|NCT00929708|19337242|P3|Overall Study|Lost to Follow-up|0
5596215|NCT00929708|19337243|P2|Overall Study|Lost to Follow-up|0
5596216|NCT00929708|19337244|P1|Overall Study|Lost to Follow-up|0
5596217|NCT00929708|19337240|P5|Overall Study|Physician Decision|1
5596218|NCT00929708|19337241|P4|Overall Study|Physician Decision|2
5596219|NCT00929708|19337242|P3|Overall Study|Physician Decision|2
5596220|NCT00929708|19337243|P2|Overall Study|Physician Decision|2
5596221|NCT00929708|19337244|P1|Overall Study|Physician Decision|0
5596222|NCT00929708|19337240|P5|Overall Study|Adverse Event|3
5596223|NCT00929708|19337241|P4|Overall Study|Adverse Event|0
5596224|NCT00929708|19337242|P3|Overall Study|Adverse Event|0
5596225|NCT00929708|19337243|P2|Overall Study|Adverse Event|0
5596226|NCT00929708|19337244|P1|Overall Study|Adverse Event|0
5596227|NCT00929708|19337240|P5|Overall Study|Withdrawal by Subject|1
5596228|NCT00929708|19337241|P4|Overall Study|Withdrawal by Subject|2
5596229|NCT00929708|19337242|P3|Overall Study|Withdrawal by Subject|0
5596230|NCT00929708|19337243|P2|Overall Study|Withdrawal by Subject|0
5596231|NCT00929708|19337244|P1|Overall Study|Withdrawal by Subject|2
5596232|NCT00929708|19337240|P5|Overall Study|Protocol Violation|1
5596233|NCT00929708|19337241|P4|Overall Study|Protocol Violation|1
5596234|NCT00929708|19337242|P3|Overall Study|Protocol Violation|1
5596235|NCT00929708|19337243|P2|Overall Study|Protocol Violation|1
5596236|NCT00929708|19337244|P1|Overall Study|Protocol Violation|2
5596237|NCT00929695|19337298|P2|Overall Study|incorrect stratification|0
5596238|NCT00929695|19337299|P1|Overall Study|incorrect stratification|2
5596239|NCT00929695|19337298|P2|Overall Study|discharge home|3
5596240|NCT00929695|19337299|P1|Overall Study|discharge home|4
5596241|NCT00929695|19337298|P2|Overall Study|Withdrawal by Subject|2
5596242|NCT00929695|19337299|P1|Overall Study|Withdrawal by Subject|0
5596243|NCT00929695|19337298|P2|Overall Study|Death|1
5596244|NCT00929695|19337299|P1|Overall Study|Death|2
5596245|NCT00929669|19337329|P1|Overall Study|elevated glucose levels|1
5596246|NCT00929656|19337336|P2|Overall Study|Lost to Follow-up|1
5596247|NCT00929656|19337337|P1|Overall Study|Lost to Follow-up|0
5596248|NCT00929643|19337351|P1|Overall Study|Protocol Violation|2
5596249|NCT00929526|19337373|P2|Overall Study|Other|6
5596250|NCT00929526|19337374|P1|Overall Study|Other|8
5596251|NCT00929526|19337373|P2|Overall Study|Lost to Follow-up|12
5596252|NCT00929526|19337374|P1|Overall Study|Lost to Follow-up|8
5596253|NCT00929526|19337373|P2|Overall Study|Withdrawal by Subject|11
5596254|NCT00929526|19337374|P1|Overall Study|Withdrawal by Subject|1
5596255|NCT00929240|19337528|P3|Maintenance Phase|Participant not treated|0
5596256|NCT00929240|19337529|P2|Maintenance Phase|Participant not treated|2
5596257|NCT00929240|19337530|P1|Maintenance Phase|Participant not treated|0
5596258|NCT00929240|19337528|P3|Maintenance Phase|Treatment ongoing at study closure|10
5596259|NCT00929240|19337529|P2|Maintenance Phase|Treatment ongoing at study closure|0
5596260|NCT00929240|19337530|P1|Maintenance Phase|Treatment ongoing at study closure|0
5596261|NCT00929240|19337528|P3|Maintenance Phase|Change of treatment|0
5596262|NCT00929240|19337529|P2|Maintenance Phase|Change of treatment|4
5596263|NCT00929240|19337530|P1|Maintenance Phase|Change of treatment|0
5596264|NCT00929240|19337528|P3|Maintenance Phase|Physician Decision|1
5596265|NCT00929240|19337529|P2|Maintenance Phase|Physician Decision|2
5596266|NCT00929240|19337530|P1|Maintenance Phase|Physician Decision|0
5596267|NCT00929240|19337528|P3|Maintenance Phase|Health authority/Study termination|2
5596268|NCT00929240|19337529|P2|Maintenance Phase|Health authority/Study termination|1
5596269|NCT00929240|19337530|P1|Maintenance Phase|Health authority/Study termination|0
5596270|NCT00929240|19337528|P3|Maintenance Phase|Protocol Violation|0
5596271|NCT00929240|19337529|P2|Maintenance Phase|Protocol Violation|1
5596272|NCT00929240|19337530|P1|Maintenance Phase|Protocol Violation|0
5596273|NCT00929240|19337528|P3|Maintenance Phase|Withdrawal by Subject|6
5596274|NCT00929240|19337529|P2|Maintenance Phase|Withdrawal by Subject|2
5596275|NCT00929240|19337530|P1|Maintenance Phase|Withdrawal by Subject|0
5596276|NCT00929240|19337528|P3|Maintenance Phase|Adverse Event|12
5596277|NCT00929240|19337529|P2|Maintenance Phase|Adverse Event|9
5596278|NCT00929240|19337530|P1|Maintenance Phase|Adverse Event|0
5596279|NCT00929240|19337528|P3|Maintenance Phase|Disease progression|60
5596280|NCT00929240|19337529|P2|Maintenance Phase|Disease progression|73
5596281|NCT00929240|19337530|P1|Maintenance Phase|Disease progression|0
5596282|NCT00929240|19337528|P3|Initial Treatment Phase|Physician Decision|0
5596283|NCT00929240|19337529|P2|Initial Treatment Phase|Physician Decision|0
5596284|NCT00929240|19337530|P1|Initial Treatment Phase|Physician Decision|4
5596285|NCT00929240|19337528|P3|Initial Treatment Phase|Health authority/Study termination|0
5596286|NCT00929240|19337529|P2|Initial Treatment Phase|Health authority/Study termination|0
5596287|NCT00929240|19337530|P1|Initial Treatment Phase|Health authority/Study termination|3
5596288|NCT00929240|19337528|P3|Initial Treatment Phase|Death|0
5596289|NCT00929240|19337529|P2|Initial Treatment Phase|Death|0
5596290|NCT00929240|19337530|P1|Initial Treatment Phase|Death|2
5596291|NCT00929240|19337528|P3|Initial Treatment Phase|Protocol Violation|0
5596292|NCT00929240|19337529|P2|Initial Treatment Phase|Protocol Violation|0
5596293|NCT00929240|19337530|P1|Initial Treatment Phase|Protocol Violation|5
5596294|NCT00929240|19337528|P3|Initial Treatment Phase|Withdrawal by Subject|0
5596295|NCT00929240|19337529|P2|Initial Treatment Phase|Withdrawal by Subject|0
5596296|NCT00929240|19337530|P1|Initial Treatment Phase|Withdrawal by Subject|13
5596297|NCT00929240|19337528|P3|Initial Treatment Phase|Disease progression|0
5596298|NCT00929240|19337529|P2|Initial Treatment Phase|Disease progression|0
5596299|NCT00929240|19337530|P1|Initial Treatment Phase|Disease progression|41
5596300|NCT00929240|19337528|P3|Initial Treatment Phase|Adverse Event|0
5596301|NCT00929240|19337529|P2|Initial Treatment Phase|Adverse Event|0
5596302|NCT00929240|19337530|P1|Initial Treatment Phase|Adverse Event|31
5596303|NCT00929201|19337557|P2|Period 1|Withdrawal by Subject|1
5596304|NCT00929201|19337558|P1|Period 1|Withdrawal by Subject|0
5596305|NCT00929162|19337568|P2|Overall Study|Other termination reason|6
5596306|NCT00929162|19337569|P1|Overall Study|Other termination reason|5
5596307|NCT00929162|19337568|P2|Overall Study|Protocol Violation|30
5596308|NCT00929162|19337569|P1|Overall Study|Protocol Violation|32
5596309|NCT00929162|19337568|P2|Overall Study|Withdrawal by Subject|1
5596310|NCT00929162|19337569|P1|Overall Study|Withdrawal by Subject|3
5596311|NCT00929162|19337568|P2|Overall Study|Adverse Event|5
5596312|NCT00929162|19337569|P1|Overall Study|Adverse Event|8
5596313|NCT00929110|19337582|P3|Overall Study|Patient inability to use the device|0
5596314|NCT00929110|19337583|P2|Overall Study|Patient inability to use the device|1
5596315|NCT00929110|19337584|P1|Overall Study|Patient inability to use the device|0
5596316|NCT00929110|19337582|P3|Overall Study|Abnormal test procedure result(s)|1
5596317|NCT00929110|19337583|P2|Overall Study|Abnormal test procedure result(s)|1
5596318|NCT00929110|19337584|P1|Overall Study|Abnormal test procedure result(s)|0
5596319|NCT00929110|19337582|P3|Overall Study|Abnormal laboratory value(s)|0
5596320|NCT00929110|19337583|P2|Overall Study|Abnormal laboratory value(s)|1
5596321|NCT00929110|19337584|P1|Overall Study|Abnormal laboratory value(s)|0
5596322|NCT00929110|19337582|P3|Overall Study|Death|2
5596323|NCT00929110|19337583|P2|Overall Study|Death|2
5596324|NCT00929110|19337584|P1|Overall Study|Death|2
5596325|NCT00929110|19337582|P3|Overall Study|Administrative problems|2
5596326|NCT00929110|19337583|P2|Overall Study|Administrative problems|1
5596327|NCT00929110|19337584|P1|Overall Study|Administrative problems|4
5596328|NCT00929110|19337582|P3|Overall Study|Protocol deviation|4
5596329|NCT00929110|19337583|P2|Overall Study|Protocol deviation|2
5596330|NCT00929110|19337584|P1|Overall Study|Protocol deviation|5
5596331|NCT00929110|19337582|P3|Overall Study|Lost to Follow-up|3
5596332|NCT00929110|19337583|P2|Overall Study|Lost to Follow-up|7
5596333|NCT00929110|19337584|P1|Overall Study|Lost to Follow-up|7
5596334|NCT00929110|19337582|P3|Overall Study|Unsatisfactory therapeutic effect|6
5596335|NCT00929110|19337583|P2|Overall Study|Unsatisfactory therapeutic effect|9
5596336|NCT00929110|19337584|P1|Overall Study|Unsatisfactory therapeutic effect|20
5596337|NCT00929110|19337582|P3|Overall Study|Subject withdrew consent|26
5596338|NCT00929110|19337583|P2|Overall Study|Subject withdrew consent|23
5596339|NCT00929110|19337584|P1|Overall Study|Subject withdrew consent|40
5596340|NCT00929110|19337582|P3|Overall Study|Adverse Event|18
5596341|NCT00929110|19337583|P2|Overall Study|Adverse Event|29
5596342|NCT00929110|19337584|P1|Overall Study|Adverse Event|40
5596343|NCT00928889|19337667|P2|Overall Study|Other|0
5596344|NCT00928889|19337668|P1|Overall Study|Other|1
5596345|NCT00928889|19337667|P2|Overall Study|Adverse Event|0
5596346|NCT00928889|19337668|P1|Overall Study|Adverse Event|1
5596347|NCT00928889|19337667|P2|Overall Study|Protocol Violation|1
5596348|NCT00928889|19337668|P1|Overall Study|Protocol Violation|0
5596349|NCT00928889|19337667|P2|Overall Study|Lost to Follow-up|1
5596350|NCT00928889|19337668|P1|Overall Study|Lost to Follow-up|3
5596351|NCT00928746|19337714|P1|Overall Study|Other|2
5596352|NCT00928746|19337714|P1|Overall Study|Withdrawal by Subject|1
5596353|NCT00928746|19337714|P1|Overall Study|Protocol Violation|1
5596354|NCT00928746|19337714|P1|Overall Study|Adverse Event|2
5596355|NCT00928707|19337764|P2|Overall Study|Protocol Violation|0
5596356|NCT00928707|19337765|P1|Overall Study|Protocol Violation|1
5596357|NCT00928668|19337786|P5|Overall Study|Other reasons not listed above|0
5596358|NCT00928668|19337787|P4|Overall Study|Other reasons not listed above|1
5596359|NCT00928668|19337788|P3|Overall Study|Other reasons not listed above|0
5596360|NCT00928668|19337789|P2|Overall Study|Other reasons not listed above|0
5596361|NCT00928668|19337790|P1|Overall Study|Other reasons not listed above|0
5596362|NCT00928668|19337786|P5|Overall Study|Withdrawal by Subject|0
5596363|NCT00928668|19337787|P4|Overall Study|Withdrawal by Subject|0
5596364|NCT00928668|19337788|P3|Overall Study|Withdrawal by Subject|1
5596365|NCT00928668|19337789|P2|Overall Study|Withdrawal by Subject|1
5596366|NCT00928668|19337790|P1|Overall Study|Withdrawal by Subject|0
5596367|NCT00928668|19337786|P5|Overall Study|Protocol Violation|1
5596368|NCT00928668|19337787|P4|Overall Study|Protocol Violation|0
5596369|NCT00928668|19337788|P3|Overall Study|Protocol Violation|0
5596370|NCT00928668|19337789|P2|Overall Study|Protocol Violation|0
5596371|NCT00928668|19337790|P1|Overall Study|Protocol Violation|0
5596372|NCT00928668|19337786|P5|Overall Study|Adverse Event|0
5596373|NCT00928668|19337787|P4|Overall Study|Adverse Event|0
5596374|NCT00928668|19337788|P3|Overall Study|Adverse Event|0
5596375|NCT00928668|19337789|P2|Overall Study|Adverse Event|0
5596376|NCT00928668|19337790|P1|Overall Study|Adverse Event|1
5596377|NCT00928512|19337846|P5|Overall Study|Administrative Problems|0
5596378|NCT00928512|19337847|P4|Overall Study|Administrative Problems|0
5596379|NCT00928512|19337848|P3|Overall Study|Administrative Problems|0
5596380|NCT00928512|19337849|P2|Overall Study|Administrative Problems|1
5596381|NCT00928512|19337850|P1|Overall Study|Administrative Problems|0
5596382|NCT00928512|19337846|P5|Overall Study|Lost to Follow-up|3
5596383|NCT00928512|19337847|P4|Overall Study|Lost to Follow-up|1
5596384|NCT00928512|19337848|P3|Overall Study|Lost to Follow-up|2
5596385|NCT00928512|19337849|P2|Overall Study|Lost to Follow-up|1
5596386|NCT00928512|19337850|P1|Overall Study|Lost to Follow-up|1
5596387|NCT00928512|19337846|P5|Overall Study|Withdrawal by Subject|0
5596388|NCT00928512|19337847|P4|Overall Study|Withdrawal by Subject|4
5596389|NCT00928512|19337848|P3|Overall Study|Withdrawal by Subject|3
5596390|NCT00928512|19337849|P2|Overall Study|Withdrawal by Subject|0
5596391|NCT00928512|19337850|P1|Overall Study|Withdrawal by Subject|3
5596392|NCT00928512|19337846|P5|Overall Study|Protocol Violation|3
5596393|NCT00928512|19337847|P4|Overall Study|Protocol Violation|1
5596394|NCT00928512|19337848|P3|Overall Study|Protocol Violation|0
5596395|NCT00928512|19337849|P2|Overall Study|Protocol Violation|1
5596396|NCT00928512|19337850|P1|Overall Study|Protocol Violation|0
5596397|NCT00928512|19337846|P5|Overall Study|Lack of Efficacy|3
5596398|NCT00928512|19337847|P4|Overall Study|Lack of Efficacy|7
5596399|NCT00928512|19337848|P3|Overall Study|Lack of Efficacy|4
5596400|NCT00928512|19337849|P2|Overall Study|Lack of Efficacy|0
5596401|NCT00928512|19337850|P1|Overall Study|Lack of Efficacy|2
5596402|NCT00928512|19337846|P5|Overall Study|Adverse Event|6
5596403|NCT00928512|19337847|P4|Overall Study|Adverse Event|8
5596404|NCT00928512|19337848|P3|Overall Study|Adverse Event|2
5596405|NCT00928512|19337849|P2|Overall Study|Adverse Event|3
5596406|NCT00928512|19337850|P1|Overall Study|Adverse Event|4
5596407|NCT00928486|19337951|P1|Overall Study|Withdrawal by Subject|1
5596408|NCT00928486|19337951|P1|Overall Study|Disease Progression|7
5596409|NCT00928486|19337951|P1|Overall Study|Adverse Event|2
5596410|NCT00928434|19337960|P3|Overall Study|Other (not meeting above criteria)|2
5596411|NCT00928434|19337961|P2|Overall Study|Other (not meeting above criteria)|1
5596412|NCT00928434|19337962|P1|Overall Study|Other (not meeting above criteria)|5
5596413|NCT00928434|19337960|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
5596414|NCT00928434|19337961|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
5596415|NCT00928434|19337962|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
5596416|NCT00928434|19337960|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
5596417|NCT00928434|19337961|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
5596418|NCT00928434|19337962|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
5596419|NCT00928434|19337960|P3|Overall Study|Withdrawal by Subject|2
5596420|NCT00928434|19337961|P2|Overall Study|Withdrawal by Subject|3
5596421|NCT00928434|19337962|P1|Overall Study|Withdrawal by Subject|5
5596422|NCT00928434|19337960|P3|Overall Study|Lost to Follow-up|3
5596423|NCT00928434|19337961|P2|Overall Study|Lost to Follow-up|0
5596424|NCT00928434|19337962|P1|Overall Study|Lost to Follow-up|1
5596425|NCT00928434|19337960|P3|Overall Study|Physician Decision|3
5596426|NCT00928434|19337961|P2|Overall Study|Physician Decision|0
5596427|NCT00928434|19337962|P1|Overall Study|Physician Decision|2
5596428|NCT00928434|19337960|P3|Overall Study|Protocol Violation|8
5596429|NCT00928434|19337961|P2|Overall Study|Protocol Violation|0
5596430|NCT00928434|19337962|P1|Overall Study|Protocol Violation|5
5596431|NCT00928434|19337960|P3|Overall Study|Adverse Event|18
5596432|NCT00928434|19337961|P2|Overall Study|Adverse Event|5
5596433|NCT00928434|19337962|P1|Overall Study|Adverse Event|14
5596434|NCT00928408|19338038|P1|Overall Study|Lost to Follow-up|12
5596435|NCT00928408|19338038|P1|Overall Study|Death|5
5596436|NCT00928408|19338038|P1|Overall Study|Withdrawal by Subject|4
5596437|NCT00928408|19338038|P1|Overall Study|Other|2
5596438|NCT00928252|19338084|P1|Overall Study|Physician Decision|3
5596439|NCT00928187|19338144|P3|Overall Study|Protocol Violation|0
5596440|NCT00928187|19338145|P2|Overall Study|Protocol Violation|1
5596441|NCT00928187|19338146|P1|Overall Study|Protocol Violation|0
5596442|NCT00928187|19338144|P3|Overall Study|Withdrawal by Subject|1
5596443|NCT00928187|19338145|P2|Overall Study|Withdrawal by Subject|1
5596444|NCT00928187|19338146|P1|Overall Study|Withdrawal by Subject|0
5596445|NCT00928187|19338144|P3|Overall Study|Lost to Follow-up|1
5596446|NCT00928187|19338145|P2|Overall Study|Lost to Follow-up|2
5596447|NCT00928187|19338146|P1|Overall Study|Lost to Follow-up|1
5596448|NCT00928187|19338144|P3|Overall Study|Death|3
5596449|NCT00928187|19338145|P2|Overall Study|Death|2
5596450|NCT00928187|19338146|P1|Overall Study|Death|1
5596451|NCT00928070|19338316|P2|Overall Study|Other|5
5596452|NCT00928070|19338317|P1|Overall Study|Other|5
5596453|NCT00928070|19338316|P2|Overall Study|Randomized but not treated|2
5596454|NCT00928070|19338317|P1|Overall Study|Randomized but not treated|2
5596455|NCT00928070|19338316|P2|Overall Study|Protocol Violation|5
5596456|NCT00928070|19338317|P1|Overall Study|Protocol Violation|6
5596457|NCT00928070|19338316|P2|Overall Study|Did not meet entrance criteria|9
5596458|NCT00928070|19338317|P1|Overall Study|Did not meet entrance criteria|16
5596459|NCT00928070|19338316|P2|Overall Study|Lack of Efficacy|5
5596460|NCT00928070|19338317|P1|Overall Study|Lack of Efficacy|9
5596461|NCT00928070|19338316|P2|Overall Study|Adverse Event|26
5596462|NCT00928070|19338317|P1|Overall Study|Adverse Event|14
5596463|NCT00928070|19338316|P2|Overall Study|Withdrawal by Subject|3
5596464|NCT00928070|19338317|P1|Overall Study|Withdrawal by Subject|10
5596465|NCT00928070|19338316|P2|Overall Study|Lost to Follow-up|2
5596466|NCT00928070|19338317|P1|Overall Study|Lost to Follow-up|1
5596467|NCT00928057|19338375|P2|Overall Study|Protocol Violation|1
5596468|NCT00928057|19338376|P1|Overall Study|Protocol Violation|0
5596469|NCT00928057|19338375|P2|Overall Study|Lost to Follow-up|1
5596470|NCT00928057|19338376|P1|Overall Study|Lost to Follow-up|0
5596471|NCT00928057|19338375|P2|Overall Study|Withdrawal by Subject|0
5596472|NCT00928057|19338376|P1|Overall Study|Withdrawal by Subject|1
5596473|NCT00928057|19338375|P2|Overall Study|Adverse Event|2
5596474|NCT00928057|19338376|P1|Overall Study|Adverse Event|1
5596475|NCT00928018|19338401|P2|Overall Study|Withdrawal by Subject|0
5596476|NCT00928018|19338402|P1|Overall Study|Withdrawal by Subject|1
5596477|NCT00927953|19338432|P2|Overall Study|Death|1
5596478|NCT00927953|19338433|P1|Overall Study|Death|2
5596479|NCT00927940|19338447|P1|Overall Study|Death|1
5596480|NCT00927927|19338467|P15|Overall Study|Withdrawal by Subject|0
5596481|NCT00927927|19338468|P14|Overall Study|Withdrawal by Subject|0
5596482|NCT00927927|19338469|P13|Overall Study|Withdrawal by Subject|0
5596483|NCT00927927|19338470|P12|Overall Study|Withdrawal by Subject|2
5596484|NCT00927927|19338471|P11|Overall Study|Withdrawal by Subject|0
5596485|NCT00927927|19338472|P10|Overall Study|Withdrawal by Subject|0
5596486|NCT00927927|19338473|P9|Overall Study|Withdrawal by Subject|0
5596487|NCT00927927|19338474|P8|Overall Study|Withdrawal by Subject|2
5596488|NCT00927927|19338475|P7|Overall Study|Withdrawal by Subject|0
5596489|NCT00927927|19338476|P6|Overall Study|Withdrawal by Subject|0
5596490|NCT00927927|19338477|P5|Overall Study|Withdrawal by Subject|0
5596491|NCT00927927|19338478|P4|Overall Study|Withdrawal by Subject|0
5596492|NCT00927927|19338479|P3|Overall Study|Withdrawal by Subject|0
5596493|NCT00927927|19338480|P2|Overall Study|Withdrawal by Subject|0
5596494|NCT00927927|19338481|P1|Overall Study|Withdrawal by Subject|0
5596495|NCT00927901|19338528|P4|Treatment Period 4|Subject withdrew consent|0
5596496|NCT00927901|19338529|P3|Treatment Period 4|Subject withdrew consent|1
5596497|NCT00927901|19338530|P2|Treatment Period 4|Subject withdrew consent|0
5596498|NCT00927901|19338531|P1|Treatment Period 4|Subject withdrew consent|0
5596499|NCT00927901|19338528|P4|Treatment Period 4|Adverse Event|1
5596500|NCT00927901|19338529|P3|Treatment Period 4|Adverse Event|0
5596501|NCT00927901|19338530|P2|Treatment Period 4|Adverse Event|0
5596502|NCT00927901|19338531|P1|Treatment Period 4|Adverse Event|0
5596503|NCT00927901|19338528|P4|Treatment Period 1|Subject withdrew consent|0
5596504|NCT00927901|19338529|P3|Treatment Period 1|Subject withdrew consent|1
5596505|NCT00927901|19338530|P2|Treatment Period 1|Subject withdrew consent|0
5596506|NCT00927901|19338531|P1|Treatment Period 1|Subject withdrew consent|0
5596507|NCT00927862|19338572|P2|Overall Study|Missing data needed for endpt analyses|45
5596508|NCT00927862|19338573|P1|Overall Study|Missing data needed for endpt analyses|27
5596509|NCT00927823|19338608|P4|Continuous Dosing Period|Other|3
5596510|NCT00927823|19338609|P3|Continuous Dosing Period|Other|9
5596511|NCT00927823|19338610|P2|Continuous Dosing Period|Other|2
5596512|NCT00927823|19338611|P1|Continuous Dosing Period|Other|1
5596513|NCT00927823|19338608|P4|Continuous Dosing Period|Withdrawal by Subject|2
5596514|NCT00927823|19338609|P3|Continuous Dosing Period|Withdrawal by Subject|2
5596515|NCT00927823|19338610|P2|Continuous Dosing Period|Withdrawal by Subject|0
5596516|NCT00927823|19338611|P1|Continuous Dosing Period|Withdrawal by Subject|1
5596517|NCT00927823|19338608|P4|Continuous Dosing Period|Lost to Follow-up|0
5596518|NCT00927823|19338609|P3|Continuous Dosing Period|Lost to Follow-up|9
5596519|NCT00927823|19338610|P2|Continuous Dosing Period|Lost to Follow-up|1
5596520|NCT00927823|19338611|P1|Continuous Dosing Period|Lost to Follow-up|1
5596521|NCT00927823|19338608|P4|Continuous Dosing Period|Death|0
5596522|NCT00927823|19338609|P3|Continuous Dosing Period|Death|6
5596523|NCT00927823|19338610|P2|Continuous Dosing Period|Death|0
5596524|NCT00927823|19338611|P1|Continuous Dosing Period|Death|0
5596525|NCT00927784|19338677|P2|Overall Study|Withdrawal by Subject|0
5596526|NCT00927784|19338678|P1|Overall Study|Withdrawal by Subject|1
5596527|NCT00927784|19338677|P2|Overall Study|Death|0
5596528|NCT00927784|19338678|P1|Overall Study|Death|1
5596529|NCT00927758|19338708|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
5596530|NCT00927758|19338709|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
5596531|NCT00927758|19338710|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
5596532|NCT00927758|19338711|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
5596533|NCT00927758|19338712|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
5596534|NCT00927758|19338713|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
5596535|NCT00927758|19338708|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
5596536|NCT00927758|19338709|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5596537|NCT00927758|19338710|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
5596538|NCT00927758|19338711|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5596539|NCT00927758|19338712|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5596540|NCT00927758|19338713|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
5596541|NCT00927589|19338721|P1|Overall Study|Non-compliance|1
5596542|NCT00927589|19338721|P1|Overall Study|Disease Progression|8
5596543|NCT00927589|19338721|P1|Overall Study|Adverse Event|2
5596544|NCT00927589|19338721|P1|Overall Study|Withdrawal by Subject|3
5596545|NCT00927589|19338721|P1|Overall Study|Physician Decision|1
5596546|NCT00927589|19338721|P1|Overall Study|Death|1
5596547|NCT00927563|19338751|P1|Overall Study|Withdrawal by Subject|1
5599603|NCT00906399|19348038|P3|Year 1|Other|7
5596548|NCT00927563|19338751|P1|Overall Study|Lost to Follow-up|1
5596549|NCT00927485|19338759|P2|Overall Study|noncompliance, prophylactic surgery, inc|2
5596550|NCT00927485|19338760|P1|Overall Study|noncompliance, prophylactic surgery, inc|2
5596551|NCT00927485|19338759|P2|Overall Study|Adverse Event|2
5596552|NCT00927485|19338760|P1|Overall Study|Adverse Event|4
5596553|NCT00927472|19338770|P2|Overall Study|Post treatment Assessment out of window|4
5596554|NCT00927472|19338771|P1|Overall Study|Post treatment Assessment out of window|0
5596555|NCT00927472|19338770|P2|Overall Study|Protocol Violation|1
5596556|NCT00927472|19338771|P1|Overall Study|Protocol Violation|0
5596557|NCT00927472|19338770|P2|Overall Study|Lost to Follow-up|6
5596558|NCT00927472|19338771|P1|Overall Study|Lost to Follow-up|1
5596559|NCT00927472|19338770|P2|Overall Study|Withdrawal by Subject|11
5596560|NCT00927472|19338771|P1|Overall Study|Withdrawal by Subject|10
5596561|NCT00927394|19338797|P2|Overall Study|Randomized in error|1
5596562|NCT00927394|19338798|P1|Overall Study|Randomized in error|0
5596563|NCT00927394|19338797|P2|Overall Study|Protocol deviation|13
5596564|NCT00927394|19338798|P1|Overall Study|Protocol deviation|16
5596565|NCT00927394|19338797|P2|Overall Study|Death|1
5596566|NCT00927394|19338798|P1|Overall Study|Death|1
5596567|NCT00927394|19338797|P2|Overall Study|Administrative Problem|0
5596568|NCT00927394|19338798|P1|Overall Study|Administrative Problem|1
5596569|NCT00927394|19338797|P2|Overall Study|Lost to Follow-up|14
5596570|NCT00927394|19338798|P1|Overall Study|Lost to Follow-up|8
5596571|NCT00927394|19338797|P2|Overall Study|Withdrawal by Subject|24
5596572|NCT00927394|19338798|P1|Overall Study|Withdrawal by Subject|20
5596573|NCT00927394|19338797|P2|Overall Study|Unsatisfactory therapeutic effect|23
5596574|NCT00927394|19338798|P1|Overall Study|Unsatisfactory therapeutic effect|17
5596575|NCT00927394|19338797|P2|Overall Study|Adverse Event|9
5596576|NCT00927394|19338798|P1|Overall Study|Adverse Event|14
5596577|NCT00927368|19338829|P3|Overall Study|cancellation of surgery|2
5596578|NCT00927368|19338830|P2|Overall Study|cancellation of surgery|1
5596579|NCT00927368|19338831|P1|Overall Study|cancellation of surgery|0
5596580|NCT00927368|19338829|P3|Overall Study|ineligible post randomization|1
5596581|NCT00927368|19338830|P2|Overall Study|ineligible post randomization|3
5596582|NCT00927368|19338831|P1|Overall Study|ineligible post randomization|0
5596583|NCT00927368|19338829|P3|Overall Study|equipment failure|0
5596584|NCT00927368|19338830|P2|Overall Study|equipment failure|0
5596585|NCT00927368|19338831|P1|Overall Study|equipment failure|1
5596586|NCT00927368|19338829|P3|Overall Study|Lost to Follow-up|0
5596587|NCT00927368|19338830|P2|Overall Study|Lost to Follow-up|0
5596588|NCT00927368|19338831|P1|Overall Study|Lost to Follow-up|4
5596589|NCT00927368|19338829|P3|Overall Study|enrollment in another study|2
5596590|NCT00927368|19338830|P2|Overall Study|enrollment in another study|1
5596591|NCT00927368|19338831|P1|Overall Study|enrollment in another study|1
5596592|NCT00927355|19338850|P2|Overall Study|Adverse Event|1
5596593|NCT00927355|19338851|P1|Overall Study|Adverse Event|1
5596594|NCT00927251|19338886|P1|Overall Study|Patients not implanted with 4296 lead|8
5596595|NCT00927186|19338892|P2|12 Months Primary Study|Withdrawal by Subject|1
5596596|NCT00927186|19338893|P1|12 Months Primary Study|Withdrawal by Subject|1
5596597|NCT00927186|19338892|P2|12 Months Primary Study|Protocol Violation|1
5596598|NCT00927186|19338893|P1|12 Months Primary Study|Protocol Violation|0
5596599|NCT00927186|19338892|P2|12 Months Primary Study|Lost to Follow-up|0
5596600|NCT00927186|19338893|P1|12 Months Primary Study|Lost to Follow-up|1
5596601|NCT00927186|19338892|P2|12 Months Primary Study|Adverse Event|2
5596602|NCT00927186|19338893|P1|12 Months Primary Study|Adverse Event|5
5596603|NCT00927095|19339023|P3|Overall Study|Physician Decision|1
5596604|NCT00927095|19339024|P2|Overall Study|Physician Decision|2
5596605|NCT00927095|19339025|P1|Overall Study|Physician Decision|1
5596606|NCT00927095|19339023|P3|Overall Study|Withdrawal by Subject|1
5596607|NCT00927095|19339024|P2|Overall Study|Withdrawal by Subject|1
5596608|NCT00927095|19339025|P1|Overall Study|Withdrawal by Subject|2
5596609|NCT00927095|19339023|P3|Overall Study|Adverse Event|0
5596610|NCT00927095|19339024|P2|Overall Study|Adverse Event|1
5596611|NCT00927095|19339025|P1|Overall Study|Adverse Event|3
5596612|NCT00927082|19339037|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
5596613|NCT00927082|19339038|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
5596614|NCT00927082|19339039|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
5596615|NCT00927082|19339040|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
5596616|NCT00927082|19339037|P4|Overall Study|Death|0
5596617|NCT00927082|19339038|P3|Overall Study|Death|1
5596618|NCT00927082|19339039|P2|Overall Study|Death|0
5596619|NCT00927082|19339040|P1|Overall Study|Death|0
5596620|NCT00927082|19339037|P4|Overall Study|Withdrawal by Subject|2
5596621|NCT00927082|19339038|P3|Overall Study|Withdrawal by Subject|7
5596622|NCT00927082|19339039|P2|Overall Study|Withdrawal by Subject|2
5596623|NCT00927082|19339040|P1|Overall Study|Withdrawal by Subject|3
5596624|NCT00927082|19339037|P4|Overall Study|Lost to Follow-up|16
5596625|NCT00927082|19339038|P3|Overall Study|Lost to Follow-up|12
5596626|NCT00927082|19339039|P2|Overall Study|Lost to Follow-up|8
5596627|NCT00927082|19339040|P1|Overall Study|Lost to Follow-up|9
5596628|NCT00927069|19339104|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
5596629|NCT00927069|19339105|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
5596630|NCT00927069|19339106|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
5596631|NCT00927069|19339107|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
5596632|NCT00927069|19339104|P4|Week 12 to Week 24|Withdrawal by Subject|0
5596633|NCT00927069|19339105|P3|Week 12 to Week 24|Withdrawal by Subject|0
5596634|NCT00927069|19339106|P2|Week 12 to Week 24|Withdrawal by Subject|0
5596635|NCT00927069|19339107|P1|Week 12 to Week 24|Withdrawal by Subject|1
5596636|NCT00927069|19339104|P4|Week 12 to Week 24|Lost to Follow-up|0
5596637|NCT00927069|19339105|P3|Week 12 to Week 24|Lost to Follow-up|1
5596638|NCT00927069|19339106|P2|Week 12 to Week 24|Lost to Follow-up|0
5596639|NCT00927069|19339107|P1|Week 12 to Week 24|Lost to Follow-up|0
5596640|NCT00927069|19339104|P4|Week 12 to Week 24|Lack of Efficacy|3
5596641|NCT00927069|19339105|P3|Week 12 to Week 24|Lack of Efficacy|2
5596642|NCT00927069|19339106|P2|Week 12 to Week 24|Lack of Efficacy|0
5596643|NCT00927069|19339107|P1|Week 12 to Week 24|Lack of Efficacy|0
5596644|NCT00927069|19339104|P4|Week 0 to Week 12|Worsening of psoriasis|0
5596645|NCT00927069|19339105|P3|Week 0 to Week 12|Worsening of psoriasis|0
5596646|NCT00927069|19339106|P2|Week 0 to Week 12|Worsening of psoriasis|1
5596647|NCT00927069|19339107|P1|Week 0 to Week 12|Worsening of psoriasis|1
5596648|NCT00926796|19339163|P2|Overall Study|Withdrawal by Subject|0
5596649|NCT00926796|19339164|P1|Overall Study|Withdrawal by Subject|1
5596650|NCT00926796|19339163|P2|Overall Study|Protocol Violation|11
5596651|NCT00926796|19339164|P1|Overall Study|Protocol Violation|15
5596652|NCT00926796|19339163|P2|Overall Study|Lost to Follow-up|13
5596653|NCT00926796|19339164|P1|Overall Study|Lost to Follow-up|22
5596654|NCT00926796|19339163|P2|Overall Study|Adverse Event|14
5596655|NCT00926796|19339164|P1|Overall Study|Adverse Event|7
5596656|NCT00926796|19339163|P2|Overall Study|Ineligible, but positive for gonorrhea|1
5596657|NCT00926796|19339164|P1|Overall Study|Ineligible, but positive for gonorrhea|1
5596658|NCT00926796|19339163|P2|Overall Study|Ineligible, negative for gonorrhea|60
5596659|NCT00926796|19339164|P1|Overall Study|Ineligible, negative for gonorrhea|57
5596660|NCT00926796|19339163|P2|Overall Study|Did not receive randomized treatment|7
5596661|NCT00926796|19339164|P1|Overall Study|Did not receive randomized treatment|4
5596662|NCT00926783|19339185|P2|Overall Study|Incomplete CFAE Procedures|3
5596663|NCT00926783|19339186|P1|Overall Study|Incomplete CFAE Procedures|3
5596664|NCT00926575|19339213|P2|Overall Study|Withdrawal by Subject|9
5596665|NCT00926575|19339214|P1|Overall Study|Withdrawal by Subject|8
5596666|NCT00926575|19339213|P2|Overall Study|Protocol Violation|0
5596667|NCT00926575|19339214|P1|Overall Study|Protocol Violation|1
5596668|NCT00926575|19339213|P2|Overall Study|Physician Decision|2
5596669|NCT00926575|19339214|P1|Overall Study|Physician Decision|1
5596670|NCT00926575|19339213|P2|Overall Study|Lost to Follow-up|1
5596671|NCT00926575|19339214|P1|Overall Study|Lost to Follow-up|1
5596672|NCT00926575|19339213|P2|Overall Study|Death|4
5596673|NCT00926575|19339214|P1|Overall Study|Death|4
5596674|NCT00926575|19339213|P2|Overall Study|Adverse Event|1
5596675|NCT00926575|19339214|P1|Overall Study|Adverse Event|1
5596676|NCT00926536|19339226|P2|Overall Study|Physician Decision|2
5596677|NCT00926536|19339227|P1|Overall Study|Physician Decision|1
5596678|NCT00926393|19339248|P2|Overall Study|Adverse Event|1
5596679|NCT00926393|19339249|P1|Overall Study|Adverse Event|1
5596680|NCT00926393|19339248|P2|Overall Study|Withdrawal by Subject|2
5596681|NCT00926393|19339249|P1|Overall Study|Withdrawal by Subject|1
5596682|NCT00926367|19339294|P2|Overall Study|Skin Irritation|2
5596683|NCT00926367|19339295|P1|Overall Study|Skin Irritation|1
5596684|NCT00926367|19339294|P2|Overall Study|Lost to Follow-up|0
5596685|NCT00926367|19339295|P1|Overall Study|Lost to Follow-up|1
5596686|NCT00926367|19339294|P2|Overall Study|Withdrawal by Subject|1
5596687|NCT00926367|19339295|P1|Overall Study|Withdrawal by Subject|0
5596688|NCT00926328|19339337|P2|Overall Study|Lost to Follow-up|14
5596689|NCT00926328|19339338|P1|Overall Study|Lost to Follow-up|12
5596690|NCT00926289|19339348|P2|Overall Study|Other|3
5596691|NCT00926289|19339349|P1|Overall Study|Other|1
5596692|NCT00926289|19339348|P2|Overall Study|Withdrawal by Subject|4
5596693|NCT00926289|19339349|P1|Overall Study|Withdrawal by Subject|4
5596694|NCT00926289|19339348|P2|Overall Study|Lost to Follow-up|6
5596695|NCT00926289|19339349|P1|Overall Study|Lost to Follow-up|3
5596696|NCT00926289|19339348|P2|Overall Study|Protocol Violation|12
5596697|NCT00926289|19339349|P1|Overall Study|Protocol Violation|8
5596698|NCT00926289|19339348|P2|Overall Study|Adverse Event|11
5596699|NCT00926289|19339349|P1|Overall Study|Adverse Event|9
5596700|NCT00926237|19339417|P2|Overall Study|Withdrawal by Subject|1
5596701|NCT00926237|19339418|P1|Overall Study|Withdrawal by Subject|2
5596702|NCT00926211|19339428|P1|Overall Study|Lost to Follow-up|1
5596703|NCT00926029|19339459|P3|Overall Study|Lost to Follow-up|1
5596704|NCT00926029|19339460|P2|Overall Study|Lost to Follow-up|1
5596705|NCT00926029|19339461|P1|Overall Study|Lost to Follow-up|2
5596706|NCT00926003|19339475|P3|Post-Training 3-month Follow-up|Lost to Follow-up|0
5596707|NCT00926003|19339476|P2|Post-Training 3-month Follow-up|Lost to Follow-up|0
5596708|NCT00926003|19339477|P1|Post-Training 3-month Follow-up|Lost to Follow-up|1
5596709|NCT00926003|19339475|P3|Post-Training Evaluation|Withdrawal by Subject|0
5596710|NCT00926003|19339476|P2|Post-Training Evaluation|Withdrawal by Subject|0
5596711|NCT00926003|19339477|P1|Post-Training Evaluation|Withdrawal by Subject|1
5596712|NCT00925990|19339490|P2|Overall Study|moved out of state, missed medication|2
5596713|NCT00925990|19339491|P1|Overall Study|moved out of state, missed medication|0
5596714|NCT00925990|19339490|P2|Overall Study|Physician Decision|1
5596715|NCT00925990|19339491|P1|Overall Study|Physician Decision|1
5596716|NCT00925990|19339490|P2|Overall Study|Lost to Follow-up|3
5596717|NCT00925990|19339491|P1|Overall Study|Lost to Follow-up|1
5596718|NCT00925990|19339490|P2|Overall Study|Withdrawal by Subject|2
5599604|NCT00906399|19348039|P2|Year 1|Other|2
5596719|NCT00925990|19339491|P1|Overall Study|Withdrawal by Subject|2
5596720|NCT00925990|19339490|P2|Overall Study|Adverse Event|3
5596721|NCT00925990|19339491|P1|Overall Study|Adverse Event|1
5596722|NCT00925899|19339526|P2|Part 1|Withdrawal by Subject|9
5596723|NCT00925899|19339527|P1|Part 1|Withdrawal by Subject|10
5596724|NCT00925899|19339526|P2|Part 1|Death|2
5596725|NCT00925899|19339527|P1|Part 1|Death|1
5596726|NCT00925769|19339555|P6|Overall Study|Adverse Event|0
5596727|NCT00925769|19339556|P5|Overall Study|Adverse Event|1
5596728|NCT00925769|19339557|P4|Overall Study|Adverse Event|0
5596729|NCT00925769|19339558|P3|Overall Study|Adverse Event|0
5596730|NCT00925769|19339559|P2|Overall Study|Adverse Event|0
5596731|NCT00925769|19339560|P1|Overall Study|Adverse Event|0
5596732|NCT00925769|19339555|P6|Overall Study|Participant is unable to swallow drug|0
5596733|NCT00925769|19339556|P5|Overall Study|Participant is unable to swallow drug|0
5596734|NCT00925769|19339557|P4|Overall Study|Participant is unable to swallow drug|1
5596735|NCT00925769|19339558|P3|Overall Study|Participant is unable to swallow drug|0
5596736|NCT00925769|19339559|P2|Overall Study|Participant is unable to swallow drug|0
5596737|NCT00925769|19339560|P1|Overall Study|Participant is unable to swallow drug|0
5596738|NCT00925769|19339555|P6|Overall Study|End of study visit not done|0
5596739|NCT00925769|19339556|P5|Overall Study|End of study visit not done|0
5596740|NCT00925769|19339557|P4|Overall Study|End of study visit not done|0
5596741|NCT00925769|19339558|P3|Overall Study|End of study visit not done|1
5596742|NCT00925769|19339559|P2|Overall Study|End of study visit not done|0
5596743|NCT00925769|19339560|P1|Overall Study|End of study visit not done|0
5596744|NCT00925769|19339555|P6|Overall Study|Missing documentation|0
5596745|NCT00925769|19339556|P5|Overall Study|Missing documentation|0
5596746|NCT00925769|19339557|P4|Overall Study|Missing documentation|0
5596747|NCT00925769|19339558|P3|Overall Study|Missing documentation|0
5596748|NCT00925769|19339559|P2|Overall Study|Missing documentation|1
5596749|NCT00925769|19339560|P1|Overall Study|Missing documentation|0
5596750|NCT00925769|19339555|P6|Overall Study|Physician Decision|0
5596751|NCT00925769|19339556|P5|Overall Study|Physician Decision|0
5596752|NCT00925769|19339557|P4|Overall Study|Physician Decision|0
5596753|NCT00925769|19339558|P3|Overall Study|Physician Decision|0
5596754|NCT00925769|19339559|P2|Overall Study|Physician Decision|0
5596755|NCT00925769|19339560|P1|Overall Study|Physician Decision|1
5596756|NCT00925769|19339555|P6|Overall Study|Death|0
5596757|NCT00925769|19339556|P5|Overall Study|Death|0
5596758|NCT00925769|19339557|P4|Overall Study|Death|0
5596759|NCT00925769|19339558|P3|Overall Study|Death|1
5596760|NCT00925769|19339559|P2|Overall Study|Death|0
5596761|NCT00925769|19339560|P1|Overall Study|Death|0
5596762|NCT00925769|19339555|P6|Overall Study|Disease progression|3
5596763|NCT00925769|19339556|P5|Overall Study|Disease progression|2
5596764|NCT00925769|19339557|P4|Overall Study|Disease progression|4
5596765|NCT00925769|19339558|P3|Overall Study|Disease progression|3
5596766|NCT00925769|19339559|P2|Overall Study|Disease progression|5
5596767|NCT00925769|19339560|P1|Overall Study|Disease progression|4
5596768|NCT00925769|19339555|P6|Overall Study|Major toxicity|0
5596769|NCT00925769|19339556|P5|Overall Study|Major toxicity|0
5596770|NCT00925769|19339557|P4|Overall Study|Major toxicity|1
5596771|NCT00925769|19339558|P3|Overall Study|Major toxicity|1
5596772|NCT00925769|19339559|P2|Overall Study|Major toxicity|0
5596773|NCT00925769|19339560|P1|Overall Study|Major toxicity|1
5596774|NCT00925704|19339634|P6|Third Intervention|Withdrew consent|1
5596775|NCT00925704|19339635|P5|Third Intervention|Withdrew consent|0
5596776|NCT00925704|19339636|P4|Third Intervention|Withdrew consent|0
5596777|NCT00925704|19339637|P3|Third Intervention|Withdrew consent|0
5596778|NCT00925704|19339638|P2|Third Intervention|Withdrew consent|0
5596779|NCT00925704|19339639|P1|Third Intervention|Withdrew consent|0
5596780|NCT00925704|19339634|P6|Second Intervention|Withdrawal by Subject|0
5596781|NCT00925704|19339635|P5|Second Intervention|Withdrawal by Subject|1
5596782|NCT00925704|19339636|P4|Second Intervention|Withdrawal by Subject|0
5596783|NCT00925704|19339637|P3|Second Intervention|Withdrawal by Subject|0
5596784|NCT00925704|19339638|P2|Second Intervention|Withdrawal by Subject|0
5596785|NCT00925704|19339639|P1|Second Intervention|Withdrawal by Subject|1
5596786|NCT00925704|19339634|P6|First Intervention|Withdrew consent|0
5596787|NCT00925704|19339635|P5|First Intervention|Withdrew consent|1
5596788|NCT00925704|19339636|P4|First Intervention|Withdrew consent|1
5596789|NCT00925704|19339637|P3|First Intervention|Withdrew consent|0
5596790|NCT00925704|19339638|P2|First Intervention|Withdrew consent|0
5596791|NCT00925704|19339639|P1|First Intervention|Withdrew consent|0
5596792|NCT00925600|19339652|P2|Overall Study|Adverse Event|2
5596793|NCT00925600|19339653|P1|Overall Study|Adverse Event|1
5596794|NCT00925600|19339652|P2|Overall Study|Other|1
5596795|NCT00925600|19339653|P1|Overall Study|Other|3
5596796|NCT00925600|19339652|P2|Overall Study|Requirement for Alternative Therapy|1
5596797|NCT00925600|19339653|P1|Overall Study|Requirement for Alternative Therapy|0
5596798|NCT00925600|19339652|P2|Overall Study|Protocol Deviation|1
5596799|NCT00925600|19339653|P1|Overall Study|Protocol Deviation|0
5596800|NCT00925600|19339652|P2|Overall Study|Ineligibility Determined|0
5596801|NCT00925600|19339653|P1|Overall Study|Ineligibility Determined|2
5596802|NCT00925600|19339652|P2|Overall Study|Noncompliance|0
5596803|NCT00925600|19339653|P1|Overall Study|Noncompliance|2
5596804|NCT00925600|19339652|P2|Overall Study|Administrative Decision|1
5596805|NCT00925600|19339653|P1|Overall Study|Administrative Decision|1
5596806|NCT00925600|19339652|P2|Overall Study|Disease Progression|3
5596807|NCT00925600|19339653|P1|Overall Study|Disease Progression|1
5596808|NCT00925600|19339652|P2|Overall Study|Lost to Follow-up|2
5596809|NCT00925600|19339653|P1|Overall Study|Lost to Follow-up|2
5596810|NCT00925600|19339652|P2|Overall Study|Death|3
5596811|NCT00925600|19339653|P1|Overall Study|Death|4
5596812|NCT00925600|19339652|P2|Overall Study|Withdrawal by Subject|14
5596813|NCT00925600|19339653|P1|Overall Study|Withdrawal by Subject|16
5596814|NCT00925587|19339675|P2|Overall Study|Lost to Follow-up|1
5596815|NCT00925587|19339676|P1|Overall Study|Lost to Follow-up|0
5596816|NCT00925587|19339675|P2|Overall Study|Adverse Event|2
5596817|NCT00925587|19339676|P1|Overall Study|Adverse Event|6
5596818|NCT00925587|19339675|P2|Overall Study|Death|5
5596819|NCT00925587|19339676|P1|Overall Study|Death|5
5596820|NCT00925587|19339675|P2|Overall Study|Withdrawal by Subject|6
5596821|NCT00925587|19339676|P1|Overall Study|Withdrawal by Subject|9
5596822|NCT00925587|19339675|P2|Overall Study|Protocol Violation|4
5596823|NCT00925587|19339676|P1|Overall Study|Protocol Violation|6
5596824|NCT00925587|19339675|P2|Overall Study|Physician Decision|1
5596825|NCT00925587|19339676|P1|Overall Study|Physician Decision|4
5596826|NCT00925587|19339675|P2|Overall Study|Protocol Specified Criteria|6
5596827|NCT00925587|19339676|P1|Overall Study|Protocol Specified Criteria|6
5596828|NCT00925548|19339790|P2|Overall Study|Discontinuation of trial by sponsor|5
5596829|NCT00925548|19339791|P1|Overall Study|Discontinuation of trial by sponsor|10
5596830|NCT00925522|19339817|P1|Overall Study|study closed -- business decision|20
5596831|NCT00925353|19339821|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
5596832|NCT00925301|19339827|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
5596833|NCT00925301|19339828|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
5596834|NCT00925301|19339829|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
5596835|NCT00925301|19339830|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
5596836|NCT00925301|19339827|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
5596837|NCT00925301|19339828|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
5596838|NCT00925301|19339829|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
5596839|NCT00925301|19339830|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
5596840|NCT00925301|19339827|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
5596841|NCT00925301|19339828|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
5596842|NCT00925301|19339829|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
5596843|NCT00925301|19339830|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
5596844|NCT00925301|19339827|P4|6-Month Open-label (Stage 2)|Adverse Event|0
5596845|NCT00925301|19339828|P3|6-Month Open-label (Stage 2)|Adverse Event|2
5596846|NCT00925301|19339829|P2|6-Month Open-label (Stage 2)|Adverse Event|0
5596847|NCT00925301|19339830|P1|6-Month Open-label (Stage 2)|Adverse Event|0
5596848|NCT00925301|19339827|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
5596849|NCT00925301|19339828|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
5596850|NCT00925301|19339829|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
5596851|NCT00925301|19339830|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
5596852|NCT00925301|19339827|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
5596853|NCT00925301|19339828|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
5596854|NCT00925301|19339829|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
5596855|NCT00925301|19339830|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
5596856|NCT00925301|19339827|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
5596857|NCT00925301|19339828|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
5596858|NCT00925301|19339829|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
5596859|NCT00925301|19339830|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
5596860|NCT00925288|19339846|P2|Overall Study|Lost to Follow-up|7
5596861|NCT00925288|19339847|P1|Overall Study|Lost to Follow-up|9
5596862|NCT00925132|19339859|P5|Overall Study|Removed due to disease progression|4
5596863|NCT00925132|19339860|P4|Overall Study|Removed due to disease progression|0
5596864|NCT00925132|19339861|P3|Overall Study|Removed due to disease progression|0
5596865|NCT00925132|19339862|P2|Overall Study|Removed due to disease progression|0
5596866|NCT00925132|19339863|P1|Overall Study|Removed due to disease progression|0
5596867|NCT00925132|19339859|P5|Overall Study|Withdrawal by Subject|1
5596868|NCT00925132|19339860|P4|Overall Study|Withdrawal by Subject|0
5596869|NCT00925132|19339861|P3|Overall Study|Withdrawal by Subject|0
5596870|NCT00925132|19339862|P2|Overall Study|Withdrawal by Subject|0
5596871|NCT00925132|19339863|P1|Overall Study|Withdrawal by Subject|2
5596872|NCT00925015|19339958|P3|Overall Study|Withdrawal by Subject|1
5596873|NCT00925015|19339959|P2|Overall Study|Withdrawal by Subject|0
5596874|NCT00925015|19339960|P1|Overall Study|Withdrawal by Subject|0
5596875|NCT00925015|19339958|P3|Overall Study|Progressive Disease|4
5596876|NCT00925015|19339959|P2|Overall Study|Progressive Disease|3
5596877|NCT00925015|19339960|P1|Overall Study|Progressive Disease|7
5596878|NCT00925015|19339958|P3|Overall Study|Physician Decision|0
5596879|NCT00925015|19339959|P2|Overall Study|Physician Decision|1
5596880|NCT00925015|19339960|P1|Overall Study|Physician Decision|0
5596881|NCT00925015|19339958|P3|Overall Study|Adverse Event|1
5596882|NCT00925015|19339959|P2|Overall Study|Adverse Event|2
5596883|NCT00925015|19339960|P1|Overall Study|Adverse Event|1
5596884|NCT00924950|19340016|P1|Overall Study|Lost to Follow-up|2
5596885|NCT00924898|19340023|P1|Overall Study|Withdrawal by Subject|2
5596886|NCT00924820|19340062|P1|Overall Study|Ineligible, Screen Failure|5
5596887|NCT00924820|19340062|P1|Overall Study|Death|2
5596888|NCT00924781|19340077|P2|Overall Study|Study terminated by sponsor|10
5596889|NCT00924781|19340078|P1|Overall Study|Study terminated by sponsor|12
5599605|NCT00906399|19348040|P1|Year 1|Other|4
5596890|NCT00924729|19340112|P2|Overall Study|Protocol Violation|0
5596891|NCT00924729|19340113|P1|Overall Study|Protocol Violation|1
5596892|NCT00924729|19340112|P2|Overall Study|insufficient volume for analysis|0
5596893|NCT00924729|19340113|P1|Overall Study|insufficient volume for analysis|1
5596894|NCT00924651|19340123|P2|Overall Study|Incomplete Form|1
5596895|NCT00924651|19340124|P1|Overall Study|Incomplete Form|2
5596896|NCT00924651|19340123|P2|Overall Study|Changed Mind|1
5596897|NCT00924651|19340124|P1|Overall Study|Changed Mind|10
5596898|NCT00924651|19340123|P2|Overall Study|Medical|3
5596899|NCT00924651|19340124|P1|Overall Study|Medical|1
5596900|NCT00924651|19340123|P2|Overall Study|Noncompliant|4
5596901|NCT00924651|19340124|P1|Overall Study|Noncompliant|1
5596902|NCT00924651|19340123|P2|Overall Study|Overwhelmed|6
5596903|NCT00924651|19340124|P1|Overall Study|Overwhelmed|6
5596904|NCT00924651|19340123|P2|Overall Study|No Reason|7
5596905|NCT00924651|19340124|P1|Overall Study|No Reason|3
5596906|NCT00924651|19340123|P2|Overall Study|Chemo started too soon|3
5596907|NCT00924651|19340124|P1|Overall Study|Chemo started too soon|2
5596908|NCT00924638|19340132|P2|Overall Study|Physician Decision|3
5596909|NCT00924638|19340133|P1|Overall Study|Physician Decision|3
5596910|NCT00924638|19340132|P2|Overall Study|Withdrawal by Subject|7
5596911|NCT00924638|19340133|P1|Overall Study|Withdrawal by Subject|5
5596912|NCT00924638|19340132|P2|Overall Study|Lost to Follow-up|1
5596913|NCT00924638|19340133|P1|Overall Study|Lost to Follow-up|1
5596914|NCT00924638|19340132|P2|Overall Study|Death|2
5596915|NCT00924638|19340133|P1|Overall Study|Death|3
5596916|NCT00924560|19340170|P3|Overall Study|Miscellaneous Reasons|10
5596917|NCT00924560|19340171|P2|Overall Study|Miscellaneous Reasons|10
5596918|NCT00924560|19340172|P1|Overall Study|Miscellaneous Reasons|13
5596919|NCT00924560|19340170|P3|Overall Study|Lost to Follow-up|45
5596920|NCT00924560|19340171|P2|Overall Study|Lost to Follow-up|94
5596921|NCT00924560|19340172|P1|Overall Study|Lost to Follow-up|78
5596922|NCT00924560|19340170|P3|Overall Study|Pregnancy|1
5596923|NCT00924560|19340171|P2|Overall Study|Pregnancy|7
5596924|NCT00924560|19340172|P1|Overall Study|Pregnancy|5
5596925|NCT00924560|19340170|P3|Overall Study|Adverse Event|0
5596926|NCT00924560|19340171|P2|Overall Study|Adverse Event|33
5596927|NCT00924560|19340172|P1|Overall Study|Adverse Event|39
5596928|NCT00924560|19340170|P3|Overall Study|Withdrawal by Subject|18
5596929|NCT00924560|19340171|P2|Overall Study|Withdrawal by Subject|44
5596930|NCT00924560|19340172|P1|Overall Study|Withdrawal by Subject|50
5596931|NCT00924560|19340170|P3|Overall Study|Physician Decision|4
5596932|NCT00924560|19340171|P2|Overall Study|Physician Decision|3
5596933|NCT00924560|19340172|P1|Overall Study|Physician Decision|2
5596934|NCT00924560|19340170|P3|Overall Study|Non Compliance with the Protocol|4
5596935|NCT00924560|19340171|P2|Overall Study|Non Compliance with the Protocol|15
5596936|NCT00924560|19340172|P1|Overall Study|Non Compliance with the Protocol|20
5596937|NCT00924560|19340170|P3|Overall Study|Did Not Meet Protocol Requirements|1
5596938|NCT00924560|19340171|P2|Overall Study|Did Not Meet Protocol Requirements|2
5596939|NCT00924560|19340172|P1|Overall Study|Did Not Meet Protocol Requirements|4
5596940|NCT00924508|19340216|P1|Overall Study|Withdrawal by Subject|3
5596941|NCT00924469|19340230|P2|Overall Study|Lost to Follow-up|1
5596942|NCT00924469|19340231|P1|Overall Study|Lost to Follow-up|0
5596943|NCT00924469|19340230|P2|Overall Study|Withdrawal by Subject|1
5596944|NCT00924469|19340231|P1|Overall Study|Withdrawal by Subject|0
5596945|NCT00924469|19340230|P2|Overall Study|Adverse Event|0
5596946|NCT00924469|19340231|P1|Overall Study|Adverse Event|2
5596947|NCT00924443|19340253|P1|Overall Study|Protocol Violation|1
5596948|NCT00924443|19340253|P1|Overall Study|Physician Decision|2
5596949|NCT00924404|19340263|P2|Overall Study|Lost to Follow-up|4
5596950|NCT00924404|19340264|P1|Overall Study|Lost to Follow-up|6
5596951|NCT00924313|19340335|P1|Overall Study|not imaged due to failed tracer imaging|1
5596952|NCT00924287|19340347|P1|Overall Study|Death|1
5596953|NCT00924170|19340363|P2|Overall Study|Death|0
5596954|NCT00924170|19340364|P1|Overall Study|Death|1
5596955|NCT00924170|19340363|P2|Overall Study|Stopped due to neutralizing antibodies|0
5596956|NCT00924170|19340364|P1|Overall Study|Stopped due to neutralizing antibodies|3
5596957|NCT00924170|19340363|P2|Overall Study|Progressive disease|6
5596958|NCT00924170|19340364|P1|Overall Study|Progressive disease|3
5596959|NCT00924170|19340363|P2|Overall Study|Physician Decision|1
5596960|NCT00924170|19340364|P1|Overall Study|Physician Decision|0
5596961|NCT00924170|19340363|P2|Overall Study|Refused further treatment|1
5596962|NCT00924170|19340364|P1|Overall Study|Refused further treatment|0
5596963|NCT00923975|19340489|P1|Overall Study|Did not meet inclusion criteria|1
5596964|NCT00923936|19340508|P2|Overall Study|Continuing in follow up period|1
5596965|NCT00923936|19340509|P1|Overall Study|Continuing in follow up period|2
5596966|NCT00923936|19340508|P2|Overall Study|Lost to follow up|0
5596967|NCT00923936|19340509|P1|Overall Study|Lost to follow up|2
5596968|NCT00923936|19340508|P2|Overall Study|Adverse Event|1
5596969|NCT00923936|19340509|P1|Overall Study|Adverse Event|2
5596970|NCT00923936|19340508|P2|Overall Study|progressive disease on study|1
5596971|NCT00923936|19340509|P1|Overall Study|progressive disease on study|2
5596972|NCT00923845|19340538|P2|Induction Therapy|Poor performance status|2
5596973|NCT00923845|19340539|P1|Induction Therapy|Poor performance status|0
5596974|NCT00923364|19340574|P2|Overall Study|Did not go to transplant|0
5596975|NCT00923364|19340575|P1|Overall Study|Did not go to transplant|1
5596976|NCT00923364|19340574|P2|Overall Study|Death|0
5596977|NCT00923364|19340575|P1|Overall Study|Death|3
5596978|NCT00923351|19340587|P3|Overall Study|no apheresis/adequate tumor sample|12
5596979|NCT00923351|19340588|P2|Overall Study|no apheresis/adequate tumor sample|0
5596980|NCT00923351|19340589|P1|Overall Study|no apheresis/adequate tumor sample|0
5596981|NCT00923273|19340604|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5596982|NCT00923273|19340605|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
5596983|NCT00923273|19340606|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5596984|NCT00923273|19340607|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5596985|NCT00923273|19340608|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
5596986|NCT00923273|19340604|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5596987|NCT00923273|19340605|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
5596988|NCT00923273|19340606|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5596989|NCT00923273|19340607|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5596990|NCT00923273|19340608|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
5596991|NCT00923260|19340633|P2|Overall Study|Lost to Follow-up|1
5596992|NCT00923260|19340634|P1|Overall Study|Lost to Follow-up|1
5596993|NCT00923195|19340797|P2|Overall Study|Death|1
5596994|NCT00923195|19340798|P1|Overall Study|Death|0
5596995|NCT00923156|19340809|P3|Overall Study|Lack of Efficacy|1
5596996|NCT00923156|19340810|P2|Overall Study|Lack of Efficacy|0
5596997|NCT00923156|19340811|P1|Overall Study|Lack of Efficacy|0
5596998|NCT00923156|19340809|P3|Overall Study|Death|0
5596999|NCT00923156|19340810|P2|Overall Study|Death|1
5597000|NCT00923156|19340811|P1|Overall Study|Death|0
5597001|NCT00923156|19340809|P3|Overall Study|Withdrawal by Subject|0
5597002|NCT00923156|19340810|P2|Overall Study|Withdrawal by Subject|1
5597003|NCT00923156|19340811|P1|Overall Study|Withdrawal by Subject|0
5597004|NCT00923156|19340809|P3|Overall Study|Abnormal laboratory values|1
5597005|NCT00923156|19340810|P2|Overall Study|Abnormal laboratory values|0
5597006|NCT00923156|19340811|P1|Overall Study|Abnormal laboratory values|0
5597007|NCT00923156|19340809|P3|Overall Study|Adverse Event|1
5597008|NCT00923156|19340810|P2|Overall Study|Adverse Event|2
5597009|NCT00923156|19340811|P1|Overall Study|Adverse Event|0
5597010|NCT00923130|19340837|P1|Overall Study|Refused further treatment|2
5597011|NCT00923130|19340837|P1|Overall Study|Switched to alternative treatment|2
5597012|NCT00923130|19340837|P1|Overall Study|Discontinued treatment due to toxicities|3
5597013|NCT00923130|19340837|P1|Overall Study|Death|1
5597014|NCT00923130|19340837|P1|Overall Study|Stopped treatment due to progression|17
5597015|NCT00923091|19340872|P13|Period VI (Open-Label)|Other Reason|0
5597016|NCT00923091|19340873|P12|Period VI (Open-Label)|Other Reason|0
5597017|NCT00923091|19340874|P11|Period VI (Open-Label)|Other Reason|0
5597018|NCT00923091|19340875|P10|Period VI (Open-Label)|Other Reason|0
5597019|NCT00923091|19340876|P9|Period VI (Open-Label)|Other Reason|0
5597020|NCT00923091|19340877|P8|Period VI (Open-Label)|Other Reason|0
5597021|NCT00923091|19340878|P7|Period VI (Open-Label)|Other Reason|0
5597022|NCT00923091|19340879|P6|Period VI (Open-Label)|Other Reason|0
5597023|NCT00923091|19340880|P5|Period VI (Open-Label)|Other Reason|1
5597024|NCT00923091|19340881|P4|Period VI (Open-Label)|Other Reason|1
5597025|NCT00923091|19340882|P3|Period VI (Open-Label)|Other Reason|0
5597026|NCT00923091|19340883|P2|Period VI (Open-Label)|Other Reason|0
5597027|NCT00923091|19340884|P1|Period VI (Open-Label)|Other Reason|0
5597028|NCT00923091|19340872|P13|Period VI (Open-Label)|Lost to Follow-up|0
5597029|NCT00923091|19340873|P12|Period VI (Open-Label)|Lost to Follow-up|0
5597030|NCT00923091|19340874|P11|Period VI (Open-Label)|Lost to Follow-up|0
5597031|NCT00923091|19340875|P10|Period VI (Open-Label)|Lost to Follow-up|0
5597032|NCT00923091|19340876|P9|Period VI (Open-Label)|Lost to Follow-up|0
5597033|NCT00923091|19340877|P8|Period VI (Open-Label)|Lost to Follow-up|0
5597034|NCT00923091|19340878|P7|Period VI (Open-Label)|Lost to Follow-up|0
5597035|NCT00923091|19340879|P6|Period VI (Open-Label)|Lost to Follow-up|0
5597036|NCT00923091|19340880|P5|Period VI (Open-Label)|Lost to Follow-up|0
5597037|NCT00923091|19340881|P4|Period VI (Open-Label)|Lost to Follow-up|0
5597038|NCT00923091|19340882|P3|Period VI (Open-Label)|Lost to Follow-up|1
5597039|NCT00923091|19340883|P2|Period VI (Open-Label)|Lost to Follow-up|0
5597040|NCT00923091|19340884|P1|Period VI (Open-Label)|Lost to Follow-up|1
5597041|NCT00923091|19340872|P13|Period VI (Open-Label)|Protocol Violation|0
5597042|NCT00923091|19340873|P12|Period VI (Open-Label)|Protocol Violation|0
5597043|NCT00923091|19340874|P11|Period VI (Open-Label)|Protocol Violation|0
5597044|NCT00923091|19340875|P10|Period VI (Open-Label)|Protocol Violation|0
5597045|NCT00923091|19340876|P9|Period VI (Open-Label)|Protocol Violation|0
5597046|NCT00923091|19340877|P8|Period VI (Open-Label)|Protocol Violation|0
5597047|NCT00923091|19340878|P7|Period VI (Open-Label)|Protocol Violation|0
5597048|NCT00923091|19340879|P6|Period VI (Open-Label)|Protocol Violation|0
5597049|NCT00923091|19340880|P5|Period VI (Open-Label)|Protocol Violation|4
5597050|NCT00923091|19340881|P4|Period VI (Open-Label)|Protocol Violation|1
5597051|NCT00923091|19340882|P3|Period VI (Open-Label)|Protocol Violation|3
5597052|NCT00923091|19340883|P2|Period VI (Open-Label)|Protocol Violation|1
5597053|NCT00923091|19340884|P1|Period VI (Open-Label)|Protocol Violation|6
5597054|NCT00923091|19340872|P13|Period VI (Open-Label)|Withdrawal by Subject|0
5597055|NCT00923091|19340873|P12|Period VI (Open-Label)|Withdrawal by Subject|0
5597056|NCT00923091|19340874|P11|Period VI (Open-Label)|Withdrawal by Subject|0
5597057|NCT00923091|19340875|P10|Period VI (Open-Label)|Withdrawal by Subject|0
5597058|NCT00923091|19340876|P9|Period VI (Open-Label)|Withdrawal by Subject|0
5597059|NCT00923091|19340877|P8|Period VI (Open-Label)|Withdrawal by Subject|0
5597060|NCT00923091|19340878|P7|Period VI (Open-Label)|Withdrawal by Subject|0
5597061|NCT00923091|19340879|P6|Period VI (Open-Label)|Withdrawal by Subject|0
5597062|NCT00923091|19340880|P5|Period VI (Open-Label)|Withdrawal by Subject|1
5597063|NCT00923091|19340881|P4|Period VI (Open-Label)|Withdrawal by Subject|0
5597064|NCT00923091|19340882|P3|Period VI (Open-Label)|Withdrawal by Subject|5
5597065|NCT00923091|19340883|P2|Period VI (Open-Label)|Withdrawal by Subject|7
5597066|NCT00923091|19340884|P1|Period VI (Open-Label)|Withdrawal by Subject|15
5597067|NCT00923091|19340872|P13|Period VI (Open-Label)|Adverse Event|0
5597068|NCT00923091|19340873|P12|Period VI (Open-Label)|Adverse Event|0
5597069|NCT00923091|19340874|P11|Period VI (Open-Label)|Adverse Event|0
5597070|NCT00923091|19340875|P10|Period VI (Open-Label)|Adverse Event|0
5597071|NCT00923091|19340876|P9|Period VI (Open-Label)|Adverse Event|0
5597072|NCT00923091|19340877|P8|Period VI (Open-Label)|Adverse Event|0
5597073|NCT00923091|19340878|P7|Period VI (Open-Label)|Adverse Event|0
5597074|NCT00923091|19340879|P6|Period VI (Open-Label)|Adverse Event|0
5597075|NCT00923091|19340880|P5|Period VI (Open-Label)|Adverse Event|1
5597076|NCT00923091|19340881|P4|Period VI (Open-Label)|Adverse Event|1
5597077|NCT00923091|19340882|P3|Period VI (Open-Label)|Adverse Event|4
5597078|NCT00923091|19340883|P2|Period VI (Open-Label)|Adverse Event|0
5597079|NCT00923091|19340884|P1|Period VI (Open-Label)|Adverse Event|17
5597080|NCT00923091|19340872|P13|Period V (Double -Blind)|Lost to Follow-up|0
5597081|NCT00923091|19340873|P12|Period V (Double -Blind)|Lost to Follow-up|0
5597082|NCT00923091|19340874|P11|Period V (Double -Blind)|Lost to Follow-up|1
5597083|NCT00923091|19340875|P10|Period V (Double -Blind)|Lost to Follow-up|0
5597084|NCT00923091|19340876|P9|Period V (Double -Blind)|Lost to Follow-up|0
5597085|NCT00923091|19340877|P8|Period V (Double -Blind)|Lost to Follow-up|0
5597086|NCT00923091|19340878|P7|Period V (Double -Blind)|Lost to Follow-up|0
5597087|NCT00923091|19340879|P6|Period V (Double -Blind)|Lost to Follow-up|0
5597088|NCT00923091|19340880|P5|Period V (Double -Blind)|Lost to Follow-up|0
5597089|NCT00923091|19340881|P4|Period V (Double -Blind)|Lost to Follow-up|0
5597090|NCT00923091|19340882|P3|Period V (Double -Blind)|Lost to Follow-up|0
5597091|NCT00923091|19340883|P2|Period V (Double -Blind)|Lost to Follow-up|0
5597092|NCT00923091|19340884|P1|Period V (Double -Blind)|Lost to Follow-up|0
5597093|NCT00923091|19340872|P13|Period V (Double -Blind)|Protocol Violation|1
5597094|NCT00923091|19340873|P12|Period V (Double -Blind)|Protocol Violation|0
5597095|NCT00923091|19340874|P11|Period V (Double -Blind)|Protocol Violation|0
5597096|NCT00923091|19340875|P10|Period V (Double -Blind)|Protocol Violation|0
5597097|NCT00923091|19340876|P9|Period V (Double -Blind)|Protocol Violation|0
5597098|NCT00923091|19340877|P8|Period V (Double -Blind)|Protocol Violation|0
5597099|NCT00923091|19340878|P7|Period V (Double -Blind)|Protocol Violation|0
5597100|NCT00923091|19340879|P6|Period V (Double -Blind)|Protocol Violation|0
5597101|NCT00923091|19340880|P5|Period V (Double -Blind)|Protocol Violation|0
5597102|NCT00923091|19340881|P4|Period V (Double -Blind)|Protocol Violation|0
5597103|NCT00923091|19340882|P3|Period V (Double -Blind)|Protocol Violation|0
5597104|NCT00923091|19340883|P2|Period V (Double -Blind)|Protocol Violation|0
5597105|NCT00923091|19340884|P1|Period V (Double -Blind)|Protocol Violation|0
5597106|NCT00923091|19340872|P13|Period V (Double -Blind)|Withdrawal by Subject|1
5597107|NCT00923091|19340873|P12|Period V (Double -Blind)|Withdrawal by Subject|0
5597108|NCT00923091|19340874|P11|Period V (Double -Blind)|Withdrawal by Subject|0
5597109|NCT00923091|19340875|P10|Period V (Double -Blind)|Withdrawal by Subject|0
5597110|NCT00923091|19340876|P9|Period V (Double -Blind)|Withdrawal by Subject|1
5597111|NCT00923091|19340877|P8|Period V (Double -Blind)|Withdrawal by Subject|0
5597112|NCT00923091|19340878|P7|Period V (Double -Blind)|Withdrawal by Subject|0
5597113|NCT00923091|19340879|P6|Period V (Double -Blind)|Withdrawal by Subject|0
5597114|NCT00923091|19340880|P5|Period V (Double -Blind)|Withdrawal by Subject|0
5597115|NCT00923091|19340881|P4|Period V (Double -Blind)|Withdrawal by Subject|0
5597116|NCT00923091|19340882|P3|Period V (Double -Blind)|Withdrawal by Subject|0
5597117|NCT00923091|19340883|P2|Period V (Double -Blind)|Withdrawal by Subject|0
5597118|NCT00923091|19340884|P1|Period V (Double -Blind)|Withdrawal by Subject|0
5597119|NCT00923091|19340872|P13|Period IV (Double-Blind)|Protocol Violation|0
5597120|NCT00923091|19340873|P12|Period IV (Double-Blind)|Protocol Violation|0
5597121|NCT00923091|19340874|P11|Period IV (Double-Blind)|Protocol Violation|0
5597122|NCT00923091|19340875|P10|Period IV (Double-Blind)|Protocol Violation|0
5597123|NCT00923091|19340876|P9|Period IV (Double-Blind)|Protocol Violation|0
5597124|NCT00923091|19340877|P8|Period IV (Double-Blind)|Protocol Violation|0
5597125|NCT00923091|19340878|P7|Period IV (Double-Blind)|Protocol Violation|0
5597126|NCT00923091|19340879|P6|Period IV (Double-Blind)|Protocol Violation|0
5597127|NCT00923091|19340880|P5|Period IV (Double-Blind)|Protocol Violation|0
5597128|NCT00923091|19340881|P4|Period IV (Double-Blind)|Protocol Violation|0
5597129|NCT00923091|19340882|P3|Period IV (Double-Blind)|Protocol Violation|0
5597130|NCT00923091|19340883|P2|Period IV (Double-Blind)|Protocol Violation|1
5597131|NCT00923091|19340884|P1|Period IV (Double-Blind)|Protocol Violation|0
5597132|NCT00923091|19340872|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
5597133|NCT00923091|19340873|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
5597134|NCT00923091|19340874|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
5597135|NCT00923091|19340875|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
5597136|NCT00923091|19340876|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
5597137|NCT00923091|19340877|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
5597138|NCT00923091|19340878|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
5597139|NCT00923091|19340879|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
5599606|NCT00906399|19348034|P7|Year 1|Death|0
5597140|NCT00923091|19340880|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
5597141|NCT00923091|19340881|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
5597142|NCT00923091|19340882|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
5597143|NCT00923091|19340883|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
5597144|NCT00923091|19340884|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
5597145|NCT00923091|19340872|P13|Period IV (Double-Blind)|Adverse Event|0
5597146|NCT00923091|19340873|P12|Period IV (Double-Blind)|Adverse Event|0
5597147|NCT00923091|19340874|P11|Period IV (Double-Blind)|Adverse Event|0
5597148|NCT00923091|19340875|P10|Period IV (Double-Blind)|Adverse Event|0
5597149|NCT00923091|19340876|P9|Period IV (Double-Blind)|Adverse Event|0
5597150|NCT00923091|19340877|P8|Period IV (Double-Blind)|Adverse Event|0
5597151|NCT00923091|19340878|P7|Period IV (Double-Blind)|Adverse Event|0
5597152|NCT00923091|19340879|P6|Period IV (Double-Blind)|Adverse Event|0
5597153|NCT00923091|19340880|P5|Period IV (Double-Blind)|Adverse Event|0
5597154|NCT00923091|19340881|P4|Period IV (Double-Blind)|Adverse Event|0
5597155|NCT00923091|19340882|P3|Period IV (Double-Blind)|Adverse Event|0
5597156|NCT00923091|19340883|P2|Period IV (Double-Blind)|Adverse Event|0
5597157|NCT00923091|19340884|P1|Period IV (Double-Blind)|Adverse Event|2
5597158|NCT00923091|19340872|P13|Period III (Single-Blind)|Lost to Follow-up|0
5597159|NCT00923091|19340873|P12|Period III (Single-Blind)|Lost to Follow-up|0
5597160|NCT00923091|19340874|P11|Period III (Single-Blind)|Lost to Follow-up|0
5597161|NCT00923091|19340875|P10|Period III (Single-Blind)|Lost to Follow-up|0
5597162|NCT00923091|19340876|P9|Period III (Single-Blind)|Lost to Follow-up|0
5597163|NCT00923091|19340877|P8|Period III (Single-Blind)|Lost to Follow-up|0
5597164|NCT00923091|19340878|P7|Period III (Single-Blind)|Lost to Follow-up|0
5597165|NCT00923091|19340879|P6|Period III (Single-Blind)|Lost to Follow-up|0
5597166|NCT00923091|19340880|P5|Period III (Single-Blind)|Lost to Follow-up|0
5597167|NCT00923091|19340881|P4|Period III (Single-Blind)|Lost to Follow-up|0
5597168|NCT00923091|19340882|P3|Period III (Single-Blind)|Lost to Follow-up|0
5597169|NCT00923091|19340883|P2|Period III (Single-Blind)|Lost to Follow-up|0
5597170|NCT00923091|19340884|P1|Period III (Single-Blind)|Lost to Follow-up|2
5597171|NCT00923091|19340872|P13|Period III (Single-Blind)|Protocol Violation|0
5597172|NCT00923091|19340873|P12|Period III (Single-Blind)|Protocol Violation|0
5597173|NCT00923091|19340874|P11|Period III (Single-Blind)|Protocol Violation|0
5597174|NCT00923091|19340875|P10|Period III (Single-Blind)|Protocol Violation|0
5597175|NCT00923091|19340876|P9|Period III (Single-Blind)|Protocol Violation|0
5597176|NCT00923091|19340877|P8|Period III (Single-Blind)|Protocol Violation|0
5597177|NCT00923091|19340878|P7|Period III (Single-Blind)|Protocol Violation|0
5597178|NCT00923091|19340879|P6|Period III (Single-Blind)|Protocol Violation|0
5597179|NCT00923091|19340880|P5|Period III (Single-Blind)|Protocol Violation|0
5597180|NCT00923091|19340881|P4|Period III (Single-Blind)|Protocol Violation|0
5597181|NCT00923091|19340882|P3|Period III (Single-Blind)|Protocol Violation|0
5597182|NCT00923091|19340883|P2|Period III (Single-Blind)|Protocol Violation|0
5597183|NCT00923091|19340884|P1|Period III (Single-Blind)|Protocol Violation|3
5597184|NCT00923091|19340872|P13|Period III (Single-Blind)|Withdrawal by Subject|0
5597185|NCT00923091|19340873|P12|Period III (Single-Blind)|Withdrawal by Subject|0
5597186|NCT00923091|19340874|P11|Period III (Single-Blind)|Withdrawal by Subject|0
5597187|NCT00923091|19340875|P10|Period III (Single-Blind)|Withdrawal by Subject|0
5597188|NCT00923091|19340876|P9|Period III (Single-Blind)|Withdrawal by Subject|0
5597189|NCT00923091|19340877|P8|Period III (Single-Blind)|Withdrawal by Subject|0
5597190|NCT00923091|19340878|P7|Period III (Single-Blind)|Withdrawal by Subject|0
5597191|NCT00923091|19340879|P6|Period III (Single-Blind)|Withdrawal by Subject|0
5597192|NCT00923091|19340880|P5|Period III (Single-Blind)|Withdrawal by Subject|0
5597193|NCT00923091|19340881|P4|Period III (Single-Blind)|Withdrawal by Subject|0
5597194|NCT00923091|19340882|P3|Period III (Single-Blind)|Withdrawal by Subject|0
5597195|NCT00923091|19340883|P2|Period III (Single-Blind)|Withdrawal by Subject|0
5597196|NCT00923091|19340884|P1|Period III (Single-Blind)|Withdrawal by Subject|10
5597197|NCT00923091|19340872|P13|Period III (Single-Blind)|Adverse Event|0
5597198|NCT00923091|19340873|P12|Period III (Single-Blind)|Adverse Event|0
5597199|NCT00923091|19340874|P11|Period III (Single-Blind)|Adverse Event|0
5597200|NCT00923091|19340875|P10|Period III (Single-Blind)|Adverse Event|0
5597201|NCT00923091|19340876|P9|Period III (Single-Blind)|Adverse Event|0
5597202|NCT00923091|19340877|P8|Period III (Single-Blind)|Adverse Event|0
5597203|NCT00923091|19340878|P7|Period III (Single-Blind)|Adverse Event|0
5597204|NCT00923091|19340879|P6|Period III (Single-Blind)|Adverse Event|0
5597205|NCT00923091|19340880|P5|Period III (Single-Blind)|Adverse Event|0
5597206|NCT00923091|19340881|P4|Period III (Single-Blind)|Adverse Event|0
5597207|NCT00923091|19340882|P3|Period III (Single-Blind)|Adverse Event|0
5597208|NCT00923091|19340883|P2|Period III (Single-Blind)|Adverse Event|0
5597209|NCT00923091|19340884|P1|Period III (Single-Blind)|Adverse Event|5
5597210|NCT00923091|19340872|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597211|NCT00923091|19340873|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597212|NCT00923091|19340874|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597213|NCT00923091|19340875|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597214|NCT00923091|19340876|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597215|NCT00923091|19340877|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597216|NCT00923091|19340878|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597217|NCT00923091|19340879|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
5597218|NCT00923091|19340880|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597219|NCT00923091|19340881|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
5597220|NCT00923091|19340882|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597221|NCT00923091|19340883|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
5597222|NCT00923091|19340884|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
5597223|NCT00923091|19340872|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597224|NCT00923091|19340873|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597225|NCT00923091|19340874|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597226|NCT00923091|19340875|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597227|NCT00923091|19340876|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597228|NCT00923091|19340877|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597229|NCT00923091|19340878|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597230|NCT00923091|19340879|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
5597231|NCT00923091|19340880|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597232|NCT00923091|19340881|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597233|NCT00923091|19340882|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597234|NCT00923091|19340883|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597235|NCT00923091|19340884|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
5597236|NCT00923091|19340872|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5597237|NCT00923091|19340873|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5597238|NCT00923091|19340874|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5597239|NCT00923091|19340875|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5597240|NCT00923091|19340876|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
5597241|NCT00923091|19340877|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
5597242|NCT00923091|19340878|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
5597243|NCT00923091|19340879|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
5597244|NCT00923091|19340880|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
5597245|NCT00923091|19340881|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
5597246|NCT00923091|19340882|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
5597247|NCT00923091|19340883|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
5597248|NCT00923091|19340884|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
5597249|NCT00923091|19340872|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5597250|NCT00923091|19340873|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5597251|NCT00923091|19340874|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5597252|NCT00923091|19340875|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5597253|NCT00923091|19340876|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
5597254|NCT00923091|19340877|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
5597255|NCT00923091|19340878|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
5597256|NCT00923091|19340879|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
5597257|NCT00923091|19340880|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
5597258|NCT00923091|19340881|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
5597259|NCT00923091|19340882|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
5597260|NCT00923091|19340883|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
5597261|NCT00923091|19340884|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
5597262|NCT00923091|19340872|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5597263|NCT00923091|19340873|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5597264|NCT00923091|19340874|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5597265|NCT00923091|19340875|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5597266|NCT00923091|19340876|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
5597267|NCT00923091|19340877|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
5597268|NCT00923091|19340878|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
5597269|NCT00923091|19340879|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
5597270|NCT00923091|19340880|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
5597271|NCT00923091|19340881|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
5597272|NCT00923091|19340882|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
5597273|NCT00923091|19340883|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
5597274|NCT00923091|19340884|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
5597275|NCT00923078|19340934|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
5597276|NCT00923078|19340935|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
5597277|NCT00923078|19340936|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
5597278|NCT00923078|19340934|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
5597279|NCT00923078|19340935|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
5597280|NCT00923078|19340936|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
5597281|NCT00922987|19340955|P1|Overall Study|Adverse Event|1
5597282|NCT00922987|19340955|P1|Overall Study|Protocol Violation|2
5597283|NCT00922987|19340955|P1|Overall Study|Insufficient clinical response|1
5597284|NCT00922974|19340970|P2|Phase III Component|Protocol Violation|6
5597285|NCT00922974|19340971|P1|Phase III Component|Protocol Violation|8
5597286|NCT00922974|19340970|P2|Phase II Component|Not evaluable for treatment review|0
5597287|NCT00922974|19340971|P1|Phase II Component|Not evaluable for treatment review|5
5597288|NCT00922974|19340970|P2|Phase II Component|Protocol Violation|0
5597289|NCT00922974|19340971|P1|Phase II Component|Protocol Violation|2
5597290|NCT00922935|19340986|P3|Overall Study|Lost to Follow-up|0
5597291|NCT00922935|19340987|P2|Overall Study|Lost to Follow-up|1
5597292|NCT00922935|19340988|P1|Overall Study|Lost to Follow-up|0
5597293|NCT00922935|19340986|P3|Overall Study|Physician Decision|0
5597294|NCT00922935|19340987|P2|Overall Study|Physician Decision|1
5597295|NCT00922935|19340988|P1|Overall Study|Physician Decision|1
5597296|NCT00922935|19340986|P3|Overall Study|Protocol Violation|0
5597297|NCT00922935|19340987|P2|Overall Study|Protocol Violation|3
5597298|NCT00922935|19340988|P1|Overall Study|Protocol Violation|0
5597299|NCT00922779|19341000|P1|Overall Study|Missing|1874
5597300|NCT00922779|19341000|P1|Overall Study|Other|27
5597301|NCT00922779|19341000|P1|Overall Study|Lost to Follow-up|44
5597302|NCT00922779|19341000|P1|Overall Study|Withdrawal by Subject|308
5597303|NCT00922779|19341000|P1|Overall Study|Pregnancy|7
5597304|NCT00922779|19341000|P1|Overall Study|Adverse Event|67
5597305|NCT00922766|19341007|P1|Overall Study|Adverse Event|1
5597306|NCT00922766|19341007|P1|Overall Study|Other|1
5597307|NCT00922766|19341007|P1|Overall Study|Withdrawal by Subject|2
5597308|NCT00922766|19341007|P1|Overall Study|Death|3
5597309|NCT00922636|19341025|P5|Overall Study|Lost to Follow-up|4
5597310|NCT00922636|19341026|P4|Overall Study|Lost to Follow-up|2
5597311|NCT00922636|19341027|P3|Overall Study|Lost to Follow-up|2
5597312|NCT00922636|19341028|P2|Overall Study|Lost to Follow-up|2
5597313|NCT00922636|19341029|P1|Overall Study|Lost to Follow-up|1
5597314|NCT00922636|19341025|P5|Overall Study|Parent/Caregiver Decision|2
5597315|NCT00922636|19341026|P4|Overall Study|Parent/Caregiver Decision|5
5597316|NCT00922636|19341027|P3|Overall Study|Parent/Caregiver Decision|3
5597317|NCT00922636|19341028|P2|Overall Study|Parent/Caregiver Decision|4
5597318|NCT00922636|19341029|P1|Overall Study|Parent/Caregiver Decision|2
5597319|NCT00922636|19341025|P5|Overall Study|Entry Criteria Not Met|0
5597320|NCT00922636|19341026|P4|Overall Study|Entry Criteria Not Met|1
5597321|NCT00922636|19341027|P3|Overall Study|Entry Criteria Not Met|1
5597322|NCT00922636|19341028|P2|Overall Study|Entry Criteria Not Met|0
5597323|NCT00922636|19341029|P1|Overall Study|Entry Criteria Not Met|0
5597324|NCT00922636|19341025|P5|Overall Study|Protocol Violation|0
5597325|NCT00922636|19341026|P4|Overall Study|Protocol Violation|2
5597326|NCT00922636|19341027|P3|Overall Study|Protocol Violation|2
5597327|NCT00922636|19341028|P2|Overall Study|Protocol Violation|0
5597328|NCT00922636|19341029|P1|Overall Study|Protocol Violation|0
5597329|NCT00922636|19341025|P5|Overall Study|Withdrawal by Subject|4
5597330|NCT00922636|19341026|P4|Overall Study|Withdrawal by Subject|2
5597331|NCT00922636|19341027|P3|Overall Study|Withdrawal by Subject|5
5597332|NCT00922636|19341028|P2|Overall Study|Withdrawal by Subject|0
5597333|NCT00922636|19341029|P1|Overall Study|Withdrawal by Subject|0
5597334|NCT00922636|19341025|P5|Overall Study|Sponsor Decision|0
5597335|NCT00922636|19341026|P4|Overall Study|Sponsor Decision|0
5597336|NCT00922636|19341027|P3|Overall Study|Sponsor Decision|2
5597337|NCT00922636|19341028|P2|Overall Study|Sponsor Decision|0
5597338|NCT00922636|19341029|P1|Overall Study|Sponsor Decision|0
5597339|NCT00922636|19341025|P5|Overall Study|Lack of Efficacy|4
5597340|NCT00922636|19341026|P4|Overall Study|Lack of Efficacy|2
5597341|NCT00922636|19341027|P3|Overall Study|Lack of Efficacy|3
5597342|NCT00922636|19341028|P2|Overall Study|Lack of Efficacy|7
5597343|NCT00922636|19341029|P1|Overall Study|Lack of Efficacy|1
5597344|NCT00922636|19341025|P5|Overall Study|Adverse Event|2
5597345|NCT00922636|19341026|P4|Overall Study|Adverse Event|3
5597346|NCT00922636|19341027|P3|Overall Study|Adverse Event|2
5597347|NCT00922636|19341028|P2|Overall Study|Adverse Event|3
5597348|NCT00922636|19341029|P1|Overall Study|Adverse Event|3
5597349|NCT00922623|19341176|P1|Overall Study|Lost to Follow-up|1
5597350|NCT00922623|19341176|P1|Overall Study|Other|4
5597351|NCT00922480|19341184|P2|Extension Study|Others|1
5597352|NCT00922480|19341185|P1|Extension Study|Others|0
5597353|NCT00922480|19341184|P2|Extension Study|Withdrawal by Subject|1
5597354|NCT00922480|19341185|P1|Extension Study|Withdrawal by Subject|1
5597355|NCT00922480|19341184|P2|Extension Study|Adverse Event|1
5597356|NCT00922480|19341185|P1|Extension Study|Adverse Event|1
5597357|NCT00922480|19341184|P2|Extension Study|Protocol Violation|0
5597358|NCT00922480|19341185|P1|Extension Study|Protocol Violation|3
5597359|NCT00922480|19341184|P2|Main Study|Physician Decision|1
5597360|NCT00922480|19341185|P1|Main Study|Physician Decision|0
5597361|NCT00922480|19341184|P2|Main Study|Lost to Follow-up|0
5597362|NCT00922480|19341185|P1|Main Study|Lost to Follow-up|5
5597363|NCT00922480|19341184|P2|Main Study|Withdrawal by Subject|15
5597364|NCT00922480|19341185|P1|Main Study|Withdrawal by Subject|20
5597365|NCT00922480|19341184|P2|Main Study|Lack of Efficacy|0
5597366|NCT00922480|19341185|P1|Main Study|Lack of Efficacy|3
5597367|NCT00922480|19341184|P2|Main Study|Adverse Event|7
5597368|NCT00922480|19341185|P1|Main Study|Adverse Event|6
5597369|NCT00922480|19341184|P2|Main Study|Protocol Violation|6
5597370|NCT00922480|19341185|P1|Main Study|Protocol Violation|3
5597371|NCT00922441|19341196|P3|Overall Study|Withdrawal by Subject|1
5597372|NCT00922441|19341197|P2|Overall Study|Withdrawal by Subject|0
5597373|NCT00922441|19341198|P1|Overall Study|Withdrawal by Subject|0
5597374|NCT00922441|19341196|P3|Overall Study|Protocol Violation|2
5597375|NCT00922441|19341197|P2|Overall Study|Protocol Violation|0
5597376|NCT00922441|19341198|P1|Overall Study|Protocol Violation|0
5597377|NCT00922428|19341206|P1|Overall Study|no medication use or questionable use|13
5597378|NCT00922428|19341206|P1|Overall Study|retrospective/extremely implausible data|2
5597379|NCT00922272|19341235|P2|Double-blind Phase|Positive urine drug screen|1
5597380|NCT00922272|19341236|P1|Double-blind Phase|Positive urine drug screen|1
5597381|NCT00922272|19341235|P2|Double-blind Phase|Noncompliance|1
5597382|NCT00922272|19341236|P1|Double-blind Phase|Noncompliance|1
5597383|NCT00922272|19341235|P2|Double-blind Phase|Withdrawal criteria met|1
5597384|NCT00922272|19341236|P1|Double-blind Phase|Withdrawal criteria met|1
5597385|NCT00922272|19341235|P2|Double-blind Phase|Lost to Follow-up|1
5597386|NCT00922272|19341236|P1|Double-blind Phase|Lost to Follow-up|2
5597387|NCT00922272|19341235|P2|Double-blind Phase|Withdrawal by Subject|1
5597388|NCT00922272|19341236|P1|Double-blind Phase|Withdrawal by Subject|1
5597389|NCT00922272|19341235|P2|Double-blind Phase|Adverse Event|1
5597390|NCT00922272|19341236|P1|Double-blind Phase|Adverse Event|1
5597391|NCT00922272|19341235|P2|Open-label Phase|Withdrawal criteria met|0
5597392|NCT00922272|19341236|P1|Open-label Phase|Withdrawal criteria met|5
5597393|NCT00922272|19341235|P2|Open-label Phase|Failure to meet randomization criteria|0
5597394|NCT00922272|19341236|P1|Open-label Phase|Failure to meet randomization criteria|1
5597395|NCT00922272|19341235|P2|Open-label Phase|Withdrawal by Subject|0
5597396|NCT00922272|19341236|P1|Open-label Phase|Withdrawal by Subject|11
5597397|NCT00922272|19341235|P2|Open-label Phase|Protocol Violation|0
5597398|NCT00922272|19341236|P1|Open-label Phase|Protocol Violation|1
5597399|NCT00922272|19341235|P2|Open-label Phase|Adverse Event|0
5597400|NCT00922272|19341236|P1|Open-label Phase|Adverse Event|5
5597401|NCT00922207|19341301|P3|Overall Study|Abnormality of Laboratory Test|1
5597402|NCT00922207|19341302|P2|Overall Study|Abnormality of Laboratory Test|1
5597403|NCT00922207|19341303|P1|Overall Study|Abnormality of Laboratory Test|0
5597404|NCT00922207|19341301|P3|Overall Study|Withdrew Consent|2
5597405|NCT00922207|19341302|P2|Overall Study|Withdrew Consent|5
5597406|NCT00922207|19341303|P1|Overall Study|Withdrew Consent|2
5597407|NCT00922207|19341301|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
5597408|NCT00922207|19341302|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
5597409|NCT00922207|19341303|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
5597410|NCT00922207|19341301|P3|Overall Study|Violation of Selection Criteria at Entry|0
5597411|NCT00922207|19341302|P2|Overall Study|Violation of Selection Criteria at Entry|1
5597412|NCT00922207|19341303|P1|Overall Study|Violation of Selection Criteria at Entry|0
5597413|NCT00922207|19341301|P3|Overall Study|Insufficient Therapeutic Response|1
5597414|NCT00922207|19341302|P2|Overall Study|Insufficient Therapeutic Response|0
5597415|NCT00922207|19341303|P1|Overall Study|Insufficient Therapeutic Response|0
5597416|NCT00922207|19341301|P3|Overall Study|Adverse Event/Intercurrent Illness|0
5597417|NCT00922207|19341302|P2|Overall Study|Adverse Event/Intercurrent Illness|0
5597418|NCT00922207|19341303|P1|Overall Study|Adverse Event/Intercurrent Illness|3
5597419|NCT00922116|19341339|P1|Overall Study|Other|5
5597420|NCT00922116|19341339|P1|Overall Study|Withdrawal by Subject|4
5597421|NCT00922116|19341339|P1|Overall Study|Lost to Follow-up|1
5597422|NCT00922116|19341339|P1|Overall Study|Death|1
5597423|NCT00922116|19341339|P1|Overall Study|Adverse Event|4
5597424|NCT00921557|19341401|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
5597425|NCT00921557|19341402|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
5597426|NCT00921557|19341403|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
5597427|NCT00921557|19341401|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
5597428|NCT00921557|19341402|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
5597429|NCT00921557|19341403|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
5597430|NCT00921557|19341401|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
5597431|NCT00921557|19341402|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
5597432|NCT00921557|19341403|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
5597433|NCT00921557|19341401|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
5597434|NCT00921557|19341402|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
5597435|NCT00921557|19341403|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
5597436|NCT00921557|19341401|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
5597437|NCT00921557|19341402|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
5597438|NCT00921557|19341403|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
5597439|NCT00921024|19341505|P2|Overall Study|Withdrawal by Subject|3
5597440|NCT00921024|19341506|P1|Overall Study|Withdrawal by Subject|0
5597441|NCT00921024|19341505|P2|Overall Study|Received concomittant therapy|0
5597442|NCT00921024|19341506|P1|Overall Study|Received concomittant therapy|2
5597443|NCT00921024|19341505|P2|Overall Study|Lost to Follow-up|0
5597444|NCT00921024|19341506|P1|Overall Study|Lost to Follow-up|2
5597445|NCT00920907|19341516|P2|Maintenance Period|Adverse Event|1
5597446|NCT00920907|19341517|P1|Maintenance Period|Adverse Event|0
5597447|NCT00920907|19341516|P2|Maintenance Period|Withdrawal by Subject|0
5597448|NCT00920907|19341517|P1|Maintenance Period|Withdrawal by Subject|1
5597449|NCT00920907|19341516|P2|Maintenance Period|Death|1
5597450|NCT00920907|19341517|P1|Maintenance Period|Death|1
5597451|NCT00920907|19341516|P2|Maintenance Period|Study Drug Toxicity|2
5597452|NCT00920907|19341517|P1|Maintenance Period|Study Drug Toxicity|0
5597453|NCT00920907|19341516|P2|Maintenance Period|Administrative (study closure)|2
5597454|NCT00920907|19341517|P1|Maintenance Period|Administrative (study closure)|7
5597455|NCT00920907|19341516|P2|Maintenance Period|Disease Progression|7
5597456|NCT00920907|19341517|P1|Maintenance Period|Disease Progression|3
5597457|NCT00920907|19341516|P2|Induction Period|Withdrawal by Subject|1
5597458|NCT00920907|19341517|P1|Induction Period|Withdrawal by Subject|1
5597459|NCT00920907|19341516|P2|Induction Period|No longer meets study criteria|1
5597460|NCT00920907|19341517|P1|Induction Period|No longer meets study criteria|0
5597461|NCT00920907|19341516|P2|Induction Period|Study Drug Toxicity|6
5597462|NCT00920907|19341517|P1|Induction Period|Study Drug Toxicity|8
5597463|NCT00920907|19341516|P2|Induction Period|Disease Progression|11
5597464|NCT00920907|19341517|P1|Induction Period|Disease Progression|12
5597465|NCT00920907|19341516|P2|Induction Period|Death|1
5597466|NCT00920907|19341517|P1|Induction Period|Death|1
5597467|NCT00920907|19341516|P2|Induction Period|Adverse Event|2
5597468|NCT00920907|19341517|P1|Induction Period|Adverse Event|0
5597469|NCT00920855|19341558|P3|Overall Study|Response plateau; started maintenance|1
5597470|NCT00920855|19341559|P2|Overall Study|Response plateau; started maintenance|0
5597471|NCT00920855|19341560|P1|Overall Study|Response plateau; started maintenance|0
5597472|NCT00920855|19341558|P3|Overall Study|Noncompliance to study medication|1
5597473|NCT00920855|19341559|P2|Overall Study|Noncompliance to study medication|0
5597474|NCT00920855|19341560|P1|Overall Study|Noncompliance to study medication|0
5597475|NCT00920855|19341558|P3|Overall Study|Disease progression|10
5597476|NCT00920855|19341559|P2|Overall Study|Disease progression|1
5597477|NCT00920855|19341560|P1|Overall Study|Disease progression|2
5597478|NCT00920855|19341558|P3|Overall Study|Withdrawal by Subject|6
5597479|NCT00920855|19341559|P2|Overall Study|Withdrawal by Subject|1
5597480|NCT00920855|19341560|P1|Overall Study|Withdrawal by Subject|2
5597481|NCT00920855|19341558|P3|Overall Study|Adverse Event|4
5597482|NCT00920855|19341559|P2|Overall Study|Adverse Event|1
5597483|NCT00920855|19341560|P1|Overall Study|Adverse Event|1
5597484|NCT00920829|19341586|P4|Available for Analysis|Required more treatment|1
5597485|NCT00920829|19341587|P3|Available for Analysis|Required more treatment|0
5597486|NCT00920829|19341588|P2|Available for Analysis|Required more treatment|2
5597487|NCT00920829|19341589|P1|Available for Analysis|Required more treatment|0
5597488|NCT00920829|19341586|P4|Available for Analysis|Protocol Violation|0
5597489|NCT00920829|19341587|P3|Available for Analysis|Protocol Violation|1
5597490|NCT00920829|19341588|P2|Available for Analysis|Protocol Violation|0
5597491|NCT00920829|19341589|P1|Available for Analysis|Protocol Violation|0
5597492|NCT00920829|19341586|P4|Available for Analysis|Death|0
5597493|NCT00920829|19341587|P3|Available for Analysis|Death|0
5597494|NCT00920829|19341588|P2|Available for Analysis|Death|0
5597495|NCT00920829|19341589|P1|Available for Analysis|Death|1
5597496|NCT00920829|19341586|P4|Available for Analysis|Adverse Event|0
5597497|NCT00920829|19341587|P3|Available for Analysis|Adverse Event|1
5597498|NCT00920829|19341588|P2|Available for Analysis|Adverse Event|2
5597499|NCT00920829|19341589|P1|Available for Analysis|Adverse Event|1
5597500|NCT00920829|19341586|P4|Available for Analysis|Required Medical Treatment|0
5597501|NCT00920829|19341587|P3|Available for Analysis|Required Medical Treatment|2
5597502|NCT00920829|19341588|P2|Available for Analysis|Required Medical Treatment|1
5597503|NCT00920829|19341589|P1|Available for Analysis|Required Medical Treatment|0
5597504|NCT00920829|19341586|P4|Available for Analysis|Withdrawal by Subject|10
5597505|NCT00920829|19341587|P3|Available for Analysis|Withdrawal by Subject|6
5597506|NCT00920829|19341588|P2|Available for Analysis|Withdrawal by Subject|6
5597507|NCT00920829|19341589|P1|Available for Analysis|Withdrawal by Subject|6
5597508|NCT00920829|19341586|P4|Allocation|No post randomization data|2
5597509|NCT00920829|19341587|P3|Allocation|No post randomization data|0
5597510|NCT00920829|19341588|P2|Allocation|No post randomization data|1
5597511|NCT00920829|19341589|P1|Allocation|No post randomization data|3
5597512|NCT00920816|19341603|P4|Overall Study|Ongoing|36
5597513|NCT00920816|19341604|P3|Overall Study|Ongoing|70
5597514|NCT00920816|19341605|P2|Overall Study|Ongoing|56
5597515|NCT00920816|19341606|P1|Overall Study|Ongoing|106
5597516|NCT00920816|19341603|P4|Overall Study|Withdrawal by Subject|1
5597517|NCT00920816|19341604|P3|Overall Study|Withdrawal by Subject|1
5597518|NCT00920816|19341605|P2|Overall Study|Withdrawal by Subject|2
5597519|NCT00920816|19341606|P1|Overall Study|Withdrawal by Subject|7
5597520|NCT00920816|19341603|P4|Overall Study|Objective progression or relapse|0
5597521|NCT00920816|19341604|P3|Overall Study|Objective progression or relapse|2
5597522|NCT00920816|19341605|P2|Overall Study|Objective progression or relapse|0
5597523|NCT00920816|19341606|P1|Overall Study|Objective progression or relapse|0
5597524|NCT00920816|19341603|P4|Overall Study|Lost to Follow-up|4
5597525|NCT00920816|19341604|P3|Overall Study|Lost to Follow-up|3
5597526|NCT00920816|19341605|P2|Overall Study|Lost to Follow-up|2
5597527|NCT00920816|19341606|P1|Overall Study|Lost to Follow-up|1
5597528|NCT00920816|19341603|P4|Overall Study|Adverse Event|0
5597529|NCT00920816|19341604|P3|Overall Study|Adverse Event|1
5597530|NCT00920816|19341605|P2|Overall Study|Adverse Event|0
5597531|NCT00920816|19341606|P1|Overall Study|Adverse Event|1
5597532|NCT00920816|19341603|P4|Overall Study|Death|28
5597533|NCT00920816|19341604|P3|Overall Study|Death|58
5597534|NCT00920816|19341605|P2|Overall Study|Death|36
5597535|NCT00920816|19341606|P1|Overall Study|Death|77
5597536|NCT00920790|19341644|P1|Overall Study|aggravation of general condition|14
5597537|NCT00920699|19341656|P3|Overall Study|Lost to Follow-up|2
5597538|NCT00920699|19341657|P2|Overall Study|Lost to Follow-up|0
5597539|NCT00920699|19341658|P1|Overall Study|Lost to Follow-up|0
5597540|NCT00920699|19341656|P3|Overall Study|no longer met eligibility|0
5597541|NCT00920699|19341657|P2|Overall Study|no longer met eligibility|1
5597542|NCT00920699|19341658|P1|Overall Study|no longer met eligibility|0
5597543|NCT00920699|19341656|P3|Overall Study|Withdrawal by Subject|2
5597544|NCT00920699|19341657|P2|Overall Study|Withdrawal by Subject|0
5597545|NCT00920699|19341658|P1|Overall Study|Withdrawal by Subject|2
5597546|NCT00920686|19341675|P3|Overall Study|Study drug dosing criteria not met|12
5597547|NCT00920686|19341676|P2|Overall Study|Study drug dosing criteria not met|19
5597548|NCT00920686|19341677|P1|Overall Study|Study drug dosing criteria not met|17
5597549|NCT00920686|19341675|P3|Overall Study|Lost to Follow-up|1
5597550|NCT00920686|19341676|P2|Overall Study|Lost to Follow-up|3
5597551|NCT00920686|19341677|P1|Overall Study|Lost to Follow-up|2
5597552|NCT00920621|19341756|P4|Overall Study|Blood sample not collected|0
5597553|NCT00920621|19341757|P3|Overall Study|Blood sample not collected|0
5597554|NCT00920621|19341758|P2|Overall Study|Blood sample not collected|14
5597555|NCT00920621|19341759|P1|Overall Study|Blood sample not collected|22
5597556|NCT00920621|19341756|P4|Overall Study|Fetal/neonatal deaths|14
5597557|NCT00920621|19341757|P3|Overall Study|Fetal/neonatal deaths|16
5597558|NCT00920621|19341758|P2|Overall Study|Fetal/neonatal deaths|14
5597559|NCT00920621|19341759|P1|Overall Study|Fetal/neonatal deaths|16
5597560|NCT00920621|19341756|P4|Overall Study|Lost to Follow-up|21
5597561|NCT00920621|19341757|P3|Overall Study|Lost to Follow-up|19
5597562|NCT00920621|19341758|P2|Overall Study|Lost to Follow-up|17
5597563|NCT00920621|19341759|P1|Overall Study|Lost to Follow-up|16
5597564|NCT00920556|19341789|P1|Overall Study|Withdrawal by Subject|1
5597565|NCT00920556|19341789|P1|Overall Study|Physician Decision|7
5597566|NCT00920556|19341789|P1|Overall Study|Adverse Event|16
5597567|NCT00920426|19341838|P4|ITZ111451|Adverse Event|0
5597568|NCT00920426|19341839|P3|ITZ111451|Adverse Event|0
5597569|NCT00920426|19341840|P2|ITZ111451|Adverse Event|0
5597570|NCT00920426|19341841|P1|ITZ111451|Adverse Event|1
5597571|NCT00920218|19341961|P4|Overall Study|Other|0
5597572|NCT00920218|19341962|P3|Overall Study|Other|1
5597573|NCT00920218|19341963|P2|Overall Study|Other|0
5597574|NCT00920218|19341964|P1|Overall Study|Other|0
5597575|NCT00920218|19341961|P4|Overall Study|Transplant failed/malignancy recurrence|3
5597576|NCT00920218|19341962|P3|Overall Study|Transplant failed/malignancy recurrence|2
5597577|NCT00920218|19341963|P2|Overall Study|Transplant failed/malignancy recurrence|1
5597578|NCT00920218|19341964|P1|Overall Study|Transplant failed/malignancy recurrence|0
5597579|NCT00920218|19341961|P4|Overall Study|Lost to Follow-up|3
5597580|NCT00920218|19341962|P3|Overall Study|Lost to Follow-up|0
5597581|NCT00920218|19341963|P2|Overall Study|Lost to Follow-up|1
5597582|NCT00920218|19341964|P1|Overall Study|Lost to Follow-up|0
5597583|NCT00920218|19341961|P4|Overall Study|Migrated/moved from study area|0
5597584|NCT00920218|19341962|P3|Overall Study|Migrated/moved from study area|1
5597585|NCT00920218|19341963|P2|Overall Study|Migrated/moved from study area|0
5597586|NCT00920218|19341964|P1|Overall Study|Migrated/moved from study area|0
5597587|NCT00920218|19341961|P4|Overall Study|Withdrawal by Subject|0
5597588|NCT00920218|19341962|P3|Overall Study|Withdrawal by Subject|2
5597589|NCT00920218|19341963|P2|Overall Study|Withdrawal by Subject|3
5597590|NCT00920218|19341964|P1|Overall Study|Withdrawal by Subject|0
5597591|NCT00920218|19341961|P4|Overall Study|Serious Adverse Event|1
5597592|NCT00920218|19341962|P3|Overall Study|Serious Adverse Event|2
5597593|NCT00920218|19341963|P2|Overall Study|Serious Adverse Event|0
5597594|NCT00920218|19341964|P1|Overall Study|Serious Adverse Event|2
5597595|NCT00920140|19342067|P5|Phase 2|Withdrawal by Subject|1
5597596|NCT00920140|19342068|P4|Phase 2|Withdrawal by Subject|2
5597597|NCT00920140|19342069|P3|Phase 2|Withdrawal by Subject|4
5597598|NCT00920140|19342070|P2|Phase 2|Withdrawal by Subject|0
5597599|NCT00920140|19342071|P1|Phase 2|Withdrawal by Subject|0
5597600|NCT00920140|19342067|P5|Phase 2|Physician Decision|2
5597601|NCT00920140|19342068|P4|Phase 2|Physician Decision|3
5597602|NCT00920140|19342069|P3|Phase 2|Physician Decision|3
5597603|NCT00920140|19342070|P2|Phase 2|Physician Decision|0
5597604|NCT00920140|19342071|P1|Phase 2|Physician Decision|0
5597605|NCT00920140|19342067|P5|Phase 2|Lost to Follow-up|0
5597606|NCT00920140|19342068|P4|Phase 2|Lost to Follow-up|1
5597607|NCT00920140|19342069|P3|Phase 2|Lost to Follow-up|0
5597608|NCT00920140|19342070|P2|Phase 2|Lost to Follow-up|0
5597609|NCT00920140|19342071|P1|Phase 2|Lost to Follow-up|0
5597610|NCT00920140|19342067|P5|Phase 2|Lack of Efficacy|5
5597611|NCT00920140|19342068|P4|Phase 2|Lack of Efficacy|14
5597612|NCT00920140|19342069|P3|Phase 2|Lack of Efficacy|29
5597613|NCT00920140|19342070|P2|Phase 2|Lack of Efficacy|0
5597614|NCT00920140|19342071|P1|Phase 2|Lack of Efficacy|0
5597615|NCT00920140|19342067|P5|Phase 2|Adverse Event|3
5597616|NCT00920140|19342068|P4|Phase 2|Adverse Event|2
5597617|NCT00920140|19342069|P3|Phase 2|Adverse Event|14
5597618|NCT00920140|19342070|P2|Phase 2|Adverse Event|0
5597619|NCT00920140|19342071|P1|Phase 2|Adverse Event|0
5597620|NCT00920140|19342067|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
5597621|NCT00920140|19342068|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
5597622|NCT00920140|19342069|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
5597623|NCT00920140|19342070|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
5597624|NCT00920140|19342071|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
5597625|NCT00920140|19342067|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
5597626|NCT00920140|19342068|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
5597627|NCT00920140|19342069|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
5597628|NCT00920140|19342070|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
5597629|NCT00920140|19342071|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
5597630|NCT00920140|19342067|P5|Phase 1 (Dose Escalation)|Adverse Event|0
5597631|NCT00920140|19342068|P4|Phase 1 (Dose Escalation)|Adverse Event|0
5597632|NCT00920140|19342069|P3|Phase 1 (Dose Escalation)|Adverse Event|0
5597633|NCT00920140|19342070|P2|Phase 1 (Dose Escalation)|Adverse Event|3
5599607|NCT00906399|19348035|P6|Year 1|Death|0
5597634|NCT00920140|19342071|P1|Phase 1 (Dose Escalation)|Adverse Event|3
5597635|NCT00919893|19342133|P2|Overall Study|Protocol Violation|9
5597636|NCT00919893|19342134|P1|Overall Study|Protocol Violation|19
5597637|NCT00919867|19342146|P6|First Intervention|Physician Decision|1
5597638|NCT00919867|19342147|P5|First Intervention|Physician Decision|0
5597639|NCT00919867|19342148|P4|First Intervention|Physician Decision|0
5597640|NCT00919867|19342149|P3|First Intervention|Physician Decision|0
5597641|NCT00919867|19342150|P2|First Intervention|Physician Decision|0
5597642|NCT00919867|19342151|P1|First Intervention|Physician Decision|0
5597643|NCT00919867|19342146|P6|First Intervention|Withdrawal by Subject|0
5597644|NCT00919867|19342147|P5|First Intervention|Withdrawal by Subject|0
5597645|NCT00919867|19342148|P4|First Intervention|Withdrawal by Subject|0
5597646|NCT00919867|19342149|P3|First Intervention|Withdrawal by Subject|1
5597647|NCT00919867|19342150|P2|First Intervention|Withdrawal by Subject|0
5597648|NCT00919867|19342151|P1|First Intervention|Withdrawal by Subject|0
5597649|NCT00919854|19342172|P1|Overall Study|Adverse Event|1
5597650|NCT00919711|19342210|P2|Overall Study|Noncompliance|0
5597651|NCT00919711|19342211|P1|Overall Study|Noncompliance|1
5597652|NCT00919711|19342210|P2|Overall Study|Death|0
5597653|NCT00919711|19342211|P1|Overall Study|Death|1
5597654|NCT00919711|19342210|P2|Overall Study|Lost to Follow-up|0
5597655|NCT00919711|19342211|P1|Overall Study|Lost to Follow-up|2
5597656|NCT00919711|19342210|P2|Overall Study|Administrative Decision|1
5597657|NCT00919711|19342211|P1|Overall Study|Administrative Decision|0
5597658|NCT00919711|19342210|P2|Overall Study|Other|2
5597659|NCT00919711|19342211|P1|Overall Study|Other|1
5597660|NCT00919711|19342210|P2|Overall Study|Adverse Event|3
5597661|NCT00919711|19342211|P1|Overall Study|Adverse Event|13
5597662|NCT00919711|19342210|P2|Overall Study|Withdrawal by Subject|7
5597663|NCT00919711|19342211|P1|Overall Study|Withdrawal by Subject|15
5597664|NCT00919633|19342227|P4|Overall Study|Viral rebound outside protocol timepoint|0
5597665|NCT00919633|19342228|P3|Overall Study|Viral rebound outside protocol timepoint|1
5597666|NCT00919633|19342229|P2|Overall Study|Viral rebound outside protocol timepoint|0
5597667|NCT00919633|19342230|P1|Overall Study|Viral rebound outside protocol timepoint|0
5597668|NCT00919633|19342227|P4|Overall Study|Request of withdrawal w/o future contact|0
5597669|NCT00919633|19342228|P3|Overall Study|Request of withdrawal w/o future contact|1
5597670|NCT00919633|19342229|P2|Overall Study|Request of withdrawal w/o future contact|0
5597671|NCT00919633|19342230|P1|Overall Study|Request of withdrawal w/o future contact|0
5597672|NCT00919633|19342227|P4|Overall Study|Physician Decision|1
5597673|NCT00919633|19342228|P3|Overall Study|Physician Decision|0
5597674|NCT00919633|19342229|P2|Overall Study|Physician Decision|0
5597675|NCT00919633|19342230|P1|Overall Study|Physician Decision|0
5597676|NCT00919633|19342227|P4|Overall Study|Protocol Violation|1
5597677|NCT00919633|19342228|P3|Overall Study|Protocol Violation|0
5597678|NCT00919633|19342229|P2|Overall Study|Protocol Violation|0
5597679|NCT00919633|19342230|P1|Overall Study|Protocol Violation|0
5597680|NCT00919633|19342227|P4|Overall Study|Withdraw consent post transition to SOC|1
5597681|NCT00919633|19342228|P3|Overall Study|Withdraw consent post transition to SOC|1
5597682|NCT00919633|19342229|P2|Overall Study|Withdraw consent post transition to SOC|0
5597683|NCT00919633|19342230|P1|Overall Study|Withdraw consent post transition to SOC|0
5597684|NCT00919633|19342227|P4|Overall Study|Lost to Follow-up|2
5597685|NCT00919633|19342228|P3|Overall Study|Lost to Follow-up|0
5597686|NCT00919633|19342229|P2|Overall Study|Lost to Follow-up|1
5597687|NCT00919633|19342230|P1|Overall Study|Lost to Follow-up|3
5597688|NCT00919633|19342227|P4|Overall Study|Withdrawal by Subject|3
5597689|NCT00919633|19342228|P3|Overall Study|Withdrawal by Subject|4
5597690|NCT00919633|19342229|P2|Overall Study|Withdrawal by Subject|2
5597691|NCT00919633|19342230|P1|Overall Study|Withdrawal by Subject|1
5597692|NCT00919633|19342227|P4|Overall Study|Lack of Efficacy|3
5597693|NCT00919633|19342228|P3|Overall Study|Lack of Efficacy|2
5597694|NCT00919633|19342229|P2|Overall Study|Lack of Efficacy|3
5597695|NCT00919633|19342230|P1|Overall Study|Lack of Efficacy|17
5597696|NCT00919633|19342227|P4|Overall Study|Death|0
5597697|NCT00919633|19342228|P3|Overall Study|Death|2
5597698|NCT00919633|19342229|P2|Overall Study|Death|0
5597699|NCT00919633|19342230|P1|Overall Study|Death|0
5597700|NCT00919633|19342227|P4|Overall Study|Adverse Event|10
5597701|NCT00919633|19342228|P3|Overall Study|Adverse Event|12
5597702|NCT00919633|19342229|P2|Overall Study|Adverse Event|9
5597703|NCT00919633|19342230|P1|Overall Study|Adverse Event|1
5597704|NCT00919061|19342328|P1|Overall Study|Withdrawal by Subject|1
5597705|NCT00919061|19342328|P1|Overall Study|Adverse Event|1
5597706|NCT00918957|19342341|P2|Overall Study|Withdrawal by Subject|0
5597707|NCT00918957|19342342|P1|Overall Study|Withdrawal by Subject|1
5597708|NCT00918957|19342341|P2|Overall Study|Adverse Event|0
5597709|NCT00918957|19342342|P1|Overall Study|Adverse Event|2
5597710|NCT00918879|19342375|P2|Overall Study|Severe non-compliance to protocol|1
5597711|NCT00918879|19342376|P1|Overall Study|Severe non-compliance to protocol|1
5597712|NCT00918879|19342375|P2|Overall Study|Lost to Follow-up|1
5597713|NCT00918879|19342376|P1|Overall Study|Lost to Follow-up|1
5597714|NCT00918879|19342375|P2|Overall Study|Withdrawal by Subject|4
5597715|NCT00918879|19342376|P1|Overall Study|Withdrawal by Subject|4
5597716|NCT00918749|19342408|P3|Overall Study|No Study Medication Taken|0
5597717|NCT00918749|19342409|P2|Overall Study|No Study Medication Taken|0
5597718|NCT00918749|19342410|P1|Overall Study|No Study Medication Taken|1
5597719|NCT00918749|19342408|P3|Overall Study|Withdrawal by Subject|5
5597720|NCT00918749|19342409|P2|Overall Study|Withdrawal by Subject|3
5597721|NCT00918749|19342410|P1|Overall Study|Withdrawal by Subject|5
5597722|NCT00918749|19342408|P3|Overall Study|Lost to Follow-up|1
5597723|NCT00918749|19342409|P2|Overall Study|Lost to Follow-up|0
5597724|NCT00918749|19342410|P1|Overall Study|Lost to Follow-up|0
5597725|NCT00918749|19342408|P3|Overall Study|Adverse Event|1
5597726|NCT00918749|19342409|P2|Overall Study|Adverse Event|0
5597727|NCT00918749|19342410|P1|Overall Study|Adverse Event|1
5597728|NCT00918736|19342442|P1|Overall Study|Withdrawal by Subject|4
5597729|NCT00918684|19342455|P1|Treatment Phase|Withdrawal by Subject|8
5597730|NCT00918684|19342455|P1|Treatment Phase|Protocol Violation|1
5597731|NCT00918684|19342455|P1|Treatment Phase|Physician Decision|8
5597732|NCT00918684|19342455|P1|Treatment Phase|Lost to Follow-up|2
5597733|NCT00918684|19342455|P1|Treatment Phase|Lack of Efficacy|6
5597734|NCT00918684|19342455|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
5597735|NCT00918645|19342466|P1|Overall Study|Withdrawal by Subject|1
5597736|NCT00918580|19342472|P1|After 6-month FU to 1-year FU|Failed to Return|2
5597737|NCT00918580|19342472|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
5597738|NCT00918580|19342472|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
5597739|NCT00918580|19342472|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
5597740|NCT00918580|19342472|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
5597741|NCT00918580|19342472|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
5597742|NCT00918580|19342472|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
5597743|NCT00918567|19342492|P2|Overall Study|Adverse Event|0
5597744|NCT00918567|19342493|P1|Overall Study|Adverse Event|1
5597745|NCT00918567|19342492|P2|Overall Study|Withdrawal by Subject|1
5597746|NCT00918567|19342493|P1|Overall Study|Withdrawal by Subject|1
5597747|NCT00918567|19342492|P2|Overall Study|Lack of Efficacy|1
5597748|NCT00918567|19342493|P1|Overall Study|Lack of Efficacy|3
5597749|NCT00918463|19342519|P1|Overall Study|Lack of Efficacy|1
5597750|NCT00918463|19342519|P1|Overall Study|Death|1
5597751|NCT00918385|19342527|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
5597752|NCT00918385|19342528|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
5597753|NCT00918385|19342527|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
5597754|NCT00918385|19342528|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
5597755|NCT00918385|19342527|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
5597756|NCT00918385|19342528|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
5597757|NCT00918385|19342527|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
5597758|NCT00918385|19342528|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
5597759|NCT00918385|19342527|P2|Monotherapy|Complicating illness|0
5597760|NCT00918385|19342528|P1|Monotherapy|Complicating illness|1
5597761|NCT00918385|19342527|P2|Monotherapy|Adverse Event|6
5597762|NCT00918385|19342528|P1|Monotherapy|Adverse Event|1
5597763|NCT00918346|19342537|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
5597764|NCT00918346|19342538|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
5597765|NCT00918333|19342554|P2|Overall Study|Withdrawal by Subject|1
5597766|NCT00918333|19342555|P1|Overall Study|Withdrawal by Subject|0
5597767|NCT00918333|19342554|P2|Overall Study|Ineligible|0
5597768|NCT00918333|19342555|P1|Overall Study|Ineligible|1
5597769|NCT00918333|19342554|P2|Overall Study|Inadequate amount of drugs provided|4
5597770|NCT00918333|19342555|P1|Overall Study|Inadequate amount of drugs provided|1
5597771|NCT00918333|19342554|P2|Overall Study|Drug not taken per protocol|0
5597772|NCT00918333|19342555|P1|Overall Study|Drug not taken per protocol|1
5597773|NCT00918281|19342575|P1|Overall Study|Physician Decision|29
5597774|NCT00918255|19342585|P3|Overall Study|Investigator discretion|0
5597775|NCT00918255|19342586|P2|Overall Study|Investigator discretion|0
5597776|NCT00918255|19342587|P1|Overall Study|Investigator discretion|1
5597777|NCT00918255|19342585|P3|Overall Study|Non-compliance|0
5597778|NCT00918255|19342586|P2|Overall Study|Non-compliance|0
5597779|NCT00918255|19342587|P1|Overall Study|Non-compliance|1
5597780|NCT00918255|19342585|P3|Overall Study|Exceeded allowed number of interventions|1
5597781|NCT00918255|19342586|P2|Overall Study|Exceeded allowed number of interventions|0
5597782|NCT00918255|19342587|P1|Overall Study|Exceeded allowed number of interventions|0
5597783|NCT00918255|19342585|P3|Overall Study|Lost to Follow-up|2
5597784|NCT00918255|19342586|P2|Overall Study|Lost to Follow-up|0
5597785|NCT00918255|19342587|P1|Overall Study|Lost to Follow-up|1
5597786|NCT00918255|19342585|P3|Overall Study|Lack of Efficacy|0
5597787|NCT00918255|19342586|P2|Overall Study|Lack of Efficacy|0
5597788|NCT00918255|19342587|P1|Overall Study|Lack of Efficacy|1
5597789|NCT00918255|19342585|P3|Overall Study|Withdrawal by Subject|2
5597790|NCT00918255|19342586|P2|Overall Study|Withdrawal by Subject|0
5597791|NCT00918255|19342587|P1|Overall Study|Withdrawal by Subject|1
5597792|NCT00918255|19342585|P3|Overall Study|Adverse Event|0
5597793|NCT00918255|19342586|P2|Overall Study|Adverse Event|0
5597794|NCT00918255|19342587|P1|Overall Study|Adverse Event|1
5597795|NCT00918203|19342620|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
5597796|NCT00918203|19342621|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
5597797|NCT00918203|19342622|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
5597798|NCT00918203|19342620|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
5597799|NCT00918203|19342621|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
5597800|NCT00918203|19342622|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
5597801|NCT00918203|19342620|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
5599608|NCT00906399|19348036|P5|Year 1|Death|0
5597802|NCT00918203|19342621|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
5597803|NCT00918203|19342622|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
5597804|NCT00918203|19342620|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
5597805|NCT00918203|19342621|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
5597806|NCT00918203|19342622|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
5597807|NCT00918138|19342653|P2|Overall Study|Death|0
5597808|NCT00918138|19342654|P1|Overall Study|Death|1
5597809|NCT00918138|19342653|P2|Overall Study|Subject withdrew consent|1
5597810|NCT00918138|19342654|P1|Overall Study|Subject withdrew consent|1
5597811|NCT00917852|19342693|P1|Overall Study|Death|6
5597812|NCT00917644|19342711|P2|Period 2: Second Intervention|family emergency|0
5597813|NCT00917644|19342712|P1|Period 2: Second Intervention|family emergency|1
5597814|NCT00917644|19342711|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
5597815|NCT00917644|19342712|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
5597816|NCT00917644|19342711|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
5597817|NCT00917644|19342712|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
5597818|NCT00917579|19342726|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
5597819|NCT00917579|19342727|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
5597820|NCT00917579|19342726|P2|Washout >= 2 Weeks|Adverse Event|0
5597821|NCT00917579|19342727|P1|Washout >= 2 Weeks|Adverse Event|1
5597822|NCT00917553|19342743|P2|Overall Study|Lost to Follow-up|1
5597823|NCT00917553|19342744|P1|Overall Study|Lost to Follow-up|2
5597824|NCT00917501|19342760|P2|Overall Study|trouble swollowing capsules|1
5597825|NCT00917501|19342761|P1|Overall Study|trouble swollowing capsules|0
5597826|NCT00917501|19342760|P2|Overall Study|Lack of Efficacy|2
5597827|NCT00917501|19342761|P1|Overall Study|Lack of Efficacy|1
5597828|NCT00917501|19342760|P2|Overall Study|Withdrawal by Subject|1
5597829|NCT00917501|19342761|P1|Overall Study|Withdrawal by Subject|3
5597830|NCT00917501|19342760|P2|Overall Study|Lost to Follow-up|1
5597831|NCT00917501|19342761|P1|Overall Study|Lost to Follow-up|4
5597832|NCT00917462|19342767|P1|Overall Study|Clinical Deterioration|1
5597833|NCT00917384|19342777|P2|Overall Study|Withdrawal by Subject|2
5597834|NCT00917384|19342778|P1|Overall Study|Withdrawal by Subject|10
5597835|NCT00917384|19342777|P2|Overall Study|Lost to Follow-up|2
5597836|NCT00917384|19342778|P1|Overall Study|Lost to Follow-up|4
5597837|NCT00917267|19342802|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
5597838|NCT00917267|19342803|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
5597839|NCT00917267|19342802|P2|Overall Study|Sponsor Decision|5
5597840|NCT00917267|19342803|P1|Overall Study|Sponsor Decision|5
5597841|NCT00917267|19342802|P2|Overall Study|Entry Criteria Not Met|0
5597842|NCT00917267|19342803|P1|Overall Study|Entry Criteria Not Met|1
5597843|NCT00917267|19342802|P2|Overall Study|Lost to follow up|2
5597844|NCT00917267|19342803|P1|Overall Study|Lost to follow up|0
5597845|NCT00917267|19342802|P2|Overall Study|Withdrawal by Subject|12
5597846|NCT00917267|19342803|P1|Overall Study|Withdrawal by Subject|5
5597847|NCT00917267|19342802|P2|Overall Study|Protocol Violation|18
5597848|NCT00917267|19342803|P1|Overall Study|Protocol Violation|9
5597849|NCT00917267|19342802|P2|Overall Study|Physician Decision|4
5597850|NCT00917267|19342803|P1|Overall Study|Physician Decision|2
5597851|NCT00917267|19342802|P2|Overall Study|Adverse Event|36
5597852|NCT00917267|19342803|P1|Overall Study|Adverse Event|15
5597853|NCT00917124|19342831|P2|Overall Study|Protocol Violation|6
5597854|NCT00917124|19342832|P1|Overall Study|Protocol Violation|4
5597855|NCT00916929|19342842|P2|Overall Study|Device unable to process impedance data|7
5597856|NCT00916929|19342843|P1|Overall Study|Device unable to process impedance data|0
5597857|NCT00916929|19342842|P2|Overall Study|Moved to another state|1
5597858|NCT00916929|19342843|P1|Overall Study|Moved to another state|0
5597859|NCT00916929|19342842|P2|Overall Study|System explant|0
5597860|NCT00916929|19342843|P1|Overall Study|System explant|1
5597861|NCT00916929|19342842|P2|Overall Study|Transferred to hospice care|1
5597862|NCT00916929|19342843|P1|Overall Study|Transferred to hospice care|1
5597863|NCT00916929|19342842|P2|Overall Study|Left ventricular epicardial lead|2
5597864|NCT00916929|19342843|P1|Overall Study|Left ventricular epicardial lead|1
5597865|NCT00916929|19342842|P2|Overall Study|Withdrawal by Subject|5
5597866|NCT00916929|19342843|P1|Overall Study|Withdrawal by Subject|1
5597867|NCT00916929|19342842|P2|Overall Study|Death|10
5597868|NCT00916929|19342843|P1|Overall Study|Death|5
5597869|NCT00916929|19342842|P2|Overall Study|Lost to Follow-up|3
5597870|NCT00916929|19342843|P1|Overall Study|Lost to Follow-up|1
5597871|NCT00916721|19342853|P2|Overall Study|Protocol Violation|4
5597872|NCT00916721|19342854|P1|Overall Study|Protocol Violation|2
5597873|NCT00916721|19342853|P2|Overall Study|Withdrawal by Subject|2
5597874|NCT00916721|19342854|P1|Overall Study|Withdrawal by Subject|2
5597875|NCT00916721|19342853|P2|Overall Study|Adverse Event|3
5597876|NCT00916721|19342854|P1|Overall Study|Adverse Event|6
5597877|NCT00916721|19342853|P2|Overall Study|Lost to Follow-up|1
5597878|NCT00916721|19342854|P1|Overall Study|Lost to Follow-up|0
5597879|NCT00916617|19342877|P4|Overall Study|Other|2
5597880|NCT00916617|19342878|P3|Overall Study|Other|0
5597881|NCT00916617|19342879|P2|Overall Study|Other|0
5597882|NCT00916617|19342880|P1|Overall Study|Other|2
5597883|NCT00916617|19342877|P4|Overall Study|Lack of Efficacy|0
5597884|NCT00916617|19342878|P3|Overall Study|Lack of Efficacy|0
5597885|NCT00916617|19342879|P2|Overall Study|Lack of Efficacy|0
5597886|NCT00916617|19342880|P1|Overall Study|Lack of Efficacy|1
5597887|NCT00916617|19342877|P4|Overall Study|Lost to Follow-up|0
5597888|NCT00916617|19342878|P3|Overall Study|Lost to Follow-up|0
5597889|NCT00916617|19342879|P2|Overall Study|Lost to Follow-up|1
5597890|NCT00916617|19342880|P1|Overall Study|Lost to Follow-up|2
5597891|NCT00916617|19342877|P4|Overall Study|Discontinuation of Study by Sponsor|1
5597892|NCT00916617|19342878|P3|Overall Study|Discontinuation of Study by Sponsor|3
5597893|NCT00916617|19342879|P2|Overall Study|Discontinuation of Study by Sponsor|13
5597894|NCT00916617|19342880|P1|Overall Study|Discontinuation of Study by Sponsor|8
5597895|NCT00916617|19342877|P4|Overall Study|Physician Decision|0
5597896|NCT00916617|19342878|P3|Overall Study|Physician Decision|0
5597897|NCT00916617|19342879|P2|Overall Study|Physician Decision|1
5597898|NCT00916617|19342880|P1|Overall Study|Physician Decision|1
5597899|NCT00916617|19342877|P4|Overall Study|Caregiver Request|0
5597900|NCT00916617|19342878|P3|Overall Study|Caregiver Request|1
5597901|NCT00916617|19342879|P2|Overall Study|Caregiver Request|2
5597902|NCT00916617|19342880|P1|Overall Study|Caregiver Request|3
5597903|NCT00916617|19342877|P4|Overall Study|Withdrawal by Subject|1
5597904|NCT00916617|19342878|P3|Overall Study|Withdrawal by Subject|0
5597905|NCT00916617|19342879|P2|Overall Study|Withdrawal by Subject|2
5597906|NCT00916617|19342880|P1|Overall Study|Withdrawal by Subject|3
5597907|NCT00916617|19342877|P4|Overall Study|Adverse Event|3
5597908|NCT00916617|19342878|P3|Overall Study|Adverse Event|6
5597909|NCT00916617|19342879|P2|Overall Study|Adverse Event|2
5597910|NCT00916617|19342880|P1|Overall Study|Adverse Event|3
5597911|NCT00916578|19342894|P1|Overall Study|Insurance Denial|2
5597912|NCT00916578|19342894|P1|Overall Study|Withdrawal by Subject|3
5597913|NCT00916578|19342894|P1|Overall Study|Physician Decision|2
5597914|NCT00916383|19342923|P1|Overall Study|Protocol Violation|1
5597915|NCT00916383|19342923|P1|Overall Study|Death|1
5597916|NCT00916383|19342923|P1|Overall Study|Adverse Event|1
5597917|NCT00916370|19342951|P2|Overall Study|Physician Decision|1
5597918|NCT00916370|19342952|P1|Overall Study|Physician Decision|0
5597919|NCT00916370|19342951|P2|Overall Study|Withdrawal by Subject|0
5597920|NCT00916370|19342952|P1|Overall Study|Withdrawal by Subject|2
5597921|NCT00916370|19342951|P2|Overall Study|Death|1
5597922|NCT00916370|19342952|P1|Overall Study|Death|3
5597923|NCT00916357|19343126|P6|Period 2|Weight loss > 3 kilograms (kg)|0
5597924|NCT00916357|19343127|P5|Period 2|Weight loss > 3 kilograms (kg)|0
5597925|NCT00916357|19343128|P4|Period 2|Weight loss > 3 kilograms (kg)|1
5597926|NCT00916357|19343129|P3|Period 2|Weight loss > 3 kilograms (kg)|0
5597927|NCT00916357|19343130|P2|Period 2|Weight loss > 3 kilograms (kg)|0
5597928|NCT00916357|19343131|P1|Period 2|Weight loss > 3 kilograms (kg)|0
5597929|NCT00916357|19343126|P6|Period 1|Withdrawal by Subject|0
5597930|NCT00916357|19343127|P5|Period 1|Withdrawal by Subject|0
5597931|NCT00916357|19343128|P4|Period 1|Withdrawal by Subject|0
5597932|NCT00916357|19343129|P3|Period 1|Withdrawal by Subject|0
5597933|NCT00916357|19343130|P2|Period 1|Withdrawal by Subject|0
5597934|NCT00916357|19343131|P1|Period 1|Withdrawal by Subject|1
5597935|NCT00916344|19343169|P1|Overall Study|Drop-out|5
5597936|NCT00916344|19343169|P1|Overall Study|ICD upgrade|1
5597937|NCT00916344|19343169|P1|Overall Study|Death|2
5597938|NCT00916305|19343176|P2|Overall Study|Withdrawal by Subject|1
5597939|NCT00916305|19343177|P1|Overall Study|Withdrawal by Subject|0
5597940|NCT00916305|19343176|P2|Overall Study|Lost to Follow-up|27
5597941|NCT00916305|19343177|P1|Overall Study|Lost to Follow-up|21
5597942|NCT00916279|19343185|P1|Overall Study|Lost to Follow-up|2
5597943|NCT00916279|19343185|P1|Overall Study|Death|2
5597944|NCT00916149|19343196|P3|Overall Study|Unable to place scalp EEG leads|0
5597945|NCT00916149|19343197|P2|Overall Study|Unable to place scalp EEG leads|0
5597946|NCT00916149|19343198|P1|Overall Study|Unable to place scalp EEG leads|1
5597947|NCT00916149|19343196|P3|Overall Study|Lost to Follow-up|0
5597948|NCT00916149|19343197|P2|Overall Study|Lost to Follow-up|2
5597949|NCT00916149|19343198|P1|Overall Study|Lost to Follow-up|3
5597950|NCT00916058|19343285|P7|Phase 2|Screen Failure|3
5597951|NCT00916058|19343286|P6|Phase 2|Screen Failure|0
5597952|NCT00916058|19343287|P5|Phase 2|Screen Failure|0
5597953|NCT00916058|19343288|P4|Phase 2|Screen Failure|0
5597954|NCT00916058|19343289|P3|Phase 2|Screen Failure|0
5597955|NCT00916058|19343290|P2|Phase 2|Screen Failure|0
5597956|NCT00916058|19343291|P1|Phase 2|Screen Failure|0
5597957|NCT00916058|19343285|P7|Phase 1|Screen Failure|0
5597958|NCT00916058|19343286|P6|Phase 1|Screen Failure|1
5597959|NCT00916058|19343287|P5|Phase 1|Screen Failure|0
5597960|NCT00916058|19343288|P4|Phase 1|Screen Failure|0
5597961|NCT00916058|19343289|P3|Phase 1|Screen Failure|0
5597962|NCT00916058|19343290|P2|Phase 1|Screen Failure|0
5597963|NCT00916058|19343291|P1|Phase 1|Screen Failure|0
5597964|NCT00916006|19343354|P2|Overall Study|Protocol Violation|1
5597965|NCT00916006|19343355|P1|Overall Study|Protocol Violation|0
5597966|NCT00916006|19343354|P2|Overall Study|Withdrawal by Subject|5
5597967|NCT00916006|19343355|P1|Overall Study|Withdrawal by Subject|2
5597968|NCT00916006|19343354|P2|Overall Study|Adverse Event|1
5597969|NCT00916006|19343355|P1|Overall Study|Adverse Event|1
5597970|NCT00915876|19343417|P2|Overall Study|Adverse Event|1
5597971|NCT00915876|19343418|P1|Overall Study|Adverse Event|0
5597972|NCT00915772|19343454|P3|Overall Study|Any other reason|7
5597973|NCT00915772|19343455|P2|Overall Study|Any other reason|7
5597974|NCT00915772|19343456|P1|Overall Study|Any other reason|4
5597975|NCT00915772|19343454|P3|Overall Study|Refused to continue trial medication|4
5597976|NCT00915772|19343455|P2|Overall Study|Refused to continue trial medication|8
5599609|NCT00906399|19348037|P4|Year 1|Death|0
5597977|NCT00915772|19343456|P1|Overall Study|Refused to continue trial medication|6
5597978|NCT00915772|19343454|P3|Overall Study|Lack of Efficacy|3
5597979|NCT00915772|19343455|P2|Overall Study|Lack of Efficacy|15
5597980|NCT00915772|19343456|P1|Overall Study|Lack of Efficacy|9
5597981|NCT00915772|19343454|P3|Overall Study|Lost to Follow-up|2
5597982|NCT00915772|19343455|P2|Overall Study|Lost to Follow-up|2
5597983|NCT00915772|19343456|P1|Overall Study|Lost to Follow-up|1
5597984|NCT00915772|19343454|P3|Overall Study|Protocol Violation|2
5597985|NCT00915772|19343455|P2|Overall Study|Protocol Violation|1
5597986|NCT00915772|19343456|P1|Overall Study|Protocol Violation|4
5597987|NCT00915772|19343454|P3|Overall Study|Adverse Event|11
5597988|NCT00915772|19343455|P2|Overall Study|Adverse Event|13
5597989|NCT00915772|19343456|P1|Overall Study|Adverse Event|12
5597990|NCT00915551|19343555|P2|Overall Study|Withdrawal by Subject|1
5597991|NCT00915551|19343556|P1|Overall Study|Withdrawal by Subject|0
5597992|NCT00915525|19343577|P2|Overall Study|Patient Moved|9
5597993|NCT00915525|19343578|P1|Overall Study|Patient Moved|15
5597994|NCT00915525|19343577|P2|Overall Study|Non-Compliance|1
5597995|NCT00915525|19343578|P1|Overall Study|Non-Compliance|3
5597996|NCT00915525|19343577|P2|Overall Study|Study Burden|12
5597997|NCT00915525|19343578|P1|Overall Study|Study Burden|28
5597998|NCT00915525|19343577|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
5597999|NCT00915525|19343578|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
5598000|NCT00915525|19343577|P2|Overall Study|Site Closed|9
5598001|NCT00915525|19343578|P1|Overall Study|Site Closed|27
5598002|NCT00915525|19343577|P2|Overall Study|Other Reason|12
5598003|NCT00915525|19343578|P1|Overall Study|Other Reason|35
5598004|NCT00915525|19343577|P2|Overall Study|Missing|1
5598005|NCT00915525|19343578|P1|Overall Study|Missing|12
5598006|NCT00915525|19343577|P2|Overall Study|Adverse Event|13
5598007|NCT00915525|19343578|P1|Overall Study|Adverse Event|29
5598008|NCT00915525|19343577|P2|Overall Study|Lack of Efficacy|32
5598009|NCT00915525|19343578|P1|Overall Study|Lack of Efficacy|15
5598010|NCT00915525|19343577|P2|Overall Study|Pregnancy|0
5598011|NCT00915525|19343578|P1|Overall Study|Pregnancy|2
5598012|NCT00915525|19343577|P2|Overall Study|Lost to Follow-up|16
5598013|NCT00915525|19343578|P1|Overall Study|Lost to Follow-up|27
5598014|NCT00915525|19343577|P2|Overall Study|Withdrawal by Subject|21
5598015|NCT00915525|19343578|P1|Overall Study|Withdrawal by Subject|59
5598016|NCT00915525|19343577|P2|Overall Study|Protocol Violation|4
5598017|NCT00915525|19343578|P1|Overall Study|Protocol Violation|9
5598018|NCT00915473|19343692|P2|4-week Follow Up|Lost to Follow-up|5
5598019|NCT00915473|19343693|P1|4-week Follow Up|Lost to Follow-up|1
5598020|NCT00915473|19343692|P2|Screening|Withdrawal by Subject|0
5598021|NCT00915473|19343693|P1|Screening|Withdrawal by Subject|1
5598022|NCT00915356|19343710|P5|Overall Study|Withdrawal by Subject|0
5598023|NCT00915356|19343711|P4|Overall Study|Withdrawal by Subject|0
5598024|NCT00915356|19343712|P3|Overall Study|Withdrawal by Subject|0
5598025|NCT00915356|19343713|P2|Overall Study|Withdrawal by Subject|0
5598026|NCT00915356|19343714|P1|Overall Study|Withdrawal by Subject|1
5598027|NCT00915343|19343776|P3|Part B - Open Label Period|Did not attend the last visit|1
5598028|NCT00915343|19343777|P2|Part B - Open Label Period|Did not attend the last visit|0
5598029|NCT00915343|19343778|P1|Part B - Open Label Period|Did not attend the last visit|0
5598030|NCT00915343|19343776|P3|Part B - Open Label Period|Treatment switch|1
5598031|NCT00915343|19343777|P2|Part B - Open Label Period|Treatment switch|0
5598032|NCT00915343|19343778|P1|Part B - Open Label Period|Treatment switch|0
5598033|NCT00915278|19343863|P6|Overall Study|Admission to hospice|0
5598034|NCT00915278|19343864|P5|Overall Study|Admission to hospice|0
5598035|NCT00915278|19343865|P4|Overall Study|Admission to hospice|0
5598036|NCT00915278|19343866|P3|Overall Study|Admission to hospice|1
5598037|NCT00915278|19343867|P2|Overall Study|Admission to hospice|0
5598038|NCT00915278|19343868|P1|Overall Study|Admission to hospice|0
5598039|NCT00915278|19343863|P6|Overall Study|Infusion related AEs|2
5598040|NCT00915278|19343864|P5|Overall Study|Infusion related AEs|0
5598041|NCT00915278|19343865|P4|Overall Study|Infusion related AEs|0
5598042|NCT00915278|19343866|P3|Overall Study|Infusion related AEs|0
5598043|NCT00915278|19343867|P2|Overall Study|Infusion related AEs|0
5598044|NCT00915278|19343868|P1|Overall Study|Infusion related AEs|0
5598045|NCT00915278|19343863|P6|Overall Study|Progressive disease/clinical progression|2
5598046|NCT00915278|19343864|P5|Overall Study|Progressive disease/clinical progression|1
5598047|NCT00915278|19343865|P4|Overall Study|Progressive disease/clinical progression|3
5598048|NCT00915278|19343866|P3|Overall Study|Progressive disease/clinical progression|0
5598049|NCT00915278|19343867|P2|Overall Study|Progressive disease/clinical progression|0
5598050|NCT00915278|19343868|P1|Overall Study|Progressive disease/clinical progression|0
5598051|NCT00915278|19343863|P6|Overall Study|Adverse Event|0
5598052|NCT00915278|19343864|P5|Overall Study|Adverse Event|0
5598053|NCT00915278|19343865|P4|Overall Study|Adverse Event|0
5598054|NCT00915278|19343866|P3|Overall Study|Adverse Event|0
5598055|NCT00915278|19343867|P2|Overall Study|Adverse Event|1
5598056|NCT00915278|19343868|P1|Overall Study|Adverse Event|4
5598057|NCT00915278|19343863|P6|Overall Study|Withdrawal by Subject|4
5598058|NCT00915278|19343864|P5|Overall Study|Withdrawal by Subject|1
5598059|NCT00915278|19343865|P4|Overall Study|Withdrawal by Subject|0
5598060|NCT00915278|19343866|P3|Overall Study|Withdrawal by Subject|0
5598061|NCT00915278|19343867|P2|Overall Study|Withdrawal by Subject|1
5598062|NCT00915278|19343868|P1|Overall Study|Withdrawal by Subject|0
5598063|NCT00915278|19343863|P6|Overall Study|Lost to Follow-up|0
5599610|NCT00906399|19348038|P3|Year 1|Death|1
5598064|NCT00915278|19343864|P5|Overall Study|Lost to Follow-up|0
5598065|NCT00915278|19343865|P4|Overall Study|Lost to Follow-up|0
5598066|NCT00915278|19343866|P3|Overall Study|Lost to Follow-up|0
5598067|NCT00915278|19343867|P2|Overall Study|Lost to Follow-up|1
5598068|NCT00915278|19343868|P1|Overall Study|Lost to Follow-up|0
5598069|NCT00915278|19343863|P6|Overall Study|Death|0
5598070|NCT00915278|19343864|P5|Overall Study|Death|0
5598071|NCT00915278|19343865|P4|Overall Study|Death|0
5598072|NCT00915278|19343866|P3|Overall Study|Death|0
5598073|NCT00915278|19343867|P2|Overall Study|Death|0
5598074|NCT00915278|19343868|P1|Overall Study|Death|1
5598075|NCT00915018|19344029|P2|Overall Study|By Sponsor due to Protocol Amendment|105
5598076|NCT00915018|19344030|P1|Overall Study|By Sponsor due to Protocol Amendment|92
5598077|NCT00915018|19344029|P2|Overall Study|Withdrawal by Subject|27
5598078|NCT00915018|19344030|P1|Overall Study|Withdrawal by Subject|38
5598079|NCT00915018|19344029|P2|Overall Study|Lost to Follow-up|5
5598080|NCT00915018|19344030|P1|Overall Study|Lost to Follow-up|10
5598081|NCT00915018|19344029|P2|Overall Study|Death|70
5598082|NCT00915018|19344030|P1|Overall Study|Death|75
5598083|NCT00915005|19344046|P2|Overall Study|Insurance denial|15
5598084|NCT00915005|19344047|P1|Overall Study|Insurance denial|3
5598085|NCT00915005|19344046|P2|Overall Study|Patient preferred protons therapy|0
5598086|NCT00915005|19344047|P1|Overall Study|Patient preferred protons therapy|6
5598087|NCT00915005|19344046|P2|Overall Study|Withdrawal by Subject|4
5598088|NCT00915005|19344047|P1|Overall Study|Withdrawal by Subject|4
5598089|NCT00914966|19344055|P1|Step 2: 2000 Units|Withdrawal by Subject|1
5598090|NCT00914966|19344055|P1|Step 1: 1500 Units|Physician Decision|1
5598091|NCT00914966|19344055|P1|Step 1: 1500 Units|Withdrawal by Subject|1
5598092|NCT00914940|19344067|P1|2 Years to 5 Years Post-transplant|Death|3
5598093|NCT00914940|19344067|P1|D101 to 2 Years Post-transplant|Death|8
5598094|NCT00914940|19344067|P1|D0 to D100 Post-transplant|Death|2
5598095|NCT00914927|19344082|P7|Overall Study|Administrative/Other|0
5598096|NCT00914927|19344083|P6|Overall Study|Administrative/Other|0
5598097|NCT00914927|19344084|P5|Overall Study|Administrative/Other|1
5598098|NCT00914927|19344085|P4|Overall Study|Administrative/Other|0
5598099|NCT00914927|19344086|P3|Overall Study|Administrative/Other|0
5598100|NCT00914927|19344087|P2|Overall Study|Administrative/Other|1
5598101|NCT00914927|19344088|P1|Overall Study|Administrative/Other|2
5598102|NCT00914927|19344082|P7|Overall Study|Lost to Follow-up|0
5598103|NCT00914927|19344083|P6|Overall Study|Lost to Follow-up|0
5598104|NCT00914927|19344084|P5|Overall Study|Lost to Follow-up|0
5598105|NCT00914927|19344085|P4|Overall Study|Lost to Follow-up|1
5598106|NCT00914927|19344086|P3|Overall Study|Lost to Follow-up|0
5598107|NCT00914927|19344087|P2|Overall Study|Lost to Follow-up|0
5598108|NCT00914927|19344088|P1|Overall Study|Lost to Follow-up|0
5598109|NCT00914927|19344082|P7|Overall Study|Withdrawal by Subject|0
5598110|NCT00914927|19344083|P6|Overall Study|Withdrawal by Subject|0
5598111|NCT00914927|19344084|P5|Overall Study|Withdrawal by Subject|0
5598112|NCT00914927|19344085|P4|Overall Study|Withdrawal by Subject|1
5598113|NCT00914927|19344086|P3|Overall Study|Withdrawal by Subject|0
5598114|NCT00914927|19344087|P2|Overall Study|Withdrawal by Subject|1
5598115|NCT00914927|19344088|P1|Overall Study|Withdrawal by Subject|0
5598116|NCT00914927|19344082|P7|Overall Study|Adverse Event|0
5598117|NCT00914927|19344083|P6|Overall Study|Adverse Event|0
5598118|NCT00914927|19344084|P5|Overall Study|Adverse Event|1
5598119|NCT00914927|19344085|P4|Overall Study|Adverse Event|0
5598120|NCT00914927|19344086|P3|Overall Study|Adverse Event|0
5598121|NCT00914927|19344087|P2|Overall Study|Adverse Event|0
5598122|NCT00914927|19344088|P1|Overall Study|Adverse Event|0
5598123|NCT00914849|19344215|P2|Overall Study|Not eligible|1
5598124|NCT00914849|19344216|P1|Overall Study|Not eligible|0
5598125|NCT00914849|19344215|P2|Overall Study|Withdrawal by Subject|0
5598126|NCT00914849|19344216|P1|Overall Study|Withdrawal by Subject|1
5598127|NCT00914810|19344250|P2|Overall Study|Hospitalized and unable to follow up.|1
5598128|NCT00914810|19344251|P1|Overall Study|Hospitalized and unable to follow up.|0
5598129|NCT00914810|19344250|P2|Overall Study|Relocated out of state|0
5598130|NCT00914810|19344251|P1|Overall Study|Relocated out of state|1
5598131|NCT00914810|19344250|P2|Overall Study|Withdrawal by Subject|0
5598132|NCT00914810|19344251|P1|Overall Study|Withdrawal by Subject|1
5598133|NCT00914589|19344262|P3|Overall Study|Death|1
5598134|NCT00914589|19344263|P2|Overall Study|Death|1
5598135|NCT00914589|19344264|P1|Overall Study|Death|0
5598136|NCT00914589|19344262|P3|Overall Study|unclassified|7
5598137|NCT00914589|19344263|P2|Overall Study|unclassified|9
5598138|NCT00914589|19344264|P1|Overall Study|unclassified|16
5598139|NCT00914589|19344262|P3|Overall Study|Protocol Violation|3
5598140|NCT00914589|19344263|P2|Overall Study|Protocol Violation|6
5598141|NCT00914589|19344264|P1|Overall Study|Protocol Violation|8
5598142|NCT00914589|19344262|P3|Overall Study|Adverse Event|1
5598143|NCT00914589|19344263|P2|Overall Study|Adverse Event|0
5598144|NCT00914589|19344264|P1|Overall Study|Adverse Event|1
5598145|NCT00914459|19344290|P2|Overall Study|Parent/Legal guardian request|0
5598146|NCT00914459|19344291|P1|Overall Study|Parent/Legal guardian request|1
5598147|NCT00914459|19344290|P2|Overall Study|Protocol Violation|1
5598148|NCT00914459|19344291|P1|Overall Study|Protocol Violation|0
5598149|NCT00914316|19344321|P4|Phase 2|Withdrawal by Subject|0
5598150|NCT00914316|19344322|P3|Phase 2|Withdrawal by Subject|1
5598151|NCT00914316|19344323|P2|Phase 2|Withdrawal by Subject|0
5598152|NCT00914316|19344324|P1|Phase 2|Withdrawal by Subject|1
5598153|NCT00914316|19344321|P4|Phase 1|Adverse Event|0
5598154|NCT00914316|19344322|P3|Phase 1|Adverse Event|0
5598155|NCT00914316|19344323|P2|Phase 1|Adverse Event|0
5598156|NCT00914316|19344324|P1|Phase 1|Adverse Event|1
5598157|NCT00914316|19344321|P4|Phase 1|Withdrawal by Subject|0
5598158|NCT00914316|19344322|P3|Phase 1|Withdrawal by Subject|4
5598159|NCT00914316|19344323|P2|Phase 1|Withdrawal by Subject|2
5598160|NCT00914316|19344324|P1|Phase 1|Withdrawal by Subject|0
5598161|NCT00914316|19344321|P4|Phase 1|Physician Decision|2
5598162|NCT00914316|19344322|P3|Phase 1|Physician Decision|1
5598163|NCT00914316|19344323|P2|Phase 1|Physician Decision|0
5598164|NCT00914316|19344324|P1|Phase 1|Physician Decision|4
5598165|NCT00913978|19344396|P2|Overall Study|Surgeon choice|3
5598166|NCT00913978|19344397|P1|Overall Study|Surgeon choice|1
5598167|NCT00913835|19344414|P2|Lip Dox: Olaratumab Monotherapy|Other|3
5598168|NCT00913835|19344415|P1|Lip Dox: Olaratumab Monotherapy|Other|0
5598169|NCT00913835|19344414|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
5598170|NCT00913835|19344415|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
5598171|NCT00913835|19344414|P2|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
5598172|NCT00913835|19344415|P1|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
5598173|NCT00913835|19344414|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
5598174|NCT00913835|19344415|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
5598175|NCT00913835|19344414|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
5598176|NCT00913835|19344415|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
5598177|NCT00913770|19344454|P3|Overall Study|Refused|8
5598178|NCT00913770|19344455|P2|Overall Study|Refused|10
5598179|NCT00913770|19344456|P1|Overall Study|Refused|11
5598180|NCT00913770|19344454|P3|Overall Study|Unable to contact|13
5598181|NCT00913770|19344455|P2|Overall Study|Unable to contact|19
5598182|NCT00913770|19344456|P1|Overall Study|Unable to contact|24
5598183|NCT00913744|19344469|P2|Overall Study|Death|0
5598184|NCT00913744|19344470|P1|Overall Study|Death|1
5598185|NCT00913744|19344469|P2|Overall Study|Withdrawal by Subject|1
5598186|NCT00913744|19344470|P1|Overall Study|Withdrawal by Subject|2
5598187|NCT00913744|19344469|P2|Overall Study|Adverse Event|0
5598188|NCT00913744|19344470|P1|Overall Study|Adverse Event|2
5598189|NCT00913692|19344476|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
5598190|NCT00913692|19344476|P1|Screening (4 Months)|Not eligible after screening phase.|6
5598191|NCT00913692|19344476|P1|Screening (4 Months)|Physician Decision|3
5598192|NCT00913523|19344570|P3|Overall Study|Inadequate Number of Tampons Used|3
5598193|NCT00913523|19344571|P2|Overall Study|Inadequate Number of Tampons Used|2
5598194|NCT00913523|19344572|P1|Overall Study|Inadequate Number of Tampons Used|7
5598195|NCT00913523|19344570|P3|Overall Study|Pregnancy|0
5598196|NCT00913523|19344571|P2|Overall Study|Pregnancy|3
5598197|NCT00913523|19344572|P1|Overall Study|Pregnancy|1
5598198|NCT00913523|19344570|P3|Overall Study|Protocol Violation|8
5598199|NCT00913523|19344571|P2|Overall Study|Protocol Violation|8
5598200|NCT00913523|19344572|P1|Overall Study|Protocol Violation|5
5598201|NCT00913523|19344570|P3|Overall Study|Adverse Event|0
5598202|NCT00913523|19344571|P2|Overall Study|Adverse Event|0
5598203|NCT00913523|19344572|P1|Overall Study|Adverse Event|1
5598204|NCT00913523|19344570|P3|Overall Study|Lost to Follow-up|1
5598205|NCT00913523|19344571|P2|Overall Study|Lost to Follow-up|1
5598206|NCT00913523|19344572|P1|Overall Study|Lost to Follow-up|1
5598207|NCT00913523|19344570|P3|Overall Study|Withdrawal by Subject|2
5598208|NCT00913523|19344571|P2|Overall Study|Withdrawal by Subject|2
5598209|NCT00913523|19344572|P1|Overall Study|Withdrawal by Subject|3
5598210|NCT00913458|19344604|P7|Phase 3|Unsatisfactory Response per Investigator|4
5598211|NCT00913458|19344605|P6|Phase 3|Unsatisfactory Response per Investigator|11
5598212|NCT00913458|19344606|P5|Phase 3|Unsatisfactory Response per Investigator|14
5598213|NCT00913458|19344607|P4|Phase 3|Unsatisfactory Response per Investigator|0
5598214|NCT00913458|19344608|P3|Phase 3|Unsatisfactory Response per Investigator|0
5598215|NCT00913458|19344609|P2|Phase 3|Unsatisfactory Response per Investigator|0
5598216|NCT00913458|19344610|P1|Phase 3|Unsatisfactory Response per Investigator|0
5598217|NCT00913458|19344604|P7|Phase 3|Withdrawal by Subject|0
5598218|NCT00913458|19344605|P6|Phase 3|Withdrawal by Subject|2
5598219|NCT00913458|19344606|P5|Phase 3|Withdrawal by Subject|1
5598220|NCT00913458|19344607|P4|Phase 3|Withdrawal by Subject|0
5598221|NCT00913458|19344608|P3|Phase 3|Withdrawal by Subject|0
5598222|NCT00913458|19344609|P2|Phase 3|Withdrawal by Subject|0
5598223|NCT00913458|19344610|P1|Phase 3|Withdrawal by Subject|0
5598224|NCT00913458|19344604|P7|Phase 3|Non-Responder|3
5598225|NCT00913458|19344605|P6|Phase 3|Non-Responder|1
5598226|NCT00913458|19344606|P5|Phase 3|Non-Responder|0
5598227|NCT00913458|19344607|P4|Phase 3|Non-Responder|0
5598228|NCT00913458|19344608|P3|Phase 3|Non-Responder|0
5598229|NCT00913458|19344609|P2|Phase 3|Non-Responder|0
5598230|NCT00913458|19344610|P1|Phase 3|Non-Responder|0
5598231|NCT00913458|19344604|P7|Phase 3|Lost to Follow-up|0
5598232|NCT00913458|19344605|P6|Phase 3|Lost to Follow-up|0
5598233|NCT00913458|19344606|P5|Phase 3|Lost to Follow-up|2
5598234|NCT00913458|19344607|P4|Phase 3|Lost to Follow-up|0
5598235|NCT00913458|19344608|P3|Phase 3|Lost to Follow-up|0
5598236|NCT00913458|19344609|P2|Phase 3|Lost to Follow-up|0
5598237|NCT00913458|19344610|P1|Phase 3|Lost to Follow-up|0
5598238|NCT00913458|19344604|P7|Phase 3|Adverse Event|1
5598239|NCT00913458|19344605|P6|Phase 3|Adverse Event|4
5598240|NCT00913458|19344606|P5|Phase 3|Adverse Event|5
5598241|NCT00913458|19344607|P4|Phase 3|Adverse Event|0
5598242|NCT00913458|19344608|P3|Phase 3|Adverse Event|0
5598243|NCT00913458|19344609|P2|Phase 3|Adverse Event|0
5598244|NCT00913458|19344610|P1|Phase 3|Adverse Event|0
5598245|NCT00913458|19344604|P7|Phase 2|Unsatisfactory Response per Investigator|0
5598246|NCT00913458|19344605|P6|Phase 2|Unsatisfactory Response per Investigator|0
5598247|NCT00913458|19344606|P5|Phase 2|Unsatisfactory Response per Investigator|0
5598248|NCT00913458|19344607|P4|Phase 2|Unsatisfactory Response per Investigator|17
5598249|NCT00913458|19344608|P3|Phase 2|Unsatisfactory Response per Investigator|11
5598250|NCT00913458|19344609|P2|Phase 2|Unsatisfactory Response per Investigator|0
5598251|NCT00913458|19344610|P1|Phase 2|Unsatisfactory Response per Investigator|0
5598252|NCT00913458|19344604|P7|Phase 2|Protocol Violation|0
5598253|NCT00913458|19344605|P6|Phase 2|Protocol Violation|0
5598254|NCT00913458|19344606|P5|Phase 2|Protocol Violation|0
5598255|NCT00913458|19344607|P4|Phase 2|Protocol Violation|0
5598256|NCT00913458|19344608|P3|Phase 2|Protocol Violation|0
5598257|NCT00913458|19344609|P2|Phase 2|Protocol Violation|2
5598258|NCT00913458|19344610|P1|Phase 2|Protocol Violation|0
5598259|NCT00913458|19344604|P7|Phase 2|Lost to Follow-up|0
5598260|NCT00913458|19344605|P6|Phase 2|Lost to Follow-up|0
5598261|NCT00913458|19344606|P5|Phase 2|Lost to Follow-up|0
5598262|NCT00913458|19344607|P4|Phase 2|Lost to Follow-up|1
5598263|NCT00913458|19344608|P3|Phase 2|Lost to Follow-up|0
5598264|NCT00913458|19344609|P2|Phase 2|Lost to Follow-up|0
5598265|NCT00913458|19344610|P1|Phase 2|Lost to Follow-up|0
5598266|NCT00913458|19344604|P7|Phase 2|Adverse Event|0
5598267|NCT00913458|19344605|P6|Phase 2|Adverse Event|0
5598268|NCT00913458|19344606|P5|Phase 2|Adverse Event|0
5598269|NCT00913458|19344607|P4|Phase 2|Adverse Event|1
5598270|NCT00913458|19344608|P3|Phase 2|Adverse Event|0
5598271|NCT00913458|19344609|P2|Phase 2|Adverse Event|3
5598272|NCT00913458|19344610|P1|Phase 2|Adverse Event|0
5598273|NCT00913458|19344604|P7|Phase 2|Subject Request|0
5598274|NCT00913458|19344605|P6|Phase 2|Subject Request|0
5598275|NCT00913458|19344606|P5|Phase 2|Subject Request|0
5598276|NCT00913458|19344607|P4|Phase 2|Subject Request|2
5598277|NCT00913458|19344608|P3|Phase 2|Subject Request|1
5598278|NCT00913458|19344609|P2|Phase 2|Subject Request|0
5598279|NCT00913458|19344610|P1|Phase 2|Subject Request|0
5598280|NCT00913458|19344604|P7|Phase 2|Non-Responder|0
5598281|NCT00913458|19344605|P6|Phase 2|Non-Responder|0
5598282|NCT00913458|19344606|P5|Phase 2|Non-Responder|0
5598283|NCT00913458|19344607|P4|Phase 2|Non-Responder|12
5598284|NCT00913458|19344608|P3|Phase 2|Non-Responder|7
5598285|NCT00913458|19344609|P2|Phase 2|Non-Responder|5
5598286|NCT00913458|19344610|P1|Phase 2|Non-Responder|0
5598287|NCT00913458|19344604|P7|Phase 1|Unsatisfactory Response per Investigator|0
5598288|NCT00913458|19344605|P6|Phase 1|Unsatisfactory Response per Investigator|0
5598289|NCT00913458|19344606|P5|Phase 1|Unsatisfactory Response per Investigator|0
5598290|NCT00913458|19344607|P4|Phase 1|Unsatisfactory Response per Investigator|0
5598291|NCT00913458|19344608|P3|Phase 1|Unsatisfactory Response per Investigator|0
5598292|NCT00913458|19344609|P2|Phase 1|Unsatisfactory Response per Investigator|0
5598293|NCT00913458|19344610|P1|Phase 1|Unsatisfactory Response per Investigator|7
5598294|NCT00913458|19344604|P7|Phase 1|Sponsor|0
5598295|NCT00913458|19344605|P6|Phase 1|Sponsor|0
5598296|NCT00913458|19344606|P5|Phase 1|Sponsor|0
5598297|NCT00913458|19344607|P4|Phase 1|Sponsor|0
5598298|NCT00913458|19344608|P3|Phase 1|Sponsor|0
5598299|NCT00913458|19344609|P2|Phase 1|Sponsor|0
5598300|NCT00913458|19344610|P1|Phase 1|Sponsor|2
5598301|NCT00913458|19344604|P7|Phase 1|Protocol Violation|0
5598302|NCT00913458|19344605|P6|Phase 1|Protocol Violation|0
5598303|NCT00913458|19344606|P5|Phase 1|Protocol Violation|0
5598304|NCT00913458|19344607|P4|Phase 1|Protocol Violation|0
5598305|NCT00913458|19344608|P3|Phase 1|Protocol Violation|0
5598306|NCT00913458|19344609|P2|Phase 1|Protocol Violation|0
5598307|NCT00913458|19344610|P1|Phase 1|Protocol Violation|10
5598308|NCT00913458|19344604|P7|Phase 1|Lost to Follow-up|0
5598309|NCT00913458|19344605|P6|Phase 1|Lost to Follow-up|0
5598310|NCT00913458|19344606|P5|Phase 1|Lost to Follow-up|0
5598311|NCT00913458|19344607|P4|Phase 1|Lost to Follow-up|0
5598312|NCT00913458|19344608|P3|Phase 1|Lost to Follow-up|0
5598313|NCT00913458|19344609|P2|Phase 1|Lost to Follow-up|0
5598314|NCT00913458|19344610|P1|Phase 1|Lost to Follow-up|2
5598315|NCT00913458|19344604|P7|Phase 1|Adverse Event|0
5598316|NCT00913458|19344605|P6|Phase 1|Adverse Event|0
5598317|NCT00913458|19344606|P5|Phase 1|Adverse Event|0
5598318|NCT00913458|19344607|P4|Phase 1|Adverse Event|0
5598319|NCT00913458|19344608|P3|Phase 1|Adverse Event|0
5598320|NCT00913458|19344609|P2|Phase 1|Adverse Event|0
5598321|NCT00913458|19344610|P1|Phase 1|Adverse Event|20
5598322|NCT00913458|19344604|P7|Phase 1|Subject Request|0
5598323|NCT00913458|19344605|P6|Phase 1|Subject Request|0
5598324|NCT00913458|19344606|P5|Phase 1|Subject Request|0
5598325|NCT00913458|19344607|P4|Phase 1|Subject Request|0
5598326|NCT00913458|19344608|P3|Phase 1|Subject Request|0
5598327|NCT00913458|19344609|P2|Phase 1|Subject Request|0
5598328|NCT00913458|19344610|P1|Phase 1|Subject Request|17
5598329|NCT00913458|19344604|P7|Phase 1|Non-Responder|0
5598330|NCT00913458|19344605|P6|Phase 1|Non-Responder|0
5598331|NCT00913458|19344606|P5|Phase 1|Non-Responder|0
5598332|NCT00913458|19344607|P4|Phase 1|Non-Responder|0
5598333|NCT00913458|19344608|P3|Phase 1|Non-Responder|0
5598334|NCT00913458|19344609|P2|Phase 1|Non-Responder|0
5599611|NCT00906399|19348039|P2|Year 1|Death|1
5598335|NCT00913458|19344610|P1|Phase 1|Non-Responder|54
5598336|NCT00913380|19344703|P2|Clinical Outcomes|Lost to Follow-up|6
5598337|NCT00913380|19344704|P1|Clinical Outcomes|Lost to Follow-up|6
5598338|NCT00912964|19344783|P3|Overall Study|Randomized but never received study drug|0
5598339|NCT00912964|19344784|P2|Overall Study|Randomized but never received study drug|1
5598340|NCT00912964|19344785|P1|Overall Study|Randomized but never received study drug|0
5598341|NCT00912964|19344783|P3|Overall Study|Violation of exclusion criterion|2
5598342|NCT00912964|19344784|P2|Overall Study|Violation of exclusion criterion|0
5598343|NCT00912964|19344785|P1|Overall Study|Violation of exclusion criterion|0
5598344|NCT00912964|19344783|P3|Overall Study|Non-compliance with study procedures|0
5598345|NCT00912964|19344784|P2|Overall Study|Non-compliance with study procedures|0
5598346|NCT00912964|19344785|P1|Overall Study|Non-compliance with study procedures|2
5598347|NCT00912964|19344783|P3|Overall Study|Medical History|0
5598348|NCT00912964|19344784|P2|Overall Study|Medical History|0
5598349|NCT00912964|19344785|P1|Overall Study|Medical History|1
5598350|NCT00912964|19344783|P3|Overall Study|Taking exclusionary medications|8
5598351|NCT00912964|19344784|P2|Overall Study|Taking exclusionary medications|4
5598352|NCT00912964|19344785|P1|Overall Study|Taking exclusionary medications|7
5598353|NCT00912964|19344783|P3|Overall Study|Protocol Violation|8
5598354|NCT00912964|19344784|P2|Overall Study|Protocol Violation|3
5598355|NCT00912964|19344785|P1|Overall Study|Protocol Violation|5
5598356|NCT00912964|19344783|P3|Overall Study|Lost to Follow-up|3
5598357|NCT00912964|19344784|P2|Overall Study|Lost to Follow-up|3
5598358|NCT00912964|19344785|P1|Overall Study|Lost to Follow-up|4
5598359|NCT00912964|19344783|P3|Overall Study|Withdrawal by Subject|18
5598360|NCT00912964|19344784|P2|Overall Study|Withdrawal by Subject|12
5598361|NCT00912964|19344785|P1|Overall Study|Withdrawal by Subject|20
5598362|NCT00912964|19344783|P3|Overall Study|Lack of Efficacy|3
5598363|NCT00912964|19344784|P2|Overall Study|Lack of Efficacy|4
5598364|NCT00912964|19344785|P1|Overall Study|Lack of Efficacy|11
5598365|NCT00912964|19344783|P3|Overall Study|Adverse Event|12
5598366|NCT00912964|19344784|P2|Overall Study|Adverse Event|18
5598367|NCT00912964|19344785|P1|Overall Study|Adverse Event|15
5598368|NCT00912964|19344783|P3|Overall Study|Eligibility criterion not met|0
5598369|NCT00912964|19344784|P2|Overall Study|Eligibility criterion not met|1
5598370|NCT00912964|19344785|P1|Overall Study|Eligibility criterion not met|1
5598371|NCT00912912|19344928|P1|Overall Study|Disease Progression|3
5598372|NCT00912912|19344928|P1|Overall Study|Withdrawal by Subject|1
5598373|NCT00912808|19344934|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
5598374|NCT00912808|19344935|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
5598375|NCT00912808|19344934|P2|Second Intervention (6 Weeks)|Adverse Event|1
5598376|NCT00912808|19344935|P1|Second Intervention (6 Weeks)|Adverse Event|0
5598377|NCT00912808|19344934|P2|Washout|Withdrawal by Subject|1
5598378|NCT00912808|19344935|P1|Washout|Withdrawal by Subject|0
5598379|NCT00912808|19344934|P2|First Intervention (6 Weeks)|Adverse Event|1
5598380|NCT00912808|19344935|P1|First Intervention (6 Weeks)|Adverse Event|2
5598381|NCT00912782|19344960|P2|Overall Study|Relocated before study completion|1
5598382|NCT00912782|19344961|P1|Overall Study|Relocated before study completion|0
5598383|NCT00912782|19344960|P2|Overall Study|Did not receive vascular access type|2
5598384|NCT00912782|19344961|P1|Overall Study|Did not receive vascular access type|1
5598385|NCT00912782|19344960|P2|Overall Study|Lost to Follow-up|1
5598386|NCT00912782|19344961|P1|Overall Study|Lost to Follow-up|0
5598387|NCT00912782|19344960|P2|Overall Study|Death|1
5598388|NCT00912782|19344961|P1|Overall Study|Death|2
5598389|NCT00912743|19344971|P2|Overall Study|End of treatment form was not collected|0
5598390|NCT00912743|19344972|P1|Overall Study|End of treatment form was not collected|1
5598391|NCT00912743|19344971|P2|Overall Study|Toxicity|1
5598392|NCT00912743|19344972|P1|Overall Study|Toxicity|0
5598393|NCT00912743|19344971|P2|Overall Study|Lack of Efficacy|18
5598394|NCT00912743|19344972|P1|Overall Study|Lack of Efficacy|9
5598395|NCT00912743|19344971|P2|Overall Study|Adverse Event|1
5598396|NCT00912743|19344972|P1|Overall Study|Adverse Event|3
5598397|NCT00912509|19344984|P2|Overall Study|Lack of Efficacy|3
5598398|NCT00912509|19344985|P1|Overall Study|Lack of Efficacy|4
5598399|NCT00912509|19344984|P2|Overall Study|Lost to Follow-up|0
5598400|NCT00912509|19344985|P1|Overall Study|Lost to Follow-up|1
5598401|NCT00912405|19344993|P1|Overall Study|Lost to Follow-up|5
5598402|NCT00912340|19345003|P3|Overall Study|Protocol revised to remove arm|4
5598403|NCT00912340|19345004|P2|Overall Study|Protocol revised to remove arm|0
5598404|NCT00912340|19345005|P1|Overall Study|Protocol revised to remove arm|0
5598405|NCT00912340|19345003|P3|Overall Study|Adverse Event|0
5598406|NCT00912340|19345004|P2|Overall Study|Adverse Event|4
5598407|NCT00912340|19345005|P1|Overall Study|Adverse Event|2
5598408|NCT00912288|19345043|P2|Overall Study|Other|0
5598409|NCT00912288|19345044|P1|Overall Study|Other|1
5598410|NCT00912288|19345043|P2|Overall Study|Study terminated by sponsor|35
5598411|NCT00912288|19345044|P1|Overall Study|Study terminated by sponsor|34
5598412|NCT00912288|19345043|P2|Overall Study|Withdrawal by Subject|3
5598413|NCT00912288|19345044|P1|Overall Study|Withdrawal by Subject|3
5598414|NCT00912288|19345043|P2|Overall Study|Protocol Violation|0
5598415|NCT00912288|19345044|P1|Overall Study|Protocol Violation|1
5598416|NCT00912288|19345043|P2|Overall Study|Lost to Follow-up|0
5598417|NCT00912288|19345044|P1|Overall Study|Lost to Follow-up|1
5598418|NCT00912288|19345043|P2|Overall Study|Adverse Event|1
5598419|NCT00912288|19345044|P1|Overall Study|Adverse Event|1
5598420|NCT00912288|19345043|P2|Overall Study|Death|1
5598421|NCT00912288|19345044|P1|Overall Study|Death|0
5598422|NCT00912223|19345066|P1|Overall Study|Transformed disease|1
5598423|NCT00912223|19345066|P1|Overall Study|Not transplanted|1
5598424|NCT00912223|19345066|P1|Overall Study|Withdrawal by Subject|1
5598425|NCT00912197|19345084|P2|Overall Study|Withdrawal by Subject|3
5598426|NCT00912197|19345085|P1|Overall Study|Withdrawal by Subject|3
5598427|NCT00912093|19345124|P5|The Controlled Phase|Lost to Follow-up|1
5598428|NCT00912093|19345125|P4|The Controlled Phase|Lost to Follow-up|0
5598429|NCT00912093|19345126|P3|The Controlled Phase|Lost to Follow-up|0
5598430|NCT00912093|19345127|P2|The Controlled Phase|Lost to Follow-up|0
5598431|NCT00912093|19345128|P1|The Controlled Phase|Lost to Follow-up|0
5598432|NCT00912093|19345124|P5|The Controlled Phase|Medical Condition|0
5598433|NCT00912093|19345125|P4|The Controlled Phase|Medical Condition|0
5598434|NCT00912093|19345126|P3|The Controlled Phase|Medical Condition|0
5598435|NCT00912093|19345127|P2|The Controlled Phase|Medical Condition|1
5598436|NCT00912093|19345128|P1|The Controlled Phase|Medical Condition|0
5598437|NCT00912093|19345124|P5|The Controlled Phase|Death|0
5598438|NCT00912093|19345125|P4|The Controlled Phase|Death|0
5598439|NCT00912093|19345126|P3|The Controlled Phase|Death|0
5598440|NCT00912093|19345127|P2|The Controlled Phase|Death|1
5598441|NCT00912093|19345128|P1|The Controlled Phase|Death|0
5598442|NCT00912028|19345147|P5|Overall Study|Withdrawal by Subject|0
5598443|NCT00912028|19345148|P4|Overall Study|Withdrawal by Subject|0
5598444|NCT00912028|19345149|P3|Overall Study|Withdrawal by Subject|0
5598445|NCT00912028|19345150|P2|Overall Study|Withdrawal by Subject|0
5598446|NCT00912028|19345151|P1|Overall Study|Withdrawal by Subject|3
5598447|NCT00912028|19345147|P5|Overall Study|Lost to Follow-up|3
5598448|NCT00912028|19345148|P4|Overall Study|Lost to Follow-up|1
5598449|NCT00912028|19345149|P3|Overall Study|Lost to Follow-up|0
5598450|NCT00912028|19345150|P2|Overall Study|Lost to Follow-up|3
5598451|NCT00912028|19345151|P1|Overall Study|Lost to Follow-up|2
5598452|NCT00912015|19345180|P4|Overall Study|Adverse Event|1
5598453|NCT00912015|19345181|P3|Overall Study|Adverse Event|0
5598454|NCT00912015|19345182|P2|Overall Study|Adverse Event|0
5598455|NCT00912015|19345183|P1|Overall Study|Adverse Event|6
5598456|NCT00912015|19345180|P4|Overall Study|Protocol Violation|1
5598457|NCT00912015|19345181|P3|Overall Study|Protocol Violation|0
5598458|NCT00912015|19345182|P2|Overall Study|Protocol Violation|0
5598459|NCT00912015|19345183|P1|Overall Study|Protocol Violation|1
5598460|NCT00912015|19345180|P4|Overall Study|Withdrawal by Subject|0
5598461|NCT00912015|19345181|P3|Overall Study|Withdrawal by Subject|3
5598462|NCT00912015|19345182|P2|Overall Study|Withdrawal by Subject|8
5598463|NCT00912015|19345183|P1|Overall Study|Withdrawal by Subject|8
5598464|NCT00912015|19345180|P4|Overall Study|Lack of Efficacy|0
5598465|NCT00912015|19345181|P3|Overall Study|Lack of Efficacy|0
5598466|NCT00912015|19345182|P2|Overall Study|Lack of Efficacy|0
5598467|NCT00912015|19345183|P1|Overall Study|Lack of Efficacy|1
5598468|NCT00911989|19345199|P1|Overall Study|Adverse Event|1
5598469|NCT00911937|19345205|P2|Overall Study|Other|5
5598470|NCT00911937|19345206|P1|Overall Study|Other|9
5598471|NCT00911937|19345205|P2|Overall Study|Randomized but not treated|13
5598472|NCT00911937|19345206|P1|Overall Study|Randomized but not treated|13
5598473|NCT00911937|19345205|P2|Overall Study|Protocol Violation|23
5598474|NCT00911937|19345206|P1|Overall Study|Protocol Violation|14
5598475|NCT00911937|19345205|P2|Overall Study|Did not meet inclusion criteria|11
5598476|NCT00911937|19345206|P1|Overall Study|Did not meet inclusion criteria|9
5598477|NCT00911937|19345205|P2|Overall Study|Lack of Efficacy|6
5598478|NCT00911937|19345206|P1|Overall Study|Lack of Efficacy|11
5598479|NCT00911937|19345205|P2|Overall Study|Adverse Event|25
5598480|NCT00911937|19345206|P1|Overall Study|Adverse Event|11
5598481|NCT00911937|19345205|P2|Overall Study|Withdrawn due to pregnancy|0
5598482|NCT00911937|19345206|P1|Overall Study|Withdrawn due to pregnancy|1
5598483|NCT00911937|19345205|P2|Overall Study|Withdrawal by Subject|7
5598484|NCT00911937|19345206|P1|Overall Study|Withdrawal by Subject|10
5598485|NCT00911937|19345205|P2|Overall Study|Lost to Follow-up|5
5598486|NCT00911937|19345206|P1|Overall Study|Lost to Follow-up|8
5598487|NCT00911937|19345205|P2|Overall Study|Death|0
5598488|NCT00911937|19345206|P1|Overall Study|Death|1
5598489|NCT00911859|19345273|P3|Follow-up Period|Study terminated by sponsor|27
5598490|NCT00911859|19345274|P2|Follow-up Period|Study terminated by sponsor|33
5598491|NCT00911859|19345275|P1|Follow-up Period|Study terminated by sponsor|5
5598492|NCT00911859|19345273|P3|Follow-up Period|Withdrawal by Subject|4
5598493|NCT00911859|19345274|P2|Follow-up Period|Withdrawal by Subject|4
5598494|NCT00911859|19345275|P1|Follow-up Period|Withdrawal by Subject|0
5598495|NCT00911859|19345273|P3|Follow-up Period|Lost to Follow-up|0
5598496|NCT00911859|19345274|P2|Follow-up Period|Lost to Follow-up|1
5598497|NCT00911859|19345275|P1|Follow-up Period|Lost to Follow-up|1
5598498|NCT00911859|19345273|P3|Follow-up Period|Death|10
5598499|NCT00911859|19345274|P2|Follow-up Period|Death|8
5598500|NCT00911859|19345275|P1|Follow-up Period|Death|5
5598501|NCT00911859|19345273|P3|Maintainance Period|Withdrawal by Subject|3
5598502|NCT00911859|19345274|P2|Maintainance Period|Withdrawal by Subject|0
5598503|NCT00911859|19345275|P1|Maintainance Period|Withdrawal by Subject|0
5598504|NCT00911859|19345273|P3|Maintainance Period|Physician Decision|9
5598505|NCT00911859|19345274|P2|Maintainance Period|Physician Decision|0
5598506|NCT00911859|19345275|P1|Maintainance Period|Physician Decision|0
5598507|NCT00911859|19345273|P3|Maintainance Period|Lack of Efficacy|9
5598508|NCT00911859|19345274|P2|Maintainance Period|Lack of Efficacy|0
5598509|NCT00911859|19345275|P1|Maintainance Period|Lack of Efficacy|0
5598510|NCT00911859|19345273|P3|Treatment Period|Did not receive study treatment|0
5598511|NCT00911859|19345274|P2|Treatment Period|Did not receive study treatment|1
5598512|NCT00911859|19345275|P1|Treatment Period|Did not receive study treatment|0
5598513|NCT00911859|19345273|P3|Treatment Period|Withdrawal by Subject|5
5598514|NCT00911859|19345274|P2|Treatment Period|Withdrawal by Subject|4
5598515|NCT00911859|19345275|P1|Treatment Period|Withdrawal by Subject|0
5598516|NCT00911859|19345273|P3|Treatment Period|Physician Decision|3
5598517|NCT00911859|19345274|P2|Treatment Period|Physician Decision|3
5598518|NCT00911859|19345275|P1|Treatment Period|Physician Decision|3
5598519|NCT00911859|19345273|P3|Treatment Period|Lack of Efficacy|5
5598520|NCT00911859|19345274|P2|Treatment Period|Lack of Efficacy|7
5598521|NCT00911859|19345275|P1|Treatment Period|Lack of Efficacy|1
5598522|NCT00911859|19345273|P3|Treatment Period|Death|5
5598523|NCT00911859|19345274|P2|Treatment Period|Death|3
5598524|NCT00911859|19345275|P1|Treatment Period|Death|1
5598525|NCT00911859|19345273|P3|Treatment Period|Adverse Event|7
5598526|NCT00911859|19345274|P2|Treatment Period|Adverse Event|3
5598527|NCT00911859|19345275|P1|Treatment Period|Adverse Event|3
5598528|NCT00911820|19345301|P2|Overall Study|Withdraw before Receive Treatment|2
5598529|NCT00911820|19345302|P1|Overall Study|Withdraw before Receive Treatment|0
5598530|NCT00911820|19345301|P2|Overall Study|Pathology Not Confirmed|0
5598531|NCT00911820|19345302|P1|Overall Study|Pathology Not Confirmed|1
5598532|NCT00911820|19345301|P2|Overall Study|Still on Therapy|2
5598533|NCT00911820|19345302|P1|Overall Study|Still on Therapy|2
5598534|NCT00911820|19345301|P2|Overall Study|Pursue Radiation|0
5598535|NCT00911820|19345302|P1|Overall Study|Pursue Radiation|1
5598536|NCT00911820|19345301|P2|Overall Study|Pursue surgery|1
5598537|NCT00911820|19345302|P1|Overall Study|Pursue surgery|1
5598538|NCT00911820|19345301|P2|Overall Study|Death|2
5598539|NCT00911820|19345302|P1|Overall Study|Death|1
5598540|NCT00911820|19345301|P2|Overall Study|Withdrawal by Subject|4
5598541|NCT00911820|19345302|P1|Overall Study|Withdrawal by Subject|3
5598542|NCT00911820|19345301|P2|Overall Study|Decline in Performance Status|2
5598543|NCT00911820|19345302|P1|Overall Study|Decline in Performance Status|4
5598544|NCT00911820|19345301|P2|Overall Study|Physician Decision|9
5598545|NCT00911820|19345302|P1|Overall Study|Physician Decision|5
5598546|NCT00911820|19345301|P2|Overall Study|Clinical Progression|5
5598547|NCT00911820|19345302|P1|Overall Study|Clinical Progression|7
5598548|NCT00911820|19345301|P2|Overall Study|Adverse Event|8
5598549|NCT00911820|19345302|P1|Overall Study|Adverse Event|8
5598550|NCT00911820|19345301|P2|Overall Study|RECIST progression|8
5598551|NCT00911820|19345302|P1|Overall Study|RECIST progression|12
5598552|NCT00911807|19345319|P3|Overall Study|Organizational reasons|1
5598553|NCT00911807|19345320|P2|Overall Study|Organizational reasons|3
5598554|NCT00911807|19345321|P1|Overall Study|Organizational reasons|1
5598555|NCT00911807|19345319|P3|Overall Study|Withdrawal by Subject|7
5598556|NCT00911807|19345320|P2|Overall Study|Withdrawal by Subject|10
5598557|NCT00911807|19345321|P1|Overall Study|Withdrawal by Subject|8
5598558|NCT00911807|19345319|P3|Overall Study|Protocol Violation|9
5598559|NCT00911807|19345320|P2|Overall Study|Protocol Violation|4
5598560|NCT00911807|19345321|P1|Overall Study|Protocol Violation|6
5598561|NCT00911807|19345319|P3|Overall Study|Death|1
5598562|NCT00911807|19345320|P2|Overall Study|Death|0
5598563|NCT00911807|19345321|P1|Overall Study|Death|0
5598564|NCT00911807|19345319|P3|Overall Study|Adverse Event|5
5598565|NCT00911807|19345320|P2|Overall Study|Adverse Event|1
5598566|NCT00911807|19345321|P1|Overall Study|Adverse Event|2
5598567|NCT00911768|19345331|P2|Overall Study|Withdrawal by Subject|0
5598568|NCT00911768|19345332|P1|Overall Study|Withdrawal by Subject|1
5598569|NCT00911768|19345331|P2|Overall Study|Protocol Violation|4
5598570|NCT00911768|19345332|P1|Overall Study|Protocol Violation|5
5598571|NCT00911625|19345361|P2|Overall Study|Lost to Follow-up|0
5598572|NCT00911625|19345362|P1|Overall Study|Lost to Follow-up|7
5598573|NCT00911547|19345396|P4|Overall Study|Withdrawal by Subject|8
5598574|NCT00911547|19345397|P3|Overall Study|Withdrawal by Subject|4
5598575|NCT00911547|19345398|P2|Overall Study|Withdrawal by Subject|10
5598576|NCT00911547|19345399|P1|Overall Study|Withdrawal by Subject|3
5598577|NCT00911547|19345396|P4|Overall Study|Protocol Violation|1
5598578|NCT00911547|19345397|P3|Overall Study|Protocol Violation|5
5598579|NCT00911547|19345398|P2|Overall Study|Protocol Violation|5
5598580|NCT00911547|19345399|P1|Overall Study|Protocol Violation|0
5598581|NCT00911547|19345396|P4|Overall Study|Lost to Follow-up|1
5598582|NCT00911547|19345397|P3|Overall Study|Lost to Follow-up|2
5598583|NCT00911547|19345398|P2|Overall Study|Lost to Follow-up|0
5598584|NCT00911547|19345399|P1|Overall Study|Lost to Follow-up|0
5598585|NCT00911547|19345396|P4|Overall Study|Adverse Event|6
5598586|NCT00911547|19345397|P3|Overall Study|Adverse Event|11
5598587|NCT00911547|19345398|P2|Overall Study|Adverse Event|27
5598588|NCT00911547|19345399|P1|Overall Study|Adverse Event|8
5598589|NCT00911534|19345427|P2|Overall Study|Other|2
5598590|NCT00911534|19345428|P1|Overall Study|Other|2
5598591|NCT00911534|19345427|P2|Overall Study|Withdrawal of consent|4
5598592|NCT00911534|19345428|P1|Overall Study|Withdrawal of consent|1
5598593|NCT00911534|19345427|P2|Overall Study|Lack of Efficacy|1
5598594|NCT00911534|19345428|P1|Overall Study|Lack of Efficacy|4
5598595|NCT00911534|19345427|P2|Overall Study|Withdrawal by Subject|1
5598596|NCT00911534|19345428|P1|Overall Study|Withdrawal by Subject|2
5599612|NCT00906399|19348040|P1|Year 1|Death|2
5598597|NCT00911534|19345427|P2|Overall Study|Lost to Follow-up|4
5598598|NCT00911534|19345428|P1|Overall Study|Lost to Follow-up|2
5598599|NCT00911534|19345427|P2|Overall Study|Adverse Event|4
5598600|NCT00911534|19345428|P1|Overall Study|Adverse Event|4
5598601|NCT00911508|19345442|P2|Overall Study|Withdrawal by Subject|112
5598602|NCT00911508|19345443|P1|Overall Study|Withdrawal by Subject|79
5598603|NCT00911508|19345442|P2|Overall Study|Lost to Follow-up|18
5598604|NCT00911508|19345443|P1|Overall Study|Lost to Follow-up|27
5598605|NCT00911300|19345518|P2|Overall Study|Randomized; No Study Medication Received|2
5598606|NCT00911300|19345519|P1|Overall Study|Randomized; No Study Medication Received|0
5598607|NCT00911300|19345518|P2|Overall Study|Treatment Stopped by Mistake|1
5598608|NCT00911300|19345519|P1|Overall Study|Treatment Stopped by Mistake|0
5598609|NCT00911300|19345518|P2|Overall Study|Physician Decision|1
5598610|NCT00911300|19345519|P1|Overall Study|Physician Decision|0
5598611|NCT00911300|19345518|P2|Overall Study|Underlying Disease (Myocarditis)|1
5598612|NCT00911300|19345519|P1|Overall Study|Underlying Disease (Myocarditis)|0
5598613|NCT00911300|19345518|P2|Overall Study|Participant Refused Hospital Consulation|1
5598614|NCT00911300|19345519|P1|Overall Study|Participant Refused Hospital Consulation|0
5598615|NCT00911300|19345518|P2|Overall Study|International Normalized Ratio Too High|1
5598616|NCT00911300|19345519|P1|Overall Study|International Normalized Ratio Too High|0
5598617|NCT00911300|19345518|P2|Overall Study|Investigator's Decision; New AF Episode|1
5598618|NCT00911300|19345519|P1|Overall Study|Investigator's Decision; New AF Episode|0
5598619|NCT00911300|19345518|P2|Overall Study|Participant Could Not Stay in Hospital|1
5598620|NCT00911300|19345519|P1|Overall Study|Participant Could Not Stay in Hospital|0
5598621|NCT00911300|19345518|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
5598622|NCT00911300|19345519|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
5598623|NCT00911300|19345518|P2|Overall Study|Nurse Unavailable in Participant's City|0
5598624|NCT00911300|19345519|P1|Overall Study|Nurse Unavailable in Participant's City|1
5598625|NCT00911300|19345518|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
5598626|NCT00911300|19345519|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
5598627|NCT00911300|19345518|P2|Overall Study|Recurrent Tachyarrhythmia|1
5598628|NCT00911300|19345519|P1|Overall Study|Recurrent Tachyarrhythmia|1
5598629|NCT00911300|19345518|P2|Overall Study|Received Commercial Treatment|0
5598630|NCT00911300|19345519|P1|Overall Study|Received Commercial Treatment|1
5598631|NCT00911300|19345518|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
5598632|NCT00911300|19345519|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
5598633|NCT00911300|19345518|P2|Overall Study|Coronary Angiography Performed|0
5598634|NCT00911300|19345519|P1|Overall Study|Coronary Angiography Performed|1
5598635|NCT00911300|19345518|P2|Overall Study|Consent Withdrawn|12
5598636|NCT00911300|19345519|P1|Overall Study|Consent Withdrawn|4
5598637|NCT00911300|19345518|P2|Overall Study|Protocol Violation|2
5598638|NCT00911300|19345519|P1|Overall Study|Protocol Violation|3
5598639|NCT00911300|19345518|P2|Overall Study|Adverse Event|6
5598640|NCT00911300|19345519|P1|Overall Study|Adverse Event|14
5598641|NCT00911300|19345518|P2|Overall Study|Thrombus Persistant in Second TEE|7
5598642|NCT00911300|19345519|P1|Overall Study|Thrombus Persistant in Second TEE|3
5598643|NCT00911300|19345518|P2|Overall Study|Death|0
5598644|NCT00911300|19345519|P1|Overall Study|Death|1
5598645|NCT00911300|19345518|P2|Overall Study|Primary Endpoint Component Occurred|2
5598646|NCT00911300|19345519|P1|Overall Study|Primary Endpoint Component Occurred|1
5598647|NCT00911170|19345556|P2|Long Term Follow-Up|Death|121
5598648|NCT00911170|19345557|P1|Long Term Follow-Up|Death|116
5598649|NCT00911170|19345556|P2|Long Term Follow-Up|Lost to Follow-up|7
5598650|NCT00911170|19345557|P1|Long Term Follow-Up|Lost to Follow-up|8
5598651|NCT00911170|19345556|P2|Long Term Follow-Up|Physician Decision|4
5598652|NCT00911170|19345557|P1|Long Term Follow-Up|Physician Decision|5
5598653|NCT00911170|19345556|P2|Long Term Follow-Up|Withdrawal by Subject|21
5598654|NCT00911170|19345557|P1|Long Term Follow-Up|Withdrawal by Subject|20
5598655|NCT00911170|19345556|P2|Long Term Follow-Up|Continuing in study|269
5598656|NCT00911170|19345557|P1|Long Term Follow-Up|Continuing in study|274
5598657|NCT00911170|19345556|P2|Treatment Period|Death|9
5598658|NCT00911170|19345557|P1|Treatment Period|Death|6
5598659|NCT00911170|19345556|P2|Treatment Period|Lost to Follow-up|1
5598660|NCT00911170|19345557|P1|Treatment Period|Lost to Follow-up|0
5598661|NCT00911170|19345556|P2|Treatment Period|Physician Decision|5
5598662|NCT00911170|19345557|P1|Treatment Period|Physician Decision|5
5598663|NCT00911170|19345556|P2|Treatment Period|Disease progression|2
5598664|NCT00911170|19345557|P1|Treatment Period|Disease progression|0
5598665|NCT00911170|19345556|P2|Treatment Period|Withdrawal by Subject|4
5598666|NCT00911170|19345557|P1|Treatment Period|Withdrawal by Subject|4
5598667|NCT00911170|19345556|P2|Treatment Period|Adverse Event|10
5598668|NCT00911170|19345557|P1|Treatment Period|Adverse Event|9
5598669|NCT00911170|19345556|P2|Treatment Period|Protocol deviation|2
5598670|NCT00911170|19345557|P1|Treatment Period|Protocol deviation|1
5598671|NCT00911170|19345556|P2|Treatment Period|Ineligibility determined|3
5598672|NCT00911170|19345557|P1|Treatment Period|Ineligibility determined|1
5598673|NCT00911170|19345556|P2|Treatment Period|Randomized in error|1
5598674|NCT00911170|19345557|P1|Treatment Period|Randomized in error|1
5598675|NCT00911157|19345581|P2|Overall Study|Need to treat for lung cancer|0
5598676|NCT00911157|19345582|P1|Overall Study|Need to treat for lung cancer|1
5598677|NCT00911157|19345581|P2|Overall Study|Need for prohibited drug (heparin)|0
5598678|NCT00911157|19345582|P1|Overall Study|Need for prohibited drug (heparin)|1
5598679|NCT00911157|19345581|P2|Overall Study|Withdrawal by Subject|1
5598680|NCT00911157|19345582|P1|Overall Study|Withdrawal by Subject|1
5598681|NCT00911157|19345581|P2|Overall Study|Adverse Event|1
5598682|NCT00911157|19345582|P1|Overall Study|Adverse Event|4
5598683|NCT00911144|19345598|P2|Overall Study|Withdrawal by Subject|5
5598684|NCT00911144|19345599|P1|Overall Study|Withdrawal by Subject|16
5598685|NCT00910988|19345653|P4|Overall Study|Lost to Follow-up|0
5598686|NCT00910988|19345654|P3|Overall Study|Lost to Follow-up|3
5598687|NCT00910988|19345655|P2|Overall Study|Lost to Follow-up|4
5598688|NCT00910988|19345656|P1|Overall Study|Lost to Follow-up|2
5598689|NCT00910962|19345701|P3|Overall Study|Reached defined stopping criteria|17
5598690|NCT00910962|19345702|P2|Overall Study|Reached defined stopping criteria|14
5598691|NCT00910962|19345703|P1|Overall Study|Reached defined stopping criteria|12
5598692|NCT00910962|19345701|P3|Overall Study|Withdrawal by Subject|32
5598693|NCT00910962|19345702|P2|Overall Study|Withdrawal by Subject|32
5598694|NCT00910962|19345703|P1|Overall Study|Withdrawal by Subject|25
5598695|NCT00910962|19345701|P3|Overall Study|Physician Decision|6
5598696|NCT00910962|19345702|P2|Overall Study|Physician Decision|6
5598697|NCT00910962|19345703|P1|Overall Study|Physician Decision|0
5598698|NCT00910962|19345701|P3|Overall Study|Lost to Follow-up|1
5598699|NCT00910962|19345702|P2|Overall Study|Lost to Follow-up|3
5598700|NCT00910962|19345703|P1|Overall Study|Lost to Follow-up|0
5598701|NCT00910962|19345701|P3|Overall Study|Protocol Violation|3
5598702|NCT00910962|19345702|P2|Overall Study|Protocol Violation|3
5598703|NCT00910962|19345703|P1|Overall Study|Protocol Violation|1
5598704|NCT00910962|19345701|P3|Overall Study|Adverse Event|17
5598705|NCT00910962|19345702|P2|Overall Study|Adverse Event|20
5598706|NCT00910962|19345703|P1|Overall Study|Adverse Event|5
5598707|NCT00910910|19345795|P2|Overall Study|Untreated before cycle 1|2
5598708|NCT00910910|19345796|P1|Overall Study|Untreated before cycle 1|1
5598709|NCT00910910|19345795|P2|Overall Study|Other|32
5598710|NCT00910910|19345796|P1|Overall Study|Other|114
5598711|NCT00910910|19345795|P2|Overall Study|Completed 13 cycles of treatment|118
5598712|NCT00910910|19345796|P1|Overall Study|Completed 13 cycles of treatment|0
5598713|NCT00910910|19345795|P2|Overall Study|Protocol Violation|2
5598714|NCT00910910|19345796|P1|Overall Study|Protocol Violation|2
5598715|NCT00910910|19345795|P2|Overall Study|Death|3
5598716|NCT00910910|19345796|P1|Overall Study|Death|9
5598717|NCT00910910|19345795|P2|Overall Study|Lost to Follow-up|2
5598718|NCT00910910|19345796|P1|Overall Study|Lost to Follow-up|2
5598719|NCT00910910|19345795|P2|Overall Study|Withdrawal by Subject|5
5598720|NCT00910910|19345796|P1|Overall Study|Withdrawal by Subject|7
5598721|NCT00910910|19345795|P2|Overall Study|PD with histologic change|2
5598722|NCT00910910|19345796|P1|Overall Study|PD with histologic change|0
5598723|NCT00910910|19345795|P2|Overall Study|PD without histologic change|23
5598724|NCT00910910|19345796|P1|Overall Study|PD without histologic change|27
5598725|NCT00910910|19345795|P2|Overall Study|Adverse Event|35
5598726|NCT00910910|19345796|P1|Overall Study|Adverse Event|63
5598727|NCT00910871|19345832|P1|Overall Study|Undefined|1
5598728|NCT00910871|19345832|P1|Overall Study|Subject didn't meet eligibility criteria|5
5598729|NCT00910871|19345832|P1|Overall Study|Withdrawal by Subject|12
5598730|NCT00910871|19345832|P1|Overall Study|Protocol Violation|11
5598731|NCT00910871|19345832|P1|Overall Study|Lost to Follow-up|8
5598732|NCT00910871|19345832|P1|Overall Study|Death|12
5598733|NCT00910871|19345832|P1|Overall Study|Adverse Event|5
5598734|NCT00910858|19345840|P3|Combined Treatment Phase|Other|1
5598735|NCT00910858|19345841|P2|Combined Treatment Phase|Other|2
5598736|NCT00910858|19345842|P1|Combined Treatment Phase|Other|0
5598737|NCT00910858|19345840|P3|Combined Treatment Phase|Protocol Violation|0
5598738|NCT00910858|19345841|P2|Combined Treatment Phase|Protocol Violation|0
5598739|NCT00910858|19345842|P1|Combined Treatment Phase|Protocol Violation|1
5598740|NCT00910858|19345840|P3|Combined Treatment Phase|Withdrawal by Subject|0
5598741|NCT00910858|19345841|P2|Combined Treatment Phase|Withdrawal by Subject|2
5598742|NCT00910858|19345842|P1|Combined Treatment Phase|Withdrawal by Subject|0
5598743|NCT00910858|19345840|P3|Combined Treatment Phase|Lack of therapeutic effect|3
5598744|NCT00910858|19345841|P2|Combined Treatment Phase|Lack of therapeutic effect|6
5598745|NCT00910858|19345842|P1|Combined Treatment Phase|Lack of therapeutic effect|8
5598746|NCT00910858|19345840|P3|Monotherapy Phase|Other|2
5598747|NCT00910858|19345841|P2|Monotherapy Phase|Other|4
5598748|NCT00910858|19345842|P1|Monotherapy Phase|Other|3
5598749|NCT00910858|19345840|P3|Monotherapy Phase|Protocol Violation|0
5598750|NCT00910858|19345841|P2|Monotherapy Phase|Protocol Violation|0
5598751|NCT00910858|19345842|P1|Monotherapy Phase|Protocol Violation|1
5598752|NCT00910858|19345840|P3|Monotherapy Phase|Withdrawal by Subject|1
5598753|NCT00910858|19345841|P2|Monotherapy Phase|Withdrawal by Subject|3
5598754|NCT00910858|19345842|P1|Monotherapy Phase|Withdrawal by Subject|1
5598755|NCT00910858|19345840|P3|Monotherapy Phase|Lack of therapeutic effect|4
5598756|NCT00910858|19345841|P2|Monotherapy Phase|Lack of therapeutic effect|6
5598757|NCT00910858|19345842|P1|Monotherapy Phase|Lack of therapeutic effect|9
5598758|NCT00910858|19345840|P3|Monotherapy Phase|Adverse Event|0
5598759|NCT00910858|19345841|P2|Monotherapy Phase|Adverse Event|2
5598760|NCT00910858|19345842|P1|Monotherapy Phase|Adverse Event|3
5598761|NCT00910858|19345840|P3|Pharmacokinetic Phase|Adverse Event|0
5598762|NCT00910858|19345841|P2|Pharmacokinetic Phase|Adverse Event|0
5598763|NCT00910858|19345842|P1|Pharmacokinetic Phase|Adverse Event|1
5598764|NCT00910728|19345887|P9|Overall Study|Adverse Event|1
5598765|NCT00910728|19345888|P8|Overall Study|Adverse Event|1
5598766|NCT00910728|19345889|P7|Overall Study|Adverse Event|2
5598767|NCT00910728|19345890|P6|Overall Study|Adverse Event|0
5598768|NCT00910728|19345891|P5|Overall Study|Adverse Event|0
5598769|NCT00910728|19345892|P4|Overall Study|Adverse Event|1
5598770|NCT00910728|19345893|P3|Overall Study|Adverse Event|1
5598771|NCT00910728|19345894|P2|Overall Study|Adverse Event|0
5598772|NCT00910728|19345895|P1|Overall Study|Adverse Event|2
5598773|NCT00910728|19345887|P9|Overall Study|(not specified)|0
5598774|NCT00910728|19345888|P8|Overall Study|(not specified)|0
5598775|NCT00910728|19345889|P7|Overall Study|(not specified)|0
5598776|NCT00910728|19345890|P6|Overall Study|(not specified)|0
5598777|NCT00910728|19345891|P5|Overall Study|(not specified)|1
5598778|NCT00910728|19345892|P4|Overall Study|(not specified)|0
5598779|NCT00910728|19345893|P3|Overall Study|(not specified)|1
5598780|NCT00910728|19345894|P2|Overall Study|(not specified)|0
5598781|NCT00910728|19345895|P1|Overall Study|(not specified)|2
5598782|NCT00910728|19345887|P9|Overall Study|Withdrawal by Subject|0
5598783|NCT00910728|19345888|P8|Overall Study|Withdrawal by Subject|0
5598784|NCT00910728|19345889|P7|Overall Study|Withdrawal by Subject|2
5598785|NCT00910728|19345890|P6|Overall Study|Withdrawal by Subject|1
5598786|NCT00910728|19345891|P5|Overall Study|Withdrawal by Subject|3
5598787|NCT00910728|19345892|P4|Overall Study|Withdrawal by Subject|0
5598788|NCT00910728|19345893|P3|Overall Study|Withdrawal by Subject|0
5598789|NCT00910728|19345894|P2|Overall Study|Withdrawal by Subject|0
5598790|NCT00910728|19345895|P1|Overall Study|Withdrawal by Subject|0
5598791|NCT00910728|19345887|P9|Overall Study|Lack of Efficacy|2
5598792|NCT00910728|19345888|P8|Overall Study|Lack of Efficacy|2
5598793|NCT00910728|19345889|P7|Overall Study|Lack of Efficacy|2
5598794|NCT00910728|19345890|P6|Overall Study|Lack of Efficacy|0
5598795|NCT00910728|19345891|P5|Overall Study|Lack of Efficacy|1
5598796|NCT00910728|19345892|P4|Overall Study|Lack of Efficacy|2
5598797|NCT00910728|19345893|P3|Overall Study|Lack of Efficacy|1
5598798|NCT00910728|19345894|P2|Overall Study|Lack of Efficacy|3
5598799|NCT00910728|19345895|P1|Overall Study|Lack of Efficacy|2
5598800|NCT00910715|19346017|P3|Overall Study|Lost to Follow-up|0
5598801|NCT00910715|19346018|P2|Overall Study|Lost to Follow-up|26
5598802|NCT00910715|19346019|P1|Overall Study|Lost to Follow-up|22
5598803|NCT00910689|19346033|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
5598804|NCT00910689|19346034|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
5598805|NCT00910689|19346035|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
5598806|NCT00910689|19346036|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
5598807|NCT00910689|19346033|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
5598808|NCT00910689|19346034|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
5598809|NCT00910689|19346035|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
5598810|NCT00910689|19346036|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
5598811|NCT00910689|19346033|P4|Months 11- 16: Evaluation Period II|Time Demands|0
5598812|NCT00910689|19346034|P3|Months 11- 16: Evaluation Period II|Time Demands|0
5598813|NCT00910689|19346035|P2|Months 11- 16: Evaluation Period II|Time Demands|1
5598814|NCT00910689|19346036|P1|Months 11- 16: Evaluation Period II|Time Demands|2
5598815|NCT00910689|19346033|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
5598816|NCT00910689|19346034|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
5598817|NCT00910689|19346035|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
5598818|NCT00910689|19346036|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
5598819|NCT00910689|19346033|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
5598820|NCT00910689|19346034|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
5598821|NCT00910689|19346035|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
5598822|NCT00910689|19346036|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
5598823|NCT00910689|19346033|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
5598824|NCT00910689|19346034|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
5598825|NCT00910689|19346035|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
5598826|NCT00910689|19346036|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
5598827|NCT00910689|19346033|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
5598828|NCT00910689|19346034|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
5598829|NCT00910689|19346035|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
5598830|NCT00910689|19346036|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
5598831|NCT00910689|19346033|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
5598832|NCT00910689|19346034|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
5598833|NCT00910689|19346035|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
5598834|NCT00910689|19346036|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
5598835|NCT00910689|19346033|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
5598836|NCT00910689|19346034|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
5598837|NCT00910689|19346035|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
5598838|NCT00910689|19346036|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
5598839|NCT00910689|19346033|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
5598840|NCT00910689|19346034|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
5598841|NCT00910689|19346035|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
5598842|NCT00910689|19346036|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
5598843|NCT00910689|19346033|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
5598844|NCT00910689|19346034|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
5598845|NCT00910689|19346035|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
5598846|NCT00910689|19346036|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
5598847|NCT00910689|19346033|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
5598848|NCT00910689|19346034|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
5598849|NCT00910689|19346035|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
5598850|NCT00910689|19346036|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
5598851|NCT00910689|19346033|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
5598852|NCT00910689|19346034|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
5598853|NCT00910689|19346035|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
5598854|NCT00910689|19346036|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
5598855|NCT00910689|19346033|P4|Month 2- 4: Treatment Period|Protocol Violation|0
5598856|NCT00910689|19346034|P3|Month 2- 4: Treatment Period|Protocol Violation|0
5598857|NCT00910689|19346035|P2|Month 2- 4: Treatment Period|Protocol Violation|0
5598858|NCT00910689|19346036|P1|Month 2- 4: Treatment Period|Protocol Violation|1
5598859|NCT00910689|19346033|P4|Month 2- 4: Treatment Period|Pregnancy|0
5598860|NCT00910689|19346034|P3|Month 2- 4: Treatment Period|Pregnancy|0
5598861|NCT00910689|19346035|P2|Month 2- 4: Treatment Period|Pregnancy|2
5598862|NCT00910689|19346036|P1|Month 2- 4: Treatment Period|Pregnancy|0
5598863|NCT00910689|19346033|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
5598864|NCT00910689|19346034|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
5598865|NCT00910689|19346035|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
5598866|NCT00910689|19346036|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
5598867|NCT00910689|19346033|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
5598868|NCT00910689|19346034|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
5598869|NCT00910689|19346035|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
5598870|NCT00910689|19346036|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
5598871|NCT00910689|19346033|P4|Month 2- 4: Treatment Period|Time Demands|8
5598872|NCT00910689|19346034|P3|Month 2- 4: Treatment Period|Time Demands|4
5598873|NCT00910689|19346035|P2|Month 2- 4: Treatment Period|Time Demands|0
5598874|NCT00910689|19346036|P1|Month 2- 4: Treatment Period|Time Demands|1
5598875|NCT00910689|19346033|P4|Month 2- 4: Treatment Period|Adverse Event|0
5598876|NCT00910689|19346034|P3|Month 2- 4: Treatment Period|Adverse Event|2
5598877|NCT00910689|19346035|P2|Month 2- 4: Treatment Period|Adverse Event|3
5598878|NCT00910689|19346036|P1|Month 2- 4: Treatment Period|Adverse Event|2
5598879|NCT00910689|19346033|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
5598880|NCT00910689|19346034|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
5598881|NCT00910689|19346035|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
5598882|NCT00910689|19346036|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
5598883|NCT00910689|19346033|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
5598884|NCT00910689|19346034|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
5598885|NCT00910689|19346035|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
5598886|NCT00910689|19346036|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
5598887|NCT00910663|19346068|P2|Period 1|Withdrawal by Subject|1
5598888|NCT00910663|19346069|P1|Period 1|Withdrawal by Subject|0
5598889|NCT00910624|19346083|P4|Follow-Up Phase|Administrative|0
5598890|NCT00910624|19346084|P3|Follow-Up Phase|Administrative|1
5598891|NCT00910624|19346085|P2|Follow-Up Phase|Administrative|1
5598892|NCT00910624|19346086|P1|Follow-Up Phase|Administrative|0
5598893|NCT00910624|19346083|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
5598894|NCT00910624|19346084|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
5598895|NCT00910624|19346085|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
5598896|NCT00910624|19346086|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
5598897|NCT00910624|19346083|P4|Follow-Up Phase|Withdrawal by Subject|0
5598898|NCT00910624|19346084|P3|Follow-Up Phase|Withdrawal by Subject|0
5598899|NCT00910624|19346085|P2|Follow-Up Phase|Withdrawal by Subject|0
5598900|NCT00910624|19346086|P1|Follow-Up Phase|Withdrawal by Subject|1
5598901|NCT00910624|19346083|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
5598902|NCT00910624|19346084|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
5598903|NCT00910624|19346085|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
5598904|NCT00910624|19346086|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
5598905|NCT00910624|19346083|P4|Follow-Up Phase|Lost to Follow-up|0
5598906|NCT00910624|19346084|P3|Follow-Up Phase|Lost to Follow-up|2
5598907|NCT00910624|19346085|P2|Follow-Up Phase|Lost to Follow-up|1
5598908|NCT00910624|19346086|P1|Follow-Up Phase|Lost to Follow-up|3
5598909|NCT00910624|19346083|P4|Follow-Up Phase|Adverse Event|0
5598910|NCT00910624|19346084|P3|Follow-Up Phase|Adverse Event|1
5598911|NCT00910624|19346085|P2|Follow-Up Phase|Adverse Event|0
5598912|NCT00910624|19346086|P1|Follow-Up Phase|Adverse Event|0
5598913|NCT00910624|19346083|P4|Treatment Phase|Non-Compliance With Protocol|0
5598914|NCT00910624|19346084|P3|Treatment Phase|Non-Compliance With Protocol|1
5598915|NCT00910624|19346085|P2|Treatment Phase|Non-Compliance With Protocol|1
5598916|NCT00910624|19346086|P1|Treatment Phase|Non-Compliance With Protocol|0
5598917|NCT00910624|19346083|P4|Treatment Phase|Withdrawal by Subject|0
5598918|NCT00910624|19346084|P3|Treatment Phase|Withdrawal by Subject|0
5598919|NCT00910624|19346085|P2|Treatment Phase|Withdrawal by Subject|1
5598920|NCT00910624|19346086|P1|Treatment Phase|Withdrawal by Subject|2
5598921|NCT00910624|19346083|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
5598922|NCT00910624|19346084|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
5598923|NCT00910624|19346085|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
5598924|NCT00910624|19346086|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
5598925|NCT00910624|19346083|P4|Treatment Phase|Lost to Follow-up|0
5598926|NCT00910624|19346084|P3|Treatment Phase|Lost to Follow-up|1
5598927|NCT00910624|19346085|P2|Treatment Phase|Lost to Follow-up|0
5598928|NCT00910624|19346086|P1|Treatment Phase|Lost to Follow-up|0
5598929|NCT00910624|19346083|P4|Treatment Phase|Treatment Failure|0
5598930|NCT00910624|19346084|P3|Treatment Phase|Treatment Failure|0
5598931|NCT00910624|19346085|P2|Treatment Phase|Treatment Failure|10
5598932|NCT00910624|19346086|P1|Treatment Phase|Treatment Failure|23
5598933|NCT00910624|19346083|P4|Treatment Phase|Adverse Event|0
5598934|NCT00910624|19346084|P3|Treatment Phase|Adverse Event|6
5598935|NCT00910624|19346085|P2|Treatment Phase|Adverse Event|6
5598936|NCT00910624|19346086|P1|Treatment Phase|Adverse Event|2
5598937|NCT00910429|19346113|P2|Overall Study|Lack of Efficacy|1
5598938|NCT00910429|19346114|P1|Overall Study|Lack of Efficacy|4
5598939|NCT00910429|19346113|P2|Overall Study|Drug non-compliance|0
5598940|NCT00910429|19346114|P1|Overall Study|Drug non-compliance|1
5598941|NCT00910429|19346113|P2|Overall Study|Adverse Event|5
5598942|NCT00910429|19346114|P1|Overall Study|Adverse Event|10
5598943|NCT00910429|19346113|P2|Overall Study|Lost to Follow-up|1
5598944|NCT00910429|19346114|P1|Overall Study|Lost to Follow-up|2
5598945|NCT00910429|19346113|P2|Overall Study|Protocol Violation|0
5598946|NCT00910429|19346114|P1|Overall Study|Protocol Violation|1
5598947|NCT00910429|19346113|P2|Overall Study|Withdrawal by Subject|2
5598948|NCT00910429|19346114|P1|Overall Study|Withdrawal by Subject|3
5598949|NCT00910429|19346113|P2|Overall Study|Death|12
5598950|NCT00910429|19346114|P1|Overall Study|Death|18
5598951|NCT00910299|19346176|P2|Overall Study|Didn't receive any study drug|1
5598952|NCT00910299|19346177|P1|Overall Study|Didn't receive any study drug|2
5598953|NCT00910299|19346176|P2|Overall Study|Sponsor Decision|60
5598954|NCT00910299|19346177|P1|Overall Study|Sponsor Decision|58
5598955|NCT00910299|19346176|P2|Overall Study|Withdrawal by Subject|13
5598956|NCT00910299|19346177|P1|Overall Study|Withdrawal by Subject|16
5598957|NCT00910273|19346189|P2|Overall Study|Lost to Follow-up|1
5598958|NCT00910273|19346190|P1|Overall Study|Lost to Follow-up|1
5598959|NCT00910273|19346189|P2|Overall Study|Protocol Violation|0
5598960|NCT00910273|19346190|P1|Overall Study|Protocol Violation|1
5598961|NCT00910273|19346189|P2|Overall Study|Discontinuation of study by sponsor|2
5598962|NCT00910273|19346190|P1|Overall Study|Discontinuation of study by sponsor|8
5598963|NCT00910273|19346189|P2|Overall Study|Withdrawal by Subject|0
5598964|NCT00910273|19346190|P1|Overall Study|Withdrawal by Subject|1
5598965|NCT00910273|19346189|P2|Overall Study|Adverse Event|1
5598966|NCT00910273|19346190|P1|Overall Study|Adverse Event|1
5598967|NCT00910273|19346189|P2|Overall Study|Lack of Efficacy|9
5598968|NCT00910273|19346190|P1|Overall Study|Lack of Efficacy|6
5598969|NCT00910247|19346240|P1|Overall Study|Not collected|4
5598970|NCT00910247|19346240|P1|Overall Study|Withdrawal by Subject|25
5598971|NCT00910247|19346240|P1|Overall Study|Protocol Violation|10
5598972|NCT00910247|19346240|P1|Overall Study|Physician Decision|3
5598973|NCT00910247|19346240|P1|Overall Study|Lost to Follow-up|10
5598974|NCT00910247|19346240|P1|Overall Study|Death|2
5598975|NCT00910247|19346240|P1|Overall Study|Adverse Event|15
5598976|NCT00910091|19346290|P2|Treatment and Survival|Adverse Event|0
5598977|NCT00910091|19346291|P1|Treatment and Survival|Adverse Event|1
5598978|NCT00910091|19346290|P2|Treatment and Survival|Withdrawal by Subject|4
5598979|NCT00910091|19346291|P1|Treatment and Survival|Withdrawal by Subject|3
5598980|NCT00910091|19346290|P2|Pre-assignment|Withdrawal by Subject|2
5598981|NCT00910091|19346291|P1|Pre-assignment|Withdrawal by Subject|0
5598982|NCT00910039|19346319|P1|Overall Study|Physician Decision|1
5598983|NCT00910000|19346336|P6|Overall Study|Withdrawal by Subject|0
5598984|NCT00910000|19346337|P5|Overall Study|Withdrawal by Subject|1
5598985|NCT00910000|19346338|P4|Overall Study|Withdrawal by Subject|0
5598986|NCT00910000|19346339|P3|Overall Study|Withdrawal by Subject|1
5598987|NCT00910000|19346340|P2|Overall Study|Withdrawal by Subject|0
5598988|NCT00910000|19346341|P1|Overall Study|Withdrawal by Subject|0
5598989|NCT00910000|19346336|P6|Overall Study|Adverse Event|1
5598990|NCT00910000|19346337|P5|Overall Study|Adverse Event|0
5598991|NCT00910000|19346338|P4|Overall Study|Adverse Event|2
5598992|NCT00910000|19346339|P3|Overall Study|Adverse Event|2
5598993|NCT00910000|19346340|P2|Overall Study|Adverse Event|3
5598994|NCT00910000|19346341|P1|Overall Study|Adverse Event|0
5598995|NCT00909870|19346359|P2|Overall Study|Other|5
5598996|NCT00909870|19346360|P1|Overall Study|Other|1
5598997|NCT00909870|19346359|P2|Overall Study|Physician Decision|2
5598998|NCT00909870|19346360|P1|Overall Study|Physician Decision|0
5598999|NCT00909870|19346359|P2|Overall Study|Lost to Follow-up|3
5599000|NCT00909870|19346360|P1|Overall Study|Lost to Follow-up|3
5599001|NCT00909870|19346359|P2|Overall Study|Withdrawal by Subject|8
5599002|NCT00909870|19346360|P1|Overall Study|Withdrawal by Subject|5
5599003|NCT00909870|19346359|P2|Overall Study|Protocol Violation|2
5599004|NCT00909870|19346360|P1|Overall Study|Protocol Violation|1
5599005|NCT00909870|19346359|P2|Overall Study|Adverse Event|7
5599006|NCT00909870|19346360|P1|Overall Study|Adverse Event|13
5599007|NCT00909857|19346372|P2|Overall Study|Did not receive study medication|24
5599008|NCT00909857|19346373|P1|Overall Study|Did not receive study medication|19
5599009|NCT00909857|19346372|P2|Overall Study|Other|0
5599010|NCT00909857|19346373|P1|Overall Study|Other|1
5599011|NCT00909857|19346372|P2|Overall Study|Pregnancy|0
5599012|NCT00909857|19346373|P1|Overall Study|Pregnancy|1
5599013|NCT00909857|19346372|P2|Overall Study|Protocol Violation|1
5599014|NCT00909857|19346373|P1|Overall Study|Protocol Violation|2
5599015|NCT00909857|19346372|P2|Overall Study|Lost to Follow-up|5
5599016|NCT00909857|19346373|P1|Overall Study|Lost to Follow-up|2
5599017|NCT00909857|19346372|P2|Overall Study|Adverse Event|5
5599018|NCT00909857|19346373|P1|Overall Study|Adverse Event|5
5599019|NCT00909857|19346372|P2|Overall Study|Withdrawal by Subject|10
5599020|NCT00909857|19346373|P1|Overall Study|Withdrawal by Subject|6
5599021|NCT00909844|19346513|P1|Overall Study|Lost to Follow-up|2
5599022|NCT00909844|19346513|P1|Overall Study|Withdrawal by Subject|1
5599023|NCT00909844|19346513|P1|Overall Study|Adverse Event|1
5599024|NCT00909792|19346531|P2|Period 2|Lost to Follow-up|1
5599025|NCT00909792|19346532|P1|Period 2|Lost to Follow-up|0
5599026|NCT00909792|19346531|P2|Period 2|Biomicroscopy|0
5599027|NCT00909792|19346532|P1|Period 2|Biomicroscopy|1
5599028|NCT00909792|19346531|P2|Period 1|Did not meet inclusion criteria|1
5599029|NCT00909792|19346532|P1|Period 1|Did not meet inclusion criteria|0
5599030|NCT00909779|19346540|P2|Overall Study|Randomized in error|1
5599031|NCT00909779|19346541|P1|Overall Study|Randomized in error|1
5599032|NCT00909779|19346540|P2|Overall Study|Noncompliance|1
5599033|NCT00909779|19346541|P1|Overall Study|Noncompliance|1
5599034|NCT00909779|19346540|P2|Overall Study|Medical Monitor Decision|0
5599035|NCT00909779|19346541|P1|Overall Study|Medical Monitor Decision|1
5599036|NCT00909779|19346540|P2|Overall Study|Site Ceasing Operation|2
5599037|NCT00909779|19346541|P1|Overall Study|Site Ceasing Operation|2
5599038|NCT00909779|19346540|P2|Overall Study|Withdrawal by Subject|80
5599039|NCT00909779|19346541|P1|Overall Study|Withdrawal by Subject|116
5599040|NCT00909779|19346540|P2|Overall Study|Protocol Violation|5
5599041|NCT00909779|19346541|P1|Overall Study|Protocol Violation|2
5599042|NCT00909779|19346540|P2|Overall Study|Physician Decision|2
5599043|NCT00909779|19346541|P1|Overall Study|Physician Decision|8
5599044|NCT00909779|19346540|P2|Overall Study|Lost to Follow-up|15
5599045|NCT00909779|19346541|P1|Overall Study|Lost to Follow-up|19
5599046|NCT00909779|19346540|P2|Overall Study|Lack of Efficacy|4
5599047|NCT00909779|19346541|P1|Overall Study|Lack of Efficacy|7
5599048|NCT00909779|19346540|P2|Overall Study|Adverse Event|55
5599049|NCT00909779|19346541|P1|Overall Study|Adverse Event|53
5599050|NCT00909753|19346565|P2|Period: Second Intervention|Protocol Violation|0
5599051|NCT00909753|19346566|P1|Period: Second Intervention|Protocol Violation|1
5599052|NCT00909753|19346565|P2|Period: Washout of 28 Days|Protocol Violation|3
5599053|NCT00909753|19346566|P1|Period: Washout of 28 Days|Protocol Violation|2
5599054|NCT00909727|19346586|P2|Overall Study|Prohibited Medication|0
5599055|NCT00909727|19346587|P1|Overall Study|Prohibited Medication|1
5599056|NCT00909727|19346586|P2|Overall Study|Withdrawal of Consent|0
5599057|NCT00909727|19346587|P1|Overall Study|Withdrawal of Consent|1
5599058|NCT00909727|19346586|P2|Overall Study|Wrong Genotype|0
5599059|NCT00909727|19346587|P1|Overall Study|Wrong Genotype|1
5599060|NCT00909727|19346586|P2|Overall Study|Adverse Event|0
5599061|NCT00909727|19346587|P1|Overall Study|Adverse Event|1
5599062|NCT00909610|19346610|P2|Period: Second Intervention|Adverse Event|0
5599063|NCT00909610|19346611|P1|Period: Second Intervention|Adverse Event|1
5599064|NCT00909610|19346610|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
5599065|NCT00909610|19346611|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
5599066|NCT00909610|19346610|P2|Period: First Intervention|Adverse Event|1
5599067|NCT00909610|19346611|P1|Period: First Intervention|Adverse Event|0
5599068|NCT00909532|19346772|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
5599069|NCT00909532|19346773|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
5599070|NCT00909532|19346772|P2|Overall Study|Wrong Genotype|0
5599071|NCT00909532|19346773|P1|Overall Study|Wrong Genotype|1
5599072|NCT00909532|19346772|P2|Overall Study|Physician Decision|0
5599073|NCT00909532|19346773|P1|Overall Study|Physician Decision|1
5599074|NCT00909532|19346772|P2|Overall Study|Noncompliance with Study Requirements|2
5599075|NCT00909532|19346773|P1|Overall Study|Noncompliance with Study Requirements|0
5599076|NCT00909532|19346772|P2|Overall Study|Withdrawal of Consent|1
5599077|NCT00909532|19346773|P1|Overall Study|Withdrawal of Consent|1
5599078|NCT00909532|19346772|P2|Overall Study|Prohibited Medication|1
5599079|NCT00909532|19346773|P1|Overall Study|Prohibited Medication|2
5599080|NCT00909532|19346772|P2|Overall Study|Pregnancy|1
5599081|NCT00909532|19346773|P1|Overall Study|Pregnancy|0
5599082|NCT00909532|19346772|P2|Overall Study|Adverse Event|1
5599083|NCT00909532|19346773|P1|Overall Study|Adverse Event|4
5599084|NCT00909480|19346791|P2|Overall Study|Unclassified|19
5599085|NCT00909480|19346792|P1|Overall Study|Unclassified|18
5599086|NCT00909480|19346791|P2|Overall Study|Withdrawal criteria|11
5599087|NCT00909480|19346792|P1|Overall Study|Withdrawal criteria|9
5599088|NCT00909480|19346791|P2|Overall Study|Protocol Violation|8
5599089|NCT00909480|19346792|P1|Overall Study|Protocol Violation|6
5599090|NCT00909480|19346791|P2|Overall Study|Adverse Event|3
5599091|NCT00909480|19346792|P1|Overall Study|Adverse Event|5
5599092|NCT00909428|19346827|P3|Overall Study|Lost to Follow-up|9
5599093|NCT00909428|19346828|P2|Overall Study|Lost to Follow-up|10
5599094|NCT00909428|19346829|P1|Overall Study|Lost to Follow-up|13
5599095|NCT00909389|19346836|P1|Overall Study|No Information|103
5599096|NCT00909389|19346836|P1|Overall Study|Lost to Follow-up|4
5599097|NCT00909389|19346836|P1|Overall Study|Poor Compliance|16
5599098|NCT00909389|19346836|P1|Overall Study|Death|4
5599099|NCT00909389|19346836|P1|Overall Study|Adverse Event|6
5599100|NCT00909363|19346843|P3|Overall Study|Lack of Efficacy|0
5599101|NCT00909363|19346844|P2|Overall Study|Lack of Efficacy|0
5599102|NCT00909363|19346845|P1|Overall Study|Lack of Efficacy|1
5599103|NCT00909363|19346843|P3|Overall Study|Withdrawal by Subject|0
5599104|NCT00909363|19346844|P2|Overall Study|Withdrawal by Subject|0
5599105|NCT00909363|19346845|P1|Overall Study|Withdrawal by Subject|1
5599106|NCT00909181|19346892|P3|Overall Study|Lost to Follow-up|33
5599107|NCT00909181|19346893|P2|Overall Study|Lost to Follow-up|18
5599108|NCT00909181|19346894|P1|Overall Study|Lost to Follow-up|39
5599109|NCT00909090|19346920|P2|Overall Study|Lost to Follow-up|17
5599110|NCT00909090|19346921|P1|Overall Study|Lost to Follow-up|17
5599111|NCT00909038|19346939|P1|Overall Study|Non-evaluable Subjects|230
5599112|NCT00909038|19346939|P1|Overall Study|Protocol Violation|187
5599113|NCT00908960|19346951|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
5599114|NCT00908960|19346952|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
5599115|NCT00908960|19346953|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
5599116|NCT00908895|19346997|P2|Overall Study|Adverse Event|1
5599117|NCT00908895|19346998|P1|Overall Study|Adverse Event|1
5599118|NCT00908895|19346997|P2|Overall Study|algodystrophy|2
5599119|NCT00908895|19346998|P1|Overall Study|algodystrophy|2
5599120|NCT00908895|19346997|P2|Overall Study|Lost to Follow-up|3
5599121|NCT00908895|19346998|P1|Overall Study|Lost to Follow-up|1
5599122|NCT00908596|19347099|P4|Overall Study|Withdrawal by Subject|1
5599123|NCT00908596|19347100|P3|Overall Study|Withdrawal by Subject|3
5599124|NCT00908596|19347101|P2|Overall Study|Withdrawal by Subject|1
5599125|NCT00908596|19347102|P1|Overall Study|Withdrawal by Subject|0
5599126|NCT00908596|19347099|P4|Overall Study|Protocol Violation|0
5599127|NCT00908596|19347100|P3|Overall Study|Protocol Violation|0
5599128|NCT00908596|19347101|P2|Overall Study|Protocol Violation|0
5599129|NCT00908596|19347102|P1|Overall Study|Protocol Violation|1
5599130|NCT00908596|19347099|P4|Overall Study|Death|32
5599131|NCT00908596|19347100|P3|Overall Study|Death|57
5599132|NCT00908596|19347101|P2|Overall Study|Death|5
5599133|NCT00908596|19347102|P1|Overall Study|Death|0
5599134|NCT00908596|19347099|P4|Overall Study|Lost to Follow-up|4
5599135|NCT00908596|19347100|P3|Overall Study|Lost to Follow-up|12
5599136|NCT00908596|19347101|P2|Overall Study|Lost to Follow-up|1
5599137|NCT00908596|19347102|P1|Overall Study|Lost to Follow-up|0
5599138|NCT00908596|19347099|P4|Overall Study|Other reasons|0
5599139|NCT00908596|19347100|P3|Overall Study|Other reasons|2
5599140|NCT00908596|19347101|P2|Overall Study|Other reasons|6
5599141|NCT00908596|19347102|P1|Overall Study|Other reasons|46
5599142|NCT00908583|19347132|P1|Phase 5|Adverse Event|3
5599143|NCT00908583|19347132|P1|Phase 4|Physician Decision|1
5599144|NCT00908583|19347132|P1|Phase 4|Adverse Event|1
5599145|NCT00908583|19347132|P1|Phase 3|Adverse Event|2
5599146|NCT00908583|19347132|P1|Phase 2|Adverse Event|1
5599147|NCT00908583|19347132|P1|Phase 2|Physician Decision|1
5599148|NCT00908583|19347132|P1|Phase 1|Adverse Event|4
5599149|NCT00908583|19347132|P1|Phase 1|Withdrawal by Subject|1
5599150|NCT00908544|19347152|P2|Overall Study|Unable to visit sutdy center|0
5599151|NCT00908544|19347153|P1|Overall Study|Unable to visit sutdy center|1
5599152|NCT00908544|19347152|P2|Overall Study|Relocation abroad|1
5599153|NCT00908544|19347153|P1|Overall Study|Relocation abroad|1
5599154|NCT00908544|19347152|P2|Overall Study|Pregnancy|0
5599155|NCT00908544|19347153|P1|Overall Study|Pregnancy|1
5599156|NCT00908544|19347152|P2|Overall Study|Lack of Efficacy|1
5599157|NCT00908544|19347153|P1|Overall Study|Lack of Efficacy|0
5599158|NCT00908544|19347152|P2|Overall Study|Withdrawal by Subject|4
5599159|NCT00908544|19347153|P1|Overall Study|Withdrawal by Subject|2
5599160|NCT00908375|19347212|P2|Overall Study|Lost to Follow-up|6
5599161|NCT00908375|19347213|P1|Overall Study|Lost to Follow-up|8
5599162|NCT00908375|19347212|P2|Overall Study|Withdrawal by Subject|4
5599163|NCT00908375|19347213|P1|Overall Study|Withdrawal by Subject|2
5599164|NCT00908349|19347223|P1|Overall Study|Various|6
5599165|NCT00908349|19347223|P1|Overall Study|Lost to Follow-up|5
5599166|NCT00908349|19347223|P1|Overall Study|Physician Decision|5
5599167|NCT00908349|19347223|P1|Overall Study|Withdrawal by Subject|9
5599168|NCT00908349|19347223|P1|Overall Study|Adverse Event|10
5599169|NCT00908310|19347227|P1|Overall Study|Other reasons|4
5599170|NCT00908310|19347227|P1|Overall Study|Screening failure|5
5599171|NCT00908310|19347227|P1|Overall Study|Lost to Follow-up|7
5599172|NCT00908310|19347227|P1|Overall Study|Withdrawal by Subject|7
5599173|NCT00908310|19347227|P1|Overall Study|Death|37
5599174|NCT00908232|19347231|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
5599175|NCT00908232|19347232|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
5599176|NCT00908232|19347233|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
5599177|NCT00908232|19347234|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
5599178|NCT00908232|19347231|P4|Randomization (Cycle 5) to Cycle 8|Other|0
5599179|NCT00908232|19347232|P3|Randomization (Cycle 5) to Cycle 8|Other|0
5599180|NCT00908232|19347233|P2|Randomization (Cycle 5) to Cycle 8|Other|1
5599181|NCT00908232|19347234|P1|Randomization (Cycle 5) to Cycle 8|Other|3
5599182|NCT00908232|19347231|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
5599183|NCT00908232|19347232|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
5599184|NCT00908232|19347233|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
5599185|NCT00908232|19347234|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
5599186|NCT00908232|19347231|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
5599187|NCT00908232|19347232|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
5599188|NCT00908232|19347233|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
5599189|NCT00908232|19347234|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
5599190|NCT00908232|19347231|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
5599191|NCT00908232|19347232|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
5599192|NCT00908232|19347233|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
5599193|NCT00908232|19347234|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
5599194|NCT00908232|19347231|P4|Randomization (Cycle 5) to Cycle 8|Death|0
5599195|NCT00908232|19347232|P3|Randomization (Cycle 5) to Cycle 8|Death|0
5599196|NCT00908232|19347233|P2|Randomization (Cycle 5) to Cycle 8|Death|0
5599197|NCT00908232|19347234|P1|Randomization (Cycle 5) to Cycle 8|Death|2
5599198|NCT00908232|19347231|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
5599199|NCT00908232|19347232|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
5599200|NCT00908232|19347233|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
5599201|NCT00908232|19347234|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
5599202|NCT00908232|19347231|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
5599203|NCT00908232|19347232|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
5599204|NCT00908232|19347233|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
5599205|NCT00908232|19347234|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
5599206|NCT00908232|19347231|P4|Cycle 1 to 4|Other|0
5599207|NCT00908232|19347232|P3|Cycle 1 to 4|Other|0
5599208|NCT00908232|19347233|P2|Cycle 1 to 4|Other|0
5599209|NCT00908232|19347234|P1|Cycle 1 to 4|Other|1
5599210|NCT00908232|19347231|P4|Cycle 1 to 4|Adverse Event|0
5599211|NCT00908232|19347232|P3|Cycle 1 to 4|Adverse Event|0
5599212|NCT00908232|19347233|P2|Cycle 1 to 4|Adverse Event|0
5599213|NCT00908232|19347234|P1|Cycle 1 to 4|Adverse Event|12
5599214|NCT00908232|19347231|P4|Cycle 1 to 4|Progressive Disease|0
5599215|NCT00908232|19347232|P3|Cycle 1 to 4|Progressive Disease|0
5599216|NCT00908232|19347233|P2|Cycle 1 to 4|Progressive Disease|0
5599217|NCT00908232|19347234|P1|Cycle 1 to 4|Progressive Disease|6
5599218|NCT00908232|19347231|P4|Cycle 1 to 4|Withdrawal by Subject|0
5599219|NCT00908232|19347232|P3|Cycle 1 to 4|Withdrawal by Subject|0
5599220|NCT00908232|19347233|P2|Cycle 1 to 4|Withdrawal by Subject|0
5599221|NCT00908232|19347234|P1|Cycle 1 to 4|Withdrawal by Subject|4
5599222|NCT00908232|19347231|P4|Cycle 1 to 4|Death|0
5599223|NCT00908232|19347232|P3|Cycle 1 to 4|Death|0
5599224|NCT00908232|19347233|P2|Cycle 1 to 4|Death|0
5599225|NCT00908232|19347234|P1|Cycle 1 to 4|Death|5
5599226|NCT00908141|19347252|P2|Overall Study|Withdrawal by Subject|1
5599227|NCT00908141|19347253|P1|Overall Study|Withdrawal by Subject|0
5599228|NCT00908115|19347270|P1|Overall Study|Other|14
5599229|NCT00908076|19347278|P2|Overall Study|Lack of Efficacy|1
5599230|NCT00908076|19347279|P1|Overall Study|Lack of Efficacy|1
5599231|NCT00908037|19347292|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599232|NCT00908037|19347293|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
5599233|NCT00908037|19347294|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599234|NCT00908037|19347295|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599235|NCT00908037|19347296|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599236|NCT00908037|19347297|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599237|NCT00908037|19347298|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599238|NCT00908037|19347299|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599239|NCT00908037|19347300|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599240|NCT00908037|19347301|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599241|NCT00908037|19347302|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599242|NCT00908037|19347303|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
5599243|NCT00908037|19347292|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599244|NCT00908037|19347293|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599245|NCT00908037|19347294|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
5599246|NCT00908037|19347295|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599247|NCT00908037|19347296|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599248|NCT00908037|19347297|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599249|NCT00908037|19347298|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599250|NCT00908037|19347299|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599251|NCT00908037|19347300|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599252|NCT00908037|19347301|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599253|NCT00908037|19347302|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599254|NCT00908037|19347303|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
5599255|NCT00908037|19347292|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599256|NCT00908037|19347293|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
5599257|NCT00908037|19347294|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599258|NCT00908037|19347295|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599259|NCT00908037|19347296|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599260|NCT00908037|19347297|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599261|NCT00908037|19347298|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599262|NCT00908037|19347299|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599263|NCT00908037|19347300|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599264|NCT00908037|19347301|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599265|NCT00908037|19347302|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599266|NCT00908037|19347303|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
5599267|NCT00908037|19347292|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599268|NCT00908037|19347293|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599269|NCT00908037|19347294|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
5599270|NCT00908037|19347295|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599271|NCT00908037|19347296|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599272|NCT00908037|19347297|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599273|NCT00908037|19347298|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599274|NCT00908037|19347299|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599275|NCT00908037|19347300|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599276|NCT00908037|19347301|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599277|NCT00908037|19347302|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599278|NCT00908037|19347303|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
5599279|NCT00908037|19347292|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
5599280|NCT00908037|19347293|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599281|NCT00908037|19347294|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
5599282|NCT00908037|19347295|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599283|NCT00908037|19347296|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599284|NCT00908037|19347297|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599285|NCT00908037|19347298|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599286|NCT00908037|19347299|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599287|NCT00908037|19347300|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599288|NCT00908037|19347301|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599289|NCT00908037|19347302|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599290|NCT00908037|19347303|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
5599291|NCT00908037|19347292|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
5599292|NCT00908037|19347293|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599293|NCT00908037|19347294|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599294|NCT00908037|19347295|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599295|NCT00908037|19347296|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599296|NCT00908037|19347297|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599297|NCT00908037|19347298|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599298|NCT00908037|19347299|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599299|NCT00908037|19347300|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599300|NCT00908037|19347301|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599301|NCT00908037|19347302|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599302|NCT00908037|19347303|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
5599303|NCT00908037|19347292|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599304|NCT00908037|19347293|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599305|NCT00908037|19347294|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599306|NCT00908037|19347295|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599307|NCT00908037|19347296|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599308|NCT00908037|19347297|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
5599309|NCT00908037|19347298|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599310|NCT00908037|19347299|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599311|NCT00908037|19347300|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
5599312|NCT00908037|19347301|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599313|NCT00908037|19347302|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599314|NCT00908037|19347303|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
5599315|NCT00908037|19347292|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599316|NCT00908037|19347293|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599317|NCT00908037|19347294|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599318|NCT00908037|19347295|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
5599319|NCT00908037|19347296|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599320|NCT00908037|19347297|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599321|NCT00908037|19347298|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599322|NCT00908037|19347299|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
5599323|NCT00908037|19347300|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599324|NCT00908037|19347301|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599325|NCT00908037|19347302|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599326|NCT00908037|19347303|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
5599327|NCT00908037|19347292|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5599328|NCT00908037|19347293|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5599329|NCT00908037|19347294|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5599330|NCT00908037|19347295|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
5599331|NCT00908037|19347296|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5599332|NCT00908037|19347297|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
5599333|NCT00908037|19347298|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5599334|NCT00908037|19347299|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
5599335|NCT00908037|19347300|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5599336|NCT00908037|19347301|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5599337|NCT00908037|19347302|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5599338|NCT00908037|19347303|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
5599339|NCT00908011|19347452|P2|Overall Study|Withdrawal by Subject|2
5599340|NCT00908011|19347453|P1|Overall Study|Withdrawal by Subject|2
5599341|NCT00907881|19347470|P1|Overall Study|Missing discontinuation information|15
5599342|NCT00907881|19347470|P1|Overall Study|Protocol Violation|1
5599343|NCT00907881|19347470|P1|Overall Study|Withdrawal by Subject|5
5599344|NCT00907881|19347470|P1|Overall Study|Noncompliance|5
5599345|NCT00907881|19347470|P1|Overall Study|Lost to Follow-up|59
5599346|NCT00907803|19347480|P3|Overall Study|Protocol Violation|0
5599347|NCT00907803|19347481|P2|Overall Study|Protocol Violation|1
5599348|NCT00907803|19347482|P1|Overall Study|Protocol Violation|0
5599349|NCT00907803|19347480|P3|Overall Study|Lost to Follow-up|0
5599350|NCT00907803|19347481|P2|Overall Study|Lost to Follow-up|1
5599351|NCT00907803|19347482|P1|Overall Study|Lost to Follow-up|0
5599352|NCT00907803|19347480|P3|Overall Study|Withdrawal by Subject|0
5599353|NCT00907803|19347481|P2|Overall Study|Withdrawal by Subject|1
5599354|NCT00907803|19347482|P1|Overall Study|Withdrawal by Subject|0
5599355|NCT00907803|19347480|P3|Overall Study|Adverse Event|0
5599356|NCT00907803|19347481|P2|Overall Study|Adverse Event|0
5599357|NCT00907803|19347482|P1|Overall Study|Adverse Event|2
5599358|NCT00907803|19347480|P3|Overall Study|Withdrawal of consent - long commute|0
5599359|NCT00907803|19347481|P2|Overall Study|Withdrawal of consent - long commute|0
5599360|NCT00907803|19347482|P1|Overall Study|Withdrawal of consent - long commute|1
5599361|NCT00907777|19347513|P2|Overall Study|Withdrawal by Subject|1
5599362|NCT00907777|19347514|P1|Overall Study|Withdrawal by Subject|0
5599363|NCT00907738|19347541|P5|Overall Study|Disease progression|2
5599364|NCT00907738|19347542|P4|Overall Study|Disease progression|4
5599365|NCT00907738|19347543|P3|Overall Study|Disease progression|6
5599366|NCT00907738|19347544|P2|Overall Study|Disease progression|1
5599367|NCT00907738|19347545|P1|Overall Study|Disease progression|8
5599368|NCT00907738|19347541|P5|Overall Study|not specified or withdrew consent|0
5599369|NCT00907738|19347542|P4|Overall Study|not specified or withdrew consent|0
5599370|NCT00907738|19347543|P3|Overall Study|not specified or withdrew consent|0
5599371|NCT00907738|19347544|P2|Overall Study|not specified or withdrew consent|0
5599372|NCT00907738|19347545|P1|Overall Study|not specified or withdrew consent|3
5599373|NCT00907738|19347541|P5|Overall Study|Adverse Event|0
5599374|NCT00907738|19347542|P4|Overall Study|Adverse Event|0
5599375|NCT00907738|19347543|P3|Overall Study|Adverse Event|1
5599376|NCT00907738|19347544|P2|Overall Study|Adverse Event|0
5599377|NCT00907738|19347545|P1|Overall Study|Adverse Event|2
5599378|NCT00907621|19347563|P2|Overall Study|intercurrent febrile illness|1
5599379|NCT00907621|19347564|P1|Overall Study|intercurrent febrile illness|1
5599380|NCT00907621|19347563|P2|Overall Study|Lost to Follow-up|3
5599381|NCT00907621|19347564|P1|Overall Study|Lost to Follow-up|6
5599382|NCT00907517|19347577|P5|Overall Study|Symptomatic Deterioration|1
5599383|NCT00907517|19347578|P4|Overall Study|Symptomatic Deterioration|0
5599384|NCT00907517|19347579|P3|Overall Study|Symptomatic Deterioration|0
5599385|NCT00907517|19347580|P2|Overall Study|Symptomatic Deterioration|0
5599386|NCT00907517|19347581|P1|Overall Study|Symptomatic Deterioration|0
5599387|NCT00907517|19347577|P5|Overall Study|Progressive Disease|4
5599388|NCT00907517|19347578|P4|Overall Study|Progressive Disease|4
5599389|NCT00907517|19347579|P3|Overall Study|Progressive Disease|4
5599390|NCT00907517|19347580|P2|Overall Study|Progressive Disease|3
5599391|NCT00907517|19347581|P1|Overall Study|Progressive Disease|3
5599392|NCT00907478|19347606|P3|Overall Study|Other|1
5599393|NCT00907478|19347607|P2|Overall Study|Other|0
5599394|NCT00907478|19347608|P1|Overall Study|Other|3
5599395|NCT00907478|19347606|P3|Overall Study|Lost to Follow-up|0
5599396|NCT00907478|19347607|P2|Overall Study|Lost to Follow-up|0
5599397|NCT00907478|19347608|P1|Overall Study|Lost to Follow-up|1
5599398|NCT00907478|19347606|P3|Overall Study|Pregnancy|1
5599399|NCT00907478|19347607|P2|Overall Study|Pregnancy|1
5599400|NCT00907478|19347608|P1|Overall Study|Pregnancy|0
5599401|NCT00907478|19347606|P3|Overall Study|Protocol-specified criteria|3
5599402|NCT00907478|19347607|P2|Overall Study|Protocol-specified criteria|2
5599403|NCT00907478|19347608|P1|Overall Study|Protocol-specified criteria|5
5599404|NCT00907478|19347606|P3|Overall Study|Death|1
5599405|NCT00907478|19347607|P2|Overall Study|Death|2
5599406|NCT00907478|19347608|P1|Overall Study|Death|4
5599407|NCT00907478|19347606|P3|Overall Study|Physician Decision|3
5599408|NCT00907478|19347607|P2|Overall Study|Physician Decision|0
5599409|NCT00907478|19347608|P1|Overall Study|Physician Decision|2
5599410|NCT00907478|19347606|P3|Overall Study|Requirement for alternative therapy|3
5599411|NCT00907478|19347607|P2|Overall Study|Requirement for alternative therapy|2
5599412|NCT00907478|19347608|P1|Overall Study|Requirement for alternative therapy|1
5599413|NCT00907478|19347606|P3|Overall Study|Withdrawal by Subject|6
5599414|NCT00907478|19347607|P2|Overall Study|Withdrawal by Subject|9
5599415|NCT00907478|19347608|P1|Overall Study|Withdrawal by Subject|8
5599416|NCT00907478|19347606|P3|Overall Study|Adverse Event|2
5599417|NCT00907478|19347607|P2|Overall Study|Adverse Event|1
5599418|NCT00907478|19347608|P1|Overall Study|Adverse Event|3
5599419|NCT00907478|19347606|P3|Overall Study|Noncompliance|1
5599420|NCT00907478|19347607|P2|Overall Study|Noncompliance|0
5599421|NCT00907478|19347608|P1|Overall Study|Noncompliance|0
5599422|NCT00907478|19347606|P3|Overall Study|Ineligibility determined|1
5599423|NCT00907478|19347607|P2|Overall Study|Ineligibility determined|0
5599424|NCT00907478|19347608|P1|Overall Study|Ineligibility determined|0
5599425|NCT00907374|19347658|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
5599426|NCT00907374|19347659|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
5599427|NCT00907335|19347673|P2|Overall Study|Lost to Follow-up|0
5599428|NCT00907335|19347674|P1|Overall Study|Lost to Follow-up|2
5599429|NCT00907335|19347673|P2|Overall Study|Adverse Event|1
5599430|NCT00907335|19347674|P1|Overall Study|Adverse Event|4
5599431|NCT00907335|19347673|P2|Overall Study|Withdrawal by Subject|0
5599432|NCT00907335|19347674|P1|Overall Study|Withdrawal by Subject|2
5599433|NCT00907296|19347700|P10|Overall Study|Lost to Follow-up|4
5599434|NCT00907296|19347701|P9|Overall Study|Lost to Follow-up|0
5599435|NCT00907296|19347702|P8|Overall Study|Lost to Follow-up|2
5599436|NCT00907296|19347703|P7|Overall Study|Lost to Follow-up|2
5599437|NCT00907296|19347704|P6|Overall Study|Lost to Follow-up|3
5599438|NCT00907296|19347705|P5|Overall Study|Lost to Follow-up|0
5599439|NCT00907296|19347706|P4|Overall Study|Lost to Follow-up|2
5599440|NCT00907296|19347707|P3|Overall Study|Lost to Follow-up|0
5599441|NCT00907296|19347708|P2|Overall Study|Lost to Follow-up|1
5599442|NCT00907296|19347709|P1|Overall Study|Lost to Follow-up|9
5599443|NCT00907296|19347700|P10|Overall Study|Withdrawal by Subject|2
5599444|NCT00907296|19347701|P9|Overall Study|Withdrawal by Subject|4
5599445|NCT00907296|19347702|P8|Overall Study|Withdrawal by Subject|2
5599446|NCT00907296|19347703|P7|Overall Study|Withdrawal by Subject|3
5599447|NCT00907296|19347704|P6|Overall Study|Withdrawal by Subject|5
5599448|NCT00907296|19347705|P5|Overall Study|Withdrawal by Subject|1
5599449|NCT00907296|19347706|P4|Overall Study|Withdrawal by Subject|1
5599450|NCT00907296|19347707|P3|Overall Study|Withdrawal by Subject|1
5599451|NCT00907296|19347708|P2|Overall Study|Withdrawal by Subject|2
5599452|NCT00907296|19347709|P1|Overall Study|Withdrawal by Subject|7
5599453|NCT00907296|19347700|P10|Overall Study|Adverse Event|1
5599454|NCT00907296|19347701|P9|Overall Study|Adverse Event|0
5599455|NCT00907296|19347702|P8|Overall Study|Adverse Event|0
5599456|NCT00907296|19347703|P7|Overall Study|Adverse Event|1
5599457|NCT00907296|19347704|P6|Overall Study|Adverse Event|0
5599458|NCT00907296|19347705|P5|Overall Study|Adverse Event|0
5599459|NCT00907296|19347706|P4|Overall Study|Adverse Event|0
5599460|NCT00907296|19347707|P3|Overall Study|Adverse Event|0
5599461|NCT00907296|19347708|P2|Overall Study|Adverse Event|0
5599462|NCT00907296|19347709|P1|Overall Study|Adverse Event|2
5599463|NCT00907296|19347700|P10|Overall Study|Noncompliance|0
5599464|NCT00907296|19347701|P9|Overall Study|Noncompliance|0
5599465|NCT00907296|19347702|P8|Overall Study|Noncompliance|2
5599466|NCT00907296|19347703|P7|Overall Study|Noncompliance|0
5599467|NCT00907296|19347704|P6|Overall Study|Noncompliance|1
5599468|NCT00907296|19347705|P5|Overall Study|Noncompliance|0
5599469|NCT00907296|19347706|P4|Overall Study|Noncompliance|0
5599470|NCT00907296|19347707|P3|Overall Study|Noncompliance|1
5599471|NCT00907296|19347708|P2|Overall Study|Noncompliance|1
5599472|NCT00907296|19347709|P1|Overall Study|Noncompliance|1
5599473|NCT00907296|19347700|P10|Overall Study|Protocol Deviation|0
5599474|NCT00907296|19347701|P9|Overall Study|Protocol Deviation|0
5599475|NCT00907296|19347702|P8|Overall Study|Protocol Deviation|0
5599476|NCT00907296|19347703|P7|Overall Study|Protocol Deviation|0
5599477|NCT00907296|19347704|P6|Overall Study|Protocol Deviation|0
5599478|NCT00907296|19347705|P5|Overall Study|Protocol Deviation|0
5599479|NCT00907296|19347706|P4|Overall Study|Protocol Deviation|0
5599480|NCT00907296|19347707|P3|Overall Study|Protocol Deviation|0
5599481|NCT00907296|19347708|P2|Overall Study|Protocol Deviation|1
5599482|NCT00907296|19347709|P1|Overall Study|Protocol Deviation|0
5599483|NCT00907296|19347700|P10|Overall Study|Ineligibility Determined|0
5599484|NCT00907296|19347701|P9|Overall Study|Ineligibility Determined|0
5599485|NCT00907296|19347702|P8|Overall Study|Ineligibility Determined|1
5599486|NCT00907296|19347703|P7|Overall Study|Ineligibility Determined|0
5599487|NCT00907296|19347704|P6|Overall Study|Ineligibility Determined|0
5599488|NCT00907296|19347705|P5|Overall Study|Ineligibility Determined|0
5599489|NCT00907296|19347706|P4|Overall Study|Ineligibility Determined|1
5599490|NCT00907296|19347707|P3|Overall Study|Ineligibility Determined|0
5599491|NCT00907296|19347708|P2|Overall Study|Ineligibility Determined|0
5599492|NCT00907296|19347709|P1|Overall Study|Ineligibility Determined|1
5599493|NCT00907257|19347763|P2|Overall Study|Personal Reasons|1
5599494|NCT00907257|19347764|P1|Overall Study|Personal Reasons|6
5599495|NCT00907257|19347763|P2|Overall Study|Moved|0
5599496|NCT00907257|19347764|P1|Overall Study|Moved|1
5599497|NCT00907257|19347763|P2|Overall Study|Per IRB-Subject became vulnerable|0
5599498|NCT00907257|19347764|P1|Overall Study|Per IRB-Subject became vulnerable|1
5599499|NCT00907257|19347763|P2|Overall Study|Withdrawal by Subject|2
5599500|NCT00907257|19347764|P1|Overall Study|Withdrawal by Subject|1
5599501|NCT00907257|19347763|P2|Overall Study|Lost to Follow-up|3
5599502|NCT00907257|19347764|P1|Overall Study|Lost to Follow-up|3
5599503|NCT00907257|19347763|P2|Overall Study|Protocol Violation|2
5599504|NCT00907257|19347764|P1|Overall Study|Protocol Violation|1
5599505|NCT00907257|19347763|P2|Overall Study|Adverse Event|4
5599506|NCT00907257|19347764|P1|Overall Study|Adverse Event|0
5599507|NCT00907153|19347786|P2|Overall Study|Withdrawal by Subject|3
5599508|NCT00907153|19347787|P1|Overall Study|Withdrawal by Subject|1
5599509|NCT00907153|19347786|P2|Overall Study|Lost to Follow-up|1
5599510|NCT00907153|19347787|P1|Overall Study|Lost to Follow-up|1
5599511|NCT00906971|19347848|P2|Overall Study|Lost to Follow-up|1
5599512|NCT00906971|19347849|P1|Overall Study|Lost to Follow-up|0
5599513|NCT00906971|19347848|P2|Overall Study|Withdrawal by Subject|2
5599514|NCT00906971|19347849|P1|Overall Study|Withdrawal by Subject|8
5599515|NCT00906945|19347862|P6|Overall Study|Physician Decision|1
5599516|NCT00906945|19347863|P5|Overall Study|Physician Decision|0
5599517|NCT00906945|19347864|P4|Overall Study|Physician Decision|0
5599518|NCT00906945|19347865|P3|Overall Study|Physician Decision|0
5599519|NCT00906945|19347866|P2|Overall Study|Physician Decision|0
5599520|NCT00906945|19347867|P1|Overall Study|Physician Decision|0
5599521|NCT00906945|19347862|P6|Overall Study|Found to be not eligible|1
5599522|NCT00906945|19347863|P5|Overall Study|Found to be not eligible|1
5599523|NCT00906945|19347864|P4|Overall Study|Found to be not eligible|1
5599524|NCT00906945|19347865|P3|Overall Study|Found to be not eligible|0
5599525|NCT00906945|19347866|P2|Overall Study|Found to be not eligible|0
5599526|NCT00906945|19347867|P1|Overall Study|Found to be not eligible|0
5599527|NCT00906698|19347927|P6|Overall Study|incl. non compliance, lost to follow-up|0
5599528|NCT00906698|19347928|P5|Overall Study|incl. non compliance, lost to follow-up|0
5599529|NCT00906698|19347929|P4|Overall Study|incl. non compliance, lost to follow-up|0
5599530|NCT00906698|19347930|P3|Overall Study|incl. non compliance, lost to follow-up|0
5599531|NCT00906698|19347931|P2|Overall Study|incl. non compliance, lost to follow-up|1
5599532|NCT00906698|19347932|P1|Overall Study|incl. non compliance, lost to follow-up|0
5599533|NCT00906698|19347927|P6|Overall Study|Withdrawal by Subject|0
5599534|NCT00906698|19347928|P5|Overall Study|Withdrawal by Subject|1
5599535|NCT00906698|19347929|P4|Overall Study|Withdrawal by Subject|0
5599536|NCT00906698|19347930|P3|Overall Study|Withdrawal by Subject|0
5599537|NCT00906698|19347931|P2|Overall Study|Withdrawal by Subject|0
5599538|NCT00906698|19347932|P1|Overall Study|Withdrawal by Subject|0
5599539|NCT00906698|19347927|P6|Overall Study|Disease progression|4
5599540|NCT00906698|19347928|P5|Overall Study|Disease progression|12
5599541|NCT00906698|19347929|P4|Overall Study|Disease progression|4
5599542|NCT00906698|19347930|P3|Overall Study|Disease progression|4
5599543|NCT00906698|19347931|P2|Overall Study|Disease progression|12
5599544|NCT00906698|19347932|P1|Overall Study|Disease progression|3
5599545|NCT00906698|19347927|P6|Overall Study|Adverse Event|1
5599546|NCT00906698|19347928|P5|Overall Study|Adverse Event|4
5599547|NCT00906698|19347929|P4|Overall Study|Adverse Event|0
5599548|NCT00906698|19347930|P3|Overall Study|Adverse Event|2
5599549|NCT00906698|19347931|P2|Overall Study|Adverse Event|0
5599550|NCT00906698|19347932|P1|Overall Study|Adverse Event|0
5599551|NCT00906698|19347927|P6|Overall Study|Dose-limiting toxicity (DLT)|0
5599552|NCT00906698|19347928|P5|Overall Study|Dose-limiting toxicity (DLT)|1
5599553|NCT00906698|19347929|P4|Overall Study|Dose-limiting toxicity (DLT)|0
5599554|NCT00906698|19347930|P3|Overall Study|Dose-limiting toxicity (DLT)|0
5599555|NCT00906698|19347931|P2|Overall Study|Dose-limiting toxicity (DLT)|6
5599556|NCT00906698|19347932|P1|Overall Study|Dose-limiting toxicity (DLT)|0
5599557|NCT00906399|19348034|P7|Year 2|Other|0
5599558|NCT00906399|19348035|P6|Year 2|Other|1
5599559|NCT00906399|19348036|P5|Year 2|Other|3
5599560|NCT00906399|19348037|P4|Year 2|Other|2
5599561|NCT00906399|19348038|P3|Year 2|Other|0
5599562|NCT00906399|19348039|P2|Year 2|Other|0
5599563|NCT00906399|19348040|P1|Year 2|Other|0
5599564|NCT00906399|19348034|P7|Year 2|Death|3
5599565|NCT00906399|19348035|P6|Year 2|Death|0
5599566|NCT00906399|19348036|P5|Year 2|Death|0
5599567|NCT00906399|19348037|P4|Year 2|Death|1
5599568|NCT00906399|19348038|P3|Year 2|Death|0
5599569|NCT00906399|19348039|P2|Year 2|Death|0
5599570|NCT00906399|19348040|P1|Year 2|Death|0
5599571|NCT00906399|19348034|P7|Year 2|Physician Decision|3
5599572|NCT00906399|19348035|P6|Year 2|Physician Decision|6
5599573|NCT00906399|19348036|P5|Year 2|Physician Decision|2
5599574|NCT00906399|19348037|P4|Year 2|Physician Decision|0
5599575|NCT00906399|19348038|P3|Year 2|Physician Decision|0
5599576|NCT00906399|19348039|P2|Year 2|Physician Decision|0
5599577|NCT00906399|19348040|P1|Year 2|Physician Decision|0
5599578|NCT00906399|19348034|P7|Year 2|Withdrawal by Subject|13
5599579|NCT00906399|19348035|P6|Year 2|Withdrawal by Subject|27
5599580|NCT00906399|19348036|P5|Year 2|Withdrawal by Subject|18
5599581|NCT00906399|19348037|P4|Year 2|Withdrawal by Subject|17
5599582|NCT00906399|19348038|P3|Year 2|Withdrawal by Subject|0
5599583|NCT00906399|19348039|P2|Year 2|Withdrawal by Subject|0
5599584|NCT00906399|19348040|P1|Year 2|Withdrawal by Subject|0
5599585|NCT00906399|19348034|P7|Year 2|Lost to Follow-up|4
5599586|NCT00906399|19348035|P6|Year 2|Lost to Follow-up|2
5599587|NCT00906399|19348036|P5|Year 2|Lost to Follow-up|4
5599588|NCT00906399|19348037|P4|Year 2|Lost to Follow-up|1
5599589|NCT00906399|19348038|P3|Year 2|Lost to Follow-up|0
5599590|NCT00906399|19348039|P2|Year 2|Lost to Follow-up|0
5599591|NCT00906399|19348040|P1|Year 2|Lost to Follow-up|0
5599592|NCT00906399|19348034|P7|Year 2|Adverse Event|6
5599593|NCT00906399|19348035|P6|Year 2|Adverse Event|11
5599594|NCT00906399|19348036|P5|Year 2|Adverse Event|8
5599595|NCT00906399|19348037|P4|Year 2|Adverse Event|9
5599596|NCT00906399|19348038|P3|Year 2|Adverse Event|0
5599597|NCT00906399|19348039|P2|Year 2|Adverse Event|0
5599598|NCT00906399|19348040|P1|Year 2|Adverse Event|0
5599613|NCT00906399|19348034|P7|Year 1|Physician Decision|0
5599614|NCT00906399|19348035|P6|Year 1|Physician Decision|0
5599615|NCT00906399|19348036|P5|Year 1|Physician Decision|0
5599616|NCT00906399|19348037|P4|Year 1|Physician Decision|0
5599617|NCT00906399|19348038|P3|Year 1|Physician Decision|3
5599618|NCT00906399|19348039|P2|Year 1|Physician Decision|1
5599619|NCT00906399|19348040|P1|Year 1|Physician Decision|0
5599620|NCT00906399|19348034|P7|Year 1|Withdrawal by Subject|0
5599621|NCT00906399|19348035|P6|Year 1|Withdrawal by Subject|0
5599622|NCT00906399|19348036|P5|Year 1|Withdrawal by Subject|0
5599623|NCT00906399|19348037|P4|Year 1|Withdrawal by Subject|0
5599624|NCT00906399|19348038|P3|Year 1|Withdrawal by Subject|36
5599625|NCT00906399|19348039|P2|Year 1|Withdrawal by Subject|32
5599626|NCT00906399|19348040|P1|Year 1|Withdrawal by Subject|30
5599627|NCT00906399|19348034|P7|Year 1|Lost to Follow-up|0
5599628|NCT00906399|19348035|P6|Year 1|Lost to Follow-up|0
5599629|NCT00906399|19348036|P5|Year 1|Lost to Follow-up|0
5599630|NCT00906399|19348037|P4|Year 1|Lost to Follow-up|0
5599631|NCT00906399|19348038|P3|Year 1|Lost to Follow-up|2
5599632|NCT00906399|19348039|P2|Year 1|Lost to Follow-up|4
5599633|NCT00906399|19348040|P1|Year 1|Lost to Follow-up|4
5599634|NCT00906399|19348034|P7|Year 1|Adverse Event|0
5599635|NCT00906399|19348035|P6|Year 1|Adverse Event|0
5599636|NCT00906399|19348036|P5|Year 1|Adverse Event|0
5599637|NCT00906399|19348037|P4|Year 1|Adverse Event|0
5599638|NCT00906399|19348038|P3|Year 1|Adverse Event|24
5599639|NCT00906399|19348039|P2|Year 1|Adverse Event|22
5599640|NCT00906399|19348040|P1|Year 1|Adverse Event|4
5599641|NCT00906399|19348034|P7|Year 1|Randomized But Not Treated|0
5599642|NCT00906399|19348035|P6|Year 1|Randomized But Not Treated|0
5599643|NCT00906399|19348036|P5|Year 1|Randomized But Not Treated|0
5599644|NCT00906399|19348037|P4|Year 1|Randomized But Not Treated|0
5599645|NCT00906399|19348038|P3|Year 1|Randomized But Not Treated|3
5599646|NCT00906399|19348039|P2|Year 1|Randomized But Not Treated|1
5599647|NCT00906399|19348040|P1|Year 1|Randomized But Not Treated|0
5599648|NCT00906373|19348063|P2|Overall Study|Still on treatment at cutoff date|2
5599649|NCT00906373|19348064|P1|Overall Study|Still on treatment at cutoff date|0
5599650|NCT00906373|19348063|P2|Overall Study|Other|1
5599651|NCT00906373|19348064|P1|Overall Study|Other|0
5599652|NCT00906373|19348063|P2|Overall Study|Withdrawal by Subject|5
5599653|NCT00906373|19348064|P1|Overall Study|Withdrawal by Subject|0
5599654|NCT00906347|19348103|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
5599655|NCT00906347|19348104|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
5599656|NCT00906347|19348103|P2|Received Study Drug|Refused study drug|0
5599657|NCT00906347|19348104|P1|Received Study Drug|Refused study drug|1
5599658|NCT00906347|19348103|P2|Received Study Drug|Nonreassuring fetal heart rate|1
5599659|NCT00906347|19348104|P1|Received Study Drug|Nonreassuring fetal heart rate|13
5599660|NCT00906347|19348103|P2|Received Study Drug|8 cm prior to initiation of study drug|30
5599661|NCT00906347|19348104|P1|Received Study Drug|8 cm prior to initiation of study drug|18
5599662|NCT00906282|19348124|P1|Preoperative Chemotherapy|Toxicity|1
5599663|NCT00906282|19348124|P1|Preoperative Chemotherapy|Progressive disease|6
5599664|NCT00906282|19348124|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
5599665|NCT00906282|19348124|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
5599666|NCT00906204|19348138|P2|Secondary Endpoints (Long-term Safety)|Death|1
5599667|NCT00906204|19348139|P1|Secondary Endpoints (Long-term Safety)|Death|0
5599668|NCT00906204|19348138|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
5599669|NCT00906204|19348139|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
5599670|NCT00906204|19348138|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
5599671|NCT00906204|19348139|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
5599672|NCT00906204|19348138|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
5599673|NCT00906204|19348139|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
5599674|NCT00906204|19348138|P2|Primary Endpoint (Early Safety)|Physician Decision|0
5599675|NCT00906204|19348139|P1|Primary Endpoint (Early Safety)|Physician Decision|1
5599676|NCT00906087|19348193|P1|Initial Washout|Physician Decision|1
5599677|NCT00906087|19348193|P1|Initial Washout|Withdrawal by Subject|1
5599678|NCT00906035|19348230|P3|Overall Study|Withdrawal by Subject|0
5599679|NCT00906035|19348231|P2|Overall Study|Withdrawal by Subject|3
5599680|NCT00906035|19348232|P1|Overall Study|Withdrawal by Subject|2
5599681|NCT00905840|19348246|P1|Overall Study|Adverse Event|1
5599682|NCT00905840|19348246|P1|Overall Study|Withdrawal by Subject|1
5599683|NCT00905840|19348246|P1|Overall Study|Death|3
5599684|NCT00905840|19348246|P1|Overall Study|Lost to Follow-up|11
5599685|NCT00905632|19348277|P7|Overall Study|Adverse Event|4
5599686|NCT00905632|19348278|P6|Overall Study|Adverse Event|1
5599687|NCT00905632|19348279|P5|Overall Study|Adverse Event|0
5599688|NCT00905632|19348280|P4|Overall Study|Adverse Event|0
5599689|NCT00905632|19348281|P3|Overall Study|Adverse Event|0
5599690|NCT00905632|19348282|P2|Overall Study|Adverse Event|0
5599691|NCT00905632|19348283|P1|Overall Study|Adverse Event|0
5599692|NCT00905606|19348421|P2|Washout|Withdrawal by Subject|0
5599693|NCT00905606|19348422|P1|Washout|Withdrawal by Subject|1
5599694|NCT00905606|19348421|P2|Period 1|Adverse Event|1
5599695|NCT00905606|19348422|P1|Period 1|Adverse Event|0
5599696|NCT00905567|19348447|P2|Washout|Withdrawal by Subject|1
5599697|NCT00905567|19348448|P1|Washout|Withdrawal by Subject|0
5599698|NCT00905489|19348480|P1|Optional Extension Phase (OEP)|Adverse Event|1
5599699|NCT00905489|19348480|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
5599700|NCT00905489|19348480|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
5599701|NCT00905437|19348570|P2|Overall Study|Other|6
5599702|NCT00905437|19348571|P1|Overall Study|Other|5
5599703|NCT00905437|19348570|P2|Overall Study|Withdrawal by Subject|1
5599704|NCT00905437|19348571|P1|Overall Study|Withdrawal by Subject|0
5599705|NCT00905437|19348570|P2|Overall Study|Lost to Follow-up|1
5599706|NCT00905437|19348571|P1|Overall Study|Lost to Follow-up|0
5599707|NCT00905437|19348570|P2|Overall Study|Adverse Event|2
5599708|NCT00905437|19348571|P1|Overall Study|Adverse Event|3
5599709|NCT00905424|19348591|P2|Overall Study|Non-adherence to visit schedule|1
5599710|NCT00905424|19348592|P1|Overall Study|Non-adherence to visit schedule|0
5599711|NCT00905424|19348591|P2|Overall Study|Positive urine drug screen|1
5599712|NCT00905424|19348592|P1|Overall Study|Positive urine drug screen|0
5599713|NCT00905424|19348591|P2|Overall Study|Sponsor decision|0
5599714|NCT00905424|19348592|P1|Overall Study|Sponsor decision|1
5599715|NCT00905424|19348591|P2|Overall Study|Non-compliance with study medication|0
5599716|NCT00905424|19348592|P1|Overall Study|Non-compliance with study medication|2
5599717|NCT00905424|19348591|P2|Overall Study|Adverse Event|2
5599718|NCT00905424|19348592|P1|Overall Study|Adverse Event|4
5599719|NCT00905424|19348591|P2|Overall Study|Withdrawal by Subject|2
5599720|NCT00905424|19348592|P1|Overall Study|Withdrawal by Subject|1
5599721|NCT00905424|19348591|P2|Overall Study|Lost to Follow-up|3
5599722|NCT00905424|19348592|P1|Overall Study|Lost to Follow-up|3
5599723|NCT00905359|19348634|P2|Overall Study|Withdrawal consent|6
5599724|NCT00905359|19348635|P1|Overall Study|Withdrawal consent|5
5599725|NCT00905359|19348634|P2|Overall Study|Death|0
5599726|NCT00905359|19348635|P1|Overall Study|Death|2
5599727|NCT00905359|19348634|P2|Overall Study|Lost to Follow-up|10
5599728|NCT00905359|19348635|P1|Overall Study|Lost to Follow-up|17
5599729|NCT00905346|19348671|P2|Period 1|Withdrawal by Subject|0
5599730|NCT00905346|19348672|P1|Period 1|Withdrawal by Subject|1
5599731|NCT00905307|19348686|P6|Overall Study|Lack of Efficacy|8
5599732|NCT00905307|19348687|P5|Overall Study|Lack of Efficacy|4
5599733|NCT00905307|19348688|P4|Overall Study|Lack of Efficacy|4
5599734|NCT00905307|19348689|P3|Overall Study|Lack of Efficacy|5
5599735|NCT00905307|19348690|P2|Overall Study|Lack of Efficacy|3
5599736|NCT00905307|19348691|P1|Overall Study|Lack of Efficacy|6
5599737|NCT00905307|19348686|P6|Overall Study|Protocol Violation|0
5599738|NCT00905307|19348687|P5|Overall Study|Protocol Violation|0
5599739|NCT00905307|19348688|P4|Overall Study|Protocol Violation|0
5599740|NCT00905307|19348689|P3|Overall Study|Protocol Violation|1
5599741|NCT00905307|19348690|P2|Overall Study|Protocol Violation|0
5599742|NCT00905307|19348691|P1|Overall Study|Protocol Violation|1
5599743|NCT00905307|19348686|P6|Overall Study|Withdrawal by Subject|13
5599744|NCT00905307|19348687|P5|Overall Study|Withdrawal by Subject|4
5599745|NCT00905307|19348688|P4|Overall Study|Withdrawal by Subject|11
5599746|NCT00905307|19348689|P3|Overall Study|Withdrawal by Subject|15
5599747|NCT00905307|19348690|P2|Overall Study|Withdrawal by Subject|13
5599748|NCT00905307|19348691|P1|Overall Study|Withdrawal by Subject|5
5599749|NCT00905307|19348686|P6|Overall Study|Adverse Event|5
5599750|NCT00905307|19348687|P5|Overall Study|Adverse Event|3
5599751|NCT00905307|19348688|P4|Overall Study|Adverse Event|11
5599752|NCT00905307|19348689|P3|Overall Study|Adverse Event|5
5599753|NCT00905307|19348690|P2|Overall Study|Adverse Event|4
5599754|NCT00905307|19348691|P1|Overall Study|Adverse Event|3
5599755|NCT00905307|19348686|P6|Overall Study|Lost to Follow-up|1
5599756|NCT00905307|19348687|P5|Overall Study|Lost to Follow-up|1
5599757|NCT00905307|19348688|P4|Overall Study|Lost to Follow-up|0
5599758|NCT00905307|19348689|P3|Overall Study|Lost to Follow-up|0
5599759|NCT00905307|19348690|P2|Overall Study|Lost to Follow-up|0
5599760|NCT00905307|19348691|P1|Overall Study|Lost to Follow-up|0
5599761|NCT00905307|19348686|P6|Overall Study|Switched to Open Label Rescue|15
5599762|NCT00905307|19348687|P5|Overall Study|Switched to Open Label Rescue|4
5599763|NCT00905307|19348688|P4|Overall Study|Switched to Open Label Rescue|11
5599764|NCT00905307|19348689|P3|Overall Study|Switched to Open Label Rescue|11
5599765|NCT00905307|19348690|P2|Overall Study|Switched to Open Label Rescue|17
5599766|NCT00905307|19348691|P1|Overall Study|Switched to Open Label Rescue|7
5599767|NCT00905255|19348786|P2|Overall Study|Familial and Personal Reasons|0
5599768|NCT00905255|19348787|P1|Overall Study|Familial and Personal Reasons|1
5599769|NCT00905255|19348786|P2|Overall Study|Withdrawal by Subject|4
5599770|NCT00905255|19348787|P1|Overall Study|Withdrawal by Subject|5
5599771|NCT00905255|19348786|P2|Overall Study|Adverse Event|5
5599772|NCT00905255|19348787|P1|Overall Study|Adverse Event|7
5599773|NCT00905164|19348805|P2|Period 1|Protocol Violation|1
5599774|NCT00905164|19348806|P1|Period 1|Protocol Violation|0
5599775|NCT00905034|19348853|P1|Overall Study|Withdrawal by Subject|1
5599776|NCT00905021|19348857|P1|Overall Study|Adverse Event|2
5599777|NCT00904982|19348877|P4|Overall Study|Withdrawal by Subject|0
5599778|NCT00904982|19348878|P3|Overall Study|Withdrawal by Subject|0
5599779|NCT00904982|19348879|P2|Overall Study|Withdrawal by Subject|0
5599780|NCT00904982|19348880|P1|Overall Study|Withdrawal by Subject|2
5599781|NCT00904969|19348890|P1|Overall Study|Case Aborted; Subject Exited|1
5599782|NCT00904969|19348890|P1|Overall Study|Additional Treatments|11
5599783|NCT00904969|19348890|P1|Overall Study|Withdrawal by Subject|3
5599784|NCT00904969|19348890|P1|Overall Study|Lost to Follow-up|4
5599785|NCT00904917|19348955|P4|Overall Study|Lost to Follow-up|2
5599786|NCT00904917|19348956|P3|Overall Study|Lost to Follow-up|2
5599787|NCT00904917|19348957|P2|Overall Study|Lost to Follow-up|2
5599788|NCT00904917|19348958|P1|Overall Study|Lost to Follow-up|2
5599789|NCT00904839|19348976|P3|Overall Study|Other than above|7
5599790|NCT00904839|19348977|P2|Overall Study|Other than above|9
5599791|NCT00904839|19348978|P1|Overall Study|Other than above|0
5599792|NCT00904839|19348976|P3|Overall Study|Not treated|1
5599793|NCT00904839|19348977|P2|Overall Study|Not treated|0
5599794|NCT00904839|19348978|P1|Overall Study|Not treated|1
5599795|NCT00904839|19348976|P3|Overall Study|Withdrawal by Subject|0
5599796|NCT00904839|19348977|P2|Overall Study|Withdrawal by Subject|2
5599797|NCT00904839|19348978|P1|Overall Study|Withdrawal by Subject|0
5599798|NCT00904839|19348976|P3|Overall Study|Lost to Follow-up|2
5599799|NCT00904839|19348977|P2|Overall Study|Lost to Follow-up|1
5599800|NCT00904839|19348978|P1|Overall Study|Lost to Follow-up|0
5599801|NCT00904839|19348976|P3|Overall Study|Protocol Violation|1
5599802|NCT00904839|19348977|P2|Overall Study|Protocol Violation|1
5599803|NCT00904839|19348978|P1|Overall Study|Protocol Violation|0
5599804|NCT00904839|19348976|P3|Overall Study|Adverse Event|4
5599805|NCT00904839|19348977|P2|Overall Study|Adverse Event|5
5599806|NCT00904839|19348978|P1|Overall Study|Adverse Event|0
5599807|NCT00904748|19349024|P6|Overall Study|Adverse Event|0
5599808|NCT00904748|19349025|P5|Overall Study|Adverse Event|1
5599809|NCT00904748|19349026|P4|Overall Study|Adverse Event|0
5599810|NCT00904748|19349027|P3|Overall Study|Adverse Event|0
5599811|NCT00904748|19349028|P2|Overall Study|Adverse Event|0
5599812|NCT00904748|19349029|P1|Overall Study|Adverse Event|0
5599813|NCT00904748|19349024|P6|Overall Study|Withdrawal by Subject|0
5599814|NCT00904748|19349025|P5|Overall Study|Withdrawal by Subject|0
5599815|NCT00904748|19349026|P4|Overall Study|Withdrawal by Subject|2
5599816|NCT00904748|19349027|P3|Overall Study|Withdrawal by Subject|1
5599817|NCT00904748|19349028|P2|Overall Study|Withdrawal by Subject|1
5599818|NCT00904748|19349029|P1|Overall Study|Withdrawal by Subject|1
5599819|NCT00904722|19349053|P1|Overall Study|Physician Decision|1
5599820|NCT00904670|19349058|P2|Open Label Phase|Lost to Follow-up|0
5599821|NCT00904670|19349059|P1|Open Label Phase|Lost to Follow-up|1
5599822|NCT00904670|19349058|P2|Open Label Phase|Lack of Efficacy|0
5599823|NCT00904670|19349059|P1|Open Label Phase|Lack of Efficacy|1
5599824|NCT00904670|19349058|P2|Open Label Phase|Adverse Event|0
5599825|NCT00904670|19349059|P1|Open Label Phase|Adverse Event|2
5599826|NCT00904670|19349058|P2|Open Label Phase|Withdrawal by Subject|0
5599827|NCT00904670|19349059|P1|Open Label Phase|Withdrawal by Subject|2
5599828|NCT00904371|19349129|P1|Overall Study|Continued with Tritace|1
5599829|NCT00904371|19349129|P1|Overall Study|Discontinued at target blood pressure|2
5599830|NCT00904371|19349129|P1|Overall Study|Lost to Follow-up|4
5599831|NCT00904371|19349129|P1|Overall Study|Adverse Event|2
5599832|NCT00904215|19349143|P1|Overall Study|Other|28
5599833|NCT00904215|19349143|P1|Overall Study|Withdrawal by Subject|9
5599834|NCT00904215|19349143|P1|Overall Study|Lost to Follow-up|63
5599835|NCT00904215|19349143|P1|Overall Study|Protocol Violation|10
5599836|NCT00904215|19349143|P1|Overall Study|Adverse Event|25
5599837|NCT00904150|19349157|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
5599838|NCT00904150|19349158|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
5599839|NCT00904150|19349157|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
5599840|NCT00904150|19349158|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
5599841|NCT00904033|19349180|P4|Overall Study|Unable to obtain final blood draw|2
5599842|NCT00904033|19349181|P3|Overall Study|Unable to obtain final blood draw|0
5599843|NCT00904033|19349182|P2|Overall Study|Unable to obtain final blood draw|0
5599844|NCT00904033|19349183|P1|Overall Study|Unable to obtain final blood draw|0
5599845|NCT00904033|19349180|P4|Overall Study|Physician Decision|0
5599846|NCT00904033|19349181|P3|Overall Study|Physician Decision|1
5599847|NCT00904033|19349182|P2|Overall Study|Physician Decision|0
5599848|NCT00904033|19349183|P1|Overall Study|Physician Decision|0
5599849|NCT00904033|19349180|P4|Overall Study|Withdrawal by Subject|0
5599850|NCT00904033|19349181|P3|Overall Study|Withdrawal by Subject|0
5599851|NCT00904033|19349182|P2|Overall Study|Withdrawal by Subject|1
5599852|NCT00904033|19349183|P1|Overall Study|Withdrawal by Subject|1
5599853|NCT00903968|19349248|P8|Overall Study|Lack of Efficacy|3
5599854|NCT00903968|19349249|P7|Overall Study|Lack of Efficacy|0
5599855|NCT00903968|19349250|P6|Overall Study|Lack of Efficacy|0
5599856|NCT00903968|19349251|P5|Overall Study|Lack of Efficacy|0
5599857|NCT00903968|19349252|P4|Overall Study|Lack of Efficacy|0
5599858|NCT00903968|19349253|P3|Overall Study|Lack of Efficacy|0
5599859|NCT00903968|19349254|P2|Overall Study|Lack of Efficacy|0
5599860|NCT00903968|19349255|P1|Overall Study|Lack of Efficacy|0
5599861|NCT00903968|19349248|P8|Overall Study|Progressive Disease|18
5599862|NCT00903968|19349249|P7|Overall Study|Progressive Disease|0
5599863|NCT00903968|19349250|P6|Overall Study|Progressive Disease|3
5599864|NCT00903968|19349251|P5|Overall Study|Progressive Disease|3
5599865|NCT00903968|19349252|P4|Overall Study|Progressive Disease|3
5599866|NCT00903968|19349253|P3|Overall Study|Progressive Disease|2
5599867|NCT00903968|19349254|P2|Overall Study|Progressive Disease|3
5599868|NCT00903968|19349255|P1|Overall Study|Progressive Disease|2
5599869|NCT00903968|19349248|P8|Overall Study|Physician Decision|0
5599870|NCT00903968|19349249|P7|Overall Study|Physician Decision|0
5599871|NCT00903968|19349250|P6|Overall Study|Physician Decision|1
5599872|NCT00903968|19349251|P5|Overall Study|Physician Decision|0
5599873|NCT00903968|19349252|P4|Overall Study|Physician Decision|0
5599874|NCT00903968|19349253|P3|Overall Study|Physician Decision|0
5599875|NCT00903968|19349254|P2|Overall Study|Physician Decision|0
5599876|NCT00903968|19349255|P1|Overall Study|Physician Decision|0
5599877|NCT00903968|19349248|P8|Overall Study|Non-Compliance|0
5599878|NCT00903968|19349249|P7|Overall Study|Non-Compliance|0
5599879|NCT00903968|19349250|P6|Overall Study|Non-Compliance|1
5599880|NCT00903968|19349251|P5|Overall Study|Non-Compliance|0
5599881|NCT00903968|19349252|P4|Overall Study|Non-Compliance|0
5599882|NCT00903968|19349253|P3|Overall Study|Non-Compliance|0
5599883|NCT00903968|19349254|P2|Overall Study|Non-Compliance|0
5599884|NCT00903968|19349255|P1|Overall Study|Non-Compliance|0
5599885|NCT00903968|19349248|P8|Overall Study|Withdrawal by Subject|4
5599886|NCT00903968|19349249|P7|Overall Study|Withdrawal by Subject|0
5599887|NCT00903968|19349250|P6|Overall Study|Withdrawal by Subject|1
5599888|NCT00903968|19349251|P5|Overall Study|Withdrawal by Subject|1
5599889|NCT00903968|19349252|P4|Overall Study|Withdrawal by Subject|0
5599890|NCT00903968|19349253|P3|Overall Study|Withdrawal by Subject|1
5599891|NCT00903968|19349254|P2|Overall Study|Withdrawal by Subject|0
5599892|NCT00903968|19349255|P1|Overall Study|Withdrawal by Subject|1
5599893|NCT00903968|19349248|P8|Overall Study|DLT|0
5599894|NCT00903968|19349249|P7|Overall Study|DLT|2
5599895|NCT00903968|19349250|P6|Overall Study|DLT|0
5599896|NCT00903968|19349251|P5|Overall Study|DLT|0
5599897|NCT00903968|19349252|P4|Overall Study|DLT|0
5599898|NCT00903968|19349253|P3|Overall Study|DLT|0
5599899|NCT00903968|19349254|P2|Overall Study|DLT|0
5599900|NCT00903968|19349255|P1|Overall Study|DLT|0
5599901|NCT00903968|19349248|P8|Overall Study|Adverse Event|8
5599902|NCT00903968|19349249|P7|Overall Study|Adverse Event|1
5599903|NCT00903968|19349250|P6|Overall Study|Adverse Event|0
5599904|NCT00903968|19349251|P5|Overall Study|Adverse Event|0
5599905|NCT00903968|19349252|P4|Overall Study|Adverse Event|0
5599906|NCT00903968|19349253|P3|Overall Study|Adverse Event|0
5599907|NCT00903968|19349254|P2|Overall Study|Adverse Event|0
5599908|NCT00903968|19349255|P1|Overall Study|Adverse Event|0
5599909|NCT00903929|19349285|P4|Overall Study|Adverse Event|1
5599910|NCT00903929|19349286|P3|Overall Study|Adverse Event|0
5599911|NCT00903929|19349287|P2|Overall Study|Adverse Event|0
5599912|NCT00903929|19349288|P1|Overall Study|Adverse Event|0
5599913|NCT00903929|19349285|P4|Overall Study|Withdrawal by Subject|2
5599914|NCT00903929|19349286|P3|Overall Study|Withdrawal by Subject|1
5599915|NCT00903929|19349287|P2|Overall Study|Withdrawal by Subject|0
5599916|NCT00903929|19349288|P1|Overall Study|Withdrawal by Subject|0
5599917|NCT00903877|19349294|P1|Overall Study|Participation put on hold|4
5599918|NCT00903877|19349294|P1|Overall Study|Lost to Follow-up|1
5599919|NCT00903877|19349294|P1|Overall Study|Adverse Event|2
5599920|NCT00903877|19349294|P1|Overall Study|Withdrawal by Subject|3
5599921|NCT00903877|19349294|P1|Overall Study|Did not meet study criteria|33
5599922|NCT00903786|19349298|P1|Overall Study|Reason other than lack of efficacy|4
5599923|NCT00903786|19349298|P1|Overall Study|Lack of Efficacy|5
5599924|NCT00903786|19349298|P1|Overall Study|Physician Decision|6
5599925|NCT00903760|19349308|P2|Overall Study|Off treatment for long period|1
5599926|NCT00903760|19349309|P1|Overall Study|Off treatment for long period|0
5599927|NCT00903760|19349308|P2|Overall Study|Withdrawal by Subject|2
5599928|NCT00903760|19349309|P1|Overall Study|Withdrawal by Subject|1
5599929|NCT00903760|19349308|P2|Overall Study|Lost to Follow-up|0
5599930|NCT00903760|19349309|P1|Overall Study|Lost to Follow-up|1
5599931|NCT00903760|19349308|P2|Overall Study|Death|1
5599932|NCT00903760|19349309|P1|Overall Study|Death|0
5599933|NCT00903760|19349308|P2|Overall Study|Physician Decision|2
5599934|NCT00903760|19349309|P1|Overall Study|Physician Decision|1
5599935|NCT00903760|19349308|P2|Overall Study|Stem Cell Transplant|4
5599936|NCT00903760|19349309|P1|Overall Study|Stem Cell Transplant|8
5599937|NCT00903760|19349308|P2|Overall Study|Disease Progression/Death|6
5599938|NCT00903760|19349309|P1|Overall Study|Disease Progression/Death|8
5599939|NCT00903695|19349319|P2|Overall Study|lung cancer|0
5599940|NCT00903695|19349320|P1|Overall Study|lung cancer|1
5599941|NCT00903695|19349319|P2|Overall Study|medical exclusion after 1st testing|0
5599942|NCT00903695|19349320|P1|Overall Study|medical exclusion after 1st testing|1
5599943|NCT00903682|19349342|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
5599944|NCT00903682|19349343|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
5599945|NCT00903682|19349342|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
5599946|NCT00903682|19349343|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
5599947|NCT00903682|19349342|P2|Overall Study|Subject Non-Compliant|0
5599948|NCT00903682|19349343|P1|Overall Study|Subject Non-Compliant|1
5599949|NCT00903682|19349342|P2|Overall Study|Subject Reached A Virologic Endpoint|1
5599950|NCT00903682|19349343|P1|Overall Study|Subject Reached A Virologic Endpoint|1
5599951|NCT00903682|19349342|P2|Overall Study|Pregnancy|1
5599952|NCT00903682|19349343|P1|Overall Study|Pregnancy|0
5599953|NCT00903682|19349342|P2|Overall Study|Withdrawal by Subject|0
5599954|NCT00903682|19349343|P1|Overall Study|Withdrawal by Subject|5
5599955|NCT00903682|19349342|P2|Overall Study|Lost to Follow-up|0
5599956|NCT00903682|19349343|P1|Overall Study|Lost to Follow-up|1
5599957|NCT00903682|19349342|P2|Overall Study|Adverse Event|13
5599958|NCT00903682|19349343|P1|Overall Study|Adverse Event|6
5599959|NCT00903630|19349364|P3|Phase 2|Adverse Event|1
5599960|NCT00903630|19349365|P2|Phase 2|Adverse Event|0
5599961|NCT00903630|19349366|P1|Phase 2|Adverse Event|0
5599962|NCT00903617|19349384|P4|Overall Study|Withdrawal by Subject|0
5599963|NCT00903617|19349385|P3|Overall Study|Withdrawal by Subject|3
5599964|NCT00903617|19349386|P2|Overall Study|Withdrawal by Subject|2
5599965|NCT00903617|19349387|P1|Overall Study|Withdrawal by Subject|1
5599966|NCT00903617|19349384|P4|Overall Study|Lost to Follow-up|1
5599967|NCT00903617|19349385|P3|Overall Study|Lost to Follow-up|1
5599968|NCT00903617|19349386|P2|Overall Study|Lost to Follow-up|0
5599969|NCT00903617|19349387|P1|Overall Study|Lost to Follow-up|2
5599970|NCT00903617|19349384|P4|Overall Study|Protocol-defined stopping criteria|0
5599971|NCT00903617|19349385|P3|Overall Study|Protocol-defined stopping criteria|0
5599972|NCT00903617|19349386|P2|Overall Study|Protocol-defined stopping criteria|2
5599973|NCT00903617|19349387|P1|Overall Study|Protocol-defined stopping criteria|0
5599974|NCT00903617|19349384|P4|Overall Study|Adverse Event|0
5599975|NCT00903617|19349385|P3|Overall Study|Adverse Event|1
5599976|NCT00903617|19349386|P2|Overall Study|Adverse Event|1
5599977|NCT00903617|19349387|P1|Overall Study|Adverse Event|0
5599978|NCT00903409|19349490|P2|Overall Study|Lost to Follow-up|6
5599979|NCT00903409|19349491|P1|Overall Study|Lost to Follow-up|2
5599980|NCT00903409|19349490|P2|Overall Study|Other|3
5599981|NCT00903409|19349491|P1|Overall Study|Other|2
5599982|NCT00903409|19349490|P2|Overall Study|Withdrawal by Subject|8
5599983|NCT00903409|19349491|P1|Overall Study|Withdrawal by Subject|8
5599984|NCT00903409|19349490|P2|Overall Study|Laboratory Abnormality|0
5599985|NCT00903409|19349491|P1|Overall Study|Laboratory Abnormality|2
5599986|NCT00903409|19349490|P2|Overall Study|Non-compliance with Protocol|1
5599987|NCT00903409|19349491|P1|Overall Study|Non-compliance with Protocol|1
5599988|NCT00903409|19349490|P2|Overall Study|Adverse Event|9
5599989|NCT00903409|19349491|P1|Overall Study|Adverse Event|11
5599990|NCT00903383|19349542|P4|Overall Study|Patient Decision|1
5599991|NCT00903383|19349543|P3|Overall Study|Patient Decision|0
5599992|NCT00903383|19349544|P2|Overall Study|Patient Decision|0
5599993|NCT00903383|19349545|P1|Overall Study|Patient Decision|0
5599994|NCT00903383|19349542|P4|Overall Study|Patient Decision - Lack of Efficacy|0
5599995|NCT00903383|19349543|P3|Overall Study|Patient Decision - Lack of Efficacy|0
5599996|NCT00903383|19349544|P2|Overall Study|Patient Decision - Lack of Efficacy|1
5599997|NCT00903383|19349545|P1|Overall Study|Patient Decision - Lack of Efficacy|0
5599998|NCT00903383|19349542|P4|Overall Study|Withdrawal by Subject|2
5599999|NCT00903383|19349543|P3|Overall Study|Withdrawal by Subject|0
5600000|NCT00903383|19349544|P2|Overall Study|Withdrawal by Subject|1
5600001|NCT00903383|19349545|P1|Overall Study|Withdrawal by Subject|4
5600002|NCT00903383|19349542|P4|Overall Study|Decision of Sponsor|0
5600003|NCT00903383|19349543|P3|Overall Study|Decision of Sponsor|0
5600004|NCT00903383|19349544|P2|Overall Study|Decision of Sponsor|0
5600005|NCT00903383|19349545|P1|Overall Study|Decision of Sponsor|1
5600006|NCT00903383|19349542|P4|Overall Study|Lost to Follow-up|1
5600007|NCT00903383|19349543|P3|Overall Study|Lost to Follow-up|0
5600008|NCT00903383|19349544|P2|Overall Study|Lost to Follow-up|0
5600009|NCT00903383|19349545|P1|Overall Study|Lost to Follow-up|0
5600010|NCT00903383|19349542|P4|Overall Study|Physician Decision|0
5600011|NCT00903383|19349543|P3|Overall Study|Physician Decision|0
5600012|NCT00903383|19349544|P2|Overall Study|Physician Decision|2
5600013|NCT00903383|19349545|P1|Overall Study|Physician Decision|1
5600014|NCT00903383|19349542|P4|Overall Study|Adverse Event|1
5600015|NCT00903383|19349543|P3|Overall Study|Adverse Event|3
5600016|NCT00903383|19349544|P2|Overall Study|Adverse Event|2
5600017|NCT00903383|19349545|P1|Overall Study|Adverse Event|1
5600018|NCT00903370|19349577|P2|Overall Study|Lost to Follow-up|8
5600019|NCT00903370|19349578|P1|Overall Study|Lost to Follow-up|6
5600020|NCT00903370|19349577|P2|Overall Study|Withdrawal by Subject|6
5600021|NCT00903370|19349578|P1|Overall Study|Withdrawal by Subject|9
5600022|NCT00903370|19349577|P2|Overall Study|Death|10
5600023|NCT00903370|19349578|P1|Overall Study|Death|13
5600024|NCT00903357|19349586|P2|Second Intervention|Lost to Follow-up|0
5600025|NCT00903357|19349587|P1|Second Intervention|Lost to Follow-up|1
5600026|NCT00903357|19349586|P2|Wash Out Period of 2 Weeks|Flu|1
5600027|NCT00903357|19349587|P1|Wash Out Period of 2 Weeks|Flu|0
5600028|NCT00903357|19349586|P2|First Intervention|Flu|1
5600029|NCT00903357|19349587|P1|First Intervention|Flu|0
5600030|NCT00903357|19349586|P2|First Intervention|Withdrawal by Subject|3
5600031|NCT00903357|19349587|P1|First Intervention|Withdrawal by Subject|5
5600032|NCT00903344|19349599|P2|Overall Study|Lost to Follow-up|0
5600033|NCT00903344|19349600|P1|Overall Study|Lost to Follow-up|3
5600034|NCT00903344|19349599|P2|Overall Study|Pregnancy|3
5600035|NCT00903344|19349600|P1|Overall Study|Pregnancy|2
5600036|NCT00903331|19349618|P2|Overall Study|Lung transplant|2
5600037|NCT00903331|19349619|P1|Overall Study|Lung transplant|0
5600038|NCT00903331|19349618|P2|Overall Study|Withdrawal of consent|8
5600039|NCT00903331|19349619|P1|Overall Study|Withdrawal of consent|1
5600040|NCT00903331|19349618|P2|Overall Study|Death|8
5600041|NCT00903331|19349619|P1|Overall Study|Death|4
5600042|NCT00903201|19349630|P3|Overall Study|Withdrawal by Subject|1
5600043|NCT00903201|19349631|P2|Overall Study|Withdrawal by Subject|0
5600044|NCT00903201|19349632|P1|Overall Study|Withdrawal by Subject|1
5600045|NCT00903201|19349630|P3|Overall Study|Physician Decision|1
5600046|NCT00903201|19349631|P2|Overall Study|Physician Decision|0
5600047|NCT00903201|19349632|P1|Overall Study|Physician Decision|1
5600048|NCT00903201|19349630|P3|Overall Study|Lost to Follow-up|0
5600049|NCT00903201|19349631|P2|Overall Study|Lost to Follow-up|1
5600050|NCT00903201|19349632|P1|Overall Study|Lost to Follow-up|0
5600051|NCT00903201|19349630|P3|Overall Study|Protocol Violation|0
5600052|NCT00903201|19349631|P2|Overall Study|Protocol Violation|1
5600053|NCT00903201|19349632|P1|Overall Study|Protocol Violation|2
5600054|NCT00903201|19349630|P3|Overall Study|Adverse Event|0
5600055|NCT00903201|19349631|P2|Overall Study|Adverse Event|4
5600056|NCT00903201|19349632|P1|Overall Study|Adverse Event|1
5600057|NCT00903175|19349690|P2|Period 2 - Second Line|Death|2
5600058|NCT00903175|19349691|P1|Period 2 - Second Line|Death|5
5600059|NCT00903175|19349690|P2|Period 2 - Second Line|Administrative problems|9
5600060|NCT00903175|19349691|P1|Period 2 - Second Line|Administrative problems|19
5600061|NCT00903175|19349690|P2|Period 2 - Second Line|Lost to Follow-up|0
5600062|NCT00903175|19349691|P1|Period 2 - Second Line|Lost to Follow-up|1
5600063|NCT00903175|19349690|P2|Period 2 - Second Line|Withdrawal by Subject|5
5600064|NCT00903175|19349691|P1|Period 2 - Second Line|Withdrawal by Subject|7
5600065|NCT00903175|19349690|P2|Period 2 - Second Line|Adverse Event|20
5600066|NCT00903175|19349691|P1|Period 2 - Second Line|Adverse Event|16
5600067|NCT00903175|19349690|P2|Period 2 - Second Line|Missing|0
5600068|NCT00903175|19349691|P1|Period 2 - Second Line|Missing|1
5600069|NCT00903175|19349690|P2|Period 1 - First Line|Death|10
5600070|NCT00903175|19349691|P1|Period 1 - First Line|Death|17
5600071|NCT00903175|19349690|P2|Period 1 - First Line|Administrative problems|13
5600072|NCT00903175|19349691|P1|Period 1 - First Line|Administrative problems|12
5600073|NCT00903175|19349690|P2|Period 1 - First Line|Withdrawal by Subject|12
5600074|NCT00903175|19349691|P1|Period 1 - First Line|Withdrawal by Subject|8
5600075|NCT00903175|19349690|P2|Period 1 - First Line|Protocol Violation|3
5600076|NCT00903175|19349691|P1|Period 1 - First Line|Protocol Violation|3
5600077|NCT00903175|19349690|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
5600078|NCT00903175|19349691|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
5600079|NCT00903175|19349690|P2|Period 1 - First Line|Abnormal lab value(s)|1
5600080|NCT00903175|19349691|P1|Period 1 - First Line|Abnormal lab value(s)|0
5600081|NCT00903175|19349690|P2|Period 1 - First Line|Adverse Event|50
5600082|NCT00903175|19349691|P1|Period 1 - First Line|Adverse Event|36
5600083|NCT00903032|19349729|P2|Overall Study|Lost to Follow-up|2
5600084|NCT00903032|19349730|P1|Overall Study|Lost to Follow-up|2
5600085|NCT00903032|19349729|P2|Overall Study|Withdrawal by Subject|3
5600086|NCT00903032|19349730|P1|Overall Study|Withdrawal by Subject|5
5600087|NCT00903006|19349740|P4|Overall Study|Progressive Disease|0
5600088|NCT00903006|19349741|P3|Overall Study|Progressive Disease|1
5600089|NCT00903006|19349742|P2|Overall Study|Progressive Disease|3
5600090|NCT00903006|19349743|P1|Overall Study|Progressive Disease|0
5600091|NCT00903006|19349740|P4|Overall Study|Withdrawal by Subject|0
5600092|NCT00903006|19349741|P3|Overall Study|Withdrawal by Subject|0
5600093|NCT00903006|19349742|P2|Overall Study|Withdrawal by Subject|0
5600094|NCT00903006|19349743|P1|Overall Study|Withdrawal by Subject|2
5600095|NCT00902850|19349755|P2|Overall Study|Physician Decision|2
5600096|NCT00902850|19349756|P1|Overall Study|Physician Decision|2
5600097|NCT00902746|19349762|P1|Overall Study|Physician Decision|2
5600098|NCT00902746|19349762|P1|Overall Study|Lost to Follow-up|3
5600099|NCT00902746|19349762|P1|Overall Study|Adverse Event|8
5600100|NCT00902746|19349762|P1|Overall Study|Withdrawal by Subject|16
5600101|NCT00902746|19349762|P1|Overall Study|Protocol Violation|7
5600102|NCT00902668|19349767|P1|Overall Study|Protocol stopped due to slow accrual.|3
5600103|NCT00902577|19349771|P1|Overall Study|FMISO production failure|2
5600104|NCT00902577|19349771|P1|Overall Study|Withdrawal by Subject|6
5600105|NCT00902564|19349800|P1|Overall Study|Withdrawal by Subject|2
5600106|NCT00902538|19349815|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5600107|NCT00902538|19349816|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5600108|NCT00902538|19349817|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
5600109|NCT00902538|19349818|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5600110|NCT00902538|19349819|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5600111|NCT00902538|19349820|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
5600112|NCT00902538|19349815|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
5600113|NCT00902538|19349816|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
5600114|NCT00902538|19349817|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
5600115|NCT00902538|19349818|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
5600116|NCT00902538|19349819|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
5600117|NCT00902538|19349820|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
5600118|NCT00902538|19349815|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
5600119|NCT00902538|19349816|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
5600120|NCT00902538|19349817|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
5600121|NCT00902538|19349818|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
5600122|NCT00902538|19349819|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
5600123|NCT00902538|19349820|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
5600124|NCT00902538|19349815|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
5600125|NCT00902538|19349816|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
5600126|NCT00902538|19349817|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
5600127|NCT00902538|19349818|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
5600128|NCT00902538|19349819|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
5600129|NCT00902538|19349820|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
5600130|NCT00902538|19349815|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5600131|NCT00902538|19349816|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5600132|NCT00902538|19349817|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5600133|NCT00902538|19349818|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5600134|NCT00902538|19349819|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
5600135|NCT00902538|19349820|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
5600208|NCT00902486|19349854|P6|Follow-up (After Week 24)|Lost to Follow-up|0
5600136|NCT00902538|19349815|P6|3-Single-blind, Single Treatment|Protocol Violation|0
5600137|NCT00902538|19349816|P5|3-Single-blind, Single Treatment|Protocol Violation|0
5600138|NCT00902538|19349817|P4|3-Single-blind, Single Treatment|Protocol Violation|0
5600139|NCT00902538|19349818|P3|3-Single-blind, Single Treatment|Protocol Violation|0
5600140|NCT00902538|19349819|P2|3-Single-blind, Single Treatment|Protocol Violation|5
5600141|NCT00902538|19349820|P1|3-Single-blind, Single Treatment|Protocol Violation|0
5600142|NCT00902538|19349815|P6|3-Single-blind, Single Treatment|Adverse Event|0
5600143|NCT00902538|19349816|P5|3-Single-blind, Single Treatment|Adverse Event|0
5600144|NCT00902538|19349817|P4|3-Single-blind, Single Treatment|Adverse Event|0
5600145|NCT00902538|19349818|P3|3-Single-blind, Single Treatment|Adverse Event|0
5600146|NCT00902538|19349819|P2|3-Single-blind, Single Treatment|Adverse Event|5
5600147|NCT00902538|19349820|P1|3-Single-blind, Single Treatment|Adverse Event|0
5600148|NCT00902538|19349815|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
5600149|NCT00902538|19349816|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
5600150|NCT00902538|19349817|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
5600151|NCT00902538|19349818|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
5600152|NCT00902538|19349819|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
5600153|NCT00902538|19349820|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
5600154|NCT00902538|19349815|P6|2-Randomized Double-blind 3 Treatments|Other|0
5600155|NCT00902538|19349816|P5|2-Randomized Double-blind 3 Treatments|Other|0
5600156|NCT00902538|19349817|P4|2-Randomized Double-blind 3 Treatments|Other|0
5600157|NCT00902538|19349818|P3|2-Randomized Double-blind 3 Treatments|Other|0
5600158|NCT00902538|19349819|P2|2-Randomized Double-blind 3 Treatments|Other|1
5600159|NCT00902538|19349820|P1|2-Randomized Double-blind 3 Treatments|Other|2
5600160|NCT00902538|19349815|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
5600161|NCT00902538|19349816|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
5600162|NCT00902538|19349817|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
5600163|NCT00902538|19349818|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
5600164|NCT00902538|19349819|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
5600165|NCT00902538|19349820|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
5600166|NCT00902538|19349815|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
5600167|NCT00902538|19349816|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
5600168|NCT00902538|19349817|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
5600169|NCT00902538|19349818|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
5600170|NCT00902538|19349819|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
5600171|NCT00902538|19349820|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
5600172|NCT00902538|19349815|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
5600173|NCT00902538|19349816|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
5600174|NCT00902538|19349817|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
5600175|NCT00902538|19349818|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
5600176|NCT00902538|19349819|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
5600177|NCT00902538|19349820|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
5600178|NCT00902538|19349815|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5600179|NCT00902538|19349816|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5600180|NCT00902538|19349817|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5600181|NCT00902538|19349818|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5600182|NCT00902538|19349819|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
5600183|NCT00902538|19349820|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
5600184|NCT00902538|19349815|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5600185|NCT00902538|19349816|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5600186|NCT00902538|19349817|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5600187|NCT00902538|19349818|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5600188|NCT00902538|19349819|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
5600189|NCT00902538|19349820|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
5600190|NCT00902538|19349815|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5600191|NCT00902538|19349816|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5600192|NCT00902538|19349817|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5600193|NCT00902538|19349818|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5600194|NCT00902538|19349819|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
5600195|NCT00902538|19349820|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
5600196|NCT00902538|19349815|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5600197|NCT00902538|19349816|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5600198|NCT00902538|19349817|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5600199|NCT00902538|19349818|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5600200|NCT00902538|19349819|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
5600201|NCT00902538|19349820|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
5600202|NCT00902538|19349815|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5600203|NCT00902538|19349816|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5600204|NCT00902538|19349817|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5600205|NCT00902538|19349818|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5600206|NCT00902538|19349819|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
5600207|NCT00902538|19349820|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
5600209|NCT00902486|19349855|P5|Follow-up (After Week 24)|Lost to Follow-up|0
5600210|NCT00902486|19349856|P4|Follow-up (After Week 24)|Lost to Follow-up|1
5600211|NCT00902486|19349857|P3|Follow-up (After Week 24)|Lost to Follow-up|0
5600212|NCT00902486|19349858|P2|Follow-up (After Week 24)|Lost to Follow-up|0
5600213|NCT00902486|19349859|P1|Follow-up (After Week 24)|Lost to Follow-up|0
5600214|NCT00902486|19349854|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5600215|NCT00902486|19349855|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5600216|NCT00902486|19349856|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5600217|NCT00902486|19349857|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
5600218|NCT00902486|19349858|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5600219|NCT00902486|19349859|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
5600220|NCT00902486|19349854|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5600221|NCT00902486|19349855|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5600222|NCT00902486|19349856|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
5600223|NCT00902486|19349857|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5600224|NCT00902486|19349858|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5600225|NCT00902486|19349859|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
5600226|NCT00902486|19349854|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
5600227|NCT00902486|19349855|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5600228|NCT00902486|19349856|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5600229|NCT00902486|19349857|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5600230|NCT00902486|19349858|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5600231|NCT00902486|19349859|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
5600232|NCT00902486|19349854|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
5600233|NCT00902486|19349855|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
5600234|NCT00902486|19349856|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
5600235|NCT00902486|19349857|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
5600236|NCT00902486|19349858|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
5600237|NCT00902486|19349859|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
5600238|NCT00902486|19349854|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
5600239|NCT00902486|19349855|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
5600240|NCT00902486|19349856|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
5600241|NCT00902486|19349857|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
5600242|NCT00902486|19349858|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
5600243|NCT00902486|19349859|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
5600244|NCT00902486|19349854|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5600245|NCT00902486|19349855|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5600246|NCT00902486|19349856|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
5600247|NCT00902486|19349857|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5600248|NCT00902486|19349858|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5600249|NCT00902486|19349859|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
5600250|NCT00902486|19349854|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5600251|NCT00902486|19349855|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5600252|NCT00902486|19349856|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
5600253|NCT00902486|19349857|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5600254|NCT00902486|19349858|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5600255|NCT00902486|19349859|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
5600256|NCT00902486|19349854|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
5600257|NCT00902486|19349855|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
5600258|NCT00902486|19349856|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
5600259|NCT00902486|19349857|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
5600260|NCT00902486|19349858|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
5600261|NCT00902486|19349859|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
5600262|NCT00902486|19349854|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
5600263|NCT00902486|19349855|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
5600264|NCT00902486|19349856|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
5600265|NCT00902486|19349857|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
5600266|NCT00902486|19349858|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
5600267|NCT00902486|19349859|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
5600268|NCT00902486|19349854|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
5600269|NCT00902486|19349855|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
5600270|NCT00902486|19349856|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
5600271|NCT00902486|19349857|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
5600272|NCT00902486|19349858|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
5600273|NCT00902486|19349859|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
5600274|NCT00902330|19349997|P2|Overall Study|No post baseline data|0
5600275|NCT00902330|19349998|P1|Overall Study|No post baseline data|1
5600276|NCT00902330|19349997|P2|Overall Study|Adverse Event|0
5600277|NCT00902330|19349998|P1|Overall Study|Adverse Event|1
5600278|NCT00902330|19349997|P2|Overall Study|Too overwhelmed by treatment|5
5600279|NCT00902330|19349998|P1|Overall Study|Too overwhelmed by treatment|2
5600280|NCT00902304|19350035|P3|Overall Study|includes pregnancy|2
5600281|NCT00902304|19350036|P2|Overall Study|includes pregnancy|9
5600282|NCT00902304|19350037|P1|Overall Study|includes pregnancy|3
5600283|NCT00902304|19350035|P3|Overall Study|Withdrawal by Subject|43
5600284|NCT00902304|19350036|P2|Overall Study|Withdrawal by Subject|22
5600285|NCT00902304|19350037|P1|Overall Study|Withdrawal by Subject|32
5600286|NCT00902304|19350035|P3|Overall Study|Protocol Violation|20
5600287|NCT00902304|19350036|P2|Overall Study|Protocol Violation|18
5600288|NCT00902304|19350037|P1|Overall Study|Protocol Violation|9
5600289|NCT00902304|19350035|P3|Overall Study|Lost to Follow-up|7
5600290|NCT00902304|19350036|P2|Overall Study|Lost to Follow-up|7
5600291|NCT00902304|19350037|P1|Overall Study|Lost to Follow-up|7
5600292|NCT00902304|19350035|P3|Overall Study|Investigator discretion|13
5600293|NCT00902304|19350036|P2|Overall Study|Investigator discretion|5
5600294|NCT00902304|19350037|P1|Overall Study|Investigator discretion|3
5600295|NCT00902304|19350035|P3|Overall Study|Adverse Event|25
5600296|NCT00902304|19350036|P2|Overall Study|Adverse Event|10
5600297|NCT00902304|19350037|P1|Overall Study|Adverse Event|4
5600298|NCT00902278|19350087|P5|Overall Study|Lost to Follow-up|1
5600299|NCT00902278|19350088|P4|Overall Study|Lost to Follow-up|0
5600300|NCT00902278|19350089|P3|Overall Study|Lost to Follow-up|3
5600301|NCT00902278|19350090|P2|Overall Study|Lost to Follow-up|2
5600302|NCT00902278|19350091|P1|Overall Study|Lost to Follow-up|3
5600303|NCT00902278|19350087|P5|Overall Study|Physician Decision|1
5600304|NCT00902278|19350088|P4|Overall Study|Physician Decision|0
5600305|NCT00902278|19350089|P3|Overall Study|Physician Decision|2
5600306|NCT00902278|19350090|P2|Overall Study|Physician Decision|0
5600307|NCT00902278|19350091|P1|Overall Study|Physician Decision|1
5600308|NCT00902265|19350108|P1|Overall Study|Protocol Violation|1
5600309|NCT00902265|19350108|P1|Overall Study|Lack of Efficacy|2
5600310|NCT00902265|19350108|P1|Overall Study|Adverse Event|2
5600311|NCT00902265|19350108|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
5600312|NCT00902174|19350132|P2|Overall Study|Administration problem|1
5600313|NCT00902174|19350133|P1|Overall Study|Administration problem|0
5600314|NCT00902174|19350132|P2|Overall Study|Protocol Violation|1
5600315|NCT00902174|19350133|P1|Overall Study|Protocol Violation|1
5600316|NCT00902174|19350132|P2|Overall Study|Abnormal labs|1
5600317|NCT00902174|19350133|P1|Overall Study|Abnormal labs|1
5600318|NCT00902174|19350132|P2|Overall Study|Withdrawal by Subject|1
5600319|NCT00902174|19350133|P1|Overall Study|Withdrawal by Subject|2
5600320|NCT00902174|19350132|P2|Overall Study|Death|2
5600321|NCT00902174|19350133|P1|Overall Study|Death|2
5600322|NCT00902174|19350132|P2|Overall Study|Lack of Efficacy|5
5600323|NCT00902174|19350133|P1|Overall Study|Lack of Efficacy|1
5600324|NCT00902174|19350132|P2|Overall Study|Adverse Event|7
5600325|NCT00902174|19350133|P1|Overall Study|Adverse Event|27
5600326|NCT00901927|19350208|P1|Overall Study|Withdrawal by Subject|2
5600327|NCT00901927|19350208|P1|Overall Study|Protocol Violation|3
5600328|NCT00901927|19350208|P1|Overall Study|Lack of Efficacy|1
5600329|NCT00901901|19350216|P2|Follow-up Period|Missing|80
5600330|NCT00901901|19350217|P1|Follow-up Period|Missing|94
5600331|NCT00901901|19350216|P2|Follow-up Period|Lost to Follow-up|8
5600332|NCT00901901|19350217|P1|Follow-up Period|Lost to Follow-up|12
5600333|NCT00901901|19350216|P2|Follow-up Period|Withdrawal by Subject|9
5600334|NCT00901901|19350217|P1|Follow-up Period|Withdrawal by Subject|6
5600335|NCT00901901|19350216|P2|Follow-up Period|Protocol driven decision point|36
5600336|NCT00901901|19350217|P1|Follow-up Period|Protocol driven decision point|47
5600337|NCT00901901|19350216|P2|Follow-up Period|Death|208
5600338|NCT00901901|19350217|P1|Follow-up Period|Death|181
5600339|NCT00901901|19350216|P2|Treatment Period|Transfer to treatment continuation study|2
5600340|NCT00901901|19350217|P1|Treatment Period|Transfer to treatment continuation study|5
5600341|NCT00901901|19350216|P2|Treatment Period|Switch to commercial drug|1
5600342|NCT00901901|19350217|P1|Treatment Period|Switch to commercial drug|1
5600343|NCT00901901|19350216|P2|Treatment Period|Protocol Violation|9
5600344|NCT00901901|19350217|P1|Treatment Period|Protocol Violation|5
5600345|NCT00901901|19350216|P2|Treatment Period|Study terminated by sponsor|0
5600346|NCT00901901|19350217|P1|Treatment Period|Study terminated by sponsor|2
5600347|NCT00901901|19350216|P2|Treatment Period|Protocol driven decision point|2
5600348|NCT00901901|19350217|P1|Treatment Period|Protocol driven decision point|0
5600349|NCT00901901|19350216|P2|Treatment Period|Never treated|3
5600350|NCT00901901|19350217|P1|Treatment Period|Never treated|0
5600351|NCT00901901|19350216|P2|Treatment Period|Missing|0
5600352|NCT00901901|19350217|P1|Treatment Period|Missing|1
5600353|NCT00901901|19350216|P2|Treatment Period|Noncompliance with study medication|1
5600354|NCT00901901|19350217|P1|Treatment Period|Noncompliance with study medication|4
5600355|NCT00901901|19350216|P2|Treatment Period|Lost to Follow-up|5
5600356|NCT00901901|19350217|P1|Treatment Period|Lost to Follow-up|3
5600357|NCT00901901|19350216|P2|Treatment Period|Physician Decision|2
5600358|NCT00901901|19350217|P1|Treatment Period|Physician Decision|2
5600359|NCT00901901|19350216|P2|Treatment Period|Withdrawal by Subject|24
5600360|NCT00901901|19350217|P1|Treatment Period|Withdrawal by Subject|26
5600361|NCT00901901|19350216|P2|Treatment Period|Adverse Event|128
5600362|NCT00901901|19350217|P1|Treatment Period|Adverse Event|120
5600363|NCT00901628|19350239|P2|Overall Study|peroneal nerve palsy|1
5600364|NCT00901628|19350240|P1|Overall Study|peroneal nerve palsy|0
5600365|NCT00901628|19350239|P2|Overall Study|disconnection of drain|1
5600366|NCT00901628|19350240|P1|Overall Study|disconnection of drain|0
5600367|NCT00901628|19350239|P2|Overall Study|disconnection of catheter|8
5600368|NCT00901628|19350240|P1|Overall Study|disconnection of catheter|4
5600369|NCT00901576|19350262|P6|Second Intervention|Physician Decision|0
5600370|NCT00901576|19350263|P5|Second Intervention|Physician Decision|0
5600371|NCT00901576|19350264|P4|Second Intervention|Physician Decision|0
5600372|NCT00901576|19350265|P3|Second Intervention|Physician Decision|0
5600373|NCT00901576|19350266|P2|Second Intervention|Physician Decision|0
5600374|NCT00901576|19350267|P1|Second Intervention|Physician Decision|1
5600375|NCT00901576|19350262|P6|Second Intervention|Withdrawal by Subject|1
5600376|NCT00901576|19350263|P5|Second Intervention|Withdrawal by Subject|0
5600377|NCT00901576|19350264|P4|Second Intervention|Withdrawal by Subject|1
5600378|NCT00901576|19350265|P3|Second Intervention|Withdrawal by Subject|0
5600379|NCT00901576|19350266|P2|Second Intervention|Withdrawal by Subject|0
5600380|NCT00901576|19350267|P1|Second Intervention|Withdrawal by Subject|0
5600381|NCT00901459|19350288|P1|Overall Study|Withdrawal by Subject|6
5600382|NCT00901394|19350302|P3|Overall Study|Physician Decision|2
5600383|NCT00901394|19350303|P2|Overall Study|Physician Decision|1
5600384|NCT00901394|19350304|P1|Overall Study|Physician Decision|1
5600385|NCT00901342|19350312|P1|Overall Study|Withdrawal by Subject|9
5600386|NCT00901342|19350312|P1|Overall Study|Disease progression|1
5600387|NCT00901342|19350312|P1|Overall Study|Death|4
5600388|NCT00901342|19350312|P1|Overall Study|Adverse Event|1
5600389|NCT00901186|19350345|P2|Overall Study|Protocol deviations|4
5600390|NCT00901186|19350346|P1|Overall Study|Protocol deviations|5
5600391|NCT00901186|19350345|P2|Overall Study|Administration problems|1
5600392|NCT00901186|19350346|P1|Overall Study|Administration problems|0
5600393|NCT00901186|19350345|P2|Overall Study|Adverse Event|4
5600394|NCT00901186|19350346|P1|Overall Study|Adverse Event|2
5600395|NCT00901186|19350345|P2|Overall Study|Lost to Follow-up|0
5600396|NCT00901186|19350346|P1|Overall Study|Lost to Follow-up|2
5600397|NCT00901186|19350345|P2|Overall Study|Abnormal laboratory values|1
5600398|NCT00901186|19350346|P1|Overall Study|Abnormal laboratory values|0
5600399|NCT00901186|19350345|P2|Overall Study|Lack of Efficacy|1
5600400|NCT00901186|19350346|P1|Overall Study|Lack of Efficacy|0
5600401|NCT00900796|19350386|P1|Phase 2|Lost to Follow-up|5
5600402|NCT00900796|19350386|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
5600403|NCT00900796|19350386|P1|Phase 1|Missing information at Week 16|7
5600404|NCT00900796|19350386|P1|Phase 1|Lacked sufficient information|4
5600405|NCT00900757|19350396|P1|Overall Study|screen failure|19
5600406|NCT00900731|19350406|P2|Overall Study|Death|2
5600407|NCT00900731|19350407|P1|Overall Study|Death|0
5600408|NCT00900731|19350406|P2|Overall Study|Lack of Efficacy|3
5600409|NCT00900731|19350407|P1|Overall Study|Lack of Efficacy|1
5600410|NCT00900731|19350406|P2|Overall Study|Lost to Follow-up|3
5600411|NCT00900731|19350407|P1|Overall Study|Lost to Follow-up|2
5600412|NCT00900731|19350406|P2|Overall Study|Abnormal Laboratory Value(s)|4
5600413|NCT00900731|19350407|P1|Overall Study|Abnormal Laboratory Value(s)|2
5600414|NCT00900731|19350406|P2|Overall Study|Abnormal Test Procedure Result(s)|0
5600415|NCT00900731|19350407|P1|Overall Study|Abnormal Test Procedure Result(s)|3
5600416|NCT00900731|19350406|P2|Overall Study|Administrative Problems|4
5600417|NCT00900731|19350407|P1|Overall Study|Administrative Problems|5
5600418|NCT00900731|19350406|P2|Overall Study|Protocol Deviation|11
5600419|NCT00900731|19350407|P1|Overall Study|Protocol Deviation|8
5600420|NCT00900731|19350406|P2|Overall Study|Withdrawal by Subject|7
5600421|NCT00900731|19350407|P1|Overall Study|Withdrawal by Subject|8
5600422|NCT00900731|19350406|P2|Overall Study|Adverse Event|27
5600423|NCT00900731|19350407|P1|Overall Study|Adverse Event|31
5600424|NCT00900627|19350444|P6|Overall Study|Death|24
5600425|NCT00900627|19350445|P5|Overall Study|Death|28
5600426|NCT00900627|19350446|P4|Overall Study|Death|0
5600427|NCT00900627|19350447|P3|Overall Study|Death|0
5600428|NCT00900627|19350448|P2|Overall Study|Death|0
5600429|NCT00900627|19350449|P1|Overall Study|Death|0
5600430|NCT00900627|19350444|P6|Overall Study|Adverse Event|0
5600431|NCT00900627|19350445|P5|Overall Study|Adverse Event|0
5600432|NCT00900627|19350446|P4|Overall Study|Adverse Event|3
5600433|NCT00900627|19350447|P3|Overall Study|Adverse Event|0
5600434|NCT00900627|19350448|P2|Overall Study|Adverse Event|2
5600435|NCT00900627|19350449|P1|Overall Study|Adverse Event|1
5600436|NCT00900627|19350444|P6|Overall Study|Withdrawal by Subject|2
5600437|NCT00900627|19350445|P5|Overall Study|Withdrawal by Subject|1
5600438|NCT00900627|19350446|P4|Overall Study|Withdrawal by Subject|0
5600439|NCT00900627|19350447|P3|Overall Study|Withdrawal by Subject|1
5600440|NCT00900627|19350448|P2|Overall Study|Withdrawal by Subject|0
5600441|NCT00900627|19350449|P1|Overall Study|Withdrawal by Subject|1
5600442|NCT00900627|19350444|P6|Overall Study|Condition under investigation worsened|0
5600443|NCT00900627|19350445|P5|Overall Study|Condition under investigation worsened|0
5600444|NCT00900627|19350446|P4|Overall Study|Condition under investigation worsened|3
5600445|NCT00900627|19350447|P3|Overall Study|Condition under investigation worsened|5
5600446|NCT00900627|19350448|P2|Overall Study|Condition under investigation worsened|0
5600447|NCT00900627|19350449|P1|Overall Study|Condition under investigation worsened|4
5600448|NCT00900601|19350467|P1|Overall Study|Physician Decision|1
5600449|NCT00900159|19350486|P2|Second Intervention|disempanelled for inappropriate behavior|0
5600450|NCT00900159|19350487|P1|Second Intervention|disempanelled for inappropriate behavior|1
5600451|NCT00900146|19350506|P5|Intermediate: Period III|Administrative problems|163
5600452|NCT00900146|19350507|P4|Intermediate: Period III|Administrative problems|90
5600453|NCT00900146|19350508|P3|Intermediate: Period III|Administrative problems|84
5600454|NCT00900146|19350509|P2|Intermediate: Period III|Administrative problems|92
5600455|NCT00900146|19350510|P1|Intermediate: Period III|Administrative problems|85
5600456|NCT00900146|19350506|P5|Intermediate: Period III|Lost to Follow-up|1
5600457|NCT00900146|19350507|P4|Intermediate: Period III|Lost to Follow-up|0
5600458|NCT00900146|19350508|P3|Intermediate: Period III|Lost to Follow-up|0
5600459|NCT00900146|19350509|P2|Intermediate: Period III|Lost to Follow-up|0
5600460|NCT00900146|19350510|P1|Intermediate: Period III|Lost to Follow-up|2
5600461|NCT00900146|19350506|P5|Intermediate: Period III|Withdrawal by Subject|3
5600462|NCT00900146|19350507|P4|Intermediate: Period III|Withdrawal by Subject|0
5600463|NCT00900146|19350508|P3|Intermediate: Period III|Withdrawal by Subject|0
5600464|NCT00900146|19350509|P2|Intermediate: Period III|Withdrawal by Subject|1
5600465|NCT00900146|19350510|P1|Intermediate: Period III|Withdrawal by Subject|0
5600466|NCT00900146|19350506|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
5600467|NCT00900146|19350507|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
5600468|NCT00900146|19350508|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
5600469|NCT00900146|19350509|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
5600470|NCT00900146|19350510|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
5600471|NCT00900146|19350506|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
5600472|NCT00900146|19350507|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
5600473|NCT00900146|19350508|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
5600474|NCT00900146|19350509|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
5600475|NCT00900146|19350510|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
5600476|NCT00900146|19350506|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
5600477|NCT00900146|19350507|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
5600478|NCT00900146|19350508|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
5600479|NCT00900146|19350509|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
5600480|NCT00900146|19350510|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
5600481|NCT00900029|19350627|P5|Overall Study|Death|0
5600482|NCT00900029|19350628|P4|Overall Study|Death|1
5600483|NCT00900029|19350629|P3|Overall Study|Death|0
5600484|NCT00900029|19350630|P2|Overall Study|Death|0
5600485|NCT00900029|19350631|P1|Overall Study|Death|1
5600486|NCT00900029|19350627|P5|Overall Study|Adverse Event|1
5600487|NCT00900029|19350628|P4|Overall Study|Adverse Event|1
5600488|NCT00900029|19350629|P3|Overall Study|Adverse Event|1
5600489|NCT00900029|19350630|P2|Overall Study|Adverse Event|0
5600490|NCT00900029|19350631|P1|Overall Study|Adverse Event|0
5600491|NCT00900029|19350627|P5|Overall Study|Withdrawal by Subject|1
5600492|NCT00900029|19350628|P4|Overall Study|Withdrawal by Subject|1
5600493|NCT00900029|19350629|P3|Overall Study|Withdrawal by Subject|1
5600494|NCT00900029|19350630|P2|Overall Study|Withdrawal by Subject|2
5600495|NCT00900029|19350631|P1|Overall Study|Withdrawal by Subject|2
5600496|NCT00900029|19350627|P5|Overall Study|Lost to Follow-up|4
5600497|NCT00900029|19350628|P4|Overall Study|Lost to Follow-up|4
5600498|NCT00900029|19350629|P3|Overall Study|Lost to Follow-up|1
5600499|NCT00900029|19350630|P2|Overall Study|Lost to Follow-up|2
5600500|NCT00900029|19350631|P1|Overall Study|Lost to Follow-up|0
5600501|NCT00899847|19350648|P1|Overall Study|Lack of suitable allogeneic donor|2
5600502|NCT00899678|19350679|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
5600503|NCT00899678|19350680|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
5600504|NCT00899678|19350681|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
5600505|NCT00899678|19350679|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
5600506|NCT00899678|19350680|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
5600507|NCT00899678|19350681|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
5600508|NCT00899678|19350679|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
5600509|NCT00899678|19350680|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
5600510|NCT00899678|19350681|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
5600511|NCT00899678|19350679|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
5600512|NCT00899678|19350680|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
5600513|NCT00899678|19350681|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
5600514|NCT00899678|19350679|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
5600515|NCT00899678|19350680|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
5600516|NCT00899678|19350681|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
5600517|NCT00899678|19350679|P3|Induction Period (Weeks 0 to 6)|Other reason|0
5600518|NCT00899678|19350680|P2|Induction Period (Weeks 0 to 6)|Other reason|0
5600519|NCT00899678|19350681|P1|Induction Period (Weeks 0 to 6)|Other reason|1
5600520|NCT00899678|19350679|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
5600521|NCT00899678|19350680|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
5600522|NCT00899678|19350681|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
5600523|NCT00899678|19350679|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
5600524|NCT00899678|19350680|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
5600525|NCT00899678|19350681|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
5600526|NCT00899678|19350679|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
5600527|NCT00899678|19350680|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
5600528|NCT00899678|19350681|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
5600529|NCT00899548|19350731|P1|Overall Study|Physician Decision|3
5600530|NCT00899431|19350825|P3|Overall Study|Physician Decision|0
5600531|NCT00899431|19350826|P2|Overall Study|Physician Decision|0
5600532|NCT00899431|19350827|P1|Overall Study|Physician Decision|1
5600533|NCT00899392|19350840|P2|Overall Study|Subject didn't finish/partial pilot data|24
5600534|NCT00899392|19350841|P1|Overall Study|Subject didn't finish/partial pilot data|21
5600535|NCT00899379|19350858|P5|Overall Study|Inc/Exc Criteria Not Met|0
5600536|NCT00899379|19350859|P4|Overall Study|Inc/Exc Criteria Not Met|0
5600537|NCT00899379|19350860|P3|Overall Study|Inc/Exc Criteria Not Met|1
5600538|NCT00899379|19350861|P2|Overall Study|Inc/Exc Criteria Not Met|0
5600539|NCT00899379|19350862|P1|Overall Study|Inc/Exc Criteria Not Met|0
5600540|NCT00899379|19350858|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
5600541|NCT00899379|19350859|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
5600542|NCT00899379|19350860|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
5600543|NCT00899379|19350861|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
5600544|NCT00899379|19350862|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
5600545|NCT00899379|19350858|P5|Overall Study|No Attack Pretreatment|4
5600546|NCT00899379|19350859|P4|Overall Study|No Attack Pretreatment|6
5600547|NCT00899379|19350860|P3|Overall Study|No Attack Pretreatment|5
5600548|NCT00899379|19350861|P2|Overall Study|No Attack Pretreatment|5
5600549|NCT00899379|19350862|P1|Overall Study|No Attack Pretreatment|3
5600550|NCT00899379|19350858|P5|Overall Study|Abnormal Baseline ECG|0
5600551|NCT00899379|19350859|P4|Overall Study|Abnormal Baseline ECG|1
5600552|NCT00899379|19350860|P3|Overall Study|Abnormal Baseline ECG|1
5600553|NCT00899379|19350861|P2|Overall Study|Abnormal Baseline ECG|0
5600554|NCT00899379|19350862|P1|Overall Study|Abnormal Baseline ECG|0
5600555|NCT00899379|19350858|P5|Overall Study|Abnormal Prestudy Labs|2
5600556|NCT00899379|19350859|P4|Overall Study|Abnormal Prestudy Labs|0
5600557|NCT00899379|19350860|P3|Overall Study|Abnormal Prestudy Labs|0
5600558|NCT00899379|19350861|P2|Overall Study|Abnormal Prestudy Labs|0
5600559|NCT00899379|19350862|P1|Overall Study|Abnormal Prestudy Labs|0
5600560|NCT00899379|19350858|P5|Overall Study|Patient Uncooperative|0
5600561|NCT00899379|19350859|P4|Overall Study|Patient Uncooperative|1
5600562|NCT00899379|19350860|P3|Overall Study|Patient Uncooperative|0
5600563|NCT00899379|19350861|P2|Overall Study|Patient Uncooperative|0
5600564|NCT00899379|19350862|P1|Overall Study|Patient Uncooperative|0
5600565|NCT00899379|19350858|P5|Overall Study|Pregnancy|0
5600566|NCT00899379|19350859|P4|Overall Study|Pregnancy|0
5600567|NCT00899379|19350860|P3|Overall Study|Pregnancy|0
5600568|NCT00899379|19350861|P2|Overall Study|Pregnancy|0
5600569|NCT00899379|19350862|P1|Overall Study|Pregnancy|1
5600570|NCT00899379|19350858|P5|Overall Study|Withdrawal by Subject|2
5600571|NCT00899379|19350859|P4|Overall Study|Withdrawal by Subject|7
5600572|NCT00899379|19350860|P3|Overall Study|Withdrawal by Subject|4
5600573|NCT00899379|19350861|P2|Overall Study|Withdrawal by Subject|7
5600574|NCT00899379|19350862|P1|Overall Study|Withdrawal by Subject|4
5600575|NCT00899379|19350858|P5|Overall Study|Lost to Follow-up|5
5600576|NCT00899379|19350859|P4|Overall Study|Lost to Follow-up|2
5600577|NCT00899379|19350860|P3|Overall Study|Lost to Follow-up|0
5600578|NCT00899379|19350861|P2|Overall Study|Lost to Follow-up|1
5600579|NCT00899379|19350862|P1|Overall Study|Lost to Follow-up|3
5600580|NCT00899379|19350858|P5|Overall Study|Study Terminated|1
5600581|NCT00899379|19350859|P4|Overall Study|Study Terminated|3
5600582|NCT00899379|19350860|P3|Overall Study|Study Terminated|3
5600583|NCT00899379|19350861|P2|Overall Study|Study Terminated|0
5600584|NCT00899379|19350862|P1|Overall Study|Study Terminated|3
5600585|NCT00899379|19350858|P5|Overall Study|Not Completed/Entered Extn|3
5600586|NCT00899379|19350859|P4|Overall Study|Not Completed/Entered Extn|4
5600587|NCT00899379|19350860|P3|Overall Study|Not Completed/Entered Extn|6
5600588|NCT00899379|19350861|P2|Overall Study|Not Completed/Entered Extn|1
5600589|NCT00899379|19350862|P1|Overall Study|Not Completed/Entered Extn|5
5600590|NCT00899379|19350858|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
5600591|NCT00899379|19350859|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
5600592|NCT00899379|19350860|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
5600593|NCT00899379|19350861|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
5600594|NCT00899379|19350862|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
5600595|NCT00899379|19350858|P5|Overall Study|Abnormal Baseline ECG|0
5600596|NCT00899379|19350859|P4|Overall Study|Abnormal Baseline ECG|1
5600597|NCT00899379|19350860|P3|Overall Study|Abnormal Baseline ECG|0
5600598|NCT00899379|19350861|P2|Overall Study|Abnormal Baseline ECG|0
5600599|NCT00899379|19350862|P1|Overall Study|Abnormal Baseline ECG|0
5600600|NCT00899379|19350858|P5|Overall Study|Patient Uncooperative|2
5600601|NCT00899379|19350859|P4|Overall Study|Patient Uncooperative|1
5600602|NCT00899379|19350860|P3|Overall Study|Patient Uncooperative|0
5600603|NCT00899379|19350861|P2|Overall Study|Patient Uncooperative|1
5600604|NCT00899379|19350862|P1|Overall Study|Patient Uncooperative|0
5600605|NCT00899379|19350858|P5|Overall Study|Pregnancy|1
5600606|NCT00899379|19350859|P4|Overall Study|Pregnancy|0
5600607|NCT00899379|19350860|P3|Overall Study|Pregnancy|1
5600608|NCT00899379|19350861|P2|Overall Study|Pregnancy|0
5600609|NCT00899379|19350862|P1|Overall Study|Pregnancy|0
5600610|NCT00899379|19350858|P5|Overall Study|Withdrawal by Subject|6
5600611|NCT00899379|19350859|P4|Overall Study|Withdrawal by Subject|3
5600612|NCT00899379|19350860|P3|Overall Study|Withdrawal by Subject|2
5600613|NCT00899379|19350861|P2|Overall Study|Withdrawal by Subject|4
5600614|NCT00899379|19350862|P1|Overall Study|Withdrawal by Subject|2
5600615|NCT00899379|19350858|P5|Overall Study|Protocol Violation|0
5600616|NCT00899379|19350859|P4|Overall Study|Protocol Violation|1
5600617|NCT00899379|19350860|P3|Overall Study|Protocol Violation|1
5600618|NCT00899379|19350861|P2|Overall Study|Protocol Violation|0
5600619|NCT00899379|19350862|P1|Overall Study|Protocol Violation|0
5600620|NCT00899379|19350858|P5|Overall Study|Lost to Follow-up|2
5600621|NCT00899379|19350859|P4|Overall Study|Lost to Follow-up|6
5600622|NCT00899379|19350860|P3|Overall Study|Lost to Follow-up|0
5600623|NCT00899379|19350861|P2|Overall Study|Lost to Follow-up|3
5600624|NCT00899379|19350862|P1|Overall Study|Lost to Follow-up|9
5600625|NCT00899379|19350858|P5|Overall Study|Lack of Efficacy|1
5600626|NCT00899379|19350859|P4|Overall Study|Lack of Efficacy|0
5600627|NCT00899379|19350860|P3|Overall Study|Lack of Efficacy|3
5600628|NCT00899379|19350861|P2|Overall Study|Lack of Efficacy|4
5600629|NCT00899379|19350862|P1|Overall Study|Lack of Efficacy|0
5600630|NCT00899379|19350858|P5|Overall Study|Adverse Event|2
5600631|NCT00899379|19350859|P4|Overall Study|Adverse Event|1
5600632|NCT00899379|19350860|P3|Overall Study|Adverse Event|1
5600633|NCT00899379|19350861|P2|Overall Study|Adverse Event|2
5600634|NCT00899379|19350862|P1|Overall Study|Adverse Event|2
5600635|NCT00899353|19350874|P1|Overall Study|Withdrawal by Subject|2
5600636|NCT00899353|19350874|P1|Overall Study|Lost to Follow-up|1
5600637|NCT00899353|19350874|P1|Overall Study|Adverse Event|2
5600638|NCT00898807|19350910|P2|Overall Study|Death|1
5600639|NCT00898807|19350911|P1|Overall Study|Death|0
5600640|NCT00898807|19350910|P2|Overall Study|Lost to Follow-up|3
5600641|NCT00898807|19350911|P1|Overall Study|Lost to Follow-up|1
5600642|NCT00898807|19350910|P2|Overall Study|Family pressure to discontinue|2
5600643|NCT00898807|19350911|P1|Overall Study|Family pressure to discontinue|2
5600644|NCT00898807|19350910|P2|Overall Study|Withdrawal by Subject|3
5600645|NCT00898807|19350911|P1|Overall Study|Withdrawal by Subject|5
5600646|NCT00898677|19350927|P4|Overall Study|Not Treated: Other (Not Specified)|0
5600647|NCT00898677|19350928|P3|Overall Study|Not Treated: Other (Not Specified)|2
5600648|NCT00898677|19350929|P2|Overall Study|Not Treated: Other (Not Specified)|0
5600649|NCT00898677|19350930|P1|Overall Study|Not Treated: Other (Not Specified)|0
5600650|NCT00898677|19350927|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
5600651|NCT00898677|19350928|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
5600652|NCT00898677|19350929|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
5600653|NCT00898677|19350930|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
5600654|NCT00898677|19350927|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
5600655|NCT00898677|19350928|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
5600656|NCT00898677|19350929|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
5600657|NCT00898677|19350930|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
5600658|NCT00898677|19350927|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
5600659|NCT00898677|19350928|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
5600660|NCT00898677|19350929|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
5600661|NCT00898677|19350930|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
5600662|NCT00898677|19350927|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
5600663|NCT00898677|19350928|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
5600664|NCT00898677|19350929|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
5600665|NCT00898677|19350930|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
5600666|NCT00898677|19350927|P4|Overall Study|Not Treated: Patient uncooperative|0
5600667|NCT00898677|19350928|P3|Overall Study|Not Treated: Patient uncooperative|1
5600668|NCT00898677|19350929|P2|Overall Study|Not Treated: Patient uncooperative|3
5600669|NCT00898677|19350930|P1|Overall Study|Not Treated: Patient uncooperative|2
5600670|NCT00898677|19350927|P4|Overall Study|Not Treated: Withdraw by Subject|3
5600671|NCT00898677|19350928|P3|Overall Study|Not Treated: Withdraw by Subject|11
5600672|NCT00898677|19350929|P2|Overall Study|Not Treated: Withdraw by Subject|16
5600673|NCT00898677|19350930|P1|Overall Study|Not Treated: Withdraw by Subject|2
5600674|NCT00898677|19350927|P4|Overall Study|Not Treated: Protocol Violation|0
5600675|NCT00898677|19350928|P3|Overall Study|Not Treated: Protocol Violation|2
5600676|NCT00898677|19350929|P2|Overall Study|Not Treated: Protocol Violation|0
5600677|NCT00898677|19350930|P1|Overall Study|Not Treated: Protocol Violation|2
5600678|NCT00898677|19350927|P4|Overall Study|Not Treated: Pregnancy|0
5600679|NCT00898677|19350928|P3|Overall Study|Not Treated: Pregnancy|1
5600680|NCT00898677|19350929|P2|Overall Study|Not Treated: Pregnancy|0
5600681|NCT00898677|19350930|P1|Overall Study|Not Treated: Pregnancy|0
5600682|NCT00898677|19350927|P4|Overall Study|Not Treated: Lost to Follow-Up|2
5600683|NCT00898677|19350928|P3|Overall Study|Not Treated: Lost to Follow-Up|5
5600684|NCT00898677|19350929|P2|Overall Study|Not Treated: Lost to Follow-Up|5
5600685|NCT00898677|19350930|P1|Overall Study|Not Treated: Lost to Follow-Up|0
5600686|NCT00898677|19350927|P4|Overall Study|Not Treated: Adverse Event|0
5600687|NCT00898677|19350928|P3|Overall Study|Not Treated: Adverse Event|1
5600688|NCT00898677|19350929|P2|Overall Study|Not Treated: Adverse Event|2
5600689|NCT00898677|19350930|P1|Overall Study|Not Treated: Adverse Event|0
5600690|NCT00898677|19350927|P4|Overall Study|Withdrawal by Subject|1
5600691|NCT00898677|19350928|P3|Overall Study|Withdrawal by Subject|0
5600692|NCT00898677|19350929|P2|Overall Study|Withdrawal by Subject|0
5600693|NCT00898677|19350930|P1|Overall Study|Withdrawal by Subject|0
5600694|NCT00898677|19350927|P4|Overall Study|Protocol Violation|0
5600695|NCT00898677|19350928|P3|Overall Study|Protocol Violation|2
5600696|NCT00898677|19350929|P2|Overall Study|Protocol Violation|1
5600697|NCT00898677|19350930|P1|Overall Study|Protocol Violation|1
5600698|NCT00898677|19350927|P4|Overall Study|Lost to Follow-up|0
5600699|NCT00898677|19350928|P3|Overall Study|Lost to Follow-up|2
5600700|NCT00898677|19350929|P2|Overall Study|Lost to Follow-up|0
5600701|NCT00898677|19350930|P1|Overall Study|Lost to Follow-up|0
5600702|NCT00898677|19350927|P4|Overall Study|Adverse Event|0
5600703|NCT00898677|19350928|P3|Overall Study|Adverse Event|1
5600704|NCT00898677|19350929|P2|Overall Study|Adverse Event|0
5600705|NCT00898677|19350930|P1|Overall Study|Adverse Event|0
5600706|NCT00898443|19350968|P2|Overall Study|Withdrawal by Subject|0
5600707|NCT00898443|19350969|P1|Overall Study|Withdrawal by Subject|1
5600708|NCT00897949|19350984|P3|Overall Study|Did not take study drug|4
5600709|NCT00897949|19350985|P2|Overall Study|Did not take study drug|3
5600710|NCT00897949|19350986|P1|Overall Study|Did not take study drug|9
5600711|NCT00897949|19350984|P3|Overall Study|Lack of Migraine Attack|19
5600712|NCT00897949|19350985|P2|Overall Study|Lack of Migraine Attack|30
5600713|NCT00897949|19350986|P1|Overall Study|Lack of Migraine Attack|29
5600714|NCT00897949|19350984|P3|Overall Study|Need for Concom. Med.|1
5600715|NCT00897949|19350985|P2|Overall Study|Need for Concom. Med.|1
5600716|NCT00897949|19350986|P1|Overall Study|Need for Concom. Med.|0
5600717|NCT00897949|19350984|P3|Overall Study|Abnormal Baseline ECG|4
5600718|NCT00897949|19350985|P2|Overall Study|Abnormal Baseline ECG|2
5600719|NCT00897949|19350986|P1|Overall Study|Abnormal Baseline ECG|2
5600720|NCT00897949|19350984|P3|Overall Study|Abnormal Prestudy Labs|4
5600721|NCT00897949|19350985|P2|Overall Study|Abnormal Prestudy Labs|3
5600722|NCT00897949|19350986|P1|Overall Study|Abnormal Prestudy Labs|2
5600723|NCT00897949|19350984|P3|Overall Study|Withdrawal by Subject|17
5600724|NCT00897949|19350985|P2|Overall Study|Withdrawal by Subject|31
5600725|NCT00897949|19350986|P1|Overall Study|Withdrawal by Subject|24
5600726|NCT00897949|19350984|P3|Overall Study|Lost to Follow-up|17
5600727|NCT00897949|19350985|P2|Overall Study|Lost to Follow-up|23
5600728|NCT00897949|19350986|P1|Overall Study|Lost to Follow-up|30
5600729|NCT00897949|19350984|P3|Overall Study|Patient Uncoorperative|1
5600730|NCT00897949|19350985|P2|Overall Study|Patient Uncoorperative|2
5600731|NCT00897949|19350986|P1|Overall Study|Patient Uncoorperative|0
5600732|NCT00897949|19350984|P3|Overall Study|Withdrawal by Subject|0
5600733|NCT00897949|19350985|P2|Overall Study|Withdrawal by Subject|2
5600734|NCT00897949|19350986|P1|Overall Study|Withdrawal by Subject|1
5600735|NCT00897949|19350984|P3|Overall Study|Protocol Violation|1
5600736|NCT00897949|19350985|P2|Overall Study|Protocol Violation|3
5600737|NCT00897949|19350986|P1|Overall Study|Protocol Violation|6
5600738|NCT00897949|19350984|P3|Overall Study|Lost to Follow-up|1
5600739|NCT00897949|19350985|P2|Overall Study|Lost to Follow-up|2
5600740|NCT00897949|19350986|P1|Overall Study|Lost to Follow-up|0
5600741|NCT00897949|19350984|P3|Overall Study|Adverse Event|0
5600742|NCT00897949|19350985|P2|Overall Study|Adverse Event|1
5600743|NCT00897949|19350986|P1|Overall Study|Adverse Event|1
5600744|NCT00897715|19351020|P2|Overall Study|increased risk of infection|0
5600745|NCT00897715|19351021|P1|Overall Study|increased risk of infection|1
5600746|NCT00897715|19351020|P2|Overall Study|Physician Decision|0
5600747|NCT00897715|19351021|P1|Overall Study|Physician Decision|1
5600748|NCT00897715|19351020|P2|Overall Study|Lost to Follow-up|1
5600749|NCT00897715|19351021|P1|Overall Study|Lost to Follow-up|0
5600750|NCT00897390|19351046|P1|Overall Study|Did not Return for the Clinic Visit|2
5600751|NCT00897390|19351046|P1|Overall Study|Personal Reasons|1
5600752|NCT00897390|19351046|P1|Overall Study|No Longer Met Study Criteria|1
5600753|NCT00897390|19351046|P1|Overall Study|Adverse Event|2
5600754|NCT00897104|19351136|P3|Overall Study|Withdrawal by Subject|1
5600755|NCT00897104|19351137|P2|Overall Study|Withdrawal by Subject|0
5600756|NCT00897104|19351138|P1|Overall Study|Withdrawal by Subject|0
5600757|NCT00897104|19351136|P3|Overall Study|Protocol Violation|0
5600758|NCT00897104|19351137|P2|Overall Study|Protocol Violation|0
5600759|NCT00897104|19351138|P1|Overall Study|Protocol Violation|1
5600760|NCT00897104|19351136|P3|Overall Study|Other|0
5600761|NCT00897104|19351137|P2|Overall Study|Other|0
5600762|NCT00897104|19351138|P1|Overall Study|Other|3
5600763|NCT00897104|19351136|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
5600764|NCT00897104|19351137|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
5600765|NCT00897104|19351138|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
5600766|NCT00897104|19351136|P3|Overall Study|Lack of Migraine Attack|1
5600767|NCT00897104|19351137|P2|Overall Study|Lack of Migraine Attack|22
5600768|NCT00897104|19351138|P1|Overall Study|Lack of Migraine Attack|20
5600769|NCT00897104|19351136|P3|Overall Study|Need for Concom. Med.|1
5600770|NCT00897104|19351137|P2|Overall Study|Need for Concom. Med.|1
5600771|NCT00897104|19351138|P1|Overall Study|Need for Concom. Med.|0
5600772|NCT00897104|19351136|P3|Overall Study|Abnormal Baseline ECG|0
5600773|NCT00897104|19351137|P2|Overall Study|Abnormal Baseline ECG|2
5600774|NCT00897104|19351138|P1|Overall Study|Abnormal Baseline ECG|2
5600775|NCT00897104|19351136|P3|Overall Study|Abnormal Prestudy Labs|0
5600776|NCT00897104|19351137|P2|Overall Study|Abnormal Prestudy Labs|0
5600777|NCT00897104|19351138|P1|Overall Study|Abnormal Prestudy Labs|2
5600778|NCT00897104|19351136|P3|Overall Study|Withdrawal by Subject|3
5600779|NCT00897104|19351137|P2|Overall Study|Withdrawal by Subject|27
5600780|NCT00897104|19351138|P1|Overall Study|Withdrawal by Subject|23
5600781|NCT00897104|19351136|P3|Overall Study|Protocol Violation|0
5600782|NCT00897104|19351137|P2|Overall Study|Protocol Violation|1
5600783|NCT00897104|19351138|P1|Overall Study|Protocol Violation|0
5600784|NCT00897104|19351136|P3|Overall Study|Pregnancy|0
5600785|NCT00897104|19351137|P2|Overall Study|Pregnancy|1
5600786|NCT00897104|19351138|P1|Overall Study|Pregnancy|0
5600787|NCT00897104|19351136|P3|Overall Study|Lost to Follow-up|2
5600788|NCT00897104|19351137|P2|Overall Study|Lost to Follow-up|17
5600789|NCT00897104|19351138|P1|Overall Study|Lost to Follow-up|12
5600790|NCT00896649|19351173|P1|Overall Study|technical difficulties|2
5600791|NCT00896649|19351173|P1|Overall Study|missing documentation|1
5600792|NCT00896649|19351173|P1|Overall Study|Pregnancy|1
5600793|NCT00896649|19351173|P1|Overall Study|Physician Decision|1
5600794|NCT00896532|19351186|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600795|NCT00896532|19351187|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
5600796|NCT00896532|19351188|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600797|NCT00896532|19351189|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600798|NCT00896532|19351190|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600799|NCT00896532|19351191|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600800|NCT00896532|19351192|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600801|NCT00896532|19351193|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600802|NCT00896532|19351194|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600803|NCT00896532|19351195|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600804|NCT00896532|19351196|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600805|NCT00896532|19351197|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600806|NCT00896532|19351198|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600807|NCT00896532|19351199|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600808|NCT00896532|19351200|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600809|NCT00896532|19351201|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600810|NCT00896532|19351202|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600811|NCT00896532|19351203|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600812|NCT00896532|19351204|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600813|NCT00896532|19351205|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600814|NCT00896532|19351206|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600815|NCT00896532|19351207|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600816|NCT00896532|19351208|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
5600817|NCT00896532|19351186|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600818|NCT00896532|19351187|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
5600819|NCT00896532|19351188|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600820|NCT00896532|19351189|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600821|NCT00896532|19351190|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600822|NCT00896532|19351191|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600823|NCT00896532|19351192|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600824|NCT00896532|19351193|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600825|NCT00896532|19351194|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600826|NCT00896532|19351195|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600827|NCT00896532|19351196|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600828|NCT00896532|19351197|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600829|NCT00896532|19351198|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600830|NCT00896532|19351199|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600831|NCT00896532|19351200|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600832|NCT00896532|19351201|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600833|NCT00896532|19351202|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600834|NCT00896532|19351203|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600835|NCT00896532|19351204|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600836|NCT00896532|19351205|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600837|NCT00896532|19351206|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600838|NCT00896532|19351207|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600839|NCT00896532|19351208|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
5600840|NCT00896532|19351186|P23|Months 48-72: Follow-on Phase|Death|0
5600841|NCT00896532|19351187|P22|Months 48-72: Follow-on Phase|Death|0
5600842|NCT00896532|19351188|P21|Months 48-72: Follow-on Phase|Death|0
5600843|NCT00896532|19351189|P20|Months 48-72: Follow-on Phase|Death|0
5600844|NCT00896532|19351190|P19|Months 48-72: Follow-on Phase|Death|1
5600845|NCT00896532|19351191|P18|Months 48-72: Follow-on Phase|Death|0
5600846|NCT00896532|19351192|P17|Months 48-72: Follow-on Phase|Death|0
5600847|NCT00896532|19351193|P16|Months 48-72: Follow-on Phase|Death|0
5600848|NCT00896532|19351194|P15|Months 48-72: Follow-on Phase|Death|0
5600849|NCT00896532|19351195|P14|Months 48-72: Follow-on Phase|Death|0
5600850|NCT00896532|19351196|P13|Months 48-72: Follow-on Phase|Death|0
5600851|NCT00896532|19351197|P12|Months 48-72: Follow-on Phase|Death|0
5600852|NCT00896532|19351198|P11|Months 48-72: Follow-on Phase|Death|0
5600853|NCT00896532|19351199|P10|Months 48-72: Follow-on Phase|Death|0
5600854|NCT00896532|19351200|P9|Months 48-72: Follow-on Phase|Death|0
5600855|NCT00896532|19351201|P8|Months 48-72: Follow-on Phase|Death|0
5600856|NCT00896532|19351202|P7|Months 48-72: Follow-on Phase|Death|0
5600857|NCT00896532|19351203|P6|Months 48-72: Follow-on Phase|Death|0
5600858|NCT00896532|19351204|P5|Months 48-72: Follow-on Phase|Death|0
5600859|NCT00896532|19351205|P4|Months 48-72: Follow-on Phase|Death|0
5600860|NCT00896532|19351206|P3|Months 48-72: Follow-on Phase|Death|0
5600861|NCT00896532|19351207|P2|Months 48-72: Follow-on Phase|Death|0
5600862|NCT00896532|19351208|P1|Months 48-72: Follow-on Phase|Death|0
5600863|NCT00896532|19351186|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600864|NCT00896532|19351187|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600865|NCT00896532|19351188|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600866|NCT00896532|19351189|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600867|NCT00896532|19351190|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600868|NCT00896532|19351191|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600869|NCT00896532|19351192|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
5600870|NCT00896532|19351193|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600871|NCT00896532|19351194|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600872|NCT00896532|19351195|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600873|NCT00896532|19351196|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600874|NCT00896532|19351197|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600875|NCT00896532|19351198|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600876|NCT00896532|19351199|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600877|NCT00896532|19351200|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600878|NCT00896532|19351201|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600879|NCT00896532|19351202|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600880|NCT00896532|19351203|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600881|NCT00896532|19351204|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600882|NCT00896532|19351205|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600883|NCT00896532|19351206|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600884|NCT00896532|19351207|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600885|NCT00896532|19351208|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
5600886|NCT00896532|19351186|P23|Months 36-48: Romosozumab Retreatment|Other|0
5600887|NCT00896532|19351187|P22|Months 36-48: Romosozumab Retreatment|Other|0
5600888|NCT00896532|19351188|P21|Months 36-48: Romosozumab Retreatment|Other|0
5600889|NCT00896532|19351189|P20|Months 36-48: Romosozumab Retreatment|Other|0
5600890|NCT00896532|19351190|P19|Months 36-48: Romosozumab Retreatment|Other|0
5600891|NCT00896532|19351191|P18|Months 36-48: Romosozumab Retreatment|Other|1
5600892|NCT00896532|19351192|P17|Months 36-48: Romosozumab Retreatment|Other|0
5600893|NCT00896532|19351193|P16|Months 36-48: Romosozumab Retreatment|Other|0
5600894|NCT00896532|19351194|P15|Months 36-48: Romosozumab Retreatment|Other|0
5600895|NCT00896532|19351195|P14|Months 36-48: Romosozumab Retreatment|Other|0
5600896|NCT00896532|19351196|P13|Months 36-48: Romosozumab Retreatment|Other|0
5600897|NCT00896532|19351197|P12|Months 36-48: Romosozumab Retreatment|Other|0
5600898|NCT00896532|19351198|P11|Months 36-48: Romosozumab Retreatment|Other|0
5600899|NCT00896532|19351199|P10|Months 36-48: Romosozumab Retreatment|Other|0
5600900|NCT00896532|19351200|P9|Months 36-48: Romosozumab Retreatment|Other|0
5600901|NCT00896532|19351201|P8|Months 36-48: Romosozumab Retreatment|Other|0
5600902|NCT00896532|19351202|P7|Months 36-48: Romosozumab Retreatment|Other|0
5600903|NCT00896532|19351203|P6|Months 36-48: Romosozumab Retreatment|Other|0
5600904|NCT00896532|19351204|P5|Months 36-48: Romosozumab Retreatment|Other|0
5600905|NCT00896532|19351205|P4|Months 36-48: Romosozumab Retreatment|Other|0
5600906|NCT00896532|19351206|P3|Months 36-48: Romosozumab Retreatment|Other|0
5600907|NCT00896532|19351207|P2|Months 36-48: Romosozumab Retreatment|Other|0
5600908|NCT00896532|19351208|P1|Months 36-48: Romosozumab Retreatment|Other|0
5600909|NCT00896532|19351186|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600910|NCT00896532|19351187|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600911|NCT00896532|19351188|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600912|NCT00896532|19351189|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600913|NCT00896532|19351190|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600914|NCT00896532|19351191|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600915|NCT00896532|19351192|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
5600916|NCT00896532|19351193|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600917|NCT00896532|19351194|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600918|NCT00896532|19351195|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600919|NCT00896532|19351196|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600920|NCT00896532|19351197|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600921|NCT00896532|19351198|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600922|NCT00896532|19351199|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600923|NCT00896532|19351200|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600924|NCT00896532|19351201|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600925|NCT00896532|19351202|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600926|NCT00896532|19351203|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600927|NCT00896532|19351204|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600928|NCT00896532|19351205|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600929|NCT00896532|19351206|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600930|NCT00896532|19351207|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600931|NCT00896532|19351208|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
5600932|NCT00896532|19351186|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600933|NCT00896532|19351187|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600934|NCT00896532|19351188|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600935|NCT00896532|19351189|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600936|NCT00896532|19351190|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5601371|NCT00895895|19351798|P1|Period 2|Lost to Follow-up|1
5600937|NCT00896532|19351191|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
5600938|NCT00896532|19351192|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
5600939|NCT00896532|19351193|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
5600940|NCT00896532|19351194|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600941|NCT00896532|19351195|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600942|NCT00896532|19351196|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600943|NCT00896532|19351197|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600944|NCT00896532|19351198|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600945|NCT00896532|19351199|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600946|NCT00896532|19351200|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600947|NCT00896532|19351201|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600948|NCT00896532|19351202|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600949|NCT00896532|19351203|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600950|NCT00896532|19351204|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600951|NCT00896532|19351205|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600952|NCT00896532|19351206|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600953|NCT00896532|19351207|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600954|NCT00896532|19351208|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
5600955|NCT00896532|19351186|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600956|NCT00896532|19351187|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600957|NCT00896532|19351188|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600958|NCT00896532|19351189|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600959|NCT00896532|19351190|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600960|NCT00896532|19351191|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600961|NCT00896532|19351192|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
5600962|NCT00896532|19351193|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
5600963|NCT00896532|19351194|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600964|NCT00896532|19351195|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600965|NCT00896532|19351196|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600966|NCT00896532|19351197|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600967|NCT00896532|19351198|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600968|NCT00896532|19351199|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600969|NCT00896532|19351200|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600970|NCT00896532|19351201|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600971|NCT00896532|19351202|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600972|NCT00896532|19351203|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600973|NCT00896532|19351204|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600974|NCT00896532|19351205|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600975|NCT00896532|19351206|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600976|NCT00896532|19351207|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600977|NCT00896532|19351208|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
5600978|NCT00896532|19351186|P23|Months 24-36: Denosumab Extension Phase|Other|0
5600979|NCT00896532|19351187|P22|Months 24-36: Denosumab Extension Phase|Other|0
5600980|NCT00896532|19351188|P21|Months 24-36: Denosumab Extension Phase|Other|0
5600981|NCT00896532|19351189|P20|Months 24-36: Denosumab Extension Phase|Other|0
5600982|NCT00896532|19351190|P19|Months 24-36: Denosumab Extension Phase|Other|0
5600983|NCT00896532|19351191|P18|Months 24-36: Denosumab Extension Phase|Other|0
5600984|NCT00896532|19351192|P17|Months 24-36: Denosumab Extension Phase|Other|0
5600985|NCT00896532|19351193|P16|Months 24-36: Denosumab Extension Phase|Other|0
5600986|NCT00896532|19351194|P15|Months 24-36: Denosumab Extension Phase|Other|0
5600987|NCT00896532|19351195|P14|Months 24-36: Denosumab Extension Phase|Other|1
5600988|NCT00896532|19351196|P13|Months 24-36: Denosumab Extension Phase|Other|2
5600989|NCT00896532|19351197|P12|Months 24-36: Denosumab Extension Phase|Other|2
5600990|NCT00896532|19351198|P11|Months 24-36: Denosumab Extension Phase|Other|1
5600991|NCT00896532|19351199|P10|Months 24-36: Denosumab Extension Phase|Other|0
5600992|NCT00896532|19351200|P9|Months 24-36: Denosumab Extension Phase|Other|0
5600993|NCT00896532|19351201|P8|Months 24-36: Denosumab Extension Phase|Other|0
5600994|NCT00896532|19351202|P7|Months 24-36: Denosumab Extension Phase|Other|0
5600995|NCT00896532|19351203|P6|Months 24-36: Denosumab Extension Phase|Other|0
5600996|NCT00896532|19351204|P5|Months 24-36: Denosumab Extension Phase|Other|0
5600997|NCT00896532|19351205|P4|Months 24-36: Denosumab Extension Phase|Other|0
5600998|NCT00896532|19351206|P3|Months 24-36: Denosumab Extension Phase|Other|0
5600999|NCT00896532|19351207|P2|Months 24-36: Denosumab Extension Phase|Other|0
5601000|NCT00896532|19351208|P1|Months 24-36: Denosumab Extension Phase|Other|0
5601001|NCT00896532|19351186|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601002|NCT00896532|19351187|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601003|NCT00896532|19351188|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601004|NCT00896532|19351189|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601005|NCT00896532|19351190|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601006|NCT00896532|19351191|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601007|NCT00896532|19351192|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601008|NCT00896532|19351193|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601372|NCT00895895|19351794|P5|Period 2|investigator request|0
5601009|NCT00896532|19351194|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601010|NCT00896532|19351195|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
5601011|NCT00896532|19351196|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
5601012|NCT00896532|19351197|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601013|NCT00896532|19351198|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601014|NCT00896532|19351199|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601015|NCT00896532|19351200|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601016|NCT00896532|19351201|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601017|NCT00896532|19351202|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601018|NCT00896532|19351203|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601019|NCT00896532|19351204|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601020|NCT00896532|19351205|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601021|NCT00896532|19351206|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601022|NCT00896532|19351207|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601023|NCT00896532|19351208|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
5601024|NCT00896532|19351186|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601025|NCT00896532|19351187|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601026|NCT00896532|19351188|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601027|NCT00896532|19351189|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601028|NCT00896532|19351190|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601029|NCT00896532|19351191|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601030|NCT00896532|19351192|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601031|NCT00896532|19351193|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601032|NCT00896532|19351194|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601033|NCT00896532|19351195|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601034|NCT00896532|19351196|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
5601035|NCT00896532|19351197|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601036|NCT00896532|19351198|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
5601037|NCT00896532|19351199|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601038|NCT00896532|19351200|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601039|NCT00896532|19351201|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601040|NCT00896532|19351202|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601041|NCT00896532|19351203|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601042|NCT00896532|19351204|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601043|NCT00896532|19351205|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601044|NCT00896532|19351206|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601045|NCT00896532|19351207|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601046|NCT00896532|19351208|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
5601047|NCT00896532|19351186|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601048|NCT00896532|19351187|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601049|NCT00896532|19351188|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601050|NCT00896532|19351189|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601051|NCT00896532|19351190|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601052|NCT00896532|19351191|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601053|NCT00896532|19351192|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601054|NCT00896532|19351193|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601055|NCT00896532|19351194|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601056|NCT00896532|19351195|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601057|NCT00896532|19351196|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
5601058|NCT00896532|19351197|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601059|NCT00896532|19351198|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601060|NCT00896532|19351199|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601061|NCT00896532|19351200|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601062|NCT00896532|19351201|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601063|NCT00896532|19351202|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601064|NCT00896532|19351203|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601065|NCT00896532|19351204|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601066|NCT00896532|19351205|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601067|NCT00896532|19351206|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601068|NCT00896532|19351207|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601069|NCT00896532|19351208|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
5601070|NCT00896532|19351186|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601071|NCT00896532|19351187|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601072|NCT00896532|19351188|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601073|NCT00896532|19351189|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601074|NCT00896532|19351190|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601075|NCT00896532|19351191|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601076|NCT00896532|19351192|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601077|NCT00896532|19351193|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601078|NCT00896532|19351194|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601079|NCT00896532|19351195|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601080|NCT00896532|19351196|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601081|NCT00896532|19351197|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601082|NCT00896532|19351198|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601083|NCT00896532|19351199|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601084|NCT00896532|19351200|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
5601085|NCT00896532|19351201|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601086|NCT00896532|19351202|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601087|NCT00896532|19351203|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601088|NCT00896532|19351204|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601089|NCT00896532|19351205|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601090|NCT00896532|19351206|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601091|NCT00896532|19351207|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601092|NCT00896532|19351208|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
5601093|NCT00896532|19351186|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
5601094|NCT00896532|19351187|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
5601095|NCT00896532|19351188|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
5601096|NCT00896532|19351189|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
5601097|NCT00896532|19351190|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
5601098|NCT00896532|19351191|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
5601099|NCT00896532|19351192|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
5601100|NCT00896532|19351193|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
5601101|NCT00896532|19351194|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
5601102|NCT00896532|19351195|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
5601103|NCT00896532|19351196|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
5601104|NCT00896532|19351197|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
5601105|NCT00896532|19351198|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
5601106|NCT00896532|19351199|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
5601107|NCT00896532|19351200|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
5601108|NCT00896532|19351201|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
5601109|NCT00896532|19351202|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
5601110|NCT00896532|19351203|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
5601111|NCT00896532|19351204|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
5601112|NCT00896532|19351205|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
5601113|NCT00896532|19351206|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
5601114|NCT00896532|19351207|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
5601115|NCT00896532|19351208|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
5601116|NCT00896532|19351186|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601117|NCT00896532|19351187|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601118|NCT00896532|19351188|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601119|NCT00896532|19351189|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601120|NCT00896532|19351190|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601121|NCT00896532|19351191|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601122|NCT00896532|19351192|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601123|NCT00896532|19351193|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601124|NCT00896532|19351194|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601125|NCT00896532|19351195|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601126|NCT00896532|19351196|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601127|NCT00896532|19351197|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601128|NCT00896532|19351198|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601129|NCT00896532|19351199|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601130|NCT00896532|19351200|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601131|NCT00896532|19351201|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601132|NCT00896532|19351202|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601133|NCT00896532|19351203|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601134|NCT00896532|19351204|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601135|NCT00896532|19351205|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
5601136|NCT00896532|19351206|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601137|NCT00896532|19351207|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601138|NCT00896532|19351208|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
5601139|NCT00896532|19351186|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601140|NCT00896532|19351187|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601141|NCT00896532|19351188|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601142|NCT00896532|19351189|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601143|NCT00896532|19351190|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601144|NCT00896532|19351191|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601145|NCT00896532|19351192|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601146|NCT00896532|19351193|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601147|NCT00896532|19351194|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601148|NCT00896532|19351195|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601149|NCT00896532|19351196|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601150|NCT00896532|19351197|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601151|NCT00896532|19351198|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601152|NCT00896532|19351199|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601153|NCT00896532|19351200|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601154|NCT00896532|19351201|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601155|NCT00896532|19351202|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601156|NCT00896532|19351203|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601157|NCT00896532|19351204|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601158|NCT00896532|19351205|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601159|NCT00896532|19351206|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
5601160|NCT00896532|19351207|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601161|NCT00896532|19351208|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
5601162|NCT00896532|19351186|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601163|NCT00896532|19351187|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601164|NCT00896532|19351188|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601165|NCT00896532|19351189|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601166|NCT00896532|19351190|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601167|NCT00896532|19351191|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601168|NCT00896532|19351192|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601169|NCT00896532|19351193|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601170|NCT00896532|19351194|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601171|NCT00896532|19351195|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601172|NCT00896532|19351196|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601173|NCT00896532|19351197|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601174|NCT00896532|19351198|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601175|NCT00896532|19351199|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601176|NCT00896532|19351200|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601177|NCT00896532|19351201|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601178|NCT00896532|19351202|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601179|NCT00896532|19351203|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601180|NCT00896532|19351204|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601181|NCT00896532|19351205|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601182|NCT00896532|19351206|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
5601183|NCT00896532|19351207|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601184|NCT00896532|19351208|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
5601185|NCT00896532|19351186|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
5601186|NCT00896532|19351187|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
5601187|NCT00896532|19351188|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
5601188|NCT00896532|19351189|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
5601189|NCT00896532|19351190|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
5601190|NCT00896532|19351191|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
5601191|NCT00896532|19351192|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
5601192|NCT00896532|19351193|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
5601193|NCT00896532|19351194|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
5601194|NCT00896532|19351195|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
5601195|NCT00896532|19351196|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
5601196|NCT00896532|19351197|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
5601197|NCT00896532|19351198|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
5601198|NCT00896532|19351199|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
5601199|NCT00896532|19351200|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
5601200|NCT00896532|19351201|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
5601201|NCT00896532|19351202|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
5601202|NCT00896532|19351203|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
5601203|NCT00896532|19351204|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
5601204|NCT00896532|19351205|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
5601205|NCT00896532|19351206|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
5601206|NCT00896532|19351207|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
5601207|NCT00896532|19351208|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
5601208|NCT00896532|19351186|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601209|NCT00896532|19351187|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601210|NCT00896532|19351188|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601211|NCT00896532|19351189|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601212|NCT00896532|19351190|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601213|NCT00896532|19351191|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601214|NCT00896532|19351192|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601215|NCT00896532|19351193|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601216|NCT00896532|19351194|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601217|NCT00896532|19351195|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601218|NCT00896532|19351196|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601219|NCT00896532|19351197|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601220|NCT00896532|19351198|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601221|NCT00896532|19351199|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601222|NCT00896532|19351200|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601223|NCT00896532|19351201|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601224|NCT00896532|19351202|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601225|NCT00896532|19351203|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601226|NCT00896532|19351204|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
5601227|NCT00896532|19351205|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601228|NCT00896532|19351206|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
5601229|NCT00896532|19351207|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601230|NCT00896532|19351208|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
5601231|NCT00896532|19351186|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601232|NCT00896532|19351187|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601233|NCT00896532|19351188|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601234|NCT00896532|19351189|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601235|NCT00896532|19351190|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601236|NCT00896532|19351191|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601237|NCT00896532|19351192|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601238|NCT00896532|19351193|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601239|NCT00896532|19351194|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601240|NCT00896532|19351195|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601241|NCT00896532|19351196|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601242|NCT00896532|19351197|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601243|NCT00896532|19351198|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601244|NCT00896532|19351199|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601245|NCT00896532|19351200|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
5601246|NCT00896532|19351201|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
5601247|NCT00896532|19351202|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
5601248|NCT00896532|19351203|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
5601249|NCT00896532|19351204|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
5601250|NCT00896532|19351205|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
5601251|NCT00896532|19351206|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
5601252|NCT00896532|19351207|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
5601253|NCT00896532|19351208|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
5601254|NCT00896532|19351186|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601255|NCT00896532|19351187|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601256|NCT00896532|19351188|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601257|NCT00896532|19351189|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601258|NCT00896532|19351190|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601259|NCT00896532|19351191|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601260|NCT00896532|19351192|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601261|NCT00896532|19351193|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601262|NCT00896532|19351194|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601263|NCT00896532|19351195|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601264|NCT00896532|19351196|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601265|NCT00896532|19351197|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601266|NCT00896532|19351198|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601267|NCT00896532|19351199|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601268|NCT00896532|19351200|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601269|NCT00896532|19351201|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
5601270|NCT00896532|19351202|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5601271|NCT00896532|19351203|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5601272|NCT00896532|19351204|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5601273|NCT00896532|19351205|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
5601274|NCT00896532|19351206|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5601275|NCT00896532|19351207|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
5601276|NCT00896532|19351208|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
5601277|NCT00896532|19351186|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601278|NCT00896532|19351187|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601279|NCT00896532|19351188|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601280|NCT00896532|19351189|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601281|NCT00896532|19351190|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601282|NCT00896532|19351191|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601283|NCT00896532|19351192|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601284|NCT00896532|19351193|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601285|NCT00896532|19351194|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601286|NCT00896532|19351195|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601287|NCT00896532|19351196|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601288|NCT00896532|19351197|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601289|NCT00896532|19351198|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601290|NCT00896532|19351199|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601291|NCT00896532|19351200|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601292|NCT00896532|19351201|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601293|NCT00896532|19351202|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601294|NCT00896532|19351203|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
5601295|NCT00896532|19351204|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601296|NCT00896532|19351205|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
5601297|NCT00896532|19351206|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601298|NCT00896532|19351207|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601299|NCT00896532|19351208|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
5601300|NCT00896480|19351335|P1|Overall Study|Disease progression/recurrence|21
5601301|NCT00896454|19351383|P1|Overall Study|Withdrawal by Subject|1
5601302|NCT00896454|19351383|P1|Overall Study|Ongoing in study|2
5601303|NCT00896454|19351383|P1|Overall Study|Requirement for alternative therapy|3
5601304|NCT00896454|19351383|P1|Overall Study|Other|4
5601305|NCT00896454|19351383|P1|Overall Study|Disease Progression|5
5601306|NCT00896454|19351383|P1|Overall Study|Adverse Event|8
5601307|NCT00896454|19351383|P1|Overall Study|Death|10
5601308|NCT00896363|19351422|P3|Overall Study|Withdrawal by Subject|5
5601309|NCT00896363|19351423|P2|Overall Study|Withdrawal by Subject|5
5601310|NCT00896363|19351424|P1|Overall Study|Withdrawal by Subject|3
5601311|NCT00896363|19351422|P3|Overall Study|Lack of Efficacy|1
5601312|NCT00896363|19351423|P2|Overall Study|Lack of Efficacy|2
5601313|NCT00896363|19351424|P1|Overall Study|Lack of Efficacy|0
5601314|NCT00896363|19351422|P3|Overall Study|Adverse Event|2
5601315|NCT00896363|19351423|P2|Overall Study|Adverse Event|4
5601316|NCT00896363|19351424|P1|Overall Study|Adverse Event|3
5601317|NCT00896337|19351476|P1|Overall Study|Lost to Follow-up|11
5601318|NCT00896337|19351476|P1|Overall Study|Withdrawal by Subject|7
5601319|NCT00896337|19351476|P1|Overall Study|Death|7
5601320|NCT00896233|19351558|P1|Overall Study|Claustrophobia during MRI|1
5601321|NCT00896168|19351571|P2|Overall Study|Other|1
5601322|NCT00896168|19351572|P1|Overall Study|Other|1
5601323|NCT00896168|19351571|P2|Overall Study|Lost to Follow-up|1
5601324|NCT00896168|19351572|P1|Overall Study|Lost to Follow-up|1
5601325|NCT00896168|19351571|P2|Overall Study|Treatment failure|10
5601326|NCT00896168|19351572|P1|Overall Study|Treatment failure|8
5601327|NCT00896168|19351571|P2|Overall Study|Adverse Event|7
5601328|NCT00896168|19351572|P1|Overall Study|Adverse Event|4
5601329|NCT00896051|19351633|P2|Overall Study|Other|1
5601330|NCT00896051|19351634|P1|Overall Study|Other|1
5601331|NCT00896051|19351633|P2|Overall Study|Subject noncompliant|3
5601332|NCT00896051|19351634|P1|Overall Study|Subject noncompliant|1
5601333|NCT00896051|19351633|P2|Overall Study|Withdrawal by Subject|2
5601334|NCT00896051|19351634|P1|Overall Study|Withdrawal by Subject|3
5601335|NCT00896051|19351633|P2|Overall Study|Lost to Follow-up|2
5601336|NCT00896051|19351634|P1|Overall Study|Lost to Follow-up|3
5601337|NCT00896051|19351633|P2|Overall Study|Adverse Event|1
5601338|NCT00896051|19351634|P1|Overall Study|Adverse Event|2
5601339|NCT00895947|19351742|P2|Overall Study|Withdrawal by Subject|0
5601340|NCT00895947|19351743|P1|Overall Study|Withdrawal by Subject|2
5601341|NCT00895947|19351742|P2|Overall Study|Protocol Violation|2
5601342|NCT00895947|19351743|P1|Overall Study|Protocol Violation|4
5601343|NCT00895947|19351742|P2|Overall Study|Lost to Follow-up|4
5601344|NCT00895947|19351743|P1|Overall Study|Lost to Follow-up|3
5601345|NCT00895947|19351742|P2|Overall Study|Adverse Event|4
5601346|NCT00895947|19351743|P1|Overall Study|Adverse Event|3
5601347|NCT00895895|19351794|P5|Period 2|unsatisfactory response-efficacy|0
5601348|NCT00895895|19351795|P4|Period 2|unsatisfactory response-efficacy|0
5601349|NCT00895895|19351796|P3|Period 2|unsatisfactory response-efficacy|0
5601350|NCT00895895|19351797|P2|Period 2|unsatisfactory response-efficacy|1
5601351|NCT00895895|19351798|P1|Period 2|unsatisfactory response-efficacy|2
5601352|NCT00895895|19351794|P5|Period 2|Withdrawal by Subject|5
5601353|NCT00895895|19351795|P4|Period 2|Withdrawal by Subject|3
5601354|NCT00895895|19351796|P3|Period 2|Withdrawal by Subject|0
5601355|NCT00895895|19351797|P2|Period 2|Withdrawal by Subject|2
5601356|NCT00895895|19351798|P1|Period 2|Withdrawal by Subject|0
5601357|NCT00895895|19351794|P5|Period 2|Protocol Violation|1
5601358|NCT00895895|19351795|P4|Period 2|Protocol Violation|1
5601359|NCT00895895|19351796|P3|Period 2|Protocol Violation|1
5601360|NCT00895895|19351797|P2|Period 2|Protocol Violation|0
5601361|NCT00895895|19351798|P1|Period 2|Protocol Violation|1
5601362|NCT00895895|19351794|P5|Period 2|Other|1
5601363|NCT00895895|19351795|P4|Period 2|Other|1
5601364|NCT00895895|19351796|P3|Period 2|Other|3
5601365|NCT00895895|19351797|P2|Period 2|Other|1
5601366|NCT00895895|19351798|P1|Period 2|Other|1
5601367|NCT00895895|19351794|P5|Period 2|Lost to Follow-up|0
5601368|NCT00895895|19351795|P4|Period 2|Lost to Follow-up|1
5601369|NCT00895895|19351796|P3|Period 2|Lost to Follow-up|1
5601370|NCT00895895|19351797|P2|Period 2|Lost to Follow-up|2
5601373|NCT00895895|19351795|P4|Period 2|investigator request|0
5601374|NCT00895895|19351796|P3|Period 2|investigator request|0
5601375|NCT00895895|19351797|P2|Period 2|investigator request|0
5601376|NCT00895895|19351798|P1|Period 2|investigator request|2
5601377|NCT00895895|19351794|P5|Period 2|failed to return|0
5601378|NCT00895895|19351795|P4|Period 2|failed to return|0
5601379|NCT00895895|19351796|P3|Period 2|failed to return|0
5601380|NCT00895895|19351797|P2|Period 2|failed to return|0
5601381|NCT00895895|19351798|P1|Period 2|failed to return|2
5601382|NCT00895895|19351794|P5|Period 2|discontinued by sponsor|37
5601383|NCT00895895|19351795|P4|Period 2|discontinued by sponsor|46
5601384|NCT00895895|19351796|P3|Period 2|discontinued by sponsor|38
5601385|NCT00895895|19351797|P2|Period 2|discontinued by sponsor|44
5601386|NCT00895895|19351798|P1|Period 2|discontinued by sponsor|44
5601387|NCT00895895|19351794|P5|Period 2|Death|0
5601388|NCT00895895|19351795|P4|Period 2|Death|0
5601389|NCT00895895|19351796|P3|Period 2|Death|1
5601390|NCT00895895|19351797|P2|Period 2|Death|0
5601391|NCT00895895|19351798|P1|Period 2|Death|0
5601392|NCT00895895|19351794|P5|Period 2|Adverse Event|5
5601393|NCT00895895|19351795|P4|Period 2|Adverse Event|2
5601394|NCT00895895|19351796|P3|Period 2|Adverse Event|5
5601395|NCT00895895|19351797|P2|Period 2|Adverse Event|3
5601396|NCT00895895|19351798|P1|Period 2|Adverse Event|3
5601397|NCT00895895|19351794|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
5601398|NCT00895895|19351795|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
5601399|NCT00895895|19351796|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
5601400|NCT00895895|19351797|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
5601401|NCT00895895|19351798|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
5601402|NCT00895895|19351794|P5|After Period 1, Prior to Period 2|Protocol Violation|1
5601403|NCT00895895|19351795|P4|After Period 1, Prior to Period 2|Protocol Violation|0
5601404|NCT00895895|19351796|P3|After Period 1, Prior to Period 2|Protocol Violation|0
5601405|NCT00895895|19351797|P2|After Period 1, Prior to Period 2|Protocol Violation|0
5601406|NCT00895895|19351798|P1|After Period 1, Prior to Period 2|Protocol Violation|0
5601407|NCT00895895|19351794|P5|After Period 1, Prior to Period 2|Other|0
5601408|NCT00895895|19351795|P4|After Period 1, Prior to Period 2|Other|0
5601409|NCT00895895|19351796|P3|After Period 1, Prior to Period 2|Other|1
5601410|NCT00895895|19351797|P2|After Period 1, Prior to Period 2|Other|0
5601411|NCT00895895|19351798|P1|After Period 1, Prior to Period 2|Other|0
5601412|NCT00895895|19351794|P5|After Period 1, Prior to Period 2|Adverse Event|0
5601413|NCT00895895|19351795|P4|After Period 1, Prior to Period 2|Adverse Event|0
5601414|NCT00895895|19351796|P3|After Period 1, Prior to Period 2|Adverse Event|1
5601415|NCT00895895|19351797|P2|After Period 1, Prior to Period 2|Adverse Event|0
5601416|NCT00895895|19351798|P1|After Period 1, Prior to Period 2|Adverse Event|0
5601417|NCT00895895|19351794|P5|Period 1|randomized and not treated|2
5601418|NCT00895895|19351795|P4|Period 1|randomized and not treated|1
5601419|NCT00895895|19351796|P3|Period 1|randomized and not treated|1
5601420|NCT00895895|19351797|P2|Period 1|randomized and not treated|3
5601421|NCT00895895|19351798|P1|Period 1|randomized and not treated|1
5601422|NCT00895895|19351794|P5|Period 1|unsatisfactory response-efficacy|0
5601423|NCT00895895|19351795|P4|Period 1|unsatisfactory response-efficacy|0
5601424|NCT00895895|19351796|P3|Period 1|unsatisfactory response-efficacy|0
5601425|NCT00895895|19351797|P2|Period 1|unsatisfactory response-efficacy|0
5601426|NCT00895895|19351798|P1|Period 1|unsatisfactory response-efficacy|2
5601427|NCT00895895|19351794|P5|Period 1|Withdrawal by Subject|4
5601428|NCT00895895|19351795|P4|Period 1|Withdrawal by Subject|2
5601429|NCT00895895|19351796|P3|Period 1|Withdrawal by Subject|8
5601430|NCT00895895|19351797|P2|Period 1|Withdrawal by Subject|6
5601431|NCT00895895|19351798|P1|Period 1|Withdrawal by Subject|6
5601432|NCT00895895|19351794|P5|Period 1|Protocol Violation|0
5601433|NCT00895895|19351795|P4|Period 1|Protocol Violation|0
5601434|NCT00895895|19351796|P3|Period 1|Protocol Violation|0
5601435|NCT00895895|19351797|P2|Period 1|Protocol Violation|1
5601436|NCT00895895|19351798|P1|Period 1|Protocol Violation|0
5601437|NCT00895895|19351794|P5|Period 1|Other|1
5601438|NCT00895895|19351795|P4|Period 1|Other|1
5601439|NCT00895895|19351796|P3|Period 1|Other|1
5601440|NCT00895895|19351797|P2|Period 1|Other|2
5601441|NCT00895895|19351798|P1|Period 1|Other|1
5601442|NCT00895895|19351794|P5|Period 1|Lost to Follow-up|3
5601443|NCT00895895|19351795|P4|Period 1|Lost to Follow-up|2
5601444|NCT00895895|19351796|P3|Period 1|Lost to Follow-up|3
5601445|NCT00895895|19351797|P2|Period 1|Lost to Follow-up|1
5601446|NCT00895895|19351798|P1|Period 1|Lost to Follow-up|2
5601447|NCT00895895|19351794|P5|Period 1|investigator request|0
5601448|NCT00895895|19351795|P4|Period 1|investigator request|0
5601449|NCT00895895|19351796|P3|Period 1|investigator request|0
5601450|NCT00895895|19351797|P2|Period 1|investigator request|1
5601451|NCT00895895|19351798|P1|Period 1|investigator request|0
5601452|NCT00895895|19351794|P5|Period 1|failed to return|1
5601453|NCT00895895|19351795|P4|Period 1|failed to return|0
5601454|NCT00895895|19351796|P3|Period 1|failed to return|1
5601455|NCT00895895|19351797|P2|Period 1|failed to return|0
5601456|NCT00895895|19351798|P1|Period 1|failed to return|0
5601457|NCT00895895|19351794|P5|Period 1|discontinued by sponsor|1
5601458|NCT00895895|19351795|P4|Period 1|discontinued by sponsor|1
5601459|NCT00895895|19351796|P3|Period 1|discontinued by sponsor|2
5601460|NCT00895895|19351797|P2|Period 1|discontinued by sponsor|1
5601461|NCT00895895|19351798|P1|Period 1|discontinued by sponsor|2
5601462|NCT00895895|19351794|P5|Period 1|Death|1
5601463|NCT00895895|19351795|P4|Period 1|Death|0
5601464|NCT00895895|19351796|P3|Period 1|Death|0
5601465|NCT00895895|19351797|P2|Period 1|Death|0
5601466|NCT00895895|19351798|P1|Period 1|Death|0
5601467|NCT00895895|19351794|P5|Period 1|Adverse Event|7
5601468|NCT00895895|19351795|P4|Period 1|Adverse Event|6
5601469|NCT00895895|19351796|P3|Period 1|Adverse Event|4
5601470|NCT00895895|19351797|P2|Period 1|Adverse Event|6
5601471|NCT00895895|19351798|P1|Period 1|Adverse Event|7
5601472|NCT00895843|19351912|P2|Overall Study|Protocol Violation|12
5601473|NCT00895843|19351913|P1|Overall Study|Protocol Violation|12
5601474|NCT00895661|19351960|P1|Overall Study|reason unknown|2
5601475|NCT00895661|19351960|P1|Overall Study|Death|1
5601476|NCT00895622|19351970|P3|Overall Study|Protocol Violation|4
5601477|NCT00895622|19351971|P2|Overall Study|Protocol Violation|4
5601478|NCT00895622|19351972|P1|Overall Study|Protocol Violation|5
5601479|NCT00895583|19351999|P2|Overall Study|Other|1
5601480|NCT00895583|19352000|P1|Overall Study|Other|0
5601481|NCT00895583|19351999|P2|Overall Study|Lack of Efficacy|0
5601482|NCT00895583|19352000|P1|Overall Study|Lack of Efficacy|5
5601483|NCT00895583|19351999|P2|Overall Study|Withdrawal by Subject|2
5601484|NCT00895583|19352000|P1|Overall Study|Withdrawal by Subject|4
5601485|NCT00895583|19351999|P2|Overall Study|Protocol Violation|0
5601486|NCT00895583|19352000|P1|Overall Study|Protocol Violation|1
5601487|NCT00895583|19351999|P2|Overall Study|Lost to Follow-up|3
5601488|NCT00895583|19352000|P1|Overall Study|Lost to Follow-up|1
5601489|NCT00895583|19351999|P2|Overall Study|Physician Decision|1
5601490|NCT00895583|19352000|P1|Overall Study|Physician Decision|3
5601491|NCT00895583|19351999|P2|Overall Study|Death|1
5601492|NCT00895583|19352000|P1|Overall Study|Death|2
5601493|NCT00895583|19351999|P2|Overall Study|Adverse Event|4
5601494|NCT00895583|19352000|P1|Overall Study|Adverse Event|28
5601495|NCT00895453|19352090|P3|Overall Study|Lost to Follow-up|23
5601496|NCT00895453|19352091|P2|Overall Study|Lost to Follow-up|25
5601497|NCT00895453|19352092|P1|Overall Study|Lost to Follow-up|25
5601498|NCT00895414|19352100|P2|First Intervention (14 Days)|Physician Decision|1
5601499|NCT00895414|19352101|P1|First Intervention (14 Days)|Physician Decision|0
5601500|NCT00895414|19352100|P2|First Intervention (14 Days)|Withdrawal by Subject|0
5601501|NCT00895414|19352101|P1|First Intervention (14 Days)|Withdrawal by Subject|1
5601502|NCT00895310|19352111|P1|Overall Study|Withdrawal by Subject|1
5601503|NCT00895245|19352127|P1|Overall Study|Lack of Efficacy|6
5601504|NCT00895154|19352205|P2|Overall Study|Withdrawal by Subject|1
5601505|NCT00895154|19352206|P1|Overall Study|Withdrawal by Subject|0
5601506|NCT00895154|19352205|P2|Overall Study|Lost to Follow-up|1
5601507|NCT00895154|19352206|P1|Overall Study|Lost to Follow-up|1
5601508|NCT00895037|19352241|P3|Overall Study|Death|1
5601509|NCT00895037|19352242|P2|Overall Study|Death|2
5601510|NCT00895037|19352243|P1|Overall Study|Death|0
5601511|NCT00895011|19352274|P3|Overall Study|schedule conflict|0
5601512|NCT00895011|19352275|P2|Overall Study|schedule conflict|0
5601513|NCT00895011|19352276|P1|Overall Study|schedule conflict|1
5601514|NCT00895011|19352274|P3|Overall Study|Adverse Event|2
5601515|NCT00895011|19352275|P2|Overall Study|Adverse Event|2
5601516|NCT00895011|19352276|P1|Overall Study|Adverse Event|1
5601517|NCT00895011|19352274|P3|Overall Study|Protocol Violation|3
5601518|NCT00895011|19352275|P2|Overall Study|Protocol Violation|1
5601519|NCT00895011|19352276|P1|Overall Study|Protocol Violation|3
5601520|NCT00895011|19352274|P3|Overall Study|Lost to Follow-up|1
5601521|NCT00895011|19352275|P2|Overall Study|Lost to Follow-up|4
5601522|NCT00895011|19352276|P1|Overall Study|Lost to Follow-up|5
5601523|NCT00895011|19352274|P3|Overall Study|Withdrawal by Subject|2
5601524|NCT00895011|19352275|P2|Overall Study|Withdrawal by Subject|7
5601525|NCT00895011|19352276|P1|Overall Study|Withdrawal by Subject|14
5601526|NCT00894933|19352290|P1|Overall Study|Did not meeting incl/excl criteria|1
5601527|NCT00894933|19352290|P1|Overall Study|Cancelled Procedure|1
5601528|NCT00894933|19352290|P1|Overall Study|Lost to Follow-up|2
5601529|NCT00894803|19352308|P2|Overall Study|Lost to Follow-up|1
5601530|NCT00894803|19352309|P1|Overall Study|Lost to Follow-up|0
5601531|NCT00894803|19352308|P2|Overall Study|Death|4
5601532|NCT00894803|19352309|P1|Overall Study|Death|20
5601533|NCT00894790|19352345|P2|Overall Study|Did not meet entrance criteria|0
5601534|NCT00894790|19352346|P1|Overall Study|Did not meet entrance criteria|1
5601535|NCT00894790|19352345|P2|Overall Study|Lost to Follow-up|1
5601536|NCT00894790|19352346|P1|Overall Study|Lost to Follow-up|0
5601537|NCT00894790|19352345|P2|Overall Study|Protocol Violation|1
5601538|NCT00894790|19352346|P1|Overall Study|Protocol Violation|0
5601539|NCT00894686|19352388|P1|Overall Study|Other|5
5601540|NCT00894686|19352388|P1|Overall Study|Physician Decision|1
5601541|NCT00894686|19352388|P1|Overall Study|Withdrawal by Subject|50
5601542|NCT00894647|19352412|P2|Overall Study|Other, not due to AE|2
5601543|NCT00894647|19352413|P1|Overall Study|Other, not due to AE|1
5601544|NCT00894647|19352412|P2|Overall Study|Non-compliance with study procedures|2
5601545|NCT00894647|19352413|P1|Overall Study|Non-compliance with study procedures|0
5601546|NCT00894647|19352412|P2|Overall Study|Lost to Follow-up|2
5601547|NCT00894647|19352413|P1|Overall Study|Lost to Follow-up|0
5601548|NCT00894647|19352412|P2|Overall Study|Withdrawal by Subject|4
5601549|NCT00894647|19352413|P1|Overall Study|Withdrawal by Subject|4
5601550|NCT00894647|19352412|P2|Overall Study|Adverse Event|4
5601551|NCT00894647|19352413|P1|Overall Study|Adverse Event|5
5601552|NCT00894556|19352426|P4|Treatment Phase|Lack of Qualifying Event|0
5601553|NCT00894556|19352427|P3|Treatment Phase|Lack of Qualifying Event|0
5601554|NCT00894556|19352428|P2|Treatment Phase|Lack of Qualifying Event|1
5601555|NCT00894556|19352429|P1|Treatment Phase|Lack of Qualifying Event|2
5601556|NCT00894556|19352426|P4|Treatment Phase|Lost to Follow-up|0
5601557|NCT00894556|19352427|P3|Treatment Phase|Lost to Follow-up|1
5601558|NCT00894556|19352428|P2|Treatment Phase|Lost to Follow-up|3
5601559|NCT00894556|19352429|P1|Treatment Phase|Lost to Follow-up|2
5601560|NCT00894556|19352426|P4|Baseline Phase|Did not meet Randomization Criteria|85
5601561|NCT00894556|19352427|P3|Baseline Phase|Did not meet Randomization Criteria|0
5601562|NCT00894556|19352428|P2|Baseline Phase|Did not meet Randomization Criteria|0
5601563|NCT00894556|19352429|P1|Baseline Phase|Did not meet Randomization Criteria|0
5601564|NCT00894543|19352440|P2|Week 4 to Week 8|No diary or lost or withdrew|2
5601565|NCT00894543|19352441|P1|Week 4 to Week 8|No diary or lost or withdrew|4
5601566|NCT00894543|19352440|P2|Baseline to Week 4|No diary or lost or withdrew|2
5601567|NCT00894543|19352441|P1|Baseline to Week 4|No diary or lost or withdrew|3
5601568|NCT00894413|19352507|P2|Overall Study|Withdrawal by Subject|4
5601569|NCT00894413|19352508|P1|Overall Study|Withdrawal by Subject|0
5601570|NCT00894413|19352507|P2|Overall Study|Adverse Event|2
5601571|NCT00894413|19352508|P1|Overall Study|Adverse Event|0
5601572|NCT00894413|19352507|P2|Overall Study|Physician Decision|2
5601573|NCT00894413|19352508|P1|Overall Study|Physician Decision|0
5601574|NCT00894387|19352516|P2|Overall Study|GCP non-compliance|2
5601575|NCT00894387|19352517|P1|Overall Study|GCP non-compliance|0
5601576|NCT00894387|19352516|P2|Overall Study|Mis-randomized|9
5601577|NCT00894387|19352517|P1|Overall Study|Mis-randomized|13
5601578|NCT00894387|19352516|P2|Overall Study|Other (Missing)|3
5601579|NCT00894387|19352517|P1|Overall Study|Other (Missing)|5
5601580|NCT00894387|19352516|P2|Overall Study|Patient's request|30
5601581|NCT00894387|19352517|P1|Overall Study|Patient's request|25
5601582|NCT00894387|19352516|P2|Overall Study|Protocol Deviation|0
5601583|NCT00894387|19352517|P1|Overall Study|Protocol Deviation|4
5601584|NCT00894387|19352516|P2|Overall Study|Death|76
5601585|NCT00894387|19352517|P1|Overall Study|Death|77
5601586|NCT00894387|19352516|P2|Overall Study|Administrative problems|2
5601587|NCT00894387|19352517|P1|Overall Study|Administrative problems|2
5601588|NCT00894387|19352516|P2|Overall Study|Lost to Follow-up|5
5601589|NCT00894387|19352517|P1|Overall Study|Lost to Follow-up|3
5601590|NCT00894387|19352516|P2|Overall Study|Unsatisfactory therapeutic effect|1
5601591|NCT00894387|19352517|P1|Overall Study|Unsatisfactory therapeutic effect|0
5601592|NCT00894387|19352516|P2|Overall Study|Abnormal Laboratory values|2
5601593|NCT00894387|19352517|P1|Overall Study|Abnormal Laboratory values|2
5601594|NCT00894387|19352516|P2|Overall Study|Adverse Event|45
5601595|NCT00894387|19352517|P1|Overall Study|Adverse Event|44
5601596|NCT00894361|19352537|P2|Overall Study|deaths and less than 2 years followup|64
5601597|NCT00894361|19352538|P1|Overall Study|deaths and less than 2 years followup|24
5601598|NCT00894322|19352549|P3|Overall Study|Withdrawal by Subject|0
5601599|NCT00894322|19352550|P2|Overall Study|Withdrawal by Subject|0
5601600|NCT00894322|19352551|P1|Overall Study|Withdrawal by Subject|1
5601601|NCT00894166|19352602|P8|Overall Study|Death|0
5601602|NCT00894166|19352603|P7|Overall Study|Death|0
5601603|NCT00894166|19352604|P6|Overall Study|Death|0
5601604|NCT00894166|19352605|P5|Overall Study|Death|0
5601605|NCT00894166|19352606|P4|Overall Study|Death|1
5601606|NCT00894166|19352607|P3|Overall Study|Death|0
5601607|NCT00894166|19352608|P2|Overall Study|Death|0
5601608|NCT00894166|19352609|P1|Overall Study|Death|0
5601609|NCT00894166|19352602|P8|Overall Study|Withdrew or Lost to Follow-Up|34
5601610|NCT00894166|19352603|P7|Overall Study|Withdrew or Lost to Follow-Up|16
5601611|NCT00894166|19352604|P6|Overall Study|Withdrew or Lost to Follow-Up|16
5601612|NCT00894166|19352605|P5|Overall Study|Withdrew or Lost to Follow-Up|24
5601613|NCT00894166|19352606|P4|Overall Study|Withdrew or Lost to Follow-Up|68
5601614|NCT00894166|19352607|P3|Overall Study|Withdrew or Lost to Follow-Up|62
5601615|NCT00894166|19352608|P2|Overall Study|Withdrew or Lost to Follow-Up|63
5601616|NCT00894166|19352609|P1|Overall Study|Withdrew or Lost to Follow-Up|61
5601617|NCT00893971|19352655|P1|Overall Study|Physician Decision|3
5601618|NCT00893789|19352773|P4|Overall Study|Lost to Follow-up|1
5601619|NCT00893789|19352774|P3|Overall Study|Lost to Follow-up|0
5601620|NCT00893789|19352775|P2|Overall Study|Lost to Follow-up|0
5601621|NCT00893789|19352776|P1|Overall Study|Lost to Follow-up|0
5601622|NCT00893789|19352773|P4|Overall Study|Protocol Violation|4
5601623|NCT00893789|19352774|P3|Overall Study|Protocol Violation|1
5601624|NCT00893789|19352775|P2|Overall Study|Protocol Violation|1
5601625|NCT00893789|19352776|P1|Overall Study|Protocol Violation|0
5601626|NCT00893789|19352773|P4|Overall Study|Adverse Event|5
5601627|NCT00893789|19352774|P3|Overall Study|Adverse Event|1
5601628|NCT00893789|19352775|P2|Overall Study|Adverse Event|2
5601629|NCT00893789|19352776|P1|Overall Study|Adverse Event|0
5601630|NCT00893789|19352773|P4|Overall Study|Taking Excluded Concomitant Medication|0
5601631|NCT00893789|19352774|P3|Overall Study|Taking Excluded Concomitant Medication|1
5601632|NCT00893789|19352775|P2|Overall Study|Taking Excluded Concomitant Medication|0
5601633|NCT00893789|19352776|P1|Overall Study|Taking Excluded Concomitant Medication|1
5601634|NCT00893789|19352773|P4|Overall Study|Noncompliance With Study Procedures|0
5601635|NCT00893789|19352774|P3|Overall Study|Noncompliance With Study Procedures|0
5601636|NCT00893789|19352775|P2|Overall Study|Noncompliance With Study Procedures|0
5601637|NCT00893789|19352776|P1|Overall Study|Noncompliance With Study Procedures|1
5601638|NCT00893789|19352773|P4|Overall Study|Noncompliance With Study Drug|2
5601639|NCT00893789|19352774|P3|Overall Study|Noncompliance With Study Drug|1
5601640|NCT00893789|19352775|P2|Overall Study|Noncompliance With Study Drug|0
5601641|NCT00893789|19352776|P1|Overall Study|Noncompliance With Study Drug|1
5601642|NCT00893789|19352773|P4|Overall Study|Withdrawal by Subject|1
5601643|NCT00893789|19352774|P3|Overall Study|Withdrawal by Subject|3
5601644|NCT00893789|19352775|P2|Overall Study|Withdrawal by Subject|1
5601645|NCT00893789|19352776|P1|Overall Study|Withdrawal by Subject|3
5601646|NCT00893763|19352860|P2|Overall Study|extubated|110
5601647|NCT00893763|19352861|P1|Overall Study|extubated|110
5601648|NCT00893737|19352869|P1|Overall Study|Lost to Follow-up|6
5601649|NCT00893737|19352869|P1|Overall Study|Withdrawal by Subject|2
5601650|NCT00893737|19352869|P1|Overall Study|Adverse Event|4
5601651|NCT00893464|19352883|P8|Overall Study|Did not complete therapy/experience PD|2
5601652|NCT00893464|19352884|P7|Overall Study|Did not complete therapy/experience PD|2
5601653|NCT00893464|19352885|P6|Overall Study|Did not complete therapy/experience PD|0
5601654|NCT00893464|19352886|P5|Overall Study|Did not complete therapy/experience PD|0
5601655|NCT00893464|19352887|P4|Overall Study|Did not complete therapy/experience PD|0
5601656|NCT00893464|19352888|P3|Overall Study|Did not complete therapy/experience PD|0
5601657|NCT00893464|19352889|P2|Overall Study|Did not complete therapy/experience PD|0
5601658|NCT00893464|19352890|P1|Overall Study|Did not complete therapy/experience PD|0
5601659|NCT00893113|19353017|P2|Overall Study|Withdrew Consent|7
5601660|NCT00893113|19353018|P1|Overall Study|Withdrew Consent|8
5601661|NCT00893113|19353017|P2|Overall Study|Early Termination|1
5601662|NCT00893113|19353018|P1|Overall Study|Early Termination|1
5601663|NCT00893113|19353017|P2|Overall Study|Lost to Follow-up|8
5601664|NCT00893113|19353018|P1|Overall Study|Lost to Follow-up|4
5601665|NCT00892957|19353048|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
5601666|NCT00892957|19353049|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
5601667|NCT00892957|19353048|P2|Between Postoperative Day 1 and Day 14|Death|2
5601668|NCT00892957|19353049|P1|Between Postoperative Day 1 and Day 14|Death|0
5601669|NCT00892775|19353137|P2|Overall Study|Lost to Follow-up|0
5601670|NCT00892775|19353138|P1|Overall Study|Lost to Follow-up|1
5601671|NCT00892775|19353137|P2|Overall Study|Withdrawal by Subject|1
5601672|NCT00892775|19353138|P1|Overall Study|Withdrawal by Subject|0
5601673|NCT00892775|19353137|P2|Overall Study|Migrated/ moved from study area|0
5601674|NCT00892775|19353138|P1|Overall Study|Migrated/ moved from study area|1
5601675|NCT00892775|19353137|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
5601676|NCT00892775|19353138|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
5601677|NCT00892775|19353137|P2|Overall Study|Subject difficulties with blood drawing|0
5601678|NCT00892775|19353138|P1|Overall Study|Subject difficulties with blood drawing|1
5601679|NCT00892775|19353137|P2|Overall Study|Protocol Violation|0
5601680|NCT00892775|19353138|P1|Overall Study|Protocol Violation|1
5601681|NCT00892723|19353165|P3|Overall Study|Withdrawal by Subject|1
5601682|NCT00892723|19353166|P2|Overall Study|Withdrawal by Subject|1
5601683|NCT00892723|19353167|P1|Overall Study|Withdrawal by Subject|1
5601684|NCT00892723|19353165|P3|Overall Study|Lost to Follow-up|1
5601685|NCT00892723|19353166|P2|Overall Study|Lost to Follow-up|3
5601686|NCT00892723|19353167|P1|Overall Study|Lost to Follow-up|1
5601687|NCT00892437|19353256|P2|Open-Label Extension Phase|Withdrew Consent|1
5601688|NCT00892437|19353257|P1|Open-Label Extension Phase|Withdrew Consent|3
5601689|NCT00892437|19353256|P2|Open-Label Extension Phase|Investigator's Discretion|0
5601690|NCT00892437|19353257|P1|Open-Label Extension Phase|Investigator's Discretion|1
5601691|NCT00892437|19353256|P2|Open-Label Extension Phase|Lost to Follow-up|1
5601692|NCT00892437|19353257|P1|Open-Label Extension Phase|Lost to Follow-up|3
5601693|NCT00892437|19353256|P2|Open-Label Extension Phase|Lack of Efficacy|0
5601694|NCT00892437|19353257|P1|Open-Label Extension Phase|Lack of Efficacy|1
5601695|NCT00892437|19353256|P2|Open-Label Extension Phase|Adverse Event|2
5601696|NCT00892437|19353257|P1|Open-Label Extension Phase|Adverse Event|4
5601697|NCT00892437|19353256|P2|Randomized Phase|Withdrew Consent|0
5601698|NCT00892437|19353257|P1|Randomized Phase|Withdrew Consent|1
5601699|NCT00892437|19353256|P2|Randomized Phase|Investigator's Discretion|0
5601700|NCT00892437|19353257|P1|Randomized Phase|Investigator's Discretion|1
5601701|NCT00892437|19353256|P2|Randomized Phase|Lost to Follow-up|3
5601702|NCT00892437|19353257|P1|Randomized Phase|Lost to Follow-up|1
5601703|NCT00892437|19353256|P2|Randomized Phase|Adverse Event|2
5601704|NCT00892437|19353257|P1|Randomized Phase|Adverse Event|2
5601705|NCT00892437|19353256|P2|Randomized Phase|Randomized but not treated|0
5601706|NCT00892437|19353257|P1|Randomized Phase|Randomized but not treated|6
5601707|NCT00892281|19353276|P2|Overall Study|Visit 4 date out of window|0
5601708|NCT00892281|19353277|P1|Overall Study|Visit 4 date out of window|1
5601709|NCT00892281|19353276|P2|Overall Study|Rash on hand|0
5601710|NCT00892281|19353277|P1|Overall Study|Rash on hand|1
5601711|NCT00892281|19353276|P2|Overall Study|Subject had history of drug abuse|0
5601712|NCT00892281|19353277|P1|Overall Study|Subject had history of drug abuse|1
5601713|NCT00892281|19353276|P2|Overall Study|Non-compliant with visits as scheduled|0
5601714|NCT00892281|19353277|P1|Overall Study|Non-compliant with visits as scheduled|1
5601715|NCT00892281|19353276|P2|Overall Study|Missed visits rescheduled out of window|0
5601716|NCT00892281|19353277|P1|Overall Study|Missed visits rescheduled out of window|1
5601717|NCT00892281|19353276|P2|Overall Study|Missed multiple visits|0
5601718|NCT00892281|19353277|P1|Overall Study|Missed multiple visits|1
5601719|NCT00892281|19353276|P2|Overall Study|No show Visit 2; prescription not filled|0
5601720|NCT00892281|19353277|P1|Overall Study|No show Visit 2; prescription not filled|1
5601721|NCT00892281|19353276|P2|Overall Study|Subject not seen by PI at final visit|0
5601722|NCT00892281|19353277|P1|Overall Study|Subject not seen by PI at final visit|1
5601723|NCT00892281|19353276|P2|Overall Study|Lack of efficacy of study product|0
5601724|NCT00892281|19353277|P1|Overall Study|Lack of efficacy of study product|2
5601725|NCT00892281|19353276|P2|Overall Study|Death in family|0
5601726|NCT00892281|19353277|P1|Overall Study|Death in family|1
5601727|NCT00892281|19353276|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
5601728|NCT00892281|19353277|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
5601729|NCT00892281|19353276|P2|Overall Study|Subject lost interest in program|1
5601730|NCT00892281|19353277|P1|Overall Study|Subject lost interest in program|0
5601731|NCT00892281|19353276|P2|Overall Study|PI complained of inadequate compensation|0
5601732|NCT00892281|19353277|P1|Overall Study|PI complained of inadequate compensation|3
5601733|NCT00892281|19353276|P2|Overall Study|Scheduled for knee replacement|1
5601734|NCT00892281|19353277|P1|Overall Study|Scheduled for knee replacement|0
5601735|NCT00892281|19353276|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
5601736|NCT00892281|19353277|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
5601737|NCT00892281|19353276|P2|Overall Study|Subject missed several visits/lost meds|0
5601738|NCT00892281|19353277|P1|Overall Study|Subject missed several visits/lost meds|1
5601739|NCT00892281|19353276|P2|Overall Study|Subject did not return for any visits|0
5601740|NCT00892281|19353277|P1|Overall Study|Subject did not return for any visits|1
5601741|NCT00892281|19353276|P2|Overall Study|Subject not good candidate for study|0
5601742|NCT00892281|19353277|P1|Overall Study|Subject not good candidate for study|1
5601743|NCT00892281|19353276|P2|Overall Study|Unable to redeem the drug voucher|0
5601744|NCT00892281|19353277|P1|Overall Study|Unable to redeem the drug voucher|1
5601745|NCT00892281|19353276|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
5601746|NCT00892281|19353277|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
5601747|NCT00892281|19353276|P2|Overall Study|Did not meet incl/excl criteria|0
5601748|NCT00892281|19353277|P1|Overall Study|Did not meet incl/excl criteria|1
5601749|NCT00892281|19353276|P2|Overall Study|Last visit not done - death in family|0
5601750|NCT00892281|19353277|P1|Overall Study|Last visit not done - death in family|1
5601751|NCT00892281|19353276|P2|Overall Study|Family emergency|0
5601752|NCT00892281|19353277|P1|Overall Study|Family emergency|1
5601753|NCT00892281|19353276|P2|Overall Study|Subject completed day after study closed|0
5601754|NCT00892281|19353277|P1|Overall Study|Subject completed day after study closed|1
5601755|NCT00892281|19353276|P2|Overall Study|Final visit completed 4 weeks late|1
5601756|NCT00892281|19353277|P1|Overall Study|Final visit completed 4 weeks late|0
5601757|NCT00892281|19353276|P2|Overall Study|Subject unable to keep follow-up visits|0
5601758|NCT00892281|19353277|P1|Overall Study|Subject unable to keep follow-up visits|1
5601759|NCT00892281|19353276|P2|Overall Study|Subject failed to return for final visit|0
5601760|NCT00892281|19353277|P1|Overall Study|Subject failed to return for final visit|2
5601761|NCT00892281|19353276|P2|Overall Study|Withdrawal by Subject|14
5601762|NCT00892281|19353277|P1|Overall Study|Withdrawal by Subject|86
5601763|NCT00892281|19353276|P2|Overall Study|Protocol Violation|2
5601764|NCT00892281|19353277|P1|Overall Study|Protocol Violation|7
5601765|NCT00892281|19353276|P2|Overall Study|Pregnancy|0
5601766|NCT00892281|19353277|P1|Overall Study|Pregnancy|1
5601767|NCT00892281|19353276|P2|Overall Study|Lost to Follow-up|8
5601768|NCT00892281|19353277|P1|Overall Study|Lost to Follow-up|81
5601769|NCT00892281|19353276|P2|Overall Study|Adverse Event|8
5601770|NCT00892281|19353277|P1|Overall Study|Adverse Event|65
5601771|NCT00892177|19353290|P6|Phase II|Withdrawal by Subject|1
5601772|NCT00892177|19353291|P5|Phase II|Withdrawal by Subject|4
5601773|NCT00892177|19353292|P4|Phase II|Withdrawal by Subject|0
5601774|NCT00892177|19353293|P3|Phase II|Withdrawal by Subject|0
5601775|NCT00892177|19353294|P2|Phase II|Withdrawal by Subject|0
5601776|NCT00892177|19353295|P1|Phase II|Withdrawal by Subject|0
5601777|NCT00892177|19353290|P6|Phase II|Ineligible|1
5601778|NCT00892177|19353291|P5|Phase II|Ineligible|1
5601779|NCT00892177|19353292|P4|Phase II|Ineligible|0
5601780|NCT00892177|19353293|P3|Phase II|Ineligible|0
5601781|NCT00892177|19353294|P2|Phase II|Ineligible|0
5601782|NCT00892177|19353295|P1|Phase II|Ineligible|0
5601783|NCT00892151|19353320|P1|Overall Study|Protocol Violation|1
5601784|NCT00892099|19353329|P3|Overall Study|Lost to Follow-up|1
5601785|NCT00892099|19353330|P2|Overall Study|Lost to Follow-up|0
5601786|NCT00892099|19353331|P1|Overall Study|Lost to Follow-up|0
5601787|NCT00892099|19353329|P3|Overall Study|investigator decision|1
5601788|NCT00892099|19353330|P2|Overall Study|investigator decision|0
5601789|NCT00892099|19353331|P1|Overall Study|investigator decision|0
5601790|NCT00892099|19353329|P3|Overall Study|kidney function recovered|0
5601791|NCT00892099|19353330|P2|Overall Study|kidney function recovered|1
5601792|NCT00892099|19353331|P1|Overall Study|kidney function recovered|0
5601793|NCT00892099|19353329|P3|Overall Study|no further details|1
5601794|NCT00892099|19353330|P2|Overall Study|no further details|0
5601795|NCT00892099|19353331|P1|Overall Study|no further details|1
5601796|NCT00892099|19353329|P3|Overall Study|Prolonged hospitalization|1
5601797|NCT00892099|19353330|P2|Overall Study|Prolonged hospitalization|0
5601798|NCT00892099|19353331|P1|Overall Study|Prolonged hospitalization|1
5601799|NCT00892099|19353329|P3|Overall Study|replocated|2
5601800|NCT00892099|19353330|P2|Overall Study|replocated|0
5601801|NCT00892099|19353331|P1|Overall Study|replocated|1
5601802|NCT00892099|19353329|P3|Overall Study|Adverse Event|0
5601803|NCT00892099|19353330|P2|Overall Study|Adverse Event|0
5601804|NCT00892099|19353331|P1|Overall Study|Adverse Event|1
5601805|NCT00892099|19353329|P3|Overall Study|Death|1
5601806|NCT00892099|19353330|P2|Overall Study|Death|0
5601807|NCT00892099|19353331|P1|Overall Study|Death|1
5601808|NCT00892047|19353356|P2|Overall Study|Lack of Efficacy|2
5601809|NCT00892047|19353357|P1|Overall Study|Lack of Efficacy|0
5601810|NCT00892047|19353356|P2|Overall Study|subject burden|3
5601811|NCT00892047|19353357|P1|Overall Study|subject burden|2
5601812|NCT00892047|19353356|P2|Overall Study|Adverse Event|2
5601813|NCT00892047|19353357|P1|Overall Study|Adverse Event|2
5601814|NCT00892008|19353373|P1|Overall Study|Adverse Event|37
5601815|NCT00892008|19353373|P1|Overall Study|Other|378
5601816|NCT00892008|19353373|P1|Overall Study|Lost to Follow-up|142
5601817|NCT00892008|19353373|P1|Overall Study|Lack of Efficacy|3
5601818|NCT00892008|19353373|P1|Overall Study|Death|5
5601819|NCT00891930|19353459|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
5601820|NCT00891930|19353459|P1|Part 2: Panitumumab + Ganitumab|Death|30
5601821|NCT00891930|19353459|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
5601822|NCT00891930|19353459|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
5601823|NCT00891930|19353459|P1|Part 1: Panitumumab +Irinotecan|Death|38
5601824|NCT00891904|19353480|P1|Overall Study|Adverse Event|1
5601825|NCT00891904|19353480|P1|Overall Study|Death|1
5601826|NCT00891839|19353506|P1|Overall Study|Disease progression|3
5601827|NCT00891839|19353506|P1|Overall Study|Withdrawal by Subject|2
5601828|NCT00891839|19353506|P1|Overall Study|Adverse Event|2
5601829|NCT00891813|19353515|P1|Overall Study|Protocol Violation|2
5601830|NCT00891813|19353515|P1|Overall Study|Patient Noncompliance|6
5601831|NCT00891813|19353515|P1|Overall Study|Withdrawal by Subject|1
5601832|NCT00891813|19353515|P1|Overall Study|Adverse Event|3
5601833|NCT00891774|19353521|P1|Overall Study|Protocol Violation|4
5601834|NCT00891774|19353521|P1|Overall Study|Withdrawal by Subject|2
5601835|NCT00891774|19353521|P1|Overall Study|Illness (Self/Mother)|3
5601836|NCT00891774|19353521|P1|Overall Study|Lost to Follow-up|5
5601837|NCT00891735|19353532|P4|Overall Study|Patient's decision to withdraw|8
5601838|NCT00891735|19353533|P3|Overall Study|Patient's decision to withdraw|4
5601839|NCT00891735|19353534|P2|Overall Study|Patient's decision to withdraw|9
5601840|NCT00891735|19353535|P1|Overall Study|Patient's decision to withdraw|4
5601841|NCT00891735|19353532|P4|Overall Study|Physician's decision to withdraw patient|0
5601842|NCT00891735|19353533|P3|Overall Study|Physician's decision to withdraw patient|0
5601843|NCT00891735|19353534|P2|Overall Study|Physician's decision to withdraw patient|0
5601844|NCT00891735|19353535|P1|Overall Study|Physician's decision to withdraw patient|1
5601845|NCT00891735|19353532|P4|Overall Study|Lost to Follow-up|2
5601846|NCT00891735|19353533|P3|Overall Study|Lost to Follow-up|2
5601847|NCT00891735|19353534|P2|Overall Study|Lost to Follow-up|2
5601848|NCT00891735|19353535|P1|Overall Study|Lost to Follow-up|2
5601849|NCT00891735|19353532|P4|Overall Study|Death|5
5601850|NCT00891735|19353533|P3|Overall Study|Death|4
5601851|NCT00891735|19353534|P2|Overall Study|Death|5
5601852|NCT00891735|19353535|P1|Overall Study|Death|8
5601853|NCT00891735|19353532|P4|Overall Study|Adverse Event|0
5601854|NCT00891735|19353533|P3|Overall Study|Adverse Event|2
5601855|NCT00891735|19353534|P2|Overall Study|Adverse Event|0
5601856|NCT00891735|19353535|P1|Overall Study|Adverse Event|2
5601857|NCT00891657|19353575|P2|Overall Study|Withdrawal by Subject|1
5601858|NCT00891657|19353576|P1|Overall Study|Withdrawal by Subject|1
5601859|NCT00891618|19353588|P1|Overall Study|Withdrawal by Subject|1
5601860|NCT00891527|19353592|P1|Overall Study|Withdrawal by Subject|2
5601861|NCT00891462|19353601|P3|Overall Study|Lost to Follow-up|0
5601862|NCT00891462|19353602|P2|Overall Study|Lost to Follow-up|2
5601863|NCT00891462|19353603|P1|Overall Study|Lost to Follow-up|0
5601864|NCT00891462|19353601|P3|Overall Study|Inclusion/exclusion criteria|2
5601865|NCT00891462|19353602|P2|Overall Study|Inclusion/exclusion criteria|2
5601866|NCT00891462|19353603|P1|Overall Study|Inclusion/exclusion criteria|0
5601867|NCT00891462|19353601|P3|Overall Study|Protocol Violation|3
5601868|NCT00891462|19353602|P2|Overall Study|Protocol Violation|1
5601869|NCT00891462|19353603|P1|Overall Study|Protocol Violation|2
5601870|NCT00891462|19353601|P3|Overall Study|Other Reason|3
5601871|NCT00891462|19353602|P2|Overall Study|Other Reason|5
5601872|NCT00891462|19353603|P1|Overall Study|Other Reason|2
5601873|NCT00891462|19353601|P3|Overall Study|COPD exacerbation|1
5601874|NCT00891462|19353602|P2|Overall Study|COPD exacerbation|4
5601875|NCT00891462|19353603|P1|Overall Study|COPD exacerbation|7
5601876|NCT00891462|19353601|P3|Overall Study|Lack of Efficacy|1
5601877|NCT00891462|19353602|P2|Overall Study|Lack of Efficacy|5
5601878|NCT00891462|19353603|P1|Overall Study|Lack of Efficacy|10
5601879|NCT00891462|19353601|P3|Overall Study|Adverse Event|7
5601880|NCT00891462|19353602|P2|Overall Study|Adverse Event|8
5601881|NCT00891462|19353603|P1|Overall Study|Adverse Event|7
5601882|NCT00891462|19353601|P3|Overall Study|Withdrawal by Subject|7
5601883|NCT00891462|19353602|P2|Overall Study|Withdrawal by Subject|6
5601884|NCT00891462|19353603|P1|Overall Study|Withdrawal by Subject|9
5601885|NCT00891371|19353625|P1|Treatment|Lost to Follow-up|1
5601886|NCT00891371|19353625|P1|Treatment|Death|1
5601887|NCT00891371|19353625|P1|Treatment|Adverse Event|2
5601888|NCT00891371|19353625|P1|Treatment|Lack of Efficacy|5
5601889|NCT00891371|19353625|P1|Pre-assignment|Consent withdrawal|1
5601890|NCT00891371|19353625|P1|Pre-assignment|Inclusion/exclusion|5
5601891|NCT00891293|19353647|P1|Overall Study|Sponsor termination|62
5601892|NCT00891293|19353647|P1|Overall Study|Subject withdrew consent|7
5601893|NCT00891293|19353647|P1|Overall Study|Lost to Follow-up|7
5601894|NCT00891293|19353647|P1|Overall Study|Laboratory abnormality|4
5601895|NCT00891293|19353647|P1|Overall Study|Protocol Violation|2
5601896|NCT00891293|19353647|P1|Overall Study|Adverse Event|2
5601897|NCT00891228|19353662|P3|Overall Study|Pregnancy|0
5601898|NCT00891228|19353663|P2|Overall Study|Pregnancy|1
5601899|NCT00891228|19353664|P1|Overall Study|Pregnancy|0
5601900|NCT00891228|19353662|P3|Overall Study|Lost to Follow-up|5
5601901|NCT00891228|19353663|P2|Overall Study|Lost to Follow-up|4
5601902|NCT00891228|19353664|P1|Overall Study|Lost to Follow-up|4
5601903|NCT00891228|19353662|P3|Overall Study|Physician Decision|0
5601904|NCT00891228|19353663|P2|Overall Study|Physician Decision|1
5601905|NCT00891228|19353664|P1|Overall Study|Physician Decision|2
5601906|NCT00891228|19353662|P3|Overall Study|Protocol Violation|2
5601907|NCT00891228|19353663|P2|Overall Study|Protocol Violation|1
5601908|NCT00891228|19353664|P1|Overall Study|Protocol Violation|3
5601909|NCT00891228|19353662|P3|Overall Study|Withdrawal by Subject|5
5601910|NCT00891228|19353663|P2|Overall Study|Withdrawal by Subject|4
5601911|NCT00891228|19353664|P1|Overall Study|Withdrawal by Subject|2
5601912|NCT00891228|19353662|P3|Overall Study|Adverse Event|3
5601913|NCT00891228|19353663|P2|Overall Study|Adverse Event|2
5601914|NCT00891228|19353664|P1|Overall Study|Adverse Event|0
5601915|NCT00891202|19353686|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
5601916|NCT00891202|19353687|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
5601917|NCT00891202|19353688|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
5601918|NCT00891202|19353689|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
5601919|NCT00891202|19353686|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
5601920|NCT00891202|19353687|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
5601921|NCT00891202|19353688|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
5601922|NCT00891202|19353689|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
5601923|NCT00891202|19353686|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
5601924|NCT00891202|19353687|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
5601925|NCT00891202|19353688|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
5601926|NCT00891202|19353689|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
5601927|NCT00891202|19353686|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
5601928|NCT00891202|19353687|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
5601929|NCT00891202|19353688|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
5601930|NCT00891202|19353689|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
5601931|NCT00891046|19353865|P5|Overall Study|Lost to Follow-up|1
5601932|NCT00891046|19353866|P4|Overall Study|Lost to Follow-up|0
5601933|NCT00891046|19353867|P3|Overall Study|Lost to Follow-up|0
5601934|NCT00891046|19353868|P2|Overall Study|Lost to Follow-up|0
5601935|NCT00891046|19353869|P1|Overall Study|Lost to Follow-up|0
5601936|NCT00891046|19353865|P5|Overall Study|Withdrawal by Subject|1
5601937|NCT00891046|19353866|P4|Overall Study|Withdrawal by Subject|1
5601938|NCT00891046|19353867|P3|Overall Study|Withdrawal by Subject|2
5601939|NCT00891046|19353868|P2|Overall Study|Withdrawal by Subject|1
5601940|NCT00891046|19353869|P1|Overall Study|Withdrawal by Subject|2
5601941|NCT00891046|19353865|P5|Overall Study|Adverse Event|14
5601942|NCT00891046|19353866|P4|Overall Study|Adverse Event|0
5601943|NCT00891046|19353867|P3|Overall Study|Adverse Event|2
5601944|NCT00891046|19353868|P2|Overall Study|Adverse Event|3
5601945|NCT00891046|19353869|P1|Overall Study|Adverse Event|4
5601946|NCT00891046|19353865|P5|Overall Study|Participant no longer required drug|1
5601947|NCT00891046|19353866|P4|Overall Study|Participant no longer required drug|0
5601948|NCT00891046|19353867|P3|Overall Study|Participant no longer required drug|0
5601949|NCT00891046|19353868|P2|Overall Study|Participant no longer required drug|2
5601950|NCT00891046|19353869|P1|Overall Study|Participant no longer required drug|0
5601951|NCT00891046|19353865|P5|Overall Study|Administrative problems|1
5601952|NCT00891046|19353866|P4|Overall Study|Administrative problems|0
5601953|NCT00891046|19353867|P3|Overall Study|Administrative problems|0
5601954|NCT00891046|19353868|P2|Overall Study|Administrative problems|0
5601955|NCT00891046|19353869|P1|Overall Study|Administrative problems|0
5601956|NCT00891046|19353865|P5|Overall Study|Unsatisfactory therapeutic effect|20
5601957|NCT00891046|19353866|P4|Overall Study|Unsatisfactory therapeutic effect|2
5601958|NCT00891046|19353867|P3|Overall Study|Unsatisfactory therapeutic effect|19
5601959|NCT00891046|19353868|P2|Overall Study|Unsatisfactory therapeutic effect|2
5601960|NCT00891046|19353869|P1|Overall Study|Unsatisfactory therapeutic effect|5
5601961|NCT00891046|19353865|P5|Overall Study|Protocol Violation|1
5601962|NCT00891046|19353866|P4|Overall Study|Protocol Violation|0
5601963|NCT00891046|19353867|P3|Overall Study|Protocol Violation|0
5601964|NCT00891046|19353868|P2|Overall Study|Protocol Violation|1
5601965|NCT00891046|19353869|P1|Overall Study|Protocol Violation|1
5601966|NCT00891020|19353945|P3|Long-term Extension Period|Administrative|2
5601967|NCT00891020|19353946|P2|Long-term Extension Period|Administrative|2
5601968|NCT00891020|19353947|P1|Long-term Extension Period|Administrative|1
5601969|NCT00891020|19353945|P3|Long-term Extension Period|Failure to return|3
5601970|NCT00891020|19353946|P2|Long-term Extension Period|Failure to return|2
5601971|NCT00891020|19353947|P1|Long-term Extension Period|Failure to return|0
5601972|NCT00891020|19353945|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
5601973|NCT00891020|19353946|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
5601974|NCT00891020|19353947|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
5601975|NCT00891020|19353945|P3|Long-term Extension Period|Protocol Violation|1
5601976|NCT00891020|19353946|P2|Long-term Extension Period|Protocol Violation|1
5601977|NCT00891020|19353947|P1|Long-term Extension Period|Protocol Violation|0
5601978|NCT00891020|19353945|P3|Long-term Extension Period|Insufficient therapeutic response|2
5601979|NCT00891020|19353946|P2|Long-term Extension Period|Insufficient therapeutic response|2
5601980|NCT00891020|19353947|P1|Long-term Extension Period|Insufficient therapeutic response|3
5601981|NCT00891020|19353945|P3|Long-term Extension Period|Death|1
5601982|NCT00891020|19353946|P2|Long-term Extension Period|Death|0
5601983|NCT00891020|19353947|P1|Long-term Extension Period|Death|0
5601984|NCT00891020|19353945|P3|Long-term Extension Period|Adverse Event|10
5601985|NCT00891020|19353946|P2|Long-term Extension Period|Adverse Event|11
5601986|NCT00891020|19353947|P1|Long-term Extension Period|Adverse Event|1
5601987|NCT00891020|19353945|P3|24 Week Treatment Period|Administrative/Other|1
5601988|NCT00891020|19353946|P2|24 Week Treatment Period|Administrative/Other|6
5601989|NCT00891020|19353947|P1|24 Week Treatment Period|Administrative/Other|5
5601990|NCT00891020|19353945|P3|24 Week Treatment Period|Withdrew consent|15
5601991|NCT00891020|19353946|P2|24 Week Treatment Period|Withdrew consent|3
5601992|NCT00891020|19353947|P1|24 Week Treatment Period|Withdrew consent|6
5601993|NCT00891020|19353945|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
5601994|NCT00891020|19353946|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
5601995|NCT00891020|19353947|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
5601996|NCT00891020|19353945|P3|24 Week Treatment Period|Other protocol violation|2
5601997|NCT00891020|19353946|P2|24 Week Treatment Period|Other protocol violation|1
5601998|NCT00891020|19353947|P1|24 Week Treatment Period|Other protocol violation|1
5601999|NCT00891020|19353945|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
5602000|NCT00891020|19353946|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
5602001|NCT00891020|19353947|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
5602002|NCT00891020|19353945|P3|24 Week Treatment Period|Failure to return|5
5602003|NCT00891020|19353946|P2|24 Week Treatment Period|Failure to return|5
5602004|NCT00891020|19353947|P1|24 Week Treatment Period|Failure to return|4
5602005|NCT00891020|19353945|P3|24 Week Treatment Period|Insufficient therapeutic response|15
5602006|NCT00891020|19353946|P2|24 Week Treatment Period|Insufficient therapeutic response|9
5602007|NCT00891020|19353947|P1|24 Week Treatment Period|Insufficient therapeutic response|6
5602008|NCT00891020|19353945|P3|24 Week Treatment Period|Death|0
5602009|NCT00891020|19353946|P2|24 Week Treatment Period|Death|2
5602010|NCT00891020|19353947|P1|24 Week Treatment Period|Death|0
5602011|NCT00891020|19353945|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
5602012|NCT00891020|19353946|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
5602013|NCT00891020|19353947|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
5602014|NCT00890929|19354011|P1|Overall Study|Physician Decision|1
5602015|NCT00890929|19354011|P1|Overall Study|Withdrawal by Subject|3
5602016|NCT00890929|19354011|P1|Overall Study|Death before treatment|2
5602017|NCT00890825|19354029|P2|Overall Study|Alive at data cut off (DCO)|14
5602018|NCT00890825|19354030|P1|Overall Study|Alive at data cut off (DCO)|13
5602019|NCT00890825|19354029|P2|Overall Study|Withdrawal by Subject|0
5602020|NCT00890825|19354030|P1|Overall Study|Withdrawal by Subject|1
5602021|NCT00890695|19354059|P2|Overall Study|Protocol Violation|0
5602022|NCT00890695|19354060|P1|Overall Study|Protocol Violation|1
5602023|NCT00890591|19354094|P1|Overall Study|Lack of Efficacy|20
5602024|NCT00890552|19354100|P1|On-treatment|Early prog disease/ death|10
5602025|NCT00890552|19354100|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
5602026|NCT00890409|19354109|P2|Overall Study|Lost to Follow-up|21
5602027|NCT00890409|19354110|P1|Overall Study|Lost to Follow-up|20
5602028|NCT00890201|19354147|P2|Overall Study|Protocol Violation|56
5602029|NCT00890201|19354148|P1|Overall Study|Protocol Violation|5
5602030|NCT00890097|19354166|P3|Overall Study|Protocol Deviation|1
5602031|NCT00890097|19354167|P2|Overall Study|Protocol Deviation|1
5602032|NCT00890097|19354168|P1|Overall Study|Protocol Deviation|1
5602033|NCT00890097|19354166|P3|Overall Study|Subject Moved|0
5602034|NCT00890097|19354167|P2|Overall Study|Subject Moved|4
5602035|NCT00890097|19354168|P1|Overall Study|Subject Moved|0
5602036|NCT00890097|19354166|P3|Overall Study|Transportation|0
5602037|NCT00890097|19354167|P2|Overall Study|Transportation|2
5602038|NCT00890097|19354168|P1|Overall Study|Transportation|0
5602039|NCT00890097|19354166|P3|Overall Study|Failed inclusion criteria|0
5602040|NCT00890097|19354167|P2|Overall Study|Failed inclusion criteria|4
5602041|NCT00890097|19354168|P1|Overall Study|Failed inclusion criteria|3
5602042|NCT00890097|19354166|P3|Overall Study|Randomization Error|0
5602043|NCT00890097|19354167|P2|Overall Study|Randomization Error|0
5602044|NCT00890097|19354168|P1|Overall Study|Randomization Error|2
5602045|NCT00890097|19354166|P3|Overall Study|Subject Decision|6
5602046|NCT00890097|19354167|P2|Overall Study|Subject Decision|2
5602047|NCT00890097|19354168|P1|Overall Study|Subject Decision|3
5602048|NCT00890097|19354166|P3|Overall Study|Did not attend final visit|0
5602049|NCT00890097|19354167|P2|Overall Study|Did not attend final visit|3
5602050|NCT00890097|19354168|P1|Overall Study|Did not attend final visit|2
5602051|NCT00890097|19354166|P3|Overall Study|Sponsor Decision|7
5602052|NCT00890097|19354167|P2|Overall Study|Sponsor Decision|11
5602053|NCT00890097|19354168|P1|Overall Study|Sponsor Decision|7
5602054|NCT00890097|19354166|P3|Overall Study|Noncompliance|4
5602055|NCT00890097|19354167|P2|Overall Study|Noncompliance|4
5602056|NCT00890097|19354168|P1|Overall Study|Noncompliance|0
5602057|NCT00890097|19354166|P3|Overall Study|Lost to Follow-up|5
5602058|NCT00890097|19354167|P2|Overall Study|Lost to Follow-up|5
5602059|NCT00890097|19354168|P1|Overall Study|Lost to Follow-up|5
5602060|NCT00890097|19354166|P3|Overall Study|Withdrew Consent|9
5602061|NCT00890097|19354167|P2|Overall Study|Withdrew Consent|6
5602062|NCT00890097|19354168|P1|Overall Study|Withdrew Consent|9
5602063|NCT00890097|19354166|P3|Overall Study|Decision Unrelated to an Adverse Event|17
5602064|NCT00890097|19354167|P2|Overall Study|Decision Unrelated to an Adverse Event|12
5602065|NCT00890097|19354168|P1|Overall Study|Decision Unrelated to an Adverse Event|15
5602066|NCT00890097|19354166|P3|Overall Study|Adverse Event|28
5602067|NCT00890097|19354167|P2|Overall Study|Adverse Event|32
5602068|NCT00890097|19354168|P1|Overall Study|Adverse Event|21
5602069|NCT00890084|19354176|P1|Overall Study|Lost to Follow-up|126
5602070|NCT00890084|19354176|P1|Overall Study|Adverse Event|16
5602071|NCT00889863|19354216|P2|Part II: Randomized Double Blind|Protocol deviation|1
5602072|NCT00889863|19354217|P1|Part II: Randomized Double Blind|Protocol deviation|0
5602073|NCT00889863|19354216|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
5602074|NCT00889863|19354217|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
5602075|NCT00889863|19354216|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
5602076|NCT00889863|19354217|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
5602077|NCT00889863|19354216|P2|Part II: Randomized Double Blind|Adverse Event|4
5602078|NCT00889863|19354217|P1|Part II: Randomized Double Blind|Adverse Event|0
5602079|NCT00889863|19354216|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
5602080|NCT00889863|19354217|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
5602081|NCT00889863|19354216|P2|Part I: Open Label|Adverse Event|0
5602082|NCT00889863|19354217|P1|Part I: Open Label|Adverse Event|4
5602083|NCT00889863|19354216|P2|Part I: Open Label|Death|0
5602084|NCT00889863|19354217|P1|Part I: Open Label|Death|1
5602085|NCT00889720|19354243|P1|Overall Study|Other|4
5602086|NCT00889720|19354243|P1|Overall Study|Withdrawal by Subject|4
5602087|NCT00889707|19354270|P2|Overall Study|Lack of Efficacy|5
5602088|NCT00889707|19354271|P1|Overall Study|Lack of Efficacy|2
5602089|NCT00889707|19354270|P2|Overall Study|Lost to Follow-up|2
5602090|NCT00889707|19354271|P1|Overall Study|Lost to Follow-up|0
5602091|NCT00889707|19354270|P2|Overall Study|Withdrawal by Subject|3
5602092|NCT00889707|19354271|P1|Overall Study|Withdrawal by Subject|4
5602093|NCT00889707|19354270|P2|Overall Study|Adverse Event|0
5602094|NCT00889707|19354271|P1|Overall Study|Adverse Event|1
5602095|NCT00889681|19354279|P1|Overall Study|Insurance disapproval|1
5602096|NCT00889681|19354279|P1|Overall Study|Not meeting qualification Criteria|2
5602097|NCT00889603|19354286|P1|Overall Study|Other|4
5602098|NCT00889603|19354286|P1|Overall Study|No longer willing to participant in stud|4
5602099|NCT00889603|19354286|P1|Overall Study|Lost to Follow-up|19
5602100|NCT00889603|19354286|P1|Overall Study|Death|3
5602101|NCT00889603|19354286|P1|Overall Study|Adverse Event|7
5602102|NCT00889421|19354308|P1|Overall Study|Lack of Efficacy|3
5602103|NCT00889265|19354349|P1|Overall Study|Protocol Violation|1
5602104|NCT00889265|19354349|P1|Overall Study|Lost to Follow-up|5
5602105|NCT00889265|19354349|P1|Overall Study|Adverse Event|1
5602106|NCT00889252|19354356|P2|Overall Study|Protocol Violation|0
5602107|NCT00889252|19354357|P1|Overall Study|Protocol Violation|2
5602108|NCT00889252|19354356|P2|Overall Study|Withdrawal by Subject|0
5602109|NCT00889252|19354357|P1|Overall Study|Withdrawal by Subject|3
5602110|NCT00889252|19354356|P2|Overall Study|Adverse Event|4
5602111|NCT00889252|19354357|P1|Overall Study|Adverse Event|2
5602112|NCT00889005|19354434|P2|Overall Study|Withdrawal by Subject|0
5602113|NCT00889005|19354435|P1|Overall Study|Withdrawal by Subject|4
5602114|NCT00889005|19354434|P2|Overall Study|Lost to Follow-up|2
5602115|NCT00889005|19354435|P1|Overall Study|Lost to Follow-up|4
5602116|NCT00888940|19354449|P2|Overall Study|Randomized Not Treated|13
5602117|NCT00888940|19354450|P1|Overall Study|Randomized Not Treated|11
5602118|NCT00888940|19354449|P2|Overall Study|Lost to Follow-up|5
5602119|NCT00888940|19354450|P1|Overall Study|Lost to Follow-up|5
5602120|NCT00888940|19354449|P2|Overall Study|Adverse Event|3
5602121|NCT00888940|19354450|P1|Overall Study|Adverse Event|12
5602122|NCT00888927|19354462|P4|Overall Study|Withdrawal of consent|1
5602123|NCT00888927|19354463|P3|Overall Study|Withdrawal of consent|0
5602124|NCT00888927|19354464|P2|Overall Study|Withdrawal of consent|0
5602125|NCT00888927|19354465|P1|Overall Study|Withdrawal of consent|0
5602126|NCT00888927|19354462|P4|Overall Study|Adverse Event|1
5602127|NCT00888927|19354463|P3|Overall Study|Adverse Event|0
5602128|NCT00888927|19354464|P2|Overall Study|Adverse Event|0
5602129|NCT00888927|19354465|P1|Overall Study|Adverse Event|0
5602130|NCT00888849|19354481|P2|Overall Study|Lost to Follow-up|2
5602131|NCT00888849|19354482|P1|Overall Study|Lost to Follow-up|1
5602132|NCT00888849|19354481|P2|Overall Study|Death|7
5602133|NCT00888849|19354482|P1|Overall Study|Death|4
5602134|NCT00888654|19354492|P1|Overall Study|Stopped meds due to headaches|1
5602135|NCT00888654|19354492|P1|Overall Study|Change in surg date|1
5602136|NCT00888654|19354492|P1|Overall Study|Inelig. due to contraindication of med|1
5602137|NCT00888654|19354492|P1|Overall Study|Withdrawal by Subject|1
5602138|NCT00888654|19354492|P1|Overall Study|Surgery aborted|2
5602139|NCT00888654|19354492|P1|Overall Study|Not enough oral meds before surgery|3
5602140|NCT00888654|19354492|P1|Overall Study|Problems swallowing oral meds.|1
5602141|NCT00888615|19354510|P1|Overall Study|No treatment|2
5602142|NCT00888433|19354534|P2|Overall Study|Missed Visit|1
5602143|NCT00888433|19354535|P1|Overall Study|Missed Visit|2
5602144|NCT00888433|19354534|P2|Overall Study|Withdrawal by Subject|2
5602145|NCT00888433|19354535|P1|Overall Study|Withdrawal by Subject|1
5602146|NCT00888381|19354543|P2|Overall Study|Lost to Follow-up|1
5602147|NCT00888381|19354544|P1|Overall Study|Lost to Follow-up|0
5602148|NCT00888355|19354564|P4|Overall Study|Withdrawal by Subject|3
5602149|NCT00888355|19354565|P3|Overall Study|Withdrawal by Subject|1
5602150|NCT00888355|19354566|P2|Overall Study|Withdrawal by Subject|3
5602151|NCT00888355|19354567|P1|Overall Study|Withdrawal by Subject|0
5602152|NCT00888355|19354564|P4|Overall Study|Protocol Violation|2
5602153|NCT00888355|19354565|P3|Overall Study|Protocol Violation|1
5602154|NCT00888355|19354566|P2|Overall Study|Protocol Violation|2
5602155|NCT00888355|19354567|P1|Overall Study|Protocol Violation|3
5602156|NCT00888355|19354564|P4|Overall Study|Lost to Follow-up|0
5602157|NCT00888355|19354565|P3|Overall Study|Lost to Follow-up|2
5602158|NCT00888355|19354566|P2|Overall Study|Lost to Follow-up|2
5602159|NCT00888355|19354567|P1|Overall Study|Lost to Follow-up|0
5602160|NCT00888355|19354564|P4|Overall Study|Lack of Efficacy|2
5602161|NCT00888355|19354565|P3|Overall Study|Lack of Efficacy|5
5602162|NCT00888355|19354566|P2|Overall Study|Lack of Efficacy|2
5602163|NCT00888355|19354567|P1|Overall Study|Lack of Efficacy|9
5602164|NCT00888355|19354564|P4|Overall Study|Adverse Event|3
5602165|NCT00888355|19354565|P3|Overall Study|Adverse Event|3
5602166|NCT00888355|19354566|P2|Overall Study|Adverse Event|0
5602167|NCT00888355|19354567|P1|Overall Study|Adverse Event|10
5602168|NCT00888329|19354623|P2|Overall Study|Physician Decision|9
5602169|NCT00888329|19354624|P1|Overall Study|Physician Decision|6
5602170|NCT00888238|19354630|P3|Washout Period After Period 2|Adverse Event|1
5602171|NCT00888238|19354631|P2|Washout Period After Period 2|Adverse Event|0
5602172|NCT00888238|19354632|P1|Washout Period After Period 2|Adverse Event|0
5602173|NCT00888173|19354640|P1|Overall Study|Ineligible: required test not done|1
5602174|NCT00888173|19354640|P1|Overall Study|Wrong Primary|1
5602175|NCT00888134|19354648|P1|Follow-up|being followed for long-term survival|1
5602176|NCT00888134|19354648|P1|Treatment With Study Drug|Withdrawal by Subject|1
5602177|NCT00887978|19354658|P2|Overall Study|Lost to Follow-up|1
5602178|NCT00887978|19354659|P1|Overall Study|Lost to Follow-up|0
5602179|NCT00887978|19354658|P2|Overall Study|Withdrawal by Subject|2
5602180|NCT00887978|19354659|P1|Overall Study|Withdrawal by Subject|1
5602181|NCT00887978|19354658|P2|Overall Study|Death|3
5602182|NCT00887978|19354659|P1|Overall Study|Death|2
5602183|NCT00887978|19354658|P2|Overall Study|Clinical Worsening|4
5602184|NCT00887978|19354659|P1|Overall Study|Clinical Worsening|4
5602185|NCT00887978|19354658|P2|Overall Study|Adverse Event|5
5602186|NCT00887978|19354659|P1|Overall Study|Adverse Event|18
5602187|NCT00887926|19354729|P4|Overall Study|Withdrawal by Subject|0
5602188|NCT00887926|19354730|P3|Overall Study|Withdrawal by Subject|0
5602189|NCT00887926|19354731|P2|Overall Study|Withdrawal by Subject|1
5602190|NCT00887926|19354732|P1|Overall Study|Withdrawal by Subject|0
5602191|NCT00887913|19354767|P1|Overall Study|Withdrawal by Subject|6
5602192|NCT00887822|19354775|P2|Overall Study|Randomized but not treated|1
5602193|NCT00887822|19354776|P1|Overall Study|Randomized but not treated|0
5602194|NCT00887822|19354775|P2|Overall Study|Protocol Violation|1
5602195|NCT00887822|19354776|P1|Overall Study|Protocol Violation|0
5602196|NCT00887822|19354775|P2|Overall Study|Death|3
5602197|NCT00887822|19354776|P1|Overall Study|Death|2
5602198|NCT00887822|19354775|P2|Overall Study|Administrative/Other than specified|4
5602199|NCT00887822|19354776|P1|Overall Study|Administrative/Other than specified|5
5602200|NCT00887822|19354775|P2|Overall Study|Refused treatment/Did not cooperate|10
5602201|NCT00887822|19354776|P1|Overall Study|Refused treatment/Did not cooperate|12
5602202|NCT00887822|19354775|P2|Overall Study|Failure to return|11
5602203|NCT00887822|19354776|P1|Overall Study|Failure to return|11
5602204|NCT00887822|19354775|P2|Overall Study|Adverse Event|17
5602205|NCT00887822|19354776|P1|Overall Study|Adverse Event|14
5602206|NCT00887822|19354775|P2|Overall Study|Insufficient therapeutic response|55
5602207|NCT00887822|19354776|P1|Overall Study|Insufficient therapeutic response|53
5602208|NCT00887809|19354808|P2|Overall Study|Death|0
5602209|NCT00887809|19354809|P1|Overall Study|Death|1
5602210|NCT00887809|19354808|P2|Overall Study|Patient Not Treated|0
5602211|NCT00887809|19354809|P1|Overall Study|Patient Not Treated|3
5602212|NCT00887744|19354815|P1|Overall Study|Various reasons|9
5602213|NCT00887744|19354815|P1|Overall Study|Withdrawal by Subject|18
5602214|NCT00887744|19354815|P1|Overall Study|Lost to Follow-up|3
5602215|NCT00887744|19354815|P1|Overall Study|Death|1
5602216|NCT00887744|19354815|P1|Overall Study|Adverse Event|3
5602217|NCT00887679|19354824|P1|Overall Study|Physician Decision|5
5602218|NCT00887679|19354824|P1|Overall Study|Lost to Follow-up|4
5602219|NCT00887679|19354824|P1|Overall Study|Withdrawal by Subject|1
5602220|NCT00887588|19354854|P2|Extension Period|Lost to Follow-up|0
5602221|NCT00887588|19354855|P1|Extension Period|Lost to Follow-up|1
5602222|NCT00887588|19354854|P2|Extension Period|Protocol deviation|0
5602223|NCT00887588|19354855|P1|Extension Period|Protocol deviation|1
5602224|NCT00887588|19354854|P2|Extension Period|Death|1
5602225|NCT00887588|19354855|P1|Extension Period|Death|0
5602226|NCT00887588|19354854|P2|Extension Period|Adverse Event|4
5602227|NCT00887588|19354855|P1|Extension Period|Adverse Event|4
5602228|NCT00887588|19354854|P2|Core Period|Adverse Event|11
5602229|NCT00887588|19354855|P1|Core Period|Adverse Event|9
5602230|NCT00887588|19354854|P2|Core Period|Withdrawal by Subject|8
5602231|NCT00887588|19354855|P1|Core Period|Withdrawal by Subject|6
5602232|NCT00887588|19354854|P2|Core Period|Lost to Follow-up|1
5602233|NCT00887588|19354855|P1|Core Period|Lost to Follow-up|3
5602234|NCT00887588|19354854|P2|Core Period|Death|1
5602235|NCT00887588|19354855|P1|Core Period|Death|1
5602236|NCT00887549|19354936|P1|Maintenance Therapy|Death due to adverse event|1
5602237|NCT00887549|19354936|P1|Maintenance Therapy|Progressive Disease|25
5602238|NCT00887549|19354936|P1|Maintenance Therapy|Physician Decision|1
5602239|NCT00887549|19354936|P1|Maintenance Therapy|Adverse Event|16
5602240|NCT00887549|19354936|P1|Induction Therapy|Death due to Study Drug Toxicity|1
5602241|NCT00887549|19354936|P1|Induction Therapy|Death due to Study Disease|4
5602242|NCT00887549|19354936|P1|Induction Therapy|Progressive Disease|13
5602243|NCT00887549|19354936|P1|Induction Therapy|Physician Decision|1
5602244|NCT00887549|19354936|P1|Induction Therapy|Adverse Event|8
5602245|NCT00887484|19354954|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
5602246|NCT00887484|19354954|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
5602247|NCT00887484|19354954|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
5602248|NCT00887354|19355042|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
5602249|NCT00887354|19355043|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
5602250|NCT00887354|19355042|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
5602251|NCT00887354|19355043|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
5602252|NCT00887354|19355042|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
5602253|NCT00887354|19355043|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
5602254|NCT00887354|19355042|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
5602255|NCT00887354|19355043|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
5602256|NCT00887354|19355042|P2|Open Label Phase (Week 26 to Week 78)|Death|2
5602257|NCT00887354|19355043|P1|Open Label Phase (Week 26 to Week 78)|Death|0
5602258|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
5602259|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
5602260|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
5602261|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
5602262|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
5602263|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
5602264|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
5602265|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
5602266|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
5602267|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
5602268|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
5602269|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
5602270|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
5602271|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
5602272|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
5602273|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
5602274|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
5602275|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
5602276|NCT00887354|19355042|P2|Treatment Phase (Week 0 to Week 26)|Death|1
5602277|NCT00887354|19355043|P1|Treatment Phase (Week 0 to Week 26)|Death|0
5602278|NCT00887341|19355063|P2|Overall Study|Lost to Follow-up|1
5602279|NCT00887341|19355064|P1|Overall Study|Lost to Follow-up|0
5602280|NCT00887341|19355063|P2|Overall Study|Adverse Event|1
5602281|NCT00887341|19355064|P1|Overall Study|Adverse Event|0
5602282|NCT00887341|19355063|P2|Overall Study|Withdrawal by Subject|1
5602283|NCT00887341|19355064|P1|Overall Study|Withdrawal by Subject|1
5602284|NCT00887341|19355063|P2|Overall Study|Refused treatment|0
5602285|NCT00887341|19355064|P1|Overall Study|Refused treatment|1
5602286|NCT00887315|19355100|P2|Overall Study|Study termination|4
5602287|NCT00887315|19355101|P1|Overall Study|Study termination|7
5602288|NCT00887289|19355109|P1|Overall Study|Other|20
5602289|NCT00887289|19355109|P1|Overall Study|Lost to Follow-up|8
5602290|NCT00887289|19355109|P1|Overall Study|Withdrawal by Subject|26
5602291|NCT00887289|19355109|P1|Overall Study|Adverse Event|27
5602292|NCT00887289|19355109|P1|Overall Study|Lack of Efficacy|14
5602293|NCT00887250|19355121|P3|Overall Study|Patient uncooperative|1
5602294|NCT00887250|19355122|P2|Overall Study|Patient uncooperative|0
5602295|NCT00887250|19355123|P1|Overall Study|Patient uncooperative|0
5602296|NCT00887250|19355121|P3|Overall Study|Withdrawal by Subject|2
5602297|NCT00887250|19355122|P2|Overall Study|Withdrawal by Subject|1
5602298|NCT00887250|19355123|P1|Overall Study|Withdrawal by Subject|2
5602299|NCT00887250|19355121|P3|Overall Study|Protocol Violation|1
5602300|NCT00887250|19355122|P2|Overall Study|Protocol Violation|2
5602301|NCT00887250|19355123|P1|Overall Study|Protocol Violation|2
5602302|NCT00887250|19355121|P3|Overall Study|Lost to Follow-up|1
5602303|NCT00887250|19355122|P2|Overall Study|Lost to Follow-up|3
5602304|NCT00887250|19355123|P1|Overall Study|Lost to Follow-up|2
5602305|NCT00887250|19355121|P3|Overall Study|Lack of Efficacy|1
5602306|NCT00887250|19355122|P2|Overall Study|Lack of Efficacy|6
5602307|NCT00887250|19355123|P1|Overall Study|Lack of Efficacy|9
5602308|NCT00887250|19355121|P3|Overall Study|Adverse Event|7
5602309|NCT00887250|19355122|P2|Overall Study|Adverse Event|0
5602310|NCT00887250|19355123|P1|Overall Study|Adverse Event|3
5602311|NCT00887224|19355146|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
5602312|NCT00887224|19355147|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
5602313|NCT00887224|19355148|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
5602314|NCT00887224|19355146|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
5602315|NCT00887224|19355147|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
5602316|NCT00887224|19355148|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
5602317|NCT00887224|19355146|P3|DB Taper Phase / Post Study Follow Up|Other|12
5602318|NCT00887224|19355147|P2|DB Taper Phase / Post Study Follow Up|Other|11
5602319|NCT00887224|19355148|P1|DB Taper Phase / Post Study Follow Up|Other|0
5602320|NCT00887224|19355146|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
5602321|NCT00887224|19355147|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
5602322|NCT00887224|19355148|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
5602323|NCT00887224|19355146|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
5602324|NCT00887224|19355147|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
5602325|NCT00887224|19355148|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
5602326|NCT00887224|19355146|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
5602327|NCT00887224|19355147|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
5602328|NCT00887224|19355148|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
5602329|NCT00887224|19355146|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
5602330|NCT00887224|19355147|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
5602331|NCT00887224|19355148|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
5602332|NCT00887224|19355146|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
5602333|NCT00887224|19355147|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
5602334|NCT00887224|19355148|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
5602335|NCT00887224|19355146|P3|Double-blind (DB) Phase|Protocol Violation|5
5602336|NCT00887224|19355147|P2|Double-blind (DB) Phase|Protocol Violation|8
5602337|NCT00887224|19355148|P1|Double-blind (DB) Phase|Protocol Violation|0
5602338|NCT00887224|19355146|P3|Double-blind (DB) Phase|Other|0
5602339|NCT00887224|19355147|P2|Double-blind (DB) Phase|Other|2
5602340|NCT00887224|19355148|P1|Double-blind (DB) Phase|Other|0
5602341|NCT00887224|19355146|P3|Double-blind (DB) Phase|Lost to Follow-up|8
5602342|NCT00887224|19355147|P2|Double-blind (DB) Phase|Lost to Follow-up|8
5602343|NCT00887224|19355148|P1|Double-blind (DB) Phase|Lost to Follow-up|0
5602344|NCT00887224|19355146|P3|Double-blind (DB) Phase|Lack of Efficacy|33
5602345|NCT00887224|19355147|P2|Double-blind (DB) Phase|Lack of Efficacy|67
5602346|NCT00887224|19355148|P1|Double-blind (DB) Phase|Lack of Efficacy|0
5602347|NCT00887224|19355146|P3|Double-blind (DB) Phase|Failed to return|2
5602348|NCT00887224|19355147|P2|Double-blind (DB) Phase|Failed to return|2
5602349|NCT00887224|19355148|P1|Double-blind (DB) Phase|Failed to return|0
5602350|NCT00887224|19355146|P3|Double-blind (DB) Phase|Adverse Event|2
5602351|NCT00887224|19355147|P2|Double-blind (DB) Phase|Adverse Event|7
5602352|NCT00887224|19355148|P1|Double-blind (DB) Phase|Adverse Event|0
5602353|NCT00887224|19355146|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
5602354|NCT00887224|19355147|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
5602355|NCT00887224|19355148|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
5602356|NCT00887224|19355146|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
5602357|NCT00887224|19355147|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
5602358|NCT00887224|19355148|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
5602359|NCT00887224|19355146|P3|OL Taper Phase / OL Follow Up|Other|0
5602360|NCT00887224|19355147|P2|OL Taper Phase / OL Follow Up|Other|0
5602361|NCT00887224|19355148|P1|OL Taper Phase / OL Follow Up|Other|30
5602362|NCT00887224|19355146|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
5602363|NCT00887224|19355147|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
5602364|NCT00887224|19355148|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
5602365|NCT00887224|19355146|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
5602366|NCT00887224|19355147|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
5602367|NCT00887224|19355148|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
5602368|NCT00887224|19355146|P3|OL Taper Phase / OL Follow Up|Failed to return|0
5602369|NCT00887224|19355147|P2|OL Taper Phase / OL Follow Up|Failed to return|0
5602370|NCT00887224|19355148|P1|OL Taper Phase / OL Follow Up|Failed to return|17
5602371|NCT00887224|19355146|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
5602372|NCT00887224|19355147|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
5602373|NCT00887224|19355148|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
5602374|NCT00887224|19355146|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
5602375|NCT00887224|19355147|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
5602376|NCT00887224|19355148|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
5602377|NCT00887224|19355146|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
5602378|NCT00887224|19355147|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
5602379|NCT00887224|19355148|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
5602380|NCT00887224|19355146|P3|Open-label Stability (OLS) Phase|Other|0
5602381|NCT00887224|19355147|P2|Open-label Stability (OLS) Phase|Other|0
5602382|NCT00887224|19355148|P1|Open-label Stability (OLS) Phase|Other|1
5602383|NCT00887224|19355146|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
5602384|NCT00887224|19355147|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
5602385|NCT00887224|19355148|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
5602386|NCT00887224|19355146|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
5602387|NCT00887224|19355147|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
5602388|NCT00887224|19355148|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
5602389|NCT00887224|19355146|P3|Open-label Stability (OLS) Phase|Failed to return|0
5602390|NCT00887224|19355147|P2|Open-label Stability (OLS) Phase|Failed to return|0
5602391|NCT00887224|19355148|P1|Open-label Stability (OLS) Phase|Failed to return|3
5602392|NCT00887224|19355146|P3|Open-label Stability (OLS) Phase|Adverse Event|0
5602393|NCT00887224|19355147|P2|Open-label Stability (OLS) Phase|Adverse Event|0
5602394|NCT00887224|19355148|P1|Open-label Stability (OLS) Phase|Adverse Event|22
5602395|NCT00887224|19355146|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
5602396|NCT00887224|19355147|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
5602397|NCT00887224|19355148|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
5602398|NCT00887224|19355146|P3|Open-label Response (OLR) Phase|Protocol Violation|0
5602399|NCT00887224|19355147|P2|Open-label Response (OLR) Phase|Protocol Violation|0
5602400|NCT00887224|19355148|P1|Open-label Response (OLR) Phase|Protocol Violation|12
5602401|NCT00887224|19355146|P3|Open-label Response (OLR) Phase|Other|0
5602402|NCT00887224|19355147|P2|Open-label Response (OLR) Phase|Other|0
5602403|NCT00887224|19355148|P1|Open-label Response (OLR) Phase|Other|1
5602404|NCT00887224|19355146|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
5602405|NCT00887224|19355147|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
5602406|NCT00887224|19355148|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
5602407|NCT00887224|19355146|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
5602408|NCT00887224|19355147|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
5602409|NCT00887224|19355148|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
5602410|NCT00887224|19355146|P3|Open-label Response (OLR) Phase|Failed to return|0
5602411|NCT00887224|19355147|P2|Open-label Response (OLR) Phase|Failed to return|0
5602412|NCT00887224|19355148|P1|Open-label Response (OLR) Phase|Failed to return|6
5602413|NCT00887224|19355146|P3|Open-label Response (OLR) Phase|Adverse Event|0
5602414|NCT00887224|19355147|P2|Open-label Response (OLR) Phase|Adverse Event|0
5602415|NCT00887224|19355148|P1|Open-label Response (OLR) Phase|Adverse Event|46
5602416|NCT00887198|19355175|P3|Cross Over (Placebo to AA)|Other|19
5602417|NCT00887198|19355176|P2|Cross Over (Placebo to AA)|Other|0
5602418|NCT00887198|19355177|P1|Cross Over (Placebo to AA)|Other|0
5602419|NCT00887198|19355175|P3|Cross Over (Placebo to AA)|Progressive disease|20
5602420|NCT00887198|19355176|P2|Cross Over (Placebo to AA)|Progressive disease|0
5602421|NCT00887198|19355177|P1|Cross Over (Placebo to AA)|Progressive disease|0
5602422|NCT00887198|19355175|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
5602423|NCT00887198|19355176|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
5602424|NCT00887198|19355177|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
5602425|NCT00887198|19355175|P3|Cross Over (Placebo to AA)|Adverse Event|9
5602426|NCT00887198|19355176|P2|Cross Over (Placebo to AA)|Adverse Event|0
5602427|NCT00887198|19355177|P1|Cross Over (Placebo to AA)|Adverse Event|0
5602428|NCT00887198|19355175|P3|Cross Over (Placebo to AA)|Ongoing|35
5602429|NCT00887198|19355176|P2|Cross Over (Placebo to AA)|Ongoing|0
5602430|NCT00887198|19355177|P1|Cross Over (Placebo to AA)|Ongoing|0
5602431|NCT00887198|19355175|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
5602432|NCT00887198|19355176|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
5602433|NCT00887198|19355177|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
5602434|NCT00887198|19355175|P3|Randomized Period|Randomized, Not treated|0
5602435|NCT00887198|19355176|P2|Randomized Period|Randomized, Not treated|2
5602436|NCT00887198|19355177|P1|Randomized Period|Randomized, Not treated|4
5602437|NCT00887198|19355175|P3|Randomized Period|Other|0
5602438|NCT00887198|19355176|P2|Randomized Period|Other|30
5602439|NCT00887198|19355177|P1|Randomized Period|Other|42
5602440|NCT00887198|19355175|P3|Randomized Period|Progressive disease|0
5602441|NCT00887198|19355176|P2|Randomized Period|Progressive disease|370
5602442|NCT00887198|19355177|P1|Randomized Period|Progressive disease|366
5602443|NCT00887198|19355175|P3|Randomized Period|Withdrawal by Subject|0
5602444|NCT00887198|19355176|P2|Randomized Period|Withdrawal by Subject|56
5602445|NCT00887198|19355177|P1|Randomized Period|Withdrawal by Subject|41
5602446|NCT00887198|19355175|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
5602447|NCT00887198|19355176|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
5602448|NCT00887198|19355177|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
5602449|NCT00887198|19355175|P3|Randomized Period|Lost to Follow-up|0
5602450|NCT00887198|19355176|P2|Randomized Period|Lost to Follow-up|0
5602451|NCT00887198|19355177|P1|Randomized Period|Lost to Follow-up|1
5602452|NCT00887198|19355175|P3|Randomized Period|Adverse Event|0
5602453|NCT00887198|19355176|P2|Randomized Period|Adverse Event|33
5602454|NCT00887198|19355177|P1|Randomized Period|Adverse Event|50
5602455|NCT00887198|19355175|P3|Randomized Period|Ongoing|0
5602456|NCT00887198|19355176|P2|Randomized Period|Ongoing|0
5602457|NCT00887198|19355177|P1|Randomized Period|Ongoing|42
5602458|NCT00887159|19355208|P3|Overall Study|Never started assigned therapy|4
5602459|NCT00887159|19355209|P2|Overall Study|Never started assigned therapy|3
5602460|NCT00887159|19355210|P1|Overall Study|Never started assigned therapy|3
5602461|NCT00887159|19355208|P3|Overall Study|Ineligible|0
5602462|NCT00887159|19355209|P2|Overall Study|Ineligible|1
5602463|NCT00887159|19355210|P1|Overall Study|Ineligible|5
5602464|NCT00887159|19355208|P3|Overall Study|Received more tx instead of observation|0
5602465|NCT00887159|19355209|P2|Overall Study|Received more tx instead of observation|0
5602466|NCT00887159|19355210|P1|Overall Study|Received more tx instead of observation|1
5602467|NCT00887159|19355208|P3|Overall Study|Pt had PD but was SD when re-measured|0
5602468|NCT00887159|19355209|P2|Overall Study|Pt had PD but was SD when re-measured|1
5602469|NCT00887159|19355210|P1|Overall Study|Pt had PD but was SD when re-measured|0
5602470|NCT00887159|19355208|P3|Overall Study|Treatment delayed|0
5602471|NCT00887159|19355209|P2|Overall Study|Treatment delayed|1
5602472|NCT00887159|19355210|P1|Overall Study|Treatment delayed|1
5602473|NCT00887159|19355208|P3|Overall Study|Sympomatic deterioration|0
5602474|NCT00887159|19355209|P2|Overall Study|Sympomatic deterioration|0
5602475|NCT00887159|19355210|P1|Overall Study|Sympomatic deterioration|1
5602476|NCT00887159|19355208|P3|Overall Study|Physician Decision|0
5602477|NCT00887159|19355209|P2|Overall Study|Physician Decision|1
5602478|NCT00887159|19355210|P1|Overall Study|Physician Decision|1
5602479|NCT00887159|19355208|P3|Overall Study|Alternative therapy|0
5602480|NCT00887159|19355209|P2|Overall Study|Alternative therapy|0
5602481|NCT00887159|19355210|P1|Overall Study|Alternative therapy|2
5602482|NCT00887159|19355208|P3|Overall Study|Withdrawal by Subject|2
5602483|NCT00887159|19355209|P2|Overall Study|Withdrawal by Subject|4
5602484|NCT00887159|19355210|P1|Overall Study|Withdrawal by Subject|4
5602485|NCT00887159|19355208|P3|Overall Study|Death|0
5602486|NCT00887159|19355209|P2|Overall Study|Death|2
5602487|NCT00887159|19355210|P1|Overall Study|Death|2
5602488|NCT00887159|19355208|P3|Overall Study|Adverse Event|17
5602489|NCT00887159|19355209|P2|Overall Study|Adverse Event|4
5602490|NCT00887159|19355210|P1|Overall Study|Adverse Event|3
5602491|NCT00887159|19355208|P3|Overall Study|Disease progression|33
5602492|NCT00887159|19355209|P2|Overall Study|Disease progression|39
5602493|NCT00887159|19355210|P1|Overall Study|Disease progression|6
5602494|NCT00887068|19355228|P2|Overall Study|Didn't meet eligibility to start cycle 1|0
5602495|NCT00887068|19355229|P1|Overall Study|Didn't meet eligibility to start cycle 1|4
5602496|NCT00887068|19355228|P2|Overall Study|Withdrawal by Subject|0
5602497|NCT00887068|19355229|P1|Overall Study|Withdrawal by Subject|2
5602498|NCT00886938|19355237|P1|Overall Study|Withdrawal by Subject|1
5602499|NCT00886938|19355237|P1|Overall Study|Adverse Event|1
5602500|NCT00886834|19355250|P2|Overall Study|Protocol Violation|3
5602501|NCT00886834|19355251|P1|Overall Study|Protocol Violation|0
5602502|NCT00886821|19355273|P14|Stage 2|Lost to Follow-up|1
5602503|NCT00886821|19355274|P13|Stage 2|Lost to Follow-up|2
5602504|NCT00886821|19355275|P12|Stage 2|Lost to Follow-up|0
5602505|NCT00886821|19355276|P11|Stage 2|Lost to Follow-up|0
5602506|NCT00886821|19355277|P10|Stage 2|Lost to Follow-up|0
5602507|NCT00886821|19355278|P9|Stage 2|Lost to Follow-up|0
5602508|NCT00886821|19355279|P8|Stage 2|Lost to Follow-up|0
5602509|NCT00886821|19355280|P7|Stage 2|Lost to Follow-up|0
5602510|NCT00886821|19355281|P6|Stage 2|Lost to Follow-up|0
5602511|NCT00886821|19355282|P5|Stage 2|Lost to Follow-up|0
5602512|NCT00886821|19355283|P4|Stage 2|Lost to Follow-up|0
5602513|NCT00886821|19355284|P3|Stage 2|Lost to Follow-up|0
5602514|NCT00886821|19355285|P2|Stage 2|Lost to Follow-up|0
5602515|NCT00886821|19355286|P1|Stage 2|Lost to Follow-up|0
5602516|NCT00886821|19355273|P14|Stage 2|Adverse Event|0
5602517|NCT00886821|19355274|P13|Stage 2|Adverse Event|3
5602518|NCT00886821|19355275|P12|Stage 2|Adverse Event|1
5602519|NCT00886821|19355276|P11|Stage 2|Adverse Event|0
5602520|NCT00886821|19355277|P10|Stage 2|Adverse Event|0
5602521|NCT00886821|19355278|P9|Stage 2|Adverse Event|0
5602522|NCT00886821|19355279|P8|Stage 2|Adverse Event|0
5602523|NCT00886821|19355280|P7|Stage 2|Adverse Event|0
5602524|NCT00886821|19355281|P6|Stage 2|Adverse Event|0
5602525|NCT00886821|19355282|P5|Stage 2|Adverse Event|0
5602526|NCT00886821|19355283|P4|Stage 2|Adverse Event|0
5602527|NCT00886821|19355284|P3|Stage 2|Adverse Event|0
5602528|NCT00886821|19355285|P2|Stage 2|Adverse Event|0
5602529|NCT00886821|19355286|P1|Stage 2|Adverse Event|0
5602530|NCT00886795|19355511|P1|Overall Study|Lack of Efficacy|1
5602531|NCT00886769|19355518|P2|Overall Study|Unsatisfactory therapeutic effect|37
5602532|NCT00886769|19355519|P1|Overall Study|Unsatisfactory therapeutic effect|6
5602533|NCT00886743|19355543|P1|Overall Study|Other|1
5602534|NCT00886743|19355543|P1|Overall Study|Adverse Event|3
5602535|NCT00886639|19355581|P1|Overall Study|non-compliance|2
5602536|NCT00886639|19355581|P1|Overall Study|acute exacerbation|14
5602537|NCT00886613|19355595|P3|Overall Study|Subject withdrew consent (Part A)|2
5602538|NCT00886613|19355596|P2|Overall Study|Subject withdrew consent (Part A)|0
5602539|NCT00886613|19355597|P1|Overall Study|Subject withdrew consent (Part A)|0
5602540|NCT00886613|19355595|P3|Overall Study|Lost to follow-up (Part B)|1
5602541|NCT00886613|19355596|P2|Overall Study|Lost to follow-up (Part B)|0
5602542|NCT00886613|19355597|P1|Overall Study|Lost to follow-up (Part B)|1
5602543|NCT00886613|19355595|P3|Overall Study|Protocol deviation (Part B)|0
5602544|NCT00886613|19355596|P2|Overall Study|Protocol deviation (Part B)|0
5602545|NCT00886613|19355597|P1|Overall Study|Protocol deviation (Part B)|1
5602546|NCT00886600|19355619|P4|Combination Therapy Period|Protocol Violation|0
5602547|NCT00886600|19355620|P3|Combination Therapy Period|Protocol Violation|1
5602548|NCT00886600|19355621|P2|Combination Therapy Period|Protocol Violation|0
5602549|NCT00886600|19355622|P1|Combination Therapy Period|Protocol Violation|0
5602550|NCT00886600|19355619|P4|Combination Therapy Period|Adverse Event|0
5602551|NCT00886600|19355620|P3|Combination Therapy Period|Adverse Event|1
5602552|NCT00886600|19355621|P2|Combination Therapy Period|Adverse Event|0
5602553|NCT00886600|19355622|P1|Combination Therapy Period|Adverse Event|0
5602554|NCT00886600|19355619|P4|Double-blind Monotherapy|Withdrawal by Subject|0
5602555|NCT00886600|19355620|P3|Double-blind Monotherapy|Withdrawal by Subject|0
5602556|NCT00886600|19355621|P2|Double-blind Monotherapy|Withdrawal by Subject|0
5602557|NCT00886600|19355622|P1|Double-blind Monotherapy|Withdrawal by Subject|1
5602558|NCT00886600|19355619|P4|Double-blind Monotherapy|Protocol Violation|1
5602559|NCT00886600|19355620|P3|Double-blind Monotherapy|Protocol Violation|0
5602560|NCT00886600|19355621|P2|Double-blind Monotherapy|Protocol Violation|0
5602561|NCT00886600|19355622|P1|Double-blind Monotherapy|Protocol Violation|0
5602562|NCT00886600|19355619|P4|Double-blind Monotherapy|Adverse Event|1
5602563|NCT00886600|19355620|P3|Double-blind Monotherapy|Adverse Event|1
5602564|NCT00886600|19355621|P2|Double-blind Monotherapy|Adverse Event|1
5602565|NCT00886600|19355622|P1|Double-blind Monotherapy|Adverse Event|1
5602566|NCT00886587|19355646|P2|Overall Study|Withdrawal by Subject|1
5602567|NCT00886587|19355647|P1|Overall Study|Withdrawal by Subject|0
5602568|NCT00886587|19355646|P2|Overall Study|Protocol Violation|0
5602569|NCT00886587|19355647|P1|Overall Study|Protocol Violation|2
5602570|NCT00886587|19355646|P2|Overall Study|Adverse Event|1
5602571|NCT00886587|19355647|P1|Overall Study|Adverse Event|2
5602572|NCT00886483|19355661|P2|Overall Study|Distance to center, poor grades|0
5602573|NCT00886483|19355662|P1|Overall Study|Distance to center, poor grades|1
5602574|NCT00886483|19355661|P2|Overall Study|Pursue medications|2
5602575|NCT00886483|19355662|P1|Overall Study|Pursue medications|1
5602576|NCT00886483|19355661|P2|Overall Study|Lost to Follow-up|1
5602577|NCT00886483|19355662|P1|Overall Study|Lost to Follow-up|0
5602578|NCT00886340|19355680|P2|Overall Study|Withdrawal by Subject|7
5602579|NCT00886340|19355681|P1|Overall Study|Withdrawal by Subject|0
5602580|NCT00886288|19355689|P2|Overall Study|Lost to Follow-up|0
5602581|NCT00886288|19355690|P1|Overall Study|Lost to Follow-up|86
5602582|NCT00886288|19355689|P2|Overall Study|no respect of the 12 weeks period|227
5602583|NCT00886288|19355690|P1|Overall Study|no respect of the 12 weeks period|657
5602584|NCT00886119|19355746|P2|Period 1|Did not meet inclusion criteria|0
5602585|NCT00886119|19355747|P1|Period 1|Did not meet inclusion criteria|1
5602586|NCT00886015|19355755|P2|Overall Study|Death|2
5602587|NCT00886015|19355756|P1|Overall Study|Death|0
5602588|NCT00885846|19355775|P3|Overall Study|Withdrawal by Subject|2
5602589|NCT00885846|19355776|P2|Overall Study|Withdrawal by Subject|5
5602590|NCT00885846|19355777|P1|Overall Study|Withdrawal by Subject|2
5602591|NCT00885755|19355792|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
5602592|NCT00885755|19355793|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
5602593|NCT00885755|19355794|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
5602594|NCT00885755|19355792|P3|Part I: Trastuzumab+Taxane|Death|1
5602595|NCT00885755|19355793|P2|Part I: Trastuzumab+Taxane|Death|0
5602596|NCT00885755|19355794|P1|Part I: Trastuzumab+Taxane|Death|0
5602597|NCT00885755|19355792|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
5602598|NCT00885755|19355793|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
5602599|NCT00885755|19355794|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
5602600|NCT00885755|19355792|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
5602601|NCT00885755|19355793|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
5602602|NCT00885755|19355794|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
5602603|NCT00885755|19355792|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
5602604|NCT00885755|19355793|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
5602605|NCT00885755|19355794|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
5602606|NCT00885703|19355837|P7|Overall Study|Ineligible (no CM)|1
5602607|NCT00885703|19355838|P6|Overall Study|Ineligible (no CM)|3
5602608|NCT00885703|19355839|P5|Overall Study|Ineligible (no CM)|2
5602609|NCT00885703|19355840|P4|Overall Study|Ineligible (no CM)|1
5602610|NCT00885703|19355841|P3|Overall Study|Ineligible (no CM)|2
5602611|NCT00885703|19355842|P2|Overall Study|Ineligible (no CM)|3
5602612|NCT00885703|19355843|P1|Overall Study|Ineligible (no CM)|1
5602613|NCT00885703|19355837|P7|Overall Study|Withdrawal by Subject|1
5602614|NCT00885703|19355838|P6|Overall Study|Withdrawal by Subject|1
5602615|NCT00885703|19355839|P5|Overall Study|Withdrawal by Subject|3
5602616|NCT00885703|19355840|P4|Overall Study|Withdrawal by Subject|1
5602617|NCT00885703|19355841|P3|Overall Study|Withdrawal by Subject|0
5602618|NCT00885703|19355842|P2|Overall Study|Withdrawal by Subject|0
5602619|NCT00885703|19355843|P1|Overall Study|Withdrawal by Subject|0
5602620|NCT00885703|19355837|P7|Overall Study|Lost to Follow-up|0
5602621|NCT00885703|19355838|P6|Overall Study|Lost to Follow-up|1
5602622|NCT00885703|19355839|P5|Overall Study|Lost to Follow-up|0
5602623|NCT00885703|19355840|P4|Overall Study|Lost to Follow-up|0
5602624|NCT00885703|19355841|P3|Overall Study|Lost to Follow-up|1
5602625|NCT00885703|19355842|P2|Overall Study|Lost to Follow-up|0
5602626|NCT00885703|19355843|P1|Overall Study|Lost to Follow-up|0
5602627|NCT00885703|19355837|P7|Overall Study|Death|4
5602628|NCT00885703|19355838|P6|Overall Study|Death|8
5602629|NCT00885703|19355839|P5|Overall Study|Death|7
5602630|NCT00885703|19355840|P4|Overall Study|Death|7
5602631|NCT00885703|19355841|P3|Overall Study|Death|8
5602632|NCT00885703|19355842|P2|Overall Study|Death|7
5602633|NCT00885703|19355843|P1|Overall Study|Death|9
5602634|NCT00885677|19355901|P2|Overall Study|Inclusion/exclusion not met|27
5602635|NCT00885677|19355902|P1|Overall Study|Inclusion/exclusion not met|25
5602636|NCT00885677|19355901|P2|Overall Study|Heart transplantation|0
5602637|NCT00885677|19355902|P1|Overall Study|Heart transplantation|1
5602638|NCT00885677|19355901|P2|Overall Study|device/lead revision or replacement|6
5602639|NCT00885677|19355902|P1|Overall Study|device/lead revision or replacement|7
5602640|NCT00885677|19355901|P2|Overall Study|premature study closure|44
5602641|NCT00885677|19355902|P1|Overall Study|premature study closure|41
5602642|NCT00885677|19355901|P2|Overall Study|Protocol Violation|54
5602643|NCT00885677|19355902|P1|Overall Study|Protocol Violation|54
5602644|NCT00885677|19355901|P2|Overall Study|Lost to Follow-up|13
5602645|NCT00885677|19355902|P1|Overall Study|Lost to Follow-up|15
5602646|NCT00885677|19355901|P2|Overall Study|Death|34
5602647|NCT00885677|19355902|P1|Overall Study|Death|40
5602648|NCT00885534|19355918|P1|Overall Study|Patient deemed ineligible|1
5602649|NCT00885482|19355922|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
5602650|NCT00885482|19355922|P1|Overall Study|Death|1
5602651|NCT00885482|19355922|P1|Overall Study|Lack of Efficacy|1
5602652|NCT00885482|19355922|P1|Overall Study|Pregnancy|1
5602653|NCT00885378|19355928|P2|Overall Study|Protocol Violation|0
5602654|NCT00885378|19355929|P1|Overall Study|Protocol Violation|2
5602655|NCT00885378|19355928|P2|Overall Study|Poor/Noncompliance|2
5602656|NCT00885378|19355929|P1|Overall Study|Poor/Noncompliance|2
5602657|NCT00885378|19355928|P2|Overall Study|Lost to Follow-up|2
5602658|NCT00885378|19355929|P1|Overall Study|Lost to Follow-up|1
5602659|NCT00885378|19355928|P2|Overall Study|Withdrawal by Subject|2
5602660|NCT00885378|19355929|P1|Overall Study|Withdrawal by Subject|1
5602661|NCT00885378|19355928|P2|Overall Study|Lack of Efficacy|2
5602662|NCT00885378|19355929|P1|Overall Study|Lack of Efficacy|2
5602663|NCT00885365|19355959|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
5602664|NCT00885365|19355960|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
5602665|NCT00885365|19355959|P2|4 Weeks ON Treatment|Protocol Violation|2
5602666|NCT00885365|19355960|P1|4 Weeks ON Treatment|Protocol Violation|1
5602667|NCT00885365|19355959|P2|4 Weeks ON Treatment|Adverse Event|4
5602668|NCT00885365|19355960|P1|4 Weeks ON Treatment|Adverse Event|2
5602669|NCT00885352|19355996|P2|Overall Study|Lab abnormalities|1
5602670|NCT00885352|19355997|P1|Overall Study|Lab abnormalities|1
5602671|NCT00885352|19355996|P2|Overall Study|Excluded medication|2
5602672|NCT00885352|19355997|P1|Overall Study|Excluded medication|2
5602673|NCT00885352|19355996|P2|Overall Study|Contradiction to study medication|2
5602674|NCT00885352|19355997|P1|Overall Study|Contradiction to study medication|0
5602675|NCT00885352|19355996|P2|Overall Study|Withdrawal by Subject|5
5602676|NCT00885352|19355997|P1|Overall Study|Withdrawal by Subject|1
5602677|NCT00885352|19355996|P2|Overall Study|Protocol Violation|2
5602678|NCT00885352|19355997|P1|Overall Study|Protocol Violation|0
5602679|NCT00885352|19355996|P2|Overall Study|Physician Decision|3
5602680|NCT00885352|19355997|P1|Overall Study|Physician Decision|0
5602681|NCT00885352|19355996|P2|Overall Study|Lost to Follow-up|2
5602682|NCT00885352|19355997|P1|Overall Study|Lost to Follow-up|2
5602683|NCT00885352|19355996|P2|Overall Study|Adverse Event|3
5602684|NCT00885352|19355997|P1|Overall Study|Adverse Event|2
5602685|NCT00885170|19356009|P2|Overall Study|Withdrawal by Subject|13
5602686|NCT00885170|19356010|P1|Overall Study|Withdrawal by Subject|13
5602687|NCT00885170|19356009|P2|Overall Study|Protocol Violation|1
5602688|NCT00885170|19356010|P1|Overall Study|Protocol Violation|3
5602689|NCT00885170|19356009|P2|Overall Study|Physician Decision|1
5602690|NCT00885170|19356010|P1|Overall Study|Physician Decision|2
5602691|NCT00885170|19356009|P2|Overall Study|Lost to Follow-up|1
5602692|NCT00885170|19356010|P1|Overall Study|Lost to Follow-up|2
5602693|NCT00885170|19356009|P2|Overall Study|Excessive bone loss|3
5602694|NCT00885170|19356010|P1|Overall Study|Excessive bone loss|6
5602695|NCT00885170|19356009|P2|Overall Study|Adverse Event|4
5602696|NCT00885170|19356010|P1|Overall Study|Adverse Event|12
5602697|NCT00885118|19356069|P5|Overall Study|Other reason not defined above|0
5602698|NCT00885118|19356070|P4|Overall Study|Other reason not defined above|0
5602699|NCT00885118|19356071|P3|Overall Study|Other reason not defined above|1
5602700|NCT00885118|19356072|P2|Overall Study|Other reason not defined above|0
5602701|NCT00885118|19356073|P1|Overall Study|Other reason not defined above|0
5602702|NCT00885118|19356069|P5|Overall Study|Withdrawal by Subject|1
5602703|NCT00885118|19356070|P4|Overall Study|Withdrawal by Subject|0
5602704|NCT00885118|19356071|P3|Overall Study|Withdrawal by Subject|0
5602705|NCT00885118|19356072|P2|Overall Study|Withdrawal by Subject|0
5602706|NCT00885118|19356073|P1|Overall Study|Withdrawal by Subject|0
5602707|NCT00885118|19356069|P5|Overall Study|Adverse Event|0
5602708|NCT00885118|19356070|P4|Overall Study|Adverse Event|0
5602709|NCT00885118|19356071|P3|Overall Study|Adverse Event|0
5602710|NCT00885118|19356072|P2|Overall Study|Adverse Event|0
5602711|NCT00885118|19356073|P1|Overall Study|Adverse Event|1
5602712|NCT00885105|19356212|P2|Overall Study|Protocol Violation|2
5602713|NCT00885105|19356213|P1|Overall Study|Protocol Violation|0
5602714|NCT00885105|19356212|P2|Overall Study|Adverse Event|0
5602715|NCT00885105|19356213|P1|Overall Study|Adverse Event|1
5602716|NCT00885105|19356212|P2|Overall Study|Withdrawal by Subject|8
5602717|NCT00885105|19356213|P1|Overall Study|Withdrawal by Subject|0
5602718|NCT00884949|19356253|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
5602719|NCT00884949|19356253|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
5602720|NCT00884832|19356288|P2|Overall Study|Withdrawal by Subject|1
5602721|NCT00884832|19356289|P1|Overall Study|Withdrawal by Subject|0
5602722|NCT00884793|19356324|P1|Overall Study|Withdrawal by Subject|1
5602723|NCT00884741|19356343|P4|Randomization|Protocol Violation|8
5602724|NCT00884741|19356344|P3|Randomization|Protocol Violation|8
5602725|NCT00884741|19356345|P2|Randomization|Protocol Violation|0
5602726|NCT00884741|19356346|P1|Randomization|Protocol Violation|0
5602727|NCT00884741|19356343|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
5602728|NCT00884741|19356344|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
5602809|NCT00884312|19356449|P2|Overall Study|Non-fatal Adverse Event|0
5602729|NCT00884741|19356345|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
5602730|NCT00884741|19356346|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
5602731|NCT00884741|19356343|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
5602732|NCT00884741|19356344|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
5602733|NCT00884741|19356345|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
5602734|NCT00884741|19356346|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
5602735|NCT00884741|19356343|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
5602736|NCT00884741|19356344|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
5602737|NCT00884741|19356345|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
5602738|NCT00884741|19356346|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
5602739|NCT00884741|19356343|P4|Step 2 Registration: Tissue Analysis|Death|0
5602740|NCT00884741|19356344|P3|Step 2 Registration: Tissue Analysis|Death|0
5602741|NCT00884741|19356345|P2|Step 2 Registration: Tissue Analysis|Death|1
5602742|NCT00884741|19356346|P1|Step 2 Registration: Tissue Analysis|Death|0
5602743|NCT00884741|19356343|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
5602744|NCT00884741|19356344|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
5602745|NCT00884741|19356345|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
5602746|NCT00884741|19356346|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
5602747|NCT00884741|19356343|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
5602748|NCT00884741|19356344|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
5602749|NCT00884741|19356345|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
5602750|NCT00884741|19356346|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
5602751|NCT00884741|19356343|P4|Step 1 Registration: Tissue Screening|Disease progression|0
5602752|NCT00884741|19356344|P3|Step 1 Registration: Tissue Screening|Disease progression|0
5602753|NCT00884741|19356345|P2|Step 1 Registration: Tissue Screening|Disease progression|0
5602754|NCT00884741|19356346|P1|Step 1 Registration: Tissue Screening|Disease progression|12
5602755|NCT00884741|19356343|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
5602756|NCT00884741|19356344|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
5602757|NCT00884741|19356345|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
5602758|NCT00884741|19356346|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
5602759|NCT00884741|19356343|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
5602760|NCT00884741|19356344|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
5602761|NCT00884741|19356345|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
5602762|NCT00884741|19356346|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
5602763|NCT00884741|19356343|P4|Step 1 Registration: Tissue Screening|Death|0
5602764|NCT00884741|19356344|P3|Step 1 Registration: Tissue Screening|Death|0
5602765|NCT00884741|19356345|P2|Step 1 Registration: Tissue Screening|Death|0
5602766|NCT00884741|19356346|P1|Step 1 Registration: Tissue Screening|Death|3
5602767|NCT00884741|19356343|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
5602768|NCT00884741|19356344|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
5602769|NCT00884741|19356345|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
5602770|NCT00884741|19356346|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
5602771|NCT00884390|19356396|P2|Overall Study|Other|1
5602772|NCT00884390|19356397|P1|Overall Study|Other|11
5602773|NCT00884390|19356396|P2|Overall Study|Discontinuation of Study by Sponsor|2
5602774|NCT00884390|19356397|P1|Overall Study|Discontinuation of Study by Sponsor|2
5602775|NCT00884390|19356396|P2|Overall Study|Withdrawal by Subject|1
5602776|NCT00884390|19356397|P1|Overall Study|Withdrawal by Subject|4
5602777|NCT00884390|19356396|P2|Overall Study|Protocol Violation|1
5602778|NCT00884390|19356397|P1|Overall Study|Protocol Violation|4
5602779|NCT00884390|19356396|P2|Overall Study|Physician Decision|1
5602780|NCT00884390|19356397|P1|Overall Study|Physician Decision|2
5602781|NCT00884390|19356396|P2|Overall Study|Lost to Follow-up|1
5602782|NCT00884390|19356397|P1|Overall Study|Lost to Follow-up|0
5602783|NCT00884390|19356396|P2|Overall Study|Adverse Event|1
5602784|NCT00884390|19356397|P1|Overall Study|Adverse Event|0
5602785|NCT00884377|19356415|P2|Overall Study|Physician Decision|1
5602786|NCT00884377|19356416|P1|Overall Study|Physician Decision|0
5602787|NCT00884377|19356415|P2|Overall Study|Could not confirm diagnosis|0
5602788|NCT00884377|19356416|P1|Overall Study|Could not confirm diagnosis|1
5602789|NCT00884377|19356415|P2|Overall Study|Withdrawal by Subject|0
5602790|NCT00884377|19356416|P1|Overall Study|Withdrawal by Subject|1
5602791|NCT00884325|19356438|P2|Overall Study|Not provided|0
5602792|NCT00884325|19356439|P1|Overall Study|Not provided|1
5602793|NCT00884325|19356438|P2|Overall Study|Withdrawal by Subject|1
5602794|NCT00884325|19356439|P1|Overall Study|Withdrawal by Subject|1
5602795|NCT00884325|19356438|P2|Overall Study|Lack of Efficacy|1
5602796|NCT00884325|19356439|P1|Overall Study|Lack of Efficacy|0
5602797|NCT00884325|19356438|P2|Overall Study|Lost to Follow-up|2
5602798|NCT00884325|19356439|P1|Overall Study|Lost to Follow-up|1
5602799|NCT00884312|19356449|P2|Overall Study|Did Not Receive Study Drug|1
5602800|NCT00884312|19356450|P1|Overall Study|Did Not Receive Study Drug|0
5602801|NCT00884312|19356449|P2|Overall Study|Other|4
5602802|NCT00884312|19356450|P1|Overall Study|Other|0
5602803|NCT00884312|19356449|P2|Overall Study|Physician Decision|1
5602804|NCT00884312|19356450|P1|Overall Study|Physician Decision|0
5602805|NCT00884312|19356449|P2|Overall Study|Withdrawal by Subject|6
5602806|NCT00884312|19356450|P1|Overall Study|Withdrawal by Subject|0
5602807|NCT00884312|19356449|P2|Overall Study|Fatal Adverse Event|4
5602808|NCT00884312|19356450|P1|Overall Study|Fatal Adverse Event|1
5602810|NCT00884312|19356450|P1|Overall Study|Non-fatal Adverse Event|1
5602811|NCT00884312|19356449|P2|Overall Study|Fatal Progressive Disease|1
5602812|NCT00884312|19356450|P1|Overall Study|Fatal Progressive Disease|0
5602813|NCT00884312|19356449|P2|Overall Study|Non-fatal Progressive Disease|8
5602814|NCT00884312|19356450|P1|Overall Study|Non-fatal Progressive Disease|0
5602815|NCT00884286|19356466|P2|Overall Study|Comprised lung carcinoma|1
5602816|NCT00884286|19356467|P1|Overall Study|Comprised lung carcinoma|0
5602817|NCT00884286|19356466|P2|Overall Study|Not treated|1
5602818|NCT00884286|19356467|P1|Overall Study|Not treated|2
5602819|NCT00884286|19356466|P2|Overall Study|Thrombus in right auricle|0
5602820|NCT00884286|19356467|P1|Overall Study|Thrombus in right auricle|1
5602821|NCT00884286|19356466|P2|Overall Study|Septic shock|0
5602822|NCT00884286|19356467|P1|Overall Study|Septic shock|1
5602823|NCT00884286|19356466|P2|Overall Study|Physician Decision|0
5602824|NCT00884286|19356467|P1|Overall Study|Physician Decision|1
5602825|NCT00884286|19356466|P2|Overall Study|Death|2
5602826|NCT00884286|19356467|P1|Overall Study|Death|2
5602827|NCT00884286|19356466|P2|Overall Study|Toxicity|1
5602828|NCT00884286|19356467|P1|Overall Study|Toxicity|4
5602829|NCT00884286|19356466|P2|Overall Study|Progressive disease|28
5602830|NCT00884286|19356467|P1|Overall Study|Progressive disease|21
5602831|NCT00884273|19356481|P2|Overall Study|Practical reasons|0
5602832|NCT00884273|19356482|P1|Overall Study|Practical reasons|1
5602833|NCT00884273|19356481|P2|Overall Study|Protocol Violation|3
5602834|NCT00884273|19356482|P1|Overall Study|Protocol Violation|1
5602835|NCT00884273|19356481|P2|Overall Study|Adverse Event|2
5602836|NCT00884273|19356482|P1|Overall Study|Adverse Event|0
5602837|NCT00884221|19356508|P2|Overall Study|Cancellation of Cycle and Other Reason|13
5602838|NCT00884221|19356509|P1|Overall Study|Cancellation of Cycle and Other Reason|12
5602839|NCT00884221|19356508|P2|Overall Study|Protocol Violation|13
5602840|NCT00884221|19356509|P1|Overall Study|Protocol Violation|16
5602841|NCT00884221|19356508|P2|Overall Study|Adverse Event|3
5602842|NCT00884221|19356509|P1|Overall Study|Adverse Event|6
5602843|NCT00884221|19356508|P2|Overall Study|Withdrawal by Subject|3
5602844|NCT00884221|19356509|P1|Overall Study|Withdrawal by Subject|0
5602845|NCT00884117|19356545|P1|Overall Study|Other|12
5602846|NCT00884117|19356545|P1|Overall Study|Lost to Follow-up|143
5602847|NCT00884117|19356545|P1|Overall Study|Death|3
5602848|NCT00884117|19356545|P1|Overall Study|Withdrawal by Subject|89
5602849|NCT00884117|19356545|P1|Overall Study|Adverse Event|2
5602850|NCT00884039|19356616|P2|Overall Study|Lack of Efficacy|0
5602851|NCT00884039|19356617|P1|Overall Study|Lack of Efficacy|2
5602852|NCT00884039|19356616|P2|Overall Study|Withdrawal by Subject|1
5602853|NCT00884039|19356617|P1|Overall Study|Withdrawal by Subject|0
5602854|NCT00883779|19356625|P2|Off-study Phase|Other|21
5602855|NCT00883779|19356626|P1|Off-study Phase|Other|18
5602856|NCT00883779|19356625|P2|Off-study Phase|Failure to return|6
5602857|NCT00883779|19356626|P1|Off-study Phase|Failure to return|5
5602858|NCT00883779|19356625|P2|Off-study Phase|Refused treatment|1
5602859|NCT00883779|19356626|P1|Off-study Phase|Refused treatment|1
5602860|NCT00883779|19356625|P2|Off-study Phase|Death|174
5602861|NCT00883779|19356626|P1|Off-study Phase|Death|185
5602862|NCT00883779|19356625|P2|Post-Study Treatment Phase|Ongoing in the study|6
5602863|NCT00883779|19356626|P1|Post-Study Treatment Phase|Ongoing in the study|0
5602864|NCT00883779|19356625|P2|Post-Study Treatment Phase|Other|0
5602865|NCT00883779|19356626|P1|Post-Study Treatment Phase|Other|3
5602866|NCT00883779|19356625|P2|Post-Study Treatment Phase|Disease progression|122
5602867|NCT00883779|19356626|P1|Post-Study Treatment Phase|Disease progression|103
5602868|NCT00883779|19356625|P2|Post-Study Treatment Phase|Refused Treatment|0
5602869|NCT00883779|19356626|P1|Post-Study Treatment Phase|Refused Treatment|3
5602870|NCT00883779|19356625|P2|Post-Study Treatment Phase|Protocol Violation|1
5602871|NCT00883779|19356626|P1|Post-Study Treatment Phase|Protocol Violation|0
5602872|NCT00883779|19356625|P2|Post-Study Treatment Phase|Death|3
5602873|NCT00883779|19356626|P1|Post-Study Treatment Phase|Death|1
5602874|NCT00883779|19356625|P2|Post-Study Treatment Phase|Adverse Event|3
5602875|NCT00883779|19356626|P1|Post-Study Treatment Phase|Adverse Event|2
5602876|NCT00883779|19356625|P2|Primary Study Treatment Phase|Other|0
5602877|NCT00883779|19356626|P1|Primary Study Treatment Phase|Other|3
5602878|NCT00883779|19356625|P2|Primary Study Treatment Phase|Refused Treatment|4
5602879|NCT00883779|19356626|P1|Primary Study Treatment Phase|Refused Treatment|5
5602880|NCT00883779|19356625|P2|Primary Study Treatment Phase|Death|3
5602881|NCT00883779|19356626|P1|Primary Study Treatment Phase|Death|2
5602882|NCT00883779|19356625|P2|Primary Study Treatment Phase|Adverse Event|16
5602883|NCT00883779|19356626|P1|Primary Study Treatment Phase|Adverse Event|16
5602884|NCT00883779|19356625|P2|Primary Study Treatment Phase|Disease progression|59
5602885|NCT00883779|19356626|P1|Primary Study Treatment Phase|Disease progression|75
5602886|NCT00883779|19356625|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
5602887|NCT00883779|19356626|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
5602888|NCT00883753|19356662|P1|Overall Study|Administrative/Other|8
5602889|NCT00883753|19356662|P1|Overall Study|Investigator's decision|17
5602890|NCT00883753|19356662|P1|Overall Study|Withdrew consent|10
5602891|NCT00883753|19356662|P1|Overall Study|Refused treatment|4
5602892|NCT00883753|19356662|P1|Overall Study|Protocol Violation|2
5602893|NCT00883753|19356662|P1|Overall Study|Violation of selection criteria at entry|7
5602894|NCT00883753|19356662|P1|Overall Study|Lost to Follow-up|4
5602895|NCT00883753|19356662|P1|Overall Study|Insufficient therapeutic response|16
5602896|NCT00883753|19356662|P1|Overall Study|Death|2
5602897|NCT00883753|19356662|P1|Overall Study|Adverse Event|37
5602898|NCT00883740|19356702|P2|Second Intervention|No longer willing to participate|1
5602899|NCT00883740|19356703|P1|Second Intervention|No longer willing to participate|0
5602900|NCT00883740|19356702|P2|Second Intervention|Protocol Violation|0
5602901|NCT00883740|19356703|P1|Second Intervention|Protocol Violation|1
5602902|NCT00883740|19356702|P2|First Intervention|Adverse Event|2
5602903|NCT00883740|19356703|P1|First Intervention|Adverse Event|1
5602904|NCT00883740|19356702|P2|First Intervention|Protocol Violation|6
5602905|NCT00883740|19356703|P1|First Intervention|Protocol Violation|3
5602906|NCT00883740|19356702|P2|First Intervention|No longer willing to participate|0
5602907|NCT00883740|19356703|P1|First Intervention|No longer willing to participate|2
5602908|NCT00883740|19356702|P2|First Intervention|Lost to Follow-up|0
5602909|NCT00883740|19356703|P1|First Intervention|Lost to Follow-up|1
5602910|NCT00883688|19356743|P1|Overall Study|Ineligible|2
5602911|NCT00883558|19356751|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
5602912|NCT00883558|19356752|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
5602913|NCT00883558|19356753|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
5602914|NCT00883558|19356751|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
5602915|NCT00883558|19356752|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
5602916|NCT00883558|19356753|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
5602917|NCT00883558|19356751|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
5602918|NCT00883558|19356752|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
5602919|NCT00883558|19356753|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
5602920|NCT00883558|19356751|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
5602921|NCT00883558|19356752|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
5602922|NCT00883558|19356753|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
5602923|NCT00883558|19356751|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
5602924|NCT00883558|19356752|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
5602925|NCT00883558|19356753|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
5602926|NCT00883493|19356765|P2|Overall Study|Other|3
5602927|NCT00883493|19356766|P1|Overall Study|Other|5
5602928|NCT00883493|19356765|P2|Overall Study|Study specific disc. criteria|0
5602929|NCT00883493|19356766|P1|Overall Study|Study specific disc. criteria|2
5602930|NCT00883493|19356765|P2|Overall Study|Eligibility Criteria not fullfilled|6
5602931|NCT00883493|19356766|P1|Overall Study|Eligibility Criteria not fullfilled|6
5602932|NCT00883493|19356765|P2|Overall Study|Withdrawal by Subject|20
5602933|NCT00883493|19356766|P1|Overall Study|Withdrawal by Subject|11
5602934|NCT00883493|19356765|P2|Overall Study|Lost to Follow-up|6
5602935|NCT00883493|19356766|P1|Overall Study|Lost to Follow-up|7
5602936|NCT00883493|19356765|P2|Overall Study|Lack of Efficacy|3
5602937|NCT00883493|19356766|P1|Overall Study|Lack of Efficacy|4
5602938|NCT00883493|19356765|P2|Overall Study|Adverse Event|12
5602939|NCT00883493|19356766|P1|Overall Study|Adverse Event|11
5602940|NCT00883337|19356801|P3|Extension Treatment Period|Other than above|5
5602941|NCT00883337|19356802|P2|Extension Treatment Period|Other than above|9
5602942|NCT00883337|19356803|P1|Extension Treatment Period|Other than above|10
5602943|NCT00883337|19356801|P3|Extension Treatment Period|Lost to Follow-up|0
5602944|NCT00883337|19356802|P2|Extension Treatment Period|Lost to Follow-up|0
5602945|NCT00883337|19356803|P1|Extension Treatment Period|Lost to Follow-up|1
5602946|NCT00883337|19356801|P3|Extension Treatment Period|Poor compliance to protocol|1
5602947|NCT00883337|19356802|P2|Extension Treatment Period|Poor compliance to protocol|1
5602948|NCT00883337|19356803|P1|Extension Treatment Period|Poor compliance to protocol|1
5602949|NCT00883337|19356801|P3|Extension Treatment Period|Lack of Efficacy|8
5602950|NCT00883337|19356802|P2|Extension Treatment Period|Lack of Efficacy|8
5602951|NCT00883337|19356803|P1|Extension Treatment Period|Lack of Efficacy|8
5602952|NCT00883337|19356801|P3|Extension Treatment Period|Adverse Event|5
5602953|NCT00883337|19356802|P2|Extension Treatment Period|Adverse Event|5
5602954|NCT00883337|19356803|P1|Extension Treatment Period|Adverse Event|8
5602955|NCT00883337|19356801|P3|Core Treatment Period|Other than above|1
5602956|NCT00883337|19356802|P2|Core Treatment Period|Other than above|1
5602957|NCT00883337|19356803|P1|Core Treatment Period|Other than above|0
5602958|NCT00883337|19356801|P3|Core Treatment Period|Poor compliance to protocol|1
5602959|NCT00883337|19356802|P2|Core Treatment Period|Poor compliance to protocol|0
5602960|NCT00883337|19356803|P1|Core Treatment Period|Poor compliance to protocol|0
5602961|NCT00883337|19356801|P3|Core Treatment Period|Wish to be pregnant|1
5602962|NCT00883337|19356802|P2|Core Treatment Period|Wish to be pregnant|2
5602963|NCT00883337|19356803|P1|Core Treatment Period|Wish to be pregnant|1
5602964|NCT00883337|19356801|P3|Core Treatment Period|Withdrawal by Subject|6
5602965|NCT00883337|19356802|P2|Core Treatment Period|Withdrawal by Subject|2
5602966|NCT00883337|19356803|P1|Core Treatment Period|Withdrawal by Subject|2
5602967|NCT00883337|19356801|P3|Core Treatment Period|Lost to Follow-up|0
5602968|NCT00883337|19356802|P2|Core Treatment Period|Lost to Follow-up|1
5602969|NCT00883337|19356803|P1|Core Treatment Period|Lost to Follow-up|1
5602970|NCT00883337|19356801|P3|Core Treatment Period|Lack of Efficacy|2
5602971|NCT00883337|19356802|P2|Core Treatment Period|Lack of Efficacy|4
5602972|NCT00883337|19356803|P1|Core Treatment Period|Lack of Efficacy|7
5602973|NCT00883337|19356801|P3|Core Treatment Period|Adverse Event|22
5602974|NCT00883337|19356802|P2|Core Treatment Period|Adverse Event|12
5602975|NCT00883337|19356803|P1|Core Treatment Period|Adverse Event|9
5602976|NCT00883181|19356870|P1|Overall Study|Noncompliance|3
5602977|NCT00883181|19356870|P1|Overall Study|Protocol Deviation|3
5602978|NCT00883181|19356870|P1|Overall Study|Other|38
5602979|NCT00883181|19356870|P1|Overall Study|Death|31
5602980|NCT00883181|19356870|P1|Overall Study|Withdrawal by Subject|4
5602981|NCT00883181|19356870|P1|Overall Study|Administrative Reason|24
5602982|NCT00883181|19356870|P1|Overall Study|Disease Progression|94
5602983|NCT00883181|19356870|P1|Overall Study|Non-hematological Adverse Event|55
5602984|NCT00883181|19356870|P1|Overall Study|Hematological Adverse Event|26
5602985|NCT00883129|19357106|P2|Overall Study|Defined Treatment Failure|2
5602986|NCT00883129|19357107|P1|Overall Study|Defined Treatment Failure|0
5602987|NCT00883129|19357106|P2|Overall Study|Death|2
5602988|NCT00883129|19357107|P1|Overall Study|Death|1
5602989|NCT00883129|19357106|P2|Overall Study|Lost to Follow-up|2
5602990|NCT00883129|19357107|P1|Overall Study|Lost to Follow-up|1
5602991|NCT00883129|19357106|P2|Overall Study|Non-compliance|6
5602992|NCT00883129|19357107|P1|Overall Study|Non-compliance|3
5602993|NCT00883129|19357106|P2|Overall Study|Withdrawal by Subject|9
5602994|NCT00883129|19357107|P1|Overall Study|Withdrawal by Subject|8
5602995|NCT00883129|19357106|P2|Overall Study|Adverse Event|15
5602996|NCT00883129|19357107|P1|Overall Study|Adverse Event|7
5602997|NCT00883116|19357131|P2|Overall Study|No longer meets study criteria|2
5602998|NCT00883116|19357132|P1|Overall Study|No longer meets study criteria|2
5602999|NCT00883116|19357131|P2|Overall Study|Withdrawal by Subject|8
5603000|NCT00883116|19357132|P1|Overall Study|Withdrawal by Subject|14
5603001|NCT00883116|19357131|P2|Overall Study|Study drug toxicity|16
5603002|NCT00883116|19357132|P1|Overall Study|Study drug toxicity|36
5603003|NCT00883116|19357131|P2|Overall Study|Not identified|6
5603004|NCT00883116|19357132|P1|Overall Study|Not identified|3
5603005|NCT00883116|19357131|P2|Overall Study|Maximum clinical benefit|46
5603006|NCT00883116|19357132|P1|Overall Study|Maximum clinical benefit|13
5603007|NCT00883116|19357131|P2|Overall Study|Lost to Follow-up|1
5603008|NCT00883116|19357132|P1|Overall Study|Lost to Follow-up|0
5603009|NCT00883116|19357131|P2|Overall Study|Disease progression|128
5603010|NCT00883116|19357132|P1|Overall Study|Disease progression|130
5603011|NCT00883116|19357131|P2|Overall Study|Death|2
5603012|NCT00883116|19357132|P1|Overall Study|Death|6
5603013|NCT00883116|19357131|P2|Overall Study|Adverse event unrelated to study drug|10
5603014|NCT00883116|19357132|P1|Overall Study|Adverse event unrelated to study drug|5
5603015|NCT00883090|19357154|P1|Overall Study|Withdrawal by Subject|1
5603016|NCT00883090|19357154|P1|Overall Study|Sponsor's decision|1
5603017|NCT00883051|19357174|P5|Overall Study|Did not use study medication|17
5603018|NCT00883051|19357175|P4|Overall Study|Did not use study medication|29
5603019|NCT00883051|19357176|P3|Overall Study|Did not use study medication|29
5603020|NCT00883051|19357177|P2|Overall Study|Did not use study medication|22
5603021|NCT00883051|19357178|P1|Overall Study|Did not use study medication|24
5603022|NCT00883051|19357174|P5|Overall Study|Lost to Follow-up|1
5603023|NCT00883051|19357175|P4|Overall Study|Lost to Follow-up|0
5603024|NCT00883051|19357176|P3|Overall Study|Lost to Follow-up|0
5603025|NCT00883051|19357177|P2|Overall Study|Lost to Follow-up|0
5603026|NCT00883051|19357178|P1|Overall Study|Lost to Follow-up|0
5603027|NCT00882999|19357282|P7|Overall Study|Physician Decision|1
5603028|NCT00882999|19357283|P6|Overall Study|Physician Decision|1
5603029|NCT00882999|19357284|P5|Overall Study|Physician Decision|0
5603030|NCT00882999|19357285|P4|Overall Study|Physician Decision|0
5603031|NCT00882999|19357286|P3|Overall Study|Physician Decision|0
5603032|NCT00882999|19357287|P2|Overall Study|Physician Decision|0
5603033|NCT00882999|19357288|P1|Overall Study|Physician Decision|1
5603034|NCT00882999|19357282|P7|Overall Study|Lost to Follow-up|2
5603035|NCT00882999|19357283|P6|Overall Study|Lost to Follow-up|1
5603036|NCT00882999|19357284|P5|Overall Study|Lost to Follow-up|1
5603037|NCT00882999|19357285|P4|Overall Study|Lost to Follow-up|2
5603038|NCT00882999|19357286|P3|Overall Study|Lost to Follow-up|1
5603039|NCT00882999|19357287|P2|Overall Study|Lost to Follow-up|1
5603040|NCT00882999|19357288|P1|Overall Study|Lost to Follow-up|0
5603041|NCT00882999|19357282|P7|Overall Study|Withdrawal by Subject|5
5603042|NCT00882999|19357283|P6|Overall Study|Withdrawal by Subject|5
5603043|NCT00882999|19357284|P5|Overall Study|Withdrawal by Subject|6
5603044|NCT00882999|19357285|P4|Overall Study|Withdrawal by Subject|3
5603045|NCT00882999|19357286|P3|Overall Study|Withdrawal by Subject|3
5603046|NCT00882999|19357287|P2|Overall Study|Withdrawal by Subject|6
5603047|NCT00882999|19357288|P1|Overall Study|Withdrawal by Subject|7
5603048|NCT00882999|19357282|P7|Overall Study|Death|0
5603049|NCT00882999|19357283|P6|Overall Study|Death|0
5603050|NCT00882999|19357284|P5|Overall Study|Death|0
5603051|NCT00882999|19357285|P4|Overall Study|Death|0
5603052|NCT00882999|19357286|P3|Overall Study|Death|0
5603053|NCT00882999|19357287|P2|Overall Study|Death|1
5603054|NCT00882999|19357288|P1|Overall Study|Death|0
5603055|NCT00882999|19357282|P7|Overall Study|Adverse Event|0
5603056|NCT00882999|19357283|P6|Overall Study|Adverse Event|0
5603057|NCT00882999|19357284|P5|Overall Study|Adverse Event|1
5603058|NCT00882999|19357285|P4|Overall Study|Adverse Event|0
5603059|NCT00882999|19357286|P3|Overall Study|Adverse Event|0
5603060|NCT00882999|19357287|P2|Overall Study|Adverse Event|0
5603061|NCT00882999|19357288|P1|Overall Study|Adverse Event|0
5603062|NCT00882921|19357415|P1|Overall Study|Withdrawal Of Consent|1
5603063|NCT00882921|19357415|P1|Overall Study|Termination By Investigator|3
5603064|NCT00882921|19357415|P1|Overall Study|Lost to Follow-up|2
5603065|NCT00882921|19357415|P1|Overall Study|Other|3
5603066|NCT00882921|19357415|P1|Overall Study|Death|2
5603067|NCT00882908|19357425|P5|Overall Study|Study terminated in error|0
5603068|NCT00882908|19357426|P4|Overall Study|Study terminated in error|1
5603069|NCT00882908|19357427|P3|Overall Study|Study terminated in error|0
5603070|NCT00882908|19357428|P2|Overall Study|Study terminated in error|0
5603071|NCT00882908|19357429|P1|Overall Study|Study terminated in error|0
5603072|NCT00882908|19357425|P5|Overall Study|Subject reached a virologic endpoint|1
5603073|NCT00882908|19357426|P4|Overall Study|Subject reached a virologic endpoint|0
5603074|NCT00882908|19357427|P3|Overall Study|Subject reached a virologic endpoint|0
5603075|NCT00882908|19357428|P2|Overall Study|Subject reached a virologic endpoint|0
5603076|NCT00882908|19357429|P1|Overall Study|Subject reached a virologic endpoint|0
5603077|NCT00882908|19357425|P5|Overall Study|Withdrawal by Subject|2
5603078|NCT00882908|19357426|P4|Overall Study|Withdrawal by Subject|5
5603079|NCT00882908|19357427|P3|Overall Study|Withdrawal by Subject|3
5603080|NCT00882908|19357428|P2|Overall Study|Withdrawal by Subject|0
5603081|NCT00882908|19357429|P1|Overall Study|Withdrawal by Subject|0
5603082|NCT00882908|19357425|P5|Overall Study|Protocol Violation|0
5603083|NCT00882908|19357426|P4|Overall Study|Protocol Violation|0
5603084|NCT00882908|19357427|P3|Overall Study|Protocol Violation|0
5603085|NCT00882908|19357428|P2|Overall Study|Protocol Violation|1
5603086|NCT00882908|19357429|P1|Overall Study|Protocol Violation|0
5603087|NCT00882908|19357425|P5|Overall Study|Lost to Follow-up|2
5603088|NCT00882908|19357426|P4|Overall Study|Lost to Follow-up|1
5603089|NCT00882908|19357427|P3|Overall Study|Lost to Follow-up|3
5603090|NCT00882908|19357428|P2|Overall Study|Lost to Follow-up|5
5603091|NCT00882908|19357429|P1|Overall Study|Lost to Follow-up|3
5603092|NCT00882908|19357425|P5|Overall Study|Adverse Event|1
5603093|NCT00882908|19357426|P4|Overall Study|Adverse Event|0
5603094|NCT00882908|19357427|P3|Overall Study|Adverse Event|1
5603095|NCT00882908|19357428|P2|Overall Study|Adverse Event|0
5603096|NCT00882908|19357429|P1|Overall Study|Adverse Event|0
5603097|NCT00882713|19357535|P1|Overall Study|Other - Reasons|2
5603098|NCT00882713|19357535|P1|Overall Study|Failure to return|2
5603099|NCT00882713|19357535|P1|Overall Study|Insufficient therapeutic response|3
5603100|NCT00882713|19357535|P1|Overall Study|Blood transfusion|2
5603101|NCT00882713|19357535|P1|Overall Study|refused treatment/withdrew consent|4
5603102|NCT00882713|19357535|P1|Overall Study|Administrative reasons|4
5603103|NCT00882713|19357535|P1|Overall Study|Death|3
5603104|NCT00882713|19357535|P1|Overall Study|Adverse Event|2
5603105|NCT00882583|19357628|P2|Overall Study|Adverse Event|1
5603106|NCT00882583|19357629|P1|Overall Study|Adverse Event|0
5603107|NCT00882583|19357628|P2|Overall Study|Physician Decision|0
5603108|NCT00882583|19357629|P1|Overall Study|Physician Decision|1
5603109|NCT00882557|19357637|P2|Overall Study|Randomized Not Treated|1
5603110|NCT00882557|19357638|P1|Overall Study|Randomized Not Treated|0
5603111|NCT00882557|19357637|P2|Overall Study|Trouble with Vein Access|0
5603112|NCT00882557|19357638|P1|Overall Study|Trouble with Vein Access|1
5603113|NCT00882557|19357637|P2|Overall Study|Withdrawal by Subject|0
5603114|NCT00882557|19357638|P1|Overall Study|Withdrawal by Subject|1
5603115|NCT00882518|19357658|P2|Overall Study|Allocating random number by mistake|1
5603116|NCT00882518|19357659|P1|Overall Study|Allocating random number by mistake|0
5603117|NCT00882518|19357658|P2|Overall Study|Central lab closure for National day|0
5603118|NCT00882518|19357659|P1|Overall Study|Central lab closure for National day|1
5603119|NCT00882518|19357658|P2|Overall Study|Incorrect enrolment|2
5603120|NCT00882518|19357659|P1|Overall Study|Incorrect enrolment|4
5603121|NCT00882518|19357658|P2|Overall Study|Severe non-compliance to protocol|1
5603122|NCT00882518|19357659|P1|Overall Study|Severe non-compliance to protocol|3
5603123|NCT00882518|19357658|P2|Overall Study|Lack of Efficacy|9
5603124|NCT00882518|19357659|P1|Overall Study|Lack of Efficacy|12
5603125|NCT00882518|19357658|P2|Overall Study|Withdrawal by Subject|13
5603126|NCT00882518|19357659|P1|Overall Study|Withdrawal by Subject|9
5603127|NCT00882518|19357658|P2|Overall Study|Adverse Event|18
5603128|NCT00882518|19357659|P1|Overall Study|Adverse Event|9
5603129|NCT00882440|19357688|P7|Overall Study|Patient Uncooperative|0
5603130|NCT00882440|19357689|P6|Overall Study|Patient Uncooperative|0
5603131|NCT00882440|19357690|P5|Overall Study|Patient Uncooperative|1
5603132|NCT00882440|19357691|P4|Overall Study|Patient Uncooperative|0
5603133|NCT00882440|19357692|P3|Overall Study|Patient Uncooperative|0
5603134|NCT00882440|19357693|P2|Overall Study|Patient Uncooperative|0
5603135|NCT00882440|19357694|P1|Overall Study|Patient Uncooperative|2
5603136|NCT00882440|19357688|P7|Overall Study|Withdrawal by Subject|1
5603137|NCT00882440|19357689|P6|Overall Study|Withdrawal by Subject|0
5603138|NCT00882440|19357690|P5|Overall Study|Withdrawal by Subject|6
5603139|NCT00882440|19357691|P4|Overall Study|Withdrawal by Subject|0
5603140|NCT00882440|19357692|P3|Overall Study|Withdrawal by Subject|1
5603141|NCT00882440|19357693|P2|Overall Study|Withdrawal by Subject|1
5603142|NCT00882440|19357694|P1|Overall Study|Withdrawal by Subject|2
5603143|NCT00882440|19357688|P7|Overall Study|Protocol Violation|0
5603144|NCT00882440|19357689|P6|Overall Study|Protocol Violation|0
5603145|NCT00882440|19357690|P5|Overall Study|Protocol Violation|1
5603146|NCT00882440|19357691|P4|Overall Study|Protocol Violation|1
5603147|NCT00882440|19357692|P3|Overall Study|Protocol Violation|1
5603148|NCT00882440|19357693|P2|Overall Study|Protocol Violation|0
5603149|NCT00882440|19357694|P1|Overall Study|Protocol Violation|0
5603150|NCT00882440|19357688|P7|Overall Study|Lost to Follow-up|1
5603151|NCT00882440|19357689|P6|Overall Study|Lost to Follow-up|0
5603152|NCT00882440|19357690|P5|Overall Study|Lost to Follow-up|1
5603153|NCT00882440|19357691|P4|Overall Study|Lost to Follow-up|1
5603154|NCT00882440|19357692|P3|Overall Study|Lost to Follow-up|1
5603155|NCT00882440|19357693|P2|Overall Study|Lost to Follow-up|0
5603156|NCT00882440|19357694|P1|Overall Study|Lost to Follow-up|2
5603157|NCT00882440|19357688|P7|Overall Study|Lack of Efficacy|0
5603158|NCT00882440|19357689|P6|Overall Study|Lack of Efficacy|3
5603159|NCT00882440|19357690|P5|Overall Study|Lack of Efficacy|0
5603160|NCT00882440|19357691|P4|Overall Study|Lack of Efficacy|0
5603161|NCT00882440|19357692|P3|Overall Study|Lack of Efficacy|2
5603162|NCT00882440|19357693|P2|Overall Study|Lack of Efficacy|5
5603163|NCT00882440|19357694|P1|Overall Study|Lack of Efficacy|3
5603164|NCT00882440|19357688|P7|Overall Study|Adverse Event|2
5603165|NCT00882440|19357689|P6|Overall Study|Adverse Event|4
5603166|NCT00882440|19357690|P5|Overall Study|Adverse Event|1
5603167|NCT00882440|19357691|P4|Overall Study|Adverse Event|1
5603168|NCT00882440|19357692|P3|Overall Study|Adverse Event|2
5603169|NCT00882440|19357693|P2|Overall Study|Adverse Event|2
5603170|NCT00882440|19357694|P1|Overall Study|Adverse Event|2
5603171|NCT00882362|19357719|P2|Overall Study|change of residence or other commitments|0
5603172|NCT00882362|19357720|P1|Overall Study|change of residence or other commitments|5
5603173|NCT00882362|19357719|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
5603174|NCT00882362|19357720|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
5603175|NCT00882362|19357719|P2|Overall Study|Physician Decision|1
5603176|NCT00882362|19357720|P1|Overall Study|Physician Decision|5
5603177|NCT00882362|19357719|P2|Overall Study|Pregnancy|0
5603178|NCT00882362|19357720|P1|Overall Study|Pregnancy|1
5603179|NCT00882362|19357719|P2|Overall Study|Protocol Violation|2
5603180|NCT00882362|19357720|P1|Overall Study|Protocol Violation|7
5603181|NCT00882362|19357719|P2|Overall Study|Lack of Efficacy|0
5603182|NCT00882362|19357720|P1|Overall Study|Lack of Efficacy|3
5603183|NCT00882362|19357719|P2|Overall Study|Withdrawal by Subject|10
5603184|NCT00882362|19357720|P1|Overall Study|Withdrawal by Subject|13
5603185|NCT00882362|19357719|P2|Overall Study|Adverse Event|10
5603186|NCT00882362|19357720|P1|Overall Study|Adverse Event|13
5603187|NCT00882310|19357726|P1|Overall Study|Adverse Event|1
5603188|NCT00882310|19357726|P1|Overall Study|Progression of disease|4
5603189|NCT00882310|19357726|P1|Overall Study|Death|6
5603190|NCT00882310|19357726|P1|Overall Study|Never received treatment|1
5603191|NCT00882310|19357726|P1|Overall Study|Screen Failure|10
5603192|NCT00882115|19357739|P1|Overall Study|did not respond to DEP challe|6
5603193|NCT00882115|19357739|P1|Overall Study|Withdrawal by Subject|3
5603194|NCT00881959|19357749|P2|Overall Study|Lost to Follow-up|4
5603195|NCT00881959|19357750|P1|Overall Study|Lost to Follow-up|2
5603196|NCT00881894|19357758|P2|Overall Study|Other reasons for premature termination|2
5603197|NCT00881894|19357759|P1|Overall Study|Other reasons for premature termination|1
5603198|NCT00881894|19357758|P2|Overall Study|Consent withdrawn|1
5603199|NCT00881894|19357759|P1|Overall Study|Consent withdrawn|0
5603200|NCT00881868|19357791|P2|Overall Study|Protocol Violation|0
5603201|NCT00881868|19357792|P1|Overall Study|Protocol Violation|2
5603202|NCT00881868|19357791|P2|Overall Study|Physician Decision|0
5603203|NCT00881868|19357792|P1|Overall Study|Physician Decision|4
5603204|NCT00881868|19357791|P2|Overall Study|Lost to Follow-up|1
5603205|NCT00881868|19357792|P1|Overall Study|Lost to Follow-up|2
5603206|NCT00881868|19357791|P2|Overall Study|Adverse Event|1
5603207|NCT00881868|19357792|P1|Overall Study|Adverse Event|0
5603208|NCT00881751|19357806|P2|Overall Study|Withdrawal by Subject|2
5603209|NCT00881751|19357807|P1|Overall Study|Withdrawal by Subject|0
5603210|NCT00881751|19357806|P2|Overall Study|Adverse Event|2
5603211|NCT00881751|19357807|P1|Overall Study|Adverse Event|0
5603212|NCT00881751|19357806|P2|Overall Study|Physician Decision|1
5603213|NCT00881751|19357807|P1|Overall Study|Physician Decision|0
5603214|NCT00881712|19357822|P3|Overall Study|Withdrawal by Subject|0
5603215|NCT00881712|19357823|P2|Overall Study|Withdrawal by Subject|0
5603216|NCT00881712|19357824|P1|Overall Study|Withdrawal by Subject|1
5603217|NCT00881712|19357822|P3|Overall Study|Death|0
5603218|NCT00881712|19357823|P2|Overall Study|Death|0
5603219|NCT00881712|19357824|P1|Overall Study|Death|1
5603220|NCT00881621|19357857|P1|Overall Study|Physician Decision|34
5603221|NCT00881608|19357869|P1|Overall Study|Study prematurely terminated|11
5603222|NCT00881569|19357888|P2|Overall Study|Disease progression|1
5603223|NCT00881569|19357889|P1|Overall Study|Disease progression|1
5603224|NCT00881530|19357905|P6|Overall Study|Other reason not defined above|2
5603225|NCT00881530|19357906|P5|Overall Study|Other reason not defined above|0
5603226|NCT00881530|19357907|P4|Overall Study|Other reason not defined above|0
5603227|NCT00881530|19357908|P3|Overall Study|Other reason not defined above|2
5603228|NCT00881530|19357909|P2|Overall Study|Other reason not defined above|1
5603229|NCT00881530|19357910|P1|Overall Study|Other reason not defined above|1
5603230|NCT00881530|19357905|P6|Overall Study|Refused to continue medication|0
5603231|NCT00881530|19357906|P5|Overall Study|Refused to continue medication|0
5603232|NCT00881530|19357907|P4|Overall Study|Refused to continue medication|2
5603233|NCT00881530|19357908|P3|Overall Study|Refused to continue medication|1
5603234|NCT00881530|19357909|P2|Overall Study|Refused to continue medication|2
5603235|NCT00881530|19357910|P1|Overall Study|Refused to continue medication|7
5603236|NCT00881530|19357905|P6|Overall Study|Lost to Follow-up|0
5603237|NCT00881530|19357906|P5|Overall Study|Lost to Follow-up|1
5603238|NCT00881530|19357907|P4|Overall Study|Lost to Follow-up|3
5603239|NCT00881530|19357908|P3|Overall Study|Lost to Follow-up|1
5603240|NCT00881530|19357909|P2|Overall Study|Lost to Follow-up|1
5603241|NCT00881530|19357910|P1|Overall Study|Lost to Follow-up|0
5603242|NCT00881530|19357905|P6|Overall Study|Not compliant with the protocol|0
5603243|NCT00881530|19357906|P5|Overall Study|Not compliant with the protocol|2
5603244|NCT00881530|19357907|P4|Overall Study|Not compliant with the protocol|0
5603245|NCT00881530|19357908|P3|Overall Study|Not compliant with the protocol|0
5603246|NCT00881530|19357909|P2|Overall Study|Not compliant with the protocol|0
5603247|NCT00881530|19357910|P1|Overall Study|Not compliant with the protocol|0
5603248|NCT00881530|19357905|P6|Overall Study|Lack of Efficacy|1
5603249|NCT00881530|19357906|P5|Overall Study|Lack of Efficacy|1
5603250|NCT00881530|19357907|P4|Overall Study|Lack of Efficacy|0
5603251|NCT00881530|19357908|P3|Overall Study|Lack of Efficacy|0
5603252|NCT00881530|19357909|P2|Overall Study|Lack of Efficacy|0
5603253|NCT00881530|19357910|P1|Overall Study|Lack of Efficacy|1
5603254|NCT00881530|19357905|P6|Overall Study|Adverse Event|2
5603255|NCT00881530|19357906|P5|Overall Study|Adverse Event|10
5603256|NCT00881530|19357907|P4|Overall Study|Adverse Event|4
5603257|NCT00881530|19357908|P3|Overall Study|Adverse Event|1
5603258|NCT00881530|19357909|P2|Overall Study|Adverse Event|1
5603259|NCT00881530|19357910|P1|Overall Study|Adverse Event|5
5603260|NCT00881504|19357966|P1|Overall Study|Withdrawal by Subject|1
5603261|NCT00881361|19357986|P3|Overall Study|Ineligible|2
5603262|NCT00881361|19357987|P2|Overall Study|Ineligible|2
5603263|NCT00881361|19357988|P1|Overall Study|Ineligible|17
5603264|NCT00881361|19357986|P3|Overall Study|Terminated prior to surgery|0
5603265|NCT00881361|19357987|P2|Overall Study|Terminated prior to surgery|7
5603266|NCT00881361|19357988|P1|Overall Study|Terminated prior to surgery|27
5603267|NCT00881335|19358003|P2|Overall Study|Lost to Follow-up|2
5603268|NCT00881335|19358004|P1|Overall Study|Lost to Follow-up|3
5603269|NCT00881205|19358024|P2|Overall Study|Condition no longer requires drug|0
5603270|NCT00881205|19358025|P1|Overall Study|Condition no longer requires drug|1
5603271|NCT00881205|19358024|P2|Overall Study|Administrative problems|1
5603272|NCT00881205|19358025|P1|Overall Study|Administrative problems|1
5603273|NCT00881205|19358024|P2|Overall Study|Lost to Follow-up|1
5603274|NCT00881205|19358025|P1|Overall Study|Lost to Follow-up|0
5603275|NCT00881205|19358024|P2|Overall Study|Withdrawal by Subject|2
5603276|NCT00881205|19358025|P1|Overall Study|Withdrawal by Subject|1
5603277|NCT00881205|19358024|P2|Overall Study|Adverse Event|3
5603278|NCT00881205|19358025|P1|Overall Study|Adverse Event|8
5603279|NCT00880906|19358093|P2|Overall Study|Did not meet criteria following patholog|6
5603280|NCT00880906|19358094|P1|Overall Study|Did not meet criteria following patholog|12
5603281|NCT00880906|19358093|P2|Overall Study|Lost to Follow-up|1
5603282|NCT00880906|19358094|P1|Overall Study|Lost to Follow-up|0
5603283|NCT00880893|19358104|P2|Overall Study|Serious adverse event|0
5603284|NCT00880893|19358105|P1|Overall Study|Serious adverse event|3
5603285|NCT00880893|19358104|P2|Overall Study|Lost to Follow-up|33
5603286|NCT00880893|19358105|P1|Overall Study|Lost to Follow-up|76
5603287|NCT00880893|19358104|P2|Overall Study|Withdrawal by Subject|11
5603288|NCT00880893|19358105|P1|Overall Study|Withdrawal by Subject|15
5603289|NCT00880893|19358104|P2|Overall Study|Protocol Violation|1
5603290|NCT00880893|19358105|P1|Overall Study|Protocol Violation|13
5603291|NCT00880763|19358157|P4|Extension Period (Part 2)|Lack of Efficacy|1
5603292|NCT00880763|19358158|P3|Extension Period (Part 2)|Lack of Efficacy|0
5603293|NCT00880763|19358159|P2|Extension Period (Part 2)|Lack of Efficacy|0
5603294|NCT00880763|19358160|P1|Extension Period (Part 2)|Lack of Efficacy|0
5603295|NCT00880763|19358157|P4|Extension Period (Part 2)|Physician Decision|0
5603296|NCT00880763|19358158|P3|Extension Period (Part 2)|Physician Decision|1
5603297|NCT00880763|19358159|P2|Extension Period (Part 2)|Physician Decision|1
5603298|NCT00880763|19358160|P1|Extension Period (Part 2)|Physician Decision|0
5603299|NCT00880763|19358157|P4|Extension Period (Part 2)|Withdrawal by Subject|1
5603300|NCT00880763|19358158|P3|Extension Period (Part 2)|Withdrawal by Subject|1
5603301|NCT00880763|19358159|P2|Extension Period (Part 2)|Withdrawal by Subject|2
5603302|NCT00880763|19358160|P1|Extension Period (Part 2)|Withdrawal by Subject|0
5603303|NCT00880763|19358157|P4|Extension Period (Part 2)|Adverse Event|1
5603304|NCT00880763|19358158|P3|Extension Period (Part 2)|Adverse Event|1
5603305|NCT00880763|19358159|P2|Extension Period (Part 2)|Adverse Event|0
5603306|NCT00880763|19358160|P1|Extension Period (Part 2)|Adverse Event|0
5603307|NCT00880750|19358192|P2|Second Intervention|Unable to collect urine|0
5603308|NCT00880750|19358193|P1|Second Intervention|Unable to collect urine|1
5603309|NCT00880750|19358192|P2|Second Intervention|Protocol Violation|0
5603310|NCT00880750|19358193|P1|Second Intervention|Protocol Violation|1
5603311|NCT00880750|19358192|P2|Second Intervention|Withdrawal by Subject|2
5603312|NCT00880750|19358193|P1|Second Intervention|Withdrawal by Subject|2
5603313|NCT00880750|19358192|P2|First Intervention|Lost to Follow-up|0
5603314|NCT00880750|19358193|P1|First Intervention|Lost to Follow-up|2
5603315|NCT00880750|19358192|P2|First Intervention|Withdrawal by Subject|0
5603316|NCT00880750|19358193|P1|First Intervention|Withdrawal by Subject|2
5603317|NCT00880750|19358192|P2|First Intervention|Non-compliance with meals|1
5603318|NCT00880750|19358193|P1|First Intervention|Non-compliance with meals|0
5603319|NCT00880750|19358192|P2|First Intervention|Unable to collect urine|0
5603320|NCT00880750|19358193|P1|First Intervention|Unable to collect urine|4
5603321|NCT00880750|19358192|P2|First Intervention|Adverse Event|0
5603322|NCT00880750|19358193|P1|First Intervention|Adverse Event|1
5603323|NCT00880698|19358211|P4|Overall Study|Lost to Follow-up|1
5603324|NCT00880698|19358212|P3|Overall Study|Lost to Follow-up|0
5603325|NCT00880698|19358213|P2|Overall Study|Lost to Follow-up|3
5603326|NCT00880698|19358214|P1|Overall Study|Lost to Follow-up|1
5603327|NCT00880698|19358211|P4|Overall Study|Death|2
5603328|NCT00880698|19358212|P3|Overall Study|Death|1
5603329|NCT00880698|19358213|P2|Overall Study|Death|0
5603330|NCT00880698|19358214|P1|Overall Study|Death|0
5603331|NCT00880685|19358240|P1|Memantine 20mg|Withdrawal by Subject|1
5603332|NCT00880685|19358240|P1|Memantine 10mg|Lost to Follow-up|2
5603333|NCT00880620|19358252|P4|Overall Study|Other|2
5603334|NCT00880620|19358253|P3|Overall Study|Other|2
5603335|NCT00880620|19358254|P2|Overall Study|Other|1
5603336|NCT00880620|19358255|P1|Overall Study|Other|1
5603337|NCT00880620|19358252|P4|Overall Study|Noncompliance|1
5603338|NCT00880620|19358253|P3|Overall Study|Noncompliance|1
5603339|NCT00880620|19358254|P2|Overall Study|Noncompliance|0
5603340|NCT00880620|19358255|P1|Overall Study|Noncompliance|0
5603341|NCT00880620|19358252|P4|Overall Study|Withdrawal by Subject|3
5603342|NCT00880620|19358253|P3|Overall Study|Withdrawal by Subject|1
5603343|NCT00880620|19358254|P2|Overall Study|Withdrawal by Subject|3
5603344|NCT00880620|19358255|P1|Overall Study|Withdrawal by Subject|4
5603345|NCT00880620|19358252|P4|Overall Study|Protocol Violation|2
5603346|NCT00880620|19358253|P3|Overall Study|Protocol Violation|0
5603347|NCT00880620|19358254|P2|Overall Study|Protocol Violation|1
5603348|NCT00880620|19358255|P1|Overall Study|Protocol Violation|0
5603349|NCT00880620|19358252|P4|Overall Study|Lost to Follow-up|0
5603350|NCT00880620|19358253|P3|Overall Study|Lost to Follow-up|1
5603351|NCT00880620|19358254|P2|Overall Study|Lost to Follow-up|1
5603352|NCT00880620|19358255|P1|Overall Study|Lost to Follow-up|0
5603353|NCT00880620|19358252|P4|Overall Study|Lack of Efficacy|1
5603354|NCT00880620|19358253|P3|Overall Study|Lack of Efficacy|0
5603355|NCT00880620|19358254|P2|Overall Study|Lack of Efficacy|4
5603356|NCT00880620|19358255|P1|Overall Study|Lack of Efficacy|12
5603357|NCT00880620|19358252|P4|Overall Study|Death|0
5603358|NCT00880620|19358253|P3|Overall Study|Death|1
5603359|NCT00880620|19358254|P2|Overall Study|Death|0
5603360|NCT00880620|19358255|P1|Overall Study|Death|0
5603361|NCT00880620|19358252|P4|Overall Study|Adverse Event|15
5603362|NCT00880620|19358253|P3|Overall Study|Adverse Event|15
5603363|NCT00880620|19358254|P2|Overall Study|Adverse Event|5
5603364|NCT00880620|19358255|P1|Overall Study|Adverse Event|4
5603365|NCT00880607|19358271|P2|Overall Study|surgery did not extend past L1 level|0
5603366|NCT00880607|19358272|P1|Overall Study|surgery did not extend past L1 level|3
5603367|NCT00880607|19358271|P2|Overall Study|Protocol Violation|1
5603368|NCT00880607|19358272|P1|Overall Study|Protocol Violation|2
5603369|NCT00880607|19358271|P2|Overall Study|Physician Decision|2
5603370|NCT00880607|19358272|P1|Overall Study|Physician Decision|2
5603371|NCT00880568|19358304|P9|Overall Study|Withdrawal by Subject|0
5603372|NCT00880568|19358305|P8|Overall Study|Withdrawal by Subject|1
5603373|NCT00880568|19358306|P7|Overall Study|Withdrawal by Subject|0
5603374|NCT00880568|19358307|P6|Overall Study|Withdrawal by Subject|0
5603375|NCT00880568|19358308|P5|Overall Study|Withdrawal by Subject|0
5603376|NCT00880568|19358309|P4|Overall Study|Withdrawal by Subject|0
5603377|NCT00880568|19358310|P3|Overall Study|Withdrawal by Subject|0
5603378|NCT00880568|19358311|P2|Overall Study|Withdrawal by Subject|0
5603379|NCT00880568|19358312|P1|Overall Study|Withdrawal by Subject|0
5603380|NCT00880568|19358304|P9|Overall Study|Adverse Event|0
5603381|NCT00880568|19358305|P8|Overall Study|Adverse Event|1
5603382|NCT00880568|19358306|P7|Overall Study|Adverse Event|1
5603383|NCT00880568|19358307|P6|Overall Study|Adverse Event|0
5603384|NCT00880568|19358308|P5|Overall Study|Adverse Event|0
5603385|NCT00880568|19358309|P4|Overall Study|Adverse Event|0
5603386|NCT00880568|19358310|P3|Overall Study|Adverse Event|0
5603387|NCT00880568|19358311|P2|Overall Study|Adverse Event|0
5603388|NCT00880568|19358312|P1|Overall Study|Adverse Event|0
5603389|NCT00880568|19358304|P9|Overall Study|Disease progression|3
5603390|NCT00880568|19358305|P8|Overall Study|Disease progression|0
5603391|NCT00880568|19358306|P7|Overall Study|Disease progression|5
5603392|NCT00880568|19358307|P6|Overall Study|Disease progression|3
5603393|NCT00880568|19358308|P5|Overall Study|Disease progression|3
5603394|NCT00880568|19358309|P4|Overall Study|Disease progression|1
5603395|NCT00880568|19358310|P3|Overall Study|Disease progression|3
5603396|NCT00880568|19358311|P2|Overall Study|Disease progression|3
5603397|NCT00880568|19358312|P1|Overall Study|Disease progression|3
5603398|NCT00880555|19358358|P6|Overall Study|Lost to Follow-up|0
5603399|NCT00880555|19358359|P5|Overall Study|Lost to Follow-up|0
5603400|NCT00880555|19358360|P4|Overall Study|Lost to Follow-up|0
5603401|NCT00880555|19358361|P3|Overall Study|Lost to Follow-up|0
5603402|NCT00880555|19358362|P2|Overall Study|Lost to Follow-up|1
5603403|NCT00880555|19358363|P1|Overall Study|Lost to Follow-up|0
5603404|NCT00880555|19358358|P6|Overall Study|Death|1
5603405|NCT00880555|19358359|P5|Overall Study|Death|0
5603406|NCT00880555|19358360|P4|Overall Study|Death|0
5603407|NCT00880555|19358361|P3|Overall Study|Death|0
5603408|NCT00880555|19358362|P2|Overall Study|Death|0
5603409|NCT00880555|19358363|P1|Overall Study|Death|0
5603410|NCT00880555|19358358|P6|Overall Study|Lack of resources (hired rater)|0
5603411|NCT00880555|19358359|P5|Overall Study|Lack of resources (hired rater)|0
5603412|NCT00880555|19358360|P4|Overall Study|Lack of resources (hired rater)|0
5603413|NCT00880555|19358361|P3|Overall Study|Lack of resources (hired rater)|5
5603414|NCT00880555|19358362|P2|Overall Study|Lack of resources (hired rater)|7
5603415|NCT00880555|19358363|P1|Overall Study|Lack of resources (hired rater)|9
5603416|NCT00880555|19358358|P6|Overall Study|Withdrawal by Subject|0
5603417|NCT00880555|19358359|P5|Overall Study|Withdrawal by Subject|0
5603418|NCT00880555|19358360|P4|Overall Study|Withdrawal by Subject|0
5603419|NCT00880555|19358361|P3|Overall Study|Withdrawal by Subject|0
5603420|NCT00880555|19358362|P2|Overall Study|Withdrawal by Subject|1
5603421|NCT00880555|19358363|P1|Overall Study|Withdrawal by Subject|1
5603422|NCT00880555|19358358|P6|Overall Study|Physician Decision|0
5603423|NCT00880555|19358359|P5|Overall Study|Physician Decision|1
5603424|NCT00880555|19358360|P4|Overall Study|Physician Decision|2
5603425|NCT00880555|19358361|P3|Overall Study|Physician Decision|0
5603426|NCT00880555|19358362|P2|Overall Study|Physician Decision|8
5603427|NCT00880555|19358363|P1|Overall Study|Physician Decision|0
5603428|NCT00880542|19358374|P1|REP: Surgical Resection|progressive disease|1
5603429|NCT00880542|19358374|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
5603430|NCT00880542|19358374|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
5603431|NCT00880399|19358391|P3|Overall Study|Withdrawal by Subject|3
5603432|NCT00880399|19358392|P2|Overall Study|Withdrawal by Subject|3
5603433|NCT00880399|19358393|P1|Overall Study|Withdrawal by Subject|6
5603434|NCT00880399|19358391|P3|Overall Study|Physician Decision|3
5603435|NCT00880399|19358392|P2|Overall Study|Physician Decision|0
5603436|NCT00880399|19358393|P1|Overall Study|Physician Decision|5
5603437|NCT00880399|19358391|P3|Overall Study|Lost to Follow-up|3
5603438|NCT00880399|19358392|P2|Overall Study|Lost to Follow-up|5
5603439|NCT00880399|19358393|P1|Overall Study|Lost to Follow-up|8
5603440|NCT00880399|19358391|P3|Overall Study|Study closed/terminated|4
5603441|NCT00880399|19358392|P2|Overall Study|Study closed/terminated|7
5603442|NCT00880399|19358393|P1|Overall Study|Study closed/terminated|3
5603443|NCT00880399|19358391|P3|Overall Study|Protocol Violation|6
5603444|NCT00880399|19358392|P2|Overall Study|Protocol Violation|4
5603445|NCT00880399|19358393|P1|Overall Study|Protocol Violation|4
5603446|NCT00880399|19358391|P3|Overall Study|Lack of Efficacy|2
5603447|NCT00880399|19358392|P2|Overall Study|Lack of Efficacy|4
5603448|NCT00880399|19358393|P1|Overall Study|Lack of Efficacy|1
5603449|NCT00880399|19358391|P3|Overall Study|Adverse Event|5
5603450|NCT00880399|19358392|P2|Overall Study|Adverse Event|6
5603451|NCT00880399|19358393|P1|Overall Study|Adverse Event|4
5603452|NCT00880334|19358456|P2|Randomized Phase|Crossover Participants|37
5603453|NCT00880334|19358457|P1|Randomized Phase|Crossover Participants|0
5603454|NCT00880334|19358456|P2|Randomized Phase|Brain Metastasis|1
5603455|NCT00880334|19358457|P1|Randomized Phase|Brain Metastasis|0
5603456|NCT00880334|19358456|P2|Randomized Phase|Inadequate Labs|1
5603457|NCT00880334|19358457|P1|Randomized Phase|Inadequate Labs|1
5603458|NCT00880334|19358456|P2|Randomized Phase|Withdrawal by Subject|1
5603459|NCT00880334|19358457|P1|Randomized Phase|Withdrawal by Subject|2
5603460|NCT00880334|19358456|P2|Randomized Phase|Physician Decision|0
5603461|NCT00880334|19358457|P1|Randomized Phase|Physician Decision|1
5603462|NCT00880269|19358474|P2|Overall Study|Adverse Event|9
5603463|NCT00880269|19358475|P1|Overall Study|Adverse Event|10
5603464|NCT00880269|19358474|P2|Overall Study|Withdrawal by Subject|4
5603465|NCT00880269|19358475|P1|Overall Study|Withdrawal by Subject|3
5603466|NCT00880269|19358474|P2|Overall Study|Lost to Follow-up|1
5603467|NCT00880269|19358475|P1|Overall Study|Lost to Follow-up|0
5603468|NCT00880269|19358474|P2|Overall Study|Death|2
5603469|NCT00880269|19358475|P1|Overall Study|Death|4
5603470|NCT00880269|19358474|P2|Overall Study|New Cancer Therapy|0
5603471|NCT00880269|19358475|P1|Overall Study|New Cancer Therapy|1
5603472|NCT00880269|19358474|P2|Overall Study|Disease Progression|11
5603473|NCT00880269|19358475|P1|Overall Study|Disease Progression|13
5603474|NCT00880269|19358474|P2|Overall Study|Protocol Violation|0
5603475|NCT00880269|19358475|P1|Overall Study|Protocol Violation|1
5603476|NCT00880256|19358491|P1|Overall Study|Lost to Follow-up|28
5603477|NCT00880191|19358518|P2|Overall Study|Hospitalization/efficacy|1
5603478|NCT00880191|19358519|P1|Overall Study|Hospitalization/efficacy|1
5603479|NCT00880191|19358518|P2|Overall Study|Adverse Event|6
5603480|NCT00880191|19358519|P1|Overall Study|Adverse Event|8
5603481|NCT00880191|19358518|P2|Overall Study|Refused further treatment|1
5603482|NCT00880191|19358519|P1|Overall Study|Refused further treatment|4
5603483|NCT00880165|19358539|P2|Overall Study|Lost to follow|15
5603484|NCT00880165|19358540|P1|Overall Study|Lost to follow|9
5603485|NCT00880165|19358539|P2|Overall Study|Required BIPAP or oxygen treatment|4
5603486|NCT00880165|19358540|P1|Overall Study|Required BIPAP or oxygen treatment|12
5603487|NCT00880165|19358539|P2|Overall Study|Not diagnosed with OSA|8
5603488|NCT00880165|19358540|P1|Overall Study|Not diagnosed with OSA|14
5603489|NCT00880165|19358539|P2|Overall Study|Withdrawal by Subject|23
5603490|NCT00880165|19358540|P1|Overall Study|Withdrawal by Subject|27
5603491|NCT00880100|19358550|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
5603492|NCT00880100|19358550|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
5603493|NCT00880100|19358550|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
5603494|NCT00880087|19358563|P2|Overall Study|Lost to Follow-up|2
5603495|NCT00880087|19358564|P1|Overall Study|Lost to Follow-up|0
5603496|NCT00880048|19358579|P3|Overall Study|Study closed/terminated|6
5603497|NCT00880048|19358580|P2|Overall Study|Study closed/terminated|7
5603498|NCT00880048|19358581|P1|Overall Study|Study closed/terminated|9
5603499|NCT00880048|19358579|P3|Overall Study|Withdrawal by Subject|5
5603500|NCT00880048|19358580|P2|Overall Study|Withdrawal by Subject|8
5603501|NCT00880048|19358581|P1|Overall Study|Withdrawal by Subject|5
5603502|NCT00880048|19358579|P3|Overall Study|Physician Decision|7
5603503|NCT00880048|19358580|P2|Overall Study|Physician Decision|1
5603504|NCT00880048|19358581|P1|Overall Study|Physician Decision|1
5603505|NCT00880048|19358579|P3|Overall Study|Lost to Follow-up|5
5603506|NCT00880048|19358580|P2|Overall Study|Lost to Follow-up|6
5603507|NCT00880048|19358581|P1|Overall Study|Lost to Follow-up|6
5603508|NCT00880048|19358579|P3|Overall Study|Protocol Violation|5
5603509|NCT00880048|19358580|P2|Overall Study|Protocol Violation|6
5603510|NCT00880048|19358581|P1|Overall Study|Protocol Violation|4
5603511|NCT00880048|19358579|P3|Overall Study|Lack of Efficacy|2
5603512|NCT00880048|19358580|P2|Overall Study|Lack of Efficacy|2
5603513|NCT00880048|19358581|P1|Overall Study|Lack of Efficacy|1
5603514|NCT00880048|19358579|P3|Overall Study|Adverse Event|5
5603515|NCT00880048|19358580|P2|Overall Study|Adverse Event|3
5603516|NCT00880048|19358581|P1|Overall Study|Adverse Event|2
5603517|NCT00880009|19358648|P1|Overall Study|Protocol Violation|1
5603518|NCT00880009|19358648|P1|Overall Study|Withdrawal by Subject|1
5603519|NCT00880009|19358648|P1|Overall Study|Study terminated by sponsor|14
5603520|NCT00879996|19358672|P2|Overall Study|put on parole|0
5603521|NCT00879996|19358673|P1|Overall Study|put on parole|1
5603522|NCT00879996|19358672|P2|Overall Study|psychiatric problem|1
5603523|NCT00879996|19358673|P1|Overall Study|psychiatric problem|0
5603524|NCT00879996|19358672|P2|Overall Study|Physician Decision|2
5603525|NCT00879996|19358673|P1|Overall Study|Physician Decision|1
5603526|NCT00879996|19358672|P2|Overall Study|non-compliance|4
5603527|NCT00879996|19358673|P1|Overall Study|non-compliance|6
5603528|NCT00879996|19358672|P2|Overall Study|Lost to Follow-up|6
5603529|NCT00879996|19358673|P1|Overall Study|Lost to Follow-up|7
5603530|NCT00879970|19358688|P5|Period 2 Vitamin D Randomization|Death|0
5603531|NCT00879970|19358689|P4|Period 2 Vitamin D Randomization|Death|2
5603532|NCT00879970|19358690|P3|Period 2 Vitamin D Randomization|Death|0
5603533|NCT00879970|19358691|P2|Period 2 Vitamin D Randomization|Death|0
5603534|NCT00879970|19358692|P1|Period 2 Vitamin D Randomization|Death|0
5603535|NCT00879970|19358688|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
5603536|NCT00879970|19358689|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
5603537|NCT00879970|19358690|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
5603538|NCT00879970|19358691|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
5603539|NCT00879970|19358692|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
5603540|NCT00879970|19358688|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
5603541|NCT00879970|19358689|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
5603542|NCT00879970|19358690|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
5603543|NCT00879970|19358691|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
5603544|NCT00879970|19358692|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
5603545|NCT00879970|19358688|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
5603546|NCT00879970|19358689|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
5603547|NCT00879970|19358690|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
5603548|NCT00879970|19358691|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
5603549|NCT00879970|19358692|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
5603550|NCT00879970|19358688|P5|Period 1 TZD Randomization|Death|0
5603551|NCT00879970|19358689|P4|Period 1 TZD Randomization|Death|0
5603552|NCT00879970|19358690|P3|Period 1 TZD Randomization|Death|0
5603553|NCT00879970|19358691|P2|Period 1 TZD Randomization|Death|1
5603554|NCT00879970|19358692|P1|Period 1 TZD Randomization|Death|2
5603555|NCT00879970|19358688|P5|Period 1 TZD Randomization|Lost to Follow-up|0
5603556|NCT00879970|19358689|P4|Period 1 TZD Randomization|Lost to Follow-up|0
5603557|NCT00879970|19358690|P3|Period 1 TZD Randomization|Lost to Follow-up|1
5603558|NCT00879970|19358691|P2|Period 1 TZD Randomization|Lost to Follow-up|0
5603559|NCT00879970|19358692|P1|Period 1 TZD Randomization|Lost to Follow-up|1
5603560|NCT00879970|19358688|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
5603561|NCT00879970|19358689|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
5603562|NCT00879970|19358690|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
5603563|NCT00879970|19358691|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
5603564|NCT00879970|19358692|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
5603565|NCT00879879|19358774|P1|Overall Study|Physician Decision|1
5603566|NCT00879879|19358774|P1|Overall Study|Withdrawal by Subject|1
5603567|NCT00879879|19358774|P1|Overall Study|Death|1
5603568|NCT00879814|19358782|P4|Overall Study|Other|0
5603569|NCT00879814|19358783|P3|Overall Study|Other|1
5603570|NCT00879814|19358784|P2|Overall Study|Other|0
5603571|NCT00879814|19358785|P1|Overall Study|Other|0
5603572|NCT00879814|19358782|P4|Overall Study|Physician Decision|0
5603573|NCT00879814|19358783|P3|Overall Study|Physician Decision|1
5603574|NCT00879814|19358784|P2|Overall Study|Physician Decision|0
5603575|NCT00879814|19358785|P1|Overall Study|Physician Decision|0
5603576|NCT00879814|19358782|P4|Overall Study|Withdrawal by Subject|2
5603577|NCT00879814|19358783|P3|Overall Study|Withdrawal by Subject|1
5603578|NCT00879814|19358784|P2|Overall Study|Withdrawal by Subject|1
5603579|NCT00879814|19358785|P1|Overall Study|Withdrawal by Subject|3
5603580|NCT00879814|19358782|P4|Overall Study|Participant Failed to Return|1
5603581|NCT00879814|19358783|P3|Overall Study|Participant Failed to Return|0
5603582|NCT00879814|19358784|P2|Overall Study|Participant Failed to Return|0
5603583|NCT00879814|19358785|P1|Overall Study|Participant Failed to Return|0
5603584|NCT00879814|19358782|P4|Overall Study|Lost to Follow-up|2
5603585|NCT00879814|19358783|P3|Overall Study|Lost to Follow-up|0
5603586|NCT00879814|19358784|P2|Overall Study|Lost to Follow-up|0
5603587|NCT00879814|19358785|P1|Overall Study|Lost to Follow-up|1
5603588|NCT00879814|19358782|P4|Overall Study|Adverse Event|0
5603589|NCT00879814|19358783|P3|Overall Study|Adverse Event|0
5603590|NCT00879814|19358784|P2|Overall Study|Adverse Event|1
5603591|NCT00879814|19358785|P1|Overall Study|Adverse Event|0
5603592|NCT00879775|19358893|P2|Overall Study|Lost to Follow-up|1
5603593|NCT00879775|19358894|P1|Overall Study|Lost to Follow-up|2
5603594|NCT00879710|19358910|P4|Phase 1 - 6 Weeks|Adverse Event|0
5603595|NCT00879710|19358911|P3|Phase 1 - 6 Weeks|Adverse Event|1
5603596|NCT00879710|19358912|P2|Phase 1 - 6 Weeks|Adverse Event|0
5603597|NCT00879710|19358913|P1|Phase 1 - 6 Weeks|Adverse Event|0
5603598|NCT00879710|19358910|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
5603599|NCT00879710|19358911|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
5603600|NCT00879710|19358912|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
5603601|NCT00879710|19358913|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
5603602|NCT00879697|19358923|P2|Overall Study|Physician Decision|2
5603603|NCT00879697|19358924|P1|Overall Study|Physician Decision|2
5603604|NCT00879684|19358930|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
5603605|NCT00879684|19358931|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
5603606|NCT00879684|19358932|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
5603607|NCT00879684|19358933|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
5603608|NCT00879684|19358934|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
5603609|NCT00879684|19358935|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
5603610|NCT00879684|19358936|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
5603611|NCT00879684|19358930|P7|Stage 2: Expanded Cohort|Progressive Disease|11
5603612|NCT00879684|19358931|P6|Stage 2: Expanded Cohort|Progressive Disease|0
5603613|NCT00879684|19358932|P5|Stage 2: Expanded Cohort|Progressive Disease|0
5603614|NCT00879684|19358933|P4|Stage 2: Expanded Cohort|Progressive Disease|0
5603615|NCT00879684|19358934|P3|Stage 2: Expanded Cohort|Progressive Disease|0
5603616|NCT00879684|19358935|P2|Stage 2: Expanded Cohort|Progressive Disease|0
5603617|NCT00879684|19358936|P1|Stage 2: Expanded Cohort|Progressive Disease|0
5603618|NCT00879684|19358930|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
5603619|NCT00879684|19358931|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
5603620|NCT00879684|19358932|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
5603621|NCT00879684|19358933|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
5603622|NCT00879684|19358934|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
5603623|NCT00879684|19358935|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
5603624|NCT00879684|19358936|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
5603625|NCT00879684|19358930|P7|Stage 1: Dose Escalation|Death|0
5603626|NCT00879684|19358931|P6|Stage 1: Dose Escalation|Death|0
5603627|NCT00879684|19358932|P5|Stage 1: Dose Escalation|Death|0
5603628|NCT00879684|19358933|P4|Stage 1: Dose Escalation|Death|0
5603629|NCT00879684|19358934|P3|Stage 1: Dose Escalation|Death|1
5603630|NCT00879684|19358935|P2|Stage 1: Dose Escalation|Death|0
5603631|NCT00879684|19358936|P1|Stage 1: Dose Escalation|Death|0
5603632|NCT00879684|19358930|P7|Stage 1: Dose Escalation|Investigator declined participation|0
5603633|NCT00879684|19358931|P6|Stage 1: Dose Escalation|Investigator declined participation|0
5603634|NCT00879684|19358932|P5|Stage 1: Dose Escalation|Investigator declined participation|0
5603635|NCT00879684|19358933|P4|Stage 1: Dose Escalation|Investigator declined participation|2
5603636|NCT00879684|19358934|P3|Stage 1: Dose Escalation|Investigator declined participation|2
5603637|NCT00879684|19358935|P2|Stage 1: Dose Escalation|Investigator declined participation|0
5603638|NCT00879684|19358936|P1|Stage 1: Dose Escalation|Investigator declined participation|0
5603639|NCT00879684|19358930|P7|Stage 1: Dose Escalation|Progressive Disease|0
5603640|NCT00879684|19358931|P6|Stage 1: Dose Escalation|Progressive Disease|3
5603641|NCT00879684|19358932|P5|Stage 1: Dose Escalation|Progressive Disease|3
5603642|NCT00879684|19358933|P4|Stage 1: Dose Escalation|Progressive Disease|4
5603643|NCT00879684|19358934|P3|Stage 1: Dose Escalation|Progressive Disease|0
5603644|NCT00879684|19358935|P2|Stage 1: Dose Escalation|Progressive Disease|3
5603645|NCT00879684|19358936|P1|Stage 1: Dose Escalation|Progressive Disease|2
5603646|NCT00879684|19358930|P7|Stage 1: Dose Escalation|Adverse Event|0
5603647|NCT00879684|19358931|P6|Stage 1: Dose Escalation|Adverse Event|0
5603648|NCT00879684|19358932|P5|Stage 1: Dose Escalation|Adverse Event|0
5603649|NCT00879684|19358933|P4|Stage 1: Dose Escalation|Adverse Event|0
5603650|NCT00879684|19358934|P3|Stage 1: Dose Escalation|Adverse Event|0
5603651|NCT00879684|19358935|P2|Stage 1: Dose Escalation|Adverse Event|0
5603652|NCT00879684|19358936|P1|Stage 1: Dose Escalation|Adverse Event|1
5603653|NCT00879658|19359005|P7|Overall Study|misrandomized (never received study med)|0
5603654|NCT00879658|19359006|P6|Overall Study|misrandomized (never received study med)|0
5603655|NCT00879658|19359007|P5|Overall Study|misrandomized (never received study med)|0
5603656|NCT00879658|19359008|P4|Overall Study|misrandomized (never received study med)|1
5603657|NCT00879658|19359009|P3|Overall Study|misrandomized (never received study med)|0
5603658|NCT00879658|19359010|P2|Overall Study|misrandomized (never received study med)|0
5603659|NCT00879658|19359011|P1|Overall Study|misrandomized (never received study med)|0
5603660|NCT00879658|19359005|P7|Overall Study|Lack of Efficacy|0
5603661|NCT00879658|19359006|P6|Overall Study|Lack of Efficacy|0
5603662|NCT00879658|19359007|P5|Overall Study|Lack of Efficacy|0
5603663|NCT00879658|19359008|P4|Overall Study|Lack of Efficacy|0
5603664|NCT00879658|19359009|P3|Overall Study|Lack of Efficacy|2
5603665|NCT00879658|19359010|P2|Overall Study|Lack of Efficacy|0
5603666|NCT00879658|19359011|P1|Overall Study|Lack of Efficacy|0
5603667|NCT00879658|19359005|P7|Overall Study|Withdrawal by Subject|0
5603668|NCT00879658|19359006|P6|Overall Study|Withdrawal by Subject|1
5603669|NCT00879658|19359007|P5|Overall Study|Withdrawal by Subject|0
5603670|NCT00879658|19359008|P4|Overall Study|Withdrawal by Subject|0
5603671|NCT00879658|19359009|P3|Overall Study|Withdrawal by Subject|2
5603672|NCT00879658|19359010|P2|Overall Study|Withdrawal by Subject|0
5603673|NCT00879658|19359011|P1|Overall Study|Withdrawal by Subject|3
5603674|NCT00879658|19359005|P7|Overall Study|Protocol Violation|0
5603675|NCT00879658|19359006|P6|Overall Study|Protocol Violation|0
5603676|NCT00879658|19359007|P5|Overall Study|Protocol Violation|0
5603677|NCT00879658|19359008|P4|Overall Study|Protocol Violation|0
5603678|NCT00879658|19359009|P3|Overall Study|Protocol Violation|0
5603679|NCT00879658|19359010|P2|Overall Study|Protocol Violation|0
5603680|NCT00879658|19359011|P1|Overall Study|Protocol Violation|1
5603681|NCT00879658|19359005|P7|Overall Study|Adverse Event|0
5603682|NCT00879658|19359006|P6|Overall Study|Adverse Event|0
5603683|NCT00879658|19359007|P5|Overall Study|Adverse Event|2
5603684|NCT00879658|19359008|P4|Overall Study|Adverse Event|1
5603685|NCT00879658|19359009|P3|Overall Study|Adverse Event|3
5603686|NCT00879658|19359010|P2|Overall Study|Adverse Event|4
5603687|NCT00879658|19359011|P1|Overall Study|Adverse Event|6
5603688|NCT00879658|19359005|P7|Overall Study|Administrative problems|0
5603689|NCT00879658|19359006|P6|Overall Study|Administrative problems|0
5603690|NCT00879658|19359007|P5|Overall Study|Administrative problems|0
5603691|NCT00879658|19359008|P4|Overall Study|Administrative problems|1
5603692|NCT00879658|19359009|P3|Overall Study|Administrative problems|0
5603693|NCT00879658|19359010|P2|Overall Study|Administrative problems|1
5603694|NCT00879658|19359011|P1|Overall Study|Administrative problems|2
5603695|NCT00879658|19359005|P7|Overall Study|Abnormal laboratory value(s)|0
5603696|NCT00879658|19359006|P6|Overall Study|Abnormal laboratory value(s)|0
5603697|NCT00879658|19359007|P5|Overall Study|Abnormal laboratory value(s)|0
5603698|NCT00879658|19359008|P4|Overall Study|Abnormal laboratory value(s)|1
5603699|NCT00879658|19359009|P3|Overall Study|Abnormal laboratory value(s)|0
5603700|NCT00879658|19359010|P2|Overall Study|Abnormal laboratory value(s)|0
5603701|NCT00879658|19359011|P1|Overall Study|Abnormal laboratory value(s)|3
5603702|NCT00879645|19359097|P4|Overall Study|Adverse Event|0
5603703|NCT00879645|19359098|P3|Overall Study|Adverse Event|0
5603704|NCT00879645|19359099|P2|Overall Study|Adverse Event|0
5603705|NCT00879645|19359100|P1|Overall Study|Adverse Event|1
5603706|NCT00879411|19359127|P1|Overall Study|lost to follow-up (non-AE)|162
5603707|NCT00879398|19359133|P1|Overall Study|Other Reasons|171
5603708|NCT00879398|19359133|P1|Overall Study|Adverse Event|41
5603709|NCT00879398|19359133|P1|Overall Study|Lack of Efficacy|64
5603710|NCT00879398|19359133|P1|Overall Study|Visit Stop|399
5603711|NCT00879333|19359151|P2|Overall Study|Protocol Violation|1
5603712|NCT00879333|19359152|P1|Overall Study|Protocol Violation|1
5603713|NCT00879333|19359151|P2|Overall Study|Disease Progression|169
5603714|NCT00879333|19359152|P1|Overall Study|Disease Progression|292
5603715|NCT00879333|19359151|P2|Overall Study|Death|5
5603716|NCT00879333|19359152|P1|Overall Study|Death|16
5603717|NCT00879333|19359151|P2|Overall Study|Administrative Problems|0
5603718|NCT00879333|19359152|P1|Overall Study|Administrative Problems|2
5603719|NCT00879333|19359151|P2|Overall Study|Lost to Follow-up|1
5603720|NCT00879333|19359152|P1|Overall Study|Lost to Follow-up|2
5603721|NCT00879333|19359151|P2|Overall Study|Withdrawal by Subject|7
5603722|NCT00879333|19359152|P1|Overall Study|Withdrawal by Subject|20
5603723|NCT00879333|19359151|P2|Overall Study|Abnormal Laboratory Value|0
5603724|NCT00879333|19359152|P1|Overall Study|Abnormal Laboratory Value|1
5603725|NCT00879333|19359151|P2|Overall Study|Adverse Event|34
5603726|NCT00879333|19359152|P1|Overall Study|Adverse Event|94
5603727|NCT00879229|19359185|P2|Overall Study|Other|0
5603728|NCT00879229|19359186|P1|Overall Study|Other|1
5603729|NCT00879229|19359185|P2|Overall Study|Clinical status did not improve|0
5603730|NCT00879229|19359186|P1|Overall Study|Clinical status did not improve|1
5603731|NCT00879229|19359185|P2|Overall Study|Withdrawal by Subject|0
5603732|NCT00879229|19359186|P1|Overall Study|Withdrawal by Subject|1
5603733|NCT00879229|19359185|P2|Overall Study|Adverse Event|0
5603734|NCT00879229|19359186|P1|Overall Study|Adverse Event|2
5603735|NCT00879229|19359185|P2|Overall Study|Death|2
5603736|NCT00879229|19359186|P1|Overall Study|Death|4
5603737|NCT00879229|19359185|P2|Overall Study|Study terminated by Sponsor|12
5603738|NCT00879229|19359186|P1|Overall Study|Study terminated by Sponsor|13
5603739|NCT00878995|19359234|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
5603740|NCT00878995|19359235|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
5603741|NCT00878969|19359336|P3|Overall Study|Pregnancy|0
5603742|NCT00878969|19359337|P2|Overall Study|Pregnancy|1
5603743|NCT00878969|19359338|P1|Overall Study|Pregnancy|0
5603744|NCT00878969|19359336|P3|Overall Study|Death|2
5603745|NCT00878969|19359337|P2|Overall Study|Death|0
5603746|NCT00878969|19359338|P1|Overall Study|Death|0
5603747|NCT00878969|19359336|P3|Overall Study|Protocol Violation|0
5603748|NCT00878969|19359337|P2|Overall Study|Protocol Violation|0
5603749|NCT00878969|19359338|P1|Overall Study|Protocol Violation|2
5603750|NCT00878969|19359336|P3|Overall Study|Lost to Follow-up|0
5603751|NCT00878969|19359337|P2|Overall Study|Lost to Follow-up|1
5603752|NCT00878969|19359338|P1|Overall Study|Lost to Follow-up|2
5603753|NCT00878969|19359336|P3|Overall Study|Adverse Event|2
5603754|NCT00878969|19359337|P2|Overall Study|Adverse Event|1
5603755|NCT00878969|19359338|P1|Overall Study|Adverse Event|3
5603756|NCT00878969|19359336|P3|Overall Study|kidney transplant|2
5603757|NCT00878969|19359337|P2|Overall Study|kidney transplant|3
5603758|NCT00878969|19359338|P1|Overall Study|kidney transplant|2
5603759|NCT00878969|19359336|P3|Overall Study|Withdrawal by Subject|3
5603760|NCT00878969|19359337|P2|Overall Study|Withdrawal by Subject|6
5603761|NCT00878969|19359338|P1|Overall Study|Withdrawal by Subject|1
5603762|NCT00878969|19359336|P3|Overall Study|Physician Decision|2
5603763|NCT00878969|19359337|P2|Overall Study|Physician Decision|3
5603764|NCT00878969|19359338|P1|Overall Study|Physician Decision|5
5603765|NCT00878800|19359386|P5|Overall Study|Other|1
5603766|NCT00878800|19359387|P4|Overall Study|Other|0
5603767|NCT00878800|19359388|P3|Overall Study|Other|0
5603768|NCT00878800|19359389|P2|Overall Study|Other|1
5603769|NCT00878800|19359390|P1|Overall Study|Other|1
5603770|NCT00878800|19359386|P5|Overall Study|Death|0
5603771|NCT00878800|19359387|P4|Overall Study|Death|0
5603772|NCT00878800|19359388|P3|Overall Study|Death|1
5603773|NCT00878800|19359389|P2|Overall Study|Death|0
5603774|NCT00878800|19359390|P1|Overall Study|Death|0
5603775|NCT00878800|19359386|P5|Overall Study|Withdrew consent|1
5603776|NCT00878800|19359387|P4|Overall Study|Withdrew consent|1
5603777|NCT00878800|19359388|P3|Overall Study|Withdrew consent|0
5603778|NCT00878800|19359389|P2|Overall Study|Withdrew consent|1
5603779|NCT00878800|19359390|P1|Overall Study|Withdrew consent|1
5603780|NCT00878800|19359386|P5|Overall Study|Progressive disease|13
5603781|NCT00878800|19359387|P4|Overall Study|Progressive disease|5
5603782|NCT00878800|19359388|P3|Overall Study|Progressive disease|6
5603783|NCT00878800|19359389|P2|Overall Study|Progressive disease|5
5603784|NCT00878800|19359390|P1|Overall Study|Progressive disease|1
5603785|NCT00878800|19359386|P5|Overall Study|Adverse Event|1
5603786|NCT00878800|19359387|P4|Overall Study|Adverse Event|0
5603787|NCT00878800|19359388|P3|Overall Study|Adverse Event|2
5603788|NCT00878800|19359389|P2|Overall Study|Adverse Event|0
5603789|NCT00878800|19359390|P1|Overall Study|Adverse Event|0
5603790|NCT00878722|19359425|P8|Overall Study|Relapse|0
5603791|NCT00878722|19359426|P7|Overall Study|Relapse|0
5603792|NCT00878722|19359427|P6|Overall Study|Relapse|0
5603793|NCT00878722|19359428|P5|Overall Study|Relapse|0
5603794|NCT00878722|19359429|P4|Overall Study|Relapse|1
5603795|NCT00878722|19359430|P3|Overall Study|Relapse|0
5603796|NCT00878722|19359431|P2|Overall Study|Relapse|0
5603797|NCT00878722|19359432|P1|Overall Study|Relapse|0
5603798|NCT00878722|19359425|P8|Overall Study|Withdrawal by Subject|2
5603799|NCT00878722|19359426|P7|Overall Study|Withdrawal by Subject|0
5603800|NCT00878722|19359427|P6|Overall Study|Withdrawal by Subject|0
5603801|NCT00878722|19359428|P5|Overall Study|Withdrawal by Subject|0
5603802|NCT00878722|19359429|P4|Overall Study|Withdrawal by Subject|0
5603803|NCT00878722|19359430|P3|Overall Study|Withdrawal by Subject|0
5603804|NCT00878722|19359431|P2|Overall Study|Withdrawal by Subject|0
5603805|NCT00878722|19359432|P1|Overall Study|Withdrawal by Subject|0
5603806|NCT00878722|19359425|P8|Overall Study|Adverse Event|0
5603807|NCT00878722|19359426|P7|Overall Study|Adverse Event|2
5603808|NCT00878722|19359427|P6|Overall Study|Adverse Event|0
5603809|NCT00878722|19359428|P5|Overall Study|Adverse Event|0
5603810|NCT00878722|19359429|P4|Overall Study|Adverse Event|0
5603811|NCT00878722|19359430|P3|Overall Study|Adverse Event|0
5603812|NCT00878722|19359431|P2|Overall Study|Adverse Event|0
5603813|NCT00878722|19359432|P1|Overall Study|Adverse Event|0
5603814|NCT00878722|19359425|P8|Overall Study|Death|2
5603815|NCT00878722|19359426|P7|Overall Study|Death|0
5603816|NCT00878722|19359427|P6|Overall Study|Death|1
5603817|NCT00878722|19359428|P5|Overall Study|Death|0
5603818|NCT00878722|19359429|P4|Overall Study|Death|1
5603819|NCT00878722|19359430|P3|Overall Study|Death|0
5603820|NCT00878722|19359431|P2|Overall Study|Death|0
5603821|NCT00878722|19359432|P1|Overall Study|Death|0
5603822|NCT00878722|19359425|P8|Overall Study|Progressive disease|3
5603823|NCT00878722|19359426|P7|Overall Study|Progressive disease|4
5603824|NCT00878722|19359427|P6|Overall Study|Progressive disease|1
5603825|NCT00878722|19359428|P5|Overall Study|Progressive disease|7
5603826|NCT00878722|19359429|P4|Overall Study|Progressive disease|7
5603827|NCT00878722|19359430|P3|Overall Study|Progressive disease|3
5603828|NCT00878722|19359431|P2|Overall Study|Progressive disease|3
5603829|NCT00878722|19359432|P1|Overall Study|Progressive disease|3
5603830|NCT00878709|19359517|P2|Overall Study|Other Reasons|84
5603831|NCT00878709|19359518|P1|Overall Study|Other Reasons|93
5603832|NCT00878709|19359517|P2|Overall Study|Lost to Follow-up|33
5603833|NCT00878709|19359518|P1|Overall Study|Lost to Follow-up|35
5603834|NCT00878709|19359517|P2|Overall Study|Withdrawal by Subject|120
5603835|NCT00878709|19359518|P1|Overall Study|Withdrawal by Subject|197
5603836|NCT00878553|19359592|P5|PK Study|Withdrawal by Subject|0
5603837|NCT00878553|19359593|P4|PK Study|Withdrawal by Subject|1
5603838|NCT00878553|19359594|P3|PK Study|Withdrawal by Subject|0
5603839|NCT00878553|19359595|P2|PK Study|Withdrawal by Subject|0
5603840|NCT00878553|19359596|P1|PK Study|Withdrawal by Subject|0
5603841|NCT00878553|19359592|P5|Sleep Study|family emergency|0
5603842|NCT00878553|19359593|P4|Sleep Study|family emergency|0
5603843|NCT00878553|19359594|P3|Sleep Study|family emergency|0
5603844|NCT00878553|19359595|P2|Sleep Study|family emergency|0
5603845|NCT00878553|19359596|P1|Sleep Study|family emergency|1
5603846|NCT00878553|19359592|P5|Sleep Study|car accident|0
5603847|NCT00878553|19359593|P4|Sleep Study|car accident|0
5603848|NCT00878553|19359594|P3|Sleep Study|car accident|0
5603849|NCT00878553|19359595|P2|Sleep Study|car accident|0
5603850|NCT00878553|19359596|P1|Sleep Study|car accident|1
5603851|NCT00878553|19359592|P5|Sleep Study|Lost to Follow-up|0
5603852|NCT00878553|19359593|P4|Sleep Study|Lost to Follow-up|0
5603853|NCT00878553|19359594|P3|Sleep Study|Lost to Follow-up|0
5603854|NCT00878553|19359595|P2|Sleep Study|Lost to Follow-up|0
5603855|NCT00878553|19359596|P1|Sleep Study|Lost to Follow-up|1
5603856|NCT00878553|19359592|P5|Sleep Study|Withdrawal by Subject|0
5603857|NCT00878553|19359593|P4|Sleep Study|Withdrawal by Subject|0
5603858|NCT00878553|19359594|P3|Sleep Study|Withdrawal by Subject|0
5603859|NCT00878553|19359595|P2|Sleep Study|Withdrawal by Subject|0
5603860|NCT00878553|19359596|P1|Sleep Study|Withdrawal by Subject|2
5603861|NCT00878501|19359655|P3|Overall Study|Administrative|1
5603862|NCT00878501|19359656|P2|Overall Study|Administrative|0
5603863|NCT00878501|19359657|P1|Overall Study|Administrative|0
5603864|NCT00878501|19359655|P3|Overall Study|Mis-randomisation of patient|0
5603865|NCT00878501|19359656|P2|Overall Study|Mis-randomisation of patient|0
5603866|NCT00878501|19359657|P1|Overall Study|Mis-randomisation of patient|1
5603867|NCT00878501|19359655|P3|Overall Study|Intake of prohibited concom. medication|1
5603868|NCT00878501|19359656|P2|Overall Study|Intake of prohibited concom. medication|0
5603869|NCT00878501|19359657|P1|Overall Study|Intake of prohibited concom. medication|0
5603870|NCT00878501|19359655|P3|Overall Study|Incorrect enrolment|0
5603871|NCT00878501|19359656|P2|Overall Study|Incorrect enrolment|2
5603872|NCT00878501|19359657|P1|Overall Study|Incorrect enrolment|1
5603873|NCT00878501|19359655|P3|Overall Study|Protocol Violation|1
5603874|NCT00878501|19359656|P2|Overall Study|Protocol Violation|0
5603875|NCT00878501|19359657|P1|Overall Study|Protocol Violation|0
5603876|NCT00878501|19359655|P3|Overall Study|Withdrawal by Subject|2
5603877|NCT00878501|19359656|P2|Overall Study|Withdrawal by Subject|1
5603878|NCT00878501|19359657|P1|Overall Study|Withdrawal by Subject|2
5603879|NCT00878501|19359655|P3|Overall Study|Lack of Efficacy|0
5603880|NCT00878501|19359656|P2|Overall Study|Lack of Efficacy|1
5603881|NCT00878501|19359657|P1|Overall Study|Lack of Efficacy|2
5603882|NCT00878501|19359655|P3|Overall Study|Adverse Event|3
5603883|NCT00878501|19359656|P2|Overall Study|Adverse Event|3
5603884|NCT00878501|19359657|P1|Overall Study|Adverse Event|11
5603885|NCT00878215|19359706|P4|Overall Study|Determined to be ineligible|0
5603886|NCT00878215|19359707|P3|Overall Study|Determined to be ineligible|0
5603887|NCT00878215|19359708|P2|Overall Study|Determined to be ineligible|10
5603888|NCT00878215|19359709|P1|Overall Study|Determined to be ineligible|0
5603889|NCT00878189|19359721|P9|Overall Study|Objection Progression or Relapse|3
5603890|NCT00878189|19359722|P8|Overall Study|Objection Progression or Relapse|0
5603891|NCT00878189|19359723|P7|Overall Study|Objection Progression or Relapse|0
5603892|NCT00878189|19359724|P6|Overall Study|Objection Progression or Relapse|0
5603893|NCT00878189|19359725|P5|Overall Study|Objection Progression or Relapse|0
5603894|NCT00878189|19359726|P4|Overall Study|Objection Progression or Relapse|0
5603895|NCT00878189|19359727|P3|Overall Study|Objection Progression or Relapse|0
5603896|NCT00878189|19359728|P2|Overall Study|Objection Progression or Relapse|0
5603897|NCT00878189|19359729|P1|Overall Study|Objection Progression or Relapse|0
5603898|NCT00878189|19359721|P9|Overall Study|Lost to Follow-up|0
5603899|NCT00878189|19359722|P8|Overall Study|Lost to Follow-up|0
5603900|NCT00878189|19359723|P7|Overall Study|Lost to Follow-up|1
5603901|NCT00878189|19359724|P6|Overall Study|Lost to Follow-up|1
5603902|NCT00878189|19359725|P5|Overall Study|Lost to Follow-up|0
5603903|NCT00878189|19359726|P4|Overall Study|Lost to Follow-up|0
5603904|NCT00878189|19359727|P3|Overall Study|Lost to Follow-up|0
5603905|NCT00878189|19359728|P2|Overall Study|Lost to Follow-up|0
5603906|NCT00878189|19359729|P1|Overall Study|Lost to Follow-up|0
5603907|NCT00878189|19359721|P9|Overall Study|Other|4
5603908|NCT00878189|19359722|P8|Overall Study|Other|3
5603909|NCT00878189|19359723|P7|Overall Study|Other|15
5603910|NCT00878189|19359724|P6|Overall Study|Other|18
5603911|NCT00878189|19359725|P5|Overall Study|Other|4
5603912|NCT00878189|19359726|P4|Overall Study|Other|7
5603913|NCT00878189|19359727|P3|Overall Study|Other|4
5603914|NCT00878189|19359728|P2|Overall Study|Other|2
5603915|NCT00878189|19359729|P1|Overall Study|Other|3
5603916|NCT00878189|19359721|P9|Overall Study|Participant Refused to Follow-up|0
5603917|NCT00878189|19359722|P8|Overall Study|Participant Refused to Follow-up|0
5603918|NCT00878189|19359723|P7|Overall Study|Participant Refused to Follow-up|0
5603919|NCT00878189|19359724|P6|Overall Study|Participant Refused to Follow-up|4
5603920|NCT00878189|19359725|P5|Overall Study|Participant Refused to Follow-up|0
5603921|NCT00878189|19359726|P4|Overall Study|Participant Refused to Follow-up|0
5603922|NCT00878189|19359727|P3|Overall Study|Participant Refused to Follow-up|0
5603923|NCT00878189|19359728|P2|Overall Study|Participant Refused to Follow-up|0
5603924|NCT00878189|19359729|P1|Overall Study|Participant Refused to Follow-up|0
5603925|NCT00878189|19359721|P9|Overall Study|Death|1
5603926|NCT00878189|19359722|P8|Overall Study|Death|0
5603927|NCT00878189|19359723|P7|Overall Study|Death|0
5603928|NCT00878189|19359724|P6|Overall Study|Death|0
5603929|NCT00878189|19359725|P5|Overall Study|Death|0
5603930|NCT00878189|19359726|P4|Overall Study|Death|1
5603931|NCT00878189|19359727|P3|Overall Study|Death|0
5603932|NCT00878189|19359728|P2|Overall Study|Death|1
5603933|NCT00878189|19359729|P1|Overall Study|Death|0
5603934|NCT00877929|19359997|P2|Overall Study|Other reason (not specified)|6
5603935|NCT00877929|19359998|P1|Overall Study|Other reason (not specified)|2
5603936|NCT00877929|19359997|P2|Overall Study|Lack of Efficacy|1
5603937|NCT00877929|19359998|P1|Overall Study|Lack of Efficacy|0
5603938|NCT00877929|19359997|P2|Overall Study|Withdrawal by Subject|4
5603939|NCT00877929|19359998|P1|Overall Study|Withdrawal by Subject|4
5603940|NCT00877929|19359997|P2|Overall Study|Lost to Follow-up|1
5603941|NCT00877929|19359998|P1|Overall Study|Lost to Follow-up|0
5603942|NCT00877929|19359997|P2|Overall Study|Protocol Violation|3
5603943|NCT00877929|19359998|P1|Overall Study|Protocol Violation|3
5603944|NCT00877929|19359997|P2|Overall Study|Adverse Event|20
5603945|NCT00877929|19359998|P1|Overall Study|Adverse Event|11
5603946|NCT00877890|19360086|P2|Overall Study|Loss of Glucose Control|4
5603947|NCT00877890|19360087|P1|Overall Study|Loss of Glucose Control|3
5603948|NCT00877890|19360086|P2|Overall Study|Investigator Decision|2
5603949|NCT00877890|19360087|P1|Overall Study|Investigator Decision|0
5603950|NCT00877890|19360086|P2|Overall Study|Withdrawal of Consent|12
5603951|NCT00877890|19360087|P1|Overall Study|Withdrawal of Consent|6
5603952|NCT00877890|19360086|P2|Overall Study|Protocol Violation|1
5603953|NCT00877890|19360087|P1|Overall Study|Protocol Violation|0
5603954|NCT00877890|19360086|P2|Overall Study|Lost to Follow-up|5
5603955|NCT00877890|19360087|P1|Overall Study|Lost to Follow-up|5
5603956|NCT00877890|19360086|P2|Overall Study|Adverse Event|6
5603957|NCT00877890|19360087|P1|Overall Study|Adverse Event|6
5603958|NCT00877799|19360152|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
5603959|NCT00877799|19360153|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
5603960|NCT00877799|19360154|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
5603961|NCT00877799|19360155|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
5603962|NCT00877799|19360156|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
5603963|NCT00877799|19360152|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
5603964|NCT00877799|19360153|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
5603965|NCT00877799|19360154|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
5603966|NCT00877799|19360155|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
5603967|NCT00877799|19360156|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
5603968|NCT00877799|19360152|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
5603969|NCT00877799|19360153|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
5603970|NCT00877799|19360154|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
5603971|NCT00877799|19360155|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
5603972|NCT00877799|19360156|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
5603973|NCT00877799|19360152|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
5603974|NCT00877799|19360153|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
5603975|NCT00877799|19360154|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
5603976|NCT00877799|19360155|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
5603977|NCT00877799|19360156|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
5603978|NCT00877799|19360152|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
5603979|NCT00877799|19360153|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
5603980|NCT00877799|19360154|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
5603981|NCT00877799|19360155|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
5603982|NCT00877799|19360156|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
5603983|NCT00877773|19360171|P1|Overall Study|Disease Progression|44
5603984|NCT00877487|19360184|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
5603985|NCT00877487|19360185|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
5603986|NCT00877487|19360184|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
5603987|NCT00877487|19360185|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
5603988|NCT00877487|19360184|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
5603989|NCT00877487|19360185|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
5603990|NCT00877487|19360184|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
5603991|NCT00877487|19360185|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
5603992|NCT00877487|19360184|P2|Open-label Treatment Phase|Out of country for business|0
5603993|NCT00877487|19360185|P1|Open-label Treatment Phase|Out of country for business|1
5603994|NCT00877487|19360184|P2|Open-label Treatment Phase|Lost to Follow-up|0
5603995|NCT00877487|19360185|P1|Open-label Treatment Phase|Lost to Follow-up|1
5603996|NCT00877487|19360184|P2|Open-label Treatment Phase|Withdrawal by Subject|0
5603997|NCT00877487|19360185|P1|Open-label Treatment Phase|Withdrawal by Subject|1
5603998|NCT00877487|19360184|P2|Open-label Treatment Phase|Protocol Violation|0
5603999|NCT00877487|19360185|P1|Open-label Treatment Phase|Protocol Violation|3
5604000|NCT00877487|19360184|P2|Open-label Treatment Phase|Adverse Event|0
5604001|NCT00877487|19360185|P1|Open-label Treatment Phase|Adverse Event|1
5604002|NCT00877383|19360233|P2|Overall Study|Death|2
5604003|NCT00877383|19360234|P1|Overall Study|Death|1
5604004|NCT00877383|19360233|P2|Overall Study|Unsatisfactory therapeutic effect|0
5604005|NCT00877383|19360234|P1|Overall Study|Unsatisfactory therapeutic effect|1
5604006|NCT00877383|19360233|P2|Overall Study|Protocol deviation|6
5604007|NCT00877383|19360234|P1|Overall Study|Protocol deviation|2
5604008|NCT00877383|19360233|P2|Overall Study|Administrative problems|0
5604009|NCT00877383|19360234|P1|Overall Study|Administrative problems|2
5604010|NCT00877383|19360233|P2|Overall Study|Subject no longer requires study drug|0
5604011|NCT00877383|19360234|P1|Overall Study|Subject no longer requires study drug|2
5604012|NCT00877383|19360233|P2|Overall Study|Subject withdrew consent|12
5604013|NCT00877383|19360234|P1|Overall Study|Subject withdrew consent|3
5604014|NCT00877383|19360233|P2|Overall Study|Lost to Follow-up|3
5604015|NCT00877383|19360234|P1|Overall Study|Lost to Follow-up|5
5604016|NCT00877383|19360233|P2|Overall Study|Adverse Event|14
5604017|NCT00877383|19360234|P1|Overall Study|Adverse Event|13
5604018|NCT00877071|19360254|P1|Overall Study|disease progression|2
5604019|NCT00877032|19360287|P7|Overall Study|Did not meet entrance criteria|2
5604020|NCT00877032|19360288|P6|Overall Study|Did not meet entrance criteria|0
5604021|NCT00877032|19360289|P5|Overall Study|Did not meet entrance criteria|0
5604022|NCT00877032|19360290|P4|Overall Study|Did not meet entrance criteria|1
5604023|NCT00877032|19360291|P3|Overall Study|Did not meet entrance criteria|0
5604024|NCT00877032|19360292|P2|Overall Study|Did not meet entrance criteria|0
5604025|NCT00877032|19360293|P1|Overall Study|Did not meet entrance criteria|0
5604026|NCT00877006|19360394|P2|Long-Term Follow-up Period|Other|9
5604027|NCT00877006|19360395|P1|Long-Term Follow-up Period|Other|7
5604028|NCT00877006|19360394|P2|Long-Term Follow-up Period|Death|18
5604029|NCT00877006|19360395|P1|Long-Term Follow-up Period|Death|26
5604030|NCT00877006|19360394|P2|Long-Term Follow-up Period|Lost to Follow-up|9
5604031|NCT00877006|19360395|P1|Long-Term Follow-up Period|Lost to Follow-up|8
5604032|NCT00877006|19360394|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
5604033|NCT00877006|19360395|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
5604034|NCT00877006|19360394|P2|Treatment Period|Randomized but Not Treated|8
5604035|NCT00877006|19360395|P1|Treatment Period|Randomized but Not Treated|3
5604036|NCT00877006|19360394|P2|Treatment Period|Other|4
5604037|NCT00877006|19360395|P1|Treatment Period|Other|4
5604038|NCT00877006|19360394|P2|Treatment Period|Started New Treatment Regimen|5
5604039|NCT00877006|19360395|P1|Treatment Period|Started New Treatment Regimen|2
5604040|NCT00877006|19360394|P2|Treatment Period|Disease Progression|2
5604041|NCT00877006|19360395|P1|Treatment Period|Disease Progression|1
5604042|NCT00877006|19360394|P2|Treatment Period|Lost to Follow-up|1
5604043|NCT00877006|19360395|P1|Treatment Period|Lost to Follow-up|0
5604044|NCT00877006|19360394|P2|Treatment Period|Protocol Violation|0
5604045|NCT00877006|19360395|P1|Treatment Period|Protocol Violation|1
5604046|NCT00877006|19360394|P2|Treatment Period|Withdrawal by Subject|3
5604047|NCT00877006|19360395|P1|Treatment Period|Withdrawal by Subject|2
5604048|NCT00877006|19360394|P2|Treatment Period|Adverse Event|3
5604049|NCT00877006|19360395|P1|Treatment Period|Adverse Event|10
5604050|NCT00877006|19360394|P2|Treatment Period|Death|1
5604051|NCT00877006|19360395|P1|Treatment Period|Death|2
5604052|NCT00876928|19360471|P2|Overall Study|Hypokalemia-affects insulin secretion|0
5604053|NCT00876928|19360472|P1|Overall Study|Hypokalemia-affects insulin secretion|1
5604054|NCT00876928|19360471|P2|Overall Study|Lost to Follow-up|5
5604055|NCT00876928|19360472|P1|Overall Study|Lost to Follow-up|2
5604056|NCT00876733|19360509|P4|Overall Study|Data not available|1
5604057|NCT00876733|19360510|P3|Overall Study|Data not available|7
5604058|NCT00876733|19360511|P2|Overall Study|Data not available|3
5604059|NCT00876733|19360512|P1|Overall Study|Data not available|14
5604060|NCT00876733|19360509|P4|Overall Study|Lost to Follow-up|2
5604061|NCT00876733|19360510|P3|Overall Study|Lost to Follow-up|3
5604062|NCT00876733|19360511|P2|Overall Study|Lost to Follow-up|10
5604063|NCT00876733|19360512|P1|Overall Study|Lost to Follow-up|26
5604064|NCT00876733|19360509|P4|Overall Study|Lack of Efficacy|1
5604065|NCT00876733|19360510|P3|Overall Study|Lack of Efficacy|10
5604066|NCT00876733|19360511|P2|Overall Study|Lack of Efficacy|9
5604067|NCT00876733|19360512|P1|Overall Study|Lack of Efficacy|17
5604068|NCT00876733|19360509|P4|Overall Study|Adverse Event|3
5604069|NCT00876733|19360510|P3|Overall Study|Adverse Event|10
5604070|NCT00876733|19360511|P2|Overall Study|Adverse Event|20
5604071|NCT00876733|19360512|P1|Overall Study|Adverse Event|34
5604072|NCT00876694|19360620|P2|Overall Study|Death|0
5604073|NCT00876694|19360621|P1|Overall Study|Death|1
5604074|NCT00876694|19360620|P2|Overall Study|Administrative problems|1
5604075|NCT00876694|19360621|P1|Overall Study|Administrative problems|1
5604076|NCT00876694|19360620|P2|Overall Study|Abnormal test procedure result(s)|0
5604077|NCT00876694|19360621|P1|Overall Study|Abnormal test procedure result(s)|1
5604078|NCT00876694|19360620|P2|Overall Study|Unsatisfactory therapeutic effect|0
5604079|NCT00876694|19360621|P1|Overall Study|Unsatisfactory therapeutic effect|2
5604080|NCT00876694|19360620|P2|Overall Study|Subject withdrew consent|4
5604081|NCT00876694|19360621|P1|Overall Study|Subject withdrew consent|6
5604082|NCT00876694|19360620|P2|Overall Study|Adverse Event|7
5604083|NCT00876694|19360621|P1|Overall Study|Adverse Event|10
5604084|NCT00876460|19360647|P8|Mono Therapy Phase|Adverse Event|0
5604085|NCT00876460|19360648|P7|Mono Therapy Phase|Adverse Event|0
5604086|NCT00876460|19360649|P6|Mono Therapy Phase|Adverse Event|0
5604087|NCT00876460|19360650|P5|Mono Therapy Phase|Adverse Event|0
5604088|NCT00876460|19360651|P4|Mono Therapy Phase|Adverse Event|1
5604089|NCT00876460|19360652|P3|Mono Therapy Phase|Adverse Event|0
5604090|NCT00876460|19360653|P2|Mono Therapy Phase|Adverse Event|0
5604091|NCT00876460|19360654|P1|Mono Therapy Phase|Adverse Event|0
5604092|NCT00876460|19360647|P8|Mono Therapy Phase|Withdrawal by Subject|0
5604093|NCT00876460|19360648|P7|Mono Therapy Phase|Withdrawal by Subject|0
5604094|NCT00876460|19360649|P6|Mono Therapy Phase|Withdrawal by Subject|0
5604095|NCT00876460|19360650|P5|Mono Therapy Phase|Withdrawal by Subject|0
5604096|NCT00876460|19360651|P4|Mono Therapy Phase|Withdrawal by Subject|0
5604097|NCT00876460|19360652|P3|Mono Therapy Phase|Withdrawal by Subject|0
5604098|NCT00876460|19360653|P2|Mono Therapy Phase|Withdrawal by Subject|1
5604099|NCT00876460|19360654|P1|Mono Therapy Phase|Withdrawal by Subject|0
5604100|NCT00876460|19360647|P8|Mono Therapy Phase|Progressive disease|3
5604101|NCT00876460|19360648|P7|Mono Therapy Phase|Progressive disease|1
5604102|NCT00876460|19360649|P6|Mono Therapy Phase|Progressive disease|0
5604103|NCT00876460|19360650|P5|Mono Therapy Phase|Progressive disease|2
5604104|NCT00876460|19360651|P4|Mono Therapy Phase|Progressive disease|0
5604105|NCT00876460|19360652|P3|Mono Therapy Phase|Progressive disease|0
5604106|NCT00876460|19360653|P2|Mono Therapy Phase|Progressive disease|0
5604107|NCT00876460|19360654|P1|Mono Therapy Phase|Progressive disease|0
5604108|NCT00876460|19360647|P8|Combination Therapy Phase|Not treated|0
5604109|NCT00876460|19360648|P7|Combination Therapy Phase|Not treated|1
5604110|NCT00876460|19360649|P6|Combination Therapy Phase|Not treated|0
5604111|NCT00876460|19360650|P5|Combination Therapy Phase|Not treated|0
5604112|NCT00876460|19360651|P4|Combination Therapy Phase|Not treated|0
5604113|NCT00876460|19360652|P3|Combination Therapy Phase|Not treated|0
5604114|NCT00876460|19360653|P2|Combination Therapy Phase|Not treated|0
5604115|NCT00876460|19360654|P1|Combination Therapy Phase|Not treated|0
5604116|NCT00876460|19360647|P8|Combination Therapy Phase|Other reason not defined above|2
5604117|NCT00876460|19360648|P7|Combination Therapy Phase|Other reason not defined above|1
5604118|NCT00876460|19360649|P6|Combination Therapy Phase|Other reason not defined above|0
5604119|NCT00876460|19360650|P5|Combination Therapy Phase|Other reason not defined above|0
5604120|NCT00876460|19360651|P4|Combination Therapy Phase|Other reason not defined above|0
5604121|NCT00876460|19360652|P3|Combination Therapy Phase|Other reason not defined above|0
5604122|NCT00876460|19360653|P2|Combination Therapy Phase|Other reason not defined above|0
5604123|NCT00876460|19360654|P1|Combination Therapy Phase|Other reason not defined above|0
5604124|NCT00876460|19360647|P8|Combination Therapy Phase|Withdrawal by Subject|0
5604125|NCT00876460|19360648|P7|Combination Therapy Phase|Withdrawal by Subject|0
5604126|NCT00876460|19360649|P6|Combination Therapy Phase|Withdrawal by Subject|0
5604127|NCT00876460|19360650|P5|Combination Therapy Phase|Withdrawal by Subject|1
5604128|NCT00876460|19360651|P4|Combination Therapy Phase|Withdrawal by Subject|0
5604129|NCT00876460|19360652|P3|Combination Therapy Phase|Withdrawal by Subject|0
5604130|NCT00876460|19360653|P2|Combination Therapy Phase|Withdrawal by Subject|1
5604131|NCT00876460|19360654|P1|Combination Therapy Phase|Withdrawal by Subject|1
5604132|NCT00876460|19360647|P8|Combination Therapy Phase|Adverse Event|2
5604133|NCT00876460|19360648|P7|Combination Therapy Phase|Adverse Event|3
5604134|NCT00876460|19360649|P6|Combination Therapy Phase|Adverse Event|0
5604135|NCT00876460|19360650|P5|Combination Therapy Phase|Adverse Event|2
5604136|NCT00876460|19360651|P4|Combination Therapy Phase|Adverse Event|2
5604137|NCT00876460|19360652|P3|Combination Therapy Phase|Adverse Event|0
5604138|NCT00876460|19360653|P2|Combination Therapy Phase|Adverse Event|2
5604139|NCT00876460|19360654|P1|Combination Therapy Phase|Adverse Event|0
5604140|NCT00876460|19360647|P8|Combination Therapy Phase|Dose limiting toxicity|1
5604141|NCT00876460|19360648|P7|Combination Therapy Phase|Dose limiting toxicity|2
5604142|NCT00876460|19360649|P6|Combination Therapy Phase|Dose limiting toxicity|2
5604143|NCT00876460|19360650|P5|Combination Therapy Phase|Dose limiting toxicity|1
5604144|NCT00876460|19360651|P4|Combination Therapy Phase|Dose limiting toxicity|1
5604145|NCT00876460|19360652|P3|Combination Therapy Phase|Dose limiting toxicity|0
5604146|NCT00876460|19360653|P2|Combination Therapy Phase|Dose limiting toxicity|1
5604147|NCT00876460|19360654|P1|Combination Therapy Phase|Dose limiting toxicity|0
5604148|NCT00876460|19360647|P8|Combination Therapy Phase|Progressive disease|1
5604149|NCT00876460|19360648|P7|Combination Therapy Phase|Progressive disease|1
5604150|NCT00876460|19360649|P6|Combination Therapy Phase|Progressive disease|1
5604151|NCT00876460|19360650|P5|Combination Therapy Phase|Progressive disease|3
5604152|NCT00876460|19360651|P4|Combination Therapy Phase|Progressive disease|3
5604153|NCT00876460|19360652|P3|Combination Therapy Phase|Progressive disease|3
5604154|NCT00876460|19360653|P2|Combination Therapy Phase|Progressive disease|3
5604155|NCT00876460|19360654|P1|Combination Therapy Phase|Progressive disease|2
5604156|NCT00876447|19360726|P2|Overall Study|Adverse Event|8
5604157|NCT00876447|19360727|P1|Overall Study|Adverse Event|4
5604158|NCT00876447|19360726|P2|Overall Study|Lack of Efficacy|3
5604159|NCT00876447|19360727|P1|Overall Study|Lack of Efficacy|5
5604160|NCT00876447|19360726|P2|Overall Study|Pregnancy|2
5604161|NCT00876447|19360727|P1|Overall Study|Pregnancy|4
5604162|NCT00876447|19360726|P2|Overall Study|Lost to Follow-up|15
5604163|NCT00876447|19360727|P1|Overall Study|Lost to Follow-up|6
5604164|NCT00876447|19360726|P2|Overall Study|Personal reasons|28
5604165|NCT00876447|19360727|P1|Overall Study|Personal reasons|30
5604166|NCT00876447|19360726|P2|Overall Study|Protocol Violation|3
5604167|NCT00876447|19360727|P1|Overall Study|Protocol Violation|9
5604168|NCT00876447|19360726|P2|Overall Study|Site closure|14
5604169|NCT00876447|19360727|P1|Overall Study|Site closure|19
5604170|NCT00876447|19360726|P2|Overall Study|Other miscellaneous reasons|8
5604171|NCT00876447|19360727|P1|Overall Study|Other miscellaneous reasons|3
5604172|NCT00876395|19360787|P2|Overall Study|Death|0
5604173|NCT00876395|19360788|P1|Overall Study|Death|12
5604174|NCT00876395|19360787|P2|Overall Study|Administrative problems|23
5604175|NCT00876395|19360788|P1|Overall Study|Administrative problems|39
5604176|NCT00876395|19360787|P2|Overall Study|Lost to Follow-up|0
5604177|NCT00876395|19360788|P1|Overall Study|Lost to Follow-up|2
5604178|NCT00876395|19360787|P2|Overall Study|Withdrawal by Subject|33
5604179|NCT00876395|19360788|P1|Overall Study|Withdrawal by Subject|66
5604180|NCT00876395|19360787|P2|Overall Study|Protocol Violation|2
5604181|NCT00876395|19360788|P1|Overall Study|Protocol Violation|5
5604182|NCT00876395|19360787|P2|Overall Study|New cancer therapy|7
5604183|NCT00876395|19360788|P1|Overall Study|New cancer therapy|25
5604184|NCT00876395|19360787|P2|Overall Study|Disease progression|162
5604185|NCT00876395|19360788|P1|Overall Study|Disease progression|259
5604186|NCT00876395|19360787|P2|Overall Study|Abnormal test procedure result(s)|0
5604187|NCT00876395|19360788|P1|Overall Study|Abnormal test procedure result(s)|1
5604188|NCT00876395|19360787|P2|Overall Study|Adverse Event|11
5604189|NCT00876395|19360788|P1|Overall Study|Adverse Event|63
5604190|NCT00876395|19360787|P2|Overall Study|Untreated|1
5604191|NCT00876395|19360788|P1|Overall Study|Untreated|8
5604192|NCT00876343|19360829|P3|Overall Study|Change of residence or other commitments|3
5604193|NCT00876343|19360830|P2|Overall Study|Change of residence or other commitments|2
5604194|NCT00876343|19360831|P1|Overall Study|Change of residence or other commitments|2
5604195|NCT00876343|19360829|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
5604196|NCT00876343|19360830|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
5604197|NCT00876343|19360831|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
5604198|NCT00876343|19360829|P3|Overall Study|Physician Decision|1
5604199|NCT00876343|19360830|P2|Overall Study|Physician Decision|1
5604200|NCT00876343|19360831|P1|Overall Study|Physician Decision|0
5604201|NCT00876343|19360829|P3|Overall Study|Protocol Violation|1
5604202|NCT00876343|19360830|P2|Overall Study|Protocol Violation|1
5604203|NCT00876343|19360831|P1|Overall Study|Protocol Violation|4
5604204|NCT00876343|19360829|P3|Overall Study|Lack of Efficacy|1
5604205|NCT00876343|19360830|P2|Overall Study|Lack of Efficacy|0
5604206|NCT00876343|19360831|P1|Overall Study|Lack of Efficacy|0
5604207|NCT00876343|19360829|P3|Overall Study|Withdrawal by Subject|3
5604208|NCT00876343|19360830|P2|Overall Study|Withdrawal by Subject|4
5604209|NCT00876343|19360831|P1|Overall Study|Withdrawal by Subject|4
5604210|NCT00876343|19360829|P3|Overall Study|Adverse Event|2
5604211|NCT00876343|19360830|P2|Overall Study|Adverse Event|8
5604212|NCT00876343|19360831|P1|Overall Study|Adverse Event|7
5604213|NCT00876265|19360845|P1|Overall Study|Withdrawal by Subject|2
5604214|NCT00876265|19360845|P1|Overall Study|Lost to Follow-up|6
5604215|NCT00876265|19360845|P1|Overall Study|Miscellaneous reasons|4
5604216|NCT00876018|19360863|P3|Overall Study|Withdrew Consent due to Adverse Event|2
5604217|NCT00876018|19360864|P2|Overall Study|Withdrew Consent due to Adverse Event|4
5604218|NCT00876018|19360865|P1|Overall Study|Withdrew Consent due to Adverse Event|5
5604219|NCT00876018|19360863|P3|Overall Study|Lost to Follow-up|1
5604220|NCT00876018|19360864|P2|Overall Study|Lost to Follow-up|1
5604221|NCT00876018|19360865|P1|Overall Study|Lost to Follow-up|0
5604222|NCT00875979|19360920|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
5604223|NCT00875979|19360921|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
5604224|NCT00875979|19360920|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
5604225|NCT00875979|19360921|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
5604226|NCT00875979|19360920|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
5604227|NCT00875979|19360921|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
5604228|NCT00875979|19360920|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
5604229|NCT00875979|19360921|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
5604230|NCT00875979|19360920|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
5604231|NCT00875979|19360921|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
5604232|NCT00875979|19360920|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
5604233|NCT00875979|19360921|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
5604234|NCT00875979|19360920|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
5604235|NCT00875979|19360921|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
5604236|NCT00875979|19360920|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
5604237|NCT00875979|19360921|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
5604238|NCT00875979|19360920|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
5604239|NCT00875979|19360921|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
5604240|NCT00875810|19360944|P1|Overall Study|Device explanted|1
5604241|NCT00875810|19360944|P1|Overall Study|Patient enroled but not implanted|2
5604242|NCT00875810|19360944|P1|Overall Study|Lost to Follow-up|39
5604243|NCT00875810|19360944|P1|Overall Study|Physician Decision|3
5604244|NCT00875810|19360944|P1|Overall Study|Withdrawal by Subject|1
5604245|NCT00875797|19360953|P2|Overall Study|Protocol Violation|3
5604246|NCT00875797|19360954|P1|Overall Study|Protocol Violation|6
5604247|NCT00875706|19360967|P3|Overall Study|Withdrawal by Subject|0
5604248|NCT00875706|19360968|P2|Overall Study|Withdrawal by Subject|0
5604249|NCT00875706|19360969|P1|Overall Study|Withdrawal by Subject|1
5604250|NCT00875667|19360988|P2|Overall Study|Randomized but no Study Drug Given|1
5604251|NCT00875667|19360989|P1|Overall Study|Randomized but no Study Drug Given|3
5604252|NCT00875667|19360988|P2|Overall Study|Miscellaneous|6
5604253|NCT00875667|19360989|P1|Overall Study|Miscellaneous|12
5604254|NCT00875667|19360988|P2|Overall Study|Disease Progression|49
5604255|NCT00875667|19360989|P1|Overall Study|Disease Progression|100
5604256|NCT00875667|19360988|P2|Overall Study|Protocol Violation|0
5604257|NCT00875667|19360989|P1|Overall Study|Protocol Violation|2
5604258|NCT00875667|19360988|P2|Overall Study|Death|2
5604259|NCT00875667|19360989|P1|Overall Study|Death|7
5604260|NCT00875667|19360988|P2|Overall Study|Withdrawal by Subject|5
5604261|NCT00875667|19360989|P1|Overall Study|Withdrawal by Subject|17
5604262|NCT00875667|19360988|P2|Overall Study|Adverse Event|10
5604263|NCT00875667|19360989|P1|Overall Study|Adverse Event|29
5604264|NCT00875615|19361124|P1|Overall Study|Withdrawal by Subject|1
5604265|NCT00875563|19361138|P1|Overall Study|Still be eligible for follow-up|7
5604266|NCT00875563|19361138|P1|Overall Study|No long-term (3-5 year) consent|6
5604267|NCT00875563|19361138|P1|Overall Study|Withdrawal by Subject|7
5604268|NCT00875563|19361138|P1|Overall Study|Death|4
5604269|NCT00875524|19361163|P2|Overall Study|Withdrawal by Subject|5
5604270|NCT00875524|19361164|P1|Overall Study|Withdrawal by Subject|3
5604271|NCT00875524|19361163|P2|Overall Study|Lost to Follow-up|0
5604272|NCT00875524|19361164|P1|Overall Study|Lost to Follow-up|1
5604273|NCT00875524|19361163|P2|Overall Study|Protocol Violation|0
5604274|NCT00875524|19361164|P1|Overall Study|Protocol Violation|4
5604275|NCT00875524|19361163|P2|Overall Study|Serious adverse event|1
5604276|NCT00875524|19361164|P1|Overall Study|Serious adverse event|0
5604277|NCT00875485|19361182|P2|Challenge Dose Epoch|Pregnancy|0
5604278|NCT00875485|19361183|P1|Challenge Dose Epoch|Pregnancy|1
5604279|NCT00875433|19361223|P1|Overall Study|Other|3
5604280|NCT00875433|19361223|P1|Overall Study|Withdrawal by Subject|2
5604281|NCT00875433|19361223|P1|Overall Study|Other Adverse Event|14
5604282|NCT00875433|19361223|P1|Overall Study|Progressive disease|41
5604283|NCT00875420|19361253|P5|Overall Study|Withdrawal by Subject|0
5604284|NCT00875420|19361254|P4|Overall Study|Withdrawal by Subject|0
5604285|NCT00875420|19361255|P3|Overall Study|Withdrawal by Subject|1
5604286|NCT00875420|19361256|P2|Overall Study|Withdrawal by Subject|0
5604287|NCT00875420|19361257|P1|Overall Study|Withdrawal by Subject|0
5604288|NCT00875420|19361253|P5|Overall Study|Sponsor decision|0
5604289|NCT00875420|19361254|P4|Overall Study|Sponsor decision|0
5604290|NCT00875420|19361255|P3|Overall Study|Sponsor decision|0
5604291|NCT00875420|19361256|P2|Overall Study|Sponsor decision|1
5604292|NCT00875420|19361257|P1|Overall Study|Sponsor decision|0
5604293|NCT00875420|19361253|P5|Overall Study|Prohibited medication|0
5604294|NCT00875420|19361254|P4|Overall Study|Prohibited medication|1
5604295|NCT00875420|19361255|P3|Overall Study|Prohibited medication|0
5604296|NCT00875420|19361256|P2|Overall Study|Prohibited medication|0
5604297|NCT00875420|19361257|P1|Overall Study|Prohibited medication|0
5604298|NCT00875420|19361253|P5|Overall Study|Personal reason|1
5604299|NCT00875420|19361254|P4|Overall Study|Personal reason|0
5604300|NCT00875420|19361255|P3|Overall Study|Personal reason|0
5604301|NCT00875420|19361256|P2|Overall Study|Personal reason|0
5604302|NCT00875420|19361257|P1|Overall Study|Personal reason|0
5604303|NCT00875420|19361253|P5|Overall Study|Lost to Follow-up|0
5604304|NCT00875420|19361254|P4|Overall Study|Lost to Follow-up|0
5604305|NCT00875420|19361255|P3|Overall Study|Lost to Follow-up|0
5604306|NCT00875420|19361256|P2|Overall Study|Lost to Follow-up|0
5604307|NCT00875420|19361257|P1|Overall Study|Lost to Follow-up|1
5604308|NCT00875420|19361253|P5|Overall Study|Inability to complete study procedures|1
5604309|NCT00875420|19361254|P4|Overall Study|Inability to complete study procedures|1
5604310|NCT00875420|19361255|P3|Overall Study|Inability to complete study procedures|1
5604311|NCT00875420|19361256|P2|Overall Study|Inability to complete study procedures|0
5604312|NCT00875420|19361257|P1|Overall Study|Inability to complete study procedures|1
5604313|NCT00875420|19361253|P5|Overall Study|Adverse Event|0
5604314|NCT00875420|19361254|P4|Overall Study|Adverse Event|0
5604315|NCT00875420|19361255|P3|Overall Study|Adverse Event|1
5604316|NCT00875420|19361256|P2|Overall Study|Adverse Event|1
5604317|NCT00875420|19361257|P1|Overall Study|Adverse Event|0
5604318|NCT00875056|19361396|P3|Overall Study|Withdrawal by Subject|1
5604319|NCT00875056|19361397|P2|Overall Study|Withdrawal by Subject|0
5604320|NCT00875056|19361398|P1|Overall Study|Withdrawal by Subject|3
5604321|NCT00875056|19361396|P3|Overall Study|Progressive Disease|3
5604322|NCT00875056|19361397|P2|Overall Study|Progressive Disease|8
5604323|NCT00875056|19361398|P1|Overall Study|Progressive Disease|14
5604324|NCT00875056|19361396|P3|Overall Study|Adverse Event|2
5604325|NCT00875056|19361397|P2|Overall Study|Adverse Event|1
5604326|NCT00875056|19361398|P1|Overall Study|Adverse Event|6
5604327|NCT00875017|19361424|P6|Fourth Intervention|Inability to comply with fasting|1
5604328|NCT00875017|19361425|P5|Fourth Intervention|Inability to comply with fasting|0
5604329|NCT00875017|19361426|P4|Fourth Intervention|Inability to comply with fasting|0
5604330|NCT00875017|19361427|P3|Fourth Intervention|Inability to comply with fasting|0
5604331|NCT00875017|19361428|P2|Fourth Intervention|Inability to comply with fasting|0
5604332|NCT00875017|19361429|P1|Fourth Intervention|Inability to comply with fasting|0
5604333|NCT00875017|19361424|P6|Washout|Withdrawal by Subject|0
5604334|NCT00875017|19361425|P5|Washout|Withdrawal by Subject|1
5604335|NCT00875017|19361426|P4|Washout|Withdrawal by Subject|0
5604336|NCT00875017|19361427|P3|Washout|Withdrawal by Subject|0
5604337|NCT00875017|19361428|P2|Washout|Withdrawal by Subject|0
5604338|NCT00875017|19361429|P1|Washout|Withdrawal by Subject|0
5604339|NCT00875017|19361424|P6|Third Intervention|Adverse Event|0
5604340|NCT00875017|19361425|P5|Third Intervention|Adverse Event|0
5604341|NCT00875017|19361426|P4|Third Intervention|Adverse Event|0
5604342|NCT00875017|19361427|P3|Third Intervention|Adverse Event|1
5604343|NCT00875017|19361428|P2|Third Intervention|Adverse Event|1
5604344|NCT00875017|19361429|P1|Third Intervention|Adverse Event|0
5604345|NCT00875017|19361424|P6|Washout|Problems collecting rectal effluent|0
5604346|NCT00875017|19361425|P5|Washout|Problems collecting rectal effluent|0
5604347|NCT00875017|19361426|P4|Washout|Problems collecting rectal effluent|0
5604348|NCT00875017|19361427|P3|Washout|Problems collecting rectal effluent|0
5604349|NCT00875017|19361428|P2|Washout|Problems collecting rectal effluent|1
5604350|NCT00875017|19361429|P1|Washout|Problems collecting rectal effluent|0
5604351|NCT00875017|19361424|P6|Second Intervention|Adverse Event|0
5604352|NCT00875017|19361425|P5|Second Intervention|Adverse Event|0
5604353|NCT00875017|19361426|P4|Second Intervention|Adverse Event|1
5604354|NCT00875017|19361427|P3|Second Intervention|Adverse Event|0
5604355|NCT00875017|19361428|P2|Second Intervention|Adverse Event|0
5604356|NCT00875017|19361429|P1|Second Intervention|Adverse Event|0
5604357|NCT00875017|19361424|P6|Washout|Problem collecting rectal effluent|0
5604358|NCT00875017|19361425|P5|Washout|Problem collecting rectal effluent|0
5604359|NCT00875017|19361426|P4|Washout|Problem collecting rectal effluent|0
5604360|NCT00875017|19361427|P3|Washout|Problem collecting rectal effluent|1
5604361|NCT00875017|19361428|P2|Washout|Problem collecting rectal effluent|0
5604362|NCT00875017|19361429|P1|Washout|Problem collecting rectal effluent|0
5604363|NCT00875017|19361424|P6|First Intervention|Intolerance to nasogastric tube|0
5604364|NCT00875017|19361425|P5|First Intervention|Intolerance to nasogastric tube|1
5604365|NCT00875017|19361426|P4|First Intervention|Intolerance to nasogastric tube|0
5604366|NCT00875017|19361427|P3|First Intervention|Intolerance to nasogastric tube|0
5604367|NCT00875017|19361428|P2|First Intervention|Intolerance to nasogastric tube|0
5604368|NCT00875017|19361429|P1|First Intervention|Intolerance to nasogastric tube|0
5604369|NCT00875017|19361424|P6|First Intervention|Problems collecting rectal effluent|0
5604370|NCT00875017|19361425|P5|First Intervention|Problems collecting rectal effluent|0
5604371|NCT00875017|19361426|P4|First Intervention|Problems collecting rectal effluent|0
5604372|NCT00875017|19361427|P3|First Intervention|Problems collecting rectal effluent|0
5604373|NCT00875017|19361428|P2|First Intervention|Problems collecting rectal effluent|0
5604374|NCT00875017|19361429|P1|First Intervention|Problems collecting rectal effluent|1
5604375|NCT00875017|19361424|P6|First Intervention|Adverse Event|0
5604376|NCT00875017|19361425|P5|First Intervention|Adverse Event|0
5604377|NCT00875017|19361426|P4|First Intervention|Adverse Event|1
5604378|NCT00875017|19361427|P3|First Intervention|Adverse Event|0
5604379|NCT00875017|19361428|P2|First Intervention|Adverse Event|0
5604380|NCT00875017|19361429|P1|First Intervention|Adverse Event|0
5604381|NCT00875017|19361424|P6|First Intervention|Withdrawal by Subject|0
5604382|NCT00875017|19361425|P5|First Intervention|Withdrawal by Subject|0
5604383|NCT00875017|19361426|P4|First Intervention|Withdrawal by Subject|0
5604384|NCT00875017|19361427|P3|First Intervention|Withdrawal by Subject|1
5604385|NCT00875017|19361428|P2|First Intervention|Withdrawal by Subject|0
5604386|NCT00875017|19361429|P1|First Intervention|Withdrawal by Subject|1
5604387|NCT00874939|19361443|P1|Overall Study|Study terminated|4
5604388|NCT00874848|19361476|P2|Overall Study|Physician Decision|2
5604389|NCT00874848|19361477|P1|Overall Study|Physician Decision|0
5604390|NCT00874848|19361476|P2|Overall Study|Failure to comply with protocol|1
5604391|NCT00874848|19361477|P1|Overall Study|Failure to comply with protocol|0
5604392|NCT00874848|19361476|P2|Overall Study|Noncompliance|1
5604393|NCT00874848|19361477|P1|Overall Study|Noncompliance|1
5604394|NCT00874848|19361476|P2|Overall Study|Withdrawal by Subject|4
5604395|NCT00874848|19361477|P1|Overall Study|Withdrawal by Subject|7
5604396|NCT00874848|19361476|P2|Overall Study|Progressive neoplastic disease|18
5604397|NCT00874848|19361477|P1|Overall Study|Progressive neoplastic disease|38
5604398|NCT00874848|19361476|P2|Overall Study|Adverse Event|2
5604399|NCT00874848|19361477|P1|Overall Study|Adverse Event|13
5604400|NCT00874822|19361493|P1|Overall Study|excluded by criteria|8
5604401|NCT00874770|19361501|P4|Overall Study|Subject no Longer Meets Study Criteria|0
5604402|NCT00874770|19361502|P3|Overall Study|Subject no Longer Meets Study Criteria|0
5604403|NCT00874770|19361503|P2|Overall Study|Subject no Longer Meets Study Criteria|0
5604404|NCT00874770|19361504|P1|Overall Study|Subject no Longer Meets Study Criteria|1
5604405|NCT00874770|19361501|P4|Overall Study|Lost to Follow-up|1
5604406|NCT00874770|19361502|P3|Overall Study|Lost to Follow-up|0
5604407|NCT00874770|19361503|P2|Overall Study|Lost to Follow-up|0
5604408|NCT00874770|19361504|P1|Overall Study|Lost to Follow-up|1
5604409|NCT00874770|19361501|P4|Overall Study|Adverse Event|2
5604410|NCT00874770|19361502|P3|Overall Study|Adverse Event|4
5604411|NCT00874770|19361503|P2|Overall Study|Adverse Event|1
5604412|NCT00874770|19361504|P1|Overall Study|Adverse Event|1
5604413|NCT00874770|19361501|P4|Overall Study|Lack of Efficacy|2
5604414|NCT00874770|19361502|P3|Overall Study|Lack of Efficacy|0
5604415|NCT00874770|19361503|P2|Overall Study|Lack of Efficacy|0
5604416|NCT00874770|19361504|P1|Overall Study|Lack of Efficacy|2
5604417|NCT00874731|19361538|P3|Part 2: Ridaforolimus 40 mg|Disease Progression|19
5604418|NCT00874731|19361539|P2|Part 2: Ridaforolimus 40 mg|Disease Progression|0
5604419|NCT00874731|19361540|P1|Part 2: Ridaforolimus 40 mg|Disease Progression|0
5604420|NCT00874731|19361538|P3|Part 2: Ridaforolimus 40 mg|Adverse Event|3
5604421|NCT00874731|19361539|P2|Part 2: Ridaforolimus 40 mg|Adverse Event|0
5604422|NCT00874731|19361540|P1|Part 2: Ridaforolimus 40 mg|Adverse Event|0
5604423|NCT00874731|19361538|P3|Part 1, Day 1: Placebo|Disease Progression|0
5604424|NCT00874731|19361539|P2|Part 1, Day 1: Placebo|Disease Progression|0
5604425|NCT00874731|19361540|P1|Part 1, Day 1: Placebo|Disease Progression|1
5604426|NCT00874549|19361581|P4|Overall Study|Withdrawal by Subject|1
5604427|NCT00874549|19361582|P3|Overall Study|Withdrawal by Subject|0
5604428|NCT00874549|19361583|P2|Overall Study|Withdrawal by Subject|1
5604429|NCT00874549|19361584|P1|Overall Study|Withdrawal by Subject|0
5604430|NCT00874549|19361581|P4|Overall Study|Lost to Follow-up|0
5604431|NCT00874549|19361582|P3|Overall Study|Lost to Follow-up|1
5604432|NCT00874549|19361583|P2|Overall Study|Lost to Follow-up|0
5604433|NCT00874549|19361584|P1|Overall Study|Lost to Follow-up|0
5604434|NCT00874549|19361581|P4|Overall Study|Protocol Violation|1
5604435|NCT00874549|19361582|P3|Overall Study|Protocol Violation|2
5604436|NCT00874549|19361583|P2|Overall Study|Protocol Violation|0
5604437|NCT00874549|19361584|P1|Overall Study|Protocol Violation|1
5604438|NCT00874549|19361581|P4|Overall Study|Adverse Event|0
5604439|NCT00874549|19361582|P3|Overall Study|Adverse Event|1
5604440|NCT00874549|19361583|P2|Overall Study|Adverse Event|0
5604441|NCT00874549|19361584|P1|Overall Study|Adverse Event|0
5604442|NCT00874497|19361661|P2|Overall Study|Withdrawal by Subject|4
5604443|NCT00874497|19361662|P1|Overall Study|Withdrawal by Subject|5
5604444|NCT00874497|19361661|P2|Overall Study|Physician Decision|1
5604445|NCT00874497|19361662|P1|Overall Study|Physician Decision|1
5604446|NCT00874497|19361661|P2|Overall Study|Met Withdrawal Criteria|2
5604447|NCT00874497|19361662|P1|Overall Study|Met Withdrawal Criteria|4
5604448|NCT00874497|19361661|P2|Overall Study|Sponsor Discontinued Trial|3
5604449|NCT00874497|19361662|P1|Overall Study|Sponsor Discontinued Trial|7
5604450|NCT00874497|19361661|P2|Overall Study|Adverse Event|4
5604451|NCT00874497|19361662|P1|Overall Study|Adverse Event|9
5604452|NCT00874497|19361661|P2|Overall Study|Lost to Follow-up|4
5604453|NCT00874497|19361662|P1|Overall Study|Lost to Follow-up|2
5604454|NCT00874432|19361704|P4|Overall Study|Other|3
5604455|NCT00874432|19361705|P3|Overall Study|Other|8
5604456|NCT00874432|19361706|P2|Overall Study|Other|2
5604457|NCT00874432|19361707|P1|Overall Study|Other|1
5604458|NCT00874432|19361704|P4|Overall Study|Physician Decision|0
5604459|NCT00874432|19361705|P3|Overall Study|Physician Decision|0
5604460|NCT00874432|19361706|P2|Overall Study|Physician Decision|0
5604461|NCT00874432|19361707|P1|Overall Study|Physician Decision|1
5604462|NCT00874432|19361704|P4|Overall Study|Withdrawal by Subject|0
5604463|NCT00874432|19361705|P3|Overall Study|Withdrawal by Subject|0
5604464|NCT00874432|19361706|P2|Overall Study|Withdrawal by Subject|0
5604465|NCT00874432|19361707|P1|Overall Study|Withdrawal by Subject|1
5604466|NCT00874276|19361725|P2|Overall Study|Withdrawal by Subject|1
5604467|NCT00874276|19361726|P1|Overall Study|Withdrawal by Subject|1
5604468|NCT00874237|19361746|P6|Overall Study|Withdrawal by Subject|0
5604469|NCT00874237|19361747|P5|Overall Study|Withdrawal by Subject|0
5604470|NCT00874237|19361748|P4|Overall Study|Withdrawal by Subject|0
5604471|NCT00874237|19361749|P3|Overall Study|Withdrawal by Subject|1
5604472|NCT00874237|19361750|P2|Overall Study|Withdrawal by Subject|0
5604473|NCT00874237|19361751|P1|Overall Study|Withdrawal by Subject|0
5604474|NCT00874237|19361746|P6|Overall Study|Physician Decision|0
5604475|NCT00874237|19361747|P5|Overall Study|Physician Decision|0
5604476|NCT00874237|19361748|P4|Overall Study|Physician Decision|0
5604477|NCT00874237|19361749|P3|Overall Study|Physician Decision|0
5604478|NCT00874237|19361750|P2|Overall Study|Physician Decision|1
5604479|NCT00874237|19361751|P1|Overall Study|Physician Decision|0
5604480|NCT00874120|19361769|P2|Second Intervention|Protocol Violation|0
5604481|NCT00874120|19361770|P1|Second Intervention|Protocol Violation|1
5604482|NCT00874120|19361769|P2|Second Intervention|Withdrawal by Subject|0
5604483|NCT00874120|19361770|P1|Second Intervention|Withdrawal by Subject|1
5604484|NCT00874120|19361769|P2|First Intervention|positive drug test|0
5604485|NCT00874120|19361770|P1|First Intervention|positive drug test|1
5604486|NCT00874120|19361769|P2|First Intervention|Protocol Violation|0
5604487|NCT00874120|19361770|P1|First Intervention|Protocol Violation|3
5604488|NCT00874120|19361769|P2|First Intervention|Lost to Follow-up|1
5604489|NCT00874120|19361770|P1|First Intervention|Lost to Follow-up|0
5604490|NCT00874120|19361769|P2|First Intervention|Withdrawal by Subject|0
5604491|NCT00874120|19361770|P1|First Intervention|Withdrawal by Subject|2
5604492|NCT00874120|19361769|P2|First Intervention|Adverse Event|1
5604493|NCT00874120|19361770|P1|First Intervention|Adverse Event|0
5604494|NCT00874029|19361783|P1|Overall Study|Lost to Follow-up|5
5604495|NCT00874029|19361783|P1|Overall Study|Adverse Event|1
5604496|NCT00874029|19361783|P1|Overall Study|Physician Decision|1
5604497|NCT00874029|19361783|P1|Overall Study|Pregnancy|4
5604498|NCT00874029|19361783|P1|Overall Study|Withdrawal by Subject|10
5604499|NCT00873912|19361799|P2|Overall Study|Lost to Follow-up|0
5604500|NCT00873912|19361800|P1|Overall Study|Lost to Follow-up|2
5604501|NCT00873912|19361799|P2|Overall Study|Withdrawal by Subject|0
5604502|NCT00873912|19361800|P1|Overall Study|Withdrawal by Subject|1
5604503|NCT00873860|19361839|P4|Overall Study|Other|0
5604504|NCT00873860|19361840|P3|Overall Study|Other|1
5604505|NCT00873860|19361841|P2|Overall Study|Other|0
5604506|NCT00873860|19361842|P1|Overall Study|Other|1
5604507|NCT00873860|19361839|P4|Overall Study|Death|0
5604508|NCT00873860|19361840|P3|Overall Study|Death|0
5604509|NCT00873860|19361841|P2|Overall Study|Death|0
5604510|NCT00873860|19361842|P1|Overall Study|Death|1
5604511|NCT00873860|19361839|P4|Overall Study|Withdrawal by Subject|0
5604512|NCT00873860|19361840|P3|Overall Study|Withdrawal by Subject|2
5604513|NCT00873860|19361841|P2|Overall Study|Withdrawal by Subject|0
5604514|NCT00873860|19361842|P1|Overall Study|Withdrawal by Subject|1
5604515|NCT00873860|19361839|P4|Overall Study|Lost to Follow-up|1
5604516|NCT00873860|19361840|P3|Overall Study|Lost to Follow-up|0
5604517|NCT00873860|19361841|P2|Overall Study|Lost to Follow-up|0
5604518|NCT00873860|19361842|P1|Overall Study|Lost to Follow-up|1
5604519|NCT00873730|19361930|P2|Overall Study|Sponsor decision|0
5604520|NCT00873730|19361931|P1|Overall Study|Sponsor decision|1
5604521|NCT00873730|19361930|P2|Overall Study|Withdrawal by Subject|1
5604522|NCT00873730|19361931|P1|Overall Study|Withdrawal by Subject|0
5604523|NCT00873730|19361930|P2|Overall Study|Adverse Event|2
5604524|NCT00873730|19361931|P1|Overall Study|Adverse Event|0
5604525|NCT00873730|19361930|P2|Overall Study|Protocol Deviation|2
5604526|NCT00873730|19361931|P1|Overall Study|Protocol Deviation|5
5604527|NCT00873366|19361974|P1|Overall Study|Refused to continue DM-BT testing|3
5604528|NCT00873366|19361974|P1|Overall Study|Off tamoxifen due to side effects|2
5604529|NCT00873366|19361974|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
5604530|NCT00873119|19361999|P2|Overall Study|Not treated|0
5604531|NCT00873119|19362000|P1|Overall Study|Not treated|2
5604532|NCT00873119|19361999|P2|Overall Study|Other|5
5604533|NCT00873119|19362000|P1|Overall Study|Other|2
5604534|NCT00873119|19361999|P2|Overall Study|Death|1
5604535|NCT00873119|19362000|P1|Overall Study|Death|2
5604536|NCT00873119|19361999|P2|Overall Study|Progressive disease|18
5604537|NCT00873119|19362000|P1|Overall Study|Progressive disease|26
5604538|NCT00873119|19361999|P2|Overall Study|Adverse Event|0
5604539|NCT00873119|19362000|P1|Overall Study|Adverse Event|8
5604540|NCT00873119|19361999|P2|Overall Study|Patient request|2
5604541|NCT00873119|19362000|P1|Overall Study|Patient request|4
5604542|NCT00873093|19362021|P5|Overall Study|Ineligible|0
5604543|NCT00873093|19362022|P4|Overall Study|Ineligible|1
5604544|NCT00873093|19362023|P3|Overall Study|Ineligible|0
5604545|NCT00873093|19362024|P2|Overall Study|Ineligible|1
5604546|NCT00873093|19362025|P1|Overall Study|Ineligible|0
5604547|NCT00873093|19362021|P5|Overall Study|Withdrawal by Subject|0
5604548|NCT00873093|19362022|P4|Overall Study|Withdrawal by Subject|0
5604549|NCT00873093|19362023|P3|Overall Study|Withdrawal by Subject|4
5604550|NCT00873093|19362024|P2|Overall Study|Withdrawal by Subject|4
5604551|NCT00873093|19362025|P1|Overall Study|Withdrawal by Subject|1
5604552|NCT00873093|19362021|P5|Overall Study|Physician Decision|2
5604553|NCT00873093|19362022|P4|Overall Study|Physician Decision|10
5604554|NCT00873093|19362023|P3|Overall Study|Physician Decision|10
5604555|NCT00873093|19362024|P2|Overall Study|Physician Decision|17
5604556|NCT00873093|19362025|P1|Overall Study|Physician Decision|0
5604557|NCT00873093|19362021|P5|Overall Study|Death|0
5604558|NCT00873093|19362022|P4|Overall Study|Death|0
5604559|NCT00873093|19362023|P3|Overall Study|Death|2
5604560|NCT00873093|19362024|P2|Overall Study|Death|3
5604561|NCT00873093|19362025|P1|Overall Study|Death|0
5604562|NCT00873093|19362021|P5|Overall Study|Adverse Event|0
5604563|NCT00873093|19362022|P4|Overall Study|Adverse Event|0
5604564|NCT00873093|19362023|P3|Overall Study|Adverse Event|0
5604565|NCT00873093|19362024|P2|Overall Study|Adverse Event|2
5604566|NCT00873093|19362025|P1|Overall Study|Adverse Event|0
5604567|NCT00873041|19362082|P3|Extension Study|Administrative reasons|1
5604568|NCT00873041|19362083|P2|Extension Study|Administrative reasons|0
5604569|NCT00873041|19362084|P1|Extension Study|Administrative reasons|0
5604570|NCT00873041|19362082|P3|Extension Study|Adverse Event|1
5604571|NCT00873041|19362083|P2|Extension Study|Adverse Event|0
5604572|NCT00873041|19362084|P1|Extension Study|Adverse Event|1
5604573|NCT00873041|19362082|P3|Core Study|Protocol deviation|1
5604574|NCT00873041|19362083|P2|Core Study|Protocol deviation|0
5604575|NCT00873041|19362084|P1|Core Study|Protocol deviation|1
5604576|NCT00873041|19362082|P3|Core Study|Abnormal laboratory value|1
5604577|NCT00873041|19362083|P2|Core Study|Abnormal laboratory value|0
5604578|NCT00873041|19362084|P1|Core Study|Abnormal laboratory value|0
5604579|NCT00873041|19362082|P3|Core Study|Lost to Follow-up|0
5604580|NCT00873041|19362083|P2|Core Study|Lost to Follow-up|1
5604581|NCT00873041|19362084|P1|Core Study|Lost to Follow-up|3
5604582|NCT00873041|19362082|P3|Core Study|Withdrawal by Subject|2
5604583|NCT00873041|19362083|P2|Core Study|Withdrawal by Subject|2
5604584|NCT00873041|19362084|P1|Core Study|Withdrawal by Subject|1
5604585|NCT00873041|19362082|P3|Core Study|Adverse Event|1
5604586|NCT00873041|19362083|P2|Core Study|Adverse Event|3
5604587|NCT00873041|19362084|P1|Core Study|Adverse Event|2
5604588|NCT00873015|19362142|P4|Overall Study|Withdrawal by Subject|0
5604589|NCT00873015|19362143|P3|Overall Study|Withdrawal by Subject|0
5604590|NCT00873015|19362144|P2|Overall Study|Withdrawal by Subject|1
5604591|NCT00873015|19362145|P1|Overall Study|Withdrawal by Subject|0
5604592|NCT00872989|19362162|P2|Overall Study|Not protocol specified|8
5604593|NCT00872989|19362163|P1|Overall Study|Not protocol specified|3
5604594|NCT00872989|19362162|P2|Overall Study|Progression/relapse|35
5604595|NCT00872989|19362163|P1|Overall Study|Progression/relapse|47
5604596|NCT00872989|19362162|P2|Overall Study|Withdrawal by Subject|5
5604597|NCT00872989|19362163|P1|Overall Study|Withdrawal by Subject|8
5604598|NCT00872989|19362162|P2|Overall Study|Adverse Event|15
5604599|NCT00872989|19362163|P1|Overall Study|Adverse Event|7
5604600|NCT00872898|19362182|P2|Part Two - Double Blind|Other reasons|0
5604601|NCT00872898|19362183|P1|Part Two - Double Blind|Other reasons|2
5604602|NCT00872898|19362182|P2|Part Two - Double Blind|Lost to Follow-up|2
5604603|NCT00872898|19362183|P1|Part Two - Double Blind|Lost to Follow-up|0
5604604|NCT00872898|19362182|P2|Part Two - Double Blind|Withdrawal by Subject|1
5604605|NCT00872898|19362183|P1|Part Two - Double Blind|Withdrawal by Subject|3
5604606|NCT00872898|19362182|P2|Part Two - Double Blind|Protocol Violation|0
5604607|NCT00872898|19362183|P1|Part Two - Double Blind|Protocol Violation|1
5604608|NCT00872898|19362182|P2|Part Two - Double Blind|Lack of Efficacy|0
5604609|NCT00872898|19362183|P1|Part Two - Double Blind|Lack of Efficacy|1
5604610|NCT00872898|19362182|P2|Part Two - Double Blind|Adverse Event|3
5604611|NCT00872898|19362183|P1|Part Two - Double Blind|Adverse Event|4
5604612|NCT00872599|19362257|P2|Second Washout Period|Adverse Event|1
5604613|NCT00872599|19362258|P1|Second Washout Period|Adverse Event|1
5604614|NCT00872521|19362278|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
5604615|NCT00872521|19362279|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
5604616|NCT00872521|19362280|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
5604617|NCT00872521|19362278|P3|Completed 3-month Follow up|Physician Decision|0
5604618|NCT00872521|19362279|P2|Completed 3-month Follow up|Physician Decision|1
5604619|NCT00872521|19362280|P1|Completed 3-month Follow up|Physician Decision|0
5604620|NCT00872521|19362278|P3|Completed 3-month Follow up|Other|0
5604621|NCT00872521|19362279|P2|Completed 3-month Follow up|Other|2
5604622|NCT00872521|19362280|P1|Completed 3-month Follow up|Other|0
5604623|NCT00872521|19362278|P3|Primary Endpoint Analysis|Patient response missing|1
5604624|NCT00872521|19362279|P2|Primary Endpoint Analysis|Patient response missing|0
5604625|NCT00872521|19362280|P1|Primary Endpoint Analysis|Patient response missing|0
5604626|NCT00872521|19362278|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
5604627|NCT00872521|19362279|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
5604628|NCT00872521|19362280|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
5604629|NCT00872521|19362278|P3|Primary Endpoint Analysis|Patient choice|0
5604630|NCT00872521|19362279|P2|Primary Endpoint Analysis|Patient choice|1
5604631|NCT00872521|19362280|P1|Primary Endpoint Analysis|Patient choice|0
5604632|NCT00872521|19362278|P3|Primary Endpoint Analysis|Other|0
5604633|NCT00872521|19362279|P2|Primary Endpoint Analysis|Other|2
5604634|NCT00872521|19362280|P1|Primary Endpoint Analysis|Other|1
5604635|NCT00872521|19362278|P3|Completed PAD Induction|Death|0
5604636|NCT00872521|19362279|P2|Completed PAD Induction|Death|1
5604637|NCT00872521|19362280|P1|Completed PAD Induction|Death|1
5604638|NCT00872521|19362278|P3|Completed PAD Induction|Adverse Event|0
5604639|NCT00872521|19362279|P2|Completed PAD Induction|Adverse Event|0
5604640|NCT00872521|19362280|P1|Completed PAD Induction|Adverse Event|4
5604641|NCT00872521|19362278|P3|Completed PAD Induction|Disease progression|0
5604642|NCT00872521|19362279|P2|Completed PAD Induction|Disease progression|2
5604643|NCT00872521|19362280|P1|Completed PAD Induction|Disease progression|0
5604644|NCT00872521|19362278|P3|Completed PAD Induction|Patient choice|0
5604645|NCT00872521|19362279|P2|Completed PAD Induction|Patient choice|1
5604646|NCT00872521|19362280|P1|Completed PAD Induction|Patient choice|0
5604647|NCT00872170|19362351|P2|Overall Study|Adverse Event|0
5604648|NCT00872170|19362352|P1|Overall Study|Adverse Event|1
5604649|NCT00872001|19362382|P2|Overall Study|Administrative|15
5604650|NCT00872001|19362383|P1|Overall Study|Administrative|23
5604651|NCT00872001|19362382|P2|Overall Study|Did Not Meet Protocol Eligibility|36
5604652|NCT00872001|19362383|P1|Overall Study|Did Not Meet Protocol Eligibility|38
5604653|NCT00872001|19362382|P2|Overall Study|Protocol Violation|8
5604654|NCT00872001|19362383|P1|Overall Study|Protocol Violation|5
5604655|NCT00872001|19362382|P2|Overall Study|Withdrawal by Subject|30
5604656|NCT00872001|19362383|P1|Overall Study|Withdrawal by Subject|18
5604657|NCT00872001|19362382|P2|Overall Study|Lost to Follow-up|12
5604658|NCT00872001|19362383|P1|Overall Study|Lost to Follow-up|13
5604659|NCT00872001|19362382|P2|Overall Study|Protocol Defined Clinical Event|7
5604660|NCT00872001|19362383|P1|Overall Study|Protocol Defined Clinical Event|5
5604661|NCT00872001|19362382|P2|Overall Study|Adverse Event|23
5604662|NCT00872001|19362383|P1|Overall Study|Adverse Event|34
5604663|NCT00871975|19362391|P1|Overall Study|Motion artifact, tracing uninterpretable|5
5604664|NCT00871975|19362391|P1|Overall Study|Patient unable to void/insufficient vol|13
5604665|NCT00871975|19362391|P1|Overall Study|Catheters could not be inserted|1
5604666|NCT00871975|19362391|P1|Overall Study|Technical difficulty w155-1ith equipment|3
5604667|NCT00871871|19362397|P4|Part II|Protocol Violation|1
5604668|NCT00871871|19362398|P3|Part II|Protocol Violation|0
5604669|NCT00871871|19362399|P2|Part II|Protocol Violation|0
5604670|NCT00871871|19362400|P1|Part II|Protocol Violation|0
5604671|NCT00871871|19362397|P4|Part II|Adverse Event|2
5604672|NCT00871871|19362398|P3|Part II|Adverse Event|1
5604673|NCT00871871|19362399|P2|Part II|Adverse Event|0
5604674|NCT00871871|19362400|P1|Part II|Adverse Event|0
5604675|NCT00871871|19362397|P4|Part II|Withdrawal by Subject|1
5604676|NCT00871871|19362398|P3|Part II|Withdrawal by Subject|2
5604677|NCT00871871|19362399|P2|Part II|Withdrawal by Subject|0
5604678|NCT00871871|19362400|P1|Part II|Withdrawal by Subject|0
5604679|NCT00871871|19362397|P4|Part II|Lack of Efficacy|0
5604680|NCT00871871|19362398|P3|Part II|Lack of Efficacy|1
5604681|NCT00871871|19362399|P2|Part II|Lack of Efficacy|0
5604682|NCT00871871|19362400|P1|Part II|Lack of Efficacy|0
5604683|NCT00871871|19362397|P4|Part I|Laboratory abnormality|0
5604684|NCT00871871|19362398|P3|Part I|Laboratory abnormality|0
5604685|NCT00871871|19362399|P2|Part I|Laboratory abnormality|1
5604686|NCT00871871|19362400|P1|Part I|Laboratory abnormality|0
5604687|NCT00871871|19362397|P4|Part I|Withdrawal by Subject|0
5604688|NCT00871871|19362398|P3|Part I|Withdrawal by Subject|0
5604689|NCT00871871|19362399|P2|Part I|Withdrawal by Subject|0
5604690|NCT00871871|19362400|P1|Part I|Withdrawal by Subject|3
5604691|NCT00871871|19362397|P4|Part I|Adverse Event|0
5604692|NCT00871871|19362398|P3|Part I|Adverse Event|0
5604693|NCT00871871|19362399|P2|Part I|Adverse Event|2
5604694|NCT00871871|19362400|P1|Part I|Adverse Event|0
5604695|NCT00871780|19362437|P1|Overall Study|Physician Decision|1
5604696|NCT00871780|19362437|P1|Overall Study|Death|1
5604697|NCT00871780|19362437|P1|Overall Study|Voluntary Discontinuation|4
5604698|NCT00871780|19362437|P1|Overall Study|Adverse Event|6
5604699|NCT00871780|19362437|P1|Overall Study|Withdrawal by Subject|9
5604700|NCT00871780|19362437|P1|Overall Study|Enrolled But Not Treated|6
5604701|NCT00871741|19362457|P2|Overall Study|Premature study termination|7
5604702|NCT00871741|19362458|P1|Overall Study|Premature study termination|9
5604703|NCT00871728|19362472|P1|Overall Study|Withdrawal of Informed Consent|5
5604704|NCT00871728|19362472|P1|Overall Study|Participant Non-compliance|1
5604705|NCT00871728|19362472|P1|Overall Study|Failed to Visit Hospital|4
5604706|NCT00871728|19362472|P1|Overall Study|Lost to Follow-up|2
5604707|NCT00871728|19362472|P1|Overall Study|Protocol Violation|7
5604708|NCT00871728|19362472|P1|Overall Study|Adverse Event|1
5604709|NCT00871715|19362485|P3|Overall Study|Lost to Follow-up|9
5604710|NCT00871715|19362486|P2|Overall Study|Lost to Follow-up|6
5604711|NCT00871715|19362487|P1|Overall Study|Lost to Follow-up|3
5604712|NCT00871715|19362485|P3|Overall Study|Physician Decision|2
5604713|NCT00871715|19362486|P2|Overall Study|Physician Decision|0
5604714|NCT00871715|19362487|P1|Overall Study|Physician Decision|6
5604715|NCT00871715|19362485|P3|Overall Study|Withdrawal by Subject|15
5604716|NCT00871715|19362486|P2|Overall Study|Withdrawal by Subject|10
5604717|NCT00871715|19362487|P1|Overall Study|Withdrawal by Subject|6
5604718|NCT00871572|19362564|P4|Overall Study|Withdrawal by Subject|1
5604719|NCT00871572|19362565|P3|Overall Study|Withdrawal by Subject|3
5604720|NCT00871572|19362566|P2|Overall Study|Withdrawal by Subject|2
5604721|NCT00871572|19362567|P1|Overall Study|Withdrawal by Subject|1
5604722|NCT00871572|19362564|P4|Overall Study|Sponsor Decision|0
5604723|NCT00871572|19362565|P3|Overall Study|Sponsor Decision|0
5604724|NCT00871572|19362566|P2|Overall Study|Sponsor Decision|0
5604725|NCT00871572|19362567|P1|Overall Study|Sponsor Decision|1
5604726|NCT00871572|19362564|P4|Overall Study|Protocol Violation|1
5604727|NCT00871572|19362565|P3|Overall Study|Protocol Violation|1
5604728|NCT00871572|19362566|P2|Overall Study|Protocol Violation|0
5604729|NCT00871572|19362567|P1|Overall Study|Protocol Violation|0
5604730|NCT00871572|19362564|P4|Overall Study|Lost to Follow-up|1
5604731|NCT00871572|19362565|P3|Overall Study|Lost to Follow-up|0
5604732|NCT00871572|19362566|P2|Overall Study|Lost to Follow-up|1
5604733|NCT00871572|19362567|P1|Overall Study|Lost to Follow-up|0
5604734|NCT00871572|19362564|P4|Overall Study|Investigator Decision|1
5604735|NCT00871572|19362565|P3|Overall Study|Investigator Decision|0
5604736|NCT00871572|19362566|P2|Overall Study|Investigator Decision|1
5604737|NCT00871572|19362567|P1|Overall Study|Investigator Decision|0
5604738|NCT00871572|19362564|P4|Overall Study|Adverse Event|3
5604739|NCT00871572|19362565|P3|Overall Study|Adverse Event|0
5604740|NCT00871572|19362566|P2|Overall Study|Adverse Event|2
5604741|NCT00871572|19362567|P1|Overall Study|Adverse Event|0
5604742|NCT00871494|19362637|P1|Overall Study|Lost to Follow-up|1
5604743|NCT00871494|19362637|P1|Overall Study|Adverse Event|4
5604744|NCT00871494|19362637|P1|Overall Study|Lack of Efficacy|4
5604745|NCT00871494|19362637|P1|Overall Study|Protocol Violation|5
5604746|NCT00871429|19362644|P1|Overall Study|Questionnaire not completed|1
5604747|NCT00871429|19362644|P1|Overall Study|Withdrawal by Subject|17
5604748|NCT00871429|19362644|P1|Overall Study|Lost to Follow-up|6
5604749|NCT00871403|19362655|P3|Monotherapy Treatment Phase|Adverse Event|0
5604750|NCT00871403|19362656|P2|Monotherapy Treatment Phase|Adverse Event|4
5604751|NCT00871403|19362657|P1|Monotherapy Treatment Phase|Adverse Event|0
5604752|NCT00871403|19362655|P3|Monotherapy Treatment Phase|Disease Progression|1
5604753|NCT00871403|19362656|P2|Monotherapy Treatment Phase|Disease Progression|9
5604754|NCT00871403|19362657|P1|Monotherapy Treatment Phase|Disease Progression|0
5604755|NCT00871403|19362655|P3|Combination Treatment Phase|Physician Decision|3
5604756|NCT00871403|19362656|P2|Combination Treatment Phase|Physician Decision|1
5604757|NCT00871403|19362657|P1|Combination Treatment Phase|Physician Decision|0
5604758|NCT00871403|19362655|P3|Combination Treatment Phase|Withdrawal by Subject|1
5604759|NCT00871403|19362656|P2|Combination Treatment Phase|Withdrawal by Subject|3
5604760|NCT00871403|19362657|P1|Combination Treatment Phase|Withdrawal by Subject|0
5604761|NCT00871403|19362655|P3|Combination Treatment Phase|Disease Progression|5
5604762|NCT00871403|19362656|P2|Combination Treatment Phase|Disease Progression|8
5604763|NCT00871403|19362657|P1|Combination Treatment Phase|Disease Progression|0
5604764|NCT00871403|19362655|P3|Combination Treatment Phase|Adverse Event|2
5604765|NCT00871403|19362656|P2|Combination Treatment Phase|Adverse Event|17
5604766|NCT00871403|19362657|P1|Combination Treatment Phase|Adverse Event|0
5604767|NCT00871403|19362655|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
5604768|NCT00871403|19362656|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
5604769|NCT00871403|19362657|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
5604770|NCT00871403|19362655|P3|Combination Treatment Phase|Randomized but Not Treated|1
5604771|NCT00871403|19362656|P2|Combination Treatment Phase|Randomized but Not Treated|1
5604772|NCT00871403|19362657|P1|Combination Treatment Phase|Randomized but Not Treated|1
5604773|NCT00871377|19362670|P6|Third Intervention (10 Weeks)|Death|0
5604774|NCT00871377|19362671|P5|Third Intervention (10 Weeks)|Death|0
5604775|NCT00871377|19362672|P4|Third Intervention (10 Weeks)|Death|1
5604776|NCT00871377|19362673|P3|Third Intervention (10 Weeks)|Death|0
5604777|NCT00871377|19362674|P2|Third Intervention (10 Weeks)|Death|0
5604778|NCT00871377|19362675|P1|Third Intervention (10 Weeks)|Death|0
5604779|NCT00871377|19362670|P6|Washout (6 Weeks)|Withdrawal by Subject|1
5604780|NCT00871377|19362671|P5|Washout (6 Weeks)|Withdrawal by Subject|0
5604781|NCT00871377|19362672|P4|Washout (6 Weeks)|Withdrawal by Subject|0
5604782|NCT00871377|19362673|P3|Washout (6 Weeks)|Withdrawal by Subject|0
5604783|NCT00871377|19362674|P2|Washout (6 Weeks)|Withdrawal by Subject|0
5604784|NCT00871377|19362675|P1|Washout (6 Weeks)|Withdrawal by Subject|0
5604785|NCT00871377|19362670|P6|Washout (6 Weeks)|Withdrawal by Subject|0
5604786|NCT00871377|19362671|P5|Washout (6 Weeks)|Withdrawal by Subject|0
5604787|NCT00871377|19362672|P4|Washout (6 Weeks)|Withdrawal by Subject|0
5604788|NCT00871377|19362673|P3|Washout (6 Weeks)|Withdrawal by Subject|0
5604789|NCT00871377|19362674|P2|Washout (6 Weeks)|Withdrawal by Subject|0
5604790|NCT00871377|19362675|P1|Washout (6 Weeks)|Withdrawal by Subject|1
5604791|NCT00871377|19362670|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
5604792|NCT00871377|19362671|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
5604793|NCT00871377|19362672|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
5604794|NCT00871377|19362673|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
5604795|NCT00871377|19362674|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
5604796|NCT00871377|19362675|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
5604797|NCT00871377|19362670|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
5604798|NCT00871377|19362671|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
5604799|NCT00871377|19362672|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
5604800|NCT00871377|19362673|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
5604801|NCT00871377|19362674|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
5604802|NCT00871377|19362675|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
5604803|NCT00871351|19362686|P3|Overall Study|Adverse Event|0
5604804|NCT00871351|19362687|P2|Overall Study|Adverse Event|1
5604805|NCT00871351|19362688|P1|Overall Study|Adverse Event|3
5604806|NCT00871351|19362686|P3|Overall Study|Withdrawal by Subject|0
5604807|NCT00871351|19362687|P2|Overall Study|Withdrawal by Subject|0
5604808|NCT00871351|19362688|P1|Overall Study|Withdrawal by Subject|1
5604809|NCT00871338|19362710|P2|Prior to Booster|Lost to Follow-up|0
5604810|NCT00871338|19362711|P1|Prior to Booster|Lost to Follow-up|1
5604811|NCT00871338|19362710|P2|Prior to Booster|Withdrawal by Subject|3
5604812|NCT00871338|19362711|P1|Prior to Booster|Withdrawal by Subject|1
5604813|NCT00871234|19362800|P1|Overall Study|Lost to Follow-up|3
5604814|NCT00871234|19362800|P1|Overall Study|Adverse Event|2
5604815|NCT00871169|19362804|P1|Overall Study|Patient did not receive study treatment|2
5604816|NCT00871169|19362804|P1|Overall Study|Protocol Violation|1
5604817|NCT00871117|19362832|P2|Overall Study|Other|4
5604818|NCT00871117|19362833|P1|Overall Study|Other|0
5604819|NCT00871117|19362832|P2|Overall Study|Lost to Follow-up|6
5604820|NCT00871117|19362833|P1|Overall Study|Lost to Follow-up|5
5604821|NCT00871000|19362867|P2|Overall Study|Withdrawal by Subject|0
5604822|NCT00871000|19362868|P1|Overall Study|Withdrawal by Subject|1
5604823|NCT00870870|19362920|P4|Overall Study|Adverse Event|2
5604824|NCT00870870|19362921|P3|Overall Study|Adverse Event|2
5604825|NCT00870870|19362922|P2|Overall Study|Adverse Event|0
5604826|NCT00870870|19362923|P1|Overall Study|Adverse Event|0
5604827|NCT00870870|19362920|P4|Overall Study|Withdrawal by Subject|3
5604828|NCT00870870|19362921|P3|Overall Study|Withdrawal by Subject|1
5604829|NCT00870870|19362922|P2|Overall Study|Withdrawal by Subject|1
5604830|NCT00870870|19362923|P1|Overall Study|Withdrawal by Subject|0
5604831|NCT00870740|19362967|P6|Overall Study|Other|5
5604832|NCT00870740|19362968|P5|Overall Study|Other|3
5604833|NCT00870740|19362969|P4|Overall Study|Other|4
5604834|NCT00870740|19362970|P3|Overall Study|Other|2
5604835|NCT00870740|19362971|P2|Overall Study|Other|5
5604836|NCT00870740|19362972|P1|Overall Study|Other|2
5604837|NCT00870740|19362967|P6|Overall Study|Death|0
5604838|NCT00870740|19362968|P5|Overall Study|Death|1
5604839|NCT00870740|19362969|P4|Overall Study|Death|0
5604840|NCT00870740|19362970|P3|Overall Study|Death|0
5604841|NCT00870740|19362971|P2|Overall Study|Death|0
5604842|NCT00870740|19362972|P1|Overall Study|Death|0
5604843|NCT00870740|19362967|P6|Overall Study|Subject Non-compliance|1
5604844|NCT00870740|19362968|P5|Overall Study|Subject Non-compliance|0
5604845|NCT00870740|19362969|P4|Overall Study|Subject Non-compliance|0
5604846|NCT00870740|19362970|P3|Overall Study|Subject Non-compliance|0
5604847|NCT00870740|19362971|P2|Overall Study|Subject Non-compliance|0
5604848|NCT00870740|19362972|P1|Overall Study|Subject Non-compliance|0
5604849|NCT00870740|19362967|P6|Overall Study|Investigator Decision|0
5604850|NCT00870740|19362968|P5|Overall Study|Investigator Decision|0
5604851|NCT00870740|19362969|P4|Overall Study|Investigator Decision|0
5604852|NCT00870740|19362970|P3|Overall Study|Investigator Decision|1
5604853|NCT00870740|19362971|P2|Overall Study|Investigator Decision|0
5604854|NCT00870740|19362972|P1|Overall Study|Investigator Decision|2
5604855|NCT00870740|19362967|P6|Overall Study|Consent Withdrawn|5
5604856|NCT00870740|19362968|P5|Overall Study|Consent Withdrawn|6
5604857|NCT00870740|19362969|P4|Overall Study|Consent Withdrawn|6
5604858|NCT00870740|19362970|P3|Overall Study|Consent Withdrawn|4
5604859|NCT00870740|19362971|P2|Overall Study|Consent Withdrawn|3
5604860|NCT00870740|19362972|P1|Overall Study|Consent Withdrawn|6
5604861|NCT00870740|19362967|P6|Overall Study|Adverse Event|6
5604862|NCT00870740|19362968|P5|Overall Study|Adverse Event|1
5604863|NCT00870740|19362969|P4|Overall Study|Adverse Event|2
5604864|NCT00870740|19362970|P3|Overall Study|Adverse Event|3
5604865|NCT00870740|19362971|P2|Overall Study|Adverse Event|1
5604866|NCT00870740|19362972|P1|Overall Study|Adverse Event|2
5604867|NCT00870727|19363048|P2|Overall Study|Adverse Event|1
5604868|NCT00870727|19363049|P1|Overall Study|Adverse Event|0
5604869|NCT00870727|19363048|P2|Overall Study|Lack of Efficacy|3
5604870|NCT00870727|19363049|P1|Overall Study|Lack of Efficacy|1
5604871|NCT00870727|19363048|P2|Overall Study|Lost to Follow-up|1
5604872|NCT00870727|19363049|P1|Overall Study|Lost to Follow-up|0
5604873|NCT00870688|19363065|P1|Overall Study|Granules in the Stools|1
5604874|NCT00870688|19363065|P1|Overall Study|Death, Unrelated|1
5604875|NCT00870688|19363065|P1|Overall Study|Lost to Follow-up|2
5604876|NCT00870584|19363070|P2|Overall Study|Protocol Deviation|2
5604877|NCT00870584|19363071|P1|Overall Study|Protocol Deviation|2
5604878|NCT00870584|19363070|P2|Overall Study|Lost to Follow-up|1
5604879|NCT00870584|19363071|P1|Overall Study|Lost to Follow-up|5
5604880|NCT00870584|19363070|P2|Overall Study|Withdrawal by Subject|7
5604881|NCT00870584|19363071|P1|Overall Study|Withdrawal by Subject|6
5604882|NCT00870584|19363070|P2|Overall Study|Adverse Event|3
5604883|NCT00870584|19363071|P1|Overall Study|Adverse Event|3
5604884|NCT00870233|19363180|P1|Overall Study|Death|1
5604885|NCT00870233|19363180|P1|Overall Study|Incompatible internet browser|2
5604886|NCT00870233|19363180|P1|Overall Study|Did not undergo laparotomy|3
5604887|NCT00870233|19363180|P1|Overall Study|Withdrawal by Subject|18
5604888|NCT00870194|19363189|P2|Overall Study|Subject Decision|2
5604889|NCT00870194|19363190|P1|Overall Study|Subject Decision|7
5604890|NCT00870194|19363189|P2|Overall Study|Entry Criteria Not Met|2
5604891|NCT00870194|19363190|P1|Overall Study|Entry Criteria Not Met|1
5604892|NCT00870194|19363189|P2|Overall Study|Protocol Violation|3
5604893|NCT00870194|19363190|P1|Overall Study|Protocol Violation|3
5604894|NCT00870194|19363189|P2|Overall Study|Physician Decision|1
5604895|NCT00870194|19363190|P1|Overall Study|Physician Decision|3
5604896|NCT00870194|19363189|P2|Overall Study|Lost to Follow-up|0
5604897|NCT00870194|19363190|P1|Overall Study|Lost to Follow-up|2
5604898|NCT00870194|19363189|P2|Overall Study|Lack of Efficacy|1
5604899|NCT00870194|19363190|P1|Overall Study|Lack of Efficacy|0
5604900|NCT00870194|19363189|P2|Overall Study|Adverse Event|5
5604901|NCT00870194|19363190|P1|Overall Study|Adverse Event|10
5604902|NCT00870103|19363228|P1|Overall Study|Lost to Follow-up|2
5604903|NCT00870103|19363228|P1|Overall Study|Physician Decision|2
5604904|NCT00869999|19363233|P1|Overall Study|removed prior to starting therapy|1
5604905|NCT00869999|19363233|P1|Overall Study|Withdrawal by Subject|1
5604906|NCT00869960|19363239|P1|Overall Study|Lost to Follow-up|2
5604907|NCT00869778|19363288|P3|Overall Study|Unblinding|0
5604908|NCT00869778|19363289|P2|Overall Study|Unblinding|0
5604909|NCT00869778|19363290|P1|Overall Study|Unblinding|1
5604910|NCT00869778|19363288|P3|Overall Study|Protocol Violation|5
5604911|NCT00869778|19363289|P2|Overall Study|Protocol Violation|3
5604912|NCT00869778|19363290|P1|Overall Study|Protocol Violation|5
5604913|NCT00869778|19363288|P3|Overall Study|Pregnancy|0
5604914|NCT00869778|19363289|P2|Overall Study|Pregnancy|0
5604915|NCT00869778|19363290|P1|Overall Study|Pregnancy|1
5604916|NCT00869778|19363288|P3|Overall Study|Withdrawal by Subject|5
5604917|NCT00869778|19363289|P2|Overall Study|Withdrawal by Subject|4
5604918|NCT00869778|19363290|P1|Overall Study|Withdrawal by Subject|3
5604919|NCT00869778|19363288|P3|Overall Study|Adverse Event|0
5604920|NCT00869778|19363289|P2|Overall Study|Adverse Event|0
5604921|NCT00869778|19363290|P1|Overall Study|Adverse Event|2
5604922|NCT00869557|19363365|P2|Extension Phase|Withdrew Consent|0
5604923|NCT00869557|19363366|P1|Extension Phase|Withdrew Consent|2
5604924|NCT00869557|19363365|P2|Extension Phase|Investigator's Discretion|0
5604925|NCT00869557|19363366|P1|Extension Phase|Investigator's Discretion|2
5604926|NCT00869557|19363365|P2|Extension Phase|Lost to Follow-up|1
5604927|NCT00869557|19363366|P1|Extension Phase|Lost to Follow-up|3
5604928|NCT00869557|19363365|P2|Extension Phase|Lack of Efficacy|0
5604929|NCT00869557|19363366|P1|Extension Phase|Lack of Efficacy|1
5604930|NCT00869557|19363365|P2|Extension Phase|Adverse Event|2
5604931|NCT00869557|19363366|P1|Extension Phase|Adverse Event|2
5604932|NCT00869557|19363365|P2|Randomized Phase|Withdrew Consent|1
5604933|NCT00869557|19363366|P1|Randomized Phase|Withdrew Consent|0
5604934|NCT00869557|19363365|P2|Randomized Phase|Investigator's Discretion|0
5604935|NCT00869557|19363366|P1|Randomized Phase|Investigator's Discretion|1
5604936|NCT00869557|19363365|P2|Randomized Phase|Lost to Follow-up|1
5604937|NCT00869557|19363366|P1|Randomized Phase|Lost to Follow-up|2
5604938|NCT00869518|19363385|P2|Overall Study|Lost to Follow-up|1
5604939|NCT00869518|19363386|P1|Overall Study|Lost to Follow-up|1
5604940|NCT00869440|19363402|P4|Overall Study|Physician Decision|0
5604941|NCT00869440|19363403|P3|Overall Study|Physician Decision|0
5604942|NCT00869440|19363404|P2|Overall Study|Physician Decision|1
5604943|NCT00869440|19363405|P1|Overall Study|Physician Decision|1
5604944|NCT00869440|19363402|P4|Overall Study|Withdrawal by Subject|0
5604945|NCT00869440|19363403|P3|Overall Study|Withdrawal by Subject|0
5604946|NCT00869440|19363404|P2|Overall Study|Withdrawal by Subject|0
5604947|NCT00869440|19363405|P1|Overall Study|Withdrawal by Subject|1
5604948|NCT00869401|19363439|P5|Overall Study|Withdrawal by Subject|3
5604949|NCT00869401|19363440|P4|Overall Study|Withdrawal by Subject|5
5604950|NCT00869401|19363441|P3|Overall Study|Withdrawal by Subject|0
5604951|NCT00869401|19363442|P2|Overall Study|Withdrawal by Subject|0
5604952|NCT00869401|19363443|P1|Overall Study|Withdrawal by Subject|0
5604953|NCT00869362|19363472|P2|Overall Study|Lost to Follow-up|3
5604954|NCT00869362|19363473|P1|Overall Study|Lost to Follow-up|1
5604955|NCT00869362|19363472|P2|Overall Study|Death|2
5604956|NCT00869362|19363473|P1|Overall Study|Death|0
5604957|NCT00869323|19363494|P1|Maintenance Therapy|concurrent illness|1
5604958|NCT00869258|19363502|P1|Overall Study|Physician Decision|1
5604959|NCT00869128|19363567|P2|Overall Study|lack of Compliance|6
5604960|NCT00869128|19363568|P1|Overall Study|lack of Compliance|6
5604961|NCT00869089|19363572|P1|Overall Study|Screen Fail|1
5604962|NCT00869089|19363572|P1|Overall Study|Withdrawal by Subject|1
5604963|NCT00869089|19363572|P1|Overall Study|Lost to Follow-up|1
5604964|NCT00869050|19363576|P1|Overall Study|Screen Failure|3
5604965|NCT00869024|19363583|P2|Overall Study|Protocol Violation|1
5604966|NCT00869024|19363584|P1|Overall Study|Protocol Violation|0
5604967|NCT00869024|19363583|P2|Overall Study|Lost to Follow-up|1
5604968|NCT00869024|19363584|P1|Overall Study|Lost to Follow-up|0
5604969|NCT00869024|19363583|P2|Overall Study|Death|3
5604970|NCT00869024|19363584|P1|Overall Study|Death|2
5604971|NCT00868998|19363600|P1|Overall Study|Death|1
5604972|NCT00868998|19363600|P1|Overall Study|Progression of disease|2
5604973|NCT00868998|19363600|P1|Overall Study|Withdrawal by Subject|1
5604974|NCT00868998|19363600|P1|Overall Study|Screen Failure|1
5604975|NCT00868790|19363611|P14|Post-study|Excluded Medication|0
5604976|NCT00868790|19363612|P13|Post-study|Excluded Medication|0
5604977|NCT00868790|19363613|P12|Post-study|Excluded Medication|0
5604978|NCT00868790|19363614|P11|Post-study|Excluded Medication|0
5604979|NCT00868790|19363615|P10|Post-study|Excluded Medication|1
5604980|NCT00868790|19363616|P9|Post-study|Excluded Medication|0
5604981|NCT00868790|19363617|P8|Post-study|Excluded Medication|2
5604982|NCT00868790|19363618|P7|Post-study|Excluded Medication|0
5604983|NCT00868790|19363619|P6|Post-study|Excluded Medication|0
5604984|NCT00868790|19363620|P5|Post-study|Excluded Medication|0
5604985|NCT00868790|19363621|P4|Post-study|Excluded Medication|0
5604986|NCT00868790|19363622|P3|Post-study|Excluded Medication|0
5604987|NCT00868790|19363623|P2|Post-study|Excluded Medication|0
5604988|NCT00868790|19363624|P1|Post-study|Excluded Medication|0
5604989|NCT00868790|19363611|P14|Post-study|Withdrawal by Subject|0
5604990|NCT00868790|19363612|P13|Post-study|Withdrawal by Subject|0
5604991|NCT00868790|19363613|P12|Post-study|Withdrawal by Subject|0
5604992|NCT00868790|19363614|P11|Post-study|Withdrawal by Subject|0
5604993|NCT00868790|19363615|P10|Post-study|Withdrawal by Subject|0
5604994|NCT00868790|19363616|P9|Post-study|Withdrawal by Subject|0
5604995|NCT00868790|19363617|P8|Post-study|Withdrawal by Subject|0
5604996|NCT00868790|19363618|P7|Post-study|Withdrawal by Subject|0
5604997|NCT00868790|19363619|P6|Post-study|Withdrawal by Subject|0
5604998|NCT00868790|19363620|P5|Post-study|Withdrawal by Subject|1
5604999|NCT00868790|19363621|P4|Post-study|Withdrawal by Subject|0
5605000|NCT00868790|19363622|P3|Post-study|Withdrawal by Subject|0
5605001|NCT00868790|19363623|P2|Post-study|Withdrawal by Subject|0
5605002|NCT00868790|19363624|P1|Post-study|Withdrawal by Subject|0
5605003|NCT00868790|19363611|P14|Period 4|Abnormal ALT/AST|0
5605004|NCT00868790|19363612|P13|Period 4|Abnormal ALT/AST|0
5605005|NCT00868790|19363613|P12|Period 4|Abnormal ALT/AST|0
5605006|NCT00868790|19363614|P11|Period 4|Abnormal ALT/AST|0
5605007|NCT00868790|19363615|P10|Period 4|Abnormal ALT/AST|0
5605008|NCT00868790|19363616|P9|Period 4|Abnormal ALT/AST|0
5605009|NCT00868790|19363617|P8|Period 4|Abnormal ALT/AST|0
5605010|NCT00868790|19363618|P7|Period 4|Abnormal ALT/AST|0
5605011|NCT00868790|19363619|P6|Period 4|Abnormal ALT/AST|0
5605012|NCT00868790|19363620|P5|Period 4|Abnormal ALT/AST|0
5605013|NCT00868790|19363621|P4|Period 4|Abnormal ALT/AST|0
5605014|NCT00868790|19363622|P3|Period 4|Abnormal ALT/AST|1
5605015|NCT00868790|19363623|P2|Period 4|Abnormal ALT/AST|0
5605016|NCT00868790|19363624|P1|Period 4|Abnormal ALT/AST|0
5605017|NCT00868790|19363611|P14|Period 4|Study Terminated by Sponsor|1
5605018|NCT00868790|19363612|P13|Period 4|Study Terminated by Sponsor|0
5605019|NCT00868790|19363613|P12|Period 4|Study Terminated by Sponsor|1
5605020|NCT00868790|19363614|P11|Period 4|Study Terminated by Sponsor|2
5605021|NCT00868790|19363615|P10|Period 4|Study Terminated by Sponsor|0
5605022|NCT00868790|19363616|P9|Period 4|Study Terminated by Sponsor|2
5605023|NCT00868790|19363617|P8|Period 4|Study Terminated by Sponsor|1
5605024|NCT00868790|19363618|P7|Period 4|Study Terminated by Sponsor|0
5605025|NCT00868790|19363619|P6|Period 4|Study Terminated by Sponsor|0
5605026|NCT00868790|19363620|P5|Period 4|Study Terminated by Sponsor|0
5605027|NCT00868790|19363621|P4|Period 4|Study Terminated by Sponsor|0
5605028|NCT00868790|19363622|P3|Period 4|Study Terminated by Sponsor|0
5605029|NCT00868790|19363623|P2|Period 4|Study Terminated by Sponsor|0
5605030|NCT00868790|19363624|P1|Period 4|Study Terminated by Sponsor|2
5605031|NCT00868790|19363611|P14|Period 4|Lost to Follow-up|0
5605032|NCT00868790|19363612|P13|Period 4|Lost to Follow-up|0
5605033|NCT00868790|19363613|P12|Period 4|Lost to Follow-up|0
5605034|NCT00868790|19363614|P11|Period 4|Lost to Follow-up|0
5605035|NCT00868790|19363615|P10|Period 4|Lost to Follow-up|0
5605036|NCT00868790|19363616|P9|Period 4|Lost to Follow-up|0
5605037|NCT00868790|19363617|P8|Period 4|Lost to Follow-up|1
5605038|NCT00868790|19363618|P7|Period 4|Lost to Follow-up|0
5605039|NCT00868790|19363619|P6|Period 4|Lost to Follow-up|0
5605040|NCT00868790|19363620|P5|Period 4|Lost to Follow-up|0
5605041|NCT00868790|19363621|P4|Period 4|Lost to Follow-up|0
5605042|NCT00868790|19363622|P3|Period 4|Lost to Follow-up|0
5605043|NCT00868790|19363623|P2|Period 4|Lost to Follow-up|0
5605044|NCT00868790|19363624|P1|Period 4|Lost to Follow-up|0
5605045|NCT00868790|19363611|P14|Period 4|Adverse Event|0
5605046|NCT00868790|19363612|P13|Period 4|Adverse Event|1
5605047|NCT00868790|19363613|P12|Period 4|Adverse Event|0
5605048|NCT00868790|19363614|P11|Period 4|Adverse Event|1
5605049|NCT00868790|19363615|P10|Period 4|Adverse Event|0
5605050|NCT00868790|19363616|P9|Period 4|Adverse Event|0
5605051|NCT00868790|19363617|P8|Period 4|Adverse Event|1
5605052|NCT00868790|19363618|P7|Period 4|Adverse Event|0
5605053|NCT00868790|19363619|P6|Period 4|Adverse Event|0
5605054|NCT00868790|19363620|P5|Period 4|Adverse Event|0
5605055|NCT00868790|19363621|P4|Period 4|Adverse Event|0
5605056|NCT00868790|19363622|P3|Period 4|Adverse Event|0
5605057|NCT00868790|19363623|P2|Period 4|Adverse Event|0
5605058|NCT00868790|19363624|P1|Period 4|Adverse Event|0
5605059|NCT00868790|19363611|P14|Period 3|Study Terminated by Sponsor|0
5605060|NCT00868790|19363612|P13|Period 3|Study Terminated by Sponsor|0
5605061|NCT00868790|19363613|P12|Period 3|Study Terminated by Sponsor|0
5605062|NCT00868790|19363614|P11|Period 3|Study Terminated by Sponsor|0
5605063|NCT00868790|19363615|P10|Period 3|Study Terminated by Sponsor|0
5605064|NCT00868790|19363616|P9|Period 3|Study Terminated by Sponsor|0
5605065|NCT00868790|19363617|P8|Period 3|Study Terminated by Sponsor|0
5605066|NCT00868790|19363618|P7|Period 3|Study Terminated by Sponsor|0
5605067|NCT00868790|19363619|P6|Period 3|Study Terminated by Sponsor|0
5605068|NCT00868790|19363620|P5|Period 3|Study Terminated by Sponsor|0
5605069|NCT00868790|19363621|P4|Period 3|Study Terminated by Sponsor|1
5605070|NCT00868790|19363622|P3|Period 3|Study Terminated by Sponsor|0
5605071|NCT00868790|19363623|P2|Period 3|Study Terminated by Sponsor|0
5605072|NCT00868790|19363624|P1|Period 3|Study Terminated by Sponsor|0
5605073|NCT00868790|19363611|P14|Period 3|Protocol Violation|0
5605074|NCT00868790|19363612|P13|Period 3|Protocol Violation|0
5605075|NCT00868790|19363613|P12|Period 3|Protocol Violation|0
5605076|NCT00868790|19363614|P11|Period 3|Protocol Violation|1
5605077|NCT00868790|19363615|P10|Period 3|Protocol Violation|0
5605078|NCT00868790|19363616|P9|Period 3|Protocol Violation|0
5605079|NCT00868790|19363617|P8|Period 3|Protocol Violation|0
5605080|NCT00868790|19363618|P7|Period 3|Protocol Violation|0
5605081|NCT00868790|19363619|P6|Period 3|Protocol Violation|0
5605082|NCT00868790|19363620|P5|Period 3|Protocol Violation|0
5605083|NCT00868790|19363621|P4|Period 3|Protocol Violation|0
5605084|NCT00868790|19363622|P3|Period 3|Protocol Violation|0
5605085|NCT00868790|19363623|P2|Period 3|Protocol Violation|0
5605086|NCT00868790|19363624|P1|Period 3|Protocol Violation|0
5605087|NCT00868790|19363611|P14|Period 3|Adverse Event|0
5605088|NCT00868790|19363612|P13|Period 3|Adverse Event|0
5605089|NCT00868790|19363613|P12|Period 3|Adverse Event|0
5605090|NCT00868790|19363614|P11|Period 3|Adverse Event|0
5605091|NCT00868790|19363615|P10|Period 3|Adverse Event|1
5605092|NCT00868790|19363616|P9|Period 3|Adverse Event|0
5605093|NCT00868790|19363617|P8|Period 3|Adverse Event|0
5605094|NCT00868790|19363618|P7|Period 3|Adverse Event|0
5605095|NCT00868790|19363619|P6|Period 3|Adverse Event|0
5605096|NCT00868790|19363620|P5|Period 3|Adverse Event|0
5605097|NCT00868790|19363621|P4|Period 3|Adverse Event|0
5605098|NCT00868790|19363622|P3|Period 3|Adverse Event|0
5605099|NCT00868790|19363623|P2|Period 3|Adverse Event|0
5605100|NCT00868790|19363624|P1|Period 3|Adverse Event|0
5605101|NCT00868790|19363611|P14|Period 2|Withdrawal by Subject|1
5605102|NCT00868790|19363612|P13|Period 2|Withdrawal by Subject|0
5605103|NCT00868790|19363613|P12|Period 2|Withdrawal by Subject|0
5605104|NCT00868790|19363614|P11|Period 2|Withdrawal by Subject|0
5605105|NCT00868790|19363615|P10|Period 2|Withdrawal by Subject|0
5605106|NCT00868790|19363616|P9|Period 2|Withdrawal by Subject|1
5605107|NCT00868790|19363617|P8|Period 2|Withdrawal by Subject|0
5605108|NCT00868790|19363618|P7|Period 2|Withdrawal by Subject|0
5605109|NCT00868790|19363619|P6|Period 2|Withdrawal by Subject|0
5605110|NCT00868790|19363620|P5|Period 2|Withdrawal by Subject|0
5605111|NCT00868790|19363621|P4|Period 2|Withdrawal by Subject|0
5605112|NCT00868790|19363622|P3|Period 2|Withdrawal by Subject|0
5605113|NCT00868790|19363623|P2|Period 2|Withdrawal by Subject|0
5605114|NCT00868790|19363624|P1|Period 2|Withdrawal by Subject|0
5605115|NCT00868790|19363611|P14|Period 2|Lost to Follow-up|0
5605116|NCT00868790|19363612|P13|Period 2|Lost to Follow-up|0
5605117|NCT00868790|19363613|P12|Period 2|Lost to Follow-up|0
5605118|NCT00868790|19363614|P11|Period 2|Lost to Follow-up|0
5605119|NCT00868790|19363615|P10|Period 2|Lost to Follow-up|0
5605120|NCT00868790|19363616|P9|Period 2|Lost to Follow-up|0
5605121|NCT00868790|19363617|P8|Period 2|Lost to Follow-up|0
5605122|NCT00868790|19363618|P7|Period 2|Lost to Follow-up|0
5605123|NCT00868790|19363619|P6|Period 2|Lost to Follow-up|1
5605124|NCT00868790|19363620|P5|Period 2|Lost to Follow-up|0
5605125|NCT00868790|19363621|P4|Period 2|Lost to Follow-up|0
5605126|NCT00868790|19363622|P3|Period 2|Lost to Follow-up|0
5605127|NCT00868790|19363623|P2|Period 2|Lost to Follow-up|1
5605128|NCT00868790|19363624|P1|Period 2|Lost to Follow-up|0
5605129|NCT00868790|19363611|P14|Period 2|Adverse Event|0
5605130|NCT00868790|19363612|P13|Period 2|Adverse Event|0
5605131|NCT00868790|19363613|P12|Period 2|Adverse Event|0
5605132|NCT00868790|19363614|P11|Period 2|Adverse Event|0
5605133|NCT00868790|19363615|P10|Period 2|Adverse Event|0
5605134|NCT00868790|19363616|P9|Period 2|Adverse Event|1
5605135|NCT00868790|19363617|P8|Period 2|Adverse Event|0
5605136|NCT00868790|19363618|P7|Period 2|Adverse Event|0
5605137|NCT00868790|19363619|P6|Period 2|Adverse Event|0
5605138|NCT00868790|19363620|P5|Period 2|Adverse Event|0
5605139|NCT00868790|19363621|P4|Period 2|Adverse Event|0
5605140|NCT00868790|19363622|P3|Period 2|Adverse Event|0
5605141|NCT00868790|19363623|P2|Period 2|Adverse Event|0
5605142|NCT00868790|19363624|P1|Period 2|Adverse Event|0
5605143|NCT00868790|19363611|P14|Period 1|Lost to Follow-up|0
5605144|NCT00868790|19363612|P13|Period 1|Lost to Follow-up|0
5605145|NCT00868790|19363613|P12|Period 1|Lost to Follow-up|0
5605146|NCT00868790|19363614|P11|Period 1|Lost to Follow-up|0
5605147|NCT00868790|19363615|P10|Period 1|Lost to Follow-up|0
5605148|NCT00868790|19363616|P9|Period 1|Lost to Follow-up|0
5605149|NCT00868790|19363617|P8|Period 1|Lost to Follow-up|0
5605150|NCT00868790|19363618|P7|Period 1|Lost to Follow-up|0
5605151|NCT00868790|19363619|P6|Period 1|Lost to Follow-up|1
5605152|NCT00868790|19363620|P5|Period 1|Lost to Follow-up|0
5605153|NCT00868790|19363621|P4|Period 1|Lost to Follow-up|0
5605154|NCT00868790|19363622|P3|Period 1|Lost to Follow-up|0
5605155|NCT00868790|19363623|P2|Period 1|Lost to Follow-up|0
5605156|NCT00868790|19363624|P1|Period 1|Lost to Follow-up|0
5605157|NCT00868790|19363611|P14|Period 1|Abnormal Triglycerides|0
5605158|NCT00868790|19363612|P13|Period 1|Abnormal Triglycerides|0
5605159|NCT00868790|19363613|P12|Period 1|Abnormal Triglycerides|0
5605160|NCT00868790|19363614|P11|Period 1|Abnormal Triglycerides|0
5605161|NCT00868790|19363615|P10|Period 1|Abnormal Triglycerides|0
5605162|NCT00868790|19363616|P9|Period 1|Abnormal Triglycerides|0
5605163|NCT00868790|19363617|P8|Period 1|Abnormal Triglycerides|0
5605164|NCT00868790|19363618|P7|Period 1|Abnormal Triglycerides|0
5605165|NCT00868790|19363619|P6|Period 1|Abnormal Triglycerides|0
5605166|NCT00868790|19363620|P5|Period 1|Abnormal Triglycerides|1
5605167|NCT00868790|19363621|P4|Period 1|Abnormal Triglycerides|0
5605168|NCT00868790|19363622|P3|Period 1|Abnormal Triglycerides|0
5605169|NCT00868790|19363623|P2|Period 1|Abnormal Triglycerides|0
5605170|NCT00868790|19363624|P1|Period 1|Abnormal Triglycerides|0
5605171|NCT00868790|19363611|P14|Period 1|Withdrawal by Subject|1
5605172|NCT00868790|19363612|P13|Period 1|Withdrawal by Subject|0
5605173|NCT00868790|19363613|P12|Period 1|Withdrawal by Subject|0
5605174|NCT00868790|19363614|P11|Period 1|Withdrawal by Subject|0
5605175|NCT00868790|19363615|P10|Period 1|Withdrawal by Subject|0
5605176|NCT00868790|19363616|P9|Period 1|Withdrawal by Subject|0
5605177|NCT00868790|19363617|P8|Period 1|Withdrawal by Subject|0
5605178|NCT00868790|19363618|P7|Period 1|Withdrawal by Subject|0
5605179|NCT00868790|19363619|P6|Period 1|Withdrawal by Subject|0
5605180|NCT00868790|19363620|P5|Period 1|Withdrawal by Subject|0
5605181|NCT00868790|19363621|P4|Period 1|Withdrawal by Subject|0
5605182|NCT00868790|19363622|P3|Period 1|Withdrawal by Subject|0
5605183|NCT00868790|19363623|P2|Period 1|Withdrawal by Subject|1
5605184|NCT00868790|19363624|P1|Period 1|Withdrawal by Subject|0
5605185|NCT00868790|19363611|P14|Period 1|Protocol Violation|0
5605186|NCT00868790|19363612|P13|Period 1|Protocol Violation|0
5605187|NCT00868790|19363613|P12|Period 1|Protocol Violation|0
5605188|NCT00868790|19363614|P11|Period 1|Protocol Violation|0
5605189|NCT00868790|19363615|P10|Period 1|Protocol Violation|0
5605190|NCT00868790|19363616|P9|Period 1|Protocol Violation|0
5605191|NCT00868790|19363617|P8|Period 1|Protocol Violation|0
5605192|NCT00868790|19363618|P7|Period 1|Protocol Violation|0
5605193|NCT00868790|19363619|P6|Period 1|Protocol Violation|0
5605194|NCT00868790|19363620|P5|Period 1|Protocol Violation|0
5605195|NCT00868790|19363621|P4|Period 1|Protocol Violation|0
5605196|NCT00868790|19363622|P3|Period 1|Protocol Violation|0
5605197|NCT00868790|19363623|P2|Period 1|Protocol Violation|0
5605198|NCT00868790|19363624|P1|Period 1|Protocol Violation|1
5605199|NCT00868790|19363611|P14|Period 1|Adverse Event|1
5605200|NCT00868790|19363612|P13|Period 1|Adverse Event|0
5605201|NCT00868790|19363613|P12|Period 1|Adverse Event|0
5605202|NCT00868790|19363614|P11|Period 1|Adverse Event|0
5605203|NCT00868790|19363615|P10|Period 1|Adverse Event|0
5605204|NCT00868790|19363616|P9|Period 1|Adverse Event|1
5605205|NCT00868790|19363617|P8|Period 1|Adverse Event|3
5605206|NCT00868790|19363618|P7|Period 1|Adverse Event|0
5605207|NCT00868790|19363619|P6|Period 1|Adverse Event|0
5605208|NCT00868790|19363620|P5|Period 1|Adverse Event|0
5605209|NCT00868790|19363621|P4|Period 1|Adverse Event|0
5605210|NCT00868790|19363622|P3|Period 1|Adverse Event|0
5605211|NCT00868790|19363623|P2|Period 1|Adverse Event|0
5605212|NCT00868790|19363624|P1|Period 1|Adverse Event|1
5605213|NCT00868608|19363707|P3|Overall Study|Other - Unspecified|0
5605214|NCT00868608|19363708|P2|Overall Study|Other - Unspecified|0
5605215|NCT00868608|19363709|P1|Overall Study|Other - Unspecified|1
5605216|NCT00868608|19363707|P3|Overall Study|Death|4
5605217|NCT00868608|19363708|P2|Overall Study|Death|2
5605218|NCT00868608|19363709|P1|Overall Study|Death|16
5605219|NCT00868608|19363707|P3|Overall Study|Lost to Follow-up|1
5605220|NCT00868608|19363708|P2|Overall Study|Lost to Follow-up|0
5605221|NCT00868608|19363709|P1|Overall Study|Lost to Follow-up|3
5605222|NCT00868608|19363707|P3|Overall Study|Withdrawal by Subject|0
5605223|NCT00868608|19363708|P2|Overall Study|Withdrawal by Subject|1
5605224|NCT00868608|19363709|P1|Overall Study|Withdrawal by Subject|3
5605225|NCT00868530|19363733|P1|Overall Study|Lost to Follow-up|1
5605226|NCT00868530|19363733|P1|Overall Study|Adverse Event|3
5605227|NCT00868517|19363748|P3|Overall Study|Protocol Violation|0
5605228|NCT00868517|19363749|P2|Overall Study|Protocol Violation|1
5605229|NCT00868517|19363750|P1|Overall Study|Protocol Violation|1
5605230|NCT00868517|19363748|P3|Overall Study|Withdrawal by Subject|2
5605231|NCT00868517|19363749|P2|Overall Study|Withdrawal by Subject|3
5605232|NCT00868517|19363750|P1|Overall Study|Withdrawal by Subject|3
5605233|NCT00868439|19363788|P2|Overall Study|Withdrawal by Subject|1
5605234|NCT00868439|19363789|P1|Overall Study|Withdrawal by Subject|0
5605235|NCT00868439|19363788|P2|Overall Study|Physician Decision|0
5605236|NCT00868439|19363789|P1|Overall Study|Physician Decision|1
5605237|NCT00868439|19363788|P2|Overall Study|Protocol Violation|1
5605238|NCT00868439|19363789|P1|Overall Study|Protocol Violation|1
5605239|NCT00868439|19363788|P2|Overall Study|Death|1
5605240|NCT00868439|19363789|P1|Overall Study|Death|0
5605241|NCT00868439|19363788|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
5605242|NCT00868439|19363789|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
5605243|NCT00868439|19363788|P2|Overall Study|Adverse Event|3
5605244|NCT00868439|19363789|P1|Overall Study|Adverse Event|4
5605245|NCT00868296|19363846|P2|Overall Study|Withdrawal by Subject|1
5605246|NCT00868296|19363847|P1|Overall Study|Withdrawal by Subject|0
5605247|NCT00868296|19363846|P2|Overall Study|Adverse Event|2
5605248|NCT00868296|19363847|P1|Overall Study|Adverse Event|0
5605249|NCT00868231|19363855|P6|Treatment Period 3|Adverse Event|0
5605250|NCT00868231|19363856|P5|Treatment Period 3|Adverse Event|0
5605251|NCT00868231|19363857|P4|Treatment Period 3|Adverse Event|0
5605252|NCT00868231|19363858|P3|Treatment Period 3|Adverse Event|1
5605253|NCT00868231|19363859|P2|Treatment Period 3|Adverse Event|0
5605254|NCT00868231|19363860|P1|Treatment Period 3|Adverse Event|0
5605255|NCT00868231|19363855|P6|Treatment Period 2|Adverse Event|0
5605256|NCT00868231|19363856|P5|Treatment Period 2|Adverse Event|0
5605257|NCT00868231|19363857|P4|Treatment Period 2|Adverse Event|0
5605258|NCT00868231|19363858|P3|Treatment Period 2|Adverse Event|0
5605259|NCT00868231|19363859|P2|Treatment Period 2|Adverse Event|0
5605260|NCT00868231|19363860|P1|Treatment Period 2|Adverse Event|1
5605261|NCT00868231|19363855|P6|Treatment Period 1|Adverse Event|0
5605262|NCT00868231|19363856|P5|Treatment Period 1|Adverse Event|1
5605263|NCT00868231|19363857|P4|Treatment Period 1|Adverse Event|0
5605264|NCT00868231|19363858|P3|Treatment Period 1|Adverse Event|0
5605265|NCT00868231|19363859|P2|Treatment Period 1|Adverse Event|0
5605266|NCT00868231|19363860|P1|Treatment Period 1|Adverse Event|0
5605267|NCT00868192|19363926|P1|Overall Study|Ineligible|4
5605268|NCT00868166|19363943|P2|Overall Study|Non-compliance with IMP|1
5605269|NCT00868166|19363944|P1|Overall Study|Non-compliance with IMP|1
5605270|NCT00868166|19363943|P2|Overall Study|Lack of efficacy, logistics, unwell|10
5605271|NCT00868166|19363944|P1|Overall Study|Lack of efficacy, logistics, unwell|9
5605272|NCT00868166|19363943|P2|Overall Study|Adverse Event|10
5605273|NCT00868166|19363944|P1|Overall Study|Adverse Event|9
5605274|NCT00868166|19363943|P2|Overall Study|Lost to Follow-up|3
5605275|NCT00868166|19363944|P1|Overall Study|Lost to Follow-up|1
5605276|NCT00868166|19363943|P2|Overall Study|Protocol Violation|0
5605277|NCT00868166|19363944|P1|Overall Study|Protocol Violation|1
5605278|NCT00868166|19363943|P2|Overall Study|Withdrawal by Subject|25
5605279|NCT00868166|19363944|P1|Overall Study|Withdrawal by Subject|33
5605280|NCT00868166|19363943|P2|Overall Study|Death|65
5605281|NCT00868166|19363944|P1|Overall Study|Death|58
5605282|NCT00867815|19364006|P1|Overall Study|Lost to Follow-up|1
5605283|NCT00867568|19364017|P1|Overall Study|Withdrawal by Subject|1
5605284|NCT00867568|19364017|P1|Overall Study|Adverse Event|4
5605285|NCT00867568|19364017|P1|Overall Study|Lack of Efficacy|10
5605286|NCT00867503|19364034|P1|Overall Study|Withdrawal by Subject|1
5605287|NCT00867490|19364040|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
5605288|NCT00867490|19364040|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
5605289|NCT00867490|19364040|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
5605290|NCT00867490|19364040|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
5605291|NCT00867490|19364040|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
5605292|NCT00867360|19364082|P2|Overall Study|Physician Decision|1
5605293|NCT00867360|19364083|P1|Overall Study|Physician Decision|0
5605294|NCT00867360|19364082|P2|Overall Study|Withdrawal by Subject|0
5605295|NCT00867360|19364083|P1|Overall Study|Withdrawal by Subject|1
5605296|NCT00867334|19364095|P2|Overall Study|Withdrawal by Subject|0
5605297|NCT00867334|19364096|P1|Overall Study|Withdrawal by Subject|1
5605298|NCT00867334|19364095|P2|Overall Study|Withdrawal by Subject|0
5605299|NCT00867334|19364096|P1|Overall Study|Withdrawal by Subject|1
5605300|NCT00867334|19364095|P2|Overall Study|Withdrawal by Subject|1
5605301|NCT00867334|19364096|P1|Overall Study|Withdrawal by Subject|0
5605302|NCT00867308|19364132|P2|Overall Study|Withdrawal by Subject|2
5605303|NCT00867308|19364133|P1|Overall Study|Withdrawal by Subject|1
5605304|NCT00867308|19364132|P2|Overall Study|Lack of Efficacy|12
5605305|NCT00867308|19364133|P1|Overall Study|Lack of Efficacy|6
5605306|NCT00867308|19364132|P2|Overall Study|Adverse Event|4
5605307|NCT00867308|19364133|P1|Overall Study|Adverse Event|1
5605308|NCT00867308|19364132|P2|Overall Study|Death|0
5605309|NCT00867308|19364133|P1|Overall Study|Death|1
5605310|NCT00867165|19364152|P2|Overall Study|Withdrawal by Subject|0
5605311|NCT00867165|19364153|P1|Overall Study|Withdrawal by Subject|1
5605312|NCT00867165|19364152|P2|Overall Study|Adverse Event|0
5605313|NCT00867165|19364153|P1|Overall Study|Adverse Event|3
5605314|NCT00867113|19364301|P1|Post Treatment After Survival Follow-up|Administrative problems|4
5605315|NCT00867113|19364301|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
5605316|NCT00867113|19364301|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
5605317|NCT00867113|19364301|P1|Post Treatment After Survival Follow-up|Death|1
5605318|NCT00867113|19364301|P1|Treatment Period|Protocol Violation|4
5605319|NCT00867113|19364301|P1|Treatment Period|Disease progression/relapse|1
5605320|NCT00867113|19364301|P1|Treatment Period|Administrative problems|1
5605321|NCT00867113|19364301|P1|Treatment Period|Lost to Follow-up|3
5605322|NCT00867113|19364301|P1|Treatment Period|Withdrawal by Subject|19
5605323|NCT00867113|19364301|P1|Treatment Period|Death|2
5605324|NCT00867113|19364301|P1|Treatment Period|Adverse Event|15
5605325|NCT00867087|19364365|P1|Overall Study|Death|37
5605326|NCT00867087|19364365|P1|Overall Study|Withdrawal by Subject|4
5605327|NCT00867087|19364365|P1|Overall Study|Other|1
5605328|NCT00867035|19364381|P2|Baseline to 1 Week|Withdrawal by Subject|0
5605329|NCT00867035|19364382|P1|Baseline to 1 Week|Withdrawal by Subject|1
5605330|NCT00867035|19364381|P2|Baseline to 1 Hour|Withdrawal by Subject|1
5605331|NCT00867035|19364382|P1|Baseline to 1 Hour|Withdrawal by Subject|1
5605332|NCT00867009|19364408|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
5605333|NCT00867009|19364408|P1|Induction Period|Progressive Disease (PD)|25
5605334|NCT00867009|19364408|P1|Induction Period|Physician Decision|3
5605335|NCT00867009|19364408|P1|Induction Period|Withdrawal by Subject|8
5605336|NCT00867009|19364408|P1|Induction Period|Protocol Violation|1
5605337|NCT00867009|19364408|P1|Induction Period|Death due to Study Disease|4
5605338|NCT00867009|19364408|P1|Induction Period|Death due to serious adverse event|6
5605339|NCT00867009|19364408|P1|Induction Period|Serious Adverse Event|10
5605340|NCT00867009|19364408|P1|Induction Period|Nonserious Adverse Event|5
5605341|NCT00866918|19364417|P2|Overall Study|Secondary malignancy|0
5605342|NCT00866918|19364418|P1|Overall Study|Secondary malignancy|1
5605343|NCT00866918|19364417|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
5605344|NCT00866918|19364418|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
5605345|NCT00866918|19364417|P2|Overall Study|Ineligible|4
5605346|NCT00866918|19364418|P1|Overall Study|Ineligible|2
5605347|NCT00866918|19364417|P2|Overall Study|Physician Decision|2
5605348|NCT00866918|19364418|P1|Overall Study|Physician Decision|10
5605349|NCT00866918|19364417|P2|Overall Study|Lack of Efficacy|1
5605350|NCT00866918|19364418|P1|Overall Study|Lack of Efficacy|1
5605351|NCT00866918|19364417|P2|Overall Study|Death|5
5605352|NCT00866918|19364418|P1|Overall Study|Death|1
5605353|NCT00866814|19364452|P1|Overall Study|Moved to area without study site|1
5605354|NCT00866814|19364452|P1|Overall Study|Unable to meet follow-up requirements|2
5605355|NCT00866814|19364452|P1|Overall Study|No longer wished to participate|1
5605356|NCT00866814|19364452|P1|Overall Study|Death|1
5605357|NCT00866814|19364452|P1|Overall Study|Physician Decision|1
5605358|NCT00866814|19364452|P1|Overall Study|Adverse Event|2
5605359|NCT00866814|19364452|P1|Overall Study|Lost to Follow-up|12
5605360|NCT00866788|19364465|P4|Overall Study|Physician Decision|1
5605361|NCT00866788|19364466|P3|Overall Study|Physician Decision|1
5605362|NCT00866788|19364467|P2|Overall Study|Physician Decision|0
5605363|NCT00866788|19364468|P1|Overall Study|Physician Decision|0
5605364|NCT00866788|19364465|P4|Overall Study|Disease progression|0
5605365|NCT00866788|19364466|P3|Overall Study|Disease progression|1
5605366|NCT00866788|19364467|P2|Overall Study|Disease progression|1
5605367|NCT00866788|19364468|P1|Overall Study|Disease progression|3
5605368|NCT00866788|19364465|P4|Overall Study|Pregnancy|0
5605369|NCT00866788|19364466|P3|Overall Study|Pregnancy|0
5605370|NCT00866788|19364467|P2|Overall Study|Pregnancy|1
5605371|NCT00866788|19364468|P1|Overall Study|Pregnancy|0
5605372|NCT00866788|19364465|P4|Overall Study|Withdrawal by Subject|1
5605373|NCT00866788|19364466|P3|Overall Study|Withdrawal by Subject|0
5605374|NCT00866788|19364467|P2|Overall Study|Withdrawal by Subject|1
5605375|NCT00866788|19364468|P1|Overall Study|Withdrawal by Subject|2
5605376|NCT00866788|19364465|P4|Overall Study|Lost to Follow-up|2
5605377|NCT00866788|19364466|P3|Overall Study|Lost to Follow-up|0
5605378|NCT00866788|19364467|P2|Overall Study|Lost to Follow-up|1
5605379|NCT00866788|19364468|P1|Overall Study|Lost to Follow-up|1
5605380|NCT00866788|19364465|P4|Overall Study|Adverse Event|1
5605381|NCT00866788|19364466|P3|Overall Study|Adverse Event|0
5605382|NCT00866788|19364467|P2|Overall Study|Adverse Event|2
5605383|NCT00866788|19364468|P1|Overall Study|Adverse Event|0
5605384|NCT00866775|19364516|P2|Overall Study|discontinued due to communication error|1
5605385|NCT00866775|19364517|P1|Overall Study|discontinued due to communication error|0
5605386|NCT00866775|19364516|P2|Overall Study|met exit criteria|17
5605387|NCT00866775|19364517|P1|Overall Study|met exit criteria|23
5605388|NCT00866775|19364516|P2|Overall Study|Withdrawal by Subject|4
5605389|NCT00866775|19364517|P1|Overall Study|Withdrawal by Subject|4
5605390|NCT00866775|19364516|P2|Overall Study|Protocol Violation|4
5605391|NCT00866775|19364517|P1|Overall Study|Protocol Violation|3
5605392|NCT00866775|19364516|P2|Overall Study|Physician Decision|3
5605393|NCT00866775|19364517|P1|Overall Study|Physician Decision|0
5605394|NCT00866775|19364516|P2|Overall Study|Lost to Follow-up|4
5605395|NCT00866775|19364517|P1|Overall Study|Lost to Follow-up|0
5605396|NCT00866775|19364516|P2|Overall Study|Death|0
5605397|NCT00866775|19364517|P1|Overall Study|Death|1
5605398|NCT00866775|19364516|P2|Overall Study|Adverse Event|19
5605399|NCT00866775|19364517|P1|Overall Study|Adverse Event|5
5605400|NCT00866723|19364560|P1|Overall Study|Disease Progression|4
5605401|NCT00866723|19364560|P1|Overall Study|Withdrawal by Subject|1
5605402|NCT00866697|19364567|P2|Overall Study|Withdrawal by Subject|57
5605403|NCT00866697|19364568|P1|Overall Study|Withdrawal by Subject|33
5605404|NCT00866697|19364567|P2|Overall Study|Physician Decision|5
5605405|NCT00866697|19364568|P1|Overall Study|Physician Decision|3
5605406|NCT00866697|19364567|P2|Overall Study|Lost to Follow-up|28
5605407|NCT00866697|19364568|P1|Overall Study|Lost to Follow-up|22
5605408|NCT00866697|19364567|P2|Overall Study|Study closed/terminated|138
5605409|NCT00866697|19364568|P1|Overall Study|Study closed/terminated|156
5605410|NCT00866658|19364610|P2|Overall Study|Familial and Personal Reasons|5
5605411|NCT00866658|19364611|P1|Overall Study|Familial and Personal Reasons|4
5605412|NCT00866658|19364610|P2|Overall Study|Protocol Violation|1
5605413|NCT00866658|19364611|P1|Overall Study|Protocol Violation|1
5605414|NCT00866658|19364610|P2|Overall Study|Withdrawal by Subject|0
5605415|NCT00866658|19364611|P1|Overall Study|Withdrawal by Subject|1
5605416|NCT00866658|19364610|P2|Overall Study|Lack of Efficacy|1
5605417|NCT00866658|19364611|P1|Overall Study|Lack of Efficacy|2
5605418|NCT00866658|19364610|P2|Overall Study|Adverse Event|14
5605419|NCT00866658|19364611|P1|Overall Study|Adverse Event|5
5605420|NCT00866619|19364643|P4|Overall Study|Lost to Follow-up|425
5605421|NCT00866619|19364644|P3|Overall Study|Lost to Follow-up|568
5605422|NCT00866619|19364645|P2|Overall Study|Lost to Follow-up|830
5605423|NCT00866619|19364646|P1|Overall Study|Lost to Follow-up|1145
5605424|NCT00866619|19364643|P4|Overall Study|Withdrawal by Subject|144
5605425|NCT00866619|19364644|P3|Overall Study|Withdrawal by Subject|272
5605426|NCT00866619|19364645|P2|Overall Study|Withdrawal by Subject|295
5605427|NCT00866619|19364646|P1|Overall Study|Withdrawal by Subject|587
5605428|NCT00866619|19364643|P4|Overall Study|Protocol Violation|17
5605429|NCT00866619|19364644|P3|Overall Study|Protocol Violation|2
5605430|NCT00866619|19364645|P2|Overall Study|Protocol Violation|39
5605431|NCT00866619|19364646|P1|Overall Study|Protocol Violation|2
5605432|NCT00866619|19364643|P4|Overall Study|Adverse Event|44
5605433|NCT00866619|19364644|P3|Overall Study|Adverse Event|47
5605434|NCT00866619|19364645|P2|Overall Study|Adverse Event|106
5605435|NCT00866619|19364646|P1|Overall Study|Adverse Event|112
5605436|NCT00866606|19364966|P1|Overall Study|Adverse Event|1
5605437|NCT00866606|19364966|P1|Overall Study|Lost to Follow-up|3
5605438|NCT00866359|19364980|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
5605439|NCT00866359|19364981|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
5605440|NCT00866359|19364982|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
5605441|NCT00866359|19364983|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
5605442|NCT00866359|19364980|P4|Treatment Phase (Days 1 to 85)|Other|0
5605443|NCT00866359|19364981|P3|Treatment Phase (Days 1 to 85)|Other|0
5605444|NCT00866359|19364982|P2|Treatment Phase (Days 1 to 85)|Other|0
5605445|NCT00866359|19364983|P1|Treatment Phase (Days 1 to 85)|Other|1
5605446|NCT00866359|19364980|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
5605447|NCT00866359|19364981|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
5605448|NCT00866359|19364982|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
5605449|NCT00866359|19364983|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
5605450|NCT00866359|19364980|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
5605451|NCT00866359|19364981|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
5605452|NCT00866359|19364982|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
5605453|NCT00866359|19364983|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
5605454|NCT00866359|19364980|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
5605455|NCT00866359|19364981|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
5605456|NCT00866359|19364982|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
5605457|NCT00866359|19364983|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
5605458|NCT00866359|19364980|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
5605459|NCT00866359|19364981|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
5605460|NCT00866359|19364982|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
5605461|NCT00866359|19364983|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
5605462|NCT00866333|19365039|P3|Overall Study|Study Terminated by Sponsor|9
5605463|NCT00866333|19365040|P2|Overall Study|Study Terminated by Sponsor|5
5605464|NCT00866333|19365041|P1|Overall Study|Study Terminated by Sponsor|2
5605465|NCT00866333|19365039|P3|Overall Study|Reason not Specified|1
5605466|NCT00866333|19365040|P2|Overall Study|Reason not Specified|1
5605467|NCT00866333|19365041|P1|Overall Study|Reason not Specified|3
5605468|NCT00866333|19365039|P3|Overall Study|Withdrawal of consent|2
5605469|NCT00866333|19365040|P2|Overall Study|Withdrawal of consent|1
5605470|NCT00866333|19365041|P1|Overall Study|Withdrawal of consent|0
5605471|NCT00866320|19365058|P1|Overall Study|Death|2
5605472|NCT00866320|19365058|P1|Overall Study|Withdrawal by Subject|4
5605473|NCT00866307|19365065|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
5605474|NCT00866307|19365066|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
5605475|NCT00866307|19365067|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
5605476|NCT00866307|19365065|P3|Consolidation/Maintenance|Non-compliance|1
5605477|NCT00866307|19365066|P2|Consolidation/Maintenance|Non-compliance|0
5605478|NCT00866307|19365067|P1|Consolidation/Maintenance|Non-compliance|0
5605479|NCT00866307|19365065|P3|Consolidation/Maintenance|Therapy error|0
5605480|NCT00866307|19365066|P2|Consolidation/Maintenance|Therapy error|1
5605481|NCT00866307|19365067|P1|Consolidation/Maintenance|Therapy error|0
5605482|NCT00866307|19365065|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
5605483|NCT00866307|19365066|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
5605484|NCT00866307|19365067|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
5605485|NCT00866307|19365065|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
5605486|NCT00866307|19365066|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
5605487|NCT00866307|19365067|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
5605488|NCT00866307|19365065|P3|Consolidation/Maintenance|Withdrawal by Subject|1
5605489|NCT00866307|19365066|P2|Consolidation/Maintenance|Withdrawal by Subject|1
5605490|NCT00866307|19365067|P1|Consolidation/Maintenance|Withdrawal by Subject|0
5605491|NCT00866307|19365065|P3|Consolidation/Maintenance|Physician Decision|2
5605492|NCT00866307|19365066|P2|Consolidation/Maintenance|Physician Decision|3
5605493|NCT00866307|19365067|P1|Consolidation/Maintenance|Physician Decision|0
5605494|NCT00866307|19365065|P3|Consolidation/Maintenance|Death|1
5605495|NCT00866307|19365066|P2|Consolidation/Maintenance|Death|0
5605496|NCT00866307|19365067|P1|Consolidation/Maintenance|Death|0
5605497|NCT00866307|19365065|P3|Consolidation/Maintenance|Adverse Event|8
5605498|NCT00866307|19365066|P2|Consolidation/Maintenance|Adverse Event|0
5605499|NCT00866307|19365067|P1|Consolidation/Maintenance|Adverse Event|0
5605500|NCT00866307|19365065|P3|Induction|Study was closed at the time|0
5605501|NCT00866307|19365066|P2|Induction|Study was closed at the time|0
5605502|NCT00866307|19365067|P1|Induction|Study was closed at the time|1
5605503|NCT00866307|19365065|P3|Induction|Improper post-induction consent|0
5605504|NCT00866307|19365066|P2|Induction|Improper post-induction consent|0
5605505|NCT00866307|19365067|P1|Induction|Improper post-induction consent|2
5605506|NCT00866307|19365065|P3|Induction|Inadequate cytognetic samples th|0
5605507|NCT00866307|19365066|P2|Induction|Inadequate cytognetic samples th|0
5605508|NCT00866307|19365067|P1|Induction|Inadequate cytognetic samples th|1
5605509|NCT00866307|19365065|P3|Induction|Identification of Patients with Day 29 M|0
5605510|NCT00866307|19365066|P2|Induction|Identification of Patients with Day 29 M|0
5605511|NCT00866307|19365067|P1|Induction|Identification of Patients with Day 29 M|3
5605512|NCT00866307|19365065|P3|Induction|Progressive Disease|0
5605513|NCT00866307|19365066|P2|Induction|Progressive Disease|0
5605514|NCT00866307|19365067|P1|Induction|Progressive Disease|1
5605515|NCT00866307|19365065|P3|Induction|Physician Decision|0
5605516|NCT00866307|19365066|P2|Induction|Physician Decision|0
5605517|NCT00866307|19365067|P1|Induction|Physician Decision|5
5605518|NCT00866307|19365065|P3|Induction|Death|0
5605519|NCT00866307|19365066|P2|Induction|Death|0
5605520|NCT00866307|19365067|P1|Induction|Death|2
5605521|NCT00866307|19365065|P3|Induction|Adverse Event|0
5605522|NCT00866307|19365066|P2|Induction|Adverse Event|0
5605523|NCT00866307|19365067|P1|Induction|Adverse Event|5
5605524|NCT00866294|19365077|P3|Overall Study|Physician Decision|1
5605525|NCT00866294|19365078|P2|Overall Study|Physician Decision|2
5605526|NCT00866294|19365079|P1|Overall Study|Physician Decision|6
5605527|NCT00866294|19365077|P3|Overall Study|Lost to Follow-up|0
5605528|NCT00866294|19365078|P2|Overall Study|Lost to Follow-up|3
5605529|NCT00866294|19365079|P1|Overall Study|Lost to Follow-up|1
5605530|NCT00866294|19365077|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
5605531|NCT00866294|19365078|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
5605532|NCT00866294|19365079|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
5605533|NCT00866294|19365077|P3|Overall Study|Protocol Violation|0
5605534|NCT00866294|19365078|P2|Overall Study|Protocol Violation|0
5605535|NCT00866294|19365079|P1|Overall Study|Protocol Violation|2
5605536|NCT00866294|19365077|P3|Overall Study|Lack of Efficacy|0
5605537|NCT00866294|19365078|P2|Overall Study|Lack of Efficacy|1
5605538|NCT00866294|19365079|P1|Overall Study|Lack of Efficacy|7
5605539|NCT00866294|19365077|P3|Overall Study|Adverse Event|9
5605540|NCT00866294|19365078|P2|Overall Study|Adverse Event|13
5605541|NCT00866294|19365079|P1|Overall Study|Adverse Event|12
5605542|NCT00866281|19365108|P2|Overall Study|New cancer therapy|4
5605543|NCT00866281|19365109|P1|Overall Study|New cancer therapy|0
5605544|NCT00866281|19365108|P2|Overall Study|Disease progression|11
5605545|NCT00866281|19365109|P1|Overall Study|Disease progression|3
5605546|NCT00866281|19365108|P2|Overall Study|Withdrawal by participants|0
5605547|NCT00866281|19365109|P1|Overall Study|Withdrawal by participants|3
5605548|NCT00866281|19365108|P2|Overall Study|Adverse Event|0
5605549|NCT00866281|19365109|P1|Overall Study|Adverse Event|1
5605550|NCT00866177|19365125|P1|Overall Study|Not Treated|151
5605551|NCT00866177|19365125|P1|Overall Study|Withdrawal by Subject|1
5605552|NCT00866047|19365129|P1|Follow-up Period|Lost to Follow-up|5
5605553|NCT00866047|19365129|P1|Treatment Period|Withdrawal by Subject|5
5605554|NCT00866047|19365129|P1|Treatment Period|Physician Decision|14
5605555|NCT00866047|19365129|P1|Treatment Period|Adverse Event|16
5605556|NCT00866047|19365129|P1|Treatment Period|Progressive disease|13
5605557|NCT00865904|19365161|P5|Overall Study|Randomized but not Treated|1
5605558|NCT00865904|19365162|P4|Overall Study|Randomized but not Treated|1
5605559|NCT00865904|19365163|P3|Overall Study|Randomized but not Treated|0
5605560|NCT00865904|19365164|P2|Overall Study|Randomized but not Treated|0
5605561|NCT00865904|19365165|P1|Overall Study|Randomized but not Treated|2
5605562|NCT00865709|19365222|P2|Treatment|Surgery|3
5605563|NCT00865709|19365223|P1|Treatment|Surgery|8
5605564|NCT00865709|19365222|P2|Treatment|Physician Decision|2
5605565|NCT00865709|19365223|P1|Treatment|Physician Decision|3
5605566|NCT00865709|19365222|P2|Treatment|Withdrawal by Subject|7
5605567|NCT00865709|19365223|P1|Treatment|Withdrawal by Subject|10
5605568|NCT00865709|19365222|P2|Treatment|Adverse Event|6
5605569|NCT00865709|19365223|P1|Treatment|Adverse Event|9
5605570|NCT00865566|19365241|P2|Overall Study|HIV infection|7
5605571|NCT00865566|19365242|P1|Overall Study|HIV infection|5
5605572|NCT00865566|19365241|P2|Overall Study|Other; N=245 due to early study closure|139
5605573|NCT00865566|19365242|P1|Overall Study|Other; N=245 due to early study closure|154
5605574|NCT00865566|19365241|P2|Overall Study|Participant unable to adhere|42
5605575|NCT00865566|19365242|P1|Overall Study|Participant unable to adhere|27
5605576|NCT00865566|19365241|P2|Overall Study|Participant relocated|107
5605577|NCT00865566|19365242|P1|Overall Study|Participant relocated|78
5605578|NCT00865566|19365241|P2|Overall Study|Physician Decision|1
5605579|NCT00865566|19365242|P1|Overall Study|Physician Decision|0
5605580|NCT00865566|19365241|P2|Overall Study|Withdrawal by Subject|65
5605581|NCT00865566|19365242|P1|Overall Study|Withdrawal by Subject|45
5605582|NCT00865566|19365241|P2|Overall Study|Lost to Follow-up|315
5605583|NCT00865566|19365242|P1|Overall Study|Lost to Follow-up|314
5605584|NCT00865566|19365241|P2|Overall Study|Death|11
5605585|NCT00865566|19365242|P1|Overall Study|Death|1
5605586|NCT00865514|19365262|P1|Overall Study|Infusion cost exceeded funding|2
5605587|NCT00865345|19365267|P1|Overall Study|Withdrawal by Subject|2
5605588|NCT00865306|19365274|P2|Controlled Trial|Withdrawal by Subject|1
5605589|NCT00865306|19365275|P1|Controlled Trial|Withdrawal by Subject|0
5605590|NCT00865306|19365274|P2|Controlled Trial|Sought treatment for conduct disorder|0
5605591|NCT00865306|19365275|P1|Controlled Trial|Sought treatment for conduct disorder|1
5605592|NCT00865306|19365274|P2|Controlled Trial|Improved btw baseline and first session|0
5605593|NCT00865306|19365275|P1|Controlled Trial|Improved btw baseline and first session|1
5605594|NCT00865306|19365274|P2|Controlled Trial|Difficulty commuting|0
5605595|NCT00865306|19365275|P1|Controlled Trial|Difficulty commuting|2
5605596|NCT00865306|19365274|P2|Controlled Trial|Lost to Follow-up|1
5605597|NCT00865306|19365275|P1|Controlled Trial|Lost to Follow-up|1
5605598|NCT00865189|19365304|P2|Overall Study|Withdrawal by Subject|0
5605599|NCT00865189|19365305|P1|Overall Study|Withdrawal by Subject|1
5605600|NCT00865189|19365304|P2|Overall Study|Lost to Follow-up|6
5605601|NCT00865189|19365305|P1|Overall Study|Lost to Follow-up|6
5605602|NCT00865189|19365304|P2|Overall Study|Death|11
5605603|NCT00865189|19365305|P1|Overall Study|Death|4
5605604|NCT00865189|19365304|P2|Overall Study|Other|2
5605605|NCT00865189|19365305|P1|Overall Study|Other|1
5605606|NCT00865124|19365333|P3|Overall Study|Withdrawn consent|0
5605607|NCT00865124|19365334|P2|Overall Study|Withdrawn consent|0
5605608|NCT00865124|19365335|P1|Overall Study|Withdrawn consent|2
5605609|NCT00865124|19365333|P3|Overall Study|Physician Decision|0
5605610|NCT00865124|19365334|P2|Overall Study|Physician Decision|1
5605611|NCT00865124|19365335|P1|Overall Study|Physician Decision|2
5605612|NCT00865098|19365352|P1|Overall Study|Progressive disease|1
5605613|NCT00865046|19365364|P3|Overall Study|Withdrawal by Subject|0
5605614|NCT00865046|19365365|P2|Overall Study|Withdrawal by Subject|0
5605615|NCT00865046|19365366|P1|Overall Study|Withdrawal by Subject|5
5605616|NCT00865046|19365364|P3|Overall Study|Death|1
5605617|NCT00865046|19365365|P2|Overall Study|Death|1
5605618|NCT00865046|19365366|P1|Overall Study|Death|0
5605619|NCT00865046|19365364|P3|Overall Study|Lost to Follow-up|0
5605620|NCT00865046|19365365|P2|Overall Study|Lost to Follow-up|4
5605621|NCT00865046|19365366|P1|Overall Study|Lost to Follow-up|1
5605622|NCT00865020|19365376|P2|Overall Study|Randomized but discontinued|4
5605623|NCT00865020|19365377|P1|Overall Study|Randomized but discontinued|2
5605624|NCT00865020|19365376|P2|Overall Study|Death|1
5605625|NCT00865020|19365377|P1|Overall Study|Death|0
5605626|NCT00865020|19365376|P2|Overall Study|Abnormal laboratory value(s)|1
5605627|NCT00865020|19365377|P1|Overall Study|Abnormal laboratory value(s)|0
5605628|NCT00865020|19365376|P2|Overall Study|Administrative problems|2
5605629|NCT00865020|19365377|P1|Overall Study|Administrative problems|0
5605630|NCT00865020|19365376|P2|Overall Study|Protocol deviation|1
5605631|NCT00865020|19365377|P1|Overall Study|Protocol deviation|4
5605632|NCT00865020|19365376|P2|Overall Study|Lost to Follow-up|4
5605633|NCT00865020|19365377|P1|Overall Study|Lost to Follow-up|6
5605634|NCT00865020|19365376|P2|Overall Study|Abnormal test procedure result(s)|8
5605635|NCT00865020|19365377|P1|Overall Study|Abnormal test procedure result(s)|6
5605636|NCT00865020|19365376|P2|Overall Study|Adverse Event|14
5605637|NCT00865020|19365377|P1|Overall Study|Adverse Event|9
5605638|NCT00865020|19365376|P2|Overall Study|Withdrawal by Subject|16
5605639|NCT00865020|19365377|P1|Overall Study|Withdrawal by Subject|22
5605640|NCT00864916|19365393|P2|Overall Study|Withdrawal by Subject|0
5605641|NCT00864916|19365394|P1|Overall Study|Withdrawal by Subject|1
5605642|NCT00864916|19365393|P2|Overall Study|Protocol Violation|0
5605643|NCT00864916|19365394|P1|Overall Study|Protocol Violation|1
5605644|NCT00864916|19365393|P2|Overall Study|Lost to Follow-up|4
5605645|NCT00864916|19365394|P1|Overall Study|Lost to Follow-up|4
5605646|NCT00864851|19365403|P3|Overall Study|Patient uncooperative|0
5605647|NCT00864851|19365404|P2|Overall Study|Patient uncooperative|0
5605648|NCT00864851|19365405|P1|Overall Study|Patient uncooperative|1
5605649|NCT00864851|19365403|P3|Overall Study|Death|0
5605650|NCT00864851|19365404|P2|Overall Study|Death|0
5605651|NCT00864851|19365405|P1|Overall Study|Death|1
5605652|NCT00864851|19365403|P3|Overall Study|Physician Decision|0
5605653|NCT00864851|19365404|P2|Overall Study|Physician Decision|0
5605654|NCT00864851|19365405|P1|Overall Study|Physician Decision|1
5605655|NCT00864851|19365403|P3|Overall Study|Withdrawal by Subject|0
5605656|NCT00864851|19365404|P2|Overall Study|Withdrawal by Subject|1
5605657|NCT00864851|19365405|P1|Overall Study|Withdrawal by Subject|0
5605658|NCT00864721|19365439|P1|Overall Study|Adverse Event|21
5605659|NCT00864721|19365439|P1|Overall Study|Drug hold/delay more than 4 weeks|1
5605660|NCT00864721|19365439|P1|Overall Study|Hospitalized|1
5605661|NCT00864721|19365439|P1|Overall Study|Patient request|11
5605662|NCT00864682|19365459|P3|Overall Study|Protocol Violation|2
5605663|NCT00864682|19365460|P2|Overall Study|Protocol Violation|1
5605664|NCT00864682|19365461|P1|Overall Study|Protocol Violation|2
5605665|NCT00864513|19365500|P1|Overall Study|Withdrawal by Subject|3
5605666|NCT00864253|19365584|P2|Overall Study|Untreated|7
5605667|NCT00864253|19365585|P1|Overall Study|Untreated|7
5605668|NCT00864253|19365584|P2|Overall Study|Ongoing|3
5605669|NCT00864253|19365585|P1|Overall Study|Ongoing|2
5605670|NCT00864253|19365584|P2|Overall Study|Death|0
5605671|NCT00864253|19365585|P1|Overall Study|Death|1
5605672|NCT00864253|19365584|P2|Overall Study|Withdrawal by Subject|18
5605673|NCT00864253|19365585|P1|Overall Study|Withdrawal by Subject|18
5605674|NCT00864253|19365584|P2|Overall Study|Lost to Follow-up|1
5605675|NCT00864253|19365585|P1|Overall Study|Lost to Follow-up|1
5605676|NCT00864253|19365584|P2|Overall Study|Protocol Violation|2
5605677|NCT00864253|19365585|P1|Overall Study|Protocol Violation|0
5605678|NCT00864253|19365584|P2|Overall Study|Physician Decision|15
5605679|NCT00864253|19365585|P1|Overall Study|Physician Decision|11
5605680|NCT00864253|19365584|P2|Overall Study|Unrelated Adverse Event|1
5605681|NCT00864253|19365585|P1|Overall Study|Unrelated Adverse Event|3
5605682|NCT00864253|19365584|P2|Overall Study|Adverse Event|11
5605683|NCT00864253|19365585|P1|Overall Study|Adverse Event|56
5605684|NCT00864227|19365615|P1|Overall Study|Disease Relapse/Progression|3
5605685|NCT00864227|19365615|P1|Overall Study|Withdrawal by Subject|1
5605686|NCT00863928|19365676|P2|Overall Study|medication allergy|0
5605687|NCT00863928|19365677|P1|Overall Study|medication allergy|3
5605688|NCT00863928|19365676|P2|Overall Study|surgery cancellation|0
5605689|NCT00863928|19365677|P1|Overall Study|surgery cancellation|4
5605690|NCT00863928|19365676|P2|Overall Study|Withdrawal by Subject|0
5605691|NCT00863928|19365677|P1|Overall Study|Withdrawal by Subject|3
5605692|NCT00863928|19365676|P2|Overall Study|Protocol Violation|0
5605693|NCT00863928|19365677|P1|Overall Study|Protocol Violation|26
5605694|NCT00863798|19365686|P3|Overall Study|Randomized not treated|3
5605695|NCT00863798|19365687|P2|Overall Study|Randomized not treated|2
5605696|NCT00863798|19365688|P1|Overall Study|Randomized not treated|4
5605697|NCT00863798|19365686|P3|Overall Study|Withdrawal by Subject|4
5605698|NCT00863798|19365687|P2|Overall Study|Withdrawal by Subject|7
5605699|NCT00863798|19365688|P1|Overall Study|Withdrawal by Subject|8
5605700|NCT00863798|19365686|P3|Overall Study|Protocol Violation|1
5605701|NCT00863798|19365687|P2|Overall Study|Protocol Violation|1
5605702|NCT00863798|19365688|P1|Overall Study|Protocol Violation|0
5605703|NCT00863798|19365686|P3|Overall Study|Other|1
5605704|NCT00863798|19365687|P2|Overall Study|Other|3
5605705|NCT00863798|19365688|P1|Overall Study|Other|2
5605706|NCT00863798|19365686|P3|Overall Study|Lost to Follow-up|5
5605707|NCT00863798|19365687|P2|Overall Study|Lost to Follow-up|9
5605708|NCT00863798|19365688|P1|Overall Study|Lost to Follow-up|6
5605709|NCT00863798|19365686|P3|Overall Study|Lack of Efficacy|6
5605710|NCT00863798|19365687|P2|Overall Study|Lack of Efficacy|3
5605711|NCT00863798|19365688|P1|Overall Study|Lack of Efficacy|4
5605712|NCT00863798|19365686|P3|Overall Study|Investigator request|1
5605713|NCT00863798|19365687|P2|Overall Study|Investigator request|2
5605714|NCT00863798|19365688|P1|Overall Study|Investigator request|1
5605715|NCT00863798|19365686|P3|Overall Study|Participant failed to return|0
5605716|NCT00863798|19365687|P2|Overall Study|Participant failed to return|1
5605717|NCT00863798|19365688|P1|Overall Study|Participant failed to return|2
5605718|NCT00863798|19365686|P3|Overall Study|Adverse Event|4
5605719|NCT00863798|19365687|P2|Overall Study|Adverse Event|2
5605720|NCT00863798|19365688|P1|Overall Study|Adverse Event|5
5605721|NCT00863746|19365740|P2|Survival Follow up|Consent Withdrawn|8
5605722|NCT00863746|19365741|P1|Survival Follow up|Consent Withdrawn|7
5605723|NCT00863746|19365740|P2|Survival Follow up|Lost to Follow-up|1
5605724|NCT00863746|19365741|P1|Survival Follow up|Lost to Follow-up|2
5605725|NCT00863746|19365740|P2|Survival Follow up|Death|271
5605726|NCT00863746|19365741|P1|Survival Follow up|Death|244
5605727|NCT00863746|19365740|P2|Treatment|Other|0
5605728|NCT00863746|19365741|P1|Treatment|Other|1
5605729|NCT00863746|19365740|P2|Treatment|Protocol Violation|3
5605730|NCT00863746|19365741|P1|Treatment|Protocol Violation|5
5605731|NCT00863746|19365740|P2|Treatment|Lost to Follow-up|0
5605732|NCT00863746|19365741|P1|Treatment|Lost to Follow-up|1
5605733|NCT00863746|19365740|P2|Treatment|Consent withdrawn|14
5605734|NCT00863746|19365741|P1|Treatment|Consent withdrawn|15
5605735|NCT00863746|19365740|P2|Treatment|non-compliant with study medication|0
5605736|NCT00863746|19365741|P1|Treatment|non-compliant with study medication|4
5605737|NCT00863746|19365740|P2|Treatment|Adverse Event|16
5605738|NCT00863746|19365741|P1|Treatment|Adverse Event|41
5605739|NCT00863746|19365740|P2|Treatment|Not treated|2
5605740|NCT00863746|19365741|P1|Treatment|Not treated|4
5605741|NCT00863707|19365767|P2|Overall Study|Randomized, but drug not received|3
5605742|NCT00863707|19365768|P1|Overall Study|Randomized, but drug not received|4
5605743|NCT00863681|19365777|P3|Overall Study|Non-compliance with study drug|0
5605744|NCT00863681|19365778|P2|Overall Study|Non-compliance with study drug|3
5605745|NCT00863681|19365779|P1|Overall Study|Non-compliance with study drug|1
5605746|NCT00863681|19365777|P3|Overall Study|Lack of Efficacy|1
5605747|NCT00863681|19365778|P2|Overall Study|Lack of Efficacy|2
5605748|NCT00863681|19365779|P1|Overall Study|Lack of Efficacy|2
5605749|NCT00863681|19365777|P3|Overall Study|Adverse Event|6
5605750|NCT00863681|19365778|P2|Overall Study|Adverse Event|10
5605751|NCT00863681|19365779|P1|Overall Study|Adverse Event|28
5605752|NCT00863681|19365777|P3|Overall Study|Lost to Follow-up|3
5605753|NCT00863681|19365778|P2|Overall Study|Lost to Follow-up|0
5605754|NCT00863681|19365779|P1|Overall Study|Lost to Follow-up|3
5605755|NCT00863681|19365777|P3|Overall Study|Protocol Violation|0
5605756|NCT00863681|19365778|P2|Overall Study|Protocol Violation|0
5605757|NCT00863681|19365779|P1|Overall Study|Protocol Violation|2
5605758|NCT00863681|19365777|P3|Overall Study|Withdrawal by Subject|2
5605759|NCT00863681|19365778|P2|Overall Study|Withdrawal by Subject|5
5605760|NCT00863681|19365779|P1|Overall Study|Withdrawal by Subject|12
5605761|NCT00863681|19365777|P3|Overall Study|Death|6
5605762|NCT00863681|19365778|P2|Overall Study|Death|23
5605763|NCT00863681|19365779|P1|Overall Study|Death|40
5605764|NCT00863681|19365777|P3|Overall Study|Missing|0
5605765|NCT00863681|19365778|P2|Overall Study|Missing|0
5605766|NCT00863681|19365779|P1|Overall Study|Missing|1
5605767|NCT00863681|19365777|P3|Overall Study|Other|0
5605768|NCT00863681|19365778|P2|Overall Study|Other|0
5605769|NCT00863681|19365779|P1|Overall Study|Other|2
5605770|NCT00863655|19365864|P2|Overall Study|Treatment completed as per protocol|1
5605771|NCT00863655|19365865|P1|Overall Study|Treatment completed as per protocol|5
5605772|NCT00863655|19365864|P2|Overall Study|Disease progression|221
5605773|NCT00863655|19365865|P1|Overall Study|Disease progression|364
5605774|NCT00863655|19365864|P2|Overall Study|New cancer therapy|1
5605775|NCT00863655|19365865|P1|Overall Study|New cancer therapy|5
5605776|NCT00863655|19365864|P2|Overall Study|Death|1
5605777|NCT00863655|19365865|P1|Overall Study|Death|7
5605778|NCT00863655|19365864|P2|Overall Study|Administrative problems|0
5605779|NCT00863655|19365865|P1|Overall Study|Administrative problems|1
5605780|NCT00863655|19365864|P2|Overall Study|Withdrawal by Subject|7
5605781|NCT00863655|19365865|P1|Overall Study|Withdrawal by Subject|47
5605782|NCT00863655|19365864|P2|Overall Study|Adverse Event|8
5605783|NCT00863655|19365865|P1|Overall Study|Adverse Event|52
5605784|NCT00863655|19365864|P2|Overall Study|Protocol Violation|0
5605785|NCT00863655|19365865|P1|Overall Study|Protocol Violation|4
5605786|NCT00863512|19365902|P2|Overall Study|Physician Decision|0
5605787|NCT00863512|19365903|P1|Overall Study|Physician Decision|1
5605788|NCT00863512|19365902|P2|Overall Study|Withdrawal by Subject|0
5605789|NCT00863512|19365903|P1|Overall Study|Withdrawal by Subject|11
5605790|NCT00863512|19365902|P2|Overall Study|Adverse Event|0
5605791|NCT00863512|19365903|P1|Overall Study|Adverse Event|2
5605792|NCT00863330|19365934|P1|Overall Study|study terminated early due to administra|6
5605793|NCT00863317|19365940|P2|Overall Study|Lost to Follow-up|9
5605794|NCT00863317|19365941|P1|Overall Study|Lost to Follow-up|8
5605795|NCT00863057|19365997|P4|Period 2 (Weeks 6-10)|Physician Decision|1
5605796|NCT00863057|19365998|P3|Period 2 (Weeks 6-10)|Physician Decision|0
5605797|NCT00863057|19365999|P2|Period 2 (Weeks 6-10)|Physician Decision|0
5605798|NCT00863057|19366000|P1|Period 2 (Weeks 6-10)|Physician Decision|0
5605799|NCT00863057|19365997|P4|Period 2 (Weeks 6-10)|Adverse Event|0
5605800|NCT00863057|19365998|P3|Period 2 (Weeks 6-10)|Adverse Event|1
5605801|NCT00863057|19365999|P2|Period 2 (Weeks 6-10)|Adverse Event|1
5605802|NCT00863057|19366000|P1|Period 2 (Weeks 6-10)|Adverse Event|0
5605803|NCT00863057|19365997|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
5605804|NCT00863057|19365998|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
5605805|NCT00863057|19365999|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
5605806|NCT00863057|19366000|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
5605807|NCT00863057|19365997|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
5605808|NCT00863057|19365998|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
5605809|NCT00863057|19365999|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
5605810|NCT00863057|19366000|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
5605811|NCT00862979|19366058|P2|Overall Study|Death|1
5605812|NCT00862979|19366059|P1|Overall Study|Death|0
5605813|NCT00862979|19366058|P2|Overall Study|Administrative problems|1
5605814|NCT00862979|19366059|P1|Overall Study|Administrative problems|0
5605815|NCT00862979|19366058|P2|Overall Study|Patient withdrew consent|1
5605816|NCT00862979|19366059|P1|Overall Study|Patient withdrew consent|2
5605817|NCT00862979|19366058|P2|Overall Study|Protocol Violation|1
5605818|NCT00862979|19366059|P1|Overall Study|Protocol Violation|0
5605819|NCT00862979|19366058|P2|Overall Study|Adverse Event|3
5605820|NCT00862979|19366059|P1|Overall Study|Adverse Event|6
5605821|NCT00862940|19366077|P2|Overall Study|Administrative or other reason(s)|3
5605822|NCT00862940|19366078|P1|Overall Study|Administrative or other reason(s)|4
5605823|NCT00862940|19366077|P2|Overall Study|Lost to Follow-up|1
5605824|NCT00862940|19366078|P1|Overall Study|Lost to Follow-up|0
5605825|NCT00862940|19366077|P2|Overall Study|Non-compliance|0
5605826|NCT00862940|19366078|P1|Overall Study|Non-compliance|4
5605827|NCT00862940|19366077|P2|Overall Study|Withdrawal by Subject|6
5605828|NCT00862940|19366078|P1|Overall Study|Withdrawal by Subject|4
5605829|NCT00862940|19366077|P2|Overall Study|Protocol Violation|5
5605830|NCT00862940|19366078|P1|Overall Study|Protocol Violation|2
5605831|NCT00862940|19366077|P2|Overall Study|Lack of Efficacy|3
5605832|NCT00862940|19366078|P1|Overall Study|Lack of Efficacy|1
5605833|NCT00862940|19366077|P2|Overall Study|Adverse Event|12
5605834|NCT00862940|19366078|P1|Overall Study|Adverse Event|15
5605835|NCT00862849|19366090|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
5605836|NCT00862849|19366091|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
5605837|NCT00862849|19366092|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
5605838|NCT00862849|19366093|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
5605839|NCT00862849|19366094|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
5605840|NCT00862849|19366095|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
5605841|NCT00862849|19366090|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5605842|NCT00862849|19366091|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5605843|NCT00862849|19366092|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5605844|NCT00862849|19366093|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5605845|NCT00862849|19366094|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
5605846|NCT00862849|19366095|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
5605847|NCT00862836|19366118|P1|Overall Study|Withdrawal by Subject|1
5605848|NCT00862823|19366129|P2|First Intervention|Withdrawal by Subject|1
5605849|NCT00862823|19366130|P1|First Intervention|Withdrawal by Subject|1
5605850|NCT00862719|19366179|P4|Overall Study|Veno-Occlusive Disease|0
5605851|NCT00862719|19366180|P3|Overall Study|Veno-Occlusive Disease|1
5605852|NCT00862719|19366181|P2|Overall Study|Veno-Occlusive Disease|0
5605853|NCT00862719|19366182|P1|Overall Study|Veno-Occlusive Disease|0
5605854|NCT00862719|19366179|P4|Overall Study|Engraftment failure|0
5605855|NCT00862719|19366180|P3|Overall Study|Engraftment failure|1
5605856|NCT00862719|19366181|P2|Overall Study|Engraftment failure|0
5605857|NCT00862719|19366182|P1|Overall Study|Engraftment failure|0
5605858|NCT00862719|19366179|P4|Overall Study|Death|1
5605859|NCT00862719|19366180|P3|Overall Study|Death|1
5605860|NCT00862719|19366181|P2|Overall Study|Death|6
5605861|NCT00862719|19366182|P1|Overall Study|Death|5
5605862|NCT00862719|19366179|P4|Overall Study|Disease Progression|0
5605863|NCT00862719|19366180|P3|Overall Study|Disease Progression|1
5605864|NCT00862719|19366181|P2|Overall Study|Disease Progression|0
5605865|NCT00862719|19366182|P1|Overall Study|Disease Progression|5
5605866|NCT00862654|19366205|P4|Overall Study|Included after end of inclusions|0
5605867|NCT00862654|19366206|P3|Overall Study|Included after end of inclusions|1
5605868|NCT00862654|19366207|P2|Overall Study|Included after end of inclusions|0
5605869|NCT00862654|19366208|P1|Overall Study|Included after end of inclusions|0
5605870|NCT00862654|19366205|P4|Overall Study|Never used study drugs|0
5605871|NCT00862654|19366206|P3|Overall Study|Never used study drugs|0
5605872|NCT00862654|19366207|P2|Overall Study|Never used study drugs|0
5605873|NCT00862654|19366208|P1|Overall Study|Never used study drugs|1
5605874|NCT00862654|19366205|P4|Overall Study|Familly constraint|0
5605875|NCT00862654|19366206|P3|Overall Study|Familly constraint|0
5605876|NCT00862654|19366207|P2|Overall Study|Familly constraint|1
5605877|NCT00862654|19366208|P1|Overall Study|Familly constraint|0
5605878|NCT00862654|19366205|P4|Overall Study|Subject mistake|0
5605879|NCT00862654|19366206|P3|Overall Study|Subject mistake|0
5605880|NCT00862654|19366207|P2|Overall Study|Subject mistake|1
5605881|NCT00862654|19366208|P1|Overall Study|Subject mistake|0
5605882|NCT00862654|19366205|P4|Overall Study|Withdrawal by Subject|3
5605883|NCT00862654|19366206|P3|Overall Study|Withdrawal by Subject|2
5605884|NCT00862654|19366207|P2|Overall Study|Withdrawal by Subject|2
5605885|NCT00862654|19366208|P1|Overall Study|Withdrawal by Subject|2
5605886|NCT00862654|19366205|P4|Overall Study|Pregnancy|0
5605887|NCT00862654|19366206|P3|Overall Study|Pregnancy|0
5605888|NCT00862654|19366207|P2|Overall Study|Pregnancy|1
5605889|NCT00862654|19366208|P1|Overall Study|Pregnancy|1
5605890|NCT00862654|19366205|P4|Overall Study|Adverse Event|0
5605891|NCT00862654|19366206|P3|Overall Study|Adverse Event|1
5605892|NCT00862654|19366207|P2|Overall Study|Adverse Event|1
5605893|NCT00862654|19366208|P1|Overall Study|Adverse Event|0
5605894|NCT00862654|19366205|P4|Overall Study|Lost to Follow-up|3
5605895|NCT00862654|19366206|P3|Overall Study|Lost to Follow-up|1
5605896|NCT00862654|19366207|P2|Overall Study|Lost to Follow-up|2
5605897|NCT00862654|19366208|P1|Overall Study|Lost to Follow-up|1
5605898|NCT00862654|19366205|P4|Overall Study|Lack of Efficacy|0
5605899|NCT00862654|19366206|P3|Overall Study|Lack of Efficacy|1
5605900|NCT00862654|19366207|P2|Overall Study|Lack of Efficacy|0
5605901|NCT00862654|19366208|P1|Overall Study|Lack of Efficacy|1
5605902|NCT00862641|19366222|P4|Overall Study|Randomized, but drug not received|4
5605903|NCT00862641|19366223|P3|Overall Study|Randomized, but drug not received|1
5605904|NCT00862641|19366224|P2|Overall Study|Randomized, but drug not received|4
5605905|NCT00862641|19366225|P1|Overall Study|Randomized, but drug not received|1
5605906|NCT00862459|19366319|P3|Overall Study|Administrative problems|0
5605907|NCT00862459|19366320|P2|Overall Study|Administrative problems|1
5605908|NCT00862459|19366321|P1|Overall Study|Administrative problems|0
5605909|NCT00862459|19366319|P3|Overall Study|Inclusion/exclusion criteria not met|0
5605910|NCT00862459|19366320|P2|Overall Study|Inclusion/exclusion criteria not met|1
5605911|NCT00862459|19366321|P1|Overall Study|Inclusion/exclusion criteria not met|0
5605912|NCT00862459|19366319|P3|Overall Study|Unable to hold still for imaging|0
5605913|NCT00862459|19366320|P2|Overall Study|Unable to hold still for imaging|1
5605914|NCT00862459|19366321|P1|Overall Study|Unable to hold still for imaging|0
5605915|NCT00862459|19366319|P3|Overall Study|Intravenous (IV) site problems|1
5605916|NCT00862459|19366320|P2|Overall Study|Intravenous (IV) site problems|0
5605917|NCT00862459|19366321|P1|Overall Study|Intravenous (IV) site problems|1
5605918|NCT00862459|19366319|P3|Overall Study|Operation|0
5605919|NCT00862459|19366320|P2|Overall Study|Operation|1
5605920|NCT00862459|19366321|P1|Overall Study|Operation|1
5605921|NCT00862459|19366319|P3|Overall Study|Personal reasons|0
5605922|NCT00862459|19366320|P2|Overall Study|Personal reasons|0
5605923|NCT00862459|19366321|P1|Overall Study|Personal reasons|1
5605924|NCT00862459|19366319|P3|Overall Study|Adverse Event|0
5605925|NCT00862459|19366320|P2|Overall Study|Adverse Event|1
5605926|NCT00862459|19366321|P1|Overall Study|Adverse Event|0
5605927|NCT00862459|19366319|P3|Overall Study|Withdrawal by Subject|3
5605928|NCT00862459|19366320|P2|Overall Study|Withdrawal by Subject|1
5605929|NCT00862459|19366321|P1|Overall Study|Withdrawal by Subject|1
5605930|NCT00862459|19366319|P3|Overall Study|Protocol Violation|0
5605931|NCT00862459|19366320|P2|Overall Study|Protocol Violation|0
5605932|NCT00862459|19366321|P1|Overall Study|Protocol Violation|1
5605933|NCT00862459|19366319|P3|Overall Study|Lost to Follow-up|2
5605934|NCT00862459|19366320|P2|Overall Study|Lost to Follow-up|2
5605935|NCT00862459|19366321|P1|Overall Study|Lost to Follow-up|1
5605936|NCT00862277|19366472|P3|Overall Study|Protocol Violation|5
5605937|NCT00862277|19366473|P2|Overall Study|Protocol Violation|2
5605938|NCT00862277|19366474|P1|Overall Study|Protocol Violation|1
5605939|NCT00862251|19366488|P3|Overall Study|Withdrawal by Subject|6
5605940|NCT00862251|19366489|P2|Overall Study|Withdrawal by Subject|2
5605941|NCT00862251|19366490|P1|Overall Study|Withdrawal by Subject|9
5605942|NCT00862251|19366488|P3|Overall Study|Protocol Violation|1
5605943|NCT00862251|19366489|P2|Overall Study|Protocol Violation|0
5605944|NCT00862251|19366490|P1|Overall Study|Protocol Violation|2
5605945|NCT00862251|19366488|P3|Overall Study|Lost to Follow-up|1
5605946|NCT00862251|19366489|P2|Overall Study|Lost to Follow-up|0
5605947|NCT00862251|19366490|P1|Overall Study|Lost to Follow-up|0
5605948|NCT00862251|19366488|P3|Overall Study|Adverse Event|1
5605949|NCT00862251|19366489|P2|Overall Study|Adverse Event|3
5605950|NCT00862251|19366490|P1|Overall Study|Adverse Event|8
5605951|NCT00862134|19366550|P2|Overall Study|Withdrew prior to dosing|0
5605952|NCT00862134|19366551|P1|Overall Study|Withdrew prior to dosing|2
5605953|NCT00862134|19366550|P2|Overall Study|Adverse Event|2
5605954|NCT00862134|19366551|P1|Overall Study|Adverse Event|2
5605955|NCT00862134|19366550|P2|Overall Study|Sponsor terminated study|7
5605956|NCT00862134|19366551|P1|Overall Study|Sponsor terminated study|5
5605957|NCT00862134|19366550|P2|Overall Study|Withdrawal by Subject|2
5605958|NCT00862134|19366551|P1|Overall Study|Withdrawal by Subject|1
5605959|NCT00862134|19366550|P2|Overall Study|Physician Decision|1
5605960|NCT00862134|19366551|P1|Overall Study|Physician Decision|0
5605961|NCT00862134|19366550|P2|Overall Study|Death|0
5605962|NCT00862134|19366551|P1|Overall Study|Death|1
5605963|NCT00862121|19366563|P2|Overall Study|Incorrect randomisation|1
5605964|NCT00862121|19366564|P1|Overall Study|Incorrect randomisation|0
5605965|NCT00862121|19366563|P2|Overall Study|Exclusion criterion violation|1
5605966|NCT00862121|19366564|P1|Overall Study|Exclusion criterion violation|0
5605967|NCT00862121|19366563|P2|Overall Study|Protocol Violation|1
5605968|NCT00862121|19366564|P1|Overall Study|Protocol Violation|0
5605969|NCT00862121|19366563|P2|Overall Study|Lack of Efficacy|3
5605970|NCT00862121|19366564|P1|Overall Study|Lack of Efficacy|0
5605971|NCT00862121|19366563|P2|Overall Study|Adverse Event|2
5605972|NCT00862121|19366564|P1|Overall Study|Adverse Event|1
5605973|NCT00862082|19366582|P2|Overall Study|Withdrawal by Subject|1
5605974|NCT00862082|19366583|P1|Overall Study|Withdrawal by Subject|0
5605975|NCT00862082|19366582|P2|Overall Study|Sponsor decision to terminate the study|0
5605976|NCT00862082|19366583|P1|Overall Study|Sponsor decision to terminate the study|5
5605977|NCT00861757|19366638|P4|Overall Study|Withdrawal by Subject|2
5605978|NCT00861757|19366639|P3|Overall Study|Withdrawal by Subject|5
5605979|NCT00861757|19366640|P2|Overall Study|Withdrawal by Subject|5
5605980|NCT00861757|19366641|P1|Overall Study|Withdrawal by Subject|1
5605981|NCT00861757|19366638|P4|Overall Study|Protocol Violation|1
5605982|NCT00861757|19366639|P3|Overall Study|Protocol Violation|4
5605983|NCT00861757|19366640|P2|Overall Study|Protocol Violation|2
5605984|NCT00861757|19366641|P1|Overall Study|Protocol Violation|2
5605985|NCT00861757|19366638|P4|Overall Study|Physician Decision|1
5605986|NCT00861757|19366639|P3|Overall Study|Physician Decision|0
5605987|NCT00861757|19366640|P2|Overall Study|Physician Decision|0
5605988|NCT00861757|19366641|P1|Overall Study|Physician Decision|0
5605989|NCT00861757|19366638|P4|Overall Study|Lost to Follow-up|1
5605990|NCT00861757|19366639|P3|Overall Study|Lost to Follow-up|1
5605991|NCT00861757|19366640|P2|Overall Study|Lost to Follow-up|0
5605992|NCT00861757|19366641|P1|Overall Study|Lost to Follow-up|1
5605993|NCT00861757|19366638|P4|Overall Study|Lack of Efficacy|1
5605994|NCT00861757|19366639|P3|Overall Study|Lack of Efficacy|0
5605995|NCT00861757|19366640|P2|Overall Study|Lack of Efficacy|1
5605996|NCT00861757|19366641|P1|Overall Study|Lack of Efficacy|3
5605997|NCT00861757|19366638|P4|Overall Study|Entry Criteria Not Met|1
5605998|NCT00861757|19366639|P3|Overall Study|Entry Criteria Not Met|1
5605999|NCT00861757|19366640|P2|Overall Study|Entry Criteria Not Met|2
5606000|NCT00861757|19366641|P1|Overall Study|Entry Criteria Not Met|1
5606001|NCT00861757|19366638|P4|Overall Study|Adverse Event|2
5606002|NCT00861757|19366639|P3|Overall Study|Adverse Event|7
5606003|NCT00861757|19366640|P2|Overall Study|Adverse Event|5
5606004|NCT00861757|19366641|P1|Overall Study|Adverse Event|1
5606005|NCT00861744|19366699|P4|Overall Study|Blood draws|1
5606006|NCT00861744|19366700|P3|Overall Study|Blood draws|0
5606007|NCT00861744|19366701|P2|Overall Study|Blood draws|0
5606008|NCT00861744|19366702|P1|Overall Study|Blood draws|0
5606009|NCT00861744|19366699|P4|Overall Study|Migration from study area|0
5606010|NCT00861744|19366700|P3|Overall Study|Migration from study area|1
5606011|NCT00861744|19366701|P2|Overall Study|Migration from study area|3
5606012|NCT00861744|19366702|P1|Overall Study|Migration from study area|0
5606013|NCT00861744|19366699|P4|Overall Study|Protocol Violation|0
5606014|NCT00861744|19366700|P3|Overall Study|Protocol Violation|0
5606015|NCT00861744|19366701|P2|Overall Study|Protocol Violation|1
5606016|NCT00861744|19366702|P1|Overall Study|Protocol Violation|0
5606017|NCT00861744|19366699|P4|Overall Study|Withdrawal by Subject|19
5606018|NCT00861744|19366700|P3|Overall Study|Withdrawal by Subject|6
5606019|NCT00861744|19366701|P2|Overall Study|Withdrawal by Subject|6
5606020|NCT00861744|19366702|P1|Overall Study|Withdrawal by Subject|10
5606021|NCT00861744|19366699|P4|Overall Study|Lost to Follow-up|12
5606022|NCT00861744|19366700|P3|Overall Study|Lost to Follow-up|17
5606023|NCT00861744|19366701|P2|Overall Study|Lost to Follow-up|19
5606024|NCT00861744|19366702|P1|Overall Study|Lost to Follow-up|7
5606025|NCT00861744|19366699|P4|Overall Study|Adverse Event|1
5606026|NCT00861744|19366700|P3|Overall Study|Adverse Event|0
5606027|NCT00861744|19366701|P2|Overall Study|Adverse Event|0
5606028|NCT00861744|19366702|P1|Overall Study|Adverse Event|0
5606029|NCT00861705|19366884|P4|Overall Study|Never Began Treatment|1
5606030|NCT00861705|19366885|P3|Overall Study|Never Began Treatment|0
5606031|NCT00861705|19366886|P2|Overall Study|Never Began Treatment|3
5606032|NCT00861705|19366887|P1|Overall Study|Never Began Treatment|7
5606033|NCT00861692|19366927|P1|Overall Study|Death|6
5606034|NCT00861614|19366939|P2|Overall Study|Other|22
5606035|NCT00861614|19366940|P1|Overall Study|Other|17
5606036|NCT00861614|19366939|P2|Overall Study|Withdrawal by Subject|35
5606037|NCT00861614|19366940|P1|Overall Study|Withdrawal by Subject|34
5606038|NCT00861614|19366939|P2|Overall Study|Adverse Event|23
5606039|NCT00861614|19366940|P1|Overall Study|Adverse Event|27
5606040|NCT00861614|19366939|P2|Overall Study|Death|19
5606041|NCT00861614|19366940|P1|Overall Study|Death|32
5606042|NCT00861614|19366939|P2|Overall Study|Study Drug Toxicity|6
5606043|NCT00861614|19366940|P1|Overall Study|Study Drug Toxicity|79
5606044|NCT00861614|19366939|P2|Overall Study|Disease Progression|263
5606045|NCT00861614|19366940|P1|Overall Study|Disease Progression|182
5606046|NCT00861471|19367025|P1|Overall Study|Physician Decision|2
5606047|NCT00861471|19367025|P1|Overall Study|treatment for lumbar laminectomy|1
5606048|NCT00861471|19367025|P1|Overall Study|Lack of Efficacy|3
5606049|NCT00861471|19367025|P1|Overall Study|Adverse Event|2
5606050|NCT00861471|19367025|P1|Overall Study|Withdrawal by Subject|1
5606051|NCT00861380|19367040|P7|Overall Study|Withdrawal Information not recorded|3020
5606052|NCT00861380|19367041|P6|Overall Study|Withdrawal Information not recorded|6249
5606053|NCT00861380|19367042|P5|Overall Study|Withdrawal Information not recorded|1812
5606054|NCT00861380|19367043|P4|Overall Study|Withdrawal Information not recorded|3689
5606055|NCT00861380|19367044|P3|Overall Study|Withdrawal Information not recorded|8872
5606056|NCT00861380|19367045|P2|Overall Study|Withdrawal Information not recorded|9112
5606057|NCT00861380|19367046|P1|Overall Study|Withdrawal Information not recorded|8427
5606058|NCT00861341|19367142|P1|Overall Study|Withdrawal by Subject|2
5606059|NCT00861198|19367151|P1|Overall Study|SpyGlass Failed|5
5606060|NCT00860951|19367168|P1|Overall Study|Lost to Follow-up|5
5606061|NCT00860951|19367168|P1|Overall Study|Withdrawal by Subject|2
5606062|NCT00860743|19367225|P2|Overall Study|Withdrawal by Subject|0
5606063|NCT00860743|19367226|P1|Overall Study|Withdrawal by Subject|3
5606064|NCT00860470|19367239|P2|Overall Study|Lost to Follow-up|39
5606065|NCT00860470|19367240|P1|Overall Study|Lost to Follow-up|34
5606066|NCT00860470|19367239|P2|Overall Study|Moved away|10
5606067|NCT00860470|19367240|P1|Overall Study|Moved away|8
5606068|NCT00860470|19367239|P2|Overall Study|Death|10
5606069|NCT00860470|19367240|P1|Overall Study|Death|6
5606070|NCT00860405|19367270|P2|Overall Study|Main reason: Follow-up data not complete|4
5606071|NCT00860405|19367271|P1|Overall Study|Main reason: Follow-up data not complete|5
5606072|NCT00860262|19367311|P3|Overall Study|Other|1
5606073|NCT00860262|19367312|P2|Overall Study|Other|3
5606074|NCT00860262|19367313|P1|Overall Study|Other|5
5606075|NCT00860262|19367311|P3|Overall Study|Lack of Efficacy|3
5606076|NCT00860262|19367312|P2|Overall Study|Lack of Efficacy|4
5606077|NCT00860262|19367313|P1|Overall Study|Lack of Efficacy|0
5606078|NCT00860262|19367311|P3|Overall Study|Withdrawal by Subject|6
5606079|NCT00860262|19367312|P2|Overall Study|Withdrawal by Subject|8
5606080|NCT00860262|19367313|P1|Overall Study|Withdrawal by Subject|4
5606081|NCT00860262|19367311|P3|Overall Study|Lost to Follow-up|1
5606082|NCT00860262|19367312|P2|Overall Study|Lost to Follow-up|0
5606083|NCT00860262|19367313|P1|Overall Study|Lost to Follow-up|2
5606084|NCT00860262|19367311|P3|Overall Study|Protocol Violation|0
5606085|NCT00860262|19367312|P2|Overall Study|Protocol Violation|1
5606086|NCT00860262|19367313|P1|Overall Study|Protocol Violation|0
5606087|NCT00860262|19367311|P3|Overall Study|Adverse Event|7
5606088|NCT00860262|19367312|P2|Overall Study|Adverse Event|6
5606089|NCT00860262|19367313|P1|Overall Study|Adverse Event|9
5606090|NCT00860249|19367426|P3|Overall Study|trial was terminated prior to completion|21
5606091|NCT00860249|19367427|P2|Overall Study|trial was terminated prior to completion|18
5606092|NCT00860249|19367428|P1|Overall Study|trial was terminated prior to completion|21
5606093|NCT00860158|19367448|P1|Overall Study|Study Terminated|1
5606094|NCT00860067|19367460|P3|Overall Study|Pregnancy|0
5606095|NCT00860067|19367461|P2|Overall Study|Pregnancy|0
5606096|NCT00860067|19367462|P1|Overall Study|Pregnancy|1
5606097|NCT00860067|19367460|P3|Overall Study|Withdrawal by Subject|0
5606098|NCT00860067|19367461|P2|Overall Study|Withdrawal by Subject|0
5606099|NCT00860067|19367462|P1|Overall Study|Withdrawal by Subject|4
5606100|NCT00860067|19367460|P3|Overall Study|Lost to Follow-up|9
5606101|NCT00860067|19367461|P2|Overall Study|Lost to Follow-up|9
5606102|NCT00860067|19367462|P1|Overall Study|Lost to Follow-up|46
5606103|NCT00860028|19367522|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
5606104|NCT00860028|19367523|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
5606105|NCT00859937|19367565|P2|Overall Study|Protocol Violation|0
5606106|NCT00859937|19367566|P1|Overall Study|Protocol Violation|1
5606107|NCT00859898|19367581|P3|Overall Study|non-specified|1
5606108|NCT00859898|19367582|P2|Overall Study|non-specified|1
5606109|NCT00859898|19367583|P1|Overall Study|non-specified|1
5606110|NCT00859898|19367581|P3|Overall Study|No longer meets criteria|0
5606111|NCT00859898|19367582|P2|Overall Study|No longer meets criteria|1
5606112|NCT00859898|19367583|P1|Overall Study|No longer meets criteria|0
5606113|NCT00859898|19367581|P3|Overall Study|poor/non-compliance|0
5606114|NCT00859898|19367582|P2|Overall Study|poor/non-compliance|0
5606115|NCT00859898|19367583|P1|Overall Study|poor/non-compliance|2
5606116|NCT00859898|19367581|P3|Overall Study|Lost to Follow-up|5
5606117|NCT00859898|19367582|P2|Overall Study|Lost to Follow-up|11
5606118|NCT00859898|19367583|P1|Overall Study|Lost to Follow-up|10
5606119|NCT00859898|19367581|P3|Overall Study|Death|1
5606120|NCT00859898|19367582|P2|Overall Study|Death|0
5606121|NCT00859898|19367583|P1|Overall Study|Death|0
5606122|NCT00859898|19367581|P3|Overall Study|Withdrawal by Subject|11
5606123|NCT00859898|19367582|P2|Overall Study|Withdrawal by Subject|8
5606124|NCT00859898|19367583|P1|Overall Study|Withdrawal by Subject|11
5606125|NCT00859898|19367581|P3|Overall Study|Adverse Event|8
5606126|NCT00859898|19367582|P2|Overall Study|Adverse Event|9
5606127|NCT00859898|19367583|P1|Overall Study|Adverse Event|4
5606128|NCT00859898|19367581|P3|Overall Study|Lack of Efficacy|1
5606129|NCT00859898|19367582|P2|Overall Study|Lack of Efficacy|1
5606130|NCT00859898|19367583|P1|Overall Study|Lack of Efficacy|0
5606131|NCT00859638|19367642|P2|Overall Study|Ill health|1
5606132|NCT00859638|19367643|P1|Overall Study|Ill health|1
5606133|NCT00859638|19367642|P2|Overall Study|Withdrawal by Subject|2
5606134|NCT00859638|19367643|P1|Overall Study|Withdrawal by Subject|3
5606135|NCT00859638|19367642|P2|Overall Study|Lost to Follow-up|1
5606136|NCT00859638|19367643|P1|Overall Study|Lost to Follow-up|6
5606137|NCT00859586|19367649|P1|Overall Study|Donors|4
5606138|NCT00859573|19367665|P2|Overall Study|Physician Decision|1
5606139|NCT00859573|19367666|P1|Overall Study|Physician Decision|1
5606140|NCT00859573|19367665|P2|Overall Study|Withdrawal by Subject|1
5606141|NCT00859573|19367666|P1|Overall Study|Withdrawal by Subject|4
5606142|NCT00859547|19367672|P1|Overall Study|Parent withdrew consent|1
5606143|NCT00859547|19367672|P1|Overall Study|Lost to Follow-up|1
5606144|NCT00859521|19367685|P2|Washout|Withdrawal by Subject|1
5606145|NCT00859521|19367686|P1|Washout|Withdrawal by Subject|0
5606146|NCT00859469|19367707|P1|Overall Study|Death|16
5606147|NCT00859469|19367707|P1|Overall Study|Withdrawal by Subject|1
5606148|NCT00859469|19367707|P1|Overall Study|Lack of Efficacy|9
5606149|NCT00859469|19367707|P1|Overall Study|Adverse Event|2
5606150|NCT00859456|19367713|P1|Overall Study|Non-compliance|3
5606151|NCT00859456|19367713|P1|Overall Study|Progressive disease|2
5606152|NCT00859456|19367713|P1|Overall Study|Adverse Event|3
5606153|NCT00859430|19367719|P2|First Intervention|Withdrawal by Subject|1
5606154|NCT00859430|19367720|P1|First Intervention|Withdrawal by Subject|0
5606155|NCT00859313|19367736|P1|Overall Study|staff error|1
5606156|NCT00859313|19367736|P1|Overall Study|Adverse Event|1
5606157|NCT00859313|19367736|P1|Overall Study|Lack of Efficacy|2
5606158|NCT00859222|19367743|P5|Overall Study|DLT|0
5606159|NCT00859222|19367744|P4|Overall Study|DLT|0
5606160|NCT00859222|19367745|P3|Overall Study|DLT|0
5606161|NCT00859222|19367746|P2|Overall Study|DLT|0
5606162|NCT00859222|19367747|P1|Overall Study|DLT|1
5606163|NCT00859222|19367743|P5|Overall Study|Adverse Event|15
5606164|NCT00859222|19367744|P4|Overall Study|Adverse Event|24
5606165|NCT00859222|19367745|P3|Overall Study|Adverse Event|6
5606166|NCT00859222|19367746|P2|Overall Study|Adverse Event|3
5606167|NCT00859222|19367747|P1|Overall Study|Adverse Event|2
5606168|NCT00859014|19367869|P1|Overall Study|Lost to Follow-up|1
5606169|NCT00859014|19367869|P1|Overall Study|Death|4
5606170|NCT00858988|19367876|P2|Analysis|Lactulose unable to be detected in urine|1
5606171|NCT00858988|19367877|P1|Analysis|Lactulose unable to be detected in urine|2
5606172|NCT00858845|19367893|P2|Overall Study|Patient underwent heart transplant.|1
5606173|NCT00858845|19367894|P1|Overall Study|Patient underwent heart transplant.|0
5606174|NCT00858832|19367906|P2|Overall Study|Adverse Event|1
5606175|NCT00858832|19367907|P1|Overall Study|Adverse Event|0
5606176|NCT00858832|19367906|P2|Overall Study|became ineligible: delivered vaginally|0
5606177|NCT00858832|19367907|P1|Overall Study|became ineligible: delivered vaginally|1
5606178|NCT00858780|19367913|P5|OL Re-Treatment (Failure to Week 48)|Other|1
5606179|NCT00858780|19367914|P4|OL Re-Treatment (Failure to Week 48)|Other|0
5606180|NCT00858780|19367915|P3|OL Re-Treatment (Failure to Week 48)|Other|0
5606181|NCT00858780|19367916|P2|OL Re-Treatment (Failure to Week 48)|Other|0
5606182|NCT00858780|19367917|P1|OL Re-Treatment (Failure to Week 48)|Other|0
5606183|NCT00858780|19367913|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
5606184|NCT00858780|19367914|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
5606185|NCT00858780|19367915|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
5606186|NCT00858780|19367916|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
5606187|NCT00858780|19367917|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
5606188|NCT00858780|19367913|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
5606189|NCT00858780|19367914|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
5606190|NCT00858780|19367915|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
5606191|NCT00858780|19367916|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
5606192|NCT00858780|19367917|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
5606193|NCT00858780|19367913|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
5606194|NCT00858780|19367914|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
5606195|NCT00858780|19367915|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
5606196|NCT00858780|19367916|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
5606197|NCT00858780|19367917|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
5606198|NCT00858780|19367913|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
5606199|NCT00858780|19367914|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
5606200|NCT00858780|19367915|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
5606201|NCT00858780|19367916|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
5606202|NCT00858780|19367917|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
5606203|NCT00858780|19367913|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
5606204|NCT00858780|19367914|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
5606205|NCT00858780|19367915|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
5606206|NCT00858780|19367916|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
5606207|NCT00858780|19367917|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
5606208|NCT00858702|19367992|P2|Overall Study|Withdrawal by Subject|0
5606209|NCT00858702|19367993|P1|Overall Study|Withdrawal by Subject|1
5606210|NCT00858702|19367992|P2|Overall Study|Other|1
5606211|NCT00858702|19367993|P1|Overall Study|Other|2
5606212|NCT00858702|19367992|P2|Overall Study|Protocol Violation|1
5606213|NCT00858702|19367993|P1|Overall Study|Protocol Violation|1
5606214|NCT00858702|19367992|P2|Overall Study|Lack of Efficacy|0
5606215|NCT00858702|19367993|P1|Overall Study|Lack of Efficacy|1
5606216|NCT00858637|19368008|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
5606217|NCT00858637|19368009|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5606218|NCT00858637|19368010|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5606219|NCT00858637|19368011|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5606220|NCT00858637|19368012|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5606221|NCT00858637|19368013|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
5606222|NCT00858637|19368008|P6|Placebo-controlled Withdrawal Phase|Death|0
5606223|NCT00858637|19368009|P5|Placebo-controlled Withdrawal Phase|Death|1
5606224|NCT00858637|19368010|P4|Placebo-controlled Withdrawal Phase|Death|0
5606225|NCT00858637|19368011|P3|Placebo-controlled Withdrawal Phase|Death|1
5606226|NCT00858637|19368012|P2|Placebo-controlled Withdrawal Phase|Death|0
5606227|NCT00858637|19368013|P1|Placebo-controlled Withdrawal Phase|Death|0
5606228|NCT00858637|19368008|P6|Active Comparison Phase|Other Reasons|0
5606229|NCT00858637|19368009|P5|Active Comparison Phase|Other Reasons|0
5606230|NCT00858637|19368010|P4|Active Comparison Phase|Other Reasons|1
5606231|NCT00858637|19368011|P3|Active Comparison Phase|Other Reasons|0
5606232|NCT00858637|19368012|P2|Active Comparison Phase|Other Reasons|0
5606233|NCT00858637|19368013|P1|Active Comparison Phase|Other Reasons|1
5606234|NCT00858637|19368008|P6|Active Comparison Phase|Withdrawal by Subject|0
5606235|NCT00858637|19368009|P5|Active Comparison Phase|Withdrawal by Subject|0
5606236|NCT00858637|19368010|P4|Active Comparison Phase|Withdrawal by Subject|6
5606237|NCT00858637|19368011|P3|Active Comparison Phase|Withdrawal by Subject|0
5606238|NCT00858637|19368012|P2|Active Comparison Phase|Withdrawal by Subject|0
5606239|NCT00858637|19368013|P1|Active Comparison Phase|Withdrawal by Subject|7
5606240|NCT00858637|19368008|P6|Active Comparison Phase|Physician Decision|0
5606241|NCT00858637|19368009|P5|Active Comparison Phase|Physician Decision|0
5606242|NCT00858637|19368010|P4|Active Comparison Phase|Physician Decision|1
5606243|NCT00858637|19368011|P3|Active Comparison Phase|Physician Decision|0
5606244|NCT00858637|19368012|P2|Active Comparison Phase|Physician Decision|0
5606245|NCT00858637|19368013|P1|Active Comparison Phase|Physician Decision|1
5606246|NCT00858637|19368008|P6|Active Comparison Phase|Death|0
5606247|NCT00858637|19368009|P5|Active Comparison Phase|Death|0
5606248|NCT00858637|19368010|P4|Active Comparison Phase|Death|1
5606249|NCT00858637|19368011|P3|Active Comparison Phase|Death|0
5606250|NCT00858637|19368012|P2|Active Comparison Phase|Death|0
5606251|NCT00858637|19368013|P1|Active Comparison Phase|Death|1
5606252|NCT00858637|19368008|P6|Active Comparison Phase|Adverse Event|0
5606253|NCT00858637|19368009|P5|Active Comparison Phase|Adverse Event|0
5606254|NCT00858637|19368010|P4|Active Comparison Phase|Adverse Event|9
5606255|NCT00858637|19368011|P3|Active Comparison Phase|Adverse Event|0
5606256|NCT00858637|19368012|P2|Active Comparison Phase|Adverse Event|0
5606257|NCT00858637|19368013|P1|Active Comparison Phase|Adverse Event|14
5606258|NCT00858442|19368054|P2|Compression:Start to Finish|Lost to Follow-up|3
5606259|NCT00858442|19368055|P1|Compression:Start to Finish|Lost to Follow-up|1
5606260|NCT00858403|19368065|P1|Overall Study|Disease Progression|1
5606261|NCT00858403|19368065|P1|Overall Study|Death|3
5606262|NCT00858403|19368065|P1|Overall Study|Withdrawal by Subject|1
5606263|NCT00858364|19368086|P2|Overall Study|Still on-study|247
5606264|NCT00858364|19368087|P1|Overall Study|Still on-study|114
5606265|NCT00858364|19368086|P2|Overall Study|Missing|1
5606266|NCT00858364|19368087|P1|Overall Study|Missing|1
5606267|NCT00858364|19368086|P2|Overall Study|Other|17
5606268|NCT00858364|19368087|P1|Overall Study|Other|9
5606269|NCT00858364|19368086|P2|Overall Study|Protocol Deviation|2
5606270|NCT00858364|19368087|P1|Overall Study|Protocol Deviation|0
5606271|NCT00858364|19368086|P2|Overall Study|Noncompliance|4
5606272|NCT00858364|19368087|P1|Overall Study|Noncompliance|3
5606273|NCT00858364|19368086|P2|Overall Study|Lost to Follow-up|54
5606274|NCT00858364|19368087|P1|Overall Study|Lost to Follow-up|24
5606275|NCT00858364|19368086|P2|Overall Study|Ineligibility Determined|10
5606276|NCT00858364|19368087|P1|Overall Study|Ineligibility Determined|1
5606277|NCT00858364|19368086|P2|Overall Study|Withdrawal by Subject|118
5606278|NCT00858364|19368087|P1|Overall Study|Withdrawal by Subject|44
5606279|NCT00858364|19368086|P2|Overall Study|Adverse Event|2
5606280|NCT00858364|19368087|P1|Overall Study|Adverse Event|5
5606281|NCT00858364|19368086|P2|Overall Study|Administrative Decision|2
5606282|NCT00858364|19368087|P1|Overall Study|Administrative Decision|3
5606283|NCT00858247|19368109|P2|Week 12 Follow-up|Withdrawal by Subject|1
5606284|NCT00858247|19368110|P1|Week 12 Follow-up|Withdrawal by Subject|0
5606285|NCT00858247|19368109|P2|Baseline Assessment|Protocol Violation|1
5606286|NCT00858247|19368110|P1|Baseline Assessment|Protocol Violation|0
5606287|NCT00858247|19368109|P2|Baseline Assessment|Poor IV access|0
5606288|NCT00858247|19368110|P1|Baseline Assessment|Poor IV access|1
5606289|NCT00858247|19368109|P2|Baseline Assessment|Withdrawal by Subject|1
5606290|NCT00858247|19368110|P1|Baseline Assessment|Withdrawal by Subject|1
5606291|NCT00858208|19368126|P1|Overall Study|Other|10
5606292|NCT00858208|19368126|P1|Overall Study|Participant refused|40
5606293|NCT00858208|19368126|P1|Overall Study|Lost to Follow-up|26
5606294|NCT00858208|19368126|P1|Overall Study|Adverse Event|3
5606295|NCT00858143|19368143|P1|Overall Study|Other|23
5606296|NCT00858143|19368143|P1|Overall Study|Death|7
5606297|NCT00858143|19368143|P1|Overall Study|Lack of Efficacy|4
5606298|NCT00858143|19368143|P1|Overall Study|Adverse Event|16
5606299|NCT00858117|19368200|P1|Follow up for 5 Years|No further data collected for study|9
5606300|NCT00858117|19368200|P1|Follow up for 5 Years|Death|4
5606301|NCT00858117|19368200|P1|Treatment on Study|Adverse Event|2
5606302|NCT00857948|19368263|P4|Overall Study|Protocol Violation|0
5606303|NCT00857948|19368264|P3|Overall Study|Protocol Violation|1
5606304|NCT00857948|19368265|P2|Overall Study|Protocol Violation|0
5606305|NCT00857948|19368266|P1|Overall Study|Protocol Violation|1
5606306|NCT00857948|19368263|P4|Overall Study|Withdrawal by Subject|0
5606307|NCT00857948|19368264|P3|Overall Study|Withdrawal by Subject|0
5606308|NCT00857948|19368265|P2|Overall Study|Withdrawal by Subject|0
5606309|NCT00857948|19368266|P1|Overall Study|Withdrawal by Subject|2
5606310|NCT00857896|19368288|P1|Baseline to Week 4|Withdrawal by Subject|1
5606311|NCT00857818|19368444|P2|Overall Study|Investigator decision|0
5606312|NCT00857818|19368445|P1|Overall Study|Investigator decision|1
5606313|NCT00857818|19368444|P2|Overall Study|Sponsor terminated study|4
5606314|NCT00857818|19368445|P1|Overall Study|Sponsor terminated study|6
5606315|NCT00857818|19368444|P2|Overall Study|Withdrawal by Subject|4
5606316|NCT00857818|19368445|P1|Overall Study|Withdrawal by Subject|0
5606317|NCT00857818|19368444|P2|Overall Study|Adverse Event|0
5606318|NCT00857818|19368445|P1|Overall Study|Adverse Event|3
5606319|NCT00857818|19368444|P2|Overall Study|Lack of Efficacy|0
5606320|NCT00857818|19368445|P1|Overall Study|Lack of Efficacy|1
5606321|NCT00857792|19368473|P1|Overall Study|inadequate image quality for analysis|12
5606322|NCT00857766|19368479|P2|Overall Study|Participant Withdrew Consent|4
5606323|NCT00857766|19368480|P1|Overall Study|Participant Withdrew Consent|4
5606324|NCT00857766|19368479|P2|Overall Study|Investigator Discretion|3
5606325|NCT00857766|19368480|P1|Overall Study|Investigator Discretion|2
5606326|NCT00857766|19368479|P2|Overall Study|Lost to Follow-up|0
5606327|NCT00857766|19368480|P1|Overall Study|Lost to Follow-up|1
5606328|NCT00857766|19368479|P2|Overall Study|Protocol Violation|11
5606329|NCT00857766|19368480|P1|Overall Study|Protocol Violation|11
5606330|NCT00857766|19368479|P2|Overall Study|Adverse Event|12
5606331|NCT00857766|19368480|P1|Overall Study|Adverse Event|13
5606332|NCT00857649|19368522|P2|Overall Study|Other Reasons|3
5606333|NCT00857649|19368523|P1|Overall Study|Other Reasons|1
5606334|NCT00857649|19368522|P2|Overall Study|Nursing Home Placement|9
5606335|NCT00857649|19368523|P1|Overall Study|Nursing Home Placement|2
5606336|NCT00857649|19368522|P2|Overall Study|Withdrawal of Consent|7
5606337|NCT00857649|19368523|P1|Overall Study|Withdrawal of Consent|10
5606338|NCT00857649|19368522|P2|Overall Study|Protocol Violation|2
5606339|NCT00857649|19368523|P1|Overall Study|Protocol Violation|2
5606340|NCT00857649|19368522|P2|Overall Study|Non-compliance|1
5606341|NCT00857649|19368523|P1|Overall Study|Non-compliance|1
5606342|NCT00857649|19368522|P2|Overall Study|Adverse Event|10
5606343|NCT00857649|19368523|P1|Overall Study|Adverse Event|15
5606344|NCT00857623|19368539|P2|Overall Study|Positive for HEP C|1
5606345|NCT00857623|19368540|P1|Overall Study|Positive for HEP C|0
5606346|NCT00857623|19368539|P2|Overall Study|Intake of prohibited medication|1
5606347|NCT00857623|19368540|P1|Overall Study|Intake of prohibited medication|0
5606348|NCT00857623|19368539|P2|Overall Study|Severe non-compliance to protocol|1
5606349|NCT00857623|19368540|P1|Overall Study|Severe non-compliance to protocol|1
5606350|NCT00857623|19368539|P2|Overall Study|Lack of Efficacy|1
5606351|NCT00857623|19368540|P1|Overall Study|Lack of Efficacy|1
5606352|NCT00857623|19368539|P2|Overall Study|Withdrawal by Subject|1
5606353|NCT00857623|19368540|P1|Overall Study|Withdrawal by Subject|2
5606354|NCT00857623|19368539|P2|Overall Study|Study-specific discontinuation criteria|3
5606355|NCT00857623|19368540|P1|Overall Study|Study-specific discontinuation criteria|5
5606356|NCT00857623|19368539|P2|Overall Study|Adverse Event|2
5606357|NCT00857623|19368540|P1|Overall Study|Adverse Event|5
5606358|NCT00857584|19368564|P2|Overall Study|Physician Decision|1
5606359|NCT00857584|19368565|P1|Overall Study|Physician Decision|1
5606360|NCT00857584|19368564|P2|Overall Study|Adverse Event|2
5606361|NCT00857584|19368565|P1|Overall Study|Adverse Event|2
5606362|NCT00857584|19368564|P2|Overall Study|Lack of Efficacy|2
5606363|NCT00857584|19368565|P1|Overall Study|Lack of Efficacy|1
5606364|NCT00857454|19368692|P1|Overall Study|MTE09 enrollment criteria not met|6
5606365|NCT00857454|19368692|P1|Overall Study|Total Testosterone <300 ng/dL|8
5606366|NCT00857454|19368692|P1|Overall Study|Total Testosterone >1050 ng/dL|1
5606367|NCT00857454|19368692|P1|Overall Study|Adverse Event|2
5606368|NCT00857454|19368692|P1|Overall Study|Lost to Follow-up|1
5606369|NCT00857454|19368692|P1|Overall Study|Withdrawal by Subject|2
5606370|NCT00857415|19368705|P2|Overall Study|Deceased with no autopsy|0
5606371|NCT00857415|19368706|P1|Overall Study|Deceased with no autopsy|2
5606372|NCT00857415|19368705|P2|Overall Study|Subject still living at end of study|0
5606373|NCT00857415|19368706|P1|Overall Study|Subject still living at end of study|110
5606374|NCT00857415|19368705|P2|Overall Study|Invalid image or not imaged|0
5606375|NCT00857415|19368706|P1|Overall Study|Invalid image or not imaged|3
5606376|NCT00857415|19368705|P2|Overall Study|Image acquisition failure|0
5606377|NCT00857415|19368706|P1|Overall Study|Image acquisition failure|2
5606378|NCT00857389|19368713|P1|Overall Study|Did not proceed to transplant|2
5606379|NCT00857311|19368727|P4|Overall Study|Lost to Follow-up|0
5606380|NCT00857311|19368728|P3|Overall Study|Lost to Follow-up|0
5606381|NCT00857311|19368729|P2|Overall Study|Lost to Follow-up|0
5606382|NCT00857311|19368730|P1|Overall Study|Lost to Follow-up|1
5606383|NCT00857285|19368742|P2|Overall Study|Randomization criteria not met|1
5606384|NCT00857285|19368743|P1|Overall Study|Randomization criteria not met|1
5606385|NCT00857285|19368742|P2|Overall Study|Withdrawal by Subject|0
5606386|NCT00857285|19368743|P1|Overall Study|Withdrawal by Subject|4
5606387|NCT00857285|19368742|P2|Overall Study|Protocol Violation|1
5606388|NCT00857285|19368743|P1|Overall Study|Protocol Violation|3
5606389|NCT00857285|19368742|P2|Overall Study|Lack of Efficacy|2
5606390|NCT00857285|19368743|P1|Overall Study|Lack of Efficacy|0
5606391|NCT00857285|19368742|P2|Overall Study|Adverse Event|2
5606392|NCT00857285|19368743|P1|Overall Study|Adverse Event|4
5606393|NCT00857259|19368759|P3|Overall Study|Protocol Violation|1
5606394|NCT00857259|19368760|P2|Overall Study|Protocol Violation|0
5606395|NCT00857259|19368761|P1|Overall Study|Protocol Violation|1
5606396|NCT00857246|19368771|P1|ChemoRT|Adverse Event|2
5606397|NCT00857246|19368771|P1|ChemoRT|Withdrawal by Subject|1
5606398|NCT00857246|19368771|P1|Surgery (Curative)|disease progression|6
5606399|NCT00857246|19368771|P1|Induction Regimen|Withdrawal by Subject|1
5606400|NCT00857246|19368771|P1|Induction Regimen|disease-related complications|1
5606401|NCT00857246|19368771|P1|Induction Regimen|Adverse Event|1
5606402|NCT00857233|19368781|P1|Overall Study|Other Reasons|2
5606403|NCT00857233|19368781|P1|Overall Study|Nursing Home Placement|14
5606404|NCT00857233|19368781|P1|Overall Study|Lost to Follow-up|4
5606405|NCT00857233|19368781|P1|Overall Study|Withdrawal of Consent|9
5606406|NCT00857233|19368781|P1|Overall Study|Non-compliance|1
5606407|NCT00857233|19368781|P1|Overall Study|Lack of Efficacy|1
5606408|NCT00857233|19368781|P1|Overall Study|Adverse Event|24
5606409|NCT00857220|19368790|P1|Overall Study|Miscellaneous|8
5606410|NCT00857220|19368790|P1|Overall Study|Site Closed|5
5606411|NCT00857220|19368790|P1|Overall Study|Clinical Hold|6
5606412|NCT00857220|19368790|P1|Overall Study|Withdrawal by Subject|67
5606413|NCT00857220|19368790|P1|Overall Study|Protocol Violation|16
5606414|NCT00857220|19368790|P1|Overall Study|Physician Decision|4
5606415|NCT00857220|19368790|P1|Overall Study|Lost to Follow-up|30
5606416|NCT00857220|19368790|P1|Overall Study|Lack of Efficacy|11
5606417|NCT00857220|19368790|P1|Overall Study|Death|1
5606418|NCT00857220|19368790|P1|Overall Study|Adverse Event|35
5606419|NCT00856999|19368807|P1|Overall Study|Withdrawal by Subject|5
5606420|NCT00856986|19368817|P5|Extension Period, Weeks 26-52|Unclassified|0
5606421|NCT00856986|19368818|P4|Extension Period, Weeks 26-52|Unclassified|0
5606422|NCT00856986|19368819|P3|Extension Period, Weeks 26-52|Unclassified|11
5606423|NCT00856986|19368820|P2|Extension Period, Weeks 26-52|Unclassified|2
5606424|NCT00856986|19368821|P1|Extension Period, Weeks 26-52|Unclassified|4
5606425|NCT00856986|19368817|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
5606426|NCT00856986|19368818|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
5606427|NCT00856986|19368819|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
5606428|NCT00856986|19368820|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
5606429|NCT00856986|19368821|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
5606430|NCT00856986|19368817|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
5606431|NCT00856986|19368818|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
5606432|NCT00856986|19368819|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
5606433|NCT00856986|19368820|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
5606434|NCT00856986|19368821|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
5606435|NCT00856986|19368817|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
5606436|NCT00856986|19368818|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
5606437|NCT00856986|19368819|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
5606438|NCT00856986|19368820|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
5606439|NCT00856986|19368821|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
5606440|NCT00856986|19368817|P5|Extension Period, Weeks 26-52|Protocol Violation|0
5606441|NCT00856986|19368818|P4|Extension Period, Weeks 26-52|Protocol Violation|0
5606442|NCT00856986|19368819|P3|Extension Period, Weeks 26-52|Protocol Violation|5
5606443|NCT00856986|19368820|P2|Extension Period, Weeks 26-52|Protocol Violation|2
5606444|NCT00856986|19368821|P1|Extension Period, Weeks 26-52|Protocol Violation|6
5606445|NCT00856986|19368817|P5|Extension Period, Weeks 26-52|Adverse Event|0
5606446|NCT00856986|19368818|P4|Extension Period, Weeks 26-52|Adverse Event|0
5606447|NCT00856986|19368819|P3|Extension Period, Weeks 26-52|Adverse Event|10
5606448|NCT00856986|19368820|P2|Extension Period, Weeks 26-52|Adverse Event|3
5606449|NCT00856986|19368821|P1|Extension Period, Weeks 26-52|Adverse Event|3
5606450|NCT00856986|19368817|P5|Main Period, Weeks 0-26|Unclassified|0
5606451|NCT00856986|19368818|P4|Main Period, Weeks 0-26|Unclassified|0
5606452|NCT00856986|19368819|P3|Main Period, Weeks 0-26|Unclassified|7
5606453|NCT00856986|19368820|P2|Main Period, Weeks 0-26|Unclassified|6
5606454|NCT00856986|19368821|P1|Main Period, Weeks 0-26|Unclassified|7
5606455|NCT00856986|19368817|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
5606456|NCT00856986|19368818|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
5606457|NCT00856986|19368819|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
5606458|NCT00856986|19368820|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
5606459|NCT00856986|19368821|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
5606460|NCT00856986|19368817|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
5606461|NCT00856986|19368818|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
5606462|NCT00856986|19368819|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
5606463|NCT00856986|19368820|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
5606464|NCT00856986|19368821|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
5606465|NCT00856986|19368817|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
5606466|NCT00856986|19368818|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
5606467|NCT00856986|19368819|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
5606468|NCT00856986|19368820|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
5606469|NCT00856986|19368821|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
5606470|NCT00856986|19368817|P5|Main Period, Weeks 0-26|Protocol Violation|0
5606471|NCT00856986|19368818|P4|Main Period, Weeks 0-26|Protocol Violation|0
5606472|NCT00856986|19368819|P3|Main Period, Weeks 0-26|Protocol Violation|7
5606473|NCT00856986|19368820|P2|Main Period, Weeks 0-26|Protocol Violation|5
5606474|NCT00856986|19368821|P1|Main Period, Weeks 0-26|Protocol Violation|4
5606475|NCT00856986|19368817|P5|Main Period, Weeks 0-26|Adverse Event|0
5606476|NCT00856986|19368818|P4|Main Period, Weeks 0-26|Adverse Event|0
5606477|NCT00856986|19368819|P3|Main Period, Weeks 0-26|Adverse Event|9
5606478|NCT00856986|19368820|P2|Main Period, Weeks 0-26|Adverse Event|4
5606479|NCT00856986|19368821|P1|Main Period, Weeks 0-26|Adverse Event|6
5606480|NCT00856986|19368817|P5|Run-in Period, Weeks -12-0|Unclassified|0
5606481|NCT00856986|19368818|P4|Run-in Period, Weeks -12-0|Unclassified|24
5606482|NCT00856986|19368819|P3|Run-in Period, Weeks -12-0|Unclassified|0
5606483|NCT00856986|19368820|P2|Run-in Period, Weeks -12-0|Unclassified|0
5606484|NCT00856986|19368821|P1|Run-in Period, Weeks -12-0|Unclassified|0
5606485|NCT00856986|19368817|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
5606486|NCT00856986|19368818|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
5606487|NCT00856986|19368819|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
5606488|NCT00856986|19368820|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
5606489|NCT00856986|19368821|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
5606490|NCT00856986|19368817|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
5606491|NCT00856986|19368818|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
5606492|NCT00856986|19368819|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
5606493|NCT00856986|19368820|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
5606494|NCT00856986|19368821|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
5606495|NCT00856986|19368817|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
5606496|NCT00856986|19368818|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
5606497|NCT00856986|19368819|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
5606498|NCT00856986|19368820|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
5606499|NCT00856986|19368821|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
5606500|NCT00856986|19368817|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
5606501|NCT00856986|19368818|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
5606502|NCT00856986|19368819|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
5606503|NCT00856986|19368820|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
5606504|NCT00856986|19368821|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
5606505|NCT00856986|19368817|P5|Run-in Period, Weeks -12-0|Adverse Event|0
5606506|NCT00856986|19368818|P4|Run-in Period, Weeks -12-0|Adverse Event|92
5606507|NCT00856986|19368819|P3|Run-in Period, Weeks -12-0|Adverse Event|0
5606508|NCT00856986|19368820|P2|Run-in Period, Weeks -12-0|Adverse Event|0
5606509|NCT00856986|19368821|P1|Run-in Period, Weeks -12-0|Adverse Event|0
5606510|NCT00856973|19368991|P3|Overall Study|Other|13
5606511|NCT00856973|19368992|P2|Overall Study|Other|12
5606512|NCT00856973|19368993|P1|Overall Study|Other|11
5606513|NCT00856973|19368991|P3|Overall Study|Withdrawal by Subject|15
5606514|NCT00856973|19368992|P2|Overall Study|Withdrawal by Subject|16
5606515|NCT00856973|19368993|P1|Overall Study|Withdrawal by Subject|13
5606516|NCT00856973|19368991|P3|Overall Study|Protocol Violation|1
5606517|NCT00856973|19368992|P2|Overall Study|Protocol Violation|2
5606518|NCT00856973|19368993|P1|Overall Study|Protocol Violation|1
5606519|NCT00856973|19368991|P3|Overall Study|Physician Decision|1
5606520|NCT00856973|19368992|P2|Overall Study|Physician Decision|3
5606521|NCT00856973|19368993|P1|Overall Study|Physician Decision|0
5606522|NCT00856973|19368991|P3|Overall Study|Lost to Follow-up|5
5606523|NCT00856973|19368992|P2|Overall Study|Lost to Follow-up|3
5606524|NCT00856973|19368993|P1|Overall Study|Lost to Follow-up|6
5606525|NCT00856973|19368991|P3|Overall Study|Adverse Event|3
5606526|NCT00856973|19368992|P2|Overall Study|Adverse Event|5
5606527|NCT00856973|19368993|P1|Overall Study|Adverse Event|5
5606528|NCT00856908|19369073|P2|Overall Study|Lost to Follow-up|0
5606529|NCT00856908|19369074|P1|Overall Study|Lost to Follow-up|1
5606530|NCT00856856|19369099|P1|4-year Clinical Follow-up|Missed visit|1
5606531|NCT00856856|19369099|P1|2-year Clinical Follow-up|Lost to Follow-up|1
5606532|NCT00856843|19369298|P2|Overall Study|Lack of Efficacy|0
5606533|NCT00856843|19369299|P1|Overall Study|Lack of Efficacy|1
5606534|NCT00856843|19369298|P2|Overall Study|Withdrawal by Subject|5
5606535|NCT00856843|19369299|P1|Overall Study|Withdrawal by Subject|1
5606536|NCT00856830|19369335|P4|Irinotecan & Bendamustine|Physician Decision|1
5606537|NCT00856830|19369336|P3|Irinotecan & Bendamustine|Physician Decision|0
5606538|NCT00856830|19369337|P2|Irinotecan & Bendamustine|Physician Decision|0
5606539|NCT00856830|19369338|P1|Irinotecan & Bendamustine|Physician Decision|0
5606540|NCT00856830|19369335|P4|Irinotecan & Bendamustine|Death|2
5606541|NCT00856830|19369336|P3|Irinotecan & Bendamustine|Death|0
5606542|NCT00856830|19369337|P2|Irinotecan & Bendamustine|Death|0
5606543|NCT00856830|19369338|P1|Irinotecan & Bendamustine|Death|0
5606544|NCT00856778|19369349|P1|Overall Study|Lost to Follow-up|5
5606545|NCT00856778|19369349|P1|Overall Study|Study deviation|2
5606546|NCT00856778|19369349|P1|Overall Study|Withdrawal by Subject|10
5606547|NCT00856778|19369349|P1|Overall Study|Adverse Event|7
5606548|NCT00856661|19369392|P2|Overall Study|Physician Judgement|5
5606549|NCT00856661|19369393|P1|Overall Study|Physician Judgement|8
5606550|NCT00856661|19369392|P2|Overall Study|Lost to Follow-up|3
5606551|NCT00856661|19369393|P1|Overall Study|Lost to Follow-up|1
5606552|NCT00856661|19369392|P2|Overall Study|Withdrawal by Subject|2
5606553|NCT00856661|19369393|P1|Overall Study|Withdrawal by Subject|1
5606554|NCT00856661|19369392|P2|Overall Study|Protocol Violation|1
5606555|NCT00856661|19369393|P1|Overall Study|Protocol Violation|2
5606556|NCT00856661|19369392|P2|Overall Study|Death|18
5606557|NCT00856661|19369393|P1|Overall Study|Death|15
5606558|NCT00856635|19369407|P2|Overall Study|Discontinued at Randomization|2
5606559|NCT00856635|19369408|P1|Overall Study|Discontinued at Randomization|2
5606560|NCT00856635|19369407|P2|Overall Study|Other|0
5606561|NCT00856635|19369408|P1|Overall Study|Other|1
5606562|NCT00856635|19369407|P2|Overall Study|Serious Adverse Event|0
5606563|NCT00856635|19369408|P1|Overall Study|Serious Adverse Event|1
5606564|NCT00856635|19369407|P2|Overall Study|Withdrawal by Subject|1
5606565|NCT00856635|19369408|P1|Overall Study|Withdrawal by Subject|3
5606566|NCT00856635|19369407|P2|Overall Study|Pregnancy|0
5606567|NCT00856635|19369408|P1|Overall Study|Pregnancy|1
5606568|NCT00856635|19369407|P2|Overall Study|Lost to Follow-up|5
5606569|NCT00856635|19369408|P1|Overall Study|Lost to Follow-up|2
5606570|NCT00856609|19369418|P2|Overall Study|Adverse Event|0
5606571|NCT00856609|19369419|P1|Overall Study|Adverse Event|1
5606572|NCT00856583|19369431|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
5606573|NCT00856583|19369432|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
5606574|NCT00856583|19369431|P2|Overall Study|Other|104
5606575|NCT00856583|19369432|P1|Overall Study|Other|92
5606576|NCT00856583|19369431|P2|Overall Study|Pregnancy|5
5606577|NCT00856583|19369432|P1|Overall Study|Pregnancy|14
5606578|NCT00856583|19369431|P2|Overall Study|Physician Decision|82
5606579|NCT00856583|19369432|P1|Overall Study|Physician Decision|59
5606580|NCT00856583|19369431|P2|Overall Study|Withdrawal by Subject|919
5606581|NCT00856583|19369432|P1|Overall Study|Withdrawal by Subject|1092
5606582|NCT00856583|19369431|P2|Overall Study|Non-compliance|262
5606583|NCT00856583|19369432|P1|Overall Study|Non-compliance|305
5606584|NCT00856583|19369431|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
5606585|NCT00856583|19369432|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
5606586|NCT00856583|19369431|P2|Overall Study|Serious Adverse Event (SAE)|65
5606587|NCT00856583|19369432|P1|Overall Study|Serious Adverse Event (SAE)|99
5606588|NCT00856583|19369431|P2|Overall Study|Lack of Efficacy|377
5606589|NCT00856583|19369432|P1|Overall Study|Lack of Efficacy|389
5606590|NCT00856557|19369462|P2|Overall Study|No patients with contextual flags|16
5606591|NCT00856557|19369463|P1|Overall Study|No patients with contextual flags|12
5606592|NCT00856544|19369477|P4|Overall Study|Withdrawal by Subject|1
5606593|NCT00856544|19369478|P3|Overall Study|Withdrawal by Subject|0
5606594|NCT00856544|19369479|P2|Overall Study|Withdrawal by Subject|5
5606595|NCT00856544|19369480|P1|Overall Study|Withdrawal by Subject|8
5606596|NCT00856544|19369477|P4|Overall Study|Lost to Follow-up|0
5606597|NCT00856544|19369478|P3|Overall Study|Lost to Follow-up|2
5606598|NCT00856544|19369479|P2|Overall Study|Lost to Follow-up|2
5606599|NCT00856544|19369480|P1|Overall Study|Lost to Follow-up|1
5606600|NCT00856544|19369477|P4|Overall Study|Other|6
5606601|NCT00856544|19369478|P3|Overall Study|Other|1
5606602|NCT00856544|19369479|P2|Overall Study|Other|16
5606603|NCT00856544|19369480|P1|Overall Study|Other|9
5606604|NCT00856544|19369477|P4|Overall Study|Lack of Efficacy|3
5606605|NCT00856544|19369478|P3|Overall Study|Lack of Efficacy|3
5606606|NCT00856544|19369479|P2|Overall Study|Lack of Efficacy|12
5606607|NCT00856544|19369480|P1|Overall Study|Lack of Efficacy|16
5606608|NCT00856544|19369477|P4|Overall Study|Adverse Event|3
5606609|NCT00856544|19369478|P3|Overall Study|Adverse Event|2
5606610|NCT00856544|19369479|P2|Overall Study|Adverse Event|29
5606611|NCT00856544|19369480|P1|Overall Study|Adverse Event|20
5606612|NCT00856544|19369477|P4|Overall Study|Death|0
5606613|NCT00856544|19369478|P3|Overall Study|Death|0
5606614|NCT00856544|19369479|P2|Overall Study|Death|2
5606615|NCT00856544|19369480|P1|Overall Study|Death|0
5606616|NCT00856544|19369477|P4|Overall Study|Randomized but not treated|0
5606617|NCT00856544|19369478|P3|Overall Study|Randomized but not treated|0
5606618|NCT00856544|19369479|P2|Overall Study|Randomized but not treated|0
5606619|NCT00856544|19369480|P1|Overall Study|Randomized but not treated|3
5606620|NCT00856518|19369659|P2|Overall Study|Lost to Follow-up|2
5606621|NCT00856518|19369660|P1|Overall Study|Lost to Follow-up|4
5606622|NCT00856492|19369673|P3|Overall Study|Ineligible or withdrew consent|2
5606623|NCT00856492|19369674|P2|Overall Study|Ineligible or withdrew consent|1
5606624|NCT00856492|19369675|P1|Overall Study|Ineligible or withdrew consent|1
5606625|NCT00856388|19369697|P1|Overall Study|Other|1
5606626|NCT00856349|19369708|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
5606627|NCT00856349|19369708|P1|Overall Study|Site closure|78
5606628|NCT00856349|19369708|P1|Overall Study|Device explant|33
5606629|NCT00856349|19369708|P1|Overall Study|Subject relocation|104
5606630|NCT00856349|19369708|P1|Overall Study|Physician Decision|13
5606631|NCT00856349|19369708|P1|Overall Study|Protocol Violation|38
5606632|NCT00856349|19369708|P1|Overall Study|Lost to Follow-up|91
5606633|NCT00856349|19369708|P1|Overall Study|Withdrawal by Subject|116
5606634|NCT00856349|19369708|P1|Overall Study|Death|418
5606635|NCT00856323|19369717|P1|Overall Study|Withdrawal by Subject|2
5606636|NCT00856297|19369729|P5|Overall Study|Unable to classify|0
5606637|NCT00856297|19369730|P4|Overall Study|Unable to classify|0
5606638|NCT00856297|19369731|P3|Overall Study|Unable to classify|0
5606639|NCT00856297|19369732|P2|Overall Study|Unable to classify|0
5606640|NCT00856297|19369733|P1|Overall Study|Unable to classify|2
5606641|NCT00856284|19369766|P3|Overall Study|Randomized in error|1
5606642|NCT00856284|19369767|P2|Overall Study|Randomized in error|0
5606643|NCT00856284|19369768|P1|Overall Study|Randomized in error|0
5606644|NCT00856284|19369766|P3|Overall Study|Other|14
5606645|NCT00856284|19369767|P2|Overall Study|Other|17
5606646|NCT00856284|19369768|P1|Overall Study|Other|15
5606647|NCT00856284|19369766|P3|Overall Study|Investigator discretion|10
5606648|NCT00856284|19369767|P2|Overall Study|Investigator discretion|8
5606649|NCT00856284|19369768|P1|Overall Study|Investigator discretion|9
5606650|NCT00856284|19369766|P3|Overall Study|Pregnancy|0
5606651|NCT00856284|19369767|P2|Overall Study|Pregnancy|2
5606652|NCT00856284|19369768|P1|Overall Study|Pregnancy|1
5606653|NCT00856284|19369766|P3|Overall Study|Voluntary withdrawal|62
5606654|NCT00856284|19369767|P2|Overall Study|Voluntary withdrawal|52
5606655|NCT00856284|19369768|P1|Overall Study|Voluntary withdrawal|48
5606656|NCT00856284|19369766|P3|Overall Study|Lost to Follow-up|28
5606657|NCT00856284|19369767|P2|Overall Study|Lost to Follow-up|22
5606658|NCT00856284|19369768|P1|Overall Study|Lost to Follow-up|20
5606659|NCT00856284|19369766|P3|Overall Study|Major protocol deviation|15
5606660|NCT00856284|19369767|P2|Overall Study|Major protocol deviation|16
5606661|NCT00856284|19369768|P1|Overall Study|Major protocol deviation|24
5606662|NCT00856284|19369766|P3|Overall Study|Adverse Event|82
5606663|NCT00856284|19369767|P2|Overall Study|Adverse Event|74
5606664|NCT00856284|19369768|P1|Overall Study|Adverse Event|60
5606665|NCT00856284|19369766|P3|Overall Study|Hyperglycemic rescue|235
5606666|NCT00856284|19369767|P2|Overall Study|Hyperglycemic rescue|201
5606667|NCT00856284|19369768|P1|Overall Study|Hyperglycemic rescue|231
5606668|NCT00856245|19369794|P1|Overall Study|Was not transplanted|5
5606669|NCT00856206|19369817|P2|Overall Study|Other than specified above|10
5606670|NCT00856206|19369818|P1|Overall Study|Other than specified above|3
5606671|NCT00856206|19369817|P2|Overall Study|Decision by the Sponsor|8
5606672|NCT00856206|19369818|P1|Overall Study|Decision by the Sponsor|4
5606673|NCT00856206|19369817|P2|Overall Study|Death|2
5606674|NCT00856206|19369818|P1|Overall Study|Death|2
5606675|NCT00856206|19369817|P2|Overall Study|Lost to Follow-up|39
5606676|NCT00856206|19369818|P1|Overall Study|Lost to Follow-up|13
5606677|NCT00856206|19369817|P2|Overall Study|Withdrawal by Subject|36
5606678|NCT00856206|19369818|P1|Overall Study|Withdrawal by Subject|15
5606679|NCT00856206|19369817|P2|Overall Study|Lack of Efficacy|2
5606680|NCT00856206|19369818|P1|Overall Study|Lack of Efficacy|1
5606681|NCT00856206|19369817|P2|Overall Study|Adverse Event|46
5606682|NCT00856206|19369818|P1|Overall Study|Adverse Event|10
5606683|NCT00856206|19369817|P2|Overall Study|Protocol Violation|18
5606684|NCT00856206|19369818|P1|Overall Study|Protocol Violation|6
5606685|NCT00856193|19369832|P2|Period 2|Lost to Follow-up|1
5606686|NCT00856193|19369833|P1|Period 2|Lost to Follow-up|0
5606687|NCT00856193|19369832|P2|Period 2|Abnormal test procedure results|1
5606688|NCT00856193|19369833|P1|Period 2|Abnormal test procedure results|0
5606689|NCT00856180|19369845|P1|Overall Study|Progressive Disease|16
5606690|NCT00856180|19369845|P1|Overall Study|Adverse Event|4
5606691|NCT00855959|19369870|P1|Overall Study|Incorrect enrolment|1
5606692|NCT00855959|19369870|P1|Overall Study|Pregnancy|1
5606693|NCT00855959|19369870|P1|Overall Study|Withdrawal by Subject|3
5606694|NCT00855959|19369870|P1|Overall Study|Lost to Follow-up|2
5606695|NCT00855959|19369870|P1|Overall Study|Adverse Event|2
5606696|NCT00855933|19369887|P2|Overall Study|Withdrawal by Subject|1
5606697|NCT00855933|19369888|P1|Overall Study|Withdrawal by Subject|0
5606698|NCT00855920|19369897|P3|Overall Study|Other than specified above|1
5606699|NCT00855920|19369898|P2|Overall Study|Other than specified above|1
5606700|NCT00855920|19369899|P1|Overall Study|Other than specified above|1
5606701|NCT00855920|19369897|P3|Overall Study|Decision by the sponsor|1
5606702|NCT00855920|19369898|P2|Overall Study|Decision by the sponsor|1
5606703|NCT00855920|19369899|P1|Overall Study|Decision by the sponsor|0
5606704|NCT00855920|19369897|P3|Overall Study|Death|0
5606705|NCT00855920|19369898|P2|Overall Study|Death|1
5606706|NCT00855920|19369899|P1|Overall Study|Death|0
5606707|NCT00855920|19369897|P3|Overall Study|Lost to Follow-up|2
5606708|NCT00855920|19369898|P2|Overall Study|Lost to Follow-up|0
5606709|NCT00855920|19369899|P1|Overall Study|Lost to Follow-up|1
5606710|NCT00855920|19369897|P3|Overall Study|Withdrawal by Subject|2
5606711|NCT00855920|19369898|P2|Overall Study|Withdrawal by Subject|3
5606712|NCT00855920|19369899|P1|Overall Study|Withdrawal by Subject|2
5606713|NCT00855920|19369897|P3|Overall Study|Lack of Efficacy|2
5606714|NCT00855920|19369898|P2|Overall Study|Lack of Efficacy|2
5606715|NCT00855920|19369899|P1|Overall Study|Lack of Efficacy|2
5606716|NCT00855920|19369897|P3|Overall Study|Adverse Event|1
5606717|NCT00855920|19369898|P2|Overall Study|Adverse Event|1
5606718|NCT00855920|19369899|P1|Overall Study|Adverse Event|2
5606719|NCT00855920|19369897|P3|Overall Study|Protocol Violation|2
5606720|NCT00855920|19369898|P2|Overall Study|Protocol Violation|0
5606721|NCT00855920|19369899|P1|Overall Study|Protocol Violation|0
5606722|NCT00855894|19369916|P1|Overall Study|Disease progression|1
5606723|NCT00855894|19369916|P1|Overall Study|Patient's decision|1
5606724|NCT00855894|19369916|P1|Overall Study|Death|31
5606725|NCT00855816|19369939|P2|Overall Study|Became ineligible|1
5606726|NCT00855816|19369940|P1|Overall Study|Became ineligible|0
5606727|NCT00855816|19369939|P2|Overall Study|Death|0
5606728|NCT00855816|19369940|P1|Overall Study|Death|1
5606729|NCT00855816|19369939|P2|Overall Study|Lost to Follow-up|5
5606730|NCT00855816|19369940|P1|Overall Study|Lost to Follow-up|3
5606731|NCT00855816|19369939|P2|Overall Study|Withdrawal by Subject|15
5606732|NCT00855816|19369940|P1|Overall Study|Withdrawal by Subject|22
5606733|NCT00855738|19369946|P1|Overall Study|Death|1
5606734|NCT00855738|19369946|P1|Overall Study|Subject Defaulted|1
5606735|NCT00855738|19369946|P1|Overall Study|Adverse Event|1
5606736|NCT00855738|19369946|P1|Overall Study|Lost to Follow-up|2
5606737|NCT00855595|19369974|P2|Overall Study|patient left country|1
5606738|NCT00855595|19369975|P1|Overall Study|patient left country|0
5606739|NCT00855595|19369974|P2|Overall Study|patient moved out of state|0
5606740|NCT00855595|19369975|P1|Overall Study|patient moved out of state|1
5606741|NCT00855595|19369974|P2|Overall Study|Adverse Event|1
5606742|NCT00855595|19369975|P1|Overall Study|Adverse Event|1
5606743|NCT00855595|19369974|P2|Overall Study|Lost to Follow-up|3
5606744|NCT00855595|19369975|P1|Overall Study|Lost to Follow-up|3
5606745|NCT00855595|19369974|P2|Overall Study|Withdrawal by Subject|2
5606746|NCT00855595|19369975|P1|Overall Study|Withdrawal by Subject|1
5606747|NCT00855582|19370014|P3|Overall Study|Withdrawal by Subject|8
5606748|NCT00855582|19370015|P2|Overall Study|Withdrawal by Subject|4
5606749|NCT00855582|19370016|P1|Overall Study|Withdrawal by Subject|7
5606750|NCT00855582|19370014|P3|Overall Study|Entry Criteria Not Met|3
5606751|NCT00855582|19370015|P2|Overall Study|Entry Criteria Not Met|6
5606752|NCT00855582|19370016|P1|Overall Study|Entry Criteria Not Met|8
5606753|NCT00855582|19370014|P3|Overall Study|Protocol Violation|6
5606754|NCT00855582|19370015|P2|Overall Study|Protocol Violation|2
5606755|NCT00855582|19370016|P1|Overall Study|Protocol Violation|6
5606756|NCT00855582|19370014|P3|Overall Study|Physician Decision|1
5606757|NCT00855582|19370015|P2|Overall Study|Physician Decision|0
5606758|NCT00855582|19370016|P1|Overall Study|Physician Decision|0
5606759|NCT00855582|19370014|P3|Overall Study|Lost to Follow-up|1
5606760|NCT00855582|19370015|P2|Overall Study|Lost to Follow-up|3
5606761|NCT00855582|19370016|P1|Overall Study|Lost to Follow-up|1
5606762|NCT00855582|19370014|P3|Overall Study|Lack of Efficacy|8
5606763|NCT00855582|19370015|P2|Overall Study|Lack of Efficacy|3
5606764|NCT00855582|19370016|P1|Overall Study|Lack of Efficacy|1
5606765|NCT00855582|19370014|P3|Overall Study|Death|0
5606766|NCT00855582|19370015|P2|Overall Study|Death|0
5606767|NCT00855582|19370016|P1|Overall Study|Death|1
5606768|NCT00855582|19370014|P3|Overall Study|Adverse Event|3
5606769|NCT00855582|19370015|P2|Overall Study|Adverse Event|6
5606770|NCT00855582|19370016|P1|Overall Study|Adverse Event|2
5606771|NCT00855465|19370105|P2|Follow-up Period (FUP)|Missing|0
5606772|NCT00855465|19370106|P1|Follow-up Period (FUP)|Missing|1
5606773|NCT00855465|19370105|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
5606774|NCT00855465|19370106|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
5606775|NCT00855465|19370105|P2|Follow-up Period (FUP)|Lost to Follow-up|0
5606776|NCT00855465|19370106|P1|Follow-up Period (FUP)|Lost to Follow-up|3
5606777|NCT00855465|19370105|P2|Follow-up Period (FUP)|Death|1
5606778|NCT00855465|19370106|P1|Follow-up Period (FUP)|Death|0
5606779|NCT00855465|19370105|P2|Follow-up Period (FUP)|Adverse Event|1
5606780|NCT00855465|19370106|P1|Follow-up Period (FUP)|Adverse Event|0
5606781|NCT00855465|19370105|P2|Treatment Period|Not treated|0
5606782|NCT00855465|19370106|P1|Treatment Period|Not treated|1
5606783|NCT00855465|19370105|P2|Treatment Period|Withdrawal by Subject|0
5606784|NCT00855465|19370106|P1|Treatment Period|Withdrawal by Subject|2
5606785|NCT00855465|19370105|P2|Treatment Period|Protocol Violation|0
5606786|NCT00855465|19370106|P1|Treatment Period|Protocol Violation|2
5606787|NCT00855465|19370105|P2|Treatment Period|Non-compliance|0
5606788|NCT00855465|19370106|P1|Treatment Period|Non-compliance|1
5606789|NCT00855465|19370105|P2|Treatment Period|Lack of Efficacy|1
5606790|NCT00855465|19370106|P1|Treatment Period|Lack of Efficacy|2
5606791|NCT00855465|19370105|P2|Treatment Period|Death|2
5606792|NCT00855465|19370106|P1|Treatment Period|Death|2
5606793|NCT00855465|19370105|P2|Treatment Period|Adverse Event|2
5606794|NCT00855465|19370106|P1|Treatment Period|Adverse Event|4
5606795|NCT00855439|19370196|P2|Overall Study|Pregnancy|0
5606796|NCT00855439|19370197|P1|Overall Study|Pregnancy|1
5606797|NCT00855439|19370196|P2|Overall Study|Withdrawal by Subject|0
5606798|NCT00855439|19370197|P1|Overall Study|Withdrawal by Subject|2
5606799|NCT00855335|19370255|P5|Overall Study|Other|1
5606800|NCT00855335|19370256|P4|Overall Study|Other|5
5606801|NCT00855335|19370257|P3|Overall Study|Other|2
5606802|NCT00855335|19370258|P2|Overall Study|Other|1
5606803|NCT00855335|19370259|P1|Overall Study|Other|2
5606804|NCT00855335|19370255|P5|Overall Study|Physician Decision|0
5606805|NCT00855335|19370256|P4|Overall Study|Physician Decision|0
5606806|NCT00855335|19370257|P3|Overall Study|Physician Decision|0
5606807|NCT00855335|19370258|P2|Overall Study|Physician Decision|1
5606808|NCT00855335|19370259|P1|Overall Study|Physician Decision|1
5606809|NCT00855335|19370255|P5|Overall Study|Adverse Event|0
5606810|NCT00855335|19370256|P4|Overall Study|Adverse Event|0
5606811|NCT00855335|19370257|P3|Overall Study|Adverse Event|0
5606812|NCT00855335|19370258|P2|Overall Study|Adverse Event|0
5606813|NCT00855335|19370259|P1|Overall Study|Adverse Event|2
5606814|NCT00855335|19370255|P5|Overall Study|Withdrawal by Subject|0
5606815|NCT00855335|19370256|P4|Overall Study|Withdrawal by Subject|1
5606816|NCT00855335|19370257|P3|Overall Study|Withdrawal by Subject|0
5606817|NCT00855335|19370258|P2|Overall Study|Withdrawal by Subject|0
5606818|NCT00855335|19370259|P1|Overall Study|Withdrawal by Subject|0
5606819|NCT00855335|19370255|P5|Overall Study|Lost to Follow-up|0
5606820|NCT00855335|19370256|P4|Overall Study|Lost to Follow-up|1
5606821|NCT00855335|19370257|P3|Overall Study|Lost to Follow-up|3
5606822|NCT00855335|19370258|P2|Overall Study|Lost to Follow-up|0
5606823|NCT00855335|19370259|P1|Overall Study|Lost to Follow-up|0
5606824|NCT00855309|19370346|P2|Overall Study|patient never recieved drug|0
5606825|NCT00855309|19370347|P1|Overall Study|patient never recieved drug|1
5606826|NCT00855218|19370355|P2|Overall Study|Clinical endpoint reached|13
5606827|NCT00855218|19370356|P1|Overall Study|Clinical endpoint reached|10
5606828|NCT00855218|19370355|P2|Overall Study|Progression measurement proven|15
5606829|NCT00855218|19370356|P1|Overall Study|Progression measurement proven|7
5606830|NCT00855218|19370355|P2|Overall Study|Second malignancy|1
5606831|NCT00855218|19370356|P1|Overall Study|Second malignancy|0
5606832|NCT00855218|19370355|P2|Overall Study|Untreatable disease progression|67
5606833|NCT00855218|19370356|P1|Overall Study|Untreatable disease progression|54
5606834|NCT00855218|19370355|P2|Overall Study|Still treated with study medication|1
5606835|NCT00855218|19370356|P1|Overall Study|Still treated with study medication|0
5606836|NCT00855218|19370355|P2|Overall Study|technical problems|1
5606837|NCT00855218|19370356|P1|Overall Study|technical problems|2
5606838|NCT00855218|19370355|P2|Overall Study|patient convenience|0
5606839|NCT00855218|19370356|P1|Overall Study|patient convenience|2
5606840|NCT00855218|19370355|P2|Overall Study|non-compliant with study drug|1
5606841|NCT00855218|19370356|P1|Overall Study|non-compliant with study drug|3
5606842|NCT00855218|19370355|P2|Overall Study|Protocol Violation|9
5606843|NCT00855218|19370356|P1|Overall Study|Protocol Violation|5
5606844|NCT00855218|19370355|P2|Overall Study|Lost to Follow-up|1
5606845|NCT00855218|19370356|P1|Overall Study|Lost to Follow-up|0
5606846|NCT00855218|19370355|P2|Overall Study|Physician Decision|11
5606847|NCT00855218|19370356|P1|Overall Study|Physician Decision|18
5606848|NCT00855218|19370355|P2|Overall Study|Withdrawal by Subject|6
5606849|NCT00855218|19370356|P1|Overall Study|Withdrawal by Subject|10
5606850|NCT00855218|19370355|P2|Overall Study|Adverse Event|27
5606851|NCT00855218|19370356|P1|Overall Study|Adverse Event|43
5606852|NCT00855166|19370374|P2|Overall Study|Subject no longer meets study criteria|1
5606853|NCT00855166|19370375|P1|Overall Study|Subject no longer meets study criteria|1
5606854|NCT00855166|19370374|P2|Overall Study|Administrative reasons by sponsor|0
5606855|NCT00855166|19370375|P1|Overall Study|Administrative reasons by sponsor|1
5606856|NCT00855166|19370374|P2|Overall Study|Poor/non-compliance|0
5606857|NCT00855166|19370375|P1|Overall Study|Poor/non-compliance|2
5606858|NCT00855166|19370374|P2|Overall Study|Withdrawal by Subject|4
5606859|NCT00855166|19370375|P1|Overall Study|Withdrawal by Subject|1
5606860|NCT00855166|19370374|P2|Overall Study|Death|1
5606861|NCT00855166|19370375|P1|Overall Study|Death|0
5606862|NCT00855166|19370374|P2|Overall Study|Adverse Event|2
5606863|NCT00855166|19370375|P1|Overall Study|Adverse Event|0
5606864|NCT00855062|19370395|P2|Step2|Initiation of antiretroviral therapy/ART|1
5606865|NCT00855062|19370396|P1|Step2|Initiation of antiretroviral therapy/ART|0
5606866|NCT00855062|19370395|P2|Step2|Adverse Event|3
5606867|NCT00855062|19370396|P1|Step2|Adverse Event|0
5606868|NCT00855062|19370395|P2|Step2|Early Study Closure|2
5606869|NCT00855062|19370396|P1|Step2|Early Study Closure|6
5606870|NCT00855062|19370395|P2|Step1|Withdrawal by Subject|3
5606871|NCT00855062|19370396|P1|Step1|Withdrawal by Subject|2
5606872|NCT00855062|19370395|P2|Step1|Pregnancy|0
5606873|NCT00855062|19370396|P1|Step1|Pregnancy|1
5606874|NCT00855062|19370395|P2|Step1|Protocol Violation|0
5606875|NCT00855062|19370396|P1|Step1|Protocol Violation|1
5606876|NCT00855062|19370395|P2|Step1|Adverse Event|1
5606877|NCT00855062|19370396|P1|Step1|Adverse Event|1
5606878|NCT00855062|19370395|P2|Step1|Early Study Closure|7
5606879|NCT00855062|19370396|P1|Step1|Early Study Closure|5
5606880|NCT00854906|19370445|P1|Overall Study|One person had no ocular history|1
5606881|NCT00854724|19370454|P2|Second Intervention|Physician Decision|1
5606882|NCT00854724|19370455|P1|Second Intervention|Physician Decision|0
5606883|NCT00854724|19370454|P2|Second Intervention|Protocol Violation|0
5606884|NCT00854724|19370455|P1|Second Intervention|Protocol Violation|1
5606885|NCT00854724|19370454|P2|Washout|Withdrawal by Subject|1
5606886|NCT00854724|19370455|P1|Washout|Withdrawal by Subject|0
5606887|NCT00854724|19370454|P2|Washout|Protocol Violation|0
5606888|NCT00854724|19370455|P1|Washout|Protocol Violation|1
5606889|NCT00854724|19370454|P2|First Intervention|Withdrawal by Subject|1
5606890|NCT00854724|19370455|P1|First Intervention|Withdrawal by Subject|1
5606891|NCT00854620|19370461|P1|Overall Study|Adverse Event|1
5606892|NCT00854607|19370465|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
5606893|NCT00854581|19370513|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
5606894|NCT00854581|19370513|P1|Induction (Up to Day 21)|Physician Decision|1
5606895|NCT00854581|19370513|P1|Induction (Up to Day 21)|Death|1
5606896|NCT00854581|19370513|P1|Induction (Up to Day 21)|Lack of Efficacy|4
5606897|NCT00854373|19370528|P2|Overall Study|Forgot to take study drug|1
5606898|NCT00854373|19370529|P1|Overall Study|Forgot to take study drug|1
5606899|NCT00854373|19370528|P2|Overall Study|Withdrawal by Subject|3
5606900|NCT00854373|19370529|P1|Overall Study|Withdrawal by Subject|1
5606901|NCT00854360|19370543|P4|Overall Study|Other|3
5606902|NCT00854360|19370544|P3|Overall Study|Other|0
5606903|NCT00854360|19370545|P2|Overall Study|Other|0
5606904|NCT00854360|19370546|P1|Overall Study|Other|0
5606905|NCT00854360|19370543|P4|Overall Study|Lack of Efficacy|0
5606906|NCT00854360|19370544|P3|Overall Study|Lack of Efficacy|0
5606907|NCT00854360|19370545|P2|Overall Study|Lack of Efficacy|1
5606908|NCT00854360|19370546|P1|Overall Study|Lack of Efficacy|2
5606909|NCT00854360|19370543|P4|Overall Study|Pregnancy|0
5606910|NCT00854360|19370544|P3|Overall Study|Pregnancy|0
5606911|NCT00854360|19370545|P2|Overall Study|Pregnancy|1
5606912|NCT00854360|19370546|P1|Overall Study|Pregnancy|0
5606913|NCT00854360|19370543|P4|Overall Study|Withdrawal by Subject|1
5606914|NCT00854360|19370544|P3|Overall Study|Withdrawal by Subject|0
5606915|NCT00854360|19370545|P2|Overall Study|Withdrawal by Subject|0
5606916|NCT00854360|19370546|P1|Overall Study|Withdrawal by Subject|0
5606917|NCT00854360|19370543|P4|Overall Study|Adverse Event|6
5606918|NCT00854360|19370544|P3|Overall Study|Adverse Event|2
5606919|NCT00854360|19370545|P2|Overall Study|Adverse Event|1
5606920|NCT00854360|19370546|P1|Overall Study|Adverse Event|0
5606921|NCT00854308|19370578|P2|Overall Study|Sponsor's decision to terminate study|1
5606922|NCT00854308|19370579|P1|Overall Study|Sponsor's decision to terminate study|0
5606923|NCT00854308|19370578|P2|Overall Study|Withdrawal by Subject|2
5606924|NCT00854308|19370579|P1|Overall Study|Withdrawal by Subject|4
5606925|NCT00854308|19370578|P2|Overall Study|Physician Decision|6
5606926|NCT00854308|19370579|P1|Overall Study|Physician Decision|6
5606927|NCT00854308|19370578|P2|Overall Study|Death|5
5606928|NCT00854308|19370579|P1|Overall Study|Death|2
5606929|NCT00854308|19370578|P2|Overall Study|Adverse Event|3
5606930|NCT00854308|19370579|P1|Overall Study|Adverse Event|8
5606931|NCT00854308|19370578|P2|Overall Study|Disease progression|50
5606932|NCT00854308|19370579|P1|Overall Study|Disease progression|42
5606933|NCT00854113|19370604|P11|Overall Study|Withdrawal by Subject|0
5606934|NCT00854113|19370605|P10|Overall Study|Withdrawal by Subject|0
5606935|NCT00854113|19370606|P9|Overall Study|Withdrawal by Subject|1
5606936|NCT00854113|19370607|P8|Overall Study|Withdrawal by Subject|1
5606937|NCT00854113|19370608|P7|Overall Study|Withdrawal by Subject|0
5606938|NCT00854113|19370609|P6|Overall Study|Withdrawal by Subject|0
5606939|NCT00854113|19370610|P5|Overall Study|Withdrawal by Subject|0
5606940|NCT00854113|19370611|P4|Overall Study|Withdrawal by Subject|0
5606941|NCT00854113|19370612|P3|Overall Study|Withdrawal by Subject|0
5606942|NCT00854113|19370613|P2|Overall Study|Withdrawal by Subject|0
5606943|NCT00854113|19370614|P1|Overall Study|Withdrawal by Subject|0
5606944|NCT00854113|19370604|P11|Overall Study|Adverse Event|0
5606945|NCT00854113|19370605|P10|Overall Study|Adverse Event|0
5606946|NCT00854113|19370606|P9|Overall Study|Adverse Event|0
5606947|NCT00854113|19370607|P8|Overall Study|Adverse Event|2
5606948|NCT00854113|19370608|P7|Overall Study|Adverse Event|0
5606949|NCT00854113|19370609|P6|Overall Study|Adverse Event|0
5606950|NCT00854113|19370610|P5|Overall Study|Adverse Event|0
5606951|NCT00854113|19370611|P4|Overall Study|Adverse Event|0
5606952|NCT00854113|19370612|P3|Overall Study|Adverse Event|0
5606953|NCT00854113|19370613|P2|Overall Study|Adverse Event|0
5606954|NCT00854113|19370614|P1|Overall Study|Adverse Event|0
5606955|NCT00854100|19370718|P3|Overall Study|Adverse Event|2
5606956|NCT00854100|19370719|P2|Overall Study|Adverse Event|1
5606957|NCT00854100|19370720|P1|Overall Study|Adverse Event|2
5606958|NCT00854100|19370718|P3|Overall Study|Protocol Violation|3
5606959|NCT00854100|19370719|P2|Overall Study|Protocol Violation|4
5606960|NCT00854100|19370720|P1|Overall Study|Protocol Violation|2
5606961|NCT00854100|19370718|P3|Overall Study|Withdrawal by Subject|2
5606962|NCT00854100|19370719|P2|Overall Study|Withdrawal by Subject|1
5606963|NCT00854100|19370720|P1|Overall Study|Withdrawal by Subject|3
5606964|NCT00854100|19370718|P3|Overall Study|Lost to Follow-up|3
5606965|NCT00854100|19370719|P2|Overall Study|Lost to Follow-up|0
5606966|NCT00854100|19370720|P1|Overall Study|Lost to Follow-up|2
5606967|NCT00854100|19370718|P3|Overall Study|Inability to complete the study visits|1
5606968|NCT00854100|19370719|P2|Overall Study|Inability to complete the study visits|0
5606969|NCT00854100|19370720|P1|Overall Study|Inability to complete the study visits|0
5606970|NCT00853970|19370759|P2|Overall Study|Cancelled surgery|2
5606971|NCT00853970|19370760|P1|Overall Study|Cancelled surgery|4
5606972|NCT00853970|19370759|P2|Overall Study|Withdrawal by Subject|1
5606973|NCT00853970|19370760|P1|Overall Study|Withdrawal by Subject|2
5606974|NCT00853957|19370770|P2|Overall Study|Protocol deviation|3
5606975|NCT00853957|19370771|P1|Overall Study|Protocol deviation|0
5606976|NCT00853957|19370770|P2|Overall Study|Lost to Follow-up|6
5606977|NCT00853957|19370771|P1|Overall Study|Lost to Follow-up|1
5606978|NCT00853957|19370770|P2|Overall Study|Subject withdrew consent|5
5606979|NCT00853957|19370771|P1|Overall Study|Subject withdrew consent|4
5606980|NCT00853957|19370770|P2|Overall Study|Unsatisfactory therapeutic effect|2
5606981|NCT00853957|19370771|P1|Overall Study|Unsatisfactory therapeutic effect|0
5606982|NCT00853957|19370770|P2|Overall Study|Adverse Event|3
5606983|NCT00853957|19370771|P1|Overall Study|Adverse Event|9
5606984|NCT00853905|19370789|P2|Overall Study|never had surgery|0
5606985|NCT00853905|19370790|P1|Overall Study|never had surgery|1
5606986|NCT00853905|19370789|P2|Overall Study|Withdrawal by Subject|1
5606987|NCT00853905|19370790|P1|Overall Study|Withdrawal by Subject|0
5606988|NCT00853905|19370789|P2|Overall Study|Lost to Follow-up|3
5606989|NCT00853905|19370790|P1|Overall Study|Lost to Follow-up|1
5606990|NCT00853827|19370822|P2|Double Blind Period (103 Weeks)|Death|6
5606991|NCT00853827|19370823|P1|Double Blind Period (103 Weeks)|Death|1
5606992|NCT00853827|19370822|P2|Double Blind Period (103 Weeks)|Administrative problems|56
5606993|NCT00853827|19370823|P1|Double Blind Period (103 Weeks)|Administrative problems|45
5606994|NCT00853827|19370822|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
5606995|NCT00853827|19370823|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
5606996|NCT00853827|19370822|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
5606997|NCT00853827|19370823|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
5606998|NCT00853827|19370822|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
5606999|NCT00853827|19370823|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
5607000|NCT00853827|19370822|P2|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
5607001|NCT00853827|19370823|P1|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
5607002|NCT00853827|19370822|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
5607003|NCT00853827|19370823|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
5607004|NCT00853827|19370822|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
5607005|NCT00853827|19370823|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
5607006|NCT00853827|19370822|P2|Double Blind Period (103 Weeks)|Adverse Event|14
5607007|NCT00853827|19370823|P1|Double Blind Period (103 Weeks)|Adverse Event|25
5607008|NCT00853827|19370822|P2|Single Blind Period (1 Week)|Protocol Violation|0
5607009|NCT00853827|19370823|P1|Single Blind Period (1 Week)|Protocol Violation|12
5607010|NCT00853827|19370822|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
5607011|NCT00853827|19370823|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
5607012|NCT00853827|19370822|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
5607013|NCT00853827|19370823|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
5607014|NCT00853827|19370822|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
5607015|NCT00853827|19370823|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
5607016|NCT00853827|19370822|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
5607017|NCT00853827|19370823|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
5607018|NCT00853827|19370822|P2|Single Blind Period (1 Week)|Adverse Event|0
5607019|NCT00853827|19370823|P1|Single Blind Period (1 Week)|Adverse Event|9
5607020|NCT00853827|19370822|P2|Single Blind Period (1 Week)|Other|0
5607021|NCT00853827|19370823|P1|Single Blind Period (1 Week)|Other|4
5607022|NCT00853762|19370839|P4|Overall Study|Randomised but not Treated|0
5607023|NCT00853762|19370840|P3|Overall Study|Randomised but not Treated|2
5607024|NCT00853762|19370841|P2|Overall Study|Randomised but not Treated|2
5607025|NCT00853762|19370842|P1|Overall Study|Randomised but not Treated|0
5607026|NCT00853762|19370839|P4|Overall Study|Other|0
5607027|NCT00853762|19370840|P3|Overall Study|Other|0
5607028|NCT00853762|19370841|P2|Overall Study|Other|2
5607029|NCT00853762|19370842|P1|Overall Study|Other|0
5607030|NCT00853762|19370839|P4|Overall Study|Withdrawal by Subject|0
5607031|NCT00853762|19370840|P3|Overall Study|Withdrawal by Subject|1
5607032|NCT00853762|19370841|P2|Overall Study|Withdrawal by Subject|0
5607033|NCT00853762|19370842|P1|Overall Study|Withdrawal by Subject|0
5607034|NCT00853762|19370839|P4|Overall Study|Protocol Violation|1
5607035|NCT00853762|19370840|P3|Overall Study|Protocol Violation|0
5607036|NCT00853762|19370841|P2|Overall Study|Protocol Violation|0
5607037|NCT00853762|19370842|P1|Overall Study|Protocol Violation|0
5607038|NCT00853762|19370839|P4|Overall Study|Premature Termination|21
5607039|NCT00853762|19370840|P3|Overall Study|Premature Termination|14
5607040|NCT00853762|19370841|P2|Overall Study|Premature Termination|15
5607041|NCT00853762|19370842|P1|Overall Study|Premature Termination|16
5607042|NCT00853749|19370910|P2|Overall Study|Lost to Follow-up|1
5607043|NCT00853749|19370911|P1|Overall Study|Lost to Follow-up|0
5607044|NCT00853723|19370932|P3|Overall Study|Protocol Violation|1
5607045|NCT00853723|19370933|P2|Overall Study|Protocol Violation|2
5607046|NCT00853723|19370934|P1|Overall Study|Protocol Violation|1
5607047|NCT00853723|19370932|P3|Overall Study|Withdrawal by Subject|0
5607048|NCT00853723|19370933|P2|Overall Study|Withdrawal by Subject|1
5607049|NCT00853723|19370934|P1|Overall Study|Withdrawal by Subject|2
5607050|NCT00853723|19370932|P3|Overall Study|Adverse Event|1
5607051|NCT00853723|19370933|P2|Overall Study|Adverse Event|4
5607052|NCT00853723|19370934|P1|Overall Study|Adverse Event|3
5607053|NCT00853658|19370988|P3|Overall Study|Missing study completion information|6
5607054|NCT00853658|19370989|P2|Overall Study|Missing study completion information|4
5607055|NCT00853658|19370990|P1|Overall Study|Missing study completion information|5
5607056|NCT00853658|19370988|P3|Overall Study|Patient's request|11
5607057|NCT00853658|19370989|P2|Overall Study|Patient's request|17
5607058|NCT00853658|19370990|P1|Overall Study|Patient's request|21
5607059|NCT00853658|19370988|P3|Overall Study|Vital Status at study end N/A|10
5607060|NCT00853658|19370989|P2|Overall Study|Vital Status at study end N/A|10
5607061|NCT00853658|19370990|P1|Overall Study|Vital Status at study end N/A|8
5607062|NCT00853658|19370988|P3|Overall Study|Vital Status unknown at study end|0
5607063|NCT00853658|19370989|P2|Overall Study|Vital Status unknown at study end|1
5607064|NCT00853658|19370990|P1|Overall Study|Vital Status unknown at study end|1
5607065|NCT00853658|19370988|P3|Overall Study|Vital Status known (alive) at study end|3
5607066|NCT00853658|19370989|P2|Overall Study|Vital Status known (alive) at study end|3
5607067|NCT00853658|19370990|P1|Overall Study|Vital Status known (alive) at study end|2
5607068|NCT00853658|19370988|P3|Overall Study|IRB request|2
5607069|NCT00853658|19370989|P2|Overall Study|IRB request|0
5607070|NCT00853658|19370990|P1|Overall Study|IRB request|0
5607071|NCT00853658|19370988|P3|Overall Study|H.A. Request|19
5607072|NCT00853658|19370989|P2|Overall Study|H.A. Request|23
5607073|NCT00853658|19370990|P1|Overall Study|H.A. Request|26
5607074|NCT00853658|19370988|P3|Overall Study|Lost to Follow-up|11
5607075|NCT00853658|19370989|P2|Overall Study|Lost to Follow-up|6
5607076|NCT00853658|19370990|P1|Overall Study|Lost to Follow-up|11
5607077|NCT00853658|19370988|P3|Overall Study|Death|753
5607078|NCT00853658|19370989|P2|Overall Study|Death|768
5607079|NCT00853658|19370990|P1|Overall Study|Death|713
5607080|NCT00853593|19371010|P1|Overall Study|Implant not attempted|4
5607081|NCT00853593|19371010|P1|Overall Study|Model 4396 lead not attempted|29
5607082|NCT00853593|19371010|P1|Overall Study|Subjects did not receive a 4396 lead|12
5607083|NCT00853580|19371037|P2|Overall Study|Commenced contraindicated therapy|2
5607084|NCT00853580|19371038|P1|Overall Study|Commenced contraindicated therapy|0
5607085|NCT00853580|19371037|P2|Overall Study|Withdrawal by Subject|8
5607086|NCT00853580|19371038|P1|Overall Study|Withdrawal by Subject|2
5607087|NCT00853580|19371037|P2|Overall Study|Protocol Violation|1
5607088|NCT00853580|19371038|P1|Overall Study|Protocol Violation|2
5607089|NCT00853580|19371037|P2|Overall Study|Lost to Follow-up|5
5607090|NCT00853580|19371038|P1|Overall Study|Lost to Follow-up|3
5607091|NCT00853567|19371085|P1|Overall Study|Study prematurely terminated|71
5607092|NCT00853489|19371095|P2|Overall Study|Lost to Follow-up|2
5607093|NCT00853489|19371096|P1|Overall Study|Lost to Follow-up|5
5607094|NCT00853385|19371111|P5|Overall Study|Other|12
5607095|NCT00853385|19371112|P4|Overall Study|Other|4
5607096|NCT00853385|19371113|P3|Overall Study|Other|4
5607097|NCT00853385|19371114|P2|Overall Study|Other|9
5607098|NCT00853385|19371115|P1|Overall Study|Other|18
5607099|NCT00853385|19371111|P5|Overall Study|Withdrawal by Subject|1
5607100|NCT00853385|19371112|P4|Overall Study|Withdrawal by Subject|1
5607101|NCT00853385|19371113|P3|Overall Study|Withdrawal by Subject|0
5607102|NCT00853385|19371114|P2|Overall Study|Withdrawal by Subject|2
5607103|NCT00853385|19371115|P1|Overall Study|Withdrawal by Subject|4
5607104|NCT00853385|19371111|P5|Overall Study|Lost to Follow-up|0
5607105|NCT00853385|19371112|P4|Overall Study|Lost to Follow-up|0
5607106|NCT00853385|19371113|P3|Overall Study|Lost to Follow-up|0
5607107|NCT00853385|19371114|P2|Overall Study|Lost to Follow-up|1
5607108|NCT00853385|19371115|P1|Overall Study|Lost to Follow-up|2
5607109|NCT00853385|19371111|P5|Overall Study|Lack of Efficacy|6
5607110|NCT00853385|19371112|P4|Overall Study|Lack of Efficacy|3
5607111|NCT00853385|19371113|P3|Overall Study|Lack of Efficacy|3
5607112|NCT00853385|19371114|P2|Overall Study|Lack of Efficacy|7
5607113|NCT00853385|19371115|P1|Overall Study|Lack of Efficacy|6
5607114|NCT00853385|19371111|P5|Overall Study|Adverse Event|22
5607115|NCT00853385|19371112|P4|Overall Study|Adverse Event|5
5607116|NCT00853385|19371113|P3|Overall Study|Adverse Event|2
5607117|NCT00853385|19371114|P2|Overall Study|Adverse Event|24
5607118|NCT00853385|19371115|P1|Overall Study|Adverse Event|24
5607119|NCT00853385|19371111|P5|Overall Study|Death|1
5607120|NCT00853385|19371112|P4|Overall Study|Death|0
5607121|NCT00853385|19371113|P3|Overall Study|Death|0
5607122|NCT00853385|19371114|P2|Overall Study|Death|0
5607123|NCT00853385|19371115|P1|Overall Study|Death|0
5607124|NCT00853372|19371330|P2|Overall Study|Full Consent Withdrawn|1
5607125|NCT00853372|19371331|P1|Overall Study|Full Consent Withdrawn|1
5607126|NCT00853372|19371330|P2|Overall Study|Lost to Follow-up|2
5607127|NCT00853372|19371331|P1|Overall Study|Lost to Follow-up|1
5607128|NCT00853372|19371330|P2|Overall Study|Death|26
5607129|NCT00853372|19371331|P1|Overall Study|Death|30
5607130|NCT00853307|19371380|P2|Overall Study|Reason Not Specified|1
5607131|NCT00853307|19371381|P1|Overall Study|Reason Not Specified|0
5607132|NCT00853307|19371380|P2|Overall Study|Withdrawal by Subject|2
5607133|NCT00853307|19371381|P1|Overall Study|Withdrawal by Subject|1
5607134|NCT00853307|19371380|P2|Overall Study|Adverse Event|2
5607135|NCT00853307|19371381|P1|Overall Study|Adverse Event|1
5607136|NCT00853242|19371408|P7|Overall Study|Other|2
5607137|NCT00853242|19371409|P6|Overall Study|Other|1
5607138|NCT00853242|19371410|P5|Overall Study|Other|0
5607139|NCT00853242|19371411|P4|Overall Study|Other|0
5607140|NCT00853242|19371412|P3|Overall Study|Other|2
5607141|NCT00853242|19371413|P2|Overall Study|Other|0
5607142|NCT00853242|19371414|P1|Overall Study|Other|2
5607143|NCT00853242|19371408|P7|Overall Study|Withdrawal by Subject|2
5607144|NCT00853242|19371409|P6|Overall Study|Withdrawal by Subject|0
5607145|NCT00853242|19371410|P5|Overall Study|Withdrawal by Subject|0
5607146|NCT00853242|19371411|P4|Overall Study|Withdrawal by Subject|4
5607147|NCT00853242|19371412|P3|Overall Study|Withdrawal by Subject|0
5607148|NCT00853242|19371413|P2|Overall Study|Withdrawal by Subject|2
5607149|NCT00853242|19371414|P1|Overall Study|Withdrawal by Subject|1
5607150|NCT00853242|19371408|P7|Overall Study|Noncompliant|0
5607151|NCT00853242|19371409|P6|Overall Study|Noncompliant|0
5607152|NCT00853242|19371410|P5|Overall Study|Noncompliant|1
5607153|NCT00853242|19371411|P4|Overall Study|Noncompliant|0
5607154|NCT00853242|19371412|P3|Overall Study|Noncompliant|0
5607155|NCT00853242|19371413|P2|Overall Study|Noncompliant|0
5607156|NCT00853242|19371414|P1|Overall Study|Noncompliant|0
5607157|NCT00853242|19371408|P7|Overall Study|Adverse Event|1
5607158|NCT00853242|19371409|P6|Overall Study|Adverse Event|1
5607159|NCT00853242|19371410|P5|Overall Study|Adverse Event|3
5607160|NCT00853242|19371411|P4|Overall Study|Adverse Event|0
5607161|NCT00853242|19371412|P3|Overall Study|Adverse Event|1
5607162|NCT00853242|19371413|P2|Overall Study|Adverse Event|1
5607163|NCT00853242|19371414|P1|Overall Study|Adverse Event|0
5607164|NCT00853229|19371456|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
5607165|NCT00853229|19371457|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
5607166|NCT00853151|19371467|P4|Overall Study|Sponsor Decision|0
5607167|NCT00853151|19371468|P3|Overall Study|Sponsor Decision|0
5607168|NCT00853151|19371469|P2|Overall Study|Sponsor Decision|3
5607169|NCT00853151|19371470|P1|Overall Study|Sponsor Decision|0
5607170|NCT00853151|19371467|P4|Overall Study|Physician Decision|0
5607171|NCT00853151|19371468|P3|Overall Study|Physician Decision|1
5607172|NCT00853151|19371469|P2|Overall Study|Physician Decision|2
5607173|NCT00853151|19371470|P1|Overall Study|Physician Decision|0
5607174|NCT00853151|19371467|P4|Overall Study|Withdrawal by Subject|1
5607175|NCT00853151|19371468|P3|Overall Study|Withdrawal by Subject|2
5607176|NCT00853151|19371469|P2|Overall Study|Withdrawal by Subject|4
5607177|NCT00853151|19371470|P1|Overall Study|Withdrawal by Subject|5
5607178|NCT00853151|19371467|P4|Overall Study|Protocol Violation|1
5607179|NCT00853151|19371468|P3|Overall Study|Protocol Violation|0
5607180|NCT00853151|19371469|P2|Overall Study|Protocol Violation|0
5607181|NCT00853151|19371470|P1|Overall Study|Protocol Violation|0
5607182|NCT00853151|19371467|P4|Overall Study|Death|1
5607183|NCT00853151|19371468|P3|Overall Study|Death|0
5607184|NCT00853151|19371469|P2|Overall Study|Death|0
5607185|NCT00853151|19371470|P1|Overall Study|Death|1
5607186|NCT00853151|19371467|P4|Overall Study|Lost to Follow-up|0
5607187|NCT00853151|19371468|P3|Overall Study|Lost to Follow-up|3
5607188|NCT00853151|19371469|P2|Overall Study|Lost to Follow-up|0
5607189|NCT00853151|19371470|P1|Overall Study|Lost to Follow-up|2
5607190|NCT00853151|19371467|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5607191|NCT00853151|19371468|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5607192|NCT00853151|19371469|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5607193|NCT00853151|19371470|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
5607194|NCT00853151|19371467|P4|Overall Study|Adverse Event|0
5607195|NCT00853151|19371468|P3|Overall Study|Adverse Event|2
5607196|NCT00853151|19371469|P2|Overall Study|Adverse Event|4
5607197|NCT00853151|19371470|P1|Overall Study|Adverse Event|1
5607198|NCT00853125|19371612|P1|Overall Study|Study participant's donor was CMV +|1
5607199|NCT00853112|19371624|P7|Overall Study|Randomized but not treated|1
5607200|NCT00853112|19371625|P6|Overall Study|Randomized but not treated|0
5607201|NCT00853112|19371626|P5|Overall Study|Randomized but not treated|0
5607202|NCT00853112|19371627|P4|Overall Study|Randomized but not treated|2
5607203|NCT00853112|19371628|P3|Overall Study|Randomized but not treated|0
5607204|NCT00853112|19371629|P2|Overall Study|Randomized but not treated|1
5607205|NCT00853112|19371630|P1|Overall Study|Randomized but not treated|0
5607206|NCT00853099|19371740|P4|Double-blind + Open-label Periods|Other|6
5607207|NCT00853099|19371741|P3|Double-blind + Open-label Periods|Other|0
5607208|NCT00853099|19371742|P2|Double-blind + Open-label Periods|Other|0
5607209|NCT00853099|19371743|P1|Double-blind + Open-label Periods|Other|0
5607210|NCT00853099|19371740|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
5607211|NCT00853099|19371741|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
5607212|NCT00853099|19371742|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
5607213|NCT00853099|19371743|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
5607214|NCT00853099|19371740|P4|Double-blind + Open-label Periods|Adverse Event|47
5607215|NCT00853099|19371741|P3|Double-blind + Open-label Periods|Adverse Event|0
5607216|NCT00853099|19371742|P2|Double-blind + Open-label Periods|Adverse Event|0
5607217|NCT00853099|19371743|P1|Double-blind + Open-label Periods|Adverse Event|0
5607218|NCT00853099|19371740|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
5607219|NCT00853099|19371741|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
5607220|NCT00853099|19371742|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
5607221|NCT00853099|19371743|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
5607222|NCT00853099|19371740|P4|Double-blind Period|Mistreated with rescue study drug|0
5607223|NCT00853099|19371741|P3|Double-blind Period|Mistreated with rescue study drug|1
5607224|NCT00853099|19371742|P2|Double-blind Period|Mistreated with rescue study drug|0
5607225|NCT00853099|19371743|P1|Double-blind Period|Mistreated with rescue study drug|0
5607226|NCT00853099|19371740|P4|Double-blind Period|Other|0
5607227|NCT00853099|19371741|P3|Double-blind Period|Other|1
5607228|NCT00853099|19371742|P2|Double-blind Period|Other|0
5607229|NCT00853099|19371743|P1|Double-blind Period|Other|0
5607230|NCT00853099|19371740|P4|Double-blind Period|Lack of Efficacy|0
5607231|NCT00853099|19371741|P3|Double-blind Period|Lack of Efficacy|16
5607232|NCT00853099|19371742|P2|Double-blind Period|Lack of Efficacy|17
5607233|NCT00853099|19371743|P1|Double-blind Period|Lack of Efficacy|14
5607234|NCT00853099|19371740|P4|Double-blind Period|Withdrawal by Subject|0
5607235|NCT00853099|19371741|P3|Double-blind Period|Withdrawal by Subject|0
5607236|NCT00853099|19371742|P2|Double-blind Period|Withdrawal by Subject|3
5607237|NCT00853099|19371743|P1|Double-blind Period|Withdrawal by Subject|2
5607238|NCT00853099|19371740|P4|Double-blind Period|Adverse Event|0
5607239|NCT00853099|19371741|P3|Double-blind Period|Adverse Event|13
5607240|NCT00853099|19371742|P2|Double-blind Period|Adverse Event|9
5607241|NCT00853099|19371743|P1|Double-blind Period|Adverse Event|7
5607242|NCT00853073|19371785|P2|Overall Study|Withdrawal by Subject|2
5607243|NCT00853073|19371786|P1|Overall Study|Withdrawal by Subject|3
5607244|NCT00853047|19371799|P6|Open-Label Extension Phase|Reason Not Specified|6
5607245|NCT00853047|19371800|P5|Open-Label Extension Phase|Reason Not Specified|0
5607246|NCT00853047|19371801|P4|Open-Label Extension Phase|Reason Not Specified|0
5607247|NCT00853047|19371802|P3|Open-Label Extension Phase|Reason Not Specified|0
5607248|NCT00853047|19371803|P2|Open-Label Extension Phase|Reason Not Specified|0
5607249|NCT00853047|19371804|P1|Open-Label Extension Phase|Reason Not Specified|0
5607250|NCT00853047|19371799|P6|Open-Label Extension Phase|Investigator Decision|1
5607251|NCT00853047|19371800|P5|Open-Label Extension Phase|Investigator Decision|0
5607252|NCT00853047|19371801|P4|Open-Label Extension Phase|Investigator Decision|0
5607253|NCT00853047|19371802|P3|Open-Label Extension Phase|Investigator Decision|0
5607254|NCT00853047|19371803|P2|Open-Label Extension Phase|Investigator Decision|0
5607255|NCT00853047|19371804|P1|Open-Label Extension Phase|Investigator Decision|0
5607256|NCT00853047|19371799|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
5607257|NCT00853047|19371800|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
5607258|NCT00853047|19371801|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
5607259|NCT00853047|19371802|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
5607260|NCT00853047|19371803|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
5607261|NCT00853047|19371804|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
5607262|NCT00853047|19371799|P6|Open-Label Extension Phase|Lost to Follow-up|1
5607263|NCT00853047|19371800|P5|Open-Label Extension Phase|Lost to Follow-up|0
5607264|NCT00853047|19371801|P4|Open-Label Extension Phase|Lost to Follow-up|0
5607265|NCT00853047|19371802|P3|Open-Label Extension Phase|Lost to Follow-up|0
5607266|NCT00853047|19371803|P2|Open-Label Extension Phase|Lost to Follow-up|0
5607267|NCT00853047|19371804|P1|Open-Label Extension Phase|Lost to Follow-up|0
5607268|NCT00853047|19371799|P6|Open-Label Extension Phase|Participant Request|7
5607269|NCT00853047|19371800|P5|Open-Label Extension Phase|Participant Request|0
5607270|NCT00853047|19371801|P4|Open-Label Extension Phase|Participant Request|0
5607271|NCT00853047|19371802|P3|Open-Label Extension Phase|Participant Request|0
5607272|NCT00853047|19371803|P2|Open-Label Extension Phase|Participant Request|0
5607273|NCT00853047|19371804|P1|Open-Label Extension Phase|Participant Request|0
5607274|NCT00853047|19371799|P6|Core Phase|Participant Request|0
5607275|NCT00853047|19371800|P5|Core Phase|Participant Request|0
5607276|NCT00853047|19371801|P4|Core Phase|Participant Request|1
5607277|NCT00853047|19371802|P3|Core Phase|Participant Request|0
5607278|NCT00853047|19371803|P2|Core Phase|Participant Request|0
5607279|NCT00853047|19371804|P1|Core Phase|Participant Request|0
5607280|NCT00853021|19371870|P1|Overall Study|Death|1
5607281|NCT00853021|19371870|P1|Overall Study|Withdrawal by Subject|2
5607282|NCT00853021|19371870|P1|Overall Study|Adverse Event|2
5607283|NCT00852995|19371882|P5|Overall Study|Moved Out of Area|0
5607284|NCT00852995|19371883|P4|Overall Study|Moved Out of Area|0
5607285|NCT00852995|19371884|P3|Overall Study|Moved Out of Area|0
5607286|NCT00852995|19371885|P2|Overall Study|Moved Out of Area|0
5607287|NCT00852995|19371886|P1|Overall Study|Moved Out of Area|1
5607288|NCT00852995|19371882|P5|Overall Study|Protocol Violation|1
5607289|NCT00852995|19371883|P4|Overall Study|Protocol Violation|0
5607290|NCT00852995|19371884|P3|Overall Study|Protocol Violation|0
5607291|NCT00852995|19371885|P2|Overall Study|Protocol Violation|0
5607292|NCT00852995|19371886|P1|Overall Study|Protocol Violation|0
5607293|NCT00852995|19371882|P5|Overall Study|Physician Decision|0
5607294|NCT00852995|19371883|P4|Overall Study|Physician Decision|0
5607295|NCT00852995|19371884|P3|Overall Study|Physician Decision|0
5607296|NCT00852995|19371885|P2|Overall Study|Physician Decision|0
5607297|NCT00852995|19371886|P1|Overall Study|Physician Decision|1
5607298|NCT00852995|19371882|P5|Overall Study|Progressive Disease|1
5607299|NCT00852995|19371883|P4|Overall Study|Progressive Disease|2
5607300|NCT00852995|19371884|P3|Overall Study|Progressive Disease|0
5607301|NCT00852995|19371885|P2|Overall Study|Progressive Disease|0
5607302|NCT00852995|19371886|P1|Overall Study|Progressive Disease|1
5607303|NCT00852995|19371882|P5|Overall Study|Non-Compliance|0
5607304|NCT00852995|19371883|P4|Overall Study|Non-Compliance|2
5607305|NCT00852995|19371884|P3|Overall Study|Non-Compliance|0
5607306|NCT00852995|19371885|P2|Overall Study|Non-Compliance|0
5607307|NCT00852995|19371886|P1|Overall Study|Non-Compliance|0
5607308|NCT00852995|19371882|P5|Overall Study|Withdrawal by Subject|2
5607309|NCT00852995|19371883|P4|Overall Study|Withdrawal by Subject|1
5607310|NCT00852995|19371884|P3|Overall Study|Withdrawal by Subject|0
5607311|NCT00852995|19371885|P2|Overall Study|Withdrawal by Subject|0
5607312|NCT00852995|19371886|P1|Overall Study|Withdrawal by Subject|4
5607313|NCT00852995|19371882|P5|Overall Study|Lost to Follow-up|0
5607314|NCT00852995|19371883|P4|Overall Study|Lost to Follow-up|0
5607315|NCT00852995|19371884|P3|Overall Study|Lost to Follow-up|1
5607316|NCT00852995|19371885|P2|Overall Study|Lost to Follow-up|1
5607317|NCT00852995|19371886|P1|Overall Study|Lost to Follow-up|0
5607318|NCT00852995|19371882|P5|Overall Study|Adverse Event|0
5607319|NCT00852995|19371883|P4|Overall Study|Adverse Event|0
5607320|NCT00852995|19371884|P3|Overall Study|Adverse Event|4
5607321|NCT00852995|19371885|P2|Overall Study|Adverse Event|0
5607322|NCT00852995|19371886|P1|Overall Study|Adverse Event|1
5607323|NCT00852969|19371930|P2|Overall Study|Lost to Follow-up|1
5607324|NCT00852969|19371931|P1|Overall Study|Lost to Follow-up|0
5607325|NCT00852969|19371930|P2|Overall Study|Adverse Event|1
5607326|NCT00852969|19371931|P1|Overall Study|Adverse Event|0
5607327|NCT00852930|19371942|P3|Overall Study|Physician Decision|1
5607328|NCT00852930|19371943|P2|Overall Study|Physician Decision|0
5607329|NCT00852930|19371944|P1|Overall Study|Physician Decision|0
5607330|NCT00852930|19371942|P3|Overall Study|Withdrawal by Subject|1
5607331|NCT00852930|19371943|P2|Overall Study|Withdrawal by Subject|1
5607332|NCT00852930|19371944|P1|Overall Study|Withdrawal by Subject|1
5607333|NCT00852917|19371965|P4|Overall Study|Death|1
5607334|NCT00852917|19371966|P3|Overall Study|Death|0
5607335|NCT00852917|19371967|P2|Overall Study|Death|0
5607336|NCT00852917|19371968|P1|Overall Study|Death|0
5607337|NCT00852917|19371965|P4|Overall Study|Physician Decision|19
5607338|NCT00852917|19371966|P3|Overall Study|Physician Decision|2
5607339|NCT00852917|19371967|P2|Overall Study|Physician Decision|7
5607340|NCT00852917|19371968|P1|Overall Study|Physician Decision|6
5607341|NCT00852917|19371965|P4|Overall Study|Withdrawal by Subject|9
5607342|NCT00852917|19371966|P3|Overall Study|Withdrawal by Subject|10
5607343|NCT00852917|19371967|P2|Overall Study|Withdrawal by Subject|8
5607344|NCT00852917|19371968|P1|Overall Study|Withdrawal by Subject|4
5607345|NCT00852917|19371965|P4|Overall Study|Lack of Efficacy|47
5607346|NCT00852917|19371966|P3|Overall Study|Lack of Efficacy|11
5607347|NCT00852917|19371967|P2|Overall Study|Lack of Efficacy|11
5607348|NCT00852917|19371968|P1|Overall Study|Lack of Efficacy|21
5607349|NCT00852917|19371965|P4|Overall Study|Adverse Event|17
5607350|NCT00852917|19371966|P3|Overall Study|Adverse Event|35
5607351|NCT00852917|19371967|P2|Overall Study|Adverse Event|20
5607352|NCT00852917|19371968|P1|Overall Study|Adverse Event|13
5607353|NCT00852540|19372096|P2|Overall Study|Did Not Receive Study Drug|3
5607354|NCT00852540|19372097|P1|Overall Study|Did Not Receive Study Drug|3
5607355|NCT00852540|19372096|P2|Overall Study|Withdrawal by Subject|1
5607356|NCT00852540|19372097|P1|Overall Study|Withdrawal by Subject|3
5607357|NCT00852540|19372096|P2|Overall Study|Investigator Discretion|3
5607358|NCT00852540|19372097|P1|Overall Study|Investigator Discretion|2
5607359|NCT00852540|19372096|P2|Overall Study|Lost to Follow-up|3
5607360|NCT00852540|19372097|P1|Overall Study|Lost to Follow-up|2
5607361|NCT00852540|19372096|P2|Overall Study|Protocol Violation|2
5607362|NCT00852540|19372097|P1|Overall Study|Protocol Violation|1
5607363|NCT00852540|19372096|P2|Overall Study|Lack of Efficacy|3
5607364|NCT00852540|19372097|P1|Overall Study|Lack of Efficacy|15
5607365|NCT00852540|19372096|P2|Overall Study|Adverse Event|3
5607366|NCT00852540|19372097|P1|Overall Study|Adverse Event|10
5607367|NCT00852475|19372131|P2|Overall Study|Lost to Follow-up|4
5607368|NCT00852475|19372132|P1|Overall Study|Lost to Follow-up|3
5607369|NCT00852397|19372143|P3|Overall Study|Protocol Violation|1
5607370|NCT00852397|19372144|P2|Overall Study|Protocol Violation|0
5607371|NCT00852397|19372145|P1|Overall Study|Protocol Violation|0
5607372|NCT00852397|19372143|P3|Overall Study|Difficulty in study site visit|0
5607373|NCT00852397|19372144|P2|Overall Study|Difficulty in study site visit|0
5607374|NCT00852397|19372145|P1|Overall Study|Difficulty in study site visit|1
5607375|NCT00852397|19372143|P3|Overall Study|Study terminated by sponsor|6
5607376|NCT00852397|19372144|P2|Overall Study|Study terminated by sponsor|1
5607377|NCT00852397|19372145|P1|Overall Study|Study terminated by sponsor|2
5607378|NCT00852397|19372143|P3|Overall Study|Withdrawal by Subject|2
5607379|NCT00852397|19372144|P2|Overall Study|Withdrawal by Subject|1
5607380|NCT00852397|19372145|P1|Overall Study|Withdrawal by Subject|4
5607381|NCT00852397|19372143|P3|Overall Study|Death|1
5607382|NCT00852397|19372144|P2|Overall Study|Death|0
5607383|NCT00852397|19372145|P1|Overall Study|Death|0
5607384|NCT00852397|19372143|P3|Overall Study|Adverse Event|4
5607385|NCT00852397|19372144|P2|Overall Study|Adverse Event|6
5607386|NCT00852397|19372145|P1|Overall Study|Adverse Event|4
5607387|NCT00852241|19372174|P1|Overall Study|Physician Decision|18
5607388|NCT00852202|19372181|P3|Overall Study|pregnancy,moving away and surgery|2
5607389|NCT00852202|19372182|P2|Overall Study|pregnancy,moving away and surgery|0
5607390|NCT00852202|19372183|P1|Overall Study|pregnancy,moving away and surgery|1
5607391|NCT00852202|19372181|P3|Overall Study|Lost to Follow-up|6
5607392|NCT00852202|19372182|P2|Overall Study|Lost to Follow-up|5
5607393|NCT00852202|19372183|P1|Overall Study|Lost to Follow-up|5
5607394|NCT00852202|19372181|P3|Overall Study|Withdrawal by Subject|2
5607395|NCT00852202|19372182|P2|Overall Study|Withdrawal by Subject|1
5607396|NCT00852202|19372183|P1|Overall Study|Withdrawal by Subject|3
5607397|NCT00852202|19372181|P3|Overall Study|Protocol Violation|7
5607398|NCT00852202|19372182|P2|Overall Study|Protocol Violation|2
5607399|NCT00852202|19372183|P1|Overall Study|Protocol Violation|2
5607400|NCT00852202|19372181|P3|Overall Study|Lack of Efficacy|2
5607401|NCT00852202|19372182|P2|Overall Study|Lack of Efficacy|1
5607402|NCT00852202|19372183|P1|Overall Study|Lack of Efficacy|4
5607403|NCT00852202|19372181|P3|Overall Study|Adverse Event|7
5607404|NCT00852202|19372182|P2|Overall Study|Adverse Event|3
5607405|NCT00852202|19372183|P1|Overall Study|Adverse Event|2
5607406|NCT00851903|19372225|P1|Overall Study|Withdrawal by Subject|2
5607407|NCT00851890|19372239|P4|Overall Study|Lost to Follow-up|1
5607408|NCT00851890|19372240|P3|Overall Study|Lost to Follow-up|0
5607409|NCT00851890|19372241|P2|Overall Study|Lost to Follow-up|1
5607410|NCT00851890|19372242|P1|Overall Study|Lost to Follow-up|0
5607411|NCT00851877|19372299|P3|Phase II|Withdrawal by Subject|3
5607412|NCT00851877|19372300|P2|Phase II|Withdrawal by Subject|0
5607413|NCT00851877|19372301|P1|Phase II|Withdrawal by Subject|0
5607414|NCT00851877|19372299|P3|Phase I-1|Death|0
5607415|NCT00851877|19372300|P2|Phase I-1|Death|0
5607416|NCT00851877|19372301|P1|Phase I-1|Death|1
5607417|NCT00851799|19372311|P3|Overall Study|Completed protocol due to pregnancy|1
5607418|NCT00851799|19372312|P2|Overall Study|Completed protocol due to pregnancy|0
5607419|NCT00851799|19372313|P1|Overall Study|Completed protocol due to pregnancy|0
5607420|NCT00851799|19372311|P3|Overall Study|Severe Debilitation|0
5607421|NCT00851799|19372312|P2|Overall Study|Severe Debilitation|1
5607422|NCT00851799|19372313|P1|Overall Study|Severe Debilitation|0
5607423|NCT00851799|19372311|P3|Overall Study|Withdrew consent prior study completion|1
5607424|NCT00851799|19372312|P2|Overall Study|Withdrew consent prior study completion|2
5607425|NCT00851799|19372313|P1|Overall Study|Withdrew consent prior study completion|1
5607426|NCT00851799|19372311|P3|Overall Study|Not willing to adhere to requirements|2
5607427|NCT00851799|19372312|P2|Overall Study|Not willing to adhere to requirements|2
5607428|NCT00851799|19372313|P1|Overall Study|Not willing to adhere to requirements|1
5607429|NCT00851799|19372311|P3|Overall Study|Not able to get to clinic|9
5607430|NCT00851799|19372312|P2|Overall Study|Not able to get to clinic|5
5607431|NCT00851799|19372313|P1|Overall Study|Not able to get to clinic|8
5607432|NCT00851799|19372311|P3|Overall Study|Lost to Follow-up|10
5607433|NCT00851799|19372312|P2|Overall Study|Lost to Follow-up|3
5607434|NCT00851799|19372313|P1|Overall Study|Lost to Follow-up|5
5607435|NCT00851799|19372311|P3|Overall Study|Death|1
5607436|NCT00851799|19372312|P2|Overall Study|Death|0
5607437|NCT00851799|19372313|P1|Overall Study|Death|1
5607438|NCT00851786|19372401|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
5607439|NCT00851786|19372402|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
5607440|NCT00851786|19372401|P2|Overall Study|Site Closure|0
5607441|NCT00851786|19372402|P1|Overall Study|Site Closure|1
5607442|NCT00851786|19372401|P2|Overall Study|Incarceration|0
5607443|NCT00851786|19372402|P1|Overall Study|Incarceration|1
5607444|NCT00851786|19372401|P2|Overall Study|Lost to Follow-up|0
5607445|NCT00851786|19372402|P1|Overall Study|Lost to Follow-up|1
5607446|NCT00851786|19372401|P2|Overall Study|Protocol Violation|1
5607447|NCT00851786|19372402|P1|Overall Study|Protocol Violation|0
5607448|NCT00851786|19372401|P2|Overall Study|Withdrawal by Subject|1
5607449|NCT00851786|19372402|P1|Overall Study|Withdrawal by Subject|0
5607450|NCT00851747|19372415|P3|Overall Study|Physician Decision|6
5607451|NCT00851747|19372416|P2|Overall Study|Physician Decision|6
5607452|NCT00851747|19372417|P1|Overall Study|Physician Decision|6
5607453|NCT00851721|19372426|P2|Overall Study|Adverse Event|1
5607454|NCT00851721|19372427|P1|Overall Study|Adverse Event|0
5607455|NCT00851721|19372426|P2|Overall Study|Death|0
5607456|NCT00851721|19372427|P1|Overall Study|Death|1
5607457|NCT00851721|19372426|P2|Overall Study|planned surgery|0
5607458|NCT00851721|19372427|P1|Overall Study|planned surgery|1
5607459|NCT00851682|19372517|P2|Overall Study|screen failure|0
5607460|NCT00851682|19372518|P1|Overall Study|screen failure|5
5607461|NCT00851643|19372532|P6|Extension Study (Up to 36 Months)|Moved|1
5607462|NCT00851643|19372533|P5|Extension Study (Up to 36 Months)|Moved|0
5607463|NCT00851643|19372534|P4|Extension Study (Up to 36 Months)|Moved|1
5607464|NCT00851643|19372535|P3|Extension Study (Up to 36 Months)|Moved|1
5607465|NCT00851643|19372536|P2|Extension Study (Up to 36 Months)|Moved|2
5607466|NCT00851643|19372537|P1|Extension Study (Up to 36 Months)|Moved|0
5607467|NCT00851643|19372532|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
5607468|NCT00851643|19372533|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
5607469|NCT00851643|19372534|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
5607470|NCT00851643|19372535|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
5607471|NCT00851643|19372536|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
5607472|NCT00851643|19372537|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
5607473|NCT00851643|19372532|P6|Base Study (Up to 12 Months)|Other|1
5607474|NCT00851643|19372533|P5|Base Study (Up to 12 Months)|Other|0
5607475|NCT00851643|19372534|P4|Base Study (Up to 12 Months)|Other|0
5607476|NCT00851643|19372535|P3|Base Study (Up to 12 Months)|Other|0
5607477|NCT00851643|19372536|P2|Base Study (Up to 12 Months)|Other|0
5607478|NCT00851643|19372537|P1|Base Study (Up to 12 Months)|Other|0
5607479|NCT00851643|19372532|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5607480|NCT00851643|19372533|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5607481|NCT00851643|19372534|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5607482|NCT00851643|19372535|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5607483|NCT00851643|19372536|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
5607484|NCT00851643|19372537|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
5607485|NCT00851630|19372558|P2|Overall Study|Clinical failure|1
5607486|NCT00851630|19372559|P1|Overall Study|Clinical failure|0
5607487|NCT00851630|19372558|P2|Overall Study|Death|1
5607488|NCT00851630|19372559|P1|Overall Study|Death|2
5607489|NCT00851591|19372573|P2|Overall Study|Withdrawal by Subject|0
5607490|NCT00851591|19372574|P1|Overall Study|Withdrawal by Subject|2
5607491|NCT00851552|19372580|P1|Overall Study|Disease Progression|4
5607492|NCT00851552|19372580|P1|Overall Study|Adverse Event|1
5607493|NCT00851552|19372580|P1|Overall Study|Death|2
5607494|NCT00851318|19372610|P4|Overall Study|Physician Decision|1
5607495|NCT00851318|19372611|P3|Overall Study|Physician Decision|1
5607496|NCT00851318|19372612|P2|Overall Study|Physician Decision|0
5607497|NCT00851318|19372613|P1|Overall Study|Physician Decision|0
5607498|NCT00851318|19372610|P4|Overall Study|Non-compliance with Study Procedures|0
5607499|NCT00851318|19372611|P3|Overall Study|Non-compliance with Study Procedures|1
5607500|NCT00851318|19372612|P2|Overall Study|Non-compliance with Study Procedures|0
5607501|NCT00851318|19372613|P1|Overall Study|Non-compliance with Study Procedures|2
5607502|NCT00851318|19372610|P4|Overall Study|Lack of Efficacy|2
5607503|NCT00851318|19372611|P3|Overall Study|Lack of Efficacy|4
5607504|NCT00851318|19372612|P2|Overall Study|Lack of Efficacy|2
5607505|NCT00851318|19372613|P1|Overall Study|Lack of Efficacy|8
5607506|NCT00851318|19372610|P4|Overall Study|Pregnancy|1
5607507|NCT00851318|19372611|P3|Overall Study|Pregnancy|1
5607508|NCT00851318|19372612|P2|Overall Study|Pregnancy|0
5607509|NCT00851318|19372613|P1|Overall Study|Pregnancy|0
5607510|NCT00851318|19372610|P4|Overall Study|Adverse Event|12
5607511|NCT00851318|19372611|P3|Overall Study|Adverse Event|9
5607512|NCT00851318|19372612|P2|Overall Study|Adverse Event|2
5607513|NCT00851318|19372613|P1|Overall Study|Adverse Event|13
5607514|NCT00851318|19372610|P4|Overall Study|Withdrawal by Subject|3
5607515|NCT00851318|19372611|P3|Overall Study|Withdrawal by Subject|5
5607516|NCT00851318|19372612|P2|Overall Study|Withdrawal by Subject|1
5607517|NCT00851318|19372613|P1|Overall Study|Withdrawal by Subject|7
5607518|NCT00851253|19372649|P2|Overall Study|Disease Progression|0
5607519|NCT00851253|19372650|P1|Overall Study|Disease Progression|1
5607520|NCT00851084|19372660|P2|Overall Study|Other|1
5607521|NCT00851084|19372661|P1|Overall Study|Other|7
5607522|NCT00851084|19372660|P2|Overall Study|Metastatic surgery|6
5607523|NCT00851084|19372661|P1|Overall Study|Metastatic surgery|6
5607524|NCT00851084|19372660|P2|Overall Study|Withdrawal by Subject|12
5607525|NCT00851084|19372661|P1|Overall Study|Withdrawal by Subject|11
5607526|NCT00851084|19372660|P2|Overall Study|Consent withdrawn|2
5607527|NCT00851084|19372661|P1|Overall Study|Consent withdrawn|0
5607528|NCT00851084|19372660|P2|Overall Study|Physician Decision|14
5607529|NCT00851084|19372661|P1|Overall Study|Physician Decision|13
5607530|NCT00851084|19372660|P2|Overall Study|Poor compliance to protocol|1
5607531|NCT00851084|19372661|P1|Overall Study|Poor compliance to protocol|1
5607532|NCT00851084|19372660|P2|Overall Study|Disease progression|47
5607533|NCT00851084|19372661|P1|Overall Study|Disease progression|52
5607534|NCT00851084|19372660|P2|Overall Study|Adverse Event|36
5607535|NCT00851084|19372661|P1|Overall Study|Adverse Event|26
5607536|NCT00851084|19372660|P2|Overall Study|Randomized but not treated|0
5607537|NCT00851084|19372661|P1|Overall Study|Randomized but not treated|1
5607538|NCT00850993|19372689|P4|Overall Study|Parent/Guardian Voluntarily Withdrew|1
5607539|NCT00850993|19372690|P3|Overall Study|Parent/Guardian Voluntarily Withdrew|0
5607540|NCT00850993|19372691|P2|Overall Study|Parent/Guardian Voluntarily Withdrew|0
5607541|NCT00850993|19372692|P1|Overall Study|Parent/Guardian Voluntarily Withdrew|1
5607542|NCT00850759|19372721|P4|Overall Study|Lost to Follow-up|3
5607543|NCT00850759|19372722|P3|Overall Study|Lost to Follow-up|5
5607544|NCT00850759|19372723|P2|Overall Study|Lost to Follow-up|5
5607545|NCT00850759|19372724|P1|Overall Study|Lost to Follow-up|7
5607546|NCT00850564|19372805|P1|Overall Study|Withdrawal by Subject|2
5607547|NCT00850538|19372810|P1|Overall Study|Protocol Violation|2
5607548|NCT00850538|19372810|P1|Overall Study|radiology error|2
5607549|NCT00850538|19372810|P1|Overall Study|Withdrawal by Subject|3
5607550|NCT00850538|19372810|P1|Overall Study|specimen unusable|7
5607551|NCT00850538|19372810|P1|Overall Study|specimen missed due to scheduling error|14
5607552|NCT00850538|19372810|P1|Overall Study|unable/unwilling to complete MRI|13
5607553|NCT00850499|19372816|P2|Overall Study|Lack of Efficacy|1
5607554|NCT00850499|19372817|P1|Overall Study|Lack of Efficacy|0
5607555|NCT00850499|19372816|P2|Overall Study|Adverse Event|1
5607556|NCT00850499|19372817|P1|Overall Study|Adverse Event|3
5607557|NCT00850460|19372831|P2|Overall Study|Lost to Follow-up|4
5607558|NCT00850460|19372832|P1|Overall Study|Lost to Follow-up|4
5607559|NCT00850395|19372846|P1|Overall Study|Other|5
5607560|NCT00850395|19372846|P1|Overall Study|Insufficient clinical response|3
5607561|NCT00850395|19372846|P1|Overall Study|Adverse Event|1
5607562|NCT00850395|19372846|P1|Overall Study|Death|1
5607563|NCT00850343|19372866|P4|Overall Study|Physician Decision|1
5607564|NCT00850343|19372867|P3|Overall Study|Physician Decision|1
5607565|NCT00850343|19372868|P2|Overall Study|Physician Decision|1
5607566|NCT00850343|19372869|P1|Overall Study|Physician Decision|2
5607567|NCT00850343|19372866|P4|Overall Study|Non-compliance with Study Procedures|1
5607568|NCT00850343|19372867|P3|Overall Study|Non-compliance with Study Procedures|1
5607569|NCT00850343|19372868|P2|Overall Study|Non-compliance with Study Procedures|0
5607570|NCT00850343|19372869|P1|Overall Study|Non-compliance with Study Procedures|1
5607571|NCT00850343|19372866|P4|Overall Study|Lack of Efficacy|2
5607572|NCT00850343|19372867|P3|Overall Study|Lack of Efficacy|3
5607573|NCT00850343|19372868|P2|Overall Study|Lack of Efficacy|0
5607574|NCT00850343|19372869|P1|Overall Study|Lack of Efficacy|17
5607575|NCT00850343|19372866|P4|Overall Study|Pregnancy|1
5607576|NCT00850343|19372867|P3|Overall Study|Pregnancy|0
5607577|NCT00850343|19372868|P2|Overall Study|Pregnancy|0
5607578|NCT00850343|19372869|P1|Overall Study|Pregnancy|0
5607579|NCT00850343|19372866|P4|Overall Study|Adverse Event|6
5607580|NCT00850343|19372867|P3|Overall Study|Adverse Event|6
5607581|NCT00850343|19372868|P2|Overall Study|Adverse Event|2
5607582|NCT00850343|19372869|P1|Overall Study|Adverse Event|15
5607583|NCT00850343|19372866|P4|Overall Study|Withdrawal by Subject|2
5607584|NCT00850343|19372867|P3|Overall Study|Withdrawal by Subject|3
5607585|NCT00850343|19372868|P2|Overall Study|Withdrawal by Subject|0
5607586|NCT00850343|19372869|P1|Overall Study|Withdrawal by Subject|11
5607587|NCT00850200|19372899|P1|Overall Study|Withdrawal by Subject|1
5607588|NCT00850200|19372899|P1|Overall Study|Did not recieve treatment|2
5607589|NCT00850200|19372899|P1|Overall Study|Physician Decision|2
5607590|NCT00850174|19372909|P2|Second Intervention|Withdrawal by Subject|0
5607591|NCT00850174|19372910|P1|Second Intervention|Withdrawal by Subject|1
5607592|NCT00850174|19372909|P2|Washout: One Week|Withdrawal by Subject|2
5607593|NCT00850174|19372910|P1|Washout: One Week|Withdrawal by Subject|0
5607594|NCT00850135|19372924|P1|Overall Study|Physician Decision|1
5607595|NCT00850070|19372943|P2|Overall Study|Adverse Event|0
5607596|NCT00850070|19372944|P1|Overall Study|Adverse Event|2
5607597|NCT00850070|19372943|P2|Overall Study|Lack of Efficacy|1
5607598|NCT00850070|19372944|P1|Overall Study|Lack of Efficacy|1
5607599|NCT00849940|19372973|P1|Overall Study|Physician Decision|4
5607600|NCT00849901|19372984|P3|Extension Phase|Lack of Efficacy|1
5607601|NCT00849901|19372985|P2|Extension Phase|Lack of Efficacy|4
5607602|NCT00849901|19372986|P1|Extension Phase|Lack of Efficacy|2
5607603|NCT00849901|19372984|P3|Extension Phase|Physician Decision|0
5607604|NCT00849901|19372985|P2|Extension Phase|Physician Decision|2
5607605|NCT00849901|19372986|P1|Extension Phase|Physician Decision|1
5607606|NCT00849901|19372984|P3|Extension Phase|Parent or Caregiver Decision|4
5607607|NCT00849901|19372985|P2|Extension Phase|Parent or Caregiver Decision|4
5607608|NCT00849901|19372986|P1|Extension Phase|Parent or Caregiver Decision|10
5607609|NCT00849901|19372984|P3|Extension Phase|Withdrawal by Subject|3
5607610|NCT00849901|19372985|P2|Extension Phase|Withdrawal by Subject|6
5607611|NCT00849901|19372986|P1|Extension Phase|Withdrawal by Subject|7
5607612|NCT00849901|19372984|P3|Extension Phase|Protocol Violation|4
5607613|NCT00849901|19372985|P2|Extension Phase|Protocol Violation|2
5607614|NCT00849901|19372986|P1|Extension Phase|Protocol Violation|2
5607615|NCT00849901|19372984|P3|Extension Phase|Lost to Follow-up|1
5607616|NCT00849901|19372985|P2|Extension Phase|Lost to Follow-up|0
5607617|NCT00849901|19372986|P1|Extension Phase|Lost to Follow-up|3
5607618|NCT00849901|19372984|P3|Extension Phase|Adverse Event|4
5607619|NCT00849901|19372985|P2|Extension Phase|Adverse Event|8
5607620|NCT00849901|19372986|P1|Extension Phase|Adverse Event|2
5607621|NCT00849901|19372984|P3|Acute Treatment Phase|Lack of Efficacy|2
5607622|NCT00849901|19372985|P2|Acute Treatment Phase|Lack of Efficacy|3
5607623|NCT00849901|19372986|P1|Acute Treatment Phase|Lack of Efficacy|2
5607624|NCT00849901|19372984|P3|Acute Treatment Phase|Sponsor Decision|0
5607625|NCT00849901|19372985|P2|Acute Treatment Phase|Sponsor Decision|0
5607626|NCT00849901|19372986|P1|Acute Treatment Phase|Sponsor Decision|1
5607627|NCT00849901|19372984|P3|Acute Treatment Phase|Physician Decision|1
5607628|NCT00849901|19372985|P2|Acute Treatment Phase|Physician Decision|1
5607629|NCT00849901|19372986|P1|Acute Treatment Phase|Physician Decision|1
5607630|NCT00849901|19372984|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
5607631|NCT00849901|19372985|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
5607632|NCT00849901|19372986|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
5607633|NCT00849901|19372984|P3|Acute Treatment Phase|Withdrawal by Subject|4
5607634|NCT00849901|19372985|P2|Acute Treatment Phase|Withdrawal by Subject|10
5607635|NCT00849901|19372986|P1|Acute Treatment Phase|Withdrawal by Subject|4
5607636|NCT00849901|19372984|P3|Acute Treatment Phase|Protocol Violation|1
5607637|NCT00849901|19372985|P2|Acute Treatment Phase|Protocol Violation|2
5607638|NCT00849901|19372986|P1|Acute Treatment Phase|Protocol Violation|0
5607639|NCT00849901|19372984|P3|Acute Treatment Phase|Lost to Follow-up|1
5607640|NCT00849901|19372985|P2|Acute Treatment Phase|Lost to Follow-up|4
5607641|NCT00849901|19372986|P1|Acute Treatment Phase|Lost to Follow-up|2
5607642|NCT00849901|19372984|P3|Acute Treatment Phase|Adverse Event|3
5607643|NCT00849901|19372985|P2|Acute Treatment Phase|Adverse Event|1
5607644|NCT00849901|19372986|P1|Acute Treatment Phase|Adverse Event|9
5607645|NCT00849875|19373033|P1|Overall Study|Lost to Follow-up|2
5607646|NCT00849875|19373033|P1|Overall Study|Others|6
5607647|NCT00849875|19373033|P1|Overall Study|Ongoing (unknown completion status)|11
5607648|NCT00849875|19373033|P1|Overall Study|Death|28
5607649|NCT00849797|19373130|P2|Washout: One Week|Withdrawal by Subject|2
5607650|NCT00849797|19373131|P1|Washout: One Week|Withdrawal by Subject|0
5607651|NCT00849797|19373130|P2|First Intervention|Adverse Event|1
5607652|NCT00849797|19373131|P1|First Intervention|Adverse Event|0
5607653|NCT00849797|19373130|P2|First Intervention|bad veins|0
5607654|NCT00849797|19373131|P1|First Intervention|bad veins|1
5607655|NCT00849693|19373149|P4|Extension Phase|Lack of Efficacy|1
5607656|NCT00849693|19373150|P3|Extension Phase|Lack of Efficacy|2
5607657|NCT00849693|19373151|P2|Extension Phase|Lack of Efficacy|2
5607658|NCT00849693|19373152|P1|Extension Phase|Lack of Efficacy|2
5607659|NCT00849693|19373149|P4|Extension Phase|Sponsor decision|1
5607660|NCT00849693|19373150|P3|Extension Phase|Sponsor decision|0
5607661|NCT00849693|19373151|P2|Extension Phase|Sponsor decision|0
5607662|NCT00849693|19373152|P1|Extension Phase|Sponsor decision|1
5607663|NCT00849693|19373149|P4|Extension Phase|Physician Decision|0
5607664|NCT00849693|19373150|P3|Extension Phase|Physician Decision|2
5607665|NCT00849693|19373151|P2|Extension Phase|Physician Decision|1
5607666|NCT00849693|19373152|P1|Extension Phase|Physician Decision|1
5607667|NCT00849693|19373149|P4|Extension Phase|Parent or caregiver decision|5
5607668|NCT00849693|19373150|P3|Extension Phase|Parent or caregiver decision|10
5607669|NCT00849693|19373151|P2|Extension Phase|Parent or caregiver decision|4
5607670|NCT00849693|19373152|P1|Extension Phase|Parent or caregiver decision|9
5607671|NCT00849693|19373149|P4|Extension Phase|Withdrawal by Subject|15
5607672|NCT00849693|19373150|P3|Extension Phase|Withdrawal by Subject|10
5607673|NCT00849693|19373151|P2|Extension Phase|Withdrawal by Subject|9
5607674|NCT00849693|19373152|P1|Extension Phase|Withdrawal by Subject|6
5607675|NCT00849693|19373149|P4|Extension Phase|Protocol Violation|3
5607676|NCT00849693|19373150|P3|Extension Phase|Protocol Violation|2
5607677|NCT00849693|19373151|P2|Extension Phase|Protocol Violation|3
5607678|NCT00849693|19373152|P1|Extension Phase|Protocol Violation|0
5607679|NCT00849693|19373149|P4|Extension Phase|Lost to Follow-up|6
5607680|NCT00849693|19373150|P3|Extension Phase|Lost to Follow-up|6
5607681|NCT00849693|19373151|P2|Extension Phase|Lost to Follow-up|5
5607682|NCT00849693|19373152|P1|Extension Phase|Lost to Follow-up|7
5607683|NCT00849693|19373149|P4|Extension Phase|Adverse Event|7
5607684|NCT00849693|19373150|P3|Extension Phase|Adverse Event|3
5607685|NCT00849693|19373151|P2|Extension Phase|Adverse Event|6
5607686|NCT00849693|19373152|P1|Extension Phase|Adverse Event|4
5607687|NCT00849693|19373149|P4|Acute Treatment Phase|Lack of Efficacy|2
5607688|NCT00849693|19373150|P3|Acute Treatment Phase|Lack of Efficacy|1
5607689|NCT00849693|19373151|P2|Acute Treatment Phase|Lack of Efficacy|3
5607690|NCT00849693|19373152|P1|Acute Treatment Phase|Lack of Efficacy|1
5607691|NCT00849693|19373149|P4|Acute Treatment Phase|Sponsor decision|0
5607692|NCT00849693|19373150|P3|Acute Treatment Phase|Sponsor decision|1
5607693|NCT00849693|19373151|P2|Acute Treatment Phase|Sponsor decision|0
5607694|NCT00849693|19373152|P1|Acute Treatment Phase|Sponsor decision|0
5607695|NCT00849693|19373149|P4|Acute Treatment Phase|Physician Decision|1
5607696|NCT00849693|19373150|P3|Acute Treatment Phase|Physician Decision|2
5607697|NCT00849693|19373151|P2|Acute Treatment Phase|Physician Decision|1
5607698|NCT00849693|19373152|P1|Acute Treatment Phase|Physician Decision|2
5607699|NCT00849693|19373149|P4|Acute Treatment Phase|Parent or caregiver decision|7
5607700|NCT00849693|19373150|P3|Acute Treatment Phase|Parent or caregiver decision|7
5607701|NCT00849693|19373151|P2|Acute Treatment Phase|Parent or caregiver decision|6
5607702|NCT00849693|19373152|P1|Acute Treatment Phase|Parent or caregiver decision|7
5607703|NCT00849693|19373149|P4|Acute Treatment Phase|Withdrawal by Subject|8
5607704|NCT00849693|19373150|P3|Acute Treatment Phase|Withdrawal by Subject|3
5607705|NCT00849693|19373151|P2|Acute Treatment Phase|Withdrawal by Subject|5
5607706|NCT00849693|19373152|P1|Acute Treatment Phase|Withdrawal by Subject|5
5607707|NCT00849693|19373149|P4|Acute Treatment Phase|Protocol Violation|6
5607708|NCT00849693|19373150|P3|Acute Treatment Phase|Protocol Violation|2
5607709|NCT00849693|19373151|P2|Acute Treatment Phase|Protocol Violation|5
5607710|NCT00849693|19373152|P1|Acute Treatment Phase|Protocol Violation|1
5607711|NCT00849693|19373149|P4|Acute Treatment Phase|Lost to Follow-up|9
5607712|NCT00849693|19373150|P3|Acute Treatment Phase|Lost to Follow-up|11
5607713|NCT00849693|19373151|P2|Acute Treatment Phase|Lost to Follow-up|8
5607714|NCT00849693|19373152|P1|Acute Treatment Phase|Lost to Follow-up|5
5607715|NCT00849693|19373149|P4|Acute Treatment Phase|Adverse Event|4
5607716|NCT00849693|19373150|P3|Acute Treatment Phase|Adverse Event|6
5607717|NCT00849693|19373151|P2|Acute Treatment Phase|Adverse Event|7
5607718|NCT00849693|19373152|P1|Acute Treatment Phase|Adverse Event|12
5607719|NCT00849680|19373219|P8|Overall Study|Subject unable to comply with protocol|0
5607720|NCT00849680|19373220|P7|Overall Study|Subject unable to comply with protocol|0
5607721|NCT00849680|19373221|P6|Overall Study|Subject unable to comply with protocol|0
5607722|NCT00849680|19373222|P5|Overall Study|Subject unable to comply with protocol|0
5607723|NCT00849680|19373223|P4|Overall Study|Subject unable to comply with protocol|0
5607724|NCT00849680|19373224|P3|Overall Study|Subject unable to comply with protocol|0
5607725|NCT00849680|19373225|P2|Overall Study|Subject unable to comply with protocol|0
5607726|NCT00849680|19373226|P1|Overall Study|Subject unable to comply with protocol|1
5607727|NCT00849680|19373219|P8|Overall Study|Withdrawal by Subject|1
5607728|NCT00849680|19373220|P7|Overall Study|Withdrawal by Subject|1
5607729|NCT00849680|19373221|P6|Overall Study|Withdrawal by Subject|2
5607730|NCT00849680|19373222|P5|Overall Study|Withdrawal by Subject|2
5607731|NCT00849680|19373223|P4|Overall Study|Withdrawal by Subject|2
5607732|NCT00849680|19373224|P3|Overall Study|Withdrawal by Subject|0
5607733|NCT00849680|19373225|P2|Overall Study|Withdrawal by Subject|0
5607734|NCT00849680|19373226|P1|Overall Study|Withdrawal by Subject|2
5607735|NCT00849680|19373219|P8|Overall Study|Subject moved|2
5607736|NCT00849680|19373220|P7|Overall Study|Subject moved|2
5607737|NCT00849680|19373221|P6|Overall Study|Subject moved|2
5607738|NCT00849680|19373222|P5|Overall Study|Subject moved|0
5607739|NCT00849680|19373223|P4|Overall Study|Subject moved|1
5607740|NCT00849680|19373224|P3|Overall Study|Subject moved|3
5607741|NCT00849680|19373225|P2|Overall Study|Subject moved|0
5607742|NCT00849680|19373226|P1|Overall Study|Subject moved|1
5607743|NCT00849680|19373219|P8|Overall Study|Lost to Follow-up|5
5607744|NCT00849680|19373220|P7|Overall Study|Lost to Follow-up|12
5607745|NCT00849680|19373221|P6|Overall Study|Lost to Follow-up|11
5607746|NCT00849680|19373222|P5|Overall Study|Lost to Follow-up|8
5607747|NCT00849680|19373223|P4|Overall Study|Lost to Follow-up|11
5607748|NCT00849680|19373224|P3|Overall Study|Lost to Follow-up|12
5607749|NCT00849680|19373225|P2|Overall Study|Lost to Follow-up|3
5607750|NCT00849680|19373226|P1|Overall Study|Lost to Follow-up|7
5607751|NCT00849680|19373219|P8|Overall Study|Adverse Event|0
5607752|NCT00849680|19373220|P7|Overall Study|Adverse Event|2
5607753|NCT00849680|19373221|P6|Overall Study|Adverse Event|0
5607754|NCT00849680|19373222|P5|Overall Study|Adverse Event|0
5607755|NCT00849680|19373223|P4|Overall Study|Adverse Event|0
5607756|NCT00849680|19373224|P3|Overall Study|Adverse Event|0
5607757|NCT00849680|19373225|P2|Overall Study|Adverse Event|0
5607758|NCT00849680|19373226|P1|Overall Study|Adverse Event|0
5607759|NCT00849524|19373268|P1|Overall Study|Lack of Efficacy|3
5607760|NCT00849472|19373285|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
5607761|NCT00849472|19373285|P1|Pazopanib Postsurgery Treatment|Moved|1
5607762|NCT00849472|19373285|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
5607763|NCT00849472|19373285|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
5607764|NCT00849472|19373285|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
5607765|NCT00849472|19373285|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
5607766|NCT00849472|19373285|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
5607767|NCT00849472|19373285|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
5607768|NCT00849472|19373285|P1|Weekly Paclitaxel|Physician Decision|3
5607769|NCT00849472|19373285|P1|Weekly Paclitaxel|Withdrawal by Subject|1
5607770|NCT00849472|19373285|P1|Weekly Paclitaxel|Adverse Event|11
5607771|NCT00849472|19373285|P1|Weekly Paclitaxel|Disease Progression|1
5607772|NCT00849472|19373285|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
5607773|NCT00849472|19373285|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
5607774|NCT00849472|19373285|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
5607775|NCT00849472|19373285|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
5607776|NCT00849472|19373285|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
5607777|NCT00849381|19373299|P1|Overall Study|Other|4
5607778|NCT00849381|19373299|P1|Overall Study|Withdrawal by Subject|6
5607779|NCT00849381|19373299|P1|Overall Study|Protocol Violation|5
5607780|NCT00849381|19373299|P1|Overall Study|Lost to Follow-up|129
5607781|NCT00849381|19373299|P1|Overall Study|Adverse Event|1
5607782|NCT00849290|19373305|P1|Overall Study|Disease Progression|20
5607783|NCT00849290|19373305|P1|Overall Study|Protocol Violation|5
5607784|NCT00849290|19373305|P1|Overall Study|Lost to Follow-up|2
5607785|NCT00849290|19373305|P1|Overall Study|Withdrawal by Subject|11
5607786|NCT00849290|19373305|P1|Overall Study|Death|14
5607787|NCT00849290|19373305|P1|Overall Study|Adverse Event|3
5607788|NCT00849212|19373316|P1|Overall Study|Miscellaneous|1
5607789|NCT00849212|19373316|P1|Overall Study|Adverse Event|2
5607790|NCT00849212|19373316|P1|Overall Study|Withdrawal by Subject|3
5607791|NCT00849212|19373316|P1|Overall Study|Lack of Efficacy|1
5607792|NCT00849186|19373321|P1|Overall Study|Other|1
5607793|NCT00849186|19373321|P1|Overall Study|not treated|6
5607794|NCT00849186|19373321|P1|Overall Study|Withdrawal by Subject|1
5607795|NCT00849186|19373321|P1|Overall Study|Adverse Event|2
5607796|NCT00849147|19373327|P1|Overall Study|Disease Relapse/Progression|2
5607797|NCT00849147|19373327|P1|Overall Study|Protocol Violation|2
5607798|NCT00849147|19373327|P1|Overall Study|Withdrawal by Subject|1
5607799|NCT00849108|19373360|P2|Cohort 2 Efficacy|Other|9
5607800|NCT00849108|19373361|P1|Cohort 2 Efficacy|Other|0
5607801|NCT00849108|19373360|P2|Cohort 2 Efficacy|Adverse Event|1
5607802|NCT00849108|19373361|P1|Cohort 2 Efficacy|Adverse Event|0
5607803|NCT00849108|19373360|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
5607804|NCT00849108|19373361|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
5607805|NCT00849056|19373371|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
5607806|NCT00849056|19373372|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
5607807|NCT00849056|19373371|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
5607808|NCT00849056|19373372|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
5607809|NCT00849056|19373371|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
5607810|NCT00849056|19373372|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
5607811|NCT00849056|19373371|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
5607812|NCT00849056|19373372|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
5607813|NCT00849056|19373371|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
5607814|NCT00849056|19373372|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
5607815|NCT00849056|19373371|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
5607816|NCT00849056|19373372|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
5607817|NCT00849056|19373371|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
5607818|NCT00849056|19373372|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
5607819|NCT00849056|19373371|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
5607820|NCT00849056|19373372|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
5607821|NCT00849056|19373371|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
5607822|NCT00849056|19373372|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
5607823|NCT00849056|19373371|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
5607824|NCT00849056|19373372|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
5607825|NCT00849056|19373371|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
5607826|NCT00849056|19373372|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
5607827|NCT00849056|19373371|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
5607828|NCT00849056|19373372|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
5607829|NCT00849056|19373371|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
5607830|NCT00849056|19373372|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
5607831|NCT00849056|19373371|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
5607832|NCT00849056|19373372|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
5607833|NCT00849056|19373371|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
5607834|NCT00849056|19373372|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
5607835|NCT00849056|19373371|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
5607836|NCT00849056|19373372|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
5607837|NCT00849017|19373397|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
5607838|NCT00849017|19373398|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
5607839|NCT00849017|19373399|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
5607840|NCT00849017|19373397|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
5607841|NCT00849017|19373398|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
5607842|NCT00849017|19373399|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
5607843|NCT00849017|19373397|P3|Follow-up Period (8 Weeks)|Physician Decision|1
5607844|NCT00849017|19373398|P2|Follow-up Period (8 Weeks)|Physician Decision|1
5607845|NCT00849017|19373399|P1|Follow-up Period (8 Weeks)|Physician Decision|0
5607846|NCT00849017|19373397|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
5607847|NCT00849017|19373398|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
5607848|NCT00849017|19373399|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
5607849|NCT00849017|19373397|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
5607850|NCT00849017|19373398|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
5607851|NCT00849017|19373399|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
5607852|NCT00849017|19373397|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
5607853|NCT00849017|19373398|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
5607854|NCT00849017|19373399|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
5607855|NCT00849017|19373397|P3|Follow-up Period (8 Weeks)|Noncompliance|0
5607856|NCT00849017|19373398|P2|Follow-up Period (8 Weeks)|Noncompliance|1
5607857|NCT00849017|19373399|P1|Follow-up Period (8 Weeks)|Noncompliance|2
5607858|NCT00849017|19373397|P3|Follow-up Period (8 Weeks)|Adverse Event|0
5607859|NCT00849017|19373398|P2|Follow-up Period (8 Weeks)|Adverse Event|0
5607860|NCT00849017|19373399|P1|Follow-up Period (8 Weeks)|Adverse Event|1
5607861|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
5607862|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
5607863|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
5607864|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Pregnancy|1
5607865|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Pregnancy|0
5607866|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Pregnancy|1
5607867|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
5607868|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
5607869|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
5607870|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
5607871|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
5607872|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
5607873|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
5607874|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
5607875|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
5607876|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
5607877|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
5607878|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
5607879|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Physician Decision|1
5607880|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Physician Decision|2
5607881|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Physician Decision|0
5607882|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
5607883|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
5607884|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
5607885|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
5607886|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
5607887|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
5607888|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Noncompliance|4
5607889|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Noncompliance|3
5607890|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Noncompliance|3
5607891|NCT00849017|19373397|P3|Treatment Period (156 Weeks)|Adverse Event|15
5607892|NCT00849017|19373398|P2|Treatment Period (156 Weeks)|Adverse Event|6
5607893|NCT00849017|19373399|P1|Treatment Period (156 Weeks)|Adverse Event|5
5607894|NCT00848965|19373442|P1|Overall Study|Withdrawal by Subject|1
5607895|NCT00848965|19373442|P1|Overall Study|Adverse Event|1
5607896|NCT00848926|19373484|P1|Follow-up Period|Other|2
5607897|NCT00848926|19373484|P1|Follow-up Period|Withdrawal by Subject|3
5607898|NCT00848926|19373484|P1|Follow-up Period|Lost to Follow-up|7
5607899|NCT00848926|19373484|P1|Treatment Period|Withdrawal by Subject|7
5607900|NCT00848926|19373484|P1|Treatment Period|Physician Decision|12
5607901|NCT00848926|19373484|P1|Treatment Period|Adverse Event|20
5607902|NCT00848926|19373484|P1|Treatment Period|Progressive disease|45
5607903|NCT00848718|19373534|P13|Overall Study|Progressive disease during treatment|2
5607904|NCT00848718|19373535|P12|Overall Study|Progressive disease during treatment|0
5607905|NCT00848718|19373536|P11|Overall Study|Progressive disease during treatment|0
5607906|NCT00848718|19373537|P10|Overall Study|Progressive disease during treatment|0
5607907|NCT00848718|19373538|P9|Overall Study|Progressive disease during treatment|0
5607908|NCT00848718|19373539|P8|Overall Study|Progressive disease during treatment|2
5607909|NCT00848718|19373540|P7|Overall Study|Progressive disease during treatment|0
5607910|NCT00848718|19373541|P6|Overall Study|Progressive disease during treatment|0
5607911|NCT00848718|19373542|P5|Overall Study|Progressive disease during treatment|0
5607912|NCT00848718|19373543|P4|Overall Study|Progressive disease during treatment|0
5607913|NCT00848718|19373544|P3|Overall Study|Progressive disease during treatment|3
5607914|NCT00848718|19373545|P2|Overall Study|Progressive disease during treatment|0
5607915|NCT00848718|19373546|P1|Overall Study|Progressive disease during treatment|3
5607916|NCT00848718|19373534|P13|Overall Study|Withdrawal by Subject|0
5607917|NCT00848718|19373535|P12|Overall Study|Withdrawal by Subject|0
5607918|NCT00848718|19373536|P11|Overall Study|Withdrawal by Subject|1
5607919|NCT00848718|19373537|P10|Overall Study|Withdrawal by Subject|0
5607920|NCT00848718|19373538|P9|Overall Study|Withdrawal by Subject|0
5607921|NCT00848718|19373539|P8|Overall Study|Withdrawal by Subject|0
5607922|NCT00848718|19373540|P7|Overall Study|Withdrawal by Subject|0
5607923|NCT00848718|19373541|P6|Overall Study|Withdrawal by Subject|0
5607924|NCT00848718|19373542|P5|Overall Study|Withdrawal by Subject|0
5607925|NCT00848718|19373543|P4|Overall Study|Withdrawal by Subject|1
5607926|NCT00848718|19373544|P3|Overall Study|Withdrawal by Subject|0
5607927|NCT00848718|19373545|P2|Overall Study|Withdrawal by Subject|0
5607928|NCT00848718|19373546|P1|Overall Study|Withdrawal by Subject|1
5607929|NCT00848718|19373534|P13|Overall Study|Protocol Violation|1
5607930|NCT00848718|19373535|P12|Overall Study|Protocol Violation|0
5607931|NCT00848718|19373536|P11|Overall Study|Protocol Violation|0
5607932|NCT00848718|19373537|P10|Overall Study|Protocol Violation|0
5607933|NCT00848718|19373538|P9|Overall Study|Protocol Violation|0
5607934|NCT00848718|19373539|P8|Overall Study|Protocol Violation|1
5607935|NCT00848718|19373540|P7|Overall Study|Protocol Violation|0
5607936|NCT00848718|19373541|P6|Overall Study|Protocol Violation|0
5607937|NCT00848718|19373542|P5|Overall Study|Protocol Violation|0
5607938|NCT00848718|19373543|P4|Overall Study|Protocol Violation|0
5607939|NCT00848718|19373544|P3|Overall Study|Protocol Violation|0
5607940|NCT00848718|19373545|P2|Overall Study|Protocol Violation|1
5607941|NCT00848718|19373546|P1|Overall Study|Protocol Violation|0
5607942|NCT00848718|19373534|P13|Overall Study|Progressive disease before treatment|2
5607943|NCT00848718|19373535|P12|Overall Study|Progressive disease before treatment|6
5607944|NCT00848718|19373536|P11|Overall Study|Progressive disease before treatment|3
5607945|NCT00848718|19373537|P10|Overall Study|Progressive disease before treatment|7
5607946|NCT00848718|19373538|P9|Overall Study|Progressive disease before treatment|2
5607947|NCT00848718|19373539|P8|Overall Study|Progressive disease before treatment|1
5607948|NCT00848718|19373540|P7|Overall Study|Progressive disease before treatment|2
5607949|NCT00848718|19373541|P6|Overall Study|Progressive disease before treatment|4
5607950|NCT00848718|19373542|P5|Overall Study|Progressive disease before treatment|4
5607951|NCT00848718|19373543|P4|Overall Study|Progressive disease before treatment|3
5607952|NCT00848718|19373544|P3|Overall Study|Progressive disease before treatment|1
5607953|NCT00848718|19373545|P2|Overall Study|Progressive disease before treatment|5
5607954|NCT00848718|19373546|P1|Overall Study|Progressive disease before treatment|1
5607955|NCT00848718|19373534|P13|Overall Study|Physician Decision|1
5607956|NCT00848718|19373535|P12|Overall Study|Physician Decision|0
5607957|NCT00848718|19373536|P11|Overall Study|Physician Decision|0
5607958|NCT00848718|19373537|P10|Overall Study|Physician Decision|2
5607959|NCT00848718|19373538|P9|Overall Study|Physician Decision|1
5607960|NCT00848718|19373539|P8|Overall Study|Physician Decision|0
5607961|NCT00848718|19373540|P7|Overall Study|Physician Decision|0
5607962|NCT00848718|19373541|P6|Overall Study|Physician Decision|1
5607963|NCT00848718|19373542|P5|Overall Study|Physician Decision|1
5607964|NCT00848718|19373543|P4|Overall Study|Physician Decision|0
5607965|NCT00848718|19373544|P3|Overall Study|Physician Decision|0
5607966|NCT00848718|19373545|P2|Overall Study|Physician Decision|1
5607967|NCT00848718|19373546|P1|Overall Study|Physician Decision|0
5607968|NCT00848718|19373534|P13|Overall Study|Lack of Efficacy|0
5607969|NCT00848718|19373535|P12|Overall Study|Lack of Efficacy|0
5607970|NCT00848718|19373536|P11|Overall Study|Lack of Efficacy|0
5607971|NCT00848718|19373537|P10|Overall Study|Lack of Efficacy|0
5607972|NCT00848718|19373538|P9|Overall Study|Lack of Efficacy|0
5607973|NCT00848718|19373539|P8|Overall Study|Lack of Efficacy|0
5607974|NCT00848718|19373540|P7|Overall Study|Lack of Efficacy|1
5607975|NCT00848718|19373541|P6|Overall Study|Lack of Efficacy|0
5607976|NCT00848718|19373542|P5|Overall Study|Lack of Efficacy|0
5607977|NCT00848718|19373543|P4|Overall Study|Lack of Efficacy|0
5607978|NCT00848718|19373544|P3|Overall Study|Lack of Efficacy|1
5607979|NCT00848718|19373545|P2|Overall Study|Lack of Efficacy|0
5607980|NCT00848718|19373546|P1|Overall Study|Lack of Efficacy|0
5607981|NCT00848718|19373534|P13|Overall Study|Adverse Event|2
5607982|NCT00848718|19373535|P12|Overall Study|Adverse Event|0
5607983|NCT00848718|19373536|P11|Overall Study|Adverse Event|0
5607984|NCT00848718|19373537|P10|Overall Study|Adverse Event|0
5607985|NCT00848718|19373538|P9|Overall Study|Adverse Event|1
5607986|NCT00848718|19373539|P8|Overall Study|Adverse Event|1
5607987|NCT00848718|19373540|P7|Overall Study|Adverse Event|0
5607988|NCT00848718|19373541|P6|Overall Study|Adverse Event|0
5607989|NCT00848718|19373542|P5|Overall Study|Adverse Event|1
5607990|NCT00848718|19373543|P4|Overall Study|Adverse Event|1
5607991|NCT00848718|19373544|P3|Overall Study|Adverse Event|1
5607992|NCT00848718|19373545|P2|Overall Study|Adverse Event|2
5607993|NCT00848718|19373546|P1|Overall Study|Adverse Event|2
5607994|NCT00848549|19373647|P2|E2090-E044-314 (Extension Study)|Other|6
5607995|NCT00848549|19373648|P1|E2090-E044-314 (Extension Study)|Other|5
5607996|NCT00848549|19373647|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
5607997|NCT00848549|19373648|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
5607998|NCT00848549|19373647|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
5607999|NCT00848549|19373648|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
5608000|NCT00848549|19373647|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
5608001|NCT00848549|19373648|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
5608002|NCT00848549|19373647|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
5608003|NCT00848549|19373648|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
5608004|NCT00848549|19373647|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
5608005|NCT00848549|19373648|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
5608006|NCT00848549|19373647|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
5608007|NCT00848549|19373648|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
5608008|NCT00848549|19373647|P2|E2090-E044-310 (Base Study) Disposition|Other|3
5608009|NCT00848549|19373648|P1|E2090-E044-310 (Base Study) Disposition|Other|4
5608010|NCT00848549|19373647|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
5608011|NCT00848549|19373648|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
5608012|NCT00848549|19373647|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
5608013|NCT00848549|19373648|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
5608014|NCT00848549|19373647|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
5608015|NCT00848549|19373648|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
5608016|NCT00848549|19373647|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
5608017|NCT00848549|19373648|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
5608018|NCT00848549|19373647|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
5608019|NCT00848549|19373648|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
5608020|NCT00848549|19373647|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
5608021|NCT00848549|19373648|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
5608022|NCT00848536|19373666|P2|Overall Study|Patient Moved|2
5608023|NCT00848536|19373667|P1|Overall Study|Patient Moved|0
5608024|NCT00848536|19373666|P2|Overall Study|Inadequate Control of IOP|1
5608025|NCT00848536|19373667|P1|Overall Study|Inadequate Control of IOP|1
5608026|NCT00848536|19373666|P2|Overall Study|Noncompliance|0
5608027|NCT00848536|19373667|P1|Overall Study|Noncompliance|1
5608028|NCT00848536|19373666|P2|Overall Study|Protocol Violation|1
5608029|NCT00848536|19373667|P1|Overall Study|Protocol Violation|0
5608030|NCT00848536|19373666|P2|Overall Study|Withdrawal by Subject|1
5608031|NCT00848536|19373667|P1|Overall Study|Withdrawal by Subject|0
5608032|NCT00848536|19373666|P2|Overall Study|Adverse Event|2
5608033|NCT00848536|19373667|P1|Overall Study|Adverse Event|2
5608034|NCT00848497|19373732|P2|Overall Study|Withdrawal by Subject|1
5608035|NCT00848497|19373733|P1|Overall Study|Withdrawal by Subject|0
5608036|NCT00848497|19373732|P2|Overall Study|Screen failure|0
5608037|NCT00848497|19373733|P1|Overall Study|Screen failure|2
5608038|NCT00848484|19373747|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
5608039|NCT00848484|19373748|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
5608040|NCT00848484|19373747|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
5608041|NCT00848484|19373748|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
5608042|NCT00848484|19373747|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
5608043|NCT00848484|19373748|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
5608044|NCT00848484|19373747|P2|First Intervention (Treatment Period 1)|Physician Decision|1
5608045|NCT00848484|19373748|P1|First Intervention (Treatment Period 1)|Physician Decision|0
5608046|NCT00848484|19373747|P2|First Intervention (Treatment Period 1)|Adverse Event|1
5608047|NCT00848484|19373748|P1|First Intervention (Treatment Period 1)|Adverse Event|2
5608048|NCT00848393|19373767|P3|Overall Study|surgical complications unrelated to stud|2
5608049|NCT00848393|19373768|P2|Overall Study|surgical complications unrelated to stud|0
5608050|NCT00848393|19373769|P1|Overall Study|surgical complications unrelated to stud|0
5608051|NCT00848393|19373767|P3|Overall Study|Protocol Violation|1
5608052|NCT00848393|19373768|P2|Overall Study|Protocol Violation|0
5608053|NCT00848393|19373769|P1|Overall Study|Protocol Violation|0
5608054|NCT00848354|19373808|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
5608055|NCT00848354|19373809|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
5608056|NCT00848354|19373808|P2|Phase 2 Year 2|Subject Request|1
5608057|NCT00848354|19373809|P1|Phase 2 Year 2|Subject Request|1
5608058|NCT00848354|19373808|P2|Phase 2 Year 2|Protocol Violation|1
5608059|NCT00848354|19373809|P1|Phase 2 Year 2|Protocol Violation|1
5608060|NCT00848354|19373808|P2|Phase 2 Year 2|Unspecified Reason|0
5608061|NCT00848354|19373809|P1|Phase 2 Year 2|Unspecified Reason|1
5608062|NCT00848354|19373808|P2|Phase 2 Year 2|Lost to Follow-up|3
5608063|NCT00848354|19373809|P1|Phase 2 Year 2|Lost to Follow-up|1
5608064|NCT00848354|19373808|P2|Phase 2 Year 2|Failed to return|0
5608065|NCT00848354|19373809|P1|Phase 2 Year 2|Failed to return|3
5608066|NCT00848354|19373808|P2|Phase 2 Year 2|Death|0
5608067|NCT00848354|19373809|P1|Phase 2 Year 2|Death|2
5608068|NCT00848354|19373808|P2|Phase 2 Year 2|Adverse Event|2
5608069|NCT00848354|19373809|P1|Phase 2 Year 2|Adverse Event|12
5608070|NCT00848354|19373808|P2|Phase 2 Year 1|Subject Request|2
5608071|NCT00848354|19373809|P1|Phase 2 Year 1|Subject Request|1
5608072|NCT00848354|19373808|P2|Phase 2 Year 1|Protocol Violation|1
5608073|NCT00848354|19373809|P1|Phase 2 Year 1|Protocol Violation|4
5608074|NCT00848354|19373808|P2|Phase 2 Year 1|Unspecified Reason|0
5608075|NCT00848354|19373809|P1|Phase 2 Year 1|Unspecified Reason|3
5608076|NCT00848354|19373808|P2|Phase 2 Year 1|Lost to Follow-up|0
5608077|NCT00848354|19373809|P1|Phase 2 Year 1|Lost to Follow-up|1
5608078|NCT00848354|19373808|P2|Phase 2 Year 1|Failed to Return|1
5608079|NCT00848354|19373809|P1|Phase 2 Year 1|Failed to Return|1
5608080|NCT00848354|19373808|P2|Phase 2 Year 1|Death|0
5608081|NCT00848354|19373809|P1|Phase 2 Year 1|Death|1
5608082|NCT00848354|19373808|P2|Phase 2 Year 1|Adverse Event|2
5608083|NCT00848354|19373809|P1|Phase 2 Year 1|Adverse Event|7
5608084|NCT00848354|19373808|P2|Phase 1|Lack of Efficacy|1
5608085|NCT00848354|19373809|P1|Phase 1|Lack of Efficacy|0
5608086|NCT00848354|19373808|P2|Phase 1|Withdrawal by Subject|4
5608087|NCT00848354|19373809|P1|Phase 1|Withdrawal by Subject|2
5608088|NCT00848354|19373808|P2|Phase 1|Protocol Violation|1
5608089|NCT00848354|19373809|P1|Phase 1|Protocol Violation|1
5608090|NCT00848354|19373808|P2|Phase 1|Unspecified Reason|1
5608091|NCT00848354|19373809|P1|Phase 1|Unspecified Reason|1
5608092|NCT00848354|19373808|P2|Phase 1|Lost to Follow-up|1
5608093|NCT00848354|19373809|P1|Phase 1|Lost to Follow-up|1
5608094|NCT00848354|19373808|P2|Phase 1|Failed to return|1
5608095|NCT00848354|19373809|P1|Phase 1|Failed to return|0
5608096|NCT00848354|19373808|P2|Phase 1|Discontinuation of study by sponsor|1
5608097|NCT00848354|19373809|P1|Phase 1|Discontinuation of study by sponsor|2
5608098|NCT00848354|19373808|P2|Phase 1|Adverse Event|4
5608099|NCT00848354|19373809|P1|Phase 1|Adverse Event|5
5608100|NCT00848250|19373961|P2|Overall Study|surgery was completed without cardiopulm|1
5608101|NCT00848250|19373962|P1|Overall Study|surgery was completed without cardiopulm|0
5608102|NCT00848211|19373993|P4|Overall Study|Adverse Event|0
5608103|NCT00848211|19373994|P3|Overall Study|Adverse Event|0
5608104|NCT00848211|19373995|P2|Overall Study|Adverse Event|0
5608105|NCT00848211|19373996|P1|Overall Study|Adverse Event|0
5608106|NCT00848211|19373993|P4|Overall Study|Protocol Violation|0
5608107|NCT00848211|19373994|P3|Overall Study|Protocol Violation|1
5608108|NCT00848211|19373995|P2|Overall Study|Protocol Violation|1
5608109|NCT00848211|19373996|P1|Overall Study|Protocol Violation|0
5608110|NCT00848198|19374014|P1|Overall Study|Incomplete Case Report Forms|15
5608111|NCT00848120|19374079|P1|Overall Study|Adverse Event|1
5608112|NCT00848107|19374091|P1|Overall Study|Pregnancy|1
5608113|NCT00848107|19374091|P1|Overall Study|Death|1
5608114|NCT00848107|19374091|P1|Overall Study|Adverse Event|9
5608115|NCT00848107|19374091|P1|Overall Study|Withdrawal by Subject|8
5608116|NCT00848107|19374091|P1|Overall Study|Lost to Follow-up|2
5608117|NCT00848081|19374101|P2|Overall Study|Withdrawal by Subject|3
5608118|NCT00848081|19374102|P1|Overall Study|Withdrawal by Subject|5
5608119|NCT00848081|19374101|P2|Overall Study|Physician Decision|3
5608120|NCT00848081|19374102|P1|Overall Study|Physician Decision|0
5608121|NCT00848081|19374101|P2|Overall Study|Lost to Follow-up|0
5608122|NCT00848081|19374102|P1|Overall Study|Lost to Follow-up|1
5608123|NCT00848081|19374101|P2|Overall Study|Protocol Violation|5
5608124|NCT00848081|19374102|P1|Overall Study|Protocol Violation|8
5608125|NCT00848081|19374101|P2|Overall Study|Adverse Event|7
5608126|NCT00848081|19374102|P1|Overall Study|Adverse Event|6
5608127|NCT00848042|19374119|P3|Overall Study|Other Therapy|0
5608128|NCT00848042|19374120|P2|Overall Study|Other Therapy|0
5608129|NCT00848042|19374121|P1|Overall Study|Other Therapy|3
5608130|NCT00848042|19374119|P3|Overall Study|Death|0
5608131|NCT00848042|19374120|P2|Overall Study|Death|2
5608132|NCT00848042|19374121|P1|Overall Study|Death|1
5608133|NCT00847912|19374157|P2|Overall Study|Withdrawal by Subject|6
5608134|NCT00847912|19374158|P1|Overall Study|Withdrawal by Subject|3
5608135|NCT00847912|19374157|P2|Overall Study|Protocol Violation|7
5608136|NCT00847912|19374158|P1|Overall Study|Protocol Violation|6
5608137|NCT00847886|19374168|P2|Overall Study|Adverse Event|1
5608138|NCT00847886|19374169|P1|Overall Study|Adverse Event|0
5608139|NCT00847808|19374195|P1|Overall Study|Participant Took Excluded Medication|1
5608140|NCT00847808|19374195|P1|Overall Study|Participant Reported Lack of Efficacy|1
5608141|NCT00847808|19374195|P1|Overall Study|Withdrawal by Subject|4
5608142|NCT00847808|19374195|P1|Overall Study|Lost to Follow-up|1
5608143|NCT00847808|19374195|P1|Overall Study|Protocol Violation|1
5608144|NCT00847808|19374195|P1|Overall Study|Adverse Event|7
5608145|NCT00847730|19374212|P1|Overall Study|Multiple interruptions in therapy|8
5608146|NCT00847704|19374216|P1|Overall Study|Withdrawal by Subject|1
5608147|NCT00847665|19374227|P2|Overall Study|Withdrawal by Subject|0
5608148|NCT00847665|19374228|P1|Overall Study|Withdrawal by Subject|1
5608149|NCT00847626|19374251|P11|Overall Study|Other|3
5608150|NCT00847626|19374252|P10|Overall Study|Other|1
5608151|NCT00847626|19374253|P9|Overall Study|Other|1
5608152|NCT00847626|19374254|P8|Overall Study|Other|3
5608153|NCT00847626|19374255|P7|Overall Study|Other|2
5608154|NCT00847626|19374256|P6|Overall Study|Other|2
5608155|NCT00847626|19374257|P5|Overall Study|Other|2
5608156|NCT00847626|19374258|P4|Overall Study|Other|1
5608157|NCT00847626|19374259|P3|Overall Study|Other|4
5608158|NCT00847626|19374260|P2|Overall Study|Other|5
5608159|NCT00847626|19374261|P1|Overall Study|Other|1
5608160|NCT00847626|19374251|P11|Overall Study|Lack of Efficacy|7
5608161|NCT00847626|19374252|P10|Overall Study|Lack of Efficacy|1
5608162|NCT00847626|19374253|P9|Overall Study|Lack of Efficacy|5
5608163|NCT00847626|19374254|P8|Overall Study|Lack of Efficacy|2
5608164|NCT00847626|19374255|P7|Overall Study|Lack of Efficacy|6
5608165|NCT00847626|19374256|P6|Overall Study|Lack of Efficacy|0
5608166|NCT00847626|19374257|P5|Overall Study|Lack of Efficacy|2
5608167|NCT00847626|19374258|P4|Overall Study|Lack of Efficacy|1
5608168|NCT00847626|19374259|P3|Overall Study|Lack of Efficacy|0
5608169|NCT00847626|19374260|P2|Overall Study|Lack of Efficacy|1
5608170|NCT00847626|19374261|P1|Overall Study|Lack of Efficacy|3
5608171|NCT00847626|19374251|P11|Overall Study|Withdrawal by Subject|2
5608172|NCT00847626|19374252|P10|Overall Study|Withdrawal by Subject|5
5608173|NCT00847626|19374253|P9|Overall Study|Withdrawal by Subject|4
5608174|NCT00847626|19374254|P8|Overall Study|Withdrawal by Subject|4
5608175|NCT00847626|19374255|P7|Overall Study|Withdrawal by Subject|8
5608176|NCT00847626|19374256|P6|Overall Study|Withdrawal by Subject|9
5608177|NCT00847626|19374257|P5|Overall Study|Withdrawal by Subject|12
5608178|NCT00847626|19374258|P4|Overall Study|Withdrawal by Subject|8
5608179|NCT00847626|19374259|P3|Overall Study|Withdrawal by Subject|3
5608180|NCT00847626|19374260|P2|Overall Study|Withdrawal by Subject|5
5608181|NCT00847626|19374261|P1|Overall Study|Withdrawal by Subject|5
5608182|NCT00847626|19374251|P11|Overall Study|Lost to Follow-up|1
5608183|NCT00847626|19374252|P10|Overall Study|Lost to Follow-up|0
5608184|NCT00847626|19374253|P9|Overall Study|Lost to Follow-up|1
5608185|NCT00847626|19374254|P8|Overall Study|Lost to Follow-up|3
5608186|NCT00847626|19374255|P7|Overall Study|Lost to Follow-up|1
5608187|NCT00847626|19374256|P6|Overall Study|Lost to Follow-up|3
5608188|NCT00847626|19374257|P5|Overall Study|Lost to Follow-up|0
5608189|NCT00847626|19374258|P4|Overall Study|Lost to Follow-up|1
5608190|NCT00847626|19374259|P3|Overall Study|Lost to Follow-up|1
5608191|NCT00847626|19374260|P2|Overall Study|Lost to Follow-up|1
5608192|NCT00847626|19374261|P1|Overall Study|Lost to Follow-up|0
5608193|NCT00847626|19374251|P11|Overall Study|Protocol Violation|1
5608194|NCT00847626|19374252|P10|Overall Study|Protocol Violation|1
5608195|NCT00847626|19374253|P9|Overall Study|Protocol Violation|0
5608196|NCT00847626|19374254|P8|Overall Study|Protocol Violation|1
5608197|NCT00847626|19374255|P7|Overall Study|Protocol Violation|1
5608198|NCT00847626|19374256|P6|Overall Study|Protocol Violation|1
5608199|NCT00847626|19374257|P5|Overall Study|Protocol Violation|1
5608200|NCT00847626|19374258|P4|Overall Study|Protocol Violation|1
5608201|NCT00847626|19374259|P3|Overall Study|Protocol Violation|2
5608202|NCT00847626|19374260|P2|Overall Study|Protocol Violation|1
5608203|NCT00847626|19374261|P1|Overall Study|Protocol Violation|2
5608204|NCT00847626|19374251|P11|Overall Study|Adverse Event|6
5608205|NCT00847626|19374252|P10|Overall Study|Adverse Event|6
5608206|NCT00847626|19374253|P9|Overall Study|Adverse Event|3
5608207|NCT00847626|19374254|P8|Overall Study|Adverse Event|6
5608208|NCT00847626|19374255|P7|Overall Study|Adverse Event|4
5608209|NCT00847626|19374256|P6|Overall Study|Adverse Event|22
5608210|NCT00847626|19374257|P5|Overall Study|Adverse Event|11
5608211|NCT00847626|19374258|P4|Overall Study|Adverse Event|19
5608212|NCT00847626|19374259|P3|Overall Study|Adverse Event|6
5608213|NCT00847626|19374260|P2|Overall Study|Adverse Event|10
5608214|NCT00847626|19374261|P1|Overall Study|Adverse Event|10
5608215|NCT00847613|19374460|P4|Overall Study|Other|0
5608216|NCT00847613|19374461|P3|Overall Study|Other|2
5608217|NCT00847613|19374462|P2|Overall Study|Other|1
5608218|NCT00847613|19374463|P1|Overall Study|Other|1
5608219|NCT00847613|19374460|P4|Overall Study|Randomized, but not treated|0
5608220|NCT00847613|19374461|P3|Overall Study|Randomized, but not treated|0
5608221|NCT00847613|19374462|P2|Overall Study|Randomized, but not treated|3
5608222|NCT00847613|19374463|P1|Overall Study|Randomized, but not treated|0
5608223|NCT00847613|19374460|P4|Overall Study|Sponsor request|0
5608224|NCT00847613|19374461|P3|Overall Study|Sponsor request|0
5608225|NCT00847613|19374462|P2|Overall Study|Sponsor request|1
5608226|NCT00847613|19374463|P1|Overall Study|Sponsor request|0
5608227|NCT00847613|19374460|P4|Overall Study|Participant moved|0
5608228|NCT00847613|19374461|P3|Overall Study|Participant moved|0
5608229|NCT00847613|19374462|P2|Overall Study|Participant moved|1
5608230|NCT00847613|19374463|P1|Overall Study|Participant moved|4
5608231|NCT00847613|19374460|P4|Overall Study|Withdrawal by Subject|2
5608232|NCT00847613|19374461|P3|Overall Study|Withdrawal by Subject|2
5608233|NCT00847613|19374462|P2|Overall Study|Withdrawal by Subject|11
5608234|NCT00847613|19374463|P1|Overall Study|Withdrawal by Subject|8
5608235|NCT00847613|19374460|P4|Overall Study|Site closure|1
5608236|NCT00847613|19374461|P3|Overall Study|Site closure|0
5608237|NCT00847613|19374462|P2|Overall Study|Site closure|0
5608238|NCT00847613|19374463|P1|Overall Study|Site closure|1
5608239|NCT00847613|19374460|P4|Overall Study|Pregnancy|0
5608240|NCT00847613|19374461|P3|Overall Study|Pregnancy|0
5608241|NCT00847613|19374462|P2|Overall Study|Pregnancy|1
5608242|NCT00847613|19374463|P1|Overall Study|Pregnancy|1
5608243|NCT00847613|19374460|P4|Overall Study|Protocol Violation|1
5608244|NCT00847613|19374461|P3|Overall Study|Protocol Violation|3
5608245|NCT00847613|19374462|P2|Overall Study|Protocol Violation|6
5608246|NCT00847613|19374463|P1|Overall Study|Protocol Violation|6
5608247|NCT00847613|19374460|P4|Overall Study|Lost to Follow-up|3
5608248|NCT00847613|19374461|P3|Overall Study|Lost to Follow-up|0
5608249|NCT00847613|19374462|P2|Overall Study|Lost to Follow-up|0
5608250|NCT00847613|19374463|P1|Overall Study|Lost to Follow-up|5
5608251|NCT00847613|19374460|P4|Overall Study|Study terminated by Sponsor|1
5608252|NCT00847613|19374461|P3|Overall Study|Study terminated by Sponsor|2
5608253|NCT00847613|19374462|P2|Overall Study|Study terminated by Sponsor|0
5608254|NCT00847613|19374463|P1|Overall Study|Study terminated by Sponsor|1
5608255|NCT00847613|19374460|P4|Overall Study|Lack of Efficacy|1
5608256|NCT00847613|19374461|P3|Overall Study|Lack of Efficacy|3
5608257|NCT00847613|19374462|P2|Overall Study|Lack of Efficacy|3
5608258|NCT00847613|19374463|P1|Overall Study|Lack of Efficacy|7
5608259|NCT00847613|19374460|P4|Overall Study|Adverse Event|6
5608260|NCT00847613|19374461|P3|Overall Study|Adverse Event|5
5608261|NCT00847613|19374462|P2|Overall Study|Adverse Event|26
5608262|NCT00847613|19374463|P1|Overall Study|Adverse Event|36
5608263|NCT00847613|19374460|P4|Overall Study|Death|0
5608264|NCT00847613|19374461|P3|Overall Study|Death|0
5608265|NCT00847613|19374462|P2|Overall Study|Death|1
5608266|NCT00847613|19374463|P1|Overall Study|Death|1
5608267|NCT00847613|19374460|P4|Overall Study|Ongoing at cut-off date|64
5608268|NCT00847613|19374461|P3|Overall Study|Ongoing at cut-off date|64
5608269|NCT00847613|19374462|P2|Overall Study|Ongoing at cut-off date|265
5608270|NCT00847613|19374463|P1|Overall Study|Ongoing at cut-off date|250
5608271|NCT00847561|19374714|P2|Overall Study|Unable to schedule|1
5608272|NCT00847561|19374715|P1|Overall Study|Unable to schedule|9
5608273|NCT00847561|19374714|P2|Overall Study|Withdrawal by Subject|3
5608274|NCT00847561|19374715|P1|Overall Study|Withdrawal by Subject|4
5608275|NCT00847535|19374721|P3|Overall Study|Lost to Follow-up|0
5608276|NCT00847535|19374722|P2|Overall Study|Lost to Follow-up|1
5608277|NCT00847535|19374723|P1|Overall Study|Lost to Follow-up|0
5608278|NCT00847535|19374721|P3|Overall Study|Withdrawal by Subject|1
5608279|NCT00847535|19374722|P2|Overall Study|Withdrawal by Subject|1
5608280|NCT00847535|19374723|P1|Overall Study|Withdrawal by Subject|2
5608281|NCT00847405|19374742|P2|Washout of 7 Days|Withdrawal by Subject|0
5608282|NCT00847405|19374743|P1|Washout of 7 Days|Withdrawal by Subject|1
5608283|NCT00847405|19374742|P2|First Intervention|Adverse Event|1
5608284|NCT00847405|19374743|P1|First Intervention|Adverse Event|0
5608285|NCT00847379|19374754|P3|Overall Study|Study terminated by Sponsor|57
5608286|NCT00847379|19374755|P2|Overall Study|Study terminated by Sponsor|57
5608287|NCT00847379|19374756|P1|Overall Study|Study terminated by Sponsor|59
5608288|NCT00847301|19374854|P1|Overall Study|Other reason not defined above|1
5608289|NCT00847301|19374854|P1|Overall Study|No prescription after hospital discharge|1
5608290|NCT00847301|19374854|P1|Overall Study|Lost to Follow-up|1
5608291|NCT00847301|19374854|P1|Overall Study|Switch to other anticoagulants|16
5608292|NCT00847301|19374854|P1|Overall Study|Adverse Event|35
5608293|NCT00847197|19374902|P2|Overall Study|Withdrawal by Subject|1
5608294|NCT00847197|19374903|P1|Overall Study|Withdrawal by Subject|3
5608295|NCT00847197|19374902|P2|Overall Study|Protocol Violation|1
5608296|NCT00847197|19374903|P1|Overall Study|Protocol Violation|0
5608297|NCT00847197|19374902|P2|Overall Study|Adverse Event|3
5608298|NCT00847197|19374903|P1|Overall Study|Adverse Event|21
5608299|NCT00847145|19374927|P8|Overall Study|Protocol Violation|1
5608300|NCT00847145|19374928|P7|Overall Study|Protocol Violation|0
5608301|NCT00847145|19374929|P6|Overall Study|Protocol Violation|0
5608302|NCT00847145|19374930|P5|Overall Study|Protocol Violation|1
5608303|NCT00847145|19374931|P4|Overall Study|Protocol Violation|0
5608304|NCT00847145|19374932|P3|Overall Study|Protocol Violation|3
5608305|NCT00847145|19374933|P2|Overall Study|Protocol Violation|0
5608306|NCT00847145|19374934|P1|Overall Study|Protocol Violation|0
5608307|NCT00847145|19374927|P8|Overall Study|Inappropriate enrollment|0
5608308|NCT00847145|19374928|P7|Overall Study|Inappropriate enrollment|0
5608309|NCT00847145|19374929|P6|Overall Study|Inappropriate enrollment|0
5608310|NCT00847145|19374930|P5|Overall Study|Inappropriate enrollment|1
5608311|NCT00847145|19374931|P4|Overall Study|Inappropriate enrollment|0
5608312|NCT00847145|19374932|P3|Overall Study|Inappropriate enrollment|0
5608313|NCT00847145|19374933|P2|Overall Study|Inappropriate enrollment|0
5608314|NCT00847145|19374934|P1|Overall Study|Inappropriate enrollment|0
5608315|NCT00847145|19374927|P8|Overall Study|Lost to Follow-up|2
5608316|NCT00847145|19374928|P7|Overall Study|Lost to Follow-up|8
5608317|NCT00847145|19374929|P6|Overall Study|Lost to Follow-up|4
5608318|NCT00847145|19374930|P5|Overall Study|Lost to Follow-up|4
5608319|NCT00847145|19374931|P4|Overall Study|Lost to Follow-up|0
5608320|NCT00847145|19374932|P3|Overall Study|Lost to Follow-up|1
5608321|NCT00847145|19374933|P2|Overall Study|Lost to Follow-up|1
5608322|NCT00847145|19374934|P1|Overall Study|Lost to Follow-up|3
5608323|NCT00847145|19374927|P8|Overall Study|Withdrawal by Subject|1
5608324|NCT00847145|19374928|P7|Overall Study|Withdrawal by Subject|1
5608325|NCT00847145|19374929|P6|Overall Study|Withdrawal by Subject|0
5608326|NCT00847145|19374930|P5|Overall Study|Withdrawal by Subject|0
5608327|NCT00847145|19374931|P4|Overall Study|Withdrawal by Subject|1
5608328|NCT00847145|19374932|P3|Overall Study|Withdrawal by Subject|6
5608329|NCT00847145|19374933|P2|Overall Study|Withdrawal by Subject|4
5608330|NCT00847145|19374934|P1|Overall Study|Withdrawal by Subject|3
5608331|NCT00847145|19374927|P8|Overall Study|AE or Death|0
5608332|NCT00847145|19374928|P7|Overall Study|AE or Death|0
5608333|NCT00847145|19374929|P6|Overall Study|AE or Death|0
5608334|NCT00847145|19374930|P5|Overall Study|AE or Death|0
5608335|NCT00847145|19374931|P4|Overall Study|AE or Death|0
5608336|NCT00847145|19374932|P3|Overall Study|AE or Death|1
5608337|NCT00847145|19374933|P2|Overall Study|AE or Death|1
5608338|NCT00847145|19374934|P1|Overall Study|AE or Death|0
5608339|NCT00847132|19374984|P2|Overall Study|Death|1
5608340|NCT00847132|19374985|P1|Overall Study|Death|1
5608341|NCT00847015|19374993|P1|Overall Study|partial cystectomy vs radical cystectomy|1
5608342|NCT00847015|19374993|P1|Overall Study|declined any surgery|1
5608343|NCT00847015|19374993|P1|Overall Study|Withdrawal by Subject|1
5608344|NCT00846846|19375021|P1|Overall Study|Withdrawal by Subject|19
5608345|NCT00846846|19375021|P1|Overall Study|Death|56
5608346|NCT00846807|19375026|P1|Overall Study|Other|60
5608347|NCT00846807|19375026|P1|Overall Study|No prescription after hospital discharge|56
5608348|NCT00846807|19375026|P1|Overall Study|Switch to other anticoagulants|89
5608349|NCT00846807|19375026|P1|Overall Study|Non compliant with European label|7
5608350|NCT00846807|19375026|P1|Overall Study|Withdrawal by Subject|56
5608351|NCT00846807|19375026|P1|Overall Study|Lost to Follow-up|94
5608352|NCT00846807|19375026|P1|Overall Study|Adverse Event|270
5608353|NCT00846768|19375034|P4|Overall Study|Adverse Event|0
5608354|NCT00846768|19375035|P3|Overall Study|Adverse Event|0
5608355|NCT00846768|19375036|P2|Overall Study|Adverse Event|1
5608356|NCT00846768|19375037|P1|Overall Study|Adverse Event|0
5608357|NCT00846742|19375107|P1|Overall Study|Withdrawal by Subject|1
5608358|NCT00846586|19375134|P2|Overall Study|Unsatisfactory therapeutic effect|1
5608359|NCT00846586|19375135|P1|Overall Study|Unsatisfactory therapeutic effect|0
5608360|NCT00846586|19375134|P2|Overall Study|Lost to Follow-up|4
5608361|NCT00846586|19375135|P1|Overall Study|Lost to Follow-up|1
5608362|NCT00846586|19375134|P2|Overall Study|Abnormal test procedure result(s)|0
5608363|NCT00846586|19375135|P1|Overall Study|Abnormal test procedure result(s)|1
5608364|NCT00846586|19375134|P2|Overall Study|Protocol deviation|6
5608365|NCT00846586|19375135|P1|Overall Study|Protocol deviation|2
5608366|NCT00846586|19375134|P2|Overall Study|Death|0
5608367|NCT00846586|19375135|P1|Overall Study|Death|2
5608368|NCT00846586|19375134|P2|Overall Study|Administrative problems|4
5608369|NCT00846586|19375135|P1|Overall Study|Administrative problems|5
5608370|NCT00846586|19375134|P2|Overall Study|Subject withdrew consent|10
5608371|NCT00846586|19375135|P1|Overall Study|Subject withdrew consent|8
5608372|NCT00846586|19375134|P2|Overall Study|Adverse Event|10
5608373|NCT00846586|19375135|P1|Overall Study|Adverse Event|20
5608374|NCT00846521|19375169|P1|Overall Study|Protocol Violation|1
5608375|NCT00846521|19375169|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
5608376|NCT00846521|19375169|P1|Overall Study|Withdrawal by Subject|5
5608377|NCT00846495|19375176|P2|Overall Study|Physician Decision|0
5608378|NCT00846495|19375177|P1|Overall Study|Physician Decision|1
5608379|NCT00846495|19375176|P2|Overall Study|Lack of Efficacy|2
5608380|NCT00846495|19375177|P1|Overall Study|Lack of Efficacy|1
5608381|NCT00846495|19375176|P2|Overall Study|Adverse Event|1
5608382|NCT00846495|19375177|P1|Overall Study|Adverse Event|5
5608383|NCT00846495|19375176|P2|Overall Study|Lost to Follow-up|0
5608384|NCT00846495|19375177|P1|Overall Study|Lost to Follow-up|1
5608385|NCT00846391|19375205|P3|Overall Study|Study Terminated by Sponsor|2
5608386|NCT00846391|19375206|P2|Overall Study|Study Terminated by Sponsor|2
5608387|NCT00846391|19375207|P1|Overall Study|Study Terminated by Sponsor|1
5608388|NCT00846391|19375205|P3|Overall Study|Physician Decision|1
5608389|NCT00846391|19375206|P2|Overall Study|Physician Decision|0
5608390|NCT00846391|19375207|P1|Overall Study|Physician Decision|0
5608391|NCT00846365|19375218|P3|Overall Study|Other|6
5608392|NCT00846365|19375219|P2|Overall Study|Other|1
5608393|NCT00846365|19375220|P1|Overall Study|Other|9
5608394|NCT00846365|19375218|P3|Overall Study|Lack of Efficacy|2
5608395|NCT00846365|19375219|P2|Overall Study|Lack of Efficacy|1
5608396|NCT00846365|19375220|P1|Overall Study|Lack of Efficacy|1
5608397|NCT00846365|19375218|P3|Overall Study|Pregnancy|0
5608398|NCT00846365|19375219|P2|Overall Study|Pregnancy|0
5608399|NCT00846365|19375220|P1|Overall Study|Pregnancy|1
5608400|NCT00846365|19375218|P3|Overall Study|Withdrawal by Subject|9
5608401|NCT00846365|19375219|P2|Overall Study|Withdrawal by Subject|11
5608402|NCT00846365|19375220|P1|Overall Study|Withdrawal by Subject|11
5608403|NCT00846365|19375218|P3|Overall Study|Lost to Follow-up|5
5608404|NCT00846365|19375219|P2|Overall Study|Lost to Follow-up|2
5608405|NCT00846365|19375220|P1|Overall Study|Lost to Follow-up|8
5608406|NCT00846365|19375218|P3|Overall Study|Protocol Violation|0
5608407|NCT00846365|19375219|P2|Overall Study|Protocol Violation|4
5608408|NCT00846365|19375220|P1|Overall Study|Protocol Violation|5
5608409|NCT00846365|19375218|P3|Overall Study|Adverse Event|11
5608410|NCT00846365|19375219|P2|Overall Study|Adverse Event|30
5608411|NCT00846365|19375220|P1|Overall Study|Adverse Event|20
5608412|NCT00846053|19375301|P2|Overall Study|Physician Decision|0
5608413|NCT00846053|19375302|P1|Overall Study|Physician Decision|3
5608414|NCT00846027|19375310|P1|Overall Study|Subject Not Treated|7
5608415|NCT00846027|19375310|P1|Overall Study|Protocol Violation|2
5608416|NCT00846027|19375310|P1|Overall Study|Investigator Discretion|29
5608417|NCT00846027|19375310|P1|Overall Study|Patient Decision|7
5608418|NCT00846027|19375310|P1|Overall Study|Toxicity|12
5608419|NCT00846027|19375310|P1|Overall Study|Disease Progression|30
5608420|NCT00846027|19375310|P1|Overall Study|Death|3
5608421|NCT00845897|19375333|P3|Overall Study|Too ill to participate|0
5608422|NCT00845897|19375334|P2|Overall Study|Too ill to participate|1
5608423|NCT00845897|19375335|P1|Overall Study|Too ill to participate|0
5608424|NCT00845897|19375333|P3|Overall Study|Ulcer did not heal|1
5608425|NCT00845897|19375334|P2|Overall Study|Ulcer did not heal|0
5608426|NCT00845897|19375335|P1|Overall Study|Ulcer did not heal|1
5608427|NCT00845897|19375333|P3|Overall Study|Withdrawal by Subject|2
5608428|NCT00845897|19375334|P2|Overall Study|Withdrawal by Subject|3
5608429|NCT00845897|19375335|P1|Overall Study|Withdrawal by Subject|0
5608430|NCT00845897|19375333|P3|Overall Study|Lost to Follow-up|0
5608431|NCT00845897|19375334|P2|Overall Study|Lost to Follow-up|1
5608432|NCT00845897|19375335|P1|Overall Study|Lost to Follow-up|1
5608433|NCT00845858|19375349|P3|Overall Study|not eligible|2
5608434|NCT00845858|19375350|P2|Overall Study|not eligible|3
5608435|NCT00845858|19375351|P1|Overall Study|not eligible|0
5608436|NCT00845858|19375349|P3|Overall Study|Protocol Violation|1
5608437|NCT00845858|19375350|P2|Overall Study|Protocol Violation|0
5608438|NCT00845858|19375351|P1|Overall Study|Protocol Violation|0
5608439|NCT00845858|19375349|P3|Overall Study|Adverse Event|4
5608440|NCT00845858|19375350|P2|Overall Study|Adverse Event|8
5608441|NCT00845858|19375351|P1|Overall Study|Adverse Event|3
5608442|NCT00845858|19375349|P3|Overall Study|Withdrawal by Subject|1
5608443|NCT00845858|19375350|P2|Overall Study|Withdrawal by Subject|1
5608444|NCT00845858|19375351|P1|Overall Study|Withdrawal by Subject|5
5608445|NCT00845845|19375364|P2|Overall Study|Lost to Follow-up|4
5608446|NCT00845845|19375365|P1|Overall Study|Lost to Follow-up|0
5608447|NCT00845832|19375376|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
5608448|NCT00845832|19375377|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
5608449|NCT00845832|19375378|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
5608450|NCT00845832|19375376|P3|Safety Follow-Up|Withdrawal by Subject|0
5608451|NCT00845832|19375377|P2|Safety Follow-Up|Withdrawal by Subject|0
5608452|NCT00845832|19375378|P1|Safety Follow-Up|Withdrawal by Subject|1
5608453|NCT00845832|19375376|P3|Treatment Period|Protocol Violation|0
5608454|NCT00845832|19375377|P2|Treatment Period|Protocol Violation|1
5608455|NCT00845832|19375378|P1|Treatment Period|Protocol Violation|1
5608456|NCT00845832|19375376|P3|Treatment Period|Adverse Event|0
5608457|NCT00845832|19375377|P2|Treatment Period|Adverse Event|2
5608458|NCT00845832|19375378|P1|Treatment Period|Adverse Event|0
5608459|NCT00845728|19375424|P2|Overall Study|Withdrawal by Subject|108
5608460|NCT00845728|19375425|P1|Overall Study|Withdrawal by Subject|105
5608461|NCT00845728|19375424|P2|Overall Study|Adverse Event|96
5608462|NCT00845728|19375425|P1|Overall Study|Adverse Event|101
5608463|NCT00845728|19375424|P2|Overall Study|Lack of Efficacy|39
5608464|NCT00845728|19375425|P1|Overall Study|Lack of Efficacy|51
5608465|NCT00845728|19375424|P2|Overall Study|Protocol Violation|24
5608466|NCT00845728|19375425|P1|Overall Study|Protocol Violation|36
5608467|NCT00845728|19375424|P2|Overall Study|Administrative Problems|26
5608468|NCT00845728|19375425|P1|Overall Study|Administrative Problems|34
5608469|NCT00845728|19375424|P2|Overall Study|Death|26
5608470|NCT00845728|19375425|P1|Overall Study|Death|24
5608471|NCT00845728|19375424|P2|Overall Study|Lost to Follow-up|13
5608472|NCT00845728|19375425|P1|Overall Study|Lost to Follow-up|22
5608473|NCT00845728|19375424|P2|Overall Study|Abnormal test procedure result (s)|2
5608474|NCT00845728|19375425|P1|Overall Study|Abnormal test procedure result (s)|7
5608475|NCT00845728|19375424|P2|Overall Study|Patient's inability to use the device|6
5608476|NCT00845728|19375425|P1|Overall Study|Patient's inability to use the device|4
5608477|NCT00845728|19375424|P2|Overall Study|Abnormal laboratory value (s)|2
5608478|NCT00845728|19375425|P1|Overall Study|Abnormal laboratory value (s)|2
5608479|NCT00845676|19375439|P1|Overall Study|Adverse Event|1
5608480|NCT00845676|19375439|P1|Overall Study|Virologic breakthrough at week 20|1
5608481|NCT00845650|19375502|P6|Overall Study|Unable to access IV line|0
5608482|NCT00845650|19375503|P5|Overall Study|Unable to access IV line|0
5608483|NCT00845650|19375504|P4|Overall Study|Unable to access IV line|0
5608484|NCT00845650|19375505|P3|Overall Study|Unable to access IV line|0
5608485|NCT00845650|19375506|P2|Overall Study|Unable to access IV line|0
5608486|NCT00845650|19375507|P1|Overall Study|Unable to access IV line|1
5608487|NCT00845650|19375502|P6|Overall Study|Sponsor hold on dosing|1
5608488|NCT00845650|19375503|P5|Overall Study|Sponsor hold on dosing|1
5608489|NCT00845650|19375504|P4|Overall Study|Sponsor hold on dosing|0
5608490|NCT00845650|19375505|P3|Overall Study|Sponsor hold on dosing|0
5608491|NCT00845650|19375506|P2|Overall Study|Sponsor hold on dosing|0
5608492|NCT00845650|19375507|P1|Overall Study|Sponsor hold on dosing|0
5608493|NCT00845650|19375502|P6|Overall Study|Lost to Follow-up|1
5608494|NCT00845650|19375503|P5|Overall Study|Lost to Follow-up|0
5608495|NCT00845650|19375504|P4|Overall Study|Lost to Follow-up|1
5608496|NCT00845650|19375505|P3|Overall Study|Lost to Follow-up|3
5608497|NCT00845650|19375506|P2|Overall Study|Lost to Follow-up|0
5608498|NCT00845650|19375507|P1|Overall Study|Lost to Follow-up|0
5608499|NCT00845650|19375502|P6|Overall Study|Withdrawal by Subject|0
5608500|NCT00845650|19375503|P5|Overall Study|Withdrawal by Subject|2
5608501|NCT00845650|19375504|P4|Overall Study|Withdrawal by Subject|0
5608502|NCT00845650|19375505|P3|Overall Study|Withdrawal by Subject|0
5608503|NCT00845650|19375506|P2|Overall Study|Withdrawal by Subject|0
5608504|NCT00845650|19375507|P1|Overall Study|Withdrawal by Subject|0
5608505|NCT00845520|19375545|P3|Overall Study|Adverse Event|1
5608506|NCT00845520|19375546|P2|Overall Study|Adverse Event|0
5608507|NCT00845520|19375547|P1|Overall Study|Adverse Event|0
5608508|NCT00845520|19375545|P3|Overall Study|Lost to Follow-up|0
5608509|NCT00845520|19375546|P2|Overall Study|Lost to Follow-up|0
5608510|NCT00845520|19375547|P1|Overall Study|Lost to Follow-up|1
5608511|NCT00845520|19375545|P3|Overall Study|Death|0
5608512|NCT00845520|19375546|P2|Overall Study|Death|2
5608513|NCT00845520|19375547|P1|Overall Study|Death|1
5608514|NCT00845429|19375584|P3|Overall Study|Serious adverse event|1
5608515|NCT00845429|19375585|P2|Overall Study|Serious adverse event|0
5608516|NCT00845429|19375586|P1|Overall Study|Serious adverse event|0
5608517|NCT00845429|19375584|P3|Overall Study|Withdrawal by Subject|2
5608518|NCT00845429|19375585|P2|Overall Study|Withdrawal by Subject|2
5608519|NCT00845429|19375586|P1|Overall Study|Withdrawal by Subject|2
5608520|NCT00845429|19375584|P3|Overall Study|Lost to Follow-up|10
5608521|NCT00845429|19375585|P2|Overall Study|Lost to Follow-up|9
5608522|NCT00845429|19375586|P1|Overall Study|Lost to Follow-up|7
5608523|NCT00845429|19375584|P3|Overall Study|Protocol Violation|7
5608524|NCT00845429|19375585|P2|Overall Study|Protocol Violation|4
5608525|NCT00845429|19375586|P1|Overall Study|Protocol Violation|5
5608526|NCT00845182|19375621|P3|Overall Study|Physician Decision|1
5608527|NCT00845182|19375622|P2|Overall Study|Physician Decision|0
5608528|NCT00845182|19375623|P1|Overall Study|Physician Decision|0
5608529|NCT00845182|19375621|P3|Overall Study|Adverse Event|1
5608530|NCT00845182|19375622|P2|Overall Study|Adverse Event|1
5608531|NCT00845182|19375623|P1|Overall Study|Adverse Event|0
5608532|NCT00845182|19375621|P3|Overall Study|Lost to Follow-up|4
5608533|NCT00845182|19375622|P2|Overall Study|Lost to Follow-up|3
5608534|NCT00845182|19375623|P1|Overall Study|Lost to Follow-up|3
5608535|NCT00845065|19375648|P2|Overall Study|Non-Medical Reasons|11
5608536|NCT00845065|19375649|P1|Overall Study|Non-Medical Reasons|1
5608537|NCT00845065|19375648|P2|Overall Study|Lack of Efficacy|21
5608538|NCT00845065|19375649|P1|Overall Study|Lack of Efficacy|43
5608539|NCT00845065|19375648|P2|Overall Study|Adverse Event|23
5608540|NCT00845065|19375649|P1|Overall Study|Adverse Event|3
5608541|NCT00844896|19375717|P2|Overall Study|Parents did not have time to complete|1
5608542|NCT00844896|19375718|P1|Overall Study|Parents did not have time to complete|0
5608543|NCT00844896|19375717|P2|Overall Study|Lost to Follow-up|16
5608544|NCT00844896|19375718|P1|Overall Study|Lost to Follow-up|12
5608545|NCT00844883|19375740|P1|Overall Study|Bridged to resection|1
5608546|NCT00844883|19375740|P1|Overall Study|Bridged to liver transplant|3
5608547|NCT00844857|19375752|P2|Overall Study|Good Clinical Practice Violations|11
5608548|NCT00844857|19375753|P1|Overall Study|Good Clinical Practice Violations|21
5608549|NCT00844857|19375752|P2|Overall Study|Did Not Take Study Drug|1
5608550|NCT00844857|19375753|P1|Overall Study|Did Not Take Study Drug|3
5608551|NCT00844857|19375752|P2|Overall Study|Lost to Follow-up|3
5608552|NCT00844857|19375753|P1|Overall Study|Lost to Follow-up|2
5608553|NCT00844857|19375752|P2|Overall Study|Entry Criteria Not Met|1
5608554|NCT00844857|19375753|P1|Overall Study|Entry Criteria Not Met|0
5608555|NCT00844857|19375752|P2|Overall Study|Clinical Relapse|1
5608556|NCT00844857|19375753|P1|Overall Study|Clinical Relapse|0
5608557|NCT00844857|19375752|P2|Overall Study|Lack of Efficacy|5
5608558|NCT00844857|19375753|P1|Overall Study|Lack of Efficacy|5
5608559|NCT00844857|19375752|P2|Overall Study|Protocol Violation|0
5608560|NCT00844857|19375753|P1|Overall Study|Protocol Violation|6
5608561|NCT00844857|19375752|P2|Overall Study|Withdrawal by Subject|7
5608562|NCT00844857|19375753|P1|Overall Study|Withdrawal by Subject|8
5608563|NCT00844857|19375752|P2|Overall Study|Parent/Caregiver Decision|2
5608564|NCT00844857|19375753|P1|Overall Study|Parent/Caregiver Decision|6
5608565|NCT00844857|19375752|P2|Overall Study|Physician Decision|0
5608566|NCT00844857|19375753|P1|Overall Study|Physician Decision|2
5608567|NCT00844857|19375752|P2|Overall Study|Sponsor Decision|1
5608568|NCT00844857|19375753|P1|Overall Study|Sponsor Decision|1
5608569|NCT00844857|19375752|P2|Overall Study|Adverse Event|5
5608570|NCT00844857|19375753|P1|Overall Study|Adverse Event|24
5608571|NCT00844844|19375797|P1|Post Treatment Period|Withdrawal by Subject|1
5608572|NCT00844844|19375797|P1|Extension Treatment Period|Adverse Event|2
5608573|NCT00844844|19375797|P1|Treatment Period (26 Weeks)|Protocol Violation|1
5608574|NCT00844844|19375797|P1|Treatment Period (26 Weeks)|Adverse Event|1
5608575|NCT00844831|19375811|P1|Overall Study|Physician Decision|1
5608576|NCT00844831|19375811|P1|Overall Study|Adverse Event|1
5608577|NCT00844831|19375811|P1|Overall Study|Withdrawal by Subject|4
5608578|NCT00844805|19375821|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
5608579|NCT00844805|19375822|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
5608580|NCT00844805|19375823|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
5608581|NCT00844805|19375824|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
5608582|NCT00844805|19375821|P4|Follow-Up Phase|Relapse/Recurrence|4
5608583|NCT00844805|19375822|P3|Follow-Up Phase|Relapse/Recurrence|2
5608584|NCT00844805|19375823|P2|Follow-Up Phase|Relapse/Recurrence|0
5608585|NCT00844805|19375824|P1|Follow-Up Phase|Relapse/Recurrence|0
5608586|NCT00844805|19375821|P4|Follow-Up Phase|Noncompliance With Protocol|1
5608587|NCT00844805|19375822|P3|Follow-Up Phase|Noncompliance With Protocol|0
5608588|NCT00844805|19375823|P2|Follow-Up Phase|Noncompliance With Protocol|0
5608589|NCT00844805|19375824|P1|Follow-Up Phase|Noncompliance With Protocol|0
5608590|NCT00844805|19375821|P4|Follow-Up Phase|Withdrawal by Subject|3
5608591|NCT00844805|19375822|P3|Follow-Up Phase|Withdrawal by Subject|6
5608592|NCT00844805|19375823|P2|Follow-Up Phase|Withdrawal by Subject|0
5608593|NCT00844805|19375824|P1|Follow-Up Phase|Withdrawal by Subject|0
5608594|NCT00844805|19375821|P4|Follow-Up Phase|Adverse Event|0
5608595|NCT00844805|19375822|P3|Follow-Up Phase|Adverse Event|1
5608596|NCT00844805|19375823|P2|Follow-Up Phase|Adverse Event|0
5608597|NCT00844805|19375824|P1|Follow-Up Phase|Adverse Event|0
5608598|NCT00844805|19375821|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
5608599|NCT00844805|19375822|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
5608600|NCT00844805|19375823|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
5608601|NCT00844805|19375824|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
5608602|NCT00844805|19375821|P4|Treatment Phase|Noncompliance With Protocol|0
5608603|NCT00844805|19375822|P3|Treatment Phase|Noncompliance With Protocol|0
5608604|NCT00844805|19375823|P2|Treatment Phase|Noncompliance With Protocol|0
5608605|NCT00844805|19375824|P1|Treatment Phase|Noncompliance With Protocol|1
5608606|NCT00844805|19375821|P4|Treatment Phase|Withdrawal by Subject|0
5608607|NCT00844805|19375822|P3|Treatment Phase|Withdrawal by Subject|0
5608608|NCT00844805|19375823|P2|Treatment Phase|Withdrawal by Subject|4
5608609|NCT00844805|19375824|P1|Treatment Phase|Withdrawal by Subject|3
5608610|NCT00844805|19375821|P4|Treatment Phase|Adverse Event|0
5608611|NCT00844805|19375822|P3|Treatment Phase|Adverse Event|0
5608612|NCT00844805|19375823|P2|Treatment Phase|Adverse Event|1
5608613|NCT00844805|19375824|P1|Treatment Phase|Adverse Event|5
5608614|NCT00844753|19375868|P4|Overall Study|Withdrawal by Subject|3
5608615|NCT00844753|19375869|P3|Overall Study|Withdrawal by Subject|0
5608616|NCT00844753|19375870|P2|Overall Study|Withdrawal by Subject|0
5608617|NCT00844753|19375871|P1|Overall Study|Withdrawal by Subject|1
5608618|NCT00844753|19375868|P4|Overall Study|could not swallow medication|0
5608619|NCT00844753|19375869|P3|Overall Study|could not swallow medication|0
5608620|NCT00844753|19375870|P2|Overall Study|could not swallow medication|0
5608621|NCT00844753|19375871|P1|Overall Study|could not swallow medication|2
5608622|NCT00844753|19375868|P4|Overall Study|Lost to Follow-up|1
5608623|NCT00844753|19375869|P3|Overall Study|Lost to Follow-up|0
5608624|NCT00844753|19375870|P2|Overall Study|Lost to Follow-up|1
5608625|NCT00844753|19375871|P1|Overall Study|Lost to Follow-up|1
5608626|NCT00844753|19375868|P4|Overall Study|Adverse Event|5
5608627|NCT00844753|19375869|P3|Overall Study|Adverse Event|5
5608628|NCT00844753|19375870|P2|Overall Study|Adverse Event|2
5608629|NCT00844753|19375871|P1|Overall Study|Adverse Event|3
5608630|NCT00844753|19375868|P4|Overall Study|Lack of Efficacy|2
5608631|NCT00844753|19375869|P3|Overall Study|Lack of Efficacy|2
5608632|NCT00844753|19375870|P2|Overall Study|Lack of Efficacy|0
5608633|NCT00844753|19375871|P1|Overall Study|Lack of Efficacy|1
5608634|NCT00844649|19375889|P2|Overall Study|Withdrew prior to starting treatment|27
5608635|NCT00844649|19375890|P1|Overall Study|Withdrew prior to starting treatment|11
5608636|NCT00844649|19375889|P2|Overall Study|Other|10
5608637|NCT00844649|19375890|P1|Overall Study|Other|7
5608638|NCT00844649|19375889|P2|Overall Study|Withdrawal by Subject|39
5608639|NCT00844649|19375890|P1|Overall Study|Withdrawal by Subject|28
5608640|NCT00844649|19375889|P2|Overall Study|Protocol Violation|6
5608641|NCT00844649|19375890|P1|Overall Study|Protocol Violation|10
5608642|NCT00844649|19375889|P2|Overall Study|Physician Decision|18
5608643|NCT00844649|19375890|P1|Overall Study|Physician Decision|25
5608644|NCT00844649|19375889|P2|Overall Study|Adverse Event|73
5608645|NCT00844649|19375890|P1|Overall Study|Adverse Event|128
5608646|NCT00844649|19375889|P2|Overall Study|Progressive Disease|245
5608647|NCT00844649|19375890|P1|Overall Study|Progressive Disease|196
5608648|NCT00844597|19375914|P6|Overall Study|Adverse Event|0
5608649|NCT00844597|19375915|P5|Overall Study|Adverse Event|0
5608650|NCT00844597|19375916|P4|Overall Study|Adverse Event|1
5608651|NCT00844597|19375917|P3|Overall Study|Adverse Event|0
5608652|NCT00844597|19375918|P2|Overall Study|Adverse Event|0
5608653|NCT00844597|19375919|P1|Overall Study|Adverse Event|0
5608654|NCT00844558|19375939|P2|Overall Study|Physician Decision|0
5608655|NCT00844558|19375940|P1|Overall Study|Physician Decision|1
5608656|NCT00844558|19375939|P2|Overall Study|Lost to Follow-up|1
5608657|NCT00844558|19375940|P1|Overall Study|Lost to Follow-up|0
5608658|NCT00844558|19375939|P2|Overall Study|Protocol Violation|1
5608659|NCT00844558|19375940|P1|Overall Study|Protocol Violation|1
5608660|NCT00844558|19375939|P2|Overall Study|Death|0
5608661|NCT00844558|19375940|P1|Overall Study|Death|1
5608662|NCT00844558|19375939|P2|Overall Study|Withdrawal by Subject|2
5608663|NCT00844558|19375940|P1|Overall Study|Withdrawal by Subject|9
5608664|NCT00844545|19375956|P1|Post Treatment Period|Withdrawal by Subject|1
5608665|NCT00844545|19375956|P1|Extension Treatment Period|Adverse Event|2
5608666|NCT00844545|19375956|P1|Treatment Period (26 Weeks)|Protocol Violation|1
5608667|NCT00844545|19375956|P1|Treatment Period (26 Weeks)|Adverse Event|1
5608668|NCT00844532|19375970|P1|Overall Study|Lost to Follow-up|7
5608669|NCT00844532|19375970|P1|Overall Study|Withdrawal by Subject|16
5608670|NCT00844532|19375970|P1|Overall Study|Death|16
5608671|NCT00844519|19376056|P2|Overall Study|Adverse Event|0
5608672|NCT00844519|19376057|P1|Overall Study|Adverse Event|1
5608673|NCT00844519|19376056|P2|Overall Study|Withdrawal by Subject|1
5608674|NCT00844519|19376057|P1|Overall Study|Withdrawal by Subject|1
5608675|NCT00844480|19376065|P2|Overall Study|Withdrawal by Subject|3
5608676|NCT00844480|19376066|P1|Overall Study|Withdrawal by Subject|2
5608677|NCT00844428|19376074|P1|Post Treatment Period (Patients Who Disc|Death|1
5608678|NCT00844428|19376074|P1|Extension Treatment Period|Death|1
5608679|NCT00844428|19376074|P1|Screening Period|Screen Failure|3
5608680|NCT00844415|19376090|P1|Overall Study|Withdrawal by Subject|1
5608681|NCT00844376|19376104|P2|Period 1: First Intervention|Withdrawal by Subject|0
5608682|NCT00844376|19376105|P1|Period 1: First Intervention|Withdrawal by Subject|1
5608683|NCT00844194|19376129|P2|Overall Study|Other reason (not specified)|0
5608684|NCT00844194|19376130|P1|Overall Study|Other reason (not specified)|1
5608685|NCT00844194|19376129|P2|Overall Study|Lack of Efficacy|0
5608686|NCT00844194|19376130|P1|Overall Study|Lack of Efficacy|3
5608687|NCT00844194|19376129|P2|Overall Study|Withdrawal by Subject|1
5608688|NCT00844194|19376130|P1|Overall Study|Withdrawal by Subject|2
5608689|NCT00844194|19376129|P2|Overall Study|Lost to Follow-up|1
5608690|NCT00844194|19376130|P1|Overall Study|Lost to Follow-up|1
5608691|NCT00844194|19376129|P2|Overall Study|Protocol Violation|1
5608692|NCT00844194|19376130|P1|Overall Study|Protocol Violation|1
5608693|NCT00844194|19376129|P2|Overall Study|Adverse Event|5
5608694|NCT00844194|19376130|P1|Overall Study|Adverse Event|17
5608695|NCT00843856|19376385|P2|Overall Study|Lost to Follow-up|2
5608696|NCT00843856|19376386|P1|Overall Study|Lost to Follow-up|1
5608697|NCT00843843|19376396|P2|Overall Study|Protocol Violation|1
5608698|NCT00843843|19376397|P1|Overall Study|Protocol Violation|1
5608699|NCT00843843|19376396|P2|Overall Study|Physician Decision|1
5608700|NCT00843843|19376397|P1|Overall Study|Physician Decision|1
5608701|NCT00843778|19376410|P1|Overall Study|Withdrawal by Subject|4
5608702|NCT00843778|19376410|P1|Overall Study|Loss of efficacy|2
5608703|NCT00843778|19376410|P1|Overall Study|Lack of Efficacy|14
5608704|NCT00843778|19376410|P1|Overall Study|Adverse Event|15
5608705|NCT00843635|19376455|P3|Overall Study|Adverse Event|0
5608706|NCT00843635|19376456|P2|Overall Study|Adverse Event|2
5608707|NCT00843635|19376457|P1|Overall Study|Adverse Event|2
5608708|NCT00843518|19376496|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
5608709|NCT00843518|19376497|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
5608710|NCT00843518|19376496|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
5608711|NCT00843518|19376497|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
5608712|NCT00843518|19376496|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
5608713|NCT00843518|19376497|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
5608714|NCT00843518|19376496|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
5608715|NCT00843518|19376497|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
5608716|NCT00843518|19376496|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
5608717|NCT00843518|19376497|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
5608718|NCT00843518|19376496|P2|Period 2 (Double-blind Treatment)|Death|1
5608719|NCT00843518|19376497|P1|Period 2 (Double-blind Treatment)|Death|0
5608720|NCT00843518|19376496|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
5608721|NCT00843518|19376497|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
5608722|NCT00843492|19376527|P2|Overall Study|Deep-vein Thrombosis|0
5608723|NCT00843492|19376528|P1|Overall Study|Deep-vein Thrombosis|1
5608724|NCT00843492|19376527|P2|Overall Study|Visit Not Performed|0
5608725|NCT00843492|19376528|P1|Overall Study|Visit Not Performed|1
5608726|NCT00843492|19376527|P2|Overall Study|Orthopedic Surgery|2
5608727|NCT00843492|19376528|P1|Overall Study|Orthopedic Surgery|0
5608728|NCT00843492|19376527|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
5608729|NCT00843492|19376528|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
5608730|NCT00843492|19376527|P2|Overall Study|Immobilization Stopped|0
5608731|NCT00843492|19376528|P1|Overall Study|Immobilization Stopped|1
5608732|NCT00843492|19376527|P2|Overall Study|Withdrawal by Subject|4
5608733|NCT00843492|19376528|P1|Overall Study|Withdrawal by Subject|0
5608734|NCT00843492|19376527|P2|Overall Study|Lost to Follow-up|4
5608735|NCT00843492|19376528|P1|Overall Study|Lost to Follow-up|4
5608736|NCT00843492|19376527|P2|Overall Study|Adverse Event|3
5608737|NCT00843492|19376528|P1|Overall Study|Adverse Event|0
5608738|NCT00843284|19376599|P1|Overall Study|Death|3
5608739|NCT00843284|19376599|P1|Overall Study|Withdrawal by Subject|4
5608740|NCT00843284|19376599|P1|Overall Study|Other|10
5608741|NCT00843284|19376599|P1|Overall Study|Lost to Follow-up|11
5608742|NCT00843284|19376599|P1|Overall Study|Lack of Efficacy|5
5608743|NCT00843284|19376599|P1|Overall Study|Adverse Event|39
5608744|NCT00843193|19376609|P2|Overall Study|Withdrawal by Subject|3
5608745|NCT00843193|19376610|P1|Overall Study|Withdrawal by Subject|3
5608746|NCT00843193|19376609|P2|Overall Study|Physician Decision|1
5608747|NCT00843193|19376610|P1|Overall Study|Physician Decision|0
5608748|NCT00843193|19376609|P2|Overall Study|Lost to Follow-up|0
5608749|NCT00843193|19376610|P1|Overall Study|Lost to Follow-up|1
5608750|NCT00843193|19376609|P2|Overall Study|Protocol Violation|2
5608751|NCT00843193|19376610|P1|Overall Study|Protocol Violation|1
5608752|NCT00843193|19376609|P2|Overall Study|Lack of Efficacy|1
5608753|NCT00843193|19376610|P1|Overall Study|Lack of Efficacy|1
5608754|NCT00843193|19376609|P2|Overall Study|Adverse Event|4
5608755|NCT00843193|19376610|P1|Overall Study|Adverse Event|2
5608756|NCT00843167|19376661|P2|Treatment Period|Withdrawal by Subject|3
5608757|NCT00843167|19376662|P1|Treatment Period|Withdrawal by Subject|2
5608758|NCT00843167|19376661|P2|Treatment Period|Adverse Event|5
5608759|NCT00843167|19376662|P1|Treatment Period|Adverse Event|1
5608760|NCT00843115|19376675|P1|Overall Study|Syndrome De Glissement|1
5608761|NCT00843115|19376675|P1|Overall Study|week 12 not done|1
5608762|NCT00843115|19376675|P1|Overall Study|hospitalized due to deterioration|1
5608763|NCT00843115|19376675|P1|Overall Study|patient never took the medication|1
5608764|NCT00843115|19376675|P1|Overall Study|patient took for 2 days then stopped|1
5608765|NCT00843115|19376675|P1|Overall Study|Family discontinued meds|1
5608766|NCT00843115|19376675|P1|Overall Study|Physician Decision|1
5608767|NCT00843115|19376675|P1|Overall Study|Does not meet entrance criteria|1
5608768|NCT00843115|19376675|P1|Overall Study|Patient forgot to take meds|1
5608769|NCT00843115|19376675|P1|Overall Study|Family does not want continuation|1
5608770|NCT00843115|19376675|P1|Overall Study|Family wanted meds stopped|1
5608771|NCT00843115|19376675|P1|Overall Study|Withdrawal by Subject|17
5608772|NCT00843115|19376675|P1|Overall Study|Lost to Follow-up|4
5608773|NCT00843115|19376675|P1|Overall Study|Adverse Event|30
5608774|NCT00843115|19376675|P1|Overall Study|Death|4
5608775|NCT00843024|19376731|P6|Double-blind Treatment Phase|Lack of Efficacy|0
5608776|NCT00843024|19376732|P5|Double-blind Treatment Phase|Lack of Efficacy|1
5608777|NCT00843024|19376733|P4|Double-blind Treatment Phase|Lack of Efficacy|0
5608778|NCT00843024|19376734|P3|Double-blind Treatment Phase|Lack of Efficacy|0
5608779|NCT00843024|19376735|P2|Double-blind Treatment Phase|Lack of Efficacy|0
5608780|NCT00843024|19376736|P1|Double-blind Treatment Phase|Lack of Efficacy|0
5608781|NCT00843024|19376731|P6|Double-blind Treatment Phase|Adverse Event|1
5608782|NCT00843024|19376732|P5|Double-blind Treatment Phase|Adverse Event|1
5608783|NCT00843024|19376733|P4|Double-blind Treatment Phase|Adverse Event|0
5608784|NCT00843024|19376734|P3|Double-blind Treatment Phase|Adverse Event|0
5608785|NCT00843024|19376735|P2|Double-blind Treatment Phase|Adverse Event|0
5608786|NCT00843024|19376736|P1|Double-blind Treatment Phase|Adverse Event|0
5608787|NCT00843024|19376731|P6|Double-blind Treatment Phase|Physician Decision|1
5608788|NCT00843024|19376732|P5|Double-blind Treatment Phase|Physician Decision|1
5608789|NCT00843024|19376733|P4|Double-blind Treatment Phase|Physician Decision|3
5608790|NCT00843024|19376734|P3|Double-blind Treatment Phase|Physician Decision|0
5608791|NCT00843024|19376735|P2|Double-blind Treatment Phase|Physician Decision|0
5608792|NCT00843024|19376736|P1|Double-blind Treatment Phase|Physician Decision|0
5608793|NCT00843024|19376731|P6|Double-blind Treatment Phase|Protocol Violation|3
5608794|NCT00843024|19376732|P5|Double-blind Treatment Phase|Protocol Violation|0
5608795|NCT00843024|19376733|P4|Double-blind Treatment Phase|Protocol Violation|0
5608796|NCT00843024|19376734|P3|Double-blind Treatment Phase|Protocol Violation|3
5608797|NCT00843024|19376735|P2|Double-blind Treatment Phase|Protocol Violation|0
5608798|NCT00843024|19376736|P1|Double-blind Treatment Phase|Protocol Violation|0
5608799|NCT00843024|19376731|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
5608800|NCT00843024|19376732|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
5608801|NCT00843024|19376733|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
5608802|NCT00843024|19376734|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
5608803|NCT00843024|19376735|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
5608804|NCT00843024|19376736|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
5608805|NCT00843024|19376731|P6|Double-blind Treatment Phase|Lost to Follow-up|4
5608806|NCT00843024|19376732|P5|Double-blind Treatment Phase|Lost to Follow-up|4
5608807|NCT00843024|19376733|P4|Double-blind Treatment Phase|Lost to Follow-up|4
5608808|NCT00843024|19376734|P3|Double-blind Treatment Phase|Lost to Follow-up|8
5608809|NCT00843024|19376735|P2|Double-blind Treatment Phase|Lost to Follow-up|0
5608810|NCT00843024|19376736|P1|Double-blind Treatment Phase|Lost to Follow-up|0
5608811|NCT00843024|19376731|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
5608812|NCT00843024|19376732|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
5608813|NCT00843024|19376733|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
5608814|NCT00843024|19376734|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
5608815|NCT00843024|19376735|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
5608816|NCT00843024|19376736|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
5608817|NCT00843024|19376731|P6|Single-blind Placebo Run-In Phase|Other|0
5608818|NCT00843024|19376732|P5|Single-blind Placebo Run-In Phase|Other|0
5608819|NCT00843024|19376733|P4|Single-blind Placebo Run-In Phase|Other|0
5608820|NCT00843024|19376734|P3|Single-blind Placebo Run-In Phase|Other|0
5608821|NCT00843024|19376735|P2|Single-blind Placebo Run-In Phase|Other|1
5608822|NCT00843024|19376736|P1|Single-blind Placebo Run-In Phase|Other|0
5608823|NCT00843024|19376731|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
5608824|NCT00843024|19376732|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
5608825|NCT00843024|19376733|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
5608826|NCT00843024|19376734|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
5608827|NCT00843024|19376735|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
5608828|NCT00843024|19376736|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
5608829|NCT00843024|19376731|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
5608830|NCT00843024|19376732|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
5608831|NCT00843024|19376733|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
5608832|NCT00843024|19376734|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
5608833|NCT00843024|19376735|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
5608834|NCT00843024|19376736|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
5608835|NCT00843024|19376731|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
5608836|NCT00843024|19376732|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
5608837|NCT00843024|19376733|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
5608838|NCT00843024|19376734|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
5608839|NCT00843024|19376735|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
5608840|NCT00843024|19376736|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
5608841|NCT00843024|19376731|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
5608842|NCT00843024|19376732|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
5608843|NCT00843024|19376733|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
5608844|NCT00843024|19376734|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
5608845|NCT00843024|19376735|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
5608846|NCT00843024|19376736|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
5608847|NCT00843024|19376731|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
5608848|NCT00843024|19376732|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
5608849|NCT00843024|19376733|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
5608850|NCT00843024|19376734|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
5608851|NCT00843024|19376735|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
5608852|NCT00843024|19376736|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
5608853|NCT00843024|19376731|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
5608854|NCT00843024|19376732|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
5608855|NCT00843024|19376733|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
5608856|NCT00843024|19376734|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
5608857|NCT00843024|19376735|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
5608858|NCT00843024|19376736|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
5608859|NCT00842985|19376801|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
5608860|NCT00842985|19376801|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
5608861|NCT00842985|19376801|P1|First Intervention|Protocol Violation|3
5608862|NCT00842985|19376801|P1|First Intervention|Withdrawal by Subject|3
5608863|NCT00842985|19376801|P1|Screening|Did not meet entrance requirements|27
5608864|NCT00842829|19376819|P3|Continuation Period|Non-compliance to study drug|1
5608865|NCT00842829|19376820|P2|Continuation Period|Non-compliance to study drug|0
5608866|NCT00842829|19376821|P1|Continuation Period|Non-compliance to study drug|0
5608867|NCT00842829|19376819|P3|Continuation Period|Non-compliance to study procedures|2
5608868|NCT00842829|19376820|P2|Continuation Period|Non-compliance to study procedures|0
5608869|NCT00842829|19376821|P1|Continuation Period|Non-compliance to study procedures|0
5608870|NCT00842829|19376819|P3|Continuation Period|Other|7
5608871|NCT00842829|19376820|P2|Continuation Period|Other|0
5608872|NCT00842829|19376821|P1|Continuation Period|Other|0
5608873|NCT00842829|19376819|P3|Continuation Period|Withdrawal by Subject|10
5608874|NCT00842829|19376820|P2|Continuation Period|Withdrawal by Subject|0
5608875|NCT00842829|19376821|P1|Continuation Period|Withdrawal by Subject|0
5608876|NCT00842829|19376819|P3|Continuation Period|Unstable persistent cancer pain|3
5608877|NCT00842829|19376820|P2|Continuation Period|Unstable persistent cancer pain|0
5608878|NCT00842829|19376821|P1|Continuation Period|Unstable persistent cancer pain|0
5608879|NCT00842829|19376819|P3|Continuation Period|Lack of Efficacy|6
5608880|NCT00842829|19376820|P2|Continuation Period|Lack of Efficacy|0
5608881|NCT00842829|19376821|P1|Continuation Period|Lack of Efficacy|0
5608882|NCT00842829|19376819|P3|Continuation Period|Adverse Event|32
5608883|NCT00842829|19376820|P2|Continuation Period|Adverse Event|0
5608884|NCT00842829|19376821|P1|Continuation Period|Adverse Event|0
5608885|NCT00842829|19376819|P3|Treatment Period|Unclear completion status|1
5608886|NCT00842829|19376820|P2|Treatment Period|Unclear completion status|0
5608887|NCT00842829|19376821|P1|Treatment Period|Unclear completion status|0
5608888|NCT00842829|19376819|P3|Treatment Period|Non-compliance to study procedures|4
5608889|NCT00842829|19376820|P2|Treatment Period|Non-compliance to study procedures|0
5608890|NCT00842829|19376821|P1|Treatment Period|Non-compliance to study procedures|0
5608891|NCT00842829|19376819|P3|Treatment Period|Other|18
5608892|NCT00842829|19376820|P2|Treatment Period|Other|0
5608893|NCT00842829|19376821|P1|Treatment Period|Other|0
5608894|NCT00842829|19376819|P3|Treatment Period|Protocol Violation|2
5608895|NCT00842829|19376820|P2|Treatment Period|Protocol Violation|0
5608896|NCT00842829|19376821|P1|Treatment Period|Protocol Violation|0
5608897|NCT00842829|19376819|P3|Treatment Period|Consistently >4 BTP episodes daily|1
5608898|NCT00842829|19376820|P2|Treatment Period|Consistently >4 BTP episodes daily|0
5608899|NCT00842829|19376821|P1|Treatment Period|Consistently >4 BTP episodes daily|0
5608900|NCT00842829|19376819|P3|Treatment Period|Withdrawal by Subject|11
5608901|NCT00842829|19376820|P2|Treatment Period|Withdrawal by Subject|0
5608902|NCT00842829|19376821|P1|Treatment Period|Withdrawal by Subject|0
5608903|NCT00842829|19376819|P3|Treatment Period|Unstable persistent cancer pain|5
5608904|NCT00842829|19376820|P2|Treatment Period|Unstable persistent cancer pain|0
5608905|NCT00842829|19376821|P1|Treatment Period|Unstable persistent cancer pain|0
5608906|NCT00842829|19376819|P3|Treatment Period|Lack of Efficacy|6
5608907|NCT00842829|19376820|P2|Treatment Period|Lack of Efficacy|0
5608908|NCT00842829|19376821|P1|Treatment Period|Lack of Efficacy|0
5608909|NCT00842829|19376819|P3|Treatment Period|Adverse Event|15
5608910|NCT00842829|19376820|P2|Treatment Period|Adverse Event|0
5608911|NCT00842829|19376821|P1|Treatment Period|Adverse Event|0
5608912|NCT00842829|19376819|P3|Dose Titration Period|Non-compliance to study drug|0
5608913|NCT00842829|19376820|P2|Dose Titration Period|Non-compliance to study drug|1
5608914|NCT00842829|19376821|P1|Dose Titration Period|Non-compliance to study drug|2
5608915|NCT00842829|19376819|P3|Dose Titration Period|Non-compliance to study procedures|0
5608916|NCT00842829|19376820|P2|Dose Titration Period|Non-compliance to study procedures|1
5608917|NCT00842829|19376821|P1|Dose Titration Period|Non-compliance to study procedures|1
5608918|NCT00842829|19376819|P3|Dose Titration Period|Other|0
5608919|NCT00842829|19376820|P2|Dose Titration Period|Other|4
5608920|NCT00842829|19376821|P1|Dose Titration Period|Other|5
5608921|NCT00842829|19376819|P3|Dose Titration Period|Withdrawal by Subject|0
5608922|NCT00842829|19376820|P2|Dose Titration Period|Withdrawal by Subject|6
5608923|NCT00842829|19376821|P1|Dose Titration Period|Withdrawal by Subject|2
5608924|NCT00842829|19376819|P3|Dose Titration Period|Unstable persistent cancer pain|0
5608925|NCT00842829|19376820|P2|Dose Titration Period|Unstable persistent cancer pain|0
5608926|NCT00842829|19376821|P1|Dose Titration Period|Unstable persistent cancer pain|1
5608927|NCT00842829|19376819|P3|Dose Titration Period|Lack of Efficacy|0
5608928|NCT00842829|19376820|P2|Dose Titration Period|Lack of Efficacy|1
5608929|NCT00842829|19376821|P1|Dose Titration Period|Lack of Efficacy|4
5608930|NCT00842829|19376819|P3|Dose Titration Period|Adverse Event|0
5608931|NCT00842829|19376820|P2|Dose Titration Period|Adverse Event|10
5608932|NCT00842829|19376821|P1|Dose Titration Period|Adverse Event|11
5608933|NCT00842712|19376880|P7|Randomized Part|Ongoing at cut-off date|2
5608934|NCT00842712|19376881|P6|Randomized Part|Ongoing at cut-off date|0
5608935|NCT00842712|19376882|P5|Randomized Part|Ongoing at cut-off date|0
5608936|NCT00842712|19376883|P4|Randomized Part|Ongoing at cut-off date|0
5608937|NCT00842712|19376884|P3|Randomized Part|Ongoing at cut-off date|0
5608938|NCT00842712|19376885|P2|Randomized Part|Ongoing at cut-off date|0
5608939|NCT00842712|19376886|P1|Randomized Part|Ongoing at cut-off date|0
5608940|NCT00842712|19376880|P7|Randomized Part|Randomized but not treated|4
5608941|NCT00842712|19376881|P6|Randomized Part|Randomized but not treated|1
5608942|NCT00842712|19376882|P5|Randomized Part|Randomized but not treated|0
5608943|NCT00842712|19376883|P4|Randomized Part|Randomized but not treated|0
5608944|NCT00842712|19376884|P3|Randomized Part|Randomized but not treated|0
5608945|NCT00842712|19376885|P2|Randomized Part|Randomized but not treated|0
5608946|NCT00842712|19376886|P1|Randomized Part|Randomized but not treated|0
5608947|NCT00842712|19376880|P7|Safety Run-in Part|Progressive disease|0
5608948|NCT00842712|19376881|P6|Safety Run-in Part|Progressive disease|0
5608949|NCT00842712|19376882|P5|Safety Run-in Part|Progressive disease|0
5608950|NCT00842712|19376883|P4|Safety Run-in Part|Progressive disease|1
5608951|NCT00842712|19376884|P3|Safety Run-in Part|Progressive disease|0
5608952|NCT00842712|19376885|P2|Safety Run-in Part|Progressive disease|1
5608953|NCT00842712|19376886|P1|Safety Run-in Part|Progressive disease|3
5608954|NCT00842712|19376880|P7|Safety Run-in Part|Adverse Event|0
5608955|NCT00842712|19376881|P6|Safety Run-in Part|Adverse Event|0
5608956|NCT00842712|19376882|P5|Safety Run-in Part|Adverse Event|0
5608957|NCT00842712|19376883|P4|Safety Run-in Part|Adverse Event|0
5608958|NCT00842712|19376884|P3|Safety Run-in Part|Adverse Event|0
5608959|NCT00842712|19376885|P2|Safety Run-in Part|Adverse Event|1
5608960|NCT00842712|19376886|P1|Safety Run-in Part|Adverse Event|0
5608961|NCT00842543|19376943|P4|Overall Study|Withdrawal by Subject|4
5608962|NCT00842543|19376944|P3|Overall Study|Withdrawal by Subject|3
5608963|NCT00842543|19376945|P2|Overall Study|Withdrawal by Subject|0
5608964|NCT00842543|19376946|P1|Overall Study|Withdrawal by Subject|2
5608965|NCT00842530|19376960|P2|Overall Study|Withdrawal by Subject|28
5608966|NCT00842530|19376961|P1|Overall Study|Withdrawal by Subject|73
5608967|NCT00842530|19376960|P2|Overall Study|Lost to Follow-up|8
5608968|NCT00842530|19376961|P1|Overall Study|Lost to Follow-up|6
5608969|NCT00842530|19376960|P2|Overall Study|Protocol Violation|14
5608970|NCT00842530|19376961|P1|Overall Study|Protocol Violation|32
5608971|NCT00842530|19376960|P2|Overall Study|Other adverse event|1
5608972|NCT00842530|19376961|P1|Overall Study|Other adverse event|6
5608973|NCT00842530|19376960|P2|Overall Study|Serious adverse event|6
5608974|NCT00842530|19376961|P1|Overall Study|Serious adverse event|0
5608975|NCT00842361|19376991|P2|Overall Study|Unclassified|2
5608976|NCT00842361|19376992|P1|Overall Study|Unclassified|0
5608977|NCT00842361|19376991|P2|Overall Study|Protocol Violation|0
5608978|NCT00842361|19376992|P1|Overall Study|Protocol Violation|1
5608979|NCT00842348|19377012|P2|Study 729|Surgical resection|0
5608980|NCT00842348|19377013|P1|Study 729|Surgical resection|1
5608981|NCT00842348|19377012|P2|Study 729|Sponsor's decision|0
5608982|NCT00842348|19377013|P1|Study 729|Sponsor's decision|1
5608983|NCT00842348|19377012|P2|Study 729|Due to non-availability of IP|1
5608984|NCT00842348|19377013|P1|Study 729|Due to non-availability of IP|0
5608985|NCT00842348|19377012|P2|Study 729|Due to Sponsor stopping the study|1
5608986|NCT00842348|19377013|P1|Study 729|Due to Sponsor stopping the study|1
5608987|NCT00842348|19377012|P2|Study 729|Withdrawal by Subject|4
5608988|NCT00842348|19377013|P1|Study 729|Withdrawal by Subject|2
5608989|NCT00842348|19377012|P2|Study 729|Protocol Violation|1
5608990|NCT00842348|19377013|P1|Study 729|Protocol Violation|1
5608991|NCT00842348|19377012|P2|Study 729|Adverse Event|1
5608992|NCT00842348|19377013|P1|Study 729|Adverse Event|1
5608993|NCT00842348|19377012|P2|Study 729|Disease progression/death|30
5608994|NCT00842348|19377013|P1|Study 729|Disease progression/death|19
5608995|NCT00842348|19377012|P2|Patients Randomised in Study 726|Did not enter Study 729|56
5608996|NCT00842348|19377013|P1|Patients Randomised in Study 726|Did not enter Study 729|59
5608997|NCT00842309|19377032|P2|Overall Study|Withdrawal by Subject|1
5608998|NCT00842309|19377033|P1|Overall Study|Withdrawal by Subject|3
5608999|NCT00842257|19377067|P1|Overall Study|Adverse Event|1
5609000|NCT00842244|19377074|P1|Overall Study|Other|17
5609001|NCT00842244|19377074|P1|Overall Study|Withdrawal by Subject|1
5609002|NCT00842244|19377074|P1|Overall Study|Death|3
5609003|NCT00842153|19377101|P2|Overall Study|Lost to Follow-up|2
5609004|NCT00842153|19377102|P1|Overall Study|Lost to Follow-up|1
5609005|NCT00842153|19377101|P2|Overall Study|Adverse Event|1
5609006|NCT00842153|19377102|P1|Overall Study|Adverse Event|0
5609007|NCT00841906|19377177|P2|Overall Study|Withdrawal by Subject|0
5609008|NCT00841906|19377178|P1|Overall Study|Withdrawal by Subject|2
5609009|NCT00841815|19377203|P2|Washout|Withdrawal by Subject|1
5609010|NCT00841815|19377204|P1|Washout|Withdrawal by Subject|0
5609011|NCT00841776|19377214|P2|Overall Study|Withdrawal by Subject|1
5609012|NCT00841776|19377215|P1|Overall Study|Withdrawal by Subject|0
5609013|NCT00841776|19377214|P2|Overall Study|Lost to Follow-up|1
5609014|NCT00841776|19377215|P1|Overall Study|Lost to Follow-up|2
5609015|NCT00841776|19377214|P2|Overall Study|Lack of Efficacy|1
5609016|NCT00841776|19377215|P1|Overall Study|Lack of Efficacy|0
5609017|NCT00841763|19377233|P4|Overall Study|Unable to Classify|0
5609018|NCT00841763|19377234|P3|Overall Study|Unable to Classify|0
5609019|NCT00841763|19377235|P2|Overall Study|Unable to Classify|1
5609020|NCT00841763|19377236|P1|Overall Study|Unable to Classify|7
5609021|NCT00841763|19377233|P4|Overall Study|Administrative Reasons|0
5609022|NCT00841763|19377234|P3|Overall Study|Administrative Reasons|0
5609023|NCT00841763|19377235|P2|Overall Study|Administrative Reasons|1
5609024|NCT00841763|19377236|P1|Overall Study|Administrative Reasons|3
5609025|NCT00841763|19377233|P4|Overall Study|Protocol Violation|0
5609026|NCT00841763|19377234|P3|Overall Study|Protocol Violation|1
5609027|NCT00841763|19377235|P2|Overall Study|Protocol Violation|3
5609028|NCT00841763|19377236|P1|Overall Study|Protocol Violation|20
5609029|NCT00841763|19377233|P4|Overall Study|Lost to Follow-up|0
5609030|NCT00841763|19377234|P3|Overall Study|Lost to Follow-up|0
5609031|NCT00841763|19377235|P2|Overall Study|Lost to Follow-up|25
5609032|NCT00841763|19377236|P1|Overall Study|Lost to Follow-up|63
5609033|NCT00841763|19377233|P4|Overall Study|Adverse Event|2
5609034|NCT00841763|19377234|P3|Overall Study|Adverse Event|3
5609035|NCT00841763|19377235|P2|Overall Study|Adverse Event|10
5609036|NCT00841763|19377236|P1|Overall Study|Adverse Event|9
5609037|NCT00841763|19377233|P4|Overall Study|Withdrawal by Subject|1
5609038|NCT00841763|19377234|P3|Overall Study|Withdrawal by Subject|4
5609039|NCT00841763|19377235|P2|Overall Study|Withdrawal by Subject|17
5609040|NCT00841763|19377236|P1|Overall Study|Withdrawal by Subject|60
5609041|NCT00841698|19377298|P2|First Intervention|Withdrawal by Subject|0
5609042|NCT00841698|19377299|P1|First Intervention|Withdrawal by Subject|1
5609043|NCT00841672|19377309|P2|Overall Study|Protocol Deviation|1
5609044|NCT00841672|19377310|P1|Overall Study|Protocol Deviation|0
5609045|NCT00841672|19377309|P2|Overall Study|Misrandomized|0
5609046|NCT00841672|19377310|P1|Overall Study|Misrandomized|1
5609047|NCT00841672|19377309|P2|Overall Study|Administrative problems|9
5609048|NCT00841672|19377310|P1|Overall Study|Administrative problems|9
5609049|NCT00841672|19377309|P2|Overall Study|Lost to Follow-up|1
5609050|NCT00841672|19377310|P1|Overall Study|Lost to Follow-up|1
5609051|NCT00841672|19377309|P2|Overall Study|Subject withdrew consent|4
5609052|NCT00841672|19377310|P1|Overall Study|Subject withdrew consent|2
5609053|NCT00841672|19377309|P2|Overall Study|Abnormal test procedure result(s)|1
5609054|NCT00841672|19377310|P1|Overall Study|Abnormal test procedure result(s)|0
5609055|NCT00841672|19377309|P2|Overall Study|Adverse Event|16
5609056|NCT00841672|19377310|P1|Overall Study|Adverse Event|7
5609057|NCT00841659|19377326|P2|Washout: 2 Weeks|Protocol Violation|0
5609058|NCT00841659|19377327|P1|Washout: 2 Weeks|Protocol Violation|1
5609059|NCT00841568|19377335|P1|Overall Study|Creatinine over the withdrawal criteria|1
5609060|NCT00841568|19377335|P1|Overall Study|Withdrawal by Subject|2
5609061|NCT00841568|19377335|P1|Overall Study|Death|1
5609062|NCT00841568|19377335|P1|Overall Study|Adverse Event|1
5609063|NCT00841542|19377363|P2|Period 1|Adverse Event|0
5609064|NCT00841542|19377364|P1|Period 1|Adverse Event|1
5609065|NCT00841321|19377379|P2|Overall Study|Adverse Event|2
5609066|NCT00841321|19377380|P1|Overall Study|Adverse Event|0
5609067|NCT00841321|19377379|P2|Overall Study|Lost to Follow-up|1
5609068|NCT00841321|19377380|P1|Overall Study|Lost to Follow-up|1
5609069|NCT00841100|19377427|P1|Phase 1 (28 Days)|Participant non-compliance|2
5609070|NCT00841100|19377427|P1|Phase 1 (28 Days)|Adverse Event|1
5609071|NCT00841035|19377452|P1|Phase 1 Overall Study|Physician Decision|13
5609072|NCT00840996|19377459|P2|Overall Study|Withdrawal by Subject|0
5609073|NCT00840996|19377460|P1|Overall Study|Withdrawal by Subject|1
5609074|NCT00840970|19377478|P3|Overall Study|Adverse Event|1
5609075|NCT00840970|19377479|P2|Overall Study|Adverse Event|0
5609076|NCT00840970|19377480|P1|Overall Study|Adverse Event|0
5609077|NCT00840879|19377500|P2|Second Intervention|Withdrawal by Subject|0
5609078|NCT00840879|19377501|P1|Second Intervention|Withdrawal by Subject|1
5609079|NCT00840827|19377537|P1|Overall Study|Physician Decision|1
5609080|NCT00840827|19377537|P1|Overall Study|Lack of Efficacy|4
5609081|NCT00840827|19377537|P1|Overall Study|Adverse Event|1
5609082|NCT00840749|19377552|P2|Overall Study|study closed|14
5609083|NCT00840749|19377553|P1|Overall Study|study closed|19
5609084|NCT00840749|19377552|P2|Overall Study|not treated on study arm|11
5609085|NCT00840749|19377553|P1|Overall Study|not treated on study arm|11
5609086|NCT00840749|19377552|P2|Overall Study|Death|2
5609087|NCT00840749|19377553|P1|Overall Study|Death|1
5609088|NCT00840658|19377565|P4|Overall Study|Lost to Follow-up|1
5609089|NCT00840658|19377566|P3|Overall Study|Lost to Follow-up|2
5609090|NCT00840658|19377567|P2|Overall Study|Lost to Follow-up|1
5609091|NCT00840658|19377568|P1|Overall Study|Lost to Follow-up|3
5609092|NCT00840658|19377565|P4|Overall Study|Death|3
5609093|NCT00840658|19377566|P3|Overall Study|Death|3
5609094|NCT00840658|19377567|P2|Overall Study|Death|2
5609095|NCT00840658|19377568|P1|Overall Study|Death|2
5609096|NCT00840632|19377586|P2|Washout|Withdrawal by Subject|1
5609097|NCT00840632|19377587|P1|Washout|Withdrawal by Subject|1
5609098|NCT00840632|19377586|P2|First Intervention|Withdrawal by Subject|1
5609099|NCT00840632|19377587|P1|First Intervention|Withdrawal by Subject|0
5609100|NCT00840463|19377614|P2|Overall Study|Adverse Event|0
5609101|NCT00840463|19377615|P1|Overall Study|Adverse Event|1
5609102|NCT00840450|19377629|P1|Overall Study|Lack of Efficacy|2
5609103|NCT00840450|19377629|P1|Overall Study|Adverse Event|1
5609104|NCT00840411|19377637|P2|Washout|Withdrawal by Subject|0
5609105|NCT00840411|19377638|P1|Washout|Withdrawal by Subject|1
5609106|NCT00840411|19377637|P2|First Intervention|Adverse Event|0
5609107|NCT00840411|19377638|P1|First Intervention|Adverse Event|1
5609108|NCT00840294|19377652|P2|Overall Study|Illness|1
5609109|NCT00840294|19377653|P1|Overall Study|Illness|0
5609110|NCT00840294|19377652|P2|Overall Study|Protocol Violation|3
5609111|NCT00840294|19377653|P1|Overall Study|Protocol Violation|1
5609112|NCT00840294|19377652|P2|Overall Study|Withdrawal by Subject|1
5609113|NCT00840294|19377653|P1|Overall Study|Withdrawal by Subject|2
5609114|NCT00840216|19377674|P2|Washout: 7 Days|Withdrawal by Subject|0
5609115|NCT00840216|19377675|P1|Washout: 7 Days|Withdrawal by Subject|1
5609116|NCT00840203|19377685|P2|Washout|Protocol Violation|0
5609117|NCT00840203|19377686|P1|Washout|Protocol Violation|1
5609118|NCT00840203|19377685|P2|First Intervention|Protocol Violation|1
5609119|NCT00840203|19377686|P1|First Intervention|Protocol Violation|1
5609120|NCT00840177|19377703|P3|Overall Study|Did not start treatment|1
5609121|NCT00840177|19377704|P2|Overall Study|Did not start treatment|0
5609122|NCT00840177|19377705|P1|Overall Study|Did not start treatment|0
5609123|NCT00840177|19377703|P3|Overall Study|Ineligible|3
5609124|NCT00840177|19377704|P2|Overall Study|Ineligible|0
5609125|NCT00840177|19377705|P1|Overall Study|Ineligible|0
5609126|NCT00840177|19377703|P3|Overall Study|not protocol specified|0
5609127|NCT00840177|19377704|P2|Overall Study|not protocol specified|3
5609128|NCT00840177|19377705|P1|Overall Study|not protocol specified|6
5609129|NCT00840177|19377703|P3|Overall Study|Death|5
5609130|NCT00840177|19377704|P2|Overall Study|Death|5
5609131|NCT00840177|19377705|P1|Overall Study|Death|4
5609132|NCT00840177|19377703|P3|Overall Study|Progression/relapse|0
5609133|NCT00840177|19377704|P2|Overall Study|Progression/relapse|0
5609134|NCT00840177|19377705|P1|Overall Study|Progression/relapse|2
5609135|NCT00840177|19377703|P3|Overall Study|Refusal unrelated to adverse events|1
5609136|NCT00840177|19377704|P2|Overall Study|Refusal unrelated to adverse events|0
5609137|NCT00840177|19377705|P1|Overall Study|Refusal unrelated to adverse events|1
5609138|NCT00840177|19377703|P3|Overall Study|Adverse Event|1
5609139|NCT00840177|19377704|P2|Overall Study|Adverse Event|1
5609140|NCT00840177|19377705|P1|Overall Study|Adverse Event|5
5609141|NCT00840086|19377739|P1|Overall Study|Lost to Follow-up|1
5609142|NCT00840086|19377739|P1|Overall Study|Protocol Violation|2
5609143|NCT00840086|19377739|P1|Overall Study|Adverse Event|1
5609144|NCT00840073|19377748|P2|Second Intervention|Missed 72 hour blood draw|1
5609145|NCT00840073|19377749|P1|Second Intervention|Missed 72 hour blood draw|1
5609146|NCT00840060|19377763|P2|Overall Study|Change in emotional/behavioral status|1
5609147|NCT00840060|19377764|P1|Overall Study|Change in emotional/behavioral status|0
5609148|NCT00840060|19377763|P2|Overall Study|Withdrawal by Subject|0
5609149|NCT00840060|19377764|P1|Overall Study|Withdrawal by Subject|1
5609150|NCT00840034|19377774|P2|Taper Phase|Withdrawal by Subject|1
5609151|NCT00840034|19377775|P1|Taper Phase|Withdrawal by Subject|1
5609152|NCT00840034|19377774|P2|Taper Phase|Lost to Follow-up|1
5609153|NCT00840034|19377775|P1|Taper Phase|Lost to Follow-up|1
5609154|NCT00840034|19377774|P2|Taper Phase|Adverse Event|0
5609155|NCT00840034|19377775|P1|Taper Phase|Adverse Event|1
5609156|NCT00840034|19377774|P2|Acute Treatment Phase|Withdrawal by Subject|11
5609157|NCT00840034|19377775|P1|Acute Treatment Phase|Withdrawal by Subject|6
5609158|NCT00840034|19377774|P2|Acute Treatment Phase|Protocol Violation|4
5609159|NCT00840034|19377775|P1|Acute Treatment Phase|Protocol Violation|2
5609160|NCT00840034|19377774|P2|Acute Treatment Phase|Physician Decision|1
5609161|NCT00840034|19377775|P1|Acute Treatment Phase|Physician Decision|0
5609162|NCT00840034|19377774|P2|Acute Treatment Phase|Lost to Follow-up|12
5609163|NCT00840034|19377775|P1|Acute Treatment Phase|Lost to Follow-up|5
5609164|NCT00840034|19377774|P2|Acute Treatment Phase|Lack of Efficacy|0
5609165|NCT00840034|19377775|P1|Acute Treatment Phase|Lack of Efficacy|2
5609166|NCT00840034|19377774|P2|Acute Treatment Phase|Adverse Event|8
5609167|NCT00840034|19377775|P1|Acute Treatment Phase|Adverse Event|6
5609168|NCT00839956|19377828|P1|Overall Study|Withdrawal by Subject|3
5609169|NCT00839956|19377828|P1|Overall Study|Physician Decision|1
5609170|NCT00839956|19377828|P1|Overall Study|Lack of Efficacy|6
5609171|NCT00839956|19377828|P1|Overall Study|Adverse Event|2
5609172|NCT00839917|19377848|P2|Overall Study|Did not receive vaccine|1
5609173|NCT00839917|19377849|P1|Overall Study|Did not receive vaccine|0
5609174|NCT00839917|19377848|P2|Overall Study|Lost to Follow-up|0
5609175|NCT00839917|19377849|P1|Overall Study|Lost to Follow-up|1
5609176|NCT00839852|19377885|P1|Overall Study|Pregnancy|1
5609177|NCT00839852|19377885|P1|Overall Study|Lack of Compliance While in Jail|1
5609178|NCT00839852|19377885|P1|Overall Study|Lost to Follow-up|7
5609179|NCT00839852|19377885|P1|Overall Study|Withdrawal of Consent|16
5609180|NCT00839852|19377885|P1|Overall Study|Protocol Violation|9
5609181|NCT00839852|19377885|P1|Overall Study|Insufficient Therapeutic Response|3
5609182|NCT00839852|19377885|P1|Overall Study|Adverse Event|10
5609183|NCT00839800|19377892|P2|Overall Study|Severe Non-Compliance to Protocol|7
5609184|NCT00839800|19377893|P1|Overall Study|Severe Non-Compliance to Protocol|7
5609185|NCT00839800|19377892|P2|Overall Study|Other|14
5609186|NCT00839800|19377893|P1|Overall Study|Other|8
5609187|NCT00839800|19377892|P2|Overall Study|Safety Reasons|1
5609188|NCT00839800|19377893|P1|Overall Study|Safety Reasons|2
5609189|NCT00839800|19377892|P2|Overall Study|Study-Specific Discontinuation Criteria|13
5609190|NCT00839800|19377893|P1|Overall Study|Study-Specific Discontinuation Criteria|6
5609191|NCT00839800|19377892|P2|Overall Study|Incorrect Enrolment|3
5609192|NCT00839800|19377893|P1|Overall Study|Incorrect Enrolment|3
5609193|NCT00839800|19377892|P2|Overall Study|Withdrawal by Subject|34
5609194|NCT00839800|19377893|P1|Overall Study|Withdrawal by Subject|28
5609195|NCT00839800|19377892|P2|Overall Study|Lost to Follow-up|26
5609196|NCT00839800|19377893|P1|Overall Study|Lost to Follow-up|31
5609197|NCT00839800|19377892|P2|Overall Study|Adverse Event|12
5609198|NCT00839800|19377893|P1|Overall Study|Adverse Event|8
5609199|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
5609200|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
5609201|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
5609202|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
5609203|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
5609204|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
5609205|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
5609206|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
5609207|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
5609208|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
5609209|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
5609210|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
5609211|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
5609212|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
5609213|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
5609214|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
5609215|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
5609216|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
5609217|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
5609218|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
5609219|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
5609220|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
5609221|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
5609222|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
5609223|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
5609224|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
5609225|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
5609226|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
5609227|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
5609228|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
5609229|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
5609230|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
5609231|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
5609232|NCT00839527|19377939|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
5609233|NCT00839527|19377940|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
5609234|NCT00839527|19377941|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
5609235|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
5609236|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
5609237|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
5609238|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
5609239|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
5609240|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
5609241|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
5609242|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
5609243|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
5609244|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
5609245|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
5609246|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
5609247|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Missing|0
5609248|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Missing|1
5609249|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Missing|0
5609250|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
5609251|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
5609252|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
5609253|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
5609254|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
5609255|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
5609256|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
5609257|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
5609258|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
5609259|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
5609260|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
5609261|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
5609262|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
5609263|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
5609264|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
5609265|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
5609266|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
5609267|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
5609268|NCT00839527|19377939|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
5609269|NCT00839527|19377940|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
5609270|NCT00839527|19377941|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
5609271|NCT00839436|19377976|P3|Overall Study|Study drug no longer available|1
5609272|NCT00839436|19377977|P2|Overall Study|Study drug no longer available|0
5609273|NCT00839436|19377978|P1|Overall Study|Study drug no longer available|0
5609274|NCT00839436|19377976|P3|Overall Study|Withdrawal by Subject|0
5609275|NCT00839436|19377977|P2|Overall Study|Withdrawal by Subject|1
5609276|NCT00839436|19377978|P1|Overall Study|Withdrawal by Subject|0
5609277|NCT00839436|19377976|P3|Overall Study|Developed exclusionary condition|0
5609278|NCT00839436|19377977|P2|Overall Study|Developed exclusionary condition|0
5609279|NCT00839436|19377978|P1|Overall Study|Developed exclusionary condition|1
5609280|NCT00839423|19377990|P4|Overall Study|Administrative or other reasons|0
5609281|NCT00839423|19377991|P3|Overall Study|Administrative or other reasons|1
5609282|NCT00839423|19377992|P2|Overall Study|Administrative or other reasons|0
5609283|NCT00839423|19377993|P1|Overall Study|Administrative or other reasons|3
5609284|NCT00839423|19377990|P4|Overall Study|Lost to Follow-up|0
5609285|NCT00839423|19377991|P3|Overall Study|Lost to Follow-up|1
5609286|NCT00839423|19377992|P2|Overall Study|Lost to Follow-up|0
5609287|NCT00839423|19377993|P1|Overall Study|Lost to Follow-up|1
5609288|NCT00839423|19377990|P4|Overall Study|Withdrawal of consent|1
5609289|NCT00839423|19377991|P3|Overall Study|Withdrawal of consent|4
5609290|NCT00839423|19377992|P2|Overall Study|Withdrawal of consent|0
5609291|NCT00839423|19377993|P1|Overall Study|Withdrawal of consent|4
5609292|NCT00839423|19377990|P4|Overall Study|Protocol Violation|0
5609293|NCT00839423|19377991|P3|Overall Study|Protocol Violation|2
5609294|NCT00839423|19377992|P2|Overall Study|Protocol Violation|1
5609295|NCT00839423|19377993|P1|Overall Study|Protocol Violation|0
5609296|NCT00839423|19377990|P4|Overall Study|Non-compliance|1
5609297|NCT00839423|19377991|P3|Overall Study|Non-compliance|0
5609298|NCT00839423|19377992|P2|Overall Study|Non-compliance|0
5609299|NCT00839423|19377993|P1|Overall Study|Non-compliance|0
5609300|NCT00839423|19377990|P4|Overall Study|Lack of Efficacy|2
5609301|NCT00839423|19377991|P3|Overall Study|Lack of Efficacy|3
5609302|NCT00839423|19377992|P2|Overall Study|Lack of Efficacy|6
5609303|NCT00839423|19377993|P1|Overall Study|Lack of Efficacy|6
5609304|NCT00839423|19377990|P4|Overall Study|Adverse Event|16
5609305|NCT00839423|19377991|P3|Overall Study|Adverse Event|7
5609306|NCT00839423|19377992|P2|Overall Study|Adverse Event|3
5609307|NCT00839423|19377993|P1|Overall Study|Adverse Event|4
5609308|NCT00839332|19378034|P3|Phase 2|Lost to Follow-up|1
5609309|NCT00839332|19378035|P2|Phase 2|Lost to Follow-up|0
5609310|NCT00839332|19378036|P1|Phase 2|Lost to Follow-up|0
5609311|NCT00839332|19378034|P3|Phase 2|Physician Decision|1
5609312|NCT00839332|19378035|P2|Phase 2|Physician Decision|4
5609313|NCT00839332|19378036|P1|Phase 2|Physician Decision|0
5609314|NCT00839332|19378034|P3|Phase 2|Withdrawal by Subject|8
5609315|NCT00839332|19378035|P2|Phase 2|Withdrawal by Subject|5
5609316|NCT00839332|19378036|P1|Phase 2|Withdrawal by Subject|0
5609317|NCT00839332|19378034|P3|Phase 2|Death|2
5609318|NCT00839332|19378035|P2|Phase 2|Death|4
5609319|NCT00839332|19378036|P1|Phase 2|Death|0
5609320|NCT00839332|19378034|P3|Phase 2|Adverse Event|6
5609321|NCT00839332|19378035|P2|Phase 2|Adverse Event|8
5609322|NCT00839332|19378036|P1|Phase 2|Adverse Event|0
5609323|NCT00839332|19378034|P3|Phase 2|Disease Progression|21
5609324|NCT00839332|19378035|P2|Phase 2|Disease Progression|46
5609325|NCT00839332|19378036|P1|Phase 2|Disease Progression|0
5609326|NCT00839332|19378034|P3|Phase 2|Protocol Violation|0
5609327|NCT00839332|19378035|P2|Phase 2|Protocol Violation|1
5609328|NCT00839332|19378036|P1|Phase 2|Protocol Violation|0
5609329|NCT00839332|19378034|P3|Phase 1|Physician Decision|0
5609330|NCT00839332|19378035|P2|Phase 1|Physician Decision|0
5609331|NCT00839332|19378036|P1|Phase 1|Physician Decision|2
5609332|NCT00839332|19378034|P3|Phase 1|Withdrawal by Subject|0
5609333|NCT00839332|19378035|P2|Phase 1|Withdrawal by Subject|0
5609334|NCT00839332|19378036|P1|Phase 1|Withdrawal by Subject|4
5609335|NCT00839332|19378034|P3|Phase 1|Adverse Event|0
5609336|NCT00839332|19378035|P2|Phase 1|Adverse Event|0
5609337|NCT00839332|19378036|P1|Phase 1|Adverse Event|6
5609338|NCT00839332|19378034|P3|Phase 1|Disease Progression|0
5609339|NCT00839332|19378035|P2|Phase 1|Disease Progression|0
5609340|NCT00839332|19378036|P1|Phase 1|Disease Progression|38
5609341|NCT00839306|19378097|P2|Overall Study|Other|18
5609342|NCT00839306|19378098|P1|Overall Study|Other|6
5609343|NCT00839306|19378097|P2|Overall Study|Lack of Efficacy|4
5609344|NCT00839306|19378098|P1|Overall Study|Lack of Efficacy|5
5609345|NCT00839306|19378097|P2|Overall Study|Withdrawal by Subject|7
5609346|NCT00839306|19378098|P1|Overall Study|Withdrawal by Subject|5
5609347|NCT00839306|19378097|P2|Overall Study|Lost to Follow-up|9
5609348|NCT00839306|19378098|P1|Overall Study|Lost to Follow-up|6
5609349|NCT00839306|19378097|P2|Overall Study|Adverse Event|5
5609350|NCT00839306|19378098|P1|Overall Study|Adverse Event|3
5609351|NCT00839254|19378114|P8|Overall Study|Lost to Follow-up|2
5609352|NCT00839254|19378115|P7|Overall Study|Lost to Follow-up|4
5609353|NCT00839254|19378116|P6|Overall Study|Lost to Follow-up|8
5609354|NCT00839254|19378117|P5|Overall Study|Lost to Follow-up|8
5609355|NCT00839254|19378118|P4|Overall Study|Lost to Follow-up|24
5609356|NCT00839254|19378119|P3|Overall Study|Lost to Follow-up|32
5609357|NCT00839254|19378120|P2|Overall Study|Lost to Follow-up|30
5609358|NCT00839254|19378121|P1|Overall Study|Lost to Follow-up|51
5609359|NCT00839254|19378114|P8|Overall Study|Withdrawn due to non-compliance|0
5609360|NCT00839254|19378115|P7|Overall Study|Withdrawn due to non-compliance|0
5609361|NCT00839254|19378116|P6|Overall Study|Withdrawn due to non-compliance|0
5609362|NCT00839254|19378117|P5|Overall Study|Withdrawn due to non-compliance|0
5609363|NCT00839254|19378118|P4|Overall Study|Withdrawn due to non-compliance|0
5609364|NCT00839254|19378119|P3|Overall Study|Withdrawn due to non-compliance|0
5609365|NCT00839254|19378120|P2|Overall Study|Withdrawn due to non-compliance|0
5609366|NCT00839254|19378121|P1|Overall Study|Withdrawn due to non-compliance|2
5609367|NCT00839254|19378114|P8|Overall Study|Parents wanted pneumococcal vaccine|0
5609368|NCT00839254|19378115|P7|Overall Study|Parents wanted pneumococcal vaccine|0
5609369|NCT00839254|19378116|P6|Overall Study|Parents wanted pneumococcal vaccine|1
5609370|NCT00839254|19378117|P5|Overall Study|Parents wanted pneumococcal vaccine|0
5609371|NCT00839254|19378118|P4|Overall Study|Parents wanted pneumococcal vaccine|0
5609372|NCT00839254|19378119|P3|Overall Study|Parents wanted pneumococcal vaccine|0
5609373|NCT00839254|19378120|P2|Overall Study|Parents wanted pneumococcal vaccine|0
5609374|NCT00839254|19378121|P1|Overall Study|Parents wanted pneumococcal vaccine|1
5609375|NCT00839254|19378114|P8|Overall Study|Wrong group allocation|0
5609376|NCT00839254|19378115|P7|Overall Study|Wrong group allocation|1
5609377|NCT00839254|19378116|P6|Overall Study|Wrong group allocation|0
5609378|NCT00839254|19378117|P5|Overall Study|Wrong group allocation|0
5609379|NCT00839254|19378118|P4|Overall Study|Wrong group allocation|0
5609380|NCT00839254|19378119|P3|Overall Study|Wrong group allocation|0
5609381|NCT00839254|19378120|P2|Overall Study|Wrong group allocation|0
5609382|NCT00839254|19378121|P1|Overall Study|Wrong group allocation|0
5609383|NCT00839254|19378114|P8|Overall Study|Withdrawal by Subject|9
5609384|NCT00839254|19378115|P7|Overall Study|Withdrawal by Subject|22
5609385|NCT00839254|19378116|P6|Overall Study|Withdrawal by Subject|15
5609386|NCT00839254|19378117|P5|Overall Study|Withdrawal by Subject|27
5609387|NCT00839254|19378118|P4|Overall Study|Withdrawal by Subject|32
5609388|NCT00839254|19378119|P3|Overall Study|Withdrawal by Subject|54
5609389|NCT00839254|19378120|P2|Overall Study|Withdrawal by Subject|53
5609390|NCT00839254|19378121|P1|Overall Study|Withdrawal by Subject|87
5609391|NCT00839254|19378114|P8|Overall Study|Adverse Event|1
5609392|NCT00839254|19378115|P7|Overall Study|Adverse Event|0
5609393|NCT00839254|19378116|P6|Overall Study|Adverse Event|1
5609394|NCT00839254|19378117|P5|Overall Study|Adverse Event|2
5609395|NCT00839254|19378118|P4|Overall Study|Adverse Event|5
5609396|NCT00839254|19378119|P3|Overall Study|Adverse Event|3
5609397|NCT00839254|19378120|P2|Overall Study|Adverse Event|6
5609398|NCT00839254|19378121|P1|Overall Study|Adverse Event|12
5609399|NCT00839254|19378114|P8|Overall Study|Wrong treatment number allocation|0
5609400|NCT00839254|19378115|P7|Overall Study|Wrong treatment number allocation|0
5609401|NCT00839254|19378116|P6|Overall Study|Wrong treatment number allocation|1
5609402|NCT00839254|19378117|P5|Overall Study|Wrong treatment number allocation|0
5609403|NCT00839254|19378118|P4|Overall Study|Wrong treatment number allocation|0
5609404|NCT00839254|19378119|P3|Overall Study|Wrong treatment number allocation|0
5609405|NCT00839254|19378120|P2|Overall Study|Wrong treatment number allocation|1
5609406|NCT00839254|19378121|P1|Overall Study|Wrong treatment number allocation|0
5609407|NCT00839254|19378114|P8|Overall Study|Physician Decision|1
5609408|NCT00839254|19378115|P7|Overall Study|Physician Decision|0
5609409|NCT00839254|19378116|P6|Overall Study|Physician Decision|0
5609410|NCT00839254|19378117|P5|Overall Study|Physician Decision|0
5609411|NCT00839254|19378118|P4|Overall Study|Physician Decision|0
5609412|NCT00839254|19378119|P3|Overall Study|Physician Decision|0
5609413|NCT00839254|19378120|P2|Overall Study|Physician Decision|1
5609414|NCT00839254|19378121|P1|Overall Study|Physician Decision|0
5609415|NCT00839254|19378114|P8|Overall Study|Protocol Violation|2
5609416|NCT00839254|19378115|P7|Overall Study|Protocol Violation|1
5609417|NCT00839254|19378116|P6|Overall Study|Protocol Violation|0
5609418|NCT00839254|19378117|P5|Overall Study|Protocol Violation|0
5609419|NCT00839254|19378118|P4|Overall Study|Protocol Violation|1
5609420|NCT00839254|19378119|P3|Overall Study|Protocol Violation|1
5609421|NCT00839254|19378120|P2|Overall Study|Protocol Violation|1
5609422|NCT00839254|19378121|P1|Overall Study|Protocol Violation|0
5609423|NCT00839098|19378445|P3|Overall Study|Withdrawal by Subject|7
5609424|NCT00839098|19378446|P2|Overall Study|Withdrawal by Subject|1
5609425|NCT00839098|19378447|P1|Overall Study|Withdrawal by Subject|2
5609426|NCT00839072|19378473|P2|Second Intervention Period|Withdrawal by Subject|0
5609427|NCT00839072|19378474|P1|Second Intervention Period|Withdrawal by Subject|1
5609428|NCT00839072|19378473|P2|First Intervention Period|Adverse Event|1
5609429|NCT00839072|19378474|P1|First Intervention Period|Adverse Event|1
5609430|NCT00839072|19378473|P2|First Intervention Period|Withdrawal by Subject|0
5609431|NCT00839072|19378474|P1|First Intervention Period|Withdrawal by Subject|1
5609432|NCT00838929|19378518|P3|Overall Study|Disease progression|1
5609433|NCT00838929|19378519|P2|Overall Study|Disease progression|2
5609434|NCT00838929|19378520|P1|Overall Study|Disease progression|0
5609435|NCT00838929|19378518|P3|Overall Study|Protocol Violation|0
5609436|NCT00838929|19378519|P2|Overall Study|Protocol Violation|1
5609437|NCT00838929|19378520|P1|Overall Study|Protocol Violation|0
5609438|NCT00838916|19378528|P2|Follow-up Period (8 Weeks)|Missing|0
5609439|NCT00838916|19378529|P1|Follow-up Period (8 Weeks)|Missing|3
5609440|NCT00838916|19378528|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
5609441|NCT00838916|19378529|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
5609442|NCT00838916|19378528|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
5609443|NCT00838916|19378529|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
5609444|NCT00838916|19378528|P2|Follow-up Period (8 Weeks)|Physician Decision|0
5609445|NCT00838916|19378529|P1|Follow-up Period (8 Weeks)|Physician Decision|2
5609446|NCT00838916|19378528|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
5609447|NCT00838916|19378529|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
5609448|NCT00838916|19378528|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
5609449|NCT00838916|19378529|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
5609450|NCT00838916|19378528|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
5609451|NCT00838916|19378529|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
5609452|NCT00838916|19378528|P2|Follow-up Period (8 Weeks)|Noncompliance|5
5609453|NCT00838916|19378529|P1|Follow-up Period (8 Weeks)|Noncompliance|6
5609454|NCT00838916|19378528|P2|Follow-up Period (8 Weeks)|Adverse Event|5
5609455|NCT00838916|19378529|P1|Follow-up Period (8 Weeks)|Adverse Event|10
5609456|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Pregnancy|0
5609457|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Pregnancy|2
5609458|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Missing|1
5609459|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Missing|3
5609460|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
5609461|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
5609462|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Physician Decision|1
5609463|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Physician Decision|6
5609464|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
5609465|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
5609466|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
5609467|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
5609468|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
5609469|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
5609470|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Noncompliance|14
5609471|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Noncompliance|21
5609472|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Protocol Violation|3
5609473|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Protocol Violation|12
5609474|NCT00838916|19378528|P2|Treatment Period (156 Weeks)|Adverse Event|11
5609475|NCT00838916|19378529|P1|Treatment Period (156 Weeks)|Adverse Event|50
5609476|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Missing|1
5609477|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Missing|1
5609478|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Missing|2
5609479|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Missing|1
5609480|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
5609481|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
5609482|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
5609483|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
5609484|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
5609485|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
5609486|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
5609487|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
5609488|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
5609489|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
5609490|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
5609491|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
5609492|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
5609493|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
5609494|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
5609495|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
5609496|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Physician Decision|1
5609497|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Physician Decision|1
5609498|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Physician Decision|1
5609499|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Physician Decision|1
5609500|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
5609501|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
5609502|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
5609503|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
5609504|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
5609505|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
5609506|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
5609507|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
5609508|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
5609509|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
5609510|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
5609511|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
5609512|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Noncompliance|5
5609513|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Noncompliance|5
5609514|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Noncompliance|8
5609515|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Noncompliance|2
5609516|NCT00838903|19378558|P4|Follow-up Period (8 Weeks)|Adverse Event|1
5609517|NCT00838903|19378559|P3|Follow-up Period (8 Weeks)|Adverse Event|3
5609518|NCT00838903|19378560|P2|Follow-up Period (8 Weeks)|Adverse Event|0
5609519|NCT00838903|19378561|P1|Follow-up Period (8 Weeks)|Adverse Event|0
5609520|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
5609521|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
5609522|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
5609523|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
5609524|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
5609525|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
5609526|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
5609527|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
5609528|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
5609529|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
5609530|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
5609531|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
5609532|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Site closed|0
5609533|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Site closed|1
5609534|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Site closed|0
5609535|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Site closed|0
5609536|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
5609537|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
5609538|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
5609539|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
5609540|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Pregnancy|0
5609541|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Pregnancy|1
5609542|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Pregnancy|0
5609543|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Pregnancy|0
5609544|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
5609545|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
5609546|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
5609547|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
5609548|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
5609549|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
5609550|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
5609551|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
5609552|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
5609553|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
5609554|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
5609555|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
5609556|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
5609557|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
5609558|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
5609559|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
5609560|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Physician Decision|2
5609561|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Physician Decision|1
5609562|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Physician Decision|2
5609563|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Physician Decision|1
5609564|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
5609565|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
5609566|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
5609567|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
5609568|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
5609569|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
5609570|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
5609571|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
5609572|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
5609573|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
5609574|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
5609575|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
5609576|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Noncompliance|6
5609577|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Noncompliance|12
5609578|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Noncompliance|13
5609579|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Noncompliance|9
5609580|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Protocol Violation|5
5609581|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Protocol Violation|6
5609582|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Protocol Violation|6
5609583|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Protocol Violation|1
5609584|NCT00838903|19378558|P4|Treatment Period (156 Weeks)|Adverse Event|25
5609585|NCT00838903|19378559|P3|Treatment Period (156 Weeks)|Adverse Event|17
5609586|NCT00838903|19378560|P2|Treatment Period (156 Weeks)|Adverse Event|13
5609587|NCT00838903|19378561|P1|Treatment Period (156 Weeks)|Adverse Event|5
5609588|NCT00838682|19378616|P2|Overall Study|Withdrawal by Subject|1
5609589|NCT00838682|19378617|P1|Overall Study|Withdrawal by Subject|0
5609590|NCT00838682|19378616|P2|Overall Study|Protocol Violation|1
5609591|NCT00838682|19378617|P1|Overall Study|Protocol Violation|0
5609592|NCT00838682|19378616|P2|Overall Study|detection of exclusion criteria|3
5609593|NCT00838682|19378617|P1|Overall Study|detection of exclusion criteria|4
5609594|NCT00838682|19378616|P2|Overall Study|Lost to Follow-up|14
5609595|NCT00838682|19378617|P1|Overall Study|Lost to Follow-up|21
5609596|NCT00838630|19378635|P2|Washout: 7 Days|Protocol Violation|0
5609597|NCT00838630|19378636|P1|Washout: 7 Days|Protocol Violation|1
5609598|NCT00838630|19378635|P2|First Intervention|Adverse Event|0
5609599|NCT00838630|19378636|P1|First Intervention|Adverse Event|1
5609600|NCT00838578|19378644|P1|Overall Study|Protocol Violation|2
5609601|NCT00838565|19378658|P6|Overall Study|Randomized but not Treated|0
5609602|NCT00838565|19378659|P5|Overall Study|Randomized but not Treated|0
5609603|NCT00838565|19378660|P4|Overall Study|Randomized but not Treated|0
5609604|NCT00838565|19378661|P3|Overall Study|Randomized but not Treated|0
5609605|NCT00838565|19378662|P2|Overall Study|Randomized but not Treated|1
5609606|NCT00838565|19378663|P1|Overall Study|Randomized but not Treated|0
5609607|NCT00838565|19378658|P6|Overall Study|Other|0
5609608|NCT00838565|19378659|P5|Overall Study|Other|0
5609609|NCT00838565|19378660|P4|Overall Study|Other|0
5609610|NCT00838565|19378661|P3|Overall Study|Other|0
5609611|NCT00838565|19378662|P2|Overall Study|Other|2
5609612|NCT00838565|19378663|P1|Overall Study|Other|0
5609613|NCT00838565|19378658|P6|Overall Study|Withdrawal by Subject|2
5609614|NCT00838565|19378659|P5|Overall Study|Withdrawal by Subject|0
5609615|NCT00838565|19378660|P4|Overall Study|Withdrawal by Subject|0
5609616|NCT00838565|19378661|P3|Overall Study|Withdrawal by Subject|1
5609617|NCT00838565|19378662|P2|Overall Study|Withdrawal by Subject|0
5609618|NCT00838565|19378663|P1|Overall Study|Withdrawal by Subject|0
5609619|NCT00838539|19378768|P12|Overall Study|Symptomatic Deterioration|0
5609620|NCT00838539|19378769|P11|Overall Study|Symptomatic Deterioration|0
5609621|NCT00838539|19378770|P10|Overall Study|Symptomatic Deterioration|1
5609622|NCT00838539|19378771|P9|Overall Study|Symptomatic Deterioration|0
5609623|NCT00838539|19378772|P8|Overall Study|Symptomatic Deterioration|0
5609624|NCT00838539|19378773|P7|Overall Study|Symptomatic Deterioration|0
5609625|NCT00838539|19378774|P6|Overall Study|Symptomatic Deterioration|1
5609626|NCT00838539|19378775|P5|Overall Study|Symptomatic Deterioration|0
5609627|NCT00838539|19378776|P4|Overall Study|Symptomatic Deterioration|1
5609628|NCT00838539|19378777|P3|Overall Study|Symptomatic Deterioration|1
5609629|NCT00838539|19378778|P2|Overall Study|Symptomatic Deterioration|0
5609630|NCT00838539|19378779|P1|Overall Study|Symptomatic Deterioration|0
5609631|NCT00838539|19378768|P12|Overall Study|Clinical Progression|0
5609632|NCT00838539|19378769|P11|Overall Study|Clinical Progression|0
5609633|NCT00838539|19378770|P10|Overall Study|Clinical Progression|0
5609634|NCT00838539|19378771|P9|Overall Study|Clinical Progression|0
5609635|NCT00838539|19378772|P8|Overall Study|Clinical Progression|0
5609636|NCT00838539|19378773|P7|Overall Study|Clinical Progression|1
5609637|NCT00838539|19378774|P6|Overall Study|Clinical Progression|0
5609638|NCT00838539|19378775|P5|Overall Study|Clinical Progression|0
5609639|NCT00838539|19378776|P4|Overall Study|Clinical Progression|0
5609640|NCT00838539|19378777|P3|Overall Study|Clinical Progression|0
5609641|NCT00838539|19378778|P2|Overall Study|Clinical Progression|0
5609642|NCT00838539|19378779|P1|Overall Study|Clinical Progression|0
5609643|NCT00838539|19378768|P12|Overall Study|Physician Decision|0
5609644|NCT00838539|19378769|P11|Overall Study|Physician Decision|0
5609645|NCT00838539|19378770|P10|Overall Study|Physician Decision|0
5609646|NCT00838539|19378771|P9|Overall Study|Physician Decision|1
5609647|NCT00838539|19378772|P8|Overall Study|Physician Decision|0
5609648|NCT00838539|19378773|P7|Overall Study|Physician Decision|0
5609649|NCT00838539|19378774|P6|Overall Study|Physician Decision|0
5609650|NCT00838539|19378775|P5|Overall Study|Physician Decision|0
5609651|NCT00838539|19378776|P4|Overall Study|Physician Decision|0
5609652|NCT00838539|19378777|P3|Overall Study|Physician Decision|0
5609653|NCT00838539|19378778|P2|Overall Study|Physician Decision|0
5609654|NCT00838539|19378779|P1|Overall Study|Physician Decision|0
5609655|NCT00838539|19378768|P12|Overall Study|Death|0
5609656|NCT00838539|19378769|P11|Overall Study|Death|0
5609657|NCT00838539|19378770|P10|Overall Study|Death|0
5609658|NCT00838539|19378771|P9|Overall Study|Death|0
5609659|NCT00838539|19378772|P8|Overall Study|Death|0
5609660|NCT00838539|19378773|P7|Overall Study|Death|1
5609661|NCT00838539|19378774|P6|Overall Study|Death|0
5609662|NCT00838539|19378775|P5|Overall Study|Death|0
5609663|NCT00838539|19378776|P4|Overall Study|Death|0
5609664|NCT00838539|19378777|P3|Overall Study|Death|0
5609665|NCT00838539|19378778|P2|Overall Study|Death|0
5609666|NCT00838539|19378779|P1|Overall Study|Death|0
5609667|NCT00838539|19378768|P12|Overall Study|Withdrawal by Subject|0
5609668|NCT00838539|19378769|P11|Overall Study|Withdrawal by Subject|2
5609669|NCT00838539|19378770|P10|Overall Study|Withdrawal by Subject|1
5609670|NCT00838539|19378771|P9|Overall Study|Withdrawal by Subject|0
5609671|NCT00838539|19378772|P8|Overall Study|Withdrawal by Subject|0
5609672|NCT00838539|19378773|P7|Overall Study|Withdrawal by Subject|0
5609673|NCT00838539|19378774|P6|Overall Study|Withdrawal by Subject|0
5609674|NCT00838539|19378775|P5|Overall Study|Withdrawal by Subject|0
5609675|NCT00838539|19378776|P4|Overall Study|Withdrawal by Subject|0
5609676|NCT00838539|19378777|P3|Overall Study|Withdrawal by Subject|0
5609677|NCT00838539|19378778|P2|Overall Study|Withdrawal by Subject|1
5609678|NCT00838539|19378779|P1|Overall Study|Withdrawal by Subject|0
5609679|NCT00838539|19378768|P12|Overall Study|Adverse Event|0
5609680|NCT00838539|19378769|P11|Overall Study|Adverse Event|2
5609681|NCT00838539|19378770|P10|Overall Study|Adverse Event|1
5609682|NCT00838539|19378771|P9|Overall Study|Adverse Event|0
5609683|NCT00838539|19378772|P8|Overall Study|Adverse Event|2
5609684|NCT00838539|19378773|P7|Overall Study|Adverse Event|0
5609685|NCT00838539|19378774|P6|Overall Study|Adverse Event|1
5609686|NCT00838539|19378775|P5|Overall Study|Adverse Event|2
5609687|NCT00838539|19378776|P4|Overall Study|Adverse Event|1
5609688|NCT00838539|19378777|P3|Overall Study|Adverse Event|1
5609689|NCT00838539|19378778|P2|Overall Study|Adverse Event|1
5609690|NCT00838539|19378779|P1|Overall Study|Adverse Event|1
5609691|NCT00838539|19378768|P12|Overall Study|Disease Progression|4
5609692|NCT00838539|19378769|P11|Overall Study|Disease Progression|1
5609693|NCT00838539|19378770|P10|Overall Study|Disease Progression|5
5609694|NCT00838539|19378771|P9|Overall Study|Disease Progression|4
5609695|NCT00838539|19378772|P8|Overall Study|Disease Progression|4
5609696|NCT00838539|19378773|P7|Overall Study|Disease Progression|3
5609697|NCT00838539|19378774|P6|Overall Study|Disease Progression|2
5609698|NCT00838539|19378775|P5|Overall Study|Disease Progression|4
5609699|NCT00838539|19378776|P4|Overall Study|Disease Progression|2
5609700|NCT00838539|19378777|P3|Overall Study|Disease Progression|3
5609701|NCT00838539|19378778|P2|Overall Study|Disease Progression|4
5609702|NCT00838539|19378779|P1|Overall Study|Disease Progression|2
5609703|NCT00838526|19378829|P2|Overall Study|Other|7
5609704|NCT00838526|19378830|P1|Overall Study|Other|11
5609705|NCT00838526|19378829|P2|Overall Study|Lack of Efficacy|3
5609706|NCT00838526|19378830|P1|Overall Study|Lack of Efficacy|2
5609707|NCT00838526|19378829|P2|Overall Study|Withdrawal by Subject|5
5609708|NCT00838526|19378830|P1|Overall Study|Withdrawal by Subject|4
5609709|NCT00838526|19378829|P2|Overall Study|Lost to Follow-up|12
5609710|NCT00838526|19378830|P1|Overall Study|Lost to Follow-up|4
5609711|NCT00838526|19378829|P2|Overall Study|Adverse Event|12
5609712|NCT00838526|19378830|P1|Overall Study|Adverse Event|3
5609713|NCT00838513|19378838|P1|Post Treatment Period (Patients Who Disc|Death|1
5609714|NCT00838513|19378838|P1|Extension Treatment Period|Death|1
5609715|NCT00838513|19378838|P1|Screening Period|Screen Failure|3
5609716|NCT00838435|19378854|P1|Part 2 (7 Years)|Withdrawal by Subject|5
5609717|NCT00838435|19378854|P1|Part 2 (7 Years)|Sponsor Decision|6
5609718|NCT00838435|19378854|P1|Part 2 (7 Years)|Physician Decision|1
5609719|NCT00838435|19378854|P1|Part 2 (7 Years)|Lost to Follow-up|2
5609720|NCT00838435|19378854|P1|Part 2 (7 Years)|Adverse Event|2
5609721|NCT00838435|19378854|P1|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2
5609722|NCT00838435|19378854|P1|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1
5609723|NCT00838331|19378867|P1|Aged Blood Transfusion|Withdrawal by Subject|9
5609724|NCT00838279|19378873|P2|Washout|Withdrawal by Subject|1
5609725|NCT00838279|19378874|P1|Washout|Withdrawal by Subject|0
5609726|NCT00838279|19378873|P2|Washout|Protocol Violation|0
5609727|NCT00838279|19378874|P1|Washout|Protocol Violation|1
5609728|NCT00838201|19378884|P2|Overall Study|Death|13
5609729|NCT00838201|19378885|P1|Overall Study|Death|11
5609730|NCT00838201|19378884|P2|Overall Study|Adverse Event|9
5609731|NCT00838201|19378885|P1|Overall Study|Adverse Event|5
5609732|NCT00838201|19378884|P2|Overall Study|Lost to Follow-up|3
5609733|NCT00838201|19378885|P1|Overall Study|Lost to Follow-up|4
5609734|NCT00838201|19378884|P2|Overall Study|Consent withdrawn|19
5609735|NCT00838201|19378885|P1|Overall Study|Consent withdrawn|16
5609736|NCT00838201|19378884|P2|Overall Study|Disease progression|3
5609737|NCT00838201|19378885|P1|Overall Study|Disease progression|3
5609738|NCT00838201|19378884|P2|Overall Study|Administrative decision|2
5609739|NCT00838201|19378885|P1|Overall Study|Administrative decision|1
5609740|NCT00838201|19378884|P2|Overall Study|Noncompliance|1
5609741|NCT00838201|19378885|P1|Overall Study|Noncompliance|0
5609742|NCT00838201|19378884|P2|Overall Study|Investigator decision, or other reasons|3
5609743|NCT00838201|19378885|P1|Overall Study|Investigator decision, or other reasons|2
5609744|NCT00838110|19378953|P4|Overall Study|Randomized but not treated|0
5609745|NCT00838110|19378954|P3|Overall Study|Randomized but not treated|0
5609746|NCT00838110|19378955|P2|Overall Study|Randomized but not treated|1
5609747|NCT00838110|19378956|P1|Overall Study|Randomized but not treated|0
5609748|NCT00838110|19378953|P4|Overall Study|Did not meet eligibility criteria|2
5609749|NCT00838110|19378954|P3|Overall Study|Did not meet eligibility criteria|1
5609750|NCT00838110|19378955|P2|Overall Study|Did not meet eligibility criteria|0
5609751|NCT00838110|19378956|P1|Overall Study|Did not meet eligibility criteria|0
5609752|NCT00838110|19378953|P4|Overall Study|Lost to Follow-up|0
5609753|NCT00838110|19378954|P3|Overall Study|Lost to Follow-up|0
5609754|NCT00838110|19378955|P2|Overall Study|Lost to Follow-up|0
5609755|NCT00838110|19378956|P1|Overall Study|Lost to Follow-up|3
5609756|NCT00838110|19378953|P4|Overall Study|Protocol Violation|1
5609757|NCT00838110|19378954|P3|Overall Study|Protocol Violation|1
5609758|NCT00838110|19378955|P2|Overall Study|Protocol Violation|2
5609759|NCT00838110|19378956|P1|Overall Study|Protocol Violation|0
5609760|NCT00838110|19378953|P4|Overall Study|Other|2
5609761|NCT00838110|19378954|P3|Overall Study|Other|3
5609762|NCT00838110|19378955|P2|Overall Study|Other|3
5609763|NCT00838110|19378956|P1|Overall Study|Other|3
5609764|NCT00838110|19378953|P4|Overall Study|Withdrawal by Subject|4
5609765|NCT00838110|19378954|P3|Overall Study|Withdrawal by Subject|3
5609766|NCT00838110|19378955|P2|Overall Study|Withdrawal by Subject|6
5609767|NCT00838110|19378956|P1|Overall Study|Withdrawal by Subject|5
5609768|NCT00838110|19378953|P4|Overall Study|Adverse Event|7
5609769|NCT00838110|19378954|P3|Overall Study|Adverse Event|8
5609770|NCT00838110|19378955|P2|Overall Study|Adverse Event|10
5609771|NCT00838110|19378956|P1|Overall Study|Adverse Event|11
5609772|NCT00838110|19378953|P4|Overall Study|Death|2
5609773|NCT00838110|19378954|P3|Overall Study|Death|1
5609774|NCT00838110|19378955|P2|Overall Study|Death|0
5609775|NCT00838110|19378956|P1|Overall Study|Death|0
5609776|NCT00838097|19378976|P1|Overall Study|Protocol-specified criteria|142
5609777|NCT00838097|19378976|P1|Overall Study|Death|6
5609778|NCT00838097|19378976|P1|Overall Study|Lost to Follow-up|11
5609779|NCT00838097|19378976|P1|Overall Study|Physician Decision|4
5609780|NCT00838097|19378976|P1|Overall Study|Requirement for alternative therapy|2
5609781|NCT00838097|19378976|P1|Overall Study|Withdrawal by Subject|3
5609782|NCT00838097|19378976|P1|Overall Study|Adverse Event|2
5609783|NCT00838097|19378976|P1|Overall Study|Ineligibility determined|6
5609784|NCT00837967|19379000|P2|Washout Period of 7 - 14 Days|Adverse Event|0
5609785|NCT00837967|19379001|P1|Washout Period of 7 - 14 Days|Adverse Event|2
5609786|NCT00837876|19379027|P1|Overall Study|disease progression|24
5609787|NCT00837876|19379027|P1|Overall Study|Withdrawal by Subject|3
5609788|NCT00837876|19379027|P1|Overall Study|Physician Decision|1
5609789|NCT00837876|19379027|P1|Overall Study|Adverse Event|7
5609790|NCT00837876|19379027|P1|Overall Study|Death|2
5609791|NCT00837811|19379049|P3|Overall Study|Sponsor Decision|0
5609792|NCT00837811|19379050|P2|Overall Study|Sponsor Decision|2
5609793|NCT00837811|19379051|P1|Overall Study|Sponsor Decision|0
5609794|NCT00837811|19379049|P3|Overall Study|Withdrawal by Subject|0
5609795|NCT00837811|19379050|P2|Overall Study|Withdrawal by Subject|9
5609796|NCT00837811|19379051|P1|Overall Study|Withdrawal by Subject|1
5609797|NCT00837811|19379049|P3|Overall Study|Physician Decision|1
5609798|NCT00837811|19379050|P2|Overall Study|Physician Decision|2
5609799|NCT00837811|19379051|P1|Overall Study|Physician Decision|0
5609800|NCT00837811|19379049|P3|Overall Study|Lost to Follow-up|0
5609801|NCT00837811|19379050|P2|Overall Study|Lost to Follow-up|3
5609802|NCT00837811|19379051|P1|Overall Study|Lost to Follow-up|1
5609803|NCT00837811|19379049|P3|Overall Study|Lack of Efficacy|0
5609804|NCT00837811|19379050|P2|Overall Study|Lack of Efficacy|11
5609805|NCT00837811|19379051|P1|Overall Study|Lack of Efficacy|0
5609806|NCT00837811|19379049|P3|Overall Study|Death|0
5609807|NCT00837811|19379050|P2|Overall Study|Death|1
5609808|NCT00837811|19379051|P1|Overall Study|Death|1
5609809|NCT00837811|19379049|P3|Overall Study|Adverse Event|0
5609810|NCT00837811|19379050|P2|Overall Study|Adverse Event|6
5609811|NCT00837811|19379051|P1|Overall Study|Adverse Event|4
5609812|NCT00837759|19379136|P1|Overall Study|Lost to Follow-up|1
5609813|NCT00837759|19379136|P1|Overall Study|Protocol Violation|3
5609814|NCT00837694|19379151|P6|Overall Study|Lost to Follow-up|1
5609815|NCT00837694|19379152|P5|Overall Study|Lost to Follow-up|1
5609816|NCT00837694|19379153|P4|Overall Study|Lost to Follow-up|1
5609817|NCT00837694|19379154|P3|Overall Study|Lost to Follow-up|2
5609818|NCT00837694|19379155|P2|Overall Study|Lost to Follow-up|0
5609819|NCT00837694|19379156|P1|Overall Study|Lost to Follow-up|2
5609820|NCT00837616|19379172|P2|Overall Study|Withdrawal by Subject|1
5609821|NCT00837616|19379173|P1|Overall Study|Withdrawal by Subject|0
5609822|NCT00837577|19379212|P2|Open-label Period|Other Reason|1
5609823|NCT00837577|19379213|P1|Open-label Period|Other Reason|1
5609824|NCT00837577|19379212|P2|Open-label Period|Withdrawal by Subject|2
5609825|NCT00837577|19379213|P1|Open-label Period|Withdrawal by Subject|1
5609826|NCT00837577|19379212|P2|Open-label Period|Lack of Efficacy|3
5609827|NCT00837577|19379213|P1|Open-label Period|Lack of Efficacy|4
5609828|NCT00837577|19379212|P2|Open-label Period|Laboratory Adverse Event|1
5609829|NCT00837577|19379213|P1|Open-label Period|Laboratory Adverse Event|0
5609830|NCT00837577|19379212|P2|Open-label Period|Clinical Adverse Event|2
5609831|NCT00837577|19379213|P1|Open-label Period|Clinical Adverse Event|2
5609832|NCT00837577|19379212|P2|Double-blind Period|Withdrawal by Subject|0
5609833|NCT00837577|19379213|P1|Double-blind Period|Withdrawal by Subject|1
5609834|NCT00837577|19379212|P2|Double-blind Period|Clinical Adverse Event|0
5609835|NCT00837577|19379213|P1|Double-blind Period|Clinical Adverse Event|1
5609836|NCT00837486|19379233|P2|Long-term Follow-up Phase - Open Label|Death|0
5609837|NCT00837486|19379234|P1|Long-term Follow-up Phase - Open Label|Death|1
5609838|NCT00837486|19379233|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
5609839|NCT00837486|19379234|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
5609840|NCT00837486|19379233|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
5609841|NCT00837486|19379234|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
5609842|NCT00837486|19379233|P2|Blinded-treatment Phase|Physician Decision|0
5609843|NCT00837486|19379234|P1|Blinded-treatment Phase|Physician Decision|1
5609844|NCT00837473|19379246|P1|Overall Study|Withdrawal by Subject|2
5609845|NCT00837473|19379246|P1|Overall Study|Lost to Follow-up|1
5609846|NCT00837434|19379266|P2|Overall Study|Unable to obtain study drug|0
5609847|NCT00837434|19379267|P1|Overall Study|Unable to obtain study drug|1
5609848|NCT00837434|19379266|P2|Overall Study|Baseline assessments not done in time|0
5609849|NCT00837434|19379267|P1|Overall Study|Baseline assessments not done in time|1
5609850|NCT00837434|19379266|P2|Overall Study|Noncompliant|0
5609851|NCT00837434|19379267|P1|Overall Study|Noncompliant|2
5609852|NCT00837434|19379266|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
5609853|NCT00837434|19379267|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
5609854|NCT00837434|19379266|P2|Overall Study|Lost to Follow-up|1
5609855|NCT00837434|19379267|P1|Overall Study|Lost to Follow-up|1
5609856|NCT00837434|19379266|P2|Overall Study|Physician Decision|0
5609857|NCT00837434|19379267|P1|Overall Study|Physician Decision|3
5609858|NCT00837330|19379287|P2|Overall Study|Lost to Follow-up|3
5609859|NCT00837330|19379288|P1|Overall Study|Lost to Follow-up|1
5609860|NCT00837213|19379311|P2|Overall Study|not stated|1
5609861|NCT00837213|19379312|P1|Overall Study|not stated|1
5609862|NCT00837213|19379311|P2|Overall Study|Withdrawal by Subject|2
5609863|NCT00837213|19379312|P1|Overall Study|Withdrawal by Subject|2
5609864|NCT00837213|19379311|P2|Overall Study|Lost to Follow-up|2
5609865|NCT00837213|19379312|P1|Overall Study|Lost to Follow-up|3
5609866|NCT00837161|19379338|P1|Overall Study|refused hysterectomy|2
5609867|NCT00837148|19379346|P1|Overall Study|Death|1
5609868|NCT00837148|19379346|P1|Overall Study|Adverse Event|1
5609869|NCT00837096|19379352|P2|Overall Study|Not reported|8
5609870|NCT00837096|19379353|P1|Overall Study|Not reported|9
5609871|NCT00837096|19379352|P2|Overall Study|Physician Decision|1
5609872|NCT00837096|19379353|P1|Overall Study|Physician Decision|1
5609873|NCT00836953|19379365|P1|Overall Study|Lost to Follow-up|1
5609874|NCT00836953|19379365|P1|Overall Study|Withdrawal by Subject|1
5609875|NCT00836927|19379376|P5|Overall Study|Withdrawal by Subject|0
5609876|NCT00836927|19379377|P4|Overall Study|Withdrawal by Subject|0
5609877|NCT00836927|19379378|P3|Overall Study|Withdrawal by Subject|0
5609878|NCT00836927|19379379|P2|Overall Study|Withdrawal by Subject|0
5609879|NCT00836927|19379380|P1|Overall Study|Withdrawal by Subject|1
5609880|NCT00836927|19379376|P5|Overall Study|Progressive disease|1
5609881|NCT00836927|19379377|P4|Overall Study|Progressive disease|1
5609882|NCT00836927|19379378|P3|Overall Study|Progressive disease|0
5609883|NCT00836927|19379379|P2|Overall Study|Progressive disease|0
5609884|NCT00836927|19379380|P1|Overall Study|Progressive disease|2
5609885|NCT00836901|19379416|P2|First Intervention|Withdrawal by Subject|0
5609886|NCT00836901|19379417|P1|First Intervention|Withdrawal by Subject|1
5609887|NCT00836875|19379466|P2|Overall Study|Withdrawal by Subject|1
5609888|NCT00836875|19379467|P1|Overall Study|Withdrawal by Subject|0
5609889|NCT00836875|19379466|P2|Overall Study|Death|2
5609890|NCT00836875|19379467|P1|Overall Study|Death|3
5609891|NCT00836810|19379483|P2|Overall Study|New diagnosis|0
5609892|NCT00836810|19379484|P1|Overall Study|New diagnosis|1
5609893|NCT00836745|19379506|P1|Overall Study|Other|2
5609894|NCT00836745|19379506|P1|Overall Study|Objective progression or relapse|4
5609895|NCT00836745|19379506|P1|Overall Study|Adverse Event|3
5609896|NCT00836745|19379506|P1|Overall Study|Lost to Follow-up|10
5609897|NCT00836745|19379506|P1|Overall Study|Death|2
5609898|NCT00836706|19379520|P2|Washout: 7 Days|Withdrawal by Subject|1
5609899|NCT00836706|19379521|P1|Washout: 7 Days|Withdrawal by Subject|0
5609900|NCT00836693|19379531|P2|Overall Study|Lost to Follow-up|0
5609901|NCT00836693|19379532|P1|Overall Study|Lost to Follow-up|1
5609902|NCT00836693|19379531|P2|Overall Study|Protocol Violation|0
5609903|NCT00836693|19379532|P1|Overall Study|Protocol Violation|1
5609904|NCT00836693|19379531|P2|Overall Study|Withdrawal by Subject|4
5609905|NCT00836693|19379532|P1|Overall Study|Withdrawal by Subject|9
5609906|NCT00836693|19379531|P2|Overall Study|Physician Decision|0
5609907|NCT00836693|19379532|P1|Overall Study|Physician Decision|2
5609908|NCT00836693|19379531|P2|Overall Study|Sponsor Decision|1
5609909|NCT00836693|19379532|P1|Overall Study|Sponsor Decision|0
5609910|NCT00836693|19379531|P2|Overall Study|Adverse Event|1
5609911|NCT00836693|19379532|P1|Overall Study|Adverse Event|4
5609912|NCT00836589|19379582|P1|Overall Study|Withdrawal by Subject or Physician|591
5609913|NCT00836589|19379582|P1|Overall Study|Death|429
5609914|NCT00836589|19379582|P1|Overall Study|Lost to Follow-up|246
5609915|NCT00836498|19379615|P2|Overall Study|Withdrawal by Subject|1
5609916|NCT00836498|19379616|P1|Overall Study|Withdrawal by Subject|2
5609917|NCT00836498|19379615|P2|Overall Study|Lost to Follow-up|0
5609918|NCT00836498|19379616|P1|Overall Study|Lost to Follow-up|1
5609919|NCT00836498|19379615|P2|Overall Study|Adverse Event|0
5609920|NCT00836498|19379616|P1|Overall Study|Adverse Event|1
5609921|NCT00836472|19379648|P2|Washout|Withdrawal by Subject|1
5609922|NCT00836472|19379649|P1|Washout|Withdrawal by Subject|1
5609923|NCT00836472|19379648|P2|Washout|Adverse Event|2
5609924|NCT00836472|19379649|P1|Washout|Adverse Event|1
5609925|NCT00836277|19379726|P1|Overall Study|Not evaluable for response|6
5609926|NCT00836186|19379734|P1|Overall Study|Blood could not be drawn|1
5609927|NCT00836095|19379742|P2|Overall Study|Physician Decision|3
5609928|NCT00836095|19379743|P1|Overall Study|Physician Decision|0
5609929|NCT00836056|19379753|P2|First Intervention|Adverse Event|0
5609930|NCT00836056|19379754|P1|First Intervention|Adverse Event|1
5609931|NCT00835991|19379783|P2|Washout|Withdrawal by Subject|1
5609932|NCT00835991|19379784|P1|Washout|Withdrawal by Subject|3
5609933|NCT00835991|19379783|P2|Washout|Protocol Violation|2
5609934|NCT00835991|19379784|P1|Washout|Protocol Violation|0
5609935|NCT00835991|19379783|P2|First Intervention|Adverse Event|1
5609936|NCT00835991|19379784|P1|First Intervention|Adverse Event|0
5609937|NCT00835978|19379802|P4|Overall Study|Study terminated by sponsor|0
5609938|NCT00835978|19379803|P3|Overall Study|Study terminated by sponsor|30
5609939|NCT00835978|19379804|P2|Overall Study|Study terminated by sponsor|8
5609940|NCT00835978|19379805|P1|Overall Study|Study terminated by sponsor|12
5609941|NCT00835978|19379802|P4|Overall Study|Withdrawal by Subject|5
5609942|NCT00835978|19379803|P3|Overall Study|Withdrawal by Subject|0
5609943|NCT00835978|19379804|P2|Overall Study|Withdrawal by Subject|3
5609944|NCT00835978|19379805|P1|Overall Study|Withdrawal by Subject|0
5609945|NCT00835978|19379802|P4|Overall Study|Adverse Event|0
5609946|NCT00835978|19379803|P3|Overall Study|Adverse Event|1
5609947|NCT00835978|19379804|P2|Overall Study|Adverse Event|0
5609948|NCT00835978|19379805|P1|Overall Study|Adverse Event|1
5609949|NCT00835978|19379802|P4|Overall Study|Objective progression or relapse|0
5609950|NCT00835978|19379803|P3|Overall Study|Objective progression or relapse|1
5609951|NCT00835978|19379804|P2|Overall Study|Objective progression or relapse|0
5609952|NCT00835978|19379805|P1|Overall Study|Objective progression or relapse|2
5609953|NCT00835978|19379802|P4|Overall Study|Other|0
5609954|NCT00835978|19379803|P3|Overall Study|Other|8
5609955|NCT00835978|19379804|P2|Overall Study|Other|1
5609956|NCT00835978|19379805|P1|Overall Study|Other|5
5609957|NCT00835978|19379802|P4|Overall Study|Lost to Follow-up|1
5609958|NCT00835978|19379803|P3|Overall Study|Lost to Follow-up|2
5609959|NCT00835978|19379804|P2|Overall Study|Lost to Follow-up|4
5609960|NCT00835978|19379805|P1|Overall Study|Lost to Follow-up|3
5609961|NCT00835978|19379802|P4|Overall Study|Death|4
5609962|NCT00835978|19379803|P3|Overall Study|Death|49
5609963|NCT00835978|19379804|P2|Overall Study|Death|40
5609964|NCT00835978|19379805|P1|Overall Study|Death|33
5609965|NCT00835796|19379916|P2|First Intervention|Withdrawal by Subject|1
5609966|NCT00835796|19379917|P1|First Intervention|Withdrawal by Subject|0
5609967|NCT00835770|19379927|P2|Overall Study|Other|1
5609968|NCT00835770|19379928|P1|Overall Study|Other|2
5609969|NCT00835770|19379927|P2|Overall Study|Other|104
5609970|NCT00835770|19379928|P1|Overall Study|Other|115
5609971|NCT00835770|19379927|P2|Overall Study|Death|6
5609972|NCT00835770|19379928|P1|Overall Study|Death|4
5609973|NCT00835770|19379927|P2|Overall Study|Participant Non-Compliance|9
5609974|NCT00835770|19379928|P1|Overall Study|Participant Non-Compliance|11
5609975|NCT00835770|19379927|P2|Overall Study|Investigator Decision|42
5609976|NCT00835770|19379928|P1|Overall Study|Investigator Decision|42
5609977|NCT00835770|19379927|P2|Overall Study|Consent Withdrawn|156
5609978|NCT00835770|19379928|P1|Overall Study|Consent Withdrawn|144
5609979|NCT00835770|19379927|P2|Overall Study|Lost to Follow-up|19
5609980|NCT00835770|19379928|P1|Overall Study|Lost to Follow-up|22
5609981|NCT00835770|19379927|P2|Overall Study|Adverse Event|124
5609982|NCT00835770|19379928|P1|Overall Study|Adverse Event|113
5609983|NCT00835770|19379927|P2|Overall Study|MS Progression|9
5609984|NCT00835770|19379928|P1|Overall Study|MS Progression|14
5609985|NCT00835770|19379927|P2|Overall Study|MS Relapse|23
5609986|NCT00835770|19379928|P1|Overall Study|MS Relapse|17
5609987|NCT00835731|19380026|P2|Overall Study|Physician Decision|1
5609988|NCT00835731|19380027|P1|Overall Study|Physician Decision|1
5609989|NCT00835731|19380026|P2|Overall Study|Withdrawal by Subject|0
5609990|NCT00835731|19380027|P1|Overall Study|Withdrawal by Subject|1
5609991|NCT00835705|19380047|P2|Second Intervention|Difficulty with vein|0
5609992|NCT00835705|19380048|P1|Second Intervention|Difficulty with vein|1
5609993|NCT00835705|19380047|P2|First Intervention|Difficulty with vein|0
5609994|NCT00835705|19380048|P1|First Intervention|Difficulty with vein|1
5609995|NCT00835692|19380064|P2|First Intervention|Withdrawal by Subject|0
5609996|NCT00835692|19380065|P1|First Intervention|Withdrawal by Subject|1
5609997|NCT00835679|19380077|P4|Overall Study|Withdrawal by Subject|0
5609998|NCT00835679|19380078|P3|Overall Study|Withdrawal by Subject|0
5609999|NCT00835679|19380079|P2|Overall Study|Withdrawal by Subject|0
5610000|NCT00835679|19380080|P1|Overall Study|Withdrawal by Subject|1
5610001|NCT00835666|19380104|P2|Washout|Withdrawal by Subject|0
5610002|NCT00835666|19380105|P1|Washout|Withdrawal by Subject|1
5610003|NCT00835666|19380104|P2|Washout|Protocol Violation|0
5610004|NCT00835666|19380105|P1|Washout|Protocol Violation|1
5610005|NCT00835640|19380115|P2|Second Intervention|Protocol Violation|0
5610006|NCT00835640|19380116|P1|Second Intervention|Protocol Violation|1
5610007|NCT00835575|19380148|P2|Washout of 14 Days|Withdrawal by Subject|0
5610008|NCT00835575|19380149|P1|Washout of 14 Days|Withdrawal by Subject|1
5610009|NCT00835549|19380159|P2|Washout of 7 Days|Withdrawal by Subject|0
5610010|NCT00835549|19380160|P1|Washout of 7 Days|Withdrawal by Subject|2
5610011|NCT00835536|19380170|P2|Washout of 5 Weeks|Withdrawal by Subject|0
5610012|NCT00835536|19380171|P1|Washout of 5 Weeks|Withdrawal by Subject|1
5610013|NCT00835406|19380232|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
5610014|NCT00835406|19380233|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
5610015|NCT00835406|19380232|P2|Period: First Intervention|Withdrawal by Subject|0
5610016|NCT00835406|19380233|P1|Period: First Intervention|Withdrawal by Subject|2
5610017|NCT00835406|19380232|P2|Period: First Intervention|Adverse Event|1
5610018|NCT00835406|19380233|P1|Period: First Intervention|Adverse Event|0
5610019|NCT00835380|19380239|P1|Overall Study|Withdrawal by Subject|2
5610020|NCT00835367|19380246|P2|Second Intervention|Adverse Event|1
5610021|NCT00835367|19380247|P1|Second Intervention|Adverse Event|1
5610022|NCT00835367|19380246|P2|Washout|Withdrawal by Subject|0
5610023|NCT00835367|19380247|P1|Washout|Withdrawal by Subject|1
5610024|NCT00835367|19380246|P2|Washout|Adverse Event|0
5610025|NCT00835367|19380247|P1|Washout|Adverse Event|2
5610026|NCT00835354|19380269|P2|First Intervention|Adverse Event|1
5610027|NCT00835354|19380270|P1|First Intervention|Adverse Event|0
5610028|NCT00835341|19380280|P2|Overall Study|Lost to Follow-up|12
5610029|NCT00835341|19380281|P1|Overall Study|Lost to Follow-up|3
5610030|NCT00835263|19380344|P2|Second Intervention|Adverse Event|0
5610031|NCT00835263|19380345|P1|Second Intervention|Adverse Event|1
5610032|NCT00835237|19380355|P2|Overall Study|Withdrawal by Subject|0
5610033|NCT00835237|19380356|P1|Overall Study|Withdrawal by Subject|2
5610034|NCT00835237|19380355|P2|Overall Study|Lost to Follow-up|0
5610035|NCT00835237|19380356|P1|Overall Study|Lost to Follow-up|4
5610036|NCT00835211|19380396|P2|Washout: 7 Days|Withdrawal by Subject|0
5610037|NCT00835211|19380397|P1|Washout: 7 Days|Withdrawal by Subject|1
5610038|NCT00835211|19380396|P2|Washout: 7 Days|Adverse Event|1
5610039|NCT00835211|19380397|P1|Washout: 7 Days|Adverse Event|2
5610040|NCT00835211|19380396|P2|First Intervention|Withdrawal by Subject|1
5610041|NCT00835211|19380397|P1|First Intervention|Withdrawal by Subject|0
5610042|NCT00835172|19380443|P2|Washout|Protocol Violation|1
5610043|NCT00835172|19380444|P1|Washout|Protocol Violation|0
5610044|NCT00835120|19380470|P1|Overall Study|Withdrawal by Subject|2
5610045|NCT00835120|19380470|P1|Overall Study|Adverse Event|2
5610046|NCT00835120|19380470|P1|Overall Study|Lost to Follow-up|3
5610047|NCT00835120|19380470|P1|Overall Study|Lack of Efficacy|1
5610048|NCT00835081|19380480|P2|Washout of 7 Days|Withdrawal by Subject|0
5610049|NCT00835081|19380481|P1|Washout of 7 Days|Withdrawal by Subject|1
5610050|NCT00835068|19380491|P2|Overall Study|Withdrawal by Subject|0
5610051|NCT00835068|19380492|P1|Overall Study|Withdrawal by Subject|1
5610052|NCT00835068|19380491|P2|Overall Study|Other|0
5610053|NCT00835068|19380492|P1|Overall Study|Other|8
5610054|NCT00835068|19380491|P2|Overall Study|Adverse Event|1
5610055|NCT00835068|19380492|P1|Overall Study|Adverse Event|0
5610056|NCT00835068|19380491|P2|Overall Study|Death|0
5610057|NCT00835068|19380492|P1|Overall Study|Death|1
5610058|NCT00835042|19380512|P2|Washout of 21 Days|Withdrawal by Subject|2
5610059|NCT00835042|19380513|P1|Washout of 21 Days|Withdrawal by Subject|0
5610060|NCT00835042|19380512|P2|First Intervention|Adverse Event|2
5610061|NCT00835042|19380513|P1|First Intervention|Adverse Event|1
5610062|NCT00835042|19380512|P2|First Intervention|Withdrawal by Subject|0
5610063|NCT00835042|19380513|P1|First Intervention|Withdrawal by Subject|3
5610064|NCT00834912|19380599|P6|Treatment Period 2|Withdrawal by Subject|0
5610065|NCT00834912|19380600|P5|Treatment Period 2|Withdrawal by Subject|1
5610066|NCT00834912|19380601|P4|Treatment Period 2|Withdrawal by Subject|0
5610067|NCT00834912|19380602|P3|Treatment Period 2|Withdrawal by Subject|1
5610068|NCT00834912|19380603|P2|Treatment Period 2|Withdrawal by Subject|0
5610069|NCT00834912|19380604|P1|Treatment Period 2|Withdrawal by Subject|0
5610070|NCT00834912|19380599|P6|Treatment Period 1|Adverse Event|0
5610071|NCT00834912|19380600|P5|Treatment Period 1|Adverse Event|0
5610072|NCT00834912|19380601|P4|Treatment Period 1|Adverse Event|1
5610073|NCT00834912|19380602|P3|Treatment Period 1|Adverse Event|0
5610074|NCT00834912|19380603|P2|Treatment Period 1|Adverse Event|1
5610075|NCT00834912|19380604|P1|Treatment Period 1|Adverse Event|0
5610076|NCT00834899|19380626|P2|Overall Study|Withdrawal by Subject|1
5610077|NCT00834899|19380627|P1|Overall Study|Withdrawal by Subject|1
5610078|NCT00834873|19380666|P2|First Intervention|Adverse Event|1
5610079|NCT00834873|19380667|P1|First Intervention|Adverse Event|0
5610080|NCT00834834|19380677|P2|Overall Study|Withdrawal by Subject|3
5610081|NCT00834834|19380678|P1|Overall Study|Withdrawal by Subject|4
5610082|NCT00834795|19380713|P2|Second Intervention|Adverse Event|0
5610083|NCT00834795|19380714|P1|Second Intervention|Adverse Event|1
5610084|NCT00834795|19380713|P2|Washout: 7 Days|Withdrawal by Subject|1
5610085|NCT00834795|19380714|P1|Washout: 7 Days|Withdrawal by Subject|0
5610086|NCT00834756|19380724|P2|Washout: 21 Days|Withdrawal by Subject|0
5610087|NCT00834756|19380725|P1|Washout: 21 Days|Withdrawal by Subject|1
5610088|NCT00834756|19380724|P2|First Intervention|Adverse Event|0
5610089|NCT00834756|19380725|P1|First Intervention|Adverse Event|1
5610090|NCT00834743|19380735|P2|Second Intervention|Withdrawal by Subject|0
5610091|NCT00834743|19380736|P1|Second Intervention|Withdrawal by Subject|1
5610092|NCT00834717|19380746|P2|First Intervention|Withdrawal by Subject|1
5610093|NCT00834717|19380747|P1|First Intervention|Withdrawal by Subject|0
5610094|NCT00834717|19380746|P2|First Intervention|Adverse Event|0
5610095|NCT00834717|19380747|P1|First Intervention|Adverse Event|1
5610096|NCT00834639|19380778|P2|Second Intervention|Physician Decision|2
5610097|NCT00834639|19380779|P1|Second Intervention|Physician Decision|0
5610098|NCT00834613|19380796|P2|First Intervention|Protocol Violation|0
5610099|NCT00834613|19380797|P1|First Intervention|Protocol Violation|1
5610100|NCT00834587|19380807|P2|Washout: 7 Days|Withdrawal by Subject|0
5610101|NCT00834587|19380808|P1|Washout: 7 Days|Withdrawal by Subject|1
5610102|NCT00834522|19380857|P2|Washout|Withdrawal by Subject|1
5610103|NCT00834522|19380858|P1|Washout|Withdrawal by Subject|2
5610104|NCT00834522|19380857|P2|Washout|Adverse Event|0
5610105|NCT00834522|19380858|P1|Washout|Adverse Event|1
5610106|NCT00834444|19380881|P2|Second Intervention|Adverse Event|0
5610107|NCT00834444|19380882|P1|Second Intervention|Adverse Event|1
5610108|NCT00834444|19380881|P2|Washout of 7 Days|Withdrawal by Subject|1
5610109|NCT00834444|19380882|P1|Washout of 7 Days|Withdrawal by Subject|0
5610110|NCT00834444|19380881|P2|First Intervention|Intolerance to Venopuncture|1
5610111|NCT00834444|19380882|P1|First Intervention|Intolerance to Venopuncture|0
5610112|NCT00834444|19380881|P2|First Intervention|Adverse Event|0
5610113|NCT00834444|19380882|P1|First Intervention|Adverse Event|1
5610114|NCT00834431|19380892|P2|Washout of 7 Days|Withdrawal by Subject|1
5610115|NCT00834431|19380893|P1|Washout of 7 Days|Withdrawal by Subject|0
5610116|NCT00834431|19380892|P2|First Intervention|Adverse Event|1
5610117|NCT00834431|19380893|P1|First Intervention|Adverse Event|0
5610118|NCT00834418|19380903|P2|Overall Study|Adverse Event|2
5610119|NCT00834418|19380904|P1|Overall Study|Adverse Event|0
5610120|NCT00834366|19380921|P2|Treatment Period 1|Adverse Event|1
5610121|NCT00834366|19380922|P1|Treatment Period 1|Adverse Event|1
5610122|NCT00834340|19380938|P2|Washout|Withdrawal by Subject|0
5610123|NCT00834340|19380939|P1|Washout|Withdrawal by Subject|1
5610124|NCT00834340|19380938|P2|Washout|Adverse Event|0
5610125|NCT00834340|19380939|P1|Washout|Adverse Event|1
5610126|NCT00834249|19380983|P2|Second Intervention|Adverse Event|0
5610127|NCT00834249|19380984|P1|Second Intervention|Adverse Event|1
5610128|NCT00834249|19380983|P2|Washout: 7 Days|Withdrawal by Subject|1
5610129|NCT00834249|19380984|P1|Washout: 7 Days|Withdrawal by Subject|1
5610130|NCT00834080|19381080|P1|Overall Study|Subject Relocated|1
5610131|NCT00834080|19381080|P1|Overall Study|Physician Decision|1
5610132|NCT00834080|19381080|P1|Overall Study|Other - False positive tests of the UDS|1
5610133|NCT00834080|19381080|P1|Overall Study|Other - Pregnancy|1
5610134|NCT00834080|19381080|P1|Overall Study|Withdrawal by Subject|5
5610135|NCT00834080|19381080|P1|Overall Study|Lost to Follow-up|7
5610136|NCT00834080|19381080|P1|Overall Study|Adverse Event|7
5610137|NCT00834067|19381086|P2|Washout of 21 Days|Protocol Violation|1
5610138|NCT00834067|19381087|P1|Washout of 21 Days|Protocol Violation|0
5610139|NCT00834041|19381109|P2|Overall Study|Lost to Follow-up|1
5610140|NCT00834041|19381110|P1|Overall Study|Lost to Follow-up|0
5610141|NCT00834041|19381109|P2|Overall Study|Withdrawal by Subject|0
5610142|NCT00834041|19381110|P1|Overall Study|Withdrawal by Subject|1
5610143|NCT00833989|19381128|P4|Overall Study|Withdrawal by Subject|1
5610144|NCT00833989|19381129|P3|Overall Study|Withdrawal by Subject|1
5610145|NCT00833989|19381130|P2|Overall Study|Withdrawal by Subject|0
5610146|NCT00833989|19381131|P1|Overall Study|Withdrawal by Subject|3
5610147|NCT00833989|19381128|P4|Overall Study|Physician Decision|1
5610148|NCT00833989|19381129|P3|Overall Study|Physician Decision|0
5610149|NCT00833989|19381130|P2|Overall Study|Physician Decision|0
5610150|NCT00833989|19381131|P1|Overall Study|Physician Decision|0
5610151|NCT00833976|19381235|P1|Overall Study|Physician Decision|1
5610152|NCT00833976|19381235|P1|Overall Study|Did not meet eligibility criteria|41
5610153|NCT00833976|19381235|P1|Overall Study|Lost to Follow-up|4
5610154|NCT00833976|19381235|P1|Overall Study|Withdrawal by Subject|5
5610155|NCT00833937|19381243|P2|Washout|Withdrawal by Subject|0
5610156|NCT00833937|19381244|P1|Washout|Withdrawal by Subject|1
5610157|NCT00833924|19381252|P1|Overall Study|In study follow-up|71
5610158|NCT00833924|19381252|P1|Overall Study|Withdrawal by Subject|13
5610159|NCT00833924|19381252|P1|Overall Study|Lost to Follow-up|2
5610160|NCT00833924|19381252|P1|Overall Study|Conversion|2
5610161|NCT00833924|19381252|P1|Overall Study|Death|21
5610162|NCT00833911|19381257|P1|Maintenance Phase II|Lack of Efficacy|1
5610163|NCT00833911|19381257|P1|Maintenance Phase II|Withdrawal by Subject|1
5610164|NCT00833911|19381257|P1|Maintenance Phase II|Physician Decision|2
5610165|NCT00833911|19381257|P1|Maintenance Phase II|Adverse Event|6
5610166|NCT00833911|19381257|P1|Maintenance Phase I|Lack of Efficacy|4
5610167|NCT00833911|19381257|P1|Maintenance Phase I|Physician Decision|10
5610168|NCT00833911|19381257|P1|Maintenance Phase I|Withdrawal by Subject|11
5610169|NCT00833911|19381257|P1|Maintenance Phase I|Adverse Event|73
5610170|NCT00833911|19381257|P1|Titration|Withdrawal by Subject|3
5610171|NCT00833911|19381257|P1|Titration|Adverse Event|18
5610172|NCT00833898|19381267|P2|Overall Study|Patient did not receive transplant|2
5610173|NCT00833898|19381268|P1|Overall Study|Patient did not receive transplant|0
5610174|NCT00833898|19381267|P2|Overall Study|Lost to Follow-up|7
5610175|NCT00833898|19381268|P1|Overall Study|Lost to Follow-up|7
5610176|NCT00833898|19381267|P2|Overall Study|Withdrawal by Subject|27
5610177|NCT00833898|19381268|P1|Overall Study|Withdrawal by Subject|33
5610178|NCT00833833|19381327|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
5610179|NCT00833833|19381328|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5610180|NCT00833833|19381329|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5610181|NCT00833833|19381330|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5610182|NCT00833833|19381331|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5610183|NCT00833833|19381332|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
5610184|NCT00833833|19381327|P6|Phase 2 (as of 01 April 2011)|Other|3
5610185|NCT00833833|19381328|P5|Phase 2 (as of 01 April 2011)|Other|4
5610186|NCT00833833|19381329|P4|Phase 2 (as of 01 April 2011)|Other|0
5610187|NCT00833833|19381330|P3|Phase 2 (as of 01 April 2011)|Other|0
5610188|NCT00833833|19381331|P2|Phase 2 (as of 01 April 2011)|Other|0
5610189|NCT00833833|19381332|P1|Phase 2 (as of 01 April 2011)|Other|0
5610190|NCT00833833|19381327|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
5610191|NCT00833833|19381328|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
5610192|NCT00833833|19381329|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
5610193|NCT00833833|19381330|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
5610194|NCT00833833|19381331|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
5610195|NCT00833833|19381332|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
5610196|NCT00833833|19381327|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
5610197|NCT00833833|19381328|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
5610198|NCT00833833|19381329|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
5610199|NCT00833833|19381330|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
5610200|NCT00833833|19381331|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
5610201|NCT00833833|19381332|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
5610202|NCT00833833|19381327|P6|Phase 2 (as of 01 April 2011)|Death|9
5610203|NCT00833833|19381328|P5|Phase 2 (as of 01 April 2011)|Death|8
5610204|NCT00833833|19381329|P4|Phase 2 (as of 01 April 2011)|Death|0
5610205|NCT00833833|19381330|P3|Phase 2 (as of 01 April 2011)|Death|0
5610206|NCT00833833|19381331|P2|Phase 2 (as of 01 April 2011)|Death|0
5610207|NCT00833833|19381332|P1|Phase 2 (as of 01 April 2011)|Death|0
5610208|NCT00833833|19381327|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
5610209|NCT00833833|19381328|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
5610210|NCT00833833|19381329|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
5610211|NCT00833833|19381330|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
5610212|NCT00833833|19381331|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
5610213|NCT00833833|19381332|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
5610214|NCT00833833|19381327|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
5610215|NCT00833833|19381328|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
5610216|NCT00833833|19381329|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
5610217|NCT00833833|19381330|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
5610218|NCT00833833|19381331|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
5610219|NCT00833833|19381332|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
5610220|NCT00833833|19381327|P6|Phase 1 (as of 01 April 2011)|Other|0
5610221|NCT00833833|19381328|P5|Phase 1 (as of 01 April 2011)|Other|0
5610222|NCT00833833|19381329|P4|Phase 1 (as of 01 April 2011)|Other|1
5610223|NCT00833833|19381330|P3|Phase 1 (as of 01 April 2011)|Other|0
5610224|NCT00833833|19381331|P2|Phase 1 (as of 01 April 2011)|Other|3
5610225|NCT00833833|19381332|P1|Phase 1 (as of 01 April 2011)|Other|1
5610226|NCT00833833|19381327|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
5610227|NCT00833833|19381328|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
5610228|NCT00833833|19381329|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
5610229|NCT00833833|19381330|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
5610230|NCT00833833|19381331|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
5610231|NCT00833833|19381332|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
5610232|NCT00833833|19381327|P6|Phase 1 (as of 01 April 2011)|Death|0
5610233|NCT00833833|19381328|P5|Phase 1 (as of 01 April 2011)|Death|0
5610234|NCT00833833|19381329|P4|Phase 1 (as of 01 April 2011)|Death|0
5610235|NCT00833833|19381330|P3|Phase 1 (as of 01 April 2011)|Death|2
5610236|NCT00833833|19381331|P2|Phase 1 (as of 01 April 2011)|Death|1
5610237|NCT00833833|19381332|P1|Phase 1 (as of 01 April 2011)|Death|0
5610238|NCT00833833|19381327|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
5610239|NCT00833833|19381328|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
5610240|NCT00833833|19381329|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
5610241|NCT00833833|19381330|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
5610242|NCT00833833|19381331|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
5610243|NCT00833833|19381332|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
5610244|NCT00833833|19381327|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
5610245|NCT00833833|19381328|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
5610246|NCT00833833|19381329|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
5610247|NCT00833833|19381330|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
5610248|NCT00833833|19381331|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
5610249|NCT00833833|19381332|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
5610250|NCT00833833|19381327|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
5610251|NCT00833833|19381328|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
5610252|NCT00833833|19381329|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
5610253|NCT00833833|19381330|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
5610254|NCT00833833|19381331|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
5610255|NCT00833833|19381332|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
5610256|NCT00833794|19381372|P2|Double-blind Phase|Administrative reason|3
5610257|NCT00833794|19381373|P1|Double-blind Phase|Administrative reason|1
5610258|NCT00833794|19381372|P2|Double-blind Phase|Physician Decision|7
5610259|NCT00833794|19381373|P1|Double-blind Phase|Physician Decision|4
5610260|NCT00833794|19381372|P2|Double-blind Phase|Withdrawal by Subject|6
5610261|NCT00833794|19381373|P1|Double-blind Phase|Withdrawal by Subject|23
5610262|NCT00833794|19381372|P2|Double-blind Phase|Lack of Efficacy|22
5610263|NCT00833794|19381373|P1|Double-blind Phase|Lack of Efficacy|34
5610264|NCT00833794|19381372|P2|Double-blind Phase|Adverse Event|11
5610265|NCT00833794|19381373|P1|Double-blind Phase|Adverse Event|44
5610266|NCT00833794|19381372|P2|Open-label Phase|enrolled in error (immediately D/C)|0
5610267|NCT00833794|19381373|P1|Open-label Phase|enrolled in error (immediately D/C)|1
5610268|NCT00833794|19381372|P2|Open-label Phase|Did not complete wash-out period|0
5610269|NCT00833794|19381373|P1|Open-label Phase|Did not complete wash-out period|12
5610270|NCT00833794|19381372|P2|Open-label Phase|Protocol Violation|0
5610271|NCT00833794|19381373|P1|Open-label Phase|Protocol Violation|47
5610272|NCT00833794|19381372|P2|Open-label Phase|Administrative reason|0
5610273|NCT00833794|19381373|P1|Open-label Phase|Administrative reason|1
5610274|NCT00833794|19381372|P2|Open-label Phase|Physician Decision|0
5610275|NCT00833794|19381373|P1|Open-label Phase|Physician Decision|20
5610276|NCT00833794|19381372|P2|Open-label Phase|Withdrawal by Subject|0
5610277|NCT00833794|19381373|P1|Open-label Phase|Withdrawal by Subject|48
5610278|NCT00833794|19381372|P2|Open-label Phase|Lack of Efficacy|0
5610279|NCT00833794|19381373|P1|Open-label Phase|Lack of Efficacy|28
5610280|NCT00833794|19381372|P2|Open-label Phase|Adverse Event|0
5610281|NCT00833794|19381373|P1|Open-label Phase|Adverse Event|225
5610282|NCT00833755|19381417|P4|Overall Study|Subject had scheduling issues|0
5610283|NCT00833755|19381418|P3|Overall Study|Subject had scheduling issues|0
5610284|NCT00833755|19381419|P2|Overall Study|Subject had scheduling issues|1
5610285|NCT00833755|19381420|P1|Overall Study|Subject had scheduling issues|0
5610286|NCT00833755|19381417|P4|Overall Study|Physician Decision|6
5610287|NCT00833755|19381418|P3|Overall Study|Physician Decision|2
5610288|NCT00833755|19381419|P2|Overall Study|Physician Decision|4
5610289|NCT00833755|19381420|P1|Overall Study|Physician Decision|4
5610290|NCT00833703|19381440|P2|Overall Study|Parent(s)/guardian(s)'s request|1
5610291|NCT00833703|19381441|P1|Overall Study|Parent(s)/guardian(s)'s request|0
5610292|NCT00833690|19381454|P3|Overall Study|Discontinued study drug|0
5610293|NCT00833690|19381455|P2|Overall Study|Discontinued study drug|2
5610294|NCT00833690|19381456|P1|Overall Study|Discontinued study drug|3
5610295|NCT00833690|19381454|P3|Overall Study|Withdrawal by Subject|0
5610296|NCT00833690|19381455|P2|Overall Study|Withdrawal by Subject|0
5610297|NCT00833690|19381456|P1|Overall Study|Withdrawal by Subject|1
5610298|NCT00833638|19381592|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
5610299|NCT00833638|19381593|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
5610300|NCT00833638|19381594|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
5610301|NCT00833638|19381592|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
5610302|NCT00833638|19381593|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
5610303|NCT00833638|19381594|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
5610304|NCT00833638|19381592|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
5610305|NCT00833638|19381593|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
5610306|NCT00833638|19381594|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
5610307|NCT00833638|19381592|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
5610308|NCT00833638|19381593|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
5610309|NCT00833638|19381594|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
5610310|NCT00833638|19381592|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
5610311|NCT00833638|19381593|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
5610312|NCT00833638|19381594|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
5610313|NCT00833638|19381592|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
5610314|NCT00833638|19381593|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
5610315|NCT00833638|19381594|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
5610316|NCT00833638|19381592|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
5610317|NCT00833638|19381593|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
5610318|NCT00833638|19381594|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
5610319|NCT00833638|19381592|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
5610320|NCT00833638|19381593|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
5610321|NCT00833638|19381594|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
5610322|NCT00833638|19381592|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
5610323|NCT00833638|19381593|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
5610324|NCT00833638|19381594|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
5610325|NCT00833560|19381645|P1|Overall Study|Other|5
5610326|NCT00833560|19381645|P1|Overall Study|Pregression of other disease|1
5610327|NCT00833560|19381645|P1|Overall Study|Death|2
5610328|NCT00833560|19381645|P1|Overall Study|Lack of Efficacy|4
5610329|NCT00833560|19381645|P1|Overall Study|Protocol Violation|6
5610330|NCT00833560|19381645|P1|Overall Study|Adverse Event|11
5610331|NCT00833560|19381645|P1|Overall Study|Toxicity|13
5610332|NCT00833547|19381654|P2|Overall Study|Withdrawal by Subject|2
5610333|NCT00833547|19381655|P1|Overall Study|Withdrawal by Subject|2
5610334|NCT00833482|19381676|P6|Days 21-30|Withdrawal by Subject|0
5610335|NCT00833482|19381677|P5|Days 21-30|Withdrawal by Subject|1
5610336|NCT00833482|19381678|P4|Days 21-30|Withdrawal by Subject|0
5610337|NCT00833482|19381679|P3|Days 21-30|Withdrawal by Subject|0
5610338|NCT00833482|19381680|P2|Days 21-30|Withdrawal by Subject|0
5610339|NCT00833482|19381681|P1|Days 21-30|Withdrawal by Subject|0
5610340|NCT00833482|19381676|P6|Days 21-30|Adverse Event|0
5610341|NCT00833482|19381677|P5|Days 21-30|Adverse Event|0
5610342|NCT00833482|19381678|P4|Days 21-30|Adverse Event|0
5610343|NCT00833482|19381679|P3|Days 21-30|Adverse Event|1
5610344|NCT00833482|19381680|P2|Days 21-30|Adverse Event|0
5610345|NCT00833482|19381681|P1|Days 21-30|Adverse Event|0
5610346|NCT00833482|19381676|P6|Days 11-20|Withdrawal by Subject|0
5610347|NCT00833482|19381677|P5|Days 11-20|Withdrawal by Subject|0
5610348|NCT00833482|19381678|P4|Days 11-20|Withdrawal by Subject|0
5610349|NCT00833482|19381679|P3|Days 11-20|Withdrawal by Subject|0
5610350|NCT00833482|19381680|P2|Days 11-20|Withdrawal by Subject|1
5610351|NCT00833482|19381681|P1|Days 11-20|Withdrawal by Subject|0
5610352|NCT00833482|19381676|P6|Days 11-20|Adverse Event|0
5610353|NCT00833482|19381677|P5|Days 11-20|Adverse Event|0
5610354|NCT00833482|19381678|P4|Days 11-20|Adverse Event|0
5610355|NCT00833482|19381679|P3|Days 11-20|Adverse Event|0
5610356|NCT00833482|19381680|P2|Days 11-20|Adverse Event|2
5610357|NCT00833482|19381681|P1|Days 11-20|Adverse Event|0
5610358|NCT00833469|19381737|P1|Overall Study|Lost to Follow-up|1
5610359|NCT00833469|19381737|P1|Overall Study|Withdrawal by Subject|1
5610360|NCT00833417|19381760|P2|Overall Study|Reason Not Specified|1
5610361|NCT00833417|19381761|P1|Overall Study|Reason Not Specified|0
5610362|NCT00833417|19381760|P2|Overall Study|Disease Progression|17
5610363|NCT00833417|19381761|P1|Overall Study|Disease Progression|18
5610364|NCT00833417|19381760|P2|Overall Study|Sponsor Decision to Terminate Study|2
5610365|NCT00833417|19381761|P1|Overall Study|Sponsor Decision to Terminate Study|1
5610366|NCT00833417|19381760|P2|Overall Study|Patient Decision to Withdraw|23
5610367|NCT00833417|19381761|P1|Overall Study|Patient Decision to Withdraw|4
5610368|NCT00833417|19381760|P2|Overall Study|Physician Decision to Withdraw Patient|7
5610369|NCT00833417|19381761|P1|Overall Study|Physician Decision to Withdraw Patient|3
5610370|NCT00833417|19381760|P2|Overall Study|Lost to Follow-up|2
5610371|NCT00833417|19381761|P1|Overall Study|Lost to Follow-up|1
5610372|NCT00833417|19381760|P2|Overall Study|Death|3
5610373|NCT00833417|19381761|P1|Overall Study|Death|1
5610374|NCT00833417|19381760|P2|Overall Study|Adverse Event|16
5610375|NCT00833417|19381761|P1|Overall Study|Adverse Event|5
5610376|NCT00833261|19381785|P1|Overall Study|Withdrawal by Subject|4
5610377|NCT00833248|19381792|P2|Overall Study|Withdrawal by Subject|1
5610378|NCT00833248|19381793|P1|Overall Study|Withdrawal by Subject|0
5610379|NCT00833248|19381792|P2|Overall Study|Protocol Violation|2
5610380|NCT00833248|19381793|P1|Overall Study|Protocol Violation|1
5610381|NCT00833248|19381792|P2|Overall Study|Adverse Event|0
5610382|NCT00833248|19381793|P1|Overall Study|Adverse Event|3
5610383|NCT00833105|19381815|P1|Overall Study|Adverse Event|2
5610384|NCT00833105|19381815|P1|Overall Study|Withdrawal by Subject|1
5610385|NCT00833092|19381833|P2|Overall Study|constipation|1
5610386|NCT00833092|19381834|P1|Overall Study|constipation|0
5610387|NCT00833092|19381833|P2|Overall Study|Diarrhea|2
5610388|NCT00833092|19381834|P1|Overall Study|Diarrhea|0
5610389|NCT00833092|19381833|P2|Overall Study|Protocol Violation|1
5610390|NCT00833092|19381834|P1|Overall Study|Protocol Violation|2
5610391|NCT00833092|19381833|P2|Overall Study|Withdrawal by Subject|3
5610392|NCT00833092|19381834|P1|Overall Study|Withdrawal by Subject|2
5610393|NCT00833053|19381842|P2|Overall Study|Protocol Violation|1
5610394|NCT00833053|19381843|P1|Overall Study|Protocol Violation|2
5610395|NCT00833053|19381842|P2|Overall Study|Withdrawal by Subject|1
5610396|NCT00833053|19381843|P1|Overall Study|Withdrawal by Subject|0
5610397|NCT00833053|19381842|P2|Overall Study|Treatment Failure|1
5610398|NCT00833053|19381843|P1|Overall Study|Treatment Failure|3
5610399|NCT00833053|19381842|P2|Overall Study|Adverse Event|0
5610400|NCT00833053|19381843|P1|Overall Study|Adverse Event|4
5610401|NCT00833040|19381861|P6|Overall Study|Adverse Event|1
5610402|NCT00833040|19381862|P5|Overall Study|Adverse Event|0
5610403|NCT00833040|19381863|P4|Overall Study|Adverse Event|0
5610404|NCT00833040|19381864|P3|Overall Study|Adverse Event|0
5610405|NCT00833040|19381865|P2|Overall Study|Adverse Event|0
5610406|NCT00833040|19381866|P1|Overall Study|Adverse Event|0
5610407|NCT00833027|19381871|P1|Overall Study|Missing|10
5610408|NCT00833027|19381871|P1|Overall Study|Withdrawal by Subject|16
5610409|NCT00833027|19381871|P1|Overall Study|Protocol Violation|115
5610410|NCT00833027|19381871|P1|Overall Study|Lost to Follow-up|24
5610411|NCT00833027|19381871|P1|Overall Study|Lack of Efficacy|12
5610412|NCT00833027|19381871|P1|Overall Study|Death|1
5610413|NCT00833027|19381871|P1|Overall Study|Adverse Event|33
5610414|NCT00832975|19381876|P1|Overall Study|Other reasons|14
5610415|NCT00832975|19381876|P1|Overall Study|Withdrawal by Subject|3
5610416|NCT00832975|19381876|P1|Overall Study|Physician Decision|4
5610417|NCT00832975|19381876|P1|Overall Study|Death|5
5610418|NCT00832975|19381876|P1|Overall Study|Protocol Violation|6
5610419|NCT00832975|19381876|P1|Overall Study|Lost to Follow-up|7
5610420|NCT00832819|19381890|P3|Overall Study|Protocol Violation|1
5610421|NCT00832819|19381891|P2|Overall Study|Protocol Violation|0
5610422|NCT00832819|19381892|P1|Overall Study|Protocol Violation|0
5610423|NCT00832819|19381890|P3|Overall Study|Adverse Event|0
5610424|NCT00832819|19381891|P2|Overall Study|Adverse Event|1
5610425|NCT00832819|19381892|P1|Overall Study|Adverse Event|0
5610426|NCT00832780|19381898|P1|Overall Study|Physician Decision|1
5610427|NCT00832780|19381898|P1|Overall Study|other complicating condition|2
5610428|NCT00832780|19381898|P1|Overall Study|no reason given|2
5610429|NCT00832780|19381898|P1|Overall Study|Lost to Follow-up|4
5610430|NCT00832780|19381898|P1|Overall Study|Death|16
5610431|NCT00832650|19381940|P3|Overall Study|Randomized but not treated|1
5610432|NCT00832650|19381941|P2|Overall Study|Randomized but not treated|0
5610433|NCT00832650|19381942|P1|Overall Study|Randomized but not treated|0
5610434|NCT00832624|19381982|P1|Overall Study|Study Terminated|10
5610435|NCT00832585|19381992|P1|Overall Study|Lost to Follow-up|1
5610436|NCT00832585|19381992|P1|Overall Study|Withdrawal by Subject|1
5610437|NCT00832455|19382017|P1|Overall Study|Patient moved|1
5610438|NCT00832455|19382017|P1|Overall Study|No improvement|3
5610439|NCT00832455|19382017|P1|Overall Study|Parent dissatisfied|1
5610440|NCT00832455|19382017|P1|Overall Study|Parent misunderstood study|1
5610441|NCT00832455|19382017|P1|Overall Study|Stopped Medication|4
5610442|NCT00832455|19382017|P1|Overall Study|Screening Failure|2
5610443|NCT00832455|19382017|P1|Overall Study|Withdrawal by Subject|17
5610444|NCT00832455|19382017|P1|Overall Study|Protocol Violation|4
5610445|NCT00832455|19382017|P1|Overall Study|Lost to Follow-up|26
5610446|NCT00832455|19382017|P1|Overall Study|Adverse Event|13
5610447|NCT00832416|19382041|P4|Overall Study|Death|0
5610448|NCT00832416|19382042|P3|Overall Study|Death|0
5610449|NCT00832416|19382043|P2|Overall Study|Death|0
5610450|NCT00832416|19382044|P1|Overall Study|Death|1
5610451|NCT00832416|19382041|P4|Overall Study|Adverse Event|10
5610452|NCT00832416|19382042|P3|Overall Study|Adverse Event|41
5610453|NCT00832416|19382043|P2|Overall Study|Adverse Event|19
5610454|NCT00832416|19382044|P1|Overall Study|Adverse Event|21
5610455|NCT00832416|19382041|P4|Overall Study|Administrative|1
5610456|NCT00832416|19382042|P3|Overall Study|Administrative|0
5610457|NCT00832416|19382043|P2|Overall Study|Administrative|0
5610458|NCT00832416|19382044|P1|Overall Study|Administrative|0
5610459|NCT00832416|19382041|P4|Overall Study|Physician Decision|10
5610460|NCT00832416|19382042|P3|Overall Study|Physician Decision|5
5610461|NCT00832416|19382043|P2|Overall Study|Physician Decision|12
5610462|NCT00832416|19382044|P1|Overall Study|Physician Decision|2
5610463|NCT00832416|19382041|P4|Overall Study|Withdrawal by Subject|10
5610464|NCT00832416|19382042|P3|Overall Study|Withdrawal by Subject|2
5610465|NCT00832416|19382043|P2|Overall Study|Withdrawal by Subject|7
5610466|NCT00832416|19382044|P1|Overall Study|Withdrawal by Subject|5
5610467|NCT00832416|19382041|P4|Overall Study|Lack of Efficacy|52
5610468|NCT00832416|19382042|P3|Overall Study|Lack of Efficacy|13
5610469|NCT00832416|19382043|P2|Overall Study|Lack of Efficacy|15
5610470|NCT00832416|19382044|P1|Overall Study|Lack of Efficacy|17
5610471|NCT00832377|19382095|P1|Overall Study|Protocol Violation|1
5610472|NCT00832117|19382141|P1|Overall Study|Disease Progression|11
5610473|NCT00832117|19382141|P1|Overall Study|Death|1
5610474|NCT00832091|19382160|P2|Overall Study|Prohibited Medication|0
5610475|NCT00832091|19382161|P1|Overall Study|Prohibited Medication|1
5610476|NCT00832091|19382160|P2|Overall Study|Withdrawal by Subject|1
5610477|NCT00832091|19382161|P1|Overall Study|Withdrawal by Subject|2
5610478|NCT00832091|19382160|P2|Overall Study|Protocol Violation|0
5610479|NCT00832091|19382161|P1|Overall Study|Protocol Violation|1
5610480|NCT00832091|19382160|P2|Overall Study|Adverse Event|1
5610481|NCT00832091|19382161|P1|Overall Study|Adverse Event|1
5610482|NCT00832078|19382169|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
5610483|NCT00832078|19382170|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
5610484|NCT00832078|19382169|P2|Test Day 1-2 Period|Lack of Efficacy|2
5610485|NCT00832078|19382170|P1|Test Day 1-2 Period|Lack of Efficacy|0
5610486|NCT00832000|19382176|P2|Overall Study|No calls to IVR in period 2|0
5610487|NCT00832000|19382177|P1|Overall Study|No calls to IVR in period 2|2
5610488|NCT00832000|19382176|P2|Overall Study|No calls to IVR in either period|1
5610489|NCT00832000|19382177|P1|Overall Study|No calls to IVR in either period|1
5610490|NCT00832000|19382176|P2|Overall Study|Withdrawal by Subject|0
5610491|NCT00832000|19382177|P1|Overall Study|Withdrawal by Subject|1
5610492|NCT00832000|19382176|P2|Overall Study|Adverse Event|0
5610493|NCT00832000|19382177|P1|Overall Study|Adverse Event|2
5610494|NCT00831844|19382238|P10|Overall Study|Ineligible|0
5610495|NCT00831844|19382239|P9|Overall Study|Ineligible|0
5610496|NCT00831844|19382240|P8|Overall Study|Ineligible|0
5610497|NCT00831844|19382241|P7|Overall Study|Ineligible|0
5610498|NCT00831844|19382242|P6|Overall Study|Ineligible|0
5610499|NCT00831844|19382243|P5|Overall Study|Ineligible|1
5610500|NCT00831844|19382244|P4|Overall Study|Ineligible|0
5610501|NCT00831844|19382245|P3|Overall Study|Ineligible|1
5610502|NCT00831844|19382246|P2|Overall Study|Ineligible|1
5610503|NCT00831844|19382247|P1|Overall Study|Ineligible|0
5610504|NCT00831844|19382238|P10|Overall Study|Withdrawal by Subject|0
5610505|NCT00831844|19382239|P9|Overall Study|Withdrawal by Subject|1
5610506|NCT00831844|19382240|P8|Overall Study|Withdrawal by Subject|1
5610507|NCT00831844|19382241|P7|Overall Study|Withdrawal by Subject|0
5610508|NCT00831844|19382242|P6|Overall Study|Withdrawal by Subject|0
5610509|NCT00831844|19382243|P5|Overall Study|Withdrawal by Subject|0
5610510|NCT00831844|19382244|P4|Overall Study|Withdrawal by Subject|0
5610511|NCT00831844|19382245|P3|Overall Study|Withdrawal by Subject|1
5610512|NCT00831844|19382246|P2|Overall Study|Withdrawal by Subject|0
5610513|NCT00831844|19382247|P1|Overall Study|Withdrawal by Subject|0
5610514|NCT00831844|19382238|P10|Overall Study|Physician Decision|0
5610515|NCT00831844|19382239|P9|Overall Study|Physician Decision|1
5610516|NCT00831844|19382240|P8|Overall Study|Physician Decision|0
5610517|NCT00831844|19382241|P7|Overall Study|Physician Decision|0
5610518|NCT00831844|19382242|P6|Overall Study|Physician Decision|1
5610519|NCT00831844|19382243|P5|Overall Study|Physician Decision|1
5610520|NCT00831844|19382244|P4|Overall Study|Physician Decision|1
5610521|NCT00831844|19382245|P3|Overall Study|Physician Decision|3
5610522|NCT00831844|19382246|P2|Overall Study|Physician Decision|1
5610523|NCT00831844|19382247|P1|Overall Study|Physician Decision|0
5610524|NCT00831844|19382238|P10|Overall Study|Lack of Efficacy|0
5610525|NCT00831844|19382239|P9|Overall Study|Lack of Efficacy|7
5610526|NCT00831844|19382240|P8|Overall Study|Lack of Efficacy|9
5610527|NCT00831844|19382241|P7|Overall Study|Lack of Efficacy|8
5610528|NCT00831844|19382242|P6|Overall Study|Lack of Efficacy|17
5610529|NCT00831844|19382243|P5|Overall Study|Lack of Efficacy|11
5610530|NCT00831844|19382244|P4|Overall Study|Lack of Efficacy|8
5610531|NCT00831844|19382245|P3|Overall Study|Lack of Efficacy|15
5610532|NCT00831844|19382246|P2|Overall Study|Lack of Efficacy|10
5610533|NCT00831844|19382247|P1|Overall Study|Lack of Efficacy|8
5610534|NCT00831844|19382238|P10|Overall Study|Death|0
5610535|NCT00831844|19382239|P9|Overall Study|Death|0
5610536|NCT00831844|19382240|P8|Overall Study|Death|0
5610537|NCT00831844|19382241|P7|Overall Study|Death|0
5610538|NCT00831844|19382242|P6|Overall Study|Death|0
5610539|NCT00831844|19382243|P5|Overall Study|Death|0
5610540|NCT00831844|19382244|P4|Overall Study|Death|1
5610541|NCT00831844|19382245|P3|Overall Study|Death|0
5610542|NCT00831844|19382246|P2|Overall Study|Death|0
5610543|NCT00831844|19382247|P1|Overall Study|Death|0
5610544|NCT00831844|19382238|P10|Overall Study|Adverse Event|0
5610545|NCT00831844|19382239|P9|Overall Study|Adverse Event|0
5610546|NCT00831844|19382240|P8|Overall Study|Adverse Event|0
5610547|NCT00831844|19382241|P7|Overall Study|Adverse Event|2
5610548|NCT00831844|19382242|P6|Overall Study|Adverse Event|1
5610549|NCT00831844|19382243|P5|Overall Study|Adverse Event|1
5610550|NCT00831844|19382244|P4|Overall Study|Adverse Event|0
5610551|NCT00831844|19382245|P3|Overall Study|Adverse Event|0
5610552|NCT00831844|19382246|P2|Overall Study|Adverse Event|0
5610553|NCT00831844|19382247|P1|Overall Study|Adverse Event|2
5610554|NCT00831792|19382269|P1|Overall Study|Lack of Efficacy|1
5610555|NCT00831792|19382269|P1|Overall Study|Death|1
5610556|NCT00831792|19382269|P1|Overall Study|Adverse Event|1
5610557|NCT00831792|19382269|P1|Overall Study|Not Eligible|3
5610558|NCT00831779|19382275|P2|Overall Study|No longer met criteria|1
5610559|NCT00831779|19382276|P1|Overall Study|No longer met criteria|0
5610560|NCT00831779|19382275|P2|Overall Study|Lost to Follow-up|0
5610561|NCT00831779|19382276|P1|Overall Study|Lost to Follow-up|1
5610562|NCT00831701|19382313|P2|Overall Study|Lost to Follow-up|3
5610563|NCT00831701|19382314|P1|Overall Study|Lost to Follow-up|1
5610564|NCT00831701|19382313|P2|Overall Study|Stone expulsion before first medication|2
5610565|NCT00831701|19382314|P1|Overall Study|Stone expulsion before first medication|2
5610566|NCT00831701|19382313|P2|Overall Study|Withdrawal by Subject|0
5610567|NCT00831701|19382314|P1|Overall Study|Withdrawal by Subject|2
5610568|NCT00831493|19382343|P1|Overall Study|Intractable nausea and vomiting|1
5610569|NCT00831441|19382353|P2|Follow Up (30 Days)|missing end of study status|1
5610570|NCT00831441|19382354|P1|Follow Up (30 Days)|missing end of study status|0
5610571|NCT00831441|19382353|P2|Follow Up (30 Days)|non-specified|26
5610572|NCT00831441|19382354|P1|Follow Up (30 Days)|non-specified|16
5610573|NCT00831441|19382353|P2|Follow Up (30 Days)|Death|86
5610574|NCT00831441|19382354|P1|Follow Up (30 Days)|Death|63
5610575|NCT00831441|19382353|P2|Follow Up (30 Days)|Lost to Follow-up|27
5610576|NCT00831441|19382354|P1|Follow Up (30 Days)|Lost to Follow-up|13
5610577|NCT00831441|19382353|P2|Follow Up (30 Days)|Withdrawal by Subject|34
5610578|NCT00831441|19382354|P1|Follow Up (30 Days)|Withdrawal by Subject|41
5610579|NCT00831441|19382353|P2|Randomized|non-specified|266
5610580|NCT00831441|19382354|P1|Randomized|non-specified|276
5610581|NCT00831441|19382353|P2|Randomized|poor/non-compliance|38
5610582|NCT00831441|19382354|P1|Randomized|poor/non-compliance|30
5610583|NCT00831441|19382353|P2|Randomized|Administrative reason by sponsor|2671
5610584|NCT00831441|19382354|P1|Randomized|Administrative reason by sponsor|2780
5610585|NCT00831441|19382353|P2|Randomized|Lost to Follow-up|35
5610586|NCT00831441|19382354|P1|Randomized|Lost to Follow-up|26
5610587|NCT00831441|19382353|P2|Randomized|Withdrawal by Subject|212
5610588|NCT00831441|19382354|P1|Randomized|Withdrawal by Subject|178
5610589|NCT00831441|19382353|P2|Randomized|No longer met criteria|19
5610590|NCT00831441|19382354|P1|Randomized|No longer met criteria|13
5610591|NCT00831441|19382353|P2|Randomized|Physician Decision|35
5610592|NCT00831441|19382354|P1|Randomized|Physician Decision|26
5610593|NCT00831441|19382353|P2|Randomized|Elective procedure|25
5610594|NCT00831441|19382354|P1|Randomized|Elective procedure|26
5610595|NCT00831441|19382353|P2|Randomized|Emergency procedure|2
5610596|NCT00831441|19382354|P1|Randomized|Emergency procedure|2
5610597|NCT00831441|19382353|P2|Randomized|Adverse Event|321
5610598|NCT00831441|19382354|P1|Randomized|Adverse Event|248
5610599|NCT00831441|19382353|P2|Randomized|Death|81
5610600|NCT00831441|19382354|P1|Randomized|Death|82
5610601|NCT00831415|19382386|P1|Overall Study|Death|1
5610602|NCT00831415|19382386|P1|Overall Study|Unsatisfactory response - Efficacy|4
5610603|NCT00831415|19382386|P1|Overall Study|Withdrawal by Subject|35
5610604|NCT00831415|19382386|P1|Overall Study|Protocol Violation|3
5610605|NCT00831415|19382386|P1|Overall Study|Lost to Follow-up|9
5610606|NCT00831415|19382386|P1|Overall Study|Physician Decision|6
5610607|NCT00831415|19382386|P1|Overall Study|Failed to return|3
5610608|NCT00831415|19382386|P1|Overall Study|Adverse Event|14
5610609|NCT00831389|19382395|P2|Overall Study|Withdrawal by Subject|1
5610610|NCT00831389|19382396|P1|Overall Study|Withdrawal by Subject|0
5610611|NCT00831311|19382422|P2|Overall Study|Withdrawal by Subject|4
5610612|NCT00831311|19382423|P1|Overall Study|Withdrawal by Subject|6
5610613|NCT00831311|19382422|P2|Overall Study|Physician Decision|1
5610614|NCT00831311|19382423|P1|Overall Study|Physician Decision|0
5610615|NCT00831311|19382422|P2|Overall Study|Lost to Follow-up|0
5610616|NCT00831311|19382423|P1|Overall Study|Lost to Follow-up|3
5610617|NCT00831311|19382422|P2|Overall Study|Definitive Contraindication|3
5610618|NCT00831311|19382423|P1|Overall Study|Definitive Contraindication|3
5610619|NCT00831233|19382460|P2|Overall Study|Selection Criteria Not Met|0
5610620|NCT00831233|19382461|P1|Overall Study|Selection Criteria Not Met|2
5610621|NCT00831233|19382460|P2|Overall Study|Protocol Violation|0
5610622|NCT00831233|19382461|P1|Overall Study|Protocol Violation|1
5610623|NCT00831233|19382460|P2|Overall Study|Adverse Event|1
5610624|NCT00831233|19382461|P1|Overall Study|Adverse Event|0
5610625|NCT00831181|19382485|P1|Overall Study|Adverse Event|12
5610626|NCT00831129|19382498|P2|Overall Study|9 lost to follow-up reasons uknown|9
5610627|NCT00831129|19382499|P1|Overall Study|9 lost to follow-up reasons uknown|0
5610628|NCT00831129|19382498|P2|Overall Study|Adverse Event|1
5610629|NCT00831129|19382499|P1|Overall Study|Adverse Event|0
5610630|NCT00830960|19382541|P6|Overall Study|No study drug received|7
5610631|NCT00830960|19382542|P5|Overall Study|No study drug received|5
5610632|NCT00830960|19382543|P4|Overall Study|No study drug received|3
5610633|NCT00830960|19382544|P3|Overall Study|No study drug received|4
5610634|NCT00830960|19382545|P2|Overall Study|No study drug received|2
5610635|NCT00830960|19382546|P1|Overall Study|No study drug received|7
5610636|NCT00830960|19382541|P6|Overall Study|Sponsor Decision|7
5610637|NCT00830960|19382542|P5|Overall Study|Sponsor Decision|5
5610638|NCT00830960|19382543|P4|Overall Study|Sponsor Decision|4
5610639|NCT00830960|19382544|P3|Overall Study|Sponsor Decision|3
5610640|NCT00830960|19382545|P2|Overall Study|Sponsor Decision|2
5610641|NCT00830960|19382546|P1|Overall Study|Sponsor Decision|1
5610642|NCT00830960|19382541|P6|Overall Study|Withdrawal by Subject|21
5610643|NCT00830960|19382542|P5|Overall Study|Withdrawal by Subject|16
5610644|NCT00830960|19382543|P4|Overall Study|Withdrawal by Subject|23
5610645|NCT00830960|19382544|P3|Overall Study|Withdrawal by Subject|18
5610646|NCT00830960|19382545|P2|Overall Study|Withdrawal by Subject|19
5610647|NCT00830960|19382546|P1|Overall Study|Withdrawal by Subject|19
5610648|NCT00830960|19382541|P6|Overall Study|Lost to Follow-up|1
5610649|NCT00830960|19382542|P5|Overall Study|Lost to Follow-up|0
5610650|NCT00830960|19382543|P4|Overall Study|Lost to Follow-up|0
5610651|NCT00830960|19382544|P3|Overall Study|Lost to Follow-up|1
5610652|NCT00830960|19382545|P2|Overall Study|Lost to Follow-up|1
5610653|NCT00830960|19382546|P1|Overall Study|Lost to Follow-up|1
5610654|NCT00830960|19382541|P6|Overall Study|Death|1
5610655|NCT00830960|19382542|P5|Overall Study|Death|6
5610656|NCT00830960|19382543|P4|Overall Study|Death|2
5610657|NCT00830960|19382544|P3|Overall Study|Death|3
5610658|NCT00830960|19382545|P2|Overall Study|Death|4
5610659|NCT00830960|19382546|P1|Overall Study|Death|5
5610660|NCT00830947|19382662|P2|Overall Study|Lost to Follow-up|4
5610661|NCT00830947|19382663|P1|Overall Study|Lost to Follow-up|4
5610662|NCT00830869|19382681|P12|Period 2: Part 2|Other|0
5610663|NCT00830869|19382682|P11|Period 2: Part 2|Other|0
5610664|NCT00830869|19382683|P10|Period 2: Part 2|Other|1
5610665|NCT00830869|19382684|P9|Period 2: Part 2|Other|0
5610666|NCT00830869|19382685|P8|Period 2: Part 2|Other|0
5610667|NCT00830869|19382686|P7|Period 2: Part 2|Other|0
5610668|NCT00830869|19382687|P6|Period 2: Part 2|Other|0
5610669|NCT00830869|19382688|P5|Period 2: Part 2|Other|0
5610670|NCT00830869|19382689|P4|Period 2: Part 2|Other|0
5610671|NCT00830869|19382690|P3|Period 2: Part 2|Other|0
5610672|NCT00830869|19382691|P2|Period 2: Part 2|Other|0
5610673|NCT00830869|19382692|P1|Period 2: Part 2|Other|0
5610674|NCT00830869|19382681|P12|Period 2: Part 2|Progressive disease|15
5610675|NCT00830869|19382682|P11|Period 2: Part 2|Progressive disease|8
5610676|NCT00830869|19382683|P10|Period 2: Part 2|Progressive disease|12
5610677|NCT00830869|19382684|P9|Period 2: Part 2|Progressive disease|11
5610678|NCT00830869|19382685|P8|Period 2: Part 2|Progressive disease|14
5610679|NCT00830869|19382686|P7|Period 2: Part 2|Progressive disease|0
5610680|NCT00830869|19382687|P6|Period 2: Part 2|Progressive disease|0
5610681|NCT00830869|19382688|P5|Period 2: Part 2|Progressive disease|0
5610682|NCT00830869|19382689|P4|Period 2: Part 2|Progressive disease|0
5610683|NCT00830869|19382690|P3|Period 2: Part 2|Progressive disease|0
5610684|NCT00830869|19382691|P2|Period 2: Part 2|Progressive disease|0
5610685|NCT00830869|19382692|P1|Period 2: Part 2|Progressive disease|0
5610686|NCT00830869|19382681|P12|Period 2: Part 2|Symptomatic Deterioration|4
5610687|NCT00830869|19382682|P11|Period 2: Part 2|Symptomatic Deterioration|1
5610688|NCT00830869|19382683|P10|Period 2: Part 2|Symptomatic Deterioration|3
5610689|NCT00830869|19382684|P9|Period 2: Part 2|Symptomatic Deterioration|6
5610690|NCT00830869|19382685|P8|Period 2: Part 2|Symptomatic Deterioration|0
5610691|NCT00830869|19382686|P7|Period 2: Part 2|Symptomatic Deterioration|0
5610692|NCT00830869|19382687|P6|Period 2: Part 2|Symptomatic Deterioration|0
5610693|NCT00830869|19382688|P5|Period 2: Part 2|Symptomatic Deterioration|0
5610694|NCT00830869|19382689|P4|Period 2: Part 2|Symptomatic Deterioration|0
5610695|NCT00830869|19382690|P3|Period 2: Part 2|Symptomatic Deterioration|0
5610696|NCT00830869|19382691|P2|Period 2: Part 2|Symptomatic Deterioration|0
5610697|NCT00830869|19382692|P1|Period 2: Part 2|Symptomatic Deterioration|0
5610698|NCT00830869|19382681|P12|Period 2: Part 2|Adverse Event|0
5610699|NCT00830869|19382682|P11|Period 2: Part 2|Adverse Event|2
5610700|NCT00830869|19382683|P10|Period 2: Part 2|Adverse Event|2
5610701|NCT00830869|19382684|P9|Period 2: Part 2|Adverse Event|3
5610702|NCT00830869|19382685|P8|Period 2: Part 2|Adverse Event|4
5610703|NCT00830869|19382686|P7|Period 2: Part 2|Adverse Event|0
5610704|NCT00830869|19382687|P6|Period 2: Part 2|Adverse Event|0
5610705|NCT00830869|19382688|P5|Period 2: Part 2|Adverse Event|0
5610706|NCT00830869|19382689|P4|Period 2: Part 2|Adverse Event|0
5610707|NCT00830869|19382690|P3|Period 2: Part 2|Adverse Event|0
5610708|NCT00830869|19382691|P2|Period 2: Part 2|Adverse Event|0
5610709|NCT00830869|19382692|P1|Period 2: Part 2|Adverse Event|0
5610710|NCT00830869|19382681|P12|Period 2: Part 2|Withdrawal by Subject|1
5610711|NCT00830869|19382682|P11|Period 2: Part 2|Withdrawal by Subject|0
5610712|NCT00830869|19382683|P10|Period 2: Part 2|Withdrawal by Subject|1
5610713|NCT00830869|19382684|P9|Period 2: Part 2|Withdrawal by Subject|2
5610714|NCT00830869|19382685|P8|Period 2: Part 2|Withdrawal by Subject|1
5610715|NCT00830869|19382686|P7|Period 2: Part 2|Withdrawal by Subject|0
5610716|NCT00830869|19382687|P6|Period 2: Part 2|Withdrawal by Subject|0
5610717|NCT00830869|19382688|P5|Period 2: Part 2|Withdrawal by Subject|0
5610718|NCT00830869|19382689|P4|Period 2: Part 2|Withdrawal by Subject|0
5610719|NCT00830869|19382690|P3|Period 2: Part 2|Withdrawal by Subject|0
5610720|NCT00830869|19382691|P2|Period 2: Part 2|Withdrawal by Subject|0
5610721|NCT00830869|19382692|P1|Period 2: Part 2|Withdrawal by Subject|0
5610722|NCT00830869|19382681|P12|Period 2: Part 2|Protocol Violation|0
5610723|NCT00830869|19382682|P11|Period 2: Part 2|Protocol Violation|0
5610724|NCT00830869|19382683|P10|Period 2: Part 2|Protocol Violation|1
5610725|NCT00830869|19382684|P9|Period 2: Part 2|Protocol Violation|0
5610726|NCT00830869|19382685|P8|Period 2: Part 2|Protocol Violation|1
5610727|NCT00830869|19382686|P7|Period 2: Part 2|Protocol Violation|0
5610728|NCT00830869|19382687|P6|Period 2: Part 2|Protocol Violation|0
5610729|NCT00830869|19382688|P5|Period 2: Part 2|Protocol Violation|0
5610730|NCT00830869|19382689|P4|Period 2: Part 2|Protocol Violation|0
5610731|NCT00830869|19382690|P3|Period 2: Part 2|Protocol Violation|0
5610732|NCT00830869|19382691|P2|Period 2: Part 2|Protocol Violation|0
5610733|NCT00830869|19382692|P1|Period 2: Part 2|Protocol Violation|0
5610734|NCT00830869|19382681|P12|Period 1: Part 1|Progressive disease|0
5610735|NCT00830869|19382682|P11|Period 1: Part 1|Progressive disease|0
5610736|NCT00830869|19382683|P10|Period 1: Part 1|Progressive disease|0
5610737|NCT00830869|19382684|P9|Period 1: Part 1|Progressive disease|0
5610738|NCT00830869|19382685|P8|Period 1: Part 1|Progressive disease|0
5610739|NCT00830869|19382686|P7|Period 1: Part 1|Progressive disease|1
5610740|NCT00830869|19382687|P6|Period 1: Part 1|Progressive disease|4
5610741|NCT00830869|19382688|P5|Period 1: Part 1|Progressive disease|4
5610742|NCT00830869|19382689|P4|Period 1: Part 1|Progressive disease|6
5610743|NCT00830869|19382690|P3|Period 1: Part 1|Progressive disease|1
5610744|NCT00830869|19382691|P2|Period 1: Part 1|Progressive disease|0
5610745|NCT00830869|19382692|P1|Period 1: Part 1|Progressive disease|1
5610746|NCT00830869|19382681|P12|Period 1: Part 1|Adverse Event|0
5610747|NCT00830869|19382682|P11|Period 1: Part 1|Adverse Event|0
5610748|NCT00830869|19382683|P10|Period 1: Part 1|Adverse Event|0
5610749|NCT00830869|19382684|P9|Period 1: Part 1|Adverse Event|0
5610750|NCT00830869|19382685|P8|Period 1: Part 1|Adverse Event|0
5610751|NCT00830869|19382686|P7|Period 1: Part 1|Adverse Event|1
5610752|NCT00830869|19382687|P6|Period 1: Part 1|Adverse Event|1
5610753|NCT00830869|19382688|P5|Period 1: Part 1|Adverse Event|0
5610754|NCT00830869|19382689|P4|Period 1: Part 1|Adverse Event|0
5610755|NCT00830869|19382690|P3|Period 1: Part 1|Adverse Event|0
5610756|NCT00830869|19382691|P2|Period 1: Part 1|Adverse Event|0
5610757|NCT00830869|19382692|P1|Period 1: Part 1|Adverse Event|0
5610758|NCT00830869|19382681|P12|Period 1: Part 1|Withdrawal by Subject|0
5610759|NCT00830869|19382682|P11|Period 1: Part 1|Withdrawal by Subject|0
5610760|NCT00830869|19382683|P10|Period 1: Part 1|Withdrawal by Subject|0
5610761|NCT00830869|19382684|P9|Period 1: Part 1|Withdrawal by Subject|0
5610762|NCT00830869|19382685|P8|Period 1: Part 1|Withdrawal by Subject|0
5610763|NCT00830869|19382686|P7|Period 1: Part 1|Withdrawal by Subject|0
5610764|NCT00830869|19382687|P6|Period 1: Part 1|Withdrawal by Subject|0
5610765|NCT00830869|19382688|P5|Period 1: Part 1|Withdrawal by Subject|0
5610766|NCT00830869|19382689|P4|Period 1: Part 1|Withdrawal by Subject|0
5610767|NCT00830869|19382690|P3|Period 1: Part 1|Withdrawal by Subject|0
5610768|NCT00830869|19382691|P2|Period 1: Part 1|Withdrawal by Subject|1
5610769|NCT00830869|19382692|P1|Period 1: Part 1|Withdrawal by Subject|0
5610770|NCT00830869|19382681|P12|Period 1: Part 1|Symptomatic deterioration|0
5610771|NCT00830869|19382682|P11|Period 1: Part 1|Symptomatic deterioration|0
5610772|NCT00830869|19382683|P10|Period 1: Part 1|Symptomatic deterioration|0
5610773|NCT00830869|19382684|P9|Period 1: Part 1|Symptomatic deterioration|0
5610774|NCT00830869|19382685|P8|Period 1: Part 1|Symptomatic deterioration|0
5610775|NCT00830869|19382686|P7|Period 1: Part 1|Symptomatic deterioration|1
5610776|NCT00830869|19382687|P6|Period 1: Part 1|Symptomatic deterioration|1
5610777|NCT00830869|19382688|P5|Period 1: Part 1|Symptomatic deterioration|0
5610778|NCT00830869|19382689|P4|Period 1: Part 1|Symptomatic deterioration|1
5610779|NCT00830869|19382690|P3|Period 1: Part 1|Symptomatic deterioration|0
5610780|NCT00830869|19382691|P2|Period 1: Part 1|Symptomatic deterioration|0
5610781|NCT00830869|19382692|P1|Period 1: Part 1|Symptomatic deterioration|0
5610782|NCT00830804|19382828|P1|Overall Study|Unwilling to adhere to study requirement|1
5610783|NCT00830804|19382828|P1|Overall Study|Consent withdrawn|2
5610784|NCT00830804|19382828|P1|Overall Study|Unable to get to clinic|7
5610785|NCT00830804|19382828|P1|Overall Study|Death|1
5610786|NCT00830804|19382828|P1|Overall Study|Lost to Follow-up|4
5610787|NCT00830765|19382908|P2|Overall Study|Protocol Violation|2
5610788|NCT00830765|19382909|P1|Overall Study|Protocol Violation|3
5610789|NCT00830518|19382942|P2|Overall Study|Reason not Specified|1
5610790|NCT00830518|19382943|P1|Overall Study|Reason not Specified|8
5610791|NCT00830518|19382942|P2|Overall Study|Withdrawal by Patient|0
5610792|NCT00830518|19382943|P1|Overall Study|Withdrawal by Patient|2
5610793|NCT00830518|19382942|P2|Overall Study|Adverse Event|1
5610794|NCT00830518|19382943|P1|Overall Study|Adverse Event|14
5610795|NCT00830518|19382942|P2|Overall Study|Symptomatic Deterioration|1
5610796|NCT00830518|19382943|P1|Overall Study|Symptomatic Deterioration|4
5610797|NCT00830518|19382942|P2|Overall Study|Progressive Disease|8
5610798|NCT00830518|19382943|P1|Overall Study|Progressive Disease|18
5610799|NCT00830440|19382962|P2|Overall Study|Adverse Event|0
5610800|NCT00830440|19382963|P1|Overall Study|Adverse Event|2
5610801|NCT00830440|19382962|P2|Overall Study|unsuccessful procedure|0
5610802|NCT00830440|19382963|P1|Overall Study|unsuccessful procedure|4
5610803|NCT00830440|19382962|P2|Overall Study|Withdrawal by Subject|0
5610804|NCT00830440|19382963|P1|Overall Study|Withdrawal by Subject|1
5610805|NCT00830440|19382962|P2|Overall Study|Protocol Violation|0
5610806|NCT00830440|19382963|P1|Overall Study|Protocol Violation|1
5610807|NCT00830375|19382978|P1|Overall Study|Lost to Follow-up|1
5610808|NCT00830336|19382993|P2|Washout: 21 Days|Withdrawal by Subject|0
5610809|NCT00830336|19382994|P1|Washout: 21 Days|Withdrawal by Subject|1
5610810|NCT00830258|19383021|P2|Washout: 7 Days|Protocol Violation|0
5610811|NCT00830258|19383022|P1|Washout: 7 Days|Protocol Violation|1
5610812|NCT00830258|19383021|P2|First Intervention|Adverse Event|0
5610813|NCT00830258|19383022|P1|First Intervention|Adverse Event|1
5610814|NCT00830219|19383041|P2|Washout of 7 Days|Withdrawal by Subject|1
5610815|NCT00830219|19383042|P1|Washout of 7 Days|Withdrawal by Subject|1
5610816|NCT00830206|19383052|P2|Washout: 21 Days|Withdrawal by Subject|1
5610817|NCT00830206|19383053|P1|Washout: 21 Days|Withdrawal by Subject|1
5610818|NCT00830167|19383063|P2|Overall Study|Other|2
5610819|NCT00830167|19383064|P1|Overall Study|Other|2
5610820|NCT00830167|19383063|P2|Overall Study|Protocol Violation|1
5610821|NCT00830167|19383064|P1|Overall Study|Protocol Violation|0
5610822|NCT00830167|19383063|P2|Overall Study|Lost to Follow-up|1
5610823|NCT00830167|19383064|P1|Overall Study|Lost to Follow-up|0
5610824|NCT00830167|19383063|P2|Overall Study|Withdrawal by Subject|0
5610825|NCT00830167|19383064|P1|Overall Study|Withdrawal by Subject|2
5610826|NCT00830167|19383063|P2|Overall Study|Not meeting entrance criteria|5
5610827|NCT00830167|19383064|P1|Overall Study|Not meeting entrance criteria|2
5610828|NCT00830167|19383063|P2|Overall Study|Adverse Event|24
5610829|NCT00830167|19383064|P1|Overall Study|Adverse Event|8
5610830|NCT00830167|19383063|P2|Overall Study|Lack of Efficacy|10
5610831|NCT00830167|19383064|P1|Overall Study|Lack of Efficacy|26
5610832|NCT00830128|19383134|P1|Overall Study|Operating a vehicle|1
5610833|NCT00830128|19383134|P1|Overall Study|Work obligation|1
5610834|NCT00830128|19383134|P1|Overall Study|Relocation|1
5610835|NCT00830128|19383134|P1|Overall Study|Family obligation|1
5610836|NCT00830128|19383134|P1|Overall Study|Withdrawal by Subject|2
5610837|NCT00830128|19383134|P1|Overall Study|Protocol Violation|1
5610838|NCT00830128|19383134|P1|Overall Study|Lack of Efficacy|7
5610839|NCT00830128|19383134|P1|Overall Study|Adverse Event|5
5610840|NCT00830115|19383149|P1|Overall Study|Improvement/recovery|1
5610841|NCT00830115|19383149|P1|Overall Study|Adverse Event|2
5610842|NCT00830037|19383176|P2|Overall Study|Active when terminated by DSMB|14
5610843|NCT00830037|19383177|P1|Overall Study|Active when terminated by DSMB|15
5610844|NCT00830037|19383176|P2|Overall Study|Lost to Follow-up|2
5610845|NCT00830037|19383177|P1|Overall Study|Lost to Follow-up|1
5610846|NCT00830037|19383176|P2|Overall Study|Withdrawal by Subject|3
5610847|NCT00830037|19383177|P1|Overall Study|Withdrawal by Subject|2
5610848|NCT00830024|19383187|P2|Washout: 7 Days|Withdrawal by Subject|0
5610849|NCT00830024|19383188|P1|Washout: 7 Days|Withdrawal by Subject|1
5610850|NCT00829998|19383198|P2|Washout|Adverse Event|1
5610851|NCT00829998|19383199|P1|Washout|Adverse Event|0
5610852|NCT00829933|19383228|P4|Overall Study|withdrew before treatment started|9
5610853|NCT00829933|19383229|P3|Overall Study|withdrew before treatment started|2
5610854|NCT00829933|19383230|P2|Overall Study|withdrew before treatment started|1
5610855|NCT00829933|19383231|P1|Overall Study|withdrew before treatment started|5
5610856|NCT00829933|19383228|P4|Overall Study|Protocol Violation|0
5610857|NCT00829933|19383229|P3|Overall Study|Protocol Violation|0
5610858|NCT00829933|19383230|P2|Overall Study|Protocol Violation|1
5610859|NCT00829933|19383231|P1|Overall Study|Protocol Violation|2
5610860|NCT00829933|19383228|P4|Overall Study|Pregnancy|2
5610861|NCT00829933|19383229|P3|Overall Study|Pregnancy|0
5610862|NCT00829933|19383230|P2|Overall Study|Pregnancy|0
5610863|NCT00829933|19383231|P1|Overall Study|Pregnancy|0
5610864|NCT00829933|19383228|P4|Overall Study|Physician Decision|1
5610865|NCT00829933|19383229|P3|Overall Study|Physician Decision|8
5610866|NCT00829933|19383230|P2|Overall Study|Physician Decision|7
5610867|NCT00829933|19383231|P1|Overall Study|Physician Decision|5
5610868|NCT00829933|19383228|P4|Overall Study|Lack of Efficacy|0
5610869|NCT00829933|19383229|P3|Overall Study|Lack of Efficacy|0
5610870|NCT00829933|19383230|P2|Overall Study|Lack of Efficacy|1
5610871|NCT00829933|19383231|P1|Overall Study|Lack of Efficacy|0
5610872|NCT00829933|19383228|P4|Overall Study|Death|1
5610873|NCT00829933|19383229|P3|Overall Study|Death|1
5610874|NCT00829933|19383230|P2|Overall Study|Death|0
5610875|NCT00829933|19383231|P1|Overall Study|Death|0
5610876|NCT00829933|19383228|P4|Overall Study|Adverse Event|1
5610877|NCT00829933|19383229|P3|Overall Study|Adverse Event|2
5610878|NCT00829933|19383230|P2|Overall Study|Adverse Event|3
5610879|NCT00829933|19383231|P1|Overall Study|Adverse Event|2
5610880|NCT00829868|19383243|P2|Washout|Physician Decision|0
5610881|NCT00829868|19383244|P1|Washout|Physician Decision|1
5610882|NCT00829829|19383255|P3|Overall Study|Other than specified above|1
5610883|NCT00829829|19383256|P2|Overall Study|Other than specified above|2
5610884|NCT00829829|19383257|P1|Overall Study|Other than specified above|2
5610885|NCT00829829|19383255|P3|Overall Study|Lost to Follow-up|3
5610886|NCT00829829|19383256|P2|Overall Study|Lost to Follow-up|3
5610887|NCT00829829|19383257|P1|Overall Study|Lost to Follow-up|7
5610888|NCT00829829|19383255|P3|Overall Study|Decision by the Sponsor|2
5610889|NCT00829829|19383256|P2|Overall Study|Decision by the Sponsor|0
5610890|NCT00829829|19383257|P1|Overall Study|Decision by the Sponsor|1
5610891|NCT00829829|19383255|P3|Overall Study|Withdrawal by Subject|2
5610892|NCT00829829|19383256|P2|Overall Study|Withdrawal by Subject|4
5610893|NCT00829829|19383257|P1|Overall Study|Withdrawal by Subject|8
5610894|NCT00829829|19383255|P3|Overall Study|Adverse Event|3
5610895|NCT00829829|19383256|P2|Overall Study|Adverse Event|4
5610896|NCT00829829|19383257|P1|Overall Study|Adverse Event|4
5610897|NCT00829829|19383255|P3|Overall Study|Protocol Violation|0
5610898|NCT00829829|19383256|P2|Overall Study|Protocol Violation|3
5610899|NCT00829829|19383257|P1|Overall Study|Protocol Violation|0
5610900|NCT00829790|19383282|P2|Washout of 14 Days|Withdrawal by Subject|1
5610901|NCT00829790|19383283|P1|Washout of 14 Days|Withdrawal by Subject|0
5610902|NCT00829764|19383293|P2|First Intervention|Withdrawal by Subject|1
5610903|NCT00829764|19383294|P1|First Intervention|Withdrawal by Subject|1
5610904|NCT00829764|19383293|P2|First Intervention|Adverse Event|0
5610905|NCT00829764|19383294|P1|First Intervention|Adverse Event|1
5610906|NCT00829712|19383320|P2|Washout of 7 Days|Withdrawal by Subject|1
5610907|NCT00829712|19383321|P1|Washout of 7 Days|Withdrawal by Subject|0
5610908|NCT00829673|19383340|P2|Washout of 7 Days|Withdrawal by Subject|0
5610909|NCT00829673|19383341|P1|Washout of 7 Days|Withdrawal by Subject|1
5610910|NCT00829621|19383351|P2|Overall Study|Lost to Follow-up|4
5610911|NCT00829621|19383352|P1|Overall Study|Lost to Follow-up|3
5610912|NCT00829621|19383351|P2|Overall Study|Death|0
5610913|NCT00829621|19383352|P1|Overall Study|Death|1
5610914|NCT00829530|19383360|P2|Second Intervention|Intolerance to Venopuncture|0
5610915|NCT00829530|19383361|P1|Second Intervention|Intolerance to Venopuncture|1
5610916|NCT00829530|19383360|P2|First Intervention|Intolerance to Venopuncture|1
5610917|NCT00829530|19383361|P1|First Intervention|Intolerance to Venopuncture|0
5610918|NCT00829530|19383360|P2|First Intervention|Adverse Event|1
5610919|NCT00829530|19383361|P1|First Intervention|Adverse Event|0
5610920|NCT00829504|19383375|P2|Second Intervention|Physician Decision|0
5610921|NCT00829504|19383376|P1|Second Intervention|Physician Decision|1
5610922|NCT00829504|19383375|P2|Washout of 7 Days|Withdrawal by Subject|0
5610923|NCT00829504|19383376|P1|Washout of 7 Days|Withdrawal by Subject|1
5610924|NCT00829504|19383375|P2|First Intervention|Adverse Event|0
5610925|NCT00829504|19383376|P1|First Intervention|Adverse Event|1
5610926|NCT00829452|19383386|P2|Second Intervention|Physician Decision|1
5610927|NCT00829452|19383387|P1|Second Intervention|Physician Decision|0
5610928|NCT00829452|19383386|P2|Washout of 42 Days|Withdrawal by Subject|1
5610929|NCT00829452|19383387|P1|Washout of 42 Days|Withdrawal by Subject|0
5610930|NCT00829452|19383386|P2|First Intervention|Withdrawal by Subject|1
5610931|NCT00829452|19383387|P1|First Intervention|Withdrawal by Subject|0
5610932|NCT00829439|19383399|P4|Overall Study|Adverse Event|0
5610933|NCT00829439|19383400|P3|Overall Study|Adverse Event|1
5610934|NCT00829439|19383401|P2|Overall Study|Adverse Event|0
5610935|NCT00829439|19383402|P1|Overall Study|Adverse Event|0
5610936|NCT00829426|19383408|P2|Washout: 7 Days|Withdrawal by Subject|0
5610937|NCT00829426|19383409|P1|Washout: 7 Days|Withdrawal by Subject|1
5610938|NCT00829413|19383417|P1|Overall Study|Indeterminate diagnosis from truth stand|3
5610939|NCT00829413|19383417|P1|Overall Study|Technically inadequate truth standard|2
5610940|NCT00829413|19383417|P1|Overall Study|No truth standard procedure available|9
5610941|NCT00829413|19383417|P1|Overall Study|Training Patients|67
5610942|NCT00829413|19383417|P1|Overall Study|No study drug admimnistered|13
5610943|NCT00829387|19383466|P2|Overall Study|Disqualified by PI|0
5610944|NCT00829387|19383467|P1|Overall Study|Disqualified by PI|1
5610945|NCT00829387|19383466|P2|Overall Study|Withdrawal by Subject|3
5610946|NCT00829387|19383467|P1|Overall Study|Withdrawal by Subject|2
5610947|NCT00829309|19383485|P2|Washout: 7 Days|Protocol Violation|0
5610948|NCT00829309|19383486|P1|Washout: 7 Days|Protocol Violation|1
5610949|NCT00829296|19383496|P2|Overall Study|Adverse Event|4
5610950|NCT00829296|19383497|P1|Overall Study|Adverse Event|5
5610951|NCT00829283|19383511|P2|Overall Study|Lost to Follow-up|25
5610952|NCT00829283|19383512|P1|Overall Study|Lost to Follow-up|7
5610953|NCT00829244|19383522|P2|Overall Study|No embryo cleavage|2
5610954|NCT00829244|19383523|P1|Overall Study|No embryo cleavage|0
5610955|NCT00829244|19383522|P2|Overall Study|All embryos discarded|3
5610956|NCT00829244|19383523|P1|Overall Study|All embryos discarded|0
5610957|NCT00829244|19383522|P2|Overall Study|No fertilization|2
5610958|NCT00829244|19383523|P1|Overall Study|No fertilization|2
5610959|NCT00829244|19383522|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
5610960|NCT00829244|19383523|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
5610961|NCT00829244|19383522|P2|Overall Study|Lack of ovarian response to stimulation|5
5610962|NCT00829244|19383523|P1|Overall Study|Lack of ovarian response to stimulation|9
5610963|NCT00829244|19383522|P2|Overall Study|Protocol Violation|0
5610964|NCT00829244|19383523|P1|Overall Study|Protocol Violation|1
5610965|NCT00829244|19383522|P2|Overall Study|Adverse Event|3
5610966|NCT00829244|19383523|P1|Overall Study|Adverse Event|1
5610967|NCT00829179|19383553|P1|Overall Study|Withdrawal by Subject|1
5610968|NCT00829166|19383559|P2|Overall Study|Reason Not Specified|3
5610969|NCT00829166|19383560|P1|Overall Study|Reason Not Specified|3
5610970|NCT00829166|19383559|P2|Overall Study|Sponsor's Decision|98
5610971|NCT00829166|19383560|P1|Overall Study|Sponsor's Decision|137
5610972|NCT00829166|19383559|P2|Overall Study|Subject's Decision|55
5610973|NCT00829166|19383560|P1|Overall Study|Subject's Decision|41
5610974|NCT00829166|19383559|P2|Overall Study|Physician's Decision|3
5610975|NCT00829166|19383560|P1|Overall Study|Physician's Decision|4
5610976|NCT00829166|19383559|P2|Overall Study|Lost to Follow-up|4
5610977|NCT00829166|19383560|P1|Overall Study|Lost to Follow-up|5
5610978|NCT00829166|19383559|P2|Overall Study|Death|333
5610979|NCT00829166|19383560|P1|Overall Study|Death|305
5610980|NCT00829010|19383623|P5|Overall Study|Migrated/Moved from study area|0
5610981|NCT00829010|19383624|P4|Overall Study|Migrated/Moved from study area|5
5610982|NCT00829010|19383625|P3|Overall Study|Migrated/Moved from study area|0
5610983|NCT00829010|19383626|P2|Overall Study|Migrated/Moved from study area|4
5610984|NCT00829010|19383627|P1|Overall Study|Migrated/Moved from study area|3
5610985|NCT00829010|19383623|P5|Overall Study|Fatality|0
5610986|NCT00829010|19383624|P4|Overall Study|Fatality|3
5610987|NCT00829010|19383625|P3|Overall Study|Fatality|0
5610988|NCT00829010|19383626|P2|Overall Study|Fatality|4
5610989|NCT00829010|19383627|P1|Overall Study|Fatality|5
5610990|NCT00829010|19383623|P5|Overall Study|Lost to Follow-up|0
5610991|NCT00829010|19383624|P4|Overall Study|Lost to Follow-up|0
5610992|NCT00829010|19383625|P3|Overall Study|Lost to Follow-up|2
5610993|NCT00829010|19383626|P2|Overall Study|Lost to Follow-up|0
5610994|NCT00829010|19383627|P1|Overall Study|Lost to Follow-up|1
5610995|NCT00829010|19383623|P5|Overall Study|Withdrawal by Subject|2
5610996|NCT00829010|19383624|P4|Overall Study|Withdrawal by Subject|0
5610997|NCT00829010|19383625|P3|Overall Study|Withdrawal by Subject|1
5610998|NCT00829010|19383626|P2|Overall Study|Withdrawal by Subject|1
5610999|NCT00829010|19383627|P1|Overall Study|Withdrawal by Subject|0
5611000|NCT00829010|19383623|P5|Overall Study|Adverse Event|0
5611001|NCT00829010|19383624|P4|Overall Study|Adverse Event|0
5611002|NCT00829010|19383625|P3|Overall Study|Adverse Event|0
5611003|NCT00829010|19383626|P2|Overall Study|Adverse Event|0
5611004|NCT00829010|19383627|P1|Overall Study|Adverse Event|1
5611005|NCT00828984|19383792|P3|Overall Study|ConMed|1
5611006|NCT00828984|19383793|P2|Overall Study|ConMed|1
5611007|NCT00828984|19383794|P1|Overall Study|ConMed|1
5611008|NCT00828984|19383792|P3|Overall Study|Noncompliant|3
5611009|NCT00828984|19383793|P2|Overall Study|Noncompliant|2
5611010|NCT00828984|19383794|P1|Overall Study|Noncompliant|1
5611011|NCT00828984|19383792|P3|Overall Study|Medical Contraindication|0
5611012|NCT00828984|19383793|P2|Overall Study|Medical Contraindication|1
5611013|NCT00828984|19383794|P1|Overall Study|Medical Contraindication|0
5611014|NCT00828984|19383792|P3|Overall Study|Ineligable|0
5611015|NCT00828984|19383793|P2|Overall Study|Ineligable|2
5611016|NCT00828984|19383794|P1|Overall Study|Ineligable|1
5611017|NCT00828984|19383792|P3|Overall Study|Withdrawal by Subject|4
5611018|NCT00828984|19383793|P2|Overall Study|Withdrawal by Subject|4
5611019|NCT00828984|19383794|P1|Overall Study|Withdrawal by Subject|4
5611020|NCT00828984|19383792|P3|Overall Study|Lost to Follow-up|1
5611021|NCT00828984|19383793|P2|Overall Study|Lost to Follow-up|3
5611022|NCT00828984|19383794|P1|Overall Study|Lost to Follow-up|5
5611023|NCT00828984|19383792|P3|Overall Study|Adverse Event|0
5611024|NCT00828984|19383793|P2|Overall Study|Adverse Event|3
5611025|NCT00828984|19383794|P1|Overall Study|Adverse Event|2
5611026|NCT00828945|19383817|P1|Overall Study|Other|36
5611027|NCT00828945|19383817|P1|Overall Study|Participant was missing|1
5611028|NCT00828945|19383817|P1|Overall Study|Death|4
5611029|NCT00828750|19383849|P1|Overall Study|Normal PC Remained While No Treatment|1
5611030|NCT00828750|19383849|P1|Overall Study|Lack of Efficacy|3
5611031|NCT00828711|19383863|P3|Overall Study|Lost to Follow-up|0
5611032|NCT00828711|19383864|P2|Overall Study|Lost to Follow-up|0
5611033|NCT00828711|19383865|P1|Overall Study|Lost to Follow-up|1
5611034|NCT00828672|19383896|P2|Post-surgery (<30 Days)|No central review materials|1
5611035|NCT00828672|19383897|P1|Post-surgery (<30 Days)|No central review materials|0
5611036|NCT00828672|19383896|P2|Study Treatment|Complete response, no surgery|1
5611037|NCT00828672|19383897|P1|Study Treatment|Complete response, no surgery|1
5611038|NCT00828672|19383896|P2|Study Treatment|Adverse Event|1
5611039|NCT00828672|19383897|P1|Study Treatment|Adverse Event|0
5611040|NCT00828672|19383896|P2|Study Treatment|Lost to Follow-up|0
5611041|NCT00828672|19383897|P1|Study Treatment|Lost to Follow-up|1
5611042|NCT00828568|19383918|P3|Treated - Received at Least One Dose|Protocol Violation|3
5611043|NCT00828568|19383919|P2|Treated - Received at Least One Dose|Protocol Violation|5
5611044|NCT00828568|19383920|P1|Treated - Received at Least One Dose|Protocol Violation|9
5611045|NCT00828568|19383918|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
5611046|NCT00828568|19383919|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
5611047|NCT00828568|19383920|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
5611048|NCT00828568|19383918|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
5611049|NCT00828568|19383919|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
5611050|NCT00828568|19383920|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
5611051|NCT00828568|19383918|P3|Treated - Received at Least One Dose|Adverse Event|1
5611052|NCT00828568|19383919|P2|Treated - Received at Least One Dose|Adverse Event|8
5611053|NCT00828568|19383920|P1|Treated - Received at Least One Dose|Adverse Event|11
5611054|NCT00828568|19383918|P3|Randomized|Withdrawal by Subject|2
5611055|NCT00828568|19383919|P2|Randomized|Withdrawal by Subject|0
5611056|NCT00828568|19383920|P1|Randomized|Withdrawal by Subject|1
5611057|NCT00828516|19383942|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
5611058|NCT00828464|19383947|P1|Overall Study|Withdrawal by Subject|1
5611059|NCT00828451|19383964|P1|Overall Study|Deterioration in clinical status|1
5611060|NCT00828451|19383964|P1|Overall Study|Withdrawal by Subject|1
5611061|NCT00828451|19383964|P1|Overall Study|Lack of intravenous line|7
5611062|NCT00828451|19383964|P1|Overall Study|Death|2
5611063|NCT00828321|19383990|P2|Second Intervention|Protocol Violation|1
5611064|NCT00828321|19383991|P1|Second Intervention|Protocol Violation|0
5611065|NCT00828321|19383990|P2|Washout of 42 Days|Withdrawal by Subject|0
5611066|NCT00828321|19383991|P1|Washout of 42 Days|Withdrawal by Subject|2
5611067|NCT00828204|19384020|P2|Extension Study|Physician Decision|2
5611068|NCT00828204|19384021|P1|Extension Study|Physician Decision|0
5611069|NCT00828204|19384020|P2|Extension Study|Lost to Follow-up|1
5611070|NCT00828204|19384021|P1|Extension Study|Lost to Follow-up|0
5611071|NCT00828204|19384020|P2|Main Study: After Study Restart|Noncompliance|1
5611072|NCT00828204|19384021|P1|Main Study: After Study Restart|Noncompliance|0
5611073|NCT00828204|19384020|P2|Main Study: After Study Restart|Adverse Event|2
5611074|NCT00828204|19384021|P1|Main Study: After Study Restart|Adverse Event|0
5611075|NCT00828204|19384020|P2|Main Study: Prior to Study Suspension|Study Suspension|0
5611076|NCT00828204|19384021|P1|Main Study: Prior to Study Suspension|Study Suspension|11
5611077|NCT00828204|19384020|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
5611078|NCT00828204|19384021|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
5611079|NCT00828204|19384020|P2|Main Study: Prior to Study Suspension|Adverse Event|0
5611080|NCT00828204|19384021|P1|Main Study: Prior to Study Suspension|Adverse Event|1
5611081|NCT00828139|19384068|P4|Overall Study|Other|2
5611082|NCT00828139|19384069|P3|Overall Study|Other|5
5611083|NCT00828139|19384070|P2|Overall Study|Other|2
5611084|NCT00828139|19384071|P1|Overall Study|Other|4
5611085|NCT00828139|19384068|P4|Overall Study|Disease Progression|39
5611086|NCT00828139|19384069|P3|Overall Study|Disease Progression|35
5611087|NCT00828139|19384070|P2|Overall Study|Disease Progression|33
5611088|NCT00828139|19384071|P1|Overall Study|Disease Progression|24
5611089|NCT00828139|19384068|P4|Overall Study|Refusal unrelated to toxicity|3
5611090|NCT00828139|19384069|P3|Overall Study|Refusal unrelated to toxicity|5
5611091|NCT00828139|19384070|P2|Overall Study|Refusal unrelated to toxicity|4
5611092|NCT00828139|19384071|P1|Overall Study|Refusal unrelated to toxicity|3
5611093|NCT00828139|19384068|P4|Overall Study|Death|2
5611094|NCT00828139|19384069|P3|Overall Study|Death|0
5611095|NCT00828139|19384070|P2|Overall Study|Death|1
5611096|NCT00828139|19384071|P1|Overall Study|Death|2
5611097|NCT00828139|19384068|P4|Overall Study|Adverse Event|5
5611098|NCT00828139|19384069|P3|Overall Study|Adverse Event|10
5611099|NCT00828139|19384070|P2|Overall Study|Adverse Event|1
5611100|NCT00828139|19384071|P1|Overall Study|Adverse Event|8
5611101|NCT00828113|19384091|P2|Overall Study|Lost to Follow-up|5
5611102|NCT00828113|19384092|P1|Overall Study|Lost to Follow-up|3
5611103|NCT00828113|19384091|P2|Overall Study|Withdrawal by Subject|26
5611104|NCT00828113|19384092|P1|Overall Study|Withdrawal by Subject|27
5611105|NCT00828009|19384130|P1|Step 2 - Maintenance Therapy|Other|1
5611106|NCT00828009|19384130|P1|Step 2 - Maintenance Therapy|Complicating disease|2
5611107|NCT00828009|19384130|P1|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
5611108|NCT00828009|19384130|P1|Step 2 - Maintenance Therapy|Death|1
5611109|NCT00828009|19384130|P1|Step 2 - Maintenance Therapy|Adverse Event|13
5611110|NCT00828009|19384130|P1|Step 2 - Maintenance Therapy|Progressive disease|12
5611111|NCT00828009|19384130|P1|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
5611112|NCT00828009|19384130|P1|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
5611113|NCT00828009|19384130|P1|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
5611114|NCT00828009|19384130|P1|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
5611115|NCT00828009|19384130|P1|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
5611116|NCT00828009|19384130|P1|Step 1 - Chemo RT/Consolidation Chemo|Death|2
5611117|NCT00828009|19384130|P1|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
5611118|NCT00827931|19384173|P2|Overall Study|Other|0
5611119|NCT00827931|19384174|P1|Overall Study|Other|1
5611120|NCT00827931|19384173|P2|Overall Study|Withdrawal by Subject|1
5611121|NCT00827931|19384174|P1|Overall Study|Withdrawal by Subject|0
5611122|NCT00827931|19384173|P2|Overall Study|Lost to Follow-up|0
5611123|NCT00827931|19384174|P1|Overall Study|Lost to Follow-up|1
5611124|NCT00827931|19384173|P2|Overall Study|Adverse Event|0
5611125|NCT00827931|19384174|P1|Overall Study|Adverse Event|1
5611126|NCT00827931|19384173|P2|Overall Study|Death|5
5611127|NCT00827931|19384174|P1|Overall Study|Death|3
5611128|NCT00827918|19384195|P3|Overall Study|Withdrawal by Subject|6
5611129|NCT00827918|19384196|P2|Overall Study|Withdrawal by Subject|2
5611130|NCT00827918|19384197|P1|Overall Study|Withdrawal by Subject|6
5611131|NCT00827918|19384195|P3|Overall Study|Protocol Violation|0
5611132|NCT00827918|19384196|P2|Overall Study|Protocol Violation|1
5611133|NCT00827918|19384197|P1|Overall Study|Protocol Violation|0
5611134|NCT00827918|19384195|P3|Overall Study|Progressive Disease|0
5611135|NCT00827918|19384196|P2|Overall Study|Progressive Disease|1
5611136|NCT00827918|19384197|P1|Overall Study|Progressive Disease|1
5611137|NCT00827918|19384195|P3|Overall Study|Pregnancy|0
5611138|NCT00827918|19384196|P2|Overall Study|Pregnancy|1
5611139|NCT00827918|19384197|P1|Overall Study|Pregnancy|0
5611140|NCT00827918|19384195|P3|Overall Study|Physician Decision|0
5611141|NCT00827918|19384196|P2|Overall Study|Physician Decision|0
5611142|NCT00827918|19384197|P1|Overall Study|Physician Decision|1
5611143|NCT00827918|19384195|P3|Overall Study|Lack of Efficacy|15
5611144|NCT00827918|19384196|P2|Overall Study|Lack of Efficacy|4
5611145|NCT00827918|19384197|P1|Overall Study|Lack of Efficacy|16
5611146|NCT00827918|19384195|P3|Overall Study|Adverse Event|0
5611147|NCT00827918|19384196|P2|Overall Study|Adverse Event|0
5611148|NCT00827918|19384197|P1|Overall Study|Adverse Event|4
5611149|NCT00827827|19384225|P2|Overall Study|Burned with water at home|0
5611150|NCT00827827|19384226|P1|Overall Study|Burned with water at home|1
5611151|NCT00827827|19384225|P2|Overall Study|Transportation issues|0
5611152|NCT00827827|19384226|P1|Overall Study|Transportation issues|1
5611153|NCT00827827|19384225|P2|Overall Study|Gout|0
5611154|NCT00827827|19384226|P1|Overall Study|Gout|1
5611155|NCT00827827|19384225|P2|Overall Study|Another cerebrovascular accident (CVA)|0
5611156|NCT00827827|19384226|P1|Overall Study|Another cerebrovascular accident (CVA)|1
5611157|NCT00827827|19384225|P2|Overall Study|Fall at home- hospitalization|0
5611158|NCT00827827|19384226|P1|Overall Study|Fall at home- hospitalization|1
5611159|NCT00827827|19384225|P2|Overall Study|Lost to Follow-up|0
5611160|NCT00827827|19384226|P1|Overall Study|Lost to Follow-up|3
5611161|NCT00827775|19384270|P2|Overall Study|Withdrawal by Subject|5
5611162|NCT00827775|19384271|P1|Overall Study|Withdrawal by Subject|0
5611163|NCT00827632|19384281|P2|Overall Study|Early withdrawal|11
5611164|NCT00827632|19384282|P1|Overall Study|Early withdrawal|14
5611165|NCT00827632|19384281|P2|Overall Study|Lost to Follow-up|12
5611166|NCT00827632|19384282|P1|Overall Study|Lost to Follow-up|8
5611167|NCT00827606|19384294|P2|Overall Study|Adverse Event|2
5611168|NCT00827606|19384295|P1|Overall Study|Adverse Event|4
5611169|NCT00827606|19384294|P2|Overall Study|LDL below 2.59 mmol/L|12
5611170|NCT00827606|19384295|P1|Overall Study|LDL below 2.59 mmol/L|4
5611171|NCT00827606|19384294|P2|Overall Study|Other|13
5611172|NCT00827606|19384295|P1|Overall Study|Other|5
5611173|NCT00827606|19384294|P2|Overall Study|Pregnancy|1
5611174|NCT00827606|19384295|P1|Overall Study|Pregnancy|0
5611175|NCT00827606|19384294|P2|Overall Study|Withdrawal by Subject|6
5611176|NCT00827606|19384295|P1|Overall Study|Withdrawal by Subject|7
5611177|NCT00827606|19384294|P2|Overall Study|Lost to Follow-up|1
5611178|NCT00827606|19384295|P1|Overall Study|Lost to Follow-up|3
5611179|NCT00827606|19384294|P2|Overall Study|Protocol Violation|3
5611180|NCT00827606|19384295|P1|Overall Study|Protocol Violation|4
5611181|NCT00827567|19384356|P1|Overall Study|Progression of Disease/Screen Failure|4
5611182|NCT00827541|19384362|P2|Overall Study|Lack of effectiveness|0
5611183|NCT00827541|19384363|P1|Overall Study|Lack of effectiveness|1
5611184|NCT00827541|19384362|P2|Overall Study|Pathogen not susceptible|0
5611185|NCT00827541|19384363|P1|Overall Study|Pathogen not susceptible|1
5611186|NCT00827541|19384362|P2|Overall Study|Other|3
5611187|NCT00827541|19384363|P1|Overall Study|Other|1
5611188|NCT00827541|19384362|P2|Overall Study|Exitus|8
5611189|NCT00827541|19384363|P1|Overall Study|Exitus|1
5611190|NCT00827502|19384375|P1|Overall Study|Withdrawal by Subject|5
5611191|NCT00827502|19384375|P1|Overall Study|Lost to Follow-up|4
5611192|NCT00827502|19384375|P1|Overall Study|Adverse Event|1
5611193|NCT00827502|19384375|P1|Overall Study|randomized but not treated|11
5611194|NCT00827372|19384381|P1|Overall Study|Lack of Efficacy|3
5611195|NCT00827372|19384381|P1|Overall Study|Adverse Event|5
5611196|NCT00827242|19384396|P2|Overall Study|Lack of Efficacy|0
5611197|NCT00827242|19384397|P1|Overall Study|Lack of Efficacy|1
5611198|NCT00827242|19384396|P2|Overall Study|Death|0
5611199|NCT00827242|19384397|P1|Overall Study|Death|1
5611200|NCT00827242|19384396|P2|Overall Study|Physician Decision|0
5611201|NCT00827242|19384397|P1|Overall Study|Physician Decision|2
5611202|NCT00827242|19384396|P2|Overall Study|Entry Criteria Not Met|1
5611203|NCT00827242|19384397|P1|Overall Study|Entry Criteria Not Met|4
5611204|NCT00827242|19384396|P2|Overall Study|Adverse Event Excluding Death|1
5611205|NCT00827242|19384397|P1|Overall Study|Adverse Event Excluding Death|2
5611206|NCT00827242|19384396|P2|Overall Study|Lost to Follow-up|3
5611207|NCT00827242|19384397|P1|Overall Study|Lost to Follow-up|0
5611208|NCT00827242|19384396|P2|Overall Study|Protocol Violation|3
5611209|NCT00827242|19384397|P1|Overall Study|Protocol Violation|1
5611210|NCT00827242|19384396|P2|Overall Study|Withdrawal by Subject|4
5611211|NCT00827242|19384397|P1|Overall Study|Withdrawal by Subject|2
5611212|NCT00827112|19384435|P2|Overall Study|Other|3
5611213|NCT00827112|19384436|P1|Overall Study|Other|1
5611214|NCT00827112|19384435|P2|Overall Study|Randomized but not treated|3
5611215|NCT00827112|19384436|P1|Overall Study|Randomized but not treated|5
5611216|NCT00827112|19384435|P2|Overall Study|Withdrawal by Subject|1
5611217|NCT00827112|19384436|P1|Overall Study|Withdrawal by Subject|2
5611218|NCT00827112|19384435|P2|Overall Study|Protocol Violation|2
5611219|NCT00827112|19384436|P1|Overall Study|Protocol Violation|0
5611220|NCT00827112|19384435|P2|Overall Study|Pregnancy|1
5611221|NCT00827112|19384436|P1|Overall Study|Pregnancy|0
5611222|NCT00827112|19384435|P2|Overall Study|Lost to Follow-up|2
5611223|NCT00827112|19384436|P1|Overall Study|Lost to Follow-up|3
5611224|NCT00827112|19384435|P2|Overall Study|Lack of Efficacy|0
5611225|NCT00827112|19384436|P1|Overall Study|Lack of Efficacy|2
5611226|NCT00827112|19384435|P2|Overall Study|Adverse Event|0
5611227|NCT00827112|19384436|P1|Overall Study|Adverse Event|2
5611228|NCT00826943|19384489|P6|Overall Study|Withdrawal by Subject|0
5611229|NCT00826943|19384490|P5|Overall Study|Withdrawal by Subject|1
5611230|NCT00826943|19384491|P4|Overall Study|Withdrawal by Subject|0
5611231|NCT00826943|19384492|P3|Overall Study|Withdrawal by Subject|0
5611232|NCT00826943|19384493|P2|Overall Study|Withdrawal by Subject|0
5611233|NCT00826943|19384494|P1|Overall Study|Withdrawal by Subject|0
5611234|NCT00826748|19384515|P3|Overall Study|Samples Did Not pass QC|1
5611235|NCT00826748|19384516|P2|Overall Study|Samples Did Not pass QC|0
5611236|NCT00826748|19384517|P1|Overall Study|Samples Did Not pass QC|0
5611237|NCT00826748|19384515|P3|Overall Study|Physician Decision|1
5611238|NCT00826748|19384516|P2|Overall Study|Physician Decision|0
5611239|NCT00826748|19384517|P1|Overall Study|Physician Decision|0
5611240|NCT00826748|19384515|P3|Overall Study|Withdrawal by Subject|2
5611241|NCT00826748|19384516|P2|Overall Study|Withdrawal by Subject|0
5611242|NCT00826748|19384517|P1|Overall Study|Withdrawal by Subject|0
5611243|NCT00826618|19384525|P1|Overall Study|Withdrawal by Subject|1
5611244|NCT00826540|19384529|P1|Overall Study|Withdrawal by Subject|1
5611245|NCT00826540|19384529|P1|Overall Study|ineligible|3
5611246|NCT00826449|19384535|P1|Overall Study|Withdrawal by Subject|1
5611247|NCT00826449|19384535|P1|Overall Study|Disease Progression|4
5611248|NCT00826280|19384544|P3|Overall Study|One or more non-interpretable scan|1
5611249|NCT00826280|19384545|P2|Overall Study|One or more non-interpretable scan|1
5611250|NCT00826280|19384546|P1|Overall Study|One or more non-interpretable scan|0
5611251|NCT00826280|19384544|P3|Overall Study|Machine Failure|0
5611252|NCT00826280|19384545|P2|Overall Study|Machine Failure|1
5611253|NCT00826280|19384546|P1|Overall Study|Machine Failure|1
5611254|NCT00826280|19384544|P3|Overall Study|Interpretation Failure|0
5611255|NCT00826280|19384545|P2|Overall Study|Interpretation Failure|0
5611256|NCT00826280|19384546|P1|Overall Study|Interpretation Failure|1
5611257|NCT00826280|19384544|P3|Overall Study|Reversible ischemic defect not present|44
5611258|NCT00826280|19384545|P2|Overall Study|Reversible ischemic defect not present|40
5611259|NCT00826280|19384546|P1|Overall Study|Reversible ischemic defect not present|43
5611260|NCT00826280|19384544|P3|Overall Study|Sponsor discontinued subject or study|0
5611261|NCT00826280|19384545|P2|Overall Study|Sponsor discontinued subject or study|0
5611262|NCT00826280|19384546|P1|Overall Study|Sponsor discontinued subject or study|1
5611263|NCT00826280|19384544|P3|Overall Study|Lost to Follow-up|0
5611264|NCT00826280|19384545|P2|Overall Study|Lost to Follow-up|1
5611265|NCT00826280|19384546|P1|Overall Study|Lost to Follow-up|0
5611266|NCT00826280|19384544|P3|Overall Study|Adverse Event|0
5611267|NCT00826280|19384545|P2|Overall Study|Adverse Event|3
5611268|NCT00826280|19384546|P1|Overall Study|Adverse Event|1
5611269|NCT00826280|19384544|P3|Overall Study|Randomized but drug not received|1
5611270|NCT00826280|19384545|P2|Overall Study|Randomized but drug not received|0
5611271|NCT00826280|19384546|P1|Overall Study|Randomized but drug not received|1
5611272|NCT00826267|19384575|P3|Overall Study|Other Adverse Event|0
5611273|NCT00826267|19384576|P2|Overall Study|Other Adverse Event|0
5611274|NCT00826267|19384577|P1|Overall Study|Other Adverse Event|1
5611275|NCT00826241|19384595|P1|Overall Study|Pt opt not to proceed w/trmt|1
5611276|NCT00826241|19384595|P1|Overall Study|Pt unable to proceed to registration|1
5611277|NCT00826241|19384595|P1|Overall Study|Screen failure|2
5611278|NCT00826241|19384595|P1|Overall Study|Could not obtain records|1
5611279|NCT00826241|19384595|P1|Overall Study|Lost to Follow-up|9
5611280|NCT00826241|19384595|P1|Overall Study|Patient refused follow-up|3
5611281|NCT00826241|19384595|P1|Overall Study|Progression of disease|1
5611282|NCT00826241|19384595|P1|Overall Study|Non-compliance|1
5611283|NCT00826241|19384595|P1|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
5611284|NCT00826241|19384595|P1|Overall Study|Death|4
5611285|NCT00826241|19384595|P1|Overall Study|Withdrew consent|2
5611286|NCT00826241|19384595|P1|Overall Study|Withdrawal from Follow-up|1
5611287|NCT00826228|19384601|P1|Overall Study|Withdrawal by Subject|1
5611288|NCT00826176|19384623|P2|Overall Study|Administrative|0
5611289|NCT00826176|19384624|P1|Overall Study|Administrative|9
5611290|NCT00826176|19384623|P2|Overall Study|Subject Withdrew Consent|0
5611291|NCT00826176|19384624|P1|Overall Study|Subject Withdrew Consent|3
5611292|NCT00826176|19384623|P2|Overall Study|Lost to Follow-up|0
5611293|NCT00826176|19384624|P1|Overall Study|Lost to Follow-up|1
5611294|NCT00826111|19384673|P2|Overall Study|Physician Decision|1
5611295|NCT00826111|19384674|P1|Overall Study|Physician Decision|1
5611296|NCT00826111|19384673|P2|Overall Study|Withdrawal by Subject|0
5611297|NCT00826111|19384674|P1|Overall Study|Withdrawal by Subject|5
5611298|NCT00826111|19384673|P2|Overall Study|Protocol Violation|0
5611299|NCT00826111|19384674|P1|Overall Study|Protocol Violation|1
5611300|NCT00826111|19384673|P2|Overall Study|Lost to Follow-up|1
5611301|NCT00826111|19384674|P1|Overall Study|Lost to Follow-up|0
5611302|NCT00825994|19384709|P1|Overall Study|Placebo Responder at V2|1
5611303|NCT00825994|19384709|P1|Overall Study|Protocol Violation|1
5611304|NCT00825994|19384709|P1|Overall Study|Lost to Follow-up|1
5611305|NCT00825994|19384709|P1|Overall Study|Withdrawal by Subject|2
5611306|NCT00825916|19384717|P3|Overall Study|Lost to Follow-up|1
5611307|NCT00825916|19384718|P2|Overall Study|Lost to Follow-up|2
5611308|NCT00825916|19384719|P1|Overall Study|Lost to Follow-up|4
5611309|NCT00825825|19384760|P6|Third Medication Period (14 Days)|poor data quality|0
5611310|NCT00825825|19384761|P5|Third Medication Period (14 Days)|poor data quality|0
5611311|NCT00825825|19384762|P4|Third Medication Period (14 Days)|poor data quality|0
5611312|NCT00825825|19384763|P3|Third Medication Period (14 Days)|poor data quality|0
5611313|NCT00825825|19384764|P2|Third Medication Period (14 Days)|poor data quality|1
5611314|NCT00825825|19384765|P1|Third Medication Period (14 Days)|poor data quality|0
5611315|NCT00825825|19384760|P6|Third Medication Period (14 Days)|Protocol Violation|2
5611316|NCT00825825|19384761|P5|Third Medication Period (14 Days)|Protocol Violation|0
5611317|NCT00825825|19384762|P4|Third Medication Period (14 Days)|Protocol Violation|0
5611318|NCT00825825|19384763|P3|Third Medication Period (14 Days)|Protocol Violation|0
5611319|NCT00825825|19384764|P2|Third Medication Period (14 Days)|Protocol Violation|0
5611320|NCT00825825|19384765|P1|Third Medication Period (14 Days)|Protocol Violation|0
5611321|NCT00825825|19384760|P6|Third Medication Period (14 Days)|Adverse Event|0
5611322|NCT00825825|19384761|P5|Third Medication Period (14 Days)|Adverse Event|0
5611323|NCT00825825|19384762|P4|Third Medication Period (14 Days)|Adverse Event|0
5611324|NCT00825825|19384763|P3|Third Medication Period (14 Days)|Adverse Event|0
5611325|NCT00825825|19384764|P2|Third Medication Period (14 Days)|Adverse Event|1
5611326|NCT00825825|19384765|P1|Third Medication Period (14 Days)|Adverse Event|0
5611327|NCT00825825|19384760|P6|Second Medication Period (14 Days)|Protocol Violation|0
5611328|NCT00825825|19384761|P5|Second Medication Period (14 Days)|Protocol Violation|1
5611329|NCT00825825|19384762|P4|Second Medication Period (14 Days)|Protocol Violation|0
5611330|NCT00825825|19384763|P3|Second Medication Period (14 Days)|Protocol Violation|0
5611331|NCT00825825|19384764|P2|Second Medication Period (14 Days)|Protocol Violation|0
5611332|NCT00825825|19384765|P1|Second Medication Period (14 Days)|Protocol Violation|1
5611333|NCT00825825|19384760|P6|Second Medication Period (14 Days)|Physician Decision|0
5611334|NCT00825825|19384761|P5|Second Medication Period (14 Days)|Physician Decision|0
5611335|NCT00825825|19384762|P4|Second Medication Period (14 Days)|Physician Decision|2
5611336|NCT00825825|19384763|P3|Second Medication Period (14 Days)|Physician Decision|0
5611337|NCT00825825|19384764|P2|Second Medication Period (14 Days)|Physician Decision|0
5611338|NCT00825825|19384765|P1|Second Medication Period (14 Days)|Physician Decision|1
5611339|NCT00825825|19384760|P6|First Medication Period (14 Days)|Physician Decision|1
5611340|NCT00825825|19384761|P5|First Medication Period (14 Days)|Physician Decision|0
5611341|NCT00825825|19384762|P4|First Medication Period (14 Days)|Physician Decision|0
5611342|NCT00825825|19384763|P3|First Medication Period (14 Days)|Physician Decision|1
5611343|NCT00825825|19384764|P2|First Medication Period (14 Days)|Physician Decision|0
5611344|NCT00825825|19384765|P1|First Medication Period (14 Days)|Physician Decision|2
5611345|NCT00825825|19384760|P6|First Medication Period (14 Days)|Adverse Event|1
5611346|NCT00825825|19384761|P5|First Medication Period (14 Days)|Adverse Event|0
5611347|NCT00825825|19384762|P4|First Medication Period (14 Days)|Adverse Event|0
5611348|NCT00825825|19384763|P3|First Medication Period (14 Days)|Adverse Event|0
5611349|NCT00825825|19384764|P2|First Medication Period (14 Days)|Adverse Event|0
5611350|NCT00825825|19384765|P1|First Medication Period (14 Days)|Adverse Event|1
5611351|NCT00825812|19384781|P4|Overall Study|Administrative|5
5611352|NCT00825812|19384782|P3|Overall Study|Administrative|3
5611353|NCT00825812|19384783|P2|Overall Study|Administrative|1
5611354|NCT00825812|19384784|P1|Overall Study|Administrative|0
5611355|NCT00825812|19384781|P4|Overall Study|Non-compliance with protocol|1
5611356|NCT00825812|19384782|P3|Overall Study|Non-compliance with protocol|0
5611357|NCT00825812|19384783|P2|Overall Study|Non-compliance with protocol|0
5611358|NCT00825812|19384784|P1|Overall Study|Non-compliance with protocol|0
5611359|NCT00825812|19384781|P4|Overall Study|Subject withdrew consent|2
5611360|NCT00825812|19384782|P3|Overall Study|Subject withdrew consent|3
5611361|NCT00825812|19384783|P2|Overall Study|Subject withdrew consent|0
5611362|NCT00825812|19384784|P1|Overall Study|Subject withdrew consent|0
5611363|NCT00825812|19384781|P4|Overall Study|Adverse Event|1
5611364|NCT00825812|19384782|P3|Overall Study|Adverse Event|0
5611365|NCT00825812|19384783|P2|Overall Study|Adverse Event|0
5611366|NCT00825812|19384784|P1|Overall Study|Adverse Event|0
5611367|NCT00825812|19384781|P4|Overall Study|Never entered follow up|1
5611368|NCT00825812|19384782|P3|Overall Study|Never entered follow up|0
5611369|NCT00825812|19384783|P2|Overall Study|Never entered follow up|0
5611370|NCT00825812|19384784|P1|Overall Study|Never entered follow up|0
5611371|NCT00825682|19384831|P2|Overall Study|personal reasons/ inconvenience|5
5611372|NCT00825682|19384832|P1|Overall Study|personal reasons/ inconvenience|13
5611373|NCT00825305|19384923|P2|Overall Study|Can not be classified|1
5611374|NCT00825305|19384924|P1|Overall Study|Can not be classified|0
5611375|NCT00825305|19384923|P2|Overall Study|Protocol Violation|9
5611376|NCT00825305|19384924|P1|Overall Study|Protocol Violation|9
5611377|NCT00825305|19384923|P2|Overall Study|Inappropriate inclusion|0
5611378|NCT00825305|19384924|P1|Overall Study|Inappropriate inclusion|1
5611379|NCT00825305|19384923|P2|Overall Study|Withdrawal by Subject|12
5611380|NCT00825305|19384924|P1|Overall Study|Withdrawal by Subject|6
5611381|NCT00825305|19384923|P2|Overall Study|Adverse Event|1
5611382|NCT00825305|19384924|P1|Overall Study|Adverse Event|1
5611383|NCT00825175|19384964|P2|Overall Study|Withdrawal by Subject|5
5611384|NCT00825175|19384965|P1|Overall Study|Withdrawal by Subject|0
5611385|NCT00825162|19384974|P3|Overall Study|Unable to attend the study visit|0
5611386|NCT00825162|19384975|P2|Overall Study|Unable to attend the study visit|2
5611387|NCT00825162|19384976|P1|Overall Study|Unable to attend the study visit|5
5611388|NCT00825162|19384974|P3|Overall Study|Move away from the study area|0
5611389|NCT00825162|19384975|P2|Overall Study|Move away from the study area|0
5611390|NCT00825162|19384976|P1|Overall Study|Move away from the study area|1
5611391|NCT00825162|19384974|P3|Overall Study|Physician Decision|0
5611392|NCT00825162|19384975|P2|Overall Study|Physician Decision|0
5611393|NCT00825162|19384976|P1|Overall Study|Physician Decision|2
5611394|NCT00825162|19384974|P3|Overall Study|Lost to Follow-up|3
5611395|NCT00825162|19384975|P2|Overall Study|Lost to Follow-up|6
5611396|NCT00825162|19384976|P1|Overall Study|Lost to Follow-up|9
5611397|NCT00825162|19384974|P3|Overall Study|Withdrawal by Subject|3
5611398|NCT00825162|19384975|P2|Overall Study|Withdrawal by Subject|13
5611399|NCT00825162|19384976|P1|Overall Study|Withdrawal by Subject|11
5611400|NCT00824993|19385002|P2|Overall Study|Death|3
5611401|NCT00824993|19385003|P1|Overall Study|Death|0
5611402|NCT00824993|19385002|P2|Overall Study|Insurance Issue|1
5611403|NCT00824993|19385003|P1|Overall Study|Insurance Issue|2
5611404|NCT00824993|19385002|P2|Overall Study|Non-Compliant|1
5611405|NCT00824993|19385003|P1|Overall Study|Non-Compliant|2
5611406|NCT00824993|19385002|P2|Overall Study|Rapid Bone Loss|1
5611407|NCT00824993|19385003|P1|Overall Study|Rapid Bone Loss|0
5611408|NCT00824993|19385002|P2|Overall Study|Malignancy Relapse|10
5611409|NCT00824993|19385003|P1|Overall Study|Malignancy Relapse|9
5611410|NCT00824993|19385002|P2|Overall Study|Withdrawal by Subject|1
5611411|NCT00824993|19385003|P1|Overall Study|Withdrawal by Subject|1
5611412|NCT00824850|19385011|P2|Overall Study|Withdrawal by Subject|1
5611413|NCT00824850|19385012|P1|Overall Study|Withdrawal by Subject|0
5611414|NCT00824772|19385065|P1|Overall Study|Withdrawal by Subject|8
5611415|NCT00824720|19385085|P3|Overall Study|Protocol Violation|1
5611416|NCT00824720|19385086|P2|Overall Study|Protocol Violation|0
5611417|NCT00824720|19385087|P1|Overall Study|Protocol Violation|0
5611418|NCT00824720|19385085|P3|Overall Study|failed plug insertion|0
5611419|NCT00824720|19385086|P2|Overall Study|failed plug insertion|1
5611420|NCT00824720|19385087|P1|Overall Study|failed plug insertion|3
5611421|NCT00824655|19385103|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
5611422|NCT00824655|19385104|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
5611423|NCT00824655|19385103|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
5611424|NCT00824655|19385104|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
5611425|NCT00824616|19385124|P2|Overall Study|Withdrawal by Subject|1
5611426|NCT00824616|19385125|P1|Overall Study|Withdrawal by Subject|1
5611427|NCT00824616|19385124|P2|Overall Study|Lost to Follow-up|1
5611428|NCT00824616|19385125|P1|Overall Study|Lost to Follow-up|0
5611429|NCT00824616|19385124|P2|Overall Study|Lack of Efficacy|1
5611430|NCT00824616|19385125|P1|Overall Study|Lack of Efficacy|2
5611431|NCT00824616|19385124|P2|Overall Study|Hyperglycemia|1
5611432|NCT00824616|19385125|P1|Overall Study|Hyperglycemia|1
5611433|NCT00824616|19385124|P2|Overall Study|Creatinine/Creatinine Clearance|2
5611434|NCT00824616|19385125|P1|Overall Study|Creatinine/Creatinine Clearance|0
5611435|NCT00824616|19385124|P2|Overall Study|Adverse Event|1
5611436|NCT00824616|19385125|P1|Overall Study|Adverse Event|2
5611437|NCT00824564|19385135|P2|Overall Study|Randomized, but not treated|0
5611438|NCT00824564|19385136|P1|Overall Study|Randomized, but not treated|1
5611439|NCT00824564|19385135|P2|Overall Study|Other|2
5611440|NCT00824564|19385136|P1|Overall Study|Other|1
5611441|NCT00824564|19385135|P2|Overall Study|Withdrawal by Subject|1
5611442|NCT00824564|19385136|P1|Overall Study|Withdrawal by Subject|1
5611443|NCT00824564|19385135|P2|Overall Study|Lost to Follow-up|7
5611444|NCT00824564|19385136|P1|Overall Study|Lost to Follow-up|5
5611445|NCT00824473|19385215|P2|Overall Study|Other|1
5611446|NCT00824473|19385216|P1|Overall Study|Other|1
5611447|NCT00824473|19385215|P2|Overall Study|Withdrawal by Subject|3
5611448|NCT00824473|19385216|P1|Overall Study|Withdrawal by Subject|2
5611449|NCT00824473|19385215|P2|Overall Study|Non-Compliance|2
5611450|NCT00824473|19385216|P1|Overall Study|Non-Compliance|4
5611451|NCT00824473|19385215|P2|Overall Study|Protocol Violation|0
5611452|NCT00824473|19385216|P1|Overall Study|Protocol Violation|2
5611453|NCT00824473|19385215|P2|Overall Study|Lack of Efficacy|2
5611454|NCT00824473|19385216|P1|Overall Study|Lack of Efficacy|2
5611455|NCT00824473|19385215|P2|Overall Study|Adverse Event|5
5611456|NCT00824473|19385216|P1|Overall Study|Adverse Event|4
5611457|NCT00824421|19385297|P3|Overall Study|Other|0
5611458|NCT00824421|19385298|P2|Overall Study|Other|1
5611459|NCT00824421|19385299|P1|Overall Study|Other|0
5611460|NCT00824421|19385297|P3|Overall Study|Randomized but not Treated|0
5611461|NCT00824421|19385298|P2|Overall Study|Randomized but not Treated|1
5611462|NCT00824421|19385299|P1|Overall Study|Randomized but not Treated|1
5611463|NCT00824421|19385297|P3|Overall Study|Withdrawal by Subject|3
5611464|NCT00824421|19385298|P2|Overall Study|Withdrawal by Subject|3
5611465|NCT00824421|19385299|P1|Overall Study|Withdrawal by Subject|2
5611466|NCT00824421|19385297|P3|Overall Study|Pregnancy|1
5611467|NCT00824421|19385298|P2|Overall Study|Pregnancy|0
5611468|NCT00824421|19385299|P1|Overall Study|Pregnancy|1
5611469|NCT00824421|19385297|P3|Overall Study|Lost to Follow-up|0
5611470|NCT00824421|19385298|P2|Overall Study|Lost to Follow-up|3
5611471|NCT00824421|19385299|P1|Overall Study|Lost to Follow-up|2
5611472|NCT00824421|19385297|P3|Overall Study|Lack of Efficacy|4
5611473|NCT00824421|19385298|P2|Overall Study|Lack of Efficacy|7
5611474|NCT00824421|19385299|P1|Overall Study|Lack of Efficacy|5
5611475|NCT00824421|19385297|P3|Overall Study|Death|0
5611476|NCT00824421|19385298|P2|Overall Study|Death|1
5611477|NCT00824421|19385299|P1|Overall Study|Death|0
5611478|NCT00824421|19385297|P3|Overall Study|Adverse Event|6
5611479|NCT00824421|19385298|P2|Overall Study|Adverse Event|6
5611480|NCT00824421|19385299|P1|Overall Study|Adverse Event|6
5611481|NCT00824408|19385350|P5|Randomized Phase|Other reason not defined above|4
5611482|NCT00824408|19385351|P4|Randomized Phase|Other reason not defined above|2
5611483|NCT00824408|19385352|P3|Randomized Phase|Other reason not defined above|4
5611484|NCT00824408|19385353|P2|Randomized Phase|Other reason not defined above|0
5611485|NCT00824408|19385354|P1|Randomized Phase|Other reason not defined above|0
5611486|NCT00824408|19385350|P5|Randomized Phase|Refused to continue medication|2
5611487|NCT00824408|19385351|P4|Randomized Phase|Refused to continue medication|2
5611488|NCT00824408|19385352|P3|Randomized Phase|Refused to continue medication|2
5611489|NCT00824408|19385353|P2|Randomized Phase|Refused to continue medication|0
5611490|NCT00824408|19385354|P1|Randomized Phase|Refused to continue medication|0
5611491|NCT00824408|19385350|P5|Randomized Phase|Adverse Event|5
5611492|NCT00824408|19385351|P4|Randomized Phase|Adverse Event|5
5611493|NCT00824408|19385352|P3|Randomized Phase|Adverse Event|4
5611494|NCT00824408|19385353|P2|Randomized Phase|Adverse Event|0
5611495|NCT00824408|19385354|P1|Randomized Phase|Adverse Event|0
5611496|NCT00824408|19385350|P5|Randomized Phase|Progressive disease|34
5611497|NCT00824408|19385351|P4|Randomized Phase|Progressive disease|36
5611498|NCT00824408|19385352|P3|Randomized Phase|Progressive disease|25
5611499|NCT00824408|19385353|P2|Randomized Phase|Progressive disease|0
5611500|NCT00824408|19385354|P1|Randomized Phase|Progressive disease|0
5611501|NCT00824408|19385350|P5|Randomized Phase|Not treated|1
5611502|NCT00824408|19385351|P4|Randomized Phase|Not treated|1
5611503|NCT00824408|19385352|P3|Randomized Phase|Not treated|1
5611504|NCT00824408|19385353|P2|Randomized Phase|Not treated|0
5611505|NCT00824408|19385354|P1|Randomized Phase|Not treated|0
5611506|NCT00824408|19385350|P5|Run-in Phase|Other reason not defined above|0
5611507|NCT00824408|19385351|P4|Run-in Phase|Other reason not defined above|0
5611508|NCT00824408|19385352|P3|Run-in Phase|Other reason not defined above|0
5611509|NCT00824408|19385353|P2|Run-in Phase|Other reason not defined above|1
5611510|NCT00824408|19385354|P1|Run-in Phase|Other reason not defined above|0
5611511|NCT00824408|19385350|P5|Run-in Phase|Refused to continue medication|0
5611512|NCT00824408|19385351|P4|Run-in Phase|Refused to continue medication|0
5611513|NCT00824408|19385352|P3|Run-in Phase|Refused to continue medication|0
5611514|NCT00824408|19385353|P2|Run-in Phase|Refused to continue medication|0
5611515|NCT00824408|19385354|P1|Run-in Phase|Refused to continue medication|1
5611516|NCT00824408|19385350|P5|Run-in Phase|Adverse Event|0
5611517|NCT00824408|19385351|P4|Run-in Phase|Adverse Event|0
5611518|NCT00824408|19385352|P3|Run-in Phase|Adverse Event|0
5611519|NCT00824408|19385353|P2|Run-in Phase|Adverse Event|1
5611520|NCT00824408|19385354|P1|Run-in Phase|Adverse Event|1
5611521|NCT00824408|19385350|P5|Run-in Phase|Progressive disease|0
5611522|NCT00824408|19385351|P4|Run-in Phase|Progressive disease|0
5611523|NCT00824408|19385352|P3|Run-in Phase|Progressive disease|0
5611524|NCT00824408|19385353|P2|Run-in Phase|Progressive disease|4
5611525|NCT00824408|19385354|P1|Run-in Phase|Progressive disease|4
5611526|NCT00824382|19385406|P4|Overall Study|Investigator's decision|0
5611527|NCT00824382|19385407|P3|Overall Study|Investigator's decision|2
5611528|NCT00824382|19385408|P2|Overall Study|Investigator's decision|1
5611529|NCT00824382|19385409|P1|Overall Study|Investigator's decision|0
5611530|NCT00824382|19385406|P4|Overall Study|Protocol Violation|1
5611531|NCT00824382|19385407|P3|Overall Study|Protocol Violation|0
5611532|NCT00824382|19385408|P2|Overall Study|Protocol Violation|0
5611533|NCT00824382|19385409|P1|Overall Study|Protocol Violation|1
5611534|NCT00824382|19385406|P4|Overall Study|Adverse Event|4
5611535|NCT00824382|19385407|P3|Overall Study|Adverse Event|1
5611536|NCT00824382|19385408|P2|Overall Study|Adverse Event|1
5611537|NCT00824382|19385409|P1|Overall Study|Adverse Event|4
5611538|NCT00824369|19385485|P6|Overall Study|Lost to Follow-up|0
5611539|NCT00824369|19385486|P5|Overall Study|Lost to Follow-up|1
5611540|NCT00824369|19385487|P4|Overall Study|Lost to Follow-up|0
5611541|NCT00824369|19385488|P3|Overall Study|Lost to Follow-up|0
5611542|NCT00824369|19385489|P2|Overall Study|Lost to Follow-up|0
5611543|NCT00824369|19385490|P1|Overall Study|Lost to Follow-up|0
5611544|NCT00824369|19385485|P6|Overall Study|Nolonger willing to participate in study|1
5611545|NCT00824369|19385486|P5|Overall Study|Nolonger willing to participate in study|0
5611546|NCT00824369|19385487|P4|Overall Study|Nolonger willing to participate in study|2
5611547|NCT00824369|19385488|P3|Overall Study|Nolonger willing to participate in study|1
5611548|NCT00824369|19385489|P2|Overall Study|Nolonger willing to participate in study|0
5611549|NCT00824369|19385490|P1|Overall Study|Nolonger willing to participate in study|1
5611550|NCT00824291|19385530|P2|Overall Study|Participant on prohibited medication|0
5611551|NCT00824291|19385531|P1|Overall Study|Participant on prohibited medication|1
5611552|NCT00824291|19385530|P2|Overall Study|Lack of Efficacy|8
5611553|NCT00824291|19385531|P1|Overall Study|Lack of Efficacy|7
5611554|NCT00824291|19385530|P2|Overall Study|Withdrawal by Subject|8
5611555|NCT00824291|19385531|P1|Overall Study|Withdrawal by Subject|14
5611556|NCT00824291|19385530|P2|Overall Study|Protocol Violation|1
5611557|NCT00824291|19385531|P1|Overall Study|Protocol Violation|4
5611558|NCT00824291|19385530|P2|Overall Study|Non-compliance|1
5611559|NCT00824291|19385531|P1|Overall Study|Non-compliance|1
5611560|NCT00824291|19385530|P2|Overall Study|Lost to Follow-up|9
5611561|NCT00824291|19385531|P1|Overall Study|Lost to Follow-up|11
5611562|NCT00824291|19385530|P2|Overall Study|Discontinuation of Study by Sponsor|2
5611563|NCT00824291|19385531|P1|Overall Study|Discontinuation of Study by Sponsor|1
5611564|NCT00824291|19385530|P2|Overall Study|Adverse Event|6
5611565|NCT00824291|19385531|P1|Overall Study|Adverse Event|15
5611566|NCT00824265|19385553|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
5611567|NCT00824265|19385554|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
5611568|NCT00824265|19385553|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
5611569|NCT00824265|19385554|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
5611570|NCT00824265|19385553|P2|Treatment Phase|Withdrawal by Subject|15
5611571|NCT00824265|19385554|P1|Treatment Phase|Withdrawal by Subject|6
5611572|NCT00824265|19385553|P2|Treatment Phase|Physician Decision|12
5611573|NCT00824265|19385554|P1|Treatment Phase|Physician Decision|6
5611574|NCT00824265|19385553|P2|Treatment Phase|Lost to Follow-up|1
5611575|NCT00824265|19385554|P1|Treatment Phase|Lost to Follow-up|1
5611576|NCT00824265|19385553|P2|Treatment Phase|Protocol Violation|0
5611577|NCT00824265|19385554|P1|Treatment Phase|Protocol Violation|1
5611578|NCT00824265|19385553|P2|Treatment Phase|Adverse Event,non-fatal|52
5611579|NCT00824265|19385554|P1|Treatment Phase|Adverse Event,non-fatal|50
5611580|NCT00824161|19385615|P1|Overall Study|Screen Failure|1
5611581|NCT00824161|19385615|P1|Overall Study|Withdrawal by Subject|1
5611582|NCT00824005|19385681|P2|Overall Study|Lost to Follow-up|1
5611583|NCT00824005|19385682|P1|Overall Study|Lost to Follow-up|0
5611584|NCT00824005|19385681|P2|Overall Study|Death|1
5611585|NCT00824005|19385682|P1|Overall Study|Death|0
5611586|NCT00823979|19385717|P3|Overall Study|Study Terminated by Sponsor|7
5611587|NCT00823979|19385718|P2|Overall Study|Study Terminated by Sponsor|5
5611588|NCT00823979|19385719|P1|Overall Study|Study Terminated by Sponsor|5
5611589|NCT00823979|19385717|P3|Overall Study|Randomized but not Treated|1
5611590|NCT00823979|19385718|P2|Overall Study|Randomized but not Treated|3
5611591|NCT00823979|19385719|P1|Overall Study|Randomized but not Treated|4
5611592|NCT00823979|19385717|P3|Overall Study|Other|1
5611593|NCT00823979|19385718|P2|Overall Study|Other|0
5611594|NCT00823979|19385719|P1|Overall Study|Other|2
5611595|NCT00823979|19385717|P3|Overall Study|Adverse Event|4
5611596|NCT00823979|19385718|P2|Overall Study|Adverse Event|2
5611597|NCT00823979|19385719|P1|Overall Study|Adverse Event|0
5611598|NCT00823979|19385717|P3|Overall Study|Pregnancy|0
5611599|NCT00823979|19385718|P2|Overall Study|Pregnancy|1
5611600|NCT00823979|19385719|P1|Overall Study|Pregnancy|0
5611601|NCT00823979|19385717|P3|Overall Study|Protocol Violation|0
5611602|NCT00823979|19385718|P2|Overall Study|Protocol Violation|1
5611603|NCT00823979|19385719|P1|Overall Study|Protocol Violation|1
5611604|NCT00823979|19385717|P3|Overall Study|Withdrawal by Subject|2
5611605|NCT00823979|19385718|P2|Overall Study|Withdrawal by Subject|3
5611606|NCT00823979|19385719|P1|Overall Study|Withdrawal by Subject|2
5611607|NCT00823979|19385717|P3|Overall Study|Lost to Follow-up|0
5611608|NCT00823979|19385718|P2|Overall Study|Lost to Follow-up|1
5611609|NCT00823979|19385719|P1|Overall Study|Lost to Follow-up|2
5611610|NCT00823979|19385717|P3|Overall Study|Lack of Efficacy|9
5611611|NCT00823979|19385718|P2|Overall Study|Lack of Efficacy|16
5611612|NCT00823979|19385719|P1|Overall Study|Lack of Efficacy|13
5611613|NCT00823901|19385764|P2|Overall Study|Lost to Follow-up|1
5611614|NCT00823901|19385765|P1|Overall Study|Lost to Follow-up|2
5611615|NCT00823901|19385764|P2|Overall Study|Lack of Efficacy|0
5611616|NCT00823901|19385765|P1|Overall Study|Lack of Efficacy|1
5611617|NCT00823901|19385764|P2|Overall Study|Adverse Event|1
5611618|NCT00823901|19385765|P1|Overall Study|Adverse Event|1
5611619|NCT00823836|19385773|P2|Long-term Phase|Withdrawal by Subject|1
5611620|NCT00823836|19385774|P1|Long-term Phase|Withdrawal by Subject|1
5611621|NCT00823836|19385773|P2|Long-term Phase|Physician Decision|2
5611622|NCT00823836|19385774|P1|Long-term Phase|Physician Decision|1
5611623|NCT00823836|19385773|P2|Long-term Phase|Adverse Event|2
5611624|NCT00823836|19385774|P1|Long-term Phase|Adverse Event|3
5611625|NCT00823836|19385773|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
5611626|NCT00823836|19385774|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
5611627|NCT00823836|19385773|P2|NV and PR/XR Switching Phases|Physician Decision|2
5611628|NCT00823836|19385774|P1|NV and PR/XR Switching Phases|Physician Decision|5
5611629|NCT00823836|19385773|P2|NV and PR/XR Switching Phases|Protocol Violation|1
5611630|NCT00823836|19385774|P1|NV and PR/XR Switching Phases|Protocol Violation|1
5611631|NCT00823836|19385773|P2|NV and PR/XR Switching Phases|Adverse Event|21
5611632|NCT00823836|19385774|P1|NV and PR/XR Switching Phases|Adverse Event|22
5611633|NCT00823823|19385880|P2|Overall Study|Protocol Violation|5
5611634|NCT00823823|19385881|P1|Overall Study|Protocol Violation|5
5611635|NCT00823823|19385880|P2|Overall Study|Lost to Follow-up|1
5611636|NCT00823823|19385881|P1|Overall Study|Lost to Follow-up|3
5611637|NCT00823719|19385905|P2|Overall Study|Disease Progression|4
5611638|NCT00823719|19385906|P1|Overall Study|Disease Progression|4
5611639|NCT00823719|19385905|P2|Overall Study|Withdrawal by Subject|1
5611640|NCT00823719|19385906|P1|Overall Study|Withdrawal by Subject|0
5611641|NCT00823719|19385905|P2|Overall Study|Physician Decision|4
5611642|NCT00823719|19385906|P1|Overall Study|Physician Decision|1
5611643|NCT00823719|19385905|P2|Overall Study|Adverse Event|2
5611644|NCT00823719|19385906|P1|Overall Study|Adverse Event|1
5611645|NCT00823615|19385959|P2|Period 2|Time/Job Conflict|2
5611646|NCT00823615|19385960|P1|Period 2|Time/Job Conflict|1
5611647|NCT00823615|19385959|P2|Period 2|Lost to Follow-up|0
5611648|NCT00823615|19385960|P1|Period 2|Lost to Follow-up|2
5611649|NCT00823472|19385970|P2|Overall Study|Physician Decision|28
5611650|NCT00823472|19385971|P1|Overall Study|Physician Decision|24
5611651|NCT00823264|19385998|P2|Overall Study|Protocol Violation|0
5611652|NCT00823264|19385999|P1|Overall Study|Protocol Violation|2
5611653|NCT00823212|19386007|P2|Overall Study|Missed 12-month visit|21
5611654|NCT00823212|19386008|P1|Overall Study|Missed 12-month visit|21
5611655|NCT00823212|19386007|P2|Overall Study|Incarcerated|1
5611656|NCT00823212|19386008|P1|Overall Study|Incarcerated|0
5611657|NCT00823212|19386007|P2|Overall Study|Withdrawal by Subject|1
5611658|NCT00823212|19386008|P1|Overall Study|Withdrawal by Subject|6
5611659|NCT00823212|19386007|P2|Overall Study|Death|10
5611660|NCT00823212|19386008|P1|Overall Study|Death|8
5611661|NCT00823199|19386090|P1|Overall Study|Withdrawal by Subject|2
5611662|NCT00823134|19386096|P1|Overall Study|Invalid measurement|1
5611663|NCT00822926|19386169|P2|Second Injection Visit|Withdrawal by Subject|1
5611664|NCT00822926|19386170|P1|Second Injection Visit|Withdrawal by Subject|0
5611665|NCT00822926|19386169|P2|Second Injection Visit|Lost to Follow-up|0
5611666|NCT00822926|19386170|P1|Second Injection Visit|Lost to Follow-up|1
5611667|NCT00822900|19386184|P2|Overall Study|Became a ward of the state|1
5611668|NCT00822900|19386185|P1|Overall Study|Became a ward of the state|2
5611669|NCT00822900|19386184|P2|Overall Study|Death|69
5611670|NCT00822900|19386185|P1|Overall Study|Death|83
5611671|NCT00822900|19386184|P2|Overall Study|Lost to Follow-up|9
5611672|NCT00822900|19386185|P1|Overall Study|Lost to Follow-up|9
5611673|NCT00822900|19386184|P2|Overall Study|Withdrawal by Subject|14
5611674|NCT00822900|19386185|P1|Overall Study|Withdrawal by Subject|14
5611675|NCT00822770|19386215|P2|Overall Study|Death|1
5611676|NCT00822770|19386216|P1|Overall Study|Death|1
5611677|NCT00822770|19386215|P2|Overall Study|Complication/Incomplete treatment|0
5611678|NCT00822770|19386216|P1|Overall Study|Complication/Incomplete treatment|1
5611679|NCT00822770|19386215|P2|Overall Study|Not treated|0
5611680|NCT00822770|19386216|P1|Overall Study|Not treated|1
5611681|NCT00822692|19386238|P2|Overall Study|Lost to Follow-up|25
5611682|NCT00822692|19386239|P1|Overall Study|Lost to Follow-up|17
5611683|NCT00822237|19386377|P2|Dose 2 Vaccination|Lost to Follow-up|9
5611684|NCT00822237|19386378|P1|Dose 2 Vaccination|Lost to Follow-up|2
5611685|NCT00822237|19386377|P2|Dose 2 Vaccination|Withdrawal by Subject|2
5611686|NCT00822237|19386378|P1|Dose 2 Vaccination|Withdrawal by Subject|2
5611687|NCT00822237|19386377|P2|Dose 1 Vaccination|Lost to Follow-up|12
5611688|NCT00822237|19386378|P1|Dose 1 Vaccination|Lost to Follow-up|9
5611689|NCT00822237|19386377|P2|Dose 1 Vaccination|Withdrawal by Subject|14
5611690|NCT00822237|19386378|P1|Dose 1 Vaccination|Withdrawal by Subject|13
5611691|NCT00822237|19386377|P2|Dose 1 Vaccination|Not vaccinated|0
5611692|NCT00822237|19386378|P1|Dose 1 Vaccination|Not vaccinated|3
5611693|NCT00822172|19386459|P2|Overall Study|Other|1
5611694|NCT00822172|19386460|P1|Overall Study|Other|0
5611695|NCT00822172|19386459|P2|Overall Study|site closed|1
5611696|NCT00822172|19386460|P1|Overall Study|site closed|0
5611697|NCT00822172|19386459|P2|Overall Study|Withdrawal by Subject|4
5611698|NCT00822172|19386460|P1|Overall Study|Withdrawal by Subject|1
5611699|NCT00822172|19386459|P2|Overall Study|Lost to Follow-up|1
5611700|NCT00822172|19386460|P1|Overall Study|Lost to Follow-up|3
5611701|NCT00822172|19386459|P2|Overall Study|Death|0
5611702|NCT00822172|19386460|P1|Overall Study|Death|1
5611703|NCT00822172|19386459|P2|Overall Study|Adverse Event|12
5611704|NCT00822172|19386460|P1|Overall Study|Adverse Event|10
5611705|NCT00822120|19386480|P6|PET-directed Therapy|Protocol Violation|0
5611706|NCT00822120|19386481|P5|PET-directed Therapy|Protocol Violation|0
5611707|NCT00822120|19386482|P4|PET-directed Therapy|Protocol Violation|6
5611708|NCT00822120|19386483|P3|PET-directed Therapy|Protocol Violation|0
5611709|NCT00822120|19386484|P2|PET-directed Therapy|Protocol Violation|0
5611710|NCT00822120|19386485|P1|PET-directed Therapy|Protocol Violation|0
5611711|NCT00822120|19386480|P6|PET-directed Therapy|Death|0
5611712|NCT00822120|19386481|P5|PET-directed Therapy|Death|0
5611713|NCT00822120|19386482|P4|PET-directed Therapy|Death|2
5611714|NCT00822120|19386483|P3|PET-directed Therapy|Death|0
5611715|NCT00822120|19386484|P2|PET-directed Therapy|Death|0
5611716|NCT00822120|19386485|P1|PET-directed Therapy|Death|0
5611717|NCT00822120|19386480|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5611718|NCT00822120|19386481|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5611719|NCT00822120|19386482|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
5611720|NCT00822120|19386483|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5611721|NCT00822120|19386484|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5611722|NCT00822120|19386485|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
5611723|NCT00822120|19386480|P6|PET-directed Therapy|Adverse Event|0
5611724|NCT00822120|19386481|P5|PET-directed Therapy|Adverse Event|0
5611725|NCT00822120|19386482|P4|PET-directed Therapy|Adverse Event|1
5611726|NCT00822120|19386483|P3|PET-directed Therapy|Adverse Event|0
5611727|NCT00822120|19386484|P2|PET-directed Therapy|Adverse Event|0
5611728|NCT00822120|19386485|P1|PET-directed Therapy|Adverse Event|0
5611729|NCT00822120|19386480|P6|Initial Registration|Ineligible|0
5611730|NCT00822120|19386481|P5|Initial Registration|Ineligible|0
5611731|NCT00822120|19386482|P4|Initial Registration|Ineligible|0
5611732|NCT00822120|19386483|P3|Initial Registration|Ineligible|0
5611733|NCT00822120|19386484|P2|Initial Registration|Ineligible|1
5611734|NCT00822120|19386485|P1|Initial Registration|Ineligible|22
5611735|NCT00822120|19386480|P6|Initial Registration|Reasons not Protocol Specified|0
5611736|NCT00822120|19386481|P5|Initial Registration|Reasons not Protocol Specified|0
5611737|NCT00822120|19386482|P4|Initial Registration|Reasons not Protocol Specified|0
5611738|NCT00822120|19386483|P3|Initial Registration|Reasons not Protocol Specified|0
5611739|NCT00822120|19386484|P2|Initial Registration|Reasons not Protocol Specified|0
5611740|NCT00822120|19386485|P1|Initial Registration|Reasons not Protocol Specified|2
5611741|NCT00822120|19386480|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
5611742|NCT00822120|19386481|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
5611743|NCT00822120|19386482|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
5611744|NCT00822120|19386483|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
5611745|NCT00822120|19386484|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
5611746|NCT00822120|19386485|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
5611747|NCT00822120|19386480|P6|Initial Registration|Adverse Event|0
5611748|NCT00822120|19386481|P5|Initial Registration|Adverse Event|0
5611749|NCT00822120|19386482|P4|Initial Registration|Adverse Event|0
5611750|NCT00822120|19386483|P3|Initial Registration|Adverse Event|0
5611751|NCT00822120|19386484|P2|Initial Registration|Adverse Event|0
5611752|NCT00822120|19386485|P1|Initial Registration|Adverse Event|1
5611753|NCT00821873|19386551|P1|Overall Study|Lost to Follow-up|4
5611754|NCT00821678|19386581|P2|Overall Study|Death|2
5611755|NCT00821678|19386582|P1|Overall Study|Death|0
5611756|NCT00821678|19386581|P2|Overall Study|Lost to Follow-up|12
5611757|NCT00821678|19386582|P1|Overall Study|Lost to Follow-up|13
5611758|NCT00821678|19386581|P2|Overall Study|Withdrawal by Subject|0
5611759|NCT00821678|19386582|P1|Overall Study|Withdrawal by Subject|8
5611760|NCT00821587|19386617|P2|Overall Study|Physician Decision|1
5611761|NCT00821587|19386618|P1|Overall Study|Physician Decision|0
5611762|NCT00821509|19386627|P3|Overall Study|Withdrawal by Subject|34
5611763|NCT00821509|19386628|P2|Overall Study|Withdrawal by Subject|11
5611764|NCT00821509|19386629|P1|Overall Study|Withdrawal by Subject|12
5611765|NCT00821431|19386642|P2|Overall Study|Physician Decision|1
5611766|NCT00821431|19386643|P1|Overall Study|Physician Decision|0
5611767|NCT00821431|19386642|P2|Overall Study|Protocol Violation|1
5611768|NCT00821431|19386643|P1|Overall Study|Protocol Violation|3
5611769|NCT00821431|19386642|P2|Overall Study|Lost to Follow-up|0
5611770|NCT00821431|19386643|P1|Overall Study|Lost to Follow-up|1
5611771|NCT00821431|19386642|P2|Overall Study|Withdrawal by Subject|0
5611772|NCT00821431|19386643|P1|Overall Study|Withdrawal by Subject|5
5611773|NCT00821431|19386642|P2|Overall Study|Adverse Event|3
5611774|NCT00821431|19386643|P1|Overall Study|Adverse Event|6
5611775|NCT00821327|19386651|P1|Overall Study|Other/Unknown|5
5611776|NCT00821327|19386651|P1|Overall Study|Disease Progression|13
5611777|NCT00821327|19386651|P1|Overall Study|Sponsor Request|1
5611778|NCT00821327|19386651|P1|Overall Study|Investigator Request|2
5611779|NCT00821327|19386651|P1|Overall Study|Patient Request|1
5611780|NCT00821327|19386651|P1|Overall Study|Adverse Event|13
5611781|NCT00821236|19386660|P1|Overall Study|Lost to Follow-up|3
5611782|NCT00821093|19386700|P2|Overall Study|Administrative problems|2
5611783|NCT00821093|19386701|P1|Overall Study|Administrative problems|1
5611784|NCT00821093|19386700|P2|Overall Study|Abnormal test procedure result(s)|1
5611785|NCT00821093|19386701|P1|Overall Study|Abnormal test procedure result(s)|1
5611786|NCT00821093|19386700|P2|Overall Study|Death|1
5611787|NCT00821093|19386701|P1|Overall Study|Death|2
5611788|NCT00821093|19386700|P2|Overall Study|Lack of Efficacy|2
5611789|NCT00821093|19386701|P1|Overall Study|Lack of Efficacy|2
5611790|NCT00821093|19386700|P2|Overall Study|Abnormal laboratory value(s)|0
5611791|NCT00821093|19386701|P1|Overall Study|Abnormal laboratory value(s)|2
5611792|NCT00821093|19386700|P2|Overall Study|Protocol deviation|6
5611793|NCT00821093|19386701|P1|Overall Study|Protocol deviation|3
5611794|NCT00821093|19386700|P2|Overall Study|Lost to Follow-up|3
5611795|NCT00821093|19386701|P1|Overall Study|Lost to Follow-up|9
5611796|NCT00821093|19386700|P2|Overall Study|Withdrawal by Subject|13
5611797|NCT00821093|19386701|P1|Overall Study|Withdrawal by Subject|9
5611798|NCT00821093|19386700|P2|Overall Study|Adverse Event|12
5611799|NCT00821093|19386701|P1|Overall Study|Adverse Event|20
5611800|NCT00821015|19386720|P1|Overall Study|Lost to Follow-up|12
5611801|NCT00820898|19386731|P1|Overall Study|Inelgible - wrong primary site|1
5611802|NCT00820755|19386745|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
5611803|NCT00820755|19386746|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
5611804|NCT00820755|19386747|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
5611805|NCT00820755|19386745|P3|Period 1: Combination Therapy Phase|Other|0
5611806|NCT00820755|19386746|P2|Period 1: Combination Therapy Phase|Other|0
5611807|NCT00820755|19386747|P1|Period 1: Combination Therapy Phase|Other|11
5611808|NCT00820755|19386745|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
5611809|NCT00820755|19386746|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
5611810|NCT00820755|19386747|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
5611811|NCT00820755|19386745|P3|Period 1: Combination Therapy Phase|Progressive disease|0
5611812|NCT00820755|19386746|P2|Period 1: Combination Therapy Phase|Progressive disease|0
5611813|NCT00820755|19386747|P1|Period 1: Combination Therapy Phase|Progressive disease|114
5611814|NCT00820755|19386745|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
5611815|NCT00820755|19386746|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
5611816|NCT00820755|19386747|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
5611817|NCT00820755|19386745|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
5611818|NCT00820755|19386746|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
5611819|NCT00820755|19386747|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
5611820|NCT00820755|19386745|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
5611821|NCT00820755|19386746|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
5611822|NCT00820755|19386747|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
5611823|NCT00820755|19386745|P3|Period 1: Combination Therapy Phase|Death|0
5611824|NCT00820755|19386746|P2|Period 1: Combination Therapy Phase|Death|0
5611825|NCT00820755|19386747|P1|Period 1: Combination Therapy Phase|Death|28
5611826|NCT00820755|19386745|P3|Period 1: Combination Therapy Phase|Adverse Event|0
5611827|NCT00820755|19386746|P2|Period 1: Combination Therapy Phase|Adverse Event|0
5611828|NCT00820755|19386747|P1|Period 1: Combination Therapy Phase|Adverse Event|77
5611829|NCT00820599|19386790|P1|Overall Study|Withdrawal by Subject|2
5611830|NCT00820599|19386790|P1|Overall Study|Death|129
5611831|NCT00820248|19386845|P2|Overall Study|No treated|1
5611832|NCT00820248|19386846|P1|Overall Study|No treated|4
5611833|NCT00820222|19386878|P2|Overall Study|Unkown|7
5611834|NCT00820222|19386879|P1|Overall Study|Unkown|11
5611835|NCT00820222|19386878|P2|Overall Study|Sponsor Terminated Study|65
5611836|NCT00820222|19386879|P1|Overall Study|Sponsor Terminated Study|43
5611837|NCT00820222|19386878|P2|Overall Study|Physician Decision|88
5611838|NCT00820222|19386879|P1|Overall Study|Physician Decision|93
5611839|NCT00820222|19386878|P2|Overall Study|Withdrawal by Subject|21
5611840|NCT00820222|19386879|P1|Overall Study|Withdrawal by Subject|19
5611841|NCT00820222|19386878|P2|Overall Study|Lost to Follow-up|9
5611842|NCT00820222|19386879|P1|Overall Study|Lost to Follow-up|10
5611843|NCT00820170|19386910|P5|Overall Study|Progressive Disease|2
5611844|NCT00820170|19386911|P4|Overall Study|Progressive Disease|0
5611845|NCT00820170|19386912|P3|Overall Study|Progressive Disease|0
5611846|NCT00820170|19386913|P2|Overall Study|Progressive Disease|0
5611847|NCT00820170|19386914|P1|Overall Study|Progressive Disease|0
5611848|NCT00820170|19386910|P5|Overall Study|Adverse Event|2
5611849|NCT00820170|19386911|P4|Overall Study|Adverse Event|0
5611850|NCT00820170|19386912|P3|Overall Study|Adverse Event|0
5611851|NCT00820170|19386913|P2|Overall Study|Adverse Event|0
5611852|NCT00820170|19386914|P1|Overall Study|Adverse Event|0
5611853|NCT00820040|19386962|P1|Overall Study|Screen failure|1
5611854|NCT00820040|19386962|P1|Overall Study|Sponsor terminated study|1
5611855|NCT00820040|19386962|P1|Overall Study|Death|1
5611856|NCT00820027|19386974|P4|Overall Study|Withdrawal by Subject|6
5611857|NCT00820027|19386975|P3|Overall Study|Withdrawal by Subject|4
5611858|NCT00820027|19386976|P2|Overall Study|Withdrawal by Subject|4
5611859|NCT00820027|19386977|P1|Overall Study|Withdrawal by Subject|6
5611860|NCT00820027|19386974|P4|Overall Study|Protocol Violation|0
5611861|NCT00820027|19386975|P3|Overall Study|Protocol Violation|4
5611862|NCT00820027|19386976|P2|Overall Study|Protocol Violation|0
5611863|NCT00820027|19386977|P1|Overall Study|Protocol Violation|3
5611864|NCT00820027|19386974|P4|Overall Study|Physician Decision|0
5611865|NCT00820027|19386975|P3|Overall Study|Physician Decision|1
5611866|NCT00820027|19386976|P2|Overall Study|Physician Decision|1
5611867|NCT00820027|19386977|P1|Overall Study|Physician Decision|0
5611868|NCT00820027|19386974|P4|Overall Study|Lack of Efficacy|2
5611869|NCT00820027|19386975|P3|Overall Study|Lack of Efficacy|2
5611870|NCT00820027|19386976|P2|Overall Study|Lack of Efficacy|1
5611871|NCT00820027|19386977|P1|Overall Study|Lack of Efficacy|2
5611872|NCT00820027|19386974|P4|Overall Study|Adverse Event|5
5611873|NCT00820027|19386975|P3|Overall Study|Adverse Event|10
5611874|NCT00820027|19386976|P2|Overall Study|Adverse Event|8
5611875|NCT00820027|19386977|P1|Overall Study|Adverse Event|15
5611876|NCT00819910|19387019|P4|Overall Study|Lost to Follow-up|0
5611877|NCT00819910|19387020|P3|Overall Study|Lost to Follow-up|0
5611878|NCT00819910|19387021|P2|Overall Study|Lost to Follow-up|0
5611879|NCT00819910|19387022|P1|Overall Study|Lost to Follow-up|1
5611880|NCT00819910|19387019|P4|Overall Study|Withdrawal by Subject|0
5611881|NCT00819910|19387020|P3|Overall Study|Withdrawal by Subject|1
5611882|NCT00819910|19387021|P2|Overall Study|Withdrawal by Subject|1
5611883|NCT00819910|19387022|P1|Overall Study|Withdrawal by Subject|1
5611884|NCT00819910|19387019|P4|Overall Study|Adverse Event|1
5611885|NCT00819910|19387020|P3|Overall Study|Adverse Event|2
5611886|NCT00819910|19387021|P2|Overall Study|Adverse Event|0
5611887|NCT00819910|19387022|P1|Overall Study|Adverse Event|0
5611888|NCT00819832|19387054|P6|Overall Study|Sponsor Termination of Study|0
5611889|NCT00819832|19387055|P5|Overall Study|Sponsor Termination of Study|0
5611890|NCT00819832|19387056|P4|Overall Study|Sponsor Termination of Study|0
5611891|NCT00819832|19387057|P3|Overall Study|Sponsor Termination of Study|0
5611892|NCT00819832|19387058|P2|Overall Study|Sponsor Termination of Study|0
5611893|NCT00819832|19387059|P1|Overall Study|Sponsor Termination of Study|3
5611894|NCT00819780|19387080|P2|Overall Study|Still in treatment|17
5611895|NCT00819780|19387081|P1|Overall Study|Still in treatment|25
5611896|NCT00819780|19387080|P2|Overall Study|Did not receive study drug|4
5611897|NCT00819780|19387081|P1|Overall Study|Did not receive study drug|3
5611898|NCT00819767|19387115|P2|Overall Study|Unsatisfactory therapeutic effect|2
5611899|NCT00819767|19387116|P1|Overall Study|Unsatisfactory therapeutic effect|1
5611900|NCT00819741|19387128|P2|Overall Study|Reasons unknown|3
5611901|NCT00819741|19387129|P1|Overall Study|Reasons unknown|3
5611902|NCT00819741|19387128|P2|Overall Study|Unclassified|0
5611903|NCT00819741|19387129|P1|Overall Study|Unclassified|6
5611904|NCT00819741|19387128|P2|Overall Study|Withdrawal by Subject|2
5611905|NCT00819741|19387129|P1|Overall Study|Withdrawal by Subject|2
5611906|NCT00819741|19387128|P2|Overall Study|Protocol Violation|4
5611907|NCT00819741|19387129|P1|Overall Study|Protocol Violation|3
5611908|NCT00819741|19387128|P2|Overall Study|Lost to Follow-up|1
5611909|NCT00819741|19387129|P1|Overall Study|Lost to Follow-up|3
5611910|NCT00819741|19387128|P2|Overall Study|Lack of Efficacy|2
5611911|NCT00819741|19387129|P1|Overall Study|Lack of Efficacy|0
5611912|NCT00819741|19387128|P2|Overall Study|Adverse Event|2
5611913|NCT00819741|19387129|P1|Overall Study|Adverse Event|5
5611914|NCT00819585|19387183|P11|Extension Study|Death|0
5611915|NCT00819585|19387184|P10|Extension Study|Death|0
5611916|NCT00819585|19387185|P9|Extension Study|Death|2
5611917|NCT00819585|19387186|P8|Extension Study|Death|0
5611918|NCT00819585|19387187|P7|Extension Study|Death|0
5611919|NCT00819585|19387188|P6|Extension Study|Death|0
5611920|NCT00819585|19387189|P5|Extension Study|Death|0
5611921|NCT00819585|19387190|P4|Extension Study|Death|0
5611922|NCT00819585|19387191|P3|Extension Study|Death|0
5611923|NCT00819585|19387192|P2|Extension Study|Death|0
5611924|NCT00819585|19387193|P1|Extension Study|Death|0
5611925|NCT00819585|19387183|P11|Extension Study|Lost to Follow-up|1
5611926|NCT00819585|19387184|P10|Extension Study|Lost to Follow-up|1
5611927|NCT00819585|19387185|P9|Extension Study|Lost to Follow-up|2
5611928|NCT00819585|19387186|P8|Extension Study|Lost to Follow-up|0
5611929|NCT00819585|19387187|P7|Extension Study|Lost to Follow-up|0
5611930|NCT00819585|19387188|P6|Extension Study|Lost to Follow-up|0
5611931|NCT00819585|19387189|P5|Extension Study|Lost to Follow-up|0
5611932|NCT00819585|19387190|P4|Extension Study|Lost to Follow-up|0
5611933|NCT00819585|19387191|P3|Extension Study|Lost to Follow-up|0
5611934|NCT00819585|19387192|P2|Extension Study|Lost to Follow-up|0
5611935|NCT00819585|19387193|P1|Extension Study|Lost to Follow-up|0
5611936|NCT00819585|19387183|P11|Extension Study|Subject Withdrew Consent|1
5611937|NCT00819585|19387184|P10|Extension Study|Subject Withdrew Consent|0
5611938|NCT00819585|19387185|P9|Extension Study|Subject Withdrew Consent|3
5611939|NCT00819585|19387186|P8|Extension Study|Subject Withdrew Consent|0
5611940|NCT00819585|19387187|P7|Extension Study|Subject Withdrew Consent|0
5611941|NCT00819585|19387188|P6|Extension Study|Subject Withdrew Consent|0
5611942|NCT00819585|19387189|P5|Extension Study|Subject Withdrew Consent|0
5611943|NCT00819585|19387190|P4|Extension Study|Subject Withdrew Consent|0
5611944|NCT00819585|19387191|P3|Extension Study|Subject Withdrew Consent|0
5611945|NCT00819585|19387192|P2|Extension Study|Subject Withdrew Consent|0
5611946|NCT00819585|19387193|P1|Extension Study|Subject Withdrew Consent|0
5611947|NCT00819585|19387183|P11|Extension Study|Abnormal Laboratory Value(s)|0
5611948|NCT00819585|19387184|P10|Extension Study|Abnormal Laboratory Value(s)|0
5611949|NCT00819585|19387185|P9|Extension Study|Abnormal Laboratory Value(s)|1
5611950|NCT00819585|19387186|P8|Extension Study|Abnormal Laboratory Value(s)|0
5611951|NCT00819585|19387187|P7|Extension Study|Abnormal Laboratory Value(s)|0
5611952|NCT00819585|19387188|P6|Extension Study|Abnormal Laboratory Value(s)|0
5611953|NCT00819585|19387189|P5|Extension Study|Abnormal Laboratory Value(s)|0
5611954|NCT00819585|19387190|P4|Extension Study|Abnormal Laboratory Value(s)|0
5611955|NCT00819585|19387191|P3|Extension Study|Abnormal Laboratory Value(s)|0
5611956|NCT00819585|19387192|P2|Extension Study|Abnormal Laboratory Value(s)|0
5611957|NCT00819585|19387193|P1|Extension Study|Abnormal Laboratory Value(s)|0
5611958|NCT00819585|19387183|P11|Core Study|Protocol Violation|0
5611959|NCT00819585|19387184|P10|Core Study|Protocol Violation|0
5611960|NCT00819585|19387185|P9|Core Study|Protocol Violation|0
5611961|NCT00819585|19387186|P8|Core Study|Protocol Violation|0
5611962|NCT00819585|19387187|P7|Core Study|Protocol Violation|3
5611963|NCT00819585|19387188|P6|Core Study|Protocol Violation|1
5611964|NCT00819585|19387189|P5|Core Study|Protocol Violation|0
5611965|NCT00819585|19387190|P4|Core Study|Protocol Violation|0
5611966|NCT00819585|19387191|P3|Core Study|Protocol Violation|1
5611967|NCT00819585|19387192|P2|Core Study|Protocol Violation|0
5611968|NCT00819585|19387193|P1|Core Study|Protocol Violation|0
5611969|NCT00819585|19387183|P11|Core Study|Death|0
5611970|NCT00819585|19387184|P10|Core Study|Death|0
5611971|NCT00819585|19387185|P9|Core Study|Death|0
5611972|NCT00819585|19387186|P8|Core Study|Death|0
5611973|NCT00819585|19387187|P7|Core Study|Death|1
5611974|NCT00819585|19387188|P6|Core Study|Death|0
5611975|NCT00819585|19387189|P5|Core Study|Death|0
5611976|NCT00819585|19387190|P4|Core Study|Death|0
5611977|NCT00819585|19387191|P3|Core Study|Death|0
5611978|NCT00819585|19387192|P2|Core Study|Death|0
5611979|NCT00819585|19387193|P1|Core Study|Death|0
5611980|NCT00819585|19387183|P11|Core Study|Administrative Problems|0
5611981|NCT00819585|19387184|P10|Core Study|Administrative Problems|0
5611982|NCT00819585|19387185|P9|Core Study|Administrative Problems|0
5611983|NCT00819585|19387186|P8|Core Study|Administrative Problems|0
5611984|NCT00819585|19387187|P7|Core Study|Administrative Problems|2
5611985|NCT00819585|19387188|P6|Core Study|Administrative Problems|0
5611986|NCT00819585|19387189|P5|Core Study|Administrative Problems|0
5611987|NCT00819585|19387190|P4|Core Study|Administrative Problems|0
5611988|NCT00819585|19387191|P3|Core Study|Administrative Problems|0
5611989|NCT00819585|19387192|P2|Core Study|Administrative Problems|0
5611990|NCT00819585|19387193|P1|Core Study|Administrative Problems|0
5611991|NCT00819585|19387183|P11|Core Study|Lost to Follow-up|0
5611992|NCT00819585|19387184|P10|Core Study|Lost to Follow-up|0
5611993|NCT00819585|19387185|P9|Core Study|Lost to Follow-up|0
5611994|NCT00819585|19387186|P8|Core Study|Lost to Follow-up|0
5611995|NCT00819585|19387187|P7|Core Study|Lost to Follow-up|1
5611996|NCT00819585|19387188|P6|Core Study|Lost to Follow-up|1
5611997|NCT00819585|19387189|P5|Core Study|Lost to Follow-up|1
5611998|NCT00819585|19387190|P4|Core Study|Lost to Follow-up|0
5611999|NCT00819585|19387191|P3|Core Study|Lost to Follow-up|2
5612000|NCT00819585|19387192|P2|Core Study|Lost to Follow-up|1
5612001|NCT00819585|19387193|P1|Core Study|Lost to Follow-up|2
5612002|NCT00819585|19387183|P11|Core Study|Subject Withdrew Consent|0
5612003|NCT00819585|19387184|P10|Core Study|Subject Withdrew Consent|0
5612004|NCT00819585|19387185|P9|Core Study|Subject Withdrew Consent|0
5612005|NCT00819585|19387186|P8|Core Study|Subject Withdrew Consent|0
5612006|NCT00819585|19387187|P7|Core Study|Subject Withdrew Consent|3
5612007|NCT00819585|19387188|P6|Core Study|Subject Withdrew Consent|0
5612008|NCT00819585|19387189|P5|Core Study|Subject Withdrew Consent|0
5612009|NCT00819585|19387190|P4|Core Study|Subject Withdrew Consent|1
5612010|NCT00819585|19387191|P3|Core Study|Subject Withdrew Consent|2
5612011|NCT00819585|19387192|P2|Core Study|Subject Withdrew Consent|3
5612012|NCT00819585|19387193|P1|Core Study|Subject Withdrew Consent|0
5612013|NCT00819585|19387183|P11|Core Study|Subject No Longer Requires Study Drug|0
5612014|NCT00819585|19387184|P10|Core Study|Subject No Longer Requires Study Drug|0
5612015|NCT00819585|19387185|P9|Core Study|Subject No Longer Requires Study Drug|0
5612016|NCT00819585|19387186|P8|Core Study|Subject No Longer Requires Study Drug|0
5612017|NCT00819585|19387187|P7|Core Study|Subject No Longer Requires Study Drug|0
5612018|NCT00819585|19387188|P6|Core Study|Subject No Longer Requires Study Drug|0
5612019|NCT00819585|19387189|P5|Core Study|Subject No Longer Requires Study Drug|1
5612020|NCT00819585|19387190|P4|Core Study|Subject No Longer Requires Study Drug|0
5612021|NCT00819585|19387191|P3|Core Study|Subject No Longer Requires Study Drug|0
5612022|NCT00819585|19387192|P2|Core Study|Subject No Longer Requires Study Drug|0
5612023|NCT00819585|19387193|P1|Core Study|Subject No Longer Requires Study Drug|0
5612024|NCT00819585|19387183|P11|Core Study|Unsatisfactory Therapeutic Effect|0
5612025|NCT00819585|19387184|P10|Core Study|Unsatisfactory Therapeutic Effect|0
5612026|NCT00819585|19387185|P9|Core Study|Unsatisfactory Therapeutic Effect|0
5612027|NCT00819585|19387186|P8|Core Study|Unsatisfactory Therapeutic Effect|0
5612028|NCT00819585|19387187|P7|Core Study|Unsatisfactory Therapeutic Effect|1
5612029|NCT00819585|19387188|P6|Core Study|Unsatisfactory Therapeutic Effect|0
5612030|NCT00819585|19387189|P5|Core Study|Unsatisfactory Therapeutic Effect|0
5612031|NCT00819585|19387190|P4|Core Study|Unsatisfactory Therapeutic Effect|0
5612032|NCT00819585|19387191|P3|Core Study|Unsatisfactory Therapeutic Effect|0
5612033|NCT00819585|19387192|P2|Core Study|Unsatisfactory Therapeutic Effect|1
5612034|NCT00819585|19387193|P1|Core Study|Unsatisfactory Therapeutic Effect|0
5612035|NCT00819585|19387183|P11|Core Study|Abnormal Laboratory Value(s)|0
5612036|NCT00819585|19387184|P10|Core Study|Abnormal Laboratory Value(s)|0
5612037|NCT00819585|19387185|P9|Core Study|Abnormal Laboratory Value(s)|0
5612038|NCT00819585|19387186|P8|Core Study|Abnormal Laboratory Value(s)|0
5612039|NCT00819585|19387187|P7|Core Study|Abnormal Laboratory Value(s)|0
5612040|NCT00819585|19387188|P6|Core Study|Abnormal Laboratory Value(s)|0
5612041|NCT00819585|19387189|P5|Core Study|Abnormal Laboratory Value(s)|0
5612042|NCT00819585|19387190|P4|Core Study|Abnormal Laboratory Value(s)|0
5612043|NCT00819585|19387191|P3|Core Study|Abnormal Laboratory Value(s)|0
5612044|NCT00819585|19387192|P2|Core Study|Abnormal Laboratory Value(s)|0
5612045|NCT00819585|19387193|P1|Core Study|Abnormal Laboratory Value(s)|2
5612046|NCT00819585|19387183|P11|Core Study|Adverse Event|0
5612047|NCT00819585|19387184|P10|Core Study|Adverse Event|0
5612048|NCT00819585|19387185|P9|Core Study|Adverse Event|0
5612049|NCT00819585|19387186|P8|Core Study|Adverse Event|0
5612050|NCT00819585|19387187|P7|Core Study|Adverse Event|2
5612051|NCT00819585|19387188|P6|Core Study|Adverse Event|0
5612052|NCT00819585|19387189|P5|Core Study|Adverse Event|1
5612053|NCT00819585|19387190|P4|Core Study|Adverse Event|4
5612054|NCT00819585|19387191|P3|Core Study|Adverse Event|1
5612055|NCT00819585|19387192|P2|Core Study|Adverse Event|1
5612056|NCT00819585|19387193|P1|Core Study|Adverse Event|2
5612057|NCT00819390|19387284|P4|Overall Study|Adverse Event|0
5612058|NCT00819390|19387285|P3|Overall Study|Adverse Event|1
5612059|NCT00819390|19387286|P2|Overall Study|Adverse Event|0
5612060|NCT00819390|19387287|P1|Overall Study|Adverse Event|0
5612061|NCT00819390|19387284|P4|Overall Study|Withdrawal by Subject|0
5612062|NCT00819390|19387285|P3|Overall Study|Withdrawal by Subject|0
5612063|NCT00819390|19387286|P2|Overall Study|Withdrawal by Subject|0
5612064|NCT00819390|19387287|P1|Overall Study|Withdrawal by Subject|2
5612065|NCT00819390|19387284|P4|Overall Study|Lost to Follow-up|0
5612066|NCT00819390|19387285|P3|Overall Study|Lost to Follow-up|0
5612067|NCT00819390|19387286|P2|Overall Study|Lost to Follow-up|1
5612068|NCT00819390|19387287|P1|Overall Study|Lost to Follow-up|1
5612069|NCT00819247|19387423|P3|Overall Study|Other|0
5612070|NCT00819247|19387424|P2|Overall Study|Other|0
5612071|NCT00819247|19387425|P1|Overall Study|Other|1
5612072|NCT00819247|19387423|P3|Overall Study|Bad prostate-specific antigen response|0
5612073|NCT00819247|19387424|P2|Overall Study|Bad prostate-specific antigen response|2
5612074|NCT00819247|19387425|P1|Overall Study|Bad prostate-specific antigen response|3
5612075|NCT00819247|19387423|P3|Overall Study|Mistakenly withdrawn|0
5612076|NCT00819247|19387424|P2|Overall Study|Mistakenly withdrawn|1
5612077|NCT00819247|19387425|P1|Overall Study|Mistakenly withdrawn|0
5612078|NCT00819247|19387423|P3|Overall Study|Protocol Violation|1
5612079|NCT00819247|19387424|P2|Overall Study|Protocol Violation|0
5612080|NCT00819247|19387425|P1|Overall Study|Protocol Violation|1
5612081|NCT00819247|19387423|P3|Overall Study|Withdrawal by Subject|0
5612082|NCT00819247|19387424|P2|Overall Study|Withdrawal by Subject|0
5612083|NCT00819247|19387425|P1|Overall Study|Withdrawal by Subject|1
5612084|NCT00819247|19387423|P3|Overall Study|Insufficient testosterone response|10
5612085|NCT00819247|19387424|P2|Overall Study|Insufficient testosterone response|8
5612086|NCT00819247|19387425|P1|Overall Study|Insufficient testosterone response|5
5612087|NCT00819247|19387423|P3|Overall Study|Adverse Event|3
5612088|NCT00819247|19387424|P2|Overall Study|Adverse Event|5
5612089|NCT00819247|19387425|P1|Overall Study|Adverse Event|0
5612090|NCT00819234|19387451|P10|Overall Study|Lost to Follow-up|2
5612091|NCT00819234|19387452|P9|Overall Study|Lost to Follow-up|1
5612092|NCT00819234|19387453|P8|Overall Study|Lost to Follow-up|1
5612093|NCT00819234|19387454|P7|Overall Study|Lost to Follow-up|1
5612094|NCT00819234|19387455|P6|Overall Study|Lost to Follow-up|1
5612095|NCT00819234|19387456|P5|Overall Study|Lost to Follow-up|1
5612096|NCT00819234|19387457|P4|Overall Study|Lost to Follow-up|2
5612097|NCT00819234|19387458|P3|Overall Study|Lost to Follow-up|0
5612098|NCT00819234|19387459|P2|Overall Study|Lost to Follow-up|2
5612099|NCT00819234|19387460|P1|Overall Study|Lost to Follow-up|2
5612100|NCT00819234|19387451|P10|Overall Study|Protocol Violation|0
5612101|NCT00819234|19387452|P9|Overall Study|Protocol Violation|0
5612102|NCT00819234|19387453|P8|Overall Study|Protocol Violation|0
5612103|NCT00819234|19387454|P7|Overall Study|Protocol Violation|0
5612104|NCT00819234|19387455|P6|Overall Study|Protocol Violation|0
5612105|NCT00819234|19387456|P5|Overall Study|Protocol Violation|0
5612106|NCT00819234|19387457|P4|Overall Study|Protocol Violation|0
5612107|NCT00819234|19387458|P3|Overall Study|Protocol Violation|1
5612108|NCT00819234|19387459|P2|Overall Study|Protocol Violation|0
5612109|NCT00819234|19387460|P1|Overall Study|Protocol Violation|0
5612110|NCT00819234|19387451|P10|Overall Study|Physician Decision|2
5612111|NCT00819234|19387452|P9|Overall Study|Physician Decision|0
5612112|NCT00819234|19387453|P8|Overall Study|Physician Decision|0
5612113|NCT00819234|19387454|P7|Overall Study|Physician Decision|0
5612114|NCT00819234|19387455|P6|Overall Study|Physician Decision|0
5612115|NCT00819234|19387456|P5|Overall Study|Physician Decision|0
5612116|NCT00819234|19387457|P4|Overall Study|Physician Decision|1
5612117|NCT00819234|19387458|P3|Overall Study|Physician Decision|0
5612118|NCT00819234|19387459|P2|Overall Study|Physician Decision|0
5612119|NCT00819234|19387460|P1|Overall Study|Physician Decision|0
5612120|NCT00819234|19387451|P10|Overall Study|Adverse Event|0
5612121|NCT00819234|19387452|P9|Overall Study|Adverse Event|0
5612122|NCT00819234|19387453|P8|Overall Study|Adverse Event|0
5612123|NCT00819234|19387454|P7|Overall Study|Adverse Event|0
5612124|NCT00819234|19387455|P6|Overall Study|Adverse Event|2
5612125|NCT00819234|19387456|P5|Overall Study|Adverse Event|0
5612126|NCT00819234|19387457|P4|Overall Study|Adverse Event|0
5612127|NCT00819234|19387458|P3|Overall Study|Adverse Event|1
5612128|NCT00819234|19387459|P2|Overall Study|Adverse Event|0
5612129|NCT00819234|19387460|P1|Overall Study|Adverse Event|0
5612130|NCT00819234|19387451|P10|Overall Study|Withdrawal by Subject|3
5612131|NCT00819234|19387452|P9|Overall Study|Withdrawal by Subject|5
5612132|NCT00819234|19387453|P8|Overall Study|Withdrawal by Subject|8
5612133|NCT00819234|19387454|P7|Overall Study|Withdrawal by Subject|4
5612134|NCT00819234|19387455|P6|Overall Study|Withdrawal by Subject|4
5612135|NCT00819234|19387456|P5|Overall Study|Withdrawal by Subject|0
5612136|NCT00819234|19387457|P4|Overall Study|Withdrawal by Subject|3
5612137|NCT00819234|19387458|P3|Overall Study|Withdrawal by Subject|6
5612138|NCT00819234|19387459|P2|Overall Study|Withdrawal by Subject|13
5612139|NCT00819234|19387460|P1|Overall Study|Withdrawal by Subject|8
5612140|NCT00819156|19387659|P6|Overall Study|Prostate-specific antigen progression|0
5612141|NCT00819156|19387660|P5|Overall Study|Prostate-specific antigen progression|1
5612142|NCT00819156|19387661|P4|Overall Study|Prostate-specific antigen progression|0
5612143|NCT00819156|19387662|P3|Overall Study|Prostate-specific antigen progression|0
5612144|NCT00819156|19387663|P2|Overall Study|Prostate-specific antigen progression|0
5612145|NCT00819156|19387664|P1|Overall Study|Prostate-specific antigen progression|0
5612146|NCT00819156|19387659|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
5612147|NCT00819156|19387660|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
5612148|NCT00819156|19387661|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
5612149|NCT00819156|19387662|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
5612150|NCT00819156|19387663|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
5612151|NCT00819156|19387664|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
5612152|NCT00819156|19387659|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
5612153|NCT00819156|19387660|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
5612154|NCT00819156|19387661|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
5612155|NCT00819156|19387662|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
5612156|NCT00819156|19387663|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
5612157|NCT00819156|19387664|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
5612158|NCT00819156|19387659|P6|Overall Study|Lost to Follow-up|2
5612159|NCT00819156|19387660|P5|Overall Study|Lost to Follow-up|0
5612160|NCT00819156|19387661|P4|Overall Study|Lost to Follow-up|0
5612161|NCT00819156|19387662|P3|Overall Study|Lost to Follow-up|0
5612162|NCT00819156|19387663|P2|Overall Study|Lost to Follow-up|1
5612163|NCT00819156|19387664|P1|Overall Study|Lost to Follow-up|0
5612164|NCT00819156|19387659|P6|Overall Study|Protocol Violation|1
5612165|NCT00819156|19387660|P5|Overall Study|Protocol Violation|0
5612166|NCT00819156|19387661|P4|Overall Study|Protocol Violation|0
5612167|NCT00819156|19387662|P3|Overall Study|Protocol Violation|1
5612168|NCT00819156|19387663|P2|Overall Study|Protocol Violation|0
5612169|NCT00819156|19387664|P1|Overall Study|Protocol Violation|1
5612170|NCT00819156|19387659|P6|Overall Study|Withdrawal by Subject|0
5612171|NCT00819156|19387660|P5|Overall Study|Withdrawal by Subject|1
5612172|NCT00819156|19387661|P4|Overall Study|Withdrawal by Subject|0
5612173|NCT00819156|19387662|P3|Overall Study|Withdrawal by Subject|2
5612174|NCT00819156|19387663|P2|Overall Study|Withdrawal by Subject|3
5612175|NCT00819156|19387664|P1|Overall Study|Withdrawal by Subject|0
5612176|NCT00819156|19387659|P6|Overall Study|Adverse Event|3
5612177|NCT00819156|19387660|P5|Overall Study|Adverse Event|2
5612178|NCT00819156|19387661|P4|Overall Study|Adverse Event|1
5612179|NCT00819156|19387662|P3|Overall Study|Adverse Event|2
5612180|NCT00819156|19387663|P2|Overall Study|Adverse Event|4
5612181|NCT00819156|19387664|P1|Overall Study|Adverse Event|1
5612182|NCT00819091|19387754|P2|Overall Study|Other|2
5612183|NCT00819091|19387755|P1|Overall Study|Other|1
5612184|NCT00819091|19387754|P2|Overall Study|Withdrawal by Subject|2
5612185|NCT00819091|19387755|P1|Overall Study|Withdrawal by Subject|1
5612186|NCT00819091|19387754|P2|Overall Study|Lost to Follow-up|0
5612187|NCT00819091|19387755|P1|Overall Study|Lost to Follow-up|2
5612188|NCT00819091|19387754|P2|Overall Study|Protocol Violation|1
5612189|NCT00819091|19387755|P1|Overall Study|Protocol Violation|0
5612190|NCT00819091|19387754|P2|Overall Study|Adverse Event|5
5612191|NCT00819091|19387755|P1|Overall Study|Adverse Event|3
5612192|NCT00819052|19387781|P2|Overall Study|Death or events leading to death|0
5612193|NCT00819052|19387782|P1|Overall Study|Death or events leading to death|1
5612194|NCT00819052|19387781|P2|Overall Study|Pregnancy|2
5612195|NCT00819052|19387782|P1|Overall Study|Pregnancy|1
5612196|NCT00819052|19387781|P2|Overall Study|Lack of Efficacy|1
5612197|NCT00819052|19387782|P1|Overall Study|Lack of Efficacy|1
5612198|NCT00819052|19387781|P2|Overall Study|Withdrawal by Subject|2
5612199|NCT00819052|19387782|P1|Overall Study|Withdrawal by Subject|1
5612200|NCT00819052|19387781|P2|Overall Study|Lost to Follow-up|2
5612201|NCT00819052|19387782|P1|Overall Study|Lost to Follow-up|1
5612202|NCT00819052|19387781|P2|Overall Study|Protocol Violation|2
5612203|NCT00819052|19387782|P1|Overall Study|Protocol Violation|1
5612204|NCT00819052|19387781|P2|Overall Study|Adverse Event|5
5612205|NCT00819052|19387782|P1|Overall Study|Adverse Event|0
5612206|NCT00819039|19387897|P3|Overall Study|Protocol Violation|0
5612207|NCT00819039|19387898|P2|Overall Study|Protocol Violation|0
5612208|NCT00819039|19387899|P1|Overall Study|Protocol Violation|1
5612209|NCT00819039|19387897|P3|Overall Study|Physician Decision|1
5612210|NCT00819039|19387898|P2|Overall Study|Physician Decision|0
5612211|NCT00819039|19387899|P1|Overall Study|Physician Decision|1
5612212|NCT00819013|19387929|P4|Overall Study|Death|1
5612213|NCT00819013|19387930|P3|Overall Study|Death|0
5612214|NCT00819013|19387931|P2|Overall Study|Death|0
5612215|NCT00819013|19387932|P1|Overall Study|Death|0
5612216|NCT00819013|19387929|P4|Overall Study|Lost to Follow-up|2
5612217|NCT00819013|19387930|P3|Overall Study|Lost to Follow-up|1
5612218|NCT00819013|19387931|P2|Overall Study|Lost to Follow-up|0
5612219|NCT00819013|19387932|P1|Overall Study|Lost to Follow-up|0
5612220|NCT00819013|19387929|P4|Overall Study|Withdrawal by Subject|0
5612221|NCT00819013|19387930|P3|Overall Study|Withdrawal by Subject|1
5612222|NCT00819013|19387931|P2|Overall Study|Withdrawal by Subject|0
5612223|NCT00819013|19387932|P1|Overall Study|Withdrawal by Subject|1
5612224|NCT00819013|19387929|P4|Overall Study|Adverse Event|0
5612225|NCT00819013|19387930|P3|Overall Study|Adverse Event|1
5612226|NCT00819013|19387931|P2|Overall Study|Adverse Event|0
5612227|NCT00819013|19387932|P1|Overall Study|Adverse Event|0
5612228|NCT00819013|19387929|P4|Overall Study|Not meeting continuing study eligibility|1
5612229|NCT00819013|19387930|P3|Overall Study|Not meeting continuing study eligibility|2
5612230|NCT00819013|19387931|P2|Overall Study|Not meeting continuing study eligibility|1
5612231|NCT00819013|19387932|P1|Overall Study|Not meeting continuing study eligibility|2
5612232|NCT00818883|19387998|P2|Overall Study|Other|7
5612233|NCT00818883|19387999|P1|Overall Study|Other|2
5612234|NCT00818883|19387998|P2|Overall Study|Lack of Efficacy|2
5612235|NCT00818883|19387999|P1|Overall Study|Lack of Efficacy|0
5612236|NCT00818883|19387998|P2|Overall Study|Withdrawal by Subject|14
5612237|NCT00818883|19387999|P1|Overall Study|Withdrawal by Subject|16
5612238|NCT00818883|19387998|P2|Overall Study|Lost to Follow-up|2
5612239|NCT00818883|19387999|P1|Overall Study|Lost to Follow-up|3
5612240|NCT00818883|19387998|P2|Overall Study|Protocol Violation|2
5612241|NCT00818883|19387999|P1|Overall Study|Protocol Violation|2
5612242|NCT00818883|19387998|P2|Overall Study|Adverse Event|19
5612243|NCT00818883|19387999|P1|Overall Study|Adverse Event|28
5612244|NCT00818779|19388046|P2|Overall Study|Adverse Event|1
5612245|NCT00818779|19388047|P1|Overall Study|Adverse Event|4
5612246|NCT00818779|19388046|P2|Overall Study|Lost to Follow-up|0
5612247|NCT00818779|19388047|P1|Overall Study|Lost to Follow-up|1
5612248|NCT00818779|19388046|P2|Overall Study|Protocol Violation|0
5612249|NCT00818779|19388047|P1|Overall Study|Protocol Violation|1
5612250|NCT00818766|19388063|P2|Overall Study|Did not Receive Allocated Intervention|0
5612251|NCT00818766|19388064|P1|Overall Study|Did not Receive Allocated Intervention|3
5612252|NCT00818766|19388063|P2|Overall Study|Death|0
5612253|NCT00818766|19388064|P1|Overall Study|Death|1
5612254|NCT00818766|19388063|P2|Overall Study|Could not be Contacted on Day 28|10
5612255|NCT00818766|19388064|P1|Overall Study|Could not be Contacted on Day 28|11
5612256|NCT00818753|19388093|P3|Overall Study|Randomised and not treated|0
5612257|NCT00818753|19388094|P2|Overall Study|Randomised and not treated|0
5612258|NCT00818753|19388095|P1|Overall Study|Randomised and not treated|2
5612259|NCT00818753|19388093|P3|Overall Study|Other reason (not specified)|1
5612260|NCT00818753|19388094|P2|Overall Study|Other reason (not specified)|0
5612261|NCT00818753|19388095|P1|Overall Study|Other reason (not specified)|0
5612262|NCT00818753|19388093|P3|Overall Study|Protocol Violation|0
5612263|NCT00818753|19388094|P2|Overall Study|Protocol Violation|0
5612264|NCT00818753|19388095|P1|Overall Study|Protocol Violation|1
5612265|NCT00818662|19388119|P4|Overall Study|Admitted to long term nursing care|0
5612266|NCT00818662|19388120|P3|Overall Study|Admitted to long term nursing care|0
5612267|NCT00818662|19388121|P2|Overall Study|Admitted to long term nursing care|1
5612268|NCT00818662|19388122|P1|Overall Study|Admitted to long term nursing care|0
5612269|NCT00818662|19388119|P4|Overall Study|Study partner decision|1
5612270|NCT00818662|19388120|P3|Overall Study|Study partner decision|0
5612271|NCT00818662|19388121|P2|Overall Study|Study partner decision|0
5612272|NCT00818662|19388122|P1|Overall Study|Study partner decision|0
5612273|NCT00818662|19388119|P4|Overall Study|Change in living situation|1
5612274|NCT00818662|19388120|P3|Overall Study|Change in living situation|0
5612275|NCT00818662|19388121|P2|Overall Study|Change in living situation|0
5612276|NCT00818662|19388122|P1|Overall Study|Change in living situation|0
5612277|NCT00818662|19388119|P4|Overall Study|Declined move to another study site|0
5612278|NCT00818662|19388120|P3|Overall Study|Declined move to another study site|0
5612279|NCT00818662|19388121|P2|Overall Study|Declined move to another study site|0
5612280|NCT00818662|19388122|P1|Overall Study|Declined move to another study site|1
5612281|NCT00818662|19388119|P4|Overall Study|Moving out of state|1
5612282|NCT00818662|19388120|P3|Overall Study|Moving out of state|0
5612283|NCT00818662|19388121|P2|Overall Study|Moving out of state|0
5612284|NCT00818662|19388122|P1|Overall Study|Moving out of state|0
5612285|NCT00818662|19388119|P4|Overall Study|Caregiver to pursue other treatment|0
5612286|NCT00818662|19388120|P3|Overall Study|Caregiver to pursue other treatment|0
5612287|NCT00818662|19388121|P2|Overall Study|Caregiver to pursue other treatment|1
5612288|NCT00818662|19388122|P1|Overall Study|Caregiver to pursue other treatment|0
5612289|NCT00818662|19388119|P4|Overall Study|Participant's health declined|1
5612290|NCT00818662|19388120|P3|Overall Study|Participant's health declined|0
5612291|NCT00818662|19388121|P2|Overall Study|Participant's health declined|0
5612292|NCT00818662|19388122|P1|Overall Study|Participant's health declined|0
5612293|NCT00818662|19388119|P4|Overall Study|Study Partner Unwilling or Unable|1
5612294|NCT00818662|19388120|P3|Overall Study|Study Partner Unwilling or Unable|1
5612295|NCT00818662|19388121|P2|Overall Study|Study Partner Unwilling or Unable|2
5612296|NCT00818662|19388122|P1|Overall Study|Study Partner Unwilling or Unable|3
5612297|NCT00818662|19388119|P4|Overall Study|Safety Risk|1
5612298|NCT00818662|19388120|P3|Overall Study|Safety Risk|0
5612299|NCT00818662|19388121|P2|Overall Study|Safety Risk|1
5612300|NCT00818662|19388122|P1|Overall Study|Safety Risk|1
5612301|NCT00818662|19388119|P4|Overall Study|Requires a Prohibited Medication|0
5612302|NCT00818662|19388120|P3|Overall Study|Requires a Prohibited Medication|0
5612303|NCT00818662|19388121|P2|Overall Study|Requires a Prohibited Medication|0
5612304|NCT00818662|19388122|P1|Overall Study|Requires a Prohibited Medication|1
5612305|NCT00818662|19388119|P4|Overall Study|Protocol Violation|0
5612306|NCT00818662|19388120|P3|Overall Study|Protocol Violation|0
5612307|NCT00818662|19388121|P2|Overall Study|Protocol Violation|1
5612308|NCT00818662|19388122|P1|Overall Study|Protocol Violation|1
5612309|NCT00818662|19388119|P4|Overall Study|Unwilling or Unable to Participate|4
5612310|NCT00818662|19388120|P3|Overall Study|Unwilling or Unable to Participate|2
5612311|NCT00818662|19388121|P2|Overall Study|Unwilling or Unable to Participate|6
5612312|NCT00818662|19388122|P1|Overall Study|Unwilling or Unable to Participate|4
5612313|NCT00818662|19388119|P4|Overall Study|Lost to Follow-up|1
5612314|NCT00818662|19388120|P3|Overall Study|Lost to Follow-up|0
5612315|NCT00818662|19388121|P2|Overall Study|Lost to Follow-up|0
5612316|NCT00818662|19388122|P1|Overall Study|Lost to Follow-up|0
5612317|NCT00818662|19388119|P4|Overall Study|Physician Decision|0
5612318|NCT00818662|19388120|P3|Overall Study|Physician Decision|0
5612319|NCT00818662|19388121|P2|Overall Study|Physician Decision|0
5612320|NCT00818662|19388122|P1|Overall Study|Physician Decision|1
5612321|NCT00818662|19388119|P4|Overall Study|Death|0
5612322|NCT00818662|19388120|P3|Overall Study|Death|0
5612323|NCT00818662|19388121|P2|Overall Study|Death|3
5612324|NCT00818662|19388122|P1|Overall Study|Death|1
5612325|NCT00818662|19388119|P4|Overall Study|Withdrawal by Subject|2
5612326|NCT00818662|19388120|P3|Overall Study|Withdrawal by Subject|2
5612327|NCT00818662|19388121|P2|Overall Study|Withdrawal by Subject|4
5612328|NCT00818662|19388122|P1|Overall Study|Withdrawal by Subject|5
5612329|NCT00818662|19388119|P4|Overall Study|Adverse Event|3
5612330|NCT00818662|19388120|P3|Overall Study|Adverse Event|4
5612331|NCT00818662|19388121|P2|Overall Study|Adverse Event|14
5612332|NCT00818662|19388122|P1|Overall Study|Adverse Event|5
5612333|NCT00818649|19388208|P1|Overall Study|Adverse Event|1
5612334|NCT00818649|19388208|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
5612335|NCT00818649|19388208|P1|Overall Study|Declining performance status|2
5612336|NCT00818623|19388222|P8|Overall Study|Disease progression|0
5612337|NCT00818623|19388223|P7|Overall Study|Disease progression|1
5612338|NCT00818623|19388224|P6|Overall Study|Disease progression|0
5612339|NCT00818623|19388225|P5|Overall Study|Disease progression|0
5612340|NCT00818623|19388226|P4|Overall Study|Disease progression|0
5612341|NCT00818623|19388227|P3|Overall Study|Disease progression|0
5612342|NCT00818623|19388228|P2|Overall Study|Disease progression|0
5612343|NCT00818623|19388229|P1|Overall Study|Disease progression|0
5612344|NCT00818623|19388222|P8|Overall Study|Lack of trial drug at site|0
5612345|NCT00818623|19388223|P7|Overall Study|Lack of trial drug at site|1
5612346|NCT00818623|19388224|P6|Overall Study|Lack of trial drug at site|0
5612347|NCT00818623|19388225|P5|Overall Study|Lack of trial drug at site|2
5612348|NCT00818623|19388226|P4|Overall Study|Lack of trial drug at site|0
5612349|NCT00818623|19388227|P3|Overall Study|Lack of trial drug at site|0
5612350|NCT00818623|19388228|P2|Overall Study|Lack of trial drug at site|0
5612351|NCT00818623|19388229|P1|Overall Study|Lack of trial drug at site|0
5612352|NCT00818623|19388222|P8|Overall Study|Need of additional treatment|0
5612353|NCT00818623|19388223|P7|Overall Study|Need of additional treatment|0
5612354|NCT00818623|19388224|P6|Overall Study|Need of additional treatment|0
5612355|NCT00818623|19388225|P5|Overall Study|Need of additional treatment|1
5612356|NCT00818623|19388226|P4|Overall Study|Need of additional treatment|0
5612357|NCT00818623|19388227|P3|Overall Study|Need of additional treatment|0
5612358|NCT00818623|19388228|P2|Overall Study|Need of additional treatment|0
5612359|NCT00818623|19388229|P1|Overall Study|Need of additional treatment|0
5612360|NCT00818623|19388222|P8|Overall Study|Protocol Violation|0
5612361|NCT00818623|19388223|P7|Overall Study|Protocol Violation|1
5612362|NCT00818623|19388224|P6|Overall Study|Protocol Violation|0
5612363|NCT00818623|19388225|P5|Overall Study|Protocol Violation|1
5612364|NCT00818623|19388226|P4|Overall Study|Protocol Violation|0
5612365|NCT00818623|19388227|P3|Overall Study|Protocol Violation|0
5612366|NCT00818623|19388228|P2|Overall Study|Protocol Violation|0
5612367|NCT00818623|19388229|P1|Overall Study|Protocol Violation|1
5612368|NCT00818623|19388222|P8|Overall Study|Withdrawal by Subject|1
5612369|NCT00818623|19388223|P7|Overall Study|Withdrawal by Subject|1
5612370|NCT00818623|19388224|P6|Overall Study|Withdrawal by Subject|1
5612371|NCT00818623|19388225|P5|Overall Study|Withdrawal by Subject|0
5612372|NCT00818623|19388226|P4|Overall Study|Withdrawal by Subject|0
5612373|NCT00818623|19388227|P3|Overall Study|Withdrawal by Subject|1
5612374|NCT00818623|19388228|P2|Overall Study|Withdrawal by Subject|1
5612375|NCT00818623|19388229|P1|Overall Study|Withdrawal by Subject|0
5612376|NCT00818623|19388222|P8|Overall Study|Bad prostate specific antigen response|0
5612377|NCT00818623|19388223|P7|Overall Study|Bad prostate specific antigen response|0
5612378|NCT00818623|19388224|P6|Overall Study|Bad prostate specific antigen response|1
5612379|NCT00818623|19388225|P5|Overall Study|Bad prostate specific antigen response|0
5612380|NCT00818623|19388226|P4|Overall Study|Bad prostate specific antigen response|5
5612381|NCT00818623|19388227|P3|Overall Study|Bad prostate specific antigen response|2
5612382|NCT00818623|19388228|P2|Overall Study|Bad prostate specific antigen response|3
5612383|NCT00818623|19388229|P1|Overall Study|Bad prostate specific antigen response|0
5612384|NCT00818623|19388222|P8|Overall Study|Adverse Event|0
5612385|NCT00818623|19388223|P7|Overall Study|Adverse Event|0
5612386|NCT00818623|19388224|P6|Overall Study|Adverse Event|1
5612387|NCT00818623|19388225|P5|Overall Study|Adverse Event|0
5612388|NCT00818623|19388226|P4|Overall Study|Adverse Event|0
5612389|NCT00818623|19388227|P3|Overall Study|Adverse Event|1
5612390|NCT00818623|19388228|P2|Overall Study|Adverse Event|0
5612391|NCT00818623|19388229|P1|Overall Study|Adverse Event|1
5612392|NCT00818519|19388305|P2|Overall Study|participant will leave for long tme|0
5612393|NCT00818519|19388306|P1|Overall Study|participant will leave for long tme|1
5612394|NCT00818519|19388305|P2|Overall Study|participant recovered completely|0
5612395|NCT00818519|19388306|P1|Overall Study|participant recovered completely|1
5612396|NCT00818519|19388305|P2|Overall Study|Withdrawal by Subject|9
5612397|NCT00818519|19388306|P1|Overall Study|Withdrawal by Subject|4
5612398|NCT00818519|19388305|P2|Overall Study|Pregnancy|1
5612399|NCT00818519|19388306|P1|Overall Study|Pregnancy|0
5612400|NCT00818519|19388305|P2|Overall Study|Protocol Violation|1
5612401|NCT00818519|19388306|P1|Overall Study|Protocol Violation|2
5612402|NCT00818519|19388305|P2|Overall Study|Lost to Follow-up|6
5612403|NCT00818519|19388306|P1|Overall Study|Lost to Follow-up|4
5612404|NCT00818519|19388305|P2|Overall Study|Adverse Event|2
5612405|NCT00818519|19388306|P1|Overall Study|Adverse Event|2
5612406|NCT00818454|19388336|P4|Treatment Period 3|Adverse Event|1
5612407|NCT00818454|19388337|P3|Treatment Period 3|Adverse Event|0
5612408|NCT00818454|19388338|P2|Treatment Period 3|Adverse Event|0
5612409|NCT00818454|19388339|P1|Treatment Period 3|Adverse Event|0
5612410|NCT00818454|19388336|P4|Treatment Period 2|Other|0
5612411|NCT00818454|19388337|P3|Treatment Period 2|Other|0
5612412|NCT00818454|19388338|P2|Treatment Period 2|Other|1
5612413|NCT00818454|19388339|P1|Treatment Period 2|Other|2
5612414|NCT00818454|19388336|P4|Washout Period of 1 Week|Other|0
5612415|NCT00818454|19388337|P3|Washout Period of 1 Week|Other|0
5612416|NCT00818454|19388338|P2|Washout Period of 1 Week|Other|2
5612417|NCT00818454|19388339|P1|Washout Period of 1 Week|Other|1
5612418|NCT00818454|19388336|P4|Washout Period of 1 Week|Protocol Violation|0
5612419|NCT00818454|19388337|P3|Washout Period of 1 Week|Protocol Violation|0
5612420|NCT00818454|19388338|P2|Washout Period of 1 Week|Protocol Violation|0
5612421|NCT00818454|19388339|P1|Washout Period of 1 Week|Protocol Violation|2
5612422|NCT00818454|19388336|P4|Washout Period of 1 Week|Adverse Event|0
5612423|NCT00818454|19388337|P3|Washout Period of 1 Week|Adverse Event|0
5612424|NCT00818454|19388338|P2|Washout Period of 1 Week|Adverse Event|1
5612425|NCT00818454|19388339|P1|Washout Period of 1 Week|Adverse Event|1
5612426|NCT00818454|19388336|P4|Treatment Period 1|Other|0
5612427|NCT00818454|19388337|P3|Treatment Period 1|Other|0
5612428|NCT00818454|19388338|P2|Treatment Period 1|Other|0
5612429|NCT00818454|19388339|P1|Treatment Period 1|Other|3
5612430|NCT00818454|19388336|P4|Treatment Period 1|Adverse Event|0
5612431|NCT00818454|19388337|P3|Treatment Period 1|Adverse Event|0
5612432|NCT00818454|19388338|P2|Treatment Period 1|Adverse Event|1
5612433|NCT00818454|19388339|P1|Treatment Period 1|Adverse Event|0
5612434|NCT00818441|19388367|P2|Overall Study|Study terminated by sponsor|2
5612435|NCT00818441|19388368|P1|Overall Study|Study terminated by sponsor|11
5612436|NCT00818441|19388367|P2|Overall Study|Adverse Event|1
5612437|NCT00818441|19388368|P1|Overall Study|Adverse Event|0
5612438|NCT00818441|19388367|P2|Overall Study|Withdrawal by Subject|0
5612439|NCT00818441|19388368|P1|Overall Study|Withdrawal by Subject|2
5612440|NCT00818441|19388367|P2|Overall Study|Lost to Follow-up|1
5612441|NCT00818441|19388368|P1|Overall Study|Lost to Follow-up|2
5612442|NCT00818441|19388367|P2|Overall Study|Other|0
5612443|NCT00818441|19388368|P1|Overall Study|Other|5
5612444|NCT00818441|19388367|P2|Overall Study|Death|26
5612445|NCT00818441|19388368|P1|Overall Study|Death|69
5612446|NCT00818389|19388390|P2|Overall Study|Adverse Event|1
5612447|NCT00818389|19388391|P1|Overall Study|Adverse Event|0
5612448|NCT00818389|19388390|P2|Overall Study|Withdrawal by Subject|2
5612449|NCT00818389|19388391|P1|Overall Study|Withdrawal by Subject|2
5612450|NCT00818389|19388390|P2|Overall Study|ALS Disease Progression|0
5612451|NCT00818389|19388391|P1|Overall Study|ALS Disease Progression|1
5612452|NCT00818389|19388390|P2|Overall Study|Death|3
5612453|NCT00818389|19388391|P1|Overall Study|Death|1
5612454|NCT00818259|19388426|P9|Part V|Adverse Event|0
5612455|NCT00818259|19388427|P8|Part V|Adverse Event|1
5612456|NCT00818259|19388428|P7|Part V|Adverse Event|0
5612457|NCT00818259|19388429|P6|Part V|Adverse Event|0
5612458|NCT00818259|19388430|P5|Part V|Adverse Event|0
5612459|NCT00818259|19388431|P4|Part V|Adverse Event|0
5612460|NCT00818259|19388432|P3|Part V|Adverse Event|0
5612461|NCT00818259|19388433|P2|Part V|Adverse Event|0
5612462|NCT00818259|19388434|P1|Part V|Adverse Event|0
5612463|NCT00818259|19388426|P9|Part IV|Physician Decision|0
5612464|NCT00818259|19388427|P8|Part IV|Physician Decision|0
5612465|NCT00818259|19388428|P7|Part IV|Physician Decision|0
5612466|NCT00818259|19388429|P6|Part IV|Physician Decision|1
5612467|NCT00818259|19388430|P5|Part IV|Physician Decision|0
5612468|NCT00818259|19388431|P4|Part IV|Physician Decision|0
5612469|NCT00818259|19388432|P3|Part IV|Physician Decision|0
5612470|NCT00818259|19388433|P2|Part IV|Physician Decision|0
5612471|NCT00818259|19388434|P1|Part IV|Physician Decision|0
5612472|NCT00818259|19388426|P9|Part II|Not Treated|0
5612473|NCT00818259|19388427|P8|Part II|Not Treated|0
5612474|NCT00818259|19388428|P7|Part II|Not Treated|0
5612475|NCT00818259|19388429|P6|Part II|Not Treated|0
5612476|NCT00818259|19388430|P5|Part II|Not Treated|0
5612477|NCT00818259|19388431|P4|Part II|Not Treated|1
5612478|NCT00818259|19388432|P3|Part II|Not Treated|0
5612479|NCT00818259|19388433|P2|Part II|Not Treated|0
5612480|NCT00818259|19388434|P1|Part II|Not Treated|0
5612481|NCT00818259|19388426|P9|Part II|Lack of Efficacy|0
5612482|NCT00818259|19388427|P8|Part II|Lack of Efficacy|0
5612483|NCT00818259|19388428|P7|Part II|Lack of Efficacy|0
5612484|NCT00818259|19388429|P6|Part II|Lack of Efficacy|0
5612485|NCT00818259|19388430|P5|Part II|Lack of Efficacy|0
5612486|NCT00818259|19388431|P4|Part II|Lack of Efficacy|1
5612487|NCT00818259|19388432|P3|Part II|Lack of Efficacy|0
5612488|NCT00818259|19388433|P2|Part II|Lack of Efficacy|0
5612489|NCT00818259|19388434|P1|Part II|Lack of Efficacy|0
5612490|NCT00818259|19388426|P9|Part II|Physician Decision|0
5612491|NCT00818259|19388427|P8|Part II|Physician Decision|0
5612492|NCT00818259|19388428|P7|Part II|Physician Decision|0
5612493|NCT00818259|19388429|P6|Part II|Physician Decision|0
5612494|NCT00818259|19388430|P5|Part II|Physician Decision|0
5612495|NCT00818259|19388431|P4|Part II|Physician Decision|0
5612496|NCT00818259|19388432|P3|Part II|Physician Decision|1
5612497|NCT00818259|19388433|P2|Part II|Physician Decision|0
5612498|NCT00818259|19388434|P1|Part II|Physician Decision|0
5612499|NCT00818259|19388426|P9|Part I|Withdrawal by Subject|0
5612500|NCT00818259|19388427|P8|Part I|Withdrawal by Subject|0
5612501|NCT00818259|19388428|P7|Part I|Withdrawal by Subject|0
5612502|NCT00818259|19388429|P6|Part I|Withdrawal by Subject|0
5612503|NCT00818259|19388430|P5|Part I|Withdrawal by Subject|0
5612504|NCT00818259|19388431|P4|Part I|Withdrawal by Subject|0
5612505|NCT00818259|19388432|P3|Part I|Withdrawal by Subject|0
5612506|NCT00818259|19388433|P2|Part I|Withdrawal by Subject|0
5612507|NCT00818259|19388434|P1|Part I|Withdrawal by Subject|1
5612508|NCT00818246|19388506|P1|Overall Study|Impossible to match pictures|5
5612509|NCT00818207|19388515|P2|Overall Study|Death|5
5612510|NCT00818207|19388516|P1|Overall Study|Death|3
5612511|NCT00818207|19388515|P2|Overall Study|Withdrawal by Subject|104
5612512|NCT00818207|19388516|P1|Overall Study|Withdrawal by Subject|42
5612513|NCT00818207|19388515|P2|Overall Study|Multiple reasons|12
5612514|NCT00818207|19388516|P1|Overall Study|Multiple reasons|11
5612515|NCT00818207|19388515|P2|Overall Study|Lost to Follow-up|146
5612516|NCT00818207|19388516|P1|Overall Study|Lost to Follow-up|160
5612517|NCT00818207|19388515|P2|Overall Study|Adverse Event|0
5612518|NCT00818207|19388516|P1|Overall Study|Adverse Event|6
5612519|NCT00818168|19388530|P1|Overall Study|Participant Moved|2
5612520|NCT00818168|19388530|P1|Overall Study|Reason for Non-completion Not reported|6
5612521|NCT00818168|19388530|P1|Overall Study|Adverse Event|19
5612522|NCT00818168|19388530|P1|Overall Study|Lost to Follow-up|7
5612523|NCT00818168|19388530|P1|Overall Study|Withdrawal by Subject|16
5612524|NCT00818168|19388530|P1|Overall Study|Pregnancy|2
5612525|NCT00818168|19388530|P1|Overall Study|Lack of Efficacy|18
5612526|NCT00817778|19388570|P2|Overall Study|Poor venous access|0
5612527|NCT00817778|19388571|P1|Overall Study|Poor venous access|1
5612528|NCT00817778|19388570|P2|Overall Study|Study-specific discontinuation criteria|1
5612529|NCT00817778|19388571|P1|Overall Study|Study-specific discontinuation criteria|0
5612530|NCT00817778|19388570|P2|Overall Study|Protocol Violation|1
5612531|NCT00817778|19388571|P1|Overall Study|Protocol Violation|0
5612532|NCT00817778|19388570|P2|Overall Study|Withdrawal by Subject|1
5612533|NCT00817778|19388571|P1|Overall Study|Withdrawal by Subject|1
5612534|NCT00817778|19388570|P2|Overall Study|Adverse Event|0
5612535|NCT00817778|19388571|P1|Overall Study|Adverse Event|1
5612536|NCT00817531|19388600|P1|Overall Study|Lack of Efficacy|1
5612537|NCT00817531|19388600|P1|Overall Study|Adverse Event|1
5612538|NCT00817479|19388606|P2|Overall Study|Physician Decision|1
5612539|NCT00817479|19388607|P1|Overall Study|Physician Decision|1
5612540|NCT00817336|19388617|P2|Overall Study|Withdrawal by Subject|1
5612541|NCT00817336|19388618|P1|Overall Study|Withdrawal by Subject|1
5612542|NCT00817206|19388644|P2|Overall Study|Physician Decision|0
5612543|NCT00817206|19388645|P1|Overall Study|Physician Decision|2
5612544|NCT00817206|19388644|P2|Overall Study|Withdrawal by Subject|3
5612545|NCT00817206|19388645|P1|Overall Study|Withdrawal by Subject|7
5612546|NCT00817206|19388644|P2|Overall Study|Death|0
5612547|NCT00817206|19388645|P1|Overall Study|Death|2
5612548|NCT00817206|19388644|P2|Overall Study|Lost to Follow-up|1
5612549|NCT00817206|19388645|P1|Overall Study|Lost to Follow-up|0
5612550|NCT00817206|19388644|P2|Overall Study|Protocol Violation|2
5612551|NCT00817206|19388645|P1|Overall Study|Protocol Violation|0
5612552|NCT00817206|19388644|P2|Overall Study|Adverse Event|3
5612553|NCT00817206|19388645|P1|Overall Study|Adverse Event|10
5612554|NCT00817089|19388655|P4|Second Alcohol Challenge|Lost to Follow-up|0
5612555|NCT00817089|19388656|P3|Second Alcohol Challenge|Lost to Follow-up|0
5612556|NCT00817089|19388657|P2|Second Alcohol Challenge|Lost to Follow-up|1
5612557|NCT00817089|19388658|P1|Second Alcohol Challenge|Lost to Follow-up|0
5612558|NCT00817089|19388655|P4|First Alcohol Challenge|Lost to Follow-up|1
5612559|NCT00817089|19388656|P3|First Alcohol Challenge|Lost to Follow-up|0
5612560|NCT00817089|19388657|P2|First Alcohol Challenge|Lost to Follow-up|0
5612561|NCT00817089|19388658|P1|First Alcohol Challenge|Lost to Follow-up|0
5612562|NCT00817063|19388674|P2|Overall Study|Abnormality of Laboratory Test|1
5612563|NCT00817063|19388675|P1|Overall Study|Abnormality of Laboratory Test|2
5612564|NCT00817063|19388674|P2|Overall Study|Administrative|4
5612565|NCT00817063|19388675|P1|Overall Study|Administrative|10
5612566|NCT00817063|19388674|P2|Overall Study|Early Improvement|4
5612567|NCT00817063|19388675|P1|Overall Study|Early Improvement|19
5612568|NCT00817063|19388674|P2|Overall Study|Withdrawal by Subject|37
5612569|NCT00817063|19388675|P1|Overall Study|Withdrawal by Subject|17
5612570|NCT00817063|19388674|P2|Overall Study|Protocol Violation|8
5612571|NCT00817063|19388675|P1|Overall Study|Protocol Violation|3
5612572|NCT00817063|19388674|P2|Overall Study|Violation of Selection at Entry|4
5612573|NCT00817063|19388675|P1|Overall Study|Violation of Selection at Entry|7
5612574|NCT00817063|19388674|P2|Overall Study|Failure to Return|12
5612575|NCT00817063|19388675|P1|Overall Study|Failure to Return|13
5612576|NCT00817063|19388674|P2|Overall Study|Lack of Efficacy|86
5612577|NCT00817063|19388675|P1|Overall Study|Lack of Efficacy|33
5612578|NCT00817063|19388674|P2|Overall Study|Death|1
5612579|NCT00817063|19388675|P1|Overall Study|Death|1
5612580|NCT00817063|19388674|P2|Overall Study|Adverse Event|13
5612581|NCT00817063|19388675|P1|Overall Study|Adverse Event|32
5612582|NCT00816595|19388803|P2|Overall Study|Withdrawal by Subject|0
5612583|NCT00816595|19388804|P1|Overall Study|Withdrawal by Subject|2
5612584|NCT00816556|19388817|P3|Overall Study|Lost to Follow-up|1
5612585|NCT00816556|19388818|P2|Overall Study|Lost to Follow-up|0
5612586|NCT00816556|19388819|P1|Overall Study|Lost to Follow-up|0
5612587|NCT00816556|19388817|P3|Overall Study|Withdrawal by Subject|1
5612588|NCT00816556|19388818|P2|Overall Study|Withdrawal by Subject|1
5612589|NCT00816556|19388819|P1|Overall Study|Withdrawal by Subject|1
5612590|NCT00816556|19388817|P3|Overall Study|Adverse Event|1
5612591|NCT00816556|19388818|P2|Overall Study|Adverse Event|1
5612592|NCT00816556|19388819|P1|Overall Study|Adverse Event|1
5612593|NCT00816400|19388842|P9|Overall Study|In hospice care at the end of the study|0
5612594|NCT00816400|19388843|P8|Overall Study|In hospice care at the end of the study|0
5612595|NCT00816400|19388844|P7|Overall Study|In hospice care at the end of the study|0
5612596|NCT00816400|19388845|P6|Overall Study|In hospice care at the end of the study|0
5612597|NCT00816400|19388846|P5|Overall Study|In hospice care at the end of the study|0
5612598|NCT00816400|19388847|P4|Overall Study|In hospice care at the end of the study|0
5612599|NCT00816400|19388848|P3|Overall Study|In hospice care at the end of the study|2
5612600|NCT00816400|19388849|P2|Overall Study|In hospice care at the end of the study|0
5612601|NCT00816400|19388850|P1|Overall Study|In hospice care at the end of the study|0
5612602|NCT00816400|19388842|P9|Overall Study|Death|6
5612603|NCT00816400|19388843|P8|Overall Study|Death|5
5612604|NCT00816400|19388844|P7|Overall Study|Death|2
5612605|NCT00816400|19388845|P6|Overall Study|Death|3
5612606|NCT00816400|19388846|P5|Overall Study|Death|2
5612607|NCT00816400|19388847|P4|Overall Study|Death|3
5612608|NCT00816400|19388848|P3|Overall Study|Death|3
5612609|NCT00816400|19388849|P2|Overall Study|Death|3
5612610|NCT00816400|19388850|P1|Overall Study|Death|2
5612611|NCT00816361|19389041|P9|Overall Study|Other|1
5612612|NCT00816361|19389042|P8|Overall Study|Other|0
5612613|NCT00816361|19389043|P7|Overall Study|Other|0
5612614|NCT00816361|19389044|P6|Overall Study|Other|0
5612615|NCT00816361|19389045|P5|Overall Study|Other|0
5612616|NCT00816361|19389046|P4|Overall Study|Other|0
5612617|NCT00816361|19389047|P3|Overall Study|Other|0
5612618|NCT00816361|19389048|P2|Overall Study|Other|0
5612619|NCT00816361|19389049|P1|Overall Study|Other|0
5612620|NCT00816361|19389041|P9|Overall Study|Death|8
5612621|NCT00816361|19389042|P8|Overall Study|Death|7
5612622|NCT00816361|19389043|P7|Overall Study|Death|3
5612623|NCT00816361|19389044|P6|Overall Study|Death|1
5612624|NCT00816361|19389045|P5|Overall Study|Death|1
5612625|NCT00816361|19389046|P4|Overall Study|Death|3
5612626|NCT00816361|19389047|P3|Overall Study|Death|3
5612627|NCT00816361|19389048|P2|Overall Study|Death|3
5612628|NCT00816361|19389049|P1|Overall Study|Death|4
5612629|NCT00816361|19389041|P9|Overall Study|Withdrawal by Subject|1
5612630|NCT00816361|19389042|P8|Overall Study|Withdrawal by Subject|2
5612631|NCT00816361|19389043|P7|Overall Study|Withdrawal by Subject|0
5612632|NCT00816361|19389044|P6|Overall Study|Withdrawal by Subject|2
5612633|NCT00816361|19389045|P5|Overall Study|Withdrawal by Subject|1
5612634|NCT00816361|19389046|P4|Overall Study|Withdrawal by Subject|0
5612635|NCT00816361|19389047|P3|Overall Study|Withdrawal by Subject|0
5612636|NCT00816361|19389048|P2|Overall Study|Withdrawal by Subject|0
5612637|NCT00816361|19389049|P1|Overall Study|Withdrawal by Subject|0
5612638|NCT00816166|19389208|P2|Overall Study|Death|2
5612639|NCT00816166|19389209|P1|Overall Study|Death|4
5612640|NCT00816166|19389208|P2|Overall Study|Lost to Follow-up|10
5612641|NCT00816166|19389209|P1|Overall Study|Lost to Follow-up|6
5612642|NCT00816036|19389241|P2|Overall Study|Withdrawal by Subject|23
5612643|NCT00816036|19389242|P1|Overall Study|Withdrawal by Subject|54
5612644|NCT00816036|19389241|P2|Overall Study|Lost to Follow-up|57
5612645|NCT00816036|19389242|P1|Overall Study|Lost to Follow-up|75
5612646|NCT00816036|19389241|P2|Overall Study|Death|28
5612647|NCT00816036|19389242|P1|Overall Study|Death|47
5612648|NCT00816023|19389256|P4|Overall Study|Randomized Not Treated|11
5612649|NCT00816023|19389257|P3|Overall Study|Randomized Not Treated|6
5612650|NCT00816023|19389258|P2|Overall Study|Randomized Not Treated|4
5612651|NCT00816023|19389259|P1|Overall Study|Randomized Not Treated|6
5612652|NCT00816023|19389256|P4|Overall Study|assessments complete prior to window|1
5612653|NCT00816023|19389257|P3|Overall Study|assessments complete prior to window|2
5612654|NCT00816023|19389258|P2|Overall Study|assessments complete prior to window|1
5612655|NCT00816023|19389259|P1|Overall Study|assessments complete prior to window|1
5612656|NCT00816023|19389256|P4|Overall Study|Physician Decision|0
5612657|NCT00816023|19389257|P3|Overall Study|Physician Decision|1
5612658|NCT00816023|19389258|P2|Overall Study|Physician Decision|0
5612659|NCT00816023|19389259|P1|Overall Study|Physician Decision|0
5612660|NCT00816023|19389256|P4|Overall Study|Withdrawal by Subject|0
5612661|NCT00816023|19389257|P3|Overall Study|Withdrawal by Subject|0
5612662|NCT00816023|19389258|P2|Overall Study|Withdrawal by Subject|0
5612663|NCT00816023|19389259|P1|Overall Study|Withdrawal by Subject|1
5612664|NCT00816023|19389256|P4|Overall Study|Lost to Follow-up|0
5612665|NCT00816023|19389257|P3|Overall Study|Lost to Follow-up|0
5612666|NCT00816023|19389258|P2|Overall Study|Lost to Follow-up|1
5612667|NCT00816023|19389259|P1|Overall Study|Lost to Follow-up|1
5612668|NCT00815919|19389296|P1|Overall Study|Lack of Efficacy|2
5612669|NCT00815919|19389296|P1|Overall Study|AML Relapse|1
5612670|NCT00815919|19389296|P1|Overall Study|Unrelated Fungal Infection|1
5612671|NCT00815659|19389339|P1|Overall Study|Protocol Violation|1
5612672|NCT00815659|19389339|P1|Overall Study|Lost to Follow-up|4
5612673|NCT00815659|19389339|P1|Overall Study|Withdrawal by Subject|9
5612674|NCT00815659|19389339|P1|Overall Study|Adverse Event|9
5612675|NCT00815633|19389382|P1|Overall Study|study terminated|1
5612676|NCT00815516|19389389|P2|Overall Study|Physician Decision|0
5612677|NCT00815516|19389390|P1|Overall Study|Physician Decision|1
5612678|NCT00815516|19389389|P2|Overall Study|Death|1
5612679|NCT00815516|19389390|P1|Overall Study|Death|3
5612680|NCT00815308|19389455|P1|Overall Study|Protocol Violation|6
5612681|NCT00815308|19389455|P1|Overall Study|Withdrawal by Subject|0
5612682|NCT00815308|19389455|P1|Overall Study|Adverse Event|4
5612683|NCT00815295|19389464|P3|Overall Study|Cetuximab hypersensitivity reaction|3
5612684|NCT00815295|19389465|P2|Overall Study|Cetuximab hypersensitivity reaction|1
5612685|NCT00815295|19389466|P1|Overall Study|Cetuximab hypersensitivity reaction|0
5612686|NCT00815191|19389478|P2|Overall Study|Protocol Violation|1
5612687|NCT00815191|19389479|P1|Overall Study|Protocol Violation|1
5612688|NCT00814983|19389516|P2|Overall Study|Graft failure|0
5612689|NCT00814983|19389517|P1|Overall Study|Graft failure|1
5612690|NCT00814983|19389516|P2|Overall Study|Withdrawal by Subject|0
5612691|NCT00814983|19389517|P1|Overall Study|Withdrawal by Subject|1
5612692|NCT00814983|19389516|P2|Overall Study|Screen failure|0
5612693|NCT00814983|19389517|P1|Overall Study|Screen failure|1
5612694|NCT00814892|19389548|P1|Overall Study|Study Termination|1
5612695|NCT00814892|19389548|P1|Overall Study|Disease Progression|1
5612696|NCT00814879|19389560|P2|By Week 48|Death|1
5612697|NCT00814879|19389561|P1|By Week 48|Death|0
5612698|NCT00814879|19389560|P2|By Week 48|Lost to Follow-up|2
5612699|NCT00814879|19389561|P1|By Week 48|Lost to Follow-up|2
5612700|NCT00814879|19389560|P2|By Week 24|Incarceration|1
5612701|NCT00814879|19389561|P1|By Week 24|Incarceration|0
5612702|NCT00814879|19389560|P2|By Week 24|Cancer Diagnosis|0
5612703|NCT00814879|19389561|P1|By Week 24|Cancer Diagnosis|1
5612704|NCT00814801|19389580|P3|Overall Study|Other|4
5612705|NCT00814801|19389581|P2|Overall Study|Other|6
5612706|NCT00814801|19389582|P1|Overall Study|Other|2
5612707|NCT00814801|19389580|P3|Overall Study|Non-compliance|1
5612708|NCT00814801|19389581|P2|Overall Study|Non-compliance|1
5612709|NCT00814801|19389582|P1|Overall Study|Non-compliance|0
5612710|NCT00814801|19389580|P3|Overall Study|Missing or change of caregiver|4
5612711|NCT00814801|19389581|P2|Overall Study|Missing or change of caregiver|2
5612712|NCT00814801|19389582|P1|Overall Study|Missing or change of caregiver|6
5612713|NCT00814801|19389580|P3|Overall Study|Change of patients for CIBIC plus-J|0
5612714|NCT00814801|19389581|P2|Overall Study|Change of patients for CIBIC plus-J|1
5612715|NCT00814801|19389582|P1|Overall Study|Change of patients for CIBIC plus-J|1
5612716|NCT00814801|19389580|P3|Overall Study|Inappropriate as a subject|1
5612717|NCT00814801|19389581|P2|Overall Study|Inappropriate as a subject|1
5612718|NCT00814801|19389582|P1|Overall Study|Inappropriate as a subject|1
5612719|NCT00814801|19389580|P3|Overall Study|Withdrawal by Subject|14
5612720|NCT00814801|19389581|P2|Overall Study|Withdrawal by Subject|11
5612721|NCT00814801|19389582|P1|Overall Study|Withdrawal by Subject|9
5612722|NCT00814801|19389580|P3|Overall Study|Adverse Event|19
5612723|NCT00814801|19389581|P2|Overall Study|Adverse Event|16
5612724|NCT00814801|19389582|P1|Overall Study|Adverse Event|15
5612725|NCT00814710|19389621|P2|Overall Study|Lost to Follow-up|3
5612726|NCT00814710|19389622|P1|Overall Study|Lost to Follow-up|7
5612727|NCT00814710|19389621|P2|Overall Study|Adverse Event|0
5612728|NCT00814710|19389622|P1|Overall Study|Adverse Event|1
5612729|NCT00814658|19389690|P2|Overall Study|Adverse Event|3
5612730|NCT00814658|19389691|P1|Overall Study|Adverse Event|3
5612731|NCT00814658|19389690|P2|Overall Study|Physician Decision|0
5612732|NCT00814658|19389691|P1|Overall Study|Physician Decision|1
5612733|NCT00814658|19389690|P2|Overall Study|Lost to Follow-up|1
5612734|NCT00814658|19389691|P1|Overall Study|Lost to Follow-up|0
5612735|NCT00814632|19389757|P1|Overall Study|Lack of Efficacy|2
5612736|NCT00814580|19389763|P2|Overall Study|Did Not Take Drug|2
5612737|NCT00814580|19389764|P1|Overall Study|Did Not Take Drug|2
5612738|NCT00814580|19389763|P2|Overall Study|Other|3
5612739|NCT00814580|19389764|P1|Overall Study|Other|1
5612740|NCT00814580|19389763|P2|Overall Study|Withdrawal by Subject|2
5612741|NCT00814580|19389764|P1|Overall Study|Withdrawal by Subject|2
5612742|NCT00814580|19389763|P2|Overall Study|Protocol Violation|0
5612743|NCT00814580|19389764|P1|Overall Study|Protocol Violation|2
5612744|NCT00814580|19389763|P2|Overall Study|Lack of Efficacy|25
5612745|NCT00814580|19389764|P1|Overall Study|Lack of Efficacy|18
5612746|NCT00814580|19389763|P2|Overall Study|Adverse Event|15
5612747|NCT00814580|19389764|P1|Overall Study|Adverse Event|6
5612748|NCT00814502|19389894|P2|Overall Study|Withdrawal by Subject|2
5612749|NCT00814502|19389895|P1|Overall Study|Withdrawal by Subject|0
5612750|NCT00814502|19389894|P2|Overall Study|Adverse Event|0
5612751|NCT00814502|19389895|P1|Overall Study|Adverse Event|1
5612752|NCT00814489|19389908|P3|Overall Study|Other|1
5612753|NCT00814489|19389909|P2|Overall Study|Other|0
5612754|NCT00814489|19389910|P1|Overall Study|Other|2
5612755|NCT00814463|19389942|P1|Overall Study|Lost to Follow-up|1
5612756|NCT00814346|19389955|P2|Open Phase (17 Months)|Not otherwise specified|0
5612757|NCT00814346|19389956|P1|Open Phase (17 Months)|Not otherwise specified|1
5612758|NCT00814346|19389955|P2|Open Phase (17 Months)|Lost to Follow-up|0
5612759|NCT00814346|19389956|P1|Open Phase (17 Months)|Lost to Follow-up|2
5612760|NCT00814346|19389955|P2|Open Phase (17 Months)|Consent|0
5612761|NCT00814346|19389956|P1|Open Phase (17 Months)|Consent|2
5612762|NCT00814346|19389955|P2|Open Phase (17 Months)|Adverse Event|0
5612763|NCT00814346|19389956|P1|Open Phase (17 Months)|Adverse Event|5
5612764|NCT00814346|19389955|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
5612765|NCT00814346|19389956|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
5612766|NCT00814346|19389955|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
5612767|NCT00814346|19389956|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
5612768|NCT00814333|19390022|P2|Enrollment|Lost to Follow-up|0
5612769|NCT00814333|19390023|P1|Enrollment|Lost to Follow-up|1
5612770|NCT00814320|19390031|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
5612771|NCT00814320|19390032|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
5612772|NCT00814320|19390031|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
5612773|NCT00814320|19390032|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
5612774|NCT00814320|19390031|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
5612775|NCT00814320|19390032|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
5612776|NCT00814320|19390031|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
5612777|NCT00814320|19390032|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
5612778|NCT00814320|19390031|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
5612779|NCT00814320|19390032|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
5612780|NCT00814320|19390031|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
5612781|NCT00814320|19390032|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
5612782|NCT00814320|19390031|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
5612783|NCT00814320|19390032|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
5612784|NCT00814320|19390031|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
5612785|NCT00814320|19390032|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
5612786|NCT00814320|19390031|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
5612787|NCT00814320|19390032|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
5612788|NCT00814320|19390031|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
5612789|NCT00814320|19390032|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
5612790|NCT00814307|19390164|P4|Overall Study|Death|0
5612791|NCT00814307|19390165|P3|Overall Study|Death|0
5612792|NCT00814307|19390166|P2|Overall Study|Death|1
5612793|NCT00814307|19390167|P1|Overall Study|Death|0
5612794|NCT00814307|19390164|P4|Overall Study|Withdrawal by Subject|2
5612795|NCT00814307|19390165|P3|Overall Study|Withdrawal by Subject|0
5612796|NCT00814307|19390166|P2|Overall Study|Withdrawal by Subject|6
5612797|NCT00814307|19390167|P1|Overall Study|Withdrawal by Subject|4
5612798|NCT00814307|19390164|P4|Overall Study|Protocol Violation|1
5612799|NCT00814307|19390165|P3|Overall Study|Protocol Violation|1
5612800|NCT00814307|19390166|P2|Overall Study|Protocol Violation|8
5612801|NCT00814307|19390167|P1|Overall Study|Protocol Violation|2
5612802|NCT00814307|19390164|P4|Overall Study|Other|1
5612803|NCT00814307|19390165|P3|Overall Study|Other|0
5612804|NCT00814307|19390166|P2|Overall Study|Other|2
5612805|NCT00814307|19390167|P1|Overall Study|Other|1
5612806|NCT00814307|19390164|P4|Overall Study|Lack of Efficacy|4
5612807|NCT00814307|19390165|P3|Overall Study|Lack of Efficacy|3
5612808|NCT00814307|19390166|P2|Overall Study|Lack of Efficacy|1
5612809|NCT00814307|19390167|P1|Overall Study|Lack of Efficacy|1
5612810|NCT00814307|19390164|P4|Overall Study|Adverse Event|2
5612811|NCT00814307|19390165|P3|Overall Study|Adverse Event|3
5612812|NCT00814307|19390166|P2|Overall Study|Adverse Event|9
5612813|NCT00814307|19390167|P1|Overall Study|Adverse Event|3
5612814|NCT00814307|19390164|P4|Overall Study|Randomized but not treated|0
5612815|NCT00814307|19390165|P3|Overall Study|Randomized but not treated|0
5612816|NCT00814307|19390166|P2|Overall Study|Randomized but not treated|0
5612817|NCT00814307|19390167|P1|Overall Study|Randomized but not treated|1
5612818|NCT00814164|19390363|P1|Overall Study|Death|5
5612819|NCT00814164|19390363|P1|Overall Study|not stated|7
5612820|NCT00814164|19390363|P1|Overall Study|Progression|7
5612821|NCT00813995|19390397|P2|Overall Study|Withdrawal by Subject|5
5612822|NCT00813995|19390398|P1|Overall Study|Withdrawal by Subject|0
5612823|NCT00813995|19390397|P2|Overall Study|Subject moved|0
5612824|NCT00813995|19390398|P1|Overall Study|Subject moved|4
5612825|NCT00813995|19390397|P2|Overall Study|Protocol Violation|2
5612826|NCT00813995|19390398|P1|Overall Study|Protocol Violation|3
5612827|NCT00813995|19390397|P2|Overall Study|Other reason|2
5612828|NCT00813995|19390398|P1|Overall Study|Other reason|2
5612829|NCT00813995|19390397|P2|Overall Study|Lost to Follow-up|2
5612830|NCT00813995|19390398|P1|Overall Study|Lost to Follow-up|4
5612831|NCT00813995|19390397|P2|Overall Study|Lack of Efficacy|0
5612832|NCT00813995|19390398|P1|Overall Study|Lack of Efficacy|1
5612833|NCT00813995|19390397|P2|Overall Study|Laboratory adverse event|2
5612834|NCT00813995|19390398|P1|Overall Study|Laboratory adverse event|0
5612835|NCT00813995|19390397|P2|Overall Study|Clinical adverse event|3
5612836|NCT00813995|19390398|P1|Overall Study|Clinical adverse event|9
5612837|NCT00813943|19390421|P3|Overall Study|Ongoing at cut-off date|3
5612838|NCT00813943|19390422|P2|Overall Study|Ongoing at cut-off date|5
5612839|NCT00813943|19390423|P1|Overall Study|Ongoing at cut-off date|5
5612840|NCT00813917|19390453|P2|Overall Study|Lost to Follow-up|1
5612841|NCT00813917|19390454|P1|Overall Study|Lost to Follow-up|3
5612842|NCT00813917|19390453|P2|Overall Study|Withdrawal by Subject|4
5612843|NCT00813917|19390454|P1|Overall Study|Withdrawal by Subject|3
5612844|NCT00813917|19390453|P2|Overall Study|Adverse Event|1
5612845|NCT00813917|19390454|P1|Overall Study|Adverse Event|0
5612846|NCT00813904|19390460|P1|Overall Study|Death|1
5612847|NCT00813865|19390466|P1|Overall Study|Withdrawal by Subject|1
5612848|NCT00813865|19390466|P1|Overall Study|Lost to Follow-up|3
5612849|NCT00813865|19390466|P1|Overall Study|Failure to Respond|3
5612850|NCT00813813|19390474|P2|Overall Study|Other|1
5612851|NCT00813813|19390475|P1|Overall Study|Other|0
5612852|NCT00813813|19390474|P2|Overall Study|Lost to Follow-up|7
5612853|NCT00813813|19390475|P1|Overall Study|Lost to Follow-up|2
5612854|NCT00813813|19390474|P2|Overall Study|Withdrawal by Subject|1
5612855|NCT00813813|19390475|P1|Overall Study|Withdrawal by Subject|1
5612856|NCT00813800|19390491|P1|Overall Study|Physician Decision|1
5612857|NCT00813800|19390491|P1|Overall Study|Worsening of depression|2
5612858|NCT00813800|19390491|P1|Overall Study|Adverse Event|1
5612859|NCT00813800|19390491|P1|Overall Study|Screen Failure after Consent|2
5612860|NCT00813761|19390499|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
5612861|NCT00813761|19390500|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
5612862|NCT00813761|19390501|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
5612863|NCT00813761|19390502|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
5612864|NCT00813761|19390499|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
5612865|NCT00813761|19390500|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
5612866|NCT00813761|19390501|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
5612867|NCT00813761|19390502|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
5612868|NCT00813761|19390499|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
5612869|NCT00813761|19390500|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
5612870|NCT00813761|19390501|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
5612871|NCT00813761|19390502|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
5612872|NCT00813761|19390499|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
5612873|NCT00813761|19390500|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
5612874|NCT00813761|19390501|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
5612875|NCT00813761|19390502|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
5612876|NCT00813761|19390499|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
5612877|NCT00813761|19390500|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
5612878|NCT00813761|19390501|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
5612879|NCT00813761|19390502|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
5612880|NCT00813761|19390499|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
5612881|NCT00813761|19390500|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
5612882|NCT00813761|19390501|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
5612883|NCT00813761|19390502|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
5612884|NCT00813761|19390499|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
5612885|NCT00813761|19390500|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
5612886|NCT00813761|19390501|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
5612887|NCT00813761|19390502|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
5612888|NCT00813761|19390499|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
5612889|NCT00813761|19390500|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
5612890|NCT00813761|19390501|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
5612891|NCT00813761|19390502|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
5612892|NCT00813761|19390499|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
5612893|NCT00813761|19390500|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
5612894|NCT00813761|19390501|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
5612895|NCT00813761|19390502|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
5612896|NCT00813761|19390499|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
5612897|NCT00813761|19390500|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
5612898|NCT00813761|19390501|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
5612899|NCT00813761|19390502|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
5612900|NCT00813761|19390499|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
5612901|NCT00813761|19390500|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
5612902|NCT00813761|19390501|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
5612903|NCT00813761|19390502|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
5612904|NCT00813761|19390499|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
5612905|NCT00813761|19390500|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
5612906|NCT00813761|19390501|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
5612907|NCT00813761|19390502|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
5612908|NCT00813748|19390552|P2|Skin Test Substudy|Physician Decision|1
5612909|NCT00813748|19390553|P1|Skin Test Substudy|Physician Decision|0
5612910|NCT00813709|19390582|P6|Open Label Period|Other|6
5612911|NCT00813709|19390583|P5|Open Label Period|Other|5
5612912|NCT00813709|19390584|P4|Open Label Period|Other|11
5612913|NCT00813709|19390585|P3|Open Label Period|Other|0
5612914|NCT00813709|19390586|P2|Open Label Period|Other|0
5612915|NCT00813709|19390587|P1|Open Label Period|Other|0
5612916|NCT00813709|19390582|P6|Open Label Period|Randomized but not treated|1
5612917|NCT00813709|19390583|P5|Open Label Period|Randomized but not treated|0
5612918|NCT00813709|19390584|P4|Open Label Period|Randomized but not treated|1
5612919|NCT00813709|19390585|P3|Open Label Period|Randomized but not treated|0
5612920|NCT00813709|19390586|P2|Open Label Period|Randomized but not treated|0
5612921|NCT00813709|19390587|P1|Open Label Period|Randomized but not treated|0
5612922|NCT00813709|19390582|P6|Open Label Period|Lack of Efficacy|1
5612923|NCT00813709|19390583|P5|Open Label Period|Lack of Efficacy|1
5612924|NCT00813709|19390584|P4|Open Label Period|Lack of Efficacy|3
5612925|NCT00813709|19390585|P3|Open Label Period|Lack of Efficacy|0
5612926|NCT00813709|19390586|P2|Open Label Period|Lack of Efficacy|0
5612927|NCT00813709|19390587|P1|Open Label Period|Lack of Efficacy|0
5612928|NCT00813709|19390582|P6|Open Label Period|Adverse Event|3
5612929|NCT00813709|19390583|P5|Open Label Period|Adverse Event|4
5612930|NCT00813709|19390584|P4|Open Label Period|Adverse Event|5
5612931|NCT00813709|19390585|P3|Open Label Period|Adverse Event|0
5612932|NCT00813709|19390586|P2|Open Label Period|Adverse Event|0
5612933|NCT00813709|19390587|P1|Open Label Period|Adverse Event|0
5612934|NCT00813709|19390582|P6|Double Blind Period|Other|0
5612935|NCT00813709|19390583|P5|Double Blind Period|Other|0
5612936|NCT00813709|19390584|P4|Double Blind Period|Other|0
5612937|NCT00813709|19390585|P3|Double Blind Period|Other|6
5612938|NCT00813709|19390586|P2|Double Blind Period|Other|9
5612939|NCT00813709|19390587|P1|Double Blind Period|Other|14
5612940|NCT00813709|19390582|P6|Double Blind Period|Randomized but not treated|0
5612941|NCT00813709|19390583|P5|Double Blind Period|Randomized but not treated|0
5612942|NCT00813709|19390584|P4|Double Blind Period|Randomized but not treated|0
5612943|NCT00813709|19390585|P3|Double Blind Period|Randomized but not treated|1
5612944|NCT00813709|19390586|P2|Double Blind Period|Randomized but not treated|3
5612945|NCT00813709|19390587|P1|Double Blind Period|Randomized but not treated|1
5612946|NCT00813709|19390582|P6|Double Blind Period|Switched to open label phase|0
5612947|NCT00813709|19390583|P5|Double Blind Period|Switched to open label phase|0
5612948|NCT00813709|19390584|P4|Double Blind Period|Switched to open label phase|0
5612949|NCT00813709|19390585|P3|Double Blind Period|Switched to open label phase|18
5612950|NCT00813709|19390586|P2|Double Blind Period|Switched to open label phase|26
5612951|NCT00813709|19390587|P1|Double Blind Period|Switched to open label phase|9
5612952|NCT00813709|19390582|P6|Double Blind Period|Lost to Follow-up|0
5612953|NCT00813709|19390583|P5|Double Blind Period|Lost to Follow-up|0
5612954|NCT00813709|19390584|P4|Double Blind Period|Lost to Follow-up|0
5612955|NCT00813709|19390585|P3|Double Blind Period|Lost to Follow-up|2
5612956|NCT00813709|19390586|P2|Double Blind Period|Lost to Follow-up|2
5612957|NCT00813709|19390587|P1|Double Blind Period|Lost to Follow-up|3
5612958|NCT00813709|19390582|P6|Double Blind Period|Adverse Event|0
5612959|NCT00813709|19390583|P5|Double Blind Period|Adverse Event|0
5612960|NCT00813709|19390584|P4|Double Blind Period|Adverse Event|0
5612961|NCT00813709|19390585|P3|Double Blind Period|Adverse Event|4
5612962|NCT00813709|19390586|P2|Double Blind Period|Adverse Event|1
5612963|NCT00813709|19390587|P1|Double Blind Period|Adverse Event|4
5612964|NCT00813592|19390667|P1|Overall Study|Disease assessment was not completed per|2
5612965|NCT00813488|19390676|P2|Open-label Extension|Other|0
5612966|NCT00813488|19390677|P1|Open-label Extension|Other|1
5612967|NCT00813488|19390676|P2|Open-label Extension|Non-compliance study procedures|1
5612968|NCT00813488|19390677|P1|Open-label Extension|Non-compliance study procedures|2
5612969|NCT00813488|19390676|P2|Open-label Extension|Non-compliance study medication|0
5612970|NCT00813488|19390677|P1|Open-label Extension|Non-compliance study medication|4
5612971|NCT00813488|19390676|P2|Open-label Extension|Protocol Violation|2
5612972|NCT00813488|19390677|P1|Open-label Extension|Protocol Violation|1
5612973|NCT00813488|19390676|P2|Open-label Extension|Withdrawal by Subject|2
5612974|NCT00813488|19390677|P1|Open-label Extension|Withdrawal by Subject|0
5612975|NCT00813488|19390676|P2|Open-label Extension|Lack of Efficacy|0
5612976|NCT00813488|19390677|P1|Open-label Extension|Lack of Efficacy|3
5612977|NCT00813488|19390676|P2|Open-label Extension|Adverse Event|2
5612978|NCT00813488|19390677|P1|Open-label Extension|Adverse Event|1
5612979|NCT00813488|19390676|P2|Double-blind Treatment Period 2|Other|0
5612980|NCT00813488|19390677|P1|Double-blind Treatment Period 2|Other|1
5612981|NCT00813488|19390676|P2|Double-blind Treatment Period 2|Protocol Violation|0
5612982|NCT00813488|19390677|P1|Double-blind Treatment Period 2|Protocol Violation|2
5612983|NCT00813488|19390676|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
5612984|NCT00813488|19390677|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
5612985|NCT00813488|19390676|P2|Double-blind Treatment Period 2|Adverse Event|0
5612986|NCT00813488|19390677|P1|Double-blind Treatment Period 2|Adverse Event|1
5612987|NCT00813488|19390676|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
5612988|NCT00813488|19390677|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
5612989|NCT00813488|19390676|P2|Double-blind Treatment Period 1|Protocol Violation|2
5612990|NCT00813488|19390677|P1|Double-blind Treatment Period 1|Protocol Violation|0
5612991|NCT00813488|19390676|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
5612992|NCT00813488|19390677|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
5612993|NCT00813488|19390676|P2|Double-blind Treatment Period 1|Adverse Event|1
5612994|NCT00813488|19390677|P1|Double-blind Treatment Period 1|Adverse Event|1
5612995|NCT00813488|19390676|P2|Titration Period 2|Non-compliance with study procedures|1
5612996|NCT00813488|19390677|P1|Titration Period 2|Non-compliance with study procedures|2
5612997|NCT00813488|19390676|P2|Titration Period 2|Lost to Follow-up|0
5612998|NCT00813488|19390677|P1|Titration Period 2|Lost to Follow-up|1
5612999|NCT00813488|19390676|P2|Titration Period 2|Protocol Violation|2
5613000|NCT00813488|19390677|P1|Titration Period 2|Protocol Violation|3
5613001|NCT00813488|19390676|P2|Titration Period 2|Lack of Efficacy|4
5613002|NCT00813488|19390677|P1|Titration Period 2|Lack of Efficacy|8
5613003|NCT00813488|19390676|P2|Titration Period 2|Adverse Event|3
5613004|NCT00813488|19390677|P1|Titration Period 2|Adverse Event|2
5613005|NCT00813488|19390676|P2|Titration Period 1|Technical Difficulties|1
5613006|NCT00813488|19390677|P1|Titration Period 1|Technical Difficulties|0
5613007|NCT00813488|19390676|P2|Titration Period 1|Non-compliance to study procedures|2
5613008|NCT00813488|19390677|P1|Titration Period 1|Non-compliance to study procedures|2
5613009|NCT00813488|19390676|P2|Titration Period 1|Non-compliance to study medication|1
5613010|NCT00813488|19390677|P1|Titration Period 1|Non-compliance to study medication|4
5613011|NCT00813488|19390676|P2|Titration Period 1|Protocol Violation|3
5613012|NCT00813488|19390677|P1|Titration Period 1|Protocol Violation|4
5613013|NCT00813488|19390676|P2|Titration Period 1|Withdrawal by Subject|2
5613014|NCT00813488|19390677|P1|Titration Period 1|Withdrawal by Subject|2
5613015|NCT00813488|19390676|P2|Titration Period 1|Lack of Efficacy|7
5613016|NCT00813488|19390677|P1|Titration Period 1|Lack of Efficacy|9
5613017|NCT00813488|19390676|P2|Titration Period 1|Adverse Event|1
5613018|NCT00813488|19390677|P1|Titration Period 1|Adverse Event|6
5613019|NCT00813293|19390788|P2|Overall Study|Adverse Event|1
5613020|NCT00813293|19390789|P1|Overall Study|Adverse Event|0
5613021|NCT00813293|19390788|P2|Overall Study|Intercurrent illness|0
5613022|NCT00813293|19390789|P1|Overall Study|Intercurrent illness|1
5613023|NCT00813150|19390828|P2|Long Term Follow-up|Progression/Relapse|24
5613024|NCT00813150|19390829|P1|Long Term Follow-up|Progression/Relapse|22
5613025|NCT00813150|19390828|P2|Long Term Follow-up|Lost to Follow-up|0
5613026|NCT00813150|19390829|P1|Long Term Follow-up|Lost to Follow-up|2
5613027|NCT00813150|19390828|P2|Long Term Follow-up|Other|3
5613028|NCT00813150|19390829|P1|Long Term Follow-up|Other|0
5613029|NCT00813150|19390828|P2|Long Term Follow-up|Death|4
5613030|NCT00813150|19390829|P1|Long Term Follow-up|Death|0
5613031|NCT00813150|19390828|P2|Treatment Period|Data not available|2
5613032|NCT00813150|19390829|P1|Treatment Period|Data not available|1
5613033|NCT00813150|19390828|P2|Treatment Period|Reason not specified|4
5613034|NCT00813150|19390829|P1|Treatment Period|Reason not specified|3
5613035|NCT00813150|19390828|P2|Treatment Period|Non compliance|1
5613036|NCT00813150|19390829|P1|Treatment Period|Non compliance|0
5613037|NCT00813150|19390828|P2|Treatment Period|Withdrawal by Subject|3
5613038|NCT00813150|19390829|P1|Treatment Period|Withdrawal by Subject|5
5613039|NCT00813150|19390828|P2|Treatment Period|Protocol Violation|4
5613040|NCT00813150|19390829|P1|Treatment Period|Protocol Violation|3
5613041|NCT00813150|19390828|P2|Treatment Period|Stable disease|2
5613042|NCT00813150|19390829|P1|Treatment Period|Stable disease|1
5613043|NCT00813150|19390828|P2|Treatment Period|Complete response|1
5613044|NCT00813150|19390829|P1|Treatment Period|Complete response|0
5613045|NCT00813150|19390828|P2|Treatment Period|Progressive disease|0
5613046|NCT00813150|19390829|P1|Treatment Period|Progressive disease|1
5613047|NCT00813150|19390828|P2|Treatment Period|Death|0
5613048|NCT00813150|19390829|P1|Treatment Period|Death|2
5613049|NCT00813150|19390828|P2|Treatment Period|Adverse Event|15
5613050|NCT00813150|19390829|P1|Treatment Period|Adverse Event|16
5613051|NCT00813098|19390853|P3|Overall Study|Withdrew Consent|0
5613052|NCT00813098|19390854|P2|Overall Study|Withdrew Consent|1
5613053|NCT00813098|19390855|P1|Overall Study|Withdrew Consent|0
5613054|NCT00813098|19390853|P3|Overall Study|Principal Investigator decision|0
5613055|NCT00813098|19390854|P2|Overall Study|Principal Investigator decision|1
5613056|NCT00813098|19390855|P1|Overall Study|Principal Investigator decision|0
5613057|NCT00813098|19390853|P3|Overall Study|Protocol Violation|1
5613058|NCT00813098|19390854|P2|Overall Study|Protocol Violation|0
5613059|NCT00813098|19390855|P1|Overall Study|Protocol Violation|0
5613060|NCT00813098|19390853|P3|Overall Study|Lost to Follow-up|0
5613061|NCT00813098|19390854|P2|Overall Study|Lost to Follow-up|1
5613062|NCT00813098|19390855|P1|Overall Study|Lost to Follow-up|0
5613063|NCT00813098|19390853|P3|Overall Study|Inability to complete study procedures|0
5613064|NCT00813098|19390854|P2|Overall Study|Inability to complete study procedures|0
5613065|NCT00813098|19390855|P1|Overall Study|Inability to complete study procedures|1
5613066|NCT00813098|19390853|P3|Overall Study|Withdrawal by Subject|0
5613067|NCT00813098|19390854|P2|Overall Study|Withdrawal by Subject|1
5613068|NCT00813098|19390855|P1|Overall Study|Withdrawal by Subject|0
5613069|NCT00813098|19390853|P3|Overall Study|Adverse Event|1
5613070|NCT00813098|19390854|P2|Overall Study|Adverse Event|4
5613071|NCT00813098|19390855|P1|Overall Study|Adverse Event|2
5613072|NCT00812981|19390880|P2|Overall Study|Other|1
5613073|NCT00812981|19390881|P1|Overall Study|Other|0
5613074|NCT00812968|19390919|P1|Overall Study|Study closed due to marketing approval|3
5613075|NCT00812968|19390919|P1|Overall Study|No further treatment required|1
5613076|NCT00812968|19390919|P1|Overall Study|Disease progression|1
5613077|NCT00812968|19390919|P1|Overall Study|Relapse after erythroid response|6
5613078|NCT00812955|19390954|P4|Overall Study|randomized in error|0
5613079|NCT00812955|19390955|P3|Overall Study|randomized in error|1
5613080|NCT00812955|19390956|P2|Overall Study|randomized in error|0
5613081|NCT00812955|19390957|P1|Overall Study|randomized in error|0
5613082|NCT00812955|19390954|P4|Overall Study|Withdrawal by Subject|2
5613083|NCT00812955|19390955|P3|Overall Study|Withdrawal by Subject|1
5613084|NCT00812955|19390956|P2|Overall Study|Withdrawal by Subject|0
5613085|NCT00812955|19390957|P1|Overall Study|Withdrawal by Subject|1
5613086|NCT00812955|19390954|P4|Overall Study|Lost to Follow-up|2
5613087|NCT00812955|19390955|P3|Overall Study|Lost to Follow-up|1
5613088|NCT00812955|19390956|P2|Overall Study|Lost to Follow-up|1
5613089|NCT00812955|19390957|P1|Overall Study|Lost to Follow-up|2
5613090|NCT00812955|19390954|P4|Overall Study|Adverse Event|4
5613091|NCT00812955|19390955|P3|Overall Study|Adverse Event|3
5613092|NCT00812955|19390956|P2|Overall Study|Adverse Event|6
5613093|NCT00812955|19390957|P1|Overall Study|Adverse Event|7
5613094|NCT00812929|19390977|P10|Washout Period 3 (7 Days)|Adverse Event|0
5613095|NCT00812929|19390978|P9|Washout Period 3 (7 Days)|Adverse Event|0
5613096|NCT00812929|19390979|P8|Washout Period 3 (7 Days)|Adverse Event|0
5613097|NCT00812929|19390980|P7|Washout Period 3 (7 Days)|Adverse Event|0
5613098|NCT00812929|19390981|P6|Washout Period 3 (7 Days)|Adverse Event|1
5613099|NCT00812929|19390982|P5|Washout Period 3 (7 Days)|Adverse Event|0
5613100|NCT00812929|19390983|P4|Washout Period 3 (7 Days)|Adverse Event|0
5613101|NCT00812929|19390984|P3|Washout Period 3 (7 Days)|Adverse Event|0
5613102|NCT00812929|19390985|P2|Washout Period 3 (7 Days)|Adverse Event|0
5613103|NCT00812929|19390986|P1|Washout Period 3 (7 Days)|Adverse Event|0
5613104|NCT00812929|19390977|P10|Washout Period 2 (7 Days)|Physician Decision|1
5613105|NCT00812929|19390978|P9|Washout Period 2 (7 Days)|Physician Decision|0
5613106|NCT00812929|19390979|P8|Washout Period 2 (7 Days)|Physician Decision|0
5613107|NCT00812929|19390980|P7|Washout Period 2 (7 Days)|Physician Decision|0
5613108|NCT00812929|19390981|P6|Washout Period 2 (7 Days)|Physician Decision|0
5613109|NCT00812929|19390982|P5|Washout Period 2 (7 Days)|Physician Decision|0
5613110|NCT00812929|19390983|P4|Washout Period 2 (7 Days)|Physician Decision|0
5613111|NCT00812929|19390984|P3|Washout Period 2 (7 Days)|Physician Decision|0
5613112|NCT00812929|19390985|P2|Washout Period 2 (7 Days)|Physician Decision|0
5613113|NCT00812929|19390986|P1|Washout Period 2 (7 Days)|Physician Decision|0
5613114|NCT00812929|19390977|P10|Washout Period 1 (7 Days)|Physician Decision|0
5613115|NCT00812929|19390978|P9|Washout Period 1 (7 Days)|Physician Decision|0
5613116|NCT00812929|19390979|P8|Washout Period 1 (7 Days)|Physician Decision|0
5613117|NCT00812929|19390980|P7|Washout Period 1 (7 Days)|Physician Decision|0
5613118|NCT00812929|19390981|P6|Washout Period 1 (7 Days)|Physician Decision|0
5613119|NCT00812929|19390982|P5|Washout Period 1 (7 Days)|Physician Decision|0
5613120|NCT00812929|19390983|P4|Washout Period 1 (7 Days)|Physician Decision|0
5613121|NCT00812929|19390984|P3|Washout Period 1 (7 Days)|Physician Decision|1
5613122|NCT00812929|19390985|P2|Washout Period 1 (7 Days)|Physician Decision|0
5613123|NCT00812929|19390986|P1|Washout Period 1 (7 Days)|Physician Decision|0
5613124|NCT00812812|19391141|P2|Overall Study|Withdrawal by Subject|2
5613125|NCT00812812|19391142|P1|Overall Study|Withdrawal by Subject|0
5613126|NCT00812812|19391141|P2|Overall Study|Lost to Follow-up|1
5613127|NCT00812812|19391142|P1|Overall Study|Lost to Follow-up|0
5613128|NCT00812812|19391141|P2|Overall Study|Lack of Efficacy|0
5613129|NCT00812812|19391142|P1|Overall Study|Lack of Efficacy|1
5613130|NCT00812812|19391141|P2|Overall Study|Adverse Event|1
5613131|NCT00812812|19391142|P1|Overall Study|Adverse Event|2
5613132|NCT00812708|19391155|P1|Overall Study|Signed consent but later withdrew|3
5613133|NCT00812708|19391155|P1|Overall Study|Surgery cancelled due to uveitis|1
5613134|NCT00812708|19391155|P1|Overall Study|Switched to another study|1
5613135|NCT00812708|19391155|P1|Overall Study|Lack of medical insurance|1
5613136|NCT00812708|19391155|P1|Overall Study|Device could not be implanted|2
5613137|NCT00812565|19391183|P8|Overall Study|Reason Not Specified|0
5613138|NCT00812565|19391184|P7|Overall Study|Reason Not Specified|0
5613139|NCT00812565|19391185|P6|Overall Study|Reason Not Specified|1
5613140|NCT00812565|19391186|P5|Overall Study|Reason Not Specified|0
5613141|NCT00812565|19391187|P4|Overall Study|Reason Not Specified|0
5613142|NCT00812565|19391188|P3|Overall Study|Reason Not Specified|0
5613143|NCT00812565|19391189|P2|Overall Study|Reason Not Specified|0
5613144|NCT00812565|19391190|P1|Overall Study|Reason Not Specified|0
5613145|NCT00812565|19391183|P8|Overall Study|Withdrawal of Consent|0
5613146|NCT00812565|19391184|P7|Overall Study|Withdrawal of Consent|0
5613147|NCT00812565|19391185|P6|Overall Study|Withdrawal of Consent|0
5613148|NCT00812565|19391186|P5|Overall Study|Withdrawal of Consent|1
5613149|NCT00812565|19391187|P4|Overall Study|Withdrawal of Consent|0
5613150|NCT00812565|19391188|P3|Overall Study|Withdrawal of Consent|0
5613151|NCT00812565|19391189|P2|Overall Study|Withdrawal of Consent|0
5613152|NCT00812565|19391190|P1|Overall Study|Withdrawal of Consent|1
5613153|NCT00812565|19391183|P8|Overall Study|Did Not Come to Study Visit|0
5613154|NCT00812565|19391184|P7|Overall Study|Did Not Come to Study Visit|0
5613155|NCT00812565|19391185|P6|Overall Study|Did Not Come to Study Visit|0
5613156|NCT00812565|19391186|P5|Overall Study|Did Not Come to Study Visit|0
5613157|NCT00812565|19391187|P4|Overall Study|Did Not Come to Study Visit|0
5613158|NCT00812565|19391188|P3|Overall Study|Did Not Come to Study Visit|0
5613159|NCT00812565|19391189|P2|Overall Study|Did Not Come to Study Visit|0
5613160|NCT00812565|19391190|P1|Overall Study|Did Not Come to Study Visit|1
5613161|NCT00812565|19391183|P8|Overall Study|Adverse Event|1
5613162|NCT00812565|19391184|P7|Overall Study|Adverse Event|0
5613163|NCT00812565|19391185|P6|Overall Study|Adverse Event|0
5613164|NCT00812565|19391186|P5|Overall Study|Adverse Event|0
5613165|NCT00812565|19391187|P4|Overall Study|Adverse Event|2
5613166|NCT00812565|19391188|P3|Overall Study|Adverse Event|0
5613167|NCT00812565|19391189|P2|Overall Study|Adverse Event|0
5613168|NCT00812565|19391190|P1|Overall Study|Adverse Event|0
5613169|NCT00812565|19391183|P8|Overall Study|Did Not Receive Study Medication|0
5613170|NCT00812565|19391184|P7|Overall Study|Did Not Receive Study Medication|0
5613171|NCT00812565|19391185|P6|Overall Study|Did Not Receive Study Medication|0
5613172|NCT00812565|19391186|P5|Overall Study|Did Not Receive Study Medication|0
5613173|NCT00812565|19391187|P4|Overall Study|Did Not Receive Study Medication|0
5613174|NCT00812565|19391188|P3|Overall Study|Did Not Receive Study Medication|0
5613175|NCT00812565|19391189|P2|Overall Study|Did Not Receive Study Medication|1
5613176|NCT00812565|19391190|P1|Overall Study|Did Not Receive Study Medication|1
5613177|NCT00812487|19391314|P2|Overall Study|Protocol Violation|1
5613178|NCT00812487|19391315|P1|Overall Study|Protocol Violation|0
5613179|NCT00812487|19391314|P2|Overall Study|Transfer to ICU prior to intervention|0
5613180|NCT00812487|19391315|P1|Overall Study|Transfer to ICU prior to intervention|1
5613181|NCT00812487|19391314|P2|Overall Study|Withdrawal by Subject|2
5613182|NCT00812487|19391315|P1|Overall Study|Withdrawal by Subject|3
5613183|NCT00812487|19391314|P2|Overall Study|Lost to Follow-up|0
5613184|NCT00812487|19391315|P1|Overall Study|Lost to Follow-up|2
5613185|NCT00812461|19391341|P2|All Treated Patients|Other Reason|21
5613186|NCT00812461|19391342|P1|All Treated Patients|Other Reason|13
5613187|NCT00812461|19391341|P2|All Treated Patients|Lost to Follow-up|14
5613188|NCT00812461|19391342|P1|All Treated Patients|Lost to Follow-up|11
5613189|NCT00812461|19391341|P2|All Treated Patients|Withdrawal by Subject|54
5613190|NCT00812461|19391342|P1|All Treated Patients|Withdrawal by Subject|45
5613191|NCT00812461|19391341|P2|All Treated Patients|Protocol Violation|27
5613192|NCT00812461|19391342|P1|All Treated Patients|Protocol Violation|36
5613193|NCT00812461|19391341|P2|All Treated Patients|Non-compliance|9
5613194|NCT00812461|19391342|P1|All Treated Patients|Non-compliance|6
5613195|NCT00812461|19391341|P2|All Treated Patients|Lack of Efficacy|7
5613196|NCT00812461|19391342|P1|All Treated Patients|Lack of Efficacy|13
5613197|NCT00812461|19391341|P2|All Treated Patients|Adverse Event|15
5613198|NCT00812461|19391342|P1|All Treated Patients|Adverse Event|8
5613199|NCT00812461|19391341|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
5613200|NCT00812461|19391342|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
5613201|NCT00812331|19391365|P5|Overall Study|Adverse Event|0
5613202|NCT00812331|19391366|P4|Overall Study|Adverse Event|0
5613203|NCT00812331|19391367|P3|Overall Study|Adverse Event|0
5613204|NCT00812331|19391368|P2|Overall Study|Adverse Event|0
5613205|NCT00812331|19391369|P1|Overall Study|Adverse Event|1
5613206|NCT00812253|19391444|P2|Overall Study|Lost to Follow-up|0
5613207|NCT00812253|19391445|P1|Overall Study|Lost to Follow-up|2
5613208|NCT00812253|19391444|P2|Overall Study|Protocol Violation|1
5613209|NCT00812253|19391445|P1|Overall Study|Protocol Violation|1
5613210|NCT00812253|19391444|P2|Overall Study|Withdrawal by Subject|2
5613211|NCT00812253|19391445|P1|Overall Study|Withdrawal by Subject|3
5613212|NCT00812097|19391470|P4|Overall Study|Unknown reasons and patient/doctor moves|5
5613213|NCT00812097|19391471|P3|Overall Study|Unknown reasons and patient/doctor moves|15
5613214|NCT00812097|19391472|P2|Overall Study|Unknown reasons and patient/doctor moves|24
5613215|NCT00812097|19391473|P1|Overall Study|Unknown reasons and patient/doctor moves|111
5613216|NCT00812097|19391470|P4|Overall Study|Explantation of study device(s)|20
5613217|NCT00812097|19391471|P3|Overall Study|Explantation of study device(s)|14
5613218|NCT00812097|19391472|P2|Overall Study|Explantation of study device(s)|29
5613219|NCT00812097|19391473|P1|Overall Study|Explantation of study device(s)|27
5613220|NCT00812097|19391470|P4|Overall Study|Lost to Follow-up|5
5613221|NCT00812097|19391471|P3|Overall Study|Lost to Follow-up|17
5613222|NCT00812097|19391472|P2|Overall Study|Lost to Follow-up|14
5613223|NCT00812097|19391473|P1|Overall Study|Lost to Follow-up|90
5613224|NCT00812097|19391470|P4|Overall Study|Withdrawal by Subject|2
5613225|NCT00812097|19391471|P3|Overall Study|Withdrawal by Subject|8
5613226|NCT00812097|19391472|P2|Overall Study|Withdrawal by Subject|12
5613227|NCT00812097|19391473|P1|Overall Study|Withdrawal by Subject|14
5613228|NCT00812097|19391470|P4|Overall Study|Death|3
5613229|NCT00812097|19391471|P3|Overall Study|Death|3
5613230|NCT00812097|19391472|P2|Overall Study|Death|10
5613231|NCT00812097|19391473|P1|Overall Study|Death|3
5613232|NCT00812006|19391502|P3|Overall Study|Lack of Qualifying Event|2
5613233|NCT00812006|19391503|P2|Overall Study|Lack of Qualifying Event|2
5613234|NCT00812006|19391504|P1|Overall Study|Lack of Qualifying Event|4
5613235|NCT00812006|19391502|P3|Overall Study|Withdrawal by Subject|1
5613236|NCT00812006|19391503|P2|Overall Study|Withdrawal by Subject|1
5613237|NCT00812006|19391504|P1|Overall Study|Withdrawal by Subject|2
5613238|NCT00812006|19391502|P3|Overall Study|Physician Decision|1
5613239|NCT00812006|19391503|P2|Overall Study|Physician Decision|0
5613240|NCT00812006|19391504|P1|Overall Study|Physician Decision|0
5613241|NCT00812006|19391502|P3|Overall Study|Lost to Follow-up|2
5613242|NCT00812006|19391503|P2|Overall Study|Lost to Follow-up|0
5613243|NCT00812006|19391504|P1|Overall Study|Lost to Follow-up|0
5613244|NCT00811954|19391521|P3|Overall Study|Complete Protocol: No follow-up|1
5613245|NCT00811954|19391522|P2|Overall Study|Complete Protocol: No follow-up|0
5613246|NCT00811954|19391523|P1|Overall Study|Complete Protocol: No follow-up|0
5613247|NCT00811954|19391521|P3|Overall Study|Severe Debilitation|1
5613248|NCT00811954|19391522|P2|Overall Study|Severe Debilitation|0
5613249|NCT00811954|19391523|P1|Overall Study|Severe Debilitation|2
5613250|NCT00811954|19391521|P3|Overall Study|Site Closure|1
5613251|NCT00811954|19391522|P2|Overall Study|Site Closure|0
5613252|NCT00811954|19391523|P1|Overall Study|Site Closure|4
5613253|NCT00811954|19391521|P3|Overall Study|Withdraw consent prior study completion|5
5613254|NCT00811954|19391522|P2|Overall Study|Withdraw consent prior study completion|6
5613255|NCT00811954|19391523|P1|Overall Study|Withdraw consent prior study completion|4
5613256|NCT00811954|19391521|P3|Overall Study|Not willing to adhere to requirements|16
5613257|NCT00811954|19391522|P2|Overall Study|Not willing to adhere to requirements|2
5613258|NCT00811954|19391523|P1|Overall Study|Not willing to adhere to requirements|12
5613259|NCT00811954|19391521|P3|Overall Study|Not able to get to clinic|30
5613260|NCT00811954|19391522|P2|Overall Study|Not able to get to clinic|35
5613261|NCT00811954|19391523|P1|Overall Study|Not able to get to clinic|28
5613262|NCT00811954|19391521|P3|Overall Study|Lost to Follow-up|34
5613263|NCT00811954|19391522|P2|Overall Study|Lost to Follow-up|23
5613264|NCT00811954|19391523|P1|Overall Study|Lost to Follow-up|29
5613265|NCT00811954|19391521|P3|Overall Study|Death|13
5613266|NCT00811954|19391522|P2|Overall Study|Death|6
5613267|NCT00811954|19391523|P1|Overall Study|Death|10
5613268|NCT00811941|19391587|P2|All Treated Patients|Other Reason|14
5613269|NCT00811941|19391588|P1|All Treated Patients|Other Reason|4
5613270|NCT00811941|19391587|P2|All Treated Patients|Lost to Follow-up|12
5613271|NCT00811941|19391588|P1|All Treated Patients|Lost to Follow-up|3
5613272|NCT00811941|19391587|P2|All Treated Patients|Withdrawal by Subject|94
5613273|NCT00811941|19391588|P1|All Treated Patients|Withdrawal by Subject|35
5613274|NCT00811941|19391587|P2|All Treated Patients|Protocol Violation|17
5613275|NCT00811941|19391588|P1|All Treated Patients|Protocol Violation|5
5613276|NCT00811941|19391587|P2|All Treated Patients|Non-compliance|8
5613277|NCT00811941|19391588|P1|All Treated Patients|Non-compliance|1
5613278|NCT00811941|19391587|P2|All Treated Patients|Lack of Efficacy|3
5613279|NCT00811941|19391588|P1|All Treated Patients|Lack of Efficacy|2
5613280|NCT00811941|19391587|P2|All Treated Patients|Adverse Event|43
5613281|NCT00811941|19391588|P1|All Treated Patients|Adverse Event|2
5613282|NCT00811941|19391587|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
5613283|NCT00811941|19391588|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
5613284|NCT00811928|19391626|P2|Overall Study|Poor Compliance|5
5613285|NCT00811928|19391627|P1|Overall Study|Poor Compliance|2
5613286|NCT00811928|19391626|P2|Overall Study|Investigator Decision|1
5613287|NCT00811928|19391627|P1|Overall Study|Investigator Decision|2
5613288|NCT00811928|19391626|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
5613289|NCT00811928|19391627|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
5613290|NCT00811928|19391626|P2|Overall Study|Did Not Take Study Drug|0
5613291|NCT00811928|19391627|P1|Overall Study|Did Not Take Study Drug|3
5613292|NCT00811928|19391626|P2|Overall Study|Withdrawal by Subject|12
5613293|NCT00811928|19391627|P1|Overall Study|Withdrawal by Subject|18
5613294|NCT00811928|19391626|P2|Overall Study|AEs and SAEs Including Death|11
5613295|NCT00811928|19391627|P1|Overall Study|AEs and SAEs Including Death|7
5613296|NCT00811733|19391671|P2|Overall Study|Withdrawal by Subject|2
5613297|NCT00811733|19391672|P1|Overall Study|Withdrawal by Subject|1
5613298|NCT00811733|19391671|P2|Overall Study|Investigator Discretion|8
5613299|NCT00811733|19391672|P1|Overall Study|Investigator Discretion|10
5613300|NCT00811720|19391720|P2|All Treated Patients|Other Reason|4
5613301|NCT00811720|19391721|P1|All Treated Patients|Other Reason|7
5613302|NCT00811720|19391720|P2|All Treated Patients|Lost to Follow-up|16
5613303|NCT00811720|19391721|P1|All Treated Patients|Lost to Follow-up|10
5613304|NCT00811720|19391720|P2|All Treated Patients|Withdrawal by Subject|34
5613305|NCT00811720|19391721|P1|All Treated Patients|Withdrawal by Subject|28
5613306|NCT00811720|19391720|P2|All Treated Patients|Protocol Violation|16
5613307|NCT00811720|19391721|P1|All Treated Patients|Protocol Violation|9
5613308|NCT00811720|19391720|P2|All Treated Patients|Non-compliance|14
5613309|NCT00811720|19391721|P1|All Treated Patients|Non-compliance|0
5613310|NCT00811720|19391720|P2|All Treated Patients|Lack of Efficacy|18
5613311|NCT00811720|19391721|P1|All Treated Patients|Lack of Efficacy|22
5613312|NCT00811720|19391720|P2|All Treated Patients|Adverse Event|62
5613313|NCT00811720|19391721|P1|All Treated Patients|Adverse Event|20
5613314|NCT00811720|19391720|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
5613315|NCT00811720|19391721|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
5613316|NCT00811655|19391739|P1|Overall Study|Physician Decision|1
5613402|NCT00811070|19392059|P2|Overall Study|Physician Decision|0
5613317|NCT00811642|19391751|P1|Overall Study|Cumulative use of antifungal agent|2
5613318|NCT00811642|19391751|P1|Overall Study|Withdrawal by Subject|7
5613319|NCT00811642|19391751|P1|Overall Study|Death|2
5613320|NCT00811642|19391751|P1|Overall Study|Protocol Violation|1
5613321|NCT00811642|19391751|P1|Overall Study|Adverse Event|3
5613322|NCT00811577|19391767|P2|Overall Study|Withdrawal by Subject|0
5613323|NCT00811577|19391768|P1|Overall Study|Withdrawal by Subject|3
5613324|NCT00811577|19391767|P2|Overall Study|Lost to Follow-up|1
5613325|NCT00811577|19391768|P1|Overall Study|Lost to Follow-up|7
5613326|NCT00811473|19391828|P2|Overall Study|Safety Reasons|0
5613327|NCT00811473|19391829|P1|Overall Study|Safety Reasons|1
5613328|NCT00811473|19391828|P2|Overall Study|Incorrect Enrollment|0
5613329|NCT00811473|19391829|P1|Overall Study|Incorrect Enrollment|1
5613330|NCT00811473|19391828|P2|Overall Study|Other 2|1
5613331|NCT00811473|19391829|P1|Overall Study|Other 2|4
5613332|NCT00811473|19391828|P2|Overall Study|Condition under investigation worsened|3
5613333|NCT00811473|19391829|P1|Overall Study|Condition under investigation worsened|1
5613334|NCT00811473|19391828|P2|Overall Study|Lack of therapeutic response|1
5613335|NCT00811473|19391829|P1|Overall Study|Lack of therapeutic response|4
5613336|NCT00811473|19391828|P2|Overall Study|Severe non-compliance to protocol|4
5613337|NCT00811473|19391829|P1|Overall Study|Severe non-compliance to protocol|2
5613338|NCT00811473|19391828|P2|Overall Study|Withdrawal by Subject|4
5613339|NCT00811473|19391829|P1|Overall Study|Withdrawal by Subject|2
5613340|NCT00811473|19391828|P2|Overall Study|Lost to Follow-up|1
5613341|NCT00811473|19391829|P1|Overall Study|Lost to Follow-up|5
5613342|NCT00811473|19391828|P2|Overall Study|Adverse Event|12
5613343|NCT00811473|19391829|P1|Overall Study|Adverse Event|3
5613344|NCT00811395|19391860|P6|Extension Treatment|Other than above|0
5613345|NCT00811395|19391861|P5|Extension Treatment|Other than above|0
5613346|NCT00811395|19391862|P4|Extension Treatment|Other than above|0
5613347|NCT00811395|19391863|P3|Extension Treatment|Other than above|1
5613348|NCT00811395|19391864|P2|Extension Treatment|Other than above|0
5613349|NCT00811395|19391865|P1|Extension Treatment|Other than above|0
5613350|NCT00811395|19391860|P6|Extension Treatment|Participant did not wish to continue|1
5613351|NCT00811395|19391861|P5|Extension Treatment|Participant did not wish to continue|0
5613352|NCT00811395|19391862|P4|Extension Treatment|Participant did not wish to continue|1
5613353|NCT00811395|19391863|P3|Extension Treatment|Participant did not wish to continue|0
5613354|NCT00811395|19391864|P2|Extension Treatment|Participant did not wish to continue|3
5613355|NCT00811395|19391865|P1|Extension Treatment|Participant did not wish to continue|0
5613356|NCT00811395|19391860|P6|Extension Treatment|Progressive disease|0
5613357|NCT00811395|19391861|P5|Extension Treatment|Progressive disease|0
5613358|NCT00811395|19391862|P4|Extension Treatment|Progressive disease|0
5613359|NCT00811395|19391863|P3|Extension Treatment|Progressive disease|0
5613360|NCT00811395|19391864|P2|Extension Treatment|Progressive disease|1
5613361|NCT00811395|19391865|P1|Extension Treatment|Progressive disease|1
5613362|NCT00811395|19391860|P6|Extension Treatment|Adverse Event|1
5613363|NCT00811395|19391861|P5|Extension Treatment|Adverse Event|0
5613364|NCT00811395|19391862|P4|Extension Treatment|Adverse Event|2
5613365|NCT00811395|19391863|P3|Extension Treatment|Adverse Event|2
5613366|NCT00811395|19391864|P2|Extension Treatment|Adverse Event|2
5613367|NCT00811395|19391865|P1|Extension Treatment|Adverse Event|1
5613368|NCT00811252|19391971|P3|Overall Study|Administrative or Other Reasons|2
5613369|NCT00811252|19391972|P2|Overall Study|Administrative or Other Reasons|3
5613370|NCT00811252|19391973|P1|Overall Study|Administrative or Other Reasons|0
5613371|NCT00811252|19391971|P3|Overall Study|Lost to Follow-up|2
5613372|NCT00811252|19391972|P2|Overall Study|Lost to Follow-up|0
5613373|NCT00811252|19391973|P1|Overall Study|Lost to Follow-up|0
5613374|NCT00811252|19391971|P3|Overall Study|Withdrawal of Consent|2
5613375|NCT00811252|19391972|P2|Overall Study|Withdrawal of Consent|2
5613376|NCT00811252|19391973|P1|Overall Study|Withdrawal of Consent|1
5613377|NCT00811252|19391971|P3|Overall Study|Protocol Violation|2
5613378|NCT00811252|19391972|P2|Overall Study|Protocol Violation|3
5613379|NCT00811252|19391973|P1|Overall Study|Protocol Violation|3
5613380|NCT00811252|19391971|P3|Overall Study|Lack of Efficacy|0
5613381|NCT00811252|19391972|P2|Overall Study|Lack of Efficacy|2
5613382|NCT00811252|19391973|P1|Overall Study|Lack of Efficacy|7
5613383|NCT00811252|19391971|P3|Overall Study|Adverse Event|15
5613384|NCT00811252|19391972|P2|Overall Study|Adverse Event|10
5613385|NCT00811252|19391973|P1|Overall Study|Adverse Event|6
5613386|NCT00811187|19392019|P2|Overall Study|Unable to place device / procedure abort|3
5613387|NCT00811187|19392020|P1|Overall Study|Unable to place device / procedure abort|3
5613388|NCT00811174|19392026|P1|Overall Study|Sponsors Decision|1
5613389|NCT00811174|19392026|P1|Overall Study|Protocol Violation|2
5613390|NCT00811135|19392037|P1|Overall Study|Ongoing|59
5613391|NCT00811135|19392037|P1|Overall Study|Administrative/Other Unspecified|11
5613392|NCT00811135|19392037|P1|Overall Study|Withdrawal by Subject|3
5613393|NCT00811135|19392037|P1|Overall Study|Refused Treatment|1
5613394|NCT00811135|19392037|P1|Overall Study|Violation of Selection Criteria|1
5613395|NCT00811135|19392037|P1|Overall Study|Protocol Violation|2
5613396|NCT00811135|19392037|P1|Overall Study|Death|3
5613397|NCT00811135|19392037|P1|Overall Study|Adverse Event/Intercurrent Illness|8
5613398|NCT00811070|19392055|P6|Overall Study|Physician Decision|1
5613399|NCT00811070|19392056|P5|Overall Study|Physician Decision|0
5613400|NCT00811070|19392057|P4|Overall Study|Physician Decision|0
5613401|NCT00811070|19392058|P3|Overall Study|Physician Decision|0
5613403|NCT00811070|19392060|P1|Overall Study|Physician Decision|0
5613404|NCT00811070|19392055|P6|Overall Study|Withdrawal by Subject|0
5613405|NCT00811070|19392056|P5|Overall Study|Withdrawal by Subject|0
5613406|NCT00811070|19392057|P4|Overall Study|Withdrawal by Subject|0
5613407|NCT00811070|19392058|P3|Overall Study|Withdrawal by Subject|0
5613408|NCT00811070|19392059|P2|Overall Study|Withdrawal by Subject|1
5613409|NCT00811070|19392060|P1|Overall Study|Withdrawal by Subject|0
5613410|NCT00811070|19392055|P6|Overall Study|Other|0
5613411|NCT00811070|19392056|P5|Overall Study|Other|0
5613412|NCT00811070|19392057|P4|Overall Study|Other|0
5613413|NCT00811070|19392058|P3|Overall Study|Other|0
5613414|NCT00811070|19392059|P2|Overall Study|Other|0
5613415|NCT00811070|19392060|P1|Overall Study|Other|1
5613416|NCT00811070|19392055|P6|Overall Study|Death|0
5613417|NCT00811070|19392056|P5|Overall Study|Death|5
5613418|NCT00811070|19392057|P4|Overall Study|Death|2
5613419|NCT00811070|19392058|P3|Overall Study|Death|0
5613420|NCT00811070|19392059|P2|Overall Study|Death|0
5613421|NCT00811070|19392060|P1|Overall Study|Death|0
5613422|NCT00811057|19392120|P3|Overall Study|Protocol Violation|10
5613423|NCT00811057|19392121|P2|Overall Study|Protocol Violation|10
5613424|NCT00811057|19392122|P1|Overall Study|Protocol Violation|5
5613425|NCT00811018|19392133|P1|Overall Study|Other|26
5613426|NCT00811018|19392133|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
5613427|NCT00811018|19392133|P1|Overall Study|Withdrawal by Subject|70
5613428|NCT00811018|19392133|P1|Overall Study|Sponsor Decision|450
5613429|NCT00811018|19392133|P1|Overall Study|Pregnancy|6
5613430|NCT00811018|19392133|P1|Overall Study|Lost to Follow-up|19
5613431|NCT00811018|19392133|P1|Overall Study|Investigator Decision|57
5613432|NCT00811018|19392133|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
5613433|NCT00811018|19392133|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
5613434|NCT00811018|19392133|P1|Overall Study|Death|147
5613435|NCT00811018|19392133|P1|Overall Study|Adverse Event|79
5613436|NCT00811018|19392133|P1|Overall Study|Additional Chronic Treatment|31
5613437|NCT00810901|19392151|P2|Overall Study|Lost to Follow-up|58
5613438|NCT00810901|19392152|P1|Overall Study|Lost to Follow-up|88
5613439|NCT00810810|19392198|P4|Overall Study|Physician Decision|5
5613440|NCT00810810|19392199|P3|Overall Study|Physician Decision|1
5613441|NCT00810810|19392200|P2|Overall Study|Physician Decision|3
5613442|NCT00810810|19392201|P1|Overall Study|Physician Decision|0
5613443|NCT00810810|19392198|P4|Overall Study|Withdrawal by Subject|8
5613444|NCT00810810|19392199|P3|Overall Study|Withdrawal by Subject|10
5613445|NCT00810810|19392200|P2|Overall Study|Withdrawal by Subject|8
5613446|NCT00810810|19392201|P1|Overall Study|Withdrawal by Subject|0
5613447|NCT00810693|19392254|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
5613448|NCT00810693|19392255|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
5613449|NCT00810693|19392256|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
5613450|NCT00810693|19392254|P3|Follow-up Period (FUP)|Protocol Violation|0
5613451|NCT00810693|19392255|P2|Follow-up Period (FUP)|Protocol Violation|1
5613452|NCT00810693|19392256|P1|Follow-up Period (FUP)|Protocol Violation|0
5613453|NCT00810693|19392254|P3|Follow-up Period (FUP)|Lost to Follow-up|2
5613454|NCT00810693|19392255|P2|Follow-up Period (FUP)|Lost to Follow-up|0
5613455|NCT00810693|19392256|P1|Follow-up Period (FUP)|Lost to Follow-up|1
5613456|NCT00810693|19392254|P3|Follow-up Period (FUP)|Death|1
5613457|NCT00810693|19392255|P2|Follow-up Period (FUP)|Death|0
5613458|NCT00810693|19392256|P1|Follow-up Period (FUP)|Death|2
5613459|NCT00810693|19392254|P3|Follow-up Period (FUP)|Adverse Event|1
5613460|NCT00810693|19392255|P2|Follow-up Period (FUP)|Adverse Event|1
5613461|NCT00810693|19392256|P1|Follow-up Period (FUP)|Adverse Event|3
5613462|NCT00810693|19392254|P3|Treatment Period|Not treated|1
5613463|NCT00810693|19392255|P2|Treatment Period|Not treated|1
5613464|NCT00810693|19392256|P1|Treatment Period|Not treated|0
5613465|NCT00810693|19392254|P3|Treatment Period|Withdrawal by Subject|3
5613466|NCT00810693|19392255|P2|Treatment Period|Withdrawal by Subject|2
5613467|NCT00810693|19392256|P1|Treatment Period|Withdrawal by Subject|6
5613468|NCT00810693|19392254|P3|Treatment Period|Protocol Violation|2
5613469|NCT00810693|19392255|P2|Treatment Period|Protocol Violation|2
5613470|NCT00810693|19392256|P1|Treatment Period|Protocol Violation|1
5613471|NCT00810693|19392254|P3|Treatment Period|Non-compliance|0
5613472|NCT00810693|19392255|P2|Treatment Period|Non-compliance|0
5613473|NCT00810693|19392256|P1|Treatment Period|Non-compliance|1
5613474|NCT00810693|19392254|P3|Treatment Period|Lost to Follow-up|0
5613475|NCT00810693|19392255|P2|Treatment Period|Lost to Follow-up|0
5613476|NCT00810693|19392256|P1|Treatment Period|Lost to Follow-up|1
5613477|NCT00810693|19392254|P3|Treatment Period|Lack of Efficacy|1
5613478|NCT00810693|19392255|P2|Treatment Period|Lack of Efficacy|0
5613479|NCT00810693|19392256|P1|Treatment Period|Lack of Efficacy|0
5613480|NCT00810693|19392254|P3|Treatment Period|Death|2
5613481|NCT00810693|19392255|P2|Treatment Period|Death|1
5613482|NCT00810693|19392256|P1|Treatment Period|Death|0
5613483|NCT00810693|19392254|P3|Treatment Period|Adverse Event|7
5613484|NCT00810693|19392255|P2|Treatment Period|Adverse Event|1
5613485|NCT00810693|19392256|P1|Treatment Period|Adverse Event|8
5613486|NCT00810641|19392288|P3|Overall Study|Withdrawal by Subject|2
5613487|NCT00810641|19392289|P2|Overall Study|Withdrawal by Subject|1
5613488|NCT00810641|19392290|P1|Overall Study|Withdrawal by Subject|0
5613489|NCT00810615|19392300|P2|Overall Study|Withdrawal by Subject|1
5613490|NCT00810615|19392301|P1|Overall Study|Withdrawal by Subject|1
5613491|NCT00810602|19392351|P2|Overall Study|Withdrawal by Subject|3
5613492|NCT00810602|19392352|P1|Overall Study|Withdrawal by Subject|8
5613493|NCT00810511|19392365|P2|Overall Study|deposits on contact lens|1
5613494|NCT00810511|19392366|P1|Overall Study|deposits on contact lens|0
5613495|NCT00810511|19392365|P2|Overall Study|Lost to Follow-up|0
5613496|NCT00810511|19392366|P1|Overall Study|Lost to Follow-up|1
5613497|NCT00810511|19392365|P2|Overall Study|death in the family|1
5613498|NCT00810511|19392366|P1|Overall Study|death in the family|0
5613499|NCT00810511|19392365|P2|Overall Study|Lack of Efficacy|1
5613500|NCT00810511|19392366|P1|Overall Study|Lack of Efficacy|9
5613501|NCT00810511|19392365|P2|Overall Study|Protocol Violation|1
5613502|NCT00810511|19392366|P1|Overall Study|Protocol Violation|0
5613503|NCT00810407|19392384|P1|Overall Study|No Visit After First Day of Treatment|3
5613504|NCT00810407|19392384|P1|Overall Study|Protocol Violation|3
5613505|NCT00810394|19392396|P1|Overall Study|Withdrawal by Subject|3
5613506|NCT00810368|19392404|P2|Overall Study|Lack of Efficacy|0
5613507|NCT00810368|19392405|P1|Overall Study|Lack of Efficacy|2
5613508|NCT00810368|19392404|P2|Overall Study|Lost to Follow-up|2
5613509|NCT00810368|19392405|P1|Overall Study|Lost to Follow-up|4
5613510|NCT00810355|19392426|P3|Overall Study|Withdrawal by Subject|0
5613511|NCT00810355|19392427|P2|Overall Study|Withdrawal by Subject|0
5613512|NCT00810355|19392428|P1|Overall Study|Withdrawal by Subject|1
5613513|NCT00810355|19392426|P3|Overall Study|Lost to Follow-up|11
5613514|NCT00810355|19392427|P2|Overall Study|Lost to Follow-up|17
5613515|NCT00810355|19392428|P1|Overall Study|Lost to Follow-up|13
5613516|NCT00810342|19392444|P2|12-month Followup|Lost to Follow-up|1
5613517|NCT00810342|19392445|P1|12-month Followup|Lost to Follow-up|3
5613518|NCT00810342|19392444|P2|12-month Followup|Pregnancy|10
5613519|NCT00810342|19392445|P1|12-month Followup|Pregnancy|9
5613520|NCT00810342|19392444|P2|6-month Follow-up|Pregnancy|2
5613521|NCT00810342|19392445|P1|6-month Follow-up|Pregnancy|6
5613522|NCT00810342|19392444|P2|6-month Follow-up|Lost to Follow-up|6
5613523|NCT00810342|19392445|P1|6-month Follow-up|Lost to Follow-up|18
5613524|NCT00810342|19392444|P2|Month 1 Follow-up|Pregnancy|0
5613525|NCT00810342|19392445|P1|Month 1 Follow-up|Pregnancy|1
5613526|NCT00810342|19392444|P2|Month 1 Follow-up|Lost to Follow-up|2
5613527|NCT00810342|19392445|P1|Month 1 Follow-up|Lost to Follow-up|4
5613528|NCT00810277|19392478|P1|Overall Study|Adverse Event|1
5613529|NCT00810264|19392491|P1|Overall Study|Death|641
5613530|NCT00810264|19392491|P1|Overall Study|Withdrawal by subject or physician|721
5613531|NCT00810264|19392491|P1|Overall Study|Lost to Follow-up|191
5613532|NCT00810199|19392518|P2|Overall Study|Did not receive study drug|1
5613533|NCT00810199|19392519|P1|Overall Study|Did not receive study drug|2
5613534|NCT00810199|19392518|P2|Overall Study|Failure to return|4
5613535|NCT00810199|19392519|P1|Overall Study|Failure to return|1
5613536|NCT00810199|19392518|P2|Overall Study|Protocol Violation|6
5613537|NCT00810199|19392519|P1|Overall Study|Protocol Violation|2
5613538|NCT00810199|19392518|P2|Overall Study|Administrative/Other|6
5613539|NCT00810199|19392519|P1|Overall Study|Administrative/Other|5
5613540|NCT00810199|19392518|P2|Overall Study|Refused treatment/Did not cooperate|7
5613541|NCT00810199|19392519|P1|Overall Study|Refused treatment/Did not cooperate|7
5613542|NCT00810199|19392518|P2|Overall Study|Insufficient therapeutic response|14
5613543|NCT00810199|19392519|P1|Overall Study|Insufficient therapeutic response|5
5613544|NCT00810199|19392518|P2|Overall Study|Withdrew consent|12
5613545|NCT00810199|19392519|P1|Overall Study|Withdrew consent|9
5613546|NCT00810199|19392518|P2|Overall Study|Death|6
5613547|NCT00810199|19392519|P1|Overall Study|Death|4
5613548|NCT00810199|19392518|P2|Overall Study|Adverse Event|26
5613549|NCT00810199|19392519|P1|Overall Study|Adverse Event|24
5613550|NCT00810108|19392597|P2|Overall Study|Withdrawal by Subject|0
5613551|NCT00810108|19392598|P1|Overall Study|Withdrawal by Subject|1
5613552|NCT00810082|19392612|P2|Overall Study|Lost to Follow-up|4
5613553|NCT00810082|19392613|P1|Overall Study|Lost to Follow-up|0
5613554|NCT00810069|19392621|P3|Double-Blind Period II|Protocol Violation|6
5613555|NCT00810069|19392622|P2|Double-Blind Period II|Protocol Violation|7
5613556|NCT00810069|19392623|P1|Double-Blind Period II|Protocol Violation|0
5613557|NCT00810069|19392621|P3|Double-Blind Period II|Clinical relapse|0
5613558|NCT00810069|19392622|P2|Double-Blind Period II|Clinical relapse|3
5613559|NCT00810069|19392623|P1|Double-Blind Period II|Clinical relapse|0
5613560|NCT00810069|19392621|P3|Double-Blind Period II|Protocol entry criterion not met|1
5613561|NCT00810069|19392622|P2|Double-Blind Period II|Protocol entry criterion not met|0
5613562|NCT00810069|19392623|P1|Double-Blind Period II|Protocol entry criterion not met|0
5613563|NCT00810069|19392621|P3|Double-Blind Period II|Withdrawal by Subject|35
5613564|NCT00810069|19392622|P2|Double-Blind Period II|Withdrawal by Subject|21
5613565|NCT00810069|19392623|P1|Double-Blind Period II|Withdrawal by Subject|0
5613566|NCT00810069|19392621|P3|Double-Blind Period II|Physician Decision|1
5613567|NCT00810069|19392622|P2|Double-Blind Period II|Physician Decision|0
5613568|NCT00810069|19392623|P1|Double-Blind Period II|Physician Decision|0
5613569|NCT00810069|19392621|P3|Double-Blind Period II|Lost to Follow-up|9
5613570|NCT00810069|19392622|P2|Double-Blind Period II|Lost to Follow-up|9
5613571|NCT00810069|19392623|P1|Double-Blind Period II|Lost to Follow-up|0
5613572|NCT00810069|19392621|P3|Double-Blind Period II|Lack of Efficacy|12
5613573|NCT00810069|19392622|P2|Double-Blind Period II|Lack of Efficacy|7
5613574|NCT00810069|19392623|P1|Double-Blind Period II|Lack of Efficacy|0
5613575|NCT00810069|19392621|P3|Double-Blind Period II|Adverse Event|8
5613576|NCT00810069|19392622|P2|Double-Blind Period II|Adverse Event|9
5613577|NCT00810069|19392623|P1|Double-Blind Period II|Adverse Event|0
5613578|NCT00810069|19392621|P3|Lead-in Period I|Randomization criteria not met|0
5613579|NCT00810069|19392622|P2|Lead-in Period I|Randomization criteria not met|0
5613580|NCT00810069|19392623|P1|Lead-in Period I|Randomization criteria not met|158
5613581|NCT00810069|19392621|P3|Lead-in Period I|Protocol entry criterion not met|0
5613582|NCT00810069|19392622|P2|Lead-in Period I|Protocol entry criterion not met|0
5613583|NCT00810069|19392623|P1|Lead-in Period I|Protocol entry criterion not met|5
5613584|NCT00810069|19392621|P3|Lead-in Period I|Withdrawal by Subject|0
5613585|NCT00810069|19392622|P2|Lead-in Period I|Withdrawal by Subject|0
5613586|NCT00810069|19392623|P1|Lead-in Period I|Withdrawal by Subject|46
5613587|NCT00810069|19392621|P3|Lead-in Period I|Protocol Violation|0
5613588|NCT00810069|19392622|P2|Lead-in Period I|Protocol Violation|0
5613589|NCT00810069|19392623|P1|Lead-in Period I|Protocol Violation|1
5613590|NCT00810069|19392621|P3|Lead-in Period I|Physician Decision|0
5613591|NCT00810069|19392622|P2|Lead-in Period I|Physician Decision|0
5613592|NCT00810069|19392623|P1|Lead-in Period I|Physician Decision|1
5613593|NCT00810069|19392621|P3|Lead-in Period I|Lost to Follow-up|0
5613594|NCT00810069|19392622|P2|Lead-in Period I|Lost to Follow-up|0
5613595|NCT00810069|19392623|P1|Lead-in Period I|Lost to Follow-up|19
5613596|NCT00810069|19392621|P3|Lead-in Period I|Lack of Efficacy|0
5613597|NCT00810069|19392622|P2|Lead-in Period I|Lack of Efficacy|0
5613598|NCT00810069|19392623|P1|Lead-in Period I|Lack of Efficacy|1
5613599|NCT00810069|19392621|P3|Lead-in Period I|Adverse Event|0
5613600|NCT00810069|19392622|P2|Lead-in Period I|Adverse Event|0
5613601|NCT00810069|19392623|P1|Lead-in Period I|Adverse Event|43
5613602|NCT00810043|19392668|P3|Overall Study|No longer met enrollment criteria|3
5613603|NCT00810043|19392669|P2|Overall Study|No longer met enrollment criteria|0
5613604|NCT00810043|19392670|P1|Overall Study|No longer met enrollment criteria|0
5613605|NCT00810043|19392668|P3|Overall Study|Non-medical problem|1
5613606|NCT00810043|19392669|P2|Overall Study|Non-medical problem|0
5613607|NCT00810043|19392670|P1|Overall Study|Non-medical problem|0
5613608|NCT00810043|19392668|P3|Overall Study|Unrelated medical problem|0
5613609|NCT00810043|19392669|P2|Overall Study|Unrelated medical problem|1
5613610|NCT00810043|19392670|P1|Overall Study|Unrelated medical problem|0
5613611|NCT00810043|19392668|P3|Overall Study|Death|0
5613612|NCT00810043|19392669|P2|Overall Study|Death|0
5613613|NCT00810043|19392670|P1|Overall Study|Death|2
5613614|NCT00810043|19392668|P3|Overall Study|Physician Decision|2
5613615|NCT00810043|19392669|P2|Overall Study|Physician Decision|0
5613616|NCT00810043|19392670|P1|Overall Study|Physician Decision|0
5613617|NCT00810043|19392668|P3|Overall Study|Lost to Follow-up|0
5613618|NCT00810043|19392669|P2|Overall Study|Lost to Follow-up|0
5613619|NCT00810043|19392670|P1|Overall Study|Lost to Follow-up|1
5613620|NCT00810043|19392668|P3|Overall Study|Withdrawal by Subject|2
5613621|NCT00810043|19392669|P2|Overall Study|Withdrawal by Subject|0
5613622|NCT00810043|19392670|P1|Overall Study|Withdrawal by Subject|1
5613623|NCT00809965|19392692|P3|Overall Study|Other Reason|189
5613624|NCT00809965|19392693|P2|Overall Study|Other Reason|170
5613625|NCT00809965|19392694|P1|Overall Study|Other Reason|167
5613626|NCT00809965|19392692|P3|Overall Study|Withdrawal by Subject|441
5613627|NCT00809965|19392693|P2|Overall Study|Withdrawal by Subject|448
5613628|NCT00809965|19392694|P1|Overall Study|Withdrawal by Subject|405
5613629|NCT00809965|19392692|P3|Overall Study|Lost to Follow-up|18
5613630|NCT00809965|19392693|P2|Overall Study|Lost to Follow-up|10
5613631|NCT00809965|19392694|P1|Overall Study|Lost to Follow-up|17
5613632|NCT00809965|19392692|P3|Overall Study|Death|196
5613633|NCT00809965|19392693|P2|Overall Study|Death|147
5613634|NCT00809965|19392694|P1|Overall Study|Death|194
5613635|NCT00809926|19392716|P2|Overall Study|Protocol deviation|2
5613636|NCT00809926|19392717|P1|Overall Study|Protocol deviation|0
5613637|NCT00809926|19392716|P2|Overall Study|Administrative Problems|1
5613638|NCT00809926|19392717|P1|Overall Study|Administrative Problems|0
5613639|NCT00809926|19392716|P2|Overall Study|Lost to Follow-up|1
5613640|NCT00809926|19392717|P1|Overall Study|Lost to Follow-up|2
5613641|NCT00809926|19392716|P2|Overall Study|Patient withdrew consent|6
5613642|NCT00809926|19392717|P1|Overall Study|Patient withdrew consent|8
5613643|NCT00809926|19392716|P2|Overall Study|Unsatisfactory therapeutic effect|3
5613644|NCT00809926|19392717|P1|Overall Study|Unsatisfactory therapeutic effect|3
5613645|NCT00809926|19392716|P2|Overall Study|Adverse Event|10
5613646|NCT00809926|19392717|P1|Overall Study|Adverse Event|18
5613647|NCT00809835|19392771|P4|Overall Study|Withdrawal by Subject|0
5613648|NCT00809835|19392772|P3|Overall Study|Withdrawal by Subject|1
5613649|NCT00809835|19392773|P2|Overall Study|Withdrawal by Subject|1
5613650|NCT00809835|19392774|P1|Overall Study|Withdrawal by Subject|1
5613651|NCT00809835|19392771|P4|Overall Study|Lost to Follow-up|2
5613652|NCT00809835|19392772|P3|Overall Study|Lost to Follow-up|10
5613653|NCT00809835|19392773|P2|Overall Study|Lost to Follow-up|6
5613654|NCT00809835|19392774|P1|Overall Study|Lost to Follow-up|7
5613655|NCT00809757|19392804|P3|Overall Study|Noncompliance with Medication|1
5613656|NCT00809757|19392805|P2|Overall Study|Noncompliance with Medication|0
5613657|NCT00809757|19392806|P1|Overall Study|Noncompliance with Medication|0
5613658|NCT00809757|19392804|P3|Overall Study|Subject Uncooperative|2
5613659|NCT00809757|19392805|P2|Overall Study|Subject Uncooperative|0
5613660|NCT00809757|19392806|P1|Overall Study|Subject Uncooperative|1
5613661|NCT00809757|19392804|P3|Overall Study|Withdrawal by Subject|3
5613662|NCT00809757|19392805|P2|Overall Study|Withdrawal by Subject|1
5613663|NCT00809757|19392806|P1|Overall Study|Withdrawal by Subject|2
5613664|NCT00809757|19392804|P3|Overall Study|Protocol Violation|1
5613665|NCT00809757|19392805|P2|Overall Study|Protocol Violation|1
5613666|NCT00809757|19392806|P1|Overall Study|Protocol Violation|1
5613667|NCT00809757|19392804|P3|Overall Study|Lost to Follow-up|1
5613668|NCT00809757|19392805|P2|Overall Study|Lost to Follow-up|0
5613669|NCT00809757|19392806|P1|Overall Study|Lost to Follow-up|0
5613670|NCT00809757|19392804|P3|Overall Study|Adverse Event|3
5613671|NCT00809757|19392805|P2|Overall Study|Adverse Event|3
5613672|NCT00809757|19392806|P1|Overall Study|Adverse Event|2
5613673|NCT00809614|19392891|P2|Overall Study|Withdrawal by Subject|1
5613674|NCT00809614|19392892|P1|Overall Study|Withdrawal by Subject|1
5613675|NCT00809614|19392891|P2|Overall Study|Lack of Efficacy|3
5613676|NCT00809614|19392892|P1|Overall Study|Lack of Efficacy|2
5613677|NCT00809471|19392936|P3|Overall Study|Requirement for restricted medication|0
5613678|NCT00809471|19392937|P2|Overall Study|Requirement for restricted medication|1
5613679|NCT00809471|19392938|P1|Overall Study|Requirement for restricted medication|1
5613680|NCT00809471|19392936|P3|Overall Study|Adverse Event|2
5613681|NCT00809471|19392937|P2|Overall Study|Adverse Event|2
5613682|NCT00809471|19392938|P1|Overall Study|Adverse Event|0
5613683|NCT00809471|19392936|P3|Overall Study|Lost to Follow-up|9
5613684|NCT00809471|19392937|P2|Overall Study|Lost to Follow-up|2
5613685|NCT00809471|19392938|P1|Overall Study|Lost to Follow-up|4
5613686|NCT00809471|19392936|P3|Overall Study|Protocol non-compliance|6
5613687|NCT00809471|19392937|P2|Overall Study|Protocol non-compliance|15
5613688|NCT00809471|19392938|P1|Overall Study|Protocol non-compliance|15
5613689|NCT00809445|19392968|P3|6 Month Follow-up|Withdrew consent|1
5613690|NCT00809445|19392969|P2|6 Month Follow-up|Withdrew consent|0
5613691|NCT00809445|19392970|P1|6 Month Follow-up|Withdrew consent|0
5613692|NCT00809445|19392968|P3|6 Month Follow-up|Incarcerated|8
5613693|NCT00809445|19392969|P2|6 Month Follow-up|Incarcerated|8
5613694|NCT00809445|19392970|P1|6 Month Follow-up|Incarcerated|6
5613695|NCT00809445|19392968|P3|6 Month Follow-up|Death|1
5613696|NCT00809445|19392969|P2|6 Month Follow-up|Death|1
5613697|NCT00809445|19392970|P1|6 Month Follow-up|Death|2
5613698|NCT00809445|19392968|P3|6 Month Follow-up|Lost contact|14
5613699|NCT00809445|19392969|P2|6 Month Follow-up|Lost contact|14
5613700|NCT00809445|19392970|P1|6 Month Follow-up|Lost contact|16
5613701|NCT00809445|19392968|P3|1 Month Follow-up|Incarcerated|1
5613702|NCT00809445|19392969|P2|1 Month Follow-up|Incarcerated|0
5613703|NCT00809445|19392970|P1|1 Month Follow-up|Incarcerated|0
5613704|NCT00809445|19392968|P3|1 Month Follow-up|Death|1
5613705|NCT00809445|19392969|P2|1 Month Follow-up|Death|1
5613706|NCT00809445|19392970|P1|1 Month Follow-up|Death|0
5613707|NCT00809445|19392968|P3|1 Month Follow-up|Withdrew consent|1
5613708|NCT00809445|19392969|P2|1 Month Follow-up|Withdrew consent|1
5613709|NCT00809445|19392970|P1|1 Month Follow-up|Withdrew consent|1
5613710|NCT00809445|19392968|P3|1 Month Follow-up|Lost contact|1
5613711|NCT00809445|19392969|P2|1 Month Follow-up|Lost contact|2
5613712|NCT00809445|19392970|P1|1 Month Follow-up|Lost contact|1
5613713|NCT00809341|19392989|P2|Overall Study|Physician Decision|1
5613714|NCT00809341|19392990|P1|Overall Study|Physician Decision|0
5613715|NCT00809328|19392998|P1|Overall Study|Withdrawal by Subject|2
5613716|NCT00809328|19392998|P1|Overall Study|Protocol Violation|3
5613717|NCT00809328|19392998|P1|Overall Study|Adverse Event|6
5613718|NCT00809328|19392998|P1|Overall Study|Lack of Efficacy|18
5613719|NCT00809159|19393020|P6|Part 1 and 2|Withdrawal by Subject|1
5613720|NCT00809159|19393021|P5|Part 1 and 2|Withdrawal by Subject|0
5613721|NCT00809159|19393022|P4|Part 1 and 2|Withdrawal by Subject|0
5613722|NCT00809159|19393023|P3|Part 1 and 2|Withdrawal by Subject|4
5613723|NCT00809159|19393024|P2|Part 1 and 2|Withdrawal by Subject|0
5613724|NCT00809159|19393025|P1|Part 1 and 2|Withdrawal by Subject|0
5613725|NCT00809159|19393020|P6|Part 1 and 2|Lost to Follow-up|0
5613726|NCT00809159|19393021|P5|Part 1 and 2|Lost to Follow-up|0
5613727|NCT00809159|19393022|P4|Part 1 and 2|Lost to Follow-up|1
5613728|NCT00809159|19393023|P3|Part 1 and 2|Lost to Follow-up|1
5613729|NCT00809159|19393024|P2|Part 1 and 2|Lost to Follow-up|0
5613730|NCT00809159|19393025|P1|Part 1 and 2|Lost to Follow-up|0
5613731|NCT00809159|19393020|P6|Part 1 and 2|Adverse Event|1
5613732|NCT00809159|19393021|P5|Part 1 and 2|Adverse Event|1
5613733|NCT00809159|19393022|P4|Part 1 and 2|Adverse Event|0
5613734|NCT00809159|19393023|P3|Part 1 and 2|Adverse Event|1
5613735|NCT00809159|19393024|P2|Part 1 and 2|Adverse Event|0
5613736|NCT00809159|19393025|P1|Part 1 and 2|Adverse Event|0
5613737|NCT00809159|19393020|P6|Part 1 and 2|Administrative problems|0
5613738|NCT00809159|19393021|P5|Part 1 and 2|Administrative problems|0
5613739|NCT00809159|19393022|P4|Part 1 and 2|Administrative problems|1
5613740|NCT00809159|19393023|P3|Part 1 and 2|Administrative problems|0
5613741|NCT00809159|19393024|P2|Part 1 and 2|Administrative problems|0
5613742|NCT00809159|19393025|P1|Part 1 and 2|Administrative problems|0
5613743|NCT00809159|19393020|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
5613744|NCT00809159|19393021|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
5613745|NCT00809159|19393022|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
5613746|NCT00809159|19393023|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
5613747|NCT00809159|19393024|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
5613748|NCT00809159|19393025|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
5613749|NCT00809159|19393020|P6|Part 1|Unsatisfactory therapeutic effect|0
5613750|NCT00809159|19393021|P5|Part 1|Unsatisfactory therapeutic effect|0
5613751|NCT00809159|19393022|P4|Part 1|Unsatisfactory therapeutic effect|0
5613752|NCT00809159|19393023|P3|Part 1|Unsatisfactory therapeutic effect|0
5613753|NCT00809159|19393024|P2|Part 1|Unsatisfactory therapeutic effect|1
5613754|NCT00809159|19393025|P1|Part 1|Unsatisfactory therapeutic effect|3
5613755|NCT00809159|19393020|P6|Part 1|Withdrawal by Subject|0
5613756|NCT00809159|19393021|P5|Part 1|Withdrawal by Subject|0
5613757|NCT00809159|19393022|P4|Part 1|Withdrawal by Subject|0
5613758|NCT00809159|19393023|P3|Part 1|Withdrawal by Subject|0
5613759|NCT00809159|19393024|P2|Part 1|Withdrawal by Subject|1
5613760|NCT00809159|19393025|P1|Part 1|Withdrawal by Subject|3
5613761|NCT00809159|19393020|P6|Part 1|Lost to Follow-up|0
5613762|NCT00809159|19393021|P5|Part 1|Lost to Follow-up|0
5613763|NCT00809159|19393022|P4|Part 1|Lost to Follow-up|0
5613764|NCT00809159|19393023|P3|Part 1|Lost to Follow-up|0
5613765|NCT00809159|19393024|P2|Part 1|Lost to Follow-up|0
5613766|NCT00809159|19393025|P1|Part 1|Lost to Follow-up|1
5613767|NCT00809159|19393020|P6|Part 1|Adverse Event|0
5613768|NCT00809159|19393021|P5|Part 1|Adverse Event|0
5613769|NCT00809159|19393022|P4|Part 1|Adverse Event|0
5613770|NCT00809159|19393023|P3|Part 1|Adverse Event|0
5613771|NCT00809159|19393024|P2|Part 1|Adverse Event|1
5613772|NCT00809159|19393025|P1|Part 1|Adverse Event|1
5613773|NCT00809133|19393130|P14|Overall Study|Other not mentioned above|0
5613774|NCT00809133|19393131|P13|Overall Study|Other not mentioned above|0
5613775|NCT00809133|19393132|P12|Overall Study|Other not mentioned above|0
5613776|NCT00809133|19393133|P11|Overall Study|Other not mentioned above|0
5613777|NCT00809133|19393134|P10|Overall Study|Other not mentioned above|0
5613778|NCT00809133|19393135|P9|Overall Study|Other not mentioned above|0
5613779|NCT00809133|19393136|P8|Overall Study|Other not mentioned above|0
5613780|NCT00809133|19393137|P7|Overall Study|Other not mentioned above|0
5613781|NCT00809133|19393138|P6|Overall Study|Other not mentioned above|1
5613782|NCT00809133|19393139|P5|Overall Study|Other not mentioned above|0
5613783|NCT00809133|19393140|P4|Overall Study|Other not mentioned above|0
5613784|NCT00809133|19393141|P3|Overall Study|Other not mentioned above|0
5613785|NCT00809133|19393142|P2|Overall Study|Other not mentioned above|1
5613786|NCT00809133|19393143|P1|Overall Study|Other not mentioned above|0
5613787|NCT00809133|19393130|P14|Overall Study|Consent withdrawn|0
5613788|NCT00809133|19393131|P13|Overall Study|Consent withdrawn|0
5613789|NCT00809133|19393132|P12|Overall Study|Consent withdrawn|0
5613790|NCT00809133|19393133|P11|Overall Study|Consent withdrawn|0
5613791|NCT00809133|19393134|P10|Overall Study|Consent withdrawn|0
5613792|NCT00809133|19393135|P9|Overall Study|Consent withdrawn|0
5613793|NCT00809133|19393136|P8|Overall Study|Consent withdrawn|0
5613794|NCT00809133|19393137|P7|Overall Study|Consent withdrawn|0
5613795|NCT00809133|19393138|P6|Overall Study|Consent withdrawn|0
5613796|NCT00809133|19393139|P5|Overall Study|Consent withdrawn|1
5613797|NCT00809133|19393140|P4|Overall Study|Consent withdrawn|0
5613798|NCT00809133|19393141|P3|Overall Study|Consent withdrawn|0
5613799|NCT00809133|19393142|P2|Overall Study|Consent withdrawn|0
5613800|NCT00809133|19393143|P1|Overall Study|Consent withdrawn|0
5613801|NCT00809133|19393130|P14|Overall Study|Lost to Follow-up|0
5613802|NCT00809133|19393131|P13|Overall Study|Lost to Follow-up|0
5613803|NCT00809133|19393132|P12|Overall Study|Lost to Follow-up|0
5613804|NCT00809133|19393133|P11|Overall Study|Lost to Follow-up|0
5613805|NCT00809133|19393134|P10|Overall Study|Lost to Follow-up|0
5613806|NCT00809133|19393135|P9|Overall Study|Lost to Follow-up|0
5613807|NCT00809133|19393136|P8|Overall Study|Lost to Follow-up|0
5613808|NCT00809133|19393137|P7|Overall Study|Lost to Follow-up|0
5613809|NCT00809133|19393138|P6|Overall Study|Lost to Follow-up|1
5613810|NCT00809133|19393139|P5|Overall Study|Lost to Follow-up|0
5613811|NCT00809133|19393140|P4|Overall Study|Lost to Follow-up|0
5613812|NCT00809133|19393141|P3|Overall Study|Lost to Follow-up|0
5613813|NCT00809133|19393142|P2|Overall Study|Lost to Follow-up|0
5613814|NCT00809133|19393143|P1|Overall Study|Lost to Follow-up|0
5613815|NCT00809133|19393130|P14|Overall Study|Other adverse event|1
5613816|NCT00809133|19393131|P13|Overall Study|Other adverse event|0
5613817|NCT00809133|19393132|P12|Overall Study|Other adverse event|1
5613818|NCT00809133|19393133|P11|Overall Study|Other adverse event|1
5613819|NCT00809133|19393134|P10|Overall Study|Other adverse event|0
5613820|NCT00809133|19393135|P9|Overall Study|Other adverse event|0
5613821|NCT00809133|19393136|P8|Overall Study|Other adverse event|4
5613822|NCT00809133|19393137|P7|Overall Study|Other adverse event|2
5613823|NCT00809133|19393138|P6|Overall Study|Other adverse event|3
5613824|NCT00809133|19393139|P5|Overall Study|Other adverse event|0
5613825|NCT00809133|19393140|P4|Overall Study|Other adverse event|0
5613826|NCT00809133|19393141|P3|Overall Study|Other adverse event|1
5613827|NCT00809133|19393142|P2|Overall Study|Other adverse event|1
5613828|NCT00809133|19393143|P1|Overall Study|Other adverse event|1
5613829|NCT00809133|19393130|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
5613830|NCT00809133|19393131|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
5613831|NCT00809133|19393132|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
5613832|NCT00809133|19393133|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
5613833|NCT00809133|19393134|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
5613834|NCT00809133|19393135|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
5613835|NCT00809133|19393136|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
5613836|NCT00809133|19393137|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
5613837|NCT00809133|19393138|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
5613838|NCT00809133|19393139|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
5613839|NCT00809133|19393140|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
5613840|NCT00809133|19393141|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
5613841|NCT00809133|19393142|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
5613842|NCT00809133|19393143|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
5613843|NCT00809133|19393130|P14|Overall Study|Progressive disease|4
5613844|NCT00809133|19393131|P13|Overall Study|Progressive disease|5
5613845|NCT00809133|19393132|P12|Overall Study|Progressive disease|7
5613846|NCT00809133|19393133|P11|Overall Study|Progressive disease|5
5613847|NCT00809133|19393134|P10|Overall Study|Progressive disease|9
5613848|NCT00809133|19393135|P9|Overall Study|Progressive disease|3
5613849|NCT00809133|19393136|P8|Overall Study|Progressive disease|3
5613850|NCT00809133|19393137|P7|Overall Study|Progressive disease|3
5613851|NCT00809133|19393138|P6|Overall Study|Progressive disease|1
5613852|NCT00809133|19393139|P5|Overall Study|Progressive disease|4
5613853|NCT00809133|19393140|P4|Overall Study|Progressive disease|3
5613854|NCT00809133|19393141|P3|Overall Study|Progressive disease|5
5613855|NCT00809133|19393142|P2|Overall Study|Progressive disease|5
5613856|NCT00809133|19393143|P1|Overall Study|Progressive disease|2
5613857|NCT00809094|19393297|P2|Overall Study|Lost to Follow-up|1
5613858|NCT00809094|19393298|P1|Overall Study|Lost to Follow-up|0
5613859|NCT00808899|19393343|P1|Overall Study|Physician Decision|3
5613860|NCT00808899|19393343|P1|Overall Study|Death|1
5613861|NCT00808808|19393357|P3|Overall Study|Employee was not vaccinated.|2255
5613862|NCT00808808|19393358|P2|Overall Study|Employee was not vaccinated.|2268
5613863|NCT00808808|19393359|P1|Overall Study|Employee was not vaccinated.|2686
5613864|NCT00808808|19393357|P3|Overall Study|Vaccinated; survey not completed|302
5613865|NCT00808808|19393358|P2|Overall Study|Vaccinated; survey not completed|169
5613866|NCT00808808|19393359|P1|Overall Study|Vaccinated; survey not completed|131
5613867|NCT00808665|19393394|P2|Overall Study|Medication stopped by resident|1
5613868|NCT00808665|19393395|P1|Overall Study|Medication stopped by resident|0
5613869|NCT00808665|19393394|P2|Overall Study|Physician Decision|1
5613870|NCT00808665|19393395|P1|Overall Study|Physician Decision|3
5613871|NCT00808665|19393394|P2|Overall Study|required an additional procedure|1
5613872|NCT00808665|19393395|P1|Overall Study|required an additional procedure|0
5613873|NCT00808665|19393394|P2|Overall Study|surgery cancelled|0
5613874|NCT00808665|19393395|P1|Overall Study|surgery cancelled|1
5613875|NCT00808665|19393394|P2|Overall Study|only required minimally invasive surgery|0
5613876|NCT00808665|19393395|P1|Overall Study|only required minimally invasive surgery|1
5613877|NCT00808665|19393394|P2|Overall Study|Withdrawal by Subject|0
5613878|NCT00808665|19393395|P1|Overall Study|Withdrawal by Subject|1
5613879|NCT00808639|19393401|P1|Overall Study|Disease progression before surgery.|1
5613880|NCT00808509|19393409|P2|Randomized Phase|Patient refused rescue therapy|3
5613881|NCT00808509|19393410|P1|Randomized Phase|Patient refused rescue therapy|0
5613882|NCT00808509|19393409|P2|Randomized Phase|Reduced methotrexate dose|2
5613883|NCT00808509|19393410|P1|Randomized Phase|Reduced methotrexate dose|1
5613884|NCT00808509|19393409|P2|Randomized Phase|Did not meet eligibility criteria|0
5613885|NCT00808509|19393410|P1|Randomized Phase|Did not meet eligibility criteria|1
5613886|NCT00808483|19393508|P2|From 5 Months to 12 Months|Lack of Efficacy|0
5613887|NCT00808483|19393509|P1|From 5 Months to 12 Months|Lack of Efficacy|1
5613888|NCT00808483|19393508|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
5613889|NCT00808483|19393509|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
5613890|NCT00808483|19393508|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
5613891|NCT00808483|19393509|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
5613892|NCT00808444|19393546|P2|Overall Study|Lost to Follow-up|1
5613893|NCT00808444|19393547|P1|Overall Study|Lost to Follow-up|0
5613894|NCT00808444|19393546|P2|Overall Study|Withdrawal by Subject|0
5613895|NCT00808444|19393547|P1|Overall Study|Withdrawal by Subject|1
5613896|NCT00808249|19393622|P4|Overall Study|All other reasons|1
5613897|NCT00808249|19393623|P3|Overall Study|All other reasons|3
5613898|NCT00808249|19393624|P2|Overall Study|All other reasons|1
5613899|NCT00808249|19393625|P1|Overall Study|All other reasons|2
5613900|NCT00808249|19393622|P4|Overall Study|study specific discontinuation criteria|0
5613901|NCT00808249|19393623|P3|Overall Study|study specific discontinuation criteria|1
5613902|NCT00808249|19393624|P2|Overall Study|study specific discontinuation criteria|0
5613903|NCT00808249|19393625|P1|Overall Study|study specific discontinuation criteria|1
5613904|NCT00808249|19393622|P4|Overall Study|Lack of Efficacy|0
5613905|NCT00808249|19393623|P3|Overall Study|Lack of Efficacy|0
5613906|NCT00808249|19393624|P2|Overall Study|Lack of Efficacy|1
5613907|NCT00808249|19393625|P1|Overall Study|Lack of Efficacy|1
5613908|NCT00808249|19393622|P4|Overall Study|Protocol Violation|0
5613909|NCT00808249|19393623|P3|Overall Study|Protocol Violation|3
5613910|NCT00808249|19393624|P2|Overall Study|Protocol Violation|3
5613911|NCT00808249|19393625|P1|Overall Study|Protocol Violation|3
5613912|NCT00808249|19393622|P4|Overall Study|Withdrawal by Subject|4
5613913|NCT00808249|19393623|P3|Overall Study|Withdrawal by Subject|2
5613914|NCT00808249|19393624|P2|Overall Study|Withdrawal by Subject|0
5613915|NCT00808249|19393625|P1|Overall Study|Withdrawal by Subject|4
5613916|NCT00808249|19393622|P4|Overall Study|Lost to Follow-up|5
5613917|NCT00808249|19393623|P3|Overall Study|Lost to Follow-up|3
5613918|NCT00808249|19393624|P2|Overall Study|Lost to Follow-up|3
5613919|NCT00808249|19393625|P1|Overall Study|Lost to Follow-up|2
5613920|NCT00808249|19393622|P4|Overall Study|Adverse Event|6
5613921|NCT00808249|19393623|P3|Overall Study|Adverse Event|10
5613922|NCT00808249|19393624|P2|Overall Study|Adverse Event|7
5613923|NCT00808249|19393625|P1|Overall Study|Adverse Event|4
5613924|NCT00808236|19393653|P2|Overall Study|Death|30
5613925|NCT00808236|19393654|P1|Overall Study|Death|18
5613926|NCT00808236|19393653|P2|Overall Study|Physician Decision|1
5613927|NCT00808236|19393654|P1|Overall Study|Physician Decision|0
5613928|NCT00808236|19393653|P2|Overall Study|Lost to Follow-up|1
5613929|NCT00808236|19393654|P1|Overall Study|Lost to Follow-up|1
5613930|NCT00808236|19393653|P2|Overall Study|Pre-defined exclusion|3
5613931|NCT00808236|19393654|P1|Overall Study|Pre-defined exclusion|13
5613932|NCT00808236|19393653|P2|Overall Study|Was not resuscitated|56
5613933|NCT00808236|19393654|P1|Overall Study|Was not resuscitated|50
5613934|NCT00808210|19393684|P2|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
5613935|NCT00808210|19393685|P1|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
5613936|NCT00808210|19393684|P2|Double-Blind TX Period|Other reasons outside Sponsor decision|1
5613937|NCT00808210|19393685|P1|Double-Blind TX Period|Other reasons outside Sponsor decision|1
5613938|NCT00808210|19393684|P2|Double-Blind TX Period|Sponsor decision to terminate study|1
5613939|NCT00808210|19393685|P1|Double-Blind TX Period|Sponsor decision to terminate study|1
5613940|NCT00808210|19393684|P2|Double-Blind TX Period|Adverse Event|1
5613941|NCT00808210|19393685|P1|Double-Blind TX Period|Adverse Event|0
5613942|NCT00808210|19393684|P2|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
5613943|NCT00808210|19393685|P1|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
5613944|NCT00808210|19393684|P2|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
5613945|NCT00808210|19393685|P1|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
5613946|NCT00808132|19393710|P5|Overall Study|Unsatisfactory response|12
5613947|NCT00808132|19393711|P4|Overall Study|Unsatisfactory response|4
5613948|NCT00808132|19393712|P3|Overall Study|Unsatisfactory response|6
5613949|NCT00808132|19393713|P2|Overall Study|Unsatisfactory response|6
5613950|NCT00808132|19393714|P1|Overall Study|Unsatisfactory response|5
5613951|NCT00808132|19393710|P5|Overall Study|Randomized, but not treated|9
5613952|NCT00808132|19393711|P4|Overall Study|Randomized, but not treated|8
5613953|NCT00808132|19393712|P3|Overall Study|Randomized, but not treated|9
5613954|NCT00808132|19393713|P2|Overall Study|Randomized, but not treated|7
5613955|NCT00808132|19393714|P1|Overall Study|Randomized, but not treated|10
5613956|NCT00808132|19393710|P5|Overall Study|Other|15
5613957|NCT00808132|19393711|P4|Overall Study|Other|2
5613958|NCT00808132|19393712|P3|Overall Study|Other|6
5613959|NCT00808132|19393713|P2|Overall Study|Other|4
5613960|NCT00808132|19393714|P1|Overall Study|Other|6
5613961|NCT00808132|19393710|P5|Overall Study|Withdrawal by Subject|16
5613962|NCT00808132|19393711|P4|Overall Study|Withdrawal by Subject|7
5613963|NCT00808132|19393712|P3|Overall Study|Withdrawal by Subject|2
5613964|NCT00808132|19393713|P2|Overall Study|Withdrawal by Subject|18
5613965|NCT00808132|19393714|P1|Overall Study|Withdrawal by Subject|27
5613966|NCT00808132|19393710|P5|Overall Study|Protocol Violation|5
5613967|NCT00808132|19393711|P4|Overall Study|Protocol Violation|9
5613968|NCT00808132|19393712|P3|Overall Study|Protocol Violation|4
5613969|NCT00808132|19393713|P2|Overall Study|Protocol Violation|9
5613970|NCT00808132|19393714|P1|Overall Study|Protocol Violation|8
5613971|NCT00808132|19393710|P5|Overall Study|Lost to Follow-up|9
5613972|NCT00808132|19393711|P4|Overall Study|Lost to Follow-up|8
5613973|NCT00808132|19393712|P3|Overall Study|Lost to Follow-up|11
5613974|NCT00808132|19393713|P2|Overall Study|Lost to Follow-up|10
5613975|NCT00808132|19393714|P1|Overall Study|Lost to Follow-up|8
5613976|NCT00808132|19393710|P5|Overall Study|Physician Decision|0
5613977|NCT00808132|19393711|P4|Overall Study|Physician Decision|0
5613978|NCT00808132|19393712|P3|Overall Study|Physician Decision|0
5613979|NCT00808132|19393713|P2|Overall Study|Physician Decision|1
5613980|NCT00808132|19393714|P1|Overall Study|Physician Decision|0
5613981|NCT00808132|19393710|P5|Overall Study|Death|1
5613982|NCT00808132|19393711|P4|Overall Study|Death|0
5613983|NCT00808132|19393712|P3|Overall Study|Death|0
5613984|NCT00808132|19393713|P2|Overall Study|Death|0
5613985|NCT00808132|19393714|P1|Overall Study|Death|0
5613986|NCT00808132|19393710|P5|Overall Study|Adverse Event|33
5613987|NCT00808132|19393711|P4|Overall Study|Adverse Event|31
5613988|NCT00808132|19393712|P3|Overall Study|Adverse Event|16
5613989|NCT00808132|19393713|P2|Overall Study|Adverse Event|33
5613990|NCT00808132|19393714|P1|Overall Study|Adverse Event|34
5613991|NCT00808080|19393786|P1|Overall Study|Patients Became Ineligible for infusion|6
5613992|NCT00808067|19393793|P2|Overall Study|Excluded from analysis|19
5613993|NCT00808067|19393794|P1|Overall Study|Excluded from analysis|13
5613994|NCT00808067|19393793|P2|Overall Study|Other reason not defined above|5
5613995|NCT00808067|19393794|P1|Overall Study|Other reason not defined above|5
5613996|NCT00808067|19393793|P2|Overall Study|Site closed for cause|19
5613997|NCT00808067|19393794|P1|Overall Study|Site closed for cause|19
5613998|NCT00808067|19393793|P2|Overall Study|Patient elected|9
5613999|NCT00808067|19393794|P1|Overall Study|Patient elected|7
5614000|NCT00808067|19393793|P2|Overall Study|Protocol Violation|11
5614001|NCT00808067|19393794|P1|Overall Study|Protocol Violation|3
5614002|NCT00808067|19393793|P2|Overall Study|Physician Decision|38
5614003|NCT00808067|19393794|P1|Overall Study|Physician Decision|47
5614004|NCT00808067|19393793|P2|Overall Study|Site closed|3
5614005|NCT00808067|19393794|P1|Overall Study|Site closed|4
5614006|NCT00808067|19393793|P2|Overall Study|Withdrawal by Subject|25
5614007|NCT00808067|19393794|P1|Overall Study|Withdrawal by Subject|21
5614008|NCT00808067|19393793|P2|Overall Study|Procedure|7
5614009|NCT00808067|19393794|P1|Overall Study|Procedure|6
5614010|NCT00808067|19393793|P2|Overall Study|Death|1
5614011|NCT00808067|19393794|P1|Overall Study|Death|1
5614012|NCT00808067|19393793|P2|Overall Study|Missing|0
5614013|NCT00808067|19393794|P1|Overall Study|Missing|1
5614014|NCT00808067|19393793|P2|Overall Study|Patient refused to take study medication|76
5614015|NCT00808067|19393794|P1|Overall Study|Patient refused to take study medication|65
5614016|NCT00808067|19393793|P2|Overall Study|Elevated LFT results|3
5614017|NCT00808067|19393794|P1|Overall Study|Elevated LFT results|7
5614018|NCT00808067|19393793|P2|Overall Study|Reduced creatinine clearance|55
5614019|NCT00808067|19393794|P1|Overall Study|Reduced creatinine clearance|53
5614020|NCT00808067|19393793|P2|Overall Study|Hospitalization due to surgery|40
5614021|NCT00808067|19393794|P1|Overall Study|Hospitalization due to surgery|37
5614022|NCT00808067|19393793|P2|Overall Study|Hospitalization (not including surgery)|17
5614023|NCT00808067|19393794|P1|Overall Study|Hospitalization (not including surgery)|18
5614024|NCT00808067|19393793|P2|Overall Study|Adverse Event|121
5614025|NCT00808067|19393794|P1|Overall Study|Adverse Event|111
5614026|NCT00808067|19393793|P2|Overall Study|Outcome event - other|25
5614027|NCT00808067|19393794|P1|Overall Study|Outcome event - other|33
5614028|NCT00808067|19393793|P2|Overall Study|Major/minor bleed|44
5614029|NCT00808067|19393794|P1|Overall Study|Major/minor bleed|30
5614030|NCT00808028|19393830|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
5614031|NCT00808028|19393831|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
5614032|NCT00808028|19393832|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
5614033|NCT00808028|19393833|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
5614034|NCT00808028|19393830|P4|Stage 2 (Followed up to 48 Months )|Death|0
5614035|NCT00808028|19393831|P3|Stage 2 (Followed up to 48 Months )|Death|1
5614036|NCT00808028|19393832|P2|Stage 2 (Followed up to 48 Months )|Death|0
5614037|NCT00808028|19393833|P1|Stage 2 (Followed up to 48 Months )|Death|0
5614038|NCT00808028|19393830|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
5614039|NCT00808028|19393831|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
5614040|NCT00808028|19393832|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
5614041|NCT00808028|19393833|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
5614042|NCT00808028|19393830|P4|Stage 2 (Followed up to 48 Months )|Other|1
5614043|NCT00808028|19393831|P3|Stage 2 (Followed up to 48 Months )|Other|1
5614044|NCT00808028|19393832|P2|Stage 2 (Followed up to 48 Months )|Other|0
5614045|NCT00808028|19393833|P1|Stage 2 (Followed up to 48 Months )|Other|0
5614046|NCT00808028|19393830|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
5614047|NCT00808028|19393831|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
5614048|NCT00808028|19393832|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
5614049|NCT00808028|19393833|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
5614050|NCT00808028|19393830|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
5614051|NCT00808028|19393831|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
5614052|NCT00808028|19393832|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
5614053|NCT00808028|19393833|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
5614054|NCT00808028|19393830|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
5614055|NCT00808028|19393831|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
5614056|NCT00808028|19393832|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
5614057|NCT00808028|19393833|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
5614058|NCT00808028|19393830|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
5614059|NCT00808028|19393831|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
5614060|NCT00808028|19393832|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
5614061|NCT00808028|19393833|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
5614062|NCT00808028|19393830|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
5614063|NCT00808028|19393831|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
5614064|NCT00808028|19393832|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
5614065|NCT00808028|19393833|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
5614066|NCT00808028|19393830|P4|Stage 1 (6 Months)|Protocol Violation|1
5614067|NCT00808028|19393831|P3|Stage 1 (6 Months)|Protocol Violation|0
5614068|NCT00808028|19393832|P2|Stage 1 (6 Months)|Protocol Violation|0
5614069|NCT00808028|19393833|P1|Stage 1 (6 Months)|Protocol Violation|0
5614070|NCT00808028|19393830|P4|Stage 1 (6 Months)|Lost to Follow-up|0
5614071|NCT00808028|19393831|P3|Stage 1 (6 Months)|Lost to Follow-up|1
5614072|NCT00808028|19393832|P2|Stage 1 (6 Months)|Lost to Follow-up|0
5614073|NCT00808028|19393833|P1|Stage 1 (6 Months)|Lost to Follow-up|1
5614074|NCT00808028|19393830|P4|Stage 1 (6 Months)|Adverse Event|2
5614075|NCT00808028|19393831|P3|Stage 1 (6 Months)|Adverse Event|1
5614076|NCT00808028|19393832|P2|Stage 1 (6 Months)|Adverse Event|0
5614077|NCT00808028|19393833|P1|Stage 1 (6 Months)|Adverse Event|0
5614078|NCT00808028|19393830|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
5614079|NCT00808028|19393831|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
5614080|NCT00808028|19393832|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
5614081|NCT00808028|19393833|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
5614082|NCT00808028|19393830|P4|Stage 1 (6 Months)|Other|4
5614083|NCT00808028|19393831|P3|Stage 1 (6 Months)|Other|2
5614084|NCT00808028|19393832|P2|Stage 1 (6 Months)|Other|0
5614085|NCT00808028|19393833|P1|Stage 1 (6 Months)|Other|1
5614086|NCT00808028|19393830|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
5614087|NCT00808028|19393831|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
5614088|NCT00808028|19393832|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
5614089|NCT00808028|19393833|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
5614090|NCT00808015|19393869|P1|Overall Study|Enrolled but not treated|4
5614091|NCT00808015|19393869|P1|Overall Study|Other|25
5614092|NCT00808015|19393869|P1|Overall Study|Adverse Event|22
5614093|NCT00808015|19393869|P1|Overall Study|Participants not willing to participate|158
5614094|NCT00808015|19393869|P1|Overall Study|Lost to Follow-up|76
5614095|NCT00808015|19393869|P1|Overall Study|Lack of Efficacy|58
5614096|NCT00808015|19393869|P1|Overall Study|Death|1
5614097|NCT00807937|19393898|P4|Overall Study|All other reasons (not provided)|1
5614098|NCT00807937|19393899|P3|Overall Study|All other reasons (not provided)|0
5614099|NCT00807937|19393900|P2|Overall Study|All other reasons (not provided)|4
5614100|NCT00807937|19393901|P1|Overall Study|All other reasons (not provided)|2
5614101|NCT00807937|19393898|P4|Overall Study|Intake of prohibited medicine|0
5614102|NCT00807937|19393899|P3|Overall Study|Intake of prohibited medicine|2
5614103|NCT00807937|19393900|P2|Overall Study|Intake of prohibited medicine|0
5614104|NCT00807937|19393901|P1|Overall Study|Intake of prohibited medicine|0
5614105|NCT00807937|19393898|P4|Overall Study|Lack of Efficacy|2
5614106|NCT00807937|19393899|P3|Overall Study|Lack of Efficacy|1
5614107|NCT00807937|19393900|P2|Overall Study|Lack of Efficacy|0
5614108|NCT00807937|19393901|P1|Overall Study|Lack of Efficacy|0
5614109|NCT00807937|19393898|P4|Overall Study|Lost to Follow-up|1
5614110|NCT00807937|19393899|P3|Overall Study|Lost to Follow-up|2
5614111|NCT00807937|19393900|P2|Overall Study|Lost to Follow-up|0
5614112|NCT00807937|19393901|P1|Overall Study|Lost to Follow-up|4
5614113|NCT00807937|19393898|P4|Overall Study|Withdrawal by Subject|4
5614114|NCT00807937|19393899|P3|Overall Study|Withdrawal by Subject|1
5614115|NCT00807937|19393900|P2|Overall Study|Withdrawal by Subject|4
5614116|NCT00807937|19393901|P1|Overall Study|Withdrawal by Subject|5
5614117|NCT00807937|19393898|P4|Overall Study|Protocol Violation|3
5614118|NCT00807937|19393899|P3|Overall Study|Protocol Violation|3
5614119|NCT00807937|19393900|P2|Overall Study|Protocol Violation|5
5614120|NCT00807937|19393901|P1|Overall Study|Protocol Violation|4
5614121|NCT00807937|19393898|P4|Overall Study|Adverse Event|4
5614122|NCT00807937|19393899|P3|Overall Study|Adverse Event|5
5614123|NCT00807937|19393900|P2|Overall Study|Adverse Event|12
5614124|NCT00807937|19393901|P1|Overall Study|Adverse Event|12
5614125|NCT00807885|19393936|P9|Overall Study|Lost to Follow-up|0
5614126|NCT00807885|19393937|P8|Overall Study|Lost to Follow-up|0
5614127|NCT00807885|19393938|P7|Overall Study|Lost to Follow-up|0
5614128|NCT00807885|19393939|P6|Overall Study|Lost to Follow-up|1
5614129|NCT00807885|19393940|P5|Overall Study|Lost to Follow-up|0
5614130|NCT00807885|19393941|P4|Overall Study|Lost to Follow-up|0
5614131|NCT00807885|19393942|P3|Overall Study|Lost to Follow-up|0
5614132|NCT00807885|19393943|P2|Overall Study|Lost to Follow-up|0
5614133|NCT00807885|19393944|P1|Overall Study|Lost to Follow-up|0
5614134|NCT00807846|19393993|P2|Overall Study|Other|2
5614135|NCT00807846|19393994|P1|Overall Study|Other|1
5614136|NCT00807846|19393993|P2|Overall Study|Withdrawal by Subject|1
5614137|NCT00807846|19393994|P1|Overall Study|Withdrawal by Subject|2
5614138|NCT00807846|19393993|P2|Overall Study|Protocol Violation|1
5614139|NCT00807846|19393994|P1|Overall Study|Protocol Violation|2
5614140|NCT00807846|19393993|P2|Overall Study|Lack of Efficacy|0
5614141|NCT00807846|19393994|P1|Overall Study|Lack of Efficacy|2
5614142|NCT00807846|19393993|P2|Overall Study|Adverse Event|0
5614143|NCT00807846|19393994|P1|Overall Study|Adverse Event|5
5614144|NCT00807742|19394047|P2|Overall Study|Lost to Follow-up|51
5614145|NCT00807742|19394048|P1|Overall Study|Lost to Follow-up|35
5614146|NCT00807742|19394047|P2|Overall Study|Withdrawal by Subject|1
5614147|NCT00807742|19394048|P1|Overall Study|Withdrawal by Subject|2
5614148|NCT00807742|19394047|P2|Overall Study|Death|2
5614149|NCT00807742|19394048|P1|Overall Study|Death|9
5614150|NCT00807599|19394107|P3|Overall Study|Withdrawal by Subject|1
5614151|NCT00807599|19394108|P2|Overall Study|Withdrawal by Subject|0
5614152|NCT00807599|19394109|P1|Overall Study|Withdrawal by Subject|0
5614153|NCT00807599|19394107|P3|Overall Study|Inadequate response to induction|9
5614154|NCT00807599|19394108|P2|Overall Study|Inadequate response to induction|0
5614155|NCT00807599|19394109|P1|Overall Study|Inadequate response to induction|0
5614156|NCT00807599|19394107|P3|Overall Study|Adverse Event|5
5614157|NCT00807599|19394108|P2|Overall Study|Adverse Event|0
5614158|NCT00807599|19394109|P1|Overall Study|Adverse Event|0
5614159|NCT00807599|19394107|P3|Overall Study|Not treated on protocol study|2
5614160|NCT00807599|19394108|P2|Overall Study|Not treated on protocol study|0
5614161|NCT00807599|19394109|P1|Overall Study|Not treated on protocol study|0
5614162|NCT00807573|19394136|P1|Overall Study|Adverse Event|1
5614163|NCT00807573|19394136|P1|Overall Study|Withdrawal by Subject|1
5614164|NCT00807495|19394182|P5|Overall Study|Reason Not Specified|3
5614165|NCT00807495|19394183|P4|Overall Study|Reason Not Specified|0
5614166|NCT00807495|19394184|P3|Overall Study|Reason Not Specified|2
5614167|NCT00807495|19394185|P2|Overall Study|Reason Not Specified|3
5614168|NCT00807495|19394186|P1|Overall Study|Reason Not Specified|0
5614169|NCT00807495|19394182|P5|Overall Study|Withdrawal by Patient|0
5614170|NCT00807495|19394183|P4|Overall Study|Withdrawal by Patient|0
5614171|NCT00807495|19394184|P3|Overall Study|Withdrawal by Patient|1
5614172|NCT00807495|19394185|P2|Overall Study|Withdrawal by Patient|0
5614173|NCT00807495|19394186|P1|Overall Study|Withdrawal by Patient|2
5614174|NCT00807495|19394182|P5|Overall Study|Adverse Event|2
5614175|NCT00807495|19394183|P4|Overall Study|Adverse Event|1
5614176|NCT00807495|19394184|P3|Overall Study|Adverse Event|1
5614177|NCT00807495|19394185|P2|Overall Study|Adverse Event|3
5614178|NCT00807495|19394186|P1|Overall Study|Adverse Event|6
5614179|NCT00807365|19394232|P1|Overall Study|Study Terminated|5
5614180|NCT00807248|19394240|P4|Overall Study|Other Reason|0
5614181|NCT00807248|19394241|P3|Overall Study|Other Reason|2
5614182|NCT00807248|19394242|P2|Overall Study|Other Reason|0
5614183|NCT00807248|19394243|P1|Overall Study|Other Reason|0
5614184|NCT00807248|19394240|P4|Overall Study|Lost to Follow-up|0
5614185|NCT00807248|19394241|P3|Overall Study|Lost to Follow-up|0
5614186|NCT00807248|19394242|P2|Overall Study|Lost to Follow-up|0
5614187|NCT00807248|19394243|P1|Overall Study|Lost to Follow-up|1
5614188|NCT00807248|19394240|P4|Overall Study|Withdrawal of Consent|5
5614189|NCT00807248|19394241|P3|Overall Study|Withdrawal of Consent|5
5614190|NCT00807248|19394242|P2|Overall Study|Withdrawal of Consent|5
5614191|NCT00807248|19394243|P1|Overall Study|Withdrawal of Consent|5
5614192|NCT00807248|19394240|P4|Overall Study|Protocol Violation|0
5614193|NCT00807248|19394241|P3|Overall Study|Protocol Violation|1
5614194|NCT00807248|19394242|P2|Overall Study|Protocol Violation|1
5614195|NCT00807248|19394243|P1|Overall Study|Protocol Violation|0
5614196|NCT00807248|19394240|P4|Overall Study|Lack of Efficacy|3
5614197|NCT00807248|19394241|P3|Overall Study|Lack of Efficacy|8
5614198|NCT00807248|19394242|P2|Overall Study|Lack of Efficacy|4
5614199|NCT00807248|19394243|P1|Overall Study|Lack of Efficacy|14
5614200|NCT00807248|19394240|P4|Overall Study|Adverse Event|6
5614201|NCT00807248|19394241|P3|Overall Study|Adverse Event|2
5614202|NCT00807248|19394242|P2|Overall Study|Adverse Event|2
5614203|NCT00807248|19394243|P1|Overall Study|Adverse Event|1
5614204|NCT00807235|19394287|P2|Overall Study|Adverse Event|0
5614205|NCT00807235|19394288|P1|Overall Study|Adverse Event|1
5614206|NCT00807092|19394333|P2|Overall Study|CGMS data collection failed|1
5614207|NCT00807092|19394334|P1|Overall Study|CGMS data collection failed|0
5614208|NCT00807092|19394333|P2|Overall Study|Withdrawal by Subject|0
5614209|NCT00807092|19394334|P1|Overall Study|Withdrawal by Subject|1
5614210|NCT00807092|19394333|P2|Overall Study|Protocol Violation|2
5614211|NCT00807092|19394334|P1|Overall Study|Protocol Violation|0
5614212|NCT00807092|19394333|P2|Overall Study|Adverse Event|1
5614213|NCT00807092|19394334|P1|Overall Study|Adverse Event|0
5614214|NCT00807040|19394364|P2|Overall Study|Lost to Follow-up|6
5614215|NCT00807040|19394365|P1|Overall Study|Lost to Follow-up|4
5614216|NCT00807040|19394364|P2|Overall Study|Withdrawal by Subject|6
5614217|NCT00807040|19394365|P1|Overall Study|Withdrawal by Subject|8
5614218|NCT00807040|19394364|P2|Overall Study|Death|29
5614219|NCT00807040|19394365|P1|Overall Study|Death|24
5614220|NCT00807014|19394375|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
5614221|NCT00807014|19394376|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
5614222|NCT00807014|19394375|P2|Overall Study|Recovery|0
5614223|NCT00807014|19394376|P1|Overall Study|Recovery|1
5614224|NCT00807014|19394375|P2|Overall Study|Lost to Follow-up|7
5614225|NCT00807014|19394376|P1|Overall Study|Lost to Follow-up|9
5614226|NCT00807014|19394375|P2|Overall Study|Adverse Event|2
5614227|NCT00807014|19394376|P1|Overall Study|Adverse Event|0
5614228|NCT00807014|19394375|P2|Overall Study|Protocol Violation|8
5614229|NCT00807014|19394376|P1|Overall Study|Protocol Violation|2
5614230|NCT00807014|19394375|P2|Overall Study|Participant Considered Disease Not Cured|7
5614231|NCT00807014|19394376|P1|Overall Study|Participant Considered Disease Not Cured|2
5614232|NCT00807014|19394375|P2|Overall Study|Participant Considered Disease Cured|2
5614233|NCT00807014|19394376|P1|Overall Study|Participant Considered Disease Cured|13
5614234|NCT00807001|19394407|P5|Overall Study|Non-compliance|0
5614235|NCT00807001|19394408|P4|Overall Study|Non-compliance|0
5614236|NCT00807001|19394409|P3|Overall Study|Non-compliance|0
5614237|NCT00807001|19394410|P2|Overall Study|Non-compliance|1
5614238|NCT00807001|19394411|P1|Overall Study|Non-compliance|0
5614239|NCT00806988|19394430|P2|Overall Study|Lost to Follow-up|19
5614240|NCT00806988|19394431|P1|Overall Study|Lost to Follow-up|4
5614241|NCT00806988|19394430|P2|Overall Study|Withdrawal by Subject|8
5614242|NCT00806988|19394431|P1|Overall Study|Withdrawal by Subject|8
5614243|NCT00806988|19394430|P2|Overall Study|Death|16
5614244|NCT00806988|19394431|P1|Overall Study|Death|15
5614245|NCT00806819|19394441|P2|Overall Study|Reasons other than stated above|41
5614246|NCT00806819|19394442|P1|Overall Study|Reasons other than stated above|25
5614247|NCT00806819|19394441|P2|Overall Study|Not treated|3
5614248|NCT00806819|19394442|P1|Overall Study|Not treated|6
5614249|NCT00806819|19394441|P2|Overall Study|Withdrawal by Subject|29
5614250|NCT00806819|19394442|P1|Overall Study|Withdrawal by Subject|32
5614251|NCT00806819|19394441|P2|Overall Study|Lost to Follow-up|0
5614252|NCT00806819|19394442|P1|Overall Study|Lost to Follow-up|1
5614253|NCT00806819|19394441|P2|Overall Study|Protocol Violation|4
5614254|NCT00806819|19394442|P1|Overall Study|Protocol Violation|9
5614255|NCT00806819|19394441|P2|Overall Study|Other AE|40
5614256|NCT00806819|19394442|P1|Overall Study|Other AE|38
5614257|NCT00806819|19394441|P2|Overall Study|Worsening or AE of underlying disease|25
5614258|NCT00806819|19394442|P1|Overall Study|Worsening or AE of underlying disease|18
5614259|NCT00806819|19394441|P2|Overall Study|progressive disease (modified RECIST )|216
5614260|NCT00806819|19394442|P1|Overall Study|progressive disease (modified RECIST )|217
5614261|NCT00806624|19394511|P3|Overall Study|discontinued before start of treatment|1
5614262|NCT00806624|19394512|P2|Overall Study|discontinued before start of treatment|0
5614263|NCT00806624|19394513|P1|Overall Study|discontinued before start of treatment|0
5614264|NCT00806624|19394511|P3|Overall Study|Withdrawal by Subject|3
5614265|NCT00806624|19394512|P2|Overall Study|Withdrawal by Subject|3
5614266|NCT00806624|19394513|P1|Overall Study|Withdrawal by Subject|6
5614267|NCT00806624|19394511|P3|Overall Study|Lost to Follow-up|1
5614268|NCT00806624|19394512|P2|Overall Study|Lost to Follow-up|0
5614269|NCT00806624|19394513|P1|Overall Study|Lost to Follow-up|1
5614270|NCT00806624|19394511|P3|Overall Study|Death|1
5614271|NCT00806624|19394512|P2|Overall Study|Death|1
5614272|NCT00806624|19394513|P1|Overall Study|Death|0
5614273|NCT00806624|19394511|P3|Overall Study|Adverse Event|0
5614274|NCT00806624|19394512|P2|Overall Study|Adverse Event|8
5614275|NCT00806624|19394513|P1|Overall Study|Adverse Event|2
5614276|NCT00806585|19394530|P5|Overall Study|Completion status unknown|12
5614277|NCT00806585|19394531|P4|Overall Study|Completion status unknown|4
5614278|NCT00806585|19394532|P3|Overall Study|Completion status unknown|12
5614279|NCT00806585|19394533|P2|Overall Study|Completion status unknown|14
5614280|NCT00806585|19394534|P1|Overall Study|Completion status unknown|15
5614281|NCT00806585|19394530|P5|Overall Study|Withdrawal by Subject|11
5614282|NCT00806585|19394531|P4|Overall Study|Withdrawal by Subject|3
5614283|NCT00806585|19394532|P3|Overall Study|Withdrawal by Subject|9
5614284|NCT00806585|19394533|P2|Overall Study|Withdrawal by Subject|8
5614285|NCT00806585|19394534|P1|Overall Study|Withdrawal by Subject|10
5614286|NCT00806585|19394530|P5|Overall Study|Adverse Event|2
5614287|NCT00806585|19394531|P4|Overall Study|Adverse Event|4
5614288|NCT00806585|19394532|P3|Overall Study|Adverse Event|3
5614289|NCT00806585|19394533|P2|Overall Study|Adverse Event|5
5614290|NCT00806585|19394534|P1|Overall Study|Adverse Event|1
5614291|NCT00806585|19394530|P5|Overall Study|Lack of Efficacy|0
5614292|NCT00806585|19394531|P4|Overall Study|Lack of Efficacy|0
5614293|NCT00806585|19394532|P3|Overall Study|Lack of Efficacy|0
5614294|NCT00806585|19394533|P2|Overall Study|Lack of Efficacy|0
5614295|NCT00806585|19394534|P1|Overall Study|Lack of Efficacy|1
5614296|NCT00806585|19394530|P5|Overall Study|Lost to Follow-up|5
5614297|NCT00806585|19394531|P4|Overall Study|Lost to Follow-up|2
5614298|NCT00806585|19394532|P3|Overall Study|Lost to Follow-up|2
5614299|NCT00806585|19394533|P2|Overall Study|Lost to Follow-up|1
5614300|NCT00806585|19394534|P1|Overall Study|Lost to Follow-up|2
5614301|NCT00806585|19394530|P5|Overall Study|Physician Decision|1
5614302|NCT00806585|19394531|P4|Overall Study|Physician Decision|0
5614303|NCT00806585|19394532|P3|Overall Study|Physician Decision|3
5614304|NCT00806585|19394533|P2|Overall Study|Physician Decision|2
5614305|NCT00806585|19394534|P1|Overall Study|Physician Decision|0
5614306|NCT00806585|19394530|P5|Overall Study|Protocol Violation|0
5614307|NCT00806585|19394531|P4|Overall Study|Protocol Violation|0
5614308|NCT00806585|19394532|P3|Overall Study|Protocol Violation|2
5614309|NCT00806585|19394533|P2|Overall Study|Protocol Violation|1
5614310|NCT00806585|19394534|P1|Overall Study|Protocol Violation|3
5614311|NCT00806585|19394530|P5|Overall Study|Study terminated by Sponsor|0
5614312|NCT00806585|19394531|P4|Overall Study|Study terminated by Sponsor|2
5614313|NCT00806585|19394532|P3|Overall Study|Study terminated by Sponsor|1
5614314|NCT00806585|19394533|P2|Overall Study|Study terminated by Sponsor|0
5614315|NCT00806585|19394534|P1|Overall Study|Study terminated by Sponsor|0
5614316|NCT00806546|19394566|P1|Overall Study|Various|42
5614317|NCT00806546|19394566|P1|Overall Study|Protocol Violation|49
5614318|NCT00806546|19394566|P1|Overall Study|Withdrawal by Subject|75
5614319|NCT00806546|19394566|P1|Overall Study|Adverse Event|74
5614320|NCT00806546|19394566|P1|Overall Study|Lost to Follow-up|32
5614321|NCT00806546|19394566|P1|Overall Study|Enrolled, not treated|35
5614322|NCT00806494|19394570|P1|Overall Study|Withdrawal by Subject|5
5614323|NCT00806494|19394570|P1|Overall Study|Other|30
5614324|NCT00806494|19394570|P1|Overall Study|Lost to Follow-up|10
5614325|NCT00806494|19394570|P1|Overall Study|Lack of Efficacy|6
5614326|NCT00806494|19394570|P1|Overall Study|Adverse Event|29
5614327|NCT00806442|19394594|P2|Overall Study|Withdrawal by Subject|5
5614328|NCT00806442|19394595|P1|Overall Study|Withdrawal by Subject|1
5614329|NCT00806442|19394594|P2|Overall Study|Lost to Follow-up|2
5614330|NCT00806442|19394595|P1|Overall Study|Lost to Follow-up|3
5614331|NCT00806416|19394617|P4|Period 1 - Part II|Withdrawal by Subject|2
5614332|NCT00806416|19394618|P3|Period 1 - Part II|Withdrawal by Subject|0
5614333|NCT00806416|19394619|P2|Period 1 - Part II|Withdrawal by Subject|0
5614334|NCT00806416|19394620|P1|Period 1 - Part II|Withdrawal by Subject|0
5614335|NCT00806416|19394617|P4|Period 1 - Part I|Withdrawal by Subject|0
5614336|NCT00806416|19394618|P3|Period 1 - Part I|Withdrawal by Subject|0
5614337|NCT00806416|19394619|P2|Period 1 - Part I|Withdrawal by Subject|1
5614338|NCT00806416|19394620|P1|Period 1 - Part I|Withdrawal by Subject|3
5614339|NCT00806416|19394617|P4|Period 1 - Part I|Lost to Follow-up|0
5614340|NCT00806416|19394618|P3|Period 1 - Part I|Lost to Follow-up|0
5614341|NCT00806416|19394619|P2|Period 1 - Part I|Lost to Follow-up|2
5614342|NCT00806416|19394620|P1|Period 1 - Part I|Lost to Follow-up|0
5614343|NCT00806416|19394617|P4|Period 1 - Part I|Adverse Event|0
5614344|NCT00806416|19394618|P3|Period 1 - Part I|Adverse Event|0
5614345|NCT00806416|19394619|P2|Period 1 - Part I|Adverse Event|1
5614346|NCT00806416|19394620|P1|Period 1 - Part I|Adverse Event|0
5614347|NCT00806403|19394633|P2|Overall Study|Death|3
5614348|NCT00806403|19394634|P1|Overall Study|Death|4
5614349|NCT00806351|19394657|P2|Overall Study|Death|4
5614350|NCT00806351|19394658|P1|Overall Study|Death|5
5614351|NCT00806286|19394692|P3|Overall Study|Due to a variety of reasons|1
5614352|NCT00806286|19394693|P2|Overall Study|Due to a variety of reasons|2
5614353|NCT00806286|19394694|P1|Overall Study|Due to a variety of reasons|7
5614354|NCT00806286|19394692|P3|Overall Study|Physician Decision|0
5614355|NCT00806286|19394693|P2|Overall Study|Physician Decision|2
5614356|NCT00806286|19394694|P1|Overall Study|Physician Decision|2
5614357|NCT00806286|19394692|P3|Overall Study|Withdrawal by Subject|1
5614358|NCT00806286|19394693|P2|Overall Study|Withdrawal by Subject|3
5614359|NCT00806286|19394694|P1|Overall Study|Withdrawal by Subject|8
5614360|NCT00806286|19394692|P3|Overall Study|Lost to Follow-up|0
5614361|NCT00806286|19394693|P2|Overall Study|Lost to Follow-up|1
5614362|NCT00806286|19394694|P1|Overall Study|Lost to Follow-up|0
5614363|NCT00806286|19394692|P3|Overall Study|Death|0
5614364|NCT00806286|19394693|P2|Overall Study|Death|6
5614365|NCT00806286|19394694|P1|Overall Study|Death|1
5614366|NCT00806286|19394692|P3|Overall Study|Disease progression|1
5614367|NCT00806286|19394693|P2|Overall Study|Disease progression|38
5614368|NCT00806286|19394694|P1|Overall Study|Disease progression|31
5614369|NCT00806286|19394692|P3|Overall Study|Adverse Event|0
5614370|NCT00806286|19394693|P2|Overall Study|Adverse Event|2
5614371|NCT00806286|19394694|P1|Overall Study|Adverse Event|5
5614372|NCT00806260|19394716|P6|Period 3|Pregnancy|0
5614373|NCT00806260|19394717|P5|Period 3|Pregnancy|0
5614374|NCT00806260|19394718|P4|Period 3|Pregnancy|0
5614375|NCT00806260|19394719|P3|Period 3|Pregnancy|0
5614376|NCT00806260|19394720|P2|Period 3|Pregnancy|0
5614377|NCT00806260|19394721|P1|Period 3|Pregnancy|1
5614378|NCT00806260|19394716|P6|Period 3|Protocol Violation|0
5614379|NCT00806260|19394717|P5|Period 3|Protocol Violation|0
5614380|NCT00806260|19394718|P4|Period 3|Protocol Violation|0
5614381|NCT00806260|19394719|P3|Period 3|Protocol Violation|1
5614382|NCT00806260|19394720|P2|Period 3|Protocol Violation|1
5614383|NCT00806260|19394721|P1|Period 3|Protocol Violation|0
5614384|NCT00806260|19394716|P6|Period 2|sponsor request|0
5614385|NCT00806260|19394717|P5|Period 2|sponsor request|0
5614386|NCT00806260|19394718|P4|Period 2|sponsor request|1
5614387|NCT00806260|19394719|P3|Period 2|sponsor request|1
5614388|NCT00806260|19394720|P2|Period 2|sponsor request|0
5614389|NCT00806260|19394721|P1|Period 2|sponsor request|0
5614390|NCT00806260|19394716|P6|Period 2|Need to take concomitant medication|0
5614391|NCT00806260|19394717|P5|Period 2|Need to take concomitant medication|0
5614392|NCT00806260|19394718|P4|Period 2|Need to take concomitant medication|0
5614393|NCT00806260|19394719|P3|Period 2|Need to take concomitant medication|0
5614394|NCT00806260|19394720|P2|Period 2|Need to take concomitant medication|0
5614395|NCT00806260|19394721|P1|Period 2|Need to take concomitant medication|1
5614396|NCT00806260|19394716|P6|Period 2|Protocol Violation|0
5614397|NCT00806260|19394717|P5|Period 2|Protocol Violation|0
5614398|NCT00806260|19394718|P4|Period 2|Protocol Violation|0
5614399|NCT00806260|19394719|P3|Period 2|Protocol Violation|1
5614400|NCT00806260|19394720|P2|Period 2|Protocol Violation|0
5614401|NCT00806260|19394721|P1|Period 2|Protocol Violation|1
5614402|NCT00806260|19394716|P6|Period 2|Adverse Event|0
5614403|NCT00806260|19394717|P5|Period 2|Adverse Event|0
5614404|NCT00806260|19394718|P4|Period 2|Adverse Event|1
5614405|NCT00806260|19394719|P3|Period 2|Adverse Event|0
5614406|NCT00806260|19394720|P2|Period 2|Adverse Event|0
5614407|NCT00806260|19394721|P1|Period 2|Adverse Event|0
5614408|NCT00806260|19394716|P6|Period 1 (1 Day)|Adverse Event|0
5614409|NCT00806260|19394717|P5|Period 1 (1 Day)|Adverse Event|3
5614410|NCT00806260|19394718|P4|Period 1 (1 Day)|Adverse Event|0
5614411|NCT00806260|19394719|P3|Period 1 (1 Day)|Adverse Event|0
5614412|NCT00806260|19394720|P2|Period 1 (1 Day)|Adverse Event|0
5614413|NCT00806260|19394721|P1|Period 1 (1 Day)|Adverse Event|0
5614414|NCT00806195|19394766|P4|Overall Study|Protocol Violation|9
5614415|NCT00806195|19394767|P3|Overall Study|Protocol Violation|26
5614416|NCT00806195|19394768|P2|Overall Study|Protocol Violation|24
5614417|NCT00806195|19394769|P1|Overall Study|Protocol Violation|34
5614418|NCT00806195|19394766|P4|Overall Study|Administrative Reason|26
5614419|NCT00806195|19394767|P3|Overall Study|Administrative Reason|66
5614420|NCT00806195|19394768|P2|Overall Study|Administrative Reason|35
5614421|NCT00806195|19394769|P1|Overall Study|Administrative Reason|113
5614422|NCT00806195|19394766|P4|Overall Study|Inappropriate Enrollment|0
5614423|NCT00806195|19394767|P3|Overall Study|Inappropriate Enrollment|0
5614424|NCT00806195|19394768|P2|Overall Study|Inappropriate Enrollment|1
5614425|NCT00806195|19394769|P1|Overall Study|Inappropriate Enrollment|0
5614426|NCT00806195|19394766|P4|Overall Study|Lost to Follow-up|34
5614427|NCT00806195|19394767|P3|Overall Study|Lost to Follow-up|90
5614428|NCT00806195|19394768|P2|Overall Study|Lost to Follow-up|66
5614429|NCT00806195|19394769|P1|Overall Study|Lost to Follow-up|217
5614430|NCT00806195|19394766|P4|Overall Study|Withdrawal by Subject|35
5614431|NCT00806195|19394767|P3|Overall Study|Withdrawal by Subject|76
5614432|NCT00806195|19394768|P2|Overall Study|Withdrawal by Subject|31
5614433|NCT00806195|19394769|P1|Overall Study|Withdrawal by Subject|119
5614434|NCT00806195|19394766|P4|Overall Study|Adverse Event|2
5614435|NCT00806195|19394767|P3|Overall Study|Adverse Event|11
5614436|NCT00806195|19394768|P2|Overall Study|Adverse Event|5
5614437|NCT00806195|19394769|P1|Overall Study|Adverse Event|25
5614438|NCT00806195|19394766|P4|Overall Study|Death|0
5614439|NCT00806195|19394767|P3|Overall Study|Death|1
5614440|NCT00806195|19394768|P2|Overall Study|Death|0
5614441|NCT00806195|19394769|P1|Overall Study|Death|6
5614442|NCT00806026|19394800|P6|Overall Study|Adverse Event|9
5614443|NCT00806026|19394801|P5|Overall Study|Adverse Event|9
5614444|NCT00806026|19394802|P4|Overall Study|Adverse Event|17
5614445|NCT00806026|19394803|P3|Overall Study|Adverse Event|44
5614446|NCT00806026|19394804|P2|Overall Study|Adverse Event|35
5614447|NCT00806026|19394805|P1|Overall Study|Adverse Event|52
5614448|NCT00806026|19394800|P6|Overall Study|Protocol Violation|3
5614449|NCT00806026|19394801|P5|Overall Study|Protocol Violation|2
5614450|NCT00806026|19394802|P4|Overall Study|Protocol Violation|0
5614451|NCT00806026|19394803|P3|Overall Study|Protocol Violation|9
5614452|NCT00806026|19394804|P2|Overall Study|Protocol Violation|9
5614453|NCT00806026|19394805|P1|Overall Study|Protocol Violation|6
5614454|NCT00806026|19394800|P6|Overall Study|Other|4
5614455|NCT00806026|19394801|P5|Overall Study|Other|0
5614456|NCT00806026|19394802|P4|Overall Study|Other|2
5614457|NCT00806026|19394803|P3|Overall Study|Other|8
5614458|NCT00806026|19394804|P2|Overall Study|Other|6
5614459|NCT00806026|19394805|P1|Overall Study|Other|3
5614460|NCT00806026|19394800|P6|Overall Study|Withdrawal by Subject|3
5614461|NCT00806026|19394801|P5|Overall Study|Withdrawal by Subject|5
5614462|NCT00806026|19394802|P4|Overall Study|Withdrawal by Subject|2
5614463|NCT00806026|19394803|P3|Overall Study|Withdrawal by Subject|9
5614464|NCT00806026|19394804|P2|Overall Study|Withdrawal by Subject|17
5614465|NCT00806026|19394805|P1|Overall Study|Withdrawal by Subject|14
5614466|NCT00806026|19394800|P6|Overall Study|Lost to Follow-up|6
5614467|NCT00806026|19394801|P5|Overall Study|Lost to Follow-up|6
5614468|NCT00806026|19394802|P4|Overall Study|Lost to Follow-up|2
5614469|NCT00806026|19394803|P3|Overall Study|Lost to Follow-up|8
5614470|NCT00806026|19394804|P2|Overall Study|Lost to Follow-up|15
5614471|NCT00806026|19394805|P1|Overall Study|Lost to Follow-up|8
5614472|NCT00806026|19394800|P6|Overall Study|Lack of Efficacy|7
5614473|NCT00806026|19394801|P5|Overall Study|Lack of Efficacy|8
5614474|NCT00806026|19394802|P4|Overall Study|Lack of Efficacy|4
5614475|NCT00806026|19394803|P3|Overall Study|Lack of Efficacy|13
5614476|NCT00806026|19394804|P2|Overall Study|Lack of Efficacy|18
5614477|NCT00806026|19394805|P1|Overall Study|Lack of Efficacy|5
5614478|NCT00806026|19394800|P6|Overall Study|Did not meet entrance criteria|0
5614479|NCT00806026|19394801|P5|Overall Study|Did not meet entrance criteria|0
5614480|NCT00806026|19394802|P4|Overall Study|Did not meet entrance criteria|1
5614481|NCT00806026|19394803|P3|Overall Study|Did not meet entrance criteria|2
5614482|NCT00806026|19394804|P2|Overall Study|Did not meet entrance criteria|1
5614483|NCT00806026|19394805|P1|Overall Study|Did not meet entrance criteria|4
5614484|NCT00806026|19394800|P6|Overall Study|Death|0
5614485|NCT00806026|19394801|P5|Overall Study|Death|0
5614486|NCT00806026|19394802|P4|Overall Study|Death|1
5614487|NCT00806026|19394803|P3|Overall Study|Death|0
5614488|NCT00806026|19394804|P2|Overall Study|Death|0
5614489|NCT00806026|19394805|P1|Overall Study|Death|0
5614490|NCT00805961|19394900|P1|Maintenance Treatment|Withdrawn Consent|1
5614491|NCT00805961|19394900|P1|Maintenance Treatment|Symptomatic Deterioration|2
5614492|NCT00805961|19394900|P1|Maintenance Treatment|Withdrawal by Subject|5
5614493|NCT00805961|19394900|P1|Maintenance Treatment|Adverse Event|6
5614494|NCT00805961|19394900|P1|Maintenance Treatment|Intercurrent Illness|7
5614495|NCT00805961|19394900|P1|Maintenance Treatment|Lack of Efficacy|13
5614496|NCT00805961|19394900|P1|Treatment-Free Interval|Lack of Efficacy|1
5614497|NCT00805961|19394900|P1|Treatment-Free Interval|Physician Decision|1
5614498|NCT00805961|19394900|P1|Treatment-Free Interval|Intercurrent Illness|2
5614499|NCT00805961|19394900|P1|Treatment-Free Interval|Adverse Event|3
5614500|NCT00805961|19394900|P1|Modality Therapy|Disease Progression|2
5614501|NCT00805961|19394900|P1|Modality Therapy|Adverse Event|1
5614502|NCT00805961|19394900|P1|Modality Therapy|Withdrawal by Subject|1
5614503|NCT00805935|19394924|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
5614504|NCT00805935|19394925|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
5614505|NCT00805935|19394926|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
5614506|NCT00805935|19394927|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
5614507|NCT00805935|19394924|P4|Overall Study|Ectopic pregnancy|0
5614508|NCT00805935|19394925|P3|Overall Study|Ectopic pregnancy|1
5614509|NCT00805935|19394926|P2|Overall Study|Ectopic pregnancy|0
5614510|NCT00805935|19394927|P1|Overall Study|Ectopic pregnancy|0
5614511|NCT00805935|19394924|P4|Overall Study|Chemical pregnancy|2
5614512|NCT00805935|19394925|P3|Overall Study|Chemical pregnancy|3
5614513|NCT00805935|19394926|P2|Overall Study|Chemical pregnancy|5
5614514|NCT00805935|19394927|P1|Overall Study|Chemical pregnancy|0
5614515|NCT00805935|19394924|P4|Overall Study|Biochemical pregnancy|0
5614516|NCT00805935|19394925|P3|Overall Study|Biochemical pregnancy|0
5614517|NCT00805935|19394926|P2|Overall Study|Biochemical pregnancy|1
5614518|NCT00805935|19394927|P1|Overall Study|Biochemical pregnancy|0
5614519|NCT00805935|19394924|P4|Overall Study|Pregnancy loss/miscarriage|0
5614520|NCT00805935|19394925|P3|Overall Study|Pregnancy loss/miscarriage|0
5614521|NCT00805935|19394926|P2|Overall Study|Pregnancy loss/miscarriage|0
5614522|NCT00805935|19394927|P1|Overall Study|Pregnancy loss/miscarriage|2
5614523|NCT00805935|19394924|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
5614524|NCT00805935|19394925|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
5614525|NCT00805935|19394926|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
5614526|NCT00805935|19394927|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
5614527|NCT00805935|19394924|P4|Overall Study|No positive serum pregnancy|5
5614528|NCT00805935|19394925|P3|Overall Study|No positive serum pregnancy|6
5614529|NCT00805935|19394926|P2|Overall Study|No positive serum pregnancy|7
5614530|NCT00805935|19394927|P1|Overall Study|No positive serum pregnancy|8
5614531|NCT00805935|19394924|P4|Overall Study|Lost to Follow-up|0
5614532|NCT00805935|19394925|P3|Overall Study|Lost to Follow-up|0
5614533|NCT00805935|19394926|P2|Overall Study|Lost to Follow-up|0
5614534|NCT00805935|19394927|P1|Overall Study|Lost to Follow-up|1
5614535|NCT00805935|19394924|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
5614536|NCT00805935|19394925|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
5614537|NCT00805935|19394926|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
5614538|NCT00805935|19394927|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
5614539|NCT00805935|19394924|P4|Overall Study|Cycle cancellation for risk of OHSS|0
5614540|NCT00805935|19394925|P3|Overall Study|Cycle cancellation for risk of OHSS|1
5614541|NCT00805935|19394926|P2|Overall Study|Cycle cancellation for risk of OHSS|0
5614542|NCT00805935|19394927|P1|Overall Study|Cycle cancellation for risk of OHSS|1
5614543|NCT00805935|19394924|P4|Overall Study|Cycle cancelled|0
5614544|NCT00805935|19394925|P3|Overall Study|Cycle cancelled|2
5614545|NCT00805935|19394926|P2|Overall Study|Cycle cancelled|0
5614546|NCT00805935|19394927|P1|Overall Study|Cycle cancelled|0
5614547|NCT00805935|19394924|P4|Overall Study|Stimulation Failure|2
5614548|NCT00805935|19394925|P3|Overall Study|Stimulation Failure|2
5614549|NCT00805935|19394926|P2|Overall Study|Stimulation Failure|5
5614550|NCT00805935|19394927|P1|Overall Study|Stimulation Failure|1
5614551|NCT00805792|19394994|P1|Overall Study|Lost to Follow-up|2
5614552|NCT00805792|19394994|P1|Overall Study|Death|3
5614553|NCT00805766|19395002|P1|Increased Dose Period|Withdrawal by Subject|1
5614554|NCT00805766|19395002|P1|Increased Dose Period|Pregnancy|1
5614555|NCT00805766|19395002|P1|Increased Dose Period|Lack of Efficacy|7
5614556|NCT00805766|19395002|P1|Increased Dose Period|Adverse Event|4
5614557|NCT00805766|19395002|P1|Screening Period|Responder|2
5614558|NCT00805766|19395002|P1|Screening Period|Pregnancy|1
5614559|NCT00805766|19395002|P1|Screening Period|Lack of Efficacy|2
5614560|NCT00805766|19395002|P1|Screening Period|Adverse Event|1
5614561|NCT00805740|19395016|P2|Overall Study|Randomized, but not treated|0
5614562|NCT00805740|19395017|P1|Overall Study|Randomized, but not treated|2
5614563|NCT00805740|19395016|P2|Overall Study|Lost to Follow-up|0
5614564|NCT00805740|19395017|P1|Overall Study|Lost to Follow-up|1
5614565|NCT00805740|19395016|P2|Overall Study|Withdrawal by Subject|0
5614566|NCT00805740|19395017|P1|Overall Study|Withdrawal by Subject|1
5614567|NCT00805740|19395016|P2|Overall Study|Death|4
5614568|NCT00805740|19395017|P1|Overall Study|Death|7
5614569|NCT00805675|19395042|P3|Overall Study|Adverse Event|1
5614570|NCT00805675|19395043|P2|Overall Study|Adverse Event|0
5614571|NCT00805675|19395044|P1|Overall Study|Adverse Event|0
5614572|NCT00805545|19395078|P2|Overall Study|Protocol Violation|1
5614573|NCT00805545|19395079|P1|Overall Study|Protocol Violation|3
5614574|NCT00805545|19395078|P2|Overall Study|Protocol Violation|2
5614575|NCT00805545|19395079|P1|Overall Study|Protocol Violation|3
5614576|NCT00805532|19395087|P2|Overall Study|invalid data|1
5614577|NCT00805532|19395088|P1|Overall Study|invalid data|0
5614578|NCT00805480|19395122|P4|Overall Study|Adverse Event|0
5614579|NCT00805480|19395123|P3|Overall Study|Adverse Event|1
5614580|NCT00805480|19395124|P2|Overall Study|Adverse Event|0
5614581|NCT00805480|19395125|P1|Overall Study|Adverse Event|0
5614582|NCT00805480|19395122|P4|Overall Study|Lost to Follow-up|0
5614583|NCT00805480|19395123|P3|Overall Study|Lost to Follow-up|0
5614584|NCT00805480|19395124|P2|Overall Study|Lost to Follow-up|2
5614585|NCT00805480|19395125|P1|Overall Study|Lost to Follow-up|1
5614586|NCT00805480|19395122|P4|Overall Study|Withdrawal by Subject|5
5614587|NCT00805480|19395123|P3|Overall Study|Withdrawal by Subject|11
5614588|NCT00805480|19395124|P2|Overall Study|Withdrawal by Subject|5
5614589|NCT00805480|19395125|P1|Overall Study|Withdrawal by Subject|13
5614590|NCT00805467|19395154|P4|Overall Study|Not reported|7
5614591|NCT00805467|19395155|P3|Overall Study|Not reported|3
5614592|NCT00805467|19395156|P2|Overall Study|Not reported|0
5614593|NCT00805467|19395157|P1|Overall Study|Not reported|0
5614594|NCT00805467|19395154|P4|Overall Study|Physician Decision|6
5614595|NCT00805467|19395155|P3|Overall Study|Physician Decision|2
5614596|NCT00805467|19395156|P2|Overall Study|Physician Decision|1
5614597|NCT00805467|19395157|P1|Overall Study|Physician Decision|0
5614598|NCT00805467|19395154|P4|Overall Study|Death|5
5614599|NCT00805467|19395155|P3|Overall Study|Death|7
5614600|NCT00805467|19395156|P2|Overall Study|Death|2
5614601|NCT00805467|19395157|P1|Overall Study|Death|0
5614602|NCT00805467|19395154|P4|Overall Study|Adverse Event|57
5614603|NCT00805467|19395155|P3|Overall Study|Adverse Event|26
5614604|NCT00805467|19395156|P2|Overall Study|Adverse Event|13
5614605|NCT00805467|19395157|P1|Overall Study|Adverse Event|0
5614606|NCT00805467|19395154|P4|Overall Study|Protocol Violation|5
5614607|NCT00805467|19395155|P3|Overall Study|Protocol Violation|0
5614608|NCT00805467|19395156|P2|Overall Study|Protocol Violation|3
5614609|NCT00805467|19395157|P1|Overall Study|Protocol Violation|0
5614610|NCT00805467|19395154|P4|Overall Study|Withdrawal by Subject|50
5614611|NCT00805467|19395155|P3|Overall Study|Withdrawal by Subject|45
5614612|NCT00805467|19395156|P2|Overall Study|Withdrawal by Subject|6
5614613|NCT00805467|19395157|P1|Overall Study|Withdrawal by Subject|0
5614614|NCT00805467|19395154|P4|Overall Study|Lost to Follow-up|21
5614615|NCT00805467|19395155|P3|Overall Study|Lost to Follow-up|7
5614616|NCT00805467|19395156|P2|Overall Study|Lost to Follow-up|1
5614617|NCT00805467|19395157|P1|Overall Study|Lost to Follow-up|0
5614618|NCT00805467|19395154|P4|Overall Study|Lack of Efficacy|86
5614619|NCT00805467|19395155|P3|Overall Study|Lack of Efficacy|13
5614620|NCT00805467|19395156|P2|Overall Study|Lack of Efficacy|8
5614621|NCT00805467|19395157|P1|Overall Study|Lack of Efficacy|0
5614622|NCT00805441|19395177|P2|Overall Study|Acute Alcohol Withdrawal|1
5614623|NCT00805441|19395178|P1|Overall Study|Acute Alcohol Withdrawal|0
5614624|NCT00805441|19395177|P2|Overall Study|Physician Decision|1
5614625|NCT00805441|19395178|P1|Overall Study|Physician Decision|0
5614626|NCT00805441|19395177|P2|Overall Study|Withdrawal by Subject|9
5614627|NCT00805441|19395178|P1|Overall Study|Withdrawal by Subject|15
5614628|NCT00805441|19395177|P2|Overall Study|Lost to Follow-up|13
5614629|NCT00805441|19395178|P1|Overall Study|Lost to Follow-up|10
5614630|NCT00805441|19395177|P2|Overall Study|Protocol Violation|8
5614631|NCT00805441|19395178|P1|Overall Study|Protocol Violation|4
5614632|NCT00805441|19395177|P2|Overall Study|Lack of Efficacy|2
5614633|NCT00805441|19395178|P1|Overall Study|Lack of Efficacy|0
5614634|NCT00805441|19395177|P2|Overall Study|Adverse Event|2
5614635|NCT00805441|19395178|P1|Overall Study|Adverse Event|5
5614636|NCT00805389|19395213|P5|Overall Study|Withdrawal by Subject|4
5614637|NCT00805389|19395214|P4|Overall Study|Withdrawal by Subject|5
5614638|NCT00805389|19395215|P3|Overall Study|Withdrawal by Subject|4
5614639|NCT00805389|19395216|P2|Overall Study|Withdrawal by Subject|2
5614640|NCT00805389|19395217|P1|Overall Study|Withdrawal by Subject|3
5614641|NCT00805389|19395213|P5|Overall Study|Protocol Violation|0
5614642|NCT00805389|19395214|P4|Overall Study|Protocol Violation|0
5614643|NCT00805389|19395215|P3|Overall Study|Protocol Violation|1
5614644|NCT00805389|19395216|P2|Overall Study|Protocol Violation|0
5614645|NCT00805389|19395217|P1|Overall Study|Protocol Violation|0
5614646|NCT00805389|19395213|P5|Overall Study|Lost to Follow-up|9
5614647|NCT00805389|19395214|P4|Overall Study|Lost to Follow-up|10
5614648|NCT00805389|19395215|P3|Overall Study|Lost to Follow-up|6
5614649|NCT00805389|19395216|P2|Overall Study|Lost to Follow-up|3
5614650|NCT00805389|19395217|P1|Overall Study|Lost to Follow-up|4
5614651|NCT00805389|19395213|P5|Overall Study|Adverse Event|0
5614652|NCT00805389|19395214|P4|Overall Study|Adverse Event|2
5614653|NCT00805389|19395215|P3|Overall Study|Adverse Event|1
5614654|NCT00805389|19395216|P2|Overall Study|Adverse Event|0
5614655|NCT00805389|19395217|P1|Overall Study|Adverse Event|0
5614656|NCT00805285|19395464|P1|Overall Study|Lack of Efficacy|1
5614657|NCT00805207|19395481|P9|Overall Study|Withdrawal by Subject|0
5614658|NCT00805207|19395482|P8|Overall Study|Withdrawal by Subject|0
5614659|NCT00805207|19395483|P7|Overall Study|Withdrawal by Subject|0
5614660|NCT00805207|19395484|P6|Overall Study|Withdrawal by Subject|2
5614661|NCT00805207|19395485|P5|Overall Study|Withdrawal by Subject|1
5614662|NCT00805207|19395486|P4|Overall Study|Withdrawal by Subject|0
5614663|NCT00805207|19395487|P3|Overall Study|Withdrawal by Subject|0
5614664|NCT00805207|19395488|P2|Overall Study|Withdrawal by Subject|1
5614665|NCT00805207|19395489|P1|Overall Study|Withdrawal by Subject|0
5614666|NCT00805207|19395481|P9|Overall Study|Physician Decision|0
5614667|NCT00805207|19395482|P8|Overall Study|Physician Decision|0
5614668|NCT00805207|19395483|P7|Overall Study|Physician Decision|0
5614669|NCT00805207|19395484|P6|Overall Study|Physician Decision|1
5614670|NCT00805207|19395485|P5|Overall Study|Physician Decision|0
5614671|NCT00805207|19395486|P4|Overall Study|Physician Decision|0
5614672|NCT00805207|19395487|P3|Overall Study|Physician Decision|0
5614673|NCT00805207|19395488|P2|Overall Study|Physician Decision|1
5614674|NCT00805207|19395489|P1|Overall Study|Physician Decision|0
5614675|NCT00805207|19395481|P9|Overall Study|Protocol Violation|0
5614676|NCT00805207|19395482|P8|Overall Study|Protocol Violation|0
5614677|NCT00805207|19395483|P7|Overall Study|Protocol Violation|0
5614678|NCT00805207|19395484|P6|Overall Study|Protocol Violation|0
5614679|NCT00805207|19395485|P5|Overall Study|Protocol Violation|0
5614680|NCT00805207|19395486|P4|Overall Study|Protocol Violation|0
5614681|NCT00805207|19395487|P3|Overall Study|Protocol Violation|1
5614682|NCT00805207|19395488|P2|Overall Study|Protocol Violation|0
5614683|NCT00805207|19395489|P1|Overall Study|Protocol Violation|0
5614684|NCT00805194|19395547|P2|Overall Study|Reasons other than stated above|16
5614685|NCT00805194|19395548|P1|Overall Study|Reasons other than stated above|20
5614686|NCT00805194|19395547|P2|Overall Study|Not treated|4
5614687|NCT00805194|19395548|P1|Overall Study|Not treated|3
5614688|NCT00805194|19395547|P2|Overall Study|Withdrawal by Subject|42
5614689|NCT00805194|19395548|P1|Overall Study|Withdrawal by Subject|60
5614690|NCT00805194|19395547|P2|Overall Study|Lost to Follow-up|5
5614691|NCT00805194|19395548|P1|Overall Study|Lost to Follow-up|5
5614692|NCT00805194|19395547|P2|Overall Study|Protocol Violation|9
5614693|NCT00805194|19395548|P1|Overall Study|Protocol Violation|9
5614694|NCT00805194|19395547|P2|Overall Study|Other AE|73
5614695|NCT00805194|19395548|P1|Overall Study|Other AE|84
5614696|NCT00805194|19395547|P2|Overall Study|Worsening or AE of underlying disease|70
5614697|NCT00805194|19395548|P1|Overall Study|Worsening or AE of underlying disease|64
5614698|NCT00805194|19395547|P2|Overall Study|Progressive disease (modified RECIST)|435
5614699|NCT00805194|19395548|P1|Overall Study|Progressive disease (modified RECIST)|404
5614700|NCT00805142|19395582|P2|Maintenance Period|Other|1
5614701|NCT00805142|19395583|P1|Maintenance Period|Other|0
5614702|NCT00805142|19395582|P2|Maintenance Period|Adverse Event|1
5614703|NCT00805142|19395583|P1|Maintenance Period|Adverse Event|0
5614704|NCT00805142|19395582|P2|Titration Period|Other|3
5614705|NCT00805142|19395583|P1|Titration Period|Other|0
5614706|NCT00805142|19395582|P2|Titration Period|Withdrawal of consent|1
5614707|NCT00805142|19395583|P1|Titration Period|Withdrawal of consent|0
5614708|NCT00805142|19395582|P2|Titration Period|Disease Progression|1
5614709|NCT00805142|19395583|P1|Titration Period|Disease Progression|2
5614710|NCT00805142|19395582|P2|Titration Period|Lost to Follow-up|1
5614711|NCT00805142|19395583|P1|Titration Period|Lost to Follow-up|0
5614712|NCT00805142|19395582|P2|Titration Period|Lack of Efficacy|1
5614713|NCT00805142|19395583|P1|Titration Period|Lack of Efficacy|1
5614714|NCT00805142|19395582|P2|Titration Period|Adverse Event|3
5614715|NCT00805142|19395583|P1|Titration Period|Adverse Event|3
5614716|NCT00805025|19395616|P1|Overall Study|Physician Decision|1
5614717|NCT00805025|19395616|P1|Overall Study|Withdrawal by Subject|2
5614718|NCT00805025|19395616|P1|Overall Study|Adverse Event|4
5614719|NCT00805025|19395616|P1|Overall Study|Screened but not enrolled/treated|42
5614720|NCT00804986|19395645|P6|Overall Study|Physician Decision|0
5614721|NCT00804986|19395646|P5|Overall Study|Physician Decision|0
5614722|NCT00804986|19395647|P4|Overall Study|Physician Decision|0
5614723|NCT00804986|19395648|P3|Overall Study|Physician Decision|0
5614724|NCT00804986|19395649|P2|Overall Study|Physician Decision|0
5614725|NCT00804986|19395650|P1|Overall Study|Physician Decision|1
5614726|NCT00804986|19395645|P6|Overall Study|Sponsor Decision|0
5614727|NCT00804986|19395646|P5|Overall Study|Sponsor Decision|0
5614728|NCT00804986|19395647|P4|Overall Study|Sponsor Decision|0
5614729|NCT00804986|19395648|P3|Overall Study|Sponsor Decision|0
5614730|NCT00804986|19395649|P2|Overall Study|Sponsor Decision|1
5614731|NCT00804986|19395650|P1|Overall Study|Sponsor Decision|0
5614732|NCT00804986|19395645|P6|Overall Study|Inclusion/Exclusion criteria not met|1
5614733|NCT00804986|19395646|P5|Overall Study|Inclusion/Exclusion criteria not met|0
5614734|NCT00804986|19395647|P4|Overall Study|Inclusion/Exclusion criteria not met|1
5614735|NCT00804986|19395648|P3|Overall Study|Inclusion/Exclusion criteria not met|0
5614736|NCT00804986|19395649|P2|Overall Study|Inclusion/Exclusion criteria not met|2
5614737|NCT00804986|19395650|P1|Overall Study|Inclusion/Exclusion criteria not met|0
5614738|NCT00804986|19395645|P6|Overall Study|Withdrawal by Subject|3
5614739|NCT00804986|19395646|P5|Overall Study|Withdrawal by Subject|5
5614740|NCT00804986|19395647|P4|Overall Study|Withdrawal by Subject|3
5614741|NCT00804986|19395648|P3|Overall Study|Withdrawal by Subject|0
5614742|NCT00804986|19395649|P2|Overall Study|Withdrawal by Subject|3
5614743|NCT00804986|19395650|P1|Overall Study|Withdrawal by Subject|0
5614744|NCT00804986|19395645|P6|Overall Study|Protocol Violation|0
5614745|NCT00804986|19395646|P5|Overall Study|Protocol Violation|0
5614746|NCT00804986|19395647|P4|Overall Study|Protocol Violation|1
5614747|NCT00804986|19395648|P3|Overall Study|Protocol Violation|0
5614748|NCT00804986|19395649|P2|Overall Study|Protocol Violation|1
5614749|NCT00804986|19395650|P1|Overall Study|Protocol Violation|0
5614750|NCT00804986|19395645|P6|Overall Study|Lost to Follow-up|3
5614751|NCT00804986|19395646|P5|Overall Study|Lost to Follow-up|1
5614752|NCT00804986|19395647|P4|Overall Study|Lost to Follow-up|1
5614753|NCT00804986|19395648|P3|Overall Study|Lost to Follow-up|0
5614754|NCT00804986|19395649|P2|Overall Study|Lost to Follow-up|0
5614755|NCT00804986|19395650|P1|Overall Study|Lost to Follow-up|0
5614756|NCT00804986|19395645|P6|Overall Study|Lack of Efficacy|3
5614757|NCT00804986|19395646|P5|Overall Study|Lack of Efficacy|0
5614758|NCT00804986|19395647|P4|Overall Study|Lack of Efficacy|1
5614759|NCT00804986|19395648|P3|Overall Study|Lack of Efficacy|0
5614760|NCT00804986|19395649|P2|Overall Study|Lack of Efficacy|0
5614761|NCT00804986|19395650|P1|Overall Study|Lack of Efficacy|0
5614762|NCT00804986|19395645|P6|Overall Study|Adverse Event|0
5614763|NCT00804986|19395646|P5|Overall Study|Adverse Event|3
5614764|NCT00804986|19395647|P4|Overall Study|Adverse Event|1
5614765|NCT00804986|19395648|P3|Overall Study|Adverse Event|2
5614766|NCT00804986|19395649|P2|Overall Study|Adverse Event|1
5614767|NCT00804986|19395650|P1|Overall Study|Adverse Event|0
5614768|NCT00804908|19395785|P3|Overall Study|Other|114
5614769|NCT00804908|19395786|P2|Overall Study|Other|116
5614770|NCT00804908|19395787|P1|Overall Study|Other|115
5614771|NCT00804843|19395818|P2|Overall Study|Withdrawal by Subject|2
5614772|NCT00804843|19395819|P1|Overall Study|Withdrawal by Subject|1
5614773|NCT00804843|19395818|P2|Overall Study|Adverse Event|5
5614774|NCT00804843|19395819|P1|Overall Study|Adverse Event|8
5614775|NCT00804843|19395818|P2|Overall Study|Protocol Violation|0
5614776|NCT00804843|19395819|P1|Overall Study|Protocol Violation|1
5614777|NCT00804687|19395837|P6|Period 5: Treatment Period|Positive drug test|0
5614778|NCT00804687|19395838|P5|Period 5: Treatment Period|Positive drug test|0
5614779|NCT00804687|19395839|P4|Period 5: Treatment Period|Positive drug test|0
5614780|NCT00804687|19395840|P3|Period 5: Treatment Period|Positive drug test|0
5614781|NCT00804687|19395841|P2|Period 5: Treatment Period|Positive drug test|0
5614782|NCT00804687|19395842|P1|Period 5: Treatment Period|Positive drug test|1
5614783|NCT00804687|19395837|P6|Period 5: Treatment Period|Positive drugs of abuse|0
5614784|NCT00804687|19395838|P5|Period 5: Treatment Period|Positive drugs of abuse|0
5614785|NCT00804687|19395839|P4|Period 5: Treatment Period|Positive drugs of abuse|0
5614786|NCT00804687|19395840|P3|Period 5: Treatment Period|Positive drugs of abuse|1
5614787|NCT00804687|19395841|P2|Period 5: Treatment Period|Positive drugs of abuse|0
5614788|NCT00804687|19395842|P1|Period 5: Treatment Period|Positive drugs of abuse|0
5614789|NCT00804687|19395837|P6|Period 5: Treatment Period|Withdrawal by Subject|0
5614790|NCT00804687|19395838|P5|Period 5: Treatment Period|Withdrawal by Subject|1
5614791|NCT00804687|19395839|P4|Period 5: Treatment Period|Withdrawal by Subject|0
5614792|NCT00804687|19395840|P3|Period 5: Treatment Period|Withdrawal by Subject|0
5614793|NCT00804687|19395841|P2|Period 5: Treatment Period|Withdrawal by Subject|0
5614794|NCT00804687|19395842|P1|Period 5: Treatment Period|Withdrawal by Subject|0
5614795|NCT00804687|19395837|P6|Period 3: Treatment Period|Positive Drug screen|0
5614796|NCT00804687|19395838|P5|Period 3: Treatment Period|Positive Drug screen|0
5614797|NCT00804687|19395839|P4|Period 3: Treatment Period|Positive Drug screen|1
5614798|NCT00804687|19395840|P3|Period 3: Treatment Period|Positive Drug screen|0
5614799|NCT00804687|19395841|P2|Period 3: Treatment Period|Positive Drug screen|0
5614800|NCT00804687|19395842|P1|Period 3: Treatment Period|Positive Drug screen|0
5614801|NCT00804570|19395921|P2|Overall Study|Withdrawal by Subject|38
5614802|NCT00804570|19395922|P1|Overall Study|Withdrawal by Subject|21
5614803|NCT00804570|19395921|P2|Overall Study|Sponsor decision|4
5614804|NCT00804570|19395922|P1|Overall Study|Sponsor decision|1
5614805|NCT00804570|19395921|P2|Overall Study|Physician Decision|2
5614806|NCT00804570|19395922|P1|Overall Study|Physician Decision|1
5614807|NCT00804570|19395921|P2|Overall Study|Protocol Violation|16
5614808|NCT00804570|19395922|P1|Overall Study|Protocol Violation|12
5614809|NCT00804570|19395921|P2|Overall Study|Entry criteria not met|5
5614810|NCT00804570|19395922|P1|Overall Study|Entry criteria not met|5
5614811|NCT00804570|19395921|P2|Overall Study|Lost to Follow-up|21
5614812|NCT00804570|19395922|P1|Overall Study|Lost to Follow-up|18
5614813|NCT00804570|19395921|P2|Overall Study|Lack of Efficacy|1
5614814|NCT00804570|19395922|P1|Overall Study|Lack of Efficacy|0
5614815|NCT00804570|19395921|P2|Overall Study|Adverse Event|7
5614816|NCT00804570|19395922|P1|Overall Study|Adverse Event|14
5614817|NCT00804193|19395996|P3|Overall Study|Withdrawal by Subject|2
5614818|NCT00804193|19395997|P2|Overall Study|Withdrawal by Subject|1
5614819|NCT00804193|19395998|P1|Overall Study|Withdrawal by Subject|3
5614820|NCT00804193|19395996|P3|Overall Study|Lost to Follow-up|4
5614821|NCT00804193|19395997|P2|Overall Study|Lost to Follow-up|3
5614822|NCT00804193|19395998|P1|Overall Study|Lost to Follow-up|3
5614823|NCT00804193|19395996|P3|Overall Study|Protocol Violation|2
5614824|NCT00804193|19395997|P2|Overall Study|Protocol Violation|8
5614825|NCT00804193|19395998|P1|Overall Study|Protocol Violation|0
5614826|NCT00804193|19395996|P3|Overall Study|Lack of Efficacy|3
5614827|NCT00804193|19395997|P2|Overall Study|Lack of Efficacy|1
5614828|NCT00804193|19395998|P1|Overall Study|Lack of Efficacy|1
5614829|NCT00804193|19395996|P3|Overall Study|Adverse Event|2
5614830|NCT00804193|19395997|P2|Overall Study|Adverse Event|0
5614831|NCT00804193|19395998|P1|Overall Study|Adverse Event|0
5614832|NCT00804193|19395996|P3|Overall Study|Lack of baseline fungus|19
5614833|NCT00804193|19395997|P2|Overall Study|Lack of baseline fungus|31
5614834|NCT00804193|19395998|P1|Overall Study|Lack of baseline fungus|32
5614835|NCT00804141|19396012|P1|Overall Study|Enrolled but not treated|6
5614836|NCT00804141|19396012|P1|Overall Study|Other than specified|30
5614837|NCT00804141|19396012|P1|Overall Study|Lack of Efficacy|46
5614838|NCT00804141|19396012|P1|Overall Study|Withdrawal by Subject|131
5614839|NCT00804141|19396012|P1|Overall Study|Protocol Violation|85
5614840|NCT00804141|19396012|P1|Overall Study|Investigator request|8
5614841|NCT00804141|19396012|P1|Overall Study|Failed to return|96
5614842|NCT00804141|19396012|P1|Overall Study|Death|4
5614843|NCT00804141|19396012|P1|Overall Study|Adverse Event|157
5614844|NCT00803790|19396052|P4|Period 2|Positive Drug Screen or Personal Reasons|0
5614845|NCT00803790|19396053|P3|Period 2|Positive Drug Screen or Personal Reasons|0
5614846|NCT00803790|19396054|P2|Period 2|Positive Drug Screen or Personal Reasons|0
5614847|NCT00803790|19396055|P1|Period 2|Positive Drug Screen or Personal Reasons|1
5614848|NCT00803790|19396052|P4|Period 2|Withdrawal by Subject|0
5614849|NCT00803790|19396053|P3|Period 2|Withdrawal by Subject|0
5614850|NCT00803790|19396054|P2|Period 2|Withdrawal by Subject|0
5614851|NCT00803790|19396055|P1|Period 2|Withdrawal by Subject|1
5614852|NCT00803790|19396052|P4|Period 2|Adverse Event|1
5614853|NCT00803790|19396053|P3|Period 2|Adverse Event|1
5614854|NCT00803790|19396054|P2|Period 2|Adverse Event|0
5614855|NCT00803790|19396055|P1|Period 2|Adverse Event|0
5614856|NCT00803790|19396052|P4|Period 1|Protocol Violation|0
5614857|NCT00803790|19396053|P3|Period 1|Protocol Violation|1
5614858|NCT00803790|19396054|P2|Period 1|Protocol Violation|0
5614859|NCT00803790|19396055|P1|Period 1|Protocol Violation|0
5614860|NCT00803790|19396052|P4|Period 1|positive drug screen or personal reasons|4
5614861|NCT00803790|19396053|P3|Period 1|positive drug screen or personal reasons|0
5614862|NCT00803790|19396054|P2|Period 1|positive drug screen or personal reasons|3
5614863|NCT00803790|19396055|P1|Period 1|positive drug screen or personal reasons|0
5614864|NCT00803790|19396052|P4|Period 1|Withdrawal by Subject|0
5614865|NCT00803790|19396053|P3|Period 1|Withdrawal by Subject|0
5614866|NCT00803790|19396054|P2|Period 1|Withdrawal by Subject|6
5614867|NCT00803790|19396055|P1|Period 1|Withdrawal by Subject|8
5614868|NCT00803790|19396052|P4|Period 1|Lost to Follow-up|0
5614869|NCT00803790|19396053|P3|Period 1|Lost to Follow-up|0
5614870|NCT00803790|19396054|P2|Period 1|Lost to Follow-up|2
5614871|NCT00803790|19396055|P1|Period 1|Lost to Follow-up|1
5614872|NCT00803790|19396052|P4|Period 1|Adverse Event|0
5614873|NCT00803790|19396053|P3|Period 1|Adverse Event|0
5614874|NCT00803790|19396054|P2|Period 1|Adverse Event|1
5614875|NCT00803790|19396055|P1|Period 1|Adverse Event|0
5614876|NCT00803738|19396095|P2|Overall Study|Positive Results for STD or abnormal PAP|8
5614877|NCT00803738|19396096|P1|Overall Study|Positive Results for STD or abnormal PAP|2
5614878|NCT00803738|19396095|P2|Overall Study|Negative Baseline Culture of Candida|63
5614879|NCT00803738|19396096|P1|Overall Study|Negative Baseline Culture of Candida|56
5614880|NCT00803738|19396095|P2|Overall Study|Lack of Efficacy|16
5614881|NCT00803738|19396096|P1|Overall Study|Lack of Efficacy|10
5614882|NCT00803738|19396095|P2|Overall Study|Withdrawal by Subject|4
5614883|NCT00803738|19396096|P1|Overall Study|Withdrawal by Subject|1
5614884|NCT00803738|19396095|P2|Overall Study|Protocol Violation|10
5614885|NCT00803738|19396096|P1|Overall Study|Protocol Violation|18
5614886|NCT00803738|19396095|P2|Overall Study|Lost to Follow-up|4
5614887|NCT00803738|19396096|P1|Overall Study|Lost to Follow-up|4
5614888|NCT00803738|19396095|P2|Overall Study|Adverse Event|5
5614889|NCT00803738|19396096|P1|Overall Study|Adverse Event|3
5614890|NCT00803712|19396108|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
5614891|NCT00803712|19396109|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
5614892|NCT00803712|19396108|P2|Overall Study|Administrative decision|3
5614893|NCT00803712|19396109|P1|Overall Study|Administrative decision|2
5614894|NCT00803712|19396108|P2|Overall Study|Protocol criteria (renal transplant)|8
5614895|NCT00803712|19396109|P1|Overall Study|Protocol criteria (renal transplant)|12
5614896|NCT00803712|19396108|P2|Overall Study|Protocol criteria (other)|2
5614897|NCT00803712|19396109|P1|Overall Study|Protocol criteria (other)|0
5614898|NCT00803712|19396108|P2|Overall Study|"Other in electronic Case Report Form"|1
5614899|NCT00803712|19396109|P1|Overall Study|"Other in electronic Case Report Form"|0
5614900|NCT00803712|19396108|P2|Overall Study|Withdrawal by Subject|4
5614901|NCT00803712|19396109|P1|Overall Study|Withdrawal by Subject|2
5614902|NCT00803712|19396108|P2|Overall Study|Lost to Follow-up|1
5614903|NCT00803712|19396109|P1|Overall Study|Lost to Follow-up|3
5614904|NCT00803712|19396108|P2|Overall Study|Death|7
5614905|NCT00803712|19396109|P1|Overall Study|Death|8
5614906|NCT00803712|19396108|P2|Overall Study|Adverse Event|0
5614907|NCT00803712|19396109|P1|Overall Study|Adverse Event|5
5614908|NCT00803712|19396108|P2|Overall Study|Noncompliance|0
5614909|NCT00803712|19396109|P1|Overall Study|Noncompliance|3
5614910|NCT00803634|19396208|P2|Overall Study|Death|2
5614911|NCT00803634|19396209|P1|Overall Study|Death|3
5614912|NCT00803634|19396208|P2|Overall Study|Lost to Follow-up|3
5614913|NCT00803634|19396209|P1|Overall Study|Lost to Follow-up|2
5614914|NCT00803634|19396208|P2|Overall Study|Withdrew Consent|0
5614915|NCT00803634|19396209|P1|Overall Study|Withdrew Consent|1
5614916|NCT00803595|19396238|P3|Overall Study|Withdrawal by Subject|3
5614917|NCT00803595|19396239|P2|Overall Study|Withdrawal by Subject|2
5614918|NCT00803595|19396240|P1|Overall Study|Withdrawal by Subject|5
5614919|NCT00803595|19396238|P3|Overall Study|Protocol Violation|12
5614920|NCT00803595|19396239|P2|Overall Study|Protocol Violation|2
5614921|NCT00803595|19396240|P1|Overall Study|Protocol Violation|7
5614922|NCT00803595|19396238|P3|Overall Study|Adverse Event|1
5614923|NCT00803595|19396239|P2|Overall Study|Adverse Event|4
5614924|NCT00803595|19396240|P1|Overall Study|Adverse Event|3
5614925|NCT00803569|19396251|P1|Overall Study|Noncompliance|1
5614926|NCT00803569|19396251|P1|Overall Study|Progressive Disease|3
5614927|NCT00803452|19396285|P2|Overall Study|Lost to Follow-up|3
5614928|NCT00803452|19396286|P1|Overall Study|Lost to Follow-up|0
5614929|NCT00803452|19396285|P2|Overall Study|Adverse Event|2
5614930|NCT00803452|19396286|P1|Overall Study|Adverse Event|0
5614931|NCT00803361|19396324|P2|Overall Study|Withdrawal by Subject|6
5614932|NCT00803361|19396325|P1|Overall Study|Withdrawal by Subject|5
5614933|NCT00803361|19396324|P2|Overall Study|Protocol Violation|4
5614934|NCT00803361|19396325|P1|Overall Study|Protocol Violation|2
5614935|NCT00803361|19396324|P2|Overall Study|Physician Decision|0
5614936|NCT00803361|19396325|P1|Overall Study|Physician Decision|1
5614937|NCT00803361|19396324|P2|Overall Study|Lost to Follow-up|2
5614938|NCT00803361|19396325|P1|Overall Study|Lost to Follow-up|1
5614939|NCT00803361|19396324|P2|Overall Study|Lack of Efficacy|13
5614940|NCT00803361|19396325|P1|Overall Study|Lack of Efficacy|4
5614941|NCT00803361|19396324|P2|Overall Study|Adverse Event|3
5614942|NCT00803361|19396325|P1|Overall Study|Adverse Event|13
5614943|NCT00803270|19396372|P2|Overall Study|Lost to Follow-up|2
5614944|NCT00803270|19396373|P1|Overall Study|Lost to Follow-up|1
5614945|NCT00803244|19396383|P2|Overall Study|Any other reason not above-mentioned|10
5614946|NCT00803244|19396384|P1|Overall Study|Any other reason not above-mentioned|4
5614947|NCT00803244|19396383|P2|Overall Study|Withdrawal by Subject|3
5614948|NCT00803244|19396384|P1|Overall Study|Withdrawal by Subject|2
5614949|NCT00803244|19396383|P2|Overall Study|Adverse Event|2
5614950|NCT00803244|19396384|P1|Overall Study|Adverse Event|1
5614951|NCT00803205|19396394|P2|Overall Study|Sponsor Decision|1
5614952|NCT00803205|19396395|P1|Overall Study|Sponsor Decision|0
5614953|NCT00803205|19396394|P2|Overall Study|Acquired a Lung Infection|1
5614954|NCT00803205|19396395|P1|Overall Study|Acquired a Lung Infection|0
5614955|NCT00803205|19396394|P2|Overall Study|Medical Monitor Decision|0
5614956|NCT00803205|19396395|P1|Overall Study|Medical Monitor Decision|1
5614957|NCT00803205|19396394|P2|Overall Study|Protocol Violation|1
5614958|NCT00803205|19396395|P1|Overall Study|Protocol Violation|1
5614959|NCT00803205|19396394|P2|Overall Study|Physician Decision|0
5614960|NCT00803205|19396395|P1|Overall Study|Physician Decision|1
5614961|NCT00803205|19396394|P2|Overall Study|Withdrawal by Subject|9
5614962|NCT00803205|19396395|P1|Overall Study|Withdrawal by Subject|9
5614963|NCT00803205|19396394|P2|Overall Study|Lost to Follow-up|0
5614964|NCT00803205|19396395|P1|Overall Study|Lost to Follow-up|1
5614965|NCT00803205|19396394|P2|Overall Study|Adverse Event|2
5614966|NCT00803205|19396395|P1|Overall Study|Adverse Event|7
5614967|NCT00803179|19396438|P1|Overall Study|Lost to Follow-up|3
5614968|NCT00803101|19396457|P2|Overall Study|Patient did not have surgery|1
5614969|NCT00803101|19396458|P1|Overall Study|Patient did not have surgery|1
5614970|NCT00803101|19396457|P2|Overall Study|Patient did not attend scheduled visit|1
5614971|NCT00803101|19396458|P1|Overall Study|Patient did not attend scheduled visit|2
5614972|NCT00803101|19396457|P2|Overall Study|Patient died outside SAE report period|0
5614973|NCT00803101|19396458|P1|Overall Study|Patient died outside SAE report period|1
5614974|NCT00803101|19396457|P2|Overall Study|Surgery finished outside protocol window|1
5614975|NCT00803101|19396458|P1|Overall Study|Surgery finished outside protocol window|1
5614976|NCT00803101|19396457|P2|Overall Study|Protocol Violation|7
5614977|NCT00803101|19396458|P1|Overall Study|Protocol Violation|1
5614978|NCT00803101|19396457|P2|Overall Study|Lost to Follow-up|2
5614979|NCT00803101|19396458|P1|Overall Study|Lost to Follow-up|2
5614980|NCT00803101|19396457|P2|Overall Study|Withdrawal by Subject|4
5614981|NCT00803101|19396458|P1|Overall Study|Withdrawal by Subject|6
5614982|NCT00803101|19396457|P2|Overall Study|Death / Serious Adverse Event|6
5614983|NCT00803101|19396458|P1|Overall Study|Death / Serious Adverse Event|4
5614984|NCT00803049|19396509|P4|Overall Study|Other than Specified Above|5
5614985|NCT00803049|19396510|P3|Overall Study|Other than Specified Above|2
5614986|NCT00803049|19396511|P2|Overall Study|Other than Specified Above|9
5614987|NCT00803049|19396512|P1|Overall Study|Other than Specified Above|3
5614988|NCT00803049|19396509|P4|Overall Study|Randomized and Not Treated|2
5614989|NCT00803049|19396510|P3|Overall Study|Randomized and Not Treated|0
5614990|NCT00803049|19396511|P2|Overall Study|Randomized and Not Treated|0
5614991|NCT00803049|19396512|P1|Overall Study|Randomized and Not Treated|0
5614992|NCT00803049|19396509|P4|Overall Study|Protocol Violation|0
5614993|NCT00803049|19396510|P3|Overall Study|Protocol Violation|1
5614994|NCT00803049|19396511|P2|Overall Study|Protocol Violation|1
5614995|NCT00803049|19396512|P1|Overall Study|Protocol Violation|0
5614996|NCT00803049|19396509|P4|Overall Study|Withdrawal by Subject|44
5614997|NCT00803049|19396510|P3|Overall Study|Withdrawal by Subject|16
5614998|NCT00803049|19396511|P2|Overall Study|Withdrawal by Subject|43
5614999|NCT00803049|19396512|P1|Overall Study|Withdrawal by Subject|19
5615000|NCT00803049|19396509|P4|Overall Study|Progressive Disease|6
5615001|NCT00803049|19396510|P3|Overall Study|Progressive Disease|6
5615002|NCT00803049|19396511|P2|Overall Study|Progressive Disease|10
5615003|NCT00803049|19396512|P1|Overall Study|Progressive Disease|6
5615004|NCT00803049|19396509|P4|Overall Study|Death|2
5615005|NCT00803049|19396510|P3|Overall Study|Death|0
5615006|NCT00803049|19396511|P2|Overall Study|Death|1
5615007|NCT00803049|19396512|P1|Overall Study|Death|2
5615008|NCT00803049|19396509|P4|Overall Study|Lost to Follow-up|3
5615009|NCT00803049|19396510|P3|Overall Study|Lost to Follow-up|0
5615010|NCT00803049|19396511|P2|Overall Study|Lost to Follow-up|2
5615011|NCT00803049|19396512|P1|Overall Study|Lost to Follow-up|0
5615012|NCT00803049|19396509|P4|Overall Study|Lack of Efficacy|13
5615013|NCT00803049|19396510|P3|Overall Study|Lack of Efficacy|6
5615014|NCT00803049|19396511|P2|Overall Study|Lack of Efficacy|19
5615015|NCT00803049|19396512|P1|Overall Study|Lack of Efficacy|10
5615016|NCT00803049|19396509|P4|Overall Study|Adverse Event|27
5615017|NCT00803049|19396510|P3|Overall Study|Adverse Event|13
5615018|NCT00803049|19396511|P2|Overall Study|Adverse Event|33
5615019|NCT00803049|19396512|P1|Overall Study|Adverse Event|21
5615020|NCT00803023|19396546|P4|Overall Study|Lack of Efficacy|1
5615021|NCT00803023|19396547|P3|Overall Study|Lack of Efficacy|1
5615022|NCT00803023|19396548|P2|Overall Study|Lack of Efficacy|1
5615023|NCT00803023|19396549|P1|Overall Study|Lack of Efficacy|0
5615024|NCT00803023|19396546|P4|Overall Study|Lost to Follow-up|1
5615025|NCT00803023|19396547|P3|Overall Study|Lost to Follow-up|2
5615026|NCT00803023|19396548|P2|Overall Study|Lost to Follow-up|1
5615027|NCT00803023|19396549|P1|Overall Study|Lost to Follow-up|0
5615028|NCT00803023|19396546|P4|Overall Study|Withdrawal by Subject|0
5615029|NCT00803023|19396547|P3|Overall Study|Withdrawal by Subject|0
5615030|NCT00803023|19396548|P2|Overall Study|Withdrawal by Subject|2
5615031|NCT00803023|19396549|P1|Overall Study|Withdrawal by Subject|0
5615032|NCT00803023|19396546|P4|Overall Study|Adverse Event|6
5615033|NCT00803023|19396547|P3|Overall Study|Adverse Event|8
5615034|NCT00803023|19396548|P2|Overall Study|Adverse Event|4
5615035|NCT00803023|19396549|P1|Overall Study|Adverse Event|5
5615036|NCT00802945|19396587|P2|Overall Study|Terminated by sponsor|12
5615037|NCT00802945|19396588|P1|Overall Study|Terminated by sponsor|8
5615038|NCT00802945|19396587|P2|Overall Study|Death|23
5615039|NCT00802945|19396588|P1|Overall Study|Death|27
5615040|NCT00802893|19396619|P1|Overall Study|study terminated|3
5615041|NCT00802867|19396643|P1|Overall Study|Withdrawal by Subject|1
5615042|NCT00802867|19396643|P1|Overall Study|Protocol Violation|6
5615043|NCT00802867|19396643|P1|Overall Study|Lost to Follow-up|6
5615044|NCT00802841|19396666|P2|Overall Study|Treatment duration completed|76
5615045|NCT00802841|19396667|P1|Overall Study|Treatment duration completed|66
5615046|NCT00802841|19396666|P2|Overall Study|Protocol deviation|6
5615047|NCT00802841|19396667|P1|Overall Study|Protocol deviation|2
5615048|NCT00802841|19396666|P2|Overall Study|Withdrawal by Subject|5
5615049|NCT00802841|19396667|P1|Overall Study|Withdrawal by Subject|9
5615050|NCT00802841|19396666|P2|Overall Study|Disease progression|3
5615051|NCT00802841|19396667|P1|Overall Study|Disease progression|7
5615052|NCT00802841|19396666|P2|Overall Study|Adverse Event|2
5615053|NCT00802841|19396667|P1|Overall Study|Adverse Event|8
5615054|NCT00802841|19396666|P2|Overall Study|Death|2
5615055|NCT00802841|19396667|P1|Overall Study|Death|1
5615056|NCT00802841|19396666|P2|Overall Study|Lost to Follow-up|1
5615057|NCT00802841|19396667|P1|Overall Study|Lost to Follow-up|2
5615058|NCT00802841|19396666|P2|Overall Study|Administrative problems|0
5615059|NCT00802841|19396667|P1|Overall Study|Administrative problems|1
5615060|NCT00802737|19396692|P3|Overall Study|Participant too Unwell|0
5615061|NCT00802737|19396693|P2|Overall Study|Participant too Unwell|2
5615062|NCT00802737|19396694|P1|Overall Study|Participant too Unwell|0
5615063|NCT00802737|19396692|P3|Overall Study|Ongoing CLL-Treatment|0
5615064|NCT00802737|19396693|P2|Overall Study|Ongoing CLL-Treatment|1
5615065|NCT00802737|19396694|P1|Overall Study|Ongoing CLL-Treatment|0
5615066|NCT00802737|19396692|P3|Overall Study|Received Prohibited Therapy|0
5615067|NCT00802737|19396693|P2|Overall Study|Received Prohibited Therapy|0
5615068|NCT00802737|19396694|P1|Overall Study|Received Prohibited Therapy|1
5615069|NCT00802737|19396692|P3|Overall Study|Adverse Event|0
5615070|NCT00802737|19396693|P2|Overall Study|Adverse Event|0
5615071|NCT00802737|19396694|P1|Overall Study|Adverse Event|1
5615072|NCT00802737|19396692|P3|Overall Study|Death|1
5615073|NCT00802737|19396693|P2|Overall Study|Death|5
5615074|NCT00802737|19396694|P1|Overall Study|Death|6
5615075|NCT00802737|19396692|P3|Overall Study|Withdrawn due to Disease Progression|0
5615076|NCT00802737|19396693|P2|Overall Study|Withdrawn due to Disease Progression|3
5615077|NCT00802737|19396694|P1|Overall Study|Withdrawn due to Disease Progression|9
5615078|NCT00802672|19396754|P3|Overall Study|other|2
5615079|NCT00802672|19396755|P2|Overall Study|other|1
5615080|NCT00802672|19396756|P1|Overall Study|other|3
5615081|NCT00802672|19396754|P3|Overall Study|Withdrawal by Subject|2
5615082|NCT00802672|19396755|P2|Overall Study|Withdrawal by Subject|1
5615083|NCT00802672|19396756|P1|Overall Study|Withdrawal by Subject|1
5615084|NCT00802672|19396754|P3|Overall Study|Lost to Follow-up|3
5615085|NCT00802672|19396755|P2|Overall Study|Lost to Follow-up|5
5615086|NCT00802672|19396756|P1|Overall Study|Lost to Follow-up|5
5615087|NCT00802672|19396754|P3|Overall Study|Protocol Violation|1
5615088|NCT00802672|19396755|P2|Overall Study|Protocol Violation|1
5615089|NCT00802672|19396756|P1|Overall Study|Protocol Violation|2
5615090|NCT00802672|19396754|P3|Overall Study|Adverse Event|1
5615091|NCT00802672|19396755|P2|Overall Study|Adverse Event|1
5615092|NCT00802672|19396756|P1|Overall Study|Adverse Event|1
5615093|NCT00802672|19396754|P3|Overall Study|Lack of fungal pathogen at baseline|25
5615094|NCT00802672|19396755|P2|Overall Study|Lack of fungal pathogen at baseline|43
5615095|NCT00802672|19396756|P1|Overall Study|Lack of fungal pathogen at baseline|56
5615096|NCT00802659|19396774|P4|Overall Study|Physician Decision|0
5615097|NCT00802659|19396775|P3|Overall Study|Physician Decision|0
5615098|NCT00802659|19396776|P2|Overall Study|Physician Decision|1
5615099|NCT00802659|19396777|P1|Overall Study|Physician Decision|0
5615100|NCT00802529|19396816|P2|Overall Study|Lost to Follow-up|1
5615101|NCT00802529|19396817|P1|Overall Study|Lost to Follow-up|0
5615102|NCT00802464|19396856|P4|Month 8 - Month 14|Lost to Follow-up|0
5615103|NCT00802464|19396857|P3|Month 8 - Month 14|Lost to Follow-up|1
5615104|NCT00802464|19396858|P2|Month 8 - Month 14|Lost to Follow-up|0
5615105|NCT00802464|19396859|P1|Month 8 - Month 14|Lost to Follow-up|0
5615106|NCT00802464|19396856|P4|Month 8 - Month 14|Withdrawal by Subject|0
5615107|NCT00802464|19396857|P3|Month 8 - Month 14|Withdrawal by Subject|0
5615108|NCT00802464|19396858|P2|Month 8 - Month 14|Withdrawal by Subject|1
5615109|NCT00802464|19396859|P1|Month 8 - Month 14|Withdrawal by Subject|1
5615110|NCT00802464|19396856|P4|Month 8 - Month 14|Adverse Event|0
5615111|NCT00802464|19396857|P3|Month 8 - Month 14|Adverse Event|0
5615112|NCT00802464|19396858|P2|Month 8 - Month 14|Adverse Event|1
5615113|NCT00802464|19396859|P1|Month 8 - Month 14|Adverse Event|0
5615114|NCT00802464|19396856|P4|Month 0 - Month 8|Other|0
5615115|NCT00802464|19396857|P3|Month 0 - Month 8|Other|1
5615116|NCT00802464|19396858|P2|Month 0 - Month 8|Other|0
5615117|NCT00802464|19396859|P1|Month 0 - Month 8|Other|0
5615118|NCT00802464|19396856|P4|Month 0 - Month 8|Lost to Follow-up|2
5615119|NCT00802464|19396857|P3|Month 0 - Month 8|Lost to Follow-up|2
5615120|NCT00802464|19396858|P2|Month 0 - Month 8|Lost to Follow-up|1
5615121|NCT00802464|19396859|P1|Month 0 - Month 8|Lost to Follow-up|0
5615122|NCT00802464|19396856|P4|Month 0 - Month 8|Withdrawal by Subject|5
5615123|NCT00802464|19396857|P3|Month 0 - Month 8|Withdrawal by Subject|2
5615124|NCT00802464|19396858|P2|Month 0 - Month 8|Withdrawal by Subject|1
5615125|NCT00802464|19396859|P1|Month 0 - Month 8|Withdrawal by Subject|0
5615126|NCT00802464|19396856|P4|Month 0 - Month 8|Protocol Violation|0
5615127|NCT00802464|19396857|P3|Month 0 - Month 8|Protocol Violation|1
5615128|NCT00802464|19396858|P2|Month 0 - Month 8|Protocol Violation|0
5615129|NCT00802464|19396859|P1|Month 0 - Month 8|Protocol Violation|0
5615130|NCT00802464|19396856|P4|Month 0 - Month 8|Adverse Event|2
5615131|NCT00802464|19396857|P3|Month 0 - Month 8|Adverse Event|1
5615132|NCT00802464|19396858|P2|Month 0 - Month 8|Adverse Event|1
5615133|NCT00802464|19396859|P1|Month 0 - Month 8|Adverse Event|0
5615134|NCT00802438|19396945|P1|Overall Study|Physician Decision|1
5615135|NCT00802438|19396945|P1|Overall Study|Withdrawal by Subject|7
5615136|NCT00802438|19396945|P1|Overall Study|Screen Failure|20
5615137|NCT00802360|19396965|P4|Overall Study|Other|3
5615138|NCT00802360|19396966|P3|Overall Study|Other|6
5615139|NCT00802360|19396967|P2|Overall Study|Other|3
5615140|NCT00802360|19396968|P1|Overall Study|Other|2
5615141|NCT00802360|19396965|P4|Overall Study|Pregnancy loss/miscarriage|3
5615142|NCT00802360|19396966|P3|Overall Study|Pregnancy loss/miscarriage|0
5615143|NCT00802360|19396967|P2|Overall Study|Pregnancy loss/miscarriage|2
5615144|NCT00802360|19396968|P1|Overall Study|Pregnancy loss/miscarriage|0
5615145|NCT00802360|19396965|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
5615146|NCT00802360|19396966|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
5615147|NCT00802360|19396967|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
5615148|NCT00802360|19396968|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
5615149|NCT00802360|19396965|P4|Overall Study|No positive serum pregnancy|10
5615150|NCT00802360|19396966|P3|Overall Study|No positive serum pregnancy|14
5615151|NCT00802360|19396967|P2|Overall Study|No positive serum pregnancy|20
5615152|NCT00802360|19396968|P1|Overall Study|No positive serum pregnancy|17
5615153|NCT00802360|19396965|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
5615154|NCT00802360|19396966|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
5615155|NCT00802360|19396967|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
5615156|NCT00802360|19396968|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
5615157|NCT00802360|19396965|P4|Overall Study|Cycle cancelled|1
5615158|NCT00802360|19396966|P3|Overall Study|Cycle cancelled|1
5615159|NCT00802360|19396967|P2|Overall Study|Cycle cancelled|1
5615160|NCT00802360|19396968|P1|Overall Study|Cycle cancelled|0
5615161|NCT00802360|19396965|P4|Overall Study|Inadequate number of oocytes retrieved|1
5615162|NCT00802360|19396966|P3|Overall Study|Inadequate number of oocytes retrieved|0
5615163|NCT00802360|19396967|P2|Overall Study|Inadequate number of oocytes retrieved|0
5615164|NCT00802360|19396968|P1|Overall Study|Inadequate number of oocytes retrieved|0
5615165|NCT00802360|19396965|P4|Overall Study|Stimulation failure|3
5615166|NCT00802360|19396966|P3|Overall Study|Stimulation failure|3
5615167|NCT00802360|19396967|P2|Overall Study|Stimulation failure|0
5615168|NCT00802360|19396968|P1|Overall Study|Stimulation failure|4
5615169|NCT00802178|19397035|P1|Overall Study|Patients wish and other reason|1
5615170|NCT00802178|19397035|P1|Overall Study|IT and patient wish|8
5615171|NCT00802178|19397035|P1|Overall Study|Lack of efficacy and patient wish|1
5615172|NCT00802178|19397035|P1|Overall Study|Other|32
5615173|NCT00802178|19397035|P1|Overall Study|Withdrawal by Subject|18
5615174|NCT00802178|19397035|P1|Overall Study|Insufficient tolerability (IT)|17
5615175|NCT00802178|19397035|P1|Overall Study|Lack of Efficacy|36
5615176|NCT00802074|19397083|P6|Overall Study|Withdrawal by Subject|0
5615177|NCT00802074|19397084|P5|Overall Study|Withdrawal by Subject|0
5615178|NCT00802074|19397085|P4|Overall Study|Withdrawal by Subject|0
5615179|NCT00802074|19397086|P3|Overall Study|Withdrawal by Subject|0
5615180|NCT00802074|19397087|P2|Overall Study|Withdrawal by Subject|0
5615181|NCT00802074|19397088|P1|Overall Study|Withdrawal by Subject|1
5615182|NCT00802074|19397083|P6|Overall Study|Adverse Event|0
5615183|NCT00802074|19397084|P5|Overall Study|Adverse Event|0
5615184|NCT00802074|19397085|P4|Overall Study|Adverse Event|0
5615185|NCT00802074|19397086|P3|Overall Study|Adverse Event|1
5615186|NCT00802074|19397087|P2|Overall Study|Adverse Event|1
5615187|NCT00802074|19397088|P1|Overall Study|Adverse Event|1
5615188|NCT00801983|19397122|P2|Period 2|Withdrawal by Subject|1
5615189|NCT00801983|19397123|P1|Period 2|Withdrawal by Subject|2
5615190|NCT00801983|19397122|P2|Period 1|Withdrawal by Subject|8
5615191|NCT00801983|19397123|P1|Period 1|Withdrawal by Subject|2
5615192|NCT00801983|19397122|P2|Period 1|Lost to Follow-up|0
5615193|NCT00801983|19397123|P1|Period 1|Lost to Follow-up|2
5615194|NCT00801892|19397138|P2|Sham Crossover Period|Lost to Follow-up|2
5615195|NCT00801892|19397139|P1|Sham Crossover Period|Lost to Follow-up|0
5615196|NCT00801892|19397138|P2|Main Study Period|Withdrawal by Subject|1
5615197|NCT00801892|19397139|P1|Main Study Period|Withdrawal by Subject|0
5615198|NCT00801632|19397199|P1|Overall Study|Re-transplant|1
5615199|NCT00801242|19397277|P1|Overall Study|Miscellaneous reasons|20
5615200|NCT00801242|19397277|P1|Overall Study|Lost to Follow-up|1
5615201|NCT00801242|19397277|P1|Overall Study|Physician Decision|3
5615202|NCT00801242|19397277|P1|Overall Study|Protocol Violation|5
5615203|NCT00801242|19397277|P1|Overall Study|Withdrawal by Subject|13
5615204|NCT00801242|19397277|P1|Overall Study|Adverse Event|10
5615205|NCT00801229|19397290|P2|Received Study Drug/Placebo|Adverse Event|1
5615206|NCT00801229|19397291|P1|Received Study Drug/Placebo|Adverse Event|1
5615207|NCT00801229|19397290|P2|Received Study Drug/Placebo|Lost to Follow-up|1
5615208|NCT00801229|19397291|P1|Received Study Drug/Placebo|Lost to Follow-up|0
5615209|NCT00801229|19397290|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
5615210|NCT00801229|19397291|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
5615211|NCT00801229|19397290|P2|Received Study Drug/Placebo|Simulator sickness|1
5615212|NCT00801229|19397291|P1|Received Study Drug/Placebo|Simulator sickness|1
5615213|NCT00801229|19397290|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
5615214|NCT00801229|19397291|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
5615215|NCT00801229|19397290|P2|Received Study Drug/Placebo|Elevated SGOT level|0
5615216|NCT00801229|19397291|P1|Received Study Drug/Placebo|Elevated SGOT level|1
5615217|NCT00801229|19397290|P2|Signed Consent|Found Ineligible|1
5615218|NCT00801229|19397291|P1|Signed Consent|Found Ineligible|1
5615219|NCT00801229|19397290|P2|Signed Consent|Withdrawal by Subject|2
5615220|NCT00801229|19397291|P1|Signed Consent|Withdrawal by Subject|2
5615221|NCT00801099|19397326|P1|Overall Study|Lost to Follow-up|101
5615222|NCT00800982|19397332|P2|Overall Study|Patient moved out of state|0
5615223|NCT00800982|19397333|P1|Overall Study|Patient moved out of state|1
5615224|NCT00800982|19397332|P2|Overall Study|Withdrawal by Subject|1
5615225|NCT00800982|19397333|P1|Overall Study|Withdrawal by Subject|0
5615226|NCT00800982|19397332|P2|Overall Study|Lost to Follow-up|2
5615227|NCT00800982|19397333|P1|Overall Study|Lost to Follow-up|1
5615228|NCT00800735|19397359|P1|Overall Study|Withdrew Consent|3
5615229|NCT00800735|19397359|P1|Overall Study|Violation of Selection Criteria at Entry|7
5615230|NCT00800735|19397359|P1|Overall Study|Insufficient Therapeutic Response|2
5615231|NCT00800735|19397359|P1|Overall Study|Administrative/Other|2
5615232|NCT00800683|19397365|P2|Overall Study|Other|2
5615233|NCT00800683|19397366|P1|Overall Study|Other|1
5615234|NCT00800683|19397365|P2|Overall Study|Lack of Efficacy|1
5615235|NCT00800683|19397366|P1|Overall Study|Lack of Efficacy|1
5615236|NCT00800683|19397365|P2|Overall Study|Withdrawal by Subject|7
5615237|NCT00800683|19397366|P1|Overall Study|Withdrawal by Subject|1
5615238|NCT00800683|19397365|P2|Overall Study|Lost to Follow-up|1
5615239|NCT00800683|19397366|P1|Overall Study|Lost to Follow-up|3
5615240|NCT00800683|19397365|P2|Overall Study|Adverse Event|8
5615241|NCT00800683|19397366|P1|Overall Study|Adverse Event|11
5615242|NCT00800540|19397412|P2|Period 2: 6 Weeks|Adverse Event|1
5615243|NCT00800540|19397413|P1|Period 2: 6 Weeks|Adverse Event|0
5615244|NCT00800540|19397412|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
5615245|NCT00800540|19397413|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
5615246|NCT00800540|19397412|P2|Period One: 6 Weeks|Noncompliance|0
5615247|NCT00800540|19397413|P1|Period One: 6 Weeks|Noncompliance|1
5615248|NCT00800436|19397448|P7|Overall Study|Withdrawal by Subject|0
5615249|NCT00800436|19397449|P6|Overall Study|Withdrawal by Subject|0
5615250|NCT00800436|19397450|P5|Overall Study|Withdrawal by Subject|0
5615251|NCT00800436|19397451|P4|Overall Study|Withdrawal by Subject|1
5615252|NCT00800436|19397452|P3|Overall Study|Withdrawal by Subject|1
5615253|NCT00800436|19397453|P2|Overall Study|Withdrawal by Subject|0
5615254|NCT00800436|19397454|P1|Overall Study|Withdrawal by Subject|0
5615255|NCT00800384|19397500|P2|Overall Study|Lost to Follow-up|26
5615256|NCT00800384|19397501|P1|Overall Study|Lost to Follow-up|17
5615257|NCT00800384|19397500|P2|Overall Study|Withdrawal by Subject|17
5615258|NCT00800384|19397501|P1|Overall Study|Withdrawal by Subject|24
5615259|NCT00800202|19397539|P2|Overall Study|Disease Progression|18
5615260|NCT00800202|19397540|P1|Overall Study|Disease Progression|54
5615261|NCT00800202|19397539|P2|Overall Study|Other|0
5615262|NCT00800202|19397540|P1|Overall Study|Other|5
5615263|NCT00800202|19397539|P2|Overall Study|Death|0
5615264|NCT00800202|19397540|P1|Overall Study|Death|1
5615265|NCT00800202|19397539|P2|Overall Study|Adverse Event|6
5615266|NCT00800202|19397540|P1|Overall Study|Adverse Event|7
5615267|NCT00800176|19397564|P6|Overall Study|Other|0
5615268|NCT00800176|19397565|P5|Overall Study|Other|2
5615269|NCT00800176|19397566|P4|Overall Study|Other|0
5615270|NCT00800176|19397567|P3|Overall Study|Other|0
5615271|NCT00800176|19397568|P2|Overall Study|Other|0
5615272|NCT00800176|19397569|P1|Overall Study|Other|1
5615273|NCT00800176|19397564|P6|Overall Study|Failure to return|0
5615274|NCT00800176|19397565|P5|Overall Study|Failure to return|0
5615275|NCT00800176|19397566|P4|Overall Study|Failure to return|2
5615276|NCT00800176|19397567|P3|Overall Study|Failure to return|0
5615277|NCT00800176|19397568|P2|Overall Study|Failure to return|3
5615278|NCT00800176|19397569|P1|Overall Study|Failure to return|3
5615279|NCT00800176|19397564|P6|Overall Study|Refused treatment|4
5615280|NCT00800176|19397565|P5|Overall Study|Refused treatment|1
5615281|NCT00800176|19397566|P4|Overall Study|Refused treatment|0
5615282|NCT00800176|19397567|P3|Overall Study|Refused treatment|0
5615283|NCT00800176|19397568|P2|Overall Study|Refused treatment|2
5615284|NCT00800176|19397569|P1|Overall Study|Refused treatment|3
5615285|NCT00800176|19397564|P6|Overall Study|Adverse Event|1
5615286|NCT00800176|19397565|P5|Overall Study|Adverse Event|1
5615287|NCT00800176|19397566|P4|Overall Study|Adverse Event|2
5615288|NCT00800176|19397567|P3|Overall Study|Adverse Event|0
5615289|NCT00800176|19397568|P2|Overall Study|Adverse Event|1
5615290|NCT00800176|19397569|P1|Overall Study|Adverse Event|2
5615291|NCT00799903|19397645|P2|Overall Study|Lost to Follow-up|80
5615292|NCT00799903|19397646|P1|Overall Study|Lost to Follow-up|69
5615293|NCT00799903|19397645|P2|Overall Study|Withdrawal by Subject|175
5615294|NCT00799903|19397646|P1|Overall Study|Withdrawal by Subject|179
5615295|NCT00799903|19397645|P2|Overall Study|Investigator Site Closed|23
5615296|NCT00799903|19397646|P1|Overall Study|Investigator Site Closed|25
5615297|NCT00799825|19397666|P1|Overall Study|Pregnancy|3
5615298|NCT00799825|19397666|P1|Overall Study|Lost to Follow-up|38
5615299|NCT00799825|19397666|P1|Overall Study|Withdrawal by Subject|6
5615300|NCT00799825|19397666|P1|Overall Study|Adverse Event|1
5615301|NCT00799708|19397706|P3|Overall Study|non-compliance|0
5615302|NCT00799708|19397707|P2|Overall Study|non-compliance|0
5615303|NCT00799708|19397708|P1|Overall Study|non-compliance|1
5615304|NCT00799617|19397731|P2|Anemia Trial|Withdrawal by Subject|3
5615305|NCT00799617|19397732|P1|Anemia Trial|Withdrawal by Subject|3
5615306|NCT00799617|19397731|P2|Cognitive Function Trial|Lost to Follow-up|1
5615307|NCT00799617|19397732|P1|Cognitive Function Trial|Lost to Follow-up|0
5615308|NCT00799617|19397731|P2|Bone Trial|Month 12 scan not available|16
5615309|NCT00799617|19397732|P1|Bone Trial|Month 12 scan not available|6
5615310|NCT00799617|19397731|P2|Cardiovascular Trial|Baseline scan not analyzable|2
5615311|NCT00799617|19397732|P1|Cardiovascular Trial|Baseline scan not analyzable|0
5615312|NCT00799617|19397731|P2|Cardiovascular Trial|Month 12 scan not available|15
5615313|NCT00799617|19397732|P1|Cardiovascular Trial|Month 12 scan not available|15
5615314|NCT00799617|19397731|P2|Vitality Trial|Lost to Follow-up|22
5615315|NCT00799617|19397732|P1|Vitality Trial|Lost to Follow-up|7
5615316|NCT00799617|19397731|P2|Physical Function Trial|Lost to Follow-up|11
5615317|NCT00799617|19397732|P1|Physical Function Trial|Lost to Follow-up|6
5615318|NCT00799617|19397731|P2|Sexual Funtion Trial|No Baseline Data|7
5615319|NCT00799617|19397732|P1|Sexual Funtion Trial|No Baseline Data|4
5615320|NCT00799617|19397731|P2|Sexual Funtion Trial|Lost to Follow-up|14
5615321|NCT00799617|19397732|P1|Sexual Funtion Trial|Lost to Follow-up|12
5615322|NCT00799617|19397731|P2|Main Testosterone Trial|Lost to Follow-up|20
5615323|NCT00799617|19397732|P1|Main Testosterone Trial|Lost to Follow-up|18
5615324|NCT00799617|19397731|P2|Main Testosterone Trial|Randomized in error|1
5615325|NCT00799617|19397732|P1|Main Testosterone Trial|Randomized in error|1
5615326|NCT00799591|19397839|P1|Overall Study|Infectious origin not probable|1
5615327|NCT00799591|19397839|P1|Overall Study|Antibiotic changed, no apparent reason|1
5615328|NCT00799591|19397839|P1|Overall Study|Persistance of fever undetermined origin|1
5615329|NCT00799591|19397839|P1|Overall Study|Resistance germ and technical failure|2
5615330|NCT00799591|19397839|P1|Overall Study|New infection|4
5615331|NCT00799591|19397839|P1|Overall Study|Resistant germ|11
5615332|NCT00799591|19397839|P1|Overall Study|Technical failure|12
5615333|NCT00799591|19397839|P1|Overall Study|Death|14
5615334|NCT00799591|19397839|P1|Overall Study|De-escalation of doses|20
5615335|NCT00799487|19397857|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
5615336|NCT00799487|19397858|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
5615337|NCT00799487|19397859|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
5615338|NCT00799487|19397857|P3|Double-Blind Assessment Period|Subject was out of the state|1
5615339|NCT00799487|19397858|P2|Double-Blind Assessment Period|Subject was out of the state|0
5615340|NCT00799487|19397859|P1|Double-Blind Assessment Period|Subject was out of the state|0
5615341|NCT00799487|19397857|P3|Double-Blind Assessment Period|Lost to Follow-up|1
5615342|NCT00799487|19397858|P2|Double-Blind Assessment Period|Lost to Follow-up|0
5615343|NCT00799487|19397859|P1|Double-Blind Assessment Period|Lost to Follow-up|0
5615344|NCT00799487|19397857|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
5615345|NCT00799487|19397858|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
5615346|NCT00799487|19397859|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
5615347|NCT00799487|19397857|P3|Dose Adjustment Period|Missed laboratory day 1|0
5615348|NCT00799487|19397858|P2|Dose Adjustment Period|Missed laboratory day 1|0
5615349|NCT00799487|19397859|P1|Dose Adjustment Period|Missed laboratory day 1|1
5615350|NCT00799487|19397857|P3|Dose Adjustment Period|Child too young (exclusion)|0
5615351|NCT00799487|19397858|P2|Dose Adjustment Period|Child too young (exclusion)|0
5615352|NCT00799487|19397859|P1|Dose Adjustment Period|Child too young (exclusion)|1
5615353|NCT00799487|19397857|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
5615354|NCT00799487|19397858|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
5615355|NCT00799487|19397859|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
5615356|NCT00799487|19397857|P3|Dose Adjustment Period|Withdrawal by Subject|0
5615357|NCT00799487|19397858|P2|Dose Adjustment Period|Withdrawal by Subject|0
5615358|NCT00799487|19397859|P1|Dose Adjustment Period|Withdrawal by Subject|3
5615359|NCT00799487|19397857|P3|Dose Adjustment Period|Investigator Discretion|0
5615360|NCT00799487|19397858|P2|Dose Adjustment Period|Investigator Discretion|0
5615361|NCT00799487|19397859|P1|Dose Adjustment Period|Investigator Discretion|2
5615362|NCT00799487|19397857|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
5615363|NCT00799487|19397858|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
5615364|NCT00799487|19397859|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
5615365|NCT00799487|19397857|P3|Dose Adjustment Period|Adverse Event|0
5615366|NCT00799487|19397858|P2|Dose Adjustment Period|Adverse Event|0
5615367|NCT00799487|19397859|P1|Dose Adjustment Period|Adverse Event|2
5615368|NCT00799487|19397857|P3|Dose Adjustment Period|Lost to Follow-up|0
5615369|NCT00799487|19397858|P2|Dose Adjustment Period|Lost to Follow-up|0
5615370|NCT00799487|19397859|P1|Dose Adjustment Period|Lost to Follow-up|1
5615371|NCT00799422|19397956|P6|First Week of Wear|Adverse Event|0
5615372|NCT00799422|19397957|P5|First Week of Wear|Adverse Event|0
5615373|NCT00799422|19397958|P4|First Week of Wear|Adverse Event|1
5615374|NCT00799422|19397959|P3|First Week of Wear|Adverse Event|0
5615375|NCT00799422|19397960|P2|First Week of Wear|Adverse Event|0
5615376|NCT00799422|19397961|P1|First Week of Wear|Adverse Event|0
5615377|NCT00799422|19397956|P6|First Week of Wear|Lost to Follow-up|0
5615378|NCT00799422|19397957|P5|First Week of Wear|Lost to Follow-up|0
5615379|NCT00799422|19397958|P4|First Week of Wear|Lost to Follow-up|0
5615380|NCT00799422|19397959|P3|First Week of Wear|Lost to Follow-up|1
5615381|NCT00799422|19397960|P2|First Week of Wear|Lost to Follow-up|0
5615382|NCT00799422|19397961|P1|First Week of Wear|Lost to Follow-up|0
5615383|NCT00799409|19397978|P3|Overall Study|medication compliance|0
5615384|NCT00799409|19397979|P2|Overall Study|medication compliance|0
5615385|NCT00799409|19397980|P1|Overall Study|medication compliance|1
5615386|NCT00799409|19397978|P3|Overall Study|Did not attend lab school day 1|0
5615387|NCT00799409|19397979|P2|Overall Study|Did not attend lab school day 1|0
5615388|NCT00799409|19397980|P1|Overall Study|Did not attend lab school day 1|1
5615389|NCT00799409|19397978|P3|Overall Study|Failure to follow study protocol)|0
5615390|NCT00799409|19397979|P2|Overall Study|Failure to follow study protocol)|0
5615391|NCT00799409|19397980|P1|Overall Study|Failure to follow study protocol)|1
5615392|NCT00799409|19397978|P3|Overall Study|Optimal Dose Not Achieved|0
5615393|NCT00799409|19397979|P2|Overall Study|Optimal Dose Not Achieved|0
5615394|NCT00799409|19397980|P1|Overall Study|Optimal Dose Not Achieved|2
5615395|NCT00799409|19397978|P3|Overall Study|Lost to Follow-up|0
5615396|NCT00799409|19397979|P2|Overall Study|Lost to Follow-up|0
5615397|NCT00799409|19397980|P1|Overall Study|Lost to Follow-up|1
5615398|NCT00799409|19397978|P3|Overall Study|Withdrawal by Subject|0
5615399|NCT00799409|19397979|P2|Overall Study|Withdrawal by Subject|0
5615400|NCT00799409|19397980|P1|Overall Study|Withdrawal by Subject|1
5615401|NCT00799396|19398060|P1|Clopidogrel Plus Aspirin|Physician Decision|4
5615402|NCT00799396|19398060|P1|Clopidogrel Plus Aspirin|Adverse Event|2
5615403|NCT00799396|19398060|P1|Clopidogrel Treatment|Withdrawal by Subject|2
5615404|NCT00799396|19398060|P1|Clopidogrel Treatment|Physician Decision|5
5615405|NCT00799396|19398060|P1|Clopidogrel Treatment|Adverse Event|6
5615406|NCT00799383|19398067|P2|Overall Study|Withdrawal by Subject|1
5615407|NCT00799383|19398068|P1|Overall Study|Withdrawal by Subject|0
5615408|NCT00799383|19398067|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
5615409|NCT00799383|19398068|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
5615410|NCT00799383|19398067|P2|Overall Study|Lost to Follow-up|2
5615411|NCT00799383|19398068|P1|Overall Study|Lost to Follow-up|1
5615412|NCT00799383|19398067|P2|Overall Study|Adverse Event|1
5615413|NCT00799383|19398068|P1|Overall Study|Adverse Event|0
5615414|NCT00799383|19398067|P2|Overall Study|Protocol Violation|1
5615415|NCT00799383|19398068|P1|Overall Study|Protocol Violation|1
5615416|NCT00799266|19398097|P2|Overall Study|Subject withdrew consent|0
5615417|NCT00799266|19398098|P1|Overall Study|Subject withdrew consent|3
5615418|NCT00799266|19398097|P2|Overall Study|Adverse Event|1
5615419|NCT00799266|19398098|P1|Overall Study|Adverse Event|0
5615420|NCT00798967|19398138|P2|Overall Study|Randomized in error by site|0
5615421|NCT00798967|19398139|P1|Overall Study|Randomized in error by site|1
5615422|NCT00798967|19398138|P2|Overall Study|Physician Decision|0
5615423|NCT00798967|19398139|P1|Overall Study|Physician Decision|1
5615424|NCT00798967|19398138|P2|Overall Study|Withdrawal by Subject|1
5615425|NCT00798967|19398139|P1|Overall Study|Withdrawal by Subject|0
5615426|NCT00798967|19398138|P2|Overall Study|Adverse Event|3
5615427|NCT00798967|19398139|P1|Overall Study|Adverse Event|2
5615428|NCT00798889|19398147|P1|Overall Study|Enrolled, Not treated|3
5615429|NCT00798889|19398147|P1|Overall Study|Decision of Sponsor|11
5615430|NCT00798889|19398147|P1|Overall Study|Lack of Efficacy|213
5615431|NCT00798889|19398147|P1|Overall Study|Lost to Follow-up|1
5615432|NCT00798889|19398147|P1|Overall Study|Withdrawal by Subject|31
5615433|NCT00798889|19398147|P1|Overall Study|Protocol Violation|2
5615434|NCT00798889|19398147|P1|Overall Study|Adverse Event|53
5615435|NCT00798759|19398153|P2|Overall Study|Other|1
5615436|NCT00798759|19398154|P1|Overall Study|Other|0
5615437|NCT00798759|19398153|P2|Overall Study|Protocol Violation|8
5615438|NCT00798759|19398154|P1|Overall Study|Protocol Violation|4
5615439|NCT00798759|19398153|P2|Overall Study|Lost to Follow-up|1
5615440|NCT00798759|19398154|P1|Overall Study|Lost to Follow-up|1
5615441|NCT00798759|19398153|P2|Overall Study|Adverse Event|3
5615442|NCT00798759|19398154|P1|Overall Study|Adverse Event|3
5615443|NCT00798707|19398172|P3|Overall Study|Randomized not treated|1
5615444|NCT00798707|19398173|P2|Overall Study|Randomized not treated|5
5615445|NCT00798707|19398174|P1|Overall Study|Randomized not treated|4
5615446|NCT00798707|19398172|P3|Overall Study|Withdrawal by Subject|2
5615447|NCT00798707|19398173|P2|Overall Study|Withdrawal by Subject|8
5615448|NCT00798707|19398174|P1|Overall Study|Withdrawal by Subject|3
5615449|NCT00798707|19398172|P3|Overall Study|Protocol Violation|2
5615450|NCT00798707|19398173|P2|Overall Study|Protocol Violation|0
5615451|NCT00798707|19398174|P1|Overall Study|Protocol Violation|4
5615452|NCT00798707|19398172|P3|Overall Study|Other|0
5615453|NCT00798707|19398173|P2|Overall Study|Other|1
5615454|NCT00798707|19398174|P1|Overall Study|Other|0
5615455|NCT00798707|19398172|P3|Overall Study|Lost to Follow-up|6
5615456|NCT00798707|19398173|P2|Overall Study|Lost to Follow-up|6
5615457|NCT00798707|19398174|P1|Overall Study|Lost to Follow-up|5
5615458|NCT00798707|19398172|P3|Overall Study|Lack of Efficacy|1
5615459|NCT00798707|19398173|P2|Overall Study|Lack of Efficacy|2
5615460|NCT00798707|19398174|P1|Overall Study|Lack of Efficacy|2
5615461|NCT00798707|19398172|P3|Overall Study|Investigator|2
5615462|NCT00798707|19398173|P2|Overall Study|Investigator|1
5615463|NCT00798707|19398174|P1|Overall Study|Investigator|0
5615464|NCT00798707|19398172|P3|Overall Study|Failed to return|0
5615465|NCT00798707|19398173|P2|Overall Study|Failed to return|2
5615466|NCT00798707|19398174|P1|Overall Study|Failed to return|2
5615467|NCT00798707|19398172|P3|Overall Study|Adverse Event|8
5615468|NCT00798707|19398173|P2|Overall Study|Adverse Event|8
5615469|NCT00798707|19398174|P1|Overall Study|Adverse Event|6
5615470|NCT00798694|19398226|P2|Overall Study|Physician Decision|0
5615471|NCT00798694|19398227|P1|Overall Study|Physician Decision|1
5615472|NCT00798694|19398226|P2|Overall Study|Lost to Follow-up|1
5615473|NCT00798694|19398227|P1|Overall Study|Lost to Follow-up|1
5615474|NCT00798655|19398251|P1|Overall Study|Did not receive at least one dose of pan|2
5615475|NCT00798603|19398256|P1|Overall Study|Lack of insurance coverage|1
5615476|NCT00798603|19398256|P1|Overall Study|Physician Decision|1
5615477|NCT00798603|19398256|P1|Overall Study|Adverse Event|22
5615478|NCT00798603|19398256|P1|Overall Study|Withdrawal by Subject|10
5615479|NCT00798603|19398256|P1|Overall Study|Still on treatment as of 11/6/2012|1
5615480|NCT00798590|19398278|P2|Overall Study|P.I, Left institution. Study terminated|8
5615481|NCT00798590|19398279|P1|Overall Study|P.I, Left institution. Study terminated|11
5615482|NCT00798434|19398313|P2|Open-Label|Not Treated|1
5615483|NCT00798434|19398314|P1|Open-Label|Not Treated|0
5615484|NCT00798434|19398313|P2|Open-Label|Other|2
5615485|NCT00798434|19398314|P1|Open-Label|Other|1
5615486|NCT00798434|19398313|P2|Open-Label|Protocol Violation|0
5615487|NCT00798434|19398314|P1|Open-Label|Protocol Violation|1
5615488|NCT00798434|19398313|P2|Open-Label|Withdrawal by Subject|7
5615489|NCT00798434|19398314|P1|Open-Label|Withdrawal by Subject|2
5615490|NCT00798434|19398313|P2|Open-Label|Lack of Efficacy|11
5615491|NCT00798434|19398314|P1|Open-Label|Lack of Efficacy|5
5615492|NCT00798434|19398313|P2|Open-Label|Adverse Event|11
5615493|NCT00798434|19398314|P1|Open-Label|Adverse Event|33
5615494|NCT00798434|19398313|P2|Double-Blind|Not Treated|6
5615495|NCT00798434|19398314|P1|Double-Blind|Not Treated|3
5615496|NCT00798434|19398313|P2|Double-Blind|Other|0
5615497|NCT00798434|19398314|P1|Double-Blind|Other|1
5615498|NCT00798434|19398313|P2|Double-Blind|Did Not Meet Entrance Criteria|1
5615499|NCT00798434|19398314|P1|Double-Blind|Did Not Meet Entrance Criteria|2
5615500|NCT00798434|19398313|P2|Double-Blind|Protocol Violation|4
5615501|NCT00798434|19398314|P1|Double-Blind|Protocol Violation|1
5615502|NCT00798434|19398313|P2|Double-Blind|Withdrawal by Subject|14
5615503|NCT00798434|19398314|P1|Double-Blind|Withdrawal by Subject|17
5615504|NCT00798434|19398313|P2|Double-Blind|Lack of Efficacy|12
5615505|NCT00798434|19398314|P1|Double-Blind|Lack of Efficacy|8
5615506|NCT00798434|19398313|P2|Double-Blind|Lost to Follow-up|0
5615507|NCT00798434|19398314|P1|Double-Blind|Lost to Follow-up|1
5615508|NCT00798434|19398313|P2|Double-Blind|Death|1
5615509|NCT00798434|19398314|P1|Double-Blind|Death|0
5615510|NCT00798434|19398313|P2|Double-Blind|Adverse Event|46
5615511|NCT00798434|19398314|P1|Double-Blind|Adverse Event|22
5615512|NCT00798369|19398400|P6|Overall Study|Adminstrative problems|1
5615513|NCT00798369|19398401|P5|Overall Study|Adminstrative problems|0
5615514|NCT00798369|19398402|P4|Overall Study|Adminstrative problems|0
5615515|NCT00798369|19398403|P3|Overall Study|Adminstrative problems|0
5615516|NCT00798369|19398404|P2|Overall Study|Adminstrative problems|0
5615517|NCT00798369|19398405|P1|Overall Study|Adminstrative problems|0
5615518|NCT00798369|19398400|P6|Overall Study|Lost to Follow-up|0
5615519|NCT00798369|19398401|P5|Overall Study|Lost to Follow-up|1
5615520|NCT00798369|19398402|P4|Overall Study|Lost to Follow-up|0
5615521|NCT00798369|19398403|P3|Overall Study|Lost to Follow-up|1
5615522|NCT00798369|19398404|P2|Overall Study|Lost to Follow-up|1
5615523|NCT00798369|19398405|P1|Overall Study|Lost to Follow-up|1
5615524|NCT00798369|19398400|P6|Overall Study|Subject withdrew consent|2
5615525|NCT00798369|19398401|P5|Overall Study|Subject withdrew consent|0
5615526|NCT00798369|19398402|P4|Overall Study|Subject withdrew consent|1
5615527|NCT00798369|19398403|P3|Overall Study|Subject withdrew consent|1
5615528|NCT00798369|19398404|P2|Overall Study|Subject withdrew consent|0
5615529|NCT00798369|19398405|P1|Overall Study|Subject withdrew consent|0
5615530|NCT00798317|19398452|P2|Overall Study|Death|0
5615531|NCT00798317|19398453|P1|Overall Study|Death|1
5615532|NCT00798317|19398452|P2|Overall Study|Adverse Event|0
5615533|NCT00798317|19398453|P1|Overall Study|Adverse Event|2
5615534|NCT00798317|19398452|P2|Overall Study|Lost to Follow-up|2
5615535|NCT00798317|19398453|P1|Overall Study|Lost to Follow-up|2
5615536|NCT00798317|19398452|P2|Overall Study|Withdrawal by Subject|4
5615537|NCT00798317|19398453|P1|Overall Study|Withdrawal by Subject|5
5615538|NCT00798317|19398452|P2|Overall Study|Physician Decision|1
5615539|NCT00798317|19398453|P1|Overall Study|Physician Decision|0
5615540|NCT00798304|19398464|P3|Overall Study|Discontinuation by Sponsor|9
5615541|NCT00798304|19398465|P2|Overall Study|Discontinuation by Sponsor|21
5615542|NCT00798304|19398466|P1|Overall Study|Discontinuation by Sponsor|14
5615543|NCT00798304|19398464|P3|Overall Study|Adverse Event|1
5615544|NCT00798304|19398465|P2|Overall Study|Adverse Event|1
5615545|NCT00798304|19398466|P1|Overall Study|Adverse Event|0
5615546|NCT00798174|19398492|P2|Overall Study|Inability to sedate for DFT testing|0
5615547|NCT00798174|19398493|P1|Overall Study|Inability to sedate for DFT testing|1
5615548|NCT00798174|19398492|P2|Overall Study|inability to implant azygos coil|3
5615549|NCT00798174|19398493|P1|Overall Study|inability to implant azygos coil|3
5615550|NCT00798161|19398504|P7|Overall Study|Other reason (incl. lack of efficacy)|5
5615551|NCT00798161|19398505|P6|Overall Study|Other reason (incl. lack of efficacy)|4
5615552|NCT00798161|19398506|P5|Overall Study|Other reason (incl. lack of efficacy)|2
5615553|NCT00798161|19398507|P4|Overall Study|Other reason (incl. lack of efficacy)|5
5615554|NCT00798161|19398508|P3|Overall Study|Other reason (incl. lack of efficacy)|3
5615555|NCT00798161|19398509|P2|Overall Study|Other reason (incl. lack of efficacy)|5
5615556|NCT00798161|19398510|P1|Overall Study|Other reason (incl. lack of efficacy)|7
5615557|NCT00798161|19398504|P7|Overall Study|Withdrawal by Subject|1
5615558|NCT00798161|19398505|P6|Overall Study|Withdrawal by Subject|3
5615559|NCT00798161|19398506|P5|Overall Study|Withdrawal by Subject|2
5615560|NCT00798161|19398507|P4|Overall Study|Withdrawal by Subject|4
5615561|NCT00798161|19398508|P3|Overall Study|Withdrawal by Subject|5
5615562|NCT00798161|19398509|P2|Overall Study|Withdrawal by Subject|4
5615563|NCT00798161|19398510|P1|Overall Study|Withdrawal by Subject|5
5615564|NCT00798161|19398504|P7|Overall Study|Lost to Follow-up|0
5615565|NCT00798161|19398505|P6|Overall Study|Lost to Follow-up|0
5615566|NCT00798161|19398506|P5|Overall Study|Lost to Follow-up|4
5615567|NCT00798161|19398507|P4|Overall Study|Lost to Follow-up|3
5615568|NCT00798161|19398508|P3|Overall Study|Lost to Follow-up|4
5615569|NCT00798161|19398509|P2|Overall Study|Lost to Follow-up|3
5615570|NCT00798161|19398510|P1|Overall Study|Lost to Follow-up|1
5615571|NCT00798161|19398504|P7|Overall Study|Protocol Violation|0
5615572|NCT00798161|19398505|P6|Overall Study|Protocol Violation|2
5615573|NCT00798161|19398506|P5|Overall Study|Protocol Violation|3
5615574|NCT00798161|19398507|P4|Overall Study|Protocol Violation|3
5615575|NCT00798161|19398508|P3|Overall Study|Protocol Violation|3
5615576|NCT00798161|19398509|P2|Overall Study|Protocol Violation|1
5615577|NCT00798161|19398510|P1|Overall Study|Protocol Violation|2
5615578|NCT00798161|19398504|P7|Overall Study|Adverse Event|4
5615579|NCT00798161|19398505|P6|Overall Study|Adverse Event|2
5615580|NCT00798161|19398506|P5|Overall Study|Adverse Event|5
5615581|NCT00798161|19398507|P4|Overall Study|Adverse Event|6
5615582|NCT00798161|19398508|P3|Overall Study|Adverse Event|6
5615583|NCT00798161|19398509|P2|Overall Study|Adverse Event|4
5615584|NCT00798161|19398510|P1|Overall Study|Adverse Event|3
5615585|NCT00798135|19398617|P1|Overall Study|Physician Decision|1
5615586|NCT00798135|19398617|P1|Overall Study|Disease progression, refractory|1
5615587|NCT00798135|19398617|P1|Overall Study|Disease progression, relapse|11
5615588|NCT00798096|19398623|P1|Overall Study|Ongoing|2
5615589|NCT00797966|19398651|P6|Phase A+|Protocol deviation|4
5615590|NCT00797966|19398652|P5|Phase A+|Protocol deviation|0
5615591|NCT00797966|19398653|P4|Phase A+|Protocol deviation|0
5615592|NCT00797966|19398654|P3|Phase A+|Protocol deviation|0
5615593|NCT00797966|19398655|P2|Phase A+|Protocol deviation|0
5615594|NCT00797966|19398656|P1|Phase A+|Protocol deviation|0
5615595|NCT00797966|19398651|P6|Phase A+|Adverse Event|4
5615596|NCT00797966|19398652|P5|Phase A+|Adverse Event|0
5615597|NCT00797966|19398653|P4|Phase A+|Adverse Event|0
5615598|NCT00797966|19398654|P3|Phase A+|Adverse Event|0
5615599|NCT00797966|19398655|P2|Phase A+|Adverse Event|0
5615600|NCT00797966|19398656|P1|Phase A+|Adverse Event|0
5615601|NCT00797966|19398651|P6|Phase A+|Withdrawal by Subject|6
5615602|NCT00797966|19398652|P5|Phase A+|Withdrawal by Subject|0
5615603|NCT00797966|19398653|P4|Phase A+|Withdrawal by Subject|0
5615604|NCT00797966|19398654|P3|Phase A+|Withdrawal by Subject|0
5615605|NCT00797966|19398655|P2|Phase A+|Withdrawal by Subject|0
5615606|NCT00797966|19398656|P1|Phase A+|Withdrawal by Subject|0
5615607|NCT00797966|19398651|P6|Phase A+|Met withdrawal criteria|5
5615608|NCT00797966|19398652|P5|Phase A+|Met withdrawal criteria|0
5615609|NCT00797966|19398653|P4|Phase A+|Met withdrawal criteria|0
5615610|NCT00797966|19398654|P3|Phase A+|Met withdrawal criteria|0
5615611|NCT00797966|19398655|P2|Phase A+|Met withdrawal criteria|0
5615612|NCT00797966|19398656|P1|Phase A+|Met withdrawal criteria|0
5615613|NCT00797966|19398651|P6|Phase A+|Lost to Follow-up|9
5615614|NCT00797966|19398652|P5|Phase A+|Lost to Follow-up|0
5615615|NCT00797966|19398653|P4|Phase A+|Lost to Follow-up|0
5615616|NCT00797966|19398654|P3|Phase A+|Lost to Follow-up|0
5615617|NCT00797966|19398655|P2|Phase A+|Lost to Follow-up|0
5615618|NCT00797966|19398656|P1|Phase A+|Lost to Follow-up|0
5615619|NCT00797966|19398651|P6|Phase B|Lack of Efficacy|0
5615620|NCT00797966|19398652|P5|Phase B|Lack of Efficacy|0
5615621|NCT00797966|19398653|P4|Phase B|Lack of Efficacy|4
5615622|NCT00797966|19398654|P3|Phase B|Lack of Efficacy|1
5615623|NCT00797966|19398655|P2|Phase B|Lack of Efficacy|1
5615624|NCT00797966|19398656|P1|Phase B|Lack of Efficacy|0
5615625|NCT00797966|19398651|P6|Phase B|Protocol Deviation|0
5615626|NCT00797966|19398652|P5|Phase B|Protocol Deviation|0
5615627|NCT00797966|19398653|P4|Phase B|Protocol Deviation|6
5615628|NCT00797966|19398654|P3|Phase B|Protocol Deviation|2
5615629|NCT00797966|19398655|P2|Phase B|Protocol Deviation|8
5615630|NCT00797966|19398656|P1|Phase B|Protocol Deviation|4
5615631|NCT00797966|19398651|P6|Phase B|Withdrawal by Subject|0
5615632|NCT00797966|19398652|P5|Phase B|Withdrawal by Subject|0
5615633|NCT00797966|19398653|P4|Phase B|Withdrawal by Subject|3
5615634|NCT00797966|19398654|P3|Phase B|Withdrawal by Subject|3
5615635|NCT00797966|19398655|P2|Phase B|Withdrawal by Subject|4
5615636|NCT00797966|19398656|P1|Phase B|Withdrawal by Subject|1
5615637|NCT00797966|19398651|P6|Phase B|Physician Decision|0
5615638|NCT00797966|19398652|P5|Phase B|Physician Decision|0
5615639|NCT00797966|19398653|P4|Phase B|Physician Decision|1
5615640|NCT00797966|19398654|P3|Phase B|Physician Decision|3
5615641|NCT00797966|19398655|P2|Phase B|Physician Decision|0
5615642|NCT00797966|19398656|P1|Phase B|Physician Decision|1
5615643|NCT00797966|19398651|P6|Phase B|Met Withdrawal Criteria|0
5615644|NCT00797966|19398652|P5|Phase B|Met Withdrawal Criteria|0
5615645|NCT00797966|19398653|P4|Phase B|Met Withdrawal Criteria|1
5615646|NCT00797966|19398654|P3|Phase B|Met Withdrawal Criteria|6
5615647|NCT00797966|19398655|P2|Phase B|Met Withdrawal Criteria|3
5615648|NCT00797966|19398656|P1|Phase B|Met Withdrawal Criteria|3
5615649|NCT00797966|19398651|P6|Phase B|Adverse Event|0
5615650|NCT00797966|19398652|P5|Phase B|Adverse Event|0
5615651|NCT00797966|19398653|P4|Phase B|Adverse Event|1
5615652|NCT00797966|19398654|P3|Phase B|Adverse Event|3
5615653|NCT00797966|19398655|P2|Phase B|Adverse Event|1
5615654|NCT00797966|19398656|P1|Phase B|Adverse Event|2
5615655|NCT00797966|19398651|P6|Phase B|Lost to Follow-up|0
5615656|NCT00797966|19398652|P5|Phase B|Lost to Follow-up|0
5615657|NCT00797966|19398653|P4|Phase B|Lost to Follow-up|0
5615658|NCT00797966|19398654|P3|Phase B|Lost to Follow-up|3
5615659|NCT00797966|19398655|P2|Phase B|Lost to Follow-up|1
5615660|NCT00797966|19398656|P1|Phase B|Lost to Follow-up|0
5615661|NCT00797966|19398651|P6|Phase A|Protocol deviation|0
5615662|NCT00797966|19398652|P5|Phase A|Protocol deviation|56
5615663|NCT00797966|19398653|P4|Phase A|Protocol deviation|0
5615664|NCT00797966|19398654|P3|Phase A|Protocol deviation|0
5615665|NCT00797966|19398655|P2|Phase A|Protocol deviation|0
5615666|NCT00797966|19398656|P1|Phase A|Protocol deviation|0
5615667|NCT00797966|19398651|P6|Phase A|Withdrawal by Subject|0
5615668|NCT00797966|19398652|P5|Phase A|Withdrawal by Subject|33
5615669|NCT00797966|19398653|P4|Phase A|Withdrawal by Subject|0
5615670|NCT00797966|19398654|P3|Phase A|Withdrawal by Subject|0
5615671|NCT00797966|19398655|P2|Phase A|Withdrawal by Subject|0
5615672|NCT00797966|19398656|P1|Phase A|Withdrawal by Subject|0
5615673|NCT00797966|19398651|P6|Phase A|Physician Decision|0
5615674|NCT00797966|19398652|P5|Phase A|Physician Decision|13
5615675|NCT00797966|19398653|P4|Phase A|Physician Decision|0
5615676|NCT00797966|19398654|P3|Phase A|Physician Decision|0
5615677|NCT00797966|19398655|P2|Phase A|Physician Decision|0
5615678|NCT00797966|19398656|P1|Phase A|Physician Decision|0
5615679|NCT00797966|19398651|P6|Phase A|Met withdrawal criteria|0
5615680|NCT00797966|19398652|P5|Phase A|Met withdrawal criteria|4
5615681|NCT00797966|19398653|P4|Phase A|Met withdrawal criteria|0
5615682|NCT00797966|19398654|P3|Phase A|Met withdrawal criteria|0
5615683|NCT00797966|19398655|P2|Phase A|Met withdrawal criteria|0
5615684|NCT00797966|19398656|P1|Phase A|Met withdrawal criteria|0
5615685|NCT00797966|19398651|P6|Phase A|Adverse Event|0
5615686|NCT00797966|19398652|P5|Phase A|Adverse Event|46
5615687|NCT00797966|19398653|P4|Phase A|Adverse Event|0
5615688|NCT00797966|19398654|P3|Phase A|Adverse Event|0
5615689|NCT00797966|19398655|P2|Phase A|Adverse Event|0
5615690|NCT00797966|19398656|P1|Phase A|Adverse Event|0
5615691|NCT00797966|19398651|P6|Phase A|Lost to Follow-up|0
5615692|NCT00797966|19398652|P5|Phase A|Lost to Follow-up|33
5615693|NCT00797966|19398653|P4|Phase A|Lost to Follow-up|0
5615694|NCT00797966|19398654|P3|Phase A|Lost to Follow-up|0
5615695|NCT00797966|19398655|P2|Phase A|Lost to Follow-up|0
5615696|NCT00797966|19398656|P1|Phase A|Lost to Follow-up|0
5615697|NCT00797862|19398721|P3|Overall Study|Mis-randomized|1
5615698|NCT00797862|19398722|P2|Overall Study|Mis-randomized|3
5615699|NCT00797862|19398723|P1|Overall Study|Mis-randomized|3
5615700|NCT00797862|19398721|P3|Overall Study|Protocol Violation|8
5615701|NCT00797862|19398722|P2|Overall Study|Protocol Violation|6
5615702|NCT00797862|19398723|P1|Overall Study|Protocol Violation|4
5615703|NCT00797862|19398721|P3|Overall Study|Administrative Problem|0
5615704|NCT00797862|19398722|P2|Overall Study|Administrative Problem|0
5615705|NCT00797862|19398723|P1|Overall Study|Administrative Problem|4
5615706|NCT00797862|19398721|P3|Overall Study|Lost to Follow-up|5
5615707|NCT00797862|19398722|P2|Overall Study|Lost to Follow-up|0
5615708|NCT00797862|19398723|P1|Overall Study|Lost to Follow-up|11
5615709|NCT00797862|19398721|P3|Overall Study|Withdrawal by Subject|7
5615710|NCT00797862|19398722|P2|Overall Study|Withdrawal by Subject|7
5615711|NCT00797862|19398723|P1|Overall Study|Withdrawal by Subject|14
5615712|NCT00797862|19398721|P3|Overall Study|No longer required study medication|0
5615713|NCT00797862|19398722|P2|Overall Study|No longer required study medication|0
5615714|NCT00797862|19398723|P1|Overall Study|No longer required study medication|1
5615715|NCT00797862|19398721|P3|Overall Study|Lack of Efficacy|6
5615716|NCT00797862|19398722|P2|Overall Study|Lack of Efficacy|7
5615717|NCT00797862|19398723|P1|Overall Study|Lack of Efficacy|1
5615718|NCT00797862|19398721|P3|Overall Study|Abnormal Test Procedure Result|1
5615719|NCT00797862|19398722|P2|Overall Study|Abnormal Test Procedure Result|1
5615720|NCT00797862|19398723|P1|Overall Study|Abnormal Test Procedure Result|0
5615721|NCT00797862|19398721|P3|Overall Study|Adverse Event|58
5615722|NCT00797862|19398722|P2|Overall Study|Adverse Event|44
5615723|NCT00797862|19398723|P1|Overall Study|Adverse Event|86
5615724|NCT00797823|19398752|P3|First Period (Initial Randomization)|Physician Decision|0
5615725|NCT00797823|19398753|P2|First Period (Initial Randomization)|Physician Decision|0
5615726|NCT00797823|19398754|P1|First Period (Initial Randomization)|Physician Decision|1
5615727|NCT00797732|19398776|P3|Overall Study|Refused to Participate|123
5615728|NCT00797732|19398777|P2|Overall Study|Refused to Participate|0
5615729|NCT00797732|19398778|P1|Overall Study|Refused to Participate|0
5615730|NCT00797732|19398776|P3|Overall Study|Excluded due to time constraints|24
5615731|NCT00797732|19398777|P2|Overall Study|Excluded due to time constraints|0
5615732|NCT00797732|19398778|P1|Overall Study|Excluded due to time constraints|0
5615733|NCT00797732|19398776|P3|Overall Study|Not meet inclusion criteria|7
5615734|NCT00797732|19398777|P2|Overall Study|Not meet inclusion criteria|0
5615735|NCT00797732|19398778|P1|Overall Study|Not meet inclusion criteria|0
5615736|NCT00797732|19398776|P3|Overall Study|Death|0
5615737|NCT00797732|19398777|P2|Overall Study|Death|0
5615738|NCT00797732|19398778|P1|Overall Study|Death|1
5615739|NCT00797732|19398776|P3|Overall Study|Lost to Follow-up|0
5615740|NCT00797732|19398777|P2|Overall Study|Lost to Follow-up|0
5615741|NCT00797732|19398778|P1|Overall Study|Lost to Follow-up|1
5615742|NCT00797732|19398776|P3|Overall Study|Withdrawal by Subject|0
5615743|NCT00797732|19398777|P2|Overall Study|Withdrawal by Subject|3
5615744|NCT00797732|19398778|P1|Overall Study|Withdrawal by Subject|3
5615745|NCT00797667|19398793|P3|Overall Study|Adverse Event|8
5615746|NCT00797667|19398794|P2|Overall Study|Adverse Event|8
5615747|NCT00797667|19398795|P1|Overall Study|Adverse Event|19
5615748|NCT00797667|19398793|P3|Overall Study|Withdrawal by Subject|2
5615749|NCT00797667|19398794|P2|Overall Study|Withdrawal by Subject|14
5615750|NCT00797667|19398795|P1|Overall Study|Withdrawal by Subject|9
5615751|NCT00797667|19398793|P3|Overall Study|Study Terminated by Sponsor|115
5615752|NCT00797667|19398794|P2|Overall Study|Study Terminated by Sponsor|216
5615753|NCT00797667|19398795|P1|Overall Study|Study Terminated by Sponsor|217
5615754|NCT00797667|19398793|P3|Overall Study|Protocol Violation|0
5615755|NCT00797667|19398794|P2|Overall Study|Protocol Violation|7
5615756|NCT00797667|19398795|P1|Overall Study|Protocol Violation|2
5615757|NCT00797667|19398793|P3|Overall Study|Pregnancy|0
5615758|NCT00797667|19398794|P2|Overall Study|Pregnancy|0
5615759|NCT00797667|19398795|P1|Overall Study|Pregnancy|2
5615760|NCT00797667|19398793|P3|Overall Study|Physician Decision|0
5615761|NCT00797667|19398794|P2|Overall Study|Physician Decision|1
5615762|NCT00797667|19398795|P1|Overall Study|Physician Decision|3
5615763|NCT00797667|19398793|P3|Overall Study|Lost to Follow-up|2
5615764|NCT00797667|19398794|P2|Overall Study|Lost to Follow-up|12
5615765|NCT00797667|19398795|P1|Overall Study|Lost to Follow-up|8
5615766|NCT00797667|19398793|P3|Overall Study|Lack of Efficacy|0
5615767|NCT00797667|19398794|P2|Overall Study|Lack of Efficacy|1
5615768|NCT00797667|19398795|P1|Overall Study|Lack of Efficacy|0
5615769|NCT00797563|19398821|P1|Overall Study|Adverse Event|1
5615770|NCT00797511|19398827|P1|Overall Study|Withdrawal by Subject|1
5615771|NCT00797316|19398845|P2|Overall Study|Unsatisfactory therapeutic effect|13
5615772|NCT00797316|19398846|P1|Overall Study|Unsatisfactory therapeutic effect|0
5615773|NCT00797316|19398845|P2|Overall Study|Patient withdrew consent|6
5615774|NCT00797316|19398846|P1|Overall Study|Patient withdrew consent|12
5615775|NCT00797316|19398845|P2|Overall Study|Protocol Deviation|2
5615776|NCT00797316|19398846|P1|Overall Study|Protocol Deviation|1
5615777|NCT00797316|19398845|P2|Overall Study|Lost to Follow-up|8
5615778|NCT00797316|19398846|P1|Overall Study|Lost to Follow-up|4
5615779|NCT00797316|19398845|P2|Overall Study|Adverse Event|3
5615780|NCT00797316|19398846|P1|Overall Study|Adverse Event|5
5615781|NCT00797316|19398845|P2|Overall Study|Administrative problems|0
5615782|NCT00797316|19398846|P1|Overall Study|Administrative problems|1
5615783|NCT00797225|19398875|P8|Weeks 13 to 24|Sponsor Decision|0
5615784|NCT00797225|19398876|P7|Weeks 13 to 24|Sponsor Decision|1
5615785|NCT00797225|19398877|P6|Weeks 13 to 24|Sponsor Decision|0
5615786|NCT00797225|19398878|P5|Weeks 13 to 24|Sponsor Decision|0
5615787|NCT00797225|19398879|P4|Weeks 13 to 24|Sponsor Decision|0
5615788|NCT00797225|19398880|P3|Weeks 13 to 24|Sponsor Decision|0
5615789|NCT00797225|19398881|P2|Weeks 13 to 24|Sponsor Decision|0
5615790|NCT00797225|19398882|P1|Weeks 13 to 24|Sponsor Decision|0
5615791|NCT00797225|19398875|P8|Weeks 13 to 24|Adverse Event|0
5615792|NCT00797225|19398876|P7|Weeks 13 to 24|Adverse Event|1
5615793|NCT00797225|19398877|P6|Weeks 13 to 24|Adverse Event|0
5615794|NCT00797225|19398878|P5|Weeks 13 to 24|Adverse Event|0
5615795|NCT00797225|19398879|P4|Weeks 13 to 24|Adverse Event|0
5615796|NCT00797225|19398880|P3|Weeks 13 to 24|Adverse Event|0
5615797|NCT00797225|19398881|P2|Weeks 13 to 24|Adverse Event|1
5615798|NCT00797225|19398882|P1|Weeks 13 to 24|Adverse Event|0
5615799|NCT00797225|19398875|P8|Weeks 13 to 24|Lost to Follow-up|0
5615800|NCT00797225|19398876|P7|Weeks 13 to 24|Lost to Follow-up|0
5615801|NCT00797225|19398877|P6|Weeks 13 to 24|Lost to Follow-up|0
5615802|NCT00797225|19398878|P5|Weeks 13 to 24|Lost to Follow-up|1
5615803|NCT00797225|19398879|P4|Weeks 13 to 24|Lost to Follow-up|0
5615804|NCT00797225|19398880|P3|Weeks 13 to 24|Lost to Follow-up|1
5615805|NCT00797225|19398881|P2|Weeks 13 to 24|Lost to Follow-up|0
5615806|NCT00797225|19398882|P1|Weeks 13 to 24|Lost to Follow-up|0
5615807|NCT00797225|19398875|P8|Weeks 13 to 24|Withdrawal by Subject|0
5615808|NCT00797225|19398876|P7|Weeks 13 to 24|Withdrawal by Subject|0
5615809|NCT00797225|19398877|P6|Weeks 13 to 24|Withdrawal by Subject|0
5615810|NCT00797225|19398878|P5|Weeks 13 to 24|Withdrawal by Subject|0
5615811|NCT00797225|19398879|P4|Weeks 13 to 24|Withdrawal by Subject|0
5615812|NCT00797225|19398880|P3|Weeks 13 to 24|Withdrawal by Subject|1
5615813|NCT00797225|19398881|P2|Weeks 13 to 24|Withdrawal by Subject|1
5615814|NCT00797225|19398882|P1|Weeks 13 to 24|Withdrawal by Subject|0
5615815|NCT00797225|19398875|P8|Weeks 13 to 24|Non-compliance|0
5615816|NCT00797225|19398876|P7|Weeks 13 to 24|Non-compliance|0
5615817|NCT00797225|19398877|P6|Weeks 13 to 24|Non-compliance|0
5615818|NCT00797225|19398878|P5|Weeks 13 to 24|Non-compliance|0
5615819|NCT00797225|19398879|P4|Weeks 13 to 24|Non-compliance|0
5615820|NCT00797225|19398880|P3|Weeks 13 to 24|Non-compliance|0
5615821|NCT00797225|19398881|P2|Weeks 13 to 24|Non-compliance|2
5615822|NCT00797225|19398882|P1|Weeks 13 to 24|Non-compliance|0
5615823|NCT00797225|19398875|P8|Weeks 1 to 12|Sponsor Decision|0
5615824|NCT00797225|19398876|P7|Weeks 1 to 12|Sponsor Decision|0
5615825|NCT00797225|19398877|P6|Weeks 1 to 12|Sponsor Decision|0
5615826|NCT00797225|19398878|P5|Weeks 1 to 12|Sponsor Decision|0
5615827|NCT00797225|19398879|P4|Weeks 1 to 12|Sponsor Decision|0
5615828|NCT00797225|19398880|P3|Weeks 1 to 12|Sponsor Decision|0
5615829|NCT00797225|19398881|P2|Weeks 1 to 12|Sponsor Decision|0
5615830|NCT00797225|19398882|P1|Weeks 1 to 12|Sponsor Decision|1
5615831|NCT00797225|19398875|P8|Weeks 1 to 12|Lack of Efficacy|0
5615832|NCT00797225|19398876|P7|Weeks 1 to 12|Lack of Efficacy|0
5615833|NCT00797225|19398877|P6|Weeks 1 to 12|Lack of Efficacy|0
5615834|NCT00797225|19398878|P5|Weeks 1 to 12|Lack of Efficacy|0
5615835|NCT00797225|19398879|P4|Weeks 1 to 12|Lack of Efficacy|0
5615836|NCT00797225|19398880|P3|Weeks 1 to 12|Lack of Efficacy|0
5615837|NCT00797225|19398881|P2|Weeks 1 to 12|Lack of Efficacy|0
5615838|NCT00797225|19398882|P1|Weeks 1 to 12|Lack of Efficacy|1
5615839|NCT00797225|19398875|P8|Weeks 1 to 12|Non-compliance|0
5615840|NCT00797225|19398876|P7|Weeks 1 to 12|Non-compliance|0
5615841|NCT00797225|19398877|P6|Weeks 1 to 12|Non-compliance|0
5615842|NCT00797225|19398878|P5|Weeks 1 to 12|Non-compliance|0
5615843|NCT00797225|19398879|P4|Weeks 1 to 12|Non-compliance|0
5615844|NCT00797225|19398880|P3|Weeks 1 to 12|Non-compliance|0
5615845|NCT00797225|19398881|P2|Weeks 1 to 12|Non-compliance|1
5615846|NCT00797225|19398882|P1|Weeks 1 to 12|Non-compliance|0
5615847|NCT00797225|19398875|P8|Weeks 1 to 12|Adverse Event|0
5615848|NCT00797225|19398876|P7|Weeks 1 to 12|Adverse Event|0
5615849|NCT00797225|19398877|P6|Weeks 1 to 12|Adverse Event|0
5615850|NCT00797225|19398878|P5|Weeks 1 to 12|Adverse Event|0
5615851|NCT00797225|19398879|P4|Weeks 1 to 12|Adverse Event|0
5615852|NCT00797225|19398880|P3|Weeks 1 to 12|Adverse Event|1
5615853|NCT00797225|19398881|P2|Weeks 1 to 12|Adverse Event|0
5615854|NCT00797225|19398882|P1|Weeks 1 to 12|Adverse Event|0
5615855|NCT00797108|19398999|P3|Overall Study|Randomized but not Treated|0
5615856|NCT00797108|19399000|P2|Overall Study|Randomized but not Treated|0
5615857|NCT00797108|19399001|P1|Overall Study|Randomized but not Treated|2
5615858|NCT00797108|19398999|P3|Overall Study|Other|2
5615859|NCT00797108|19399000|P2|Overall Study|Other|0
5615860|NCT00797108|19399001|P1|Overall Study|Other|0
5615861|NCT00797108|19398999|P3|Overall Study|Lack of Efficacy|1
5615862|NCT00797108|19399000|P2|Overall Study|Lack of Efficacy|0
5615863|NCT00797108|19399001|P1|Overall Study|Lack of Efficacy|1
5615864|NCT00797108|19398999|P3|Overall Study|Global Deterioration of Health Status|0
5615865|NCT00797108|19399000|P2|Overall Study|Global Deterioration of Health Status|1
5615866|NCT00797108|19399001|P1|Overall Study|Global Deterioration of Health Status|0
5615867|NCT00797108|19398999|P3|Overall Study|Did Not Meet Entrance Criteria|0
5615868|NCT00797108|19399000|P2|Overall Study|Did Not Meet Entrance Criteria|1
5615869|NCT00797108|19399001|P1|Overall Study|Did Not Meet Entrance Criteria|0
5615870|NCT00797108|19398999|P3|Overall Study|Adverse Event|3
5615871|NCT00797108|19399000|P2|Overall Study|Adverse Event|0
5615872|NCT00797108|19399001|P1|Overall Study|Adverse Event|1
5615873|NCT00796991|19399036|P3|Overall Study|Withdrawal by Subject|1
5615874|NCT00796991|19399037|P2|Overall Study|Withdrawal by Subject|0
5615875|NCT00796991|19399038|P1|Overall Study|Withdrawal by Subject|0
5615876|NCT00796991|19399036|P3|Overall Study|Study Drug Toxicity|5
5615877|NCT00796991|19399037|P2|Overall Study|Study Drug Toxicity|3
5615878|NCT00796991|19399038|P1|Overall Study|Study Drug Toxicity|3
5615879|NCT00796991|19399036|P3|Overall Study|Disease Progression|7
5615880|NCT00796991|19399037|P2|Overall Study|Disease Progression|9
5615881|NCT00796991|19399038|P1|Overall Study|Disease Progression|10
5615882|NCT00796991|19399036|P3|Overall Study|Death|0
5615883|NCT00796991|19399037|P2|Overall Study|Death|0
5615884|NCT00796991|19399038|P1|Overall Study|Death|2
5615885|NCT00796991|19399036|P3|Overall Study|Adverse Event|1
5615886|NCT00796991|19399037|P2|Overall Study|Adverse Event|0
5615887|NCT00796991|19399038|P1|Overall Study|Adverse Event|0
5615888|NCT00796978|19399136|P1|Overall Study|Withdrawal by Subject|3
5615889|NCT00796978|19399136|P1|Overall Study|Adverse Event|4
5615890|NCT00796978|19399136|P1|Overall Study|Cardiac adverse event|5
5615891|NCT00796861|19399162|P1|Overall Study|Death|2
5615892|NCT00796861|19399162|P1|Overall Study|Withdrawal by Subject|2
5615893|NCT00796822|19399168|P2|Overall Study|Adverse Event|0
5615894|NCT00796822|19399169|P1|Overall Study|Adverse Event|1
5615895|NCT00796822|19399168|P2|Overall Study|Lost to Follow-up|0
5615896|NCT00796822|19399169|P1|Overall Study|Lost to Follow-up|2
5615897|NCT00796757|19399177|P1|Overall Study|Other|7
5615898|NCT00796757|19399177|P1|Overall Study|Investigator's decision|2
5615899|NCT00796757|19399177|P1|Overall Study|Participant noncompliance|1
5615900|NCT00796757|19399177|P1|Overall Study|Protocol Violation|1
5615901|NCT00796757|19399177|P1|Overall Study|Death|61
5615902|NCT00796757|19399177|P1|Overall Study|Withdrawal by Subject|14
5615903|NCT00796718|19399211|P1|Overall Study|Withdrawal by Informed Consent|1
5615904|NCT00796718|19399211|P1|Overall Study|Lost to Follow-up|5
5615905|NCT00796718|19399211|P1|Overall Study|Exclusion Criteria|1
5615906|NCT00796718|19399211|P1|Overall Study|Adverse Event|2
5615907|NCT00796666|19399263|P2|Overall Study|Randomized and not treated|0
5615908|NCT00796666|19399264|P1|Overall Study|Randomized and not treated|1
5615909|NCT00796666|19399263|P2|Overall Study|Terminated by sponsor|55
5615910|NCT00796666|19399264|P1|Overall Study|Terminated by sponsor|53
5615911|NCT00796666|19399263|P2|Overall Study|Other|0
5615912|NCT00796666|19399264|P1|Overall Study|Other|1
5615913|NCT00796666|19399263|P2|Overall Study|Protocol Violation|0
5615914|NCT00796666|19399264|P1|Overall Study|Protocol Violation|1
5615915|NCT00796666|19399263|P2|Overall Study|Adverse Event|5
5615916|NCT00796666|19399264|P1|Overall Study|Adverse Event|7
5615917|NCT00796666|19399263|P2|Overall Study|Withdrawal by Subject|0
5615918|NCT00796666|19399264|P1|Overall Study|Withdrawal by Subject|2
5615919|NCT00796666|19399263|P2|Overall Study|Death|4
5615920|NCT00796666|19399264|P1|Overall Study|Death|2
5615921|NCT00796653|19399298|P4|Overall Study|Other reason not described above|4
5615922|NCT00796653|19399299|P3|Overall Study|Other reason not described above|7
5615923|NCT00796653|19399300|P2|Overall Study|Other reason not described above|9
5615924|NCT00796653|19399301|P1|Overall Study|Other reason not described above|4
5615925|NCT00796653|19399298|P4|Overall Study|Non compliance with protocol|2
5615926|NCT00796653|19399299|P3|Overall Study|Non compliance with protocol|0
5615927|NCT00796653|19399300|P2|Overall Study|Non compliance with protocol|2
5615928|NCT00796653|19399301|P1|Overall Study|Non compliance with protocol|2
5615929|NCT00796653|19399298|P4|Overall Study|Lack of Efficacy|2
5615930|NCT00796653|19399299|P3|Overall Study|Lack of Efficacy|3
5615931|NCT00796653|19399300|P2|Overall Study|Lack of Efficacy|1
5615932|NCT00796653|19399301|P1|Overall Study|Lack of Efficacy|8
5615933|NCT00796653|19399298|P4|Overall Study|Withdrawal by Subject|13
5615934|NCT00796653|19399299|P3|Overall Study|Withdrawal by Subject|8
5615935|NCT00796653|19399300|P2|Overall Study|Withdrawal by Subject|8
5615936|NCT00796653|19399301|P1|Overall Study|Withdrawal by Subject|16
5615937|NCT00796653|19399298|P4|Overall Study|Lost to Follow-up|3
5615938|NCT00796653|19399299|P3|Overall Study|Lost to Follow-up|2
5615939|NCT00796653|19399300|P2|Overall Study|Lost to Follow-up|1
5615940|NCT00796653|19399301|P1|Overall Study|Lost to Follow-up|2
5615941|NCT00796653|19399298|P4|Overall Study|Adverse Event|16
5615942|NCT00796653|19399299|P3|Overall Study|Adverse Event|16
5615943|NCT00796653|19399300|P2|Overall Study|Adverse Event|16
5615944|NCT00796653|19399301|P1|Overall Study|Adverse Event|19
5615945|NCT00796614|19399586|P4|Overall Study|Other than stated|0
5615946|NCT00796614|19399587|P3|Overall Study|Other than stated|0
5615947|NCT00796614|19399588|P2|Overall Study|Other than stated|0
5615948|NCT00796614|19399589|P1|Overall Study|Other than stated|1
5615949|NCT00796614|19399586|P4|Overall Study|Withdrawal by Subject|1
5615950|NCT00796614|19399587|P3|Overall Study|Withdrawal by Subject|0
5615951|NCT00796614|19399588|P2|Overall Study|Withdrawal by Subject|0
5615952|NCT00796614|19399589|P1|Overall Study|Withdrawal by Subject|1
5615953|NCT00796614|19399586|P4|Overall Study|Lost to Follow-up|0
5615954|NCT00796614|19399587|P3|Overall Study|Lost to Follow-up|1
5615955|NCT00796614|19399588|P2|Overall Study|Lost to Follow-up|2
5615956|NCT00796614|19399589|P1|Overall Study|Lost to Follow-up|2
5615957|NCT00796614|19399586|P4|Overall Study|Protocol Violation|0
5615958|NCT00796614|19399587|P3|Overall Study|Protocol Violation|2
5615959|NCT00796614|19399588|P2|Overall Study|Protocol Violation|0
5615960|NCT00796614|19399589|P1|Overall Study|Protocol Violation|0
5615961|NCT00796614|19399586|P4|Overall Study|Adverse Event|0
5615962|NCT00796614|19399587|P3|Overall Study|Adverse Event|0
5615963|NCT00796614|19399588|P2|Overall Study|Adverse Event|2
5615964|NCT00796614|19399589|P1|Overall Study|Adverse Event|1
5615965|NCT00796562|19399631|P1|Overall Study|Death|49
5615966|NCT00796549|19399640|P1|Overall Study|Progressive disease|56
5615967|NCT00796549|19399640|P1|Overall Study|Other|2
5615968|NCT00796549|19399640|P1|Overall Study|not entered|149
5615969|NCT00796549|19399640|P1|Overall Study|Adverse Event|11
5615970|NCT00796523|19399657|P2|Overall Study|Lost to Follow-up|7
5615971|NCT00796523|19399658|P1|Overall Study|Lost to Follow-up|9
5615972|NCT00796510|19399668|P2|Overall Study|Study Terminated|0
5615973|NCT00796510|19399669|P1|Overall Study|Study Terminated|2
5615974|NCT00796510|19399668|P2|Overall Study|Death|0
5615975|NCT00796510|19399669|P1|Overall Study|Death|1
5615976|NCT00796445|19399681|P2|Overall Study|Withdrawal by Subject|9
5615977|NCT00796445|19399682|P1|Overall Study|Withdrawal by Subject|18
5615978|NCT00796445|19399681|P2|Overall Study|Other|7
5615979|NCT00796445|19399682|P1|Overall Study|Other|10
5615980|NCT00796445|19399681|P2|Overall Study|Disease progression/recurrence|268
5615981|NCT00796445|19399682|P1|Overall Study|Disease progression/recurrence|537
5615982|NCT00796445|19399681|P2|Overall Study|Adverse event, non-fatal|0
5615983|NCT00796445|19399682|P1|Overall Study|Adverse event, non-fatal|4
5615984|NCT00796445|19399681|P2|Overall Study|Adverse event, serious fatal|5
5615985|NCT00796445|19399682|P1|Overall Study|Adverse event, serious fatal|10
5615986|NCT00796445|19399681|P2|Overall Study|Protocol Violation|3
5615987|NCT00796445|19399682|P1|Overall Study|Protocol Violation|5
5615988|NCT00796419|19399734|P2|Overall Study|Death|1
5615989|NCT00796419|19399735|P1|Overall Study|Death|0
5615990|NCT00796367|19399748|P3|Overall Study|other|3
5615991|NCT00796367|19399749|P2|Overall Study|other|4
5615992|NCT00796367|19399750|P1|Overall Study|other|2
5615993|NCT00796367|19399748|P3|Overall Study|Requirement for restricted medication|2
5615994|NCT00796367|19399749|P2|Overall Study|Requirement for restricted medication|0
5615995|NCT00796367|19399750|P1|Overall Study|Requirement for restricted medication|2
5615996|NCT00796367|19399748|P3|Overall Study|Pregnancy|1
5615997|NCT00796367|19399749|P2|Overall Study|Pregnancy|0
5615998|NCT00796367|19399750|P1|Overall Study|Pregnancy|1
5615999|NCT00796367|19399748|P3|Overall Study|non compliance|1
5616000|NCT00796367|19399749|P2|Overall Study|non compliance|1
5616001|NCT00796367|19399750|P1|Overall Study|non compliance|3
5616002|NCT00796367|19399748|P3|Overall Study|Lack of Efficacy|0
5616003|NCT00796367|19399749|P2|Overall Study|Lack of Efficacy|1
5616004|NCT00796367|19399750|P1|Overall Study|Lack of Efficacy|2
5616005|NCT00796367|19399748|P3|Overall Study|Withdrawal by Subject|12
5616006|NCT00796367|19399749|P2|Overall Study|Withdrawal by Subject|11
5616007|NCT00796367|19399750|P1|Overall Study|Withdrawal by Subject|9
5616008|NCT00796367|19399748|P3|Overall Study|Lost to Follow-up|21
5616009|NCT00796367|19399749|P2|Overall Study|Lost to Follow-up|4
5616010|NCT00796367|19399750|P1|Overall Study|Lost to Follow-up|5
5616011|NCT00796367|19399748|P3|Overall Study|Adverse Event|7
5616012|NCT00796367|19399749|P2|Overall Study|Adverse Event|4
5616013|NCT00796367|19399750|P1|Overall Study|Adverse Event|6
5616014|NCT00796328|19399761|P1|Overall Study|experienced hypotension requiring tx|6
5616015|NCT00796315|19399765|P3|Overall Study|Protocol Violation|0
5616016|NCT00796315|19399766|P2|Overall Study|Protocol Violation|1
5616017|NCT00796315|19399767|P1|Overall Study|Protocol Violation|0
5616018|NCT00796224|19399795|P2|Overall Study|Protocol Violation|1
5616019|NCT00796224|19399796|P1|Overall Study|Protocol Violation|0
5616020|NCT00796224|19399795|P2|Overall Study|Adverse Event|0
5616021|NCT00796224|19399796|P1|Overall Study|Adverse Event|1
5616022|NCT00796120|19399816|P2|Overall Study|Randomized but not treated|3
5616023|NCT00796120|19399817|P1|Overall Study|Randomized but not treated|0
5616024|NCT00796120|19399816|P2|Overall Study|Physician Decision|17
5616025|NCT00796120|19399817|P1|Overall Study|Physician Decision|16
5616026|NCT00796120|19399816|P2|Overall Study|Other|17
5616027|NCT00796120|19399817|P1|Overall Study|Other|6
5616028|NCT00796120|19399816|P2|Overall Study|Participant refusal|4
5616029|NCT00796120|19399817|P1|Overall Study|Participant refusal|3
5616030|NCT00796120|19399816|P2|Overall Study|Progressive disease|13
5616031|NCT00796120|19399817|P1|Overall Study|Progressive disease|22
5616032|NCT00796120|19399816|P2|Overall Study|Adverse Event|6
5616033|NCT00796120|19399817|P1|Overall Study|Adverse Event|11
5616034|NCT00796120|19399816|P2|Overall Study|Death|0
5616035|NCT00796120|19399817|P1|Overall Study|Death|3
5616036|NCT00796107|19399831|P1|Overall Study|Progressive Disease|5
5616037|NCT00796107|19399831|P1|Overall Study|Lack of Efficacy|1
5616038|NCT00796003|19399840|P2|Overall Study|Participants Not treated|2
5616039|NCT00796003|19399841|P1|Overall Study|Participants Not treated|0
5616040|NCT00796003|19399840|P2|Overall Study|Other|1
5616041|NCT00796003|19399841|P1|Overall Study|Other|0
5616042|NCT00796003|19399840|P2|Overall Study|Withdrawal by Subject|1
5616043|NCT00796003|19399841|P1|Overall Study|Withdrawal by Subject|0
5616044|NCT00796003|19399840|P2|Overall Study|Physician Decision|4
5616045|NCT00796003|19399841|P1|Overall Study|Physician Decision|0
5616046|NCT00796003|19399840|P2|Overall Study|Specified organ function not met|1
5616047|NCT00796003|19399841|P1|Overall Study|Specified organ function not met|0
5616048|NCT00796003|19399840|P2|Overall Study|Adverse Event|7
5616049|NCT00796003|19399841|P1|Overall Study|Adverse Event|1
5616050|NCT00796003|19399840|P2|Overall Study|Disease Progression|13
5616051|NCT00796003|19399841|P1|Overall Study|Disease Progression|2
5616052|NCT00795951|19399862|P1|Overall Study|Withdrawal by Subject|1
5616053|NCT00795951|19399862|P1|Overall Study|Lost to Follow-up|1
5616054|NCT00795886|19399955|P1|Overall Study|Death|10
5616055|NCT00795821|19399963|P2|Taper Phase|Withdrawal by Subject|0
5616056|NCT00795821|19399964|P1|Taper Phase|Withdrawal by Subject|4
5616057|NCT00795821|19399963|P2|Taper Phase|Physician Decision|0
5616058|NCT00795821|19399964|P1|Taper Phase|Physician Decision|2
5616059|NCT00795821|19399963|P2|Taper Phase|Lost to Follow-up|0
5616060|NCT00795821|19399964|P1|Taper Phase|Lost to Follow-up|1
5616061|NCT00795821|19399963|P2|Taper Phase|Adverse Event|0
5616062|NCT00795821|19399964|P1|Taper Phase|Adverse Event|2
5616063|NCT00795821|19399963|P2|Long-term Extension Phase|Withdrawal by Subject|25
5616064|NCT00795821|19399964|P1|Long-term Extension Phase|Withdrawal by Subject|25
5616065|NCT00795821|19399963|P2|Long-term Extension Phase|Protocol Violation|5
5616066|NCT00795821|19399964|P1|Long-term Extension Phase|Protocol Violation|3
5616067|NCT00795821|19399963|P2|Long-term Extension Phase|Physician Decision|2
5616068|NCT00795821|19399964|P1|Long-term Extension Phase|Physician Decision|1
5616069|NCT00795821|19399963|P2|Long-term Extension Phase|Lost to Follow-up|16
5616070|NCT00795821|19399964|P1|Long-term Extension Phase|Lost to Follow-up|20
5616071|NCT00795821|19399963|P2|Long-term Extension Phase|Lack of Efficacy|12
5616072|NCT00795821|19399964|P1|Long-term Extension Phase|Lack of Efficacy|16
5616073|NCT00795821|19399963|P2|Long-term Extension Phase|Adverse Event|32
5616074|NCT00795821|19399964|P1|Long-term Extension Phase|Adverse Event|25
5616075|NCT00795821|19399963|P2|Acute Treatment Phase|Withdrawal by Subject|10
5616076|NCT00795821|19399964|P1|Acute Treatment Phase|Withdrawal by Subject|16
5616077|NCT00795821|19399963|P2|Acute Treatment Phase|Protocol Violation|2
5616078|NCT00795821|19399964|P1|Acute Treatment Phase|Protocol Violation|1
5616079|NCT00795821|19399963|P2|Acute Treatment Phase|Physician Decision|1
5616080|NCT00795821|19399964|P1|Acute Treatment Phase|Physician Decision|1
5616081|NCT00795821|19399963|P2|Acute Treatment Phase|Lost to Follow-up|12
5616082|NCT00795821|19399964|P1|Acute Treatment Phase|Lost to Follow-up|9
5616083|NCT00795821|19399963|P2|Acute Treatment Phase|Lack of Efficacy|2
5616084|NCT00795821|19399964|P1|Acute Treatment Phase|Lack of Efficacy|5
5616085|NCT00795821|19399963|P2|Acute Treatment Phase|Death|0
5616086|NCT00795821|19399964|P1|Acute Treatment Phase|Death|1
5616087|NCT00795821|19399963|P2|Acute Treatment Phase|Adverse Event|4
5616088|NCT00795821|19399964|P1|Acute Treatment Phase|Adverse Event|23
5616089|NCT00795717|19400039|P2|Phase II|too busy|1
5616090|NCT00795717|19400040|P1|Phase II|too busy|0
5616091|NCT00795717|19400039|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
5616092|NCT00795717|19400040|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
5616093|NCT00795717|19400039|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
5616094|NCT00795717|19400040|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
5616095|NCT00795717|19400039|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
5616096|NCT00795717|19400040|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
5616097|NCT00795704|19400052|P2|Overall Study|Adverse Event|1
5616098|NCT00795704|19400053|P1|Overall Study|Adverse Event|1
5616099|NCT00795704|19400052|P2|Overall Study|Withdrawal by Subject|2
5616100|NCT00795704|19400053|P1|Overall Study|Withdrawal by Subject|3
5616101|NCT00795639|19400073|P2|Overall Study|Randomized and not treated|1
5616102|NCT00795639|19400074|P1|Overall Study|Randomized and not treated|0
5616103|NCT00795639|19400073|P2|Overall Study|Terminated by sponsor|12
5616104|NCT00795639|19400074|P1|Overall Study|Terminated by sponsor|13
5616105|NCT00795639|19400073|P2|Overall Study|Other|2
5616106|NCT00795639|19400074|P1|Overall Study|Other|0
5616107|NCT00795639|19400073|P2|Overall Study|Adverse Event|2
5616108|NCT00795639|19400074|P1|Overall Study|Adverse Event|5
5616109|NCT00795639|19400073|P2|Overall Study|Pregnancy|0
5616110|NCT00795639|19400074|P1|Overall Study|Pregnancy|1
5616111|NCT00795639|19400073|P2|Overall Study|Withdrawal by Subject|3
5616112|NCT00795639|19400074|P1|Overall Study|Withdrawal by Subject|1
5616113|NCT00795639|19400073|P2|Overall Study|Death|6
5616114|NCT00795639|19400074|P1|Overall Study|Death|1
5616115|NCT00795600|19400086|P2|Overall Study|Unclassified|1
5616116|NCT00795600|19400087|P1|Overall Study|Unclassified|1
5616117|NCT00795600|19400086|P2|Overall Study|Withdrawal by Subject|0
5616118|NCT00795600|19400087|P1|Overall Study|Withdrawal by Subject|1
5616119|NCT00795600|19400086|P2|Overall Study|Protocol Violation|2
5616120|NCT00795600|19400087|P1|Overall Study|Protocol Violation|1
5616121|NCT00795600|19400086|P2|Overall Study|Adverse Event|1
5616122|NCT00795600|19400087|P1|Overall Study|Adverse Event|1
5616123|NCT00795535|19400207|P1|Overall Study|incomplete data and technical problems|20
5616124|NCT00795509|19400214|P1|Overall Study|Protocol Violation|31
5616125|NCT00795184|19400283|P2|Overall Study|Tissue sampling incomplete/conclusive|13
5616126|NCT00795184|19400284|P1|Overall Study|Tissue sampling incomplete/conclusive|8
5616127|NCT00795132|19400345|P1|Overall Study|Relapse|2
5616128|NCT00795132|19400345|P1|Overall Study|Death|1
5616129|NCT00794963|19400372|P2|Overall Study|Withdrawal by Subject|4
5616130|NCT00794963|19400373|P1|Overall Study|Withdrawal by Subject|1
5616131|NCT00794950|19400379|P1|Beginning Sunitinib Treatment|Lost to Follow-up|1
5616132|NCT00794950|19400379|P1|Beginning Sunitinib Treatment|Withdrawal by Subject|1
5616133|NCT00794950|19400379|P1|Beginning Sunitinib Treatment|Physician Decision|5
5616134|NCT00794950|19400379|P1|Beginning Sunitinib Treatment|cystectomy|5
5616135|NCT00794950|19400379|P1|BCG Induction|Adverse Event|1
5616136|NCT00794950|19400379|P1|BCG Induction|noncompliant w. BCG|1
5616137|NCT00794950|19400379|P1|BCG Induction|ineligible|3
5616138|NCT00794950|19400379|P1|BCG Induction|Withdrawal by Subject|2
5616139|NCT00794924|19400388|P2|Overall Study|Adverse Event|2
5616140|NCT00794924|19400389|P1|Overall Study|Adverse Event|6
5616141|NCT00794924|19400388|P2|Overall Study|Withdrawal by Subject|60
5616142|NCT00794924|19400389|P1|Overall Study|Withdrawal by Subject|48
5616143|NCT00794924|19400388|P2|Overall Study|Lost to Follow-up|8
5616144|NCT00794924|19400389|P1|Overall Study|Lost to Follow-up|6
5616145|NCT00794820|19400393|P1|Overall Study|Ineligible/Screen Failure|1
5616146|NCT00794820|19400393|P1|Overall Study|Resistant Disease|2
5616147|NCT00794820|19400393|P1|Overall Study|Secondary Malignancies|2
5616148|NCT00794820|19400393|P1|Overall Study|Adverse Event|11
5616149|NCT00794677|19400401|P2|First Intervention|Withdrawal by Subject|0
5616150|NCT00794677|19400402|P1|First Intervention|Withdrawal by Subject|2
5616151|NCT00794664|19400424|P2|Follow-up Period|Protocol non-compliance|1
5616152|NCT00794664|19400425|P1|Follow-up Period|Protocol non-compliance|0
5616153|NCT00794664|19400424|P2|Follow-up Period|Withdrawal by Subject|2
5616154|NCT00794664|19400425|P1|Follow-up Period|Withdrawal by Subject|0
5616155|NCT00794664|19400424|P2|Follow-up Period|Other|2
5616156|NCT00794664|19400425|P1|Follow-up Period|Other|1
5616157|NCT00794664|19400424|P2|Treatment Period|Adverse Event|8
5616158|NCT00794664|19400425|P1|Treatment Period|Adverse Event|1
5616159|NCT00794664|19400424|P2|Treatment Period|Other|1
5616160|NCT00794664|19400425|P1|Treatment Period|Other|0
5616161|NCT00794664|19400424|P2|Treatment Period|Protocol non-compliance|1
5616162|NCT00794664|19400425|P1|Treatment Period|Protocol non-compliance|0
5616163|NCT00794664|19400424|P2|Treatment Period|Withdrawal by Subject|2
5616164|NCT00794664|19400425|P1|Treatment Period|Withdrawal by Subject|0
5616165|NCT00794573|19400471|P2|Overall Study|Lost to Follow-up|33
5616166|NCT00794573|19400472|P1|Overall Study|Lost to Follow-up|26
5616167|NCT00794573|19400471|P2|Overall Study|Withdrawal by Subject|12
5616168|NCT00794573|19400472|P1|Overall Study|Withdrawal by Subject|9
5616169|NCT00794573|19400471|P2|Overall Study|Death|0
5616170|NCT00794573|19400472|P1|Overall Study|Death|3
5616171|NCT00794417|19400545|P4|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13
5616172|NCT00794417|19400546|P3|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
5616173|NCT00794417|19400547|P2|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
5616174|NCT00794417|19400548|P1|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
5616175|NCT00794417|19400545|P4|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4
5616176|NCT00794417|19400546|P3|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
5616177|NCT00794417|19400547|P2|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
5616178|NCT00794417|19400548|P1|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
5616179|NCT00794417|19400545|P4|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11
5616180|NCT00794417|19400546|P3|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
5616181|NCT00794417|19400547|P2|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
5616182|NCT00794417|19400548|P1|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
5616183|NCT00794417|19400545|P4|Phase 2: Baseline (Day 421) to Day 972|Death|7
5616184|NCT00794417|19400546|P3|Phase 2: Baseline (Day 421) to Day 972|Death|0
5616185|NCT00794417|19400547|P2|Phase 2: Baseline (Day 421) to Day 972|Death|0
5616186|NCT00794417|19400548|P1|Phase 2: Baseline (Day 421) to Day 972|Death|0
5616187|NCT00794417|19400545|P4|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0
5616188|NCT00794417|19400546|P3|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1
5616189|NCT00794417|19400547|P2|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
5616190|NCT00794417|19400548|P1|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
5616191|NCT00794417|19400545|P4|Phase 1: Baseline (Day 1) up to Day 751|Death|0
5616192|NCT00794417|19400546|P3|Phase 1: Baseline (Day 1) up to Day 751|Death|2
5616193|NCT00794417|19400547|P2|Phase 1: Baseline (Day 1) up to Day 751|Death|0
5616194|NCT00794417|19400548|P1|Phase 1: Baseline (Day 1) up to Day 751|Death|0
5616195|NCT00794365|19400601|P1|Overall Study|Lack of Efficacy|3
5616196|NCT00794365|19400601|P1|Overall Study|Adverse Event|10
5616197|NCT00794365|19400601|P1|Overall Study|Poor Compliance|11
5616198|NCT00794365|19400601|P1|Overall Study|Other|17
5616199|NCT00794365|19400601|P1|Overall Study|Lost to Follow-up|38
5616200|NCT00794196|19400622|P2|Overall Study|Lost to Follow-up|23
5616201|NCT00794196|19400623|P1|Overall Study|Lost to Follow-up|5
5616202|NCT00794157|19400643|P3|Overall Study|Protocol deviation|1
5616203|NCT00794157|19400644|P2|Overall Study|Protocol deviation|1
5616204|NCT00794157|19400645|P1|Overall Study|Protocol deviation|0
5616205|NCT00794157|19400643|P3|Overall Study|Abnormal test procedure result(s)|0
5616206|NCT00794157|19400644|P2|Overall Study|Abnormal test procedure result(s)|1
5616207|NCT00794157|19400645|P1|Overall Study|Abnormal test procedure result(s)|0
5616208|NCT00794157|19400643|P3|Overall Study|Administrative problems|4
5616209|NCT00794157|19400644|P2|Overall Study|Administrative problems|7
5616210|NCT00794157|19400645|P1|Overall Study|Administrative problems|1
5616211|NCT00794157|19400643|P3|Overall Study|Unsatisfactory therapeutic effect|2
5616212|NCT00794157|19400644|P2|Overall Study|Unsatisfactory therapeutic effect|0
5616213|NCT00794157|19400645|P1|Overall Study|Unsatisfactory therapeutic effect|1
5616214|NCT00794157|19400643|P3|Overall Study|Lost to Follow-up|1
5616215|NCT00794157|19400644|P2|Overall Study|Lost to Follow-up|0
5616216|NCT00794157|19400645|P1|Overall Study|Lost to Follow-up|2
5616217|NCT00794157|19400643|P3|Overall Study|Subject withdrew consent|3
5616218|NCT00794157|19400644|P2|Overall Study|Subject withdrew consent|0
5616219|NCT00794157|19400645|P1|Overall Study|Subject withdrew consent|2
5616220|NCT00794157|19400643|P3|Overall Study|Adverse Event|8
5616221|NCT00794157|19400644|P2|Overall Study|Adverse Event|1
5616222|NCT00794157|19400645|P1|Overall Study|Adverse Event|4
5616223|NCT00794118|19400674|P1|Overall Study|Changed hospital center|2
5616224|NCT00794118|19400674|P1|Overall Study|Withdrawal by Subject|9
5616225|NCT00794118|19400674|P1|Overall Study|Lost to Follow-up|16
5616226|NCT00794040|19400734|P2|Overall Study|Physician Decision|1
5616227|NCT00794040|19400735|P1|Overall Study|Physician Decision|0
5616228|NCT00794040|19400734|P2|Overall Study|Withdrawal by Subject|4
5616229|NCT00794040|19400735|P1|Overall Study|Withdrawal by Subject|3
5616230|NCT00793910|19400751|P2|Overall Study|Withdrawal by Subject|1
5616231|NCT00793910|19400752|P1|Overall Study|Withdrawal by Subject|0
5616232|NCT00793910|19400751|P2|Overall Study|decided to undergo LASIK instead of PRK|1
5616233|NCT00793910|19400752|P1|Overall Study|decided to undergo LASIK instead of PRK|2
5616234|NCT00793910|19400751|P2|Overall Study|ineligible based on entry criteria|3
5616235|NCT00793910|19400752|P1|Overall Study|ineligible based on entry criteria|2
5616236|NCT00793910|19400751|P2|Overall Study|did not pick up medications|1
5616237|NCT00793910|19400752|P1|Overall Study|did not pick up medications|1
5616238|NCT00793910|19400751|P2|Overall Study|discarded study pills|1
5616239|NCT00793910|19400752|P1|Overall Study|discarded study pills|0
5616240|NCT00793871|19400766|P1|Overall Study|Study terminated by the Sponsor|7
5616241|NCT00793871|19400766|P1|Overall Study|Lost to Follow-up|3
5616242|NCT00793871|19400766|P1|Overall Study|Death|50
5616243|NCT00793819|19400780|P2|Overall Study|Lost to Follow-up|1
5616244|NCT00793819|19400781|P1|Overall Study|Lost to Follow-up|1
5616245|NCT00793819|19400780|P2|Overall Study|Withdrawal by Subject|3
5616246|NCT00793819|19400781|P1|Overall Study|Withdrawal by Subject|4
5616247|NCT00793819|19400780|P2|Overall Study|Lack of Efficacy|1
5616248|NCT00793819|19400781|P1|Overall Study|Lack of Efficacy|1
5616249|NCT00793819|19400780|P2|Overall Study|Adverse Event|4
5616250|NCT00793819|19400781|P1|Overall Study|Adverse Event|8
5616251|NCT00793793|19400799|P12|Overall Study|reason not specified|4
5616252|NCT00793793|19400800|P11|Overall Study|reason not specified|2
5616253|NCT00793793|19400801|P10|Overall Study|reason not specified|6
5616254|NCT00793793|19400802|P9|Overall Study|reason not specified|7
5616255|NCT00793793|19400803|P8|Overall Study|reason not specified|0
5616256|NCT00793793|19400804|P7|Overall Study|reason not specified|2
5616257|NCT00793793|19400805|P6|Overall Study|reason not specified|1
5616258|NCT00793793|19400806|P5|Overall Study|reason not specified|1
5616259|NCT00793793|19400807|P4|Overall Study|reason not specified|1
5616260|NCT00793793|19400808|P3|Overall Study|reason not specified|0
5616261|NCT00793793|19400809|P2|Overall Study|reason not specified|1
5616262|NCT00793793|19400810|P1|Overall Study|reason not specified|0
5616263|NCT00793793|19400799|P12|Overall Study|Withdrawal by Subject|0
5616264|NCT00793793|19400800|P11|Overall Study|Withdrawal by Subject|0
5616265|NCT00793793|19400801|P10|Overall Study|Withdrawal by Subject|0
5616266|NCT00793793|19400802|P9|Overall Study|Withdrawal by Subject|1
5616267|NCT00793793|19400803|P8|Overall Study|Withdrawal by Subject|0
5616268|NCT00793793|19400804|P7|Overall Study|Withdrawal by Subject|0
5616269|NCT00793793|19400805|P6|Overall Study|Withdrawal by Subject|0
5616270|NCT00793793|19400806|P5|Overall Study|Withdrawal by Subject|1
5616271|NCT00793793|19400807|P4|Overall Study|Withdrawal by Subject|0
5616272|NCT00793793|19400808|P3|Overall Study|Withdrawal by Subject|0
5616273|NCT00793793|19400809|P2|Overall Study|Withdrawal by Subject|0
5616274|NCT00793793|19400810|P1|Overall Study|Withdrawal by Subject|0
5616275|NCT00793793|19400799|P12|Overall Study|Lost to Follow-up|0
5616276|NCT00793793|19400800|P11|Overall Study|Lost to Follow-up|1
5616277|NCT00793793|19400801|P10|Overall Study|Lost to Follow-up|3
5616278|NCT00793793|19400802|P9|Overall Study|Lost to Follow-up|1
5616279|NCT00793793|19400803|P8|Overall Study|Lost to Follow-up|0
5616280|NCT00793793|19400804|P7|Overall Study|Lost to Follow-up|0
5616281|NCT00793793|19400805|P6|Overall Study|Lost to Follow-up|0
5616282|NCT00793793|19400806|P5|Overall Study|Lost to Follow-up|0
5616283|NCT00793793|19400807|P4|Overall Study|Lost to Follow-up|0
5616284|NCT00793793|19400808|P3|Overall Study|Lost to Follow-up|1
5616285|NCT00793793|19400809|P2|Overall Study|Lost to Follow-up|0
5616286|NCT00793793|19400810|P1|Overall Study|Lost to Follow-up|0
5616287|NCT00793793|19400799|P12|Overall Study|Protocol Violation|0
5616288|NCT00793793|19400800|P11|Overall Study|Protocol Violation|0
5616289|NCT00793793|19400801|P10|Overall Study|Protocol Violation|0
5616290|NCT00793793|19400802|P9|Overall Study|Protocol Violation|0
5616291|NCT00793793|19400803|P8|Overall Study|Protocol Violation|0
5616292|NCT00793793|19400804|P7|Overall Study|Protocol Violation|0
5616293|NCT00793793|19400805|P6|Overall Study|Protocol Violation|0
5616294|NCT00793793|19400806|P5|Overall Study|Protocol Violation|0
5616295|NCT00793793|19400807|P4|Overall Study|Protocol Violation|1
5616296|NCT00793793|19400808|P3|Overall Study|Protocol Violation|0
5616297|NCT00793793|19400809|P2|Overall Study|Protocol Violation|0
5616298|NCT00793793|19400810|P1|Overall Study|Protocol Violation|0
5616299|NCT00793793|19400799|P12|Overall Study|Adverse Event|2
5616300|NCT00793793|19400800|P11|Overall Study|Adverse Event|0
5616301|NCT00793793|19400801|P10|Overall Study|Adverse Event|0
5616302|NCT00793793|19400802|P9|Overall Study|Adverse Event|0
5616303|NCT00793793|19400803|P8|Overall Study|Adverse Event|0
5616304|NCT00793793|19400804|P7|Overall Study|Adverse Event|2
5616305|NCT00793793|19400805|P6|Overall Study|Adverse Event|1
5616306|NCT00793793|19400806|P5|Overall Study|Adverse Event|0
5616307|NCT00793793|19400807|P4|Overall Study|Adverse Event|1
5616308|NCT00793793|19400808|P3|Overall Study|Adverse Event|1
5616309|NCT00793793|19400809|P2|Overall Study|Adverse Event|0
5616310|NCT00793793|19400810|P1|Overall Study|Adverse Event|0
5616311|NCT00793780|19401185|P2|Overall Study|Withdrawal by Subject|1
5616312|NCT00793780|19401186|P1|Overall Study|Withdrawal by Subject|2
5616313|NCT00793624|19401217|P4|Overall Study|Other reason not described above|3
5616314|NCT00793624|19401218|P3|Overall Study|Other reason not described above|6
5616315|NCT00793624|19401219|P2|Overall Study|Other reason not described above|4
5616316|NCT00793624|19401220|P1|Overall Study|Other reason not described above|6
5616317|NCT00793624|19401217|P4|Overall Study|Non compliance with protocol|3
5616318|NCT00793624|19401218|P3|Overall Study|Non compliance with protocol|2
5616319|NCT00793624|19401219|P2|Overall Study|Non compliance with protocol|3
5616320|NCT00793624|19401220|P1|Overall Study|Non compliance with protocol|2
5616321|NCT00793624|19401217|P4|Overall Study|Lack of Efficacy|3
5616322|NCT00793624|19401218|P3|Overall Study|Lack of Efficacy|1
5616323|NCT00793624|19401219|P2|Overall Study|Lack of Efficacy|2
5616324|NCT00793624|19401220|P1|Overall Study|Lack of Efficacy|9
5616325|NCT00793624|19401217|P4|Overall Study|Withdrawal by Subject|14
5616326|NCT00793624|19401218|P3|Overall Study|Withdrawal by Subject|11
5616327|NCT00793624|19401219|P2|Overall Study|Withdrawal by Subject|9
5616328|NCT00793624|19401220|P1|Overall Study|Withdrawal by Subject|20
5616329|NCT00793624|19401217|P4|Overall Study|Lost to Follow-up|0
5616330|NCT00793624|19401218|P3|Overall Study|Lost to Follow-up|4
5616331|NCT00793624|19401219|P2|Overall Study|Lost to Follow-up|2
5616332|NCT00793624|19401220|P1|Overall Study|Lost to Follow-up|2
5616333|NCT00793624|19401217|P4|Overall Study|Adverse Event|20
5616334|NCT00793624|19401218|P3|Overall Study|Adverse Event|15
5616335|NCT00793624|19401219|P2|Overall Study|Adverse Event|16
5616336|NCT00793624|19401220|P1|Overall Study|Adverse Event|18
5616337|NCT00793585|19401501|P2|Overall Study|Protocol Violation|2
5616338|NCT00793585|19401502|P1|Overall Study|Protocol Violation|1
5616339|NCT00793585|19401501|P2|Overall Study|Adverse Event|1
5616340|NCT00793585|19401502|P1|Overall Study|Adverse Event|1
5616341|NCT00793546|19401521|P2|Overall Study|Other|0
5616342|NCT00793546|19401522|P1|Overall Study|Other|1
5616343|NCT00793546|19401521|P2|Overall Study|Study Terminated by Sponsor|27
5616344|NCT00793546|19401522|P1|Overall Study|Study Terminated by Sponsor|8
5616345|NCT00793546|19401521|P2|Overall Study|Withdrawal by Subject|1
5616346|NCT00793546|19401522|P1|Overall Study|Withdrawal by Subject|1
5616347|NCT00793546|19401521|P2|Overall Study|Lost to Follow-up|0
5616348|NCT00793546|19401522|P1|Overall Study|Lost to Follow-up|1
5616349|NCT00793546|19401521|P2|Overall Study|Death|0
5616350|NCT00793546|19401522|P1|Overall Study|Death|3
5616351|NCT00793403|19401572|P1|Overall Study|Other|73
5616352|NCT00793325|19401619|P1|Overall Study|Lost to Follow-up|1
5616353|NCT00793325|19401619|P1|Overall Study|Protocol Violation|18
5616354|NCT00793182|19401645|P2|Overall Study|Adverse Event|1
5616355|NCT00793182|19401646|P1|Overall Study|Adverse Event|0
5616356|NCT00793104|19401656|P1|Overall Study|Lost to Follow-up|1
5616357|NCT00792948|19401664|P1|Overall Study|Protocol Violation|1
5616358|NCT00792948|19401664|P1|Overall Study|Physician Decision|11
5616359|NCT00792948|19401664|P1|Overall Study|Insurance denial - not treated|1
5616360|NCT00792948|19401664|P1|Overall Study|Ineligible|2
5616361|NCT00792948|19401664|P1|Overall Study|Withdrawal by Subject|3
5616362|NCT00792948|19401664|P1|Overall Study|Death|4
5616363|NCT00792948|19401664|P1|Overall Study|Adverse Event|6
5616364|NCT00792935|19401675|P2|Overall Study|Withdrawal by Subject|1
5616365|NCT00792935|19401676|P1|Overall Study|Withdrawal by Subject|0
5616366|NCT00792935|19401675|P2|Overall Study|Protocol Violation|0
5616367|NCT00792935|19401676|P1|Overall Study|Protocol Violation|2
5616368|NCT00792935|19401675|P2|Overall Study|Lost to Follow-up|1
5616369|NCT00792935|19401676|P1|Overall Study|Lost to Follow-up|0
5616370|NCT00792935|19401675|P2|Overall Study|Adverse Event|1
5616371|NCT00792935|19401676|P1|Overall Study|Adverse Event|2
5616372|NCT00792909|19401708|P3|Overall Study|Withdrawal by Subject|0
5616373|NCT00792909|19401709|P2|Overall Study|Withdrawal by Subject|1
5616374|NCT00792909|19401710|P1|Overall Study|Withdrawal by Subject|0
5616375|NCT00792805|19401766|P3|Overall Study|Protocol deviation|1
5616376|NCT00792805|19401767|P2|Overall Study|Protocol deviation|1
5616377|NCT00792805|19401768|P1|Overall Study|Protocol deviation|0
5616378|NCT00792805|19401766|P3|Overall Study|Abnormal laboratory value(s)|1
5616379|NCT00792805|19401767|P2|Overall Study|Abnormal laboratory value(s)|0
5616380|NCT00792805|19401768|P1|Overall Study|Abnormal laboratory value(s)|0
5616381|NCT00792805|19401766|P3|Overall Study|Lost to Follow-up|6
5616382|NCT00792805|19401767|P2|Overall Study|Lost to Follow-up|1
5616383|NCT00792805|19401768|P1|Overall Study|Lost to Follow-up|1
5616384|NCT00792805|19401766|P3|Overall Study|Unsatisfactory therapeutic effect|6
5616385|NCT00792805|19401767|P2|Overall Study|Unsatisfactory therapeutic effect|6
5616386|NCT00792805|19401768|P1|Overall Study|Unsatisfactory therapeutic effect|1
5616387|NCT00792805|19401766|P3|Overall Study|Abnormal test procedure result(s)|0
5616388|NCT00792805|19401767|P2|Overall Study|Abnormal test procedure result(s)|2
5616389|NCT00792805|19401768|P1|Overall Study|Abnormal test procedure result(s)|1
5616390|NCT00792805|19401766|P3|Overall Study|Administrative problems|4
5616391|NCT00792805|19401767|P2|Overall Study|Administrative problems|0
5616392|NCT00792805|19401768|P1|Overall Study|Administrative problems|2
5616393|NCT00792805|19401766|P3|Overall Study|Subject withdrew consent|5
5616394|NCT00792805|19401767|P2|Overall Study|Subject withdrew consent|6
5616395|NCT00792805|19401768|P1|Overall Study|Subject withdrew consent|5
5616396|NCT00792805|19401766|P3|Overall Study|Adverse Event|10
5616397|NCT00792805|19401767|P2|Overall Study|Adverse Event|10
5616398|NCT00792805|19401768|P1|Overall Study|Adverse Event|12
5616399|NCT00792701|19401778|P2|Overall Study|Not protocol specified|0
5616400|NCT00792701|19401779|P1|Overall Study|Not protocol specified|17
5616401|NCT00792701|19401778|P2|Overall Study|Withdrawal by Subject|19
5616402|NCT00792701|19401779|P1|Overall Study|Withdrawal by Subject|1
5616403|NCT00792701|19401778|P2|Overall Study|Ineligible|3
5616404|NCT00792701|19401779|P1|Overall Study|Ineligible|1
5616405|NCT00792701|19401778|P2|Overall Study|Adverse Event|22
5616406|NCT00792701|19401779|P1|Overall Study|Adverse Event|0
5616407|NCT00792636|19401809|P3|Overall Study|Investigator Discretion|2
5616408|NCT00792636|19401810|P2|Overall Study|Investigator Discretion|0
5616409|NCT00792636|19401811|P1|Overall Study|Investigator Discretion|2
5616410|NCT00792636|19401809|P3|Overall Study|Adverse Event|3
5616411|NCT00792636|19401810|P2|Overall Study|Adverse Event|2
5616412|NCT00792636|19401811|P1|Overall Study|Adverse Event|4
5616413|NCT00792636|19401809|P3|Overall Study|Lack of Efficacy|13
5616414|NCT00792636|19401810|P2|Overall Study|Lack of Efficacy|4
5616415|NCT00792636|19401811|P1|Overall Study|Lack of Efficacy|3
5616416|NCT00792636|19401809|P3|Overall Study|Withdrew Consent|9
5616417|NCT00792636|19401810|P2|Overall Study|Withdrew Consent|13
5616418|NCT00792636|19401811|P1|Overall Study|Withdrew Consent|10
5616419|NCT00792636|19401809|P3|Overall Study|Lost to Follow-up|14
5616420|NCT00792636|19401810|P2|Overall Study|Lost to Follow-up|19
5616421|NCT00792636|19401811|P1|Overall Study|Lost to Follow-up|13
5616422|NCT00792636|19401809|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
5616423|NCT00792636|19401810|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
5616424|NCT00792636|19401811|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
5616425|NCT00792636|19401809|P3|Overall Study|Protocol Violation|20
5616426|NCT00792636|19401810|P2|Overall Study|Protocol Violation|23
5616427|NCT00792636|19401811|P1|Overall Study|Protocol Violation|17
5616428|NCT00792623|19401848|P1|Overall Study|Withdrawal by Subject|5
5616429|NCT00792623|19401848|P1|Overall Study|Adverse Event|2
5616430|NCT00792571|19401865|P1|Overall Study|Other|4
5616431|NCT00792571|19401865|P1|Overall Study|Withdrawal by Subject|1
5616432|NCT00792571|19401865|P1|Overall Study|Adverse Event|4
5616433|NCT00792571|19401865|P1|Overall Study|Death|1
5616434|NCT00792298|19401885|P8|Treatment Period 2|Withdrawal by Subject|2
5616435|NCT00792298|19401886|P7|Treatment Period 2|Withdrawal by Subject|0
5616436|NCT00792298|19401887|P6|Treatment Period 2|Withdrawal by Subject|0
5616437|NCT00792298|19401888|P5|Treatment Period 2|Withdrawal by Subject|1
5616438|NCT00792298|19401889|P4|Treatment Period 2|Withdrawal by Subject|2
5616439|NCT00792298|19401890|P3|Treatment Period 2|Withdrawal by Subject|0
5616440|NCT00792298|19401891|P2|Treatment Period 2|Withdrawal by Subject|1
5616441|NCT00792298|19401892|P1|Treatment Period 2|Withdrawal by Subject|1
5616442|NCT00792298|19401885|P8|Treatment Period 2|Pregnancy|0
5616443|NCT00792298|19401886|P7|Treatment Period 2|Pregnancy|0
5616444|NCT00792298|19401887|P6|Treatment Period 2|Pregnancy|0
5616445|NCT00792298|19401888|P5|Treatment Period 2|Pregnancy|0
5616446|NCT00792298|19401889|P4|Treatment Period 2|Pregnancy|0
5616447|NCT00792298|19401890|P3|Treatment Period 2|Pregnancy|1
5616448|NCT00792298|19401891|P2|Treatment Period 2|Pregnancy|0
5616449|NCT00792298|19401892|P1|Treatment Period 2|Pregnancy|0
5616450|NCT00792298|19401885|P8|Treatment Period 2|Physician Decision|0
5616451|NCT00792298|19401886|P7|Treatment Period 2|Physician Decision|1
5616452|NCT00792298|19401887|P6|Treatment Period 2|Physician Decision|0
5616453|NCT00792298|19401888|P5|Treatment Period 2|Physician Decision|0
5616454|NCT00792298|19401889|P4|Treatment Period 2|Physician Decision|0
5616455|NCT00792298|19401890|P3|Treatment Period 2|Physician Decision|0
5616456|NCT00792298|19401891|P2|Treatment Period 2|Physician Decision|0
5616457|NCT00792298|19401892|P1|Treatment Period 2|Physician Decision|0
5616458|NCT00792298|19401885|P8|Treatment Period 2|Lack of Efficacy|0
5616459|NCT00792298|19401886|P7|Treatment Period 2|Lack of Efficacy|0
5616460|NCT00792298|19401887|P6|Treatment Period 2|Lack of Efficacy|0
5616461|NCT00792298|19401888|P5|Treatment Period 2|Lack of Efficacy|1
5616462|NCT00792298|19401889|P4|Treatment Period 2|Lack of Efficacy|0
5616463|NCT00792298|19401890|P3|Treatment Period 2|Lack of Efficacy|0
5616464|NCT00792298|19401891|P2|Treatment Period 2|Lack of Efficacy|0
5616465|NCT00792298|19401892|P1|Treatment Period 2|Lack of Efficacy|0
5616466|NCT00792298|19401885|P8|Washout|Withdrawal by Subject|0
5616467|NCT00792298|19401886|P7|Washout|Withdrawal by Subject|0
5616468|NCT00792298|19401887|P6|Washout|Withdrawal by Subject|1
5616469|NCT00792298|19401888|P5|Washout|Withdrawal by Subject|0
5616470|NCT00792298|19401889|P4|Washout|Withdrawal by Subject|0
5616471|NCT00792298|19401890|P3|Washout|Withdrawal by Subject|1
5616472|NCT00792298|19401891|P2|Washout|Withdrawal by Subject|0
5616473|NCT00792298|19401892|P1|Washout|Withdrawal by Subject|0
5616474|NCT00792298|19401885|P8|Washout|Adverse Event|0
5616475|NCT00792298|19401886|P7|Washout|Adverse Event|0
5616476|NCT00792298|19401887|P6|Washout|Adverse Event|1
5616477|NCT00792298|19401888|P5|Washout|Adverse Event|0
5616478|NCT00792298|19401889|P4|Washout|Adverse Event|0
5616479|NCT00792298|19401890|P3|Washout|Adverse Event|0
5616480|NCT00792298|19401891|P2|Washout|Adverse Event|0
5616481|NCT00792298|19401892|P1|Washout|Adverse Event|0
5616482|NCT00792298|19401885|P8|Treatment Period 1|Protocol Violation|1
5616483|NCT00792298|19401886|P7|Treatment Period 1|Protocol Violation|0
5616484|NCT00792298|19401887|P6|Treatment Period 1|Protocol Violation|0
5616485|NCT00792298|19401888|P5|Treatment Period 1|Protocol Violation|0
5616486|NCT00792298|19401889|P4|Treatment Period 1|Protocol Violation|0
5616487|NCT00792298|19401890|P3|Treatment Period 1|Protocol Violation|0
5616488|NCT00792298|19401891|P2|Treatment Period 1|Protocol Violation|0
5616489|NCT00792298|19401892|P1|Treatment Period 1|Protocol Violation|0
5616490|NCT00792298|19401885|P8|Treatment Period 1|Physician Decision|0
5616491|NCT00792298|19401886|P7|Treatment Period 1|Physician Decision|1
5616492|NCT00792298|19401887|P6|Treatment Period 1|Physician Decision|0
5616493|NCT00792298|19401888|P5|Treatment Period 1|Physician Decision|0
5616494|NCT00792298|19401889|P4|Treatment Period 1|Physician Decision|1
5616495|NCT00792298|19401890|P3|Treatment Period 1|Physician Decision|0
5616496|NCT00792298|19401891|P2|Treatment Period 1|Physician Decision|0
5616497|NCT00792298|19401892|P1|Treatment Period 1|Physician Decision|0
5616498|NCT00792298|19401885|P8|Treatment Period 1|Lost to Follow-up|0
5616499|NCT00792298|19401886|P7|Treatment Period 1|Lost to Follow-up|1
5616500|NCT00792298|19401887|P6|Treatment Period 1|Lost to Follow-up|0
5616501|NCT00792298|19401888|P5|Treatment Period 1|Lost to Follow-up|0
5616502|NCT00792298|19401889|P4|Treatment Period 1|Lost to Follow-up|0
5616503|NCT00792298|19401890|P3|Treatment Period 1|Lost to Follow-up|0
5616504|NCT00792298|19401891|P2|Treatment Period 1|Lost to Follow-up|0
5616505|NCT00792298|19401892|P1|Treatment Period 1|Lost to Follow-up|0
5616506|NCT00792298|19401885|P8|Treatment Period 1|Withdrawal by Subject|0
5616507|NCT00792298|19401886|P7|Treatment Period 1|Withdrawal by Subject|1
5616508|NCT00792298|19401887|P6|Treatment Period 1|Withdrawal by Subject|2
5616509|NCT00792298|19401888|P5|Treatment Period 1|Withdrawal by Subject|0
5616510|NCT00792298|19401889|P4|Treatment Period 1|Withdrawal by Subject|2
5616511|NCT00792298|19401890|P3|Treatment Period 1|Withdrawal by Subject|1
5616512|NCT00792298|19401891|P2|Treatment Period 1|Withdrawal by Subject|0
5616513|NCT00792298|19401892|P1|Treatment Period 1|Withdrawal by Subject|1
5616514|NCT00792298|19401885|P8|Treatment Period 1|Lack of Efficacy|0
5616515|NCT00792298|19401886|P7|Treatment Period 1|Lack of Efficacy|0
5616516|NCT00792298|19401887|P6|Treatment Period 1|Lack of Efficacy|0
5616517|NCT00792298|19401888|P5|Treatment Period 1|Lack of Efficacy|0
5616518|NCT00792298|19401889|P4|Treatment Period 1|Lack of Efficacy|0
5616519|NCT00792298|19401890|P3|Treatment Period 1|Lack of Efficacy|1
5616520|NCT00792298|19401891|P2|Treatment Period 1|Lack of Efficacy|0
5616521|NCT00792298|19401892|P1|Treatment Period 1|Lack of Efficacy|0
5616522|NCT00792298|19401885|P8|Treatment Period 1|Adverse Event|0
5616523|NCT00792298|19401886|P7|Treatment Period 1|Adverse Event|1
5616524|NCT00792298|19401887|P6|Treatment Period 1|Adverse Event|1
5616525|NCT00792298|19401888|P5|Treatment Period 1|Adverse Event|0
5616526|NCT00792298|19401889|P4|Treatment Period 1|Adverse Event|1
5616527|NCT00792298|19401890|P3|Treatment Period 1|Adverse Event|0
5616528|NCT00792298|19401891|P2|Treatment Period 1|Adverse Event|1
5616529|NCT00792298|19401892|P1|Treatment Period 1|Adverse Event|0
5616530|NCT00792259|19401922|P3|Overall Study|Poor Quality Scans|0
5616531|NCT00792259|19401923|P2|Overall Study|Poor Quality Scans|0
5616532|NCT00792259|19401924|P1|Overall Study|Poor Quality Scans|1
5616533|NCT00792116|19401941|P2|Overall Study|Discontnued intervention|0
5616534|NCT00792116|19401942|P1|Overall Study|Discontnued intervention|1
5616535|NCT00792116|19401941|P2|Overall Study|Lost to Follow-up|1
5616536|NCT00792116|19401942|P1|Overall Study|Lost to Follow-up|0
5616537|NCT00792103|19401952|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
5616538|NCT00792103|19401952|P1|Overall Study|Protocol Violation|10
5616539|NCT00792103|19401952|P1|Overall Study|Withdrawal by Subject|52
5616540|NCT00792103|19401952|P1|Overall Study|Adverse Event|25
5616541|NCT00792103|19401952|P1|Overall Study|Lost to Follow-up|17
5616542|NCT00792103|19401952|P1|Overall Study|Enrolled, not treated|15
5616543|NCT00791999|19401964|P4|Overall Study|Reason other than those above|0
5616544|NCT00791999|19401965|P3|Overall Study|Reason other than those above|1
5616545|NCT00791999|19401966|P2|Overall Study|Reason other than those above|0
5616546|NCT00791999|19401967|P1|Overall Study|Reason other than those above|1
5616547|NCT00791999|19401964|P4|Overall Study|Lack of Efficacy|2
5616548|NCT00791999|19401965|P3|Overall Study|Lack of Efficacy|0
5616549|NCT00791999|19401966|P2|Overall Study|Lack of Efficacy|1
5616550|NCT00791999|19401967|P1|Overall Study|Lack of Efficacy|0
5616551|NCT00791999|19401964|P4|Overall Study|Adverse Event|3
5616552|NCT00791999|19401965|P3|Overall Study|Adverse Event|7
5616553|NCT00791999|19401966|P2|Overall Study|Adverse Event|3
5616554|NCT00791999|19401967|P1|Overall Study|Adverse Event|3
5616555|NCT00791999|19401964|P4|Overall Study|Protocol Violation|0
5616556|NCT00791999|19401965|P3|Overall Study|Protocol Violation|1
5616557|NCT00791999|19401966|P2|Overall Study|Protocol Violation|0
5616558|NCT00791999|19401967|P1|Overall Study|Protocol Violation|3
5616559|NCT00791999|19401964|P4|Overall Study|Withdrawal by Subject|2
5616560|NCT00791999|19401965|P3|Overall Study|Withdrawal by Subject|0
5616561|NCT00791999|19401966|P2|Overall Study|Withdrawal by Subject|1
5616562|NCT00791999|19401967|P1|Overall Study|Withdrawal by Subject|0
5616563|NCT00791999|19401964|P4|Overall Study|Protocol planed withdrawal|45
5616564|NCT00791999|19401965|P3|Overall Study|Protocol planed withdrawal|11
5616565|NCT00791999|19401966|P2|Overall Study|Protocol planed withdrawal|11
5616566|NCT00791999|19401967|P1|Overall Study|Protocol planed withdrawal|14
5616567|NCT00791934|19401992|P1|Overall Study|Did not consent for extended follow-up|13
5616568|NCT00791934|19401992|P1|Overall Study|Withdrawal by Subject|2
5616569|NCT00791921|19402002|P2|Overall Study|Reason other than those above|1
5616570|NCT00791921|19402003|P1|Overall Study|Reason other than those above|0
5616571|NCT00791921|19402002|P2|Overall Study|Lack of study drug administration|1
5616572|NCT00791921|19402003|P1|Overall Study|Lack of study drug administration|1
5616573|NCT00791921|19402002|P2|Overall Study|Lack of Efficacy|2
5616574|NCT00791921|19402003|P1|Overall Study|Lack of Efficacy|0
5616575|NCT00791921|19402002|P2|Overall Study|Adverse Event|2
5616576|NCT00791921|19402003|P1|Overall Study|Adverse Event|8
5616577|NCT00791921|19402002|P2|Overall Study|Withdrawal by Subject|2
5616578|NCT00791921|19402003|P1|Overall Study|Withdrawal by Subject|1
5616579|NCT00791921|19402002|P2|Overall Study|Protocol planed|88
5616580|NCT00791921|19402003|P1|Overall Study|Protocol planed|24
5616581|NCT00791778|19402034|P2|Follow-up|Lost to Follow-up|1
5616582|NCT00791778|19402035|P1|Follow-up|Lost to Follow-up|2
5616583|NCT00791778|19402034|P2|Follow-up|Withdrawal by Subject|0
5616584|NCT00791778|19402035|P1|Follow-up|Withdrawal by Subject|3
5616585|NCT00791778|19402034|P2|Double-blind Treatment|Non-compliant with study medication|0
5616586|NCT00791778|19402035|P1|Double-blind Treatment|Non-compliant with study medication|2
5616587|NCT00791778|19402034|P2|Double-blind Treatment|Withdrawal by Subject|9
5616588|NCT00791778|19402035|P1|Double-blind Treatment|Withdrawal by Subject|20
5616589|NCT00791778|19402034|P2|Double-blind Treatment|Protocol Violation|4
5616590|NCT00791778|19402035|P1|Double-blind Treatment|Protocol Violation|0
5616591|NCT00791778|19402034|P2|Double-blind Treatment|Physician Decision|26
5616592|NCT00791778|19402035|P1|Double-blind Treatment|Physician Decision|6
5616593|NCT00791778|19402034|P2|Double-blind Treatment|Adverse Event|9
5616594|NCT00791778|19402035|P1|Double-blind Treatment|Adverse Event|49
5616595|NCT00791765|19402089|P2|Weeks 13 to 24|Other|1
5616596|NCT00791765|19402090|P1|Weeks 13 to 24|Other|0
5616597|NCT00791765|19402089|P2|Weeks 13 to 24|Lost to Follow-up|2
5616598|NCT00791765|19402090|P1|Weeks 13 to 24|Lost to Follow-up|1
5616599|NCT00791765|19402089|P2|Weeks 13 to 24|Disease progression|1
5616600|NCT00791765|19402090|P1|Weeks 13 to 24|Disease progression|0
5616601|NCT00791765|19402089|P2|Weeks 13 to 24|Withdrawal by Subject|1
5616602|NCT00791765|19402090|P1|Weeks 13 to 24|Withdrawal by Subject|2
5616603|NCT00791765|19402089|P2|Weeks 13 to 24|Adverse Event|3
5616604|NCT00791765|19402090|P1|Weeks 13 to 24|Adverse Event|0
5616605|NCT00791765|19402089|P2|Weeks 13 to 24|Protocol deviation|0
5616606|NCT00791765|19402090|P1|Weeks 13 to 24|Protocol deviation|2
5616607|NCT00791765|19402089|P2|Weeks 1 to 12|Ineligibility determined|3
5616608|NCT00791765|19402090|P1|Weeks 1 to 12|Ineligibility determined|0
5616609|NCT00791765|19402089|P2|Weeks 1 to 12|Disease progression|0
5616610|NCT00791765|19402090|P1|Weeks 1 to 12|Disease progression|3
5616611|NCT00791765|19402089|P2|Weeks 1 to 12|Physician Decision|0
5616612|NCT00791765|19402090|P1|Weeks 1 to 12|Physician Decision|1
5616613|NCT00791765|19402089|P2|Weeks 1 to 12|Withdrawal by Subject|0
5616614|NCT00791765|19402090|P1|Weeks 1 to 12|Withdrawal by Subject|3
5616615|NCT00791765|19402089|P2|Weeks 1 to 12|Lost to Follow-up|0
5616616|NCT00791765|19402090|P1|Weeks 1 to 12|Lost to Follow-up|1
5616617|NCT00791765|19402089|P2|Weeks 1 to 12|Adverse Event|1
5616618|NCT00791765|19402090|P1|Weeks 1 to 12|Adverse Event|0
5616619|NCT00791700|19402105|P4|Overall Study|Adverse Event|1
5616620|NCT00791700|19402106|P3|Overall Study|Adverse Event|1
5616621|NCT00791700|19402107|P2|Overall Study|Adverse Event|0
5616622|NCT00791700|19402108|P1|Overall Study|Adverse Event|0
5616623|NCT00791700|19402105|P4|Overall Study|Lost to Follow-up|6
5616624|NCT00791700|19402106|P3|Overall Study|Lost to Follow-up|4
5616625|NCT00791700|19402107|P2|Overall Study|Lost to Follow-up|3
5616626|NCT00791700|19402108|P1|Overall Study|Lost to Follow-up|4
5616627|NCT00791700|19402105|P4|Overall Study|Death|1
5616628|NCT00791700|19402106|P3|Overall Study|Death|0
5616629|NCT00791700|19402107|P2|Overall Study|Death|0
5616630|NCT00791700|19402108|P1|Overall Study|Death|0
5616631|NCT00791700|19402105|P4|Overall Study|Other|1
5616632|NCT00791700|19402106|P3|Overall Study|Other|0
5616633|NCT00791700|19402107|P2|Overall Study|Other|1
5616634|NCT00791700|19402108|P1|Overall Study|Other|0
5616635|NCT00791700|19402105|P4|Overall Study|Withdrawn due to pregnancy|1
5616636|NCT00791700|19402106|P3|Overall Study|Withdrawn due to pregnancy|0
5616637|NCT00791700|19402107|P2|Overall Study|Withdrawn due to pregnancy|0
5616638|NCT00791700|19402108|P1|Overall Study|Withdrawn due to pregnancy|0
5616639|NCT00791700|19402105|P4|Overall Study|Non-compliance with study treatment|4
5616640|NCT00791700|19402106|P3|Overall Study|Non-compliance with study treatment|0
5616641|NCT00791700|19402107|P2|Overall Study|Non-compliance with study treatment|2
5616642|NCT00791700|19402108|P1|Overall Study|Non-compliance with study treatment|0
5616643|NCT00791700|19402105|P4|Overall Study|No longer willing to participate|8
5616644|NCT00791700|19402106|P3|Overall Study|No longer willing to participate|0
5616645|NCT00791700|19402107|P2|Overall Study|No longer willing to participate|1
5616646|NCT00791700|19402108|P1|Overall Study|No longer willing to participate|1
5616647|NCT00791700|19402105|P4|Overall Study|Insufficient clinical response|8
5616648|NCT00791700|19402106|P3|Overall Study|Insufficient clinical response|1
5616649|NCT00791700|19402107|P2|Overall Study|Insufficient clinical response|4
5616650|NCT00791700|19402108|P1|Overall Study|Insufficient clinical response|1
5616651|NCT00791661|19402196|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
5616652|NCT00791661|19402197|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
5616653|NCT00791661|19402198|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
5616654|NCT00791661|19402196|P3|7 Day Wash-out|Adverse Event|1
5616655|NCT00791661|19402197|P2|7 Day Wash-out|Adverse Event|0
5616656|NCT00791661|19402198|P1|7 Day Wash-out|Adverse Event|0
5616657|NCT00791648|19402291|P2|Overall Study|Withdrawal by Subject|1
5616658|NCT00791648|19402292|P1|Overall Study|Withdrawal by Subject|0
5616659|NCT00791648|19402291|P2|Overall Study|Physician Decision|1
5616660|NCT00791648|19402292|P1|Overall Study|Physician Decision|0
5616661|NCT00791557|19402328|P1|Overall Study|Adverse Event|1
5616662|NCT00791518|19402332|P1|Overall Study|Protocol Violation|93
5616663|NCT00791492|19402360|P2|Overall Study|Liver transplantation|1
5616664|NCT00791492|19402361|P1|Overall Study|Liver transplantation|5
5616665|NCT00791492|19402360|P2|Overall Study|Withdrawal by Subject|2
5616666|NCT00791492|19402361|P1|Overall Study|Withdrawal by Subject|1
5616667|NCT00791479|19402409|P6|Overall Study|Withdrawal by Subject|1
5616668|NCT00791479|19402410|P5|Overall Study|Withdrawal by Subject|0
5616669|NCT00791479|19402411|P4|Overall Study|Withdrawal by Subject|1
5616670|NCT00791479|19402412|P3|Overall Study|Withdrawal by Subject|0
5616671|NCT00791479|19402413|P2|Overall Study|Withdrawal by Subject|0
5616672|NCT00791479|19402414|P1|Overall Study|Withdrawal by Subject|0
5616673|NCT00791479|19402409|P6|Overall Study|Protocol Violation|0
5616674|NCT00791479|19402410|P5|Overall Study|Protocol Violation|0
5616675|NCT00791479|19402411|P4|Overall Study|Protocol Violation|1
5616676|NCT00791479|19402412|P3|Overall Study|Protocol Violation|0
5616677|NCT00791479|19402413|P2|Overall Study|Protocol Violation|1
5616678|NCT00791479|19402414|P1|Overall Study|Protocol Violation|2
5616679|NCT00791479|19402409|P6|Overall Study|Lost to Follow-up|1
5616680|NCT00791479|19402410|P5|Overall Study|Lost to Follow-up|0
5616681|NCT00791479|19402411|P4|Overall Study|Lost to Follow-up|0
5616682|NCT00791479|19402412|P3|Overall Study|Lost to Follow-up|0
5616683|NCT00791479|19402413|P2|Overall Study|Lost to Follow-up|1
5616684|NCT00791479|19402414|P1|Overall Study|Lost to Follow-up|0
5616685|NCT00791479|19402409|P6|Overall Study|Adverse Event|1
5616686|NCT00791479|19402410|P5|Overall Study|Adverse Event|0
5616687|NCT00791479|19402411|P4|Overall Study|Adverse Event|2
5616688|NCT00791479|19402412|P3|Overall Study|Adverse Event|0
5616689|NCT00791479|19402413|P2|Overall Study|Adverse Event|1
5616690|NCT00791479|19402414|P1|Overall Study|Adverse Event|0
5616691|NCT00791479|19402409|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
5616692|NCT00791479|19402410|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
5616693|NCT00791479|19402411|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
5616694|NCT00791479|19402412|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
5616695|NCT00791479|19402413|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
5616696|NCT00791479|19402414|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
5616697|NCT00791388|19402513|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
5616698|NCT00791388|19402514|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
5616699|NCT00791388|19402515|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
5616700|NCT00791388|19402516|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
5616701|NCT00791388|19402517|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
5616702|NCT00791388|19402513|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
5616703|NCT00791388|19402514|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
5616704|NCT00791388|19402515|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
5616705|NCT00791388|19402516|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
5616706|NCT00791388|19402517|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
5616707|NCT00791388|19402513|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
5616708|NCT00791388|19402514|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
5616709|NCT00791388|19402515|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
5616710|NCT00791388|19402516|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
5616711|NCT00791388|19402517|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
5616712|NCT00791258|19402559|P1|Overall Study|Lack of Efficacy|1
5616713|NCT00791258|19402559|P1|Overall Study|Subject required restricted medication|1
5616714|NCT00791258|19402559|P1|Overall Study|Subject incarcerated|1
5616715|NCT00791258|19402559|P1|Overall Study|non-compliance|3
5616716|NCT00791258|19402559|P1|Overall Study|subject left area|2
5616717|NCT00791258|19402559|P1|Overall Study|Did not take medication for >3 days|1
5616718|NCT00791258|19402559|P1|Overall Study|Withdrawal by Subject|40
5616719|NCT00791258|19402559|P1|Overall Study|Protocol Violation|109
5616720|NCT00791258|19402559|P1|Overall Study|Lost to Follow-up|18
5616721|NCT00791258|19402559|P1|Overall Study|Adverse Event|87
5616722|NCT00791128|19402652|P1|Overall Study|abdominal tumor, unrelated to device|1
5616723|NCT00791128|19402652|P1|Overall Study|non-compliance by subject|2
5616724|NCT00791128|19402652|P1|Overall Study|Device migration|2
5616725|NCT00791128|19402652|P1|Overall Study|Adverse Event|4
5616726|NCT00791076|19402683|P1|Overall Study|Study was terminated,PI left institution|8
5616727|NCT00790933|19402703|P5|Overall Study|Reason Not Specified|9
5616728|NCT00790933|19402704|P4|Overall Study|Reason Not Specified|1
5616729|NCT00790933|19402705|P3|Overall Study|Reason Not Specified|4
5616730|NCT00790933|19402706|P2|Overall Study|Reason Not Specified|16
5616731|NCT00790933|19402707|P1|Overall Study|Reason Not Specified|8
5616732|NCT00790933|19402703|P5|Overall Study|Lost to Follow-up|15
5616733|NCT00790933|19402704|P4|Overall Study|Lost to Follow-up|1
5616734|NCT00790933|19402705|P3|Overall Study|Lost to Follow-up|10
5616735|NCT00790933|19402706|P2|Overall Study|Lost to Follow-up|31
5616736|NCT00790933|19402707|P1|Overall Study|Lost to Follow-up|13
5616737|NCT00790933|19402703|P5|Overall Study|Withdrawal by Subject|50
5616738|NCT00790933|19402704|P4|Overall Study|Withdrawal by Subject|6
5616739|NCT00790933|19402705|P3|Overall Study|Withdrawal by Subject|52
5616740|NCT00790933|19402706|P2|Overall Study|Withdrawal by Subject|120
5616741|NCT00790933|19402707|P1|Overall Study|Withdrawal by Subject|123
5616742|NCT00790933|19402703|P5|Overall Study|Study Terminated by Sponsor|0
5616743|NCT00790933|19402704|P4|Overall Study|Study Terminated by Sponsor|0
5616744|NCT00790933|19402705|P3|Overall Study|Study Terminated by Sponsor|1
5616745|NCT00790933|19402706|P2|Overall Study|Study Terminated by Sponsor|0
5616746|NCT00790933|19402707|P1|Overall Study|Study Terminated by Sponsor|0
5616747|NCT00790933|19402703|P5|Overall Study|Lack of Efficacy|121
5616748|NCT00790933|19402704|P4|Overall Study|Lack of Efficacy|1
5616749|NCT00790933|19402705|P3|Overall Study|Lack of Efficacy|130
5616750|NCT00790933|19402706|P2|Overall Study|Lack of Efficacy|176
5616751|NCT00790933|19402707|P1|Overall Study|Lack of Efficacy|192
5616752|NCT00790933|19402703|P5|Overall Study|Protocol Violation(s)|12
5616753|NCT00790933|19402704|P4|Overall Study|Protocol Violation(s)|0
5616754|NCT00790933|19402705|P3|Overall Study|Protocol Violation(s)|7
5616755|NCT00790933|19402706|P2|Overall Study|Protocol Violation(s)|18
5616756|NCT00790933|19402707|P1|Overall Study|Protocol Violation(s)|8
5616757|NCT00790933|19402703|P5|Overall Study|Adverse Event|69
5616758|NCT00790933|19402704|P4|Overall Study|Adverse Event|5
5616759|NCT00790933|19402705|P3|Overall Study|Adverse Event|65
5616760|NCT00790933|19402706|P2|Overall Study|Adverse Event|119
5616761|NCT00790933|19402707|P1|Overall Study|Adverse Event|94
5616762|NCT00790907|19403238|P3|Overall Study|Did Not Receive Study Drug|0
5616763|NCT00790907|19403239|P2|Overall Study|Did Not Receive Study Drug|0
5616764|NCT00790907|19403240|P1|Overall Study|Did Not Receive Study Drug|10
5616765|NCT00790907|19403238|P3|Overall Study|Verbatim Reason on the Case Report Form|29
5616766|NCT00790907|19403239|P2|Overall Study|Verbatim Reason on the Case Report Form|20
5616767|NCT00790907|19403240|P1|Overall Study|Verbatim Reason on the Case Report Form|74
5616768|NCT00790907|19403238|P3|Overall Study|Qualifying Condition Not Present|16
5616769|NCT00790907|19403239|P2|Overall Study|Qualifying Condition Not Present|14
5616770|NCT00790907|19403240|P1|Overall Study|Qualifying Condition Not Present|29
5616771|NCT00790907|19403238|P3|Overall Study|Required Protocol-prohibited Therapy|7
5616772|NCT00790907|19403239|P2|Overall Study|Required Protocol-prohibited Therapy|5
5616773|NCT00790907|19403240|P1|Overall Study|Required Protocol-prohibited Therapy|17
5616774|NCT00790907|19403238|P3|Overall Study|Bleeding Event|21
5616775|NCT00790907|19403239|P2|Overall Study|Bleeding Event|16
5616776|NCT00790907|19403240|P1|Overall Study|Bleeding Event|11
5616777|NCT00790907|19403238|P3|Overall Study|Withdrawal by Subject|5
5616778|NCT00790907|19403239|P2|Overall Study|Withdrawal by Subject|7
5616779|NCT00790907|19403240|P1|Overall Study|Withdrawal by Subject|1
5616780|NCT00790907|19403238|P3|Overall Study|Physician Decision|255
5616781|NCT00790907|19403239|P2|Overall Study|Physician Decision|271
5616782|NCT00790907|19403240|P1|Overall Study|Physician Decision|304
5616783|NCT00790907|19403238|P3|Overall Study|Adverse Event|6
5616784|NCT00790907|19403239|P2|Overall Study|Adverse Event|7
5616785|NCT00790907|19403240|P1|Overall Study|Adverse Event|9
5616786|NCT00790868|19403263|P2|Overall Study|Lost to Follow-up|12
5616787|NCT00790868|19403264|P1|Overall Study|Lost to Follow-up|2
5616788|NCT00790868|19403263|P2|Overall Study|Withdrawal by Subject|5
5616789|NCT00790868|19403264|P1|Overall Study|Withdrawal by Subject|4
5616790|NCT00790842|19403286|P11|Expansion Cohort|Study Closure|0
5616791|NCT00790842|19403287|P10|Expansion Cohort|Study Closure|0
5616792|NCT00790842|19403288|P9|Expansion Cohort|Study Closure|0
5616793|NCT00790842|19403289|P8|Expansion Cohort|Study Closure|0
5616794|NCT00790842|19403290|P7|Expansion Cohort|Study Closure|0
5616795|NCT00790842|19403291|P6|Expansion Cohort|Study Closure|0
5616796|NCT00790842|19403292|P5|Expansion Cohort|Study Closure|0
5616797|NCT00790842|19403293|P4|Expansion Cohort|Study Closure|0
5616798|NCT00790842|19403294|P3|Expansion Cohort|Study Closure|1
5616799|NCT00790842|19403295|P2|Expansion Cohort|Study Closure|0
5616800|NCT00790842|19403296|P1|Expansion Cohort|Study Closure|0
5616801|NCT00790842|19403286|P11|Expansion Cohort|Withdrawal by Subject|0
5616802|NCT00790842|19403287|P10|Expansion Cohort|Withdrawal by Subject|0
5616803|NCT00790842|19403288|P9|Expansion Cohort|Withdrawal by Subject|0
5616804|NCT00790842|19403289|P8|Expansion Cohort|Withdrawal by Subject|0
5616805|NCT00790842|19403290|P7|Expansion Cohort|Withdrawal by Subject|0
5616806|NCT00790842|19403291|P6|Expansion Cohort|Withdrawal by Subject|0
5616807|NCT00790842|19403292|P5|Expansion Cohort|Withdrawal by Subject|0
5616808|NCT00790842|19403293|P4|Expansion Cohort|Withdrawal by Subject|0
5616809|NCT00790842|19403294|P3|Expansion Cohort|Withdrawal by Subject|3
5616810|NCT00790842|19403295|P2|Expansion Cohort|Withdrawal by Subject|0
5616811|NCT00790842|19403296|P1|Expansion Cohort|Withdrawal by Subject|0
5616812|NCT00790842|19403286|P11|Expansion Cohort|Physician Decision|0
5616813|NCT00790842|19403287|P10|Expansion Cohort|Physician Decision|0
5616814|NCT00790842|19403288|P9|Expansion Cohort|Physician Decision|0
5616815|NCT00790842|19403289|P8|Expansion Cohort|Physician Decision|0
5616816|NCT00790842|19403290|P7|Expansion Cohort|Physician Decision|0
5616817|NCT00790842|19403291|P6|Expansion Cohort|Physician Decision|0
5616818|NCT00790842|19403292|P5|Expansion Cohort|Physician Decision|0
5616819|NCT00790842|19403293|P4|Expansion Cohort|Physician Decision|0
5616820|NCT00790842|19403294|P3|Expansion Cohort|Physician Decision|1
5616821|NCT00790842|19403295|P2|Expansion Cohort|Physician Decision|0
5616822|NCT00790842|19403296|P1|Expansion Cohort|Physician Decision|0
5616823|NCT00790842|19403286|P11|Expansion Cohort|Death|0
5616824|NCT00790842|19403287|P10|Expansion Cohort|Death|0
5616825|NCT00790842|19403288|P9|Expansion Cohort|Death|0
5616826|NCT00790842|19403289|P8|Expansion Cohort|Death|0
5616827|NCT00790842|19403290|P7|Expansion Cohort|Death|0
5616828|NCT00790842|19403291|P6|Expansion Cohort|Death|0
5616829|NCT00790842|19403292|P5|Expansion Cohort|Death|0
5616830|NCT00790842|19403293|P4|Expansion Cohort|Death|0
5616831|NCT00790842|19403294|P3|Expansion Cohort|Death|2
5616832|NCT00790842|19403295|P2|Expansion Cohort|Death|0
5616833|NCT00790842|19403296|P1|Expansion Cohort|Death|0
5616834|NCT00790842|19403286|P11|Expansion Cohort|Adverse Event|0
5616835|NCT00790842|19403287|P10|Expansion Cohort|Adverse Event|0
5616836|NCT00790842|19403288|P9|Expansion Cohort|Adverse Event|0
5616837|NCT00790842|19403289|P8|Expansion Cohort|Adverse Event|0
5616838|NCT00790842|19403290|P7|Expansion Cohort|Adverse Event|1
5616839|NCT00790842|19403291|P6|Expansion Cohort|Adverse Event|0
5616840|NCT00790842|19403292|P5|Expansion Cohort|Adverse Event|0
5616841|NCT00790842|19403293|P4|Expansion Cohort|Adverse Event|0
5616842|NCT00790842|19403294|P3|Expansion Cohort|Adverse Event|0
5616843|NCT00790842|19403295|P2|Expansion Cohort|Adverse Event|0
5616844|NCT00790842|19403296|P1|Expansion Cohort|Adverse Event|0
5616845|NCT00790842|19403286|P11|Dose Level 4|Withdrawal by Subject|1
5616846|NCT00790842|19403287|P10|Dose Level 4|Withdrawal by Subject|0
5616847|NCT00790842|19403288|P9|Dose Level 4|Withdrawal by Subject|0
5616848|NCT00790842|19403289|P8|Dose Level 4|Withdrawal by Subject|0
5616849|NCT00790842|19403290|P7|Dose Level 4|Withdrawal by Subject|0
5616850|NCT00790842|19403291|P6|Dose Level 4|Withdrawal by Subject|0
5616851|NCT00790842|19403292|P5|Dose Level 4|Withdrawal by Subject|0
5616852|NCT00790842|19403293|P4|Dose Level 4|Withdrawal by Subject|0
5616853|NCT00790842|19403294|P3|Dose Level 4|Withdrawal by Subject|0
5616854|NCT00790842|19403295|P2|Dose Level 4|Withdrawal by Subject|0
5616855|NCT00790842|19403296|P1|Dose Level 4|Withdrawal by Subject|0
5616856|NCT00790842|19403286|P11|Dose Level 4|Physician Decision|1
5616857|NCT00790842|19403287|P10|Dose Level 4|Physician Decision|0
5616858|NCT00790842|19403288|P9|Dose Level 4|Physician Decision|0
5616859|NCT00790842|19403289|P8|Dose Level 4|Physician Decision|0
5616860|NCT00790842|19403290|P7|Dose Level 4|Physician Decision|1
5616861|NCT00790842|19403291|P6|Dose Level 4|Physician Decision|0
5616862|NCT00790842|19403292|P5|Dose Level 4|Physician Decision|0
5616863|NCT00790842|19403293|P4|Dose Level 4|Physician Decision|0
5616864|NCT00790842|19403294|P3|Dose Level 4|Physician Decision|0
5616865|NCT00790842|19403295|P2|Dose Level 4|Physician Decision|0
5616866|NCT00790842|19403296|P1|Dose Level 4|Physician Decision|0
5616867|NCT00790842|19403286|P11|Dose Level 4|Adverse Event|0
5616868|NCT00790842|19403287|P10|Dose Level 4|Adverse Event|0
5616869|NCT00790842|19403288|P9|Dose Level 4|Adverse Event|0
5616870|NCT00790842|19403289|P8|Dose Level 4|Adverse Event|0
5616871|NCT00790842|19403290|P7|Dose Level 4|Adverse Event|1
5616872|NCT00790842|19403291|P6|Dose Level 4|Adverse Event|0
5616873|NCT00790842|19403292|P5|Dose Level 4|Adverse Event|0
5616874|NCT00790842|19403293|P4|Dose Level 4|Adverse Event|0
5616875|NCT00790842|19403294|P3|Dose Level 4|Adverse Event|0
5616876|NCT00790842|19403295|P2|Dose Level 4|Adverse Event|0
5616877|NCT00790842|19403296|P1|Dose Level 4|Adverse Event|0
5616878|NCT00790842|19403286|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616879|NCT00790842|19403287|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616880|NCT00790842|19403288|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616881|NCT00790842|19403289|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616882|NCT00790842|19403290|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616883|NCT00790842|19403291|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616884|NCT00790842|19403292|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616885|NCT00790842|19403293|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616886|NCT00790842|19403294|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
5616887|NCT00790842|19403295|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616888|NCT00790842|19403296|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
5616889|NCT00790842|19403286|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616890|NCT00790842|19403287|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616891|NCT00790842|19403288|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616892|NCT00790842|19403289|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616893|NCT00790842|19403290|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616894|NCT00790842|19403291|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
5616895|NCT00790842|19403292|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616896|NCT00790842|19403293|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616897|NCT00790842|19403294|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616898|NCT00790842|19403295|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616899|NCT00790842|19403296|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
5616900|NCT00790842|19403286|P11|Dose Level 3|Withdrawal by Subject|0
5616901|NCT00790842|19403287|P10|Dose Level 3|Withdrawal by Subject|2
5616902|NCT00790842|19403288|P9|Dose Level 3|Withdrawal by Subject|0
5616903|NCT00790842|19403289|P8|Dose Level 3|Withdrawal by Subject|0
5616904|NCT00790842|19403290|P7|Dose Level 3|Withdrawal by Subject|0
5616905|NCT00790842|19403291|P6|Dose Level 3|Withdrawal by Subject|0
5616906|NCT00790842|19403292|P5|Dose Level 3|Withdrawal by Subject|0
5616907|NCT00790842|19403293|P4|Dose Level 3|Withdrawal by Subject|0
5616908|NCT00790842|19403294|P3|Dose Level 3|Withdrawal by Subject|3
5616909|NCT00790842|19403295|P2|Dose Level 3|Withdrawal by Subject|0
5616910|NCT00790842|19403296|P1|Dose Level 3|Withdrawal by Subject|0
5616911|NCT00790842|19403286|P11|Dose Level 3|Adverse Event|0
5616912|NCT00790842|19403287|P10|Dose Level 3|Adverse Event|0
5616913|NCT00790842|19403288|P9|Dose Level 3|Adverse Event|0
5616914|NCT00790842|19403289|P8|Dose Level 3|Adverse Event|0
5616915|NCT00790842|19403290|P7|Dose Level 3|Adverse Event|0
5616916|NCT00790842|19403291|P6|Dose Level 3|Adverse Event|0
5616917|NCT00790842|19403292|P5|Dose Level 3|Adverse Event|0
5616918|NCT00790842|19403293|P4|Dose Level 3|Adverse Event|0
5616919|NCT00790842|19403294|P3|Dose Level 3|Adverse Event|1
5616920|NCT00790842|19403295|P2|Dose Level 3|Adverse Event|0
5616921|NCT00790842|19403296|P1|Dose Level 3|Adverse Event|0
5616922|NCT00790842|19403286|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616923|NCT00790842|19403287|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616924|NCT00790842|19403288|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
5616925|NCT00790842|19403289|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616926|NCT00790842|19403290|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616927|NCT00790842|19403291|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616928|NCT00790842|19403292|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616929|NCT00790842|19403293|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616930|NCT00790842|19403294|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616931|NCT00790842|19403295|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616932|NCT00790842|19403296|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
5616933|NCT00790842|19403286|P11|Dose Level 2|Withdrawal by Subject|0
5616934|NCT00790842|19403287|P10|Dose Level 2|Withdrawal by Subject|0
5616935|NCT00790842|19403288|P9|Dose Level 2|Withdrawal by Subject|0
5616936|NCT00790842|19403289|P8|Dose Level 2|Withdrawal by Subject|0
5616937|NCT00790842|19403290|P7|Dose Level 2|Withdrawal by Subject|0
5616938|NCT00790842|19403291|P6|Dose Level 2|Withdrawal by Subject|0
5616939|NCT00790842|19403292|P5|Dose Level 2|Withdrawal by Subject|0
5616940|NCT00790842|19403293|P4|Dose Level 2|Withdrawal by Subject|0
5616941|NCT00790842|19403294|P3|Dose Level 2|Withdrawal by Subject|0
5616942|NCT00790842|19403295|P2|Dose Level 2|Withdrawal by Subject|1
5616943|NCT00790842|19403296|P1|Dose Level 2|Withdrawal by Subject|0
5616944|NCT00790842|19403286|P11|Dose Level 2|Physician Decision|0
5616945|NCT00790842|19403287|P10|Dose Level 2|Physician Decision|0
5616946|NCT00790842|19403288|P9|Dose Level 2|Physician Decision|0
5616947|NCT00790842|19403289|P8|Dose Level 2|Physician Decision|0
5616948|NCT00790842|19403290|P7|Dose Level 2|Physician Decision|0
5616949|NCT00790842|19403291|P6|Dose Level 2|Physician Decision|0
5616950|NCT00790842|19403292|P5|Dose Level 2|Physician Decision|0
5616951|NCT00790842|19403293|P4|Dose Level 2|Physician Decision|0
5616952|NCT00790842|19403294|P3|Dose Level 2|Physician Decision|0
5616953|NCT00790842|19403295|P2|Dose Level 2|Physician Decision|1
5616954|NCT00790842|19403296|P1|Dose Level 2|Physician Decision|0
5616955|NCT00790842|19403286|P11|Dose Level 2|Death|0
5616956|NCT00790842|19403287|P10|Dose Level 2|Death|0
5616957|NCT00790842|19403288|P9|Dose Level 2|Death|0
5616958|NCT00790842|19403289|P8|Dose Level 2|Death|0
5616959|NCT00790842|19403290|P7|Dose Level 2|Death|0
5616960|NCT00790842|19403291|P6|Dose Level 2|Death|0
5616961|NCT00790842|19403292|P5|Dose Level 2|Death|1
5616962|NCT00790842|19403293|P4|Dose Level 2|Death|0
5616963|NCT00790842|19403294|P3|Dose Level 2|Death|0
5616964|NCT00790842|19403295|P2|Dose Level 2|Death|1
5616965|NCT00790842|19403296|P1|Dose Level 2|Death|0
5616966|NCT00790842|19403286|P11|Dose Level 1|Withdrawal by Subject|0
5616967|NCT00790842|19403287|P10|Dose Level 1|Withdrawal by Subject|0
5616968|NCT00790842|19403288|P9|Dose Level 1|Withdrawal by Subject|0
5616969|NCT00790842|19403289|P8|Dose Level 1|Withdrawal by Subject|0
5616970|NCT00790842|19403290|P7|Dose Level 1|Withdrawal by Subject|0
5616971|NCT00790842|19403291|P6|Dose Level 1|Withdrawal by Subject|0
5616972|NCT00790842|19403292|P5|Dose Level 1|Withdrawal by Subject|0
5616973|NCT00790842|19403293|P4|Dose Level 1|Withdrawal by Subject|0
5616974|NCT00790842|19403294|P3|Dose Level 1|Withdrawal by Subject|0
5616975|NCT00790842|19403295|P2|Dose Level 1|Withdrawal by Subject|0
5616976|NCT00790842|19403296|P1|Dose Level 1|Withdrawal by Subject|1
5616977|NCT00790842|19403286|P11|Dose Level 1|Physician Decision|0
5616978|NCT00790842|19403287|P10|Dose Level 1|Physician Decision|0
5616979|NCT00790842|19403288|P9|Dose Level 1|Physician Decision|0
5616980|NCT00790842|19403289|P8|Dose Level 1|Physician Decision|1
5616981|NCT00790842|19403290|P7|Dose Level 1|Physician Decision|0
5616982|NCT00790842|19403291|P6|Dose Level 1|Physician Decision|0
5616983|NCT00790842|19403292|P5|Dose Level 1|Physician Decision|0
5616984|NCT00790842|19403293|P4|Dose Level 1|Physician Decision|0
5616985|NCT00790842|19403294|P3|Dose Level 1|Physician Decision|0
5616986|NCT00790842|19403295|P2|Dose Level 1|Physician Decision|0
5616987|NCT00790842|19403296|P1|Dose Level 1|Physician Decision|1
5616988|NCT00790842|19403286|P11|Dose Level 1|Adverse Event|0
5616989|NCT00790842|19403287|P10|Dose Level 1|Adverse Event|0
5616990|NCT00790842|19403288|P9|Dose Level 1|Adverse Event|0
5616991|NCT00790842|19403289|P8|Dose Level 1|Adverse Event|1
5616992|NCT00790842|19403290|P7|Dose Level 1|Adverse Event|0
5616993|NCT00790842|19403291|P6|Dose Level 1|Adverse Event|0
5616994|NCT00790842|19403292|P5|Dose Level 1|Adverse Event|0
5616995|NCT00790842|19403293|P4|Dose Level 1|Adverse Event|2
5616996|NCT00790842|19403294|P3|Dose Level 1|Adverse Event|0
5616997|NCT00790842|19403295|P2|Dose Level 1|Adverse Event|0
5616998|NCT00790842|19403296|P1|Dose Level 1|Adverse Event|1
5616999|NCT00790790|19403364|P3|Study Period 2: Therapy Phase|Physician Decision|0
5617000|NCT00790790|19403365|P2|Study Period 2: Therapy Phase|Physician Decision|1
5617001|NCT00790790|19403366|P1|Study Period 2: Therapy Phase|Physician Decision|0
5617002|NCT00790790|19403364|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
5617003|NCT00790790|19403365|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
5617004|NCT00790790|19403366|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
5617005|NCT00790790|19403364|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
5617006|NCT00790790|19403365|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
5617007|NCT00790790|19403366|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
5617008|NCT00790790|19403364|P3|Study Period 2: Therapy Phase|Protocol Violation|0
5617009|NCT00790790|19403365|P2|Study Period 2: Therapy Phase|Protocol Violation|1
5617010|NCT00790790|19403366|P1|Study Period 2: Therapy Phase|Protocol Violation|1
5617011|NCT00790790|19403364|P3|Study Period 2: Therapy Phase|Adverse Event|16
5617012|NCT00790790|19403365|P2|Study Period 2: Therapy Phase|Adverse Event|16
5617013|NCT00790790|19403366|P1|Study Period 2: Therapy Phase|Adverse Event|3
5617014|NCT00790751|19403443|P4|Overall Study|Physician Decision|1
5617015|NCT00790751|19403444|P3|Overall Study|Physician Decision|0
5617016|NCT00790751|19403445|P2|Overall Study|Physician Decision|0
5617017|NCT00790751|19403446|P1|Overall Study|Physician Decision|0
5617018|NCT00790751|19403443|P4|Overall Study|Death|0
5617019|NCT00790751|19403444|P3|Overall Study|Death|1
5617020|NCT00790751|19403445|P2|Overall Study|Death|0
5617021|NCT00790751|19403446|P1|Overall Study|Death|0
5617022|NCT00790751|19403443|P4|Overall Study|Requirement for restricted medication|0
5617023|NCT00790751|19403444|P3|Overall Study|Requirement for restricted medication|0
5617024|NCT00790751|19403445|P2|Overall Study|Requirement for restricted medication|2
5617025|NCT00790751|19403446|P1|Overall Study|Requirement for restricted medication|0
5617026|NCT00790751|19403443|P4|Overall Study|Adverse Event|4
5617027|NCT00790751|19403444|P3|Overall Study|Adverse Event|5
5617028|NCT00790751|19403445|P2|Overall Study|Adverse Event|3
5617029|NCT00790751|19403446|P1|Overall Study|Adverse Event|5
5617030|NCT00790751|19403443|P4|Overall Study|Lost to Follow-up|5
5617031|NCT00790751|19403444|P3|Overall Study|Lost to Follow-up|4
5617032|NCT00790751|19403445|P2|Overall Study|Lost to Follow-up|9
5617033|NCT00790751|19403446|P1|Overall Study|Lost to Follow-up|4
5617034|NCT00790751|19403443|P4|Overall Study|Protocol non-compliance|11
5617035|NCT00790751|19403444|P3|Overall Study|Protocol non-compliance|10
5617036|NCT00790751|19403445|P2|Overall Study|Protocol non-compliance|16
5617037|NCT00790751|19403446|P1|Overall Study|Protocol non-compliance|16
5617038|NCT00790647|19403505|P1|Overall Study|Adverse Event|1
5617039|NCT00790582|19403514|P2|Overall Study|Withdrawal by Subject|51
5617040|NCT00790582|19403515|P1|Overall Study|Withdrawal by Subject|7
5617041|NCT00790582|19403514|P2|Overall Study|Lost to Follow-up|3
5617042|NCT00790582|19403515|P1|Overall Study|Lost to Follow-up|3
5617043|NCT00790582|19403514|P2|Overall Study|Physician Decision|1
5617044|NCT00790582|19403515|P1|Overall Study|Physician Decision|7
5617045|NCT00790582|19403514|P2|Overall Study|Death|32
5617046|NCT00790582|19403515|P1|Overall Study|Death|14
5617047|NCT00790569|19403526|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
5617048|NCT00790569|19403527|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
5617049|NCT00790569|19403528|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
5617050|NCT00790569|19403526|P3|End of Treatment (6 Month Interview)|Incarcerated|3
5617051|NCT00790569|19403527|P2|End of Treatment (6 Month Interview)|Incarcerated|0
5617052|NCT00790569|19403528|P1|End of Treatment (6 Month Interview)|Incarcerated|0
5617053|NCT00790569|19403526|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
5617054|NCT00790569|19403527|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
5617055|NCT00790569|19403528|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
5617056|NCT00790569|19403526|P3|End of Treatment (6 Month Interview)|Hospitalized|0
5617057|NCT00790569|19403527|P2|End of Treatment (6 Month Interview)|Hospitalized|0
5617058|NCT00790569|19403528|P1|End of Treatment (6 Month Interview)|Hospitalized|2
5617059|NCT00790569|19403526|P3|End of Treatment (6 Month Interview)|Death|1
5617060|NCT00790569|19403527|P2|End of Treatment (6 Month Interview)|Death|2
5617061|NCT00790569|19403528|P1|End of Treatment (6 Month Interview)|Death|0
5617062|NCT00790569|19403526|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
5617063|NCT00790569|19403527|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
5617064|NCT00790569|19403528|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
5617065|NCT00790556|19403569|P2|Treatment Period 1|Withdrawal by Subject|0
5617066|NCT00790556|19403570|P1|Treatment Period 1|Withdrawal by Subject|1
5617067|NCT00790556|19403569|P2|Treatment Period 1|Physician Decision|0
5617068|NCT00790556|19403570|P1|Treatment Period 1|Physician Decision|1
5617069|NCT00790452|19403582|P2|Overall Study|Drug supply issue|0
5617070|NCT00790452|19403583|P1|Overall Study|Drug supply issue|1
5617071|NCT00790400|19403591|P2|Everolimus Period (Core or Extension)|New treatment|0
5617072|NCT00790400|19403592|P1|Everolimus Period (Core or Extension)|New treatment|2
5617073|NCT00790400|19403591|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
5617074|NCT00790400|19403592|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
5617075|NCT00790400|19403591|P2|Everolimus Period (Core or Extension)|Disease progression|0
5617076|NCT00790400|19403592|P1|Everolimus Period (Core or Extension)|Disease progression|5
5617077|NCT00790400|19403591|P2|Everolimus Period (Core or Extension)|Death|0
5617078|NCT00790400|19403592|P1|Everolimus Period (Core or Extension)|Death|1
5617079|NCT00790400|19403591|P2|Everolimus Period (Core or Extension)|Administrative problems|0
5617080|NCT00790400|19403592|P1|Everolimus Period (Core or Extension)|Administrative problems|2
5617081|NCT00790400|19403591|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
5617082|NCT00790400|19403592|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
5617083|NCT00790400|19403591|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
5617084|NCT00790400|19403592|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
5617085|NCT00790400|19403591|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
5617086|NCT00790400|19403592|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
5617087|NCT00790400|19403591|P2|Everolimus Period (Core or Extension)|Adverse Event|0
5617088|NCT00790400|19403592|P1|Everolimus Period (Core or Extension)|Adverse Event|9
5617089|NCT00790400|19403591|P2|Double-blind Period (Core Phase)|Death|0
5617090|NCT00790400|19403592|P1|Double-blind Period (Core Phase)|Death|1
5617091|NCT00790400|19403591|P2|Double-blind Period (Core Phase)|Administrative problems|0
5617092|NCT00790400|19403592|P1|Double-blind Period (Core Phase)|Administrative problems|1
5617093|NCT00790400|19403591|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
5617094|NCT00790400|19403592|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
5617095|NCT00790400|19403591|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
5617096|NCT00790400|19403592|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
5617097|NCT00790400|19403591|P2|Double-blind Period (Core Phase)|Adverse Event|4
5617098|NCT00790400|19403592|P1|Double-blind Period (Core Phase)|Adverse Event|2
5617099|NCT00790400|19403591|P2|Double-blind Period (Core Phase)|Progressive disease|9
5617100|NCT00790400|19403592|P1|Double-blind Period (Core Phase)|Progressive disease|0
5617101|NCT00790400|19403591|P2|Double-blind Period (Core Phase)|Protocol Violation|0
5617102|NCT00790400|19403592|P1|Double-blind Period (Core Phase)|Protocol Violation|1
5617103|NCT00790296|19403682|P2|Overall Study|Adverse Event|1
5617104|NCT00790296|19403683|P1|Overall Study|Adverse Event|0
5617105|NCT00790296|19403682|P2|Overall Study|Did not meet study eligibility criteria|1
5617106|NCT00790296|19403683|P1|Overall Study|Did not meet study eligibility criteria|1
5617107|NCT00790218|19403705|P3|Overall Study|Death|0
5617108|NCT00790218|19403706|P2|Overall Study|Death|0
5617109|NCT00790218|19403707|P1|Overall Study|Death|1
5617110|NCT00790205|19403717|P2|Overall Study|Withdrawal by Subject|363
5617111|NCT00790205|19403718|P1|Overall Study|Withdrawal by Subject|299
5617112|NCT00790205|19403717|P2|Overall Study|Lost to Follow-up|71
5617113|NCT00790205|19403718|P1|Overall Study|Lost to Follow-up|61
5617114|NCT00790088|19403779|P1|Overall Study|Physician Decision|4
5617115|NCT00790088|19403779|P1|Overall Study|Lost to Follow-up|7
5617116|NCT00790088|19403779|P1|Overall Study|Withdrawal by Subject|17
5617117|NCT00790088|19403779|P1|Overall Study|Protocol Violation|11
5617118|NCT00790036|19403825|P2|Overall Study|Subject/guardian decision|7
5617119|NCT00790036|19403826|P1|Overall Study|Subject/guardian decision|20
5617120|NCT00790036|19403825|P2|Overall Study|Withdrawal by Subject|7
5617121|NCT00790036|19403826|P1|Overall Study|Withdrawal by Subject|18
5617122|NCT00790036|19403825|P2|Overall Study|Protocol Violation|2
5617123|NCT00790036|19403826|P1|Overall Study|Protocol Violation|10
5617124|NCT00790036|19403825|P2|Overall Study|Lost to Follow-up|2
5617125|NCT00790036|19403826|P1|Overall Study|Lost to Follow-up|1
5617126|NCT00790036|19403825|P2|Overall Study|Disease progression|48
5617127|NCT00790036|19403826|P1|Overall Study|Disease progression|24
5617128|NCT00790036|19403825|P2|Overall Study|Death|0
5617129|NCT00790036|19403826|P1|Overall Study|Death|1
5617130|NCT00790036|19403825|P2|Overall Study|Adverse Event|44
5617131|NCT00790036|19403826|P1|Overall Study|Adverse Event|113
5617132|NCT00790036|19403825|P2|Overall Study|Administrative problems|9
5617133|NCT00790036|19403826|P1|Overall Study|Administrative problems|5
5617134|NCT00790036|19403825|P2|Overall Study|Abnormal lab values|2
5617135|NCT00790036|19403826|P1|Overall Study|Abnormal lab values|3
5617136|NCT00790023|19403840|P3|Overall Study|Other|8
5617137|NCT00790023|19403841|P2|Overall Study|Other|5
5617138|NCT00790023|19403842|P1|Overall Study|Other|5
5617139|NCT00790023|19403840|P3|Overall Study|Lost to Follow-up|1
5617140|NCT00790023|19403841|P2|Overall Study|Lost to Follow-up|0
5617141|NCT00790023|19403842|P1|Overall Study|Lost to Follow-up|0
5617142|NCT00790023|19403840|P3|Overall Study|Withdrawal by Subject|6
5617143|NCT00790023|19403841|P2|Overall Study|Withdrawal by Subject|0
5617144|NCT00790023|19403842|P1|Overall Study|Withdrawal by Subject|2
5617145|NCT00790023|19403840|P3|Overall Study|Protocol Violation|2
5617146|NCT00790023|19403841|P2|Overall Study|Protocol Violation|4
5617147|NCT00790023|19403842|P1|Overall Study|Protocol Violation|2
5617148|NCT00790023|19403840|P3|Overall Study|Adverse Event|4
5617149|NCT00790023|19403841|P2|Overall Study|Adverse Event|1
5617150|NCT00790023|19403842|P1|Overall Study|Adverse Event|2
5617151|NCT00789958|19403941|P1|Overall Study|Not eligible/not analyzable|26
5617152|NCT00789958|19403941|P1|Overall Study|not protocol specified|1
5617153|NCT00789958|19403941|P1|Overall Study|Progression|3
5617154|NCT00789958|19403941|P1|Overall Study|Withdrawal by Subject|4
5617155|NCT00789958|19403941|P1|Overall Study|Adverse Event|3
5617156|NCT00789880|19403960|P6|Overall Study|Withdrawal by Subject|0
5617157|NCT00789880|19403961|P5|Overall Study|Withdrawal by Subject|2
5617158|NCT00789880|19403962|P4|Overall Study|Withdrawal by Subject|0
5617159|NCT00789880|19403963|P3|Overall Study|Withdrawal by Subject|0
5617160|NCT00789880|19403964|P2|Overall Study|Withdrawal by Subject|0
5617161|NCT00789880|19403965|P1|Overall Study|Withdrawal by Subject|1
5617162|NCT00789880|19403960|P6|Overall Study|Protocol Violation|0
5617163|NCT00789880|19403961|P5|Overall Study|Protocol Violation|0
5617164|NCT00789880|19403962|P4|Overall Study|Protocol Violation|1
5617165|NCT00789880|19403963|P3|Overall Study|Protocol Violation|0
5617166|NCT00789880|19403964|P2|Overall Study|Protocol Violation|1
5617167|NCT00789880|19403965|P1|Overall Study|Protocol Violation|0
5617168|NCT00789880|19403960|P6|Overall Study|Adverse Event|0
5617169|NCT00789880|19403961|P5|Overall Study|Adverse Event|1
5617170|NCT00789880|19403962|P4|Overall Study|Adverse Event|0
5617171|NCT00789880|19403963|P3|Overall Study|Adverse Event|0
5617172|NCT00789880|19403964|P2|Overall Study|Adverse Event|0
5617173|NCT00789880|19403965|P1|Overall Study|Adverse Event|0
5617174|NCT00789854|19404022|P3|Overall Study|Other|5
5617175|NCT00789854|19404023|P2|Overall Study|Other|0
5617176|NCT00789854|19404024|P1|Overall Study|Other|6
5617177|NCT00789854|19404022|P3|Overall Study|Safety reasons|2
5617178|NCT00789854|19404023|P2|Overall Study|Safety reasons|0
5617179|NCT00789854|19404024|P1|Overall Study|Safety reasons|0
5617180|NCT00789854|19404022|P3|Overall Study|Severe non-compliance to the protocol|0
5617181|NCT00789854|19404023|P2|Overall Study|Severe non-compliance to the protocol|0
5617182|NCT00789854|19404024|P1|Overall Study|Severe non-compliance to the protocol|3
5617183|NCT00789854|19404022|P3|Overall Study|Eligibility criteria not fulfilled|1
5617184|NCT00789854|19404023|P2|Overall Study|Eligibility criteria not fulfilled|5
5617185|NCT00789854|19404024|P1|Overall Study|Eligibility criteria not fulfilled|2
5617186|NCT00789854|19404022|P3|Overall Study|Withdrawal by Subject|17
5617187|NCT00789854|19404023|P2|Overall Study|Withdrawal by Subject|6
5617188|NCT00789854|19404024|P1|Overall Study|Withdrawal by Subject|9
5617189|NCT00789854|19404022|P3|Overall Study|Lost to Follow-up|4
5617190|NCT00789854|19404023|P2|Overall Study|Lost to Follow-up|1
5617191|NCT00789854|19404024|P1|Overall Study|Lost to Follow-up|1
5617192|NCT00789854|19404022|P3|Overall Study|Adverse Event|18
5617193|NCT00789854|19404023|P2|Overall Study|Adverse Event|23
5617194|NCT00789854|19404024|P1|Overall Study|Adverse Event|28
5617195|NCT00789828|19404121|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
5617196|NCT00789828|19404122|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
5617197|NCT00789828|19404121|P2|Open-label Extension Period (4 Years)|Disease progression|0
5617198|NCT00789828|19404122|P1|Open-label Extension Period (4 Years)|Disease progression|1
5617199|NCT00789828|19404121|P2|Open-label Extension Period (4 Years)|Death|0
5617200|NCT00789828|19404122|P1|Open-label Extension Period (4 Years)|Death|1
5617201|NCT00789828|19404121|P2|Open-label Extension Period (4 Years)|Administrative problems|0
5617202|NCT00789828|19404122|P1|Open-label Extension Period (4 Years)|Administrative problems|7
5617203|NCT00789828|19404121|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
5617204|NCT00789828|19404122|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
5617205|NCT00789828|19404121|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
5617206|NCT00789828|19404122|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
5617207|NCT00789828|19404121|P2|Open-label Extension Period (4 Years)|Adverse Event|0
5617208|NCT00789828|19404122|P1|Open-label Extension Period (4 Years)|Adverse Event|10
5617209|NCT00789828|19404121|P2|Core Period (48 Weeks)|Lost to Follow-up|1
5617210|NCT00789828|19404122|P1|Core Period (48 Weeks)|Lost to Follow-up|0
5617211|NCT00789828|19404121|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
5617212|NCT00789828|19404122|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
5617213|NCT00789828|19404121|P2|Core Period (48 Weeks)|Administrative problems|1
5617214|NCT00789828|19404122|P1|Core Period (48 Weeks)|Administrative problems|0
5617215|NCT00789815|19404156|P2|Overall Study|Intubation due to massive bleeding|0
5617216|NCT00789815|19404157|P1|Overall Study|Intubation due to massive bleeding|1
5617217|NCT00789815|19404156|P2|Overall Study|Protocol Violation|1
5617218|NCT00789815|19404157|P1|Overall Study|Protocol Violation|6
5617219|NCT00789737|19404267|P2|Overall Study|Other|7
5617220|NCT00789737|19404268|P1|Overall Study|Other|11
5617221|NCT00789737|19404267|P2|Overall Study|hyperglycemia that met protocol-specifie|4
5617222|NCT00789737|19404268|P1|Overall Study|hyperglycemia that met protocol-specifie|0
5617223|NCT00789737|19404267|P2|Overall Study|Lack of Efficacy|0
5617224|NCT00789737|19404268|P1|Overall Study|Lack of Efficacy|3
5617225|NCT00789737|19404267|P2|Overall Study|Protocol Violation|0
5617226|NCT00789737|19404268|P1|Overall Study|Protocol Violation|3
5617227|NCT00789737|19404267|P2|Overall Study|Adverse Event|8
5617228|NCT00789737|19404268|P1|Overall Study|Adverse Event|8
5617229|NCT00789737|19404267|P2|Overall Study|Lost to Follow-up|14
5617230|NCT00789737|19404268|P1|Overall Study|Lost to Follow-up|10
5617231|NCT00789737|19404267|P2|Overall Study|Withdrawal by Subject|22
5617232|NCT00789737|19404268|P1|Overall Study|Withdrawal by Subject|13
5617233|NCT00789698|19404311|P4|Overall Study|Administrative|1
5617234|NCT00789698|19404312|P3|Overall Study|Administrative|3
5617235|NCT00789698|19404313|P2|Overall Study|Administrative|3
5617236|NCT00789698|19404314|P1|Overall Study|Administrative|0
5617237|NCT00789698|19404311|P4|Overall Study|Withdrawal by Subject|19
5617238|NCT00789698|19404312|P3|Overall Study|Withdrawal by Subject|12
5617239|NCT00789698|19404313|P2|Overall Study|Withdrawal by Subject|15
5617240|NCT00789698|19404314|P1|Overall Study|Withdrawal by Subject|14
5617241|NCT00789698|19404311|P4|Overall Study|Protocol Violation|1
5617242|NCT00789698|19404312|P3|Overall Study|Protocol Violation|2
5617243|NCT00789698|19404313|P2|Overall Study|Protocol Violation|1
5617244|NCT00789698|19404314|P1|Overall Study|Protocol Violation|6
5617245|NCT00789698|19404311|P4|Overall Study|Lost to Follow-up|9
5617246|NCT00789698|19404312|P3|Overall Study|Lost to Follow-up|2
5617247|NCT00789698|19404313|P2|Overall Study|Lost to Follow-up|5
5617248|NCT00789698|19404314|P1|Overall Study|Lost to Follow-up|5
5617249|NCT00789698|19404311|P4|Overall Study|Adverse Event|4
5617250|NCT00789698|19404312|P3|Overall Study|Adverse Event|3
5617251|NCT00789698|19404313|P2|Overall Study|Adverse Event|5
5617252|NCT00789698|19404314|P1|Overall Study|Adverse Event|5
5617253|NCT00789698|19404311|P4|Overall Study|Lack of Efficacy|18
5617254|NCT00789698|19404312|P3|Overall Study|Lack of Efficacy|5
5617255|NCT00789698|19404313|P2|Overall Study|Lack of Efficacy|4
5617256|NCT00789698|19404314|P1|Overall Study|Lack of Efficacy|10
5617257|NCT00789581|19404369|P2|Adjuvant Therapy|Other|1
5617258|NCT00789581|19404370|P1|Adjuvant Therapy|Other|0
5617259|NCT00789581|19404369|P2|Adjuvant Therapy|Protocol Violation|1
5617260|NCT00789581|19404370|P1|Adjuvant Therapy|Protocol Violation|1
5617261|NCT00789581|19404369|P2|Adjuvant Therapy|Intercurrent Illness|3
5617262|NCT00789581|19404370|P1|Adjuvant Therapy|Intercurrent Illness|1
5617263|NCT00789581|19404369|P2|Adjuvant Therapy|Disease recurrence|1
5617264|NCT00789581|19404370|P1|Adjuvant Therapy|Disease recurrence|2
5617265|NCT00789581|19404369|P2|Adjuvant Therapy|Withdrawal by Subject|5
5617266|NCT00789581|19404370|P1|Adjuvant Therapy|Withdrawal by Subject|14
5617267|NCT00789581|19404369|P2|Adjuvant Therapy|Adverse Event|44
5617268|NCT00789581|19404370|P1|Adjuvant Therapy|Adverse Event|20
5617269|NCT00789581|19404369|P2|Adjuvant Therapy|Never treated|2
5617270|NCT00789581|19404370|P1|Adjuvant Therapy|Never treated|2
5617271|NCT00789581|19404369|P2|AC Therapy|Other|2
5617272|NCT00789581|19404370|P1|AC Therapy|Other|0
5617273|NCT00789581|19404369|P2|AC Therapy|Never Treated|4
5617274|NCT00789581|19404370|P1|AC Therapy|Never Treated|1
5617275|NCT00789581|19404369|P2|AC Therapy|Intercurrent Illness|0
5617276|NCT00789581|19404370|P1|AC Therapy|Intercurrent Illness|1
5617277|NCT00789581|19404369|P2|AC Therapy|Disease recurrence|1
5617278|NCT00789581|19404370|P1|AC Therapy|Disease recurrence|3
5617279|NCT00789581|19404369|P2|AC Therapy|Withdrawal by Subject|7
5617280|NCT00789581|19404370|P1|AC Therapy|Withdrawal by Subject|4
5617281|NCT00789581|19404369|P2|AC Therapy|Adverse Event|3
5617282|NCT00789581|19404370|P1|AC Therapy|Adverse Event|2
5617283|NCT00789555|19404381|P3|Overall Study|Protocol Violation|13
5617284|NCT00789555|19404382|P2|Overall Study|Protocol Violation|9
5617285|NCT00789555|19404383|P1|Overall Study|Protocol Violation|6
5617286|NCT00789555|19404381|P3|Overall Study|Treatment failure|12
5617287|NCT00789555|19404382|P2|Overall Study|Treatment failure|8
5617288|NCT00789555|19404383|P1|Overall Study|Treatment failure|11
5617289|NCT00789555|19404381|P3|Overall Study|Patient decision unnrelated to adv event|26
5617290|NCT00789555|19404382|P2|Overall Study|Patient decision unnrelated to adv event|29
5617291|NCT00789555|19404383|P1|Overall Study|Patient decision unnrelated to adv event|38
5617292|NCT00789555|19404381|P3|Overall Study|Lost to Follow-up|18
5617293|NCT00789555|19404382|P2|Overall Study|Lost to Follow-up|10
5617294|NCT00789555|19404383|P1|Overall Study|Lost to Follow-up|9
5617295|NCT00789555|19404381|P3|Overall Study|Adverse Event|10
5617296|NCT00789555|19404382|P2|Overall Study|Adverse Event|7
5617297|NCT00789555|19404383|P1|Overall Study|Adverse Event|17
5617298|NCT00789555|19404381|P3|Overall Study|Protocol Amendment|80
5617299|NCT00789555|19404382|P2|Overall Study|Protocol Amendment|76
5617300|NCT00789555|19404383|P1|Overall Study|Protocol Amendment|78
5617301|NCT00789529|19404408|P2|Overall Study|Other Reason|0
5617302|NCT00789529|19404409|P1|Overall Study|Other Reason|1
5617303|NCT00789529|19404408|P2|Overall Study|Withdrawal by Subject|1
5617304|NCT00789529|19404409|P1|Overall Study|Withdrawal by Subject|0
5617305|NCT00789477|19404422|P5|Overall Study|Other|0
5617306|NCT00789477|19404423|P4|Overall Study|Other|3
5617307|NCT00789477|19404424|P3|Overall Study|Other|1
5617308|NCT00789477|19404425|P2|Overall Study|Other|0
5617309|NCT00789477|19404426|P1|Overall Study|Other|2
5617310|NCT00789477|19404422|P5|Overall Study|Lack of Efficacy|0
5617311|NCT00789477|19404423|P4|Overall Study|Lack of Efficacy|0
5617312|NCT00789477|19404424|P3|Overall Study|Lack of Efficacy|0
5617313|NCT00789477|19404425|P2|Overall Study|Lack of Efficacy|0
5617314|NCT00789477|19404426|P1|Overall Study|Lack of Efficacy|2
5617315|NCT00789477|19404422|P5|Overall Study|Lost to Follow-up|4
5617316|NCT00789477|19404423|P4|Overall Study|Lost to Follow-up|2
5617317|NCT00789477|19404424|P3|Overall Study|Lost to Follow-up|4
5617318|NCT00789477|19404425|P2|Overall Study|Lost to Follow-up|1
5617319|NCT00789477|19404426|P1|Overall Study|Lost to Follow-up|0
5617320|NCT00789477|19404422|P5|Overall Study|Death|0
5617321|NCT00789477|19404423|P4|Overall Study|Death|2
5617322|NCT00789477|19404424|P3|Overall Study|Death|2
5617323|NCT00789477|19404425|P2|Overall Study|Death|1
5617324|NCT00789477|19404426|P1|Overall Study|Death|1
5617325|NCT00789477|19404422|P5|Overall Study|Adverse Event|0
5617326|NCT00789477|19404423|P4|Overall Study|Adverse Event|0
5617327|NCT00789477|19404424|P3|Overall Study|Adverse Event|1
5617328|NCT00789477|19404425|P2|Overall Study|Adverse Event|3
5617329|NCT00789477|19404426|P1|Overall Study|Adverse Event|3
5617330|NCT00789477|19404422|P5|Overall Study|Protocol Violation|0
5617331|NCT00789477|19404423|P4|Overall Study|Protocol Violation|1
5617332|NCT00789477|19404424|P3|Overall Study|Protocol Violation|0
5617333|NCT00789477|19404425|P2|Overall Study|Protocol Violation|0
5617334|NCT00789477|19404426|P1|Overall Study|Protocol Violation|1
5617335|NCT00789477|19404422|P5|Overall Study|Withdrawal by Subject|3
5617336|NCT00789477|19404423|P4|Overall Study|Withdrawal by Subject|2
5617337|NCT00789477|19404424|P3|Overall Study|Withdrawal by Subject|3
5617338|NCT00789477|19404425|P2|Overall Study|Withdrawal by Subject|1
5617339|NCT00789477|19404426|P1|Overall Study|Withdrawal by Subject|2
5617340|NCT00789373|19404471|P3|Maintenance|Participants On-Going at Data Cut-Off|0
5617341|NCT00789373|19404472|P2|Maintenance|Participants On-Going at Data Cut-Off|4
5617342|NCT00789373|19404473|P1|Maintenance|Participants On-Going at Data Cut-Off|0
5617343|NCT00789373|19404471|P3|Maintenance|Sponsor Decision|2
5617344|NCT00789373|19404472|P2|Maintenance|Sponsor Decision|0
5617345|NCT00789373|19404473|P1|Maintenance|Sponsor Decision|0
5617346|NCT00789373|19404471|P3|Maintenance|Withdrawal by Subject|8
5617347|NCT00789373|19404472|P2|Maintenance|Withdrawal by Subject|21
5617348|NCT00789373|19404473|P1|Maintenance|Withdrawal by Subject|0
5617349|NCT00789373|19404471|P3|Maintenance|Progressive Disease|152
5617350|NCT00789373|19404472|P2|Maintenance|Progressive Disease|253
5617351|NCT00789373|19404473|P1|Maintenance|Progressive Disease|0
5617352|NCT00789373|19404471|P3|Maintenance|Lost to Follow-up|0
5617353|NCT00789373|19404472|P2|Maintenance|Lost to Follow-up|2
5617354|NCT00789373|19404473|P1|Maintenance|Lost to Follow-up|0
5617355|NCT00789373|19404471|P3|Maintenance|Protocol entry criteria not met|0
5617356|NCT00789373|19404472|P2|Maintenance|Protocol entry criteria not met|2
5617357|NCT00789373|19404473|P1|Maintenance|Protocol entry criteria not met|0
5617358|NCT00789373|19404471|P3|Maintenance|Investigator Decision|2
5617359|NCT00789373|19404472|P2|Maintenance|Investigator Decision|4
5617360|NCT00789373|19404473|P1|Maintenance|Investigator Decision|0
5617361|NCT00789373|19404471|P3|Maintenance|Death due to toxicity|2
5617362|NCT00789373|19404472|P2|Maintenance|Death due to toxicity|1
5617363|NCT00789373|19404473|P1|Maintenance|Death due to toxicity|0
5617364|NCT00789373|19404471|P3|Maintenance|Death due to adverse event|1
5617365|NCT00789373|19404472|P2|Maintenance|Death due to adverse event|4
5617366|NCT00789373|19404473|P1|Maintenance|Death due to adverse event|0
5617367|NCT00789373|19404471|P3|Maintenance|Death due to study disease|1
5617368|NCT00789373|19404472|P2|Maintenance|Death due to study disease|3
5617369|NCT00789373|19404473|P1|Maintenance|Death due to study disease|0
5617370|NCT00789373|19404471|P3|Maintenance|Adverse Event|12
5617371|NCT00789373|19404472|P2|Maintenance|Adverse Event|65
5617372|NCT00789373|19404473|P1|Maintenance|Adverse Event|0
5617373|NCT00789373|19404471|P3|Induction|Withdrawal by Subject|0
5617374|NCT00789373|19404472|P2|Induction|Withdrawal by Subject|0
5617375|NCT00789373|19404473|P1|Induction|Withdrawal by Subject|37
5617376|NCT00789373|19404471|P3|Induction|Progressive Disease|0
5617377|NCT00789373|19404472|P2|Induction|Progressive Disease|0
5617378|NCT00789373|19404473|P1|Induction|Progressive Disease|220
5617379|NCT00789373|19404471|P3|Induction|Protocol Violation|0
5617380|NCT00789373|19404472|P2|Induction|Protocol Violation|0
5617381|NCT00789373|19404473|P1|Induction|Protocol Violation|1
5617382|NCT00789373|19404471|P3|Induction|Lost to Follow-up|0
5617383|NCT00789373|19404472|P2|Induction|Lost to Follow-up|0
5617384|NCT00789373|19404473|P1|Induction|Lost to Follow-up|6
5617385|NCT00789373|19404471|P3|Induction|Protocol entry criteria not met|0
5617386|NCT00789373|19404472|P2|Induction|Protocol entry criteria not met|0
5617387|NCT00789373|19404473|P1|Induction|Protocol entry criteria not met|9
5617388|NCT00789373|19404471|P3|Induction|Investigator decision|0
5617389|NCT00789373|19404472|P2|Induction|Investigator decision|0
5617390|NCT00789373|19404473|P1|Induction|Investigator decision|7
5617391|NCT00789373|19404471|P3|Induction|Death due to procedure|0
5617392|NCT00789373|19404472|P2|Induction|Death due to procedure|0
5617393|NCT00789373|19404473|P1|Induction|Death due to procedure|1
5617394|NCT00789373|19404471|P3|Induction|Death due to toxicity|0
5617395|NCT00789373|19404472|P2|Induction|Death due to toxicity|0
5617396|NCT00789373|19404473|P1|Induction|Death due to toxicity|11
5617397|NCT00789373|19404471|P3|Induction|Death due to adverse event|0
5617398|NCT00789373|19404472|P2|Induction|Death due to adverse event|0
5617399|NCT00789373|19404473|P1|Induction|Death due to adverse event|19
5617400|NCT00789373|19404471|P3|Induction|Death Due to study disease|0
5617401|NCT00789373|19404472|P2|Induction|Death Due to study disease|0
5617402|NCT00789373|19404473|P1|Induction|Death Due to study disease|24
5617403|NCT00789373|19404471|P3|Induction|Adverse Event|0
5617404|NCT00789373|19404472|P2|Induction|Adverse Event|0
5617405|NCT00789373|19404473|P1|Induction|Adverse Event|64
5617406|NCT00789360|19404500|P2|Overall Study|Protocol Violation|1
5617407|NCT00789360|19404501|P1|Overall Study|Protocol Violation|3
5617408|NCT00789321|19404511|P2|Overall Study|Adverse Event|1
5617409|NCT00789321|19404512|P1|Overall Study|Adverse Event|0
5617410|NCT00789191|19404534|P2|Overall Study|Unclassified|3
5617411|NCT00789191|19404535|P1|Overall Study|Unclassified|5
5617412|NCT00789191|19404534|P2|Overall Study|Withdrawal Criteria|4
5617413|NCT00789191|19404535|P1|Overall Study|Withdrawal Criteria|2
5617414|NCT00789191|19404534|P2|Overall Study|Protocol Violation|3
5617415|NCT00789191|19404535|P1|Overall Study|Protocol Violation|5
5617416|NCT00789191|19404534|P2|Overall Study|Lack of Efficacy|5
5617417|NCT00789191|19404535|P1|Overall Study|Lack of Efficacy|0
5617418|NCT00789191|19404534|P2|Overall Study|Adverse Event|4
5617419|NCT00789191|19404535|P1|Overall Study|Adverse Event|2
5617420|NCT00789035|19404592|P5|Overall Study|Other reason not defined above|1
5617421|NCT00789035|19404593|P4|Overall Study|Other reason not defined above|0
5617422|NCT00789035|19404594|P3|Overall Study|Other reason not defined above|1
5617423|NCT00789035|19404595|P2|Overall Study|Other reason not defined above|3
5617424|NCT00789035|19404596|P1|Overall Study|Other reason not defined above|2
5617425|NCT00789035|19404592|P5|Overall Study|Withdrawal by Subject|0
5617426|NCT00789035|19404593|P4|Overall Study|Withdrawal by Subject|0
5617427|NCT00789035|19404594|P3|Overall Study|Withdrawal by Subject|0
5617428|NCT00789035|19404595|P2|Overall Study|Withdrawal by Subject|2
5617429|NCT00789035|19404596|P1|Overall Study|Withdrawal by Subject|0
5617430|NCT00789035|19404592|P5|Overall Study|Protocol Violation|0
5617431|NCT00789035|19404593|P4|Overall Study|Protocol Violation|0
5617432|NCT00789035|19404594|P3|Overall Study|Protocol Violation|0
5617433|NCT00789035|19404595|P2|Overall Study|Protocol Violation|0
5617434|NCT00789035|19404596|P1|Overall Study|Protocol Violation|1
5617435|NCT00789035|19404592|P5|Overall Study|Lack of Efficacy|2
5617436|NCT00789035|19404593|P4|Overall Study|Lack of Efficacy|0
5617437|NCT00789035|19404594|P3|Overall Study|Lack of Efficacy|0
5617438|NCT00789035|19404595|P2|Overall Study|Lack of Efficacy|0
5617439|NCT00789035|19404596|P1|Overall Study|Lack of Efficacy|3
5617440|NCT00789035|19404592|P5|Overall Study|Adverse Event|3
5617441|NCT00789035|19404593|P4|Overall Study|Adverse Event|1
5617442|NCT00789035|19404594|P3|Overall Study|Adverse Event|0
5617443|NCT00789035|19404595|P2|Overall Study|Adverse Event|2
5617444|NCT00789035|19404596|P1|Overall Study|Adverse Event|0
5617445|NCT00788957|19404655|P6|Part 3|On-study at time of data cut-off|0
5617446|NCT00788957|19404656|P5|Part 3|On-study at time of data cut-off|1
5617447|NCT00788957|19404657|P4|Part 3|On-study at time of data cut-off|0
5617448|NCT00788957|19404658|P3|Part 3|On-study at time of data cut-off|0
5617449|NCT00788957|19404659|P2|Part 3|On-study at time of data cut-off|0
5617450|NCT00788957|19404660|P1|Part 3|On-study at time of data cut-off|0
5617451|NCT00788957|19404655|P6|Part 3|Death|9
5617452|NCT00788957|19404656|P5|Part 3|Death|8
5617453|NCT00788957|19404657|P4|Part 3|Death|0
5617454|NCT00788957|19404658|P3|Part 3|Death|0
5617455|NCT00788957|19404659|P2|Part 3|Death|0
5617456|NCT00788957|19404660|P1|Part 3|Death|0
5617457|NCT00788957|19404655|P6|Part 3|Withdrawal by Subject|2
5617458|NCT00788957|19404656|P5|Part 3|Withdrawal by Subject|0
5617459|NCT00788957|19404657|P4|Part 3|Withdrawal by Subject|0
5617460|NCT00788957|19404658|P3|Part 3|Withdrawal by Subject|0
5617461|NCT00788957|19404659|P2|Part 3|Withdrawal by Subject|0
5617462|NCT00788957|19404660|P1|Part 3|Withdrawal by Subject|0
5617463|NCT00788957|19404655|P6|Part 2|On-study at time of data cut-off|0
5617464|NCT00788957|19404656|P5|Part 2|On-study at time of data cut-off|0
5617465|NCT00788957|19404657|P4|Part 2|On-study at time of data cut-off|1
5617466|NCT00788957|19404658|P3|Part 2|On-study at time of data cut-off|1
5617467|NCT00788957|19404659|P2|Part 2|On-study at time of data cut-off|1
5617468|NCT00788957|19404660|P1|Part 2|On-study at time of data cut-off|0
5617469|NCT00788957|19404655|P6|Part 2|Lost to Follow-up|0
5617470|NCT00788957|19404656|P5|Part 2|Lost to Follow-up|0
5617471|NCT00788957|19404657|P4|Part 2|Lost to Follow-up|0
5617472|NCT00788957|19404658|P3|Part 2|Lost to Follow-up|3
5617473|NCT00788957|19404659|P2|Part 2|Lost to Follow-up|0
5617474|NCT00788957|19404660|P1|Part 2|Lost to Follow-up|0
5617475|NCT00788957|19404655|P6|Part 2|Death|0
5617476|NCT00788957|19404656|P5|Part 2|Death|0
5617477|NCT00788957|19404657|P4|Part 2|Death|37
5617478|NCT00788957|19404658|P3|Part 2|Death|35
5617479|NCT00788957|19404659|P2|Part 2|Death|32
5617480|NCT00788957|19404660|P1|Part 2|Death|0
5617481|NCT00788957|19404655|P6|Part 2|Withdrawal by Subject|0
5617482|NCT00788957|19404656|P5|Part 2|Withdrawal by Subject|0
5617483|NCT00788957|19404657|P4|Part 2|Withdrawal by Subject|3
5617484|NCT00788957|19404658|P3|Part 2|Withdrawal by Subject|5
5617485|NCT00788957|19404659|P2|Part 2|Withdrawal by Subject|9
5617486|NCT00788957|19404660|P1|Part 2|Withdrawal by Subject|0
5617487|NCT00788957|19404655|P6|Part 1|Lost to Follow-up|0
5617488|NCT00788957|19404656|P5|Part 1|Lost to Follow-up|0
5617489|NCT00788957|19404657|P4|Part 1|Lost to Follow-up|0
5617490|NCT00788957|19404658|P3|Part 1|Lost to Follow-up|0
5617491|NCT00788957|19404659|P2|Part 1|Lost to Follow-up|0
5617492|NCT00788957|19404660|P1|Part 1|Lost to Follow-up|1
5617493|NCT00788957|19404655|P6|Part 1|Death|0
5617494|NCT00788957|19404656|P5|Part 1|Death|0
5617495|NCT00788957|19404657|P4|Part 1|Death|0
5617496|NCT00788957|19404658|P3|Part 1|Death|0
5617497|NCT00788957|19404659|P2|Part 1|Death|0
5617498|NCT00788957|19404660|P1|Part 1|Death|8
5617499|NCT00788827|19404733|P1|Overall Study|Lack of Efficacy|2
5617500|NCT00788775|19404747|P2|Overall Study|Patient's measurable disease resected.|0
5617501|NCT00788775|19404748|P1|Overall Study|Patient's measurable disease resected.|1
5617502|NCT00788775|19404747|P2|Overall Study|Patient Non-Compliance|0
5617503|NCT00788775|19404748|P1|Overall Study|Patient Non-Compliance|1
5617504|NCT00788775|19404747|P2|Overall Study|Withdrawal by Subject|2
5617505|NCT00788775|19404748|P1|Overall Study|Withdrawal by Subject|0
5617506|NCT00788775|19404747|P2|Overall Study|Progressive Disease|6
5617507|NCT00788775|19404748|P1|Overall Study|Progressive Disease|8
5617508|NCT00788710|19404763|P3|Overall Study|Withdrawal by Subject|0
5617509|NCT00788710|19404764|P2|Overall Study|Withdrawal by Subject|2
5617510|NCT00788710|19404765|P1|Overall Study|Withdrawal by Subject|2
5617511|NCT00788710|19404763|P3|Overall Study|Protocol Violation|1
5617512|NCT00788710|19404764|P2|Overall Study|Protocol Violation|1
5617513|NCT00788710|19404765|P1|Overall Study|Protocol Violation|0
5617514|NCT00788710|19404763|P3|Overall Study|Physician Decision|0
5617515|NCT00788710|19404764|P2|Overall Study|Physician Decision|1
5617516|NCT00788710|19404765|P1|Overall Study|Physician Decision|2
5617517|NCT00788710|19404763|P3|Overall Study|Lost to Follow-up|0
5617518|NCT00788710|19404764|P2|Overall Study|Lost to Follow-up|1
5617519|NCT00788710|19404765|P1|Overall Study|Lost to Follow-up|0
5617520|NCT00788710|19404763|P3|Overall Study|Lack of Efficacy|1
5617521|NCT00788710|19404764|P2|Overall Study|Lack of Efficacy|0
5617522|NCT00788710|19404765|P1|Overall Study|Lack of Efficacy|0
5617523|NCT00788710|19404763|P3|Overall Study|Adverse Event|4
5617524|NCT00788710|19404764|P2|Overall Study|Adverse Event|3
5617525|NCT00788710|19404765|P1|Overall Study|Adverse Event|1
5617526|NCT00788697|19404779|P1|Overall Study|Indeterminate diagnosis from truth stand|17
5617527|NCT00788697|19404779|P1|Overall Study|Technically inadequate truth standard|1
5617528|NCT00788697|19404779|P1|Overall Study|no truth standard procedure available|5
5617529|NCT00788697|19404779|P1|Overall Study|Training Patients|74
5617530|NCT00788697|19404779|P1|Overall Study|No study drug administered|12
5617531|NCT00788593|19404826|P3|Second Intervention Period|Other|1
5617532|NCT00788593|19404827|P2|Second Intervention Period|Other|0
5617533|NCT00788593|19404828|P1|Second Intervention Period|Other|0
5617534|NCT00788593|19404826|P3|Second Intervention Period|Lost to Follow-up|0
5617535|NCT00788593|19404827|P2|Second Intervention Period|Lost to Follow-up|1
5617536|NCT00788593|19404828|P1|Second Intervention Period|Lost to Follow-up|0
5617537|NCT00788593|19404826|P3|First Intervention Period|Adverse Event|0
5617538|NCT00788593|19404827|P2|First Intervention Period|Adverse Event|1
5617539|NCT00788593|19404828|P1|First Intervention Period|Adverse Event|0
5617540|NCT00788593|19404826|P3|Placebo Run-in Phase|Protocol Violation|0
5617541|NCT00788593|19404827|P2|Placebo Run-in Phase|Protocol Violation|0
5617542|NCT00788593|19404828|P1|Placebo Run-in Phase|Protocol Violation|2
5617543|NCT00788593|19404826|P3|Placebo Run-in Phase|Withdrawal by Subject|0
5617544|NCT00788593|19404827|P2|Placebo Run-in Phase|Withdrawal by Subject|0
5617545|NCT00788593|19404828|P1|Placebo Run-in Phase|Withdrawal by Subject|2
5617546|NCT00788593|19404826|P3|Placebo Run-in Phase|Adverse Event|0
5617547|NCT00788593|19404827|P2|Placebo Run-in Phase|Adverse Event|0
5617548|NCT00788593|19404828|P1|Placebo Run-in Phase|Adverse Event|2
5617549|NCT00788372|19404845|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
5617550|NCT00788372|19404845|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
5617551|NCT00788372|19404845|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
5617552|NCT00788372|19404845|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
5617553|NCT00788372|19404845|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
5617554|NCT00788372|19404845|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
5617555|NCT00788372|19404845|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
5617556|NCT00788151|19404874|P2|Overall Study|Enrolled but not treated|1
5617557|NCT00788151|19404875|P1|Overall Study|Enrolled but not treated|1
5617558|NCT00788151|19404874|P2|Overall Study|Withdrawal by Subject|6
5617559|NCT00788151|19404875|P1|Overall Study|Withdrawal by Subject|13
5617560|NCT00788151|19404874|P2|Overall Study|Protocol Violation|1
5617561|NCT00788151|19404875|P1|Overall Study|Protocol Violation|0
5617562|NCT00788151|19404874|P2|Overall Study|Other adverse event|2
5617563|NCT00788151|19404875|P1|Overall Study|Other adverse event|0
5617564|NCT00788073|19404919|P2|Placebo Then STX209|Protocol Violation|1
5617565|NCT00788073|19404920|P1|Placebo Then STX209|Protocol Violation|0
5617566|NCT00788073|19404919|P2|Placebo Then STX209|Adverse Event|0
5617567|NCT00788073|19404920|P1|Placebo Then STX209|Adverse Event|2
5617568|NCT00788073|19404919|P2|STX209 Then Placebo|unable to return due to travel|1
5617569|NCT00788073|19404920|P1|STX209 Then Placebo|unable to return due to travel|0
5617570|NCT00788073|19404919|P2|STX209 Then Placebo|Withdrawal by Subject|1
5617571|NCT00788073|19404920|P1|STX209 Then Placebo|Withdrawal by Subject|0
5617572|NCT00788073|19404919|P2|STX209 Then Placebo|Lost to Follow-up|1
5617573|NCT00788073|19404920|P1|STX209 Then Placebo|Lost to Follow-up|0
5617574|NCT00788073|19404919|P2|STX209 Then Placebo|Adverse Event|0
5617575|NCT00788073|19404920|P1|STX209 Then Placebo|Adverse Event|1
5617576|NCT00787930|19404945|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
5617577|NCT00787917|19404960|P2|Open Label|Administrative problems|0
5617578|NCT00787917|19404961|P1|Open Label|Administrative problems|3
5617579|NCT00787917|19404960|P2|Open Label|Unsatisfactory therapeutic effect|0
5617580|NCT00787917|19404961|P1|Open Label|Unsatisfactory therapeutic effect|1
5617581|NCT00787917|19404960|P2|Blinded Treatment|Administrative problems|2
5617582|NCT00787917|19404961|P1|Blinded Treatment|Administrative problems|3
5617583|NCT00787917|19404960|P2|Blinded Treatment|Lack of Efficacy|0
5617584|NCT00787917|19404961|P1|Blinded Treatment|Lack of Efficacy|1
5617585|NCT00787917|19404960|P2|Blinded Treatment|Adverse Event|0
5617586|NCT00787917|19404961|P1|Blinded Treatment|Adverse Event|1
5617587|NCT00787891|19404991|P2|Maintenance Double-blind Phase (Part 2)|Other|2
5617588|NCT00787891|19404992|P1|Maintenance Double-blind Phase (Part 2)|Other|5
5617589|NCT00787891|19404991|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
5617590|NCT00787891|19404992|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
5617591|NCT00787891|19404991|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
5617592|NCT00787891|19404992|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
5617593|NCT00787891|19404991|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
5617594|NCT00787891|19404992|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
5617595|NCT00787891|19404991|P2|Short-term Double-blind Phase (Part 1)|Other|2
5617596|NCT00787891|19404992|P1|Short-term Double-blind Phase (Part 1)|Other|0
5617597|NCT00787891|19404991|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
5617598|NCT00787891|19404992|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
5617599|NCT00787891|19404991|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
5617600|NCT00787891|19404992|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
5617601|NCT00787891|19404991|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
5617602|NCT00787891|19404992|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
5617603|NCT00787891|19404991|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
5617604|NCT00787891|19404992|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
5617605|NCT00787891|19404991|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
5617606|NCT00787891|19404992|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
5617607|NCT00787839|19405019|P1|Overall Study|Failure to have the OGTT was most common|404
5617608|NCT00787800|19405042|P2|Overall Study|Death|2
5617609|NCT00787800|19405043|P1|Overall Study|Death|0
5617610|NCT00787800|19405042|P2|Overall Study|Withdrawal by Subject|5
5617611|NCT00787800|19405043|P1|Overall Study|Withdrawal by Subject|3
5617612|NCT00787787|19405059|P1|Overall Study|Adverse Event|3
5617613|NCT00787787|19405059|P1|Overall Study|Lack of Efficacy|4
5617614|NCT00787644|19405087|P2|Overall Study|Withdrawal by Subject|1
5617615|NCT00787644|19405088|P1|Overall Study|Withdrawal by Subject|1
5617616|NCT00787644|19405087|P2|Overall Study|Lost to Follow-up|1
5617617|NCT00787644|19405088|P1|Overall Study|Lost to Follow-up|1
5617618|NCT00787605|19405109|P2|Overall Study|Lack of Efficacy|9
5617619|NCT00787605|19405110|P1|Overall Study|Lack of Efficacy|13
5617620|NCT00787605|19405109|P2|Overall Study|Withdrawal by Subject|13
5617621|NCT00787605|19405110|P1|Overall Study|Withdrawal by Subject|6
5617622|NCT00787605|19405109|P2|Overall Study|Protocol Violation|3
5617623|NCT00787605|19405110|P1|Overall Study|Protocol Violation|7
5617624|NCT00787605|19405109|P2|Overall Study|Lost to Follow-up|6
5617625|NCT00787605|19405110|P1|Overall Study|Lost to Follow-up|3
5617626|NCT00787605|19405109|P2|Overall Study|Adverse Event|25
5617627|NCT00787605|19405110|P1|Overall Study|Adverse Event|14
5617628|NCT00787605|19405109|P2|Overall Study|Administrative Problems|0
5617629|NCT00787605|19405110|P1|Overall Study|Administrative Problems|3
5617630|NCT00787566|19405129|P3|Overall Study|AE related to chemotherapy|0
5617631|NCT00787566|19405130|P2|Overall Study|AE related to chemotherapy|1
5617632|NCT00787566|19405131|P1|Overall Study|AE related to chemotherapy|0
5617633|NCT00787527|19405139|P1|Overall Study|Toxicity|3
5617634|NCT00787319|19405156|P1|Overall Study|Inactive disease|5
5617635|NCT00787319|19405156|P1|Overall Study|Stabilized disease findings|3
5617636|NCT00787319|19405156|P1|Overall Study|No health insurance reimbursement|2
5617637|NCT00787319|19405156|P1|Overall Study|Unresponsiveness to visit invitation|1
5617638|NCT00787319|19405156|P1|Overall Study|Budget exhausted/exceeded|1
5617639|NCT00787319|19405156|P1|Overall Study|Lack of Efficacy|1
5617640|NCT00787319|19405156|P1|Overall Study|Objective progression or relapse|30
5617641|NCT00787319|19405156|P1|Overall Study|Adverse Event|3
5617642|NCT00787319|19405156|P1|Overall Study|Withdrawal by Subject|15
5617643|NCT00787319|19405156|P1|Overall Study|Lost to Follow-up|2
5617644|NCT00787267|19405168|P1|Overall Study|Withdrawal by Subject|1
5617645|NCT00787267|19405168|P1|Overall Study|No Reason Provided|1
5617646|NCT00787267|19405168|P1|Overall Study|Screen failure/Ineligible|10
5617647|NCT00787254|19405178|P2|Overall Study|Physician Decision|8
5617648|NCT00787254|19405179|P1|Overall Study|Physician Decision|4
5617649|NCT00787254|19405178|P2|Overall Study|Institution closed|0
5617650|NCT00787254|19405179|P1|Overall Study|Institution closed|1
5617651|NCT00787254|19405178|P2|Overall Study|NSAIDs discontinuation|2
5617652|NCT00787254|19405179|P1|Overall Study|NSAIDs discontinuation|1
5617653|NCT00787254|19405178|P2|Overall Study|Lack of Efficacy|15
5617654|NCT00787254|19405179|P1|Overall Study|Lack of Efficacy|4
5617655|NCT00787254|19405178|P2|Overall Study|Withdrawal by Subject|11
5617656|NCT00787254|19405179|P1|Overall Study|Withdrawal by Subject|16
5617657|NCT00787254|19405178|P2|Overall Study|Protocol Violation|23
5617658|NCT00787254|19405179|P1|Overall Study|Protocol Violation|26
5617659|NCT00787254|19405178|P2|Overall Study|Adverse Event|23
5617660|NCT00787254|19405179|P1|Overall Study|Adverse Event|24
5617661|NCT00787202|19405303|P5|Overall Study|Randomized, not treated|0
5617662|NCT00787202|19405304|P4|Overall Study|Randomized, not treated|0
5617663|NCT00787202|19405305|P3|Overall Study|Randomized, not treated|0
5617664|NCT00787202|19405306|P2|Overall Study|Randomized, not treated|0
5617665|NCT00787202|19405307|P1|Overall Study|Randomized, not treated|1
5617666|NCT00787202|19405303|P5|Overall Study|Protocol Violation|1
5617667|NCT00787202|19405304|P4|Overall Study|Protocol Violation|0
5617668|NCT00787202|19405305|P3|Overall Study|Protocol Violation|0
5617669|NCT00787202|19405306|P2|Overall Study|Protocol Violation|1
5617670|NCT00787202|19405307|P1|Overall Study|Protocol Violation|2
5617671|NCT00787202|19405303|P5|Overall Study|Withdrawal by Subject|0
5617672|NCT00787202|19405304|P4|Overall Study|Withdrawal by Subject|0
5617673|NCT00787202|19405305|P3|Overall Study|Withdrawal by Subject|2
5617674|NCT00787202|19405306|P2|Overall Study|Withdrawal by Subject|2
5617675|NCT00787202|19405307|P1|Overall Study|Withdrawal by Subject|2
5617676|NCT00787202|19405303|P5|Overall Study|Lost to Follow-up|0
5617677|NCT00787202|19405304|P4|Overall Study|Lost to Follow-up|0
5617678|NCT00787202|19405305|P3|Overall Study|Lost to Follow-up|0
5617679|NCT00787202|19405306|P2|Overall Study|Lost to Follow-up|0
5617680|NCT00787202|19405307|P1|Overall Study|Lost to Follow-up|1
5617681|NCT00787202|19405303|P5|Overall Study|Lack of Efficacy|1
5617682|NCT00787202|19405304|P4|Overall Study|Lack of Efficacy|2
5617683|NCT00787202|19405305|P3|Overall Study|Lack of Efficacy|5
5617684|NCT00787202|19405306|P2|Overall Study|Lack of Efficacy|6
5617685|NCT00787202|19405307|P1|Overall Study|Lack of Efficacy|5
5617686|NCT00787202|19405303|P5|Overall Study|Adverse Event|2
5617687|NCT00787202|19405304|P4|Overall Study|Adverse Event|0
5617688|NCT00787202|19405305|P3|Overall Study|Adverse Event|0
5617689|NCT00787202|19405306|P2|Overall Study|Adverse Event|2
5617690|NCT00787202|19405307|P1|Overall Study|Adverse Event|3
5617691|NCT00787189|19405360|P2|Overall Study|Lost to Follow-up|2
5617692|NCT00787189|19405361|P1|Overall Study|Lost to Follow-up|2
5617693|NCT00787150|19405370|P3|Overall Study|Dosing incorrect study durg|0
5617694|NCT00787150|19405371|P2|Overall Study|Dosing incorrect study durg|0
5617695|NCT00787150|19405372|P1|Overall Study|Dosing incorrect study durg|2
5617696|NCT00787150|19405370|P3|Overall Study|Withdrawal by Subject|0
5617697|NCT00787150|19405371|P2|Overall Study|Withdrawal by Subject|1
5617698|NCT00787150|19405372|P1|Overall Study|Withdrawal by Subject|2
5617699|NCT00787150|19405370|P3|Overall Study|Physician Decision|1
5617700|NCT00787150|19405371|P2|Overall Study|Physician Decision|2
5617701|NCT00787150|19405372|P1|Overall Study|Physician Decision|1
5617702|NCT00787150|19405370|P3|Overall Study|Adverse Event|4
5617703|NCT00787150|19405371|P2|Overall Study|Adverse Event|4
5617704|NCT00787150|19405372|P1|Overall Study|Adverse Event|4
5617705|NCT00787137|19405417|P3|Overall Study|Study Termination|1
5617706|NCT00787137|19405418|P2|Overall Study|Study Termination|0
5617707|NCT00787137|19405419|P1|Overall Study|Study Termination|0
5617708|NCT00786864|19405494|P2|Overall Study|Sustained serious back injury|0
5617709|NCT00786864|19405495|P1|Overall Study|Sustained serious back injury|1
5617710|NCT00786864|19405494|P2|Overall Study|Lost to Follow-up|1
5617711|NCT00786864|19405495|P1|Overall Study|Lost to Follow-up|0
5617712|NCT00786838|19405507|P1|Overall Study|Withdrawal by Subject|4
5617713|NCT00786838|19405507|P1|Overall Study|Progressive disease|31
5617714|NCT00786838|19405507|P1|Overall Study|Adverse Event|6
5617715|NCT00786838|19405507|P1|Overall Study|Death|4
5617716|NCT00786838|19405507|P1|Overall Study|Physician Decision|4
5617717|NCT00786799|19405543|P2|Overall Study|Lost to Follow-up|1
5617718|NCT00786799|19405544|P1|Overall Study|Lost to Follow-up|1
5617719|NCT00786565|19405574|P1|Post Surgery|Adapt AO implanted posterior side up|1
5617720|NCT00786565|19405574|P1|Post Surgery|Abnormal macular pucker|1
5617721|NCT00786565|19405574|P1|Enrollment Prior to Surgery|Protocol Violation|3
5617722|NCT00786565|19405574|P1|Enrollment Prior to Surgery|Site Closed|3
5617723|NCT00786474|19405631|P2|Overall Study|Other|4
5617724|NCT00786474|19405632|P1|Overall Study|Other|4
5617725|NCT00786474|19405631|P2|Overall Study|Physician Decision|1
5617726|NCT00786474|19405632|P1|Overall Study|Physician Decision|2
5617727|NCT00786474|19405631|P2|Overall Study|Lost to Follow-up|3
5617728|NCT00786474|19405632|P1|Overall Study|Lost to Follow-up|3
5617729|NCT00786474|19405631|P2|Overall Study|Withdrawal by Subject|31
5617730|NCT00786474|19405632|P1|Overall Study|Withdrawal by Subject|23
5617731|NCT00786474|19405631|P2|Overall Study|Death|4
5617732|NCT00786474|19405632|P1|Overall Study|Death|5
5617733|NCT00786422|19405644|P1|Follow-up Period|End-of-study done up to 4 days early|2
5617734|NCT00786422|19405644|P1|Follow-up Period|Death|1
5617735|NCT00786422|19405644|P1|Rivaroxaban Treatment|Adverse Event|2
5617736|NCT00786422|19405644|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
5617737|NCT00786422|19405644|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
5617738|NCT00786422|19405644|P1|Rivaroxaban Treatment|Physician Decision|1
5617739|NCT00786422|19405644|P1|Rivaroxaban Treatment|Lack of Efficacy|1
5617740|NCT00786422|19405644|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
5617741|NCT00786422|19405644|P1|Rivaroxaban Treatment|Death|2
5617742|NCT00786409|19405660|P1|Overall Study|Lost to Follow-up|1
5617743|NCT00786409|19405660|P1|Overall Study|Pregnancy|2
5617744|NCT00786409|19405660|P1|Overall Study|Adverse Event|2
5617745|NCT00786409|19405660|P1|Overall Study|Withdrawal by Subject|2
5617746|NCT00786188|19405677|P2|Overall Study|Withdrawal by Subject|0
5617747|NCT00786188|19405678|P1|Overall Study|Withdrawal by Subject|2
5617748|NCT00786188|19405677|P2|Overall Study|Adverse Event|1
5617749|NCT00786188|19405678|P1|Overall Study|Adverse Event|3
5617750|NCT00786032|19405704|P1|Overall Study|Did not complete in the timeframe|6
5617751|NCT00786032|19405704|P1|Overall Study|Withdrawal by Subject|14
5617752|NCT00786032|19405704|P1|Overall Study|Death|4
5617753|NCT00785980|19405725|P1|7 Day Washout Period|Protocol Violation|3
5617754|NCT00785928|19405743|P7|Treatment Phase|Withdrawal by Subject|0
5617755|NCT00785928|19405744|P6|Treatment Phase|Withdrawal by Subject|0
5617756|NCT00785928|19405745|P5|Treatment Phase|Withdrawal by Subject|1
5617757|NCT00785928|19405746|P4|Treatment Phase|Withdrawal by Subject|0
5617758|NCT00785928|19405747|P3|Treatment Phase|Withdrawal by Subject|0
5617759|NCT00785928|19405748|P2|Treatment Phase|Withdrawal by Subject|2
5617760|NCT00785928|19405749|P1|Treatment Phase|Withdrawal by Subject|1
5617761|NCT00785928|19405743|P7|Treatment Phase|Sponsor Decision|1
5617762|NCT00785928|19405744|P6|Treatment Phase|Sponsor Decision|0
5617763|NCT00785928|19405745|P5|Treatment Phase|Sponsor Decision|0
5617764|NCT00785928|19405746|P4|Treatment Phase|Sponsor Decision|0
5617765|NCT00785928|19405747|P3|Treatment Phase|Sponsor Decision|0
5617766|NCT00785928|19405748|P2|Treatment Phase|Sponsor Decision|0
5617767|NCT00785928|19405749|P1|Treatment Phase|Sponsor Decision|1
5617768|NCT00785928|19405743|P7|Treatment Phase|Physician Decision|0
5617769|NCT00785928|19405744|P6|Treatment Phase|Physician Decision|0
5617770|NCT00785928|19405745|P5|Treatment Phase|Physician Decision|1
5617771|NCT00785928|19405746|P4|Treatment Phase|Physician Decision|0
5617772|NCT00785928|19405747|P3|Treatment Phase|Physician Decision|0
5617773|NCT00785928|19405748|P2|Treatment Phase|Physician Decision|0
5617774|NCT00785928|19405749|P1|Treatment Phase|Physician Decision|0
5617775|NCT00785928|19405743|P7|Treatment Phase|Lack of Efficacy|0
5617776|NCT00785928|19405744|P6|Treatment Phase|Lack of Efficacy|0
5617777|NCT00785928|19405745|P5|Treatment Phase|Lack of Efficacy|0
5617778|NCT00785928|19405746|P4|Treatment Phase|Lack of Efficacy|0
5617779|NCT00785928|19405747|P3|Treatment Phase|Lack of Efficacy|1
5617780|NCT00785928|19405748|P2|Treatment Phase|Lack of Efficacy|1
5617781|NCT00785928|19405749|P1|Treatment Phase|Lack of Efficacy|0
5617782|NCT00785928|19405743|P7|Treatment Phase|Inadequate Response|0
5617783|NCT00785928|19405744|P6|Treatment Phase|Inadequate Response|0
5617784|NCT00785928|19405745|P5|Treatment Phase|Inadequate Response|0
5617785|NCT00785928|19405746|P4|Treatment Phase|Inadequate Response|0
5617786|NCT00785928|19405747|P3|Treatment Phase|Inadequate Response|0
5617787|NCT00785928|19405748|P2|Treatment Phase|Inadequate Response|1
5617788|NCT00785928|19405749|P1|Treatment Phase|Inadequate Response|0
5617789|NCT00785928|19405743|P7|Treatment Phase|Adverse Event|2
5617790|NCT00785928|19405744|P6|Treatment Phase|Adverse Event|0
5617791|NCT00785928|19405745|P5|Treatment Phase|Adverse Event|0
5617792|NCT00785928|19405746|P4|Treatment Phase|Adverse Event|0
5617793|NCT00785928|19405747|P3|Treatment Phase|Adverse Event|2
5617794|NCT00785928|19405748|P2|Treatment Phase|Adverse Event|1
5617795|NCT00785928|19405749|P1|Treatment Phase|Adverse Event|1
5617796|NCT00785785|19405896|P2|Optional Extension Phase|Study terminated by sponsor|37
5617797|NCT00785785|19405897|P1|Optional Extension Phase|Study terminated by sponsor|3
5617798|NCT00785785|19405896|P2|Optional Extension Phase|Protocol deviation|2
5617799|NCT00785785|19405897|P1|Optional Extension Phase|Protocol deviation|0
5617800|NCT00785785|19405896|P2|Optional Extension Phase|Disease progression|70
5617801|NCT00785785|19405897|P1|Optional Extension Phase|Disease progression|22
5617802|NCT00785785|19405896|P2|Optional Extension Phase|Death|5
5617803|NCT00785785|19405897|P1|Optional Extension Phase|Death|1
5617804|NCT00785785|19405896|P2|Optional Extension Phase|Administrative problems|0
5617805|NCT00785785|19405897|P1|Optional Extension Phase|Administrative problems|2
5617806|NCT00785785|19405896|P2|Optional Extension Phase|Lost to Follow-up|0
5617807|NCT00785785|19405897|P1|Optional Extension Phase|Lost to Follow-up|1
5617808|NCT00785785|19405896|P2|Optional Extension Phase|Withdrawal by Subject|6
5617809|NCT00785785|19405897|P1|Optional Extension Phase|Withdrawal by Subject|6
5617810|NCT00785785|19405896|P2|Optional Extension Phase|Adverse Event|5
5617811|NCT00785785|19405897|P1|Optional Extension Phase|Adverse Event|4
5617812|NCT00785785|19405896|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
5617813|NCT00785785|19405897|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
5617814|NCT00785785|19405896|P2|Core Phase up to 36 Months|Protocol deviation|6
5617815|NCT00785785|19405897|P1|Core Phase up to 36 Months|Protocol deviation|5
5617816|NCT00785785|19405896|P2|Core Phase up to 36 Months|Disease progression|119
5617817|NCT00785785|19405897|P1|Core Phase up to 36 Months|Disease progression|139
5617818|NCT00785785|19405896|P2|Core Phase up to 36 Months|Death|8
5617819|NCT00785785|19405897|P1|Core Phase up to 36 Months|Death|5
5617820|NCT00785785|19405896|P2|Core Phase up to 36 Months|Administrative problems|3
5617821|NCT00785785|19405897|P1|Core Phase up to 36 Months|Administrative problems|3
5617822|NCT00785785|19405896|P2|Core Phase up to 36 Months|Lost to Follow-up|7
5617823|NCT00785785|19405897|P1|Core Phase up to 36 Months|Lost to Follow-up|3
5617824|NCT00785785|19405896|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
5617825|NCT00785785|19405897|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
5617826|NCT00785785|19405896|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
5617827|NCT00785785|19405897|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
5617828|NCT00785785|19405896|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
5617829|NCT00785785|19405897|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
5617830|NCT00785785|19405896|P2|Core Phase up to 36 Months|Adverse Event|21
5617831|NCT00785785|19405897|P1|Core Phase up to 36 Months|Adverse Event|31
5617832|NCT00785785|19405896|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
5617833|NCT00785785|19405897|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
5617834|NCT00785707|19405911|P1|Overall Study|Lost to Follow-up|7
5617835|NCT00785629|19405920|P4|Overall Study|Withdrawal by Subject|2
5617836|NCT00785629|19405921|P3|Overall Study|Withdrawal by Subject|2
5617837|NCT00785629|19405922|P2|Overall Study|Withdrawal by Subject|1
5617838|NCT00785629|19405923|P1|Overall Study|Withdrawal by Subject|0
5617839|NCT00785629|19405920|P4|Overall Study|administrative decision|4
5617840|NCT00785629|19405921|P3|Overall Study|administrative decision|3
5617841|NCT00785629|19405922|P2|Overall Study|administrative decision|1
5617842|NCT00785629|19405923|P1|Overall Study|administrative decision|5
5617843|NCT00785629|19405920|P4|Overall Study|Protocol Violation|5
5617844|NCT00785629|19405921|P3|Overall Study|Protocol Violation|4
5617845|NCT00785629|19405922|P2|Overall Study|Protocol Violation|2
5617846|NCT00785629|19405923|P1|Overall Study|Protocol Violation|1
5617847|NCT00785629|19405920|P4|Overall Study|Adverse Event|5
5617848|NCT00785629|19405921|P3|Overall Study|Adverse Event|1
5617849|NCT00785629|19405922|P2|Overall Study|Adverse Event|1
5617850|NCT00785629|19405923|P1|Overall Study|Adverse Event|2
5617851|NCT00785577|19405936|P5|Study Period 3: 1-Week Washout Phase|Death|1
5617852|NCT00785577|19405937|P4|Study Period 3: 1-Week Washout Phase|Death|0
5617853|NCT00785577|19405938|P3|Study Period 3: 1-Week Washout Phase|Death|0
5617854|NCT00785577|19405939|P2|Study Period 3: 1-Week Washout Phase|Death|0
5617855|NCT00785577|19405940|P1|Study Period 3: 1-Week Washout Phase|Death|0
5617856|NCT00785577|19405936|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
5617857|NCT00785577|19405937|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
5617858|NCT00785577|19405938|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
5617859|NCT00785577|19405939|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
5617860|NCT00785577|19405940|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
5617861|NCT00785577|19405936|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
5617862|NCT00785577|19405937|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
5617863|NCT00785577|19405938|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
5617864|NCT00785577|19405939|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
5617865|NCT00785577|19405940|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
5617866|NCT00785577|19405936|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
5617867|NCT00785577|19405937|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
5617868|NCT00785577|19405938|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
5617869|NCT00785577|19405939|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
5617870|NCT00785577|19405940|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
5617871|NCT00785577|19405936|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
5617872|NCT00785577|19405937|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
5617873|NCT00785577|19405938|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
5617874|NCT00785577|19405939|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
5617875|NCT00785577|19405940|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
5617876|NCT00785577|19405936|P5|Study Period 2: Therapy Phase|Protocol Violation|1
5617877|NCT00785577|19405937|P4|Study Period 2: Therapy Phase|Protocol Violation|0
5617878|NCT00785577|19405938|P3|Study Period 2: Therapy Phase|Protocol Violation|1
5617879|NCT00785577|19405939|P2|Study Period 2: Therapy Phase|Protocol Violation|1
5617880|NCT00785577|19405940|P1|Study Period 2: Therapy Phase|Protocol Violation|1
5617881|NCT00785577|19405936|P5|Study Period 2: Therapy Phase|Physician Decision|0
5617882|NCT00785577|19405937|P4|Study Period 2: Therapy Phase|Physician Decision|0
5617883|NCT00785577|19405938|P3|Study Period 2: Therapy Phase|Physician Decision|0
5617884|NCT00785577|19405939|P2|Study Period 2: Therapy Phase|Physician Decision|0
5617885|NCT00785577|19405940|P1|Study Period 2: Therapy Phase|Physician Decision|1
5617886|NCT00785577|19405936|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
5617887|NCT00785577|19405937|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
5617888|NCT00785577|19405938|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
5617889|NCT00785577|19405939|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
5617890|NCT00785577|19405940|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
5617891|NCT00785577|19405936|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
5617892|NCT00785577|19405937|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
5617893|NCT00785577|19405938|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
5617894|NCT00785577|19405939|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
5617895|NCT00785577|19405940|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
5617896|NCT00785577|19405936|P5|Study Period 2: Therapy Phase|Adverse Event|17
5617897|NCT00785577|19405937|P4|Study Period 2: Therapy Phase|Adverse Event|10
5617898|NCT00785577|19405938|P3|Study Period 2: Therapy Phase|Adverse Event|14
5617899|NCT00785577|19405939|P2|Study Period 2: Therapy Phase|Adverse Event|7
5617900|NCT00785577|19405940|P1|Study Period 2: Therapy Phase|Adverse Event|5
5617901|NCT00785538|19406080|P4|Treatment Period|Withdrawal by Subject|1
5617902|NCT00785538|19406081|P3|Treatment Period|Withdrawal by Subject|0
5617903|NCT00785538|19406082|P2|Treatment Period|Withdrawal by Subject|0
5617904|NCT00785538|19406083|P1|Treatment Period|Withdrawal by Subject|0
5617905|NCT00785538|19406080|P4|Treatment Period|Adverse Event|0
5617906|NCT00785538|19406081|P3|Treatment Period|Adverse Event|2
5617907|NCT00785538|19406082|P2|Treatment Period|Adverse Event|2
5617908|NCT00785538|19406083|P1|Treatment Period|Adverse Event|1
5617909|NCT00785512|19406131|P2|Overall Study|Lack of compliance|1
5617910|NCT00785512|19406132|P1|Overall Study|Lack of compliance|0
5617911|NCT00785512|19406131|P2|Overall Study|Physician Decision|0
5617912|NCT00785512|19406132|P1|Overall Study|Physician Decision|0
5617913|NCT00785512|19406131|P2|Overall Study|IVRS Programing Error|0
5617914|NCT00785512|19406132|P1|Overall Study|IVRS Programing Error|0
5617915|NCT00785512|19406131|P2|Overall Study|Precedure Refused|0
5617916|NCT00785512|19406132|P1|Overall Study|Precedure Refused|0
5617917|NCT00785512|19406131|P2|Overall Study|Lost to Follow-up|0
5617918|NCT00785512|19406132|P1|Overall Study|Lost to Follow-up|3
5617919|NCT00785512|19406131|P2|Overall Study|Withdrawal by Subject|1
5617920|NCT00785512|19406132|P1|Overall Study|Withdrawal by Subject|0
5617921|NCT00785512|19406131|P2|Overall Study|Lack of Efficacy|2
5617922|NCT00785512|19406132|P1|Overall Study|Lack of Efficacy|0
5617923|NCT00785512|19406131|P2|Overall Study|Adverse Event|0
5617924|NCT00785512|19406132|P1|Overall Study|Adverse Event|0
5617925|NCT00785512|19406131|P2|Overall Study|Inclusion/Exclusion not meet|0
5617926|NCT00785512|19406132|P1|Overall Study|Inclusion/Exclusion not meet|0
5617927|NCT00785486|19406141|P1|Midazolam Alone|Withdrawal by Subject|1
5617928|NCT00785356|19406165|P1|Overall Study|Study prematurely terminated|8
5617929|NCT00785291|19406176|P3|Overall Study|Other Medical Reasons|15
5617930|NCT00785291|19406177|P2|Overall Study|Other Medical Reasons|25
5617931|NCT00785291|19406178|P1|Overall Study|Other Medical Reasons|29
5617932|NCT00785291|19406176|P3|Overall Study|Complicating illness|4
5617933|NCT00785291|19406177|P2|Overall Study|Complicating illness|4
5617934|NCT00785291|19406178|P1|Overall Study|Complicating illness|6
5617935|NCT00785291|19406176|P3|Overall Study|Alternative Therapy|7
5617936|NCT00785291|19406177|P2|Overall Study|Alternative Therapy|6
5617937|NCT00785291|19406178|P1|Overall Study|Alternative Therapy|12
5617938|NCT00785291|19406176|P3|Overall Study|Withdrawal by Subject|17
5617939|NCT00785291|19406177|P2|Overall Study|Withdrawal by Subject|36
5617940|NCT00785291|19406178|P1|Overall Study|Withdrawal by Subject|35
5617941|NCT00785291|19406176|P3|Overall Study|Death|3
5617942|NCT00785291|19406177|P2|Overall Study|Death|4
5617943|NCT00785291|19406178|P1|Overall Study|Death|7
5617944|NCT00785291|19406176|P3|Overall Study|Adverse Event|56
5617945|NCT00785291|19406177|P2|Overall Study|Adverse Event|70
5617946|NCT00785291|19406178|P1|Overall Study|Adverse Event|39
5617947|NCT00785291|19406176|P3|Overall Study|Never began treatment|4
5617948|NCT00785291|19406177|P2|Overall Study|Never began treatment|4
5617949|NCT00785291|19406178|P1|Overall Study|Never began treatment|8
5617950|NCT00785213|19406198|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
5617951|NCT00785213|19406198|P1|Quinine Sulfate Alone|Adverse Event|4
5617952|NCT00785044|19406209|P1|Overall Study|Withdrawal by Subject|1
5617953|NCT00785044|19406209|P1|Overall Study|Lost to Follow-up|266
5617954|NCT00785044|19406209|P1|Overall Study|Death|77
5617955|NCT00785044|19406209|P1|Overall Study|Dosed at non-participating sites|152
5617956|NCT00784979|19406214|P1|Overall Study|incomplete data|6
5617957|NCT00784927|19406218|P1|Overall Study|Ineligible|1
5617958|NCT00784927|19406218|P1|Overall Study|Protocol Violation|1
5617959|NCT00784927|19406218|P1|Overall Study|Cancel Prior to Initiating Treatment|1
5617960|NCT00784875|19406230|P4|Period D|Lost to Follow-up|1
5617961|NCT00784875|19406231|P3|Period D|Lost to Follow-up|1
5617962|NCT00784875|19406232|P2|Period D|Lost to Follow-up|0
5617963|NCT00784875|19406233|P1|Period D|Lost to Follow-up|1
5617964|NCT00784875|19406230|P4|Period D|Sponsor Decision|0
5617965|NCT00784875|19406231|P3|Period D|Sponsor Decision|1
5617966|NCT00784875|19406232|P2|Period D|Sponsor Decision|1
5617967|NCT00784875|19406233|P1|Period D|Sponsor Decision|1
5617968|NCT00784875|19406230|P4|Period D|Physician Decision|0
5617969|NCT00784875|19406231|P3|Period D|Physician Decision|0
5617970|NCT00784875|19406232|P2|Period D|Physician Decision|1
5617971|NCT00784875|19406233|P1|Period D|Physician Decision|0
5617972|NCT00784875|19406230|P4|Period D|Withdrawal by Subject|0
5617973|NCT00784875|19406231|P3|Period D|Withdrawal by Subject|2
5617974|NCT00784875|19406232|P2|Period D|Withdrawal by Subject|0
5617975|NCT00784875|19406233|P1|Period D|Withdrawal by Subject|2
5617976|NCT00784875|19406230|P4|Period D|Protocol Violation|0
5617977|NCT00784875|19406231|P3|Period D|Protocol Violation|0
5617978|NCT00784875|19406232|P2|Period D|Protocol Violation|0
5617979|NCT00784875|19406233|P1|Period D|Protocol Violation|1
5617980|NCT00784875|19406230|P4|Period D|Adverse Event|0
5617981|NCT00784875|19406231|P3|Period D|Adverse Event|2
5617982|NCT00784875|19406232|P2|Period D|Adverse Event|2
5617983|NCT00784875|19406233|P1|Period D|Adverse Event|0
5617984|NCT00784875|19406230|P4|Period C|Sponsor Decision|2
5617985|NCT00784875|19406231|P3|Period C|Sponsor Decision|4
5617986|NCT00784875|19406232|P2|Period C|Sponsor Decision|5
5617987|NCT00784875|19406233|P1|Period C|Sponsor Decision|5
5617988|NCT00784875|19406230|P4|Period C|Physician Decision|1
5617989|NCT00784875|19406231|P3|Period C|Physician Decision|1
5617990|NCT00784875|19406232|P2|Period C|Physician Decision|0
5617991|NCT00784875|19406233|P1|Period C|Physician Decision|0
5617992|NCT00784875|19406230|P4|Period C|Withdrawal by Subject|0
5617993|NCT00784875|19406231|P3|Period C|Withdrawal by Subject|2
5617994|NCT00784875|19406232|P2|Period C|Withdrawal by Subject|1
5617995|NCT00784875|19406233|P1|Period C|Withdrawal by Subject|1
5617996|NCT00784875|19406230|P4|Period C|Lack of Efficacy|0
5617997|NCT00784875|19406231|P3|Period C|Lack of Efficacy|1
5617998|NCT00784875|19406232|P2|Period C|Lack of Efficacy|0
5617999|NCT00784875|19406233|P1|Period C|Lack of Efficacy|0
5618000|NCT00784875|19406230|P4|Period C|Protocol Violation|2
5618001|NCT00784875|19406231|P3|Period C|Protocol Violation|1
5618002|NCT00784875|19406232|P2|Period C|Protocol Violation|0
5618003|NCT00784875|19406233|P1|Period C|Protocol Violation|0
5618004|NCT00784875|19406230|P4|Period C|Adverse Event|2
5618005|NCT00784875|19406231|P3|Period C|Adverse Event|4
5618006|NCT00784875|19406232|P2|Period C|Adverse Event|0
5618007|NCT00784875|19406233|P1|Period C|Adverse Event|1
5618008|NCT00784875|19406230|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
5618009|NCT00784875|19406231|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
5618010|NCT00784875|19406232|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
5618011|NCT00784875|19406233|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
5618012|NCT00784875|19406230|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
5618013|NCT00784875|19406231|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
5618014|NCT00784875|19406232|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
5618015|NCT00784875|19406233|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
5618016|NCT00784875|19406230|P4|Period B - Efficacy Endpoint|Physician Decision|0
5618017|NCT00784875|19406231|P3|Period B - Efficacy Endpoint|Physician Decision|1
5618018|NCT00784875|19406232|P2|Period B - Efficacy Endpoint|Physician Decision|0
5618019|NCT00784875|19406233|P1|Period B - Efficacy Endpoint|Physician Decision|0
5618020|NCT00784875|19406230|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
5618021|NCT00784875|19406231|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
5618022|NCT00784875|19406232|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
5618023|NCT00784875|19406233|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
5618024|NCT00784875|19406230|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
5618025|NCT00784875|19406231|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
5618026|NCT00784875|19406232|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
5618027|NCT00784875|19406233|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
5618028|NCT00784875|19406230|P4|Period B - Efficacy Endpoint|Protocol Violation|3
5618029|NCT00784875|19406231|P3|Period B - Efficacy Endpoint|Protocol Violation|2
5618030|NCT00784875|19406232|P2|Period B - Efficacy Endpoint|Protocol Violation|1
5618031|NCT00784875|19406233|P1|Period B - Efficacy Endpoint|Protocol Violation|1
5618032|NCT00784875|19406230|P4|Period B - Efficacy Endpoint|Adverse Event|1
5618033|NCT00784875|19406231|P3|Period B - Efficacy Endpoint|Adverse Event|2
5618034|NCT00784875|19406232|P2|Period B - Efficacy Endpoint|Adverse Event|3
5618035|NCT00784875|19406233|P1|Period B - Efficacy Endpoint|Adverse Event|0
5618036|NCT00784875|19406230|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
5618037|NCT00784875|19406231|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
5618038|NCT00784875|19406232|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
5618039|NCT00784875|19406233|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
5618040|NCT00784875|19406230|P4|Period A - Baseline|Lost to Follow-up|2
5618041|NCT00784875|19406231|P3|Period A - Baseline|Lost to Follow-up|0
5618042|NCT00784875|19406232|P2|Period A - Baseline|Lost to Follow-up|0
5618043|NCT00784875|19406233|P1|Period A - Baseline|Lost to Follow-up|0
5618044|NCT00784875|19406230|P4|Period A - Baseline|Sponsor Decision|113
5618045|NCT00784875|19406231|P3|Period A - Baseline|Sponsor Decision|0
5618046|NCT00784875|19406232|P2|Period A - Baseline|Sponsor Decision|0
5618047|NCT00784875|19406233|P1|Period A - Baseline|Sponsor Decision|0
5618048|NCT00784875|19406230|P4|Period A - Baseline|Physician Decision|2
5618049|NCT00784875|19406231|P3|Period A - Baseline|Physician Decision|0
5618050|NCT00784875|19406232|P2|Period A - Baseline|Physician Decision|0
5618051|NCT00784875|19406233|P1|Period A - Baseline|Physician Decision|0
5618052|NCT00784875|19406230|P4|Period A - Baseline|Withdrawal by Subject|27
5618053|NCT00784875|19406231|P3|Period A - Baseline|Withdrawal by Subject|0
5618054|NCT00784875|19406232|P2|Period A - Baseline|Withdrawal by Subject|0
5618055|NCT00784875|19406233|P1|Period A - Baseline|Withdrawal by Subject|0
5618056|NCT00784875|19406230|P4|Period A - Baseline|Protocol Violation|25
5618057|NCT00784875|19406231|P3|Period A - Baseline|Protocol Violation|0
5618058|NCT00784875|19406232|P2|Period A - Baseline|Protocol Violation|0
5618059|NCT00784875|19406233|P1|Period A - Baseline|Protocol Violation|0
5618060|NCT00784875|19406230|P4|Period A - Baseline|Adverse Event|8
5618061|NCT00784875|19406231|P3|Period A - Baseline|Adverse Event|0
5618062|NCT00784875|19406232|P2|Period A - Baseline|Adverse Event|0
5618063|NCT00784875|19406233|P1|Period A - Baseline|Adverse Event|0
5618064|NCT00784875|19406230|P4|Period A - Baseline|Entry Criteria Not Met|5
5618065|NCT00784875|19406231|P3|Period A - Baseline|Entry Criteria Not Met|0
5618066|NCT00784875|19406232|P2|Period A - Baseline|Entry Criteria Not Met|0
5618067|NCT00784875|19406233|P1|Period A - Baseline|Entry Criteria Not Met|0
5618068|NCT00784836|19406353|P1|Overall Study|Early Study Termination|3
5618069|NCT00784810|19406360|P2|Overall Study|Lost to Follow-up|1
5618070|NCT00784810|19406361|P1|Overall Study|Lost to Follow-up|1
5618071|NCT00784810|19406360|P2|Overall Study|Administrative|8
5618072|NCT00784810|19406361|P1|Overall Study|Administrative|5
5618073|NCT00784810|19406360|P2|Overall Study|Withdrawal by Subject|9
5618074|NCT00784810|19406361|P1|Overall Study|Withdrawal by Subject|11
5618075|NCT00784810|19406360|P2|Overall Study|Lack of Efficacy|11
5618076|NCT00784810|19406361|P1|Overall Study|Lack of Efficacy|14
5618077|NCT00784810|19406360|P2|Overall Study|Adverse Event|20
5618078|NCT00784810|19406361|P1|Overall Study|Adverse Event|32
5618079|NCT00784784|19406371|P2|Overall Study|Withdrawal by Subject|2
5618080|NCT00784784|19406372|P1|Overall Study|Withdrawal by Subject|2
5618081|NCT00784758|19406382|P2|Overall Study|Adverse Event|0
5618082|NCT00784758|19406383|P1|Overall Study|Adverse Event|1
5618083|NCT00784758|19406382|P2|Overall Study|Withdrawal by Subject|0
5618084|NCT00784758|19406383|P1|Overall Study|Withdrawal by Subject|3
5618085|NCT00784719|19406432|P7|Overall Study|Withdrawal by Subject|1
5618086|NCT00784719|19406433|P6|Overall Study|Withdrawal by Subject|0
5618087|NCT00784719|19406434|P5|Overall Study|Withdrawal by Subject|2
5618088|NCT00784719|19406435|P4|Overall Study|Withdrawal by Subject|0
5618089|NCT00784719|19406436|P3|Overall Study|Withdrawal by Subject|0
5618090|NCT00784719|19406437|P2|Overall Study|Withdrawal by Subject|0
5618091|NCT00784719|19406438|P1|Overall Study|Withdrawal by Subject|1
5618092|NCT00784719|19406432|P7|Overall Study|Other|3
5618093|NCT00784719|19406433|P6|Overall Study|Other|1
5618094|NCT00784719|19406434|P5|Overall Study|Other|2
5618095|NCT00784719|19406435|P4|Overall Study|Other|0
5618096|NCT00784719|19406436|P3|Overall Study|Other|1
5618097|NCT00784719|19406437|P2|Overall Study|Other|1
5618098|NCT00784719|19406438|P1|Overall Study|Other|2
5618099|NCT00784719|19406432|P7|Overall Study|Lost to Follow-up|0
5618100|NCT00784719|19406433|P6|Overall Study|Lost to Follow-up|1
5618101|NCT00784719|19406434|P5|Overall Study|Lost to Follow-up|1
5618102|NCT00784719|19406435|P4|Overall Study|Lost to Follow-up|0
5618103|NCT00784719|19406436|P3|Overall Study|Lost to Follow-up|0
5618104|NCT00784719|19406437|P2|Overall Study|Lost to Follow-up|0
5618105|NCT00784719|19406438|P1|Overall Study|Lost to Follow-up|0
5618106|NCT00784719|19406432|P7|Overall Study|Adverse Event|1
5618107|NCT00784719|19406433|P6|Overall Study|Adverse Event|1
5618108|NCT00784719|19406434|P5|Overall Study|Adverse Event|1
5618109|NCT00784719|19406435|P4|Overall Study|Adverse Event|0
5618110|NCT00784719|19406436|P3|Overall Study|Adverse Event|0
5618111|NCT00784719|19406437|P2|Overall Study|Adverse Event|2
5618112|NCT00784719|19406438|P1|Overall Study|Adverse Event|0
5618113|NCT00784654|19406608|P3|Randomized Withdrawal Period|Family reasons|1
5618114|NCT00784654|19406609|P2|Randomized Withdrawal Period|Family reasons|0
5618115|NCT00784654|19406610|P1|Randomized Withdrawal Period|Family reasons|0
5618116|NCT00784654|19406608|P3|Randomized Withdrawal Period|Did not complete a visit|0
5618117|NCT00784654|19406609|P2|Randomized Withdrawal Period|Did not complete a visit|1
5618118|NCT00784654|19406610|P1|Randomized Withdrawal Period|Did not complete a visit|0
5618119|NCT00784654|19406608|P3|Randomized Withdrawal Period|Adverse Event|1
5618120|NCT00784654|19406609|P2|Randomized Withdrawal Period|Adverse Event|1
5618121|NCT00784654|19406610|P1|Randomized Withdrawal Period|Adverse Event|0
5618122|NCT00784654|19406608|P3|Randomized Withdrawal Period|Protocol Violation|1
5618123|NCT00784654|19406609|P2|Randomized Withdrawal Period|Protocol Violation|2
5618124|NCT00784654|19406610|P1|Randomized Withdrawal Period|Protocol Violation|0
5618125|NCT00784654|19406608|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
5618126|NCT00784654|19406609|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
5618127|NCT00784654|19406610|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
5618128|NCT00784654|19406608|P3|Randomized Withdrawal Period|Lack of Efficacy|18
5618129|NCT00784654|19406609|P2|Randomized Withdrawal Period|Lack of Efficacy|5
5618130|NCT00784654|19406610|P1|Randomized Withdrawal Period|Lack of Efficacy|0
5618131|NCT00784654|19406608|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
5618132|NCT00784654|19406609|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
5618133|NCT00784654|19406610|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
5618134|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
5618135|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
5618136|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
5618137|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
5618138|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
5618139|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
5618140|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
5618141|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
5618142|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
5618143|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
5618144|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
5618145|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
5618146|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
5618147|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
5618148|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
5618149|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
5618150|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
5618151|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
5618152|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
5618153|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
5618154|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
5618155|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
5618156|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
5618157|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
5618158|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
5618159|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
5618160|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
5618161|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
5618162|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
5618163|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
5618164|NCT00784654|19406608|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
5618165|NCT00784654|19406609|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
5618166|NCT00784654|19406610|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
5618167|NCT00784563|19406658|P3|Year 3|Adverse Event|1
5618168|NCT00784563|19406659|P2|Year 3|Adverse Event|0
5618169|NCT00784563|19406660|P1|Year 3|Adverse Event|0
5618170|NCT00784563|19406658|P3|Year 3|Withdrawal by Subject|2
5618171|NCT00784563|19406659|P2|Year 3|Withdrawal by Subject|0
5618172|NCT00784563|19406660|P1|Year 3|Withdrawal by Subject|0
5618173|NCT00784563|19406658|P3|Years 1 & 2|Adverse Event|0
5618174|NCT00784563|19406659|P2|Years 1 & 2|Adverse Event|3
5618175|NCT00784563|19406660|P1|Years 1 & 2|Adverse Event|0
5618176|NCT00784563|19406658|P3|Years 1 & 2|Withdrawal by Subject|0
5618177|NCT00784563|19406659|P2|Years 1 & 2|Withdrawal by Subject|2
5618178|NCT00784563|19406660|P1|Years 1 & 2|Withdrawal by Subject|3
5618179|NCT00784550|19406678|P2|Overall Study|Withdrawal by Subject|13
5618180|NCT00784550|19406679|P1|Overall Study|Withdrawal by Subject|4
5618181|NCT00784550|19406678|P2|Overall Study|Physician Decision|3
5618182|NCT00784550|19406679|P1|Overall Study|Physician Decision|2
5618183|NCT00784550|19406678|P2|Overall Study|Lost to Follow-up|5
5618184|NCT00784550|19406679|P1|Overall Study|Lost to Follow-up|8
5618185|NCT00784550|19406678|P2|Overall Study|Protocol Violation|10
5618186|NCT00784550|19406679|P1|Overall Study|Protocol Violation|10
5618187|NCT00784550|19406678|P2|Overall Study|Lack of Efficacy|1
5618188|NCT00784550|19406679|P1|Overall Study|Lack of Efficacy|0
5618189|NCT00784550|19406678|P2|Overall Study|Adverse Event|10
5618190|NCT00784550|19406679|P1|Overall Study|Adverse Event|12
5618191|NCT00784459|19406705|P2|Overall Study|Adverse Event|2
5618192|NCT00784459|19406706|P1|Overall Study|Adverse Event|0
5618193|NCT00784368|19406717|P3|Overall Study|Withdrawal of informed consent|0
5618194|NCT00784368|19406718|P2|Overall Study|Withdrawal of informed consent|1
5618195|NCT00784368|19406719|P1|Overall Study|Withdrawal of informed consent|0
5618196|NCT00784368|19406717|P3|Overall Study|Worsening of symptoms|0
5618197|NCT00784368|19406718|P2|Overall Study|Worsening of symptoms|1
5618198|NCT00784368|19406719|P1|Overall Study|Worsening of symptoms|0
5618199|NCT00784368|19406717|P3|Overall Study|Worsening of complications|1
5618200|NCT00784368|19406718|P2|Overall Study|Worsening of complications|0
5618201|NCT00784368|19406719|P1|Overall Study|Worsening of complications|0
5618202|NCT00784368|19406717|P3|Overall Study|Diagnosis of fever|1
5618203|NCT00784368|19406718|P2|Overall Study|Diagnosis of fever|0
5618204|NCT00784368|19406719|P1|Overall Study|Diagnosis of fever|0
5618205|NCT00784368|19406717|P3|Overall Study|Adverse Event|2
5618206|NCT00784368|19406718|P2|Overall Study|Adverse Event|9
5618207|NCT00784368|19406719|P1|Overall Study|Adverse Event|6
5618208|NCT00784368|19406717|P3|Overall Study|Lack of Efficacy|1
5618209|NCT00784368|19406718|P2|Overall Study|Lack of Efficacy|0
5618210|NCT00784368|19406719|P1|Overall Study|Lack of Efficacy|2
5618211|NCT00784368|19406717|P3|Overall Study|Physician Decision|6
5618212|NCT00784368|19406718|P2|Overall Study|Physician Decision|0
5618213|NCT00784368|19406719|P1|Overall Study|Physician Decision|0
5618214|NCT00784277|19406795|P7|ER Treatment|Other|2
5618215|NCT00784277|19406796|P6|ER Treatment|Other|3
5618216|NCT00784277|19406797|P5|ER Treatment|Other|1
5618217|NCT00784277|19406798|P4|ER Treatment|Other|0
5618218|NCT00784277|19406799|P3|ER Treatment|Other|0
5618219|NCT00784277|19406800|P2|ER Treatment|Other|0
5618220|NCT00784277|19406801|P1|ER Treatment|Other|0
5618221|NCT00784277|19406795|P7|ER Treatment|Study Medication Non-Compliant|3
5618222|NCT00784277|19406796|P6|ER Treatment|Study Medication Non-Compliant|3
5618223|NCT00784277|19406797|P5|ER Treatment|Study Medication Non-Compliant|2
5618224|NCT00784277|19406798|P4|ER Treatment|Study Medication Non-Compliant|0
5618225|NCT00784277|19406799|P3|ER Treatment|Study Medication Non-Compliant|0
5618226|NCT00784277|19406800|P2|ER Treatment|Study Medication Non-Compliant|0
5618227|NCT00784277|19406801|P1|ER Treatment|Study Medication Non-Compliant|0
5618228|NCT00784277|19406795|P7|ER Treatment|Withdrawal by Subject|3
5618229|NCT00784277|19406796|P6|ER Treatment|Withdrawal by Subject|5
5618230|NCT00784277|19406797|P5|ER Treatment|Withdrawal by Subject|2
5618231|NCT00784277|19406798|P4|ER Treatment|Withdrawal by Subject|0
5618232|NCT00784277|19406799|P3|ER Treatment|Withdrawal by Subject|0
5618233|NCT00784277|19406800|P2|ER Treatment|Withdrawal by Subject|0
5618234|NCT00784277|19406801|P1|ER Treatment|Withdrawal by Subject|0
5618235|NCT00784277|19406795|P7|ER Treatment|Lost to Follow-up|0
5618236|NCT00784277|19406796|P6|ER Treatment|Lost to Follow-up|2
5618237|NCT00784277|19406797|P5|ER Treatment|Lost to Follow-up|0
5618238|NCT00784277|19406798|P4|ER Treatment|Lost to Follow-up|0
5618239|NCT00784277|19406799|P3|ER Treatment|Lost to Follow-up|0
5618240|NCT00784277|19406800|P2|ER Treatment|Lost to Follow-up|0
5618241|NCT00784277|19406801|P1|ER Treatment|Lost to Follow-up|0
5618242|NCT00784277|19406795|P7|ER Treatment|Lack of Efficacy|0
5618243|NCT00784277|19406796|P6|ER Treatment|Lack of Efficacy|4
5618244|NCT00784277|19406797|P5|ER Treatment|Lack of Efficacy|3
5618245|NCT00784277|19406798|P4|ER Treatment|Lack of Efficacy|0
5618246|NCT00784277|19406799|P3|ER Treatment|Lack of Efficacy|0
5618247|NCT00784277|19406800|P2|ER Treatment|Lack of Efficacy|0
5618248|NCT00784277|19406801|P1|ER Treatment|Lack of Efficacy|0
5618249|NCT00784277|19406795|P7|ER Treatment|Adverse Event|7
5618250|NCT00784277|19406796|P6|ER Treatment|Adverse Event|7
5618251|NCT00784277|19406797|P5|ER Treatment|Adverse Event|1
5618252|NCT00784277|19406798|P4|ER Treatment|Adverse Event|0
5618253|NCT00784277|19406799|P3|ER Treatment|Adverse Event|0
5618254|NCT00784277|19406800|P2|ER Treatment|Adverse Event|0
5618255|NCT00784277|19406801|P1|ER Treatment|Adverse Event|0
5618256|NCT00784277|19406795|P7|IR Treatment|Other|0
5618257|NCT00784277|19406796|P6|IR Treatment|Other|0
5618258|NCT00784277|19406797|P5|IR Treatment|Other|0
5618259|NCT00784277|19406798|P4|IR Treatment|Other|2
5618260|NCT00784277|19406799|P3|IR Treatment|Other|3
5618261|NCT00784277|19406800|P2|IR Treatment|Other|3
5618262|NCT00784277|19406801|P1|IR Treatment|Other|2
5618263|NCT00784277|19406795|P7|IR Treatment|Resolution Of Pain|0
5618264|NCT00784277|19406796|P6|IR Treatment|Resolution Of Pain|0
5618265|NCT00784277|19406797|P5|IR Treatment|Resolution Of Pain|0
5618266|NCT00784277|19406798|P4|IR Treatment|Resolution Of Pain|0
5618267|NCT00784277|19406799|P3|IR Treatment|Resolution Of Pain|0
5618268|NCT00784277|19406800|P2|IR Treatment|Resolution Of Pain|1
5618269|NCT00784277|19406801|P1|IR Treatment|Resolution Of Pain|0
5618270|NCT00784277|19406795|P7|IR Treatment|Withdrawal by Subject|0
5618271|NCT00784277|19406796|P6|IR Treatment|Withdrawal by Subject|0
5618272|NCT00784277|19406797|P5|IR Treatment|Withdrawal by Subject|0
5618273|NCT00784277|19406798|P4|IR Treatment|Withdrawal by Subject|6
5618274|NCT00784277|19406799|P3|IR Treatment|Withdrawal by Subject|4
5618275|NCT00784277|19406800|P2|IR Treatment|Withdrawal by Subject|1
5618276|NCT00784277|19406801|P1|IR Treatment|Withdrawal by Subject|5
5618277|NCT00784277|19406795|P7|IR Treatment|Lost to Follow-up|0
5618278|NCT00784277|19406796|P6|IR Treatment|Lost to Follow-up|0
5618279|NCT00784277|19406797|P5|IR Treatment|Lost to Follow-up|0
5618280|NCT00784277|19406798|P4|IR Treatment|Lost to Follow-up|0
5618281|NCT00784277|19406799|P3|IR Treatment|Lost to Follow-up|1
5618282|NCT00784277|19406800|P2|IR Treatment|Lost to Follow-up|0
5618283|NCT00784277|19406801|P1|IR Treatment|Lost to Follow-up|1
5618284|NCT00784277|19406795|P7|IR Treatment|Lack of Efficacy|0
5618285|NCT00784277|19406796|P6|IR Treatment|Lack of Efficacy|0
5618286|NCT00784277|19406797|P5|IR Treatment|Lack of Efficacy|0
5618287|NCT00784277|19406798|P4|IR Treatment|Lack of Efficacy|0
5618288|NCT00784277|19406799|P3|IR Treatment|Lack of Efficacy|1
5618289|NCT00784277|19406800|P2|IR Treatment|Lack of Efficacy|4
5618290|NCT00784277|19406801|P1|IR Treatment|Lack of Efficacy|4
5618291|NCT00784277|19406795|P7|IR Treatment|Adverse Event|0
5618292|NCT00784277|19406796|P6|IR Treatment|Adverse Event|0
5618293|NCT00784277|19406797|P5|IR Treatment|Adverse Event|0
5618294|NCT00784277|19406798|P4|IR Treatment|Adverse Event|35
5618295|NCT00784277|19406799|P3|IR Treatment|Adverse Event|19
5618296|NCT00784277|19406800|P2|IR Treatment|Adverse Event|8
5618297|NCT00784277|19406801|P1|IR Treatment|Adverse Event|4
5618298|NCT00784238|19406818|P1|Overall Study|Other|14
5618299|NCT00784238|19406818|P1|Overall Study|Withdrawal by Subject|26
5618300|NCT00784238|19406818|P1|Overall Study|Pregnancy|1
5618301|NCT00784238|19406818|P1|Overall Study|Lost to Follow-up|29
5618302|NCT00784238|19406818|P1|Overall Study|Lack of Efficacy|33
5618303|NCT00784238|19406818|P1|Overall Study|Death|2
5618304|NCT00784238|19406818|P1|Overall Study|Adverse Event|14
5618305|NCT00784147|19406890|P2|Overall Study|Death|0
5618306|NCT00784147|19406891|P1|Overall Study|Death|2
5618307|NCT00784147|19406890|P2|Overall Study|Protocol Violation|1
5618308|NCT00784147|19406891|P1|Overall Study|Protocol Violation|1
5618309|NCT00784147|19406890|P2|Overall Study|Physician Decision|1
5618310|NCT00784147|19406891|P1|Overall Study|Physician Decision|2
5618311|NCT00784147|19406890|P2|Overall Study|Withdrawal by Subject|3
5618312|NCT00784147|19406891|P1|Overall Study|Withdrawal by Subject|1
5618313|NCT00784147|19406890|P2|Overall Study|Lost to Follow-up|4
5618314|NCT00784147|19406891|P1|Overall Study|Lost to Follow-up|2
5618315|NCT00784134|19406911|P2|Overall Study|Lost to Follow-up|6
5618316|NCT00784134|19406912|P1|Overall Study|Lost to Follow-up|3
5618317|NCT00784043|19407035|P2|Overall Study|Protocol Terminated|1
5618318|NCT00784043|19407036|P1|Overall Study|Protocol Terminated|23
5618319|NCT00784043|19407035|P2|Overall Study|Withdrawal by Subject|5
5618320|NCT00784043|19407036|P1|Overall Study|Withdrawal by Subject|8
5618321|NCT00783835|19407071|P1|Overall Study|Participant not Adherent|3
5618322|NCT00783835|19407071|P1|Overall Study|Lost to Follow-up|1
5618323|NCT00783835|19407071|P1|Overall Study|Withdrawal by Subject|2
5618324|NCT00783835|19407071|P1|Overall Study|Medical Criteria|1
5618325|NCT00783835|19407071|P1|Overall Study|Adverse Event|3
5618326|NCT00783796|19407083|P1|Overall Study|Received commercial XIENCE V stent|1
5618327|NCT00783796|19407083|P1|Overall Study|Received non-XIENCE V stent|1
5618328|NCT00783796|19407083|P1|Overall Study|Did not receive any stent|4
5618329|NCT00783718|19407188|P7|Maintenance Phase|Lost to Follow-up|2
5618330|NCT00783718|19407189|P6|Maintenance Phase|Lost to Follow-up|0
5618331|NCT00783718|19407190|P5|Maintenance Phase|Lost to Follow-up|2
5618332|NCT00783718|19407191|P4|Maintenance Phase|Lost to Follow-up|0
5618333|NCT00783718|19407192|P3|Maintenance Phase|Lost to Follow-up|0
5618334|NCT00783718|19407193|P2|Maintenance Phase|Lost to Follow-up|0
5618335|NCT00783718|19407194|P1|Maintenance Phase|Lost to Follow-up|3
5618336|NCT00783718|19407188|P7|Maintenance Phase|Withdrawal by Subject|20
5618337|NCT00783718|19407189|P6|Maintenance Phase|Withdrawal by Subject|2
5618338|NCT00783718|19407190|P5|Maintenance Phase|Withdrawal by Subject|5
5618339|NCT00783718|19407191|P4|Maintenance Phase|Withdrawal by Subject|2
5618340|NCT00783718|19407192|P3|Maintenance Phase|Withdrawal by Subject|0
5618341|NCT00783718|19407193|P2|Maintenance Phase|Withdrawal by Subject|0
5618342|NCT00783718|19407194|P1|Maintenance Phase|Withdrawal by Subject|6
5618343|NCT00783718|19407188|P7|Maintenance Phase|Lack of Efficacy|155
5618344|NCT00783718|19407189|P6|Maintenance Phase|Lack of Efficacy|33
5618345|NCT00783718|19407190|P5|Maintenance Phase|Lack of Efficacy|31
5618346|NCT00783718|19407191|P4|Maintenance Phase|Lack of Efficacy|61
5618347|NCT00783718|19407192|P3|Maintenance Phase|Lack of Efficacy|0
5618348|NCT00783718|19407193|P2|Maintenance Phase|Lack of Efficacy|0
5618349|NCT00783718|19407194|P1|Maintenance Phase|Lack of Efficacy|83
5618350|NCT00783718|19407188|P7|Maintenance Phase|Protocol Violation|2
5618351|NCT00783718|19407189|P6|Maintenance Phase|Protocol Violation|0
5618352|NCT00783718|19407190|P5|Maintenance Phase|Protocol Violation|0
5618353|NCT00783718|19407191|P4|Maintenance Phase|Protocol Violation|0
5618354|NCT00783718|19407192|P3|Maintenance Phase|Protocol Violation|0
5618355|NCT00783718|19407193|P2|Maintenance Phase|Protocol Violation|0
5618356|NCT00783718|19407194|P1|Maintenance Phase|Protocol Violation|1
5618357|NCT00783718|19407188|P7|Maintenance Phase|Adverse Event|16
5618358|NCT00783718|19407189|P6|Maintenance Phase|Adverse Event|6
5618359|NCT00783718|19407190|P5|Maintenance Phase|Adverse Event|7
5618360|NCT00783718|19407191|P4|Maintenance Phase|Adverse Event|15
5618361|NCT00783718|19407192|P3|Maintenance Phase|Adverse Event|0
5618362|NCT00783718|19407193|P2|Maintenance Phase|Adverse Event|0
5618363|NCT00783718|19407194|P1|Maintenance Phase|Adverse Event|12
5618364|NCT00783718|19407188|P7|Induction Phase|Lost to Follow-up|0
5618365|NCT00783718|19407189|P6|Induction Phase|Lost to Follow-up|0
5618366|NCT00783718|19407190|P5|Induction Phase|Lost to Follow-up|0
5618367|NCT00783718|19407191|P4|Induction Phase|Lost to Follow-up|0
5618368|NCT00783718|19407192|P3|Induction Phase|Lost to Follow-up|1
5618369|NCT00783718|19407193|P2|Induction Phase|Lost to Follow-up|0
5618370|NCT00783718|19407194|P1|Induction Phase|Lost to Follow-up|1
5618371|NCT00783718|19407188|P7|Induction Phase|Withdrawal by Subject|0
5618372|NCT00783718|19407189|P6|Induction Phase|Withdrawal by Subject|0
5618373|NCT00783718|19407190|P5|Induction Phase|Withdrawal by Subject|0
5618374|NCT00783718|19407191|P4|Induction Phase|Withdrawal by Subject|0
5618375|NCT00783718|19407192|P3|Induction Phase|Withdrawal by Subject|8
5618376|NCT00783718|19407193|P2|Induction Phase|Withdrawal by Subject|4
5618377|NCT00783718|19407194|P1|Induction Phase|Withdrawal by Subject|3
5618378|NCT00783718|19407188|P7|Induction Phase|Lack of Efficacy|0
5618379|NCT00783718|19407189|P6|Induction Phase|Lack of Efficacy|0
5618380|NCT00783718|19407190|P5|Induction Phase|Lack of Efficacy|0
5618381|NCT00783718|19407191|P4|Induction Phase|Lack of Efficacy|0
5618382|NCT00783718|19407192|P3|Induction Phase|Lack of Efficacy|14
5618383|NCT00783718|19407193|P2|Induction Phase|Lack of Efficacy|2
5618384|NCT00783718|19407194|P1|Induction Phase|Lack of Efficacy|5
5618385|NCT00783718|19407188|P7|Induction Phase|Protocol Violation|0
5618386|NCT00783718|19407189|P6|Induction Phase|Protocol Violation|0
5618387|NCT00783718|19407190|P5|Induction Phase|Protocol Violation|0
5618388|NCT00783718|19407191|P4|Induction Phase|Protocol Violation|0
5618389|NCT00783718|19407192|P3|Induction Phase|Protocol Violation|6
5618390|NCT00783718|19407193|P2|Induction Phase|Protocol Violation|1
5618391|NCT00783718|19407194|P1|Induction Phase|Protocol Violation|1
5618392|NCT00783718|19407188|P7|Induction Phase|Adverse Event|0
5618393|NCT00783718|19407189|P6|Induction Phase|Adverse Event|0
5618394|NCT00783718|19407190|P5|Induction Phase|Adverse Event|0
5618395|NCT00783718|19407191|P4|Induction Phase|Adverse Event|0
5618396|NCT00783718|19407192|P3|Induction Phase|Adverse Event|7
5618397|NCT00783718|19407193|P2|Induction Phase|Adverse Event|0
5618398|NCT00783718|19407194|P1|Induction Phase|Adverse Event|4
5618399|NCT00783705|19407222|P2|Overall Study|Lost to Follow-up|3
5618400|NCT00783705|19407223|P1|Overall Study|Lost to Follow-up|1
5618401|NCT00783705|19407222|P2|Overall Study|Withdrawal by Subject|2
5618402|NCT00783705|19407223|P1|Overall Study|Withdrawal by Subject|3
5618403|NCT00783705|19407222|P2|Overall Study|Adverse Event|0
5618404|NCT00783705|19407223|P1|Overall Study|Adverse Event|2
5618405|NCT00783692|19407270|P7|Maintenance Phase|Other|1
5618406|NCT00783692|19407271|P6|Maintenance Phase|Other|1
5618407|NCT00783692|19407272|P5|Maintenance Phase|Other|0
5618408|NCT00783692|19407273|P4|Maintenance Phase|Other|1
5618409|NCT00783692|19407274|P3|Maintenance Phase|Other|0
5618410|NCT00783692|19407275|P2|Maintenance Phase|Other|0
5618411|NCT00783692|19407276|P1|Maintenance Phase|Other|0
5618412|NCT00783692|19407270|P7|Maintenance Phase|Lost to Follow-up|5
5618413|NCT00783692|19407271|P6|Maintenance Phase|Lost to Follow-up|2
5618414|NCT00783692|19407272|P5|Maintenance Phase|Lost to Follow-up|3
5618415|NCT00783692|19407273|P4|Maintenance Phase|Lost to Follow-up|1
5618416|NCT00783692|19407274|P3|Maintenance Phase|Lost to Follow-up|0
5618417|NCT00783692|19407275|P2|Maintenance Phase|Lost to Follow-up|0
5618418|NCT00783692|19407276|P1|Maintenance Phase|Lost to Follow-up|2
5618419|NCT00783692|19407270|P7|Maintenance Phase|Withdrawal by Subject|24
5618420|NCT00783692|19407271|P6|Maintenance Phase|Withdrawal by Subject|9
5618421|NCT00783692|19407272|P5|Maintenance Phase|Withdrawal by Subject|6
5618422|NCT00783692|19407273|P4|Maintenance Phase|Withdrawal by Subject|7
5618423|NCT00783692|19407274|P3|Maintenance Phase|Withdrawal by Subject|0
5618424|NCT00783692|19407275|P2|Maintenance Phase|Withdrawal by Subject|0
5618425|NCT00783692|19407276|P1|Maintenance Phase|Withdrawal by Subject|7
5618426|NCT00783692|19407270|P7|Maintenance Phase|Lack of Efficacy|177
5618427|NCT00783692|19407271|P6|Maintenance Phase|Lack of Efficacy|48
5618428|NCT00783692|19407272|P5|Maintenance Phase|Lack of Efficacy|58
5618429|NCT00783692|19407273|P4|Maintenance Phase|Lack of Efficacy|64
5618430|NCT00783692|19407274|P3|Maintenance Phase|Lack of Efficacy|0
5618431|NCT00783692|19407275|P2|Maintenance Phase|Lack of Efficacy|0
5618432|NCT00783692|19407276|P1|Maintenance Phase|Lack of Efficacy|79
5618433|NCT00783692|19407270|P7|Maintenance Phase|Protocol Violation|4
5618434|NCT00783692|19407271|P6|Maintenance Phase|Protocol Violation|3
5618435|NCT00783692|19407272|P5|Maintenance Phase|Protocol Violation|2
5618436|NCT00783692|19407273|P4|Maintenance Phase|Protocol Violation|1
5618437|NCT00783692|19407274|P3|Maintenance Phase|Protocol Violation|0
5618438|NCT00783692|19407275|P2|Maintenance Phase|Protocol Violation|0
5618439|NCT00783692|19407276|P1|Maintenance Phase|Protocol Violation|0
5618440|NCT00783692|19407270|P7|Maintenance Phase|Adverse Event|38
5618441|NCT00783692|19407271|P6|Maintenance Phase|Adverse Event|9
5618442|NCT00783692|19407272|P5|Maintenance Phase|Adverse Event|12
5618443|NCT00783692|19407273|P4|Maintenance Phase|Adverse Event|15
5618444|NCT00783692|19407274|P3|Maintenance Phase|Adverse Event|0
5618445|NCT00783692|19407275|P2|Maintenance Phase|Adverse Event|0
5618446|NCT00783692|19407276|P1|Maintenance Phase|Adverse Event|7
5618447|NCT00783692|19407270|P7|Induction Phase|Other|0
5618448|NCT00783692|19407271|P6|Induction Phase|Other|0
5618449|NCT00783692|19407272|P5|Induction Phase|Other|0
5618450|NCT00783692|19407273|P4|Induction Phase|Other|0
5618451|NCT00783692|19407274|P3|Induction Phase|Other|2
5618452|NCT00783692|19407275|P2|Induction Phase|Other|0
5618453|NCT00783692|19407276|P1|Induction Phase|Other|0
5618454|NCT00783692|19407270|P7|Induction Phase|Lost to Follow-up|0
5618455|NCT00783692|19407271|P6|Induction Phase|Lost to Follow-up|0
5618456|NCT00783692|19407272|P5|Induction Phase|Lost to Follow-up|0
5618457|NCT00783692|19407273|P4|Induction Phase|Lost to Follow-up|0
5618458|NCT00783692|19407274|P3|Induction Phase|Lost to Follow-up|3
5618459|NCT00783692|19407275|P2|Induction Phase|Lost to Follow-up|0
5618460|NCT00783692|19407276|P1|Induction Phase|Lost to Follow-up|0
5618461|NCT00783692|19407270|P7|Induction Phase|Withdrawal by Subject|0
5618462|NCT00783692|19407271|P6|Induction Phase|Withdrawal by Subject|0
5618463|NCT00783692|19407272|P5|Induction Phase|Withdrawal by Subject|0
5618464|NCT00783692|19407273|P4|Induction Phase|Withdrawal by Subject|0
5618465|NCT00783692|19407274|P3|Induction Phase|Withdrawal by Subject|16
5618466|NCT00783692|19407275|P2|Induction Phase|Withdrawal by Subject|9
5618467|NCT00783692|19407276|P1|Induction Phase|Withdrawal by Subject|3
5618468|NCT00783692|19407270|P7|Induction Phase|Lack of Efficacy|0
5618469|NCT00783692|19407271|P6|Induction Phase|Lack of Efficacy|0
5618470|NCT00783692|19407272|P5|Induction Phase|Lack of Efficacy|0
5618471|NCT00783692|19407273|P4|Induction Phase|Lack of Efficacy|0
5618472|NCT00783692|19407274|P3|Induction Phase|Lack of Efficacy|28
5618473|NCT00783692|19407275|P2|Induction Phase|Lack of Efficacy|3
5618474|NCT00783692|19407276|P1|Induction Phase|Lack of Efficacy|1
5618475|NCT00783692|19407270|P7|Induction Phase|Protocol Violation|0
5618476|NCT00783692|19407271|P6|Induction Phase|Protocol Violation|0
5618477|NCT00783692|19407272|P5|Induction Phase|Protocol Violation|0
5618478|NCT00783692|19407273|P4|Induction Phase|Protocol Violation|0
5618479|NCT00783692|19407274|P3|Induction Phase|Protocol Violation|1
5618480|NCT00783692|19407275|P2|Induction Phase|Protocol Violation|0
5618481|NCT00783692|19407276|P1|Induction Phase|Protocol Violation|0
5618482|NCT00783692|19407270|P7|Induction Phase|Adverse Event|0
5618483|NCT00783692|19407271|P6|Induction Phase|Adverse Event|0
5618484|NCT00783692|19407272|P5|Induction Phase|Adverse Event|0
5618485|NCT00783692|19407273|P4|Induction Phase|Adverse Event|0
5618486|NCT00783692|19407274|P3|Induction Phase|Adverse Event|24
5618487|NCT00783692|19407275|P2|Induction Phase|Adverse Event|9
5618488|NCT00783692|19407276|P1|Induction Phase|Adverse Event|7
5618489|NCT00783432|19407322|P2|Overall Study|Protocol Violation|9
5618490|NCT00783432|19407323|P1|Overall Study|Protocol Violation|6
5618491|NCT00783432|19407322|P2|Overall Study|subject moved|5
5618492|NCT00783432|19407323|P1|Overall Study|subject moved|3
5618493|NCT00783432|19407322|P2|Overall Study|Withdrawal by Subject|20
5618494|NCT00783432|19407323|P1|Overall Study|Withdrawal by Subject|23
5618495|NCT00783432|19407322|P2|Overall Study|Lost to Follow-up|6
5618496|NCT00783432|19407323|P1|Overall Study|Lost to Follow-up|11
5618497|NCT00783432|19407322|P2|Overall Study|Lack of Efficacy|21
5618498|NCT00783432|19407323|P1|Overall Study|Lack of Efficacy|20
5618499|NCT00783432|19407322|P2|Overall Study|Adverse Event|17
5618500|NCT00783432|19407323|P1|Overall Study|Adverse Event|22
5618501|NCT00783302|19407333|P1|Overall Study|Withdrawal by Subject|3
5618502|NCT00783302|19407333|P1|Overall Study|Physician Decision|1
5618503|NCT00783302|19407333|P1|Overall Study|Protocol Violation|3
5618504|NCT00783302|19407333|P1|Overall Study|Technical Problems|11
5618505|NCT00783302|19407333|P1|Overall Study|Lost to Follow-up|17
5618506|NCT00783289|19407355|P4|Overall Study|Protocol Violation|0
5618507|NCT00783289|19407356|P3|Overall Study|Protocol Violation|0
5618508|NCT00783289|19407357|P2|Overall Study|Protocol Violation|1
5618509|NCT00783289|19407358|P1|Overall Study|Protocol Violation|0
5618510|NCT00783263|19407388|P4|Overall Study|Withdrawal by Subject|2
5618511|NCT00783263|19407389|P3|Overall Study|Withdrawal by Subject|1
5618512|NCT00783263|19407390|P2|Overall Study|Withdrawal by Subject|1
5618513|NCT00783263|19407391|P1|Overall Study|Withdrawal by Subject|0
5618514|NCT00783263|19407388|P4|Overall Study|Lost to Follow-up|0
5618515|NCT00783263|19407389|P3|Overall Study|Lost to Follow-up|0
5618516|NCT00783263|19407390|P2|Overall Study|Lost to Follow-up|1
5618517|NCT00783263|19407391|P1|Overall Study|Lost to Follow-up|1
5618518|NCT00783263|19407388|P4|Overall Study|Adverse Event|1
5618519|NCT00783263|19407389|P3|Overall Study|Adverse Event|2
5618520|NCT00783263|19407390|P2|Overall Study|Adverse Event|0
5618521|NCT00783263|19407391|P1|Overall Study|Adverse Event|3
5618522|NCT00783224|19407421|P4|Overall Study|Inappropriate as a study subject|1
5618523|NCT00783224|19407422|P3|Overall Study|Inappropriate as a study subject|0
5618524|NCT00783224|19407423|P2|Overall Study|Inappropriate as a study subject|0
5618525|NCT00783224|19407424|P1|Overall Study|Inappropriate as a study subject|0
5618526|NCT00783224|19407421|P4|Overall Study|Discarded the Investigational Drug Used|1
5618527|NCT00783224|19407422|P3|Overall Study|Discarded the Investigational Drug Used|0
5618528|NCT00783224|19407423|P2|Overall Study|Discarded the Investigational Drug Used|0
5618529|NCT00783224|19407424|P1|Overall Study|Discarded the Investigational Drug Used|0
5618530|NCT00783224|19407421|P4|Overall Study|Adverse Event|0
5618531|NCT00783224|19407422|P3|Overall Study|Adverse Event|1
5618532|NCT00783224|19407423|P2|Overall Study|Adverse Event|0
5618533|NCT00783224|19407424|P1|Overall Study|Adverse Event|0
5618534|NCT00783198|19407436|P3|Overall Study|Administrative|2
5618535|NCT00783198|19407437|P2|Overall Study|Administrative|1
5618536|NCT00783198|19407438|P1|Overall Study|Administrative|2
5618537|NCT00783198|19407436|P3|Overall Study|Did not meet protocol eligibility|0
5618538|NCT00783198|19407437|P2|Overall Study|Did not meet protocol eligibility|1
5618539|NCT00783198|19407438|P1|Overall Study|Did not meet protocol eligibility|0
5618540|NCT00783198|19407436|P3|Overall Study|Noncompliance with protocol|10
5618541|NCT00783198|19407437|P2|Overall Study|Noncompliance with protocol|7
5618542|NCT00783198|19407438|P1|Overall Study|Noncompliance with protocol|7
5618543|NCT00783198|19407436|P3|Overall Study|Withdrawal by Subject|20
5618544|NCT00783198|19407437|P2|Overall Study|Withdrawal by Subject|14
5618545|NCT00783198|19407438|P1|Overall Study|Withdrawal by Subject|22
5618546|NCT00783198|19407436|P3|Overall Study|Lost to Follow-up|7
5618547|NCT00783198|19407437|P2|Overall Study|Lost to Follow-up|1
5618548|NCT00783198|19407438|P1|Overall Study|Lost to Follow-up|11
5618549|NCT00783198|19407436|P3|Overall Study|Adverse Event|3
5618550|NCT00783198|19407437|P2|Overall Study|Adverse Event|19
5618551|NCT00783198|19407438|P1|Overall Study|Adverse Event|15
5618552|NCT00783094|19407461|P3|Open-Label Extension Period|Lack of Efficacy|0
5618553|NCT00783094|19407462|P2|Open-Label Extension Period|Lack of Efficacy|4
5618554|NCT00783094|19407463|P1|Open-Label Extension Period|Lack of Efficacy|1
5618555|NCT00783094|19407461|P3|Open-Label Extension Period|Physician Decision|3
5618556|NCT00783094|19407462|P2|Open-Label Extension Period|Physician Decision|2
5618557|NCT00783094|19407463|P1|Open-Label Extension Period|Physician Decision|4
5618558|NCT00783094|19407461|P3|Open-Label Extension Period|Withdrawal by Subject|3
5618559|NCT00783094|19407462|P2|Open-Label Extension Period|Withdrawal by Subject|1
5618560|NCT00783094|19407463|P1|Open-Label Extension Period|Withdrawal by Subject|1
5618561|NCT00783094|19407461|P3|Open-Label Extension Period|Protocol Violation|7
5618562|NCT00783094|19407462|P2|Open-Label Extension Period|Protocol Violation|5
5618563|NCT00783094|19407463|P1|Open-Label Extension Period|Protocol Violation|4
5618564|NCT00783094|19407461|P3|Open-Label Extension Period|Death|1
5618565|NCT00783094|19407462|P2|Open-Label Extension Period|Death|0
5618566|NCT00783094|19407463|P1|Open-Label Extension Period|Death|0
5618567|NCT00783094|19407461|P3|Open-Label Extension Period|Adverse Event|16
5618568|NCT00783094|19407462|P2|Open-Label Extension Period|Adverse Event|7
5618569|NCT00783094|19407463|P1|Open-Label Extension Period|Adverse Event|12
5618570|NCT00783094|19407461|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
5618571|NCT00783094|19407462|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
5618572|NCT00783094|19407463|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
5618573|NCT00783094|19407461|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
5618574|NCT00783094|19407462|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
5618575|NCT00783094|19407463|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
5618576|NCT00783094|19407461|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
5618577|NCT00783094|19407462|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
5618578|NCT00783094|19407463|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
5618579|NCT00783094|19407461|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
5618580|NCT00783094|19407462|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
5618581|NCT00783094|19407463|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
5618582|NCT00783094|19407461|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
5618583|NCT00783094|19407462|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
5618584|NCT00783094|19407463|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
5618585|NCT00782834|19407539|P1|Treatment Phase|fibrous tumor not GIST|1
5618586|NCT00782795|19407579|P2|Overall Study|Withdrawal by Subject|2
5618587|NCT00782795|19407580|P1|Overall Study|Withdrawal by Subject|1
5618588|NCT00782717|19407620|P2|Overall Study|Exited in error|2
5618589|NCT00782717|19407621|P1|Overall Study|Exited in error|0
5618590|NCT00782717|19407620|P2|Overall Study|Did not meet entrance criteria|3
5618591|NCT00782717|19407621|P1|Overall Study|Did not meet entrance criteria|1
5618592|NCT00782717|19407620|P2|Overall Study|Enrollment close prior to surgery|0
5618593|NCT00782717|19407621|P1|Overall Study|Enrollment close prior to surgery|1
5618594|NCT00782717|19407620|P2|Overall Study|Treatment failure|14
5618595|NCT00782717|19407621|P1|Overall Study|Treatment failure|3
5618596|NCT00782717|19407620|P2|Overall Study|Noncompliance|1
5618597|NCT00782717|19407621|P1|Overall Study|Noncompliance|2
5618598|NCT00782717|19407620|P2|Overall Study|Patient decision unrelated to AE|3
5618599|NCT00782717|19407621|P1|Overall Study|Patient decision unrelated to AE|6
5618600|NCT00782717|19407620|P2|Overall Study|Adverse Event|5
5618601|NCT00782717|19407621|P1|Overall Study|Adverse Event|2
5618602|NCT00782626|19407648|P1|Overall Study|Other Complicating Disease|1
5618603|NCT00782626|19407648|P1|Overall Study|Progressive Disease|5
5618604|NCT00782626|19407648|P1|Overall Study|Adverse Event|1
5618605|NCT00782509|19407655|P3|Overall Study|Lack of Efficacy|2
5618606|NCT00782509|19407656|P2|Overall Study|Lack of Efficacy|5
5618607|NCT00782509|19407657|P1|Overall Study|Lack of Efficacy|10
5618608|NCT00782509|19407655|P3|Overall Study|Other reasons not stated above|3
5618609|NCT00782509|19407656|P2|Overall Study|Other reasons not stated above|2
5618610|NCT00782509|19407657|P1|Overall Study|Other reasons not stated above|5
5618611|NCT00782509|19407655|P3|Overall Study|Non compliance with protocol|0
5618612|NCT00782509|19407656|P2|Overall Study|Non compliance with protocol|0
5618613|NCT00782509|19407657|P1|Overall Study|Non compliance with protocol|2
5618614|NCT00782509|19407655|P3|Overall Study|Withdrawal by Subject|8
5618615|NCT00782509|19407656|P2|Overall Study|Withdrawal by Subject|5
5618616|NCT00782509|19407657|P1|Overall Study|Withdrawal by Subject|3
5618617|NCT00782509|19407655|P3|Overall Study|Lost to Follow-up|3
5618618|NCT00782509|19407656|P2|Overall Study|Lost to Follow-up|2
5618619|NCT00782509|19407657|P1|Overall Study|Lost to Follow-up|1
5618620|NCT00782509|19407655|P3|Overall Study|Adverse Event|20
5618621|NCT00782509|19407656|P2|Overall Study|Adverse Event|10
5618622|NCT00782509|19407657|P1|Overall Study|Adverse Event|20
5618623|NCT00782496|19407850|P2|Overall Study|Lost to Follow-up|15
5618624|NCT00782496|19407851|P1|Overall Study|Lost to Follow-up|14
5618625|NCT00782483|19407858|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
5618626|NCT00782418|19407862|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
5618627|NCT00782418|19407863|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
5618628|NCT00782418|19407864|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
5618629|NCT00782418|19407865|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
5618630|NCT00782418|19407866|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
5618631|NCT00782418|19407867|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
5618632|NCT00782418|19407868|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
5618633|NCT00782418|19407862|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
5618634|NCT00782418|19407863|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
5618635|NCT00782418|19407864|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
5618636|NCT00782418|19407865|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
5618637|NCT00782418|19407866|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
5618638|NCT00782418|19407867|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
5618639|NCT00782418|19407868|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
5618640|NCT00782340|19407905|P3|Open Label Titration|Randomized in error|0
5618641|NCT00782340|19407906|P2|Open Label Titration|Randomized in error|0
5618642|NCT00782340|19407907|P1|Open Label Titration|Randomized in error|6
5618643|NCT00782340|19407905|P3|Open Label Titration|Lost to Follow-up|0
5618644|NCT00782340|19407906|P2|Open Label Titration|Lost to Follow-up|0
5618645|NCT00782340|19407907|P1|Open Label Titration|Lost to Follow-up|5
5618646|NCT00782340|19407905|P3|Open Label Titration|Did not meet responder criteria|0
5618647|NCT00782340|19407906|P2|Open Label Titration|Did not meet responder criteria|0
5618648|NCT00782340|19407907|P1|Open Label Titration|Did not meet responder criteria|2
5618649|NCT00782340|19407905|P3|Open Label Titration|Enrollment capped|0
5618650|NCT00782340|19407906|P2|Open Label Titration|Enrollment capped|0
5618651|NCT00782340|19407907|P1|Open Label Titration|Enrollment capped|16
5618652|NCT00782340|19407905|P3|Open Label Titration|Withdrawal by Subject|0
5618653|NCT00782340|19407906|P2|Open Label Titration|Withdrawal by Subject|0
5618654|NCT00782340|19407907|P1|Open Label Titration|Withdrawal by Subject|5
5618655|NCT00782340|19407905|P3|Open Label Titration|Protocol Violation|0
5618656|NCT00782340|19407906|P2|Open Label Titration|Protocol Violation|0
5618657|NCT00782340|19407907|P1|Open Label Titration|Protocol Violation|5
5618658|NCT00782340|19407905|P3|Open Label Titration|Treatment failure|0
5618659|NCT00782340|19407906|P2|Open Label Titration|Treatment failure|0
5618660|NCT00782340|19407907|P1|Open Label Titration|Treatment failure|50
5618661|NCT00782340|19407905|P3|Open Label Titration|Adverse Event|0
5618662|NCT00782340|19407906|P2|Open Label Titration|Adverse Event|0
5618663|NCT00782340|19407907|P1|Open Label Titration|Adverse Event|12
5618664|NCT00782275|19407977|P1|Overall Study|Other|3
5618665|NCT00782275|19407977|P1|Overall Study|Not started treatment|1
5618666|NCT00782275|19407977|P1|Overall Study|Physician Decision|4
5618667|NCT00782275|19407977|P1|Overall Study|Progressive Disease|21
5618668|NCT00782275|19407977|P1|Overall Study|Withdrawal by Subject|1
5618669|NCT00782275|19407977|P1|Overall Study|Adverse Event|11
5618670|NCT00782210|19407986|P3|Overall Study|Other reason not described above|3
5618671|NCT00782210|19407987|P2|Overall Study|Other reason not described above|2
5618672|NCT00782210|19407988|P1|Overall Study|Other reason not described above|3
5618673|NCT00782210|19407986|P3|Overall Study|Lack of Efficacy|1
5618674|NCT00782210|19407987|P2|Overall Study|Lack of Efficacy|4
5618675|NCT00782210|19407988|P1|Overall Study|Lack of Efficacy|13
5618676|NCT00782210|19407986|P3|Overall Study|Non compliance with protocol|2
5618677|NCT00782210|19407987|P2|Overall Study|Non compliance with protocol|3
5618678|NCT00782210|19407988|P1|Overall Study|Non compliance with protocol|0
5618679|NCT00782210|19407986|P3|Overall Study|Withdrawal by Subject|11
5618680|NCT00782210|19407987|P2|Overall Study|Withdrawal by Subject|8
5618681|NCT00782210|19407988|P1|Overall Study|Withdrawal by Subject|11
5618682|NCT00782210|19407986|P3|Overall Study|Lost to Follow-up|2
5618683|NCT00782210|19407987|P2|Overall Study|Lost to Follow-up|1
5618684|NCT00782210|19407988|P1|Overall Study|Lost to Follow-up|2
5618685|NCT00782210|19407986|P3|Overall Study|Adverse Event|16
5618686|NCT00782210|19407987|P2|Overall Study|Adverse Event|17
5618687|NCT00782210|19407988|P1|Overall Study|Adverse Event|21
5618688|NCT00782184|19408181|P2|Overall Study|Withdrawal by Subject|2
5618689|NCT00782184|19408182|P1|Overall Study|Withdrawal by Subject|3
5618690|NCT00782184|19408181|P2|Overall Study|Protocol Violation|1
5618691|NCT00782184|19408182|P1|Overall Study|Protocol Violation|0
5618692|NCT00782184|19408181|P2|Overall Study|Adverse Event|2
5618693|NCT00782184|19408182|P1|Overall Study|Adverse Event|1
5618694|NCT00782171|19408219|P2|Overall Study|not eligible|6
5618695|NCT00782171|19408220|P1|Overall Study|not eligible|8
5618696|NCT00782171|19408219|P2|Overall Study|others|9
5618697|NCT00782171|19408220|P1|Overall Study|others|7
5618698|NCT00782171|19408219|P2|Overall Study|complications|1
5618699|NCT00782171|19408220|P1|Overall Study|complications|3
5618700|NCT00782171|19408219|P2|Overall Study|Withdrawal by Subject|1
5618701|NCT00782171|19408220|P1|Overall Study|Withdrawal by Subject|2
5618702|NCT00782171|19408219|P2|Overall Study|Lost to Follow-up|2
5618703|NCT00782171|19408220|P1|Overall Study|Lost to Follow-up|2
5618704|NCT00782067|19408252|P1|Overall Study|Protocol deviation|2
5618705|NCT00782067|19408252|P1|Overall Study|Disease progression|43
5618706|NCT00782067|19408252|P1|Overall Study|Death|9
5618707|NCT00782067|19408252|P1|Overall Study|Administrative problems|14
5618708|NCT00782067|19408252|P1|Overall Study|Lost to Follow-up|2
5618709|NCT00782067|19408252|P1|Overall Study|Subject withdrew consent|11
5618710|NCT00782067|19408252|P1|Overall Study|Adverse Event|35
5618711|NCT00781963|19408264|P2|Overall Study|Refused follow-up|0
5618712|NCT00781963|19408265|P1|Overall Study|Refused follow-up|9
5618713|NCT00781963|19408264|P2|Overall Study|Withdrawal by Subject|1
5618714|NCT00781963|19408265|P1|Overall Study|Withdrawal by Subject|3
5618715|NCT00781963|19408264|P2|Overall Study|Lost to Follow-up|1
5618716|NCT00781963|19408265|P1|Overall Study|Lost to Follow-up|2
5618717|NCT00781963|19408264|P2|Overall Study|Death|0
5618718|NCT00781963|19408265|P1|Overall Study|Death|3
5618719|NCT00781937|19408294|P2|Follow up Period (Week 56-68)|Unclassified|4
5618720|NCT00781937|19408295|P1|Follow up Period (Week 56-68)|Unclassified|5
5618721|NCT00781937|19408294|P2|Follow up Period (Week 56-68)|Protocol Violation|1
5618722|NCT00781937|19408295|P1|Follow up Period (Week 56-68)|Protocol Violation|1
5618723|NCT00781937|19408294|P2|Main Trial Period Through Week 56|Unclassified|15
5618724|NCT00781937|19408295|P1|Main Trial Period Through Week 56|Unclassified|10
5618725|NCT00781937|19408294|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
5618726|NCT00781937|19408295|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
5618727|NCT00781937|19408294|P2|Main Trial Period Through Week 56|Protocol Violation|5
5618728|NCT00781937|19408295|P1|Main Trial Period Through Week 56|Protocol Violation|8
5618729|NCT00781937|19408294|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
5618730|NCT00781937|19408295|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
5618731|NCT00781937|19408294|P2|Main Trial Period Through Week 56|Adverse Event|18
5618732|NCT00781937|19408295|P1|Main Trial Period Through Week 56|Adverse Event|18
5618733|NCT00781911|19408353|P2|Overall Study|Sponsor Decision|0
5618734|NCT00781911|19408354|P1|Overall Study|Sponsor Decision|1
5618735|NCT00781911|19408353|P2|Overall Study|Physician Decision|2
5618736|NCT00781911|19408354|P1|Overall Study|Physician Decision|0
5618737|NCT00781911|19408353|P2|Overall Study|Withdrawal by Subject|2
5618738|NCT00781911|19408354|P1|Overall Study|Withdrawal by Subject|1
5618739|NCT00781911|19408353|P2|Overall Study|Adverse Event|4
5618740|NCT00781911|19408354|P1|Overall Study|Adverse Event|4
5618741|NCT00781885|19408389|P1|Overall Study|Physician Decision|1
5618742|NCT00781859|19408406|P2|Overall Study|Death|0
5618743|NCT00781859|19408407|P1|Overall Study|Death|3
5618744|NCT00781859|19408406|P2|Overall Study|Lost to Follow-up|3
5618745|NCT00781859|19408407|P1|Overall Study|Lost to Follow-up|6
5618746|NCT00781859|19408406|P2|Overall Study|Withdrawal by Subject|4
5618747|NCT00781859|19408407|P1|Overall Study|Withdrawal by Subject|8
5618748|NCT00781859|19408406|P2|Overall Study|Adverse Event|2
5618749|NCT00781859|19408407|P1|Overall Study|Adverse Event|2
5618750|NCT00781768|19408417|P2|Overall Study|Not transplanted.|2
5618751|NCT00781768|19408418|P1|Overall Study|Not transplanted.|0
5618752|NCT00781599|19408426|P2|Overall Study|Lost to Follow-up|4
5618753|NCT00781599|19408427|P1|Overall Study|Lost to Follow-up|7
5618754|NCT00781456|19408452|P2|Overall Study|Other Reason, Unknown|1
5618755|NCT00781456|19408453|P1|Overall Study|Other Reason, Unknown|0
5618756|NCT00781456|19408452|P2|Overall Study|Lost to Follow-up|5
5618757|NCT00781456|19408453|P1|Overall Study|Lost to Follow-up|10
5618758|NCT00781456|19408452|P2|Overall Study|Noncompliance With Protocol|1
5618759|NCT00781456|19408453|P1|Overall Study|Noncompliance With Protocol|1
5618760|NCT00781456|19408452|P2|Overall Study|Protocol Violation|1
5618761|NCT00781456|19408453|P1|Overall Study|Protocol Violation|4
5618762|NCT00781456|19408452|P2|Overall Study|Withdrawal by Subject|5
5618763|NCT00781456|19408453|P1|Overall Study|Withdrawal by Subject|3
5618764|NCT00781456|19408452|P2|Overall Study|Adverse Event|3
5618765|NCT00781456|19408453|P1|Overall Study|Adverse Event|3
5618766|NCT00781391|19408476|P3|Overall Study|Lost to Follow-up|1
5618767|NCT00781391|19408477|P2|Overall Study|Lost to Follow-up|0
5618768|NCT00781391|19408478|P1|Overall Study|Lost to Follow-up|0
5618769|NCT00781391|19408476|P3|Overall Study|Withdrawal by Subject|25
5618770|NCT00781391|19408477|P2|Overall Study|Withdrawal by Subject|37
5618771|NCT00781391|19408478|P1|Overall Study|Withdrawal by Subject|47
5618772|NCT00781391|19408476|P3|Overall Study|Death|706
5618773|NCT00781391|19408477|P2|Overall Study|Death|730
5618774|NCT00781391|19408478|P1|Overall Study|Death|789
5618775|NCT00781391|19408476|P3|Overall Study|Protocol Violation|20
5618776|NCT00781391|19408477|P2|Overall Study|Protocol Violation|17
5618777|NCT00781391|19408478|P1|Overall Study|Protocol Violation|19
5618778|NCT00781391|19408476|P3|Overall Study|never received study drug|32
5618779|NCT00781391|19408477|P2|Overall Study|never received study drug|23
5618780|NCT00781391|19408478|P1|Overall Study|never received study drug|24
5618781|NCT00781365|19408512|P2|Overall Study|Language barrier|0
5618782|NCT00781365|19408513|P1|Overall Study|Language barrier|1
5618783|NCT00781365|19408512|P2|Overall Study|Did Not Attend Visit|28
5618784|NCT00781365|19408513|P1|Overall Study|Did Not Attend Visit|20
5618785|NCT00781365|19408512|P2|Overall Study|Withdrawal by Subject|8
5618786|NCT00781365|19408513|P1|Overall Study|Withdrawal by Subject|13
5618787|NCT00781326|19408523|P1|Phase I|Physician Decision|2
5618788|NCT00781326|19408523|P1|Phase I|Withdrawal by Subject|1
5618789|NCT00781326|19408523|P1|Phase I|Adverse Event|1
5618790|NCT00781274|19408527|P1|Overall Study|Withdrawal by Subject|2
5618791|NCT00780975|19408550|P1|Overall Study|Toxicity|5
5618792|NCT00780975|19408550|P1|Overall Study|Progressive disease|3
5618793|NCT00780910|19408568|P1|Overall Study|Adverse Event|2
5618794|NCT00780559|19408630|P2|Overall Study|Death|0
5618795|NCT00780559|19408631|P1|Overall Study|Death|1
5618796|NCT00780559|19408630|P2|Overall Study|Lost to Follow-up|7
5618797|NCT00780559|19408631|P1|Overall Study|Lost to Follow-up|2
5618798|NCT00780416|19408699|P2|Overall Study|Withdrawal by Subject|6
5618799|NCT00780416|19408700|P1|Overall Study|Withdrawal by Subject|8
5618800|NCT00780416|19408699|P2|Overall Study|Protocol Violation|0
5618801|NCT00780416|19408700|P1|Overall Study|Protocol Violation|1
5618802|NCT00780416|19408699|P2|Overall Study|Physician Decision|3
5618803|NCT00780416|19408700|P1|Overall Study|Physician Decision|3
5618804|NCT00780273|19408745|P1|Overall Study|Lost to Follow-up|1
5618805|NCT00780273|19408745|P1|Overall Study|Death|1
5618806|NCT00780143|19408768|P1|Overall Study|Adverse Event|1
5618807|NCT00780143|19408768|P1|Overall Study|Toxicity|1
5618808|NCT00780143|19408768|P1|Overall Study|Progressive disease|1
5618809|NCT00779909|19408799|P4|Overall Study|Withdrawal by Subject|0
5618810|NCT00779909|19408800|P3|Overall Study|Withdrawal by Subject|0
5618811|NCT00779909|19408801|P2|Overall Study|Withdrawal by Subject|1
5618812|NCT00779909|19408802|P1|Overall Study|Withdrawal by Subject|0
5618813|NCT00779909|19408799|P4|Overall Study|Lost to Follow-up|1
5618814|NCT00779909|19408800|P3|Overall Study|Lost to Follow-up|0
5618815|NCT00779909|19408801|P2|Overall Study|Lost to Follow-up|0
5618816|NCT00779909|19408802|P1|Overall Study|Lost to Follow-up|1
5618817|NCT00779857|19408866|P1|Overall Study|Missed Visit|2
5618818|NCT00779857|19408866|P1|Overall Study|Withdrawal by Subject|3
5618819|NCT00779857|19408866|P1|Overall Study|Death|1
5618820|NCT00779779|19408871|P1|Overall Study|Lost to Follow-up|5
5618821|NCT00779779|19408871|P1|Overall Study|Withdrawal by Subject|4
5618822|NCT00779779|19408871|P1|Overall Study|Protocol Violation|14
5618823|NCT00779779|19408871|P1|Overall Study|Adverse Event|1
5618824|NCT00779766|19408880|P2|Month 72|Other|1
5618825|NCT00779766|19408881|P1|Month 72|Other|0
5618826|NCT00779766|19408880|P2|Month 72|Lost to Follow-up|8
5618827|NCT00779766|19408881|P1|Month 72|Lost to Follow-up|6
5618828|NCT00779766|19408880|P2|Month 72|Migrated/moved from study area|109
5618829|NCT00779766|19408881|P1|Month 72|Migrated/moved from study area|124
5618830|NCT00779766|19408880|P2|Month 72|Withdrawal by Subject|71
5618831|NCT00779766|19408881|P1|Month 72|Withdrawal by Subject|55
5618832|NCT00779766|19408880|P2|Month 48|Other|0
5618833|NCT00779766|19408881|P1|Month 48|Other|1
5618834|NCT00779766|19408880|P2|Month 48|Lost to Follow-up|30
5618835|NCT00779766|19408881|P1|Month 48|Lost to Follow-up|29
5618836|NCT00779766|19408880|P2|Month 48|Migrated/moved from study area|75
5618837|NCT00779766|19408881|P1|Month 48|Migrated/moved from study area|76
5618838|NCT00779766|19408880|P2|Month 48|Withdrawal by Subject|63
5618839|NCT00779766|19408881|P1|Month 48|Withdrawal by Subject|68
5618840|NCT00779766|19408880|P2|Month 24|Other|27
5618841|NCT00779766|19408881|P1|Month 24|Other|18
5618842|NCT00779766|19408880|P2|Month 24|Lost to Follow-up|9
5618843|NCT00779766|19408881|P1|Month 24|Lost to Follow-up|9
5618844|NCT00779766|19408880|P2|Month 24|Migrated/moved from study area|162
5618845|NCT00779766|19408881|P1|Month 24|Migrated/moved from study area|138
5618846|NCT00779766|19408880|P2|Month 24|Withdrawal by Subject|127
5618847|NCT00779766|19408881|P1|Month 24|Withdrawal by Subject|159
5618848|NCT00779766|19408880|P2|Month 24|Protocol Violation|1
5618849|NCT00779766|19408881|P1|Month 24|Protocol Violation|3
5618850|NCT00779766|19408880|P2|Month 24|Adverse Event|3
5618851|NCT00779766|19408881|P1|Month 24|Adverse Event|3
5618852|NCT00779766|19408880|P2|Month 24|Serious Adverse Event|3
5618853|NCT00779766|19408881|P1|Month 24|Serious Adverse Event|2
5618854|NCT00779675|19408969|P1|Extended Treatment Period|Lost to Follow-up|6
5618855|NCT00779675|19408969|P1|Extended Treatment Period|Protocol defined clinical event|1
5618856|NCT00779675|19408969|P1|Extended Treatment Period|Treatment Failure|11
5618857|NCT00779675|19408969|P1|Extended Treatment Period|Adverse Event|6
5618858|NCT00779675|19408969|P1|Extended Treatment Period|Protocol Violation|13
5618859|NCT00779675|19408969|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
5618860|NCT00779675|19408969|P1|Treatment Period|Administrative|3
5618861|NCT00779675|19408969|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
5618862|NCT00779675|19408969|P1|Treatment Period|Protocol Violation|54
5618863|NCT00779675|19408969|P1|Treatment Period|Withdrawal by Subject|46
5618864|NCT00779675|19408969|P1|Treatment Period|Lost to Follow-up|23
5618865|NCT00779675|19408969|P1|Treatment Period|Transferred to Another Study|38
5618866|NCT00779675|19408969|P1|Treatment Period|Treatment Failure|80
5618867|NCT00779675|19408969|P1|Treatment Period|Adverse Event|87
5618868|NCT00779584|19408997|P9|Overall Study|Ongoing in Study|0
5618869|NCT00779584|19408998|P8|Overall Study|Ongoing in Study|0
5618870|NCT00779584|19408999|P7|Overall Study|Ongoing in Study|0
5618871|NCT00779584|19409000|P6|Overall Study|Ongoing in Study|1
5618872|NCT00779584|19409001|P5|Overall Study|Ongoing in Study|1
5618873|NCT00779584|19409002|P4|Overall Study|Ongoing in Study|0
5618874|NCT00779584|19409003|P3|Overall Study|Ongoing in Study|0
5618875|NCT00779584|19409004|P2|Overall Study|Ongoing in Study|0
5618876|NCT00779584|19409005|P1|Overall Study|Ongoing in Study|0
5618877|NCT00779584|19408997|P9|Overall Study|Symptomatic Deterioration|0
5618878|NCT00779584|19408998|P8|Overall Study|Symptomatic Deterioration|0
5618879|NCT00779584|19408999|P7|Overall Study|Symptomatic Deterioration|1
5618880|NCT00779584|19409000|P6|Overall Study|Symptomatic Deterioration|1
5618881|NCT00779584|19409001|P5|Overall Study|Symptomatic Deterioration|0
5618882|NCT00779584|19409002|P4|Overall Study|Symptomatic Deterioration|0
5618883|NCT00779584|19409003|P3|Overall Study|Symptomatic Deterioration|1
5618884|NCT00779584|19409004|P2|Overall Study|Symptomatic Deterioration|1
5618885|NCT00779584|19409005|P1|Overall Study|Symptomatic Deterioration|1
5618886|NCT00779584|19408997|P9|Overall Study|Adverse Event|1
5618887|NCT00779584|19408998|P8|Overall Study|Adverse Event|1
5618888|NCT00779584|19408999|P7|Overall Study|Adverse Event|2
5618889|NCT00779584|19409000|P6|Overall Study|Adverse Event|0
5618890|NCT00779584|19409001|P5|Overall Study|Adverse Event|0
5618891|NCT00779584|19409002|P4|Overall Study|Adverse Event|0
5618892|NCT00779584|19409003|P3|Overall Study|Adverse Event|2
5618893|NCT00779584|19409004|P2|Overall Study|Adverse Event|0
5618894|NCT00779584|19409005|P1|Overall Study|Adverse Event|1
5618895|NCT00779584|19408997|P9|Overall Study|Progression of Disease|1
5618896|NCT00779584|19408998|P8|Overall Study|Progression of Disease|2
5618897|NCT00779584|19408999|P7|Overall Study|Progression of Disease|4
5618898|NCT00779584|19409000|P6|Overall Study|Progression of Disease|1
5618899|NCT00779584|19409001|P5|Overall Study|Progression of Disease|5
5618900|NCT00779584|19409002|P4|Overall Study|Progression of Disease|6
5618901|NCT00779584|19409003|P3|Overall Study|Progression of Disease|2
5618902|NCT00779584|19409004|P2|Overall Study|Progression of Disease|1
5618903|NCT00779584|19409005|P1|Overall Study|Progression of Disease|0
5618904|NCT00779584|19408997|P9|Overall Study|Lost to Follow-up|0
5618905|NCT00779584|19408998|P8|Overall Study|Lost to Follow-up|0
5618906|NCT00779584|19408999|P7|Overall Study|Lost to Follow-up|0
5618907|NCT00779584|19409000|P6|Overall Study|Lost to Follow-up|0
5618908|NCT00779584|19409001|P5|Overall Study|Lost to Follow-up|1
5618909|NCT00779584|19409002|P4|Overall Study|Lost to Follow-up|0
5618910|NCT00779584|19409003|P3|Overall Study|Lost to Follow-up|0
5618911|NCT00779584|19409004|P2|Overall Study|Lost to Follow-up|0
5618912|NCT00779584|19409005|P1|Overall Study|Lost to Follow-up|0
5618913|NCT00779584|19408997|P9|Overall Study|Withdrawal by Subject|0
5618914|NCT00779584|19408998|P8|Overall Study|Withdrawal by Subject|0
5618915|NCT00779584|19408999|P7|Overall Study|Withdrawal by Subject|1
5618916|NCT00779584|19409000|P6|Overall Study|Withdrawal by Subject|2
5618917|NCT00779584|19409001|P5|Overall Study|Withdrawal by Subject|0
5618918|NCT00779584|19409002|P4|Overall Study|Withdrawal by Subject|0
5618919|NCT00779584|19409003|P3|Overall Study|Withdrawal by Subject|2
5618920|NCT00779584|19409004|P2|Overall Study|Withdrawal by Subject|1
5618921|NCT00779584|19409005|P1|Overall Study|Withdrawal by Subject|1
5618922|NCT00779584|19408997|P9|Overall Study|Protocol Violation|0
5618923|NCT00779584|19408998|P8|Overall Study|Protocol Violation|0
5618924|NCT00779584|19408999|P7|Overall Study|Protocol Violation|0
5618925|NCT00779584|19409000|P6|Overall Study|Protocol Violation|1
5618926|NCT00779584|19409001|P5|Overall Study|Protocol Violation|0
5618927|NCT00779584|19409002|P4|Overall Study|Protocol Violation|0
5618928|NCT00779584|19409003|P3|Overall Study|Protocol Violation|0
5618929|NCT00779584|19409004|P2|Overall Study|Protocol Violation|0
5618930|NCT00779584|19409005|P1|Overall Study|Protocol Violation|0
5618931|NCT00779506|19409096|P1|Overall Study|Lost to Follow-up|1
5618932|NCT00779506|19409096|P1|Overall Study|Withdrawal by Subject|6
5618933|NCT00779506|19409096|P1|Overall Study|Protocol Violation|5
5618934|NCT00779506|19409096|P1|Overall Study|Lack of Efficacy|11
5618935|NCT00779506|19409096|P1|Overall Study|Adverse Event|4
5618936|NCT00779506|19409096|P1|Overall Study|Screening Failed|2
5618937|NCT00779467|19409110|P4|Overall Study|unavailable research staff|1
5618938|NCT00779467|19409111|P3|Overall Study|unavailable research staff|0
5618939|NCT00779467|19409112|P2|Overall Study|unavailable research staff|0
5618940|NCT00779467|19409113|P1|Overall Study|unavailable research staff|0
5618941|NCT00779467|19409110|P4|Overall Study|technical issue|1
5618942|NCT00779467|19409111|P3|Overall Study|technical issue|2
5618943|NCT00779467|19409112|P2|Overall Study|technical issue|0
5618944|NCT00779467|19409113|P1|Overall Study|technical issue|0
5618945|NCT00779467|19409110|P4|Overall Study|missing data|4
5618946|NCT00779467|19409111|P3|Overall Study|missing data|1
5618947|NCT00779467|19409112|P2|Overall Study|missing data|0
5618948|NCT00779467|19409113|P1|Overall Study|missing data|1
5618949|NCT00779467|19409110|P4|Overall Study|failed inclusion criteria|2
5618950|NCT00779467|19409111|P3|Overall Study|failed inclusion criteria|1
5618951|NCT00779467|19409112|P2|Overall Study|failed inclusion criteria|3
5618952|NCT00779467|19409113|P1|Overall Study|failed inclusion criteria|3
5618953|NCT00779467|19409110|P4|Overall Study|Lack of Efficacy|11
5618954|NCT00779467|19409111|P3|Overall Study|Lack of Efficacy|6
5618955|NCT00779467|19409112|P2|Overall Study|Lack of Efficacy|2
5618956|NCT00779467|19409113|P1|Overall Study|Lack of Efficacy|11
5618957|NCT00779402|19409153|P2|Long-term Follow-up|Completed Protocol Visits|2
5618958|NCT00779402|19409154|P1|Long-term Follow-up|Completed Protocol Visits|6
5618959|NCT00779402|19409153|P2|Long-term Follow-up|Closure of Study|4
5618960|NCT00779402|19409154|P1|Long-term Follow-up|Closure of Study|8
5618961|NCT00779402|19409153|P2|Long-term Follow-up|Other|0
5618962|NCT00779402|19409154|P1|Long-term Follow-up|Other|5
5618963|NCT00779402|19409153|P2|Long-term Follow-up|Patient refused to continue|0
5618964|NCT00779402|19409154|P1|Long-term Follow-up|Patient refused to continue|2
5618965|NCT00779402|19409153|P2|Surveillance Phase|Completed Protocol Visits|2
5618966|NCT00779402|19409154|P1|Surveillance Phase|Completed Protocol Visits|3
5618967|NCT00779402|19409153|P2|Surveillance Phase|Closure of study|6
5618968|NCT00779402|19409154|P1|Surveillance Phase|Closure of study|5
5618969|NCT00779402|19409153|P2|Surveillance Phase|Withdrawal by Subject|1
5618970|NCT00779402|19409154|P1|Surveillance Phase|Withdrawal by Subject|4
5618971|NCT00779402|19409153|P2|Surveillance Phase|Other|5
5618972|NCT00779402|19409154|P1|Surveillance Phase|Other|5
5618973|NCT00779402|19409153|P2|Surveillance Phase|Intercurrent Illness|0
5618974|NCT00779402|19409154|P1|Surveillance Phase|Intercurrent Illness|2
5618975|NCT00779402|19409153|P2|Surveillance Phase|Death|1
5618976|NCT00779402|19409154|P1|Surveillance Phase|Death|0
5618977|NCT00779402|19409153|P2|Surveillance Phase|Lost to Follow-up|1
5618978|NCT00779402|19409154|P1|Surveillance Phase|Lost to Follow-up|2
5618979|NCT00779402|19409153|P2|Surveillance Phase|Patient refused to continue|14
5618980|NCT00779402|19409154|P1|Surveillance Phase|Patient refused to continue|22
5618981|NCT00779402|19409153|P2|Surveillance Phase|Protocol Violation|1
5618982|NCT00779402|19409154|P1|Surveillance Phase|Protocol Violation|0
5618983|NCT00779402|19409153|P2|Treatment Phase 1|Completed Protocol Visits|6
5618984|NCT00779402|19409154|P1|Treatment Phase 1|Completed Protocol Visits|3
5618985|NCT00779402|19409153|P2|Treatment Phase 1|Closure of Study|2
5618986|NCT00779402|19409154|P1|Treatment Phase 1|Closure of Study|3
5618987|NCT00779402|19409153|P2|Treatment Phase 1|Other|2
5618988|NCT00779402|19409154|P1|Treatment Phase 1|Other|4
5618989|NCT00779402|19409153|P2|Treatment Phase 1|Withdrawal by Subject|0
5618990|NCT00779402|19409154|P1|Treatment Phase 1|Withdrawal by Subject|1
5618991|NCT00779402|19409153|P2|Treatment Phase 1|Intercurrent Illness|1
5618992|NCT00779402|19409154|P1|Treatment Phase 1|Intercurrent Illness|1
5618993|NCT00779402|19409153|P2|Treatment Phase 1|Death|1
5618994|NCT00779402|19409154|P1|Treatment Phase 1|Death|0
5618995|NCT00779402|19409153|P2|Treatment Phase 1|Lost to Follow-up|1
5618996|NCT00779402|19409154|P1|Treatment Phase 1|Lost to Follow-up|0
5618997|NCT00779402|19409153|P2|Treatment Phase 1|Patient Refused to Continue|2
5618998|NCT00779402|19409154|P1|Treatment Phase 1|Patient Refused to Continue|17
5618999|NCT00779402|19409153|P2|Treatment Phase 1|Protocol Violation|0
5619000|NCT00779402|19409154|P1|Treatment Phase 1|Protocol Violation|1
5619001|NCT00779402|19409153|P2|Treatment Phase 1|Adverse Event|0
5619002|NCT00779402|19409154|P1|Treatment Phase 1|Adverse Event|2
5619003|NCT00779402|19409153|P2|Treatment Phase 1|Disease Progression|0
5619004|NCT00779402|19409154|P1|Treatment Phase 1|Disease Progression|1
5619005|NCT00779259|19409197|P1|Quinine Alone|Adverse Event|2
5619006|NCT00779246|19409218|P2|Overall Study|Missing sufficient data for analysis|53
5619007|NCT00779246|19409219|P1|Overall Study|Missing sufficient data for analysis|33
5619008|NCT00779142|19409238|P1|Overall Study|Screen Failures|3
5619009|NCT00779038|19409252|P1|Overall Study|Study Prematurely Terminated|13
5619010|NCT00779025|19409261|P1|Overall Study|Withdrawal by Subject|1
5619011|NCT00778999|19409272|P2|Overall Study|Did not receive recFSH|20
5619012|NCT00778999|19409273|P1|Overall Study|Did not receive recFSH|14
5619013|NCT00778999|19409272|P2|Overall Study|Discontinuation: no embryo transfer|14
5619014|NCT00778999|19409273|P1|Overall Study|Discontinuation: no embryo transfer|14
5619015|NCT00778921|19409282|P3|Overall Study|Not treated|2
5619016|NCT00778921|19409283|P2|Overall Study|Not treated|2
5619017|NCT00778921|19409284|P1|Overall Study|Not treated|0
5619018|NCT00778921|19409282|P3|Overall Study|Protocol Violation|2
5619019|NCT00778921|19409283|P2|Overall Study|Protocol Violation|0
5619020|NCT00778921|19409284|P1|Overall Study|Protocol Violation|3
5619021|NCT00778921|19409282|P3|Overall Study|Administrative Problems|0
5619022|NCT00778921|19409283|P2|Overall Study|Administrative Problems|2
5619023|NCT00778921|19409284|P1|Overall Study|Administrative Problems|1
5619024|NCT00778921|19409282|P3|Overall Study|Lost to Follow-up|1
5619025|NCT00778921|19409283|P2|Overall Study|Lost to Follow-up|2
5619026|NCT00778921|19409284|P1|Overall Study|Lost to Follow-up|0
5619027|NCT00778921|19409282|P3|Overall Study|Patient withdrew request|6
5619028|NCT00778921|19409283|P2|Overall Study|Patient withdrew request|1
5619029|NCT00778921|19409284|P1|Overall Study|Patient withdrew request|3
5619030|NCT00778921|19409282|P3|Overall Study|Patient No Longer Requires Study Drug|0
5619031|NCT00778921|19409283|P2|Overall Study|Patient No Longer Requires Study Drug|1
5619032|NCT00778921|19409284|P1|Overall Study|Patient No Longer Requires Study Drug|0
5619033|NCT00778921|19409282|P3|Overall Study|Unsatisfactory therapeutic response|1
5619034|NCT00778921|19409283|P2|Overall Study|Unsatisfactory therapeutic response|1
5619035|NCT00778921|19409284|P1|Overall Study|Unsatisfactory therapeutic response|1
5619036|NCT00778921|19409282|P3|Overall Study|Abnormal Test Procedure Result(s)|2
5619037|NCT00778921|19409283|P2|Overall Study|Abnormal Test Procedure Result(s)|0
5619038|NCT00778921|19409284|P1|Overall Study|Abnormal Test Procedure Result(s)|0
5619039|NCT00778921|19409282|P3|Overall Study|Abnormal Laboratory Value(s)|0
5619040|NCT00778921|19409283|P2|Overall Study|Abnormal Laboratory Value(s)|0
5619041|NCT00778921|19409284|P1|Overall Study|Abnormal Laboratory Value(s)|1
5619042|NCT00778921|19409282|P3|Overall Study|Adverse Event|14
5619043|NCT00778921|19409283|P2|Overall Study|Adverse Event|10
5619044|NCT00778921|19409284|P1|Overall Study|Adverse Event|9
5619045|NCT00778895|19409301|P3|ESFU Phase|Other|0
5619046|NCT00778895|19409302|P2|ESFU Phase|Other|0
5619047|NCT00778895|19409303|P1|ESFU Phase|Other|2
5619048|NCT00778895|19409301|P3|ESFU Phase|Lost to Follow-up|2
5619049|NCT00778895|19409302|P2|ESFU Phase|Lost to Follow-up|7
5619050|NCT00778895|19409303|P1|ESFU Phase|Lost to Follow-up|6
5619051|NCT00778895|19409301|P3|ESFU Phase|Withdrawal by Subject|0
5619052|NCT00778895|19409302|P2|ESFU Phase|Withdrawal by Subject|4
5619053|NCT00778895|19409303|P1|ESFU Phase|Withdrawal by Subject|1
5619054|NCT00778895|19409301|P3|ESFU Phase|Adverse Event|0
5619055|NCT00778895|19409302|P2|ESFU Phase|Adverse Event|1
5619056|NCT00778895|19409303|P1|ESFU Phase|Adverse Event|2
5619057|NCT00778895|19409301|P3|Active Phase|Other|0
5619058|NCT00778895|19409302|P2|Active Phase|Other|0
5619059|NCT00778895|19409303|P1|Active Phase|Other|2
5619060|NCT00778895|19409301|P3|Active Phase|Lost to Follow-up|0
5619061|NCT00778895|19409302|P2|Active Phase|Lost to Follow-up|1
5619062|NCT00778895|19409303|P1|Active Phase|Lost to Follow-up|1
5619063|NCT00778895|19409301|P3|Active Phase|Withdrawal by Subject|0
5619064|NCT00778895|19409302|P2|Active Phase|Withdrawal by Subject|4
5619065|NCT00778895|19409303|P1|Active Phase|Withdrawal by Subject|1
5619066|NCT00778895|19409301|P3|Active Phase|Adverse Event|0
5619067|NCT00778895|19409302|P2|Active Phase|Adverse Event|1
5619068|NCT00778895|19409303|P1|Active Phase|Adverse Event|3
5619069|NCT00778830|19409347|P2|Overall Study|Ongoing at data cut-off|1
5619070|NCT00778830|19409348|P1|Overall Study|Ongoing at data cut-off|0
5619071|NCT00778817|19409360|P1|Overall Study|Withdrawal by Subject|2
5619072|NCT00778817|19409360|P1|Overall Study|Adverse Event|2
5619073|NCT00778622|19409387|P3|Overall Study|Other|1
5619074|NCT00778622|19409388|P2|Overall Study|Other|0
5619075|NCT00778622|19409389|P1|Overall Study|Other|1
5619076|NCT00778622|19409387|P3|Overall Study|immigration|0
5619077|NCT00778622|19409388|P2|Overall Study|immigration|0
5619078|NCT00778622|19409389|P1|Overall Study|immigration|1
5619079|NCT00778622|19409387|P3|Overall Study|Lack of Efficacy|0
5619080|NCT00778622|19409388|P2|Overall Study|Lack of Efficacy|0
5619081|NCT00778622|19409389|P1|Overall Study|Lack of Efficacy|2
5619082|NCT00778622|19409387|P3|Overall Study|Protocol Violation|0
5619083|NCT00778622|19409388|P2|Overall Study|Protocol Violation|3
5619084|NCT00778622|19409389|P1|Overall Study|Protocol Violation|0
5619085|NCT00778622|19409387|P3|Overall Study|Lost to Follow-up|2
5619086|NCT00778622|19409388|P2|Overall Study|Lost to Follow-up|3
5619087|NCT00778622|19409389|P1|Overall Study|Lost to Follow-up|3
5619088|NCT00778622|19409387|P3|Overall Study|Withdrawal by Subject|5
5619089|NCT00778622|19409388|P2|Overall Study|Withdrawal by Subject|5
5619090|NCT00778622|19409389|P1|Overall Study|Withdrawal by Subject|4
5619091|NCT00778622|19409387|P3|Overall Study|Adverse Event|7
5619092|NCT00778622|19409388|P2|Overall Study|Adverse Event|4
5619093|NCT00778622|19409389|P1|Overall Study|Adverse Event|5
5619094|NCT00778375|19409442|P1|Overall Study|Ineligible|3
5619095|NCT00778336|19409456|P4|3 Month Follow Up|Death|0
5619096|NCT00778336|19409457|P3|3 Month Follow Up|Death|2
5619097|NCT00778336|19409458|P2|3 Month Follow Up|Death|3
5619098|NCT00778336|19409459|P1|3 Month Follow Up|Death|8
5619099|NCT00778336|19409456|P4|3 Month Follow Up|Lost to Follow-up|0
5619100|NCT00778336|19409457|P3|3 Month Follow Up|Lost to Follow-up|3
5619101|NCT00778336|19409458|P2|3 Month Follow Up|Lost to Follow-up|20
5619102|NCT00778336|19409459|P1|3 Month Follow Up|Lost to Follow-up|15
5619103|NCT00778336|19409456|P4|Index Procedure-Discharge|Death|0
5619104|NCT00778336|19409457|P3|Index Procedure-Discharge|Death|2
5619105|NCT00778336|19409458|P2|Index Procedure-Discharge|Death|3
5619106|NCT00778336|19409459|P1|Index Procedure-Discharge|Death|6
5619107|NCT00778258|19409497|P9|Overall Study|Other|0
5619108|NCT00778258|19409498|P8|Overall Study|Other|0
5619109|NCT00778258|19409499|P7|Overall Study|Other|1
5619110|NCT00778258|19409500|P6|Overall Study|Other|0
5619111|NCT00778258|19409501|P5|Overall Study|Other|0
5619112|NCT00778258|19409502|P4|Overall Study|Other|0
5619113|NCT00778258|19409503|P3|Overall Study|Other|0
5619114|NCT00778258|19409504|P2|Overall Study|Other|0
5619115|NCT00778258|19409505|P1|Overall Study|Other|0
5619116|NCT00778258|19409497|P9|Overall Study|Non-compliance|0
5619117|NCT00778258|19409498|P8|Overall Study|Non-compliance|0
5619118|NCT00778258|19409499|P7|Overall Study|Non-compliance|0
5619119|NCT00778258|19409500|P6|Overall Study|Non-compliance|0
5619120|NCT00778258|19409501|P5|Overall Study|Non-compliance|0
5619121|NCT00778258|19409502|P4|Overall Study|Non-compliance|1
5619122|NCT00778258|19409503|P3|Overall Study|Non-compliance|0
5619123|NCT00778258|19409504|P2|Overall Study|Non-compliance|0
5619124|NCT00778258|19409505|P1|Overall Study|Non-compliance|0
5619125|NCT00778258|19409497|P9|Overall Study|New Contraindication|0
5619126|NCT00778258|19409498|P8|Overall Study|New Contraindication|1
5619127|NCT00778258|19409499|P7|Overall Study|New Contraindication|0
5619128|NCT00778258|19409500|P6|Overall Study|New Contraindication|0
5619129|NCT00778258|19409501|P5|Overall Study|New Contraindication|0
5619130|NCT00778258|19409502|P4|Overall Study|New Contraindication|0
5619131|NCT00778258|19409503|P3|Overall Study|New Contraindication|0
5619132|NCT00778258|19409504|P2|Overall Study|New Contraindication|0
5619133|NCT00778258|19409505|P1|Overall Study|New Contraindication|0
5619134|NCT00778258|19409497|P9|Overall Study|Withdrawal by Subject|4
5619135|NCT00778258|19409498|P8|Overall Study|Withdrawal by Subject|12
5619136|NCT00778258|19409499|P7|Overall Study|Withdrawal by Subject|12
5619137|NCT00778258|19409500|P6|Overall Study|Withdrawal by Subject|6
5619138|NCT00778258|19409501|P5|Overall Study|Withdrawal by Subject|0
5619139|NCT00778258|19409502|P4|Overall Study|Withdrawal by Subject|2
5619140|NCT00778258|19409503|P3|Overall Study|Withdrawal by Subject|8
5619141|NCT00778258|19409504|P2|Overall Study|Withdrawal by Subject|2
5619142|NCT00778258|19409505|P1|Overall Study|Withdrawal by Subject|6
5619143|NCT00778258|19409497|P9|Overall Study|Lost to Follow-up|0
5619144|NCT00778258|19409498|P8|Overall Study|Lost to Follow-up|2
5619145|NCT00778258|19409499|P7|Overall Study|Lost to Follow-up|2
5619146|NCT00778258|19409500|P6|Overall Study|Lost to Follow-up|3
5619147|NCT00778258|19409501|P5|Overall Study|Lost to Follow-up|0
5619148|NCT00778258|19409502|P4|Overall Study|Lost to Follow-up|0
5619149|NCT00778258|19409503|P3|Overall Study|Lost to Follow-up|2
5619150|NCT00778258|19409504|P2|Overall Study|Lost to Follow-up|0
5619151|NCT00778258|19409505|P1|Overall Study|Lost to Follow-up|0
5619152|NCT00778258|19409497|P9|Overall Study|Adverse Event|0
5619153|NCT00778258|19409498|P8|Overall Study|Adverse Event|0
5619154|NCT00778258|19409499|P7|Overall Study|Adverse Event|0
5619155|NCT00778258|19409500|P6|Overall Study|Adverse Event|1
5619156|NCT00778258|19409501|P5|Overall Study|Adverse Event|0
5619157|NCT00778258|19409502|P4|Overall Study|Adverse Event|0
5619158|NCT00778258|19409503|P3|Overall Study|Adverse Event|0
5619159|NCT00778258|19409504|P2|Overall Study|Adverse Event|0
5619160|NCT00778258|19409505|P1|Overall Study|Adverse Event|1
5619161|NCT00778102|19409572|P2|Overall Study|Administrative Reason|10
5619162|NCT00778102|19409573|P1|Overall Study|Administrative Reason|7
5619163|NCT00778102|19409572|P2|Overall Study|Withdrawal by Subject|1
5619164|NCT00778102|19409573|P1|Overall Study|Withdrawal by Subject|1
5619165|NCT00778102|19409572|P2|Overall Study|Refused Treatment|3
5619166|NCT00778102|19409573|P1|Overall Study|Refused Treatment|2
5619167|NCT00778102|19409572|P2|Overall Study|Protocol Violation|1
5619168|NCT00778102|19409573|P1|Overall Study|Protocol Violation|0
5619169|NCT00778102|19409572|P2|Overall Study|Violation of Selection Criteria|1
5619170|NCT00778102|19409573|P1|Overall Study|Violation of Selection Criteria|1
5619171|NCT00778102|19409572|P2|Overall Study|Lost to Follow-up|0
5619172|NCT00778102|19409573|P1|Overall Study|Lost to Follow-up|1
5619173|NCT00778102|19409572|P2|Overall Study|Death|1
5619174|NCT00778102|19409573|P1|Overall Study|Death|1
5619175|NCT00778102|19409572|P2|Overall Study|Adverse Event|5
5619176|NCT00778102|19409573|P1|Overall Study|Adverse Event|8
5619177|NCT00777946|19409608|P3|Overall Study|Randomized in error|0
5619178|NCT00777946|19409609|P2|Overall Study|Randomized in error|1
5619179|NCT00777946|19409610|P1|Overall Study|Randomized in error|1
5619180|NCT00777946|19409608|P3|Overall Study|Protocol deviation|1
5619181|NCT00777946|19409609|P2|Overall Study|Protocol deviation|1
5619182|NCT00777946|19409610|P1|Overall Study|Protocol deviation|2
5619183|NCT00777946|19409608|P3|Overall Study|Lost to Follow-up|0
5619184|NCT00777946|19409609|P2|Overall Study|Lost to Follow-up|1
5619185|NCT00777946|19409610|P1|Overall Study|Lost to Follow-up|3
5619186|NCT00777946|19409608|P3|Overall Study|Patient withdrew consent|3
5619187|NCT00777946|19409609|P2|Overall Study|Patient withdrew consent|2
5619188|NCT00777946|19409610|P1|Overall Study|Patient withdrew consent|3
5619189|NCT00777946|19409608|P3|Overall Study|Condition no longer required study drug|0
5619190|NCT00777946|19409609|P2|Overall Study|Condition no longer required study drug|0
5619191|NCT00777946|19409610|P1|Overall Study|Condition no longer required study drug|1
5619192|NCT00777946|19409608|P3|Overall Study|Lack of Efficacy|9
5619193|NCT00777946|19409609|P2|Overall Study|Lack of Efficacy|0
5619194|NCT00777946|19409610|P1|Overall Study|Lack of Efficacy|0
5619195|NCT00777946|19409608|P3|Overall Study|Adverse Event|3
5619196|NCT00777946|19409609|P2|Overall Study|Adverse Event|1
5619197|NCT00777946|19409610|P1|Overall Study|Adverse Event|11
5619198|NCT00777920|19409633|P1|Overall Study|Other, not specified|4
5619199|NCT00777920|19409633|P1|Overall Study|Clinical status did not improve|1
5619200|NCT00777920|19409633|P1|Overall Study|Investigator's discretion|1
5619201|NCT00777920|19409633|P1|Overall Study|Lost to Follow-up|1
5619202|NCT00777920|19409633|P1|Overall Study|Withdrawal of Consent|4
5619203|NCT00777920|19409633|P1|Overall Study|Adverse Event|39
5619204|NCT00777803|19409649|P2|Overall Study|Non-compliance|2
5619205|NCT00777803|19409650|P1|Overall Study|Non-compliance|2
5619206|NCT00777803|19409649|P2|Overall Study|Adverse Event|0
5619207|NCT00777803|19409650|P1|Overall Study|Adverse Event|1
5619208|NCT00777803|19409649|P2|Overall Study|Lost to Follow-up|5
5619209|NCT00777803|19409650|P1|Overall Study|Lost to Follow-up|12
5619210|NCT00777608|19409729|P2|Overall Study|Investigator Decision|2
5619211|NCT00777608|19409730|P1|Overall Study|Investigator Decision|1
5619212|NCT00777608|19409729|P2|Overall Study|Protocol Violation|0
5619213|NCT00777608|19409730|P1|Overall Study|Protocol Violation|1
5619214|NCT00777608|19409729|P2|Overall Study|Withdrawal by Subject|3
5619215|NCT00777608|19409730|P1|Overall Study|Withdrawal by Subject|1
5619216|NCT00777608|19409729|P2|Overall Study|Lost to Follow-up|1
5619217|NCT00777608|19409730|P1|Overall Study|Lost to Follow-up|1
5619218|NCT00777556|19409740|P1|Overall Study|Did not complete all 3 follow-up visits|20
5619219|NCT00777556|19409740|P1|Overall Study|Dispensed but did not use product|12
5619220|NCT00777556|19409740|P1|Overall Study|Inappropriate self-selection|34
5619221|NCT00777491|19409749|P2|Overall Study|Did not receive any protocol treatment|0
5619222|NCT00777491|19409750|P1|Overall Study|Did not receive any protocol treatment|2
5619223|NCT00777491|19409749|P2|Overall Study|Protocol Violation|2
5619224|NCT00777491|19409750|P1|Overall Study|Protocol Violation|0
5619225|NCT00777296|19409783|P4|Overall Study|CRF form not completed|0
5619226|NCT00777296|19409784|P3|Overall Study|CRF form not completed|2
5619227|NCT00777296|19409785|P2|Overall Study|CRF form not completed|0
5619228|NCT00777296|19409786|P1|Overall Study|CRF form not completed|0
5619229|NCT00777296|19409783|P4|Overall Study|Withdrawal by Subject|0
5619230|NCT00777296|19409784|P3|Overall Study|Withdrawal by Subject|0
5619231|NCT00777296|19409785|P2|Overall Study|Withdrawal by Subject|0
5619232|NCT00777296|19409786|P1|Overall Study|Withdrawal by Subject|1
5619233|NCT00777296|19409783|P4|Overall Study|Adverse Event|1
5619234|NCT00777296|19409784|P3|Overall Study|Adverse Event|0
5619235|NCT00777296|19409785|P2|Overall Study|Adverse Event|1
5619236|NCT00777296|19409786|P1|Overall Study|Adverse Event|0
5619237|NCT00777257|19409828|P3|Overall Study|Withdrawal by Subject|5
5619238|NCT00777257|19409829|P2|Overall Study|Withdrawal by Subject|6
5619239|NCT00777257|19409830|P1|Overall Study|Withdrawal by Subject|3
5619240|NCT00777257|19409828|P3|Overall Study|Protocol Violation|2
5619241|NCT00777257|19409829|P2|Overall Study|Protocol Violation|2
5619242|NCT00777257|19409830|P1|Overall Study|Protocol Violation|2
5619243|NCT00777257|19409828|P3|Overall Study|Lost to Follow-up|2
5619244|NCT00777257|19409829|P2|Overall Study|Lost to Follow-up|3
5619245|NCT00777257|19409830|P1|Overall Study|Lost to Follow-up|3
5619246|NCT00777257|19409828|P3|Overall Study|Adverse Event|0
5619247|NCT00777257|19409829|P2|Overall Study|Adverse Event|1
5619248|NCT00777257|19409830|P1|Overall Study|Adverse Event|3
5619249|NCT00777205|19409849|P2|Overall Study|Protocol Violation|56
5619250|NCT00777205|19409850|P1|Overall Study|Protocol Violation|0
5619251|NCT00777205|19409849|P2|Overall Study|Death|2
5619252|NCT00777205|19409850|P1|Overall Study|Death|0
5619253|NCT00777205|19409849|P2|Overall Study|Withdrawal by Subject|4
5619254|NCT00777205|19409850|P1|Overall Study|Withdrawal by Subject|6
5619255|NCT00777205|19409849|P2|Overall Study|Lost to Follow-up|9
5619256|NCT00777205|19409850|P1|Overall Study|Lost to Follow-up|25
5619257|NCT00777153|19409884|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
5619258|NCT00777153|19409885|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
5619259|NCT00777153|19409886|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
5619260|NCT00777153|19409884|P3|Overall Study|Withdrawal by Subject|3
5619261|NCT00777153|19409885|P2|Overall Study|Withdrawal by Subject|4
5619262|NCT00777153|19409886|P1|Overall Study|Withdrawal by Subject|3
5619263|NCT00777153|19409884|P3|Overall Study|Death|33
5619264|NCT00777153|19409885|P2|Overall Study|Death|73
5619265|NCT00777153|19409886|P1|Overall Study|Death|85
5619266|NCT00777153|19409884|P3|Overall Study|Lost to Follow-up|0
5619267|NCT00777153|19409885|P2|Overall Study|Lost to Follow-up|1
5619268|NCT00777153|19409886|P1|Overall Study|Lost to Follow-up|1
5619269|NCT00777101|19409911|P2|Overall Study|Failed to Return|1
5619270|NCT00777101|19409912|P1|Overall Study|Failed to Return|0
5619271|NCT00777101|19409911|P2|Overall Study|Discontinuation of Study by Sponsor|0
5619272|NCT00777101|19409912|P1|Overall Study|Discontinuation of Study by Sponsor|1
5619273|NCT00777101|19409911|P2|Overall Study|Lost to Follow-up|1
5619274|NCT00777101|19409912|P1|Overall Study|Lost to Follow-up|2
5619275|NCT00777101|19409911|P2|Overall Study|Withdrawal by Subject|6
5619276|NCT00777101|19409912|P1|Overall Study|Withdrawal by Subject|11
5619277|NCT00777101|19409911|P2|Overall Study|Death|43
5619278|NCT00777101|19409912|P1|Overall Study|Death|48
5619279|NCT00777088|19409930|P1|Overall Study|PED Treatment not attempted|1
5619280|NCT00777049|19409955|P2|Overall Study|No treatment (elevated liver enzymes)|1
5619281|NCT00777049|19409956|P1|Overall Study|No treatment (elevated liver enzymes)|0
5619282|NCT00777049|19409955|P2|Overall Study|Withdrawal by Subject|0
5619283|NCT00777049|19409956|P1|Overall Study|Withdrawal by Subject|1
5619284|NCT00777036|19409965|P3|Follow-Up|Death|0
5619285|NCT00777036|19409966|P2|Follow-Up|Death|8
5619286|NCT00777036|19409967|P1|Follow-Up|Death|1
5619287|NCT00777036|19409965|P3|Follow-Up|Withdrawal by Subject|4
5619288|NCT00777036|19409966|P2|Follow-Up|Withdrawal by Subject|0
5619289|NCT00777036|19409967|P1|Follow-Up|Withdrawal by Subject|1
5619290|NCT00777036|19409965|P3|Follow-Up|Reason Not Specified|0
5619291|NCT00777036|19409966|P2|Follow-Up|Reason Not Specified|0
5619292|NCT00777036|19409967|P1|Follow-Up|Reason Not Specified|2
5619293|NCT00777036|19409965|P3|Follow-Up|Lost to Follow-up|0
5619294|NCT00777036|19409966|P2|Follow-Up|Lost to Follow-up|0
5619295|NCT00777036|19409967|P1|Follow-Up|Lost to Follow-up|1
5619296|NCT00777036|19409965|P3|On Treatment|Progressive Disease|6
5619297|NCT00777036|19409966|P2|On Treatment|Progressive Disease|4
5619298|NCT00777036|19409967|P1|On Treatment|Progressive Disease|5
5619299|NCT00777036|19409965|P3|On Treatment|Study Drug Toxicity|1
5619300|NCT00777036|19409966|P2|On Treatment|Study Drug Toxicity|0
5619301|NCT00777036|19409967|P1|On Treatment|Study Drug Toxicity|0
5619302|NCT00777036|19409965|P3|On Treatment|Death|0
5619303|NCT00777036|19409966|P2|On Treatment|Death|2
5619304|NCT00777036|19409967|P1|On Treatment|Death|0
5619305|NCT00777036|19409965|P3|On Treatment|Withdrawal by Subject|3
5619306|NCT00777036|19409966|P2|On Treatment|Withdrawal by Subject|2
5619307|NCT00777036|19409967|P1|On Treatment|Withdrawal by Subject|3
5619308|NCT00777036|19409965|P3|On Treatment|Maximum Clinical Benefit|1
5619309|NCT00777036|19409966|P2|On Treatment|Maximum Clinical Benefit|0
5619310|NCT00777036|19409967|P1|On Treatment|Maximum Clinical Benefit|2
5619311|NCT00777036|19409965|P3|On Treatment|Non-compliance with Study Drug|0
5619312|NCT00777036|19409966|P2|On Treatment|Non-compliance with Study Drug|0
5619313|NCT00777036|19409967|P1|On Treatment|Non-compliance with Study Drug|1
5619314|NCT00777036|19409965|P3|On Treatment|Failure to Meet Study Criteria|0
5619315|NCT00777036|19409966|P2|On Treatment|Failure to Meet Study Criteria|1
5619316|NCT00777036|19409967|P1|On Treatment|Failure to Meet Study Criteria|0
5619317|NCT00777036|19409965|P3|On Treatment|Reason Not Specified|12
5619318|NCT00777036|19409966|P2|On Treatment|Reason Not Specified|7
5619319|NCT00777036|19409967|P1|On Treatment|Reason Not Specified|4
5619320|NCT00777023|19410063|P3|Overall Study|Last dose date unknown|1
5619321|NCT00777023|19410064|P2|Overall Study|Last dose date unknown|3
5619322|NCT00777023|19410065|P1|Overall Study|Last dose date unknown|3
5619323|NCT00777023|19410063|P3|Overall Study|Reasons not specified|2
5619324|NCT00777023|19410064|P2|Overall Study|Reasons not specified|4
5619325|NCT00777023|19410065|P1|Overall Study|Reasons not specified|4
5619326|NCT00777023|19410063|P3|Overall Study|Missing data|0
5619327|NCT00777023|19410064|P2|Overall Study|Missing data|1
5619328|NCT00777023|19410065|P1|Overall Study|Missing data|1
5619329|NCT00777023|19410063|P3|Overall Study|Withdrawal by Subject|8
5619330|NCT00777023|19410064|P2|Overall Study|Withdrawal by Subject|7
5619331|NCT00777023|19410065|P1|Overall Study|Withdrawal by Subject|7
5619332|NCT00777023|19410063|P3|Overall Study|Death|0
5619333|NCT00777023|19410064|P2|Overall Study|Death|1
5619334|NCT00777023|19410065|P1|Overall Study|Death|0
5619335|NCT00777023|19410063|P3|Overall Study|Lost to Follow-up|3
5619336|NCT00777023|19410064|P2|Overall Study|Lost to Follow-up|3
5619337|NCT00777023|19410065|P1|Overall Study|Lost to Follow-up|2
5619338|NCT00777023|19410063|P3|Overall Study|Protocol Violation|1
5619339|NCT00777023|19410064|P2|Overall Study|Protocol Violation|1
5619340|NCT00777023|19410065|P1|Overall Study|Protocol Violation|2
5619341|NCT00777023|19410063|P3|Overall Study|Lack of Efficacy|14
5619342|NCT00777023|19410064|P2|Overall Study|Lack of Efficacy|0
5619343|NCT00777023|19410065|P1|Overall Study|Lack of Efficacy|1
5619344|NCT00777023|19410063|P3|Overall Study|Adverse Event|8
5619345|NCT00777023|19410064|P2|Overall Study|Adverse Event|21
5619346|NCT00777023|19410065|P1|Overall Study|Adverse Event|15
5619347|NCT00776997|19410082|P1|Overall Study|Adverse Event|2
5619348|NCT00776984|19410091|P2|Overall Study|Other|9
5619349|NCT00776984|19410092|P1|Overall Study|Other|5
5619350|NCT00776984|19410091|P2|Overall Study|Lack of Efficacy|1
5619351|NCT00776984|19410092|P1|Overall Study|Lack of Efficacy|0
5619352|NCT00776984|19410091|P2|Overall Study|Withdrawal by Subject|7
5619353|NCT00776984|19410092|P1|Overall Study|Withdrawal by Subject|12
5619354|NCT00776984|19410091|P2|Overall Study|Lost to Follow-up|0
5619355|NCT00776984|19410092|P1|Overall Study|Lost to Follow-up|2
5619356|NCT00776984|19410091|P2|Overall Study|Protocol Violation|2
5619357|NCT00776984|19410092|P1|Overall Study|Protocol Violation|4
5619358|NCT00776984|19410091|P2|Overall Study|Adverse Event|2
5619359|NCT00776984|19410092|P1|Overall Study|Adverse Event|8
5619360|NCT00776919|19410166|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
5619361|NCT00776919|19410167|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
5619362|NCT00776919|19410168|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
5619363|NCT00776919|19410169|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
5619364|NCT00776919|19410166|P4|Overall Study|Protocol Violation|1
5619365|NCT00776919|19410167|P3|Overall Study|Protocol Violation|0
5619366|NCT00776919|19410168|P2|Overall Study|Protocol Violation|2
5619367|NCT00776919|19410169|P1|Overall Study|Protocol Violation|1
5619368|NCT00776919|19410166|P4|Overall Study|Adverse Event|2
5619369|NCT00776919|19410167|P3|Overall Study|Adverse Event|2
5619370|NCT00776919|19410168|P2|Overall Study|Adverse Event|0
5619371|NCT00776919|19410169|P1|Overall Study|Adverse Event|1
5619372|NCT00776919|19410166|P4|Overall Study|Lost to Follow-up|8
5619373|NCT00776919|19410167|P3|Overall Study|Lost to Follow-up|11
5619374|NCT00776919|19410168|P2|Overall Study|Lost to Follow-up|12
5619375|NCT00776919|19410169|P1|Overall Study|Lost to Follow-up|8
5619376|NCT00776919|19410166|P4|Overall Study|Withdrawal by Subject|26
5619377|NCT00776919|19410167|P3|Overall Study|Withdrawal by Subject|15
5619378|NCT00776919|19410168|P2|Overall Study|Withdrawal by Subject|14
5619379|NCT00776919|19410169|P1|Overall Study|Withdrawal by Subject|16
5619380|NCT00776789|19410233|P2|Overall Study|Poor quality video|1
5619381|NCT00776789|19410234|P1|Overall Study|Poor quality video|1
5619382|NCT00776789|19410233|P2|Overall Study|Consent refusal|2
5619383|NCT00776789|19410234|P1|Overall Study|Consent refusal|2
5619384|NCT00776659|19410246|P1|Overall Study|Study Terminated by Sponsor|1
5619385|NCT00776659|19410246|P1|Overall Study|Withdrawal by Subject|10
5619386|NCT00776659|19410246|P1|Overall Study|Lost to Follow-up|15
5619387|NCT00776555|19410273|P2|Overall Study|Study terminated|0
5619388|NCT00776555|19410274|P1|Overall Study|Study terminated|3
5619389|NCT00776230|19410292|P3|Overall Study|Subject missed Visit 4|0
5619390|NCT00776230|19410293|P2|Overall Study|Subject missed Visit 4|1
5619391|NCT00776230|19410294|P1|Overall Study|Subject missed Visit 4|0
5619392|NCT00776230|19410292|P3|Overall Study|Withdrawal by Subject|0
5619393|NCT00776230|19410293|P2|Overall Study|Withdrawal by Subject|1
5619394|NCT00776230|19410294|P1|Overall Study|Withdrawal by Subject|0
5619395|NCT00776230|19410292|P3|Overall Study|Not vaccinated at Day 0|0
5619396|NCT00776230|19410293|P2|Overall Study|Not vaccinated at Day 0|0
5619397|NCT00776230|19410294|P1|Overall Study|Not vaccinated at Day 0|1
5619398|NCT00776230|19410292|P3|Overall Study|Lost to Follow-up|5
5619399|NCT00776230|19410293|P2|Overall Study|Lost to Follow-up|1
5619400|NCT00776230|19410294|P1|Overall Study|Lost to Follow-up|2
5619401|NCT00776100|19410304|P2|Overall Study|Disease Progression|0
5619402|NCT00776100|19410305|P1|Overall Study|Disease Progression|1
5619403|NCT00776009|19410327|P6|Period 3: Third Intervention|Withdrawal by Subject|0
5619404|NCT00776009|19410328|P5|Period 3: Third Intervention|Withdrawal by Subject|0
5619405|NCT00776009|19410329|P4|Period 3: Third Intervention|Withdrawal by Subject|0
5619406|NCT00776009|19410330|P3|Period 3: Third Intervention|Withdrawal by Subject|0
5619407|NCT00776009|19410331|P2|Period 3: Third Intervention|Withdrawal by Subject|0
5619408|NCT00776009|19410332|P1|Period 3: Third Intervention|Withdrawal by Subject|1
5619409|NCT00776009|19410327|P6|Period 2: Second Intervention|Protocol Violation|0
5619410|NCT00776009|19410328|P5|Period 2: Second Intervention|Protocol Violation|0
5619411|NCT00776009|19410329|P4|Period 2: Second Intervention|Protocol Violation|0
5619412|NCT00776009|19410330|P3|Period 2: Second Intervention|Protocol Violation|1
5619413|NCT00776009|19410331|P2|Period 2: Second Intervention|Protocol Violation|0
5619414|NCT00776009|19410332|P1|Period 2: Second Intervention|Protocol Violation|1
5619415|NCT00776009|19410327|P6|Period 2: Second Intervention|Withdrawal by Subject|1
5619416|NCT00776009|19410328|P5|Period 2: Second Intervention|Withdrawal by Subject|0
5619417|NCT00776009|19410329|P4|Period 2: Second Intervention|Withdrawal by Subject|0
5619418|NCT00776009|19410330|P3|Period 2: Second Intervention|Withdrawal by Subject|0
5619419|NCT00776009|19410331|P2|Period 2: Second Intervention|Withdrawal by Subject|0
5619420|NCT00776009|19410332|P1|Period 2: Second Intervention|Withdrawal by Subject|0
5619421|NCT00776009|19410327|P6|Period 1: First Intervention|Protocol Violation|0
5619422|NCT00776009|19410328|P5|Period 1: First Intervention|Protocol Violation|1
5619423|NCT00776009|19410329|P4|Period 1: First Intervention|Protocol Violation|0
5619424|NCT00776009|19410330|P3|Period 1: First Intervention|Protocol Violation|0
5619425|NCT00776009|19410331|P2|Period 1: First Intervention|Protocol Violation|1
5619426|NCT00776009|19410332|P1|Period 1: First Intervention|Protocol Violation|0
5619427|NCT00776009|19410327|P6|Period 1: First Intervention|Withdrawal by Subject|0
5619428|NCT00776009|19410328|P5|Period 1: First Intervention|Withdrawal by Subject|1
5619429|NCT00776009|19410329|P4|Period 1: First Intervention|Withdrawal by Subject|0
5619430|NCT00776009|19410330|P3|Period 1: First Intervention|Withdrawal by Subject|1
5619431|NCT00776009|19410331|P2|Period 1: First Intervention|Withdrawal by Subject|0
5619432|NCT00776009|19410332|P1|Period 1: First Intervention|Withdrawal by Subject|0
5619433|NCT00775983|19410354|P2|Overall Study|Protocol Violation|2
5619434|NCT00775983|19410355|P1|Overall Study|Protocol Violation|1
5619435|NCT00775606|19410481|P2|Overall Study|Study sponsor terminated funding|0
5619436|NCT00775606|19410482|P1|Overall Study|Study sponsor terminated funding|3
5619437|NCT00775593|19410492|P1|Overall Study|Death|1
5619438|NCT00775593|19410492|P1|Overall Study|Unmet eligibility criteria|6
5619439|NCT00775528|19410499|P1|Overall Study|Protocol Violation|1
5619440|NCT00775463|19410508|P2|Overall Study|Lack of Efficacy|1
5619441|NCT00775463|19410509|P1|Overall Study|Lack of Efficacy|1
5619442|NCT00775463|19410508|P2|Overall Study|Lost to Follow-up|0
5619443|NCT00775463|19410509|P1|Overall Study|Lost to Follow-up|1
5619444|NCT00775463|19410508|P2|Overall Study|Protocol Violation|2
5619445|NCT00775463|19410509|P1|Overall Study|Protocol Violation|2
5619446|NCT00775463|19410508|P2|Overall Study|Adverse Event|9
5619447|NCT00775463|19410509|P1|Overall Study|Adverse Event|7
5619448|NCT00775463|19410508|P2|Overall Study|Withdrawal by Subject|1
5619449|NCT00775463|19410509|P1|Overall Study|Withdrawal by Subject|0
5619450|NCT00775450|19410546|P5|Overall Study|Withdrawal by Subject|1
5619451|NCT00775450|19410547|P4|Overall Study|Withdrawal by Subject|0
5619452|NCT00775450|19410548|P3|Overall Study|Withdrawal by Subject|0
5619453|NCT00775450|19410549|P2|Overall Study|Withdrawal by Subject|0
5619454|NCT00775450|19410550|P1|Overall Study|Withdrawal by Subject|1
5619455|NCT00775450|19410546|P5|Overall Study|Protocol Violation|1
5619456|NCT00775450|19410547|P4|Overall Study|Protocol Violation|0
5619457|NCT00775450|19410548|P3|Overall Study|Protocol Violation|0
5619458|NCT00775450|19410549|P2|Overall Study|Protocol Violation|0
5619459|NCT00775450|19410550|P1|Overall Study|Protocol Violation|0
5619460|NCT00775450|19410546|P5|Overall Study|Serious Adverse Event|0
5619461|NCT00775450|19410547|P4|Overall Study|Serious Adverse Event|0
5619462|NCT00775450|19410548|P3|Overall Study|Serious Adverse Event|0
5619463|NCT00775450|19410549|P2|Overall Study|Serious Adverse Event|0
5619464|NCT00775450|19410550|P1|Overall Study|Serious Adverse Event|2
5619465|NCT00775437|19410577|P1|Overall Study|Lost to Follow-up|1
5619466|NCT00775437|19410577|P1|Overall Study|Withdrawal by Subject|3
5619467|NCT00775437|19410577|P1|Overall Study|Loss of efficacy|2
5619468|NCT00775203|19410652|P2|Overall Study|Physician Decision|1
5619469|NCT00775203|19410653|P1|Overall Study|Physician Decision|0
5619470|NCT00775203|19410652|P2|Overall Study|Entered other study|0
5619471|NCT00775203|19410653|P1|Overall Study|Entered other study|1
5619472|NCT00775203|19410652|P2|Overall Study|Protocol Violation|1
5619473|NCT00775203|19410653|P1|Overall Study|Protocol Violation|0
5619474|NCT00775203|19410652|P2|Overall Study|Noncompliance|2
5619475|NCT00775203|19410653|P1|Overall Study|Noncompliance|4
5619476|NCT00775203|19410652|P2|Overall Study|Administrative reason|0
5619477|NCT00775203|19410653|P1|Overall Study|Administrative reason|2
5619478|NCT00775203|19410652|P2|Overall Study|Lost to Follow-up|15
5619479|NCT00775203|19410653|P1|Overall Study|Lost to Follow-up|11
5619480|NCT00775203|19410652|P2|Overall Study|Withdrawal by Subject|9
5619481|NCT00775203|19410653|P1|Overall Study|Withdrawal by Subject|11
5619482|NCT00775203|19410652|P2|Overall Study|Lack of Efficacy|9
5619483|NCT00775203|19410653|P1|Overall Study|Lack of Efficacy|8
5619484|NCT00775203|19410652|P2|Overall Study|Adverse Event|6
5619485|NCT00775203|19410653|P1|Overall Study|Adverse Event|25
5619486|NCT00775190|19410687|P2|Overall Study|Protocol Violation|0
5619487|NCT00775190|19410688|P1|Overall Study|Protocol Violation|1
5619488|NCT00775190|19410687|P2|Overall Study|Withdrawal by Subject|2
5619489|NCT00775190|19410688|P1|Overall Study|Withdrawal by Subject|1
5619490|NCT00775190|19410687|P2|Overall Study|Lost to Follow-up|3
5619491|NCT00775190|19410688|P1|Overall Study|Lost to Follow-up|2
5619492|NCT00775138|19410714|P4|Overall Study|Adverse Event|0
5619493|NCT00775138|19410715|P3|Overall Study|Adverse Event|1
5619494|NCT00775138|19410716|P2|Overall Study|Adverse Event|0
5619495|NCT00775138|19410717|P1|Overall Study|Adverse Event|0
5619496|NCT00775138|19410714|P4|Overall Study|Withdrawal by Subject|2
5619497|NCT00775138|19410715|P3|Overall Study|Withdrawal by Subject|2
5619498|NCT00775138|19410716|P2|Overall Study|Withdrawal by Subject|0
5619499|NCT00775138|19410717|P1|Overall Study|Withdrawal by Subject|0
5619500|NCT00775021|19410763|P2|Second Intervention|Adverse Event|1
5619501|NCT00775021|19410764|P1|Second Intervention|Adverse Event|0
5619502|NCT00775021|19410763|P2|First Intervention|Lost to Follow-up|0
5619503|NCT00775021|19410764|P1|First Intervention|Lost to Follow-up|1
5619504|NCT00774995|19410782|P4|Overall Study|Protocol Violation|0
5619505|NCT00774995|19410783|P3|Overall Study|Protocol Violation|1
5619506|NCT00774995|19410784|P2|Overall Study|Protocol Violation|0
5619507|NCT00774995|19410785|P1|Overall Study|Protocol Violation|0
5619508|NCT00774930|19410825|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
5619509|NCT00774930|19410826|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
5619510|NCT00774930|19410825|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
5619511|NCT00774930|19410826|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
5619512|NCT00774930|19410825|P2|LTOLE Phase|Disease Progression|5
5619513|NCT00774930|19410826|P1|LTOLE Phase|Disease Progression|2
5619514|NCT00774930|19410825|P2|LTOLE Phase|Sponsor decision|1
5619515|NCT00774930|19410826|P1|LTOLE Phase|Sponsor decision|2
5619516|NCT00774930|19410825|P2|LTOLE Phase|Physician Decision|1
5619517|NCT00774930|19410826|P1|LTOLE Phase|Physician Decision|4
5619518|NCT00774930|19410825|P2|LTOLE Phase|Subject decision|5
5619519|NCT00774930|19410826|P1|LTOLE Phase|Subject decision|0
5619520|NCT00774930|19410825|P2|LTOLE Phase|Adverse Event|3
5619521|NCT00774930|19410826|P1|LTOLE Phase|Adverse Event|7
5619522|NCT00774930|19410825|P2|IOL Phase|Brain radiation|1
5619523|NCT00774930|19410826|P1|IOL Phase|Brain radiation|0
5619524|NCT00774930|19410825|P2|IOL Phase|Other|0
5619525|NCT00774930|19410826|P1|IOL Phase|Other|1
5619526|NCT00774930|19410825|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
5619527|NCT00774930|19410826|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
5619528|NCT00774930|19410825|P2|IOL Phase|Subject Consumed Prohibited Medication|0
5619529|NCT00774930|19410826|P1|IOL Phase|Subject Consumed Prohibited Medication|1
5619530|NCT00774930|19410825|P2|IOL Phase|Disease Progression|1
5619531|NCT00774930|19410826|P1|IOL Phase|Disease Progression|2
5619532|NCT00774930|19410825|P2|IOL Phase|Sponsor Decision|0
5619533|NCT00774930|19410826|P1|IOL Phase|Sponsor Decision|1
5619534|NCT00774930|19410825|P2|IOL Phase|Physician Decision|2
5619535|NCT00774930|19410826|P1|IOL Phase|Physician Decision|3
5619536|NCT00774930|19410825|P2|IOL Phase|Subject Decision|3
5619537|NCT00774930|19410826|P1|IOL Phase|Subject Decision|4
5619538|NCT00774930|19410825|P2|IOL Phase|Adverse Event|1
5619539|NCT00774930|19410826|P1|IOL Phase|Adverse Event|1
5619540|NCT00774930|19410825|P2|DB Phase|Started Nonprotocol Radiation therapy|1
5619541|NCT00774930|19410826|P1|DB Phase|Started Nonprotocol Radiation therapy|0
5619542|NCT00774930|19410825|P2|DB Phase|Disease Progression|1
5619543|NCT00774930|19410826|P1|DB Phase|Disease Progression|1
5619544|NCT00774930|19410825|P2|DB Phase|Sponsor Decision|1
5619545|NCT00774930|19410826|P1|DB Phase|Sponsor Decision|0
5619546|NCT00774930|19410825|P2|DB Phase|Subject Decision|5
5619547|NCT00774930|19410826|P1|DB Phase|Subject Decision|1
5619548|NCT00774930|19410825|P2|DB Phase|Adverse Event|2
5619549|NCT00774930|19410826|P1|DB Phase|Adverse Event|1
5619550|NCT00774930|19410825|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
5619551|NCT00774930|19410826|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
5619552|NCT00774852|19410854|P2|Overall Study|Subject received prohibited medication|0
5619553|NCT00774852|19410855|P1|Overall Study|Subject received prohibited medication|1
5619554|NCT00774852|19410854|P2|Overall Study|Protocol Violation|0
5619555|NCT00774852|19410855|P1|Overall Study|Protocol Violation|1
5619556|NCT00774852|19410854|P2|Overall Study|Subject non-compliance|1
5619557|NCT00774852|19410855|P1|Overall Study|Subject non-compliance|0
5619558|NCT00774852|19410854|P2|Overall Study|Non-responder|11
5619559|NCT00774852|19410855|P1|Overall Study|Non-responder|15
5619560|NCT00774852|19410854|P2|Overall Study|Withdrawal by Subject|2
5619561|NCT00774852|19410855|P1|Overall Study|Withdrawal by Subject|2
5619562|NCT00774852|19410854|P2|Overall Study|Pregnancy|2
5619563|NCT00774852|19410855|P1|Overall Study|Pregnancy|1
5619564|NCT00774852|19410854|P2|Overall Study|Physician Decision|6
5619565|NCT00774852|19410855|P1|Overall Study|Physician Decision|2
5619566|NCT00774852|19410854|P2|Overall Study|Lost to Follow-up|5
5619567|NCT00774852|19410855|P1|Overall Study|Lost to Follow-up|9
5619568|NCT00774852|19410854|P2|Overall Study|Lack of Efficacy|7
5619569|NCT00774852|19410855|P1|Overall Study|Lack of Efficacy|3
5619570|NCT00774852|19410854|P2|Overall Study|Death|1
5619571|NCT00774852|19410855|P1|Overall Study|Death|2
5619572|NCT00774852|19410854|P2|Overall Study|Adverse Event|6
5619573|NCT00774852|19410855|P1|Overall Study|Adverse Event|9
5619574|NCT00774800|19410903|P1|Intervention 4|Withdrawal by Subject|1
5619575|NCT00774787|19410925|P1|Overall Study|Lost to Follow-up|1
5619576|NCT00774748|19410932|P1|Overall Study|Lost to Follow-up|3
5619577|NCT00774397|19410958|P7|Overall Study|Other than those stated above|1
5619578|NCT00774397|19410959|P6|Overall Study|Other than those stated above|0
5619579|NCT00774397|19410960|P5|Overall Study|Other than those stated above|2
5619580|NCT00774397|19410961|P4|Overall Study|Other than those stated above|2
5619581|NCT00774397|19410962|P3|Overall Study|Other than those stated above|3
5619582|NCT00774397|19410963|P2|Overall Study|Other than those stated above|1
5619583|NCT00774397|19410964|P1|Overall Study|Other than those stated above|1
5619584|NCT00774397|19410958|P7|Overall Study|Not treated|1
5619585|NCT00774397|19410959|P6|Overall Study|Not treated|0
5619586|NCT00774397|19410960|P5|Overall Study|Not treated|1
5619587|NCT00774397|19410961|P4|Overall Study|Not treated|0
5619588|NCT00774397|19410962|P3|Overall Study|Not treated|0
5619589|NCT00774397|19410963|P2|Overall Study|Not treated|0
5619590|NCT00774397|19410964|P1|Overall Study|Not treated|0
5619591|NCT00774397|19410958|P7|Overall Study|Refused to continue trial medication|3
5619592|NCT00774397|19410959|P6|Overall Study|Refused to continue trial medication|2
5619593|NCT00774397|19410960|P5|Overall Study|Refused to continue trial medication|6
5619594|NCT00774397|19410961|P4|Overall Study|Refused to continue trial medication|2
5619595|NCT00774397|19410962|P3|Overall Study|Refused to continue trial medication|2
5619596|NCT00774397|19410963|P2|Overall Study|Refused to continue trial medication|3
5619597|NCT00774397|19410964|P1|Overall Study|Refused to continue trial medication|1
5619598|NCT00774397|19410958|P7|Overall Study|Lost to Follow-up|0
5619599|NCT00774397|19410959|P6|Overall Study|Lost to Follow-up|1
5619600|NCT00774397|19410960|P5|Overall Study|Lost to Follow-up|0
5619601|NCT00774397|19410961|P4|Overall Study|Lost to Follow-up|1
5619602|NCT00774397|19410962|P3|Overall Study|Lost to Follow-up|1
5619603|NCT00774397|19410963|P2|Overall Study|Lost to Follow-up|1
5619604|NCT00774397|19410964|P1|Overall Study|Lost to Follow-up|0
5619605|NCT00774397|19410958|P7|Overall Study|Protocol Violation|0
5619606|NCT00774397|19410959|P6|Overall Study|Protocol Violation|1
5619607|NCT00774397|19410960|P5|Overall Study|Protocol Violation|2
5619608|NCT00774397|19410961|P4|Overall Study|Protocol Violation|1
5619609|NCT00774397|19410962|P3|Overall Study|Protocol Violation|3
5619610|NCT00774397|19410963|P2|Overall Study|Protocol Violation|1
5619611|NCT00774397|19410964|P1|Overall Study|Protocol Violation|0
5619612|NCT00774397|19410958|P7|Overall Study|Lack of Efficacy|9
5619613|NCT00774397|19410959|P6|Overall Study|Lack of Efficacy|15
5619614|NCT00774397|19410960|P5|Overall Study|Lack of Efficacy|27
5619615|NCT00774397|19410961|P4|Overall Study|Lack of Efficacy|3
5619616|NCT00774397|19410962|P3|Overall Study|Lack of Efficacy|5
5619617|NCT00774397|19410963|P2|Overall Study|Lack of Efficacy|4
5619618|NCT00774397|19410964|P1|Overall Study|Lack of Efficacy|11
5619619|NCT00774397|19410958|P7|Overall Study|Adverse Event|16
5619620|NCT00774397|19410959|P6|Overall Study|Adverse Event|3
5619621|NCT00774397|19410960|P5|Overall Study|Adverse Event|8
5619622|NCT00774397|19410961|P4|Overall Study|Adverse Event|8
5619623|NCT00774397|19410962|P3|Overall Study|Adverse Event|16
5619624|NCT00774397|19410963|P2|Overall Study|Adverse Event|3
5619625|NCT00774397|19410964|P1|Overall Study|Adverse Event|1
5619626|NCT00774306|19411200|P4|Overall Study|Death|0
5619627|NCT00774306|19411201|P3|Overall Study|Death|0
5619628|NCT00774306|19411202|P2|Overall Study|Death|1
5619629|NCT00774306|19411203|P1|Overall Study|Death|1
5619630|NCT00774306|19411200|P4|Overall Study|Lost to Follow-up|5
5619631|NCT00774306|19411201|P3|Overall Study|Lost to Follow-up|4
5619632|NCT00774306|19411202|P2|Overall Study|Lost to Follow-up|0
5619633|NCT00774306|19411203|P1|Overall Study|Lost to Follow-up|6
5619634|NCT00774306|19411200|P4|Overall Study|Withdrawal by Subject|0
5619635|NCT00774306|19411201|P3|Overall Study|Withdrawal by Subject|1
5619636|NCT00774306|19411202|P2|Overall Study|Withdrawal by Subject|1
5619637|NCT00774306|19411203|P1|Overall Study|Withdrawal by Subject|6
5619638|NCT00774306|19411200|P4|Overall Study|Protocol Violation|0
5619639|NCT00774306|19411201|P3|Overall Study|Protocol Violation|3
5619640|NCT00774306|19411202|P2|Overall Study|Protocol Violation|0
5619641|NCT00774306|19411203|P1|Overall Study|Protocol Violation|2
5619642|NCT00774306|19411200|P4|Overall Study|Adverse Event|0
5619643|NCT00774306|19411201|P3|Overall Study|Adverse Event|0
5619644|NCT00774306|19411202|P2|Overall Study|Adverse Event|0
5619645|NCT00774306|19411203|P1|Overall Study|Adverse Event|3
5619646|NCT00774046|19411284|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
5619647|NCT00774046|19411284|P1|Enrollment|Desired other therapy/refused|28
5619648|NCT00774046|19411284|P1|Screening|Not eligible|56
5619649|NCT00773968|19411294|P1|Overall Study|Other|8
5619650|NCT00773968|19411294|P1|Overall Study|Screen Failure|17
5619651|NCT00773968|19411294|P1|Overall Study|Withdrawal by Subject|11
5619652|NCT00773968|19411294|P1|Overall Study|Protocol Violation|1
5619653|NCT00773968|19411294|P1|Overall Study|Lack of Efficacy|3
5619654|NCT00773968|19411294|P1|Overall Study|Failure to Return|2
5619655|NCT00773968|19411294|P1|Overall Study|Death|1
5619656|NCT00773968|19411294|P1|Overall Study|Adverse Event|2
5619657|NCT00773734|19411325|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
5619658|NCT00773734|19411326|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
5619659|NCT00773734|19411327|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
5619660|NCT00773734|19411328|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
5619661|NCT00773734|19411329|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
5619662|NCT00773734|19411330|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
5619663|NCT00773734|19411325|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
5619664|NCT00773734|19411326|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
5619665|NCT00773734|19411327|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
5619666|NCT00773734|19411328|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
5619667|NCT00773734|19411329|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
5619668|NCT00773734|19411330|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
5619669|NCT00773734|19411325|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
5619670|NCT00773734|19411326|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
5619671|NCT00773734|19411327|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
5619672|NCT00773734|19411328|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
5619673|NCT00773734|19411329|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
5619674|NCT00773734|19411330|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
5619675|NCT00773734|19411325|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
5619676|NCT00773734|19411326|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
5619677|NCT00773734|19411327|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
5619678|NCT00773734|19411328|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
5619679|NCT00773734|19411329|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
5619680|NCT00773734|19411330|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
5619681|NCT00773734|19411325|P6|Extension: Active Treatment Week 24-52|Other|1
5619682|NCT00773734|19411326|P5|Extension: Active Treatment Week 24-52|Other|0
5619683|NCT00773734|19411327|P4|Extension: Active Treatment Week 24-52|Other|2
5619684|NCT00773734|19411328|P3|Extension: Active Treatment Week 24-52|Other|1
5619685|NCT00773734|19411329|P2|Extension: Active Treatment Week 24-52|Other|0
5619686|NCT00773734|19411330|P1|Extension: Active Treatment Week 24-52|Other|0
5619687|NCT00773734|19411325|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
5619688|NCT00773734|19411326|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
5619689|NCT00773734|19411327|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
5619690|NCT00773734|19411328|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
5619691|NCT00773734|19411329|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
5619692|NCT00773734|19411330|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
5619693|NCT00773734|19411325|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
5619694|NCT00773734|19411326|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
5619695|NCT00773734|19411327|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
5619696|NCT00773734|19411328|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
5619697|NCT00773734|19411329|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
5619698|NCT00773734|19411330|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
5619699|NCT00773734|19411325|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
5619700|NCT00773734|19411326|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
5619701|NCT00773734|19411327|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
5619702|NCT00773734|19411328|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
5619703|NCT00773734|19411329|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
5619704|NCT00773734|19411330|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
5619705|NCT00773734|19411325|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
5619706|NCT00773734|19411326|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
5619707|NCT00773734|19411327|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
5619708|NCT00773734|19411328|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
5619709|NCT00773734|19411329|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
5619710|NCT00773734|19411330|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
5619711|NCT00773734|19411325|P6|Core: Active Treatment Phase Week 16-24|Other|0
5619712|NCT00773734|19411326|P5|Core: Active Treatment Phase Week 16-24|Other|0
5619713|NCT00773734|19411327|P4|Core: Active Treatment Phase Week 16-24|Other|0
5619714|NCT00773734|19411328|P3|Core: Active Treatment Phase Week 16-24|Other|0
5619715|NCT00773734|19411329|P2|Core: Active Treatment Phase Week 16-24|Other|1
5619716|NCT00773734|19411330|P1|Core: Active Treatment Phase Week 16-24|Other|0
5619717|NCT00773734|19411325|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
5619718|NCT00773734|19411326|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
5619719|NCT00773734|19411327|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
5619720|NCT00773734|19411328|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
5619721|NCT00773734|19411329|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
5619722|NCT00773734|19411330|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
5619723|NCT00773734|19411325|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
5619724|NCT00773734|19411326|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
5619725|NCT00773734|19411327|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
5619726|NCT00773734|19411328|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
5619727|NCT00773734|19411329|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
5619728|NCT00773734|19411330|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
5619729|NCT00773734|19411325|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
5619730|NCT00773734|19411326|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
5619731|NCT00773734|19411327|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
5619732|NCT00773734|19411328|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
5619733|NCT00773734|19411329|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
5619734|NCT00773734|19411330|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
5619735|NCT00773734|19411325|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
5619736|NCT00773734|19411326|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
5619737|NCT00773734|19411327|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
5619738|NCT00773734|19411328|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
5619739|NCT00773734|19411329|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
5619740|NCT00773734|19411330|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
5619741|NCT00773734|19411325|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
5619742|NCT00773734|19411326|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
5619743|NCT00773734|19411327|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
5619744|NCT00773734|19411328|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
5619745|NCT00773734|19411329|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
5619746|NCT00773734|19411330|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
5619747|NCT00773734|19411325|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
5619748|NCT00773734|19411326|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
5619749|NCT00773734|19411327|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
5619750|NCT00773734|19411328|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
5619751|NCT00773734|19411329|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
5619752|NCT00773734|19411330|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
5619753|NCT00773734|19411325|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
5619754|NCT00773734|19411326|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
5619755|NCT00773734|19411327|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
5619756|NCT00773734|19411328|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
5619757|NCT00773734|19411329|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
5619758|NCT00773734|19411330|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
5619759|NCT00773734|19411325|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
5619760|NCT00773734|19411326|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
5619761|NCT00773734|19411327|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
5619762|NCT00773734|19411328|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
5619763|NCT00773734|19411329|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
5619764|NCT00773734|19411330|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
5619765|NCT00773734|19411325|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
5619766|NCT00773734|19411326|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
5619767|NCT00773734|19411327|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
5619768|NCT00773734|19411328|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
5619769|NCT00773734|19411329|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
5619770|NCT00773734|19411330|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
5619771|NCT00773734|19411325|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
5619772|NCT00773734|19411326|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
5619773|NCT00773734|19411327|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
5619774|NCT00773734|19411328|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
5619775|NCT00773734|19411329|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
5619776|NCT00773734|19411330|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
5619777|NCT00773734|19411325|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
5619778|NCT00773734|19411326|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
5619779|NCT00773734|19411327|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
5619780|NCT00773734|19411328|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
5619781|NCT00773734|19411329|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
5619782|NCT00773734|19411330|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
5619783|NCT00773734|19411325|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
5619784|NCT00773734|19411326|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
5619785|NCT00773734|19411327|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
5619786|NCT00773734|19411328|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
5619787|NCT00773734|19411329|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
5619788|NCT00773734|19411330|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
5619789|NCT00773513|19411898|P2|Overall Study|Death|545
5619790|NCT00773513|19411899|P1|Overall Study|Death|531
5619791|NCT00773513|19411898|P2|Overall Study|Reason Not Specified|126
5619792|NCT00773513|19411899|P1|Overall Study|Reason Not Specified|159
5619793|NCT00773513|19411898|P2|Overall Study|Insufficient Therapeutic Response|18
5619794|NCT00773513|19411899|P1|Overall Study|Insufficient Therapeutic Response|1
5619795|NCT00773513|19411898|P2|Overall Study|Failure to Return|8
5619796|NCT00773513|19411899|P1|Overall Study|Failure to Return|22
5619797|NCT00773513|19411898|P2|Overall Study|Refused Treatment / Did not Cooperate|32
5619798|NCT00773513|19411899|P1|Overall Study|Refused Treatment / Did not Cooperate|26
5619799|NCT00773513|19411898|P2|Overall Study|Withdrew Consent|69
5619800|NCT00773513|19411899|P1|Overall Study|Withdrew Consent|68
5619801|NCT00773513|19411898|P2|Overall Study|Adverse Event / Intercurrent Illness|48
5619802|NCT00773513|19411899|P1|Overall Study|Adverse Event / Intercurrent Illness|40
5619803|NCT00773513|19411898|P2|Overall Study|Renal Transplant|263
5619804|NCT00773513|19411899|P1|Overall Study|Renal Transplant|254
5619805|NCT00773461|19411928|P2|Overall Study|Withdrawal by Subject|1
5619806|NCT00773461|19411929|P1|Overall Study|Withdrawal by Subject|4
5619807|NCT00773461|19411928|P2|Overall Study|Adverse Event|3
5619808|NCT00773461|19411929|P1|Overall Study|Adverse Event|1
5619809|NCT00773383|19411983|P1|Overall Study|No study dose received|1
5619810|NCT00773383|19411983|P1|Overall Study|Other|2
5619811|NCT00773383|19411983|P1|Overall Study|Progression of Disease|23
5619812|NCT00773383|19411983|P1|Overall Study|Death|1
5619813|NCT00773383|19411983|P1|Overall Study|Adverse Event|4
5619814|NCT00773279|19412018|P2|Period 2|Unclassified|2
5619815|NCT00773279|19412019|P1|Period 2|Unclassified|2
5619816|NCT00773279|19412018|P2|Period 2|Protocol Violation|3
5619817|NCT00773279|19412019|P1|Period 2|Protocol Violation|0
5619818|NCT00773279|19412018|P2|Period 2|Lack of Efficacy|0
5619819|NCT00773279|19412019|P1|Period 2|Lack of Efficacy|1
5619820|NCT00773279|19412018|P2|Period 2|Adverse Event|1
5619821|NCT00773279|19412019|P1|Period 2|Adverse Event|0
5619822|NCT00773279|19412018|P2|Period 1|Unclassified|1
5619823|NCT00773279|19412019|P1|Period 1|Unclassified|5
5619824|NCT00773279|19412018|P2|Period 1|Lack of Efficacy|2
5619825|NCT00773279|19412019|P1|Period 1|Lack of Efficacy|0
5619826|NCT00773279|19412018|P2|Period 1|Adverse Event|1
5619827|NCT00773279|19412019|P1|Period 1|Adverse Event|2
5619828|NCT00773253|19412040|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
5619829|NCT00773253|19412041|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
5619830|NCT00773175|19412051|P2|Overall Study|Consent Withdrawn|2
5619831|NCT00773175|19412052|P1|Overall Study|Consent Withdrawn|0
5619832|NCT00773175|19412051|P2|Overall Study|Adverse Event|0
5619833|NCT00773175|19412052|P1|Overall Study|Adverse Event|2
5619834|NCT00773136|19412144|P1|Overall Study|Physician Decision|2
5619835|NCT00773097|19412149|P1|Overall Study|Physician Decision|6
5619836|NCT00773097|19412149|P1|Overall Study|Withdrawal by Subject|1
5619837|NCT00772967|19412155|P6|Crossover Treatment 3|Adverse Event|0
5619838|NCT00772967|19412156|P5|Crossover Treatment 3|Adverse Event|1
5619839|NCT00772967|19412157|P4|Crossover Treatment 3|Adverse Event|0
5619840|NCT00772967|19412158|P3|Crossover Treatment 3|Adverse Event|0
5619841|NCT00772967|19412159|P2|Crossover Treatment 3|Adverse Event|0
5619842|NCT00772967|19412160|P1|Crossover Treatment 3|Adverse Event|0
5619843|NCT00772967|19412155|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
5619844|NCT00772967|19412156|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
5619845|NCT00772967|19412157|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
5619846|NCT00772967|19412158|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
5619847|NCT00772967|19412159|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
5619848|NCT00772967|19412160|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
5619849|NCT00772967|19412155|P6|Crossover Treatment 1|Adverse Event (Pain)|0
5619850|NCT00772967|19412156|P5|Crossover Treatment 1|Adverse Event (Pain)|0
5619851|NCT00772967|19412157|P4|Crossover Treatment 1|Adverse Event (Pain)|1
5619852|NCT00772967|19412158|P3|Crossover Treatment 1|Adverse Event (Pain)|0
5619853|NCT00772967|19412159|P2|Crossover Treatment 1|Adverse Event (Pain)|0
5619854|NCT00772967|19412160|P1|Crossover Treatment 1|Adverse Event (Pain)|0
5619855|NCT00772954|19412180|P3|Overall Study|Adverse Event|1
5619856|NCT00772954|19412181|P2|Overall Study|Adverse Event|0
5619857|NCT00772954|19412182|P1|Overall Study|Adverse Event|0
5619858|NCT00772941|19412190|P1|Overall Study|GPSP Violation|90
5619859|NCT00772941|19412190|P1|Overall Study|Poor Compliance|7
5619860|NCT00772941|19412190|P1|Overall Study|Missed Visits|374
5619861|NCT00772941|19412190|P1|Overall Study|Study not completed|16
5619862|NCT00772941|19412190|P1|Overall Study|CRFs not available|195
5619863|NCT00772928|19412221|P2|Overall Study|Did not receive vaccine|1
5619864|NCT00772928|19412222|P1|Overall Study|Did not receive vaccine|0
5619865|NCT00772928|19412221|P2|Overall Study|Withdrawal by Subject|22
5619866|NCT00772928|19412222|P1|Overall Study|Withdrawal by Subject|25
5619867|NCT00772928|19412221|P2|Overall Study|Protocol Violation|12
5619868|NCT00772928|19412222|P1|Overall Study|Protocol Violation|10
5619869|NCT00772928|19412221|P2|Overall Study|Lost to Follow-up|6
5619870|NCT00772928|19412222|P1|Overall Study|Lost to Follow-up|9
5619871|NCT00772889|19412243|P3|Overall Study|Lost to Follow-up|7
5619872|NCT00772889|19412244|P2|Overall Study|Lost to Follow-up|6
5619873|NCT00772889|19412245|P1|Overall Study|Lost to Follow-up|6
5619874|NCT00772889|19412243|P3|Overall Study|Withdrawal by Subject|9
5619875|NCT00772889|19412244|P2|Overall Study|Withdrawal by Subject|8
5619876|NCT00772889|19412245|P1|Overall Study|Withdrawal by Subject|9
5619877|NCT00772889|19412243|P3|Overall Study|Adverse Event|0
5619878|NCT00772889|19412244|P2|Overall Study|Adverse Event|4
5619879|NCT00772889|19412245|P1|Overall Study|Adverse Event|7
5619880|NCT00772707|19412303|P1|Overall Study|Withdrawn|3
5619881|NCT00772668|19412308|P1|Overall Study|Physician Decision|3
5619882|NCT00772629|19412317|P2|Overall Study|Subject was not vaccinated|0
5619883|NCT00772629|19412318|P1|Overall Study|Subject was not vaccinated|1
5619884|NCT00772603|19412327|P3|Overall Study|Other|2
5619885|NCT00772603|19412328|P2|Overall Study|Other|0
5619886|NCT00772603|19412329|P1|Overall Study|Other|2
5619887|NCT00772603|19412327|P3|Overall Study|Physician Decision|1
5619888|NCT00772603|19412328|P2|Overall Study|Physician Decision|0
5619889|NCT00772603|19412329|P1|Overall Study|Physician Decision|0
5619890|NCT00772603|19412327|P3|Overall Study|Lost to Follow-up|2
5619891|NCT00772603|19412328|P2|Overall Study|Lost to Follow-up|5
5619892|NCT00772603|19412329|P1|Overall Study|Lost to Follow-up|1
5619893|NCT00772603|19412327|P3|Overall Study|Protocol Violation|1
5619894|NCT00772603|19412328|P2|Overall Study|Protocol Violation|1
5619895|NCT00772603|19412329|P1|Overall Study|Protocol Violation|0
5619896|NCT00772603|19412327|P3|Overall Study|Subject Non-compliance|4
5619897|NCT00772603|19412328|P2|Overall Study|Subject Non-compliance|6
5619898|NCT00772603|19412329|P1|Overall Study|Subject Non-compliance|1
5619899|NCT00772603|19412327|P3|Overall Study|Adverse Event|10
5619900|NCT00772603|19412328|P2|Overall Study|Adverse Event|18
5619901|NCT00772603|19412329|P1|Overall Study|Adverse Event|37
5619902|NCT00772603|19412327|P3|Overall Study|Withdrawal by Subject|6
5619903|NCT00772603|19412328|P2|Overall Study|Withdrawal by Subject|10
5619904|NCT00772603|19412329|P1|Overall Study|Withdrawal by Subject|11
5619905|NCT00772577|19412368|P2|Overall Study|Protocol Deviation|2
5619906|NCT00772577|19412369|P1|Overall Study|Protocol Deviation|3
5619907|NCT00772577|19412368|P2|Overall Study|Administrative problems|1
5619908|NCT00772577|19412369|P1|Overall Study|Administrative problems|2
5619909|NCT00772577|19412368|P2|Overall Study|Lost to Follow-up|3
5619910|NCT00772577|19412369|P1|Overall Study|Lost to Follow-up|4
5619911|NCT00772577|19412368|P2|Overall Study|Patient withdrew consent|5
5619912|NCT00772577|19412369|P1|Overall Study|Patient withdrew consent|8
5619913|NCT00772577|19412368|P2|Overall Study|Unsatisfactory therapeutic effect|8
5619914|NCT00772577|19412369|P1|Overall Study|Unsatisfactory therapeutic effect|0
5619915|NCT00772577|19412368|P2|Overall Study|Abnormal laboratory values|1
5619916|NCT00772577|19412369|P1|Overall Study|Abnormal laboratory values|0
5619917|NCT00772577|19412368|P2|Overall Study|Adverse Event|3
5619918|NCT00772577|19412369|P1|Overall Study|Adverse Event|6
5619919|NCT00772538|19412385|P2|Overall Study|Other|7
5619920|NCT00772538|19412386|P1|Overall Study|Other|7
5619921|NCT00772538|19412385|P2|Overall Study|Lack of Efficacy|1
5619922|NCT00772538|19412386|P1|Overall Study|Lack of Efficacy|0
5619923|NCT00772538|19412385|P2|Overall Study|Withdrawal by Subject|8
5619924|NCT00772538|19412386|P1|Overall Study|Withdrawal by Subject|3
5619925|NCT00772538|19412385|P2|Overall Study|Lost to Follow-up|1
5619926|NCT00772538|19412386|P1|Overall Study|Lost to Follow-up|1
5619927|NCT00772538|19412385|P2|Overall Study|Protocol Violation|3
5619928|NCT00772538|19412386|P1|Overall Study|Protocol Violation|3
5619929|NCT00772538|19412385|P2|Overall Study|Adverse Event|6
5619930|NCT00772538|19412386|P1|Overall Study|Adverse Event|6
5619931|NCT00772447|19412458|P2|Overall Study|all others|2
5619932|NCT00772447|19412459|P1|Overall Study|all others|2
5619933|NCT00772447|19412458|P2|Overall Study|Protocol Violation|1
5619934|NCT00772447|19412459|P1|Overall Study|Protocol Violation|0
5619935|NCT00772447|19412458|P2|Overall Study|incorrect enrolment|4
5619936|NCT00772447|19412459|P1|Overall Study|incorrect enrolment|3
5619937|NCT00772447|19412458|P2|Overall Study|Lost to Follow-up|4
5619938|NCT00772447|19412459|P1|Overall Study|Lost to Follow-up|2
5619939|NCT00772447|19412458|P2|Overall Study|Physician Decision|8
5619940|NCT00772447|19412459|P1|Overall Study|Physician Decision|4
5619941|NCT00772447|19412458|P2|Overall Study|Withdrawal by Subject|5
5619942|NCT00772447|19412459|P1|Overall Study|Withdrawal by Subject|9
5619943|NCT00772382|19412487|P1|Overall Study|Other Reasons|10
5619944|NCT00772382|19412487|P1|Overall Study|Withdrawal by Subject|10
5619945|NCT00772382|19412487|P1|Overall Study|Protocol Violation|1
5619946|NCT00772382|19412487|P1|Overall Study|Physician Decision|5
5619947|NCT00772382|19412487|P1|Overall Study|Lack of Efficacy|4
5619948|NCT00772382|19412487|P1|Overall Study|Death|6
5619949|NCT00772382|19412487|P1|Overall Study|Adverse Event|19
5619950|NCT00772369|19412492|P1|Overall Study|Did not return record release form|1
5619951|NCT00772148|19412503|P2|Maintenance Phase (Week 52)|Administrative/other|2
5619952|NCT00772148|19412504|P1|Maintenance Phase (Week 52)|Administrative/other|1
5619953|NCT00772148|19412503|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
5619954|NCT00772148|19412504|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
5619955|NCT00772148|19412503|P2|Maintenance Phase (Week 52)|Adverse Event|0
5619956|NCT00772148|19412504|P1|Maintenance Phase (Week 52)|Adverse Event|1
5619957|NCT00772148|19412503|P2|Maintenance Phase (Week 52)|Death|2
5619958|NCT00772148|19412504|P1|Maintenance Phase (Week 52)|Death|2
5619959|NCT00772148|19412503|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
5619960|NCT00772148|19412504|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
5619961|NCT00772148|19412503|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
5619962|NCT00772148|19412504|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
5619963|NCT00772148|19412503|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
5619964|NCT00772148|19412504|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
5619965|NCT00772109|19412524|P4|Overall Study|Withdrawal by Subject|16
5619966|NCT00772109|19412525|P3|Overall Study|Withdrawal by Subject|6
5619967|NCT00772109|19412526|P2|Overall Study|Withdrawal by Subject|8
5619968|NCT00772109|19412527|P1|Overall Study|Withdrawal by Subject|8
5619969|NCT00772109|19412524|P4|Overall Study|Lost to Follow-up|9
5619970|NCT00772109|19412525|P3|Overall Study|Lost to Follow-up|5
5619971|NCT00772109|19412526|P2|Overall Study|Lost to Follow-up|3
5619972|NCT00772109|19412527|P1|Overall Study|Lost to Follow-up|7
5619973|NCT00772109|19412524|P4|Overall Study|Protocol Violation|6
5619974|NCT00772109|19412525|P3|Overall Study|Protocol Violation|7
5619975|NCT00772109|19412526|P2|Overall Study|Protocol Violation|8
5619976|NCT00772109|19412527|P1|Overall Study|Protocol Violation|5
5619977|NCT00772109|19412524|P4|Overall Study|Serious adverse event|0
5619978|NCT00772109|19412525|P3|Overall Study|Serious adverse event|1
5619979|NCT00772109|19412526|P2|Overall Study|Serious adverse event|0
5619980|NCT00772109|19412527|P1|Overall Study|Serious adverse event|1
5619981|NCT00772070|19412551|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
5619982|NCT00772070|19412552|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
5619983|NCT00772070|19412551|P2|Overall Study|Withdrawal by Subject|2
5619984|NCT00772070|19412552|P1|Overall Study|Withdrawal by Subject|0
5619985|NCT00772070|19412551|P2|Overall Study|Lost to Follow-up|8
5619986|NCT00772070|19412552|P1|Overall Study|Lost to Follow-up|0
5619987|NCT00772031|19412564|P2|Overall Study|Lost to Follow-up|33
5619988|NCT00772031|19412565|P1|Overall Study|Lost to Follow-up|20
5619989|NCT00772031|19412564|P2|Overall Study|Early termination of trial|10
5619990|NCT00772031|19412565|P1|Overall Study|Early termination of trial|12
5619991|NCT00772005|19412591|P4|Overall Study|Non-compliance with drug administration|1
5619992|NCT00772005|19412592|P3|Overall Study|Non-compliance with drug administration|1
5619993|NCT00772005|19412593|P2|Overall Study|Non-compliance with drug administration|0
5619994|NCT00772005|19412594|P1|Overall Study|Non-compliance with drug administration|3
5619995|NCT00772005|19412591|P4|Overall Study|Non-compliance with study procedures|1
5619996|NCT00772005|19412592|P3|Overall Study|Non-compliance with study procedures|0
5619997|NCT00772005|19412593|P2|Overall Study|Non-compliance with study procedures|1
5619998|NCT00772005|19412594|P1|Overall Study|Non-compliance with study procedures|1
5619999|NCT00772005|19412591|P4|Overall Study|Lost to Follow-up|3
5620000|NCT00772005|19412592|P3|Overall Study|Lost to Follow-up|6
5620001|NCT00772005|19412593|P2|Overall Study|Lost to Follow-up|3
5620002|NCT00772005|19412594|P1|Overall Study|Lost to Follow-up|7
5620003|NCT00772005|19412591|P4|Overall Study|Protocol Violation|6
5620004|NCT00772005|19412592|P3|Overall Study|Protocol Violation|1
5620005|NCT00772005|19412593|P2|Overall Study|Protocol Violation|4
5620006|NCT00772005|19412594|P1|Overall Study|Protocol Violation|2
5620007|NCT00772005|19412591|P4|Overall Study|Withdrawal by Subject|2
5620008|NCT00772005|19412592|P3|Overall Study|Withdrawal by Subject|10
5620009|NCT00772005|19412593|P2|Overall Study|Withdrawal by Subject|7
5620010|NCT00772005|19412594|P1|Overall Study|Withdrawal by Subject|3
5620011|NCT00772005|19412591|P4|Overall Study|Lack of Efficacy|0
5620012|NCT00772005|19412592|P3|Overall Study|Lack of Efficacy|0
5620013|NCT00772005|19412593|P2|Overall Study|Lack of Efficacy|1
5620014|NCT00772005|19412594|P1|Overall Study|Lack of Efficacy|0
5620015|NCT00772005|19412591|P4|Overall Study|Adverse Event|13
5620016|NCT00772005|19412592|P3|Overall Study|Adverse Event|10
5620017|NCT00772005|19412593|P2|Overall Study|Adverse Event|14
5620018|NCT00772005|19412594|P1|Overall Study|Adverse Event|9
5620019|NCT00771953|19413282|P2|Overall Study|Withdrawal by Subject|3
5620020|NCT00771953|19413283|P1|Overall Study|Withdrawal by Subject|0
5620021|NCT00771953|19413282|P2|Overall Study|Other complicating disease|0
5620022|NCT00771953|19413283|P1|Overall Study|Other complicating disease|1
5620023|NCT00771953|19413282|P2|Overall Study|Sponsor decision|0
5620024|NCT00771953|19413283|P1|Overall Study|Sponsor decision|1
5620025|NCT00771953|19413282|P2|Overall Study|Progression before active Tx|2
5620026|NCT00771953|19413283|P1|Overall Study|Progression before active Tx|1
5620027|NCT00771953|19413282|P2|Overall Study|Death|2
5620028|NCT00771953|19413283|P1|Overall Study|Death|2
5620029|NCT00771953|19413282|P2|Overall Study|Adverse Event|3
5620030|NCT00771953|19413283|P1|Overall Study|Adverse Event|5
5620031|NCT00771927|19413293|P2|Overall Study|Other reason|27
5620032|NCT00771927|19413294|P1|Overall Study|Other reason|23
5620033|NCT00771927|19413293|P2|Overall Study|Withdrawal by Subject|17
5620034|NCT00771927|19413294|P1|Overall Study|Withdrawal by Subject|16
5620035|NCT00771927|19413293|P2|Overall Study|Lost to Follow-up|46
5620036|NCT00771927|19413294|P1|Overall Study|Lost to Follow-up|46
5620037|NCT00771927|19413293|P2|Overall Study|Lack of Efficacy|42
5620038|NCT00771927|19413294|P1|Overall Study|Lack of Efficacy|70
5620039|NCT00771927|19413293|P2|Overall Study|Adverse Event|105
5620040|NCT00771927|19413294|P1|Overall Study|Adverse Event|100
5620041|NCT00771914|19413306|P4|Overall Study|Lost to Follow-up|1
5620042|NCT00771914|19413307|P3|Overall Study|Lost to Follow-up|0
5620043|NCT00771914|19413308|P2|Overall Study|Lost to Follow-up|0
5620044|NCT00771914|19413309|P1|Overall Study|Lost to Follow-up|0
5620045|NCT00771914|19413306|P4|Overall Study|Physician Decision|1
5620046|NCT00771914|19413307|P3|Overall Study|Physician Decision|0
5620047|NCT00771914|19413308|P2|Overall Study|Physician Decision|0
5620048|NCT00771914|19413309|P1|Overall Study|Physician Decision|0
5620049|NCT00771901|19413322|P3|Overall Study|Dissat w/# of study medication (40/day)|4
5620050|NCT00771901|19413323|P2|Overall Study|Dissat w/# of study medication (40/day)|0
5620051|NCT00771901|19413324|P1|Overall Study|Dissat w/# of study medication (40/day)|0
5620052|NCT00771849|19413371|P2|Overall Study|Not vaccinated|1
5620053|NCT00771849|19413372|P1|Overall Study|Not vaccinated|0
5620054|NCT00771849|19413371|P2|Overall Study|Withdrawal by Subject|1
5620055|NCT00771849|19413372|P1|Overall Study|Withdrawal by Subject|1
5620056|NCT00771849|19413371|P2|Overall Study|Lost to Follow-up|2
5620057|NCT00771849|19413372|P1|Overall Study|Lost to Follow-up|1
5620058|NCT00771810|19413383|P3|Overall Study|Other|1
5620059|NCT00771810|19413384|P2|Overall Study|Other|0
5620060|NCT00771810|19413385|P1|Overall Study|Other|0
5620061|NCT00771810|19413383|P3|Overall Study|Withdrawal by Subject|0
5620062|NCT00771810|19413384|P2|Overall Study|Withdrawal by Subject|2
5620063|NCT00771810|19413385|P1|Overall Study|Withdrawal by Subject|1
5620064|NCT00771810|19413383|P3|Overall Study|Protocol Violation|1
5620065|NCT00771810|19413384|P2|Overall Study|Protocol Violation|1
5620066|NCT00771810|19413385|P1|Overall Study|Protocol Violation|0
5620067|NCT00771810|19413383|P3|Overall Study|Physician Decision|2
5620068|NCT00771810|19413384|P2|Overall Study|Physician Decision|2
5620069|NCT00771810|19413385|P1|Overall Study|Physician Decision|1
5620070|NCT00771810|19413383|P3|Overall Study|Lost to Follow-up|1
5620071|NCT00771810|19413384|P2|Overall Study|Lost to Follow-up|0
5620072|NCT00771810|19413385|P1|Overall Study|Lost to Follow-up|0
5620073|NCT00771810|19413383|P3|Overall Study|Adverse Event|2
5620074|NCT00771810|19413384|P2|Overall Study|Adverse Event|0
5620075|NCT00771810|19413385|P1|Overall Study|Adverse Event|3
5620076|NCT00771758|19413423|P3|Overall Study|Other|0
5620077|NCT00771758|19413424|P2|Overall Study|Other|2
5620078|NCT00771758|19413425|P1|Overall Study|Other|3
5620079|NCT00771758|19413423|P3|Overall Study|Withdrawal by Subject|0
5620080|NCT00771758|19413424|P2|Overall Study|Withdrawal by Subject|0
5620081|NCT00771758|19413425|P1|Overall Study|Withdrawal by Subject|1
5620082|NCT00771758|19413423|P3|Overall Study|Protocol Violation|0
5620083|NCT00771758|19413424|P2|Overall Study|Protocol Violation|0
5620084|NCT00771758|19413425|P1|Overall Study|Protocol Violation|1
5620085|NCT00771758|19413423|P3|Overall Study|Lost to Follow-up|0
5620086|NCT00771758|19413424|P2|Overall Study|Lost to Follow-up|0
5620087|NCT00771758|19413425|P1|Overall Study|Lost to Follow-up|1
5620088|NCT00771758|19413423|P3|Overall Study|Lack of Efficacy|1
5620089|NCT00771758|19413424|P2|Overall Study|Lack of Efficacy|2
5620090|NCT00771758|19413425|P1|Overall Study|Lack of Efficacy|0
5620091|NCT00771758|19413423|P3|Overall Study|Adverse Event|1
5620092|NCT00771758|19413424|P2|Overall Study|Adverse Event|8
5620093|NCT00771758|19413425|P1|Overall Study|Adverse Event|2
5620094|NCT00771667|19413586|P10|Maintenance Phase|Other|3
5620095|NCT00771667|19413587|P9|Maintenance Phase|Other|3
5620096|NCT00771667|19413588|P8|Maintenance Phase|Other|2
5620097|NCT00771667|19413589|P7|Maintenance Phase|Other|2
5620098|NCT00771667|19413590|P6|Maintenance Phase|Other|1
5620099|NCT00771667|19413591|P5|Maintenance Phase|Other|0
5620100|NCT00771667|19413592|P4|Maintenance Phase|Other|0
5620101|NCT00771667|19413593|P3|Maintenance Phase|Other|0
5620102|NCT00771667|19413594|P2|Maintenance Phase|Other|0
5620103|NCT00771667|19413595|P1|Maintenance Phase|Other|0
5620104|NCT00771667|19413586|P10|Maintenance Phase|Lack of Efficacy|7
5620105|NCT00771667|19413587|P9|Maintenance Phase|Lack of Efficacy|11
5620106|NCT00771667|19413588|P8|Maintenance Phase|Lack of Efficacy|2
5620107|NCT00771667|19413589|P7|Maintenance Phase|Lack of Efficacy|3
5620108|NCT00771667|19413590|P6|Maintenance Phase|Lack of Efficacy|3
5620109|NCT00771667|19413591|P5|Maintenance Phase|Lack of Efficacy|1
5620110|NCT00771667|19413592|P4|Maintenance Phase|Lack of Efficacy|0
5620111|NCT00771667|19413593|P3|Maintenance Phase|Lack of Efficacy|0
5620112|NCT00771667|19413594|P2|Maintenance Phase|Lack of Efficacy|0
5620113|NCT00771667|19413595|P1|Maintenance Phase|Lack of Efficacy|0
5620114|NCT00771667|19413586|P10|Maintenance Phase|Adverse Event|7
5620115|NCT00771667|19413587|P9|Maintenance Phase|Adverse Event|8
5620116|NCT00771667|19413588|P8|Maintenance Phase|Adverse Event|1
5620117|NCT00771667|19413589|P7|Maintenance Phase|Adverse Event|5
5620118|NCT00771667|19413590|P6|Maintenance Phase|Adverse Event|3
5620119|NCT00771667|19413591|P5|Maintenance Phase|Adverse Event|1
5620120|NCT00771667|19413592|P4|Maintenance Phase|Adverse Event|0
5620121|NCT00771667|19413593|P3|Maintenance Phase|Adverse Event|0
5620122|NCT00771667|19413594|P2|Maintenance Phase|Adverse Event|0
5620123|NCT00771667|19413595|P1|Maintenance Phase|Adverse Event|0
5620124|NCT00771667|19413586|P10|Induction Phase|Other|0
5620125|NCT00771667|19413587|P9|Induction Phase|Other|0
5620126|NCT00771667|19413588|P8|Induction Phase|Other|0
5620127|NCT00771667|19413589|P7|Induction Phase|Other|0
5620128|NCT00771667|19413590|P6|Induction Phase|Other|0
5620129|NCT00771667|19413591|P5|Induction Phase|Other|0
5620130|NCT00771667|19413592|P4|Induction Phase|Other|4
5620131|NCT00771667|19413593|P3|Induction Phase|Other|3
5620132|NCT00771667|19413594|P2|Induction Phase|Other|6
5620133|NCT00771667|19413595|P1|Induction Phase|Other|4
5620134|NCT00771667|19413586|P10|Induction Phase|Lost to Follow-up|0
5620135|NCT00771667|19413587|P9|Induction Phase|Lost to Follow-up|0
5620136|NCT00771667|19413588|P8|Induction Phase|Lost to Follow-up|0
5620137|NCT00771667|19413589|P7|Induction Phase|Lost to Follow-up|0
5620138|NCT00771667|19413590|P6|Induction Phase|Lost to Follow-up|0
5620139|NCT00771667|19413591|P5|Induction Phase|Lost to Follow-up|0
5620140|NCT00771667|19413592|P4|Induction Phase|Lost to Follow-up|0
5620141|NCT00771667|19413593|P3|Induction Phase|Lost to Follow-up|1
5620142|NCT00771667|19413594|P2|Induction Phase|Lost to Follow-up|0
5620143|NCT00771667|19413595|P1|Induction Phase|Lost to Follow-up|1
5620144|NCT00771667|19413586|P10|Induction Phase|Lack of Efficacy|0
5620145|NCT00771667|19413587|P9|Induction Phase|Lack of Efficacy|0
5620146|NCT00771667|19413588|P8|Induction Phase|Lack of Efficacy|0
5620147|NCT00771667|19413589|P7|Induction Phase|Lack of Efficacy|0
5620148|NCT00771667|19413590|P6|Induction Phase|Lack of Efficacy|0
5620149|NCT00771667|19413591|P5|Induction Phase|Lack of Efficacy|0
5620150|NCT00771667|19413592|P4|Induction Phase|Lack of Efficacy|3
5620151|NCT00771667|19413593|P3|Induction Phase|Lack of Efficacy|4
5620152|NCT00771667|19413594|P2|Induction Phase|Lack of Efficacy|2
5620153|NCT00771667|19413595|P1|Induction Phase|Lack of Efficacy|9
5620154|NCT00771667|19413586|P10|Induction Phase|Adverse Event|0
5620155|NCT00771667|19413587|P9|Induction Phase|Adverse Event|0
5620156|NCT00771667|19413588|P8|Induction Phase|Adverse Event|0
5620157|NCT00771667|19413589|P7|Induction Phase|Adverse Event|0
5620158|NCT00771667|19413590|P6|Induction Phase|Adverse Event|0
5620159|NCT00771667|19413591|P5|Induction Phase|Adverse Event|0
5620160|NCT00771667|19413592|P4|Induction Phase|Adverse Event|1
5620161|NCT00771667|19413593|P3|Induction Phase|Adverse Event|4
5620162|NCT00771667|19413594|P2|Induction Phase|Adverse Event|2
5620163|NCT00771667|19413595|P1|Induction Phase|Adverse Event|5
5620164|NCT00771615|19413640|P9|Overall Study|Lost to Follow-up|0
5620165|NCT00771615|19413641|P8|Overall Study|Lost to Follow-up|0
5620166|NCT00771615|19413642|P7|Overall Study|Lost to Follow-up|1
5620167|NCT00771615|19413643|P6|Overall Study|Lost to Follow-up|1
5620168|NCT00771615|19413644|P5|Overall Study|Lost to Follow-up|0
5620169|NCT00771615|19413645|P4|Overall Study|Lost to Follow-up|1
5620170|NCT00771615|19413646|P3|Overall Study|Lost to Follow-up|1
5620171|NCT00771615|19413647|P2|Overall Study|Lost to Follow-up|1
5620172|NCT00771615|19413648|P1|Overall Study|Lost to Follow-up|1
5620173|NCT00771615|19413640|P9|Overall Study|Withdrawal by Subject|0
5620174|NCT00771615|19413641|P8|Overall Study|Withdrawal by Subject|1
5620175|NCT00771615|19413642|P7|Overall Study|Withdrawal by Subject|0
5620176|NCT00771615|19413643|P6|Overall Study|Withdrawal by Subject|0
5620177|NCT00771615|19413644|P5|Overall Study|Withdrawal by Subject|0
5620178|NCT00771615|19413645|P4|Overall Study|Withdrawal by Subject|0
5620179|NCT00771615|19413646|P3|Overall Study|Withdrawal by Subject|0
5620180|NCT00771615|19413647|P2|Overall Study|Withdrawal by Subject|1
5620181|NCT00771615|19413648|P1|Overall Study|Withdrawal by Subject|0
5620182|NCT00771472|19413909|P2|Overall Study|Protocol Violation|0
5620183|NCT00771472|19413910|P1|Overall Study|Protocol Violation|1
5620184|NCT00771472|19413909|P2|Overall Study|Progressive Disease|1
5620185|NCT00771472|19413910|P1|Overall Study|Progressive Disease|3
5620186|NCT00771472|19413909|P2|Overall Study|Physician Decision|3
5620187|NCT00771472|19413910|P1|Overall Study|Physician Decision|2
5620188|NCT00771316|19413930|P2|Overall Study|Discontinued due to early termination|0
5620189|NCT00771316|19413931|P1|Overall Study|Discontinued due to early termination|1
5620190|NCT00771316|19413930|P2|Overall Study|Patient withdrew consent|0
5620191|NCT00771316|19413931|P1|Overall Study|Patient withdrew consent|1
5620192|NCT00771316|19413930|P2|Overall Study|Adverse Event|1
5620193|NCT00771316|19413931|P1|Overall Study|Adverse Event|0
5620194|NCT00770991|19413983|P2|Overall Study|Pregnancy|0
5620195|NCT00770991|19413984|P1|Overall Study|Pregnancy|1
5620196|NCT00770991|19413983|P2|Overall Study|Adverse Event|5
5620197|NCT00770991|19413984|P1|Overall Study|Adverse Event|1
5620198|NCT00770991|19413983|P2|Overall Study|Withdrawal by Subject|0
5620199|NCT00770991|19413984|P1|Overall Study|Withdrawal by Subject|1
5620200|NCT00770991|19413983|P2|Overall Study|Physician Decision|0
5620201|NCT00770991|19413984|P1|Overall Study|Physician Decision|2
5620202|NCT00770965|19414000|P4|Excluded Set|Withdrawal by Subject|3
5620203|NCT00770965|19414001|P3|Excluded Set|Withdrawal by Subject|2
5620204|NCT00770965|19414002|P2|Excluded Set|Withdrawal by Subject|1
5620205|NCT00770965|19414003|P1|Excluded Set|Withdrawal by Subject|1
5620206|NCT00770965|19414000|P4|Excluded Set|Administrative problems|10
5620207|NCT00770965|19414001|P3|Excluded Set|Administrative problems|12
5620208|NCT00770965|19414002|P2|Excluded Set|Administrative problems|12
5620209|NCT00770965|19414003|P1|Excluded Set|Administrative problems|14
5620210|NCT00770965|19414000|P4|Safety Set|Protocol deviation|0
5620211|NCT00770965|19414001|P3|Safety Set|Protocol deviation|1
5620212|NCT00770965|19414002|P2|Safety Set|Protocol deviation|0
5620213|NCT00770965|19414003|P1|Safety Set|Protocol deviation|0
5620214|NCT00770965|19414000|P4|Safety Set|Withdrawal by Subject|1
5620215|NCT00770965|19414001|P3|Safety Set|Withdrawal by Subject|0
5620216|NCT00770965|19414002|P2|Safety Set|Withdrawal by Subject|0
5620217|NCT00770965|19414003|P1|Safety Set|Withdrawal by Subject|0
5620218|NCT00770913|19414024|P3|Overall Study|Incorrect drug was allocated|0
5620219|NCT00770913|19414025|P2|Overall Study|Incorrect drug was allocated|0
5620220|NCT00770913|19414026|P1|Overall Study|Incorrect drug was allocated|1
5620221|NCT00770913|19414024|P3|Overall Study|Protocol Violation|1
5620222|NCT00770913|19414025|P2|Overall Study|Protocol Violation|0
5620223|NCT00770913|19414026|P1|Overall Study|Protocol Violation|3
5620224|NCT00770913|19414024|P3|Overall Study|Physician Decision|1
5620225|NCT00770913|19414025|P2|Overall Study|Physician Decision|1
5620226|NCT00770913|19414026|P1|Overall Study|Physician Decision|0
5620227|NCT00770913|19414024|P3|Overall Study|Refusal to continue participation|5
5620228|NCT00770913|19414025|P2|Overall Study|Refusal to continue participation|4
5620229|NCT00770913|19414026|P1|Overall Study|Refusal to continue participation|6
5620230|NCT00770913|19414024|P3|Overall Study|Adverse Event|6
5620231|NCT00770913|19414025|P2|Overall Study|Adverse Event|3
5620232|NCT00770913|19414026|P1|Overall Study|Adverse Event|1
5620233|NCT00770809|19414059|P3|Overall Study|Other Medical Reasons|3
5620234|NCT00770809|19414060|P2|Overall Study|Other Medical Reasons|4
5620235|NCT00770809|19414061|P1|Overall Study|Other Medical Reasons|2
5620236|NCT00770809|19414059|P3|Overall Study|Complicating illness|1
5620237|NCT00770809|19414060|P2|Overall Study|Complicating illness|0
5620238|NCT00770809|19414061|P1|Overall Study|Complicating illness|0
5620239|NCT00770809|19414059|P3|Overall Study|Progression|0
5620240|NCT00770809|19414060|P2|Overall Study|Progression|2
5620241|NCT00770809|19414061|P1|Overall Study|Progression|2
5620242|NCT00770809|19414059|P3|Overall Study|Withdrawal by Subject|7
5620243|NCT00770809|19414060|P2|Overall Study|Withdrawal by Subject|3
5620244|NCT00770809|19414061|P1|Overall Study|Withdrawal by Subject|3
5620245|NCT00770809|19414059|P3|Overall Study|Death|0
5620246|NCT00770809|19414060|P2|Overall Study|Death|0
5620247|NCT00770809|19414061|P1|Overall Study|Death|1
5620248|NCT00770809|19414059|P3|Overall Study|Adverse Event|12
5620249|NCT00770809|19414060|P2|Overall Study|Adverse Event|1
5620250|NCT00770809|19414061|P1|Overall Study|Adverse Event|9
5620251|NCT00770770|19414071|P2|Overall Study|Study Terminated|0
5620252|NCT00770770|19414072|P1|Overall Study|Study Terminated|8
5620253|NCT00770770|19414071|P2|Overall Study|Death|1
5620254|NCT00770770|19414072|P1|Overall Study|Death|0
5620255|NCT00770770|19414071|P2|Overall Study|Withdrawal by Subject|0
5620256|NCT00770770|19414072|P1|Overall Study|Withdrawal by Subject|1
5620257|NCT00770770|19414071|P2|Overall Study|Lost to Follow-up|0
5620258|NCT00770770|19414072|P1|Overall Study|Lost to Follow-up|1
5620259|NCT00770692|19414090|P4|Overall Study|Investigator judgment|1
5620260|NCT00770692|19414091|P3|Overall Study|Investigator judgment|1
5620261|NCT00770692|19414092|P2|Overall Study|Investigator judgment|0
5620262|NCT00770692|19414093|P1|Overall Study|Investigator judgment|2
5620263|NCT00770692|19414090|P4|Overall Study|Adverse Event|4
5620264|NCT00770692|19414091|P3|Overall Study|Adverse Event|4
5620265|NCT00770692|19414092|P2|Overall Study|Adverse Event|0
5620266|NCT00770692|19414093|P1|Overall Study|Adverse Event|3
5620267|NCT00770692|19414090|P4|Overall Study|Withdrawal by Subject|6
5620268|NCT00770692|19414091|P3|Overall Study|Withdrawal by Subject|9
5620269|NCT00770692|19414092|P2|Overall Study|Withdrawal by Subject|9
5620270|NCT00770692|19414093|P1|Overall Study|Withdrawal by Subject|7
5620271|NCT00770679|19414119|P1|Overall Study|Follow-up LDL measurement not collected|3
5620272|NCT00770679|19414119|P1|Overall Study|Lost to Follow-up|3
5620273|NCT00770653|19414127|P2|Overall Study|Physician Decision|0
5620274|NCT00770653|19414128|P1|Overall Study|Physician Decision|1
5620275|NCT00770653|19414127|P2|Overall Study|Lost to Follow-up|2
5620276|NCT00770653|19414128|P1|Overall Study|Lost to Follow-up|1
5620277|NCT00770653|19414127|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
5620278|NCT00770653|19414128|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
5620279|NCT00770653|19414127|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
5620280|NCT00770653|19414128|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
5620281|NCT00770653|19414127|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
5620282|NCT00770653|19414128|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
5620283|NCT00770653|19414127|P2|Overall Study|Lack of Compliance|4
5620284|NCT00770653|19414128|P1|Overall Study|Lack of Compliance|1
5620285|NCT00770653|19414127|P2|Overall Study|Withdrawal by Subject|7
5620286|NCT00770653|19414128|P1|Overall Study|Withdrawal by Subject|4
5620287|NCT00770653|19414127|P2|Overall Study|Protocol Violation|6
5620288|NCT00770653|19414128|P1|Overall Study|Protocol Violation|8
5620289|NCT00770653|19414127|P2|Overall Study|Adverse Event|5
5620290|NCT00770653|19414128|P1|Overall Study|Adverse Event|13
5620291|NCT00770588|19414198|P2|Overall Study|Withdrawal by Subject|1
5620292|NCT00770588|19414199|P1|Overall Study|Withdrawal by Subject|1
5620293|NCT00770588|19414198|P2|Overall Study|Lost to Follow-up|1
5620294|NCT00770588|19414199|P1|Overall Study|Lost to Follow-up|1
5620295|NCT00770588|19414198|P2|Overall Study|Death caused by progression of disease|91
5620296|NCT00770588|19414199|P1|Overall Study|Death caused by progression of disease|70
5620297|NCT00770588|19414198|P2|Overall Study|Adverse Event|2
5620298|NCT00770588|19414199|P1|Overall Study|Adverse Event|9
5620299|NCT00770562|19414215|P2|Overall Study|Did not take treatment|1
5620300|NCT00770562|19414216|P1|Overall Study|Did not take treatment|1
5620301|NCT00770510|19414227|P1|Overall Study|Withdrawal by Subject|2
5620302|NCT00770510|19414227|P1|Overall Study|Pregnancy|1
5620303|NCT00770510|19414227|P1|Overall Study|Lost to Follow-up|2
5620304|NCT00770484|19414266|P2|Overall Study|Withdrawal by Subject|0
5620305|NCT00770484|19414267|P1|Overall Study|Withdrawal by Subject|1
5620306|NCT00770432|19414275|P2|Overall Study|Non-compliance|1
5620307|NCT00770432|19414276|P1|Overall Study|Non-compliance|0
5620308|NCT00770432|19414275|P2|Overall Study|Other|6
5620309|NCT00770432|19414276|P1|Overall Study|Other|4
5620310|NCT00770367|19414284|P2|Second Intervention|Lost to Follow-up|0
5620311|NCT00770367|19414285|P1|Second Intervention|Lost to Follow-up|2
5620312|NCT00770367|19414284|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
5620313|NCT00770367|19414285|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
5620314|NCT00770367|19414284|P2|First Intervention|Withdrawal by Subject|2
5620315|NCT00770367|19414285|P1|First Intervention|Withdrawal by Subject|0
5620316|NCT00770341|19414296|P3|Overall Study|Not treated|0
5620317|NCT00770341|19414297|P2|Overall Study|Not treated|0
5620318|NCT00770341|19414298|P1|Overall Study|Not treated|1
5620319|NCT00770341|19414296|P3|Overall Study|Other|0
5620320|NCT00770341|19414297|P2|Overall Study|Other|0
5620321|NCT00770341|19414298|P1|Overall Study|Other|1
5620322|NCT00770341|19414296|P3|Overall Study|Lack of Efficacy|1
5620323|NCT00770341|19414297|P2|Overall Study|Lack of Efficacy|0
5620324|NCT00770341|19414298|P1|Overall Study|Lack of Efficacy|3
5620325|NCT00770341|19414296|P3|Overall Study|Laboratory adverse event|0
5620326|NCT00770341|19414297|P2|Overall Study|Laboratory adverse event|3
5620327|NCT00770341|19414298|P1|Overall Study|Laboratory adverse event|3
5620328|NCT00770341|19414296|P3|Overall Study|Clinical Adverse Event|2
5620329|NCT00770341|19414297|P2|Overall Study|Clinical Adverse Event|1
5620330|NCT00770341|19414298|P1|Overall Study|Clinical Adverse Event|3
5620331|NCT00770341|19414296|P3|Overall Study|Withdrawal by Subject|0
5620332|NCT00770341|19414297|P2|Overall Study|Withdrawal by Subject|1
5620333|NCT00770341|19414298|P1|Overall Study|Withdrawal by Subject|0
5620334|NCT00770341|19414296|P3|Overall Study|Did not meet eligibility criteria|0
5620335|NCT00770341|19414297|P2|Overall Study|Did not meet eligibility criteria|0
5620336|NCT00770341|19414298|P1|Overall Study|Did not meet eligibility criteria|1
5620337|NCT00770328|19414324|P2|Overall Study|Lost to Follow-up|2
5620338|NCT00770328|19414325|P1|Overall Study|Lost to Follow-up|2
5620339|NCT00770328|19414324|P2|Overall Study|Adverse Event|2
5620340|NCT00770328|19414325|P1|Overall Study|Adverse Event|11
5620341|NCT00770315|19414341|P4|Overall Study|Noncompliance with Protocol|9
5620342|NCT00770315|19414342|P3|Overall Study|Noncompliance with Protocol|7
5620343|NCT00770315|19414343|P2|Overall Study|Noncompliance with Protocol|4
5620344|NCT00770315|19414344|P1|Overall Study|Noncompliance with Protocol|7
5620345|NCT00770315|19414341|P4|Overall Study|Withdrawal by Subject|20
5620346|NCT00770315|19414342|P3|Overall Study|Withdrawal by Subject|24
5620347|NCT00770315|19414343|P2|Overall Study|Withdrawal by Subject|17
5620348|NCT00770315|19414344|P1|Overall Study|Withdrawal by Subject|13
5620349|NCT00770315|19414341|P4|Overall Study|Lost to Follow-up|3
5620350|NCT00770315|19414342|P3|Overall Study|Lost to Follow-up|10
5620351|NCT00770315|19414343|P2|Overall Study|Lost to Follow-up|5
5620352|NCT00770315|19414344|P1|Overall Study|Lost to Follow-up|9
5620353|NCT00770315|19414341|P4|Overall Study|Adverse Event|6
5620354|NCT00770315|19414342|P3|Overall Study|Adverse Event|16
5620355|NCT00770315|19414343|P2|Overall Study|Adverse Event|17
5620356|NCT00770315|19414344|P1|Overall Study|Adverse Event|11
5620357|NCT00770289|19414370|P1|Overall Study|Other|6
5620358|NCT00770224|19414379|P2|Step 2: Maintenance|Ineligible|2
5620359|NCT00770224|19414380|P1|Step 2: Maintenance|Ineligible|0
5620360|NCT00770224|19414379|P2|Step 2: Maintenance|Other reason not protocol specified|7
5620361|NCT00770224|19414380|P1|Step 2: Maintenance|Other reason not protocol specified|0
5620362|NCT00770224|19414379|P2|Step 2: Maintenance|Death|2
5620363|NCT00770224|19414380|P1|Step 2: Maintenance|Death|0
5620364|NCT00770224|19414379|P2|Step 2: Maintenance|Progression/relapse|1
5620365|NCT00770224|19414380|P1|Step 2: Maintenance|Progression/relapse|0
5620366|NCT00770224|19414379|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
5620367|NCT00770224|19414380|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
5620368|NCT00770224|19414379|P2|Step 2: Maintenance|Adverse Event|10
5620369|NCT00770224|19414380|P1|Step 2: Maintenance|Adverse Event|0
5620370|NCT00770224|19414379|P2|Step 1: Induction|No protocol treatment given|0
5620371|NCT00770224|19414380|P1|Step 1: Induction|No protocol treatment given|1
5620372|NCT00770224|19414379|P2|Step 1: Induction|Ineligible|0
5620373|NCT00770224|19414380|P1|Step 1: Induction|Ineligible|2
5620374|NCT00770224|19414379|P2|Step 1: Induction|Other reason not protocol specified|0
5620375|NCT00770224|19414380|P1|Step 1: Induction|Other reason not protocol specified|2
5620376|NCT00770224|19414379|P2|Step 1: Induction|Refusal unrelated to adverse event|0
5620377|NCT00770224|19414380|P1|Step 1: Induction|Refusal unrelated to adverse event|6
5620378|NCT00770224|19414379|P2|Step 1: Induction|Adverse Event|0
5620379|NCT00770224|19414380|P1|Step 1: Induction|Adverse Event|3
5620380|NCT00770211|19414392|P2|Overall Study|Withdrawal by Subject|2
5620381|NCT00770211|19414393|P1|Overall Study|Withdrawal by Subject|0
5620382|NCT00770211|19414392|P2|Overall Study|Lost to Follow-up|0
5620383|NCT00770211|19414393|P1|Overall Study|Lost to Follow-up|1
5620384|NCT00770146|19414409|P2|Follow-up Period|Other|5
5620385|NCT00770146|19414410|P1|Follow-up Period|Other|4
5620386|NCT00770146|19414409|P2|Follow-up Period|Adverse Event|2
5620387|NCT00770146|19414410|P1|Follow-up Period|Adverse Event|0
5620388|NCT00770146|19414409|P2|Follow-up Period|Withdrawal by Subject|13
5620389|NCT00770146|19414410|P1|Follow-up Period|Withdrawal by Subject|7
5620390|NCT00770146|19414409|P2|Treatment Period|Protocol non-compliance|1
5620391|NCT00770146|19414410|P1|Treatment Period|Protocol non-compliance|0
5620392|NCT00770146|19414409|P2|Treatment Period|Other|5
5620393|NCT00770146|19414410|P1|Treatment Period|Other|1
5620394|NCT00770146|19414409|P2|Treatment Period|Adverse Event|26
5620395|NCT00770146|19414410|P1|Treatment Period|Adverse Event|2
5620396|NCT00770146|19414409|P2|Treatment Period|Withdrawal by Subject|13
5620397|NCT00770146|19414410|P1|Treatment Period|Withdrawal by Subject|6
5620398|NCT00770120|19414499|P1|Overall Study|Reason under Review|1
5620399|NCT00770120|19414499|P1|Overall Study|Never Received Treatment/Not Analyzable|1
5620400|NCT00770120|19414499|P1|Overall Study|Ineligible|1
5620401|NCT00770120|19414499|P1|Overall Study|Withdrawal by Subject|2
5620402|NCT00770120|19414499|P1|Overall Study|Death|3
5620403|NCT00770120|19414499|P1|Overall Study|Not Protocol Specified|11
5620404|NCT00770120|19414499|P1|Overall Study|Adverse Event|11
5620405|NCT00770120|19414499|P1|Overall Study|Progression|31
5620406|NCT00770029|19414508|P2|Overall Study|Adverse Event|0
5620407|NCT00770029|19414509|P1|Overall Study|Adverse Event|1
5620408|NCT00770029|19414508|P2|Overall Study|Withdrawal by Subject|3
5620409|NCT00770029|19414509|P1|Overall Study|Withdrawal by Subject|3
5620410|NCT00770029|19414508|P2|Overall Study|Lost to Follow-up|0
5620411|NCT00770029|19414509|P1|Overall Study|Lost to Follow-up|2
5620412|NCT00769860|19414570|P2|Overall Study|Withdrawal by Subject|0
5620413|NCT00769860|19414571|P1|Overall Study|Withdrawal by Subject|2
5620414|NCT00769704|19414609|P2|Overall Study|Other|2
5620415|NCT00769704|19414610|P1|Overall Study|Other|1
5620416|NCT00769704|19414609|P2|Overall Study|Withdrawal by Subject|5
5620417|NCT00769704|19414610|P1|Overall Study|Withdrawal by Subject|12
5620418|NCT00769704|19414609|P2|Overall Study|Death|190
5620419|NCT00769704|19414610|P1|Overall Study|Death|95
5620420|NCT00769704|19414609|P2|Overall Study|Lost to Follow-up|2
5620421|NCT00769704|19414610|P1|Overall Study|Lost to Follow-up|3
5620422|NCT00769561|19414660|P2|Overall Study|Lost to Follow-up|3
5620423|NCT00769561|19414661|P1|Overall Study|Lost to Follow-up|1
5620424|NCT00769561|19414660|P2|Overall Study|Withdrawal by Subject|2
5620425|NCT00769561|19414661|P1|Overall Study|Withdrawal by Subject|2
5620426|NCT00769483|19414687|P6|Overall Study|Withdrawal by Subject|0
5620427|NCT00769483|19414688|P5|Overall Study|Withdrawal by Subject|1
5620428|NCT00769483|19414689|P4|Overall Study|Withdrawal by Subject|0
5620429|NCT00769483|19414690|P3|Overall Study|Withdrawal by Subject|0
5620430|NCT00769483|19414691|P2|Overall Study|Withdrawal by Subject|1
5620431|NCT00769483|19414692|P1|Overall Study|Withdrawal by Subject|0
5620432|NCT00769184|19414764|P2|No Treatment (6 Weeks)|Adverse Event|1
5620433|NCT00769184|19414765|P1|No Treatment (6 Weeks)|Adverse Event|1
5620434|NCT00769184|19414764|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
5620435|NCT00769184|19414765|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
5620436|NCT00769184|19414764|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
5620437|NCT00769184|19414765|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
5620438|NCT00769132|19414773|P4|Period 4|Withdrawal by Subject|0
5620439|NCT00769132|19414774|P3|Period 4|Withdrawal by Subject|0
5620440|NCT00769132|19414775|P2|Period 4|Withdrawal by Subject|1
5620441|NCT00769132|19414776|P1|Period 4|Withdrawal by Subject|0
5620442|NCT00769132|19414773|P4|Period 3|Withdrawal by Subject|0
5620443|NCT00769132|19414774|P3|Period 3|Withdrawal by Subject|0
5620444|NCT00769132|19414775|P2|Period 3|Withdrawal by Subject|0
5620445|NCT00769132|19414776|P1|Period 3|Withdrawal by Subject|1
5620446|NCT00769132|19414773|P4|Period 2|Withdrawal by Subject|1
5620447|NCT00769132|19414774|P3|Period 2|Withdrawal by Subject|0
5620448|NCT00769132|19414775|P2|Period 2|Withdrawal by Subject|0
5620449|NCT00769132|19414776|P1|Period 2|Withdrawal by Subject|0
5620450|NCT00769132|19414773|P4|Period 1|Adverse Event|1
5620451|NCT00769132|19414774|P3|Period 1|Adverse Event|0
5620452|NCT00769132|19414775|P2|Period 1|Adverse Event|0
5620453|NCT00769132|19414776|P1|Period 1|Adverse Event|1
5620454|NCT00769119|19414792|P2|Overall Study|Disallowed medication|0
5620455|NCT00769119|19414793|P1|Overall Study|Disallowed medication|1
5620456|NCT00769119|19414792|P2|Overall Study|Adverse Event|1
5620457|NCT00769119|19414793|P1|Overall Study|Adverse Event|1
5620458|NCT00769119|19414792|P2|Overall Study|Voluntary discontinuation|2
5620459|NCT00769119|19414793|P1|Overall Study|Voluntary discontinuation|0
5620460|NCT00769067|19414839|P2|Overall Study|Withdrawal by Subject|1
5620461|NCT00769067|19414840|P1|Overall Study|Withdrawal by Subject|0
5620462|NCT00769067|19414839|P2|Overall Study|Other|3
5620463|NCT00769067|19414840|P1|Overall Study|Other|1
5620464|NCT00769067|19414839|P2|Overall Study|Study terminated by sponsor|3
5620465|NCT00769067|19414840|P1|Overall Study|Study terminated by sponsor|1
5620466|NCT00769067|19414839|P2|Overall Study|Lost to Follow-up|1
5620467|NCT00769067|19414840|P1|Overall Study|Lost to Follow-up|3
5620468|NCT00769067|19414839|P2|Overall Study|Death|86
5620469|NCT00769067|19414840|P1|Overall Study|Death|89
5620470|NCT00769002|19414890|P2|Overall Study|Study was not completed, no data|9
5620471|NCT00769002|19414891|P1|Overall Study|Study was not completed, no data|9
5620472|NCT00768989|19414898|P2|On or After Week 36|Sponsor Termination|26
5620473|NCT00768989|19414899|P1|On or After Week 36|Sponsor Termination|45
5620474|NCT00768989|19414898|P2|On or After Week 36|Did not attend termination visit|0
5620475|NCT00768989|19414899|P1|On or After Week 36|Did not attend termination visit|2
5620476|NCT00768989|19414898|P2|On or After Week 36|Protocol Violation|0
5620477|NCT00768989|19414899|P1|On or After Week 36|Protocol Violation|1
5620478|NCT00768989|19414898|P2|On or After Week 36|Poor Compliance|0
5620479|NCT00768989|19414899|P1|On or After Week 36|Poor Compliance|1
5620480|NCT00768989|19414898|P2|On or After Week 36|Lost to Follow-up|0
5620481|NCT00768989|19414899|P1|On or After Week 36|Lost to Follow-up|1
5620482|NCT00768989|19414898|P2|On or After Week 36|Adverse Event|1
5620483|NCT00768989|19414899|P1|On or After Week 36|Adverse Event|0
5620484|NCT00768989|19414898|P2|On or After Week 36|Lack of Efficacy|0
5620485|NCT00768989|19414899|P1|On or After Week 36|Lack of Efficacy|1
5620486|NCT00768989|19414898|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
5620487|NCT00768989|19414899|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
5620488|NCT00768989|19414898|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
5620489|NCT00768989|19414899|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
5620490|NCT00768989|19414898|P2|Week 24 to Prior to Week 36|Adverse Event|0
5620491|NCT00768989|19414899|P1|Week 24 to Prior to Week 36|Adverse Event|1
5620492|NCT00768989|19414898|P2|Prior to Week 24|Protocol Violation|2
5620493|NCT00768989|19414899|P1|Prior to Week 24|Protocol Violation|0
5620494|NCT00768989|19414898|P2|Prior to Week 24|Lost to Follow-up|1
5620495|NCT00768989|19414899|P1|Prior to Week 24|Lost to Follow-up|0
5620496|NCT00768989|19414898|P2|Prior to Week 24|Adverse Event|0
5620497|NCT00768989|19414899|P1|Prior to Week 24|Adverse Event|3
5620498|NCT00768989|19414898|P2|Prior to Week 24|Withdrawal by Subject|0
5620499|NCT00768989|19414899|P1|Prior to Week 24|Withdrawal by Subject|1
5620500|NCT00768898|19414947|P1|Overall Study|Headache|1
5620501|NCT00768898|19414947|P1|Overall Study|Unrelated injury|1
5620502|NCT00768755|19414971|P4|Phase 2|Randomized but not treated|2
5620503|NCT00768755|19414972|P3|Phase 2|Randomized but not treated|0
5620504|NCT00768755|19414973|P2|Phase 2|Randomized but not treated|0
5620505|NCT00768755|19414974|P1|Phase 2|Randomized but not treated|0
5620506|NCT00768755|19414971|P4|Phase 2|Study Terminated by Sponsor|14
5620507|NCT00768755|19414972|P3|Phase 2|Study Terminated by Sponsor|7
5620508|NCT00768755|19414973|P2|Phase 2|Study Terminated by Sponsor|13
5620509|NCT00768755|19414974|P1|Phase 2|Study Terminated by Sponsor|0
5620510|NCT00768755|19414971|P4|Phase 2|Other|4
5620511|NCT00768755|19414972|P3|Phase 2|Other|2
5620512|NCT00768755|19414973|P2|Phase 2|Other|1
5620513|NCT00768755|19414974|P1|Phase 2|Other|0
5620514|NCT00768755|19414971|P4|Phase 2|Withdrawal by Subject|1
5620515|NCT00768755|19414972|P3|Phase 2|Withdrawal by Subject|0
5620516|NCT00768755|19414973|P2|Phase 2|Withdrawal by Subject|1
5620517|NCT00768755|19414974|P1|Phase 2|Withdrawal by Subject|0
5620518|NCT00768755|19414971|P4|Phase 2|Lost to Follow-up|4
5620519|NCT00768755|19414972|P3|Phase 2|Lost to Follow-up|1
5620520|NCT00768755|19414973|P2|Phase 2|Lost to Follow-up|1
5620521|NCT00768755|19414974|P1|Phase 2|Lost to Follow-up|0
5620522|NCT00768755|19414971|P4|Phase 2|Protocol Violation|1
5620523|NCT00768755|19414972|P3|Phase 2|Protocol Violation|0
5620524|NCT00768755|19414973|P2|Phase 2|Protocol Violation|2
5620525|NCT00768755|19414974|P1|Phase 2|Protocol Violation|0
5620526|NCT00768755|19414971|P4|Phase 2|Death|31
5620527|NCT00768755|19414972|P3|Phase 2|Death|48
5620528|NCT00768755|19414973|P2|Phase 2|Death|37
5620529|NCT00768755|19414974|P1|Phase 2|Death|0
5620530|NCT00768755|19414971|P4|Phase 1|Other|0
5620531|NCT00768755|19414972|P3|Phase 1|Other|0
5620532|NCT00768755|19414973|P2|Phase 1|Other|0
5620533|NCT00768755|19414974|P1|Phase 1|Other|4
5620534|NCT00768755|19414971|P4|Phase 1|Death|0
5620535|NCT00768755|19414972|P3|Phase 1|Death|0
5620536|NCT00768755|19414973|P2|Phase 1|Death|0
5620537|NCT00768755|19414974|P1|Phase 1|Death|6
5620538|NCT00768651|19415022|P1|Overall Study|Withdrawal by Subject|1
5620539|NCT00768560|19415061|P6|Intervention Set 1|Adverse Event|0
5620540|NCT00768560|19415062|P5|Intervention Set 1|Adverse Event|0
5620541|NCT00768560|19415063|P4|Intervention Set 1|Adverse Event|0
5620542|NCT00768560|19415064|P3|Intervention Set 1|Adverse Event|0
5620543|NCT00768560|19415065|P2|Intervention Set 1|Adverse Event|1
5620544|NCT00768560|19415066|P1|Intervention Set 1|Adverse Event|0
5620545|NCT00768469|19415103|P2|Overall Study|Withdrawal by Subject|1
5620546|NCT00768469|19415104|P1|Overall Study|Withdrawal by Subject|0
5620547|NCT00768469|19415103|P2|Overall Study|Disease Progression|4
5620548|NCT00768469|19415104|P1|Overall Study|Disease Progression|3
5620549|NCT00768469|19415103|P2|Overall Study|Adverse Event|2
5620550|NCT00768469|19415104|P1|Overall Study|Adverse Event|0
5620551|NCT00768430|19415119|P2|7 Day Endpoint|Withdrawal by Subject|3
5620552|NCT00768430|19415120|P1|7 Day Endpoint|Withdrawal by Subject|2
5620553|NCT00768300|19415128|P2|Overall Study|Missing data|0
5620554|NCT00768300|19415129|P1|Overall Study|Missing data|1
5620555|NCT00768300|19415128|P2|Overall Study|Treated but never dosed with Study drug|0
5620556|NCT00768300|19415129|P1|Overall Study|Treated but never dosed with Study drug|1
5620557|NCT00768300|19415128|P2|Overall Study|Began prohibited concomitant medication|1
5620558|NCT00768300|19415129|P1|Overall Study|Began prohibited concomitant medication|0
5620559|NCT00768300|19415128|P2|Overall Study|Lost to Follow-up|1
5620560|NCT00768300|19415129|P1|Overall Study|Lost to Follow-up|0
5620561|NCT00768300|19415128|P2|Overall Study|Received lung transplant|1
5620562|NCT00768300|19415129|P1|Overall Study|Received lung transplant|1
5620563|NCT00768300|19415128|P2|Overall Study|Screen failure following randomization|0
5620564|NCT00768300|19415129|P1|Overall Study|Screen failure following randomization|1
5620565|NCT00768300|19415128|P2|Overall Study|Subject moved to pursue lung transplant|1
5620566|NCT00768300|19415129|P1|Overall Study|Subject moved to pursue lung transplant|1
5620567|NCT00768300|19415128|P2|Overall Study|Death|5
5620568|NCT00768300|19415129|P1|Overall Study|Death|21
5620569|NCT00768300|19415128|P2|Overall Study|Study discontinued by Sponsor|140
5620570|NCT00768300|19415129|P1|Overall Study|Study discontinued by Sponsor|271
5620571|NCT00768300|19415128|P2|Overall Study|Physician Decision|3
5620572|NCT00768300|19415129|P1|Overall Study|Physician Decision|2
5620573|NCT00768300|19415128|P2|Overall Study|Withdrawal by Subject|7
5620574|NCT00768300|19415129|P1|Overall Study|Withdrawal by Subject|13
5620575|NCT00768300|19415128|P2|Overall Study|Protocol Violation|1
5620576|NCT00768300|19415129|P1|Overall Study|Protocol Violation|6
5620577|NCT00768300|19415128|P2|Overall Study|Adverse Event|2
5620578|NCT00768300|19415129|P1|Overall Study|Adverse Event|10
5620579|NCT00768300|19415128|P2|Overall Study|Randomized but not treated|1
5620580|NCT00768300|19415129|P1|Overall Study|Randomized but not treated|1
5620581|NCT00768248|19415213|P2|Overall Study|Research coordinator didn't collect data|1
5620582|NCT00768248|19415214|P1|Overall Study|Research coordinator didn't collect data|1
5620583|NCT00768222|19415230|P2|Overall Study|Protocol Violation|2
5620584|NCT00768222|19415231|P1|Overall Study|Protocol Violation|0
5620585|NCT00768222|19415230|P2|Overall Study|Withdrawal by Subject|1
5620586|NCT00768222|19415231|P1|Overall Study|Withdrawal by Subject|3
5620587|NCT00768222|19415230|P2|Overall Study|Lost to Follow-up|1
5620588|NCT00768222|19415231|P1|Overall Study|Lost to Follow-up|1
5620589|NCT00768144|19415253|P1|Overall Study|Pt Withdrew Consent|1
5620590|NCT00768144|19415253|P1|Overall Study|Patient or MD Decision to End Treatment|1
5620591|NCT00768144|19415253|P1|Overall Study|Progressive Disease|21
5620592|NCT00768144|19415253|P1|Overall Study|Adverse Event|13
5620593|NCT00768079|19415266|P3|Overall Study|Participant incarcerated|0
5620594|NCT00768079|19415267|P2|Overall Study|Participant incarcerated|1
5620595|NCT00768079|19415268|P1|Overall Study|Participant incarcerated|0
5620596|NCT00768079|19415266|P3|Overall Study|Lost to Follow-up|4
5620597|NCT00768079|19415267|P2|Overall Study|Lost to Follow-up|0
5620598|NCT00768079|19415268|P1|Overall Study|Lost to Follow-up|2
5620599|NCT00768066|19415325|P3|Overall Study|Did not receive study product injection.|0
5620600|NCT00768066|19415326|P2|Overall Study|Did not receive study product injection.|3
5620601|NCT00768066|19415327|P1|Overall Study|Did not receive study product injection.|3
5620602|NCT00768053|19415359|P1|Overall Study|Lost to Follow-up|1
5620603|NCT00768053|19415359|P1|Overall Study|Adverse Event|10
5620604|NCT00768040|19415390|P2|Overall Study|Abnormal laboratory value|1
5620605|NCT00768040|19415391|P1|Overall Study|Abnormal laboratory value|1
5620606|NCT00768040|19415390|P2|Overall Study|Adverse Event|2
5620607|NCT00768040|19415391|P1|Overall Study|Adverse Event|3
5620608|NCT00767819|19415400|P3|Overall Study|Lost to Follow-up|0
5620609|NCT00767819|19415401|P2|Overall Study|Lost to Follow-up|0
5620610|NCT00767819|19415402|P1|Overall Study|Lost to Follow-up|1
5620611|NCT00767819|19415400|P3|Overall Study|Abnormal lab values|0
5620612|NCT00767819|19415401|P2|Overall Study|Abnormal lab values|0
5620613|NCT00767819|19415402|P1|Overall Study|Abnormal lab values|1
5620614|NCT00767819|19415400|P3|Overall Study|Adverse Event|0
5620615|NCT00767819|19415401|P2|Overall Study|Adverse Event|0
5620616|NCT00767819|19415402|P1|Overall Study|Adverse Event|2
5620617|NCT00767819|19415400|P3|Overall Study|Death|0
5620618|NCT00767819|19415401|P2|Overall Study|Death|3
5620619|NCT00767819|19415402|P1|Overall Study|Death|2
5620620|NCT00767819|19415400|P3|Overall Study|Administrative problems|0
5620621|NCT00767819|19415401|P2|Overall Study|Administrative problems|1
5620622|NCT00767819|19415402|P1|Overall Study|Administrative problems|0
5620623|NCT00767819|19415400|P3|Overall Study|Withdrawal by Subject|0
5620624|NCT00767819|19415401|P2|Overall Study|Withdrawal by Subject|1
5620625|NCT00767819|19415402|P1|Overall Study|Withdrawal by Subject|1
5620626|NCT00767819|19415400|P3|Overall Study|Unsatisfactory therapeutic effect|0
5620627|NCT00767819|19415401|P2|Overall Study|Unsatisfactory therapeutic effect|14
5620628|NCT00767819|19415402|P1|Overall Study|Unsatisfactory therapeutic effect|18
5620629|NCT00767806|19415427|P2|Overall Study|Sponsor Decision|1
5620630|NCT00767806|19415428|P1|Overall Study|Sponsor Decision|0
5620631|NCT00767806|19415427|P2|Overall Study|Entry Criteria Not Met|1
5620632|NCT00767806|19415428|P1|Overall Study|Entry Criteria Not Met|1
5620633|NCT00767806|19415427|P2|Overall Study|Lost to Follow-up|4
5620634|NCT00767806|19415428|P1|Overall Study|Lost to Follow-up|1
5620635|NCT00767806|19415427|P2|Overall Study|Physician Decision|3
5620636|NCT00767806|19415428|P1|Overall Study|Physician Decision|4
5620637|NCT00767806|19415427|P2|Overall Study|Lack of Efficacy|9
5620638|NCT00767806|19415428|P1|Overall Study|Lack of Efficacy|1
5620639|NCT00767806|19415427|P2|Overall Study|Protocol Violation|5
5620640|NCT00767806|19415428|P1|Overall Study|Protocol Violation|6
5620641|NCT00767806|19415427|P2|Overall Study|Withdrawal by Subject|13
5620642|NCT00767806|19415428|P1|Overall Study|Withdrawal by Subject|8
5620643|NCT00767806|19415427|P2|Overall Study|Adverse Event|11
5620644|NCT00767806|19415428|P1|Overall Study|Adverse Event|30
5620645|NCT00767676|19415505|P1|Overall Study|Investigator error|54
5620646|NCT00767520|19415528|P2|Overall Study|Randomized in error and Never treated|2
5620647|NCT00767520|19415529|P1|Overall Study|Randomized in error and Never treated|0
5620648|NCT00767520|19415528|P2|Overall Study|Participants still on treatment|15
5620649|NCT00767520|19415529|P1|Overall Study|Participants still on treatment|11
5620650|NCT00767455|19415582|P1|Overall Study|Investigator error|19
5620651|NCT00767325|19415616|P1|Overall Study|Missed visit due to family reasons|1
5620652|NCT00767325|19415616|P1|Overall Study|No longer met study criteria|2
5620653|NCT00767325|19415616|P1|Overall Study|Lost to Follow-up|3
5620654|NCT00767325|19415616|P1|Overall Study|Adverse Event|7
5620655|NCT00767325|19415616|P1|Overall Study|Lack of Efficacy|2
5620656|NCT00767104|19415627|P2|Overall Study|Lost to Follow-up|2
5620657|NCT00767104|19415628|P1|Overall Study|Lost to Follow-up|1
5620658|NCT00767039|19415638|P2|Overall Study|Death|2
5620659|NCT00767039|19415639|P1|Overall Study|Death|5
5620660|NCT00767000|19415670|P5|Optional 104-week Extension|Study terminated by sponsor|4
5620661|NCT00767000|19415671|P4|Optional 104-week Extension|Study terminated by sponsor|2
5620662|NCT00767000|19415672|P3|Optional 104-week Extension|Study terminated by sponsor|7
5620663|NCT00767000|19415673|P2|Optional 104-week Extension|Study terminated by sponsor|3
5620664|NCT00767000|19415674|P1|Optional 104-week Extension|Study terminated by sponsor|7
5620665|NCT00767000|19415670|P5|54-week Study|Reason not reported|0
5620666|NCT00767000|19415671|P4|54-week Study|Reason not reported|1
5620667|NCT00767000|19415672|P3|54-week Study|Reason not reported|0
5620668|NCT00767000|19415673|P2|54-week Study|Reason not reported|0
5620669|NCT00767000|19415674|P1|54-week Study|Reason not reported|0
5620670|NCT00767000|19415670|P5|54-week Study|Study terminated by sponsor|194
5620671|NCT00767000|19415671|P4|54-week Study|Study terminated by sponsor|196
5620672|NCT00767000|19415672|P3|54-week Study|Study terminated by sponsor|89
5620673|NCT00767000|19415673|P2|54-week Study|Study terminated by sponsor|102
5620674|NCT00767000|19415674|P1|54-week Study|Study terminated by sponsor|90
5620675|NCT00767000|19415670|P5|54-week Study|Withdrawal by Subject|13
5620676|NCT00767000|19415671|P4|54-week Study|Withdrawal by Subject|11
5620677|NCT00767000|19415672|P3|54-week Study|Withdrawal by Subject|5
5620678|NCT00767000|19415673|P2|54-week Study|Withdrawal by Subject|3
5620679|NCT00767000|19415674|P1|54-week Study|Withdrawal by Subject|2
5620680|NCT00767000|19415670|P5|54-week Study|Protocol Violation|0
5620681|NCT00767000|19415671|P4|54-week Study|Protocol Violation|2
5620682|NCT00767000|19415672|P3|54-week Study|Protocol Violation|1
5620683|NCT00767000|19415673|P2|54-week Study|Protocol Violation|0
5620684|NCT00767000|19415674|P1|54-week Study|Protocol Violation|0
5620685|NCT00767000|19415670|P5|54-week Study|Progressive disease|0
5620686|NCT00767000|19415671|P4|54-week Study|Progressive disease|0
5620687|NCT00767000|19415672|P3|54-week Study|Progressive disease|1
5620688|NCT00767000|19415673|P2|54-week Study|Progressive disease|0
5620689|NCT00767000|19415674|P1|54-week Study|Progressive disease|0
5620690|NCT00767000|19415670|P5|54-week Study|Physician Decision|1
5620691|NCT00767000|19415671|P4|54-week Study|Physician Decision|1
5620692|NCT00767000|19415672|P3|54-week Study|Physician Decision|1
5620693|NCT00767000|19415673|P2|54-week Study|Physician Decision|0
5620694|NCT00767000|19415674|P1|54-week Study|Physician Decision|4
5620695|NCT00767000|19415670|P5|54-week Study|Lost to Follow-up|2
5620696|NCT00767000|19415671|P4|54-week Study|Lost to Follow-up|4
5620697|NCT00767000|19415672|P3|54-week Study|Lost to Follow-up|1
5620698|NCT00767000|19415673|P2|54-week Study|Lost to Follow-up|0
5620699|NCT00767000|19415674|P1|54-week Study|Lost to Follow-up|4
5620700|NCT00767000|19415670|P5|54-week Study|Lack of Efficacy|5
5620701|NCT00767000|19415671|P4|54-week Study|Lack of Efficacy|0
5620702|NCT00767000|19415672|P3|54-week Study|Lack of Efficacy|1
5620703|NCT00767000|19415673|P2|54-week Study|Lack of Efficacy|0
5620704|NCT00767000|19415674|P1|54-week Study|Lack of Efficacy|2
5620705|NCT00767000|19415670|P5|54-week Study|Interruption of study medication|0
5620706|NCT00767000|19415671|P4|54-week Study|Interruption of study medication|0
5620707|NCT00767000|19415672|P3|54-week Study|Interruption of study medication|1
5620708|NCT00767000|19415673|P2|54-week Study|Interruption of study medication|0
5620709|NCT00767000|19415674|P1|54-week Study|Interruption of study medication|0
5620710|NCT00767000|19415670|P5|54-week Study|Hypoglycemia|0
5620711|NCT00767000|19415671|P4|54-week Study|Hypoglycemia|0
5620712|NCT00767000|19415672|P3|54-week Study|Hypoglycemia|0
5620713|NCT00767000|19415673|P2|54-week Study|Hypoglycemia|1
5620714|NCT00767000|19415674|P1|54-week Study|Hypoglycemia|0
5620715|NCT00767000|19415670|P5|54-week Study|Hyperglycemia|1
5620716|NCT00767000|19415671|P4|54-week Study|Hyperglycemia|0
5620717|NCT00767000|19415672|P3|54-week Study|Hyperglycemia|1
5620718|NCT00767000|19415673|P2|54-week Study|Hyperglycemia|0
5620719|NCT00767000|19415674|P1|54-week Study|Hyperglycemia|0
5620720|NCT00767000|19415670|P5|54-week Study|Creaninine/creatinine clearance|4
5620721|NCT00767000|19415671|P4|54-week Study|Creaninine/creatinine clearance|2
5620722|NCT00767000|19415672|P3|54-week Study|Creaninine/creatinine clearance|2
5620723|NCT00767000|19415673|P2|54-week Study|Creaninine/creatinine clearance|1
5620724|NCT00767000|19415674|P1|54-week Study|Creaninine/creatinine clearance|2
5620725|NCT00767000|19415670|P5|54-week Study|Adverse Event|4
5620726|NCT00767000|19415671|P4|54-week Study|Adverse Event|8
5620727|NCT00767000|19415672|P3|54-week Study|Adverse Event|6
5620728|NCT00767000|19415673|P2|54-week Study|Adverse Event|6
5620729|NCT00767000|19415674|P1|54-week Study|Adverse Event|4
5620730|NCT00766831|19415716|P1|Overall Study|Other|28
5620731|NCT00766831|19415716|P1|Overall Study|Non cooperation by participants|14
5620732|NCT00766831|19415716|P1|Overall Study|Withdrawal of consent|26
5620733|NCT00766831|19415716|P1|Overall Study|Physician Decision|5
5620734|NCT00766831|19415716|P1|Overall Study|Protocol Violation|15
5620735|NCT00766831|19415716|P1|Overall Study|Adverse Event|20
5620736|NCT00766831|19415716|P1|Overall Study|Lost to Follow-up|3
5620737|NCT00766831|19415716|P1|Overall Study|Withdrawal by Subject|4
5620738|NCT00766675|19415752|P1|Overall Study|Insufficient therapy|1
5620739|NCT00766675|19415752|P1|Overall Study|Receive other anti-neoplastic treatment|1
5620740|NCT00766675|19415752|P1|Overall Study|Participant took prohibited medication|1
5620741|NCT00766675|19415752|P1|Overall Study|Protocol Violation|8
5620742|NCT00766675|19415752|P1|Overall Study|Withdrawal by Subject|11
5620743|NCT00766675|19415752|P1|Overall Study|Lost to Follow-up|2
5620744|NCT00766675|19415752|P1|Overall Study|Adverse Event|16
5620745|NCT00766636|19415781|P2|Overall Study|Disease Progression|0
5620746|NCT00766636|19415782|P1|Overall Study|Disease Progression|1
5620747|NCT00766636|19415781|P2|Overall Study|Adverse Event|0
5620748|NCT00766636|19415782|P1|Overall Study|Adverse Event|1
5620749|NCT00766636|19415781|P2|Overall Study|Incomplete Treatment|1
5620750|NCT00766636|19415782|P1|Overall Study|Incomplete Treatment|0
5620751|NCT00766636|19415781|P2|Overall Study|Withdrawal by Subject|1
5620752|NCT00766636|19415782|P1|Overall Study|Withdrawal by Subject|1
5620753|NCT00766597|19415788|P1|Overall Study|Without CCR5-tropic virus|5
5620754|NCT00766597|19415788|P1|Overall Study|Unexpected closure of study|4
5620755|NCT00766532|19415800|P1|Overall Study|Protocol Violation|2
5620756|NCT00766506|19415806|P2|Overall Study|Other|2
5620757|NCT00766506|19415807|P1|Overall Study|Other|2
5620758|NCT00766506|19415806|P2|Overall Study|Use rescue medication after 3 hours|0
5620759|NCT00766506|19415807|P1|Overall Study|Use rescue medication after 3 hours|3
5620760|NCT00766493|19415831|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
5620761|NCT00766493|19415831|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
5620762|NCT00766493|19415831|P1|30 Days Post-Procedure|Discontinued|7
5620763|NCT00766467|19415841|P2|Overall Study|Physician Decision|0
5620764|NCT00766467|19415842|P1|Overall Study|Physician Decision|1
5620765|NCT00766467|19415841|P2|Overall Study|Tumor Progression on Study|1
5620766|NCT00766467|19415842|P1|Overall Study|Tumor Progression on Study|0
5620767|NCT00766467|19415841|P2|Overall Study|Protocol Violation|4
5620768|NCT00766467|19415842|P1|Overall Study|Protocol Violation|2
5620769|NCT00766467|19415841|P2|Overall Study|Adverse Event|1
5620770|NCT00766467|19415842|P1|Overall Study|Adverse Event|1
5620771|NCT00766467|19415841|P2|Overall Study|Withdrawal by Subject|2
5620772|NCT00766467|19415842|P1|Overall Study|Withdrawal by Subject|7
5620773|NCT00766415|19415854|P2|Overall Study|Withdrawal by Subject|1
5620774|NCT00766415|19415855|P1|Overall Study|Withdrawal by Subject|0
5620775|NCT00766376|19415903|P1|Overall Study|Withdrawal by Subject|27
5620776|NCT00766363|19415912|P4|Overall Study|Adverse Event Prior to Randomization|0
5620777|NCT00766363|19415913|P3|Overall Study|Adverse Event Prior to Randomization|0
5620778|NCT00766363|19415914|P2|Overall Study|Adverse Event Prior to Randomization|1
5620779|NCT00766363|19415915|P1|Overall Study|Adverse Event Prior to Randomization|0
5620780|NCT00766363|19415912|P4|Overall Study|Withdrawal by Subject|0
5620781|NCT00766363|19415913|P3|Overall Study|Withdrawal by Subject|0
5620782|NCT00766363|19415914|P2|Overall Study|Withdrawal by Subject|0
5620783|NCT00766363|19415915|P1|Overall Study|Withdrawal by Subject|1
5620784|NCT00766090|19415961|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620785|NCT00766090|19415962|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620786|NCT00766090|19415963|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620787|NCT00766090|19415964|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620788|NCT00766090|19415965|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620789|NCT00766090|19415966|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620790|NCT00766090|19415967|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620791|NCT00766090|19415968|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
5620792|NCT00766090|19415969|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620793|NCT00766090|19415970|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620794|NCT00766090|19415971|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620795|NCT00766090|19415972|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
5620796|NCT00766090|19415961|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
5620797|NCT00766090|19415962|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5620798|NCT00766090|19415963|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5620799|NCT00766090|19415964|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5620800|NCT00766090|19415965|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5620801|NCT00766090|19415966|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5620802|NCT00766090|19415967|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5620803|NCT00766090|19415968|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5620804|NCT00766090|19415969|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
5620805|NCT00766090|19415970|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5620806|NCT00766090|19415971|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
5620807|NCT00766090|19415972|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
5620808|NCT00766090|19415961|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
5620809|NCT00766090|19415962|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
5620810|NCT00766090|19415963|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
5620811|NCT00766090|19415964|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
5620812|NCT00766090|19415965|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
5620813|NCT00766090|19415966|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
5620814|NCT00766090|19415967|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
5620815|NCT00766090|19415968|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
5620816|NCT00766090|19415969|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
5620817|NCT00766090|19415970|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
5620818|NCT00766090|19415971|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
5620819|NCT00766090|19415972|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
5620820|NCT00766090|19415961|P12|Washout Period 2 (14 Days)|Physician Decision|0
5620821|NCT00766090|19415962|P11|Washout Period 2 (14 Days)|Physician Decision|0
5620822|NCT00766090|19415963|P10|Washout Period 2 (14 Days)|Physician Decision|0
5620823|NCT00766090|19415964|P9|Washout Period 2 (14 Days)|Physician Decision|0
5620824|NCT00766090|19415965|P8|Washout Period 2 (14 Days)|Physician Decision|0
5620825|NCT00766090|19415966|P7|Washout Period 2 (14 Days)|Physician Decision|0
5620826|NCT00766090|19415967|P6|Washout Period 2 (14 Days)|Physician Decision|0
5620827|NCT00766090|19415968|P5|Washout Period 2 (14 Days)|Physician Decision|0
5620828|NCT00766090|19415969|P4|Washout Period 2 (14 Days)|Physician Decision|0
5620829|NCT00766090|19415970|P3|Washout Period 2 (14 Days)|Physician Decision|1
5620830|NCT00766090|19415971|P2|Washout Period 2 (14 Days)|Physician Decision|0
5620831|NCT00766090|19415972|P1|Washout Period 2 (14 Days)|Physician Decision|0
5620832|NCT00766090|19415961|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620833|NCT00766090|19415962|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620834|NCT00766090|19415963|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620835|NCT00766090|19415964|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620836|NCT00766090|19415965|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620837|NCT00766090|19415966|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620838|NCT00766090|19415967|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620839|NCT00766090|19415968|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620840|NCT00766090|19415969|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620841|NCT00766090|19415970|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
5620842|NCT00766090|19415971|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620843|NCT00766090|19415972|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
5620844|NCT00766090|19415961|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620845|NCT00766090|19415962|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620846|NCT00766090|19415963|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620847|NCT00766090|19415964|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620848|NCT00766090|19415965|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620849|NCT00766090|19415966|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620850|NCT00766090|19415967|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620851|NCT00766090|19415968|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
5620852|NCT00766090|19415969|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620853|NCT00766090|19415970|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620854|NCT00766090|19415971|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620855|NCT00766090|19415972|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
5620856|NCT00766090|19415961|P12|Washout Period 1 (14 Days)|Protocol Violation|0
5620857|NCT00766090|19415962|P11|Washout Period 1 (14 Days)|Protocol Violation|0
5620858|NCT00766090|19415963|P10|Washout Period 1 (14 Days)|Protocol Violation|0
5620859|NCT00766090|19415964|P9|Washout Period 1 (14 Days)|Protocol Violation|0
5620860|NCT00766090|19415965|P8|Washout Period 1 (14 Days)|Protocol Violation|0
5620861|NCT00766090|19415966|P7|Washout Period 1 (14 Days)|Protocol Violation|0
5620862|NCT00766090|19415967|P6|Washout Period 1 (14 Days)|Protocol Violation|0
5620863|NCT00766090|19415968|P5|Washout Period 1 (14 Days)|Protocol Violation|0
5620864|NCT00766090|19415969|P4|Washout Period 1 (14 Days)|Protocol Violation|0
5620865|NCT00766090|19415970|P3|Washout Period 1 (14 Days)|Protocol Violation|1
5620866|NCT00766090|19415971|P2|Washout Period 1 (14 Days)|Protocol Violation|0
5620867|NCT00766090|19415972|P1|Washout Period 1 (14 Days)|Protocol Violation|0
5620868|NCT00766090|19415961|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620869|NCT00766090|19415962|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620870|NCT00766090|19415963|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620871|NCT00766090|19415964|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620872|NCT00766090|19415965|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620873|NCT00766090|19415966|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620874|NCT00766090|19415967|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620875|NCT00766090|19415968|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620876|NCT00766090|19415969|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5620877|NCT00766090|19415970|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620878|NCT00766090|19415971|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
5620879|NCT00766090|19415972|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
5620880|NCT00766090|19415961|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620881|NCT00766090|19415962|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620882|NCT00766090|19415963|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620883|NCT00766090|19415964|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620884|NCT00766090|19415965|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620885|NCT00766090|19415966|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620886|NCT00766090|19415967|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620887|NCT00766090|19415968|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620888|NCT00766090|19415969|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620889|NCT00766090|19415970|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620890|NCT00766090|19415971|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
5620891|NCT00766090|19415972|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
5620892|NCT00766090|19415961|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620893|NCT00766090|19415962|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620894|NCT00766090|19415963|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620895|NCT00766090|19415964|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
5620896|NCT00766090|19415965|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620897|NCT00766090|19415966|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620898|NCT00766090|19415967|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620899|NCT00766090|19415968|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620900|NCT00766090|19415969|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620901|NCT00766090|19415970|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620902|NCT00766090|19415971|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620903|NCT00766090|19415972|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
5620904|NCT00766051|19416013|P2|Overall Study|Withdrawal by Subject|0
5620905|NCT00766051|19416014|P1|Overall Study|Withdrawal by Subject|2
5620906|NCT00766038|19416026|P2|Overall Study|Lost to Follow-up|14
5620907|NCT00766038|19416027|P1|Overall Study|Lost to Follow-up|15
5620908|NCT00765999|19416043|P1|Overall Study|Other Miscellaneous Reasons|51
5620909|NCT00765999|19416043|P1|Overall Study|Study Terminated by Sponsor|2
5620910|NCT00765999|19416043|P1|Overall Study|Lost to Follow-up|131
5620911|NCT00765999|19416043|P1|Overall Study|Consent Withdrawn|202
5620912|NCT00765999|19416043|P1|Overall Study|Protocol Violation|95
5620913|NCT00765999|19416043|P1|Overall Study|Insufficient Therapeutic Response|100
5620914|NCT00765999|19416043|P1|Overall Study|Adverse Event|203
5620915|NCT00765882|19416070|P3|Overall Study|Other Reason|2
5620916|NCT00765882|19416071|P2|Overall Study|Other Reason|1
5620917|NCT00765882|19416072|P1|Overall Study|Other Reason|3
5620918|NCT00765882|19416070|P3|Overall Study|Lost to Follow-up|6
5620919|NCT00765882|19416071|P2|Overall Study|Lost to Follow-up|9
5620920|NCT00765882|19416072|P1|Overall Study|Lost to Follow-up|1
5620921|NCT00765882|19416070|P3|Overall Study|Withdrawal by Subject|6
5620922|NCT00765882|19416071|P2|Overall Study|Withdrawal by Subject|6
5620923|NCT00765882|19416072|P1|Overall Study|Withdrawal by Subject|2
5620924|NCT00765882|19416070|P3|Overall Study|Protocol Violation|1
5620925|NCT00765882|19416071|P2|Overall Study|Protocol Violation|3
5620926|NCT00765882|19416072|P1|Overall Study|Protocol Violation|4
5620927|NCT00765882|19416070|P3|Overall Study|Lack of Efficacy|1
5620928|NCT00765882|19416071|P2|Overall Study|Lack of Efficacy|0
5620929|NCT00765882|19416072|P1|Overall Study|Lack of Efficacy|4
5620930|NCT00765882|19416070|P3|Overall Study|Adverse Event|20
5620931|NCT00765882|19416071|P2|Overall Study|Adverse Event|21
5620932|NCT00765882|19416072|P1|Overall Study|Adverse Event|10
5620933|NCT00765843|19416118|P3|Overall Study|Adverse Event|1
5620934|NCT00765843|19416119|P2|Overall Study|Adverse Event|0
5620935|NCT00765843|19416120|P1|Overall Study|Adverse Event|0
5620936|NCT00765843|19416118|P3|Overall Study|did not return to receive intervention|0
5620937|NCT00765843|19416119|P2|Overall Study|did not return to receive intervention|1
5620938|NCT00765843|19416120|P1|Overall Study|did not return to receive intervention|0
5620939|NCT00765843|19416118|P3|Overall Study|Lost to Follow-up|2
5620940|NCT00765843|19416119|P2|Overall Study|Lost to Follow-up|3
5620941|NCT00765843|19416120|P1|Overall Study|Lost to Follow-up|1
5620942|NCT00765817|19416130|P2|Overall Study|Subject decision|11
5620943|NCT00765817|19416131|P1|Overall Study|Subject decision|7
5620944|NCT00765817|19416130|P2|Overall Study|Protocol Violation|1
5620945|NCT00765817|19416131|P1|Overall Study|Protocol Violation|1
5620946|NCT00765817|19416130|P2|Overall Study|Physician Decision|1
5620947|NCT00765817|19416131|P1|Overall Study|Physician Decision|2
5620948|NCT00765817|19416130|P2|Overall Study|Lost to Follow-up|3
5620949|NCT00765817|19416131|P1|Overall Study|Lost to Follow-up|1
5620950|NCT00765817|19416130|P2|Overall Study|Loss of glucose control|2
5620951|NCT00765817|19416131|P1|Overall Study|Loss of glucose control|0
5620952|NCT00765817|19416130|P2|Overall Study|Entry criteria not met|2
5620953|NCT00765817|19416131|P1|Overall Study|Entry criteria not met|2
5620954|NCT00765817|19416130|P2|Overall Study|Death|1
5620955|NCT00765817|19416131|P1|Overall Study|Death|0
5620956|NCT00765817|19416130|P2|Overall Study|Adverse Event|1
5620957|NCT00765817|19416131|P1|Overall Study|Adverse Event|13
5620958|NCT00765726|19416179|P1|Overall Study|Discontinuation of study by sponsor|8
5620959|NCT00765726|19416179|P1|Overall Study|Withdrawal by Subject|1
5620960|NCT00765674|19416187|P4|Overall Study|Randomized in Error - No Study Drug|1
5620961|NCT00765674|19416188|P3|Overall Study|Randomized in Error - No Study Drug|0
5620962|NCT00765674|19416189|P2|Overall Study|Randomized in Error - No Study Drug|1
5620963|NCT00765674|19416190|P1|Overall Study|Randomized in Error - No Study Drug|0
5620964|NCT00765674|19416187|P4|Overall Study|Lost to Follow-up|1
5620965|NCT00765674|19416188|P3|Overall Study|Lost to Follow-up|2
5620966|NCT00765674|19416189|P2|Overall Study|Lost to Follow-up|6
5620967|NCT00765674|19416190|P1|Overall Study|Lost to Follow-up|4
5620968|NCT00765674|19416187|P4|Overall Study|Withdrawal by Subject|8
5620969|NCT00765674|19416188|P3|Overall Study|Withdrawal by Subject|3
5620970|NCT00765674|19416189|P2|Overall Study|Withdrawal by Subject|7
5620971|NCT00765674|19416190|P1|Overall Study|Withdrawal by Subject|5
5620972|NCT00765674|19416187|P4|Overall Study|Protocol Violation|0
5620973|NCT00765674|19416188|P3|Overall Study|Protocol Violation|1
5620974|NCT00765674|19416189|P2|Overall Study|Protocol Violation|0
5620975|NCT00765674|19416190|P1|Overall Study|Protocol Violation|2
5620976|NCT00765674|19416187|P4|Overall Study|Lack of Efficacy|2
5620977|NCT00765674|19416188|P3|Overall Study|Lack of Efficacy|1
5620978|NCT00765674|19416189|P2|Overall Study|Lack of Efficacy|3
5620979|NCT00765674|19416190|P1|Overall Study|Lack of Efficacy|2
5620980|NCT00765674|19416187|P4|Overall Study|Abnormal Test Procedure Result(s)|2
5620981|NCT00765674|19416188|P3|Overall Study|Abnormal Test Procedure Result(s)|1
5620982|NCT00765674|19416189|P2|Overall Study|Abnormal Test Procedure Result(s)|3
5620983|NCT00765674|19416190|P1|Overall Study|Abnormal Test Procedure Result(s)|1
5620984|NCT00765674|19416187|P4|Overall Study|Abnormal Laboratory Value(s)|0
5620985|NCT00765674|19416188|P3|Overall Study|Abnormal Laboratory Value(s)|1
5620986|NCT00765674|19416189|P2|Overall Study|Abnormal Laboratory Value(s)|0
5620987|NCT00765674|19416190|P1|Overall Study|Abnormal Laboratory Value(s)|0
5620988|NCT00765674|19416187|P4|Overall Study|Adverse Event|11
5620989|NCT00765674|19416188|P3|Overall Study|Adverse Event|8
5620990|NCT00765674|19416189|P2|Overall Study|Adverse Event|2
5620991|NCT00765674|19416190|P1|Overall Study|Adverse Event|7
5620992|NCT00765388|19416257|P2|Period 1|Hip operation|1
5620993|NCT00765388|19416258|P1|Period 1|Hip operation|0
5620994|NCT00765388|19416257|P2|Period 1|Herpes Zoster|1
5620995|NCT00765388|19416258|P1|Period 1|Herpes Zoster|0
5620996|NCT00765388|19416257|P2|Period 1|Lost to Follow-up|1
5620997|NCT00765388|19416258|P1|Period 1|Lost to Follow-up|0
5620998|NCT00765388|19416257|P2|Period 1|Lack of Efficacy|2
5620999|NCT00765388|19416258|P1|Period 1|Lack of Efficacy|1
5621000|NCT00765362|19416292|P1|Overall Study|Lost to Follow-up|95
5621001|NCT00765362|19416292|P1|Overall Study|Withdrawal by Subject|13
5621002|NCT00765362|19416292|P1|Overall Study|Protocol Violation|18
5621003|NCT00765362|19416292|P1|Overall Study|Adverse Event|2
5621004|NCT00765362|19416292|P1|Overall Study|Death|9
5621005|NCT00765336|19416300|P2|Overall Study|Adverse Event|1
5621006|NCT00765336|19416301|P1|Overall Study|Adverse Event|2
5621007|NCT00765336|19416300|P2|Overall Study|Lost to Follow-up|9
5621008|NCT00765336|19416301|P1|Overall Study|Lost to Follow-up|7
5621009|NCT00765336|19416300|P2|Overall Study|Withdrawal by Subject|4
5621010|NCT00765336|19416301|P1|Overall Study|Withdrawal by Subject|6
5621011|NCT00765336|19416300|P2|Overall Study|Protocol Violation|2
5621012|NCT00765336|19416301|P1|Overall Study|Protocol Violation|4
5621013|NCT00765245|19416309|P2|Overall Study|Death|0
5621014|NCT00765245|19416310|P1|Overall Study|Death|1
5621015|NCT00765245|19416309|P2|Overall Study|Physician Decision|0
5621016|NCT00765245|19416310|P1|Overall Study|Physician Decision|1
5621017|NCT00765245|19416309|P2|Overall Study|Adverse Event|0
5621018|NCT00765245|19416310|P1|Overall Study|Adverse Event|5
5621019|NCT00765245|19416309|P2|Overall Study|Withdrawal by Subject|0
5621020|NCT00765245|19416310|P1|Overall Study|Withdrawal by Subject|3
5621021|NCT00765245|19416309|P2|Overall Study|disease progression|2
5621022|NCT00765245|19416310|P1|Overall Study|disease progression|3
5621023|NCT00765102|19416356|P1|Overall Study|Protocol Violation|1
5621024|NCT00765102|19416356|P1|Overall Study|Withdrawal by Subject|2
5621025|NCT00765102|19416356|P1|Overall Study|Physician Decision|4
5621026|NCT00765102|19416356|P1|Overall Study|Adverse Event|6
5621027|NCT00765102|19416356|P1|Overall Study|Progressive disease|18
5621028|NCT00765076|19416381|P3|Overall Study|Withdrawal by Subject|1
5621029|NCT00765076|19416382|P2|Overall Study|Withdrawal by Subject|0
5621030|NCT00765076|19416383|P1|Overall Study|Withdrawal by Subject|0
5621031|NCT00765076|19416381|P3|Overall Study|Adverse Event|0
5621032|NCT00765076|19416382|P2|Overall Study|Adverse Event|0
5621033|NCT00765076|19416383|P1|Overall Study|Adverse Event|1
5621034|NCT00765063|19416436|P1|Overall Study|Adverse Event|4
5621035|NCT00765063|19416436|P1|Overall Study|Protocol Violation|6
5621036|NCT00765063|19416436|P1|Overall Study|Other|16
5621037|NCT00765063|19416436|P1|Overall Study|Withdrawal by Subject|1
5621038|NCT00765063|19416436|P1|Overall Study|Lack of Efficacy|5
5621039|NCT00765037|19416452|P1|Overall Study|Adverse Event|1
5621040|NCT00765037|19416452|P1|Overall Study|Lost to Follow-up|5
5621041|NCT00764946|19416459|P3|Overall Study|Never Treated|1
5621042|NCT00764946|19416460|P2|Overall Study|Never Treated|1
5621043|NCT00764946|19416461|P1|Overall Study|Never Treated|1
5621044|NCT00764946|19416459|P3|Overall Study|Withdrawal by Subject|2
5621045|NCT00764946|19416460|P2|Overall Study|Withdrawal by Subject|6
5621046|NCT00764946|19416461|P1|Overall Study|Withdrawal by Subject|3
5621047|NCT00764946|19416459|P3|Overall Study|Adverse Event|1
5621048|NCT00764946|19416460|P2|Overall Study|Adverse Event|2
5621049|NCT00764946|19416461|P1|Overall Study|Adverse Event|3
5621050|NCT00764946|19416459|P3|Overall Study|Physician Decision|0
5621051|NCT00764946|19416460|P2|Overall Study|Physician Decision|4
5621052|NCT00764946|19416461|P1|Overall Study|Physician Decision|2
5621053|NCT00764946|19416459|P3|Overall Study|Lost to Follow-up|0
5621054|NCT00764946|19416460|P2|Overall Study|Lost to Follow-up|4
5621055|NCT00764946|19416461|P1|Overall Study|Lost to Follow-up|3
5621056|NCT00764946|19416459|P3|Overall Study|Lack of Efficacy|0
5621057|NCT00764946|19416460|P2|Overall Study|Lack of Efficacy|0
5621058|NCT00764946|19416461|P1|Overall Study|Lack of Efficacy|1
5621059|NCT00764881|19416489|P2|Overall Study|no treatment or no observation|2
5621060|NCT00764881|19416490|P1|Overall Study|no treatment or no observation|2
5621061|NCT00764881|19416489|P2|Overall Study|Possibly noncompliant (study drug)|2
5621062|NCT00764881|19416490|P1|Overall Study|Possibly noncompliant (study drug)|0
5621063|NCT00764881|19416489|P2|Overall Study|Carcinoma detected|0
5621064|NCT00764881|19416490|P1|Overall Study|Carcinoma detected|1
5621065|NCT00764881|19416489|P2|Overall Study|Wished to become pregnant|0
5621066|NCT00764881|19416490|P1|Overall Study|Wished to become pregnant|1
5621067|NCT00764881|19416489|P2|Overall Study|Accidentally discontinued study drug|0
5621068|NCT00764881|19416490|P1|Overall Study|Accidentally discontinued study drug|1
5621069|NCT00764881|19416489|P2|Overall Study|Noncompliant|0
5621070|NCT00764881|19416490|P1|Overall Study|Noncompliant|1
5621071|NCT00764881|19416489|P2|Overall Study|Lost to Follow-up|0
5621072|NCT00764881|19416490|P1|Overall Study|Lost to Follow-up|2
5621073|NCT00764881|19416489|P2|Overall Study|Protocol Violation|2
5621074|NCT00764881|19416490|P1|Overall Study|Protocol Violation|2
5621075|NCT00764881|19416489|P2|Overall Study|Withdrawal by Subject|3
5621076|NCT00764881|19416490|P1|Overall Study|Withdrawal by Subject|1
5621077|NCT00764881|19416489|P2|Overall Study|Adverse Event|1
5621078|NCT00764881|19416490|P1|Overall Study|Adverse Event|5
5621079|NCT00764868|19416714|P1|Overall Study|Sponsor requested withdrawal|1
5621080|NCT00764868|19416714|P1|Overall Study|Positive drug screen|2
5621081|NCT00764868|19416714|P1|Overall Study|Met an exclusion criteria|1
5621082|NCT00764868|19416714|P1|Overall Study|Subject sent to boarding school|1
5621083|NCT00764868|19416714|P1|Overall Study|Misuse and compliance of study drug|1
5621084|NCT00764868|19416714|P1|Overall Study|Out of town|1
5621085|NCT00764868|19416714|P1|Overall Study|Prohibited medication|1
5621086|NCT00764868|19416714|P1|Overall Study|Pregnancy|3
5621087|NCT00764868|19416714|P1|Overall Study|Subject moved|7
5621088|NCT00764868|19416714|P1|Overall Study|Lack of Efficacy|5
5621089|NCT00764868|19416714|P1|Overall Study|Lost to Follow-up|25
5621090|NCT00764868|19416714|P1|Overall Study|Non-compliance|16
5621091|NCT00764868|19416714|P1|Overall Study|Withdrawal by Subject|31
5621092|NCT00764868|19416714|P1|Overall Study|Adverse Event|18
5621093|NCT00764790|19416723|P3|Overall Study|Lost to Follow-up|23
5621094|NCT00764790|19416724|P2|Overall Study|Lost to Follow-up|29
5621095|NCT00764790|19416725|P1|Overall Study|Lost to Follow-up|28
5621096|NCT00764790|19416723|P3|Overall Study|Withdrawal by Subject|6
5621097|NCT00764790|19416724|P2|Overall Study|Withdrawal by Subject|12
5621098|NCT00764790|19416725|P1|Overall Study|Withdrawal by Subject|10
5621099|NCT00764790|19416723|P3|Overall Study|Protocol Violation|1
5621100|NCT00764790|19416724|P2|Overall Study|Protocol Violation|0
5621101|NCT00764790|19416725|P1|Overall Study|Protocol Violation|0
5621102|NCT00764751|19416759|P2|Overall Study|Psoriasis flare up on the scalp|0
5621103|NCT00764751|19416760|P1|Overall Study|Psoriasis flare up on the scalp|1
5621104|NCT00764751|19416759|P2|Overall Study|Adverse Event|1
5621105|NCT00764751|19416760|P1|Overall Study|Adverse Event|1
5621106|NCT00764699|19416823|P1|Overall Study|PI left and study terminated|3
5621107|NCT00764673|19416827|P1|Overall Study|Revision of Device|2
5621108|NCT00764673|19416827|P1|Overall Study|Withdrawal by Subject|6
5621109|NCT00764673|19416827|P1|Overall Study|Lost to Follow-up|3
5621110|NCT00764673|19416827|P1|Overall Study|Death|1
5621111|NCT00764660|19416837|P2|Overall Study|Did Not Meet Protocol Eligibility|0
5621112|NCT00764660|19416838|P1|Overall Study|Did Not Meet Protocol Eligibility|1
5621113|NCT00764660|19416837|P2|Overall Study|Noncompliance With Protocol|1
5621114|NCT00764660|19416838|P1|Overall Study|Noncompliance With Protocol|5
5621115|NCT00764660|19416837|P2|Overall Study|Withdrawal by Subject|3
5621116|NCT00764660|19416838|P1|Overall Study|Withdrawal by Subject|7
5621117|NCT00764660|19416837|P2|Overall Study|Lost to Follow-up|4
5621118|NCT00764660|19416838|P1|Overall Study|Lost to Follow-up|3
5621119|NCT00764660|19416837|P2|Overall Study|Adverse Event|3
5621120|NCT00764660|19416838|P1|Overall Study|Adverse Event|6
5621121|NCT00764517|19416872|P2|Overall Study|Physician Decision|0
5621122|NCT00764517|19416873|P1|Overall Study|Physician Decision|3
5621123|NCT00764517|19416872|P2|Overall Study|Death|11
5621124|NCT00764517|19416873|P1|Overall Study|Death|3
5621125|NCT00764517|19416872|P2|Overall Study|Adverse Event|3
5621126|NCT00764517|19416873|P1|Overall Study|Adverse Event|9
5621127|NCT00764504|19416894|P3|Overall Study|Lost to Follow-up|72
5621128|NCT00764504|19416895|P2|Overall Study|Lost to Follow-up|34
5621129|NCT00764504|19416896|P1|Overall Study|Lost to Follow-up|40
5621130|NCT00764504|19416894|P3|Overall Study|Withdrawal by Subject|4
5621131|NCT00764504|19416895|P2|Overall Study|Withdrawal by Subject|7
5621132|NCT00764504|19416896|P1|Overall Study|Withdrawal by Subject|1
5621133|NCT00764504|19416894|P3|Overall Study|Physician Decision|0
5621134|NCT00764504|19416895|P2|Overall Study|Physician Decision|0
5621135|NCT00764504|19416896|P1|Overall Study|Physician Decision|1
5621136|NCT00764504|19416894|P3|Overall Study|Revision of Device|14
5621137|NCT00764504|19416895|P2|Overall Study|Revision of Device|23
5621138|NCT00764504|19416896|P1|Overall Study|Revision of Device|12
5621139|NCT00764504|19416894|P3|Overall Study|Death|13
5621140|NCT00764504|19416895|P2|Overall Study|Death|6
5621141|NCT00764504|19416896|P1|Overall Study|Death|12
5621142|NCT00764478|19416925|P3|Overall Study|Protocol Violation|1
5621143|NCT00764478|19416926|P2|Overall Study|Protocol Violation|1
5621144|NCT00764478|19416927|P1|Overall Study|Protocol Violation|0
5621145|NCT00764478|19416925|P3|Overall Study|Lost to Follow-up|5
5621146|NCT00764478|19416926|P2|Overall Study|Lost to Follow-up|8
5621147|NCT00764478|19416927|P1|Overall Study|Lost to Follow-up|7
5621148|NCT00764478|19416925|P3|Overall Study|Withdrawal by Subject|1
5621149|NCT00764478|19416926|P2|Overall Study|Withdrawal by Subject|12
5621150|NCT00764478|19416927|P1|Overall Study|Withdrawal by Subject|7
5621151|NCT00764478|19416925|P3|Overall Study|Adverse Event|1
5621152|NCT00764478|19416926|P2|Overall Study|Adverse Event|1
5621153|NCT00764478|19416927|P1|Overall Study|Adverse Event|1
5621154|NCT00764465|19417007|P6|Overall Study|Withdrawal by Subject|0
5621155|NCT00764465|19417008|P5|Overall Study|Withdrawal by Subject|0
5621156|NCT00764465|19417009|P4|Overall Study|Withdrawal by Subject|0
5621157|NCT00764465|19417010|P3|Overall Study|Withdrawal by Subject|1
5621158|NCT00764465|19417011|P2|Overall Study|Withdrawal by Subject|1
5621159|NCT00764465|19417012|P1|Overall Study|Withdrawal by Subject|0
5621160|NCT00764465|19417007|P6|Overall Study|Adverse Event|1
5621161|NCT00764465|19417008|P5|Overall Study|Adverse Event|1
5621162|NCT00764465|19417009|P4|Overall Study|Adverse Event|1
5621163|NCT00764465|19417010|P3|Overall Study|Adverse Event|0
5621164|NCT00764465|19417011|P2|Overall Study|Adverse Event|0
5621165|NCT00764465|19417012|P1|Overall Study|Adverse Event|2
5621166|NCT00764361|19417040|P2|Overall Study|Adverse Event|1
5621167|NCT00764361|19417041|P1|Overall Study|Adverse Event|0
5621168|NCT00764361|19417040|P2|Overall Study|Withdrawal by Subject|3
5621169|NCT00764361|19417041|P1|Overall Study|Withdrawal by Subject|2
5621170|NCT00764322|19417049|P1|Overall Study|No CYP2D6 genotyping|9
5621171|NCT00764322|19417049|P1|Overall Study|Withdrawal by Subject|11
5621172|NCT00763971|19417076|P3|Overall Study|Participation in 489-326 required|0
5621173|NCT00763971|19417077|P2|Overall Study|Participation in 489-326 required|0
5621174|NCT00763971|19417078|P1|Overall Study|Participation in 489-326 required|1
5621175|NCT00763971|19417076|P3|Overall Study|Performed final visit on phone|0
5621176|NCT00763971|19417077|P2|Overall Study|Performed final visit on phone|1
5621177|NCT00763971|19417078|P1|Overall Study|Performed final visit on phone|0
5621178|NCT00763971|19417076|P3|Overall Study|Lack of availability|0
5621179|NCT00763971|19417077|P2|Overall Study|Lack of availability|1
5621180|NCT00763971|19417078|P1|Overall Study|Lack of availability|0
5621181|NCT00763971|19417076|P3|Overall Study|Subject wanted dose reduction|0
5621182|NCT00763971|19417077|P2|Overall Study|Subject wanted dose reduction|1
5621183|NCT00763971|19417078|P1|Overall Study|Subject wanted dose reduction|0
5621184|NCT00763971|19417076|P3|Overall Study|Moved to another country|0
5621185|NCT00763971|19417077|P2|Overall Study|Moved to another country|1
5621186|NCT00763971|19417078|P1|Overall Study|Moved to another country|0
5621187|NCT00763971|19417076|P3|Overall Study|Medical monitor decision|1
5621188|NCT00763971|19417077|P2|Overall Study|Medical monitor decision|0
5621189|NCT00763971|19417078|P1|Overall Study|Medical monitor decision|0
5621190|NCT00763971|19417076|P3|Overall Study|Randomization error|1
5621191|NCT00763971|19417077|P2|Overall Study|Randomization error|0
5621192|NCT00763971|19417078|P1|Overall Study|Randomization error|0
5621193|NCT00763971|19417076|P3|Overall Study|Due to holiday season|1
5621194|NCT00763971|19417077|P2|Overall Study|Due to holiday season|0
5621195|NCT00763971|19417078|P1|Overall Study|Due to holiday season|2
5621196|NCT00763971|19417076|P3|Overall Study|Sponsor decision|0
5621197|NCT00763971|19417077|P2|Overall Study|Sponsor decision|0
5621198|NCT00763971|19417078|P1|Overall Study|Sponsor decision|1
5621199|NCT00763971|19417076|P3|Overall Study|Exclusion criteria met|0
5621200|NCT00763971|19417077|P2|Overall Study|Exclusion criteria met|0
5621201|NCT00763971|19417078|P1|Overall Study|Exclusion criteria met|1
5621202|NCT00763971|19417076|P3|Overall Study|Personal reason|0
5621203|NCT00763971|19417077|P2|Overall Study|Personal reason|0
5621204|NCT00763971|19417078|P1|Overall Study|Personal reason|3
5621205|NCT00763971|19417076|P3|Overall Study|Unable to swallow capsule|1
5621206|NCT00763971|19417077|P2|Overall Study|Unable to swallow capsule|1
5621207|NCT00763971|19417078|P1|Overall Study|Unable to swallow capsule|2
5621208|NCT00763971|19417076|P3|Overall Study|Lack of Efficacy|54
5621209|NCT00763971|19417077|P2|Overall Study|Lack of Efficacy|22
5621210|NCT00763971|19417078|P1|Overall Study|Lack of Efficacy|11
5621211|NCT00763971|19417076|P3|Overall Study|Lost to Follow-up|0
5621212|NCT00763971|19417077|P2|Overall Study|Lost to Follow-up|1
5621213|NCT00763971|19417078|P1|Overall Study|Lost to Follow-up|0
5621214|NCT00763971|19417076|P3|Overall Study|Withdrawal by Subject|5
5621215|NCT00763971|19417077|P2|Overall Study|Withdrawal by Subject|5
5621216|NCT00763971|19417078|P1|Overall Study|Withdrawal by Subject|4
5621217|NCT00763971|19417076|P3|Overall Study|Protocol Violation|2
5621218|NCT00763971|19417077|P2|Overall Study|Protocol Violation|3
5621219|NCT00763971|19417078|P1|Overall Study|Protocol Violation|3
5621220|NCT00763971|19417076|P3|Overall Study|Adverse Event|4
5621221|NCT00763971|19417077|P2|Overall Study|Adverse Event|2
5621222|NCT00763971|19417078|P1|Overall Study|Adverse Event|5
5621223|NCT00763958|19417109|P2|Overall Study|Believed they were receiving placebo|5
5621224|NCT00763958|19417110|P1|Overall Study|Believed they were receiving placebo|0
5621225|NCT00763958|19417109|P2|Overall Study|Lost to Follow-up|2
5621226|NCT00763958|19417110|P1|Overall Study|Lost to Follow-up|10
5621227|NCT00763958|19417109|P2|Overall Study|did not meet final criteria|4
5621228|NCT00763958|19417110|P1|Overall Study|did not meet final criteria|4
5621229|NCT00763815|19417245|P2|Overall Study|Sponsor's Decision|1
5621230|NCT00763815|19417246|P1|Overall Study|Sponsor's Decision|0
5621231|NCT00763815|19417245|P2|Overall Study|Protocol Violation|5
5621232|NCT00763815|19417246|P1|Overall Study|Protocol Violation|2
5621233|NCT00763815|19417245|P2|Overall Study|Withdrawal by Subject|12
5621234|NCT00763815|19417246|P1|Overall Study|Withdrawal by Subject|7
5621235|NCT00763815|19417245|P2|Overall Study|Physician Decision|0
5621236|NCT00763815|19417246|P1|Overall Study|Physician Decision|1
5621237|NCT00763815|19417245|P2|Overall Study|Familial and Personal Reasons|16
5621238|NCT00763815|19417246|P1|Overall Study|Familial and Personal Reasons|9
5621239|NCT00763815|19417245|P2|Overall Study|Early Termination|0
5621240|NCT00763815|19417246|P1|Overall Study|Early Termination|1
5621241|NCT00763815|19417245|P2|Overall Study|Lost to Follow-up|4
5621242|NCT00763815|19417246|P1|Overall Study|Lost to Follow-up|2
5621243|NCT00763815|19417245|P2|Overall Study|Poor Compliance to Protocol|6
5621244|NCT00763815|19417246|P1|Overall Study|Poor Compliance to Protocol|6
5621245|NCT00763815|19417245|P2|Overall Study|Lack of Efficacy|11
5621246|NCT00763815|19417246|P1|Overall Study|Lack of Efficacy|10
5621247|NCT00763815|19417245|P2|Overall Study|Adverse Event|29
5621248|NCT00763815|19417246|P1|Overall Study|Adverse Event|14
5621249|NCT00763698|19417274|P1|Overall Study|Withdrawal by Subject|1
5621250|NCT00763698|19417274|P1|Overall Study|Death|4
5621251|NCT00763698|19417274|P1|Overall Study|Unsuccessful Implant|5
5621252|NCT00763451|19417291|P4|Overall Study|Study Site Reason|1
5621253|NCT00763451|19417292|P3|Overall Study|Study Site Reason|1
5621254|NCT00763451|19417293|P2|Overall Study|Study Site Reason|1
5621255|NCT00763451|19417294|P1|Overall Study|Study Site Reason|0
5621256|NCT00763451|19417291|P4|Overall Study|Randomized but not Treated|0
5621257|NCT00763451|19417292|P3|Overall Study|Randomized but not Treated|0
5621258|NCT00763451|19417293|P2|Overall Study|Randomized but not Treated|1
5621259|NCT00763451|19417294|P1|Overall Study|Randomized but not Treated|1
5621260|NCT00763451|19417291|P4|Overall Study|Familial and Personal Reasons|4
5621261|NCT00763451|19417292|P3|Overall Study|Familial and Personal Reasons|5
5621262|NCT00763451|19417293|P2|Overall Study|Familial and Personal Reasons|3
5621263|NCT00763451|19417294|P1|Overall Study|Familial and Personal Reasons|5
5621264|NCT00763451|19417291|P4|Overall Study|Poor Compliance to Protocol|2
5621265|NCT00763451|19417292|P3|Overall Study|Poor Compliance to Protocol|2
5621266|NCT00763451|19417293|P2|Overall Study|Poor Compliance to Protocol|1
5621267|NCT00763451|19417294|P1|Overall Study|Poor Compliance to Protocol|1
5621268|NCT00763451|19417291|P4|Overall Study|Protocol Violation|0
5621269|NCT00763451|19417292|P3|Overall Study|Protocol Violation|1
5621270|NCT00763451|19417293|P2|Overall Study|Protocol Violation|0
5621271|NCT00763451|19417294|P1|Overall Study|Protocol Violation|0
5621272|NCT00763451|19417291|P4|Overall Study|Withdrawal by Subject|7
5621273|NCT00763451|19417292|P3|Overall Study|Withdrawal by Subject|9
5621274|NCT00763451|19417293|P2|Overall Study|Withdrawal by Subject|6
5621275|NCT00763451|19417294|P1|Overall Study|Withdrawal by Subject|1
5621276|NCT00763451|19417291|P4|Overall Study|Lack of Efficacy|2
5621277|NCT00763451|19417292|P3|Overall Study|Lack of Efficacy|3
5621278|NCT00763451|19417293|P2|Overall Study|Lack of Efficacy|4
5621279|NCT00763451|19417294|P1|Overall Study|Lack of Efficacy|1
5621280|NCT00763451|19417291|P4|Overall Study|Adverse Event|14
5621281|NCT00763451|19417292|P3|Overall Study|Adverse Event|19
5621282|NCT00763451|19417293|P2|Overall Study|Adverse Event|6
5621283|NCT00763451|19417294|P1|Overall Study|Adverse Event|4
5621284|NCT00763386|19417353|P2|Overall Study|Study Prosthesis Removed|0
5621285|NCT00763386|19417354|P1|Overall Study|Study Prosthesis Removed|1
5621286|NCT00763386|19417353|P2|Overall Study|CRF missing|1
5621287|NCT00763386|19417354|P1|Overall Study|CRF missing|0
5621288|NCT00763386|19417353|P2|Overall Study|Withdrawal by Subject|1
5621289|NCT00763386|19417354|P1|Overall Study|Withdrawal by Subject|0
5621290|NCT00763386|19417353|P2|Overall Study|Lost to Follow-up|3
5621291|NCT00763386|19417354|P1|Overall Study|Lost to Follow-up|3
5621292|NCT00763386|19417353|P2|Overall Study|Death|2
5621293|NCT00763386|19417354|P1|Overall Study|Death|1
5621294|NCT00763386|19417353|P2|Overall Study|Adverse Event|33
5621295|NCT00763386|19417354|P1|Overall Study|Adverse Event|43
5621296|NCT00763321|19417387|P3|Double-blind Period|Other|3
5621297|NCT00763321|19417388|P2|Double-blind Period|Other|2
5621298|NCT00763321|19417389|P1|Double-blind Period|Other|0
5621299|NCT00763321|19417387|P3|Double-blind Period|Withdrawal by Subject|3
5621300|NCT00763321|19417388|P2|Double-blind Period|Withdrawal by Subject|2
5621301|NCT00763321|19417389|P1|Double-blind Period|Withdrawal by Subject|0
5621302|NCT00763321|19417387|P3|Double-blind Period|Lost to Follow-up|2
5621303|NCT00763321|19417388|P2|Double-blind Period|Lost to Follow-up|4
5621304|NCT00763321|19417389|P1|Double-blind Period|Lost to Follow-up|0
5621305|NCT00763321|19417387|P3|Double-blind Period|Adverse Event|4
5621306|NCT00763321|19417388|P2|Double-blind Period|Adverse Event|4
5621307|NCT00763321|19417389|P1|Double-blind Period|Adverse Event|0
5621308|NCT00763321|19417387|P3|Double-blind Period|Lack of Efficacy|17
5621309|NCT00763321|19417388|P2|Double-blind Period|Lack of Efficacy|9
5621310|NCT00763321|19417389|P1|Double-blind Period|Lack of Efficacy|0
5621311|NCT00763321|19417387|P3|Open-label Period|Other|0
5621312|NCT00763321|19417388|P2|Open-label Period|Other|0
5621313|NCT00763321|19417389|P1|Open-label Period|Other|4
5621314|NCT00763321|19417387|P3|Open-label Period|Lack of Efficacy|0
5621315|NCT00763321|19417388|P2|Open-label Period|Lack of Efficacy|0
5621316|NCT00763321|19417389|P1|Open-label Period|Lack of Efficacy|2
5621317|NCT00763321|19417387|P3|Open-label Period|Did not meet DB randomization criteria|0
5621318|NCT00763321|19417388|P2|Open-label Period|Did not meet DB randomization criteria|0
5621319|NCT00763321|19417389|P1|Open-label Period|Did not meet DB randomization criteria|5
5621320|NCT00763321|19417387|P3|Open-label Period|Subject noncompliant|0
5621321|NCT00763321|19417388|P2|Open-label Period|Subject noncompliant|0
5621322|NCT00763321|19417389|P1|Open-label Period|Subject noncompliant|7
5621323|NCT00763321|19417387|P3|Open-label Period|Withdrawal by Subject|0
5621324|NCT00763321|19417388|P2|Open-label Period|Withdrawal by Subject|0
5621325|NCT00763321|19417389|P1|Open-label Period|Withdrawal by Subject|7
5621326|NCT00763321|19417387|P3|Open-label Period|Lost to Follow-up|0
5621327|NCT00763321|19417388|P2|Open-label Period|Lost to Follow-up|0
5621328|NCT00763321|19417389|P1|Open-label Period|Lost to Follow-up|14
5621329|NCT00763321|19417387|P3|Open-label Period|Adverse Event|0
5621330|NCT00763321|19417388|P2|Open-label Period|Adverse Event|0
5621331|NCT00763321|19417389|P1|Open-label Period|Adverse Event|24
5621332|NCT00763282|19417400|P2|Overall Study|Lost to Follow-up|26
5621333|NCT00763282|19417401|P1|Overall Study|Lost to Follow-up|22
5621334|NCT00763282|19417400|P2|Overall Study|Death|3
5621335|NCT00763282|19417401|P1|Overall Study|Death|4
5621336|NCT00763282|19417400|P2|Overall Study|Withdrawal by Subject|5
5621337|NCT00763282|19417401|P1|Overall Study|Withdrawal by Subject|6
5621338|NCT00763269|19417417|P2|Overall Study|Lost to Follow-up|13
5621339|NCT00763269|19417418|P1|Overall Study|Lost to Follow-up|12
5621340|NCT00763256|19417432|P2|Overall Study|Didn't return for appointments|10
5621341|NCT00763256|19417433|P1|Overall Study|Didn't return for appointments|7
5621342|NCT00763139|19417469|P2|Overall Study|med change not allowed by protocol|0
5621343|NCT00763139|19417470|P1|Overall Study|med change not allowed by protocol|1
5621344|NCT00763139|19417469|P2|Overall Study|Withdrawal by Subject|1
5621345|NCT00763139|19417470|P1|Overall Study|Withdrawal by Subject|0
5621346|NCT00763139|19417469|P2|Overall Study|Adverse Event|2
5621347|NCT00763139|19417470|P1|Overall Study|Adverse Event|4
5621348|NCT00763035|19417532|P2|Second Intervention|Physician Decision|0
5621349|NCT00763035|19417533|P1|Second Intervention|Physician Decision|2
5621350|NCT00763035|19417532|P2|Second Intervention|Adverse Event|0
5621351|NCT00763035|19417533|P1|Second Intervention|Adverse Event|1
5621352|NCT00763035|19417532|P2|First Intervention|Adverse Event|1
5621353|NCT00763035|19417533|P1|First Intervention|Adverse Event|0
5621354|NCT00763035|19417532|P2|First Intervention|Did not meeting inclusion/exclusion|0
5621355|NCT00763035|19417533|P1|First Intervention|Did not meeting inclusion/exclusion|1
5621356|NCT00763009|19417551|P1|Overall Study|Coronary Anatomy unsuitable|1
5621357|NCT00762996|19417556|P4|Period One|Withdrawal by Subject|0
5621358|NCT00762996|19417557|P3|Period One|Withdrawal by Subject|1
5621359|NCT00762996|19417558|P2|Period One|Withdrawal by Subject|0
5621360|NCT00762996|19417559|P1|Period One|Withdrawal by Subject|0
5621361|NCT00762996|19417556|P4|Period One|Adverse Event|0
5621362|NCT00762996|19417557|P3|Period One|Adverse Event|1
5621363|NCT00762996|19417558|P2|Period One|Adverse Event|0
5621364|NCT00762996|19417559|P1|Period One|Adverse Event|0
5621365|NCT00762996|19417556|P4|Period One|ineligible|1
5621366|NCT00762996|19417557|P3|Period One|ineligible|1
5621367|NCT00762996|19417558|P2|Period One|ineligible|0
5621368|NCT00762996|19417559|P1|Period One|ineligible|0
5621369|NCT00762996|19417556|P4|Period One|Protocol Violation|0
5621370|NCT00762996|19417557|P3|Period One|Protocol Violation|1
5621371|NCT00762996|19417558|P2|Period One|Protocol Violation|0
5621372|NCT00762996|19417559|P1|Period One|Protocol Violation|0
5621373|NCT00762970|19417572|P3|Overall Study|Difficulty of handling lens|0
5621374|NCT00762970|19417573|P2|Overall Study|Difficulty of handling lens|2
5621375|NCT00762970|19417574|P1|Overall Study|Difficulty of handling lens|1
5621376|NCT00762970|19417572|P3|Overall Study|Lost to Follow-up|0
5621377|NCT00762970|19417573|P2|Overall Study|Lost to Follow-up|2
5621378|NCT00762970|19417574|P1|Overall Study|Lost to Follow-up|1
5621379|NCT00762970|19417572|P3|Overall Study|Protocol Violation|1
5621380|NCT00762970|19417573|P2|Overall Study|Protocol Violation|1
5621381|NCT00762970|19417574|P1|Overall Study|Protocol Violation|3
5621382|NCT00762970|19417572|P3|Overall Study|Withdrawal by Subject|0
5621383|NCT00762970|19417573|P2|Overall Study|Withdrawal by Subject|4
5621384|NCT00762970|19417574|P1|Overall Study|Withdrawal by Subject|7
5621385|NCT00762892|19417592|P2|Overall Study|Incarceration|0
5621386|NCT00762892|19417593|P1|Overall Study|Incarceration|1
5621387|NCT00762892|19417592|P2|Overall Study|Pregnancy|0
5621388|NCT00762892|19417593|P1|Overall Study|Pregnancy|1
5621389|NCT00762892|19417592|P2|Overall Study|Death|0
5621390|NCT00762892|19417593|P1|Overall Study|Death|1
5621391|NCT00762892|19417592|P2|Overall Study|Withdrawal by Subject|1
5621392|NCT00762892|19417593|P1|Overall Study|Withdrawal by Subject|0
5621393|NCT00762892|19417592|P2|Overall Study|Lost to Follow-up|5
5621394|NCT00762892|19417593|P1|Overall Study|Lost to Follow-up|2
5621395|NCT00762788|19417622|P6|Overall Study|Lost to Follow-up|21
5621396|NCT00762788|19417623|P5|Overall Study|Lost to Follow-up|13
5621397|NCT00762788|19417624|P4|Overall Study|Lost to Follow-up|26
5621398|NCT00762788|19417625|P3|Overall Study|Lost to Follow-up|21
5621399|NCT00762788|19417626|P2|Overall Study|Lost to Follow-up|37
5621400|NCT00762788|19417627|P1|Overall Study|Lost to Follow-up|26
5621401|NCT00762762|19417649|P2|Overall Study|Did not report for appointments|10
5621402|NCT00762762|19417650|P1|Overall Study|Did not report for appointments|8
5621403|NCT00762723|19417667|P3|Overall Study|Study Terminated slow enrollement|3
5621404|NCT00762723|19417668|P2|Overall Study|Study Terminated slow enrollement|5
5621405|NCT00762723|19417669|P1|Overall Study|Study Terminated slow enrollement|5
5621406|NCT00762606|19417842|P2|Overall Study|Lost to Follow-up|13
5621407|NCT00762606|19417843|P1|Overall Study|Lost to Follow-up|18
5621408|NCT00762502|19417888|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
5621409|NCT00762502|19417889|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
5621410|NCT00762502|19417890|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
5621411|NCT00762502|19417888|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
5621412|NCT00762502|19417889|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
5621413|NCT00762502|19417890|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
5621414|NCT00762502|19417888|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
5621415|NCT00762502|19417889|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
5621416|NCT00762502|19417890|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
5621417|NCT00762476|19417904|P2|Overall Study|Seasonal allergies|0
5621418|NCT00762476|19417905|P1|Overall Study|Seasonal allergies|1
5621419|NCT00762476|19417904|P2|Overall Study|non-compliance with study visits|2
5621420|NCT00762476|19417905|P1|Overall Study|non-compliance with study visits|0
5621421|NCT00762476|19417904|P2|Overall Study|antibiotic use|1
5621422|NCT00762476|19417905|P1|Overall Study|antibiotic use|0
5621423|NCT00762476|19417904|P2|Overall Study|Withdrawal by Subject|12
5621424|NCT00762476|19417905|P1|Overall Study|Withdrawal by Subject|6
5621425|NCT00762476|19417904|P2|Overall Study|Physician Decision|14
5621426|NCT00762476|19417905|P1|Overall Study|Physician Decision|2
5621427|NCT00762476|19417904|P2|Overall Study|Protocol Violation|6
5621428|NCT00762476|19417905|P1|Overall Study|Protocol Violation|5
5621429|NCT00762476|19417904|P2|Overall Study|Lost to Follow-up|0
5621430|NCT00762476|19417905|P1|Overall Study|Lost to Follow-up|2
5621431|NCT00762476|19417904|P2|Overall Study|Adverse Event|1
5621432|NCT00762476|19417905|P1|Overall Study|Adverse Event|7
5621433|NCT00762463|19417917|P4|Extension Phase (Week 6 to Week 12)|Other|1
5621434|NCT00762463|19417918|P3|Extension Phase (Week 6 to Week 12)|Other|0
5621435|NCT00762463|19417919|P2|Extension Phase (Week 6 to Week 12)|Other|0
5621436|NCT00762463|19417920|P1|Extension Phase (Week 6 to Week 12)|Other|0
5621437|NCT00762463|19417917|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
5621438|NCT00762463|19417918|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
5621439|NCT00762463|19417919|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
5621440|NCT00762463|19417920|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
5621441|NCT00762463|19417917|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
5621442|NCT00762463|19417918|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
5621443|NCT00762463|19417919|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
5621444|NCT00762463|19417920|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
5621445|NCT00762463|19417917|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
5621446|NCT00762463|19417918|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
5621447|NCT00762463|19417919|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
5621448|NCT00762463|19417920|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
5621449|NCT00762463|19417917|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
5621450|NCT00762463|19417918|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
5621451|NCT00762463|19417919|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
5621452|NCT00762463|19417920|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
5621453|NCT00762463|19417917|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
5621454|NCT00762463|19417918|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
5621455|NCT00762463|19417919|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
5621456|NCT00762463|19417920|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
5621457|NCT00762463|19417917|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
5621458|NCT00762463|19417918|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
5621459|NCT00762463|19417919|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
5621460|NCT00762463|19417920|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
5621461|NCT00762463|19417917|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
5621462|NCT00762463|19417918|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
5621463|NCT00762463|19417919|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
5621464|NCT00762463|19417920|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
5621465|NCT00762411|19418026|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
5621466|NCT00762411|19418027|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
5621467|NCT00762411|19418026|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
5621468|NCT00762411|19418027|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
5621469|NCT00762411|19418026|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
5621470|NCT00762411|19418027|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
5621471|NCT00762411|19418026|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
5621472|NCT00762411|19418027|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
5621473|NCT00762411|19418026|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
5621474|NCT00762411|19418027|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
5621475|NCT00762411|19418026|P2|Safety Follow Up (SFU)-Optional|Death|8
5621476|NCT00762411|19418027|P1|Safety Follow Up (SFU)-Optional|Death|1
5621477|NCT00762411|19418026|P2|Delayed Start|Caregiver Decision|1
5621478|NCT00762411|19418027|P1|Delayed Start|Caregiver Decision|1
5621479|NCT00762411|19418026|P2|Delayed Start|Sponsor Decision|20
5621480|NCT00762411|19418027|P1|Delayed Start|Sponsor Decision|16
5621481|NCT00762411|19418026|P2|Delayed Start|Protocol Violation|1
5621482|NCT00762411|19418027|P1|Delayed Start|Protocol Violation|0
5621483|NCT00762411|19418026|P2|Delayed Start|Adverse Event|4
5621484|NCT00762411|19418027|P1|Delayed Start|Adverse Event|0
5621485|NCT00762411|19418026|P2|Initial Treatment|Entry Criteria Exclusion|1
5621486|NCT00762411|19418027|P1|Initial Treatment|Entry Criteria Exclusion|0
5621487|NCT00762411|19418026|P2|Initial Treatment|Abnormal Lab/ECG Result|4
5621488|NCT00762411|19418027|P1|Initial Treatment|Abnormal Lab/ECG Result|6
5621489|NCT00762411|19418026|P2|Initial Treatment|Caregiver Decision|16
5621490|NCT00762411|19418027|P1|Initial Treatment|Caregiver Decision|21
5621491|NCT00762411|19418026|P2|Initial Treatment|Lost to Follow-up|0
5621492|NCT00762411|19418027|P1|Initial Treatment|Lost to Follow-up|5
5621493|NCT00762411|19418026|P2|Initial Treatment|Sponsor Decision|401
5621494|NCT00762411|19418027|P1|Initial Treatment|Sponsor Decision|293
5621495|NCT00762411|19418026|P2|Initial Treatment|Physician Decision|0
5621496|NCT00762411|19418027|P1|Initial Treatment|Physician Decision|1
5621497|NCT00762411|19418026|P2|Initial Treatment|Withdrawal by Subject|52
5621498|NCT00762411|19418027|P1|Initial Treatment|Withdrawal by Subject|65
5621499|NCT00762411|19418026|P2|Initial Treatment|Protocol Violation|1
5621500|NCT00762411|19418027|P1|Initial Treatment|Protocol Violation|4
5621501|NCT00762411|19418026|P2|Initial Treatment|Adverse Event|40
5621502|NCT00762411|19418027|P1|Initial Treatment|Adverse Event|132
5621503|NCT00762411|19418026|P2|Initial Treatment|Death|6
5621504|NCT00762411|19418027|P1|Initial Treatment|Death|7
5621505|NCT00762385|19418091|P2|Second Intervention|Protocol Violation|3
5621506|NCT00762385|19418092|P1|Second Intervention|Protocol Violation|3
5621507|NCT00762385|19418091|P2|First Intervention|Protocol Violation|1
5621508|NCT00762385|19418092|P1|First Intervention|Protocol Violation|0
5621509|NCT00762385|19418091|P2|First Intervention|Ineligible|0
5621510|NCT00762385|19418092|P1|First Intervention|Ineligible|1
5621511|NCT00762385|19418091|P2|First Intervention|Lost to Follow-up|2
5621512|NCT00762385|19418092|P1|First Intervention|Lost to Follow-up|0
5621513|NCT00762385|19418091|P2|First Intervention|Lens Issue|1
5621514|NCT00762385|19418092|P1|First Intervention|Lens Issue|1
5621515|NCT00762372|19418105|P3|Overall Study|Adverse Event|0
5621516|NCT00762372|19418106|P2|Overall Study|Adverse Event|0
5621517|NCT00762372|19418107|P1|Overall Study|Adverse Event|1
5621518|NCT00762359|19418183|P2|Overall Study|Withdrew consent|0
5621519|NCT00762359|19418184|P1|Overall Study|Withdrew consent|1
5621520|NCT00762359|19418183|P2|Overall Study|Removal|1
5621521|NCT00762359|19418184|P1|Overall Study|Removal|0
5621522|NCT00762359|19418183|P2|Overall Study|Physician Decision|3
5621523|NCT00762359|19418184|P1|Overall Study|Physician Decision|2
5621524|NCT00762359|19418183|P2|Overall Study|Institution closed|3
5621525|NCT00762359|19418184|P1|Overall Study|Institution closed|2
5621526|NCT00762359|19418183|P2|Overall Study|Lack of Efficacy|4
5621527|NCT00762359|19418184|P1|Overall Study|Lack of Efficacy|0
5621528|NCT00762359|19418183|P2|Overall Study|Withdrawal by Subject|10
5621529|NCT00762359|19418184|P1|Overall Study|Withdrawal by Subject|13
5621530|NCT00762359|19418183|P2|Overall Study|Protocol Violation|13
5621531|NCT00762359|19418184|P1|Overall Study|Protocol Violation|21
5621532|NCT00762359|19418183|P2|Overall Study|Adverse Event|23
5621533|NCT00762359|19418184|P1|Overall Study|Adverse Event|20
5621534|NCT00762268|19418301|P2|Overall Study|Withdrawal by Subject|3
5621535|NCT00762268|19418302|P1|Overall Study|Withdrawal by Subject|3
5621536|NCT00762229|19418314|P2|Overall Study|did not recveive intervention|1
5621537|NCT00762229|19418315|P1|Overall Study|did not recveive intervention|0
5621538|NCT00762229|19418314|P2|Overall Study|Lost to Follow-up|1
5621539|NCT00762229|19418315|P1|Overall Study|Lost to Follow-up|1
5621540|NCT00762164|19418412|P2|Overall Study|Withdrawal by Subject|1
5621541|NCT00762164|19418413|P1|Overall Study|Withdrawal by Subject|0
5621542|NCT00762164|19418412|P2|Overall Study|Discontinued medication|0
5621543|NCT00762164|19418413|P1|Overall Study|Discontinued medication|2
5621544|NCT00762164|19418412|P2|Overall Study|Lost to Follow-up|1
5621545|NCT00762164|19418413|P1|Overall Study|Lost to Follow-up|1
5621546|NCT00762086|19418423|P2|Overall Study|Ineligible to participate in the study|0
5621547|NCT00762086|19418424|P1|Overall Study|Ineligible to participate in the study|1
5621548|NCT00762086|19418423|P2|Overall Study|Withdrawal by Subject|2
5621549|NCT00762086|19418424|P1|Overall Study|Withdrawal by Subject|2
5621550|NCT00762086|19418423|P2|Overall Study|Non compliance|0
5621551|NCT00762086|19418424|P1|Overall Study|Non compliance|1
5621552|NCT00762086|19418423|P2|Overall Study|Lost to Follow-up|2
5621553|NCT00762086|19418424|P1|Overall Study|Lost to Follow-up|0
5621554|NCT00762086|19418423|P2|Overall Study|Adverse Event|0
5621555|NCT00762086|19418424|P1|Overall Study|Adverse Event|2
5621556|NCT00762073|19418434|P4|Overall Study|Not on treatment for >/= 77 days|0
5621557|NCT00762073|19418435|P3|Overall Study|Not on treatment for >/= 77 days|0
5621558|NCT00762073|19418436|P2|Overall Study|Not on treatment for >/= 77 days|0
5621559|NCT00762073|19418437|P1|Overall Study|Not on treatment for >/= 77 days|1
5621560|NCT00762073|19418434|P4|Overall Study|Withdrawal by Subject|1
5621561|NCT00762073|19418435|P3|Overall Study|Withdrawal by Subject|1
5621562|NCT00762073|19418436|P2|Overall Study|Withdrawal by Subject|2
5621563|NCT00762073|19418437|P1|Overall Study|Withdrawal by Subject|1
5621564|NCT00762073|19418434|P4|Overall Study|Significant Subject Noncompliance|1
5621565|NCT00762073|19418435|P3|Overall Study|Significant Subject Noncompliance|0
5621566|NCT00762073|19418436|P2|Overall Study|Significant Subject Noncompliance|1
5621567|NCT00762073|19418437|P1|Overall Study|Significant Subject Noncompliance|0
5621568|NCT00762073|19418434|P4|Overall Study|Adverse Event|1
5621569|NCT00762073|19418435|P3|Overall Study|Adverse Event|1
5621570|NCT00762073|19418436|P2|Overall Study|Adverse Event|0
5621571|NCT00762073|19418437|P1|Overall Study|Adverse Event|1
5621572|NCT00762073|19418434|P4|Overall Study|Lack of Efficacy|0
5621573|NCT00762073|19418435|P3|Overall Study|Lack of Efficacy|0
5621574|NCT00762073|19418436|P2|Overall Study|Lack of Efficacy|1
5621575|NCT00762073|19418437|P1|Overall Study|Lack of Efficacy|1
5621576|NCT00762034|19418501|P2|Maintenance Period|Other|1
5621577|NCT00762034|19418502|P1|Maintenance Period|Other|1
5621578|NCT00762034|19418501|P2|Maintenance Period|Death due to study disease|3
5621579|NCT00762034|19418502|P1|Maintenance Period|Death due to study disease|3
5621580|NCT00762034|19418501|P2|Maintenance Period|Death not due to study disease|5
5621581|NCT00762034|19418502|P1|Maintenance Period|Death not due to study disease|2
5621582|NCT00762034|19418501|P2|Maintenance Period|Withdrawal by Subject|14
5621583|NCT00762034|19418502|P1|Maintenance Period|Withdrawal by Subject|34
5621584|NCT00762034|19418501|P2|Maintenance Period|Physician Decision|20
5621585|NCT00762034|19418502|P1|Maintenance Period|Physician Decision|25
5621586|NCT00762034|19418501|P2|Maintenance Period|Progressive Disease|224
5621587|NCT00762034|19418502|P1|Maintenance Period|Progressive Disease|186
5621588|NCT00762034|19418501|P2|Maintenance Period|Adverse Event|26
5621589|NCT00762034|19418502|P1|Maintenance Period|Adverse Event|42
5621590|NCT00762034|19418501|P2|Maintenance Period|Entry Criterion Not Met|2
5621591|NCT00762034|19418502|P1|Maintenance Period|Entry Criterion Not Met|0
5621592|NCT00762034|19418501|P2|Maintenance Period|Protocol Violation|3
5621593|NCT00762034|19418502|P1|Maintenance Period|Protocol Violation|1
5621594|NCT00762034|19418501|P2|Induction Period|Deaths Due to Study Disease|9
5621595|NCT00762034|19418502|P1|Induction Period|Deaths Due to Study Disease|9
5621596|NCT00762034|19418501|P2|Induction Period|Deaths Not Due to Study Disease|14
5621597|NCT00762034|19418502|P1|Induction Period|Deaths Not Due to Study Disease|19
5621598|NCT00762034|19418501|P2|Induction Period|Withdrawal by Subject|19
5621599|NCT00762034|19418502|P1|Induction Period|Withdrawal by Subject|15
5621600|NCT00762034|19418501|P2|Induction Period|Physician Decision|20
5621601|NCT00762034|19418502|P1|Induction Period|Physician Decision|21
5621602|NCT00762034|19418501|P2|Induction Period|Progressive Disease|55
5621603|NCT00762034|19418502|P1|Induction Period|Progressive Disease|73
5621604|NCT00762034|19418501|P2|Induction Period|Lost to Follow-up|1
5621605|NCT00762034|19418502|P1|Induction Period|Lost to Follow-up|1
5621606|NCT00762034|19418501|P2|Induction Period|Adverse Event|38
5621607|NCT00762034|19418502|P1|Induction Period|Adverse Event|27
5621608|NCT00762034|19418501|P2|Induction Period|Entry Criterion Not Met|11
5621609|NCT00762034|19418502|P1|Induction Period|Entry Criterion Not Met|12
5621610|NCT00762034|19418501|P2|Induction Period|Protocol Violation|2
5621611|NCT00762034|19418502|P1|Induction Period|Protocol Violation|1
5621612|NCT00761969|19418574|P2|Overall Study|Lost to Follow-up|93
5621613|NCT00761969|19418575|P1|Overall Study|Lost to Follow-up|88
5621614|NCT00761969|19418574|P2|Overall Study|Death|47
5621615|NCT00761969|19418575|P1|Overall Study|Death|112
5621616|NCT00761956|19418585|P2|Overall Study|Adverse Event|34
5621617|NCT00761956|19418586|P1|Overall Study|Adverse Event|26
5621618|NCT00761956|19418585|P2|Overall Study|Death|1
5621619|NCT00761956|19418586|P1|Overall Study|Death|0
5621620|NCT00761956|19418585|P2|Overall Study|Withdrawal by Subject|8
5621621|NCT00761956|19418586|P1|Overall Study|Withdrawal by Subject|3
5621622|NCT00761956|19418585|P2|Overall Study|Lost to Follow-up|11
5621623|NCT00761956|19418586|P1|Overall Study|Lost to Follow-up|6
5621624|NCT00761891|19418613|P1|Overall Study|Withdrawal by Subject|10
5621625|NCT00761865|19418620|P2|Overall Study|Lost to Follow-up|7
5621626|NCT00761865|19418621|P1|Overall Study|Lost to Follow-up|8
5621627|NCT00761774|19418642|P1|Overall Study|IP stopped by hospital physician|1
5621628|NCT00761774|19418642|P1|Overall Study|Subject IP non-compliance|1
5621629|NCT00761774|19418642|P1|Overall Study|Coordinator leaving site|1
5621630|NCT00761774|19418642|P1|Overall Study|Patient moved out of study area|1
5621631|NCT00761774|19418642|P1|Overall Study|Investigator clinical judgement|1
5621632|NCT00761774|19418642|P1|Overall Study|Sponsor decision|1
5621633|NCT00761774|19418642|P1|Overall Study|Medical decision to read SUSAR reports|1
5621634|NCT00761774|19418642|P1|Overall Study|Reclassification of seizures|1
5621635|NCT00761774|19418642|P1|Overall Study|End of study|2
5621636|NCT00761774|19418642|P1|Overall Study|Non-compliance|4
5621637|NCT00761774|19418642|P1|Overall Study|Withdrawal by Subject|9
5621638|NCT00761774|19418642|P1|Overall Study|Lost to Follow-up|2
5621639|NCT00761774|19418642|P1|Overall Study|Lack of Efficacy|37
5621640|NCT00761774|19418642|P1|Overall Study|Adverse Event|17
5621641|NCT00761761|19418653|P2|Overall Study|Withdrawal by Subject|0
5621642|NCT00761761|19418654|P1|Overall Study|Withdrawal by Subject|3
5621643|NCT00761761|19418653|P2|Overall Study|Lost to Follow-up|1
5621644|NCT00761761|19418654|P1|Overall Study|Lost to Follow-up|3
5621645|NCT00761748|19418666|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
5621646|NCT00761748|19418667|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
5621647|NCT00761748|19418666|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
5621648|NCT00761748|19418667|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
5621649|NCT00761735|19418673|P1|Overall Study|Administrative|1
5621650|NCT00761735|19418673|P1|Overall Study|Non-compliance with protocol|1
5621651|NCT00761735|19418673|P1|Overall Study|Withdrawal by Subject|6
5621652|NCT00761735|19418673|P1|Overall Study|Lost to Follow-up|6
5621653|NCT00761631|19418689|P6|Overall Study|Other|1
5621654|NCT00761631|19418690|P5|Overall Study|Other|1
5621655|NCT00761631|19418691|P4|Overall Study|Other|0
5621656|NCT00761631|19418692|P3|Overall Study|Other|0
5621657|NCT00761631|19418693|P2|Overall Study|Other|0
5621658|NCT00761631|19418694|P1|Overall Study|Other|0
5621659|NCT00761631|19418689|P6|Overall Study|Physician Decision|0
5621660|NCT00761631|19418690|P5|Overall Study|Physician Decision|0
5621661|NCT00761631|19418691|P4|Overall Study|Physician Decision|0
5621662|NCT00761631|19418692|P3|Overall Study|Physician Decision|0
5621663|NCT00761631|19418693|P2|Overall Study|Physician Decision|0
5621664|NCT00761631|19418694|P1|Overall Study|Physician Decision|1
5621665|NCT00761631|19418689|P6|Overall Study|Failed to return|2
5621666|NCT00761631|19418690|P5|Overall Study|Failed to return|5
5621667|NCT00761631|19418691|P4|Overall Study|Failed to return|1
5621668|NCT00761631|19418692|P3|Overall Study|Failed to return|1
5621669|NCT00761631|19418693|P2|Overall Study|Failed to return|0
5621670|NCT00761631|19418694|P1|Overall Study|Failed to return|1
5621671|NCT00761631|19418689|P6|Overall Study|Randomized, not treated|0
5621672|NCT00761631|19418690|P5|Overall Study|Randomized, not treated|0
5621673|NCT00761631|19418691|P4|Overall Study|Randomized, not treated|0
5621674|NCT00761631|19418692|P3|Overall Study|Randomized, not treated|0
5621675|NCT00761631|19418693|P2|Overall Study|Randomized, not treated|0
5621676|NCT00761631|19418694|P1|Overall Study|Randomized, not treated|1
5621677|NCT00761631|19418689|P6|Overall Study|Protocol Violation|1
5621678|NCT00761631|19418690|P5|Overall Study|Protocol Violation|5
5621679|NCT00761631|19418691|P4|Overall Study|Protocol Violation|1
5621680|NCT00761631|19418692|P3|Overall Study|Protocol Violation|0
5621681|NCT00761631|19418693|P2|Overall Study|Protocol Violation|0
5621682|NCT00761631|19418694|P1|Overall Study|Protocol Violation|2
5621683|NCT00761631|19418689|P6|Overall Study|Lost to Follow-up|1
5621684|NCT00761631|19418690|P5|Overall Study|Lost to Follow-up|6
5621685|NCT00761631|19418691|P4|Overall Study|Lost to Follow-up|1
5621686|NCT00761631|19418692|P3|Overall Study|Lost to Follow-up|7
5621687|NCT00761631|19418693|P2|Overall Study|Lost to Follow-up|4
5621688|NCT00761631|19418694|P1|Overall Study|Lost to Follow-up|2
5621689|NCT00761631|19418689|P6|Overall Study|Parent/legal guardian request|0
5621690|NCT00761631|19418690|P5|Overall Study|Parent/legal guardian request|5
5621691|NCT00761631|19418691|P4|Overall Study|Parent/legal guardian request|0
5621692|NCT00761631|19418692|P3|Overall Study|Parent/legal guardian request|8
5621693|NCT00761631|19418693|P2|Overall Study|Parent/legal guardian request|3
5621694|NCT00761631|19418694|P1|Overall Study|Parent/legal guardian request|8
5621695|NCT00761605|19418729|P1|Overall Study|Other|21
5621696|NCT00761605|19418729|P1|Overall Study|Withdrawal by Subject|37
5621697|NCT00761605|19418729|P1|Overall Study|Lost to Follow-up|29
5621698|NCT00761605|19418729|P1|Overall Study|Lack of Efficacy|26
5621699|NCT00761605|19418729|P1|Overall Study|Death|2
5621700|NCT00761605|19418729|P1|Overall Study|Adverse Event|26
5621701|NCT00761579|19418773|P1|Overall Study|Intake of prohibited concomitant drug|1
5621702|NCT00761579|19418773|P1|Overall Study|Lost survey form|1
5621703|NCT00761579|19418773|P1|Overall Study|Aggravation of symptoms by changing drug|1
5621704|NCT00761579|19418773|P1|Overall Study|Aggravation of depression|1
5621705|NCT00761579|19418773|P1|Overall Study|Drug overdose|1
5621706|NCT00761579|19418773|P1|Overall Study|Protocol deviation|1
5621707|NCT00761579|19418773|P1|Overall Study|Lack of compliance|2
5621708|NCT00761579|19418773|P1|Overall Study|Withdrawal by Subject|34
5621709|NCT00761579|19418773|P1|Overall Study|Pregnancy|1
5621710|NCT00761579|19418773|P1|Overall Study|Lost to Follow-up|16
5621711|NCT00761579|19418773|P1|Overall Study|Lack of Efficacy|21
5621712|NCT00761579|19418773|P1|Overall Study|Death|2
5621713|NCT00761579|19418773|P1|Overall Study|Adverse Event|10
5621714|NCT00761527|19418806|P1|Overall Study|Unknown reason|2
5621715|NCT00761527|19418806|P1|Overall Study|Lost to Follow-up|9
5621716|NCT00761527|19418806|P1|Overall Study|Poor Compliance|8
5621717|NCT00761527|19418806|P1|Overall Study|Adverse Event|3
5621718|NCT00761514|19418813|P1|Overall Study|Unable to pay for medications|1
5621719|NCT00761514|19418813|P1|Overall Study|Problem complying with study visit|1
5621720|NCT00761514|19418813|P1|Overall Study|Health insurance didn't cover study drug|1
5621721|NCT00761514|19418813|P1|Overall Study|Lost to Follow-up|1
5621722|NCT00761514|19418813|P1|Overall Study|Withdrawal by Subject|2
5621723|NCT00761514|19418813|P1|Overall Study|Adverse Event|1
5621724|NCT00761462|19418820|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
5621725|NCT00761462|19418821|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
5621726|NCT00761462|19418820|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
5621727|NCT00761462|19418821|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
5621728|NCT00761462|19418820|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
5621729|NCT00761462|19418821|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
5621730|NCT00761462|19418820|P2|Treatment|Subjects never received study medication|12
5621731|NCT00761462|19418821|P1|Treatment|Subjects never received study medication|23
5621732|NCT00761319|19418835|P2|Overall Study|Missing|0
5621733|NCT00761319|19418836|P1|Overall Study|Missing|1
5621734|NCT00761319|19418835|P2|Overall Study|Nonspecified|2
5621735|NCT00761319|19418836|P1|Overall Study|Nonspecified|2
5621736|NCT00761319|19418835|P2|Overall Study|Lost to Follow-up|1
5621737|NCT00761319|19418836|P1|Overall Study|Lost to Follow-up|1
5621738|NCT00761319|19418835|P2|Overall Study|Noncompliance|3
5621739|NCT00761319|19418836|P1|Overall Study|Noncompliance|4
5621740|NCT00761319|19418835|P2|Overall Study|Withdrawal by Subject|7
5621741|NCT00761319|19418836|P1|Overall Study|Withdrawal by Subject|8
5621742|NCT00761319|19418835|P2|Overall Study|Adverse Event|7
5621743|NCT00761319|19418836|P1|Overall Study|Adverse Event|11
5621744|NCT00761319|19418835|P2|Overall Study|Protocol Violation|14
5621745|NCT00761319|19418836|P1|Overall Study|Protocol Violation|21
5621746|NCT00761306|19418844|P1|Overall Study|Administrative or Other Reasons|5
5621747|NCT00761306|19418844|P1|Overall Study|Lost to Follow-up|1
5621748|NCT00761306|19418844|P1|Overall Study|Withdrawal of Consent|3
5621749|NCT00761306|19418844|P1|Overall Study|Protocol Violation|2
5621750|NCT00761306|19418844|P1|Overall Study|Lack of Efficacy|4
5621751|NCT00761306|19418844|P1|Overall Study|Adverse Event|5
5621752|NCT00761280|19418855|P2|First Dose to End of Study|Lost to Follow-up|1
5621753|NCT00761280|19418856|P1|First Dose to End of Study|Lost to Follow-up|0
5621754|NCT00761280|19418855|P2|First Dose to End of Study|Death|0
5621755|NCT00761280|19418856|P1|First Dose to End of Study|Death|1
5621756|NCT00761280|19418855|P2|First Dose to End of Study|Sponsor decision|2
5621757|NCT00761280|19418856|P1|First Dose to End of Study|Sponsor decision|1
5621758|NCT00761280|19418855|P2|First Dose to End of Study|Progressive disease|3
5621759|NCT00761280|19418856|P1|First Dose to End of Study|Progressive disease|5
5621760|NCT00761280|19418855|P2|First Dose to End of Study|End of trial|5
5621761|NCT00761280|19418856|P1|First Dose to End of Study|End of trial|5
5621762|NCT00761280|19418855|P2|Randomization to First Dose|Other|0
5621763|NCT00761280|19418856|P1|Randomization to First Dose|Other|1
5621764|NCT00761280|19418855|P2|Randomization to First Dose|Sponsor decision|0
5621765|NCT00761280|19418856|P1|Randomization to First Dose|Sponsor decision|1
5621766|NCT00761280|19418855|P2|Randomization to First Dose|Withdrawal by Subject|2
5621767|NCT00761280|19418856|P1|Randomization to First Dose|Withdrawal by Subject|0
5621768|NCT00761267|19418887|P3|Overall Study|Withdrawal by Subject|0
5621769|NCT00761267|19418888|P2|Overall Study|Withdrawal by Subject|1
5621770|NCT00761267|19418889|P1|Overall Study|Withdrawal by Subject|0
5621771|NCT00761267|19418887|P3|Overall Study|Randomized but not treated|0
5621772|NCT00761267|19418888|P2|Overall Study|Randomized but not treated|1
5621773|NCT00761267|19418889|P1|Overall Study|Randomized but not treated|1
5621774|NCT00761267|19418887|P3|Overall Study|Lost to Follow-up|1
5621775|NCT00761267|19418888|P2|Overall Study|Lost to Follow-up|0
5621776|NCT00761267|19418889|P1|Overall Study|Lost to Follow-up|0
5621777|NCT00761267|19418887|P3|Overall Study|Death|5
5621778|NCT00761267|19418888|P2|Overall Study|Death|2
5621779|NCT00761267|19418889|P1|Overall Study|Death|1
5621780|NCT00761215|19418940|P3|Overall Study|Bacteremia|0
5621781|NCT00761215|19418941|P2|Overall Study|Bacteremia|0
5621782|NCT00761215|19418942|P1|Overall Study|Bacteremia|1
5621783|NCT00761215|19418940|P3|Overall Study|Withdrawal by Subject|0
5621784|NCT00761215|19418941|P2|Overall Study|Withdrawal by Subject|0
5621785|NCT00761215|19418942|P1|Overall Study|Withdrawal by Subject|1
5621786|NCT00761215|19418940|P3|Overall Study|Lost to Follow-up|6
5621787|NCT00761215|19418941|P2|Overall Study|Lost to Follow-up|3
5621788|NCT00761215|19418942|P1|Overall Study|Lost to Follow-up|6
5621789|NCT00761215|19418940|P3|Overall Study|Randomized but didn't receive drug|2
5621790|NCT00761215|19418941|P2|Overall Study|Randomized but didn't receive drug|1
5621791|NCT00761215|19418942|P1|Overall Study|Randomized but didn't receive drug|1
5621792|NCT00761189|19418984|P1|Overall Study|Other|13
5621793|NCT00761189|19418984|P1|Overall Study|Withdrawal by Subject|49
5621794|NCT00761189|19418984|P1|Overall Study|Lost to Follow-up|36
5621795|NCT00761189|19418984|P1|Overall Study|Lack of Efficacy|45
5621796|NCT00761189|19418984|P1|Overall Study|Adverse Event|42
5621797|NCT00761176|19419001|P2|Overall Study|Withdrawal by Subject|1
5621798|NCT00761176|19419002|P1|Overall Study|Withdrawal by Subject|1
5621799|NCT00761176|19419001|P2|Overall Study|Death|0
5621800|NCT00761176|19419002|P1|Overall Study|Death|1
5621801|NCT00761150|19419011|P3|Double-blind Period|Other|3
5621802|NCT00761150|19419012|P2|Double-blind Period|Other|3
5621803|NCT00761150|19419013|P1|Double-blind Period|Other|0
5621804|NCT00761150|19419011|P3|Double-blind Period|Noncompliance|0
5621805|NCT00761150|19419012|P2|Double-blind Period|Noncompliance|1
5621806|NCT00761150|19419013|P1|Double-blind Period|Noncompliance|0
5621807|NCT00761150|19419011|P3|Double-blind Period|Did not meet DB randomization criteria|1
5621808|NCT00761150|19419012|P2|Double-blind Period|Did not meet DB randomization criteria|0
5621809|NCT00761150|19419013|P1|Double-blind Period|Did not meet DB randomization criteria|0
5621810|NCT00761150|19419011|P3|Double-blind Period|Lost to Follow-up|1
5621811|NCT00761150|19419012|P2|Double-blind Period|Lost to Follow-up|2
5621812|NCT00761150|19419013|P1|Double-blind Period|Lost to Follow-up|0
5621813|NCT00761150|19419011|P3|Double-blind Period|Withdrawal by Subject|2
5621814|NCT00761150|19419012|P2|Double-blind Period|Withdrawal by Subject|3
5621815|NCT00761150|19419013|P1|Double-blind Period|Withdrawal by Subject|0
5621816|NCT00761150|19419011|P3|Double-blind Period|Adverse Event|3
5621817|NCT00761150|19419012|P2|Double-blind Period|Adverse Event|3
5621818|NCT00761150|19419013|P1|Double-blind Period|Adverse Event|0
5621819|NCT00761150|19419011|P3|Double-blind Period|Lack of Efficacy|19
5621820|NCT00761150|19419012|P2|Double-blind Period|Lack of Efficacy|2
5621821|NCT00761150|19419013|P1|Double-blind Period|Lack of Efficacy|0
5621822|NCT00761150|19419011|P3|Open-label Period|Other|0
5621823|NCT00761150|19419012|P2|Open-label Period|Other|0
5621824|NCT00761150|19419013|P1|Open-label Period|Other|5
5621825|NCT00761150|19419011|P3|Open-label Period|Noncompliance|0
5621826|NCT00761150|19419012|P2|Open-label Period|Noncompliance|0
5621827|NCT00761150|19419013|P1|Open-label Period|Noncompliance|2
5621828|NCT00761150|19419011|P3|Open-label Period|Withdrawal by Subject|0
5621829|NCT00761150|19419012|P2|Open-label Period|Withdrawal by Subject|0
5621830|NCT00761150|19419013|P1|Open-label Period|Withdrawal by Subject|5
5621831|NCT00761150|19419011|P3|Open-label Period|Lack of Efficacy|0
5621832|NCT00761150|19419012|P2|Open-label Period|Lack of Efficacy|0
5621833|NCT00761150|19419013|P1|Open-label Period|Lack of Efficacy|4
5621834|NCT00761150|19419011|P3|Open-label Period|Lost to Follow-up|0
5621835|NCT00761150|19419012|P2|Open-label Period|Lost to Follow-up|0
5621836|NCT00761150|19419013|P1|Open-label Period|Lost to Follow-up|7
5621837|NCT00761150|19419011|P3|Open-label Period|Did not meet DB randomization criteria|0
5621838|NCT00761150|19419012|P2|Open-label Period|Did not meet DB randomization criteria|0
5621839|NCT00761150|19419013|P1|Open-label Period|Did not meet DB randomization criteria|11
5621840|NCT00761150|19419011|P3|Open-label Period|Adverse Event|0
5621841|NCT00761150|19419012|P2|Open-label Period|Adverse Event|0
5621842|NCT00761150|19419013|P1|Open-label Period|Adverse Event|36
5621843|NCT00760994|19419086|P3|Overall Study|Lost to Follow-up|3
5621844|NCT00760994|19419087|P2|Overall Study|Lost to Follow-up|4
5621845|NCT00760994|19419088|P1|Overall Study|Lost to Follow-up|4
5621846|NCT00760877|19419101|P2|Overall Study|Treatment failure|0
5621847|NCT00760877|19419102|P1|Overall Study|Treatment failure|1
5621848|NCT00760877|19419101|P2|Overall Study|Participants transferred to AMN107A2408|1
5621849|NCT00760877|19419102|P1|Overall Study|Participants transferred to AMN107A2408|11
5621850|NCT00760877|19419101|P2|Overall Study|Physician Decision|2
5621851|NCT00760877|19419102|P1|Overall Study|Physician Decision|1
5621852|NCT00760877|19419101|P2|Overall Study|Participant not eligible to cross-over|1
5621853|NCT00760877|19419102|P1|Overall Study|Participant not eligible to cross-over|0
5621854|NCT00760877|19419101|P2|Overall Study|Participant diagnosed with AML|1
5621855|NCT00760877|19419102|P1|Overall Study|Participant diagnosed with AML|0
5621856|NCT00760877|19419101|P2|Overall Study|Adverse Event|12
5621857|NCT00760877|19419102|P1|Overall Study|Adverse Event|19
5621858|NCT00760877|19419101|P2|Overall Study|Withdrawal by Subject|3
5621859|NCT00760877|19419102|P1|Overall Study|Withdrawal by Subject|7
5621860|NCT00760877|19419101|P2|Overall Study|Death|1
5621861|NCT00760877|19419102|P1|Overall Study|Death|2
5621862|NCT00760877|19419101|P2|Overall Study|Pregnancy|4
5621863|NCT00760877|19419102|P1|Overall Study|Pregnancy|1
5621864|NCT00760877|19419101|P2|Overall Study|Non-compliance with protocol treatment|1
5621865|NCT00760877|19419102|P1|Overall Study|Non-compliance with protocol treatment|2
5621866|NCT00760877|19419101|P2|Overall Study|Protocol Violation|0
5621867|NCT00760877|19419102|P1|Overall Study|Protocol Violation|1
5621868|NCT00760838|19419120|P2|Overall Study|Withdrawal by Subject|1
5621869|NCT00760838|19419121|P1|Overall Study|Withdrawal by Subject|1
5621870|NCT00760838|19419120|P2|Overall Study|Lost to Follow-up|0
5621871|NCT00760838|19419121|P1|Overall Study|Lost to Follow-up|2
5621872|NCT00760838|19419120|P2|Overall Study|Lack of Efficacy|0
5621873|NCT00760838|19419121|P1|Overall Study|Lack of Efficacy|1
5621874|NCT00760838|19419120|P2|Overall Study|Adverse Event|1
5621875|NCT00760838|19419121|P1|Overall Study|Adverse Event|1
5621876|NCT00760747|19419139|P2|Study Period III|Physician Decision|1
5621877|NCT00760747|19419140|P1|Study Period III|Physician Decision|0
5621878|NCT00760747|19419139|P2|Study Period III|Protocol Violation|1
5621879|NCT00760747|19419140|P1|Study Period III|Protocol Violation|1
5621880|NCT00760747|19419139|P2|Study Period III|Parent/Caregiver Decision|1
5621881|NCT00760747|19419140|P1|Study Period III|Parent/Caregiver Decision|0
5621882|NCT00760747|19419139|P2|Study Period III|Lack of Efficacy|0
5621883|NCT00760747|19419140|P1|Study Period III|Lack of Efficacy|1
5621884|NCT00760747|19419139|P2|Study Period III|Adverse Event|0
5621885|NCT00760747|19419140|P1|Study Period III|Adverse Event|1
5621886|NCT00760747|19419139|P2|Study Period II|No drug administered|1
5621887|NCT00760747|19419140|P1|Study Period II|No drug administered|0
5621888|NCT00760747|19419139|P2|Study Period II|Withdrawal by Subject|0
5621889|NCT00760747|19419140|P1|Study Period II|Withdrawal by Subject|1
5621890|NCT00760747|19419139|P2|Study Period II|Protocol Violation|3
5621891|NCT00760747|19419140|P1|Study Period II|Protocol Violation|6
5621892|NCT00760747|19419139|P2|Study Period II|Parent/Caregiver Decision|0
5621893|NCT00760747|19419140|P1|Study Period II|Parent/Caregiver Decision|3
5621894|NCT00760747|19419139|P2|Study Period II|Lack of Efficacy|6
5621895|NCT00760747|19419140|P1|Study Period II|Lack of Efficacy|0
5621896|NCT00760747|19419139|P2|Study Period II|Adverse Event|4
5621897|NCT00760747|19419140|P1|Study Period II|Adverse Event|3
5621898|NCT00760669|19419168|P1|Overall Study|Took drug before entering in contract|5
5621899|NCT00760669|19419168|P1|Overall Study|Participants with overlapping cases|1
5621900|NCT00760669|19419168|P1|Overall Study|Participants missing efficacy assessment|6
5621901|NCT00760669|19419168|P1|Overall Study|Not assessed for overall improvement|18
5621902|NCT00760617|19419185|P3|Overall Study|Lost to Follow-up|5
5621903|NCT00760617|19419186|P2|Overall Study|Lost to Follow-up|0
5621904|NCT00760617|19419187|P1|Overall Study|Lost to Follow-up|0
5621905|NCT00760617|19419185|P3|Overall Study|Adverse Event|0
5621906|NCT00760617|19419186|P2|Overall Study|Adverse Event|2
5621907|NCT00760617|19419187|P1|Overall Study|Adverse Event|5
5621908|NCT00760552|19419301|P2|Overall Study|Lost to Follow-up|10
5621909|NCT00760552|19419302|P1|Overall Study|Lost to Follow-up|11
5621910|NCT00760552|19419301|P2|Overall Study|Death|0
5621911|NCT00760552|19419302|P1|Overall Study|Death|2
5621912|NCT00760513|19419338|P2|Overall Study|Withdrawal by Subject|7
5621913|NCT00760513|19419339|P1|Overall Study|Withdrawal by Subject|5
5621914|NCT00760487|19419349|P1|Overall Study|Unilateral implantation|3
5621915|NCT00760474|19419355|P2|Period 2 (P2)|Adverse Event|1
5621916|NCT00760474|19419356|P1|Period 2 (P2)|Adverse Event|0
5621917|NCT00760474|19419355|P2|Period 2 (P2)|Lost to Follow-up|0
5621918|NCT00760474|19419356|P1|Period 2 (P2)|Lost to Follow-up|1
5621919|NCT00760474|19419355|P2|Placebo Washout Period|Other|1
5621920|NCT00760474|19419356|P1|Placebo Washout Period|Other|0
5621921|NCT00760474|19419355|P2|Period 1 (P1)|Discontinued then re-entered|1
5621922|NCT00760474|19419356|P1|Period 1 (P1)|Discontinued then re-entered|1
5621923|NCT00760383|19419413|P2|Overall Study|moved away; withdrew; medical reasons|7
5621924|NCT00760383|19419414|P1|Overall Study|moved away; withdrew; medical reasons|5
5621925|NCT00760266|19419426|P2|Overall Study|Administrative Problems|1
5621926|NCT00760266|19419427|P1|Overall Study|Administrative Problems|0
5621927|NCT00760266|19419426|P2|Overall Study|Lost to Follow-up|1
5621928|NCT00760266|19419427|P1|Overall Study|Lost to Follow-up|2
5621929|NCT00760266|19419426|P2|Overall Study|Patient withdrew consent|3
5621930|NCT00760266|19419427|P1|Overall Study|Patient withdrew consent|3
5621931|NCT00760266|19419426|P2|Overall Study|Protocol deviation|4
5621932|NCT00760266|19419427|P1|Overall Study|Protocol deviation|2
5621933|NCT00760266|19419426|P2|Overall Study|Lack of Efficacy|2
5621934|NCT00760266|19419427|P1|Overall Study|Lack of Efficacy|2
5621935|NCT00760266|19419426|P2|Overall Study|Abnormal test procedure result(s)|0
5621936|NCT00760266|19419427|P1|Overall Study|Abnormal test procedure result(s)|1
5621937|NCT00760266|19419426|P2|Overall Study|Abnormal laboratory value(s)|0
5621938|NCT00760266|19419427|P1|Overall Study|Abnormal laboratory value(s)|1
5621939|NCT00760266|19419426|P2|Overall Study|Adverse Event|7
5621940|NCT00760266|19419427|P1|Overall Study|Adverse Event|13
5621941|NCT00760214|19419444|P3|Overall Study|Other|6
5621942|NCT00760214|19419445|P2|Overall Study|Other|4
5621943|NCT00760214|19419446|P1|Overall Study|Other|3
5621944|NCT00760214|19419444|P3|Overall Study|Physician Decision|1
5621945|NCT00760214|19419445|P2|Overall Study|Physician Decision|1
5621946|NCT00760214|19419446|P1|Overall Study|Physician Decision|1
5621947|NCT00760214|19419444|P3|Overall Study|Pregnancy|1
5621948|NCT00760214|19419445|P2|Overall Study|Pregnancy|0
5621949|NCT00760214|19419446|P1|Overall Study|Pregnancy|0
5621950|NCT00760214|19419444|P3|Overall Study|Lack of Efficacy|4
5621951|NCT00760214|19419445|P2|Overall Study|Lack of Efficacy|2
5621952|NCT00760214|19419446|P1|Overall Study|Lack of Efficacy|3
5621953|NCT00760214|19419444|P3|Overall Study|Withdrawal by Subject|13
5621954|NCT00760214|19419445|P2|Overall Study|Withdrawal by Subject|14
5621955|NCT00760214|19419446|P1|Overall Study|Withdrawal by Subject|12
5621956|NCT00760214|19419444|P3|Overall Study|Lost to Follow-up|1
5621957|NCT00760214|19419445|P2|Overall Study|Lost to Follow-up|0
5621958|NCT00760214|19419446|P1|Overall Study|Lost to Follow-up|0
5621959|NCT00760214|19419444|P3|Overall Study|Protocol Violation|3
5621960|NCT00760214|19419445|P2|Overall Study|Protocol Violation|0
5621961|NCT00760214|19419446|P1|Overall Study|Protocol Violation|3
5621962|NCT00760214|19419444|P3|Overall Study|Adverse Event|12
5621963|NCT00760214|19419445|P2|Overall Study|Adverse Event|9
5621964|NCT00760214|19419446|P1|Overall Study|Adverse Event|8
5621965|NCT00760084|19419487|P1|Overall Study|Progressive Disease|3
5621966|NCT00760084|19419487|P1|Overall Study|Withdrawal by Subject|2
5621967|NCT00760084|19419487|P1|Overall Study|Physician Decision|5
5621968|NCT00759954|19419530|P2|Overall Study|Adverse Event|2
5621969|NCT00759954|19419531|P1|Overall Study|Adverse Event|1
5621970|NCT00759954|19419530|P2|Overall Study|Personal reason|0
5621971|NCT00759954|19419531|P1|Overall Study|Personal reason|1
5621972|NCT00759941|19419545|P2|Overall Study|Exited in error by site|1
5621973|NCT00759941|19419546|P1|Overall Study|Exited in error by site|1
5621974|NCT00759941|19419545|P2|Overall Study|Adverse Event|0
5621975|NCT00759941|19419546|P1|Overall Study|Adverse Event|1
5621976|NCT00759941|19419545|P2|Overall Study|Use of medication|0
5621977|NCT00759941|19419546|P1|Overall Study|Use of medication|1
5621978|NCT00759915|19419560|P2|Overall Study|Adverse Event|1
5621979|NCT00759915|19419561|P1|Overall Study|Adverse Event|0
5621980|NCT00759915|19419560|P2|Overall Study|Withdrawal by Subject|0
5621981|NCT00759915|19419561|P1|Overall Study|Withdrawal by Subject|1
5621982|NCT00759902|19419575|P2|Overall Study|Adverse Event|1
5621983|NCT00759902|19419576|P1|Overall Study|Adverse Event|0
5621984|NCT00759876|19419588|P1|Overall Study|Sponsor terminated study early|36
5621985|NCT00759863|19419612|P2|Overall Study|Death, moved, or lost contact|18
5621986|NCT00759863|19419613|P1|Overall Study|Death, moved, or lost contact|20
5621987|NCT00759785|19419634|P2|Overall Study|Withdrawal by Subject|1
5621988|NCT00759785|19419635|P1|Overall Study|Withdrawal by Subject|0
5621989|NCT00759785|19419634|P2|Overall Study|Physician Decision|1
5621990|NCT00759785|19419635|P1|Overall Study|Physician Decision|0
5621991|NCT00759785|19419634|P2|Overall Study|Protocol Violation|0
5621992|NCT00759785|19419635|P1|Overall Study|Protocol Violation|1
5621993|NCT00759785|19419634|P2|Overall Study|Participant sample lost|1
5621994|NCT00759785|19419635|P1|Overall Study|Participant sample lost|0
5621995|NCT00759785|19419634|P2|Overall Study|Participant sample not evaluable|2
5621996|NCT00759785|19419635|P1|Overall Study|Participant sample not evaluable|11
5621997|NCT00759759|19419658|P2|Overall Study|Withdrawal by Subject|1
5621998|NCT00759759|19419659|P1|Overall Study|Withdrawal by Subject|2
5621999|NCT00759759|19419658|P2|Overall Study|Didn't receive drug in period 2|0
5622000|NCT00759759|19419659|P1|Overall Study|Didn't receive drug in period 2|1
5622001|NCT00759759|19419658|P2|Overall Study|didn't return for period 2|0
5622002|NCT00759759|19419659|P1|Overall Study|didn't return for period 2|1
5622003|NCT00759681|19419677|P2|Overall Study|Lost to Follow-up|5
5622004|NCT00759681|19419678|P1|Overall Study|Lost to Follow-up|8
5622005|NCT00759681|19419677|P2|Overall Study|Death|5
5622006|NCT00759681|19419678|P1|Overall Study|Death|2
5622007|NCT00759655|19419705|P1|Overall Study|Termination of the study by sponsor|1
5622008|NCT00759564|19419733|P5|Washout Period (at Least 14 Days)|Adverse Event|1
5622009|NCT00759564|19419734|P4|Washout Period (at Least 14 Days)|Adverse Event|0
5622010|NCT00759564|19419735|P3|Washout Period (at Least 14 Days)|Adverse Event|0
5622011|NCT00759564|19419736|P2|Washout Period (at Least 14 Days)|Adverse Event|0
5622012|NCT00759564|19419737|P1|Washout Period (at Least 14 Days)|Adverse Event|0
5622013|NCT00759395|19419914|P2|Overall Study|Lack of Efficacy|2
5622014|NCT00759395|19419915|P1|Overall Study|Lack of Efficacy|0
5622015|NCT00759395|19419914|P2|Overall Study|Withdrawal by Subject|0
5622016|NCT00759395|19419915|P1|Overall Study|Withdrawal by Subject|1
5622017|NCT00759395|19419914|P2|Overall Study|Adverse Event|0
5622018|NCT00759395|19419915|P1|Overall Study|Adverse Event|1
5622019|NCT00759356|19419931|P2|Overall Study|Subject was unable to return|0
5622020|NCT00759356|19419932|P1|Overall Study|Subject was unable to return|1
5622021|NCT00759356|19419931|P2|Overall Study|Withdrawal by Subject|2
5622022|NCT00759356|19419932|P1|Overall Study|Withdrawal by Subject|0
5622023|NCT00759356|19419931|P2|Overall Study|Adverse Event|1
5622024|NCT00759356|19419932|P1|Overall Study|Adverse Event|0
5622025|NCT00759174|19420012|P2|Overall Study|Other|2
5622026|NCT00759174|19420013|P1|Overall Study|Other|0
5622027|NCT00759148|19420037|P2|Overall Study|Reason not given|0
5622028|NCT00759148|19420038|P1|Overall Study|Reason not given|1
5622029|NCT00759148|19420037|P2|Overall Study|Treatment Failure|10
5622030|NCT00759148|19420038|P1|Overall Study|Treatment Failure|6
5622031|NCT00759148|19420037|P2|Overall Study|Lost to Follow-up|9
5622032|NCT00759148|19420038|P1|Overall Study|Lost to Follow-up|3
5622033|NCT00759148|19420037|P2|Overall Study|Withdrawal by Subject|7
5622034|NCT00759148|19420038|P1|Overall Study|Withdrawal by Subject|3
5622035|NCT00759148|19420037|P2|Overall Study|Adverse Event|6
5622036|NCT00759148|19420038|P1|Overall Study|Adverse Event|1
5622037|NCT00759109|19420048|P2|Overall Study|Lost during study|0
5622038|NCT00759109|19420049|P1|Overall Study|Lost during study|1
5622039|NCT00759109|19420048|P2|Overall Study|Participant had a liver transplant|1
5622040|NCT00759109|19420049|P1|Overall Study|Participant had a liver transplant|0
5622041|NCT00759109|19420048|P2|Overall Study|Participant moved to a different city|1
5622042|NCT00759109|19420049|P1|Overall Study|Participant moved to a different city|0
5622043|NCT00759109|19420048|P2|Overall Study|HCV RNA negative|0
5622044|NCT00759109|19420049|P1|Overall Study|HCV RNA negative|1
5622045|NCT00759109|19420048|P2|Overall Study|Started new therapy|6
5622046|NCT00759109|19420049|P1|Overall Study|Started new therapy|2
5622047|NCT00759109|19420048|P2|Overall Study|Lost to Follow-up|6
5622048|NCT00759109|19420049|P1|Overall Study|Lost to Follow-up|4
5622049|NCT00759109|19420048|P2|Overall Study|Death|3
5622050|NCT00759109|19420049|P1|Overall Study|Death|4
5622051|NCT00759109|19420048|P2|Overall Study|Withdrawal by Subject|5
5622052|NCT00759109|19420049|P1|Overall Study|Withdrawal by Subject|9
5622053|NCT00759109|19420048|P2|Overall Study|Inability to comply|1
5622054|NCT00759109|19420049|P1|Overall Study|Inability to comply|1
5622055|NCT00759109|19420048|P2|Overall Study|Adverse Event|12
5622056|NCT00759109|19420049|P1|Overall Study|Adverse Event|17
5622057|NCT00759031|19420071|P2|First Intervention (1 Day)|Screening failure|0
5622058|NCT00759031|19420072|P1|First Intervention (1 Day)|Screening failure|1
5622059|NCT00759031|19420071|P2|First Intervention (1 Day)|Withdrawal by Subject|1
5622060|NCT00759031|19420072|P1|First Intervention (1 Day)|Withdrawal by Subject|0
5622061|NCT00759031|19420071|P2|First Intervention (1 Day)|Physician Decision|0
5622062|NCT00759031|19420072|P1|First Intervention (1 Day)|Physician Decision|1
5622063|NCT00758771|19420131|P2|Overall Study|Did not meet eligibility criteria|4
5622064|NCT00758771|19420132|P1|Overall Study|Did not meet eligibility criteria|2
5622065|NCT00758771|19420131|P2|Overall Study|Withdrawal by Subject|1
5622066|NCT00758771|19420132|P1|Overall Study|Withdrawal by Subject|1
5622067|NCT00758706|19420190|P2|Overall Study|Adverse Event|4
5622068|NCT00758706|19420191|P1|Overall Study|Adverse Event|4
5622069|NCT00758680|19420227|P10|Overall Study|Withdrawal by Subject|0
5622070|NCT00758680|19420228|P9|Overall Study|Withdrawal by Subject|1
5622071|NCT00758680|19420229|P8|Overall Study|Withdrawal by Subject|0
5622072|NCT00758680|19420230|P7|Overall Study|Withdrawal by Subject|1
5622073|NCT00758680|19420231|P6|Overall Study|Withdrawal by Subject|0
5622074|NCT00758680|19420232|P5|Overall Study|Withdrawal by Subject|0
5622075|NCT00758680|19420233|P4|Overall Study|Withdrawal by Subject|0
5622076|NCT00758680|19420234|P3|Overall Study|Withdrawal by Subject|0
5622077|NCT00758680|19420235|P2|Overall Study|Withdrawal by Subject|0
5622078|NCT00758680|19420236|P1|Overall Study|Withdrawal by Subject|0
5622079|NCT00758680|19420227|P10|Overall Study|Laboratory Adverse Event|0
5622080|NCT00758680|19420228|P9|Overall Study|Laboratory Adverse Event|1
5622081|NCT00758680|19420229|P8|Overall Study|Laboratory Adverse Event|0
5622082|NCT00758680|19420230|P7|Overall Study|Laboratory Adverse Event|0
5622083|NCT00758680|19420231|P6|Overall Study|Laboratory Adverse Event|0
5622084|NCT00758680|19420232|P5|Overall Study|Laboratory Adverse Event|0
5622085|NCT00758680|19420233|P4|Overall Study|Laboratory Adverse Event|0
5622086|NCT00758680|19420234|P3|Overall Study|Laboratory Adverse Event|0
5622087|NCT00758680|19420235|P2|Overall Study|Laboratory Adverse Event|0
5622088|NCT00758680|19420236|P1|Overall Study|Laboratory Adverse Event|0
5622089|NCT00758680|19420227|P10|Overall Study|Adverse Event|1
5622090|NCT00758680|19420228|P9|Overall Study|Adverse Event|0
5622091|NCT00758680|19420229|P8|Overall Study|Adverse Event|1
5622092|NCT00758680|19420230|P7|Overall Study|Adverse Event|0
5622093|NCT00758680|19420231|P6|Overall Study|Adverse Event|0
5622094|NCT00758680|19420232|P5|Overall Study|Adverse Event|0
5622095|NCT00758680|19420233|P4|Overall Study|Adverse Event|0
5622096|NCT00758680|19420234|P3|Overall Study|Adverse Event|0
5622097|NCT00758680|19420235|P2|Overall Study|Adverse Event|0
5622098|NCT00758680|19420236|P1|Overall Study|Adverse Event|0
5622099|NCT00758602|19420289|P2|Overall Study|Reason not specified|3
5622100|NCT00758602|19420290|P1|Overall Study|Reason not specified|3
5622101|NCT00758602|19420289|P2|Overall Study|Death|1
5622102|NCT00758602|19420290|P1|Overall Study|Death|0
5622103|NCT00758602|19420289|P2|Overall Study|Protocol Violation|2
5622104|NCT00758602|19420290|P1|Overall Study|Protocol Violation|0
5622105|NCT00758602|19420289|P2|Overall Study|Withdrawal by Subject|3
5622106|NCT00758602|19420290|P1|Overall Study|Withdrawal by Subject|1
5622107|NCT00758602|19420289|P2|Overall Study|Lost to Follow-up|3
5622108|NCT00758602|19420290|P1|Overall Study|Lost to Follow-up|4
5622109|NCT00758602|19420289|P2|Overall Study|Adverse Event|10
5622110|NCT00758602|19420290|P1|Overall Study|Adverse Event|11
5622111|NCT00758589|19420316|P4|Overall Study|Palm stopped to work|1
5622112|NCT00758589|19420317|P3|Overall Study|Palm stopped to work|0
5622113|NCT00758589|19420318|P2|Overall Study|Palm stopped to work|0
5622114|NCT00758589|19420319|P1|Overall Study|Palm stopped to work|0
5622115|NCT00758589|19420316|P4|Overall Study|Withdrawal by Subject|1
5622116|NCT00758589|19420317|P3|Overall Study|Withdrawal by Subject|1
5622117|NCT00758589|19420318|P2|Overall Study|Withdrawal by Subject|1
5622118|NCT00758589|19420319|P1|Overall Study|Withdrawal by Subject|0
5622119|NCT00758589|19420316|P4|Overall Study|Adverse Event|4
5622120|NCT00758589|19420317|P3|Overall Study|Adverse Event|5
5622121|NCT00758589|19420318|P2|Overall Study|Adverse Event|2
5622122|NCT00758589|19420319|P1|Overall Study|Adverse Event|3
5622123|NCT00758498|19420412|P3|Overall Study|Noncompliance to study procedures|1
5622124|NCT00758498|19420413|P2|Overall Study|Noncompliance to study procedures|0
5622125|NCT00758498|19420414|P1|Overall Study|Noncompliance to study procedures|0
5622126|NCT00758498|19420412|P3|Overall Study|Withdrawal by Subject|1
5622127|NCT00758498|19420413|P2|Overall Study|Withdrawal by Subject|0
5622128|NCT00758498|19420414|P1|Overall Study|Withdrawal by Subject|0
5622129|NCT00758498|19420412|P3|Overall Study|Subject legally detained out of state|0
5622130|NCT00758498|19420413|P2|Overall Study|Subject legally detained out of state|0
5622131|NCT00758498|19420414|P1|Overall Study|Subject legally detained out of state|1
5622132|NCT00758498|19420412|P3|Overall Study|Adverse Event|3
5622133|NCT00758498|19420413|P2|Overall Study|Adverse Event|2
5622134|NCT00758498|19420414|P1|Overall Study|Adverse Event|2
5622135|NCT00758485|19420499|P2|Overall Study|Not Treated|2
5622136|NCT00758485|19420500|P1|Overall Study|Not Treated|1
5622137|NCT00758485|19420499|P2|Overall Study|Lost to Follow-up|1
5622138|NCT00758485|19420500|P1|Overall Study|Lost to Follow-up|0
5622139|NCT00758459|19420512|P2|Overall Study|Withdrawal by Subject|1
5622140|NCT00758459|19420513|P1|Overall Study|Withdrawal by Subject|0
5622141|NCT00758459|19420512|P2|Overall Study|Protocol Violation|1
5622142|NCT00758459|19420513|P1|Overall Study|Protocol Violation|0
5622143|NCT00758459|19420512|P2|Overall Study|Adverse Event|2
5622144|NCT00758459|19420513|P1|Overall Study|Adverse Event|3
5622145|NCT00758394|19420558|P4|3rd Intervention|Lost to Follow-up|1
5622146|NCT00758394|19420559|P3|3rd Intervention|Lost to Follow-up|0
5622147|NCT00758394|19420560|P2|3rd Intervention|Lost to Follow-up|0
5622148|NCT00758394|19420561|P1|3rd Intervention|Lost to Follow-up|1
5622149|NCT00758394|19420558|P4|2nd Intervention Order|Lost to Follow-up|0
5622150|NCT00758394|19420559|P3|2nd Intervention Order|Lost to Follow-up|0
5622151|NCT00758394|19420560|P2|2nd Intervention Order|Lost to Follow-up|1
5622152|NCT00758394|19420561|P1|2nd Intervention Order|Lost to Follow-up|0
5622153|NCT00758264|19420590|P3|Active Phase|Other|4
5622154|NCT00758264|19420591|P2|Active Phase|Other|0
5622155|NCT00758264|19420592|P1|Active Phase|Other|0
5622156|NCT00758264|19420590|P3|Active Phase|Lost to Follow-up|0
5622157|NCT00758264|19420591|P2|Active Phase|Lost to Follow-up|0
5622158|NCT00758264|19420592|P1|Active Phase|Lost to Follow-up|1
5622159|NCT00758264|19420590|P3|Active Phase|Withdrawal by Subject|1
5622160|NCT00758264|19420591|P2|Active Phase|Withdrawal by Subject|0
5622161|NCT00758264|19420592|P1|Active Phase|Withdrawal by Subject|0
5622162|NCT00758160|19420651|P1|Overall Study|Withdrawal by Subject|8
5622163|NCT00758160|19420651|P1|Overall Study|Protocol Violation|12
5622164|NCT00758160|19420651|P1|Overall Study|Lost to Follow-up|14
5622165|NCT00758160|19420651|P1|Overall Study|Lack of Efficacy|10
5622166|NCT00758160|19420651|P1|Overall Study|Adverse Event|15
5622167|NCT00758160|19420651|P1|Overall Study|Administration Problems|3
5622168|NCT00758160|19420651|P1|Overall Study|No Longer Requires Study Medication|4
5622169|NCT00758069|19420672|P3|Overall Study|Incorrect Study Drug|0
5622170|NCT00758069|19420673|P2|Overall Study|Incorrect Study Drug|0
5622171|NCT00758069|19420674|P1|Overall Study|Incorrect Study Drug|1
5622172|NCT00758069|19420672|P3|Overall Study|Lack of Efficacy|1
5622173|NCT00758069|19420673|P2|Overall Study|Lack of Efficacy|0
5622174|NCT00758069|19420674|P1|Overall Study|Lack of Efficacy|0
5622175|NCT00758043|19420689|P4|Overall Study|Other Reasons|5
5622176|NCT00758043|19420690|P3|Overall Study|Other Reasons|0
5622177|NCT00758043|19420691|P2|Overall Study|Other Reasons|1
5622178|NCT00758043|19420692|P1|Overall Study|Other Reasons|0
5622179|NCT00758043|19420689|P4|Overall Study|Non-Compliant With study Drug|1
5622180|NCT00758043|19420690|P3|Overall Study|Non-Compliant With study Drug|0
5622181|NCT00758043|19420691|P2|Overall Study|Non-Compliant With study Drug|0
5622182|NCT00758043|19420692|P1|Overall Study|Non-Compliant With study Drug|0
5622183|NCT00758043|19420689|P4|Overall Study|Required Prohibited Medication|3
5622184|NCT00758043|19420690|P3|Overall Study|Required Prohibited Medication|1
5622185|NCT00758043|19420691|P2|Overall Study|Required Prohibited Medication|0
5622186|NCT00758043|19420692|P1|Overall Study|Required Prohibited Medication|0
5622187|NCT00758043|19420689|P4|Overall Study|Withdrawal by Subject|4
5622188|NCT00758043|19420690|P3|Overall Study|Withdrawal by Subject|1
5622189|NCT00758043|19420691|P2|Overall Study|Withdrawal by Subject|1
5622190|NCT00758043|19420692|P1|Overall Study|Withdrawal by Subject|0
5622191|NCT00758043|19420689|P4|Overall Study|Lost to Follow-up|5
5622192|NCT00758043|19420690|P3|Overall Study|Lost to Follow-up|2
5622193|NCT00758043|19420691|P2|Overall Study|Lost to Follow-up|2
5622194|NCT00758043|19420692|P1|Overall Study|Lost to Follow-up|0
5622195|NCT00758043|19420689|P4|Overall Study|Refused Further Treatment|8
5622196|NCT00758043|19420690|P3|Overall Study|Refused Further Treatment|5
5622197|NCT00758043|19420691|P2|Overall Study|Refused Further Treatment|11
5622198|NCT00758043|19420692|P1|Overall Study|Refused Further Treatment|0
5622199|NCT00758043|19420689|P4|Overall Study|Lack of Efficacy|12
5622200|NCT00758043|19420690|P3|Overall Study|Lack of Efficacy|18
5622201|NCT00758043|19420691|P2|Overall Study|Lack of Efficacy|6
5622202|NCT00758043|19420692|P1|Overall Study|Lack of Efficacy|0
5622203|NCT00758043|19420689|P4|Overall Study|Adverse Event|62
5622204|NCT00758043|19420690|P3|Overall Study|Adverse Event|12
5622205|NCT00758043|19420691|P2|Overall Study|Adverse Event|20
5622206|NCT00758043|19420692|P1|Overall Study|Adverse Event|1
5622207|NCT00757848|19420720|P2|Overall Study|Incorrect enrolment|0
5622208|NCT00757848|19420721|P1|Overall Study|Incorrect enrolment|1
5622209|NCT00757848|19420720|P2|Overall Study|Adverse Event|2
5622210|NCT00757848|19420721|P1|Overall Study|Adverse Event|1
5622211|NCT00757848|19420720|P2|Overall Study|Voluntary discontinuation|0
5622212|NCT00757848|19420721|P1|Overall Study|Voluntary discontinuation|1
5622213|NCT00757783|19420790|P2|Overall Study|Other|2
5622214|NCT00757783|19420791|P1|Overall Study|Other|1
5622215|NCT00757783|19420790|P2|Overall Study|Withdrawal by Subject|1
5622216|NCT00757783|19420791|P1|Overall Study|Withdrawal by Subject|2
5622217|NCT00757783|19420790|P2|Overall Study|Protocol Violation|0
5622218|NCT00757783|19420791|P1|Overall Study|Protocol Violation|1
5622219|NCT00757783|19420790|P2|Overall Study|Lost to Follow-up|1
5622220|NCT00757783|19420791|P1|Overall Study|Lost to Follow-up|1
5622221|NCT00757783|19420790|P2|Overall Study|Adverse Event|2
5622222|NCT00757783|19420791|P1|Overall Study|Adverse Event|0
5622223|NCT00757705|19420827|P1|Overall Study|Other|18
5622224|NCT00757705|19420827|P1|Overall Study|Non-compliant|9
5622225|NCT00757705|19420827|P1|Overall Study|Ineligible to continue|8
5622226|NCT00757705|19420827|P1|Overall Study|Insufficient Response|26
5622227|NCT00757705|19420827|P1|Overall Study|Withdrawal by Subject|25
5622228|NCT00757705|19420827|P1|Overall Study|Lost to Follow-up|16
5622229|NCT00757705|19420827|P1|Overall Study|Adverse Event|19
5622230|NCT00757627|19420856|P1|Overall Study|Other|1
5622231|NCT00757627|19420856|P1|Overall Study|Withdrawal by Subject|27
5622232|NCT00757627|19420856|P1|Overall Study|Lost to Follow-up|28
5622233|NCT00757627|19420856|P1|Overall Study|Lack of Efficacy|10
5622234|NCT00757627|19420856|P1|Overall Study|Adverse Event|15
5622235|NCT00757588|19420991|P2|Period 2: Long-term (52-week) Phase|Other|0
5622236|NCT00757588|19420992|P1|Period 2: Long-term (52-week) Phase|Other|1
5622237|NCT00757588|19420991|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
5622238|NCT00757588|19420992|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
5622239|NCT00757588|19420991|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
5622240|NCT00757588|19420992|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
5622241|NCT00757588|19420991|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
5622242|NCT00757588|19420992|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
5622243|NCT00757588|19420991|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
5622244|NCT00757588|19420992|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
5622245|NCT00757588|19420991|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
5622246|NCT00757588|19420992|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
5622247|NCT00757588|19420991|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
5622248|NCT00757588|19420992|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
5622249|NCT00757588|19420991|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
5622250|NCT00757588|19420992|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
5622251|NCT00757588|19420991|P2|Period 1: Short-term (24-week) Phase|Other|1
5622252|NCT00757588|19420992|P1|Period 1: Short-term (24-week) Phase|Other|0
5622253|NCT00757588|19420991|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
5622254|NCT00757588|19420992|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
5622255|NCT00757588|19420991|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
5622256|NCT00757588|19420992|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
5622257|NCT00757588|19420991|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
5622258|NCT00757588|19420992|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
5622259|NCT00757588|19420991|P2|Period 1: Short-term (24-week) Phase|Death|0
5622260|NCT00757588|19420992|P1|Period 1: Short-term (24-week) Phase|Death|1
5622261|NCT00757588|19420991|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
5622262|NCT00757588|19420992|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
5622263|NCT00757588|19420991|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
5622264|NCT00757588|19420992|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
5622265|NCT00757588|19420991|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
5622266|NCT00757588|19420992|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
5622267|NCT00757237|19421033|P2|Overall Study|Other|2
5622268|NCT00757237|19421034|P1|Overall Study|Other|0
5622269|NCT00757237|19421033|P2|Overall Study|Safety or Tolerability|5
5622270|NCT00757237|19421034|P1|Overall Study|Safety or Tolerability|3
5622271|NCT00757237|19421033|P2|Overall Study|Withdrawal by Subject|12
5622272|NCT00757237|19421034|P1|Overall Study|Withdrawal by Subject|8
5622273|NCT00757237|19421033|P2|Overall Study|Physician Decision|3
5622274|NCT00757237|19421034|P1|Overall Study|Physician Decision|2
5622275|NCT00757237|19421033|P2|Overall Study|Protocol Violation|2
5622276|NCT00757237|19421034|P1|Overall Study|Protocol Violation|0
5622277|NCT00757237|19421033|P2|Overall Study|Lost to Follow-up|1
5622278|NCT00757237|19421034|P1|Overall Study|Lost to Follow-up|0
5622279|NCT00757172|19421062|P1|Overall Study|Progression|4
5622280|NCT00757172|19421062|P1|Overall Study|Physician Decision|3
5622281|NCT00757172|19421062|P1|Overall Study|Withdrawal by Subject|4
5622282|NCT00757003|19421070|P1|Overall Study|Not implanted|1
5622283|NCT00757003|19421070|P1|Overall Study|Surgically explanted|2
5622284|NCT00757003|19421070|P1|Overall Study|Withdrawal by Subject|4
5622285|NCT00757003|19421070|P1|Overall Study|Lost to Follow-up|9
5622286|NCT00757003|19421070|P1|Overall Study|Death|33
5622287|NCT00756938|19421117|P4|Optional Extension|Adverse Event|1
5622288|NCT00756938|19421118|P3|Optional Extension|Adverse Event|0
5622289|NCT00756938|19421119|P2|Optional Extension|Adverse Event|0
5622290|NCT00756938|19421120|P1|Optional Extension|Adverse Event|0
5622291|NCT00756938|19421117|P4|Optional Extension|Withdrawal by Subject|10
5622292|NCT00756938|19421118|P3|Optional Extension|Withdrawal by Subject|0
5622293|NCT00756938|19421119|P2|Optional Extension|Withdrawal by Subject|0
5622294|NCT00756938|19421120|P1|Optional Extension|Withdrawal by Subject|0
5622295|NCT00756938|19421117|P4|Optional Extension|Protocol Violation|1
5622296|NCT00756938|19421118|P3|Optional Extension|Protocol Violation|0
5622297|NCT00756938|19421119|P2|Optional Extension|Protocol Violation|0
5622298|NCT00756938|19421120|P1|Optional Extension|Protocol Violation|0
5622299|NCT00756938|19421117|P4|Optional Extension|Lost to Follow-up|1
5622300|NCT00756938|19421118|P3|Optional Extension|Lost to Follow-up|0
5622301|NCT00756938|19421119|P2|Optional Extension|Lost to Follow-up|0
5622302|NCT00756938|19421120|P1|Optional Extension|Lost to Follow-up|0
5622303|NCT00756938|19421117|P4|Optional Extension|Physician Decision|3
5622304|NCT00756938|19421118|P3|Optional Extension|Physician Decision|0
5622305|NCT00756938|19421119|P2|Optional Extension|Physician Decision|0
5622306|NCT00756938|19421120|P1|Optional Extension|Physician Decision|0
5622307|NCT00756938|19421117|P4|Optional Extension|Protocol-specific criteria met|9
5622308|NCT00756938|19421118|P3|Optional Extension|Protocol-specific criteria met|0
5622309|NCT00756938|19421119|P2|Optional Extension|Protocol-specific criteria met|0
5622310|NCT00756938|19421120|P1|Optional Extension|Protocol-specific criteria met|0
5622311|NCT00756938|19421117|P4|Optional Extension|End of Study|11
5622312|NCT00756938|19421118|P3|Optional Extension|End of Study|0
5622313|NCT00756938|19421119|P2|Optional Extension|End of Study|0
5622314|NCT00756938|19421120|P1|Optional Extension|End of Study|0
5622315|NCT00756938|19421117|P4|Optional Extension|Lack of Efficacy|1
5622316|NCT00756938|19421118|P3|Optional Extension|Lack of Efficacy|0
5622317|NCT00756938|19421119|P2|Optional Extension|Lack of Efficacy|0
5622318|NCT00756938|19421120|P1|Optional Extension|Lack of Efficacy|0
5622319|NCT00756938|19421117|P4|12-week Base Study|Lost to Follow-up|0
5622320|NCT00756938|19421118|P3|12-week Base Study|Lost to Follow-up|0
5622321|NCT00756938|19421119|P2|12-week Base Study|Lost to Follow-up|0
5622322|NCT00756938|19421120|P1|12-week Base Study|Lost to Follow-up|1
5622323|NCT00756938|19421117|P4|12-week Base Study|Protocol Violation|0
5622324|NCT00756938|19421118|P3|12-week Base Study|Protocol Violation|1
5622325|NCT00756938|19421119|P2|12-week Base Study|Protocol Violation|0
5622326|NCT00756938|19421120|P1|12-week Base Study|Protocol Violation|0
5622327|NCT00756938|19421117|P4|12-week Base Study|Protocol-specific Criteria Met|0
5622328|NCT00756938|19421118|P3|12-week Base Study|Protocol-specific Criteria Met|1
5622329|NCT00756938|19421119|P2|12-week Base Study|Protocol-specific Criteria Met|0
5622330|NCT00756938|19421120|P1|12-week Base Study|Protocol-specific Criteria Met|1
5622331|NCT00756886|19421148|P2|Overall Study|Ineligible|4
5622332|NCT00756886|19421149|P1|Overall Study|Ineligible|9
5622333|NCT00756886|19421148|P2|Overall Study|Lack of Efficacy|0
5622334|NCT00756886|19421149|P1|Overall Study|Lack of Efficacy|1
5622335|NCT00756886|19421148|P2|Overall Study|Adverse Event|3
5622336|NCT00756886|19421149|P1|Overall Study|Adverse Event|0
5622337|NCT00756886|19421148|P2|Overall Study|Lost to Follow-up|0
5622338|NCT00756886|19421149|P1|Overall Study|Lost to Follow-up|1
5622339|NCT00756730|19421157|P2|Overall Study|persistent low-level viremmia|1
5622340|NCT00756730|19421158|P1|Overall Study|persistent low-level viremmia|0
5622341|NCT00756730|19421157|P2|Overall Study|discontinued due to rash prior to week 4|1
5622342|NCT00756730|19421158|P1|Overall Study|discontinued due to rash prior to week 4|0
5622343|NCT00756717|19421178|P1|Overall Study|Withdrawal by Subject|2
5622344|NCT00756652|19421195|P2|Re-Op Phase|Withdrawn after explant|0
5622345|NCT00756652|19421196|P1|Re-Op Phase|Withdrawn after explant|14
5622346|NCT00756652|19421195|P2|Re-Op Phase|Site Closed|0
5622347|NCT00756652|19421196|P1|Re-Op Phase|Site Closed|2454
5622348|NCT00756652|19421195|P2|Re-Op Phase|Lost to Follow-up|0
5622349|NCT00756652|19421196|P1|Re-Op Phase|Lost to Follow-up|340
5622350|NCT00756652|19421195|P2|Re-Op Phase|Death|0
5622351|NCT00756652|19421196|P1|Re-Op Phase|Death|6
5622352|NCT00756652|19421195|P2|Re-Op Phase|Withdrawal by Subject|0
5622353|NCT00756652|19421196|P1|Re-Op Phase|Withdrawal by Subject|62
5622354|NCT00756652|19421195|P2|Original Phase|Not due for F/U at Phase One closure|2
5622355|NCT00756652|19421196|P1|Original Phase|Not due for F/U at Phase One closure|11076
5622356|NCT00756652|19421195|P2|Original Phase|Death|1
5622357|NCT00756652|19421196|P1|Original Phase|Death|168
5622358|NCT00756652|19421195|P2|Original Phase|Participants without data|466
5622359|NCT00756652|19421196|P1|Original Phase|Participants without data|3259
5622360|NCT00756652|19421195|P2|Original Phase|Unknown Discontinuation Reason|0
5622361|NCT00756652|19421196|P1|Original Phase|Unknown Discontinuation Reason|2
5622362|NCT00756652|19421195|P2|Original Phase|Participant Noncompliance|424
5622363|NCT00756652|19421196|P1|Original Phase|Participant Noncompliance|18622
5622364|NCT00756652|19421195|P2|Original Phase|Other Discontinuation|5
5622365|NCT00756652|19421196|P1|Original Phase|Other Discontinuation|797
5622366|NCT00756652|19421195|P2|Original Phase|Lost to Follow-up|0
5622367|NCT00756652|19421196|P1|Original Phase|Lost to Follow-up|601
5622368|NCT00756652|19421195|P2|Original Phase|Withdrawal by Subject|23
5622369|NCT00756652|19421196|P1|Original Phase|Withdrawal by Subject|864
5622370|NCT00756574|19421307|P2|Overall Study|Lost to Follow-up|4
5622371|NCT00756574|19421308|P1|Overall Study|Lost to Follow-up|4
5622372|NCT00756574|19421307|P2|Overall Study|Withdrawal by Subject|7
5622373|NCT00756574|19421308|P1|Overall Study|Withdrawal by Subject|9
5622374|NCT00756470|19421357|P1|Overall Study|Adverse Event|4
5622375|NCT00756470|19421357|P1|Overall Study|Withdrawal by Subject|1
5622376|NCT00756457|19421364|P2|Overall Study|Lost to Follow-up|2
5622377|NCT00756457|19421365|P1|Overall Study|Lost to Follow-up|1
5622378|NCT00756444|19421395|P2|Overall Study|Ineligibility Determined|0
5622379|NCT00756444|19421396|P1|Overall Study|Ineligibility Determined|1
5622380|NCT00756444|19421395|P2|Overall Study|Disease Progression|7
5622381|NCT00756444|19421396|P1|Overall Study|Disease Progression|2
5622382|NCT00756444|19421395|P2|Overall Study|Death|4
5622383|NCT00756444|19421396|P1|Overall Study|Death|5
5622384|NCT00756444|19421395|P2|Overall Study|Lost to Follow-up|1
5622385|NCT00756444|19421396|P1|Overall Study|Lost to Follow-up|0
5622386|NCT00756444|19421395|P2|Overall Study|Withdrawal by Subject|8
5622387|NCT00756444|19421396|P1|Overall Study|Withdrawal by Subject|6
5622388|NCT00756444|19421395|P2|Overall Study|Adverse Event|1
5622389|NCT00756444|19421396|P1|Overall Study|Adverse Event|1
5622390|NCT00756314|19421407|P2|Overall Study|Lost to Follow-up|59
5622391|NCT00756314|19421408|P1|Overall Study|Lost to Follow-up|2
5622392|NCT00756275|19421424|P2|Overall Study|Withdrawal by Subject|7
5622393|NCT00756275|19421425|P1|Overall Study|Withdrawal by Subject|4
5622394|NCT00756275|19421424|P2|Overall Study|Lost to Follow-up|21
5622395|NCT00756275|19421425|P1|Overall Study|Lost to Follow-up|25
5622396|NCT00756002|19421489|P2|Double-Blind Treatment Period|Other|2
5622397|NCT00756002|19421490|P1|Double-Blind Treatment Period|Other|2
5622398|NCT00756002|19421489|P2|Double-Blind Treatment Period|Protocol Violation|5
5622399|NCT00756002|19421490|P1|Double-Blind Treatment Period|Protocol Violation|6
5622400|NCT00756002|19421489|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
5622401|NCT00756002|19421490|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
5622402|NCT00756002|19421489|P2|Double-Blind Treatment Period|Lost to Follow-up|1
5622403|NCT00756002|19421490|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5622404|NCT00756002|19421489|P2|Double-Blind Treatment Period|Lack of Efficacy|1
5622405|NCT00756002|19421490|P1|Double-Blind Treatment Period|Lack of Efficacy|1
5622406|NCT00755937|19421584|P1|Observational Follow-up|Lost to Follow-up|148
5622407|NCT00755937|19421584|P1|Recruitment|Unknown if infliximab received|164
5622408|NCT00755846|19421611|P6|Overall Study|Participant Non-compliance|0
5622409|NCT00755846|19421612|P5|Overall Study|Participant Non-compliance|1
5622410|NCT00755846|19421613|P4|Overall Study|Participant Non-compliance|0
5622411|NCT00755846|19421614|P3|Overall Study|Participant Non-compliance|0
5622412|NCT00755846|19421615|P2|Overall Study|Participant Non-compliance|0
5622413|NCT00755846|19421616|P1|Overall Study|Participant Non-compliance|0
5622414|NCT00755846|19421611|P6|Overall Study|Administrative Error|0
5622415|NCT00755846|19421612|P5|Overall Study|Administrative Error|0
5622416|NCT00755846|19421613|P4|Overall Study|Administrative Error|0
5622417|NCT00755846|19421614|P3|Overall Study|Administrative Error|0
5622418|NCT00755846|19421615|P2|Overall Study|Administrative Error|1
5622419|NCT00755846|19421616|P1|Overall Study|Administrative Error|0
5622420|NCT00755846|19421611|P6|Overall Study|Physician Decision|1
5622421|NCT00755846|19421612|P5|Overall Study|Physician Decision|0
5622422|NCT00755846|19421613|P4|Overall Study|Physician Decision|1
5622423|NCT00755846|19421614|P3|Overall Study|Physician Decision|0
5622424|NCT00755846|19421615|P2|Overall Study|Physician Decision|3
5622425|NCT00755846|19421616|P1|Overall Study|Physician Decision|1
5622426|NCT00755846|19421611|P6|Overall Study|Hyperglycemic Rescue|7
5622427|NCT00755846|19421612|P5|Overall Study|Hyperglycemic Rescue|8
5622428|NCT00755846|19421613|P4|Overall Study|Hyperglycemic Rescue|8
5622429|NCT00755846|19421614|P3|Overall Study|Hyperglycemic Rescue|5
5622430|NCT00755846|19421615|P2|Overall Study|Hyperglycemic Rescue|7
5622431|NCT00755846|19421616|P1|Overall Study|Hyperglycemic Rescue|21
5622432|NCT00755846|19421611|P6|Overall Study|Withdrawal by Subject|1
5622433|NCT00755846|19421612|P5|Overall Study|Withdrawal by Subject|0
5622434|NCT00755846|19421613|P4|Overall Study|Withdrawal by Subject|2
5622435|NCT00755846|19421614|P3|Overall Study|Withdrawal by Subject|5
5622436|NCT00755846|19421615|P2|Overall Study|Withdrawal by Subject|3
5622437|NCT00755846|19421616|P1|Overall Study|Withdrawal by Subject|2
5622438|NCT00755846|19421611|P6|Overall Study|Lost to Follow-up|2
5622439|NCT00755846|19421612|P5|Overall Study|Lost to Follow-up|4
5622440|NCT00755846|19421613|P4|Overall Study|Lost to Follow-up|0
5622441|NCT00755846|19421614|P3|Overall Study|Lost to Follow-up|1
5622442|NCT00755846|19421615|P2|Overall Study|Lost to Follow-up|2
5622443|NCT00755846|19421616|P1|Overall Study|Lost to Follow-up|0
5622444|NCT00755846|19421611|P6|Overall Study|Protocol Violation|1
5622445|NCT00755846|19421612|P5|Overall Study|Protocol Violation|1
5622446|NCT00755846|19421613|P4|Overall Study|Protocol Violation|1
5622447|NCT00755846|19421614|P3|Overall Study|Protocol Violation|1
5622448|NCT00755846|19421615|P2|Overall Study|Protocol Violation|1
5622449|NCT00755846|19421616|P1|Overall Study|Protocol Violation|1
5622450|NCT00755846|19421611|P6|Overall Study|Adverse Event|2
5622451|NCT00755846|19421612|P5|Overall Study|Adverse Event|3
5622452|NCT00755846|19421613|P4|Overall Study|Adverse Event|1
5622453|NCT00755846|19421614|P3|Overall Study|Adverse Event|0
5622454|NCT00755846|19421615|P2|Overall Study|Adverse Event|0
5622455|NCT00755846|19421616|P1|Overall Study|Adverse Event|0
5622456|NCT00755807|19421716|P2|Open-label Extension Phase|Sponsor Decision|1
5622457|NCT00755807|19421717|P1|Open-label Extension Phase|Sponsor Decision|0
5622458|NCT00755807|19421716|P2|Open-label Extension Phase|Lost to Follow-up|0
5622459|NCT00755807|19421717|P1|Open-label Extension Phase|Lost to Follow-up|2
5622460|NCT00755807|19421716|P2|Open-label Extension Phase|Withdrawal by Subject|3
5622461|NCT00755807|19421717|P1|Open-label Extension Phase|Withdrawal by Subject|1
5622462|NCT00755807|19421716|P2|Open-label Extension Phase|Lack of Efficacy|3
5622463|NCT00755807|19421717|P1|Open-label Extension Phase|Lack of Efficacy|3
5622464|NCT00755807|19421716|P2|Open-label Extension Phase|Protocol Violation|2
5622465|NCT00755807|19421717|P1|Open-label Extension Phase|Protocol Violation|5
5622466|NCT00755807|19421716|P2|Open-label Extension Phase|Adverse Event|7
5622467|NCT00755807|19421717|P1|Open-label Extension Phase|Adverse Event|7
5622468|NCT00755807|19421716|P2|Acute Phase|Physician Decision|1
5622469|NCT00755807|19421717|P1|Acute Phase|Physician Decision|0
5622470|NCT00755807|19421716|P2|Acute Phase|Lack of Efficacy|1
5622471|NCT00755807|19421717|P1|Acute Phase|Lack of Efficacy|0
5622472|NCT00755807|19421716|P2|Acute Phase|Withdrawal by Subject|2
5622473|NCT00755807|19421717|P1|Acute Phase|Withdrawal by Subject|1
5622474|NCT00755807|19421716|P2|Acute Phase|Protocol Violation|3
5622475|NCT00755807|19421717|P1|Acute Phase|Protocol Violation|1
5622476|NCT00755807|19421716|P2|Acute Phase|Adverse Event|5
5622477|NCT00755807|19421717|P1|Acute Phase|Adverse Event|16
5622478|NCT00755716|19421797|P3|Overall Study|work schedule issues|1
5622479|NCT00755716|19421798|P2|Overall Study|work schedule issues|1
5622480|NCT00755716|19421799|P1|Overall Study|work schedule issues|0
5622481|NCT00755716|19421797|P3|Overall Study|Lost to Follow-up|1
5622482|NCT00755716|19421798|P2|Overall Study|Lost to Follow-up|3
5622483|NCT00755716|19421799|P1|Overall Study|Lost to Follow-up|5
5622484|NCT00755716|19421797|P3|Overall Study|Lack of Efficacy|0
5622485|NCT00755716|19421798|P2|Overall Study|Lack of Efficacy|0
5622486|NCT00755716|19421799|P1|Overall Study|Lack of Efficacy|2
5622487|NCT00755716|19421797|P3|Overall Study|Adverse Event|1
5622488|NCT00755716|19421798|P2|Overall Study|Adverse Event|4
5622489|NCT00755716|19421799|P1|Overall Study|Adverse Event|1
5622490|NCT00755417|19421813|P3|Overall Study|Not specified or missing data|12
5622491|NCT00755417|19421814|P2|Overall Study|Not specified or missing data|18
5622492|NCT00755417|19421815|P1|Overall Study|Not specified or missing data|9
5622493|NCT00755417|19421813|P3|Overall Study|Withdrawal by Subject|12
5622494|NCT00755417|19421814|P2|Overall Study|Withdrawal by Subject|12
5622495|NCT00755417|19421815|P1|Overall Study|Withdrawal by Subject|12
5622496|NCT00755417|19421813|P3|Overall Study|Lost to Follow-up|1
5622497|NCT00755417|19421814|P2|Overall Study|Lost to Follow-up|0
5622498|NCT00755417|19421815|P1|Overall Study|Lost to Follow-up|3
5622499|NCT00755417|19421813|P3|Overall Study|Protocol Violation|1
5622500|NCT00755417|19421814|P2|Overall Study|Protocol Violation|1
5622501|NCT00755417|19421815|P1|Overall Study|Protocol Violation|2
5622502|NCT00755417|19421813|P3|Overall Study|Lack of Efficacy|9
5622503|NCT00755417|19421814|P2|Overall Study|Lack of Efficacy|4
5622504|NCT00755417|19421815|P1|Overall Study|Lack of Efficacy|8
5622505|NCT00755417|19421813|P3|Overall Study|Adverse Event|7
5622506|NCT00755417|19421814|P2|Overall Study|Adverse Event|20
5622507|NCT00755417|19421815|P1|Overall Study|Adverse Event|28
5622508|NCT00755326|19421834|P2|Overall Study|Lost to Follow-up|3
5622509|NCT00755326|19421835|P1|Overall Study|Lost to Follow-up|2
5622510|NCT00755222|19421885|P2|Overall Study|Protocol Violation|0
5622511|NCT00755222|19421886|P1|Overall Study|Protocol Violation|2
5622512|NCT00755222|19421885|P2|Overall Study|Adverse Event|0
5622513|NCT00755222|19421886|P1|Overall Study|Adverse Event|2
5622514|NCT00755222|19421885|P2|Overall Study|Withdrawal by Subject|2
5622515|NCT00755222|19421886|P1|Overall Study|Withdrawal by Subject|4
5622516|NCT00755196|19421900|P1|Overall Study|Lack of Efficiency|1
5622517|NCT00755196|19421900|P1|Overall Study|Lost to Follow-up|1
5622518|NCT00755183|19421907|P2|Overall Study|Administrative|1
5622519|NCT00755183|19421908|P1|Overall Study|Administrative|2
5622520|NCT00755183|19421907|P2|Overall Study|Withdrawal by Subject|2
5622521|NCT00755183|19421908|P1|Overall Study|Withdrawal by Subject|0
5622522|NCT00755183|19421907|P2|Overall Study|Protocol Violation|1
5622523|NCT00755183|19421908|P1|Overall Study|Protocol Violation|0
5622524|NCT00755183|19421907|P2|Overall Study|Adverse Event|2
5622525|NCT00755183|19421908|P1|Overall Study|Adverse Event|5
5622526|NCT00755105|19421932|P3|Overall Study|Withdrawal by Subject|4
5622527|NCT00755105|19421933|P2|Overall Study|Withdrawal by Subject|11
5622528|NCT00755105|19421934|P1|Overall Study|Withdrawal by Subject|9
5622529|NCT00755079|19421944|P2|Overall Study|Withdrawal by Subject|2
5622530|NCT00755079|19421945|P1|Overall Study|Withdrawal by Subject|0
5622531|NCT00755079|19421944|P2|Overall Study|Adverse Event|1
5622532|NCT00755079|19421945|P1|Overall Study|Adverse Event|0
5622533|NCT00755079|19421944|P2|Overall Study|Lost to Follow-up|3
5622534|NCT00755079|19421945|P1|Overall Study|Lost to Follow-up|1
5622535|NCT00754936|19421964|P1|Overall Study|Inter-current medical events|3
5622536|NCT00754936|19421964|P1|Overall Study|Side Effects|3
5622537|NCT00754936|19421964|P1|Overall Study|Withdrawal by Subject|2
5622538|NCT00754936|19421964|P1|Overall Study|Physician Decision|1
5622539|NCT00754936|19421964|P1|Overall Study|Lost to Follow-up|3
5622540|NCT00754793|19422004|P2|Overall Study|voluntary withdrawn from study|1
5622541|NCT00754793|19422005|P1|Overall Study|voluntary withdrawn from study|0
5622542|NCT00754741|19422023|P3|Overall Study|Died or disenrolled|54
5622543|NCT00754741|19422024|P2|Overall Study|Died or disenrolled|69
5622544|NCT00754741|19422025|P1|Overall Study|Died or disenrolled|57
5622545|NCT00754650|19422072|P1|Overall Study|Disease Progression|2
5622546|NCT00754624|19422077|P1|Overall Study|Lost to Follow-up|3
5622547|NCT00754624|19422077|P1|Overall Study|Various|12
5622548|NCT00754624|19422077|P1|Overall Study|Withdrawal by Subject|28
5622549|NCT00754624|19422077|P1|Overall Study|Protocol Violation|1
5622550|NCT00754624|19422077|P1|Overall Study|Physician Decision|8
5622551|NCT00754624|19422077|P1|Overall Study|Death|1
5622552|NCT00754624|19422077|P1|Overall Study|Adverse Event|16
5622553|NCT00754572|19422087|P1|Overall Study|Lost to Follow-up|1
5622554|NCT00754572|19422087|P1|Overall Study|Administrative Reason|3
5622555|NCT00754572|19422087|P1|Overall Study|Death|1
5622556|NCT00754572|19422087|P1|Overall Study|Lack of Efficacy|2
5622557|NCT00754572|19422087|P1|Overall Study|Withdrawal by Subject|3
5622558|NCT00754572|19422087|P1|Overall Study|Protocol Violation|3
5622559|NCT00754572|19422087|P1|Overall Study|Other|39
5622560|NCT00754572|19422087|P1|Overall Study|Adverse Event|19
5622561|NCT00754559|19422114|P1|Overall Study|Withdrawal by Subject|3
5622562|NCT00754559|19422114|P1|Overall Study|Other|5
5622563|NCT00754559|19422114|P1|Overall Study|Administrative reason|1
5622564|NCT00754559|19422114|P1|Overall Study|Lost to Follow-up|2
5622565|NCT00754559|19422114|P1|Overall Study|Lack of Efficacy|10
5622566|NCT00754559|19422114|P1|Overall Study|Protocol Violation|11
5622567|NCT00754559|19422114|P1|Overall Study|Adverse Event|15
5622568|NCT00754442|19422214|P2|Overall Study|Withdrawal by Subject|3
5622569|NCT00754442|19422215|P1|Overall Study|Withdrawal by Subject|5
5622570|NCT00754390|19422222|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
5622571|NCT00754390|19422222|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
5622572|NCT00754390|19422222|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
5622573|NCT00754390|19422222|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
5622574|NCT00754338|19422244|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
5622575|NCT00754338|19422245|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
5622576|NCT00754338|19422246|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
5622577|NCT00754338|19422247|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
5622578|NCT00754338|19422244|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
5622579|NCT00754338|19422245|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
5622580|NCT00754338|19422246|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
5622581|NCT00754338|19422247|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
5622582|NCT00754325|19422279|P2|Initial Treatment|Disease Progression|35
5622583|NCT00754325|19422280|P1|Initial Treatment|Disease Progression|35
5622584|NCT00754325|19422279|P2|Initial Treatment|Sponsor Request|1
5622585|NCT00754325|19422280|P1|Initial Treatment|Sponsor Request|0
5622586|NCT00754325|19422279|P2|Initial Treatment|Physician Decision|0
5622587|NCT00754325|19422280|P1|Initial Treatment|Physician Decision|2
5622588|NCT00754325|19422279|P2|Initial Treatment|Withdrawal by Subject|2
5622589|NCT00754325|19422280|P1|Initial Treatment|Withdrawal by Subject|2
5622590|NCT00754325|19422279|P2|Initial Treatment|Adverse Event|6
5622591|NCT00754325|19422280|P1|Initial Treatment|Adverse Event|7
5622592|NCT00754325|19422279|P2|Initial Treatment|Continuing Active Treatment|5
5622593|NCT00754325|19422280|P1|Initial Treatment|Continuing Active Treatment|4
5622594|NCT00754234|19422333|P1|Overall Study|Withdrawal by Subject|3
5622595|NCT00754065|19422419|P2|Overall Study|Reason not specified or unknown, etc.|27
5622596|NCT00754065|19422420|P1|Overall Study|Reason not specified or unknown, etc.|21
5622597|NCT00754065|19422419|P2|Overall Study|Pregnancy|0
5622598|NCT00754065|19422420|P1|Overall Study|Pregnancy|6
5622599|NCT00754065|19422419|P2|Overall Study|Withdrawal by Subject|5
5622600|NCT00754065|19422420|P1|Overall Study|Withdrawal by Subject|4
5622601|NCT00754065|19422419|P2|Overall Study|Protocol Violation|10
5622602|NCT00754065|19422420|P1|Overall Study|Protocol Violation|12
5622603|NCT00754065|19422419|P2|Overall Study|Lost to Follow-up|11
5622604|NCT00754065|19422420|P1|Overall Study|Lost to Follow-up|7
5622605|NCT00754065|19422419|P2|Overall Study|Adverse Event|25
5622606|NCT00754065|19422420|P1|Overall Study|Adverse Event|19
5622607|NCT00754065|19422419|P2|Overall Study|Never received treatment|2
5622608|NCT00754065|19422420|P1|Overall Study|Never received treatment|12
5622609|NCT00754052|19422660|P2|Overall Study|Study terminated by Sponsor|3
5622610|NCT00754052|19422661|P1|Overall Study|Study terminated by Sponsor|5
5622611|NCT00754013|19422675|P2|Overall Study|didn't return after study termed|4
5622612|NCT00754013|19422676|P1|Overall Study|didn't return after study termed|3
5622613|NCT00754013|19422675|P2|Overall Study|Lost to Follow-up|1
5622614|NCT00754013|19422676|P1|Overall Study|Lost to Follow-up|1
5622615|NCT00753922|19422713|P4|Overall Study|Discontinuation Due to Explantation|4
5622616|NCT00753922|19422714|P3|Overall Study|Discontinuation Due to Explantation|14
5622617|NCT00753922|19422715|P2|Overall Study|Discontinuation Due to Explantation|14
5622618|NCT00753922|19422716|P1|Overall Study|Discontinuation Due to Explantation|14
5622619|NCT00753922|19422713|P4|Overall Study|Death|1
5622620|NCT00753922|19422714|P3|Overall Study|Death|2
5622621|NCT00753922|19422715|P2|Overall Study|Death|23
5622622|NCT00753922|19422716|P1|Overall Study|Death|2
5622623|NCT00753922|19422713|P4|Overall Study|Patients Not Completing Visit|0
5622624|NCT00753922|19422714|P3|Overall Study|Patients Not Completing Visit|1
5622625|NCT00753922|19422715|P2|Overall Study|Patients Not Completing Visit|0
5622626|NCT00753922|19422716|P1|Overall Study|Patients Not Completing Visit|11
5622627|NCT00753922|19422713|P4|Overall Study|Patient Non-compliance|11
5622628|NCT00753922|19422714|P3|Overall Study|Patient Non-compliance|14
5622629|NCT00753922|19422715|P2|Overall Study|Patient Non-compliance|22
5622630|NCT00753922|19422716|P1|Overall Study|Patient Non-compliance|55
5622631|NCT00753922|19422713|P4|Overall Study|Withdrawal by Subject|2
5622632|NCT00753922|19422714|P3|Overall Study|Withdrawal by Subject|4
5622633|NCT00753922|19422715|P2|Overall Study|Withdrawal by Subject|11
5622634|NCT00753922|19422716|P1|Overall Study|Withdrawal by Subject|9
5622635|NCT00753922|19422713|P4|Overall Study|Lost to Follow-up|5
5622636|NCT00753922|19422714|P3|Overall Study|Lost to Follow-up|28
5622637|NCT00753922|19422715|P2|Overall Study|Lost to Follow-up|24
5622638|NCT00753922|19422716|P1|Overall Study|Lost to Follow-up|155
5622639|NCT00753896|19422746|P1|Overall Study|Entry Criteria Not Met|4
5622640|NCT00753896|19422746|P1|Overall Study|Withdrawal by Subject|4
5622641|NCT00753896|19422746|P1|Overall Study|Protocol Violation|1
5622642|NCT00753896|19422746|P1|Overall Study|Lost to Follow-up|2
5622643|NCT00753896|19422746|P1|Overall Study|Death|1
5622644|NCT00753896|19422746|P1|Overall Study|Adverse Event|4
5622645|NCT00753766|19422762|P2|Overall Study|Physician Decision|0
5622646|NCT00753766|19422763|P1|Overall Study|Physician Decision|1
5622647|NCT00753714|19422785|P2|Overall Study|Other|5
5622648|NCT00753714|19422786|P1|Overall Study|Other|7
5622649|NCT00753714|19422785|P2|Overall Study|Death|3
5622650|NCT00753714|19422786|P1|Overall Study|Death|3
5622651|NCT00753714|19422785|P2|Overall Study|Withdrawal by Subject|1
5622652|NCT00753714|19422786|P1|Overall Study|Withdrawal by Subject|2
5622653|NCT00753714|19422785|P2|Overall Study|Lost to Follow-up|1
5622654|NCT00753714|19422786|P1|Overall Study|Lost to Follow-up|0
5622655|NCT00753714|19422785|P2|Overall Study|Protocol Violation|0
5622656|NCT00753714|19422786|P1|Overall Study|Protocol Violation|1
5622657|NCT00753714|19422785|P2|Overall Study|Adverse Event|18
5622658|NCT00753714|19422786|P1|Overall Study|Adverse Event|26
5622659|NCT00753714|19422785|P2|Overall Study|Lack of Efficacy|34
5622660|NCT00753714|19422786|P1|Overall Study|Lack of Efficacy|21
5622661|NCT00753688|19422802|P2|Overall Study|Adverse Event|1
5622662|NCT00753688|19422803|P1|Overall Study|Adverse Event|0
5622663|NCT00753688|19422802|P2|Overall Study|Ongoing - in Follow-up|31
5622664|NCT00753688|19422803|P1|Overall Study|Ongoing - in Follow-up|15
5622665|NCT00753688|19422802|P2|Overall Study|Participant Withdrew Consent|2
5622666|NCT00753688|19422803|P1|Overall Study|Participant Withdrew Consent|2
5622667|NCT00753688|19422802|P2|Overall Study|Missing|9
5622668|NCT00753688|19422803|P1|Overall Study|Missing|4
5622669|NCT00753688|19422802|P2|Overall Study|Death|203
5622670|NCT00753688|19422803|P1|Overall Study|Death|102
5622671|NCT00753675|19422832|P3|Overall Study|Lost to Follow-up|0
5622672|NCT00753675|19422833|P2|Overall Study|Lost to Follow-up|0
5622673|NCT00753675|19422834|P1|Overall Study|Lost to Follow-up|1
5622674|NCT00753675|19422832|P3|Overall Study|Withdrawal by Subject|0
5622675|NCT00753675|19422833|P2|Overall Study|Withdrawal by Subject|1
5622676|NCT00753675|19422834|P1|Overall Study|Withdrawal by Subject|0
5622677|NCT00753675|19422832|P3|Overall Study|Objective progression of disease|35
5622678|NCT00753675|19422833|P2|Overall Study|Objective progression of disease|35
5622679|NCT00753675|19422834|P1|Overall Study|Objective progression of disease|35
5622680|NCT00753675|19422832|P3|Overall Study|Adverse Event|4
5622681|NCT00753675|19422833|P2|Overall Study|Adverse Event|9
5622682|NCT00753675|19422834|P1|Overall Study|Adverse Event|11
5622683|NCT00753675|19422832|P3|Overall Study|Death|4
5622684|NCT00753675|19422833|P2|Overall Study|Death|2
5622685|NCT00753675|19422834|P1|Overall Study|Death|1
5622686|NCT00753675|19422832|P3|Overall Study|other reason|13
5622687|NCT00753675|19422833|P2|Overall Study|other reason|12
5622688|NCT00753675|19422834|P1|Overall Study|other reason|11
5622689|NCT00753649|19422856|P2|Overall Study|Protocol Violation|0
5622690|NCT00753649|19422857|P1|Overall Study|Protocol Violation|2
5622691|NCT00753649|19422856|P2|Overall Study|Lost to follow-up-complete vaccination|0
5622692|NCT00753649|19422857|P1|Overall Study|Lost to follow-up-complete vaccination|1
5622693|NCT00753649|19422856|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
5622694|NCT00753649|19422857|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
5622695|NCT00753649|19422856|P2|Overall Study|Migrated/moved from study area|0
5622696|NCT00753649|19422857|P1|Overall Study|Migrated/moved from study area|1
5622697|NCT00753623|19422889|P2|Phase II (14 Days)|Physician Decision|1
5622698|NCT00753623|19422890|P1|Phase II (14 Days)|Physician Decision|0
5622699|NCT00753623|19422889|P2|Washout (7 Days)|Physician Decision|0
5622700|NCT00753623|19422890|P1|Washout (7 Days)|Physician Decision|1
5622701|NCT00753623|19422889|P2|Phase I (14 Days)|Adverse Event|1
5622702|NCT00753623|19422890|P1|Phase I (14 Days)|Adverse Event|0
5622703|NCT00753623|19422889|P2|Phase I (14 Days)|Physician Decision|2
5622704|NCT00753623|19422890|P1|Phase I (14 Days)|Physician Decision|1
5622705|NCT00753623|19422889|P2|Phase I (14 Days)|Withdrawal by Subject|1
5622706|NCT00753623|19422890|P1|Phase I (14 Days)|Withdrawal by Subject|1
5622707|NCT00753545|19422898|P2|Overall Study|Voluntary Discontinuation of Patient|3
5622708|NCT00753545|19422899|P1|Overall Study|Voluntary Discontinuation of Patient|7
5622709|NCT00753545|19422898|P2|Overall Study|Protocol Violation|0
5622710|NCT00753545|19422899|P1|Overall Study|Protocol Violation|1
5622711|NCT00753545|19422898|P2|Overall Study|Lost to Follow-up|3
5622712|NCT00753545|19422899|P1|Overall Study|Lost to Follow-up|2
5622713|NCT00753545|19422898|P2|Overall Study|Death|112
5622714|NCT00753545|19422899|P1|Overall Study|Death|98
5622715|NCT00753519|19422937|P2|Overall Study|Withdrawal by Subject|2
5622716|NCT00753519|19422938|P1|Overall Study|Withdrawal by Subject|0
5622717|NCT00753506|19422960|P2|Overall Study|Other reason|1
5622718|NCT00753506|19422961|P1|Overall Study|Other reason|1
5622719|NCT00753506|19422960|P2|Overall Study|Lost to Follow-up|0
5622720|NCT00753506|19422961|P1|Overall Study|Lost to Follow-up|2
5622721|NCT00753506|19422960|P2|Overall Study|Withdrawal by Subject|1
5622722|NCT00753506|19422961|P1|Overall Study|Withdrawal by Subject|4
5622723|NCT00753454|19422967|P1|Overall Study|Investigator Decision|1
5622724|NCT00753454|19422967|P1|Overall Study|Withdrawal by Subject|5
5622725|NCT00753454|19422967|P1|Overall Study|Lost to Follow-up|3
5622726|NCT00753454|19422967|P1|Overall Study|Lack of Efficacy|1
5622727|NCT00753454|19422967|P1|Overall Study|Adverse Event|4
5622728|NCT00753415|19423001|P10|Part B|Disease progression|1
5622729|NCT00753415|19423002|P9|Part B|Disease progression|2
5622730|NCT00753415|19423003|P8|Part B|Disease progression|0
5622731|NCT00753415|19423004|P7|Part B|Disease progression|0
5622732|NCT00753415|19423005|P6|Part B|Disease progression|0
5622733|NCT00753415|19423006|P5|Part B|Disease progression|0
5622734|NCT00753415|19423007|P4|Part B|Disease progression|0
5622735|NCT00753415|19423008|P3|Part B|Disease progression|0
5622736|NCT00753415|19423009|P2|Part B|Disease progression|0
5622737|NCT00753415|19423010|P1|Part B|Disease progression|0
5622738|NCT00753415|19423001|P10|Part B|Lost to Follow-up|0
5622739|NCT00753415|19423002|P9|Part B|Lost to Follow-up|1
5622740|NCT00753415|19423003|P8|Part B|Lost to Follow-up|1
5622741|NCT00753415|19423004|P7|Part B|Lost to Follow-up|0
5622742|NCT00753415|19423005|P6|Part B|Lost to Follow-up|0
5622743|NCT00753415|19423006|P5|Part B|Lost to Follow-up|0
5622744|NCT00753415|19423007|P4|Part B|Lost to Follow-up|0
5622745|NCT00753415|19423008|P3|Part B|Lost to Follow-up|0
5622746|NCT00753415|19423009|P2|Part B|Lost to Follow-up|0
5622747|NCT00753415|19423010|P1|Part B|Lost to Follow-up|0
5622748|NCT00753415|19423001|P10|Part A|Withdrawal by Subject|0
5622749|NCT00753415|19423002|P9|Part A|Withdrawal by Subject|0
5622750|NCT00753415|19423003|P8|Part A|Withdrawal by Subject|0
5622751|NCT00753415|19423004|P7|Part A|Withdrawal by Subject|0
5622752|NCT00753415|19423005|P6|Part A|Withdrawal by Subject|0
5622753|NCT00753415|19423006|P5|Part A|Withdrawal by Subject|0
5622754|NCT00753415|19423007|P4|Part A|Withdrawal by Subject|0
5622755|NCT00753415|19423008|P3|Part A|Withdrawal by Subject|1
5622756|NCT00753415|19423009|P2|Part A|Withdrawal by Subject|0
5622757|NCT00753415|19423010|P1|Part A|Withdrawal by Subject|0
5622758|NCT00753415|19423001|P10|Part A|Disease progression|0
5622759|NCT00753415|19423002|P9|Part A|Disease progression|0
5622760|NCT00753415|19423003|P8|Part A|Disease progression|0
5622761|NCT00753415|19423004|P7|Part A|Disease progression|0
5622762|NCT00753415|19423005|P6|Part A|Disease progression|0
5622763|NCT00753415|19423006|P5|Part A|Disease progression|0
5622764|NCT00753415|19423007|P4|Part A|Disease progression|2
5622765|NCT00753415|19423008|P3|Part A|Disease progression|1
5622766|NCT00753415|19423009|P2|Part A|Disease progression|0
5622767|NCT00753415|19423010|P1|Part A|Disease progression|1
5622768|NCT00753272|19423100|P2|Overall Study|Other|1088
5622769|NCT00753272|19423101|P1|Overall Study|Other|1104
5622770|NCT00753272|19423100|P2|Overall Study|Lost to Follow-up|497
5622771|NCT00753272|19423101|P1|Overall Study|Lost to Follow-up|491
5622772|NCT00753272|19423100|P2|Overall Study|Withdrawal by Subject|2407
5622773|NCT00753272|19423101|P1|Overall Study|Withdrawal by Subject|2481
5622774|NCT00753272|19423100|P2|Overall Study|Protocol Violation|46
5622775|NCT00753272|19423101|P1|Overall Study|Protocol Violation|28
5622776|NCT00753272|19423100|P2|Overall Study|Adverse Event|869
5622777|NCT00753272|19423101|P1|Overall Study|Adverse Event|878
5622778|NCT00753012|19423185|P2|Overall Study|Confounded endpoint data|0
5622779|NCT00753012|19423186|P1|Overall Study|Confounded endpoint data|1
5622780|NCT00753012|19423185|P2|Overall Study|Lost to Follow-up|0
5622781|NCT00753012|19423186|P1|Overall Study|Lost to Follow-up|4
5622782|NCT00753012|19423185|P2|Overall Study|Withdrawal by Subject|1
5622783|NCT00753012|19423186|P1|Overall Study|Withdrawal by Subject|0
5622784|NCT00753012|19423185|P2|Overall Study|Adverse Event|0
5622785|NCT00753012|19423186|P1|Overall Study|Adverse Event|2
5622786|NCT00753012|19423185|P2|Overall Study|Ineligible, abnormal cardiac histo|0
5622787|NCT00753012|19423186|P1|Overall Study|Ineligible, abnormal cardiac histo|1
5622788|NCT00752986|19423199|P3|Overall Study|Protocol Violation|0
5622789|NCT00752986|19423200|P2|Overall Study|Protocol Violation|0
5622790|NCT00752986|19423201|P1|Overall Study|Protocol Violation|3
5622791|NCT00752986|19423199|P3|Overall Study|Withdrawal by Subject|2
5622792|NCT00752986|19423200|P2|Overall Study|Withdrawal by Subject|1
5622793|NCT00752986|19423201|P1|Overall Study|Withdrawal by Subject|2
5622794|NCT00752895|19423241|P2|Overall Study|Withdrawal by Subject|3
5622795|NCT00752895|19423242|P1|Overall Study|Withdrawal by Subject|8
5622796|NCT00752856|19423252|P2|Overall Study|randomized but did not do viral kinetics|1
5622797|NCT00752856|19423253|P1|Overall Study|randomized but did not do viral kinetics|0
5622798|NCT00752791|19423265|P1|Overall Study|Protocol deviation|1
5622799|NCT00752791|19423265|P1|Overall Study|Switched to hemodialysis|2
5622800|NCT00752791|19423265|P1|Overall Study|Renal transplant|3
5622801|NCT00752791|19423265|P1|Overall Study|Death|1
5622802|NCT00752791|19423265|P1|Overall Study|Physician Decision|1
5622803|NCT00752791|19423265|P1|Overall Study|Withdrawal by Subject|1
5622804|NCT00752791|19423265|P1|Overall Study|Adverse Event|7
5622805|NCT00752726|19423277|P2|Overall Study|Other Reason|2
5622806|NCT00752726|19423278|P1|Overall Study|Other Reason|1
5622807|NCT00752726|19423277|P2|Overall Study|Withdrawal by Subject|10
5622808|NCT00752726|19423278|P1|Overall Study|Withdrawal by Subject|5
5622809|NCT00752726|19423277|P2|Overall Study|Adverse Event|0
5622810|NCT00752726|19423278|P1|Overall Study|Adverse Event|3
5622811|NCT00752726|19423277|P2|Overall Study|Lost to Follow-up|1
5622812|NCT00752726|19423278|P1|Overall Study|Lost to Follow-up|2
5622813|NCT00752622|19423303|P1|Interventional Phase|Premature Study Termination|5
5622814|NCT00752622|19423303|P1|Interventional Phase|Physician Decision|1
5622815|NCT00752622|19423303|P1|Interventional Phase|Non-responder|2
5622816|NCT00752622|19423303|P1|Observational Phase|Other|2
5622817|NCT00752622|19423303|P1|Observational Phase|Adverse Event|1
5622818|NCT00752622|19423303|P1|Observational Phase|Withdrawal by Subject|2
5622819|NCT00752622|19423303|P1|Observational Phase|Non-responder|2
5622820|NCT00752622|19423303|P1|Observational Phase|Premature Study Termination|36
5622821|NCT00752622|19423303|P1|Induction Phase|Premature study termination|14
5622822|NCT00752622|19423303|P1|Induction Phase|Withdrawal by Subject|1
5622823|NCT00752622|19423303|P1|Induction Phase|Non-responder|14
5622824|NCT00752622|19423303|P1|Induction Phase|Other|3
5622825|NCT00752622|19423303|P1|Induction Phase|Adverse Event|3
5622826|NCT00752609|19423316|P2|Overall Study|Received Aranesp in error|0
5622827|NCT00752609|19423317|P1|Overall Study|Received Aranesp in error|1
5622828|NCT00752609|19423316|P2|Overall Study|Met exclusion criteria|0
5622829|NCT00752609|19423317|P1|Overall Study|Met exclusion criteria|1
5622830|NCT00752609|19423316|P2|Overall Study|Death|0
5622831|NCT00752609|19423317|P1|Overall Study|Death|1
5622832|NCT00752609|19423316|P2|Overall Study|Physician Decision|0
5622833|NCT00752609|19423317|P1|Overall Study|Physician Decision|1
5622834|NCT00752609|19423316|P2|Overall Study|Withdrawal by Subject|0
5622835|NCT00752609|19423317|P1|Overall Study|Withdrawal by Subject|3
5622836|NCT00752609|19423316|P2|Overall Study|Adverse Event|2
5622837|NCT00752609|19423317|P1|Overall Study|Adverse Event|2
5622838|NCT00752557|19423339|P3|Overall Study|Lost to Follow-up|1
5622839|NCT00752557|19423340|P2|Overall Study|Lost to Follow-up|0
5622840|NCT00752557|19423341|P1|Overall Study|Lost to Follow-up|1
5622841|NCT00752557|19423339|P3|Overall Study|Unspecified resaons|2
5622842|NCT00752557|19423340|P2|Overall Study|Unspecified resaons|2
5622843|NCT00752557|19423341|P1|Overall Study|Unspecified resaons|0
5622844|NCT00752557|19423339|P3|Overall Study|Withdrawal by Subject|3
5622845|NCT00752557|19423340|P2|Overall Study|Withdrawal by Subject|3
5622846|NCT00752557|19423341|P1|Overall Study|Withdrawal by Subject|4
5622847|NCT00752232|19423373|P7|Overall Study|Caregiver could not attend the subject|0
5622848|NCT00752232|19423374|P6|Overall Study|Caregiver could not attend the subject|0
5622849|NCT00752232|19423375|P5|Overall Study|Caregiver could not attend the subject|1
5622850|NCT00752232|19423376|P4|Overall Study|Caregiver could not attend the subject|0
5622851|NCT00752232|19423377|P3|Overall Study|Caregiver could not attend the subject|0
5622852|NCT00752232|19423378|P2|Overall Study|Caregiver could not attend the subject|0
5622853|NCT00752232|19423379|P1|Overall Study|Caregiver could not attend the subject|0
5622854|NCT00752232|19423373|P7|Overall Study|Group home admission|0
5622855|NCT00752232|19423374|P6|Overall Study|Group home admission|0
5622856|NCT00752232|19423375|P5|Overall Study|Group home admission|0
5622857|NCT00752232|19423376|P4|Overall Study|Group home admission|1
5622858|NCT00752232|19423377|P3|Overall Study|Group home admission|0
5622859|NCT00752232|19423378|P2|Overall Study|Group home admission|0
5622860|NCT00752232|19423379|P1|Overall Study|Group home admission|0
5622861|NCT00752232|19423373|P7|Overall Study|Subject request|0
5622862|NCT00752232|19423374|P6|Overall Study|Subject request|0
5622863|NCT00752232|19423375|P5|Overall Study|Subject request|0
5622864|NCT00752232|19423376|P4|Overall Study|Subject request|0
5622865|NCT00752232|19423377|P3|Overall Study|Subject request|1
5622866|NCT00752232|19423378|P2|Overall Study|Subject request|0
5622867|NCT00752232|19423379|P1|Overall Study|Subject request|0
5622868|NCT00752232|19423373|P7|Overall Study|Investigator request|0
5622869|NCT00752232|19423374|P6|Overall Study|Investigator request|0
5622870|NCT00752232|19423375|P5|Overall Study|Investigator request|1
5622871|NCT00752232|19423376|P4|Overall Study|Investigator request|0
5622872|NCT00752232|19423377|P3|Overall Study|Investigator request|0
5622873|NCT00752232|19423378|P2|Overall Study|Investigator request|0
5622874|NCT00752232|19423379|P1|Overall Study|Investigator request|0
5622875|NCT00752232|19423373|P7|Overall Study|Caregiver request|0
5622876|NCT00752232|19423374|P6|Overall Study|Caregiver request|0
5622877|NCT00752232|19423375|P5|Overall Study|Caregiver request|1
5622878|NCT00752232|19423376|P4|Overall Study|Caregiver request|0
5622879|NCT00752232|19423377|P3|Overall Study|Caregiver request|0
5622880|NCT00752232|19423378|P2|Overall Study|Caregiver request|0
5622881|NCT00752232|19423379|P1|Overall Study|Caregiver request|2
5622882|NCT00752232|19423373|P7|Overall Study|Protocol Violation|0
5622883|NCT00752232|19423374|P6|Overall Study|Protocol Violation|1
5622884|NCT00752232|19423375|P5|Overall Study|Protocol Violation|0
5622885|NCT00752232|19423376|P4|Overall Study|Protocol Violation|0
5622886|NCT00752232|19423377|P3|Overall Study|Protocol Violation|0
5622887|NCT00752232|19423378|P2|Overall Study|Protocol Violation|0
5622888|NCT00752232|19423379|P1|Overall Study|Protocol Violation|0
5622889|NCT00752219|19423453|P2|Overall Study|Other|0
5622890|NCT00752219|19423454|P1|Overall Study|Other|3
5622891|NCT00752219|19423453|P2|Overall Study|Randomized but not treated|0
5622892|NCT00752219|19423454|P1|Overall Study|Randomized but not treated|1
5622893|NCT00752219|19423453|P2|Overall Study|Lost to Follow-up|2
5622894|NCT00752219|19423454|P1|Overall Study|Lost to Follow-up|1
5622895|NCT00752219|19423453|P2|Overall Study|Protocol deviation|0
5622896|NCT00752219|19423454|P1|Overall Study|Protocol deviation|1
5622897|NCT00752219|19423453|P2|Overall Study|Adverse Event|3
5622898|NCT00752219|19423454|P1|Overall Study|Adverse Event|5
5622899|NCT00752219|19423453|P2|Overall Study|Clinical failure|1
5622900|NCT00752219|19423454|P1|Overall Study|Clinical failure|0
5622901|NCT00752206|19423480|P2|Overall Study|Pregnancy|0
5622902|NCT00752206|19423481|P1|Overall Study|Pregnancy|1
5622903|NCT00752206|19423480|P2|Overall Study|Disease progression|11
5622904|NCT00752206|19423481|P1|Overall Study|Disease progression|8
5622905|NCT00752128|19423499|P1|Overall Study|Withdrawal by Subject|4
5622906|NCT00752089|19423513|P1|Overall Study|Cannot continue the study|1
5622907|NCT00752089|19423513|P1|Overall Study|Not capable of wearing partial denture|1
5622908|NCT00752089|19423513|P1|Overall Study|Could not attend visit 9|1
5622909|NCT00752089|19423513|P1|Overall Study|Protocol Deviation|2
5622910|NCT00752089|19423513|P1|Overall Study|Adverse Event|1
5622911|NCT00751998|19423527|P1|Overall Study|Withdrawal by Subject|2
5622912|NCT00751998|19423527|P1|Overall Study|Death|11
5622913|NCT00751998|19423527|P1|Overall Study|Lost to Follow-up|7
5622914|NCT00751933|19423546|P4|Overall Study|Physician Decision|1
5622915|NCT00751933|19423547|P3|Overall Study|Physician Decision|1
5622916|NCT00751933|19423548|P2|Overall Study|Physician Decision|0
5622917|NCT00751933|19423549|P1|Overall Study|Physician Decision|0
5622918|NCT00751933|19423546|P4|Overall Study|Withdrawal by Subject|0
5622919|NCT00751933|19423547|P3|Overall Study|Withdrawal by Subject|0
5622920|NCT00751933|19423548|P2|Overall Study|Withdrawal by Subject|1
5622921|NCT00751933|19423549|P1|Overall Study|Withdrawal by Subject|0
5622922|NCT00751881|19423557|P3|Extension Study Period|Other than specified above|18
5622923|NCT00751881|19423558|P2|Extension Study Period|Other than specified above|30
5622924|NCT00751881|19423559|P1|Extension Study Period|Other than specified above|26
5622925|NCT00751881|19423557|P3|Extension Study Period|Poor Compliance to Protocol|1
5622926|NCT00751881|19423558|P2|Extension Study Period|Poor Compliance to Protocol|2
5622927|NCT00751881|19423559|P1|Extension Study Period|Poor Compliance to Protocol|3
5622928|NCT00751881|19423557|P3|Extension Study Period|Lost to Follow-up|6
5622929|NCT00751881|19423558|P2|Extension Study Period|Lost to Follow-up|9
5622930|NCT00751881|19423559|P1|Extension Study Period|Lost to Follow-up|4
5622931|NCT00751881|19423557|P3|Extension Study Period|Lack of Efficacy|20
5622932|NCT00751881|19423558|P2|Extension Study Period|Lack of Efficacy|10
5622933|NCT00751881|19423559|P1|Extension Study Period|Lack of Efficacy|14
5622934|NCT00751881|19423557|P3|Extension Study Period|Adverse Event|21
5622935|NCT00751881|19423558|P2|Extension Study Period|Adverse Event|20
5622936|NCT00751881|19423559|P1|Extension Study Period|Adverse Event|18
5622937|NCT00751881|19423557|P3|Core Treatment Period|Other:participant's decision/unspecified|16
5622938|NCT00751881|19423558|P2|Core Treatment Period|Other:participant's decision/unspecified|22
5622939|NCT00751881|19423559|P1|Core Treatment Period|Other:participant's decision/unspecified|19
5622940|NCT00751881|19423557|P3|Core Treatment Period|Other: tolerability complaints|0
5622941|NCT00751881|19423558|P2|Core Treatment Period|Other: tolerability complaints|0
5622942|NCT00751881|19423559|P1|Core Treatment Period|Other: tolerability complaints|2
5622943|NCT00751881|19423557|P3|Core Treatment Period|Other: MS treatment change|4
5622944|NCT00751881|19423558|P2|Core Treatment Period|Other: MS treatment change|4
5622945|NCT00751881|19423559|P1|Core Treatment Period|Other: MS treatment change|6
5622946|NCT00751881|19423557|P3|Core Treatment Period|Other: personal/family constraints|10
5622947|NCT00751881|19423558|P2|Core Treatment Period|Other: personal/family constraints|7
5622948|NCT00751881|19423559|P1|Core Treatment Period|Other: personal/family constraints|6
5622949|NCT00751881|19423557|P3|Core Treatment Period|Other: wish to parent|4
5622950|NCT00751881|19423558|P2|Core Treatment Period|Other: wish to parent|7
5622951|NCT00751881|19423559|P1|Core Treatment Period|Other: wish to parent|5
5622952|NCT00751881|19423557|P3|Core Treatment Period|Other: protocol deviation|7
5622953|NCT00751881|19423558|P2|Core Treatment Period|Other: protocol deviation|3
5622954|NCT00751881|19423559|P1|Core Treatment Period|Other: protocol deviation|3
5622955|NCT00751881|19423557|P3|Core Treatment Period|Lost to Follow-up|3
5622956|NCT00751881|19423558|P2|Core Treatment Period|Lost to Follow-up|4
5622957|NCT00751881|19423559|P1|Core Treatment Period|Lost to Follow-up|6
5622958|NCT00751881|19423557|P3|Core Treatment Period|Poor compliance to protocol|4
5622959|NCT00751881|19423558|P2|Core Treatment Period|Poor compliance to protocol|3
5622960|NCT00751881|19423559|P1|Core Treatment Period|Poor compliance to protocol|15
5622961|NCT00751881|19423557|P3|Core Treatment Period|Lack of Efficacy|20
5622962|NCT00751881|19423558|P2|Core Treatment Period|Lack of Efficacy|30
5622963|NCT00751881|19423559|P1|Core Treatment Period|Lack of Efficacy|37
5622964|NCT00751881|19423557|P3|Core Treatment Period|Adverse Event|58
5622965|NCT00751881|19423558|P2|Core Treatment Period|Adverse Event|54
5622966|NCT00751881|19423559|P1|Core Treatment Period|Adverse Event|26
5622967|NCT00751881|19423557|P3|Core Treatment Period|Not treated|2
5622968|NCT00751881|19423558|P2|Core Treatment Period|Not treated|1
5622969|NCT00751881|19423559|P1|Core Treatment Period|Not treated|1
5622970|NCT00751790|19423606|P1|Overall Study|Withdrawal by Subject|1
5622971|NCT00751790|19423606|P1|Overall Study|Death|3
5622972|NCT00751790|19423606|P1|Overall Study|Lost to Follow-up|1
5622973|NCT00751621|19423637|P1|Overall Study|Poor adherence to asthma treatment|1
5622974|NCT00751621|19423637|P1|Overall Study|Subject moved to another country|1
5622975|NCT00751621|19423637|P1|Overall Study|Withdrawal by Subject|1
5622976|NCT00751621|19423637|P1|Overall Study|Adverse Event|1
5622977|NCT00751400|19423671|P1|Overall Study|Lost to Follow-up|10
5622978|NCT00751348|19423686|P2|Overall Study|Migration from study area|0
5622979|NCT00751348|19423687|P1|Overall Study|Migration from study area|1
5622980|NCT00751348|19423686|P2|Overall Study|Withdrawal by Subject|2
5622981|NCT00751348|19423687|P1|Overall Study|Withdrawal by Subject|5
5622982|NCT00751296|19423720|P1|Overall Study|Adverse Event|2
5622983|NCT00751140|19423748|P1|Overall Study|benign angioma excluded from analysis|1
5622984|NCT00751114|19423758|P2|Overall Study|Move to another city|0
5622985|NCT00751114|19423759|P1|Overall Study|Move to another city|1
5622986|NCT00751114|19423758|P2|Overall Study|Out of country for 2 months|0
5622987|NCT00751114|19423759|P1|Overall Study|Out of country for 2 months|1
5622988|NCT00751114|19423758|P2|Overall Study|Not Treated|1
5622989|NCT00751114|19423759|P1|Overall Study|Not Treated|13
5622990|NCT00751114|19423758|P2|Overall Study|Lack of Efficacy|7
5622991|NCT00751114|19423759|P1|Overall Study|Lack of Efficacy|0
5622992|NCT00751114|19423758|P2|Overall Study|Lost to Follow-up|7
5622993|NCT00751114|19423759|P1|Overall Study|Lost to Follow-up|4
5622994|NCT00751114|19423758|P2|Overall Study|Withdrawal by Subject|4
5622995|NCT00751114|19423759|P1|Overall Study|Withdrawal by Subject|9
5622996|NCT00751114|19423758|P2|Overall Study|Protocol Violation|9
5622997|NCT00751114|19423759|P1|Overall Study|Protocol Violation|8
5622998|NCT00751114|19423758|P2|Overall Study|Adverse Event|4
5622999|NCT00751114|19423759|P1|Overall Study|Adverse Event|2
5623000|NCT00751101|19423784|P2|Overall Study|Physician Decision|1
5623001|NCT00751101|19423785|P1|Overall Study|Physician Decision|0
5623002|NCT00751101|19423784|P2|Overall Study|Never began capecitabine|0
5623003|NCT00751101|19423785|P1|Overall Study|Never began capecitabine|1
5623004|NCT00751101|19423784|P2|Overall Study|No HFS / Never Started Patch/|4
5623005|NCT00751101|19423785|P1|Overall Study|No HFS / Never Started Patch/|0
5623006|NCT00751101|19423784|P2|Overall Study|Withdrawal by Subject|0
5623007|NCT00751101|19423785|P1|Overall Study|Withdrawal by Subject|1
5623008|NCT00751036|19423805|P2|Overall Study|Missing end of Treatment Page|3
5623009|NCT00751036|19423806|P1|Overall Study|Missing end of Treatment Page|2
5623010|NCT00751036|19423805|P2|Overall Study|Protocol Violation|0
5623011|NCT00751036|19423806|P1|Overall Study|Protocol Violation|1
5623012|NCT00751036|19423805|P2|Overall Study|Lost to Follow-up|1
5623013|NCT00751036|19423806|P1|Overall Study|Lost to Follow-up|0
5623014|NCT00751036|19423805|P2|Overall Study|Death|3
5623015|NCT00751036|19423806|P1|Overall Study|Death|3
5623016|NCT00751036|19423805|P2|Overall Study|Withdrawal by Subject|2
5623017|NCT00751036|19423806|P1|Overall Study|Withdrawal by Subject|5
5623018|NCT00751036|19423805|P2|Overall Study|Administrative Problems|4
5623019|NCT00751036|19423806|P1|Overall Study|Administrative Problems|3
5623020|NCT00751036|19423805|P2|Overall Study|Adverse Event|4
5623021|NCT00751036|19423806|P1|Overall Study|Adverse Event|6
5623022|NCT00751036|19423805|P2|Overall Study|Disease Progression|29
5623023|NCT00751036|19423806|P1|Overall Study|Disease Progression|28
5623024|NCT00751023|19423820|P2|Overall Study|Lost to Follow-up|7
5623025|NCT00751023|19423821|P1|Overall Study|Lost to Follow-up|11
5623026|NCT00750919|19423841|P1|Overall Study|Other|36
5623027|NCT00750919|19423841|P1|Overall Study|Could not cooperate, unrelated to trial|4
5623028|NCT00750919|19423841|P1|Overall Study|Lack of Efficacy|8
5623029|NCT00750919|19423841|P1|Overall Study|Withdrawal by Subject|1
5623030|NCT00750919|19423841|P1|Overall Study|Adverse Event|9
5623031|NCT00750893|19423849|P1|Overall Study|Other|17
5623032|NCT00750893|19423849|P1|Overall Study|Lost to Follow-up|510
5623033|NCT00750893|19423849|P1|Overall Study|Withdrawal by Subject|10
5623034|NCT00750893|19423849|P1|Overall Study|Adverse Event|5
5623035|NCT00750880|19423861|P1|Overall Study|Administrative|11
5623036|NCT00750880|19423861|P1|Overall Study|Physician Decision|20
5623037|NCT00750880|19423861|P1|Overall Study|Withdrawal by Subject|33
5623038|NCT00750880|19423861|P1|Overall Study|Protocol Violation|15
5623039|NCT00750880|19423861|P1|Overall Study|Lost to Follow-up|10
5623040|NCT00750880|19423861|P1|Overall Study|Lack of Efficacy|46
5623041|NCT00750880|19423861|P1|Overall Study|Death|4
5623042|NCT00750880|19423861|P1|Overall Study|Adverse Event|76
5623043|NCT00750867|19423884|P1|Overall Study|Adverse Event|2
5623044|NCT00750737|19423905|P2|Overall Study|Withdrawal by Subject|3
5623045|NCT00750737|19423906|P1|Overall Study|Withdrawal by Subject|3
5623046|NCT00750438|19423921|P2|Overall Study|Withdrawal by Subject|1
5623047|NCT00750438|19423922|P1|Overall Study|Withdrawal by Subject|1
5623048|NCT00750438|19423921|P2|Overall Study|Physician Decision|2
5623049|NCT00750438|19423922|P1|Overall Study|Physician Decision|2
5623050|NCT00750438|19423921|P2|Overall Study|Protocol Violation|1
5623051|NCT00750438|19423922|P1|Overall Study|Protocol Violation|4
5623052|NCT00750308|19423988|P12|Third Treatment|Withdrawal by Subject|0
5623053|NCT00750308|19423989|P11|Third Treatment|Withdrawal by Subject|0
5623054|NCT00750308|19423990|P10|Third Treatment|Withdrawal by Subject|0
5623055|NCT00750308|19423991|P9|Third Treatment|Withdrawal by Subject|0
5623056|NCT00750308|19423992|P8|Third Treatment|Withdrawal by Subject|0
5623057|NCT00750308|19423993|P7|Third Treatment|Withdrawal by Subject|0
5623058|NCT00750308|19423994|P6|Third Treatment|Withdrawal by Subject|0
5623059|NCT00750308|19423995|P5|Third Treatment|Withdrawal by Subject|0
5623060|NCT00750308|19423996|P4|Third Treatment|Withdrawal by Subject|0
5623061|NCT00750308|19423997|P3|Third Treatment|Withdrawal by Subject|0
5623062|NCT00750308|19423998|P2|Third Treatment|Withdrawal by Subject|1
5623063|NCT00750308|19423999|P1|Third Treatment|Withdrawal by Subject|0
5623064|NCT00750308|19423988|P12|Second Treatment|Withdrawal by Subject|0
5623065|NCT00750308|19423989|P11|Second Treatment|Withdrawal by Subject|0
5623066|NCT00750308|19423990|P10|Second Treatment|Withdrawal by Subject|0
5623067|NCT00750308|19423991|P9|Second Treatment|Withdrawal by Subject|0
5623068|NCT00750308|19423992|P8|Second Treatment|Withdrawal by Subject|0
5623069|NCT00750308|19423993|P7|Second Treatment|Withdrawal by Subject|0
5623070|NCT00750308|19423994|P6|Second Treatment|Withdrawal by Subject|0
5623071|NCT00750308|19423995|P5|Second Treatment|Withdrawal by Subject|1
5623072|NCT00750308|19423996|P4|Second Treatment|Withdrawal by Subject|0
5623073|NCT00750308|19423997|P3|Second Treatment|Withdrawal by Subject|0
5623074|NCT00750308|19423998|P2|Second Treatment|Withdrawal by Subject|0
5623075|NCT00750308|19423999|P1|Second Treatment|Withdrawal by Subject|0
5623076|NCT00750308|19423988|P12|Second Treatment|Adverse Event|0
5623077|NCT00750308|19423989|P11|Second Treatment|Adverse Event|0
5623078|NCT00750308|19423990|P10|Second Treatment|Adverse Event|0
5623079|NCT00750308|19423991|P9|Second Treatment|Adverse Event|1
5623080|NCT00750308|19423992|P8|Second Treatment|Adverse Event|0
5623081|NCT00750308|19423993|P7|Second Treatment|Adverse Event|0
5623082|NCT00750308|19423994|P6|Second Treatment|Adverse Event|1
5623083|NCT00750308|19423995|P5|Second Treatment|Adverse Event|0
5623084|NCT00750308|19423996|P4|Second Treatment|Adverse Event|0
5623085|NCT00750308|19423997|P3|Second Treatment|Adverse Event|0
5623086|NCT00750308|19423998|P2|Second Treatment|Adverse Event|0
5623087|NCT00750308|19423999|P1|Second Treatment|Adverse Event|0
5623088|NCT00750308|19423988|P12|First Treatment|Withdrawal by Subject|0
5623089|NCT00750308|19423989|P11|First Treatment|Withdrawal by Subject|0
5623090|NCT00750308|19423990|P10|First Treatment|Withdrawal by Subject|0
5623091|NCT00750308|19423991|P9|First Treatment|Withdrawal by Subject|0
5623092|NCT00750308|19423992|P8|First Treatment|Withdrawal by Subject|1
5623093|NCT00750308|19423993|P7|First Treatment|Withdrawal by Subject|0
5623094|NCT00750308|19423994|P6|First Treatment|Withdrawal by Subject|0
5623095|NCT00750308|19423995|P5|First Treatment|Withdrawal by Subject|0
5623096|NCT00750308|19423996|P4|First Treatment|Withdrawal by Subject|1
5623097|NCT00750308|19423997|P3|First Treatment|Withdrawal by Subject|0
5623098|NCT00750308|19423998|P2|First Treatment|Withdrawal by Subject|0
5623099|NCT00750308|19423999|P1|First Treatment|Withdrawal by Subject|0
5623100|NCT00750308|19423988|P12|First Treatment|Adverse Event|1
5623101|NCT00750308|19423989|P11|First Treatment|Adverse Event|1
5623102|NCT00750308|19423990|P10|First Treatment|Adverse Event|0
5623103|NCT00750308|19423991|P9|First Treatment|Adverse Event|0
5623104|NCT00750308|19423992|P8|First Treatment|Adverse Event|0
5623105|NCT00750308|19423993|P7|First Treatment|Adverse Event|0
5623106|NCT00750308|19423994|P6|First Treatment|Adverse Event|0
5623107|NCT00750308|19423995|P5|First Treatment|Adverse Event|0
5623108|NCT00750308|19423996|P4|First Treatment|Adverse Event|0
5623109|NCT00750308|19423997|P3|First Treatment|Adverse Event|0
5623110|NCT00750308|19423998|P2|First Treatment|Adverse Event|1
5623111|NCT00750308|19423999|P1|First Treatment|Adverse Event|0
5623112|NCT00750269|19424049|P5|Overall Study|Fiducials could not be placed|1
5623113|NCT00750269|19424050|P4|Overall Study|Fiducials could not be placed|0
5623114|NCT00750269|19424051|P3|Overall Study|Fiducials could not be placed|0
5623115|NCT00750269|19424052|P2|Overall Study|Fiducials could not be placed|0
5623116|NCT00750269|19424053|P1|Overall Study|Fiducials could not be placed|0
5623117|NCT00750269|19424049|P5|Overall Study|SBRT plan could not be drawn|1
5623118|NCT00750269|19424050|P4|Overall Study|SBRT plan could not be drawn|0
5623119|NCT00750269|19424051|P3|Overall Study|SBRT plan could not be drawn|0
5623120|NCT00750269|19424052|P2|Overall Study|SBRT plan could not be drawn|0
5623121|NCT00750269|19424053|P1|Overall Study|SBRT plan could not be drawn|0
5623122|NCT00750269|19424049|P5|Overall Study|Site error|0
5623123|NCT00750269|19424050|P4|Overall Study|Site error|1
5623124|NCT00750269|19424051|P3|Overall Study|Site error|0
5623125|NCT00750269|19424052|P2|Overall Study|Site error|0
5623126|NCT00750269|19424053|P1|Overall Study|Site error|0
5623127|NCT00750269|19424049|P5|Overall Study|Patient too large for positioning|0
5623128|NCT00750269|19424050|P4|Overall Study|Patient too large for positioning|0
5623129|NCT00750269|19424051|P3|Overall Study|Patient too large for positioning|1
5623130|NCT00750269|19424052|P2|Overall Study|Patient too large for positioning|0
5623131|NCT00750269|19424053|P1|Overall Study|Patient too large for positioning|0
5623132|NCT00750269|19424049|P5|Overall Study|Physician Decision|2
5623133|NCT00750269|19424050|P4|Overall Study|Physician Decision|0
5623134|NCT00750269|19424051|P3|Overall Study|Physician Decision|0
5623135|NCT00750269|19424052|P2|Overall Study|Physician Decision|0
5623136|NCT00750269|19424053|P1|Overall Study|Physician Decision|0
5623137|NCT00750269|19424049|P5|Overall Study|Withdrawal by Subject|2
5623138|NCT00750269|19424050|P4|Overall Study|Withdrawal by Subject|2
5623139|NCT00750269|19424051|P3|Overall Study|Withdrawal by Subject|2
5623140|NCT00750269|19424052|P2|Overall Study|Withdrawal by Subject|0
5623141|NCT00750269|19424053|P1|Overall Study|Withdrawal by Subject|0
5623142|NCT00750269|19424049|P5|Overall Study|Protocol Violation|4
5623143|NCT00750269|19424050|P4|Overall Study|Protocol Violation|2
5623144|NCT00750269|19424051|P3|Overall Study|Protocol Violation|1
5623145|NCT00750269|19424052|P2|Overall Study|Protocol Violation|1
5623146|NCT00750269|19424053|P1|Overall Study|Protocol Violation|0
5623147|NCT00750204|19424100|P2|Overall Study|study halted prematurely|1
5623148|NCT00750204|19424101|P1|Overall Study|study halted prematurely|1
5623149|NCT00750152|19424131|P2|Overall Study|Other|8
5623150|NCT00750152|19424132|P1|Overall Study|Other|7
5623151|NCT00750152|19424131|P2|Overall Study|Termination by sponsor|0
5623152|NCT00750152|19424132|P1|Overall Study|Termination by sponsor|1
5623153|NCT00750152|19424131|P2|Overall Study|Non-compliance|1
5623154|NCT00750152|19424132|P1|Overall Study|Non-compliance|0
5623155|NCT00750152|19424131|P2|Overall Study|Physician Decision|1
5623156|NCT00750152|19424132|P1|Overall Study|Physician Decision|1
5623157|NCT00750152|19424131|P2|Overall Study|Withdrawal by Subject|3
5623158|NCT00750152|19424132|P1|Overall Study|Withdrawal by Subject|3
5623159|NCT00750152|19424131|P2|Overall Study|Lost to Follow-up|13
5623160|NCT00750152|19424132|P1|Overall Study|Lost to Follow-up|8
5623161|NCT00750152|19424131|P2|Overall Study|Adverse Event|1
5623162|NCT00750152|19424132|P1|Overall Study|Adverse Event|2
5623163|NCT00750139|19424144|P4|Overall Study|Non-specific|33
5623164|NCT00750139|19424145|P3|Overall Study|Non-specific|79
5623165|NCT00750139|19424146|P2|Overall Study|Non-specific|42
5623166|NCT00750139|19424147|P1|Overall Study|Non-specific|62
5623167|NCT00750139|19424144|P4|Overall Study|Termination by sponsor|1
5623168|NCT00750139|19424145|P3|Overall Study|Termination by sponsor|0
5623169|NCT00750139|19424146|P2|Overall Study|Termination by sponsor|0
5623170|NCT00750139|19424147|P1|Overall Study|Termination by sponsor|4
5623171|NCT00750139|19424144|P4|Overall Study|Non-compliance|3
5623172|NCT00750139|19424145|P3|Overall Study|Non-compliance|1
5623173|NCT00750139|19424146|P2|Overall Study|Non-compliance|0
5623174|NCT00750139|19424147|P1|Overall Study|Non-compliance|1
5623175|NCT00750139|19424144|P4|Overall Study|Physician Decision|0
5623176|NCT00750139|19424145|P3|Overall Study|Physician Decision|0
5623177|NCT00750139|19424146|P2|Overall Study|Physician Decision|1
5623178|NCT00750139|19424147|P1|Overall Study|Physician Decision|1
5623179|NCT00750139|19424144|P4|Overall Study|Withdrawal by Subject|2
5623180|NCT00750139|19424145|P3|Overall Study|Withdrawal by Subject|6
5623181|NCT00750139|19424146|P2|Overall Study|Withdrawal by Subject|2
5623182|NCT00750139|19424147|P1|Overall Study|Withdrawal by Subject|3
5623183|NCT00750139|19424144|P4|Overall Study|Lost to Follow-up|6
5623184|NCT00750139|19424145|P3|Overall Study|Lost to Follow-up|15
5623185|NCT00750139|19424146|P2|Overall Study|Lost to Follow-up|12
5623186|NCT00750139|19424147|P1|Overall Study|Lost to Follow-up|17
5623187|NCT00750139|19424144|P4|Overall Study|Adverse Event|1
5623188|NCT00750139|19424145|P3|Overall Study|Adverse Event|0
5623189|NCT00750139|19424146|P2|Overall Study|Adverse Event|2
5623190|NCT00750139|19424147|P1|Overall Study|Adverse Event|1
5623191|NCT00750061|19424163|P2|Overall Study|Physician Decision|1
5623192|NCT00750061|19424164|P1|Overall Study|Physician Decision|0
5623193|NCT00750061|19424163|P2|Overall Study|Withdrawal by Subject|1
5623194|NCT00750061|19424164|P1|Overall Study|Withdrawal by Subject|0
5623195|NCT00750061|19424163|P2|Overall Study|Adverse Event|0
5623196|NCT00750061|19424164|P1|Overall Study|Adverse Event|2
5623197|NCT00749996|19424174|P2|Overall Study|Death|0
5623198|NCT00749996|19424175|P1|Overall Study|Death|1
5623199|NCT00749996|19424174|P2|Overall Study|Adverse Event|0
5623200|NCT00749996|19424175|P1|Overall Study|Adverse Event|1
5623201|NCT00749996|19424174|P2|Overall Study|Pregnancy|2
5623202|NCT00749996|19424175|P1|Overall Study|Pregnancy|0
5623203|NCT00749996|19424174|P2|Overall Study|Physician Decision|0
5623204|NCT00749996|19424175|P1|Overall Study|Physician Decision|2
5623205|NCT00749996|19424174|P2|Overall Study|Protocol Violation|3
5623206|NCT00749996|19424175|P1|Overall Study|Protocol Violation|2
5623207|NCT00749996|19424174|P2|Overall Study|Withdrawal by Subject|4
5623208|NCT00749996|19424175|P1|Overall Study|Withdrawal by Subject|5
5623209|NCT00749996|19424174|P2|Overall Study|Lost to Follow-up|4
5623210|NCT00749996|19424175|P1|Overall Study|Lost to Follow-up|7
5623211|NCT00749944|19424198|P2|Overall Study|Withdrawal by Subject|0
5623212|NCT00749944|19424199|P1|Overall Study|Withdrawal by Subject|2
5623213|NCT00749944|19424198|P2|Overall Study|Other|0
5623214|NCT00749944|19424199|P1|Overall Study|Other|1
5623215|NCT00749944|19424198|P2|Overall Study|Lost to Follow-up|1
5623216|NCT00749944|19424199|P1|Overall Study|Lost to Follow-up|2
5623217|NCT00749892|19424278|P1|Overall Study|Withdrawal by Subject|3
5623218|NCT00749775|19424314|P1|Overall Study|No drug administration|3
5623219|NCT00749775|19424314|P1|Overall Study|No visit after first day of treatment|44
5623220|NCT00749775|19424314|P1|Overall Study|Lost to Follow-up|36
5623221|NCT00749775|19424314|P1|Overall Study|Protocol Violation|24
5623222|NCT00749684|19424351|P1|Overall Study|Missing|9
5623223|NCT00749684|19424351|P1|Overall Study|AE+discontinuation on participants wish|1
5623224|NCT00749684|19424351|P1|Overall Study|Therapy according to protocol + AE|2
5623225|NCT00749684|19424351|P1|Overall Study|Progressive Desease|31
5623226|NCT00749684|19424351|P1|Overall Study|Not Documented|1
5623227|NCT00749684|19424351|P1|Overall Study|Participant's Wish|10
5623228|NCT00749684|19424351|P1|Overall Study|Adverse Event|27
5623229|NCT00749684|19424351|P1|Overall Study|Death|1
5623230|NCT00749580|19424399|P2|Overall Study|Adverse Event|1
5623231|NCT00749580|19424400|P1|Overall Study|Adverse Event|0
5623232|NCT00749580|19424399|P2|Overall Study|Lost to Follow-up|8
5623233|NCT00749580|19424400|P1|Overall Study|Lost to Follow-up|4
5623234|NCT00749463|19424434|P3|Overall Study|Withdrawal by Subject|0
5623235|NCT00749463|19424435|P2|Overall Study|Withdrawal by Subject|0
5623236|NCT00749463|19424436|P1|Overall Study|Withdrawal by Subject|1
5623237|NCT00749463|19424434|P3|Overall Study|Adverse Event|1
5623238|NCT00749463|19424435|P2|Overall Study|Adverse Event|4
5623239|NCT00749463|19424436|P1|Overall Study|Adverse Event|0
5623240|NCT00749411|19424464|P2|Overall Study|Protocol-defined stopping criteria|1
5623241|NCT00749411|19424465|P1|Overall Study|Protocol-defined stopping criteria|0
5623242|NCT00749411|19424464|P2|Overall Study|Protocol Violation|1
5623243|NCT00749411|19424465|P1|Overall Study|Protocol Violation|1
5623244|NCT00749411|19424464|P2|Overall Study|Lack of Efficacy|1
5623245|NCT00749411|19424465|P1|Overall Study|Lack of Efficacy|0
5623246|NCT00749411|19424464|P2|Overall Study|Adverse Event|2
5623247|NCT00749411|19424465|P1|Overall Study|Adverse Event|0
5623248|NCT00749398|19424473|P1|Overall Study|Unknown reason|1
5623249|NCT00749398|19424473|P1|Overall Study|Reason not specified|2
5623250|NCT00749398|19424473|P1|Overall Study|Lost to Follow-up|11
5623251|NCT00749398|19424473|P1|Overall Study|Withdrawal by Subject|17
5623252|NCT00749398|19424473|P1|Overall Study|Serious adverse event|11
5623253|NCT00749398|19424473|P1|Overall Study|Adverse Event|4
5623254|NCT00749398|19424473|P1|Overall Study|Lack of Efficacy|7
5623255|NCT00749203|19424516|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
5623256|NCT00749203|19424517|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
5623257|NCT00749203|19424516|P2|Second Infusion at 2 Weeks|Protocol Violation|1
5623258|NCT00749203|19424517|P1|Second Infusion at 2 Weeks|Protocol Violation|0
5623259|NCT00749203|19424516|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
5623260|NCT00749203|19424517|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
5623261|NCT00749203|19424516|P2|no Infusion at Week 1|delayed-onset sedation|1
5623262|NCT00749203|19424517|P1|no Infusion at Week 1|delayed-onset sedation|0
5623263|NCT00749203|19424516|P2|no Infusion at Week 1|Withdrawal by Subject|1
5623264|NCT00749203|19424517|P1|no Infusion at Week 1|Withdrawal by Subject|0
5623265|NCT00749203|19424516|P2|no Infusion at Week 1|Lost to Follow-up|1
5623266|NCT00749203|19424517|P1|no Infusion at Week 1|Lost to Follow-up|0
5623267|NCT00749190|19424538|P7|Overall Study|Other reason not defined above|0
5623268|NCT00749190|19424539|P6|Overall Study|Other reason not defined above|0
5623269|NCT00749190|19424540|P5|Overall Study|Other reason not defined above|0
5623270|NCT00749190|19424541|P4|Overall Study|Other reason not defined above|1
5623271|NCT00749190|19424542|P3|Overall Study|Other reason not defined above|0
5623272|NCT00749190|19424543|P2|Overall Study|Other reason not defined above|0
5623273|NCT00749190|19424544|P1|Overall Study|Other reason not defined above|0
5623274|NCT00749190|19424538|P7|Overall Study|Protocol Violation|1
5623275|NCT00749190|19424539|P6|Overall Study|Protocol Violation|0
5623276|NCT00749190|19424540|P5|Overall Study|Protocol Violation|0
5623277|NCT00749190|19424541|P4|Overall Study|Protocol Violation|0
5623278|NCT00749190|19424542|P3|Overall Study|Protocol Violation|0
5623279|NCT00749190|19424543|P2|Overall Study|Protocol Violation|1
5623280|NCT00749190|19424544|P1|Overall Study|Protocol Violation|0
5623281|NCT00749190|19424538|P7|Overall Study|Withdrawal by Subject|0
5623282|NCT00749190|19424539|P6|Overall Study|Withdrawal by Subject|1
5623283|NCT00749190|19424540|P5|Overall Study|Withdrawal by Subject|0
5623284|NCT00749190|19424541|P4|Overall Study|Withdrawal by Subject|0
5623285|NCT00749190|19424542|P3|Overall Study|Withdrawal by Subject|0
5623286|NCT00749190|19424543|P2|Overall Study|Withdrawal by Subject|1
5623287|NCT00749190|19424544|P1|Overall Study|Withdrawal by Subject|2
5623288|NCT00749190|19424538|P7|Overall Study|Lack of Efficacy|0
5623289|NCT00749190|19424539|P6|Overall Study|Lack of Efficacy|1
5623290|NCT00749190|19424540|P5|Overall Study|Lack of Efficacy|0
5623291|NCT00749190|19424541|P4|Overall Study|Lack of Efficacy|0
5623292|NCT00749190|19424542|P3|Overall Study|Lack of Efficacy|1
5623293|NCT00749190|19424543|P2|Overall Study|Lack of Efficacy|1
5623294|NCT00749190|19424544|P1|Overall Study|Lack of Efficacy|3
5623295|NCT00749190|19424538|P7|Overall Study|Adverse Event|0
5623296|NCT00749190|19424539|P6|Overall Study|Adverse Event|3
5623297|NCT00749190|19424540|P5|Overall Study|Adverse Event|0
5623298|NCT00749190|19424541|P4|Overall Study|Adverse Event|4
5623299|NCT00749190|19424542|P3|Overall Study|Adverse Event|0
5623300|NCT00749190|19424543|P2|Overall Study|Adverse Event|2
5623301|NCT00749190|19424544|P1|Overall Study|Adverse Event|0
5623302|NCT00748969|19424653|P2|Overall Study|Withdrawal by Subject|1
5623303|NCT00748969|19424654|P1|Overall Study|Withdrawal by Subject|0
5623304|NCT00748969|19424653|P2|Overall Study|Withdrawal by Subject|0
5623305|NCT00748969|19424654|P1|Overall Study|Withdrawal by Subject|1
5623306|NCT00748709|19424704|P1|Overall Study|Other Reasons|1
5623307|NCT00748709|19424704|P1|Overall Study|Withdrawal by Subject|1
5623308|NCT00748709|19424704|P1|Overall Study|Other Adverse Event|1
5623309|NCT00748709|19424704|P1|Overall Study|Drug reducing Toxity|2
5623310|NCT00748709|19424704|P1|Overall Study|Progressive disease|15
5623311|NCT00748566|19424747|P1|Overall Study|Other|9
5623312|NCT00748566|19424747|P1|Overall Study|Study terminated by sponsor|5
5623313|NCT00748566|19424747|P1|Overall Study|Withdrawal by Subject|22
5623314|NCT00748566|19424747|P1|Overall Study|Protocol Violation|13
5623315|NCT00748566|19424747|P1|Overall Study|Lost to Follow-up|1
5623316|NCT00748566|19424747|P1|Overall Study|Lack of Efficacy|12
5623317|NCT00748566|19424747|P1|Overall Study|Death|1
5623318|NCT00748566|19424747|P1|Overall Study|Adverse Event|49
5623319|NCT00748553|19424777|P2|Overall Study|noncompliance|0
5623320|NCT00748553|19424778|P1|Overall Study|noncompliance|1
5623321|NCT00748553|19424777|P2|Overall Study|disease progression|0
5623322|NCT00748553|19424778|P1|Overall Study|disease progression|2
5623323|NCT00748553|19424777|P2|Overall Study|Adverse Event|1
5623324|NCT00748553|19424778|P1|Overall Study|Adverse Event|0
5623325|NCT00748540|19424785|P1|Overall Study|Physician Decision|1
5623326|NCT00748241|19424811|P1|Overall Study|Death|2
5623327|NCT00748241|19424811|P1|Overall Study|Lost to Follow-up|5
5623328|NCT00748241|19424811|P1|Overall Study|Implant failure|1
5623329|NCT00748215|19424821|P2|Overall Study|Adverse Event|5
5623330|NCT00748215|19424822|P1|Overall Study|Adverse Event|0
5623331|NCT00748215|19424821|P2|Overall Study|Non-compliant|2
5623332|NCT00748215|19424822|P1|Overall Study|Non-compliant|0
5623333|NCT00748215|19424821|P2|Overall Study|Change in patient condition|3
5623334|NCT00748215|19424822|P1|Overall Study|Change in patient condition|0
5623335|NCT00748215|19424821|P2|Overall Study|Treatment change|1
5623336|NCT00748215|19424822|P1|Overall Study|Treatment change|2
5623337|NCT00748215|19424821|P2|Overall Study|Withdrawal by Subject|7
5623338|NCT00748215|19424822|P1|Overall Study|Withdrawal by Subject|7
5623339|NCT00748189|19424830|P2|Overall Study|Study terminated by Sponsor|79
5623340|NCT00748189|19424831|P1|Overall Study|Study terminated by Sponsor|70
5623341|NCT00748189|19424830|P2|Overall Study|Lost to Follow-up|15
5623342|NCT00748189|19424831|P1|Overall Study|Lost to Follow-up|8
5623343|NCT00748189|19424830|P2|Overall Study|Physician Decision|5
5623344|NCT00748189|19424831|P1|Overall Study|Physician Decision|16
5623345|NCT00748189|19424830|P2|Overall Study|Withdrawal by Subject|29
5623346|NCT00748189|19424831|P1|Overall Study|Withdrawal by Subject|23
5623347|NCT00748189|19424830|P2|Overall Study|Death|84
5623348|NCT00748189|19424831|P1|Overall Study|Death|99
5623349|NCT00748098|19424886|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
5623350|NCT00748098|19424887|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
5623351|NCT00748098|19424886|P2|Second Treatment Intervention Period|Lost to Follow-up|1
5623352|NCT00748098|19424887|P1|Second Treatment Intervention Period|Lost to Follow-up|1
5623353|NCT00748098|19424886|P2|Second Treatment Intervention Period|Adverse Event|1
5623354|NCT00748098|19424887|P1|Second Treatment Intervention Period|Adverse Event|4
5623355|NCT00748098|19424886|P2|1-Week Washout Period|Withdrawal by Subject|0
5623356|NCT00748098|19424887|P1|1-Week Washout Period|Withdrawal by Subject|2
5623357|NCT00748098|19424886|P2|1-Week Washout Period|Adverse Event|1
5623358|NCT00748098|19424887|P1|1-Week Washout Period|Adverse Event|0
5623359|NCT00748098|19424886|P2|First Taper Period|Protocol Stopping Criteria Met|1
5623360|NCT00748098|19424887|P1|First Taper Period|Protocol Stopping Criteria Met|0
5623361|NCT00748098|19424886|P2|First Taper Period|Withdrawal by Subject|0
5623362|NCT00748098|19424887|P1|First Taper Period|Withdrawal by Subject|2
5623363|NCT00748098|19424886|P2|First Taper Period|Protocol Violation|0
5623364|NCT00748098|19424887|P1|First Taper Period|Protocol Violation|1
5623365|NCT00748098|19424886|P2|First Treatment Intervention Period|Withdrawal by Subject|0
5623366|NCT00748098|19424887|P1|First Treatment Intervention Period|Withdrawal by Subject|2
5623367|NCT00748098|19424886|P2|First Treatment Intervention Period|Lost to Follow-up|0
5623368|NCT00748098|19424887|P1|First Treatment Intervention Period|Lost to Follow-up|1
5623369|NCT00748098|19424886|P2|First Treatment Intervention Period|Protocol Violation|0
5623370|NCT00748098|19424887|P1|First Treatment Intervention Period|Protocol Violation|1
5623371|NCT00748098|19424886|P2|First Treatment Intervention Period|Adverse Event|1
5623372|NCT00748098|19424887|P1|First Treatment Intervention Period|Adverse Event|1
5623373|NCT00747812|19424968|P2|Overall Study|Research Site Staff Relocation|3
5623374|NCT00747812|19424969|P1|Overall Study|Research Site Staff Relocation|5
5623375|NCT00747643|19425007|P2|Overall Study|Withdrawal by Subject|27
5623376|NCT00747643|19425008|P1|Overall Study|Withdrawal by Subject|36
5623377|NCT00747617|19425022|P2|Overall Study|Lost to Follow-up|1
5623378|NCT00747617|19425023|P1|Overall Study|Lost to Follow-up|3
5623379|NCT00747565|19425033|P2|Overall Study|Lost to Follow-up|1
5623380|NCT00747565|19425034|P1|Overall Study|Lost to Follow-up|4
5623381|NCT00747565|19425033|P2|Overall Study|Withdrawal by Subject|6
5623382|NCT00747565|19425034|P1|Overall Study|Withdrawal by Subject|10
5623383|NCT00747474|19425047|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623384|NCT00747474|19425048|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623385|NCT00747474|19425049|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623386|NCT00747474|19425050|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623387|NCT00747474|19425051|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
5623388|NCT00747474|19425052|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623389|NCT00747474|19425053|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623390|NCT00747474|19425054|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623391|NCT00747474|19425055|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623392|NCT00747474|19425056|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623393|NCT00747474|19425057|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623394|NCT00747474|19425058|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
5623395|NCT00747461|19425084|P1|Overall Study|study terminated by sponsor|5
5623396|NCT00747435|19425089|P1|Overall Study|Still undergoing follow up|1
5623397|NCT00747435|19425089|P1|Overall Study|Withdrawal by Subject|3
5623398|NCT00747435|19425089|P1|Overall Study|Lost to Follow-up|2
5623399|NCT00747344|19425099|P4|After Controlled Period|Adverse Event|1
5623400|NCT00747344|19425100|P3|After Controlled Period|Adverse Event|0
5623401|NCT00747344|19425101|P2|After Controlled Period|Adverse Event|0
5623402|NCT00747344|19425102|P1|After Controlled Period|Adverse Event|0
5623403|NCT00747344|19425099|P4|Controlled Period|Other|0
5623404|NCT00747344|19425100|P3|Controlled Period|Other|0
5623405|NCT00747344|19425101|P2|Controlled Period|Other|3
5623406|NCT00747344|19425102|P1|Controlled Period|Other|0
5623407|NCT00747344|19425099|P4|Controlled Period|Lack of Efficacy|0
5623408|NCT00747344|19425100|P3|Controlled Period|Lack of Efficacy|0
5623409|NCT00747344|19425101|P2|Controlled Period|Lack of Efficacy|1
5623410|NCT00747344|19425102|P1|Controlled Period|Lack of Efficacy|2
5623411|NCT00747344|19425099|P4|Controlled Period|Adverse Event|0
5623412|NCT00747344|19425100|P3|Controlled Period|Adverse Event|0
5623413|NCT00747344|19425101|P2|Controlled Period|Adverse Event|0
5623414|NCT00747344|19425102|P1|Controlled Period|Adverse Event|3
5623415|NCT00747227|19425116|P2|Overall Study|Illness|1
5623416|NCT00747227|19425117|P1|Overall Study|Illness|1
5623417|NCT00747227|19425116|P2|Overall Study|Lost to Follow-up|2
5623418|NCT00747227|19425117|P1|Overall Study|Lost to Follow-up|1
5623419|NCT00747227|19425116|P2|Overall Study|Withdrawal by Subject|0
5623420|NCT00747227|19425117|P1|Overall Study|Withdrawal by Subject|1
5623421|NCT00747227|19425116|P2|Overall Study|Death|1
5623422|NCT00747227|19425117|P1|Overall Study|Death|3
5623423|NCT00747149|19425146|P2|Overall Study|Not reported|4
5623424|NCT00747149|19425147|P1|Overall Study|Not reported|1
5623425|NCT00747149|19425146|P2|Overall Study|Severe non-compliance to protocol|1
5623426|NCT00747149|19425147|P1|Overall Study|Severe non-compliance to protocol|0
5623427|NCT00747149|19425146|P2|Overall Study|Incorrect enrollment|6
5623428|NCT00747149|19425147|P1|Overall Study|Incorrect enrollment|0
5623429|NCT00747149|19425146|P2|Overall Study|Did not receive treatment|1
5623430|NCT00747149|19425147|P1|Overall Study|Did not receive treatment|0
5623431|NCT00747149|19425146|P2|Overall Study|Withdrawal by Subject|6
5623432|NCT00747149|19425147|P1|Overall Study|Withdrawal by Subject|0
5623433|NCT00747149|19425146|P2|Overall Study|Lost to Follow-up|10
5623434|NCT00747149|19425147|P1|Overall Study|Lost to Follow-up|0
5623435|NCT00747149|19425146|P2|Overall Study|Adverse Event|15
5623436|NCT00747149|19425147|P1|Overall Study|Adverse Event|0
5623437|NCT00747006|19425162|P3|Overall Study|Physician Decision|1
5623438|NCT00747006|19425163|P2|Overall Study|Physician Decision|0
5623439|NCT00747006|19425164|P1|Overall Study|Physician Decision|2
5623440|NCT00747006|19425162|P3|Overall Study|Lost to Follow-up|0
5623441|NCT00747006|19425163|P2|Overall Study|Lost to Follow-up|1
5623442|NCT00747006|19425164|P1|Overall Study|Lost to Follow-up|0
5623443|NCT00747006|19425162|P3|Overall Study|Adverse Event|0
5623444|NCT00747006|19425163|P2|Overall Study|Adverse Event|0
5623445|NCT00747006|19425164|P1|Overall Study|Adverse Event|1
5623446|NCT00746941|19425242|P4|Overall Study|Adverse Event|1
5623447|NCT00746941|19425243|P3|Overall Study|Adverse Event|0
5623448|NCT00746941|19425244|P2|Overall Study|Adverse Event|0
5623449|NCT00746941|19425245|P1|Overall Study|Adverse Event|0
5623450|NCT00746941|19425242|P4|Overall Study|Other, reason not provided|4
5623451|NCT00746941|19425243|P3|Overall Study|Other, reason not provided|0
5623452|NCT00746941|19425244|P2|Overall Study|Other, reason not provided|4
5623453|NCT00746941|19425245|P1|Overall Study|Other, reason not provided|2
5623454|NCT00746941|19425242|P4|Overall Study|Withdrawal by Subject|2
5623455|NCT00746941|19425243|P3|Overall Study|Withdrawal by Subject|0
5623456|NCT00746941|19425244|P2|Overall Study|Withdrawal by Subject|0
5623457|NCT00746941|19425245|P1|Overall Study|Withdrawal by Subject|3
5623458|NCT00746941|19425242|P4|Overall Study|Physician Decision|0
5623459|NCT00746941|19425243|P3|Overall Study|Physician Decision|2
5623460|NCT00746941|19425244|P2|Overall Study|Physician Decision|0
5623461|NCT00746941|19425245|P1|Overall Study|Physician Decision|0
5623462|NCT00746941|19425242|P4|Overall Study|Death|6
5623463|NCT00746941|19425243|P3|Overall Study|Death|0
5623464|NCT00746941|19425244|P2|Overall Study|Death|0
5623465|NCT00746941|19425245|P1|Overall Study|Death|2
5623466|NCT00746798|19425303|P4|Overall Study|Participant unable to return for visit|0
5623467|NCT00746798|19425304|P3|Overall Study|Participant unable to return for visit|0
5623468|NCT00746798|19425305|P2|Overall Study|Participant unable to return for visit|0
5623469|NCT00746798|19425306|P1|Overall Study|Participant unable to return for visit|1
5623470|NCT00746798|19425303|P4|Overall Study|Death|0
5623471|NCT00746798|19425304|P3|Overall Study|Death|2
5623472|NCT00746798|19425305|P2|Overall Study|Death|0
5623473|NCT00746798|19425306|P1|Overall Study|Death|0
5623474|NCT00746798|19425303|P4|Overall Study|Withdrawal by Subject|0
5623475|NCT00746798|19425304|P3|Overall Study|Withdrawal by Subject|1
5623476|NCT00746798|19425305|P2|Overall Study|Withdrawal by Subject|1
5623477|NCT00746798|19425306|P1|Overall Study|Withdrawal by Subject|0
5623478|NCT00746798|19425303|P4|Overall Study|Protocol Violation|0
5623479|NCT00746798|19425304|P3|Overall Study|Protocol Violation|0
5623480|NCT00746798|19425305|P2|Overall Study|Protocol Violation|1
5623481|NCT00746798|19425306|P1|Overall Study|Protocol Violation|0
5623482|NCT00746785|19425331|P3|Overall Study|Lost to Follow-up|27
5623483|NCT00746785|19425332|P2|Overall Study|Lost to Follow-up|25
5623484|NCT00746785|19425333|P1|Overall Study|Lost to Follow-up|29
5623485|NCT00746733|19425341|P2|Third Intervention|Withdrawal by Subject|1
5623486|NCT00746733|19425342|P1|Third Intervention|Withdrawal by Subject|1
5623487|NCT00746733|19425341|P2|Second Intervention|Adverse Event|0
5623488|NCT00746733|19425342|P1|Second Intervention|Adverse Event|1
5623489|NCT00746590|19425426|P1|Overall Study|Death|1
5623490|NCT00746564|19425430|P1|Overall Study|Required Pacemaker/ICD Implant|2
5623491|NCT00746551|19425445|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
5623492|NCT00746551|19425446|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
5623493|NCT00746551|19425445|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
5623494|NCT00746551|19425446|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
5623495|NCT00746551|19425445|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
5623496|NCT00746551|19425446|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
5623497|NCT00746356|19425497|P2|Overall Study|Patient relocated|0
5623498|NCT00746356|19425498|P1|Overall Study|Patient relocated|1
5623499|NCT00746356|19425497|P2|Overall Study|Removal of Device|1
5623500|NCT00746356|19425498|P1|Overall Study|Removal of Device|0
5623501|NCT00746356|19425497|P2|Overall Study|Lost to Follow-up|0
5623502|NCT00746356|19425498|P1|Overall Study|Lost to Follow-up|1
5623503|NCT00746356|19425497|P2|Overall Study|Death|3
5623504|NCT00746356|19425498|P1|Overall Study|Death|7
5623505|NCT00746356|19425497|P2|Overall Study|Withdrawal by Subject|3
5623506|NCT00746356|19425498|P1|Overall Study|Withdrawal by Subject|2
5623507|NCT00746330|19425510|P4|Period 1|Abnormal test procedure result|0
5623508|NCT00746330|19425511|P3|Period 1|Abnormal test procedure result|1
5623509|NCT00746330|19425512|P2|Period 1|Abnormal test procedure result|0
5623510|NCT00746330|19425513|P1|Period 1|Abnormal test procedure result|0
5623511|NCT00746252|19425543|P2|Overall Study|weight gain >7.5 %|2
5623512|NCT00746252|19425544|P1|Overall Study|weight gain >7.5 %|1
5623513|NCT00746096|19425579|P2|Overall Study|No study drug treatment|1
5623514|NCT00746096|19425580|P1|Overall Study|No study drug treatment|1
5623515|NCT00746096|19425579|P2|Overall Study|Protocol Violation|0
5623516|NCT00746096|19425580|P1|Overall Study|Protocol Violation|1
5623517|NCT00746096|19425579|P2|Overall Study|Lost to Follow-up|1
5623518|NCT00746096|19425580|P1|Overall Study|Lost to Follow-up|2
5623519|NCT00746096|19425579|P2|Overall Study|Withdrawal by Subject|1
5623520|NCT00746096|19425580|P1|Overall Study|Withdrawal by Subject|5
5623521|NCT00746096|19425579|P2|Overall Study|Adverse Event|0
5623522|NCT00746096|19425580|P1|Overall Study|Adverse Event|1
5623523|NCT00745901|19425611|P2|Overall Study|Patient didn't take any study medication|3
5623524|NCT00745901|19425612|P1|Overall Study|Patient didn't take any study medication|7
5623525|NCT00745901|19425611|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
5623526|NCT00745901|19425612|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
5623527|NCT00745901|19425611|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
5623528|NCT00745901|19425612|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
5623529|NCT00745901|19425611|P2|Overall Study|Patient's next menses did not start with|0
5623530|NCT00745901|19425612|P1|Overall Study|Patient's next menses did not start with|1
5623531|NCT00745901|19425611|P2|Overall Study|Lack of compliance|2
5623532|NCT00745901|19425612|P1|Overall Study|Lack of compliance|2
5623533|NCT00745901|19425611|P2|Overall Study|Pregnancy|4
5623534|NCT00745901|19425612|P1|Overall Study|Pregnancy|2
5623535|NCT00745901|19425611|P2|Overall Study|Lost to Follow-up|4
5623536|NCT00745901|19425612|P1|Overall Study|Lost to Follow-up|7
5623537|NCT00745901|19425611|P2|Overall Study|Withdrawal by Subject|0
5623538|NCT00745901|19425612|P1|Overall Study|Withdrawal by Subject|1
5623539|NCT00745901|19425611|P2|Overall Study|Protocol Violation|1
5623540|NCT00745901|19425612|P1|Overall Study|Protocol Violation|0
5623541|NCT00745901|19425611|P2|Overall Study|Adverse Event|4
5623542|NCT00745901|19425612|P1|Overall Study|Adverse Event|3
5623543|NCT00745875|19425658|P2|Overall Study|Continuing study treatment|4
5623544|NCT00745875|19425659|P1|Overall Study|Continuing study treatment|4
5623545|NCT00745849|19425667|P2|Second Intervention|Lost to Follow-up|1
5623546|NCT00745849|19425668|P1|Second Intervention|Lost to Follow-up|2
5623547|NCT00745849|19425667|P2|First Intervention|Lost to Follow-up|1
5623548|NCT00745849|19425668|P1|First Intervention|Lost to Follow-up|1
5623549|NCT00745849|19425667|P2|First Intervention|Withdrawal by Subject|1
5623550|NCT00745849|19425668|P1|First Intervention|Withdrawal by Subject|0
5623551|NCT00745823|19425676|P2|Overall Study|Study Terminated by Sponsor|349
5623552|NCT00745823|19425677|P1|Overall Study|Study Terminated by Sponsor|326
5623553|NCT00745823|19425676|P2|Overall Study|Withdrawal by Subject|8
5623554|NCT00745823|19425677|P1|Overall Study|Withdrawal by Subject|14
5623555|NCT00745823|19425676|P2|Overall Study|Pregnancy|4
5623556|NCT00745823|19425677|P1|Overall Study|Pregnancy|0
5623557|NCT00745823|19425676|P2|Overall Study|Physician Decision|5
5623558|NCT00745823|19425677|P1|Overall Study|Physician Decision|10
5623559|NCT00745823|19425676|P2|Overall Study|Lost to Follow-up|11
5623560|NCT00745823|19425677|P1|Overall Study|Lost to Follow-up|10
5623561|NCT00745823|19425676|P2|Overall Study|Lack of Efficacy|6
5623562|NCT00745823|19425677|P1|Overall Study|Lack of Efficacy|20
5623563|NCT00745823|19425676|P2|Overall Study|Adverse Event|3
5623564|NCT00745823|19425677|P1|Overall Study|Adverse Event|5
5623565|NCT00745615|19425705|P6|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
5623566|NCT00745615|19425706|P5|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
5623567|NCT00745615|19425707|P4|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
5623568|NCT00745615|19425708|P3|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
5623569|NCT00745615|19425709|P2|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
5623570|NCT00745615|19425710|P1|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
5623571|NCT00745615|19425705|P6|Open-Label (up to Approx 10.5 Years)|Death|1
5623572|NCT00745615|19425706|P5|Open-Label (up to Approx 10.5 Years)|Death|0
5623573|NCT00745615|19425707|P4|Open-Label (up to Approx 10.5 Years)|Death|0
5623574|NCT00745615|19425708|P3|Open-Label (up to Approx 10.5 Years)|Death|0
5623575|NCT00745615|19425709|P2|Open-Label (up to Approx 10.5 Years)|Death|0
5623576|NCT00745615|19425710|P1|Open-Label (up to Approx 10.5 Years)|Death|0
5623577|NCT00745615|19425705|P6|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
5623578|NCT00745615|19425706|P5|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5623579|NCT00745615|19425707|P4|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5623580|NCT00745615|19425708|P3|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5623581|NCT00745615|19425709|P2|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5623582|NCT00745615|19425710|P1|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
5623583|NCT00745615|19425705|P6|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
5623584|NCT00745615|19425706|P5|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
5623585|NCT00745615|19425707|P4|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
5623586|NCT00745615|19425708|P3|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
5623587|NCT00745615|19425709|P2|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
5623588|NCT00745615|19425710|P1|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
5623589|NCT00745615|19425705|P6|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
5623590|NCT00745615|19425706|P5|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
5623591|NCT00745615|19425707|P4|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
5623592|NCT00745615|19425708|P3|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
5623593|NCT00745615|19425709|P2|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
5623594|NCT00745615|19425710|P1|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
5623595|NCT00745615|19425705|P6|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
5623596|NCT00745615|19425706|P5|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
5623597|NCT00745615|19425707|P4|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
5623598|NCT00745615|19425708|P3|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
5623599|NCT00745615|19425709|P2|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
5623600|NCT00745615|19425710|P1|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
5623601|NCT00745615|19425705|P6|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
5623602|NCT00745615|19425706|P5|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
5623603|NCT00745615|19425707|P4|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
5623604|NCT00745615|19425708|P3|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
5623605|NCT00745615|19425709|P2|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
5623606|NCT00745615|19425710|P1|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
5623607|NCT00745615|19425705|P6|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
5623608|NCT00745615|19425706|P5|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
5623609|NCT00745615|19425707|P4|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
5623610|NCT00745615|19425708|P3|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
5623611|NCT00745615|19425709|P2|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
5623612|NCT00745615|19425710|P1|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
5623613|NCT00745615|19425705|P6|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
5623614|NCT00745615|19425706|P5|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
5623615|NCT00745615|19425707|P4|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
5623616|NCT00745615|19425708|P3|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
5623617|NCT00745615|19425709|P2|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
5623618|NCT00745615|19425710|P1|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
5623619|NCT00745615|19425705|P6|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5623620|NCT00745615|19425706|P5|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5623621|NCT00745615|19425707|P4|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5623622|NCT00745615|19425708|P3|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5623623|NCT00745615|19425709|P2|Double-Blind Extension (36 Weeks)|Other Than Specified|1
5623624|NCT00745615|19425710|P1|Double-Blind Extension (36 Weeks)|Other Than Specified|0
5623625|NCT00745615|19425705|P6|Double-Blind Extension (36 Weeks)|Pregnancy|0
5623626|NCT00745615|19425706|P5|Double-Blind Extension (36 Weeks)|Pregnancy|0
5623627|NCT00745615|19425707|P4|Double-Blind Extension (36 Weeks)|Pregnancy|0
5623628|NCT00745615|19425708|P3|Double-Blind Extension (36 Weeks)|Pregnancy|0
5623629|NCT00745615|19425709|P2|Double-Blind Extension (36 Weeks)|Pregnancy|1
5623630|NCT00745615|19425710|P1|Double-Blind Extension (36 Weeks)|Pregnancy|0
5623631|NCT00745615|19425705|P6|Double-Blind Extension (36 Weeks)|Adverse Event|0
5623632|NCT00745615|19425706|P5|Double-Blind Extension (36 Weeks)|Adverse Event|0
5623633|NCT00745615|19425707|P4|Double-Blind Extension (36 Weeks)|Adverse Event|1
5623634|NCT00745615|19425708|P3|Double-Blind Extension (36 Weeks)|Adverse Event|1
5623635|NCT00745615|19425709|P2|Double-Blind Extension (36 Weeks)|Adverse Event|3
5623636|NCT00745615|19425710|P1|Double-Blind Extension (36 Weeks)|Adverse Event|2
5623637|NCT00745615|19425705|P6|Double-Blind Extension (36 Weeks)|Physician Decision|0
5623638|NCT00745615|19425706|P5|Double-Blind Extension (36 Weeks)|Physician Decision|0
5623639|NCT00745615|19425707|P4|Double-Blind Extension (36 Weeks)|Physician Decision|0
5623640|NCT00745615|19425708|P3|Double-Blind Extension (36 Weeks)|Physician Decision|0
5623641|NCT00745615|19425709|P2|Double-Blind Extension (36 Weeks)|Physician Decision|1
5623642|NCT00745615|19425710|P1|Double-Blind Extension (36 Weeks)|Physician Decision|0
5623643|NCT00745615|19425705|P6|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
5623644|NCT00745615|19425706|P5|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
5623645|NCT00745615|19425707|P4|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
5623646|NCT00745615|19425708|P3|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
5623647|NCT00745615|19425709|P2|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
5623648|NCT00745615|19425710|P1|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
5623649|NCT00745498|19425759|P3|Overall Study|Edophthalmitis after preoperative IVB|0
5623650|NCT00745498|19425760|P2|Overall Study|Edophthalmitis after preoperative IVB|0
5623651|NCT00745498|19425761|P1|Overall Study|Edophthalmitis after preoperative IVB|1
5623652|NCT00745498|19425759|P3|Overall Study|Non-PDR related VH|1
5623653|NCT00745498|19425760|P2|Overall Study|Non-PDR related VH|1
5623654|NCT00745498|19425761|P1|Overall Study|Non-PDR related VH|0
5623655|NCT00745498|19425759|P3|Overall Study|Injection of intravitreal silicone oil o|4
5623656|NCT00745498|19425760|P2|Overall Study|Injection of intravitreal silicone oil o|4
5623657|NCT00745498|19425761|P1|Overall Study|Injection of intravitreal silicone oil o|3
5623658|NCT00745498|19425759|P3|Overall Study|Lost to Follow-up|3
5623659|NCT00745498|19425760|P2|Overall Study|Lost to Follow-up|1
5623660|NCT00745498|19425761|P1|Overall Study|Lost to Follow-up|1
5623661|NCT00745420|19425775|P1|Overall Study|Ineligible|1
5623662|NCT00745368|19425792|P1|Overall Study|Unable to provide sample|3
5623663|NCT00745251|19425814|P2|Overall Study|Withdrawal by Subject|1
5623664|NCT00745251|19425815|P1|Overall Study|Withdrawal by Subject|1
5623665|NCT00745251|19425814|P2|Overall Study|Adverse Event|2
5623666|NCT00745251|19425815|P1|Overall Study|Adverse Event|1
5623667|NCT00745121|19425825|P2|Overall Study|Withdrawal by Subject|2
5623668|NCT00745121|19425826|P1|Overall Study|Withdrawal by Subject|4
5623669|NCT00745121|19425825|P2|Overall Study|Lost to Follow-up|0
5623670|NCT00745121|19425826|P1|Overall Study|Lost to Follow-up|1
5623671|NCT00745121|19425825|P2|Overall Study|Adverse Event|0
5623672|NCT00745121|19425826|P1|Overall Study|Adverse Event|1
5623673|NCT00745121|19425825|P2|Overall Study|Death|0
5623674|NCT00745121|19425826|P1|Overall Study|Death|3
5623675|NCT00745095|19425838|P6|Overall Study|Ineligible due to GFR criteria|28
5623676|NCT00745095|19425839|P5|Overall Study|Ineligible due to GFR criteria|30
5623677|NCT00745095|19425840|P4|Overall Study|Ineligible due to GFR criteria|3
5623678|NCT00745095|19425841|P3|Overall Study|Ineligible due to GFR criteria|3
5623679|NCT00745095|19425842|P2|Overall Study|Ineligible due to GFR criteria|2
5623680|NCT00745095|19425843|P1|Overall Study|Ineligible due to GFR criteria|0
5623681|NCT00745095|19425838|P6|Overall Study|Declined to participate|95
5623682|NCT00745095|19425839|P5|Overall Study|Declined to participate|92
5623683|NCT00745095|19425840|P4|Overall Study|Declined to participate|0
5623684|NCT00745095|19425841|P3|Overall Study|Declined to participate|0
5623685|NCT00745095|19425842|P2|Overall Study|Declined to participate|0
5623686|NCT00745095|19425843|P1|Overall Study|Declined to participate|1
5623687|NCT00744991|19425872|P1|Overall Study|Protocol Entry Criteria Unmet|1
5623688|NCT00744991|19425872|P1|Overall Study|Adverse Event|2
5623689|NCT00744991|19425872|P1|Overall Study|Physician Decision|3
5623690|NCT00744991|19425872|P1|Overall Study|Withdrawal by Subject|8
5623691|NCT00744991|19425872|P1|Overall Study|Progressive Disease|11
5623692|NCT00744978|19425889|P2|Period 2|Adverse Event|1
5623693|NCT00744978|19425890|P1|Period 2|Adverse Event|0
5623694|NCT00744978|19425889|P2|Period 1|Randomized but not Treated|1
5623695|NCT00744978|19425890|P1|Period 1|Randomized but not Treated|1
5623696|NCT00744978|19425889|P2|Period 1|Adverse Event|0
5623697|NCT00744978|19425890|P1|Period 1|Adverse Event|4
5623698|NCT00744978|19425889|P2|Period 1|Other|2
5623699|NCT00744978|19425890|P1|Period 1|Other|0
5623700|NCT00744978|19425889|P2|Period 1|Withdrawal by Subject|2
5623701|NCT00744978|19425890|P1|Period 1|Withdrawal by Subject|0
5623702|NCT00744978|19425889|P2|Period 1|Lost to Follow-up|0
5623703|NCT00744978|19425890|P1|Period 1|Lost to Follow-up|1
5623704|NCT00744939|19425971|P1|Overall Study|incorrect race|1
5623705|NCT00744939|19425971|P1|Overall Study|coma|1
5623706|NCT00744939|19425971|P1|Overall Study|Failed inclusion/exclusion criteria|19
5623707|NCT00744939|19425971|P1|Overall Study|Did not receive Magnevist|7
5623708|NCT00744939|19425971|P1|Overall Study|Medical history exclusionary|1
5623709|NCT00744939|19425971|P1|Overall Study|Lost to Follow-up|12
5623710|NCT00744939|19425971|P1|Overall Study|distance|4
5623711|NCT00744939|19425971|P1|Overall Study|Death|24
5623712|NCT00744939|19425971|P1|Overall Study|Protocol Violation|13
5623713|NCT00744939|19425971|P1|Overall Study|Withdrawal by Subject|9
5623714|NCT00744874|19426007|P1|Overall Study|Unable to accomodate schedule|1
5623715|NCT00744874|19426007|P1|Overall Study|Study Device not available at procedure|1
5623716|NCT00744874|19426007|P1|Overall Study|Withdrawal by Subject|1
5623717|NCT00744874|19426007|P1|Overall Study|Lost to Follow-up|1
5623718|NCT00744796|19426032|P1|Post-Operative 6-9 Months|Lost to Follow-up|12
5623719|NCT00744757|19426038|P1|Overall Study|Adverse Event|2
5623720|NCT00744757|19426038|P1|Overall Study|Death|6
5623721|NCT00744757|19426038|P1|Overall Study|Withdrawal by Subject|1
5623722|NCT00744757|19426038|P1|Overall Study|Physician Decision|5
5623723|NCT00744757|19426038|P1|Overall Study|Objective disease progression|7
5623724|NCT00744653|19426063|P1|Overall Study|Physician Decision|3
5623725|NCT00744653|19426063|P1|Overall Study|Lost to Follow-up|1
5623726|NCT00744653|19426063|P1|Overall Study|Death|1
5623727|NCT00744653|19426063|P1|Overall Study|antineoplastic treatment|11
5623728|NCT00744627|19426071|P2|Overall Study|Other|0
5623729|NCT00744627|19426072|P1|Overall Study|Other|1
5623730|NCT00744627|19426071|P2|Overall Study|Lost to Follow-up|1
5623731|NCT00744627|19426072|P1|Overall Study|Lost to Follow-up|2
5623732|NCT00744627|19426071|P2|Overall Study|Voluntary Withdrawal|6
5623733|NCT00744627|19426072|P1|Overall Study|Voluntary Withdrawal|9
5623734|NCT00744627|19426071|P2|Overall Study|Protocol Deviations|2
5623735|NCT00744627|19426072|P1|Overall Study|Protocol Deviations|0
5623736|NCT00744627|19426071|P2|Overall Study|Noncompliance|1
5623737|NCT00744627|19426072|P1|Overall Study|Noncompliance|0
5623738|NCT00744627|19426071|P2|Overall Study|Lack of Efficacy|3
5623739|NCT00744627|19426072|P1|Overall Study|Lack of Efficacy|7
5623740|NCT00744627|19426071|P2|Overall Study|Adverse Event|9
5623741|NCT00744627|19426072|P1|Overall Study|Adverse Event|6
5623742|NCT00744523|19426128|P2|30 Days After the Procedure|Insufficient follow-up|5
5623743|NCT00744523|19426129|P1|30 Days After the Procedure|Insufficient follow-up|0
5623744|NCT00744497|19426149|P2|Overall Study|Not defined|13
5623745|NCT00744497|19426150|P1|Overall Study|Not defined|19
5623746|NCT00744497|19426149|P2|Overall Study|Maximum clinical benefit|142
5623747|NCT00744497|19426150|P1|Overall Study|Maximum clinical benefit|141
5623748|NCT00744497|19426149|P2|Overall Study|Patient requested to stop study drug|80
5623749|NCT00744497|19426150|P1|Overall Study|Patient requested to stop study drug|65
5623750|NCT00744497|19426149|P2|Overall Study|Adverse event unrelated to study drug|122
5623751|NCT00744497|19426150|P1|Overall Study|Adverse event unrelated to study drug|78
5623752|NCT00744497|19426149|P2|Overall Study|Study drug toxicity|141
5623753|NCT00744497|19426150|P1|Overall Study|Study drug toxicity|68
5623754|NCT00744497|19426149|P2|Overall Study|Disease progression|219
5623755|NCT00744497|19426150|P1|Overall Study|Disease progression|312
5623756|NCT00744497|19426149|P2|Overall Study|Administrative Reason By Sponsor|8
5623757|NCT00744497|19426150|P1|Overall Study|Administrative Reason By Sponsor|25
5623758|NCT00744497|19426149|P2|Overall Study|No longer meets study criteria|3
5623759|NCT00744497|19426150|P1|Overall Study|No longer meets study criteria|7
5623760|NCT00744497|19426149|P2|Overall Study|Poor compliance/noncompliance|5
5623761|NCT00744497|19426150|P1|Overall Study|Poor compliance/noncompliance|9
5623762|NCT00744497|19426149|P2|Overall Study|Lost to Follow-up|2
5623763|NCT00744497|19426150|P1|Overall Study|Lost to Follow-up|4
5623764|NCT00744497|19426149|P2|Overall Study|Death|9
5623765|NCT00744497|19426150|P1|Overall Study|Death|11
5623766|NCT00744497|19426149|P2|Overall Study|Withdrawal by Subject|18
5623767|NCT00744497|19426150|P1|Overall Study|Withdrawal by Subject|21
5623768|NCT00744328|19426210|P3|Overall Study|Found ineligible after randomization|1
5623769|NCT00744328|19426211|P2|Overall Study|Found ineligible after randomization|0
5623770|NCT00744328|19426212|P1|Overall Study|Found ineligible after randomization|0
5623771|NCT00744328|19426210|P3|Overall Study|Withdrawal by Subject|4
5623772|NCT00744328|19426211|P2|Overall Study|Withdrawal by Subject|3
5623773|NCT00744328|19426212|P1|Overall Study|Withdrawal by Subject|5
5623774|NCT00744328|19426210|P3|Overall Study|Lost to Follow-up|3
5623775|NCT00744328|19426211|P2|Overall Study|Lost to Follow-up|5
5623776|NCT00744328|19426212|P1|Overall Study|Lost to Follow-up|2
5623777|NCT00744263|19426225|P2|Overall Study|Other|2
5623778|NCT00744263|19426226|P1|Overall Study|Other|2
5623779|NCT00744263|19426225|P2|Overall Study|Adverse Event|0
5623780|NCT00744263|19426226|P1|Overall Study|Adverse Event|1
5623781|NCT00744263|19426225|P2|Overall Study|Protocol Violation|5
5623782|NCT00744263|19426226|P1|Overall Study|Protocol Violation|3
5623783|NCT00744263|19426225|P2|Overall Study|Physician Decision|23
5623784|NCT00744263|19426226|P1|Overall Study|Physician Decision|20
5623785|NCT00744263|19426225|P2|Overall Study|Withdrawal by Subject|150
5623786|NCT00744263|19426226|P1|Overall Study|Withdrawal by Subject|166
5623787|NCT00744263|19426225|P2|Overall Study|Lost to Follow-up|2135
5623788|NCT00744263|19426226|P1|Overall Study|Lost to Follow-up|2038
5623789|NCT00744263|19426225|P2|Overall Study|Death|3005
5623790|NCT00744263|19426226|P1|Overall Study|Death|3006
5623791|NCT00744237|19426249|P3|Overall Study|Adverse Event|5
5623792|NCT00744237|19426250|P2|Overall Study|Adverse Event|13
5623793|NCT00744237|19426251|P1|Overall Study|Adverse Event|9
5623794|NCT00744237|19426249|P3|Overall Study|Administrative. Site Closed|1
5623795|NCT00744237|19426250|P2|Overall Study|Administrative. Site Closed|1
5623796|NCT00744237|19426251|P1|Overall Study|Administrative. Site Closed|1
5623797|NCT00744237|19426249|P3|Overall Study|Poor Compliance|0
5623798|NCT00744237|19426250|P2|Overall Study|Poor Compliance|2
5623799|NCT00744237|19426251|P1|Overall Study|Poor Compliance|0
5623800|NCT00744237|19426249|P3|Overall Study|Prohibited Concomitant Medication|1
5623801|NCT00744237|19426250|P2|Overall Study|Prohibited Concomitant Medication|0
5623802|NCT00744237|19426251|P1|Overall Study|Prohibited Concomitant Medication|0
5623803|NCT00744237|19426249|P3|Overall Study|Study Drug Error|0
5623804|NCT00744237|19426250|P2|Overall Study|Study Drug Error|0
5623805|NCT00744237|19426251|P1|Overall Study|Study Drug Error|1
5623806|NCT00744237|19426249|P3|Overall Study|Dosing Error|1
5623807|NCT00744237|19426250|P2|Overall Study|Dosing Error|0
5623808|NCT00744237|19426251|P1|Overall Study|Dosing Error|1
5623809|NCT00744237|19426249|P3|Overall Study|Inclusion/Exclusion criteria not met|0
5623810|NCT00744237|19426250|P2|Overall Study|Inclusion/Exclusion criteria not met|0
5623811|NCT00744237|19426251|P1|Overall Study|Inclusion/Exclusion criteria not met|1
5623812|NCT00744237|19426249|P3|Overall Study|Protocol Violation|3
5623813|NCT00744237|19426250|P2|Overall Study|Protocol Violation|4
5623814|NCT00744237|19426251|P1|Overall Study|Protocol Violation|3
5623815|NCT00744237|19426249|P3|Overall Study|Lost to Follow-up|1
5623816|NCT00744237|19426250|P2|Overall Study|Lost to Follow-up|1
5623817|NCT00744237|19426251|P1|Overall Study|Lost to Follow-up|1
5623818|NCT00744237|19426249|P3|Overall Study|Withdrawal by Subject|3
5623819|NCT00744237|19426250|P2|Overall Study|Withdrawal by Subject|5
5623820|NCT00744237|19426251|P1|Overall Study|Withdrawal by Subject|9
5623821|NCT00744237|19426249|P3|Overall Study|Lack of Efficacy|0
5623822|NCT00744237|19426250|P2|Overall Study|Lack of Efficacy|1
5623823|NCT00744237|19426251|P1|Overall Study|Lack of Efficacy|1
5623824|NCT00744055|19426285|P2|Overall Study|Lost to Follow-up|1
5623825|NCT00744055|19426286|P1|Overall Study|Lost to Follow-up|0
5623826|NCT00744055|19426285|P2|Overall Study|Protocol Violation|1
5623827|NCT00744055|19426286|P1|Overall Study|Protocol Violation|1
5623828|NCT00744055|19426285|P2|Overall Study|Physician Decision|2
5623829|NCT00744055|19426286|P1|Overall Study|Physician Decision|0
5623830|NCT00744055|19426285|P2|Overall Study|Lack of Efficacy|1
5623831|NCT00744055|19426286|P1|Overall Study|Lack of Efficacy|0
5623832|NCT00744055|19426285|P2|Overall Study|Withdrawal by Subject|9
5623833|NCT00744055|19426286|P1|Overall Study|Withdrawal by Subject|6
5623834|NCT00744042|19426294|P1|Overall Study|Withdrawal by Subject|1
5623835|NCT00743652|19426340|P5|Overall Study|Lost to Follow-up|0
5623836|NCT00743652|19426341|P4|Overall Study|Lost to Follow-up|0
5623837|NCT00743652|19426342|P3|Overall Study|Lost to Follow-up|0
5623838|NCT00743652|19426343|P2|Overall Study|Lost to Follow-up|0
5623839|NCT00743652|19426344|P1|Overall Study|Lost to Follow-up|1
5623840|NCT00743652|19426340|P5|Overall Study|Other|0
5623841|NCT00743652|19426341|P4|Overall Study|Other|0
5623842|NCT00743652|19426342|P3|Overall Study|Other|0
5623843|NCT00743652|19426343|P2|Overall Study|Other|1
5623844|NCT00743652|19426344|P1|Overall Study|Other|1
5623845|NCT00743652|19426340|P5|Overall Study|Investigator Request|0
5623846|NCT00743652|19426341|P4|Overall Study|Investigator Request|2
5623847|NCT00743652|19426342|P3|Overall Study|Investigator Request|0
5623848|NCT00743652|19426343|P2|Overall Study|Investigator Request|0
5623849|NCT00743652|19426344|P1|Overall Study|Investigator Request|0
5623850|NCT00743652|19426340|P5|Overall Study|Death|0
5623851|NCT00743652|19426341|P4|Overall Study|Death|0
5623852|NCT00743652|19426342|P3|Overall Study|Death|0
5623853|NCT00743652|19426343|P2|Overall Study|Death|0
5623854|NCT00743652|19426344|P1|Overall Study|Death|2
5623855|NCT00743652|19426340|P5|Overall Study|Adverse Event|0
5623856|NCT00743652|19426341|P4|Overall Study|Adverse Event|0
5623857|NCT00743652|19426342|P3|Overall Study|Adverse Event|0
5623858|NCT00743652|19426343|P2|Overall Study|Adverse Event|0
5623859|NCT00743652|19426344|P1|Overall Study|Adverse Event|3
5623860|NCT00743652|19426340|P5|Overall Study|Parent/Legal Guardian Request|0
5623861|NCT00743652|19426341|P4|Overall Study|Parent/Legal Guardian Request|2
5623862|NCT00743652|19426342|P3|Overall Study|Parent/Legal Guardian Request|2
5623863|NCT00743652|19426343|P2|Overall Study|Parent/Legal Guardian Request|2
5623864|NCT00743652|19426344|P1|Overall Study|Parent/Legal Guardian Request|3
5623865|NCT00743509|19426428|P1|Overall Study|Withdrawal by Subject|2
5623866|NCT00743483|19426433|P1|Treatment Period|Adverse Event|1
5623867|NCT00743483|19426433|P1|Baseline Period|Physician Decision|1
5623868|NCT00743444|19426437|P2|Washout Period|Adverse Event|1
5623869|NCT00743444|19426438|P1|Washout Period|Adverse Event|0
5623870|NCT00743444|19426437|P2|First Intervention|Catheter placement problems|1
5623871|NCT00743444|19426438|P1|First Intervention|Catheter placement problems|0
5623872|NCT00743431|19426447|P1|Overall Study|No documentation available|13
5623873|NCT00743431|19426447|P1|Overall Study|Reason for discontinuation not specified|29
5623874|NCT00743431|19426447|P1|Overall Study|Death|9
5623875|NCT00743431|19426447|P1|Overall Study|Withdrawal by Subject|13
5623876|NCT00743431|19426447|P1|Overall Study|Tumor progression|56
5623877|NCT00743431|19426447|P1|Overall Study|Toxicity|6
5623878|NCT00743366|19426451|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
5623879|NCT00743366|19426452|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
5623880|NCT00743340|19426458|P1|Overall Study|Participant Relocated|1
5623881|NCT00743340|19426458|P1|Overall Study|Rolled over to other Gilead Study|23
5623882|NCT00743340|19426458|P1|Overall Study|Pregnancy|1
5623883|NCT00743340|19426458|P1|Overall Study|Virologic failure|8
5623884|NCT00743340|19426458|P1|Overall Study|Protocol Violation|1
5623885|NCT00743340|19426458|P1|Overall Study|Withdrawal from the Study|5
5623886|NCT00743340|19426458|P1|Overall Study|Lost to Follow-up|1
5623887|NCT00743340|19426458|P1|Overall Study|Study medication non-compliance|1
5623888|NCT00743288|19426462|P7|Overall Study|Worsening of condition (Not PD)|0
5623889|NCT00743288|19426463|P6|Overall Study|Worsening of condition (Not PD)|0
5623890|NCT00743288|19426464|P5|Overall Study|Worsening of condition (Not PD)|0
5623891|NCT00743288|19426465|P4|Overall Study|Worsening of condition (Not PD)|1
5623892|NCT00743288|19426466|P3|Overall Study|Worsening of condition (Not PD)|1
5623893|NCT00743288|19426467|P2|Overall Study|Worsening of condition (Not PD)|2
5623894|NCT00743288|19426468|P1|Overall Study|Worsening of condition (Not PD)|0
5623895|NCT00743288|19426462|P7|Overall Study|Progressive disease (PD)|6
5623896|NCT00743288|19426463|P6|Overall Study|Progressive disease (PD)|3
5623897|NCT00743288|19426464|P5|Overall Study|Progressive disease (PD)|5
5623898|NCT00743288|19426465|P4|Overall Study|Progressive disease (PD)|4
5623899|NCT00743288|19426466|P3|Overall Study|Progressive disease (PD)|1
5623900|NCT00743288|19426467|P2|Overall Study|Progressive disease (PD)|0
5623901|NCT00743288|19426468|P1|Overall Study|Progressive disease (PD)|2
5623902|NCT00743288|19426462|P7|Overall Study|Withdrawal by Subject|1
5623903|NCT00743288|19426463|P6|Overall Study|Withdrawal by Subject|1
5623904|NCT00743288|19426464|P5|Overall Study|Withdrawal by Subject|0
5623905|NCT00743288|19426465|P4|Overall Study|Withdrawal by Subject|0
5623906|NCT00743288|19426466|P3|Overall Study|Withdrawal by Subject|1
5623907|NCT00743288|19426467|P2|Overall Study|Withdrawal by Subject|0
5623908|NCT00743288|19426468|P1|Overall Study|Withdrawal by Subject|0
5623909|NCT00743288|19426462|P7|Overall Study|Adverse Event|2
5623910|NCT00743288|19426463|P6|Overall Study|Adverse Event|1
5623911|NCT00743288|19426464|P5|Overall Study|Adverse Event|1
5623912|NCT00743288|19426465|P4|Overall Study|Adverse Event|2
5623913|NCT00743288|19426466|P3|Overall Study|Adverse Event|2
5623914|NCT00743288|19426467|P2|Overall Study|Adverse Event|1
5623915|NCT00743288|19426468|P1|Overall Study|Adverse Event|1
5623916|NCT00743275|19426482|P2|Overall Study|Protocol Violation|1
5623917|NCT00743275|19426483|P1|Overall Study|Protocol Violation|0
5623918|NCT00743249|19426503|P2|Overall Study|Unsuccessful insertion of stent|1
5623919|NCT00743249|19426504|P1|Overall Study|Unsuccessful insertion of stent|2
5623920|NCT00743249|19426503|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
5623921|NCT00743249|19426504|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
5623922|NCT00743249|19426503|P2|Overall Study|Adverse Event|4
5623923|NCT00743249|19426504|P1|Overall Study|Adverse Event|0
5623924|NCT00743197|19426514|P2|Overall Study|Study terminated due to departure of PI.|2
5623925|NCT00743197|19426515|P1|Overall Study|Study terminated due to departure of PI.|1
5623926|NCT00743145|19426521|P1|Overall Study|Pregnancy|1
5623927|NCT00743145|19426521|P1|Overall Study|Adverse Event|2
5623928|NCT00743145|19426521|P1|Overall Study|Withdrawal by Subject|1
5623929|NCT00743119|19426535|P1|Overall Study|Withdrawal by Subject|1
5623930|NCT00743119|19426535|P1|Overall Study|unreliable|3
5623931|NCT00743106|19426549|P2|Overall Study|Met intraoperative exclusion criterion|5
5623932|NCT00743106|19426550|P1|Overall Study|Met intraoperative exclusion criterion|8
5623933|NCT00742924|19426577|P4|Overall Study|Withdrawal by Subject|0
5623934|NCT00742924|19426578|P3|Overall Study|Withdrawal by Subject|1
5623935|NCT00742924|19426579|P2|Overall Study|Withdrawal by Subject|1
5623936|NCT00742924|19426580|P1|Overall Study|Withdrawal by Subject|0
5623937|NCT00742924|19426577|P4|Overall Study|Physician Decision|1
5623938|NCT00742924|19426578|P3|Overall Study|Physician Decision|0
5623939|NCT00742924|19426579|P2|Overall Study|Physician Decision|0
5623940|NCT00742924|19426580|P1|Overall Study|Physician Decision|0
5623941|NCT00742924|19426577|P4|Overall Study|Lack of Efficacy|4
5623942|NCT00742924|19426578|P3|Overall Study|Lack of Efficacy|2
5623943|NCT00742924|19426579|P2|Overall Study|Lack of Efficacy|1
5623944|NCT00742924|19426580|P1|Overall Study|Lack of Efficacy|5
5623945|NCT00742924|19426577|P4|Overall Study|Adverse Event|1
5623946|NCT00742924|19426578|P3|Overall Study|Adverse Event|1
5623947|NCT00742924|19426579|P2|Overall Study|Adverse Event|0
5623948|NCT00742924|19426580|P1|Overall Study|Adverse Event|0
5623949|NCT00742885|19426592|P2|Overall Study|Lost to Follow-up|0
5623950|NCT00742885|19426593|P1|Overall Study|Lost to Follow-up|1
5623951|NCT00742859|19426652|P4|Overall Study|Site error|1
5623952|NCT00742859|19426653|P3|Overall Study|Site error|1
5623953|NCT00742859|19426654|P2|Overall Study|Site error|0
5623954|NCT00742859|19426655|P1|Overall Study|Site error|0
5623955|NCT00742859|19426652|P4|Overall Study|Sponsor request patient out of town|1
5623956|NCT00742859|19426653|P3|Overall Study|Sponsor request patient out of town|1
5623957|NCT00742859|19426654|P2|Overall Study|Sponsor request patient out of town|0
5623958|NCT00742859|19426655|P1|Overall Study|Sponsor request patient out of town|0
5623959|NCT00742859|19426652|P4|Overall Study|Sponsor req visit schedule noncompliance|1
5623960|NCT00742859|19426653|P3|Overall Study|Sponsor req visit schedule noncompliance|0
5623961|NCT00742859|19426654|P2|Overall Study|Sponsor req visit schedule noncompliance|0
5623962|NCT00742859|19426655|P1|Overall Study|Sponsor req visit schedule noncompliance|0
5623963|NCT00742859|19426652|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
5623964|NCT00742859|19426653|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
5623965|NCT00742859|19426654|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
5623966|NCT00742859|19426655|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
5623967|NCT00742859|19426652|P4|Overall Study|Endpoint|2
5623968|NCT00742859|19426653|P3|Overall Study|Endpoint|1
5623969|NCT00742859|19426654|P2|Overall Study|Endpoint|1
5623970|NCT00742859|19426655|P1|Overall Study|Endpoint|0
5623971|NCT00742859|19426652|P4|Overall Study|Withdrawal by Subject|1
5623972|NCT00742859|19426653|P3|Overall Study|Withdrawal by Subject|4
5623973|NCT00742859|19426654|P2|Overall Study|Withdrawal by Subject|2
5623974|NCT00742859|19426655|P1|Overall Study|Withdrawal by Subject|4
5623975|NCT00742859|19426652|P4|Overall Study|Physician Decision|0
5623976|NCT00742859|19426653|P3|Overall Study|Physician Decision|0
5623977|NCT00742859|19426654|P2|Overall Study|Physician Decision|2
5623978|NCT00742859|19426655|P1|Overall Study|Physician Decision|1
5623979|NCT00742859|19426652|P4|Overall Study|Death|1
5623980|NCT00742859|19426653|P3|Overall Study|Death|0
5623981|NCT00742859|19426654|P2|Overall Study|Death|0
5623982|NCT00742859|19426655|P1|Overall Study|Death|1
5623983|NCT00742859|19426652|P4|Overall Study|Adverse Event|1
5623984|NCT00742859|19426653|P3|Overall Study|Adverse Event|3
5623985|NCT00742859|19426654|P2|Overall Study|Adverse Event|6
5623986|NCT00742859|19426655|P1|Overall Study|Adverse Event|5
5623987|NCT00742781|19426669|P1|Overall Study|Withdrawal by Subject|3
5623988|NCT00742625|19426678|P1|Consolidation|Non protocol therapy|13
5623989|NCT00742625|19426678|P1|Consolidation|Refused|1
5623990|NCT00742625|19426678|P1|Consolidation|Death|1
5623991|NCT00742625|19426678|P1|Consolidation|Adverse Event|1
5623992|NCT00742625|19426678|P1|Consolidation|Progression|5
5623993|NCT00742625|19426678|P1|Remission Induction|Other, not specified|5
5623994|NCT00742625|19426678|P1|Remission Induction|Non protocol treatment|17
5623995|NCT00742625|19426678|P1|Remission Induction|Refusal|5
5623996|NCT00742625|19426678|P1|Remission Induction|Death|10
5623997|NCT00742625|19426678|P1|Remission Induction|Adverse Event|3
5623998|NCT00742625|19426678|P1|Remission Induction|Failed induction|8
5623999|NCT00742625|19426678|P1|Remission Induction|Progression|6
5624000|NCT00742560|19426703|P5|Overall Study|MIssing|1
5624001|NCT00742560|19426704|P4|Overall Study|MIssing|0
5624002|NCT00742560|19426705|P3|Overall Study|MIssing|0
5624003|NCT00742560|19426706|P2|Overall Study|MIssing|0
5624004|NCT00742560|19426707|P1|Overall Study|MIssing|0
5624005|NCT00742560|19426703|P5|Overall Study|Other|9
5624006|NCT00742560|19426704|P4|Overall Study|Other|9
5624007|NCT00742560|19426705|P3|Overall Study|Other|8
5624008|NCT00742560|19426706|P2|Overall Study|Other|1
5624009|NCT00742560|19426707|P1|Overall Study|Other|0
5624010|NCT00742560|19426703|P5|Overall Study|New Multiple Myeloma Therapy|4
5624011|NCT00742560|19426704|P4|Overall Study|New Multiple Myeloma Therapy|3
5624012|NCT00742560|19426705|P3|Overall Study|New Multiple Myeloma Therapy|2
5624013|NCT00742560|19426706|P2|Overall Study|New Multiple Myeloma Therapy|0
5624014|NCT00742560|19426707|P1|Overall Study|New Multiple Myeloma Therapy|1
5624015|NCT00742560|19426703|P5|Overall Study|Disease Progression|16
5624016|NCT00742560|19426704|P4|Overall Study|Disease Progression|17
5624017|NCT00742560|19426705|P3|Overall Study|Disease Progression|5
5624018|NCT00742560|19426706|P2|Overall Study|Disease Progression|0
5624019|NCT00742560|19426707|P1|Overall Study|Disease Progression|1
5624020|NCT00742560|19426703|P5|Overall Study|Investigator's Decision|0
5624021|NCT00742560|19426704|P4|Overall Study|Investigator's Decision|1
5624022|NCT00742560|19426705|P3|Overall Study|Investigator's Decision|4
5624023|NCT00742560|19426706|P2|Overall Study|Investigator's Decision|0
5624024|NCT00742560|19426707|P1|Overall Study|Investigator's Decision|0
5624025|NCT00742560|19426703|P5|Overall Study|Subject's Decision|3
5624026|NCT00742560|19426704|P4|Overall Study|Subject's Decision|3
5624027|NCT00742560|19426705|P3|Overall Study|Subject's Decision|2
5624028|NCT00742560|19426706|P2|Overall Study|Subject's Decision|0
5624029|NCT00742560|19426707|P1|Overall Study|Subject's Decision|1
5624030|NCT00742560|19426703|P5|Overall Study|Death|3
5624031|NCT00742560|19426704|P4|Overall Study|Death|2
5624032|NCT00742560|19426705|P3|Overall Study|Death|0
5624033|NCT00742560|19426706|P2|Overall Study|Death|2
5624034|NCT00742560|19426707|P1|Overall Study|Death|0
5624035|NCT00742560|19426703|P5|Overall Study|Adverse Event|1
5624036|NCT00742560|19426704|P4|Overall Study|Adverse Event|1
5624037|NCT00742560|19426705|P3|Overall Study|Adverse Event|1
5624038|NCT00742560|19426706|P2|Overall Study|Adverse Event|0
5624039|NCT00742560|19426707|P1|Overall Study|Adverse Event|0
5624040|NCT00742508|19426781|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
5624041|NCT00742508|19426782|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
5624042|NCT00742508|19426781|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
5624043|NCT00742508|19426782|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
5624044|NCT00742508|19426781|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
5624045|NCT00742508|19426782|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
5624046|NCT00742508|19426781|P2|8-Week Primary Evaluation Period|Protocol Violation|0
5624047|NCT00742508|19426782|P1|8-Week Primary Evaluation Period|Protocol Violation|1
5624048|NCT00742508|19426781|P2|8-Week Primary Evaluation Period|Adverse Event|4
5624049|NCT00742508|19426782|P1|8-Week Primary Evaluation Period|Adverse Event|2
5624050|NCT00742417|19426855|P2|Intensive Period|Adverse Event|0
5624051|NCT00742417|19426856|P1|Intensive Period|Adverse Event|2
5624052|NCT00742417|19426855|P2|Intensive Period|Withdrawal by Subject|1
5624053|NCT00742417|19426856|P1|Intensive Period|Withdrawal by Subject|1
5624054|NCT00742417|19426855|P2|Randomized|Physician Decision|0
5624055|NCT00742417|19426856|P1|Randomized|Physician Decision|1
5624056|NCT00742417|19426855|P2|Randomized|Withdrawal by Subject|0
5624057|NCT00742417|19426856|P1|Randomized|Withdrawal by Subject|1
5624058|NCT00742417|19426855|P2|Randomized|Withdrawal by legal representative|1
5624059|NCT00742417|19426856|P1|Randomized|Withdrawal by legal representative|0
5624060|NCT00742391|19426880|P2|Overall Study|Protocol Violation|0
5624061|NCT00742391|19426881|P1|Overall Study|Protocol Violation|1
5624062|NCT00742391|19426880|P2|Overall Study|Lost to Follow-up|0
5624063|NCT00742391|19426881|P1|Overall Study|Lost to Follow-up|1
5624064|NCT00742391|19426880|P2|Overall Study|Adverse Event|1
5624065|NCT00742391|19426881|P1|Overall Study|Adverse Event|2
5624066|NCT00742326|19426891|P2|Overall Study|Physician Decision|1
5624067|NCT00742326|19426892|P1|Overall Study|Physician Decision|0
5624068|NCT00742274|19426911|P2|Overall Study|Removed for medical reasons|1
5624069|NCT00742274|19426912|P1|Overall Study|Removed for medical reasons|1
5624070|NCT00742274|19426911|P2|Overall Study|Withdrawal by Subject|2
5624071|NCT00742274|19426912|P1|Overall Study|Withdrawal by Subject|1
5624072|NCT00742274|19426911|P2|Overall Study|Death|0
5624073|NCT00742274|19426912|P1|Overall Study|Death|1
5624074|NCT00742235|19426920|P2|Overall Study|Lost to Follow-up|31
5624075|NCT00742235|19426921|P1|Overall Study|Lost to Follow-up|0
5624076|NCT00742209|19426934|P5|Overall Study|Investigator Discretion|1
5624077|NCT00742209|19426935|P4|Overall Study|Investigator Discretion|1
5624078|NCT00742209|19426936|P3|Overall Study|Investigator Discretion|5
5624079|NCT00742209|19426937|P2|Overall Study|Investigator Discretion|0
5624080|NCT00742209|19426938|P1|Overall Study|Investigator Discretion|0
5624081|NCT00742209|19426934|P5|Overall Study|Lack of Efficacy|1
5624082|NCT00742209|19426935|P4|Overall Study|Lack of Efficacy|3
5624083|NCT00742209|19426936|P3|Overall Study|Lack of Efficacy|1
5624084|NCT00742209|19426937|P2|Overall Study|Lack of Efficacy|1
5624085|NCT00742209|19426938|P1|Overall Study|Lack of Efficacy|6
5624086|NCT00742209|19426934|P5|Overall Study|Lost to Follow-up|3
5624087|NCT00742209|19426935|P4|Overall Study|Lost to Follow-up|5
5624088|NCT00742209|19426936|P3|Overall Study|Lost to Follow-up|5
5624089|NCT00742209|19426937|P2|Overall Study|Lost to Follow-up|4
5624090|NCT00742209|19426938|P1|Overall Study|Lost to Follow-up|3
5624091|NCT00742209|19426934|P5|Overall Study|Protocol Violation|3
5624092|NCT00742209|19426935|P4|Overall Study|Protocol Violation|5
5624093|NCT00742209|19426936|P3|Overall Study|Protocol Violation|4
5624094|NCT00742209|19426937|P2|Overall Study|Protocol Violation|5
5624095|NCT00742209|19426938|P1|Overall Study|Protocol Violation|6
5624096|NCT00742209|19426934|P5|Overall Study|Participant Withdrew Consent|4
5624097|NCT00742209|19426935|P4|Overall Study|Participant Withdrew Consent|7
5624098|NCT00742209|19426936|P3|Overall Study|Participant Withdrew Consent|14
5624099|NCT00742209|19426937|P2|Overall Study|Participant Withdrew Consent|4
5624100|NCT00742209|19426938|P1|Overall Study|Participant Withdrew Consent|8
5624101|NCT00742209|19426934|P5|Overall Study|Adverse Event|13
5624102|NCT00742209|19426935|P4|Overall Study|Adverse Event|16
5624103|NCT00742209|19426936|P3|Overall Study|Adverse Event|17
5624104|NCT00742209|19426937|P2|Overall Study|Adverse Event|4
5624105|NCT00742209|19426938|P1|Overall Study|Adverse Event|11
5624106|NCT00742183|19427041|P2|Overall Study|Lack of Efficacy|3
5624107|NCT00742183|19427042|P1|Overall Study|Lack of Efficacy|0
5624108|NCT00742183|19427041|P2|Overall Study|Withdrawal by Subject|0
5624109|NCT00742183|19427042|P1|Overall Study|Withdrawal by Subject|1
5624110|NCT00742183|19427041|P2|Overall Study|Required skin-graft|1
5624111|NCT00742183|19427042|P1|Overall Study|Required skin-graft|1
5624112|NCT00742183|19427041|P2|Overall Study|Lost to Follow-up|4
5624113|NCT00742183|19427042|P1|Overall Study|Lost to Follow-up|4
5624114|NCT00742183|19427041|P2|Overall Study|Physician Decision|2
5624115|NCT00742183|19427042|P1|Overall Study|Physician Decision|0
5624116|NCT00742183|19427041|P2|Overall Study|Death|0
5624117|NCT00742183|19427042|P1|Overall Study|Death|1
5624118|NCT00742183|19427041|P2|Overall Study|Adverse Event|2
5624119|NCT00742183|19427042|P1|Overall Study|Adverse Event|2
5624120|NCT00742079|19427061|P2|Overall Study|Lost to Follow-up|1
5624121|NCT00742079|19427062|P1|Overall Study|Lost to Follow-up|0
5624122|NCT00742001|19427083|P3|Overall Study|Withdrawn; health exclusion (flu)|1
5624123|NCT00742001|19427084|P2|Overall Study|Withdrawn; health exclusion (flu)|0
5624124|NCT00742001|19427085|P1|Overall Study|Withdrawn; health exclusion (flu)|0
5624125|NCT00741988|19427101|P2|Overall Study|Lack of Efficacy|0
5624126|NCT00741988|19427102|P1|Overall Study|Lack of Efficacy|2
5624127|NCT00741988|19427101|P2|Overall Study|Adverse Event|4
5624128|NCT00741988|19427102|P1|Overall Study|Adverse Event|2
5624129|NCT00741936|19427114|P2|Overall Study|Low compliance|0
5624130|NCT00741936|19427115|P1|Overall Study|Low compliance|3
5624131|NCT00741936|19427114|P2|Overall Study|Lack of Efficacy|2
5624132|NCT00741936|19427115|P1|Overall Study|Lack of Efficacy|0
5624133|NCT00741936|19427114|P2|Overall Study|Protocol Violation|0
5624134|NCT00741936|19427115|P1|Overall Study|Protocol Violation|2
5624135|NCT00741936|19427114|P2|Overall Study|Pregnancy|1
5624136|NCT00741936|19427115|P1|Overall Study|Pregnancy|0
5624137|NCT00741936|19427114|P2|Overall Study|Adverse Event|4
5624138|NCT00741936|19427115|P1|Overall Study|Adverse Event|3
5624139|NCT00741936|19427114|P2|Overall Study|Lost to Follow-up|1
5624140|NCT00741936|19427115|P1|Overall Study|Lost to Follow-up|1
5624141|NCT00741819|19427150|P1|Overall Study|Disease progression|1
5624142|NCT00741819|19427150|P1|Overall Study|Death|1
5624143|NCT00741819|19427150|P1|Overall Study|Withdrawal by Subject|3
5624144|NCT00741819|19427150|P1|Overall Study|Adverse Event|3
5624145|NCT00741611|19427164|P3|Overall Study|Withdrawal by Subject|2
5624146|NCT00741611|19427165|P2|Overall Study|Withdrawal by Subject|2
5624147|NCT00741611|19427166|P1|Overall Study|Withdrawal by Subject|0
5624148|NCT00741611|19427164|P3|Overall Study|Death|1
5624149|NCT00741611|19427165|P2|Overall Study|Death|0
5624150|NCT00741611|19427166|P1|Overall Study|Death|0
5624151|NCT00741598|19427185|P2|Overall Study|Withdrawal by Subject|2
5624152|NCT00741598|19427186|P1|Overall Study|Withdrawal by Subject|3
5624153|NCT00741598|19427185|P2|Overall Study|Pregnancy|0
5624154|NCT00741598|19427186|P1|Overall Study|Pregnancy|1
5624155|NCT00741598|19427185|P2|Overall Study|Physician Decision|1
5624156|NCT00741598|19427186|P1|Overall Study|Physician Decision|1
5624157|NCT00741598|19427185|P2|Overall Study|Lack of Efficacy|2
5624158|NCT00741598|19427186|P1|Overall Study|Lack of Efficacy|1
5624159|NCT00741598|19427185|P2|Overall Study|Lost to Follow-up|4
5624160|NCT00741598|19427186|P1|Overall Study|Lost to Follow-up|3
5624161|NCT00741338|19427241|P2|Overall Study|Adverse Event|1
5624162|NCT00741338|19427242|P1|Overall Study|Adverse Event|0
5624163|NCT00741286|19427252|P2|Overall Study|Primary Outcome|1
5624164|NCT00741286|19427253|P1|Overall Study|Primary Outcome|1
5624165|NCT00741286|19427252|P2|Overall Study|Protocol Violation|2
5624166|NCT00741286|19427253|P1|Overall Study|Protocol Violation|3
5624167|NCT00741286|19427252|P2|Overall Study|Adverse Event|6
5624168|NCT00741286|19427253|P1|Overall Study|Adverse Event|1
5624169|NCT00741286|19427252|P2|Overall Study|Lost to Follow-up|10
5624170|NCT00741286|19427253|P1|Overall Study|Lost to Follow-up|15
5624171|NCT00741260|19427287|P7|Overall Study|Other|1
5624172|NCT00741260|19427288|P6|Overall Study|Other|3
5624173|NCT00741260|19427289|P5|Overall Study|Other|1
5624174|NCT00741260|19427290|P4|Overall Study|Other|2
5624175|NCT00741260|19427291|P3|Overall Study|Other|1
5624176|NCT00741260|19427292|P2|Overall Study|Other|1
5624177|NCT00741260|19427293|P1|Overall Study|Other|2
5624178|NCT00741260|19427287|P7|Overall Study|Physician Decision|0
5624179|NCT00741260|19427288|P6|Overall Study|Physician Decision|0
5624180|NCT00741260|19427289|P5|Overall Study|Physician Decision|0
5624181|NCT00741260|19427290|P4|Overall Study|Physician Decision|0
5624182|NCT00741260|19427291|P3|Overall Study|Physician Decision|0
5624183|NCT00741260|19427292|P2|Overall Study|Physician Decision|1
5624184|NCT00741260|19427293|P1|Overall Study|Physician Decision|1
5624185|NCT00741260|19427287|P7|Overall Study|Withdrawal by Subject|1
5624186|NCT00741260|19427288|P6|Overall Study|Withdrawal by Subject|3
5624187|NCT00741260|19427289|P5|Overall Study|Withdrawal by Subject|1
5624188|NCT00741260|19427290|P4|Overall Study|Withdrawal by Subject|0
5624189|NCT00741260|19427291|P3|Overall Study|Withdrawal by Subject|0
5624190|NCT00741260|19427292|P2|Overall Study|Withdrawal by Subject|0
5624191|NCT00741260|19427293|P1|Overall Study|Withdrawal by Subject|0
5624192|NCT00741260|19427287|P7|Overall Study|Death|1
5624193|NCT00741260|19427288|P6|Overall Study|Death|2
5624194|NCT00741260|19427289|P5|Overall Study|Death|2
5624195|NCT00741260|19427290|P4|Overall Study|Death|1
5624196|NCT00741260|19427291|P3|Overall Study|Death|0
5624197|NCT00741260|19427292|P2|Overall Study|Death|1
5624198|NCT00741260|19427293|P1|Overall Study|Death|0
5624199|NCT00741260|19427287|P7|Overall Study|Disease Progression|4
5624200|NCT00741260|19427288|P6|Overall Study|Disease Progression|37
5624201|NCT00741260|19427289|P5|Overall Study|Disease Progression|5
5624202|NCT00741260|19427290|P4|Overall Study|Disease Progression|3
5624203|NCT00741260|19427291|P3|Overall Study|Disease Progression|3
5624204|NCT00741260|19427292|P2|Overall Study|Disease Progression|5
5624205|NCT00741260|19427293|P1|Overall Study|Disease Progression|3
5624206|NCT00741091|19427342|P1|Overall Study|Missed Visit|22
5624207|NCT00741091|19427342|P1|Overall Study|Withdrawal by Subject|6
5624208|NCT00741091|19427342|P1|Overall Study|Lost to Follow-up|16
5624209|NCT00741091|19427342|P1|Overall Study|Death|13
5624210|NCT00741039|19427352|P2|Overall Study|Patient non-compliance|0
5624211|NCT00741039|19427353|P1|Overall Study|Patient non-compliance|2
5624212|NCT00741013|19427390|P3|Overall Study|Discovered failed screen after enrolled|0
5624213|NCT00741013|19427391|P2|Overall Study|Discovered failed screen after enrolled|2
5624214|NCT00741013|19427392|P1|Overall Study|Discovered failed screen after enrolled|0
5624215|NCT00741013|19427390|P3|Overall Study|Withdrawal by Subject|1
5624216|NCT00741013|19427391|P2|Overall Study|Withdrawal by Subject|0
5624217|NCT00741013|19427392|P1|Overall Study|Withdrawal by Subject|0
5624218|NCT00741013|19427390|P3|Overall Study|Adverse Event|0
5624219|NCT00741013|19427391|P2|Overall Study|Adverse Event|0
5624220|NCT00741013|19427392|P1|Overall Study|Adverse Event|1
5624221|NCT00740870|19427403|P1|Overall Study|Further testing contraindicated implant|17
5624222|NCT00740870|19427403|P1|Overall Study|Not Catheterized|4
5624223|NCT00740857|19427418|P3|Overall Study|Withdrawal by Subject|0
5624224|NCT00740857|19427419|P2|Overall Study|Withdrawal by Subject|0
5624225|NCT00740857|19427420|P1|Overall Study|Withdrawal by Subject|1
5624226|NCT00740792|19427475|P4|Overall Study|administrative|2
5624227|NCT00740792|19427476|P3|Overall Study|administrative|8
5624228|NCT00740792|19427477|P2|Overall Study|administrative|3
5624229|NCT00740792|19427478|P1|Overall Study|administrative|3
5624230|NCT00740792|19427475|P4|Overall Study|Withdrawal by Subject|0
5624231|NCT00740792|19427476|P3|Overall Study|Withdrawal by Subject|0
5624232|NCT00740792|19427477|P2|Overall Study|Withdrawal by Subject|1
5624233|NCT00740792|19427478|P1|Overall Study|Withdrawal by Subject|1
5624234|NCT00740792|19427475|P4|Overall Study|Protocol Violation|2
5624235|NCT00740792|19427476|P3|Overall Study|Protocol Violation|0
5624236|NCT00740792|19427477|P2|Overall Study|Protocol Violation|1
5624237|NCT00740792|19427478|P1|Overall Study|Protocol Violation|0
5624238|NCT00740792|19427475|P4|Overall Study|Lost to Follow-up|0
5624239|NCT00740792|19427476|P3|Overall Study|Lost to Follow-up|0
5624240|NCT00740792|19427477|P2|Overall Study|Lost to Follow-up|1
5624241|NCT00740792|19427478|P1|Overall Study|Lost to Follow-up|2
5624242|NCT00740792|19427475|P4|Overall Study|Lack of Efficacy|3
5624243|NCT00740792|19427476|P3|Overall Study|Lack of Efficacy|0
5624244|NCT00740792|19427477|P2|Overall Study|Lack of Efficacy|1
5624245|NCT00740792|19427478|P1|Overall Study|Lack of Efficacy|1
5624246|NCT00740792|19427475|P4|Overall Study|Adverse Event|3
5624247|NCT00740792|19427476|P3|Overall Study|Adverse Event|1
5624248|NCT00740792|19427477|P2|Overall Study|Adverse Event|1
5624249|NCT00740792|19427478|P1|Overall Study|Adverse Event|3
5624250|NCT00740779|19427499|P3|Overall Study|Lost to Follow-up|5
5624251|NCT00740779|19427500|P2|Overall Study|Lost to Follow-up|3
5624252|NCT00740779|19427501|P1|Overall Study|Lost to Follow-up|2
5624253|NCT00740779|19427499|P3|Overall Study|Withdrawal by Subject|2
5624254|NCT00740779|19427500|P2|Overall Study|Withdrawal by Subject|4
5624255|NCT00740779|19427501|P1|Overall Study|Withdrawal by Subject|2
5624256|NCT00740779|19427499|P3|Overall Study|Lack of Efficacy|2
5624257|NCT00740779|19427500|P2|Overall Study|Lack of Efficacy|0
5624258|NCT00740779|19427501|P1|Overall Study|Lack of Efficacy|0
5624259|NCT00740779|19427499|P3|Overall Study|Protocol Violation|1
5624260|NCT00740779|19427500|P2|Overall Study|Protocol Violation|1
5624261|NCT00740779|19427501|P1|Overall Study|Protocol Violation|1
5624262|NCT00740779|19427499|P3|Overall Study|Adverse Event|3
5624263|NCT00740779|19427500|P2|Overall Study|Adverse Event|6
5624264|NCT00740779|19427501|P1|Overall Study|Adverse Event|4
5624265|NCT00740714|19427518|P3|Overall Study|Withdrawal by Subject|29
5624266|NCT00740714|19427519|P2|Overall Study|Withdrawal by Subject|19
5624267|NCT00740714|19427520|P1|Overall Study|Withdrawal by Subject|17
5624268|NCT00740636|19427596|P2|Overall Study|Death|0
5624269|NCT00740636|19427597|P1|Overall Study|Death|1
5624270|NCT00740636|19427596|P2|Overall Study|Progressive Disease|0
5624271|NCT00740636|19427597|P1|Overall Study|Progressive Disease|1
5624272|NCT00740636|19427596|P2|Overall Study|Patient Not Treated|1
5624273|NCT00740636|19427597|P1|Overall Study|Patient Not Treated|0
5624274|NCT00740636|19427596|P2|Overall Study|Patient Ineligible|1
5624275|NCT00740636|19427597|P1|Overall Study|Patient Ineligible|0
5624276|NCT00740636|19427596|P2|Overall Study|Adverse Event|2
5624277|NCT00740636|19427597|P1|Overall Study|Adverse Event|0
5624278|NCT00740597|19427603|P1|Overall Study|insurance would not cover treatment|1
5624279|NCT00740584|19427607|P1|Overall Study|Withdrawal by Subject|1
5624280|NCT00740480|19427612|P1|Overall Study|Physician Decision|1
5624281|NCT00740480|19427612|P1|Overall Study|Adverse Event|1
5624282|NCT00740220|19427637|P1|Overall Study|screen failures (non-COPD patients)|9
5624283|NCT00740051|19427662|P2|Overall Study|Other reason (not specified)|1
5624284|NCT00740051|19427663|P1|Overall Study|Other reason (not specified)|4
5624285|NCT00740051|19427662|P2|Overall Study|Withdrawal by Subject|8
5624286|NCT00740051|19427663|P1|Overall Study|Withdrawal by Subject|6
5624287|NCT00740051|19427662|P2|Overall Study|Lost to Follow-up|8
5624288|NCT00740051|19427663|P1|Overall Study|Lost to Follow-up|3
5624289|NCT00740051|19427662|P2|Overall Study|Protocol Violation|6
5624290|NCT00740051|19427663|P1|Overall Study|Protocol Violation|2
5624291|NCT00740051|19427662|P2|Overall Study|Adverse Event|4
5624292|NCT00740051|19427663|P1|Overall Study|Adverse Event|1
5624293|NCT00740051|19427662|P2|Overall Study|Lack of Efficacy|5
5624294|NCT00740051|19427663|P1|Overall Study|Lack of Efficacy|2
5624295|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5624296|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5624297|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
5624298|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5624299|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5624602|NCT00738400|19428293|P2|Overall Study|Withdrawal by Subject|1
5624300|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5624301|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5624302|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
5624303|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
5624304|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
5624305|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
5624306|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
5624307|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
5624308|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
5624309|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
5624310|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
5624311|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
5624312|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
5624313|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5624314|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5624315|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
5624316|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5624317|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5624318|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5624319|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5624320|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5624321|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
5624322|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
5624323|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
5624324|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
5624325|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
5624326|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
5624327|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
5624328|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
5624329|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
5624330|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
5624331|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5624332|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
5624333|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
5624334|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5624335|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5624336|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
5624337|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5624338|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
5624339|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
5624340|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5624341|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5624342|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5624343|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5624344|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5624345|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5624346|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
5624347|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5624348|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
5624349|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
5624350|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
5624351|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
5624352|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
5624353|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
5624354|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
5624355|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
5624356|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
5624357|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
5624358|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5624359|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5624360|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5624361|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5624362|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5624363|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5624603|NCT00738400|19428294|P1|Overall Study|Withdrawal by Subject|0
5624364|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
5624365|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
5624366|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
5624367|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5624368|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
5624369|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5624370|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5624371|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
5624372|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5624373|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5624374|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5624375|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
5624376|NCT00739973|19427766|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
5624377|NCT00739973|19427767|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
5624378|NCT00739973|19427768|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
5624379|NCT00739973|19427769|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
5624380|NCT00739973|19427770|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
5624381|NCT00739973|19427771|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
5624382|NCT00739973|19427772|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
5624383|NCT00739973|19427773|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
5624384|NCT00739973|19427774|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
5624385|NCT00739973|19427766|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5624386|NCT00739973|19427767|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5624387|NCT00739973|19427768|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5624388|NCT00739973|19427769|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5624389|NCT00739973|19427770|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5624390|NCT00739973|19427771|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5624391|NCT00739973|19427772|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5624392|NCT00739973|19427773|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
5624393|NCT00739973|19427774|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
5624394|NCT00739973|19427766|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5624395|NCT00739973|19427767|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5624396|NCT00739973|19427768|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5624397|NCT00739973|19427769|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5624398|NCT00739973|19427770|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5624399|NCT00739973|19427771|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5624400|NCT00739973|19427772|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5624401|NCT00739973|19427773|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
5624402|NCT00739973|19427774|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
5624403|NCT00739973|19427766|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5624404|NCT00739973|19427767|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5624405|NCT00739973|19427768|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5624406|NCT00739973|19427769|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5624407|NCT00739973|19427770|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5624408|NCT00739973|19427771|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5624409|NCT00739973|19427772|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5624410|NCT00739973|19427773|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
5624411|NCT00739973|19427774|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
5624412|NCT00739973|19427766|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5624413|NCT00739973|19427767|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5624414|NCT00739973|19427768|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5624415|NCT00739973|19427769|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5624416|NCT00739973|19427770|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5624417|NCT00739973|19427771|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5624418|NCT00739973|19427772|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5624419|NCT00739973|19427773|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
5624420|NCT00739973|19427774|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
5624421|NCT00739973|19427766|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5624422|NCT00739973|19427767|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5624423|NCT00739973|19427768|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5624424|NCT00739973|19427769|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5624425|NCT00739973|19427770|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5624426|NCT00739973|19427771|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5624427|NCT00739973|19427772|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5624428|NCT00739973|19427773|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
5624429|NCT00739973|19427774|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
5624430|NCT00739973|19427766|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5624431|NCT00739973|19427767|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5624432|NCT00739973|19427768|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5624433|NCT00739973|19427769|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5624434|NCT00739973|19427770|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5624435|NCT00739973|19427771|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5624436|NCT00739973|19427772|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5624437|NCT00739973|19427773|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
5624438|NCT00739973|19427774|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
5624439|NCT00739973|19427766|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5624440|NCT00739973|19427767|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5624441|NCT00739973|19427768|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5624442|NCT00739973|19427769|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5624443|NCT00739973|19427770|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5624444|NCT00739973|19427771|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5624445|NCT00739973|19427772|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5624446|NCT00739973|19427773|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
5624447|NCT00739973|19427774|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
5624448|NCT00739934|19427865|P1|Voriconazole Oral|Other|3
5624449|NCT00739934|19427865|P1|Voriconazole IV|Adverse Event|6
5624450|NCT00739908|19427887|P2|Overall Study|Relocation|1
5624451|NCT00739908|19427888|P1|Overall Study|Relocation|0
5624452|NCT00739908|19427887|P2|Overall Study|Lack of Efficacy|1
5624453|NCT00739908|19427888|P1|Overall Study|Lack of Efficacy|0
5624454|NCT00739908|19427887|P2|Overall Study|Non-Compliance With Study Medication|3
5624455|NCT00739908|19427888|P1|Overall Study|Non-Compliance With Study Medication|0
5624456|NCT00739908|19427887|P2|Overall Study|Non-Compliance With Study Procedures|3
5624457|NCT00739908|19427888|P1|Overall Study|Non-Compliance With Study Procedures|2
5624458|NCT00739908|19427887|P2|Overall Study|Lost to Follow-up|9
5624459|NCT00739908|19427888|P1|Overall Study|Lost to Follow-up|14
5624460|NCT00739908|19427887|P2|Overall Study|Withdrawal by Subject|2
5624461|NCT00739908|19427888|P1|Overall Study|Withdrawal by Subject|4
5624462|NCT00739908|19427887|P2|Overall Study|Adverse Event|6
5624463|NCT00739908|19427888|P1|Overall Study|Adverse Event|5
5624464|NCT00739882|19427908|P2|Open-label Period|Other|5
5624465|NCT00739882|19427909|P1|Open-label Period|Other|9
5624466|NCT00739882|19427908|P2|Open-label Period|Adverse Event|0
5624467|NCT00739882|19427909|P1|Open-label Period|Adverse Event|1
5624468|NCT00739882|19427908|P2|Double-blind Period|Other|8
5624469|NCT00739882|19427909|P1|Double-blind Period|Other|16
5624470|NCT00739882|19427908|P2|Double-blind Period|Lack of Efficacy|1
5624471|NCT00739882|19427909|P1|Double-blind Period|Lack of Efficacy|1
5624472|NCT00739882|19427908|P2|Double-blind Period|Protocol Violation|0
5624473|NCT00739882|19427909|P1|Double-blind Period|Protocol Violation|1
5624474|NCT00739882|19427908|P2|Double-blind Period|Adverse Event|2
5624475|NCT00739882|19427909|P1|Double-blind Period|Adverse Event|1
5624476|NCT00739674|19427970|P2|Overall Study|Erectile dysfunction|1
5624477|NCT00739674|19427971|P1|Overall Study|Erectile dysfunction|0
5624478|NCT00739674|19427970|P2|Overall Study|Home monitoring off meds|0
5624479|NCT00739674|19427971|P1|Overall Study|Home monitoring off meds|1
5624480|NCT00739674|19427970|P2|Overall Study|Unable to attend visit|1
5624481|NCT00739674|19427971|P1|Overall Study|Unable to attend visit|3
5624482|NCT00739674|19427970|P2|Overall Study|Non compliant|0
5624483|NCT00739674|19427971|P1|Overall Study|Non compliant|4
5624484|NCT00739674|19427970|P2|Overall Study|Patient moved|2
5624485|NCT00739674|19427971|P1|Overall Study|Patient moved|3
5624486|NCT00739674|19427970|P2|Overall Study|Clinic closed|4
5624487|NCT00739674|19427971|P1|Overall Study|Clinic closed|6
5624488|NCT00739674|19427970|P2|Overall Study|Reason missing|0
5624489|NCT00739674|19427971|P1|Overall Study|Reason missing|2
5624490|NCT00739674|19427970|P2|Overall Study|Withdrawal by Subject|9
5624491|NCT00739674|19427971|P1|Overall Study|Withdrawal by Subject|9
5624492|NCT00739674|19427970|P2|Overall Study|Protocol Violation|5
5624493|NCT00739674|19427971|P1|Overall Study|Protocol Violation|5
5624494|NCT00739674|19427970|P2|Overall Study|Lost to Follow-up|30
5624495|NCT00739674|19427971|P1|Overall Study|Lost to Follow-up|52
5624496|NCT00739674|19427970|P2|Overall Study|Lack of Efficacy|0
5624497|NCT00739674|19427971|P1|Overall Study|Lack of Efficacy|1
5624498|NCT00739674|19427970|P2|Overall Study|Death|0
5624499|NCT00739674|19427971|P1|Overall Study|Death|1
5624500|NCT00739674|19427970|P2|Overall Study|Adverse Event|13
5624501|NCT00739674|19427971|P1|Overall Study|Adverse Event|22
5624502|NCT00739674|19427970|P2|Overall Study|Dietician consultation >30 days|9
5624503|NCT00739674|19427971|P1|Overall Study|Dietician consultation >30 days|1
5624504|NCT00739674|19427970|P2|Overall Study|No follow-up data|18
5624505|NCT00739674|19427971|P1|Overall Study|No follow-up data|33
5624506|NCT00739674|19427970|P2|Overall Study|Site 212 removal|13
5624507|NCT00739674|19427971|P1|Overall Study|Site 212 removal|19
5624508|NCT00739674|19427970|P2|Overall Study|Screening failures|17
5624509|NCT00739674|19427971|P1|Overall Study|Screening failures|19
5624510|NCT00739661|19427999|P2|Overall Study|Reason for discontinuation not available|1
5624511|NCT00739661|19428000|P1|Overall Study|Reason for discontinuation not available|1
5624512|NCT00739661|19427999|P2|Overall Study|Disease progression, radiographic|37
5624513|NCT00739661|19428000|P1|Overall Study|Disease progression, radiographic|33
5624514|NCT00739661|19427999|P2|Overall Study|Patient decision to withdraw|4
5624515|NCT00739661|19428000|P1|Overall Study|Patient decision to withdraw|9
5624516|NCT00739661|19427999|P2|Overall Study|Physician decision to withdraw patient|0
5624517|NCT00739661|19428000|P1|Overall Study|Physician decision to withdraw patient|1
5624518|NCT00739661|19427999|P2|Overall Study|Adverse Event|0
5624519|NCT00739661|19428000|P1|Overall Study|Adverse Event|2
5624520|NCT00739648|19428012|P2|Overall Study|Do not know|6
5624521|NCT00739648|19428013|P1|Overall Study|Do not know|4
5624522|NCT00739648|19428012|P2|Overall Study|Death|0
5624523|NCT00739648|19428013|P1|Overall Study|Death|2
5624524|NCT00739648|19428012|P2|Overall Study|Lost to Follow-up|7
5624525|NCT00739648|19428013|P1|Overall Study|Lost to Follow-up|4
5624526|NCT00739648|19428012|P2|Overall Study|Withdrawal by Subject|25
5624527|NCT00739648|19428013|P1|Overall Study|Withdrawal by Subject|13
5624528|NCT00739648|19428012|P2|Overall Study|Adverse Event|15
5624529|NCT00739648|19428013|P1|Overall Study|Adverse Event|3
5624530|NCT00739596|19428027|P2|Overall Study|Protocol Deviation|1
5624531|NCT00739596|19428028|P1|Overall Study|Protocol Deviation|1
5624532|NCT00739596|19428027|P2|Overall Study|Lost to Follow-up|2
5624533|NCT00739596|19428028|P1|Overall Study|Lost to Follow-up|0
5624534|NCT00739596|19428027|P2|Overall Study|Patient Withdrew Consent|8
5624535|NCT00739596|19428028|P1|Overall Study|Patient Withdrew Consent|8
5624536|NCT00739596|19428027|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
5624537|NCT00739596|19428028|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
5624538|NCT00739596|19428027|P2|Overall Study|Adverse Event|6
5624539|NCT00739596|19428028|P1|Overall Study|Adverse Event|12
5624540|NCT00739310|19428070|P1|Overall Study|Lost to Follow-up|2
5624541|NCT00739310|19428070|P1|Overall Study|Withdrawal by Subject|1
5624542|NCT00739310|19428070|P1|Overall Study|Poor adherance to prescribed therapy|4
5624543|NCT00739297|19428075|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
5624544|NCT00739297|19428076|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
5624545|NCT00739297|19428077|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5624546|NCT00739297|19428078|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5624547|NCT00739297|19428079|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5624548|NCT00739297|19428080|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5624549|NCT00739297|19428081|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
5624550|NCT00739297|19428075|P7|First Washout Period of 4-7 Days|Adverse Event|2
5624551|NCT00739297|19428076|P6|First Washout Period of 4-7 Days|Adverse Event|0
5624552|NCT00739297|19428077|P5|First Washout Period of 4-7 Days|Adverse Event|0
5624553|NCT00739297|19428078|P4|First Washout Period of 4-7 Days|Adverse Event|2
5624554|NCT00739297|19428079|P3|First Washout Period of 4-7 Days|Adverse Event|0
5624555|NCT00739297|19428080|P2|First Washout Period of 4-7 Days|Adverse Event|0
5624556|NCT00739297|19428081|P1|First Washout Period of 4-7 Days|Adverse Event|0
5624557|NCT00739102|19428109|P1|Overall Study|Withdrawal by Subject|10
5624558|NCT00739102|19428109|P1|Overall Study|Death|5
5624559|NCT00739063|19428125|P1|Overall Study|Screen failures|8
5624560|NCT00738894|19428170|P2|Overall Study|Death|0
5624561|NCT00738894|19428171|P1|Overall Study|Death|2
5624562|NCT00738894|19428170|P2|Overall Study|Physician Decision|5
5624563|NCT00738894|19428171|P1|Overall Study|Physician Decision|4
5624564|NCT00738894|19428170|P2|Overall Study|Withdrawal by Subject|15
5624565|NCT00738894|19428171|P1|Overall Study|Withdrawal by Subject|10
5624566|NCT00738894|19428170|P2|Overall Study|Lost to Follow-up|13
5624567|NCT00738894|19428171|P1|Overall Study|Lost to Follow-up|23
5624568|NCT00738881|19428184|P2|Overall Study|Withdrawal by Subject|2
5624569|NCT00738881|19428185|P1|Overall Study|Withdrawal by Subject|0
5624570|NCT00738699|19428199|P2|Overall Study|Other|0
5624571|NCT00738699|19428200|P1|Overall Study|Other|2
5624572|NCT00738699|19428199|P2|Overall Study|Discontinuation of study by Sponsor|72
5624573|NCT00738699|19428200|P1|Overall Study|Discontinuation of study by Sponsor|123
5624574|NCT00738699|19428199|P2|Overall Study|Death|68
5624575|NCT00738699|19428200|P1|Overall Study|Death|144
5624576|NCT00738699|19428199|P2|Overall Study|Lost to Follow-up|0
5624577|NCT00738699|19428200|P1|Overall Study|Lost to Follow-up|1
5624578|NCT00738699|19428199|P2|Overall Study|Withdrawal by Subject|0
5624579|NCT00738699|19428200|P1|Overall Study|Withdrawal by Subject|5
5624580|NCT00738673|19428218|P2|Overall Study|Withdrawal by Subject|1
5624581|NCT00738673|19428219|P1|Overall Study|Withdrawal by Subject|3
5624582|NCT00738673|19428218|P2|Overall Study|Protocol Violation|2
5624583|NCT00738673|19428219|P1|Overall Study|Protocol Violation|1
5624584|NCT00738673|19428218|P2|Overall Study|Lack of Efficacy|8
5624585|NCT00738673|19428219|P1|Overall Study|Lack of Efficacy|19
5624586|NCT00738673|19428218|P2|Overall Study|Adverse Event|0
5624587|NCT00738673|19428219|P1|Overall Study|Adverse Event|1
5624588|NCT00738530|19428257|P2|Overall Study|Withdrawal by Subject|8
5624589|NCT00738530|19428258|P1|Overall Study|Withdrawal by Subject|6
5624590|NCT00738530|19428257|P2|Overall Study|Lost to Follow-up|6
5624591|NCT00738530|19428258|P1|Overall Study|Lost to Follow-up|8
5624592|NCT00738530|19428257|P2|Overall Study|Death|224
5624593|NCT00738530|19428258|P1|Overall Study|Death|220
5624594|NCT00738400|19428293|P2|Overall Study|Non-compliant with study medication|1
5624595|NCT00738400|19428294|P1|Overall Study|Non-compliant with study medication|0
5624596|NCT00738400|19428293|P2|Overall Study|Protocol Violation|0
5624597|NCT00738400|19428294|P1|Overall Study|Protocol Violation|1
5624598|NCT00738400|19428293|P2|Overall Study|Lost to Follow-up|3
5624599|NCT00738400|19428294|P1|Overall Study|Lost to Follow-up|0
5624600|NCT00738400|19428293|P2|Overall Study|Lack of Efficacy|1
5624601|NCT00738400|19428294|P1|Overall Study|Lack of Efficacy|0
5624604|NCT00738400|19428293|P2|Overall Study|Adverse Event|1
5624605|NCT00738400|19428294|P1|Overall Study|Adverse Event|3
5624606|NCT00738374|19428315|P4|Maintenance Treatment/Observation Phase|Other|0
5624607|NCT00738374|19428316|P3|Maintenance Treatment/Observation Phase|Other|0
5624608|NCT00738374|19428317|P2|Maintenance Treatment/Observation Phase|Other|1
5624609|NCT00738374|19428318|P1|Maintenance Treatment/Observation Phase|Other|0
5624610|NCT00738374|19428315|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
5624611|NCT00738374|19428316|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
5624612|NCT00738374|19428317|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
5624613|NCT00738374|19428318|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
5624614|NCT00738374|19428315|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
5624615|NCT00738374|19428316|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
5624616|NCT00738374|19428317|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
5624617|NCT00738374|19428318|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
5624618|NCT00738374|19428315|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
5624619|NCT00738374|19428316|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
5624620|NCT00738374|19428317|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
5624621|NCT00738374|19428318|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
5624622|NCT00738374|19428315|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
5624623|NCT00738374|19428316|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
5624624|NCT00738374|19428317|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
5624625|NCT00738374|19428318|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
5624626|NCT00738374|19428315|P4|Induction Treatment Phase|Withdrawal by Subject|0
5624627|NCT00738374|19428316|P3|Induction Treatment Phase|Withdrawal by Subject|0
5624628|NCT00738374|19428317|P2|Induction Treatment Phase|Withdrawal by Subject|0
5624629|NCT00738374|19428318|P1|Induction Treatment Phase|Withdrawal by Subject|1
5624630|NCT00738374|19428315|P4|Induction Treatment Phase|Non-compliance|0
5624631|NCT00738374|19428316|P3|Induction Treatment Phase|Non-compliance|0
5624632|NCT00738374|19428317|P2|Induction Treatment Phase|Non-compliance|0
5624633|NCT00738374|19428318|P1|Induction Treatment Phase|Non-compliance|1
5624634|NCT00738374|19428315|P4|Induction Treatment Phase|Protocol Violation|0
5624635|NCT00738374|19428316|P3|Induction Treatment Phase|Protocol Violation|0
5624636|NCT00738374|19428317|P2|Induction Treatment Phase|Protocol Violation|0
5624637|NCT00738374|19428318|P1|Induction Treatment Phase|Protocol Violation|2
5624638|NCT00738374|19428315|P4|Induction Treatment Phase|Physician Decision|0
5624639|NCT00738374|19428316|P3|Induction Treatment Phase|Physician Decision|0
5624640|NCT00738374|19428317|P2|Induction Treatment Phase|Physician Decision|0
5624641|NCT00738374|19428318|P1|Induction Treatment Phase|Physician Decision|2
5624642|NCT00738374|19428315|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
5624643|NCT00738374|19428316|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
5624644|NCT00738374|19428317|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
5624645|NCT00738374|19428318|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
5624646|NCT00738374|19428315|P4|Induction Treatment Phase|Adverse Event|0
5624647|NCT00738374|19428316|P3|Induction Treatment Phase|Adverse Event|0
5624648|NCT00738374|19428317|P2|Induction Treatment Phase|Adverse Event|0
5624649|NCT00738374|19428318|P1|Induction Treatment Phase|Adverse Event|14
5624650|NCT00738283|19428356|P1|Overall Study|Discharge home prior to end of study|1
5624651|NCT00738283|19428356|P1|Overall Study|Transfer to another facility|2
5624652|NCT00738283|19428356|P1|Overall Study|Death|1
5624653|NCT00738101|19428360|P1|Overall Study|Repeat enrollment|1
5624654|NCT00738101|19428360|P1|Overall Study|Death|1
5624655|NCT00738101|19428360|P1|Overall Study|Physician Decision|5
5624656|NCT00738062|19428375|P3|Open-Label Extension|Study Terminated|0
5624657|NCT00738062|19428376|P2|Open-Label Extension|Study Terminated|0
5624658|NCT00738062|19428377|P1|Open-Label Extension|Study Terminated|2
5624659|NCT00738062|19428375|P3|Open-Label Extension|Protocol Violation|0
5624660|NCT00738062|19428376|P2|Open-Label Extension|Protocol Violation|0
5624661|NCT00738062|19428377|P1|Open-Label Extension|Protocol Violation|1
5624662|NCT00738062|19428375|P3|Open-Label Extension|Withdrawal by Subject|0
5624663|NCT00738062|19428376|P2|Open-Label Extension|Withdrawal by Subject|0
5624664|NCT00738062|19428377|P1|Open-Label Extension|Withdrawal by Subject|6
5624665|NCT00738062|19428375|P3|Open-Label Extension|Lack of Efficacy|0
5624666|NCT00738062|19428376|P2|Open-Label Extension|Lack of Efficacy|0
5624667|NCT00738062|19428377|P1|Open-Label Extension|Lack of Efficacy|2
5624668|NCT00738062|19428375|P3|Open-Label Extension|Physician Decision|0
5624669|NCT00738062|19428376|P2|Open-Label Extension|Physician Decision|0
5624670|NCT00738062|19428377|P1|Open-Label Extension|Physician Decision|1
5624671|NCT00738062|19428375|P3|Open-Label Extension|Adverse Event|0
5624672|NCT00738062|19428376|P2|Open-Label Extension|Adverse Event|0
5624673|NCT00738062|19428377|P1|Open-Label Extension|Adverse Event|5
5624674|NCT00738062|19428375|P3|Open Label Treatment|Investigator Decision|0
5624675|NCT00738062|19428376|P2|Open Label Treatment|Investigator Decision|0
5624676|NCT00738062|19428377|P1|Open Label Treatment|Investigator Decision|1
5624677|NCT00738062|19428375|P3|Open Label Treatment|Withdrawal by Subject|0
5624678|NCT00738062|19428376|P2|Open Label Treatment|Withdrawal by Subject|0
5624679|NCT00738062|19428377|P1|Open Label Treatment|Withdrawal by Subject|9
5624680|NCT00738062|19428375|P3|Open Label Treatment|Protocol Violation|0
5624681|NCT00738062|19428376|P2|Open Label Treatment|Protocol Violation|0
5624682|NCT00738062|19428377|P1|Open Label Treatment|Protocol Violation|2
5624683|NCT00738062|19428375|P3|Open Label Treatment|Adverse Event|0
5624684|NCT00738062|19428376|P2|Open Label Treatment|Adverse Event|0
5624685|NCT00738062|19428377|P1|Open Label Treatment|Adverse Event|11
5624686|NCT00738062|19428375|P3|Open Label Treatment|Lack of Efficacy|0
5624687|NCT00738062|19428376|P2|Open Label Treatment|Lack of Efficacy|0
5624688|NCT00738062|19428377|P1|Open Label Treatment|Lack of Efficacy|5
5624689|NCT00737711|19428490|P1|Overall Study|Other|5
5624690|NCT00737711|19428490|P1|Overall Study|Blood transfusion|6
5624691|NCT00737711|19428490|P1|Overall Study|Withdrawal by Subject|5
5624692|NCT00737711|19428490|P1|Overall Study|Protocol Violation|1
5624693|NCT00737711|19428490|P1|Overall Study|Failure to return|4
5624694|NCT00737711|19428490|P1|Overall Study|Death|8
5624695|NCT00737711|19428490|P1|Overall Study|Adverse Event|2
5624696|NCT00737698|19428524|P3|Overall Study|Death|1
5624697|NCT00737698|19428525|P2|Overall Study|Death|0
5624698|NCT00737698|19428526|P1|Overall Study|Death|0
5624699|NCT00737698|19428524|P3|Overall Study|Withdrawal by Subject|3
5624700|NCT00737698|19428525|P2|Overall Study|Withdrawal by Subject|5
5624701|NCT00737698|19428526|P1|Overall Study|Withdrawal by Subject|6
5624702|NCT00737672|19428536|P2|Overall Study|Physician Decision|2
5624703|NCT00737672|19428537|P1|Overall Study|Physician Decision|0
5624704|NCT00737672|19428536|P2|Overall Study|Miscellaneous|1
5624705|NCT00737672|19428537|P1|Overall Study|Miscellaneous|7
5624706|NCT00737672|19428536|P2|Overall Study|Lost to Follow-up|0
5624707|NCT00737672|19428537|P1|Overall Study|Lost to Follow-up|1
5624708|NCT00737672|19428536|P2|Overall Study|Withdrawal by Subject|2
5624709|NCT00737672|19428537|P1|Overall Study|Withdrawal by Subject|1
5624710|NCT00737672|19428536|P2|Overall Study|Death|22
5624711|NCT00737672|19428537|P1|Overall Study|Death|23
5624712|NCT00737672|19428536|P2|Overall Study|Graft Abandonment|56
5624713|NCT00737672|19428537|P1|Overall Study|Graft Abandonment|48
5624714|NCT00737633|19428575|P2|Overall Study|protocol non-compliance|1
5624715|NCT00737633|19428576|P1|Overall Study|protocol non-compliance|0
5624716|NCT00737633|19428575|P2|Overall Study|Lost to Follow-up|1
5624717|NCT00737633|19428576|P1|Overall Study|Lost to Follow-up|0
5624718|NCT00737633|19428575|P2|Overall Study|Study terminated by sponsor|55
5624719|NCT00737633|19428576|P1|Overall Study|Study terminated by sponsor|44
5624720|NCT00737568|19428599|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
5624721|NCT00737568|19428600|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
5624722|NCT00737568|19428599|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
5624723|NCT00737568|19428600|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
5624724|NCT00737568|19428599|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
5624725|NCT00737568|19428600|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
5624726|NCT00737568|19428599|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
5624727|NCT00737568|19428600|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
5624728|NCT00737568|19428599|P2|Treatment Period Through Week 240|Protocol Violation|3
5624729|NCT00737568|19428600|P1|Treatment Period Through Week 240|Protocol Violation|2
5624730|NCT00737568|19428599|P2|Treatment Period Through Week 240|Lost to Follow-up|3
5624731|NCT00737568|19428600|P1|Treatment Period Through Week 240|Lost to Follow-up|3
5624732|NCT00737568|19428599|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
5624733|NCT00737568|19428600|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
5624734|NCT00737568|19428599|P2|Treatment Period Through Week 240|Withdrew Consent|6
5624735|NCT00737568|19428600|P1|Treatment Period Through Week 240|Withdrew Consent|5
5624736|NCT00737568|19428599|P2|Treatment Period Through Week 240|Investigator's Discretion|5
5624737|NCT00737568|19428600|P1|Treatment Period Through Week 240|Investigator's Discretion|6
5624738|NCT00737529|19428630|P1|Overall Study|Other|4
5624739|NCT00737529|19428630|P1|Overall Study|Protocol Violation|1
5624740|NCT00737529|19428630|P1|Overall Study|Death|4
5624741|NCT00737529|19428630|P1|Overall Study|Withdrawal by Subject|5
5624742|NCT00737529|19428630|P1|Overall Study|Adverse Event|24
5624743|NCT00737529|19428630|P1|Overall Study|Disease Progression|95
5624744|NCT00737477|19428644|P1|Overall Study|Other|4
5624745|NCT00737477|19428644|P1|Overall Study|Renal Transplantation|10
5624746|NCT00737477|19428644|P1|Overall Study|Withdrawal by Subject|1
5624747|NCT00737477|19428644|P1|Overall Study|Treatment Refusal|1
5624748|NCT00737477|19428644|P1|Overall Study|Death|9
5624749|NCT00737477|19428644|P1|Overall Study|Adverse Event|9
5624750|NCT00737464|19428660|P1|Overall Study|Other reasons|4
5624751|NCT00737464|19428660|P1|Overall Study|Refused Treatment / Withdrew Consent|6
5624752|NCT00737464|19428660|P1|Overall Study|Other - Failure to Return|1
5624753|NCT00737464|19428660|P1|Overall Study|Death|6
5624754|NCT00737464|19428660|P1|Overall Study|Adverse Event|1
5624755|NCT00737438|19428681|P1|Overall Study|Patient ineligible|1
5624756|NCT00737438|19428681|P1|Overall Study|Withdrawal by Subject|2
5624757|NCT00737282|19428694|P1|Overall Study|Study prematurely terminated|175
5624758|NCT00737100|19428737|P3|Overall Study|Reason discontinued not explained above|1
5624759|NCT00737100|19428738|P2|Overall Study|Reason discontinued not explained above|1
5624760|NCT00737100|19428739|P1|Overall Study|Reason discontinued not explained above|1
5624761|NCT00737100|19428737|P3|Overall Study|Withdrawal by Subject|3
5624762|NCT00737100|19428738|P2|Overall Study|Withdrawal by Subject|0
5624763|NCT00737100|19428739|P1|Overall Study|Withdrawal by Subject|0
5624764|NCT00737100|19428737|P3|Overall Study|Lost to Follow-up|0
5624765|NCT00737100|19428738|P2|Overall Study|Lost to Follow-up|1
5624766|NCT00737100|19428739|P1|Overall Study|Lost to Follow-up|0
5624767|NCT00737100|19428737|P3|Overall Study|Adverse Event|3
5624768|NCT00737100|19428738|P2|Overall Study|Adverse Event|5
5624769|NCT00737100|19428739|P1|Overall Study|Adverse Event|6
5624770|NCT00737061|19428783|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
5624771|NCT00737061|19428783|P1|1 Year Wearing Period|Discontinued reilance|3
5624772|NCT00737061|19428783|P1|1 Year Wearing Period|Withdrawal by Subject|2
5624773|NCT00737061|19428783|P1|1 Year Wearing Period|Lost to Follow-up|11
5624774|NCT00737061|19428783|P1|Waiting Period|Elected surgical tubal ligation|5
5624775|NCT00737061|19428783|P1|Waiting Period|Alternative contraception failure|3
5624776|NCT00737061|19428783|P1|Waiting Period|Deemed patent following HSG|26
5624777|NCT00737061|19428783|P1|Waiting Period|Bilateral placement failure|34
5624778|NCT00737061|19428783|P1|Waiting Period|Withdrawal by Subject|1
5624779|NCT00737061|19428783|P1|Waiting Period|Lost to Follow-up|6
5624780|NCT00737048|19428800|P3|Overall Study|Worsening of the symptoms|3
5624781|NCT00737048|19428801|P2|Overall Study|Worsening of the symptoms|5
5624782|NCT00737048|19428802|P1|Overall Study|Worsening of the symptoms|3
5624783|NCT00737048|19428800|P3|Overall Study|Adverse Event|0
5624784|NCT00737048|19428801|P2|Overall Study|Adverse Event|1
5624785|NCT00737048|19428802|P1|Overall Study|Adverse Event|0
5624786|NCT00737048|19428800|P3|Overall Study|Physician Decision|1
5624787|NCT00737048|19428801|P2|Overall Study|Physician Decision|0
5624788|NCT00737048|19428802|P1|Overall Study|Physician Decision|0
5624789|NCT00736996|19428846|P3|Overall Study|Lost to Follow-up|2
5624790|NCT00736996|19428847|P2|Overall Study|Lost to Follow-up|9
5624791|NCT00736996|19428848|P1|Overall Study|Lost to Follow-up|1
5624792|NCT00736957|19428862|P1|Overall Study|Physician Decision|5
5624793|NCT00736957|19428862|P1|Overall Study|not eligible for Treatment Period I|22
5624794|NCT00736957|19428862|P1|Overall Study|did not attend hospital appointments|1
5624795|NCT00736957|19428862|P1|Overall Study|violation of eligibility criteria|2
5624796|NCT00736957|19428862|P1|Overall Study|Withdrawal by Subject|49
5624797|NCT00736957|19428862|P1|Overall Study|Adverse Event|43
5624798|NCT00736944|19428872|P1|Definitive Treatment|Physician Decision|1
5624799|NCT00736944|19428872|P1|Induction|Death|1
5624800|NCT00736879|19428906|P4|Follow up Period - No Drug Treatment|non-specified|0
5624801|NCT00736879|19428907|P3|Follow up Period - No Drug Treatment|non-specified|0
5624802|NCT00736879|19428908|P2|Follow up Period - No Drug Treatment|non-specified|2
5624803|NCT00736879|19428909|P1|Follow up Period - No Drug Treatment|non-specified|1
5624804|NCT00736879|19428906|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
5624805|NCT00736879|19428907|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
5624806|NCT00736879|19428908|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
5624807|NCT00736879|19428909|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
5624808|NCT00736879|19428906|P4|Double Blind Treatment Period|non-specified|0
5624809|NCT00736879|19428907|P3|Double Blind Treatment Period|non-specified|0
5624810|NCT00736879|19428908|P2|Double Blind Treatment Period|non-specified|1
5624811|NCT00736879|19428909|P1|Double Blind Treatment Period|non-specified|0
5624812|NCT00736879|19428906|P4|Double Blind Treatment Period|No longer met criteria|0
5624813|NCT00736879|19428907|P3|Double Blind Treatment Period|No longer met criteria|0
5624814|NCT00736879|19428908|P2|Double Blind Treatment Period|No longer met criteria|1
5624815|NCT00736879|19428909|P1|Double Blind Treatment Period|No longer met criteria|0
5624816|NCT00736879|19428906|P4|Double Blind Treatment Period|Poor non-compliance|1
5624817|NCT00736879|19428907|P3|Double Blind Treatment Period|Poor non-compliance|1
5624818|NCT00736879|19428908|P2|Double Blind Treatment Period|Poor non-compliance|0
5624819|NCT00736879|19428909|P1|Double Blind Treatment Period|Poor non-compliance|0
5624820|NCT00736879|19428906|P4|Double Blind Treatment Period|Lost to Follow-up|1
5624821|NCT00736879|19428907|P3|Double Blind Treatment Period|Lost to Follow-up|2
5624822|NCT00736879|19428908|P2|Double Blind Treatment Period|Lost to Follow-up|0
5624823|NCT00736879|19428909|P1|Double Blind Treatment Period|Lost to Follow-up|0
5624824|NCT00736879|19428906|P4|Double Blind Treatment Period|Withdrawal by Subject|3
5624825|NCT00736879|19428907|P3|Double Blind Treatment Period|Withdrawal by Subject|3
5624826|NCT00736879|19428908|P2|Double Blind Treatment Period|Withdrawal by Subject|1
5624827|NCT00736879|19428909|P1|Double Blind Treatment Period|Withdrawal by Subject|2
5624828|NCT00736879|19428906|P4|Double Blind Treatment Period|Adverse Event|0
5624829|NCT00736879|19428907|P3|Double Blind Treatment Period|Adverse Event|1
5624830|NCT00736879|19428908|P2|Double Blind Treatment Period|Adverse Event|1
5624831|NCT00736879|19428909|P1|Double Blind Treatment Period|Adverse Event|0
5624832|NCT00736879|19428906|P4|Double Blind Treatment Period|Lack of Efficacy|0
5624833|NCT00736879|19428907|P3|Double Blind Treatment Period|Lack of Efficacy|0
5624834|NCT00736879|19428908|P2|Double Blind Treatment Period|Lack of Efficacy|0
5624835|NCT00736879|19428909|P1|Double Blind Treatment Period|Lack of Efficacy|1
5624836|NCT00736853|19428963|P3|Double-Blind Period|Ineligible to participate the study|0
5624837|NCT00736853|19428964|P2|Double-Blind Period|Ineligible to participate the study|1
5624838|NCT00736853|19428965|P1|Double-Blind Period|Ineligible to participate the study|0
5624839|NCT00736853|19428963|P3|Double-Blind Period|Withdrawal by Subject|4
5624840|NCT00736853|19428964|P2|Double-Blind Period|Withdrawal by Subject|1
5624841|NCT00736853|19428965|P1|Double-Blind Period|Withdrawal by Subject|0
5624842|NCT00736853|19428963|P3|Double-Blind Period|Adverse Event|2
5624843|NCT00736853|19428964|P2|Double-Blind Period|Adverse Event|3
5624844|NCT00736853|19428965|P1|Double-Blind Period|Adverse Event|0
5624845|NCT00736853|19428963|P3|Double-Blind Period|Lack of Efficacy|42
5624846|NCT00736853|19428964|P2|Double-Blind Period|Lack of Efficacy|19
5624847|NCT00736853|19428965|P1|Double-Blind Period|Lack of Efficacy|0
5624848|NCT00736853|19428963|P3|Open-Label Period|Unable to attend hospital appointments|0
5624849|NCT00736853|19428964|P2|Open-Label Period|Unable to attend hospital appointments|0
5624850|NCT00736853|19428965|P1|Open-Label Period|Unable to attend hospital appointments|1
5624851|NCT00736853|19428963|P3|Open-Label Period|Failed to meet the transfer criteria|0
5624852|NCT00736853|19428964|P2|Open-Label Period|Failed to meet the transfer criteria|0
5624853|NCT00736853|19428965|P1|Open-Label Period|Failed to meet the transfer criteria|40
5624854|NCT00736853|19428963|P3|Open-Label Period|Started but not treated|0
5624855|NCT00736853|19428964|P2|Open-Label Period|Started but not treated|0
5624856|NCT00736853|19428965|P1|Open-Label Period|Started but not treated|42
5624857|NCT00736853|19428963|P3|Open-Label Period|Withdrawal by Subject|0
5624858|NCT00736853|19428964|P2|Open-Label Period|Withdrawal by Subject|0
5624859|NCT00736853|19428965|P1|Open-Label Period|Withdrawal by Subject|16
5624860|NCT00736853|19428963|P3|Open-Label Period|Adverse Event|0
5624861|NCT00736853|19428964|P2|Open-Label Period|Adverse Event|0
5624862|NCT00736853|19428965|P1|Open-Label Period|Adverse Event|31
5624863|NCT00736853|19428963|P3|Open-Label Period|Physician Decision|0
5624864|NCT00736853|19428964|P2|Open-Label Period|Physician Decision|0
5624865|NCT00736853|19428965|P1|Open-Label Period|Physician Decision|2
5624866|NCT00736840|19429005|P1|Overall Study|Lost to Follow-up|13
5624867|NCT00736723|19429012|P2|Overall Study|Withdrawal by Subject|3
5624868|NCT00736723|19429013|P1|Overall Study|Withdrawal by Subject|4
5624869|NCT00736645|19429023|P4|Overall Study|Adverse Event|0
5624870|NCT00736645|19429024|P3|Overall Study|Adverse Event|0
5624871|NCT00736645|19429025|P2|Overall Study|Adverse Event|2
5624872|NCT00736645|19429026|P1|Overall Study|Adverse Event|0
5624873|NCT00736502|19429076|P1|Overall Study|Lost to Follow-up|27
5624874|NCT00736502|19429076|P1|Overall Study|Lack of Efficacy|16
5624875|NCT00736502|19429076|P1|Overall Study|Adverse Event|22
5624876|NCT00736489|19429082|P6|Period 1|Withdrawal by Subject|1
5624877|NCT00736489|19429083|P5|Period 1|Withdrawal by Subject|0
5624878|NCT00736489|19429084|P4|Period 1|Withdrawal by Subject|0
5624879|NCT00736489|19429085|P3|Period 1|Withdrawal by Subject|0
5624880|NCT00736489|19429086|P2|Period 1|Withdrawal by Subject|0
5624881|NCT00736489|19429087|P1|Period 1|Withdrawal by Subject|0
5624882|NCT00736489|19429082|P6|Period 1|Lost to Follow-up|0
5624883|NCT00736489|19429083|P5|Period 1|Lost to Follow-up|0
5624884|NCT00736489|19429084|P4|Period 1|Lost to Follow-up|0
5624885|NCT00736489|19429085|P3|Period 1|Lost to Follow-up|0
5624886|NCT00736489|19429086|P2|Period 1|Lost to Follow-up|0
5624887|NCT00736489|19429087|P1|Period 1|Lost to Follow-up|1
5624888|NCT00736476|19429241|P2|Overall Study|Adverse Event|0
5624889|NCT00736476|19429242|P1|Overall Study|Adverse Event|1
5624890|NCT00736450|19429262|P1|Overall Study|Physician Decision|1
5624891|NCT00736450|19429262|P1|Overall Study|Withdrawal by Subject|5
5624892|NCT00736450|19429262|P1|Overall Study|Not ABC gene eligible|19
5624893|NCT00736385|19429270|P2|Overall Study|Adverse Event|1
5624894|NCT00736385|19429271|P1|Overall Study|Adverse Event|0
5624895|NCT00736385|19429270|P2|Overall Study|Withdrawal by Subject|2
5624896|NCT00736385|19429271|P1|Overall Study|Withdrawal by Subject|2
5624897|NCT00736333|19429283|P1|Overall Study|Other|4
5624898|NCT00736333|19429283|P1|Overall Study|Death|7
5624899|NCT00736333|19429283|P1|Overall Study|Withdrawal by Subject|10
5624900|NCT00736333|19429283|P1|Overall Study|Toxicity|6
5624901|NCT00736333|19429283|P1|Overall Study|Tumor Progression|75
5624902|NCT00736333|19429283|P1|Overall Study|Data Missing|2
5624903|NCT00736333|19429283|P1|Overall Study|Did Not Receive Drug or Not Documented|7
5624904|NCT00736255|19429294|P2|Overall Study|Non-compliance|1
5624905|NCT00736255|19429295|P1|Overall Study|Non-compliance|1
5624906|NCT00736255|19429294|P2|Overall Study|Physician Decision|0
5624907|NCT00736255|19429295|P1|Overall Study|Physician Decision|1
5624908|NCT00736255|19429294|P2|Overall Study|Adverse Event|0
5624909|NCT00736255|19429295|P1|Overall Study|Adverse Event|1
5624910|NCT00736190|19429342|P1|Overall Study|Adverse Event|1
5624911|NCT00736190|19429342|P1|Overall Study|Withdrawal by Subject|1
5624912|NCT00736190|19429342|P1|Overall Study|Pregnancy|1
5624913|NCT00736099|19429372|P2|Overall Study|Other reason|10
5624914|NCT00736099|19429373|P1|Overall Study|Other reason|43
5624915|NCT00736099|19429372|P2|Overall Study|Lack of Efficacy|8
5624916|NCT00736099|19429373|P1|Overall Study|Lack of Efficacy|15
5624917|NCT00736099|19429372|P2|Overall Study|Withdrawal by Subject|13
5624918|NCT00736099|19429373|P1|Overall Study|Withdrawal by Subject|42
5624919|NCT00736099|19429372|P2|Overall Study|Lost to Follow-up|5
5624920|NCT00736099|19429373|P1|Overall Study|Lost to Follow-up|12
5624921|NCT00736099|19429372|P2|Overall Study|Protocol Violation|4
5624922|NCT00736099|19429373|P1|Overall Study|Protocol Violation|10
5624923|NCT00736099|19429372|P2|Overall Study|Adverse Event|18
5624924|NCT00736099|19429373|P1|Overall Study|Adverse Event|61
5624925|NCT00736034|19429482|P1|Overall Study|Adverse Event|2
5624926|NCT00735943|19429490|P1|Overall Study|Adverse Event|1
5624927|NCT00735943|19429490|P1|Overall Study|Lost to Follow-up|1
5624928|NCT00735904|19429515|P1|Overall Study|Other|8
5624929|NCT00735904|19429515|P1|Overall Study|Study Terminated by Sponsor|5
5624930|NCT00735904|19429515|P1|Overall Study|Withdrawal by Subject|1
5624931|NCT00735904|19429515|P1|Overall Study|Protocol Violation|1
5624932|NCT00735904|19429515|P1|Overall Study|Death|20
5624933|NCT00735904|19429515|P1|Overall Study|Adverse Event|3
5624934|NCT00735878|19429525|P3|Phase I- Dose Determination|Withdrawal by Subject|1
5624935|NCT00735878|19429526|P2|Phase I- Dose Determination|Withdrawal by Subject|0
5624936|NCT00735878|19429527|P1|Phase I- Dose Determination|Withdrawal by Subject|0
5624937|NCT00735709|19429606|P4|Overall Study|Excluded medication|1
5624938|NCT00735709|19429607|P3|Overall Study|Excluded medication|0
5624939|NCT00735709|19429608|P2|Overall Study|Excluded medication|0
5624940|NCT00735709|19429609|P1|Overall Study|Excluded medication|1
5624941|NCT00735709|19429606|P4|Overall Study|Lost to Follow-up|1
5624942|NCT00735709|19429607|P3|Overall Study|Lost to Follow-up|1
5624943|NCT00735709|19429608|P2|Overall Study|Lost to Follow-up|1
5624944|NCT00735709|19429609|P1|Overall Study|Lost to Follow-up|0
5624945|NCT00735709|19429606|P4|Overall Study|Voluntary Withdrawal|7
5624946|NCT00735709|19429607|P3|Overall Study|Voluntary Withdrawal|5
5624947|NCT00735709|19429608|P2|Overall Study|Voluntary Withdrawal|3
5624948|NCT00735709|19429609|P1|Overall Study|Voluntary Withdrawal|1
5624949|NCT00735709|19429606|P4|Overall Study|Protocol deviations|1
5624950|NCT00735709|19429607|P3|Overall Study|Protocol deviations|1
5624951|NCT00735709|19429608|P2|Overall Study|Protocol deviations|2
5624952|NCT00735709|19429609|P1|Overall Study|Protocol deviations|1
5624953|NCT00735709|19429606|P4|Overall Study|Noncompliance|0
5624954|NCT00735709|19429607|P3|Overall Study|Noncompliance|1
5624955|NCT00735709|19429608|P2|Overall Study|Noncompliance|0
5624956|NCT00735709|19429609|P1|Overall Study|Noncompliance|0
5624957|NCT00735709|19429606|P4|Overall Study|Lack of Efficacy|3
5624958|NCT00735709|19429607|P3|Overall Study|Lack of Efficacy|2
5624959|NCT00735709|19429608|P2|Overall Study|Lack of Efficacy|4
5624960|NCT00735709|19429609|P1|Overall Study|Lack of Efficacy|8
5624961|NCT00735709|19429606|P4|Overall Study|Adverse Event|5
5624962|NCT00735709|19429607|P3|Overall Study|Adverse Event|1
5624963|NCT00735709|19429608|P2|Overall Study|Adverse Event|3
5624964|NCT00735709|19429609|P1|Overall Study|Adverse Event|2
5624965|NCT00735696|19429719|P1|Overall Study|Enrolled but never Treated|1
5624966|NCT00735696|19429719|P1|Overall Study|Withdrawal by Subject|1
5624967|NCT00735644|19429747|P5|Overall Study|Withdrawal by Subject|0
5624968|NCT00735644|19429748|P4|Overall Study|Withdrawal by Subject|1
5624969|NCT00735644|19429749|P3|Overall Study|Withdrawal by Subject|1
5624970|NCT00735644|19429750|P2|Overall Study|Withdrawal by Subject|1
5624971|NCT00735644|19429751|P1|Overall Study|Withdrawal by Subject|0
5624972|NCT00735644|19429747|P5|Overall Study|Did not receive study vaccine|0
5624973|NCT00735644|19429748|P4|Overall Study|Did not receive study vaccine|0
5624974|NCT00735644|19429749|P3|Overall Study|Did not receive study vaccine|0
5624975|NCT00735644|19429750|P2|Overall Study|Did not receive study vaccine|1
5624976|NCT00735644|19429751|P1|Overall Study|Did not receive study vaccine|0
5624977|NCT00735553|19429795|P1|Overall Study|Study prematurely terminated|77
5624978|NCT00735475|19429805|P2|Overall Study|Withdrawal by Subject|5
5624979|NCT00735475|19429806|P1|Overall Study|Withdrawal by Subject|4
5624980|NCT00735475|19429805|P2|Overall Study|Physician Decision|1
5624981|NCT00735475|19429806|P1|Overall Study|Physician Decision|0
5624982|NCT00735475|19429805|P2|Overall Study|Lost to Follow-up|3
5624983|NCT00735475|19429806|P1|Overall Study|Lost to Follow-up|3
5624984|NCT00735475|19429805|P2|Overall Study|Death|1
5624985|NCT00735475|19429806|P1|Overall Study|Death|1
5624986|NCT00735475|19429805|P2|Overall Study|Adverse Event|1
5624987|NCT00735475|19429806|P1|Overall Study|Adverse Event|0
5624988|NCT00735397|19429866|P1|Overall Study|Administrative/Other|502
5624989|NCT00735397|19429866|P1|Overall Study|Inadequate therapeutic effect|202
5624990|NCT00735397|19429866|P1|Overall Study|Participant choice|252
5624991|NCT00735397|19429866|P1|Overall Study|Lost to Follow-up|33
5624992|NCT00735397|19429866|P1|Overall Study|Adverse Event|194
5624993|NCT00735371|19429880|P4|Overall Study|Exclusion criteria|0
5624994|NCT00735371|19429881|P3|Overall Study|Exclusion criteria|0
5624995|NCT00735371|19429882|P2|Overall Study|Exclusion criteria|0
5624996|NCT00735371|19429883|P1|Overall Study|Exclusion criteria|1
5624997|NCT00735371|19429880|P4|Overall Study|Prior Vyvanse Exposure|0
5624998|NCT00735371|19429881|P3|Overall Study|Prior Vyvanse Exposure|0
5624999|NCT00735371|19429882|P2|Overall Study|Prior Vyvanse Exposure|1
5625000|NCT00735371|19429883|P1|Overall Study|Prior Vyvanse Exposure|1
5625001|NCT00735371|19429880|P4|Overall Study|Protocol Violation|0
5625002|NCT00735371|19429881|P3|Overall Study|Protocol Violation|2
5625003|NCT00735371|19429882|P2|Overall Study|Protocol Violation|1
5625004|NCT00735371|19429883|P1|Overall Study|Protocol Violation|0
5625005|NCT00735371|19429880|P4|Overall Study|Sponsor Decision|1
5625006|NCT00735371|19429881|P3|Overall Study|Sponsor Decision|0
5625007|NCT00735371|19429882|P2|Overall Study|Sponsor Decision|1
5625008|NCT00735371|19429883|P1|Overall Study|Sponsor Decision|3
5625009|NCT00735371|19429880|P4|Overall Study|Lack of Efficacy|4
5625010|NCT00735371|19429881|P3|Overall Study|Lack of Efficacy|0
5625011|NCT00735371|19429882|P2|Overall Study|Lack of Efficacy|2
5625012|NCT00735371|19429883|P1|Overall Study|Lack of Efficacy|4
5625013|NCT00735371|19429880|P4|Overall Study|Lost to Follow-up|1
5625014|NCT00735371|19429881|P3|Overall Study|Lost to Follow-up|3
5625015|NCT00735371|19429882|P2|Overall Study|Lost to Follow-up|1
5625016|NCT00735371|19429883|P1|Overall Study|Lost to Follow-up|1
5625017|NCT00735371|19429880|P4|Overall Study|Withdrawal by Subject|0
5625018|NCT00735371|19429881|P3|Overall Study|Withdrawal by Subject|2
5625019|NCT00735371|19429882|P2|Overall Study|Withdrawal by Subject|2
5625020|NCT00735371|19429883|P1|Overall Study|Withdrawal by Subject|0
5625021|NCT00735371|19429880|P4|Overall Study|Protocol Violation|3
5625022|NCT00735371|19429881|P3|Overall Study|Protocol Violation|0
5625023|NCT00735371|19429882|P2|Overall Study|Protocol Violation|2
5625024|NCT00735371|19429883|P1|Overall Study|Protocol Violation|2
5625025|NCT00735371|19429880|P4|Overall Study|Adverse Event|1
5625026|NCT00735371|19429881|P3|Overall Study|Adverse Event|4
5625027|NCT00735371|19429882|P2|Overall Study|Adverse Event|3
5625028|NCT00735371|19429883|P1|Overall Study|Adverse Event|3
5625029|NCT00735254|19429911|P4|Overall Study|Protocol Violation|0
5625030|NCT00735254|19429912|P3|Overall Study|Protocol Violation|1
5625031|NCT00735254|19429913|P2|Overall Study|Protocol Violation|1
5625032|NCT00735254|19429914|P1|Overall Study|Protocol Violation|1
5625033|NCT00735072|19429926|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
5625034|NCT00735072|19429927|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
5625035|NCT00735072|19429926|P2|Overall Study|interrupted study med during ARV change|0
5625036|NCT00735072|19429927|P1|Overall Study|interrupted study med during ARV change|1
5625037|NCT00735007|19429941|P1|Overall Study|Protocol Violation|1
5625038|NCT00735007|19429941|P1|Overall Study|Adverse Event|4
5625039|NCT00734994|19429966|P1|Overall Study|Withdrawal by Subject|1
5625040|NCT00734929|19429986|P2|Overall Study|No intervention/ screen fail|3
5625041|NCT00734929|19429987|P1|Overall Study|No intervention/ screen fail|5
5625042|NCT00734929|19429986|P2|Overall Study|Lost to Follow-up|2
5625043|NCT00734929|19429987|P1|Overall Study|Lost to Follow-up|1
5625044|NCT00734851|19430044|P1|Overall Study|Physician Decision|18
5625045|NCT00734851|19430044|P1|Overall Study|Lost to Follow-up|1
5625046|NCT00734851|19430044|P1|Overall Study|Withdrawal by Subject|2
5625047|NCT00734747|19430065|P1|6 Month Follow-up|Did not meet inclusion criteria|3
5625048|NCT00734747|19430065|P1|SRS Procedure|No staples placed|3
5625049|NCT00734656|19430079|P4|Lab Session 4|Withdrawal by Subject|1
5625050|NCT00734656|19430080|P3|Lab Session 4|Withdrawal by Subject|0
5625051|NCT00734656|19430081|P2|Lab Session 4|Withdrawal by Subject|0
5625052|NCT00734656|19430082|P1|Lab Session 4|Withdrawal by Subject|0
5625053|NCT00734656|19430079|P4|Washout 3|Withdrawal by Subject|1
5625054|NCT00734656|19430080|P3|Washout 3|Withdrawal by Subject|0
5625055|NCT00734656|19430081|P2|Washout 3|Withdrawal by Subject|0
5625056|NCT00734656|19430082|P1|Washout 3|Withdrawal by Subject|1
5625057|NCT00734656|19430079|P4|Washout 2|Withdrawal by Subject|0
5625058|NCT00734656|19430080|P3|Washout 2|Withdrawal by Subject|1
5625059|NCT00734656|19430081|P2|Washout 2|Withdrawal by Subject|1
5625060|NCT00734656|19430082|P1|Washout 2|Withdrawal by Subject|1
5625061|NCT00734656|19430079|P4|Lab Session 2|Withdrawal by Subject|1
5625062|NCT00734656|19430080|P3|Lab Session 2|Withdrawal by Subject|0
5625063|NCT00734656|19430081|P2|Lab Session 2|Withdrawal by Subject|0
5625064|NCT00734656|19430082|P1|Lab Session 2|Withdrawal by Subject|1
5625065|NCT00734656|19430079|P4|Washout 1|Withdrawal by Subject|3
5625066|NCT00734656|19430080|P3|Washout 1|Withdrawal by Subject|2
5625067|NCT00734656|19430081|P2|Washout 1|Withdrawal by Subject|5
5625068|NCT00734656|19430082|P1|Washout 1|Withdrawal by Subject|1
5625069|NCT00734656|19430079|P4|Lab Session 1|Withdrawal by Subject|0
5625070|NCT00734656|19430080|P3|Lab Session 1|Withdrawal by Subject|0
5625071|NCT00734656|19430081|P2|Lab Session 1|Withdrawal by Subject|0
5625072|NCT00734656|19430082|P1|Lab Session 1|Withdrawal by Subject|2
5625073|NCT00734630|19430106|P2|Overall Study|Poor Compliance|1
5625074|NCT00734630|19430107|P1|Overall Study|Poor Compliance|1
5625075|NCT00734630|19430106|P2|Overall Study|Tested Positive for Illegal Drug Use|1
5625076|NCT00734630|19430107|P1|Overall Study|Tested Positive for Illegal Drug Use|1
5625077|NCT00734630|19430106|P2|Overall Study|Randomized in Error|1
5625078|NCT00734630|19430107|P1|Overall Study|Randomized in Error|0
5625079|NCT00734630|19430106|P2|Overall Study|Adverse Event|6
5625080|NCT00734630|19430107|P1|Overall Study|Adverse Event|3
5625081|NCT00734630|19430106|P2|Overall Study|Inclusion/Exclusion criteria not met|1
5625082|NCT00734630|19430107|P1|Overall Study|Inclusion/Exclusion criteria not met|0
5625083|NCT00734630|19430106|P2|Overall Study|Protocol Violation|3
5625084|NCT00734630|19430107|P1|Overall Study|Protocol Violation|0
5625085|NCT00734630|19430106|P2|Overall Study|Lost to Follow-up|7
5625086|NCT00734630|19430107|P1|Overall Study|Lost to Follow-up|13
5625087|NCT00734630|19430106|P2|Overall Study|Withdrawal by Subject|9
5625088|NCT00734630|19430107|P1|Overall Study|Withdrawal by Subject|7
5625089|NCT00734630|19430106|P2|Overall Study|Lack of Efficacy|4
5625090|NCT00734630|19430107|P1|Overall Study|Lack of Efficacy|4
5625091|NCT00734617|19430117|P2|Overall Study|Withdrawal by Subject|95
5625092|NCT00734617|19430118|P1|Overall Study|Withdrawal by Subject|103
5625093|NCT00734617|19430117|P2|Overall Study|Adverse Event|7
5625094|NCT00734617|19430118|P1|Overall Study|Adverse Event|4
5625095|NCT00734604|19430130|P6|Overall Study|Lack of Efficacy|0
5625096|NCT00734604|19430131|P5|Overall Study|Lack of Efficacy|0
5625097|NCT00734604|19430132|P4|Overall Study|Lack of Efficacy|0
5625098|NCT00734604|19430133|P3|Overall Study|Lack of Efficacy|1
5625099|NCT00734604|19430134|P2|Overall Study|Lack of Efficacy|1
5625100|NCT00734604|19430135|P1|Overall Study|Lack of Efficacy|0
5625101|NCT00734604|19430130|P6|Overall Study|Withdrawal by Subject|1
5625102|NCT00734604|19430131|P5|Overall Study|Withdrawal by Subject|2
5625103|NCT00734604|19430132|P4|Overall Study|Withdrawal by Subject|1
5625104|NCT00734604|19430133|P3|Overall Study|Withdrawal by Subject|0
5625105|NCT00734604|19430134|P2|Overall Study|Withdrawal by Subject|2
5625106|NCT00734604|19430135|P1|Overall Study|Withdrawal by Subject|0
5625107|NCT00734604|19430130|P6|Overall Study|Sponsor Decision|0
5625108|NCT00734604|19430131|P5|Overall Study|Sponsor Decision|2
5625109|NCT00734604|19430132|P4|Overall Study|Sponsor Decision|0
5625110|NCT00734604|19430133|P3|Overall Study|Sponsor Decision|1
5625111|NCT00734604|19430134|P2|Overall Study|Sponsor Decision|2
5625112|NCT00734604|19430135|P1|Overall Study|Sponsor Decision|1
5625113|NCT00734604|19430130|P6|Overall Study|Protocol Violation|0
5625114|NCT00734604|19430131|P5|Overall Study|Protocol Violation|1
5625115|NCT00734604|19430132|P4|Overall Study|Protocol Violation|0
5625116|NCT00734604|19430133|P3|Overall Study|Protocol Violation|0
5625117|NCT00734604|19430134|P2|Overall Study|Protocol Violation|2
5625118|NCT00734604|19430135|P1|Overall Study|Protocol Violation|0
5625119|NCT00734604|19430130|P6|Overall Study|Physician Decision|0
5625120|NCT00734604|19430131|P5|Overall Study|Physician Decision|0
5625121|NCT00734604|19430132|P4|Overall Study|Physician Decision|0
5625122|NCT00734604|19430133|P3|Overall Study|Physician Decision|1
5625123|NCT00734604|19430134|P2|Overall Study|Physician Decision|1
5625124|NCT00734604|19430135|P1|Overall Study|Physician Decision|0
5625125|NCT00734604|19430130|P6|Overall Study|Lost to Follow-up|3
5625126|NCT00734604|19430131|P5|Overall Study|Lost to Follow-up|2
5625127|NCT00734604|19430132|P4|Overall Study|Lost to Follow-up|4
5625128|NCT00734604|19430133|P3|Overall Study|Lost to Follow-up|2
5625129|NCT00734604|19430134|P2|Overall Study|Lost to Follow-up|2
5625130|NCT00734604|19430135|P1|Overall Study|Lost to Follow-up|1
5625131|NCT00734604|19430130|P6|Overall Study|Serious Adverse Event|1
5625132|NCT00734604|19430131|P5|Overall Study|Serious Adverse Event|0
5625133|NCT00734604|19430132|P4|Overall Study|Serious Adverse Event|2
5625134|NCT00734604|19430133|P3|Overall Study|Serious Adverse Event|1
5625135|NCT00734604|19430134|P2|Overall Study|Serious Adverse Event|0
5625136|NCT00734604|19430135|P1|Overall Study|Serious Adverse Event|1
5625137|NCT00734604|19430130|P6|Overall Study|Adverse Event|1
5625138|NCT00734604|19430131|P5|Overall Study|Adverse Event|1
5625139|NCT00734604|19430132|P4|Overall Study|Adverse Event|2
5625140|NCT00734604|19430133|P3|Overall Study|Adverse Event|0
5625141|NCT00734604|19430134|P2|Overall Study|Adverse Event|2
5625142|NCT00734604|19430135|P1|Overall Study|Adverse Event|0
5625143|NCT00734591|19430185|P2|Prospective Period|Other|2
5625144|NCT00734591|19430186|P1|Prospective Period|Other|2
5625145|NCT00734591|19430185|P2|Prospective Period|Study Terminated|0
5625146|NCT00734591|19430186|P1|Prospective Period|Study Terminated|1
5625147|NCT00734591|19430185|P2|Prospective Period|Lost to Follow-up|33
5625148|NCT00734591|19430186|P1|Prospective Period|Lost to Follow-up|37
5625149|NCT00734591|19430185|P2|Prospective Period|Withdrawal by Subject|9
5625150|NCT00734591|19430186|P1|Prospective Period|Withdrawal by Subject|11
5625151|NCT00734591|19430185|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
5625152|NCT00734591|19430186|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
5625153|NCT00734591|19430185|P2|Screening for Prospective Period|Site did not participate|1488
5625154|NCT00734591|19430186|P1|Screening for Prospective Period|Site did not participate|1604
5625155|NCT00734578|19430201|P3|Overall Study|Exclusion criteria|0
5625156|NCT00734578|19430202|P2|Overall Study|Exclusion criteria|0
5625157|NCT00734578|19430203|P1|Overall Study|Exclusion criteria|1
5625158|NCT00734578|19430201|P3|Overall Study|Randomized in error|0
5625159|NCT00734578|19430202|P2|Overall Study|Randomized in error|0
5625160|NCT00734578|19430203|P1|Overall Study|Randomized in error|1
5625161|NCT00734578|19430201|P3|Overall Study|Lack of Efficacy|5
5625162|NCT00734578|19430202|P2|Overall Study|Lack of Efficacy|2
5625163|NCT00734578|19430203|P1|Overall Study|Lack of Efficacy|3
5625164|NCT00734578|19430201|P3|Overall Study|Lost to Follow-up|5
5625165|NCT00734578|19430202|P2|Overall Study|Lost to Follow-up|3
5625166|NCT00734578|19430203|P1|Overall Study|Lost to Follow-up|9
5625167|NCT00734578|19430201|P3|Overall Study|Withdrawal by Subject|11
5625168|NCT00734578|19430202|P2|Overall Study|Withdrawal by Subject|8
5625169|NCT00734578|19430203|P1|Overall Study|Withdrawal by Subject|7
5625170|NCT00734578|19430201|P3|Overall Study|Protocol Violation|3
5625171|NCT00734578|19430202|P2|Overall Study|Protocol Violation|6
5625172|NCT00734578|19430203|P1|Overall Study|Protocol Violation|8
5625173|NCT00734578|19430201|P3|Overall Study|Adverse Event|1
5625174|NCT00734578|19430202|P2|Overall Study|Adverse Event|6
5625175|NCT00734578|19430203|P1|Overall Study|Adverse Event|4
5625176|NCT00734539|19430237|P2|Main Study|Enrolled in error; ineligible|0
5625177|NCT00734539|19430238|P1|Main Study|Enrolled in error; ineligible|1
5625178|NCT00734539|19430237|P2|Main Study|Withdrawal by Subject|3
5625179|NCT00734539|19430238|P1|Main Study|Withdrawal by Subject|1
5625180|NCT00734539|19430237|P2|Main Study|Physician Decision|0
5625181|NCT00734539|19430238|P1|Main Study|Physician Decision|2
5625182|NCT00734539|19430237|P2|Main Study|Death|32
5625183|NCT00734539|19430238|P1|Main Study|Death|33
5625184|NCT00734474|19430280|P9|Overall Study|Lack of Efficacy|6
5625185|NCT00734474|19430281|P8|Overall Study|Lack of Efficacy|4
5625186|NCT00734474|19430282|P7|Overall Study|Lack of Efficacy|0
5625187|NCT00734474|19430283|P6|Overall Study|Lack of Efficacy|0
5625188|NCT00734474|19430284|P5|Overall Study|Lack of Efficacy|0
5625189|NCT00734474|19430285|P4|Overall Study|Lack of Efficacy|0
5625190|NCT00734474|19430286|P3|Overall Study|Lack of Efficacy|4
5625191|NCT00734474|19430287|P2|Overall Study|Lack of Efficacy|0
5625192|NCT00734474|19430288|P1|Overall Study|Lack of Efficacy|0
5625193|NCT00734474|19430280|P9|Overall Study|Death|1
5625194|NCT00734474|19430281|P8|Overall Study|Death|2
5625195|NCT00734474|19430282|P7|Overall Study|Death|0
5625196|NCT00734474|19430283|P6|Overall Study|Death|0
5625197|NCT00734474|19430284|P5|Overall Study|Death|0
5625198|NCT00734474|19430285|P4|Overall Study|Death|0
5625199|NCT00734474|19430286|P3|Overall Study|Death|1
5625200|NCT00734474|19430287|P2|Overall Study|Death|0
5625201|NCT00734474|19430288|P1|Overall Study|Death|0
5625202|NCT00734474|19430280|P9|Overall Study|Sponsor Decision|0
5625203|NCT00734474|19430281|P8|Overall Study|Sponsor Decision|0
5625204|NCT00734474|19430282|P7|Overall Study|Sponsor Decision|0
5625205|NCT00734474|19430283|P6|Overall Study|Sponsor Decision|0
5625206|NCT00734474|19430284|P5|Overall Study|Sponsor Decision|2
5625207|NCT00734474|19430285|P4|Overall Study|Sponsor Decision|0
5625208|NCT00734474|19430286|P3|Overall Study|Sponsor Decision|0
5625209|NCT00734474|19430287|P2|Overall Study|Sponsor Decision|0
5625210|NCT00734474|19430288|P1|Overall Study|Sponsor Decision|0
5625211|NCT00734474|19430280|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
5625212|NCT00734474|19430281|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
5625213|NCT00734474|19430282|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
5625214|NCT00734474|19430283|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
5625215|NCT00734474|19430284|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
5625216|NCT00734474|19430285|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
5625217|NCT00734474|19430286|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
5625218|NCT00734474|19430287|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
5625219|NCT00734474|19430288|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
5625220|NCT00734474|19430280|P9|Overall Study|Protocol Violation|1
5625221|NCT00734474|19430281|P8|Overall Study|Protocol Violation|3
5625222|NCT00734474|19430282|P7|Overall Study|Protocol Violation|0
5625223|NCT00734474|19430283|P6|Overall Study|Protocol Violation|0
5625224|NCT00734474|19430284|P5|Overall Study|Protocol Violation|3
5625225|NCT00734474|19430285|P4|Overall Study|Protocol Violation|0
5625226|NCT00734474|19430286|P3|Overall Study|Protocol Violation|4
5625227|NCT00734474|19430287|P2|Overall Study|Protocol Violation|0
5625228|NCT00734474|19430288|P1|Overall Study|Protocol Violation|0
5625229|NCT00734474|19430280|P9|Overall Study|Adverse Event|39
5625230|NCT00734474|19430281|P8|Overall Study|Adverse Event|65
5625231|NCT00734474|19430282|P7|Overall Study|Adverse Event|1
5625232|NCT00734474|19430283|P6|Overall Study|Adverse Event|0
5625233|NCT00734474|19430284|P5|Overall Study|Adverse Event|64
5625234|NCT00734474|19430285|P4|Overall Study|Adverse Event|1
5625235|NCT00734474|19430286|P3|Overall Study|Adverse Event|63
5625236|NCT00734474|19430287|P2|Overall Study|Adverse Event|4
5625237|NCT00734474|19430288|P1|Overall Study|Adverse Event|4
5625238|NCT00734474|19430280|P9|Overall Study|Physician Decision|9
5625239|NCT00734474|19430281|P8|Overall Study|Physician Decision|9
5625240|NCT00734474|19430282|P7|Overall Study|Physician Decision|0
5625241|NCT00734474|19430283|P6|Overall Study|Physician Decision|0
5625242|NCT00734474|19430284|P5|Overall Study|Physician Decision|11
5625243|NCT00734474|19430285|P4|Overall Study|Physician Decision|1
5625244|NCT00734474|19430286|P3|Overall Study|Physician Decision|4
5625245|NCT00734474|19430287|P2|Overall Study|Physician Decision|0
5625246|NCT00734474|19430288|P1|Overall Study|Physician Decision|0
5625247|NCT00734474|19430280|P9|Overall Study|Withdrawal by Subject|21
5625248|NCT00734474|19430281|P8|Overall Study|Withdrawal by Subject|36
5625249|NCT00734474|19430282|P7|Overall Study|Withdrawal by Subject|0
5625250|NCT00734474|19430283|P6|Overall Study|Withdrawal by Subject|2
5625251|NCT00734474|19430284|P5|Overall Study|Withdrawal by Subject|24
5625252|NCT00734474|19430285|P4|Overall Study|Withdrawal by Subject|0
5625253|NCT00734474|19430286|P3|Overall Study|Withdrawal by Subject|18
5625254|NCT00734474|19430287|P2|Overall Study|Withdrawal by Subject|1
5625255|NCT00734474|19430288|P1|Overall Study|Withdrawal by Subject|2
5625256|NCT00734474|19430280|P9|Overall Study|Lost to Follow-up|4
5625257|NCT00734474|19430281|P8|Overall Study|Lost to Follow-up|9
5625258|NCT00734474|19430282|P7|Overall Study|Lost to Follow-up|0
5625259|NCT00734474|19430283|P6|Overall Study|Lost to Follow-up|1
5625260|NCT00734474|19430284|P5|Overall Study|Lost to Follow-up|11
5625261|NCT00734474|19430285|P4|Overall Study|Lost to Follow-up|0
5625262|NCT00734474|19430286|P3|Overall Study|Lost to Follow-up|13
5625263|NCT00734474|19430287|P2|Overall Study|Lost to Follow-up|0
5625264|NCT00734474|19430288|P1|Overall Study|Lost to Follow-up|1
5625265|NCT00734474|19430280|P9|Overall Study|Entry Criteria Not Met|1
5625266|NCT00734474|19430281|P8|Overall Study|Entry Criteria Not Met|1
5625267|NCT00734474|19430282|P7|Overall Study|Entry Criteria Not Met|0
5625268|NCT00734474|19430283|P6|Overall Study|Entry Criteria Not Met|1
5625269|NCT00734474|19430284|P5|Overall Study|Entry Criteria Not Met|3
5625270|NCT00734474|19430285|P4|Overall Study|Entry Criteria Not Met|0
5625271|NCT00734474|19430286|P3|Overall Study|Entry Criteria Not Met|5
5625272|NCT00734474|19430287|P2|Overall Study|Entry Criteria Not Met|0
5625273|NCT00734474|19430288|P1|Overall Study|Entry Criteria Not Met|0
5625274|NCT00734214|19430578|P2|Overall Study|MD withdrawal|0
5625275|NCT00734214|19430579|P1|Overall Study|MD withdrawal|1
5625276|NCT00734214|19430578|P2|Overall Study|Withdrawal by Subject|4
5625277|NCT00734214|19430579|P1|Overall Study|Withdrawal by Subject|3
5625278|NCT00734162|19430589|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
5625279|NCT00734162|19430590|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
5625280|NCT00734162|19430591|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
5625281|NCT00734162|19430592|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
5625282|NCT00734162|19430589|P4|Open-Label Phase|Lost to Follow-up|1
5625283|NCT00734162|19430590|P3|Open-Label Phase|Lost to Follow-up|0
5625284|NCT00734162|19430591|P2|Open-Label Phase|Lost to Follow-up|2
5625285|NCT00734162|19430592|P1|Open-Label Phase|Lost to Follow-up|1
5625286|NCT00734162|19430589|P4|Open-Label Phase|Withdrew Consent|1
5625287|NCT00734162|19430590|P3|Open-Label Phase|Withdrew Consent|1
5625288|NCT00734162|19430591|P2|Open-Label Phase|Withdrew Consent|0
5625289|NCT00734162|19430592|P1|Open-Label Phase|Withdrew Consent|1
5625290|NCT00734162|19430589|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
5625291|NCT00734162|19430590|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
5625292|NCT00734162|19430591|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
5625293|NCT00734162|19430592|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
5625294|NCT00734162|19430589|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
5625295|NCT00734162|19430590|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
5625296|NCT00734162|19430591|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
5625297|NCT00734162|19430592|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
5625298|NCT00734162|19430589|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
5625299|NCT00734162|19430590|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
5625300|NCT00734162|19430591|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
5625301|NCT00734162|19430592|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
5625302|NCT00734149|19430816|P1|Overall Study|Withdrawal by Subject|1
5625303|NCT00734097|19430823|P1|Open Label|Protocol Violation|4
5625304|NCT00734097|19430823|P1|Open Label|Withdrawal by Subject|5
5625305|NCT00734097|19430823|P1|Open Label|Lost to Follow-up|7
5625306|NCT00734097|19430823|P1|Screening|Unconfirmed pregnancy|1
5625307|NCT00734097|19430823|P1|Screening|Lost to Follow-up|2
5625308|NCT00734097|19430823|P1|Screening|Withdrawal by Subject|5
5625309|NCT00734097|19430823|P1|Screening|Protocol Violation|12
5625310|NCT00734071|19430840|P2|Overall Study|Other|2
5625311|NCT00734071|19430841|P1|Overall Study|Other|1
5625312|NCT00734071|19430840|P2|Overall Study|Lost to Follow-up|8
5625313|NCT00734071|19430841|P1|Overall Study|Lost to Follow-up|16
5625314|NCT00734071|19430840|P2|Overall Study|Voluntary Withdrawal|7
5625315|NCT00734071|19430841|P1|Overall Study|Voluntary Withdrawal|9
5625316|NCT00734071|19430840|P2|Overall Study|Protocol Deviations|4
5625317|NCT00734071|19430841|P1|Overall Study|Protocol Deviations|3
5625318|NCT00734071|19430840|P2|Overall Study|Noncompliance|2
5625319|NCT00734071|19430841|P1|Overall Study|Noncompliance|2
5625320|NCT00734071|19430840|P2|Overall Study|Lack of Efficacy|1
5625321|NCT00734071|19430841|P1|Overall Study|Lack of Efficacy|3
5625322|NCT00734071|19430840|P2|Overall Study|Adverse Event|3
5625323|NCT00734071|19430841|P1|Overall Study|Adverse Event|4
5625324|NCT00734032|19430899|P4|Overall Study|Adverse Event|0
5625325|NCT00734032|19430900|P3|Overall Study|Adverse Event|0
5625326|NCT00734032|19430901|P2|Overall Study|Adverse Event|1
5625327|NCT00734032|19430902|P1|Overall Study|Adverse Event|0
5625328|NCT00733980|19430958|P2|Overall Study|Withdrawal by Subject|2
5625329|NCT00733980|19430959|P1|Overall Study|Withdrawal by Subject|6
5625330|NCT00733980|19430958|P2|Overall Study|Physician Decision|3
5625331|NCT00733980|19430959|P1|Overall Study|Physician Decision|2
5625332|NCT00733980|19430958|P2|Overall Study|Lost to Follow-up|11
5625333|NCT00733980|19430959|P1|Overall Study|Lost to Follow-up|6
5625334|NCT00733980|19430958|P2|Overall Study|Protocol defined stopping criteria reach|1
5625335|NCT00733980|19430959|P1|Overall Study|Protocol defined stopping criteria reach|1
5625336|NCT00733980|19430958|P2|Overall Study|Protocol Violation|1
5625337|NCT00733980|19430959|P1|Overall Study|Protocol Violation|2
5625338|NCT00733980|19430958|P2|Overall Study|Lack of Efficacy|1
5625339|NCT00733980|19430959|P1|Overall Study|Lack of Efficacy|0
5625340|NCT00733980|19430958|P2|Overall Study|Adverse Event|2
5625341|NCT00733980|19430959|P1|Overall Study|Adverse Event|5
5625342|NCT00733954|19431003|P2|Overall Study|Withdrawal by Subject|0
5625343|NCT00733954|19431004|P1|Overall Study|Withdrawal by Subject|2
5625344|NCT00733954|19431003|P2|Overall Study|Protocol Violation|0
5625345|NCT00733954|19431004|P1|Overall Study|Protocol Violation|1
5625346|NCT00733954|19431003|P2|Overall Study|Lost to Follow-up|2
5625347|NCT00733954|19431004|P1|Overall Study|Lost to Follow-up|5
5625348|NCT00733824|19431051|P5|Phase I|Withdrawal by Subject|0
5625349|NCT00733824|19431052|P4|Phase I|Withdrawal by Subject|0
5625350|NCT00733824|19431053|P3|Phase I|Withdrawal by Subject|0
5625351|NCT00733824|19431054|P2|Phase I|Withdrawal by Subject|0
5625352|NCT00733824|19431055|P1|Phase I|Withdrawal by Subject|1
5625353|NCT00733746|19431074|P1|Overall Study|Ineligible|5
5625354|NCT00733499|19431089|P2|10 Year Followup|missing, unable to locate|2
5625355|NCT00733499|19431090|P1|10 Year Followup|missing, unable to locate|0
5625356|NCT00733499|19431089|P2|10 Year Followup|Withdrawal by Subject|5
5625357|NCT00733499|19431090|P1|10 Year Followup|Withdrawal by Subject|5
5625358|NCT00733499|19431089|P2|10 Year Followup|Lost to Follow-up|2
5625359|NCT00733499|19431090|P1|10 Year Followup|Lost to Follow-up|3
5625360|NCT00733499|19431089|P2|10 Year Followup|Adverse Event|3
5625361|NCT00733499|19431090|P1|10 Year Followup|Adverse Event|3
5625362|NCT00733499|19431089|P2|10 Year Followup|Death|7
5625363|NCT00733499|19431090|P1|10 Year Followup|Death|9
5625364|NCT00733499|19431089|P2|5 Year Followup|Withdrawal by Subject|1
5625365|NCT00733499|19431090|P1|5 Year Followup|Withdrawal by Subject|4
5625366|NCT00733499|19431089|P2|5 Year Followup|missing, unable to locate|1
5625367|NCT00733499|19431090|P1|5 Year Followup|missing, unable to locate|0
5625368|NCT00733499|19431089|P2|5 Year Followup|Death|19
5625369|NCT00733499|19431090|P1|5 Year Followup|Death|13
5625370|NCT00733499|19431089|P2|5 Year Followup|Lost to Follow-up|0
5625371|NCT00733499|19431090|P1|5 Year Followup|Lost to Follow-up|2
5625372|NCT00733499|19431089|P2|5 Year Followup|Revision of Study Implant|1
5625373|NCT00733499|19431090|P1|5 Year Followup|Revision of Study Implant|0
5625374|NCT00733499|19431089|P2|5 Year Followup|Non device related AE|1
5625375|NCT00733499|19431090|P1|5 Year Followup|Non device related AE|0
5625376|NCT00733499|19431089|P2|5 Year Followup|Adverse Event|2
5625377|NCT00733499|19431090|P1|5 Year Followup|Adverse Event|2
5625378|NCT00733499|19431089|P2|24 Months Follow-up|Death|1
5625379|NCT00733499|19431090|P1|24 Months Follow-up|Death|0
5625380|NCT00733499|19431089|P2|12 Months Follow-up|Death|1
5625381|NCT00733499|19431090|P1|12 Months Follow-up|Death|2
5625382|NCT00733499|19431089|P2|6 Months Follow-up|Adverse Event|1
5625383|NCT00733499|19431090|P1|6 Months Follow-up|Adverse Event|0
5625384|NCT00733499|19431089|P2|6 Months Follow-up|Death|2
5625385|NCT00733499|19431090|P1|6 Months Follow-up|Death|0
5625386|NCT00733499|19431089|P2|3 Months Follow-up|Death|2
5625387|NCT00733499|19431090|P1|3 Months Follow-up|Death|1
5625388|NCT00733499|19431089|P2|Pre-operative|Protocol Violation|1
5625389|NCT00733499|19431090|P1|Pre-operative|Protocol Violation|0
5625390|NCT00733421|19431150|P2|Overall Study|Withdrawal by Subject|1
5625391|NCT00733421|19431151|P1|Overall Study|Withdrawal by Subject|1
5625392|NCT00733408|19431173|P1|Overall Study|Adverse Event|4
5625393|NCT00733369|19431185|P2|Overall Study|Protocol Violation|4
5625394|NCT00733369|19431186|P1|Overall Study|Protocol Violation|4
5625395|NCT00733369|19431185|P2|Overall Study|Adverse Event|4
5625396|NCT00733369|19431186|P1|Overall Study|Adverse Event|4
5625397|NCT00733369|19431185|P2|Overall Study|Lost to Follow-up|1
5625398|NCT00733369|19431186|P1|Overall Study|Lost to Follow-up|2
5625399|NCT00733304|19431485|P3|Overall Study|Withdrawal by Subject|0
5625400|NCT00733304|19431486|P2|Overall Study|Withdrawal by Subject|1
5625401|NCT00733304|19431487|P1|Overall Study|Withdrawal by Subject|1
5625402|NCT00733304|19431485|P3|Overall Study|Physician Decision|3
5625403|NCT00733304|19431486|P2|Overall Study|Physician Decision|1
5625404|NCT00733304|19431487|P1|Overall Study|Physician Decision|3
5625405|NCT00733304|19431485|P3|Overall Study|Lost to Follow-up|0
5625406|NCT00733304|19431486|P2|Overall Study|Lost to Follow-up|1
5625407|NCT00733304|19431487|P1|Overall Study|Lost to Follow-up|0
5625408|NCT00733304|19431485|P3|Overall Study|Lack of Efficacy|2
5625409|NCT00733304|19431486|P2|Overall Study|Lack of Efficacy|0
5625410|NCT00733304|19431487|P1|Overall Study|Lack of Efficacy|0
5625411|NCT00733304|19431485|P3|Overall Study|Adverse Event|0
5625412|NCT00733304|19431486|P2|Overall Study|Adverse Event|0
5625413|NCT00733304|19431487|P1|Overall Study|Adverse Event|3
5625414|NCT00733291|19431569|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
5625415|NCT00733291|19431570|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
5625416|NCT00733291|19431571|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
5625417|NCT00733291|19431572|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
5625418|NCT00733226|19431601|P2|Overall Study|moved to another place|0
5625419|NCT00733226|19431602|P1|Overall Study|moved to another place|2
5625420|NCT00733226|19431601|P2|Overall Study|Lost to Follow-up|0
5625421|NCT00733226|19431602|P1|Overall Study|Lost to Follow-up|2
5625422|NCT00733226|19431601|P2|Overall Study|Withdrawal by Subject|0
5625423|NCT00733226|19431602|P1|Overall Study|Withdrawal by Subject|1
5625424|NCT00733005|19431651|P2|Overall Study|Protocol Violation|0
5625425|NCT00733005|19431652|P1|Overall Study|Protocol Violation|2
5625426|NCT00733005|19431651|P2|Overall Study|Withdrawal by Subject|1
5625427|NCT00733005|19431652|P1|Overall Study|Withdrawal by Subject|0
5625428|NCT00733005|19431651|P2|Overall Study|Treatment Failure|1
5625429|NCT00733005|19431652|P1|Overall Study|Treatment Failure|0
5625430|NCT00733005|19431651|P2|Overall Study|Adverse Event|1
5625431|NCT00733005|19431652|P1|Overall Study|Adverse Event|0
5625432|NCT00732992|19431662|P2|Overall Study|Withdrawal by Subject|0
5625433|NCT00732992|19431663|P1|Overall Study|Withdrawal by Subject|1
5625434|NCT00732992|19431662|P2|Overall Study|Global Deterioration of Health Status|0
5625435|NCT00732992|19431663|P1|Overall Study|Global Deterioration of Health Status|1
5625436|NCT00732992|19431662|P2|Overall Study|Objective Progression or Relapse|5
5625437|NCT00732992|19431663|P1|Overall Study|Objective Progression or Relapse|3
5625438|NCT00732992|19431662|P2|Overall Study|Adverse Event|1
5625439|NCT00732992|19431663|P1|Overall Study|Adverse Event|1
5625440|NCT00732940|19431682|P2|Overall Study|Lost to Follow-up|0
5625441|NCT00732940|19431683|P1|Overall Study|Lost to Follow-up|1
5625442|NCT00732940|19431682|P2|Overall Study|Adverse Event|1
5625443|NCT00732940|19431683|P1|Overall Study|Adverse Event|0
5625444|NCT00732940|19431682|P2|Overall Study|Withdrawal by Subject|2
5625445|NCT00732940|19431683|P1|Overall Study|Withdrawal by Subject|1
5625446|NCT00732875|19431764|P1|Overall Study|Lack of Efficacy|13
5625447|NCT00732875|19431764|P1|Overall Study|Withdrawal by Subject|6
5625448|NCT00732875|19431764|P1|Overall Study|Adverse Event|16
5625449|NCT00732758|19431772|P2|Overall Study|Lost to Follow-up|16
5625450|NCT00732758|19431773|P1|Overall Study|Lost to Follow-up|8
5625451|NCT00732641|19431813|P2|Overall Study|Other|5
5625452|NCT00732641|19431814|P1|Overall Study|Other|18
5625453|NCT00732641|19431813|P2|Overall Study|Unable to Complete|1
5625454|NCT00732641|19431814|P1|Overall Study|Unable to Complete|1
5625455|NCT00732641|19431813|P2|Overall Study|Withdrawal by Subject|2
5625456|NCT00732641|19431814|P1|Overall Study|Withdrawal by Subject|4
5625457|NCT00732641|19431813|P2|Overall Study|Physician Decision|0
5625458|NCT00732641|19431814|P1|Overall Study|Physician Decision|6
5625459|NCT00732641|19431813|P2|Overall Study|Serious Adverse Events|3
5625460|NCT00732641|19431814|P1|Overall Study|Serious Adverse Events|12
5625461|NCT00732641|19431813|P2|Overall Study|Relapse or Progressive Disease|101
5625462|NCT00732641|19431814|P1|Overall Study|Relapse or Progressive Disease|65
5625463|NCT00732615|19431834|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
5625464|NCT00732615|19431835|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
5625465|NCT00732615|19431834|P2|Overall Study|Physician Decision|0
5625466|NCT00732615|19431835|P1|Overall Study|Physician Decision|3
5625467|NCT00732615|19431834|P2|Overall Study|Adverse Event|2
5625468|NCT00732615|19431835|P1|Overall Study|Adverse Event|0
5625469|NCT00732615|19431834|P2|Overall Study|Lost to Follow-up|1
5625470|NCT00732615|19431835|P1|Overall Study|Lost to Follow-up|0
5625471|NCT00732615|19431834|P2|Overall Study|Withdrawal by Subject|1
5625472|NCT00732615|19431835|P1|Overall Study|Withdrawal by Subject|3
5625473|NCT00732498|19431847|P1|Overall Study|Physician Decision|3
5625474|NCT00732498|19431847|P1|Overall Study|Adverse Event|2
5625475|NCT00732498|19431847|P1|Overall Study|Ineligible|1
5625476|NCT00732472|19431858|P4|Overall Study|Withdrawal by Subject|1
5625477|NCT00732472|19431859|P3|Overall Study|Withdrawal by Subject|0
5625478|NCT00732472|19431860|P2|Overall Study|Withdrawal by Subject|2
5625479|NCT00732472|19431861|P1|Overall Study|Withdrawal by Subject|0
5625480|NCT00732472|19431858|P4|Overall Study|Protocol Violation|1
5625481|NCT00732472|19431859|P3|Overall Study|Protocol Violation|0
5625482|NCT00732472|19431860|P2|Overall Study|Protocol Violation|0
5625483|NCT00732472|19431861|P1|Overall Study|Protocol Violation|0
5625484|NCT00732472|19431858|P4|Overall Study|Adverse Event|1
5625485|NCT00732472|19431859|P3|Overall Study|Adverse Event|1
5625486|NCT00732472|19431860|P2|Overall Study|Adverse Event|1
5625487|NCT00732472|19431861|P1|Overall Study|Adverse Event|0
5625488|NCT00732381|19431961|P2|Overall Study|Treatment Failure|1
5625489|NCT00732381|19431962|P1|Overall Study|Treatment Failure|1
5625490|NCT00732381|19431961|P2|Overall Study|Adverse Event|0
5625491|NCT00732381|19431962|P1|Overall Study|Adverse Event|1
5625492|NCT00732303|19431970|P1|Overall Study|Study Terminated|2
5625493|NCT00732251|19431976|P1|Overall Study|Early Term due to Site Closure|1
5625494|NCT00732251|19431976|P1|Overall Study|Withdrawal by Subject|3
5625495|NCT00732251|19431976|P1|Overall Study|Lost to Follow-up|3
5625496|NCT00732238|19431984|P2|Overall Study|Asymptomatic bacteriuria|0
5625497|NCT00732238|19431985|P1|Overall Study|Asymptomatic bacteriuria|1
5625498|NCT00732238|19431984|P2|Overall Study|Bacteremia|1
5625499|NCT00732238|19431985|P1|Overall Study|Bacteremia|4
5625500|NCT00732199|19432086|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
5625501|NCT00732199|19432087|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
5625502|NCT00732199|19432086|P2|Overall Study|Withdrawal by Subject|18
5625503|NCT00732199|19432087|P1|Overall Study|Withdrawal by Subject|25
5625504|NCT00732160|19432102|P4|Overall Study|scheduling|1
5625505|NCT00732160|19432103|P3|Overall Study|scheduling|2
5625506|NCT00732160|19432104|P2|Overall Study|scheduling|4
5625507|NCT00732160|19432105|P1|Overall Study|scheduling|4
5625508|NCT00732160|19432102|P4|Overall Study|Adverse Event|1
5625509|NCT00732160|19432103|P3|Overall Study|Adverse Event|1
5625510|NCT00732160|19432104|P2|Overall Study|Adverse Event|0
5625511|NCT00732160|19432105|P1|Overall Study|Adverse Event|1
5625512|NCT00732069|19432119|P6|Washout After First Study Drug|Adverse Event|0
5625513|NCT00732069|19432120|P5|Washout After First Study Drug|Adverse Event|0
5625514|NCT00732069|19432121|P4|Washout After First Study Drug|Adverse Event|0
5625515|NCT00732069|19432122|P3|Washout After First Study Drug|Adverse Event|0
5625516|NCT00732069|19432123|P2|Washout After First Study Drug|Adverse Event|0
5625517|NCT00732069|19432124|P1|Washout After First Study Drug|Adverse Event|1
5625518|NCT00731939|19432142|P1|Overall Study|Did not meet enrollment criteria|2
5625519|NCT00731939|19432142|P1|Overall Study|Withdrawal by Subject|2
5625520|NCT00731939|19432142|P1|Overall Study|Not implanted with study device|9
5625521|NCT00731939|19432142|P1|Overall Study|Lost to Follow-up|15
5625522|NCT00731939|19432142|P1|Overall Study|Adverse Event|6
5625523|NCT00731822|19432219|P2|Overall Study|Lost to Follow-up|0
5625524|NCT00731822|19432220|P1|Overall Study|Lost to Follow-up|1
5625525|NCT00731822|19432219|P2|Overall Study|Protocol Violation|0
5625526|NCT00731822|19432220|P1|Overall Study|Protocol Violation|1
5625527|NCT00731822|19432219|P2|Overall Study|Adverse Event|1
5625528|NCT00731822|19432220|P1|Overall Study|Adverse Event|2
5625529|NCT00731783|19432234|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
5625530|NCT00731783|19432235|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
5625531|NCT00731783|19432234|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
5625532|NCT00731783|19432235|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
5625533|NCT00731783|19432234|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
5625534|NCT00731783|19432235|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
5625535|NCT00731783|19432234|P2|One Month Follow-Up Visit|Lost to Follow-up|22
5625536|NCT00731783|19432235|P1|One Month Follow-Up Visit|Lost to Follow-up|14
5625537|NCT00731731|19432269|P3|Overall Study|Cancel prior to treatment|2
5625538|NCT00731731|19432270|P2|Overall Study|Cancel prior to treatment|0
5625539|NCT00731731|19432271|P1|Overall Study|Cancel prior to treatment|0
5625540|NCT00731731|19432269|P3|Overall Study|Protocol Violation|1
5625541|NCT00731731|19432270|P2|Overall Study|Protocol Violation|0
5625542|NCT00731731|19432271|P1|Overall Study|Protocol Violation|0
5625543|NCT00731692|19432289|P3|Extension Phase|Adverse Event|15
5625544|NCT00731692|19432290|P2|Extension Phase|Adverse Event|1
5625545|NCT00731692|19432291|P1|Extension Phase|Adverse Event|1
5625546|NCT00731692|19432289|P3|Extension Phase|Withdrawal by Subject|3
5625547|NCT00731692|19432290|P2|Extension Phase|Withdrawal by Subject|5
5625548|NCT00731692|19432291|P1|Extension Phase|Withdrawal by Subject|4
5625549|NCT00731692|19432289|P3|Extension Phase|Lost to Follow-up|4
5625550|NCT00731692|19432290|P2|Extension Phase|Lost to Follow-up|1
5625551|NCT00731692|19432291|P1|Extension Phase|Lost to Follow-up|0
5625552|NCT00731692|19432289|P3|Extension Phase|Abnormal lab values|1
5625553|NCT00731692|19432290|P2|Extension Phase|Abnormal lab values|0
5625554|NCT00731692|19432291|P1|Extension Phase|Abnormal lab values|0
5625555|NCT00731692|19432289|P3|Extension Phase|Abnormal test procedure|1
5625556|NCT00731692|19432290|P2|Extension Phase|Abnormal test procedure|0
5625557|NCT00731692|19432291|P1|Extension Phase|Abnormal test procedure|0
5625558|NCT00731692|19432289|P3|Extension Phase|Admin Problems: Terminated # patients|277
5625559|NCT00731692|19432290|P2|Extension Phase|Admin Problems: Terminated # patients|189
5625560|NCT00731692|19432291|P1|Extension Phase|Admin Problems: Terminated # patients|69
5625561|NCT00731692|19432289|P3|Core Study (36 Months)|Withdrawal by Subject|46
5625562|NCT00731692|19432290|P2|Core Study (36 Months)|Withdrawal by Subject|32
5625563|NCT00731692|19432291|P1|Core Study (36 Months)|Withdrawal by Subject|12
5625564|NCT00731692|19432289|P3|Core Study (36 Months)|Adverse Event|29
5625565|NCT00731692|19432290|P2|Core Study (36 Months)|Adverse Event|28
5625566|NCT00731692|19432291|P1|Core Study (36 Months)|Adverse Event|25
5625567|NCT00731692|19432289|P3|Core Study (36 Months)|Abnormal Lab values|5
5625568|NCT00731692|19432290|P2|Core Study (36 Months)|Abnormal Lab values|19
5625569|NCT00731692|19432291|P1|Core Study (36 Months)|Abnormal Lab values|6
5625570|NCT00731692|19432289|P3|Core Study (36 Months)|Protocol Violation|8
5625571|NCT00731692|19432290|P2|Core Study (36 Months)|Protocol Violation|5
5625572|NCT00731692|19432291|P1|Core Study (36 Months)|Protocol Violation|4
5625573|NCT00731692|19432289|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
5625574|NCT00731692|19432290|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
5625575|NCT00731692|19432291|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
5625576|NCT00731692|19432289|P3|Core Study (36 Months)|Administrative|6
5625577|NCT00731692|19432290|P2|Core Study (36 Months)|Administrative|2
5625578|NCT00731692|19432291|P1|Core Study (36 Months)|Administrative|2
5625579|NCT00731692|19432289|P3|Core Study (36 Months)|Lost to Follow-up|3
5625580|NCT00731692|19432290|P2|Core Study (36 Months)|Lost to Follow-up|3
5625581|NCT00731692|19432291|P1|Core Study (36 Months)|Lost to Follow-up|1
5625582|NCT00731692|19432289|P3|Core Study (36 Months)|Death|2
5625583|NCT00731692|19432290|P2|Core Study (36 Months)|Death|1
5625584|NCT00731692|19432291|P1|Core Study (36 Months)|Death|2
5625585|NCT00731692|19432289|P3|Core Study (36 Months)|Physician Decision|2
5625586|NCT00731692|19432290|P2|Core Study (36 Months)|Physician Decision|0
5625587|NCT00731692|19432291|P1|Core Study (36 Months)|Physician Decision|1
5625588|NCT00731692|19432289|P3|Core Study (36 Months)|Lack of Efficacy|64
5625589|NCT00731692|19432290|P2|Core Study (36 Months)|Lack of Efficacy|23
5625590|NCT00731692|19432291|P1|Core Study (36 Months)|Lack of Efficacy|11
5625591|NCT00731679|19432337|P2|Overall Study|Pregnancy|1
5625592|NCT00731679|19432338|P1|Overall Study|Pregnancy|0
5625593|NCT00731679|19432337|P2|Overall Study|Noncompliance|1
5625594|NCT00731679|19432338|P1|Overall Study|Noncompliance|0
5625595|NCT00731679|19432337|P2|Overall Study|Lost to Follow-up|8
5625596|NCT00731679|19432338|P1|Overall Study|Lost to Follow-up|7
5625597|NCT00731679|19432337|P2|Overall Study|Withdrawal by Subject|8
5625598|NCT00731679|19432338|P1|Overall Study|Withdrawal by Subject|8
5625599|NCT00731679|19432337|P2|Overall Study|Adverse Event|8
5625600|NCT00731679|19432338|P1|Overall Study|Adverse Event|7
5625601|NCT00731666|19432346|P1|Overall Study|Withdrawal by Subject|2
5625602|NCT00731666|19432346|P1|Overall Study|Lost to Follow-up|8
5625603|NCT00731666|19432346|P1|Overall Study|Adverse Event|2
5625604|NCT00731549|19432382|P1|Overall Study|Lack of efficacy without AE|6
5625605|NCT00731549|19432382|P1|Overall Study|Lack of efficacy with AE|37
5625606|NCT00731549|19432382|P1|Overall Study|Adverse Event|31
5625607|NCT00731549|19432382|P1|Overall Study|Protocol deviation|1
5625608|NCT00731549|19432382|P1|Overall Study|Withdrawal by Subject|89
5625609|NCT00731549|19432382|P1|Overall Study|Physician Decision|16
5625610|NCT00731549|19432382|P1|Overall Study|Met withdrawal criteria|24
5625611|NCT00731549|19432382|P1|Overall Study|Lost to Follow-up|19
5625612|NCT00731133|19432422|P1|Overall Study|Withdrawal by Subject|10
5625613|NCT00731120|19432430|P3|Overall Study|Other|1
5625614|NCT00731120|19432431|P2|Overall Study|Other|0
5625615|NCT00731120|19432432|P1|Overall Study|Other|4
5625616|NCT00731120|19432430|P3|Overall Study|Lost to Follow-up|17
5625617|NCT00731120|19432431|P2|Overall Study|Lost to Follow-up|15
5625618|NCT00731120|19432432|P1|Overall Study|Lost to Follow-up|10
5625619|NCT00731120|19432430|P3|Overall Study|Withdrawal of Consent|4
5625620|NCT00731120|19432431|P2|Overall Study|Withdrawal of Consent|8
5625621|NCT00731120|19432432|P1|Overall Study|Withdrawal of Consent|13
5625622|NCT00731120|19432430|P3|Overall Study|Protocol Deviations|1
5625623|NCT00731120|19432431|P2|Overall Study|Protocol Deviations|6
5625624|NCT00731120|19432432|P1|Overall Study|Protocol Deviations|1
5625625|NCT00731120|19432430|P3|Overall Study|Noncompliance with Study Drug|1
5625626|NCT00731120|19432431|P2|Overall Study|Noncompliance with Study Drug|3
5625627|NCT00731120|19432432|P1|Overall Study|Noncompliance with Study Drug|3
5625628|NCT00731120|19432430|P3|Overall Study|Lack of Efficacy|4
5625629|NCT00731120|19432431|P2|Overall Study|Lack of Efficacy|5
5625630|NCT00731120|19432432|P1|Overall Study|Lack of Efficacy|4
5625631|NCT00731120|19432430|P3|Overall Study|Adverse Event|8
5625632|NCT00731120|19432431|P2|Overall Study|Adverse Event|6
5625633|NCT00731120|19432432|P1|Overall Study|Adverse Event|7
5625634|NCT00731042|19432549|P2|Second Intervention|Did not meet inclusion criteria|2
5625635|NCT00731042|19432550|P1|Second Intervention|Did not meet inclusion criteria|0
5625636|NCT00730925|19432561|P1|Overall Study|Other|1
5625637|NCT00730925|19432561|P1|Overall Study|Switch to combination therapy|8
5625638|NCT00730925|19432561|P1|Overall Study|Withdrawal by Subject|1
5625639|NCT00730925|19432561|P1|Overall Study|Protocol Violation|1
5625640|NCT00730925|19432561|P1|Overall Study|Other Averse Event|7
5625641|NCT00730925|19432561|P1|Overall Study|Dose reducing Event|2
5625642|NCT00730925|19432561|P1|Overall Study|Progressive Disease|21
5625643|NCT00730912|19432571|P3|Overall Study|Discontinued|1
5625644|NCT00730912|19432572|P2|Overall Study|Discontinued|0
5625645|NCT00730912|19432573|P1|Overall Study|Discontinued|0
5625646|NCT00730886|19432586|P2|Overall Study|Physician Decision|0
5625647|NCT00730886|19432587|P1|Overall Study|Physician Decision|1
5625648|NCT00730886|19432586|P2|Overall Study|Lost to Follow-up|0
5625649|NCT00730886|19432587|P1|Overall Study|Lost to Follow-up|1
5625650|NCT00730847|19432611|P1|Overall Study|Other|24
5625651|NCT00730847|19432611|P1|Overall Study|Unknown completion status|21
5625652|NCT00730847|19432611|P1|Overall Study|Lost to Follow-up|67
5625653|NCT00730847|19432611|P1|Overall Study|Withdrawal by Subject|16
5625654|NCT00730847|19432611|P1|Overall Study|Protocol Violation|2
5625655|NCT00730847|19432611|P1|Overall Study|Adverse Event|1
5625656|NCT00730756|19432620|P2|Overall Study|Withdrew Consent|1
5625657|NCT00730756|19432621|P1|Overall Study|Withdrew Consent|0
5625658|NCT00730756|19432620|P2|Overall Study|Lost to Follow-up|1
5625659|NCT00730756|19432621|P1|Overall Study|Lost to Follow-up|0
5625660|NCT00730756|19432620|P2|Overall Study|Protocol Deviation|2
5625661|NCT00730756|19432621|P1|Overall Study|Protocol Deviation|1
5625662|NCT00730756|19432620|P2|Overall Study|Lack of Efficacy|1
5625663|NCT00730756|19432621|P1|Overall Study|Lack of Efficacy|1
5625664|NCT00730756|19432620|P2|Overall Study|Adverse Event|0
5625665|NCT00730756|19432621|P1|Overall Study|Adverse Event|2
5625666|NCT00730691|19432655|P5|Overall Study|Other|2
5625667|NCT00730691|19432656|P4|Overall Study|Other|2
5625668|NCT00730691|19432657|P3|Overall Study|Other|1
5625669|NCT00730691|19432658|P2|Overall Study|Other|1
5625670|NCT00730691|19432659|P1|Overall Study|Other|1
5625671|NCT00730691|19432655|P5|Overall Study|Lost to Follow-up|13
5625672|NCT00730691|19432656|P4|Overall Study|Lost to Follow-up|15
5625673|NCT00730691|19432657|P3|Overall Study|Lost to Follow-up|13
5625674|NCT00730691|19432658|P2|Overall Study|Lost to Follow-up|8
5625675|NCT00730691|19432659|P1|Overall Study|Lost to Follow-up|11
5625676|NCT00730691|19432655|P5|Overall Study|Withdrawal of Consent|3
5625677|NCT00730691|19432656|P4|Overall Study|Withdrawal of Consent|6
5625678|NCT00730691|19432657|P3|Overall Study|Withdrawal of Consent|3
5625679|NCT00730691|19432658|P2|Overall Study|Withdrawal of Consent|9
5625680|NCT00730691|19432659|P1|Overall Study|Withdrawal of Consent|7
5625681|NCT00730691|19432655|P5|Overall Study|Protocol Deviations|5
5625682|NCT00730691|19432656|P4|Overall Study|Protocol Deviations|7
5625683|NCT00730691|19432657|P3|Overall Study|Protocol Deviations|3
5625684|NCT00730691|19432658|P2|Overall Study|Protocol Deviations|5
5625685|NCT00730691|19432659|P1|Overall Study|Protocol Deviations|3
5625686|NCT00730691|19432655|P5|Overall Study|Non-compliance with Study Drug|3
5625687|NCT00730691|19432656|P4|Overall Study|Non-compliance with Study Drug|3
5625688|NCT00730691|19432657|P3|Overall Study|Non-compliance with Study Drug|6
5625689|NCT00730691|19432658|P2|Overall Study|Non-compliance with Study Drug|1
5625690|NCT00730691|19432659|P1|Overall Study|Non-compliance with Study Drug|6
5625691|NCT00730691|19432655|P5|Overall Study|Lack of Efficacy|1
5625692|NCT00730691|19432656|P4|Overall Study|Lack of Efficacy|1
5625693|NCT00730691|19432657|P3|Overall Study|Lack of Efficacy|2
5625694|NCT00730691|19432658|P2|Overall Study|Lack of Efficacy|4
5625695|NCT00730691|19432659|P1|Overall Study|Lack of Efficacy|4
5625696|NCT00730691|19432655|P5|Overall Study|Adverse Event|23
5625697|NCT00730691|19432656|P4|Overall Study|Adverse Event|11
5625698|NCT00730691|19432657|P3|Overall Study|Adverse Event|11
5625699|NCT00730691|19432658|P2|Overall Study|Adverse Event|8
5625700|NCT00730691|19432659|P1|Overall Study|Adverse Event|4
5625701|NCT00730639|19432751|P5|Overall Study|Treatment on-going|4
5625702|NCT00730639|19432752|P4|Overall Study|Treatment on-going|4
5625703|NCT00730639|19432753|P3|Overall Study|Treatment on-going|5
5625704|NCT00730639|19432754|P2|Overall Study|Treatment on-going|5
5625705|NCT00730639|19432755|P1|Overall Study|Treatment on-going|2
5625706|NCT00730639|19432751|P5|Overall Study|Withdrawal by Subject|4
5625707|NCT00730639|19432752|P4|Overall Study|Withdrawal by Subject|3
5625708|NCT00730639|19432753|P3|Overall Study|Withdrawal by Subject|6
5625709|NCT00730639|19432754|P2|Overall Study|Withdrawal by Subject|0
5625710|NCT00730639|19432755|P1|Overall Study|Withdrawal by Subject|0
5625711|NCT00730639|19432751|P5|Overall Study|Protocol Violation|0
5625712|NCT00730639|19432752|P4|Overall Study|Protocol Violation|0
5625713|NCT00730639|19432753|P3|Overall Study|Protocol Violation|1
5625714|NCT00730639|19432754|P2|Overall Study|Protocol Violation|0
5625715|NCT00730639|19432755|P1|Overall Study|Protocol Violation|0
5625716|NCT00730639|19432751|P5|Overall Study|non-specified|3
5625717|NCT00730639|19432752|P4|Overall Study|non-specified|2
5625718|NCT00730639|19432753|P3|Overall Study|non-specified|4
5625719|NCT00730639|19432754|P2|Overall Study|non-specified|0
5625720|NCT00730639|19432755|P1|Overall Study|non-specified|0
5625721|NCT00730639|19432751|P5|Overall Study|Disease Progression|88
5625722|NCT00730639|19432752|P4|Overall Study|Disease Progression|32
5625723|NCT00730639|19432753|P3|Overall Study|Disease Progression|48
5625724|NCT00730639|19432754|P2|Overall Study|Disease Progression|13
5625725|NCT00730639|19432755|P1|Overall Study|Disease Progression|12
5625726|NCT00730639|19432751|P5|Overall Study|Death|2
5625727|NCT00730639|19432752|P4|Overall Study|Death|0
5625728|NCT00730639|19432753|P3|Overall Study|Death|0
5625729|NCT00730639|19432754|P2|Overall Study|Death|0
5625730|NCT00730639|19432755|P1|Overall Study|Death|0
5625731|NCT00730639|19432751|P5|Overall Study|Completed Maximum Cycles|6
5625732|NCT00730639|19432752|P4|Overall Study|Completed Maximum Cycles|3
5625733|NCT00730639|19432753|P3|Overall Study|Completed Maximum Cycles|11
5625734|NCT00730639|19432754|P2|Overall Study|Completed Maximum Cycles|0
5625735|NCT00730639|19432755|P1|Overall Study|Completed Maximum Cycles|0
5625736|NCT00730639|19432751|P5|Overall Study|Complete Response|1
5625737|NCT00730639|19432752|P4|Overall Study|Complete Response|2
5625738|NCT00730639|19432753|P3|Overall Study|Complete Response|2
5625739|NCT00730639|19432754|P2|Overall Study|Complete Response|0
5625740|NCT00730639|19432755|P1|Overall Study|Complete Response|0
5625741|NCT00730639|19432751|P5|Overall Study|Adverse Event|23
5625742|NCT00730639|19432752|P4|Overall Study|Adverse Event|8
5625743|NCT00730639|19432753|P3|Overall Study|Adverse Event|9
5625744|NCT00730639|19432754|P2|Overall Study|Adverse Event|0
5625745|NCT00730639|19432755|P1|Overall Study|Adverse Event|3
5625746|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
5625747|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
5625748|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
5625749|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
5625750|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
5625751|NCT00730405|19432843|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
5625752|NCT00730405|19432844|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
5625753|NCT00730405|19432845|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
5625754|NCT00730405|19432846|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
5625755|NCT00730405|19432847|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
5625756|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Other Protocol violation|0
5625757|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Other Protocol violation|0
5625758|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Other Protocol violation|1
5625759|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Other Protocol violation|0
5625760|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Other Protocol violation|0
5625761|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Mis-randomized|0
5625762|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Mis-randomized|0
5625763|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Mis-randomized|0
5625764|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Mis-randomized|1
5625765|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Mis-randomized|0
5625766|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
5625767|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
5625768|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
5625769|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
5625770|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
5625771|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
5625772|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
5625773|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
5625774|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
5625775|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
5625776|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Missing|0
5625777|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Missing|0
5625778|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Missing|2
5625779|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Missing|0
5625780|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Missing|0
5625781|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Non-compliance|0
5625782|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Non-compliance|0
5625783|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Non-compliance|2
5625784|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Non-compliance|0
5625785|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Non-compliance|1
5625786|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Use of restricted medication|0
5625787|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Use of restricted medication|0
5625788|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Use of restricted medication|0
5625789|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Use of restricted medication|1
5625790|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Use of restricted medication|0
5625791|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
5625792|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
5625793|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
5625794|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
5625795|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
5625796|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
5625797|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
5625798|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
5625799|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
5625800|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
5625801|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
5625802|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
5625803|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
5625804|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
5625805|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
5625806|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
5625807|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
5625808|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
5625809|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
5625810|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
5625811|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
5625812|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
5625813|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
5625814|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
5625815|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
5625816|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
5625817|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
5625818|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
5625819|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
5625820|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
5625821|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
5625822|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
5625823|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
5625824|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
5625825|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
5625826|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Did not met eligibility|0
5625827|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Did not met eligibility|0
5625828|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Did not met eligibility|1
5625829|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Did not met eligibility|0
5625830|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Did not met eligibility|0
5625831|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Change of location|0
5625832|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Change of location|1
5625833|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Change of location|0
5625834|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Change of location|1
5625835|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Change of location|1
5625836|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Death|0
5625837|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Death|1
5625838|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Death|0
5625839|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Death|1
5625840|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Death|0
5625841|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
5625842|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
5625843|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
5625844|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
5625845|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
5625846|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
5625847|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
5625848|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
5625849|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
5625850|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
5625851|NCT00730405|19432843|P5|Overall Study-follow-up Phase|Adverse Event|4
5625852|NCT00730405|19432844|P4|Overall Study-follow-up Phase|Adverse Event|3
5625853|NCT00730405|19432845|P3|Overall Study-follow-up Phase|Adverse Event|2
5625854|NCT00730405|19432846|P2|Overall Study-follow-up Phase|Adverse Event|6
5625855|NCT00730405|19432847|P1|Overall Study-follow-up Phase|Adverse Event|2
5625856|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
5625857|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
5625858|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
5625859|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
5625860|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
5625861|NCT00730405|19432843|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
5625862|NCT00730405|19432844|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
5625863|NCT00730405|19432845|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
5625864|NCT00730405|19432846|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
5625865|NCT00730405|19432847|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
5625866|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Pregnancy|0
5625867|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Pregnancy|0
5625868|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Pregnancy|0
5625869|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Pregnancy|1
5625870|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Pregnancy|0
5625871|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Change of location|0
5625872|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Change of location|1
5625873|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Change of location|0
5625874|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Change of location|0
5625875|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Change of location|0
5625876|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
5625877|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
5625878|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
5625879|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
5625880|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
5625881|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
5625882|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
5625883|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
5625884|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
5625885|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
5625886|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Study drug interrupted|0
5625887|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Study drug interrupted|0
5625888|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Study drug interrupted|0
5625889|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Study drug interrupted|1
5625890|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Study drug interrupted|0
5625891|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Misrandomized|0
5625892|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Misrandomized|0
5625893|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Misrandomized|0
5625894|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Misrandomized|1
5625895|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Misrandomized|0
5625896|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
5625897|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
5625898|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
5625899|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
5625900|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
5625901|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
5625902|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
5625903|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
5625904|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
5625905|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
5625906|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
5625907|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
5625908|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
5625909|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
5625910|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
5625911|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
5625912|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
5625913|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
5625914|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
5625915|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
5625916|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
5625917|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
5625918|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
5625919|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
5625920|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
5625921|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Did not met eligibility|0
5625922|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Did not met eligibility|0
5625923|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Did not met eligibility|1
5625924|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Did not met eligibility|0
5625925|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Did not met eligibility|0
5625926|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
5625927|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
5625928|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
5625929|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
5625930|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
5625931|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
5625932|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
5625933|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
5625934|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
5625935|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
5625936|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
5625937|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
5625938|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
5625939|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
5625940|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
5625941|NCT00730405|19432843|P5|Overall Study-Treatment Phase|Adverse Event|4
5625942|NCT00730405|19432844|P4|Overall Study-Treatment Phase|Adverse Event|8
5625943|NCT00730405|19432845|P3|Overall Study-Treatment Phase|Adverse Event|4
5625944|NCT00730405|19432846|P2|Overall Study-Treatment Phase|Adverse Event|10
5625945|NCT00730405|19432847|P1|Overall Study-Treatment Phase|Adverse Event|5
5625946|NCT00730327|19432894|P2|Overall Study|Subject withdrew (reason not specified)|7
5625947|NCT00730327|19432895|P1|Overall Study|Subject withdrew (reason not specified)|2
5625948|NCT00730327|19432894|P2|Overall Study|Withdrawal by Subject|13
5625949|NCT00730327|19432895|P1|Overall Study|Withdrawal by Subject|3
5625950|NCT00730327|19432894|P2|Overall Study|Adverse Event|1
5625951|NCT00730327|19432895|P1|Overall Study|Adverse Event|8
5625952|NCT00730327|19432894|P2|Overall Study|Lost to Follow-up|16
5625953|NCT00730327|19432895|P1|Overall Study|Lost to Follow-up|14
5625954|NCT00730275|19432920|P4|Overall Study|Withdrawal by Subject|1
5625955|NCT00730275|19432921|P3|Overall Study|Withdrawal by Subject|0
5625956|NCT00730275|19432922|P2|Overall Study|Withdrawal by Subject|0
5625957|NCT00730275|19432923|P1|Overall Study|Withdrawal by Subject|0
5625958|NCT00730236|19432949|P1|Overall Study|Non-compliance|1
5625959|NCT00730236|19432949|P1|Overall Study|Withdrawal by Subject|1
5625960|NCT00730236|19432949|P1|Overall Study|Adverse Event|4
5625961|NCT00730171|19432964|P1|Overall Study|Other|61
5625962|NCT00730171|19432964|P1|Overall Study|Insufficient Therapeutic Response|141
5625963|NCT00730171|19432964|P1|Overall Study|Lost to Follow-up|121
5625964|NCT00730171|19432964|P1|Overall Study|Withdrawal by Subject|202
5625965|NCT00730171|19432964|P1|Overall Study|Protocol Violation|48
5625966|NCT00730171|19432964|P1|Overall Study|Adverse Event|193
5625967|NCT00730171|19432964|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
5625968|NCT00730158|19432974|P2|Overall Study|Withdrawal by Subject|1
5625969|NCT00730158|19432975|P1|Overall Study|Withdrawal by Subject|1
5625970|NCT00730132|19433013|P1|Overall Study|Death|1
5625971|NCT00730132|19433013|P1|Overall Study|Protocol Violation|154
5625972|NCT00730041|19433031|P2|Overall Study|Lost to Follow-up|2
5625973|NCT00730041|19433032|P1|Overall Study|Lost to Follow-up|0
5625974|NCT00730028|19433055|P5|Overall Study|Randomization Error|2
5625975|NCT00730028|19433056|P4|Overall Study|Randomization Error|0
5625976|NCT00730028|19433057|P3|Overall Study|Randomization Error|0
5625977|NCT00730028|19433058|P2|Overall Study|Randomization Error|0
5625978|NCT00730028|19433059|P1|Overall Study|Randomization Error|1
5625979|NCT00730028|19433055|P5|Overall Study|Treatment Failure|1
5625980|NCT00730028|19433056|P4|Overall Study|Treatment Failure|0
5625981|NCT00730028|19433057|P3|Overall Study|Treatment Failure|0
5625982|NCT00730028|19433058|P2|Overall Study|Treatment Failure|5
5625983|NCT00730028|19433059|P1|Overall Study|Treatment Failure|5
5625984|NCT00730028|19433055|P5|Overall Study|Physician Decision|2
5625985|NCT00730028|19433056|P4|Overall Study|Physician Decision|3
5625986|NCT00730028|19433057|P3|Overall Study|Physician Decision|2
5625987|NCT00730028|19433058|P2|Overall Study|Physician Decision|3
5625988|NCT00730028|19433059|P1|Overall Study|Physician Decision|3
5625989|NCT00730028|19433055|P5|Overall Study|Withdrawal by Subject|9
5625990|NCT00730028|19433056|P4|Overall Study|Withdrawal by Subject|5
5625991|NCT00730028|19433057|P3|Overall Study|Withdrawal by Subject|4
5625992|NCT00730028|19433058|P2|Overall Study|Withdrawal by Subject|5
5625993|NCT00730028|19433059|P1|Overall Study|Withdrawal by Subject|9
5625994|NCT00730028|19433055|P5|Overall Study|Protocol Violation|0
5625995|NCT00730028|19433056|P4|Overall Study|Protocol Violation|2
5625996|NCT00730028|19433057|P3|Overall Study|Protocol Violation|1
5625997|NCT00730028|19433058|P2|Overall Study|Protocol Violation|1
5625998|NCT00730028|19433059|P1|Overall Study|Protocol Violation|6
5625999|NCT00730028|19433055|P5|Overall Study|Lost to Follow-up|25
5626000|NCT00730028|19433056|P4|Overall Study|Lost to Follow-up|26
5626001|NCT00730028|19433057|P3|Overall Study|Lost to Follow-up|22
5626002|NCT00730028|19433058|P2|Overall Study|Lost to Follow-up|26
5626003|NCT00730028|19433059|P1|Overall Study|Lost to Follow-up|13
5626004|NCT00730028|19433055|P5|Overall Study|Adverse Event|43
5626005|NCT00730028|19433056|P4|Overall Study|Adverse Event|20
5626006|NCT00730028|19433057|P3|Overall Study|Adverse Event|16
5626007|NCT00730028|19433058|P2|Overall Study|Adverse Event|26
5626008|NCT00730028|19433059|P1|Overall Study|Adverse Event|23
5626009|NCT00730015|19433109|P3|Overall Study|Other Reason|1
5626010|NCT00730015|19433110|P2|Overall Study|Other Reason|0
5626011|NCT00730015|19433111|P1|Overall Study|Other Reason|1
5626012|NCT00730015|19433109|P3|Overall Study|Lack of Efficacy|8
5626013|NCT00730015|19433110|P2|Overall Study|Lack of Efficacy|2
5626014|NCT00730015|19433111|P1|Overall Study|Lack of Efficacy|1
5626015|NCT00730015|19433109|P3|Overall Study|Lost to Follow-up|3
5626016|NCT00730015|19433110|P2|Overall Study|Lost to Follow-up|10
5626017|NCT00730015|19433111|P1|Overall Study|Lost to Follow-up|4
5626018|NCT00730015|19433109|P3|Overall Study|Withdrawal by Subject|8
5626019|NCT00730015|19433110|P2|Overall Study|Withdrawal by Subject|12
5626020|NCT00730015|19433111|P1|Overall Study|Withdrawal by Subject|12
5626021|NCT00730015|19433109|P3|Overall Study|Protocol Violation|4
5626022|NCT00730015|19433110|P2|Overall Study|Protocol Violation|6
5626023|NCT00730015|19433111|P1|Overall Study|Protocol Violation|2
5626024|NCT00730015|19433109|P3|Overall Study|Adverse Event|8
5626025|NCT00730015|19433110|P2|Overall Study|Adverse Event|10
5626026|NCT00730015|19433111|P1|Overall Study|Adverse Event|11
5626027|NCT00729937|19433151|P6|Overall Study|Incarcerated|0
5626028|NCT00729937|19433152|P5|Overall Study|Incarcerated|0
5626029|NCT00729937|19433153|P4|Overall Study|Incarcerated|1
5626030|NCT00729937|19433154|P3|Overall Study|Incarcerated|1
5626031|NCT00729937|19433155|P2|Overall Study|Incarcerated|2
5626032|NCT00729937|19433156|P1|Overall Study|Incarcerated|0
5626033|NCT00729937|19433151|P6|Overall Study|Did not meet eligibility criteria|0
5626034|NCT00729937|19433152|P5|Overall Study|Did not meet eligibility criteria|0
5626035|NCT00729937|19433153|P4|Overall Study|Did not meet eligibility criteria|0
5626036|NCT00729937|19433154|P3|Overall Study|Did not meet eligibility criteria|0
5626037|NCT00729937|19433155|P2|Overall Study|Did not meet eligibility criteria|1
5626038|NCT00729937|19433156|P1|Overall Study|Did not meet eligibility criteria|2
5626039|NCT00729937|19433151|P6|Overall Study|Randomized but not treated|3
5626040|NCT00729937|19433152|P5|Overall Study|Randomized but not treated|1
5626041|NCT00729937|19433153|P4|Overall Study|Randomized but not treated|0
5626042|NCT00729937|19433154|P3|Overall Study|Randomized but not treated|1
5626043|NCT00729937|19433155|P2|Overall Study|Randomized but not treated|6
5626044|NCT00729937|19433156|P1|Overall Study|Randomized but not treated|12
5626045|NCT00729937|19433151|P6|Overall Study|Withdrawal by Subject|2
5626046|NCT00729937|19433152|P5|Overall Study|Withdrawal by Subject|4
5626047|NCT00729937|19433153|P4|Overall Study|Withdrawal by Subject|0
5626048|NCT00729937|19433154|P3|Overall Study|Withdrawal by Subject|6
5626049|NCT00729937|19433155|P2|Overall Study|Withdrawal by Subject|5
5626050|NCT00729937|19433156|P1|Overall Study|Withdrawal by Subject|3
5626051|NCT00729937|19433151|P6|Overall Study|Death|1
5626052|NCT00729937|19433152|P5|Overall Study|Death|0
5626053|NCT00729937|19433153|P4|Overall Study|Death|0
5626054|NCT00729937|19433154|P3|Overall Study|Death|1
5626055|NCT00729937|19433155|P2|Overall Study|Death|0
5626056|NCT00729937|19433156|P1|Overall Study|Death|1
5626057|NCT00729937|19433151|P6|Overall Study|Physician Decision|8
5626058|NCT00729937|19433152|P5|Overall Study|Physician Decision|5
5626059|NCT00729937|19433153|P4|Overall Study|Physician Decision|0
5626060|NCT00729937|19433154|P3|Overall Study|Physician Decision|2
5626061|NCT00729937|19433155|P2|Overall Study|Physician Decision|16
5626062|NCT00729937|19433156|P1|Overall Study|Physician Decision|7
5626063|NCT00729937|19433151|P6|Overall Study|Lost to Follow-up|23
5626064|NCT00729937|19433152|P5|Overall Study|Lost to Follow-up|18
5626065|NCT00729937|19433153|P4|Overall Study|Lost to Follow-up|33
5626066|NCT00729937|19433154|P3|Overall Study|Lost to Follow-up|18
5626067|NCT00729937|19433155|P2|Overall Study|Lost to Follow-up|58
5626068|NCT00729937|19433156|P1|Overall Study|Lost to Follow-up|49
5626069|NCT00729859|19433360|P3|Overall Study|Withdrawal by Subject|0
5626070|NCT00729859|19433361|P2|Overall Study|Withdrawal by Subject|1
5626071|NCT00729859|19433362|P1|Overall Study|Withdrawal by Subject|0
5626072|NCT00729859|19433360|P3|Overall Study|Adverse Event|0
5626073|NCT00729859|19433361|P2|Overall Study|Adverse Event|1
5626074|NCT00729859|19433362|P1|Overall Study|Adverse Event|0
5626075|NCT00729833|19433406|P4|Overall Study|Unspecified Reasons|1
5626076|NCT00729833|19433407|P3|Overall Study|Unspecified Reasons|5
5626077|NCT00729833|19433408|P2|Overall Study|Unspecified Reasons|5
5626078|NCT00729833|19433409|P1|Overall Study|Unspecified Reasons|11
5626079|NCT00729833|19433406|P4|Overall Study|Withdrawal by Subject|0
5626080|NCT00729833|19433407|P3|Overall Study|Withdrawal by Subject|3
5626081|NCT00729833|19433408|P2|Overall Study|Withdrawal by Subject|1
5626082|NCT00729833|19433409|P1|Overall Study|Withdrawal by Subject|3
5626083|NCT00729833|19433406|P4|Overall Study|Lost to Follow-up|0
5626084|NCT00729833|19433407|P3|Overall Study|Lost to Follow-up|0
5626085|NCT00729833|19433408|P2|Overall Study|Lost to Follow-up|0
5626086|NCT00729833|19433409|P1|Overall Study|Lost to Follow-up|1
5626087|NCT00729833|19433406|P4|Overall Study|Study Terminated by Sponsor|0
5626088|NCT00729833|19433407|P3|Overall Study|Study Terminated by Sponsor|1
5626089|NCT00729833|19433408|P2|Overall Study|Study Terminated by Sponsor|0
5626090|NCT00729833|19433409|P1|Overall Study|Study Terminated by Sponsor|0
5626091|NCT00729833|19433406|P4|Overall Study|Death|5
5626092|NCT00729833|19433407|P3|Overall Study|Death|3
5626093|NCT00729833|19433408|P2|Overall Study|Death|1
5626094|NCT00729833|19433409|P1|Overall Study|Death|5
5626095|NCT00729690|19433467|P3|Overall Study|IT Catheter Malfunction|2
5626096|NCT00729690|19433468|P2|Overall Study|IT Catheter Malfunction|2
5626097|NCT00729690|19433469|P1|Overall Study|IT Catheter Malfunction|0
5626098|NCT00729651|19433499|P2|Overall Study|Subject's private reason|0
5626099|NCT00729651|19433500|P1|Overall Study|Subject's private reason|2
5626100|NCT00729651|19433499|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
5626101|NCT00729651|19433500|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
5626102|NCT00729651|19433499|P2|Overall Study|Adverse Event|3
5626103|NCT00729651|19433500|P1|Overall Study|Adverse Event|7
5626104|NCT00729651|19433499|P2|Overall Study|Protocol Violation|1
5626105|NCT00729651|19433500|P1|Overall Study|Protocol Violation|0
5626106|NCT00729651|19433499|P2|Overall Study|Lost to Follow-up|4
5626107|NCT00729651|19433500|P1|Overall Study|Lost to Follow-up|5
5626108|NCT00729651|19433499|P2|Overall Study|Withdrawal by Subject|6
5626109|NCT00729651|19433500|P1|Overall Study|Withdrawal by Subject|5
5626110|NCT00729612|19433512|P1|Overall Study|Non evaluable for response|10
5626111|NCT00729586|19433521|P2|Overall Study|never treated|0
5626112|NCT00729586|19433522|P1|Overall Study|never treated|1
5626113|NCT00729586|19433521|P2|Overall Study|Ineligible|1
5626114|NCT00729586|19433522|P1|Overall Study|Ineligible|0
5626115|NCT00729560|19433535|P1|Overall Study|Withdrawal by Subject|3
5626116|NCT00729469|19433561|P2|Overall Study|Other-Not mentioned|4
5626117|NCT00729469|19433562|P1|Overall Study|Other-Not mentioned|9
5626118|NCT00729469|19433561|P2|Overall Study|Withdrawal by Subject|8
5626119|NCT00729469|19433562|P1|Overall Study|Withdrawal by Subject|19
5626120|NCT00729469|19433561|P2|Overall Study|Protocol Violation|1
5626121|NCT00729469|19433562|P1|Overall Study|Protocol Violation|2
5626122|NCT00729469|19433561|P2|Overall Study|Lost to Follow-up|9
5626123|NCT00729469|19433562|P1|Overall Study|Lost to Follow-up|9
5626124|NCT00729469|19433561|P2|Overall Study|Adverse Event|25
5626125|NCT00729469|19433562|P1|Overall Study|Adverse Event|14
5626126|NCT00729378|19433615|P2|36-months|Lost to Follow-up|6
5626127|NCT00729378|19433616|P1|36-months|Lost to Follow-up|15
5626128|NCT00729378|19433615|P2|24-months|Lost to Follow-up|51
5626129|NCT00729378|19433616|P1|24-months|Lost to Follow-up|72
5626130|NCT00729378|19433615|P2|12-months|Lost to Follow-up|65
5626131|NCT00729378|19433616|P1|12-months|Lost to Follow-up|100
5626132|NCT00729378|19433615|P2|Baseline|Withdrawal by Subject|59
5626133|NCT00729378|19433616|P1|Baseline|Withdrawal by Subject|66
5626134|NCT00729378|19433615|P2|Baseline|Did not complete study measurements|33
5626135|NCT00729378|19433616|P1|Baseline|Did not complete study measurements|72
5626136|NCT00729365|19433815|P3|Overall Study|Physician Decision|7
5626137|NCT00729365|19433816|P2|Overall Study|Physician Decision|6
5626138|NCT00729365|19433817|P1|Overall Study|Physician Decision|33
5626139|NCT00729326|19433830|P2|Overall Study|Sponsor Decision|2
5626140|NCT00729326|19433831|P1|Overall Study|Sponsor Decision|1
5626141|NCT00729326|19433830|P2|Overall Study|Subject Decision|4
5626142|NCT00729326|19433831|P1|Overall Study|Subject Decision|4
5626143|NCT00729326|19433830|P2|Overall Study|Protocol Violation|2
5626144|NCT00729326|19433831|P1|Overall Study|Protocol Violation|3
5626145|NCT00729326|19433830|P2|Overall Study|Physician Decision|1
5626146|NCT00729326|19433831|P1|Overall Study|Physician Decision|0
5626147|NCT00729326|19433830|P2|Overall Study|Lost to Follow-up|0
5626148|NCT00729326|19433831|P1|Overall Study|Lost to Follow-up|2
5626149|NCT00729248|19433873|P1|Overall Study|Physician Decision|2
5626150|NCT00729183|19433880|P2|Overall Study|Withdrawal by Subject|7
5626151|NCT00729183|19433881|P1|Overall Study|Withdrawal by Subject|9
5626152|NCT00729183|19433880|P2|Overall Study|Protocol Violation|0
5626153|NCT00729183|19433881|P1|Overall Study|Protocol Violation|1
5626154|NCT00729183|19433880|P2|Overall Study|Physician Decision|1
5626155|NCT00729183|19433881|P1|Overall Study|Physician Decision|1
5626156|NCT00729183|19433880|P2|Overall Study|Lost to Follow-up|1
5626157|NCT00729183|19433881|P1|Overall Study|Lost to Follow-up|3
5626158|NCT00729183|19433880|P2|Overall Study|Lack of Efficacy|1
5626159|NCT00729183|19433881|P1|Overall Study|Lack of Efficacy|0
5626160|NCT00729183|19433880|P2|Overall Study|Adverse Event|5
5626161|NCT00729183|19433881|P1|Overall Study|Adverse Event|11
5626162|NCT00729157|19433913|P1|Overall Study|Withdrawal by Subject|1
5626163|NCT00728988|19433956|P2|Overall Study|Withdrawal by Subject|6
5626164|NCT00728988|19433957|P1|Overall Study|Withdrawal by Subject|2
5626165|NCT00728988|19433956|P2|Overall Study|Other|77
5626166|NCT00728988|19433957|P1|Overall Study|Other|85
5626167|NCT00728988|19433956|P2|Overall Study|Adverse Event|2
5626168|NCT00728988|19433957|P1|Overall Study|Adverse Event|3
5626169|NCT00728988|19433956|P2|Overall Study|Death|1
5626170|NCT00728988|19433957|P1|Overall Study|Death|1
5626171|NCT00728988|19433956|P2|Overall Study|Not Treated|2
5626172|NCT00728988|19433957|P1|Overall Study|Not Treated|2
5626173|NCT00728962|19433975|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
5626174|NCT00728962|19433975|P1|Permanent Prosthesis Placement|Adverse Event|3
5626175|NCT00728962|19433975|P1|Implant Placement Surgery|Protocol Violation|1
5626176|NCT00728962|19433975|P1|Implant Placement Surgery|Lost to Follow-up|1
5626177|NCT00728962|19433975|P1|Implant Placement Surgery|Adverse Event|8
5626178|NCT00728949|19433981|P2|Overall Study|On treatment at cutoff date|0
5626179|NCT00728949|19433982|P1|Overall Study|On treatment at cutoff date|1
5626180|NCT00728949|19433981|P2|Overall Study|Abnormal Lab Results|2
5626181|NCT00728949|19433982|P1|Overall Study|Abnormal Lab Results|0
5626182|NCT00728949|19433981|P2|Overall Study|Withdrawal by Subject|2
5626183|NCT00728949|19433982|P1|Overall Study|Withdrawal by Subject|2
5626184|NCT00728949|19433981|P2|Overall Study|Adverse Event|0
5626185|NCT00728949|19433982|P1|Overall Study|Adverse Event|8
5626186|NCT00728936|19434007|P7|Overall Study|Withdrawal by Subject|0
5626187|NCT00728936|19434008|P6|Overall Study|Withdrawal by Subject|1
5626188|NCT00728936|19434009|P5|Overall Study|Withdrawal by Subject|0
5626189|NCT00728936|19434010|P4|Overall Study|Withdrawal by Subject|0
5626190|NCT00728936|19434011|P3|Overall Study|Withdrawal by Subject|0
5626191|NCT00728936|19434012|P2|Overall Study|Withdrawal by Subject|0
5626192|NCT00728936|19434013|P1|Overall Study|Withdrawal by Subject|0
5626193|NCT00728884|19434046|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
5626194|NCT00728884|19434046|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
5626195|NCT00728754|19434082|P2|One Year Post Placement Follow-up|Adverse Event|0
5626196|NCT00728754|19434083|P1|One Year Post Placement Follow-up|Adverse Event|1
5626197|NCT00728754|19434082|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
5626198|NCT00728754|19434083|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
5626199|NCT00728754|19434082|P2|Permanent Prosthesis Placement|Adverse Event|1
5626200|NCT00728754|19434083|P1|Permanent Prosthesis Placement|Adverse Event|1
5626201|NCT00728689|19434112|P2|Washout Period (Days 4 - 10)|Death in family|0
5626202|NCT00728689|19434113|P1|Washout Period (Days 4 - 10)|Death in family|1
5626203|NCT00728494|19434142|P2|Overall Study|No data available|1
5626204|NCT00728494|19434143|P1|Overall Study|No data available|0
5626205|NCT00728494|19434142|P2|Overall Study|Lack of Efficacy|4
5626206|NCT00728494|19434143|P1|Overall Study|Lack of Efficacy|2
5626207|NCT00728494|19434142|P2|Overall Study|Withdrawal by Subject|2
5626208|NCT00728494|19434143|P1|Overall Study|Withdrawal by Subject|0
5626209|NCT00728494|19434142|P2|Overall Study|Adverse Event|0
5626210|NCT00728494|19434143|P1|Overall Study|Adverse Event|7
5626211|NCT00728481|19434161|P2|Overall Study|Incorrectly assigned to opposite arm|0
5626212|NCT00728481|19434162|P1|Overall Study|Incorrectly assigned to opposite arm|1
5626213|NCT00728481|19434161|P2|Overall Study|Study medication non-compliance|2
5626214|NCT00728481|19434162|P1|Overall Study|Study medication non-compliance|0
5626215|NCT00728481|19434161|P2|Overall Study|Adverse Event|1
5626216|NCT00728481|19434162|P1|Overall Study|Adverse Event|0
5626217|NCT00728481|19434161|P2|Overall Study|Withdrawal by Subject|1
5626218|NCT00728481|19434162|P1|Overall Study|Withdrawal by Subject|0
5626219|NCT00728468|19434178|P1|Overall Study|Study terminated by sponsor|1
5626220|NCT00728468|19434178|P1|Overall Study|Objective progression or relapse|9
5626221|NCT00728468|19434178|P1|Overall Study|Protocol Violation|4
5626222|NCT00728468|19434178|P1|Overall Study|Death|1
5626223|NCT00728468|19434178|P1|Overall Study|Enrolled but not treated|1
5626224|NCT00728416|19434202|P2|Overall Study|Withdrawal by Subject|0
5626225|NCT00728416|19434203|P1|Overall Study|Withdrawal by Subject|1
5626226|NCT00728416|19434202|P2|Overall Study|Treatment Failure|1
5626227|NCT00728416|19434203|P1|Overall Study|Treatment Failure|0
5626228|NCT00728416|19434202|P2|Overall Study|Adverse Event|1
5626229|NCT00728416|19434203|P1|Overall Study|Adverse Event|1
5626230|NCT00728182|19434219|P2|Overall Study|Protocol Noncompliance|1
5626231|NCT00728182|19434220|P1|Overall Study|Protocol Noncompliance|0
5626232|NCT00728182|19434219|P2|Overall Study|Death|2
5626233|NCT00728182|19434220|P1|Overall Study|Death|0
5626234|NCT00728182|19434219|P2|Overall Study|Lost to Follow-up|0
5626235|NCT00728182|19434220|P1|Overall Study|Lost to Follow-up|2
5626236|NCT00728182|19434219|P2|Overall Study|Adverse Event|0
5626237|NCT00728182|19434220|P1|Overall Study|Adverse Event|1
5626238|NCT00728130|19434248|P1|Overall Study|Physician Decision|1
5626239|NCT00728130|19434248|P1|Overall Study|Paperwork not completed in time|1
5626240|NCT00728130|19434248|P1|Overall Study|Withdrawal by Subject|1
5626241|NCT00727961|19434253|P1|Overall Study|Progression|30
5626242|NCT00727961|19434253|P1|Overall Study|Patient's refusal|2
5626243|NCT00727961|19434253|P1|Overall Study|Adverse Event|4
5626244|NCT00727961|19434253|P1|Overall Study|Lost to Follow-up|1
5626245|NCT00727909|19434263|P4|Overall Study|Death|0
5626246|NCT00727909|19434264|P3|Overall Study|Death|1
5626247|NCT00727909|19434265|P2|Overall Study|Death|0
5626248|NCT00727909|19434266|P1|Overall Study|Death|0
5626249|NCT00727909|19434263|P4|Overall Study|Withdrawal by Subject|5
5626250|NCT00727909|19434264|P3|Overall Study|Withdrawal by Subject|8
5626251|NCT00727909|19434265|P2|Overall Study|Withdrawal by Subject|11
5626252|NCT00727909|19434266|P1|Overall Study|Withdrawal by Subject|5
5626253|NCT00727844|19434363|P4|Initial Randomization|Physician Decision|0
5626254|NCT00727844|19434364|P3|Initial Randomization|Physician Decision|0
5626255|NCT00727844|19434365|P2|Initial Randomization|Physician Decision|0
5626256|NCT00727844|19434366|P1|Initial Randomization|Physician Decision|2
5626257|NCT00727714|19434380|P1|Overall Study|Lost to Follow-up|2
5626258|NCT00727649|19434390|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
5626259|NCT00727649|19434391|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
5626260|NCT00727649|19434390|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
5626261|NCT00727649|19434391|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
5626262|NCT00727649|19434390|P2|Second Intervention (4-weeks)|Death|0
5626263|NCT00727649|19434391|P1|Second Intervention (4-weeks)|Death|1
5626264|NCT00727649|19434390|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
5626265|NCT00727649|19434391|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
5626266|NCT00727649|19434390|P2|Wash-out (2-weeks)|Lost to Follow-up|1
5626267|NCT00727649|19434391|P1|Wash-out (2-weeks)|Lost to Follow-up|3
5626268|NCT00727649|19434390|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
5626269|NCT00727649|19434391|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
5626270|NCT00727649|19434390|P2|First Intervention (4-weeks)|Lost to Follow-up|2
5626271|NCT00727649|19434391|P1|First Intervention (4-weeks)|Lost to Follow-up|1
5626272|NCT00727571|19434433|P4|Overall Study|Other|0
5626273|NCT00727571|19434434|P3|Overall Study|Other|6
5626274|NCT00727571|19434435|P2|Overall Study|Other|4
5626275|NCT00727571|19434436|P1|Overall Study|Other|0
5626276|NCT00727571|19434433|P4|Overall Study|AE not leading to hospitalization|0
5626277|NCT00727571|19434434|P3|Overall Study|AE not leading to hospitalization|2
5626278|NCT00727571|19434435|P2|Overall Study|AE not leading to hospitalization|0
5626279|NCT00727571|19434436|P1|Overall Study|AE not leading to hospitalization|0
5626280|NCT00727571|19434433|P4|Overall Study|Hospitalization|1
5626281|NCT00727571|19434434|P3|Overall Study|Hospitalization|0
5626282|NCT00727571|19434435|P2|Overall Study|Hospitalization|1
5626283|NCT00727571|19434436|P1|Overall Study|Hospitalization|0
5626284|NCT00727571|19434433|P4|Overall Study|Dismissed from nursing home|0
5626285|NCT00727571|19434434|P3|Overall Study|Dismissed from nursing home|5
5626286|NCT00727571|19434435|P2|Overall Study|Dismissed from nursing home|9
5626287|NCT00727571|19434436|P1|Overall Study|Dismissed from nursing home|0
5626288|NCT00727571|19434433|P4|Overall Study|Subject Non Compliance|4
5626289|NCT00727571|19434434|P3|Overall Study|Subject Non Compliance|0
5626290|NCT00727571|19434435|P2|Overall Study|Subject Non Compliance|6
5626291|NCT00727571|19434436|P1|Overall Study|Subject Non Compliance|0
5626292|NCT00727571|19434433|P4|Overall Study|Withdrawal by Subject|0
5626293|NCT00727571|19434434|P3|Overall Study|Withdrawal by Subject|11
5626294|NCT00727571|19434435|P2|Overall Study|Withdrawal by Subject|10
5626295|NCT00727571|19434436|P1|Overall Study|Withdrawal by Subject|0
5626296|NCT00727571|19434433|P4|Overall Study|Physician Decision|0
5626297|NCT00727571|19434434|P3|Overall Study|Physician Decision|0
5626298|NCT00727571|19434435|P2|Overall Study|Physician Decision|5
5626299|NCT00727571|19434436|P1|Overall Study|Physician Decision|0
5626300|NCT00727571|19434433|P4|Overall Study|Death|1
5626301|NCT00727571|19434434|P3|Overall Study|Death|5
5626302|NCT00727571|19434435|P2|Overall Study|Death|19
5626303|NCT00727571|19434436|P1|Overall Study|Death|0
5626304|NCT00727571|19434433|P4|Overall Study|Ineligibility determined|0
5626305|NCT00727571|19434434|P3|Overall Study|Ineligibility determined|1
5626306|NCT00727571|19434435|P2|Overall Study|Ineligibility determined|1
5626307|NCT00727571|19434436|P1|Overall Study|Ineligibility determined|1
5626308|NCT00727558|19434463|P2|Overall Study|Lost to Follow-up|0
5626309|NCT00727558|19434464|P1|Overall Study|Lost to Follow-up|1
5626310|NCT00727558|19434463|P2|Overall Study|Subject unable to return for follow-up|1
5626311|NCT00727558|19434464|P1|Overall Study|Subject unable to return for follow-up|1
5626312|NCT00727558|19434463|P2|Overall Study|Adverse Event|1
5626313|NCT00727558|19434464|P1|Overall Study|Adverse Event|0
5626314|NCT00727558|19434463|P2|Overall Study|Lens issue|1
5626315|NCT00727558|19434464|P1|Overall Study|Lens issue|0
5626316|NCT00727532|19434482|P1|Overall Study|Withdrawal by Subject|1
5626317|NCT00727532|19434482|P1|Overall Study|Adverse Event|1
5626318|NCT00727506|19434494|P6|Overall Study|Other reason not described above|1
5626319|NCT00727506|19434495|P5|Overall Study|Other reason not described above|1
5626320|NCT00727506|19434496|P4|Overall Study|Other reason not described above|4
5626321|NCT00727506|19434497|P3|Overall Study|Other reason not described above|1
5626322|NCT00727506|19434498|P2|Overall Study|Other reason not described above|0
5626323|NCT00727506|19434499|P1|Overall Study|Other reason not described above|0
5626324|NCT00727506|19434494|P6|Overall Study|Refused to continue medication|2
5626325|NCT00727506|19434495|P5|Overall Study|Refused to continue medication|1
5626326|NCT00727506|19434496|P4|Overall Study|Refused to continue medication|3
5626327|NCT00727506|19434497|P3|Overall Study|Refused to continue medication|2
5626328|NCT00727506|19434498|P2|Overall Study|Refused to continue medication|1
5626329|NCT00727506|19434499|P1|Overall Study|Refused to continue medication|0
5626330|NCT00727506|19434494|P6|Overall Study|Progressive disease|28
5626331|NCT00727506|19434495|P5|Overall Study|Progressive disease|38
5626332|NCT00727506|19434496|P4|Overall Study|Progressive disease|28
5626333|NCT00727506|19434497|P3|Overall Study|Progressive disease|9
5626334|NCT00727506|19434498|P2|Overall Study|Progressive disease|7
5626335|NCT00727506|19434499|P1|Overall Study|Progressive disease|4
5626336|NCT00727506|19434494|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
5626337|NCT00727506|19434495|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
5626338|NCT00727506|19434496|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
5626339|NCT00727506|19434497|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
5626340|NCT00727506|19434498|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
5626341|NCT00727506|19434499|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
5626342|NCT00727506|19434494|P6|Overall Study|Adverse Event|8
5626343|NCT00727506|19434495|P5|Overall Study|Adverse Event|1
5626344|NCT00727506|19434496|P4|Overall Study|Adverse Event|4
5626345|NCT00727506|19434497|P3|Overall Study|Adverse Event|4
5626346|NCT00727506|19434498|P2|Overall Study|Adverse Event|0
5626347|NCT00727506|19434499|P1|Overall Study|Adverse Event|0
5626348|NCT00727441|19434595|P3|Overall Study|Withdrawal by Subject|0
5626349|NCT00727441|19434596|P2|Overall Study|Withdrawal by Subject|1
5626350|NCT00727441|19434597|P1|Overall Study|Withdrawal by Subject|0
5626351|NCT00727441|19434595|P3|Overall Study|Physician Decision|0
5626352|NCT00727441|19434596|P2|Overall Study|Physician Decision|1
5626353|NCT00727441|19434597|P1|Overall Study|Physician Decision|0
5626354|NCT00727441|19434595|P3|Overall Study|Death|1
5626355|NCT00727441|19434596|P2|Overall Study|Death|1
5626356|NCT00727441|19434597|P1|Overall Study|Death|0
5626357|NCT00727441|19434595|P3|Overall Study|Eligibility|7
5626358|NCT00727441|19434596|P2|Overall Study|Eligibility|5
5626359|NCT00727441|19434597|P1|Overall Study|Eligibility|7
5626360|NCT00727441|19434595|P3|Overall Study|Disease Progression|17
5626361|NCT00727441|19434596|P2|Overall Study|Disease Progression|14
5626362|NCT00727441|19434597|P1|Overall Study|Disease Progression|11
5626363|NCT00727415|19434617|P1|Phase I|Dose Limiting Toxicity|2
5626364|NCT00727402|19434626|P1|Overall Study|Physician Decision|116
5626365|NCT00727311|19434655|P1|Overall Study|Multiple reasons|39
5626366|NCT00727311|19434655|P1|Overall Study|Other|97
5626367|NCT00727311|19434655|P1|Overall Study|Withdrawal by Subject|77
5626368|NCT00727311|19434655|P1|Overall Study|Lost to Follow-up|73
5626369|NCT00727311|19434655|P1|Overall Study|Lack of Efficacy|242
5626370|NCT00727311|19434655|P1|Overall Study|Adverse Event|58
5626371|NCT00727311|19434655|P1|Overall Study|Missing end of therapy data|205
5626372|NCT00727311|19434655|P1|Overall Study|Did not receive drug|316
5626373|NCT00727272|19434668|P3|Washout Period B|Withdrawal by Subject|1
5626374|NCT00727272|19434669|P2|Washout Period B|Withdrawal by Subject|0
5626375|NCT00727272|19434670|P1|Washout Period B|Withdrawal by Subject|0
5626376|NCT00727272|19434668|P3|Washout Period A|Adverse Event|1
5626377|NCT00727272|19434669|P2|Washout Period A|Adverse Event|0
5626378|NCT00727272|19434670|P1|Washout Period A|Adverse Event|0
5626379|NCT00727259|19434687|P1|Overall Study|Not all questionnaires completed|1055
5626380|NCT00727246|19434696|P4|Overall Study|withdrawn|0
5626381|NCT00727246|19434697|P3|Overall Study|withdrawn|1
5626382|NCT00727246|19434698|P2|Overall Study|withdrawn|0
5626383|NCT00727246|19434699|P1|Overall Study|withdrawn|0
5626384|NCT00727246|19434696|P4|Overall Study|incidental finding|1
5626385|NCT00727246|19434697|P3|Overall Study|incidental finding|0
5626386|NCT00727246|19434698|P2|Overall Study|incidental finding|0
5626387|NCT00727246|19434699|P1|Overall Study|incidental finding|0
5626388|NCT00727246|19434696|P4|Overall Study|could not complete MRI|1
5626389|NCT00727246|19434697|P3|Overall Study|could not complete MRI|0
5626390|NCT00727246|19434698|P2|Overall Study|could not complete MRI|1
5626391|NCT00727246|19434699|P1|Overall Study|could not complete MRI|0
5626392|NCT00727194|19434722|P3|Treatment Period 2|Lack of Efficacy|0
5626393|NCT00727194|19434723|P2|Treatment Period 2|Lack of Efficacy|1
5626394|NCT00727194|19434724|P1|Treatment Period 2|Lack of Efficacy|0
5626395|NCT00727194|19434722|P3|Screening Period|History of thymoma|1
5626396|NCT00727194|19434723|P2|Screening Period|History of thymoma|0
5626397|NCT00727194|19434724|P1|Screening Period|History of thymoma|0
5626398|NCT00727194|19434722|P3|Screening Period|Severe infections|2
5626399|NCT00727194|19434723|P2|Screening Period|Severe infections|0
5626400|NCT00727194|19434724|P1|Screening Period|Severe infections|0
5626401|NCT00727194|19434722|P3|Screening Period|Not stable on concomitant MG therapy|2
5626402|NCT00727194|19434723|P2|Screening Period|Not stable on concomitant MG therapy|0
5626403|NCT00727194|19434724|P1|Screening Period|Not stable on concomitant MG therapy|0
5626404|NCT00727194|19434722|P3|Screening Period|Lacked AChR antibodies|5
5626405|NCT00727194|19434723|P2|Screening Period|Lacked AChR antibodies|0
5626406|NCT00727194|19434724|P1|Screening Period|Lacked AChR antibodies|0
5626407|NCT00727194|19434722|P3|Screening Period|Low QMG scores|6
5626408|NCT00727194|19434723|P2|Screening Period|Low QMG scores|0
5626409|NCT00727194|19434724|P1|Screening Period|Low QMG scores|0
5626410|NCT00727025|19434796|P1|Overall Study|Physician Decision|23
5626411|NCT00726999|19434808|P2|Overall Study|Protocol Violation|0
5626412|NCT00726999|19434809|P1|Overall Study|Protocol Violation|1
5626413|NCT00726999|19434808|P2|Overall Study|Withdrawal by Subject|0
5626414|NCT00726999|19434809|P1|Overall Study|Withdrawal by Subject|2
5626415|NCT00726999|19434808|P2|Overall Study|Physician Decision|1
5626416|NCT00726999|19434809|P1|Overall Study|Physician Decision|0
5626417|NCT00726986|19434821|P1|Maintenance Phase|Lack of Efficacy|2
5626418|NCT00726986|19434821|P1|Maintenance Phase|Adverse Event|1
5626419|NCT00726986|19434821|P1|Induction Phase|Secondary Disease|2
5626420|NCT00726986|19434821|P1|Induction Phase|Lack of Efficacy|5
5626421|NCT00726986|19434821|P1|Induction Phase|Death|2
5626422|NCT00726986|19434821|P1|Induction Phase|Withdrawal by Subject|2
5626423|NCT00726986|19434821|P1|Induction Phase|Adverse Event|4
5626424|NCT00726895|19434828|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5626425|NCT00726895|19434829|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5626426|NCT00726882|19434842|P1|Overall Study|Other|10
5626427|NCT00726882|19434842|P1|Overall Study|Lost to Follow-up|7
5626428|NCT00726882|19434842|P1|Overall Study|Withdrawal by Subject|5
5626429|NCT00726752|19434857|P1|Overall Study|Lack of Efficacy|6
5626430|NCT00726661|19434919|P2|Overall Study|Other|35
5626431|NCT00726661|19434920|P1|Overall Study|Other|47
5626432|NCT00726661|19434919|P2|Overall Study|Physician Decision|13
5626433|NCT00726661|19434920|P1|Overall Study|Physician Decision|25
5626434|NCT00726661|19434919|P2|Overall Study|Death|159
5626435|NCT00726661|19434920|P1|Overall Study|Death|475
5626436|NCT00726661|19434919|P2|Overall Study|Trial terminated by sponsor|187
5626437|NCT00726661|19434920|P1|Overall Study|Trial terminated by sponsor|214
5626438|NCT00726661|19434919|P2|Overall Study|Withdrawal by Subject|13
5626439|NCT00726661|19434920|P1|Overall Study|Withdrawal by Subject|17
5626440|NCT00726661|19434919|P2|Overall Study|Lost to Follow-up|11
5626441|NCT00726661|19434920|P1|Overall Study|Lost to Follow-up|36
5626442|NCT00726622|19434937|P2|Overall Study|Metastasis|0
5626443|NCT00726622|19434938|P1|Overall Study|Metastasis|2
5626444|NCT00726622|19434937|P2|Overall Study|Physician Decision|1
5626445|NCT00726622|19434938|P1|Overall Study|Physician Decision|0
5626446|NCT00726622|19434937|P2|Overall Study|Withdrawal by Subject|2
5626447|NCT00726622|19434938|P1|Overall Study|Withdrawal by Subject|16
5626448|NCT00726609|19434956|P1|Overall Study|Other|3
5626449|NCT00726609|19434956|P1|Overall Study|Missing|42
5626450|NCT00726609|19434956|P1|Overall Study|Other|16
5626451|NCT00726609|19434956|P1|Overall Study|Lack of Efficacy|25
5626452|NCT00726609|19434956|P1|Overall Study|Withdrawal by Subject|2
5626453|NCT00726609|19434956|P1|Overall Study|Adverse Event|10
5626454|NCT00726557|19434960|P1|Overall Study|Inclusion criteria not met|15
5626455|NCT00726557|19434960|P1|Overall Study|Treatment less than 3 months|17
5626456|NCT00726557|19434960|P1|Overall Study|No follow-up documentation available|55
5626457|NCT00726557|19434960|P1|Overall Study|No end of treatment documentation|37
5626458|NCT00726557|19434960|P1|Overall Study|Screening failure|4
5626459|NCT00726453|19434967|P2|38 mm Length Group|Death|3
5626460|NCT00726453|19434968|P1|38 mm Length Group|Death|0
5626461|NCT00726453|19434967|P2|Primary Enrollment Group|Withdrawal by Subject|0
5626462|NCT00726453|19434968|P1|Primary Enrollment Group|Withdrawal by Subject|13
5626463|NCT00726453|19434967|P2|Primary Enrollment Group|Death|0
5626464|NCT00726453|19434968|P1|Primary Enrollment Group|Death|18
5626465|NCT00726323|19434996|P2|Overall Study|Metastatic lesions inferred cyst|1
5626466|NCT00726323|19434997|P1|Overall Study|Metastatic lesions inferred cyst|0
5626467|NCT00726323|19434996|P2|Overall Study|Participant wished to discontinue|1
5626468|NCT00726323|19434997|P1|Overall Study|Participant wished to discontinue|0
5626469|NCT00726323|19434996|P2|Overall Study|Death|0
5626470|NCT00726323|19434997|P1|Overall Study|Death|1
5626471|NCT00726323|19434996|P2|Overall Study|Adverse Event|9
5626472|NCT00726323|19434997|P1|Overall Study|Adverse Event|9
5626473|NCT00726323|19434996|P2|Overall Study|Clinical progression|3
5626474|NCT00726323|19434997|P1|Overall Study|Clinical progression|0
5626475|NCT00726323|19434996|P2|Overall Study|Progressive disease|16
5626476|NCT00726323|19434997|P1|Overall Study|Progressive disease|23
5626477|NCT00726323|19434996|P2|Overall Study|Physician Decision|0
5626478|NCT00726323|19434997|P1|Overall Study|Physician Decision|1
5626479|NCT00726323|19434996|P2|Overall Study|Withdrawal by Subject|1
5626480|NCT00726323|19434997|P1|Overall Study|Withdrawal by Subject|3
5626481|NCT00726232|19435027|P8|Expansion Phase|Unspecified reason|0
5626482|NCT00726232|19435028|P7|Expansion Phase|Unspecified reason|1
5626483|NCT00726232|19435029|P6|Expansion Phase|Unspecified reason|0
5626484|NCT00726232|19435030|P5|Expansion Phase|Unspecified reason|0
5626485|NCT00726232|19435031|P4|Expansion Phase|Unspecified reason|0
5626486|NCT00726232|19435032|P3|Expansion Phase|Unspecified reason|0
5626487|NCT00726232|19435033|P2|Expansion Phase|Unspecified reason|0
5626488|NCT00726232|19435034|P1|Expansion Phase|Unspecified reason|0
5626489|NCT00726232|19435027|P8|Expansion Phase|Per Investigator: lack of response|7
5626490|NCT00726232|19435028|P7|Expansion Phase|Per Investigator: lack of response|1
5626491|NCT00726232|19435029|P6|Expansion Phase|Per Investigator: lack of response|0
5626492|NCT00726232|19435030|P5|Expansion Phase|Per Investigator: lack of response|0
5626493|NCT00726232|19435031|P4|Expansion Phase|Per Investigator: lack of response|0
5626494|NCT00726232|19435032|P3|Expansion Phase|Per Investigator: lack of response|0
5626495|NCT00726232|19435033|P2|Expansion Phase|Per Investigator: lack of response|0
5626496|NCT00726232|19435034|P1|Expansion Phase|Per Investigator: lack of response|0
5626497|NCT00726232|19435027|P8|Expansion Phase|Termination of the trial by sponsor|16
5626498|NCT00726232|19435028|P7|Expansion Phase|Termination of the trial by sponsor|10
5626499|NCT00726232|19435029|P6|Expansion Phase|Termination of the trial by sponsor|0
5626500|NCT00726232|19435030|P5|Expansion Phase|Termination of the trial by sponsor|0
5626501|NCT00726232|19435031|P4|Expansion Phase|Termination of the trial by sponsor|0
5626502|NCT00726232|19435032|P3|Expansion Phase|Termination of the trial by sponsor|0
5626503|NCT00726232|19435033|P2|Expansion Phase|Termination of the trial by sponsor|0
5626504|NCT00726232|19435034|P1|Expansion Phase|Termination of the trial by sponsor|0
5626505|NCT00726232|19435027|P8|Expansion Phase|Disease progression|0
5626506|NCT00726232|19435028|P7|Expansion Phase|Disease progression|4
5626507|NCT00726232|19435029|P6|Expansion Phase|Disease progression|0
5626508|NCT00726232|19435030|P5|Expansion Phase|Disease progression|0
5626509|NCT00726232|19435031|P4|Expansion Phase|Disease progression|0
5626510|NCT00726232|19435032|P3|Expansion Phase|Disease progression|0
5626511|NCT00726232|19435033|P2|Expansion Phase|Disease progression|0
5626512|NCT00726232|19435034|P1|Expansion Phase|Disease progression|0
5626513|NCT00726232|19435027|P8|Expansion Phase|Withdrawal by Subject|3
5626514|NCT00726232|19435028|P7|Expansion Phase|Withdrawal by Subject|2
5626515|NCT00726232|19435029|P6|Expansion Phase|Withdrawal by Subject|0
5626516|NCT00726232|19435030|P5|Expansion Phase|Withdrawal by Subject|0
5626517|NCT00726232|19435031|P4|Expansion Phase|Withdrawal by Subject|0
5626518|NCT00726232|19435032|P3|Expansion Phase|Withdrawal by Subject|0
5626519|NCT00726232|19435033|P2|Expansion Phase|Withdrawal by Subject|0
5626520|NCT00726232|19435034|P1|Expansion Phase|Withdrawal by Subject|0
5626521|NCT00726232|19435027|P8|Expansion Phase|Adverse Event|11
5626522|NCT00726232|19435028|P7|Expansion Phase|Adverse Event|6
5626523|NCT00726232|19435029|P6|Expansion Phase|Adverse Event|0
5626524|NCT00726232|19435030|P5|Expansion Phase|Adverse Event|0
5626525|NCT00726232|19435031|P4|Expansion Phase|Adverse Event|0
5626526|NCT00726232|19435032|P3|Expansion Phase|Adverse Event|0
5626527|NCT00726232|19435033|P2|Expansion Phase|Adverse Event|0
5626528|NCT00726232|19435034|P1|Expansion Phase|Adverse Event|0
5626529|NCT00726232|19435027|P8|Expansion Phase|Death|1
5626530|NCT00726232|19435028|P7|Expansion Phase|Death|0
5626531|NCT00726232|19435029|P6|Expansion Phase|Death|0
5626532|NCT00726232|19435030|P5|Expansion Phase|Death|0
5626533|NCT00726232|19435031|P4|Expansion Phase|Death|0
5626534|NCT00726232|19435032|P3|Expansion Phase|Death|0
5626535|NCT00726232|19435033|P2|Expansion Phase|Death|0
5626536|NCT00726232|19435034|P1|Expansion Phase|Death|0
5626537|NCT00726232|19435027|P8|Initial Phase (Dose-finding)|Unspecified reason|0
5626538|NCT00726232|19435028|P7|Initial Phase (Dose-finding)|Unspecified reason|0
5626539|NCT00726232|19435029|P6|Initial Phase (Dose-finding)|Unspecified reason|0
5626540|NCT00726232|19435030|P5|Initial Phase (Dose-finding)|Unspecified reason|0
5626541|NCT00726232|19435031|P4|Initial Phase (Dose-finding)|Unspecified reason|0
5626542|NCT00726232|19435032|P3|Initial Phase (Dose-finding)|Unspecified reason|0
5626543|NCT00726232|19435033|P2|Initial Phase (Dose-finding)|Unspecified reason|0
5626544|NCT00726232|19435034|P1|Initial Phase (Dose-finding)|Unspecified reason|1
5626545|NCT00726232|19435027|P8|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
5626546|NCT00726232|19435028|P7|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
5626547|NCT00726232|19435029|P6|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
5626548|NCT00726232|19435030|P5|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
5626549|NCT00726232|19435031|P4|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
5626550|NCT00726232|19435032|P3|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
5626551|NCT00726232|19435033|P2|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
5626552|NCT00726232|19435034|P1|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
5626553|NCT00726232|19435027|P8|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
5626554|NCT00726232|19435028|P7|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
5626555|NCT00726232|19435029|P6|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
5626556|NCT00726232|19435030|P5|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
5626557|NCT00726232|19435031|P4|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
5626558|NCT00726232|19435032|P3|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
5626559|NCT00726232|19435033|P2|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
5626560|NCT00726232|19435034|P1|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
5626561|NCT00726232|19435027|P8|Initial Phase (Dose-finding)|Disease progression|0
5626562|NCT00726232|19435028|P7|Initial Phase (Dose-finding)|Disease progression|0
5626563|NCT00726232|19435029|P6|Initial Phase (Dose-finding)|Disease progression|0
5626564|NCT00726232|19435030|P5|Initial Phase (Dose-finding)|Disease progression|0
5626565|NCT00726232|19435031|P4|Initial Phase (Dose-finding)|Disease progression|0
5626566|NCT00726232|19435032|P3|Initial Phase (Dose-finding)|Disease progression|0
5626567|NCT00726232|19435033|P2|Initial Phase (Dose-finding)|Disease progression|1
5626568|NCT00726232|19435034|P1|Initial Phase (Dose-finding)|Disease progression|3
5626569|NCT00726232|19435027|P8|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5626570|NCT00726232|19435028|P7|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5626571|NCT00726232|19435029|P6|Initial Phase (Dose-finding)|Withdrawal by Subject|2
5626572|NCT00726232|19435030|P5|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5626573|NCT00726232|19435031|P4|Initial Phase (Dose-finding)|Withdrawal by Subject|1
5626574|NCT00726232|19435032|P3|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5626575|NCT00726232|19435033|P2|Initial Phase (Dose-finding)|Withdrawal by Subject|0
5626576|NCT00726232|19435034|P1|Initial Phase (Dose-finding)|Withdrawal by Subject|2
5626577|NCT00726232|19435027|P8|Initial Phase (Dose-finding)|Adverse Event|0
5626578|NCT00726232|19435028|P7|Initial Phase (Dose-finding)|Adverse Event|0
5626579|NCT00726232|19435029|P6|Initial Phase (Dose-finding)|Adverse Event|3
5626580|NCT00726232|19435030|P5|Initial Phase (Dose-finding)|Adverse Event|7
5626581|NCT00726232|19435031|P4|Initial Phase (Dose-finding)|Adverse Event|1
5626582|NCT00726232|19435032|P3|Initial Phase (Dose-finding)|Adverse Event|2
5626583|NCT00726232|19435033|P2|Initial Phase (Dose-finding)|Adverse Event|2
5626584|NCT00726232|19435034|P1|Initial Phase (Dose-finding)|Adverse Event|2
5626585|NCT00726232|19435027|P8|Initial Phase (Dose-finding)|Death|0
5626586|NCT00726232|19435028|P7|Initial Phase (Dose-finding)|Death|0
5626587|NCT00726232|19435029|P6|Initial Phase (Dose-finding)|Death|0
5626588|NCT00726232|19435030|P5|Initial Phase (Dose-finding)|Death|1
5626589|NCT00726232|19435031|P4|Initial Phase (Dose-finding)|Death|0
5626590|NCT00726232|19435032|P3|Initial Phase (Dose-finding)|Death|0
5626591|NCT00726232|19435033|P2|Initial Phase (Dose-finding)|Death|0
5626592|NCT00726232|19435034|P1|Initial Phase (Dose-finding)|Death|0
5626593|NCT00726063|19435086|P2|Overall Study|Adverse Event|7
5626594|NCT00726063|19435087|P1|Overall Study|Adverse Event|9
5626595|NCT00725985|19435101|P12|LTFU (No Cladribine Treatment)|Other|14
5626596|NCT00725985|19435102|P11|LTFU (No Cladribine Treatment)|Other|36
5626597|NCT00725985|19435103|P10|LTFU (No Cladribine Treatment)|Other|34
5626598|NCT00725985|19435104|P9|LTFU (No Cladribine Treatment)|Other|0
5626599|NCT00725985|19435105|P8|LTFU (No Cladribine Treatment)|Other|0
5626600|NCT00725985|19435106|P7|LTFU (No Cladribine Treatment)|Other|0
5626601|NCT00725985|19435107|P6|LTFU (No Cladribine Treatment)|Other|0
5626602|NCT00725985|19435108|P5|LTFU (No Cladribine Treatment)|Other|0
5626603|NCT00725985|19435109|P4|LTFU (No Cladribine Treatment)|Other|0
5626604|NCT00725985|19435110|P3|LTFU (No Cladribine Treatment)|Other|0
5626605|NCT00725985|19435111|P2|LTFU (No Cladribine Treatment)|Other|0
5626606|NCT00725985|19435112|P1|LTFU (No Cladribine Treatment)|Other|0
5626607|NCT00725985|19435101|P12|LTFU (With Cladribine Treatment)|Other|0
5626608|NCT00725985|19435102|P11|LTFU (With Cladribine Treatment)|Other|0
5626609|NCT00725985|19435103|P10|LTFU (With Cladribine Treatment)|Other|0
5626610|NCT00725985|19435104|P9|LTFU (With Cladribine Treatment)|Other|16
5626611|NCT00725985|19435105|P8|LTFU (With Cladribine Treatment)|Other|8
5626612|NCT00725985|19435106|P7|LTFU (With Cladribine Treatment)|Other|9
5626613|NCT00725985|19435107|P6|LTFU (With Cladribine Treatment)|Other|0
5626614|NCT00725985|19435108|P5|LTFU (With Cladribine Treatment)|Other|0
5626615|NCT00725985|19435109|P4|LTFU (With Cladribine Treatment)|Other|0
5626616|NCT00725985|19435110|P3|LTFU (With Cladribine Treatment)|Other|0
5626617|NCT00725985|19435111|P2|LTFU (With Cladribine Treatment)|Other|0
5626618|NCT00725985|19435112|P1|LTFU (With Cladribine Treatment)|Other|0
5626619|NCT00725985|19435101|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626620|NCT00725985|19435102|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626621|NCT00725985|19435103|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626622|NCT00725985|19435104|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
5626623|NCT00725985|19435105|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626624|NCT00725985|19435106|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626625|NCT00725985|19435107|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626626|NCT00725985|19435108|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626627|NCT00725985|19435109|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626628|NCT00725985|19435110|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626629|NCT00725985|19435111|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626630|NCT00725985|19435112|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
5626631|NCT00725985|19435101|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
5626632|NCT00725985|19435102|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
5626633|NCT00725985|19435103|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
5626634|NCT00725985|19435104|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
5626635|NCT00725985|19435105|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
5626636|NCT00725985|19435106|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
5626637|NCT00725985|19435107|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
5626638|NCT00725985|19435108|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
5626639|NCT00725985|19435109|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
5626640|NCT00725985|19435110|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
5626641|NCT00725985|19435111|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
5626642|NCT00725985|19435112|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
5626643|NCT00725985|19435101|P12|OLMP|Other|0
5626644|NCT00725985|19435102|P11|OLMP|Other|0
5626645|NCT00725985|19435103|P10|OLMP|Other|0
5626646|NCT00725985|19435104|P9|OLMP|Other|0
5626647|NCT00725985|19435105|P8|OLMP|Other|0
5626648|NCT00725985|19435106|P7|OLMP|Other|0
5626649|NCT00725985|19435107|P6|OLMP|Other|44
5626650|NCT00725985|19435108|P5|OLMP|Other|20
5626651|NCT00725985|19435109|P4|OLMP|Other|15
5626652|NCT00725985|19435110|P3|OLMP|Other|0
5626653|NCT00725985|19435111|P2|OLMP|Other|0
5626654|NCT00725985|19435112|P1|OLMP|Other|0
5626655|NCT00725985|19435101|P12|OLMP|Disease progression|0
5626656|NCT00725985|19435102|P11|OLMP|Disease progression|0
5626657|NCT00725985|19435103|P10|OLMP|Disease progression|0
5626658|NCT00725985|19435104|P9|OLMP|Disease progression|0
5626659|NCT00725985|19435105|P8|OLMP|Disease progression|0
5626660|NCT00725985|19435106|P7|OLMP|Disease progression|0
5626661|NCT00725985|19435107|P6|OLMP|Disease progression|4
5626662|NCT00725985|19435108|P5|OLMP|Disease progression|0
5626663|NCT00725985|19435109|P4|OLMP|Disease progression|0
5626664|NCT00725985|19435110|P3|OLMP|Disease progression|0
5626665|NCT00725985|19435111|P2|OLMP|Disease progression|0
5626666|NCT00725985|19435112|P1|OLMP|Disease progression|0
5626667|NCT00725985|19435101|P12|OLMP|Lost to Follow-up|0
5626668|NCT00725985|19435102|P11|OLMP|Lost to Follow-up|0
5626669|NCT00725985|19435103|P10|OLMP|Lost to Follow-up|0
5626670|NCT00725985|19435104|P9|OLMP|Lost to Follow-up|0
5626671|NCT00725985|19435105|P8|OLMP|Lost to Follow-up|0
5626672|NCT00725985|19435106|P7|OLMP|Lost to Follow-up|0
5626673|NCT00725985|19435107|P6|OLMP|Lost to Follow-up|0
5626674|NCT00725985|19435108|P5|OLMP|Lost to Follow-up|0
5626675|NCT00725985|19435109|P4|OLMP|Lost to Follow-up|1
5626676|NCT00725985|19435110|P3|OLMP|Lost to Follow-up|0
5626677|NCT00725985|19435111|P2|OLMP|Lost to Follow-up|0
5626678|NCT00725985|19435112|P1|OLMP|Lost to Follow-up|0
5626679|NCT00725985|19435101|P12|OLMP|Death|0
5626680|NCT00725985|19435102|P11|OLMP|Death|0
5626681|NCT00725985|19435103|P10|OLMP|Death|0
5626682|NCT00725985|19435104|P9|OLMP|Death|0
5626683|NCT00725985|19435105|P8|OLMP|Death|0
5626684|NCT00725985|19435106|P7|OLMP|Death|0
5626685|NCT00725985|19435107|P6|OLMP|Death|0
5626686|NCT00725985|19435108|P5|OLMP|Death|1
5626687|NCT00725985|19435109|P4|OLMP|Death|0
5626688|NCT00725985|19435110|P3|OLMP|Death|0
5626689|NCT00725985|19435111|P2|OLMP|Death|0
5626690|NCT00725985|19435112|P1|OLMP|Death|0
5626691|NCT00725985|19435101|P12|OLMP|Adverse Event|0
5626692|NCT00725985|19435102|P11|OLMP|Adverse Event|0
5626693|NCT00725985|19435103|P10|OLMP|Adverse Event|0
5626694|NCT00725985|19435104|P9|OLMP|Adverse Event|0
5626695|NCT00725985|19435105|P8|OLMP|Adverse Event|0
5626696|NCT00725985|19435106|P7|OLMP|Adverse Event|0
5626697|NCT00725985|19435107|P6|OLMP|Adverse Event|5
5626698|NCT00725985|19435108|P5|OLMP|Adverse Event|2
5626699|NCT00725985|19435109|P4|OLMP|Adverse Event|2
5626700|NCT00725985|19435110|P3|OLMP|Adverse Event|0
5626701|NCT00725985|19435111|P2|OLMP|Adverse Event|0
5626702|NCT00725985|19435112|P1|OLMP|Adverse Event|0
5626703|NCT00725985|19435101|P12|ITP (Up to 96 Weeks)|Other|0
5626704|NCT00725985|19435102|P11|ITP (Up to 96 Weeks)|Other|0
5626705|NCT00725985|19435103|P10|ITP (Up to 96 Weeks)|Other|0
5626706|NCT00725985|19435104|P9|ITP (Up to 96 Weeks)|Other|0
5626707|NCT00725985|19435105|P8|ITP (Up to 96 Weeks)|Other|0
5626708|NCT00725985|19435106|P7|ITP (Up to 96 Weeks)|Other|0
5626709|NCT00725985|19435107|P6|ITP (Up to 96 Weeks)|Other|0
5626710|NCT00725985|19435108|P5|ITP (Up to 96 Weeks)|Other|0
5626711|NCT00725985|19435109|P4|ITP (Up to 96 Weeks)|Other|0
5626712|NCT00725985|19435110|P3|ITP (Up to 96 Weeks)|Other|24
5626713|NCT00725985|19435111|P2|ITP (Up to 96 Weeks)|Other|38
5626714|NCT00725985|19435112|P1|ITP (Up to 96 Weeks)|Other|50
5626715|NCT00725985|19435101|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
5626716|NCT00725985|19435102|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
5626717|NCT00725985|19435103|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
5626718|NCT00725985|19435104|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
5626719|NCT00725985|19435105|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
5626720|NCT00725985|19435106|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
5626721|NCT00725985|19435107|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
5626722|NCT00725985|19435108|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
5626723|NCT00725985|19435109|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
5626724|NCT00725985|19435110|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
5626725|NCT00725985|19435111|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
5626726|NCT00725985|19435112|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
5626727|NCT00725985|19435101|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626728|NCT00725985|19435102|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626729|NCT00725985|19435103|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626730|NCT00725985|19435104|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626731|NCT00725985|19435105|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626732|NCT00725985|19435106|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626733|NCT00725985|19435107|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626734|NCT00725985|19435108|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626735|NCT00725985|19435109|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626736|NCT00725985|19435110|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626737|NCT00725985|19435111|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
5626738|NCT00725985|19435112|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
5626739|NCT00725985|19435101|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626740|NCT00725985|19435102|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626741|NCT00725985|19435103|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626742|NCT00725985|19435104|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626743|NCT00725985|19435105|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626744|NCT00725985|19435106|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626745|NCT00725985|19435107|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626746|NCT00725985|19435108|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626747|NCT00725985|19435109|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626748|NCT00725985|19435110|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
5626749|NCT00725985|19435111|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626750|NCT00725985|19435112|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
5626751|NCT00725985|19435101|P12|ITP (Up to 96 Weeks)|Adverse Event|0
5626752|NCT00725985|19435102|P11|ITP (Up to 96 Weeks)|Adverse Event|0
5626753|NCT00725985|19435103|P10|ITP (Up to 96 Weeks)|Adverse Event|0
5626754|NCT00725985|19435104|P9|ITP (Up to 96 Weeks)|Adverse Event|0
5626755|NCT00725985|19435105|P8|ITP (Up to 96 Weeks)|Adverse Event|0
5626756|NCT00725985|19435106|P7|ITP (Up to 96 Weeks)|Adverse Event|0
5626757|NCT00725985|19435107|P6|ITP (Up to 96 Weeks)|Adverse Event|0
5626758|NCT00725985|19435108|P5|ITP (Up to 96 Weeks)|Adverse Event|0
5626759|NCT00725985|19435109|P4|ITP (Up to 96 Weeks)|Adverse Event|0
5626760|NCT00725985|19435110|P3|ITP (Up to 96 Weeks)|Adverse Event|5
5626761|NCT00725985|19435111|P2|ITP (Up to 96 Weeks)|Adverse Event|10
5626762|NCT00725985|19435112|P1|ITP (Up to 96 Weeks)|Adverse Event|20
5626763|NCT00725920|19435149|P2|Overall Study|Lack of Efficacy|6
5626764|NCT00725920|19435150|P1|Overall Study|Lack of Efficacy|3
5626765|NCT00725842|19435156|P1|Overall Study|No Visit 1 data|1
5626766|NCT00725842|19435156|P1|Overall Study|Inclusion criterion not met|1
5626767|NCT00725842|19435156|P1|Overall Study|Consent date prior to study start date|5
5626768|NCT00725842|19435156|P1|Overall Study|Positive HCV-RNA at Visit 2|13
5626769|NCT00725842|19435156|P1|Overall Study|Death|1
5626770|NCT00725842|19435156|P1|Overall Study|Lost to Follow-up|19
5626771|NCT00725764|19435163|P1|Overall Study|Decline in performance status|1
5626772|NCT00725764|19435163|P1|Overall Study|Participant non compliant with protocol|1
5626773|NCT00725764|19435163|P1|Overall Study|Death|1
5626774|NCT00725764|19435163|P1|Overall Study|Lost to Follow-up|1
5626775|NCT00725764|19435163|P1|Overall Study|Progressive Disease|7
5626776|NCT00725764|19435163|P1|Overall Study|Physician Decision|1
5626777|NCT00725764|19435163|P1|Overall Study|Withdrawal by Subject|2
5626778|NCT00725725|19435196|P3|Overall Study|Protocol Violation|0
5626779|NCT00725725|19435197|P2|Overall Study|Protocol Violation|1
5626780|NCT00725725|19435198|P1|Overall Study|Protocol Violation|0
5626781|NCT00725725|19435196|P3|Overall Study|Withdrawal by Subject|1
5626782|NCT00725725|19435197|P2|Overall Study|Withdrawal by Subject|0
5626783|NCT00725725|19435198|P1|Overall Study|Withdrawal by Subject|1
5626784|NCT00725725|19435196|P3|Overall Study|Lost to Follow-up|2
5626785|NCT00725725|19435197|P2|Overall Study|Lost to Follow-up|0
5626786|NCT00725725|19435198|P1|Overall Study|Lost to Follow-up|2
5626787|NCT00725725|19435196|P3|Overall Study|Adverse Event|2
5626788|NCT00725725|19435197|P2|Overall Study|Adverse Event|3
5626789|NCT00725725|19435198|P1|Overall Study|Adverse Event|1
5626790|NCT00725712|19435241|P2|Overall Study|Hospitalized, unable to continue|1
5626791|NCT00725712|19435242|P1|Overall Study|Hospitalized, unable to continue|0
5626792|NCT00725712|19435241|P2|Overall Study|Other: Death|0
5626793|NCT00725712|19435242|P1|Overall Study|Other: Death|1
5626794|NCT00725712|19435241|P2|Overall Study|Death|0
5626795|NCT00725712|19435242|P1|Overall Study|Death|2
5626796|NCT00725712|19435241|P2|Overall Study|Adverse Event|5
5626797|NCT00725712|19435242|P1|Overall Study|Adverse Event|5
5626798|NCT00725712|19435241|P2|Overall Study|Clinical progression not based on RECIST|3
5626799|NCT00725712|19435242|P1|Overall Study|Clinical progression not based on RECIST|0
5626800|NCT00725712|19435241|P2|Overall Study|Progressive disease|16
5626801|NCT00725712|19435242|P1|Overall Study|Progressive disease|37
5626802|NCT00725712|19435241|P2|Overall Study|Protocol Violation|0
5626803|NCT00725712|19435242|P1|Overall Study|Protocol Violation|1
5626804|NCT00725712|19435241|P2|Overall Study|Withdrawal by Subject|1
5626805|NCT00725712|19435242|P1|Overall Study|Withdrawal by Subject|2
5626806|NCT00725621|19435278|P1|Overall Study|Reason not specified|55
5626807|NCT00725621|19435278|P1|Overall Study|Prepared for elective surgery|1
5626808|NCT00725621|19435278|P1|Overall Study|Switched to other drug|1
5626809|NCT00725621|19435278|P1|Overall Study|Switched to other study|1
5626810|NCT00725621|19435278|P1|Overall Study|Continued treatment by other physician|6
5626811|NCT00725621|19435278|P1|Overall Study|Non-compliance|8
5626812|NCT00725621|19435278|P1|Overall Study|Lost to Follow-up|52
5626813|NCT00725621|19435278|P1|Overall Study|Physician Decision|19
5626814|NCT00725621|19435278|P1|Overall Study|Withdrawal by Subject|57
5626815|NCT00725621|19435278|P1|Overall Study|Lack of Efficacy|46
5626816|NCT00725621|19435278|P1|Overall Study|Adverse Event|25
5626817|NCT00725608|19435301|P1|Overall Study|Other|7
5626818|NCT00725608|19435301|P1|Overall Study|Individual reasons|86
5626819|NCT00725608|19435301|P1|Overall Study|Adverse Event|14
5626820|NCT00725608|19435301|P1|Overall Study|Lost to Follow-up|60
5626821|NCT00725543|19435307|P1|Overall Study|Other|119
5626822|NCT00725543|19435307|P1|Overall Study|Non-compliance|2
5626823|NCT00725543|19435307|P1|Overall Study|Lost to Follow-up|4
5626824|NCT00725543|19435307|P1|Overall Study|Physician Decision|5
5626825|NCT00725543|19435307|P1|Overall Study|Withdrawal by Subject|10
5626826|NCT00725543|19435307|P1|Overall Study|Lack of Efficacy|3
5626827|NCT00725543|19435307|P1|Overall Study|Adverse Event|10
5626828|NCT00725491|19435332|P2|Overall Study|No/too few embryos/ bad quality embryos|2
5626829|NCT00725491|19435333|P1|Overall Study|No/too few embryos/ bad quality embryos|3
5626830|NCT00725491|19435332|P2|Overall Study|Fertilization failure|1
5626831|NCT00725491|19435333|P1|Overall Study|Fertilization failure|0
5626832|NCT00725491|19435332|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
5626833|NCT00725491|19435333|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
5626834|NCT00725491|19435332|P2|Overall Study|Risk for hyperstimulation|9
5626835|NCT00725491|19435333|P1|Overall Study|Risk for hyperstimulation|2
5626836|NCT00725491|19435332|P2|Overall Study|Pregnancy|3
5626837|NCT00725491|19435333|P1|Overall Study|Pregnancy|0
5626838|NCT00725491|19435332|P2|Overall Study|Adverse Event|2
5626839|NCT00725491|19435333|P1|Overall Study|Adverse Event|3
5626840|NCT00725452|19435339|P1|Overall Study|Lost to Follow-up|1
5626841|NCT00725452|19435339|P1|Overall Study|Withdrawal by Subject|3
5626842|NCT00725452|19435339|P1|Overall Study|Physician Decision|1
5626843|NCT00725452|19435339|P1|Overall Study|Reason not specified|1
5626844|NCT00725452|19435339|P1|Overall Study|Lack of Efficacy|2
5626845|NCT00725452|19435339|P1|Overall Study|Adverse Event|3
5626846|NCT00725322|19435358|P2|Washout (28 Days)|Protocol Violation|1
5626847|NCT00725322|19435359|P1|Washout (28 Days)|Protocol Violation|0
5626848|NCT00725322|19435358|P2|Washout (28 Days)|Withdrawal by Subject|0
5626849|NCT00725322|19435359|P1|Washout (28 Days)|Withdrawal by Subject|2
5626850|NCT00725296|19435367|P1|Overall Study|Other|38
5626851|NCT00725296|19435367|P1|Overall Study|Lost to Follow-up|1
5626852|NCT00725296|19435367|P1|Overall Study|Non-Compliance|2
5626853|NCT00725296|19435367|P1|Overall Study|Withdrawal by Subject|3
5626854|NCT00725296|19435367|P1|Overall Study|Lack of Efficacy|7
5626855|NCT00725296|19435367|P1|Overall Study|Adverse Event|11
5626856|NCT00725283|19435376|P1|Overall Study|Withdrawal by Subject|10
5626857|NCT00725283|19435376|P1|Overall Study|Other|6
5626858|NCT00725283|19435376|P1|Overall Study|Death|5
5626859|NCT00725283|19435376|P1|Overall Study|Missing Code|3
5626860|NCT00725205|19435397|P1|Overall Study|Treatment Failure|41
5626861|NCT00725205|19435397|P1|Overall Study|Protocol Defined Clinical Event|1
5626862|NCT00725205|19435397|P1|Overall Study|Other|8
5626863|NCT00725205|19435397|P1|Overall Study|Non-compliance With Protocol|14
5626864|NCT00725205|19435397|P1|Overall Study|Investigator Discontinued|1
5626865|NCT00725205|19435397|P1|Overall Study|Adverse Event|22
5626866|NCT00725101|19435410|P1|Overall Study|not specified/no reason given|11
5626867|NCT00725101|19435410|P1|Overall Study|Withdrawal by Subject|127
5626868|NCT00725101|19435410|P1|Overall Study|Protocol Violation|1
5626869|NCT00725101|19435410|P1|Overall Study|Lost to Follow-up|353
5626870|NCT00725101|19435410|P1|Overall Study|Death|3
5626871|NCT00725075|19435433|P3|Overall Study|Other|0
5626872|NCT00725075|19435434|P2|Overall Study|Other|0
5626873|NCT00725075|19435435|P1|Overall Study|Other|1
5626874|NCT00725075|19435433|P3|Overall Study|Inclusion/Exclusion Criteria|1
5626875|NCT00725075|19435434|P2|Overall Study|Inclusion/Exclusion Criteria|0
5626876|NCT00725075|19435435|P1|Overall Study|Inclusion/Exclusion Criteria|1
5626877|NCT00725075|19435433|P3|Overall Study|Worsening of Disease|2
5626878|NCT00725075|19435434|P2|Overall Study|Worsening of Disease|1
5626879|NCT00725075|19435435|P1|Overall Study|Worsening of Disease|2
5626880|NCT00725075|19435433|P3|Overall Study|Adverse Event|1
5626881|NCT00725075|19435434|P2|Overall Study|Adverse Event|1
5626882|NCT00725075|19435435|P1|Overall Study|Adverse Event|2
5626883|NCT00725075|19435433|P3|Overall Study|Withdrawal by Subject|4
5626884|NCT00725075|19435434|P2|Overall Study|Withdrawal by Subject|5
5626885|NCT00725075|19435435|P1|Overall Study|Withdrawal by Subject|4
5626886|NCT00725075|19435433|P3|Overall Study|Lost to Follow-up|0
5626887|NCT00725075|19435434|P2|Overall Study|Lost to Follow-up|0
5626888|NCT00725075|19435435|P1|Overall Study|Lost to Follow-up|1
5626889|NCT00725075|19435433|P3|Overall Study|Protocol Violation|1
5626890|NCT00725075|19435434|P2|Overall Study|Protocol Violation|0
5626891|NCT00725075|19435435|P1|Overall Study|Protocol Violation|0
5626892|NCT00725075|19435433|P3|Overall Study|Use of Excluded Medication|0
5626893|NCT00725075|19435434|P2|Overall Study|Use of Excluded Medication|1
5626894|NCT00725075|19435435|P1|Overall Study|Use of Excluded Medication|0
5626895|NCT00725010|19435488|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
5626896|NCT00725010|19435488|P1|Overall Study|No further documentation|1
5626897|NCT00725010|19435488|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
5626898|NCT00725010|19435488|P1|Overall Study|Hepatopathy probably not Temodal-related|1
5626899|NCT00725010|19435488|P1|Overall Study|Lost to Follow-up|1
5626900|NCT00725010|19435488|P1|Overall Study|Death|1
5626901|NCT00725010|19435488|P1|Overall Study|Withdrawal by Subject|2
5626902|NCT00725010|19435488|P1|Overall Study|Tumor Progression|7
5626903|NCT00725010|19435488|P1|Overall Study|Toxicity|9
5626904|NCT00724971|19435521|P1|Overall Study|Withdrawal by Subject|1
5626905|NCT00724971|19435521|P1|Overall Study|Adverse Event|5
5626906|NCT00724958|19435536|P1|Overall Study|No documentation for end of therapy|13
5626907|NCT00724958|19435536|P1|Overall Study|Other Reason|76
5626908|NCT00724958|19435536|P1|Overall Study|Remission|7
5626909|NCT00724958|19435536|P1|Overall Study|No Response|18
5626910|NCT00724958|19435536|P1|Overall Study|Loss of Response|40
5626911|NCT00724958|19435536|P1|Overall Study|Adverse Event|28
5626912|NCT00724945|19435545|P2|Period 2|lens physiology issue|0
5626913|NCT00724945|19435546|P1|Period 2|lens physiology issue|1
5626914|NCT00724945|19435545|P2|Period 2|lens comfort issue|0
5626915|NCT00724945|19435546|P1|Period 2|lens comfort issue|3
5626916|NCT00724945|19435545|P2|Period 1|Lost to Follow-up|0
5626917|NCT00724945|19435546|P1|Period 1|Lost to Follow-up|1
5626918|NCT00724945|19435545|P2|Period 1|Adverse Event|1
5626919|NCT00724945|19435546|P1|Period 1|Adverse Event|1
5626920|NCT00724945|19435545|P2|Period 1|non-compliance|0
5626921|NCT00724945|19435546|P1|Period 1|non-compliance|1
5626922|NCT00724932|19435558|P2|Overall Study|Not treated|3
5626923|NCT00724932|19435559|P1|Overall Study|Not treated|4
5626924|NCT00724932|19435558|P2|Overall Study|Lost to Follow-up|0
5626925|NCT00724932|19435559|P1|Overall Study|Lost to Follow-up|1
5626926|NCT00724893|19435630|P2|Overall Study|Unknown, missing data|1
5626927|NCT00724893|19435631|P1|Overall Study|Unknown, missing data|1
5626928|NCT00724893|19435630|P2|Overall Study|Lost to Follow-up|52
5626929|NCT00724893|19435631|P1|Overall Study|Lost to Follow-up|0
5626930|NCT00724893|19435630|P2|Overall Study|Assigned shorter treatment|2
5626931|NCT00724893|19435631|P1|Overall Study|Assigned shorter treatment|0
5626932|NCT00724893|19435630|P2|Overall Study|Financial reasons|2
5626933|NCT00724893|19435631|P1|Overall Study|Financial reasons|0
5626934|NCT00724893|19435630|P2|Overall Study|Substance abuse|3
5626935|NCT00724893|19435631|P1|Overall Study|Substance abuse|0
5626936|NCT00724893|19435630|P2|Overall Study|Incarceration|9
5626937|NCT00724893|19435631|P1|Overall Study|Incarceration|0
5626938|NCT00724893|19435630|P2|Overall Study|Geographic reasons|11
5626939|NCT00724893|19435631|P1|Overall Study|Geographic reasons|0
5626940|NCT00724893|19435630|P2|Overall Study|Patient choice|26
5626941|NCT00724893|19435631|P1|Overall Study|Patient choice|0
5626942|NCT00724893|19435630|P2|Overall Study|Reason not specified|7
5626943|NCT00724893|19435631|P1|Overall Study|Reason not specified|193
5626944|NCT00724893|19435630|P2|Overall Study|Lack of virologic response|202
5626945|NCT00724893|19435631|P1|Overall Study|Lack of virologic response|94
5626946|NCT00724893|19435630|P2|Overall Study|Withdrawal by Subject|1
5626947|NCT00724893|19435631|P1|Overall Study|Withdrawal by Subject|0
5626948|NCT00724893|19435630|P2|Overall Study|Adverse Event|142
5626949|NCT00724893|19435631|P1|Overall Study|Adverse Event|76
5626950|NCT00724867|19435699|P1|Overall Study|Elected to exit due to site closure|2
5626951|NCT00724867|19435699|P1|Overall Study|Subject moved out of state|1
5626952|NCT00724867|19435699|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
5626953|NCT00724867|19435699|P1|Overall Study|Subject incarcerated|1
5626954|NCT00724867|19435699|P1|Overall Study|Sponsor decision to end study|14
5626955|NCT00724867|19435699|P1|Overall Study|Withdrawal by Subject|31
5626956|NCT00724867|19435699|P1|Overall Study|Protocol Violation|1
5626957|NCT00724867|19435699|P1|Overall Study|Physician Decision|17
5626958|NCT00724867|19435699|P1|Overall Study|Non-compliance with study drug|6
5626959|NCT00724867|19435699|P1|Overall Study|Lost to Follow-up|12
5626960|NCT00724867|19435699|P1|Overall Study|Lack of Efficacy|14
5626961|NCT00724867|19435699|P1|Overall Study|Adverse Event|25
5626962|NCT00724854|19435739|P2|Overall Study|Adverse event + lack of efficacy|1
5626963|NCT00724854|19435740|P1|Overall Study|Adverse event + lack of efficacy|2
5626964|NCT00724854|19435739|P2|Overall Study|Withdrawal by Subject|0
5626965|NCT00724854|19435740|P1|Overall Study|Withdrawal by Subject|5
5626966|NCT00724854|19435739|P2|Overall Study|Change of treatment|0
5626967|NCT00724854|19435740|P1|Overall Study|Change of treatment|7
5626968|NCT00724854|19435739|P2|Overall Study|Death|0
5626969|NCT00724854|19435740|P1|Overall Study|Death|11
5626970|NCT00724854|19435739|P2|Overall Study|Other|3
5626971|NCT00724854|19435740|P1|Overall Study|Other|42
5626972|NCT00724854|19435739|P2|Overall Study|Adverse Event|4
5626973|NCT00724854|19435740|P1|Overall Study|Adverse Event|62
5626974|NCT00724854|19435739|P2|Overall Study|Lost to Follow-up|10
5626975|NCT00724854|19435740|P1|Overall Study|Lost to Follow-up|87
5626976|NCT00724854|19435739|P2|Overall Study|Lack of Efficacy|13
5626977|NCT00724854|19435740|P1|Overall Study|Lack of Efficacy|187
5626978|NCT00724815|19435757|P2|Overall Study|Other Various|5
5626979|NCT00724815|19435758|P1|Overall Study|Other Various|3
5626980|NCT00724815|19435757|P2|Overall Study|Lost to Follow-up|1
5626981|NCT00724815|19435758|P1|Overall Study|Lost to Follow-up|4
5626982|NCT00724815|19435757|P2|Overall Study|Adverse Event|3
5626983|NCT00724815|19435758|P1|Overall Study|Adverse Event|5
5626984|NCT00724815|19435757|P2|Overall Study|Randomized, not treated|30
5626985|NCT00724815|19435758|P1|Overall Study|Randomized, not treated|31
5626986|NCT00724711|19435791|P2|Overall Study|Protocol Violation|0
5626987|NCT00724711|19435792|P1|Overall Study|Protocol Violation|1
5626988|NCT00724711|19435791|P2|Overall Study|Lost to Follow-up|5
5626989|NCT00724711|19435792|P1|Overall Study|Lost to Follow-up|4
5626990|NCT00724711|19435791|P2|Overall Study|Withdrawal by Subject|4
5626991|NCT00724711|19435792|P1|Overall Study|Withdrawal by Subject|5
5626992|NCT00724711|19435791|P2|Overall Study|Physician Decision|3
5626993|NCT00724711|19435792|P1|Overall Study|Physician Decision|0
5626994|NCT00724711|19435791|P2|Overall Study|Lack of Efficacy|1
5626995|NCT00724711|19435792|P1|Overall Study|Lack of Efficacy|0
5626996|NCT00724711|19435791|P2|Overall Study|Pregnancy|1
5626997|NCT00724711|19435792|P1|Overall Study|Pregnancy|0
5626998|NCT00724711|19435791|P2|Overall Study|Adverse Event|3
5626999|NCT00724711|19435792|P1|Overall Study|Adverse Event|7
5627000|NCT00724698|19435824|P1|Overall Study|No Info|25
5627001|NCT00724698|19435824|P1|Overall Study|Lost to Follow-up|36
5627002|NCT00724698|19435824|P1|Overall Study|Poor Compliance|16
5627003|NCT00724698|19435824|P1|Overall Study|Failure of Therapy|4
5627004|NCT00724698|19435824|P1|Overall Study|Adverse Event|9
5627005|NCT00724503|19435877|P2|Overall Study|Not otherwise specified|7
5627006|NCT00724503|19435878|P1|Overall Study|Not otherwise specified|4
5627007|NCT00724503|19435877|P2|Overall Study|Adverse Event|0
5627008|NCT00724503|19435878|P1|Overall Study|Adverse Event|1
5627009|NCT00724503|19435877|P2|Overall Study|Death|182
5627010|NCT00724503|19435878|P1|Overall Study|Death|190
5627011|NCT00724503|19435877|P2|Overall Study|Withdrawal by Subject|23
5627012|NCT00724503|19435878|P1|Overall Study|Withdrawal by Subject|11
5627013|NCT00724503|19435877|P2|Overall Study|Lost to Follow-up|8
5627014|NCT00724503|19435878|P1|Overall Study|Lost to Follow-up|4
5627015|NCT00724451|19435902|P1|Overall Study|Investigator + Participant Decision|13
5627016|NCT00724451|19435902|P1|Overall Study|Withdrawal by Subject|45
5627017|NCT00724451|19435902|P1|Overall Study|Physician Decision|116
5627018|NCT00724451|19435902|P1|Overall Study|Unknown; No Data Sources Available|9
5627019|NCT00724451|19435902|P1|Overall Study|Never Started Treatment|89
5627020|NCT00724451|19435902|P1|Overall Study|Participant Refused Treatment|89
5627021|NCT00724451|19435902|P1|Overall Study|Not Eligible for Treatment|431
5627022|NCT00724451|19435902|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
5627023|NCT00724451|19435902|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
5627024|NCT00724373|19435908|P1|Overall Study|Tolerability|23
5627025|NCT00724373|19435908|P1|Overall Study|Drug Relapse|1
5627026|NCT00724373|19435908|P1|Overall Study|Acute HCV infection|1
5627027|NCT00724373|19435908|P1|Overall Study|Viral Relapse|1
5627028|NCT00724373|19435908|P1|Overall Study|Only to have 24 week regimen|1
5627029|NCT00724373|19435908|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
5627030|NCT00724373|19435908|P1|Overall Study|Participant moved away|1
5627031|NCT00724373|19435908|P1|Overall Study|HCV RNA negative after 4 weeks|9
5627032|NCT00724373|19435908|P1|Overall Study|Non-compliance|2
5627033|NCT00724373|19435908|P1|Overall Study|Lost to Follow-up|7
5627034|NCT00724373|19435908|P1|Overall Study|Lack of Efficacy|82
5627035|NCT00724373|19435908|P1|Overall Study|Adverse Event|41
5627036|NCT00724282|19435933|P1|Overall Study|Physician Decision|1
5627037|NCT00724282|19435933|P1|Overall Study|Withdrawal by Subject|3
5627038|NCT00724243|19435937|P1|Overall Study|Adverse Event|5
5627039|NCT00724243|19435937|P1|Overall Study|Lack of Efficacy|10
5627040|NCT00724152|19435947|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
5627041|NCT00724152|19435948|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
5627042|NCT00724152|19435949|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
5627043|NCT00724152|19435947|P3|Two-arm Study Period|Withdrawal by Subject|0
5627044|NCT00724152|19435948|P2|Two-arm Study Period|Withdrawal by Subject|2
5627045|NCT00724152|19435949|P1|Two-arm Study Period|Withdrawal by Subject|3
5627046|NCT00724126|19435966|P2|Overall Study|Subject had to leave vicinity of site|1
5627047|NCT00724126|19435967|P1|Overall Study|Subject had to leave vicinity of site|0
5627048|NCT00724126|19435966|P2|Overall Study|Subject randomized although ineligible|1
5627049|NCT00724126|19435967|P1|Overall Study|Subject randomized although ineligible|1
5627050|NCT00724126|19435966|P2|Overall Study|Noncompliance|1
5627051|NCT00724126|19435967|P1|Overall Study|Noncompliance|2
5627052|NCT00724126|19435966|P2|Overall Study|Lost to Follow-up|6
5627053|NCT00724126|19435967|P1|Overall Study|Lost to Follow-up|6
5627054|NCT00724126|19435966|P2|Overall Study|Withdrawal by Subject|6
5627055|NCT00724126|19435967|P1|Overall Study|Withdrawal by Subject|8
5627056|NCT00724126|19435966|P2|Overall Study|Adverse Event|0
5627057|NCT00724126|19435967|P1|Overall Study|Adverse Event|2
5627058|NCT00724061|19435975|P1|Dose Escalation Phase|Disease Progression|3
5627059|NCT00724061|19435975|P1|Dose Escalation Phase|Adverse Event|2
5627060|NCT00723957|19435995|P2|Overall Study|Never received treatment|3
5627061|NCT00723957|19435996|P1|Overall Study|Never received treatment|3
5627062|NCT00723957|19435995|P2|Overall Study|Reason not analyzed|0
5627063|NCT00723957|19435996|P1|Overall Study|Reason not analyzed|1
5627064|NCT00723957|19435995|P2|Overall Study|Withdrawal by Subject|5
5627065|NCT00723957|19435996|P1|Overall Study|Withdrawal by Subject|7
5627066|NCT00723957|19435995|P2|Overall Study|Study drug toxicity|6
5627067|NCT00723957|19435996|P1|Overall Study|Study drug toxicity|4
5627068|NCT00723957|19435995|P2|Overall Study|Investigator decision|1
5627069|NCT00723957|19435996|P1|Overall Study|Investigator decision|1
5627070|NCT00723957|19435995|P2|Overall Study|Maximum clinical benefit|5
5627071|NCT00723957|19435996|P1|Overall Study|Maximum clinical benefit|4
5627072|NCT00723957|19435995|P2|Overall Study|Disease progression|25
5627073|NCT00723957|19435996|P1|Overall Study|Disease progression|27
5627074|NCT00723957|19435995|P2|Overall Study|Death|4
5627075|NCT00723957|19435996|P1|Overall Study|Death|3
5627076|NCT00723957|19435995|P2|Overall Study|Adverse event unrelated to study drug|4
5627077|NCT00723957|19435996|P1|Overall Study|Adverse event unrelated to study drug|1
5627078|NCT00723944|19436020|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
5627079|NCT00723944|19436021|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
5627080|NCT00723944|19436020|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
5627081|NCT00723944|19436021|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
5627082|NCT00723944|19436020|P2|Permanent Prosthesis Placement|Adverse Event|7
5627083|NCT00723944|19436021|P1|Permanent Prosthesis Placement|Adverse Event|1
5627084|NCT00723892|19436034|P2|Overall Study|Drug addiction|0
5627085|NCT00723892|19436035|P1|Overall Study|Drug addiction|1
5627086|NCT00723892|19436034|P2|Overall Study|Intercurrent infection|0
5627087|NCT00723892|19436035|P1|Overall Study|Intercurrent infection|2
5627088|NCT00723892|19436034|P2|Overall Study|Alcohol abuse|1
5627089|NCT00723892|19436035|P1|Overall Study|Alcohol abuse|0
5627090|NCT00723892|19436034|P2|Overall Study|Weight loss|3
5627091|NCT00723892|19436035|P1|Overall Study|Weight loss|1
5627092|NCT00723892|19436034|P2|Overall Study|Study end|3
5627093|NCT00723892|19436035|P1|Overall Study|Study end|1
5627094|NCT00723892|19436034|P2|Overall Study|Other|3
5627095|NCT00723892|19436035|P1|Overall Study|Other|6
5627096|NCT00723892|19436034|P2|Overall Study|Multiple reasons|12
5627097|NCT00723892|19436035|P1|Overall Study|Multiple reasons|17
5627098|NCT00723892|19436034|P2|Overall Study|Bad tolerance|5
5627099|NCT00723892|19436035|P1|Overall Study|Bad tolerance|5
5627100|NCT00723892|19436034|P2|Overall Study|End planned|7
5627101|NCT00723892|19436035|P1|Overall Study|End planned|11
5627102|NCT00723892|19436034|P2|Overall Study|Withdrawal by Subject|9
5627103|NCT00723892|19436035|P1|Overall Study|Withdrawal by Subject|6
5627104|NCT00723892|19436034|P2|Overall Study|Virological criterion|9
5627105|NCT00723892|19436035|P1|Overall Study|Virological criterion|24
5627106|NCT00723892|19436034|P2|Overall Study|Participant not tracked|35
5627107|NCT00723892|19436035|P1|Overall Study|Participant not tracked|33
5627108|NCT00723840|19436042|P1|Overall Study|Unspecified reason|2
5627109|NCT00723840|19436042|P1|Overall Study|Other Medical Event|2
5627110|NCT00723840|19436042|P1|Overall Study|Serious Adverse Events|3
5627111|NCT00723840|19436042|P1|Overall Study|Withdrawal by Subject|55
5627112|NCT00723840|19436042|P1|Overall Study|Failure to return|18
5627113|NCT00723840|19436042|P1|Overall Study|Lost to Follow-up|2
5627114|NCT00723801|19436063|P2|Overall Study|Protocol Violation|1
5627115|NCT00723801|19436064|P1|Overall Study|Protocol Violation|2
5627116|NCT00723801|19436063|P2|Overall Study|Lost to Follow-up|2
5627117|NCT00723801|19436064|P1|Overall Study|Lost to Follow-up|1
5627118|NCT00723710|19436089|P1|Overall Study|Physician Decision|2
5627119|NCT00723710|19436089|P1|Overall Study|Withdrawal by Subject|36
5627120|NCT00723710|19436089|P1|Overall Study|Adverse Event|88
5627121|NCT00723710|19436089|P1|Overall Study|Disease progression|48
5627122|NCT00723697|19436093|P1|Overall Study|Other exclusion criteria applied|6
5627123|NCT00723697|19436093|P1|Overall Study|Missing Informed Consent Form|10
5627124|NCT00723697|19436093|P1|Overall Study|Physician questionnaires not received|2
5627125|NCT00723606|19436114|P2|Overall Study|Withdrawal by Subject|2
5627126|NCT00723606|19436115|P1|Overall Study|Withdrawal by Subject|0
5627127|NCT00723606|19436114|P2|Overall Study|Other|0
5627128|NCT00723606|19436115|P1|Overall Study|Other|2
5627129|NCT00723606|19436114|P2|Overall Study|Adverse Event|5
5627130|NCT00723606|19436115|P1|Overall Study|Adverse Event|2
5627131|NCT00723554|19436135|P1|Overall Study|Non-compliance|1
5627132|NCT00723554|19436135|P1|Overall Study|Lost to Follow-up|1
5627133|NCT00723554|19436135|P1|Overall Study|Other|3
5627134|NCT00723554|19436135|P1|Overall Study|Withdrawal of consent|3
5627135|NCT00723554|19436135|P1|Overall Study|Inhaled medication other than iloprost|4
5627136|NCT00723554|19436135|P1|Overall Study|Investigator's judgement|5
5627137|NCT00723554|19436135|P1|Overall Study|Adverse Event|12
5627138|NCT00723528|19436185|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
5627139|NCT00723528|19436186|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5627140|NCT00723528|19436187|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5627141|NCT00723528|19436188|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5627142|NCT00723528|19436189|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5627143|NCT00723528|19436190|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5627144|NCT00723528|19436191|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
5627145|NCT00723528|19436185|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
5627146|NCT00723528|19436186|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5627147|NCT00723528|19436187|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5627148|NCT00723528|19436188|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5627149|NCT00723528|19436189|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5627150|NCT00723528|19436190|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5627151|NCT00723528|19436191|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
5627152|NCT00723528|19436185|P7|Period 2: After Controlled Period|Adverse Event|1
5627153|NCT00723528|19436186|P6|Period 2: After Controlled Period|Adverse Event|0
5627154|NCT00723528|19436187|P5|Period 2: After Controlled Period|Adverse Event|1
5627155|NCT00723528|19436188|P4|Period 2: After Controlled Period|Adverse Event|0
5627156|NCT00723528|19436189|P3|Period 2: After Controlled Period|Adverse Event|0
5627157|NCT00723528|19436190|P2|Period 2: After Controlled Period|Adverse Event|0
5627158|NCT00723528|19436191|P1|Period 2: After Controlled Period|Adverse Event|0
5627159|NCT00723528|19436185|P7|Period 2: After Controlled Period|Other|0
5627160|NCT00723528|19436186|P6|Period 2: After Controlled Period|Other|4
5627161|NCT00723528|19436187|P5|Period 2: After Controlled Period|Other|1
5627162|NCT00723528|19436188|P4|Period 2: After Controlled Period|Other|0
5627163|NCT00723528|19436189|P3|Period 2: After Controlled Period|Other|0
5627164|NCT00723528|19436190|P2|Period 2: After Controlled Period|Other|0
5627165|NCT00723528|19436191|P1|Period 2: After Controlled Period|Other|0
5627166|NCT00723528|19436185|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5627167|NCT00723528|19436186|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
5627168|NCT00723528|19436187|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5627169|NCT00723528|19436188|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5627170|NCT00723528|19436189|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5627171|NCT00723528|19436190|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5627172|NCT00723528|19436191|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
5627173|NCT00723528|19436185|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
5627174|NCT00723528|19436186|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
5627175|NCT00723528|19436187|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
5627176|NCT00723528|19436188|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
5627177|NCT00723528|19436189|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
5627178|NCT00723528|19436190|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
5627179|NCT00723528|19436191|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
5627180|NCT00723528|19436185|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5627181|NCT00723528|19436186|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5627182|NCT00723528|19436187|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5627183|NCT00723528|19436188|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5627184|NCT00723528|19436189|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
5627185|NCT00723528|19436190|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
5627186|NCT00723528|19436191|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
5627187|NCT00723528|19436185|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5627188|NCT00723528|19436186|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5627189|NCT00723528|19436187|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5627190|NCT00723528|19436188|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5627191|NCT00723528|19436189|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
5627192|NCT00723528|19436190|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5627193|NCT00723528|19436191|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
5627194|NCT00723528|19436185|P7|Period 1: Controlled Period (CP)|Physician Decision|0
5627195|NCT00723528|19436186|P6|Period 1: Controlled Period (CP)|Physician Decision|0
5627196|NCT00723528|19436187|P5|Period 1: Controlled Period (CP)|Physician Decision|0
5627197|NCT00723528|19436188|P4|Period 1: Controlled Period (CP)|Physician Decision|0
5627198|NCT00723528|19436189|P3|Period 1: Controlled Period (CP)|Physician Decision|1
5627199|NCT00723528|19436190|P2|Period 1: Controlled Period (CP)|Physician Decision|0
5627200|NCT00723528|19436191|P1|Period 1: Controlled Period (CP)|Physician Decision|0
5627201|NCT00723528|19436185|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5627202|NCT00723528|19436186|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5627203|NCT00723528|19436187|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5627204|NCT00723528|19436188|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5627205|NCT00723528|19436189|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5627206|NCT00723528|19436190|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
5627207|NCT00723528|19436191|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
5627208|NCT00723528|19436185|P7|Period 1: Controlled Period (CP)|Adverse Event|0
5627209|NCT00723528|19436186|P6|Period 1: Controlled Period (CP)|Adverse Event|0
5627210|NCT00723528|19436187|P5|Period 1: Controlled Period (CP)|Adverse Event|0
5627211|NCT00723528|19436188|P4|Period 1: Controlled Period (CP)|Adverse Event|0
5627212|NCT00723528|19436189|P3|Period 1: Controlled Period (CP)|Adverse Event|1
5627213|NCT00723528|19436190|P2|Period 1: Controlled Period (CP)|Adverse Event|0
5627214|NCT00723528|19436191|P1|Period 1: Controlled Period (CP)|Adverse Event|0
5627215|NCT00723489|19436253|P4|Overall Study|Samples Collected Out of Window|0
5627216|NCT00723489|19436254|P3|Overall Study|Samples Collected Out of Window|0
5627217|NCT00723489|19436255|P2|Overall Study|Samples Collected Out of Window|3
5627218|NCT00723489|19436256|P1|Overall Study|Samples Collected Out of Window|0
5627219|NCT00723489|19436253|P4|Overall Study|Prohibited Medication|1
5627220|NCT00723489|19436254|P3|Overall Study|Prohibited Medication|0
5627221|NCT00723489|19436255|P2|Overall Study|Prohibited Medication|0
5627222|NCT00723489|19436256|P1|Overall Study|Prohibited Medication|0
5627223|NCT00723489|19436253|P4|Overall Study|Seropositive at baseline|0
5627224|NCT00723489|19436254|P3|Overall Study|Seropositive at baseline|0
5627225|NCT00723489|19436255|P2|Overall Study|Seropositive at baseline|0
5627226|NCT00723489|19436256|P1|Overall Study|Seropositive at baseline|1
5627227|NCT00723489|19436253|P4|Overall Study|Withdrawal by Subject|1
5627228|NCT00723489|19436254|P3|Overall Study|Withdrawal by Subject|0
5627229|NCT00723489|19436255|P2|Overall Study|Withdrawal by Subject|0
5627230|NCT00723489|19436256|P1|Overall Study|Withdrawal by Subject|0
5627231|NCT00723489|19436253|P4|Overall Study|Pregnancy|1
5627232|NCT00723489|19436254|P3|Overall Study|Pregnancy|0
5627233|NCT00723489|19436255|P2|Overall Study|Pregnancy|0
5627234|NCT00723489|19436256|P1|Overall Study|Pregnancy|0
5627235|NCT00723489|19436253|P4|Overall Study|Physician Decision|0
5627236|NCT00723489|19436254|P3|Overall Study|Physician Decision|0
5627237|NCT00723489|19436255|P2|Overall Study|Physician Decision|1
5627238|NCT00723489|19436256|P1|Overall Study|Physician Decision|0
5627239|NCT00723450|19436284|P3|Randomized Phase|Withdrawal by Subject|22
5627240|NCT00723450|19436285|P2|Randomized Phase|Withdrawal by Subject|14
5627241|NCT00723450|19436286|P1|Randomized Phase|Withdrawal by Subject|0
5627242|NCT00723450|19436284|P3|Randomized Phase|Physician Decision|1
5627243|NCT00723450|19436285|P2|Randomized Phase|Physician Decision|3
5627244|NCT00723450|19436286|P1|Randomized Phase|Physician Decision|0
5627245|NCT00723450|19436284|P3|Randomized Phase|Lost to Follow-up|3
5627246|NCT00723450|19436285|P2|Randomized Phase|Lost to Follow-up|2
5627247|NCT00723450|19436286|P1|Randomized Phase|Lost to Follow-up|0
5627248|NCT00723450|19436284|P3|Randomized Phase|Protocol Violation|13
5627249|NCT00723450|19436285|P2|Randomized Phase|Protocol Violation|9
5627250|NCT00723450|19436286|P1|Randomized Phase|Protocol Violation|0
5627251|NCT00723450|19436284|P3|Randomized Phase|Lack of Efficacy|11
5627252|NCT00723450|19436285|P2|Randomized Phase|Lack of Efficacy|11
5627253|NCT00723450|19436286|P1|Randomized Phase|Lack of Efficacy|0
5627254|NCT00723450|19436284|P3|Randomized Phase|Adverse Event|17
5627255|NCT00723450|19436285|P2|Randomized Phase|Adverse Event|26
5627256|NCT00723450|19436286|P1|Randomized Phase|Adverse Event|0
5627257|NCT00723450|19436284|P3|Open-Label Phase|Withdrawal by Subject|0
5627258|NCT00723450|19436285|P2|Open-Label Phase|Withdrawal by Subject|0
5627259|NCT00723450|19436286|P1|Open-Label Phase|Withdrawal by Subject|37
5627260|NCT00723450|19436284|P3|Open-Label Phase|Physician Decision|0
5627261|NCT00723450|19436285|P2|Open-Label Phase|Physician Decision|0
5627262|NCT00723450|19436286|P1|Open-Label Phase|Physician Decision|2
5627263|NCT00723450|19436284|P3|Open-Label Phase|Lost to Follow-up|0
5627264|NCT00723450|19436285|P2|Open-Label Phase|Lost to Follow-up|0
5627265|NCT00723450|19436286|P1|Open-Label Phase|Lost to Follow-up|7
5627266|NCT00723450|19436284|P3|Open-Label Phase|Protocol Violation|0
5627267|NCT00723450|19436285|P2|Open-Label Phase|Protocol Violation|0
5627268|NCT00723450|19436286|P1|Open-Label Phase|Protocol Violation|35
5627269|NCT00723450|19436284|P3|Open-Label Phase|Lack of Efficacy|0
5627270|NCT00723450|19436285|P2|Open-Label Phase|Lack of Efficacy|0
5627271|NCT00723450|19436286|P1|Open-Label Phase|Lack of Efficacy|18
5627272|NCT00723450|19436284|P3|Open-Label Phase|Adverse Event|0
5627273|NCT00723450|19436285|P2|Open-Label Phase|Adverse Event|0
5627274|NCT00723450|19436286|P1|Open-Label Phase|Adverse Event|26
5627275|NCT00723398|19436332|P5|Overall Study|Lost to Follow-up|0
5627276|NCT00723398|19436333|P4|Overall Study|Lost to Follow-up|0
5627277|NCT00723398|19436334|P3|Overall Study|Lost to Follow-up|0
5627278|NCT00723398|19436335|P2|Overall Study|Lost to Follow-up|1
5627279|NCT00723398|19436336|P1|Overall Study|Lost to Follow-up|0
5627280|NCT00723398|19436332|P5|Overall Study|Adverse Event|4
5627281|NCT00723398|19436333|P4|Overall Study|Adverse Event|1
5627282|NCT00723398|19436334|P3|Overall Study|Adverse Event|3
5627283|NCT00723398|19436335|P2|Overall Study|Adverse Event|5
5627284|NCT00723398|19436336|P1|Overall Study|Adverse Event|0
5627285|NCT00723398|19436332|P5|Overall Study|Physician Decision|1
5627286|NCT00723398|19436333|P4|Overall Study|Physician Decision|0
5627287|NCT00723398|19436334|P3|Overall Study|Physician Decision|5
5627288|NCT00723398|19436335|P2|Overall Study|Physician Decision|2
5627289|NCT00723398|19436336|P1|Overall Study|Physician Decision|2
5627290|NCT00723398|19436332|P5|Overall Study|Protocol Violation|0
5627291|NCT00723398|19436333|P4|Overall Study|Protocol Violation|0
5627292|NCT00723398|19436334|P3|Overall Study|Protocol Violation|5
5627293|NCT00723398|19436335|P2|Overall Study|Protocol Violation|1
5627294|NCT00723398|19436336|P1|Overall Study|Protocol Violation|2
5627295|NCT00723398|19436332|P5|Overall Study|Withdrawal by Subject|4
5627296|NCT00723398|19436333|P4|Overall Study|Withdrawal by Subject|4
5627297|NCT00723398|19436334|P3|Overall Study|Withdrawal by Subject|4
5627298|NCT00723398|19436335|P2|Overall Study|Withdrawal by Subject|6
5627299|NCT00723398|19436336|P1|Overall Study|Withdrawal by Subject|2
5627300|NCT00723294|19436398|P1|Overall Study|No treatment due to probe failure|1
5627301|NCT00723294|19436398|P1|Overall Study|Withdrawal by Subject|1
5627302|NCT00723294|19436398|P1|Overall Study|Benign lesion|1
5627303|NCT00723294|19436398|P1|Overall Study|Treated by non-credentialed surgeon|1
5627304|NCT00723294|19436398|P1|Overall Study|Treated prior to registration|1
5627305|NCT00723294|19436398|P1|Overall Study|Did not undergo surgery|1
5627306|NCT00723294|19436398|P1|Overall Study|No cryoabalation|2
5627307|NCT00723294|19436398|P1|Overall Study|1.0-Tesla MRI|1
5627308|NCT00723294|19436398|P1|Overall Study|No MRI tumor enhancement|1
5627309|NCT00723294|19436398|P1|Overall Study|>25% intraductal component|1
5627310|NCT00723294|19436398|P1|Overall Study|Lobular histology|2
5627311|NCT00723255|19436403|P1|Overall Study|Ineligible: Wrong Primary|2
5627312|NCT00723255|19436403|P1|Overall Study|Ineligible: Second primary|1
5627313|NCT00723255|19436403|P1|Overall Study|Ineligible: Inadequate pathology|1
5627314|NCT00723229|19436430|P2|First Intervention|Lost to Follow-up|3
5627315|NCT00723229|19436431|P1|First Intervention|Lost to Follow-up|7
5627316|NCT00723203|19436443|P1|Overall Study|Withdrawal by Subject|3
5627317|NCT00723190|19436447|P1|Overall Study|Other-Not included in safety population|2
5627318|NCT00723190|19436447|P1|Overall Study|Other-Premature Discontinuation|9
5627319|NCT00723190|19436447|P1|Overall Study|Protocol Violation|15
5627320|NCT00723190|19436447|P1|Overall Study|Lack of Efficacy|16
5627321|NCT00723190|19436447|P1|Overall Study|Adverse Event|18
5627322|NCT00723190|19436447|P1|Overall Study|Lost to Follow-up|37
5627323|NCT00723190|19436447|P1|Overall Study|Withdrawal by Subject|45
5627324|NCT00723125|19436480|P2|Overall Study|Adverse Event|0
5627325|NCT00723125|19436481|P1|Overall Study|Adverse Event|2
5627326|NCT00723125|19436480|P2|Overall Study|Withdrawal by Subject|6
5627327|NCT00723125|19436481|P1|Overall Study|Withdrawal by Subject|15
5627328|NCT00723125|19436480|P2|Overall Study|Met Dx|0
5627329|NCT00723125|19436481|P1|Overall Study|Met Dx|1
5627330|NCT00723021|19436530|P5|Intervention Period 4|Adverse Event|1
5627331|NCT00723021|19436531|P4|Intervention Period 4|Adverse Event|0
5627332|NCT00723021|19436532|P3|Intervention Period 4|Adverse Event|0
5627333|NCT00723021|19436533|P2|Intervention Period 4|Adverse Event|0
5627334|NCT00723021|19436534|P1|Intervention Period 4|Adverse Event|0
5627335|NCT00723008|19436588|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
5627336|NCT00723008|19436589|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
5627337|NCT00723008|19436588|P2|4-Week Unblinded Treatment|Adverse Event|0
5627338|NCT00723008|19436589|P1|4-Week Unblinded Treatment|Adverse Event|1
5627339|NCT00723008|19436588|P2|4-Week Double Blinded|Lost to Follow-up|3
5627340|NCT00723008|19436589|P1|4-Week Double Blinded|Lost to Follow-up|4
5627341|NCT00723008|19436588|P2|4-Week Double Blinded|Withdrawal by Subject|1
5627342|NCT00723008|19436589|P1|4-Week Double Blinded|Withdrawal by Subject|1
5627343|NCT00723008|19436588|P2|4-Week Double Blinded|Lack of Efficacy|1
5627344|NCT00723008|19436589|P1|4-Week Double Blinded|Lack of Efficacy|0
5627345|NCT00723008|19436588|P2|Enrollment|Lost to Follow-up|0
5627346|NCT00723008|19436589|P1|Enrollment|Lost to Follow-up|1
5627347|NCT00722800|19436621|P2|Overall Study|Physician Decision|0
5627348|NCT00722800|19436622|P1|Overall Study|Physician Decision|1
5627349|NCT00722800|19436621|P2|Overall Study|Withdrawal by Subject|0
5627350|NCT00722800|19436622|P1|Overall Study|Withdrawal by Subject|1
5627351|NCT00722761|19436634|P2|Overall Study|Withdrawal by Subject|2
5627352|NCT00722761|19436635|P1|Overall Study|Withdrawal by Subject|5
5627353|NCT00722761|19436634|P2|Overall Study|Lost to Follow-up|4
5627354|NCT00722761|19436635|P1|Overall Study|Lost to Follow-up|1
5627355|NCT00722423|19436692|P2|Overall Study|Protocol Violation|1
5627356|NCT00722423|19436693|P1|Overall Study|Protocol Violation|0
5627357|NCT00722371|19436708|P7|Overall Study|Withdrawal by Subject|26
5627358|NCT00722371|19436709|P6|Overall Study|Withdrawal by Subject|18
5627359|NCT00722371|19436710|P5|Overall Study|Withdrawal by Subject|19
5627360|NCT00722371|19436711|P4|Overall Study|Withdrawal by Subject|23
5627361|NCT00722371|19436712|P3|Overall Study|Withdrawal by Subject|19
5627362|NCT00722371|19436713|P2|Overall Study|Withdrawal by Subject|27
5627363|NCT00722371|19436714|P1|Overall Study|Withdrawal by Subject|18
5627364|NCT00722371|19436708|P7|Overall Study|Protocol Violation|1
5627365|NCT00722371|19436709|P6|Overall Study|Protocol Violation|2
5627366|NCT00722371|19436710|P5|Overall Study|Protocol Violation|4
5627367|NCT00722371|19436711|P4|Overall Study|Protocol Violation|1
5627368|NCT00722371|19436712|P3|Overall Study|Protocol Violation|0
5627369|NCT00722371|19436713|P2|Overall Study|Protocol Violation|1
5627370|NCT00722371|19436714|P1|Overall Study|Protocol Violation|6
5627371|NCT00722371|19436708|P7|Overall Study|Pregnancy|0
5627372|NCT00722371|19436709|P6|Overall Study|Pregnancy|1
5627373|NCT00722371|19436710|P5|Overall Study|Pregnancy|0
5627374|NCT00722371|19436711|P4|Overall Study|Pregnancy|0
5627375|NCT00722371|19436712|P3|Overall Study|Pregnancy|0
5627376|NCT00722371|19436713|P2|Overall Study|Pregnancy|1
5627377|NCT00722371|19436714|P1|Overall Study|Pregnancy|1
5627378|NCT00722371|19436708|P7|Overall Study|Physician Decision|4
5627379|NCT00722371|19436709|P6|Overall Study|Physician Decision|3
5627380|NCT00722371|19436710|P5|Overall Study|Physician Decision|2
5627381|NCT00722371|19436711|P4|Overall Study|Physician Decision|5
5627382|NCT00722371|19436712|P3|Overall Study|Physician Decision|2
5627383|NCT00722371|19436713|P2|Overall Study|Physician Decision|2
5627384|NCT00722371|19436714|P1|Overall Study|Physician Decision|5
5627385|NCT00722371|19436708|P7|Overall Study|Lost to Follow-up|13
5627386|NCT00722371|19436709|P6|Overall Study|Lost to Follow-up|16
5627387|NCT00722371|19436710|P5|Overall Study|Lost to Follow-up|8
5627388|NCT00722371|19436711|P4|Overall Study|Lost to Follow-up|13
5627389|NCT00722371|19436712|P3|Overall Study|Lost to Follow-up|21
5627390|NCT00722371|19436713|P2|Overall Study|Lost to Follow-up|14
5627391|NCT00722371|19436714|P1|Overall Study|Lost to Follow-up|11
5627392|NCT00722371|19436708|P7|Overall Study|Lack of Efficacy|0
5627393|NCT00722371|19436709|P6|Overall Study|Lack of Efficacy|3
5627394|NCT00722371|19436710|P5|Overall Study|Lack of Efficacy|2
5627395|NCT00722371|19436711|P4|Overall Study|Lack of Efficacy|6
5627396|NCT00722371|19436712|P3|Overall Study|Lack of Efficacy|6
5627397|NCT00722371|19436713|P2|Overall Study|Lack of Efficacy|6
5627398|NCT00722371|19436714|P1|Overall Study|Lack of Efficacy|4
5627399|NCT00722371|19436708|P7|Overall Study|Hypoglycemia|0
5627400|NCT00722371|19436709|P6|Overall Study|Hypoglycemia|0
5627401|NCT00722371|19436710|P5|Overall Study|Hypoglycemia|0
5627402|NCT00722371|19436711|P4|Overall Study|Hypoglycemia|0
5627403|NCT00722371|19436712|P3|Overall Study|Hypoglycemia|0
5627404|NCT00722371|19436713|P2|Overall Study|Hypoglycemia|0
5627405|NCT00722371|19436714|P1|Overall Study|Hypoglycemia|1
5627406|NCT00722371|19436708|P7|Overall Study|Hyperglycemia|1
5627407|NCT00722371|19436709|P6|Overall Study|Hyperglycemia|1
5627408|NCT00722371|19436710|P5|Overall Study|Hyperglycemia|5
5627409|NCT00722371|19436711|P4|Overall Study|Hyperglycemia|2
5627410|NCT00722371|19436712|P3|Overall Study|Hyperglycemia|4
5627411|NCT00722371|19436713|P2|Overall Study|Hyperglycemia|6
5627412|NCT00722371|19436714|P1|Overall Study|Hyperglycemia|2
5627413|NCT00722371|19436708|P7|Overall Study|Excluded medication|1
5627414|NCT00722371|19436709|P6|Overall Study|Excluded medication|0
5627415|NCT00722371|19436710|P5|Overall Study|Excluded medication|0
5627416|NCT00722371|19436711|P4|Overall Study|Excluded medication|0
5627417|NCT00722371|19436712|P3|Overall Study|Excluded medication|1
5627418|NCT00722371|19436713|P2|Overall Study|Excluded medication|1
5627419|NCT00722371|19436714|P1|Overall Study|Excluded medication|0
5627420|NCT00722371|19436708|P7|Overall Study|Creatinine / Creatinine clearance|1
5627421|NCT00722371|19436709|P6|Overall Study|Creatinine / Creatinine clearance|1
5627422|NCT00722371|19436710|P5|Overall Study|Creatinine / Creatinine clearance|2
5627423|NCT00722371|19436711|P4|Overall Study|Creatinine / Creatinine clearance|3
5627424|NCT00722371|19436712|P3|Overall Study|Creatinine / Creatinine clearance|2
5627425|NCT00722371|19436713|P2|Overall Study|Creatinine / Creatinine clearance|1
5627426|NCT00722371|19436714|P1|Overall Study|Creatinine / Creatinine clearance|2
5627427|NCT00722371|19436708|P7|Overall Study|Contraindication|0
5627428|NCT00722371|19436709|P6|Overall Study|Contraindication|0
5627429|NCT00722371|19436710|P5|Overall Study|Contraindication|0
5627430|NCT00722371|19436711|P4|Overall Study|Contraindication|0
5627431|NCT00722371|19436712|P3|Overall Study|Contraindication|1
5627432|NCT00722371|19436713|P2|Overall Study|Contraindication|0
5627433|NCT00722371|19436714|P1|Overall Study|Contraindication|0
5627434|NCT00722371|19436708|P7|Overall Study|Adverse Event|4
5627435|NCT00722371|19436709|P6|Overall Study|Adverse Event|8
5627436|NCT00722371|19436710|P5|Overall Study|Adverse Event|6
5627437|NCT00722371|19436711|P4|Overall Study|Adverse Event|10
5627438|NCT00722371|19436712|P3|Overall Study|Adverse Event|9
5627439|NCT00722371|19436713|P2|Overall Study|Adverse Event|13
5627440|NCT00722371|19436714|P1|Overall Study|Adverse Event|6
5627441|NCT00722137|19436767|P2|Overall Study|Randomized But Not Treated|3
5627442|NCT00722137|19436768|P1|Overall Study|Randomized But Not Treated|2
5627443|NCT00722137|19436767|P2|Overall Study|Other Reason Unknown|4
5627444|NCT00722137|19436768|P1|Overall Study|Other Reason Unknown|3
5627445|NCT00722137|19436767|P2|Overall Study|Withdrawal by Subject|9
5627446|NCT00722137|19436768|P1|Overall Study|Withdrawal by Subject|6
5627447|NCT00722137|19436767|P2|Overall Study|Death|7
5627448|NCT00722137|19436768|P1|Overall Study|Death|12
5627449|NCT00722137|19436767|P2|Overall Study|Adverse Event|21
5627450|NCT00722137|19436768|P1|Overall Study|Adverse Event|17
5627451|NCT00722137|19436767|P2|Overall Study|Overt Disease Progression|4
5627452|NCT00722137|19436768|P1|Overall Study|Overt Disease Progression|5
5627453|NCT00721968|19436846|P2|Overall Study|Lost to Follow-up|0
5627454|NCT00721968|19436847|P1|Overall Study|Lost to Follow-up|2
5627455|NCT00721955|19436858|P3|Overall Study|Adverse Event|2
5627456|NCT00721955|19436859|P2|Overall Study|Adverse Event|0
5627457|NCT00721955|19436860|P1|Overall Study|Adverse Event|0
5627458|NCT00721799|19436874|P1|Overall Study|withdraw by subject after scan 1|1
5627459|NCT00721799|19436874|P1|Overall Study|Withdrawal by Subject|7
5627460|NCT00721734|19436914|P5|Overall Study|Other|0
5627461|NCT00721734|19436915|P4|Overall Study|Other|1
5627462|NCT00721734|19436916|P3|Overall Study|Other|0
5627463|NCT00721734|19436917|P2|Overall Study|Other|0
5627464|NCT00721734|19436918|P1|Overall Study|Other|0
5627465|NCT00721734|19436914|P5|Overall Study|Withdrawal by Subject|1
5627466|NCT00721734|19436915|P4|Overall Study|Withdrawal by Subject|0
5627467|NCT00721734|19436916|P3|Overall Study|Withdrawal by Subject|0
5627468|NCT00721734|19436917|P2|Overall Study|Withdrawal by Subject|1
5627469|NCT00721734|19436918|P1|Overall Study|Withdrawal by Subject|2
5627470|NCT00721734|19436914|P5|Overall Study|Adverse Event|3
5627471|NCT00721734|19436915|P4|Overall Study|Adverse Event|0
5627472|NCT00721734|19436916|P3|Overall Study|Adverse Event|4
5627473|NCT00721734|19436917|P2|Overall Study|Adverse Event|1
5627474|NCT00721734|19436918|P1|Overall Study|Adverse Event|3
5627475|NCT00721734|19436914|P5|Overall Study|Progressive Disease|2
5627476|NCT00721734|19436915|P4|Overall Study|Progressive Disease|5
5627477|NCT00721734|19436916|P3|Overall Study|Progressive Disease|4
5627478|NCT00721734|19436917|P2|Overall Study|Progressive Disease|10
5627479|NCT00721734|19436918|P1|Overall Study|Progressive Disease|3
5627480|NCT00721630|19437030|P1|Overall Study|Participant found to be ineligible|1
5627481|NCT00721578|19437059|P2|Overall Study|Withdrawal by Subject|1
5627482|NCT00721578|19437060|P1|Overall Study|Withdrawal by Subject|1
5627483|NCT00721578|19437059|P2|Overall Study|Death|1
5627484|NCT00721578|19437060|P1|Overall Study|Death|1
5627485|NCT00721409|19437115|P3|Overall Study|Objective progression or relapse|62
5627486|NCT00721409|19437116|P2|Overall Study|Objective progression or relapse|55
5627487|NCT00721409|19437117|P1|Overall Study|Objective progression or relapse|8
5627488|NCT00721409|19437115|P3|Overall Study|Withdrawal by Subject|5
5627489|NCT00721409|19437116|P2|Overall Study|Withdrawal by Subject|6
5627490|NCT00721409|19437117|P1|Overall Study|Withdrawal by Subject|1
5627491|NCT00721409|19437115|P3|Overall Study|Lost to Follow-up|1
5627492|NCT00721409|19437116|P2|Overall Study|Lost to Follow-up|0
5627493|NCT00721409|19437117|P1|Overall Study|Lost to Follow-up|0
5627494|NCT00721409|19437115|P3|Overall Study|Adverse Event|2
5627495|NCT00721409|19437116|P2|Overall Study|Adverse Event|13
5627496|NCT00721409|19437117|P1|Overall Study|Adverse Event|0
5627497|NCT00721409|19437115|P3|Overall Study|Reason not specified|2
5627498|NCT00721409|19437116|P2|Overall Study|Reason not specified|0
5627499|NCT00721409|19437117|P1|Overall Study|Reason not specified|1
5627500|NCT00721409|19437115|P3|Overall Study|Randomized not Treated|4
5627501|NCT00721409|19437116|P2|Overall Study|Randomized not Treated|1
5627502|NCT00721409|19437117|P1|Overall Study|Randomized not Treated|0
5627503|NCT00721409|19437115|P3|Overall Study|Death|0
5627504|NCT00721409|19437116|P2|Overall Study|Death|1
5627505|NCT00721409|19437117|P1|Overall Study|Death|0
5627506|NCT00721409|19437115|P3|Overall Study|Global deterioration of health status|3
5627507|NCT00721409|19437116|P2|Overall Study|Global deterioration of health status|6
5627508|NCT00721409|19437117|P1|Overall Study|Global deterioration of health status|2
5627509|NCT00721396|19437244|P4|Overall Study|Administrative reason|0
5627510|NCT00721396|19437245|P3|Overall Study|Administrative reason|1
5627511|NCT00721396|19437246|P2|Overall Study|Administrative reason|0
5627512|NCT00721396|19437247|P1|Overall Study|Administrative reason|3
5627513|NCT00721396|19437244|P4|Overall Study|Inappropriate enrollment|0
5627514|NCT00721396|19437245|P3|Overall Study|Inappropriate enrollment|0
5627515|NCT00721396|19437246|P2|Overall Study|Inappropriate enrollment|2
5627516|NCT00721396|19437247|P1|Overall Study|Inappropriate enrollment|0
5627517|NCT00721396|19437244|P4|Overall Study|Protocol Violation|0
5627518|NCT00721396|19437245|P3|Overall Study|Protocol Violation|1
5627519|NCT00721396|19437246|P2|Overall Study|Protocol Violation|3
5627520|NCT00721396|19437247|P1|Overall Study|Protocol Violation|4
5627521|NCT00721396|19437244|P4|Overall Study|Lost to Follow-up|3
5627522|NCT00721396|19437245|P3|Overall Study|Lost to Follow-up|3
5627523|NCT00721396|19437246|P2|Overall Study|Lost to Follow-up|9
5627524|NCT00721396|19437247|P1|Overall Study|Lost to Follow-up|7
5627525|NCT00721396|19437244|P4|Overall Study|Withdrawal by Subject|7
5627526|NCT00721396|19437245|P3|Overall Study|Withdrawal by Subject|3
5627527|NCT00721396|19437246|P2|Overall Study|Withdrawal by Subject|15
5627528|NCT00721396|19437247|P1|Overall Study|Withdrawal by Subject|12
5627529|NCT00721396|19437244|P4|Overall Study|Adverse Event|0
5627530|NCT00721396|19437245|P3|Overall Study|Adverse Event|2
5627531|NCT00721396|19437246|P2|Overall Study|Adverse Event|7
5627532|NCT00721396|19437247|P1|Overall Study|Adverse Event|4
5627533|NCT00721279|19437298|P2|Overall Study|Other|16
5627534|NCT00721279|19437299|P1|Overall Study|Other|12
5627535|NCT00721279|19437298|P2|Overall Study|Withdrawal by Subject|3
5627536|NCT00721279|19437299|P1|Overall Study|Withdrawal by Subject|13
5627537|NCT00721279|19437298|P2|Overall Study|Tolerability insufficient|2
5627538|NCT00721279|19437299|P1|Overall Study|Tolerability insufficient|5
5627539|NCT00721279|19437298|P2|Overall Study|Lack of Efficacy|3
5627540|NCT00721279|19437299|P1|Overall Study|Lack of Efficacy|6
5627541|NCT00721227|19437327|P2|Overall Study|Noncompliance with scheduled visits.|0
5627542|NCT00721227|19437328|P1|Overall Study|Noncompliance with scheduled visits.|1
5627543|NCT00721227|19437327|P2|Overall Study|Lost to Follow-up|0
5627544|NCT00721227|19437328|P1|Overall Study|Lost to Follow-up|3
5627545|NCT00721214|19437338|P1|Overall Study|Death|3
5627546|NCT00721214|19437338|P1|Overall Study|Chose another center for transplant|1
5627547|NCT00721149|19437388|P1|Overall Study|Physician Decision|1
5627548|NCT00721123|19437422|P1|Overall Study|Withdrawal by Subject|5
5627549|NCT00721123|19437422|P1|Overall Study|Failure to Return|9
5627550|NCT00721123|19437422|P1|Overall Study|Refused Treatment|41
5627551|NCT00721123|19437422|P1|Overall Study|Protocol Violation|1
5627552|NCT00721123|19437422|P1|Overall Study|Insufficient Therapeutic Response|21
5627553|NCT00721123|19437422|P1|Overall Study|Death|10
5627554|NCT00721123|19437422|P1|Overall Study|Adverse Event|96
5627555|NCT00721110|19437500|P4|Overall Study|vertical incision|0
5627556|NCT00721110|19437501|P3|Overall Study|vertical incision|1
5627557|NCT00721110|19437502|P2|Overall Study|vertical incision|0
5627558|NCT00721110|19437503|P1|Overall Study|vertical incision|0
5627559|NCT00721110|19437500|P4|Overall Study|Ultram use|0
5627560|NCT00721110|19437501|P3|Overall Study|Ultram use|0
5627561|NCT00721110|19437502|P2|Overall Study|Ultram use|0
5627562|NCT00721110|19437503|P1|Overall Study|Ultram use|1
5627563|NCT00720941|19437531|P2|Overall Study|Ongoing|23
5627564|NCT00720941|19437532|P1|Overall Study|Ongoing|34
5627565|NCT00720941|19437531|P2|Overall Study|Withdrawal by Subject|35
5627566|NCT00720941|19437532|P1|Overall Study|Withdrawal by Subject|27
5627567|NCT00720941|19437531|P2|Overall Study|Physician Decision|5
5627568|NCT00720941|19437532|P1|Overall Study|Physician Decision|1
5627569|NCT00720941|19437531|P2|Overall Study|Lost to Follow-up|15
5627570|NCT00720941|19437532|P1|Overall Study|Lost to Follow-up|17
5627571|NCT00720941|19437531|P2|Overall Study|Protocol Violation|2
5627572|NCT00720941|19437532|P1|Overall Study|Protocol Violation|0
5627573|NCT00720941|19437531|P2|Overall Study|Death|335
5627574|NCT00720941|19437532|P1|Overall Study|Death|334
5627575|NCT00720876|19437572|P1|Overall Study|found to be ineligible after starting tx|2
5627576|NCT00720798|19437578|P1|Overall Study|Reason not Specified|83
5627577|NCT00720798|19437578|P1|Overall Study|Failure to Return|46
5627578|NCT00720798|19437578|P1|Overall Study|Refused Treatment|151
5627579|NCT00720798|19437578|P1|Overall Study|Protocol Violation|4
5627580|NCT00720798|19437578|P1|Overall Study|Insufficient Therapeutic Response|129
5627581|NCT00720798|19437578|P1|Overall Study|Death|39
5627582|NCT00720798|19437578|P1|Overall Study|Adverse Event|304
5627583|NCT00720759|19437601|P4|Overall Study|Lost to Follow-up|0
5627584|NCT00720759|19437602|P3|Overall Study|Lost to Follow-up|1
5627585|NCT00720759|19437603|P2|Overall Study|Lost to Follow-up|1
5627586|NCT00720759|19437604|P1|Overall Study|Lost to Follow-up|0
5627587|NCT00720499|19437624|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
5627588|NCT00720499|19437625|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
5627589|NCT00720499|19437624|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
5627590|NCT00720499|19437625|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
5627591|NCT00720499|19437624|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
5627592|NCT00720499|19437625|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
5627593|NCT00720434|19437718|P4|Open-Label Period (Week 5-72)|Other|2
5627594|NCT00720434|19437719|P3|Open-Label Period (Week 5-72)|Other|3
5627595|NCT00720434|19437720|P2|Open-Label Period (Week 5-72)|Other|3
5627596|NCT00720434|19437721|P1|Open-Label Period (Week 5-72)|Other|4
5627597|NCT00720434|19437718|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
5627598|NCT00720434|19437719|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
5627599|NCT00720434|19437720|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
5627600|NCT00720434|19437721|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
5627601|NCT00720434|19437718|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
5627602|NCT00720434|19437719|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
5627603|NCT00720434|19437720|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
5627604|NCT00720434|19437721|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
5627605|NCT00720434|19437718|P4|Open-Label Period (Week 5-72)|Adverse Event|2
5627606|NCT00720434|19437719|P3|Open-Label Period (Week 5-72)|Adverse Event|0
5627607|NCT00720434|19437720|P2|Open-Label Period (Week 5-72)|Adverse Event|0
5627608|NCT00720434|19437721|P1|Open-Label Period (Week 5-72)|Adverse Event|0
5627609|NCT00720434|19437718|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
5627610|NCT00720434|19437719|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
5627611|NCT00720434|19437720|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
5627612|NCT00720434|19437721|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
5627613|NCT00720382|19437745|P2|Overall Study|administrative|5
5627614|NCT00720382|19437746|P1|Overall Study|administrative|14
5627615|NCT00720382|19437745|P2|Overall Study|Lost to Follow-up|14
5627616|NCT00720382|19437746|P1|Overall Study|Lost to Follow-up|28
5627617|NCT00720382|19437745|P2|Overall Study|Withdrawal by Subject|11
5627618|NCT00720382|19437746|P1|Overall Study|Withdrawal by Subject|47
5627619|NCT00720382|19437745|P2|Overall Study|Non-Compliance|5
5627620|NCT00720382|19437746|P1|Overall Study|Non-Compliance|15
5627621|NCT00720382|19437745|P2|Overall Study|Lack of Efficacy|7
5627622|NCT00720382|19437746|P1|Overall Study|Lack of Efficacy|18
5627623|NCT00720382|19437745|P2|Overall Study|Adverse Event|17
5627624|NCT00720382|19437746|P1|Overall Study|Adverse Event|54
5627625|NCT00720356|19437765|P1|Follow up Until Death|Alive at last data collection|4
5627626|NCT00720356|19437765|P1|Follow up Until Death|Withdrawal by Subject|1
5627627|NCT00720356|19437765|P1|Went on to be Treated Cycle 3|Physician Decision|1
5627628|NCT00720356|19437765|P1|Went on to be Treated Cycle 3|Adverse Event|1
5627629|NCT00720356|19437765|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
5627630|NCT00720356|19437765|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
5627631|NCT00720356|19437765|P1|Registration to Study|Determined to have methylated MGMT|67
5627632|NCT00720343|19437779|P1|Overall Study|No data|3
5627633|NCT00720343|19437779|P1|Overall Study|Physician Decision|3
5627634|NCT00720278|19437813|P3|Overall Study|eligibility criteria violation|1
5627635|NCT00720278|19437814|P2|Overall Study|eligibility criteria violation|0
5627636|NCT00720278|19437815|P1|Overall Study|eligibility criteria violation|1
5627637|NCT00720278|19437813|P3|Overall Study|Non-compliance|0
5627638|NCT00720278|19437814|P2|Overall Study|Non-compliance|0
5627639|NCT00720278|19437815|P1|Overall Study|Non-compliance|1
5627640|NCT00720278|19437813|P3|Overall Study|Lost to Follow-up|1
5627641|NCT00720278|19437814|P2|Overall Study|Lost to Follow-up|0
5627642|NCT00720278|19437815|P1|Overall Study|Lost to Follow-up|0
5627643|NCT00720278|19437813|P3|Overall Study|Withdrawal by Subject|0
5627644|NCT00720278|19437814|P2|Overall Study|Withdrawal by Subject|1
5627645|NCT00720278|19437815|P1|Overall Study|Withdrawal by Subject|0
5627646|NCT00720278|19437813|P3|Overall Study|Adverse Event|4
5627647|NCT00720278|19437814|P2|Overall Study|Adverse Event|3
5627648|NCT00720278|19437815|P1|Overall Study|Adverse Event|5
5627649|NCT00720226|19437837|P2|Overall Study|Withdrawal by Subject|4
5627650|NCT00720226|19437838|P1|Overall Study|Withdrawal by Subject|7
5627651|NCT00720213|19437846|P3|Screening Phase With Diagnostic PSG|Screen Failure|0
5627652|NCT00720213|19437847|P2|Screening Phase With Diagnostic PSG|Screen Failure|0
5627653|NCT00720213|19437848|P1|Screening Phase With Diagnostic PSG|Screen Failure|7
5627654|NCT00720122|19437886|P1|Overall Study|Withdrawal by Subject|7
5627655|NCT00720122|19437886|P1|Overall Study|Physician Decision|1
5627656|NCT00720122|19437886|P1|Overall Study|Lost to Follow-up|1
5627657|NCT00720109|19437890|P3|Risk Stratification Period|Development of second malignant neoplasm|0
5627658|NCT00720109|19437891|P2|Risk Stratification Period|Development of second malignant neoplasm|1
5627659|NCT00720109|19437892|P1|Risk Stratification Period|Development of second malignant neoplasm|0
5627660|NCT00720109|19437890|P3|Risk Stratification Period|Disease progression or relapse|0
5627661|NCT00720109|19437891|P2|Risk Stratification Period|Disease progression or relapse|2
5627662|NCT00720109|19437892|P1|Risk Stratification Period|Disease progression or relapse|0
5627663|NCT00720109|19437890|P3|Risk Stratification Period|Bone marrow transplant|7
5627664|NCT00720109|19437891|P2|Risk Stratification Period|Bone marrow transplant|9
5627665|NCT00720109|19437892|P1|Risk Stratification Period|Bone marrow transplant|0
5627666|NCT00720109|19437890|P3|Risk Stratification Period|Physician Decision|1
5627667|NCT00720109|19437891|P2|Risk Stratification Period|Physician Decision|2
5627668|NCT00720109|19437892|P1|Risk Stratification Period|Physician Decision|0
5627669|NCT00720109|19437890|P3|Risk Stratification Period|Adverse Event|0
5627670|NCT00720109|19437891|P2|Risk Stratification Period|Adverse Event|1
5627671|NCT00720109|19437892|P1|Risk Stratification Period|Adverse Event|0
5627672|NCT00720109|19437890|P3|Induction Period|Physician Decision|0
5627673|NCT00720109|19437891|P2|Induction Period|Physician Decision|0
5627674|NCT00720109|19437892|P1|Induction Period|Physician Decision|1
5627675|NCT00720109|19437890|P3|Induction Period|Bone Marrow Transplant|0
5627676|NCT00720109|19437891|P2|Induction Period|Bone Marrow Transplant|0
5627677|NCT00720109|19437892|P1|Induction Period|Bone Marrow Transplant|2
5627678|NCT00720109|19437890|P3|Induction Period|Did not meet eligibility criteria|0
5627679|NCT00720109|19437891|P2|Induction Period|Did not meet eligibility criteria|0
5627680|NCT00720109|19437892|P1|Induction Period|Did not meet eligibility criteria|3
5627681|NCT00720096|19437912|P2|Overall Study|Withdrawal by Subject|2
5627682|NCT00720096|19437913|P1|Overall Study|Withdrawal by Subject|0
5627683|NCT00720083|19437925|P2|Overall Study|Ineligible|2
5627684|NCT00720083|19437926|P1|Overall Study|Ineligible|1
5627685|NCT00720057|19437934|P2|Overall Study|Withdrawal by Subject|1
5627686|NCT00720057|19437935|P1|Overall Study|Withdrawal by Subject|0
5627687|NCT00720057|19437934|P2|Overall Study|Protocol Violation|0
5627688|NCT00720057|19437935|P1|Overall Study|Protocol Violation|1
5627689|NCT00720057|19437934|P2|Overall Study|Lost to Follow-up|2
5627690|NCT00720057|19437935|P1|Overall Study|Lost to Follow-up|0
5627691|NCT00719953|19437951|P1|Overall Study|Adverse Event|4
5627692|NCT00719901|19437964|P1|Overall Study|Availability of Study Drug|1
5627693|NCT00719901|19437964|P1|Overall Study|Disease Progression|3
5627694|NCT00719901|19437964|P1|Overall Study|Alternate Treatment|1
5627695|NCT00719901|19437964|P1|Overall Study|Withdrawal by Subject|1
5627696|NCT00719901|19437964|P1|Overall Study|Adverse Event|5
5627697|NCT00719862|19437976|P2|Overall Study|Other|3
5627698|NCT00719862|19437977|P1|Overall Study|Other|2
5627699|NCT00719862|19437976|P2|Overall Study|Lost to Follow-up|1
5627700|NCT00719862|19437977|P1|Overall Study|Lost to Follow-up|0
5627701|NCT00719862|19437976|P2|Overall Study|Withdrawal by Subject|0
5627702|NCT00719862|19437977|P1|Overall Study|Withdrawal by Subject|1
5627703|NCT00719862|19437976|P2|Overall Study|Non-Compliance|0
5627704|NCT00719862|19437977|P1|Overall Study|Non-Compliance|1
5627705|NCT00719862|19437976|P2|Overall Study|Lack of Efficacy|0
5627706|NCT00719862|19437977|P1|Overall Study|Lack of Efficacy|3
5627707|NCT00719862|19437976|P2|Overall Study|Adverse Event|2
5627708|NCT00719862|19437977|P1|Overall Study|Adverse Event|1
5627709|NCT00719849|19437995|P2|Overall Study|Death|1
5627710|NCT00719849|19437996|P1|Overall Study|Death|0
5627711|NCT00719810|19438035|P3|Overall Study|Withdrawal by Subject|2
5627712|NCT00719810|19438036|P2|Overall Study|Withdrawal by Subject|1
5627713|NCT00719810|19438037|P1|Overall Study|Withdrawal by Subject|1
5627714|NCT00719810|19438035|P3|Overall Study|Physician Decision|0
5627715|NCT00719810|19438036|P2|Overall Study|Physician Decision|1
5627716|NCT00719810|19438037|P1|Overall Study|Physician Decision|0
5627717|NCT00719810|19438035|P3|Overall Study|Lost to Follow-up|3
5627718|NCT00719810|19438036|P2|Overall Study|Lost to Follow-up|0
5627719|NCT00719810|19438037|P1|Overall Study|Lost to Follow-up|2
5627720|NCT00719810|19438035|P3|Overall Study|Adverse Event|3
5627721|NCT00719810|19438036|P2|Overall Study|Adverse Event|2
5627722|NCT00719810|19438037|P1|Overall Study|Adverse Event|0
5627723|NCT00719732|19438048|P1|Overall Study|Illness not associated with device|1
5627724|NCT00719732|19438048|P1|Overall Study|Unilateral (not bilateral) implantation|1
5627725|NCT00719732|19438048|P1|Overall Study|Lost to Follow-up|20
5627726|NCT00719706|19438054|P2|Overall Study|Protocol Violation|0
5627727|NCT00719706|19438055|P1|Overall Study|Protocol Violation|3
5627728|NCT00719706|19438054|P2|Overall Study|Withdrawal by Subject|2
5627729|NCT00719706|19438055|P1|Overall Study|Withdrawal by Subject|1
5627730|NCT00719706|19438054|P2|Overall Study|Adverse Event|4
5627731|NCT00719706|19438055|P1|Overall Study|Adverse Event|5
5627732|NCT00719680|19438069|P1|Overall Study|Withdrawal by Subject|3
5627733|NCT00719680|19438069|P1|Overall Study|Lost to Follow-up|1
5627734|NCT00719680|19438069|P1|Overall Study|Adverse Event|1
5627735|NCT00719563|19438125|P2|Overall Study|Lost to Follow-up|3
5627736|NCT00719563|19438126|P1|Overall Study|Lost to Follow-up|5
5627737|NCT00719563|19438125|P2|Overall Study|Noncompliant|1
5627738|NCT00719563|19438126|P1|Overall Study|Noncompliant|1
5627739|NCT00719563|19438125|P2|Overall Study|Unknown reasons|6
5627740|NCT00719563|19438126|P1|Overall Study|Unknown reasons|4
5627741|NCT00719563|19438125|P2|Overall Study|Personal reasons|7
5627742|NCT00719563|19438126|P1|Overall Study|Personal reasons|6
5627743|NCT00719563|19438125|P2|Overall Study|Lack of Efficacy|7
5627744|NCT00719563|19438126|P1|Overall Study|Lack of Efficacy|3
5627745|NCT00719563|19438125|P2|Overall Study|Medical condition changed|5
5627746|NCT00719563|19438126|P1|Overall Study|Medical condition changed|3
5627747|NCT00719563|19438125|P2|Overall Study|Adverse Event|13
5627748|NCT00719563|19438126|P1|Overall Study|Adverse Event|16
5627749|NCT00719537|19438158|P2|Overall Study|Lost to Follow-up|1
5627750|NCT00719537|19438159|P1|Overall Study|Lost to Follow-up|0
5627751|NCT00719537|19438158|P2|Overall Study|Withdrawal by Subject|0
5627752|NCT00719537|19438159|P1|Overall Study|Withdrawal by Subject|1
5627753|NCT00719472|19438165|P1|Received Cycle 2 Treatment|Various Reasons|25
5627754|NCT00719472|19438165|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
5627755|NCT00719472|19438165|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
5627756|NCT00719472|19438165|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
5627757|NCT00719472|19438165|P1|Received Cycle 2 Treatment|Disease progression|3
5627758|NCT00719472|19438165|P1|Received Cycle 2 Treatment|Death|6
5627759|NCT00719472|19438165|P1|Received Cycle 2 Treatment|Adverse Event|12
5627760|NCT00719472|19438165|P1|Received Cycle 1 Treatment|Various Reasons|13
5627761|NCT00719472|19438165|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
5627762|NCT00719472|19438165|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
5627763|NCT00719472|19438165|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
5627764|NCT00719472|19438165|P1|Received Cycle 1 Treatment|Death|5
5627765|NCT00719472|19438165|P1|Received Cycle 1 Treatment|Adverse Event|8
5627766|NCT00719472|19438165|P1|Enrolled in Study|Various Reasons|17
5627767|NCT00719472|19438165|P1|Enrolled in Study|Subject decision to withdraw|8
5627768|NCT00719472|19438165|P1|Enrolled in Study|Physician decision to withdraw patient|1
5627769|NCT00719355|19438176|P2|Overall Study|Moved|1
5627770|NCT00719355|19438177|P1|Overall Study|Moved|0
5627771|NCT00719355|19438176|P2|Overall Study|Compliance|6
5627772|NCT00719355|19438177|P1|Overall Study|Compliance|4
5627773|NCT00719355|19438176|P2|Overall Study|Medical|5
5627774|NCT00719355|19438177|P1|Overall Study|Medical|14
5627775|NCT00719355|19438176|P2|Overall Study|Death|1
5627776|NCT00719355|19438177|P1|Overall Study|Death|0
5627777|NCT00719264|19438206|P2|Overall Study|Disease Progression|107
5627778|NCT00719264|19438207|P1|Overall Study|Disease Progression|104
5627779|NCT00719264|19438206|P2|Overall Study|New Cancer Therapy|2
5627780|NCT00719264|19438207|P1|Overall Study|New Cancer Therapy|4
5627781|NCT00719264|19438206|P2|Overall Study|Protocol Deviation|3
5627782|NCT00719264|19438207|P1|Overall Study|Protocol Deviation|1
5627783|NCT00719264|19438206|P2|Overall Study|Withdrawal by Subject|7
5627784|NCT00719264|19438207|P1|Overall Study|Withdrawal by Subject|12
5627785|NCT00719264|19438206|P2|Overall Study|Lost to Follow-up|1
5627786|NCT00719264|19438207|P1|Overall Study|Lost to Follow-up|1
5627787|NCT00719264|19438206|P2|Overall Study|Administrative Problems|4
5627788|NCT00719264|19438207|P1|Overall Study|Administrative Problems|6
5627789|NCT00719264|19438206|P2|Overall Study|Death|10
5627790|NCT00719264|19438207|P1|Overall Study|Death|13
5627791|NCT00719264|19438206|P2|Overall Study|Adverse Event|49
5627792|NCT00719264|19438207|P1|Overall Study|Adverse Event|41
5627793|NCT00719212|19438226|P1|Overall Study|Withdrawal by Subject|1
5627794|NCT00719212|19438226|P1|Overall Study|Lost to Follow-up|2
5627795|NCT00719212|19438226|P1|Overall Study|Death|41
5627796|NCT00719043|19438274|P7|Overall Study|Withdrawal by Subject|14
5627797|NCT00719043|19438275|P6|Overall Study|Withdrawal by Subject|18
5627798|NCT00719043|19438276|P5|Overall Study|Withdrawal by Subject|16
5627799|NCT00719043|19438277|P4|Overall Study|Withdrawal by Subject|10
5627800|NCT00719043|19438278|P3|Overall Study|Withdrawal by Subject|9
5627801|NCT00719043|19438279|P2|Overall Study|Withdrawal by Subject|14
5627802|NCT00719043|19438280|P1|Overall Study|Withdrawal by Subject|12
5627803|NCT00719043|19438274|P7|Overall Study|Other|1
5627804|NCT00719043|19438275|P6|Overall Study|Other|2
5627805|NCT00719043|19438276|P5|Overall Study|Other|0
5627806|NCT00719043|19438277|P4|Overall Study|Other|2
5627807|NCT00719043|19438278|P3|Overall Study|Other|1
5627808|NCT00719043|19438279|P2|Overall Study|Other|0
5627809|NCT00719043|19438280|P1|Overall Study|Other|1
5627810|NCT00719043|19438274|P7|Overall Study|Protocol Violation|0
5627811|NCT00719043|19438275|P6|Overall Study|Protocol Violation|1
5627812|NCT00719043|19438276|P5|Overall Study|Protocol Violation|0
5627813|NCT00719043|19438277|P4|Overall Study|Protocol Violation|0
5627814|NCT00719043|19438278|P3|Overall Study|Protocol Violation|0
5627815|NCT00719043|19438279|P2|Overall Study|Protocol Violation|0
5627816|NCT00719043|19438280|P1|Overall Study|Protocol Violation|0
5627817|NCT00719043|19438274|P7|Overall Study|Lost to Follow-up|9
5627818|NCT00719043|19438275|P6|Overall Study|Lost to Follow-up|9
5627819|NCT00719043|19438276|P5|Overall Study|Lost to Follow-up|10
5627820|NCT00719043|19438277|P4|Overall Study|Lost to Follow-up|9
5627821|NCT00719043|19438278|P3|Overall Study|Lost to Follow-up|8
5627822|NCT00719043|19438279|P2|Overall Study|Lost to Follow-up|10
5627823|NCT00719043|19438280|P1|Overall Study|Lost to Follow-up|14
5627824|NCT00719043|19438274|P7|Overall Study|Adverse Event|4
5627825|NCT00719043|19438275|P6|Overall Study|Adverse Event|4
5627826|NCT00719043|19438276|P5|Overall Study|Adverse Event|1
5627827|NCT00719043|19438277|P4|Overall Study|Adverse Event|2
5627828|NCT00719043|19438278|P3|Overall Study|Adverse Event|2
5627829|NCT00719043|19438279|P2|Overall Study|Adverse Event|1
5627830|NCT00719043|19438280|P1|Overall Study|Adverse Event|5
5627831|NCT00718887|19438404|P2|Overall Study|Not identified|7
5627832|NCT00718887|19438405|P1|Overall Study|Not identified|2
5627833|NCT00718887|19438404|P2|Overall Study|Withdrawal by Subject|2
5627834|NCT00718887|19438405|P1|Overall Study|Withdrawal by Subject|3
5627835|NCT00718861|19438429|P2|Overall Study|Death|5
5627836|NCT00718861|19438430|P1|Overall Study|Death|1
5627837|NCT00718861|19438429|P2|Overall Study|Administrative Problems|1
5627838|NCT00718861|19438430|P1|Overall Study|Administrative Problems|1
5627839|NCT00718861|19438429|P2|Overall Study|Lost to Follow-up|1
5627840|NCT00718861|19438430|P1|Overall Study|Lost to Follow-up|2
5627841|NCT00718861|19438429|P2|Overall Study|Adverse Event|1
5627842|NCT00718861|19438430|P1|Overall Study|Adverse Event|2
5627843|NCT00718861|19438429|P2|Overall Study|Withdrawal by Subject|10
5627844|NCT00718861|19438430|P1|Overall Study|Withdrawal by Subject|15
5627845|NCT00718809|19438458|P2|Overall Study|Noncompliance|0
5627846|NCT00718809|19438459|P1|Overall Study|Noncompliance|1
5627847|NCT00718809|19438458|P2|Overall Study|Lost to Follow-up|0
5627848|NCT00718809|19438459|P1|Overall Study|Lost to Follow-up|1
5627849|NCT00718809|19438458|P2|Overall Study|Withdrawal by Subject|1
5627850|NCT00718809|19438459|P1|Overall Study|Withdrawal by Subject|0
5627851|NCT00718809|19438458|P2|Overall Study|Adverse Event|1
5627852|NCT00718809|19438459|P1|Overall Study|Adverse Event|1
5627853|NCT00718809|19438458|P2|Overall Study|Disease progression|7
5627854|NCT00718809|19438459|P1|Overall Study|Disease progression|9
5627855|NCT00718770|19438473|P1|Overall Study|Adverse Event|1
5627856|NCT00718770|19438473|P1|Overall Study|Lack of Efficacy|1
5627857|NCT00718770|19438473|P1|Overall Study|Adverse Event|1
5627858|NCT00718770|19438473|P1|Overall Study|Lack of Efficacy|1
5627859|NCT00718770|19438473|P1|Overall Study|Adverse Event|1
5627860|NCT00718770|19438473|P1|Overall Study|Lack of Efficacy|1
5627861|NCT00718770|19438473|P1|Overall Study|Lack of Efficacy|1
5627862|NCT00718770|19438473|P1|Overall Study|Adverse Event|1
5627863|NCT00718718|19438484|P10|Week 12 to End of Study|Other|0
5627864|NCT00718718|19438485|P9|Week 12 to End of Study|Other|0
5627865|NCT00718718|19438486|P8|Week 12 to End of Study|Other|0
5627866|NCT00718718|19438487|P7|Week 12 to End of Study|Other|1
5627867|NCT00718718|19438488|P6|Week 12 to End of Study|Other|0
5627868|NCT00718718|19438489|P5|Week 12 to End of Study|Other|0
5627869|NCT00718718|19438490|P4|Week 12 to End of Study|Other|1
5627870|NCT00718718|19438491|P3|Week 12 to End of Study|Other|0
5627871|NCT00718718|19438492|P2|Week 12 to End of Study|Other|1
5627872|NCT00718718|19438493|P1|Week 12 to End of Study|Other|0
5627873|NCT00718718|19438484|P10|Week 12 to End of Study|Lost to Follow-up|0
5627874|NCT00718718|19438485|P9|Week 12 to End of Study|Lost to Follow-up|1
5627875|NCT00718718|19438486|P8|Week 12 to End of Study|Lost to Follow-up|0
5627876|NCT00718718|19438487|P7|Week 12 to End of Study|Lost to Follow-up|0
5627877|NCT00718718|19438488|P6|Week 12 to End of Study|Lost to Follow-up|0
5627878|NCT00718718|19438489|P5|Week 12 to End of Study|Lost to Follow-up|0
5627879|NCT00718718|19438490|P4|Week 12 to End of Study|Lost to Follow-up|0
5627880|NCT00718718|19438491|P3|Week 12 to End of Study|Lost to Follow-up|0
5627881|NCT00718718|19438492|P2|Week 12 to End of Study|Lost to Follow-up|0
5627882|NCT00718718|19438493|P1|Week 12 to End of Study|Lost to Follow-up|0
5627883|NCT00718718|19438484|P10|Week 12 to End of Study|Withdrawal by Subject|0
5627884|NCT00718718|19438485|P9|Week 12 to End of Study|Withdrawal by Subject|0
5627885|NCT00718718|19438486|P8|Week 12 to End of Study|Withdrawal by Subject|0
5627886|NCT00718718|19438487|P7|Week 12 to End of Study|Withdrawal by Subject|1
5627887|NCT00718718|19438488|P6|Week 12 to End of Study|Withdrawal by Subject|2
5627888|NCT00718718|19438489|P5|Week 12 to End of Study|Withdrawal by Subject|0
5627889|NCT00718718|19438490|P4|Week 12 to End of Study|Withdrawal by Subject|0
5627890|NCT00718718|19438491|P3|Week 12 to End of Study|Withdrawal by Subject|0
5627891|NCT00718718|19438492|P2|Week 12 to End of Study|Withdrawal by Subject|0
5627892|NCT00718718|19438493|P1|Week 12 to End of Study|Withdrawal by Subject|0
5627893|NCT00718718|19438484|P10|Week 12 to End of Study|Death|0
5627894|NCT00718718|19438485|P9|Week 12 to End of Study|Death|0
5627895|NCT00718718|19438486|P8|Week 12 to End of Study|Death|0
5627896|NCT00718718|19438487|P7|Week 12 to End of Study|Death|0
5627897|NCT00718718|19438488|P6|Week 12 to End of Study|Death|1
5627898|NCT00718718|19438489|P5|Week 12 to End of Study|Death|0
5627899|NCT00718718|19438490|P4|Week 12 to End of Study|Death|0
5627900|NCT00718718|19438491|P3|Week 12 to End of Study|Death|0
5627901|NCT00718718|19438492|P2|Week 12 to End of Study|Death|0
5627902|NCT00718718|19438493|P1|Week 12 to End of Study|Death|0
5627903|NCT00718718|19438484|P10|Week 12 to End of Study|Adverse Event|0
5627904|NCT00718718|19438485|P9|Week 12 to End of Study|Adverse Event|0
5627905|NCT00718718|19438486|P8|Week 12 to End of Study|Adverse Event|1
5627906|NCT00718718|19438487|P7|Week 12 to End of Study|Adverse Event|0
5627907|NCT00718718|19438488|P6|Week 12 to End of Study|Adverse Event|0
5627908|NCT00718718|19438489|P5|Week 12 to End of Study|Adverse Event|0
5627909|NCT00718718|19438490|P4|Week 12 to End of Study|Adverse Event|0
5627910|NCT00718718|19438491|P3|Week 12 to End of Study|Adverse Event|0
5627911|NCT00718718|19438492|P2|Week 12 to End of Study|Adverse Event|0
5627912|NCT00718718|19438493|P1|Week 12 to End of Study|Adverse Event|0
5627913|NCT00718718|19438484|P10|Prior to Week 12|Other|0
5627914|NCT00718718|19438485|P9|Prior to Week 12|Other|0
5627915|NCT00718718|19438486|P8|Prior to Week 12|Other|0
5627916|NCT00718718|19438487|P7|Prior to Week 12|Other|0
5627917|NCT00718718|19438488|P6|Prior to Week 12|Other|0
5627918|NCT00718718|19438489|P5|Prior to Week 12|Other|0
5627919|NCT00718718|19438490|P4|Prior to Week 12|Other|0
5627920|NCT00718718|19438491|P3|Prior to Week 12|Other|1
5627921|NCT00718718|19438492|P2|Prior to Week 12|Other|0
5627922|NCT00718718|19438493|P1|Prior to Week 12|Other|1
5627923|NCT00718718|19438484|P10|Prior to Week 12|Withdrawal by Subject|0
5627924|NCT00718718|19438485|P9|Prior to Week 12|Withdrawal by Subject|1
5627925|NCT00718718|19438486|P8|Prior to Week 12|Withdrawal by Subject|1
5627926|NCT00718718|19438487|P7|Prior to Week 12|Withdrawal by Subject|1
5627927|NCT00718718|19438488|P6|Prior to Week 12|Withdrawal by Subject|0
5627928|NCT00718718|19438489|P5|Prior to Week 12|Withdrawal by Subject|3
5627929|NCT00718718|19438490|P4|Prior to Week 12|Withdrawal by Subject|0
5627930|NCT00718718|19438491|P3|Prior to Week 12|Withdrawal by Subject|0
5627931|NCT00718718|19438492|P2|Prior to Week 12|Withdrawal by Subject|0
5627932|NCT00718718|19438493|P1|Prior to Week 12|Withdrawal by Subject|0
5627933|NCT00718718|19438484|P10|Prior to Week 12|Adverse Event|0
5627934|NCT00718718|19438485|P9|Prior to Week 12|Adverse Event|1
5627935|NCT00718718|19438486|P8|Prior to Week 12|Adverse Event|1
5627936|NCT00718718|19438487|P7|Prior to Week 12|Adverse Event|0
5627937|NCT00718718|19438488|P6|Prior to Week 12|Adverse Event|0
5627938|NCT00718718|19438489|P5|Prior to Week 12|Adverse Event|0
5627939|NCT00718718|19438490|P4|Prior to Week 12|Adverse Event|0
5627940|NCT00718718|19438491|P3|Prior to Week 12|Adverse Event|0
5627941|NCT00718718|19438492|P2|Prior to Week 12|Adverse Event|0
5627942|NCT00718718|19438493|P1|Prior to Week 12|Adverse Event|0
5627943|NCT00718666|19438536|P3|Booster Phase Year 5|Lost to Follow-up|4
5627944|NCT00718666|19438537|P2|Booster Phase Year 5|Lost to Follow-up|0
5627945|NCT00718666|19438538|P1|Booster Phase Year 5|Lost to Follow-up|1
5627946|NCT00718666|19438536|P3|Booster Phase Year 5|Withdrawal by Subject|1
5627947|NCT00718666|19438537|P2|Booster Phase Year 5|Withdrawal by Subject|0
5627948|NCT00718666|19438538|P1|Booster Phase Year 5|Withdrawal by Subject|0
5627949|NCT00718666|19438536|P3|Booster Phase Year 5|Declined v-4 serology|0
5627950|NCT00718666|19438537|P2|Booster Phase Year 5|Declined v-4 serology|0
5627951|NCT00718666|19438538|P1|Booster Phase Year 5|Declined v-4 serology|1
5627952|NCT00718666|19438536|P3|Booster Phase Year 5|No active participation request|1
5627953|NCT00718666|19438537|P2|Booster Phase Year 5|No active participation request|0
5627954|NCT00718666|19438538|P1|Booster Phase Year 5|No active participation request|0
5627955|NCT00718640|19438622|P1|Overall Study|Unresolved toxicity after 2 weeks|2
5627956|NCT00718640|19438622|P1|Overall Study|Death|1
5627957|NCT00718640|19438622|P1|Overall Study|Adverse Event|4
5627958|NCT00718549|19438634|P3|Maintenance/ Observation Phase|Relapse|2
5627959|NCT00718549|19438635|P2|Maintenance/ Observation Phase|Relapse|3
5627960|NCT00718549|19438636|P1|Maintenance/ Observation Phase|Relapse|0
5627961|NCT00718549|19438634|P3|Maintenance/ Observation Phase|Progression|14
5627962|NCT00718549|19438635|P2|Maintenance/ Observation Phase|Progression|5
5627963|NCT00718549|19438636|P1|Maintenance/ Observation Phase|Progression|0
5627964|NCT00718549|19438634|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
5627965|NCT00718549|19438635|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
5627966|NCT00718549|19438636|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
5627967|NCT00718549|19438634|P3|Maintenance/ Observation Phase|Death|2
5627968|NCT00718549|19438635|P2|Maintenance/ Observation Phase|Death|1
5627969|NCT00718549|19438636|P1|Maintenance/ Observation Phase|Death|0
5627970|NCT00718549|19438634|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
5627971|NCT00718549|19438635|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
5627972|NCT00718549|19438636|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
5627973|NCT00718549|19438634|P3|Induction Phase|Early Termination - No Additional Info|0
5627974|NCT00718549|19438635|P2|Induction Phase|Early Termination - No Additional Info|0
5627975|NCT00718549|19438636|P1|Induction Phase|Early Termination - No Additional Info|59
5627976|NCT00718549|19438634|P3|Induction Phase|Eligibility Criteria Violation|0
5627977|NCT00718549|19438635|P2|Induction Phase|Eligibility Criteria Violation|0
5627978|NCT00718549|19438636|P1|Induction Phase|Eligibility Criteria Violation|2
5627979|NCT00718549|19438634|P3|Induction Phase|Disease Progression|0
5627980|NCT00718549|19438635|P2|Induction Phase|Disease Progression|0
5627981|NCT00718549|19438636|P1|Induction Phase|Disease Progression|1
5627982|NCT00718523|19438661|P2|Overall Study|Death|17
5627983|NCT00718523|19438662|P1|Overall Study|Death|13
5627984|NCT00718523|19438661|P2|Overall Study|Withdrawal by Subject|7
5627985|NCT00718523|19438662|P1|Overall Study|Withdrawal by Subject|5
5627986|NCT00718510|19438674|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
5627987|NCT00718510|19438675|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
5627988|NCT00718510|19438674|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
5627989|NCT00718510|19438675|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
5627990|NCT00718419|19438687|P2|Overall Study|Death Due to Adverse Events|0
5627991|NCT00718419|19438688|P1|Overall Study|Death Due to Adverse Events|1
5627992|NCT00718419|19438687|P2|Overall Study|Death Due to Study Drug Related|1
5627993|NCT00718419|19438688|P1|Overall Study|Death Due to Study Drug Related|0
5627994|NCT00718419|19438687|P2|Overall Study|Death Due to Progressive Disease|0
5627995|NCT00718419|19438688|P1|Overall Study|Death Due to Progressive Disease|2
5627996|NCT00718419|19438687|P2|Overall Study|Progressive Disease|25
5627997|NCT00718419|19438688|P1|Overall Study|Progressive Disease|7
5627998|NCT00718419|19438687|P2|Overall Study|Withdrawal by Subject|5
5627999|NCT00718419|19438688|P1|Overall Study|Withdrawal by Subject|0
5628000|NCT00718419|19438687|P2|Overall Study|Sponsor decision|1
5628001|NCT00718419|19438688|P1|Overall Study|Sponsor decision|0
5628002|NCT00718419|19438687|P2|Overall Study|Physician Decision|6
5628003|NCT00718419|19438688|P1|Overall Study|Physician Decision|1
5628004|NCT00718419|19438687|P2|Overall Study|Adverse Event|1
5628005|NCT00718419|19438688|P1|Overall Study|Adverse Event|2
5628006|NCT00718328|19438704|P2|Overall Study|Lost to Follow-up|0
5628007|NCT00718328|19438705|P1|Overall Study|Lost to Follow-up|1
5628008|NCT00718315|19438714|P3|Overall Study|Use of ATB and Corticoids|2
5628009|NCT00718315|19438715|P2|Overall Study|Use of ATB and Corticoids|1
5628010|NCT00718315|19438716|P1|Overall Study|Use of ATB and Corticoids|0
5628011|NCT00718315|19438714|P3|Overall Study|Other|1
5628012|NCT00718315|19438715|P2|Overall Study|Other|0
5628013|NCT00718315|19438716|P1|Overall Study|Other|0
5628014|NCT00718315|19438714|P3|Overall Study|Disease progression|1
5628015|NCT00718315|19438715|P2|Overall Study|Disease progression|1
5628016|NCT00718315|19438716|P1|Overall Study|Disease progression|0
5628017|NCT00718315|19438714|P3|Overall Study|Use of Minocyclin|1
5628018|NCT00718315|19438715|P2|Overall Study|Use of Minocyclin|1
5628019|NCT00718315|19438716|P1|Overall Study|Use of Minocyclin|1
5628020|NCT00718315|19438714|P3|Overall Study|Erlotinib dose decreased|1
5628021|NCT00718315|19438715|P2|Overall Study|Erlotinib dose decreased|3
5628022|NCT00718315|19438716|P1|Overall Study|Erlotinib dose decreased|4
5628023|NCT00718315|19438714|P3|Overall Study|Protocol Violation|3
5628024|NCT00718315|19438715|P2|Overall Study|Protocol Violation|5
5628025|NCT00718315|19438716|P1|Overall Study|Protocol Violation|5
5628026|NCT00718315|19438714|P3|Overall Study|Lost to Follow-up|4
5628027|NCT00718315|19438715|P2|Overall Study|Lost to Follow-up|3
5628028|NCT00718315|19438716|P1|Overall Study|Lost to Follow-up|2
5628029|NCT00718315|19438714|P3|Overall Study|Death|5
5628030|NCT00718315|19438715|P2|Overall Study|Death|6
5628031|NCT00718315|19438716|P1|Overall Study|Death|6
5628032|NCT00718315|19438714|P3|Overall Study|Adverse Event|3
5628033|NCT00718315|19438715|P2|Overall Study|Adverse Event|2
5628034|NCT00718315|19438716|P1|Overall Study|Adverse Event|1
5628035|NCT00718237|19438767|P2|Overall Study|Withdrawal by Subject|10
5628036|NCT00718237|19438768|P1|Overall Study|Withdrawal by Subject|9
5628037|NCT00718237|19438767|P2|Overall Study|Physician Decision|0
5628038|NCT00718237|19438768|P1|Overall Study|Physician Decision|1
5628039|NCT00718237|19438767|P2|Overall Study|Lost to Follow-up|2
5628040|NCT00718237|19438768|P1|Overall Study|Lost to Follow-up|2
5628041|NCT00718237|19438767|P2|Overall Study|Adverse Event|3
5628042|NCT00718237|19438768|P1|Overall Study|Adverse Event|1
5628043|NCT00718159|19438785|P7|Overall Study|Investigator Decision|1
5628044|NCT00718159|19438786|P6|Overall Study|Investigator Decision|1
5628045|NCT00718159|19438787|P5|Overall Study|Investigator Decision|0
5628046|NCT00718159|19438788|P4|Overall Study|Investigator Decision|0
5628047|NCT00718159|19438789|P3|Overall Study|Investigator Decision|0
5628048|NCT00718159|19438790|P2|Overall Study|Investigator Decision|0
5628049|NCT00718159|19438791|P1|Overall Study|Investigator Decision|0
5628050|NCT00718159|19438785|P7|Overall Study|Death due to Study Drug Toxicity|0
5628051|NCT00718159|19438786|P6|Overall Study|Death due to Study Drug Toxicity|0
5628052|NCT00718159|19438787|P5|Overall Study|Death due to Study Drug Toxicity|0
5628053|NCT00718159|19438788|P4|Overall Study|Death due to Study Drug Toxicity|2
5628054|NCT00718159|19438789|P3|Overall Study|Death due to Study Drug Toxicity|1
5628055|NCT00718159|19438790|P2|Overall Study|Death due to Study Drug Toxicity|0
5628056|NCT00718159|19438791|P1|Overall Study|Death due to Study Drug Toxicity|0
5628057|NCT00718159|19438785|P7|Overall Study|Death due to Adverse Event|0
5628058|NCT00718159|19438786|P6|Overall Study|Death due to Adverse Event|0
5628059|NCT00718159|19438787|P5|Overall Study|Death due to Adverse Event|2
5628060|NCT00718159|19438788|P4|Overall Study|Death due to Adverse Event|2
5628061|NCT00718159|19438789|P3|Overall Study|Death due to Adverse Event|0
5628062|NCT00718159|19438790|P2|Overall Study|Death due to Adverse Event|0
5628063|NCT00718159|19438791|P1|Overall Study|Death due to Adverse Event|0
5628064|NCT00718159|19438785|P7|Overall Study|Progressive Disease|0
5628065|NCT00718159|19438786|P6|Overall Study|Progressive Disease|0
5628066|NCT00718159|19438787|P5|Overall Study|Progressive Disease|6
5628067|NCT00718159|19438788|P4|Overall Study|Progressive Disease|0
5628068|NCT00718159|19438789|P3|Overall Study|Progressive Disease|2
5628069|NCT00718159|19438790|P2|Overall Study|Progressive Disease|3
5628070|NCT00718159|19438791|P1|Overall Study|Progressive Disease|3
5628071|NCT00718081|19438848|P3|Overall Study|Lack of Efficacy|21
5628072|NCT00718081|19438849|P2|Overall Study|Lack of Efficacy|3
5628073|NCT00718081|19438850|P1|Overall Study|Lack of Efficacy|7
5628074|NCT00718081|19438848|P3|Overall Study|Adverse Event|0
5628075|NCT00718081|19438849|P2|Overall Study|Adverse Event|1
5628076|NCT00718081|19438850|P1|Overall Study|Adverse Event|0
5628077|NCT00718042|19438867|P6|Donor Follow-up|Lost to Follow-up|0
5628078|NCT00718042|19438868|P5|Donor Follow-up|Lost to Follow-up|19
5628079|NCT00718042|19438869|P4|Donor Follow-up|Lost to Follow-up|0
5628080|NCT00718042|19438870|P3|Donor Follow-up|Lost to Follow-up|0
5628081|NCT00718042|19438871|P2|Donor Follow-up|Lost to Follow-up|0
5628082|NCT00718042|19438872|P1|Donor Follow-up|Lost to Follow-up|13
5628083|NCT00718042|19438867|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5628084|NCT00718042|19438868|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5628085|NCT00718042|19438869|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5628086|NCT00718042|19438870|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5628087|NCT00718042|19438871|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
5628088|NCT00718042|19438872|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
5628089|NCT00718042|19438867|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
5628090|NCT00718042|19438868|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
5628091|NCT00718042|19438869|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
5628092|NCT00718042|19438870|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
5628093|NCT00718042|19438871|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
5628094|NCT00718042|19438872|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
5628095|NCT00718042|19438867|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
5628096|NCT00718042|19438868|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
5628259|NCT00717093|19439173|P2|Overall Study|Withdrawal by Subject|19
5628097|NCT00718042|19438869|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
5628098|NCT00718042|19438870|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
5628099|NCT00718042|19438871|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
5628100|NCT00718042|19438872|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
5628101|NCT00718042|19438867|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5628102|NCT00718042|19438868|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
5628103|NCT00718042|19438869|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5628104|NCT00718042|19438870|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5628105|NCT00718042|19438871|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5628106|NCT00718042|19438872|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
5628107|NCT00717886|19438928|P1|Overall Study|Treatment Failure|1
5628108|NCT00717886|19438928|P1|Overall Study|Withdrawal by Subject|3
5628109|NCT00717860|19438943|P2|Overall Study|Withdrew consent|3
5628110|NCT00717860|19438944|P1|Overall Study|Withdrew consent|7
5628111|NCT00717860|19438943|P2|Overall Study|Discontinued for other reason|1
5628112|NCT00717860|19438944|P1|Overall Study|Discontinued for other reason|6
5628113|NCT00717860|19438943|P2|Overall Study|Lack of Efficacy|13
5628114|NCT00717860|19438944|P1|Overall Study|Lack of Efficacy|7
5628115|NCT00717860|19438943|P2|Overall Study|Laboratory adverse experience|2
5628116|NCT00717860|19438944|P1|Overall Study|Laboratory adverse experience|2
5628117|NCT00717860|19438943|P2|Overall Study|Clinical adverse experience|9
5628118|NCT00717860|19438944|P1|Overall Study|Clinical adverse experience|5
5628119|NCT00717756|19438954|P1|Overall Study|Withdrawal by Subject|1
5628120|NCT00717522|19438977|P1|Overall Study|Death|1
5628121|NCT00717522|19438977|P1|Overall Study|Adverse Event|1
5628122|NCT00717522|19438977|P1|Overall Study|Disease Progression|5
5628123|NCT00717366|19439013|P2|Extension Period (52 Weeks)|Withdrew consent|1
5628124|NCT00717366|19439014|P1|Extension Period (52 Weeks)|Withdrew consent|1
5628125|NCT00717366|19439013|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
5628126|NCT00717366|19439014|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
5628127|NCT00717366|19439013|P2|Extension Period (52 Weeks)|Renal transplant|13
5628128|NCT00717366|19439014|P1|Extension Period (52 Weeks)|Renal transplant|3
5628129|NCT00717366|19439013|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
5628130|NCT00717366|19439014|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
5628131|NCT00717366|19439013|P2|Core Study Period (20 Weeks)|Death|1
5628132|NCT00717366|19439014|P1|Core Study Period (20 Weeks)|Death|0
5628133|NCT00717366|19439013|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
5628134|NCT00717366|19439014|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
5628135|NCT00717366|19439013|P2|Core Study Period (20 Weeks)|Renal transplant|9
5628136|NCT00717366|19439014|P1|Core Study Period (20 Weeks)|Renal transplant|4
5628137|NCT00717314|19439038|P2|Overall Study|Withdrawal by Subject|3
5628138|NCT00717314|19439039|P1|Overall Study|Withdrawal by Subject|1
5628139|NCT00717314|19439038|P2|Overall Study|Lost to Follow-up|5
5628140|NCT00717314|19439039|P1|Overall Study|Lost to Follow-up|1
5628141|NCT00717314|19439038|P2|Overall Study|Protocol Violation|0
5628142|NCT00717314|19439039|P1|Overall Study|Protocol Violation|1
5628143|NCT00717314|19439038|P2|Overall Study|Adverse Event|2
5628144|NCT00717314|19439039|P1|Overall Study|Adverse Event|3
5628145|NCT00717275|19439076|P1|Overall Study|Premature study termination.|3
5628146|NCT00717249|19439082|P2|Overall Study|Headaches|0
5628147|NCT00717249|19439083|P1|Overall Study|Headaches|1
5628148|NCT00717249|19439082|P2|Overall Study|Subject relocated|0
5628149|NCT00717249|19439083|P1|Overall Study|Subject relocated|1
5628150|NCT00717249|19439082|P2|Overall Study|Diagnosed with Multiple Scletosis|0
5628151|NCT00717249|19439083|P1|Overall Study|Diagnosed with Multiple Scletosis|1
5628152|NCT00717249|19439082|P2|Overall Study|Diagnosed with Diabetes|0
5628153|NCT00717249|19439083|P1|Overall Study|Diagnosed with Diabetes|1
5628154|NCT00717249|19439082|P2|Overall Study|Gastric Surgery|1
5628155|NCT00717249|19439083|P1|Overall Study|Gastric Surgery|0
5628156|NCT00717249|19439082|P2|Overall Study|Unsatisfactory Physiological Response|1
5628157|NCT00717249|19439083|P1|Overall Study|Unsatisfactory Physiological Response|0
5628158|NCT00717249|19439082|P2|Overall Study|Subject became Ineligible|1
5628159|NCT00717249|19439083|P1|Overall Study|Subject became Ineligible|1
5628160|NCT00717249|19439082|P2|Overall Study|Protocol Violation|2
5628161|NCT00717249|19439083|P1|Overall Study|Protocol Violation|0
5628162|NCT00717249|19439082|P2|Overall Study|Pregnancy|3
5628163|NCT00717249|19439083|P1|Overall Study|Pregnancy|6
5628164|NCT00717249|19439082|P2|Overall Study|Withdrawal by Subject|2
5628165|NCT00717249|19439083|P1|Overall Study|Withdrawal by Subject|1
5628166|NCT00717249|19439082|P2|Overall Study|Lost to Follow-up|0
5628167|NCT00717249|19439083|P1|Overall Study|Lost to Follow-up|2
5628168|NCT00717249|19439082|P2|Overall Study|Adverse Event|2
5628169|NCT00717249|19439083|P1|Overall Study|Adverse Event|4
5628170|NCT00717249|19439082|P2|Overall Study|Unsatisfactory visual Response|2
5628171|NCT00717249|19439083|P1|Overall Study|Unsatisfactory visual Response|0
5628172|NCT00717249|19439082|P2|Overall Study|Lens Discomfort|1
5628173|NCT00717249|19439083|P1|Overall Study|Lens Discomfort|4
5628174|NCT00717236|19439097|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
5628175|NCT00717236|19439098|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
5628176|NCT00717236|19439097|P2|Open-Label Period|Other: Completion Accidently Performed|0
5628177|NCT00717236|19439098|P1|Open-Label Period|Other: Completion Accidently Performed|1
5628178|NCT00717236|19439097|P2|Open-Label Period|Other: Administration of Golimumab|0
5628179|NCT00717236|19439098|P1|Open-Label Period|Other: Administration of Golimumab|1
5628180|NCT00717236|19439097|P2|Open-Label Period|Other: Cataract Surgery|0
5628181|NCT00717236|19439098|P1|Open-Label Period|Other: Cataract Surgery|1
5628182|NCT00717236|19439097|P2|Open-Label Period|Other: Sponsor Request|0
5628183|NCT00717236|19439098|P1|Open-Label Period|Other: Sponsor Request|3
5628184|NCT00717236|19439097|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
5628185|NCT00717236|19439098|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
5628186|NCT00717236|19439097|P2|Open-Label Period|Other: Investigator Decision|0
5628187|NCT00717236|19439098|P1|Open-Label Period|Other: Investigator Decision|1
5628188|NCT00717236|19439097|P2|Open-Label Period|Other: Moved|0
5628189|NCT00717236|19439098|P1|Open-Label Period|Other: Moved|1
5628190|NCT00717236|19439097|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
5628191|NCT00717236|19439098|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
5628192|NCT00717236|19439097|P2|Open-Label Period|Other: Lack of Compliance|1
5628193|NCT00717236|19439098|P1|Open-Label Period|Other: Lack of Compliance|1
5628194|NCT00717236|19439097|P2|Open-Label Period|Other: Peripheral Neuropathy|1
5628195|NCT00717236|19439098|P1|Open-Label Period|Other: Peripheral Neuropathy|0
5628196|NCT00717236|19439097|P2|Open-Label Period|Loss of Efficacy|1
5628197|NCT00717236|19439098|P1|Open-Label Period|Loss of Efficacy|6
5628198|NCT00717236|19439097|P2|Open-Label Period|Withdrawal by Subject|2
5628199|NCT00717236|19439098|P1|Open-Label Period|Withdrawal by Subject|20
5628200|NCT00717236|19439097|P2|Open-Label Period|Lost to Follow-up|4
5628201|NCT00717236|19439098|P1|Open-Label Period|Lost to Follow-up|28
5628202|NCT00717236|19439097|P2|Open-Label Period|Lack of Efficacy|8
5628203|NCT00717236|19439098|P1|Open-Label Period|Lack of Efficacy|30
5628204|NCT00717236|19439097|P2|Open-Label Period|Adverse Event|4
5628205|NCT00717236|19439098|P1|Open-Label Period|Adverse Event|29
5628206|NCT00717236|19439097|P2|Double-Blind Period|Other: Investigator Decision|1
5628207|NCT00717236|19439098|P1|Double-Blind Period|Other: Investigator Decision|0
5628208|NCT00717236|19439097|P2|Double-Blind Period|Other: Transportation problems|1
5628209|NCT00717236|19439098|P1|Double-Blind Period|Other: Transportation problems|0
5628210|NCT00717236|19439097|P2|Double-Blind Period|Other: Prohibited medication taken|2
5628211|NCT00717236|19439098|P1|Double-Blind Period|Other: Prohibited medication taken|2
5628212|NCT00717236|19439097|P2|Double-Blind Period|Other: Stopped taking DMARD|0
5628213|NCT00717236|19439098|P1|Double-Blind Period|Other: Stopped taking DMARD|1
5628214|NCT00717236|19439097|P2|Double-Blind Period|Other: Subject moved|1
5628215|NCT00717236|19439098|P1|Double-Blind Period|Other: Subject moved|1
5628216|NCT00717236|19439097|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
5628217|NCT00717236|19439098|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
5628218|NCT00717236|19439097|P2|Double-Blind Period|Other: Inappropriate randomization|0
5628219|NCT00717236|19439098|P1|Double-Blind Period|Other: Inappropriate randomization|1
5628220|NCT00717236|19439097|P2|Double-Blind Period|Other: Sponsor request|0
5628221|NCT00717236|19439098|P1|Double-Blind Period|Other: Sponsor request|1
5628222|NCT00717236|19439097|P2|Double-Blind Period|Other: History of cancer|0
5628223|NCT00717236|19439098|P1|Double-Blind Period|Other: History of cancer|1
5628224|NCT00717236|19439097|P2|Double-Blind Period|Other: History of adenoid grown|0
5628225|NCT00717236|19439098|P1|Double-Blind Period|Other: History of adenoid grown|1
5628226|NCT00717236|19439097|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
5628227|NCT00717236|19439098|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
5628228|NCT00717236|19439097|P2|Double-Blind Period|Other: subject withdrew consent|1
5628229|NCT00717236|19439098|P1|Double-Blind Period|Other: subject withdrew consent|1
5628230|NCT00717236|19439097|P2|Double-Blind Period|Other: Screening failure|0
5628231|NCT00717236|19439098|P1|Double-Blind Period|Other: Screening failure|1
5628232|NCT00717236|19439097|P2|Double-Blind Period|Other: Site withdrew|0
5628233|NCT00717236|19439098|P1|Double-Blind Period|Other: Site withdrew|2
5628234|NCT00717236|19439097|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
5628235|NCT00717236|19439098|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
5628236|NCT00717236|19439097|P2|Double-Blind Period|Other: Protocol Violation|0
5628237|NCT00717236|19439098|P1|Double-Blind Period|Other: Protocol Violation|2
5628238|NCT00717236|19439097|P2|Double-Blind Period|Other: Pregnancy|0
5628239|NCT00717236|19439098|P1|Double-Blind Period|Other: Pregnancy|1
5628240|NCT00717236|19439097|P2|Double-Blind Period|Other: Death|0
5628241|NCT00717236|19439098|P1|Double-Blind Period|Other: Death|1
5628242|NCT00717236|19439097|P2|Double-Blind Period|Loss of efficacy|0
5628243|NCT00717236|19439098|P1|Double-Blind Period|Loss of efficacy|3
5628244|NCT00717236|19439097|P2|Double-Blind Period|Withdrawal by Subject|2
5628245|NCT00717236|19439098|P1|Double-Blind Period|Withdrawal by Subject|10
5628246|NCT00717236|19439097|P2|Double-Blind Period|Lost to Follow-up|5
5628247|NCT00717236|19439098|P1|Double-Blind Period|Lost to Follow-up|3
5628248|NCT00717236|19439097|P2|Double-Blind Period|Lack of Efficacy|6
5628249|NCT00717236|19439098|P1|Double-Blind Period|Lack of Efficacy|6
5628250|NCT00717236|19439097|P2|Double-Blind Period|Adverse Event|6
5628251|NCT00717236|19439098|P1|Double-Blind Period|Adverse Event|33
5628252|NCT00717197|19439167|P1|Overall Study|Physician Decision|1
5628253|NCT00717197|19439167|P1|Overall Study|Tumor Progression|1
5628254|NCT00717197|19439167|P1|Overall Study|Unable to purchase study drug|5
5628255|NCT00717093|19439173|P2|Overall Study|Randomized but not treated|0
5628256|NCT00717093|19439174|P1|Overall Study|Randomized but not treated|1
5628257|NCT00717093|19439173|P2|Overall Study|Other|1
5628258|NCT00717093|19439174|P1|Overall Study|Other|0
5628260|NCT00717093|19439174|P1|Overall Study|Withdrawal by Subject|12
5628261|NCT00717093|19439173|P2|Overall Study|Lost to Follow-up|6
5628262|NCT00717093|19439174|P1|Overall Study|Lost to Follow-up|9
5628263|NCT00717093|19439173|P2|Overall Study|Lack of Efficacy|13
5628264|NCT00717093|19439174|P1|Overall Study|Lack of Efficacy|3
5628265|NCT00717093|19439173|P2|Overall Study|Adverse Event|9
5628266|NCT00717093|19439174|P1|Overall Study|Adverse Event|19
5628267|NCT00717067|19439191|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
5628268|NCT00717067|19439192|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
5628269|NCT00717067|19439193|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
5628270|NCT00717067|19439194|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
5628271|NCT00717067|19439195|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
5628272|NCT00716976|19439302|P2|Overall Study|Ineligibles|2
5628273|NCT00716976|19439303|P1|Overall Study|Ineligibles|4
5628274|NCT00716976|19439302|P2|Overall Study|Radiation during protocol|0
5628275|NCT00716976|19439303|P1|Overall Study|Radiation during protocol|1
5628276|NCT00716976|19439302|P2|Overall Study|Premature discontinuation cisplatin|4
5628277|NCT00716976|19439303|P1|Overall Study|Premature discontinuation cisplatin|5
5628278|NCT00716976|19439302|P2|Overall Study|Withdrawal by Subject|1
5628279|NCT00716976|19439303|P1|Overall Study|Withdrawal by Subject|5
5628280|NCT00716976|19439302|P2|Overall Study|Physician Decision|2
5628281|NCT00716976|19439303|P1|Overall Study|Physician Decision|2
5628282|NCT00716976|19439302|P2|Overall Study|Death|0
5628283|NCT00716976|19439303|P1|Overall Study|Death|1
5628284|NCT00716976|19439302|P2|Overall Study|Adverse Event|0
5628285|NCT00716976|19439303|P1|Overall Study|Adverse Event|2
5628286|NCT00716859|19439343|P2|Overall Study|Not treated|1
5628287|NCT00716859|19439344|P1|Overall Study|Not treated|1
5628288|NCT00716859|19439343|P2|Overall Study|Withdrawal by Subject|3
5628289|NCT00716859|19439344|P1|Overall Study|Withdrawal by Subject|1
5628290|NCT00716859|19439343|P2|Overall Study|Lack of Efficacy|0
5628291|NCT00716859|19439344|P1|Overall Study|Lack of Efficacy|3
5628292|NCT00716859|19439343|P2|Overall Study|Adverse Event|1
5628293|NCT00716859|19439344|P1|Overall Study|Adverse Event|4
5628294|NCT00716625|19439429|P1|Overall Study|Safety was not Assessable|1
5628295|NCT00716482|19439454|P1|Overall Study|inclusion/exclusion criteria not met|25
5628296|NCT00716482|19439454|P1|Overall Study|technical/machine error|28
5628297|NCT00716482|19439454|P1|Overall Study|no pathology obtained|10
5628298|NCT00716482|19439454|P1|Overall Study|Inadequate acquisition or analysis|50
5628299|NCT00716482|19439454|P1|Overall Study|Lost to Follow-up|6
5628300|NCT00716456|19439467|P3|Overall Study|Adverse Event|0
5628301|NCT00716456|19439468|P2|Overall Study|Adverse Event|2
5628302|NCT00716456|19439469|P1|Overall Study|Adverse Event|0
5628303|NCT00716417|19439520|P10|Overall Study|On patient request due to toxicities|0
5628304|NCT00716417|19439521|P9|Overall Study|On patient request due to toxicities|0
5628305|NCT00716417|19439522|P8|Overall Study|On patient request due to toxicities|1
5628306|NCT00716417|19439523|P7|Overall Study|On patient request due to toxicities|0
5628307|NCT00716417|19439524|P6|Overall Study|On patient request due to toxicities|0
5628308|NCT00716417|19439525|P5|Overall Study|On patient request due to toxicities|0
5628309|NCT00716417|19439526|P4|Overall Study|On patient request due to toxicities|0
5628310|NCT00716417|19439527|P3|Overall Study|On patient request due to toxicities|0
5628311|NCT00716417|19439528|P2|Overall Study|On patient request due to toxicities|0
5628312|NCT00716417|19439529|P1|Overall Study|On patient request due to toxicities|0
5628313|NCT00716417|19439520|P10|Overall Study|Dose limiting toxicity (DLT)|0
5628314|NCT00716417|19439521|P9|Overall Study|Dose limiting toxicity (DLT)|0
5628315|NCT00716417|19439522|P8|Overall Study|Dose limiting toxicity (DLT)|0
5628316|NCT00716417|19439523|P7|Overall Study|Dose limiting toxicity (DLT)|0
5628317|NCT00716417|19439524|P6|Overall Study|Dose limiting toxicity (DLT)|0
5628318|NCT00716417|19439525|P5|Overall Study|Dose limiting toxicity (DLT)|1
5628319|NCT00716417|19439526|P4|Overall Study|Dose limiting toxicity (DLT)|0
5628320|NCT00716417|19439527|P3|Overall Study|Dose limiting toxicity (DLT)|0
5628321|NCT00716417|19439528|P2|Overall Study|Dose limiting toxicity (DLT)|0
5628322|NCT00716417|19439529|P1|Overall Study|Dose limiting toxicity (DLT)|0
5628323|NCT00716417|19439520|P10|Overall Study|Progressive disease|0
5628324|NCT00716417|19439521|P9|Overall Study|Progressive disease|5
5628325|NCT00716417|19439522|P8|Overall Study|Progressive disease|1
5628326|NCT00716417|19439523|P7|Overall Study|Progressive disease|3
5628327|NCT00716417|19439524|P6|Overall Study|Progressive disease|3
5628328|NCT00716417|19439525|P5|Overall Study|Progressive disease|0
5628329|NCT00716417|19439526|P4|Overall Study|Progressive disease|8
5628330|NCT00716417|19439527|P3|Overall Study|Progressive disease|3
5628331|NCT00716417|19439528|P2|Overall Study|Progressive disease|5
5628332|NCT00716417|19439529|P1|Overall Study|Progressive disease|3
5628333|NCT00716417|19439520|P10|Overall Study|Withdrawal by Subject|0
5628334|NCT00716417|19439521|P9|Overall Study|Withdrawal by Subject|0
5628335|NCT00716417|19439522|P8|Overall Study|Withdrawal by Subject|0
5628336|NCT00716417|19439523|P7|Overall Study|Withdrawal by Subject|1
5628337|NCT00716417|19439524|P6|Overall Study|Withdrawal by Subject|0
5628338|NCT00716417|19439525|P5|Overall Study|Withdrawal by Subject|0
5628339|NCT00716417|19439526|P4|Overall Study|Withdrawal by Subject|2
5628340|NCT00716417|19439527|P3|Overall Study|Withdrawal by Subject|0
5628341|NCT00716417|19439528|P2|Overall Study|Withdrawal by Subject|1
5628342|NCT00716417|19439529|P1|Overall Study|Withdrawal by Subject|0
5628343|NCT00716417|19439520|P10|Overall Study|Adverse Event|3
5628344|NCT00716417|19439521|P9|Overall Study|Adverse Event|0
5628345|NCT00716417|19439522|P8|Overall Study|Adverse Event|1
5628346|NCT00716417|19439523|P7|Overall Study|Adverse Event|3
5628347|NCT00716417|19439524|P6|Overall Study|Adverse Event|0
5628348|NCT00716417|19439525|P5|Overall Study|Adverse Event|0
5628349|NCT00716417|19439526|P4|Overall Study|Adverse Event|1
5628350|NCT00716417|19439527|P3|Overall Study|Adverse Event|2
5628351|NCT00716417|19439528|P2|Overall Study|Adverse Event|0
5628352|NCT00716417|19439529|P1|Overall Study|Adverse Event|0
5628353|NCT00716274|19439576|P6|Study Period III (16-Weeks)|Adverse Event|0
5628354|NCT00716274|19439577|P5|Study Period III (16-Weeks)|Adverse Event|1
5628355|NCT00716274|19439578|P4|Study Period III (16-Weeks)|Adverse Event|0
5628356|NCT00716274|19439579|P3|Study Period III (16-Weeks)|Adverse Event|0
5628357|NCT00716274|19439580|P2|Study Period III (16-Weeks)|Adverse Event|0
5628358|NCT00716274|19439581|P1|Study Period III (16-Weeks)|Adverse Event|0
5628359|NCT00716274|19439576|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
5628360|NCT00716274|19439577|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
5628361|NCT00716274|19439578|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
5628362|NCT00716274|19439579|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
5628363|NCT00716274|19439580|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
5628364|NCT00716274|19439581|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
5628365|NCT00716274|19439576|P6|Study Period III (16-Weeks)|Physician Decision|0
5628366|NCT00716274|19439577|P5|Study Period III (16-Weeks)|Physician Decision|1
5628367|NCT00716274|19439578|P4|Study Period III (16-Weeks)|Physician Decision|0
5628368|NCT00716274|19439579|P3|Study Period III (16-Weeks)|Physician Decision|0
5628369|NCT00716274|19439580|P2|Study Period III (16-Weeks)|Physician Decision|0
5628370|NCT00716274|19439581|P1|Study Period III (16-Weeks)|Physician Decision|0
5628371|NCT00716274|19439576|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
5628372|NCT00716274|19439577|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
5628373|NCT00716274|19439578|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
5628374|NCT00716274|19439579|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
5628375|NCT00716274|19439580|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
5628376|NCT00716274|19439581|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
5628377|NCT00716274|19439576|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
5628378|NCT00716274|19439577|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
5628379|NCT00716274|19439578|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
5628380|NCT00716274|19439579|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
5628381|NCT00716274|19439580|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
5628382|NCT00716274|19439581|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
5628383|NCT00716274|19439576|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
5628384|NCT00716274|19439577|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
5628385|NCT00716274|19439578|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
5628386|NCT00716274|19439579|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
5628387|NCT00716274|19439580|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
5628388|NCT00716274|19439581|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
5628389|NCT00716274|19439576|P6|Study Period II (16-Weeks)|Physician Decision|1
5628390|NCT00716274|19439577|P5|Study Period II (16-Weeks)|Physician Decision|0
5628391|NCT00716274|19439578|P4|Study Period II (16-Weeks)|Physician Decision|0
5628392|NCT00716274|19439579|P3|Study Period II (16-Weeks)|Physician Decision|0
5628393|NCT00716274|19439580|P2|Study Period II (16-Weeks)|Physician Decision|1
5628394|NCT00716274|19439581|P1|Study Period II (16-Weeks)|Physician Decision|3
5628395|NCT00716274|19439576|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
5628396|NCT00716274|19439577|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
5628397|NCT00716274|19439578|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
5628398|NCT00716274|19439579|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
5628399|NCT00716274|19439580|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
5628400|NCT00716274|19439581|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
5628401|NCT00716274|19439576|P6|Study Period II (16-Weeks)|Protocol Violation|1
5628402|NCT00716274|19439577|P5|Study Period II (16-Weeks)|Protocol Violation|0
5628403|NCT00716274|19439578|P4|Study Period II (16-Weeks)|Protocol Violation|0
5628404|NCT00716274|19439579|P3|Study Period II (16-Weeks)|Protocol Violation|0
5628405|NCT00716274|19439580|P2|Study Period II (16-Weeks)|Protocol Violation|3
5628406|NCT00716274|19439581|P1|Study Period II (16-Weeks)|Protocol Violation|0
5628407|NCT00716274|19439576|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5628408|NCT00716274|19439577|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5628409|NCT00716274|19439578|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5628410|NCT00716274|19439579|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5628411|NCT00716274|19439580|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
5628412|NCT00716274|19439581|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
5628413|NCT00716144|19439715|P4|Overall Study|Clinical Depression|0
5628414|NCT00716144|19439716|P3|Overall Study|Clinical Depression|0
5628415|NCT00716144|19439717|P2|Overall Study|Clinical Depression|1
5628416|NCT00716144|19439718|P1|Overall Study|Clinical Depression|0
5628417|NCT00716144|19439715|P4|Overall Study|Adverse event: left foot pain|0
5628418|NCT00716144|19439716|P3|Overall Study|Adverse event: left foot pain|0
5628419|NCT00716144|19439717|P2|Overall Study|Adverse event: left foot pain|1
5628420|NCT00716144|19439718|P1|Overall Study|Adverse event: left foot pain|0
5628421|NCT00716144|19439715|P4|Overall Study|Withdrew consent, allowed use of data|0
5628422|NCT00716144|19439716|P3|Overall Study|Withdrew consent, allowed use of data|1
5628423|NCT00716144|19439717|P2|Overall Study|Withdrew consent, allowed use of data|0
5628424|NCT00716144|19439718|P1|Overall Study|Withdrew consent, allowed use of data|0
5628425|NCT00716144|19439715|P4|Overall Study|Intercurrent illness|0
5628426|NCT00716144|19439716|P3|Overall Study|Intercurrent illness|1
5628427|NCT00716144|19439717|P2|Overall Study|Intercurrent illness|0
5628428|NCT00716144|19439718|P1|Overall Study|Intercurrent illness|0
5628429|NCT00716144|19439715|P4|Overall Study|Physician Decision|2
5628430|NCT00716144|19439716|P3|Overall Study|Physician Decision|2
5628431|NCT00716144|19439717|P2|Overall Study|Physician Decision|1
5628432|NCT00716144|19439718|P1|Overall Study|Physician Decision|0
5628433|NCT00716144|19439715|P4|Overall Study|Protocol Violation|0
5628434|NCT00716144|19439716|P3|Overall Study|Protocol Violation|1
5628435|NCT00716144|19439717|P2|Overall Study|Protocol Violation|0
5628436|NCT00716144|19439718|P1|Overall Study|Protocol Violation|2
5628437|NCT00716144|19439715|P4|Overall Study|Non-compliance|0
5628438|NCT00716144|19439716|P3|Overall Study|Non-compliance|0
5628439|NCT00716144|19439717|P2|Overall Study|Non-compliance|0
5628440|NCT00716144|19439718|P1|Overall Study|Non-compliance|1
5628441|NCT00716144|19439715|P4|Overall Study|Adverse Event|2
5628442|NCT00716144|19439716|P3|Overall Study|Adverse Event|0
5628443|NCT00716144|19439717|P2|Overall Study|Adverse Event|0
5628444|NCT00716144|19439718|P1|Overall Study|Adverse Event|0
5628445|NCT00716144|19439715|P4|Overall Study|Lost to Follow-up|2
5628446|NCT00716144|19439716|P3|Overall Study|Lost to Follow-up|1
5628447|NCT00716144|19439717|P2|Overall Study|Lost to Follow-up|2
5628448|NCT00716144|19439718|P1|Overall Study|Lost to Follow-up|2
5628449|NCT00716144|19439715|P4|Overall Study|Withdrawal by Subject|6
5628450|NCT00716144|19439716|P3|Overall Study|Withdrawal by Subject|6
5628451|NCT00716144|19439717|P2|Overall Study|Withdrawal by Subject|2
5628452|NCT00716144|19439718|P1|Overall Study|Withdrawal by Subject|4
5628453|NCT00716092|19439743|P3|Overall Study|Other incl. Lack of Efficacy|0
5628454|NCT00716092|19439744|P2|Overall Study|Other incl. Lack of Efficacy|1
5628455|NCT00716092|19439745|P1|Overall Study|Other incl. Lack of Efficacy|2
5628456|NCT00715949|19439798|P1|Overall Study|could not finish first test|4
5628457|NCT00715910|19439806|P6|Booster and ESFU Phase|Other|0
5628458|NCT00715910|19439807|P5|Booster and ESFU Phase|Other|1
5628459|NCT00715910|19439808|P4|Booster and ESFU Phase|Other|5
5628460|NCT00715910|19439809|P3|Booster and ESFU Phase|Other|0
5628461|NCT00715910|19439810|P2|Booster and ESFU Phase|Other|0
5628462|NCT00715910|19439811|P1|Booster and ESFU Phase|Other|0
5628463|NCT00715910|19439806|P6|Booster and ESFU Phase|Lost to Follow-up|13
5628464|NCT00715910|19439807|P5|Booster and ESFU Phase|Lost to Follow-up|1
5628465|NCT00715910|19439808|P4|Booster and ESFU Phase|Lost to Follow-up|6
5628466|NCT00715910|19439809|P3|Booster and ESFU Phase|Lost to Follow-up|0
5628467|NCT00715910|19439810|P2|Booster and ESFU Phase|Lost to Follow-up|0
5628468|NCT00715910|19439811|P1|Booster and ESFU Phase|Lost to Follow-up|0
5628469|NCT00715793|19439930|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
5628470|NCT00715793|19439931|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
5628471|NCT00715793|19439930|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
5628472|NCT00715793|19439931|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
5628473|NCT00715676|19439992|P3|Overall Study|Elevated Blood Glucose|0
5628474|NCT00715676|19439993|P2|Overall Study|Elevated Blood Glucose|1
5628475|NCT00715676|19439994|P1|Overall Study|Elevated Blood Glucose|0
5628476|NCT00715676|19439992|P3|Overall Study|Use of Exclusionary Medication|1
5628477|NCT00715676|19439993|P2|Overall Study|Use of Exclusionary Medication|0
5628478|NCT00715676|19439994|P1|Overall Study|Use of Exclusionary Medication|0
5628479|NCT00715676|19439992|P3|Overall Study|Did Not Meet Entry Criteria|1
5628480|NCT00715676|19439993|P2|Overall Study|Did Not Meet Entry Criteria|0
5628481|NCT00715676|19439994|P1|Overall Study|Did Not Meet Entry Criteria|0
5628482|NCT00715676|19439992|P3|Overall Study|Terminated by Sponsor|0
5628483|NCT00715676|19439993|P2|Overall Study|Terminated by Sponsor|0
5628484|NCT00715676|19439994|P1|Overall Study|Terminated by Sponsor|1
5628485|NCT00715676|19439992|P3|Overall Study|Lost to Follow-up|1
5628486|NCT00715676|19439993|P2|Overall Study|Lost to Follow-up|2
5628487|NCT00715676|19439994|P1|Overall Study|Lost to Follow-up|1
5628488|NCT00715676|19439992|P3|Overall Study|Withdrawal by Subject|8
5628489|NCT00715676|19439993|P2|Overall Study|Withdrawal by Subject|3
5628490|NCT00715676|19439994|P1|Overall Study|Withdrawal by Subject|1
5628491|NCT00715676|19439992|P3|Overall Study|Adverse Event|21
5628492|NCT00715676|19439993|P2|Overall Study|Adverse Event|5
5628493|NCT00715676|19439994|P1|Overall Study|Adverse Event|3
5628494|NCT00715624|19440037|P2|Overall Study|Other|1
5628495|NCT00715624|19440038|P1|Overall Study|Other|0
5628496|NCT00715624|19440037|P2|Overall Study|Incorrect randomization (not treated)|1
5628497|NCT00715624|19440038|P1|Overall Study|Incorrect randomization (not treated)|0
5628498|NCT00715624|19440037|P2|Overall Study|Sponsor decision|4
5628499|NCT00715624|19440038|P1|Overall Study|Sponsor decision|0
5628500|NCT00715624|19440037|P2|Overall Study|Poor compliance|13
5628501|NCT00715624|19440038|P1|Overall Study|Poor compliance|6
5628502|NCT00715624|19440037|P2|Overall Study|Familial and personal reasons|22
5628503|NCT00715624|19440038|P1|Overall Study|Familial and personal reasons|10
5628504|NCT00715624|19440037|P2|Overall Study|Withdrawal by Subject|25
5628505|NCT00715624|19440038|P1|Overall Study|Withdrawal by Subject|11
5628506|NCT00715624|19440037|P2|Overall Study|Protocol Violation|0
5628507|NCT00715624|19440038|P1|Overall Study|Protocol Violation|1
5628508|NCT00715624|19440037|P2|Overall Study|Lost to Follow-up|2
5628509|NCT00715624|19440038|P1|Overall Study|Lost to Follow-up|1
5628510|NCT00715624|19440037|P2|Overall Study|Lack of Efficacy|11
5628511|NCT00715624|19440038|P1|Overall Study|Lack of Efficacy|11
5628512|NCT00715624|19440037|P2|Overall Study|Adverse Event|37
5628513|NCT00715624|19440038|P1|Overall Study|Adverse Event|12
5628514|NCT00715559|19440066|P1|Overall Study|medication not tolerated - nausea|1
5628515|NCT00715520|19440076|P3|Overall Study|Withdrawal by Subject|1
5628516|NCT00715520|19440077|P2|Overall Study|Withdrawal by Subject|0
5628517|NCT00715520|19440078|P1|Overall Study|Withdrawal by Subject|2
5628518|NCT00715520|19440076|P3|Overall Study|Screen failure|1
5628519|NCT00715520|19440077|P2|Overall Study|Screen failure|1
5628520|NCT00715520|19440078|P1|Overall Study|Screen failure|8
5628521|NCT00715429|19440093|P2|Overall Study|Did not complete the study diary|1
5628522|NCT00715429|19440094|P1|Overall Study|Did not complete the study diary|0
5628523|NCT00715403|19440109|P7|Overall Study|Other reason not defined above|0
5628524|NCT00715403|19440110|P6|Overall Study|Other reason not defined above|1
5628525|NCT00715403|19440111|P5|Overall Study|Other reason not defined above|1
5628526|NCT00715403|19440112|P4|Overall Study|Other reason not defined above|0
5628527|NCT00715403|19440113|P3|Overall Study|Other reason not defined above|1
5628528|NCT00715403|19440114|P2|Overall Study|Other reason not defined above|0
5628529|NCT00715403|19440115|P1|Overall Study|Other reason not defined above|0
5628530|NCT00715403|19440109|P7|Overall Study|Protocol Violation|0
5628531|NCT00715403|19440110|P6|Overall Study|Protocol Violation|1
5628532|NCT00715403|19440111|P5|Overall Study|Protocol Violation|0
5628533|NCT00715403|19440112|P4|Overall Study|Protocol Violation|0
5628534|NCT00715403|19440113|P3|Overall Study|Protocol Violation|0
5628535|NCT00715403|19440114|P2|Overall Study|Protocol Violation|0
5628536|NCT00715403|19440115|P1|Overall Study|Protocol Violation|0
5628537|NCT00715403|19440109|P7|Overall Study|Other Adverse Event than DLT|0
5628538|NCT00715403|19440110|P6|Overall Study|Other Adverse Event than DLT|2
5628539|NCT00715403|19440111|P5|Overall Study|Other Adverse Event than DLT|0
5628540|NCT00715403|19440112|P4|Overall Study|Other Adverse Event than DLT|0
5628541|NCT00715403|19440113|P3|Overall Study|Other Adverse Event than DLT|0
5628542|NCT00715403|19440114|P2|Overall Study|Other Adverse Event than DLT|0
5628543|NCT00715403|19440115|P1|Overall Study|Other Adverse Event than DLT|1
5628544|NCT00715403|19440109|P7|Overall Study|Dose limiting Toxicity (DLT)|0
5628545|NCT00715403|19440110|P6|Overall Study|Dose limiting Toxicity (DLT)|1
5628546|NCT00715403|19440111|P5|Overall Study|Dose limiting Toxicity (DLT)|0
5628547|NCT00715403|19440112|P4|Overall Study|Dose limiting Toxicity (DLT)|0
5628548|NCT00715403|19440113|P3|Overall Study|Dose limiting Toxicity (DLT)|0
5628549|NCT00715403|19440114|P2|Overall Study|Dose limiting Toxicity (DLT)|0
5628550|NCT00715403|19440115|P1|Overall Study|Dose limiting Toxicity (DLT)|0
5628551|NCT00715403|19440109|P7|Overall Study|Progressive disease|1
5628552|NCT00715403|19440110|P6|Overall Study|Progressive disease|14
5628553|NCT00715403|19440111|P5|Overall Study|Progressive disease|5
5628554|NCT00715403|19440112|P4|Overall Study|Progressive disease|9
5628555|NCT00715403|19440113|P3|Overall Study|Progressive disease|3
5628556|NCT00715403|19440114|P2|Overall Study|Progressive disease|1
5628557|NCT00715403|19440115|P1|Overall Study|Progressive disease|0
5628558|NCT00715299|19440254|P1|Overall Study|failed the pre-screen exercise test|2
5628559|NCT00715299|19440254|P1|Overall Study|Adverse Event|3
5628560|NCT00715299|19440254|P1|Overall Study|Withdrawal by Subject|1
5628561|NCT00715208|19440260|P2|Overall Study|Lack of Efficacy|2
5628562|NCT00715208|19440261|P1|Overall Study|Lack of Efficacy|0
5628563|NCT00715208|19440260|P2|Overall Study|Adverse Event|6
5628564|NCT00715208|19440261|P1|Overall Study|Adverse Event|0
5628565|NCT00715208|19440260|P2|Overall Study|Withdrawal by Subject|1
5628566|NCT00715208|19440261|P1|Overall Study|Withdrawal by Subject|1
5628567|NCT00715117|19440277|P2|Overall Study|Crohn's flare and rescue with steroids|1
5628568|NCT00715117|19440278|P1|Overall Study|Crohn's flare and rescue with steroids|0
5628569|NCT00715078|19440346|P3|Overall Study|Unable to start due to disease prog.|1
5628570|NCT00715078|19440347|P2|Overall Study|Unable to start due to disease prog.|0
5628571|NCT00715078|19440348|P1|Overall Study|Unable to start due to disease prog.|0
5628572|NCT00715078|19440346|P3|Overall Study|Withdrawal by Subject|1
5628573|NCT00715078|19440347|P2|Overall Study|Withdrawal by Subject|0
5628574|NCT00715078|19440348|P1|Overall Study|Withdrawal by Subject|1
5628575|NCT00715078|19440346|P3|Overall Study|Death|36
5628576|NCT00715078|19440347|P2|Overall Study|Death|36
5628577|NCT00715078|19440348|P1|Overall Study|Death|29
5628578|NCT00715026|19440356|P1|Overall Study|Surgery done on non-study consented hip|1
5628579|NCT00715026|19440356|P1|Overall Study|Protocol Violation|1
5628580|NCT00715026|19440356|P1|Overall Study|Lost to Follow-up|3
5628581|NCT00715026|19440356|P1|Overall Study|Withdrawal by Subject|5
5628582|NCT00714948|19440361|P1|Overall Study|Adverse Event|2
5628583|NCT00714870|19440367|P2|Overall Study|did not attend minimum of 4 sessions|0
5628584|NCT00714870|19440368|P1|Overall Study|did not attend minimum of 4 sessions|4
5628585|NCT00714870|19440367|P2|Overall Study|patient unable to come b/c back pain|0
5628586|NCT00714870|19440368|P1|Overall Study|patient unable to come b/c back pain|1
5628587|NCT00714870|19440367|P2|Overall Study|Lost to Follow-up|5
5628588|NCT00714870|19440368|P1|Overall Study|Lost to Follow-up|22
5628589|NCT00714714|19440392|P1|Overall Study|Adverse Event|1
5628590|NCT00714688|19440401|P3|Overall Study|Other|5
5628591|NCT00714688|19440402|P2|Overall Study|Other|6
5628592|NCT00714688|19440403|P1|Overall Study|Other|1
5628593|NCT00714688|19440401|P3|Overall Study|Sponsor's Decision|0
5628594|NCT00714688|19440402|P2|Overall Study|Sponsor's Decision|2
5628595|NCT00714688|19440403|P1|Overall Study|Sponsor's Decision|0
5628596|NCT00714688|19440401|P3|Overall Study|Ineligible to Continue the Study|1
5628597|NCT00714688|19440402|P2|Overall Study|Ineligible to Continue the Study|1
5628598|NCT00714688|19440403|P1|Overall Study|Ineligible to Continue the Study|0
5628599|NCT00714688|19440401|P3|Overall Study|Subject Non-compliant|5
5628600|NCT00714688|19440402|P2|Overall Study|Subject Non-compliant|5
5628601|NCT00714688|19440403|P1|Overall Study|Subject Non-compliant|3
5628602|NCT00714688|19440401|P3|Overall Study|Adverse Event|19
5628603|NCT00714688|19440402|P2|Overall Study|Adverse Event|15
5628604|NCT00714688|19440403|P1|Overall Study|Adverse Event|2
5628605|NCT00714688|19440401|P3|Overall Study|Lost to Follow-up|0
5628606|NCT00714688|19440402|P2|Overall Study|Lost to Follow-up|2
5628607|NCT00714688|19440403|P1|Overall Study|Lost to Follow-up|5
5628608|NCT00714688|19440401|P3|Overall Study|Withdrawal by Subject|3
5628609|NCT00714688|19440402|P2|Overall Study|Withdrawal by Subject|3
5628610|NCT00714688|19440403|P1|Overall Study|Withdrawal by Subject|4
5628611|NCT00714688|19440401|P3|Overall Study|Lack of Efficacy|4
5628612|NCT00714688|19440402|P2|Overall Study|Lack of Efficacy|1
5628613|NCT00714688|19440403|P1|Overall Study|Lack of Efficacy|14
5628614|NCT00714493|19440445|P1|Overall Study|OTHER|2
5628615|NCT00714493|19440445|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
5628616|NCT00714493|19440445|P1|Overall Study|Protocol Violation|12
5628617|NCT00714493|19440445|P1|Overall Study|Lost to Follow-up|3
5628618|NCT00714493|19440445|P1|Overall Study|Lack of Efficacy|10
5628619|NCT00714493|19440445|P1|Overall Study|Death|3
5628620|NCT00714493|19440445|P1|Overall Study|Adverse Event|11
5628621|NCT00714415|19440457|P2|Overall Study|Death|0
5628622|NCT00714415|19440458|P1|Overall Study|Death|1
5628623|NCT00714415|19440457|P2|Overall Study|Lack of Efficacy|0
5628624|NCT00714415|19440458|P1|Overall Study|Lack of Efficacy|1
5628625|NCT00714285|19440508|P4|Overall Study|Migrated/moved from study area|0
5628626|NCT00714285|19440509|P3|Overall Study|Migrated/moved from study area|0
5628627|NCT00714285|19440510|P2|Overall Study|Migrated/moved from study area|1
5628628|NCT00714285|19440511|P1|Overall Study|Migrated/moved from study area|0
5628629|NCT00714285|19440508|P4|Overall Study|Lost to Follow-up|1
5628630|NCT00714285|19440509|P3|Overall Study|Lost to Follow-up|0
5628631|NCT00714285|19440510|P2|Overall Study|Lost to Follow-up|2
5628632|NCT00714285|19440511|P1|Overall Study|Lost to Follow-up|0
5628633|NCT00714259|19440572|P1|Overall Study|Death|2
5628634|NCT00714168|19440618|P2|Overall Study|Non-study medical condition|2
5628635|NCT00714168|19440619|P1|Overall Study|Non-study medical condition|3
5628636|NCT00714168|19440618|P2|Overall Study|Relocation|3
5628637|NCT00714168|19440619|P1|Overall Study|Relocation|4
5628638|NCT00714168|19440618|P2|Overall Study|Lost to Follow-up|50
5628639|NCT00714168|19440619|P1|Overall Study|Lost to Follow-up|32
5628640|NCT00714168|19440618|P2|Overall Study|Pregnancy|4
5628641|NCT00714168|19440619|P1|Overall Study|Pregnancy|5
5628642|NCT00714051|19440635|P2|Overall Study|Death|1
5628643|NCT00714051|19440636|P1|Overall Study|Death|0
5628644|NCT00714051|19440635|P2|Overall Study|Withdrawal by Subject|0
5628645|NCT00714051|19440636|P1|Overall Study|Withdrawal by Subject|1
5628646|NCT00713830|19440644|P2|Overall Study|Sponsor Decision|10
5628647|NCT00713830|19440645|P1|Overall Study|Sponsor Decision|4
5628648|NCT00713830|19440644|P2|Overall Study|Familial and Personal Reasons|34
5628649|NCT00713830|19440645|P1|Overall Study|Familial and Personal Reasons|9
5628650|NCT00713830|19440644|P2|Overall Study|Poor Compliance to Protocol|14
5628651|NCT00713830|19440645|P1|Overall Study|Poor Compliance to Protocol|7
5628652|NCT00713830|19440644|P2|Overall Study|Withdrawal by Subject|23
5628653|NCT00713830|19440645|P1|Overall Study|Withdrawal by Subject|13
5628654|NCT00713830|19440644|P2|Overall Study|Lost to Follow-up|9
5628655|NCT00713830|19440645|P1|Overall Study|Lost to Follow-up|2
5628656|NCT00713830|19440644|P2|Overall Study|Lack of Efficacy|16
5628657|NCT00713830|19440645|P1|Overall Study|Lack of Efficacy|24
5628658|NCT00713830|19440644|P2|Overall Study|Adverse Event|71
5628659|NCT00713830|19440645|P1|Overall Study|Adverse Event|23
5628660|NCT00713700|19440702|P1|Overall Study|Withdrawal by Subject|1
5628661|NCT00713700|19440702|P1|Overall Study|Lost to Follow-up|3
5628662|NCT00713648|19440728|P1|Overall Study|Development of antibodies|3
5628663|NCT00713648|19440728|P1|Overall Study|According to Protocol|2
5628664|NCT00713648|19440728|P1|Overall Study|Unclassified|2
5628665|NCT00713648|19440728|P1|Overall Study|Adverse Event|1
5628666|NCT00713609|19440741|P6|Overall Study|Protocol Violation|0
5628667|NCT00713609|19440742|P5|Overall Study|Protocol Violation|2
5628668|NCT00713609|19440743|P4|Overall Study|Protocol Violation|1
5628669|NCT00713609|19440744|P3|Overall Study|Protocol Violation|1
5628670|NCT00713609|19440745|P2|Overall Study|Protocol Violation|3
5628671|NCT00713609|19440746|P1|Overall Study|Protocol Violation|6
5628672|NCT00713609|19440741|P6|Overall Study|Withdrawal by Subject|7
5628673|NCT00713609|19440742|P5|Overall Study|Withdrawal by Subject|5
5628674|NCT00713609|19440743|P4|Overall Study|Withdrawal by Subject|1
5628675|NCT00713609|19440744|P3|Overall Study|Withdrawal by Subject|5
5628676|NCT00713609|19440745|P2|Overall Study|Withdrawal by Subject|1
5628677|NCT00713609|19440746|P1|Overall Study|Withdrawal by Subject|6
5628678|NCT00713609|19440741|P6|Overall Study|Non-Compliance with Study Treatment|0
5628679|NCT00713609|19440742|P5|Overall Study|Non-Compliance with Study Treatment|1
5628680|NCT00713609|19440743|P4|Overall Study|Non-Compliance with Study Treatment|0
5628681|NCT00713609|19440744|P3|Overall Study|Non-Compliance with Study Treatment|2
5628682|NCT00713609|19440745|P2|Overall Study|Non-Compliance with Study Treatment|1
5628683|NCT00713609|19440746|P1|Overall Study|Non-Compliance with Study Treatment|1
5628684|NCT00713609|19440741|P6|Overall Study|Lack of Efficacy|0
5628685|NCT00713609|19440742|P5|Overall Study|Lack of Efficacy|1
5628686|NCT00713609|19440743|P4|Overall Study|Lack of Efficacy|0
5628687|NCT00713609|19440744|P3|Overall Study|Lack of Efficacy|0
5628688|NCT00713609|19440745|P2|Overall Study|Lack of Efficacy|3
5628689|NCT00713609|19440746|P1|Overall Study|Lack of Efficacy|1
5628690|NCT00713609|19440741|P6|Overall Study|Lost to Follow-up|0
5628691|NCT00713609|19440742|P5|Overall Study|Lost to Follow-up|7
5628692|NCT00713609|19440743|P4|Overall Study|Lost to Follow-up|5
5628693|NCT00713609|19440744|P3|Overall Study|Lost to Follow-up|5
5628694|NCT00713609|19440745|P2|Overall Study|Lost to Follow-up|7
5628695|NCT00713609|19440746|P1|Overall Study|Lost to Follow-up|5
5628696|NCT00713609|19440741|P6|Overall Study|Adverse Event|1
5628697|NCT00713609|19440742|P5|Overall Study|Adverse Event|3
5628698|NCT00713609|19440743|P4|Overall Study|Adverse Event|2
5628699|NCT00713609|19440744|P3|Overall Study|Adverse Event|2
5628700|NCT00713609|19440745|P2|Overall Study|Adverse Event|0
5628701|NCT00713609|19440746|P1|Overall Study|Adverse Event|2
5628702|NCT00713596|19440781|P3|Overall Study|Study was terminated|2
5628703|NCT00713596|19440782|P2|Overall Study|Study was terminated|3
5628704|NCT00713596|19440783|P1|Overall Study|Study was terminated|2
5628705|NCT00713544|19440809|P6|Overall Study|Hepatotoxicity - not an AE|0
5628706|NCT00713544|19440810|P5|Overall Study|Hepatotoxicity - not an AE|1
5628707|NCT00713544|19440811|P4|Overall Study|Hepatotoxicity - not an AE|0
5628708|NCT00713544|19440812|P3|Overall Study|Hepatotoxicity - not an AE|0
5628709|NCT00713544|19440813|P2|Overall Study|Hepatotoxicity - not an AE|0
5628710|NCT00713544|19440814|P1|Overall Study|Hepatotoxicity - not an AE|0
5628711|NCT00713544|19440809|P6|Overall Study|Incorrect enrollment|0
5628712|NCT00713544|19440810|P5|Overall Study|Incorrect enrollment|0
5628713|NCT00713544|19440811|P4|Overall Study|Incorrect enrollment|0
5628714|NCT00713544|19440812|P3|Overall Study|Incorrect enrollment|0
5628715|NCT00713544|19440813|P2|Overall Study|Incorrect enrollment|1
5628716|NCT00713544|19440814|P1|Overall Study|Incorrect enrollment|0
5628717|NCT00713544|19440809|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
5628718|NCT00713544|19440810|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
5628719|NCT00713544|19440811|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
5628720|NCT00713544|19440812|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
5628721|NCT00713544|19440813|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
5628722|NCT00713544|19440814|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
5628723|NCT00713544|19440809|P6|Overall Study|Lost to Follow-up|0
5628724|NCT00713544|19440810|P5|Overall Study|Lost to Follow-up|0
5628725|NCT00713544|19440811|P4|Overall Study|Lost to Follow-up|0
5628726|NCT00713544|19440812|P3|Overall Study|Lost to Follow-up|1
5628727|NCT00713544|19440813|P2|Overall Study|Lost to Follow-up|0
5628728|NCT00713544|19440814|P1|Overall Study|Lost to Follow-up|0
5628729|NCT00713544|19440809|P6|Overall Study|Lack of Efficacy|0
5628730|NCT00713544|19440810|P5|Overall Study|Lack of Efficacy|1
5628731|NCT00713544|19440811|P4|Overall Study|Lack of Efficacy|1
5628732|NCT00713544|19440812|P3|Overall Study|Lack of Efficacy|0
5628733|NCT00713544|19440813|P2|Overall Study|Lack of Efficacy|1
5628734|NCT00713544|19440814|P1|Overall Study|Lack of Efficacy|0
5628735|NCT00713544|19440809|P6|Overall Study|Physician Decision|2
5628736|NCT00713544|19440810|P5|Overall Study|Physician Decision|0
5628737|NCT00713544|19440811|P4|Overall Study|Physician Decision|0
5628738|NCT00713544|19440812|P3|Overall Study|Physician Decision|0
5628739|NCT00713544|19440813|P2|Overall Study|Physician Decision|0
5628740|NCT00713544|19440814|P1|Overall Study|Physician Decision|0
5628741|NCT00713544|19440809|P6|Overall Study|Protocol Violation|1
5628742|NCT00713544|19440810|P5|Overall Study|Protocol Violation|0
5628743|NCT00713544|19440811|P4|Overall Study|Protocol Violation|0
5628744|NCT00713544|19440812|P3|Overall Study|Protocol Violation|0
5628745|NCT00713544|19440813|P2|Overall Study|Protocol Violation|0
5628746|NCT00713544|19440814|P1|Overall Study|Protocol Violation|0
5628747|NCT00713544|19440809|P6|Overall Study|Withdrawal by Subject|1
5628748|NCT00713544|19440810|P5|Overall Study|Withdrawal by Subject|3
5628749|NCT00713544|19440811|P4|Overall Study|Withdrawal by Subject|2
5628750|NCT00713544|19440812|P3|Overall Study|Withdrawal by Subject|3
5628751|NCT00713544|19440813|P2|Overall Study|Withdrawal by Subject|0
5628752|NCT00713544|19440814|P1|Overall Study|Withdrawal by Subject|2
5628753|NCT00713544|19440809|P6|Overall Study|Adverse Event|5
5628754|NCT00713544|19440810|P5|Overall Study|Adverse Event|3
5628755|NCT00713544|19440811|P4|Overall Study|Adverse Event|7
5628756|NCT00713544|19440812|P3|Overall Study|Adverse Event|7
5628757|NCT00713544|19440813|P2|Overall Study|Adverse Event|3
5628758|NCT00713544|19440814|P1|Overall Study|Adverse Event|5
5628759|NCT00713349|19440865|P1|Overall Study|Protocol Violation|1
5628760|NCT00713323|19440871|P1|Overall Study|Treatment that may interact with Sativex|1
5628761|NCT00713323|19440871|P1|Overall Study|Subject travelling to Dominica Republic|1
5628762|NCT00713323|19440871|P1|Overall Study|Subject travelling to USA|1
5628763|NCT00713323|19440871|P1|Overall Study|Pain resolved|1
5628764|NCT00713323|19440871|P1|Overall Study|Non-compliance|1
5628765|NCT00713323|19440871|P1|Overall Study|Pain free|1
5628766|NCT00713323|19440871|P1|Overall Study|Surgery cured allodynic pain|1
5628767|NCT00713323|19440871|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
5628768|NCT00713323|19440871|P1|Overall Study|Low creatine clearance at screening|1
5628769|NCT00713323|19440871|P1|Overall Study|Lack of Efficacy|36
5628770|NCT00713323|19440871|P1|Overall Study|Lost to Follow-up|11
5628771|NCT00713323|19440871|P1|Overall Study|Withdrawal by Subject|15
5628772|NCT00713323|19440871|P1|Overall Study|Adverse Event|75
5628773|NCT00713310|19440884|P2|Overall Study|Withdrawal by Subject|2
5628774|NCT00713310|19440885|P1|Overall Study|Withdrawal by Subject|0
5628775|NCT00713310|19440884|P2|Overall Study|Lack of Efficacy|2
5628776|NCT00713310|19440885|P1|Overall Study|Lack of Efficacy|0
5628777|NCT00713310|19440884|P2|Overall Study|Adverse Event|2
5628778|NCT00713310|19440885|P1|Overall Study|Adverse Event|5
5628779|NCT00713258|19440899|P2|Overall Study|Other|1
5628780|NCT00713258|19440900|P1|Overall Study|Other|1
5628781|NCT00713258|19440899|P2|Overall Study|Non-Compliance|1
5628782|NCT00713258|19440900|P1|Overall Study|Non-Compliance|2
5628783|NCT00713258|19440899|P2|Overall Study|Adverse Event|4
5628784|NCT00713258|19440900|P1|Overall Study|Adverse Event|2
5628785|NCT00713219|19440908|P1|Overall Study|Protocol Violation|1
5628786|NCT00713219|19440908|P1|Overall Study|Death|1
5628787|NCT00713206|19440914|P2|Overall Study|Adverse Event|1
5628788|NCT00713206|19440915|P1|Overall Study|Adverse Event|2
5628789|NCT00713206|19440914|P2|Overall Study|Lost to Follow-up|2
5628790|NCT00713206|19440915|P1|Overall Study|Lost to Follow-up|5
5628791|NCT00712985|19440921|P1|Overall Study|Lack of Efficacy|3
5628792|NCT00712985|19440921|P1|Overall Study|1 patient moved out of state|1
5628793|NCT00712985|19440921|P1|Overall Study|1 withdrew prior to start of drug|1
5628794|NCT00712959|19440927|P2|Overall Study|Withdrawal by Subject|0
5628795|NCT00712959|19440928|P1|Overall Study|Withdrawal by Subject|3
5628796|NCT00712959|19440927|P2|Overall Study|Lost to Follow-up|2
5628797|NCT00712959|19440928|P1|Overall Study|Lost to Follow-up|13
5628798|NCT00712959|19440927|P2|Overall Study|Protocol Violation|1
5628799|NCT00712959|19440928|P1|Overall Study|Protocol Violation|3
5628800|NCT00712933|19440946|P1|Overall Study|Withdrawal by Subject|151
5628801|NCT00712933|19440946|P1|Overall Study|Protocol Violation|4
5628802|NCT00712933|19440946|P1|Overall Study|Physician Decision|36
5628803|NCT00712933|19440946|P1|Overall Study|Participant received medication|1
5628804|NCT00712933|19440946|P1|Overall Study|Not committed to contraception|1
5628805|NCT00712933|19440946|P1|Overall Study|Other Physician decision|1
5628806|NCT00712933|19440946|P1|Overall Study|Death of patient|1
5628807|NCT00712933|19440946|P1|Overall Study|Participant travelled overseas|2
5628808|NCT00712933|19440946|P1|Overall Study|Participant hospitalized|1
5628809|NCT00712933|19440946|P1|Overall Study|Involved in Clinical research|3
5628810|NCT00712933|19440946|P1|Overall Study|Hip replacement surgery|1
5628811|NCT00712933|19440946|P1|Overall Study|Withdrew consent|4
5628812|NCT00712933|19440946|P1|Overall Study|Sponsor decision|14
5628813|NCT00712933|19440946|P1|Overall Study|Other Pregnancy|37
5628814|NCT00712933|19440946|P1|Overall Study|Non-compliance with study drug|13
5628815|NCT00712933|19440946|P1|Overall Study|Lost to Follow-up|22
5628816|NCT00712933|19440946|P1|Overall Study|Lack of Efficacy|6
5628817|NCT00712933|19440946|P1|Overall Study|Adverse Event|69
5628818|NCT00712920|19440976|P3|Overall Study|Non-compliance|0
5628819|NCT00712920|19440977|P2|Overall Study|Non-compliance|0
5628820|NCT00712920|19440978|P1|Overall Study|Non-compliance|3
5628821|NCT00712920|19440976|P3|Overall Study|Other|3
5628822|NCT00712920|19440977|P2|Overall Study|Other|7
5628823|NCT00712920|19440978|P1|Overall Study|Other|5
5628824|NCT00712920|19440976|P3|Overall Study|Lack of Efficacy|1
5628825|NCT00712920|19440977|P2|Overall Study|Lack of Efficacy|0
5628826|NCT00712920|19440978|P1|Overall Study|Lack of Efficacy|1
5628827|NCT00712920|19440976|P3|Overall Study|Lost to Follow-up|0
5628828|NCT00712920|19440977|P2|Overall Study|Lost to Follow-up|4
5628829|NCT00712920|19440978|P1|Overall Study|Lost to Follow-up|1
5628830|NCT00712920|19440976|P3|Overall Study|Withdrawal by Subject|1
5628831|NCT00712920|19440977|P2|Overall Study|Withdrawal by Subject|2
5628832|NCT00712920|19440978|P1|Overall Study|Withdrawal by Subject|4
5628833|NCT00712920|19440976|P3|Overall Study|Adverse Event|7
5628834|NCT00712920|19440977|P2|Overall Study|Adverse Event|4
5628835|NCT00712920|19440978|P1|Overall Study|Adverse Event|3
5628836|NCT00712725|19441006|P8|Overall Study|Protocol Specified Criteria|1
5628837|NCT00712725|19441007|P7|Overall Study|Protocol Specified Criteria|2
5628838|NCT00712725|19441008|P6|Overall Study|Protocol Specified Criteria|0
5628839|NCT00712725|19441009|P5|Overall Study|Protocol Specified Criteria|1
5628840|NCT00712725|19441010|P4|Overall Study|Protocol Specified Criteria|2
5628841|NCT00712725|19441011|P3|Overall Study|Protocol Specified Criteria|1
5628842|NCT00712725|19441012|P2|Overall Study|Protocol Specified Criteria|0
5628843|NCT00712725|19441013|P1|Overall Study|Protocol Specified Criteria|3
5628844|NCT00712725|19441006|P8|Overall Study|Lack of Qualifying Event|6
5628845|NCT00712725|19441007|P7|Overall Study|Lack of Qualifying Event|11
5628846|NCT00712725|19441008|P6|Overall Study|Lack of Qualifying Event|13
5628847|NCT00712725|19441009|P5|Overall Study|Lack of Qualifying Event|11
5628848|NCT00712725|19441010|P4|Overall Study|Lack of Qualifying Event|8
5628849|NCT00712725|19441011|P3|Overall Study|Lack of Qualifying Event|6
5628850|NCT00712725|19441012|P2|Overall Study|Lack of Qualifying Event|2
5628851|NCT00712725|19441013|P1|Overall Study|Lack of Qualifying Event|16
5628852|NCT00712725|19441006|P8|Overall Study|Withdrawal by Subject|2
5628853|NCT00712725|19441007|P7|Overall Study|Withdrawal by Subject|1
5628854|NCT00712725|19441008|P6|Overall Study|Withdrawal by Subject|1
5628855|NCT00712725|19441009|P5|Overall Study|Withdrawal by Subject|1
5628856|NCT00712725|19441010|P4|Overall Study|Withdrawal by Subject|2
5628857|NCT00712725|19441011|P3|Overall Study|Withdrawal by Subject|1
5628858|NCT00712725|19441012|P2|Overall Study|Withdrawal by Subject|1
5628859|NCT00712725|19441013|P1|Overall Study|Withdrawal by Subject|2
5628860|NCT00712725|19441006|P8|Overall Study|Protocol Violation|1
5628861|NCT00712725|19441007|P7|Overall Study|Protocol Violation|1
5628862|NCT00712725|19441008|P6|Overall Study|Protocol Violation|0
5628863|NCT00712725|19441009|P5|Overall Study|Protocol Violation|2
5628864|NCT00712725|19441010|P4|Overall Study|Protocol Violation|3
5628865|NCT00712725|19441011|P3|Overall Study|Protocol Violation|1
5628866|NCT00712725|19441012|P2|Overall Study|Protocol Violation|0
5628867|NCT00712725|19441013|P1|Overall Study|Protocol Violation|2
5628868|NCT00712725|19441006|P8|Overall Study|Pregnancy|0
5628869|NCT00712725|19441007|P7|Overall Study|Pregnancy|2
5628870|NCT00712725|19441008|P6|Overall Study|Pregnancy|0
5628871|NCT00712725|19441009|P5|Overall Study|Pregnancy|1
5628872|NCT00712725|19441010|P4|Overall Study|Pregnancy|0
5628873|NCT00712725|19441011|P3|Overall Study|Pregnancy|0
5628874|NCT00712725|19441012|P2|Overall Study|Pregnancy|1
5628875|NCT00712725|19441013|P1|Overall Study|Pregnancy|0
5628876|NCT00712725|19441006|P8|Overall Study|Physician Decision|0
5628877|NCT00712725|19441007|P7|Overall Study|Physician Decision|2
5628878|NCT00712725|19441008|P6|Overall Study|Physician Decision|0
5628879|NCT00712725|19441009|P5|Overall Study|Physician Decision|1
5628880|NCT00712725|19441010|P4|Overall Study|Physician Decision|0
5628881|NCT00712725|19441011|P3|Overall Study|Physician Decision|0
5628882|NCT00712725|19441012|P2|Overall Study|Physician Decision|0
5628883|NCT00712725|19441013|P1|Overall Study|Physician Decision|2
5628884|NCT00712725|19441006|P8|Overall Study|Lost to Follow-up|1
5628885|NCT00712725|19441007|P7|Overall Study|Lost to Follow-up|3
5628886|NCT00712725|19441008|P6|Overall Study|Lost to Follow-up|2
5628887|NCT00712725|19441009|P5|Overall Study|Lost to Follow-up|2
5628888|NCT00712725|19441010|P4|Overall Study|Lost to Follow-up|1
5628889|NCT00712725|19441011|P3|Overall Study|Lost to Follow-up|1
5628890|NCT00712725|19441012|P2|Overall Study|Lost to Follow-up|2
5628891|NCT00712725|19441013|P1|Overall Study|Lost to Follow-up|3
5628892|NCT00712725|19441006|P8|Overall Study|Adverse Event|0
5628893|NCT00712725|19441007|P7|Overall Study|Adverse Event|0
5628894|NCT00712725|19441008|P6|Overall Study|Adverse Event|0
5628895|NCT00712725|19441009|P5|Overall Study|Adverse Event|0
5628896|NCT00712725|19441010|P4|Overall Study|Adverse Event|1
5628897|NCT00712725|19441011|P3|Overall Study|Adverse Event|0
5628898|NCT00712725|19441012|P2|Overall Study|Adverse Event|0
5628899|NCT00712725|19441013|P1|Overall Study|Adverse Event|1
5628900|NCT00712673|19441074|P4|Overall Study|Protocol Violation|0
5628901|NCT00712673|19441075|P3|Overall Study|Protocol Violation|2
5628902|NCT00712673|19441076|P2|Overall Study|Protocol Violation|0
5628903|NCT00712673|19441077|P1|Overall Study|Protocol Violation|0
5628904|NCT00712673|19441074|P4|Overall Study|Investigator's Decision|0
5628905|NCT00712673|19441075|P3|Overall Study|Investigator's Decision|0
5628906|NCT00712673|19441076|P2|Overall Study|Investigator's Decision|0
5628907|NCT00712673|19441077|P1|Overall Study|Investigator's Decision|1
5628908|NCT00712673|19441074|P4|Overall Study|Familial and Personal Reasons|2
5628909|NCT00712673|19441075|P3|Overall Study|Familial and Personal Reasons|5
5628910|NCT00712673|19441076|P2|Overall Study|Familial and Personal Reasons|0
5628911|NCT00712673|19441077|P1|Overall Study|Familial and Personal Reasons|5
5628912|NCT00712673|19441074|P4|Overall Study|Withdrawal by Subject|20
5628913|NCT00712673|19441075|P3|Overall Study|Withdrawal by Subject|15
5628914|NCT00712673|19441076|P2|Overall Study|Withdrawal by Subject|7
5628915|NCT00712673|19441077|P1|Overall Study|Withdrawal by Subject|6
5628916|NCT00712673|19441074|P4|Overall Study|Lost to Follow-up|0
5628917|NCT00712673|19441075|P3|Overall Study|Lost to Follow-up|2
5628918|NCT00712673|19441076|P2|Overall Study|Lost to Follow-up|0
5628919|NCT00712673|19441077|P1|Overall Study|Lost to Follow-up|1
5628920|NCT00712673|19441074|P4|Overall Study|Poor Compliance to Protocol|16
5628921|NCT00712673|19441075|P3|Overall Study|Poor Compliance to Protocol|4
5628922|NCT00712673|19441076|P2|Overall Study|Poor Compliance to Protocol|3
5628923|NCT00712673|19441077|P1|Overall Study|Poor Compliance to Protocol|3
5628924|NCT00712673|19441074|P4|Overall Study|Lack of Efficacy|6
5628925|NCT00712673|19441075|P3|Overall Study|Lack of Efficacy|8
5628926|NCT00712673|19441076|P2|Overall Study|Lack of Efficacy|8
5628927|NCT00712673|19441077|P1|Overall Study|Lack of Efficacy|2
5628928|NCT00712673|19441074|P4|Overall Study|Adverse Event|26
5628929|NCT00712673|19441075|P3|Overall Study|Adverse Event|21
5628930|NCT00712673|19441076|P2|Overall Study|Adverse Event|3
5628931|NCT00712673|19441077|P1|Overall Study|Adverse Event|3
5628932|NCT00712543|19441141|P2|Day 8-14|Lost to Follow-up|2
5628933|NCT00712543|19441142|P1|Day 8-14|Lost to Follow-up|0
5628934|NCT00712348|19441176|P1|Overall Study|Withdrawal by Subject|1
5628935|NCT00712335|19441188|P5|Overall Study|Other Reason|0
5628936|NCT00712335|19441189|P4|Overall Study|Other Reason|0
5628937|NCT00712335|19441190|P3|Overall Study|Other Reason|1
5628938|NCT00712335|19441191|P2|Overall Study|Other Reason|3
5628939|NCT00712335|19441192|P1|Overall Study|Other Reason|0
5628940|NCT00712335|19441188|P5|Overall Study|Lack of Efficacy|0
5628941|NCT00712335|19441189|P4|Overall Study|Lack of Efficacy|1
5628942|NCT00712335|19441190|P3|Overall Study|Lack of Efficacy|1
5628943|NCT00712335|19441191|P2|Overall Study|Lack of Efficacy|0
5628944|NCT00712335|19441192|P1|Overall Study|Lack of Efficacy|0
5628945|NCT00712335|19441188|P5|Overall Study|Protocol Violation|0
5628946|NCT00712335|19441189|P4|Overall Study|Protocol Violation|0
5628947|NCT00712335|19441190|P3|Overall Study|Protocol Violation|1
5628948|NCT00712335|19441191|P2|Overall Study|Protocol Violation|2
5628949|NCT00712335|19441192|P1|Overall Study|Protocol Violation|1
5628950|NCT00712335|19441188|P5|Overall Study|Lost to Follow-up|0
5628951|NCT00712335|19441189|P4|Overall Study|Lost to Follow-up|1
5628952|NCT00712335|19441190|P3|Overall Study|Lost to Follow-up|0
5628953|NCT00712335|19441191|P2|Overall Study|Lost to Follow-up|5
5628954|NCT00712335|19441192|P1|Overall Study|Lost to Follow-up|2
5628955|NCT00712335|19441188|P5|Overall Study|Withdrawal by Subject|0
5628956|NCT00712335|19441189|P4|Overall Study|Withdrawal by Subject|3
5628957|NCT00712335|19441190|P3|Overall Study|Withdrawal by Subject|2
5628958|NCT00712335|19441191|P2|Overall Study|Withdrawal by Subject|7
5628959|NCT00712335|19441192|P1|Overall Study|Withdrawal by Subject|0
5628960|NCT00712270|19441322|P1|Overall Study|Screen Failure|3
5628961|NCT00712270|19441322|P1|Overall Study|Withdrawal by Subject|11
5628962|NCT00712166|19441386|P2|Overall Study|Noncompliance|1
5628963|NCT00712166|19441387|P1|Overall Study|Noncompliance|0
5628964|NCT00712010|19441430|P1|Washout (7 Days)|Withdrawal by Subject|1
5628965|NCT00711971|19441469|P3|Overall Study|Lost to Follow-up|1
5628966|NCT00711971|19441470|P2|Overall Study|Lost to Follow-up|4
5628967|NCT00711971|19441471|P1|Overall Study|Lost to Follow-up|3
5628968|NCT00711958|19441505|P2|Overall Study|Progression of disease|0
5628969|NCT00711958|19441506|P1|Overall Study|Progression of disease|1
5628970|NCT00711958|19441505|P2|Overall Study|Death|5
5628971|NCT00711958|19441506|P1|Overall Study|Death|10
5628972|NCT00711958|19441505|P2|Overall Study|Lost to Follow-up|2
5628973|NCT00711958|19441506|P1|Overall Study|Lost to Follow-up|2
5628974|NCT00711958|19441505|P2|Overall Study|Protocol Violation|0
5628975|NCT00711958|19441506|P1|Overall Study|Protocol Violation|1
5628976|NCT00711958|19441505|P2|Overall Study|Adverse Event|7
5628977|NCT00711958|19441506|P1|Overall Study|Adverse Event|9
5628978|NCT00711958|19441505|P2|Overall Study|Clinical deterioration|0
5628979|NCT00711958|19441506|P1|Overall Study|Clinical deterioration|1
5628980|NCT00711958|19441505|P2|Overall Study|Lack of Efficacy|1
5628981|NCT00711958|19441506|P1|Overall Study|Lack of Efficacy|3
5628982|NCT00711958|19441505|P2|Overall Study|Withdrawal by Subject|8
5628983|NCT00711958|19441506|P1|Overall Study|Withdrawal by Subject|6
5628984|NCT00711880|19441514|P2|Overall Study|Lack of Efficacy|5
5628985|NCT00711880|19441515|P1|Overall Study|Lack of Efficacy|1
5628986|NCT00711880|19441514|P2|Overall Study|Patient non-compliance|0
5628987|NCT00711880|19441515|P1|Overall Study|Patient non-compliance|1
5628988|NCT00711880|19441514|P2|Overall Study|Adverse Event|2
5628989|NCT00711880|19441515|P1|Overall Study|Adverse Event|11
5628990|NCT00711802|19441577|P8|Overall Study|Reason not reported|0
5628991|NCT00711802|19441578|P7|Overall Study|Reason not reported|1
5628992|NCT00711802|19441579|P6|Overall Study|Reason not reported|0
5628993|NCT00711802|19441580|P5|Overall Study|Reason not reported|1
5628994|NCT00711802|19441581|P4|Overall Study|Reason not reported|0
5628995|NCT00711802|19441582|P3|Overall Study|Reason not reported|1
5628996|NCT00711802|19441583|P2|Overall Study|Reason not reported|1
5628997|NCT00711802|19441584|P1|Overall Study|Reason not reported|0
5628998|NCT00711802|19441577|P8|Overall Study|Lost to Follow-up|2
5628999|NCT00711802|19441578|P7|Overall Study|Lost to Follow-up|4
5629000|NCT00711802|19441579|P6|Overall Study|Lost to Follow-up|6
5629001|NCT00711802|19441580|P5|Overall Study|Lost to Follow-up|10
5629002|NCT00711802|19441581|P4|Overall Study|Lost to Follow-up|1
5629003|NCT00711802|19441582|P3|Overall Study|Lost to Follow-up|3
5629004|NCT00711802|19441583|P2|Overall Study|Lost to Follow-up|0
5629005|NCT00711802|19441584|P1|Overall Study|Lost to Follow-up|0
5629006|NCT00711802|19441577|P8|Overall Study|Withdrawal by Subject|0
5629007|NCT00711802|19441578|P7|Overall Study|Withdrawal by Subject|0
5629008|NCT00711802|19441579|P6|Overall Study|Withdrawal by Subject|0
5629009|NCT00711802|19441580|P5|Overall Study|Withdrawal by Subject|0
5629010|NCT00711802|19441581|P4|Overall Study|Withdrawal by Subject|1
5629011|NCT00711802|19441582|P3|Overall Study|Withdrawal by Subject|0
5629012|NCT00711802|19441583|P2|Overall Study|Withdrawal by Subject|1
5629013|NCT00711802|19441584|P1|Overall Study|Withdrawal by Subject|0
5629014|NCT00711802|19441577|P8|Overall Study|Physician Decision|0
5629015|NCT00711802|19441578|P7|Overall Study|Physician Decision|0
5629016|NCT00711802|19441579|P6|Overall Study|Physician Decision|0
5629017|NCT00711802|19441580|P5|Overall Study|Physician Decision|0
5629018|NCT00711802|19441581|P4|Overall Study|Physician Decision|0
5629019|NCT00711802|19441582|P3|Overall Study|Physician Decision|0
5629020|NCT00711802|19441583|P2|Overall Study|Physician Decision|2
5629021|NCT00711802|19441584|P1|Overall Study|Physician Decision|0
5629022|NCT00711802|19441577|P8|Overall Study|Protocol Violation|0
5629023|NCT00711802|19441578|P7|Overall Study|Protocol Violation|0
5629024|NCT00711802|19441579|P6|Overall Study|Protocol Violation|0
5629025|NCT00711802|19441580|P5|Overall Study|Protocol Violation|0
5629026|NCT00711802|19441581|P4|Overall Study|Protocol Violation|1
5629027|NCT00711802|19441582|P3|Overall Study|Protocol Violation|0
5629028|NCT00711802|19441583|P2|Overall Study|Protocol Violation|0
5629029|NCT00711802|19441584|P1|Overall Study|Protocol Violation|0
5629030|NCT00711802|19441577|P8|Overall Study|Microbiological failure|0
5629031|NCT00711802|19441578|P7|Overall Study|Microbiological failure|0
5629032|NCT00711802|19441579|P6|Overall Study|Microbiological failure|1
5629033|NCT00711802|19441580|P5|Overall Study|Microbiological failure|0
5629034|NCT00711802|19441581|P4|Overall Study|Microbiological failure|0
5629035|NCT00711802|19441582|P3|Overall Study|Microbiological failure|0
5629036|NCT00711802|19441583|P2|Overall Study|Microbiological failure|1
5629037|NCT00711802|19441584|P1|Overall Study|Microbiological failure|0
5629038|NCT00711802|19441577|P8|Overall Study|Adverse Event|0
5629039|NCT00711802|19441578|P7|Overall Study|Adverse Event|0
5629040|NCT00711802|19441579|P6|Overall Study|Adverse Event|1
5629041|NCT00711802|19441580|P5|Overall Study|Adverse Event|1
5629042|NCT00711802|19441581|P4|Overall Study|Adverse Event|0
5629043|NCT00711802|19441582|P3|Overall Study|Adverse Event|0
5629044|NCT00711802|19441583|P2|Overall Study|Adverse Event|0
5629045|NCT00711802|19441584|P1|Overall Study|Adverse Event|0
5629046|NCT00711802|19441577|P8|Overall Study|Not treated (no further detail)|0
5629047|NCT00711802|19441578|P7|Overall Study|Not treated (no further detail)|0
5629048|NCT00711802|19441579|P6|Overall Study|Not treated (no further detail)|0
5629049|NCT00711802|19441580|P5|Overall Study|Not treated (no further detail)|2
5629050|NCT00711802|19441581|P4|Overall Study|Not treated (no further detail)|0
5629051|NCT00711802|19441582|P3|Overall Study|Not treated (no further detail)|2
5629052|NCT00711802|19441583|P2|Overall Study|Not treated (no further detail)|1
5629053|NCT00711802|19441584|P1|Overall Study|Not treated (no further detail)|2
5629054|NCT00711646|19441627|P2|Overall Study|patient non-compliance|0
5629055|NCT00711646|19441628|P1|Overall Study|patient non-compliance|1
5629056|NCT00711646|19441627|P2|Overall Study|administrative decision|1
5629057|NCT00711646|19441628|P1|Overall Study|administrative decision|0
5629058|NCT00711646|19441627|P2|Overall Study|Lost to Follow-up|0
5629059|NCT00711646|19441628|P1|Overall Study|Lost to Follow-up|1
5629060|NCT00711646|19441627|P2|Overall Study|Protocol Violation|1
5629061|NCT00711646|19441628|P1|Overall Study|Protocol Violation|0
5629062|NCT00711646|19441627|P2|Overall Study|Withdrawal by Subject|0
5629063|NCT00711646|19441628|P1|Overall Study|Withdrawal by Subject|4
5629064|NCT00711646|19441627|P2|Overall Study|Adverse Event|1
5629065|NCT00711646|19441628|P1|Overall Study|Adverse Event|6
5629066|NCT00711594|19441650|P4|Overall Study|Withdrawal by Subject|2
5629067|NCT00711594|19441651|P3|Overall Study|Withdrawal by Subject|0
5629068|NCT00711594|19441652|P2|Overall Study|Withdrawal by Subject|1
5629069|NCT00711594|19441653|P1|Overall Study|Withdrawal by Subject|0
5629070|NCT00711594|19441650|P4|Overall Study|Other Adverse Event|16
5629071|NCT00711594|19441651|P3|Overall Study|Other Adverse Event|0
5629072|NCT00711594|19441652|P2|Overall Study|Other Adverse Event|0
5629073|NCT00711594|19441653|P1|Overall Study|Other Adverse Event|1
5629074|NCT00711594|19441650|P4|Overall Study|Progressive disease|44
5629075|NCT00711594|19441651|P3|Overall Study|Progressive disease|6
5629076|NCT00711594|19441652|P2|Overall Study|Progressive disease|2
5629077|NCT00711594|19441653|P1|Overall Study|Progressive disease|2
5629078|NCT00711555|19441690|P1|Overall Study|Adverse Event|3
5629079|NCT00711529|19441699|P2|Overall Study|Withdrawal by Subject|6
5629080|NCT00711529|19441700|P1|Overall Study|Withdrawal by Subject|2
5629081|NCT00711529|19441699|P2|Overall Study|Protocol Violation|0
5629082|NCT00711529|19441700|P1|Overall Study|Protocol Violation|2
5629083|NCT00711516|19441724|P2|Overall Study|Protocol Violation|1
5629084|NCT00711516|19441725|P1|Overall Study|Protocol Violation|0
5629085|NCT00711516|19441724|P2|Overall Study|Withdrawal by Subject|1
5629086|NCT00711516|19441725|P1|Overall Study|Withdrawal by Subject|0
5629087|NCT00711516|19441724|P2|Overall Study|Adverse Event|1
5629088|NCT00711516|19441725|P1|Overall Study|Adverse Event|1
5629089|NCT00711477|19441832|P2|Overall Study|Noncompliance|1
5629090|NCT00711477|19441833|P1|Overall Study|Noncompliance|0
5629091|NCT00711477|19441832|P2|Overall Study|Lost to Follow-up|1
5629092|NCT00711477|19441833|P1|Overall Study|Lost to Follow-up|0
5629093|NCT00711477|19441832|P2|Overall Study|Adverse Event|1
5629094|NCT00711477|19441833|P1|Overall Study|Adverse Event|3
5629095|NCT00711425|19441879|P1|Overall Study|Lost to Follow-up|1
5629096|NCT00711425|19441879|P1|Overall Study|Death|2
5629097|NCT00711425|19441879|P1|Overall Study|Protocol Violation|1
5629098|NCT00711412|19441885|P1|Survival Follow up Until Death|Other|12
5629099|NCT00711412|19441885|P1|Evaluation for Response and Surgery|Death|1
5629100|NCT00711412|19441885|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
5629101|NCT00711412|19441885|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
5629102|NCT00711412|19441885|P1|Evaluation for Response and Surgery|Progressive Disease|2
5629103|NCT00711412|19441885|P1|Combination Treatment|Progressive Disease|1
5629104|NCT00711412|19441885|P1|Evaluated for Combination Treatment|Progressive disease|2
5629105|NCT00711412|19441885|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
5629106|NCT00711412|19441885|P1|Evaluated for Combination Treatment|Death|1
5629107|NCT00711412|19441885|P1|Evaluated for Combination Treatment|Adverse Event|2
5629108|NCT00711412|19441885|P1|Induction Treatment|Other|1
5629109|NCT00711412|19441885|P1|Induction Treatment|Adverse Event|1
5629110|NCT00711412|19441885|P1|Induction Treatment|Death|2
5629111|NCT00711243|19441963|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
5629112|NCT00711243|19441964|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5629113|NCT00711243|19441965|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5629114|NCT00711243|19441966|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5629115|NCT00711243|19441967|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5629116|NCT00711243|19441968|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
5629117|NCT00711243|19441963|P6|Treated Cycle 5 After First Response|Decline in performance status|1
5629118|NCT00711243|19441964|P5|Treated Cycle 5 After First Response|Decline in performance status|0
5629119|NCT00711243|19441965|P4|Treated Cycle 5 After First Response|Decline in performance status|0
5629120|NCT00711243|19441966|P3|Treated Cycle 5 After First Response|Decline in performance status|0
5629121|NCT00711243|19441967|P2|Treated Cycle 5 After First Response|Decline in performance status|0
5629122|NCT00711243|19441968|P1|Treated Cycle 5 After First Response|Decline in performance status|0
5629123|NCT00711243|19441963|P6|Treated Cycle 5 After First Response|Death|2
5629124|NCT00711243|19441964|P5|Treated Cycle 5 After First Response|Death|0
5629125|NCT00711243|19441965|P4|Treated Cycle 5 After First Response|Death|0
5629126|NCT00711243|19441966|P3|Treated Cycle 5 After First Response|Death|0
5629127|NCT00711243|19441967|P2|Treated Cycle 5 After First Response|Death|0
5629128|NCT00711243|19441968|P1|Treated Cycle 5 After First Response|Death|0
5629129|NCT00711243|19441963|P6|Treated Cycle 5 After First Response|Progressive disease|1
5629130|NCT00711243|19441964|P5|Treated Cycle 5 After First Response|Progressive disease|1
5629131|NCT00711243|19441965|P4|Treated Cycle 5 After First Response|Progressive disease|0
5629132|NCT00711243|19441966|P3|Treated Cycle 5 After First Response|Progressive disease|0
5629133|NCT00711243|19441967|P2|Treated Cycle 5 After First Response|Progressive disease|2
5629134|NCT00711243|19441968|P1|Treated Cycle 5 After First Response|Progressive disease|1
5629135|NCT00711243|19441963|P6|Reached First Response/4 Cycles|Progressive disease|0
5629136|NCT00711243|19441964|P5|Reached First Response/4 Cycles|Progressive disease|0
5629137|NCT00711243|19441965|P4|Reached First Response/4 Cycles|Progressive disease|1
5629138|NCT00711243|19441966|P3|Reached First Response/4 Cycles|Progressive disease|0
5629139|NCT00711243|19441967|P2|Reached First Response/4 Cycles|Progressive disease|0
5629140|NCT00711243|19441968|P1|Reached First Response/4 Cycles|Progressive disease|0
5629141|NCT00711243|19441963|P6|Reached First Response/4 Cycles|Death|2
5629142|NCT00711243|19441964|P5|Reached First Response/4 Cycles|Death|0
5629143|NCT00711243|19441965|P4|Reached First Response/4 Cycles|Death|0
5629144|NCT00711243|19441966|P3|Reached First Response/4 Cycles|Death|0
5629145|NCT00711243|19441967|P2|Reached First Response/4 Cycles|Death|0
5629146|NCT00711243|19441968|P1|Reached First Response/4 Cycles|Death|0
5629147|NCT00711243|19441963|P6|Registed and Started Treatment|Withdrawal by Subject|1
5629148|NCT00711243|19441964|P5|Registed and Started Treatment|Withdrawal by Subject|0
5629149|NCT00711243|19441965|P4|Registed and Started Treatment|Withdrawal by Subject|0
5629150|NCT00711243|19441966|P3|Registed and Started Treatment|Withdrawal by Subject|0
5629151|NCT00711243|19441967|P2|Registed and Started Treatment|Withdrawal by Subject|0
5629152|NCT00711243|19441968|P1|Registed and Started Treatment|Withdrawal by Subject|0
5629153|NCT00711191|19441991|P3|Overall Study|Withdrawal by Subject|3
5629154|NCT00711191|19441992|P2|Overall Study|Withdrawal by Subject|1
5629155|NCT00711191|19441993|P1|Overall Study|Withdrawal by Subject|0
5629156|NCT00711191|19441991|P3|Overall Study|Objective progression or relapse|7
5629157|NCT00711191|19441992|P2|Overall Study|Objective progression or relapse|3
5629158|NCT00711191|19441993|P1|Overall Study|Objective progression or relapse|2
5629159|NCT00711191|19441991|P3|Overall Study|Adverse Event|2
5629160|NCT00711191|19441992|P2|Overall Study|Adverse Event|1
5629161|NCT00711191|19441993|P1|Overall Study|Adverse Event|1
5629162|NCT00711113|19442030|P1|Overall Study|Implant lost|2
5629163|NCT00711113|19442030|P1|Overall Study|Lost to Follow-up|9
5629164|NCT00711100|19442036|P1|Overall Study|Withdrawal by Subject|8
5629165|NCT00711100|19442036|P1|Overall Study|Lack of Efficacy|5
5629166|NCT00711087|19442054|P2|Overall Study|Lost to Follow-up|0
5629167|NCT00711087|19442055|P1|Overall Study|Lost to Follow-up|1
5629168|NCT00711009|19442067|P2|Overall Study|Dose adjustment|0
5629169|NCT00711009|19442068|P1|Overall Study|Dose adjustment|1
5629170|NCT00711009|19442067|P2|Overall Study|Site closing|1
5629171|NCT00711009|19442068|P1|Overall Study|Site closing|0
5629172|NCT00711009|19442067|P2|Overall Study|Pregnancy|0
5629173|NCT00711009|19442068|P1|Overall Study|Pregnancy|1
5629174|NCT00711009|19442067|P2|Overall Study|Virologic Failure|1
5629175|NCT00711009|19442068|P1|Overall Study|Virologic Failure|2
5629176|NCT00711009|19442067|P2|Overall Study|Participant Noncompliant|1
5629177|NCT00711009|19442068|P1|Overall Study|Participant Noncompliant|0
5629178|NCT00711009|19442067|P2|Overall Study|Lost to Follow-up|9
5629179|NCT00711009|19442068|P1|Overall Study|Lost to Follow-up|3
5629180|NCT00711009|19442067|P2|Overall Study|Withdrawal by Subject|2
5629181|NCT00711009|19442068|P1|Overall Study|Withdrawal by Subject|4
5629182|NCT00711009|19442067|P2|Overall Study|Adverse Event/HIV-Related Event|5
5629183|NCT00711009|19442068|P1|Overall Study|Adverse Event/HIV-Related Event|4
5629184|NCT00710970|19442249|P1|Overall Study|Never took drug|2
5629185|NCT00710970|19442249|P1|Overall Study|Lost to Follow-up|8
5629186|NCT00710879|19442276|P2|Overall Study|Protocol Violation|3
5629187|NCT00710879|19442277|P1|Overall Study|Protocol Violation|0
5629188|NCT00710879|19442276|P2|Overall Study|Lost to Follow-up|1
5629189|NCT00710879|19442277|P1|Overall Study|Lost to Follow-up|2
5629190|NCT00710866|19442289|P2|Overall Study|Failed to meet eligibility|1
5629191|NCT00710866|19442290|P1|Overall Study|Failed to meet eligibility|1
5629192|NCT00710866|19442289|P2|Overall Study|Lost to Follow-up|0
5629193|NCT00710866|19442290|P1|Overall Study|Lost to Follow-up|1
5629194|NCT00710866|19442289|P2|Overall Study|Withdrawal by Subject|1
5629195|NCT00710866|19442290|P1|Overall Study|Withdrawal by Subject|2
5629196|NCT00710866|19442289|P2|Overall Study|Protocol Violation|4
5629197|NCT00710866|19442290|P1|Overall Study|Protocol Violation|5
5629198|NCT00710762|19442336|P2|Overall Study|Reason other than listed above|2
5629199|NCT00710762|19442337|P1|Overall Study|Reason other than listed above|2
5629200|NCT00710762|19442336|P2|Overall Study|Lost to Follow-up|0
5629201|NCT00710762|19442337|P1|Overall Study|Lost to Follow-up|1
5629202|NCT00710762|19442336|P2|Overall Study|Other Adverse Event|7
5629203|NCT00710762|19442337|P1|Overall Study|Other Adverse Event|7
5629204|NCT00710762|19442336|P2|Overall Study|Adverse Event other disease worsening|1
5629205|NCT00710762|19442337|P1|Overall Study|Adverse Event other disease worsening|2
5629206|NCT00710762|19442336|P2|Overall Study|Progressive disease|30
5629207|NCT00710762|19442337|P1|Overall Study|Progressive disease|27
5629208|NCT00710749|19442353|P2|First Intervention|Withdrawal by Subject|0
5629209|NCT00710749|19442354|P1|First Intervention|Withdrawal by Subject|1
5629210|NCT00710684|19442365|P3|Overall Study|Did not continue after week 24|16
5629211|NCT00710684|19442366|P2|Overall Study|Did not continue after week 24|21
5629212|NCT00710684|19442367|P1|Overall Study|Did not continue after week 24|25
5629213|NCT00710684|19442365|P3|Overall Study|Missing|0
5629214|NCT00710684|19442366|P2|Overall Study|Missing|0
5629215|NCT00710684|19442367|P1|Overall Study|Missing|1
5629216|NCT00710684|19442365|P3|Overall Study|Withdrawal by Subject|11
5629217|NCT00710684|19442366|P2|Overall Study|Withdrawal by Subject|18
5629218|NCT00710684|19442367|P1|Overall Study|Withdrawal by Subject|24
5629219|NCT00710684|19442365|P3|Overall Study|Physician Decision|4
5629220|NCT00710684|19442366|P2|Overall Study|Physician Decision|2
5629221|NCT00710684|19442367|P1|Overall Study|Physician Decision|0
5629222|NCT00710684|19442365|P3|Overall Study|Lost to Follow-up|7
5629223|NCT00710684|19442366|P2|Overall Study|Lost to Follow-up|6
5629224|NCT00710684|19442367|P1|Overall Study|Lost to Follow-up|4
5629225|NCT00710684|19442365|P3|Overall Study|Protocol Violation|5
5629226|NCT00710684|19442366|P2|Overall Study|Protocol Violation|5
5629227|NCT00710684|19442367|P1|Overall Study|Protocol Violation|5
5629228|NCT00710684|19442365|P3|Overall Study|Lack of Efficacy|5
5629229|NCT00710684|19442366|P2|Overall Study|Lack of Efficacy|3
5629230|NCT00710684|19442367|P1|Overall Study|Lack of Efficacy|4
5629231|NCT00710684|19442365|P3|Overall Study|Adverse Event|16
5629232|NCT00710684|19442366|P2|Overall Study|Adverse Event|19
5629233|NCT00710684|19442367|P1|Overall Study|Adverse Event|11
5629234|NCT00710606|19442424|P2|Overall Study|Adverse Event|2
5629235|NCT00710606|19442425|P1|Overall Study|Adverse Event|0
5629236|NCT00710593|19442437|P2|Overall Study|Prem disc vaccine, completed all visits|2
5629237|NCT00710593|19442438|P1|Overall Study|Prem disc vaccine, completed all visits|6
5629238|NCT00710593|19442437|P2|Overall Study|Protocol Violation|1
5629239|NCT00710593|19442438|P1|Overall Study|Protocol Violation|1
5629240|NCT00710593|19442437|P2|Overall Study|Failure to adhere or complete study eval|1
5629241|NCT00710593|19442438|P1|Overall Study|Failure to adhere or complete study eval|1
5629242|NCT00710593|19442437|P2|Overall Study|Moved out of area|0
5629243|NCT00710593|19442438|P1|Overall Study|Moved out of area|1
5629244|NCT00710593|19442437|P2|Overall Study|Lost to Follow-up|1
5629245|NCT00710593|19442438|P1|Overall Study|Lost to Follow-up|3
5629246|NCT00710593|19442437|P2|Overall Study|Unable to complete Wk 48 within window|0
5629247|NCT00710593|19442438|P1|Overall Study|Unable to complete Wk 48 within window|2
5629248|NCT00710593|19442437|P2|Overall Study|Incarceration|0
5629249|NCT00710593|19442438|P1|Overall Study|Incarceration|1
5629250|NCT00710554|19442481|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
5629251|NCT00710554|19442482|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
5629252|NCT00710554|19442481|P2|Overall Study|Lack of Efficacy|12
5629253|NCT00710554|19442482|P1|Overall Study|Lack of Efficacy|11
5629254|NCT00710554|19442481|P2|Overall Study|Lost to Follow-up|1
5629255|NCT00710554|19442482|P1|Overall Study|Lost to Follow-up|7
5629256|NCT00710554|19442481|P2|Overall Study|Withdrawal by Subject|3
5629257|NCT00710554|19442482|P1|Overall Study|Withdrawal by Subject|7
5629258|NCT00710554|19442481|P2|Overall Study|Adverse Event|7
5629259|NCT00710554|19442482|P1|Overall Study|Adverse Event|24
5629260|NCT00710424|19442510|P2|Overall Study|Felt good so stopped treatment|1
5629261|NCT00710424|19442511|P1|Overall Study|Felt good so stopped treatment|0
5629262|NCT00710424|19442510|P2|Overall Study|Subject preferred paracetamol|1
5629263|NCT00710424|19442511|P1|Overall Study|Subject preferred paracetamol|0
5629264|NCT00710424|19442510|P2|Overall Study|Ceased treatment due to travel|0
5629265|NCT00710424|19442511|P1|Overall Study|Ceased treatment due to travel|1
5629266|NCT00710424|19442510|P2|Overall Study|Subject thought medication changed|0
5629267|NCT00710424|19442511|P1|Overall Study|Subject thought medication changed|1
5629268|NCT00710424|19442510|P2|Overall Study|Did not meet entry criteria at visit 1|0
5629269|NCT00710424|19442511|P1|Overall Study|Did not meet entry criteria at visit 1|1
5629270|NCT00710424|19442510|P2|Overall Study|Non-compliance with stable analgesia|0
5629271|NCT00710424|19442511|P1|Overall Study|Non-compliance with stable analgesia|1
5629272|NCT00710424|19442510|P2|Overall Study|Refused medication, no side effects|0
5629273|NCT00710424|19442511|P1|Overall Study|Refused medication, no side effects|1
5629274|NCT00710424|19442510|P2|Overall Study|Lost to Follow-up|1
5629275|NCT00710424|19442511|P1|Overall Study|Lost to Follow-up|0
5629276|NCT00710424|19442510|P2|Overall Study|Withdrawal by Subject|3
5629277|NCT00710424|19442511|P1|Overall Study|Withdrawal by Subject|5
5629278|NCT00710424|19442510|P2|Overall Study|Lack of Efficacy|5
5629279|NCT00710424|19442511|P1|Overall Study|Lack of Efficacy|4
5629280|NCT00710424|19442510|P2|Overall Study|Adverse Event|12
5629281|NCT00710424|19442511|P1|Overall Study|Adverse Event|30
5629282|NCT00710385|19442535|P1|Overall Study|Undisclosed excessive methadone use|1
5629283|NCT00710385|19442535|P1|Overall Study|Physician Decision|1
5629284|NCT00710385|19442535|P1|Overall Study|Undisclosed back pain|1
5629285|NCT00710385|19442535|P1|Overall Study|Withdrawal by Subject|1
5629286|NCT00710385|19442535|P1|Overall Study|Did not qualify|1
5629287|NCT00710034|19442580|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
5629288|NCT00710034|19442581|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
5629289|NCT00710034|19442580|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
5629290|NCT00710034|19442581|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
5629291|NCT00710034|19442580|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
5629292|NCT00710034|19442581|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
5629293|NCT00710034|19442580|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
5629294|NCT00710034|19442581|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
5629295|NCT00710034|19442580|P2|Completed 12 Weeks of Treatment|Adverse Event|1
5629296|NCT00710034|19442581|P1|Completed 12 Weeks of Treatment|Adverse Event|0
5629297|NCT00710034|19442580|P2|Completed 6 Weeks of Treatment|Physician Decision|0
5629298|NCT00710034|19442581|P1|Completed 6 Weeks of Treatment|Physician Decision|1
5629299|NCT00710034|19442580|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
5629300|NCT00710034|19442581|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
5629301|NCT00710034|19442580|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
5629302|NCT00710034|19442581|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
5629303|NCT00710034|19442580|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
5629304|NCT00710034|19442581|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
5629305|NCT00710034|19442580|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
5629306|NCT00710034|19442581|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
5629307|NCT00710034|19442580|P2|Completed 6 Weeks of Treatment|Adverse Event|12
5629308|NCT00710034|19442581|P1|Completed 6 Weeks of Treatment|Adverse Event|5
5629309|NCT00710021|19442598|P3|Overall Study|Physician Decision|0
5629310|NCT00710021|19442599|P2|Overall Study|Physician Decision|1
5629311|NCT00710021|19442600|P1|Overall Study|Physician Decision|0
5629312|NCT00710021|19442598|P3|Overall Study|Subject misrandomized|1
5629313|NCT00710021|19442599|P2|Overall Study|Subject misrandomized|1
5629314|NCT00710021|19442600|P1|Overall Study|Subject misrandomized|0
5629315|NCT00710021|19442598|P3|Overall Study|Subject's Decision|0
5629316|NCT00710021|19442599|P2|Overall Study|Subject's Decision|1
5629317|NCT00710021|19442600|P1|Overall Study|Subject's Decision|0
5629318|NCT00710021|19442598|P3|Overall Study|Lost to Follow-up|0
5629319|NCT00710021|19442599|P2|Overall Study|Lost to Follow-up|0
5629320|NCT00710021|19442600|P1|Overall Study|Lost to Follow-up|1
5629321|NCT00709995|19442715|P2|Overall Study|Withdrawal by Subject|3
5629322|NCT00709995|19442716|P1|Overall Study|Withdrawal by Subject|1
5629323|NCT00709995|19442715|P2|Overall Study|Adverse Event|2
5629324|NCT00709995|19442716|P1|Overall Study|Adverse Event|4
5629325|NCT00709956|19442734|P2|Overall Study|Inclusion/exclusion criteria violation|3
5629326|NCT00709956|19442735|P1|Overall Study|Inclusion/exclusion criteria violation|2
5629327|NCT00709956|19442734|P2|Overall Study|Withdrawal by Subject|1
5629328|NCT00709956|19442735|P1|Overall Study|Withdrawal by Subject|1
5629329|NCT00709852|19442765|P2|Period 2|No 72-hour follow-up|0
5629330|NCT00709852|19442766|P1|Period 2|No 72-hour follow-up|3
5629331|NCT00709852|19442765|P2|Period 2|Lost to Follow-up|0
5629332|NCT00709852|19442766|P1|Period 2|Lost to Follow-up|1
5629333|NCT00709852|19442765|P2|Period 2|Adverse Event|1
5629334|NCT00709852|19442766|P1|Period 2|Adverse Event|1
5629335|NCT00709852|19442765|P2|Period 2|Protocol Violation|1
5629336|NCT00709852|19442766|P1|Period 2|Protocol Violation|4
5629337|NCT00709852|19442765|P2|Period 1|Lost to Follow-up|0
5629338|NCT00709852|19442766|P1|Period 1|Lost to Follow-up|1
5629339|NCT00709852|19442765|P2|Period 1|Defective scanner|1
5629340|NCT00709852|19442766|P1|Period 1|Defective scanner|0
5629341|NCT00709852|19442765|P2|Period 1|Protocol Violation|0
5629342|NCT00709852|19442766|P1|Period 1|Protocol Violation|1
5629343|NCT00709852|19442765|P2|Period 1|Withdrawal by Subject|2
5629344|NCT00709852|19442766|P1|Period 1|Withdrawal by Subject|4
5629345|NCT00709852|19442765|P2|Period 1|Adverse Event|0
5629346|NCT00709852|19442766|P1|Period 1|Adverse Event|2
5629347|NCT00709761|19442930|P1|Overall Study|Lost to Follow-up|2
5629348|NCT00709761|19442930|P1|Overall Study|study closed/terminated|17
5629349|NCT00709761|19442930|P1|Overall Study|Withdrawal by Subject|8
5629350|NCT00709735|19442941|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
5629351|NCT00709735|19442942|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
5629352|NCT00709735|19442941|P2|Overall Study|Relapse into Opioid Abuse|1
5629353|NCT00709735|19442942|P1|Overall Study|Relapse into Opioid Abuse|0
5629354|NCT00709735|19442941|P2|Overall Study|Lost to Follow-up|1
5629355|NCT00709735|19442942|P1|Overall Study|Lost to Follow-up|1
5629356|NCT00709722|19442950|P1|Overall Study|Adverse Event|1
5629357|NCT00709618|19442965|P1|Overall Study|Study Closed/Terminated|25
5629358|NCT00709618|19442965|P1|Overall Study|Lost to Follow-up|1
5629359|NCT00709618|19442965|P1|Overall Study|Withdrawal by Subject|4
5629360|NCT00709592|19442977|P2|Overall Study|Unable to proceed to transplant|1
5629361|NCT00709592|19442978|P1|Overall Study|Unable to proceed to transplant|0
5629362|NCT00709319|19443000|P1|Overall Study|Withdrawal by Subject|2
5629363|NCT00709319|19443000|P1|Overall Study|Death|4
5629364|NCT00709228|19443029|P1|Overall Study|Non-compliance|5
5629365|NCT00709228|19443029|P1|Overall Study|Lost to Follow-up|6
5629366|NCT00709228|19443029|P1|Overall Study|Disease progression|1
5629367|NCT00709228|19443029|P1|Overall Study|Discontinued follow-up|5
5629368|NCT00709228|19443029|P1|Overall Study|Did not enter follow-up|4
5629369|NCT00709228|19443029|P1|Overall Study|Discontinued treatment|14
5629370|NCT00709228|19443029|P1|Overall Study|Adverse events|2
5629371|NCT00709228|19443029|P1|Overall Study|Eligibility criteria not met|281
5629372|NCT00709228|19443029|P1|Overall Study|Not treated|14
5629373|NCT00709202|19443035|P2|Overall Study|Withdrawal by Subject|6
5629374|NCT00709202|19443036|P1|Overall Study|Withdrawal by Subject|6
5629375|NCT00709124|19443064|P2|Overall Study|encephalopathy; can't do assessment|0
5629376|NCT00709124|19443065|P1|Overall Study|encephalopathy; can't do assessment|1
5629377|NCT00709124|19443064|P2|Overall Study|Death|1
5629378|NCT00709124|19443065|P1|Overall Study|Death|3
5629379|NCT00709111|19443099|P1|Overall Study|Unable to attend clinic visits|1
5629380|NCT00709111|19443099|P1|Overall Study|Withdrawal by Subject|1
5629381|NCT00709098|19443140|P3|Open-label Period|Lost to Follow-up|1
5629382|NCT00709098|19443141|P2|Open-label Period|Lost to Follow-up|0
5629383|NCT00709098|19443142|P1|Open-label Period|Lost to Follow-up|0
5629384|NCT00709098|19443140|P3|Open-label Period|Death|1
5629385|NCT00709098|19443141|P2|Open-label Period|Death|0
5629386|NCT00709098|19443142|P1|Open-label Period|Death|0
5629387|NCT00709098|19443140|P3|Open-label Period|Administrative reason|5
5629388|NCT00709098|19443141|P2|Open-label Period|Administrative reason|0
5629389|NCT00709098|19443142|P1|Open-label Period|Administrative reason|0
5629390|NCT00709098|19443140|P3|Open-label Period|Withdrawal of consent|7
5629391|NCT00709098|19443141|P2|Open-label Period|Withdrawal of consent|0
5629392|NCT00709098|19443142|P1|Open-label Period|Withdrawal of consent|0
5629393|NCT00709098|19443140|P3|Double-blind Period|Lost to Follow-up|0
5629394|NCT00709098|19443141|P2|Double-blind Period|Lost to Follow-up|1
5629395|NCT00709098|19443142|P1|Double-blind Period|Lost to Follow-up|1
5629396|NCT00709098|19443140|P3|Double-blind Period|Death|0
5629397|NCT00709098|19443141|P2|Double-blind Period|Death|1
5629398|NCT00709098|19443142|P1|Double-blind Period|Death|1
5629399|NCT00709098|19443140|P3|Double-blind Period|Administrative reason|0
5629400|NCT00709098|19443141|P2|Double-blind Period|Administrative reason|3
5629401|NCT00709098|19443142|P1|Double-blind Period|Administrative reason|1
5629402|NCT00709098|19443140|P3|Double-blind Period|Withdrawal of consent|0
5629403|NCT00709098|19443141|P2|Double-blind Period|Withdrawal of consent|3
5629404|NCT00709098|19443142|P1|Double-blind Period|Withdrawal of consent|3
5629405|NCT00709059|19443161|P1|Overall Study|Serious side effects|11
5629406|NCT00709059|19443161|P1|Overall Study|Side effects|20
5629407|NCT00709059|19443161|P1|Overall Study|Disease complication|3
5629408|NCT00709059|19443161|P1|Overall Study|Physician Decision|7
5629409|NCT00709059|19443161|P1|Overall Study|Withdrawal by Subject|19
5629410|NCT00709059|19443161|P1|Overall Study|Lost to Follow-up|34
5629411|NCT00708734|19443208|P1|Overall Study|leg fracture|1
5629412|NCT00708734|19443208|P1|Overall Study|vertigo|1
5629413|NCT00708734|19443208|P1|Overall Study|knee replacement|1
5629414|NCT00708734|19443208|P1|Overall Study|leg injury|1
5629415|NCT00708734|19443208|P1|Overall Study|moved|1
5629416|NCT00708734|19443208|P1|Overall Study|scheduling conflict|2
5629417|NCT00708708|19443228|P1|Overall Study|Missing values|392
5629418|NCT00708708|19443228|P1|Overall Study|Adverse Event|3
5629419|NCT00708708|19443228|P1|Overall Study|Pregnancy|3
5629420|NCT00708708|19443228|P1|Overall Study|Lack of compliance|3
5629421|NCT00708708|19443228|P1|Overall Study|Lack of effectiveness|4
5629422|NCT00708708|19443228|P1|Overall Study|Administrative reasons|7
5629423|NCT00708708|19443228|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
5629424|NCT00708708|19443228|P1|Overall Study|Good effectiveness|9
5629425|NCT00708708|19443228|P1|Overall Study|Other unspecified|11
5629426|NCT00708708|19443228|P1|Overall Study|Another therapy along with Enbrel|15
5629427|NCT00708708|19443228|P1|Overall Study|Intolerance|42
5629428|NCT00708708|19443228|P1|Overall Study|Withdrawal by Subject|51
5629429|NCT00708708|19443228|P1|Overall Study|Lost to Follow-up|52
5629430|NCT00708708|19443228|P1|Overall Study|Another therapy instead of Enbrel|141
5629431|NCT00708682|19443276|P1|Toddler Dose|Failed to Return|4
5629432|NCT00708682|19443276|P1|Toddler Dose|Lost to Follow-up|3
5629433|NCT00708682|19443276|P1|Toddler Dose|Parent/Legal Guardian Request|1
5629434|NCT00708682|19443276|P1|After Infant Series|Parent/Legal Guardian Request|1
5629435|NCT00708682|19443276|P1|Infant Series|Other|19
5629436|NCT00708682|19443276|P1|Infant Series|Failed to return|2
5629437|NCT00708682|19443276|P1|Infant Series|Parent/legal guardian request|6
5629438|NCT00708682|19443276|P1|Infant Series|Protocol Violation|1
5629439|NCT00708682|19443276|P1|Infant Series|Lost to Follow-up|4
5629440|NCT00708682|19443276|P1|Infant Series|Adverse Event|1
5629441|NCT00708643|19443297|P2|Overall Study|Adverse Event|1
5629442|NCT00708643|19443298|P1|Overall Study|Adverse Event|0
5629443|NCT00708552|19443318|P4|Overall Study|Withdrawal by Subject|10
5629444|NCT00708552|19443319|P3|Overall Study|Withdrawal by Subject|8
5629445|NCT00708552|19443320|P2|Overall Study|Withdrawal by Subject|7
5629446|NCT00708552|19443321|P1|Overall Study|Withdrawal by Subject|12
5629447|NCT00708552|19443318|P4|Overall Study|Physician Decision|0
5629448|NCT00708552|19443319|P3|Overall Study|Physician Decision|0
5629449|NCT00708552|19443320|P2|Overall Study|Physician Decision|2
5629450|NCT00708552|19443321|P1|Overall Study|Physician Decision|1
5629451|NCT00708552|19443318|P4|Overall Study|Lost to Follow-up|1
5629452|NCT00708552|19443319|P3|Overall Study|Lost to Follow-up|0
5629453|NCT00708552|19443320|P2|Overall Study|Lost to Follow-up|2
5629454|NCT00708552|19443321|P1|Overall Study|Lost to Follow-up|4
5629455|NCT00708552|19443318|P4|Overall Study|Protocol Violation|4
5629456|NCT00708552|19443319|P3|Overall Study|Protocol Violation|2
5629457|NCT00708552|19443320|P2|Overall Study|Protocol Violation|0
5629458|NCT00708552|19443321|P1|Overall Study|Protocol Violation|0
5629459|NCT00708552|19443318|P4|Overall Study|Lack of Efficacy|0
5629460|NCT00708552|19443319|P3|Overall Study|Lack of Efficacy|1
5629461|NCT00708552|19443320|P2|Overall Study|Lack of Efficacy|4
5629462|NCT00708552|19443321|P1|Overall Study|Lack of Efficacy|0
5629463|NCT00708552|19443318|P4|Overall Study|Adverse Event|6
5629464|NCT00708552|19443319|P3|Overall Study|Adverse Event|4
5629465|NCT00708552|19443320|P2|Overall Study|Adverse Event|3
5629466|NCT00708552|19443321|P1|Overall Study|Adverse Event|10
5629467|NCT00708500|19443483|P3|FOLLOWUP|Non-compliance with protocol|1
5629468|NCT00708500|19443484|P2|FOLLOWUP|Non-compliance with protocol|0
5629469|NCT00708500|19443485|P1|FOLLOWUP|Non-compliance with protocol|5
5629470|NCT00708500|19443483|P3|FOLLOWUP|Subject withdrew consent|5
5629471|NCT00708500|19443484|P2|FOLLOWUP|Subject withdrew consent|4
5629472|NCT00708500|19443485|P1|FOLLOWUP|Subject withdrew consent|31
5629473|NCT00708500|19443483|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
5629474|NCT00708500|19443484|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
5629475|NCT00708500|19443485|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
5629476|NCT00708500|19443483|P3|FOLLOWUP|Lost to Follow-up|4
5629477|NCT00708500|19443484|P2|FOLLOWUP|Lost to Follow-up|6
5629478|NCT00708500|19443485|P1|FOLLOWUP|Lost to Follow-up|1
5629479|NCT00708500|19443483|P3|FOLLOWUP|Adverse Event|0
5629480|NCT00708500|19443484|P2|FOLLOWUP|Adverse Event|1
5629481|NCT00708500|19443485|P1|FOLLOWUP|Adverse Event|0
5629482|NCT00708500|19443483|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
5629483|NCT00708500|19443484|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
5629484|NCT00708500|19443485|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
5629485|NCT00708500|19443483|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
5629486|NCT00708500|19443484|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
5629487|NCT00708500|19443485|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
5629488|NCT00708500|19443483|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
5629489|NCT00708500|19443484|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
5629490|NCT00708500|19443485|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
5629491|NCT00708500|19443483|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
5629492|NCT00708500|19443484|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
5629493|NCT00708500|19443485|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
5629494|NCT00708500|19443483|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
5629495|NCT00708500|19443484|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
5629496|NCT00708500|19443485|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
5629497|NCT00708500|19443483|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
5629498|NCT00708500|19443484|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
5629499|NCT00708500|19443485|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
5629500|NCT00708500|19443483|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
5629501|NCT00708500|19443484|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
5629502|NCT00708500|19443485|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
5629503|NCT00708500|19443483|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
5629504|NCT00708500|19443484|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
5629505|NCT00708500|19443485|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
5629506|NCT00708500|19443483|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
5629507|NCT00708500|19443484|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
5629508|NCT00708500|19443485|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
5629509|NCT00708500|19443483|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
5629510|NCT00708500|19443484|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
5629511|NCT00708500|19443485|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
5629512|NCT00708500|19443483|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
5629513|NCT00708500|19443484|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
5629514|NCT00708500|19443485|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
5629515|NCT00708500|19443483|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
5629516|NCT00708500|19443484|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
5629517|NCT00708500|19443485|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
5629518|NCT00708500|19443483|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
5629519|NCT00708500|19443484|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
5629520|NCT00708500|19443485|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
5629521|NCT00708461|19443504|P2|Overall Study|left workforce|180
5629522|NCT00708461|19443505|P1|Overall Study|left workforce|115
5629523|NCT00708461|19443504|P2|Overall Study|Withdrawal by Subject|9
5629524|NCT00708461|19443505|P1|Overall Study|Withdrawal by Subject|8
5629525|NCT00708461|19443504|P2|Overall Study|Lost to Follow-up|11
5629526|NCT00708461|19443505|P1|Overall Study|Lost to Follow-up|18
5629527|NCT00708435|19443513|P2|Overall Study|Refused hospitalization|0
5629528|NCT00708435|19443514|P1|Overall Study|Refused hospitalization|1
5629529|NCT00708435|19443513|P2|Overall Study|Intervention by primary care physician|0
5629530|NCT00708435|19443514|P1|Overall Study|Intervention by primary care physician|1
5629531|NCT00708435|19443513|P2|Overall Study|Protocol Violation|1
5629532|NCT00708435|19443514|P1|Overall Study|Protocol Violation|0
5629533|NCT00708435|19443513|P2|Overall Study|Adverse Event|0
5629534|NCT00708435|19443514|P1|Overall Study|Adverse Event|1
5629535|NCT00708435|19443513|P2|Overall Study|Withdrawal by Subject|7
5629536|NCT00708435|19443514|P1|Overall Study|Withdrawal by Subject|3
5629537|NCT00708435|19443513|P2|Overall Study|Lost to Follow-up|4
5629538|NCT00708435|19443514|P1|Overall Study|Lost to Follow-up|9
5629539|NCT00708435|19443513|P2|Overall Study|Death / Serious Adverse Event|5
5629540|NCT00708435|19443514|P1|Overall Study|Death / Serious Adverse Event|10
5629541|NCT00708422|19443541|P2|Overall Study|Withdrawal by Subject|0
5629542|NCT00708422|19443542|P1|Overall Study|Withdrawal by Subject|1
5629543|NCT00708422|19443541|P2|Overall Study|Adverse Event|1
5629544|NCT00708422|19443542|P1|Overall Study|Adverse Event|3
5629545|NCT00708305|19443550|P4|Period 3|Other Reason|0
5629546|NCT00708305|19443551|P3|Period 3|Other Reason|0
5629547|NCT00708305|19443552|P2|Period 3|Other Reason|0
5629548|NCT00708305|19443553|P1|Period 3|Other Reason|1
5629549|NCT00708305|19443550|P4|Period 3|Protocol Violation|0
5629550|NCT00708305|19443551|P3|Period 3|Protocol Violation|0
5629551|NCT00708305|19443552|P2|Period 3|Protocol Violation|2
5629552|NCT00708305|19443553|P1|Period 3|Protocol Violation|0
5629553|NCT00708305|19443550|P4|Period 2|Other Reason|1
5629554|NCT00708305|19443551|P3|Period 2|Other Reason|0
5629555|NCT00708305|19443552|P2|Period 2|Other Reason|0
5629556|NCT00708305|19443553|P1|Period 2|Other Reason|1
5629557|NCT00708305|19443550|P4|Period 2|Protocol Violation|0
5629558|NCT00708305|19443551|P3|Period 2|Protocol Violation|0
5629559|NCT00708305|19443552|P2|Period 2|Protocol Violation|1
5629560|NCT00708305|19443553|P1|Period 2|Protocol Violation|0
5629561|NCT00708305|19443550|P4|Period 2|Lost to Follow-up|0
5629562|NCT00708305|19443551|P3|Period 2|Lost to Follow-up|0
5629563|NCT00708305|19443552|P2|Period 2|Lost to Follow-up|1
5629564|NCT00708305|19443553|P1|Period 2|Lost to Follow-up|0
5629565|NCT00708305|19443550|P4|Period 1|Other Reason|2
5629566|NCT00708305|19443551|P3|Period 1|Other Reason|0
5629567|NCT00708305|19443552|P2|Period 1|Other Reason|0
5629568|NCT00708305|19443553|P1|Period 1|Other Reason|0
5629569|NCT00708305|19443550|P4|Period 1|Protocol Violation|0
5629570|NCT00708305|19443551|P3|Period 1|Protocol Violation|1
5629571|NCT00708305|19443552|P2|Period 1|Protocol Violation|0
5629572|NCT00708305|19443553|P1|Period 1|Protocol Violation|1
5629573|NCT00708227|19443589|P4|Overall Study|Withdrawal by Subject|1
5629574|NCT00708227|19443590|P3|Overall Study|Withdrawal by Subject|0
5629575|NCT00708227|19443591|P2|Overall Study|Withdrawal by Subject|2
5629576|NCT00708227|19443592|P1|Overall Study|Withdrawal by Subject|1
5629577|NCT00708227|19443589|P4|Overall Study|Physician Decision|2
5629578|NCT00708227|19443590|P3|Overall Study|Physician Decision|1
5629579|NCT00708227|19443591|P2|Overall Study|Physician Decision|3
5629580|NCT00708227|19443592|P1|Overall Study|Physician Decision|0
5629581|NCT00708214|19443625|P3|Overall Study|Progressive Disease|5
5629582|NCT00708214|19443626|P2|Overall Study|Progressive Disease|6
5629583|NCT00708214|19443627|P1|Overall Study|Progressive Disease|4
5629584|NCT00708214|19443625|P3|Overall Study|Other|1
5629585|NCT00708214|19443626|P2|Overall Study|Other|1
5629586|NCT00708214|19443627|P1|Overall Study|Other|0
5629587|NCT00708214|19443625|P3|Overall Study|Other Adverse Event|2
5629588|NCT00708214|19443626|P2|Overall Study|Other Adverse Event|6
5629589|NCT00708214|19443627|P1|Overall Study|Other Adverse Event|3
5629590|NCT00708201|19443670|P2|Overall Study|Protocol Violation|1
5629591|NCT00708201|19443671|P1|Overall Study|Protocol Violation|0
5629592|NCT00708201|19443670|P2|Overall Study|Lost to Follow-up|0
5629593|NCT00708201|19443671|P1|Overall Study|Lost to Follow-up|2
5629594|NCT00708201|19443670|P2|Overall Study|Withdrawal by Subject|1
5629595|NCT00708201|19443671|P1|Overall Study|Withdrawal by Subject|1
5629596|NCT00708201|19443670|P2|Overall Study|Adverse Event|4
5629597|NCT00708201|19443671|P1|Overall Study|Adverse Event|4
5629598|NCT00708175|19443695|P2|Overall Study|BMD loss >7%|3
5629599|NCT00708175|19443696|P1|Overall Study|BMD loss >7%|2
5629600|NCT00708175|19443695|P2|Overall Study|Withdrawal by Subject|7
5629601|NCT00708175|19443696|P1|Overall Study|Withdrawal by Subject|5
5629602|NCT00708175|19443695|P2|Overall Study|Lost to Follow-up|3
5629603|NCT00708175|19443696|P1|Overall Study|Lost to Follow-up|5
5629604|NCT00708175|19443695|P2|Overall Study|Protocol Violation|3
5629605|NCT00708175|19443696|P1|Overall Study|Protocol Violation|2
5629606|NCT00708175|19443695|P2|Overall Study|Adverse Event|5
5629607|NCT00708175|19443696|P1|Overall Study|Adverse Event|4
5629608|NCT00708162|19443712|P2|Open-Label Phase|Other|0
5629609|NCT00708162|19443713|P1|Open-Label Phase|Other|1
5629610|NCT00708162|19443712|P2|Open-Label Phase|Adverse Event|2
5629611|NCT00708162|19443713|P1|Open-Label Phase|Adverse Event|1
5629612|NCT00708162|19443712|P2|Open-Label Phase|Death|1
5629613|NCT00708162|19443713|P1|Open-Label Phase|Death|3
5629614|NCT00708162|19443712|P2|Open-Label Phase|Investigator's Discretion|2
5629615|NCT00708162|19443713|P1|Open-Label Phase|Investigator's Discretion|3
5629616|NCT00708162|19443712|P2|Open-Label Phase|Lack of Efficacy|4
5629617|NCT00708162|19443713|P1|Open-Label Phase|Lack of Efficacy|7
5629618|NCT00708162|19443712|P2|Open-Label Phase|Participant Noncompliance|7
5629619|NCT00708162|19443713|P1|Open-Label Phase|Participant Noncompliance|7
5629620|NCT00708162|19443712|P2|Open-Label Phase|Withdrew Consent|6
5629621|NCT00708162|19443713|P1|Open-Label Phase|Withdrew Consent|12
5629622|NCT00708162|19443712|P2|Open-Label Phase|Lost to Follow-up|8
5629623|NCT00708162|19443713|P1|Open-Label Phase|Lost to Follow-up|10
5629624|NCT00708162|19443712|P2|Randomized Phase|Pregnancy|0
5629625|NCT00708162|19443713|P1|Randomized Phase|Pregnancy|3
5629626|NCT00708162|19443712|P2|Randomized Phase|Death|9
5629627|NCT00708162|19443713|P1|Randomized Phase|Death|2
5629628|NCT00708162|19443712|P2|Randomized Phase|Investigator's Discretion|10
5629629|NCT00708162|19443713|P1|Randomized Phase|Investigator's Discretion|7
5629630|NCT00708162|19443712|P2|Randomized Phase|Adverse Event|12
5629631|NCT00708162|19443713|P1|Randomized Phase|Adverse Event|8
5629632|NCT00708162|19443712|P2|Randomized Phase|Protocol Violation|11
5629633|NCT00708162|19443713|P1|Randomized Phase|Protocol Violation|10
5629634|NCT00708162|19443712|P2|Randomized Phase|Lack of Efficacy|19
5629635|NCT00708162|19443713|P1|Randomized Phase|Lack of Efficacy|14
5629636|NCT00708162|19443712|P2|Randomized Phase|Withdrew Consent|22
5629637|NCT00708162|19443713|P1|Randomized Phase|Withdrew Consent|31
5629638|NCT00708162|19443712|P2|Randomized Phase|Lost to Follow-up|34
5629639|NCT00708162|19443713|P1|Randomized Phase|Lost to Follow-up|34
5629640|NCT00708162|19443712|P2|Randomized Phase|Participant Noncompliance|32
5629641|NCT00708162|19443713|P1|Randomized Phase|Participant Noncompliance|40
5629642|NCT00708162|19443712|P2|Randomized Phase|Randomized but Not Treated|5
5629643|NCT00708162|19443713|P1|Randomized Phase|Randomized but Not Treated|7
5629644|NCT00708123|19443754|P5|Period 4|Protocol Violation|0
5629645|NCT00708123|19443755|P4|Period 4|Protocol Violation|0
5629646|NCT00708123|19443756|P3|Period 4|Protocol Violation|0
5629647|NCT00708123|19443757|P2|Period 4|Protocol Violation|1
5629648|NCT00708123|19443758|P1|Period 4|Protocol Violation|0
5629649|NCT00708123|19443754|P5|Period 3|Lost to Follow-up|0
5629650|NCT00708123|19443755|P4|Period 3|Lost to Follow-up|1
5629651|NCT00708123|19443756|P3|Period 3|Lost to Follow-up|1
5629652|NCT00708123|19443757|P2|Period 3|Lost to Follow-up|0
5629653|NCT00708123|19443758|P1|Period 3|Lost to Follow-up|0
5629654|NCT00708123|19443754|P5|Period 2|Other Reason|0
5629655|NCT00708123|19443755|P4|Period 2|Other Reason|0
5629656|NCT00708123|19443756|P3|Period 2|Other Reason|0
5629657|NCT00708123|19443757|P2|Period 2|Other Reason|0
5629658|NCT00708123|19443758|P1|Period 2|Other Reason|1
5629659|NCT00708123|19443754|P5|Period 2|Protocol Violation|0
5629660|NCT00708123|19443755|P4|Period 2|Protocol Violation|1
5629661|NCT00708123|19443756|P3|Period 2|Protocol Violation|0
5629662|NCT00708123|19443757|P2|Period 2|Protocol Violation|0
5629663|NCT00708123|19443758|P1|Period 2|Protocol Violation|0
5629664|NCT00708123|19443754|P5|Period 1|Adverse Event|0
5629665|NCT00708123|19443755|P4|Period 1|Adverse Event|0
5629666|NCT00708123|19443756|P3|Period 1|Adverse Event|1
5629667|NCT00708123|19443757|P2|Period 1|Adverse Event|0
5629668|NCT00708123|19443758|P1|Period 1|Adverse Event|0
5629669|NCT00708123|19443754|P5|Period 1|Protocol Violation|0
5629670|NCT00708123|19443755|P4|Period 1|Protocol Violation|1
5629671|NCT00708123|19443756|P3|Period 1|Protocol Violation|0
5629672|NCT00708123|19443757|P2|Period 1|Protocol Violation|1
5629673|NCT00708123|19443758|P1|Period 1|Protocol Violation|0
5629674|NCT00708097|19443891|P5|Period 2|Protocol Violation|0
5629675|NCT00708097|19443892|P4|Period 2|Protocol Violation|1
5629676|NCT00708097|19443893|P3|Period 2|Protocol Violation|1
5629677|NCT00708097|19443894|P2|Period 2|Protocol Violation|1
5629678|NCT00708097|19443895|P1|Period 2|Protocol Violation|0
5629679|NCT00708097|19443891|P5|Period 1|Other Reason|1
5629680|NCT00708097|19443892|P4|Period 1|Other Reason|0
5629681|NCT00708097|19443893|P3|Period 1|Other Reason|0
5629682|NCT00708097|19443894|P2|Period 1|Other Reason|0
5629683|NCT00708097|19443895|P1|Period 1|Other Reason|0
5629684|NCT00708097|19443891|P5|Period 1|Protocol Violation|0
5629685|NCT00708097|19443892|P4|Period 1|Protocol Violation|2
5629686|NCT00708097|19443893|P3|Period 1|Protocol Violation|0
5629687|NCT00708097|19443894|P2|Period 1|Protocol Violation|1
5629688|NCT00708097|19443895|P1|Period 1|Protocol Violation|0
5629689|NCT00708032|19444005|P2|Overall Study|Withdrawal by Subject|1
5629690|NCT00708032|19444006|P1|Overall Study|Withdrawal by Subject|0
5629691|NCT00708032|19444005|P2|Overall Study|Protocol Violation|1
5629692|NCT00708032|19444006|P1|Overall Study|Protocol Violation|4
5629693|NCT00708032|19444005|P2|Overall Study|Did not meet protocol criteria|2
5629694|NCT00708032|19444006|P1|Overall Study|Did not meet protocol criteria|1
5629695|NCT00708032|19444005|P2|Overall Study|Visit out of range at month 12|1
5629696|NCT00708032|19444006|P1|Overall Study|Visit out of range at month 12|4
5629697|NCT00708032|19444005|P2|Overall Study|Poor vision|6
5629698|NCT00708032|19444006|P1|Overall Study|Poor vision|0
5629699|NCT00708032|19444005|P2|Overall Study|Pregnancy|1
5629700|NCT00708032|19444006|P1|Overall Study|Pregnancy|0
5629701|NCT00708032|19444005|P2|Overall Study|Lost to Follow-up|2
5629702|NCT00708032|19444006|P1|Overall Study|Lost to Follow-up|1
5629703|NCT00708032|19444005|P2|Overall Study|Adverse Event|2
5629704|NCT00708032|19444006|P1|Overall Study|Adverse Event|0
5629705|NCT00707993|19444033|P2|Overall Study|Other|0
5629706|NCT00707993|19444034|P1|Overall Study|Other|2
5629707|NCT00707993|19444033|P2|Overall Study|Hyperglycemic Rescue|47
5629708|NCT00707993|19444034|P1|Overall Study|Hyperglycemic Rescue|55
5629709|NCT00707993|19444033|P2|Overall Study|Withdrawal by Subject|16
5629710|NCT00707993|19444034|P1|Overall Study|Withdrawal by Subject|12
5629711|NCT00707993|19444033|P2|Overall Study|Lost to Follow-up|4
5629712|NCT00707993|19444034|P1|Overall Study|Lost to Follow-up|0
5629713|NCT00707993|19444033|P2|Overall Study|Protocol Violation|7
5629714|NCT00707993|19444034|P1|Overall Study|Protocol Violation|4
5629715|NCT00707993|19444033|P2|Overall Study|Adverse Event|20
5629716|NCT00707993|19444034|P1|Overall Study|Adverse Event|16
5629717|NCT00707980|19444076|P1|Overall Study|Other|39
5629718|NCT00707980|19444076|P1|Overall Study|Lost to Follow-up|59
5629719|NCT00707980|19444076|P1|Overall Study|Withdrawal of Consent|81
5629720|NCT00707980|19444076|P1|Overall Study|Protocol Deviations|19
5629721|NCT00707980|19444076|P1|Overall Study|Non-Compliance with Study Drug|28
5629722|NCT00707980|19444076|P1|Overall Study|Lack of Efficacy|35
5629723|NCT00707980|19444076|P1|Overall Study|Adverse Event|49
5629724|NCT00707954|19444160|P5|Overall Study|Physician Decision|1
5629725|NCT00707954|19444161|P4|Overall Study|Physician Decision|0
5629726|NCT00707954|19444162|P3|Overall Study|Physician Decision|0
5629727|NCT00707954|19444163|P2|Overall Study|Physician Decision|0
5629728|NCT00707954|19444164|P1|Overall Study|Physician Decision|0
5629729|NCT00707746|19444205|P2|Treatment Period|Ineligibility|1
5629730|NCT00707746|19444206|P1|Treatment Period|Ineligibility|0
5629731|NCT00707746|19444205|P2|Treatment Period|Adverse Event|4
5629732|NCT00707746|19444206|P1|Treatment Period|Adverse Event|2
5629733|NCT00707577|19444267|P2|Overall Study|Pregnancy|1
5629734|NCT00707577|19444268|P1|Overall Study|Pregnancy|4
5629735|NCT00707577|19444267|P2|Overall Study|Left employment|10
5629736|NCT00707577|19444268|P1|Overall Study|Left employment|13
5629737|NCT00707577|19444267|P2|Overall Study|Lost to Follow-up|25
5629738|NCT00707577|19444268|P1|Overall Study|Lost to Follow-up|34
5629739|NCT00707577|19444267|P2|Overall Study|Withdrawal by Subject|2
5629740|NCT00707577|19444268|P1|Overall Study|Withdrawal by Subject|3
5629741|NCT00707486|19444274|P1|Overall Study|Withdrawal by Subject|1
5629742|NCT00707434|19444310|P1|Overall Study|Adverse Event|1
5629743|NCT00707239|19444321|P3|Overall Study|Other|5
5629744|NCT00707239|19444322|P2|Overall Study|Other|3
5629745|NCT00707239|19444323|P1|Overall Study|Other|8
5629746|NCT00707239|19444321|P3|Overall Study|Randomized, but not treated|1
5629747|NCT00707239|19444322|P2|Overall Study|Randomized, but not treated|1
5629748|NCT00707239|19444323|P1|Overall Study|Randomized, but not treated|1
5629749|NCT00707239|19444321|P3|Overall Study|Lack of Efficacy|0
5629750|NCT00707239|19444322|P2|Overall Study|Lack of Efficacy|2
5629751|NCT00707239|19444323|P1|Overall Study|Lack of Efficacy|1
5629752|NCT00707239|19444321|P3|Overall Study|Protocol Violation|1
5629753|NCT00707239|19444322|P2|Overall Study|Protocol Violation|0
5629754|NCT00707239|19444323|P1|Overall Study|Protocol Violation|0
5629755|NCT00707239|19444321|P3|Overall Study|Physician Decision|2
5629756|NCT00707239|19444322|P2|Overall Study|Physician Decision|1
5629757|NCT00707239|19444323|P1|Overall Study|Physician Decision|1
5629758|NCT00707239|19444321|P3|Overall Study|Death|3
5629759|NCT00707239|19444322|P2|Overall Study|Death|1
5629760|NCT00707239|19444323|P1|Overall Study|Death|3
5629761|NCT00707239|19444321|P3|Overall Study|Adverse Event|2
5629762|NCT00707239|19444322|P2|Overall Study|Adverse Event|3
5629763|NCT00707239|19444323|P1|Overall Study|Adverse Event|5
5629764|NCT00707174|19444371|P2|Overall Study|Withdrawal by Subject|1
5629765|NCT00707174|19444372|P1|Overall Study|Withdrawal by Subject|4
5629766|NCT00707174|19444371|P2|Overall Study|Adverse Event|6
5629767|NCT00707174|19444372|P1|Overall Study|Adverse Event|1
5629768|NCT00707161|19444378|P1|Overall Study|Physician Decision|6
5629769|NCT00707057|19444384|P2|Overall Study|Dosed incorrectly|1
5629770|NCT00707057|19444385|P1|Overall Study|Dosed incorrectly|0
5629771|NCT00707057|19444384|P2|Overall Study|Withdrawal by Subject|3
5629772|NCT00707057|19444385|P1|Overall Study|Withdrawal by Subject|8
5629773|NCT00707031|19444419|P2|Overall Study|Sponsor Decision|8
5629774|NCT00707031|19444420|P1|Overall Study|Sponsor Decision|9
5629775|NCT00707031|19444419|P2|Overall Study|Serious Noncompliance|3
5629776|NCT00707031|19444420|P1|Overall Study|Serious Noncompliance|2
5629777|NCT00707031|19444419|P2|Overall Study|Familial or Personal Reasons|15
5629778|NCT00707031|19444420|P1|Overall Study|Familial or Personal Reasons|12
5629779|NCT00707031|19444419|P2|Overall Study|Poor Compliance to Protocol|13
5629780|NCT00707031|19444420|P1|Overall Study|Poor Compliance to Protocol|7
5629781|NCT00707031|19444419|P2|Overall Study|Withdrawal by Subject|8
5629782|NCT00707031|19444420|P1|Overall Study|Withdrawal by Subject|7
5629783|NCT00707031|19444419|P2|Overall Study|Protocol Violation|0
5629784|NCT00707031|19444420|P1|Overall Study|Protocol Violation|1
5629785|NCT00707031|19444419|P2|Overall Study|Lost to Follow-up|1
5629786|NCT00707031|19444420|P1|Overall Study|Lost to Follow-up|2
5629787|NCT00707031|19444419|P2|Overall Study|Lack of Efficacy|6
5629788|NCT00707031|19444420|P1|Overall Study|Lack of Efficacy|19
5629789|NCT00707031|19444419|P2|Overall Study|Adverse Event|45
5629790|NCT00707031|19444420|P1|Overall Study|Adverse Event|45
5629791|NCT00706992|19444449|P7|Overall Study|Disease progression before treatment|0
5629792|NCT00706992|19444450|P6|Overall Study|Disease progression before treatment|0
5629793|NCT00706992|19444451|P5|Overall Study|Disease progression before treatment|1
5629794|NCT00706992|19444452|P4|Overall Study|Disease progression before treatment|0
5629795|NCT00706992|19444453|P3|Overall Study|Disease progression before treatment|0
5629796|NCT00706992|19444454|P2|Overall Study|Disease progression before treatment|0
5629797|NCT00706992|19444455|P1|Overall Study|Disease progression before treatment|0
5629798|NCT00706992|19444449|P7|Overall Study|Study termination|3
5629799|NCT00706992|19444450|P6|Overall Study|Study termination|2
5629800|NCT00706992|19444451|P5|Overall Study|Study termination|3
5629801|NCT00706992|19444452|P4|Overall Study|Study termination|2
5629802|NCT00706992|19444453|P3|Overall Study|Study termination|6
5629803|NCT00706992|19444454|P2|Overall Study|Study termination|5
5629804|NCT00706992|19444455|P1|Overall Study|Study termination|5
5629805|NCT00706966|19444487|P1|Overall Study|Adverse Event|1
5629806|NCT00706914|19444523|P3|Overall Study|Protocol Violation|1
5629807|NCT00706914|19444524|P2|Overall Study|Protocol Violation|1
5629808|NCT00706914|19444525|P1|Overall Study|Protocol Violation|3
5629809|NCT00706914|19444523|P3|Overall Study|Adverse Event|0
5629810|NCT00706914|19444524|P2|Overall Study|Adverse Event|2
5629811|NCT00706914|19444525|P1|Overall Study|Adverse Event|2
5629812|NCT00706914|19444523|P3|Overall Study|Lost to Follow-up|0
5629813|NCT00706914|19444524|P2|Overall Study|Lost to Follow-up|0
5629814|NCT00706914|19444525|P1|Overall Study|Lost to Follow-up|1
5629815|NCT00706914|19444523|P3|Overall Study|Lack of Efficacy|0
5629816|NCT00706914|19444524|P2|Overall Study|Lack of Efficacy|1
5629817|NCT00706914|19444525|P1|Overall Study|Lack of Efficacy|0
5629818|NCT00706901|19444548|P3|Overall Study|Death|0
5629819|NCT00706901|19444549|P2|Overall Study|Death|0
5629820|NCT00706901|19444550|P1|Overall Study|Death|1
5629821|NCT00706901|19444548|P3|Overall Study|In Jail|1
5629822|NCT00706901|19444549|P2|Overall Study|In Jail|0
5629823|NCT00706901|19444550|P1|Overall Study|In Jail|1
5629824|NCT00706901|19444548|P3|Overall Study|Withdrawal by Subject|5
5629825|NCT00706901|19444549|P2|Overall Study|Withdrawal by Subject|2
5629826|NCT00706901|19444550|P1|Overall Study|Withdrawal by Subject|4
5629827|NCT00706901|19444548|P3|Overall Study|Lost to Follow-up|2
5629828|NCT00706901|19444549|P2|Overall Study|Lost to Follow-up|3
5629829|NCT00706901|19444550|P1|Overall Study|Lost to Follow-up|2
5629830|NCT00706849|19444575|P2|Follow-up Period|Protocol non-compliance|1
5629831|NCT00706849|19444576|P1|Follow-up Period|Protocol non-compliance|0
5629832|NCT00706849|19444575|P2|Follow-up Period|Withdrawal by Subject|2
5629833|NCT00706849|19444576|P1|Follow-up Period|Withdrawal by Subject|0
5629834|NCT00706849|19444575|P2|Treatment Period|Other|1
5629835|NCT00706849|19444576|P1|Treatment Period|Other|0
5629836|NCT00706849|19444575|P2|Treatment Period|Adverse Event|9
5629837|NCT00706849|19444576|P1|Treatment Period|Adverse Event|0
5629838|NCT00706797|19444654|P2|Overall Study|Other|0
5629839|NCT00706797|19444655|P1|Overall Study|Other|1
5629840|NCT00706797|19444654|P2|Overall Study|Lost to Follow-up|2
5629841|NCT00706797|19444655|P1|Overall Study|Lost to Follow-up|1
5629842|NCT00706797|19444654|P2|Overall Study|Protocol Violation|2
5629843|NCT00706797|19444655|P1|Overall Study|Protocol Violation|3
5629844|NCT00706797|19444654|P2|Overall Study|Discontinuation of study by sponsor|63
5629845|NCT00706797|19444655|P1|Overall Study|Discontinuation of study by sponsor|52
5629846|NCT00706797|19444654|P2|Overall Study|Death|0
5629847|NCT00706797|19444655|P1|Overall Study|Death|1
5629848|NCT00706797|19444654|P2|Overall Study|Withdrawal by Subject|1
5629849|NCT00706797|19444655|P1|Overall Study|Withdrawal by Subject|8
5629850|NCT00706797|19444654|P2|Overall Study|Adverse Event|3
5629851|NCT00706797|19444655|P1|Overall Study|Adverse Event|0
5629852|NCT00706797|19444654|P2|Overall Study|Lack of Efficacy|0
5629853|NCT00706797|19444655|P1|Overall Study|Lack of Efficacy|3
5629854|NCT00706706|19444724|P1|Overall Study|Study endpoint had reached|45
5629855|NCT00706706|19444724|P1|Overall Study|Lost to Follow-up|7
5629856|NCT00706706|19444724|P1|Overall Study|Death|53
5629857|NCT00706654|19444734|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
5629858|NCT00706654|19444735|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
5629859|NCT00706654|19444736|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
5629860|NCT00706654|19444737|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
5629861|NCT00706654|19444734|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
5629862|NCT00706654|19444735|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
5629863|NCT00706654|19444736|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
5629864|NCT00706654|19444737|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
5629865|NCT00706654|19444734|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
5629866|NCT00706654|19444735|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
5629867|NCT00706654|19444736|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
5629868|NCT00706654|19444737|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
5629869|NCT00706654|19444734|P4|Depot Maintenance Phase|Protocol Deviation|1
5629870|NCT00706654|19444735|P3|Depot Maintenance Phase|Protocol Deviation|3
5629871|NCT00706654|19444736|P2|Depot Maintenance Phase|Protocol Deviation|2
5629872|NCT00706654|19444737|P1|Depot Maintenance Phase|Protocol Deviation|0
5629873|NCT00706654|19444734|P4|Depot Maintenance Phase|Withdrew Consent|14
5629874|NCT00706654|19444735|P3|Depot Maintenance Phase|Withdrew Consent|29
5629875|NCT00706654|19444736|P2|Depot Maintenance Phase|Withdrew Consent|21
5629876|NCT00706654|19444737|P1|Depot Maintenance Phase|Withdrew Consent|0
5629877|NCT00706654|19444734|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
5629878|NCT00706654|19444735|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
5629879|NCT00706654|19444736|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
5629880|NCT00706654|19444737|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
5629881|NCT00706654|19444734|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
5629882|NCT00706654|19444735|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
5629883|NCT00706654|19444736|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
5629884|NCT00706654|19444737|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
5629885|NCT00706654|19444734|P4|Depot Maintenance Phase|Lost to Follow-up|6
5629886|NCT00706654|19444735|P3|Depot Maintenance Phase|Lost to Follow-up|10
5629887|NCT00706654|19444736|P2|Depot Maintenance Phase|Lost to Follow-up|4
5629888|NCT00706654|19444737|P1|Depot Maintenance Phase|Lost to Follow-up|0
5629889|NCT00706654|19444734|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5629890|NCT00706654|19444735|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5629891|NCT00706654|19444736|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5629892|NCT00706654|19444737|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
5629893|NCT00706654|19444734|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5629894|NCT00706654|19444735|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5629895|NCT00706654|19444736|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5629896|NCT00706654|19444737|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
5629897|NCT00706654|19444734|P4|Oral Stabilization Phase|Adverse Event|0
5629898|NCT00706654|19444735|P3|Oral Stabilization Phase|Adverse Event|0
5629899|NCT00706654|19444736|P2|Oral Stabilization Phase|Adverse Event|0
5629900|NCT00706654|19444737|P1|Oral Stabilization Phase|Adverse Event|21
5629901|NCT00706654|19444734|P4|Oral Stabilization Phase|Protocol Deviation|0
5629902|NCT00706654|19444735|P3|Oral Stabilization Phase|Protocol Deviation|0
5629903|NCT00706654|19444736|P2|Oral Stabilization Phase|Protocol Deviation|0
5629904|NCT00706654|19444737|P1|Oral Stabilization Phase|Protocol Deviation|2
5629905|NCT00706654|19444734|P4|Oral Stabilization Phase|Withdrew consent|0
5629906|NCT00706654|19444735|P3|Oral Stabilization Phase|Withdrew consent|0
5629907|NCT00706654|19444736|P2|Oral Stabilization Phase|Withdrew consent|0
5629908|NCT00706654|19444737|P1|Oral Stabilization Phase|Withdrew consent|55
5629909|NCT00706654|19444734|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
5629910|NCT00706654|19444735|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
5629911|NCT00706654|19444736|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
5629912|NCT00706654|19444737|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
5629913|NCT00706654|19444734|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
5629914|NCT00706654|19444735|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
5629915|NCT00706654|19444736|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
5629916|NCT00706654|19444737|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
5629917|NCT00706654|19444734|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
5629918|NCT00706654|19444735|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
5629919|NCT00706654|19444736|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
5629920|NCT00706654|19444737|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
5629921|NCT00706654|19444734|P4|Oral Stabilization Phase|Lost to Follow-up|0
5629922|NCT00706654|19444735|P3|Oral Stabilization Phase|Lost to Follow-up|0
5629923|NCT00706654|19444736|P2|Oral Stabilization Phase|Lost to Follow-up|0
5629924|NCT00706654|19444737|P1|Oral Stabilization Phase|Lost to Follow-up|17
5629925|NCT00706654|19444734|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
5629926|NCT00706654|19444735|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
5629927|NCT00706654|19444736|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
5629928|NCT00706654|19444737|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
5629929|NCT00706654|19444734|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
5629930|NCT00706654|19444735|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
5629931|NCT00706654|19444736|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
5629932|NCT00706654|19444737|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
5629933|NCT00706654|19444734|P4|Conversion Phase|Adverse Event|0
5629934|NCT00706654|19444735|P3|Conversion Phase|Adverse Event|0
5629935|NCT00706654|19444736|P2|Conversion Phase|Adverse Event|0
5629936|NCT00706654|19444737|P1|Conversion Phase|Adverse Event|18
5629937|NCT00706654|19444734|P4|Conversion Phase|Withdrew Consent|0
5629938|NCT00706654|19444735|P3|Conversion Phase|Withdrew Consent|0
5629939|NCT00706654|19444736|P2|Conversion Phase|Withdrew Consent|0
5629940|NCT00706654|19444737|P1|Conversion Phase|Withdrew Consent|38
5629941|NCT00706654|19444734|P4|Conversion Phase|Withdrawn by Investigator|0
5629942|NCT00706654|19444735|P3|Conversion Phase|Withdrawn by Investigator|0
5629943|NCT00706654|19444736|P2|Conversion Phase|Withdrawn by Investigator|0
5629944|NCT00706654|19444737|P1|Conversion Phase|Withdrawn by Investigator|14
5629945|NCT00706654|19444734|P4|Conversion Phase|Met Withdrawal Criteria|0
5629946|NCT00706654|19444735|P3|Conversion Phase|Met Withdrawal Criteria|0
5629947|NCT00706654|19444736|P2|Conversion Phase|Met Withdrawal Criteria|0
5629948|NCT00706654|19444737|P1|Conversion Phase|Met Withdrawal Criteria|2
5629949|NCT00706654|19444734|P4|Conversion Phase|Sponsor Discontinued Trial|0
5629950|NCT00706654|19444735|P3|Conversion Phase|Sponsor Discontinued Trial|0
5629951|NCT00706654|19444736|P2|Conversion Phase|Sponsor Discontinued Trial|0
5629952|NCT00706654|19444737|P1|Conversion Phase|Sponsor Discontinued Trial|8
5629953|NCT00706654|19444734|P4|Conversion Phase|Lost to Follow-up|0
5629954|NCT00706654|19444735|P3|Conversion Phase|Lost to Follow-up|0
5629955|NCT00706654|19444736|P2|Conversion Phase|Lost to Follow-up|0
5629956|NCT00706654|19444737|P1|Conversion Phase|Lost to Follow-up|4
5629957|NCT00706641|19444756|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
5629958|NCT00706641|19444756|P1|Dasatinib Administration|Ineligible after start of therapy|1
5629959|NCT00706641|19444756|P1|Dasatinib Administration|Withdrawal by Subject|1
5629960|NCT00706628|19444770|P4|Overall Study|Not treated|0
5629961|NCT00706628|19444771|P3|Overall Study|Not treated|0
5629962|NCT00706628|19444772|P2|Overall Study|Not treated|1
5629963|NCT00706628|19444773|P1|Overall Study|Not treated|1
5629964|NCT00706628|19444770|P4|Overall Study|Other than those stated above|0
5629965|NCT00706628|19444771|P3|Overall Study|Other than those stated above|0
5629966|NCT00706628|19444772|P2|Overall Study|Other than those stated above|0
5629967|NCT00706628|19444773|P1|Overall Study|Other than those stated above|4
5629968|NCT00706628|19444770|P4|Overall Study|Progressive disease|1
5629969|NCT00706628|19444771|P3|Overall Study|Progressive disease|8
5629970|NCT00706628|19444772|P2|Overall Study|Progressive disease|13
5629971|NCT00706628|19444773|P1|Overall Study|Progressive disease|20
5629972|NCT00706628|19444770|P4|Overall Study|Consent withdrawn|0
5629973|NCT00706628|19444771|P3|Overall Study|Consent withdrawn|3
5629974|NCT00706628|19444772|P2|Overall Study|Consent withdrawn|1
5629975|NCT00706628|19444773|P1|Overall Study|Consent withdrawn|6
5629976|NCT00706628|19444770|P4|Overall Study|Non compliant with protocol|0
5629977|NCT00706628|19444771|P3|Overall Study|Non compliant with protocol|0
5629978|NCT00706628|19444772|P2|Overall Study|Non compliant with protocol|1
5629979|NCT00706628|19444773|P1|Overall Study|Non compliant with protocol|0
5629980|NCT00706628|19444770|P4|Overall Study|Other Adverse Event|2
5629981|NCT00706628|19444771|P3|Overall Study|Other Adverse Event|5
5629982|NCT00706628|19444772|P2|Overall Study|Other Adverse Event|5
5629983|NCT00706628|19444773|P1|Overall Study|Other Adverse Event|16
5629984|NCT00706511|19444878|P4|Overall Study|Withdrawal by Subject|0
5629985|NCT00706511|19444879|P3|Overall Study|Withdrawal by Subject|0
5629986|NCT00706511|19444880|P2|Overall Study|Withdrawal by Subject|0
5629987|NCT00706511|19444881|P1|Overall Study|Withdrawal by Subject|1
5629988|NCT00706433|19444972|P4|Overall Study|new job|1
5629989|NCT00706433|19444973|P3|Overall Study|new job|0
5629990|NCT00706433|19444974|P2|Overall Study|new job|0
5629991|NCT00706433|19444975|P1|Overall Study|new job|0
5629992|NCT00706433|19444972|P4|Overall Study|Protocol Violation|0
5629993|NCT00706433|19444973|P3|Overall Study|Protocol Violation|0
5629994|NCT00706433|19444974|P2|Overall Study|Protocol Violation|0
5629995|NCT00706433|19444975|P1|Overall Study|Protocol Violation|1
5629996|NCT00706433|19444972|P4|Overall Study|Adverse Event|0
5629997|NCT00706433|19444973|P3|Overall Study|Adverse Event|1
5629998|NCT00706433|19444974|P2|Overall Study|Adverse Event|0
5629999|NCT00706433|19444975|P1|Overall Study|Adverse Event|0
5630000|NCT00706433|19444972|P4|Overall Study|Withdrawal by Subject|1
5630001|NCT00706433|19444973|P3|Overall Study|Withdrawal by Subject|3
5630002|NCT00706433|19444974|P2|Overall Study|Withdrawal by Subject|2
5630003|NCT00706433|19444975|P1|Overall Study|Withdrawal by Subject|1
5630004|NCT00706433|19444972|P4|Overall Study|Lost to Follow-up|0
5630005|NCT00706433|19444973|P3|Overall Study|Lost to Follow-up|6
5630006|NCT00706433|19444974|P2|Overall Study|Lost to Follow-up|1
5630007|NCT00706433|19444975|P1|Overall Study|Lost to Follow-up|3
5630008|NCT00706381|19445302|P4|Overall Study|Lost to Follow-up|0
5630009|NCT00706381|19445303|P3|Overall Study|Lost to Follow-up|1
5630010|NCT00706381|19445304|P2|Overall Study|Lost to Follow-up|1
5630011|NCT00706381|19445305|P1|Overall Study|Lost to Follow-up|0
5630012|NCT00706355|19445326|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
5630013|NCT00706355|19445327|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
5630014|NCT00706355|19445328|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
5630015|NCT00706355|19445329|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
5630016|NCT00706355|19445326|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
5630017|NCT00706355|19445327|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
5630018|NCT00706355|19445328|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
5630019|NCT00706355|19445329|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
5630020|NCT00706355|19445326|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
5630021|NCT00706355|19445327|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
5630022|NCT00706355|19445328|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
5630023|NCT00706355|19445329|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
5630024|NCT00706355|19445326|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
5630025|NCT00706355|19445327|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
5630026|NCT00706355|19445328|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
5630027|NCT00706355|19445329|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
5630028|NCT00706355|19445326|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
5630029|NCT00706355|19445327|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
5630030|NCT00706355|19445328|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
5630031|NCT00706355|19445329|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
5630032|NCT00706355|19445326|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
5630033|NCT00706355|19445327|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
5630034|NCT00706355|19445328|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
5630035|NCT00706355|19445329|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
5630036|NCT00706355|19445326|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
5630037|NCT00706355|19445327|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
5630038|NCT00706355|19445328|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
5630039|NCT00706355|19445329|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
5630040|NCT00706355|19445326|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
5630041|NCT00706355|19445327|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
5630042|NCT00706355|19445328|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
5630043|NCT00706355|19445329|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
5630044|NCT00706355|19445326|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
5630045|NCT00706355|19445327|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
5630046|NCT00706355|19445328|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
5630047|NCT00706355|19445329|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
5630048|NCT00706342|19445381|P1|Overall Study|WIthdrawal of consent|1
5630049|NCT00706342|19445381|P1|Overall Study|Ongoing|6
5630050|NCT00706342|19445381|P1|Overall Study|Non-responder Week 12|1
5630051|NCT00706342|19445381|P1|Overall Study|Investigator discretion|2
5630052|NCT00706342|19445381|P1|Overall Study|Withdrew from the study on his own.|1
5630053|NCT00706342|19445381|P1|Overall Study|Death|1
5630054|NCT00706342|19445381|P1|Overall Study|Withdrawn due to failure to respond|1
5630055|NCT00706342|19445381|P1|Overall Study|Not responding to treatment|2
5630056|NCT00706342|19445381|P1|Overall Study|Adverse Event|3
5630057|NCT00706238|19445394|P1|Overall Study|Other|1
5630058|NCT00706238|19445394|P1|Overall Study|Disease progression|4
5630059|NCT00706134|19445411|P4|Overall Study|Did not meet study criteria|0
5630060|NCT00706134|19445412|P3|Overall Study|Did not meet study criteria|0
5630061|NCT00706134|19445413|P2|Overall Study|Did not meet study criteria|0
5630062|NCT00706134|19445414|P1|Overall Study|Did not meet study criteria|2
5630063|NCT00706134|19445411|P4|Overall Study|Unsatisfactory therapeutic effect|5
5630064|NCT00706134|19445412|P3|Overall Study|Unsatisfactory therapeutic effect|3
5630065|NCT00706134|19445413|P2|Overall Study|Unsatisfactory therapeutic effect|3
5630066|NCT00706134|19445414|P1|Overall Study|Unsatisfactory therapeutic effect|9
5630067|NCT00706134|19445411|P4|Overall Study|Withdrawal by Subject|0
5630068|NCT00706134|19445412|P3|Overall Study|Withdrawal by Subject|1
5630069|NCT00706134|19445413|P2|Overall Study|Withdrawal by Subject|2
5630070|NCT00706134|19445414|P1|Overall Study|Withdrawal by Subject|1
5630071|NCT00706134|19445411|P4|Overall Study|Protocol Violation|3
5630072|NCT00706134|19445412|P3|Overall Study|Protocol Violation|0
5630073|NCT00706134|19445413|P2|Overall Study|Protocol Violation|6
5630074|NCT00706134|19445414|P1|Overall Study|Protocol Violation|0
5630075|NCT00706134|19445411|P4|Overall Study|Lost to Follow-up|0
5630076|NCT00706134|19445412|P3|Overall Study|Lost to Follow-up|0
5630077|NCT00706134|19445413|P2|Overall Study|Lost to Follow-up|1
5630078|NCT00706134|19445414|P1|Overall Study|Lost to Follow-up|0
5630079|NCT00706134|19445411|P4|Overall Study|Adverse Event|3
5630080|NCT00706134|19445412|P3|Overall Study|Adverse Event|2
5630081|NCT00706134|19445413|P2|Overall Study|Adverse Event|7
5630082|NCT00706134|19445414|P1|Overall Study|Adverse Event|8
5630083|NCT00706095|19445480|P3|Overall Study|Withdrawal by Subject|0
5630084|NCT00706095|19445481|P2|Overall Study|Withdrawal by Subject|0
5630085|NCT00706095|19445482|P1|Overall Study|Withdrawal by Subject|1
5630086|NCT00706095|19445480|P3|Overall Study|Clinical Progression|2
5630087|NCT00706095|19445481|P2|Overall Study|Clinical Progression|2
5630088|NCT00706095|19445482|P1|Overall Study|Clinical Progression|1
5630089|NCT00706095|19445480|P3|Overall Study|Progressive Disease|3
5630090|NCT00706095|19445481|P2|Overall Study|Progressive Disease|5
5630091|NCT00706095|19445482|P1|Overall Study|Progressive Disease|4
5630092|NCT00706030|19445500|P4|Overall Study|Death|0
5630093|NCT00706030|19445501|P3|Overall Study|Death|1
5630094|NCT00706030|19445502|P2|Overall Study|Death|0
5630095|NCT00706030|19445503|P1|Overall Study|Death|0
5630096|NCT00706030|19445500|P4|Overall Study|No treatment received|1
5630097|NCT00706030|19445501|P3|Overall Study|No treatment received|0
5630098|NCT00706030|19445502|P2|Overall Study|No treatment received|0
5630099|NCT00706030|19445503|P1|Overall Study|No treatment received|0
5630100|NCT00706030|19445500|P4|Overall Study|Symptomatic Deterioration|0
5630101|NCT00706030|19445501|P3|Overall Study|Symptomatic Deterioration|1
5630102|NCT00706030|19445502|P2|Overall Study|Symptomatic Deterioration|0
5630103|NCT00706030|19445503|P1|Overall Study|Symptomatic Deterioration|0
5630104|NCT00706030|19445500|P4|Overall Study|Failed to return|0
5630105|NCT00706030|19445501|P3|Overall Study|Failed to return|1
5630106|NCT00706030|19445502|P2|Overall Study|Failed to return|0
5630107|NCT00706030|19445503|P1|Overall Study|Failed to return|0
5630108|NCT00706030|19445500|P4|Overall Study|Protocol Violation|1
5630109|NCT00706030|19445501|P3|Overall Study|Protocol Violation|1
5630110|NCT00706030|19445502|P2|Overall Study|Protocol Violation|0
5630111|NCT00706030|19445503|P1|Overall Study|Protocol Violation|0
5630112|NCT00706030|19445500|P4|Overall Study|Not recorded|0
5630113|NCT00706030|19445501|P3|Overall Study|Not recorded|2
5630114|NCT00706030|19445502|P2|Overall Study|Not recorded|0
5630115|NCT00706030|19445503|P1|Overall Study|Not recorded|0
5630116|NCT00706030|19445500|P4|Overall Study|Physician Decision|0
5630117|NCT00706030|19445501|P3|Overall Study|Physician Decision|2
5630118|NCT00706030|19445502|P2|Overall Study|Physician Decision|0
5630119|NCT00706030|19445503|P1|Overall Study|Physician Decision|0
5630120|NCT00706030|19445500|P4|Overall Study|Withdrawal by Subject|0
5630121|NCT00706030|19445501|P3|Overall Study|Withdrawal by Subject|2
5630122|NCT00706030|19445502|P2|Overall Study|Withdrawal by Subject|0
5630123|NCT00706030|19445503|P1|Overall Study|Withdrawal by Subject|1
5630124|NCT00706030|19445500|P4|Overall Study|Adverse Event|2
5630125|NCT00706030|19445501|P3|Overall Study|Adverse Event|4
5630126|NCT00706030|19445502|P2|Overall Study|Adverse Event|0
5630127|NCT00706030|19445503|P1|Overall Study|Adverse Event|1
5630128|NCT00706030|19445500|P4|Overall Study|Disease Progression|12
5630129|NCT00706030|19445501|P3|Overall Study|Disease Progression|46
5630130|NCT00706030|19445502|P2|Overall Study|Disease Progression|6
5630131|NCT00706030|19445503|P1|Overall Study|Disease Progression|4
5630132|NCT00706004|19445518|P1|Overall Study|Did not meet eligibility criteria|2
5630133|NCT00705939|19445546|P3|Overall Study|Physician Decision|0
5630134|NCT00705939|19445547|P2|Overall Study|Physician Decision|1
5630135|NCT00705939|19445548|P1|Overall Study|Physician Decision|0
5630136|NCT00705939|19445546|P3|Overall Study|Withdrawal by Subject|3
5630137|NCT00705939|19445547|P2|Overall Study|Withdrawal by Subject|1
5630138|NCT00705939|19445548|P1|Overall Study|Withdrawal by Subject|0
5630139|NCT00705939|19445546|P3|Overall Study|Protocol Violation|1
5630140|NCT00705939|19445547|P2|Overall Study|Protocol Violation|0
5630141|NCT00705939|19445548|P1|Overall Study|Protocol Violation|0
5630142|NCT00705783|19445602|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
5630143|NCT00705783|19445603|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
5630144|NCT00705783|19445604|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
5630145|NCT00705783|19445602|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
5630146|NCT00705783|19445603|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
5630147|NCT00705783|19445604|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
5630148|NCT00705783|19445602|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
5630149|NCT00705783|19445603|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
5630150|NCT00705783|19445604|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
5630151|NCT00705783|19445602|P3|Depot Maintenance Phase|Protocol Deviation|0
5630152|NCT00705783|19445603|P2|Depot Maintenance Phase|Protocol Deviation|2
5630153|NCT00705783|19445604|P1|Depot Maintenance Phase|Protocol Deviation|0
5630154|NCT00705783|19445602|P3|Depot Maintenance Phase|Withdrew Consent|4
5630155|NCT00705783|19445603|P2|Depot Maintenance Phase|Withdrew Consent|14
5630156|NCT00705783|19445604|P1|Depot Maintenance Phase|Withdrew Consent|0
5630157|NCT00705783|19445602|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
5630158|NCT00705783|19445603|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
5630159|NCT00705783|19445604|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
5630160|NCT00705783|19445602|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
5630161|NCT00705783|19445603|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
5630162|NCT00705783|19445604|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
5630163|NCT00705783|19445602|P3|Depot Maintenance Phase|Lost to Follow-up|3
5630164|NCT00705783|19445603|P2|Depot Maintenance Phase|Lost to Follow-up|5
5630165|NCT00705783|19445604|P1|Depot Maintenance Phase|Lost to Follow-up|0
5630166|NCT00705783|19445602|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
5630167|NCT00705783|19445603|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
5630168|NCT00705783|19445604|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
5630169|NCT00705783|19445602|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
5630170|NCT00705783|19445603|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
5630171|NCT00705783|19445604|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
5630172|NCT00705783|19445602|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
5630173|NCT00705783|19445603|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
5630174|NCT00705783|19445604|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
5630175|NCT00705783|19445602|P3|Depot Stabilization Phase|Adverse Event|0
5630176|NCT00705783|19445603|P2|Depot Stabilization Phase|Adverse Event|0
5630177|NCT00705783|19445604|P1|Depot Stabilization Phase|Adverse Event|17
5630178|NCT00705783|19445602|P3|Depot Stabilization Phase|Withdrew Consent|0
5630179|NCT00705783|19445603|P2|Depot Stabilization Phase|Withdrew Consent|0
5630180|NCT00705783|19445604|P1|Depot Stabilization Phase|Withdrew Consent|29
5630181|NCT00705783|19445602|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
5630182|NCT00705783|19445603|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
5630183|NCT00705783|19445604|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
5630184|NCT00705783|19445602|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
5630185|NCT00705783|19445603|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
5630186|NCT00705783|19445604|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
5630187|NCT00705783|19445602|P3|Depot Stabilization Phase|Lost to Follow-up|0
5630188|NCT00705783|19445603|P2|Depot Stabilization Phase|Lost to Follow-up|0
5630189|NCT00705783|19445604|P1|Depot Stabilization Phase|Lost to Follow-up|11
5630190|NCT00705783|19445602|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
5630191|NCT00705783|19445603|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
5630192|NCT00705783|19445604|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
5630193|NCT00705783|19445602|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5630194|NCT00705783|19445603|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
5630195|NCT00705783|19445604|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
5630196|NCT00705783|19445602|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5630197|NCT00705783|19445603|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
5630198|NCT00705783|19445604|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
5630199|NCT00705783|19445602|P3|Oral Stabilization Phase|Adverse Event|0
5630200|NCT00705783|19445603|P2|Oral Stabilization Phase|Adverse Event|0
5630201|NCT00705783|19445604|P1|Oral Stabilization Phase|Adverse Event|14
5630202|NCT00705783|19445602|P3|Oral Stabilization Phase|Withdrew Consent|0
5630203|NCT00705783|19445603|P2|Oral Stabilization Phase|Withdrew Consent|0
5630204|NCT00705783|19445604|P1|Oral Stabilization Phase|Withdrew Consent|29
5630205|NCT00705783|19445602|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
5630206|NCT00705783|19445603|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
5630207|NCT00705783|19445604|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
5630208|NCT00705783|19445602|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
5630209|NCT00705783|19445603|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
5630210|NCT00705783|19445604|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
5630211|NCT00705783|19445602|P3|Oral Stabilization Phase|Lost to Follow-up|0
5630212|NCT00705783|19445603|P2|Oral Stabilization Phase|Lost to Follow-up|0
5630213|NCT00705783|19445604|P1|Oral Stabilization Phase|Lost to Follow-up|7
5630214|NCT00705783|19445602|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
5630215|NCT00705783|19445603|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
5630216|NCT00705783|19445604|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
5630217|NCT00705783|19445602|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
5630218|NCT00705783|19445603|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
5630219|NCT00705783|19445604|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
5630220|NCT00705783|19445602|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
5630221|NCT00705783|19445603|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
5630222|NCT00705783|19445604|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
5630223|NCT00705783|19445602|P3|Conversion Phase|Adverse Event|0
5630224|NCT00705783|19445603|P2|Conversion Phase|Adverse Event|0
5630225|NCT00705783|19445604|P1|Conversion Phase|Adverse Event|11
5630226|NCT00705783|19445602|P3|Conversion Phase|Protocol Deviation|0
5630227|NCT00705783|19445603|P2|Conversion Phase|Protocol Deviation|0
5630228|NCT00705783|19445604|P1|Conversion Phase|Protocol Deviation|2
5630229|NCT00705783|19445602|P3|Conversion Phase|Withdrew Consent|0
5630230|NCT00705783|19445603|P2|Conversion Phase|Withdrew Consent|0
5630231|NCT00705783|19445604|P1|Conversion Phase|Withdrew Consent|24
5630232|NCT00705783|19445602|P3|Conversion Phase|Withdrawn by Investigator|0
5630233|NCT00705783|19445603|P2|Conversion Phase|Withdrawn by Investigator|0
5630234|NCT00705783|19445604|P1|Conversion Phase|Withdrawn by Investigator|4
5630235|NCT00705783|19445602|P3|Conversion Phase|Met Withdrawal Criteria|0
5630236|NCT00705783|19445603|P2|Conversion Phase|Met Withdrawal Criteria|0
5630237|NCT00705783|19445604|P1|Conversion Phase|Met Withdrawal Criteria|4
5630238|NCT00705783|19445602|P3|Conversion Phase|Lost to Follow-up|0
5630239|NCT00705783|19445603|P2|Conversion Phase|Lost to Follow-up|0
5630240|NCT00705783|19445604|P1|Conversion Phase|Lost to Follow-up|13
5630241|NCT00705783|19445602|P3|Conversion Phase|Sponsor Discontinued Study|0
5630242|NCT00705783|19445603|P2|Conversion Phase|Sponsor Discontinued Study|0
5630243|NCT00705783|19445604|P1|Conversion Phase|Sponsor Discontinued Study|54
5630244|NCT00705757|19445634|P3|Overall Study|Withdrawal by Subject|2
5630245|NCT00705757|19445635|P2|Overall Study|Withdrawal by Subject|1
5630246|NCT00705757|19445636|P1|Overall Study|Withdrawal by Subject|1
5630247|NCT00705757|19445634|P3|Overall Study|Lost to Follow-up|6
5630248|NCT00705757|19445635|P2|Overall Study|Lost to Follow-up|6
5630249|NCT00705757|19445636|P1|Overall Study|Lost to Follow-up|7
5630250|NCT00705757|19445634|P3|Overall Study|Lack of Efficacy|3
5630251|NCT00705757|19445635|P2|Overall Study|Lack of Efficacy|1
5630252|NCT00705757|19445636|P1|Overall Study|Lack of Efficacy|5
5630253|NCT00705718|19445646|P2|Overall Study|Follow up not done|4
5630254|NCT00705718|19445647|P1|Overall Study|Follow up not done|1
5630255|NCT00705718|19445646|P2|Overall Study|Not due for Visit|12
5630256|NCT00705718|19445647|P1|Overall Study|Not due for Visit|0
5630257|NCT00705718|19445646|P2|Overall Study|Death|6
5630258|NCT00705718|19445647|P1|Overall Study|Death|6
5630259|NCT00705679|19445668|P5|Overall Study|Withdrawal by Subject|33
5630260|NCT00705679|19445669|P4|Overall Study|Withdrawal by Subject|47
5630261|NCT00705679|19445670|P3|Overall Study|Withdrawal by Subject|68
5630262|NCT00705679|19445671|P2|Overall Study|Withdrawal by Subject|77
5630263|NCT00705679|19445672|P1|Overall Study|Withdrawal by Subject|32
5630264|NCT00705679|19445668|P5|Overall Study|Physician Decision|0
5630265|NCT00705679|19445669|P4|Overall Study|Physician Decision|1
5630266|NCT00705679|19445670|P3|Overall Study|Physician Decision|0
5630267|NCT00705679|19445671|P2|Overall Study|Physician Decision|1
5630268|NCT00705679|19445672|P1|Overall Study|Physician Decision|0
5630269|NCT00705679|19445668|P5|Overall Study|Lost to Follow-up|35
5630270|NCT00705679|19445669|P4|Overall Study|Lost to Follow-up|30
5630271|NCT00705679|19445670|P3|Overall Study|Lost to Follow-up|44
5630272|NCT00705679|19445671|P2|Overall Study|Lost to Follow-up|60
5630273|NCT00705679|19445672|P1|Overall Study|Lost to Follow-up|32
5630274|NCT00705679|19445668|P5|Overall Study|Death|1
5630275|NCT00705679|19445669|P4|Overall Study|Death|2
5630276|NCT00705679|19445670|P3|Overall Study|Death|3
5630277|NCT00705679|19445671|P2|Overall Study|Death|0
5630278|NCT00705679|19445672|P1|Overall Study|Death|0
5630279|NCT00705679|19445668|P5|Overall Study|Adverse Event|0
5630280|NCT00705679|19445669|P4|Overall Study|Adverse Event|0
5630281|NCT00705679|19445670|P3|Overall Study|Adverse Event|0
5630282|NCT00705679|19445671|P2|Overall Study|Adverse Event|1
5630283|NCT00705679|19445672|P1|Overall Study|Adverse Event|1
5630284|NCT00705666|19445707|P1|Overall Study|Untreated|5
5630285|NCT00705666|19445707|P1|Overall Study|Lack of data|3
5630286|NCT00705666|19445707|P1|Overall Study|Other|2
5630287|NCT00705666|19445707|P1|Overall Study|Other|12
5630288|NCT00705666|19445707|P1|Overall Study|Adverse Event|4
5630289|NCT00705666|19445707|P1|Overall Study|Death|1
5630290|NCT00705666|19445707|P1|Overall Study|Lost to Follow-up|5
5630291|NCT00705666|19445707|P1|Overall Study|Physician Decision|7
5630292|NCT00705666|19445707|P1|Overall Study|Withdrawal by Subject|21
5630293|NCT00705666|19445707|P1|Overall Study|No post-treatment questionnaire|279
5630294|NCT00705614|19445718|P2|Switch to Remicade|Administrative Reason|9
5630295|NCT00705614|19445719|P1|Switch to Remicade|Administrative Reason|0
5630296|NCT00705614|19445718|P2|Switch to Remicade|Withdrawal by Subject|12
5630297|NCT00705614|19445719|P1|Switch to Remicade|Withdrawal by Subject|0
5630298|NCT00705614|19445718|P2|Switch to Remicade|Lost to Follow-up|23
5630299|NCT00705614|19445719|P1|Switch to Remicade|Lost to Follow-up|0
5630300|NCT00705614|19445718|P2|Switch to Remicade|Adverse Event|5
5630301|NCT00705614|19445719|P1|Switch to Remicade|Adverse Event|0
5630302|NCT00705614|19445718|P2|Initial Intervention|Status completion unknown|0
5630303|NCT00705614|19445719|P1|Initial Intervention|Status completion unknown|3
5630304|NCT00705614|19445718|P2|Initial Intervention|Administrative Reason|38
5630305|NCT00705614|19445719|P1|Initial Intervention|Administrative Reason|51
5630306|NCT00705614|19445718|P2|Initial Intervention|Withdrawal by Subject|71
5630307|NCT00705614|19445719|P1|Initial Intervention|Withdrawal by Subject|114
5630308|NCT00705614|19445718|P2|Initial Intervention|Lost to Follow-up|191
5630309|NCT00705614|19445719|P1|Initial Intervention|Lost to Follow-up|310
5630310|NCT00705614|19445718|P2|Initial Intervention|Adverse Event|21
5630311|NCT00705614|19445719|P1|Initial Intervention|Adverse Event|40
5630312|NCT00705575|19445768|P2|Overall Study|Withdrawal by Subject|10
5630313|NCT00705575|19445769|P1|Overall Study|Withdrawal by Subject|5
5630314|NCT00705575|19445768|P2|Overall Study|Protocol Violation|2
5630315|NCT00705575|19445769|P1|Overall Study|Protocol Violation|2
5630316|NCT00705575|19445768|P2|Overall Study|Lost to Follow-up|4
5630317|NCT00705575|19445769|P1|Overall Study|Lost to Follow-up|3
5630318|NCT00705575|19445768|P2|Overall Study|Adverse Event|15
5630319|NCT00705575|19445769|P1|Overall Study|Adverse Event|11
5630320|NCT00705575|19445768|P2|Overall Study|Abnormal test procedure result(s)|12
5630321|NCT00705575|19445769|P1|Overall Study|Abnormal test procedure result(s)|2
5630322|NCT00705575|19445768|P2|Overall Study|Abnormal laboratory value(s)|3
5630323|NCT00705575|19445769|P1|Overall Study|Abnormal laboratory value(s)|0
5630324|NCT00705536|19445783|P4|Start Period 1|Withdrawal by Subject|1
5630325|NCT00705536|19445784|P3|Start Period 1|Withdrawal by Subject|0
5630326|NCT00705536|19445785|P2|Start Period 1|Withdrawal by Subject|0
5630327|NCT00705536|19445786|P1|Start Period 1|Withdrawal by Subject|0
5630328|NCT00705523|19445847|P2|Overall Study|Lost to Follow-up|3
5630329|NCT00705523|19445848|P1|Overall Study|Lost to Follow-up|2
5630330|NCT00705484|19445858|P2|Overall Study|Administrative|59
5630331|NCT00705484|19445859|P1|Overall Study|Administrative|89
5630332|NCT00705484|19445858|P2|Overall Study|Withdrawal by Subject|72
5630333|NCT00705484|19445859|P1|Overall Study|Withdrawal by Subject|96
5630334|NCT00705484|19445858|P2|Overall Study|Lost to Follow-up|250
5630335|NCT00705484|19445859|P1|Overall Study|Lost to Follow-up|169
5630336|NCT00705484|19445858|P2|Overall Study|Adverse Event|27
5630337|NCT00705484|19445859|P1|Overall Study|Adverse Event|28
5630338|NCT00705432|19445873|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
5630339|NCT00705432|19445874|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
5630340|NCT00705432|19445875|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
5630341|NCT00705432|19445876|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
5630342|NCT00705432|19445877|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
5630343|NCT00705432|19445878|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
5630344|NCT00705432|19445873|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
5630345|NCT00705432|19445874|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
5630346|NCT00705432|19445875|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
5630347|NCT00705432|19445876|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
5630348|NCT00705432|19445877|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
5630349|NCT00705432|19445878|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
5630350|NCT00705432|19445873|P6|Treatment Period|Non medical reason|7
5630351|NCT00705432|19445874|P5|Treatment Period|Non medical reason|7
5630352|NCT00705432|19445875|P4|Treatment Period|Non medical reason|4
5630353|NCT00705432|19445876|P3|Treatment Period|Non medical reason|37
5630354|NCT00705432|19445877|P2|Treatment Period|Non medical reason|32
5630355|NCT00705432|19445878|P1|Treatment Period|Non medical reason|26
5630356|NCT00705432|19445873|P6|Treatment Period|Treatment failure|14
5630357|NCT00705432|19445874|P5|Treatment Period|Treatment failure|13
5630358|NCT00705432|19445875|P4|Treatment Period|Treatment failure|25
5630359|NCT00705432|19445876|P3|Treatment Period|Treatment failure|33
5630360|NCT00705432|19445877|P2|Treatment Period|Treatment failure|42
5630361|NCT00705432|19445878|P1|Treatment Period|Treatment failure|92
5630362|NCT00705432|19445873|P6|Treatment Period|Adverse Event|9
5630363|NCT00705432|19445874|P5|Treatment Period|Adverse Event|8
5630364|NCT00705432|19445875|P4|Treatment Period|Adverse Event|12
5630365|NCT00705432|19445876|P3|Treatment Period|Adverse Event|51
5630366|NCT00705432|19445877|P2|Treatment Period|Adverse Event|37
5630367|NCT00705432|19445878|P1|Treatment Period|Adverse Event|45
5630368|NCT00705406|19445915|P2|Overall Study|Did not receive study drug|2
5630369|NCT00705406|19445916|P1|Overall Study|Did not receive study drug|1
5630370|NCT00705406|19445915|P2|Overall Study|Lost to Follow-up|3
5630371|NCT00705406|19445916|P1|Overall Study|Lost to Follow-up|3
5630372|NCT00705367|19445940|P2|Long-term Extension Period|Administrative reason by sponsor|0
5630373|NCT00705367|19445941|P1|Long-term Extension Period|Administrative reason by sponsor|3
5630374|NCT00705367|19445940|P2|Long-term Extension Period|No longer met study criteria|0
5630375|NCT00705367|19445941|P1|Long-term Extension Period|No longer met study criteria|1
5630376|NCT00705367|19445940|P2|Long-term Extension Period|Lack of Efficacy|0
5630377|NCT00705367|19445941|P1|Long-term Extension Period|Lack of Efficacy|1
5630378|NCT00705367|19445940|P2|Long-term Extension Period|Withdrawal by Subject|0
5630379|NCT00705367|19445941|P1|Long-term Extension Period|Withdrawal by Subject|2
5630380|NCT00705367|19445940|P2|Long-term Extension Period|Adverse Event|0
5630381|NCT00705367|19445941|P1|Long-term Extension Period|Adverse Event|2
5630382|NCT00705341|19445968|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
5630383|NCT00705341|19445969|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
5630384|NCT00705341|19445970|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
5630385|NCT00705341|19445971|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
5630386|NCT00705341|19445968|P4|Phase 2: Trial|Withdrawal by Subject|4
5630387|NCT00705341|19445969|P3|Phase 2: Trial|Withdrawal by Subject|6
5630388|NCT00705341|19445970|P2|Phase 2: Trial|Withdrawal by Subject|0
5630389|NCT00705341|19445971|P1|Phase 2: Trial|Withdrawal by Subject|0
5630390|NCT00705289|19445979|P1|Overall Study|Subject or treating physician's choice|131
5630391|NCT00705263|19446003|P1|Overall Study|Withdrawal by Subject|2
5630392|NCT00705250|19446007|P1|Overall Study|Patient died in car accident|1
5630393|NCT00705250|19446007|P1|Overall Study|Withdrawal by Subject|1
5630394|NCT00705224|19446011|P1|Overall Study|Lost to Follow-up|5
5630395|NCT00705224|19446011|P1|Overall Study|Withdrawal by Subject|3
5630396|NCT00705224|19446011|P1|Overall Study|Lack of Efficacy|2
5630397|NCT00705224|19446011|P1|Overall Study|Adverse Event|1
5630398|NCT00705159|19446027|P4|Overall Study|Screen Failure|1
5630399|NCT00705159|19446028|P3|Overall Study|Screen Failure|0
5630400|NCT00705159|19446029|P2|Overall Study|Screen Failure|0
5630401|NCT00705159|19446030|P1|Overall Study|Screen Failure|0
5630402|NCT00705159|19446027|P4|Overall Study|Lost to Follow-up|2
5630403|NCT00705159|19446028|P3|Overall Study|Lost to Follow-up|3
5630404|NCT00705159|19446029|P2|Overall Study|Lost to Follow-up|0
5630405|NCT00705159|19446030|P1|Overall Study|Lost to Follow-up|0
5630406|NCT00705159|19446027|P4|Overall Study|Adverse Event|0
5630407|NCT00705159|19446028|P3|Overall Study|Adverse Event|1
5630408|NCT00705159|19446029|P2|Overall Study|Adverse Event|0
5630409|NCT00705159|19446030|P1|Overall Study|Adverse Event|0
5630410|NCT00705159|19446027|P4|Overall Study|Protocol Violation|0
5630411|NCT00705159|19446028|P3|Overall Study|Protocol Violation|0
5630412|NCT00705159|19446029|P2|Overall Study|Protocol Violation|1
5630413|NCT00705159|19446030|P1|Overall Study|Protocol Violation|0
5630414|NCT00705159|19446027|P4|Overall Study|Withdrawal by Subject|1
5630415|NCT00705159|19446028|P3|Overall Study|Withdrawal by Subject|1
5630416|NCT00705159|19446029|P2|Overall Study|Withdrawal by Subject|1
5630417|NCT00705159|19446030|P1|Overall Study|Withdrawal by Subject|0
5630418|NCT00705146|19446050|P2|Overall Study|Lost to Follow-up|1
5630419|NCT00705146|19446051|P1|Overall Study|Lost to Follow-up|1
5630420|NCT00705016|19446087|P3|Overall Study|Other|6
5630421|NCT00705016|19446088|P2|Overall Study|Other|6
5630422|NCT00705016|19446089|P1|Overall Study|Other|9
5630423|NCT00705016|19446087|P3|Overall Study|Symptomatic Deterioration|1
5630424|NCT00705016|19446088|P2|Overall Study|Symptomatic Deterioration|1
5630425|NCT00705016|19446089|P1|Overall Study|Symptomatic Deterioration|3
5630426|NCT00705016|19446087|P3|Overall Study|Progressive Disease|33
5630427|NCT00705016|19446088|P2|Overall Study|Progressive Disease|29
5630428|NCT00705016|19446089|P1|Overall Study|Progressive Disease|33
5630429|NCT00705016|19446087|P3|Overall Study|Withdrawal by Subject|2
5630430|NCT00705016|19446088|P2|Overall Study|Withdrawal by Subject|3
5630431|NCT00705016|19446089|P1|Overall Study|Withdrawal by Subject|4
5630432|NCT00705016|19446087|P3|Overall Study|Protocol Violation|1
5630433|NCT00705016|19446088|P2|Overall Study|Protocol Violation|1
5630434|NCT00705016|19446089|P1|Overall Study|Protocol Violation|0
5630435|NCT00705016|19446087|P3|Overall Study|Death|5
5630436|NCT00705016|19446088|P2|Overall Study|Death|7
5630437|NCT00705016|19446089|P1|Overall Study|Death|5
5630438|NCT00705016|19446087|P3|Overall Study|Adverse Event|10
5630439|NCT00705016|19446088|P2|Overall Study|Adverse Event|11
5630440|NCT00705016|19446089|P1|Overall Study|Adverse Event|6
5630441|NCT00704964|19446140|P1|Overall Study|Not completed on time|328
5630442|NCT00704808|19446201|P1|Overall Study|Treatment change|1
5630443|NCT00704808|19446201|P1|Overall Study|Lost to Follow-up|1
5630444|NCT00704808|19446201|P1|Overall Study|Adverse Event|1
5630445|NCT00704808|19446201|P1|Overall Study|Early therapy discontinuation|16
5630446|NCT00704808|19446201|P1|Overall Study|Patient's decision|11
5630447|NCT00704808|19446201|P1|Overall Study|Tumor progression|80
5630448|NCT00704808|19446201|P1|Overall Study|Death|7
5630449|NCT00704808|19446201|P1|Overall Study|Discontinued prior to starting treatment|14
5630450|NCT00704730|19446212|P2|Overall Study|Withdrawal by Subject|13
5630451|NCT00704730|19446213|P1|Overall Study|Withdrawal by Subject|9
5630452|NCT00704730|19446212|P2|Overall Study|data unavailable|0
5630453|NCT00704730|19446213|P1|Overall Study|data unavailable|1
5630454|NCT00704730|19446212|P2|Overall Study|Disease progression per PI|67
5630455|NCT00704730|19446213|P1|Overall Study|Disease progression per PI|58
5630456|NCT00704730|19446212|P2|Overall Study|Did not receive drug|2
5630457|NCT00704730|19446213|P1|Overall Study|Did not receive drug|5
5630458|NCT00704730|19446212|P2|Overall Study|Physician Decision|0
5630459|NCT00704730|19446213|P1|Overall Study|Physician Decision|2
5630460|NCT00704730|19446212|P2|Overall Study|Death|5
5630461|NCT00704730|19446213|P1|Overall Study|Death|11
5630462|NCT00704730|19446212|P2|Overall Study|Adverse Event|9
5630463|NCT00704730|19446213|P1|Overall Study|Adverse Event|35
5630464|NCT00704535|19446233|P1|Overall Study|Completed status not on Case Report Form|124
5630465|NCT00704535|19446233|P1|Overall Study|Protocol Violation|10
5630466|NCT00704535|19446233|P1|Overall Study|Lost to Follow-up|8
5630467|NCT00704535|19446233|P1|Overall Study|Death|2
5630468|NCT00704535|19446233|P1|Overall Study|Adverse Event|2
5630469|NCT00704522|19446246|P2|Overall Study|No information on therapy end|2
5630470|NCT00704522|19446247|P1|Overall Study|No information on therapy end|27
5630471|NCT00704522|19446246|P2|Overall Study|Undefined causes|7
5630472|NCT00704522|19446247|P1|Overall Study|Undefined causes|9
5630473|NCT00704522|19446246|P2|Overall Study|Adverse Event|1
5630474|NCT00704522|19446247|P1|Overall Study|Adverse Event|9
5630475|NCT00704522|19446246|P2|Overall Study|Withdrawal by Subject|8
5630476|NCT00704522|19446247|P1|Overall Study|Withdrawal by Subject|17
5630477|NCT00704522|19446246|P2|Overall Study|Failure to appear again at hospital|10
5630478|NCT00704522|19446247|P1|Overall Study|Failure to appear again at hospital|56
5630479|NCT00704522|19446246|P2|Overall Study|Lack of Efficacy|17
5630480|NCT00704522|19446247|P1|Overall Study|Lack of Efficacy|65
5630481|NCT00704418|19446267|P2|Overall Study|Over-enrolled/surgery postponed|6
5630482|NCT00704418|19446268|P1|Overall Study|Over-enrolled/surgery postponed|3
5630483|NCT00704418|19446267|P2|Overall Study|Withdrawal by Subject|0
5630484|NCT00704418|19446268|P1|Overall Study|Withdrawal by Subject|2
5630485|NCT00704405|19446281|P5|Overall Study (C Population)|Lost to Follow-up|0
5630486|NCT00704405|19446282|P4|Overall Study (C Population)|Lost to Follow-up|0
5630487|NCT00704405|19446283|P3|Overall Study (C Population)|Lost to Follow-up|0
5630488|NCT00704405|19446284|P2|Overall Study (C Population)|Lost to Follow-up|2
5630489|NCT00704405|19446285|P1|Overall Study (C Population)|Lost to Follow-up|0
5630490|NCT00704405|19446281|P5|Overall Study (C Population)|Withdrawal by Subject|0
5630491|NCT00704405|19446282|P4|Overall Study (C Population)|Withdrawal by Subject|1
5630492|NCT00704405|19446283|P3|Overall Study (C Population)|Withdrawal by Subject|1
5630493|NCT00704405|19446284|P2|Overall Study (C Population)|Withdrawal by Subject|1
5630494|NCT00704405|19446285|P1|Overall Study (C Population)|Withdrawal by Subject|1
5630495|NCT00704405|19446281|P5|Overall Study (NC Population)|Other|1
5630496|NCT00704405|19446282|P4|Overall Study (NC Population)|Other|0
5630497|NCT00704405|19446283|P3|Overall Study (NC Population)|Other|0
5630498|NCT00704405|19446284|P2|Overall Study (NC Population)|Other|0
5630499|NCT00704405|19446285|P1|Overall Study (NC Population)|Other|0
5630500|NCT00704405|19446281|P5|Overall Study (NC Population)|Withdrawal by Subject|2
5630501|NCT00704405|19446282|P4|Overall Study (NC Population)|Withdrawal by Subject|2
5630502|NCT00704405|19446283|P3|Overall Study (NC Population)|Withdrawal by Subject|2
5630503|NCT00704405|19446284|P2|Overall Study (NC Population)|Withdrawal by Subject|3
5630504|NCT00704405|19446285|P1|Overall Study (NC Population)|Withdrawal by Subject|2
5630505|NCT00704405|19446281|P5|Overall Study (NC Population)|Lost to Follow-up|2
5630506|NCT00704405|19446282|P4|Overall Study (NC Population)|Lost to Follow-up|2
5630507|NCT00704405|19446283|P3|Overall Study (NC Population)|Lost to Follow-up|1
5630508|NCT00704405|19446284|P2|Overall Study (NC Population)|Lost to Follow-up|1
5630509|NCT00704405|19446285|P1|Overall Study (NC Population)|Lost to Follow-up|2
5630510|NCT00704405|19446281|P5|Overall Study (NC Population)|Adverse Event|0
5630511|NCT00704405|19446282|P4|Overall Study (NC Population)|Adverse Event|0
5630512|NCT00704405|19446283|P3|Overall Study (NC Population)|Adverse Event|0
5630513|NCT00704405|19446284|P2|Overall Study (NC Population)|Adverse Event|0
5630514|NCT00704405|19446285|P1|Overall Study (NC Population)|Adverse Event|1
5630515|NCT00704340|19446343|P2|Overall Study|Death|1
5630516|NCT00704340|19446344|P1|Overall Study|Death|0
5630517|NCT00704340|19446343|P2|Overall Study|Lost to Follow-up|1
5630518|NCT00704340|19446344|P1|Overall Study|Lost to Follow-up|2
5630519|NCT00704184|19446375|P5|Open-Label Treatment|Withdrawal by Subject|0
5630520|NCT00704184|19446376|P4|Open-Label Treatment|Withdrawal by Subject|3
5630521|NCT00704184|19446377|P3|Open-Label Treatment|Withdrawal by Subject|0
5630522|NCT00704184|19446378|P2|Open-Label Treatment|Withdrawal by Subject|0
5630523|NCT00704184|19446379|P1|Open-Label Treatment|Withdrawal by Subject|1
5630524|NCT00704184|19446375|P5|Open-Label Treatment|Physician Decision|1
5630525|NCT00704184|19446376|P4|Open-Label Treatment|Physician Decision|0
5630526|NCT00704184|19446377|P3|Open-Label Treatment|Physician Decision|0
5630527|NCT00704184|19446378|P2|Open-Label Treatment|Physician Decision|0
5630528|NCT00704184|19446379|P1|Open-Label Treatment|Physician Decision|0
5630529|NCT00704184|19446375|P5|Open-Label Treatment|Lack of Efficacy|1
5630530|NCT00704184|19446376|P4|Open-Label Treatment|Lack of Efficacy|2
5630531|NCT00704184|19446377|P3|Open-Label Treatment|Lack of Efficacy|2
5630532|NCT00704184|19446378|P2|Open-Label Treatment|Lack of Efficacy|2
5630533|NCT00704184|19446379|P1|Open-Label Treatment|Lack of Efficacy|0
5630534|NCT00704184|19446375|P5|Open-Label Treatment|Adverse Event|1
5630535|NCT00704184|19446376|P4|Open-Label Treatment|Adverse Event|0
5630536|NCT00704184|19446377|P3|Open-Label Treatment|Adverse Event|2
5630537|NCT00704184|19446378|P2|Open-Label Treatment|Adverse Event|0
5630538|NCT00704184|19446379|P1|Open-Label Treatment|Adverse Event|0
5630539|NCT00704184|19446375|P5|Double-Blind Treatment|Withdrawal by Subject|0
5630540|NCT00704184|19446376|P4|Double-Blind Treatment|Withdrawal by Subject|0
5630541|NCT00704184|19446377|P3|Double-Blind Treatment|Withdrawal by Subject|0
5630542|NCT00704184|19446378|P2|Double-Blind Treatment|Withdrawal by Subject|0
5630543|NCT00704184|19446379|P1|Double-Blind Treatment|Withdrawal by Subject|1
5630544|NCT00704171|19446418|P2|Overall Study|Withdrawal by Subject|0
5630545|NCT00704171|19446419|P1|Overall Study|Withdrawal by Subject|1
5630546|NCT00704132|19446437|P2|Overall Study|Withdrawal by Subject|1
5630547|NCT00704132|19446438|P1|Overall Study|Withdrawal by Subject|0
5630548|NCT00704132|19446437|P2|Overall Study|Lack of Efficacy|1
5630549|NCT00704132|19446438|P1|Overall Study|Lack of Efficacy|0
5630550|NCT00704132|19446437|P2|Overall Study|Clinical Adverse Experience|0
5630551|NCT00704132|19446438|P1|Overall Study|Clinical Adverse Experience|1
5630552|NCT00703963|19446466|P2|Overall Study|Physician Decision|1
5630553|NCT00703963|19446467|P1|Overall Study|Physician Decision|0
5630554|NCT00703963|19446466|P2|Overall Study|Withdrawal by Subject|13
5630555|NCT00703963|19446467|P1|Overall Study|Withdrawal by Subject|7
5630556|NCT00703924|19446488|P2|Overall Study|Withdrawal by Subject|1
5630557|NCT00703924|19446489|P1|Overall Study|Withdrawal by Subject|1
5630558|NCT00703911|19446505|P1|Overall Study|Withdrawal by Subject|2
5630559|NCT00703911|19446505|P1|Overall Study|Lost to Follow-up|1
5630560|NCT00703911|19446505|P1|Overall Study|Physician Decision|6
5630561|NCT00703911|19446505|P1|Overall Study|Death|1
5630562|NCT00703846|19446538|P1|Overall Study|Did Not Receive Study Drug|2
5630563|NCT00703846|19446538|P1|Overall Study|Other|14
5630564|NCT00703846|19446538|P1|Overall Study|Death|1
5630565|NCT00703846|19446538|P1|Overall Study|Withdrawal by Subject|40
5630566|NCT00703846|19446538|P1|Overall Study|Noncompliance with Study Treatment|2
5630567|NCT00703846|19446538|P1|Overall Study|Lack of Efficacy|15
5630568|NCT00703846|19446538|P1|Overall Study|Lost to Follow-up|55
5630569|NCT00703846|19446538|P1|Overall Study|Adverse Event|8
5630570|NCT00703820|19446554|P2|Overall Study|Withdrawal by Subject|1
5630571|NCT00703820|19446555|P1|Overall Study|Withdrawal by Subject|2
5630572|NCT00703820|19446554|P2|Overall Study|Physician Decision|5
5630573|NCT00703820|19446555|P1|Overall Study|Physician Decision|4
5630574|NCT00703820|19446554|P2|Overall Study|Received non-protocol therapy|0
5630575|NCT00703820|19446555|P1|Overall Study|Received non-protocol therapy|1
5630576|NCT00703820|19446554|P2|Overall Study|Lack of Efficacy|11
5630577|NCT00703820|19446555|P1|Overall Study|Lack of Efficacy|11
5630578|NCT00703820|19446554|P2|Overall Study|Death|0
5630579|NCT00703820|19446555|P1|Overall Study|Death|5
5630580|NCT00703820|19446554|P2|Overall Study|Adverse Event|17
5630581|NCT00703820|19446555|P1|Overall Study|Adverse Event|12
5630582|NCT00703781|19446564|P2|Overall Study|Cancelled surgery|0
5630583|NCT00703781|19446565|P1|Overall Study|Cancelled surgery|1
5630584|NCT00703781|19446564|P2|Overall Study|Withdrawal by Subject|2
5630585|NCT00703781|19446565|P1|Overall Study|Withdrawal by Subject|1
5630586|NCT00703677|19446610|P1|Overall Study|Dropout-withdrawal not related to drug|3
5630587|NCT00703534|19446650|P2|Overall Study|Severe Non Compliance|5
5630588|NCT00703534|19446651|P1|Overall Study|Severe Non Compliance|1
5630589|NCT00703534|19446650|P2|Overall Study|Lost to Follow-up|4
5630590|NCT00703534|19446651|P1|Overall Study|Lost to Follow-up|1
5630591|NCT00703534|19446650|P2|Overall Study|Incorrect Enrollment|6
5630592|NCT00703534|19446651|P1|Overall Study|Incorrect Enrollment|6
5630593|NCT00703534|19446650|P2|Overall Study|Withdrawal by Subject|7
5630594|NCT00703534|19446651|P1|Overall Study|Withdrawal by Subject|8
5630595|NCT00703534|19446650|P2|Overall Study|Adverse Event|3
5630596|NCT00703534|19446651|P1|Overall Study|Adverse Event|14
5630597|NCT00703326|19446723|P2|Overall Study|Withdrawal by Subject|20
5630598|NCT00703326|19446724|P1|Overall Study|Withdrawal by Subject|42
5630599|NCT00703326|19446723|P2|Overall Study|Lost to Follow-up|8
5630600|NCT00703326|19446724|P1|Overall Study|Lost to Follow-up|25
5630601|NCT00703326|19446723|P2|Overall Study|Still on study|197
5630602|NCT00703326|19446724|P1|Overall Study|Still on study|380
5630603|NCT00703157|19446756|P2|Overall Study|source data permanently lost/ other|1
5630604|NCT00703157|19446757|P1|Overall Study|source data permanently lost/ other|4
5630605|NCT00703157|19446756|P2|Overall Study|Lost to Follow-up|1
5630606|NCT00703157|19446757|P1|Overall Study|Lost to Follow-up|0
5630607|NCT00703118|19446791|P3|Overall Study|Other|1
5630608|NCT00703118|19446792|P2|Overall Study|Other|0
5630609|NCT00703118|19446793|P1|Overall Study|Other|0
5630610|NCT00703118|19446791|P3|Overall Study|Withdrawal by Subject|13
5630611|NCT00703118|19446792|P2|Overall Study|Withdrawal by Subject|7
5630612|NCT00703118|19446793|P1|Overall Study|Withdrawal by Subject|8
5630613|NCT00703118|19446791|P3|Overall Study|Lost to Follow-up|4
5630614|NCT00703118|19446792|P2|Overall Study|Lost to Follow-up|4
5630615|NCT00703118|19446793|P1|Overall Study|Lost to Follow-up|6
5630616|NCT00703118|19446791|P3|Overall Study|Subject Ineligible To Continue The Trial|2
5630617|NCT00703118|19446792|P2|Overall Study|Subject Ineligible To Continue The Trial|3
5630618|NCT00703118|19446793|P1|Overall Study|Subject Ineligible To Continue The Trial|6
5630619|NCT00703118|19446791|P3|Overall Study|Adverse Event|2
5630620|NCT00703118|19446792|P2|Overall Study|Adverse Event|2
5630621|NCT00703118|19446793|P1|Overall Study|Adverse Event|1
5630622|NCT00703092|19446824|P1|Overall Study|Withdrawal by Subject|2
5630623|NCT00703014|19447032|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
5630624|NCT00703014|19447033|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
5630625|NCT00703014|19447034|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
5630626|NCT00703014|19447035|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
5630627|NCT00703014|19447032|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
5630628|NCT00703014|19447033|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
5630629|NCT00703014|19447034|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
5630630|NCT00703014|19447035|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
5630631|NCT00702962|19447055|P2|Overall Study|Hospitalized for other health disorder|0
5630632|NCT00702962|19447056|P1|Overall Study|Hospitalized for other health disorder|1
5630633|NCT00702962|19447055|P2|Overall Study|Progressive disease|1
5630634|NCT00702962|19447056|P1|Overall Study|Progressive disease|0
5630635|NCT00702949|19447067|P3|Overall Study|Other Medical Reason/unknown|3
5630636|NCT00702949|19447068|P2|Overall Study|Other Medical Reason/unknown|1
5630637|NCT00702949|19447069|P1|Overall Study|Other Medical Reason/unknown|1
5630638|NCT00702949|19447067|P3|Overall Study|Adverse Event|3
5630639|NCT00702949|19447068|P2|Overall Study|Adverse Event|6
5630640|NCT00702949|19447069|P1|Overall Study|Adverse Event|1
5630641|NCT00702949|19447067|P3|Overall Study|Refusal|2
5630642|NCT00702949|19447068|P2|Overall Study|Refusal|2
5630643|NCT00702949|19447069|P1|Overall Study|Refusal|3
5630644|NCT00702923|19447094|P1|Overall Study|Adverse Event|1
5630645|NCT00702845|19447117|P2|Overall Study|Not randomized|1
5630646|NCT00702845|19447118|P1|Overall Study|Not randomized|0
5630647|NCT00702845|19447117|P2|Overall Study|Patient's decision|1
5630648|NCT00702845|19447118|P1|Overall Study|Patient's decision|2
5630649|NCT00702845|19447117|P2|Overall Study|No or abnormal fertilization|2
5630650|NCT00702845|19447118|P1|Overall Study|No or abnormal fertilization|4
5630651|NCT00702845|19447117|P2|Overall Study|No/too few/bad quality embryos retrieved|1
5630652|NCT00702845|19447118|P1|Overall Study|No/too few/bad quality embryos retrieved|7
5630653|NCT00702845|19447117|P2|Overall Study|Insufficient ovarian response|0
5630654|NCT00702845|19447118|P1|Overall Study|Insufficient ovarian response|1
5630655|NCT00702845|19447117|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
5630656|NCT00702845|19447118|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
5630657|NCT00702845|19447117|P2|Overall Study|Too high ovarian response|1
5630658|NCT00702845|19447118|P1|Overall Study|Too high ovarian response|5
5630659|NCT00702845|19447117|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
5630660|NCT00702845|19447118|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
5630661|NCT00702715|19447180|P2|Overall Study|Lost to Follow-up|0
5630662|NCT00702715|19447181|P1|Overall Study|Lost to Follow-up|1
5630663|NCT00702702|19447194|P1|Overall Study|Study prematurely terminated|56
5630664|NCT00702689|19447202|P1|Overall Study|Adverse Event|1
5630665|NCT00702689|19447202|P1|Overall Study|Recurrent malignancy|1
5630666|NCT00702689|19447202|P1|Overall Study|Withdrawal by Subject|4
5630667|NCT00702650|19447213|P1|Overall Study|Adverse Event|3
5630668|NCT00702650|19447213|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
5630669|NCT00702650|19447213|P1|Overall Study|Sponsor Request|1
5630670|NCT00702650|19447213|P1|Overall Study|Non-Compliance with Site Directives|1
5630671|NCT00702650|19447213|P1|Overall Study|Lost to Follow-up|2
5630672|NCT00702650|19447213|P1|Overall Study|Non-Compliance of Study Drug|3
5630673|NCT00702650|19447213|P1|Overall Study|Withdrawal by Subject|9
5630674|NCT00702520|19447275|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
5630675|NCT00702520|19447276|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
5630676|NCT00702520|19447277|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
5630677|NCT00702520|19447278|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
5630678|NCT00702520|19447275|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
5630679|NCT00702520|19447276|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
5630680|NCT00702520|19447277|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
5630681|NCT00702520|19447278|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
5630682|NCT00702520|19447275|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
5630683|NCT00702520|19447276|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
5630684|NCT00702520|19447277|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
5630685|NCT00702520|19447278|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
5630686|NCT00702507|19447294|P1|Follow-up Phase|Late Enrollment|1
5630687|NCT00702507|19447294|P1|Follow-up Phase|Lost to Follow-up|23
5630688|NCT00702507|19447294|P1|Follow-up Phase|Protocol Violation|2
5630689|NCT00702507|19447294|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
5630690|NCT00702507|19447294|P1|Initial Treatment Phase|Negative Candida Culture|34
5630691|NCT00702507|19447294|P1|Initial Treatment Phase|Lost to Follow-up|2
5630692|NCT00702507|19447294|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
5630693|NCT00702507|19447294|P1|Initial Treatment Phase|Adverse Event|2
5630694|NCT00702403|19447331|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
5630695|NCT00702403|19447331|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
5630696|NCT00702403|19447331|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
5630697|NCT00702403|19447331|P1|From Engraftment to Study Completion|Suicide|1
5630698|NCT00702403|19447331|P1|From Engraftment to Study Completion|Liver GVHD|1
5630699|NCT00702403|19447331|P1|From Engraftment to Study Completion|Adenocarcinoma|1
5630700|NCT00702403|19447331|P1|From Engraftment to Study Completion|Non-compliance|2
5630701|NCT00702403|19447331|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
5630702|NCT00702403|19447331|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
5630703|NCT00702403|19447331|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
5630704|NCT00702403|19447331|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
5630705|NCT00702403|19447331|P1|From Consent to Engraftment|Myocardial infarction|1
5630706|NCT00702403|19447331|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
5630707|NCT00702403|19447331|P1|From Consent to Engraftment|Critically ill|2
5630708|NCT00702403|19447331|P1|From Consent to Engraftment|Progressive leukemia|6
5630709|NCT00702325|19447385|P2|Overall Study|Incorrectly Discontinued|1
5630710|NCT00702325|19447386|P1|Overall Study|Incorrectly Discontinued|0
5630711|NCT00702325|19447385|P2|Overall Study|Withdrew consent|1
5630712|NCT00702325|19447386|P1|Overall Study|Withdrew consent|0
5630713|NCT00702325|19447385|P2|Overall Study|Didn't follow study medication dosage|2
5630714|NCT00702325|19447386|P1|Overall Study|Didn't follow study medication dosage|0
5630715|NCT00702325|19447385|P2|Overall Study|Termination due to lab results|0
5630716|NCT00702325|19447386|P1|Overall Study|Termination due to lab results|1
5630717|NCT00702325|19447385|P2|Overall Study|Severe noncompliance to protocol|3
5630718|NCT00702325|19447386|P1|Overall Study|Severe noncompliance to protocol|3
5630719|NCT00702325|19447385|P2|Overall Study|Developed study discontinuation criteria|28
5630720|NCT00702325|19447386|P1|Overall Study|Developed study discontinuation criteria|18
5630721|NCT00702325|19447385|P2|Overall Study|Incorrect enrollment|7
5630722|NCT00702325|19447386|P1|Overall Study|Incorrect enrollment|5
5630723|NCT00702325|19447385|P2|Overall Study|Lost to Follow-up|4
5630724|NCT00702325|19447386|P1|Overall Study|Lost to Follow-up|3
5630725|NCT00702325|19447385|P2|Overall Study|Withdrawal by Subject|7
5630726|NCT00702325|19447386|P1|Overall Study|Withdrawal by Subject|7
5630727|NCT00702325|19447385|P2|Overall Study|Adverse Event|0
5630728|NCT00702325|19447386|P1|Overall Study|Adverse Event|1
5630729|NCT00702221|19447482|P2|Overall Study|Adverse Event|3
5630730|NCT00702221|19447483|P1|Overall Study|Adverse Event|4
5630731|NCT00702208|19447489|P1|Overall Study|Unsatisfactory colposcopy|2
5630732|NCT00702208|19447489|P1|Overall Study|Did not self-lavage|1
5630733|NCT00702208|19447489|P1|Overall Study|Lost to Follow-up|28
5630734|NCT00702143|19447498|P3|Overall Study|Lost to Follow-up|1
5630735|NCT00702143|19447499|P2|Overall Study|Lost to Follow-up|0
5630736|NCT00702143|19447500|P1|Overall Study|Lost to Follow-up|0
5630737|NCT00701805|19447549|P4|Overall Study|Resumption criteria were not met|0
5630738|NCT00701805|19447550|P3|Overall Study|Resumption criteria were not met|0
5630739|NCT00701805|19447551|P2|Overall Study|Resumption criteria were not met|1
5630740|NCT00701805|19447552|P1|Overall Study|Resumption criteria were not met|0
5630741|NCT00701805|19447549|P4|Overall Study|Difficult to travel to dialysis site|0
5630742|NCT00701805|19447550|P3|Overall Study|Difficult to travel to dialysis site|1
5630743|NCT00701805|19447551|P2|Overall Study|Difficult to travel to dialysis site|0
5630744|NCT00701805|19447552|P1|Overall Study|Difficult to travel to dialysis site|0
5630745|NCT00701805|19447549|P4|Overall Study|Physician decision, change of therapy|1
5630746|NCT00701805|19447550|P3|Overall Study|Physician decision, change of therapy|0
5630747|NCT00701805|19447551|P2|Overall Study|Physician decision, change of therapy|0
5630748|NCT00701805|19447552|P1|Overall Study|Physician decision, change of therapy|0
5630749|NCT00701805|19447549|P4|Overall Study|Admitted to hospital for 2 weeks|0
5630750|NCT00701805|19447550|P3|Overall Study|Admitted to hospital for 2 weeks|1
5630751|NCT00701805|19447551|P2|Overall Study|Admitted to hospital for 2 weeks|0
5630752|NCT00701805|19447552|P1|Overall Study|Admitted to hospital for 2 weeks|0
5630753|NCT00701805|19447549|P4|Overall Study|Missed 7 consecutive doses|0
5630754|NCT00701805|19447550|P3|Overall Study|Missed 7 consecutive doses|0
5630755|NCT00701805|19447551|P2|Overall Study|Missed 7 consecutive doses|1
5630756|NCT00701805|19447552|P1|Overall Study|Missed 7 consecutive doses|0
5630757|NCT00701805|19447549|P4|Overall Study|Adverse Event|0
5630758|NCT00701805|19447550|P3|Overall Study|Adverse Event|1
5630759|NCT00701805|19447551|P2|Overall Study|Adverse Event|1
5630760|NCT00701805|19447552|P1|Overall Study|Adverse Event|0
5630761|NCT00701805|19447549|P4|Overall Study|Withdrawal by Subject|3
5630762|NCT00701805|19447550|P3|Overall Study|Withdrawal by Subject|4
5630763|NCT00701805|19447551|P2|Overall Study|Withdrawal by Subject|1
5630764|NCT00701805|19447552|P1|Overall Study|Withdrawal by Subject|3
5630765|NCT00701779|19447602|P1|Overall Study|Withdrawal by Subject|2
5630766|NCT00701779|19447602|P1|Overall Study|Lost to Follow-up|1
5630767|NCT00701779|19447602|P1|Overall Study|Adverse Event|6
5630768|NCT00701727|19447614|P2|Second Treatment Period|Withdrawal by Subject|0
5630769|NCT00701727|19447615|P1|Second Treatment Period|Withdrawal by Subject|2
5630770|NCT00701727|19447614|P2|First Treatment Period|Lost to Follow-up|1
5630771|NCT00701727|19447615|P1|First Treatment Period|Lost to Follow-up|0
5630772|NCT00701727|19447614|P2|First Treatment Period|sponsor decision|1
5630773|NCT00701727|19447615|P1|First Treatment Period|sponsor decision|0
5630774|NCT00701727|19447614|P2|First Treatment Period|Withdrawal by Subject|0
5630775|NCT00701727|19447615|P1|First Treatment Period|Withdrawal by Subject|1
5630776|NCT00701727|19447614|P2|First Treatment Period|Adverse Event|0
5630777|NCT00701727|19447615|P1|First Treatment Period|Adverse Event|0
5630778|NCT00701701|19447650|P2|Overall Study|Adverse Event|1
5630779|NCT00701701|19447651|P1|Overall Study|Adverse Event|0
5630780|NCT00701701|19447650|P2|Overall Study|Withdrawal by Subject|1
5630781|NCT00701701|19447651|P1|Overall Study|Withdrawal by Subject|0
5630782|NCT00701662|19447686|P1|Overall Study|Lack of Efficacy|1
5630783|NCT00701558|19447711|P1|Overall Study|Lost to Follow-up|8
5630784|NCT00701558|19447711|P1|Overall Study|Death|7
5630785|NCT00701441|19447719|P2|Overall Study|failure in cpap compliance|4
5630786|NCT00701441|19447720|P1|Overall Study|failure in cpap compliance|0
5630787|NCT00701415|19447732|P2|Overall Study|Social/family issues and needle phobia|0
5630788|NCT00701415|19447733|P1|Overall Study|Social/family issues and needle phobia|1
5630789|NCT00701415|19447732|P2|Overall Study|Adverse Event|1
5630790|NCT00701415|19447733|P1|Overall Study|Adverse Event|0
5630791|NCT00701363|19447792|P4|Treatment Phase 2|Withdrawal by Subject|0
5630792|NCT00701363|19447793|P3|Treatment Phase 2|Withdrawal by Subject|1
5630793|NCT00701363|19447794|P2|Treatment Phase 2|Withdrawal by Subject|0
5630794|NCT00701363|19447795|P1|Treatment Phase 2|Withdrawal by Subject|0
5630795|NCT00701363|19447792|P4|Treatment Phase 2|Adverse Event|0
5630796|NCT00701363|19447793|P3|Treatment Phase 2|Adverse Event|1
5630797|NCT00701363|19447794|P2|Treatment Phase 2|Adverse Event|0
5630798|NCT00701363|19447795|P1|Treatment Phase 2|Adverse Event|0
5630799|NCT00701363|19447792|P4|Treatment Phase 1|Lack of Efficacy|0
5630800|NCT00701363|19447793|P3|Treatment Phase 1|Lack of Efficacy|0
5630801|NCT00701363|19447794|P2|Treatment Phase 1|Lack of Efficacy|0
5630802|NCT00701363|19447795|P1|Treatment Phase 1|Lack of Efficacy|1
5630803|NCT00701363|19447792|P4|Treatment Phase 1|Withdrawal by Subject|0
5630804|NCT00701363|19447793|P3|Treatment Phase 1|Withdrawal by Subject|0
5630805|NCT00701363|19447794|P2|Treatment Phase 1|Withdrawal by Subject|0
5630806|NCT00701363|19447795|P1|Treatment Phase 1|Withdrawal by Subject|5
5630807|NCT00701363|19447792|P4|Treatment Phase 1|Protocol Violation|0
5630808|NCT00701363|19447793|P3|Treatment Phase 1|Protocol Violation|0
5630809|NCT00701363|19447794|P2|Treatment Phase 1|Protocol Violation|0
5630810|NCT00701363|19447795|P1|Treatment Phase 1|Protocol Violation|1
5630811|NCT00701363|19447792|P4|Treatment Phase 1|Adverse Event|0
5630812|NCT00701363|19447793|P3|Treatment Phase 1|Adverse Event|0
5630813|NCT00701363|19447794|P2|Treatment Phase 1|Adverse Event|0
5630814|NCT00701363|19447795|P1|Treatment Phase 1|Adverse Event|7
5630815|NCT00701363|19447792|P4|Treatment Phase 1|Does not meet entry Criteria|0
5630816|NCT00701363|19447793|P3|Treatment Phase 1|Does not meet entry Criteria|0
5630817|NCT00701363|19447794|P2|Treatment Phase 1|Does not meet entry Criteria|0
5630818|NCT00701363|19447795|P1|Treatment Phase 1|Does not meet entry Criteria|1
5630819|NCT00701363|19447792|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
5630820|NCT00701363|19447793|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
5630821|NCT00701363|19447794|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
5630822|NCT00701363|19447795|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
5630823|NCT00701311|19447835|P1|Overall Study|Withdrawal by Subject|2
5630824|NCT00701311|19447835|P1|Overall Study|Adverse Event|3
5630825|NCT00701311|19447835|P1|Overall Study|Lack of Efficacy|3
5630826|NCT00701129|19447839|P1|Overall Study|Death|2
5630827|NCT00701103|19447861|P11|Overall Study|Other|0
5630828|NCT00701103|19447862|P10|Overall Study|Other|1
5630829|NCT00701103|19447863|P9|Overall Study|Other|1
5630830|NCT00701103|19447864|P8|Overall Study|Other|0
5630831|NCT00701103|19447865|P7|Overall Study|Other|0
5630832|NCT00701103|19447866|P6|Overall Study|Other|0
5630833|NCT00701103|19447867|P5|Overall Study|Other|0
5630834|NCT00701103|19447868|P4|Overall Study|Other|0
5630835|NCT00701103|19447869|P3|Overall Study|Other|0
5630836|NCT00701103|19447870|P2|Overall Study|Other|0
5630837|NCT00701103|19447871|P1|Overall Study|Other|0
5630838|NCT00701103|19447861|P11|Overall Study|Withdrawal by Subject|0
5630839|NCT00701103|19447862|P10|Overall Study|Withdrawal by Subject|0
5630840|NCT00701103|19447863|P9|Overall Study|Withdrawal by Subject|0
5630841|NCT00701103|19447864|P8|Overall Study|Withdrawal by Subject|0
5630842|NCT00701103|19447865|P7|Overall Study|Withdrawal by Subject|0
5630843|NCT00701103|19447866|P6|Overall Study|Withdrawal by Subject|0
5630844|NCT00701103|19447867|P5|Overall Study|Withdrawal by Subject|0
5630845|NCT00701103|19447868|P4|Overall Study|Withdrawal by Subject|0
5630846|NCT00701103|19447869|P3|Overall Study|Withdrawal by Subject|1
5630847|NCT00701103|19447870|P2|Overall Study|Withdrawal by Subject|1
5630848|NCT00701103|19447871|P1|Overall Study|Withdrawal by Subject|0
5630849|NCT00701103|19447861|P11|Overall Study|Progressive Disease|11
5630850|NCT00701103|19447862|P10|Overall Study|Progressive Disease|8
5630851|NCT00701103|19447863|P9|Overall Study|Progressive Disease|8
5630852|NCT00701103|19447864|P8|Overall Study|Progressive Disease|7
5630853|NCT00701103|19447865|P7|Overall Study|Progressive Disease|7
5630854|NCT00701103|19447866|P6|Overall Study|Progressive Disease|5
5630855|NCT00701103|19447867|P5|Overall Study|Progressive Disease|6
5630856|NCT00701103|19447868|P4|Overall Study|Progressive Disease|5
5630857|NCT00701103|19447869|P3|Overall Study|Progressive Disease|6
5630858|NCT00701103|19447870|P2|Overall Study|Progressive Disease|2
5630859|NCT00701103|19447871|P1|Overall Study|Progressive Disease|5
5630860|NCT00701103|19447861|P11|Overall Study|Adverse Event|0
5630861|NCT00701103|19447862|P10|Overall Study|Adverse Event|2
5630862|NCT00701103|19447863|P9|Overall Study|Adverse Event|0
5630863|NCT00701103|19447864|P8|Overall Study|Adverse Event|0
5630864|NCT00701103|19447865|P7|Overall Study|Adverse Event|1
5630865|NCT00701103|19447866|P6|Overall Study|Adverse Event|1
5630866|NCT00701103|19447867|P5|Overall Study|Adverse Event|0
5630867|NCT00701103|19447868|P4|Overall Study|Adverse Event|1
5630868|NCT00701103|19447869|P3|Overall Study|Adverse Event|1
5630869|NCT00701103|19447870|P2|Overall Study|Adverse Event|0
5630870|NCT00701103|19447871|P1|Overall Study|Adverse Event|0
5630871|NCT00701090|19447977|P2|Overall Study|Other|12
5630872|NCT00701090|19447978|P1|Overall Study|Other|7
5630873|NCT00701090|19447977|P2|Overall Study|Withdrawal by Subject|16
5630874|NCT00701090|19447978|P1|Overall Study|Withdrawal by Subject|11
5630875|NCT00701090|19447977|P2|Overall Study|Protocol Violation|3
5630876|NCT00701090|19447978|P1|Overall Study|Protocol Violation|2
5630877|NCT00701090|19447977|P2|Overall Study|Physician Decision|4
5630878|NCT00701090|19447978|P1|Overall Study|Physician Decision|3
5630879|NCT00701090|19447977|P2|Overall Study|Lost to Follow-up|9
5630880|NCT00701090|19447978|P1|Overall Study|Lost to Follow-up|9
5630881|NCT00701090|19447977|P2|Overall Study|Lack of Efficacy|4
5630882|NCT00701090|19447978|P1|Overall Study|Lack of Efficacy|5
5630883|NCT00701090|19447977|P2|Overall Study|Death|1
5630884|NCT00701090|19447978|P1|Overall Study|Death|0
5630885|NCT00701090|19447977|P2|Overall Study|Adverse Event|2
5630886|NCT00701090|19447978|P1|Overall Study|Adverse Event|11
5630887|NCT00701064|19447996|P2|Overall Study|initiated other PTSD treatment|2
5630888|NCT00701064|19447997|P1|Overall Study|initiated other PTSD treatment|2
5630889|NCT00701064|19447996|P2|Overall Study|Withdrawal by Subject|1
5630890|NCT00701064|19447997|P1|Overall Study|Withdrawal by Subject|1
5630891|NCT00701064|19447996|P2|Overall Study|Protocol Violation|1
5630892|NCT00701064|19447997|P1|Overall Study|Protocol Violation|1
5630893|NCT00701051|19448009|P3|Exercise Intervention|time conflict; non-study related illness|3
5630894|NCT00701051|19448010|P2|Exercise Intervention|time conflict; non-study related illness|5
5630895|NCT00701051|19448011|P1|Exercise Intervention|time conflict; non-study related illness|0
5630896|NCT00701051|19448009|P3|Screening|Time conflicts|0
5630897|NCT00701051|19448010|P2|Screening|Time conflicts|0
5630898|NCT00701051|19448011|P1|Screening|Time conflicts|19
5630899|NCT00701051|19448009|P3|Screening|Failed Screening|0
5630900|NCT00701051|19448010|P2|Screening|Failed Screening|0
5630901|NCT00701051|19448011|P1|Screening|Failed Screening|40
5630902|NCT00701038|19448029|P2|Overall Study|study amended pilot group of patients|4
5630903|NCT00701038|19448030|P1|Overall Study|study amended pilot group of patients|4
5630904|NCT00700999|19448038|P2|Overall Study|Withdrawal by Subject|1
5630905|NCT00700999|19448039|P1|Overall Study|Withdrawal by Subject|8
5630906|NCT00700999|19448038|P2|Overall Study|Excluded - did not meet study criteria|1
5630907|NCT00700999|19448039|P1|Overall Study|Excluded - did not meet study criteria|0
5630908|NCT00700999|19448038|P2|Overall Study|Lost to Follow-up|7
5630909|NCT00700999|19448039|P1|Overall Study|Lost to Follow-up|7
5630910|NCT00700882|19448054|P1|Overall Study|No KIT mutation|51
5630911|NCT00700882|19448054|P1|Overall Study|Ineligible|2
5630912|NCT00700882|19448054|P1|Overall Study|Never received treatment|6
5630913|NCT00700817|19448063|P5|Week 52-78 (Extension Period 2)|Unclassified|1
5630914|NCT00700817|19448064|P4|Week 52-78 (Extension Period 2)|Unclassified|0
5630915|NCT00700817|19448065|P3|Week 52-78 (Extension Period 2)|Unclassified|0
5630916|NCT00700817|19448066|P2|Week 52-78 (Extension Period 2)|Unclassified|4
5630917|NCT00700817|19448067|P1|Week 52-78 (Extension Period 2)|Unclassified|2
5630918|NCT00700817|19448063|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
5630919|NCT00700817|19448064|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
5630920|NCT00700817|19448065|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
5630921|NCT00700817|19448066|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
5630922|NCT00700817|19448067|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
5630923|NCT00700817|19448063|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
5630924|NCT00700817|19448064|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
5630925|NCT00700817|19448065|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
5630926|NCT00700817|19448066|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
5630927|NCT00700817|19448067|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
5630928|NCT00700817|19448063|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
5630929|NCT00700817|19448064|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
5630930|NCT00700817|19448065|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
5630931|NCT00700817|19448066|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
5630932|NCT00700817|19448067|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
5630933|NCT00700817|19448063|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
5630934|NCT00700817|19448064|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
5630935|NCT00700817|19448065|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
5630936|NCT00700817|19448066|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
5630937|NCT00700817|19448067|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
5630938|NCT00700817|19448063|P5|Week 26-52 (Extension Period 1)|Unclassified|0
5630939|NCT00700817|19448064|P4|Week 26-52 (Extension Period 1)|Unclassified|0
5630940|NCT00700817|19448065|P3|Week 26-52 (Extension Period 1)|Unclassified|1
5630941|NCT00700817|19448066|P2|Week 26-52 (Extension Period 1)|Unclassified|3
5630942|NCT00700817|19448067|P1|Week 26-52 (Extension Period 1)|Unclassified|4
5630943|NCT00700817|19448063|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
5630944|NCT00700817|19448064|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
5630945|NCT00700817|19448065|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
5630946|NCT00700817|19448066|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
5630947|NCT00700817|19448067|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
5630948|NCT00700817|19448063|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
5630949|NCT00700817|19448064|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
5630950|NCT00700817|19448065|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
5630951|NCT00700817|19448066|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
5630952|NCT00700817|19448067|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
5630953|NCT00700817|19448063|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
5630954|NCT00700817|19448064|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
5630955|NCT00700817|19448065|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
5630956|NCT00700817|19448066|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
5630957|NCT00700817|19448067|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
5630958|NCT00700817|19448063|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
5630959|NCT00700817|19448064|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
5630960|NCT00700817|19448065|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
5630961|NCT00700817|19448066|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
5630962|NCT00700817|19448067|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
5630963|NCT00700817|19448063|P5|Week 0-26 (Main Period)|Unclassified|0
5630964|NCT00700817|19448064|P4|Week 0-26 (Main Period)|Unclassified|0
5630965|NCT00700817|19448065|P3|Week 0-26 (Main Period)|Unclassified|8
5630966|NCT00700817|19448066|P2|Week 0-26 (Main Period)|Unclassified|4
5630967|NCT00700817|19448067|P1|Week 0-26 (Main Period)|Unclassified|14
5630968|NCT00700817|19448063|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
5630969|NCT00700817|19448064|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
5630970|NCT00700817|19448065|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
5630971|NCT00700817|19448066|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
5630972|NCT00700817|19448067|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
5630973|NCT00700817|19448063|P5|Week 0-26 (Main Period)|Protocol Violation|0
5630974|NCT00700817|19448064|P4|Week 0-26 (Main Period)|Protocol Violation|0
5630975|NCT00700817|19448065|P3|Week 0-26 (Main Period)|Protocol Violation|4
5630976|NCT00700817|19448066|P2|Week 0-26 (Main Period)|Protocol Violation|4
5630977|NCT00700817|19448067|P1|Week 0-26 (Main Period)|Protocol Violation|14
5630978|NCT00700817|19448063|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
5630979|NCT00700817|19448064|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
5630980|NCT00700817|19448065|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
5630981|NCT00700817|19448066|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
5630982|NCT00700817|19448067|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
5630983|NCT00700817|19448063|P5|Week 0-26 (Main Period)|Adverse Event|0
5630984|NCT00700817|19448064|P4|Week 0-26 (Main Period)|Adverse Event|0
5630985|NCT00700817|19448065|P3|Week 0-26 (Main Period)|Adverse Event|4
5630986|NCT00700817|19448066|P2|Week 0-26 (Main Period)|Adverse Event|15
5630987|NCT00700817|19448067|P1|Week 0-26 (Main Period)|Adverse Event|14
5630988|NCT00700804|19448449|P2|Overall Study|Loose Stools|1
5630989|NCT00700804|19448450|P1|Overall Study|Loose Stools|1
5630990|NCT00700804|19448449|P2|Overall Study|Protocol Violation|1
5630991|NCT00700804|19448450|P1|Overall Study|Protocol Violation|1
5630992|NCT00700804|19448449|P2|Overall Study|Withdrawal by Subject|2
5630993|NCT00700804|19448450|P1|Overall Study|Withdrawal by Subject|1
5630994|NCT00700752|19448458|P2|First Intervention|Withdrawal by Subject|2
5630995|NCT00700752|19448459|P1|First Intervention|Withdrawal by Subject|0
5630996|NCT00700739|19448467|P2|Overall Study|Lost to Follow-up|4
5630997|NCT00700739|19448468|P1|Overall Study|Lost to Follow-up|4
5630998|NCT00700713|19448507|P3|Overall Study|Withdrawal by Subject|1
5630999|NCT00700713|19448508|P2|Overall Study|Withdrawal by Subject|0
5631000|NCT00700713|19448509|P1|Overall Study|Withdrawal by Subject|0
5631001|NCT00700713|19448507|P3|Overall Study|Protocol Violation|1
5631002|NCT00700713|19448508|P2|Overall Study|Protocol Violation|0
5631003|NCT00700713|19448509|P1|Overall Study|Protocol Violation|1
5631004|NCT00700635|19448526|P3|Overall Study|Withdrawal by Subject|1
5631005|NCT00700635|19448527|P2|Overall Study|Withdrawal by Subject|3
5631006|NCT00700635|19448528|P1|Overall Study|Withdrawal by Subject|7
5631007|NCT00700635|19448526|P3|Overall Study|Protocol Violation|0
5631008|NCT00700635|19448527|P2|Overall Study|Protocol Violation|2
5631009|NCT00700635|19448528|P1|Overall Study|Protocol Violation|2
5631010|NCT00700635|19448526|P3|Overall Study|Lost to Follow-up|0
5631011|NCT00700635|19448527|P2|Overall Study|Lost to Follow-up|3
5631012|NCT00700635|19448528|P1|Overall Study|Lost to Follow-up|1
5631013|NCT00700635|19448526|P3|Overall Study|Adverse Event|0
5631014|NCT00700635|19448527|P2|Overall Study|Adverse Event|0
5631015|NCT00700635|19448528|P1|Overall Study|Adverse Event|1
5631016|NCT00700622|19448550|P2|Overall Study|Other|1
5631017|NCT00700622|19448551|P1|Overall Study|Other|3
5631018|NCT00700622|19448550|P2|Overall Study|Withdrawal by Subject|1
5631019|NCT00700622|19448551|P1|Overall Study|Withdrawal by Subject|4
5631020|NCT00700622|19448550|P2|Overall Study|Protocol Violation|1
5631021|NCT00700622|19448551|P1|Overall Study|Protocol Violation|0
5631022|NCT00700622|19448550|P2|Overall Study|Physician Decision|1
5631023|NCT00700622|19448551|P1|Overall Study|Physician Decision|2
5631024|NCT00700622|19448550|P2|Overall Study|Lost to Follow-up|1
5631025|NCT00700622|19448551|P1|Overall Study|Lost to Follow-up|0
5631026|NCT00700622|19448550|P2|Overall Study|Adverse Event|0
5631027|NCT00700622|19448551|P1|Overall Study|Adverse Event|4
5631028|NCT00700570|19448559|P2|Overall Study|Withdrawal by Subject|6
5631029|NCT00700570|19448560|P1|Overall Study|Withdrawal by Subject|1
5631030|NCT00700570|19448559|P2|Overall Study|Disease Progression|11
5631031|NCT00700570|19448560|P1|Overall Study|Disease Progression|8
5631032|NCT00700570|19448559|P2|Overall Study|Discretion of Investigator or Sponsor|3
5631033|NCT00700570|19448560|P1|Overall Study|Discretion of Investigator or Sponsor|0
5631034|NCT00700570|19448559|P2|Overall Study|Adverse Event|6
5631035|NCT00700570|19448560|P1|Overall Study|Adverse Event|2
5631036|NCT00700427|19448576|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
5631037|NCT00700427|19448577|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
5631038|NCT00700427|19448578|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
5631039|NCT00700427|19448579|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
5631040|NCT00700427|19448580|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
5631041|NCT00700427|19448576|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
5631042|NCT00700427|19448577|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
5631043|NCT00700427|19448578|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
5631044|NCT00700427|19448579|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
5631045|NCT00700427|19448580|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
5631046|NCT00700427|19448576|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
5631047|NCT00700427|19448577|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
5631048|NCT00700427|19448578|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
5631049|NCT00700427|19448579|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
5631050|NCT00700427|19448580|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
5631051|NCT00700427|19448576|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
5631052|NCT00700427|19448577|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
5631053|NCT00700427|19448578|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
5631054|NCT00700427|19448579|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
5631055|NCT00700427|19448580|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
5631056|NCT00700427|19448576|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
5631057|NCT00700427|19448577|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
5631058|NCT00700427|19448578|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
5631059|NCT00700427|19448579|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
5631060|NCT00700427|19448580|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
5631061|NCT00700427|19448576|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
5631062|NCT00700427|19448577|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
5631063|NCT00700427|19448578|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
5631064|NCT00700427|19448579|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
5631065|NCT00700427|19448580|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
5631066|NCT00700427|19448576|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
5631067|NCT00700427|19448577|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
5631068|NCT00700427|19448578|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
5631069|NCT00700427|19448579|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
5631070|NCT00700427|19448580|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
5631071|NCT00700427|19448576|P5|Study Period 4 (Open-Label Extension)|Death|1
5631072|NCT00700427|19448577|P4|Study Period 4 (Open-Label Extension)|Death|0
5631073|NCT00700427|19448578|P3|Study Period 4 (Open-Label Extension)|Death|0
5631074|NCT00700427|19448579|P2|Study Period 4 (Open-Label Extension)|Death|0
5631075|NCT00700427|19448580|P1|Study Period 4 (Open-Label Extension)|Death|0
5631076|NCT00700427|19448576|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
5631077|NCT00700427|19448577|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
5631078|NCT00700427|19448578|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
5631079|NCT00700427|19448579|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
5631080|NCT00700427|19448580|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
5631081|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Death|0
5631082|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Death|0
5631083|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Death|1
5631084|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Death|0
5631085|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Death|0
5631086|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
5631087|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
5631088|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
5631089|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
5631090|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
5631091|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
5631092|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
5631093|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
5631094|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
5631095|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
5631096|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
5631097|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
5631098|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
5631099|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
5631100|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
5631101|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
5631102|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
5631103|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
5631104|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
5631105|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
5631106|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
5631107|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
5631108|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
5631109|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
5631110|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
5631111|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
5631112|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
5631113|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
5631114|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
5631115|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
5631116|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
5631117|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
5631118|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
5631119|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
5631120|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
5631121|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
5631122|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
5631123|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
5631124|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
5631125|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
5631126|NCT00700427|19448576|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
5631127|NCT00700427|19448577|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
5631128|NCT00700427|19448578|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
5631129|NCT00700427|19448579|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
5631130|NCT00700427|19448580|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
5631131|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
5631132|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
5631133|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
5631134|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
5631135|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
5631136|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
5631137|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
5631138|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
5631139|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
5631140|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
5631141|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
5631142|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
5631143|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
5631144|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
5631145|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
5631146|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
5631147|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
5631148|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
5631149|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
5631150|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
5631151|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
5631152|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
5631153|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
5631154|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
5631155|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
5631156|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
5631157|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
5631158|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
5631159|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
5631160|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
5631161|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
5631162|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
5631163|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
5631164|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
5631165|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
5631166|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
5631167|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
5631168|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
5631169|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
5631170|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
5631171|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
5631172|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
5631173|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
5631174|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
5631175|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
5631176|NCT00700427|19448576|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
5631177|NCT00700427|19448577|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
5631178|NCT00700427|19448578|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
5631179|NCT00700427|19448579|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
5631180|NCT00700427|19448580|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
5631181|NCT00700427|19448576|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
5631182|NCT00700427|19448577|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
5631183|NCT00700427|19448578|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
5631184|NCT00700427|19448579|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
5631185|NCT00700427|19448580|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
5631186|NCT00700427|19448576|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
5631187|NCT00700427|19448577|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
5631188|NCT00700427|19448578|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
5631189|NCT00700427|19448579|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
5631190|NCT00700427|19448580|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
5631191|NCT00700427|19448576|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
5631192|NCT00700427|19448577|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
5631193|NCT00700427|19448578|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
5631194|NCT00700427|19448579|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
5631195|NCT00700427|19448580|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
5631196|NCT00700427|19448576|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
5631197|NCT00700427|19448577|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
5631198|NCT00700427|19448578|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
5631199|NCT00700427|19448579|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
5631200|NCT00700427|19448580|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
5631201|NCT00700427|19448576|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
5631202|NCT00700427|19448577|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
5631203|NCT00700427|19448578|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
5631204|NCT00700427|19448579|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
5631205|NCT00700427|19448580|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
5631206|NCT00700427|19448576|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
5631207|NCT00700427|19448577|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
5631208|NCT00700427|19448578|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
5631209|NCT00700427|19448579|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
5631210|NCT00700427|19448580|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
5631211|NCT00700427|19448576|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
5631212|NCT00700427|19448577|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
5631213|NCT00700427|19448578|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
5631214|NCT00700427|19448579|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
5631215|NCT00700427|19448580|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
5631216|NCT00700427|19448576|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
5631217|NCT00700427|19448577|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
5631218|NCT00700427|19448578|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
5631219|NCT00700427|19448579|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
5631220|NCT00700427|19448580|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
5631221|NCT00700427|19448576|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
5631222|NCT00700427|19448577|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
5631223|NCT00700427|19448578|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
5631224|NCT00700427|19448579|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
5631225|NCT00700427|19448580|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
5631226|NCT00700401|19448602|P1|Overall Study|Withdrawal by Subject|2
5631227|NCT00700401|19448602|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
5631228|NCT00700401|19448602|P1|Overall Study|Treatment never started|1
5631229|NCT00700401|19448602|P1|Overall Study|Lost to Follow-up|1
5631230|NCT00700401|19448602|P1|Overall Study|Refused Treatment|2
5631231|NCT00700401|19448602|P1|Overall Study|Adverse Event|5
5631232|NCT00700401|19448602|P1|Overall Study|Detectable HCV RNA after Week 4|82
5631233|NCT00700310|19448626|P4|Overall Study|Randomized, Not Treated|2
5631234|NCT00700310|19448627|P3|Overall Study|Randomized, Not Treated|2
5631235|NCT00700310|19448628|P2|Overall Study|Randomized, Not Treated|0
5631236|NCT00700310|19448629|P1|Overall Study|Randomized, Not Treated|2
5631237|NCT00700310|19448626|P4|Overall Study|Administrative/Other|3
5631238|NCT00700310|19448627|P3|Overall Study|Administrative/Other|1
5631239|NCT00700310|19448628|P2|Overall Study|Administrative/Other|3
5631240|NCT00700310|19448629|P1|Overall Study|Administrative/Other|1
5631241|NCT00700310|19448626|P4|Overall Study|Lack of Efficacy|1
5631242|NCT00700310|19448627|P3|Overall Study|Lack of Efficacy|0
5631243|NCT00700310|19448628|P2|Overall Study|Lack of Efficacy|3
5631244|NCT00700310|19448629|P1|Overall Study|Lack of Efficacy|0
5631245|NCT00700310|19448626|P4|Overall Study|Withdrawal by Subject|8
5631246|NCT00700310|19448627|P3|Overall Study|Withdrawal by Subject|8
5631247|NCT00700310|19448628|P2|Overall Study|Withdrawal by Subject|9
5631248|NCT00700310|19448629|P1|Overall Study|Withdrawal by Subject|8
5631249|NCT00700310|19448626|P4|Overall Study|Lost to Follow-up|1
5631250|NCT00700310|19448627|P3|Overall Study|Lost to Follow-up|0
5631251|NCT00700310|19448628|P2|Overall Study|Lost to Follow-up|1
5631252|NCT00700310|19448629|P1|Overall Study|Lost to Follow-up|4
5631253|NCT00700310|19448626|P4|Overall Study|Adverse Event|11
5631254|NCT00700310|19448627|P3|Overall Study|Adverse Event|5
5631255|NCT00700310|19448628|P2|Overall Study|Adverse Event|10
5631256|NCT00700310|19448629|P1|Overall Study|Adverse Event|6
5631257|NCT00700271|19448649|P2|Overall Study|Lost to Follow-up|2
5631258|NCT00700271|19448650|P1|Overall Study|Lost to Follow-up|2
5631259|NCT00700271|19448649|P2|Overall Study|Withdrawal by Subject|4
5631260|NCT00700271|19448650|P1|Overall Study|Withdrawal by Subject|6
5631261|NCT00700271|19448649|P2|Overall Study|Administrative Reasons|0
5631262|NCT00700271|19448650|P1|Overall Study|Administrative Reasons|1
5631263|NCT00700271|19448649|P2|Overall Study|Protocol Violation|0
5631264|NCT00700271|19448650|P1|Overall Study|Protocol Violation|1
5631265|NCT00700271|19448649|P2|Overall Study|Adverse Event|6
5631266|NCT00700271|19448650|P1|Overall Study|Adverse Event|4
5631267|NCT00700180|19448678|P2|Overall Study|Lost to Follow-up|5
5631268|NCT00700180|19448679|P1|Overall Study|Lost to Follow-up|4
5631269|NCT00700180|19448678|P2|Overall Study|Alive in follow-up|27
5631270|NCT00700180|19448679|P1|Overall Study|Alive in follow-up|46
5631271|NCT00700180|19448678|P2|Overall Study|Alive on treatment|3
5631272|NCT00700180|19448679|P1|Overall Study|Alive on treatment|5
5631273|NCT00700180|19448678|P2|Overall Study|Death|114
5631274|NCT00700180|19448679|P1|Overall Study|Death|99
5631275|NCT00700115|19448708|P2|Overall Study|Lost to Follow-up|1
5631276|NCT00700115|19448709|P1|Overall Study|Lost to Follow-up|0
5631277|NCT00700115|19448708|P2|Overall Study|Withdrawal by Subject|0
5631278|NCT00700115|19448709|P1|Overall Study|Withdrawal by Subject|1
5631279|NCT00700102|19448719|P2|Overall Study|Lost to Follow-up|10
5631280|NCT00700102|19448720|P1|Overall Study|Lost to Follow-up|8
5631281|NCT00700102|19448719|P2|Overall Study|Died|385
5631282|NCT00700102|19448720|P1|Overall Study|Died|394
5631283|NCT00700011|19448859|P2|Overall Study|Death|1
5631284|NCT00700011|19448860|P1|Overall Study|Death|0
5631285|NCT00699998|19448876|P4|Overall Study|Lost to Follow-up|1
5631286|NCT00699998|19448877|P3|Overall Study|Lost to Follow-up|3
5631287|NCT00699998|19448878|P2|Overall Study|Lost to Follow-up|1
5631288|NCT00699998|19448879|P1|Overall Study|Lost to Follow-up|2
5631289|NCT00699998|19448876|P4|Overall Study|Physician Decision|1
5631290|NCT00699998|19448877|P3|Overall Study|Physician Decision|1
5631291|NCT00699998|19448878|P2|Overall Study|Physician Decision|2
5631292|NCT00699998|19448879|P1|Overall Study|Physician Decision|3
5631293|NCT00699998|19448876|P4|Overall Study|Withdrawal by Subject|80
5631294|NCT00699998|19448877|P3|Overall Study|Withdrawal by Subject|202
5631295|NCT00699998|19448878|P2|Overall Study|Withdrawal by Subject|83
5631296|NCT00699998|19448879|P1|Overall Study|Withdrawal by Subject|194
5631297|NCT00699972|19448924|P3|Overall Study|Randomized, Not Treated|1
5631298|NCT00699972|19448925|P2|Overall Study|Randomized, Not Treated|0
5631299|NCT00699972|19448926|P1|Overall Study|Randomized, Not Treated|1
5631300|NCT00699972|19448924|P3|Overall Study|Administrative/Other|4
5631301|NCT00699972|19448925|P2|Overall Study|Administrative/Other|1
5631302|NCT00699972|19448926|P1|Overall Study|Administrative/Other|3
5631303|NCT00699972|19448924|P3|Overall Study|Lack of Efficacy|2
5631304|NCT00699972|19448925|P2|Overall Study|Lack of Efficacy|0
5631305|NCT00699972|19448926|P1|Overall Study|Lack of Efficacy|2
5631306|NCT00699972|19448924|P3|Overall Study|Withdrawal by Subject|4
5631307|NCT00699972|19448925|P2|Overall Study|Withdrawal by Subject|7
5631308|NCT00699972|19448926|P1|Overall Study|Withdrawal by Subject|3
5631309|NCT00699972|19448924|P3|Overall Study|Lost to Follow-up|0
5631310|NCT00699972|19448925|P2|Overall Study|Lost to Follow-up|2
5631311|NCT00699972|19448926|P1|Overall Study|Lost to Follow-up|0
5631312|NCT00699972|19448924|P3|Overall Study|Adverse Event|24
5631313|NCT00699972|19448925|P2|Overall Study|Adverse Event|9
5631314|NCT00699972|19448926|P1|Overall Study|Adverse Event|7
5631315|NCT00699907|19448943|P3|Overall Study|No usable sample|8
5631316|NCT00699907|19448944|P2|Overall Study|No usable sample|9
5631317|NCT00699907|19448945|P1|Overall Study|No usable sample|0
5631318|NCT00699907|19448943|P3|Overall Study|Withdrawal by Subject|0
5631319|NCT00699907|19448944|P2|Overall Study|Withdrawal by Subject|1
5631320|NCT00699907|19448945|P1|Overall Study|Withdrawal by Subject|2
5631321|NCT00699842|19448980|P3|Overall Study|Death|0
5631322|NCT00699842|19448981|P2|Overall Study|Death|1
5631323|NCT00699842|19448982|P1|Overall Study|Death|0
5631324|NCT00699816|19448995|P2|Overall Study|Protocol Violation|3
5631325|NCT00699816|19448996|P1|Overall Study|Protocol Violation|1
5631326|NCT00699751|19449023|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
5631327|NCT00699751|19449024|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
5631328|NCT00699751|19449023|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
5631329|NCT00699751|19449024|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
5631330|NCT00699751|19449023|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
5631331|NCT00699751|19449024|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
5631332|NCT00699751|19449023|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
5631333|NCT00699751|19449024|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
5631334|NCT00699751|19449023|P2|Period 1: Without/Before Drug Switch|Other|20
5631335|NCT00699751|19449024|P1|Period 1: Without/Before Drug Switch|Other|30
5631336|NCT00699751|19449023|P2|Period 1: Without/Before Drug Switch|Subject Request|23
5631337|NCT00699751|19449024|P1|Period 1: Without/Before Drug Switch|Subject Request|43
5631338|NCT00699751|19449023|P2|Period 1: Without/Before Drug Switch|Death|29
5631339|NCT00699751|19449024|P1|Period 1: Without/Before Drug Switch|Death|28
5631340|NCT00699751|19449023|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
5631341|NCT00699751|19449024|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
5631342|NCT00699699|19449109|P1|Overall Study|Individual different reasons|21
5631343|NCT00699699|19449109|P1|Overall Study|Adverse Event|36
5631344|NCT00699660|19449118|P2|Overall Study|missing reports and recording failures|6
5631345|NCT00699660|19449119|P1|Overall Study|missing reports and recording failures|10
5631346|NCT00699660|19449118|P2|Overall Study|Lost to Follow-up|2
5631347|NCT00699660|19449119|P1|Overall Study|Lost to Follow-up|4
5631348|NCT00699608|19449131|P6|Second Intervention|Withdrawal by Subject|0
5631349|NCT00699608|19449132|P5|Second Intervention|Withdrawal by Subject|0
5631350|NCT00699608|19449133|P4|Second Intervention|Withdrawal by Subject|1
5631351|NCT00699608|19449134|P3|Second Intervention|Withdrawal by Subject|0
5631352|NCT00699608|19449135|P2|Second Intervention|Withdrawal by Subject|0
5631353|NCT00699608|19449136|P1|Second Intervention|Withdrawal by Subject|0
5631354|NCT00699608|19449131|P6|Second Intervention|Adverse Event|0
5631355|NCT00699608|19449132|P5|Second Intervention|Adverse Event|0
5631356|NCT00699608|19449133|P4|Second Intervention|Adverse Event|0
5631357|NCT00699608|19449134|P3|Second Intervention|Adverse Event|1
5631358|NCT00699608|19449135|P2|Second Intervention|Adverse Event|0
5631359|NCT00699608|19449136|P1|Second Intervention|Adverse Event|0
5631360|NCT00699608|19449131|P6|First Intervention|Protocol Violation|0
5631361|NCT00699608|19449132|P5|First Intervention|Protocol Violation|1
5631362|NCT00699608|19449133|P4|First Intervention|Protocol Violation|0
5631363|NCT00699608|19449134|P3|First Intervention|Protocol Violation|0
5631364|NCT00699608|19449135|P2|First Intervention|Protocol Violation|0
5631365|NCT00699608|19449136|P1|First Intervention|Protocol Violation|0
5631366|NCT00699608|19449131|P6|First Intervention|Withdrawal by Subject|0
5631367|NCT00699608|19449132|P5|First Intervention|Withdrawal by Subject|0
5631368|NCT00699608|19449133|P4|First Intervention|Withdrawal by Subject|0
5631369|NCT00699608|19449134|P3|First Intervention|Withdrawal by Subject|1
5631370|NCT00699608|19449135|P2|First Intervention|Withdrawal by Subject|0
5631371|NCT00699608|19449136|P1|First Intervention|Withdrawal by Subject|0
5631372|NCT00699582|19449189|P3|Overall Study|Randomized, Not Treated|0
5631373|NCT00699582|19449190|P2|Overall Study|Randomized, Not Treated|1
5631374|NCT00699582|19449191|P1|Overall Study|Randomized, Not Treated|2
5631375|NCT00699582|19449189|P3|Overall Study|Administrative/Other|0
5631376|NCT00699582|19449190|P2|Overall Study|Administrative/Other|3
5631377|NCT00699582|19449191|P1|Overall Study|Administrative/Other|4
5631378|NCT00699582|19449189|P3|Overall Study|Progressive Disease|0
5631379|NCT00699582|19449190|P2|Overall Study|Progressive Disease|0
5631380|NCT00699582|19449191|P1|Overall Study|Progressive Disease|1
5631381|NCT00699582|19449189|P3|Overall Study|Lack of Efficacy|1
5631382|NCT00699582|19449190|P2|Overall Study|Lack of Efficacy|0
5631383|NCT00699582|19449191|P1|Overall Study|Lack of Efficacy|1
5631384|NCT00699582|19449189|P3|Overall Study|Withdrawal by Subject|4
5631385|NCT00699582|19449190|P2|Overall Study|Withdrawal by Subject|7
5631386|NCT00699582|19449191|P1|Overall Study|Withdrawal by Subject|6
5631387|NCT00699582|19449189|P3|Overall Study|Adverse Event|23
5631388|NCT00699582|19449190|P2|Overall Study|Adverse Event|11
5631389|NCT00699582|19449191|P1|Overall Study|Adverse Event|4
5631390|NCT00699413|19449246|P2|Overall Study|Study terminated by sponsor|2
5631391|NCT00699413|19449247|P1|Overall Study|Study terminated by sponsor|4
5631392|NCT00699413|19449246|P2|Overall Study|Withdrawal by Subject|2
5631393|NCT00699413|19449247|P1|Overall Study|Withdrawal by Subject|0
5631394|NCT00699374|19449301|P2|Overall Study|Died 28 days after last dose|9
5631395|NCT00699374|19449302|P1|Overall Study|Died 28 days after last dose|5
5631396|NCT00699374|19449301|P2|Overall Study|Randomized but not treated|2
5631397|NCT00699374|19449302|P1|Overall Study|Randomized but not treated|4
5631398|NCT00699374|19449301|P2|Overall Study|Study terminated by sponsor|28
5631399|NCT00699374|19449302|P1|Overall Study|Study terminated by sponsor|13
5631400|NCT00699374|19449301|P2|Overall Study|Protocol Violation|6
5631401|NCT00699374|19449302|P1|Overall Study|Protocol Violation|2
5631402|NCT00699374|19449301|P2|Overall Study|Other|15
5631403|NCT00699374|19449302|P1|Overall Study|Other|18
5631404|NCT00699374|19449301|P2|Overall Study|Objective progression or relapse|277
5631405|NCT00699374|19449302|P1|Overall Study|Objective progression or relapse|281
5631406|NCT00699374|19449301|P2|Overall Study|Withdrawal by Subject|44
5631407|NCT00699374|19449302|P1|Overall Study|Withdrawal by Subject|34
5631408|NCT00699374|19449301|P2|Overall Study|Lost to Follow-up|5
5631409|NCT00699374|19449302|P1|Overall Study|Lost to Follow-up|3
5631410|NCT00699374|19449301|P2|Overall Study|Global deterioration of health status|8
5631411|NCT00699374|19449302|P1|Overall Study|Global deterioration of health status|7
5631412|NCT00699374|19449301|P2|Overall Study|Adverse Event|67
5631413|NCT00699374|19449302|P1|Overall Study|Adverse Event|70
5631414|NCT00699374|19449301|P2|Overall Study|Death|83
5631415|NCT00699374|19449302|P1|Overall Study|Death|93
5631416|NCT00699348|19449314|P1|Overall Study|Other|5
5631417|NCT00699348|19449314|P1|Overall Study|Renal transplantation|10
5631418|NCT00699348|19449314|P1|Overall Study|Blood transfusion|24
5631419|NCT00699348|19449314|P1|Overall Study|Failure to return|1
5631420|NCT00699348|19449314|P1|Overall Study|Lack of Efficacy|8
5631421|NCT00699348|19449314|P1|Overall Study|Protocol Violation|10
5631422|NCT00699348|19449314|P1|Overall Study|Withdrawal by Subject|11
5631423|NCT00699348|19449314|P1|Overall Study|Adverse Event|15
5631424|NCT00699348|19449314|P1|Overall Study|Death|6
5631425|NCT00699335|19449323|P1|Overall Study|Missing data|52
5631426|NCT00699335|19449323|P1|Overall Study|Combination of multiple reasons|176
5631427|NCT00699283|19449356|P2|Overall Study|AE of unknown type|0
5631428|NCT00699283|19449357|P1|Overall Study|AE of unknown type|1
5631429|NCT00699283|19449356|P2|Overall Study|AE, non-serious non-fatal|1
5631430|NCT00699283|19449357|P1|Overall Study|AE, non-serious non-fatal|8
5631431|NCT00699283|19449356|P2|Overall Study|SAE, non-fatal|1
5631432|NCT00699283|19449357|P1|Overall Study|SAE, non-fatal|1
5631433|NCT00699283|19449356|P2|Overall Study|Other Reason|1
5631434|NCT00699283|19449357|P1|Overall Study|Other Reason|5
5631435|NCT00699283|19449356|P2|Overall Study|Withdrawal by Subject|0
5631436|NCT00699283|19449357|P1|Overall Study|Withdrawal by Subject|1
5631437|NCT00699283|19449356|P2|Overall Study|Lost to Follow-up|0
5631438|NCT00699283|19449357|P1|Overall Study|Lost to Follow-up|2
5631439|NCT00699283|19449356|P2|Overall Study|Lack of Efficacy|5
5631440|NCT00699283|19449357|P1|Overall Study|Lack of Efficacy|15
5631441|NCT00699192|19449370|P3|Overall Study|Protocol Violation|0
5631442|NCT00699192|19449371|P2|Overall Study|Protocol Violation|2
5631443|NCT00699192|19449372|P1|Overall Study|Protocol Violation|2
5631444|NCT00699192|19449370|P3|Overall Study|Administrative problems|1
5631445|NCT00699192|19449371|P2|Overall Study|Administrative problems|3
5631446|NCT00699192|19449372|P1|Overall Study|Administrative problems|1
5631447|NCT00699192|19449370|P3|Overall Study|Withdrawal by Subject|4
5631448|NCT00699192|19449371|P2|Overall Study|Withdrawal by Subject|2
5631449|NCT00699192|19449372|P1|Overall Study|Withdrawal by Subject|3
5631450|NCT00699192|19449370|P3|Overall Study|Lack of Efficacy|1
5631451|NCT00699192|19449371|P2|Overall Study|Lack of Efficacy|0
5631452|NCT00699192|19449372|P1|Overall Study|Lack of Efficacy|0
5631453|NCT00699192|19449370|P3|Overall Study|Abnormal test procedure result(s)|1
5631454|NCT00699192|19449371|P2|Overall Study|Abnormal test procedure result(s)|0
5631455|NCT00699192|19449372|P1|Overall Study|Abnormal test procedure result(s)|0
5631456|NCT00699192|19449370|P3|Overall Study|Adverse Event|3
5631457|NCT00699192|19449371|P2|Overall Study|Adverse Event|4
5631458|NCT00699192|19449372|P1|Overall Study|Adverse Event|9
5631459|NCT00699192|19449370|P3|Overall Study|Missing|1
5631460|NCT00699192|19449371|P2|Overall Study|Missing|1
5631461|NCT00699192|19449372|P1|Overall Study|Missing|1
5631462|NCT00699153|19449394|P2|Overall Study|Travel Problem|0
5631463|NCT00699153|19449395|P1|Overall Study|Travel Problem|1
5631464|NCT00699153|19449394|P2|Overall Study|Protocol Violation|0
5631465|NCT00699153|19449395|P1|Overall Study|Protocol Violation|1
5631466|NCT00699153|19449394|P2|Overall Study|Adverse Event|2
5631467|NCT00699153|19449395|P1|Overall Study|Adverse Event|0
5631468|NCT00699153|19449394|P2|Overall Study|Lost to Follow-up|0
5631469|NCT00699153|19449395|P1|Overall Study|Lost to Follow-up|1
5631470|NCT00698997|19449430|P2|Overall Study|Withdrawal by Subject|27
5631471|NCT00698997|19449431|P1|Overall Study|Withdrawal by Subject|7
5631472|NCT00698997|19449430|P2|Overall Study|Lost to Follow-up|0
5631473|NCT00698997|19449431|P1|Overall Study|Lost to Follow-up|3
5631474|NCT00698932|19449445|P2|Overall Study|Death|0
5631475|NCT00698932|19449446|P1|Overall Study|Death|1
5631476|NCT00698932|19449445|P2|Overall Study|Safety reasons|2
5631477|NCT00698932|19449446|P1|Overall Study|Safety reasons|0
5631478|NCT00698932|19449445|P2|Overall Study|Severe non-compliance to protocol|2
5631479|NCT00698932|19449446|P1|Overall Study|Severe non-compliance to protocol|1
5631480|NCT00698932|19449445|P2|Overall Study|Lost to Follow-up|1
5631481|NCT00698932|19449446|P1|Overall Study|Lost to Follow-up|6
5631482|NCT00698932|19449445|P2|Overall Study|Withdrawal by Subject|23
5631483|NCT00698932|19449446|P1|Overall Study|Withdrawal by Subject|11
5631484|NCT00698932|19449445|P2|Overall Study|Study specific discontinuation criteria|4
5631485|NCT00698932|19449446|P1|Overall Study|Study specific discontinuation criteria|3
5631486|NCT00698932|19449445|P2|Overall Study|Incorrect enrollment|2
5631487|NCT00698932|19449446|P1|Overall Study|Incorrect enrollment|0
5631488|NCT00698932|19449445|P2|Overall Study|Adverse Event|2
5631489|NCT00698932|19449446|P1|Overall Study|Adverse Event|0
5631490|NCT00698841|19449472|P1|Overall Study|Other|2
5631491|NCT00698841|19449472|P1|Overall Study|Study drug toxicity|2
5631492|NCT00698841|19449472|P1|Overall Study|Failure to meet eligibility criteria|2
5631493|NCT00698841|19449472|P1|Overall Study|Disease progression|7
5631494|NCT00698841|19449472|P1|Overall Study|Adverse Event|3
5631495|NCT00698841|19449472|P1|Overall Study|Withdrawal by Subject|2
5631496|NCT00698815|19449486|P3|Overall Study|Did not receive protocol treatment|2
5631497|NCT00698815|19449487|P2|Overall Study|Did not receive protocol treatment|2
5631498|NCT00698815|19449488|P1|Overall Study|Did not receive protocol treatment|1
5631499|NCT00698815|19449486|P3|Overall Study|MD discretion|2
5631500|NCT00698815|19449487|P2|Overall Study|MD discretion|7
5631501|NCT00698815|19449488|P1|Overall Study|MD discretion|2
5631502|NCT00698815|19449486|P3|Overall Study|Withdrawal by Subject|2
5631503|NCT00698815|19449487|P2|Overall Study|Withdrawal by Subject|3
5631504|NCT00698815|19449488|P1|Overall Study|Withdrawal by Subject|6
5631505|NCT00698815|19449486|P3|Overall Study|Death|4
5631506|NCT00698815|19449487|P2|Overall Study|Death|2
5631507|NCT00698815|19449488|P1|Overall Study|Death|1
5631508|NCT00698685|19449505|P1|Overall Study|Off study pre transplant by clinic MD|1
5631509|NCT00698685|19449505|P1|Overall Study|Sister withdrew as donor|1
5631510|NCT00698646|19449513|P3|Overall Study|Administrative problems|1
5631511|NCT00698646|19449514|P2|Overall Study|Administrative problems|0
5631512|NCT00698646|19449515|P1|Overall Study|Administrative problems|1
5631513|NCT00698646|19449513|P3|Overall Study|Lost to Follow-up|2
5631514|NCT00698646|19449514|P2|Overall Study|Lost to Follow-up|0
5631515|NCT00698646|19449515|P1|Overall Study|Lost to Follow-up|0
5631516|NCT00698646|19449513|P3|Overall Study|Withdrawal by Subject|8
5631517|NCT00698646|19449514|P2|Overall Study|Withdrawal by Subject|11
5631518|NCT00698646|19449515|P1|Overall Study|Withdrawal by Subject|10
5631519|NCT00698646|19449513|P3|Overall Study|Protocol Deviation|3
5631520|NCT00698646|19449514|P2|Overall Study|Protocol Deviation|2
5631521|NCT00698646|19449515|P1|Overall Study|Protocol Deviation|6
5631522|NCT00698646|19449513|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
5631523|NCT00698646|19449514|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
5631524|NCT00698646|19449515|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
5631525|NCT00698646|19449513|P3|Overall Study|Adverse Event|8
5631526|NCT00698646|19449514|P2|Overall Study|Adverse Event|7
5631527|NCT00698646|19449515|P1|Overall Study|Adverse Event|8
5631528|NCT00698581|19449540|P2|Overall Study|AE of unknown type|0
5631529|NCT00698581|19449541|P1|Overall Study|AE of unknown type|1
5631530|NCT00698581|19449540|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5631531|NCT00698581|19449541|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5631532|NCT00698581|19449540|P2|Overall Study|AE, non-serious non-fatal|0
5631533|NCT00698581|19449541|P1|Overall Study|AE, non-serious non-fatal|4
5631534|NCT00698581|19449540|P2|Overall Study|SAE, non-fatal|0
5631535|NCT00698581|19449541|P1|Overall Study|SAE, non-fatal|1
5631536|NCT00698581|19449540|P2|Overall Study|Other reason|1
5631537|NCT00698581|19449541|P1|Overall Study|Other reason|9
5631538|NCT00698581|19449540|P2|Overall Study|Withdrawal by Subject|0
5631539|NCT00698581|19449541|P1|Overall Study|Withdrawal by Subject|6
5631540|NCT00698581|19449540|P2|Overall Study|Lack of Efficacy|11
5631541|NCT00698581|19449541|P1|Overall Study|Lack of Efficacy|23
5631542|NCT00698516|19449552|P1|Overall Study|Withdrawal by Subject|3
5631543|NCT00698516|19449552|P1|Overall Study|Study Termination|2
5631544|NCT00698451|19449570|P1|Overall Study|Disease progression|3
5631545|NCT00698451|19449570|P1|Overall Study|Withdrawal by Subject|6
5631546|NCT00698451|19449570|P1|Overall Study|Protocol Violation|6
5631547|NCT00698451|19449570|P1|Overall Study|Physician Decision|2
5631548|NCT00698451|19449570|P1|Overall Study|Adverse Event|22
5631549|NCT00698204|19449577|P2|Overall Study|Withdrawal by Subject|0
5631550|NCT00698204|19449578|P1|Overall Study|Withdrawal by Subject|1
5631551|NCT00698009|19449638|P1|Overall Study|Withdrawal by Subject|1
5631552|NCT00697827|19449644|P2|Overall Study|enrolled but not treated|1
5631553|NCT00697827|19449645|P1|Overall Study|enrolled but not treated|2
5631554|NCT00697788|19449672|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5631555|NCT00697788|19449673|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5631556|NCT00697788|19449674|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5631557|NCT00697788|19449675|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
5631558|NCT00697788|19449676|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5631559|NCT00697788|19449677|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5631560|NCT00697788|19449678|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5631561|NCT00697788|19449679|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
5631562|NCT00697788|19449672|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5631563|NCT00697788|19449673|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5631564|NCT00697788|19449674|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5631565|NCT00697788|19449675|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5631566|NCT00697788|19449676|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5631567|NCT00697788|19449677|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5631568|NCT00697788|19449678|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
5631569|NCT00697788|19449679|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
5631570|NCT00697619|19449734|P2|Overall Study|Adverse Event|6
5631571|NCT00697619|19449735|P1|Overall Study|Adverse Event|4
5631572|NCT00697619|19449734|P2|Overall Study|Lack of Efficacy|2
5631573|NCT00697619|19449735|P1|Overall Study|Lack of Efficacy|2
5631574|NCT00697593|19449741|P1|Overall Study|Suspension of the study by sponsor|12
5631575|NCT00697593|19449741|P1|Overall Study|Lack of Efficacy|3
5631576|NCT00697593|19449741|P1|Overall Study|Protocol Violation|1
5631577|NCT00697593|19449741|P1|Overall Study|Adverse Event|3
5631578|NCT00697515|19449785|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
5631579|NCT00697515|19449786|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
5631580|NCT00697515|19449785|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
5631581|NCT00697515|19449786|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
5631582|NCT00697515|19449785|P2|First Intervention (Crossover Period)|Adverse Event|2
5631583|NCT00697515|19449786|P1|First Intervention (Crossover Period)|Adverse Event|0
5631584|NCT00697515|19449785|P2|First Intervention (Crossover Period)|Natural disaster|9
5631585|NCT00697515|19449786|P1|First Intervention (Crossover Period)|Natural disaster|8
5631586|NCT00697515|19449785|P2|Dose Optimization Period|elevated QTc|0
5631587|NCT00697515|19449786|P1|Dose Optimization Period|elevated QTc|1
5631588|NCT00697515|19449785|P2|Dose Optimization Period|called to active duty|0
5631589|NCT00697515|19449786|P1|Dose Optimization Period|called to active duty|1
5631590|NCT00697515|19449785|P2|Dose Optimization Period|sponsor request|0
5631591|NCT00697515|19449786|P1|Dose Optimization Period|sponsor request|2
5631592|NCT00697515|19449785|P2|Dose Optimization Period|Lost to Follow-up|0
5631593|NCT00697515|19449786|P1|Dose Optimization Period|Lost to Follow-up|2
5631594|NCT00697515|19449785|P2|Dose Optimization Period|Withdrawal by Subject|0
5631595|NCT00697515|19449786|P1|Dose Optimization Period|Withdrawal by Subject|5
5631596|NCT00697515|19449785|P2|Dose Optimization Period|Adverse Event|0
5631597|NCT00697515|19449786|P1|Dose Optimization Period|Adverse Event|4
5631598|NCT00697463|19449814|P1|Overall Study|Withdrawal by Subject|1
5631599|NCT00697346|19449821|P3|Overall Study|Reason not Specified|1
5631600|NCT00697346|19449822|P2|Overall Study|Reason not Specified|0
5631601|NCT00697346|19449823|P1|Overall Study|Reason not Specified|3
5631602|NCT00697346|19449821|P3|Overall Study|Withdrawal by Subject|0
5631603|NCT00697346|19449822|P2|Overall Study|Withdrawal by Subject|2
5631604|NCT00697346|19449823|P1|Overall Study|Withdrawal by Subject|2
5631605|NCT00697346|19449821|P3|Overall Study|Symptomatic Deterioration|0
5631606|NCT00697346|19449822|P2|Overall Study|Symptomatic Deterioration|1
5631607|NCT00697346|19449823|P1|Overall Study|Symptomatic Deterioration|0
5631608|NCT00697346|19449821|P3|Overall Study|Progressive Disease|0
5631609|NCT00697346|19449822|P2|Overall Study|Progressive Disease|18
5631610|NCT00697346|19449823|P1|Overall Study|Progressive Disease|19
5631611|NCT00697346|19449821|P3|Overall Study|Adverse Event|0
5631612|NCT00697346|19449822|P2|Overall Study|Adverse Event|5
5631613|NCT00697346|19449823|P1|Overall Study|Adverse Event|4
5631614|NCT00697255|19449931|P2|Stage 1b|Insufficient ovarian response|1
5631615|NCT00697255|19449932|P1|Stage 1b|Insufficient ovarian response|0
5631616|NCT00697255|19449931|P2|Stage 1b|Not growing of dominant follicle|1
5631617|NCT00697255|19449932|P1|Stage 1b|Not growing of dominant follicle|0
5631618|NCT00697255|19449931|P2|Stage 1a|Not growing of dominant follicle|0
5631619|NCT00697255|19449932|P1|Stage 1a|Not growing of dominant follicle|1
5631620|NCT00697255|19449931|P2|Stage 1a|Multifollicular growth|0
5631621|NCT00697255|19449932|P1|Stage 1a|Multifollicular growth|1
5631622|NCT00697255|19449931|P2|Stage 1a|Insufficient ovarian response|0
5631623|NCT00697255|19449932|P1|Stage 1a|Insufficient ovarian response|1
5631624|NCT00697112|19450020|P1|Overall Study|Did not meet inclusion criteria|1
5631625|NCT00697112|19450020|P1|Overall Study|Lost to Follow-up|1
5631626|NCT00697112|19450020|P1|Overall Study|Adverse Event|8
5631627|NCT00697073|19450044|P1|Overall Study|non compliance and other|6
5631628|NCT00697073|19450044|P1|Overall Study|Pregnancy|1
5631629|NCT00697073|19450044|P1|Overall Study|Withdrawal by Subject|2
5631630|NCT00696878|19450048|P1|Overall Study|Other reason (not specified)|55
5631631|NCT00696878|19450048|P1|Overall Study|Trial stopped|32
5631632|NCT00696878|19450048|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
5631633|NCT00696878|19450048|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
5631634|NCT00696878|19450048|P1|Overall Study|Withdrawal by Subject|87
5631635|NCT00696878|19450048|P1|Overall Study|Adverse Event|8
5631636|NCT00696800|19450122|P2|Overall Study|Not treated|2
5631637|NCT00696800|19450123|P1|Overall Study|Not treated|1
5631638|NCT00696800|19450122|P2|Overall Study|Other Reasons|3
5631639|NCT00696800|19450123|P1|Overall Study|Other Reasons|5
5631640|NCT00696800|19450122|P2|Overall Study|No/too few/bad quality embryos|18
5631641|NCT00696800|19450123|P1|Overall Study|No/too few/bad quality embryos|24
5631642|NCT00696800|19450122|P2|Overall Study|No/abnormal fertilization|13
5631643|NCT00696800|19450123|P1|Overall Study|No/abnormal fertilization|11
5631644|NCT00696800|19450122|P2|Overall Study|No/too few/bad quality oocytes|3
5631645|NCT00696800|19450123|P1|Overall Study|No/too few/bad quality oocytes|4
5631646|NCT00696800|19450122|P2|Overall Study|Too high ovarian response|1
5631647|NCT00696800|19450123|P1|Overall Study|Too high ovarian response|6
5631648|NCT00696800|19450122|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
5631649|NCT00696800|19450123|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
5631650|NCT00696800|19450122|P2|Overall Study|Insufficient ovarian response|1
5631651|NCT00696800|19450123|P1|Overall Study|Insufficient ovarian response|4
5631652|NCT00696800|19450122|P2|Overall Study|Insufficient ovarian response on Day 8|1
5631653|NCT00696800|19450123|P1|Overall Study|Insufficient ovarian response on Day 8|4
5631654|NCT00696800|19450122|P2|Overall Study|Insufficient compliance with medication|1
5631655|NCT00696800|19450123|P1|Overall Study|Insufficient compliance with medication|2
5631656|NCT00696800|19450122|P2|Overall Study|Adverse Event|3
5631657|NCT00696800|19450123|P1|Overall Study|Adverse Event|16
5631658|NCT00696787|19450176|P3|Overall Study|Failed to return|1
5631659|NCT00696787|19450177|P2|Overall Study|Failed to return|3
5631660|NCT00696787|19450178|P1|Overall Study|Failed to return|1
5631661|NCT00696787|19450176|P3|Overall Study|Withdrawal by Subject|2
5631662|NCT00696787|19450177|P2|Overall Study|Withdrawal by Subject|3
5631663|NCT00696787|19450178|P1|Overall Study|Withdrawal by Subject|0
5631664|NCT00696787|19450176|P3|Overall Study|Lost to Follow-up|3
5631665|NCT00696787|19450177|P2|Overall Study|Lost to Follow-up|0
5631666|NCT00696787|19450178|P1|Overall Study|Lost to Follow-up|4
5631667|NCT00696787|19450176|P3|Overall Study|Lack of Efficacy|0
5631668|NCT00696787|19450177|P2|Overall Study|Lack of Efficacy|1
5631669|NCT00696787|19450178|P1|Overall Study|Lack of Efficacy|0
5631670|NCT00696787|19450176|P3|Overall Study|Discontinuation by Sponsor|14
5631671|NCT00696787|19450177|P2|Overall Study|Discontinuation by Sponsor|13
5631672|NCT00696787|19450178|P1|Overall Study|Discontinuation by Sponsor|9
5631673|NCT00696787|19450176|P3|Overall Study|Adverse Event|6
5631674|NCT00696787|19450177|P2|Overall Study|Adverse Event|0
5631675|NCT00696787|19450178|P1|Overall Study|Adverse Event|1
5631676|NCT00696774|19450192|P3|Period III|Lack of Efficacy|0
5631677|NCT00696774|19450193|P2|Period III|Lack of Efficacy|2
5631678|NCT00696774|19450194|P1|Period III|Lack of Efficacy|0
5631679|NCT00696774|19450192|P3|Period III|Sponsor Decision|0
5631680|NCT00696774|19450193|P2|Period III|Sponsor Decision|0
5631681|NCT00696774|19450194|P1|Period III|Sponsor Decision|2
5631682|NCT00696774|19450192|P3|Period III|Withdrawal by Subject|0
5631683|NCT00696774|19450193|P2|Period III|Withdrawal by Subject|2
5631684|NCT00696774|19450194|P1|Period III|Withdrawal by Subject|1
5631685|NCT00696774|19450192|P3|Period III|Protocol Violation|0
5631686|NCT00696774|19450193|P2|Period III|Protocol Violation|1
5631687|NCT00696774|19450194|P1|Period III|Protocol Violation|1
5631688|NCT00696774|19450192|P3|Period III|Lost to Follow-up|0
5631689|NCT00696774|19450193|P2|Period III|Lost to Follow-up|1
5631690|NCT00696774|19450194|P1|Period III|Lost to Follow-up|2
5631691|NCT00696774|19450192|P3|Period III|Adverse Event|0
5631692|NCT00696774|19450193|P2|Period III|Adverse Event|1
5631693|NCT00696774|19450194|P1|Period III|Adverse Event|1
5631694|NCT00696774|19450192|P3|Period II|Lack of Efficacy|2
5631695|NCT00696774|19450193|P2|Period II|Lack of Efficacy|0
5631696|NCT00696774|19450194|P1|Period II|Lack of Efficacy|0
5631697|NCT00696774|19450192|P3|Period II|Sponsor Decision|0
5631698|NCT00696774|19450193|P2|Period II|Sponsor Decision|0
5631699|NCT00696774|19450194|P1|Period II|Sponsor Decision|0
5631700|NCT00696774|19450192|P3|Period II|Withdrawal by Subject|4
5631701|NCT00696774|19450193|P2|Period II|Withdrawal by Subject|0
5631702|NCT00696774|19450194|P1|Period II|Withdrawal by Subject|0
5631703|NCT00696774|19450192|P3|Period II|Protocol Violation|11
5631704|NCT00696774|19450193|P2|Period II|Protocol Violation|0
5631705|NCT00696774|19450194|P1|Period II|Protocol Violation|0
5631706|NCT00696774|19450192|P3|Period II|Lost to Follow-up|4
5631707|NCT00696774|19450193|P2|Period II|Lost to Follow-up|0
5631708|NCT00696774|19450194|P1|Period II|Lost to Follow-up|0
5631709|NCT00696774|19450192|P3|Period II|Adverse Event|15
5631710|NCT00696774|19450193|P2|Period II|Adverse Event|0
5631711|NCT00696774|19450194|P1|Period II|Adverse Event|0
5631712|NCT00696709|19450254|P5|Overall Study|Adverse Event|0
5631713|NCT00696709|19450255|P4|Overall Study|Adverse Event|1
5631714|NCT00696709|19450256|P3|Overall Study|Adverse Event|0
5631715|NCT00696709|19450257|P2|Overall Study|Adverse Event|0
5631716|NCT00696709|19450258|P1|Overall Study|Adverse Event|0
5631717|NCT00696709|19450254|P5|Overall Study|Lost to Follow-up|0
5631718|NCT00696709|19450255|P4|Overall Study|Lost to Follow-up|0
5631719|NCT00696709|19450256|P3|Overall Study|Lost to Follow-up|0
5631720|NCT00696709|19450257|P2|Overall Study|Lost to Follow-up|1
5631721|NCT00696709|19450258|P1|Overall Study|Lost to Follow-up|1
5631722|NCT00696709|19450254|P5|Overall Study|Protocol Violation|0
5631723|NCT00696709|19450255|P4|Overall Study|Protocol Violation|0
5631724|NCT00696709|19450256|P3|Overall Study|Protocol Violation|0
5631725|NCT00696709|19450257|P2|Overall Study|Protocol Violation|0
5631726|NCT00696709|19450258|P1|Overall Study|Protocol Violation|1
5631727|NCT00696709|19450254|P5|Overall Study|Withdrawal by Subject|3
5631728|NCT00696709|19450255|P4|Overall Study|Withdrawal by Subject|4
5631729|NCT00696709|19450256|P3|Overall Study|Withdrawal by Subject|1
5631730|NCT00696709|19450257|P2|Overall Study|Withdrawal by Subject|2
5631731|NCT00696709|19450258|P1|Overall Study|Withdrawal by Subject|1
5631732|NCT00696696|19450294|P1|Overall Study|Death|3
5631733|NCT00696696|19450294|P1|Overall Study|Physician Decision|2
5631734|NCT00696696|19450294|P1|Overall Study|Withdrawal by Subject|8
5631735|NCT00696696|19450294|P1|Overall Study|Adverse Event|5
5631736|NCT00696657|19450309|P9|Overall Study|Adverse Event|5
5631737|NCT00696657|19450310|P8|Overall Study|Adverse Event|2
5631738|NCT00696657|19450311|P7|Overall Study|Adverse Event|14
5631739|NCT00696657|19450312|P6|Overall Study|Adverse Event|9
5631740|NCT00696657|19450313|P5|Overall Study|Adverse Event|6
5631741|NCT00696657|19450314|P4|Overall Study|Adverse Event|7
5631742|NCT00696657|19450315|P3|Overall Study|Adverse Event|3
5631743|NCT00696657|19450316|P2|Overall Study|Adverse Event|0
5631744|NCT00696657|19450317|P1|Overall Study|Adverse Event|0
5631745|NCT00696657|19450309|P9|Overall Study|Unclassified|1
5631746|NCT00696657|19450310|P8|Overall Study|Unclassified|0
5631747|NCT00696657|19450311|P7|Overall Study|Unclassified|0
5631748|NCT00696657|19450312|P6|Overall Study|Unclassified|2
5631749|NCT00696657|19450313|P5|Overall Study|Unclassified|4
5631750|NCT00696657|19450314|P4|Overall Study|Unclassified|2
5631751|NCT00696657|19450315|P3|Overall Study|Unclassified|3
5631752|NCT00696657|19450316|P2|Overall Study|Unclassified|1
5631753|NCT00696657|19450317|P1|Overall Study|Unclassified|0
5631754|NCT00696657|19450309|P9|Overall Study|Withdrawal criteria|2
5631755|NCT00696657|19450310|P8|Overall Study|Withdrawal criteria|1
5631756|NCT00696657|19450311|P7|Overall Study|Withdrawal criteria|1
5631757|NCT00696657|19450312|P6|Overall Study|Withdrawal criteria|0
5631758|NCT00696657|19450313|P5|Overall Study|Withdrawal criteria|0
5631759|NCT00696657|19450314|P4|Overall Study|Withdrawal criteria|2
5631760|NCT00696657|19450315|P3|Overall Study|Withdrawal criteria|2
5631761|NCT00696657|19450316|P2|Overall Study|Withdrawal criteria|3
5631762|NCT00696657|19450317|P1|Overall Study|Withdrawal criteria|1
5631763|NCT00696657|19450309|P9|Overall Study|Lack of Efficacy|0
5631764|NCT00696657|19450310|P8|Overall Study|Lack of Efficacy|0
5631765|NCT00696657|19450311|P7|Overall Study|Lack of Efficacy|0
5631766|NCT00696657|19450312|P6|Overall Study|Lack of Efficacy|0
5631767|NCT00696657|19450313|P5|Overall Study|Lack of Efficacy|0
5631768|NCT00696657|19450314|P4|Overall Study|Lack of Efficacy|0
5631769|NCT00696657|19450315|P3|Overall Study|Lack of Efficacy|0
5631770|NCT00696657|19450316|P2|Overall Study|Lack of Efficacy|1
5631771|NCT00696657|19450317|P1|Overall Study|Lack of Efficacy|0
5631772|NCT00696657|19450309|P9|Overall Study|Protocol Violation|1
5631773|NCT00696657|19450310|P8|Overall Study|Protocol Violation|0
5631774|NCT00696657|19450311|P7|Overall Study|Protocol Violation|0
5631775|NCT00696657|19450312|P6|Overall Study|Protocol Violation|1
5631776|NCT00696657|19450313|P5|Overall Study|Protocol Violation|0
5631777|NCT00696657|19450314|P4|Overall Study|Protocol Violation|0
5631778|NCT00696657|19450315|P3|Overall Study|Protocol Violation|0
5631779|NCT00696657|19450316|P2|Overall Study|Protocol Violation|0
5631780|NCT00696657|19450317|P1|Overall Study|Protocol Violation|0
5631781|NCT00696436|19450686|P5|Overall Study|Missing|0
5631782|NCT00696436|19450687|P4|Overall Study|Missing|0
5631783|NCT00696436|19450688|P3|Overall Study|Missing|1
5631784|NCT00696436|19450689|P2|Overall Study|Missing|1
5631785|NCT00696436|19450690|P1|Overall Study|Missing|0
5631786|NCT00696436|19450686|P5|Overall Study|Administrative Decision|0
5631787|NCT00696436|19450687|P4|Overall Study|Administrative Decision|0
5631788|NCT00696436|19450688|P3|Overall Study|Administrative Decision|0
5631789|NCT00696436|19450689|P2|Overall Study|Administrative Decision|0
5631790|NCT00696436|19450690|P1|Overall Study|Administrative Decision|1
5631791|NCT00696436|19450686|P5|Overall Study|Participant Non-compliance|0
5631792|NCT00696436|19450687|P4|Overall Study|Participant Non-compliance|2
5631793|NCT00696436|19450688|P3|Overall Study|Participant Non-compliance|1
5631794|NCT00696436|19450689|P2|Overall Study|Participant Non-compliance|0
5631795|NCT00696436|19450690|P1|Overall Study|Participant Non-compliance|0
5631796|NCT00696436|19450686|P5|Overall Study|Administrative Error|0
5631797|NCT00696436|19450687|P4|Overall Study|Administrative Error|0
5631798|NCT00696436|19450688|P3|Overall Study|Administrative Error|2
5631799|NCT00696436|19450689|P2|Overall Study|Administrative Error|0
5631800|NCT00696436|19450690|P1|Overall Study|Administrative Error|2
5631801|NCT00696436|19450686|P5|Overall Study|Participant Unavailability|0
5631802|NCT00696436|19450687|P4|Overall Study|Participant Unavailability|1
5631803|NCT00696436|19450688|P3|Overall Study|Participant Unavailability|2
5631804|NCT00696436|19450689|P2|Overall Study|Participant Unavailability|0
5631805|NCT00696436|19450690|P1|Overall Study|Participant Unavailability|2
5631806|NCT00696436|19450686|P5|Overall Study|Lack of Efficacy|4
5631807|NCT00696436|19450687|P4|Overall Study|Lack of Efficacy|2
5631808|NCT00696436|19450688|P3|Overall Study|Lack of Efficacy|5
5631809|NCT00696436|19450689|P2|Overall Study|Lack of Efficacy|1
5631810|NCT00696436|19450690|P1|Overall Study|Lack of Efficacy|3
5631811|NCT00696436|19450686|P5|Overall Study|Withdrawal by Subject|1
5631812|NCT00696436|19450687|P4|Overall Study|Withdrawal by Subject|7
5631813|NCT00696436|19450688|P3|Overall Study|Withdrawal by Subject|5
5631814|NCT00696436|19450689|P2|Overall Study|Withdrawal by Subject|11
5631815|NCT00696436|19450690|P1|Overall Study|Withdrawal by Subject|4
5631816|NCT00696436|19450686|P5|Overall Study|Lost to Follow-up|3
5631817|NCT00696436|19450687|P4|Overall Study|Lost to Follow-up|4
5631818|NCT00696436|19450688|P3|Overall Study|Lost to Follow-up|2
5631819|NCT00696436|19450689|P2|Overall Study|Lost to Follow-up|6
5631820|NCT00696436|19450690|P1|Overall Study|Lost to Follow-up|1
5631821|NCT00696436|19450686|P5|Overall Study|Protocol Violation|1
5631822|NCT00696436|19450687|P4|Overall Study|Protocol Violation|0
5631823|NCT00696436|19450688|P3|Overall Study|Protocol Violation|2
5631824|NCT00696436|19450689|P2|Overall Study|Protocol Violation|2
5631825|NCT00696436|19450690|P1|Overall Study|Protocol Violation|3
5631826|NCT00696436|19450686|P5|Overall Study|Adverse Event|4
5631827|NCT00696436|19450687|P4|Overall Study|Adverse Event|6
5631828|NCT00696436|19450688|P3|Overall Study|Adverse Event|8
5631829|NCT00696436|19450689|P2|Overall Study|Adverse Event|9
5631830|NCT00696436|19450690|P1|Overall Study|Adverse Event|7
5631831|NCT00696423|19450774|P2|Overall Study|Lost to Follow-up|5
5631832|NCT00696423|19450775|P1|Overall Study|Lost to Follow-up|0
5631833|NCT00696410|19450807|P2|Overall Study|Physician Decision|0
5631834|NCT00696410|19450808|P1|Overall Study|Physician Decision|3
5631835|NCT00696410|19450807|P2|Overall Study|Withdrawal by Subject|0
5631836|NCT00696410|19450808|P1|Overall Study|Withdrawal by Subject|8
5631837|NCT00696410|19450807|P2|Overall Study|Lost to Follow-up|0
5631838|NCT00696410|19450808|P1|Overall Study|Lost to Follow-up|2
5631839|NCT00696384|19450822|P3|Double Blind Phase|Physician Decision|0
5631840|NCT00696384|19450823|P2|Double Blind Phase|Physician Decision|2
5631841|NCT00696384|19450824|P1|Double Blind Phase|Physician Decision|0
5631842|NCT00696384|19450822|P3|Double Blind Phase|Lack of Efficacy|0
5631843|NCT00696384|19450823|P2|Double Blind Phase|Lack of Efficacy|1
5631844|NCT00696384|19450824|P1|Double Blind Phase|Lack of Efficacy|0
5631845|NCT00696384|19450822|P3|Double Blind Phase|Withdrawal by Subject|3
5631846|NCT00696384|19450823|P2|Double Blind Phase|Withdrawal by Subject|4
5631847|NCT00696384|19450824|P1|Double Blind Phase|Withdrawal by Subject|0
5631848|NCT00696384|19450822|P3|Double Blind Phase|Lost to Follow-up|1
5631849|NCT00696384|19450823|P2|Double Blind Phase|Lost to Follow-up|2
5631850|NCT00696384|19450824|P1|Double Blind Phase|Lost to Follow-up|0
5631851|NCT00696384|19450822|P3|Double Blind Phase|Adverse Event|2
5631852|NCT00696384|19450823|P2|Double Blind Phase|Adverse Event|2
5631853|NCT00696384|19450824|P1|Double Blind Phase|Adverse Event|0
5631854|NCT00696384|19450822|P3|Open Label Phase|Physician Decision|0
5631855|NCT00696384|19450823|P2|Open Label Phase|Physician Decision|0
5631856|NCT00696384|19450824|P1|Open Label Phase|Physician Decision|4
5631857|NCT00696384|19450822|P3|Open Label Phase|Lack of Efficacy|0
5631858|NCT00696384|19450823|P2|Open Label Phase|Lack of Efficacy|0
5631859|NCT00696384|19450824|P1|Open Label Phase|Lack of Efficacy|3
5631860|NCT00696384|19450822|P3|Open Label Phase|Other|0
5631861|NCT00696384|19450823|P2|Open Label Phase|Other|0
5631862|NCT00696384|19450824|P1|Open Label Phase|Other|6
5631863|NCT00696384|19450822|P3|Open Label Phase|Withdrawal by Subject|0
5631864|NCT00696384|19450823|P2|Open Label Phase|Withdrawal by Subject|0
5631865|NCT00696384|19450824|P1|Open Label Phase|Withdrawal by Subject|37
5631866|NCT00696384|19450822|P3|Open Label Phase|Lost to Follow-up|0
5631867|NCT00696384|19450823|P2|Open Label Phase|Lost to Follow-up|0
5631868|NCT00696384|19450824|P1|Open Label Phase|Lost to Follow-up|24
5631869|NCT00696384|19450822|P3|Open Label Phase|Protocol Violation|0
5631870|NCT00696384|19450823|P2|Open Label Phase|Protocol Violation|0
5631871|NCT00696384|19450824|P1|Open Label Phase|Protocol Violation|18
5631872|NCT00696384|19450822|P3|Open Label Phase|Adverse Event|0
5631873|NCT00696384|19450823|P2|Open Label Phase|Adverse Event|0
5631874|NCT00696384|19450824|P1|Open Label Phase|Adverse Event|27
5631875|NCT00696241|19450848|P5|Overall Study|Other|1
5631876|NCT00696241|19450849|P4|Overall Study|Other|2
5631877|NCT00696241|19450850|P3|Overall Study|Other|5
5631878|NCT00696241|19450851|P2|Overall Study|Other|1
5631879|NCT00696241|19450852|P1|Overall Study|Other|6
5631880|NCT00696241|19450848|P5|Overall Study|Lack of Efficacy|3
5631881|NCT00696241|19450849|P4|Overall Study|Lack of Efficacy|5
5631882|NCT00696241|19450850|P3|Overall Study|Lack of Efficacy|4
5631883|NCT00696241|19450851|P2|Overall Study|Lack of Efficacy|5
5631884|NCT00696241|19450852|P1|Overall Study|Lack of Efficacy|1
5631885|NCT00696241|19450848|P5|Overall Study|Withdrawal by Subject|0
5631886|NCT00696241|19450849|P4|Overall Study|Withdrawal by Subject|1
5631887|NCT00696241|19450850|P3|Overall Study|Withdrawal by Subject|6
5631888|NCT00696241|19450851|P2|Overall Study|Withdrawal by Subject|8
5631889|NCT00696241|19450852|P1|Overall Study|Withdrawal by Subject|4
5631890|NCT00696241|19450848|P5|Overall Study|Lost to Follow-up|0
5631891|NCT00696241|19450849|P4|Overall Study|Lost to Follow-up|2
5631892|NCT00696241|19450850|P3|Overall Study|Lost to Follow-up|1
5631893|NCT00696241|19450851|P2|Overall Study|Lost to Follow-up|4
5631894|NCT00696241|19450852|P1|Overall Study|Lost to Follow-up|1
5631895|NCT00696241|19450848|P5|Overall Study|Protocol Violation|3
5631896|NCT00696241|19450849|P4|Overall Study|Protocol Violation|0
5631897|NCT00696241|19450850|P3|Overall Study|Protocol Violation|2
5631898|NCT00696241|19450851|P2|Overall Study|Protocol Violation|1
5631899|NCT00696241|19450852|P1|Overall Study|Protocol Violation|1
5631900|NCT00696241|19450848|P5|Overall Study|Adverse Event|5
5631901|NCT00696241|19450849|P4|Overall Study|Adverse Event|4
5631902|NCT00696241|19450850|P3|Overall Study|Adverse Event|6
5631903|NCT00696241|19450851|P2|Overall Study|Adverse Event|3
5631904|NCT00696241|19450852|P1|Overall Study|Adverse Event|11
5631905|NCT00696137|19450934|P1|Overall Study|Withdrawal by Subject|2
5631906|NCT00696072|19450940|P2|Overall Study|Non-specified|2
5631907|NCT00696072|19450941|P1|Overall Study|Non-specified|1
5631908|NCT00696072|19450940|P2|Overall Study|Disease Progression|30
5631909|NCT00696072|19450941|P1|Overall Study|Disease Progression|32
5631910|NCT00696072|19450940|P2|Overall Study|Sponsor Request|1
5631911|NCT00696072|19450941|P1|Overall Study|Sponsor Request|0
5631912|NCT00696072|19450940|P2|Overall Study|Investigator Request|4
5631913|NCT00696072|19450941|P1|Overall Study|Investigator Request|1
5631914|NCT00696072|19450940|P2|Overall Study|Patient Request|7
5631915|NCT00696072|19450941|P1|Overall Study|Patient Request|3
5631916|NCT00696072|19450940|P2|Overall Study|Adverse Event|6
5631917|NCT00696072|19450941|P1|Overall Study|Adverse Event|10
5631918|NCT00696072|19450940|P2|Overall Study|continuing active treatment|13
5631919|NCT00696072|19450941|P1|Overall Study|continuing active treatment|10
5631920|NCT00696020|19450962|P4|Overall Study|Other not stated above|1
5631921|NCT00696020|19450963|P3|Overall Study|Other not stated above|1
5631922|NCT00696020|19450964|P2|Overall Study|Other not stated above|0
5631923|NCT00696020|19450965|P1|Overall Study|Other not stated above|0
5631924|NCT00696020|19450962|P4|Overall Study|Withdrawal by Subject|1
5631925|NCT00696020|19450963|P3|Overall Study|Withdrawal by Subject|0
5631926|NCT00696020|19450964|P2|Overall Study|Withdrawal by Subject|1
5631927|NCT00696020|19450965|P1|Overall Study|Withdrawal by Subject|0
5631928|NCT00696020|19450962|P4|Overall Study|Protocol Violation|1
5631929|NCT00696020|19450963|P3|Overall Study|Protocol Violation|0
5631930|NCT00696020|19450964|P2|Overall Study|Protocol Violation|0
5631931|NCT00696020|19450965|P1|Overall Study|Protocol Violation|0
5631932|NCT00696020|19450962|P4|Overall Study|Lack of Efficacy|0
5631933|NCT00696020|19450963|P3|Overall Study|Lack of Efficacy|0
5631934|NCT00696020|19450964|P2|Overall Study|Lack of Efficacy|0
5631935|NCT00696020|19450965|P1|Overall Study|Lack of Efficacy|1
5631936|NCT00696020|19450962|P4|Overall Study|Adverse Event|1
5631937|NCT00696020|19450963|P3|Overall Study|Adverse Event|2
5631938|NCT00696020|19450964|P2|Overall Study|Adverse Event|1
5631939|NCT00696020|19450965|P1|Overall Study|Adverse Event|3
5631940|NCT00695955|19451073|P1|Cohort 2|Other|5
5631941|NCT00695955|19451073|P1|Cohort 2|Lack of Efficacy|4
5631942|NCT00695955|19451073|P1|Cohort 2|Withdrawal by Subject|28
5631943|NCT00695955|19451073|P1|Cohort 2|Lost to Follow-up|38
5631944|NCT00695955|19451073|P1|Cohort 2|Protocol Violation|5
5631945|NCT00695955|19451073|P1|Cohort 2|Adverse Event|24
5631946|NCT00695955|19451073|P1|Cohort 1|Other|16
5631947|NCT00695955|19451073|P1|Cohort 1|Lack of Efficacy|3
5631948|NCT00695955|19451073|P1|Cohort 1|Withdrawal by Subject|25
5631949|NCT00695955|19451073|P1|Cohort 1|Lost to Follow-up|30
5631950|NCT00695955|19451073|P1|Cohort 1|Protocol Violation|2
5631951|NCT00695955|19451073|P1|Cohort 1|Adverse Event|26
5631952|NCT00695903|19451085|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
5631953|NCT00695903|19451086|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
5631954|NCT00695903|19451085|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
5631955|NCT00695903|19451086|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
5631956|NCT00695903|19451085|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
5631957|NCT00695903|19451086|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
5631958|NCT00695903|19451085|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
5631959|NCT00695903|19451086|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
5631960|NCT00695903|19451085|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
5631961|NCT00695903|19451086|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
5631962|NCT00695903|19451085|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
5631963|NCT00695903|19451086|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
5631964|NCT00695903|19451085|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
5631965|NCT00695903|19451086|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
5631966|NCT00695903|19451085|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
5631967|NCT00695903|19451086|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
5631968|NCT00695903|19451085|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
5631969|NCT00695903|19451086|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
5631970|NCT00695864|19451098|P1|Placebo|Physician Decision|4
5631971|NCT00695864|19451098|P1|Placebo|Withdrawal by Subject|1
5631972|NCT00695669|19451108|P4|Overall Study|Lost to Follow-up|4
5631973|NCT00695669|19451109|P3|Overall Study|Lost to Follow-up|1
5631974|NCT00695669|19451110|P2|Overall Study|Lost to Follow-up|4
5631975|NCT00695669|19451111|P1|Overall Study|Lost to Follow-up|4
5631976|NCT00695669|19451108|P4|Overall Study|Adverse Event|0
5631977|NCT00695669|19451109|P3|Overall Study|Adverse Event|2
5631978|NCT00695669|19451110|P2|Overall Study|Adverse Event|0
5631979|NCT00695669|19451111|P1|Overall Study|Adverse Event|0
5631980|NCT00695565|19451196|P2|Overall Study|Subject did not follow instructions|1
5631981|NCT00695565|19451197|P1|Overall Study|Subject did not follow instructions|1
5631982|NCT00695565|19451196|P2|Overall Study|Lack of Efficacy|1
5631983|NCT00695565|19451197|P1|Overall Study|Lack of Efficacy|1
5631984|NCT00695565|19451196|P2|Overall Study|Withdrawal by Subject|1
5631985|NCT00695565|19451197|P1|Overall Study|Withdrawal by Subject|1
5631986|NCT00695565|19451196|P2|Overall Study|Protocol Violation|1
5631987|NCT00695565|19451197|P1|Overall Study|Protocol Violation|3
5631988|NCT00695565|19451196|P2|Overall Study|Adverse Event|1
5631989|NCT00695565|19451197|P1|Overall Study|Adverse Event|3
5631990|NCT00695565|19451196|P2|Overall Study|Lost to Follow-up|4
5631991|NCT00695565|19451197|P1|Overall Study|Lost to Follow-up|4
5631992|NCT00695396|19451270|P3|Overall Study|Withdrawal by Subject|0
5631993|NCT00695396|19451271|P2|Overall Study|Withdrawal by Subject|2
5631994|NCT00695396|19451272|P1|Overall Study|Withdrawal by Subject|2
5631995|NCT00695396|19451270|P3|Overall Study|Study Closed Prematurely|8
5631996|NCT00695396|19451271|P2|Overall Study|Study Closed Prematurely|6
5631997|NCT00695396|19451272|P1|Overall Study|Study Closed Prematurely|5
5631998|NCT00695318|19451288|P2|Overall Study|Study Terminated|0
5631999|NCT00695318|19451289|P1|Overall Study|Study Terminated|1
5632000|NCT00695318|19451288|P2|Overall Study|Death|1
5632001|NCT00695318|19451289|P1|Overall Study|Death|1
5632002|NCT00695318|19451288|P2|Overall Study|Withdrawal by Subject|0
5632003|NCT00695318|19451289|P1|Overall Study|Withdrawal by Subject|2
5632004|NCT00695318|19451288|P2|Overall Study|Lost to Follow-up|0
5632005|NCT00695318|19451289|P1|Overall Study|Lost to Follow-up|1
5632006|NCT00695136|19451314|P1|Overall Study|unrelated adverse event|1
5632007|NCT00695136|19451314|P1|Overall Study|Withdrawal by Subject|1
5632008|NCT00695019|19451330|P3|Overall Study|Various|4
5632009|NCT00695019|19451331|P2|Overall Study|Various|5
5632010|NCT00695019|19451332|P1|Overall Study|Various|4
5632011|NCT00695019|19451330|P3|Overall Study|Lack of Efficacy|1
5632012|NCT00695019|19451331|P2|Overall Study|Lack of Efficacy|0
5632013|NCT00695019|19451332|P1|Overall Study|Lack of Efficacy|0
5632014|NCT00695019|19451330|P3|Overall Study|Protocol Violation|1
5632015|NCT00695019|19451331|P2|Overall Study|Protocol Violation|3
5632016|NCT00695019|19451332|P1|Overall Study|Protocol Violation|1
5632017|NCT00695019|19451330|P3|Overall Study|Withdrawal by Subject|4
5632018|NCT00695019|19451331|P2|Overall Study|Withdrawal by Subject|6
5632019|NCT00695019|19451332|P1|Overall Study|Withdrawal by Subject|8
5632020|NCT00694707|19451366|P5|Overall Study|Notification of Past Head Injury|0
5632021|NCT00694707|19451367|P4|Overall Study|Notification of Past Head Injury|1
5632022|NCT00694707|19451368|P3|Overall Study|Notification of Past Head Injury|0
5632023|NCT00694707|19451369|P2|Overall Study|Notification of Past Head Injury|0
5632024|NCT00694707|19451370|P1|Overall Study|Notification of Past Head Injury|0
5632025|NCT00694707|19451366|P5|Overall Study|Administrative Reasons|0
5632026|NCT00694707|19451367|P4|Overall Study|Administrative Reasons|2
5632027|NCT00694707|19451368|P3|Overall Study|Administrative Reasons|0
5632028|NCT00694707|19451369|P2|Overall Study|Administrative Reasons|1
5632029|NCT00694707|19451370|P1|Overall Study|Administrative Reasons|0
5632030|NCT00694707|19451366|P5|Overall Study|Arrest by Police|0
5632031|NCT00694707|19451367|P4|Overall Study|Arrest by Police|0
5632032|NCT00694707|19451368|P3|Overall Study|Arrest by Police|0
5632033|NCT00694707|19451369|P2|Overall Study|Arrest by Police|1
5632034|NCT00694707|19451370|P1|Overall Study|Arrest by Police|0
5632035|NCT00694707|19451366|P5|Overall Study|Death in the Family|0
5632036|NCT00694707|19451367|P4|Overall Study|Death in the Family|0
5632037|NCT00694707|19451368|P3|Overall Study|Death in the Family|0
5632038|NCT00694707|19451369|P2|Overall Study|Death in the Family|0
5632039|NCT00694707|19451370|P1|Overall Study|Death in the Family|1
5632040|NCT00694707|19451366|P5|Overall Study|Jeopardizing Parole Status|0
5632041|NCT00694707|19451367|P4|Overall Study|Jeopardizing Parole Status|0
5632042|NCT00694707|19451368|P3|Overall Study|Jeopardizing Parole Status|0
5632043|NCT00694707|19451369|P2|Overall Study|Jeopardizing Parole Status|0
5632044|NCT00694707|19451370|P1|Overall Study|Jeopardizing Parole Status|1
5632045|NCT00694707|19451366|P5|Overall Study|Lost to Follow-up|0
5632046|NCT00694707|19451367|P4|Overall Study|Lost to Follow-up|0
5632047|NCT00694707|19451368|P3|Overall Study|Lost to Follow-up|2
5632048|NCT00694707|19451369|P2|Overall Study|Lost to Follow-up|1
5632049|NCT00694707|19451370|P1|Overall Study|Lost to Follow-up|0
5632050|NCT00694707|19451366|P5|Overall Study|Withdrawal of Consent|15
5632051|NCT00694707|19451367|P4|Overall Study|Withdrawal of Consent|16
5632052|NCT00694707|19451368|P3|Overall Study|Withdrawal of Consent|22
5632053|NCT00694707|19451369|P2|Overall Study|Withdrawal of Consent|18
5632054|NCT00694707|19451370|P1|Overall Study|Withdrawal of Consent|14
5632055|NCT00694707|19451366|P5|Overall Study|Protocol Violation|1
5632056|NCT00694707|19451367|P4|Overall Study|Protocol Violation|3
5632057|NCT00694707|19451368|P3|Overall Study|Protocol Violation|1
5632058|NCT00694707|19451369|P2|Overall Study|Protocol Violation|2
5632059|NCT00694707|19451370|P1|Overall Study|Protocol Violation|1
5632060|NCT00694707|19451366|P5|Overall Study|Insufficient Therapeutic Response|10
5632061|NCT00694707|19451367|P4|Overall Study|Insufficient Therapeutic Response|15
5632062|NCT00694707|19451368|P3|Overall Study|Insufficient Therapeutic Response|17
5632063|NCT00694707|19451369|P2|Overall Study|Insufficient Therapeutic Response|18
5632064|NCT00694707|19451370|P1|Overall Study|Insufficient Therapeutic Response|33
5632065|NCT00694707|19451366|P5|Overall Study|Adverse Event|13
5632066|NCT00694707|19451367|P4|Overall Study|Adverse Event|12
5632067|NCT00694707|19451368|P3|Overall Study|Adverse Event|8
5632068|NCT00694707|19451369|P2|Overall Study|Adverse Event|14
5632069|NCT00694707|19451370|P1|Overall Study|Adverse Event|22
5632070|NCT00694707|19451366|P5|Overall Study|Did Not Receive Treatment|1
5632071|NCT00694707|19451367|P4|Overall Study|Did Not Receive Treatment|1
5632072|NCT00694707|19451368|P3|Overall Study|Did Not Receive Treatment|1
5632073|NCT00694707|19451369|P2|Overall Study|Did Not Receive Treatment|0
5632074|NCT00694707|19451370|P1|Overall Study|Did Not Receive Treatment|0
5632075|NCT00694551|19451399|P3|Overall Study|Disease Progression|1
5632076|NCT00694551|19451400|P2|Overall Study|Disease Progression|0
5632077|NCT00694551|19451401|P1|Overall Study|Disease Progression|1
5632078|NCT00694369|19451430|P5|Overall Study|Withdrawal by Subject|2
5632079|NCT00694369|19451431|P4|Overall Study|Withdrawal by Subject|1
5632080|NCT00694369|19451432|P3|Overall Study|Withdrawal by Subject|1
5632081|NCT00694369|19451433|P2|Overall Study|Withdrawal by Subject|1
5632082|NCT00694369|19451434|P1|Overall Study|Withdrawal by Subject|1
5632083|NCT00694369|19451430|P5|Overall Study|Protocol Violation|0
5632084|NCT00694369|19451431|P4|Overall Study|Protocol Violation|0
5632085|NCT00694369|19451432|P3|Overall Study|Protocol Violation|0
5632086|NCT00694369|19451433|P2|Overall Study|Protocol Violation|1
5632087|NCT00694369|19451434|P1|Overall Study|Protocol Violation|0
5632088|NCT00694369|19451430|P5|Overall Study|Physician Decision|1
5632089|NCT00694369|19451431|P4|Overall Study|Physician Decision|0
5632090|NCT00694369|19451432|P3|Overall Study|Physician Decision|0
5632091|NCT00694369|19451433|P2|Overall Study|Physician Decision|0
5632092|NCT00694369|19451434|P1|Overall Study|Physician Decision|0
5632093|NCT00694369|19451430|P5|Overall Study|Lost to Follow-up|0
5632094|NCT00694369|19451431|P4|Overall Study|Lost to Follow-up|1
5632095|NCT00694369|19451432|P3|Overall Study|Lost to Follow-up|1
5632096|NCT00694369|19451433|P2|Overall Study|Lost to Follow-up|0
5632097|NCT00694369|19451434|P1|Overall Study|Lost to Follow-up|0
5632098|NCT00694369|19451430|P5|Overall Study|Adverse Event|3
5632099|NCT00694369|19451431|P4|Overall Study|Adverse Event|1
5632100|NCT00694369|19451432|P3|Overall Study|Adverse Event|0
5632101|NCT00694369|19451433|P2|Overall Study|Adverse Event|1
5632102|NCT00694369|19451434|P1|Overall Study|Adverse Event|0
5632103|NCT00694356|19451454|P3|Overall Study|Progressive Disease|6
5632104|NCT00694356|19451455|P2|Overall Study|Progressive Disease|6
5632105|NCT00694356|19451456|P1|Overall Study|Progressive Disease|2
5632106|NCT00694356|19451454|P3|Overall Study|Adverse Event|0
5632107|NCT00694356|19451455|P2|Overall Study|Adverse Event|0
5632108|NCT00694356|19451456|P1|Overall Study|Adverse Event|1
5632109|NCT00694304|19451491|P1|Overall Study|Administrative or Other Reasons|32
5632110|NCT00694304|19451491|P1|Overall Study|Lost to Follow-up|15
5632111|NCT00694304|19451491|P1|Overall Study|Withdrawal of Consent|61
5632112|NCT00694304|19451491|P1|Overall Study|Protocol Violation|6
5632113|NCT00694304|19451491|P1|Overall Study|Non-compliance With Study Product|16
5632114|NCT00694304|19451491|P1|Overall Study|Lack of Efficacy|35
5632115|NCT00694304|19451491|P1|Overall Study|Adverse Event|42
5632116|NCT00694161|19451504|P1|Part 2 (After Week 6 up to Month 12)|Death|1
5632117|NCT00694161|19451504|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
5632118|NCT00694161|19451504|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
5632119|NCT00694122|19451543|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
5632120|NCT00694122|19451544|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
5632121|NCT00694122|19451543|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
5632122|NCT00694122|19451544|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
5632123|NCT00694122|19451543|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
5632124|NCT00694122|19451544|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
5632125|NCT00694109|19451560|P1|Overall Study|Consented but no additional treatment|3
5632126|NCT00694109|19451560|P1|Overall Study|Other|2
5632127|NCT00694109|19451560|P1|Overall Study|Enrolled but not treated|1
5632128|NCT00694109|19451560|P1|Overall Study|Pregnancy|1
5632129|NCT00694109|19451560|P1|Overall Study|Withdrawal by Subject|13
5632130|NCT00694109|19451560|P1|Overall Study|Lack of Efficacy|2
5632131|NCT00694109|19451560|P1|Overall Study|Not consent of more 2 years of treatment|18
5632132|NCT00694109|19451560|P1|Overall Study|Adverse Event|74
5632133|NCT00694109|19451560|P1|Overall Study|Physician Decision|3
5632134|NCT00694096|19451584|P1|Overall Study|Withdrawal by Subject|5
5632135|NCT00693784|19451624|P1|Overall Study|Withdrawal by Subject|2
5632136|NCT00693784|19451624|P1|Overall Study|Lost to Follow-up|2
5632137|NCT00693706|19451637|P2|Overall Study|Protocol Violation|1
5632138|NCT00693706|19451638|P1|Overall Study|Protocol Violation|0
5632139|NCT00693693|19451665|P3|Overall Study|Lost to Follow-up|2
5632140|NCT00693693|19451666|P2|Overall Study|Lost to Follow-up|1
5632141|NCT00693693|19451667|P1|Overall Study|Lost to Follow-up|1
5632142|NCT00693472|19451726|P4|Part 2|Withdrew - reason unrelated to treatment|2
5632143|NCT00693472|19451727|P3|Part 2|Withdrew - reason unrelated to treatment|1
5632144|NCT00693472|19451728|P2|Part 2|Withdrew - reason unrelated to treatment|0
5632145|NCT00693472|19451729|P1|Part 2|Withdrew - reason unrelated to treatment|0
5632146|NCT00693472|19451726|P4|Part 2|Adverse Event|0
5632147|NCT00693472|19451727|P3|Part 2|Adverse Event|1
5632148|NCT00693472|19451728|P2|Part 2|Adverse Event|0
5632149|NCT00693472|19451729|P1|Part 2|Adverse Event|0
5632150|NCT00693472|19451726|P4|Part 1|Withdrew - reason unrelated to treatment|0
5632151|NCT00693472|19451727|P3|Part 1|Withdrew - reason unrelated to treatment|0
5632152|NCT00693472|19451728|P2|Part 1|Withdrew - reason unrelated to treatment|2
5632153|NCT00693472|19451729|P1|Part 1|Withdrew - reason unrelated to treatment|5
5632154|NCT00693472|19451726|P4|Part 1|Lost to Follow-up|0
5632155|NCT00693472|19451727|P3|Part 1|Lost to Follow-up|0
5632156|NCT00693472|19451728|P2|Part 1|Lost to Follow-up|1
5632157|NCT00693472|19451729|P1|Part 1|Lost to Follow-up|0
5632158|NCT00693472|19451726|P4|Part 1|Adverse Event|0
5632159|NCT00693472|19451727|P3|Part 1|Adverse Event|0
5632160|NCT00693472|19451728|P2|Part 1|Adverse Event|1
5632161|NCT00693472|19451729|P1|Part 1|Adverse Event|1
5632162|NCT00693420|19451749|P2|Overall Study|Personal Reasons|4
5632163|NCT00693420|19451750|P1|Overall Study|Personal Reasons|1
5632164|NCT00693420|19451749|P2|Overall Study|Sponsor Request - Conflict of Interest|2
5632165|NCT00693420|19451750|P1|Overall Study|Sponsor Request - Conflict of Interest|0
5632166|NCT00693420|19451749|P2|Overall Study|Protocol Violation|2
5632167|NCT00693420|19451750|P1|Overall Study|Protocol Violation|0
5632168|NCT00693420|19451749|P2|Overall Study|Withdrawal by Subject|0
5632169|NCT00693420|19451750|P1|Overall Study|Withdrawal by Subject|1
5632170|NCT00693420|19451749|P2|Overall Study|Lost to Follow-up|3
5632171|NCT00693420|19451750|P1|Overall Study|Lost to Follow-up|0
5632172|NCT00693420|19451749|P2|Overall Study|Adverse Event|4
5632173|NCT00693420|19451750|P1|Overall Study|Adverse Event|4
5632174|NCT00693225|19451789|P2|Overall Study|Adverse Event|3
5632175|NCT00693225|19451790|P1|Overall Study|Adverse Event|1
5632176|NCT00693225|19451789|P2|Overall Study|Lost to Follow-up|2
5632177|NCT00693225|19451790|P1|Overall Study|Lost to Follow-up|1
5632178|NCT00693017|19451813|P2|Overall Study|Death|1
5632179|NCT00693017|19451814|P1|Overall Study|Death|0
5632180|NCT00693017|19451813|P2|Overall Study|Sponsor Decision|1
5632181|NCT00693017|19451814|P1|Overall Study|Sponsor Decision|2
5632182|NCT00692913|19451845|P2|Overall Study|Withdrawal by Subject|20
5632183|NCT00692913|19451846|P1|Overall Study|Withdrawal by Subject|15
5632184|NCT00692913|19451845|P2|Overall Study|Protocol Violation|1
5632185|NCT00692913|19451846|P1|Overall Study|Protocol Violation|1
5632186|NCT00692913|19451845|P2|Overall Study|Physician Decision|0
5632187|NCT00692913|19451846|P1|Overall Study|Physician Decision|2
5632188|NCT00692913|19451845|P2|Overall Study|Lost to Follow-up|5
5632189|NCT00692913|19451846|P1|Overall Study|Lost to Follow-up|3
5632190|NCT00692913|19451845|P2|Overall Study|Adverse Event|4
5632191|NCT00692913|19451846|P1|Overall Study|Adverse Event|8
5632192|NCT00692770|19451868|P2|Overall Study|Randomized but not treated|4
5632193|NCT00692770|19451869|P1|Overall Study|Randomized but not treated|3
5632194|NCT00692770|19451868|P2|Overall Study|Study terminated by sponsor|2
5632195|NCT00692770|19451869|P1|Overall Study|Study terminated by sponsor|2
5632196|NCT00692770|19451868|P2|Overall Study|Clinical endpoint reached|43
5632197|NCT00692770|19451869|P1|Overall Study|Clinical endpoint reached|16
5632198|NCT00692770|19451868|P2|Overall Study|Radiological and clinical progression|8
5632199|NCT00692770|19451869|P1|Overall Study|Radiological and clinical progression|8
5632200|NCT00692770|19451868|P2|Overall Study|Completed all planned assessments|101
5632201|NCT00692770|19451869|P1|Overall Study|Completed all planned assessments|79
5632202|NCT00692770|19451868|P2|Overall Study|Protocol driven decision point|7
5632203|NCT00692770|19451869|P1|Overall Study|Protocol driven decision point|3
5632204|NCT00692770|19451868|P2|Overall Study|Disease progression, recurrence/relapse|279
5632205|NCT00692770|19451869|P1|Overall Study|Disease progression, recurrence/relapse|170
5632206|NCT00692770|19451868|P2|Overall Study|Physician decision not protocol driven|14
5632207|NCT00692770|19451869|P1|Overall Study|Physician decision not protocol driven|10
5632208|NCT00692770|19451868|P2|Overall Study|Progression by clinical judgment|3
5632209|NCT00692770|19451869|P1|Overall Study|Progression by clinical judgment|2
5632210|NCT00692770|19451868|P2|Overall Study|Non-compliant with study medication|5
5632211|NCT00692770|19451869|P1|Overall Study|Non-compliant with study medication|11
5632212|NCT00692770|19451868|P2|Overall Study|Lost to Follow-up|3
5632213|NCT00692770|19451869|P1|Overall Study|Lost to Follow-up|7
5632214|NCT00692770|19451868|P2|Overall Study|Death|5
5632215|NCT00692770|19451869|P1|Overall Study|Death|10
5632216|NCT00692770|19451868|P2|Overall Study|Adverse Event|41
5632217|NCT00692770|19451869|P1|Overall Study|Adverse Event|136
5632218|NCT00692770|19451868|P2|Overall Study|Withdrawal by Subject|36
5632219|NCT00692770|19451869|P1|Overall Study|Withdrawal by Subject|97
5632220|NCT00692770|19451868|P2|Overall Study|Protocol Violation|7
5632221|NCT00692770|19451869|P1|Overall Study|Protocol Violation|2
5632222|NCT00692406|19451915|P1|Overall Study|PI dropped, bad data|57
5632223|NCT00692237|19451986|P2|Overall Study|Adverse Event|1
5632224|NCT00692237|19451987|P1|Overall Study|Adverse Event|0
5632225|NCT00692237|19451986|P2|Overall Study|Withdrawal by Subject|3
5632226|NCT00692237|19451987|P1|Overall Study|Withdrawal by Subject|1
5632227|NCT00692003|19452074|P2|Overall Study|Sponsor Decision|1
5632228|NCT00692003|19452075|P1|Overall Study|Sponsor Decision|5
5632229|NCT00691938|19452090|P7|Overall Study|QTc prolongation|0
5632230|NCT00691938|19452091|P6|Overall Study|QTc prolongation|0
5632231|NCT00691938|19452092|P5|Overall Study|QTc prolongation|0
5632232|NCT00691938|19452093|P4|Overall Study|QTc prolongation|0
5632233|NCT00691938|19452094|P3|Overall Study|QTc prolongation|0
5632234|NCT00691938|19452095|P2|Overall Study|QTc prolongation|0
5632235|NCT00691938|19452096|P1|Overall Study|QTc prolongation|1
5632236|NCT00691704|19452163|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
5632237|NCT00691704|19452163|P1|Two Years of Maintenance Therapy|Physician Decision|4
5632238|NCT00691704|19452163|P1|Two Years of Maintenance Therapy|Disease Progression|8
5632239|NCT00691704|19452163|P1|Induction Therapy|Active Hepatitis|1
5632240|NCT00691704|19452163|P1|Induction Therapy|Disease Progression|1
5632241|NCT00691483|19452224|P2|Overall Study|Randomized by not treated|1
5632242|NCT00691483|19452225|P1|Overall Study|Randomized by not treated|7
5632243|NCT00691483|19452224|P2|Overall Study|Other known cause|1
5632244|NCT00691483|19452225|P1|Overall Study|Other known cause|6
5632245|NCT00691483|19452224|P2|Overall Study|Withdrawal by Subject|7
5632246|NCT00691483|19452225|P1|Overall Study|Withdrawal by Subject|24
5632247|NCT00691483|19452224|P2|Overall Study|Lost to Follow-up|10
5632248|NCT00691483|19452225|P1|Overall Study|Lost to Follow-up|17
5632249|NCT00691483|19452224|P2|Overall Study|Adverse Event|6
5632250|NCT00691483|19452225|P1|Overall Study|Adverse Event|14
5632251|NCT00691301|19452268|P1|Overall Study|Did not initiate study treatment|1
5632252|NCT00691301|19452268|P1|Overall Study|other reason|3
5632253|NCT00691301|19452268|P1|Overall Study|Concurrent illness|2
5632254|NCT00691301|19452268|P1|Overall Study|Withdrawal by Subject|4
5632255|NCT00691301|19452268|P1|Overall Study|Lack of Efficacy|32
5632256|NCT00691301|19452268|P1|Overall Study|Death|2
5632257|NCT00691301|19452268|P1|Overall Study|Adverse Event|10
5632258|NCT00691210|19452288|P8|Overall Study|Lack of Efficacy|0
5632259|NCT00691210|19452289|P7|Overall Study|Lack of Efficacy|0
5632260|NCT00691210|19452290|P6|Overall Study|Lack of Efficacy|1
5632261|NCT00691210|19452291|P5|Overall Study|Lack of Efficacy|0
5632262|NCT00691210|19452292|P4|Overall Study|Lack of Efficacy|1
5632263|NCT00691210|19452293|P3|Overall Study|Lack of Efficacy|0
5632264|NCT00691210|19452294|P2|Overall Study|Lack of Efficacy|0
5632265|NCT00691210|19452295|P1|Overall Study|Lack of Efficacy|0
5632266|NCT00691210|19452288|P8|Overall Study|Progression of Disease|0
5632267|NCT00691210|19452289|P7|Overall Study|Progression of Disease|0
5632268|NCT00691210|19452290|P6|Overall Study|Progression of Disease|0
5632269|NCT00691210|19452291|P5|Overall Study|Progression of Disease|0
5632270|NCT00691210|19452292|P4|Overall Study|Progression of Disease|2
5632271|NCT00691210|19452293|P3|Overall Study|Progression of Disease|0
5632272|NCT00691210|19452294|P2|Overall Study|Progression of Disease|0
5632273|NCT00691210|19452295|P1|Overall Study|Progression of Disease|0
5632274|NCT00691132|19452330|P2|Overall Study|Withdrawal by Subject|10
5632275|NCT00691132|19452331|P1|Overall Study|Withdrawal by Subject|10
5632276|NCT00691132|19452330|P2|Overall Study|Adverse Event|3
5632277|NCT00691132|19452331|P1|Overall Study|Adverse Event|2
5632278|NCT00691093|19452350|P1|Overall Study|Ongoing at Date of Cut-Off|4
5632279|NCT00691093|19452350|P1|Overall Study|Lack of Efficacy|1
5632280|NCT00691093|19452350|P1|Overall Study|Lost to Follow-up|1
5632281|NCT00691093|19452350|P1|Overall Study|Adverse Event|1
5632282|NCT00691054|19452384|P1|Overall Study|Withdrawal by Subject|1
5632283|NCT00691028|19452396|P4|Double-blind Period|not come to a hospital.|0
5632284|NCT00691028|19452397|P3|Double-blind Period|not come to a hospital.|0
5632285|NCT00691028|19452398|P2|Double-blind Period|not come to a hospital.|1
5632286|NCT00691028|19452399|P1|Double-blind Period|not come to a hospital.|0
5632287|NCT00691028|19452396|P4|Double-blind Period|Withdrawal by Subject|0
5632288|NCT00691028|19452397|P3|Double-blind Period|Withdrawal by Subject|1
5632289|NCT00691028|19452398|P2|Double-blind Period|Withdrawal by Subject|0
5632290|NCT00691028|19452399|P1|Double-blind Period|Withdrawal by Subject|1
5632291|NCT00691028|19452396|P4|Double-blind Period|Lack of Efficacy|0
5632292|NCT00691028|19452397|P3|Double-blind Period|Lack of Efficacy|2
5632293|NCT00691028|19452398|P2|Double-blind Period|Lack of Efficacy|3
5632294|NCT00691028|19452399|P1|Double-blind Period|Lack of Efficacy|4
5632295|NCT00691028|19452396|P4|Double-blind Period|Adverse Event|0
5632296|NCT00691028|19452397|P3|Double-blind Period|Adverse Event|6
5632297|NCT00691028|19452398|P2|Double-blind Period|Adverse Event|9
5632298|NCT00691028|19452399|P1|Double-blind Period|Adverse Event|8
5632299|NCT00691028|19452396|P4|Open-label Period|not come to a hospital|1
5632300|NCT00691028|19452397|P3|Open-label Period|not come to a hospital|0
5632301|NCT00691028|19452398|P2|Open-label Period|not come to a hospital|0
5632302|NCT00691028|19452399|P1|Open-label Period|not come to a hospital|0
5632303|NCT00691028|19452396|P4|Open-label Period|Withdrawal by Subject|3
5632304|NCT00691028|19452397|P3|Open-label Period|Withdrawal by Subject|0
5632305|NCT00691028|19452398|P2|Open-label Period|Withdrawal by Subject|0
5632306|NCT00691028|19452399|P1|Open-label Period|Withdrawal by Subject|0
5632307|NCT00691028|19452396|P4|Open-label Period|Adverse Event|16
5632308|NCT00691028|19452397|P3|Open-label Period|Adverse Event|0
5632309|NCT00691028|19452398|P2|Open-label Period|Adverse Event|0
5632310|NCT00691028|19452399|P1|Open-label Period|Adverse Event|0
5632311|NCT00691015|19452432|P1|Overall Study|Refused further treatment|1
5632312|NCT00690898|19452447|P1|TREATMENT|Other (not otherwise specified)|1
5632313|NCT00690898|19452447|P1|TREATMENT|Withdrawal by Subject|4
5632314|NCT00690898|19452447|P1|TREATMENT|Lack of Efficacy|18
5632315|NCT00690898|19452447|P1|TREATMENT|Adverse Event|3
5632316|NCT00690898|19452447|P1|SCREENING|Screen failure|18
5632317|NCT00690820|19452467|P2|Period 1|Withdrawal by Subject|1
5632318|NCT00690820|19452468|P1|Period 1|Withdrawal by Subject|0
5632319|NCT00690794|19452490|P2|Overall Study|Other not specified|3
5632320|NCT00690794|19452491|P1|Overall Study|Other not specified|1
5632321|NCT00690794|19452490|P2|Overall Study|Noncompliance|2
5632322|NCT00690794|19452491|P1|Overall Study|Noncompliance|1
5632323|NCT00690794|19452490|P2|Overall Study|Protocol Violation|7
5632324|NCT00690794|19452491|P1|Overall Study|Protocol Violation|6
5632325|NCT00690794|19452490|P2|Overall Study|Withdrawal by Subject|9
5632326|NCT00690794|19452491|P1|Overall Study|Withdrawal by Subject|0
5632327|NCT00690794|19452490|P2|Overall Study|Lost to Follow-up|4
5632328|NCT00690794|19452491|P1|Overall Study|Lost to Follow-up|1
5632329|NCT00690794|19452490|P2|Overall Study|Adverse Event|10
5632330|NCT00690794|19452491|P1|Overall Study|Adverse Event|12
5632331|NCT00690755|19452506|P7|Overall Study|Physician Decision|0
5632332|NCT00690755|19452507|P6|Overall Study|Physician Decision|4
5632333|NCT00690755|19452508|P5|Overall Study|Physician Decision|0
5632334|NCT00690755|19452509|P4|Overall Study|Physician Decision|5
5632335|NCT00690755|19452510|P3|Overall Study|Physician Decision|46
5632336|NCT00690755|19452511|P2|Overall Study|Physician Decision|0
5632337|NCT00690755|19452512|P1|Overall Study|Physician Decision|2
5632338|NCT00690612|19452528|P1|Overall Study|Withdrawal by Subject|2
5632339|NCT00690612|19452528|P1|Overall Study|Adverse Event|1
5632340|NCT00690573|19452533|P1|Overall Study|Withdrawal by Subject|1
5632341|NCT00690573|19452533|P1|Overall Study|Lack of Efficacy|8
5632342|NCT00690482|19452552|P2|Overall Study|withdrew consent at rand.day|1
5632343|NCT00690482|19452553|P1|Overall Study|withdrew consent at rand.day|0
5632344|NCT00690482|19452552|P2|Overall Study|Intake of prohibited medicine|0
5632345|NCT00690482|19452553|P1|Overall Study|Intake of prohibited medicine|1
5632346|NCT00690482|19452552|P2|Overall Study|Study-specific discontinuation criteria|0
5632347|NCT00690482|19452553|P1|Overall Study|Study-specific discontinuation criteria|1
5632348|NCT00690482|19452552|P2|Overall Study|Incorrect enrolment|1
5632349|NCT00690482|19452553|P1|Overall Study|Incorrect enrolment|0
5632350|NCT00690482|19452552|P2|Overall Study|Adverse Event|1
5632351|NCT00690482|19452553|P1|Overall Study|Adverse Event|2
5632352|NCT00690443|19452587|P2|Overall Study|Adverse Event|2
5632353|NCT00690443|19452588|P1|Overall Study|Adverse Event|1
5632354|NCT00690430|19452598|P3|Extension Phase|Early Termination|3
5632355|NCT00690430|19452599|P2|Extension Phase|Early Termination|1
5632356|NCT00690430|19452600|P1|Extension Phase|Early Termination|10
5632357|NCT00690430|19452598|P3|Extension Phase|Withdrawal by Subject|2
5632358|NCT00690430|19452599|P2|Extension Phase|Withdrawal by Subject|0
5632359|NCT00690430|19452600|P1|Extension Phase|Withdrawal by Subject|0
5632360|NCT00690430|19452598|P3|Extension Phase|Death|1
5632361|NCT00690430|19452599|P2|Extension Phase|Death|1
5632362|NCT00690430|19452600|P1|Extension Phase|Death|1
5632363|NCT00690430|19452598|P3|Extension Phase|Adverse Event|2
5632364|NCT00690430|19452599|P2|Extension Phase|Adverse Event|1
5632365|NCT00690430|19452600|P1|Extension Phase|Adverse Event|2
5632366|NCT00690430|19452598|P3|Extension Phase|Administrative Problems|1
5632367|NCT00690430|19452599|P2|Extension Phase|Administrative Problems|1
5632368|NCT00690430|19452600|P1|Extension Phase|Administrative Problems|0
5632369|NCT00690430|19452598|P3|Extension Phase|Abnormal test procedure results|0
5632370|NCT00690430|19452599|P2|Extension Phase|Abnormal test procedure results|0
5632371|NCT00690430|19452600|P1|Extension Phase|Abnormal test procedure results|1
5632372|NCT00690430|19452598|P3|Extension Phase|Abnormal Lab Values|0
5632373|NCT00690430|19452599|P2|Extension Phase|Abnormal Lab Values|0
5632374|NCT00690430|19452600|P1|Extension Phase|Abnormal Lab Values|1
5632375|NCT00690430|19452598|P3|Extension Phase|Lack of Efficacy|4
5632376|NCT00690430|19452599|P2|Extension Phase|Lack of Efficacy|1
5632377|NCT00690430|19452600|P1|Extension Phase|Lack of Efficacy|3
5632378|NCT00690430|19452598|P3|Core Phase|Early Termination|0
5632379|NCT00690430|19452599|P2|Core Phase|Early Termination|5
5632380|NCT00690430|19452600|P1|Core Phase|Early Termination|0
5632381|NCT00690430|19452598|P3|Core Phase|Administrative Problems|0
5632382|NCT00690430|19452599|P2|Core Phase|Administrative Problems|1
5632383|NCT00690430|19452600|P1|Core Phase|Administrative Problems|0
5632384|NCT00690430|19452598|P3|Core Phase|Lack of Efficacy|0
5632385|NCT00690430|19452599|P2|Core Phase|Lack of Efficacy|10
5632386|NCT00690430|19452600|P1|Core Phase|Lack of Efficacy|8
5632387|NCT00690430|19452598|P3|Core Phase|Subject no longer requires study drug|0
5632388|NCT00690430|19452599|P2|Core Phase|Subject no longer requires study drug|0
5632389|NCT00690430|19452600|P1|Core Phase|Subject no longer requires study drug|1
5632390|NCT00690430|19452598|P3|Core Phase|Withdrawal by Subject|0
5632391|NCT00690430|19452599|P2|Core Phase|Withdrawal by Subject|3
5632392|NCT00690430|19452600|P1|Core Phase|Withdrawal by Subject|3
5632393|NCT00690430|19452598|P3|Core Phase|Protocol Violation|0
5632394|NCT00690430|19452599|P2|Core Phase|Protocol Violation|0
5632395|NCT00690430|19452600|P1|Core Phase|Protocol Violation|1
5632396|NCT00690430|19452598|P3|Core Phase|Death|0
5632397|NCT00690430|19452599|P2|Core Phase|Death|2
5632398|NCT00690430|19452600|P1|Core Phase|Death|0
5632399|NCT00690430|19452598|P3|Core Phase|Adverse Event|0
5632400|NCT00690430|19452599|P2|Core Phase|Adverse Event|1
5632401|NCT00690430|19452600|P1|Core Phase|Adverse Event|5
5632402|NCT00690430|19452598|P3|Core Phase|Abnormal Laboratory value|0
5632403|NCT00690430|19452599|P2|Core Phase|Abnormal Laboratory value|1
5632404|NCT00690430|19452600|P1|Core Phase|Abnormal Laboratory value|0
5632405|NCT00690378|19452629|P2|Overall Study|Social problem|0
5632406|NCT00690378|19452630|P1|Overall Study|Social problem|1
5632407|NCT00690378|19452629|P2|Overall Study|Did not meet inc/exc criteria|11
5632408|NCT00690378|19452630|P1|Overall Study|Did not meet inc/exc criteria|13
5632409|NCT00690378|19452629|P2|Overall Study|Lost to Follow-up|3
5632410|NCT00690378|19452630|P1|Overall Study|Lost to Follow-up|2
5632411|NCT00690378|19452629|P2|Overall Study|Protocol Violation|0
5632412|NCT00690378|19452630|P1|Overall Study|Protocol Violation|1
5632413|NCT00690378|19452629|P2|Overall Study|Withdrawal by Subject|0
5632414|NCT00690378|19452630|P1|Overall Study|Withdrawal by Subject|2
5632415|NCT00690378|19452629|P2|Overall Study|Adverse Event|0
5632416|NCT00690378|19452630|P1|Overall Study|Adverse Event|1
5632417|NCT00689936|19452727|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
5632418|NCT00689936|19452728|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
5632419|NCT00689936|19452729|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
5632420|NCT00689936|19452727|P3|Active Treatment Phase|Miscellaneous|47
5632421|NCT00689936|19452728|P2|Active Treatment Phase|Miscellaneous|34
5632422|NCT00689936|19452729|P1|Active Treatment Phase|Miscellaneous|52
5632423|NCT00689936|19452727|P3|Active Treatment Phase|Study Close Out|21
5632424|NCT00689936|19452728|P2|Active Treatment Phase|Study Close Out|26
5632425|NCT00689936|19452729|P1|Active Treatment Phase|Study Close Out|64
5632426|NCT00689936|19452727|P3|Active Treatment Phase|Protocol Violation|4
5632427|NCT00689936|19452728|P2|Active Treatment Phase|Protocol Violation|2
5632428|NCT00689936|19452729|P1|Active Treatment Phase|Protocol Violation|2
5632429|NCT00689936|19452727|P3|Active Treatment Phase|Lost to Follow-up|2
5632430|NCT00689936|19452728|P2|Active Treatment Phase|Lost to Follow-up|2
5632431|NCT00689936|19452729|P1|Active Treatment Phase|Lost to Follow-up|0
5632432|NCT00689936|19452727|P3|Active Treatment Phase|Death|37
5632433|NCT00689936|19452728|P2|Active Treatment Phase|Death|28
5632434|NCT00689936|19452729|P1|Active Treatment Phase|Death|60
5632435|NCT00689936|19452727|P3|Active Treatment Phase|Withdrawal by Subject|21
5632436|NCT00689936|19452728|P2|Active Treatment Phase|Withdrawal by Subject|16
5632437|NCT00689936|19452729|P1|Active Treatment Phase|Withdrawal by Subject|16
5632438|NCT00689936|19452727|P3|Active Treatment Phase|Disease Progression|339
5632439|NCT00689936|19452728|P2|Active Treatment Phase|Disease Progression|362
5632440|NCT00689936|19452729|P1|Active Treatment Phase|Disease Progression|273
5632441|NCT00689936|19452727|P3|Active Treatment Phase|Adverse Event|76
5632442|NCT00689936|19452728|P2|Active Treatment Phase|Adverse Event|71
5632443|NCT00689936|19452729|P1|Active Treatment Phase|Adverse Event|68
5632444|NCT00689871|19452878|P4|Overall Study|Physician Decision|0
5632445|NCT00689871|19452879|P3|Overall Study|Physician Decision|1
5632446|NCT00689871|19452880|P2|Overall Study|Physician Decision|1
5632447|NCT00689871|19452881|P1|Overall Study|Physician Decision|2
5632448|NCT00689871|19452878|P4|Overall Study|Death|2
5632449|NCT00689871|19452879|P3|Overall Study|Death|2
5632450|NCT00689871|19452880|P2|Overall Study|Death|10
5632451|NCT00689871|19452881|P1|Overall Study|Death|1
5632452|NCT00689871|19452878|P4|Overall Study|Withdrawal by Subject|1
5632453|NCT00689871|19452879|P3|Overall Study|Withdrawal by Subject|4
5632454|NCT00689871|19452880|P2|Overall Study|Withdrawal by Subject|3
5632455|NCT00689871|19452881|P1|Overall Study|Withdrawal by Subject|13
5632456|NCT00689871|19452878|P4|Overall Study|Explanted of All Study Devices|3
5632457|NCT00689871|19452879|P3|Overall Study|Explanted of All Study Devices|29
5632458|NCT00689871|19452880|P2|Overall Study|Explanted of All Study Devices|25
5632459|NCT00689871|19452881|P1|Overall Study|Explanted of All Study Devices|36
5632460|NCT00689871|19452878|P4|Overall Study|Lost to Follow-up|1
5632461|NCT00689871|19452879|P3|Overall Study|Lost to Follow-up|37
5632462|NCT00689871|19452880|P2|Overall Study|Lost to Follow-up|13
5632463|NCT00689871|19452881|P1|Overall Study|Lost to Follow-up|123
5632464|NCT00689793|19452908|P2|Overall Study|Lost to Follow-up|5
5632465|NCT00689793|19452909|P1|Overall Study|Lost to Follow-up|4
5632466|NCT00689728|19452928|P3|Optional Follow-Up|Withdrawal by Subject|3
5632467|NCT00689728|19452929|P2|Optional Follow-Up|Withdrawal by Subject|4
5632468|NCT00689728|19452930|P1|Optional Follow-Up|Withdrawal by Subject|2
5632469|NCT00689728|19452928|P3|Optional Follow-Up|Protocol Violation|1
5632470|NCT00689728|19452929|P2|Optional Follow-Up|Protocol Violation|0
5632471|NCT00689728|19452930|P1|Optional Follow-Up|Protocol Violation|0
5632472|NCT00689728|19452928|P3|Optional Follow-Up|Lost to Follow-up|1
5632473|NCT00689728|19452929|P2|Optional Follow-Up|Lost to Follow-up|1
5632474|NCT00689728|19452930|P1|Optional Follow-Up|Lost to Follow-up|0
5632475|NCT00689728|19452928|P3|Optional Follow-Up|Lack of Efficacy|1
5632476|NCT00689728|19452929|P2|Optional Follow-Up|Lack of Efficacy|1
5632477|NCT00689728|19452930|P1|Optional Follow-Up|Lack of Efficacy|0
5632478|NCT00689728|19452928|P3|Optional Follow-Up|Adverse Event|0
5632479|NCT00689728|19452929|P2|Optional Follow-Up|Adverse Event|0
5632480|NCT00689728|19452930|P1|Optional Follow-Up|Adverse Event|1
5632481|NCT00689728|19452928|P3|Rescue|Withdrawal by Subject|1
5632482|NCT00689728|19452929|P2|Rescue|Withdrawal by Subject|1
5632483|NCT00689728|19452930|P1|Rescue|Withdrawal by Subject|1
5632484|NCT00689728|19452928|P3|Rescue|Adverse Event|0
5632485|NCT00689728|19452929|P2|Rescue|Adverse Event|1
5632486|NCT00689728|19452930|P1|Rescue|Adverse Event|0
5632487|NCT00689728|19452928|P3|Double-Blind Treatment|Lack of Efficacy|2
5632488|NCT00689728|19452929|P2|Double-Blind Treatment|Lack of Efficacy|1
5632489|NCT00689728|19452930|P1|Double-Blind Treatment|Lack of Efficacy|0
5632490|NCT00689728|19452928|P3|Double-Blind Treatment|Withdrawal by Subject|2
5632491|NCT00689728|19452929|P2|Double-Blind Treatment|Withdrawal by Subject|3
5632492|NCT00689728|19452930|P1|Double-Blind Treatment|Withdrawal by Subject|3
5632493|NCT00689728|19452928|P3|Double-Blind Treatment|Protocol Violation|1
5632494|NCT00689728|19452929|P2|Double-Blind Treatment|Protocol Violation|0
5632495|NCT00689728|19452930|P1|Double-Blind Treatment|Protocol Violation|0
5632496|NCT00689728|19452928|P3|Double-Blind Treatment|Adverse Event|0
5632497|NCT00689728|19452929|P2|Double-Blind Treatment|Adverse Event|0
5632498|NCT00689728|19452930|P1|Double-Blind Treatment|Adverse Event|1
5632499|NCT00689611|19453013|P2|Overall Study|Lost to Follow-up|28
5632500|NCT00689611|19453014|P1|Overall Study|Lost to Follow-up|27
5632501|NCT00689611|19453013|P2|Overall Study|Withdrawal by Subject|9
5632502|NCT00689611|19453014|P1|Overall Study|Withdrawal by Subject|8
5632503|NCT00689611|19453013|P2|Overall Study|Death|9
5632504|NCT00689611|19453014|P1|Overall Study|Death|6
5632505|NCT00689481|19453024|P2|Overall Study|Subject early term, left on vacation|1
5632506|NCT00689481|19453025|P1|Overall Study|Subject early term, left on vacation|0
5632507|NCT00689481|19453024|P2|Overall Study|Excluded medication started during study|1
5632508|NCT00689481|19453025|P1|Overall Study|Excluded medication started during study|0
5632509|NCT00689481|19453024|P2|Overall Study|Withdrawal by Subject|4
5632510|NCT00689481|19453025|P1|Overall Study|Withdrawal by Subject|8
5632511|NCT00689481|19453024|P2|Overall Study|Non-compliance with study treatment|1
5632512|NCT00689481|19453025|P1|Overall Study|Non-compliance with study treatment|1
5632513|NCT00689481|19453024|P2|Overall Study|Lack of Efficacy|3
5632514|NCT00689481|19453025|P1|Overall Study|Lack of Efficacy|4
5632515|NCT00689481|19453024|P2|Overall Study|Lost to Follow-up|3
5632516|NCT00689481|19453025|P1|Overall Study|Lost to Follow-up|4
5632517|NCT00689481|19453024|P2|Overall Study|Adverse Event|1
5632518|NCT00689481|19453025|P1|Overall Study|Adverse Event|7
5632519|NCT00689390|19453043|P2|Overall Study|Administrative|0
5632520|NCT00689390|19453044|P1|Overall Study|Administrative|37
5632521|NCT00689390|19453043|P2|Overall Study|Did Not Meet Protocol Eligibility|0
5632522|NCT00689390|19453044|P1|Overall Study|Did Not Meet Protocol Eligibility|1
5632523|NCT00689390|19453043|P2|Overall Study|Non-Compliance With Protocol|0
5632524|NCT00689390|19453044|P1|Overall Study|Non-Compliance With Protocol|21
5632525|NCT00689390|19453043|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
5632526|NCT00689390|19453044|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
5632527|NCT00689390|19453043|P2|Overall Study|Withdrawal by Subject|3
5632528|NCT00689390|19453044|P1|Overall Study|Withdrawal by Subject|117
5632529|NCT00689390|19453043|P2|Overall Study|Lost to Follow-up|7
5632530|NCT00689390|19453044|P1|Overall Study|Lost to Follow-up|179
5632531|NCT00689390|19453043|P2|Overall Study|Adverse Event|0
5632532|NCT00689390|19453044|P1|Overall Study|Adverse Event|19
5632533|NCT00689351|19453062|P2|After Infant Series|Parent/legal guardian request|0
5632534|NCT00689351|19453063|P1|After Infant Series|Parent/legal guardian request|1
5632535|NCT00689351|19453062|P2|Infant Series of Dosing|Lost to Follow-up|1
5632536|NCT00689351|19453063|P1|Infant Series of Dosing|Lost to Follow-up|0
5632537|NCT00689351|19453062|P2|Infant Series of Dosing|Adverse Event|0
5632538|NCT00689351|19453063|P1|Infant Series of Dosing|Adverse Event|1
5632539|NCT00689351|19453062|P2|Infant Series of Dosing|Parent/legal guardian request|0
5632540|NCT00689351|19453063|P1|Infant Series of Dosing|Parent/legal guardian request|5
5632541|NCT00689338|19453095|P1|Overall Study|Protocol Violation|15
5632542|NCT00689338|19453095|P1|Overall Study|Withdrawal by Subject|3
5632543|NCT00689338|19453095|P1|Overall Study|Lost to Follow-up|5
5632544|NCT00689338|19453095|P1|Overall Study|Did not Meet Entrance Criteria|27
5632545|NCT00689338|19453095|P1|Overall Study|Other|8
5632546|NCT00689338|19453095|P1|Overall Study|Lack of Efficacy|6
5632547|NCT00689338|19453095|P1|Overall Study|Insufficient Clinical Response|1
5632548|NCT00689338|19453095|P1|Overall Study|Adverse Event|13
5632549|NCT00689338|19453095|P1|Overall Study|Death|65
5632550|NCT00689299|19453108|P3|Overall Study|Protocol Violation|0
5632551|NCT00689299|19453109|P2|Overall Study|Protocol Violation|0
5632552|NCT00689299|19453110|P1|Overall Study|Protocol Violation|1
5632553|NCT00689299|19453108|P3|Overall Study|Withdrawal by Subject|3
5632554|NCT00689299|19453109|P2|Overall Study|Withdrawal by Subject|1
5632555|NCT00689299|19453110|P1|Overall Study|Withdrawal by Subject|4
5632556|NCT00689299|19453108|P3|Overall Study|Lost to Follow-up|1
5632557|NCT00689299|19453109|P2|Overall Study|Lost to Follow-up|1
5632558|NCT00689299|19453110|P1|Overall Study|Lost to Follow-up|0
5632559|NCT00689299|19453108|P3|Overall Study|Adverse Event|1
5632560|NCT00689299|19453109|P2|Overall Study|Adverse Event|1
5632561|NCT00689299|19453110|P1|Overall Study|Adverse Event|2
5632562|NCT00689221|19453139|P2|Overall Study|Ongoing at cut-off date|36
5632563|NCT00689221|19453140|P1|Overall Study|Ongoing at cut-off date|39
5632564|NCT00689117|19453169|P4|Overall Study|Dispensing Error|0
5632565|NCT00689117|19453170|P3|Overall Study|Dispensing Error|0
5632566|NCT00689117|19453171|P2|Overall Study|Dispensing Error|1
5632567|NCT00689117|19453172|P1|Overall Study|Dispensing Error|0
5632568|NCT00689117|19453169|P4|Overall Study|Personal Reason|0
5632569|NCT00689117|19453170|P3|Overall Study|Personal Reason|0
5632570|NCT00689117|19453171|P2|Overall Study|Personal Reason|1
5632571|NCT00689117|19453172|P1|Overall Study|Personal Reason|0
5632572|NCT00689117|19453169|P4|Overall Study|Patient Withdrew from Study|1
5632573|NCT00689117|19453170|P3|Overall Study|Patient Withdrew from Study|0
5632574|NCT00689117|19453171|P2|Overall Study|Patient Withdrew from Study|0
5632575|NCT00689117|19453172|P1|Overall Study|Patient Withdrew from Study|0
5632576|NCT00689117|19453169|P4|Overall Study|Transportation|0
5632577|NCT00689117|19453170|P3|Overall Study|Transportation|0
5632578|NCT00689117|19453171|P2|Overall Study|Transportation|0
5632579|NCT00689117|19453172|P1|Overall Study|Transportation|1
5632580|NCT00689117|19453169|P4|Overall Study|Fear of Birth Defects|0
5632581|NCT00689117|19453170|P3|Overall Study|Fear of Birth Defects|1
5632582|NCT00689117|19453171|P2|Overall Study|Fear of Birth Defects|0
5632583|NCT00689117|19453172|P1|Overall Study|Fear of Birth Defects|0
5632584|NCT00689117|19453169|P4|Overall Study|Incarceration|0
5632585|NCT00689117|19453170|P3|Overall Study|Incarceration|0
5632586|NCT00689117|19453171|P2|Overall Study|Incarceration|0
5632587|NCT00689117|19453172|P1|Overall Study|Incarceration|2
5632588|NCT00689117|19453169|P4|Overall Study|Pregnancy|2
5632589|NCT00689117|19453170|P3|Overall Study|Pregnancy|0
5632590|NCT00689117|19453171|P2|Overall Study|Pregnancy|2
5632591|NCT00689117|19453172|P1|Overall Study|Pregnancy|0
5632592|NCT00689117|19453169|P4|Overall Study|Use of Prohibitive Medication|0
5632593|NCT00689117|19453170|P3|Overall Study|Use of Prohibitive Medication|3
5632594|NCT00689117|19453171|P2|Overall Study|Use of Prohibitive Medication|1
5632595|NCT00689117|19453172|P1|Overall Study|Use of Prohibitive Medication|2
5632596|NCT00689117|19453169|P4|Overall Study|Change/Discontinuation of Birth Control|0
5632597|NCT00689117|19453170|P3|Overall Study|Change/Discontinuation of Birth Control|1
5632598|NCT00689117|19453171|P2|Overall Study|Change/Discontinuation of Birth Control|1
5632599|NCT00689117|19453172|P1|Overall Study|Change/Discontinuation of Birth Control|1
5632600|NCT00689117|19453169|P4|Overall Study|Non-compliance with Treatment Regimen|0
5632601|NCT00689117|19453170|P3|Overall Study|Non-compliance with Treatment Regimen|0
5632602|NCT00689117|19453171|P2|Overall Study|Non-compliance with Treatment Regimen|1
5632603|NCT00689117|19453172|P1|Overall Study|Non-compliance with Treatment Regimen|0
5632604|NCT00689117|19453169|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5632605|NCT00689117|19453170|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5632606|NCT00689117|19453171|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
5632607|NCT00689117|19453172|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
5632608|NCT00689117|19453169|P4|Overall Study|Unable to Comply with Visit Schedule|1
5632609|NCT00689117|19453170|P3|Overall Study|Unable to Comply with Visit Schedule|1
5632610|NCT00689117|19453171|P2|Overall Study|Unable to Comply with Visit Schedule|0
5632611|NCT00689117|19453172|P1|Overall Study|Unable to Comply with Visit Schedule|0
5632612|NCT00689117|19453169|P4|Overall Study|Withdrawal by Subject|13
5632613|NCT00689117|19453170|P3|Overall Study|Withdrawal by Subject|26
5632614|NCT00689117|19453171|P2|Overall Study|Withdrawal by Subject|18
5632615|NCT00689117|19453172|P1|Overall Study|Withdrawal by Subject|19
5632616|NCT00689117|19453169|P4|Overall Study|Non-Compliance with Study Treatment|1
5632617|NCT00689117|19453170|P3|Overall Study|Non-Compliance with Study Treatment|3
5632618|NCT00689117|19453171|P2|Overall Study|Non-Compliance with Study Treatment|3
5632619|NCT00689117|19453172|P1|Overall Study|Non-Compliance with Study Treatment|3
5632620|NCT00689117|19453169|P4|Overall Study|Lack of Efficacy|2
5632621|NCT00689117|19453170|P3|Overall Study|Lack of Efficacy|2
5632622|NCT00689117|19453171|P2|Overall Study|Lack of Efficacy|2
5632623|NCT00689117|19453172|P1|Overall Study|Lack of Efficacy|1
5632624|NCT00689117|19453169|P4|Overall Study|Lost to Follow-up|11
5632625|NCT00689117|19453170|P3|Overall Study|Lost to Follow-up|17
5632626|NCT00689117|19453171|P2|Overall Study|Lost to Follow-up|19
5632627|NCT00689117|19453172|P1|Overall Study|Lost to Follow-up|26
5632628|NCT00689117|19453169|P4|Overall Study|Adverse Event|0
5632629|NCT00689117|19453170|P3|Overall Study|Adverse Event|5
5632630|NCT00689117|19453171|P2|Overall Study|Adverse Event|0
5632631|NCT00689117|19453172|P1|Overall Study|Adverse Event|6
5632632|NCT00689104|19453202|P4|Overall Study|Non-compliance with study procedures|0
5632633|NCT00689104|19453203|P3|Overall Study|Non-compliance with study procedures|1
5632634|NCT00689104|19453204|P2|Overall Study|Non-compliance with study procedures|0
5632635|NCT00689104|19453205|P1|Overall Study|Non-compliance with study procedures|0
5632636|NCT00689104|19453202|P4|Overall Study|Physician Decision|0
5632637|NCT00689104|19453203|P3|Overall Study|Physician Decision|0
5632638|NCT00689104|19453204|P2|Overall Study|Physician Decision|0
5632639|NCT00689104|19453205|P1|Overall Study|Physician Decision|1
5632640|NCT00689104|19453202|P4|Overall Study|Randomized but never received study drug|0
5632641|NCT00689104|19453203|P3|Overall Study|Randomized but never received study drug|1
5632642|NCT00689104|19453204|P2|Overall Study|Randomized but never received study drug|1
5632643|NCT00689104|19453205|P1|Overall Study|Randomized but never received study drug|2
5632644|NCT00689104|19453202|P4|Overall Study|Protocol Violation|3
5632645|NCT00689104|19453203|P3|Overall Study|Protocol Violation|5
5632646|NCT00689104|19453204|P2|Overall Study|Protocol Violation|3
5632647|NCT00689104|19453205|P1|Overall Study|Protocol Violation|2
5632648|NCT00689104|19453202|P4|Overall Study|Lost to Follow-up|5
5632649|NCT00689104|19453203|P3|Overall Study|Lost to Follow-up|2
5632650|NCT00689104|19453204|P2|Overall Study|Lost to Follow-up|3
5632651|NCT00689104|19453205|P1|Overall Study|Lost to Follow-up|4
5632652|NCT00689104|19453202|P4|Overall Study|Withdrawal by Subject|11
5632653|NCT00689104|19453203|P3|Overall Study|Withdrawal by Subject|18
5632654|NCT00689104|19453204|P2|Overall Study|Withdrawal by Subject|11
5632655|NCT00689104|19453205|P1|Overall Study|Withdrawal by Subject|12
5632656|NCT00689104|19453202|P4|Overall Study|Lack of Efficacy|3
5632657|NCT00689104|19453203|P3|Overall Study|Lack of Efficacy|2
5632658|NCT00689104|19453204|P2|Overall Study|Lack of Efficacy|6
5632659|NCT00689104|19453205|P1|Overall Study|Lack of Efficacy|5
5632660|NCT00689104|19453202|P4|Overall Study|Adverse Event|24
5632661|NCT00689104|19453203|P3|Overall Study|Adverse Event|16
5632662|NCT00689104|19453204|P2|Overall Study|Adverse Event|25
5632663|NCT00689104|19453205|P1|Overall Study|Adverse Event|13
5632664|NCT00689104|19453202|P4|Overall Study|Eligibility criterion not met|4
5632665|NCT00689104|19453203|P3|Overall Study|Eligibility criterion not met|0
5632666|NCT00689104|19453204|P2|Overall Study|Eligibility criterion not met|8
5632667|NCT00689104|19453205|P1|Overall Study|Eligibility criterion not met|5
5632668|NCT00689052|19453411|P2|Overall Study|Early termination of the trial|24
5632669|NCT00689052|19453412|P1|Overall Study|Early termination of the trial|22
5632670|NCT00689052|19453411|P2|Overall Study|Withdrawal by Subject|0
5632671|NCT00689052|19453412|P1|Overall Study|Withdrawal by Subject|2
5632672|NCT00689052|19453411|P2|Overall Study|Lost to Follow-up|0
5632673|NCT00689052|19453412|P1|Overall Study|Lost to Follow-up|2
5632674|NCT00689052|19453411|P2|Overall Study|Protocol Violation|0
5632675|NCT00689052|19453412|P1|Overall Study|Protocol Violation|1
5632676|NCT00689052|19453411|P2|Overall Study|Adverse Event|6
5632677|NCT00689052|19453412|P1|Overall Study|Adverse Event|4
5632678|NCT00689026|19453444|P2|Overall Study|Withdrawal by Subject|6
5632679|NCT00689026|19453445|P1|Overall Study|Withdrawal by Subject|13
5632680|NCT00688870|19453458|P2|Infant Series|Parent or legal guardian request|0
5632681|NCT00688870|19453459|P1|Infant Series|Parent or legal guardian request|4
5632682|NCT00688844|19453491|P1|Overall Study|Lost to Follow-up|10
5632683|NCT00688753|19453501|P1|Overall Study|Lost to Follow-up|3
5632684|NCT00688753|19453501|P1|Overall Study|Protocol Violation|1
5632685|NCT00688753|19453501|P1|Overall Study|Adverse Event|20
5632686|NCT00688753|19453501|P1|Overall Study|Withdrawal by Subject|3
5632687|NCT00688753|19453501|P1|Overall Study|Death|9
5632688|NCT00688753|19453501|P1|Overall Study|Missing|1
5632689|NCT00688753|19453501|P1|Overall Study|Disease progression|55
5632690|NCT00688740|19453512|P2|Overall Study|Violation of Inclusion Criteria|3
5632691|NCT00688740|19453513|P1|Overall Study|Violation of Inclusion Criteria|1
5632692|NCT00688740|19453512|P2|Overall Study|Breast Cancer Relapse|4
5632693|NCT00688740|19453513|P1|Overall Study|Breast Cancer Relapse|1
5632694|NCT00688740|19453512|P2|Overall Study|Consent Withdrawn|17
5632695|NCT00688740|19453513|P1|Overall Study|Consent Withdrawn|17
5632696|NCT00688740|19453512|P2|Overall Study|Lost to Follow-up|1
5632697|NCT00688740|19453513|P1|Overall Study|Lost to Follow-up|0
5632698|NCT00688740|19453512|P2|Overall Study|Death|2
5632699|NCT00688740|19453513|P1|Overall Study|Death|2
5632700|NCT00688740|19453512|P2|Overall Study|Adverse Event|8
5632701|NCT00688740|19453513|P1|Overall Study|Adverse Event|45
5632702|NCT00688701|19453526|P4|Overall Study|Poor compliance to protocol|0
5632703|NCT00688701|19453527|P3|Overall Study|Poor compliance to protocol|1
5632704|NCT00688701|19453528|P2|Overall Study|Poor compliance to protocol|1
5632705|NCT00688701|19453529|P1|Overall Study|Poor compliance to protocol|0
5632706|NCT00688701|19453526|P4|Overall Study|Withdrawal by Subject|8
5632707|NCT00688701|19453527|P3|Overall Study|Withdrawal by Subject|4
5632708|NCT00688701|19453528|P2|Overall Study|Withdrawal by Subject|3
5632709|NCT00688701|19453529|P1|Overall Study|Withdrawal by Subject|3
5632710|NCT00688701|19453526|P4|Overall Study|Lack of Efficacy|0
5632711|NCT00688701|19453527|P3|Overall Study|Lack of Efficacy|0
5632712|NCT00688701|19453528|P2|Overall Study|Lack of Efficacy|1
5632713|NCT00688701|19453529|P1|Overall Study|Lack of Efficacy|0
5632714|NCT00688701|19453526|P4|Overall Study|Adverse Event|3
5632715|NCT00688701|19453527|P3|Overall Study|Adverse Event|5
5632716|NCT00688701|19453528|P2|Overall Study|Adverse Event|0
5632717|NCT00688701|19453529|P1|Overall Study|Adverse Event|1
5632718|NCT00688688|19453570|P3|Overall Study|Violation of exclusion criterion|0
5632719|NCT00688688|19453571|P2|Overall Study|Violation of exclusion criterion|1
5632720|NCT00688688|19453572|P1|Overall Study|Violation of exclusion criterion|0
5632721|NCT00688688|19453570|P3|Overall Study|Site closure|0
5632722|NCT00688688|19453571|P2|Overall Study|Site closure|1
5632723|NCT00688688|19453572|P1|Overall Study|Site closure|0
5632724|NCT00688688|19453570|P3|Overall Study|Taking exclusionary medications|0
5632725|NCT00688688|19453571|P2|Overall Study|Taking exclusionary medications|0
5632726|NCT00688688|19453572|P1|Overall Study|Taking exclusionary medications|1
5632727|NCT00688688|19453570|P3|Overall Study|Non-compliance with study procedures|4
5632728|NCT00688688|19453571|P2|Overall Study|Non-compliance with study procedures|3
5632729|NCT00688688|19453572|P1|Overall Study|Non-compliance with study procedures|5
5632730|NCT00688688|19453570|P3|Overall Study|Randomized but never received study drug|0
5632731|NCT00688688|19453571|P2|Overall Study|Randomized but never received study drug|0
5632732|NCT00688688|19453572|P1|Overall Study|Randomized but never received study drug|1
5632733|NCT00688688|19453570|P3|Overall Study|Protocol Violation|11
5632734|NCT00688688|19453571|P2|Overall Study|Protocol Violation|9
5632735|NCT00688688|19453572|P1|Overall Study|Protocol Violation|6
5632736|NCT00688688|19453570|P3|Overall Study|Lost to Follow-up|7
5632737|NCT00688688|19453571|P2|Overall Study|Lost to Follow-up|7
5632738|NCT00688688|19453572|P1|Overall Study|Lost to Follow-up|14
5632739|NCT00688688|19453570|P3|Overall Study|Withdrawal by Subject|65
5632740|NCT00688688|19453571|P2|Overall Study|Withdrawal by Subject|75
5632741|NCT00688688|19453572|P1|Overall Study|Withdrawal by Subject|66
5632742|NCT00688688|19453570|P3|Overall Study|Lack of Efficacy|45
5632743|NCT00688688|19453571|P2|Overall Study|Lack of Efficacy|25
5632744|NCT00688688|19453572|P1|Overall Study|Lack of Efficacy|34
5632745|NCT00688688|19453570|P3|Overall Study|Adverse Event|50
5632746|NCT00688688|19453571|P2|Overall Study|Adverse Event|51
5632747|NCT00688688|19453572|P1|Overall Study|Adverse Event|52
5632748|NCT00688688|19453570|P3|Overall Study|Eligibility criterion not met|10
5632749|NCT00688688|19453571|P2|Overall Study|Eligibility criterion not met|7
5632750|NCT00688688|19453572|P1|Overall Study|Eligibility criterion not met|7
5632751|NCT00688636|19453674|P2|Overall Study|Adverse Event|1
5632752|NCT00688636|19453675|P1|Overall Study|Adverse Event|2
5632753|NCT00688623|19453689|P1|Overall Study|Protocol Violation|2
5632754|NCT00688623|19453689|P1|Overall Study|disease progression|23
5632755|NCT00688623|19453689|P1|Overall Study|Death|3
5632756|NCT00688623|19453689|P1|Overall Study|Withdrawal by Subject|4
5632757|NCT00688623|19453689|P1|Overall Study|abnormal lab value|1
5632758|NCT00688623|19453689|P1|Overall Study|Adverse Event|22
5632759|NCT00688597|19453703|P3|Overall Study|Physician Decision|0
5632760|NCT00688597|19453704|P2|Overall Study|Physician Decision|0
5632761|NCT00688597|19453705|P1|Overall Study|Physician Decision|1
5632762|NCT00688597|19453703|P3|Overall Study|Adverse Event|0
5632763|NCT00688597|19453704|P2|Overall Study|Adverse Event|0
5632764|NCT00688597|19453705|P1|Overall Study|Adverse Event|2
5632765|NCT00688545|19453718|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
5632766|NCT00688545|19453719|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
5632767|NCT00688545|19453718|P2|Overall Study|Withdrawal by Subject|3
5632768|NCT00688545|19453719|P1|Overall Study|Withdrawal by Subject|2
5632769|NCT00688545|19453718|P2|Overall Study|Insurance/cost of drug|1
5632770|NCT00688545|19453719|P1|Overall Study|Insurance/cost of drug|0
5632771|NCT00688545|19453718|P2|Overall Study|Lost to Follow-up|4
5632772|NCT00688545|19453719|P1|Overall Study|Lost to Follow-up|1
5632773|NCT00688519|19453729|P2|Overall Study|Pregnancy|1
5632774|NCT00688519|19453730|P1|Overall Study|Pregnancy|0
5632775|NCT00688519|19453729|P2|Overall Study|Subject moved out of area|0
5632776|NCT00688519|19453730|P1|Overall Study|Subject moved out of area|1
5632777|NCT00688519|19453729|P2|Overall Study|Investigator decision|0
5632778|NCT00688519|19453730|P1|Overall Study|Investigator decision|1
5632779|NCT00688519|19453729|P2|Overall Study|Subject moved out of state|0
5632780|NCT00688519|19453730|P1|Overall Study|Subject moved out of state|1
5632781|NCT00688519|19453729|P2|Overall Study|Non-compliance|1
5632782|NCT00688519|19453730|P1|Overall Study|Non-compliance|0
5632783|NCT00688519|19453729|P2|Overall Study|Prohibited medication|0
5632784|NCT00688519|19453730|P1|Overall Study|Prohibited medication|1
5632785|NCT00688519|19453729|P2|Overall Study|Withdrawal by Subject|6
5632786|NCT00688519|19453730|P1|Overall Study|Withdrawal by Subject|7
5632787|NCT00688519|19453729|P2|Overall Study|Lack of Efficacy|1
5632788|NCT00688519|19453730|P1|Overall Study|Lack of Efficacy|3
5632789|NCT00688519|19453729|P2|Overall Study|Lost to Follow-up|3
5632790|NCT00688519|19453730|P1|Overall Study|Lost to Follow-up|3
5632791|NCT00688519|19453729|P2|Overall Study|Adverse Event|3
5632792|NCT00688519|19453730|P1|Overall Study|Adverse Event|2
5632793|NCT00688467|19453748|P2|Treatment Period 2|Adverse Event|1
5632794|NCT00688467|19453749|P1|Treatment Period 2|Adverse Event|0
5632795|NCT00688467|19453748|P2|Treatment Period 2|Protocol Violation|1
5632796|NCT00688467|19453749|P1|Treatment Period 2|Protocol Violation|0
5632797|NCT00688467|19453748|P2|Treatment Period 1|Did not meet protocol eligibility|1
5632798|NCT00688467|19453749|P1|Treatment Period 1|Did not meet protocol eligibility|0
5632799|NCT00688467|19453748|P2|Treatment Period 1|Adverse Event|1
5632800|NCT00688467|19453749|P1|Treatment Period 1|Adverse Event|2
5632801|NCT00688376|19453781|P2|Blinded Extension Phase|Other|0
5632802|NCT00688376|19453782|P1|Blinded Extension Phase|Other|1
5632803|NCT00688376|19453781|P2|Blinded Extension Phase|Physician Decision|0
5632804|NCT00688376|19453782|P1|Blinded Extension Phase|Physician Decision|1
5632805|NCT00688376|19453781|P2|Blinded Extension Phase|Withdrawal by Subject|1
5632806|NCT00688376|19453782|P1|Blinded Extension Phase|Withdrawal by Subject|0
5632807|NCT00688376|19453781|P2|Blinded Extension Phase|Adverse Event|4
5632808|NCT00688376|19453782|P1|Blinded Extension Phase|Adverse Event|3
5632809|NCT00688376|19453781|P2|Double-Blind Phase|Not treated|1
5632810|NCT00688376|19453782|P1|Double-Blind Phase|Not treated|0
5632811|NCT00688376|19453781|P2|Double-Blind Phase|Withdrawal by Subject|0
5632812|NCT00688376|19453782|P1|Double-Blind Phase|Withdrawal by Subject|1
5632813|NCT00688376|19453781|P2|Double-Blind Phase|Protocol Violation|2
5632814|NCT00688376|19453782|P1|Double-Blind Phase|Protocol Violation|1
5632815|NCT00688376|19453781|P2|Double-Blind Phase|Adverse Event|4
5632816|NCT00688376|19453782|P1|Double-Blind Phase|Adverse Event|4
5632817|NCT00688324|19453796|P1|Overall Study|Lost to Follow-up|1
5632818|NCT00688324|19453796|P1|Overall Study|Physician Decision|5
5632819|NCT00688324|19453796|P1|Overall Study|Withdrawal by Subject|2
5632820|NCT00688259|19453841|P2|Overall Study|Hospitalized at Follow-up|1
5632821|NCT00688259|19453842|P1|Overall Study|Hospitalized at Follow-up|0
5632822|NCT00688259|19453841|P2|Overall Study|Declined Interview|3
5632823|NCT00688259|19453842|P1|Overall Study|Declined Interview|2
5632824|NCT00688259|19453841|P2|Overall Study|Withdrawal by Subject|0
5632825|NCT00688259|19453842|P1|Overall Study|Withdrawal by Subject|2
5632826|NCT00688259|19453841|P2|Overall Study|Physician Decision|0
5632827|NCT00688259|19453842|P1|Overall Study|Physician Decision|1
5632828|NCT00688259|19453841|P2|Overall Study|Lost to Follow-up|4
5632829|NCT00688259|19453842|P1|Overall Study|Lost to Follow-up|2
5632830|NCT00688155|19453862|P4|Overall Study|Withdrawal by Subject|1
5632831|NCT00688155|19453863|P3|Overall Study|Withdrawal by Subject|1
5632832|NCT00688155|19453864|P2|Overall Study|Withdrawal by Subject|2
5632833|NCT00688155|19453865|P1|Overall Study|Withdrawal by Subject|2
5632834|NCT00688103|19453885|P2|Overall Study|complex reasons|9
5632835|NCT00688103|19453886|P1|Overall Study|complex reasons|11
5632836|NCT00688103|19453885|P2|Overall Study|Withdrawal by Subject|2
5632837|NCT00688103|19453886|P1|Overall Study|Withdrawal by Subject|4
5632838|NCT00688103|19453885|P2|Overall Study|Lack of Efficacy|1
5632839|NCT00688103|19453886|P1|Overall Study|Lack of Efficacy|11
5632840|NCT00688103|19453885|P2|Overall Study|Adverse Event|1
5632841|NCT00688103|19453886|P1|Overall Study|Adverse Event|4
5632842|NCT00688064|19453898|P2|Overall Study|Any other reasons|3
5632843|NCT00688064|19453899|P1|Overall Study|Any other reasons|1
5632844|NCT00688064|19453898|P2|Overall Study|Pregnancy|0
5632845|NCT00688064|19453899|P1|Overall Study|Pregnancy|1
5632846|NCT00688064|19453898|P2|Overall Study|Lack of Efficacy|1
5632847|NCT00688064|19453899|P1|Overall Study|Lack of Efficacy|0
5632848|NCT00688064|19453898|P2|Overall Study|Lost to Follow-up|10
5632849|NCT00688064|19453899|P1|Overall Study|Lost to Follow-up|10
5632850|NCT00688064|19453898|P2|Overall Study|Withdrawal by Subject|7
5632851|NCT00688064|19453899|P1|Overall Study|Withdrawal by Subject|7
5632852|NCT00688064|19453898|P2|Overall Study|Adverse Event|4
5632853|NCT00688064|19453899|P1|Overall Study|Adverse Event|2
5632854|NCT00688064|19453898|P2|Overall Study|Protocol Violation|1
5632855|NCT00688064|19453899|P1|Overall Study|Protocol Violation|0
5632856|NCT00687973|19453915|P2|Overall Study|Withdrawal by Subject|3
5632857|NCT00687973|19453916|P1|Overall Study|Withdrawal by Subject|3
5632858|NCT00687973|19453915|P2|Overall Study|Administrative Reasons|2
5632859|NCT00687973|19453916|P1|Overall Study|Administrative Reasons|0
5632860|NCT00687973|19453915|P2|Overall Study|Protocol Violation|2
5632861|NCT00687973|19453916|P1|Overall Study|Protocol Violation|1
5632862|NCT00687973|19453915|P2|Overall Study|Lack of Efficacy|3
5632863|NCT00687973|19453916|P1|Overall Study|Lack of Efficacy|2
5632864|NCT00687973|19453915|P2|Overall Study|Adverse Event|28
5632865|NCT00687973|19453916|P1|Overall Study|Adverse Event|18
5632866|NCT00687804|19453978|P3|Open-Label Extension Study|Death|3
5632867|NCT00687804|19453979|P2|Open-Label Extension Study|Death|3
5632868|NCT00687804|19453980|P1|Open-Label Extension Study|Death|2
5632869|NCT00687804|19453978|P3|Open-Label Extension Study|Administrative problems|0
5632870|NCT00687804|19453979|P2|Open-Label Extension Study|Administrative problems|1
5632871|NCT00687804|19453980|P1|Open-Label Extension Study|Administrative problems|1
5632872|NCT00687804|19453978|P3|Open-Label Extension Study|Lost to Follow-up|2
5632873|NCT00687804|19453979|P2|Open-Label Extension Study|Lost to Follow-up|1
5632874|NCT00687804|19453980|P1|Open-Label Extension Study|Lost to Follow-up|2
5632875|NCT00687804|19453978|P3|Open-Label Extension Study|Subject withdrew consent|4
5632876|NCT00687804|19453979|P2|Open-Label Extension Study|Subject withdrew consent|4
5632877|NCT00687804|19453980|P1|Open-Label Extension Study|Subject withdrew consent|3
5632878|NCT00687804|19453978|P3|Open-Label Extension Study|Adverse Event|2
5632879|NCT00687804|19453979|P2|Open-Label Extension Study|Adverse Event|2
5632880|NCT00687804|19453980|P1|Open-Label Extension Study|Adverse Event|2
5632881|NCT00687804|19453978|P3|Core Study|Protocol Violation|0
5632882|NCT00687804|19453979|P2|Core Study|Protocol Violation|1
5632883|NCT00687804|19453980|P1|Core Study|Protocol Violation|1
5632884|NCT00687804|19453978|P3|Core Study|Death|2
5632885|NCT00687804|19453979|P2|Core Study|Death|2
5632886|NCT00687804|19453980|P1|Core Study|Death|2
5632887|NCT00687804|19453978|P3|Core Study|Lost to Follow-up|0
5632888|NCT00687804|19453979|P2|Core Study|Lost to Follow-up|1
5632889|NCT00687804|19453980|P1|Core Study|Lost to Follow-up|0
5632890|NCT00687804|19453978|P3|Core Study|Withdrawal by Subject|7
5632891|NCT00687804|19453979|P2|Core Study|Withdrawal by Subject|7
5632892|NCT00687804|19453980|P1|Core Study|Withdrawal by Subject|4
5632893|NCT00687804|19453978|P3|Core Study|Lack of Efficacy|1
5632894|NCT00687804|19453979|P2|Core Study|Lack of Efficacy|1
5632895|NCT00687804|19453980|P1|Core Study|Lack of Efficacy|1
5632896|NCT00687804|19453978|P3|Core Study|Abnormal laboratory value(s)|0
5632897|NCT00687804|19453979|P2|Core Study|Abnormal laboratory value(s)|0
5632898|NCT00687804|19453980|P1|Core Study|Abnormal laboratory value(s)|1
5632899|NCT00687804|19453978|P3|Core Study|Adverse Event|3
5632900|NCT00687804|19453979|P2|Core Study|Adverse Event|3
5632901|NCT00687804|19453980|P1|Core Study|Adverse Event|5
5632902|NCT00687739|19454027|P4|Overall Study|Adverse Event|0
5632903|NCT00687739|19454028|P3|Overall Study|Adverse Event|1
5632904|NCT00687739|19454029|P2|Overall Study|Adverse Event|1
5632905|NCT00687739|19454030|P1|Overall Study|Adverse Event|0
5632906|NCT00687739|19454027|P4|Overall Study|Lost to Follow-up|2
5632907|NCT00687739|19454028|P3|Overall Study|Lost to Follow-up|1
5632908|NCT00687739|19454029|P2|Overall Study|Lost to Follow-up|2
5632909|NCT00687739|19454030|P1|Overall Study|Lost to Follow-up|2
5632910|NCT00687609|19454072|P1|Overall Study|Withdrawal by Subject|2
5632911|NCT00687609|19454072|P1|Overall Study|Physician Decision|1
5632912|NCT00687531|19454095|P1|Overall Study|Lost to Follow-up|26
5632913|NCT00687531|19454095|P1|Overall Study|Adverse Event|5
5632914|NCT00687531|19454095|P1|Overall Study|Did not meet protocol eligibility|104
5632915|NCT00687440|19454118|P1|Overall Study|Missing|1
5632916|NCT00687440|19454118|P1|Overall Study|Other|1
5632917|NCT00687440|19454118|P1|Overall Study|Death|2
5632918|NCT00687440|19454118|P1|Overall Study|Lack of Efficacy|2
5632919|NCT00687440|19454118|P1|Overall Study|Lost to Follow-up|3
5632920|NCT00687440|19454118|P1|Overall Study|Adverse Event|3
5632921|NCT00687401|19454122|P1|Overall Study|For reasons different from those above|4
5632922|NCT00687401|19454122|P1|Overall Study|Did not return for visit|3
5632923|NCT00687401|19454122|P1|Overall Study|Withdrawal by Subject|4
5632924|NCT00687401|19454122|P1|Overall Study|Lack of Efficacy|6
5632925|NCT00687401|19454122|P1|Overall Study|Adverse Event|6
5632926|NCT00687401|19454122|P1|Overall Study|Protocol Violation|7
5632927|NCT00687362|19454127|P1|Overall Study|Withdrawal by Subject|1
5632928|NCT00687362|19454127|P1|Overall Study|Protocol Violation|2
5632929|NCT00687323|19454131|P1|Overall Study|Screen failure|148
5632930|NCT00687323|19454131|P1|Overall Study|Excluded from efficacy evaluations|6
5632931|NCT00687323|19454131|P1|Overall Study|Withdrawal by Subject|1
5632932|NCT00687323|19454131|P1|Overall Study|Death|25
5632933|NCT00687297|19454147|P2|Induction|Other|1
5632934|NCT00687297|19454148|P1|Induction|Other|0
5632935|NCT00687297|19454147|P2|Induction|Physician Decision|2
5632936|NCT00687297|19454148|P1|Induction|Physician Decision|0
5632937|NCT00687297|19454147|P2|Induction|Patient Noncompliance|0
5632938|NCT00687297|19454148|P1|Induction|Patient Noncompliance|1
5632939|NCT00687297|19454147|P2|Induction|Ineligible|1
5632940|NCT00687297|19454148|P1|Induction|Ineligible|0
5632941|NCT00687297|19454147|P2|Induction|Lack of Efficacy|21
5632942|NCT00687297|19454148|P1|Induction|Lack of Efficacy|17
5632943|NCT00687297|19454147|P2|Induction|Death|11
5632944|NCT00687297|19454148|P1|Induction|Death|7
5632945|NCT00687297|19454147|P2|Induction|Adverse Event|15
5632946|NCT00687297|19454148|P1|Induction|Adverse Event|16
5632947|NCT00687297|19454147|P2|Induction|Withdrawal by Subject|4
5632948|NCT00687297|19454148|P1|Induction|Withdrawal by Subject|4
5632949|NCT00687297|19454147|P2|Randomization|Withdrew before treatment, ineligible|1
5632950|NCT00687297|19454148|P1|Randomization|Withdrew before treatment, ineligible|1
5632951|NCT00687297|19454147|P2|Randomization|Withdrawal by Subject|0
5632952|NCT00687297|19454148|P1|Randomization|Withdrawal by Subject|2
5632953|NCT00687271|19454162|P4|Overall Study|Withdrawal by Subject|0
5632954|NCT00687271|19454163|P3|Overall Study|Withdrawal by Subject|3
5632955|NCT00687271|19454164|P2|Overall Study|Withdrawal by Subject|1
5632956|NCT00687271|19454165|P1|Overall Study|Withdrawal by Subject|0
5632957|NCT00687271|19454162|P4|Overall Study|Protocol Violation|0
5632958|NCT00687271|19454163|P3|Overall Study|Protocol Violation|1
5632959|NCT00687271|19454164|P2|Overall Study|Protocol Violation|1
5632960|NCT00687271|19454165|P1|Overall Study|Protocol Violation|2
5632961|NCT00687271|19454162|P4|Overall Study|Lost to Follow-up|0
5632962|NCT00687271|19454163|P3|Overall Study|Lost to Follow-up|0
5632963|NCT00687271|19454164|P2|Overall Study|Lost to Follow-up|1
5632964|NCT00687271|19454165|P1|Overall Study|Lost to Follow-up|0
5632965|NCT00687271|19454162|P4|Overall Study|Adverse Event|0
5632966|NCT00687271|19454163|P3|Overall Study|Adverse Event|1
5632967|NCT00687271|19454164|P2|Overall Study|Adverse Event|3
5632968|NCT00687271|19454165|P1|Overall Study|Adverse Event|1
5632969|NCT00687219|19454203|P1|Overall Study|Lack of Efficacy|1
5632970|NCT00687219|19454203|P1|Overall Study|Withdrawal by Subject|1
5632971|NCT00687219|19454203|P1|Overall Study|HCV-RNA positive conversion|34
5632972|NCT00687219|19454203|P1|Overall Study|Discontinuance criteria met|7
5632973|NCT00687219|19454203|P1|Overall Study|Adverse Event|8
5632974|NCT00687193|19454215|P6|Overall Study|Protocol Violation|0
5632975|NCT00687193|19454216|P5|Overall Study|Protocol Violation|2
5632976|NCT00687193|19454217|P4|Overall Study|Protocol Violation|1
5632977|NCT00687193|19454218|P3|Overall Study|Protocol Violation|0
5632978|NCT00687193|19454219|P2|Overall Study|Protocol Violation|2
5632979|NCT00687193|19454220|P1|Overall Study|Protocol Violation|1
5632980|NCT00687193|19454215|P6|Overall Study|Lack of Efficacy|2
5632981|NCT00687193|19454216|P5|Overall Study|Lack of Efficacy|0
5632982|NCT00687193|19454217|P4|Overall Study|Lack of Efficacy|0
5632983|NCT00687193|19454218|P3|Overall Study|Lack of Efficacy|0
5632984|NCT00687193|19454219|P2|Overall Study|Lack of Efficacy|1
5632985|NCT00687193|19454220|P1|Overall Study|Lack of Efficacy|1
5632986|NCT00687193|19454215|P6|Overall Study|Adverse Event|2
5632987|NCT00687193|19454216|P5|Overall Study|Adverse Event|0
5632988|NCT00687193|19454217|P4|Overall Study|Adverse Event|3
5632989|NCT00687193|19454218|P3|Overall Study|Adverse Event|2
5632990|NCT00687193|19454219|P2|Overall Study|Adverse Event|1
5632991|NCT00687193|19454220|P1|Overall Study|Adverse Event|0
5632992|NCT00686998|19454430|P3|Overall Study|Safety Reasons|0
5632993|NCT00686998|19454431|P2|Overall Study|Safety Reasons|0
5632994|NCT00686998|19454432|P1|Overall Study|Safety Reasons|1
5632995|NCT00686998|19454430|P3|Overall Study|Other|1
5632996|NCT00686998|19454431|P2|Overall Study|Other|0
5632997|NCT00686998|19454432|P1|Overall Study|Other|0
5632998|NCT00686998|19454430|P3|Overall Study|Lack of Efficacy|0
5632999|NCT00686998|19454431|P2|Overall Study|Lack of Efficacy|5
5633000|NCT00686998|19454432|P1|Overall Study|Lack of Efficacy|7
5633001|NCT00686998|19454430|P3|Overall Study|Withdrawal by Subject|2
5633002|NCT00686998|19454431|P2|Overall Study|Withdrawal by Subject|1
5633003|NCT00686998|19454432|P1|Overall Study|Withdrawal by Subject|2
5633004|NCT00686998|19454430|P3|Overall Study|Adverse Event|1
5633005|NCT00686998|19454431|P2|Overall Study|Adverse Event|2
5633006|NCT00686998|19454432|P1|Overall Study|Adverse Event|3
5633007|NCT00686972|19454440|P1|Overall Study|P.I, Left institution. Study terminated|51
5633008|NCT00686959|19454446|P2|Overall Study|Participants censored (no death events)|117
5633009|NCT00686959|19454447|P1|Overall Study|Participants censored (no death events)|124
5633010|NCT00686920|19454467|P2|Overall Study|Principal Investigator Decision|0
5633011|NCT00686920|19454468|P1|Overall Study|Principal Investigator Decision|2
5633012|NCT00686920|19454467|P2|Overall Study|Noncompliance|0
5633013|NCT00686920|19454468|P1|Overall Study|Noncompliance|9
5633014|NCT00686920|19454467|P2|Overall Study|Transferred to Nursing Home|0
5633015|NCT00686920|19454468|P1|Overall Study|Transferred to Nursing Home|1
5633016|NCT00686920|19454467|P2|Overall Study|Moved to Another State|0
5633017|NCT00686920|19454468|P1|Overall Study|Moved to Another State|1
5633018|NCT00686920|19454467|P2|Overall Study|Lost to Follow-up|3
5633019|NCT00686920|19454468|P1|Overall Study|Lost to Follow-up|15
5633020|NCT00686920|19454467|P2|Overall Study|Personal Reason|1
5633021|NCT00686920|19454468|P1|Overall Study|Personal Reason|0
5633022|NCT00686920|19454467|P2|Overall Study|Adverse Event|2
5633023|NCT00686920|19454468|P1|Overall Study|Adverse Event|10
5633024|NCT00686920|19454467|P2|Overall Study|Protocol Violation|1
5633025|NCT00686920|19454468|P1|Overall Study|Protocol Violation|2
5633026|NCT00686920|19454467|P2|Overall Study|Withdrawal by Subject|5
5633027|NCT00686920|19454468|P1|Overall Study|Withdrawal by Subject|23
5633028|NCT00686920|19454467|P2|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
5633029|NCT00686920|19454468|P1|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
5633030|NCT00686920|19454467|P2|Overall Study|Liver Transplant|8
5633031|NCT00686920|19454468|P1|Overall Study|Liver Transplant|23
5633032|NCT00686920|19454467|P2|Overall Study|Death|14
5633033|NCT00686920|19454468|P1|Overall Study|Death|45
5633034|NCT00686894|19454480|P1|Overall Study|Protocol Violation|4
5633035|NCT00686894|19454480|P1|Overall Study|Relapse|2
5633036|NCT00686881|19454486|P2|Overall Study|Never received study drug|6
5633037|NCT00686881|19454487|P1|Overall Study|Never received study drug|2
5633038|NCT00686881|19454486|P2|Overall Study|Study discontinuation|32
5633039|NCT00686881|19454487|P1|Overall Study|Study discontinuation|35
5633040|NCT00686881|19454486|P2|Overall Study|Irregular visits|0
5633041|NCT00686881|19454487|P1|Overall Study|Irregular visits|1
5633042|NCT00686881|19454486|P2|Overall Study|Did not meet protocol eligibility|0
5633043|NCT00686881|19454487|P1|Overall Study|Did not meet protocol eligibility|1
5633044|NCT00686881|19454486|P2|Overall Study|Circumstances of site|1
5633045|NCT00686881|19454487|P1|Overall Study|Circumstances of site|1
5633046|NCT00686881|19454486|P2|Overall Study|Physician Decision|0
5633047|NCT00686881|19454487|P1|Overall Study|Physician Decision|1
5633048|NCT00686881|19454486|P2|Overall Study|Lack of Efficacy|3
5633049|NCT00686881|19454487|P1|Overall Study|Lack of Efficacy|4
5633050|NCT00686881|19454486|P2|Overall Study|Onset of malignant tumor|11
5633051|NCT00686881|19454487|P1|Overall Study|Onset of malignant tumor|11
5633052|NCT00686881|19454486|P2|Overall Study|Met discontinuation criteria|0
5633053|NCT00686881|19454487|P1|Overall Study|Met discontinuation criteria|5
5633054|NCT00686881|19454486|P2|Overall Study|Treatment-related adverse event|9
5633055|NCT00686881|19454487|P1|Overall Study|Treatment-related adverse event|10
5633056|NCT00686881|19454486|P2|Overall Study|Lost to Follow-up|1
5633057|NCT00686881|19454487|P1|Overall Study|Lost to Follow-up|0
5633058|NCT00686881|19454486|P2|Overall Study|Withdrawal by Subject|18
5633059|NCT00686881|19454487|P1|Overall Study|Withdrawal by Subject|11
5633060|NCT00686855|19454499|P2|Overall Study|Progressive GVHD|1
5633061|NCT00686855|19454500|P1|Overall Study|Progressive GVHD|0
5633062|NCT00686855|19454499|P2|Overall Study|Lost to Follow-up|0
5633063|NCT00686855|19454500|P1|Overall Study|Lost to Follow-up|1
5633064|NCT00686829|19454510|P1|Overall Study|Sponsor discontinued VCV|47
5633065|NCT00686829|19454510|P1|Overall Study|Protocol Violation|3
5633066|NCT00686829|19454510|P1|Overall Study|Withdrawal by Subject|14
5633067|NCT00686829|19454510|P1|Overall Study|Lost to Follow-up|4
5633068|NCT00686829|19454510|P1|Overall Study|Lack of Efficacy|6
5633069|NCT00686829|19454510|P1|Overall Study|Adverse Event|5
5633070|NCT00686790|19454540|P1|Overall Study|Lost to Follow-up|12
5633071|NCT00686790|19454540|P1|Overall Study|Death|1
5633072|NCT00686790|19454540|P1|Overall Study|Withdrawal by Subject|1
5633073|NCT00686790|19454540|P1|Overall Study|Adverse Event|2
5633074|NCT00686777|19454548|P1|Overall Study|No Visit|1
5633075|NCT00686777|19454548|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
5633076|NCT00686777|19454548|P1|Overall Study|Withdrawal by Subject|2
5633077|NCT00686777|19454548|P1|Overall Study|Pregnancy|1
5633078|NCT00686777|19454548|P1|Overall Study|Adverse Event|2
5633079|NCT00686725|19454556|P2|Overall Study|Other|3
5633080|NCT00686725|19454557|P1|Overall Study|Other|1
5633081|NCT00686725|19454556|P2|Overall Study|Protocol Violation|3
5633082|NCT00686725|19454557|P1|Overall Study|Protocol Violation|1
5633083|NCT00686725|19454556|P2|Overall Study|Withdrawal by Subject|4
5633084|NCT00686725|19454557|P1|Overall Study|Withdrawal by Subject|13
5633085|NCT00686725|19454556|P2|Overall Study|Death|3
5633086|NCT00686725|19454557|P1|Overall Study|Death|6
5633087|NCT00686725|19454556|P2|Overall Study|Lost to Follow-up|5
5633088|NCT00686725|19454557|P1|Overall Study|Lost to Follow-up|7
5633089|NCT00686725|19454556|P2|Overall Study|Progressive Disease|23
5633090|NCT00686725|19454557|P1|Overall Study|Progressive Disease|17
5633091|NCT00686725|19454556|P2|Overall Study|Adverse Event|1
5633092|NCT00686725|19454557|P1|Overall Study|Adverse Event|1
5633093|NCT00686712|19454582|P3|Overall Study|Adverse Event|0
5633094|NCT00686712|19454583|P2|Overall Study|Adverse Event|1
5633095|NCT00686712|19454584|P1|Overall Study|Adverse Event|1
5633096|NCT00686712|19454582|P3|Overall Study|Lost to Follow-up|3
5633097|NCT00686712|19454583|P2|Overall Study|Lost to Follow-up|2
5633098|NCT00686712|19454584|P1|Overall Study|Lost to Follow-up|1
5633099|NCT00686712|19454582|P3|Overall Study|Protocol Violation|10
5633100|NCT00686712|19454583|P2|Overall Study|Protocol Violation|8
5633101|NCT00686712|19454584|P1|Overall Study|Protocol Violation|8
5633102|NCT00686699|19454612|P2|Treatment Period 1|Adverse Event|2
5633103|NCT00686699|19454613|P1|Treatment Period 1|Adverse Event|0
5633104|NCT00686686|19454637|P1|Overall Study|Lost to Follow-up|3
5633105|NCT00686686|19454637|P1|Overall Study|Adverse Event|2
5633106|NCT00686686|19454637|P1|Overall Study|Non-compliance|1
5633107|NCT00686647|19454645|P1|Overall Study|Death|1
5633108|NCT00686647|19454645|P1|Overall Study|Lost to Follow-up|1
5633109|NCT00686634|19454651|P1|Overall Study|Protocol Violation|6
5633110|NCT00686595|19454658|P1|Overall Study|Poor Compliance|1
5633111|NCT00686595|19454658|P1|Overall Study|Lack of Efficacy|1
5633112|NCT00686595|19454658|P1|Overall Study|Lost to Follow-up|1
5633113|NCT00686595|19454658|P1|Overall Study|Protocol Violation|1
5633114|NCT00686595|19454658|P1|Overall Study|Adverse Event|3
5633115|NCT00686543|19454718|P4|Overall Study|Protocol Violation|1
5633116|NCT00686543|19454719|P3|Overall Study|Protocol Violation|2
5633117|NCT00686543|19454720|P2|Overall Study|Protocol Violation|0
5633118|NCT00686543|19454721|P1|Overall Study|Protocol Violation|3
5633119|NCT00686543|19454718|P4|Overall Study|Withdrawal by Subject|0
5633120|NCT00686543|19454719|P3|Overall Study|Withdrawal by Subject|0
5633121|NCT00686543|19454720|P2|Overall Study|Withdrawal by Subject|0
5633122|NCT00686543|19454721|P1|Overall Study|Withdrawal by Subject|2
5633123|NCT00686543|19454718|P4|Overall Study|Adverse Event|2
5633124|NCT00686543|19454719|P3|Overall Study|Adverse Event|3
5633125|NCT00686543|19454720|P2|Overall Study|Adverse Event|1
5633126|NCT00686543|19454721|P1|Overall Study|Adverse Event|9
5633127|NCT00686517|19454742|P3|Treatment|Protocol Violation|0
5633128|NCT00686517|19454743|P2|Treatment|Protocol Violation|1
5633129|NCT00686517|19454744|P1|Treatment|Protocol Violation|2
5633130|NCT00686517|19454742|P3|Treatment|Poor Protocol Compliance|0
5633131|NCT00686517|19454743|P2|Treatment|Poor Protocol Compliance|0
5633132|NCT00686517|19454744|P1|Treatment|Poor Protocol Compliance|1
5633133|NCT00686517|19454742|P3|Treatment|Adverse Event|0
5633134|NCT00686517|19454743|P2|Treatment|Adverse Event|0
5633135|NCT00686517|19454744|P1|Treatment|Adverse Event|2
5633136|NCT00686517|19454742|P3|Treatment|Serious Adverse Event|1
5633137|NCT00686517|19454743|P2|Treatment|Serious Adverse Event|2
5633138|NCT00686517|19454744|P1|Treatment|Serious Adverse Event|1
5633139|NCT00686374|19454767|P1|Overall Study|Other, not specified|4
5633140|NCT00686374|19454767|P1|Overall Study|Missing reason|33
5633141|NCT00686374|19454767|P1|Overall Study|Lost to Follow-up|1
5633142|NCT00686374|19454767|P1|Overall Study|Withdrew consent|5
5633143|NCT00686374|19454767|P1|Overall Study|Adverse Event|8
5633144|NCT00686374|19454767|P1|Overall Study|Lack of Efficacy|10
5633145|NCT00686335|19454778|P1|Run-in Period|violation of inclusion/exclusion criteri|3
5633146|NCT00686335|19454778|P1|Run-in Period|asthma exacerbation|1
5633147|NCT00686335|19454778|P1|Run-in Period|Adverse Event|1
5633148|NCT00686205|19454822|P2|Overall Study|Specimens not confirmed HIV positive|981
5633149|NCT00686205|19454823|P1|Overall Study|Specimens not confirmed HIV positive|0
5633150|NCT00686205|19454822|P2|Overall Study|Specimen handling procedure altered|0
5633151|NCT00686205|19454823|P1|Overall Study|Specimen handling procedure altered|5878
5633152|NCT00686205|19454822|P2|Overall Study|Withdrawal by Subject|0
5633153|NCT00686205|19454823|P1|Overall Study|Withdrawal by Subject|2
5633154|NCT00686205|19454822|P2|Overall Study|Protocol Violation|0
5633155|NCT00686205|19454823|P1|Overall Study|Protocol Violation|127
5633156|NCT00686166|19454829|P1|Overall Study|Did not begin protocol therapy|4
5633157|NCT00686166|19454829|P1|Overall Study|Ineligible|5
5633158|NCT00686166|19454829|P1|Overall Study|Not Protocol Specified|1
5633159|NCT00686166|19454829|P1|Overall Study|Death|1
5633160|NCT00686166|19454829|P1|Overall Study|Progression/Relapse|1
5633161|NCT00686166|19454829|P1|Overall Study|Withdrawal by Subject|1
5633162|NCT00686166|19454829|P1|Overall Study|Adverse Event|7
5633163|NCT00686127|19454841|P2|Overall Study|Withdrawal by Subject|6
5633164|NCT00686127|19454842|P1|Overall Study|Withdrawal by Subject|14
5633165|NCT00686075|19454858|P10|Overall Study|Other|1
5633166|NCT00686075|19454859|P9|Overall Study|Other|0
5633167|NCT00686075|19454860|P8|Overall Study|Other|0
5633168|NCT00686075|19454861|P7|Overall Study|Other|0
5633169|NCT00686075|19454862|P6|Overall Study|Other|0
5633170|NCT00686075|19454863|P5|Overall Study|Other|0
5633171|NCT00686075|19454864|P4|Overall Study|Other|0
5633172|NCT00686075|19454865|P3|Overall Study|Other|0
5633173|NCT00686075|19454866|P2|Overall Study|Other|1
5633174|NCT00686075|19454867|P1|Overall Study|Other|1
5633175|NCT00686075|19454858|P10|Overall Study|Lost to Follow-up|3
5633176|NCT00686075|19454859|P9|Overall Study|Lost to Follow-up|2
5633177|NCT00686075|19454860|P8|Overall Study|Lost to Follow-up|0
5633178|NCT00686075|19454861|P7|Overall Study|Lost to Follow-up|0
5633179|NCT00686075|19454862|P6|Overall Study|Lost to Follow-up|3
5633180|NCT00686075|19454863|P5|Overall Study|Lost to Follow-up|3
5633181|NCT00686075|19454864|P4|Overall Study|Lost to Follow-up|2
5633182|NCT00686075|19454865|P3|Overall Study|Lost to Follow-up|3
5633183|NCT00686075|19454866|P2|Overall Study|Lost to Follow-up|6
5633184|NCT00686075|19454867|P1|Overall Study|Lost to Follow-up|3
5633185|NCT00686075|19454858|P10|Overall Study|Withdrawal by Subject|6
5633186|NCT00686075|19454859|P9|Overall Study|Withdrawal by Subject|4
5633187|NCT00686075|19454860|P8|Overall Study|Withdrawal by Subject|2
5633188|NCT00686075|19454861|P7|Overall Study|Withdrawal by Subject|0
5633189|NCT00686075|19454862|P6|Overall Study|Withdrawal by Subject|0
5633190|NCT00686075|19454863|P5|Overall Study|Withdrawal by Subject|1
5633191|NCT00686075|19454864|P4|Overall Study|Withdrawal by Subject|7
5633192|NCT00686075|19454865|P3|Overall Study|Withdrawal by Subject|3
5633193|NCT00686075|19454866|P2|Overall Study|Withdrawal by Subject|3
5633194|NCT00686075|19454867|P1|Overall Study|Withdrawal by Subject|4
5633195|NCT00686036|19455061|P2|Overall Study|Other reasons not identified|4
5633196|NCT00686036|19455062|P1|Overall Study|Other reasons not identified|0
5633197|NCT00686036|19455061|P2|Overall Study|PSA ≥ 10ng/mL|0
5633198|NCT00686036|19455062|P1|Overall Study|PSA ≥ 10ng/mL|1
5633199|NCT00686036|19455061|P2|Overall Study|Study terminated by AstraZeneca|1
5633200|NCT00686036|19455062|P1|Overall Study|Study terminated by AstraZeneca|2
5633201|NCT00686036|19455061|P2|Overall Study|Withdrawal by Subject|1
5633202|NCT00686036|19455062|P1|Overall Study|Withdrawal by Subject|3
5633203|NCT00686036|19455061|P2|Overall Study|Adverse Event|0
5633204|NCT00686036|19455062|P1|Overall Study|Adverse Event|3
5633205|NCT00685945|19455074|P1|L-NMMA + Bradykinin|Physician Decision|1
5633206|NCT00685802|19455109|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5633207|NCT00685802|19455110|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5633208|NCT00685802|19455109|P2|Washout Period of 7 Days|Protocol Violation|0
5633209|NCT00685802|19455110|P1|Washout Period of 7 Days|Protocol Violation|2
5633210|NCT00685763|19455120|P1|Overall Study|Protocol Violation|1
5633211|NCT00685763|19455120|P1|Overall Study|Intercurrent death-incomplete treatment|1
5633212|NCT00685750|19455131|P7|Overall Study|Eligibility criteria not fulfilled|0
5633213|NCT00685750|19455132|P6|Overall Study|Eligibility criteria not fulfilled|0
5633214|NCT00685750|19455133|P5|Overall Study|Eligibility criteria not fulfilled|0
5633215|NCT00685750|19455134|P4|Overall Study|Eligibility criteria not fulfilled|0
5633216|NCT00685750|19455135|P3|Overall Study|Eligibility criteria not fulfilled|1
5633217|NCT00685750|19455136|P2|Overall Study|Eligibility criteria not fulfilled|0
5633218|NCT00685750|19455137|P1|Overall Study|Eligibility criteria not fulfilled|0
5633219|NCT00685750|19455131|P7|Overall Study|Patient didn't receive the treatment|1
5633220|NCT00685750|19455132|P6|Overall Study|Patient didn't receive the treatment|0
5633221|NCT00685750|19455133|P5|Overall Study|Patient didn't receive the treatment|0
5633222|NCT00685750|19455134|P4|Overall Study|Patient didn't receive the treatment|0
5633223|NCT00685750|19455135|P3|Overall Study|Patient didn't receive the treatment|0
5633224|NCT00685750|19455136|P2|Overall Study|Patient didn't receive the treatment|0
5633225|NCT00685750|19455137|P1|Overall Study|Patient didn't receive the treatment|0
5633226|NCT00685750|19455131|P7|Overall Study|Tumor sampling failure|0
5633227|NCT00685750|19455132|P6|Overall Study|Tumor sampling failure|0
5633228|NCT00685750|19455133|P5|Overall Study|Tumor sampling failure|0
5633229|NCT00685750|19455134|P4|Overall Study|Tumor sampling failure|0
5633230|NCT00685750|19455135|P3|Overall Study|Tumor sampling failure|1
5633231|NCT00685750|19455136|P2|Overall Study|Tumor sampling failure|0
5633232|NCT00685750|19455137|P1|Overall Study|Tumor sampling failure|0
5633233|NCT00685698|19455165|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
5633234|NCT00685698|19455165|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
5633235|NCT00685698|19455165|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
5633236|NCT00685698|19455165|P1|Overall Study|Adverse Event|3
5633237|NCT00685698|19455165|P1|Overall Study|Protocol Violation|6
5633238|NCT00685698|19455165|P1|Overall Study|Withdrawal by Subject|1
5633239|NCT00685685|19455200|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5633240|NCT00685685|19455201|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5633241|NCT00685685|19455200|P2|Washout Period of 7 Days|Adverse Event|0
5633242|NCT00685685|19455201|P1|Washout Period of 7 Days|Adverse Event|2
5633243|NCT00685399|19455354|P8|Extension|Adverse Event|0
5633244|NCT00685399|19455355|P7|Extension|Adverse Event|0
5633245|NCT00685399|19455356|P6|Extension|Adverse Event|0
5633246|NCT00685399|19455357|P5|Extension|Adverse Event|0
5633247|NCT00685399|19455358|P4|Extension|Adverse Event|2
5633248|NCT00685399|19455359|P3|Extension|Adverse Event|0
5633249|NCT00685399|19455360|P2|Extension|Adverse Event|0
5633250|NCT00685399|19455361|P1|Extension|Adverse Event|0
5633251|NCT00685399|19455354|P8|Extension|Lack of Efficacy|0
5633252|NCT00685399|19455355|P7|Extension|Lack of Efficacy|0
5633253|NCT00685399|19455356|P6|Extension|Lack of Efficacy|0
5633254|NCT00685399|19455357|P5|Extension|Lack of Efficacy|0
5633255|NCT00685399|19455358|P4|Extension|Lack of Efficacy|2
5633256|NCT00685399|19455359|P3|Extension|Lack of Efficacy|0
5633257|NCT00685399|19455360|P2|Extension|Lack of Efficacy|0
5633258|NCT00685399|19455361|P1|Extension|Lack of Efficacy|0
5633259|NCT00685399|19455354|P8|Extension|Protocol Violation|0
5633260|NCT00685399|19455355|P7|Extension|Protocol Violation|0
5633261|NCT00685399|19455356|P6|Extension|Protocol Violation|0
5633262|NCT00685399|19455357|P5|Extension|Protocol Violation|0
5633263|NCT00685399|19455358|P4|Extension|Protocol Violation|1
5633264|NCT00685399|19455359|P3|Extension|Protocol Violation|0
5633265|NCT00685399|19455360|P2|Extension|Protocol Violation|0
5633266|NCT00685399|19455361|P1|Extension|Protocol Violation|0
5633267|NCT00685399|19455354|P8|Extension|Withdrawal by Subject|0
5633268|NCT00685399|19455355|P7|Extension|Withdrawal by Subject|0
5633269|NCT00685399|19455356|P6|Extension|Withdrawal by Subject|0
5633270|NCT00685399|19455357|P5|Extension|Withdrawal by Subject|0
5633271|NCT00685399|19455358|P4|Extension|Withdrawal by Subject|1
5633272|NCT00685399|19455359|P3|Extension|Withdrawal by Subject|0
5633273|NCT00685399|19455360|P2|Extension|Withdrawal by Subject|0
5633274|NCT00685399|19455361|P1|Extension|Withdrawal by Subject|0
5633275|NCT00685399|19455354|P8|Extension|Administrative Issues|0
5633276|NCT00685399|19455355|P7|Extension|Administrative Issues|0
5633277|NCT00685399|19455356|P6|Extension|Administrative Issues|0
5633278|NCT00685399|19455357|P5|Extension|Administrative Issues|0
5633279|NCT00685399|19455358|P4|Extension|Administrative Issues|1
5633280|NCT00685399|19455359|P3|Extension|Administrative Issues|0
5633281|NCT00685399|19455360|P2|Extension|Administrative Issues|0
5633282|NCT00685399|19455361|P1|Extension|Administrative Issues|0
5633283|NCT00685399|19455354|P8|Treatment Period 2|Lack of Efficacy|0
5633284|NCT00685399|19455355|P7|Treatment Period 2|Lack of Efficacy|0
5633285|NCT00685399|19455356|P6|Treatment Period 2|Lack of Efficacy|1
5633286|NCT00685399|19455357|P5|Treatment Period 2|Lack of Efficacy|0
5633287|NCT00685399|19455358|P4|Treatment Period 2|Lack of Efficacy|0
5633288|NCT00685399|19455359|P3|Treatment Period 2|Lack of Efficacy|2
5633289|NCT00685399|19455360|P2|Treatment Period 2|Lack of Efficacy|10
5633290|NCT00685399|19455361|P1|Treatment Period 2|Lack of Efficacy|0
5633291|NCT00685399|19455354|P8|Treatment Period 2|Adverse Event|0
5633292|NCT00685399|19455355|P7|Treatment Period 2|Adverse Event|0
5633293|NCT00685399|19455356|P6|Treatment Period 2|Adverse Event|1
5633294|NCT00685399|19455357|P5|Treatment Period 2|Adverse Event|0
5633295|NCT00685399|19455358|P4|Treatment Period 2|Adverse Event|0
5633296|NCT00685399|19455359|P3|Treatment Period 2|Adverse Event|0
5633297|NCT00685399|19455360|P2|Treatment Period 2|Adverse Event|0
5633298|NCT00685399|19455361|P1|Treatment Period 2|Adverse Event|0
5633299|NCT00685399|19455354|P8|Treatment Period 2|Withdrawal by Subject|2
5633300|NCT00685399|19455355|P7|Treatment Period 2|Withdrawal by Subject|0
5633301|NCT00685399|19455356|P6|Treatment Period 2|Withdrawal by Subject|0
5633302|NCT00685399|19455357|P5|Treatment Period 2|Withdrawal by Subject|0
5633303|NCT00685399|19455358|P4|Treatment Period 2|Withdrawal by Subject|0
5633304|NCT00685399|19455359|P3|Treatment Period 2|Withdrawal by Subject|0
5633305|NCT00685399|19455360|P2|Treatment Period 2|Withdrawal by Subject|0
5633306|NCT00685399|19455361|P1|Treatment Period 2|Withdrawal by Subject|0
5633307|NCT00685399|19455354|P8|Treatment Period 2|Administrative Problems|0
5633308|NCT00685399|19455355|P7|Treatment Period 2|Administrative Problems|0
5633309|NCT00685399|19455356|P6|Treatment Period 2|Administrative Problems|0
5633310|NCT00685399|19455357|P5|Treatment Period 2|Administrative Problems|0
5633311|NCT00685399|19455358|P4|Treatment Period 2|Administrative Problems|0
5633312|NCT00685399|19455359|P3|Treatment Period 2|Administrative Problems|1
5633313|NCT00685399|19455360|P2|Treatment Period 2|Administrative Problems|2
5633314|NCT00685399|19455361|P1|Treatment Period 2|Administrative Problems|0
5633315|NCT00685399|19455354|P8|Treatment Period 1|Lack of Efficacy|0
5633316|NCT00685399|19455355|P7|Treatment Period 1|Lack of Efficacy|0
5633317|NCT00685399|19455356|P6|Treatment Period 1|Lack of Efficacy|0
5633318|NCT00685399|19455357|P5|Treatment Period 1|Lack of Efficacy|0
5633319|NCT00685399|19455358|P4|Treatment Period 1|Lack of Efficacy|0
5633320|NCT00685399|19455359|P3|Treatment Period 1|Lack of Efficacy|0
5633321|NCT00685399|19455360|P2|Treatment Period 1|Lack of Efficacy|0
5633322|NCT00685399|19455361|P1|Treatment Period 1|Lack of Efficacy|1
5633323|NCT00685399|19455354|P8|Treatment Period 1|Administrative|0
5633324|NCT00685399|19455355|P7|Treatment Period 1|Administrative|0
5633325|NCT00685399|19455356|P6|Treatment Period 1|Administrative|0
5633326|NCT00685399|19455357|P5|Treatment Period 1|Administrative|0
5633327|NCT00685399|19455358|P4|Treatment Period 1|Administrative|0
5633328|NCT00685399|19455359|P3|Treatment Period 1|Administrative|0
5633329|NCT00685399|19455360|P2|Treatment Period 1|Administrative|0
5633330|NCT00685399|19455361|P1|Treatment Period 1|Administrative|2
5633331|NCT00685399|19455354|P8|Treatment Period 1|Protocol Violation|0
5633332|NCT00685399|19455355|P7|Treatment Period 1|Protocol Violation|0
5633333|NCT00685399|19455356|P6|Treatment Period 1|Protocol Violation|0
5633334|NCT00685399|19455357|P5|Treatment Period 1|Protocol Violation|0
5633335|NCT00685399|19455358|P4|Treatment Period 1|Protocol Violation|0
5633336|NCT00685399|19455359|P3|Treatment Period 1|Protocol Violation|0
5633337|NCT00685399|19455360|P2|Treatment Period 1|Protocol Violation|0
5633338|NCT00685399|19455361|P1|Treatment Period 1|Protocol Violation|1
5633339|NCT00685399|19455354|P8|Treatment Period 1|Withdrawal by Subject|0
5633340|NCT00685399|19455355|P7|Treatment Period 1|Withdrawal by Subject|0
5633341|NCT00685399|19455356|P6|Treatment Period 1|Withdrawal by Subject|0
5633342|NCT00685399|19455357|P5|Treatment Period 1|Withdrawal by Subject|0
5633343|NCT00685399|19455358|P4|Treatment Period 1|Withdrawal by Subject|0
5633344|NCT00685399|19455359|P3|Treatment Period 1|Withdrawal by Subject|0
5633345|NCT00685399|19455360|P2|Treatment Period 1|Withdrawal by Subject|0
5633346|NCT00685399|19455361|P1|Treatment Period 1|Withdrawal by Subject|2
5633347|NCT00685373|19455394|P1|Overall Study|Protocol Violation|1
5633348|NCT00685373|19455394|P1|Overall Study|Lost to Follow-up|2
5633349|NCT00685373|19455394|P1|Overall Study|Condition no longer requires study drug|1
5633350|NCT00685373|19455394|P1|Overall Study|Lack of Efficacy|3
5633351|NCT00685373|19455394|P1|Overall Study|Withdrawal by Subject|5
5633352|NCT00685373|19455394|P1|Overall Study|Adverse Event|3
5633353|NCT00685334|19455403|P2|Overall Study|Chose to enter hospital|1
5633354|NCT00685334|19455404|P1|Overall Study|Chose to enter hospital|1
5633355|NCT00685334|19455403|P2|Overall Study|Lost to Follow-up|0
5633356|NCT00685334|19455404|P1|Overall Study|Lost to Follow-up|4
5633357|NCT00685334|19455403|P2|Overall Study|Withdrawal by Subject|6
5633358|NCT00685334|19455404|P1|Overall Study|Withdrawal by Subject|5
5633359|NCT00685178|19455429|P4|Overall Study|Pregnancy|1
5633360|NCT00685178|19455430|P3|Overall Study|Pregnancy|0
5633361|NCT00685178|19455431|P2|Overall Study|Pregnancy|0
5633362|NCT00685178|19455432|P1|Overall Study|Pregnancy|0
5633363|NCT00685178|19455429|P4|Overall Study|administrative (disciplinary) discharge|2
5633364|NCT00685178|19455430|P3|Overall Study|administrative (disciplinary) discharge|0
5633365|NCT00685178|19455431|P2|Overall Study|administrative (disciplinary) discharge|1
5633366|NCT00685178|19455432|P1|Overall Study|administrative (disciplinary) discharge|0
5633367|NCT00685178|19455429|P4|Overall Study|incarcerated|0
5633368|NCT00685178|19455430|P3|Overall Study|incarcerated|7
5633369|NCT00685178|19455431|P2|Overall Study|incarcerated|3
5633370|NCT00685178|19455432|P1|Overall Study|incarcerated|1
5633371|NCT00685178|19455429|P4|Overall Study|voluntary study discharge|1
5633372|NCT00685178|19455430|P3|Overall Study|voluntary study discharge|1
5633373|NCT00685178|19455431|P2|Overall Study|voluntary study discharge|5
5633374|NCT00685178|19455432|P1|Overall Study|voluntary study discharge|4
5633375|NCT00685178|19455429|P4|Overall Study|missed 3 consecutive methadone clin days|6
5633376|NCT00685178|19455430|P3|Overall Study|missed 3 consecutive methadone clin days|2
5633377|NCT00685178|19455431|P2|Overall Study|missed 3 consecutive methadone clin days|5
5633378|NCT00685178|19455432|P1|Overall Study|missed 3 consecutive methadone clin days|7
5633379|NCT00685178|19455429|P4|Overall Study|Adverse Event|4
5633380|NCT00685178|19455430|P3|Overall Study|Adverse Event|2
5633381|NCT00685178|19455431|P2|Overall Study|Adverse Event|5
5633382|NCT00685178|19455432|P1|Overall Study|Adverse Event|1
5633383|NCT00685165|19455446|P2|Washout Period of 14 Days|Adverse Event|0
5633384|NCT00685165|19455447|P1|Washout Period of 14 Days|Adverse Event|1
5633385|NCT00685035|19455466|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
5633386|NCT00685035|19455467|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
5633387|NCT00684996|19455491|P1|Overall Study|Other reasons not protocol specified|1
5633388|NCT00684996|19455491|P1|Overall Study|Progression/relapse|2
5633389|NCT00684996|19455491|P1|Overall Study|Refusal unrelated to adverse event|1
5633390|NCT00684996|19455491|P1|Overall Study|Adverse Event|1
5633391|NCT00684814|19455523|P2|Second Intervention|Adverse Event|0
5633392|NCT00684814|19455524|P1|Second Intervention|Adverse Event|1
5633393|NCT00684814|19455523|P2|Washout Period of 7 Days|Withdrawal by Subject|2
5633394|NCT00684814|19455524|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5633395|NCT00684814|19455523|P2|Washout Period of 7 Days|Adverse Event|2
5633396|NCT00684814|19455524|P1|Washout Period of 7 Days|Adverse Event|1
5633397|NCT00684762|19455576|P2|Washout Period of 7 Days|Withdrawal by Subject|2
5633398|NCT00684762|19455577|P1|Washout Period of 7 Days|Withdrawal by Subject|2
5633399|NCT00684671|19455605|P3|Overall Study|Alcoholic dependance|0
5633400|NCT00684671|19455606|P2|Overall Study|Alcoholic dependance|0
5633401|NCT00684671|19455607|P1|Overall Study|Alcoholic dependance|1
5633402|NCT00684671|19455605|P3|Overall Study|Lost to Follow-up|0
5633403|NCT00684671|19455606|P2|Overall Study|Lost to Follow-up|0
5633404|NCT00684671|19455607|P1|Overall Study|Lost to Follow-up|1
5633405|NCT00684671|19455605|P3|Overall Study|Adverse Event|0
5633406|NCT00684671|19455606|P2|Overall Study|Adverse Event|0
5633407|NCT00684671|19455607|P1|Overall Study|Adverse Event|1
5633408|NCT00684645|19455636|P1|Overall Study|Other|15
5633409|NCT00684645|19455636|P1|Overall Study|Lost to Follow-up|3
5633410|NCT00684645|19455636|P1|Overall Study|Adverse Event|27
5633411|NCT00684645|19455636|P1|Overall Study|Progressive disease|67
5633412|NCT00684645|19455636|P1|Overall Study|Death|2
5633413|NCT00684593|19455656|P2|Overall Study|Adverse Event|2
5633414|NCT00684593|19455657|P1|Overall Study|Adverse Event|0
5633415|NCT00684567|19455669|P1|Monotherapy Period|Progression of primary disease|11
5633416|NCT00684567|19455669|P1|Monotherapy Period|Death|1
5633417|NCT00684567|19455669|P1|Monotherapy Period|Adverse Event|2
5633418|NCT00684567|19455669|P1|Concomitant Radiotherapy Period|Adverse Event|2
5633419|NCT00684515|19455702|P3|Overall Study|Protocol-Defined Clinical Event|0
5633420|NCT00684515|19455703|P2|Overall Study|Protocol-Defined Clinical Event|0
5633421|NCT00684515|19455704|P1|Overall Study|Protocol-Defined Clinical Event|1
5633422|NCT00684515|19455702|P3|Overall Study|Adverse Event|1
5633423|NCT00684515|19455703|P2|Overall Study|Adverse Event|3
5633424|NCT00684515|19455704|P1|Overall Study|Adverse Event|3
5633425|NCT00684424|19455727|P1|Overall Study|Other|2
5633426|NCT00684424|19455727|P1|Overall Study|Lost to Follow-up|2
5633427|NCT00684424|19455727|P1|Overall Study|Adverse Event|1
5633428|NCT00684411|19455742|P1|Overall Study|Adverse Event|1
5633429|NCT00684411|19455742|P1|Overall Study|Disease Progression|10
5633430|NCT00684411|19455742|P1|Overall Study|New Primary Cancer|1
5633431|NCT00684307|19455764|P5|Overall Study|Criteria from the CSR|3
5633432|NCT00684307|19455765|P4|Overall Study|Criteria from the CSR|3
5633433|NCT00684307|19455766|P3|Overall Study|Criteria from the CSR|1
5633434|NCT00684307|19455767|P2|Overall Study|Criteria from the CSR|0
5633435|NCT00684307|19455768|P1|Overall Study|Criteria from the CSR|0
5633436|NCT00684307|19455764|P5|Overall Study|Participant not willing to continue|8
5633437|NCT00684307|19455765|P4|Overall Study|Participant not willing to continue|5
5633438|NCT00684307|19455766|P3|Overall Study|Participant not willing to continue|11
5633439|NCT00684307|19455767|P2|Overall Study|Participant not willing to continue|10
5633440|NCT00684307|19455768|P1|Overall Study|Participant not willing to continue|7
5633441|NCT00684307|19455764|P5|Overall Study|Severe non compliance to protocol|2
5633442|NCT00684307|19455765|P4|Overall Study|Severe non compliance to protocol|1
5633443|NCT00684307|19455766|P3|Overall Study|Severe non compliance to protocol|0
5633444|NCT00684307|19455767|P2|Overall Study|Severe non compliance to protocol|0
5633445|NCT00684307|19455768|P1|Overall Study|Severe non compliance to protocol|1
5633446|NCT00684307|19455764|P5|Overall Study|Interupted IP for more than 7 days|3
5633447|NCT00684307|19455765|P4|Overall Study|Interupted IP for more than 7 days|3
5633448|NCT00684307|19455766|P3|Overall Study|Interupted IP for more than 7 days|1
5633449|NCT00684307|19455767|P2|Overall Study|Interupted IP for more than 7 days|4
5633450|NCT00684307|19455768|P1|Overall Study|Interupted IP for more than 7 days|0
5633451|NCT00684307|19455764|P5|Overall Study|Incorrect enrolment or randomization|0
5633452|NCT00684307|19455765|P4|Overall Study|Incorrect enrolment or randomization|0
5633453|NCT00684307|19455766|P3|Overall Study|Incorrect enrolment or randomization|0
5633454|NCT00684307|19455767|P2|Overall Study|Incorrect enrolment or randomization|0
5633455|NCT00684307|19455768|P1|Overall Study|Incorrect enrolment or randomization|4
5633456|NCT00684307|19455764|P5|Overall Study|Fullfillment of exclusion criteria|1
5633457|NCT00684307|19455765|P4|Overall Study|Fullfillment of exclusion criteria|3
5633458|NCT00684307|19455766|P3|Overall Study|Fullfillment of exclusion criteria|0
5633459|NCT00684307|19455767|P2|Overall Study|Fullfillment of exclusion criteria|0
5633460|NCT00684307|19455768|P1|Overall Study|Fullfillment of exclusion criteria|1
5633461|NCT00684307|19455764|P5|Overall Study|Development of increasing Liver Function|0
5633462|NCT00684307|19455765|P4|Overall Study|Development of increasing Liver Function|1
5633463|NCT00684307|19455766|P3|Overall Study|Development of increasing Liver Function|0
5633464|NCT00684307|19455767|P2|Overall Study|Development of increasing Liver Function|2
5633465|NCT00684307|19455768|P1|Overall Study|Development of increasing Liver Function|0
5633466|NCT00684307|19455764|P5|Overall Study|Adverse Event|8
5633467|NCT00684307|19455765|P4|Overall Study|Adverse Event|16
5633468|NCT00684307|19455766|P3|Overall Study|Adverse Event|15
5633469|NCT00684307|19455767|P2|Overall Study|Adverse Event|6
5633470|NCT00684307|19455768|P1|Overall Study|Adverse Event|11
5633471|NCT00684203|19455850|P6|Overall Study|Did not meet protocol eligibility|0
5633472|NCT00684203|19455851|P5|Overall Study|Did not meet protocol eligibility|0
5633473|NCT00684203|19455852|P4|Overall Study|Did not meet protocol eligibility|0
5633474|NCT00684203|19455853|P3|Overall Study|Did not meet protocol eligibility|0
5633475|NCT00684203|19455854|P2|Overall Study|Did not meet protocol eligibility|1
5633476|NCT00684203|19455855|P1|Overall Study|Did not meet protocol eligibility|0
5633477|NCT00684203|19455850|P6|Overall Study|Withdrawal by Subject|0
5633478|NCT00684203|19455851|P5|Overall Study|Withdrawal by Subject|0
5633479|NCT00684203|19455852|P4|Overall Study|Withdrawal by Subject|0
5633480|NCT00684203|19455853|P3|Overall Study|Withdrawal by Subject|1
5633481|NCT00684203|19455854|P2|Overall Study|Withdrawal by Subject|2
5633482|NCT00684203|19455855|P1|Overall Study|Withdrawal by Subject|0
5633483|NCT00684203|19455850|P6|Overall Study|Protocol-defined clinical event|0
5633484|NCT00684203|19455851|P5|Overall Study|Protocol-defined clinical event|0
5633485|NCT00684203|19455852|P4|Overall Study|Protocol-defined clinical event|0
5633486|NCT00684203|19455853|P3|Overall Study|Protocol-defined clinical event|0
5633487|NCT00684203|19455854|P2|Overall Study|Protocol-defined clinical event|1
5633488|NCT00684203|19455855|P1|Overall Study|Protocol-defined clinical event|3
5633489|NCT00684203|19455850|P6|Overall Study|Adverse Event|0
5633490|NCT00684203|19455851|P5|Overall Study|Adverse Event|0
5633491|NCT00684203|19455852|P4|Overall Study|Adverse Event|0
5633492|NCT00684203|19455853|P3|Overall Study|Adverse Event|8
5633493|NCT00684203|19455854|P2|Overall Study|Adverse Event|4
5633494|NCT00684203|19455855|P1|Overall Study|Adverse Event|6
5633495|NCT00684177|19455916|P2|Overall Study|Other|2
5633496|NCT00684177|19455917|P1|Overall Study|Other|1
5633497|NCT00684177|19455916|P2|Overall Study|Withdrawal by Subject|2
5633498|NCT00684177|19455917|P1|Overall Study|Withdrawal by Subject|1
5633499|NCT00684177|19455916|P2|Overall Study|Physician Decision|0
5633500|NCT00684177|19455917|P1|Overall Study|Physician Decision|2
5633501|NCT00684177|19455916|P2|Overall Study|Lost to Follow-up|1
5633502|NCT00684177|19455917|P1|Overall Study|Lost to Follow-up|2
5633503|NCT00684177|19455916|P2|Overall Study|Protocol Violation|0
5633504|NCT00684177|19455917|P1|Overall Study|Protocol Violation|1
5633505|NCT00684177|19455916|P2|Overall Study|Lack of Efficacy|15
5633506|NCT00684177|19455917|P1|Overall Study|Lack of Efficacy|10
5633507|NCT00684177|19455916|P2|Overall Study|Adverse Event|3
5633508|NCT00684177|19455917|P1|Overall Study|Adverse Event|4
5633509|NCT00684073|19455952|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
5633510|NCT00684073|19455952|P1|Selection|request of the sponsor|1
5633511|NCT00684073|19455952|P1|Selection|Lost to Follow-up|1
5633512|NCT00684073|19455952|P1|Selection|noncompliance|1
5633513|NCT00684073|19455952|P1|Selection|Death|1
5633514|NCT00684073|19455952|P1|Selection|Selection/non-selection criteria|3
5633515|NCT00684060|19455962|P2|Overall Study|Death|1
5633516|NCT00684060|19455963|P1|Overall Study|Death|0
5633517|NCT00684060|19455962|P2|Overall Study|Unable to collect MRI|2
5633518|NCT00684060|19455963|P1|Overall Study|Unable to collect MRI|1
5633519|NCT00684060|19455962|P2|Overall Study|New stenosis identified|0
5633520|NCT00684060|19455963|P1|Overall Study|New stenosis identified|1
5633521|NCT00684060|19455962|P2|Overall Study|Lost to Follow-up|0
5633522|NCT00684060|19455963|P1|Overall Study|Lost to Follow-up|1
5633523|NCT00684021|19456002|P4|Overall Study|Death|0
5633524|NCT00684021|19456003|P3|Overall Study|Death|0
5633525|NCT00684021|19456004|P2|Overall Study|Death|0
5633526|NCT00684021|19456005|P1|Overall Study|Death|1
5633527|NCT00684021|19456002|P4|Overall Study|MRI not performed|2
5633528|NCT00684021|19456003|P3|Overall Study|MRI not performed|1
5633529|NCT00684021|19456004|P2|Overall Study|MRI not performed|1
5633530|NCT00684021|19456005|P1|Overall Study|MRI not performed|0
5633531|NCT00684021|19456002|P4|Overall Study|MRI Contraindicated|0
5633532|NCT00684021|19456003|P3|Overall Study|MRI Contraindicated|1
5633533|NCT00684021|19456004|P2|Overall Study|MRI Contraindicated|1
5633534|NCT00684021|19456005|P1|Overall Study|MRI Contraindicated|1
5633535|NCT00683917|19456066|P1|Overall Study|Study prematurely terminated|10
5633536|NCT00683904|19456076|P2|Dose Level 2|Adverse Event|2
5633537|NCT00683904|19456077|P1|Dose Level 2|Adverse Event|0
5633538|NCT00683904|19456076|P2|Dose Level 1|Adverse Event|0
5633539|NCT00683904|19456077|P1|Dose Level 1|Adverse Event|1
5633540|NCT00683904|19456076|P2|Dose Level 1|Disease progression|0
5633541|NCT00683904|19456077|P1|Dose Level 1|Disease progression|2
5633542|NCT00683878|19456113|P3|Overall Study|Non-compliance, not met criteria etc.|0
5633543|NCT00683878|19456114|P2|Overall Study|Non-compliance, not met criteria etc.|2
5633544|NCT00683878|19456115|P1|Overall Study|Non-compliance, not met criteria etc.|3
5633545|NCT00683878|19456113|P3|Overall Study|Lost to Follow-up|4
5633546|NCT00683878|19456114|P2|Overall Study|Lost to Follow-up|2
5633547|NCT00683878|19456115|P1|Overall Study|Lost to Follow-up|4
5633548|NCT00683878|19456113|P3|Overall Study|Death|0
5633549|NCT00683878|19456114|P2|Overall Study|Death|1
5633550|NCT00683878|19456115|P1|Overall Study|Death|0
5633551|NCT00683878|19456113|P3|Overall Study|Withdrawal by Subject|6
5633552|NCT00683878|19456114|P2|Overall Study|Withdrawal by Subject|8
5633553|NCT00683878|19456115|P1|Overall Study|Withdrawal by Subject|9
5633554|NCT00683878|19456113|P3|Overall Study|Adverse Event|3
5633555|NCT00683878|19456114|P2|Overall Study|Adverse Event|3
5633556|NCT00683878|19456115|P1|Overall Study|Adverse Event|4
5633557|NCT00683878|19456113|P3|Overall Study|Lack of Efficacy|1
5633558|NCT00683878|19456114|P2|Overall Study|Lack of Efficacy|0
5633559|NCT00683878|19456115|P1|Overall Study|Lack of Efficacy|3
5633560|NCT00683800|19456189|P2|Overall Study|Randomized, not treated|33
5633561|NCT00683800|19456190|P1|Overall Study|Randomized, not treated|35
5633562|NCT00683800|19456189|P2|Overall Study|Lack of Efficacy|104
5633563|NCT00683800|19456190|P1|Overall Study|Lack of Efficacy|61
5633564|NCT00683800|19456189|P2|Overall Study|Withdrawal by Subject|64
5633565|NCT00683800|19456190|P1|Overall Study|Withdrawal by Subject|66
5633566|NCT00683800|19456189|P2|Overall Study|Protocol Violation|16
5633567|NCT00683800|19456190|P1|Overall Study|Protocol Violation|13
5633568|NCT00683800|19456189|P2|Overall Study|Other|2
5633569|NCT00683800|19456190|P1|Overall Study|Other|5
5633570|NCT00683800|19456189|P2|Overall Study|Lost to Follow-up|44
5633571|NCT00683800|19456190|P1|Overall Study|Lost to Follow-up|57
5633572|NCT00683800|19456189|P2|Overall Study|Death|1
5633573|NCT00683800|19456190|P1|Overall Study|Death|0
5633574|NCT00683800|19456189|P2|Overall Study|Adverse Event|102
5633575|NCT00683800|19456190|P1|Overall Study|Adverse Event|195
5633576|NCT00683787|19456257|P3|Overall Study|Adverse Event|2
5633577|NCT00683787|19456258|P2|Overall Study|Adverse Event|0
5633578|NCT00683787|19456259|P1|Overall Study|Adverse Event|0
5633579|NCT00683787|19456257|P3|Overall Study|Progression|0
5633580|NCT00683787|19456258|P2|Overall Study|Progression|3
5633581|NCT00683787|19456259|P1|Overall Study|Progression|3
5633582|NCT00683774|19456278|P2|Overall Study|Physician Decision|0
5633583|NCT00683774|19456279|P1|Overall Study|Physician Decision|3
5633584|NCT00683774|19456278|P2|Overall Study|Withdrawal by Subject|1
5633585|NCT00683774|19456279|P1|Overall Study|Withdrawal by Subject|0
5633586|NCT00683696|19456289|P2|Overall Study|Death|30
5633587|NCT00683696|19456290|P1|Overall Study|Death|46
5633588|NCT00683696|19456289|P2|Overall Study|Vital status follow-up only|3
5633589|NCT00683696|19456290|P1|Overall Study|Vital status follow-up only|3
5633590|NCT00683696|19456289|P2|Overall Study|Lost to Follow-up|6
5633591|NCT00683696|19456290|P1|Overall Study|Lost to Follow-up|5
5633592|NCT00683696|19456289|P2|Overall Study|Withdrawn prior to study closure|28
5633593|NCT00683696|19456290|P1|Overall Study|Withdrawn prior to study closure|13
5633594|NCT00683696|19456289|P2|Overall Study|Withdrawn due to study closure|338
5633595|NCT00683696|19456290|P1|Overall Study|Withdrawn due to study closure|337
5633596|NCT00683657|19456309|P2|Overall Study|Subject Withdrew Consent|0
5633597|NCT00683657|19456310|P1|Overall Study|Subject Withdrew Consent|1
5633598|NCT00683657|19456309|P2|Overall Study|Adverse Event|1
5633599|NCT00683657|19456310|P1|Overall Study|Adverse Event|0
5633600|NCT00683644|19456326|P2|Overall Study|Low copper, other health problems,|6
5633601|NCT00683644|19456327|P1|Overall Study|Low copper, other health problems,|7
5633602|NCT00683644|19456326|P2|Overall Study|Adverse Event|2
5633603|NCT00683644|19456327|P1|Overall Study|Adverse Event|1
5633604|NCT00683644|19456326|P2|Overall Study|Lost to Follow-up|4
5633605|NCT00683644|19456327|P1|Overall Study|Lost to Follow-up|1
5633606|NCT00683644|19456326|P2|Overall Study|Withdrawal by Subject|2
5633607|NCT00683644|19456327|P1|Overall Study|Withdrawal by Subject|4
5633608|NCT00683618|19456340|P3|Extension Treatment Period|Protocol Violation|0
5633609|NCT00683618|19456341|P2|Extension Treatment Period|Protocol Violation|0
5633610|NCT00683618|19456342|P1|Extension Treatment Period|Protocol Violation|1
5633611|NCT00683618|19456340|P3|Extension Treatment Period|Adverse Event|0
5633612|NCT00683618|19456341|P2|Extension Treatment Period|Adverse Event|0
5633613|NCT00683618|19456342|P1|Extension Treatment Period|Adverse Event|1
5633614|NCT00683618|19456340|P3|Extension Treatment Period|Withdrawal by Subject|0
5633615|NCT00683618|19456341|P2|Extension Treatment Period|Withdrawal by Subject|0
5633616|NCT00683618|19456342|P1|Extension Treatment Period|Withdrawal by Subject|1
5633617|NCT00683618|19456340|P3|Randomised Treatment Period|Reason not provided|2
5633618|NCT00683618|19456341|P2|Randomised Treatment Period|Reason not provided|0
5633619|NCT00683618|19456342|P1|Randomised Treatment Period|Reason not provided|0
5633620|NCT00683618|19456340|P3|Randomised Treatment Period|Adverse Event|2
5633621|NCT00683618|19456341|P2|Randomised Treatment Period|Adverse Event|0
5633622|NCT00683618|19456342|P1|Randomised Treatment Period|Adverse Event|2
5633623|NCT00683618|19456340|P3|Randomised Treatment Period|Protocol Violation|0
5633624|NCT00683618|19456341|P2|Randomised Treatment Period|Protocol Violation|1
5633625|NCT00683618|19456342|P1|Randomised Treatment Period|Protocol Violation|0
5633626|NCT00683618|19456340|P3|Randomised Treatment Period|Withdrawal by Subject|2
5633627|NCT00683618|19456341|P2|Randomised Treatment Period|Withdrawal by Subject|1
5633628|NCT00683618|19456342|P1|Randomised Treatment Period|Withdrawal by Subject|4
5633629|NCT00683592|19456392|P2|Overall Study|Other|1
5633630|NCT00683592|19456393|P1|Overall Study|Other|1
5633631|NCT00683592|19456392|P2|Overall Study|Non-compliance|5
5633632|NCT00683592|19456393|P1|Overall Study|Non-compliance|3
5633633|NCT00683592|19456392|P2|Overall Study|Physician Decision|1
5633634|NCT00683592|19456393|P1|Overall Study|Physician Decision|0
5633635|NCT00683592|19456392|P2|Overall Study|Lack of Efficacy|7
5633636|NCT00683592|19456393|P1|Overall Study|Lack of Efficacy|3
5633637|NCT00683592|19456392|P2|Overall Study|Lost to Follow-up|17
5633638|NCT00683592|19456393|P1|Overall Study|Lost to Follow-up|17
5633639|NCT00683592|19456392|P2|Overall Study|Withdrawal by Subject|11
5633640|NCT00683592|19456393|P1|Overall Study|Withdrawal by Subject|11
5633641|NCT00683592|19456392|P2|Overall Study|Adverse Event|4
5633642|NCT00683592|19456393|P1|Overall Study|Adverse Event|12
5633643|NCT00683475|19456411|P2|Overall Study|Never Treated: Progressive Disease|0
5633644|NCT00683475|19456412|P1|Overall Study|Never Treated: Progressive Disease|1
5633645|NCT00683475|19456411|P2|Overall Study|Never Treated: Adverse Event|3
5633646|NCT00683475|19456412|P1|Overall Study|Never Treated: Adverse Event|2
5633647|NCT00683475|19456411|P2|Overall Study|Withdrawal by Subject|0
5633648|NCT00683475|19456412|P1|Overall Study|Withdrawal by Subject|1
5633649|NCT00683449|19456447|P5|Overall Study|Lost to Follow-up|0
5633650|NCT00683449|19456448|P4|Overall Study|Lost to Follow-up|0
5633651|NCT00683449|19456449|P3|Overall Study|Lost to Follow-up|0
5633652|NCT00683449|19456450|P2|Overall Study|Lost to Follow-up|1
5633653|NCT00683449|19456451|P1|Overall Study|Lost to Follow-up|0
5633654|NCT00683384|19456477|P1|Overall Study|Adverse Event|1
5633655|NCT00683384|19456477|P1|Overall Study|Death|1
5633656|NCT00683293|19456487|P2|Overall Study|Withdrawal by Subject|3
5633657|NCT00683293|19456488|P1|Overall Study|Withdrawal by Subject|2
5633658|NCT00682929|19456551|P3|Overall Study|lag in DEA renewal|0
5633659|NCT00682929|19456552|P2|Overall Study|lag in DEA renewal|0
5633660|NCT00682929|19456553|P1|Overall Study|lag in DEA renewal|1
5633661|NCT00682929|19456551|P3|Overall Study|dosing compliance < 80%|0
5633662|NCT00682929|19456552|P2|Overall Study|dosing compliance < 80%|2
5633663|NCT00682929|19456553|P1|Overall Study|dosing compliance < 80%|0
5633664|NCT00682929|19456551|P3|Overall Study|Withdrawal by Subject|1
5633665|NCT00682929|19456552|P2|Overall Study|Withdrawal by Subject|2
5633666|NCT00682929|19456553|P1|Overall Study|Withdrawal by Subject|1
5633667|NCT00682929|19456551|P3|Overall Study|Adverse Event|1
5633668|NCT00682929|19456552|P2|Overall Study|Adverse Event|1
5633669|NCT00682929|19456553|P1|Overall Study|Adverse Event|4
5633670|NCT00682890|19456722|P2|Overall Study|heavy menstrual bleeding|0
5633671|NCT00682890|19456723|P1|Overall Study|heavy menstrual bleeding|1
5633672|NCT00682890|19456722|P2|Overall Study|subject moved away|1
5633673|NCT00682890|19456723|P1|Overall Study|subject moved away|0
5633674|NCT00682890|19456722|P2|Overall Study|Lost to Follow-up|1
5633675|NCT00682890|19456723|P1|Overall Study|Lost to Follow-up|1
5633676|NCT00682786|19456765|P2|Overall Study|Did not receive irinotecan|1
5633677|NCT00682786|19456766|P1|Overall Study|Did not receive irinotecan|0
5633678|NCT00682786|19456765|P2|Overall Study|Withdrawal by Subject|2
5633679|NCT00682786|19456766|P1|Overall Study|Withdrawal by Subject|2
5633680|NCT00682643|19456815|P2|Overall Study|Did Not Receive Study Drug|1
5633681|NCT00682643|19456816|P1|Overall Study|Did Not Receive Study Drug|1
5633682|NCT00682643|19456815|P2|Overall Study|Withdrawal by Subject|53
5633683|NCT00682643|19456816|P1|Overall Study|Withdrawal by Subject|19
5633684|NCT00682643|19456815|P2|Overall Study|Physician Decision|6
5633685|NCT00682643|19456816|P1|Overall Study|Physician Decision|2
5633686|NCT00682643|19456815|P2|Overall Study|Lost to Follow-up|6
5633687|NCT00682643|19456816|P1|Overall Study|Lost to Follow-up|1
5633688|NCT00682643|19456815|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
5633689|NCT00682643|19456816|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
5633690|NCT00682643|19456815|P2|Overall Study|Protocol Violation|76
5633691|NCT00682643|19456816|P1|Overall Study|Protocol Violation|38
5633692|NCT00682643|19456815|P2|Overall Study|Lack of Efficacy|0
5633693|NCT00682643|19456816|P1|Overall Study|Lack of Efficacy|2
5633694|NCT00682643|19456815|P2|Overall Study|Adverse Event|23
5633695|NCT00682643|19456816|P1|Overall Study|Adverse Event|12
5633696|NCT00682539|19456890|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
5633697|NCT00682539|19456891|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
5633698|NCT00682539|19456892|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
5633699|NCT00682539|19456890|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
5633700|NCT00682539|19456891|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
5633701|NCT00682539|19456892|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
5633702|NCT00682461|19456905|P2|Overall Study|Withdrawal by Subject|19
5633703|NCT00682461|19456906|P1|Overall Study|Withdrawal by Subject|12
5633704|NCT00682461|19456905|P2|Overall Study|Lost to Follow-up|5
5633705|NCT00682461|19456906|P1|Overall Study|Lost to Follow-up|8
5633706|NCT00682461|19456905|P2|Overall Study|Adverse Event|7
5633707|NCT00682461|19456906|P1|Overall Study|Adverse Event|5
5633708|NCT00682435|19456920|P1|Overall Study|Erroneously enrolled twice|2
5633709|NCT00682435|19456920|P1|Overall Study|Insufficient data|5
5633710|NCT00681863|19456953|P1|Overall Study|Other|18
5633711|NCT00681863|19456953|P1|Overall Study|Lack of Efficacy|2
5633712|NCT00681863|19456953|P1|Overall Study|Lost to Follow-up|2
5633713|NCT00681863|19456953|P1|Overall Study|Adverse Event|1
5633714|NCT00681824|19457001|P3|Overall Study|Death|0
5633715|NCT00681824|19457002|P2|Overall Study|Death|1
5633716|NCT00681824|19457003|P1|Overall Study|Death|0
5633717|NCT00681824|19457001|P3|Overall Study|scheduling conflict|0
5633718|NCT00681824|19457002|P2|Overall Study|scheduling conflict|0
5633719|NCT00681824|19457003|P1|Overall Study|scheduling conflict|1
5633720|NCT00681824|19457001|P3|Overall Study|withdrawn by investigator|1
5633721|NCT00681824|19457002|P2|Overall Study|withdrawn by investigator|0
5633722|NCT00681824|19457003|P1|Overall Study|withdrawn by investigator|0
5633723|NCT00681811|19457021|P2|Overall Study|Non-compliance|1
5633724|NCT00681811|19457022|P1|Overall Study|Non-compliance|0
5633725|NCT00681811|19457021|P2|Overall Study|Withdrawal by Subject|2
5633726|NCT00681811|19457022|P1|Overall Study|Withdrawal by Subject|2
5633727|NCT00681811|19457021|P2|Overall Study|Adverse Event|1
5633728|NCT00681811|19457022|P1|Overall Study|Adverse Event|1
5633729|NCT00681668|19457050|P1|Overall Study|Withdrawal by Subject|1
5633730|NCT00681668|19457050|P1|Overall Study|Protocol Violation|1
5633731|NCT00681629|19457059|P2|Overall Study|Adverse Event|0
5633732|NCT00681629|19457060|P1|Overall Study|Adverse Event|1
5633733|NCT00681629|19457059|P2|Overall Study|Study termination|2
5633734|NCT00681629|19457060|P1|Overall Study|Study termination|4
5633735|NCT00681590|19457106|P2|Overall Study|Withdrawal by Subject|12
5633736|NCT00681590|19457107|P1|Overall Study|Withdrawal by Subject|2
5633737|NCT00681564|19457117|P2|Overall Study|Death|1
5633738|NCT00681564|19457118|P1|Overall Study|Death|0
5633739|NCT00681564|19457117|P2|Overall Study|Withdrawal by Subject|1
5633740|NCT00681564|19457118|P1|Overall Study|Withdrawal by Subject|0
5633741|NCT00681564|19457117|P2|Overall Study|Lost to Follow-up|6
5633742|NCT00681564|19457118|P1|Overall Study|Lost to Follow-up|6
5633743|NCT00681187|19457210|P2|Overall Study|Adverse Event|1
5633744|NCT00681187|19457211|P1|Overall Study|Adverse Event|0
5633745|NCT00681187|19457210|P2|Overall Study|Death|1
5633746|NCT00681187|19457211|P1|Overall Study|Death|0
5633747|NCT00681187|19457210|P2|Overall Study|Withdrawal by Subject|0
5633748|NCT00681187|19457211|P1|Overall Study|Withdrawal by Subject|1
5633749|NCT00681109|19457246|P3|Overall Study|Lost to Follow-up|0
5633750|NCT00681109|19457247|P2|Overall Study|Lost to Follow-up|6
5633751|NCT00681109|19457248|P1|Overall Study|Lost to Follow-up|2
5633752|NCT00680992|19457289|P3|Overall Study|Ineligibility Determined|0
5633753|NCT00680992|19457290|P2|Overall Study|Ineligibility Determined|1
5633754|NCT00680992|19457291|P1|Overall Study|Ineligibility Determined|0
5633755|NCT00680992|19457289|P3|Overall Study|Death|0
5633756|NCT00680992|19457290|P2|Overall Study|Death|1
5633757|NCT00680992|19457291|P1|Overall Study|Death|5
5633758|NCT00680992|19457289|P3|Overall Study|Pregnancy|1
5633759|NCT00680992|19457290|P2|Overall Study|Pregnancy|0
5633760|NCT00680992|19457291|P1|Overall Study|Pregnancy|5
5633761|NCT00680992|19457289|P3|Overall Study|Requirement for Alternative Therapy|0
5633762|NCT00680992|19457290|P2|Overall Study|Requirement for Alternative Therapy|2
5633763|NCT00680992|19457291|P1|Overall Study|Requirement for Alternative Therapy|8
5633764|NCT00680992|19457289|P3|Overall Study|Noncompliance|0
5633765|NCT00680992|19457290|P2|Overall Study|Noncompliance|6
5633766|NCT00680992|19457291|P1|Overall Study|Noncompliance|4
5633767|NCT00680992|19457289|P3|Overall Study|Lost to Follow-up|0
5633768|NCT00680992|19457290|P2|Overall Study|Lost to Follow-up|14
5633769|NCT00680992|19457291|P1|Overall Study|Lost to Follow-up|12
5633770|NCT00680992|19457289|P3|Overall Study|Disease Progression|0
5633771|NCT00680992|19457290|P2|Overall Study|Disease Progression|9
5633772|NCT00680992|19457291|P1|Overall Study|Disease Progression|21
5633773|NCT00680992|19457289|P3|Overall Study|Other|1
5633774|NCT00680992|19457290|P2|Overall Study|Other|14
5633775|NCT00680992|19457291|P1|Overall Study|Other|19
5633776|NCT00680992|19457289|P3|Overall Study|Adverse Event|1
5633777|NCT00680992|19457290|P2|Overall Study|Adverse Event|19
5633778|NCT00680992|19457291|P1|Overall Study|Adverse Event|21
5633779|NCT00680992|19457289|P3|Overall Study|Withdrawal by Subject|1
5633780|NCT00680992|19457290|P2|Overall Study|Withdrawal by Subject|11
5633781|NCT00680992|19457291|P1|Overall Study|Withdrawal by Subject|33
5633782|NCT00680992|19457289|P3|Overall Study|End of Trial|3
5633783|NCT00680992|19457290|P2|Overall Study|End of Trial|12
5633784|NCT00680992|19457291|P1|Overall Study|End of Trial|32
5633785|NCT00680992|19457289|P3|Overall Study|Administrative Decision|5
5633786|NCT00680992|19457290|P2|Overall Study|Administrative Decision|42
5633787|NCT00680992|19457291|P1|Overall Study|Administrative Decision|83
5633788|NCT00680992|19457289|P3|Overall Study|Complete Resection (as per protocol)|0
5633789|NCT00680992|19457290|P2|Overall Study|Complete Resection (as per protocol)|121
5633790|NCT00680992|19457291|P1|Overall Study|Complete Resection (as per protocol)|25
5633791|NCT00680914|19457325|P2|Overall Study|serious adverse event (SAE)|1
5633792|NCT00680914|19457326|P1|Overall Study|serious adverse event (SAE)|0
5633793|NCT00680914|19457325|P2|Overall Study|Lost to Follow-up|0
5633794|NCT00680914|19457326|P1|Overall Study|Lost to Follow-up|4
5633795|NCT00680914|19457325|P2|Overall Study|Consent withdrawal|3
5633796|NCT00680914|19457326|P1|Overall Study|Consent withdrawal|6
5633797|NCT00680901|19457360|P2|Overall Study|Ongoing: In Follow Up|41
5633798|NCT00680901|19457361|P1|Overall Study|Ongoing: In Follow Up|45
5633799|NCT00680901|19457360|P2|Overall Study|Ongoing: On Study Treatment|13
5633800|NCT00680901|19457361|P1|Overall Study|Ongoing: On Study Treatment|16
5633801|NCT00680901|19457360|P2|Overall Study|Physician Decision|1
5633802|NCT00680901|19457361|P1|Overall Study|Physician Decision|0
5633803|NCT00680901|19457360|P2|Overall Study|Withdrawal by Subject|13
5633804|NCT00680901|19457361|P1|Overall Study|Withdrawal by Subject|4
5633805|NCT00680901|19457360|P2|Overall Study|Lost to Follow-up|8
5633806|NCT00680901|19457361|P1|Overall Study|Lost to Follow-up|8
5633807|NCT00680836|19457399|P2|Overall Study|Physician Decision|1
5633808|NCT00680836|19457400|P1|Overall Study|Physician Decision|2
5633809|NCT00680836|19457399|P2|Overall Study|Lost to Follow-up|1
5633810|NCT00680836|19457400|P1|Overall Study|Lost to Follow-up|3
5633811|NCT00680836|19457399|P2|Overall Study|Withdrawal by Subject|0
5633812|NCT00680836|19457400|P1|Overall Study|Withdrawal by Subject|3
5633813|NCT00680771|19457454|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
5633814|NCT00680771|19457455|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
5633815|NCT00680771|19457454|P2|Overall Study|Sleep Apnea suspected after PSG|0
5633816|NCT00680771|19457455|P1|Overall Study|Sleep Apnea suspected after PSG|1
5633817|NCT00680771|19457454|P2|Overall Study|Withdrawal by Subject|0
5633818|NCT00680771|19457455|P1|Overall Study|Withdrawal by Subject|1
5633819|NCT00680745|19457465|P4|Overall Study|False Treatment|0
5633820|NCT00680745|19457466|P3|Overall Study|False Treatment|3
5633821|NCT00680745|19457467|P2|Overall Study|False Treatment|1
5633822|NCT00680745|19457468|P1|Overall Study|False Treatment|0
5633823|NCT00680745|19457465|P4|Overall Study|Subject No Longer Meets Study Criteria|2
5633824|NCT00680745|19457466|P3|Overall Study|Subject No Longer Meets Study Criteria|0
5633825|NCT00680745|19457467|P2|Overall Study|Subject No Longer Meets Study Criteria|2
5633826|NCT00680745|19457468|P1|Overall Study|Subject No Longer Meets Study Criteria|0
5633827|NCT00680745|19457465|P4|Overall Study|Poor/Non-compliance|0
5633828|NCT00680745|19457466|P3|Overall Study|Poor/Non-compliance|0
5633829|NCT00680745|19457467|P2|Overall Study|Poor/Non-compliance|3
5633830|NCT00680745|19457468|P1|Overall Study|Poor/Non-compliance|0
5633831|NCT00680745|19457465|P4|Overall Study|Adverse Event|3
5633832|NCT00680745|19457466|P3|Overall Study|Adverse Event|3
5633833|NCT00680745|19457467|P2|Overall Study|Adverse Event|3
5633834|NCT00680745|19457468|P1|Overall Study|Adverse Event|5
5633835|NCT00680745|19457465|P4|Overall Study|Death|0
5633836|NCT00680745|19457466|P3|Overall Study|Death|1
5633837|NCT00680745|19457467|P2|Overall Study|Death|0
5633838|NCT00680745|19457468|P1|Overall Study|Death|1
5633839|NCT00680745|19457465|P4|Overall Study|Lost to Follow-up|0
5633840|NCT00680745|19457466|P3|Overall Study|Lost to Follow-up|1
5633841|NCT00680745|19457467|P2|Overall Study|Lost to Follow-up|1
5633842|NCT00680745|19457468|P1|Overall Study|Lost to Follow-up|0
5633843|NCT00680745|19457465|P4|Overall Study|Withdrawal by Subject|8
5633844|NCT00680745|19457466|P3|Overall Study|Withdrawal by Subject|2
5633845|NCT00680745|19457467|P2|Overall Study|Withdrawal by Subject|3
5633846|NCT00680745|19457468|P1|Overall Study|Withdrawal by Subject|8
5633847|NCT00680407|19457542|P3|Overall Study|Withdrawal by Subject|2
5633848|NCT00680407|19457543|P2|Overall Study|Withdrawal by Subject|2
5633849|NCT00680407|19457544|P1|Overall Study|Withdrawal by Subject|5
5633850|NCT00680407|19457542|P3|Overall Study|Lost to Follow-up|1
5633851|NCT00680407|19457543|P2|Overall Study|Lost to Follow-up|3
5633852|NCT00680407|19457544|P1|Overall Study|Lost to Follow-up|3
5633853|NCT00680368|19457558|P1|Overall Study|not supervised, not eligible|15
5633854|NCT00680186|19457586|P2|Overall Study|Other|1
5633855|NCT00680186|19457587|P1|Overall Study|Other|4
5633856|NCT00680186|19457586|P2|Overall Study|Withdrawal by Subject|39
5633857|NCT00680186|19457587|P1|Overall Study|Withdrawal by Subject|32
5633858|NCT00680186|19457586|P2|Overall Study|Lost to Follow-up|6
5633859|NCT00680186|19457587|P1|Overall Study|Lost to Follow-up|11
5633860|NCT00680186|19457586|P2|Overall Study|Protocol Violation|26
5633861|NCT00680186|19457587|P1|Overall Study|Protocol Violation|31
5633862|NCT00680186|19457586|P2|Overall Study|Adverse Event|44
5633863|NCT00680186|19457587|P1|Overall Study|Adverse Event|47
5633864|NCT00680121|19457613|P2|Overall Study|Lost to Follow-up|23
5633865|NCT00680121|19457614|P1|Overall Study|Lost to Follow-up|27
5633866|NCT00680056|19457628|P2|Second Intervention|Protocol Violation|1
5633867|NCT00680056|19457629|P1|Second Intervention|Protocol Violation|3
5633868|NCT00680056|19457628|P2|First Intervention|Mainly Exacerbation of COPD|2
5633869|NCT00680056|19457629|P1|First Intervention|Mainly Exacerbation of COPD|1
5633870|NCT00680043|19457640|P3|Overall Study|Renal Transplant|4
5633871|NCT00680043|19457641|P2|Overall Study|Renal Transplant|0
5633872|NCT00680043|19457642|P1|Overall Study|Renal Transplant|1
5633873|NCT00680043|19457640|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
5633874|NCT00680043|19457641|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
5633875|NCT00680043|19457642|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
5633876|NCT00680043|19457640|P3|Overall Study|Withdrawal by Subject|0
5633877|NCT00680043|19457641|P2|Overall Study|Withdrawal by Subject|0
5633878|NCT00680043|19457642|P1|Overall Study|Withdrawal by Subject|1
5633879|NCT00680017|19457658|P2|Overall Study|Lost to Follow-up|0
5633880|NCT00680017|19457659|P1|Overall Study|Lost to Follow-up|2
5633881|NCT00680017|19457658|P2|Overall Study|Withdrawal by Subject|5
5633882|NCT00680017|19457659|P1|Overall Study|Withdrawal by Subject|2
5633883|NCT00680017|19457658|P2|Overall Study|Adverse Event|7
5633884|NCT00680017|19457659|P1|Overall Study|Adverse Event|13
5633885|NCT00679939|19457678|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
5633886|NCT00679939|19457679|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
5633887|NCT00679939|19457678|P2|24-Week Open-Label (OL) Period|Physician Decision|0
5633888|NCT00679939|19457679|P1|24-Week Open-Label (OL) Period|Physician Decision|1
5633889|NCT00679939|19457678|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
5633890|NCT00679939|19457679|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
5633891|NCT00679939|19457678|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
5633892|NCT00679939|19457679|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
5633893|NCT00679939|19457678|P2|24-Week Open-Label (OL) Period|Adverse Event|1
5633894|NCT00679939|19457679|P1|24-Week Open-Label (OL) Period|Adverse Event|0
5633895|NCT00679939|19457678|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
5633896|NCT00679939|19457679|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
5633897|NCT00679939|19457678|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
5633898|NCT00679939|19457679|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
5633899|NCT00679939|19457678|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
5633900|NCT00679939|19457679|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
5633901|NCT00679939|19457678|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
5633902|NCT00679939|19457679|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
5633903|NCT00679939|19457678|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
5633904|NCT00679939|19457679|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
5633905|NCT00679913|19457845|P2|Overall Study|Protocol Violation|13
5633906|NCT00679913|19457846|P1|Overall Study|Protocol Violation|18
5633907|NCT00679783|19457861|P7|Overall Study|Ongoing at data cut-off|0
5633908|NCT00679783|19457862|P6|Overall Study|Ongoing at data cut-off|0
5633909|NCT00679783|19457863|P5|Overall Study|Ongoing at data cut-off|1
5633910|NCT00679783|19457864|P4|Overall Study|Ongoing at data cut-off|9
5633911|NCT00679783|19457865|P3|Overall Study|Ongoing at data cut-off|0
5633912|NCT00679783|19457866|P2|Overall Study|Ongoing at data cut-off|2
5633913|NCT00679783|19457867|P1|Overall Study|Ongoing at data cut-off|2
5633914|NCT00679783|19457861|P7|Overall Study|Not Captured|0
5633915|NCT00679783|19457862|P6|Overall Study|Not Captured|0
5633916|NCT00679783|19457863|P5|Overall Study|Not Captured|0
5633917|NCT00679783|19457864|P4|Overall Study|Not Captured|5
5633918|NCT00679783|19457865|P3|Overall Study|Not Captured|0
5633919|NCT00679783|19457866|P2|Overall Study|Not Captured|0
5633920|NCT00679783|19457867|P1|Overall Study|Not Captured|0
5633921|NCT00679783|19457861|P7|Overall Study|Withdrawal by Subject|0
5633922|NCT00679783|19457862|P6|Overall Study|Withdrawal by Subject|0
5633923|NCT00679783|19457863|P5|Overall Study|Withdrawal by Subject|0
5633924|NCT00679783|19457864|P4|Overall Study|Withdrawal by Subject|1
5633925|NCT00679783|19457865|P3|Overall Study|Withdrawal by Subject|1
5633926|NCT00679783|19457866|P2|Overall Study|Withdrawal by Subject|0
5633927|NCT00679783|19457867|P1|Overall Study|Withdrawal by Subject|0
5633928|NCT00679783|19457861|P7|Overall Study|Lack of Efficacy|0
5633929|NCT00679783|19457862|P6|Overall Study|Lack of Efficacy|0
5633930|NCT00679783|19457863|P5|Overall Study|Lack of Efficacy|0
5633931|NCT00679783|19457864|P4|Overall Study|Lack of Efficacy|2
5633932|NCT00679783|19457865|P3|Overall Study|Lack of Efficacy|0
5633933|NCT00679783|19457866|P2|Overall Study|Lack of Efficacy|1
5633934|NCT00679783|19457867|P1|Overall Study|Lack of Efficacy|0
5633935|NCT00679783|19457861|P7|Overall Study|Adverse Event|1
5633936|NCT00679783|19457862|P6|Overall Study|Adverse Event|0
5633937|NCT00679783|19457863|P5|Overall Study|Adverse Event|0
5633938|NCT00679783|19457864|P4|Overall Study|Adverse Event|3
5633939|NCT00679783|19457865|P3|Overall Study|Adverse Event|0
5633940|NCT00679783|19457866|P2|Overall Study|Adverse Event|0
5633941|NCT00679783|19457867|P1|Overall Study|Adverse Event|0
5633942|NCT00679627|19457920|P2|Overall Study|Early Study Closure|405
5633943|NCT00679627|19457921|P1|Overall Study|Early Study Closure|425
5633944|NCT00679627|19457920|P2|Overall Study|Lost to Follow-up|26
5633945|NCT00679627|19457921|P1|Overall Study|Lost to Follow-up|22
5633946|NCT00679627|19457920|P2|Overall Study|Withdrawal by Subject|172
5633947|NCT00679627|19457921|P1|Overall Study|Withdrawal by Subject|168
5633948|NCT00679627|19457920|P2|Overall Study|Adverse Event|53
5633949|NCT00679627|19457921|P1|Overall Study|Adverse Event|43
5633950|NCT00679627|19457920|P2|Overall Study|Death|29
5633951|NCT00679627|19457921|P1|Overall Study|Death|41
5633952|NCT00679549|19457945|P2|Overall Study|missing outcome echocardiograms|5
5633953|NCT00679549|19457946|P1|Overall Study|missing outcome echocardiograms|4
5633954|NCT00679549|19457945|P2|Overall Study|dropout|4
5633955|NCT00679549|19457946|P1|Overall Study|dropout|2
5633956|NCT00679432|19457956|P4|Overall Study|Randomization error, return to prior Rx|0
5633957|NCT00679432|19457957|P3|Overall Study|Randomization error, return to prior Rx|3
5633958|NCT00679432|19457958|P2|Overall Study|Randomization error, return to prior Rx|0
5633959|NCT00679432|19457959|P1|Overall Study|Randomization error, return to prior Rx|0
5633960|NCT00679432|19457956|P4|Overall Study|Infectious colitis, normal histology|3
5633961|NCT00679432|19457957|P3|Overall Study|Infectious colitis, normal histology|8
5633962|NCT00679432|19457958|P2|Overall Study|Infectious colitis, normal histology|4
5633963|NCT00679432|19457959|P1|Overall Study|Infectious colitis, normal histology|5
5633964|NCT00679432|19457956|P4|Overall Study|Lack of Efficacy|8
5633965|NCT00679432|19457957|P3|Overall Study|Lack of Efficacy|14
5633966|NCT00679432|19457958|P2|Overall Study|Lack of Efficacy|9
5633967|NCT00679432|19457959|P1|Overall Study|Lack of Efficacy|13
5633968|NCT00679432|19457956|P4|Overall Study|Sponsor decision|0
5633969|NCT00679432|19457957|P3|Overall Study|Sponsor decision|0
5633970|NCT00679432|19457958|P2|Overall Study|Sponsor decision|0
5633971|NCT00679432|19457959|P1|Overall Study|Sponsor decision|1
5633972|NCT00679432|19457956|P4|Overall Study|Physician Decision|2
5633973|NCT00679432|19457957|P3|Overall Study|Physician Decision|2
5633974|NCT00679432|19457958|P2|Overall Study|Physician Decision|2
5633975|NCT00679432|19457959|P1|Overall Study|Physician Decision|3
5633976|NCT00679432|19457956|P4|Overall Study|Lost to Follow-up|2
5633977|NCT00679432|19457957|P3|Overall Study|Lost to Follow-up|4
5633978|NCT00679432|19457958|P2|Overall Study|Lost to Follow-up|5
5633979|NCT00679432|19457959|P1|Overall Study|Lost to Follow-up|1
5633980|NCT00679432|19457956|P4|Overall Study|Withdrawal by Subject|9
5633981|NCT00679432|19457957|P3|Overall Study|Withdrawal by Subject|10
5633982|NCT00679432|19457958|P2|Overall Study|Withdrawal by Subject|11
5633983|NCT00679432|19457959|P1|Overall Study|Withdrawal by Subject|8
5633984|NCT00679432|19457956|P4|Overall Study|Protocol Violation|1
5633985|NCT00679432|19457957|P3|Overall Study|Protocol Violation|2
5633986|NCT00679432|19457958|P2|Overall Study|Protocol Violation|1
5633987|NCT00679432|19457959|P1|Overall Study|Protocol Violation|1
5633988|NCT00679432|19457956|P4|Overall Study|Adverse Event|7
5633989|NCT00679432|19457957|P3|Overall Study|Adverse Event|10
5633990|NCT00679432|19457958|P2|Overall Study|Adverse Event|6
5633991|NCT00679432|19457959|P1|Overall Study|Adverse Event|5
5633992|NCT00679367|19458002|P1|Overall Study|Withdrawal by Subject|1
5633993|NCT00679367|19458002|P1|Overall Study|Lack of Efficacy|3
5633994|NCT00679367|19458002|P1|Overall Study|inability to swallow oral drugs|1
5633995|NCT00679367|19458002|P1|Overall Study|Adverse Event|7
5633996|NCT00679354|19458008|P1|Overall Study|Ineligible|1
5633997|NCT00679354|19458008|P1|Overall Study|Physician Decision|4
5633998|NCT00679354|19458008|P1|Overall Study|Lack of Efficacy|22
5633999|NCT00679354|19458008|P1|Overall Study|Death|3
5634000|NCT00679341|19458026|P2|Overall Study|Physician/patient decision to withdraw|6
5634001|NCT00679341|19458027|P1|Overall Study|Physician/patient decision to withdraw|0
5634002|NCT00679341|19458026|P2|Overall Study|Not treated|2
5634003|NCT00679341|19458027|P1|Overall Study|Not treated|0
5634004|NCT00679341|19458026|P2|Overall Study|Physician Decision|0
5634005|NCT00679341|19458027|P1|Overall Study|Physician Decision|1
5634006|NCT00679341|19458026|P2|Overall Study|Other|0
5634007|NCT00679341|19458027|P1|Overall Study|Other|1
5634008|NCT00679341|19458026|P2|Overall Study|Death|1
5634009|NCT00679341|19458027|P1|Overall Study|Death|1
5634010|NCT00679341|19458026|P2|Overall Study|Subject/guardian decision to discontinue|0
5634011|NCT00679341|19458027|P1|Overall Study|Subject/guardian decision to discontinue|3
5634012|NCT00679341|19458026|P2|Overall Study|Adverse Event|6
5634013|NCT00679341|19458027|P1|Overall Study|Adverse Event|5
5634014|NCT00679341|19458026|P2|Overall Study|Disease progression|36
5634015|NCT00679341|19458027|P1|Overall Study|Disease progression|42
5634016|NCT00679302|19458047|P2|Overall Study|Lost to Follow-up|4
5634017|NCT00679302|19458048|P1|Overall Study|Lost to Follow-up|8
5634018|NCT00679289|19458059|P3|Overall Study|Physician Decision|1
5634019|NCT00679289|19458060|P2|Overall Study|Physician Decision|0
5634020|NCT00679289|19458061|P1|Overall Study|Physician Decision|1
5634021|NCT00679289|19458059|P3|Overall Study|Adverse Event|3
5634022|NCT00679289|19458060|P2|Overall Study|Adverse Event|0
5634023|NCT00679289|19458061|P1|Overall Study|Adverse Event|0
5634024|NCT00679289|19458059|P3|Overall Study|Withdrawal by Subject|1
5634025|NCT00679289|19458060|P2|Overall Study|Withdrawal by Subject|1
5634026|NCT00679289|19458061|P1|Overall Study|Withdrawal by Subject|0
5634027|NCT00679289|19458059|P3|Overall Study|Progressive disease|18
5634028|NCT00679289|19458060|P2|Overall Study|Progressive disease|5
5634029|NCT00679289|19458061|P1|Overall Study|Progressive disease|4
5634030|NCT00679263|19458083|P3|Visit 2/Dose 1|subject not compliance|0
5634031|NCT00679263|19458084|P2|Visit 2/Dose 1|subject not compliance|1
5634032|NCT00679263|19458085|P1|Visit 2/Dose 1|subject not compliance|1
5634033|NCT00679263|19458083|P3|Visit 2/Dose 1|Adverse Event|0
5634034|NCT00679263|19458084|P2|Visit 2/Dose 1|Adverse Event|0
5634035|NCT00679263|19458085|P1|Visit 2/Dose 1|Adverse Event|1
5634036|NCT00679211|19458096|P1|Overall Study|Other|1
5634037|NCT00679211|19458096|P1|Overall Study|Transferred to extension study TDM4529g|12
5634038|NCT00679211|19458096|P1|Overall Study|Refused to undergo protocol procedures|1
5634039|NCT00679211|19458096|P1|Overall Study|Physician Decision|5
5634040|NCT00679211|19458096|P1|Overall Study|Withdrawal by Subject|2
5634041|NCT00679211|19458096|P1|Overall Study|Adverse Event|7
5634042|NCT00679211|19458096|P1|Overall Study|Progressive disease|82
5634043|NCT00679172|19458113|P5|Overall Study|Other not specified|0
5634044|NCT00679172|19458114|P4|Overall Study|Other not specified|0
5634045|NCT00679172|19458115|P3|Overall Study|Other not specified|1
5634046|NCT00679172|19458116|P2|Overall Study|Other not specified|0
5634047|NCT00679172|19458117|P1|Overall Study|Other not specified|0
5634048|NCT00679172|19458113|P5|Overall Study|Non-compliance|0
5634049|NCT00679172|19458114|P4|Overall Study|Non-compliance|1
5634050|NCT00679172|19458115|P3|Overall Study|Non-compliance|0
5634051|NCT00679172|19458116|P2|Overall Study|Non-compliance|1
5634052|NCT00679172|19458117|P1|Overall Study|Non-compliance|1
5634053|NCT00679081|19458180|P1|Overall Study|Lost to Follow-up|1
5634054|NCT00679055|19458190|P2|Overall Study|Study Terminated|1
5634055|NCT00679055|19458191|P1|Overall Study|Study Terminated|2
5634056|NCT00679055|19458190|P2|Overall Study|Other|3
5634057|NCT00679055|19458191|P1|Overall Study|Other|0
5634058|NCT00679055|19458190|P2|Overall Study|Adverse Event|1
5634059|NCT00679055|19458191|P1|Overall Study|Adverse Event|0
5634060|NCT00679029|19458201|P1|Overall Study|Lost to Follow-up|1
5634061|NCT00679029|19458201|P1|Overall Study|Withdrawal by Subject|1
5634062|NCT00679029|19458201|P1|Overall Study|Adverse Event|3
5634063|NCT00678899|19458208|P1|Overall Study|Adverse Event|1
5634064|NCT00678886|19458217|P4|Overall Study|Other|0
5634065|NCT00678886|19458218|P3|Overall Study|Other|1
5634066|NCT00678886|19458219|P2|Overall Study|Other|0
5634067|NCT00678886|19458220|P1|Overall Study|Other|0
5634068|NCT00678886|19458217|P4|Overall Study|Lost to Follow-up|2
5634069|NCT00678886|19458218|P3|Overall Study|Lost to Follow-up|3
5634070|NCT00678886|19458219|P2|Overall Study|Lost to Follow-up|0
5634071|NCT00678886|19458220|P1|Overall Study|Lost to Follow-up|0
5634072|NCT00678886|19458217|P4|Overall Study|Physician Decision|1
5634073|NCT00678886|19458218|P3|Overall Study|Physician Decision|1
5634074|NCT00678886|19458219|P2|Overall Study|Physician Decision|0
5634075|NCT00678886|19458220|P1|Overall Study|Physician Decision|0
5634076|NCT00678886|19458217|P4|Overall Study|Withdrawal by Subject|6
5634077|NCT00678886|19458218|P3|Overall Study|Withdrawal by Subject|4
5634078|NCT00678886|19458219|P2|Overall Study|Withdrawal by Subject|0
5634079|NCT00678886|19458220|P1|Overall Study|Withdrawal by Subject|0
5634080|NCT00678795|19458289|P2|Overall Study|Lack of Efficacy|1
5634081|NCT00678795|19458290|P1|Overall Study|Lack of Efficacy|1
5634082|NCT00678795|19458289|P2|Overall Study|Lost to Follow-up|1
5634083|NCT00678795|19458290|P1|Overall Study|Lost to Follow-up|0
5634084|NCT00678795|19458289|P2|Overall Study|Protocol Violation|1
5634085|NCT00678795|19458290|P1|Overall Study|Protocol Violation|0
5634086|NCT00678795|19458289|P2|Overall Study|Withdrawal by Subject|0
5634087|NCT00678795|19458290|P1|Overall Study|Withdrawal by Subject|3
5634088|NCT00678795|19458289|P2|Overall Study|Adverse Event|3
5634089|NCT00678795|19458290|P1|Overall Study|Adverse Event|7
5634090|NCT00678691|19458312|P2|Overall Study|Adverse Event|4
5634091|NCT00678691|19458313|P1|Overall Study|Adverse Event|6
5634092|NCT00678652|19458323|P4|Overall Study|Relocation|0
5634093|NCT00678652|19458324|P3|Overall Study|Relocation|0
5634094|NCT00678652|19458325|P2|Overall Study|Relocation|0
5634095|NCT00678652|19458326|P1|Overall Study|Relocation|1
5634096|NCT00678652|19458323|P4|Overall Study|Pregnancy|0
5634097|NCT00678652|19458324|P3|Overall Study|Pregnancy|1
5634098|NCT00678652|19458325|P2|Overall Study|Pregnancy|0
5634099|NCT00678652|19458326|P1|Overall Study|Pregnancy|0
5634100|NCT00678652|19458323|P4|Overall Study|Protocol Violation|0
5634101|NCT00678652|19458324|P3|Overall Study|Protocol Violation|0
5634102|NCT00678652|19458325|P2|Overall Study|Protocol Violation|0
5634103|NCT00678652|19458326|P1|Overall Study|Protocol Violation|2
5634104|NCT00678639|19458350|P2|Overall Study|Lost to Follow-up at 30 days|0
5634105|NCT00678639|19458351|P1|Overall Study|Lost to Follow-up at 30 days|2
5634106|NCT00678587|19458366|P2|Overall Study|Withdrew Consent|3
5634107|NCT00678587|19458367|P1|Overall Study|Withdrew Consent|8
5634108|NCT00678587|19458366|P2|Overall Study|Investigator Discretion|6
5634109|NCT00678587|19458367|P1|Overall Study|Investigator Discretion|2
5634110|NCT00678587|19458366|P2|Overall Study|Lost to Follow-up|5
5634111|NCT00678587|19458367|P1|Overall Study|Lost to Follow-up|3
5634112|NCT00678587|19458366|P2|Overall Study|Study Closed/Terminated|0
5634113|NCT00678587|19458367|P1|Overall Study|Study Closed/Terminated|1
5634114|NCT00678587|19458366|P2|Overall Study|Protocol Violation|1
5634115|NCT00678587|19458367|P1|Overall Study|Protocol Violation|2
5634116|NCT00678587|19458366|P2|Overall Study|Lack of Efficacy|0
5634117|NCT00678587|19458367|P1|Overall Study|Lack of Efficacy|1
5634118|NCT00678587|19458366|P2|Overall Study|Adverse Event|3
5634119|NCT00678587|19458367|P1|Overall Study|Adverse Event|3
5634120|NCT00678561|19458416|P8|Overall Study|Withdrawal by Subject|1
5634121|NCT00678561|19458417|P7|Overall Study|Withdrawal by Subject|0
5634122|NCT00678561|19458418|P6|Overall Study|Withdrawal by Subject|0
5634123|NCT00678561|19458419|P5|Overall Study|Withdrawal by Subject|0
5634124|NCT00678561|19458420|P4|Overall Study|Withdrawal by Subject|0
5634125|NCT00678561|19458421|P3|Overall Study|Withdrawal by Subject|0
5634126|NCT00678561|19458422|P2|Overall Study|Withdrawal by Subject|0
5634127|NCT00678561|19458423|P1|Overall Study|Withdrawal by Subject|0
5634128|NCT00678561|19458416|P8|Overall Study|Protocol Violation|0
5634129|NCT00678561|19458417|P7|Overall Study|Protocol Violation|0
5634130|NCT00678561|19458418|P6|Overall Study|Protocol Violation|1
5634131|NCT00678561|19458419|P5|Overall Study|Protocol Violation|1
5634132|NCT00678561|19458420|P4|Overall Study|Protocol Violation|0
5634133|NCT00678561|19458421|P3|Overall Study|Protocol Violation|0
5634134|NCT00678561|19458422|P2|Overall Study|Protocol Violation|0
5634135|NCT00678561|19458423|P1|Overall Study|Protocol Violation|0
5634136|NCT00678561|19458416|P8|Overall Study|Adverse Event|0
5634137|NCT00678561|19458417|P7|Overall Study|Adverse Event|0
5634138|NCT00678561|19458418|P6|Overall Study|Adverse Event|0
5634139|NCT00678561|19458419|P5|Overall Study|Adverse Event|1
5634140|NCT00678561|19458420|P4|Overall Study|Adverse Event|0
5634141|NCT00678561|19458421|P3|Overall Study|Adverse Event|1
5634142|NCT00678561|19458422|P2|Overall Study|Adverse Event|1
5634143|NCT00678561|19458423|P1|Overall Study|Adverse Event|0
5634144|NCT00678392|19458529|P2|Overall Study|Other|53
5634145|NCT00678392|19458530|P1|Overall Study|Other|56
5634146|NCT00678392|19458529|P2|Overall Study|Randomized But Not Treated|7
5634147|NCT00678392|19458530|P1|Overall Study|Randomized But Not Treated|2
5634148|NCT00678392|19458529|P2|Overall Study|Withdrawal by Subject|4
5634149|NCT00678392|19458530|P1|Overall Study|Withdrawal by Subject|4
5634150|NCT00678392|19458529|P2|Overall Study|Sponsor's Decision|2
5634151|NCT00678392|19458530|P1|Overall Study|Sponsor's Decision|1
5634152|NCT00678392|19458529|P2|Overall Study|Objective Progression or Relapse|8
5634153|NCT00678392|19458530|P1|Overall Study|Objective Progression or Relapse|3
5634154|NCT00678392|19458529|P2|Overall Study|Lost to Follow-up|13
5634155|NCT00678392|19458530|P1|Overall Study|Lost to Follow-up|15
5634156|NCT00678392|19458529|P2|Overall Study|Death|269
5634157|NCT00678392|19458530|P1|Overall Study|Death|280
5634158|NCT00678392|19458529|P2|Overall Study|Adverse Event|6
5634159|NCT00678392|19458530|P1|Overall Study|Adverse Event|0
5634160|NCT00678379|19458565|P3|Overall Study|Incomplete Data|3
5634161|NCT00678379|19458566|P2|Overall Study|Incomplete Data|3
5634162|NCT00678379|19458567|P1|Overall Study|Incomplete Data|4
5634163|NCT00678379|19458565|P3|Overall Study|Injection performed after tonsillectomy|1
5634164|NCT00678379|19458566|P2|Overall Study|Injection performed after tonsillectomy|0
5634165|NCT00678379|19458567|P1|Overall Study|Injection performed after tonsillectomy|2
5634166|NCT00678301|19458595|P2|Overall Study|Lost to Follow-up|1
5634167|NCT00678301|19458596|P1|Overall Study|Lost to Follow-up|3
5634168|NCT00678301|19458595|P2|Overall Study|Withdrawal by Subject|0
5634169|NCT00678301|19458596|P1|Overall Study|Withdrawal by Subject|4
5634170|NCT00678301|19458595|P2|Overall Study|Adverse Event|0
5634171|NCT00678301|19458596|P1|Overall Study|Adverse Event|1
5634172|NCT00678301|19458595|P2|Overall Study|Non-compliance with study procedures|1
5634173|NCT00678301|19458596|P1|Overall Study|Non-compliance with study procedures|0
5634174|NCT00678288|19458654|P2|Overall Study|Disease progression/recurrence/relapse|1
5634175|NCT00678288|19458655|P1|Overall Study|Disease progression/recurrence/relapse|6
5634176|NCT00678288|19458654|P2|Overall Study|Reason not reported|0
5634177|NCT00678288|19458655|P1|Overall Study|Reason not reported|1
5634178|NCT00678288|19458654|P2|Overall Study|Switch to commercial drug|1
5634179|NCT00678288|19458655|P1|Overall Study|Switch to commercial drug|0
5634180|NCT00678288|19458654|P2|Overall Study|Not compliant with study medication|1
5634181|NCT00678288|19458655|P1|Overall Study|Not compliant with study medication|0
5634182|NCT00678288|19458654|P2|Overall Study|Study terminated by the sponsor|0
5634183|NCT00678288|19458655|P1|Overall Study|Study terminated by the sponsor|2
5634184|NCT00678288|19458654|P2|Overall Study|Withdrawal by Subject|1
5634185|NCT00678288|19458655|P1|Overall Study|Withdrawal by Subject|1
5634186|NCT00678288|19458654|P2|Overall Study|Adverse Event|2
5634187|NCT00678288|19458655|P1|Overall Study|Adverse Event|0
5634188|NCT00678210|19458710|P4|Overall Study|Other|0
5634189|NCT00678210|19458711|P3|Overall Study|Other|1
5634190|NCT00678210|19458712|P2|Overall Study|Other|0
5634191|NCT00678210|19458713|P1|Overall Study|Other|1
5634192|NCT00678210|19458710|P4|Overall Study|Withdrawal by Subject|7
5634193|NCT00678210|19458711|P3|Overall Study|Withdrawal by Subject|1
5634194|NCT00678210|19458712|P2|Overall Study|Withdrawal by Subject|4
5634195|NCT00678210|19458713|P1|Overall Study|Withdrawal by Subject|3
5634196|NCT00678210|19458710|P4|Overall Study|Lost to Follow-up|1
5634197|NCT00678210|19458711|P3|Overall Study|Lost to Follow-up|0
5634198|NCT00678210|19458712|P2|Overall Study|Lost to Follow-up|2
5634199|NCT00678210|19458713|P1|Overall Study|Lost to Follow-up|4
5634200|NCT00678210|19458710|P4|Overall Study|Lack of Efficacy|9
5634201|NCT00678210|19458711|P3|Overall Study|Lack of Efficacy|1
5634202|NCT00678210|19458712|P2|Overall Study|Lack of Efficacy|3
5634203|NCT00678210|19458713|P1|Overall Study|Lack of Efficacy|2
5634204|NCT00678210|19458710|P4|Overall Study|Adverse Event|3
5634205|NCT00678210|19458711|P3|Overall Study|Adverse Event|3
5634206|NCT00678210|19458712|P2|Overall Study|Adverse Event|2
5634207|NCT00678210|19458713|P1|Overall Study|Adverse Event|1
5634208|NCT00678080|19458749|P2|Overall Study|Withdrawal by Subject|1
5634209|NCT00678080|19458750|P1|Overall Study|Withdrawal by Subject|0
5634210|NCT00678080|19458749|P2|Overall Study|Lost to Follow-up|0
5634211|NCT00678080|19458750|P1|Overall Study|Lost to Follow-up|1
5634212|NCT00678080|19458749|P2|Overall Study|Physician Decision|0
5634213|NCT00678080|19458750|P1|Overall Study|Physician Decision|2
5634214|NCT00678041|19458776|P2|Overall Study|Physician Decision|5
5634215|NCT00678041|19458777|P1|Overall Study|Physician Decision|5
5634216|NCT00677833|19458830|P4|Overall Study|Lost to Follow-up|0
5634217|NCT00677833|19458831|P3|Overall Study|Lost to Follow-up|1
5634218|NCT00677833|19458832|P2|Overall Study|Lost to Follow-up|0
5634219|NCT00677833|19458833|P1|Overall Study|Lost to Follow-up|0
5634220|NCT00677833|19458830|P4|Overall Study|Withdrawal by Subject|3
5634221|NCT00677833|19458831|P3|Overall Study|Withdrawal by Subject|1
5634222|NCT00677833|19458832|P2|Overall Study|Withdrawal by Subject|0
5634223|NCT00677833|19458833|P1|Overall Study|Withdrawal by Subject|4
5634224|NCT00677820|19458883|P2|Overall Study|Lost to Follow-up|0
5634225|NCT00677820|19458884|P1|Overall Study|Lost to Follow-up|1
5634226|NCT00677807|19458905|P3|Overall Study|Protocol Deviation|0
5634227|NCT00677807|19458906|P2|Overall Study|Protocol Deviation|3
5634228|NCT00677807|19458907|P1|Overall Study|Protocol Deviation|1
5634229|NCT00677807|19458905|P3|Overall Study|Death|1
5634230|NCT00677807|19458906|P2|Overall Study|Death|1
5634231|NCT00677807|19458907|P1|Overall Study|Death|0
5634232|NCT00677807|19458905|P3|Overall Study|Administrative problems|2
5634233|NCT00677807|19458906|P2|Overall Study|Administrative problems|1
5634234|NCT00677807|19458907|P1|Overall Study|Administrative problems|1
5634235|NCT00677807|19458905|P3|Overall Study|Lost to Follow-up|2
5634236|NCT00677807|19458906|P2|Overall Study|Lost to Follow-up|2
5634237|NCT00677807|19458907|P1|Overall Study|Lost to Follow-up|2
5634238|NCT00677807|19458905|P3|Overall Study|Withdrawal by Subject|6
5634239|NCT00677807|19458906|P2|Overall Study|Withdrawal by Subject|3
5634240|NCT00677807|19458907|P1|Overall Study|Withdrawal by Subject|10
5634241|NCT00677807|19458905|P3|Overall Study|Participant no longer needs study drug|1
5634242|NCT00677807|19458906|P2|Overall Study|Participant no longer needs study drug|0
5634243|NCT00677807|19458907|P1|Overall Study|Participant no longer needs study drug|0
5634244|NCT00677807|19458905|P3|Overall Study|Lack of Efficacy|2
5634245|NCT00677807|19458906|P2|Overall Study|Lack of Efficacy|0
5634246|NCT00677807|19458907|P1|Overall Study|Lack of Efficacy|0
5634247|NCT00677807|19458905|P3|Overall Study|Adverse Event|6
5634248|NCT00677807|19458906|P2|Overall Study|Adverse Event|1
5634249|NCT00677807|19458907|P1|Overall Study|Adverse Event|4
5634250|NCT00677534|19458953|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
5634251|NCT00677534|19458953|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
5634252|NCT00677534|19458953|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
5634253|NCT00677365|19458961|P4|Overall Study|Other reason|1
5634254|NCT00677365|19458962|P3|Overall Study|Other reason|0
5634255|NCT00677365|19458963|P2|Overall Study|Other reason|0
5634256|NCT00677365|19458964|P1|Overall Study|Other reason|0
5634257|NCT00677365|19458961|P4|Overall Study|Withdrawal by Subject|0
5634258|NCT00677365|19458962|P3|Overall Study|Withdrawal by Subject|1
5634259|NCT00677365|19458963|P2|Overall Study|Withdrawal by Subject|0
5634260|NCT00677365|19458964|P1|Overall Study|Withdrawal by Subject|0
5634261|NCT00677365|19458961|P4|Overall Study|Adverse Event|2
5634262|NCT00677365|19458962|P3|Overall Study|Adverse Event|1
5634263|NCT00677365|19458963|P2|Overall Study|Adverse Event|1
5634264|NCT00677365|19458964|P1|Overall Study|Adverse Event|2
5634265|NCT00677352|19458996|P2|Tapering Phase|Job transfer|1
5634266|NCT00677352|19458997|P1|Tapering Phase|Job transfer|0
5634267|NCT00677352|19458996|P2|Tapering Phase|Pregnancy|1
5634268|NCT00677352|19458997|P1|Tapering Phase|Pregnancy|0
5634269|NCT00677352|19458996|P2|Tapering Phase|Withdrawal by Subject|3
5634270|NCT00677352|19458997|P1|Tapering Phase|Withdrawal by Subject|5
5634271|NCT00677352|19458996|P2|Tapering Phase|Adverse Event|5
5634272|NCT00677352|19458997|P1|Tapering Phase|Adverse Event|1
5634273|NCT00677352|19458996|P2|Treatment Phase|Not treated|2
5634274|NCT00677352|19458997|P1|Treatment Phase|Not treated|0
5634275|NCT00677352|19458996|P2|Treatment Phase|Transference or work related matter|5
5634276|NCT00677352|19458997|P1|Treatment Phase|Transference or work related matter|0
5634277|NCT00677352|19458996|P2|Treatment Phase|Protocol Violation|1
5634278|NCT00677352|19458997|P1|Treatment Phase|Protocol Violation|1
5634279|NCT00677352|19458996|P2|Treatment Phase|Pregnancy|1
5634280|NCT00677352|19458997|P1|Treatment Phase|Pregnancy|0
5634281|NCT00677352|19458996|P2|Treatment Phase|Physician Decision|0
5634282|NCT00677352|19458997|P1|Treatment Phase|Physician Decision|1
5634283|NCT00677352|19458996|P2|Treatment Phase|Withdrawal by Subject|7
5634284|NCT00677352|19458997|P1|Treatment Phase|Withdrawal by Subject|7
5634285|NCT00677352|19458996|P2|Treatment Phase|Lost to Follow-up|1
5634286|NCT00677352|19458997|P1|Treatment Phase|Lost to Follow-up|0
5634287|NCT00677352|19458996|P2|Treatment Phase|Lack of Efficacy|3
5634288|NCT00677352|19458997|P1|Treatment Phase|Lack of Efficacy|2
5634289|NCT00677352|19458996|P2|Treatment Phase|Adverse Event|22
5634290|NCT00677352|19458997|P1|Treatment Phase|Adverse Event|14
5634291|NCT00677235|19459017|P2|Overall Study|Adverse Experience|0
5634292|NCT00677235|19459018|P1|Overall Study|Adverse Experience|1
5634293|NCT00677235|19459017|P2|Overall Study|Death|36
5634294|NCT00677235|19459018|P1|Overall Study|Death|37
5634295|NCT00677235|19459017|P2|Overall Study|Lost to Follow-up|1
5634296|NCT00677235|19459018|P1|Overall Study|Lost to Follow-up|2
5634297|NCT00677235|19459017|P2|Overall Study|Withdrawal by Subject|1
5634298|NCT00677235|19459018|P1|Overall Study|Withdrawal by Subject|1
5634299|NCT00677092|19459058|P1|Overall Study|Death Prior to Receiving Treatment|1
5634300|NCT00677092|19459058|P1|Overall Study|Withdrawal by Subject|3
5634301|NCT00677092|19459058|P1|Overall Study|Lost to Follow-up|1
5634302|NCT00677092|19459058|P1|Overall Study|Adverse Event|1
5634303|NCT00677014|19459075|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
5634304|NCT00677014|19459076|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
5634305|NCT00677014|19459077|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
5634306|NCT00677014|19459075|P3|Overall Study|Death|7
5634307|NCT00677014|19459076|P2|Overall Study|Death|15
5634308|NCT00677014|19459077|P1|Overall Study|Death|6
5634309|NCT00677014|19459075|P3|Overall Study|Lost to Follow-up|24
5634310|NCT00677014|19459076|P2|Overall Study|Lost to Follow-up|12
5634311|NCT00677014|19459077|P1|Overall Study|Lost to Follow-up|20
5634312|NCT00676715|19459130|P4|Overall Study|Participants Ongoing|24
5634313|NCT00676715|19459131|P3|Overall Study|Participants Ongoing|17
5634314|NCT00676715|19459132|P2|Overall Study|Participants Ongoing|29
5634315|NCT00676715|19459133|P1|Overall Study|Participants Ongoing|29
5634316|NCT00676715|19459130|P4|Overall Study|Adverse Event|0
5634317|NCT00676715|19459131|P3|Overall Study|Adverse Event|2
5634318|NCT00676715|19459132|P2|Overall Study|Adverse Event|1
5634319|NCT00676715|19459133|P1|Overall Study|Adverse Event|0
5634320|NCT00676715|19459130|P4|Overall Study|Death|0
5634321|NCT00676715|19459131|P3|Overall Study|Death|1
5634322|NCT00676715|19459132|P2|Overall Study|Death|1
5634323|NCT00676715|19459133|P1|Overall Study|Death|1
5634324|NCT00676715|19459130|P4|Overall Study|Lost to Follow-up|3
5634325|NCT00676715|19459131|P3|Overall Study|Lost to Follow-up|7
5634326|NCT00676715|19459132|P2|Overall Study|Lost to Follow-up|1
5634327|NCT00676715|19459133|P1|Overall Study|Lost to Follow-up|1
5634328|NCT00676715|19459130|P4|Overall Study|Other|3
5634329|NCT00676715|19459131|P3|Overall Study|Other|4
5634330|NCT00676715|19459132|P2|Overall Study|Other|6
5634331|NCT00676715|19459133|P1|Overall Study|Other|2
5634332|NCT00676715|19459130|P4|Overall Study|Withdrawal by Subject|10
5634333|NCT00676715|19459131|P3|Overall Study|Withdrawal by Subject|10
5634334|NCT00676715|19459132|P2|Overall Study|Withdrawal by Subject|9
5634335|NCT00676715|19459133|P1|Overall Study|Withdrawal by Subject|7
5634336|NCT00676689|19459163|P1|Overall Study|Continuing FU|49
5634337|NCT00676689|19459163|P1|Overall Study|Withdrawal by Subject|3
5634338|NCT00676689|19459163|P1|Overall Study|Physician Decision|1
5634339|NCT00676689|19459163|P1|Overall Study|Lost to Follow-up|4
5634340|NCT00676689|19459163|P1|Overall Study|Death|2
5634341|NCT00676689|19459163|P1|Overall Study|Screen Failure|2
5634342|NCT00676663|19459175|P2|Overall Study|Lost to Follow-up|3
5634343|NCT00676663|19459176|P1|Overall Study|Lost to Follow-up|1
5634344|NCT00676663|19459175|P2|Overall Study|Withdrew Consent|8
5634345|NCT00676663|19459176|P1|Overall Study|Withdrew Consent|1
5634346|NCT00676663|19459175|P2|Overall Study|Death|27
5634347|NCT00676663|19459176|P1|Overall Study|Death|43
5634348|NCT00676650|19459192|P2|Overall Study|Randomized but not treated|4
5634349|NCT00676650|19459193|P1|Overall Study|Randomized but not treated|3
5634350|NCT00676650|19459192|P2|Overall Study|Withdrawal by Subject|24
5634351|NCT00676650|19459193|P1|Overall Study|Withdrawal by Subject|48
5634352|NCT00676650|19459192|P2|Overall Study|Study terminated by sponsor|43
5634353|NCT00676650|19459193|P1|Overall Study|Study terminated by sponsor|57
5634354|NCT00676650|19459192|P2|Overall Study|Protocol Violation|1
5634355|NCT00676650|19459193|P1|Overall Study|Protocol Violation|3
5634356|NCT00676650|19459192|P2|Overall Study|Other|10
5634357|NCT00676650|19459193|P1|Overall Study|Other|14
5634358|NCT00676650|19459192|P2|Overall Study|Objective progression or relapse|140
5634359|NCT00676650|19459193|P1|Overall Study|Objective progression or relapse|189
5634360|NCT00676650|19459192|P2|Overall Study|Lost to Follow-up|1
5634361|NCT00676650|19459193|P1|Overall Study|Lost to Follow-up|0
5634362|NCT00676650|19459192|P2|Overall Study|Global deterioration of health status|31
5634363|NCT00676650|19459193|P1|Overall Study|Global deterioration of health status|66
5634364|NCT00676650|19459192|P2|Overall Study|Adverse Event|21
5634365|NCT00676650|19459193|P1|Overall Study|Adverse Event|159
5634366|NCT00676650|19459192|P2|Overall Study|Death|14
5634367|NCT00676650|19459193|P1|Overall Study|Death|45
5634368|NCT00676520|19459235|P1|Overall Study|Other Reason|18
5634369|NCT00676520|19459235|P1|Overall Study|Ineligible for Randomization to DAPT|209
5634370|NCT00676520|19459235|P1|Overall Study|Physician Decision|20
5634371|NCT00676520|19459235|P1|Overall Study|Death|159
5634372|NCT00676520|19459235|P1|Overall Study|Lost to Follow-up|162
5634373|NCT00676520|19459235|P1|Overall Study|Withdrawal by Subject|163
5634374|NCT00676494|19459292|P1|Overall Study|Withdrawal by Subject|6
5634375|NCT00676494|19459292|P1|Overall Study|Missed Visit|8
5634376|NCT00676403|19459309|P6|Overall Study|Withdrawal by Subject|1
5634377|NCT00676403|19459310|P5|Overall Study|Withdrawal by Subject|0
5634378|NCT00676403|19459311|P4|Overall Study|Withdrawal by Subject|0
5634379|NCT00676403|19459312|P3|Overall Study|Withdrawal by Subject|0
5634380|NCT00676403|19459313|P2|Overall Study|Withdrawal by Subject|0
5634381|NCT00676403|19459314|P1|Overall Study|Withdrawal by Subject|0
5634382|NCT00676403|19459309|P6|Overall Study|Reason Unspecified|1
5634383|NCT00676403|19459310|P5|Overall Study|Reason Unspecified|0
5634384|NCT00676403|19459311|P4|Overall Study|Reason Unspecified|0
5634385|NCT00676403|19459312|P3|Overall Study|Reason Unspecified|1
5634386|NCT00676403|19459313|P2|Overall Study|Reason Unspecified|0
5634387|NCT00676403|19459314|P1|Overall Study|Reason Unspecified|1
5634388|NCT00676403|19459309|P6|Overall Study|Lost to Follow-up|1
5634389|NCT00676403|19459310|P5|Overall Study|Lost to Follow-up|0
5634390|NCT00676403|19459311|P4|Overall Study|Lost to Follow-up|0
5634391|NCT00676403|19459312|P3|Overall Study|Lost to Follow-up|0
5634392|NCT00676403|19459313|P2|Overall Study|Lost to Follow-up|0
5634393|NCT00676403|19459314|P1|Overall Study|Lost to Follow-up|0
5634394|NCT00676403|19459309|P6|Overall Study|Adverse Event|2
5634395|NCT00676403|19459310|P5|Overall Study|Adverse Event|1
5634396|NCT00676403|19459311|P4|Overall Study|Adverse Event|5
5634397|NCT00676403|19459312|P3|Overall Study|Adverse Event|0
5634398|NCT00676403|19459313|P2|Overall Study|Adverse Event|2
5634399|NCT00676403|19459314|P1|Overall Study|Adverse Event|1
5634400|NCT00676338|19459457|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
5634401|NCT00676338|19459458|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
5634402|NCT00676338|19459459|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
5634403|NCT00676338|19459460|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
5634404|NCT00676338|19459457|P4|Overall Study|Entry Criteria Not Met|1
5634405|NCT00676338|19459458|P3|Overall Study|Entry Criteria Not Met|1
5634406|NCT00676338|19459459|P2|Overall Study|Entry Criteria Not Met|2
5634407|NCT00676338|19459460|P1|Overall Study|Entry Criteria Not Met|0
5634408|NCT00676338|19459457|P4|Overall Study|Withdrawal by Subject|6
5634409|NCT00676338|19459458|P3|Overall Study|Withdrawal by Subject|12
5634410|NCT00676338|19459459|P2|Overall Study|Withdrawal by Subject|9
5634411|NCT00676338|19459460|P1|Overall Study|Withdrawal by Subject|17
5634412|NCT00676338|19459457|P4|Overall Study|Protocol Violation|5
5634413|NCT00676338|19459458|P3|Overall Study|Protocol Violation|2
5634414|NCT00676338|19459459|P2|Overall Study|Protocol Violation|9
5634415|NCT00676338|19459460|P1|Overall Study|Protocol Violation|5
5634416|NCT00676338|19459457|P4|Overall Study|Physician Decision|3
5634417|NCT00676338|19459458|P3|Overall Study|Physician Decision|2
5634418|NCT00676338|19459459|P2|Overall Study|Physician Decision|3
5634419|NCT00676338|19459460|P1|Overall Study|Physician Decision|3
5634420|NCT00676338|19459457|P4|Overall Study|Lost to Follow-up|4
5634421|NCT00676338|19459458|P3|Overall Study|Lost to Follow-up|3
5634422|NCT00676338|19459459|P2|Overall Study|Lost to Follow-up|1
5634423|NCT00676338|19459460|P1|Overall Study|Lost to Follow-up|4
5634424|NCT00676338|19459457|P4|Overall Study|Adverse Event|1
5634425|NCT00676338|19459458|P3|Overall Study|Adverse Event|5
5634426|NCT00676338|19459459|P2|Overall Study|Adverse Event|6
5634427|NCT00676338|19459460|P1|Overall Study|Adverse Event|6
5634428|NCT00676208|19459512|P2|Overall Study|Incomplete data|4
5634429|NCT00676208|19459513|P1|Overall Study|Incomplete data|2
5634430|NCT00676208|19459512|P2|Overall Study|Lost to Follow-up|2
5634431|NCT00676208|19459513|P1|Overall Study|Lost to Follow-up|0
5634432|NCT00676195|19459521|P1|Overall Study|Physician Decision|1
5634433|NCT00676195|19459521|P1|Overall Study|Adverse Event|1
5634434|NCT00676195|19459521|P1|Overall Study|Lost to Follow-up|1
5634435|NCT00676143|19459546|P2|Overall Study|Vasogenic edema recurrence|3
5634436|NCT00676143|19459547|P1|Overall Study|Vasogenic edema recurrence|1
5634437|NCT00676143|19459546|P2|Overall Study|Participant participation unknown|4
5634438|NCT00676143|19459547|P1|Overall Study|Participant participation unknown|1
5634439|NCT00676143|19459546|P2|Overall Study|Other|20
5634440|NCT00676143|19459547|P1|Overall Study|Other|11
5634441|NCT00676143|19459546|P2|Overall Study|Loss of caregiver|3
5634442|NCT00676143|19459547|P1|Overall Study|Loss of caregiver|5
5634443|NCT00676143|19459546|P2|Overall Study|Failed to return|1
5634444|NCT00676143|19459547|P1|Overall Study|Failed to return|2
5634445|NCT00676143|19459546|P2|Overall Study|Discontinuation of study by sponsor|88
5634446|NCT00676143|19459547|P1|Overall Study|Discontinuation of study by sponsor|65
5634447|NCT00676143|19459546|P2|Overall Study|Withdrawal by Subject|42
5634448|NCT00676143|19459547|P1|Overall Study|Withdrawal by Subject|24
5634449|NCT00676143|19459546|P2|Overall Study|Protocol Violation|8
5634450|NCT00676143|19459547|P1|Overall Study|Protocol Violation|4
5634451|NCT00676143|19459546|P2|Overall Study|Physician Decision|8
5634452|NCT00676143|19459547|P1|Overall Study|Physician Decision|5
5634453|NCT00676143|19459546|P2|Overall Study|Lost to Follow-up|13
5634454|NCT00676143|19459547|P1|Overall Study|Lost to Follow-up|0
5634455|NCT00676143|19459546|P2|Overall Study|Lack of Efficacy|6
5634456|NCT00676143|19459547|P1|Overall Study|Lack of Efficacy|0
5634457|NCT00676143|19459546|P2|Overall Study|Death|4
5634458|NCT00676143|19459547|P1|Overall Study|Death|4
5634459|NCT00676143|19459546|P2|Overall Study|Adverse Event|60
5634460|NCT00676143|19459547|P1|Overall Study|Adverse Event|34
5634461|NCT00676130|19459587|P2|Overall Study|Withdrawal by Subject|1
5634462|NCT00676130|19459588|P1|Overall Study|Withdrawal by Subject|0
5634463|NCT00676130|19459587|P2|Overall Study|Found ineligible|2
5634464|NCT00676130|19459588|P1|Overall Study|Found ineligible|3
5634465|NCT00676130|19459587|P2|Overall Study|Lost to Follow-up|1
5634466|NCT00676130|19459588|P1|Overall Study|Lost to Follow-up|0
5634467|NCT00676091|19459598|P2|Toddler Dose|Parent or legal guardian request|0
5634468|NCT00676091|19459599|P1|Toddler Dose|Parent or legal guardian request|1
5634469|NCT00676091|19459598|P2|Toddler Dose|Failed to return|0
5634470|NCT00676091|19459599|P1|Toddler Dose|Failed to return|2
5634471|NCT00676091|19459598|P2|After Infant Series|Failed to return|1
5634472|NCT00676091|19459599|P1|After Infant Series|Failed to return|1
5634473|NCT00676091|19459598|P2|After Infant Series|Protocol Violation|1
5634474|NCT00676091|19459599|P1|After Infant Series|Protocol Violation|0
5634475|NCT00676091|19459598|P2|After Infant Series|Adverse Event|1
5634476|NCT00676091|19459599|P1|After Infant Series|Adverse Event|0
5634477|NCT00676091|19459598|P2|Infant Series|Died prior to receiving 7vPnC|1
5634478|NCT00676091|19459599|P1|Infant Series|Died prior to receiving 7vPnC|0
5634479|NCT00676091|19459598|P2|Infant Series|Lost to Follow-up|0
5634480|NCT00676091|19459599|P1|Infant Series|Lost to Follow-up|1
5634481|NCT00676091|19459598|P2|Infant Series|Failed to return|3
5634482|NCT00676091|19459599|P1|Infant Series|Failed to return|1
5634483|NCT00676091|19459598|P2|Infant Series|Adverse Event|3
5634484|NCT00676091|19459599|P1|Infant Series|Adverse Event|2
5634485|NCT00676091|19459598|P2|Infant Series|Protocol Violation|3
5634486|NCT00676091|19459599|P1|Infant Series|Protocol Violation|6
5634487|NCT00676091|19459598|P2|Infant Series|Parent or legal guardian request|8
5634488|NCT00676091|19459599|P1|Infant Series|Parent or legal guardian request|10
5634489|NCT00676052|19459656|P6|Overall Study|Withdrawal by Subject|0
5634490|NCT00676052|19459657|P5|Overall Study|Withdrawal by Subject|0
5634491|NCT00676052|19459658|P4|Overall Study|Withdrawal by Subject|0
5634492|NCT00676052|19459659|P3|Overall Study|Withdrawal by Subject|1
5634493|NCT00676052|19459660|P2|Overall Study|Withdrawal by Subject|0
5634494|NCT00676052|19459661|P1|Overall Study|Withdrawal by Subject|1
5634495|NCT00676052|19459656|P6|Overall Study|Physician Decision|1
5634496|NCT00676052|19459657|P5|Overall Study|Physician Decision|0
5634497|NCT00676052|19459658|P4|Overall Study|Physician Decision|0
5634498|NCT00676052|19459659|P3|Overall Study|Physician Decision|1
5634499|NCT00676052|19459660|P2|Overall Study|Physician Decision|1
5634500|NCT00676052|19459661|P1|Overall Study|Physician Decision|1
5634501|NCT00676052|19459656|P6|Overall Study|Lost to Follow-up|0
5634502|NCT00676052|19459657|P5|Overall Study|Lost to Follow-up|1
5634503|NCT00676052|19459658|P4|Overall Study|Lost to Follow-up|0
5634504|NCT00676052|19459659|P3|Overall Study|Lost to Follow-up|0
5634505|NCT00676052|19459660|P2|Overall Study|Lost to Follow-up|0
5634506|NCT00676052|19459661|P1|Overall Study|Lost to Follow-up|0
5634507|NCT00676052|19459656|P6|Overall Study|Protocol Violation|2
5634508|NCT00676052|19459657|P5|Overall Study|Protocol Violation|1
5634509|NCT00676052|19459658|P4|Overall Study|Protocol Violation|2
5634510|NCT00676052|19459659|P3|Overall Study|Protocol Violation|2
5634511|NCT00676052|19459660|P2|Overall Study|Protocol Violation|3
5634512|NCT00676052|19459661|P1|Overall Study|Protocol Violation|5
5634513|NCT00676052|19459656|P6|Overall Study|Lack of Efficacy|1
5634514|NCT00676052|19459657|P5|Overall Study|Lack of Efficacy|2
5634515|NCT00676052|19459658|P4|Overall Study|Lack of Efficacy|1
5634516|NCT00676052|19459659|P3|Overall Study|Lack of Efficacy|1
5634517|NCT00676052|19459660|P2|Overall Study|Lack of Efficacy|2
5634518|NCT00676052|19459661|P1|Overall Study|Lack of Efficacy|2
5634519|NCT00676052|19459656|P6|Overall Study|Adverse Event|2
5634520|NCT00676052|19459657|P5|Overall Study|Adverse Event|2
5634521|NCT00676052|19459658|P4|Overall Study|Adverse Event|2
5634522|NCT00676052|19459659|P3|Overall Study|Adverse Event|1
5634523|NCT00676052|19459660|P2|Overall Study|Adverse Event|1
5634524|NCT00676052|19459661|P1|Overall Study|Adverse Event|0
5634525|NCT00675948|19459731|P2|Overall Study|Patient feels unable to take medication|1
5634526|NCT00675948|19459732|P1|Overall Study|Patient feels unable to take medication|0
5634527|NCT00675948|19459731|P2|Overall Study|Patient unable to comply with diaries|0
5634528|NCT00675948|19459732|P1|Overall Study|Patient unable to comply with diaries|1
5634529|NCT00675948|19459731|P2|Overall Study|Patient died|0
5634530|NCT00675948|19459732|P1|Overall Study|Patient died|1
5634531|NCT00675948|19459731|P2|Overall Study|Sponsor decision|1
5634532|NCT00675948|19459732|P1|Overall Study|Sponsor decision|0
5634533|NCT00675948|19459731|P2|Overall Study|Pain under control|0
5634534|NCT00675948|19459732|P1|Overall Study|Pain under control|1
5634535|NCT00675948|19459731|P2|Overall Study|Protocol Violation|0
5634536|NCT00675948|19459732|P1|Overall Study|Protocol Violation|1
5634537|NCT00675948|19459731|P2|Overall Study|Lost to Follow-up|0
5634538|NCT00675948|19459732|P1|Overall Study|Lost to Follow-up|2
5634539|NCT00675948|19459731|P2|Overall Study|Withdrawal by Subject|0
5634540|NCT00675948|19459732|P1|Overall Study|Withdrawal by Subject|7
5634541|NCT00675948|19459731|P2|Overall Study|Lack of Efficacy|0
5634542|NCT00675948|19459732|P1|Overall Study|Lack of Efficacy|3
5634543|NCT00675948|19459731|P2|Overall Study|Adverse Event|1
5634544|NCT00675948|19459732|P1|Overall Study|Adverse Event|23
5634545|NCT00675766|19459795|P4|Overall Study|Lost to Follow-up|26
5634546|NCT00675766|19459796|P3|Overall Study|Lost to Follow-up|21
5634547|NCT00675766|19459797|P2|Overall Study|Lost to Follow-up|5
5634548|NCT00675766|19459798|P1|Overall Study|Lost to Follow-up|6
5634549|NCT00675597|19459808|P1|Overall Study|Withdrawal by Subject|3
5634550|NCT00675506|19459862|P2|Overall Study|Schedule conflict|1
5634551|NCT00675506|19459863|P1|Overall Study|Schedule conflict|0
5634552|NCT00675506|19459862|P2|Overall Study|Declined participation|0
5634553|NCT00675506|19459863|P1|Overall Study|Declined participation|1
5634554|NCT00675506|19459862|P2|Overall Study|Disclosed history of cancer|0
5634555|NCT00675506|19459863|P1|Overall Study|Disclosed history of cancer|1
5634556|NCT00675506|19459862|P2|Overall Study|Hypersensitivity Reaction|0
5634557|NCT00675506|19459863|P1|Overall Study|Hypersensitivity Reaction|1
5634558|NCT00675506|19459862|P2|Overall Study|Elevated IGF-1|0
5634559|NCT00675506|19459863|P1|Overall Study|Elevated IGF-1|2
5634560|NCT00675506|19459862|P2|Overall Study|Elevated IGF-1 prior to treatment|0
5634561|NCT00675506|19459863|P1|Overall Study|Elevated IGF-1 prior to treatment|1
5634562|NCT00675506|19459862|P2|Overall Study|Elevated fasting glucose|1
5634563|NCT00675506|19459863|P1|Overall Study|Elevated fasting glucose|2
5634564|NCT00675506|19459862|P2|Overall Study|Lost interest|5
5634565|NCT00675506|19459863|P1|Overall Study|Lost interest|3
5634566|NCT00675506|19459862|P2|Overall Study|Lost to Follow-up|5
5634567|NCT00675506|19459863|P1|Overall Study|Lost to Follow-up|1
5634568|NCT00675441|19459879|P1|Overall Study|Death|1
5634569|NCT00675441|19459879|P1|Overall Study|Withdrawal by Subject|2
5634570|NCT00675428|19459885|P2|Overall Study|Physician Decision|0
5634571|NCT00675428|19459886|P1|Overall Study|Physician Decision|1
5634572|NCT00675428|19459885|P2|Overall Study|No Disease Response After Cycle 6|1
5634573|NCT00675428|19459886|P1|Overall Study|No Disease Response After Cycle 6|0
5634574|NCT00675428|19459885|P2|Overall Study|Disease Progression|2
5634575|NCT00675428|19459886|P1|Overall Study|Disease Progression|2
5634576|NCT00675103|19459928|P1|Overall Study|Adverse Event|1
5634577|NCT00675103|19459928|P1|Overall Study|Lack of Efficacy|2
5634578|NCT00674986|19459935|P2|Overall Study|Other reasons|8
5634579|NCT00674986|19459936|P1|Overall Study|Other reasons|4
5634580|NCT00674986|19459935|P2|Overall Study|Lost to Follow-up|53
5634581|NCT00674986|19459936|P1|Overall Study|Lost to Follow-up|25
5634582|NCT00674986|19459935|P2|Overall Study|Subject withdrew consent|19
5634583|NCT00674986|19459936|P1|Overall Study|Subject withdrew consent|12
5634584|NCT00674986|19459935|P2|Overall Study|Adverse Event|1
5634585|NCT00674986|19459936|P1|Overall Study|Adverse Event|2
5634586|NCT00674973|19459957|P2|Overall Study|Protocol Violation|1
5634587|NCT00674973|19459958|P1|Overall Study|Protocol Violation|0
5634588|NCT00674973|19459957|P2|Overall Study|Death|15
5634589|NCT00674973|19459958|P1|Overall Study|Death|19
5634590|NCT00674973|19459957|P2|Overall Study|Adverse Event|9
5634591|NCT00674973|19459958|P1|Overall Study|Adverse Event|2
5634592|NCT00674973|19459957|P2|Overall Study|Failure to Return|0
5634593|NCT00674973|19459958|P1|Overall Study|Failure to Return|1
5634594|NCT00674973|19459957|P2|Overall Study|Refused Treatment|5
5634595|NCT00674973|19459958|P1|Overall Study|Refused Treatment|1
5634596|NCT00674973|19459957|P2|Overall Study|Insufficient Therapeutic Response|72
5634597|NCT00674973|19459958|P1|Overall Study|Insufficient Therapeutic Response|77
5634598|NCT00674817|19459972|P1|Period 4|Adverse Event|1
5634599|NCT00674817|19459972|P1|Period 3|Protocol Violation|1
5634600|NCT00674817|19459972|P1|Period 3|Adverse Event|1
5634601|NCT00674817|19459972|P1|Period 1|Protocol Violation|1
5634602|NCT00674817|19459972|P1|Period 1|Withdrawal by Subject|2
5634603|NCT00674700|19460149|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
5634604|NCT00674700|19460150|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
5634605|NCT00674700|19460151|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
5634606|NCT00674700|19460149|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
5634607|NCT00674700|19460150|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
5634608|NCT00674700|19460151|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
5634609|NCT00674700|19460149|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
5634610|NCT00674700|19460150|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
5634611|NCT00674700|19460151|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
5634612|NCT00674700|19460149|P3|Year 1|Any other reason not above-mentioned|6
5634613|NCT00674700|19460150|P2|Year 1|Any other reason not above-mentioned|7
5634614|NCT00674700|19460151|P1|Year 1|Any other reason not above-mentioned|7
5634615|NCT00674700|19460149|P3|Year 1|Withdrawal by Subject|6
5634616|NCT00674700|19460150|P2|Year 1|Withdrawal by Subject|7
5634617|NCT00674700|19460151|P1|Year 1|Withdrawal by Subject|7
5634618|NCT00674700|19460149|P3|Year 1|Adverse Event|5
5634619|NCT00674700|19460150|P2|Year 1|Adverse Event|20
5634620|NCT00674700|19460151|P1|Year 1|Adverse Event|17
5634621|NCT00674661|19460164|P2|Overall Study|Withdrawal by Subject|5
5634622|NCT00674661|19460165|P1|Overall Study|Withdrawal by Subject|0
5634623|NCT00674661|19460164|P2|Overall Study|Lost to Follow-up|3
5634624|NCT00674661|19460165|P1|Overall Study|Lost to Follow-up|6
5634625|NCT00674661|19460164|P2|Overall Study|Other|7
5634626|NCT00674661|19460165|P1|Overall Study|Other|5
5634627|NCT00674570|19460263|P3|Overall Study|Withdrawal by Subject|0
5634628|NCT00674570|19460264|P2|Overall Study|Withdrawal by Subject|2
5634629|NCT00674570|19460265|P1|Overall Study|Withdrawal by Subject|0
5634630|NCT00674362|19460304|P2|Open Label|Other: Subject moved to extension study|0
5634631|NCT00674362|19460305|P1|Open Label|Other: Subject moved to extension study|1
5634632|NCT00674362|19460304|P2|Open Label|Adverse Event|0
5634633|NCT00674362|19460305|P1|Open Label|Adverse Event|1
5634634|NCT00674362|19460304|P2|Double Blind|Other: Surgery|1
5634635|NCT00674362|19460305|P1|Double Blind|Other: Surgery|0
5634636|NCT00674362|19460304|P2|Double Blind|Other: Loss of Patient Compliance|1
5634637|NCT00674362|19460305|P1|Double Blind|Other: Loss of Patient Compliance|0
5634638|NCT00674362|19460304|P2|Double Blind|Withdrawal by Subject|3
5634639|NCT00674362|19460305|P1|Double Blind|Withdrawal by Subject|4
5634640|NCT00674362|19460304|P2|Double Blind|Loss of efficacy|1
5634641|NCT00674362|19460305|P1|Double Blind|Loss of efficacy|0
5634642|NCT00674362|19460304|P2|Double Blind|Lack of Efficacy|6
5634643|NCT00674362|19460305|P1|Double Blind|Lack of Efficacy|2
5634644|NCT00674362|19460304|P2|Double Blind|Adverse Event|6
5634645|NCT00674362|19460305|P1|Double Blind|Adverse Event|6
5634646|NCT00674323|19460373|P3|Overall Study|Protocol Violation|0
5634647|NCT00674323|19460374|P2|Overall Study|Protocol Violation|0
5634648|NCT00674323|19460375|P1|Overall Study|Protocol Violation|1
5634649|NCT00674323|19460373|P3|Overall Study|Adverse Event|0
5634650|NCT00674323|19460374|P2|Overall Study|Adverse Event|1
5634651|NCT00674323|19460375|P1|Overall Study|Adverse Event|0
5634652|NCT00674154|19460426|P2|Overall Study|Did not want parathyroidectomy|2
5634653|NCT00674154|19460427|P1|Overall Study|Did not want parathyroidectomy|0
5634654|NCT00674154|19460426|P2|Overall Study|Withdrawal by Subject|1
5634655|NCT00674154|19460427|P1|Overall Study|Withdrawal by Subject|3
5634656|NCT00674128|19460435|P2|Overall Study|Withdrawal by Subject|23
5634657|NCT00674128|19460436|P1|Overall Study|Withdrawal by Subject|25
5634658|NCT00673933|19460461|P1|Overall Study|Lost to Follow-up|1
5634659|NCT00673933|19460461|P1|Overall Study|Withdrawal by Subject|2
5634660|NCT00673920|19460485|P8|Week 24 to Week 48|Adminstrative/Other|0
5634661|NCT00673920|19460486|P7|Week 24 to Week 48|Adminstrative/Other|0
5634662|NCT00673920|19460487|P6|Week 24 to Week 48|Adminstrative/Other|0
5634663|NCT00673920|19460488|P5|Week 24 to Week 48|Adminstrative/Other|0
5634664|NCT00673920|19460489|P4|Week 24 to Week 48|Adminstrative/Other|1
5634665|NCT00673920|19460490|P3|Week 24 to Week 48|Adminstrative/Other|0
5634666|NCT00673920|19460491|P2|Week 24 to Week 48|Adminstrative/Other|0
5634667|NCT00673920|19460492|P1|Week 24 to Week 48|Adminstrative/Other|0
5634668|NCT00673920|19460485|P8|Week 24 to Week 48|Death|0
5634669|NCT00673920|19460486|P7|Week 24 to Week 48|Death|0
5634670|NCT00673920|19460487|P6|Week 24 to Week 48|Death|1
5634671|NCT00673920|19460488|P5|Week 24 to Week 48|Death|0
5634672|NCT00673920|19460489|P4|Week 24 to Week 48|Death|0
5634673|NCT00673920|19460490|P3|Week 24 to Week 48|Death|0
5634674|NCT00673920|19460491|P2|Week 24 to Week 48|Death|0
5634675|NCT00673920|19460492|P1|Week 24 to Week 48|Death|0
5634676|NCT00673920|19460485|P8|Week 24 to Week 48|Insufficient therapeutic response|0
5634677|NCT00673920|19460486|P7|Week 24 to Week 48|Insufficient therapeutic response|0
5634678|NCT00673920|19460487|P6|Week 24 to Week 48|Insufficient therapeutic response|1
5634679|NCT00673920|19460488|P5|Week 24 to Week 48|Insufficient therapeutic response|0
5634680|NCT00673920|19460489|P4|Week 24 to Week 48|Insufficient therapeutic response|0
5634681|NCT00673920|19460490|P3|Week 24 to Week 48|Insufficient therapeutic response|0
5634682|NCT00673920|19460491|P2|Week 24 to Week 48|Insufficient therapeutic response|0
5634683|NCT00673920|19460492|P1|Week 24 to Week 48|Insufficient therapeutic response|0
5634684|NCT00673920|19460485|P8|Week 24 to Week 48|Failure to return|0
5634685|NCT00673920|19460486|P7|Week 24 to Week 48|Failure to return|0
5634686|NCT00673920|19460487|P6|Week 24 to Week 48|Failure to return|1
5634687|NCT00673920|19460488|P5|Week 24 to Week 48|Failure to return|0
5634688|NCT00673920|19460489|P4|Week 24 to Week 48|Failure to return|0
5634689|NCT00673920|19460490|P3|Week 24 to Week 48|Failure to return|0
5634690|NCT00673920|19460491|P2|Week 24 to Week 48|Failure to return|0
5634691|NCT00673920|19460492|P1|Week 24 to Week 48|Failure to return|0
5634692|NCT00673920|19460485|P8|Week 24 to Week 48|Adverse event/intercurrent illness|0
5634693|NCT00673920|19460486|P7|Week 24 to Week 48|Adverse event/intercurrent illness|1
5634694|NCT00673920|19460487|P6|Week 24 to Week 48|Adverse event/intercurrent illness|0
5634695|NCT00673920|19460488|P5|Week 24 to Week 48|Adverse event/intercurrent illness|0
5634696|NCT00673920|19460489|P4|Week 24 to Week 48|Adverse event/intercurrent illness|0
5634697|NCT00673920|19460490|P3|Week 24 to Week 48|Adverse event/intercurrent illness|0
5634698|NCT00673920|19460491|P2|Week 24 to Week 48|Adverse event/intercurrent illness|0
5634699|NCT00673920|19460492|P1|Week 24 to Week 48|Adverse event/intercurrent illness|0
5634700|NCT00673920|19460485|P8|Baseline up to Week 48|Adverse event/intercurrent illness|0
5634701|NCT00673920|19460486|P7|Baseline up to Week 48|Adverse event/intercurrent illness|0
5634702|NCT00673920|19460487|P6|Baseline up to Week 48|Adverse event/intercurrent illness|0
5634703|NCT00673920|19460488|P5|Baseline up to Week 48|Adverse event/intercurrent illness|0
5634704|NCT00673920|19460489|P4|Baseline up to Week 48|Adverse event/intercurrent illness|0
5634705|NCT00673920|19460490|P3|Baseline up to Week 48|Adverse event/intercurrent illness|1
5634706|NCT00673920|19460491|P2|Baseline up to Week 48|Adverse event/intercurrent illness|1
5634707|NCT00673920|19460492|P1|Baseline up to Week 48|Adverse event/intercurrent illness|0
5634708|NCT00673920|19460485|P8|Baseline up to Week 48|Administrative/Other|0
5634709|NCT00673920|19460486|P7|Baseline up to Week 48|Administrative/Other|0
5634710|NCT00673920|19460487|P6|Baseline up to Week 48|Administrative/Other|0
5634711|NCT00673920|19460488|P5|Baseline up to Week 48|Administrative/Other|0
5634712|NCT00673920|19460489|P4|Baseline up to Week 48|Administrative/Other|0
5634713|NCT00673920|19460490|P3|Baseline up to Week 48|Administrative/Other|2
5634714|NCT00673920|19460491|P2|Baseline up to Week 48|Administrative/Other|1
5634715|NCT00673920|19460492|P1|Baseline up to Week 48|Administrative/Other|0
5634716|NCT00673920|19460485|P8|Baseline up to Week 48|Violation of selection criteria at entry|0
5634717|NCT00673920|19460486|P7|Baseline up to Week 48|Violation of selection criteria at entry|0
5634718|NCT00673920|19460487|P6|Baseline up to Week 48|Violation of selection criteria at entry|0
5634719|NCT00673920|19460488|P5|Baseline up to Week 48|Violation of selection criteria at entry|0
5634720|NCT00673920|19460489|P4|Baseline up to Week 48|Violation of selection criteria at entry|0
5634721|NCT00673920|19460490|P3|Baseline up to Week 48|Violation of selection criteria at entry|1
5634722|NCT00673920|19460491|P2|Baseline up to Week 48|Violation of selection criteria at entry|0
5634723|NCT00673920|19460492|P1|Baseline up to Week 48|Violation of selection criteria at entry|0
5634724|NCT00673920|19460485|P8|Baseline up to Week 48|Protocol Violation|0
5634725|NCT00673920|19460486|P7|Baseline up to Week 48|Protocol Violation|0
5634726|NCT00673920|19460487|P6|Baseline up to Week 48|Protocol Violation|0
5634727|NCT00673920|19460488|P5|Baseline up to Week 48|Protocol Violation|0
5634728|NCT00673920|19460489|P4|Baseline up to Week 48|Protocol Violation|0
5634729|NCT00673920|19460490|P3|Baseline up to Week 48|Protocol Violation|1
5634730|NCT00673920|19460491|P2|Baseline up to Week 48|Protocol Violation|0
5634731|NCT00673920|19460492|P1|Baseline up to Week 48|Protocol Violation|0
5634732|NCT00673920|19460485|P8|Baseline up to Week 48|Insufficient therapeutic response|0
5634733|NCT00673920|19460486|P7|Baseline up to Week 48|Insufficient therapeutic response|0
5634734|NCT00673920|19460487|P6|Baseline up to Week 48|Insufficient therapeutic response|0
5634735|NCT00673920|19460488|P5|Baseline up to Week 48|Insufficient therapeutic response|0
5634736|NCT00673920|19460489|P4|Baseline up to Week 48|Insufficient therapeutic response|0
5634737|NCT00673920|19460490|P3|Baseline up to Week 48|Insufficient therapeutic response|0
5634738|NCT00673920|19460491|P2|Baseline up to Week 48|Insufficient therapeutic response|1
5634739|NCT00673920|19460492|P1|Baseline up to Week 48|Insufficient therapeutic response|2
5634740|NCT00673920|19460485|P8|Baseline up to Week 48|Refused treatment|0
5634741|NCT00673920|19460486|P7|Baseline up to Week 48|Refused treatment|0
5634742|NCT00673920|19460487|P6|Baseline up to Week 48|Refused treatment|0
5634743|NCT00673920|19460488|P5|Baseline up to Week 48|Refused treatment|0
5634744|NCT00673920|19460489|P4|Baseline up to Week 48|Refused treatment|0
5634745|NCT00673920|19460490|P3|Baseline up to Week 48|Refused treatment|0
5634746|NCT00673920|19460491|P2|Baseline up to Week 48|Refused treatment|0
5634747|NCT00673920|19460492|P1|Baseline up to Week 48|Refused treatment|1
5634748|NCT00673920|19460485|P8|Baseline up to Week 48|Withdrew consent|0
5634749|NCT00673920|19460486|P7|Baseline up to Week 48|Withdrew consent|0
5634750|NCT00673920|19460487|P6|Baseline up to Week 48|Withdrew consent|0
5634751|NCT00673920|19460488|P5|Baseline up to Week 48|Withdrew consent|0
5634752|NCT00673920|19460489|P4|Baseline up to Week 48|Withdrew consent|0
5634753|NCT00673920|19460490|P3|Baseline up to Week 48|Withdrew consent|2
5634754|NCT00673920|19460491|P2|Baseline up to Week 48|Withdrew consent|0
5634755|NCT00673920|19460492|P1|Baseline up to Week 48|Withdrew consent|1
5634756|NCT00673894|19460638|P2|First Intervention 4 Weeks|Adverse Event|0
5634757|NCT00673894|19460639|P1|First Intervention 4 Weeks|Adverse Event|1
5634758|NCT00673894|19460638|P2|First Intervention 4 Weeks|Withdrawal by Subject|0
5634759|NCT00673894|19460639|P1|First Intervention 4 Weeks|Withdrawal by Subject|1
5634760|NCT00673881|19460647|P1|Overall Study|Withdrawal by Subject|1
5634761|NCT00673816|19460661|P1|Overall Study|Withdrawal by Subject|1
5634762|NCT00673816|19460661|P1|Overall Study|Adverse Event|1
5634763|NCT00673790|19460671|P3|Overall Study|Randomization criteria not met|0
5634764|NCT00673790|19460672|P2|Overall Study|Randomization criteria not met|1
5634765|NCT00673790|19460673|P1|Overall Study|Randomization criteria not met|0
5634766|NCT00673790|19460671|P3|Overall Study|Unconfirmed pregnancy|0
5634767|NCT00673790|19460672|P2|Overall Study|Unconfirmed pregnancy|1
5634768|NCT00673790|19460673|P1|Overall Study|Unconfirmed pregnancy|0
5634769|NCT00673790|19460671|P3|Overall Study|Participated in two Nebivolol studies|1
5634770|NCT00673790|19460672|P2|Overall Study|Participated in two Nebivolol studies|0
5634771|NCT00673790|19460673|P1|Overall Study|Participated in two Nebivolol studies|0
5634772|NCT00673790|19460671|P3|Overall Study|Poor compliance|0
5634773|NCT00673790|19460672|P2|Overall Study|Poor compliance|0
5634774|NCT00673790|19460673|P1|Overall Study|Poor compliance|1
5634775|NCT00673790|19460671|P3|Overall Study|Sponsor Terminated due to PI oversight|0
5634776|NCT00673790|19460672|P2|Overall Study|Sponsor Terminated due to PI oversight|1
5634777|NCT00673790|19460673|P1|Overall Study|Sponsor Terminated due to PI oversight|0
5634778|NCT00673790|19460671|P3|Overall Study|Lost to Follow-up|5
5634779|NCT00673790|19460672|P2|Overall Study|Lost to Follow-up|6
5634780|NCT00673790|19460673|P1|Overall Study|Lost to Follow-up|6
5634781|NCT00673790|19460671|P3|Overall Study|Withdrawal by Subject|1
5634782|NCT00673790|19460672|P2|Overall Study|Withdrawal by Subject|4
5634783|NCT00673790|19460673|P1|Overall Study|Withdrawal by Subject|7
5634784|NCT00673790|19460671|P3|Overall Study|Protocol Violation|1
5634785|NCT00673790|19460672|P2|Overall Study|Protocol Violation|9
5634786|NCT00673790|19460673|P1|Overall Study|Protocol Violation|6
5634787|NCT00673790|19460671|P3|Overall Study|Lack of Efficacy|2
5634788|NCT00673790|19460672|P2|Overall Study|Lack of Efficacy|2
5634789|NCT00673790|19460673|P1|Overall Study|Lack of Efficacy|2
5634790|NCT00673790|19460671|P3|Overall Study|Adverse Event|2
5634791|NCT00673790|19460672|P2|Overall Study|Adverse Event|14
5634792|NCT00673790|19460673|P1|Overall Study|Adverse Event|23
5634793|NCT00673673|19460711|P1|Overall Study|Investigators' discretion|2
5634794|NCT00673673|19460711|P1|Overall Study|Withdrawal by Subject|3
5634795|NCT00673673|19460711|P1|Overall Study|Adverse Event|4
5634796|NCT00673673|19460711|P1|Overall Study|Progressive disease|27
5634797|NCT00673660|19460717|P1|Overall Study|Lost to Follow-up|107
5634798|NCT00673465|19460739|P12|Part 1/Period 2 (United States)|Protocol Violation|0
5634799|NCT00673465|19460740|P11|Part 1/Period 2 (United States)|Protocol Violation|0
5634800|NCT00673465|19460741|P10|Part 1/Period 2 (United States)|Protocol Violation|0
5634801|NCT00673465|19460742|P9|Part 1/Period 2 (United States)|Protocol Violation|0
5634802|NCT00673465|19460743|P8|Part 1/Period 2 (United States)|Protocol Violation|0
5634803|NCT00673465|19460744|P7|Part 1/Period 2 (United States)|Protocol Violation|0
5634804|NCT00673465|19460745|P6|Part 1/Period 2 (United States)|Protocol Violation|0
5634805|NCT00673465|19460746|P5|Part 1/Period 2 (United States)|Protocol Violation|1
5634806|NCT00673465|19460747|P4|Part 1/Period 2 (United States)|Protocol Violation|0
5634807|NCT00673465|19460748|P3|Part 1/Period 2 (United States)|Protocol Violation|0
5634808|NCT00673465|19460749|P2|Part 1/Period 2 (United States)|Protocol Violation|0
5634809|NCT00673465|19460750|P1|Part 1/Period 2 (United States)|Protocol Violation|0
5634810|NCT00673465|19460739|P12|Part 1/Period 1 (United States)|Protocol Violation|0
5634811|NCT00673465|19460740|P11|Part 1/Period 1 (United States)|Protocol Violation|0
5634812|NCT00673465|19460741|P10|Part 1/Period 1 (United States)|Protocol Violation|0
5634813|NCT00673465|19460742|P9|Part 1/Period 1 (United States)|Protocol Violation|0
5634814|NCT00673465|19460743|P8|Part 1/Period 1 (United States)|Protocol Violation|0
5634815|NCT00673465|19460744|P7|Part 1/Period 1 (United States)|Protocol Violation|0
5634816|NCT00673465|19460745|P6|Part 1/Period 1 (United States)|Protocol Violation|1
5634817|NCT00673465|19460746|P5|Part 1/Period 1 (United States)|Protocol Violation|1
5634818|NCT00673465|19460747|P4|Part 1/Period 1 (United States)|Protocol Violation|0
5634819|NCT00673465|19460748|P3|Part 1/Period 1 (United States)|Protocol Violation|0
5634820|NCT00673465|19460749|P2|Part 1/Period 1 (United States)|Protocol Violation|0
5634821|NCT00673465|19460750|P1|Part 1/Period 1 (United States)|Protocol Violation|0
5634822|NCT00673452|19460799|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
5634823|NCT00673452|19460800|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
5634824|NCT00673452|19460799|P2|Continuation Double-Blind Phase|Physician Decision|0
5634825|NCT00673452|19460800|P1|Continuation Double-Blind Phase|Physician Decision|2
5634826|NCT00673452|19460799|P2|Continuation Double-Blind Phase|Sponsor Decision|3
5634827|NCT00673452|19460800|P1|Continuation Double-Blind Phase|Sponsor Decision|0
5634828|NCT00673452|19460799|P2|Continuation Double-Blind Phase|Protocol Violation|3
5634829|NCT00673452|19460800|P1|Continuation Double-Blind Phase|Protocol Violation|2
5634830|NCT00673452|19460799|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
5634831|NCT00673452|19460800|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
5634832|NCT00673452|19460799|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
5634833|NCT00673452|19460800|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
5634834|NCT00673452|19460799|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
5634835|NCT00673452|19460800|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
5634836|NCT00673452|19460799|P2|Continuation Double-Blind Phase|Adverse Event|13
5634837|NCT00673452|19460800|P1|Continuation Double-Blind Phase|Adverse Event|5
5634838|NCT00673452|19460799|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
5634839|NCT00673452|19460800|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
5634840|NCT00673452|19460799|P2|Acute Double-Blind Phase|Sponsor Decision|1
5634841|NCT00673452|19460800|P1|Acute Double-Blind Phase|Sponsor Decision|0
5634842|NCT00673452|19460799|P2|Acute Double-Blind Phase|Protocol Violation|3
5634843|NCT00673452|19460800|P1|Acute Double-Blind Phase|Protocol Violation|5
5634844|NCT00673452|19460799|P2|Acute Double-Blind Phase|Physician Decision|6
5634845|NCT00673452|19460800|P1|Acute Double-Blind Phase|Physician Decision|0
5634846|NCT00673452|19460799|P2|Acute Double-Blind Phase|Lost to Follow-up|19
5634847|NCT00673452|19460800|P1|Acute Double-Blind Phase|Lost to Follow-up|16
5634848|NCT00673452|19460799|P2|Acute Double-Blind Phase|Lack of Efficacy|14
5634849|NCT00673452|19460800|P1|Acute Double-Blind Phase|Lack of Efficacy|9
5634850|NCT00673452|19460799|P2|Acute Double-Blind Phase|Adverse Event|24
5634851|NCT00673452|19460800|P1|Acute Double-Blind Phase|Adverse Event|41
5634852|NCT00673387|19460864|P8|Overall Study|Lost to Follow-up|5
5634853|NCT00673387|19460865|P7|Overall Study|Lost to Follow-up|8
5634854|NCT00673387|19460866|P6|Overall Study|Lost to Follow-up|5
5634855|NCT00673387|19460867|P5|Overall Study|Lost to Follow-up|6
5634856|NCT00673387|19460868|P4|Overall Study|Lost to Follow-up|6
5634857|NCT00673387|19460869|P3|Overall Study|Lost to Follow-up|5
5634858|NCT00673387|19460870|P2|Overall Study|Lost to Follow-up|6
5634859|NCT00673387|19460871|P1|Overall Study|Lost to Follow-up|8
5634860|NCT00673387|19460864|P8|Overall Study|Protocol Violation|3
5634861|NCT00673387|19460865|P7|Overall Study|Protocol Violation|1
5634862|NCT00673387|19460866|P6|Overall Study|Protocol Violation|1
5634863|NCT00673387|19460867|P5|Overall Study|Protocol Violation|0
5634864|NCT00673387|19460868|P4|Overall Study|Protocol Violation|2
5634865|NCT00673387|19460869|P3|Overall Study|Protocol Violation|1
5634866|NCT00673387|19460870|P2|Overall Study|Protocol Violation|0
5634867|NCT00673387|19460871|P1|Overall Study|Protocol Violation|3
5634868|NCT00673387|19460864|P8|Overall Study|Physician Decision|1
5634869|NCT00673387|19460865|P7|Overall Study|Physician Decision|1
5634870|NCT00673387|19460866|P6|Overall Study|Physician Decision|5
5634871|NCT00673387|19460867|P5|Overall Study|Physician Decision|0
5634872|NCT00673387|19460868|P4|Overall Study|Physician Decision|0
5634873|NCT00673387|19460869|P3|Overall Study|Physician Decision|0
5634874|NCT00673387|19460870|P2|Overall Study|Physician Decision|0
5634875|NCT00673387|19460871|P1|Overall Study|Physician Decision|0
5634876|NCT00673387|19460864|P8|Overall Study|Adverse Event|5
5634877|NCT00673387|19460865|P7|Overall Study|Adverse Event|5
5634878|NCT00673387|19460866|P6|Overall Study|Adverse Event|2
5634879|NCT00673387|19460867|P5|Overall Study|Adverse Event|6
5634880|NCT00673387|19460868|P4|Overall Study|Adverse Event|2
5634881|NCT00673387|19460869|P3|Overall Study|Adverse Event|5
5634882|NCT00673387|19460870|P2|Overall Study|Adverse Event|1
5634883|NCT00673387|19460871|P1|Overall Study|Adverse Event|3
5634884|NCT00673387|19460864|P8|Overall Study|Withdrawal by Subject|21
5634885|NCT00673387|19460865|P7|Overall Study|Withdrawal by Subject|15
5634886|NCT00673387|19460866|P6|Overall Study|Withdrawal by Subject|21
5634887|NCT00673387|19460867|P5|Overall Study|Withdrawal by Subject|18
5634888|NCT00673387|19460868|P4|Overall Study|Withdrawal by Subject|16
5634889|NCT00673387|19460869|P3|Overall Study|Withdrawal by Subject|20
5634890|NCT00673387|19460870|P2|Overall Study|Withdrawal by Subject|16
5634891|NCT00673387|19460871|P1|Overall Study|Withdrawal by Subject|15
5634892|NCT00673361|19461087|P1|Overall Study|Screen Failure|2
5634893|NCT00673257|19461123|P1|Overall Study|Unable to obtain specimen|1
5634894|NCT00673257|19461123|P1|Overall Study|Withdrawal by Subject|4
5634895|NCT00673231|19461141|P4|Overall Study|Study criteria,compliance,safety, other|4
5634896|NCT00673231|19461142|P3|Overall Study|Study criteria,compliance,safety, other|7
5634897|NCT00673231|19461143|P2|Overall Study|Study criteria,compliance,safety, other|5
5634898|NCT00673231|19461144|P1|Overall Study|Study criteria,compliance,safety, other|8
5634899|NCT00673231|19461141|P4|Overall Study|Death|0
5634900|NCT00673231|19461142|P3|Overall Study|Death|1
5634901|NCT00673231|19461143|P2|Overall Study|Death|0
5634902|NCT00673231|19461144|P1|Overall Study|Death|0
5634903|NCT00673231|19461141|P4|Overall Study|Lost to Follow-up|2
5634904|NCT00673231|19461142|P3|Overall Study|Lost to Follow-up|1
5634905|NCT00673231|19461143|P2|Overall Study|Lost to Follow-up|2
5634906|NCT00673231|19461144|P1|Overall Study|Lost to Follow-up|1
5634907|NCT00673231|19461141|P4|Overall Study|Adverse Event|6
5634908|NCT00673231|19461142|P3|Overall Study|Adverse Event|9
5634909|NCT00673231|19461143|P2|Overall Study|Adverse Event|5
5634910|NCT00673231|19461144|P1|Overall Study|Adverse Event|6
5634911|NCT00673231|19461141|P4|Overall Study|Withdrawal by Subject|6
5634912|NCT00673231|19461142|P3|Overall Study|Withdrawal by Subject|8
5634913|NCT00673231|19461143|P2|Overall Study|Withdrawal by Subject|10
5634914|NCT00673231|19461144|P1|Overall Study|Withdrawal by Subject|14
5634915|NCT00673179|19461176|P2|Overall Study|Toxicity/Complications|0
5634916|NCT00673179|19461177|P1|Overall Study|Toxicity/Complications|3
5634917|NCT00673049|19461226|P4|After Progression on Erlotinib|study terminated by sponsor|4
5634918|NCT00673049|19461227|P3|After Progression on Erlotinib|study terminated by sponsor|0
5634919|NCT00673049|19461228|P2|After Progression on Erlotinib|study terminated by sponsor|0
5634920|NCT00673049|19461229|P1|After Progression on Erlotinib|study terminated by sponsor|0
5634921|NCT00673049|19461226|P4|After Progression on Erlotinib|Withdrawal by Subject|5
5634922|NCT00673049|19461227|P3|After Progression on Erlotinib|Withdrawal by Subject|0
5634923|NCT00673049|19461228|P2|After Progression on Erlotinib|Withdrawal by Subject|0
5634924|NCT00673049|19461229|P1|After Progression on Erlotinib|Withdrawal by Subject|0
5634925|NCT00673049|19461226|P4|After Progression on Erlotinib|Lost to Follow-up|3
5634926|NCT00673049|19461227|P3|After Progression on Erlotinib|Lost to Follow-up|0
5634927|NCT00673049|19461228|P2|After Progression on Erlotinib|Lost to Follow-up|0
5634928|NCT00673049|19461229|P1|After Progression on Erlotinib|Lost to Follow-up|0
5634929|NCT00673049|19461226|P4|After Progression on Erlotinib|Death|71
5634930|NCT00673049|19461227|P3|After Progression on Erlotinib|Death|0
5634931|NCT00673049|19461228|P2|After Progression on Erlotinib|Death|0
5634932|NCT00673049|19461229|P1|After Progression on Erlotinib|Death|0
5634933|NCT00673049|19461226|P4|Before Progression on Erlotinib|Switched to figitumumab|0
5634934|NCT00673049|19461227|P3|Before Progression on Erlotinib|Switched to figitumumab|0
5634935|NCT00673049|19461228|P2|Before Progression on Erlotinib|Switched to figitumumab|83
5634936|NCT00673049|19461229|P1|Before Progression on Erlotinib|Switched to figitumumab|0
5634937|NCT00673049|19461226|P4|Before Progression on Erlotinib|study terminated by sponsor|0
5634938|NCT00673049|19461227|P3|Before Progression on Erlotinib|study terminated by sponsor|0
5634939|NCT00673049|19461228|P2|Before Progression on Erlotinib|study terminated by sponsor|14
5634940|NCT00673049|19461229|P1|Before Progression on Erlotinib|study terminated by sponsor|18
5634941|NCT00673049|19461226|P4|Before Progression on Erlotinib|Other|0
5634942|NCT00673049|19461227|P3|Before Progression on Erlotinib|Other|0
5634943|NCT00673049|19461228|P2|Before Progression on Erlotinib|Other|2
5634944|NCT00673049|19461229|P1|Before Progression on Erlotinib|Other|1
5634945|NCT00673049|19461226|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
5634946|NCT00673049|19461227|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
5634947|NCT00673049|19461228|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
5634948|NCT00673049|19461229|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
5634949|NCT00673049|19461226|P4|Before Progression on Erlotinib|Lost to Follow-up|0
5634950|NCT00673049|19461227|P3|Before Progression on Erlotinib|Lost to Follow-up|0
5634951|NCT00673049|19461228|P2|Before Progression on Erlotinib|Lost to Follow-up|5
5634952|NCT00673049|19461229|P1|Before Progression on Erlotinib|Lost to Follow-up|9
5634953|NCT00673049|19461226|P4|Before Progression on Erlotinib|Death|0
5634954|NCT00673049|19461227|P3|Before Progression on Erlotinib|Death|1
5634955|NCT00673049|19461228|P2|Before Progression on Erlotinib|Death|167
5634956|NCT00673049|19461229|P1|Before Progression on Erlotinib|Death|235
5634957|NCT00673049|19461226|P4|Before Progression on Erlotinib|Randomized but not treated|0
5634958|NCT00673049|19461227|P3|Before Progression on Erlotinib|Randomized but not treated|0
5634959|NCT00673049|19461228|P2|Before Progression on Erlotinib|Randomized but not treated|1
5634960|NCT00673049|19461229|P1|Before Progression on Erlotinib|Randomized but not treated|3
5634961|NCT00672984|19461253|P3|Third Intervention|Adverse Event|1
5634962|NCT00672984|19461254|P2|Third Intervention|Adverse Event|0
5634963|NCT00672984|19461255|P1|Third Intervention|Adverse Event|1
5634964|NCT00672984|19461253|P3|Second Intervention|Protocol Violation|1
5634965|NCT00672984|19461254|P2|Second Intervention|Protocol Violation|1
5634966|NCT00672984|19461255|P1|Second Intervention|Protocol Violation|0
5634967|NCT00672984|19461253|P3|Second Intervention|Withdrawal by Subject|0
5634968|NCT00672984|19461254|P2|Second Intervention|Withdrawal by Subject|3
5634969|NCT00672984|19461255|P1|Second Intervention|Withdrawal by Subject|0
5634970|NCT00672984|19461253|P3|Second Intervention|Non-compliance with facility policies|0
5634971|NCT00672984|19461254|P2|Second Intervention|Non-compliance with facility policies|2
5634972|NCT00672984|19461255|P1|Second Intervention|Non-compliance with facility policies|0
5634973|NCT00672984|19461253|P3|First Intervention|Sponsor decision|0
5634974|NCT00672984|19461254|P2|First Intervention|Sponsor decision|0
5634975|NCT00672984|19461255|P1|First Intervention|Sponsor decision|3
5634976|NCT00672984|19461253|P3|First Intervention|Withdrawal by Subject|2
5634977|NCT00672984|19461254|P2|First Intervention|Withdrawal by Subject|2
5634978|NCT00672984|19461255|P1|First Intervention|Withdrawal by Subject|1
5634979|NCT00672984|19461253|P3|First Intervention|Adverse Event|0
5634980|NCT00672984|19461254|P2|First Intervention|Adverse Event|0
5634981|NCT00672984|19461255|P1|First Intervention|Adverse Event|5
5634982|NCT00672958|19461306|P2|Overall Study|Reason not specified|3
5634983|NCT00672958|19461307|P1|Overall Study|Reason not specified|0
5634984|NCT00672958|19461306|P2|Overall Study|Lost to Follow-up|17
5634985|NCT00672958|19461307|P1|Overall Study|Lost to Follow-up|22
5634986|NCT00672958|19461306|P2|Overall Study|Voluntary withdrawal|8
5634987|NCT00672958|19461307|P1|Overall Study|Voluntary withdrawal|12
5634988|NCT00672958|19461306|P2|Overall Study|Protocol deviations|5
5634989|NCT00672958|19461307|P1|Overall Study|Protocol deviations|11
5634990|NCT00672958|19461306|P2|Overall Study|Non-compliance with study drug|3
5634991|NCT00672958|19461307|P1|Overall Study|Non-compliance with study drug|2
5634992|NCT00672958|19461306|P2|Overall Study|Lack of Efficacy|11
5634993|NCT00672958|19461307|P1|Overall Study|Lack of Efficacy|6
5634994|NCT00672958|19461306|P2|Overall Study|Adverse Event|9
5634995|NCT00672958|19461307|P1|Overall Study|Adverse Event|11
5634996|NCT00672841|19461373|P2|Overall Study|Pregnancy|1
5634997|NCT00672841|19461374|P1|Overall Study|Pregnancy|0
5634998|NCT00672841|19461373|P2|Overall Study|Adverse Event|3
5634999|NCT00672841|19461374|P1|Overall Study|Adverse Event|0
5635000|NCT00672841|19461373|P2|Overall Study|Antifungal therapy, negative glucan|4
5635001|NCT00672841|19461374|P1|Overall Study|Antifungal therapy, negative glucan|0
5635002|NCT00672841|19461373|P2|Overall Study|icteric specimens|3
5635003|NCT00672841|19461374|P1|Overall Study|icteric specimens|0
5635004|NCT00672841|19461373|P2|Overall Study|Comfort care|4
5635005|NCT00672841|19461374|P1|Overall Study|Comfort care|1
5635006|NCT00672646|19461396|P3|Overall Study|Withdrawal by Subject|1
5635007|NCT00672646|19461397|P2|Overall Study|Withdrawal by Subject|0
5635008|NCT00672646|19461398|P1|Overall Study|Withdrawal by Subject|0
5635009|NCT00672646|19461396|P3|Overall Study|Lost to Follow-up|2
5635010|NCT00672646|19461397|P2|Overall Study|Lost to Follow-up|1
5635011|NCT00672646|19461398|P1|Overall Study|Lost to Follow-up|0
5635012|NCT00672633|19461423|P2|Overall Study|Withdrawal by Subject|1
5635013|NCT00672633|19461424|P1|Overall Study|Withdrawal by Subject|0
5635014|NCT00672620|19461438|P4|Overall Study|Reason not Specified|1
5635015|NCT00672620|19461439|P3|Overall Study|Reason not Specified|2
5635016|NCT00672620|19461440|P2|Overall Study|Reason not Specified|3
5635017|NCT00672620|19461441|P1|Overall Study|Reason not Specified|3
5635018|NCT00672620|19461438|P4|Overall Study|Lost to Follow-up|11
5635019|NCT00672620|19461439|P3|Overall Study|Lost to Follow-up|8
5635020|NCT00672620|19461440|P2|Overall Study|Lost to Follow-up|19
5635021|NCT00672620|19461441|P1|Overall Study|Lost to Follow-up|8
5635022|NCT00672620|19461438|P4|Overall Study|Withdrawal of Consent|6
5635023|NCT00672620|19461439|P3|Overall Study|Withdrawal of Consent|5
5635024|NCT00672620|19461440|P2|Overall Study|Withdrawal of Consent|12
5635025|NCT00672620|19461441|P1|Overall Study|Withdrawal of Consent|6
5635026|NCT00672620|19461438|P4|Overall Study|Protocol Deviations|5
5635027|NCT00672620|19461439|P3|Overall Study|Protocol Deviations|2
5635028|NCT00672620|19461440|P2|Overall Study|Protocol Deviations|7
5635029|NCT00672620|19461441|P1|Overall Study|Protocol Deviations|5
5635030|NCT00672620|19461438|P4|Overall Study|Noncompliance with Study Drug|2
5635031|NCT00672620|19461439|P3|Overall Study|Noncompliance with Study Drug|0
5635032|NCT00672620|19461440|P2|Overall Study|Noncompliance with Study Drug|4
5635033|NCT00672620|19461441|P1|Overall Study|Noncompliance with Study Drug|3
5635034|NCT00672620|19461438|P4|Overall Study|Lack of Efficacy|0
5635035|NCT00672620|19461439|P3|Overall Study|Lack of Efficacy|2
5635036|NCT00672620|19461440|P2|Overall Study|Lack of Efficacy|2
5635037|NCT00672620|19461441|P1|Overall Study|Lack of Efficacy|1
5635038|NCT00672620|19461438|P4|Overall Study|Adverse Event|17
5635039|NCT00672620|19461439|P3|Overall Study|Adverse Event|12
5635040|NCT00672620|19461440|P2|Overall Study|Adverse Event|7
5635041|NCT00672620|19461441|P1|Overall Study|Adverse Event|7
5635042|NCT00672555|19461506|P1|Overall Study|Did not want to answer questionnaire|2
5635043|NCT00672555|19461506|P1|Overall Study|Lost to Follow-up|4
5635044|NCT00672490|19461517|P2|Overall Study|No reason was provided|2
5635045|NCT00672490|19461518|P1|Overall Study|No reason was provided|6
5635046|NCT00672490|19461517|P2|Overall Study|Lost to Follow-up|5
5635047|NCT00672490|19461518|P1|Overall Study|Lost to Follow-up|1
5635048|NCT00672490|19461517|P2|Overall Study|Intolerance|2
5635049|NCT00672490|19461518|P1|Overall Study|Intolerance|0
5635050|NCT00672490|19461517|P2|Overall Study|Violation of Concomitant Medicine|0
5635051|NCT00672490|19461518|P1|Overall Study|Violation of Concomitant Medicine|1
5635052|NCT00672490|19461517|P2|Overall Study|Adverse Event|8
5635053|NCT00672490|19461518|P1|Overall Study|Adverse Event|5
5635054|NCT00672490|19461517|P2|Overall Study|Mismatch Include/Exclude Criteria|0
5635055|NCT00672490|19461518|P1|Overall Study|Mismatch Include/Exclude Criteria|1
5635056|NCT00672490|19461517|P2|Overall Study|Lack of Compliance|7
5635057|NCT00672490|19461518|P1|Overall Study|Lack of Compliance|2
5635058|NCT00672490|19461517|P2|Overall Study|Withdrawal by Subject|8
5635059|NCT00672490|19461518|P1|Overall Study|Withdrawal by Subject|8
5635060|NCT00672477|19461542|P2|Overall Study|no study drug for low GFR, health cond.|3
5635061|NCT00672477|19461543|P1|Overall Study|no study drug for low GFR, health cond.|1
5635062|NCT00672477|19461542|P2|Overall Study|Lack of Efficacy|1
5635063|NCT00672477|19461543|P1|Overall Study|Lack of Efficacy|1
5635064|NCT00672477|19461542|P2|Overall Study|Withdrawal by Subject|3
5635065|NCT00672477|19461543|P1|Overall Study|Withdrawal by Subject|5
5635066|NCT00672477|19461542|P2|Overall Study|Protocol Violation|1
5635067|NCT00672477|19461543|P1|Overall Study|Protocol Violation|1
5635068|NCT00672477|19461542|P2|Overall Study|Physician Decision|0
5635069|NCT00672477|19461543|P1|Overall Study|Physician Decision|2
5635070|NCT00672477|19461542|P2|Overall Study|Death|11
5635071|NCT00672477|19461543|P1|Overall Study|Death|7
5635072|NCT00672477|19461542|P2|Overall Study|Adverse Event|7
5635073|NCT00672477|19461543|P1|Overall Study|Adverse Event|10
5635074|NCT00672256|19461596|P1|Overall Study|PI dropped, bad data|44
5635075|NCT00672139|19461621|P2|Overall Study|hospice discharge, caregiver requests|2
5635076|NCT00672139|19461622|P1|Overall Study|hospice discharge, caregiver requests|3
5635077|NCT00672139|19461621|P2|Overall Study|Protocol Violation|1
5635078|NCT00672139|19461622|P1|Overall Study|Protocol Violation|1
5635079|NCT00672139|19461621|P2|Overall Study|Lack of Efficacy|1
5635080|NCT00672139|19461622|P1|Overall Study|Lack of Efficacy|4
5635081|NCT00672139|19461621|P2|Overall Study|Physician Decision|0
5635082|NCT00672139|19461622|P1|Overall Study|Physician Decision|2
5635083|NCT00672139|19461621|P2|Overall Study|Adverse Event|7
5635084|NCT00672139|19461622|P1|Overall Study|Adverse Event|4
5635085|NCT00672139|19461621|P2|Overall Study|Withdrawal by Subject|11
5635086|NCT00672139|19461622|P1|Overall Study|Withdrawal by Subject|2
5635087|NCT00672139|19461621|P2|Overall Study|Death|23
5635088|NCT00672139|19461622|P1|Overall Study|Death|14
5635089|NCT00671931|19461679|P5|Overall Study|Physician Decision|1
5635090|NCT00671931|19461680|P4|Overall Study|Physician Decision|2
5635091|NCT00671931|19461681|P3|Overall Study|Physician Decision|0
5635092|NCT00671931|19461682|P2|Overall Study|Physician Decision|0
5635093|NCT00671931|19461683|P1|Overall Study|Physician Decision|1
5635094|NCT00671879|19461703|P3|Overall Study|Withdrawal by Subject|6
5635095|NCT00671879|19461704|P2|Overall Study|Withdrawal by Subject|4
5635096|NCT00671879|19461705|P1|Overall Study|Withdrawal by Subject|0
5635097|NCT00671853|19461718|P2|Overall Study|Non-adherence with study procedures|4
5635098|NCT00671853|19461719|P1|Overall Study|Non-adherence with study procedures|1
5635099|NCT00671853|19461718|P2|Overall Study|Physician Decision|2
5635100|NCT00671853|19461719|P1|Overall Study|Physician Decision|0
5635101|NCT00671853|19461718|P2|Overall Study|Lost to Follow-up|8
5635102|NCT00671853|19461719|P1|Overall Study|Lost to Follow-up|8
5635103|NCT00671853|19461718|P2|Overall Study|Withdrawal by Subject|5
5635104|NCT00671853|19461719|P1|Overall Study|Withdrawal by Subject|1
5635105|NCT00671853|19461718|P2|Overall Study|Adverse Event|1
5635106|NCT00671853|19461719|P1|Overall Study|Adverse Event|7
5635107|NCT00671853|19461718|P2|Overall Study|Lack of Efficacy|7
5635108|NCT00671853|19461719|P1|Overall Study|Lack of Efficacy|3
5635109|NCT00671788|19461735|P1|Overall Study|Other|1
5635110|NCT00671788|19461735|P1|Overall Study|MD Decision|1
5635111|NCT00671788|19461735|P1|Overall Study|Ineligible|1
5635112|NCT00671788|19461735|P1|Overall Study|Refused further treatment|3
5635113|NCT00671788|19461735|P1|Overall Study|Adverse Event|8
5635114|NCT00671749|19461742|P1|Overall Study|Lost to Follow-up|1
5635115|NCT00671749|19461742|P1|Overall Study|Protocol Violation|1
5635116|NCT00671749|19461742|P1|Overall Study|Withdrawal by Subject|4
5635117|NCT00671749|19461742|P1|Overall Study|Adverse Event|2
5635118|NCT00671658|19461797|P1|Overall Study|Physician Decision|5
5635119|NCT00671554|19461805|P1|Overall Study|Disease progression|3
5635120|NCT00671437|19461844|P1|Overall Study|Ineligible post-hoc|1
5635121|NCT00671437|19461844|P1|Overall Study|Adverse Event|3
5635122|NCT00671437|19461844|P1|Overall Study|Cutaneous SCC of head and neck|3
5635123|NCT00671437|19461844|P1|Overall Study|Progressive disease before C1 week 8|8
5635124|NCT00671060|19461878|P2|Overall Study|Physician Decision|1
5635125|NCT00671060|19461879|P1|Overall Study|Physician Decision|0
5635126|NCT00671060|19461878|P2|Overall Study|Protocol Violation|0
5635127|NCT00671060|19461879|P1|Overall Study|Protocol Violation|1
5635128|NCT00671034|19461888|P3|Overall Study|includes Alternative therapy, etc.|7
5635129|NCT00671034|19461889|P2|Overall Study|includes Alternative therapy, etc.|1
5635130|NCT00671034|19461890|P1|Overall Study|includes Alternative therapy, etc.|6
5635131|NCT00671034|19461888|P3|Overall Study|Refusal|5
5635132|NCT00671034|19461889|P2|Overall Study|Refusal|3
5635133|NCT00671034|19461890|P1|Overall Study|Refusal|5
5635134|NCT00671034|19461888|P3|Overall Study|VHR ALL feature|5
5635135|NCT00671034|19461889|P2|Overall Study|VHR ALL feature|3
5635136|NCT00671034|19461890|P1|Overall Study|VHR ALL feature|8
5635137|NCT00671034|19461888|P3|Overall Study|Physician Decision|5
5635138|NCT00671034|19461889|P2|Overall Study|Physician Decision|4
5635139|NCT00671034|19461890|P1|Overall Study|Physician Decision|12
5635140|NCT00671034|19461888|P3|Overall Study|Death|1
5635141|NCT00671034|19461889|P2|Overall Study|Death|2
5635142|NCT00671034|19461890|P1|Overall Study|Death|3
5635143|NCT00671034|19461888|P3|Overall Study|Adverse Event|1
5635144|NCT00671034|19461889|P2|Overall Study|Adverse Event|7
5635145|NCT00671034|19461890|P1|Overall Study|Adverse Event|5
5635146|NCT00670930|19461945|P2|Overall Study|Lost to Follow-up|0
5635147|NCT00670930|19461946|P1|Overall Study|Lost to Follow-up|1
5635148|NCT00670930|19461945|P2|Overall Study|Adminstrative Problem|1
5635149|NCT00670930|19461946|P1|Overall Study|Adminstrative Problem|0
5635150|NCT00670800|19461962|P2|Overall Study|2 controls were insulin resistant|2
5635151|NCT00670800|19461963|P1|Overall Study|2 controls were insulin resistant|0
5635152|NCT00670748|19461994|P4|Overall Study|Not off study|1
5635153|NCT00670748|19461995|P3|Overall Study|Not off study|1
5635154|NCT00670748|19461996|P2|Overall Study|Not off study|1
5635155|NCT00670748|19461997|P1|Overall Study|Not off study|2
5635156|NCT00670748|19461994|P4|Overall Study|Death during treatment|0
5635157|NCT00670748|19461995|P3|Overall Study|Death during treatment|1
5635158|NCT00670748|19461996|P2|Overall Study|Death during treatment|1
5635159|NCT00670748|19461997|P1|Overall Study|Death during treatment|1
5635160|NCT00670540|19462032|P1|Overall Study|missing information inclusion criteria|1
5635161|NCT00670540|19462032|P1|Overall Study|controls randomised for no follow up|2770
5635162|NCT00670540|19462032|P1|Overall Study|refused to participate|189
5635163|NCT00670540|19462032|P1|Overall Study|not living in France|348
5635164|NCT00670540|19462032|P1|Overall Study|ineligible|17
5635165|NCT00670488|19462052|P10|Overall Study|Withdrawal by Subject|0
5635166|NCT00670488|19462053|P9|Overall Study|Withdrawal by Subject|1
5635167|NCT00670488|19462054|P8|Overall Study|Withdrawal by Subject|0
5635168|NCT00670488|19462055|P7|Overall Study|Withdrawal by Subject|1
5635169|NCT00670488|19462056|P6|Overall Study|Withdrawal by Subject|0
5635170|NCT00670488|19462057|P5|Overall Study|Withdrawal by Subject|0
5635171|NCT00670488|19462058|P4|Overall Study|Withdrawal by Subject|1
5635172|NCT00670488|19462059|P3|Overall Study|Withdrawal by Subject|0
5635173|NCT00670488|19462060|P2|Overall Study|Withdrawal by Subject|1
5635174|NCT00670488|19462061|P1|Overall Study|Withdrawal by Subject|0
5635175|NCT00670488|19462052|P10|Overall Study|Progressive Disease|1
5635176|NCT00670488|19462053|P9|Overall Study|Progressive Disease|2
5635177|NCT00670488|19462054|P8|Overall Study|Progressive Disease|2
5635178|NCT00670488|19462055|P7|Overall Study|Progressive Disease|11
5635179|NCT00670488|19462056|P6|Overall Study|Progressive Disease|4
5635180|NCT00670488|19462057|P5|Overall Study|Progressive Disease|2
5635181|NCT00670488|19462058|P4|Overall Study|Progressive Disease|2
5635182|NCT00670488|19462059|P3|Overall Study|Progressive Disease|3
5635183|NCT00670488|19462060|P2|Overall Study|Progressive Disease|41
5635184|NCT00670488|19462061|P1|Overall Study|Progressive Disease|2
5635185|NCT00670488|19462052|P10|Overall Study|Physician Decision|0
5635186|NCT00670488|19462053|P9|Overall Study|Physician Decision|0
5635187|NCT00670488|19462054|P8|Overall Study|Physician Decision|0
5635188|NCT00670488|19462055|P7|Overall Study|Physician Decision|0
5635189|NCT00670488|19462056|P6|Overall Study|Physician Decision|0
5635190|NCT00670488|19462057|P5|Overall Study|Physician Decision|0
5635191|NCT00670488|19462058|P4|Overall Study|Physician Decision|1
5635192|NCT00670488|19462059|P3|Overall Study|Physician Decision|0
5635193|NCT00670488|19462060|P2|Overall Study|Physician Decision|9
5635194|NCT00670488|19462061|P1|Overall Study|Physician Decision|1
5635195|NCT00670488|19462052|P10|Overall Study|Adverse Event|1
5635196|NCT00670488|19462053|P9|Overall Study|Adverse Event|0
5635197|NCT00670488|19462054|P8|Overall Study|Adverse Event|1
5635198|NCT00670488|19462055|P7|Overall Study|Adverse Event|5
5635199|NCT00670488|19462056|P6|Overall Study|Adverse Event|1
5635200|NCT00670488|19462057|P5|Overall Study|Adverse Event|1
5635201|NCT00670488|19462058|P4|Overall Study|Adverse Event|3
5635202|NCT00670488|19462059|P3|Overall Study|Adverse Event|0
5635203|NCT00670488|19462060|P2|Overall Study|Adverse Event|7
5635204|NCT00670488|19462061|P1|Overall Study|Adverse Event|0
5635205|NCT00670449|19462248|P4|Overall Study|Abnormal Laboratory Value(s)|0
5635206|NCT00670449|19462249|P3|Overall Study|Abnormal Laboratory Value(s)|0
5635207|NCT00670449|19462250|P2|Overall Study|Abnormal Laboratory Value(s)|2
5635208|NCT00670449|19462251|P1|Overall Study|Abnormal Laboratory Value(s)|0
5635209|NCT00670449|19462248|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
5635210|NCT00670449|19462249|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
5635211|NCT00670449|19462250|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
5635212|NCT00670449|19462251|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
5635213|NCT00670449|19462248|P4|Overall Study|Subject Withdrew Consent|1
5635214|NCT00670449|19462249|P3|Overall Study|Subject Withdrew Consent|0
5635215|NCT00670449|19462250|P2|Overall Study|Subject Withdrew Consent|2
5635216|NCT00670449|19462251|P1|Overall Study|Subject Withdrew Consent|0
5635217|NCT00670449|19462248|P4|Overall Study|Administrative Problems|1
5635218|NCT00670449|19462249|P3|Overall Study|Administrative Problems|0
5635219|NCT00670449|19462250|P2|Overall Study|Administrative Problems|2
5635220|NCT00670449|19462251|P1|Overall Study|Administrative Problems|0
5635221|NCT00670449|19462248|P4|Overall Study|Protocol Deviation|1
5635222|NCT00670449|19462249|P3|Overall Study|Protocol Deviation|0
5635223|NCT00670449|19462250|P2|Overall Study|Protocol Deviation|2
5635224|NCT00670449|19462251|P1|Overall Study|Protocol Deviation|1
5635225|NCT00670449|19462248|P4|Overall Study|Adverse Event|5
5635226|NCT00670449|19462249|P3|Overall Study|Adverse Event|8
5635227|NCT00670449|19462250|P2|Overall Study|Adverse Event|2
5635228|NCT00670449|19462251|P1|Overall Study|Adverse Event|6
5635229|NCT00670306|19462275|P1|Overall Study|incl/excl criterias did not meet|19
5635230|NCT00670306|19462275|P1|Overall Study|Lost to Follow-up|8
5635231|NCT00670306|19462275|P1|Overall Study|Physician Decision|1
5635232|NCT00670306|19462275|P1|Overall Study|Withdrawal by Subject|9
5635233|NCT00670306|19462275|P1|Overall Study|Lack of Efficacy|10
5635234|NCT00670306|19462275|P1|Overall Study|Adverse Event|8
5635235|NCT00670228|19462314|P2|Overall Study|Not meeting the selection criteria|0
5635236|NCT00670228|19462315|P1|Overall Study|Not meeting the selection criteria|2
5635237|NCT00670228|19462314|P2|Overall Study|Not treated|2
5635238|NCT00670228|19462315|P1|Overall Study|Not treated|2
5635239|NCT00670228|19462314|P2|Overall Study|Death or MACE|1
5635240|NCT00670228|19462315|P1|Overall Study|Death or MACE|0
5635241|NCT00670228|19462314|P2|Overall Study|Adverse Event|0
5635242|NCT00670228|19462315|P1|Overall Study|Adverse Event|1
5635243|NCT00670111|19462339|P3|Enrollment to One Month|Physician Decision|0
5635244|NCT00670111|19462340|P2|Enrollment to One Month|Physician Decision|0
5635245|NCT00670111|19462341|P1|Enrollment to One Month|Physician Decision|1
5635246|NCT00670111|19462339|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
5635247|NCT00670111|19462340|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
5635248|NCT00670111|19462341|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
5635249|NCT00670111|19462339|P3|Enrollment to One Month|Testing Failure|13
5635250|NCT00670111|19462340|P2|Enrollment to One Month|Testing Failure|0
5635251|NCT00670111|19462341|P1|Enrollment to One Month|Testing Failure|0
5635252|NCT00670046|19462351|P2|Overall Study|Withdrawal by Subject|1
5635253|NCT00670046|19462352|P1|Overall Study|Withdrawal by Subject|0
5635254|NCT00670046|19462351|P2|Overall Study|Lost to Follow-up|1
5635255|NCT00670046|19462352|P1|Overall Study|Lost to Follow-up|1
5635256|NCT00670007|19462366|P1|Overall Study|Withdrawal by Subject|4
5635257|NCT00670007|19462366|P1|Overall Study|Adverse Event|1
5635258|NCT00670007|19462366|P1|Overall Study|Adverse event, serious fatal|1
5635259|NCT00670007|19462366|P1|Overall Study|Travel/Vacation|1
5635260|NCT00670007|19462366|P1|Overall Study|Lung transplant|1
5635261|NCT00670007|19462366|P1|Overall Study|Drug abuse|1
5635262|NCT00669955|19462393|P2|Overall Study|not compliant with study drug/visit|3
5635263|NCT00669955|19462394|P1|Overall Study|not compliant with study drug/visit|2
5635264|NCT00669955|19462393|P2|Overall Study|Investigator Sponsor Judgement|1
5635265|NCT00669955|19462394|P1|Overall Study|Investigator Sponsor Judgement|0
5635266|NCT00669955|19462393|P2|Overall Study|Protocol Violation|7
5635267|NCT00669955|19462394|P1|Overall Study|Protocol Violation|2
5635268|NCT00669955|19462393|P2|Overall Study|Lost to Follow-up|7
5635269|NCT00669955|19462394|P1|Overall Study|Lost to Follow-up|5
5635270|NCT00669955|19462393|P2|Overall Study|Withdrawal by Subject|3
5635271|NCT00669955|19462394|P1|Overall Study|Withdrawal by Subject|2
5635272|NCT00669955|19462393|P2|Overall Study|Death|1
5635273|NCT00669955|19462394|P1|Overall Study|Death|0
5635274|NCT00669955|19462393|P2|Overall Study|Adverse Event|5
5635275|NCT00669955|19462394|P1|Overall Study|Adverse Event|3
5635276|NCT00669942|19462424|P12|Parts 2 and 3|Protocol Violation|0
5635277|NCT00669942|19462425|P11|Parts 2 and 3|Protocol Violation|0
5635278|NCT00669942|19462426|P10|Parts 2 and 3|Protocol Violation|0
5635279|NCT00669942|19462427|P9|Parts 2 and 3|Protocol Violation|0
5635280|NCT00669942|19462428|P8|Parts 2 and 3|Protocol Violation|0
5635281|NCT00669942|19462429|P7|Parts 2 and 3|Protocol Violation|0
5635282|NCT00669942|19462430|P6|Parts 2 and 3|Protocol Violation|1
5635283|NCT00669942|19462431|P5|Parts 2 and 3|Protocol Violation|0
5635284|NCT00669942|19462432|P4|Parts 2 and 3|Protocol Violation|0
5635285|NCT00669942|19462433|P3|Parts 2 and 3|Protocol Violation|0
5635286|NCT00669942|19462434|P2|Parts 2 and 3|Protocol Violation|0
5635287|NCT00669942|19462435|P1|Parts 2 and 3|Protocol Violation|0
5635288|NCT00669942|19462424|P12|Parts 2 and 3|Withdrawal by Subject|0
5635289|NCT00669942|19462425|P11|Parts 2 and 3|Withdrawal by Subject|0
5635290|NCT00669942|19462426|P10|Parts 2 and 3|Withdrawal by Subject|0
5635291|NCT00669942|19462427|P9|Parts 2 and 3|Withdrawal by Subject|2
5635292|NCT00669942|19462428|P8|Parts 2 and 3|Withdrawal by Subject|0
5635293|NCT00669942|19462429|P7|Parts 2 and 3|Withdrawal by Subject|0
5635294|NCT00669942|19462430|P6|Parts 2 and 3|Withdrawal by Subject|1
5635295|NCT00669942|19462431|P5|Parts 2 and 3|Withdrawal by Subject|0
5635296|NCT00669942|19462432|P4|Parts 2 and 3|Withdrawal by Subject|0
5635297|NCT00669942|19462433|P3|Parts 2 and 3|Withdrawal by Subject|0
5635298|NCT00669942|19462434|P2|Parts 2 and 3|Withdrawal by Subject|0
5635299|NCT00669942|19462435|P1|Parts 2 and 3|Withdrawal by Subject|0
5635300|NCT00669942|19462424|P12|Parts 2 and 3|Adverse Event|0
5635301|NCT00669942|19462425|P11|Parts 2 and 3|Adverse Event|0
5635302|NCT00669942|19462426|P10|Parts 2 and 3|Adverse Event|0
5635303|NCT00669942|19462427|P9|Parts 2 and 3|Adverse Event|1
5635304|NCT00669942|19462428|P8|Parts 2 and 3|Adverse Event|2
5635305|NCT00669942|19462429|P7|Parts 2 and 3|Adverse Event|0
5635306|NCT00669942|19462430|P6|Parts 2 and 3|Adverse Event|0
5635307|NCT00669942|19462431|P5|Parts 2 and 3|Adverse Event|0
5635308|NCT00669942|19462432|P4|Parts 2 and 3|Adverse Event|0
5635309|NCT00669942|19462433|P3|Parts 2 and 3|Adverse Event|0
5635310|NCT00669942|19462434|P2|Parts 2 and 3|Adverse Event|0
5635311|NCT00669942|19462435|P1|Parts 2 and 3|Adverse Event|0
5635312|NCT00669903|19462518|P4|Overall Study|Protocol Violation|0
5635313|NCT00669903|19462519|P3|Overall Study|Protocol Violation|0
5635314|NCT00669903|19462520|P2|Overall Study|Protocol Violation|1
5635315|NCT00669903|19462521|P1|Overall Study|Protocol Violation|0
5635316|NCT00669903|19462518|P4|Overall Study|Lost to Follow-up|1
5635317|NCT00669903|19462519|P3|Overall Study|Lost to Follow-up|0
5635318|NCT00669903|19462520|P2|Overall Study|Lost to Follow-up|1
5635319|NCT00669903|19462521|P1|Overall Study|Lost to Follow-up|1
5635320|NCT00669903|19462518|P4|Overall Study|Withdrawal by Subject|2
5635321|NCT00669903|19462519|P3|Overall Study|Withdrawal by Subject|2
5635322|NCT00669903|19462520|P2|Overall Study|Withdrawal by Subject|2
5635323|NCT00669903|19462521|P1|Overall Study|Withdrawal by Subject|0
5635324|NCT00669903|19462518|P4|Overall Study|Adverse Event|1
5635325|NCT00669903|19462519|P3|Overall Study|Adverse Event|3
5635326|NCT00669903|19462520|P2|Overall Study|Adverse Event|1
5635327|NCT00669903|19462521|P1|Overall Study|Adverse Event|0
5635328|NCT00669877|19462551|P1|Overall Study|Disease Progression/Death|4
5635329|NCT00669864|19462556|P1|Overall Study|Other|2
5635330|NCT00669864|19462556|P1|Overall Study|Withdrawal by Subject|3
5635331|NCT00669864|19462556|P1|Overall Study|Protocol Violation|2
5635332|NCT00669864|19462556|P1|Overall Study|Lost to Follow-up|2
5635333|NCT00669669|19462570|P1|Overall Study|To late to start treatment|1
5635334|NCT00669617|19462575|P5|Period 3|Lost to Follow-up|0
5635335|NCT00669617|19462576|P4|Period 3|Lost to Follow-up|0
5635336|NCT00669617|19462577|P3|Period 3|Lost to Follow-up|0
5635337|NCT00669617|19462578|P2|Period 3|Lost to Follow-up|0
5635338|NCT00669617|19462579|P1|Period 3|Lost to Follow-up|1
5635339|NCT00669617|19462575|P5|Period 1|Protocol Deviation|1
5635340|NCT00669617|19462576|P4|Period 1|Protocol Deviation|0
5635341|NCT00669617|19462577|P3|Period 1|Protocol Deviation|0
5635342|NCT00669617|19462578|P2|Period 1|Protocol Deviation|0
5635343|NCT00669617|19462579|P1|Period 1|Protocol Deviation|0
5635344|NCT00669617|19462575|P5|Period 1|Withdrawal by Subject|0
5635345|NCT00669617|19462576|P4|Period 1|Withdrawal by Subject|0
5635346|NCT00669617|19462577|P3|Period 1|Withdrawal by Subject|1
5635347|NCT00669617|19462578|P2|Period 1|Withdrawal by Subject|0
5635348|NCT00669617|19462579|P1|Period 1|Withdrawal by Subject|0
5635349|NCT00669396|19462627|P2|Overall Study|Lost to Follow-up|12
5635350|NCT00669396|19462628|P1|Overall Study|Lost to Follow-up|10
5635351|NCT00669331|19462655|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
5635352|NCT00669331|19462656|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
5635353|NCT00669331|19462655|P2|Blinded Treatment Period|Physician Decision|3
5635354|NCT00669331|19462656|P1|Blinded Treatment Period|Physician Decision|3
5635355|NCT00669331|19462655|P2|Blinded Treatment Period|Death|2
5635356|NCT00669331|19462656|P1|Blinded Treatment Period|Death|0
5635357|NCT00669331|19462655|P2|Blinded Treatment Period|Lost to Follow-up|2
5635358|NCT00669331|19462656|P1|Blinded Treatment Period|Lost to Follow-up|3
5635359|NCT00669331|19462655|P2|Blinded Treatment Period|Withdrawal by Subject|19
5635360|NCT00669331|19462656|P1|Blinded Treatment Period|Withdrawal by Subject|17
5635361|NCT00669331|19462655|P2|Blinded Treatment Period|Protocol Violation|1
5635362|NCT00669331|19462656|P1|Blinded Treatment Period|Protocol Violation|1
5635363|NCT00669331|19462655|P2|Blinded Treatment Period|Adverse Event|10
5635364|NCT00669331|19462656|P1|Blinded Treatment Period|Adverse Event|16
5635365|NCT00669331|19462655|P2|Randomisation to First Dose|Randomised in error|10
5635366|NCT00669331|19462656|P1|Randomisation to First Dose|Randomised in error|3
5635367|NCT00669331|19462655|P2|Randomisation to First Dose|Sponsor decision|1
5635368|NCT00669331|19462656|P1|Randomisation to First Dose|Sponsor decision|0
5635369|NCT00669331|19462655|P2|Randomisation to First Dose|Death|0
5635370|NCT00669331|19462656|P1|Randomisation to First Dose|Death|1
5635371|NCT00669331|19462655|P2|Randomisation to First Dose|Lost to Follow-up|0
5635372|NCT00669331|19462656|P1|Randomisation to First Dose|Lost to Follow-up|2
5635373|NCT00669331|19462655|P2|Randomisation to First Dose|Withdrawal by Subject|2
5635374|NCT00669331|19462656|P1|Randomisation to First Dose|Withdrawal by Subject|3
5635375|NCT00669331|19462655|P2|Randomisation to First Dose|Protocol Violation|0
5635376|NCT00669331|19462656|P1|Randomisation to First Dose|Protocol Violation|1
5635377|NCT00669331|19462655|P2|Randomisation to First Dose|Adverse Event|0
5635378|NCT00669331|19462656|P1|Randomisation to First Dose|Adverse Event|1
5635379|NCT00669318|19462698|P1|Overall Study|Withdrawal by Subject|2
5635380|NCT00669240|19462715|P1|Overall Study|Enrolled but no dosing record|1
5635381|NCT00669240|19462715|P1|Overall Study|Enrolled but not treated|15
5635382|NCT00669240|19462715|P1|Overall Study|Other|19
5635383|NCT00669240|19462715|P1|Overall Study|Adverse Event|21
5635384|NCT00669240|19462715|P1|Overall Study|Lost to Follow-up|34
5635385|NCT00669240|19462715|P1|Overall Study|Withdrawal by Subject|42
5635386|NCT00669240|19462715|P1|Overall Study|Lack of Efficacy|33
5635387|NCT00669162|19462764|P1|Overall Study|Withdrawal by Subject|1
5635388|NCT00669110|19462770|P2|Overall Study|Withdrawal by Subject|2
5635389|NCT00669110|19462771|P1|Overall Study|Withdrawal by Subject|0
5635390|NCT00669110|19462770|P2|Overall Study|Protocol Violation|5
5635391|NCT00669110|19462771|P1|Overall Study|Protocol Violation|0
5635392|NCT00669110|19462770|P2|Overall Study|Lost to Follow-up|0
5635393|NCT00669110|19462771|P1|Overall Study|Lost to Follow-up|1
5635394|NCT00669110|19462770|P2|Overall Study|Physician Decision|1
5635395|NCT00669110|19462771|P1|Overall Study|Physician Decision|0
5635396|NCT00669110|19462770|P2|Overall Study|Caregiver request|2
5635397|NCT00669110|19462771|P1|Overall Study|Caregiver request|3
5635398|NCT00669110|19462770|P2|Overall Study|Adverse Event|3
5635399|NCT00669110|19462771|P1|Overall Study|Adverse Event|4
5635400|NCT00669071|19462807|P1|Overall Study|Final visit 40 days out of window|1
5635401|NCT00669071|19462807|P1|Overall Study|Lost to Follow-up|3
5635402|NCT00669032|19462828|P2|Overall Study|No fulfilment of the selection criteria|5
5635403|NCT00669032|19462829|P1|Overall Study|No fulfilment of the selection criteria|5
5635404|NCT00669032|19462828|P2|Overall Study|Physician Decision|1
5635405|NCT00669032|19462829|P1|Overall Study|Physician Decision|1
5635406|NCT00669032|19462828|P2|Overall Study|Adverse Event|16
5635407|NCT00669032|19462829|P1|Overall Study|Adverse Event|12
5635408|NCT00669032|19462828|P2|Overall Study|Withdrawal by Subject|13
5635409|NCT00669032|19462829|P1|Overall Study|Withdrawal by Subject|12
5635410|NCT00669032|19462828|P2|Overall Study|Lack of Efficacy|19
5635411|NCT00669032|19462829|P1|Overall Study|Lack of Efficacy|8
5635412|NCT00669032|19462828|P2|Overall Study|Lost to Follow-up|5
5635413|NCT00669032|19462829|P1|Overall Study|Lost to Follow-up|6
5635414|NCT00668863|19462875|P1|Overall Study|Physician Decision|1
5635415|NCT00668863|19462875|P1|Overall Study|Subject's work scheduling problem|1
5635416|NCT00668863|19462875|P1|Overall Study|Surgery|1
5635417|NCT00668863|19462875|P1|Overall Study|Withdrawal by Subject|1
5635418|NCT00668863|19462875|P1|Overall Study|Global Deterioration of Health Status|4
5635419|NCT00668863|19462875|P1|Overall Study|Study Terminated by Sponsor|8
5635420|NCT00668863|19462875|P1|Overall Study|Adverse Event|13
5635421|NCT00668863|19462875|P1|Overall Study|Objective Progression or Relapse|42
5635422|NCT00668746|19462907|P2|Overall Study|Lost to Follow-up|1
5635423|NCT00668746|19462908|P1|Overall Study|Lost to Follow-up|2
5635424|NCT00668733|19462928|P2|Overall Study|Withdrawal by Subject|4
5635425|NCT00668733|19462929|P1|Overall Study|Withdrawal by Subject|0
5635426|NCT00668733|19462928|P2|Overall Study|Lost to Follow-up|3
5635427|NCT00668733|19462929|P1|Overall Study|Lost to Follow-up|2
5635428|NCT00668395|19462974|P3|Overall Study|Physician Decision|0
5635429|NCT00668395|19462975|P2|Overall Study|Physician Decision|1
5635430|NCT00668395|19462976|P1|Overall Study|Physician Decision|1
5635431|NCT00668395|19462974|P3|Overall Study|Adverse Event|0
5635432|NCT00668395|19462975|P2|Overall Study|Adverse Event|1
5635433|NCT00668395|19462976|P1|Overall Study|Adverse Event|1
5635434|NCT00668395|19462974|P3|Overall Study|Withdrawal by Subject|1
5635435|NCT00668395|19462975|P2|Overall Study|Withdrawal by Subject|4
5635436|NCT00668395|19462976|P1|Overall Study|Withdrawal by Subject|4
5635437|NCT00668317|19462988|P1|Overall Study|Adverse Event|2
5635438|NCT00668200|19463003|P1|Overall Study|Lost to Follow-up|1
5635439|NCT00668200|19463003|P1|Overall Study|Withdrawal by Subject|2
5635440|NCT00668148|19463009|P1|Overall Study|Withdrawal of Consent|2
5635441|NCT00668148|19463009|P1|Overall Study|Progressive Disease Before Treatment|2
5635442|NCT00668148|19463009|P1|Overall Study|Subject Non-compliance|1
5635443|NCT00668148|19463009|P1|Overall Study|Adverse Event|5
5635444|NCT00667992|19463048|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
5635445|NCT00667992|19463049|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
5635446|NCT00667992|19463048|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
5635447|NCT00667992|19463049|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
5635448|NCT00667992|19463048|P2|Wash-out|Withdrawal by Subject|0
5635449|NCT00667992|19463049|P1|Wash-out|Withdrawal by Subject|1
5635450|NCT00667992|19463048|P2|Wash-out|Failure to wash-out|2
5635451|NCT00667992|19463049|P1|Wash-out|Failure to wash-out|2
5635452|NCT00667992|19463048|P2|Wash-out|Not within one doubling dilution|3
5635453|NCT00667992|19463049|P1|Wash-out|Not within one doubling dilution|4
5635454|NCT00667992|19463048|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
5635455|NCT00667992|19463049|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
5635456|NCT00667992|19463048|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
5635457|NCT00667992|19463049|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
5635458|NCT00667992|19463048|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
5635459|NCT00667992|19463049|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
5635460|NCT00667992|19463048|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
5635461|NCT00667992|19463049|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
5635462|NCT00667992|19463048|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
5635463|NCT00667992|19463049|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
5635464|NCT00667992|19463048|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
5635465|NCT00667992|19463049|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
5635466|NCT00667992|19463048|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
5635467|NCT00667992|19463049|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
5635468|NCT00667992|19463048|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
5635469|NCT00667992|19463049|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
5635470|NCT00667875|19463106|P3|Overall Study|Withdrawal by Subject|7
5635471|NCT00667875|19463107|P2|Overall Study|Withdrawal by Subject|9
5635472|NCT00667875|19463108|P1|Overall Study|Withdrawal by Subject|10
5635473|NCT00667875|19463106|P3|Overall Study|Adverse Event|6
5635474|NCT00667875|19463107|P2|Overall Study|Adverse Event|2
5635475|NCT00667875|19463108|P1|Overall Study|Adverse Event|0
5635476|NCT00667810|19463142|P4|Overall Study|Other|0
5635477|NCT00667810|19463143|P3|Overall Study|Other|5
5635478|NCT00667810|19463144|P2|Overall Study|Other|6
5635479|NCT00667810|19463145|P1|Overall Study|Other|6
5635480|NCT00667810|19463142|P4|Overall Study|Vasogenic Edema Recurrence|0
5635481|NCT00667810|19463143|P3|Overall Study|Vasogenic Edema Recurrence|0
5635482|NCT00667810|19463144|P2|Overall Study|Vasogenic Edema Recurrence|3
5635483|NCT00667810|19463145|P1|Overall Study|Vasogenic Edema Recurrence|0
5635484|NCT00667810|19463142|P4|Overall Study|Loss of Caregiver|0
5635485|NCT00667810|19463143|P3|Overall Study|Loss of Caregiver|3
5635486|NCT00667810|19463144|P2|Overall Study|Loss of Caregiver|1
5635487|NCT00667810|19463145|P1|Overall Study|Loss of Caregiver|0
5635488|NCT00667810|19463142|P4|Overall Study|Failed to Return|0
5635489|NCT00667810|19463143|P3|Overall Study|Failed to Return|2
5635490|NCT00667810|19463144|P2|Overall Study|Failed to Return|0
5635491|NCT00667810|19463145|P1|Overall Study|Failed to Return|0
5635492|NCT00667810|19463142|P4|Overall Study|Discontinuation of Study by Sponsor|0
5635493|NCT00667810|19463143|P3|Overall Study|Discontinuation of Study by Sponsor|155
5635494|NCT00667810|19463144|P2|Overall Study|Discontinuation of Study by Sponsor|118
5635495|NCT00667810|19463145|P1|Overall Study|Discontinuation of Study by Sponsor|130
5635496|NCT00667810|19463142|P4|Overall Study|Withdrawal by Subject|1
5635497|NCT00667810|19463143|P3|Overall Study|Withdrawal by Subject|29
5635498|NCT00667810|19463144|P2|Overall Study|Withdrawal by Subject|20
5635499|NCT00667810|19463145|P1|Overall Study|Withdrawal by Subject|14
5635500|NCT00667810|19463142|P4|Overall Study|Protocol Violation|0
5635501|NCT00667810|19463143|P3|Overall Study|Protocol Violation|0
5635502|NCT00667810|19463144|P2|Overall Study|Protocol Violation|2
5635503|NCT00667810|19463145|P1|Overall Study|Protocol Violation|0
5635504|NCT00667810|19463142|P4|Overall Study|Physician Decision|0
5635505|NCT00667810|19463143|P3|Overall Study|Physician Decision|2
5635506|NCT00667810|19463144|P2|Overall Study|Physician Decision|1
5635507|NCT00667810|19463145|P1|Overall Study|Physician Decision|1
5635508|NCT00667810|19463142|P4|Overall Study|Lost to Follow-up|0
5635509|NCT00667810|19463143|P3|Overall Study|Lost to Follow-up|2
5635510|NCT00667810|19463144|P2|Overall Study|Lost to Follow-up|4
5635511|NCT00667810|19463145|P1|Overall Study|Lost to Follow-up|1
5635512|NCT00667810|19463142|P4|Overall Study|Lack of Efficacy|0
5635513|NCT00667810|19463143|P3|Overall Study|Lack of Efficacy|2
5635514|NCT00667810|19463144|P2|Overall Study|Lack of Efficacy|0
5635515|NCT00667810|19463145|P1|Overall Study|Lack of Efficacy|1
5635516|NCT00667810|19463142|P4|Overall Study|Death|0
5635517|NCT00667810|19463143|P3|Overall Study|Death|3
5635518|NCT00667810|19463144|P2|Overall Study|Death|1
5635519|NCT00667810|19463145|P1|Overall Study|Death|1
5635520|NCT00667810|19463142|P4|Overall Study|Adverse Event|1
5635521|NCT00667810|19463143|P3|Overall Study|Adverse Event|19
5635522|NCT00667810|19463144|P2|Overall Study|Adverse Event|14
5635523|NCT00667810|19463145|P1|Overall Study|Adverse Event|13
5635524|NCT00667732|19463221|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
5635525|NCT00667732|19463222|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
5635526|NCT00667732|19463223|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
5635527|NCT00667732|19463221|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
5635528|NCT00667732|19463222|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
5635529|NCT00667732|19463223|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
5635530|NCT00667732|19463221|P3|Run -In (8 Weeks)|Adverse Event|0
5635531|NCT00667732|19463222|P2|Run -In (8 Weeks)|Adverse Event|0
5635532|NCT00667732|19463223|P1|Run -In (8 Weeks)|Adverse Event|4
5635533|NCT00667602|19463259|P3|Overall Study|Protocol Violation|0
5635534|NCT00667602|19463260|P2|Overall Study|Protocol Violation|1
5635535|NCT00667602|19463261|P1|Overall Study|Protocol Violation|0
5635536|NCT00667602|19463259|P3|Overall Study|Administrative reason|2
5635537|NCT00667602|19463260|P2|Overall Study|Administrative reason|0
5635538|NCT00667602|19463261|P1|Overall Study|Administrative reason|0
5635539|NCT00667602|19463259|P3|Overall Study|Lost to Follow-up|6
5635540|NCT00667602|19463260|P2|Overall Study|Lost to Follow-up|5
5635541|NCT00667602|19463261|P1|Overall Study|Lost to Follow-up|4
5635542|NCT00667602|19463259|P3|Overall Study|Withdrawal by Subject|10
5635543|NCT00667602|19463260|P2|Overall Study|Withdrawal by Subject|9
5635544|NCT00667602|19463261|P1|Overall Study|Withdrawal by Subject|4
5635545|NCT00667576|19463329|P5|Overall Study|Missed Visit|0
5635546|NCT00667576|19463330|P4|Overall Study|Missed Visit|1
5635547|NCT00667576|19463331|P3|Overall Study|Missed Visit|0
5635548|NCT00667576|19463332|P2|Overall Study|Missed Visit|0
5635549|NCT00667576|19463333|P1|Overall Study|Missed Visit|0
5635550|NCT00667576|19463329|P5|Overall Study|Physician Decision|0
5635551|NCT00667576|19463330|P4|Overall Study|Physician Decision|1
5635552|NCT00667576|19463331|P3|Overall Study|Physician Decision|0
5635553|NCT00667576|19463332|P2|Overall Study|Physician Decision|0
5635554|NCT00667576|19463333|P1|Overall Study|Physician Decision|0
5635555|NCT00667576|19463329|P5|Overall Study|Protocol Violation|0
5635556|NCT00667576|19463330|P4|Overall Study|Protocol Violation|1
5635557|NCT00667576|19463331|P3|Overall Study|Protocol Violation|0
5635558|NCT00667576|19463332|P2|Overall Study|Protocol Violation|0
5635559|NCT00667576|19463333|P1|Overall Study|Protocol Violation|0
5635560|NCT00667576|19463329|P5|Overall Study|Lost to Follow-up|0
5635561|NCT00667576|19463330|P4|Overall Study|Lost to Follow-up|0
5635562|NCT00667576|19463331|P3|Overall Study|Lost to Follow-up|1
5635563|NCT00667576|19463332|P2|Overall Study|Lost to Follow-up|0
5635564|NCT00667576|19463333|P1|Overall Study|Lost to Follow-up|0
5635565|NCT00667576|19463329|P5|Overall Study|Adverse Event|0
5635566|NCT00667576|19463330|P4|Overall Study|Adverse Event|0
5635567|NCT00667576|19463331|P3|Overall Study|Adverse Event|0
5635568|NCT00667576|19463332|P2|Overall Study|Adverse Event|1
5635569|NCT00667576|19463333|P1|Overall Study|Adverse Event|1
5635570|NCT00667576|19463329|P5|Overall Study|Withdrawal by Subject|1
5635571|NCT00667576|19463330|P4|Overall Study|Withdrawal by Subject|1
5635572|NCT00667576|19463331|P3|Overall Study|Withdrawal by Subject|1
5635573|NCT00667576|19463332|P2|Overall Study|Withdrawal by Subject|0
5635574|NCT00667576|19463333|P1|Overall Study|Withdrawal by Subject|1
5635575|NCT00667563|19463380|P1|Overall Study|Protocol Violation|24
5635576|NCT00667459|19463400|P2|Overall Study|Lost to Follow-up|43
5635577|NCT00667459|19463401|P1|Overall Study|Lost to Follow-up|8
5635578|NCT00667459|19463400|P2|Overall Study|Death|2
5635579|NCT00667459|19463401|P1|Overall Study|Death|0
5635580|NCT00667446|19463443|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
5635581|NCT00667446|19463444|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
5635582|NCT00667446|19463443|P2|Treatment Period (36 Months)|Therapeutic Failure|1
5635583|NCT00667446|19463444|P1|Treatment Period (36 Months)|Therapeutic Failure|1
5635584|NCT00667446|19463443|P2|Treatment Period (36 Months)|Protocol Violation|1
5635585|NCT00667446|19463444|P1|Treatment Period (36 Months)|Protocol Violation|1
5635586|NCT00667446|19463443|P2|Treatment Period (36 Months)|Lost to Follow-up|0
5635587|NCT00667446|19463444|P1|Treatment Period (36 Months)|Lost to Follow-up|1
5635588|NCT00667446|19463443|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
5635589|NCT00667446|19463444|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
5635590|NCT00667446|19463443|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
5635591|NCT00667446|19463444|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
5635592|NCT00667446|19463443|P2|Treatment Period (36 Months)|Personal reasons|2
5635593|NCT00667446|19463444|P1|Treatment Period (36 Months)|Personal reasons|2
5635594|NCT00667446|19463443|P2|Treatment Period (36 Months)|Other|2
5635595|NCT00667446|19463444|P1|Treatment Period (36 Months)|Other|2
5635596|NCT00667446|19463443|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
5635597|NCT00667446|19463444|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
5635598|NCT00667420|19463466|P1|Overall Study|Withdrawal by Subject|2
5635599|NCT00667420|19463466|P1|Overall Study|Physician Decision|1
5635600|NCT00667420|19463466|P1|Overall Study|Lack of Efficacy|5
5635601|NCT00667420|19463466|P1|Overall Study|Adverse Event|2
5635602|NCT00667394|19463476|P2|Overall Study|Progressive disease|0
5635603|NCT00667394|19463477|P1|Overall Study|Progressive disease|1
5635604|NCT00667394|19463476|P2|Overall Study|Adverse Event|0
5635605|NCT00667394|19463477|P1|Overall Study|Adverse Event|3
5635606|NCT00667368|19463504|P2|Overall Study|Discontinued early|17
5635607|NCT00667368|19463505|P1|Overall Study|Discontinued early|24
5635608|NCT00667368|19463504|P2|Overall Study|Lost to Follow-up|155
5635609|NCT00667368|19463505|P1|Overall Study|Lost to Follow-up|176
5635610|NCT00667355|19463513|P1|Overall Study|Other reason was not specified|5
5635611|NCT00667355|19463513|P1|Overall Study|Lost to Follow-up|1
5635612|NCT00667355|19463513|P1|Overall Study|Adverse Event|5
5635613|NCT00667342|19463538|P3|Overall Study|Ineligible|1
5635614|NCT00667342|19463539|P2|Overall Study|Ineligible|0
5635615|NCT00667342|19463540|P1|Overall Study|Ineligible|0
5635616|NCT00667342|19463538|P3|Overall Study|Adverse Event|1
5635617|NCT00667342|19463539|P2|Overall Study|Adverse Event|0
5635618|NCT00667342|19463540|P1|Overall Study|Adverse Event|0
5635619|NCT00667342|19463538|P3|Overall Study|Relapse or tumor progression|7
5635620|NCT00667342|19463539|P2|Overall Study|Relapse or tumor progression|0
5635621|NCT00667342|19463540|P1|Overall Study|Relapse or tumor progression|9
5635622|NCT00667342|19463538|P3|Overall Study|Physician Decision|0
5635623|NCT00667342|19463539|P2|Overall Study|Physician Decision|0
5635624|NCT00667342|19463540|P1|Overall Study|Physician Decision|3
5635625|NCT00667342|19463538|P3|Overall Study|Withdrawal by Subject|0
5635626|NCT00667342|19463539|P2|Overall Study|Withdrawal by Subject|0
5635627|NCT00667342|19463540|P1|Overall Study|Withdrawal by Subject|1
5635628|NCT00667342|19463538|P3|Overall Study|Protocol Violation|0
5635629|NCT00667342|19463539|P2|Overall Study|Protocol Violation|0
5635630|NCT00667342|19463540|P1|Overall Study|Protocol Violation|1
5635631|NCT00667277|19463578|P1|Overall Study|Withdrawal by Subject|2
5635632|NCT00667251|19463585|P2|Overall Study|Symptomatic progression|2
5635633|NCT00667251|19463586|P1|Overall Study|Symptomatic progression|1
5635634|NCT00667251|19463585|P2|Overall Study|Intercurrent Illness|3
5635635|NCT00667251|19463586|P1|Overall Study|Intercurrent Illness|4
5635636|NCT00667251|19463585|P2|Overall Study|Other/missing|84
5635637|NCT00667251|19463586|P1|Overall Study|Other/missing|46
5635638|NCT00667251|19463585|P2|Overall Study|Withdrawal by Subject|2
5635639|NCT00667251|19463586|P1|Overall Study|Withdrawal by Subject|6
5635640|NCT00667251|19463585|P2|Overall Study|Adverse Event|4
5635641|NCT00667251|19463586|P1|Overall Study|Adverse Event|13
5635642|NCT00667225|19463612|P2|Overall Study|Lost to Follow-up|1
5635643|NCT00667225|19463613|P1|Overall Study|Lost to Follow-up|0
5635644|NCT00667225|19463612|P2|Overall Study|Subject had no more lesions to treat.|0
5635645|NCT00667225|19463613|P1|Overall Study|Subject had no more lesions to treat.|1
5635646|NCT00667095|19463634|P2|Overall Study|Withdrawal by Subject|1
5635647|NCT00667095|19463635|P1|Overall Study|Withdrawal by Subject|0
5635648|NCT00667017|19463651|P1|Overall Study|Withdrawal by Subject|1
5635649|NCT00666965|19463680|P4|Overall Study|Withdrawal by Subject|2
5635650|NCT00666965|19463681|P3|Overall Study|Withdrawal by Subject|0
5635651|NCT00666965|19463682|P2|Overall Study|Withdrawal by Subject|0
5635652|NCT00666965|19463683|P1|Overall Study|Withdrawal by Subject|0
5635653|NCT00666965|19463680|P4|Overall Study|Discontinuation criteria|2
5635654|NCT00666965|19463681|P3|Overall Study|Discontinuation criteria|1
5635655|NCT00666965|19463682|P2|Overall Study|Discontinuation criteria|1
5635656|NCT00666965|19463683|P1|Overall Study|Discontinuation criteria|2
5635657|NCT00666965|19463680|P4|Overall Study|Protocol Violation|2
5635658|NCT00666965|19463681|P3|Overall Study|Protocol Violation|0
5635659|NCT00666965|19463682|P2|Overall Study|Protocol Violation|0
5635660|NCT00666965|19463683|P1|Overall Study|Protocol Violation|0
5635661|NCT00666965|19463680|P4|Overall Study|Lack of Efficacy|0
5635662|NCT00666965|19463681|P3|Overall Study|Lack of Efficacy|0
5635663|NCT00666965|19463682|P2|Overall Study|Lack of Efficacy|1
5635664|NCT00666965|19463683|P1|Overall Study|Lack of Efficacy|1
5635665|NCT00666965|19463680|P4|Overall Study|Adverse Event|9
5635666|NCT00666965|19463681|P3|Overall Study|Adverse Event|1
5635667|NCT00666965|19463682|P2|Overall Study|Adverse Event|2
5635668|NCT00666965|19463683|P1|Overall Study|Adverse Event|0
5635669|NCT00666926|19463713|P16|Overall Study|Death|0
5635670|NCT00666926|19463714|P15|Overall Study|Death|0
5635671|NCT00666926|19463715|P14|Overall Study|Death|0
5635672|NCT00666926|19463716|P13|Overall Study|Death|0
5635673|NCT00666926|19463717|P12|Overall Study|Death|1
5635674|NCT00666926|19463718|P11|Overall Study|Death|0
5635675|NCT00666926|19463719|P10|Overall Study|Death|0
5635676|NCT00666926|19463720|P9|Overall Study|Death|0
5635677|NCT00666926|19463721|P8|Overall Study|Death|0
5635678|NCT00666926|19463722|P7|Overall Study|Death|0
5635679|NCT00666926|19463723|P6|Overall Study|Death|0
5635680|NCT00666926|19463724|P5|Overall Study|Death|0
5635681|NCT00666926|19463725|P4|Overall Study|Death|0
5635682|NCT00666926|19463726|P3|Overall Study|Death|0
5635683|NCT00666926|19463727|P2|Overall Study|Death|0
5635684|NCT00666926|19463728|P1|Overall Study|Death|0
5635685|NCT00666926|19463713|P16|Overall Study|Withdrawal by Subject|3
5635686|NCT00666926|19463714|P15|Overall Study|Withdrawal by Subject|3
5635687|NCT00666926|19463715|P14|Overall Study|Withdrawal by Subject|1
5635688|NCT00666926|19463716|P13|Overall Study|Withdrawal by Subject|0
5635689|NCT00666926|19463717|P12|Overall Study|Withdrawal by Subject|3
5635690|NCT00666926|19463718|P11|Overall Study|Withdrawal by Subject|0
5635691|NCT00666926|19463719|P10|Overall Study|Withdrawal by Subject|3
5635692|NCT00666926|19463720|P9|Overall Study|Withdrawal by Subject|0
5635693|NCT00666926|19463721|P8|Overall Study|Withdrawal by Subject|1
5635694|NCT00666926|19463722|P7|Overall Study|Withdrawal by Subject|0
5635695|NCT00666926|19463723|P6|Overall Study|Withdrawal by Subject|0
5635696|NCT00666926|19463724|P5|Overall Study|Withdrawal by Subject|0
5635697|NCT00666926|19463725|P4|Overall Study|Withdrawal by Subject|0
5635698|NCT00666926|19463726|P3|Overall Study|Withdrawal by Subject|0
5635699|NCT00666926|19463727|P2|Overall Study|Withdrawal by Subject|0
5635700|NCT00666926|19463728|P1|Overall Study|Withdrawal by Subject|0
5635701|NCT00666926|19463713|P16|Overall Study|Other|4
5635702|NCT00666926|19463714|P15|Overall Study|Other|4
5635703|NCT00666926|19463715|P14|Overall Study|Other|2
5635704|NCT00666926|19463716|P13|Overall Study|Other|3
5635705|NCT00666926|19463717|P12|Overall Study|Other|26
5635706|NCT00666926|19463718|P11|Overall Study|Other|3
5635707|NCT00666926|19463719|P10|Overall Study|Other|5
5635708|NCT00666926|19463720|P9|Overall Study|Other|3
5635709|NCT00666926|19463721|P8|Overall Study|Other|0
5635710|NCT00666926|19463722|P7|Overall Study|Other|4
5635711|NCT00666926|19463723|P6|Overall Study|Other|3
5635712|NCT00666926|19463724|P5|Overall Study|Other|3
5635713|NCT00666926|19463725|P4|Overall Study|Other|3
5635714|NCT00666926|19463726|P3|Overall Study|Other|3
5635715|NCT00666926|19463727|P2|Overall Study|Other|4
5635716|NCT00666926|19463728|P1|Overall Study|Other|2
5635717|NCT00666926|19463713|P16|Overall Study|Lost to Follow-up|0
5635718|NCT00666926|19463714|P15|Overall Study|Lost to Follow-up|0
5635719|NCT00666926|19463715|P14|Overall Study|Lost to Follow-up|0
5635720|NCT00666926|19463716|P13|Overall Study|Lost to Follow-up|0
5635721|NCT00666926|19463717|P12|Overall Study|Lost to Follow-up|0
5635722|NCT00666926|19463718|P11|Overall Study|Lost to Follow-up|0
5635723|NCT00666926|19463719|P10|Overall Study|Lost to Follow-up|0
5635724|NCT00666926|19463720|P9|Overall Study|Lost to Follow-up|0
5635725|NCT00666926|19463721|P8|Overall Study|Lost to Follow-up|0
5635726|NCT00666926|19463722|P7|Overall Study|Lost to Follow-up|0
5635727|NCT00666926|19463723|P6|Overall Study|Lost to Follow-up|0
5635728|NCT00666926|19463724|P5|Overall Study|Lost to Follow-up|0
5635729|NCT00666926|19463725|P4|Overall Study|Lost to Follow-up|1
5635730|NCT00666926|19463726|P3|Overall Study|Lost to Follow-up|0
5635731|NCT00666926|19463727|P2|Overall Study|Lost to Follow-up|0
5635732|NCT00666926|19463728|P1|Overall Study|Lost to Follow-up|0
5635733|NCT00666926|19463713|P16|Overall Study|Lack of Efficacy|0
5635734|NCT00666926|19463714|P15|Overall Study|Lack of Efficacy|0
5635735|NCT00666926|19463715|P14|Overall Study|Lack of Efficacy|0
5635736|NCT00666926|19463716|P13|Overall Study|Lack of Efficacy|0
5635737|NCT00666926|19463717|P12|Overall Study|Lack of Efficacy|1
5635738|NCT00666926|19463718|P11|Overall Study|Lack of Efficacy|0
5635739|NCT00666926|19463719|P10|Overall Study|Lack of Efficacy|0
5635740|NCT00666926|19463720|P9|Overall Study|Lack of Efficacy|0
5635741|NCT00666926|19463721|P8|Overall Study|Lack of Efficacy|0
5635742|NCT00666926|19463722|P7|Overall Study|Lack of Efficacy|0
5635743|NCT00666926|19463723|P6|Overall Study|Lack of Efficacy|1
5635744|NCT00666926|19463724|P5|Overall Study|Lack of Efficacy|0
5635745|NCT00666926|19463725|P4|Overall Study|Lack of Efficacy|0
5635746|NCT00666926|19463726|P3|Overall Study|Lack of Efficacy|0
5635747|NCT00666926|19463727|P2|Overall Study|Lack of Efficacy|0
5635748|NCT00666926|19463728|P1|Overall Study|Lack of Efficacy|0
5635749|NCT00666926|19463713|P16|Overall Study|Laboratory abnormality|1
5635750|NCT00666926|19463714|P15|Overall Study|Laboratory abnormality|0
5635751|NCT00666926|19463715|P14|Overall Study|Laboratory abnormality|0
5635752|NCT00666926|19463716|P13|Overall Study|Laboratory abnormality|0
5635753|NCT00666926|19463717|P12|Overall Study|Laboratory abnormality|0
5635754|NCT00666926|19463718|P11|Overall Study|Laboratory abnormality|1
5635755|NCT00666926|19463719|P10|Overall Study|Laboratory abnormality|0
5635756|NCT00666926|19463720|P9|Overall Study|Laboratory abnormality|0
5635757|NCT00666926|19463721|P8|Overall Study|Laboratory abnormality|0
5635758|NCT00666926|19463722|P7|Overall Study|Laboratory abnormality|0
5635759|NCT00666926|19463723|P6|Overall Study|Laboratory abnormality|0
5635760|NCT00666926|19463724|P5|Overall Study|Laboratory abnormality|0
5635761|NCT00666926|19463725|P4|Overall Study|Laboratory abnormality|0
5635762|NCT00666926|19463726|P3|Overall Study|Laboratory abnormality|0
5635763|NCT00666926|19463727|P2|Overall Study|Laboratory abnormality|0
5635764|NCT00666926|19463728|P1|Overall Study|Laboratory abnormality|0
5635765|NCT00666926|19463713|P16|Overall Study|Adverse Event|0
5635766|NCT00666926|19463714|P15|Overall Study|Adverse Event|0
5635767|NCT00666926|19463715|P14|Overall Study|Adverse Event|1
5635768|NCT00666926|19463716|P13|Overall Study|Adverse Event|0
5635769|NCT00666926|19463717|P12|Overall Study|Adverse Event|2
5635770|NCT00666926|19463718|P11|Overall Study|Adverse Event|2
5635771|NCT00666926|19463719|P10|Overall Study|Adverse Event|2
5635772|NCT00666926|19463720|P9|Overall Study|Adverse Event|0
5635773|NCT00666926|19463721|P8|Overall Study|Adverse Event|0
5635774|NCT00666926|19463722|P7|Overall Study|Adverse Event|0
5635775|NCT00666926|19463723|P6|Overall Study|Adverse Event|0
5635776|NCT00666926|19463724|P5|Overall Study|Adverse Event|0
5635777|NCT00666926|19463725|P4|Overall Study|Adverse Event|0
5635778|NCT00666926|19463726|P3|Overall Study|Adverse Event|0
5635779|NCT00666926|19463727|P2|Overall Study|Adverse Event|0
5635780|NCT00666926|19463728|P1|Overall Study|Adverse Event|0
5635781|NCT00666835|19464037|P2|Overall Study|Physician Decision|2
5635782|NCT00666835|19464038|P1|Overall Study|Physician Decision|1
5635783|NCT00666835|19464037|P2|Overall Study|Planned operation|0
5635784|NCT00666835|19464038|P1|Overall Study|Planned operation|2
5635785|NCT00666835|19464037|P2|Overall Study|Hemoglobulin concentration|3
5635786|NCT00666835|19464038|P1|Overall Study|Hemoglobulin concentration|4
5635787|NCT00666835|19464037|P2|Overall Study|Kidney Transplantation (NTX)|2
5635788|NCT00666835|19464038|P1|Overall Study|Kidney Transplantation (NTX)|10
5635789|NCT00666835|19464037|P2|Overall Study|Death|4
5635790|NCT00666835|19464038|P1|Overall Study|Death|15
5635791|NCT00666835|19464037|P2|Overall Study|Protocol Violation|0
5635792|NCT00666835|19464038|P1|Overall Study|Protocol Violation|2
5635793|NCT00666835|19464037|P2|Overall Study|Adverse Event|6
5635794|NCT00666835|19464038|P1|Overall Study|Adverse Event|7
5635795|NCT00666835|19464037|P2|Overall Study|Incl./excl. not fulfilled|2
5635796|NCT00666835|19464038|P1|Overall Study|Incl./excl. not fulfilled|7
5635797|NCT00666835|19464037|P2|Overall Study|Lack of Efficacy|1
5635798|NCT00666835|19464038|P1|Overall Study|Lack of Efficacy|0
5635799|NCT00666835|19464037|P2|Overall Study|Withdrawal by Subject|2
5635800|NCT00666835|19464038|P1|Overall Study|Withdrawal by Subject|5
5635801|NCT00666757|19464048|P2|Overall Study|Sponsor decision|1
5635802|NCT00666757|19464049|P1|Overall Study|Sponsor decision|0
5635803|NCT00666757|19464048|P2|Overall Study|Physician Decision|2
5635804|NCT00666757|19464049|P1|Overall Study|Physician Decision|0
5635805|NCT00666757|19464048|P2|Overall Study|Lack of Efficacy|6
5635806|NCT00666757|19464049|P1|Overall Study|Lack of Efficacy|3
5635807|NCT00666757|19464048|P2|Overall Study|Withdrawal by Subject|17
5635808|NCT00666757|19464049|P1|Overall Study|Withdrawal by Subject|13
5635809|NCT00666757|19464048|P2|Overall Study|Adverse Event|12
5635810|NCT00666757|19464049|P1|Overall Study|Adverse Event|22
5635811|NCT00666757|19464048|P2|Overall Study|Protocol Violation|24
5635812|NCT00666757|19464049|P1|Overall Study|Protocol Violation|23
5635813|NCT00666757|19464048|P2|Overall Study|Lost to Follow-up|35
5635814|NCT00666757|19464049|P1|Overall Study|Lost to Follow-up|39
5635815|NCT00666718|19464108|P2|Overall Study|Physician Decision|2
5635816|NCT00666718|19464109|P1|Overall Study|Physician Decision|0
5635817|NCT00666718|19464108|P2|Overall Study|Withdrawal by Subject|12
5635818|NCT00666718|19464109|P1|Overall Study|Withdrawal by Subject|7
5635819|NCT00666718|19464108|P2|Overall Study|Protocol Violation|3
5635820|NCT00666718|19464109|P1|Overall Study|Protocol Violation|1
5635821|NCT00666718|19464108|P2|Overall Study|Entry Criteria Not Met|0
5635822|NCT00666718|19464109|P1|Overall Study|Entry Criteria Not Met|2
5635823|NCT00666718|19464108|P2|Overall Study|Lost to Follow-up|0
5635824|NCT00666718|19464109|P1|Overall Study|Lost to Follow-up|1
5635825|NCT00666718|19464108|P2|Overall Study|Death|0
5635826|NCT00666718|19464109|P1|Overall Study|Death|1
5635827|NCT00666718|19464108|P2|Overall Study|Adverse Event|1
5635828|NCT00666718|19464109|P1|Overall Study|Adverse Event|0
5635829|NCT00666705|19464135|P1|Overall Study|Withdrawal by Subject|1
5635830|NCT00666679|19464154|P2|Second Intervention|Death|1
5635831|NCT00666679|19464155|P1|Second Intervention|Death|0
5635832|NCT00666679|19464154|P2|Second Intervention|Adverse Event|0
5635833|NCT00666679|19464155|P1|Second Intervention|Adverse Event|1
5635834|NCT00666679|19464154|P2|Washout Period of 1 Week|Protocol Violation|1
5635835|NCT00666679|19464155|P1|Washout Period of 1 Week|Protocol Violation|0
5635836|NCT00666679|19464154|P2|Washout Period of 1 Week|Lost to Follow-up|1
5635837|NCT00666679|19464155|P1|Washout Period of 1 Week|Lost to Follow-up|0
5635838|NCT00666679|19464154|P2|First Intervention|Randomized did not start treatment|1
5635839|NCT00666679|19464155|P1|First Intervention|Randomized did not start treatment|1
5635840|NCT00666679|19464154|P2|First Intervention|Withdrawal by Subject|0
5635841|NCT00666679|19464155|P1|First Intervention|Withdrawal by Subject|1
5635842|NCT00666679|19464154|P2|First Intervention|Protocol Violation|0
5635843|NCT00666679|19464155|P1|First Intervention|Protocol Violation|1
5635844|NCT00666679|19464154|P2|First Intervention|Lost to Follow-up|0
5635845|NCT00666679|19464155|P1|First Intervention|Lost to Follow-up|1
5635846|NCT00666588|19464185|P4|Overall Study|inevaluable|0
5635847|NCT00666588|19464186|P3|Overall Study|inevaluable|0
5635848|NCT00666588|19464187|P2|Overall Study|inevaluable|0
5635849|NCT00666588|19464188|P1|Overall Study|inevaluable|2
5635850|NCT00666588|19464185|P4|Overall Study|ineligible|2
5635851|NCT00666588|19464186|P3|Overall Study|ineligible|0
5635852|NCT00666588|19464187|P2|Overall Study|ineligible|0
5635853|NCT00666588|19464188|P1|Overall Study|ineligible|2
5635854|NCT00666562|19464221|P3|Overall Study|Concomitant Medication|0
5635855|NCT00666562|19464222|P2|Overall Study|Concomitant Medication|1
5635856|NCT00666562|19464223|P1|Overall Study|Concomitant Medication|0
5635857|NCT00666562|19464221|P3|Overall Study|Withdrawal by Subject|0
5635858|NCT00666562|19464222|P2|Overall Study|Withdrawal by Subject|1
5635859|NCT00666562|19464223|P1|Overall Study|Withdrawal by Subject|0
5635860|NCT00666536|19464270|P2|Overall Study|Lost to Follow-up|3
5635861|NCT00666536|19464271|P1|Overall Study|Lost to Follow-up|4
5635862|NCT00666536|19464270|P2|Overall Study|Withdrawal by Subject|9
5635863|NCT00666536|19464271|P1|Overall Study|Withdrawal by Subject|10
5635864|NCT00666536|19464270|P2|Overall Study|Protocol deviation(s)|6
5635865|NCT00666536|19464271|P1|Overall Study|Protocol deviation(s)|8
5635866|NCT00666536|19464270|P2|Overall Study|Unsatisfactory therapeutic effect|0
5635867|NCT00666536|19464271|P1|Overall Study|Unsatisfactory therapeutic effect|2
5635868|NCT00666536|19464270|P2|Overall Study|Adverse Event|19
5635869|NCT00666536|19464271|P1|Overall Study|Adverse Event|9
5635870|NCT00666458|19464289|P2|Overall Study|Medical history of anemia|0
5635871|NCT00666458|19464290|P1|Overall Study|Medical history of anemia|1
5635872|NCT00666458|19464289|P2|Overall Study|Safety reasons|0
5635873|NCT00666458|19464290|P1|Overall Study|Safety reasons|1
5635874|NCT00666458|19464289|P2|Overall Study|Severe non-compliance to the protocol|1
5635875|NCT00666458|19464290|P1|Overall Study|Severe non-compliance to the protocol|1
5635876|NCT00666458|19464289|P2|Overall Study|Study specific discontinuation criteria|7
5635877|NCT00666458|19464290|P1|Overall Study|Study specific discontinuation criteria|14
5635878|NCT00666458|19464289|P2|Overall Study|Incorrect enrollment|1
5635879|NCT00666458|19464290|P1|Overall Study|Incorrect enrollment|7
5635880|NCT00666458|19464289|P2|Overall Study|Administrative reason by sponsor|1
5635881|NCT00666458|19464290|P1|Overall Study|Administrative reason by sponsor|1
5635882|NCT00666458|19464289|P2|Overall Study|Lost to Follow-up|3
5635883|NCT00666458|19464290|P1|Overall Study|Lost to Follow-up|0
5635884|NCT00666458|19464289|P2|Overall Study|Withdrawal by Subject|4
5635885|NCT00666458|19464290|P1|Overall Study|Withdrawal by Subject|5
5635886|NCT00666458|19464289|P2|Overall Study|Adverse Event|7
5635887|NCT00666458|19464290|P1|Overall Study|Adverse Event|8
5635888|NCT00666328|19464378|P1|Overall Study|No longer met eligibility criteria|1
5635889|NCT00666328|19464378|P1|Overall Study|Lost to Follow-up|2
5635890|NCT00666328|19464378|P1|Overall Study|Death|2
5635891|NCT00666276|19464391|P1|Overall Study|Protocol Violation|34
5635892|NCT00666263|19464415|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
5635893|NCT00666263|19464416|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
5635894|NCT00666263|19464415|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
5635895|NCT00666263|19464416|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
5635896|NCT00666263|19464415|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
5635897|NCT00666263|19464416|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
5635898|NCT00666224|19464560|P2|Open-Label|Undefined/Unknown|1
5635899|NCT00666224|19464561|P1|Open-Label|Undefined/Unknown|1
5635900|NCT00666224|19464560|P2|Open-Label|Noncompliance|1
5635901|NCT00666224|19464561|P1|Open-Label|Noncompliance|2
5635902|NCT00666224|19464560|P2|Open-Label|Pregnancy|5
5635903|NCT00666224|19464561|P1|Open-Label|Pregnancy|1
5635904|NCT00666224|19464560|P2|Open-Label|Physician Decision|5
5635905|NCT00666224|19464561|P1|Open-Label|Physician Decision|7
5635906|NCT00666224|19464560|P2|Open-Label|Withdrawal by Subject|25
5635907|NCT00666224|19464561|P1|Open-Label|Withdrawal by Subject|12
5635908|NCT00666224|19464560|P2|Open-Label|Lost to Follow-up|5
5635909|NCT00666224|19464561|P1|Open-Label|Lost to Follow-up|4
5635910|NCT00666224|19464560|P2|Open-Label|Adverse Event|43
5635911|NCT00666224|19464561|P1|Open-Label|Adverse Event|8
5635912|NCT00666224|19464560|P2|Double-Blind|Undefined/Unknown|1
5635913|NCT00666224|19464561|P1|Double-Blind|Undefined/Unknown|4
5635914|NCT00666224|19464560|P2|Double-Blind|Death|0
5635915|NCT00666224|19464561|P1|Double-Blind|Death|1
5635916|NCT00666224|19464560|P2|Double-Blind|Noncompliance|0
5635917|NCT00666224|19464561|P1|Double-Blind|Noncompliance|1
5635918|NCT00666224|19464560|P2|Double-Blind|Pregnancy|2
5635919|NCT00666224|19464561|P1|Double-Blind|Pregnancy|3
5635920|NCT00666224|19464560|P2|Double-Blind|Sponsor decision|0
5635921|NCT00666224|19464561|P1|Double-Blind|Sponsor decision|1
5635922|NCT00666224|19464560|P2|Double-Blind|Physician Decision|3
5635923|NCT00666224|19464561|P1|Double-Blind|Physician Decision|0
5635924|NCT00666224|19464560|P2|Double-Blind|Withdrawal by Subject|14
5635925|NCT00666224|19464561|P1|Double-Blind|Withdrawal by Subject|18
5635926|NCT00666224|19464560|P2|Double-Blind|Lost to Follow-up|2
5635927|NCT00666224|19464561|P1|Double-Blind|Lost to Follow-up|2
5635928|NCT00666224|19464560|P2|Double-Blind|Adverse Event|5
5635929|NCT00666224|19464561|P1|Double-Blind|Adverse Event|15
5635930|NCT00666211|19464580|P2|Overall Study|Physician Decision|1
5635931|NCT00666211|19464581|P1|Overall Study|Physician Decision|0
5635932|NCT00666211|19464580|P2|Overall Study|off tx for other complicating disease|1
5635933|NCT00666211|19464581|P1|Overall Study|off tx for other complicating disease|0
5635934|NCT00666211|19464580|P2|Overall Study|Death|2
5635935|NCT00666211|19464581|P1|Overall Study|Death|0
5635936|NCT00666211|19464580|P2|Overall Study|hospital admission|5
5635937|NCT00666211|19464581|P1|Overall Study|hospital admission|0
5635938|NCT00666211|19464580|P2|Overall Study|toxicity|2
5635939|NCT00666211|19464581|P1|Overall Study|toxicity|0
5635940|NCT00666211|19464580|P2|Overall Study|Lost to Follow-up|0
5635941|NCT00666211|19464581|P1|Overall Study|Lost to Follow-up|2
5635942|NCT00666211|19464580|P2|Overall Study|disease progression|8
5635943|NCT00666211|19464581|P1|Overall Study|disease progression|1
5635944|NCT00666211|19464580|P2|Overall Study|patient non-compliant|6
5635945|NCT00666211|19464581|P1|Overall Study|patient non-compliant|6
5635946|NCT00666211|19464580|P2|Overall Study|went off medication, no more pain|0
5635947|NCT00666211|19464581|P1|Overall Study|went off medication, no more pain|1
5635948|NCT00666211|19464580|P2|Overall Study|Withdrawal by Subject|13
5635949|NCT00666211|19464581|P1|Overall Study|Withdrawal by Subject|10
5635950|NCT00666198|19464599|P1|Overall Study|No Drug Administration|4
5635951|NCT00666198|19464599|P1|Overall Study|Safety Not Assessable|6
5635952|NCT00666198|19464599|P1|Overall Study|No Visit After First Day of Treatment|13
5635953|NCT00666198|19464599|P1|Overall Study|Protocol Violation|10
5635954|NCT00665925|19464627|P4|Overall Study|Due to exclusion criteria|0
5635955|NCT00665925|19464628|P3|Overall Study|Due to exclusion criteria|0
5635956|NCT00665925|19464629|P2|Overall Study|Due to exclusion criteria|0
5635957|NCT00665925|19464630|P1|Overall Study|Due to exclusion criteria|1
5635958|NCT00665925|19464627|P4|Overall Study|Enrolled by mistake|1
5635959|NCT00665925|19464628|P3|Overall Study|Enrolled by mistake|0
5635960|NCT00665925|19464629|P2|Overall Study|Enrolled by mistake|0
5635961|NCT00665925|19464630|P1|Overall Study|Enrolled by mistake|0
5635962|NCT00665925|19464627|P4|Overall Study|Adverse Event|5
5635963|NCT00665925|19464628|P3|Overall Study|Adverse Event|10
5635964|NCT00665925|19464629|P2|Overall Study|Adverse Event|5
5635965|NCT00665925|19464630|P1|Overall Study|Adverse Event|1
5635966|NCT00665925|19464627|P4|Overall Study|Severe Non-Compliance to Protocol|1
5635967|NCT00665925|19464628|P3|Overall Study|Severe Non-Compliance to Protocol|1
5635968|NCT00665925|19464629|P2|Overall Study|Severe Non-Compliance to Protocol|0
5635969|NCT00665925|19464630|P1|Overall Study|Severe Non-Compliance to Protocol|0
5635970|NCT00665925|19464627|P4|Overall Study|Physician Decision|2
5635971|NCT00665925|19464628|P3|Overall Study|Physician Decision|1
5635972|NCT00665925|19464629|P2|Overall Study|Physician Decision|0
5635973|NCT00665925|19464630|P1|Overall Study|Physician Decision|0
5635974|NCT00665925|19464627|P4|Overall Study|Withdrawal by Subject|2
5635975|NCT00665925|19464628|P3|Overall Study|Withdrawal by Subject|3
5635976|NCT00665925|19464629|P2|Overall Study|Withdrawal by Subject|2
5635977|NCT00665925|19464630|P1|Overall Study|Withdrawal by Subject|2
5635978|NCT00665925|19464627|P4|Overall Study|Lost to Follow-up|2
5635979|NCT00665925|19464628|P3|Overall Study|Lost to Follow-up|2
5635980|NCT00665925|19464629|P2|Overall Study|Lost to Follow-up|2
5635981|NCT00665925|19464630|P1|Overall Study|Lost to Follow-up|1
5635982|NCT00665925|19464627|P4|Overall Study|Lack of Efficacy|8
5635983|NCT00665925|19464628|P3|Overall Study|Lack of Efficacy|9
5635984|NCT00665925|19464629|P2|Overall Study|Lack of Efficacy|8
5635985|NCT00665925|19464630|P1|Overall Study|Lack of Efficacy|10
5635986|NCT00665847|19465041|P1|Overall Study|Switch to Commercial Medication|1
5635987|NCT00665847|19465041|P1|Overall Study|Subject ineligible to continue the trial|1
5635988|NCT00665847|19465041|P1|Overall Study|Resistance to TMC125|1
5635989|NCT00665847|19465041|P1|Overall Study|Subject reached a virologic endpoint|4
5635990|NCT00665847|19465041|P1|Overall Study|Subject non-compliant|8
5635991|NCT00665847|19465041|P1|Overall Study|Withdrawal by Subject|2
5635992|NCT00665847|19465041|P1|Overall Study|Adverse Event|8
5635993|NCT00665652|19465058|P1|Overall Study|No longer met inclusion criteria.|1
5635994|NCT00665652|19465058|P1|Overall Study|Death|1
5635995|NCT00665652|19465058|P1|Overall Study|Adverse Event|4
5635996|NCT00665626|19465064|P2|Overall Study|Death|0
5635997|NCT00665626|19465065|P1|Overall Study|Death|1
5635998|NCT00665626|19465064|P2|Overall Study|Unably to comply with dosing regimen|1
5635999|NCT00665626|19465065|P1|Overall Study|Unably to comply with dosing regimen|0
5636000|NCT00665626|19465064|P2|Overall Study|Did not fulfil inclusion criteria|1
5636001|NCT00665626|19465065|P1|Overall Study|Did not fulfil inclusion criteria|0
5636002|NCT00665626|19465064|P2|Overall Study|Due to exclusion criteria|1
5636003|NCT00665626|19465065|P1|Overall Study|Due to exclusion criteria|0
5636004|NCT00665626|19465064|P2|Overall Study|Adverse Event|9
5636005|NCT00665626|19465065|P1|Overall Study|Adverse Event|1
5636006|NCT00665626|19465064|P2|Overall Study|Protocol Violation|2
5636007|NCT00665626|19465065|P1|Overall Study|Protocol Violation|0
5636008|NCT00665626|19465064|P2|Overall Study|Withdrawal by Subject|1
5636009|NCT00665626|19465065|P1|Overall Study|Withdrawal by Subject|0
5636010|NCT00665626|19465064|P2|Overall Study|Lost to Follow-up|2
5636011|NCT00665626|19465065|P1|Overall Study|Lost to Follow-up|0
5636012|NCT00665626|19465064|P2|Overall Study|Lack of Efficacy|5
5636013|NCT00665626|19465065|P1|Overall Study|Lack of Efficacy|8
5636014|NCT00665561|19465133|P2|Overall Study|Withdrawn due to pregnancy|1
5636015|NCT00665561|19465134|P1|Overall Study|Withdrawn due to pregnancy|0
5636016|NCT00665561|19465133|P2|Overall Study|Site closed|0
5636017|NCT00665561|19465134|P1|Overall Study|Site closed|8
5636018|NCT00665561|19465133|P2|Overall Study|Other|108
5636019|NCT00665561|19465134|P1|Overall Study|Other|123
5636020|NCT00665561|19465133|P2|Overall Study|Withdrawal by Subject|65
5636021|NCT00665561|19465134|P1|Overall Study|Withdrawal by Subject|74
5636022|NCT00665561|19465133|P2|Overall Study|Lost to Follow-up|264
5636023|NCT00665561|19465134|P1|Overall Study|Lost to Follow-up|203
5636024|NCT00665561|19465133|P2|Overall Study|Does not meet entrance criteria|21
5636025|NCT00665561|19465134|P1|Overall Study|Does not meet entrance criteria|19
5636026|NCT00665561|19465133|P2|Overall Study|Death recorded on subject summary pages|75
5636027|NCT00665561|19465134|P1|Overall Study|Death recorded on subject summary pages|75
5636028|NCT00665444|19465184|P1|Overall Study|Study Terminated by Study Sponsor|1
5636029|NCT00665444|19465184|P1|Overall Study|Physician Decision|1
5636030|NCT00665431|19465196|P3|Overall Study|Other|2
5636031|NCT00665431|19465197|P2|Overall Study|Other|7
5636032|NCT00665431|19465198|P1|Overall Study|Other|4
5636033|NCT00665431|19465196|P3|Overall Study|Lost to Follow-up|1
5636034|NCT00665431|19465197|P2|Overall Study|Lost to Follow-up|3
5636035|NCT00665431|19465198|P1|Overall Study|Lost to Follow-up|3
5636036|NCT00665431|19465196|P3|Overall Study|Withdrawal by Subject|15
5636037|NCT00665431|19465197|P2|Overall Study|Withdrawal by Subject|25
5636038|NCT00665431|19465198|P1|Overall Study|Withdrawal by Subject|17
5636039|NCT00665431|19465196|P3|Overall Study|Adverse Event|6
5636040|NCT00665431|19465197|P2|Overall Study|Adverse Event|22
5636041|NCT00665431|19465198|P1|Overall Study|Adverse Event|16
5636042|NCT00665366|19465241|P2|Overall Study|Other reasons|1
5636043|NCT00665366|19465242|P1|Overall Study|Other reasons|4
5636044|NCT00665366|19465241|P2|Overall Study|No longer meets study criteria|1
5636045|NCT00665366|19465242|P1|Overall Study|No longer meets study criteria|0
5636046|NCT00665366|19465241|P2|Overall Study|Pregnancy|0
5636047|NCT00665366|19465242|P1|Overall Study|Pregnancy|1
5636048|NCT00665366|19465241|P2|Overall Study|Poor compliance/noncompliance|5
5636049|NCT00665366|19465242|P1|Overall Study|Poor compliance/noncompliance|3
5636050|NCT00665366|19465241|P2|Overall Study|Lost to Follow-up|5
5636051|NCT00665366|19465242|P1|Overall Study|Lost to Follow-up|3
5636052|NCT00665366|19465241|P2|Overall Study|Withdrawal by Subject|14
5636053|NCT00665366|19465242|P1|Overall Study|Withdrawal by Subject|11
5636054|NCT00665366|19465241|P2|Overall Study|Adverse Event|23
5636055|NCT00665366|19465242|P1|Overall Study|Adverse Event|25
5636056|NCT00665366|19465241|P2|Overall Study|Lack of Efficacy|10
5636057|NCT00665366|19465242|P1|Overall Study|Lack of Efficacy|11
5636058|NCT00665353|19465270|P1|Study Step 2|Lack of Efficacy|12
5636059|NCT00665353|19465270|P1|Study Step 2|Lost to Follow-up|2
5636060|NCT00665353|19465270|P1|Study Step 1|Withdrawal by Subject|2
5636061|NCT00665353|19465270|P1|Study Step 1|Adverse Event|1
5636062|NCT00665002|19465287|P1|Overall Study|Cytogenetic resistance|1
5636063|NCT00665002|19465287|P1|Overall Study|Progression/relapse during treatment|11
5636064|NCT00664859|19465295|P3|Overall Study|Other|2
5636065|NCT00664859|19465296|P2|Overall Study|Other|1
5636066|NCT00664859|19465297|P1|Overall Study|Other|0
5636067|NCT00664859|19465295|P3|Overall Study|Lost to Follow-up|1
5636068|NCT00664859|19465296|P2|Overall Study|Lost to Follow-up|2
5636069|NCT00664859|19465297|P1|Overall Study|Lost to Follow-up|2
5636070|NCT00664859|19465295|P3|Overall Study|Withdrawal by Subject|3
5636071|NCT00664859|19465296|P2|Overall Study|Withdrawal by Subject|1
5636072|NCT00664859|19465297|P1|Overall Study|Withdrawal by Subject|4
5636073|NCT00664859|19465295|P3|Overall Study|Laboratory abnormality|4
5636074|NCT00664859|19465296|P2|Overall Study|Laboratory abnormality|1
5636075|NCT00664859|19465297|P1|Overall Study|Laboratory abnormality|2
5636076|NCT00664859|19465295|P3|Overall Study|Noncompliance with protocol|4
5636077|NCT00664859|19465296|P2|Overall Study|Noncompliance with protocol|0
5636078|NCT00664859|19465297|P1|Overall Study|Noncompliance with protocol|1
5636079|NCT00664859|19465295|P3|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
5636080|NCT00664859|19465296|P2|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
5636081|NCT00664859|19465297|P1|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
5636082|NCT00664859|19465295|P3|Overall Study|Adverse Event|3
5636083|NCT00664859|19465296|P2|Overall Study|Adverse Event|1
5636084|NCT00664859|19465297|P1|Overall Study|Adverse Event|2
5636085|NCT00664742|19465317|P1|Overall Study|Lost to Follow-up|92
5636086|NCT00664742|19465317|P1|Overall Study|Withdrawal by Subject|31
5636087|NCT00664742|19465317|P1|Overall Study|Withdrawn due to adverse events|3
5636088|NCT00664560|19465325|P3|Overall Study|Other|5
5636089|NCT00664560|19465326|P2|Overall Study|Other|4
5636090|NCT00664560|19465327|P1|Overall Study|Other|11
5636091|NCT00664560|19465325|P3|Overall Study|Lost to Follow-up|0
5636092|NCT00664560|19465326|P2|Overall Study|Lost to Follow-up|2
5636093|NCT00664560|19465327|P1|Overall Study|Lost to Follow-up|0
5636094|NCT00664560|19465325|P3|Overall Study|Withdrawal by Subject|7
5636095|NCT00664560|19465326|P2|Overall Study|Withdrawal by Subject|13
5636096|NCT00664560|19465327|P1|Overall Study|Withdrawal by Subject|9
5636097|NCT00664560|19465325|P3|Overall Study|Adverse Event|7
5636098|NCT00664560|19465326|P2|Overall Study|Adverse Event|16
5636099|NCT00664560|19465327|P1|Overall Study|Adverse Event|19
5636100|NCT00664534|19465370|P2|Overall Study|Sponsor decision|6
5636101|NCT00664534|19465371|P1|Overall Study|Sponsor decision|8
5636102|NCT00664534|19465370|P2|Overall Study|Physician Decision|0
5636103|NCT00664534|19465371|P1|Overall Study|Physician Decision|8
5636104|NCT00664534|19465370|P2|Overall Study|Withdrawal by Subject|6
5636105|NCT00664534|19465371|P1|Overall Study|Withdrawal by Subject|7
5636106|NCT00664534|19465370|P2|Overall Study|Protocol Violation|8
5636107|NCT00664534|19465371|P1|Overall Study|Protocol Violation|10
5636108|NCT00664534|19465370|P2|Overall Study|Lost to Follow-up|10
5636109|NCT00664534|19465371|P1|Overall Study|Lost to Follow-up|6
5636110|NCT00664534|19465370|P2|Overall Study|Adverse Event|3
5636111|NCT00664534|19465371|P1|Overall Study|Adverse Event|2
5636112|NCT00664521|19465399|P2|Overall Study|Other|0
5636113|NCT00664521|19465400|P1|Overall Study|Other|1
5636114|NCT00664521|19465399|P2|Overall Study|Lost to Follow-up|0
5636115|NCT00664521|19465400|P1|Overall Study|Lost to Follow-up|1
5636116|NCT00664521|19465399|P2|Overall Study|Adverse Event|1
5636117|NCT00664521|19465400|P1|Overall Study|Adverse Event|4
5636118|NCT00664326|19465426|P1|Overall Study|Disease Progression/Recurrence/Relapse|24
5636119|NCT00664326|19465426|P1|Overall Study|Death|2
5636120|NCT00664326|19465426|P1|Overall Study|Other Reasons|3
5636121|NCT00664326|19465426|P1|Overall Study|Physician Decision|1
5636122|NCT00664326|19465426|P1|Overall Study|Withdrawal by Subject|1
5636123|NCT00664326|19465426|P1|Overall Study|Noncompliance with study medication|3
5636124|NCT00664326|19465426|P1|Overall Study|Adverse Event|14
5636125|NCT00664209|19465445|P1|Study Treatment Period|Withdrawal by Subject|2
5636126|NCT00664209|19465445|P1|Study Treatment Period|Physician Decision|4
5636127|NCT00664209|19465445|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
5636128|NCT00664105|19465453|P1|Overall Study|Disease progression|7
5636129|NCT00664105|19465453|P1|Overall Study|Adverse Event|9
5636130|NCT00664105|19465453|P1|Overall Study|Withdrawal by Subject|5
5636131|NCT00664105|19465453|P1|Overall Study|Death|3
5636132|NCT00664066|19465460|P1|Overall Study|Study terminated|3
5636133|NCT00663962|19465466|P2|Overall Study|somnolence|0
5636134|NCT00663962|19465467|P1|Overall Study|somnolence|1
5636135|NCT00663923|19465473|P1|Overall Study|Lost to Follow-up|2
5636136|NCT00663858|19465490|P3|Overall Study|Other|4
5636137|NCT00663858|19465491|P2|Overall Study|Other|2
5636138|NCT00663858|19465492|P1|Overall Study|Other|8
5636139|NCT00663858|19465490|P3|Overall Study|Protocol Violation|4
5636140|NCT00663858|19465491|P2|Overall Study|Protocol Violation|3
5636141|NCT00663858|19465492|P1|Overall Study|Protocol Violation|5
5636142|NCT00663858|19465490|P3|Overall Study|Withdrawal by Subject|3
5636143|NCT00663858|19465491|P2|Overall Study|Withdrawal by Subject|3
5636144|NCT00663858|19465492|P1|Overall Study|Withdrawal by Subject|7
5636145|NCT00663858|19465490|P3|Overall Study|Lack of Efficacy|3
5636146|NCT00663858|19465491|P2|Overall Study|Lack of Efficacy|1
5636147|NCT00663858|19465492|P1|Overall Study|Lack of Efficacy|5
5636148|NCT00663858|19465490|P3|Overall Study|Adverse Event|6
5636149|NCT00663858|19465491|P2|Overall Study|Adverse Event|1
5636150|NCT00663858|19465492|P1|Overall Study|Adverse Event|9
5636151|NCT00663702|19465530|P2|Overall Study|Lack of Efficacy|3
5636152|NCT00663702|19465531|P1|Overall Study|Lack of Efficacy|3
5636153|NCT00663702|19465530|P2|Overall Study|Death|1
5636154|NCT00663702|19465531|P1|Overall Study|Death|1
5636155|NCT00663702|19465530|P2|Overall Study|Lost to Follow-up|0
5636156|NCT00663702|19465531|P1|Overall Study|Lost to Follow-up|3
5636157|NCT00663702|19465530|P2|Overall Study|Pregnancy|1
5636158|NCT00663702|19465531|P1|Overall Study|Pregnancy|0
5636159|NCT00663702|19465530|P2|Overall Study|Withdrawal by Subject|1
5636160|NCT00663702|19465531|P1|Overall Study|Withdrawal by Subject|3
5636161|NCT00663702|19465530|P2|Overall Study|Adverse Event|4
5636162|NCT00663702|19465531|P1|Overall Study|Adverse Event|8
5636163|NCT00663260|19465567|P3|Overall Study|non-compliance, not met criteria, etc.|3
5636164|NCT00663260|19465568|P2|Overall Study|non-compliance, not met criteria, etc.|2
5636165|NCT00663260|19465569|P1|Overall Study|non-compliance, not met criteria, etc.|3
5636166|NCT00663260|19465567|P3|Overall Study|Lost to Follow-up|0
5636167|NCT00663260|19465568|P2|Overall Study|Lost to Follow-up|1
5636168|NCT00663260|19465569|P1|Overall Study|Lost to Follow-up|0
5636169|NCT00663260|19465567|P3|Overall Study|Death|1
5636170|NCT00663260|19465568|P2|Overall Study|Death|0
5636171|NCT00663260|19465569|P1|Overall Study|Death|1
5636172|NCT00663260|19465567|P3|Overall Study|Withdrawal by Subject|6
5636173|NCT00663260|19465568|P2|Overall Study|Withdrawal by Subject|1
5636174|NCT00663260|19465569|P1|Overall Study|Withdrawal by Subject|3
5636175|NCT00663260|19465567|P3|Overall Study|Adverse Event|6
5636176|NCT00663260|19465568|P2|Overall Study|Adverse Event|7
5636177|NCT00663260|19465569|P1|Overall Study|Adverse Event|12
5636178|NCT00663260|19465567|P3|Overall Study|Lack of Efficacy|0
5636179|NCT00663260|19465568|P2|Overall Study|Lack of Efficacy|0
5636180|NCT00663260|19465569|P1|Overall Study|Lack of Efficacy|2
5636181|NCT00663234|19465583|P1|Overall Study|Not willing to adhere to requirements|1
5636182|NCT00663208|19465616|P7|Follow-up Period|Other reason|1
5636183|NCT00663208|19465617|P6|Follow-up Period|Other reason|0
5636184|NCT00663208|19465618|P5|Follow-up Period|Other reason|0
5636185|NCT00663208|19465619|P4|Follow-up Period|Other reason|0
5636186|NCT00663208|19465620|P3|Follow-up Period|Other reason|0
5636187|NCT00663208|19465621|P2|Follow-up Period|Other reason|0
5636188|NCT00663208|19465622|P1|Follow-up Period|Other reason|1
5636189|NCT00663208|19465616|P7|Follow-up Period|Lost to Follow-up|0
5636190|NCT00663208|19465617|P6|Follow-up Period|Lost to Follow-up|0
5636191|NCT00663208|19465618|P5|Follow-up Period|Lost to Follow-up|0
5636192|NCT00663208|19465619|P4|Follow-up Period|Lost to Follow-up|2
5636193|NCT00663208|19465620|P3|Follow-up Period|Lost to Follow-up|3
5636194|NCT00663208|19465621|P2|Follow-up Period|Lost to Follow-up|0
5636195|NCT00663208|19465622|P1|Follow-up Period|Lost to Follow-up|2
5636196|NCT00663208|19465616|P7|Treatment Period|Lost to Follow-up|0
5636197|NCT00663208|19465617|P6|Treatment Period|Lost to Follow-up|0
5636198|NCT00663208|19465618|P5|Treatment Period|Lost to Follow-up|0
5636199|NCT00663208|19465619|P4|Treatment Period|Lost to Follow-up|0
5636200|NCT00663208|19465620|P3|Treatment Period|Lost to Follow-up|0
5636201|NCT00663208|19465621|P2|Treatment Period|Lost to Follow-up|1
5636202|NCT00663208|19465622|P1|Treatment Period|Lost to Follow-up|0
5636203|NCT00663117|19465800|P2|Overall Study|Lack of Efficacy|0
5636204|NCT00663117|19465801|P1|Overall Study|Lack of Efficacy|1
5636205|NCT00663052|19465815|P2|Overall Study|Other|1
5636206|NCT00663052|19465816|P1|Overall Study|Other|0
5636207|NCT00663052|19465815|P2|Overall Study|Unsatisfactory Response - Efficacy|1
5636208|NCT00663052|19465816|P1|Overall Study|Unsatisfactory Response - Efficacy|1
5636209|NCT00663052|19465815|P2|Overall Study|Withdrawal by Subject|5
5636210|NCT00663052|19465816|P1|Overall Study|Withdrawal by Subject|2
5636211|NCT00663052|19465815|P2|Overall Study|Protocol Violation|0
5636212|NCT00663052|19465816|P1|Overall Study|Protocol Violation|1
5636213|NCT00663052|19465815|P2|Overall Study|Discontinuation of Study by Sponsor|0
5636214|NCT00663052|19465816|P1|Overall Study|Discontinuation of Study by Sponsor|2
5636215|NCT00663052|19465815|P2|Overall Study|Adverse Event|3
5636216|NCT00663052|19465816|P1|Overall Study|Adverse Event|6
5636217|NCT00663026|19465922|P3|Overall Study|Withdrawal by Subject|1
5636218|NCT00663026|19465923|P2|Overall Study|Withdrawal by Subject|0
5636219|NCT00663026|19465924|P1|Overall Study|Withdrawal by Subject|0
5636220|NCT00663026|19465922|P3|Overall Study|Caregiver Request|0
5636221|NCT00663026|19465923|P2|Overall Study|Caregiver Request|2
5636222|NCT00663026|19465924|P1|Overall Study|Caregiver Request|0
5636223|NCT00663026|19465922|P3|Overall Study|Adverse Event|3
5636224|NCT00663026|19465923|P2|Overall Study|Adverse Event|2
5636225|NCT00663026|19465924|P1|Overall Study|Adverse Event|0
5636226|NCT00663026|19465922|P3|Overall Study|Other|0
5636227|NCT00663026|19465923|P2|Overall Study|Other|2
5636228|NCT00663026|19465924|P1|Overall Study|Other|1
5636229|NCT00663026|19465922|P3|Overall Study|Lost to Follow-up|0
5636230|NCT00663026|19465923|P2|Overall Study|Lost to Follow-up|0
5636231|NCT00663026|19465924|P1|Overall Study|Lost to Follow-up|1
5636232|NCT00662909|19465947|P3|Overall Study|Eligibility criterion not met|1
5636233|NCT00662909|19465948|P2|Overall Study|Eligibility criterion not met|1
5636234|NCT00662909|19465949|P1|Overall Study|Eligibility criterion not met|0
5636235|NCT00662909|19465947|P3|Overall Study|Physician Decision|2
5636236|NCT00662909|19465948|P2|Overall Study|Physician Decision|1
5636237|NCT00662909|19465949|P1|Overall Study|Physician Decision|1
5636238|NCT00662909|19465947|P3|Overall Study|Non-compliance with study procedures|2
5636239|NCT00662909|19465948|P2|Overall Study|Non-compliance with study procedures|3
5636240|NCT00662909|19465949|P1|Overall Study|Non-compliance with study procedures|3
5636241|NCT00662909|19465947|P3|Overall Study|Randomized- never received study drug|0
5636242|NCT00662909|19465948|P2|Overall Study|Randomized- never received study drug|0
5636243|NCT00662909|19465949|P1|Overall Study|Randomized- never received study drug|1
5636244|NCT00662909|19465947|P3|Overall Study|Protocol Violation|5
5636245|NCT00662909|19465948|P2|Overall Study|Protocol Violation|4
5636246|NCT00662909|19465949|P1|Overall Study|Protocol Violation|7
5636247|NCT00662909|19465947|P3|Overall Study|Lost to Follow-up|3
5636248|NCT00662909|19465948|P2|Overall Study|Lost to Follow-up|9
5636249|NCT00662909|19465949|P1|Overall Study|Lost to Follow-up|2
5636250|NCT00662909|19465947|P3|Overall Study|Withdrawal by Subject|16
5636251|NCT00662909|19465948|P2|Overall Study|Withdrawal by Subject|22
5636252|NCT00662909|19465949|P1|Overall Study|Withdrawal by Subject|29
5636253|NCT00662909|19465947|P3|Overall Study|Lack of Efficacy|5
5636254|NCT00662909|19465948|P2|Overall Study|Lack of Efficacy|1
5636255|NCT00662909|19465949|P1|Overall Study|Lack of Efficacy|9
5636256|NCT00662909|19465947|P3|Overall Study|Adverse Event|19
5636257|NCT00662909|19465948|P2|Overall Study|Adverse Event|18
5636258|NCT00662909|19465949|P1|Overall Study|Adverse Event|17
5636259|NCT00662857|19466047|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
5636260|NCT00662857|19466048|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
5636261|NCT00662857|19466047|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
5636262|NCT00662857|19466048|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
5636263|NCT00662857|19466047|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
5636264|NCT00662857|19466048|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
5636265|NCT00662831|19466063|P2|Overall Study|Adverse Event|16
5636266|NCT00662831|19466064|P1|Overall Study|Adverse Event|23
5636267|NCT00662831|19466063|P2|Overall Study|Protocol Violation|4
5636268|NCT00662831|19466064|P1|Overall Study|Protocol Violation|8
5636269|NCT00662831|19466063|P2|Overall Study|Other|31
5636270|NCT00662831|19466064|P1|Overall Study|Other|62
5636271|NCT00662831|19466063|P2|Overall Study|Withdrawal by Subject|1
5636272|NCT00662831|19466064|P1|Overall Study|Withdrawal by Subject|2
5636273|NCT00662831|19466063|P2|Overall Study|Lost to Follow-up|0
5636274|NCT00662831|19466064|P1|Overall Study|Lost to Follow-up|1
5636275|NCT00662831|19466063|P2|Overall Study|Lack of Efficacy|6
5636276|NCT00662831|19466064|P1|Overall Study|Lack of Efficacy|6
5636277|NCT00662831|19466063|P2|Overall Study|Death|1
5636278|NCT00662831|19466064|P1|Overall Study|Death|4
5636279|NCT00662649|19466144|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
5636280|NCT00662649|19466145|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
5636281|NCT00662649|19466146|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
5636282|NCT00662649|19466147|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
5636283|NCT00662649|19466148|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
5636284|NCT00662649|19466144|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
5636285|NCT00662649|19466145|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
5636286|NCT00662649|19466146|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
5636287|NCT00662649|19466147|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
5636288|NCT00662649|19466148|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
5636289|NCT00662649|19466144|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
5636290|NCT00662649|19466145|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
5636291|NCT00662649|19466146|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
5636292|NCT00662649|19466147|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
5636293|NCT00662649|19466148|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
5636294|NCT00662649|19466144|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
5636295|NCT00662649|19466145|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
5636296|NCT00662649|19466146|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
5636297|NCT00662649|19466147|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
5636298|NCT00662649|19466148|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
5636299|NCT00662649|19466144|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
5636300|NCT00662649|19466145|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
5636301|NCT00662649|19466146|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
5636302|NCT00662649|19466147|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
5636303|NCT00662649|19466148|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
5636304|NCT00662649|19466144|P5|Extension Study (Month 24 to 60)|Adverse Event|10
5636305|NCT00662649|19466145|P4|Extension Study (Month 24 to 60)|Adverse Event|6
5636306|NCT00662649|19466146|P3|Extension Study (Month 24 to 60)|Adverse Event|0
5636307|NCT00662649|19466147|P2|Extension Study (Month 24 to 60)|Adverse Event|9
5636308|NCT00662649|19466148|P1|Extension Study (Month 24 to 60)|Adverse Event|6
5636309|NCT00662649|19466144|P5|Extension Study (Month 24 to 60)|Administrative problems|0
5636310|NCT00662649|19466145|P4|Extension Study (Month 24 to 60)|Administrative problems|1
5636311|NCT00662649|19466146|P3|Extension Study (Month 24 to 60)|Administrative problems|0
5636312|NCT00662649|19466147|P2|Extension Study (Month 24 to 60)|Administrative problems|0
5636313|NCT00662649|19466148|P1|Extension Study (Month 24 to 60)|Administrative problems|0
5636314|NCT00662649|19466144|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
5636315|NCT00662649|19466145|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
5636316|NCT00662649|19466146|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
5636317|NCT00662649|19466147|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
5636318|NCT00662649|19466148|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
5636319|NCT00662649|19466144|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
5636320|NCT00662649|19466145|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
5636321|NCT00662649|19466146|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
5636322|NCT00662649|19466147|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
5636323|NCT00662649|19466148|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
5636324|NCT00662649|19466144|P5|Core Study (24 Months)|Death|0
5636325|NCT00662649|19466145|P4|Core Study (24 Months)|Death|0
5636326|NCT00662649|19466146|P3|Core Study (24 Months)|Death|2
5636327|NCT00662649|19466147|P2|Core Study (24 Months)|Death|0
5636328|NCT00662649|19466148|P1|Core Study (24 Months)|Death|1
5636329|NCT00662649|19466144|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
5636330|NCT00662649|19466145|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
5636331|NCT00662649|19466146|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
5636332|NCT00662649|19466147|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
5636333|NCT00662649|19466148|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
5636334|NCT00662649|19466144|P5|Core Study (24 Months)|Protocol Violation|0
5636335|NCT00662649|19466145|P4|Core Study (24 Months)|Protocol Violation|0
5636336|NCT00662649|19466146|P3|Core Study (24 Months)|Protocol Violation|4
5636337|NCT00662649|19466147|P2|Core Study (24 Months)|Protocol Violation|5
5636338|NCT00662649|19466148|P1|Core Study (24 Months)|Protocol Violation|5
5636339|NCT00662649|19466144|P5|Core Study (24 Months)|Lost to Follow-up|0
5636340|NCT00662649|19466145|P4|Core Study (24 Months)|Lost to Follow-up|0
5636341|NCT00662649|19466146|P3|Core Study (24 Months)|Lost to Follow-up|7
5636342|NCT00662649|19466147|P2|Core Study (24 Months)|Lost to Follow-up|5
5636343|NCT00662649|19466148|P1|Core Study (24 Months)|Lost to Follow-up|3
5636344|NCT00662649|19466144|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
5636345|NCT00662649|19466145|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
5636346|NCT00662649|19466146|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
5636347|NCT00662649|19466147|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
5636348|NCT00662649|19466148|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
5636349|NCT00662649|19466144|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
5636350|NCT00662649|19466145|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
5636351|NCT00662649|19466146|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
5636352|NCT00662649|19466147|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
5636353|NCT00662649|19466148|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
5636354|NCT00662649|19466144|P5|Core Study (24 Months)|Adverse Event|0
5636355|NCT00662649|19466145|P4|Core Study (24 Months)|Adverse Event|0
5636356|NCT00662649|19466146|P3|Core Study (24 Months)|Adverse Event|18
5636357|NCT00662649|19466147|P2|Core Study (24 Months)|Adverse Event|13
5636358|NCT00662649|19466148|P1|Core Study (24 Months)|Adverse Event|22
5636359|NCT00662649|19466144|P5|Core Study (24 Months)|Withdrawal by Subject|0
5636360|NCT00662649|19466145|P4|Core Study (24 Months)|Withdrawal by Subject|0
5636361|NCT00662649|19466146|P3|Core Study (24 Months)|Withdrawal by Subject|28
5636362|NCT00662649|19466147|P2|Core Study (24 Months)|Withdrawal by Subject|17
5636363|NCT00662649|19466148|P1|Core Study (24 Months)|Withdrawal by Subject|31
5636364|NCT00662558|19466188|P2|Overall Study|Randomized But Did Not Receive Treatment|8
5636365|NCT00662558|19466189|P1|Overall Study|Randomized But Did Not Receive Treatment|2
5636366|NCT00662558|19466188|P2|Overall Study|Withdrawal by Subject|12
5636367|NCT00662558|19466189|P1|Overall Study|Withdrawal by Subject|7
5636368|NCT00662558|19466188|P2|Overall Study|Other|14
5636369|NCT00662558|19466189|P1|Overall Study|Other|9
5636370|NCT00662558|19466188|P2|Overall Study|Lost to Follow-up|10
5636371|NCT00662558|19466189|P1|Overall Study|Lost to Follow-up|13
5636372|NCT00662558|19466188|P2|Overall Study|Lack of Efficacy|7
5636373|NCT00662558|19466189|P1|Overall Study|Lack of Efficacy|4
5636374|NCT00662558|19466188|P2|Overall Study|Adverse Event|59
5636375|NCT00662558|19466189|P1|Overall Study|Adverse Event|21
5636376|NCT00662532|19466240|P2|Overall Study|Lost to Follow-up|1
5636377|NCT00662532|19466241|P1|Overall Study|Lost to Follow-up|0
5636378|NCT00662532|19466240|P2|Overall Study|Adverse Event|1
5636379|NCT00662532|19466241|P1|Overall Study|Adverse Event|0
5636380|NCT00662363|19466256|P2|Overall Study|Protocol Violation|1
5636381|NCT00662363|19466257|P1|Overall Study|Protocol Violation|1
5636382|NCT00662363|19466256|P2|Overall Study|Discharged early from rehab|1
5636383|NCT00662363|19466257|P1|Overall Study|Discharged early from rehab|4
5636384|NCT00662363|19466256|P2|Overall Study|Adverse Event|3
5636385|NCT00662363|19466257|P1|Overall Study|Adverse Event|0
5636386|NCT00662363|19466256|P2|Overall Study|Withdrawal by Subject|5
5636387|NCT00662363|19466257|P1|Overall Study|Withdrawal by Subject|6
5636388|NCT00662311|19466268|P3|Overall Study|Respiratory Infection|0
5636389|NCT00662311|19466269|P2|Overall Study|Respiratory Infection|0
5636390|NCT00662311|19466270|P1|Overall Study|Respiratory Infection|1
5636391|NCT00662259|19466305|P2|Overall Study|Adverse Event|0
5636392|NCT00662259|19466306|P1|Overall Study|Adverse Event|2
5636393|NCT00662129|19466348|P1|Overall Study|Ineligible|1
5636394|NCT00662129|19466348|P1|Overall Study|Cancel prior to beginning treatment|1
5636395|NCT00662129|19466348|P1|Overall Study|Protocol Violation|1
5636396|NCT00662038|19466358|P1|Overall Study|Continued treatment|5
5636397|NCT00662038|19466358|P1|Overall Study|Adverse Event|358
5636398|NCT00662038|19466358|P1|Overall Study|Death|95
5636399|NCT00662038|19466358|P1|Overall Study|Lost to Follow-up|1
5636400|NCT00662038|19466358|P1|Overall Study|Lung transplantation|44
5636401|NCT00662038|19466358|P1|Overall Study|Physician Decision|19
5636402|NCT00662038|19466358|P1|Overall Study|Sponsor decision|1
5636403|NCT00662038|19466358|P1|Overall Study|Withdrawal by Subject|83
5636404|NCT00662038|19466358|P1|Overall Study|Withdrawn consent|22
5636405|NCT00662038|19466358|P1|Overall Study|Reason not specified|3
5636406|NCT00662025|19466362|P1|Overall Study|Domestic circumstances|1
5636407|NCT00662025|19466362|P1|Overall Study|Target lesion cannot be evaluated|1
5636408|NCT00662025|19466362|P1|Overall Study|Results of other clinical study|2
5636409|NCT00662025|19466362|P1|Overall Study|Withdrawal by Subject|1
5636410|NCT00662025|19466362|P1|Overall Study|Adverse Event|7
5636411|NCT00662025|19466362|P1|Overall Study|Objective progression or relapse|51
5636412|NCT00662012|19466382|P1|Overall Study|Withdrawal by Subject|1
5636413|NCT00662012|19466382|P1|Overall Study|Death|1
5636414|NCT00662012|19466382|P1|Overall Study|Lost to Follow-up|85
5636415|NCT00661999|19466390|P3|Overall Study|Other Medical Problems|9
5636416|NCT00661999|19466391|P2|Overall Study|Other Medical Problems|4
5636417|NCT00661999|19466392|P1|Overall Study|Other Medical Problems|4
5636418|NCT00661999|19466390|P3|Overall Study|Alternative Treatment|0
5636419|NCT00661999|19466391|P2|Overall Study|Alternative Treatment|0
5636420|NCT00661999|19466392|P1|Overall Study|Alternative Treatment|1
5636421|NCT00661999|19466390|P3|Overall Study|Withdrawal by Subject|14
5636422|NCT00661999|19466391|P2|Overall Study|Withdrawal by Subject|23
5636423|NCT00661999|19466392|P1|Overall Study|Withdrawal by Subject|30
5636424|NCT00661999|19466390|P3|Overall Study|Other Reasons|23
5636425|NCT00661999|19466391|P2|Overall Study|Other Reasons|12
5636426|NCT00661999|19466392|P1|Overall Study|Other Reasons|5
5636427|NCT00661999|19466390|P3|Overall Study|Death|3
5636428|NCT00661999|19466391|P2|Overall Study|Death|6
5636429|NCT00661999|19466392|P1|Overall Study|Death|8
5636430|NCT00661999|19466390|P3|Overall Study|Adverse Event|8
5636431|NCT00661999|19466391|P2|Overall Study|Adverse Event|5
5636432|NCT00661999|19466392|P1|Overall Study|Adverse Event|11
5636433|NCT00661830|19466469|P2|Overall Study|Other reason|5
5636434|NCT00661830|19466470|P1|Overall Study|Other reason|1
5636435|NCT00661830|19466469|P2|Overall Study|Withdrawal by Subject|1
5636436|NCT00661830|19466470|P1|Overall Study|Withdrawal by Subject|1
5636437|NCT00661830|19466469|P2|Overall Study|Lost to Follow-up|3
5636438|NCT00661830|19466470|P1|Overall Study|Lost to Follow-up|1
5636439|NCT00661830|19466469|P2|Overall Study|Death|33
5636440|NCT00661830|19466470|P1|Overall Study|Death|37
5636441|NCT00661778|19466482|P1|Overall Study|Withdrawal of Consent|1
5636442|NCT00661778|19466482|P1|Overall Study|Protocol Violation|2
5636443|NCT00661778|19466482|P1|Overall Study|Reason not Specified|6
5636444|NCT00661778|19466482|P1|Overall Study|Adverse Event|18
5636445|NCT00661778|19466482|P1|Overall Study|Disease Progression|23
5636446|NCT00661726|19466489|P1|Overall Study|Adverse Event|1
5636447|NCT00661713|19466512|P8|Overall Study|Inappropriate Enrollment|0
5636448|NCT00661713|19466513|P7|Overall Study|Inappropriate Enrollment|1
5636449|NCT00661713|19466514|P6|Overall Study|Inappropriate Enrollment|0
5636450|NCT00661713|19466515|P5|Overall Study|Inappropriate Enrollment|0
5636451|NCT00661713|19466516|P4|Overall Study|Inappropriate Enrollment|0
5636452|NCT00661713|19466517|P3|Overall Study|Inappropriate Enrollment|0
5636453|NCT00661713|19466518|P2|Overall Study|Inappropriate Enrollment|0
5636454|NCT00661713|19466519|P1|Overall Study|Inappropriate Enrollment|0
5636455|NCT00661713|19466512|P8|Overall Study|Adverse Event|0
5636456|NCT00661713|19466513|P7|Overall Study|Adverse Event|1
5636457|NCT00661713|19466514|P6|Overall Study|Adverse Event|0
5636458|NCT00661713|19466515|P5|Overall Study|Adverse Event|0
5636459|NCT00661713|19466516|P4|Overall Study|Adverse Event|0
5636460|NCT00661713|19466517|P3|Overall Study|Adverse Event|0
5636461|NCT00661713|19466518|P2|Overall Study|Adverse Event|0
5636462|NCT00661713|19466519|P1|Overall Study|Adverse Event|0
5636463|NCT00661713|19466512|P8|Overall Study|Administrative Reason|0
5636464|NCT00661713|19466513|P7|Overall Study|Administrative Reason|1
5636465|NCT00661713|19466514|P6|Overall Study|Administrative Reason|2
5636466|NCT00661713|19466515|P5|Overall Study|Administrative Reason|2
5636467|NCT00661713|19466516|P4|Overall Study|Administrative Reason|2
5636468|NCT00661713|19466517|P3|Overall Study|Administrative Reason|0
5636469|NCT00661713|19466518|P2|Overall Study|Administrative Reason|1
5636470|NCT00661713|19466519|P1|Overall Study|Administrative Reason|0
5636471|NCT00661713|19466512|P8|Overall Study|Lost to Follow-up|1
5636472|NCT00661713|19466513|P7|Overall Study|Lost to Follow-up|14
5636473|NCT00661713|19466514|P6|Overall Study|Lost to Follow-up|7
5636474|NCT00661713|19466515|P5|Overall Study|Lost to Follow-up|5
5636475|NCT00661713|19466516|P4|Overall Study|Lost to Follow-up|2
5636476|NCT00661713|19466517|P3|Overall Study|Lost to Follow-up|2
5636477|NCT00661713|19466518|P2|Overall Study|Lost to Follow-up|7
5636478|NCT00661713|19466519|P1|Overall Study|Lost to Follow-up|2
5636479|NCT00661713|19466512|P8|Overall Study|Withdrawal by Subject|9
5636480|NCT00661713|19466513|P7|Overall Study|Withdrawal by Subject|45
5636481|NCT00661713|19466514|P6|Overall Study|Withdrawal by Subject|26
5636482|NCT00661713|19466515|P5|Overall Study|Withdrawal by Subject|12
5636483|NCT00661713|19466516|P4|Overall Study|Withdrawal by Subject|21
5636484|NCT00661713|19466517|P3|Overall Study|Withdrawal by Subject|12
5636485|NCT00661713|19466518|P2|Overall Study|Withdrawal by Subject|25
5636486|NCT00661713|19466519|P1|Overall Study|Withdrawal by Subject|11
5636487|NCT00661713|19466512|P8|Overall Study|Protocol Violation|1
5636488|NCT00661713|19466513|P7|Overall Study|Protocol Violation|2
5636489|NCT00661713|19466514|P6|Overall Study|Protocol Violation|2
5636490|NCT00661713|19466515|P5|Overall Study|Protocol Violation|0
5636491|NCT00661713|19466516|P4|Overall Study|Protocol Violation|3
5636492|NCT00661713|19466517|P3|Overall Study|Protocol Violation|3
5636493|NCT00661713|19466518|P2|Overall Study|Protocol Violation|6
5636494|NCT00661713|19466519|P1|Overall Study|Protocol Violation|1
5636495|NCT00661713|19466512|P8|Overall Study|Unable to Classify|0
5636496|NCT00661713|19466513|P7|Overall Study|Unable to Classify|0
5636497|NCT00661713|19466514|P6|Overall Study|Unable to Classify|0
5636498|NCT00661713|19466515|P5|Overall Study|Unable to Classify|0
5636499|NCT00661713|19466516|P4|Overall Study|Unable to Classify|0
5636500|NCT00661713|19466517|P3|Overall Study|Unable to Classify|0
5636501|NCT00661713|19466518|P2|Overall Study|Unable to Classify|0
5636502|NCT00661713|19466519|P1|Overall Study|Unable to Classify|1
5636503|NCT00661713|19466512|P8|Overall Study|Death|0
5636504|NCT00661713|19466513|P7|Overall Study|Death|0
5636505|NCT00661713|19466514|P6|Overall Study|Death|0
5636506|NCT00661713|19466515|P5|Overall Study|Death|1
5636507|NCT00661713|19466516|P4|Overall Study|Death|0
5636508|NCT00661713|19466517|P3|Overall Study|Death|0
5636509|NCT00661713|19466518|P2|Overall Study|Death|0
5636510|NCT00661713|19466519|P1|Overall Study|Death|1
5636511|NCT00661687|19466611|P1|Overall Study|Adverse Event|2
5636512|NCT00661687|19466611|P1|Overall Study|Physician Decision|1
5636513|NCT00661687|19466611|P1|Overall Study|Inability to maintain wearing schedule|3
5636514|NCT00661687|19466611|P1|Overall Study|Positive slit lamp findings|4
5636515|NCT00661687|19466611|P1|Overall Study|Study related symptoms and complaints|5
5636516|NCT00661661|19466639|P2|Overall Study|Not assigned treatment|0
5636517|NCT00661661|19466640|P1|Overall Study|Not assigned treatment|1
5636518|NCT00661661|19466639|P2|Overall Study|Other|7
5636519|NCT00661661|19466640|P1|Overall Study|Other|22
5636520|NCT00661661|19466639|P2|Overall Study|Withdrawal by Subject|5
5636521|NCT00661661|19466640|P1|Overall Study|Withdrawal by Subject|15
5636522|NCT00661661|19466639|P2|Overall Study|Lost to Follow-up|1
5636523|NCT00661661|19466640|P1|Overall Study|Lost to Follow-up|0
5636524|NCT00661661|19466639|P2|Overall Study|Lack of Efficacy|2
5636525|NCT00661661|19466640|P1|Overall Study|Lack of Efficacy|3
5636526|NCT00661661|19466639|P2|Overall Study|Adverse Event|24
5636527|NCT00661661|19466640|P1|Overall Study|Adverse Event|99
5636528|NCT00661622|19466716|P2|Overall Study|Protocol Violation|0
5636529|NCT00661622|19466717|P1|Overall Study|Protocol Violation|1
5636530|NCT00661609|19466731|P1|Overall Study|Disease progression|3
5636531|NCT00661609|19466731|P1|Overall Study|Survival follow up stage discontinued|11
5636532|NCT00661609|19466731|P1|Overall Study|PI Decision|1
5636533|NCT00661609|19466731|P1|Overall Study|Withdrawal by Subject|2
5636534|NCT00661609|19466731|P1|Overall Study|Death|20
5636535|NCT00661609|19466731|P1|Overall Study|Adverse Event|4
5636536|NCT00661531|19466798|P1|Overall Study|Withdrawal by Subject|3
5636537|NCT00661505|19466803|P1|Overall Study|Other|2
5636538|NCT00661505|19466803|P1|Overall Study|Lost to Follow-up|3
5636539|NCT00661505|19466803|P1|Overall Study|Withdrawal by Subject|8
5636540|NCT00661505|19466803|P1|Overall Study|Protocol Violation|14
5636541|NCT00661505|19466803|P1|Overall Study|Adverse Event|3
5636542|NCT00661492|19466831|P2|Overall Study|Other|0
5636543|NCT00661492|19466832|P1|Overall Study|Other|1
5636544|NCT00661492|19466831|P2|Overall Study|Lost to Follow-up|1
5636545|NCT00661492|19466832|P1|Overall Study|Lost to Follow-up|0
5636546|NCT00661492|19466831|P2|Overall Study|Investigator Request|0
5636547|NCT00661492|19466832|P1|Overall Study|Investigator Request|1
5636548|NCT00661492|19466831|P2|Overall Study|Patient Request|1
5636549|NCT00661492|19466832|P1|Overall Study|Patient Request|6
5636550|NCT00661492|19466831|P2|Overall Study|Disease Progression|14
5636551|NCT00661492|19466832|P1|Overall Study|Disease Progression|44
5636552|NCT00661492|19466831|P2|Overall Study|Adverse Event|13
5636553|NCT00661492|19466832|P1|Overall Study|Adverse Event|16
5636554|NCT00661427|19466907|P2|Overall Study|Patient not treated|2
5636555|NCT00661427|19466908|P1|Overall Study|Patient not treated|0
5636556|NCT00661427|19466907|P2|Overall Study|Adverse Event|5
5636557|NCT00661427|19466908|P1|Overall Study|Adverse Event|5
5636558|NCT00661388|19466916|P1|Overall Study|Administrative reasons|1
5636559|NCT00661388|19466916|P1|Overall Study|Dialysis initiation|1
5636560|NCT00661388|19466916|P1|Overall Study|Renal transplantation|1
5636561|NCT00661388|19466916|P1|Overall Study|Protocol Violation|7
5636562|NCT00661388|19466916|P1|Overall Study|Adverse Event|14
5636563|NCT00661362|19466939|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
5636564|NCT00661362|19466940|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
5636565|NCT00661362|19466939|P2|Overall Study|Safety reasons|0
5636566|NCT00661362|19466940|P1|Overall Study|Safety reasons|1
5636567|NCT00661362|19466939|P2|Overall Study|Severe non-compliance to protocol|1
5636568|NCT00661362|19466940|P1|Overall Study|Severe non-compliance to protocol|0
5636569|NCT00661362|19466939|P2|Overall Study|Lost to Follow-up|1
5636570|NCT00661362|19466940|P1|Overall Study|Lost to Follow-up|3
5636571|NCT00661362|19466939|P2|Overall Study|Withdrawal by Subject|23
5636572|NCT00661362|19466940|P1|Overall Study|Withdrawal by Subject|13
5636573|NCT00661362|19466939|P2|Overall Study|Study specific discontinuation criteria|11
5636574|NCT00661362|19466940|P1|Overall Study|Study specific discontinuation criteria|4
5636575|NCT00661362|19466939|P2|Overall Study|Incorrect enrollment|0
5636576|NCT00661362|19466940|P1|Overall Study|Incorrect enrollment|2
5636577|NCT00661362|19466939|P2|Overall Study|Adverse Event|4
5636578|NCT00661362|19466940|P1|Overall Study|Adverse Event|5
5636579|NCT00661271|19466958|P2|Overall Study|Lost to Follow-up|25
5636580|NCT00661271|19466959|P1|Overall Study|Lost to Follow-up|28
5636581|NCT00661258|19466969|P2|Overall Study|caught by police and in detox center|1
5636582|NCT00661258|19466970|P1|Overall Study|caught by police and in detox center|2
5636583|NCT00661258|19466969|P2|Overall Study|Death|0
5636584|NCT00661258|19466970|P1|Overall Study|Death|1
5636585|NCT00661193|19466980|P2|Overall Study|Not protocol specified|0
5636586|NCT00661193|19466981|P1|Overall Study|Not protocol specified|1
5636587|NCT00661193|19466980|P2|Overall Study|Progression|24
5636588|NCT00661193|19466981|P1|Overall Study|Progression|27
5636589|NCT00661193|19466980|P2|Overall Study|Withdrawal by Subject|1
5636590|NCT00661193|19466981|P1|Overall Study|Withdrawal by Subject|3
5636591|NCT00661193|19466980|P2|Overall Study|Adverse Event|1
5636592|NCT00661193|19466981|P1|Overall Study|Adverse Event|2
5636593|NCT00661089|19467206|P2|Overall Study|death at 8 weeks due to new stroke|1
5636594|NCT00661089|19467207|P1|Overall Study|death at 8 weeks due to new stroke|0
5636595|NCT00661089|19467206|P2|Overall Study|1 subject withdrawal|1
5636596|NCT00661089|19467207|P1|Overall Study|1 subject withdrawal|0
5636597|NCT00660907|19467255|P2|Overall Study|Various|8
5636598|NCT00660907|19467256|P1|Overall Study|Various|11
5636599|NCT00660907|19467255|P2|Overall Study|Death|3
5636600|NCT00660907|19467256|P1|Overall Study|Death|1
5636601|NCT00660907|19467255|P2|Overall Study|Safety|0
5636602|NCT00660907|19467256|P1|Overall Study|Safety|1
5636603|NCT00660907|19467255|P2|Overall Study|Poor/Non-Compliance|1
5636604|NCT00660907|19467256|P1|Overall Study|Poor/Non-Compliance|5
5636605|NCT00660907|19467255|P2|Overall Study|Lost to Follow-up|3
5636606|NCT00660907|19467256|P1|Overall Study|Lost to Follow-up|3
5636607|NCT00660907|19467255|P2|Overall Study|Withdrawal by Subject|32
5636608|NCT00660907|19467256|P1|Overall Study|Withdrawal by Subject|23
5636609|NCT00660907|19467255|P2|Overall Study|Subject No Longer Meets Study Criteria|27
5636610|NCT00660907|19467256|P1|Overall Study|Subject No Longer Meets Study Criteria|6
5636611|NCT00660907|19467255|P2|Overall Study|Adverse Event|19
5636612|NCT00660907|19467256|P1|Overall Study|Adverse Event|33
5636613|NCT00660907|19467255|P2|Overall Study|Incorrect Enrollment|1
5636614|NCT00660907|19467256|P1|Overall Study|Incorrect Enrollment|1
5636615|NCT00660829|19467270|P2|Overall Study|Other|4
5636616|NCT00660829|19467271|P1|Overall Study|Other|9
5636617|NCT00660829|19467270|P2|Overall Study|Lost to Follow-up|2
5636618|NCT00660829|19467271|P1|Overall Study|Lost to Follow-up|3
5636619|NCT00660829|19467270|P2|Overall Study|Withdrawal by Subject|2
5636620|NCT00660829|19467271|P1|Overall Study|Withdrawal by Subject|1
5636621|NCT00660829|19467270|P2|Overall Study|Non-Compliance|4
5636622|NCT00660829|19467271|P1|Overall Study|Non-Compliance|0
5636623|NCT00660829|19467270|P2|Overall Study|Lack of Efficacy|3
5636624|NCT00660829|19467271|P1|Overall Study|Lack of Efficacy|2
5636625|NCT00660829|19467270|P2|Overall Study|Adverse Event|4
5636626|NCT00660829|19467271|P1|Overall Study|Adverse Event|3
5636627|NCT00660816|19467289|P2|Overall Study|Complicating Disease|1
5636628|NCT00660816|19467290|P1|Overall Study|Complicating Disease|0
5636629|NCT00660816|19467289|P2|Overall Study|Disease Progression|12
5636630|NCT00660816|19467290|P1|Overall Study|Disease Progression|16
5636631|NCT00660816|19467289|P2|Overall Study|Protocol Violation|0
5636632|NCT00660816|19467290|P1|Overall Study|Protocol Violation|1
5636633|NCT00660816|19467289|P2|Overall Study|Physician Decision|2
5636634|NCT00660816|19467290|P1|Overall Study|Physician Decision|0
5636635|NCT00660816|19467289|P2|Overall Study|Lack of Efficacy|0
5636636|NCT00660816|19467290|P1|Overall Study|Lack of Efficacy|1
5636637|NCT00660816|19467289|P2|Overall Study|Death|2
5636638|NCT00660816|19467290|P1|Overall Study|Death|0
5636639|NCT00660816|19467289|P2|Overall Study|Withdrawal by Subject|0
5636640|NCT00660816|19467290|P1|Overall Study|Withdrawal by Subject|1
5636641|NCT00660816|19467289|P2|Overall Study|Adverse Event|2
5636642|NCT00660816|19467290|P1|Overall Study|Adverse Event|1
5636643|NCT00660790|19467302|P1|3 Months to 2 Years|Withdrawal by Subject|17
5636644|NCT00660790|19467302|P1|Baseline to 3 Months|Withdrawal by Subject|2
5636645|NCT00660790|19467302|P1|Baseline to 3 Months|Death|1
5636646|NCT00660699|19467306|P1|Overall Study|Withdrawal by Subject|2
5636647|NCT00660660|19467322|P2|Overall Study|New medication after randomization|0
5636648|NCT00660660|19467323|P1|Overall Study|New medication after randomization|1
5636649|NCT00660660|19467322|P2|Overall Study|Incorrect enrollment and other|1
5636650|NCT00660660|19467323|P1|Overall Study|Incorrect enrollment and other|0
5636651|NCT00660660|19467322|P2|Overall Study|Withdrawal by Subject|0
5636652|NCT00660660|19467323|P1|Overall Study|Withdrawal by Subject|3
5636653|NCT00660660|19467322|P2|Overall Study|Lack of Efficacy|2
5636654|NCT00660660|19467323|P1|Overall Study|Lack of Efficacy|0
5636655|NCT00660660|19467322|P2|Overall Study|Lost to Follow-up|6
5636656|NCT00660660|19467323|P1|Overall Study|Lost to Follow-up|0
5636657|NCT00660660|19467322|P2|Overall Study|Adverse Event|0
5636658|NCT00660660|19467323|P1|Overall Study|Adverse Event|1
5636659|NCT00660595|19467423|P2|Overall Study|Non Specified reasons|0
5636660|NCT00660595|19467424|P1|Overall Study|Non Specified reasons|5
5636661|NCT00660595|19467423|P2|Overall Study|Participant left hospital|0
5636662|NCT00660595|19467424|P1|Overall Study|Participant left hospital|1
5636663|NCT00660595|19467423|P2|Overall Study|Did not consent to participate in study|8
5636664|NCT00660595|19467424|P1|Overall Study|Did not consent to participate in study|12
5636665|NCT00660595|19467423|P2|Overall Study|Lost to Follow-up|1
5636666|NCT00660595|19467424|P1|Overall Study|Lost to Follow-up|0
5636667|NCT00660400|19467491|P1|Overall Study|Withdrawal by Subject|1
5636668|NCT00660400|19467491|P1|Overall Study|Intracranial hemorrhage|1
5636669|NCT00660400|19467491|P1|Overall Study|Suboptimal organ function|1
5636670|NCT00660400|19467491|P1|Overall Study|Lack of insurance approval|1
5636671|NCT00660387|19467500|P2|Overall Study|Protocol Violation|0
5636672|NCT00660387|19467501|P1|Overall Study|Protocol Violation|1
5636673|NCT00660387|19467500|P2|Overall Study|Lack of Efficacy|1
5636674|NCT00660387|19467501|P1|Overall Study|Lack of Efficacy|0
5636675|NCT00660387|19467500|P2|Overall Study|Adverse Event|2
5636676|NCT00660387|19467501|P1|Overall Study|Adverse Event|1
5636677|NCT00660348|19467555|P2|Overall Study|Withdrawal by Subject|0
5636678|NCT00660348|19467556|P1|Overall Study|Withdrawal by Subject|1
5636679|NCT00660309|19467564|P2|Overall Study|Withdrawal by Subject|3
5636680|NCT00660309|19467565|P1|Overall Study|Withdrawal by Subject|0
5636681|NCT00660309|19467564|P2|Overall Study|Adverse Event|0
5636682|NCT00660309|19467565|P1|Overall Study|Adverse Event|2
5636683|NCT00660192|19467606|P2|Overall Study|Lost to Follow-up|3
5636684|NCT00660192|19467607|P1|Overall Study|Lost to Follow-up|2
5636685|NCT00660179|19467618|P3|Overall Study|Incorrect randomization|0
5636686|NCT00660179|19467619|P2|Overall Study|Incorrect randomization|0
5636687|NCT00660179|19467620|P1|Overall Study|Incorrect randomization|1
5636688|NCT00660179|19467618|P3|Overall Study|Administrative reason|1
5636689|NCT00660179|19467619|P2|Overall Study|Administrative reason|0
5636690|NCT00660179|19467620|P1|Overall Study|Administrative reason|0
5636691|NCT00660179|19467618|P3|Overall Study|Lost to Follow-up|2
5636692|NCT00660179|19467619|P2|Overall Study|Lost to Follow-up|5
5636693|NCT00660179|19467620|P1|Overall Study|Lost to Follow-up|7
5636694|NCT00660179|19467618|P3|Overall Study|Withdrawal of consent|4
5636695|NCT00660179|19467619|P2|Overall Study|Withdrawal of consent|6
5636696|NCT00660179|19467620|P1|Overall Study|Withdrawal of consent|4
5636697|NCT00660179|19467618|P3|Overall Study|Death|34
5636698|NCT00660179|19467619|P2|Overall Study|Death|47
5636699|NCT00660179|19467620|P1|Overall Study|Death|44
5636700|NCT00660023|19467665|P1|Overall Study|Other Screening Failure|9
5636701|NCT00660023|19467665|P1|Overall Study|Missed Pregnancy Test|1
5636702|NCT00660023|19467665|P1|Overall Study|Withdrawal by Subject|1
5636703|NCT00660023|19467665|P1|Overall Study|Renal Transplantation|3
5636704|NCT00660023|19467665|P1|Overall Study|Blood Transfusion|5
5636705|NCT00660023|19467665|P1|Overall Study|Death|8
5636706|NCT00660023|19467665|P1|Overall Study|Adverse Event|2
5636707|NCT00660010|19467676|P1|Overall Study|Noncompliance with visit schedule|3
5636708|NCT00660010|19467676|P1|Overall Study|Adverse Event|1
5636709|NCT00660010|19467676|P1|Overall Study|Lost to Follow-up|3
5636710|NCT00660010|19467676|P1|Overall Study|Withdrawal by Subject|2
5636711|NCT00659984|19467690|P1|Overall Study|Adverse Event|1
5636712|NCT00659880|19467710|P1|Overall Study|Lost to Follow-up|5
5636713|NCT00659815|19467723|P2|Overall Study|Withdrawal by Subject|1
5636714|NCT00659815|19467724|P1|Overall Study|Withdrawal by Subject|1
5636715|NCT00659815|19467723|P2|Overall Study|Inability to maintain wearing schedule|2
5636716|NCT00659815|19467724|P1|Overall Study|Inability to maintain wearing schedule|1
5636717|NCT00659815|19467723|P2|Overall Study|Study related symptoms and complaints|1
5636718|NCT00659815|19467724|P1|Overall Study|Study related symptoms and complaints|2
5636719|NCT00659607|19467803|P1|Overall Study|Inconsistent BP measuring date|2
5636720|NCT00659607|19467803|P1|Overall Study|No recorded efficacy data|15
5636721|NCT00659607|19467803|P1|Overall Study|'Unable to evaluate' for the final asses|67
5636722|NCT00659607|19467803|P1|Overall Study|Unknown measuring date of blood pressure|85
5636723|NCT00659607|19467803|P1|Overall Study|No blood pressure recorded|147
5636724|NCT00659581|19467821|P1|Overall Study|Other|6393
5636725|NCT00659581|19467821|P1|Overall Study|Lack of Efficacy|1183
5636726|NCT00659581|19467821|P1|Overall Study|Adverse Event|1006
5636727|NCT00659529|19467833|P1|Overall Study|Screen failure|9
5636728|NCT00659529|19467833|P1|Overall Study|Protocol Violation|3
5636729|NCT00659529|19467833|P1|Overall Study|Withdrawal by Subject|4
5636730|NCT00659490|19467840|P3|Overall Study|Lost to Follow-up|1
5636731|NCT00659490|19467841|P2|Overall Study|Lost to Follow-up|0
5636732|NCT00659490|19467842|P1|Overall Study|Lost to Follow-up|2
5636733|NCT00659438|19467915|P2|Overall Study|Lost to Follow-up|0
5636734|NCT00659438|19467916|P1|Overall Study|Lost to Follow-up|1
5636735|NCT00659438|19467915|P2|Overall Study|Death|6
5636736|NCT00659438|19467916|P1|Overall Study|Death|11
5636737|NCT00659438|19467915|P2|Overall Study|Withdrawal by Subject|2
5636738|NCT00659438|19467916|P1|Overall Study|Withdrawal by Subject|2
5636739|NCT00659425|19467948|P10|Overall Study|Other|6
5636740|NCT00659425|19467949|P9|Overall Study|Other|0
5636741|NCT00659425|19467950|P8|Overall Study|Other|2
5636742|NCT00659425|19467951|P7|Overall Study|Other|3
5636743|NCT00659425|19467952|P6|Overall Study|Other|0
5636744|NCT00659425|19467953|P5|Overall Study|Other|4
5636745|NCT00659425|19467954|P4|Overall Study|Other|2
5636746|NCT00659425|19467955|P3|Overall Study|Other|1
5636747|NCT00659425|19467956|P2|Overall Study|Other|1
5636748|NCT00659425|19467957|P1|Overall Study|Other|0
5636749|NCT00659425|19467948|P10|Overall Study|Investigator Discretion|0
5636750|NCT00659425|19467949|P9|Overall Study|Investigator Discretion|0
5636751|NCT00659425|19467950|P8|Overall Study|Investigator Discretion|3
5636752|NCT00659425|19467951|P7|Overall Study|Investigator Discretion|0
5636753|NCT00659425|19467952|P6|Overall Study|Investigator Discretion|1
5636754|NCT00659425|19467953|P5|Overall Study|Investigator Discretion|0
5636755|NCT00659425|19467954|P4|Overall Study|Investigator Discretion|0
5636756|NCT00659425|19467955|P3|Overall Study|Investigator Discretion|0
5636757|NCT00659425|19467956|P2|Overall Study|Investigator Discretion|0
5636758|NCT00659425|19467957|P1|Overall Study|Investigator Discretion|0
5636759|NCT00659425|19467948|P10|Overall Study|Adverse Event|4
5636760|NCT00659425|19467949|P9|Overall Study|Adverse Event|1
5636761|NCT00659425|19467950|P8|Overall Study|Adverse Event|3
5636762|NCT00659425|19467951|P7|Overall Study|Adverse Event|0
5636763|NCT00659425|19467952|P6|Overall Study|Adverse Event|1
5636764|NCT00659425|19467953|P5|Overall Study|Adverse Event|0
5636765|NCT00659425|19467954|P4|Overall Study|Adverse Event|0
5636766|NCT00659425|19467955|P3|Overall Study|Adverse Event|0
5636767|NCT00659425|19467956|P2|Overall Study|Adverse Event|0
5636768|NCT00659425|19467957|P1|Overall Study|Adverse Event|0
5636769|NCT00659425|19467948|P10|Overall Study|Death|0
5636770|NCT00659425|19467949|P9|Overall Study|Death|0
5636771|NCT00659425|19467950|P8|Overall Study|Death|0
5636772|NCT00659425|19467951|P7|Overall Study|Death|1
5636773|NCT00659425|19467952|P6|Overall Study|Death|0
5636774|NCT00659425|19467953|P5|Overall Study|Death|0
5636775|NCT00659425|19467954|P4|Overall Study|Death|1
5636776|NCT00659425|19467955|P3|Overall Study|Death|0
5636777|NCT00659425|19467956|P2|Overall Study|Death|0
5636778|NCT00659425|19467957|P1|Overall Study|Death|0
5636779|NCT00659425|19467948|P10|Overall Study|Disease progression|3
5636780|NCT00659425|19467949|P9|Overall Study|Disease progression|5
5636781|NCT00659425|19467950|P8|Overall Study|Disease progression|3
5636782|NCT00659425|19467951|P7|Overall Study|Disease progression|4
5636783|NCT00659425|19467952|P6|Overall Study|Disease progression|2
5636784|NCT00659425|19467953|P5|Overall Study|Disease progression|0
5636785|NCT00659425|19467954|P4|Overall Study|Disease progression|1
5636786|NCT00659425|19467955|P3|Overall Study|Disease progression|0
5636787|NCT00659425|19467956|P2|Overall Study|Disease progression|0
5636788|NCT00659425|19467957|P1|Overall Study|Disease progression|1
5636789|NCT00659373|19468188|P2|Overall Study|Assessment Missed|2
5636790|NCT00659373|19468189|P1|Overall Study|Assessment Missed|2
5636791|NCT00659373|19468188|P2|Overall Study|Withdrawal by Subject|5
5636792|NCT00659373|19468189|P1|Overall Study|Withdrawal by Subject|3
5636793|NCT00659334|19468211|P7|Overall Study|Screen Failure|1
5636794|NCT00659334|19468212|P6|Overall Study|Screen Failure|0
5636795|NCT00659334|19468213|P5|Overall Study|Screen Failure|0
5636796|NCT00659334|19468214|P4|Overall Study|Screen Failure|0
5636797|NCT00659334|19468215|P3|Overall Study|Screen Failure|0
5636798|NCT00659334|19468216|P2|Overall Study|Screen Failure|5
5636799|NCT00659334|19468217|P1|Overall Study|Screen Failure|8
5636800|NCT00659269|19468244|P2|Overall Study|Physician Decision|1
5636801|NCT00659269|19468245|P1|Overall Study|Physician Decision|1
5636802|NCT00659230|19468275|P2|Overall Study|Did not return post-randomization|3
5636803|NCT00659230|19468276|P1|Overall Study|Did not return post-randomization|2
5636804|NCT00659230|19468275|P2|Overall Study|Lost source documentation|4
5636805|NCT00659230|19468276|P1|Overall Study|Lost source documentation|5
5636806|NCT00659230|19468275|P2|Overall Study|Lost to Follow-up|5
5636807|NCT00659230|19468276|P1|Overall Study|Lost to Follow-up|2
5636808|NCT00659061|19468299|P2|Overall Study|Migration due to political unrest|15
5636809|NCT00659061|19468300|P1|Overall Study|Migration due to political unrest|21
5636810|NCT00658996|19468318|P2|Second Intervention|Positive slit lamp finding|1
5636811|NCT00658996|19468319|P1|Second Intervention|Positive slit lamp finding|0
5636812|NCT00658996|19468318|P2|Second Intervention|Developed a stye on upper lid|0
5636813|NCT00658996|19468319|P1|Second Intervention|Developed a stye on upper lid|1
5636814|NCT00658996|19468318|P2|Crossover Period|Ineligible|1
5636815|NCT00658996|19468319|P1|Crossover Period|Ineligible|1
5636816|NCT00658996|19468318|P2|Crossover Period|Physician Decision|0
5636817|NCT00658996|19468319|P1|Crossover Period|Physician Decision|1
5636818|NCT00658996|19468318|P2|First Intervention|Lack of lenses|1
5636819|NCT00658996|19468319|P1|First Intervention|Lack of lenses|0
5636820|NCT00658996|19468318|P2|First Intervention|Positive slit lamp finding|0
5636821|NCT00658996|19468319|P1|First Intervention|Positive slit lamp finding|1
5636822|NCT00658879|19468329|P1|Overall Study|Protocol Violation|1
5636823|NCT00658814|19468346|P2|Maintenance Therapy|Not eligible|0
5636824|NCT00658814|19468347|P1|Maintenance Therapy|Not eligible|1
5636825|NCT00658814|19468346|P2|Maintenance Therapy|Not protocol specified|0
5636826|NCT00658814|19468347|P1|Maintenance Therapy|Not protocol specified|1
5636827|NCT00658814|19468346|P2|Maintenance Therapy|Adverse Event|1
5636828|NCT00658814|19468347|P1|Maintenance Therapy|Adverse Event|1
5636829|NCT00658814|19468346|P2|Consolidation Therapy|Not eligible|2
5636830|NCT00658814|19468347|P1|Consolidation Therapy|Not eligible|2
5636831|NCT00658814|19468346|P2|Consolidation Therapy|Not protocol specified|1
5636832|NCT00658814|19468347|P1|Consolidation Therapy|Not protocol specified|0
5636833|NCT00658814|19468346|P2|Remission Induction Chemotherapy|Not eligible|2
5636834|NCT00658814|19468347|P1|Remission Induction Chemotherapy|Not eligible|1
5636835|NCT00658814|19468346|P2|Remission Induction Chemotherapy|Not protocol specified|4
5636836|NCT00658814|19468347|P1|Remission Induction Chemotherapy|Not protocol specified|2
5636837|NCT00658814|19468346|P2|Remission Induction Chemotherapy|Death|4
5636838|NCT00658814|19468347|P1|Remission Induction Chemotherapy|Death|1
5636839|NCT00658814|19468346|P2|Remission Induction Chemotherapy|Progression/Relapse|1
5636840|NCT00658814|19468347|P1|Remission Induction Chemotherapy|Progression/Relapse|0
5636841|NCT00658814|19468346|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
5636842|NCT00658814|19468347|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
5636843|NCT00658814|19468346|P2|Remission Induction Chemotherapy|Adverse Event|3
5636844|NCT00658814|19468347|P1|Remission Induction Chemotherapy|Adverse Event|1
5636845|NCT00658788|19468361|P1|Overall Study|Treatment Discontinuation|32
5636846|NCT00658788|19468361|P1|Overall Study|Lost to Follow-up|18
5636847|NCT00658788|19468361|P1|Overall Study|Withdrawal by Subject|13
5636848|NCT00658788|19468361|P1|Overall Study|Adverse Event|11
5636849|NCT00658775|19468416|P2|Overall Study|Other|8
5636850|NCT00658775|19468417|P1|Overall Study|Other|7
5636851|NCT00658775|19468416|P2|Overall Study|Withdrawal of consent|7
5636852|NCT00658775|19468417|P1|Overall Study|Withdrawal of consent|8
5636853|NCT00658775|19468416|P2|Overall Study|Withdrawal by Subject|4
5636854|NCT00658775|19468417|P1|Overall Study|Withdrawal by Subject|6
5636855|NCT00658775|19468416|P2|Overall Study|Lost to Follow-up|18
5636856|NCT00658775|19468417|P1|Overall Study|Lost to Follow-up|17
5636857|NCT00658775|19468416|P2|Overall Study|Adverse Event|6
5636858|NCT00658775|19468417|P1|Overall Study|Adverse Event|4
5636859|NCT00658723|19468440|P3|Overall Study|Withdrawal by Subject|1
5636860|NCT00658723|19468441|P2|Overall Study|Withdrawal by Subject|0
5636861|NCT00658723|19468442|P1|Overall Study|Withdrawal by Subject|1
5636862|NCT00658723|19468440|P3|Overall Study|Scheduling Issue|0
5636863|NCT00658723|19468441|P2|Overall Study|Scheduling Issue|1
5636864|NCT00658723|19468442|P1|Overall Study|Scheduling Issue|1
5636865|NCT00658723|19468440|P3|Overall Study|Death|4
5636866|NCT00658723|19468441|P2|Overall Study|Death|1
5636867|NCT00658723|19468442|P1|Overall Study|Death|2
5636868|NCT00658723|19468440|P3|Overall Study|Lost to Follow-up|2
5636869|NCT00658723|19468441|P2|Overall Study|Lost to Follow-up|2
5636870|NCT00658723|19468442|P1|Overall Study|Lost to Follow-up|0
5636871|NCT00658684|19468480|P4|Overall Study|Pregnancy|0
5636872|NCT00658684|19468481|P3|Overall Study|Pregnancy|0
5636873|NCT00658684|19468482|P2|Overall Study|Pregnancy|1
5636874|NCT00658684|19468483|P1|Overall Study|Pregnancy|1
5636875|NCT00658684|19468480|P4|Overall Study|Protocol Violation|0
5636876|NCT00658684|19468481|P3|Overall Study|Protocol Violation|0
5636877|NCT00658684|19468482|P2|Overall Study|Protocol Violation|1
5636878|NCT00658684|19468483|P1|Overall Study|Protocol Violation|1
5636879|NCT00658684|19468480|P4|Overall Study|Lack of Efficacy|0
5636880|NCT00658684|19468481|P3|Overall Study|Lack of Efficacy|0
5636881|NCT00658684|19468482|P2|Overall Study|Lack of Efficacy|1
5636882|NCT00658684|19468483|P1|Overall Study|Lack of Efficacy|1
5636883|NCT00658684|19468480|P4|Overall Study|Withdrawal by Subject|1
5636884|NCT00658684|19468481|P3|Overall Study|Withdrawal by Subject|1
5636885|NCT00658684|19468482|P2|Overall Study|Withdrawal by Subject|4
5636886|NCT00658684|19468483|P1|Overall Study|Withdrawal by Subject|6
5636887|NCT00658684|19468480|P4|Overall Study|Adverse Event|0
5636888|NCT00658684|19468481|P3|Overall Study|Adverse Event|2
5636889|NCT00658684|19468482|P2|Overall Study|Adverse Event|8
5636890|NCT00658684|19468483|P1|Overall Study|Adverse Event|10
5636891|NCT00658658|19468538|P5|Overall Study|Other|1
5636892|NCT00658658|19468539|P4|Overall Study|Other|0
5636893|NCT00658658|19468540|P3|Overall Study|Other|0
5636894|NCT00658658|19468541|P2|Overall Study|Other|0
5636895|NCT00658658|19468542|P1|Overall Study|Other|0
5636896|NCT00658658|19468538|P5|Overall Study|Protocol-specified Criteria|0
5636897|NCT00658658|19468539|P4|Overall Study|Protocol-specified Criteria|0
5636898|NCT00658658|19468540|P3|Overall Study|Protocol-specified Criteria|0
5636899|NCT00658658|19468541|P2|Overall Study|Protocol-specified Criteria|0
5636900|NCT00658658|19468542|P1|Overall Study|Protocol-specified Criteria|1
5636901|NCT00658658|19468538|P5|Overall Study|Disease Progression|3
5636902|NCT00658658|19468539|P4|Overall Study|Disease Progression|1
5636903|NCT00658658|19468540|P3|Overall Study|Disease Progression|0
5636904|NCT00658658|19468541|P2|Overall Study|Disease Progression|1
5636905|NCT00658658|19468542|P1|Overall Study|Disease Progression|0
5636906|NCT00658658|19468538|P5|Overall Study|Death|1
5636907|NCT00658658|19468539|P4|Overall Study|Death|1
5636908|NCT00658658|19468540|P3|Overall Study|Death|0
5636909|NCT00658658|19468541|P2|Overall Study|Death|0
5636910|NCT00658658|19468542|P1|Overall Study|Death|4
5636911|NCT00658658|19468538|P5|Overall Study|Withdrawal by Subject|0
5636912|NCT00658658|19468539|P4|Overall Study|Withdrawal by Subject|0
5636913|NCT00658658|19468540|P3|Overall Study|Withdrawal by Subject|0
5636914|NCT00658658|19468541|P2|Overall Study|Withdrawal by Subject|1
5636915|NCT00658658|19468542|P1|Overall Study|Withdrawal by Subject|0
5636916|NCT00658632|19468601|P2|Overall Study|Other|8
5636917|NCT00658632|19468602|P1|Overall Study|Other|7
5636918|NCT00658632|19468601|P2|Overall Study|Pregnancy|1
5636919|NCT00658632|19468602|P1|Overall Study|Pregnancy|1
5636920|NCT00658632|19468601|P2|Overall Study|Withdrawal of consent|14
5636921|NCT00658632|19468602|P1|Overall Study|Withdrawal of consent|8
5636922|NCT00658632|19468601|P2|Overall Study|Lack of Efficacy|1
5636923|NCT00658632|19468602|P1|Overall Study|Lack of Efficacy|0
5636924|NCT00658632|19468601|P2|Overall Study|Withdrawal by Subject|7
5636925|NCT00658632|19468602|P1|Overall Study|Withdrawal by Subject|10
5636926|NCT00658632|19468601|P2|Overall Study|Lost to Follow-up|23
5636927|NCT00658632|19468602|P1|Overall Study|Lost to Follow-up|25
5636928|NCT00658632|19468601|P2|Overall Study|Adverse Event|11
5636929|NCT00658632|19468602|P1|Overall Study|Adverse Event|13
5636930|NCT00658606|19468643|P2|Overall Study|Lack of Compliance|3
5636931|NCT00658606|19468644|P1|Overall Study|Lack of Compliance|0
5636932|NCT00658606|19468643|P2|Overall Study|Withdrawal by Subject|16
5636933|NCT00658606|19468644|P1|Overall Study|Withdrawal by Subject|7
5636934|NCT00658606|19468643|P2|Overall Study|Lost to Follow-up|0
5636935|NCT00658606|19468644|P1|Overall Study|Lost to Follow-up|1
5636936|NCT00658606|19468643|P2|Overall Study|Lack of Efficacy|3
5636937|NCT00658606|19468644|P1|Overall Study|Lack of Efficacy|6
5636938|NCT00658606|19468643|P2|Overall Study|Adverse Event|1
5636939|NCT00658606|19468644|P1|Overall Study|Adverse Event|2
5636940|NCT00658567|19468673|P3|Overall Study|At Discretion of Sponsor|1
5636941|NCT00658567|19468674|P2|Overall Study|At Discretion of Sponsor|1
5636942|NCT00658567|19468675|P1|Overall Study|At Discretion of Sponsor|1
5636943|NCT00658567|19468673|P3|Overall Study|Physician Decision|0
5636944|NCT00658567|19468674|P2|Overall Study|Physician Decision|1
5636945|NCT00658567|19468675|P1|Overall Study|Physician Decision|0
5636946|NCT00658567|19468673|P3|Overall Study|Voluntary Withdrawal of Consent|2
5636947|NCT00658567|19468674|P2|Overall Study|Voluntary Withdrawal of Consent|0
5636948|NCT00658567|19468675|P1|Overall Study|Voluntary Withdrawal of Consent|2
5636949|NCT00658567|19468673|P3|Overall Study|Adverse Event|3
5636950|NCT00658567|19468674|P2|Overall Study|Adverse Event|2
5636951|NCT00658567|19468675|P1|Overall Study|Adverse Event|5
5636952|NCT00658541|19468686|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5636953|NCT00658541|19468687|P1|Washout Period of 7 Days|Withdrawal by Subject|0
5636954|NCT00658541|19468686|P2|Washout Period of 7 Days|Withdrawal by Subject|1
5636955|NCT00658541|19468687|P1|Washout Period of 7 Days|Withdrawal by Subject|1
5636956|NCT00658528|19468699|P2|Overall Study|Other|4
5636957|NCT00658528|19468700|P1|Overall Study|Other|8
5636958|NCT00658528|19468699|P2|Overall Study|Withdrawal of consent|6
5636959|NCT00658528|19468700|P1|Overall Study|Withdrawal of consent|5
5636960|NCT00658528|19468699|P2|Overall Study|Withdrawal by Subject|6
5636961|NCT00658528|19468700|P1|Overall Study|Withdrawal by Subject|8
5636962|NCT00658528|19468699|P2|Overall Study|Lost to Follow-up|22
5636963|NCT00658528|19468700|P1|Overall Study|Lost to Follow-up|14
5636964|NCT00658528|19468699|P2|Overall Study|Adverse Event|7
5636965|NCT00658528|19468700|P1|Overall Study|Adverse Event|5
5636966|NCT00658359|19468740|P3|Overall Study|Lack of Efficacy|0
5636967|NCT00658359|19468741|P2|Overall Study|Lack of Efficacy|1
5636968|NCT00658359|19468742|P1|Overall Study|Lack of Efficacy|0
5636969|NCT00658359|19468740|P3|Overall Study|Lost to Follow-up|4
5636970|NCT00658359|19468741|P2|Overall Study|Lost to Follow-up|2
5636971|NCT00658359|19468742|P1|Overall Study|Lost to Follow-up|2
5636972|NCT00658359|19468740|P3|Overall Study|Withdrawal by Subject|2
5636973|NCT00658359|19468741|P2|Overall Study|Withdrawal by Subject|4
5636974|NCT00658359|19468742|P1|Overall Study|Withdrawal by Subject|7
5636975|NCT00658359|19468740|P3|Overall Study|Includes protocol Amendments 3 and 4|29
5636976|NCT00658359|19468741|P2|Overall Study|Includes protocol Amendments 3 and 4|31
5636977|NCT00658359|19468742|P1|Overall Study|Includes protocol Amendments 3 and 4|2
5636978|NCT00658359|19468740|P3|Overall Study|Protocol Violation|0
5636979|NCT00658359|19468741|P2|Overall Study|Protocol Violation|0
5636980|NCT00658359|19468742|P1|Overall Study|Protocol Violation|1
5636981|NCT00658359|19468740|P3|Overall Study|Adverse Event|9
5636982|NCT00658359|19468741|P2|Overall Study|Adverse Event|6
5636983|NCT00658359|19468742|P1|Overall Study|Adverse Event|13
5636984|NCT00658359|19468740|P3|Overall Study|Death|2
5636985|NCT00658359|19468741|P2|Overall Study|Death|1
5636986|NCT00658359|19468742|P1|Overall Study|Death|3
5636987|NCT00658333|19468830|P2|Overall Study|Adverse Event|1
5636988|NCT00658333|19468831|P1|Overall Study|Adverse Event|2
5636989|NCT00658320|19468841|P2|Extension Study: After Month 24|Subject withdrew consent|0
5636990|NCT00658320|19468842|P1|Extension Study: After Month 24|Subject withdrew consent|2
5636991|NCT00658320|19468841|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
5636992|NCT00658320|19468842|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
5636993|NCT00658320|19468841|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
5636994|NCT00658320|19468842|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
5636995|NCT00658320|19468841|P2|Core Study: 12 Months|Subject withdrew consent|3
5636996|NCT00658320|19468842|P1|Core Study: 12 Months|Subject withdrew consent|5
5636997|NCT00658021|19468877|P3|Long-term Safety Follow-up Period|Physician Decision|0
5636998|NCT00658021|19468878|P2|Long-term Safety Follow-up Period|Physician Decision|2
5636999|NCT00658021|19468879|P1|Long-term Safety Follow-up Period|Physician Decision|0
5637000|NCT00658021|19468877|P3|Long-term Safety Follow-up Period|Withdrawal by Subject|0
5637001|NCT00658021|19468878|P2|Long-term Safety Follow-up Period|Withdrawal by Subject|1
5637002|NCT00658021|19468879|P1|Long-term Safety Follow-up Period|Withdrawal by Subject|0
5637003|NCT00658021|19468877|P3|28-Week Treatment Period|Did not receive treatment|0
5637004|NCT00658021|19468878|P2|28-Week Treatment Period|Did not receive treatment|0
5637005|NCT00658021|19468879|P1|28-Week Treatment Period|Did not receive treatment|2
5637006|NCT00658021|19468877|P3|28-Week Treatment Period|Other|1
5637007|NCT00658021|19468878|P2|28-Week Treatment Period|Other|3
5637008|NCT00658021|19468879|P1|28-Week Treatment Period|Other|2
5637009|NCT00658021|19468877|P3|28-Week Treatment Period|Loss of glucose control|10
5637010|NCT00658021|19468878|P2|28-Week Treatment Period|Loss of glucose control|1
5637011|NCT00658021|19468879|P1|28-Week Treatment Period|Loss of glucose control|1
5637012|NCT00658021|19468877|P3|28-Week Treatment Period|Withdrawal by parent/guardian|1
5637013|NCT00658021|19468878|P2|28-Week Treatment Period|Withdrawal by parent/guardian|1
5637014|NCT00658021|19468879|P1|28-Week Treatment Period|Withdrawal by parent/guardian|1
5637015|NCT00658021|19468877|P3|28-Week Treatment Period|Physician Decision|1
5637016|NCT00658021|19468878|P2|28-Week Treatment Period|Physician Decision|2
5637017|NCT00658021|19468879|P1|28-Week Treatment Period|Physician Decision|1
5637018|NCT00658021|19468877|P3|28-Week Treatment Period|Withdrawal by Subject|3
5637019|NCT00658021|19468878|P2|28-Week Treatment Period|Withdrawal by Subject|1
5637020|NCT00658021|19468879|P1|28-Week Treatment Period|Withdrawal by Subject|1
5637021|NCT00658021|19468877|P3|28-Week Treatment Period|Protocol Violation|1
5637022|NCT00658021|19468878|P2|28-Week Treatment Period|Protocol Violation|2
5637023|NCT00658021|19468879|P1|28-Week Treatment Period|Protocol Violation|0
5637024|NCT00658021|19468877|P3|28-Week Treatment Period|Developed study withdrawal criteria|0
5637025|NCT00658021|19468878|P2|28-Week Treatment Period|Developed study withdrawal criteria|2
5637026|NCT00658021|19468879|P1|28-Week Treatment Period|Developed study withdrawal criteria|0
5637027|NCT00658021|19468877|P3|28-Week Treatment Period|Adverse Event|0
5637028|NCT00658021|19468878|P2|28-Week Treatment Period|Adverse Event|1
5637029|NCT00658021|19468879|P1|28-Week Treatment Period|Adverse Event|3
5637030|NCT00657709|19468914|P5|Overall Study|Protocol Violation|2
5637031|NCT00657709|19468915|P4|Overall Study|Protocol Violation|1
5637032|NCT00657709|19468916|P3|Overall Study|Protocol Violation|0
5637033|NCT00657709|19468917|P2|Overall Study|Protocol Violation|2
5637034|NCT00657709|19468918|P1|Overall Study|Protocol Violation|0
5637035|NCT00657709|19468914|P5|Overall Study|Lost to Follow-up|21
5637036|NCT00657709|19468915|P4|Overall Study|Lost to Follow-up|1
5637037|NCT00657709|19468916|P3|Overall Study|Lost to Follow-up|7
5637038|NCT00657709|19468917|P2|Overall Study|Lost to Follow-up|9
5637039|NCT00657709|19468918|P1|Overall Study|Lost to Follow-up|9
5637040|NCT00657709|19468914|P5|Overall Study|Withdrawal by Subject|9
5637041|NCT00657709|19468915|P4|Overall Study|Withdrawal by Subject|5
5637042|NCT00657709|19468916|P3|Overall Study|Withdrawal by Subject|15
5637043|NCT00657709|19468917|P2|Overall Study|Withdrawal by Subject|15
5637044|NCT00657709|19468918|P1|Overall Study|Withdrawal by Subject|7
5637045|NCT00657709|19468914|P5|Overall Study|AE or Death|1
5637046|NCT00657709|19468915|P4|Overall Study|AE or Death|7
5637047|NCT00657709|19468916|P3|Overall Study|AE or Death|6
5637048|NCT00657709|19468917|P2|Overall Study|AE or Death|7
5637049|NCT00657709|19468918|P1|Overall Study|AE or Death|7
5637050|NCT00657618|19468967|P1|Overall Study|didn't start due to schedule conflicts|1
5637051|NCT00657618|19468967|P1|Overall Study|negative for leishmaniasis|2
5637052|NCT00657618|19468967|P1|Overall Study|Withdrawal by Subject|8
5637053|NCT00657618|19468967|P1|Overall Study|Adverse Event|32
5637054|NCT00657553|19468979|P2|Overall Study|low accrual, no analysis run|5
5637055|NCT00657553|19468980|P1|Overall Study|low accrual, no analysis run|5
5637056|NCT00657540|19468988|P2|Overall Study|Lost to Follow-up|4
5637057|NCT00657540|19468989|P1|Overall Study|Lost to Follow-up|1
5637058|NCT00657371|19469003|P1|Overall Study|Pre-existing medical condition|4
5637059|NCT00657371|19469003|P1|Overall Study|Device- related reasons|13
5637060|NCT00657371|19469003|P1|Overall Study|Protocol Violation|2
5637061|NCT00657371|19469003|P1|Overall Study|Unable to intubate the cecum|5
5637062|NCT00657371|19469003|P1|Overall Study|Poor bowel preparation|15
5637063|NCT00657358|19469008|P1|Overall Study|Lack of Efficacy|6
5637064|NCT00657267|19469020|P1|Overall Study|Adverse Event|9
5637065|NCT00657267|19469020|P1|Overall Study|Progressive disease|45
5637066|NCT00657150|19469030|P2|Treatment|Other|15
5637067|NCT00657150|19469031|P1|Treatment|Other|13
5637068|NCT00657150|19469030|P2|Treatment|Withdrawal by Subject|20
5637069|NCT00657150|19469031|P1|Treatment|Withdrawal by Subject|23
5637070|NCT00657150|19469030|P2|Treatment|Lost to Follow-up|0
5637071|NCT00657150|19469031|P1|Treatment|Lost to Follow-up|1
5637072|NCT00657150|19469030|P2|Treatment|Non-compliant with protocol|9
5637073|NCT00657150|19469031|P1|Treatment|Non-compliant with protocol|10
5637074|NCT00657150|19469030|P2|Treatment|Adverse Event|53
5637075|NCT00657150|19469031|P1|Treatment|Adverse Event|60
5637076|NCT00657150|19469030|P2|Overall Study|Other|38
5637077|NCT00657150|19469031|P1|Overall Study|Other|38
5637078|NCT00657150|19469030|P2|Overall Study|Withdrawal by Subject|36
5637079|NCT00657150|19469031|P1|Overall Study|Withdrawal by Subject|51
5637080|NCT00657150|19469030|P2|Overall Study|Lost to Follow-up|0
5637081|NCT00657150|19469031|P1|Overall Study|Lost to Follow-up|2
5637082|NCT00657150|19469030|P2|Overall Study|Non-compliant with protocol|9
5637083|NCT00657150|19469031|P1|Overall Study|Non-compliant with protocol|5
5637084|NCT00657150|19469030|P2|Overall Study|Adverse Event|10
5637085|NCT00657150|19469031|P1|Overall Study|Adverse Event|19
5637086|NCT00657046|19469062|P3|Overall Study|Surgery|1
5637087|NCT00657046|19469063|P2|Overall Study|Surgery|0
5637088|NCT00657046|19469064|P1|Overall Study|Surgery|0
5637089|NCT00657046|19469062|P3|Overall Study|Death|1
5637090|NCT00657046|19469063|P2|Overall Study|Death|0
5637091|NCT00657046|19469064|P1|Overall Study|Death|0
5637092|NCT00657046|19469062|P3|Overall Study|Withdrawal by Subject|0
5637093|NCT00657046|19469063|P2|Overall Study|Withdrawal by Subject|0
5637094|NCT00657046|19469064|P1|Overall Study|Withdrawal by Subject|1
5637095|NCT00657046|19469062|P3|Overall Study|Protocol Violation|0
5637096|NCT00657046|19469063|P2|Overall Study|Protocol Violation|2
5637097|NCT00657046|19469064|P1|Overall Study|Protocol Violation|2
5637098|NCT00657046|19469062|P3|Overall Study|Adverse Event|0
5637099|NCT00657046|19469063|P2|Overall Study|Adverse Event|1
5637100|NCT00657046|19469064|P1|Overall Study|Adverse Event|1
5637101|NCT00657020|19469096|P2|PERIOD 1|Adverse Event|1
5637102|NCT00657020|19469097|P1|PERIOD 1|Adverse Event|0
5637103|NCT00656851|19469147|P2|Overall Study|Withdrawal by Subject|4
5637104|NCT00656851|19469148|P1|Overall Study|Withdrawal by Subject|0
5637105|NCT00656799|19469170|P1|Overall Study|Death|2
5637106|NCT00656669|19469192|P1|AC (Cycles 6-9)|Did not start segment 3|1
5637107|NCT00656669|19469192|P1|AC (Cycles 6-9)|Adverse Event|1
5637108|NCT00656669|19469192|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
5637109|NCT00656669|19469192|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
5637110|NCT00656617|19469231|P1|Overall Study|Move to different clinical trial|2
5637111|NCT00656617|19469231|P1|Overall Study|Insurance Issues|2
5637112|NCT00656617|19469231|P1|Overall Study|Death|2
5637113|NCT00656617|19469231|P1|Overall Study|Adverse Event|1
5637114|NCT00656513|19469240|P3|Overall Study|Missing baseline form|5
5637115|NCT00656513|19469241|P2|Overall Study|Missing baseline form|5
5637116|NCT00656513|19469242|P1|Overall Study|Missing baseline form|0
5637117|NCT00656513|19469240|P3|Overall Study|Treatment completed outside of timeframe|1
5637118|NCT00656513|19469241|P2|Overall Study|Treatment completed outside of timeframe|3
5637119|NCT00656513|19469242|P1|Overall Study|Treatment completed outside of timeframe|0
5637120|NCT00656513|19469240|P3|Overall Study|Incomplete treatment|0
5637121|NCT00656513|19469241|P2|Overall Study|Incomplete treatment|0
5637122|NCT00656513|19469242|P1|Overall Study|Incomplete treatment|3
5637123|NCT00656513|19469240|P3|Overall Study|Missing data|9
5637124|NCT00656513|19469241|P2|Overall Study|Missing data|11
5637125|NCT00656513|19469242|P1|Overall Study|Missing data|0
5637126|NCT00656513|19469240|P3|Overall Study|Death|1
5637127|NCT00656513|19469241|P2|Overall Study|Death|0
5637128|NCT00656513|19469242|P1|Overall Study|Death|0
5637129|NCT00656513|19469240|P3|Overall Study|Withdrawal by Subject|4
5637130|NCT00656513|19469241|P2|Overall Study|Withdrawal by Subject|11
5637131|NCT00656513|19469242|P1|Overall Study|Withdrawal by Subject|0
5637132|NCT00656513|19469240|P3|Overall Study|Protocol Violation|2
5637133|NCT00656513|19469241|P2|Overall Study|Protocol Violation|0
5637134|NCT00656513|19469242|P1|Overall Study|Protocol Violation|1
5637135|NCT00656474|19469289|P1|Overall Study|Other Reason|1
5637136|NCT00656370|19469307|P1|Overall Study|Alternates|3
5637137|NCT00656370|19469307|P1|Overall Study|Screen Failures|7
5637138|NCT00656292|19469336|P2|Overall Study|Screen failure|2
5637139|NCT00656292|19469337|P1|Overall Study|Screen failure|1
5637140|NCT00656292|19469336|P2|Overall Study|Withdrawal by Subject|3
5637141|NCT00656292|19469337|P1|Overall Study|Withdrawal by Subject|2
5637142|NCT00656175|19469364|P2|Overall Study|Transportation issues|1
5637143|NCT00656175|19469365|P1|Overall Study|Transportation issues|0
5637144|NCT00656175|19469364|P2|Overall Study|Adverse Event|0
5637145|NCT00656175|19469365|P1|Overall Study|Adverse Event|1
5637146|NCT00656136|19469373|P2|Overall Study|Unknown and others|4
5637147|NCT00656136|19469374|P1|Overall Study|Unknown and others|4
5637148|NCT00656136|19469373|P2|Overall Study|Patient refused to take study medication|10
5637149|NCT00656136|19469374|P1|Overall Study|Patient refused to take study medication|7
5637150|NCT00656136|19469373|P2|Overall Study|Protocol Violation|3
5637151|NCT00656136|19469374|P1|Overall Study|Protocol Violation|2
5637152|NCT00656136|19469373|P2|Overall Study|Other Adverse Event|51
5637153|NCT00656136|19469374|P1|Overall Study|Other Adverse Event|5
5637154|NCT00656136|19469373|P2|Overall Study|Progressive disease|322
5637155|NCT00656136|19469374|P1|Overall Study|Progressive disease|177
5637156|NCT00656084|19469384|P1|Overall Study|Investigator Request|1
5637157|NCT00656084|19469384|P1|Overall Study|Patient Request|1
5637158|NCT00656084|19469384|P1|Overall Study|Withdrawal by Subject|1
5637159|NCT00656084|19469384|P1|Overall Study|Adverse Event|4
5637160|NCT00656058|19469391|P1|Overall Study|Withdrawal by Subject|4
5637161|NCT00656058|19469391|P1|Overall Study|Withdrawal by Subject|2
5637162|NCT00656019|19469404|P4|Overall Study|Lost to Follow-up|0
5637163|NCT00656019|19469405|P3|Overall Study|Lost to Follow-up|0
5637164|NCT00656019|19469406|P2|Overall Study|Lost to Follow-up|1
5637165|NCT00656019|19469407|P1|Overall Study|Lost to Follow-up|2
5637166|NCT00656019|19469404|P4|Overall Study|Withdrawal by Subject|0
5637167|NCT00656019|19469405|P3|Overall Study|Withdrawal by Subject|0
5637168|NCT00656019|19469406|P2|Overall Study|Withdrawal by Subject|0
5637169|NCT00656019|19469407|P1|Overall Study|Withdrawal by Subject|2
5637170|NCT00656019|19469404|P4|Overall Study|Not Eligible|0
5637171|NCT00656019|19469405|P3|Overall Study|Not Eligible|0
5637172|NCT00656019|19469406|P2|Overall Study|Not Eligible|0
5637173|NCT00656019|19469407|P1|Overall Study|Not Eligible|10
5637174|NCT00655980|19469420|P3|Overall Study|surgery canceled; or subject or anesthes|5
5637175|NCT00655980|19469421|P2|Overall Study|surgery canceled; or subject or anesthes|31
5637176|NCT00655980|19469422|P1|Overall Study|surgery canceled; or subject or anesthes|26
5637177|NCT00655928|19469435|P2|Overall Study|Physician Decision|1
5637178|NCT00655928|19469436|P1|Overall Study|Physician Decision|1
5637179|NCT00655928|19469435|P2|Overall Study|Withdrawal by Subject|1
5637180|NCT00655928|19469436|P1|Overall Study|Withdrawal by Subject|2
5637181|NCT00655889|19469442|P1|Overall Study|Protocol Violation|1
5637182|NCT00655889|19469442|P1|Overall Study|Inadequate cell growth|1
5637183|NCT00655876|19469449|P2|Overall Study|Protocol Violation|7
5637184|NCT00655876|19469450|P1|Overall Study|Protocol Violation|9
5637185|NCT00655863|19469469|P3|Overall Study|Lost to Follow-up|1
5637186|NCT00655863|19469470|P2|Overall Study|Lost to Follow-up|0
5637187|NCT00655863|19469471|P1|Overall Study|Lost to Follow-up|0
5637188|NCT00655850|19469530|P1|Overall Study|Withdrawal by Subject|1
5637189|NCT00655850|19469530|P1|Overall Study|Death|2
5637190|NCT00655824|19469537|P1|Overall Study|Deterioration of Trial Disease|2
5637191|NCT00655824|19469537|P1|Overall Study|Withdrawal by Subject|4
5637192|NCT00655824|19469537|P1|Overall Study|Protocol Violation|1
5637193|NCT00655824|19469537|P1|Overall Study|Early Termination of Study by Sponsor|74
5637194|NCT00655824|19469537|P1|Overall Study|Adverse Event|3
5637195|NCT00655746|19469585|P1|Overall Study|Withdrawal by Subject|1
5637196|NCT00655733|19469604|P2|Overall Study|Physician Decision|1
5637197|NCT00655733|19469605|P1|Overall Study|Physician Decision|0
5637198|NCT00655733|19469604|P2|Overall Study|Withdrawal by Subject|3
5637199|NCT00655733|19469605|P1|Overall Study|Withdrawal by Subject|3
5637200|NCT00655733|19469604|P2|Overall Study|Adverse Event|2
5637201|NCT00655733|19469605|P1|Overall Study|Adverse Event|2
5637202|NCT00655733|19469604|P2|Overall Study|Lost to Follow-up|2
5637203|NCT00655733|19469605|P1|Overall Study|Lost to Follow-up|2
5637204|NCT00655668|19469638|P1|Overall Study|Withdrawal by Subject|2
5637205|NCT00655668|19469638|P1|Overall Study|New Lymphoma Treatment Started|4
5637206|NCT00655668|19469638|P1|Overall Study|Other|1
5637207|NCT00655668|19469638|P1|Overall Study|Study Terminated|9
5637208|NCT00655668|19469638|P1|Overall Study|Disease Progression|27
5637209|NCT00655668|19469638|P1|Overall Study|Death|5
5637210|NCT00655668|19469638|P1|Overall Study|Adverse Event|6
5637211|NCT00655629|19469665|P2|Overall Study|consent withdrawn|4
5637212|NCT00655629|19469666|P1|Overall Study|consent withdrawn|6
5637213|NCT00655629|19469665|P2|Overall Study|Protocol Violation|3
5637214|NCT00655629|19469666|P1|Overall Study|Protocol Violation|5
5637215|NCT00655629|19469665|P2|Overall Study|Lost to Follow-up|3
5637216|NCT00655629|19469666|P1|Overall Study|Lost to Follow-up|4
5637217|NCT00655629|19469665|P2|Overall Study|Lack of Efficacy|12
5637218|NCT00655629|19469666|P1|Overall Study|Lack of Efficacy|2
5637219|NCT00655629|19469665|P2|Overall Study|Adverse Event|1
5637220|NCT00655629|19469666|P1|Overall Study|Adverse Event|4
5637221|NCT00655564|19469702|P1|Overall Study|Desired Alternate Therapy|1
5637222|NCT00655564|19469702|P1|Overall Study|Lost to Follow-up|1
5637223|NCT00655564|19469702|P1|Overall Study|Adverse Event|1
5637224|NCT00655551|19469710|P3|Period 4 (up to 7 Days)|Adverse Event|0
5637225|NCT00655551|19469711|P2|Period 4 (up to 7 Days)|Adverse Event|2
5637226|NCT00655551|19469712|P1|Period 4 (up to 7 Days)|Adverse Event|0
5637227|NCT00655551|19469710|P3|Period 3 (up to 7 Days)|Adverse Event|4
5637228|NCT00655551|19469711|P2|Period 3 (up to 7 Days)|Adverse Event|0
5637229|NCT00655551|19469712|P1|Period 3 (up to 7 Days)|Adverse Event|0
5637230|NCT00655551|19469710|P3|Period 2 (up to 7 Days)|Adverse Event|0
5637231|NCT00655551|19469711|P2|Period 2 (up to 7 Days)|Adverse Event|1
5637232|NCT00655551|19469712|P1|Period 2 (up to 7 Days)|Adverse Event|0
5637233|NCT00655551|19469710|P3|All Periods Combined|Adverse Event|4
5637234|NCT00655551|19469711|P2|All Periods Combined|Adverse Event|3
5637235|NCT00655551|19469712|P1|All Periods Combined|Adverse Event|0
5637236|NCT00655486|19469749|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
5637237|NCT00655486|19469749|P1|Overall Study|Other: Could not tolerate BID dosing|1
5637238|NCT00655486|19469749|P1|Overall Study|Other: Pregnancy|1
5637239|NCT00655486|19469749|P1|Overall Study|Unsatisfactory compliance|2
5637240|NCT00655486|19469749|P1|Overall Study|Protocol Violation|1
5637241|NCT00655486|19469749|P1|Overall Study|Withdrawal by Subject|4
5637242|NCT00655486|19469749|P1|Overall Study|Lack of Efficacy|8
5637243|NCT00655486|19469749|P1|Overall Study|Adverse Event|10
5637244|NCT00655356|19469777|P2|Overall Study|Other Reason|0
5637245|NCT00655356|19469778|P1|Overall Study|Other Reason|1
5637246|NCT00655356|19469777|P2|Overall Study|Protocol Violation|1
5637247|NCT00655356|19469778|P1|Overall Study|Protocol Violation|2
5637248|NCT00655356|19469777|P2|Overall Study|Adverse Event|1
5637249|NCT00655356|19469778|P1|Overall Study|Adverse Event|1
5637250|NCT00655356|19469777|P2|Overall Study|Sponsor Request|4
5637251|NCT00655356|19469778|P1|Overall Study|Sponsor Request|10
5637252|NCT00655356|19469777|P2|Overall Study|Withdrawal by Subject|4
5637253|NCT00655356|19469778|P1|Overall Study|Withdrawal by Subject|3
5637254|NCT00654940|19469842|P2|Period 1|Intolerable Pain Level|0
5637255|NCT00654940|19469843|P1|Period 1|Intolerable Pain Level|1
5637256|NCT00654940|19469842|P2|Period 1|Adverse Event|1
5637257|NCT00654940|19469843|P1|Period 1|Adverse Event|0
5637258|NCT00654901|19469867|P4|Overall Study|Withdrawal by Subject|0
5637259|NCT00654901|19469868|P3|Overall Study|Withdrawal by Subject|1
5637260|NCT00654901|19469869|P2|Overall Study|Withdrawal by Subject|0
5637261|NCT00654901|19469870|P1|Overall Study|Withdrawal by Subject|3
5637262|NCT00654901|19469867|P4|Overall Study|Lost to Follow-up|0
5637263|NCT00654901|19469868|P3|Overall Study|Lost to Follow-up|1
5637264|NCT00654901|19469869|P2|Overall Study|Lost to Follow-up|0
5637265|NCT00654901|19469870|P1|Overall Study|Lost to Follow-up|1
5637266|NCT00654875|19469890|P2|Overall Study|Administrative Problems|0
5637267|NCT00654875|19469891|P1|Overall Study|Administrative Problems|1
5637268|NCT00654875|19469890|P2|Overall Study|Abnormal Test Procedure Result(s)|0
5637269|NCT00654875|19469891|P1|Overall Study|Abnormal Test Procedure Result(s)|1
5637270|NCT00654875|19469890|P2|Overall Study|Lost to Follow-up|3
5637271|NCT00654875|19469891|P1|Overall Study|Lost to Follow-up|1
5637272|NCT00654875|19469890|P2|Overall Study|Lack of Efficacy|2
5637273|NCT00654875|19469891|P1|Overall Study|Lack of Efficacy|2
5637274|NCT00654875|19469890|P2|Overall Study|Protocol Violation|3
5637275|NCT00654875|19469891|P1|Overall Study|Protocol Violation|3
5637276|NCT00654875|19469890|P2|Overall Study|Withdrawal by Subject|4
5637277|NCT00654875|19469891|P1|Overall Study|Withdrawal by Subject|4
5637278|NCT00654875|19469890|P2|Overall Study|Adverse Event|5
5637279|NCT00654875|19469891|P1|Overall Study|Adverse Event|5
5637280|NCT00654745|19469924|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
5637281|NCT00654745|19469924|P1|Overall Study|Withdrawal by Subject|10
5637282|NCT00654745|19469924|P1|Overall Study|Protocol Violation|11
5637283|NCT00654745|19469924|P1|Overall Study|Lost to Follow-up|7
5637284|NCT00654745|19469924|P1|Overall Study|Adverse Event|12
5637285|NCT00654732|19469964|P2|Overall Study|Adverse Event|6
5637286|NCT00654732|19469965|P1|Overall Study|Adverse Event|4
5637287|NCT00654641|19469978|P2|Overall Study|Lost to Follow-up|3
5637288|NCT00654641|19469979|P1|Overall Study|Lost to Follow-up|2
5637289|NCT00654628|19469985|P1|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
5637290|NCT00654628|19469985|P1|6 -Week Extension Period (Single Site)|Adverse Event|4
5637291|NCT00654628|19469985|P1|6-week Active Treatment Period|Out of window period|1
5637292|NCT00654628|19469985|P1|6-week Active Treatment Period|Transferred to branch hospital|1
5637293|NCT00654628|19469985|P1|6-week Active Treatment Period|Lost to Follow-up|10
5637294|NCT00654628|19469985|P1|6-week Active Treatment Period|Adverse Event|9
5637295|NCT00654498|19470034|P2|Overall Study|Other reason not defined above|5
5637296|NCT00654498|19470035|P1|Overall Study|Other reason not defined above|4
5637297|NCT00654498|19470034|P2|Overall Study|Withdrawal by Subject|0
5637298|NCT00654498|19470035|P1|Overall Study|Withdrawal by Subject|1
5637299|NCT00654498|19470034|P2|Overall Study|Lost to Follow-up|5
5637300|NCT00654498|19470035|P1|Overall Study|Lost to Follow-up|1
5637301|NCT00654498|19470034|P2|Overall Study|Protocol Violation|1
5637302|NCT00654498|19470035|P1|Overall Study|Protocol Violation|1
5637303|NCT00654498|19470034|P2|Overall Study|Adverse Event|1
5637304|NCT00654498|19470035|P1|Overall Study|Adverse Event|6
5637305|NCT00654498|19470034|P2|Overall Study|Not Treated|0
5637306|NCT00654498|19470035|P1|Overall Study|Not Treated|1
5637307|NCT00654420|19470067|P4|Phase II|Missing Disposition Record|0
5637308|NCT00654420|19470068|P3|Phase II|Missing Disposition Record|1
5637309|NCT00654420|19470069|P2|Phase II|Missing Disposition Record|0
5637310|NCT00654420|19470070|P1|Phase II|Missing Disposition Record|0
5637311|NCT00654420|19470067|P4|Phase II|Withdrawal by Subject|1
5637312|NCT00654420|19470068|P3|Phase II|Withdrawal by Subject|4
5637313|NCT00654420|19470069|P2|Phase II|Withdrawal by Subject|0
5637314|NCT00654420|19470070|P1|Phase II|Withdrawal by Subject|0
5637315|NCT00654420|19470067|P4|Phase II|Progressive Disease|29
5637316|NCT00654420|19470068|P3|Phase II|Progressive Disease|29
5637317|NCT00654420|19470069|P2|Phase II|Progressive Disease|0
5637318|NCT00654420|19470070|P1|Phase II|Progressive Disease|0
5637319|NCT00654420|19470067|P4|Phase II|Physician Decision|4
5637320|NCT00654420|19470068|P3|Phase II|Physician Decision|0
5637321|NCT00654420|19470069|P2|Phase II|Physician Decision|0
5637322|NCT00654420|19470070|P1|Phase II|Physician Decision|0
5637323|NCT00654420|19470067|P4|Phase II|Lost to Follow-up|1
5637324|NCT00654420|19470068|P3|Phase II|Lost to Follow-up|0
5637325|NCT00654420|19470069|P2|Phase II|Lost to Follow-up|0
5637326|NCT00654420|19470070|P1|Phase II|Lost to Follow-up|0
5637327|NCT00654420|19470067|P4|Phase II|Adverse Event|3
5637328|NCT00654420|19470068|P3|Phase II|Adverse Event|3
5637329|NCT00654420|19470069|P2|Phase II|Adverse Event|0
5637330|NCT00654420|19470070|P1|Phase II|Adverse Event|0
5637331|NCT00654420|19470067|P4|Phase I (Dose Escalation)|Progressive Disease|0
5637332|NCT00654420|19470068|P3|Phase I (Dose Escalation)|Progressive Disease|0
5637333|NCT00654420|19470069|P2|Phase I (Dose Escalation)|Progressive Disease|15
5637334|NCT00654420|19470070|P1|Phase I (Dose Escalation)|Progressive Disease|4
5637335|NCT00654420|19470067|P4|Phase I (Dose Escalation)|Adverse Event|0
5637336|NCT00654420|19470068|P3|Phase I (Dose Escalation)|Adverse Event|0
5637337|NCT00654420|19470069|P2|Phase I (Dose Escalation)|Adverse Event|1
5637338|NCT00654420|19470070|P1|Phase I (Dose Escalation)|Adverse Event|0
5637339|NCT00654381|19470096|P6|Extension Stage|Closure of the trial site|1
5637340|NCT00654381|19470097|P5|Extension Stage|Closure of the trial site|1
5637341|NCT00654381|19470098|P4|Extension Stage|Closure of the trial site|0
5637342|NCT00654381|19470099|P3|Extension Stage|Closure of the trial site|0
5637343|NCT00654381|19470100|P2|Extension Stage|Closure of the trial site|0
5637344|NCT00654381|19470101|P1|Extension Stage|Closure of the trial site|0
5637345|NCT00654381|19470096|P6|Extension Stage|Withdrawal by Subject|1
5637346|NCT00654381|19470097|P5|Extension Stage|Withdrawal by Subject|1
5637347|NCT00654381|19470098|P4|Extension Stage|Withdrawal by Subject|1
5637348|NCT00654381|19470099|P3|Extension Stage|Withdrawal by Subject|1
5637349|NCT00654381|19470100|P2|Extension Stage|Withdrawal by Subject|0
5637350|NCT00654381|19470101|P1|Extension Stage|Withdrawal by Subject|0
5637351|NCT00654381|19470096|P6|Extension Stage|Lack of Efficacy|0
5637352|NCT00654381|19470097|P5|Extension Stage|Lack of Efficacy|0
5637353|NCT00654381|19470098|P4|Extension Stage|Lack of Efficacy|0
5637354|NCT00654381|19470099|P3|Extension Stage|Lack of Efficacy|1
5637355|NCT00654381|19470100|P2|Extension Stage|Lack of Efficacy|0
5637356|NCT00654381|19470101|P1|Extension Stage|Lack of Efficacy|0
5637357|NCT00654381|19470096|P6|Extension Stage|Protocol Violation|0
5637358|NCT00654381|19470097|P5|Extension Stage|Protocol Violation|0
5637359|NCT00654381|19470098|P4|Extension Stage|Protocol Violation|1
5637360|NCT00654381|19470099|P3|Extension Stage|Protocol Violation|0
5637361|NCT00654381|19470100|P2|Extension Stage|Protocol Violation|0
5637362|NCT00654381|19470101|P1|Extension Stage|Protocol Violation|0
5637363|NCT00654381|19470096|P6|Extension Stage|Adverse Event|1
5637364|NCT00654381|19470097|P5|Extension Stage|Adverse Event|1
5637365|NCT00654381|19470098|P4|Extension Stage|Adverse Event|7
5637366|NCT00654381|19470099|P3|Extension Stage|Adverse Event|9
5637367|NCT00654381|19470100|P2|Extension Stage|Adverse Event|2
5637368|NCT00654381|19470101|P1|Extension Stage|Adverse Event|1
5637369|NCT00654381|19470096|P6|2nd Stage|Investigator's decision|0
5637370|NCT00654381|19470097|P5|2nd Stage|Investigator's decision|0
5637371|NCT00654381|19470098|P4|2nd Stage|Investigator's decision|1
5637372|NCT00654381|19470099|P3|2nd Stage|Investigator's decision|1
5637373|NCT00654381|19470100|P2|2nd Stage|Investigator's decision|0
5637374|NCT00654381|19470101|P1|2nd Stage|Investigator's decision|0
5637375|NCT00654381|19470096|P6|2nd Stage|Withdrawal by Subject|1
5637376|NCT00654381|19470097|P5|2nd Stage|Withdrawal by Subject|1
5637377|NCT00654381|19470098|P4|2nd Stage|Withdrawal by Subject|0
5637378|NCT00654381|19470099|P3|2nd Stage|Withdrawal by Subject|0
5637379|NCT00654381|19470100|P2|2nd Stage|Withdrawal by Subject|0
5637380|NCT00654381|19470101|P1|2nd Stage|Withdrawal by Subject|0
5637381|NCT00654381|19470096|P6|2nd Stage|Adverse Event|2
5637382|NCT00654381|19470097|P5|2nd Stage|Adverse Event|7
5637383|NCT00654381|19470098|P4|2nd Stage|Adverse Event|3
5637384|NCT00654381|19470099|P3|2nd Stage|Adverse Event|2
5637385|NCT00654381|19470100|P2|2nd Stage|Adverse Event|0
5637386|NCT00654381|19470101|P1|2nd Stage|Adverse Event|2
5637387|NCT00654381|19470096|P6|1st Stage|Investigator's decision|0
5637388|NCT00654381|19470097|P5|1st Stage|Investigator's decision|0
5637389|NCT00654381|19470098|P4|1st Stage|Investigator's decision|1
5637390|NCT00654381|19470099|P3|1st Stage|Investigator's decision|0
5637391|NCT00654381|19470100|P2|1st Stage|Investigator's decision|0
5637392|NCT00654381|19470101|P1|1st Stage|Investigator's decision|0
5637393|NCT00654381|19470096|P6|1st Stage|Withdrawal by Subject|1
5637394|NCT00654381|19470097|P5|1st Stage|Withdrawal by Subject|0
5637395|NCT00654381|19470098|P4|1st Stage|Withdrawal by Subject|1
5637396|NCT00654381|19470099|P3|1st Stage|Withdrawal by Subject|0
5637397|NCT00654381|19470100|P2|1st Stage|Withdrawal by Subject|0
5637398|NCT00654381|19470101|P1|1st Stage|Withdrawal by Subject|0
5637399|NCT00654381|19470096|P6|1st Stage|Adverse Event|1
5637400|NCT00654381|19470097|P5|1st Stage|Adverse Event|2
5637401|NCT00654381|19470098|P4|1st Stage|Adverse Event|3
5637402|NCT00654381|19470099|P3|1st Stage|Adverse Event|3
5637403|NCT00654381|19470100|P2|1st Stage|Adverse Event|3
5637404|NCT00654381|19470101|P1|1st Stage|Adverse Event|3
5637405|NCT00654368|19470138|P3|Overall Study|Adverse Event|6
5637406|NCT00654368|19470139|P2|Overall Study|Adverse Event|9
5637407|NCT00654368|19470140|P1|Overall Study|Adverse Event|14
5637408|NCT00654368|19470138|P3|Overall Study|Other|3
5637409|NCT00654368|19470139|P2|Overall Study|Other|2
5637410|NCT00654368|19470140|P1|Overall Study|Other|0
5637411|NCT00654368|19470138|P3|Overall Study|Pregnancy|2
5637412|NCT00654368|19470139|P2|Overall Study|Pregnancy|0
5637413|NCT00654368|19470140|P1|Overall Study|Pregnancy|0
5637414|NCT00654368|19470138|P3|Overall Study|Death|0
5637415|NCT00654368|19470139|P2|Overall Study|Death|0
5637416|NCT00654368|19470140|P1|Overall Study|Death|1
5637417|NCT00654368|19470138|P3|Overall Study|Physician Decision|2
5637418|NCT00654368|19470139|P2|Overall Study|Physician Decision|0
5637419|NCT00654368|19470140|P1|Overall Study|Physician Decision|0
5637420|NCT00654368|19470138|P3|Overall Study|Requirement for alternative therapy|1
5637421|NCT00654368|19470139|P2|Overall Study|Requirement for alternative therapy|1
5637422|NCT00654368|19470140|P1|Overall Study|Requirement for alternative therapy|1
5637423|NCT00654368|19470138|P3|Overall Study|Disease progression|13
5637424|NCT00654368|19470139|P2|Overall Study|Disease progression|31
5637425|NCT00654368|19470140|P1|Overall Study|Disease progression|21
5637426|NCT00654368|19470138|P3|Overall Study|Withdrawal by Subject|2
5637427|NCT00654368|19470139|P2|Overall Study|Withdrawal by Subject|2
5637428|NCT00654368|19470140|P1|Overall Study|Withdrawal by Subject|5
5637429|NCT00654368|19470138|P3|Overall Study|Non-compliance|2
5637430|NCT00654368|19470139|P2|Overall Study|Non-compliance|1
5637431|NCT00654368|19470140|P1|Overall Study|Non-compliance|2
5637432|NCT00654368|19470138|P3|Overall Study|Protocol deviation|1
5637433|NCT00654368|19470139|P2|Overall Study|Protocol deviation|2
5637434|NCT00654368|19470140|P1|Overall Study|Protocol deviation|3
5637435|NCT00654368|19470138|P3|Overall Study|Ineligibility determined|0
5637436|NCT00654368|19470139|P2|Overall Study|Ineligibility determined|0
5637437|NCT00654368|19470140|P1|Overall Study|Ineligibility determined|6
5637438|NCT00654355|19470173|P2|Overall Study|Lost to Follow-up|2
5637439|NCT00654355|19470174|P1|Overall Study|Lost to Follow-up|2
5637440|NCT00654238|19470205|P1|Overall Study|Screen Failures|4
5637441|NCT00654186|19470210|P1|Overall Study|Withdrawal by Subject|5
5637442|NCT00654095|19470235|P1|Overall Study|Did not meet inclusion criteria|1
5637443|NCT00654095|19470235|P1|Overall Study|Adverse reaction did not improve (5)|4
5637444|NCT00654095|19470235|P1|Overall Study|Elevated alanine aminotransferase (4)|7
5637445|NCT00654095|19470235|P1|Overall Study|Withdrawal by Subject|5
5637446|NCT00654095|19470235|P1|Overall Study|Adverse Event|11
5637447|NCT00654095|19470235|P1|Overall Study|Elevated alanine aminotransferase (3)|1
5637448|NCT00654095|19470235|P1|Overall Study|Elevated triglyceride level (2)|1
5637449|NCT00654095|19470235|P1|Overall Study|Drop in low density lipoprotein (1)|2
5637450|NCT00654004|19470258|P2|Overall Study|Lost to Follow-up|0
5637451|NCT00654004|19470259|P1|Overall Study|Lost to Follow-up|1
5637452|NCT00653991|19470275|P2|6 Month Follow-up|Participant would not respond|141
5637453|NCT00653991|19470276|P1|6 Month Follow-up|Participant would not respond|133
5637454|NCT00653991|19470275|P2|3 Month Follow-up|Participant would not respond|157
5637455|NCT00653991|19470276|P1|3 Month Follow-up|Participant would not respond|150
5637456|NCT00653939|19470288|P2|Overall Study|Other|6
5637457|NCT00653939|19470289|P1|Overall Study|Other|2
5637458|NCT00653939|19470288|P2|Overall Study|Disease Progression|3
5637459|NCT00653939|19470289|P1|Overall Study|Disease Progression|2
5637460|NCT00653939|19470288|P2|Overall Study|Physician Decision|0
5637461|NCT00653939|19470289|P1|Overall Study|Physician Decision|4
5637462|NCT00653939|19470288|P2|Overall Study|Withdrawal by Subject|3
5637463|NCT00653939|19470289|P1|Overall Study|Withdrawal by Subject|3
5637464|NCT00653939|19470288|P2|Overall Study|Adverse Event|3
5637465|NCT00653939|19470289|P1|Overall Study|Adverse Event|1
5637466|NCT00653523|19470314|P1|Overall Study|Adverse reaction did not improve (4)|1
5637467|NCT00653523|19470314|P1|Overall Study|Elevated alanine aminotransferase (3)|2
5637468|NCT00653523|19470314|P1|Overall Study|Withdrawal by Subject|6
5637469|NCT00653523|19470314|P1|Overall Study|Adverse Event|7
5637470|NCT00653523|19470314|P1|Overall Study|Elevated creatine phosphokinase (2)|1
5637471|NCT00653523|19470314|P1|Overall Study|Drop in low density lipoprotein (1)|2
5637472|NCT00653432|19470320|P2|Overall Study|Other - Reason Not Provided|3
5637473|NCT00653432|19470321|P1|Overall Study|Other - Reason Not Provided|5
5637474|NCT00653432|19470320|P2|Overall Study|Use/Need of Con Therapy|1
5637475|NCT00653432|19470321|P1|Overall Study|Use/Need of Con Therapy|2
5637476|NCT00653432|19470320|P2|Overall Study|Lost to Follow-up|6
5637477|NCT00653432|19470321|P1|Overall Study|Lost to Follow-up|7
5637478|NCT00653432|19470320|P2|Overall Study|Withdrawal by Subject|5
5637479|NCT00653432|19470321|P1|Overall Study|Withdrawal by Subject|4
5637480|NCT00653432|19470320|P2|Overall Study|Adverse Event|1
5637481|NCT00653432|19470321|P1|Overall Study|Adverse Event|4
5637482|NCT00653328|19470345|P1|Overall Study|Drug manufacturer no longing making drug|2
5637483|NCT00653328|19470345|P1|Overall Study|Disease progression|10
5637484|NCT00653328|19470345|P1|Overall Study|Adverse Event|2
5637485|NCT00653328|19470345|P1|Overall Study|Withdrawal by Subject|1
5637486|NCT00653263|19470352|P1|Overall Study|Physician Decision|1
5637487|NCT00653263|19470352|P1|Overall Study|Withdrawal by Subject|1
5637488|NCT00653224|19470360|P2|Overall Study|Other|4
5637489|NCT00653224|19470361|P1|Overall Study|Other|2
5637490|NCT00653224|19470360|P2|Overall Study|Lost to Follow-up|0
5637491|NCT00653224|19470361|P1|Overall Study|Lost to Follow-up|1
5637492|NCT00653224|19470360|P2|Overall Study|Loss of efficacy|0
5637493|NCT00653224|19470361|P1|Overall Study|Loss of efficacy|1
5637494|NCT00653224|19470360|P2|Overall Study|Lack of Efficacy|2
5637495|NCT00653224|19470361|P1|Overall Study|Lack of Efficacy|1
5637496|NCT00653224|19470360|P2|Overall Study|Adverse Event|1
5637497|NCT00653224|19470361|P1|Overall Study|Adverse Event|2
5637498|NCT00653159|19470547|P2|Overall Study|Lost to Follow-up|2
5637499|NCT00653159|19470548|P1|Overall Study|Lost to Follow-up|1
5637500|NCT00653159|19470547|P2|Overall Study|Adverse Event|1
5637501|NCT00653159|19470548|P1|Overall Study|Adverse Event|4
5637502|NCT00653068|19470575|P1|Overall Study|Ineligible|2
5637503|NCT00653068|19470575|P1|Overall Study|Withdrawal by Subject|1
5637504|NCT00653068|19470575|P1|Overall Study|Physician Decision|4
5637505|NCT00653068|19470575|P1|Overall Study|Lack of Efficacy|34
5637506|NCT00653068|19470575|P1|Overall Study|Death|9
5637507|NCT00652951|19470589|P3|Booster Phase|Other|0
5637508|NCT00652951|19470590|P2|Booster Phase|Other|0
5637509|NCT00652951|19470591|P1|Booster Phase|Other|1
5637510|NCT00652951|19470589|P3|Booster Phase|Adverse event, non-fatal|0
5637511|NCT00652951|19470590|P2|Booster Phase|Adverse event, non-fatal|1
5637512|NCT00652951|19470591|P1|Booster Phase|Adverse event, non-fatal|0
5637513|NCT00652938|19470728|P3|Overall Study|fear of blood sampling|0
5637514|NCT00652938|19470729|P2|Overall Study|fear of blood sampling|1
5637515|NCT00652938|19470730|P1|Overall Study|fear of blood sampling|0
5637516|NCT00652938|19470728|P3|Overall Study|Lost to Follow-up|2
5637517|NCT00652938|19470729|P2|Overall Study|Lost to Follow-up|0
5637518|NCT00652938|19470730|P1|Overall Study|Lost to Follow-up|0
5637519|NCT00652938|19470728|P3|Overall Study|Withdrawal by Subject|1
5637520|NCT00652938|19470729|P2|Overall Study|Withdrawal by Subject|6
5637521|NCT00652938|19470730|P1|Overall Study|Withdrawal by Subject|0
5637522|NCT00652938|19470728|P3|Overall Study|Adverse Event|2
5637523|NCT00652938|19470729|P2|Overall Study|Adverse Event|0
5637524|NCT00652938|19470730|P1|Overall Study|Adverse Event|1
5637525|NCT00652899|19470795|P1|Overall Study|Treating physician decision|1
5637526|NCT00652899|19470795|P1|Overall Study|Death|1
5637527|NCT00652834|19470805|P1|Overall Study|Lost to Follow-up|2
5637528|NCT00652834|19470805|P1|Overall Study|Withdrawal by Subject|3
5637529|NCT00652743|19470812|P3|Months 36-42|Other|8
5637530|NCT00652743|19470813|P2|Months 36-42|Other|2
5637531|NCT00652743|19470814|P1|Months 36-42|Other|4
5637532|NCT00652743|19470812|P3|Months 36-42|Migrated/moved from study area|0
5637533|NCT00652743|19470813|P2|Months 36-42|Migrated/moved from study area|0
5637534|NCT00652743|19470814|P1|Months 36-42|Migrated/moved from study area|1
5637535|NCT00652743|19470812|P3|Months 36-42|Lost to Follow-up|0
5637536|NCT00652743|19470813|P2|Months 36-42|Lost to Follow-up|1
5637537|NCT00652743|19470814|P1|Months 36-42|Lost to Follow-up|0
5637538|NCT00652743|19470812|P3|Months 36-42|Withdrawal by Subject|0
5637539|NCT00652743|19470813|P2|Months 36-42|Withdrawal by Subject|1
5637540|NCT00652743|19470814|P1|Months 36-42|Withdrawal by Subject|1
5637541|NCT00652743|19470812|P3|Months 36-42|Serious Adverse Events|1
5637542|NCT00652743|19470813|P2|Months 36-42|Serious Adverse Events|1
5637543|NCT00652743|19470814|P1|Months 36-42|Serious Adverse Events|0
5637544|NCT00652743|19470812|P3|Months 24-30|Other|11
5637545|NCT00652743|19470813|P2|Months 24-30|Other|1
5637546|NCT00652743|19470814|P1|Months 24-30|Other|5
5637547|NCT00652743|19470812|P3|Months 12-18|Lost to Follow-up|7
5637548|NCT00652743|19470813|P2|Months 12-18|Lost to Follow-up|2
5637549|NCT00652743|19470814|P1|Months 12-18|Lost to Follow-up|1
5637550|NCT00652626|19470896|P7|Extension Phase|Death|1
5637551|NCT00652626|19470897|P6|Extension Phase|Death|1
5637552|NCT00652626|19470898|P5|Extension Phase|Death|0
5637553|NCT00652626|19470899|P4|Extension Phase|Death|0
5637554|NCT00652626|19470900|P3|Extension Phase|Death|0
5637555|NCT00652626|19470901|P2|Extension Phase|Death|0
5637556|NCT00652626|19470902|P1|Extension Phase|Death|0
5637557|NCT00652626|19470896|P7|Extension Phase|Physician Decision|1
5637558|NCT00652626|19470897|P6|Extension Phase|Physician Decision|1
5637559|NCT00652626|19470898|P5|Extension Phase|Physician Decision|0
5637560|NCT00652626|19470899|P4|Extension Phase|Physician Decision|0
5637561|NCT00652626|19470900|P3|Extension Phase|Physician Decision|0
5637562|NCT00652626|19470901|P2|Extension Phase|Physician Decision|0
5637563|NCT00652626|19470902|P1|Extension Phase|Physician Decision|0
5637564|NCT00652626|19470896|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
5637565|NCT00652626|19470897|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
5637566|NCT00652626|19470898|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
5637567|NCT00652626|19470899|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
5637568|NCT00652626|19470900|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
5637569|NCT00652626|19470901|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
5637570|NCT00652626|19470902|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
5637571|NCT00652626|19470896|P7|Extension Phase|Adverse Event|1
5637572|NCT00652626|19470897|P6|Extension Phase|Adverse Event|2
5637573|NCT00652626|19470898|P5|Extension Phase|Adverse Event|0
5637574|NCT00652626|19470899|P4|Extension Phase|Adverse Event|0
5637575|NCT00652626|19470900|P3|Extension Phase|Adverse Event|0
5637576|NCT00652626|19470901|P2|Extension Phase|Adverse Event|0
5637577|NCT00652626|19470902|P1|Extension Phase|Adverse Event|0
5637578|NCT00652626|19470896|P7|Extension Phase|Withdrawal by Subject|0
5637579|NCT00652626|19470897|P6|Extension Phase|Withdrawal by Subject|2
5637580|NCT00652626|19470898|P5|Extension Phase|Withdrawal by Subject|0
5637581|NCT00652626|19470899|P4|Extension Phase|Withdrawal by Subject|0
5637582|NCT00652626|19470900|P3|Extension Phase|Withdrawal by Subject|0
5637583|NCT00652626|19470901|P2|Extension Phase|Withdrawal by Subject|0
5637584|NCT00652626|19470902|P1|Extension Phase|Withdrawal by Subject|0
5637585|NCT00652626|19470896|P7|Initial Treatment Phase|Lost to Follow-up|0
5637586|NCT00652626|19470897|P6|Initial Treatment Phase|Lost to Follow-up|0
5637587|NCT00652626|19470898|P5|Initial Treatment Phase|Lost to Follow-up|1
5637588|NCT00652626|19470899|P4|Initial Treatment Phase|Lost to Follow-up|0
5637589|NCT00652626|19470900|P3|Initial Treatment Phase|Lost to Follow-up|0
5637590|NCT00652626|19470901|P2|Initial Treatment Phase|Lost to Follow-up|0
5637591|NCT00652626|19470902|P1|Initial Treatment Phase|Lost to Follow-up|0
5637592|NCT00652626|19470896|P7|Initial Treatment Phase|Sponsor Request|0
5637593|NCT00652626|19470897|P6|Initial Treatment Phase|Sponsor Request|0
5637594|NCT00652626|19470898|P5|Initial Treatment Phase|Sponsor Request|0
5637595|NCT00652626|19470899|P4|Initial Treatment Phase|Sponsor Request|0
5637596|NCT00652626|19470900|P3|Initial Treatment Phase|Sponsor Request|1
5637597|NCT00652626|19470901|P2|Initial Treatment Phase|Sponsor Request|0
5637598|NCT00652626|19470902|P1|Initial Treatment Phase|Sponsor Request|0
5637599|NCT00652626|19470896|P7|Initial Treatment Phase|Physician Decision|0
5637600|NCT00652626|19470897|P6|Initial Treatment Phase|Physician Decision|0
5637601|NCT00652626|19470898|P5|Initial Treatment Phase|Physician Decision|1
5637602|NCT00652626|19470899|P4|Initial Treatment Phase|Physician Decision|0
5637603|NCT00652626|19470900|P3|Initial Treatment Phase|Physician Decision|0
5637604|NCT00652626|19470901|P2|Initial Treatment Phase|Physician Decision|0
5637605|NCT00652626|19470902|P1|Initial Treatment Phase|Physician Decision|0
5637606|NCT00652626|19470896|P7|Initial Treatment Phase|Protocol Violation|0
5637607|NCT00652626|19470897|P6|Initial Treatment Phase|Protocol Violation|0
5637608|NCT00652626|19470898|P5|Initial Treatment Phase|Protocol Violation|0
5637609|NCT00652626|19470899|P4|Initial Treatment Phase|Protocol Violation|1
5637610|NCT00652626|19470900|P3|Initial Treatment Phase|Protocol Violation|0
5637611|NCT00652626|19470901|P2|Initial Treatment Phase|Protocol Violation|0
5637612|NCT00652626|19470902|P1|Initial Treatment Phase|Protocol Violation|0
5637613|NCT00652626|19470896|P7|Initial Treatment Phase|Adverse Event|0
5637614|NCT00652626|19470897|P6|Initial Treatment Phase|Adverse Event|0
5637615|NCT00652626|19470898|P5|Initial Treatment Phase|Adverse Event|1
5637616|NCT00652626|19470899|P4|Initial Treatment Phase|Adverse Event|0
5637617|NCT00652626|19470900|P3|Initial Treatment Phase|Adverse Event|0
5637618|NCT00652626|19470901|P2|Initial Treatment Phase|Adverse Event|0
5637619|NCT00652626|19470902|P1|Initial Treatment Phase|Adverse Event|0
5637620|NCT00652366|19470971|P5|Overall Study|Other|0
5637621|NCT00652366|19470972|P4|Overall Study|Other|4
5637622|NCT00652366|19470973|P3|Overall Study|Other|3
5637623|NCT00652366|19470974|P2|Overall Study|Other|2
5637624|NCT00652366|19470975|P1|Overall Study|Other|5
5637625|NCT00652366|19470971|P5|Overall Study|Refused treatment|5
5637626|NCT00652366|19470972|P4|Overall Study|Refused treatment|17
5637627|NCT00652366|19470973|P3|Overall Study|Refused treatment|6
5637628|NCT00652366|19470974|P2|Overall Study|Refused treatment|7
5637629|NCT00652366|19470975|P1|Overall Study|Refused treatment|3
5637630|NCT00652366|19470971|P5|Overall Study|Protocol Violation|0
5637631|NCT00652366|19470972|P4|Overall Study|Protocol Violation|0
5637632|NCT00652366|19470973|P3|Overall Study|Protocol Violation|0
5637633|NCT00652366|19470974|P2|Overall Study|Protocol Violation|0
5637634|NCT00652366|19470975|P1|Overall Study|Protocol Violation|1
5637635|NCT00652366|19470971|P5|Overall Study|Violation of Selection Criteria|0
5637636|NCT00652366|19470972|P4|Overall Study|Violation of Selection Criteria|0
5637637|NCT00652366|19470973|P3|Overall Study|Violation of Selection Criteria|1
5637638|NCT00652366|19470974|P2|Overall Study|Violation of Selection Criteria|0
5637639|NCT00652366|19470975|P1|Overall Study|Violation of Selection Criteria|0
5637640|NCT00652366|19470971|P5|Overall Study|Lack of Efficacy|13
5637641|NCT00652366|19470972|P4|Overall Study|Lack of Efficacy|133
5637642|NCT00652366|19470973|P3|Overall Study|Lack of Efficacy|53
5637643|NCT00652366|19470974|P2|Overall Study|Lack of Efficacy|58
5637644|NCT00652366|19470975|P1|Overall Study|Lack of Efficacy|84
5637645|NCT00652366|19470971|P5|Overall Study|Death|5
5637646|NCT00652366|19470972|P4|Overall Study|Death|8
5637647|NCT00652366|19470973|P3|Overall Study|Death|1
5637648|NCT00652366|19470974|P2|Overall Study|Death|4
5637649|NCT00652366|19470975|P1|Overall Study|Death|5
5637650|NCT00652366|19470971|P5|Overall Study|Adverse Event|13
5637651|NCT00652366|19470972|P4|Overall Study|Adverse Event|17
5637652|NCT00652366|19470973|P3|Overall Study|Adverse Event|7
5637653|NCT00652366|19470974|P2|Overall Study|Adverse Event|4
5637654|NCT00652366|19470975|P1|Overall Study|Adverse Event|8
5637655|NCT00652340|19471010|P2|Overall Study|Had not progressed.|3
5637656|NCT00652340|19471011|P1|Overall Study|Had not progressed.|4
5637657|NCT00652327|19471021|P2|Overall Study|Lost to Follow-up|3
5637658|NCT00652327|19471022|P1|Overall Study|Lost to Follow-up|0
5637659|NCT00652327|19471021|P2|Overall Study|Adverse Event|2
5637660|NCT00652327|19471022|P1|Overall Study|Adverse Event|0
5637661|NCT00652093|19471064|P6|Overall Study|Physician Decision|0
5637662|NCT00652093|19471065|P5|Overall Study|Physician Decision|1
5637663|NCT00652093|19471066|P4|Overall Study|Physician Decision|0
5637664|NCT00652093|19471067|P3|Overall Study|Physician Decision|0
5637665|NCT00652093|19471068|P2|Overall Study|Physician Decision|0
5637666|NCT00652093|19471069|P1|Overall Study|Physician Decision|0
5637667|NCT00652093|19471064|P6|Overall Study|Withdrawal by Subject|0
5637668|NCT00652093|19471065|P5|Overall Study|Withdrawal by Subject|1
5637669|NCT00652093|19471066|P4|Overall Study|Withdrawal by Subject|0
5637670|NCT00652093|19471067|P3|Overall Study|Withdrawal by Subject|1
5637671|NCT00652093|19471068|P2|Overall Study|Withdrawal by Subject|0
5637672|NCT00652093|19471069|P1|Overall Study|Withdrawal by Subject|0
5637673|NCT00652028|19471159|P4|Overall Study|Physician Decision|0
5637674|NCT00652028|19471160|P3|Overall Study|Physician Decision|1
5637675|NCT00652028|19471161|P2|Overall Study|Physician Decision|0
5637676|NCT00652028|19471162|P1|Overall Study|Physician Decision|0
5637677|NCT00652028|19471159|P4|Overall Study|No Longer Meets Entry Criteria|0
5637678|NCT00652028|19471160|P3|Overall Study|No Longer Meets Entry Criteria|0
5637679|NCT00652028|19471161|P2|Overall Study|No Longer Meets Entry Criteria|1
5637680|NCT00652028|19471162|P1|Overall Study|No Longer Meets Entry Criteria|0
5637681|NCT00652028|19471159|P4|Overall Study|Adverse Event|0
5637682|NCT00652028|19471160|P3|Overall Study|Adverse Event|0
5637683|NCT00652028|19471161|P2|Overall Study|Adverse Event|0
5637684|NCT00652028|19471162|P1|Overall Study|Adverse Event|1
5637685|NCT00651937|19471206|P2|Overall Study|Withdrawal by Subject|1
5637686|NCT00651937|19471207|P1|Overall Study|Withdrawal by Subject|4
5637687|NCT00651924|19471217|P2|Overall Study|Withdrawal by Subject|5
5637688|NCT00651924|19471218|P1|Overall Study|Withdrawal by Subject|0
5637689|NCT00651924|19471217|P2|Overall Study|Withdrawal by PI|2
5637690|NCT00651924|19471218|P1|Overall Study|Withdrawal by PI|0
5637691|NCT00651820|19471224|P1|Overall Study|Lost to Follow-up|2
5637692|NCT00651755|19471256|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
5637693|NCT00651755|19471257|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
5637694|NCT00651755|19471256|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
5637695|NCT00651755|19471257|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
5637696|NCT00651664|19471283|P10|Overall Study|Reason not Specified|0
5637697|NCT00651664|19471284|P9|Overall Study|Reason not Specified|0
5637698|NCT00651664|19471285|P8|Overall Study|Reason not Specified|0
5637699|NCT00651664|19471286|P7|Overall Study|Reason not Specified|1
5637700|NCT00651664|19471287|P6|Overall Study|Reason not Specified|0
5637701|NCT00651664|19471288|P5|Overall Study|Reason not Specified|0
5637702|NCT00651664|19471289|P4|Overall Study|Reason not Specified|0
5637703|NCT00651664|19471290|P3|Overall Study|Reason not Specified|0
5637704|NCT00651664|19471291|P2|Overall Study|Reason not Specified|0
5637705|NCT00651664|19471292|P1|Overall Study|Reason not Specified|0
5637706|NCT00651664|19471283|P10|Overall Study|Symptomatic Deterioration|0
5637707|NCT00651664|19471284|P9|Overall Study|Symptomatic Deterioration|1
5637708|NCT00651664|19471285|P8|Overall Study|Symptomatic Deterioration|0
5637709|NCT00651664|19471286|P7|Overall Study|Symptomatic Deterioration|1
5637710|NCT00651664|19471287|P6|Overall Study|Symptomatic Deterioration|0
5637711|NCT00651664|19471288|P5|Overall Study|Symptomatic Deterioration|0
5637712|NCT00651664|19471289|P4|Overall Study|Symptomatic Deterioration|1
5637713|NCT00651664|19471290|P3|Overall Study|Symptomatic Deterioration|0
5637714|NCT00651664|19471291|P2|Overall Study|Symptomatic Deterioration|0
5637715|NCT00651664|19471292|P1|Overall Study|Symptomatic Deterioration|0
5637716|NCT00651664|19471283|P10|Overall Study|Patient Declined Further Treatment|1
5637717|NCT00651664|19471284|P9|Overall Study|Patient Declined Further Treatment|0
5637718|NCT00651664|19471285|P8|Overall Study|Patient Declined Further Treatment|0
5637719|NCT00651664|19471286|P7|Overall Study|Patient Declined Further Treatment|0
5637720|NCT00651664|19471287|P6|Overall Study|Patient Declined Further Treatment|1
5637721|NCT00651664|19471288|P5|Overall Study|Patient Declined Further Treatment|1
5637722|NCT00651664|19471289|P4|Overall Study|Patient Declined Further Treatment|1
5637723|NCT00651664|19471290|P3|Overall Study|Patient Declined Further Treatment|0
5637724|NCT00651664|19471291|P2|Overall Study|Patient Declined Further Treatment|0
5637725|NCT00651664|19471292|P1|Overall Study|Patient Declined Further Treatment|0
5637726|NCT00651664|19471283|P10|Overall Study|Progressive Disease|5
5637727|NCT00651664|19471284|P9|Overall Study|Progressive Disease|5
5637728|NCT00651664|19471285|P8|Overall Study|Progressive Disease|6
5637729|NCT00651664|19471286|P7|Overall Study|Progressive Disease|3
5637730|NCT00651664|19471287|P6|Overall Study|Progressive Disease|1
5637731|NCT00651664|19471288|P5|Overall Study|Progressive Disease|4
5637732|NCT00651664|19471289|P4|Overall Study|Progressive Disease|12
5637733|NCT00651664|19471290|P3|Overall Study|Progressive Disease|3
5637734|NCT00651664|19471291|P2|Overall Study|Progressive Disease|3
5637735|NCT00651664|19471292|P1|Overall Study|Progressive Disease|3
5637736|NCT00651664|19471283|P10|Overall Study|Unsatisfactory Therapeutic Response|1
5637737|NCT00651664|19471284|P9|Overall Study|Unsatisfactory Therapeutic Response|0
5637738|NCT00651664|19471285|P8|Overall Study|Unsatisfactory Therapeutic Response|1
5637739|NCT00651664|19471286|P7|Overall Study|Unsatisfactory Therapeutic Response|0
5637740|NCT00651664|19471287|P6|Overall Study|Unsatisfactory Therapeutic Response|1
5637741|NCT00651664|19471288|P5|Overall Study|Unsatisfactory Therapeutic Response|1
5637742|NCT00651664|19471289|P4|Overall Study|Unsatisfactory Therapeutic Response|0
5637743|NCT00651664|19471290|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5637744|NCT00651664|19471291|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5637745|NCT00651664|19471292|P1|Overall Study|Unsatisfactory Therapeutic Response|0
5637746|NCT00651664|19471283|P10|Overall Study|Occurrence of Adverse Event(s)|0
5637747|NCT00651664|19471284|P9|Overall Study|Occurrence of Adverse Event(s)|1
5637748|NCT00651664|19471285|P8|Overall Study|Occurrence of Adverse Event(s)|0
5637749|NCT00651664|19471286|P7|Overall Study|Occurrence of Adverse Event(s)|1
5637750|NCT00651664|19471287|P6|Overall Study|Occurrence of Adverse Event(s)|0
5637751|NCT00651664|19471288|P5|Overall Study|Occurrence of Adverse Event(s)|0
5637752|NCT00651664|19471289|P4|Overall Study|Occurrence of Adverse Event(s)|0
5637753|NCT00651664|19471290|P3|Overall Study|Occurrence of Adverse Event(s)|0
5637754|NCT00651664|19471291|P2|Overall Study|Occurrence of Adverse Event(s)|0
5637755|NCT00651664|19471292|P1|Overall Study|Occurrence of Adverse Event(s)|0
5637756|NCT00651313|19471464|P2|Overall Study|Adminstrative Discontinuation|3
5637757|NCT00651313|19471465|P1|Overall Study|Adminstrative Discontinuation|2
5637758|NCT00651313|19471464|P2|Overall Study|Lost to Follow-up|1
5637759|NCT00651313|19471465|P1|Overall Study|Lost to Follow-up|1
5637760|NCT00651313|19471464|P2|Overall Study|Withdrawal by Subject|1
5637761|NCT00651313|19471465|P1|Overall Study|Withdrawal by Subject|3
5637762|NCT00651313|19471464|P2|Overall Study|Adverse Event|1
5637763|NCT00651313|19471465|P1|Overall Study|Adverse Event|0
5637764|NCT00651261|19471473|P2|Overall Study|Never treated|3
5637765|NCT00651261|19471474|P1|Overall Study|Never treated|5
5637766|NCT00651261|19471473|P2|Overall Study|Other disease or participant decisions|23
5637767|NCT00651261|19471474|P1|Overall Study|Other disease or participant decisions|23
5637768|NCT00651261|19471473|P2|Overall Study|Alternative therapy|107
5637769|NCT00651261|19471474|P1|Overall Study|Alternative therapy|109
5637770|NCT00651261|19471473|P2|Overall Study|Disease progression|58
5637771|NCT00651261|19471474|P1|Overall Study|Disease progression|58
5637772|NCT00651261|19471473|P2|Overall Study|Induction failure|35
5637773|NCT00651261|19471474|P1|Overall Study|Induction failure|24
5637774|NCT00651261|19471473|P2|Overall Study|Withdrawal by Subject|40
5637775|NCT00651261|19471474|P1|Overall Study|Withdrawal by Subject|22
5637776|NCT00651261|19471473|P2|Overall Study|Death|18
5637777|NCT00651261|19471474|P1|Overall Study|Death|18
5637778|NCT00651261|19471473|P2|Overall Study|Adverse Event|22
5637779|NCT00651261|19471474|P1|Overall Study|Adverse Event|32
5637780|NCT00651183|19471490|P2|Overall Study|missing|0
5637781|NCT00651183|19471491|P1|Overall Study|missing|1
5637782|NCT00651183|19471490|P2|Overall Study|Other reasons|2
5637783|NCT00651183|19471491|P1|Overall Study|Other reasons|4
5637784|NCT00651183|19471490|P2|Overall Study|Lost to Follow-up|1
5637785|NCT00651183|19471491|P1|Overall Study|Lost to Follow-up|3
5637786|NCT00651183|19471490|P2|Overall Study|Withdrawal by Subject|3
5637787|NCT00651183|19471491|P1|Overall Study|Withdrawal by Subject|6
5637788|NCT00651183|19471490|P2|Overall Study|Tolerability insufficient +Patients wish|1
5637789|NCT00651183|19471491|P1|Overall Study|Tolerability insufficient +Patients wish|0
5637790|NCT00651183|19471490|P2|Overall Study|Tolerability insufficient|2
5637791|NCT00651183|19471491|P1|Overall Study|Tolerability insufficient|5
5637792|NCT00651183|19471490|P2|Overall Study|Efficacy insufficient + patients wish|1
5637793|NCT00651183|19471491|P1|Overall Study|Efficacy insufficient + patients wish|0
5637794|NCT00651183|19471490|P2|Overall Study|Lack of Efficacy|0
5637795|NCT00651183|19471491|P1|Overall Study|Lack of Efficacy|1
5637796|NCT00651157|19471503|P1|Overall Study|Protocol Violation|1
5637797|NCT00651157|19471503|P1|Overall Study|Death|1
5637798|NCT00651118|19471513|P4|Overall Study|Withdrawal by Subject|1
5637799|NCT00651118|19471514|P3|Overall Study|Withdrawal by Subject|1
5637800|NCT00651118|19471515|P2|Overall Study|Withdrawal by Subject|1
5637801|NCT00651118|19471516|P1|Overall Study|Withdrawal by Subject|0
5637802|NCT00651118|19471513|P4|Overall Study|administrative|1
5637803|NCT00651118|19471514|P3|Overall Study|administrative|2
5637804|NCT00651118|19471515|P2|Overall Study|administrative|4
5637805|NCT00651118|19471516|P1|Overall Study|administrative|1
5637806|NCT00651118|19471513|P4|Overall Study|Lost to Follow-up|2
5637807|NCT00651118|19471514|P3|Overall Study|Lost to Follow-up|1
5637808|NCT00651118|19471515|P2|Overall Study|Lost to Follow-up|0
5637809|NCT00651118|19471516|P1|Overall Study|Lost to Follow-up|2
5637810|NCT00651118|19471513|P4|Overall Study|Protocol Violation|2
5637811|NCT00651118|19471514|P3|Overall Study|Protocol Violation|6
5637812|NCT00651118|19471515|P2|Overall Study|Protocol Violation|2
5637813|NCT00651118|19471516|P1|Overall Study|Protocol Violation|2
5637814|NCT00651118|19471513|P4|Overall Study|Adverse Event|1
5637815|NCT00651118|19471514|P3|Overall Study|Adverse Event|1
5637816|NCT00651118|19471515|P2|Overall Study|Adverse Event|0
5637817|NCT00651118|19471516|P1|Overall Study|Adverse Event|4
5637818|NCT00650845|19471585|P2|Overall Study|Protocol Violation|13
5637819|NCT00650845|19471586|P1|Overall Study|Protocol Violation|0
5637820|NCT00650845|19471585|P2|Overall Study|Withdrawal by Subject|0
5637821|NCT00650845|19471586|P1|Overall Study|Withdrawal by Subject|5
5637822|NCT00650806|19471606|P4|Overall Study|Other|0
5637823|NCT00650806|19471607|P3|Overall Study|Other|2
5637824|NCT00650806|19471608|P2|Overall Study|Other|1
5637825|NCT00650806|19471609|P1|Overall Study|Other|1
5637826|NCT00650806|19471606|P4|Overall Study|Study terminated by sponsor|4
5637827|NCT00650806|19471607|P3|Overall Study|Study terminated by sponsor|5
5637828|NCT00650806|19471608|P2|Overall Study|Study terminated by sponsor|3
5637829|NCT00650806|19471609|P1|Overall Study|Study terminated by sponsor|2
5637830|NCT00650806|19471606|P4|Overall Study|Noncompliance with study drug regimen|0
5637831|NCT00650806|19471607|P3|Overall Study|Noncompliance with study drug regimen|0
5637832|NCT00650806|19471608|P2|Overall Study|Noncompliance with study drug regimen|1
5637833|NCT00650806|19471609|P1|Overall Study|Noncompliance with study drug regimen|1
5637834|NCT00650806|19471606|P4|Overall Study|Withdrawal by Subject|6
5637835|NCT00650806|19471607|P3|Overall Study|Withdrawal by Subject|8
5637836|NCT00650806|19471608|P2|Overall Study|Withdrawal by Subject|5
5637837|NCT00650806|19471609|P1|Overall Study|Withdrawal by Subject|7
5637838|NCT00650806|19471606|P4|Overall Study|Pregnancy|1
5637839|NCT00650806|19471607|P3|Overall Study|Pregnancy|0
5637840|NCT00650806|19471608|P2|Overall Study|Pregnancy|0
5637841|NCT00650806|19471609|P1|Overall Study|Pregnancy|0
5637842|NCT00650806|19471606|P4|Overall Study|Protocol Violation|1
5637843|NCT00650806|19471607|P3|Overall Study|Protocol Violation|0
5637844|NCT00650806|19471608|P2|Overall Study|Protocol Violation|0
5637845|NCT00650806|19471609|P1|Overall Study|Protocol Violation|0
5637846|NCT00650806|19471606|P4|Overall Study|Lost to Follow-up|10
5637847|NCT00650806|19471607|P3|Overall Study|Lost to Follow-up|11
5637848|NCT00650806|19471608|P2|Overall Study|Lost to Follow-up|6
5637849|NCT00650806|19471609|P1|Overall Study|Lost to Follow-up|7
5637850|NCT00650806|19471606|P4|Overall Study|Adverse Event|4
5637851|NCT00650806|19471607|P3|Overall Study|Adverse Event|3
5637852|NCT00650806|19471608|P2|Overall Study|Adverse Event|5
5637853|NCT00650806|19471609|P1|Overall Study|Adverse Event|0
5637854|NCT00650767|19471651|P4|Overall Study|Other|0
5637855|NCT00650767|19471652|P3|Overall Study|Other|0
5637856|NCT00650767|19471653|P2|Overall Study|Other|1
5637857|NCT00650767|19471654|P1|Overall Study|Other|1
5637858|NCT00650767|19471651|P4|Overall Study|Lost to Follow-up|0
5637859|NCT00650767|19471652|P3|Overall Study|Lost to Follow-up|1
5637860|NCT00650767|19471653|P2|Overall Study|Lost to Follow-up|1
5637861|NCT00650767|19471654|P1|Overall Study|Lost to Follow-up|1
5637862|NCT00650767|19471651|P4|Overall Study|Withdrawal by Subject|3
5637863|NCT00650767|19471652|P3|Overall Study|Withdrawal by Subject|3
5637864|NCT00650767|19471653|P2|Overall Study|Withdrawal by Subject|4
5637865|NCT00650767|19471654|P1|Overall Study|Withdrawal by Subject|2
5637866|NCT00650767|19471651|P4|Overall Study|Death|0
5637867|NCT00650767|19471652|P3|Overall Study|Death|0
5637868|NCT00650767|19471653|P2|Overall Study|Death|0
5637869|NCT00650767|19471654|P1|Overall Study|Death|1
5637870|NCT00650767|19471651|P4|Overall Study|Adverse Event|8
5637871|NCT00650767|19471652|P3|Overall Study|Adverse Event|10
5637872|NCT00650767|19471653|P2|Overall Study|Adverse Event|3
5637873|NCT00650767|19471654|P1|Overall Study|Adverse Event|0
5637874|NCT00650585|19472158|P2|Overall Study|Excluded/ruled ineligible|129
5637875|NCT00650585|19472159|P1|Overall Study|Excluded/ruled ineligible|357
5637876|NCT00650585|19472158|P2|Overall Study|No parental consent|866
5637877|NCT00650585|19472159|P1|Overall Study|No parental consent|935
5637878|NCT00650585|19472158|P2|Overall Study|Lost to Follow-up|482
5637879|NCT00650585|19472159|P1|Overall Study|Lost to Follow-up|505
5637880|NCT00650104|19472203|P1|Overall Study|Sponsor Terminated Dosing|1
5637881|NCT00650104|19472203|P1|Overall Study|Non-compliance|2
5637882|NCT00650104|19472203|P1|Overall Study|Lost to Follow-up|1
5637883|NCT00650104|19472203|P1|Overall Study|Physician Decision|7
5637884|NCT00650104|19472203|P1|Overall Study|Withdrawal by Subject|11
5637885|NCT00650104|19472203|P1|Overall Study|Death|2
5637886|NCT00650104|19472203|P1|Overall Study|Adverse Event|17
5637887|NCT00650091|19472218|P3|Amended Study Design|Other|0
5637888|NCT00650091|19472219|P2|Amended Study Design|Other|3
5637889|NCT00650091|19472220|P1|Amended Study Design|Other|1
5637890|NCT00650091|19472218|P3|Amended Study Design|Lung transplantation|0
5637891|NCT00650091|19472219|P2|Amended Study Design|Lung transplantation|2
5637892|NCT00650091|19472220|P1|Amended Study Design|Lung transplantation|4
5637893|NCT00650091|19472218|P3|Amended Study Design|Adverse Event|0
5637894|NCT00650091|19472219|P2|Amended Study Design|Adverse Event|4
5637895|NCT00650091|19472220|P1|Amended Study Design|Adverse Event|1
5637896|NCT00650091|19472218|P3|Amended Study Design|Physician Decision|0
5637897|NCT00650091|19472219|P2|Amended Study Design|Physician Decision|0
5637898|NCT00650091|19472220|P1|Amended Study Design|Physician Decision|5
5637899|NCT00650091|19472218|P3|Amended Study Design|Withdrawal by Subject|0
5637900|NCT00650091|19472219|P2|Amended Study Design|Withdrawal by Subject|11
5637901|NCT00650091|19472220|P1|Amended Study Design|Withdrawal by Subject|12
5637902|NCT00649428|19472263|P2|Overall Study|Physician Decision|1
5637903|NCT00649428|19472264|P1|Overall Study|Physician Decision|0
5637904|NCT00649428|19472263|P2|Overall Study|Protocol Violation|2
5637905|NCT00649428|19472264|P1|Overall Study|Protocol Violation|6
5637906|NCT00649428|19472263|P2|Overall Study|Insufficient manufacturing yield|1
5637907|NCT00649428|19472264|P1|Overall Study|Insufficient manufacturing yield|5
5637908|NCT00649428|19472263|P2|Overall Study|Lost to Follow-up|3
5637909|NCT00649428|19472264|P1|Overall Study|Lost to Follow-up|1
5637910|NCT00649428|19472263|P2|Overall Study|Withdrawal by Subject|6
5637911|NCT00649428|19472264|P1|Overall Study|Withdrawal by Subject|6
5637912|NCT00649428|19472263|P2|Overall Study|Adverse Event|2
5637913|NCT00649428|19472264|P1|Overall Study|Adverse Event|2
5637914|NCT00649389|19472280|P4|Overall Study|Other|6
5637915|NCT00649389|19472281|P3|Overall Study|Other|1
5637916|NCT00649389|19472282|P2|Overall Study|Other|9
5637917|NCT00649389|19472283|P1|Overall Study|Other|3
5637918|NCT00649389|19472280|P4|Overall Study|Withdrawal by Subject|23
5637919|NCT00649389|19472281|P3|Overall Study|Withdrawal by Subject|19
5637920|NCT00649389|19472282|P2|Overall Study|Withdrawal by Subject|21
5637921|NCT00649389|19472283|P1|Overall Study|Withdrawal by Subject|20
5637922|NCT00649389|19472280|P4|Overall Study|Protocol Violation|8
5637923|NCT00649389|19472281|P3|Overall Study|Protocol Violation|9
5637924|NCT00649389|19472282|P2|Overall Study|Protocol Violation|13
5637925|NCT00649389|19472283|P1|Overall Study|Protocol Violation|11
5637926|NCT00649389|19472280|P4|Overall Study|Lost to Follow-up|26
5637927|NCT00649389|19472281|P3|Overall Study|Lost to Follow-up|21
5637928|NCT00649389|19472282|P2|Overall Study|Lost to Follow-up|17
5637929|NCT00649389|19472283|P1|Overall Study|Lost to Follow-up|15
5637930|NCT00649389|19472280|P4|Overall Study|Adverse Event|48
5637931|NCT00649389|19472281|P3|Overall Study|Adverse Event|38
5637932|NCT00649389|19472282|P2|Overall Study|Adverse Event|46
5637933|NCT00649389|19472283|P1|Overall Study|Adverse Event|22
5637934|NCT00649220|19472305|P1|Overall Study|Withdrawal by Subject|1
5637935|NCT00649220|19472305|P1|Overall Study|Adverse Event|2
5637936|NCT00648895|19472326|P2|Overall Study|Lack of Efficacy|1
5637937|NCT00648895|19472327|P1|Overall Study|Lack of Efficacy|0
5637938|NCT00648739|19472333|P7|Overall Study|Follow-up Visits Not Completed|0
5637939|NCT00648739|19472334|P6|Overall Study|Follow-up Visits Not Completed|0
5637940|NCT00648739|19472335|P5|Overall Study|Follow-up Visits Not Completed|0
5637941|NCT00648739|19472336|P4|Overall Study|Follow-up Visits Not Completed|0
5637942|NCT00648739|19472337|P3|Overall Study|Follow-up Visits Not Completed|0
5637943|NCT00648739|19472338|P2|Overall Study|Follow-up Visits Not Completed|1
5637944|NCT00648739|19472339|P1|Overall Study|Follow-up Visits Not Completed|0
5637945|NCT00648739|19472333|P7|Overall Study|Positive Human Anti-human Antibody|0
5637946|NCT00648739|19472334|P6|Overall Study|Positive Human Anti-human Antibody|0
5637947|NCT00648739|19472335|P5|Overall Study|Positive Human Anti-human Antibody|0
5637948|NCT00648739|19472336|P4|Overall Study|Positive Human Anti-human Antibody|0
5637949|NCT00648739|19472337|P3|Overall Study|Positive Human Anti-human Antibody|1
5637950|NCT00648739|19472338|P2|Overall Study|Positive Human Anti-human Antibody|0
5637951|NCT00648739|19472339|P1|Overall Study|Positive Human Anti-human Antibody|0
5637952|NCT00648739|19472333|P7|Overall Study|Death|0
5637953|NCT00648739|19472334|P6|Overall Study|Death|0
5637954|NCT00648739|19472335|P5|Overall Study|Death|0
5637955|NCT00648739|19472336|P4|Overall Study|Death|0
5637956|NCT00648739|19472337|P3|Overall Study|Death|0
5637957|NCT00648739|19472338|P2|Overall Study|Death|1
5637958|NCT00648739|19472339|P1|Overall Study|Death|0
5637959|NCT00648739|19472333|P7|Overall Study|Investigator Considered it Advisable|1
5637960|NCT00648739|19472334|P6|Overall Study|Investigator Considered it Advisable|1
5637961|NCT00648739|19472335|P5|Overall Study|Investigator Considered it Advisable|0
5637962|NCT00648739|19472336|P4|Overall Study|Investigator Considered it Advisable|0
5637963|NCT00648739|19472337|P3|Overall Study|Investigator Considered it Advisable|0
5637964|NCT00648739|19472338|P2|Overall Study|Investigator Considered it Advisable|0
5637965|NCT00648739|19472339|P1|Overall Study|Investigator Considered it Advisable|0
5637966|NCT00648739|19472333|P7|Overall Study|Lack of Efficacy|0
5637967|NCT00648739|19472334|P6|Overall Study|Lack of Efficacy|2
5637968|NCT00648739|19472335|P5|Overall Study|Lack of Efficacy|1
5637969|NCT00648739|19472336|P4|Overall Study|Lack of Efficacy|0
5637970|NCT00648739|19472337|P3|Overall Study|Lack of Efficacy|0
5637971|NCT00648739|19472338|P2|Overall Study|Lack of Efficacy|0
5637972|NCT00648739|19472339|P1|Overall Study|Lack of Efficacy|0
5637973|NCT00648739|19472333|P7|Overall Study|Withdrawal by Subject|0
5637974|NCT00648739|19472334|P6|Overall Study|Withdrawal by Subject|2
5637975|NCT00648739|19472335|P5|Overall Study|Withdrawal by Subject|0
5637976|NCT00648739|19472336|P4|Overall Study|Withdrawal by Subject|0
5637977|NCT00648739|19472337|P3|Overall Study|Withdrawal by Subject|1
5637978|NCT00648739|19472338|P2|Overall Study|Withdrawal by Subject|0
5637979|NCT00648739|19472339|P1|Overall Study|Withdrawal by Subject|1
5637980|NCT00648739|19472333|P7|Overall Study|Adverse Event|0
5637981|NCT00648739|19472334|P6|Overall Study|Adverse Event|0
5637982|NCT00648739|19472335|P5|Overall Study|Adverse Event|1
5637983|NCT00648739|19472336|P4|Overall Study|Adverse Event|2
5637984|NCT00648739|19472337|P3|Overall Study|Adverse Event|1
5637985|NCT00648739|19472338|P2|Overall Study|Adverse Event|0
5637986|NCT00648739|19472339|P1|Overall Study|Adverse Event|1
5637987|NCT00648167|19472673|P1|Overall Study|unable to swallow tablets|1
5637988|NCT00648167|19472673|P1|Overall Study|Adverse Event|6
5637989|NCT00648037|19472693|P1|Overall Study|Other|1
5637990|NCT00648037|19472693|P1|Overall Study|Relapse|2
5637991|NCT00648037|19472693|P1|Overall Study|Adverse Event|11
5637992|NCT00648037|19472693|P1|Overall Study|Withdrawal by Subject|1
5637993|NCT00648037|19472693|P1|Overall Study|Not Treated|1
5637994|NCT00647699|19472712|P2|Overall Study|Withdrawal by Subject|8
5637995|NCT00647699|19472713|P1|Overall Study|Withdrawal by Subject|3
5637996|NCT00647699|19472712|P2|Overall Study|Lost to Follow-up|4
5637997|NCT00647699|19472713|P1|Overall Study|Lost to Follow-up|5
5637998|NCT00647556|19472721|P2|Overall Study|Surgery for pre-existing neck pain|0
5637999|NCT00647556|19472722|P1|Overall Study|Surgery for pre-existing neck pain|1
5638000|NCT00647556|19472721|P2|Overall Study|Withdrawal by Subject|0
5638001|NCT00647556|19472722|P1|Overall Study|Withdrawal by Subject|1
5638002|NCT00647556|19472721|P2|Overall Study|Protocol Violation|1
5638003|NCT00647556|19472722|P1|Overall Study|Protocol Violation|0
5638004|NCT00647556|19472721|P2|Overall Study|Lost to Follow-up|0
5638005|NCT00647556|19472722|P1|Overall Study|Lost to Follow-up|1
5638006|NCT00647556|19472721|P2|Overall Study|Adverse Event|1
5638007|NCT00647556|19472722|P1|Overall Study|Adverse Event|0
5638008|NCT00647426|19472736|P1|Overall Study|Withdrawal by Subject|2
5638009|NCT00647348|19472758|P2|Overall Study|Lost to Follow-up|6
5638010|NCT00647348|19472759|P1|Overall Study|Lost to Follow-up|3
5638011|NCT00647270|19472784|P3|Period 2, Placebo Switched to Adalimumab|Other|0
5638012|NCT00647270|19472785|P2|Period 2, Placebo Switched to Adalimumab|Other|6
5638013|NCT00647270|19472786|P1|Period 2, Placebo Switched to Adalimumab|Other|2
5638014|NCT00647270|19472784|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
5638015|NCT00647270|19472785|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
5638016|NCT00647270|19472786|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
5638017|NCT00647270|19472784|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
5638018|NCT00647270|19472785|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
5638019|NCT00647270|19472786|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
5638020|NCT00647270|19472784|P3|Period 1, Placebo-control (12 Weeks)|Other|8
5638021|NCT00647270|19472785|P2|Period 1, Placebo-control (12 Weeks)|Other|4
5638022|NCT00647270|19472786|P1|Period 1, Placebo-control (12 Weeks)|Other|4
5638023|NCT00647270|19472784|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
5638024|NCT00647270|19472785|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
5638025|NCT00647270|19472786|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
5638026|NCT00647270|19472784|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
5638027|NCT00647270|19472785|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
5638028|NCT00647270|19472786|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
5638029|NCT00647270|19472784|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
5638030|NCT00647270|19472785|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
5638031|NCT00647270|19472786|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
5638032|NCT00646958|19472812|P3|Overall Study|Did not receive study drug|2
5638033|NCT00646958|19472813|P2|Overall Study|Did not receive study drug|0
5638034|NCT00646958|19472814|P1|Overall Study|Did not receive study drug|2
5638035|NCT00646958|19472812|P3|Overall Study|Withdrawal by Subject|0
5638036|NCT00646958|19472813|P2|Overall Study|Withdrawal by Subject|2
5638037|NCT00646958|19472814|P1|Overall Study|Withdrawal by Subject|1
5638038|NCT00646958|19472812|P3|Overall Study|Abnormal screening lab tests|0
5638039|NCT00646958|19472813|P2|Overall Study|Abnormal screening lab tests|1
5638040|NCT00646958|19472814|P1|Overall Study|Abnormal screening lab tests|1
5638041|NCT00646958|19472812|P3|Overall Study|Protocol Violation|0
5638042|NCT00646958|19472813|P2|Overall Study|Protocol Violation|1
5638043|NCT00646958|19472814|P1|Overall Study|Protocol Violation|1
5638044|NCT00646958|19472812|P3|Overall Study|Lost to Follow-up|7
5638045|NCT00646958|19472813|P2|Overall Study|Lost to Follow-up|5
5638046|NCT00646958|19472814|P1|Overall Study|Lost to Follow-up|1
5638047|NCT00646958|19472812|P3|Overall Study|Adverse Event|0
5638048|NCT00646958|19472813|P2|Overall Study|Adverse Event|0
5638049|NCT00646958|19472814|P1|Overall Study|Adverse Event|4
5638050|NCT00646958|19472812|P3|Overall Study|Lack of Efficacy|0
5638051|NCT00646958|19472813|P2|Overall Study|Lack of Efficacy|0
5638052|NCT00646958|19472814|P1|Overall Study|Lack of Efficacy|1
5638053|NCT00646906|19472829|P7|Crossover Period 2|Physician Decision|1
5638054|NCT00646906|19472830|P6|Crossover Period 2|Physician Decision|0
5638055|NCT00646906|19472831|P5|Crossover Period 2|Physician Decision|0
5638056|NCT00646906|19472832|P4|Crossover Period 2|Physician Decision|0
5638057|NCT00646906|19472833|P3|Crossover Period 2|Physician Decision|0
5638058|NCT00646906|19472834|P2|Crossover Period 2|Physician Decision|0
5638059|NCT00646906|19472835|P1|Crossover Period 2|Physician Decision|0
5638060|NCT00646906|19472829|P7|Crossover Period 2|Withdrawal by Subject|0
5638061|NCT00646906|19472830|P6|Crossover Period 2|Withdrawal by Subject|0
5638062|NCT00646906|19472831|P5|Crossover Period 2|Withdrawal by Subject|0
5638063|NCT00646906|19472832|P4|Crossover Period 2|Withdrawal by Subject|1
5638064|NCT00646906|19472833|P3|Crossover Period 2|Withdrawal by Subject|2
5638065|NCT00646906|19472834|P2|Crossover Period 2|Withdrawal by Subject|1
5638066|NCT00646906|19472835|P1|Crossover Period 2|Withdrawal by Subject|0
5638067|NCT00646906|19472829|P7|Crossover Period 1|Withdrawal by Subject|0
5638068|NCT00646906|19472830|P6|Crossover Period 1|Withdrawal by Subject|1
5638069|NCT00646906|19472831|P5|Crossover Period 1|Withdrawal by Subject|0
5638070|NCT00646906|19472832|P4|Crossover Period 1|Withdrawal by Subject|0
5638071|NCT00646906|19472833|P3|Crossover Period 1|Withdrawal by Subject|0
5638072|NCT00646906|19472834|P2|Crossover Period 1|Withdrawal by Subject|0
5638073|NCT00646906|19472835|P1|Crossover Period 1|Withdrawal by Subject|1
5638074|NCT00646776|19472854|P2|Overall Study|Investigator discretion|4
5638075|NCT00646776|19472855|P1|Overall Study|Investigator discretion|0
5638076|NCT00646776|19472854|P2|Overall Study|Adverse Event|9
5638077|NCT00646776|19472855|P1|Overall Study|Adverse Event|1
5638078|NCT00646399|19472953|P2|Overall Study|Other Reason|11
5638079|NCT00646399|19472954|P1|Overall Study|Other Reason|11
5638080|NCT00646399|19472953|P2|Overall Study|Withdrawal by Subject|10
5638081|NCT00646399|19472954|P1|Overall Study|Withdrawal by Subject|9
5638082|NCT00646399|19472953|P2|Overall Study|Death|53
5638083|NCT00646399|19472954|P1|Overall Study|Death|63
5638084|NCT00646282|19472962|P2|Overall Study|Protocol terminated|4
5638085|NCT00646282|19472963|P1|Overall Study|Protocol terminated|4
5638086|NCT00646113|19472969|P1|Overall Study|Adverse Event|3
5638087|NCT00646113|19472969|P1|Overall Study|Lost to Follow-up|5
5638088|NCT00645944|19472990|P2|Received Medication|Protocol Violation|1
5638089|NCT00645944|19472991|P1|Received Medication|Protocol Violation|2
5638090|NCT00645944|19472990|P2|Received Medication|Lost to Follow-up|0
5638091|NCT00645944|19472991|P1|Received Medication|Lost to Follow-up|1
5638092|NCT00645944|19472990|P2|Received Medication|Withdrawal by Subject|1
5638093|NCT00645944|19472991|P1|Received Medication|Withdrawal by Subject|1
5638094|NCT00645944|19472990|P2|Received Medication|Adverse Event|1
5638095|NCT00645944|19472991|P1|Received Medication|Adverse Event|2
5638096|NCT00645944|19472990|P2|Randomized|Withdrawal by Subject|2
5638097|NCT00645944|19472991|P1|Randomized|Withdrawal by Subject|1
5638098|NCT00645853|19472999|P2|Overall Study|recall of ICF, planned operation, death|4
5638099|NCT00645853|19473000|P1|Overall Study|recall of ICF, planned operation, death|7
5638100|NCT00645853|19472999|P2|Overall Study|Discontinuation criteria|2
5638101|NCT00645853|19473000|P1|Overall Study|Discontinuation criteria|2
5638102|NCT00645853|19472999|P2|Overall Study|Protocol Violation|2
5638103|NCT00645853|19473000|P1|Overall Study|Protocol Violation|0
5638104|NCT00645853|19472999|P2|Overall Study|Withdrawal by Subject|2
5638105|NCT00645853|19473000|P1|Overall Study|Withdrawal by Subject|5
5638106|NCT00645853|19472999|P2|Overall Study|AZ study closure in Hungary|40
5638107|NCT00645853|19473000|P1|Overall Study|AZ study closure in Hungary|60
5638108|NCT00645853|19472999|P2|Overall Study|Adverse Event|7
5638109|NCT00645853|19473000|P1|Overall Study|Adverse Event|18
5638110|NCT00645840|19473018|P1|Overall Study|Protocol Violation|3
5638111|NCT00645788|19473036|P4|Overall Study|Pulmonary exacerbation|9
5638112|NCT00645788|19473037|P3|Overall Study|Pulmonary exacerbation|11
5638113|NCT00645788|19473038|P2|Overall Study|Pulmonary exacerbation|16
5638114|NCT00645788|19473039|P1|Overall Study|Pulmonary exacerbation|13
5638115|NCT00645788|19473036|P4|Overall Study|Withdrawal by Subject|2
5638116|NCT00645788|19473037|P3|Overall Study|Withdrawal by Subject|0
5638117|NCT00645788|19473038|P2|Overall Study|Withdrawal by Subject|1
5638118|NCT00645788|19473039|P1|Overall Study|Withdrawal by Subject|0
5638119|NCT00645788|19473036|P4|Overall Study|Protocol Violation|0
5638120|NCT00645788|19473037|P3|Overall Study|Protocol Violation|2
5638121|NCT00645788|19473038|P2|Overall Study|Protocol Violation|0
5638122|NCT00645788|19473039|P1|Overall Study|Protocol Violation|1
5638123|NCT00645788|19473036|P4|Overall Study|Lost to Follow-up|0
5638124|NCT00645788|19473037|P3|Overall Study|Lost to Follow-up|0
5638125|NCT00645788|19473038|P2|Overall Study|Lost to Follow-up|0
5638126|NCT00645788|19473039|P1|Overall Study|Lost to Follow-up|1
5638127|NCT00645788|19473036|P4|Overall Study|Adverse Event|3
5638128|NCT00645788|19473037|P3|Overall Study|Adverse Event|5
5638129|NCT00645788|19473038|P2|Overall Study|Adverse Event|9
5638130|NCT00645788|19473039|P1|Overall Study|Adverse Event|4
5638131|NCT00645788|19473036|P4|Overall Study|Did not receive study drug|0
5638132|NCT00645788|19473037|P3|Overall Study|Did not receive study drug|0
5638133|NCT00645788|19473038|P2|Overall Study|Did not receive study drug|1
5638134|NCT00645788|19473039|P1|Overall Study|Did not receive study drug|1
5638135|NCT00645671|19473117|P2|Overall Study|Physician Decision|1
5638136|NCT00645671|19473118|P1|Overall Study|Physician Decision|0
5638137|NCT00645671|19473117|P2|Overall Study|Adverse Event|1
5638138|NCT00645671|19473118|P1|Overall Study|Adverse Event|0
5638139|NCT00645671|19473117|P2|Overall Study|Withdrawal by Subject|4
5638140|NCT00645671|19473118|P1|Overall Study|Withdrawal by Subject|0
5638141|NCT00645671|19473117|P2|Overall Study|Protocol Violation|0
5638142|NCT00645671|19473118|P1|Overall Study|Protocol Violation|1
5638143|NCT00645593|19473132|P2|Overall Study|Later found to be ineligible|0
5638144|NCT00645593|19473133|P1|Overall Study|Later found to be ineligible|1
5638145|NCT00645567|19473145|P1|Overall Study|Adverse Event|1
5638146|NCT00645528|19473153|P1|Overall Study|Did not show up for Visit 2|7
5638147|NCT00645411|19473175|P4|Overall Study|Unable to classify|4
5638148|NCT00645411|19473176|P3|Overall Study|Unable to classify|3
5638149|NCT00645411|19473177|P2|Overall Study|Unable to classify|0
5638150|NCT00645411|19473178|P1|Overall Study|Unable to classify|0
5638151|NCT00645411|19473175|P4|Overall Study|Inappropriate enrollment|1
5638152|NCT00645411|19473176|P3|Overall Study|Inappropriate enrollment|4
5638153|NCT00645411|19473177|P2|Overall Study|Inappropriate enrollment|0
5638154|NCT00645411|19473178|P1|Overall Study|Inappropriate enrollment|0
5638155|NCT00645411|19473175|P4|Overall Study|Protocol Violation|0
5638156|NCT00645411|19473176|P3|Overall Study|Protocol Violation|1
5638157|NCT00645411|19473177|P2|Overall Study|Protocol Violation|0
5638158|NCT00645411|19473178|P1|Overall Study|Protocol Violation|1
5638159|NCT00645411|19473175|P4|Overall Study|Lost to Follow-up|75
5638160|NCT00645411|19473176|P3|Overall Study|Lost to Follow-up|124
5638161|NCT00645411|19473177|P2|Overall Study|Lost to Follow-up|5
5638162|NCT00645411|19473178|P1|Overall Study|Lost to Follow-up|10
5638163|NCT00645411|19473175|P4|Overall Study|Withdrawal by Subject|21
5638164|NCT00645411|19473176|P3|Overall Study|Withdrawal by Subject|19
5638165|NCT00645411|19473177|P2|Overall Study|Withdrawal by Subject|1
5638166|NCT00645411|19473178|P1|Overall Study|Withdrawal by Subject|2
5638167|NCT00645411|19473175|P4|Overall Study|Adverse Event|2
5638168|NCT00645411|19473176|P3|Overall Study|Adverse Event|0
5638169|NCT00645411|19473177|P2|Overall Study|Adverse Event|0
5638170|NCT00645411|19473178|P1|Overall Study|Adverse Event|0
5638171|NCT00645164|19473220|P1|Overall Study|Protocol Violation|1
5638172|NCT00645164|19473220|P1|Overall Study|Withdrawal by Subject|4
5638173|NCT00645164|19473220|P1|Overall Study|Lost to Follow-up|2
5638174|NCT00645099|19473226|P2|Overall Study|Other|5
5638175|NCT00645099|19473227|P1|Overall Study|Other|9
5638176|NCT00645099|19473226|P2|Overall Study|Adverse Event|5
5638177|NCT00645099|19473227|P1|Overall Study|Adverse Event|11
5638178|NCT00645099|19473226|P2|Overall Study|Lost to Follow-up|4
5638179|NCT00645099|19473227|P1|Overall Study|Lost to Follow-up|6
5638180|NCT00645099|19473226|P2|Overall Study|Withdrawal by Subject|22
5638181|NCT00645099|19473227|P1|Overall Study|Withdrawal by Subject|30
5638182|NCT00645099|19473226|P2|Overall Study|Lack of Efficacy|6
5638183|NCT00645099|19473227|P1|Overall Study|Lack of Efficacy|15
5638184|NCT00644995|19473296|P2|Overall Study|Refused|0
5638185|NCT00644995|19473297|P1|Overall Study|Refused|1
5638186|NCT00644995|19473296|P2|Overall Study|Lost to Follow-up|4
5638187|NCT00644995|19473297|P1|Overall Study|Lost to Follow-up|1
5638188|NCT00644969|19473317|P2|Post Treatment Phase|Other|0
5638189|NCT00644969|19473318|P1|Post Treatment Phase|Other|1
5638190|NCT00644969|19473317|P2|Post Treatment Phase|Lost to Follow-up|1
5638191|NCT00644969|19473318|P1|Post Treatment Phase|Lost to Follow-up|4
5638192|NCT00644969|19473317|P2|Post Treatment Phase|Withdrawal by Subject|2
5638193|NCT00644969|19473318|P1|Post Treatment Phase|Withdrawal by Subject|4
5638194|NCT00644969|19473317|P2|Post Treatment Phase|Death|0
5638195|NCT00644969|19473318|P1|Post Treatment Phase|Death|1
5638196|NCT00644969|19473317|P2|Treatment Phase|Other|1
5638197|NCT00644969|19473318|P1|Treatment Phase|Other|4
5638198|NCT00644969|19473317|P2|Treatment Phase|Lost to Follow-up|2
5638199|NCT00644969|19473318|P1|Treatment Phase|Lost to Follow-up|2
5638200|NCT00644969|19473317|P2|Treatment Phase|Withdrawal by Subject|0
5638201|NCT00644969|19473318|P1|Treatment Phase|Withdrawal by Subject|4
5638202|NCT00644969|19473317|P2|Treatment Phase|Adverse Event|0
5638203|NCT00644969|19473318|P1|Treatment Phase|Adverse Event|3
5638204|NCT00644969|19473317|P2|Treatment Phase|Randomized, not treated|0
5638205|NCT00644969|19473318|P1|Treatment Phase|Randomized, not treated|1
5638206|NCT00644917|19473364|P1|Overall Study|Withdrawal by Subject|2
5638207|NCT00644787|19473372|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
5638208|NCT00644787|19473373|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
5638209|NCT00644787|19473374|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
5638210|NCT00644787|19473372|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
5638211|NCT00644787|19473373|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
5638212|NCT00644787|19473374|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
5638213|NCT00644787|19473372|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
5638214|NCT00644787|19473373|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
5638215|NCT00644787|19473374|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
5638216|NCT00644787|19473372|P3|Period 2: Double Blind Phase|Adverse Event|4
5638217|NCT00644787|19473373|P2|Period 2: Double Blind Phase|Adverse Event|2
5638218|NCT00644787|19473374|P1|Period 2: Double Blind Phase|Adverse Event|0
5638219|NCT00644787|19473372|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
5638220|NCT00644787|19473373|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
5638221|NCT00644787|19473374|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
5638222|NCT00644787|19473372|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
5638223|NCT00644787|19473373|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
5638224|NCT00644787|19473374|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
5638225|NCT00644787|19473372|P3|Period 1: Titration Phase|Worsening of symptoms|0
5638226|NCT00644787|19473373|P2|Period 1: Titration Phase|Worsening of symptoms|0
5638227|NCT00644787|19473374|P1|Period 1: Titration Phase|Worsening of symptoms|1
5638228|NCT00644787|19473372|P3|Period 1: Titration Phase|Worsening of complications|0
5638229|NCT00644787|19473373|P2|Period 1: Titration Phase|Worsening of complications|0
5638230|NCT00644787|19473374|P1|Period 1: Titration Phase|Worsening of complications|1
5638231|NCT00644787|19473372|P3|Period 1: Titration Phase|Worsening of underlying disease|0
5638232|NCT00644787|19473373|P2|Period 1: Titration Phase|Worsening of underlying disease|0
5638233|NCT00644787|19473374|P1|Period 1: Titration Phase|Worsening of underlying disease|5
5638234|NCT00644787|19473372|P3|Period 1: Titration Phase|Physician Decision|0
5638235|NCT00644787|19473373|P2|Period 1: Titration Phase|Physician Decision|0
5638236|NCT00644787|19473374|P1|Period 1: Titration Phase|Physician Decision|1
5638237|NCT00644787|19473372|P3|Period 1: Titration Phase|Withdrawal by Subject|0
5638238|NCT00644787|19473373|P2|Period 1: Titration Phase|Withdrawal by Subject|0
5638239|NCT00644787|19473374|P1|Period 1: Titration Phase|Withdrawal by Subject|2
5638240|NCT00644787|19473372|P3|Period 1: Titration Phase|Adverse Event|0
5638241|NCT00644787|19473373|P2|Period 1: Titration Phase|Adverse Event|0
5638242|NCT00644787|19473374|P1|Period 1: Titration Phase|Adverse Event|11
5638243|NCT00644423|19473418|P2|Overall Study|Lost to Follow-up|1
5638244|NCT00644423|19473419|P1|Overall Study|Lost to Follow-up|1
5638245|NCT00644358|19473437|P1|Overall Study|Other Unspecified|11
5638246|NCT00644358|19473437|P1|Overall Study|Noncompliance|14
5638247|NCT00644358|19473437|P1|Overall Study|Protocol Violation|5
5638248|NCT00644358|19473437|P1|Overall Study|Lack of Effectiveness|39
5638249|NCT00644358|19473437|P1|Overall Study|Consent Withdrawal|64
5638250|NCT00644358|19473437|P1|Overall Study|Lost to Follow-up|105
5638251|NCT00644358|19473437|P1|Overall Study|Adverse Event|124
5638252|NCT00644332|19473444|P1|Overall Study|Could Not Attend Scheduled Visits|1
5638253|NCT00644332|19473444|P1|Overall Study|Did Not Meet Eligibility Requirements|1
5638254|NCT00644332|19473444|P1|Overall Study|Completion Status Unknown|2
5638255|NCT00644332|19473444|P1|Overall Study|Withdrawal by Subject|6
5638256|NCT00644332|19473444|P1|Overall Study|Adverse Event|11
5638257|NCT00644228|19473470|P2|Maintenance|On Treatment|40
5638258|NCT00644228|19473471|P1|Maintenance|On Treatment|26
5638259|NCT00644228|19473470|P2|Maintenance|Not Protocol-Specified|15
5638260|NCT00644228|19473471|P1|Maintenance|Not Protocol-Specified|14
5638261|NCT00644228|19473470|P2|Maintenance|Death|3
5638262|NCT00644228|19473471|P1|Maintenance|Death|3
5638263|NCT00644228|19473470|P2|Maintenance|Progression/Relapse|42
5638264|NCT00644228|19473471|P1|Maintenance|Progression/Relapse|67
5638265|NCT00644228|19473470|P2|Maintenance|Withdrawal by Subject|4
5638266|NCT00644228|19473471|P1|Maintenance|Withdrawal by Subject|6
5638267|NCT00644228|19473470|P2|Maintenance|Adverse Event|31
5638268|NCT00644228|19473471|P1|Maintenance|Adverse Event|27
5638269|NCT00644228|19473470|P2|Induction Therapy|Not Protocol-Specified|28
5638270|NCT00644228|19473471|P1|Induction Therapy|Not Protocol-Specified|24
5638271|NCT00644228|19473470|P2|Induction Therapy|Death|7
5638272|NCT00644228|19473471|P1|Induction Therapy|Death|3
5638273|NCT00644228|19473470|P2|Induction Therapy|Progression/Relapse|12
5638274|NCT00644228|19473471|P1|Induction Therapy|Progression/Relapse|24
5638275|NCT00644228|19473470|P2|Induction Therapy|Withdrawal by Subject|3
5638276|NCT00644228|19473471|P1|Induction Therapy|Withdrawal by Subject|10
5638277|NCT00644228|19473470|P2|Induction Therapy|Adverse Event|55
5638278|NCT00644228|19473471|P1|Induction Therapy|Adverse Event|22
5638279|NCT00644228|19473470|P2|Randomization & Eligibility|Invalid Consent|1
5638280|NCT00644228|19473471|P1|Randomization & Eligibility|Invalid Consent|0
5638281|NCT00644228|19473470|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
5638282|NCT00644228|19473471|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
5638283|NCT00644228|19473470|P2|Randomization & Eligibility|Ineligible|21
5638284|NCT00644228|19473471|P1|Randomization & Eligibility|Ineligible|31
5638285|NCT00644059|19473500|P3|Overall Study|Unable to classify|3
5638286|NCT00644059|19473501|P2|Overall Study|Unable to classify|2
5638287|NCT00644059|19473502|P1|Overall Study|Unable to classify|6
5638288|NCT00644059|19473500|P3|Overall Study|Protocol Deviation/violation|15
5638289|NCT00644059|19473501|P2|Overall Study|Protocol Deviation/violation|19
5638290|NCT00644059|19473502|P1|Overall Study|Protocol Deviation/violation|20
5638291|NCT00644059|19473500|P3|Overall Study|Inappropriate Enrollment|0
5638292|NCT00644059|19473501|P2|Overall Study|Inappropriate Enrollment|3
5638293|NCT00644059|19473502|P1|Overall Study|Inappropriate Enrollment|1
5638294|NCT00644059|19473500|P3|Overall Study|Adverse Event|1
5638295|NCT00644059|19473501|P2|Overall Study|Adverse Event|5
5638296|NCT00644059|19473502|P1|Overall Study|Adverse Event|8
5638297|NCT00644059|19473500|P3|Overall Study|Withdrawal by Subject|30
5638298|NCT00644059|19473501|P2|Overall Study|Withdrawal by Subject|60
5638299|NCT00644059|19473502|P1|Overall Study|Withdrawal by Subject|52
5638300|NCT00644059|19473500|P3|Overall Study|Lost to Follow-up|16
5638301|NCT00644059|19473501|P2|Overall Study|Lost to Follow-up|34
5638302|NCT00644059|19473502|P1|Overall Study|Lost to Follow-up|37
5638303|NCT00643916|19473592|P6|Overall Study|Not Vaccinated|0
5638304|NCT00643916|19473593|P5|Overall Study|Not Vaccinated|2
5638305|NCT00643916|19473594|P4|Overall Study|Not Vaccinated|0
5638306|NCT00643916|19473595|P3|Overall Study|Not Vaccinated|3
5638307|NCT00643916|19473596|P2|Overall Study|Not Vaccinated|2
5638308|NCT00643916|19473597|P1|Overall Study|Not Vaccinated|2
5638309|NCT00643916|19473592|P6|Overall Study|Withdrawal by Subject|1
5638310|NCT00643916|19473593|P5|Overall Study|Withdrawal by Subject|0
5638311|NCT00643916|19473594|P4|Overall Study|Withdrawal by Subject|1
5638312|NCT00643916|19473595|P3|Overall Study|Withdrawal by Subject|2
5638313|NCT00643916|19473596|P2|Overall Study|Withdrawal by Subject|2
5638314|NCT00643916|19473597|P1|Overall Study|Withdrawal by Subject|2
5638315|NCT00643916|19473592|P6|Overall Study|Lost to Follow-up|0
5638316|NCT00643916|19473593|P5|Overall Study|Lost to Follow-up|0
5638317|NCT00643916|19473594|P4|Overall Study|Lost to Follow-up|0
5638318|NCT00643916|19473595|P3|Overall Study|Lost to Follow-up|0
5638319|NCT00643916|19473596|P2|Overall Study|Lost to Follow-up|1
5638320|NCT00643916|19473597|P1|Overall Study|Lost to Follow-up|0
5638321|NCT00643916|19473592|P6|Overall Study|Protocol Violation|0
5638322|NCT00643916|19473593|P5|Overall Study|Protocol Violation|0
5638323|NCT00643916|19473594|P4|Overall Study|Protocol Violation|1
5638324|NCT00643916|19473595|P3|Overall Study|Protocol Violation|1
5638325|NCT00643916|19473596|P2|Overall Study|Protocol Violation|1
5638326|NCT00643916|19473597|P1|Overall Study|Protocol Violation|0
5638327|NCT00643851|19473626|P3|Overall Study|Non-compl., not met criteria, etc.|6
5638328|NCT00643851|19473627|P2|Overall Study|Non-compl., not met criteria, etc.|4
5638329|NCT00643851|19473628|P1|Overall Study|Non-compl., not met criteria, etc.|3
5638330|NCT00643851|19473626|P3|Overall Study|Withdrawal by Subject|9
5638331|NCT00643851|19473627|P2|Overall Study|Withdrawal by Subject|15
5638332|NCT00643851|19473628|P1|Overall Study|Withdrawal by Subject|8
5638333|NCT00643851|19473626|P3|Overall Study|Lost to Follow-up|9
5638334|NCT00643851|19473627|P2|Overall Study|Lost to Follow-up|6
5638335|NCT00643851|19473628|P1|Overall Study|Lost to Follow-up|4
5638336|NCT00643851|19473626|P3|Overall Study|Adverse Event|6
5638337|NCT00643851|19473627|P2|Overall Study|Adverse Event|6
5638338|NCT00643851|19473628|P1|Overall Study|Adverse Event|2
5638339|NCT00643851|19473626|P3|Overall Study|Lack of Efficacy|0
5638340|NCT00643851|19473627|P2|Overall Study|Lack of Efficacy|1
5638341|NCT00643851|19473628|P1|Overall Study|Lack of Efficacy|0
5638342|NCT00643851|19473626|P3|Overall Study|Death|0
5638343|NCT00643851|19473627|P2|Overall Study|Death|1
5638344|NCT00643851|19473628|P1|Overall Study|Death|0
5638345|NCT00643760|19473656|P5|Overall Study|Withdrawal by Subject|1
5638346|NCT00643760|19473657|P4|Overall Study|Withdrawal by Subject|4
5638347|NCT00643760|19473658|P3|Overall Study|Withdrawal by Subject|2
5638348|NCT00643760|19473659|P2|Overall Study|Withdrawal by Subject|1
5638349|NCT00643760|19473660|P1|Overall Study|Withdrawal by Subject|3
5638350|NCT00643760|19473656|P5|Overall Study|Investigator Discretion|0
5638351|NCT00643760|19473657|P4|Overall Study|Investigator Discretion|2
5638352|NCT00643760|19473658|P3|Overall Study|Investigator Discretion|0
5638353|NCT00643760|19473659|P2|Overall Study|Investigator Discretion|0
5638354|NCT00643760|19473660|P1|Overall Study|Investigator Discretion|0
5638355|NCT00643760|19473656|P5|Overall Study|Lost to Follow-up|3
5638356|NCT00643760|19473657|P4|Overall Study|Lost to Follow-up|3
5638357|NCT00643760|19473658|P3|Overall Study|Lost to Follow-up|1
5638358|NCT00643760|19473659|P2|Overall Study|Lost to Follow-up|2
5638359|NCT00643760|19473660|P1|Overall Study|Lost to Follow-up|6
5638360|NCT00643760|19473656|P5|Overall Study|Protocol Violation|6
5638361|NCT00643760|19473657|P4|Overall Study|Protocol Violation|4
5638362|NCT00643760|19473658|P3|Overall Study|Protocol Violation|4
5638363|NCT00643760|19473659|P2|Overall Study|Protocol Violation|6
5638364|NCT00643760|19473660|P1|Overall Study|Protocol Violation|7
5638365|NCT00643760|19473656|P5|Overall Study|Lack of Efficacy|3
5638366|NCT00643760|19473657|P4|Overall Study|Lack of Efficacy|4
5638367|NCT00643760|19473658|P3|Overall Study|Lack of Efficacy|0
5638368|NCT00643760|19473659|P2|Overall Study|Lack of Efficacy|1
5638369|NCT00643760|19473660|P1|Overall Study|Lack of Efficacy|3
5638370|NCT00643760|19473656|P5|Overall Study|Adverse Event|6
5638371|NCT00643760|19473657|P4|Overall Study|Adverse Event|21
5638372|NCT00643760|19473658|P3|Overall Study|Adverse Event|12
5638373|NCT00643760|19473659|P2|Overall Study|Adverse Event|5
5638374|NCT00643760|19473660|P1|Overall Study|Adverse Event|11
5638375|NCT00643682|19473764|P2|Overall Study|did not keep appointment|509
5638376|NCT00643682|19473765|P1|Overall Study|did not keep appointment|522
5638377|NCT00643604|19473777|P1|Overall Study|Death|1
5638378|NCT00643565|19473805|P2|Overall Study|Adverse Event|8
5638379|NCT00643565|19473806|P1|Overall Study|Adverse Event|5
5638380|NCT00643565|19473805|P2|Overall Study|Administrative|16
5638381|NCT00643565|19473806|P1|Overall Study|Administrative|22
5638382|NCT00643565|19473805|P2|Overall Study|Did Not Cooperate|1
5638383|NCT00643565|19473806|P1|Overall Study|Did Not Cooperate|0
5638384|NCT00643565|19473805|P2|Overall Study|Protocol Violation|0
5638385|NCT00643565|19473806|P1|Overall Study|Protocol Violation|3
5638386|NCT00643565|19473805|P2|Overall Study|Progression of Disease|14
5638387|NCT00643565|19473806|P1|Overall Study|Progression of Disease|18
5638388|NCT00643565|19473805|P2|Overall Study|Recurrence of Disease|1
5638389|NCT00643565|19473806|P1|Overall Study|Recurrence of Disease|2
5638390|NCT00643565|19473805|P2|Overall Study|Refused Treatment / Did Not Cooperate|1
5638391|NCT00643565|19473806|P1|Overall Study|Refused Treatment / Did Not Cooperate|0
5638392|NCT00643565|19473805|P2|Overall Study|Other|8
5638393|NCT00643565|19473806|P1|Overall Study|Other|7
5638394|NCT00643565|19473805|P2|Overall Study|Lost to Follow-up|6
5638395|NCT00643565|19473806|P1|Overall Study|Lost to Follow-up|0
5638396|NCT00643565|19473805|P2|Overall Study|Withdrawal by Subject|1
5638397|NCT00643565|19473806|P1|Overall Study|Withdrawal by Subject|4
5638398|NCT00643565|19473805|P2|Overall Study|Death|11
5638399|NCT00643565|19473806|P1|Overall Study|Death|12
5638400|NCT00643487|19473828|P1|Overall Study|Technical difficulty|3
5638401|NCT00643448|19473835|P3|Overall Study|QTcF>550 ms|0
5638402|NCT00643448|19473836|P2|Overall Study|QTcF>550 ms|3
5638403|NCT00643448|19473837|P1|Overall Study|QTcF>550 ms|0
5638404|NCT00643448|19473835|P3|Overall Study|Adverse Event|2
5638405|NCT00643448|19473836|P2|Overall Study|Adverse Event|2
5638406|NCT00643448|19473837|P1|Overall Study|Adverse Event|2
5638407|NCT00643448|19473835|P3|Overall Study|Lack of Efficacy|4
5638408|NCT00643448|19473836|P2|Overall Study|Lack of Efficacy|0
5638409|NCT00643448|19473837|P1|Overall Study|Lack of Efficacy|2
5638410|NCT00643279|19473854|P2|Overall Study|Physician Decision|1
5638411|NCT00643279|19473855|P1|Overall Study|Physician Decision|0
5638412|NCT00643279|19473854|P2|Overall Study|Lost to Follow-up|1
5638413|NCT00643279|19473855|P1|Overall Study|Lost to Follow-up|0
5638414|NCT00643279|19473854|P2|Overall Study|Withdrawal by Subject|0
5638415|NCT00643279|19473855|P1|Overall Study|Withdrawal by Subject|3
5638416|NCT00643279|19473854|P2|Overall Study|Death|11
5638417|NCT00643279|19473855|P1|Overall Study|Death|13
5638418|NCT00643201|19473877|P2|Completed Study Follow Up|non-specified|0
5638419|NCT00643201|19473878|P1|Completed Study Follow Up|non-specified|1
5638420|NCT00643201|19473877|P2|Completed Study Follow Up|Lost to Follow-up|16
5638421|NCT00643201|19473878|P1|Completed Study Follow Up|Lost to Follow-up|18
5638422|NCT00643201|19473877|P2|Completed Study Follow Up|Withdrawal by Subject|29
5638423|NCT00643201|19473878|P1|Completed Study Follow Up|Withdrawal by Subject|23
5638424|NCT00643201|19473877|P2|Completed Study Follow Up|Death|34
5638425|NCT00643201|19473878|P1|Completed Study Follow Up|Death|28
5638426|NCT00643201|19473877|P2|Randomized, Completed 6 Months of Study|Other|107
5638427|NCT00643201|19473878|P1|Randomized, Completed 6 Months of Study|Other|107
5638428|NCT00643201|19473877|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
5638429|NCT00643201|19473878|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
5638430|NCT00643201|19473877|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
5638431|NCT00643201|19473878|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
5638432|NCT00643201|19473877|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
5638433|NCT00643201|19473878|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
5638434|NCT00643201|19473877|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
5638435|NCT00643201|19473878|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
5638436|NCT00643201|19473877|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
5638437|NCT00643201|19473878|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
5638438|NCT00643201|19473877|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
5638439|NCT00643201|19473878|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
5638440|NCT00643201|19473877|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
5638441|NCT00643201|19473878|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
5638442|NCT00643201|19473877|P2|Randomized, Completed 6 Months of Study|Death|26
5638443|NCT00643201|19473878|P1|Randomized, Completed 6 Months of Study|Death|20
5638444|NCT00643162|19473926|P2|Overall Study|Withdrawal by Subject|1
5638445|NCT00643162|19473927|P1|Overall Study|Withdrawal by Subject|1
5638446|NCT00643123|19473939|P2|Overall Study|Withdrawal by Subject|1
5638447|NCT00643123|19473940|P1|Overall Study|Withdrawal by Subject|1
5638448|NCT00643123|19473939|P2|Overall Study|Lost to Follow-up|0
5638449|NCT00643123|19473940|P1|Overall Study|Lost to Follow-up|4
5638450|NCT00643006|19473972|P2|Overall Study|Lost to Follow-up|4
5638451|NCT00643006|19473973|P1|Overall Study|Lost to Follow-up|5
5638452|NCT00642993|19473983|P2|Overall Study|Administrative|0
5638453|NCT00642993|19473984|P1|Overall Study|Administrative|1
5638454|NCT00642993|19473983|P2|Overall Study|Did not meet protocol eligibility|1
5638455|NCT00642993|19473984|P1|Overall Study|Did not meet protocol eligibility|0
5638456|NCT00642993|19473983|P2|Overall Study|Protocol Violation|4
5638457|NCT00642993|19473984|P1|Overall Study|Protocol Violation|1
5638458|NCT00642993|19473983|P2|Overall Study|Withdrew - reason unrelated to treatment|3
5638459|NCT00642993|19473984|P1|Overall Study|Withdrew - reason unrelated to treatment|11
5638460|NCT00642993|19473983|P2|Overall Study|Lost to Follow-up|4
5638461|NCT00642993|19473984|P1|Overall Study|Lost to Follow-up|8
5638462|NCT00642993|19473983|P2|Overall Study|Adverse Event|4
5638463|NCT00642993|19473984|P1|Overall Study|Adverse Event|85
5638464|NCT00642954|19474003|P5|Overall Study|Adverse Event|6
5638465|NCT00642954|19474004|P4|Overall Study|Adverse Event|0
5638466|NCT00642954|19474005|P3|Overall Study|Adverse Event|0
5638467|NCT00642954|19474006|P2|Overall Study|Adverse Event|1
5638468|NCT00642954|19474007|P1|Overall Study|Adverse Event|1
5638469|NCT00642954|19474003|P5|Overall Study|Withdrawal by Subject|1
5638470|NCT00642954|19474004|P4|Overall Study|Withdrawal by Subject|0
5638471|NCT00642954|19474005|P3|Overall Study|Withdrawal by Subject|0
5638472|NCT00642954|19474006|P2|Overall Study|Withdrawal by Subject|0
5638473|NCT00642954|19474007|P1|Overall Study|Withdrawal by Subject|0
5638474|NCT00642954|19474003|P5|Overall Study|Progressive Disease|9
5638475|NCT00642954|19474004|P4|Overall Study|Progressive Disease|3
5638476|NCT00642954|19474005|P3|Overall Study|Progressive Disease|3
5638477|NCT00642954|19474006|P2|Overall Study|Progressive Disease|3
5638478|NCT00642954|19474007|P1|Overall Study|Progressive Disease|3
5638479|NCT00642902|19474033|P4|Overall Study|Other|4
5638480|NCT00642902|19474034|P3|Overall Study|Other|1
5638481|NCT00642902|19474035|P2|Overall Study|Other|5
5638482|NCT00642902|19474036|P1|Overall Study|Other|1
5638483|NCT00642902|19474033|P4|Overall Study|Randomized, but not treated|0
5638484|NCT00642902|19474034|P3|Overall Study|Randomized, but not treated|1
5638485|NCT00642902|19474035|P2|Overall Study|Randomized, but not treated|0
5638486|NCT00642902|19474036|P1|Overall Study|Randomized, but not treated|0
5638487|NCT00642902|19474033|P4|Overall Study|Premature termination of clinical trial|35
5638488|NCT00642902|19474034|P3|Overall Study|Premature termination of clinical trial|35
5638489|NCT00642902|19474035|P2|Overall Study|Premature termination of clinical trial|32
5638490|NCT00642902|19474036|P1|Overall Study|Premature termination of clinical trial|37
5638491|NCT00642902|19474033|P4|Overall Study|Death|0
5638492|NCT00642902|19474034|P3|Overall Study|Death|0
5638493|NCT00642902|19474035|P2|Overall Study|Death|0
5638494|NCT00642902|19474036|P1|Overall Study|Death|1
5638495|NCT00642902|19474033|P4|Overall Study|Lack of Efficacy|0
5638496|NCT00642902|19474034|P3|Overall Study|Lack of Efficacy|3
5638497|NCT00642902|19474035|P2|Overall Study|Lack of Efficacy|3
5638498|NCT00642902|19474036|P1|Overall Study|Lack of Efficacy|0
5638499|NCT00642902|19474033|P4|Overall Study|Lost to Follow-up|0
5638500|NCT00642902|19474034|P3|Overall Study|Lost to Follow-up|0
5638501|NCT00642902|19474035|P2|Overall Study|Lost to Follow-up|1
5638502|NCT00642902|19474036|P1|Overall Study|Lost to Follow-up|1
5638503|NCT00642902|19474033|P4|Overall Study|Adverse Event|1
5638504|NCT00642902|19474034|P3|Overall Study|Adverse Event|3
5638505|NCT00642902|19474035|P2|Overall Study|Adverse Event|1
5638506|NCT00642902|19474036|P1|Overall Study|Adverse Event|0
5638507|NCT00642850|19474058|P1|Overall Study|Other reasons|7
5638508|NCT00642850|19474058|P1|Overall Study|Blood transfusion|6
5638509|NCT00642850|19474058|P1|Overall Study|Kidney transplantation|8
5638510|NCT00642850|19474058|P1|Overall Study|Protocol Violation|2
5638511|NCT00642850|19474058|P1|Overall Study|Lack of Efficacy|1
5638512|NCT00642850|19474058|P1|Overall Study|Adverse Event|2
5638513|NCT00642850|19474058|P1|Overall Study|Death|7
5638514|NCT00642811|19474074|P6|Overall Study|Other|0
5638515|NCT00642811|19474075|P5|Overall Study|Other|0
5638516|NCT00642811|19474076|P4|Overall Study|Other|1
5638517|NCT00642811|19474077|P3|Overall Study|Other|0
5638518|NCT00642811|19474078|P2|Overall Study|Other|1
5638519|NCT00642811|19474079|P1|Overall Study|Other|0
5638520|NCT00642811|19474074|P6|Overall Study|Severe Non-compliance to protocol|0
5638521|NCT00642811|19474075|P5|Overall Study|Severe Non-compliance to protocol|0
5638522|NCT00642811|19474076|P4|Overall Study|Severe Non-compliance to protocol|0
5638523|NCT00642811|19474077|P3|Overall Study|Severe Non-compliance to protocol|0
5638524|NCT00642811|19474078|P2|Overall Study|Severe Non-compliance to protocol|0
5638525|NCT00642811|19474079|P1|Overall Study|Severe Non-compliance to protocol|1
5638526|NCT00642811|19474074|P6|Overall Study|Developement of discontinuation criteria|0
5638527|NCT00642811|19474075|P5|Overall Study|Developement of discontinuation criteria|1
5638528|NCT00642811|19474076|P4|Overall Study|Developement of discontinuation criteria|0
5638529|NCT00642811|19474077|P3|Overall Study|Developement of discontinuation criteria|0
5638530|NCT00642811|19474078|P2|Overall Study|Developement of discontinuation criteria|0
5638531|NCT00642811|19474079|P1|Overall Study|Developement of discontinuation criteria|0
5638532|NCT00642811|19474074|P6|Overall Study|Adverse Event|1
5638533|NCT00642811|19474075|P5|Overall Study|Adverse Event|0
5638534|NCT00642811|19474076|P4|Overall Study|Adverse Event|0
5638535|NCT00642811|19474077|P3|Overall Study|Adverse Event|0
5638536|NCT00642811|19474078|P2|Overall Study|Adverse Event|3
5638537|NCT00642811|19474079|P1|Overall Study|Adverse Event|2
5638538|NCT00642772|19474101|P1|Overall Study|Withdrawal by Subject|7
5638539|NCT00642772|19474101|P1|Overall Study|Lost to Follow-up|3
5638540|NCT00642759|19474105|P1|Overall Study|Protocol Violation|1
5638541|NCT00642746|19474114|P2|Overall Study|Patient unevaluable|0
5638542|NCT00642746|19474115|P1|Overall Study|Patient unevaluable|1
5638543|NCT00642707|19474129|P4|Overall Study|Withdrawal by Subject|0
5638544|NCT00642707|19474130|P3|Overall Study|Withdrawal by Subject|0
5638545|NCT00642707|19474131|P2|Overall Study|Withdrawal by Subject|0
5638546|NCT00642707|19474132|P1|Overall Study|Withdrawal by Subject|1
5638547|NCT00642707|19474129|P4|Overall Study|Adverse Event|2
5638548|NCT00642707|19474130|P3|Overall Study|Adverse Event|0
5638549|NCT00642707|19474131|P2|Overall Study|Adverse Event|0
5638550|NCT00642707|19474132|P1|Overall Study|Adverse Event|0
5638551|NCT00642668|19474167|P1|Overall Study|Blood Transfusion|2
5638552|NCT00642668|19474167|P1|Overall Study|Dialysis Initiation|5
5638553|NCT00642668|19474167|P1|Overall Study|Failure to Return|1
5638554|NCT00642668|19474167|P1|Overall Study|Insufficient Therapeutic Response|1
5638555|NCT00642668|19474167|P1|Overall Study|Death|2
5638556|NCT00642668|19474167|P1|Overall Study|Adverse Event|2
5638557|NCT00642668|19474167|P1|Overall Study|Lost to Follow-up|1
5638558|NCT00642642|19474175|P1|Treatment & Follow Up|Lost to Follow-up|10
5638559|NCT00642642|19474175|P1|Treatment & Follow Up|Withdrawal by Subject|5
5638560|NCT00642642|19474175|P1|Treatment & Follow Up|Adverse Event|2
5638561|NCT00642616|19474192|P4|Overall Study|Physician Decision|1
5638562|NCT00642616|19474193|P3|Overall Study|Physician Decision|1
5638563|NCT00642616|19474194|P2|Overall Study|Physician Decision|0
5638564|NCT00642616|19474195|P1|Overall Study|Physician Decision|0
5638565|NCT00642616|19474192|P4|Overall Study|Protocol Violation|0
5638566|NCT00642616|19474193|P3|Overall Study|Protocol Violation|2
5638567|NCT00642616|19474194|P2|Overall Study|Protocol Violation|0
5638568|NCT00642616|19474195|P1|Overall Study|Protocol Violation|0
5638569|NCT00642616|19474192|P4|Overall Study|Withdrawal by Subject|1
5638570|NCT00642616|19474193|P3|Overall Study|Withdrawal by Subject|1
5638571|NCT00642616|19474194|P2|Overall Study|Withdrawal by Subject|1
5638572|NCT00642616|19474195|P1|Overall Study|Withdrawal by Subject|0
5638573|NCT00642616|19474192|P4|Overall Study|Study Terminated by Sponsor|5
5638574|NCT00642616|19474193|P3|Overall Study|Study Terminated by Sponsor|4
5638575|NCT00642616|19474194|P2|Overall Study|Study Terminated by Sponsor|6
5638576|NCT00642616|19474195|P1|Overall Study|Study Terminated by Sponsor|7
5638577|NCT00642616|19474192|P4|Overall Study|Adverse Event|0
5638578|NCT00642616|19474193|P3|Overall Study|Adverse Event|1
5638579|NCT00642616|19474194|P2|Overall Study|Adverse Event|0
5638580|NCT00642616|19474195|P1|Overall Study|Adverse Event|2
5638581|NCT00642473|19474228|P2|Overall Study|Other|2
5638582|NCT00642473|19474229|P1|Overall Study|Other|2
5638583|NCT00642473|19474228|P2|Overall Study|Progression or death|4
5638584|NCT00642473|19474229|P1|Overall Study|Progression or death|2
5638585|NCT00642473|19474228|P2|Overall Study|Withdrawal by Subject|5
5638586|NCT00642473|19474229|P1|Overall Study|Withdrawal by Subject|0
5638587|NCT00642460|19474243|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
5638588|NCT00642460|19474244|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
5638589|NCT00642460|19474245|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
5638590|NCT00642460|19474246|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
5638591|NCT00642460|19474247|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
5638592|NCT00642460|19474248|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
5638593|NCT00642460|19474243|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
5638594|NCT00642460|19474244|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
5638595|NCT00642460|19474245|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
5638596|NCT00642460|19474246|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
5638597|NCT00642460|19474247|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
5638598|NCT00642460|19474248|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
5638599|NCT00642460|19474243|P6|Part III: Open-Label Up to Week 260|Death|3
5638600|NCT00642460|19474244|P5|Part III: Open-Label Up to Week 260|Death|0
5638601|NCT00642460|19474245|P4|Part III: Open-Label Up to Week 260|Death|0
5638602|NCT00642460|19474246|P3|Part III: Open-Label Up to Week 260|Death|0
5638603|NCT00642460|19474247|P2|Part III: Open-Label Up to Week 260|Death|0
5638604|NCT00642460|19474248|P1|Part III: Open-Label Up to Week 260|Death|0
5638605|NCT00642460|19474243|P6|Part III: Open-Label Up to Week 260|Other|2
5638606|NCT00642460|19474244|P5|Part III: Open-Label Up to Week 260|Other|2
5638607|NCT00642460|19474245|P4|Part III: Open-Label Up to Week 260|Other|0
5638608|NCT00642460|19474246|P3|Part III: Open-Label Up to Week 260|Other|0
5638609|NCT00642460|19474247|P2|Part III: Open-Label Up to Week 260|Other|0
5638610|NCT00642460|19474248|P1|Part III: Open-Label Up to Week 260|Other|0
5638611|NCT00642460|19474243|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
5638612|NCT00642460|19474244|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
5638613|NCT00642460|19474245|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
5638614|NCT00642460|19474246|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
5638615|NCT00642460|19474247|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
5638616|NCT00642460|19474248|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
5638617|NCT00642460|19474243|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
5638618|NCT00642460|19474244|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
5638619|NCT00642460|19474245|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
5638620|NCT00642460|19474246|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
5638621|NCT00642460|19474247|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
5638622|NCT00642460|19474248|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
5638623|NCT00642460|19474243|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
5638624|NCT00642460|19474244|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
5638625|NCT00642460|19474245|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
5638626|NCT00642460|19474246|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
5638627|NCT00642460|19474247|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
5638628|NCT00642460|19474248|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
5638629|NCT00642460|19474243|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
5638630|NCT00642460|19474244|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
5638631|NCT00642460|19474245|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
5638632|NCT00642460|19474246|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
5638633|NCT00642460|19474247|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
5638634|NCT00642460|19474248|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
5638635|NCT00642460|19474243|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
5638636|NCT00642460|19474244|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
5638637|NCT00642460|19474245|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
5638638|NCT00642460|19474246|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
5638639|NCT00642460|19474247|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
5638640|NCT00642460|19474248|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
5638641|NCT00642460|19474243|P6|Part II: Open-Label Up to Week 92|Failure to return|0
5638642|NCT00642460|19474244|P5|Part II: Open-Label Up to Week 92|Failure to return|0
5638643|NCT00642460|19474245|P4|Part II: Open-Label Up to Week 92|Failure to return|0
5638644|NCT00642460|19474246|P3|Part II: Open-Label Up to Week 92|Failure to return|0
5638645|NCT00642460|19474247|P2|Part II: Open-Label Up to Week 92|Failure to return|1
5638646|NCT00642460|19474248|P1|Part II: Open-Label Up to Week 92|Failure to return|0
5638647|NCT00642460|19474243|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
5638648|NCT00642460|19474244|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
5638649|NCT00642460|19474245|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
5638650|NCT00642460|19474246|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
5638651|NCT00642460|19474247|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
5638652|NCT00642460|19474248|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
5638653|NCT00642460|19474243|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
5638654|NCT00642460|19474244|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
5638655|NCT00642460|19474245|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
5638656|NCT00642460|19474246|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
5638657|NCT00642460|19474247|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
5638658|NCT00642460|19474248|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
5638659|NCT00642460|19474243|P6|Part II: Open-Label Up to Week 92|Death|0
5638660|NCT00642460|19474244|P5|Part II: Open-Label Up to Week 92|Death|0
5638661|NCT00642460|19474245|P4|Part II: Open-Label Up to Week 92|Death|2
5638662|NCT00642460|19474246|P3|Part II: Open-Label Up to Week 92|Death|0
5638663|NCT00642460|19474247|P2|Part II: Open-Label Up to Week 92|Death|1
5638664|NCT00642460|19474248|P1|Part II: Open-Label Up to Week 92|Death|0
5638665|NCT00642460|19474243|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
5638666|NCT00642460|19474244|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
5638667|NCT00642460|19474245|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
5638668|NCT00642460|19474246|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
5638669|NCT00642460|19474247|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
5638670|NCT00642460|19474248|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
5638671|NCT00642460|19474243|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
5638672|NCT00642460|19474244|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
5638673|NCT00642460|19474245|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
5638674|NCT00642460|19474246|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
5638675|NCT00642460|19474247|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
5638676|NCT00642460|19474248|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
5638677|NCT00642460|19474243|P6|Part I: 12 Week Double-Blind|Adverse Event|0
5638678|NCT00642460|19474244|P5|Part I: 12 Week Double-Blind|Adverse Event|0
5638679|NCT00642460|19474245|P4|Part I: 12 Week Double-Blind|Adverse Event|0
5638680|NCT00642460|19474246|P3|Part I: 12 Week Double-Blind|Adverse Event|1
5638681|NCT00642460|19474247|P2|Part I: 12 Week Double-Blind|Adverse Event|1
5638682|NCT00642460|19474248|P1|Part I: 12 Week Double-Blind|Adverse Event|0
5638683|NCT00642369|19474323|P2|Overall Study|Lack of Efficacy|2
5638684|NCT00642369|19474324|P1|Overall Study|Lack of Efficacy|2
5638685|NCT00642369|19474323|P2|Overall Study|misdiagnosis|1
5638686|NCT00642369|19474324|P1|Overall Study|misdiagnosis|0
5638687|NCT00642369|19474323|P2|Overall Study|Withdrawal by Subject|0
5638688|NCT00642369|19474324|P1|Overall Study|Withdrawal by Subject|1
5638689|NCT00642369|19474323|P2|Overall Study|Adverse Event|3
5638690|NCT00642369|19474324|P1|Overall Study|Adverse Event|2
5638691|NCT00642356|19474334|P2|Overall Study|Lack of Efficacy|0
5638692|NCT00642356|19474335|P1|Overall Study|Lack of Efficacy|1
5638693|NCT00642356|19474334|P2|Overall Study|Protocol Violation|3
5638694|NCT00642356|19474335|P1|Overall Study|Protocol Violation|0
5638695|NCT00642356|19474334|P2|Overall Study|Adverse Event|0
5638696|NCT00642356|19474335|P1|Overall Study|Adverse Event|1
5638697|NCT00642304|19474343|P1|Overall Study|Transplantation|1
5638698|NCT00642304|19474343|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
5638699|NCT00642304|19474343|P1|Overall Study|Blood transfusion|2
5638700|NCT00642304|19474343|P1|Overall Study|Death|1
5638701|NCT00642304|19474343|P1|Overall Study|Adverse Event|1
5638702|NCT00642278|19474359|P7|Overall Study|Other|0
5638703|NCT00642278|19474360|P6|Overall Study|Other|1
5638704|NCT00642278|19474361|P5|Overall Study|Other|0
5638705|NCT00642278|19474362|P4|Overall Study|Other|1
5638706|NCT00642278|19474363|P3|Overall Study|Other|0
5638707|NCT00642278|19474364|P2|Overall Study|Other|1
5638708|NCT00642278|19474365|P1|Overall Study|Other|2
5638709|NCT00642278|19474359|P7|Overall Study|Noncompliance with study drug regimen|0
5638710|NCT00642278|19474360|P6|Overall Study|Noncompliance with study drug regimen|0
5638711|NCT00642278|19474361|P5|Overall Study|Noncompliance with study drug regimen|0
5638712|NCT00642278|19474362|P4|Overall Study|Noncompliance with study drug regimen|1
5638713|NCT00642278|19474363|P3|Overall Study|Noncompliance with study drug regimen|0
5638714|NCT00642278|19474364|P2|Overall Study|Noncompliance with study drug regimen|0
5638715|NCT00642278|19474365|P1|Overall Study|Noncompliance with study drug regimen|0
5638716|NCT00642278|19474359|P7|Overall Study|Withdrawal by Subject|2
5638717|NCT00642278|19474360|P6|Overall Study|Withdrawal by Subject|2
5638718|NCT00642278|19474361|P5|Overall Study|Withdrawal by Subject|6
5638719|NCT00642278|19474362|P4|Overall Study|Withdrawal by Subject|3
5638720|NCT00642278|19474363|P3|Overall Study|Withdrawal by Subject|1
5638721|NCT00642278|19474364|P2|Overall Study|Withdrawal by Subject|1
5638722|NCT00642278|19474365|P1|Overall Study|Withdrawal by Subject|1
5638723|NCT00642278|19474359|P7|Overall Study|Protocol Violation|2
5638724|NCT00642278|19474360|P6|Overall Study|Protocol Violation|1
5638725|NCT00642278|19474361|P5|Overall Study|Protocol Violation|0
5638726|NCT00642278|19474362|P4|Overall Study|Protocol Violation|1
5638727|NCT00642278|19474363|P3|Overall Study|Protocol Violation|1
5638728|NCT00642278|19474364|P2|Overall Study|Protocol Violation|0
5638729|NCT00642278|19474365|P1|Overall Study|Protocol Violation|0
5638730|NCT00642278|19474359|P7|Overall Study|Physician Decision|0
5638731|NCT00642278|19474360|P6|Overall Study|Physician Decision|0
5638732|NCT00642278|19474361|P5|Overall Study|Physician Decision|0
5638733|NCT00642278|19474362|P4|Overall Study|Physician Decision|1
5638734|NCT00642278|19474363|P3|Overall Study|Physician Decision|0
5638735|NCT00642278|19474364|P2|Overall Study|Physician Decision|0
5638736|NCT00642278|19474365|P1|Overall Study|Physician Decision|0
5638737|NCT00642278|19474359|P7|Overall Study|Lost to Follow-up|1
5638738|NCT00642278|19474360|P6|Overall Study|Lost to Follow-up|1
5638739|NCT00642278|19474361|P5|Overall Study|Lost to Follow-up|0
5638740|NCT00642278|19474362|P4|Overall Study|Lost to Follow-up|1
5638741|NCT00642278|19474363|P3|Overall Study|Lost to Follow-up|0
5638742|NCT00642278|19474364|P2|Overall Study|Lost to Follow-up|1
5638743|NCT00642278|19474365|P1|Overall Study|Lost to Follow-up|5
5638744|NCT00642278|19474359|P7|Overall Study|Lack of Efficacy|0
5638745|NCT00642278|19474360|P6|Overall Study|Lack of Efficacy|0
5638746|NCT00642278|19474361|P5|Overall Study|Lack of Efficacy|0
5638747|NCT00642278|19474362|P4|Overall Study|Lack of Efficacy|0
5638748|NCT00642278|19474363|P3|Overall Study|Lack of Efficacy|0
5638749|NCT00642278|19474364|P2|Overall Study|Lack of Efficacy|1
5638750|NCT00642278|19474365|P1|Overall Study|Lack of Efficacy|0
5638751|NCT00642278|19474359|P7|Overall Study|Adverse Event|0
5638752|NCT00642278|19474360|P6|Overall Study|Adverse Event|2
5638753|NCT00642278|19474361|P5|Overall Study|Adverse Event|2
5638754|NCT00642278|19474362|P4|Overall Study|Adverse Event|1
5638755|NCT00642278|19474363|P3|Overall Study|Adverse Event|3
5638756|NCT00642278|19474364|P2|Overall Study|Adverse Event|1
5638757|NCT00642278|19474365|P1|Overall Study|Adverse Event|2
5638758|NCT00642174|19474418|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
5638759|NCT00642174|19474419|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
5638760|NCT00642018|19474435|P2|Overall Study|Entry Criteria Not Met|1
5638761|NCT00642018|19474436|P1|Overall Study|Entry Criteria Not Met|0
5638762|NCT00642018|19474435|P2|Overall Study|Death|3
5638763|NCT00642018|19474436|P1|Overall Study|Death|0
5638764|NCT00642018|19474435|P2|Overall Study|Protocol Violation|1
5638765|NCT00642018|19474436|P1|Overall Study|Protocol Violation|0
5638766|NCT00642018|19474435|P2|Overall Study|Physician Decision|10
5638767|NCT00642018|19474436|P1|Overall Study|Physician Decision|0
5638768|NCT00642018|19474435|P2|Overall Study|Progressive Disease|18
5638769|NCT00642018|19474436|P1|Overall Study|Progressive Disease|13
5638770|NCT00642018|19474435|P2|Overall Study|Withdrawal by Subject|10
5638771|NCT00642018|19474436|P1|Overall Study|Withdrawal by Subject|4
5638772|NCT00642018|19474435|P2|Overall Study|Adverse Event|36
5638773|NCT00642018|19474436|P1|Overall Study|Adverse Event|11
5638774|NCT00641719|19474503|P2|Overall Study|Reason Not Specified|2
5638775|NCT00641719|19474504|P1|Overall Study|Reason Not Specified|1
5638776|NCT00641719|19474503|P2|Overall Study|Withdrawal by Subject|4
5638777|NCT00641719|19474504|P1|Overall Study|Withdrawal by Subject|4
5638778|NCT00641719|19474503|P2|Overall Study|Adverse Event|29
5638779|NCT00641719|19474504|P1|Overall Study|Adverse Event|24
5638780|NCT00641719|19474503|P2|Overall Study|Lack of Efficacy|2
5638781|NCT00641719|19474504|P1|Overall Study|Lack of Efficacy|1
5638782|NCT00641706|19474528|P2|Overall Study|Lead Investigator Decision|1
5638783|NCT00641706|19474529|P1|Overall Study|Lead Investigator Decision|0
5638784|NCT00641706|19474528|P2|Overall Study|Clinical Decline|0
5638785|NCT00641706|19474529|P1|Overall Study|Clinical Decline|1
5638786|NCT00641706|19474528|P2|Overall Study|Withdrawal by Subject|1
5638787|NCT00641706|19474529|P1|Overall Study|Withdrawal by Subject|6
5638788|NCT00641706|19474528|P2|Overall Study|Adverse Event|1
5638789|NCT00641706|19474529|P1|Overall Study|Adverse Event|2
5638790|NCT00641667|19474541|P1|Overall Study|Worsening of underlying disease|3
5638791|NCT00641667|19474541|P1|Overall Study|Physician Decision|1
5638792|NCT00641667|19474541|P1|Overall Study|Adverse Event|1
5638793|NCT00641667|19474541|P1|Overall Study|Withdrawal by Subject|1
5638794|NCT00641537|19474569|P8|24-Week Supplemental Follow-up Period|Other|1
5638795|NCT00641537|19474570|P7|24-Week Supplemental Follow-up Period|Other|1
5638796|NCT00641537|19474571|P6|24-Week Supplemental Follow-up Period|Other|0
5638797|NCT00641537|19474572|P5|24-Week Supplemental Follow-up Period|Other|3
5638798|NCT00641537|19474573|P4|24-Week Supplemental Follow-up Period|Other|1
5638799|NCT00641537|19474574|P3|24-Week Supplemental Follow-up Period|Other|2
5638800|NCT00641537|19474575|P2|24-Week Supplemental Follow-up Period|Other|2
5638801|NCT00641537|19474576|P1|24-Week Supplemental Follow-up Period|Other|0
5638802|NCT00641537|19474569|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
5638803|NCT00641537|19474570|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
5638804|NCT00641537|19474571|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
5638805|NCT00641537|19474572|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
5638806|NCT00641537|19474573|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
5638807|NCT00641537|19474574|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
5638808|NCT00641537|19474575|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
5638809|NCT00641537|19474576|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
5638810|NCT00641537|19474569|P8|96-week Period|Other|6
5638811|NCT00641537|19474570|P7|96-week Period|Other|4
5638812|NCT00641537|19474571|P6|96-week Period|Other|6
5638813|NCT00641537|19474572|P5|96-week Period|Other|11
5638814|NCT00641537|19474573|P4|96-week Period|Other|9
5638815|NCT00641537|19474574|P3|96-week Period|Other|14
5638816|NCT00641537|19474575|P2|96-week Period|Other|7
5638817|NCT00641537|19474576|P1|96-week Period|Other|4
5638818|NCT00641537|19474569|P8|96-week Period|Death|0
5638819|NCT00641537|19474570|P7|96-week Period|Death|0
5638820|NCT00641537|19474571|P6|96-week Period|Death|0
5638821|NCT00641537|19474572|P5|96-week Period|Death|0
5638822|NCT00641537|19474573|P4|96-week Period|Death|0
5638823|NCT00641537|19474574|P3|96-week Period|Death|1
5638824|NCT00641537|19474575|P2|96-week Period|Death|0
5638825|NCT00641537|19474576|P1|96-week Period|Death|2
5638826|NCT00641537|19474569|P8|96-week Period|Protocol Violation|0
5638827|NCT00641537|19474570|P7|96-week Period|Protocol Violation|0
5638828|NCT00641537|19474571|P6|96-week Period|Protocol Violation|1
5638829|NCT00641537|19474572|P5|96-week Period|Protocol Violation|0
5638830|NCT00641537|19474573|P4|96-week Period|Protocol Violation|1
5638831|NCT00641537|19474574|P3|96-week Period|Protocol Violation|0
5638832|NCT00641537|19474575|P2|96-week Period|Protocol Violation|1
5638833|NCT00641537|19474576|P1|96-week Period|Protocol Violation|0
5638834|NCT00641537|19474569|P8|96-week Period|Lost to Follow-up|0
5638835|NCT00641537|19474570|P7|96-week Period|Lost to Follow-up|1
5638836|NCT00641537|19474571|P6|96-week Period|Lost to Follow-up|0
5638837|NCT00641537|19474572|P5|96-week Period|Lost to Follow-up|4
5638838|NCT00641537|19474573|P4|96-week Period|Lost to Follow-up|2
5638839|NCT00641537|19474574|P3|96-week Period|Lost to Follow-up|2
5638840|NCT00641537|19474575|P2|96-week Period|Lost to Follow-up|1
5638841|NCT00641537|19474576|P1|96-week Period|Lost to Follow-up|3
5638842|NCT00641537|19474569|P8|96-week Period|Adverse Event|0
5638843|NCT00641537|19474570|P7|96-week Period|Adverse Event|0
5638844|NCT00641537|19474571|P6|96-week Period|Adverse Event|0
5638845|NCT00641537|19474572|P5|96-week Period|Adverse Event|2
5638846|NCT00641537|19474573|P4|96-week Period|Adverse Event|0
5638847|NCT00641537|19474574|P3|96-week Period|Adverse Event|3
5638848|NCT00641537|19474575|P2|96-week Period|Adverse Event|1
5638849|NCT00641537|19474576|P1|96-week Period|Adverse Event|0
5638850|NCT00641147|19474664|P2|Completed 16 Months.|Lost to Follow-up|0
5638851|NCT00641147|19474665|P1|Completed 16 Months.|Lost to Follow-up|1
5638852|NCT00641147|19474664|P2|Completed 16 Months.|Physician Decision|0
5638853|NCT00641147|19474665|P1|Completed 16 Months.|Physician Decision|1
5638854|NCT00641147|19474664|P2|Completed 12 Months.|Withdrawal by Subject|1
5638855|NCT00641147|19474665|P1|Completed 12 Months.|Withdrawal by Subject|0
5638856|NCT00641147|19474664|P2|Completed 12 Months.|Physician Decision|1
5638857|NCT00641147|19474665|P1|Completed 12 Months.|Physician Decision|1
5638858|NCT00641147|19474664|P2|Completed 8 Months.|Withdrawal by Subject|1
5638859|NCT00641147|19474665|P1|Completed 8 Months.|Withdrawal by Subject|0
5638860|NCT00641147|19474664|P2|Completed 8 Months.|non compliance|0
5638861|NCT00641147|19474665|P1|Completed 8 Months.|non compliance|1
5638862|NCT00641147|19474664|P2|Completed 8 Months.|Physician Decision|1
5638863|NCT00641147|19474665|P1|Completed 8 Months.|Physician Decision|2
5638864|NCT00641147|19474664|P2|Completed 4 Months.|Adverse Event|0
5638865|NCT00641147|19474665|P1|Completed 4 Months.|Adverse Event|1
5638866|NCT00641147|19474664|P2|Completed 4 Months.|Physician Decision|0
5638867|NCT00641147|19474665|P1|Completed 4 Months.|Physician Decision|1
5638868|NCT00641056|19474718|P2|Overall Study|Sponsor Decision|2
5638869|NCT00641056|19474719|P1|Overall Study|Sponsor Decision|1
5638870|NCT00641056|19474718|P2|Overall Study|Subject Decision|19
5638871|NCT00641056|19474719|P1|Overall Study|Subject Decision|6
5638872|NCT00641056|19474718|P2|Overall Study|Entry Criteria Not Met|0
5638873|NCT00641056|19474719|P1|Overall Study|Entry Criteria Not Met|3
5638874|NCT00641056|19474718|P2|Overall Study|Protocol Violation|0
5638875|NCT00641056|19474719|P1|Overall Study|Protocol Violation|2
5638876|NCT00641056|19474718|P2|Overall Study|Physician Decision|1
5638877|NCT00641056|19474719|P1|Overall Study|Physician Decision|3
5638878|NCT00641056|19474718|P2|Overall Study|Lost to Follow-up|1
5638879|NCT00641056|19474719|P1|Overall Study|Lost to Follow-up|2
5638880|NCT00641056|19474718|P2|Overall Study|Adverse Event|2
5638881|NCT00641056|19474719|P1|Overall Study|Adverse Event|12
5638882|NCT00641043|19474747|P2|Overall Study|Other incl. lack of efficacy|2
5638883|NCT00641043|19474748|P1|Overall Study|Other incl. lack of efficacy|4
5638884|NCT00641043|19474747|P2|Overall Study|Withdrawal by Subject|4
5638885|NCT00641043|19474748|P1|Overall Study|Withdrawal by Subject|4
5638886|NCT00641043|19474747|P2|Overall Study|Lost to Follow-up|2
5638887|NCT00641043|19474748|P1|Overall Study|Lost to Follow-up|3
5638888|NCT00641043|19474747|P2|Overall Study|Protocol Violation|3
5638889|NCT00641043|19474748|P1|Overall Study|Protocol Violation|2
5638890|NCT00641043|19474747|P2|Overall Study|Adverse Event|4
5638891|NCT00641043|19474748|P1|Overall Study|Adverse Event|6
5638892|NCT00640926|19474785|P3|Overall Study|Withdrawal by Subject|1
5638893|NCT00640926|19474786|P2|Overall Study|Withdrawal by Subject|0
5638894|NCT00640926|19474787|P1|Overall Study|Withdrawal by Subject|1
5638895|NCT00640926|19474785|P3|Overall Study|Lost to Follow-up|2
5638896|NCT00640926|19474786|P2|Overall Study|Lost to Follow-up|1
5638897|NCT00640926|19474787|P1|Overall Study|Lost to Follow-up|3
5638898|NCT00640926|19474785|P3|Overall Study|Protocol Violation|2
5638899|NCT00640926|19474786|P2|Overall Study|Protocol Violation|0
5638900|NCT00640926|19474787|P1|Overall Study|Protocol Violation|2
5638901|NCT00640926|19474785|P3|Overall Study|Lack of Efficacy|1
5638902|NCT00640926|19474786|P2|Overall Study|Lack of Efficacy|2
5638903|NCT00640926|19474787|P1|Overall Study|Lack of Efficacy|0
5638904|NCT00640926|19474785|P3|Overall Study|Adverse Event|2
5638905|NCT00640926|19474786|P2|Overall Study|Adverse Event|3
5638906|NCT00640926|19474787|P1|Overall Study|Adverse Event|2
5638907|NCT00640835|19474800|P2|Overall Study|Other Reason|4
5638908|NCT00640835|19474801|P1|Overall Study|Other Reason|19
5638909|NCT00640835|19474800|P2|Overall Study|Lost to Follow-up|13
5638910|NCT00640835|19474801|P1|Overall Study|Lost to Follow-up|17
5638911|NCT00640835|19474800|P2|Overall Study|Protocol Violation|2
5638912|NCT00640835|19474801|P1|Overall Study|Protocol Violation|2
5638913|NCT00640835|19474800|P2|Overall Study|Sponsor's Decision|7
5638914|NCT00640835|19474801|P1|Overall Study|Sponsor's Decision|11
5638915|NCT00640835|19474800|P2|Overall Study|Physician Decision|14
5638916|NCT00640835|19474801|P1|Overall Study|Physician Decision|10
5638917|NCT00640835|19474800|P2|Overall Study|Withdrawal by Subject|14
5638918|NCT00640835|19474801|P1|Overall Study|Withdrawal by Subject|12
5638919|NCT00640835|19474800|P2|Overall Study|Adverse Event|3
5638920|NCT00640835|19474801|P1|Overall Study|Adverse Event|5
5638921|NCT00640614|19474865|P2|Overall Study|Lost to Follow-up|0
5638922|NCT00640614|19474866|P1|Overall Study|Lost to Follow-up|1
5638923|NCT00640601|19474908|P1|Overall Study|treatment naive, combination therapy|10
5638924|NCT00640601|19474908|P1|Overall Study|Physician Decision|8
5638925|NCT00640601|19474908|P1|Overall Study|Lost to Follow-up|9
5638926|NCT00640601|19474908|P1|Overall Study|Lack of Efficacy|16
5638927|NCT00640601|19474908|P1|Overall Study|Protocol Violation|6
5638928|NCT00640601|19474908|P1|Overall Study|Withdrawal by Subject|20
5638929|NCT00640601|19474908|P1|Overall Study|Adverse Event|43
5638930|NCT00640562|19474924|P2|Overall Study|Glycosylated Hemoglobin >8|0
5638931|NCT00640562|19474925|P1|Overall Study|Glycosylated Hemoglobin >8|1
5638932|NCT00640562|19474924|P2|Overall Study|Low study drug dose|1
5638933|NCT00640562|19474925|P1|Overall Study|Low study drug dose|0
5638934|NCT00640562|19474924|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
5638935|NCT00640562|19474925|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
5638936|NCT00640562|19474924|P2|Overall Study|Known risperidone intolerance|1
5638937|NCT00640562|19474925|P1|Overall Study|Known risperidone intolerance|0
5638938|NCT00640562|19474924|P2|Overall Study|Withdrawal by Subject|10
5638939|NCT00640562|19474925|P1|Overall Study|Withdrawal by Subject|6
5638940|NCT00640562|19474924|P2|Overall Study|Protocol Violation|4
5638941|NCT00640562|19474925|P1|Overall Study|Protocol Violation|2
5638942|NCT00640562|19474924|P2|Overall Study|Lack of Efficacy|4
5638943|NCT00640562|19474925|P1|Overall Study|Lack of Efficacy|1
5638944|NCT00640562|19474924|P2|Overall Study|Adverse Event|5
5638945|NCT00640562|19474925|P1|Overall Study|Adverse Event|8
5638946|NCT00640510|19474953|P2|Overall Study|Physician Decision|1
5638947|NCT00640510|19474954|P1|Overall Study|Physician Decision|0
5638948|NCT00640510|19474953|P2|Overall Study|Protocol Violation|0
5638949|NCT00640510|19474954|P1|Overall Study|Protocol Violation|1
5638950|NCT00640510|19474953|P2|Overall Study|Lack of Efficacy|1
5638951|NCT00640510|19474954|P1|Overall Study|Lack of Efficacy|0
5638952|NCT00640393|19474966|P3|Part 2|Adverse Event|0
5638953|NCT00640393|19474967|P2|Part 2|Adverse Event|1
5638954|NCT00640393|19474968|P1|Part 2|Adverse Event|0
5638955|NCT00640393|19474966|P3|Part 2|Non-adherence|0
5638956|NCT00640393|19474967|P2|Part 2|Non-adherence|1
5638957|NCT00640393|19474968|P1|Part 2|Non-adherence|0
5638958|NCT00640393|19474966|P3|Part 2|Withdrawal by Subject|1
5638959|NCT00640393|19474967|P2|Part 2|Withdrawal by Subject|6
5638960|NCT00640393|19474968|P1|Part 2|Withdrawal by Subject|0
5638961|NCT00640393|19474966|P3|Part 2|Lost to Follow-up|2
5638962|NCT00640393|19474967|P2|Part 2|Lost to Follow-up|2
5638963|NCT00640393|19474968|P1|Part 2|Lost to Follow-up|0
5638964|NCT00640393|19474966|P3|Randomization|Never randomized by site|0
5638965|NCT00640393|19474967|P2|Randomization|Never randomized by site|0
5638966|NCT00640393|19474968|P1|Randomization|Never randomized by site|2
5638967|NCT00640393|19474966|P3|Randomization|Withdrawn per protocol|0
5638968|NCT00640393|19474967|P2|Randomization|Withdrawn per protocol|0
5638969|NCT00640393|19474968|P1|Randomization|Withdrawn per protocol|17
5638970|NCT00640393|19474966|P3|Part 1|Withdrawal by Subject|0
5638971|NCT00640393|19474967|P2|Part 1|Withdrawal by Subject|0
5638972|NCT00640393|19474968|P1|Part 1|Withdrawal by Subject|3
5638973|NCT00640393|19474966|P3|Part 1|Lost to Follow-up|0
5638974|NCT00640393|19474967|P2|Part 1|Lost to Follow-up|0
5638975|NCT00640393|19474968|P1|Part 1|Lost to Follow-up|2
5638976|NCT00640341|19475033|P3|Overall Study|Adverse event and positive slit lamp|0
5638977|NCT00640341|19475034|P2|Overall Study|Adverse event and positive slit lamp|0
5638978|NCT00640341|19475035|P1|Overall Study|Adverse event and positive slit lamp|1
5638979|NCT00640341|19475033|P3|Overall Study|Ineligable at Baseline|2
5638980|NCT00640341|19475034|P2|Overall Study|Ineligable at Baseline|3
5638981|NCT00640341|19475035|P1|Overall Study|Ineligable at Baseline|5
5638982|NCT00640341|19475033|P3|Overall Study|Poor fit/Uncomfortable|0
5638983|NCT00640341|19475034|P2|Overall Study|Poor fit/Uncomfortable|0
5638984|NCT00640341|19475035|P1|Overall Study|Poor fit/Uncomfortable|4
5638985|NCT00640341|19475033|P3|Overall Study|Unacceptable Lens Movement|0
5638986|NCT00640341|19475034|P2|Overall Study|Unacceptable Lens Movement|0
5638987|NCT00640341|19475035|P1|Overall Study|Unacceptable Lens Movement|1
5638988|NCT00640341|19475033|P3|Overall Study|Withdrawal by Subject|1
5638989|NCT00640341|19475034|P2|Overall Study|Withdrawal by Subject|0
5638990|NCT00640341|19475035|P1|Overall Study|Withdrawal by Subject|4
5638991|NCT00640341|19475033|P3|Overall Study|Lost to Follow-up|0
5638992|NCT00640341|19475034|P2|Overall Study|Lost to Follow-up|0
5638993|NCT00640341|19475035|P1|Overall Study|Lost to Follow-up|2
5638994|NCT00640341|19475033|P3|Overall Study|Failure to Follow Subject Instructions|0
5638995|NCT00640341|19475034|P2|Overall Study|Failure to Follow Subject Instructions|0
5638996|NCT00640341|19475035|P1|Overall Study|Failure to Follow Subject Instructions|1
5638997|NCT00640341|19475033|P3|Overall Study|Inability to Maintain Wearing Schedule|0
5638998|NCT00640341|19475034|P2|Overall Study|Inability to Maintain Wearing Schedule|1
5638999|NCT00640341|19475035|P1|Overall Study|Inability to Maintain Wearing Schedule|1
5639000|NCT00640341|19475033|P3|Overall Study|Study Related Symptoms/Complaints|2
5639001|NCT00640341|19475034|P2|Overall Study|Study Related Symptoms/Complaints|1
5639002|NCT00640341|19475035|P1|Overall Study|Study Related Symptoms/Complaints|2
5639003|NCT00640341|19475033|P3|Overall Study|Positive Slit Lamp Findings|1
5639004|NCT00640341|19475034|P2|Overall Study|Positive Slit Lamp Findings|0
5639005|NCT00640341|19475035|P1|Overall Study|Positive Slit Lamp Findings|0
5639006|NCT00640341|19475033|P3|Overall Study|Adverse Event|1
5639007|NCT00640341|19475034|P2|Overall Study|Adverse Event|0
5639008|NCT00640341|19475035|P1|Overall Study|Adverse Event|0
5639009|NCT00640328|19475055|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
5639010|NCT00640328|19475056|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
5639011|NCT00640328|19475057|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
5639012|NCT00640328|19475058|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
5639013|NCT00640328|19475059|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
5639014|NCT00640328|19475060|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
5639015|NCT00640328|19475055|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5639016|NCT00640328|19475056|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5639017|NCT00640328|19475057|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5639018|NCT00640328|19475058|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
5639019|NCT00640328|19475059|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5639020|NCT00640328|19475060|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
5639021|NCT00640328|19475055|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5639022|NCT00640328|19475056|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
5639023|NCT00640328|19475057|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5639024|NCT00640328|19475058|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5639025|NCT00640328|19475059|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5639026|NCT00640328|19475060|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
5639027|NCT00640328|19475055|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
5639028|NCT00640328|19475056|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
5639029|NCT00640328|19475057|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
5639030|NCT00640328|19475058|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
5639031|NCT00640328|19475059|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
5639032|NCT00640328|19475060|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
5639033|NCT00640315|19475226|P2|Overall Study|Withdrawal by Subject|1
5639034|NCT00640315|19475227|P1|Overall Study|Withdrawal by Subject|0
5639035|NCT00640289|19475353|P1|Overall Study|Missing status|5
5639036|NCT00640289|19475353|P1|Overall Study|Transferred to another center|1
5639037|NCT00640289|19475353|P1|Overall Study|Data collected under different amendment|2
5639038|NCT00640289|19475353|P1|Overall Study|Lost to Follow-up|1
5639039|NCT00640289|19475353|P1|Overall Study|Withdrawal by Subject|1
5639040|NCT00640289|19475353|P1|Overall Study|Death|3
5639041|NCT00640224|19475465|P4|Overall Study|Headaches|0
5639042|NCT00640224|19475466|P3|Overall Study|Headaches|0
5639043|NCT00640224|19475467|P2|Overall Study|Headaches|1
5639044|NCT00640224|19475468|P1|Overall Study|Headaches|0
5639045|NCT00640224|19475465|P4|Overall Study|Withdrawal by Subject|0
5639046|NCT00640224|19475466|P3|Overall Study|Withdrawal by Subject|0
5639047|NCT00640224|19475467|P2|Overall Study|Withdrawal by Subject|0
5639048|NCT00640224|19475468|P1|Overall Study|Withdrawal by Subject|1
5639049|NCT00640224|19475465|P4|Overall Study|Lost to Follow-up|0
5639050|NCT00640224|19475466|P3|Overall Study|Lost to Follow-up|0
5639051|NCT00640224|19475467|P2|Overall Study|Lost to Follow-up|2
5639052|NCT00640224|19475468|P1|Overall Study|Lost to Follow-up|5
5639053|NCT00640146|19475568|P2|Overall Study|Randomized but not treated|3
5639054|NCT00640146|19475569|P1|Overall Study|Randomized but not treated|1
5639055|NCT00640146|19475568|P2|Overall Study|Withdrawal by Subject|1
5639056|NCT00640146|19475569|P1|Overall Study|Withdrawal by Subject|1
5639057|NCT00640146|19475568|P2|Overall Study|Lack of Efficacy|1
5639058|NCT00640146|19475569|P1|Overall Study|Lack of Efficacy|0
5639059|NCT00640146|19475568|P2|Overall Study|Lost to Follow-up|1
5639060|NCT00640146|19475569|P1|Overall Study|Lost to Follow-up|0
5639061|NCT00640146|19475568|P2|Overall Study|Adverse Event|0
5639062|NCT00640146|19475569|P1|Overall Study|Adverse Event|2
5639063|NCT00640133|19475581|P2|Open Label Phase (Month 4-12)|Adverse Event|0
5639064|NCT00640133|19475582|P1|Open Label Phase (Month 4-12)|Adverse Event|1
5639065|NCT00640133|19475581|P2|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
5639066|NCT00640133|19475582|P1|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
5639067|NCT00640133|19475581|P2|Open Label Phase (Month 4-12)|Lack of Efficacy|0
5639068|NCT00640133|19475582|P1|Open Label Phase (Month 4-12)|Lack of Efficacy|1
5639069|NCT00640042|19475602|P1|Enrollment|Did not receive study drug|83
5639070|NCT00640016|19475618|P4|Overall Study|Adverse Event|1
5639071|NCT00640016|19475619|P3|Overall Study|Adverse Event|0
5639072|NCT00640016|19475620|P2|Overall Study|Adverse Event|0
5639073|NCT00640016|19475621|P1|Overall Study|Adverse Event|0
5639074|NCT00640016|19475618|P4|Overall Study|Study termination|2
5639075|NCT00640016|19475619|P3|Overall Study|Study termination|3
5639076|NCT00640016|19475620|P2|Overall Study|Study termination|1
5639077|NCT00640016|19475621|P1|Overall Study|Study termination|2
5639078|NCT00640016|19475618|P4|Overall Study|Withdrawal by Subject|0
5639079|NCT00640016|19475619|P3|Overall Study|Withdrawal by Subject|0
5639080|NCT00640016|19475620|P2|Overall Study|Withdrawal by Subject|1
5639081|NCT00640016|19475621|P1|Overall Study|Withdrawal by Subject|0
5639082|NCT00639769|19475673|P1|Overall Study|Withdrawal by Subject|4
5639083|NCT00639769|19475673|P1|Overall Study|Disease progression|26
5639084|NCT00639769|19475673|P1|Overall Study|Lack of Efficacy|1
5639085|NCT00639769|19475673|P1|Overall Study|Adverse Event|7
5639086|NCT00639769|19475673|P1|Overall Study|Death|2
5639087|NCT00639678|19475690|P4|Overall Study|Lack of Compliance|0
5639088|NCT00639678|19475691|P3|Overall Study|Lack of Compliance|1
5639089|NCT00639678|19475692|P2|Overall Study|Lack of Compliance|0
5639090|NCT00639678|19475693|P1|Overall Study|Lack of Compliance|0
5639091|NCT00639678|19475690|P4|Overall Study|Adverse Event|0
5639092|NCT00639678|19475691|P3|Overall Study|Adverse Event|0
5639093|NCT00639678|19475692|P2|Overall Study|Adverse Event|1
5639094|NCT00639678|19475693|P1|Overall Study|Adverse Event|0
5639095|NCT00639678|19475690|P4|Overall Study|Lost to Follow-up|0
5639096|NCT00639678|19475691|P3|Overall Study|Lost to Follow-up|6
5639097|NCT00639678|19475692|P2|Overall Study|Lost to Follow-up|0
5639098|NCT00639678|19475693|P1|Overall Study|Lost to Follow-up|1
5639099|NCT00639678|19475690|P4|Overall Study|Withdrawal by Subject|0
5639100|NCT00639678|19475691|P3|Overall Study|Withdrawal by Subject|4
5639101|NCT00639678|19475692|P2|Overall Study|Withdrawal by Subject|0
5639102|NCT00639678|19475693|P1|Overall Study|Withdrawal by Subject|3
5639103|NCT00639509|19475758|P1|Overall Study|Death|1
5639104|NCT00639457|19475766|P2|Overall Study|Withdrawal by Subject|3
5639105|NCT00639457|19475767|P1|Overall Study|Withdrawal by Subject|2
5639106|NCT00639379|19475826|P2|Period 1 - 2 Weeks|lens issue|0
5639107|NCT00639379|19475827|P1|Period 1 - 2 Weeks|lens issue|3
5639108|NCT00639379|19475826|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
5639109|NCT00639379|19475827|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
5639110|NCT00639223|19475843|P2|Overall Study|Lost to Follow-up|2
5639111|NCT00639223|19475844|P1|Overall Study|Lost to Follow-up|0
5639112|NCT00639002|19475884|P1|Overall Study|Lack of Efficacy|1
5639113|NCT00639002|19475884|P1|Overall Study|Physician Decision|6
5639114|NCT00639002|19475884|P1|Overall Study|Disease progression|3
5639115|NCT00639002|19475884|P1|Overall Study|Protocol Violation|1
5639116|NCT00639002|19475884|P1|Overall Study|Adverse Event|1
5639117|NCT00639002|19475884|P1|Overall Study|Death|1
5639118|NCT00638989|19475893|P3|Overall Study|Lost to Follow-up|1
5639119|NCT00638989|19475894|P2|Overall Study|Lost to Follow-up|0
5639120|NCT00638989|19475895|P1|Overall Study|Lost to Follow-up|0
5639121|NCT00638963|19475935|P2|Overall Study|Withdrawal by Subject|0
5639122|NCT00638963|19475936|P1|Overall Study|Withdrawal by Subject|1
5639123|NCT00638846|19475977|P2|Overall Study|lens issue|3
5639124|NCT00638846|19475978|P1|Overall Study|lens issue|1
5639125|NCT00638846|19475977|P2|Overall Study|Lost to Follow-up|2
5639126|NCT00638846|19475978|P1|Overall Study|Lost to Follow-up|3
5639127|NCT00638846|19475977|P2|Overall Study|Adverse Event|1
5639128|NCT00638846|19475978|P1|Overall Study|Adverse Event|0
5639129|NCT00638690|19476022|P2|Overall Study|Lost to Follow-up|2
5639130|NCT00638690|19476023|P1|Overall Study|Lost to Follow-up|4
5639131|NCT00638690|19476022|P2|Overall Study|Withdrawal by Subject|5
5639132|NCT00638690|19476023|P1|Overall Study|Withdrawal by Subject|22
5639133|NCT00638690|19476022|P2|Overall Study|Death|335
5639134|NCT00638690|19476023|P1|Overall Study|Death|655
5639135|NCT00638508|19476043|P2|Overall Study|Physician Decision|2
5639136|NCT00638508|19476044|P1|Overall Study|Physician Decision|5
5639137|NCT00638456|19476090|P2|Overall Study|Withdrawal by Subject|2
5639138|NCT00638456|19476091|P1|Overall Study|Withdrawal by Subject|6
5639139|NCT00638443|19476101|P2|First Intervention|Adverse Event|1
5639140|NCT00638443|19476102|P1|First Intervention|Adverse Event|2
5639141|NCT00638404|19476132|P2|Overall Study|Physician Decision|0
5639142|NCT00638404|19476133|P1|Overall Study|Physician Decision|8
5639143|NCT00638378|19476145|P1|Overall Study|Physician Decision|4
5639144|NCT00638378|19476145|P1|Overall Study|Disease progression|15
5639145|NCT00638378|19476145|P1|Overall Study|Adverse Event|1
5639146|NCT00638378|19476145|P1|Overall Study|Death|2
5639147|NCT00638235|19476185|P9|Overall Study|Lost to Follow-up|18
5639148|NCT00638235|19476186|P8|Overall Study|Lost to Follow-up|1
5639149|NCT00638235|19476187|P7|Overall Study|Lost to Follow-up|0
5639150|NCT00638235|19476188|P6|Overall Study|Lost to Follow-up|26
5639151|NCT00638235|19476189|P5|Overall Study|Lost to Follow-up|13
5639152|NCT00638235|19476190|P4|Overall Study|Lost to Follow-up|10
5639153|NCT00638235|19476191|P3|Overall Study|Lost to Follow-up|18
5639154|NCT00638235|19476192|P2|Overall Study|Lost to Follow-up|3
5639155|NCT00638235|19476193|P1|Overall Study|Lost to Follow-up|31
5639156|NCT00638183|19476603|P1|Overall Study|Other reason not defined above|27
5639157|NCT00638183|19476603|P1|Overall Study|Lost to Follow-up|46
5639158|NCT00638183|19476603|P1|Overall Study|Physician Decision|9
5639159|NCT00638183|19476603|P1|Overall Study|Lack of Efficacy|14
5639160|NCT00638183|19476603|P1|Overall Study|Adverse Event|23
5639161|NCT00638157|19476612|P2|Overall Study|Randomized, not treated|0
5639162|NCT00638157|19476613|P1|Overall Study|Randomized, not treated|2
5639163|NCT00638157|19476612|P2|Overall Study|Other|2
5639164|NCT00638157|19476613|P1|Overall Study|Other|1
5639165|NCT00638157|19476612|P2|Overall Study|Physician Decision|0
5639166|NCT00638157|19476613|P1|Overall Study|Physician Decision|1
5639167|NCT00638157|19476612|P2|Overall Study|Lost to Follow-up|0
5639168|NCT00638157|19476613|P1|Overall Study|Lost to Follow-up|1
5639169|NCT00638157|19476612|P2|Overall Study|Microbiological failure|0
5639170|NCT00638157|19476613|P1|Overall Study|Microbiological failure|1
5639171|NCT00638157|19476612|P2|Overall Study|Clinical (symptomatic) failure|1
5639172|NCT00638157|19476613|P1|Overall Study|Clinical (symptomatic) failure|1
5639173|NCT00638157|19476612|P2|Overall Study|Adverse Event|1
5639174|NCT00638157|19476613|P1|Overall Study|Adverse Event|0
5639175|NCT00638027|19476623|P2|Overall Study|Adverse Event|2
5639176|NCT00638027|19476624|P1|Overall Study|Adverse Event|0
5639177|NCT00637806|19476671|P4|Extension Phase|Study Discontinued|1
5639178|NCT00637806|19476672|P3|Extension Phase|Study Discontinued|0
5639179|NCT00637806|19476673|P2|Extension Phase|Study Discontinued|0
5639180|NCT00637806|19476674|P1|Extension Phase|Study Discontinued|0
5639181|NCT00637806|19476671|P4|Double-blind Phase|Study Discontinued|0
5639182|NCT00637806|19476672|P3|Double-blind Phase|Study Discontinued|1
5639183|NCT00637806|19476673|P2|Double-blind Phase|Study Discontinued|0
5639184|NCT00637806|19476674|P1|Double-blind Phase|Study Discontinued|2
5639185|NCT00637728|19476709|P3|Double-blind Phase|Study Discontinued|0
5639186|NCT00637728|19476710|P2|Double-blind Phase|Study Discontinued|1
5639187|NCT00637728|19476711|P1|Double-blind Phase|Study Discontinued|1
5639188|NCT00637728|19476709|P3|Double-blind Phase|Non-compliance|0
5639189|NCT00637728|19476710|P2|Double-blind Phase|Non-compliance|0
5639190|NCT00637728|19476711|P1|Double-blind Phase|Non-compliance|2
5639191|NCT00637728|19476709|P3|Double-blind Phase|Adverse Event|0
5639192|NCT00637728|19476710|P2|Double-blind Phase|Adverse Event|0
5639193|NCT00637728|19476711|P1|Double-blind Phase|Adverse Event|1
5639194|NCT00637572|19476726|P2|Overall Study|Illicit Drug Use|0
5639195|NCT00637572|19476727|P1|Overall Study|Illicit Drug Use|1
5639196|NCT00637572|19476726|P2|Overall Study|Withdrawal by Subject|2
5639197|NCT00637572|19476727|P1|Overall Study|Withdrawal by Subject|0
5639198|NCT00637572|19476726|P2|Overall Study|Physician Decision|1
5639199|NCT00637572|19476727|P1|Overall Study|Physician Decision|1
5639200|NCT00637572|19476726|P2|Overall Study|Lost to Follow-up|1
5639201|NCT00637572|19476727|P1|Overall Study|Lost to Follow-up|0
5639202|NCT00637572|19476726|P2|Overall Study|Death|1
5639203|NCT00637572|19476727|P1|Overall Study|Death|0
5639204|NCT00637572|19476726|P2|Overall Study|Adverse Event|2
5639205|NCT00637572|19476727|P1|Overall Study|Adverse Event|1
5639206|NCT00637416|19476766|P2|Overall Study|Unable to take study drug|1
5639207|NCT00637416|19476767|P1|Overall Study|Unable to take study drug|0
5639208|NCT00637416|19476766|P2|Overall Study|Lost to Follow-up|1
5639209|NCT00637416|19476767|P1|Overall Study|Lost to Follow-up|1
5639210|NCT00637377|19476777|P4|Overall Study|Other (no further information available)|5
5639211|NCT00637377|19476778|P3|Overall Study|Other (no further information available)|10
5639212|NCT00637377|19476779|P2|Overall Study|Other (no further information available)|6
5639213|NCT00637377|19476780|P1|Overall Study|Other (no further information available)|7
5639214|NCT00637377|19476777|P4|Overall Study|Withdrawal by Subject|11
5639215|NCT00637377|19476778|P3|Overall Study|Withdrawal by Subject|13
5639216|NCT00637377|19476779|P2|Overall Study|Withdrawal by Subject|15
5639217|NCT00637377|19476780|P1|Overall Study|Withdrawal by Subject|11
5639218|NCT00637377|19476777|P4|Overall Study|Protocol Violation|0
5639219|NCT00637377|19476778|P3|Overall Study|Protocol Violation|1
5639220|NCT00637377|19476779|P2|Overall Study|Protocol Violation|1
5639221|NCT00637377|19476780|P1|Overall Study|Protocol Violation|2
5639222|NCT00637377|19476777|P4|Overall Study|Lost to Follow-up|2
5639223|NCT00637377|19476778|P3|Overall Study|Lost to Follow-up|2
5639224|NCT00637377|19476779|P2|Overall Study|Lost to Follow-up|1
5639225|NCT00637377|19476780|P1|Overall Study|Lost to Follow-up|4
5639226|NCT00637377|19476777|P4|Overall Study|Lack of Efficacy|1
5639227|NCT00637377|19476778|P3|Overall Study|Lack of Efficacy|1
5639228|NCT00637377|19476779|P2|Overall Study|Lack of Efficacy|0
5639229|NCT00637377|19476780|P1|Overall Study|Lack of Efficacy|0
5639230|NCT00637377|19476777|P4|Overall Study|Death|1
5639231|NCT00637377|19476778|P3|Overall Study|Death|2
5639232|NCT00637377|19476779|P2|Overall Study|Death|3
5639233|NCT00637377|19476780|P1|Overall Study|Death|1
5639234|NCT00637377|19476777|P4|Overall Study|Adverse Event|9
5639235|NCT00637377|19476778|P3|Overall Study|Adverse Event|8
5639236|NCT00637377|19476779|P2|Overall Study|Adverse Event|6
5639237|NCT00637377|19476780|P1|Overall Study|Adverse Event|2
5639238|NCT00637273|19476829|P3|Overall Study|Loss of Glucose Control|1
5639239|NCT00637273|19476830|P2|Overall Study|Loss of Glucose Control|1
5639240|NCT00637273|19476831|P1|Overall Study|Loss of Glucose Control|1
5639241|NCT00637273|19476829|P3|Overall Study|Administrative|0
5639242|NCT00637273|19476830|P2|Overall Study|Administrative|0
5639243|NCT00637273|19476831|P1|Overall Study|Administrative|2
5639244|NCT00637273|19476829|P3|Overall Study|Investigator Decision|1
5639245|NCT00637273|19476830|P2|Overall Study|Investigator Decision|3
5639246|NCT00637273|19476831|P1|Overall Study|Investigator Decision|1
5639247|NCT00637273|19476829|P3|Overall Study|Withdrawal of Consent|18
5639248|NCT00637273|19476830|P2|Overall Study|Withdrawal of Consent|6
5639249|NCT00637273|19476831|P1|Overall Study|Withdrawal of Consent|18
5639250|NCT00637273|19476829|P3|Overall Study|Protocol Violation|1
5639251|NCT00637273|19476830|P2|Overall Study|Protocol Violation|4
5639252|NCT00637273|19476831|P1|Overall Study|Protocol Violation|2
5639253|NCT00637273|19476829|P3|Overall Study|Lost to Follow-up|13
5639254|NCT00637273|19476830|P2|Overall Study|Lost to Follow-up|9
5639255|NCT00637273|19476831|P1|Overall Study|Lost to Follow-up|8
5639256|NCT00637273|19476829|P3|Overall Study|Adverse Event|7
5639257|NCT00637273|19476830|P2|Overall Study|Adverse Event|5
5639258|NCT00637273|19476831|P1|Overall Study|Adverse Event|11
5639259|NCT00637195|19476889|P2|Overall Study|Withdrawal by Subject|1
5639260|NCT00637195|19476890|P1|Overall Study|Withdrawal by Subject|0
5639261|NCT00637195|19476889|P2|Overall Study|Other|0
5639262|NCT00637195|19476890|P1|Overall Study|Other|2
5639263|NCT00637195|19476889|P2|Overall Study|Lost to Follow-up|0
5639264|NCT00637195|19476890|P1|Overall Study|Lost to Follow-up|1
5639265|NCT00637156|19476926|P2|Overall Study|Lost to Follow-up|16
5639266|NCT00637156|19476927|P1|Overall Study|Lost to Follow-up|10
5639267|NCT00637156|19476926|P2|Overall Study|Death|1
5639268|NCT00637156|19476927|P1|Overall Study|Death|0
5639269|NCT00637156|19476926|P2|Overall Study|Withdrawal by Subject|7
5639270|NCT00637156|19476927|P1|Overall Study|Withdrawal by Subject|0
5639271|NCT00637000|19476969|P2|Overall Study|Withdrawal by Subject|3
5639272|NCT00637000|19476970|P1|Overall Study|Withdrawal by Subject|4
5639273|NCT00636987|19477010|P1|Overall Study|5 year visit window not complete|69
5639274|NCT00636987|19477010|P1|Overall Study|Lost to Follow-up|63
5639275|NCT00636987|19477010|P1|Overall Study|Explanted|13
5639276|NCT00636987|19477010|P1|Overall Study|Death|44
5639277|NCT00636961|19477020|P2|Period 2|Adverse Event|0
5639278|NCT00636961|19477021|P1|Period 2|Adverse Event|1
5639279|NCT00636961|19477020|P2|Period 1|Administrative problems|1
5639280|NCT00636961|19477021|P1|Period 1|Administrative problems|1
5639281|NCT00636818|19477035|P1|Overall Study|Withdrawal by Subject|4
5639282|NCT00636818|19477035|P1|Overall Study|Protocol Violation|1
5639283|NCT00636818|19477035|P1|Overall Study|Entry Criteria Exclusion|3
5639284|NCT00636818|19477035|P1|Overall Study|Lost to Follow-up|2
5639285|NCT00636818|19477035|P1|Overall Study|Adverse Event|1
5639286|NCT00636792|19477060|P1|Overall Study|Other|3
5639287|NCT00636792|19477060|P1|Overall Study|Withdrawal by Subject|3
5639288|NCT00636792|19477060|P1|Overall Study|Progressive Disease|4
5639289|NCT00636792|19477060|P1|Overall Study|Physician Decision|7
5639290|NCT00636792|19477060|P1|Overall Study|Adverse Event|16
5639291|NCT00636675|19477076|P2|Overall Study|Withdrawal by Subject|10
5639292|NCT00636675|19477077|P1|Overall Study|Withdrawal by Subject|19
5639293|NCT00636675|19477076|P2|Overall Study|Lost to Follow-up|31
5639294|NCT00636675|19477077|P1|Overall Study|Lost to Follow-up|121
5639295|NCT00636636|19477120|P2|Overall Study|Withdrawal by Subject|9
5639296|NCT00636636|19477121|P1|Overall Study|Withdrawal by Subject|4
5639297|NCT00636636|19477120|P2|Overall Study|Death|1
5639298|NCT00636636|19477121|P1|Overall Study|Death|0
5639299|NCT00636636|19477120|P2|Overall Study|Lost to Follow-up|1
5639300|NCT00636636|19477121|P1|Overall Study|Lost to Follow-up|0
5639301|NCT00636636|19477120|P2|Overall Study|Protocol Violation|2
5639302|NCT00636636|19477121|P1|Overall Study|Protocol Violation|2
5639303|NCT00636636|19477120|P2|Overall Study|Lack of Efficacy|12
5639304|NCT00636636|19477121|P1|Overall Study|Lack of Efficacy|7
5639305|NCT00636636|19477120|P2|Overall Study|Adverse Event|8
5639306|NCT00636636|19477121|P1|Overall Study|Adverse Event|19
5639307|NCT00636636|19477120|P2|Overall Study|Other reason|6
5639308|NCT00636636|19477121|P1|Overall Study|Other reason|4
5639309|NCT00636610|19477137|P2|Overall Study|Reason for discontinuation not available|2
5639310|NCT00636610|19477138|P1|Overall Study|Reason for discontinuation not available|3
5639311|NCT00636610|19477137|P2|Overall Study|Disease progression - clinical|3
5639312|NCT00636610|19477138|P1|Overall Study|Disease progression - clinical|8
5639313|NCT00636610|19477137|P2|Overall Study|Disease progression - radiographic|51
5639314|NCT00636610|19477138|P1|Overall Study|Disease progression - radiographic|41
5639315|NCT00636610|19477137|P2|Overall Study|Subject decision to withdraw|11
5639316|NCT00636610|19477138|P1|Overall Study|Subject decision to withdraw|15
5639317|NCT00636610|19477137|P2|Overall Study|Physician decision to withdraw patient|9
5639318|NCT00636610|19477138|P1|Overall Study|Physician decision to withdraw patient|15
5639319|NCT00636610|19477137|P2|Overall Study|Death|3
5639320|NCT00636610|19477138|P1|Overall Study|Death|6
5639321|NCT00636610|19477137|P2|Overall Study|Adverse Event|4
5639322|NCT00636610|19477138|P1|Overall Study|Adverse Event|4
5639323|NCT00636506|19477148|P1|Overall Study|Procedure aborted|1
5639324|NCT00636506|19477148|P1|Overall Study|Withdrawal by Subject|6
5639325|NCT00636506|19477148|P1|Overall Study|Explanted|1
5639326|NCT00636506|19477148|P1|Overall Study|Lost to Follow-up|8
5639327|NCT00636441|19477195|P7|Overall Study|Screen Failure|17
5639328|NCT00636441|19477196|P6|Overall Study|Screen Failure|0
5639329|NCT00636441|19477197|P5|Overall Study|Screen Failure|0
5639330|NCT00636441|19477198|P4|Overall Study|Screen Failure|0
5639331|NCT00636441|19477199|P3|Overall Study|Screen Failure|0
5639332|NCT00636441|19477200|P2|Overall Study|Screen Failure|0
5639333|NCT00636441|19477201|P1|Overall Study|Screen Failure|0
5639334|NCT00636441|19477195|P7|Overall Study|Late, ineligible|1
5639335|NCT00636441|19477196|P6|Overall Study|Late, ineligible|0
5639336|NCT00636441|19477197|P5|Overall Study|Late, ineligible|0
5639337|NCT00636441|19477198|P4|Overall Study|Late, ineligible|0
5639338|NCT00636441|19477199|P3|Overall Study|Late, ineligible|0
5639339|NCT00636441|19477200|P2|Overall Study|Late, ineligible|0
5639340|NCT00636441|19477201|P1|Overall Study|Late, ineligible|0
5639341|NCT00636441|19477195|P7|Overall Study|Adverse Event|0
5639342|NCT00636441|19477196|P6|Overall Study|Adverse Event|1
5639343|NCT00636441|19477197|P5|Overall Study|Adverse Event|0
5639344|NCT00636441|19477198|P4|Overall Study|Adverse Event|0
5639345|NCT00636441|19477199|P3|Overall Study|Adverse Event|1
5639346|NCT00636441|19477200|P2|Overall Study|Adverse Event|1
5639347|NCT00636441|19477201|P1|Overall Study|Adverse Event|0
5639348|NCT00636363|19477244|P3|Overall Study|Withdrawal by Subject|2
5639349|NCT00636363|19477245|P2|Overall Study|Withdrawal by Subject|3
5639350|NCT00636363|19477246|P1|Overall Study|Withdrawal by Subject|1
5639351|NCT00636363|19477244|P3|Overall Study|Lost to Follow-up|2
5639352|NCT00636363|19477245|P2|Overall Study|Lost to Follow-up|4
5639353|NCT00636363|19477246|P1|Overall Study|Lost to Follow-up|3
5639354|NCT00636363|19477244|P3|Overall Study|Protocol Violation|0
5639355|NCT00636363|19477245|P2|Overall Study|Protocol Violation|3
5639356|NCT00636363|19477246|P1|Overall Study|Protocol Violation|0
5639357|NCT00636363|19477244|P3|Overall Study|Lack of motivation|1
5639358|NCT00636363|19477245|P2|Overall Study|Lack of motivation|0
5639359|NCT00636363|19477246|P1|Overall Study|Lack of motivation|1
5639360|NCT00636363|19477244|P3|Overall Study|Missed > 1 visit|3
5639361|NCT00636363|19477245|P2|Overall Study|Missed > 1 visit|1
5639362|NCT00636363|19477246|P1|Overall Study|Missed > 1 visit|0
5639363|NCT00636363|19477244|P3|Overall Study|Met ineligibility criteria|3
5639364|NCT00636363|19477245|P2|Overall Study|Met ineligibility criteria|0
5639365|NCT00636363|19477246|P1|Overall Study|Met ineligibility criteria|0
5639366|NCT00636363|19477244|P3|Overall Study|Study related symptoms/complaints|4
5639367|NCT00636363|19477245|P2|Overall Study|Study related symptoms/complaints|7
5639368|NCT00636363|19477246|P1|Overall Study|Study related symptoms/complaints|8
5639369|NCT00636363|19477244|P3|Overall Study|Positive slit lamp finding|1
5639370|NCT00636363|19477245|P2|Overall Study|Positive slit lamp finding|2
5639371|NCT00636363|19477246|P1|Overall Study|Positive slit lamp finding|0
5639372|NCT00636363|19477244|P3|Overall Study|Adverse Event|1
5639373|NCT00636363|19477245|P2|Overall Study|Adverse Event|0
5639374|NCT00636363|19477246|P1|Overall Study|Adverse Event|0
5639375|NCT00636363|19477244|P3|Overall Study|Conjunctivitis|1
5639376|NCT00636363|19477245|P2|Overall Study|Conjunctivitis|0
5639377|NCT00636363|19477246|P1|Overall Study|Conjunctivitis|0
5639378|NCT00636207|19477267|P7|Overall Study|Withdrawal by Subject|0
5639379|NCT00636207|19477268|P6|Overall Study|Withdrawal by Subject|0
5639380|NCT00636207|19477269|P5|Overall Study|Withdrawal by Subject|1
5639381|NCT00636207|19477270|P4|Overall Study|Withdrawal by Subject|0
5639382|NCT00636207|19477271|P3|Overall Study|Withdrawal by Subject|0
5639383|NCT00636207|19477272|P2|Overall Study|Withdrawal by Subject|1
5639384|NCT00636207|19477273|P1|Overall Study|Withdrawal by Subject|0
5639385|NCT00636207|19477267|P7|Overall Study|Adverse Event|0
5639386|NCT00636207|19477268|P6|Overall Study|Adverse Event|0
5639387|NCT00636207|19477269|P5|Overall Study|Adverse Event|0
5639388|NCT00636207|19477270|P4|Overall Study|Adverse Event|0
5639389|NCT00636207|19477271|P3|Overall Study|Adverse Event|0
5639390|NCT00636207|19477272|P2|Overall Study|Adverse Event|0
5639391|NCT00636207|19477273|P1|Overall Study|Adverse Event|1
5639392|NCT00636194|19477337|P2|Overall Study|Protocol Violation|0
5639393|NCT00636194|19477338|P1|Overall Study|Protocol Violation|2
5639394|NCT00636194|19477337|P2|Overall Study|Study related symptoms and complaints|0
5639395|NCT00636194|19477338|P1|Overall Study|Study related symptoms and complaints|1
5639396|NCT00636181|19477351|P3|Overall Study|Withdrawal by Subject|10
5639397|NCT00636181|19477352|P2|Overall Study|Withdrawal by Subject|6
5639398|NCT00636181|19477353|P1|Overall Study|Withdrawal by Subject|8
5639399|NCT00636168|19477381|P2|Long Term Follow-Up|Death|9
5639400|NCT00636168|19477382|P1|Long Term Follow-Up|Death|8
5639401|NCT00636168|19477381|P2|Long Term Follow-Up|Participant withdrew consent|2
5639402|NCT00636168|19477382|P1|Long Term Follow-Up|Participant withdrew consent|0
5639403|NCT00636168|19477381|P2|Long Term Follow-Up|Lost to Follow-up|3
5639404|NCT00636168|19477382|P1|Long Term Follow-Up|Lost to Follow-up|3
5639405|NCT00636168|19477381|P2|Treated With Study Drug|Other reason|3
5639406|NCT00636168|19477382|P1|Treated With Study Drug|Other reason|1
5639407|NCT00636168|19477381|P2|Treated With Study Drug|No longer meets study criteria|0
5639408|NCT00636168|19477382|P1|Treated With Study Drug|No longer meets study criteria|1
5639409|NCT00636168|19477381|P2|Treated With Study Drug|Pregnancy|0
5639410|NCT00636168|19477382|P1|Treated With Study Drug|Pregnancy|1
5639411|NCT00636168|19477381|P2|Treated With Study Drug|Death|0
5639412|NCT00636168|19477382|P1|Treated With Study Drug|Death|3
5639413|NCT00636168|19477381|P2|Treated With Study Drug|Poor/non-compliance|3
5639414|NCT00636168|19477382|P1|Treated With Study Drug|Poor/non-compliance|1
5639415|NCT00636168|19477381|P2|Treated With Study Drug|Participant withdrew consent|21
5639416|NCT00636168|19477382|P1|Treated With Study Drug|Participant withdrew consent|16
5639417|NCT00636168|19477381|P2|Treated With Study Drug|Adverse Event|22
5639418|NCT00636168|19477382|P1|Treated With Study Drug|Adverse Event|250
5639419|NCT00636168|19477381|P2|Treated With Study Drug|Recurrence of disease|282
5639420|NCT00636168|19477382|P1|Treated With Study Drug|Recurrence of disease|135
5639421|NCT00636168|19477381|P2|Randomized to Study Drug|No longer meets study criteria|0
5639422|NCT00636168|19477382|P1|Randomized to Study Drug|No longer meets study criteria|1
5639423|NCT00636168|19477381|P2|Randomized to Study Drug|Adverse Event|0
5639424|NCT00636168|19477382|P1|Randomized to Study Drug|Adverse Event|1
5639425|NCT00636168|19477381|P2|Randomized to Study Drug|Withdrawal by Subject|2
5639426|NCT00636168|19477382|P1|Randomized to Study Drug|Withdrawal by Subject|2
5639427|NCT00636155|19477410|P1|Overall Study|Physician Decision|5
5639428|NCT00636155|19477410|P1|Overall Study|Stem cell transplant|1
5639429|NCT00636155|19477410|P1|Overall Study|Withdrawal by Subject|3
5639430|NCT00636155|19477410|P1|Overall Study|Lack of Efficacy|1
5639431|NCT00636155|19477410|P1|Overall Study|Adverse Event|8
5639432|NCT00635999|19477452|P3|Overall Study|Withdrawal by Subject|1
5639433|NCT00635999|19477453|P2|Overall Study|Withdrawal by Subject|2
5639434|NCT00635999|19477454|P1|Overall Study|Withdrawal by Subject|4
5639435|NCT00635882|19477471|P6|Overall Study|Protocol Violation|0
5639436|NCT00635882|19477472|P5|Overall Study|Protocol Violation|0
5639437|NCT00635882|19477473|P4|Overall Study|Protocol Violation|0
5639438|NCT00635882|19477474|P3|Overall Study|Protocol Violation|0
5639439|NCT00635882|19477475|P2|Overall Study|Protocol Violation|0
5639440|NCT00635882|19477476|P1|Overall Study|Protocol Violation|1
5639441|NCT00635804|19477606|P8|Overall Study|Withdrawal by Subject|0
5639442|NCT00635804|19477607|P7|Overall Study|Withdrawal by Subject|0
5639443|NCT00635804|19477608|P6|Overall Study|Withdrawal by Subject|0
5639444|NCT00635804|19477609|P5|Overall Study|Withdrawal by Subject|0
5639445|NCT00635804|19477610|P4|Overall Study|Withdrawal by Subject|0
5639446|NCT00635804|19477611|P3|Overall Study|Withdrawal by Subject|0
5639447|NCT00635804|19477612|P2|Overall Study|Withdrawal by Subject|0
5639448|NCT00635804|19477613|P1|Overall Study|Withdrawal by Subject|1
5639449|NCT00635804|19477606|P8|Overall Study|Adverse Event|0
5639450|NCT00635804|19477607|P7|Overall Study|Adverse Event|0
5639451|NCT00635804|19477608|P6|Overall Study|Adverse Event|1
5639452|NCT00635804|19477609|P5|Overall Study|Adverse Event|0
5639453|NCT00635804|19477610|P4|Overall Study|Adverse Event|0
5639454|NCT00635804|19477611|P3|Overall Study|Adverse Event|0
5639455|NCT00635804|19477612|P2|Overall Study|Adverse Event|0
5639456|NCT00635804|19477613|P1|Overall Study|Adverse Event|0
5639457|NCT00635778|19477717|P7|Overall Study|Progressive disease|4
5639458|NCT00635778|19477718|P6|Overall Study|Progressive disease|14
5639459|NCT00635778|19477719|P5|Overall Study|Progressive disease|5
5639460|NCT00635778|19477720|P4|Overall Study|Progressive disease|4
5639461|NCT00635778|19477721|P3|Overall Study|Progressive disease|3
5639462|NCT00635778|19477722|P2|Overall Study|Progressive disease|3
5639463|NCT00635778|19477723|P1|Overall Study|Progressive disease|0
5639464|NCT00635778|19477717|P7|Overall Study|Withdrawal by Subject|1
5639465|NCT00635778|19477718|P6|Overall Study|Withdrawal by Subject|1
5639466|NCT00635778|19477719|P5|Overall Study|Withdrawal by Subject|0
5639467|NCT00635778|19477720|P4|Overall Study|Withdrawal by Subject|1
5639468|NCT00635778|19477721|P3|Overall Study|Withdrawal by Subject|0
5639469|NCT00635778|19477722|P2|Overall Study|Withdrawal by Subject|0
5639470|NCT00635778|19477723|P1|Overall Study|Withdrawal by Subject|0
5639471|NCT00635778|19477717|P7|Overall Study|Adverse Event|1
5639472|NCT00635778|19477718|P6|Overall Study|Adverse Event|6
5639473|NCT00635778|19477719|P5|Overall Study|Adverse Event|3
5639474|NCT00635778|19477720|P4|Overall Study|Adverse Event|3
5639475|NCT00635778|19477721|P3|Overall Study|Adverse Event|0
5639476|NCT00635778|19477722|P2|Overall Study|Adverse Event|0
5639477|NCT00635778|19477723|P1|Overall Study|Adverse Event|1
5639478|NCT00635661|19477794|P1|Overall Study|Withdrawal by Subject|4
5639479|NCT00635648|19477798|P1|Overall Study|Other reason|2
5639480|NCT00635648|19477798|P1|Overall Study|Noncompliance with protocol|1
5639481|NCT00635648|19477798|P1|Overall Study|No improvement after 7-10 days treatment|4
5639482|NCT00635648|19477798|P1|Overall Study|Use of other antifungal agent needed|1
5639483|NCT00635648|19477798|P1|Overall Study|Rapid progression of baseline disease|4
5639484|NCT00635648|19477798|P1|Overall Study|Physician Decision|4
5639485|NCT00635648|19477798|P1|Overall Study|Withdrawal by Subject|9
5639486|NCT00635648|19477798|P1|Overall Study|Adverse Event|12
5639487|NCT00635570|19477820|P2|Overall Study|Early termination(No sexual activity)|1
5639488|NCT00635570|19477821|P1|Overall Study|Early termination(No sexual activity)|1
5639489|NCT00635570|19477820|P2|Overall Study|Did not complete survey|1
5639490|NCT00635570|19477821|P1|Overall Study|Did not complete survey|2
5639491|NCT00635570|19477820|P2|Overall Study|Physician Decision|0
5639492|NCT00635570|19477821|P1|Overall Study|Physician Decision|1
5639493|NCT00635570|19477820|P2|Overall Study|Adverse Event|0
5639494|NCT00635570|19477821|P1|Overall Study|Adverse Event|2
5639495|NCT00635570|19477820|P2|Overall Study|Withdrawal by Subject|1
5639496|NCT00635570|19477821|P1|Overall Study|Withdrawal by Subject|1
5639497|NCT00635570|19477820|P2|Overall Study|Lost to Follow-up|8
5639498|NCT00635570|19477821|P1|Overall Study|Lost to Follow-up|8
5639499|NCT00635492|19477835|P2|Overall Study|Withdrawal by Subject|45
5639500|NCT00635492|19477836|P1|Overall Study|Withdrawal by Subject|82
5639501|NCT00635492|19477835|P2|Overall Study|Sponsor decision|3
5639502|NCT00635492|19477836|P1|Overall Study|Sponsor decision|2
5639503|NCT00635492|19477835|P2|Overall Study|Physician Decision|22
5639504|NCT00635492|19477836|P1|Overall Study|Physician Decision|32
5639505|NCT00635492|19477835|P2|Overall Study|Lost to Follow-up|172
5639506|NCT00635492|19477836|P1|Overall Study|Lost to Follow-up|151
5639507|NCT00635492|19477835|P2|Overall Study|Death|40
5639508|NCT00635492|19477836|P1|Overall Study|Death|12
5639509|NCT00635427|19477909|P5|Overall Study|Withdrawal Of Consent|2
5639510|NCT00635427|19477910|P4|Overall Study|Withdrawal Of Consent|2
5639511|NCT00635427|19477911|P3|Overall Study|Withdrawal Of Consent|0
5639512|NCT00635427|19477912|P2|Overall Study|Withdrawal Of Consent|0
5639513|NCT00635427|19477913|P1|Overall Study|Withdrawal Of Consent|0
5639514|NCT00635427|19477909|P5|Overall Study|Termination Of Study By Sponsor|6
5639515|NCT00635427|19477910|P4|Overall Study|Termination Of Study By Sponsor|6
5639516|NCT00635427|19477911|P3|Overall Study|Termination Of Study By Sponsor|10
5639517|NCT00635427|19477912|P2|Overall Study|Termination Of Study By Sponsor|6
5639518|NCT00635427|19477913|P1|Overall Study|Termination Of Study By Sponsor|12
5639519|NCT00635427|19477909|P5|Overall Study|Death|0
5639520|NCT00635427|19477910|P4|Overall Study|Death|1
5639521|NCT00635427|19477911|P3|Overall Study|Death|0
5639522|NCT00635427|19477912|P2|Overall Study|Death|0
5639523|NCT00635427|19477913|P1|Overall Study|Death|0
5639524|NCT00635427|19477909|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
5639525|NCT00635427|19477910|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
5639526|NCT00635427|19477911|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
5639527|NCT00635427|19477912|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
5639528|NCT00635427|19477913|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
5639529|NCT00635349|19477952|P2|Overall Study|Adverse Event|9
5639530|NCT00635349|19477953|P1|Overall Study|Adverse Event|11
5639531|NCT00635349|19477952|P2|Overall Study|Lost to Follow-up|3
5639532|NCT00635349|19477953|P1|Overall Study|Lost to Follow-up|4
5639533|NCT00635349|19477952|P2|Overall Study|Withdrawal by Subject|8
5639534|NCT00635349|19477953|P1|Overall Study|Withdrawal by Subject|3
5639535|NCT00635349|19477952|P2|Overall Study|Protocol Violation|22
5639536|NCT00635349|19477953|P1|Overall Study|Protocol Violation|18
5639537|NCT00635349|19477952|P2|Overall Study|Other|6
5639538|NCT00635349|19477953|P1|Overall Study|Other|8
5639539|NCT00635219|19478007|P5|Overall Study|Administrative or Other Reasons|1
5639540|NCT00635219|19478008|P4|Overall Study|Administrative or Other Reasons|0
5639541|NCT00635219|19478009|P3|Overall Study|Administrative or Other Reasons|1
5639542|NCT00635219|19478010|P2|Overall Study|Administrative or Other Reasons|1
5639543|NCT00635219|19478011|P1|Overall Study|Administrative or Other Reasons|0
5639544|NCT00635219|19478007|P5|Overall Study|Lost to Follow-up|3
5639545|NCT00635219|19478008|P4|Overall Study|Lost to Follow-up|0
5639546|NCT00635219|19478009|P3|Overall Study|Lost to Follow-up|2
5639547|NCT00635219|19478010|P2|Overall Study|Lost to Follow-up|0
5639548|NCT00635219|19478011|P1|Overall Study|Lost to Follow-up|0
5639549|NCT00635219|19478007|P5|Overall Study|Withdrawal of Consent|8
5639550|NCT00635219|19478008|P4|Overall Study|Withdrawal of Consent|11
5639551|NCT00635219|19478009|P3|Overall Study|Withdrawal of Consent|8
5639552|NCT00635219|19478010|P2|Overall Study|Withdrawal of Consent|6
5639553|NCT00635219|19478011|P1|Overall Study|Withdrawal of Consent|8
5639554|NCT00635219|19478007|P5|Overall Study|Protocol Violation|4
5639555|NCT00635219|19478008|P4|Overall Study|Protocol Violation|2
5639556|NCT00635219|19478009|P3|Overall Study|Protocol Violation|3
5639557|NCT00635219|19478010|P2|Overall Study|Protocol Violation|2
5639558|NCT00635219|19478011|P1|Overall Study|Protocol Violation|0
5639559|NCT00635219|19478007|P5|Overall Study|Non-compliance With Study Product|1
5639560|NCT00635219|19478008|P4|Overall Study|Non-compliance With Study Product|2
5639561|NCT00635219|19478009|P3|Overall Study|Non-compliance With Study Product|0
5639562|NCT00635219|19478010|P2|Overall Study|Non-compliance With Study Product|0
5639563|NCT00635219|19478011|P1|Overall Study|Non-compliance With Study Product|0
5639564|NCT00635219|19478007|P5|Overall Study|Lack of Efficacy|6
5639565|NCT00635219|19478008|P4|Overall Study|Lack of Efficacy|4
5639566|NCT00635219|19478009|P3|Overall Study|Lack of Efficacy|3
5639567|NCT00635219|19478010|P2|Overall Study|Lack of Efficacy|6
5639568|NCT00635219|19478011|P1|Overall Study|Lack of Efficacy|5
5639569|NCT00635219|19478007|P5|Overall Study|Adverse Event|19
5639570|NCT00635219|19478008|P4|Overall Study|Adverse Event|15
5639571|NCT00635219|19478009|P3|Overall Study|Adverse Event|18
5639572|NCT00635219|19478010|P2|Overall Study|Adverse Event|10
5639573|NCT00635219|19478011|P1|Overall Study|Adverse Event|12
5639574|NCT00635154|19478074|P1|Overall Study|Still on treatment|21
5639575|NCT00635154|19478074|P1|Overall Study|Other|4
5639576|NCT00635154|19478074|P1|Overall Study|Alternative Treatment|8
5639577|NCT00635102|19478117|P2|Overall Study|Withdrawal by Subject|8
5639578|NCT00635102|19478118|P1|Overall Study|Withdrawal by Subject|7
5639579|NCT00635089|19478212|P1|Overall Study|Other|31
5639580|NCT00635089|19478212|P1|Overall Study|Lost to Follow-up|8
5639581|NCT00635089|19478212|P1|Overall Study|Protocol Deviation|4
5639582|NCT00635089|19478212|P1|Overall Study|Lack of Efficacy|28
5639583|NCT00635089|19478212|P1|Overall Study|Adverse Event|7
5639584|NCT00635050|19478239|P1|Overall Study|Withdrawal by Subject|1
5639585|NCT00635024|19478246|P1|Overall Study|Adverse Event|1
5639586|NCT00634933|19478266|P5|Part B: Week 24 to Week 52|Other|1
5639587|NCT00634933|19478267|P4|Part B: Week 24 to Week 52|Other|0
5639588|NCT00634933|19478268|P3|Part B: Week 24 to Week 52|Other|5
5639589|NCT00634933|19478269|P2|Part B: Week 24 to Week 52|Other|0
5639590|NCT00634933|19478270|P1|Part B: Week 24 to Week 52|Other|0
5639591|NCT00634933|19478266|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
5639592|NCT00634933|19478267|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
5639593|NCT00634933|19478268|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
5639594|NCT00634933|19478269|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
5639595|NCT00634933|19478270|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
5639596|NCT00634933|19478266|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
5639597|NCT00634933|19478267|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
5639598|NCT00634933|19478268|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
5639599|NCT00634933|19478269|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
5639600|NCT00634933|19478270|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
5639601|NCT00634933|19478266|P5|Part B: Week 24 to Week 52|Protocol Violation|1
5639602|NCT00634933|19478267|P4|Part B: Week 24 to Week 52|Protocol Violation|0
5639603|NCT00634933|19478268|P3|Part B: Week 24 to Week 52|Protocol Violation|0
5639604|NCT00634933|19478269|P2|Part B: Week 24 to Week 52|Protocol Violation|0
5639605|NCT00634933|19478270|P1|Part B: Week 24 to Week 52|Protocol Violation|0
5639606|NCT00634933|19478266|P5|Part B: Week 24 to Week 52|Physician Decision|0
5639607|NCT00634933|19478267|P4|Part B: Week 24 to Week 52|Physician Decision|0
5639608|NCT00634933|19478268|P3|Part B: Week 24 to Week 52|Physician Decision|1
5639609|NCT00634933|19478269|P2|Part B: Week 24 to Week 52|Physician Decision|1
5639610|NCT00634933|19478270|P1|Part B: Week 24 to Week 52|Physician Decision|0
5639611|NCT00634933|19478266|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
5639612|NCT00634933|19478267|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
5639613|NCT00634933|19478268|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
5639614|NCT00634933|19478269|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
5639615|NCT00634933|19478270|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
5639616|NCT00634933|19478266|P5|Part B: Week 24 to Week 52|Adverse Event|0
5639617|NCT00634933|19478267|P4|Part B: Week 24 to Week 52|Adverse Event|1
5639618|NCT00634933|19478268|P3|Part B: Week 24 to Week 52|Adverse Event|1
5639619|NCT00634933|19478269|P2|Part B: Week 24 to Week 52|Adverse Event|1
5639620|NCT00634933|19478270|P1|Part B: Week 24 to Week 52|Adverse Event|0
5639621|NCT00634933|19478266|P5|Between Part A and Part B|Physician Decision|0
5639622|NCT00634933|19478267|P4|Between Part A and Part B|Physician Decision|0
5639623|NCT00634933|19478268|P3|Between Part A and Part B|Physician Decision|0
5639624|NCT00634933|19478269|P2|Between Part A and Part B|Physician Decision|1
5639625|NCT00634933|19478270|P1|Between Part A and Part B|Physician Decision|0
5639626|NCT00634933|19478266|P5|Part A: Baseline to Week 24|Other|0
5639627|NCT00634933|19478267|P4|Part A: Baseline to Week 24|Other|0
5639628|NCT00634933|19478268|P3|Part A: Baseline to Week 24|Other|5
5639629|NCT00634933|19478269|P2|Part A: Baseline to Week 24|Other|8
5639630|NCT00634933|19478270|P1|Part A: Baseline to Week 24|Other|1
5639631|NCT00634933|19478266|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
5639632|NCT00634933|19478267|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
5639633|NCT00634933|19478268|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
5639634|NCT00634933|19478269|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
5639635|NCT00634933|19478270|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
5639636|NCT00634933|19478266|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
5639637|NCT00634933|19478267|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
5639638|NCT00634933|19478268|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
5639639|NCT00634933|19478269|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
5639640|NCT00634933|19478270|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
5639641|NCT00634933|19478266|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
5639642|NCT00634933|19478267|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
5639643|NCT00634933|19478268|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
5639644|NCT00634933|19478269|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
5639645|NCT00634933|19478270|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
5639646|NCT00634933|19478266|P5|Part A: Baseline to Week 24|Investigator Request|0
5639647|NCT00634933|19478267|P4|Part A: Baseline to Week 24|Investigator Request|0
5639648|NCT00634933|19478268|P3|Part A: Baseline to Week 24|Investigator Request|1
5639649|NCT00634933|19478269|P2|Part A: Baseline to Week 24|Investigator Request|1
5639650|NCT00634933|19478270|P1|Part A: Baseline to Week 24|Investigator Request|1
5639651|NCT00634933|19478266|P5|Part A: Baseline to Week 24|Failed to Return|0
5639652|NCT00634933|19478267|P4|Part A: Baseline to Week 24|Failed to Return|0
5639653|NCT00634933|19478268|P3|Part A: Baseline to Week 24|Failed to Return|0
5639654|NCT00634933|19478269|P2|Part A: Baseline to Week 24|Failed to Return|0
5639655|NCT00634933|19478270|P1|Part A: Baseline to Week 24|Failed to Return|1
5639656|NCT00634933|19478266|P5|Part A: Baseline to Week 24|Death|0
5639657|NCT00634933|19478267|P4|Part A: Baseline to Week 24|Death|0
5639658|NCT00634933|19478268|P3|Part A: Baseline to Week 24|Death|0
5639659|NCT00634933|19478269|P2|Part A: Baseline to Week 24|Death|0
5639660|NCT00634933|19478270|P1|Part A: Baseline to Week 24|Death|1
5639661|NCT00634933|19478266|P5|Part A: Baseline to Week 24|Adverse Event|0
5639662|NCT00634933|19478267|P4|Part A: Baseline to Week 24|Adverse Event|0
5639663|NCT00634933|19478268|P3|Part A: Baseline to Week 24|Adverse Event|8
5639664|NCT00634933|19478269|P2|Part A: Baseline to Week 24|Adverse Event|4
5639665|NCT00634933|19478270|P1|Part A: Baseline to Week 24|Adverse Event|4
5639666|NCT00634920|19478339|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
5639667|NCT00634920|19478340|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
5639668|NCT00634920|19478341|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
5639669|NCT00634920|19478339|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
5639670|NCT00634920|19478340|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
5639671|NCT00634920|19478341|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
5639672|NCT00634920|19478339|P3|Period 2 - Post-Randomization|Death|0
5639673|NCT00634920|19478340|P2|Period 2 - Post-Randomization|Death|5
5639674|NCT00634920|19478341|P1|Period 2 - Post-Randomization|Death|2
5639675|NCT00634920|19478339|P3|Period 2 - Post-Randomization|Rejection|0
5639676|NCT00634920|19478340|P2|Period 2 - Post-Randomization|Rejection|5
5639677|NCT00634920|19478341|P1|Period 2 - Post-Randomization|Rejection|11
5639678|NCT00634920|19478339|P3|Period 2 - Post-Randomization|Adverse Event|0
5639679|NCT00634920|19478340|P2|Period 2 - Post-Randomization|Adverse Event|9
5639680|NCT00634920|19478341|P1|Period 2 - Post-Randomization|Adverse Event|37
5639681|NCT00634920|19478339|P3|Period 1 - Pre-Randomization|Other issues|6
5639682|NCT00634920|19478340|P2|Period 1 - Pre-Randomization|Other issues|0
5639683|NCT00634920|19478341|P1|Period 1 - Pre-Randomization|Other issues|0
5639684|NCT00634920|19478339|P3|Period 1 - Pre-Randomization|Non-Compliance|3
5639685|NCT00634920|19478340|P2|Period 1 - Pre-Randomization|Non-Compliance|0
5639686|NCT00634920|19478341|P1|Period 1 - Pre-Randomization|Non-Compliance|0
5639687|NCT00634920|19478339|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
5639688|NCT00634920|19478340|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
5639689|NCT00634920|19478341|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
5639690|NCT00634920|19478339|P3|Period 1 - Pre-Randomization|Rejections|55
5639691|NCT00634920|19478340|P2|Period 1 - Pre-Randomization|Rejections|0
5639692|NCT00634920|19478341|P1|Period 1 - Pre-Randomization|Rejections|0
5639693|NCT00634920|19478339|P3|Period 1 - Pre-Randomization|Wound healing problems|16
5639694|NCT00634920|19478340|P2|Period 1 - Pre-Randomization|Wound healing problems|0
5639695|NCT00634920|19478341|P1|Period 1 - Pre-Randomization|Wound healing problems|0
5639696|NCT00634920|19478339|P3|Period 1 - Pre-Randomization|Adverse Event|36
5639697|NCT00634920|19478340|P2|Period 1 - Pre-Randomization|Adverse Event|0
5639698|NCT00634920|19478341|P1|Period 1 - Pre-Randomization|Adverse Event|0
5639699|NCT00634907|19478385|P2|Overall Study|Withdrawal by Subject|8
5639700|NCT00634907|19478386|P1|Overall Study|Withdrawal by Subject|11
5639701|NCT00634907|19478385|P2|Overall Study|Physician Decision|9
5639702|NCT00634907|19478386|P1|Overall Study|Physician Decision|3
5639703|NCT00634907|19478385|P2|Overall Study|Withdrawal by Subject|0
5639704|NCT00634907|19478386|P1|Overall Study|Withdrawal by Subject|3
5639705|NCT00634842|19478410|P2|Overall Study|Subject off study drug for too long|1
5639706|NCT00634842|19478411|P1|Overall Study|Subject off study drug for too long|0
5639707|NCT00634842|19478410|P2|Overall Study|No wish to keep taking Avandia|1
5639708|NCT00634842|19478411|P1|Overall Study|No wish to keep taking Avandia|0
5639709|NCT00634842|19478410|P2|Overall Study|No need of study drug to treat diabetes|1
5639710|NCT00634842|19478411|P1|Overall Study|No need of study drug to treat diabetes|0
5639711|NCT00634842|19478410|P2|Overall Study|Discontinued due to injection|2
5639712|NCT00634842|19478411|P1|Overall Study|Discontinued due to injection|0
5639713|NCT00634842|19478410|P2|Overall Study|Lack of time and intolerance to drug|1
5639714|NCT00634842|19478411|P1|Overall Study|Lack of time and intolerance to drug|0
5639715|NCT00634842|19478410|P2|Overall Study|Withdrawal by Subject|3
5639716|NCT00634842|19478411|P1|Overall Study|Withdrawal by Subject|1
5639717|NCT00634842|19478410|P2|Overall Study|Physician Decision|0
5639718|NCT00634842|19478411|P1|Overall Study|Physician Decision|1
5639719|NCT00634842|19478410|P2|Overall Study|Lost to Follow-up|2
5639720|NCT00634842|19478411|P1|Overall Study|Lost to Follow-up|1
5639721|NCT00634842|19478410|P2|Overall Study|Inclusion criteria were not met|0
5639722|NCT00634842|19478411|P1|Overall Study|Inclusion criteria were not met|1
5639723|NCT00634842|19478410|P2|Overall Study|Move to another state|0
5639724|NCT00634842|19478411|P1|Overall Study|Move to another state|1
5639725|NCT00634842|19478410|P2|Overall Study|Protocol Violation|4
5639726|NCT00634842|19478411|P1|Overall Study|Protocol Violation|8
5639727|NCT00634842|19478410|P2|Overall Study|Adverse Event|3
5639728|NCT00634842|19478411|P1|Overall Study|Adverse Event|2
5639729|NCT00634803|19478426|P3|Overall Study|Lost to Follow-up|7
5639730|NCT00634803|19478427|P2|Overall Study|Lost to Follow-up|7
5639731|NCT00634803|19478428|P1|Overall Study|Lost to Follow-up|6
5639732|NCT00634751|19478446|P4|Pancreatic and Bilial Tract Cancer|Death|1
5639733|NCT00634751|19478447|P3|Pancreatic and Bilial Tract Cancer|Death|1
5639734|NCT00634751|19478448|P2|Pancreatic and Bilial Tract Cancer|Death|0
5639735|NCT00634751|19478449|P1|Pancreatic and Bilial Tract Cancer|Death|0
5639736|NCT00634751|19478446|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
5639737|NCT00634751|19478447|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
5639738|NCT00634751|19478448|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
5639739|NCT00634751|19478449|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
5639740|NCT00634751|19478446|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
5639741|NCT00634751|19478447|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
5639742|NCT00634751|19478448|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
5639743|NCT00634751|19478449|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
5639744|NCT00634647|19478467|P1|Overall Study|declined to participate before treatment|1
5639745|NCT00634647|19478467|P1|Overall Study|refused further treatment|3
5639746|NCT00634647|19478467|P1|Overall Study|death on study|3
5639747|NCT00634569|19478487|P2|Overall Study|Physician Decision|1
5639748|NCT00634569|19478488|P1|Overall Study|Physician Decision|0
5639749|NCT00634569|19478487|P2|Overall Study|Withdrawal by Subject|4
5639750|NCT00634569|19478488|P1|Overall Study|Withdrawal by Subject|0
5639751|NCT00634543|19478502|P2|Overall Study|Lost to Follow-up|1
5639752|NCT00634543|19478503|P1|Overall Study|Lost to Follow-up|0
5639753|NCT00634543|19478502|P2|Overall Study|Withdrawal by Subject|4
5639754|NCT00634543|19478503|P1|Overall Study|Withdrawal by Subject|4
5639755|NCT00634543|19478502|P2|Overall Study|Adverse Event|11
5639756|NCT00634543|19478503|P1|Overall Study|Adverse Event|11
5639757|NCT00634543|19478502|P2|Overall Study|Protocol Violation|3
5639758|NCT00634543|19478503|P1|Overall Study|Protocol Violation|3
5639759|NCT00634543|19478502|P2|Overall Study|Other|2
5639760|NCT00634543|19478503|P1|Overall Study|Other|1
5639761|NCT00634504|19478521|P2|Overall Study|Protocol Violation|0
5639762|NCT00634504|19478522|P1|Overall Study|Protocol Violation|1
5639763|NCT00634244|19478581|P3|Overall Study|Other complicating disease|0
5639764|NCT00634244|19478582|P2|Overall Study|Other complicating disease|1
5639765|NCT00634244|19478583|P1|Overall Study|Other complicating disease|0
5639766|NCT00634244|19478581|P3|Overall Study|Disease progression/relapse|0
5639767|NCT00634244|19478582|P2|Overall Study|Disease progression/relapse|1
5639768|NCT00634244|19478583|P1|Overall Study|Disease progression/relapse|0
5639769|NCT00634244|19478581|P3|Overall Study|Physician Decision|0
5639770|NCT00634244|19478582|P2|Overall Study|Physician Decision|1
5639771|NCT00634244|19478583|P1|Overall Study|Physician Decision|0
5639772|NCT00634244|19478581|P3|Overall Study|Withdrawal by Subject|0
5639773|NCT00634244|19478582|P2|Overall Study|Withdrawal by Subject|1
5639774|NCT00634244|19478583|P1|Overall Study|Withdrawal by Subject|0
5639775|NCT00634244|19478581|P3|Overall Study|Adverse Event|0
5639776|NCT00634244|19478582|P2|Overall Study|Adverse Event|2
5639777|NCT00634244|19478583|P1|Overall Study|Adverse Event|0
5639778|NCT00634244|19478581|P3|Overall Study|Death|0
5639779|NCT00634244|19478582|P2|Overall Study|Death|6
5639780|NCT00634244|19478583|P1|Overall Study|Death|1
5639781|NCT00634244|19478581|P3|Overall Study|Never started treatment|0
5639782|NCT00634244|19478582|P2|Overall Study|Never started treatment|1
5639783|NCT00634244|19478583|P1|Overall Study|Never started treatment|0
5639784|NCT00634179|19478594|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
5639785|NCT00634114|19478613|P3|Overall Study|Other reason|1
5639786|NCT00634114|19478614|P2|Overall Study|Other reason|1
5639787|NCT00634114|19478615|P1|Overall Study|Other reason|1
5639788|NCT00634114|19478613|P3|Overall Study|Difficult to continue|1
5639789|NCT00634114|19478614|P2|Overall Study|Difficult to continue|1
5639790|NCT00634114|19478615|P1|Overall Study|Difficult to continue|3
5639791|NCT00634114|19478613|P3|Overall Study|Recurrence of reflux esophagitis|21
5639792|NCT00634114|19478614|P2|Overall Study|Recurrence of reflux esophagitis|15
5639793|NCT00634114|19478615|P1|Overall Study|Recurrence of reflux esophagitis|5
5639794|NCT00634114|19478613|P3|Overall Study|Incorrect enrolment|0
5639795|NCT00634114|19478614|P2|Overall Study|Incorrect enrolment|1
5639796|NCT00634114|19478615|P1|Overall Study|Incorrect enrolment|0
5639797|NCT00634114|19478613|P3|Overall Study|Pregnancy|0
5639798|NCT00634114|19478614|P2|Overall Study|Pregnancy|0
5639799|NCT00634114|19478615|P1|Overall Study|Pregnancy|1
5639800|NCT00634114|19478613|P3|Overall Study|Protocol Violation|1
5639801|NCT00634114|19478614|P2|Overall Study|Protocol Violation|3
5639802|NCT00634114|19478615|P1|Overall Study|Protocol Violation|3
5639803|NCT00634114|19478613|P3|Overall Study|Lost to Follow-up|1
5639804|NCT00634114|19478614|P2|Overall Study|Lost to Follow-up|0
5639805|NCT00634114|19478615|P1|Overall Study|Lost to Follow-up|0
5639806|NCT00634114|19478613|P3|Overall Study|Withdrawal by Subject|11
5639807|NCT00634114|19478614|P2|Overall Study|Withdrawal by Subject|6
5639808|NCT00634114|19478615|P1|Overall Study|Withdrawal by Subject|9
5639809|NCT00634114|19478613|P3|Overall Study|Adverse Event|3
5639810|NCT00634114|19478614|P2|Overall Study|Adverse Event|8
5639811|NCT00634114|19478615|P1|Overall Study|Adverse Event|6
5639812|NCT00634101|19478631|P2|Overall Study|Lost to Follow-up|0
5639813|NCT00634101|19478632|P1|Overall Study|Lost to Follow-up|2
5639814|NCT00634101|19478631|P2|Overall Study|Study Terminated|3
5639815|NCT00634101|19478632|P1|Overall Study|Study Terminated|3
5639816|NCT00634088|19478666|P4|Time Period 3: Dose Level 3|Progressive disease|0
5639817|NCT00634088|19478667|P3|Time Period 3: Dose Level 3|Progressive disease|1
5639818|NCT00634088|19478668|P2|Time Period 3: Dose Level 3|Progressive disease|0
5639819|NCT00634088|19478669|P1|Time Period 3: Dose Level 3|Progressive disease|0
5639820|NCT00634088|19478666|P4|Time Period 2: Dose Level 2|Progressive disease|0
5639821|NCT00634088|19478667|P3|Time Period 2: Dose Level 2|Progressive disease|0
5639822|NCT00634088|19478668|P2|Time Period 2: Dose Level 2|Progressive disease|1
5639823|NCT00634088|19478669|P1|Time Period 2: Dose Level 2|Progressive disease|0
5639824|NCT00634088|19478666|P4|Time Period 2: Dose Level 2|Adverse Event|0
5639825|NCT00634088|19478667|P3|Time Period 2: Dose Level 2|Adverse Event|0
5639826|NCT00634088|19478668|P2|Time Period 2: Dose Level 2|Adverse Event|2
5639827|NCT00634088|19478669|P1|Time Period 2: Dose Level 2|Adverse Event|0
5639828|NCT00634088|19478666|P4|Time Period 1: Dose Level 1|Adverse Event|0
5639829|NCT00634088|19478667|P3|Time Period 1: Dose Level 1|Adverse Event|0
5639830|NCT00634088|19478668|P2|Time Period 1: Dose Level 1|Adverse Event|0
5639831|NCT00634088|19478669|P1|Time Period 1: Dose Level 1|Adverse Event|3
5639832|NCT00634088|19478666|P4|Time Period 1: Dose Level 1|Physician Decision|0
5639833|NCT00634088|19478667|P3|Time Period 1: Dose Level 1|Physician Decision|0
5639834|NCT00634088|19478668|P2|Time Period 1: Dose Level 1|Physician Decision|0
5639835|NCT00634088|19478669|P1|Time Period 1: Dose Level 1|Physician Decision|1
5639836|NCT00634088|19478666|P4|Time Period 1: Dose Level 1|Disease progression|0
5639837|NCT00634088|19478667|P3|Time Period 1: Dose Level 1|Disease progression|0
5639838|NCT00634088|19478668|P2|Time Period 1: Dose Level 1|Disease progression|0
5639839|NCT00634088|19478669|P1|Time Period 1: Dose Level 1|Disease progression|2
5639840|NCT00634049|19478720|P1|Overall Study|Screening failure|1
5639841|NCT00634049|19478720|P1|Overall Study|Died prior to receiving study drug|1
5639842|NCT00634049|19478720|P1|Overall Study|Never received study drug|1
5639843|NCT00634036|19478799|P2|Overall Study|Withdrawal by Subject|1
5639844|NCT00634036|19478800|P1|Overall Study|Withdrawal by Subject|1
5639845|NCT00634036|19478799|P2|Overall Study|Lost to Follow-up|1
5639846|NCT00634036|19478800|P1|Overall Study|Lost to Follow-up|1
5639847|NCT00634010|19478814|P2|Overall Study|Non-Compliant|1
5639848|NCT00634010|19478815|P1|Overall Study|Non-Compliant|1
5639849|NCT00634010|19478814|P2|Overall Study|Disease Progression|1
5639850|NCT00634010|19478815|P1|Overall Study|Disease Progression|1
5639851|NCT00634010|19478814|P2|Overall Study|Physician Decision|1
5639852|NCT00634010|19478815|P1|Overall Study|Physician Decision|1
5639853|NCT00634010|19478814|P2|Overall Study|Withdrawal by Subject|6
5639854|NCT00634010|19478815|P1|Overall Study|Withdrawal by Subject|5
5639855|NCT00634010|19478814|P2|Overall Study|Adverse Event|5
5639856|NCT00634010|19478815|P1|Overall Study|Adverse Event|2
5639857|NCT00633984|19478823|P2|Overall Study|Hospitalized|0
5639858|NCT00633984|19478824|P1|Overall Study|Hospitalized|1
5639859|NCT00633984|19478823|P2|Overall Study|Withdrawal by Subject|7
5639860|NCT00633984|19478824|P1|Overall Study|Withdrawal by Subject|8
5639861|NCT00633984|19478823|P2|Overall Study|Lost to Follow-up|6
5639862|NCT00633984|19478824|P1|Overall Study|Lost to Follow-up|0
5639863|NCT00633945|19478832|P1|Overall Study|Physician Decision|2
5639864|NCT00633932|19478848|P3|Overall Study|Moved Away|0
5639865|NCT00633932|19478849|P2|Overall Study|Moved Away|0
5639866|NCT00633932|19478850|P1|Overall Study|Moved Away|1
5639867|NCT00633932|19478848|P3|Overall Study|Doctor's judgement|0
5639868|NCT00633932|19478849|P2|Overall Study|Doctor's judgement|0
5639869|NCT00633932|19478850|P1|Overall Study|Doctor's judgement|1
5639870|NCT00633932|19478848|P3|Overall Study|Physician Decision|1
5639871|NCT00633932|19478849|P2|Overall Study|Physician Decision|0
5639872|NCT00633932|19478850|P1|Overall Study|Physician Decision|0
5639873|NCT00633932|19478848|P3|Overall Study|Protocol Violation|3
5639874|NCT00633932|19478849|P2|Overall Study|Protocol Violation|2
5639875|NCT00633932|19478850|P1|Overall Study|Protocol Violation|5
5639876|NCT00633932|19478848|P3|Overall Study|Lost to Follow-up|2
5639877|NCT00633932|19478849|P2|Overall Study|Lost to Follow-up|0
5639878|NCT00633932|19478850|P1|Overall Study|Lost to Follow-up|1
5639879|NCT00633932|19478848|P3|Overall Study|Withdrawal by Subject|1
5639880|NCT00633932|19478849|P2|Overall Study|Withdrawal by Subject|9
5639881|NCT00633932|19478850|P1|Overall Study|Withdrawal by Subject|3
5639882|NCT00633932|19478848|P3|Overall Study|Adverse Event|4
5639883|NCT00633932|19478849|P2|Overall Study|Adverse Event|3
5639884|NCT00633932|19478850|P1|Overall Study|Adverse Event|1
5639885|NCT00633893|19478881|P3|Overall Study|Other|31
5639886|NCT00633893|19478882|P2|Overall Study|Other|33
5639887|NCT00633893|19478883|P1|Overall Study|Other|28
5639888|NCT00633893|19478881|P3|Overall Study|Not meet/no longer meets criteria|4
5639889|NCT00633893|19478882|P2|Overall Study|Not meet/no longer meets criteria|6
5639890|NCT00633893|19478883|P1|Overall Study|Not meet/no longer meets criteria|4
5639891|NCT00633893|19478881|P3|Overall Study|Pregnancy|1
5639892|NCT00633893|19478882|P2|Overall Study|Pregnancy|1
5639893|NCT00633893|19478883|P1|Overall Study|Pregnancy|2
5639894|NCT00633893|19478881|P3|Overall Study|Poor/non-compliance|3
5639895|NCT00633893|19478882|P2|Overall Study|Poor/non-compliance|12
5639896|NCT00633893|19478883|P1|Overall Study|Poor/non-compliance|5
5639897|NCT00633893|19478881|P3|Overall Study|Lost to Follow-up|8
5639898|NCT00633893|19478882|P2|Overall Study|Lost to Follow-up|4
5639899|NCT00633893|19478883|P1|Overall Study|Lost to Follow-up|2
5639900|NCT00633893|19478881|P3|Overall Study|Withdrawal by Subject|6
5639901|NCT00633893|19478882|P2|Overall Study|Withdrawal by Subject|12
5639902|NCT00633893|19478883|P1|Overall Study|Withdrawal by Subject|7
5639903|NCT00633893|19478881|P3|Overall Study|Adverse Event|126
5639904|NCT00633893|19478882|P2|Overall Study|Adverse Event|58
5639905|NCT00633893|19478883|P1|Overall Study|Adverse Event|65
5639906|NCT00633893|19478881|P3|Overall Study|Death|9
5639907|NCT00633893|19478882|P2|Overall Study|Death|3
5639908|NCT00633893|19478883|P1|Overall Study|Death|1
5639909|NCT00633880|19478957|P3|Open Label Titration|Withdrawal by Subject|0
5639910|NCT00633880|19478958|P2|Open Label Titration|Withdrawal by Subject|0
5639911|NCT00633880|19478959|P1|Open Label Titration|Withdrawal by Subject|4
5639912|NCT00633880|19478957|P3|Open Label Titration|Physician Decision|0
5639913|NCT00633880|19478958|P2|Open Label Titration|Physician Decision|0
5639914|NCT00633880|19478959|P1|Open Label Titration|Physician Decision|1
5639915|NCT00633880|19478957|P3|Open Label Titration|Protocol Violation|0
5639916|NCT00633880|19478958|P2|Open Label Titration|Protocol Violation|0
5639917|NCT00633880|19478959|P1|Open Label Titration|Protocol Violation|6
5639918|NCT00633880|19478957|P3|Open Label Titration|Treatment Failure|0
5639919|NCT00633880|19478958|P2|Open Label Titration|Treatment Failure|0
5639920|NCT00633880|19478959|P1|Open Label Titration|Treatment Failure|55
5639921|NCT00633880|19478957|P3|Open Label Titration|Adverse Event|0
5639922|NCT00633880|19478958|P2|Open Label Titration|Adverse Event|0
5639923|NCT00633880|19478959|P1|Open Label Titration|Adverse Event|13
5639924|NCT00633880|19478957|P3|Open Label Titration|Lack of Efficacy|0
5639925|NCT00633880|19478958|P2|Open Label Titration|Lack of Efficacy|0
5639926|NCT00633880|19478959|P1|Open Label Titration|Lack of Efficacy|1
5639927|NCT00633750|19478995|P1|Overall Study|Withdrawal by Subject|3
5639928|NCT00633750|19478995|P1|Overall Study|Adverse Event|2
5639929|NCT00633594|19479004|P3|Overall Study|Disease Progression|1
5639930|NCT00633594|19479005|P2|Overall Study|Disease Progression|0
5639931|NCT00633594|19479006|P1|Overall Study|Disease Progression|0
5639932|NCT00633594|19479004|P3|Overall Study|Death|2
5639933|NCT00633594|19479005|P2|Overall Study|Death|1
5639934|NCT00633594|19479006|P1|Overall Study|Death|0
5639935|NCT00633594|19479004|P3|Overall Study|Adverse Event|7
5639936|NCT00633594|19479005|P2|Overall Study|Adverse Event|4
5639937|NCT00633594|19479006|P1|Overall Study|Adverse Event|0
5639938|NCT00633477|19479035|P2|Overall Study|Randomized but not treated|0
5639939|NCT00633477|19479036|P1|Overall Study|Randomized but not treated|1
5639940|NCT00633477|19479035|P2|Overall Study|Death|0
5639941|NCT00633477|19479036|P1|Overall Study|Death|1
5639942|NCT00633464|19479052|P2|Overall Study|Never Treated (Randomized in error)|1
5639943|NCT00633464|19479053|P1|Overall Study|Never Treated (Randomized in error)|0
5639944|NCT00633464|19479052|P2|Overall Study|Never Treated (Not met study criteria)|1
5639945|NCT00633464|19479053|P1|Overall Study|Never Treated (Not met study criteria)|0
5639946|NCT00633360|19479088|P2|Overall Study|Protocol Violation|1
5639947|NCT00633360|19479089|P1|Overall Study|Protocol Violation|0
5639948|NCT00633360|19479088|P2|Overall Study|Adverse Event|1
5639949|NCT00633360|19479089|P1|Overall Study|Adverse Event|3
5639950|NCT00633360|19479088|P2|Overall Study|Lost to Follow-up|1
5639951|NCT00633360|19479089|P1|Overall Study|Lost to Follow-up|1
5639952|NCT00633243|19479112|P2|Overall Study|Couldn't tolerate side-effects|1
5639953|NCT00633243|19479113|P1|Overall Study|Couldn't tolerate side-effects|1
5639954|NCT00633243|19479112|P2|Overall Study|Mental Health--Depression|1
5639955|NCT00633243|19479113|P1|Overall Study|Mental Health--Depression|0
5639956|NCT00633243|19479112|P2|Overall Study|Not comfortable with self-injecting|1
5639957|NCT00633243|19479113|P1|Overall Study|Not comfortable with self-injecting|0
5639958|NCT00633243|19479112|P2|Overall Study|Homeless--no refrigeration for meds|1
5639959|NCT00633243|19479113|P1|Overall Study|Homeless--no refrigeration for meds|0
5639960|NCT00633243|19479112|P2|Overall Study|incarceration|2
5639961|NCT00633243|19479113|P1|Overall Study|incarceration|0
5639962|NCT00633243|19479112|P2|Overall Study|Withdrawal by Subject|1
5639963|NCT00633243|19479113|P1|Overall Study|Withdrawal by Subject|0
5639964|NCT00633217|19479121|P2|Overall Study|Withdrew Consent|3
5639965|NCT00633217|19479122|P1|Overall Study|Withdrew Consent|3
5639966|NCT00633217|19479121|P2|Overall Study|Investigator Discretion|0
5639967|NCT00633217|19479122|P1|Overall Study|Investigator Discretion|2
5639968|NCT00633217|19479121|P2|Overall Study|Lost to Follow-up|2
5639969|NCT00633217|19479122|P1|Overall Study|Lost to Follow-up|2
5639970|NCT00633217|19479121|P2|Overall Study|Protocol Violation|7
5639971|NCT00633217|19479122|P1|Overall Study|Protocol Violation|3
5639972|NCT00633217|19479121|P2|Overall Study|Lack of Efficacy|2
5639973|NCT00633217|19479122|P1|Overall Study|Lack of Efficacy|0
5639974|NCT00633217|19479121|P2|Overall Study|Adverse Event|9
5639975|NCT00633217|19479122|P1|Overall Study|Adverse Event|5
5639976|NCT00633152|19479134|P2|Overall Study|Miscellaneous Other|2
5639977|NCT00633152|19479135|P1|Overall Study|Miscellaneous Other|3
5639978|NCT00633152|19479134|P2|Overall Study|Lost to Follow-up|1
5639979|NCT00633152|19479135|P1|Overall Study|Lost to Follow-up|4
5639980|NCT00633152|19479134|P2|Overall Study|Withdrawal by Subject|1
5639981|NCT00633152|19479135|P1|Overall Study|Withdrawal by Subject|1
5639982|NCT00633152|19479134|P2|Overall Study|Randomized, did not receive study drug|2
5639983|NCT00633152|19479135|P1|Overall Study|Randomized, did not receive study drug|5
5639984|NCT00633152|19479134|P2|Overall Study|Adverse Event|0
5639985|NCT00633152|19479135|P1|Overall Study|Adverse Event|1
5639986|NCT00633139|19479146|P3|Overall Study|Withdrawal by Subject|0
5639987|NCT00633139|19479147|P2|Overall Study|Withdrawal by Subject|1
5639988|NCT00633139|19479148|P1|Overall Study|Withdrawal by Subject|0
5639989|NCT00633139|19479146|P3|Overall Study|Non compliance|1
5639990|NCT00633139|19479147|P2|Overall Study|Non compliance|0
5639991|NCT00633139|19479148|P1|Overall Study|Non compliance|0
5639992|NCT00633126|19479162|P1|Overall Study|Did not receive full dose|1
5639993|NCT00633074|19479176|P2|Overall Study|Adverse Event|0
5639994|NCT00633074|19479177|P1|Overall Study|Adverse Event|1
5639995|NCT00633061|19479207|P2|Overall Study|Study closed|0
5639996|NCT00633061|19479208|P1|Overall Study|Study closed|86
5639997|NCT00633022|19479219|P3|Overall Study|Physician Decision|0
5639998|NCT00633022|19479220|P2|Overall Study|Physician Decision|1
5639999|NCT00633022|19479221|P1|Overall Study|Physician Decision|0
5640000|NCT00633022|19479219|P3|Overall Study|Adverse Event|5
5640001|NCT00633022|19479220|P2|Overall Study|Adverse Event|0
5640002|NCT00633022|19479221|P1|Overall Study|Adverse Event|1
5640003|NCT00632931|19479283|P3|Part 2|Withdrawal by Subject|3
5640004|NCT00632931|19479284|P2|Part 2|Withdrawal by Subject|0
5640005|NCT00632931|19479285|P1|Part 2|Withdrawal by Subject|0
5640006|NCT00632931|19479283|P3|Part 2|Lack of Efficacy|17
5640007|NCT00632931|19479284|P2|Part 2|Lack of Efficacy|0
5640008|NCT00632931|19479285|P1|Part 2|Lack of Efficacy|0
5640009|NCT00632931|19479283|P3|Part 2|Death|1
5640010|NCT00632931|19479284|P2|Part 2|Death|0
5640011|NCT00632931|19479285|P1|Part 2|Death|0
5640012|NCT00632931|19479283|P3|Part 2|Adverse Event|3
5640013|NCT00632931|19479284|P2|Part 2|Adverse Event|0
5640014|NCT00632931|19479285|P1|Part 2|Adverse Event|0
5640015|NCT00632931|19479283|P3|Part 1, Period 1|Withdrawal by Subject|0
5640016|NCT00632931|19479284|P2|Part 1, Period 1|Withdrawal by Subject|0
5640017|NCT00632931|19479285|P1|Part 1, Period 1|Withdrawal by Subject|1
5640018|NCT00632931|19479283|P3|Part 1, Period 1|Protocol Violation|0
5640019|NCT00632931|19479284|P2|Part 1, Period 1|Protocol Violation|0
5640020|NCT00632931|19479285|P1|Part 1, Period 1|Protocol Violation|1
5640021|NCT00632827|19479304|P1|Overall Study|Lost to Follow-up|1
5640022|NCT00632827|19479304|P1|Overall Study|Adverse Event|5
5640023|NCT00632827|19479304|P1|Overall Study|Death|2
5640024|NCT00632827|19479304|P1|Overall Study|Excluded after GVD (Not evaluable)|2
5640025|NCT00632749|19479362|P14|Overall Study|Reason other than those specified above|2
5640026|NCT00632749|19479363|P13|Overall Study|Reason other than those specified above|0
5640027|NCT00632749|19479364|P12|Overall Study|Reason other than those specified above|1
5640028|NCT00632749|19479365|P11|Overall Study|Reason other than those specified above|2
5640029|NCT00632749|19479366|P10|Overall Study|Reason other than those specified above|0
5640030|NCT00632749|19479367|P9|Overall Study|Reason other than those specified above|0
5640031|NCT00632749|19479368|P8|Overall Study|Reason other than those specified above|0
5640032|NCT00632749|19479369|P7|Overall Study|Reason other than those specified above|1
5640033|NCT00632749|19479370|P6|Overall Study|Reason other than those specified above|0
5640034|NCT00632749|19479371|P5|Overall Study|Reason other than those specified above|1
5640035|NCT00632749|19479372|P4|Overall Study|Reason other than those specified above|0
5640036|NCT00632749|19479373|P3|Overall Study|Reason other than those specified above|0
5640037|NCT00632749|19479374|P2|Overall Study|Reason other than those specified above|2
5640038|NCT00632749|19479375|P1|Overall Study|Reason other than those specified above|0
5640039|NCT00632749|19479362|P14|Overall Study|Refuse to continue medication|0
5640040|NCT00632749|19479363|P13|Overall Study|Refuse to continue medication|0
5640041|NCT00632749|19479364|P12|Overall Study|Refuse to continue medication|0
5640042|NCT00632749|19479365|P11|Overall Study|Refuse to continue medication|0
5640043|NCT00632749|19479366|P10|Overall Study|Refuse to continue medication|1
5640044|NCT00632749|19479367|P9|Overall Study|Refuse to continue medication|0
5640045|NCT00632749|19479368|P8|Overall Study|Refuse to continue medication|0
5640046|NCT00632749|19479369|P7|Overall Study|Refuse to continue medication|0
5640047|NCT00632749|19479370|P6|Overall Study|Refuse to continue medication|0
5640048|NCT00632749|19479371|P5|Overall Study|Refuse to continue medication|0
5640049|NCT00632749|19479372|P4|Overall Study|Refuse to continue medication|1
5640050|NCT00632749|19479373|P3|Overall Study|Refuse to continue medication|0
5640051|NCT00632749|19479374|P2|Overall Study|Refuse to continue medication|0
5640052|NCT00632749|19479375|P1|Overall Study|Refuse to continue medication|0
5640053|NCT00632749|19479362|P14|Overall Study|Other Adverse event|0
5640054|NCT00632749|19479363|P13|Overall Study|Other Adverse event|1
5640055|NCT00632749|19479364|P12|Overall Study|Other Adverse event|0
5640056|NCT00632749|19479365|P11|Overall Study|Other Adverse event|1
5640057|NCT00632749|19479366|P10|Overall Study|Other Adverse event|0
5640058|NCT00632749|19479367|P9|Overall Study|Other Adverse event|2
5640059|NCT00632749|19479368|P8|Overall Study|Other Adverse event|2
5640060|NCT00632749|19479369|P7|Overall Study|Other Adverse event|1
5640061|NCT00632749|19479370|P6|Overall Study|Other Adverse event|4
5640062|NCT00632749|19479371|P5|Overall Study|Other Adverse event|2
5640063|NCT00632749|19479372|P4|Overall Study|Other Adverse event|1
5640064|NCT00632749|19479373|P3|Overall Study|Other Adverse event|1
5640065|NCT00632749|19479374|P2|Overall Study|Other Adverse event|1
5640066|NCT00632749|19479375|P1|Overall Study|Other Adverse event|1
5640067|NCT00632749|19479362|P14|Overall Study|Progressive disease|4
5640068|NCT00632749|19479363|P13|Overall Study|Progressive disease|2
5640069|NCT00632749|19479364|P12|Overall Study|Progressive disease|3
5640070|NCT00632749|19479365|P11|Overall Study|Progressive disease|4
5640071|NCT00632749|19479366|P10|Overall Study|Progressive disease|2
5640072|NCT00632749|19479367|P9|Overall Study|Progressive disease|3
5640073|NCT00632749|19479368|P8|Overall Study|Progressive disease|2
5640074|NCT00632749|19479369|P7|Overall Study|Progressive disease|3
5640075|NCT00632749|19479370|P6|Overall Study|Progressive disease|4
5640076|NCT00632749|19479371|P5|Overall Study|Progressive disease|4
5640077|NCT00632749|19479372|P4|Overall Study|Progressive disease|2
5640078|NCT00632749|19479373|P3|Overall Study|Progressive disease|2
5640079|NCT00632749|19479374|P2|Overall Study|Progressive disease|2
5640080|NCT00632749|19479375|P1|Overall Study|Progressive disease|3
5640081|NCT00632736|19479669|P1|Overall Study|Other|16
5640082|NCT00632736|19479669|P1|Overall Study|Non-compliance|10
5640083|NCT00632736|19479669|P1|Overall Study|Sponsor terminated study|5
5640084|NCT00632736|19479669|P1|Overall Study|Lack of Efficacy|5
5640085|NCT00632736|19479669|P1|Overall Study|Withdrawal by Subject|99
5640086|NCT00632736|19479669|P1|Overall Study|Protocol Violation|14
5640087|NCT00632736|19479669|P1|Overall Study|Lost to Follow-up|15
5640088|NCT00632736|19479669|P1|Overall Study|Adverse Event|104
5640089|NCT00632541|19479704|P1|Overall Study|Adverse Event|7
5640090|NCT00632502|19479713|P2|Overall Study|Randomized not treated|0
5640091|NCT00632502|19479714|P1|Overall Study|Randomized not treated|3
5640092|NCT00632502|19479713|P2|Overall Study|Adverse Event|1
5640093|NCT00632502|19479714|P1|Overall Study|Adverse Event|0
5640094|NCT00632463|19479758|P3|Overall Study|Adverse Event|0
5640095|NCT00632463|19479759|P2|Overall Study|Adverse Event|1
5640096|NCT00632463|19479760|P1|Overall Study|Adverse Event|0
5640097|NCT00632424|19479777|P1|Overall Study|Study Drug Toxicity|1
5640098|NCT00632424|19479777|P1|Overall Study|Disease Progression|17
5640099|NCT00632359|19479808|P1|Overall Study|Withdrawal by Subject|2
5640100|NCT00632229|19479821|P2|Overall Study|Undisclosed reasons within the first wee|1
5640101|NCT00632229|19479822|P1|Overall Study|Undisclosed reasons within the first wee|0
5640102|NCT00632229|19479821|P2|Overall Study|Lack of Efficacy|2
5640103|NCT00632229|19479822|P1|Overall Study|Lack of Efficacy|0
5640104|NCT00632229|19479821|P2|Overall Study|Lost to Follow-up|3
5640105|NCT00632229|19479822|P1|Overall Study|Lost to Follow-up|0
5640106|NCT00632229|19479821|P2|Overall Study|Adverse Event|0
5640107|NCT00632229|19479822|P1|Overall Study|Adverse Event|6
5640108|NCT00632203|19479832|P2|Overall Study|Did not start study treatment|0
5640109|NCT00632203|19479833|P1|Overall Study|Did not start study treatment|1
5640110|NCT00632125|19479851|P1|Overall Study|Moved to other dialysis unit, etc.|102
5640111|NCT00632125|19479851|P1|Overall Study|Development of uncontrolled hypertension|5
5640112|NCT00632125|19479851|P1|Overall Study|Non-compliance|8
5640113|NCT00632125|19479851|P1|Overall Study|Need for systemic immunosuppressive medi|8
5640114|NCT00632125|19479851|P1|Overall Study|Renal transplantation|17
5640115|NCT00632125|19479851|P1|Overall Study|Adverse Event|36
5640116|NCT00632125|19479851|P1|Overall Study|Withdrawal by Subject|44
5640117|NCT00632125|19479851|P1|Overall Study|Death|82
5640118|NCT00632099|19479857|P2|Overall Study|Lost to Follow-up|3
5640119|NCT00632099|19479858|P1|Overall Study|Lost to Follow-up|3
5640120|NCT00632021|19479866|P2|Overall Study|Withdrawal/death|7
5640121|NCT00632021|19479867|P1|Overall Study|Withdrawal/death|4
5640122|NCT00631969|19479877|P2|Overall Study|No Drug Exposure|2
5640123|NCT00631969|19479878|P1|Overall Study|No Drug Exposure|2
5640124|NCT00631969|19479877|P2|Overall Study|Noncompliant With Study Medication|1
5640125|NCT00631969|19479878|P1|Overall Study|Noncompliant With Study Medication|0
5640126|NCT00631969|19479877|P2|Overall Study|Consent Withdrawn|7
5640127|NCT00631969|19479878|P1|Overall Study|Consent Withdrawn|5
5640128|NCT00631969|19479877|P2|Overall Study|Protocol Violation|1
5640129|NCT00631969|19479878|P1|Overall Study|Protocol Violation|1
5640130|NCT00631969|19479877|P2|Overall Study|Lost to Follow-up|1
5640131|NCT00631969|19479878|P1|Overall Study|Lost to Follow-up|2
5640132|NCT00631969|19479877|P2|Overall Study|Lack of Efficacy|8
5640133|NCT00631969|19479878|P1|Overall Study|Lack of Efficacy|2
5640134|NCT00631969|19479877|P2|Overall Study|Adverse Event|1
5640135|NCT00631969|19479878|P1|Overall Study|Adverse Event|3
5640136|NCT00631917|19479924|P2|Overall Study|Death|0
5640137|NCT00631917|19479925|P1|Overall Study|Death|1
5640138|NCT00631917|19479924|P2|Overall Study|Administrative problems|0
5640139|NCT00631917|19479925|P1|Overall Study|Administrative problems|2
5640140|NCT00631917|19479924|P2|Overall Study|Lost to Follow-up|7
5640141|NCT00631917|19479925|P1|Overall Study|Lost to Follow-up|7
5640142|NCT00631917|19479924|P2|Overall Study|Subject withdrew consent|33
5640143|NCT00631917|19479925|P1|Overall Study|Subject withdrew consent|25
5640144|NCT00631917|19479924|P2|Overall Study|Protocol deviation|5
5640145|NCT00631917|19479925|P1|Overall Study|Protocol deviation|6
5640146|NCT00631917|19479924|P2|Overall Study|No longer required study drug|1
5640147|NCT00631917|19479925|P1|Overall Study|No longer required study drug|0
5640148|NCT00631917|19479924|P2|Overall Study|Unsatisfactory therapeutic effect|14
5640149|NCT00631917|19479925|P1|Overall Study|Unsatisfactory therapeutic effect|8
5640150|NCT00631917|19479924|P2|Overall Study|Abnormal test procedure result(s)|2
5640151|NCT00631917|19479925|P1|Overall Study|Abnormal test procedure result(s)|3
5640152|NCT00631917|19479924|P2|Overall Study|Abnormal laboratory value(s)|1
5640153|NCT00631917|19479925|P1|Overall Study|Abnormal laboratory value(s)|2
5640154|NCT00631917|19479924|P2|Overall Study|Adverse Event|45
5640155|NCT00631917|19479925|P1|Overall Study|Adverse Event|34
5640156|NCT00631696|19479952|P2|Overall Study|Adverse Event|0
5640157|NCT00631696|19479953|P1|Overall Study|Adverse Event|5
5640158|NCT00631696|19479952|P2|Overall Study|Study terminated by sponsor|3
5640159|NCT00631696|19479953|P1|Overall Study|Study terminated by sponsor|3
5640160|NCT00631696|19479952|P2|Overall Study|Protocol Violation|9
5640161|NCT00631696|19479953|P1|Overall Study|Protocol Violation|9
5640162|NCT00631696|19479952|P2|Overall Study|Other|8
5640163|NCT00631696|19479953|P1|Overall Study|Other|8
5640164|NCT00631696|19479952|P2|Overall Study|Withdrawal by Subject|9
5640165|NCT00631696|19479953|P1|Overall Study|Withdrawal by Subject|2
5640166|NCT00631696|19479952|P2|Overall Study|Lost to Follow-up|10
5640167|NCT00631696|19479953|P1|Overall Study|Lost to Follow-up|7
5640168|NCT00631696|19479952|P2|Overall Study|Follow up after database release date|0
5640169|NCT00631696|19479953|P1|Overall Study|Follow up after database release date|1
5640170|NCT00631696|19479952|P2|Overall Study|Discontinued after database release date|0
5640171|NCT00631696|19479953|P1|Overall Study|Discontinued after database release date|1
5640172|NCT00631696|19479952|P2|Overall Study|Entered, not randomized to treatment|1
5640173|NCT00631696|19479953|P1|Overall Study|Entered, not randomized to treatment|1
5640174|NCT00631657|19479996|P3|7-Day Discontinuation Period|Other|0
5640175|NCT00631657|19479997|P2|7-Day Discontinuation Period|Other|0
5640176|NCT00631657|19479998|P1|7-Day Discontinuation Period|Other|1
5640177|NCT00631657|19479996|P3|7-Day Discontinuation Period|Not Treated|1
5640178|NCT00631657|19479997|P2|7-Day Discontinuation Period|Not Treated|1
5640179|NCT00631657|19479998|P1|7-Day Discontinuation Period|Not Treated|1
5640180|NCT00631657|19479996|P3|6-Month Treatment Period|Not Treated|1
5640181|NCT00631657|19479997|P2|6-Month Treatment Period|Not Treated|0
5640182|NCT00631657|19479998|P1|6-Month Treatment Period|Not Treated|2
5640183|NCT00631657|19479996|P3|6-Month Treatment Period|Other|4
5640184|NCT00631657|19479997|P2|6-Month Treatment Period|Other|0
5640185|NCT00631657|19479998|P1|6-Month Treatment Period|Other|16
5640186|NCT00631657|19479996|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
5640187|NCT00631657|19479997|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
5640188|NCT00631657|19479998|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
5640189|NCT00631657|19479996|P3|6-Month Treatment Period|Lost to Follow-up|2
5640190|NCT00631657|19479997|P2|6-Month Treatment Period|Lost to Follow-up|0
5640191|NCT00631657|19479998|P1|6-Month Treatment Period|Lost to Follow-up|7
5640192|NCT00631657|19479996|P3|6-Month Treatment Period|Lack of Efficacy|25
5640193|NCT00631657|19479997|P2|6-Month Treatment Period|Lack of Efficacy|0
5640194|NCT00631657|19479998|P1|6-Month Treatment Period|Lack of Efficacy|34
5640195|NCT00631657|19479996|P3|6-Month Treatment Period|Withdrawal by Subject|5
5640196|NCT00631657|19479997|P2|6-Month Treatment Period|Withdrawal by Subject|0
5640197|NCT00631657|19479998|P1|6-Month Treatment Period|Withdrawal by Subject|14
5640198|NCT00631657|19479996|P3|6-Month Treatment Period|Adverse Event|7
5640199|NCT00631657|19479997|P2|6-Month Treatment Period|Adverse Event|0
5640200|NCT00631657|19479998|P1|6-Month Treatment Period|Adverse Event|47
5640201|NCT00631540|19480047|P1|Overall Study|Core Lab Data Unavailable|3
5640202|NCT00631540|19480047|P1|Overall Study|Lost to Follow-up|2
5640203|NCT00631540|19480047|P1|Overall Study|Death|4
5640204|NCT00631540|19480047|P1|Overall Study|Withdrawal by Subject|5
5640205|NCT00631488|19480059|P3|Overall Study|Protocol Violation|1
5640206|NCT00631488|19480060|P2|Overall Study|Protocol Violation|0
5640207|NCT00631488|19480061|P1|Overall Study|Protocol Violation|0
5640208|NCT00631488|19480059|P3|Overall Study|Physician Decision|1
5640209|NCT00631488|19480060|P2|Overall Study|Physician Decision|0
5640210|NCT00631488|19480061|P1|Overall Study|Physician Decision|1
5640211|NCT00631488|19480059|P3|Overall Study|Lost to Follow-up|0
5640212|NCT00631488|19480060|P2|Overall Study|Lost to Follow-up|2
5640213|NCT00631488|19480061|P1|Overall Study|Lost to Follow-up|2
5640214|NCT00631488|19480059|P3|Overall Study|Adverse Event|0
5640215|NCT00631488|19480060|P2|Overall Study|Adverse Event|0
5640216|NCT00631488|19480061|P1|Overall Study|Adverse Event|1
5640217|NCT00631475|19480081|P1|Overall Study|Preparation for lung transplant|8
5640218|NCT00631475|19480081|P1|Overall Study|Withdrew consent|5
5640219|NCT00631475|19480081|P1|Overall Study|Adverse Event|14
5640220|NCT00631475|19480081|P1|Overall Study|Death|18
5640221|NCT00631410|19480102|P2|Overall Study|Surgery|0
5640222|NCT00631410|19480103|P1|Overall Study|Surgery|1
5640223|NCT00631410|19480102|P2|Overall Study|Objective Progression or Relapse|3
5640224|NCT00631410|19480103|P1|Overall Study|Objective Progression or Relapse|4
5640225|NCT00631410|19480102|P2|Overall Study|Adverse Event|3
5640226|NCT00631410|19480103|P1|Overall Study|Adverse Event|1
5640227|NCT00631371|19480122|P2|Overall Study|Death|239
5640228|NCT00631371|19480123|P1|Overall Study|Death|263
5640229|NCT00631371|19480122|P2|Overall Study|Discontinuation of study by Sponsor|76
5640230|NCT00631371|19480123|P1|Overall Study|Discontinuation of study by Sponsor|70
5640231|NCT00631371|19480122|P2|Overall Study|subject request|45
5640232|NCT00631371|19480123|P1|Overall Study|subject request|38
5640233|NCT00631371|19480122|P2|Overall Study|Other reason|12
5640234|NCT00631371|19480123|P1|Overall Study|Other reason|5
5640235|NCT00631371|19480122|P2|Overall Study|Lost to Follow-up|19
5640236|NCT00631371|19480123|P1|Overall Study|Lost to Follow-up|24
5640237|NCT00631189|19480166|P4|Treatment Phase|patient did not take pravastatin|0
5640238|NCT00631189|19480167|P3|Treatment Phase|patient did not take pravastatin|1
5640239|NCT00631189|19480168|P2|Treatment Phase|patient did not take pravastatin|0
5640240|NCT00631189|19480169|P1|Treatment Phase|patient did not take pravastatin|0
5640241|NCT00631189|19480166|P4|Treatment Phase|Pregnancy|0
5640242|NCT00631189|19480167|P3|Treatment Phase|Pregnancy|1
5640243|NCT00631189|19480168|P2|Treatment Phase|Pregnancy|0
5640244|NCT00631189|19480169|P1|Treatment Phase|Pregnancy|0
5640245|NCT00631189|19480166|P4|Treatment Phase|Lost to Follow-up|0
5640246|NCT00631189|19480167|P3|Treatment Phase|Lost to Follow-up|0
5640247|NCT00631189|19480168|P2|Treatment Phase|Lost to Follow-up|1
5640248|NCT00631189|19480169|P1|Treatment Phase|Lost to Follow-up|0
5640249|NCT00631189|19480166|P4|Treatment Phase|Adverse Event|4
5640250|NCT00631189|19480167|P3|Treatment Phase|Adverse Event|2
5640251|NCT00631189|19480168|P2|Treatment Phase|Adverse Event|3
5640252|NCT00631189|19480169|P1|Treatment Phase|Adverse Event|0
5640253|NCT00631189|19480166|P4|Treatment Phase|Protocol Violation|2
5640254|NCT00631189|19480167|P3|Treatment Phase|Protocol Violation|6
5640255|NCT00631189|19480168|P2|Treatment Phase|Protocol Violation|1
5640256|NCT00631189|19480169|P1|Treatment Phase|Protocol Violation|0
5640257|NCT00631189|19480166|P4|Treatment Phase|Withdrawal by Subject|1
5640258|NCT00631189|19480167|P3|Treatment Phase|Withdrawal by Subject|1
5640259|NCT00631189|19480168|P2|Treatment Phase|Withdrawal by Subject|2
5640260|NCT00631189|19480169|P1|Treatment Phase|Withdrawal by Subject|0
5640261|NCT00631189|19480166|P4|Initial Phase|Withdrawal by Subject|0
5640262|NCT00631189|19480167|P3|Initial Phase|Withdrawal by Subject|0
5640263|NCT00631189|19480168|P2|Initial Phase|Withdrawal by Subject|0
5640264|NCT00631189|19480169|P1|Initial Phase|Withdrawal by Subject|4
5640265|NCT00631189|19480166|P4|Initial Phase|Protocol Violation|0
5640266|NCT00631189|19480167|P3|Initial Phase|Protocol Violation|0
5640267|NCT00631189|19480168|P2|Initial Phase|Protocol Violation|0
5640268|NCT00631189|19480169|P1|Initial Phase|Protocol Violation|347
5640269|NCT00631137|19480213|P2|Overall Study|Withdrawal by Subject|0
5640270|NCT00631137|19480214|P1|Overall Study|Withdrawal by Subject|1
5640271|NCT00631020|19480232|P1|Overall Study|Incarcerated|1
5640272|NCT00631020|19480232|P1|Overall Study|Lost to Follow-up|7
5640273|NCT00631007|19480247|P6|Overall Study|Other|0
5640274|NCT00631007|19480248|P5|Overall Study|Other|1
5640275|NCT00631007|19480249|P4|Overall Study|Other|0
5640276|NCT00631007|19480250|P3|Overall Study|Other|0
5640277|NCT00631007|19480251|P2|Overall Study|Other|1
5640278|NCT00631007|19480252|P1|Overall Study|Other|2
5640279|NCT00631007|19480247|P6|Overall Study|Withdrawal by Subject|3
5640280|NCT00631007|19480248|P5|Overall Study|Withdrawal by Subject|1
5640281|NCT00631007|19480249|P4|Overall Study|Withdrawal by Subject|2
5640282|NCT00631007|19480250|P3|Overall Study|Withdrawal by Subject|2
5640283|NCT00631007|19480251|P2|Overall Study|Withdrawal by Subject|5
5640284|NCT00631007|19480252|P1|Overall Study|Withdrawal by Subject|4
5640285|NCT00631007|19480247|P6|Overall Study|Persistent Hyperglycemia|5
5640286|NCT00631007|19480248|P5|Overall Study|Persistent Hyperglycemia|2
5640287|NCT00631007|19480249|P4|Overall Study|Persistent Hyperglycemia|1
5640288|NCT00631007|19480250|P3|Overall Study|Persistent Hyperglycemia|5
5640289|NCT00631007|19480251|P2|Overall Study|Persistent Hyperglycemia|2
5640290|NCT00631007|19480252|P1|Overall Study|Persistent Hyperglycemia|2
5640291|NCT00631007|19480247|P6|Overall Study|Physician Decision|2
5640292|NCT00631007|19480248|P5|Overall Study|Physician Decision|0
5640293|NCT00631007|19480249|P4|Overall Study|Physician Decision|0
5640294|NCT00631007|19480250|P3|Overall Study|Physician Decision|1
5640295|NCT00631007|19480251|P2|Overall Study|Physician Decision|0
5640296|NCT00631007|19480252|P1|Overall Study|Physician Decision|1
5640297|NCT00631007|19480247|P6|Overall Study|Lost to Follow-up|3
5640298|NCT00631007|19480248|P5|Overall Study|Lost to Follow-up|5
5640299|NCT00631007|19480249|P4|Overall Study|Lost to Follow-up|4
5640300|NCT00631007|19480250|P3|Overall Study|Lost to Follow-up|2
5640301|NCT00631007|19480251|P2|Overall Study|Lost to Follow-up|1
5640302|NCT00631007|19480252|P1|Overall Study|Lost to Follow-up|2
5640303|NCT00631007|19480247|P6|Overall Study|Adverse Event|2
5640304|NCT00631007|19480248|P5|Overall Study|Adverse Event|3
5640305|NCT00631007|19480249|P4|Overall Study|Adverse Event|2
5640306|NCT00631007|19480250|P3|Overall Study|Adverse Event|0
5640307|NCT00631007|19480251|P2|Overall Study|Adverse Event|2
5640308|NCT00631007|19480252|P1|Overall Study|Adverse Event|0
5640309|NCT00630994|19480272|P1|Overall Study|Other|1
5640310|NCT00630994|19480272|P1|Overall Study|Lack of Efficacy|1
5640311|NCT00630994|19480272|P1|Overall Study|Disease Progression|1
5640312|NCT00630994|19480272|P1|Overall Study|Adverse Event|1
5640313|NCT00630916|19480302|P1|Overall Study|Lack of Efficacy|3
5640314|NCT00630916|19480302|P1|Overall Study|Physician Decision|47
5640315|NCT00630916|19480302|P1|Overall Study|Protocol Violation|7
5640316|NCT00630916|19480302|P1|Overall Study|Withdrawal by Subject|30
5640317|NCT00630916|19480302|P1|Overall Study|Lost to Follow-up|5
5640318|NCT00630916|19480302|P1|Overall Study|Explant|8
5640319|NCT00630916|19480302|P1|Overall Study|Death|110
5640320|NCT00630877|19480312|P3|Overall Study|Personal reasons|1
5640321|NCT00630877|19480313|P2|Overall Study|Personal reasons|0
5640322|NCT00630877|19480314|P1|Overall Study|Personal reasons|0
5640323|NCT00630877|19480312|P3|Overall Study|Protocol violation|1
5640324|NCT00630877|19480313|P2|Overall Study|Protocol violation|0
5640325|NCT00630877|19480314|P1|Overall Study|Protocol violation|1
5640326|NCT00630877|19480312|P3|Overall Study|Noncompliance|1
5640327|NCT00630877|19480313|P2|Overall Study|Noncompliance|3
5640328|NCT00630877|19480314|P1|Overall Study|Noncompliance|2
5640329|NCT00630877|19480312|P3|Overall Study|Lost to Follow-up|0
5640330|NCT00630877|19480313|P2|Overall Study|Lost to Follow-up|0
5640331|NCT00630877|19480314|P1|Overall Study|Lost to Follow-up|2
5640332|NCT00630877|19480312|P3|Overall Study|Withdrawal by Subject|0
5640333|NCT00630877|19480313|P2|Overall Study|Withdrawal by Subject|4
5640334|NCT00630877|19480314|P1|Overall Study|Withdrawal by Subject|3
5640335|NCT00630877|19480312|P3|Overall Study|Adverse Event|7
5640336|NCT00630877|19480313|P2|Overall Study|Adverse Event|8
5640337|NCT00630877|19480314|P1|Overall Study|Adverse Event|11
5640338|NCT00630864|19480332|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
5640339|NCT00630864|19480332|P1|Part 1 (up to Week 6)|Adverse Event|1
5640340|NCT00630838|19480371|P2|Overall Study|Lost to Follow-up|1
5640341|NCT00630838|19480372|P1|Overall Study|Lost to Follow-up|0
5640342|NCT00630838|19480371|P2|Overall Study|Death|1
5640343|NCT00630838|19480372|P1|Overall Study|Death|0
5640344|NCT00630825|19480384|P4|Overall Study|Withdrawal by Subject|3
5640345|NCT00630825|19480385|P3|Overall Study|Withdrawal by Subject|2
5640346|NCT00630825|19480386|P2|Overall Study|Withdrawal by Subject|2
5640347|NCT00630825|19480387|P1|Overall Study|Withdrawal by Subject|2
5640348|NCT00630825|19480384|P4|Overall Study|Physician Decision|0
5640349|NCT00630825|19480385|P3|Overall Study|Physician Decision|0
5640350|NCT00630825|19480386|P2|Overall Study|Physician Decision|0
5640351|NCT00630825|19480387|P1|Overall Study|Physician Decision|1
5640352|NCT00630825|19480384|P4|Overall Study|Lost to Follow-up|1
5640353|NCT00630825|19480385|P3|Overall Study|Lost to Follow-up|1
5640354|NCT00630825|19480386|P2|Overall Study|Lost to Follow-up|1
5640355|NCT00630825|19480387|P1|Overall Study|Lost to Follow-up|1
5640356|NCT00630825|19480384|P4|Overall Study|Entry Criteria Not Met|1
5640357|NCT00630825|19480385|P3|Overall Study|Entry Criteria Not Met|2
5640358|NCT00630825|19480386|P2|Overall Study|Entry Criteria Not Met|0
5640359|NCT00630825|19480387|P1|Overall Study|Entry Criteria Not Met|1
5640360|NCT00630825|19480384|P4|Overall Study|Adverse Event|1
5640361|NCT00630825|19480385|P3|Overall Study|Adverse Event|3
5640362|NCT00630825|19480386|P2|Overall Study|Adverse Event|4
5640363|NCT00630825|19480387|P1|Overall Study|Adverse Event|4
5640364|NCT00630812|19480458|P2|Double Blind Treatment Period|Non-compliance|1
5640365|NCT00630812|19480459|P1|Double Blind Treatment Period|Non-compliance|0
5640366|NCT00630812|19480458|P2|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
5640367|NCT00630812|19480459|P1|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
5640368|NCT00630812|19480458|P2|Double Blind Treatment Period|Withdrawal by Subject|7
5640369|NCT00630812|19480459|P1|Double Blind Treatment Period|Withdrawal by Subject|13
5640370|NCT00630812|19480458|P2|Double Blind Treatment Period|Protocol Violation|0
5640371|NCT00630812|19480459|P1|Double Blind Treatment Period|Protocol Violation|1
5640372|NCT00630812|19480458|P2|Double Blind Treatment Period|Physician Decision|1
5640373|NCT00630812|19480459|P1|Double Blind Treatment Period|Physician Decision|2
5640374|NCT00630812|19480458|P2|Double Blind Treatment Period|Lost to Follow-up|0
5640375|NCT00630812|19480459|P1|Double Blind Treatment Period|Lost to Follow-up|1
5640376|NCT00630812|19480458|P2|Double Blind Treatment Period|Adverse Event|5
5640377|NCT00630812|19480459|P1|Double Blind Treatment Period|Adverse Event|13
5640378|NCT00630812|19480458|P2|Randomisation to First Dose|Protocol Violation|1
5640379|NCT00630812|19480459|P1|Randomisation to First Dose|Protocol Violation|4
5640380|NCT00630812|19480458|P2|Randomisation to First Dose|Lost to Follow-up|0
5640381|NCT00630812|19480459|P1|Randomisation to First Dose|Lost to Follow-up|1
5640382|NCT00630812|19480458|P2|Randomisation to First Dose|Withdrawal by Subject|3
5640383|NCT00630812|19480459|P1|Randomisation to First Dose|Withdrawal by Subject|2
5640384|NCT00630812|19480458|P2|Randomisation to First Dose|Adverse Event|1
5640385|NCT00630812|19480459|P1|Randomisation to First Dose|Adverse Event|1
5640386|NCT00630786|19480484|P3|Overall Study|Other|0
5640387|NCT00630786|19480485|P2|Overall Study|Other|0
5640388|NCT00630786|19480486|P1|Overall Study|Other|1
5640389|NCT00630786|19480484|P3|Overall Study|Lost to Follow-up|0
5640390|NCT00630786|19480485|P2|Overall Study|Lost to Follow-up|1
5640391|NCT00630786|19480486|P1|Overall Study|Lost to Follow-up|0
5640392|NCT00630786|19480484|P3|Overall Study|Withdrawal by Subject|1
5640393|NCT00630786|19480485|P2|Overall Study|Withdrawal by Subject|1
5640394|NCT00630786|19480486|P1|Overall Study|Withdrawal by Subject|0
5640395|NCT00630786|19480484|P3|Overall Study|Physician Decision|1
5640396|NCT00630786|19480485|P2|Overall Study|Physician Decision|0
5640397|NCT00630786|19480486|P1|Overall Study|Physician Decision|0
5640398|NCT00630747|19480505|P1|Overall Study|Returned to country of origin|1
5640399|NCT00630747|19480505|P1|Overall Study|Transferred to Study TKT031NPU|7
5640400|NCT00630747|19480505|P1|Overall Study|Death|1
5640401|NCT00630539|19480558|P4|Overall Study|Withdrawal by Subject|1
5640402|NCT00630539|19480559|P3|Overall Study|Withdrawal by Subject|0
5640403|NCT00630539|19480560|P2|Overall Study|Withdrawal by Subject|1
5640404|NCT00630539|19480561|P1|Overall Study|Withdrawal by Subject|0
5640405|NCT00630539|19480558|P4|Overall Study|Adverse Event|2
5640406|NCT00630539|19480559|P3|Overall Study|Adverse Event|1
5640407|NCT00630539|19480560|P2|Overall Study|Adverse Event|3
5640408|NCT00630539|19480561|P1|Overall Study|Adverse Event|1
5640409|NCT00630396|19480657|P1|Overall Study|Lost to Follow-up|3
5640410|NCT00630396|19480657|P1|Overall Study|Death|4
5640411|NCT00630344|19480663|P1|Overall Study|Other|1
5640412|NCT00630344|19480663|P1|Overall Study|Intercurrent Illness|1
5640413|NCT00630344|19480663|P1|Overall Study|Withdrawal by Subject|1
5640414|NCT00630344|19480663|P1|Overall Study|Physician Decision|9
5640415|NCT00630344|19480663|P1|Overall Study|Progressive Disease|19
5640416|NCT00630344|19480663|P1|Overall Study|Adverse Event|5
5640417|NCT00630331|19480675|P3|Overall Study|Protocol Violation|6
5640418|NCT00630331|19480676|P2|Overall Study|Protocol Violation|5
5640419|NCT00630331|19480677|P1|Overall Study|Protocol Violation|4
5640420|NCT00630331|19480675|P3|Overall Study|Unable to classify|3
5640421|NCT00630331|19480676|P2|Overall Study|Unable to classify|4
5640422|NCT00630331|19480677|P1|Overall Study|Unable to classify|9
5640423|NCT00630331|19480675|P3|Overall Study|Inappropriate enrollment|3
5640424|NCT00630331|19480676|P2|Overall Study|Inappropriate enrollment|6
5640425|NCT00630331|19480677|P1|Overall Study|Inappropriate enrollment|3
5640426|NCT00630331|19480675|P3|Overall Study|Lost to Follow-up|170
5640427|NCT00630331|19480676|P2|Overall Study|Lost to Follow-up|143
5640428|NCT00630331|19480677|P1|Overall Study|Lost to Follow-up|175
5640429|NCT00630331|19480675|P3|Overall Study|Withdrawal by Subject|5
5640430|NCT00630331|19480676|P2|Overall Study|Withdrawal by Subject|7
5640431|NCT00630331|19480677|P1|Overall Study|Withdrawal by Subject|12
5640432|NCT00630331|19480675|P3|Overall Study|Adverse Event|0
5640433|NCT00630331|19480676|P2|Overall Study|Adverse Event|0
5640434|NCT00630331|19480677|P1|Overall Study|Adverse Event|1
5640435|NCT00630331|19480675|P3|Overall Study|Death|1
5640436|NCT00630331|19480676|P2|Overall Study|Death|1
5640437|NCT00630331|19480677|P1|Overall Study|Death|2
5640438|NCT00630305|19480718|P1|Overall Study|Inability to insert contact lens|1
5640439|NCT00630305|19480718|P1|Overall Study|Withdrawal by Subject|1
5640440|NCT00630292|19480740|P1|Overall Study|Withdrawal by Subject|1
5640441|NCT00630058|19480746|P2|Overall Study|stopping criteria|2
5640442|NCT00630058|19480747|P1|Overall Study|stopping criteria|3
5640443|NCT00630058|19480746|P2|Overall Study|Withdrawal by Subject|1
5640444|NCT00630058|19480747|P1|Overall Study|Withdrawal by Subject|0
5640445|NCT00630058|19480746|P2|Overall Study|Adverse Event|1
5640446|NCT00630058|19480747|P1|Overall Study|Adverse Event|1
5640447|NCT00629772|19480778|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
5640448|NCT00629772|19480779|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
5640449|NCT00629772|19480778|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
5640450|NCT00629772|19480779|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
5640451|NCT00629707|19480799|P2|Overall Study|Physician Decision|1
5640452|NCT00629707|19480800|P1|Overall Study|Physician Decision|0
5640453|NCT00629707|19480799|P2|Overall Study|Withdrawal by Subject|1
5640454|NCT00629707|19480800|P1|Overall Study|Withdrawal by Subject|0
5640455|NCT00629265|19480820|P2|Overall Study|Unknown Reason|2
5640456|NCT00629265|19480821|P1|Overall Study|Unknown Reason|2
5640457|NCT00629265|19480820|P2|Overall Study|Unrelated Medical Complications|1
5640458|NCT00629265|19480821|P1|Overall Study|Unrelated Medical Complications|3
5640459|NCT00629265|19480820|P2|Overall Study|Needed Esophageal Dilation|1
5640460|NCT00629265|19480821|P1|Overall Study|Needed Esophageal Dilation|4
5640461|NCT00629265|19480820|P2|Overall Study|Other CA Requiring Treatment|3
5640462|NCT00629265|19480821|P1|Overall Study|Other CA Requiring Treatment|1
5640463|NCT00629265|19480820|P2|Overall Study|HNC Recurrence|0
5640464|NCT00629265|19480821|P1|Overall Study|HNC Recurrence|4
5640465|NCT00629265|19480820|P2|Overall Study|Adverse Event|0
5640466|NCT00629265|19480821|P1|Overall Study|Adverse Event|2
5640467|NCT00629265|19480820|P2|Overall Study|Death|0
5640468|NCT00629265|19480821|P1|Overall Study|Death|1
5640469|NCT00629265|19480820|P2|Overall Study|Withdrawal by Subject|8
5640470|NCT00629265|19480821|P1|Overall Study|Withdrawal by Subject|11
5640471|NCT00629265|19480820|P2|Overall Study|Lost to Follow-up|5
5640472|NCT00629265|19480821|P1|Overall Study|Lost to Follow-up|4
5640473|NCT00629239|19480831|P2|Overall Study|Physician Decision|0
5640474|NCT00629239|19480832|P1|Overall Study|Physician Decision|1
5640475|NCT00629239|19480831|P2|Overall Study|Adverse Event|4
5640476|NCT00629239|19480832|P1|Overall Study|Adverse Event|7
5640477|NCT00629083|19480885|P2|Overall Study|Refused to return for 12 month visit|0
5640478|NCT00629083|19480886|P1|Overall Study|Refused to return for 12 month visit|1
5640479|NCT00629083|19480885|P2|Overall Study|Moved out of country/state|1
5640480|NCT00629083|19480886|P1|Overall Study|Moved out of country/state|2
5640481|NCT00629083|19480885|P2|Overall Study|Lost to Follow-up|8
5640482|NCT00629083|19480886|P1|Overall Study|Lost to Follow-up|12
5640483|NCT00629083|19480885|P2|Overall Study|Withdrawal by Subject|2
5640484|NCT00629083|19480886|P1|Overall Study|Withdrawal by Subject|10
5640485|NCT00629083|19480885|P2|Overall Study|Lack of Efficacy|1
5640486|NCT00629083|19480886|P1|Overall Study|Lack of Efficacy|3
5640487|NCT00629083|19480885|P2|Overall Study|Adverse Event|2
5640488|NCT00629083|19480886|P1|Overall Study|Adverse Event|0
5640489|NCT00628927|19480917|P2|Overall Study|Equipment failure|0
5640490|NCT00628927|19480918|P1|Overall Study|Equipment failure|1
5640491|NCT00628927|19480917|P2|Overall Study|Lost to Follow-up|0
5640492|NCT00628927|19480918|P1|Overall Study|Lost to Follow-up|1
5640493|NCT00628927|19480917|P2|Overall Study|Problems performing blood draw|0
5640494|NCT00628927|19480918|P1|Overall Study|Problems performing blood draw|6
5640495|NCT00628862|19480963|P3|Overall Study|COPD Exacerbation|0
5640496|NCT00628862|19480964|P2|Overall Study|COPD Exacerbation|1
5640497|NCT00628862|19480965|P1|Overall Study|COPD Exacerbation|0
5640498|NCT00628862|19480963|P3|Overall Study|Protocol Violation|0
5640499|NCT00628862|19480964|P2|Overall Study|Protocol Violation|0
5640500|NCT00628862|19480965|P1|Overall Study|Protocol Violation|1
5640501|NCT00628862|19480963|P3|Overall Study|Lost to Follow-up|1
5640502|NCT00628862|19480964|P2|Overall Study|Lost to Follow-up|2
5640503|NCT00628862|19480965|P1|Overall Study|Lost to Follow-up|0
5640504|NCT00628862|19480963|P3|Overall Study|Withdrawal by Subject|11
5640505|NCT00628862|19480964|P2|Overall Study|Withdrawal by Subject|6
5640506|NCT00628862|19480965|P1|Overall Study|Withdrawal by Subject|4
5640507|NCT00628862|19480963|P3|Overall Study|Adverse Event|10
5640508|NCT00628862|19480964|P2|Overall Study|Adverse Event|8
5640509|NCT00628862|19480965|P1|Overall Study|Adverse Event|6
5640510|NCT00628758|19481011|P2|Overall Study|Treatment Failure|2
5640511|NCT00628758|19481012|P1|Overall Study|Treatment Failure|0
5640512|NCT00628758|19481011|P2|Overall Study|Investigator Moved|0
5640513|NCT00628758|19481012|P1|Overall Study|Investigator Moved|3
5640514|NCT00628758|19481011|P2|Overall Study|Pregnancy|2
5640515|NCT00628758|19481012|P1|Overall Study|Pregnancy|2
5640516|NCT00628758|19481011|P2|Overall Study|Lost to Follow-up|31
5640517|NCT00628758|19481012|P1|Overall Study|Lost to Follow-up|25
5640518|NCT00628758|19481011|P2|Overall Study|Protocol Violation|1
5640519|NCT00628758|19481012|P1|Overall Study|Protocol Violation|5
5640520|NCT00628758|19481011|P2|Overall Study|Death|0
5640521|NCT00628758|19481012|P1|Overall Study|Death|1
5640522|NCT00628758|19481011|P2|Overall Study|Withdrawal by Subject|3
5640523|NCT00628758|19481012|P1|Overall Study|Withdrawal by Subject|6
5640524|NCT00628758|19481011|P2|Overall Study|Adverse Event|3
5640525|NCT00628758|19481012|P1|Overall Study|Adverse Event|2
5640526|NCT00628446|19481056|P1|Overall Study|Protocol Violation|3
5640527|NCT00628446|19481056|P1|Overall Study|Withdrawal by Subject|1
5640528|NCT00628446|19481056|P1|Overall Study|Lost to Follow-up|3
5640529|NCT00628355|19481088|P2|Overall Study|Withdrawal by Subject|1
5640530|NCT00628355|19481089|P1|Overall Study|Withdrawal by Subject|1
5640531|NCT00628251|19481100|P3|Ongoing Initial Study Treatment at DCO|Other|2
5640532|NCT00628251|19481101|P2|Ongoing Initial Study Treatment at DCO|Other|0
5640533|NCT00628251|19481102|P1|Ongoing Initial Study Treatment at DCO|Other|1
5640534|NCT00628251|19481100|P3|Ongoing Initial Study Treatment at DCO|Other reason|6
5640535|NCT00628251|19481101|P2|Ongoing Initial Study Treatment at DCO|Other reason|1
5640536|NCT00628251|19481102|P1|Ongoing Initial Study Treatment at DCO|Other reason|0
5640537|NCT00628251|19481100|P3|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
5640538|NCT00628251|19481101|P2|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
5640539|NCT00628251|19481102|P1|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
5640540|NCT00628251|19481100|P3|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
5640541|NCT00628251|19481101|P2|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
5640542|NCT00628251|19481102|P1|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
5640543|NCT00628251|19481100|P3|Ongoing Initial Study Treatment at DCO|Adverse Event|3
5640544|NCT00628251|19481101|P2|Ongoing Initial Study Treatment at DCO|Adverse Event|2
5640545|NCT00628251|19481102|P1|Ongoing Initial Study Treatment at DCO|Adverse Event|1
5640546|NCT00628251|19481100|P3|Randomised Part|Withdrawal by Subject|1
5640547|NCT00628251|19481101|P2|Randomised Part|Withdrawal by Subject|0
5640548|NCT00628251|19481102|P1|Randomised Part|Withdrawal by Subject|0
5640549|NCT00628212|19481148|P4|Overall Study|Physician Decision|3
5640550|NCT00628212|19481149|P3|Overall Study|Physician Decision|2
5640551|NCT00628212|19481150|P2|Overall Study|Physician Decision|1
5640552|NCT00628212|19481151|P1|Overall Study|Physician Decision|1
5640553|NCT00628212|19481148|P4|Overall Study|Adverse Event|2
5640554|NCT00628212|19481149|P3|Overall Study|Adverse Event|1
5640555|NCT00628212|19481150|P2|Overall Study|Adverse Event|0
5640556|NCT00628212|19481151|P1|Overall Study|Adverse Event|2
5640557|NCT00628108|19481199|P2|Overall Study|Withdrawal by Subject|0
5640558|NCT00628108|19481200|P1|Overall Study|Withdrawal by Subject|1
5640559|NCT00628108|19481199|P2|Overall Study|Adverse Event|3
5640560|NCT00628108|19481200|P1|Overall Study|Adverse Event|0
5640561|NCT00628030|19481232|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
5640562|NCT00628030|19481233|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
5640563|NCT00628030|19481232|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
5640564|NCT00628030|19481233|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
5640565|NCT00628030|19481232|P2|Baseline to Post-Assessment|Lost to Follow-up|29
5640566|NCT00628030|19481233|P1|Baseline to Post-Assessment|Lost to Follow-up|28
5640567|NCT00627926|19481259|P3|Overall Study|Noncompliance/unspecified|17
5640568|NCT00627926|19481260|P2|Overall Study|Noncompliance/unspecified|23
5640569|NCT00627926|19481261|P1|Overall Study|Noncompliance/unspecified|8
5640570|NCT00627926|19481259|P3|Overall Study|Lack of Efficacy|38
5640571|NCT00627926|19481260|P2|Overall Study|Lack of Efficacy|40
5640572|NCT00627926|19481261|P1|Overall Study|Lack of Efficacy|118
5640573|NCT00627926|19481259|P3|Overall Study|Withdrawal by Subject|0
5640574|NCT00627926|19481260|P2|Overall Study|Withdrawal by Subject|1
5640575|NCT00627926|19481261|P1|Overall Study|Withdrawal by Subject|2
5640576|NCT00627926|19481259|P3|Overall Study|Lost to Follow-up|4
5640577|NCT00627926|19481260|P2|Overall Study|Lost to Follow-up|3
5640578|NCT00627926|19481261|P1|Overall Study|Lost to Follow-up|4
5640579|NCT00627926|19481259|P3|Overall Study|Death|0
5640580|NCT00627926|19481260|P2|Overall Study|Death|0
5640581|NCT00627926|19481261|P1|Overall Study|Death|1
5640582|NCT00627926|19481259|P3|Overall Study|Adverse Event|36
5640583|NCT00627926|19481260|P2|Overall Study|Adverse Event|37
5640584|NCT00627926|19481261|P1|Overall Study|Adverse Event|26
5640585|NCT00627705|19481313|P2|Overall Study|Lost to Follow-up|1
5640586|NCT00627705|19481314|P1|Overall Study|Lost to Follow-up|0
5640587|NCT00627705|19481313|P2|Overall Study|Withdrawal by Subject|2
5640588|NCT00627705|19481314|P1|Overall Study|Withdrawal by Subject|0
5640589|NCT00627705|19481313|P2|Overall Study|Adverse Event|0
5640590|NCT00627705|19481314|P1|Overall Study|Adverse Event|1
5640591|NCT00627705|19481313|P2|Overall Study|Unwilling to take the compound (taste)|3
5640592|NCT00627705|19481314|P1|Overall Study|Unwilling to take the compound (taste)|1
5640593|NCT00627523|19481365|P2|Overall Study|Other|0
5640594|NCT00627523|19481366|P1|Overall Study|Other|1
5640595|NCT00627523|19481365|P2|Overall Study|Withdrawal by Subject|2
5640596|NCT00627523|19481366|P1|Overall Study|Withdrawal by Subject|0
5640597|NCT00627523|19481365|P2|Overall Study|Lack of Efficacy|0
5640598|NCT00627523|19481366|P1|Overall Study|Lack of Efficacy|1
5640599|NCT00627497|19481394|P4|Overall Study|Lost to Follow-up|0
5640600|NCT00627497|19481395|P3|Overall Study|Lost to Follow-up|0
5640601|NCT00627497|19481396|P2|Overall Study|Lost to Follow-up|1
5640602|NCT00627497|19481397|P1|Overall Study|Lost to Follow-up|1
5640603|NCT00627458|19481458|P3|Overall Study|Lost to Follow-up|0
5640604|NCT00627458|19481459|P2|Overall Study|Lost to Follow-up|1
5640605|NCT00627458|19481460|P1|Overall Study|Lost to Follow-up|1
5640606|NCT00627458|19481458|P3|Overall Study|Withdrawal by Subject|5
5640607|NCT00627458|19481459|P2|Overall Study|Withdrawal by Subject|6
5640608|NCT00627458|19481460|P1|Overall Study|Withdrawal by Subject|2
5640609|NCT00627458|19481458|P3|Overall Study|Migrated from study area|1
5640610|NCT00627458|19481459|P2|Overall Study|Migrated from study area|0
5640611|NCT00627458|19481460|P1|Overall Study|Migrated from study area|1
5640612|NCT00627445|19481535|P2|Overall Study|Other|8
5640613|NCT00627445|19481536|P1|Overall Study|Other|6
5640614|NCT00627445|19481535|P2|Overall Study|Lack of Efficacy|1
5640615|NCT00627445|19481536|P1|Overall Study|Lack of Efficacy|0
5640616|NCT00627445|19481535|P2|Overall Study|Adverse Event|3
5640617|NCT00627445|19481536|P1|Overall Study|Adverse Event|3
5640618|NCT00627393|19481579|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
5640619|NCT00627393|19481580|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
5640620|NCT00627393|19481579|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
5640621|NCT00627393|19481580|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
5640622|NCT00627393|19481579|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
5640623|NCT00627393|19481580|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
5640624|NCT00627393|19481579|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
5640625|NCT00627393|19481580|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
5640626|NCT00627094|19481616|P2|Overall Study|Other reason|0
5640627|NCT00627094|19481617|P1|Overall Study|Other reason|1
5640628|NCT00627094|19481616|P2|Overall Study|ulcer healed|7
5640629|NCT00627094|19481617|P1|Overall Study|ulcer healed|1
5640630|NCT00627094|19481616|P2|Overall Study|Withdrawal by Subject|1
5640631|NCT00627094|19481617|P1|Overall Study|Withdrawal by Subject|1
5640632|NCT00627094|19481616|P2|Overall Study|Lost to Follow-up|0
5640633|NCT00627094|19481617|P1|Overall Study|Lost to Follow-up|1
5640634|NCT00627094|19481616|P2|Overall Study|Adverse Event|7
5640635|NCT00627094|19481617|P1|Overall Study|Adverse Event|8
5640636|NCT00627042|19481629|P1|Overall Study|Withdrawal by Subject|2
5640637|NCT00627016|19481641|P2|Overall Study|Pregnancy|0
5640638|NCT00627016|19481642|P1|Overall Study|Pregnancy|1
5640639|NCT00627016|19481641|P2|Overall Study|Placed on Excluded Drugs|0
5640640|NCT00627016|19481642|P1|Overall Study|Placed on Excluded Drugs|1
5640641|NCT00627016|19481641|P2|Overall Study|Lack of Efficacy|0
5640642|NCT00627016|19481642|P1|Overall Study|Lack of Efficacy|1
5640643|NCT00627016|19481641|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
5640644|NCT00627016|19481642|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
5640645|NCT00627016|19481641|P2|Overall Study|Withdrawal by Subject|1
5640646|NCT00627016|19481642|P1|Overall Study|Withdrawal by Subject|2
5640647|NCT00627016|19481641|P2|Overall Study|Lost to Follow-up|1
5640648|NCT00627016|19481642|P1|Overall Study|Lost to Follow-up|0
5640649|NCT00627016|19481641|P2|Overall Study|Protocol Violation|2
5640650|NCT00627016|19481642|P1|Overall Study|Protocol Violation|0
5640651|NCT00627016|19481641|P2|Overall Study|Adverse Event|1
5640652|NCT00627016|19481642|P1|Overall Study|Adverse Event|1
5640653|NCT00626925|19481654|P2|Overall Study|Time constraints|1
5640654|NCT00626925|19481655|P1|Overall Study|Time constraints|3
5640655|NCT00626925|19481654|P2|Overall Study|Lack of Efficacy|4
5640656|NCT00626925|19481655|P1|Overall Study|Lack of Efficacy|1
5640657|NCT00626925|19481654|P2|Overall Study|Adverse effect|2
5640658|NCT00626925|19481655|P1|Overall Study|Adverse effect|6
5640659|NCT00626925|19481654|P2|Overall Study|relapse|0
5640660|NCT00626925|19481655|P1|Overall Study|relapse|1
5640661|NCT00626925|19481654|P2|Overall Study|Lost to Follow-up|2
5640662|NCT00626925|19481655|P1|Overall Study|Lost to Follow-up|1
5640663|NCT00626821|19481702|P1|Overall Study|other/unknown reason|104
5640664|NCT00626821|19481702|P1|Overall Study|Product dysfunction|21
5640665|NCT00626821|19481702|P1|Overall Study|Physician Decision|9
5640666|NCT00626821|19481702|P1|Overall Study|Withdrawal by Subject|10
5640667|NCT00626821|19481702|P1|Overall Study|Protocol Violation|33
5640668|NCT00626821|19481702|P1|Overall Study|Adverse Event|44
5640669|NCT00626795|19481782|P3|Blinded Treatment|Missing reason for withdrawal|5
5640670|NCT00626795|19481783|P2|Blinded Treatment|Missing reason for withdrawal|3
5640671|NCT00626795|19481784|P1|Blinded Treatment|Missing reason for withdrawal|5
5640672|NCT00626795|19481782|P3|Blinded Treatment|Other reasons|2
5640673|NCT00626795|19481783|P2|Blinded Treatment|Other reasons|0
5640674|NCT00626795|19481784|P1|Blinded Treatment|Other reasons|2
5640675|NCT00626795|19481782|P3|Blinded Treatment|Withdrawal by Subject|0
5640676|NCT00626795|19481783|P2|Blinded Treatment|Withdrawal by Subject|1
5640677|NCT00626795|19481784|P1|Blinded Treatment|Withdrawal by Subject|1
5640678|NCT00626795|19481782|P3|Blinded Treatment|Protocol Violation|1
5640679|NCT00626795|19481783|P2|Blinded Treatment|Protocol Violation|1
5640680|NCT00626795|19481784|P1|Blinded Treatment|Protocol Violation|0
5640681|NCT00626795|19481782|P3|Blinded Treatment|Unacceptable adverse event|1
5640682|NCT00626795|19481783|P2|Blinded Treatment|Unacceptable adverse event|0
5640683|NCT00626795|19481784|P1|Blinded Treatment|Unacceptable adverse event|0
5640684|NCT00626795|19481782|P3|Blinded Treatment|Lack of Efficacy|0
5640685|NCT00626795|19481783|P2|Blinded Treatment|Lack of Efficacy|0
5640686|NCT00626795|19481784|P1|Blinded Treatment|Lack of Efficacy|2
5640687|NCT00626795|19481782|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
5640688|NCT00626795|19481783|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
5640689|NCT00626795|19481784|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
5640690|NCT00626639|19481835|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
5640691|NCT00626639|19481836|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
5640692|NCT00626561|19481882|P1|Overall Study|Disease Progression|2
5640693|NCT00626561|19481882|P1|Overall Study|Withdrawal by Subject|2
5640694|NCT00626548|19481888|P2|Overall Study|Other termination reason|613
5640695|NCT00626548|19481889|P1|Overall Study|Other termination reason|493
5640696|NCT00626548|19481888|P2|Overall Study|Lost to Follow-up|2
5640697|NCT00626548|19481889|P1|Overall Study|Lost to Follow-up|2
5640698|NCT00626548|19481888|P2|Overall Study|Protocol Violation|11
5640699|NCT00626548|19481889|P1|Overall Study|Protocol Violation|4
5640700|NCT00626548|19481888|P2|Overall Study|Withdrawal by Subject|46
5640701|NCT00626548|19481889|P1|Overall Study|Withdrawal by Subject|42
5640702|NCT00626548|19481888|P2|Overall Study|Adverse Event|44
5640703|NCT00626548|19481889|P1|Overall Study|Adverse Event|164
5640704|NCT00626522|19481903|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
5640705|NCT00626522|19481904|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
5640706|NCT00626522|19481905|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
5640707|NCT00626522|19481906|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
5640708|NCT00626522|19481907|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
5640709|NCT00626522|19481908|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
5640710|NCT00626522|19481903|P6|Overall Study|Inconsistent reason reported|0
5640711|NCT00626522|19481904|P5|Overall Study|Inconsistent reason reported|0
5640712|NCT00626522|19481905|P4|Overall Study|Inconsistent reason reported|0
5640713|NCT00626522|19481906|P3|Overall Study|Inconsistent reason reported|0
5640714|NCT00626522|19481907|P2|Overall Study|Inconsistent reason reported|0
5640715|NCT00626522|19481908|P1|Overall Study|Inconsistent reason reported|1
5640716|NCT00626522|19481903|P6|Overall Study|Lost to Follow-up|0
5640717|NCT00626522|19481904|P5|Overall Study|Lost to Follow-up|0
5640718|NCT00626522|19481905|P4|Overall Study|Lost to Follow-up|0
5640719|NCT00626522|19481906|P3|Overall Study|Lost to Follow-up|0
5640720|NCT00626522|19481907|P2|Overall Study|Lost to Follow-up|1
5640721|NCT00626522|19481908|P1|Overall Study|Lost to Follow-up|0
5640722|NCT00626522|19481903|P6|Overall Study|COPD exacerbation|0
5640723|NCT00626522|19481904|P5|Overall Study|COPD exacerbation|1
5640724|NCT00626522|19481905|P4|Overall Study|COPD exacerbation|1
5640725|NCT00626522|19481906|P3|Overall Study|COPD exacerbation|0
5640726|NCT00626522|19481907|P2|Overall Study|COPD exacerbation|0
5640727|NCT00626522|19481908|P1|Overall Study|COPD exacerbation|0
5640728|NCT00626522|19481903|P6|Overall Study|Withdrawal by Subject|1
5640729|NCT00626522|19481904|P5|Overall Study|Withdrawal by Subject|4
5640730|NCT00626522|19481905|P4|Overall Study|Withdrawal by Subject|0
5640731|NCT00626522|19481906|P3|Overall Study|Withdrawal by Subject|5
5640732|NCT00626522|19481907|P2|Overall Study|Withdrawal by Subject|5
5640733|NCT00626522|19481908|P1|Overall Study|Withdrawal by Subject|2
5640734|NCT00626522|19481903|P6|Overall Study|Adverse Event|1
5640735|NCT00626522|19481904|P5|Overall Study|Adverse Event|1
5640736|NCT00626522|19481905|P4|Overall Study|Adverse Event|0
5640737|NCT00626522|19481906|P3|Overall Study|Adverse Event|2
5640738|NCT00626522|19481907|P2|Overall Study|Adverse Event|1
5640739|NCT00626522|19481908|P1|Overall Study|Adverse Event|2
5640740|NCT00626522|19481903|P6|Overall Study|Protocol Violation|0
5640741|NCT00626522|19481904|P5|Overall Study|Protocol Violation|1
5640742|NCT00626522|19481905|P4|Overall Study|Protocol Violation|0
5640743|NCT00626522|19481906|P3|Overall Study|Protocol Violation|0
5640744|NCT00626522|19481907|P2|Overall Study|Protocol Violation|0
5640745|NCT00626522|19481908|P1|Overall Study|Protocol Violation|0
5640746|NCT00626405|19481971|P2|Overall Study|Withdrawal by Subject|1
5640747|NCT00626405|19481972|P1|Overall Study|Withdrawal by Subject|0
5640748|NCT00626405|19481971|P2|Overall Study|Deemed Ineligible|0
5640749|NCT00626405|19481972|P1|Overall Study|Deemed Ineligible|1
5640750|NCT00626392|19481988|P6|Coadministration Period|Other|1
5640751|NCT00626392|19481989|P5|Coadministration Period|Other|1
5640752|NCT00626392|19481990|P4|Coadministration Period|Other|1
5640753|NCT00626392|19481991|P3|Coadministration Period|Other|3
5640754|NCT00626392|19481992|P2|Coadministration Period|Other|2
5640755|NCT00626392|19481993|P1|Coadministration Period|Other|0
5640756|NCT00626392|19481988|P6|Coadministration Period|Protocol Violation|0
5640757|NCT00626392|19481989|P5|Coadministration Period|Protocol Violation|1
5640758|NCT00626392|19481990|P4|Coadministration Period|Protocol Violation|1
5640759|NCT00626392|19481991|P3|Coadministration Period|Protocol Violation|0
5640760|NCT00626392|19481992|P2|Coadministration Period|Protocol Violation|1
5640761|NCT00626392|19481993|P1|Coadministration Period|Protocol Violation|0
5640762|NCT00626392|19481988|P6|Coadministration Period|Withdrawal by Subject|1
5640763|NCT00626392|19481989|P5|Coadministration Period|Withdrawal by Subject|0
5640764|NCT00626392|19481990|P4|Coadministration Period|Withdrawal by Subject|1
5640765|NCT00626392|19481991|P3|Coadministration Period|Withdrawal by Subject|0
5640766|NCT00626392|19481992|P2|Coadministration Period|Withdrawal by Subject|1
5640767|NCT00626392|19481993|P1|Coadministration Period|Withdrawal by Subject|1
5640768|NCT00626392|19481988|P6|Coadministration Period|Adverse Event|4
5640769|NCT00626392|19481989|P5|Coadministration Period|Adverse Event|3
5640770|NCT00626392|19481990|P4|Coadministration Period|Adverse Event|4
5640771|NCT00626392|19481991|P3|Coadministration Period|Adverse Event|7
5640772|NCT00626392|19481992|P2|Coadministration Period|Adverse Event|1
5640773|NCT00626392|19481993|P1|Coadministration Period|Adverse Event|3
5640774|NCT00626392|19481988|P6|Run-in Period|Noncompliance|0
5640775|NCT00626392|19481989|P5|Run-in Period|Noncompliance|0
5640776|NCT00626392|19481990|P4|Run-in Period|Noncompliance|0
5640777|NCT00626392|19481991|P3|Run-in Period|Noncompliance|1
5640778|NCT00626392|19481992|P2|Run-in Period|Noncompliance|0
5640779|NCT00626392|19481993|P1|Run-in Period|Noncompliance|1
5640780|NCT00626392|19481988|P6|Run-in Period|Withdrawal by Subject|1
5640781|NCT00626392|19481989|P5|Run-in Period|Withdrawal by Subject|3
5640782|NCT00626392|19481990|P4|Run-in Period|Withdrawal by Subject|1
5640783|NCT00626392|19481991|P3|Run-in Period|Withdrawal by Subject|1
5640784|NCT00626392|19481992|P2|Run-in Period|Withdrawal by Subject|1
5640785|NCT00626392|19481993|P1|Run-in Period|Withdrawal by Subject|0
5640786|NCT00626392|19481988|P6|Run-in Period|Adverse Event|0
5640787|NCT00626392|19481989|P5|Run-in Period|Adverse Event|1
5640788|NCT00626392|19481990|P4|Run-in Period|Adverse Event|0
5640789|NCT00626392|19481991|P3|Run-in Period|Adverse Event|1
5640790|NCT00626392|19481992|P2|Run-in Period|Adverse Event|0
5640791|NCT00626392|19481993|P1|Run-in Period|Adverse Event|0
5640792|NCT00626327|19482021|P3|Overall Study|Protocol Violation|26
5640793|NCT00626327|19482022|P2|Overall Study|Protocol Violation|4
5640794|NCT00626327|19482023|P1|Overall Study|Protocol Violation|26
5640795|NCT00626327|19482021|P3|Overall Study|Administrative Reason|6
5640796|NCT00626327|19482022|P2|Overall Study|Administrative Reason|0
5640797|NCT00626327|19482023|P1|Overall Study|Administrative Reason|2
5640798|NCT00626327|19482021|P3|Overall Study|Inappropriate enrollment|3
5640799|NCT00626327|19482022|P2|Overall Study|Inappropriate enrollment|5
5640800|NCT00626327|19482023|P1|Overall Study|Inappropriate enrollment|4
5640801|NCT00626327|19482021|P3|Overall Study|Lost to Follow-up|23
5640802|NCT00626327|19482022|P2|Overall Study|Lost to Follow-up|21
5640803|NCT00626327|19482023|P1|Overall Study|Lost to Follow-up|24
5640804|NCT00626327|19482021|P3|Overall Study|Adverse Event|0
5640805|NCT00626327|19482022|P2|Overall Study|Adverse Event|0
5640806|NCT00626327|19482023|P1|Overall Study|Adverse Event|1
5640807|NCT00626327|19482021|P3|Overall Study|Withdrawal by Subject|30
5640808|NCT00626327|19482022|P2|Overall Study|Withdrawal by Subject|29
5640809|NCT00626327|19482023|P1|Overall Study|Withdrawal by Subject|21
5640810|NCT00626275|19482049|P8|Part B|Withdrawal by Subject|1
5640811|NCT00626275|19482050|P7|Part B|Withdrawal by Subject|0
5640812|NCT00626275|19482051|P6|Part B|Withdrawal by Subject|0
5640813|NCT00626275|19482052|P5|Part B|Withdrawal by Subject|0
5640814|NCT00626275|19482053|P4|Part B|Withdrawal by Subject|0
5640815|NCT00626275|19482054|P3|Part B|Withdrawal by Subject|0
5640816|NCT00626275|19482055|P2|Part B|Withdrawal by Subject|0
5640817|NCT00626275|19482056|P1|Part B|Withdrawal by Subject|0
5640818|NCT00626275|19482049|P8|Part B|Lost to Follow-up|0
5640819|NCT00626275|19482050|P7|Part B|Lost to Follow-up|1
5640820|NCT00626275|19482051|P6|Part B|Lost to Follow-up|0
5640821|NCT00626275|19482052|P5|Part B|Lost to Follow-up|0
5640822|NCT00626275|19482053|P4|Part B|Lost to Follow-up|0
5640823|NCT00626275|19482054|P3|Part B|Lost to Follow-up|0
5640824|NCT00626275|19482055|P2|Part B|Lost to Follow-up|0
5640825|NCT00626275|19482056|P1|Part B|Lost to Follow-up|0
5640826|NCT00626275|19482049|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
5640827|NCT00626275|19482050|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
5640828|NCT00626275|19482051|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
5640829|NCT00626275|19482052|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
5640830|NCT00626275|19482053|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
5640831|NCT00626275|19482054|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
5640832|NCT00626275|19482055|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
5640833|NCT00626275|19482056|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
5640834|NCT00626275|19482049|P8|Part A - Treatment Period 1|Adverse Event|0
5640835|NCT00626275|19482050|P7|Part A - Treatment Period 1|Adverse Event|0
5640836|NCT00626275|19482051|P6|Part A - Treatment Period 1|Adverse Event|0
5640837|NCT00626275|19482052|P5|Part A - Treatment Period 1|Adverse Event|0
5640838|NCT00626275|19482053|P4|Part A - Treatment Period 1|Adverse Event|0
5640839|NCT00626275|19482054|P3|Part A - Treatment Period 1|Adverse Event|0
5640840|NCT00626275|19482055|P2|Part A - Treatment Period 1|Adverse Event|0
5640841|NCT00626275|19482056|P1|Part A - Treatment Period 1|Adverse Event|1
5640842|NCT00626197|19482103|P3|Overall Study|Administrative reasons|55
5640843|NCT00626197|19482104|P2|Overall Study|Administrative reasons|19
5640844|NCT00626197|19482105|P1|Overall Study|Administrative reasons|15
5640845|NCT00626197|19482103|P3|Overall Study|Withdrawal by Subject|7
5640846|NCT00626197|19482104|P2|Overall Study|Withdrawal by Subject|17
5640847|NCT00626197|19482105|P1|Overall Study|Withdrawal by Subject|17
5640848|NCT00626197|19482103|P3|Overall Study|Adverse Event|2
5640849|NCT00626197|19482104|P2|Overall Study|Adverse Event|1
5640850|NCT00626197|19482105|P1|Overall Study|Adverse Event|1
5640851|NCT00626197|19482103|P3|Overall Study|Adverse event, serious fatal|6
5640852|NCT00626197|19482104|P2|Overall Study|Adverse event, serious fatal|6
5640853|NCT00626197|19482105|P1|Overall Study|Adverse event, serious fatal|3
5640854|NCT00626197|19482103|P3|Overall Study|Failure to return|6
5640855|NCT00626197|19482104|P2|Overall Study|Failure to return|5
5640856|NCT00626197|19482105|P1|Overall Study|Failure to return|6
5640857|NCT00626197|19482103|P3|Overall Study|Did not cooperate|1
5640858|NCT00626197|19482104|P2|Overall Study|Did not cooperate|6
5640859|NCT00626197|19482105|P1|Overall Study|Did not cooperate|2
5640860|NCT00626093|19482182|P1|Overall Study|One of the required devices not implante|6
5640861|NCT00626093|19482182|P1|Overall Study|Protocol Violation|1
5640862|NCT00626093|19482182|P1|Overall Study|Withdrawal by Subject|6
5640863|NCT00626093|19482182|P1|Overall Study|Physician Decision|4
5640864|NCT00626093|19482182|P1|Overall Study|Death|1
5640865|NCT00626093|19482182|P1|Overall Study|Lost to Follow-up|5
5640866|NCT00626028|19482189|P2|Overall Study|Inclusion/Exclusion Criteria|6
5640867|NCT00626028|19482190|P1|Overall Study|Inclusion/Exclusion Criteria|3
5640868|NCT00626028|19482189|P2|Overall Study|Physician Decision|1
5640869|NCT00626028|19482190|P1|Overall Study|Physician Decision|2
5640870|NCT00626028|19482189|P2|Overall Study|Device Failure|1
5640871|NCT00626028|19482190|P1|Overall Study|Device Failure|0
5640872|NCT00626028|19482189|P2|Overall Study|Adverse Event|1
5640873|NCT00626028|19482190|P1|Overall Study|Adverse Event|1
5640874|NCT00625872|19482214|P2|Overall Study|Randomized but not treated|1
5640875|NCT00625872|19482215|P1|Overall Study|Randomized but not treated|0
5640876|NCT00625872|19482214|P2|Overall Study|Terminated by sponsor|5
5640877|NCT00625872|19482215|P1|Overall Study|Terminated by sponsor|2
5640878|NCT00625872|19482214|P2|Overall Study|Does not meet inclusion criteria|0
5640879|NCT00625872|19482215|P1|Overall Study|Does not meet inclusion criteria|1
5640880|NCT00625872|19482214|P2|Overall Study|Withdrawal by Subject|0
5640881|NCT00625872|19482215|P1|Overall Study|Withdrawal by Subject|1
5640882|NCT00625846|19482329|P4|Overall Study|Withdrawal by Subject|2
5640883|NCT00625846|19482330|P3|Overall Study|Withdrawal by Subject|1
5640884|NCT00625846|19482331|P2|Overall Study|Withdrawal by Subject|0
5640885|NCT00625846|19482332|P1|Overall Study|Withdrawal by Subject|2
5640886|NCT00625820|19482358|P1|Overall Study|Withdrawal by Subject|1
5640887|NCT00625807|19482366|P2|Overall Study|schedule conflict|8
5640888|NCT00625807|19482367|P1|Overall Study|schedule conflict|2
5640889|NCT00625742|19482383|P1|Overall Study|Ineligible|1
5640890|NCT00625742|19482383|P1|Overall Study|Lost to Follow-up|4
5640891|NCT00625742|19482383|P1|Overall Study|Adverse Event|4
5640892|NCT00625742|19482383|P1|Overall Study|Withdrawal by Subject|1
5640893|NCT00625742|19482383|P1|Overall Study|Disease Progression|2
5640894|NCT00625586|19482402|P1|Overall Study|Adverse Event|1
5640895|NCT00625443|19482415|P3|Overall Study|Other|1
5640896|NCT00625443|19482416|P2|Overall Study|Other|1
5640897|NCT00625443|19482417|P1|Overall Study|Other|0
5640898|NCT00625443|19482415|P3|Overall Study|Physician Decision|2
5640899|NCT00625443|19482416|P2|Overall Study|Physician Decision|4
5640900|NCT00625443|19482417|P1|Overall Study|Physician Decision|0
5640901|NCT00625443|19482415|P3|Overall Study|Withdrawal by Subject|2
5640902|NCT00625443|19482416|P2|Overall Study|Withdrawal by Subject|1
5640903|NCT00625443|19482417|P1|Overall Study|Withdrawal by Subject|0
5640904|NCT00625443|19482415|P3|Overall Study|Platelet count increase >=500,000/mm3|0
5640905|NCT00625443|19482416|P2|Overall Study|Platelet count increase >=500,000/mm3|0
5640906|NCT00625443|19482417|P1|Overall Study|Platelet count increase >=500,000/mm3|1
5640907|NCT00625443|19482415|P3|Overall Study|Non-compliance with protocol|0
5640908|NCT00625443|19482416|P2|Overall Study|Non-compliance with protocol|1
5640909|NCT00625443|19482417|P1|Overall Study|Non-compliance with protocol|0
5640910|NCT00625443|19482415|P3|Overall Study|Adverse Event|0
5640911|NCT00625443|19482416|P2|Overall Study|Adverse Event|4
5640912|NCT00625443|19482417|P1|Overall Study|Adverse Event|1
5640913|NCT00625365|19482497|P1|Overall Study|VSD|1
5640914|NCT00625365|19482497|P1|Overall Study|No IV access|5
5640915|NCT00625365|19482497|P1|Overall Study|Withdrawal by Subject|1
5640916|NCT00625183|19482503|P1|Overall Study|Disease Progression|1
5640917|NCT00625131|19482514|P3|Overall Study|Withdrawal by Subject|5
5640918|NCT00625131|19482515|P2|Overall Study|Withdrawal by Subject|0
5640919|NCT00625131|19482516|P1|Overall Study|Withdrawal by Subject|1
5640920|NCT00625131|19482514|P3|Overall Study|Lost to Follow-up|0
5640921|NCT00625131|19482515|P2|Overall Study|Lost to Follow-up|2
5640922|NCT00625131|19482516|P1|Overall Study|Lost to Follow-up|3
5640923|NCT00624832|19482545|P4|Overall Study|Abnormal Laboratory Value|0
5640924|NCT00624832|19482546|P3|Overall Study|Abnormal Laboratory Value|0
5640925|NCT00624832|19482547|P2|Overall Study|Abnormal Laboratory Value|0
5640926|NCT00624832|19482548|P1|Overall Study|Abnormal Laboratory Value|2
5640927|NCT00624832|19482545|P4|Overall Study|Adverse Event|1
5640928|NCT00624832|19482546|P3|Overall Study|Adverse Event|0
5640929|NCT00624832|19482547|P2|Overall Study|Adverse Event|1
5640930|NCT00624832|19482548|P1|Overall Study|Adverse Event|0
5640931|NCT00624819|19482564|P4|Follow-up Period: Year 4|Lost to Follow-up|0
5640932|NCT00624819|19482565|P3|Follow-up Period: Year 4|Lost to Follow-up|0
5640933|NCT00624819|19482566|P2|Follow-up Period: Year 4|Lost to Follow-up|1
5640934|NCT00624819|19482567|P1|Follow-up Period: Year 4|Lost to Follow-up|1
5640935|NCT00624819|19482564|P4|Follow-up Period: Year 4|Parents decision|0
5640936|NCT00624819|19482565|P3|Follow-up Period: Year 4|Parents decision|1
5640937|NCT00624819|19482566|P2|Follow-up Period: Year 4|Parents decision|0
5640938|NCT00624819|19482567|P1|Follow-up Period: Year 4|Parents decision|0
5640939|NCT00624780|19482744|P6|Follow-up (Week 26)|Other|0
5640940|NCT00624780|19482745|P5|Follow-up (Week 26)|Other|0
5640941|NCT00624780|19482746|P4|Follow-up (Week 26)|Other|0
5640942|NCT00624780|19482747|P3|Follow-up (Week 26)|Other|0
5640943|NCT00624780|19482748|P2|Follow-up (Week 26)|Other|1
5640944|NCT00624780|19482749|P1|Follow-up (Week 26)|Other|1
5640945|NCT00624780|19482744|P6|Follow-up (Week 26)|Withdrawal by Subject|0
5640946|NCT00624780|19482745|P5|Follow-up (Week 26)|Withdrawal by Subject|0
5640947|NCT00624780|19482746|P4|Follow-up (Week 26)|Withdrawal by Subject|0
5640948|NCT00624780|19482747|P3|Follow-up (Week 26)|Withdrawal by Subject|0
5640949|NCT00624780|19482748|P2|Follow-up (Week 26)|Withdrawal by Subject|0
5640950|NCT00624780|19482749|P1|Follow-up (Week 26)|Withdrawal by Subject|1
5640951|NCT00624780|19482744|P6|Follow-up (Week 26)|Lost to Follow-up|0
5640952|NCT00624780|19482745|P5|Follow-up (Week 26)|Lost to Follow-up|1
5640953|NCT00624780|19482746|P4|Follow-up (Week 26)|Lost to Follow-up|0
5640954|NCT00624780|19482747|P3|Follow-up (Week 26)|Lost to Follow-up|1
5640955|NCT00624780|19482748|P2|Follow-up (Week 26)|Lost to Follow-up|0
5640956|NCT00624780|19482749|P1|Follow-up (Week 26)|Lost to Follow-up|0
5640957|NCT00624780|19482744|P6|Follow-up (Week 26)|Adverse Event|0
5640958|NCT00624780|19482745|P5|Follow-up (Week 26)|Adverse Event|1
5640959|NCT00624780|19482746|P4|Follow-up (Week 26)|Adverse Event|0
5640960|NCT00624780|19482747|P3|Follow-up (Week 26)|Adverse Event|0
5640961|NCT00624780|19482748|P2|Follow-up (Week 26)|Adverse Event|0
5640962|NCT00624780|19482749|P1|Follow-up (Week 26)|Adverse Event|0
5640963|NCT00624780|19482744|P6|Follow-up (Week 26)|Death|0
5640964|NCT00624780|19482745|P5|Follow-up (Week 26)|Death|0
5640965|NCT00624780|19482746|P4|Follow-up (Week 26)|Death|0
5640966|NCT00624780|19482747|P3|Follow-up (Week 26)|Death|1
5640967|NCT00624780|19482748|P2|Follow-up (Week 26)|Death|0
5640968|NCT00624780|19482749|P1|Follow-up (Week 26)|Death|0
5640969|NCT00624780|19482744|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5640970|NCT00624780|19482745|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5640971|NCT00624780|19482746|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5640972|NCT00624780|19482747|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
5640973|NCT00624780|19482748|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5640974|NCT00624780|19482749|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
5640975|NCT00624780|19482744|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5640976|NCT00624780|19482745|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5640977|NCT00624780|19482746|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5640978|NCT00624780|19482747|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5640979|NCT00624780|19482748|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
5640980|NCT00624780|19482749|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
5640981|NCT00624780|19482744|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
5640982|NCT00624780|19482745|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
5640983|NCT00624780|19482746|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
5640984|NCT00624780|19482747|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
5640985|NCT00624780|19482748|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
5640986|NCT00624780|19482749|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
5640987|NCT00624780|19482744|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
5640988|NCT00624780|19482745|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
5640989|NCT00624780|19482746|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
5640990|NCT00624780|19482747|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
5640991|NCT00624780|19482748|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
5640992|NCT00624780|19482749|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
5640993|NCT00624780|19482744|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
5640994|NCT00624780|19482745|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
5640995|NCT00624780|19482746|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
5640996|NCT00624780|19482747|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
5640997|NCT00624780|19482748|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
5640998|NCT00624780|19482749|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
5640999|NCT00624780|19482744|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5641000|NCT00624780|19482745|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5641001|NCT00624780|19482746|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
5641002|NCT00624780|19482747|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5641003|NCT00624780|19482748|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
5641004|NCT00624780|19482749|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
5641005|NCT00624780|19482744|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
5641006|NCT00624780|19482745|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
5641007|NCT00624780|19482746|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
5641008|NCT00624780|19482747|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
5641009|NCT00624780|19482748|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
5641010|NCT00624780|19482749|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
5641011|NCT00624780|19482744|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
5641012|NCT00624780|19482745|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
5641013|NCT00624780|19482746|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
5641014|NCT00624780|19482747|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
5641015|NCT00624780|19482748|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
5641016|NCT00624780|19482749|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
5641017|NCT00624780|19482744|P6|Treatment Optimization (Up to Week 12)|Other|0
5641018|NCT00624780|19482745|P5|Treatment Optimization (Up to Week 12)|Other|9
5641019|NCT00624780|19482746|P4|Treatment Optimization (Up to Week 12)|Other|2
5641020|NCT00624780|19482747|P3|Treatment Optimization (Up to Week 12)|Other|8
5641021|NCT00624780|19482748|P2|Treatment Optimization (Up to Week 12)|Other|4
5641022|NCT00624780|19482749|P1|Treatment Optimization (Up to Week 12)|Other|10
5641023|NCT00624780|19482744|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
5641024|NCT00624780|19482745|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
5641025|NCT00624780|19482746|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
5641026|NCT00624780|19482747|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
5641027|NCT00624780|19482748|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
5641028|NCT00624780|19482749|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
5641029|NCT00624780|19482744|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
5641030|NCT00624780|19482745|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
5641031|NCT00624780|19482746|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
5641032|NCT00624780|19482747|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
5641033|NCT00624780|19482748|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
5641034|NCT00624780|19482749|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
5641035|NCT00624780|19482744|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
5641036|NCT00624780|19482745|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
5641037|NCT00624780|19482746|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
5641038|NCT00624780|19482747|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
5641039|NCT00624780|19482748|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
5641040|NCT00624780|19482749|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
5641041|NCT00624780|19482744|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
5641042|NCT00624780|19482745|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
5641043|NCT00624780|19482746|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
5641044|NCT00624780|19482747|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
5641045|NCT00624780|19482748|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
5641046|NCT00624780|19482749|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
5641047|NCT00624585|19482940|P1|Overall Study|Adverse Event|3
5641048|NCT00624585|19482940|P1|Overall Study|Disease Progression|6
5641049|NCT00624585|19482940|P1|Overall Study|Death|3
5641050|NCT00624520|19482970|P2|Overall Study|Death|1
5641051|NCT00624520|19482971|P1|Overall Study|Death|0
5641052|NCT00624520|19482970|P2|Overall Study|Withdrawal by Subject|7
5641053|NCT00624520|19482971|P1|Overall Study|Withdrawal by Subject|12
5641054|NCT00624468|19482998|P4|Safety Follow-up (SFU) Period|Other|1
5641055|NCT00624468|19482999|P3|Safety Follow-up (SFU) Period|Other|1
5641056|NCT00624468|19483000|P2|Safety Follow-up (SFU) Period|Other|0
5641057|NCT00624468|19483001|P1|Safety Follow-up (SFU) Period|Other|0
5641058|NCT00624468|19482998|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
5641059|NCT00624468|19482999|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
5641060|NCT00624468|19483000|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
5641061|NCT00624468|19483001|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
5641062|NCT00624468|19482998|P4|Double-blind Period|Withdrew Prematurely|0
5641063|NCT00624468|19482999|P3|Double-blind Period|Withdrew Prematurely|0
5641064|NCT00624468|19483000|P2|Double-blind Period|Withdrew Prematurely|1
5641065|NCT00624468|19483001|P1|Double-blind Period|Withdrew Prematurely|1
5641066|NCT00624468|19482998|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
5641067|NCT00624468|19482999|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
5641068|NCT00624468|19483000|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
5641069|NCT00624468|19483001|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
5641070|NCT00624377|19483068|P1|Overall Study|Non-evaluable population|84
5641071|NCT00624377|19483068|P1|Overall Study|Other|91
5641072|NCT00624377|19483068|P1|Overall Study|Adverse Event|14
5641073|NCT00624377|19483068|P1|Overall Study|Withdrawal by Subject|100
5641074|NCT00624377|19483068|P1|Overall Study|Lost to Follow-up|355
5641075|NCT00624338|19483082|P3|Overall Study|Randomized but not treated|3
5641076|NCT00624338|19483083|P2|Overall Study|Randomized but not treated|1
5641077|NCT00624338|19483084|P1|Overall Study|Randomized but not treated|2
5641078|NCT00624338|19483082|P3|Overall Study|Other|9
5641079|NCT00624338|19483083|P2|Overall Study|Other|5
5641080|NCT00624338|19483084|P1|Overall Study|Other|15
5641081|NCT00624338|19483082|P3|Overall Study|Termination of 150 mg group by Sponsor|0
5641082|NCT00624338|19483083|P2|Overall Study|Termination of 150 mg group by Sponsor|55
5641083|NCT00624338|19483084|P1|Overall Study|Termination of 150 mg group by Sponsor|0
5641084|NCT00624338|19483082|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
5641085|NCT00624338|19483083|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
5641086|NCT00624338|19483084|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
5641087|NCT00624338|19483082|P3|Overall Study|Death|0
5641088|NCT00624338|19483083|P2|Overall Study|Death|2
5641089|NCT00624338|19483084|P1|Overall Study|Death|0
5641090|NCT00624338|19483082|P3|Overall Study|Protocol Violation|2
5641091|NCT00624338|19483083|P2|Overall Study|Protocol Violation|3
5641092|NCT00624338|19483084|P1|Overall Study|Protocol Violation|3
5641093|NCT00624338|19483082|P3|Overall Study|Lack of Efficacy|14
5641094|NCT00624338|19483083|P2|Overall Study|Lack of Efficacy|3
5641095|NCT00624338|19483084|P1|Overall Study|Lack of Efficacy|11
5641096|NCT00624338|19483082|P3|Overall Study|Lost to Follow-up|0
5641097|NCT00624338|19483083|P2|Overall Study|Lost to Follow-up|0
5641098|NCT00624338|19483084|P1|Overall Study|Lost to Follow-up|1
5641099|NCT00624338|19483082|P3|Overall Study|Adverse Event|18
5641100|NCT00624338|19483083|P2|Overall Study|Adverse Event|14
5641101|NCT00624338|19483084|P1|Overall Study|Adverse Event|14
5641102|NCT00624286|19483106|P2|Overall Study|Death|1
5641103|NCT00624286|19483107|P1|Overall Study|Death|0
5641104|NCT00624286|19483106|P2|Overall Study|Abnormal test procedure result(s)|1
5641105|NCT00624286|19483107|P1|Overall Study|Abnormal test procedure result(s)|0
5641106|NCT00624286|19483106|P2|Overall Study|Not stated|1
5641107|NCT00624286|19483107|P1|Overall Study|Not stated|0
5641108|NCT00624286|19483106|P2|Overall Study|Lack of Efficacy|6
5641109|NCT00624286|19483107|P1|Overall Study|Lack of Efficacy|1
5641110|NCT00624286|19483106|P2|Overall Study|Administrative problems|0
5641111|NCT00624286|19483107|P1|Overall Study|Administrative problems|3
5641112|NCT00624286|19483106|P2|Overall Study|Lost to Follow-up|2
5641113|NCT00624286|19483107|P1|Overall Study|Lost to Follow-up|3
5641114|NCT00624286|19483106|P2|Overall Study|Withdrawal by Subject|4
5641115|NCT00624286|19483107|P1|Overall Study|Withdrawal by Subject|5
5641116|NCT00624286|19483106|P2|Overall Study|Adverse Event|3
5641117|NCT00624286|19483107|P1|Overall Study|Adverse Event|6
5641118|NCT00624286|19483106|P2|Overall Study|Protocol Deviation|9
5641119|NCT00624286|19483107|P1|Overall Study|Protocol Deviation|7
5641120|NCT00624065|19483160|P2|Overall Study|Met protocol-defined stopping criteria|9
5641121|NCT00624065|19483161|P1|Overall Study|Met protocol-defined stopping criteria|4
5641122|NCT00624065|19483160|P2|Overall Study|Lack of Efficacy|3
5641123|NCT00624065|19483161|P1|Overall Study|Lack of Efficacy|0
5641124|NCT00624065|19483160|P2|Overall Study|Consent withdrawn|5
5641125|NCT00624065|19483161|P1|Overall Study|Consent withdrawn|6
5641126|NCT00624065|19483160|P2|Overall Study|Lost to Follow-up|1
5641127|NCT00624065|19483161|P1|Overall Study|Lost to Follow-up|4
5641128|NCT00624065|19483160|P2|Overall Study|Adverse Event|6
5641129|NCT00624065|19483161|P1|Overall Study|Adverse Event|5
5641130|NCT00624052|19483173|P4|Overall Study|Changed job/ran out if meds|0
5641131|NCT00624052|19483174|P3|Overall Study|Changed job/ran out if meds|0
5641132|NCT00624052|19483175|P2|Overall Study|Changed job/ran out if meds|2
5641133|NCT00624052|19483176|P1|Overall Study|Changed job/ran out if meds|0
5641134|NCT00624052|19483173|P4|Overall Study|Consent withdrawn|0
5641135|NCT00624052|19483174|P3|Overall Study|Consent withdrawn|1
5641136|NCT00624052|19483175|P2|Overall Study|Consent withdrawn|1
5641137|NCT00624052|19483176|P1|Overall Study|Consent withdrawn|3
5641138|NCT00624052|19483173|P4|Overall Study|Non compliant with the protocol|1
5641139|NCT00624052|19483174|P3|Overall Study|Non compliant with the protocol|1
5641140|NCT00624052|19483175|P2|Overall Study|Non compliant with the protocol|1
5641141|NCT00624052|19483176|P1|Overall Study|Non compliant with the protocol|2
5641142|NCT00624052|19483173|P4|Overall Study|Lost to Follow-up|0
5641143|NCT00624052|19483174|P3|Overall Study|Lost to Follow-up|1
5641144|NCT00624052|19483175|P2|Overall Study|Lost to Follow-up|3
5641145|NCT00624052|19483176|P1|Overall Study|Lost to Follow-up|2
5641146|NCT00624052|19483173|P4|Overall Study|Lack of Efficacy|0
5641147|NCT00624052|19483174|P3|Overall Study|Lack of Efficacy|0
5641148|NCT00624052|19483175|P2|Overall Study|Lack of Efficacy|1
5641149|NCT00624052|19483176|P1|Overall Study|Lack of Efficacy|1
5641150|NCT00624052|19483173|P4|Overall Study|Adverse Event|3
5641151|NCT00624052|19483174|P3|Overall Study|Adverse Event|0
5641152|NCT00624052|19483175|P2|Overall Study|Adverse Event|6
5641153|NCT00624052|19483176|P1|Overall Study|Adverse Event|7
5641154|NCT00623935|19483253|P1|Overall Study|Patient Declined Transplant|1
5641155|NCT00623935|19483253|P1|Overall Study|Death|1
5641156|NCT00623831|19483260|P2|Overall Study|Progressive Disease|1
5641157|NCT00623831|19483261|P1|Overall Study|Progressive Disease|0
5641158|NCT00623831|19483260|P2|Overall Study|Withdrawal by Subject|0
5641159|NCT00623831|19483261|P1|Overall Study|Withdrawal by Subject|1
5641160|NCT00623805|19483273|P2|Overall Study|Reason not Specified|6
5641161|NCT00623805|19483274|P1|Overall Study|Reason not Specified|3
5641162|NCT00623805|19483273|P2|Overall Study|Protocol Violation|1
5641163|NCT00623805|19483274|P1|Overall Study|Protocol Violation|1
5641164|NCT00623805|19483273|P2|Overall Study|Lost to Follow-up|2
5641165|NCT00623805|19483274|P1|Overall Study|Lost to Follow-up|2
5641166|NCT00623805|19483273|P2|Overall Study|Lack of Efficacy|7
5641167|NCT00623805|19483274|P1|Overall Study|Lack of Efficacy|3
5641168|NCT00623805|19483273|P2|Overall Study|Death|0
5641169|NCT00623805|19483274|P1|Overall Study|Death|2
5641170|NCT00623805|19483273|P2|Overall Study|Adverse Event|6
5641171|NCT00623805|19483274|P1|Overall Study|Adverse Event|9
5641172|NCT00623779|19483291|P3|Overall Study|Criteria from CSR|1
5641173|NCT00623779|19483292|P2|Overall Study|Criteria from CSR|0
5641174|NCT00623779|19483293|P1|Overall Study|Criteria from CSR|2
5641175|NCT00623779|19483291|P3|Overall Study|Adverse Event|0
5641176|NCT00623779|19483292|P2|Overall Study|Adverse Event|3
5641177|NCT00623779|19483293|P1|Overall Study|Adverse Event|1
5641178|NCT00623766|19483342|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
5641179|NCT00623766|19483343|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
5641180|NCT00623766|19483342|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
5641181|NCT00623766|19483343|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
5641182|NCT00623766|19483342|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
5641183|NCT00623766|19483343|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
5641184|NCT00623766|19483342|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
5641185|NCT00623766|19483343|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
5641186|NCT00623766|19483342|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
5641187|NCT00623766|19483343|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
5641188|NCT00623727|19483367|P2|Open Label Follow-up|Participant convenience|1
5641189|NCT00623727|19483368|P1|Open Label Follow-up|Participant convenience|0
5641190|NCT00623727|19483367|P2|Open Label Follow-up|Study termination|6
5641191|NCT00623727|19483368|P1|Open Label Follow-up|Study termination|0
5641192|NCT00623727|19483367|P2|Open Label Follow-up|Withdrawal by Subject|1
5641193|NCT00623727|19483368|P1|Open Label Follow-up|Withdrawal by Subject|0
5641194|NCT00623727|19483367|P2|Double Blind (DB)|Protocol Violation|2
5641195|NCT00623727|19483368|P1|Double Blind (DB)|Protocol Violation|2
5641196|NCT00623727|19483367|P2|Double Blind (DB)|Lost to Follow-up|1
5641197|NCT00623727|19483368|P1|Double Blind (DB)|Lost to Follow-up|1
5641198|NCT00623727|19483367|P2|Double Blind (DB)|Termination of the double-blind period|21
5641199|NCT00623727|19483368|P1|Double Blind (DB)|Termination of the double-blind period|22
5641200|NCT00623727|19483367|P2|Double Blind (DB)|Lack of Efficacy|2
5641201|NCT00623727|19483368|P1|Double Blind (DB)|Lack of Efficacy|2
5641202|NCT00623727|19483367|P2|Double Blind (DB)|Withdrawal by Subject|2
5641203|NCT00623727|19483368|P1|Double Blind (DB)|Withdrawal by Subject|8
5641204|NCT00623727|19483367|P2|Double Blind (DB)|Physician Decision|1
5641205|NCT00623727|19483368|P1|Double Blind (DB)|Physician Decision|0
5641206|NCT00623727|19483367|P2|Double Blind (DB)|Adverse Event|3
5641207|NCT00623727|19483368|P1|Double Blind (DB)|Adverse Event|1
5641208|NCT00623623|19483423|P2|Overall Study|Previous enrolment into this study|1
5641209|NCT00623623|19483424|P1|Overall Study|Previous enrolment into this study|1
5641210|NCT00623597|19483480|P2|Overall Study|Failed to return|0
5641211|NCT00623597|19483481|P1|Overall Study|Failed to return|1
5641212|NCT00623545|19483544|P1|Overall Study|Withdrawal by Subject|4
5641213|NCT00623545|19483544|P1|Overall Study|Adverse Event|6
5641214|NCT00623480|19483564|P2|Overall Study|Site closed by sponsor|1
5641215|NCT00623480|19483565|P1|Overall Study|Site closed by sponsor|0
5641216|NCT00623480|19483564|P2|Overall Study|Protocol Violation|1
5641217|NCT00623480|19483565|P1|Overall Study|Protocol Violation|0
5641218|NCT00623480|19483564|P2|Overall Study|Non-compliant with study medication|0
5641219|NCT00623480|19483565|P1|Overall Study|Non-compliant with study medication|4
5641220|NCT00623480|19483564|P2|Overall Study|Lack of Efficacy|0
5641221|NCT00623480|19483565|P1|Overall Study|Lack of Efficacy|1
5641222|NCT00623480|19483564|P2|Overall Study|Withdrawal by Subject|4
5641223|NCT00623480|19483565|P1|Overall Study|Withdrawal by Subject|2
5641224|NCT00623480|19483564|P2|Overall Study|Lost to Follow-up|1
5641225|NCT00623480|19483565|P1|Overall Study|Lost to Follow-up|0
5641226|NCT00623467|19483577|P1|Overall Study|Withdrawal by Subject|2
5641227|NCT00623467|19483577|P1|Overall Study|Protocol Violation|4
5641228|NCT00623467|19483577|P1|Overall Study|Lost to Follow-up|1
5641229|NCT00623428|19483647|P2|Follow-up Period|Death|1
5641230|NCT00623428|19483648|P1|Follow-up Period|Death|0
5641231|NCT00623428|19483647|P2|Follow-up Period|Reason not specified|1
5641232|NCT00623428|19483648|P1|Follow-up Period|Reason not specified|1
5641233|NCT00623428|19483647|P2|Follow-up Period|Did not cooperate|3
5641234|NCT00623428|19483648|P1|Follow-up Period|Did not cooperate|0
5641235|NCT00623428|19483647|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
5641236|NCT00623428|19483648|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
5641237|NCT00623428|19483647|P2|Follow-up Period|Patient withdrew consent|4
5641238|NCT00623428|19483648|P1|Follow-up Period|Patient withdrew consent|5
5641239|NCT00623428|19483647|P2|Follow-up Period|Failure to return|2
5641240|NCT00623428|19483648|P1|Follow-up Period|Failure to return|10
5641241|NCT00623428|19483647|P2|Follow-up Period|Relapse post-treatment|3
5641242|NCT00623428|19483648|P1|Follow-up Period|Relapse post-treatment|11
5641243|NCT00623428|19483647|P2|Treatment Period|Withdrawal by Subject|1
5641244|NCT00623428|19483648|P1|Treatment Period|Withdrawal by Subject|0
5641245|NCT00623428|19483647|P2|Treatment Period|Other|1
5641246|NCT00623428|19483648|P1|Treatment Period|Other|0
5641247|NCT00623428|19483647|P2|Treatment Period|Insufficient therapeutic response|2
5641248|NCT00623428|19483648|P1|Treatment Period|Insufficient therapeutic response|0
5641249|NCT00623428|19483647|P2|Treatment Period|Did not cooperate / refused treatment|13
5641250|NCT00623428|19483648|P1|Treatment Period|Did not cooperate / refused treatment|0
5641251|NCT00623428|19483647|P2|Treatment Period|Death|1
5641252|NCT00623428|19483648|P1|Treatment Period|Death|0
5641253|NCT00623428|19483647|P2|Treatment Period|Adverse event/intercurrent illness|9
5641254|NCT00623428|19483648|P1|Treatment Period|Adverse event/intercurrent illness|0
5641255|NCT00623233|19483666|P1|Overall Study|Withdrawal by Subject|3
5641256|NCT00623233|19483666|P1|Overall Study|Lost to Follow-up|1
5641257|NCT00623233|19483666|P1|Overall Study|Physician Decision|10
5641258|NCT00623233|19483666|P1|Overall Study|Adverse Event|10
5641259|NCT00623194|19483673|P1|Overall Study|Unclassified|1
5641260|NCT00623194|19483673|P1|Overall Study|Protocol Violation|3
5641261|NCT00623194|19483673|P1|Overall Study|Lack of Efficacy|1
5641262|NCT00623103|19483710|P2|Overall Study|Protocol deviation|1
5641263|NCT00623103|19483711|P1|Overall Study|Protocol deviation|2
5641264|NCT00623103|19483710|P2|Overall Study|Death|11
5641265|NCT00623103|19483711|P1|Overall Study|Death|11
5641266|NCT00623103|19483710|P2|Overall Study|Administrative problems|4
5641267|NCT00623103|19483711|P1|Overall Study|Administrative problems|2
5641268|NCT00623103|19483710|P2|Overall Study|Lost to Follow-up|1
5641269|NCT00623103|19483711|P1|Overall Study|Lost to Follow-up|4
5641270|NCT00623103|19483710|P2|Overall Study|Withdrawal by Subject|24
5641271|NCT00623103|19483711|P1|Overall Study|Withdrawal by Subject|18
5641272|NCT00623103|19483710|P2|Overall Study|Unsatisfactory therapeutic effect|12
5641273|NCT00623103|19483711|P1|Overall Study|Unsatisfactory therapeutic effect|4
5641274|NCT00623103|19483710|P2|Overall Study|Adverse Event|60
5641275|NCT00623103|19483711|P1|Overall Study|Adverse Event|70
5641276|NCT00622908|19483739|P2|Overall Study|Termination by study sponser|1
5641277|NCT00622908|19483740|P1|Overall Study|Termination by study sponser|0
5641278|NCT00622908|19483739|P2|Overall Study|Refusal|1
5641279|NCT00622908|19483740|P1|Overall Study|Refusal|0
5641280|NCT00622908|19483739|P2|Overall Study|Lost to Follow-up|0
5641281|NCT00622908|19483740|P1|Overall Study|Lost to Follow-up|1
5641282|NCT00622908|19483739|P2|Overall Study|Lack of Efficacy|7
5641283|NCT00622908|19483740|P1|Overall Study|Lack of Efficacy|1
5641284|NCT00622908|19483739|P2|Overall Study|Adverse Event|1
5641285|NCT00622908|19483740|P1|Overall Study|Adverse Event|0
5641286|NCT00622908|19483739|P2|Overall Study|Protocol Violation|0
5641287|NCT00622908|19483740|P1|Overall Study|Protocol Violation|1
5641288|NCT00622869|19483770|P3|Overall Study|Missing|1
5641289|NCT00622869|19483771|P2|Overall Study|Missing|1
5641290|NCT00622869|19483772|P1|Overall Study|Missing|0
5641291|NCT00622869|19483770|P3|Overall Study|Graft Loss|2
5641292|NCT00622869|19483771|P2|Overall Study|Graft Loss|3
5641293|NCT00622869|19483772|P1|Overall Study|Graft Loss|5
5641294|NCT00622869|19483770|P3|Overall Study|Lost to Follow-up|2
5641295|NCT00622869|19483771|P2|Overall Study|Lost to Follow-up|4
5641296|NCT00622869|19483772|P1|Overall Study|Lost to Follow-up|2
5641297|NCT00622869|19483770|P3|Overall Study|Death|10
5641298|NCT00622869|19483771|P2|Overall Study|Death|15
5641299|NCT00622869|19483772|P1|Overall Study|Death|12
5641300|NCT00622869|19483770|P3|Overall Study|Administrative Problems|13
5641301|NCT00622869|19483771|P2|Overall Study|Administrative Problems|17
5641302|NCT00622869|19483772|P1|Overall Study|Administrative Problems|11
5641303|NCT00622869|19483770|P3|Overall Study|Subject Withdrew Consent|11
5641304|NCT00622869|19483771|P2|Overall Study|Subject Withdrew Consent|17
5641305|NCT00622869|19483772|P1|Overall Study|Subject Withdrew Consent|13
5641306|NCT00622739|19483791|P2|Overall Study|Lost to Follow-up|1
5641307|NCT00622739|19483792|P1|Overall Study|Lost to Follow-up|0
5641308|NCT00622739|19483791|P2|Overall Study|Withdrawal by Subject|1
5641309|NCT00622739|19483792|P1|Overall Study|Withdrawal by Subject|0
5641310|NCT00622739|19483791|P2|Overall Study|Lack of Efficacy|2
5641311|NCT00622739|19483792|P1|Overall Study|Lack of Efficacy|0
5641312|NCT00622739|19483791|P2|Overall Study|Adverse Event|2
5641313|NCT00622739|19483792|P1|Overall Study|Adverse Event|1
5641314|NCT00622739|19483791|P2|Overall Study|Physician Decision|0
5641315|NCT00622739|19483792|P1|Overall Study|Physician Decision|1
5641316|NCT00622726|19483810|P2|August, 2010 to April, 2013|Death|5
5641317|NCT00622726|19483811|P1|August, 2010 to April, 2013|Death|1
5641318|NCT00622726|19483810|P2|March, 2008 to August, 2010|Death|2
5641319|NCT00622726|19483811|P1|March, 2008 to August, 2010|Death|5
5641320|NCT00622713|19483821|P1|Overall Study|Did not meet eligibility criteria|1
5641321|NCT00622713|19483821|P1|Overall Study|Subject no longer required study drug|1
5641322|NCT00622713|19483821|P1|Overall Study|Death|2
5641323|NCT00622713|19483821|P1|Overall Study|Lost to Follow-up|5
5641324|NCT00622713|19483821|P1|Overall Study|Withdrawal by Subject|11
5641325|NCT00622713|19483821|P1|Overall Study|Administrative problems|4
5641326|NCT00622713|19483821|P1|Overall Study|Adverse Event|35
5641327|NCT00622700|19483832|P7|Extension Treatment Period|Other than specified above|1
5641328|NCT00622700|19483833|P6|Extension Treatment Period|Other than specified above|1
5641329|NCT00622700|19483834|P5|Extension Treatment Period|Other than specified above|0
5641330|NCT00622700|19483835|P4|Extension Treatment Period|Other than specified above|0
5641331|NCT00622700|19483836|P3|Extension Treatment Period|Other than specified above|0
5641332|NCT00622700|19483837|P2|Extension Treatment Period|Other than specified above|0
5641333|NCT00622700|19483838|P1|Extension Treatment Period|Other than specified above|0
5641334|NCT00622700|19483832|P7|Extension Treatment Period|Missing|0
5641335|NCT00622700|19483833|P6|Extension Treatment Period|Missing|1
5641336|NCT00622700|19483834|P5|Extension Treatment Period|Missing|3
5641337|NCT00622700|19483835|P4|Extension Treatment Period|Missing|2
5641338|NCT00622700|19483836|P3|Extension Treatment Period|Missing|0
5641339|NCT00622700|19483837|P2|Extension Treatment Period|Missing|0
5641340|NCT00622700|19483838|P1|Extension Treatment Period|Missing|0
5641341|NCT00622700|19483832|P7|Extension Treatment Period|Withdrawal by Subject|10
5641342|NCT00622700|19483833|P6|Extension Treatment Period|Withdrawal by Subject|6
5641343|NCT00622700|19483834|P5|Extension Treatment Period|Withdrawal by Subject|16
5641344|NCT00622700|19483835|P4|Extension Treatment Period|Withdrawal by Subject|11
5641345|NCT00622700|19483836|P3|Extension Treatment Period|Withdrawal by Subject|0
5641346|NCT00622700|19483837|P2|Extension Treatment Period|Withdrawal by Subject|0
5641347|NCT00622700|19483838|P1|Extension Treatment Period|Withdrawal by Subject|0
5641348|NCT00622700|19483832|P7|Extension Treatment Period|Progressive Disease|2
5641349|NCT00622700|19483833|P6|Extension Treatment Period|Progressive Disease|0
5641350|NCT00622700|19483834|P5|Extension Treatment Period|Progressive Disease|2
5641351|NCT00622700|19483835|P4|Extension Treatment Period|Progressive Disease|1
5641352|NCT00622700|19483836|P3|Extension Treatment Period|Progressive Disease|0
5641353|NCT00622700|19483837|P2|Extension Treatment Period|Progressive Disease|0
5641354|NCT00622700|19483838|P1|Extension Treatment Period|Progressive Disease|0
5641355|NCT00622700|19483832|P7|Extension Treatment Period|Lost to Follow-up|0
5641356|NCT00622700|19483833|P6|Extension Treatment Period|Lost to Follow-up|0
5641357|NCT00622700|19483834|P5|Extension Treatment Period|Lost to Follow-up|1
5641358|NCT00622700|19483835|P4|Extension Treatment Period|Lost to Follow-up|0
5641359|NCT00622700|19483836|P3|Extension Treatment Period|Lost to Follow-up|0
5641360|NCT00622700|19483837|P2|Extension Treatment Period|Lost to Follow-up|0
5641361|NCT00622700|19483838|P1|Extension Treatment Period|Lost to Follow-up|0
5641362|NCT00622700|19483832|P7|Extension Treatment Period|Protocol Violation|0
5641363|NCT00622700|19483833|P6|Extension Treatment Period|Protocol Violation|2
5641364|NCT00622700|19483834|P5|Extension Treatment Period|Protocol Violation|0
5641365|NCT00622700|19483835|P4|Extension Treatment Period|Protocol Violation|0
5641366|NCT00622700|19483836|P3|Extension Treatment Period|Protocol Violation|0
5641367|NCT00622700|19483837|P2|Extension Treatment Period|Protocol Violation|0
5641368|NCT00622700|19483838|P1|Extension Treatment Period|Protocol Violation|0
5641369|NCT00622700|19483832|P7|Extension Treatment Period|Lack of Efficacy|9
5641370|NCT00622700|19483833|P6|Extension Treatment Period|Lack of Efficacy|1
5641371|NCT00622700|19483834|P5|Extension Treatment Period|Lack of Efficacy|8
5641372|NCT00622700|19483835|P4|Extension Treatment Period|Lack of Efficacy|2
5641373|NCT00622700|19483836|P3|Extension Treatment Period|Lack of Efficacy|0
5641374|NCT00622700|19483837|P2|Extension Treatment Period|Lack of Efficacy|0
5641375|NCT00622700|19483838|P1|Extension Treatment Period|Lack of Efficacy|0
5641376|NCT00622700|19483832|P7|Extension Treatment Period|Adverse Event|8
5641377|NCT00622700|19483833|P6|Extension Treatment Period|Adverse Event|6
5641378|NCT00622700|19483834|P5|Extension Treatment Period|Adverse Event|9
5641379|NCT00622700|19483835|P4|Extension Treatment Period|Adverse Event|5
5641380|NCT00622700|19483836|P3|Extension Treatment Period|Adverse Event|0
5641381|NCT00622700|19483837|P2|Extension Treatment Period|Adverse Event|0
5641382|NCT00622700|19483838|P1|Extension Treatment Period|Adverse Event|0
5641383|NCT00622700|19483832|P7|Core Treatment Period|Other than specified above|0
5641384|NCT00622700|19483833|P6|Core Treatment Period|Other than specified above|0
5641385|NCT00622700|19483834|P5|Core Treatment Period|Other than specified above|0
5641386|NCT00622700|19483835|P4|Core Treatment Period|Other than specified above|0
5641387|NCT00622700|19483836|P3|Core Treatment Period|Other than specified above|5
5641388|NCT00622700|19483837|P2|Core Treatment Period|Other than specified above|2
5641389|NCT00622700|19483838|P1|Core Treatment Period|Other than specified above|2
5641390|NCT00622700|19483832|P7|Core Treatment Period|Withdrawal by Subject|0
5641391|NCT00622700|19483833|P6|Core Treatment Period|Withdrawal by Subject|0
5641392|NCT00622700|19483834|P5|Core Treatment Period|Withdrawal by Subject|0
5641393|NCT00622700|19483835|P4|Core Treatment Period|Withdrawal by Subject|0
5641394|NCT00622700|19483836|P3|Core Treatment Period|Withdrawal by Subject|15
5641395|NCT00622700|19483837|P2|Core Treatment Period|Withdrawal by Subject|18
5641396|NCT00622700|19483838|P1|Core Treatment Period|Withdrawal by Subject|12
5641397|NCT00622700|19483832|P7|Core Treatment Period|Progressive Disease|0
5641398|NCT00622700|19483833|P6|Core Treatment Period|Progressive Disease|0
5641399|NCT00622700|19483834|P5|Core Treatment Period|Progressive Disease|0
5641400|NCT00622700|19483835|P4|Core Treatment Period|Progressive Disease|0
5641401|NCT00622700|19483836|P3|Core Treatment Period|Progressive Disease|0
5641402|NCT00622700|19483837|P2|Core Treatment Period|Progressive Disease|1
5641403|NCT00622700|19483838|P1|Core Treatment Period|Progressive Disease|3
5641404|NCT00622700|19483832|P7|Core Treatment Period|Death|0
5641405|NCT00622700|19483833|P6|Core Treatment Period|Death|0
5641406|NCT00622700|19483834|P5|Core Treatment Period|Death|0
5641407|NCT00622700|19483835|P4|Core Treatment Period|Death|0
5641408|NCT00622700|19483836|P3|Core Treatment Period|Death|0
5641409|NCT00622700|19483837|P2|Core Treatment Period|Death|0
5641410|NCT00622700|19483838|P1|Core Treatment Period|Death|1
5641411|NCT00622700|19483832|P7|Core Treatment Period|Lost to Follow-up|0
5641412|NCT00622700|19483833|P6|Core Treatment Period|Lost to Follow-up|0
5641413|NCT00622700|19483834|P5|Core Treatment Period|Lost to Follow-up|0
5641414|NCT00622700|19483835|P4|Core Treatment Period|Lost to Follow-up|0
5641415|NCT00622700|19483836|P3|Core Treatment Period|Lost to Follow-up|1
5641416|NCT00622700|19483837|P2|Core Treatment Period|Lost to Follow-up|1
5641417|NCT00622700|19483838|P1|Core Treatment Period|Lost to Follow-up|1
5641418|NCT00622700|19483832|P7|Core Treatment Period|Lack of Efficacy|0
5641419|NCT00622700|19483833|P6|Core Treatment Period|Lack of Efficacy|0
5641420|NCT00622700|19483834|P5|Core Treatment Period|Lack of Efficacy|0
5641421|NCT00622700|19483835|P4|Core Treatment Period|Lack of Efficacy|0
5641422|NCT00622700|19483836|P3|Core Treatment Period|Lack of Efficacy|12
5641423|NCT00622700|19483837|P2|Core Treatment Period|Lack of Efficacy|6
5641424|NCT00622700|19483838|P1|Core Treatment Period|Lack of Efficacy|19
5641425|NCT00622700|19483832|P7|Core Treatment Period|Adverse Event|0
5641426|NCT00622700|19483833|P6|Core Treatment Period|Adverse Event|0
5641427|NCT00622700|19483834|P5|Core Treatment Period|Adverse Event|0
5641428|NCT00622700|19483835|P4|Core Treatment Period|Adverse Event|0
5641429|NCT00622700|19483836|P3|Core Treatment Period|Adverse Event|18
5641430|NCT00622700|19483837|P2|Core Treatment Period|Adverse Event|25
5641431|NCT00622700|19483838|P1|Core Treatment Period|Adverse Event|18
5641432|NCT00622700|19483832|P7|Core Treatment Period|Randomized but Not Treated|0
5641433|NCT00622700|19483833|P6|Core Treatment Period|Randomized but Not Treated|0
5641434|NCT00622700|19483834|P5|Core Treatment Period|Randomized but Not Treated|0
5641435|NCT00622700|19483835|P4|Core Treatment Period|Randomized but Not Treated|0
5641436|NCT00622700|19483836|P3|Core Treatment Period|Randomized but Not Treated|2
5641437|NCT00622700|19483837|P2|Core Treatment Period|Randomized but Not Treated|2
5641438|NCT00622700|19483838|P1|Core Treatment Period|Randomized but Not Treated|0
5641439|NCT00622635|19483897|P6|Treatment Period 3|Withdrawal by Subject|0
5641440|NCT00622635|19483898|P5|Treatment Period 3|Withdrawal by Subject|0
5641441|NCT00622635|19483899|P4|Treatment Period 3|Withdrawal by Subject|1
5641442|NCT00622635|19483900|P3|Treatment Period 3|Withdrawal by Subject|0
5641443|NCT00622635|19483901|P2|Treatment Period 3|Withdrawal by Subject|0
5641444|NCT00622635|19483902|P1|Treatment Period 3|Withdrawal by Subject|0
5641445|NCT00622635|19483897|P6|Treatment Period 3|Adverse Event|0
5641446|NCT00622635|19483898|P5|Treatment Period 3|Adverse Event|0
5641447|NCT00622635|19483899|P4|Treatment Period 3|Adverse Event|2
5641448|NCT00622635|19483900|P3|Treatment Period 3|Adverse Event|0
5641449|NCT00622635|19483901|P2|Treatment Period 3|Adverse Event|0
5641450|NCT00622635|19483902|P1|Treatment Period 3|Adverse Event|0
5641451|NCT00622635|19483897|P6|Treatment Period 2|Adverse Event|0
5641452|NCT00622635|19483898|P5|Treatment Period 2|Adverse Event|0
5641453|NCT00622635|19483899|P4|Treatment Period 2|Adverse Event|0
5641454|NCT00622635|19483900|P3|Treatment Period 2|Adverse Event|0
5641455|NCT00622635|19483901|P2|Treatment Period 2|Adverse Event|0
5641456|NCT00622635|19483902|P1|Treatment Period 2|Adverse Event|1
5641457|NCT00622635|19483897|P6|Treatment Period 1|Abnormal test procedure result(s)|0
5641458|NCT00622635|19483898|P5|Treatment Period 1|Abnormal test procedure result(s)|1
5641459|NCT00622635|19483899|P4|Treatment Period 1|Abnormal test procedure result(s)|0
5641460|NCT00622635|19483900|P3|Treatment Period 1|Abnormal test procedure result(s)|0
5641461|NCT00622635|19483901|P2|Treatment Period 1|Abnormal test procedure result(s)|0
5641462|NCT00622635|19483902|P1|Treatment Period 1|Abnormal test procedure result(s)|0
5641463|NCT00622635|19483897|P6|Treatment Period 1|Withdrawal by Subject|0
5641464|NCT00622635|19483898|P5|Treatment Period 1|Withdrawal by Subject|0
5641465|NCT00622635|19483899|P4|Treatment Period 1|Withdrawal by Subject|0
5641466|NCT00622635|19483900|P3|Treatment Period 1|Withdrawal by Subject|0
5641467|NCT00622635|19483901|P2|Treatment Period 1|Withdrawal by Subject|1
5641468|NCT00622635|19483902|P1|Treatment Period 1|Withdrawal by Subject|0
5641469|NCT00622635|19483897|P6|Treatment Period 1|Adverse Event|0
5641470|NCT00622635|19483898|P5|Treatment Period 1|Adverse Event|0
5641471|NCT00622635|19483899|P4|Treatment Period 1|Adverse Event|0
5641472|NCT00622635|19483900|P3|Treatment Period 1|Adverse Event|1
5641473|NCT00622635|19483901|P2|Treatment Period 1|Adverse Event|0
5641474|NCT00622635|19483902|P1|Treatment Period 1|Adverse Event|0
5641475|NCT00622466|19483983|P1|Overall Study|Withdrawal by Subject|2
5641476|NCT00622466|19483983|P1|Overall Study|Adverse Event|1
5641477|NCT00622466|19483983|P1|Overall Study|Death|1
5641478|NCT00622440|19483996|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
5641479|NCT00622440|19483997|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
5641480|NCT00622440|19483996|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
5641481|NCT00622440|19483997|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
5641482|NCT00622440|19483996|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
5641483|NCT00622440|19483997|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
5641484|NCT00622440|19483996|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
5641485|NCT00622440|19483997|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
5641486|NCT00622401|19484023|P3|Overall Study|Disease progression prior to treatment|0
5641487|NCT00622401|19484024|P2|Overall Study|Disease progression prior to treatment|2
5641488|NCT00622401|19484025|P1|Overall Study|Disease progression prior to treatment|3
5641489|NCT00622388|19484032|P1|Overall Study|Insurance Expired|1
5641490|NCT00622388|19484032|P1|Overall Study|Withdrew Consent|1
5641491|NCT00622388|19484032|P1|Overall Study|Took Prohibited Medication|2
5641492|NCT00622388|19484032|P1|Overall Study|Received Alternate Anticancer Therapy|8
5641493|NCT00622388|19484032|P1|Overall Study|Death|3
5641494|NCT00622388|19484032|P1|Overall Study|Participant Refusal|1
5641495|NCT00622388|19484032|P1|Overall Study|Protocol Violation|3
5641496|NCT00622388|19484032|P1|Overall Study|Adverse Event|6
5641497|NCT00622388|19484032|P1|Overall Study|Disease Progression|47
5641498|NCT00622336|19484050|P1|Extension Phase|Other|9
5641499|NCT00622336|19484050|P1|Extension Phase|Lost to Follow-up|1
5641500|NCT00622336|19484050|P1|Extension Phase|Withdrawal by Subject|1
5641501|NCT00622336|19484050|P1|Extension Phase|Lack of therapeutic effect|2
5641502|NCT00622336|19484050|P1|Extension Phase|Progressive Disease|6
5641503|NCT00622336|19484050|P1|Extension Phase|Adverse Event|2
5641504|NCT00622336|19484050|P1|Treatment Phase|Lost to Follow-up|2
5641505|NCT00622336|19484050|P1|Treatment Phase|Withdrawal by Subject|13
5641506|NCT00622336|19484050|P1|Treatment Phase|Lack of therapeutic effect|13
5641507|NCT00622336|19484050|P1|Treatment Phase|Death|14
5641508|NCT00622336|19484050|P1|Treatment Phase|Other|40
5641509|NCT00622336|19484050|P1|Treatment Phase|Adverse Event|46
5641510|NCT00622336|19484050|P1|Treatment Phase|Progression of Disease|181
5641511|NCT00622284|19484061|P2|Overall Study|Other reason (not specified)|24
5641512|NCT00622284|19484062|P1|Overall Study|Other reason (not specified)|33
5641513|NCT00622284|19484061|P2|Overall Study|Withdrawal by Subject|24
5641514|NCT00622284|19484062|P1|Overall Study|Withdrawal by Subject|27
5641515|NCT00622284|19484061|P2|Overall Study|Lost to Follow-up|13
5641516|NCT00622284|19484062|P1|Overall Study|Lost to Follow-up|11
5641517|NCT00622284|19484061|P2|Overall Study|Protocol Violation|5
5641518|NCT00622284|19484062|P1|Overall Study|Protocol Violation|12
5641519|NCT00622284|19484061|P2|Overall Study|Adverse Event|90
5641520|NCT00622284|19484062|P1|Overall Study|Adverse Event|61
5641521|NCT00622284|19484061|P2|Overall Study|Lack of Efficacy|15
5641522|NCT00622284|19484062|P1|Overall Study|Lack of Efficacy|45
5641523|NCT00622180|19484124|P2|Overall Study|Lost to Follow-up|2
5641524|NCT00622180|19484125|P1|Overall Study|Lost to Follow-up|1
5641525|NCT00622167|19484131|P1|Overall Study|Did not meet angiographic criteria|20
5641526|NCT00621985|19484135|P1|Dexamethasone Admission|Adverse Event|1
5641527|NCT00621959|19484143|P2|Overall Study|Other|3
5641528|NCT00621959|19484144|P1|Overall Study|Other|1
5641529|NCT00621959|19484143|P2|Overall Study|Withdrawal by Subject|1
5641530|NCT00621959|19484144|P1|Overall Study|Withdrawal by Subject|1
5641531|NCT00621959|19484143|P2|Overall Study|Lost to Follow-up|2
5641532|NCT00621959|19484144|P1|Overall Study|Lost to Follow-up|0
5641533|NCT00621959|19484143|P2|Overall Study|Lack of Efficacy|1
5641534|NCT00621959|19484144|P1|Overall Study|Lack of Efficacy|1
5641535|NCT00621959|19484143|P2|Overall Study|Adverse Event|2
5641536|NCT00621959|19484144|P1|Overall Study|Adverse Event|4
5641537|NCT00621855|19484183|P5|Overall Study|Patients did not receive study drug|2
5641538|NCT00621855|19484184|P4|Overall Study|Patients did not receive study drug|4
5641539|NCT00621855|19484185|P3|Overall Study|Patients did not receive study drug|5
5641540|NCT00621855|19484186|P2|Overall Study|Patients did not receive study drug|3
5641541|NCT00621855|19484187|P1|Overall Study|Patients did not receive study drug|3
5641542|NCT00621855|19484183|P5|Overall Study|Other|4
5641543|NCT00621855|19484184|P4|Overall Study|Other|5
5641544|NCT00621855|19484185|P3|Overall Study|Other|6
5641545|NCT00621855|19484186|P2|Overall Study|Other|7
5641546|NCT00621855|19484187|P1|Overall Study|Other|9
5641547|NCT00621855|19484183|P5|Overall Study|Withdrawal by Subject|9
5641548|NCT00621855|19484184|P4|Overall Study|Withdrawal by Subject|13
5641549|NCT00621855|19484185|P3|Overall Study|Withdrawal by Subject|13
5641550|NCT00621855|19484186|P2|Overall Study|Withdrawal by Subject|11
5641551|NCT00621855|19484187|P1|Overall Study|Withdrawal by Subject|16
5641552|NCT00621855|19484183|P5|Overall Study|Protocol Violation|8
5641553|NCT00621855|19484184|P4|Overall Study|Protocol Violation|7
5641554|NCT00621855|19484185|P3|Overall Study|Protocol Violation|6
5641555|NCT00621855|19484186|P2|Overall Study|Protocol Violation|8
5641556|NCT00621855|19484187|P1|Overall Study|Protocol Violation|16
5641557|NCT00621855|19484183|P5|Overall Study|Lost to Follow-up|1
5641558|NCT00621855|19484184|P4|Overall Study|Lost to Follow-up|4
5641559|NCT00621855|19484185|P3|Overall Study|Lost to Follow-up|3
5641560|NCT00621855|19484186|P2|Overall Study|Lost to Follow-up|1
5641561|NCT00621855|19484187|P1|Overall Study|Lost to Follow-up|0
5641562|NCT00621855|19484183|P5|Overall Study|Adverse Event|31
5641563|NCT00621855|19484184|P4|Overall Study|Adverse Event|34
5641564|NCT00621855|19484185|P3|Overall Study|Adverse Event|48
5641565|NCT00621855|19484186|P2|Overall Study|Adverse Event|31
5641566|NCT00621855|19484187|P1|Overall Study|Adverse Event|32
5641567|NCT00621842|19484229|P1|Overall Study|Lack of Efficacy|2
5641568|NCT00621842|19484229|P1|Overall Study|Protocol Violation|4
5641569|NCT00621842|19484229|P1|Overall Study|Withdrawal by Subject|7
5641570|NCT00621842|19484229|P1|Overall Study|Adverse Event|6
5641571|NCT00621777|19484246|P2|Randomized Phase|Death|1
5641572|NCT00621777|19484247|P1|Randomized Phase|Death|0
5641573|NCT00621777|19484246|P2|Randomized Phase|administrative|3
5641574|NCT00621777|19484247|P1|Randomized Phase|administrative|0
5641575|NCT00621777|19484246|P2|Randomized Phase|Withdrawal by Subject|9
5641576|NCT00621777|19484247|P1|Randomized Phase|Withdrawal by Subject|1
5641577|NCT00621777|19484246|P2|Randomized Phase|Lost to Follow-up|3
5641578|NCT00621777|19484247|P1|Randomized Phase|Lost to Follow-up|3
5641579|NCT00621777|19484246|P2|Randomized Phase|Adverse Event|3
5641580|NCT00621777|19484247|P1|Randomized Phase|Adverse Event|3
5641581|NCT00621777|19484246|P2|Open Phase|Lost to Follow-up|0
5641582|NCT00621777|19484247|P1|Open Phase|Lost to Follow-up|10
5641583|NCT00621777|19484246|P2|Open Phase|administrative|0
5641584|NCT00621777|19484247|P1|Open Phase|administrative|13
5641585|NCT00621777|19484246|P2|Open Phase|Withdrawal by Subject|0
5641586|NCT00621777|19484247|P1|Open Phase|Withdrawal by Subject|17
5641587|NCT00621777|19484246|P2|Open Phase|Did not abstain during open phase|0
5641588|NCT00621777|19484247|P1|Open Phase|Did not abstain during open phase|56
5641589|NCT00621777|19484246|P2|Open Phase|Adverse Event|0
5641590|NCT00621777|19484247|P1|Open Phase|Adverse Event|20
5641591|NCT00621764|19484262|P4|Overall Study|Protocol Violation|1
5641592|NCT00621764|19484263|P3|Overall Study|Protocol Violation|0
5641593|NCT00621764|19484264|P2|Overall Study|Protocol Violation|0
5641594|NCT00621764|19484265|P1|Overall Study|Protocol Violation|0
5641595|NCT00621621|19484311|P2|Overall Study|Subjects were exited at EP study|0
5641596|NCT00621621|19484312|P1|Overall Study|Subjects were exited at EP study|30
5641597|NCT00621582|19484320|P1|Overall Study|issues not identified by investigators|18
5641598|NCT00621582|19484320|P1|Overall Study|Lost to Follow-up|24
5641599|NCT00621582|19484320|P1|Overall Study|Protocol Violation|57
5641600|NCT00621582|19484320|P1|Overall Study|Adverse Event|7
5641601|NCT00621543|19484327|P1|Overall Study|Lost to Follow-up|23
5641602|NCT00621517|19484351|P2|Overall Study|Adverse Event|0
5641603|NCT00621517|19484352|P1|Overall Study|Adverse Event|1
5641604|NCT00621517|19484351|P2|Overall Study|Withdrawal by Subject|4
5641605|NCT00621517|19484352|P1|Overall Study|Withdrawal by Subject|3
5641606|NCT00621517|19484351|P2|Overall Study|Lost to Follow-up|3
5641607|NCT00621517|19484352|P1|Overall Study|Lost to Follow-up|3
5641608|NCT00621504|19484364|P2|Overall Study|Death|6
5641609|NCT00621504|19484365|P1|Overall Study|Death|6
5641610|NCT00621504|19484364|P2|Overall Study|Other|0
5641611|NCT00621504|19484365|P1|Overall Study|Other|1
5641612|NCT00621504|19484364|P2|Overall Study|Lost to Follow-up|10
5641613|NCT00621504|19484365|P1|Overall Study|Lost to Follow-up|8
5641614|NCT00621504|19484364|P2|Overall Study|Withdrew consent|6
5641615|NCT00621504|19484365|P1|Overall Study|Withdrew consent|9
5641616|NCT00621504|19484364|P2|Overall Study|At the request of sponsor/investigator|0
5641617|NCT00621504|19484365|P1|Overall Study|At the request of sponsor/investigator|1
5641618|NCT00621504|19484364|P2|Overall Study|Adverse Event|3
5641619|NCT00621504|19484365|P1|Overall Study|Adverse Event|1
5641620|NCT00621322|19484399|P6|Overall Study|Migrated/moved from study area|2
5641621|NCT00621322|19484400|P5|Overall Study|Migrated/moved from study area|0
5641622|NCT00621322|19484401|P4|Overall Study|Migrated/moved from study area|1
5641623|NCT00621322|19484402|P3|Overall Study|Migrated/moved from study area|1
5641624|NCT00621322|19484403|P2|Overall Study|Migrated/moved from study area|0
5641625|NCT00621322|19484404|P1|Overall Study|Migrated/moved from study area|1
5641626|NCT00621322|19484399|P6|Overall Study|Withdrawal by Subject|2
5641627|NCT00621322|19484400|P5|Overall Study|Withdrawal by Subject|0
5641628|NCT00621322|19484401|P4|Overall Study|Withdrawal by Subject|1
5641629|NCT00621322|19484402|P3|Overall Study|Withdrawal by Subject|0
5641630|NCT00621322|19484403|P2|Overall Study|Withdrawal by Subject|0
5641631|NCT00621322|19484404|P1|Overall Study|Withdrawal by Subject|0
5641632|NCT00621322|19484399|P6|Overall Study|Physician Decision|0
5641633|NCT00621322|19484400|P5|Overall Study|Physician Decision|0
5641634|NCT00621322|19484401|P4|Overall Study|Physician Decision|1
5641635|NCT00621322|19484402|P3|Overall Study|Physician Decision|1
5641636|NCT00621322|19484403|P2|Overall Study|Physician Decision|0
5641637|NCT00621322|19484404|P1|Overall Study|Physician Decision|0
5641638|NCT00621322|19484399|P6|Overall Study|Lost to Follow-up|0
5641639|NCT00621322|19484400|P5|Overall Study|Lost to Follow-up|1
5641640|NCT00621322|19484401|P4|Overall Study|Lost to Follow-up|0
5641641|NCT00621322|19484402|P3|Overall Study|Lost to Follow-up|0
5641642|NCT00621322|19484403|P2|Overall Study|Lost to Follow-up|0
5641643|NCT00621322|19484404|P1|Overall Study|Lost to Follow-up|0
5641644|NCT00621309|19484484|P6|Overall Study|Withdrawal by Subject|1
5641645|NCT00621309|19484485|P5|Overall Study|Withdrawal by Subject|1
5641646|NCT00621309|19484486|P4|Overall Study|Withdrawal by Subject|1
5641647|NCT00621309|19484487|P3|Overall Study|Withdrawal by Subject|1
5641648|NCT00621309|19484488|P2|Overall Study|Withdrawal by Subject|0
5641649|NCT00621309|19484489|P1|Overall Study|Withdrawal by Subject|2
5641650|NCT00621296|19484495|P1|Overall Study|Stopping Criteria|3
5641651|NCT00621296|19484495|P1|Overall Study|Unmatch Criteria|1
5641652|NCT00621296|19484495|P1|Overall Study|Physician Decision|7
5641653|NCT00621296|19484495|P1|Overall Study|Lack of Efficacy|1
5641654|NCT00621296|19484495|P1|Overall Study|Adverse Event|2
5641655|NCT00621257|19484504|P5|Overall Study|Withdrawal by Subject|1
5641656|NCT00621257|19484505|P4|Overall Study|Withdrawal by Subject|1
5641657|NCT00621257|19484506|P3|Overall Study|Withdrawal by Subject|0
5641658|NCT00621257|19484507|P2|Overall Study|Withdrawal by Subject|0
5641659|NCT00621257|19484508|P1|Overall Study|Withdrawal by Subject|0
5641660|NCT00621257|19484504|P5|Overall Study|Physician Decision|1
5641661|NCT00621257|19484505|P4|Overall Study|Physician Decision|1
5641662|NCT00621257|19484506|P3|Overall Study|Physician Decision|0
5641663|NCT00621257|19484507|P2|Overall Study|Physician Decision|2
5641664|NCT00621257|19484508|P1|Overall Study|Physician Decision|0
5641665|NCT00621257|19484504|P5|Overall Study|Adverse Event|0
5641666|NCT00621257|19484505|P4|Overall Study|Adverse Event|0
5641667|NCT00621257|19484506|P3|Overall Study|Adverse Event|1
5641668|NCT00621257|19484507|P2|Overall Study|Adverse Event|1
5641669|NCT00621257|19484508|P1|Overall Study|Adverse Event|0
5641670|NCT00621257|19484504|P5|Overall Study|Lost to Follow-up|7
5641671|NCT00621257|19484505|P4|Overall Study|Lost to Follow-up|4
5641672|NCT00621257|19484506|P3|Overall Study|Lost to Follow-up|2
5641673|NCT00621257|19484507|P2|Overall Study|Lost to Follow-up|0
5641674|NCT00621257|19484508|P1|Overall Study|Lost to Follow-up|4
5641675|NCT00621244|19484524|P4|Overall Study|Administrative problems|2
5641676|NCT00621244|19484525|P3|Overall Study|Administrative problems|0
5641677|NCT00621244|19484526|P2|Overall Study|Administrative problems|1
5641678|NCT00621244|19484527|P1|Overall Study|Administrative problems|5
5641679|NCT00621244|19484524|P4|Overall Study|Adverse Event|2
5641680|NCT00621244|19484525|P3|Overall Study|Adverse Event|9
5641681|NCT00621244|19484526|P2|Overall Study|Adverse Event|7
5641682|NCT00621244|19484527|P1|Overall Study|Adverse Event|27
5641683|NCT00621244|19484524|P4|Overall Study|Death|1
5641684|NCT00621244|19484525|P3|Overall Study|Death|1
5641685|NCT00621244|19484526|P2|Overall Study|Death|3
5641686|NCT00621244|19484527|P1|Overall Study|Death|3
5641687|NCT00621244|19484524|P4|Overall Study|Disease progression|15
5641688|NCT00621244|19484525|P3|Overall Study|Disease progression|20
5641689|NCT00621244|19484526|P2|Overall Study|Disease progression|20
5641690|NCT00621244|19484527|P1|Overall Study|Disease progression|44
5641691|NCT00621244|19484524|P4|Overall Study|Withdrawal by Subject|3
5641692|NCT00621244|19484525|P3|Overall Study|Withdrawal by Subject|3
5641693|NCT00621244|19484526|P2|Overall Study|Withdrawal by Subject|3
5641694|NCT00621244|19484527|P1|Overall Study|Withdrawal by Subject|7
5641695|NCT00621192|19484631|P4|Overall Study|Final Assessments not Completed|1
5641696|NCT00621192|19484632|P3|Overall Study|Final Assessments not Completed|3
5641697|NCT00621192|19484633|P2|Overall Study|Final Assessments not Completed|0
5641698|NCT00621192|19484634|P1|Overall Study|Final Assessments not Completed|0
5641699|NCT00621192|19484631|P4|Overall Study|Death|0
5641700|NCT00621192|19484632|P3|Overall Study|Death|0
5641701|NCT00621192|19484633|P2|Overall Study|Death|5
5641702|NCT00621192|19484634|P1|Overall Study|Death|2
5641703|NCT00621192|19484631|P4|Overall Study|Adverse Event|1
5641704|NCT00621192|19484632|P3|Overall Study|Adverse Event|0
5641705|NCT00621192|19484633|P2|Overall Study|Adverse Event|1
5641706|NCT00621192|19484634|P1|Overall Study|Adverse Event|0
5641707|NCT00621192|19484631|P4|Overall Study|Protocol Violation|1
5641708|NCT00621192|19484632|P3|Overall Study|Protocol Violation|0
5641709|NCT00621192|19484633|P2|Overall Study|Protocol Violation|0
5641710|NCT00621192|19484634|P1|Overall Study|Protocol Violation|1
5641711|NCT00621192|19484631|P4|Overall Study|Physician Decision|0
5641712|NCT00621192|19484632|P3|Overall Study|Physician Decision|0
5641713|NCT00621192|19484633|P2|Overall Study|Physician Decision|3
5641714|NCT00621192|19484634|P1|Overall Study|Physician Decision|1
5641715|NCT00621192|19484631|P4|Overall Study|Withdrawal by Subject|0
5641716|NCT00621192|19484632|P3|Overall Study|Withdrawal by Subject|2
5641717|NCT00621192|19484633|P2|Overall Study|Withdrawal by Subject|0
5641718|NCT00621192|19484634|P1|Overall Study|Withdrawal by Subject|0
5641719|NCT00621153|19484675|P2|Overall Study|Withdrawal by Subject|5
5641720|NCT00621153|19484676|P1|Overall Study|Withdrawal by Subject|4
5641721|NCT00621153|19484675|P2|Overall Study|Lost to Follow-up|1
5641722|NCT00621153|19484676|P1|Overall Study|Lost to Follow-up|5
5641723|NCT00621153|19484675|P2|Overall Study|Adverse Event|2
5641724|NCT00621153|19484676|P1|Overall Study|Adverse Event|3
5641725|NCT00621153|19484675|P2|Overall Study|Safety Reason|7
5641726|NCT00621153|19484676|P1|Overall Study|Safety Reason|8
5641727|NCT00621140|19484684|P2|Overall Study|Other incl. lack of efficacy|5
5641728|NCT00621140|19484685|P1|Overall Study|Other incl. lack of efficacy|6
5641729|NCT00621140|19484684|P2|Overall Study|Withdrawal by Subject|6
5641730|NCT00621140|19484685|P1|Overall Study|Withdrawal by Subject|4
5641731|NCT00621140|19484684|P2|Overall Study|Lost to Follow-up|2
5641732|NCT00621140|19484685|P1|Overall Study|Lost to Follow-up|1
5641733|NCT00621140|19484684|P2|Overall Study|Adverse Event|5
5641734|NCT00621140|19484685|P1|Overall Study|Adverse Event|4
5641735|NCT00621023|19484732|P1|Overall Study|Follow up discontinued|1
5641736|NCT00621023|19484732|P1|Overall Study|Death|5
5641737|NCT00620854|19484749|P6|Washout 1|Withdrawal by Subject|0
5641738|NCT00620854|19484750|P5|Washout 1|Withdrawal by Subject|0
5641739|NCT00620854|19484751|P4|Washout 1|Withdrawal by Subject|1
5641740|NCT00620854|19484752|P3|Washout 1|Withdrawal by Subject|1
5641741|NCT00620854|19484753|P2|Washout 1|Withdrawal by Subject|0
5641742|NCT00620854|19484754|P1|Washout 1|Withdrawal by Subject|0
5641743|NCT00620815|19484785|P3|Overall Study|Protocol Violation|1
5641744|NCT00620815|19484786|P2|Overall Study|Protocol Violation|2
5641745|NCT00620815|19484787|P1|Overall Study|Protocol Violation|1
5641746|NCT00620815|19484785|P3|Overall Study|Inappropriate enrolment|1
5641747|NCT00620815|19484786|P2|Overall Study|Inappropriate enrolment|0
5641748|NCT00620815|19484787|P1|Overall Study|Inappropriate enrolment|0
5641749|NCT00620815|19484785|P3|Overall Study|Lost to Follow-up|3
5641750|NCT00620815|19484786|P2|Overall Study|Lost to Follow-up|6
5641751|NCT00620815|19484787|P1|Overall Study|Lost to Follow-up|1
5641752|NCT00620815|19484785|P3|Overall Study|Withdrawal by Subject|0
5641753|NCT00620815|19484786|P2|Overall Study|Withdrawal by Subject|2
5641754|NCT00620815|19484787|P1|Overall Study|Withdrawal by Subject|1
5641755|NCT00620815|19484785|P3|Overall Study|Adverse Event|2
5641756|NCT00620815|19484786|P2|Overall Study|Adverse Event|1
5641757|NCT00620815|19484787|P1|Overall Study|Adverse Event|1
5641758|NCT00620776|19484827|P2|Overall Study|Withdrawal by Subject|2
5641759|NCT00620776|19484828|P1|Overall Study|Withdrawal by Subject|3
5641760|NCT00620776|19484827|P2|Overall Study|Lost to Follow-up|5
5641761|NCT00620776|19484828|P1|Overall Study|Lost to Follow-up|2
5641762|NCT00620776|19484827|P2|Overall Study|Lack of Efficacy|1
5641763|NCT00620776|19484828|P1|Overall Study|Lack of Efficacy|2
5641764|NCT00620776|19484827|P2|Overall Study|Adverse Event|3
5641765|NCT00620776|19484828|P1|Overall Study|Adverse Event|2
5641766|NCT00620776|19484827|P2|Overall Study|Did not receive treatment|5
5641767|NCT00620776|19484828|P1|Overall Study|Did not receive treatment|3
5641768|NCT00620763|19484856|P2|Period: Second Intervention|Withdrawal by Subject|0
5641769|NCT00620763|19484857|P1|Period: Second Intervention|Withdrawal by Subject|1
5641770|NCT00620763|19484856|P2|Period: First Intervention|Protocol Violation|3
5641771|NCT00620763|19484857|P1|Period: First Intervention|Protocol Violation|0
5641772|NCT00620763|19484856|P2|Period: First Intervention|Withdrawal by Subject|2
5641773|NCT00620763|19484857|P1|Period: First Intervention|Withdrawal by Subject|0
5641774|NCT00620750|19484863|P1|Overall Study|Lost to Follow-up|25
5641775|NCT00620659|19484878|P6|Treatment Period 3|Withdrawal by Subject|0
5641776|NCT00620659|19484879|P5|Treatment Period 3|Withdrawal by Subject|0
5641777|NCT00620659|19484880|P4|Treatment Period 3|Withdrawal by Subject|1
5641778|NCT00620659|19484881|P3|Treatment Period 3|Withdrawal by Subject|0
5641779|NCT00620659|19484882|P2|Treatment Period 3|Withdrawal by Subject|0
5641780|NCT00620659|19484883|P1|Treatment Period 3|Withdrawal by Subject|0
5641781|NCT00620659|19484878|P6|Treatment Period 3|Adverse Event|0
5641782|NCT00620659|19484879|P5|Treatment Period 3|Adverse Event|0
5641783|NCT00620659|19484880|P4|Treatment Period 3|Adverse Event|0
5641784|NCT00620659|19484881|P3|Treatment Period 3|Adverse Event|0
5641785|NCT00620659|19484882|P2|Treatment Period 3|Adverse Event|2
5641786|NCT00620659|19484883|P1|Treatment Period 3|Adverse Event|0
5641787|NCT00620659|19484878|P6|Placebo Washout Period 2|Adverse Event|0
5641788|NCT00620659|19484879|P5|Placebo Washout Period 2|Adverse Event|0
5641789|NCT00620659|19484880|P4|Placebo Washout Period 2|Adverse Event|0
5641790|NCT00620659|19484881|P3|Placebo Washout Period 2|Adverse Event|0
5641791|NCT00620659|19484882|P2|Placebo Washout Period 2|Adverse Event|0
5641792|NCT00620659|19484883|P1|Placebo Washout Period 2|Adverse Event|2
5641793|NCT00620659|19484878|P6|Treatment Period 2|Withdrawal by Subject|0
5641794|NCT00620659|19484879|P5|Treatment Period 2|Withdrawal by Subject|3
5641795|NCT00620659|19484880|P4|Treatment Period 2|Withdrawal by Subject|0
5641796|NCT00620659|19484881|P3|Treatment Period 2|Withdrawal by Subject|1
5641797|NCT00620659|19484882|P2|Treatment Period 2|Withdrawal by Subject|0
5641798|NCT00620659|19484883|P1|Treatment Period 2|Withdrawal by Subject|0
5641799|NCT00620659|19484878|P6|Treatment Period 2|Adverse Event|0
5641800|NCT00620659|19484879|P5|Treatment Period 2|Adverse Event|2
5641801|NCT00620659|19484880|P4|Treatment Period 2|Adverse Event|0
5641802|NCT00620659|19484881|P3|Treatment Period 2|Adverse Event|0
5641803|NCT00620659|19484882|P2|Treatment Period 2|Adverse Event|3
5641804|NCT00620659|19484883|P1|Treatment Period 2|Adverse Event|0
5641805|NCT00620659|19484878|P6|Placebo Washout Period 1|Withdrawal by Subject|0
5641806|NCT00620659|19484879|P5|Placebo Washout Period 1|Withdrawal by Subject|0
5641807|NCT00620659|19484880|P4|Placebo Washout Period 1|Withdrawal by Subject|1
5641808|NCT00620659|19484881|P3|Placebo Washout Period 1|Withdrawal by Subject|0
5641809|NCT00620659|19484882|P2|Placebo Washout Period 1|Withdrawal by Subject|0
5641810|NCT00620659|19484883|P1|Placebo Washout Period 1|Withdrawal by Subject|0
5641811|NCT00620659|19484878|P6|Treatment Period 1|Withdrawal by Subject|0
5641812|NCT00620659|19484879|P5|Treatment Period 1|Withdrawal by Subject|1
5641813|NCT00620659|19484880|P4|Treatment Period 1|Withdrawal by Subject|0
5641814|NCT00620659|19484881|P3|Treatment Period 1|Withdrawal by Subject|1
5641815|NCT00620659|19484882|P2|Treatment Period 1|Withdrawal by Subject|0
5641816|NCT00620659|19484883|P1|Treatment Period 1|Withdrawal by Subject|1
5641817|NCT00620659|19484878|P6|Treatment Period 1|Protocol Violation|0
5641818|NCT00620659|19484879|P5|Treatment Period 1|Protocol Violation|0
5641819|NCT00620659|19484880|P4|Treatment Period 1|Protocol Violation|0
5641820|NCT00620659|19484881|P3|Treatment Period 1|Protocol Violation|0
5641821|NCT00620659|19484882|P2|Treatment Period 1|Protocol Violation|0
5641822|NCT00620659|19484883|P1|Treatment Period 1|Protocol Violation|1
5641823|NCT00620659|19484878|P6|Treatment Period 1|Adverse Event|0
5641824|NCT00620659|19484879|P5|Treatment Period 1|Adverse Event|0
5641825|NCT00620659|19484880|P4|Treatment Period 1|Adverse Event|3
5641826|NCT00620659|19484881|P3|Treatment Period 1|Adverse Event|0
5641827|NCT00620659|19484882|P2|Treatment Period 1|Adverse Event|0
5641828|NCT00620659|19484883|P1|Treatment Period 1|Adverse Event|1
5641829|NCT00620555|19484901|P1|Overall Study|Visit failure against planned|1
5641830|NCT00620555|19484901|P1|Overall Study|Choice of other treatment|1
5641831|NCT00620555|19484901|P1|Overall Study|Withdrawal by Subject|1
5641832|NCT00620555|19484901|P1|Overall Study|Lack of Efficacy|12
5641833|NCT00620555|19484901|P1|Overall Study|Protocol Violation|2
5641834|NCT00620555|19484901|P1|Overall Study|Adverse Event|4
5641835|NCT00620542|19484910|P4|Part B (2 Year Core Study)|IVUS not available|2
5641836|NCT00620542|19484911|P3|Part B (2 Year Core Study)|IVUS not available|3
5641837|NCT00620542|19484912|P2|Part B (2 Year Core Study)|IVUS not available|0
5641838|NCT00620542|19484913|P1|Part B (2 Year Core Study)|IVUS not available|0
5641839|NCT00620542|19484910|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
5641840|NCT00620542|19484911|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
5641841|NCT00620542|19484912|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
5641842|NCT00620542|19484913|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
5641843|NCT00620542|19484910|P4|Part B (2 Year Core Study)|Safety reasons|3
5641844|NCT00620542|19484911|P3|Part B (2 Year Core Study)|Safety reasons|2
5641845|NCT00620542|19484912|P2|Part B (2 Year Core Study)|Safety reasons|0
5641846|NCT00620542|19484913|P1|Part B (2 Year Core Study)|Safety reasons|0
5641847|NCT00620542|19484910|P4|Part B (2 Year Core Study)|Protocol Violation|16
5641848|NCT00620542|19484911|P3|Part B (2 Year Core Study)|Protocol Violation|13
5641849|NCT00620542|19484912|P2|Part B (2 Year Core Study)|Protocol Violation|0
5641850|NCT00620542|19484913|P1|Part B (2 Year Core Study)|Protocol Violation|0
5641851|NCT00620542|19484910|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
5641852|NCT00620542|19484911|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
5641853|NCT00620542|19484912|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
5641854|NCT00620542|19484913|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
5641855|NCT00620542|19484910|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
5641856|NCT00620542|19484911|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
5641857|NCT00620542|19484912|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
5641858|NCT00620542|19484913|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
5641859|NCT00620542|19484910|P4|Part B (2 Year Core Study)|Protocol Violation|5
5641860|NCT00620542|19484911|P3|Part B (2 Year Core Study)|Protocol Violation|3
5641861|NCT00620542|19484912|P2|Part B (2 Year Core Study)|Protocol Violation|0
5641862|NCT00620542|19484913|P1|Part B (2 Year Core Study)|Protocol Violation|0
5641863|NCT00620542|19484910|P4|Part B (2 Year Core Study)|Adverse Event|49
5641864|NCT00620542|19484911|P3|Part B (2 Year Core Study)|Adverse Event|46
5641865|NCT00620542|19484912|P2|Part B (2 Year Core Study)|Adverse Event|0
5641866|NCT00620542|19484913|P1|Part B (2 Year Core Study)|Adverse Event|0
5641867|NCT00620542|19484910|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
5641868|NCT00620542|19484911|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
5641869|NCT00620542|19484912|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
5641870|NCT00620542|19484913|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
5641871|NCT00620542|19484910|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
5641872|NCT00620542|19484911|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
5641873|NCT00620542|19484912|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
5641874|NCT00620542|19484913|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
5641875|NCT00620542|19484910|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5641876|NCT00620542|19484911|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5641877|NCT00620542|19484912|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
5641878|NCT00620542|19484913|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5641879|NCT00620542|19484910|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
5641880|NCT00620542|19484911|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
5641881|NCT00620542|19484912|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
5641882|NCT00620542|19484913|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
5641883|NCT00620542|19484910|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
5641884|NCT00620542|19484911|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
5641885|NCT00620542|19484912|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
5641886|NCT00620542|19484913|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
5641887|NCT00620542|19484910|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5641888|NCT00620542|19484911|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
5641889|NCT00620542|19484912|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
5641890|NCT00620542|19484913|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
5641891|NCT00620542|19484910|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
5641892|NCT00620542|19484911|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
5641893|NCT00620542|19484912|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
5641894|NCT00620542|19484913|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
5641895|NCT00620464|19484978|P2|Overall Study|Used prohibited medication|0
5641896|NCT00620464|19484979|P1|Overall Study|Used prohibited medication|1
5641897|NCT00620464|19484978|P2|Overall Study|Personal|2
5641898|NCT00620464|19484979|P1|Overall Study|Personal|2
5641899|NCT00620464|19484978|P2|Overall Study|Planning Pregnancy|4
5641900|NCT00620464|19484979|P1|Overall Study|Planning Pregnancy|1
5641901|NCT00620464|19484978|P2|Overall Study|Lost to Follow-up|1
5641902|NCT00620464|19484979|P1|Overall Study|Lost to Follow-up|1
5641903|NCT00620464|19484978|P2|Overall Study|Adverse Event|17
5641904|NCT00620464|19484979|P1|Overall Study|Adverse Event|15
5641905|NCT00620373|19484998|P1|Overall Study|Unverified cancer status|33
5641906|NCT00620321|19485016|P2|Overall Study|Withdrawal by Subject|1
5641907|NCT00620321|19485017|P1|Overall Study|Withdrawal by Subject|1
5641908|NCT00620321|19485016|P2|Overall Study|Sponsor Decision|1
5641909|NCT00620321|19485017|P1|Overall Study|Sponsor Decision|0
5641910|NCT00620321|19485016|P2|Overall Study|Progressive Disease|5
5641911|NCT00620321|19485017|P1|Overall Study|Progressive Disease|5
5641912|NCT00620321|19485016|P2|Overall Study|Physician Decision|7
5641913|NCT00620321|19485017|P1|Overall Study|Physician Decision|0
5641914|NCT00620321|19485016|P2|Overall Study|Death|1
5641915|NCT00620321|19485017|P1|Overall Study|Death|1
5641916|NCT00620321|19485016|P2|Overall Study|Adverse Event|1
5641917|NCT00620321|19485017|P1|Overall Study|Adverse Event|1
5641918|NCT00620282|19485036|P3|Overall Study|Withdrawal by Subject|0
5641919|NCT00620282|19485037|P2|Overall Study|Withdrawal by Subject|1
5641920|NCT00620282|19485038|P1|Overall Study|Withdrawal by Subject|0
5641921|NCT00620282|19485036|P3|Overall Study|Arterial line unable to be placed|1
5641922|NCT00620282|19485037|P2|Overall Study|Arterial line unable to be placed|0
5641923|NCT00620282|19485038|P1|Overall Study|Arterial line unable to be placed|0
5641924|NCT00620282|19485036|P3|Overall Study|Adverse Event|0
5641925|NCT00620282|19485037|P2|Overall Study|Adverse Event|1
5641926|NCT00620282|19485038|P1|Overall Study|Adverse Event|0
5641927|NCT00620113|19485117|P4|Overall Study|Withdrawal by Subject|5
5641928|NCT00620113|19485118|P3|Overall Study|Withdrawal by Subject|3
5641929|NCT00620113|19485119|P2|Overall Study|Withdrawal by Subject|1
5641930|NCT00620113|19485120|P1|Overall Study|Withdrawal by Subject|5
5641931|NCT00620113|19485117|P4|Overall Study|Protocol Violation|0
5641932|NCT00620113|19485118|P3|Overall Study|Protocol Violation|0
5641933|NCT00620113|19485119|P2|Overall Study|Protocol Violation|1
5641934|NCT00620113|19485120|P1|Overall Study|Protocol Violation|2
5641935|NCT00620113|19485117|P4|Overall Study|Physician Decision|2
5641936|NCT00620113|19485118|P3|Overall Study|Physician Decision|0
5641937|NCT00620113|19485119|P2|Overall Study|Physician Decision|0
5641938|NCT00620113|19485120|P1|Overall Study|Physician Decision|1
5641939|NCT00620113|19485117|P4|Overall Study|Lack of Efficacy|2
5641940|NCT00620113|19485118|P3|Overall Study|Lack of Efficacy|0
5641941|NCT00620113|19485119|P2|Overall Study|Lack of Efficacy|3
5641942|NCT00620113|19485120|P1|Overall Study|Lack of Efficacy|2
5641943|NCT00620113|19485117|P4|Overall Study|Adverse Event|1
5641944|NCT00620113|19485118|P3|Overall Study|Adverse Event|2
5641945|NCT00620113|19485119|P2|Overall Study|Adverse Event|2
5641946|NCT00620113|19485120|P1|Overall Study|Adverse Event|3
5641947|NCT00620074|19485170|P1|Overall Study|Adverse Event|1
5641948|NCT00620035|19485193|P1|Overall Study|Other Reason|38
5641949|NCT00620035|19485193|P1|Overall Study|Withdrawal of Informed Consent|1
5641950|NCT00620035|19485193|P1|Overall Study|Adverse Event|106
5641951|NCT00620022|19485203|P2|Treatment Period 2|Adverse Event|2
5641952|NCT00620022|19485204|P1|Treatment Period 2|Adverse Event|2
5641953|NCT00620022|19485203|P2|Treatment Period 1|Subject withdrew consent|0
5641954|NCT00620022|19485204|P1|Treatment Period 1|Subject withdrew consent|1
5641955|NCT00620022|19485203|P2|Treatment Period 1|Adverse Event|6
5641956|NCT00620022|19485204|P1|Treatment Period 1|Adverse Event|4
5641957|NCT00619983|19485216|P4|Test Drug Alone|Failure of daily diary device|2
5641958|NCT00619983|19485217|P3|Test Drug Alone|Failure of daily diary device|2
5641959|NCT00619983|19485218|P2|Test Drug Alone|Failure of daily diary device|1
5641960|NCT00619983|19485219|P1|Test Drug Alone|Failure of daily diary device|1
5641961|NCT00619983|19485216|P4|Test Drug Alone|Withdrawal by Subject|1
5641962|NCT00619983|19485217|P3|Test Drug Alone|Withdrawal by Subject|0
5641963|NCT00619983|19485218|P2|Test Drug Alone|Withdrawal by Subject|0
5641964|NCT00619983|19485219|P1|Test Drug Alone|Withdrawal by Subject|1
5641965|NCT00619957|19485246|P2|Month 48 Open-Label|Withdrawal by Subject|9
5641966|NCT00619957|19485247|P1|Month 48 Open-Label|Withdrawal by Subject|6
5641967|NCT00619957|19485246|P2|Month 48 Open-Label|Lost to Follow-up|4
5641968|NCT00619957|19485247|P1|Month 48 Open-Label|Lost to Follow-up|2
5641969|NCT00619957|19485246|P2|Month 48 Open-Label|Adverse Event|4
5641970|NCT00619957|19485247|P1|Month 48 Open-Label|Adverse Event|4
5641971|NCT00619957|19485246|P2|Month 24 Double-Blind|Did not take any study medication|1
5641972|NCT00619957|19485247|P1|Month 24 Double-Blind|Did not take any study medication|0
5641973|NCT00619957|19485246|P2|Month 24 Double-Blind|Lost to Follow-up|0
5641974|NCT00619957|19485247|P1|Month 24 Double-Blind|Lost to Follow-up|1
5641975|NCT00619957|19485246|P2|Month 24 Double-Blind|Withdrawal by Subject|9
5641976|NCT00619957|19485247|P1|Month 24 Double-Blind|Withdrawal by Subject|7
5641977|NCT00619957|19485246|P2|Month 24 Double-Blind|Protocol Violation|0
5641978|NCT00619957|19485247|P1|Month 24 Double-Blind|Protocol Violation|1
5641979|NCT00619957|19485246|P2|Month 24 Double-Blind|Adverse Event|7
5641980|NCT00619957|19485247|P1|Month 24 Double-Blind|Adverse Event|9
5641981|NCT00619918|19485329|P2|Overall Study|Left before receiving first dose|8
5641982|NCT00619918|19485330|P1|Overall Study|Left before receiving first dose|5
5641983|NCT00619918|19485329|P2|Overall Study|Transfer to outside facility|3
5641984|NCT00619918|19485330|P1|Overall Study|Transfer to outside facility|3
5641985|NCT00619918|19485329|P2|Overall Study|Physician Decision|8
5641986|NCT00619918|19485330|P1|Overall Study|Physician Decision|8
5641987|NCT00619918|19485329|P2|Overall Study|Withdrawal by Subject|3
5641988|NCT00619918|19485330|P1|Overall Study|Withdrawal by Subject|4
5641989|NCT00619892|19485340|P2|Overall Study|Intercurrent illness|1
5641990|NCT00619892|19485341|P1|Overall Study|Intercurrent illness|0
5641991|NCT00619892|19485340|P2|Overall Study|Lost to Follow-up|1
5641992|NCT00619892|19485341|P1|Overall Study|Lost to Follow-up|0
5641993|NCT00619892|19485340|P2|Overall Study|Adverse Event|0
5641994|NCT00619892|19485341|P1|Overall Study|Adverse Event|3
5641995|NCT00619866|19485352|P5|Weeks 13 - 24|Lost to Follow-up|0
5641996|NCT00619866|19485353|P4|Weeks 13 - 24|Lost to Follow-up|0
5641997|NCT00619866|19485354|P3|Weeks 13 - 24|Lost to Follow-up|0
5641998|NCT00619866|19485355|P2|Weeks 13 - 24|Lost to Follow-up|3
5641999|NCT00619866|19485356|P1|Weeks 13 - 24|Lost to Follow-up|0
5642000|NCT00619866|19485352|P5|Weeks 13 - 24|Non-compliance|0
5642001|NCT00619866|19485353|P4|Weeks 13 - 24|Non-compliance|0
5642002|NCT00619866|19485354|P3|Weeks 13 - 24|Non-compliance|1
5642003|NCT00619866|19485355|P2|Weeks 13 - 24|Non-compliance|1
5642004|NCT00619866|19485356|P1|Weeks 13 - 24|Non-compliance|0
5642005|NCT00619866|19485352|P5|Weeks 13 - 24|Withdrawal by Subject|2
5642006|NCT00619866|19485353|P4|Weeks 13 - 24|Withdrawal by Subject|2
5642007|NCT00619866|19485354|P3|Weeks 13 - 24|Withdrawal by Subject|2
5642008|NCT00619866|19485355|P2|Weeks 13 - 24|Withdrawal by Subject|3
5642009|NCT00619866|19485356|P1|Weeks 13 - 24|Withdrawal by Subject|0
5642010|NCT00619866|19485352|P5|Weeks 13 - 24|Protocol Deviation|0
5642011|NCT00619866|19485353|P4|Weeks 13 - 24|Protocol Deviation|1
5642012|NCT00619866|19485354|P3|Weeks 13 - 24|Protocol Deviation|0
5642013|NCT00619866|19485355|P2|Weeks 13 - 24|Protocol Deviation|0
5642014|NCT00619866|19485356|P1|Weeks 13 - 24|Protocol Deviation|0
5642015|NCT00619866|19485352|P5|Weeks 13 - 24|Adverse Event|0
5642016|NCT00619866|19485353|P4|Weeks 13 - 24|Adverse Event|1
5642017|NCT00619866|19485354|P3|Weeks 13 - 24|Adverse Event|2
5642018|NCT00619866|19485355|P2|Weeks 13 - 24|Adverse Event|0
5642019|NCT00619866|19485356|P1|Weeks 13 - 24|Adverse Event|0
5642020|NCT00619866|19485352|P5|Weeks 1 - 12|Sponsor Decision|0
5642021|NCT00619866|19485353|P4|Weeks 1 - 12|Sponsor Decision|0
5642022|NCT00619866|19485354|P3|Weeks 1 - 12|Sponsor Decision|0
5642023|NCT00619866|19485355|P2|Weeks 1 - 12|Sponsor Decision|1
5642024|NCT00619866|19485356|P1|Weeks 1 - 12|Sponsor Decision|0
5642025|NCT00619866|19485352|P5|Weeks 1 - 12|Lost to Follow-up|0
5642026|NCT00619866|19485353|P4|Weeks 1 - 12|Lost to Follow-up|0
5642027|NCT00619866|19485354|P3|Weeks 1 - 12|Lost to Follow-up|2
5642028|NCT00619866|19485355|P2|Weeks 1 - 12|Lost to Follow-up|0
5642029|NCT00619866|19485356|P1|Weeks 1 - 12|Lost to Follow-up|4
5642030|NCT00619866|19485352|P5|Weeks 1 - 12|Lack of Efficacy|0
5642031|NCT00619866|19485353|P4|Weeks 1 - 12|Lack of Efficacy|0
5642032|NCT00619866|19485354|P3|Weeks 1 - 12|Lack of Efficacy|1
5642033|NCT00619866|19485355|P2|Weeks 1 - 12|Lack of Efficacy|2
5642034|NCT00619866|19485356|P1|Weeks 1 - 12|Lack of Efficacy|3
5642035|NCT00619866|19485352|P5|Weeks 1 - 12|Withdrawal by Subject|0
5642036|NCT00619866|19485353|P4|Weeks 1 - 12|Withdrawal by Subject|0
5642037|NCT00619866|19485354|P3|Weeks 1 - 12|Withdrawal by Subject|4
5642038|NCT00619866|19485355|P2|Weeks 1 - 12|Withdrawal by Subject|2
5642039|NCT00619866|19485356|P1|Weeks 1 - 12|Withdrawal by Subject|7
5642040|NCT00619866|19485352|P5|Weeks 1 - 12|Non-compliance|0
5642041|NCT00619866|19485353|P4|Weeks 1 - 12|Non-compliance|0
5642042|NCT00619866|19485354|P3|Weeks 1 - 12|Non-compliance|1
5642043|NCT00619866|19485355|P2|Weeks 1 - 12|Non-compliance|0
5642044|NCT00619866|19485356|P1|Weeks 1 - 12|Non-compliance|0
5642045|NCT00619866|19485352|P5|Weeks 1 - 12|Adverse Event|0
5642046|NCT00619866|19485353|P4|Weeks 1 - 12|Adverse Event|0
5642047|NCT00619866|19485354|P3|Weeks 1 - 12|Adverse Event|2
5642048|NCT00619866|19485355|P2|Weeks 1 - 12|Adverse Event|1
5642049|NCT00619866|19485356|P1|Weeks 1 - 12|Adverse Event|0
5642050|NCT00619827|19485443|P2|Overall Study|Withdrawal by Subject|2
5642051|NCT00619827|19485444|P1|Overall Study|Withdrawal by Subject|2
5642052|NCT00619827|19485443|P2|Overall Study|Adverse Event|2
5642053|NCT00619827|19485444|P1|Overall Study|Adverse Event|1
5642054|NCT00619801|19485452|P2|Overall Study|Loss of efficacy|1
5642055|NCT00619801|19485453|P1|Overall Study|Loss of efficacy|0
5642056|NCT00619801|19485452|P2|Overall Study|Withdrawal by Subject|1
5642057|NCT00619801|19485453|P1|Overall Study|Withdrawal by Subject|1
5642058|NCT00619801|19485452|P2|Overall Study|Lack of Efficacy|1
5642059|NCT00619801|19485453|P1|Overall Study|Lack of Efficacy|0
5642060|NCT00619645|19485510|P1|Overall Study|Adverse Event|1
5642061|NCT00619619|19485524|P8|Overall Study|Adverse Event|2
5642062|NCT00619619|19485525|P7|Overall Study|Adverse Event|0
5642063|NCT00619619|19485526|P6|Overall Study|Adverse Event|0
5642064|NCT00619619|19485527|P5|Overall Study|Adverse Event|2
5642065|NCT00619619|19485528|P4|Overall Study|Adverse Event|0
5642066|NCT00619619|19485529|P3|Overall Study|Adverse Event|0
5642067|NCT00619619|19485530|P2|Overall Study|Adverse Event|0
5642068|NCT00619619|19485531|P1|Overall Study|Adverse Event|0
5642069|NCT00619619|19485524|P8|Overall Study|Protocol Violation|1
5642070|NCT00619619|19485525|P7|Overall Study|Protocol Violation|1
5642071|NCT00619619|19485526|P6|Overall Study|Protocol Violation|0
5642072|NCT00619619|19485527|P5|Overall Study|Protocol Violation|0
5642073|NCT00619619|19485528|P4|Overall Study|Protocol Violation|1
5642074|NCT00619619|19485529|P3|Overall Study|Protocol Violation|0
5642075|NCT00619619|19485530|P2|Overall Study|Protocol Violation|0
5642076|NCT00619619|19485531|P1|Overall Study|Protocol Violation|0
5642077|NCT00619619|19485524|P8|Overall Study|Physician Decision|0
5642078|NCT00619619|19485525|P7|Overall Study|Physician Decision|0
5642079|NCT00619619|19485526|P6|Overall Study|Physician Decision|0
5642080|NCT00619619|19485527|P5|Overall Study|Physician Decision|0
5642081|NCT00619619|19485528|P4|Overall Study|Physician Decision|0
5642082|NCT00619619|19485529|P3|Overall Study|Physician Decision|1
5642083|NCT00619619|19485530|P2|Overall Study|Physician Decision|0
5642084|NCT00619619|19485531|P1|Overall Study|Physician Decision|0
5642085|NCT00619515|19485616|P1|Overall Study|Study Termination by IRB|73
5642086|NCT00619502|19485630|P2|Overall Study|Lost to Follow-up|10
5642087|NCT00619502|19485631|P1|Overall Study|Lost to Follow-up|8
5642088|NCT00619489|19485643|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
5642089|NCT00619489|19485644|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
5642090|NCT00619489|19485643|P2|Overall Study|Lack of Efficacy|11
5642091|NCT00619489|19485644|P1|Overall Study|Lack of Efficacy|0
5642092|NCT00619489|19485643|P2|Overall Study|Withdrawal by Subject|1
5642093|NCT00619489|19485644|P1|Overall Study|Withdrawal by Subject|1
5642094|NCT00619489|19485643|P2|Overall Study|Adverse Event|7
5642095|NCT00619489|19485644|P1|Overall Study|Adverse Event|0
5642096|NCT00619476|19485666|P4|Overall Study|Withdrawal by Subject|4
5642097|NCT00619476|19485667|P3|Overall Study|Withdrawal by Subject|5
5642098|NCT00619476|19485668|P2|Overall Study|Withdrawal by Subject|7
5642099|NCT00619476|19485669|P1|Overall Study|Withdrawal by Subject|5
5642100|NCT00619476|19485666|P4|Overall Study|Investigator Discretion|0
5642101|NCT00619476|19485667|P3|Overall Study|Investigator Discretion|2
5642102|NCT00619476|19485668|P2|Overall Study|Investigator Discretion|2
5642103|NCT00619476|19485669|P1|Overall Study|Investigator Discretion|2
5642104|NCT00619476|19485666|P4|Overall Study|Lost to Follow-up|1
5642105|NCT00619476|19485667|P3|Overall Study|Lost to Follow-up|0
5642106|NCT00619476|19485668|P2|Overall Study|Lost to Follow-up|2
5642107|NCT00619476|19485669|P1|Overall Study|Lost to Follow-up|1
5642108|NCT00619476|19485666|P4|Overall Study|Protocol Violation|9
5642109|NCT00619476|19485667|P3|Overall Study|Protocol Violation|4
5642110|NCT00619476|19485668|P2|Overall Study|Protocol Violation|4
5642111|NCT00619476|19485669|P1|Overall Study|Protocol Violation|5
5642112|NCT00619476|19485666|P4|Overall Study|Lack of Efficacy|4
5642113|NCT00619476|19485667|P3|Overall Study|Lack of Efficacy|1
5642114|NCT00619476|19485668|P2|Overall Study|Lack of Efficacy|1
5642115|NCT00619476|19485669|P1|Overall Study|Lack of Efficacy|6
5642116|NCT00619476|19485666|P4|Overall Study|Adverse Event|16
5642117|NCT00619476|19485667|P3|Overall Study|Adverse Event|12
5642118|NCT00619476|19485668|P2|Overall Study|Adverse Event|6
5642119|NCT00619476|19485669|P1|Overall Study|Adverse Event|12
5642120|NCT00619385|19485754|P3|Overall Study|Other|1
5642121|NCT00619385|19485755|P2|Overall Study|Other|2
5642122|NCT00619385|19485756|P1|Overall Study|Other|1
5642123|NCT00619385|19485754|P3|Overall Study|Adverse Event|3
5642124|NCT00619385|19485755|P2|Overall Study|Adverse Event|0
5642125|NCT00619385|19485756|P1|Overall Study|Adverse Event|0
5642126|NCT00619359|19485771|P2|Overall Study|Progressive Disease|1
5642127|NCT00619359|19485772|P1|Overall Study|Progressive Disease|3
5642128|NCT00619359|19485771|P2|Overall Study|Withdrawal by Subject|20
5642129|NCT00619359|19485772|P1|Overall Study|Withdrawal by Subject|19
5642130|NCT00619359|19485771|P2|Overall Study|Protocol Violation|1
5642131|NCT00619359|19485772|P1|Overall Study|Protocol Violation|1
5642132|NCT00619359|19485771|P2|Overall Study|Physician Decision|7
5642133|NCT00619359|19485772|P1|Overall Study|Physician Decision|0
5642134|NCT00619359|19485771|P2|Overall Study|Lost to Follow-up|16
5642135|NCT00619359|19485772|P1|Overall Study|Lost to Follow-up|12
5642136|NCT00619359|19485771|P2|Overall Study|Adverse Event|36
5642137|NCT00619359|19485772|P1|Overall Study|Adverse Event|32
5642138|NCT00619307|19485784|P2|Overall Study|MS attack plus steroids|1
5642139|NCT00619307|19485785|P1|Overall Study|MS attack plus steroids|0
5642140|NCT00619307|19485784|P2|Overall Study|Severe migraine|1
5642141|NCT00619307|19485785|P1|Overall Study|Severe migraine|0
5642142|NCT00619307|19485784|P2|Overall Study|Withdrew consent|0
5642143|NCT00619307|19485785|P1|Overall Study|Withdrew consent|1
5642144|NCT00619307|19485784|P2|Overall Study|Protocol Violation|0
5642145|NCT00619307|19485785|P1|Overall Study|Protocol Violation|3
5642146|NCT00619307|19485784|P2|Overall Study|Lost to Follow-up|1
5642147|NCT00619307|19485785|P1|Overall Study|Lost to Follow-up|0
5642148|NCT00619307|19485784|P2|Overall Study|Adverse Event|1
5642149|NCT00619307|19485785|P1|Overall Study|Adverse Event|0
5642150|NCT00619229|19485822|P2|Overall Study|Investigator planned Cataract Operation|0
5642151|NCT00619229|19485823|P1|Overall Study|Investigator planned Cataract Operation|1
5642152|NCT00619229|19485822|P2|Overall Study|Termination of the Study by the Sponsor|1
5642153|NCT00619229|19485823|P1|Overall Study|Termination of the Study by the Sponsor|1
5642154|NCT00619229|19485822|P2|Overall Study|Lost to Follow-up|0
5642155|NCT00619229|19485823|P1|Overall Study|Lost to Follow-up|1
5642156|NCT00619229|19485822|P2|Overall Study|Withdrawal by Subject|1
5642157|NCT00619229|19485823|P1|Overall Study|Withdrawal by Subject|1
5642158|NCT00619177|19485862|P1|Overall Study|Not specified reasons|6
5642159|NCT00619177|19485862|P1|Overall Study|Missing termination information|481
5642160|NCT00619177|19485862|P1|Overall Study|Lack of Efficacy|1
5642161|NCT00619177|19485862|P1|Overall Study|Lost to Follow-up|2
5642162|NCT00619177|19485862|P1|Overall Study|Adverse Event|18
5642163|NCT00619151|19485872|P2|Overall Study|Study terminated prior to followup|0
5642164|NCT00619151|19485873|P1|Overall Study|Study terminated prior to followup|1
5642165|NCT00619112|19485883|P2|Overall Study|Adverse Event|2
5642166|NCT00619112|19485884|P1|Overall Study|Adverse Event|1
5642167|NCT00619099|19485905|P2|Overall Study|Physician Decision|6
5642168|NCT00619099|19485906|P1|Overall Study|Physician Decision|9
5642169|NCT00619099|19485905|P2|Overall Study|Withdrawal by Subject|2
5642170|NCT00619099|19485906|P1|Overall Study|Withdrawal by Subject|10
5642171|NCT00619099|19485905|P2|Overall Study|Emergence of Clinically Significant Lab|2
5642172|NCT00619099|19485906|P1|Overall Study|Emergence of Clinically Significant Lab|1
5642173|NCT00619099|19485905|P2|Overall Study|Adverse Event|3
5642174|NCT00619099|19485906|P1|Overall Study|Adverse Event|4
5642175|NCT00619099|19485905|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
5642176|NCT00619099|19485906|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
5642177|NCT00619099|19485905|P2|Overall Study|Progressive Disease|5
5642178|NCT00619099|19485906|P1|Overall Study|Progressive Disease|7
5642179|NCT00618995|19485928|P4|Period 4|Adverse Event|0
5642180|NCT00618995|19485929|P3|Period 4|Adverse Event|0
5642181|NCT00618995|19485930|P2|Period 4|Adverse Event|0
5642182|NCT00618995|19485931|P1|Period 4|Adverse Event|1
5642183|NCT00618995|19485928|P4|Period 2|Protocol Violation|0
5642184|NCT00618995|19485929|P3|Period 2|Protocol Violation|1
5642185|NCT00618995|19485930|P2|Period 2|Protocol Violation|0
5642186|NCT00618995|19485931|P1|Period 2|Protocol Violation|0
5642187|NCT00618995|19485928|P4|Period 1|Protocol Violation|0
5642188|NCT00618995|19485929|P3|Period 1|Protocol Violation|1
5642189|NCT00618995|19485930|P2|Period 1|Protocol Violation|1
5642190|NCT00618995|19485931|P1|Period 1|Protocol Violation|0
5642191|NCT00618995|19485928|P4|Period 1|Adverse Event|0
5642192|NCT00618995|19485929|P3|Period 1|Adverse Event|1
5642193|NCT00618995|19485930|P2|Period 1|Adverse Event|0
5642194|NCT00618995|19485931|P1|Period 1|Adverse Event|0
5642195|NCT00618982|19485945|P1|Overall Study|ongoing, still treated with study med.|25
5642196|NCT00618982|19485945|P1|Overall Study|Protocol Violation|1
5642197|NCT00618982|19485945|P1|Overall Study|Withdrawal by Subject|1
5642198|NCT00618982|19485945|P1|Overall Study|Adverse Event|23
5642199|NCT00618956|19485968|P2|Overall Study|did not meet criteria, non-compliance|1
5642200|NCT00618956|19485969|P1|Overall Study|did not meet criteria, non-compliance|2
5642201|NCT00618956|19485968|P2|Overall Study|Protocol Violation|2
5642202|NCT00618956|19485969|P1|Overall Study|Protocol Violation|2
5642203|NCT00618956|19485968|P2|Overall Study|Lost to Follow-up|5
5642204|NCT00618956|19485969|P1|Overall Study|Lost to Follow-up|4
5642205|NCT00618956|19485968|P2|Overall Study|Withdrawal by Subject|7
5642206|NCT00618956|19485969|P1|Overall Study|Withdrawal by Subject|5
5642207|NCT00618956|19485968|P2|Overall Study|Lack of Efficacy|1
5642208|NCT00618956|19485969|P1|Overall Study|Lack of Efficacy|2
5642209|NCT00618956|19485968|P2|Overall Study|Adverse Event|34
5642210|NCT00618956|19485969|P1|Overall Study|Adverse Event|10
5642211|NCT00618826|19485994|P1|Overall Study|Adverse Event|1
5642212|NCT00618813|19485999|P1|Overall Study|Withdrawal by Subject|1
5642213|NCT00618813|19485999|P1|Overall Study|Physician Decision|2
5642214|NCT00618813|19485999|P1|Overall Study|Lack of Efficacy|1
5642215|NCT00618787|19486009|P2|Overall Study|Lost to Follow-up|0
5642216|NCT00618787|19486010|P1|Overall Study|Lost to Follow-up|1
5642217|NCT00618787|19486009|P2|Overall Study|Withdrawal by Subject|1
5642218|NCT00618787|19486010|P1|Overall Study|Withdrawal by Subject|2
5642219|NCT00618787|19486009|P2|Overall Study|Adverse Event|1
5642220|NCT00618787|19486010|P1|Overall Study|Adverse Event|0
5642221|NCT00618774|19486018|P2|Overall Study|Withdrawal by Subject|0
5642222|NCT00618774|19486019|P1|Overall Study|Withdrawal by Subject|1
5642223|NCT00618774|19486018|P2|Overall Study|Adverse Event|3
5642224|NCT00618774|19486019|P1|Overall Study|Adverse Event|5
5642225|NCT00618748|19486052|P3|Overall Study|Withdrawal by Subject|5
5642226|NCT00618748|19486053|P2|Overall Study|Withdrawal by Subject|1
5642227|NCT00618748|19486054|P1|Overall Study|Withdrawal by Subject|4
5642228|NCT00618748|19486052|P3|Overall Study|Physician Decision|1
5642229|NCT00618748|19486053|P2|Overall Study|Physician Decision|1
5642230|NCT00618748|19486054|P1|Overall Study|Physician Decision|3
5642231|NCT00618748|19486052|P3|Overall Study|Adverse Event|8
5642232|NCT00618748|19486053|P2|Overall Study|Adverse Event|3
5642233|NCT00618748|19486054|P1|Overall Study|Adverse Event|4
5642234|NCT00618722|19486099|P4|Overall Study|Miscellaneous Reasons|1
5642235|NCT00618722|19486100|P3|Overall Study|Miscellaneous Reasons|1
5642236|NCT00618722|19486101|P2|Overall Study|Miscellaneous Reasons|0
5642237|NCT00618722|19486102|P1|Overall Study|Miscellaneous Reasons|0
5642238|NCT00618722|19486099|P4|Overall Study|Lost to Follow-up|2
5642239|NCT00618722|19486100|P3|Overall Study|Lost to Follow-up|0
5642240|NCT00618722|19486101|P2|Overall Study|Lost to Follow-up|0
5642241|NCT00618722|19486102|P1|Overall Study|Lost to Follow-up|2
5642242|NCT00618722|19486099|P4|Overall Study|Inability to Complete Study Procedure|0
5642243|NCT00618722|19486100|P3|Overall Study|Inability to Complete Study Procedure|0
5642244|NCT00618722|19486101|P2|Overall Study|Inability to Complete Study Procedure|1
5642245|NCT00618722|19486102|P1|Overall Study|Inability to Complete Study Procedure|0
5642246|NCT00618722|19486099|P4|Overall Study|Patient Request|1
5642247|NCT00618722|19486100|P3|Overall Study|Patient Request|1
5642248|NCT00618722|19486101|P2|Overall Study|Patient Request|1
5642249|NCT00618722|19486102|P1|Overall Study|Patient Request|1
5642250|NCT00618722|19486099|P4|Overall Study|Refusal of Treatment|0
5642251|NCT00618722|19486100|P3|Overall Study|Refusal of Treatment|1
5642252|NCT00618722|19486101|P2|Overall Study|Refusal of Treatment|0
5642253|NCT00618722|19486102|P1|Overall Study|Refusal of Treatment|0
5642254|NCT00618618|19486140|P4|Overall Study|Death|0
5642255|NCT00618618|19486141|P3|Overall Study|Death|0
5642256|NCT00618618|19486142|P2|Overall Study|Death|1
5642257|NCT00618618|19486143|P1|Overall Study|Death|0
5642258|NCT00618618|19486140|P4|Overall Study|Did Not Meet Entry Criteria|0
5642259|NCT00618618|19486141|P3|Overall Study|Did Not Meet Entry Criteria|1
5642260|NCT00618618|19486142|P2|Overall Study|Did Not Meet Entry Criteria|0
5642261|NCT00618618|19486143|P1|Overall Study|Did Not Meet Entry Criteria|0
5642262|NCT00618618|19486140|P4|Overall Study|Non-compliance|0
5642263|NCT00618618|19486141|P3|Overall Study|Non-compliance|0
5642264|NCT00618618|19486142|P2|Overall Study|Non-compliance|1
5642265|NCT00618618|19486143|P1|Overall Study|Non-compliance|1
5642266|NCT00618618|19486140|P4|Overall Study|Lost to Follow-up|1
5642267|NCT00618618|19486141|P3|Overall Study|Lost to Follow-up|0
5642268|NCT00618618|19486142|P2|Overall Study|Lost to Follow-up|0
5642269|NCT00618618|19486143|P1|Overall Study|Lost to Follow-up|3
5642270|NCT00618618|19486140|P4|Overall Study|Inability to Complete Study Procedures|0
5642271|NCT00618618|19486141|P3|Overall Study|Inability to Complete Study Procedures|0
5642272|NCT00618618|19486142|P2|Overall Study|Inability to Complete Study Procedures|1
5642273|NCT00618618|19486143|P1|Overall Study|Inability to Complete Study Procedures|0
5642274|NCT00618618|19486140|P4|Overall Study|Patient Request|0
5642275|NCT00618618|19486141|P3|Overall Study|Patient Request|2
5642276|NCT00618618|19486142|P2|Overall Study|Patient Request|0
5642277|NCT00618618|19486143|P1|Overall Study|Patient Request|0
5642278|NCT00618514|19486202|P3|Overall Study|Lost to Follow-up|4
5642279|NCT00618514|19486203|P2|Overall Study|Lost to Follow-up|12
5642280|NCT00618514|19486204|P1|Overall Study|Lost to Follow-up|11
5642281|NCT00618449|19486224|P2|Overall Study|Lost to Follow-up|110
5642282|NCT00618449|19486225|P1|Overall Study|Lost to Follow-up|98
5642283|NCT00618410|19486244|P2|Washout Period (2 Weeks)|Physician Decision|1
5642284|NCT00618410|19486245|P1|Washout Period (2 Weeks)|Physician Decision|0
5642285|NCT00618371|19486261|P1|Overall Study|Withdrawal by Subject|2
5642286|NCT00618072|19486294|P3|Overall Study|Physician Decision|1
5642287|NCT00618072|19486295|P2|Overall Study|Physician Decision|1
5642288|NCT00618072|19486296|P1|Overall Study|Physician Decision|0
5642289|NCT00618072|19486294|P3|Overall Study|Lost to Follow-up|3
5642290|NCT00618072|19486295|P2|Overall Study|Lost to Follow-up|0
5642291|NCT00618072|19486296|P1|Overall Study|Lost to Follow-up|2
5642292|NCT00617929|19486352|P1|Overall Study|Physician Decision|1
5642293|NCT00617903|19486364|P2|Overall Study|noncompliance|1
5642294|NCT00617903|19486365|P1|Overall Study|noncompliance|0
5642295|NCT00617903|19486364|P2|Overall Study|Adverse Event|1
5642296|NCT00617903|19486365|P1|Overall Study|Adverse Event|0
5642297|NCT00617903|19486364|P2|Overall Study|Lack of Efficacy|1
5642298|NCT00617903|19486365|P1|Overall Study|Lack of Efficacy|0
5642299|NCT00617903|19486364|P2|Overall Study|Lost to Follow-up|1
5642300|NCT00617903|19486365|P1|Overall Study|Lost to Follow-up|1
5642301|NCT00617903|19486364|P2|Overall Study|Withdrawal by Subject|3
5642302|NCT00617903|19486365|P1|Overall Study|Withdrawal by Subject|2
5642303|NCT00617890|19486411|P4|Overall Study|Not treated|1
5642304|NCT00617890|19486412|P3|Overall Study|Not treated|1
5642305|NCT00617890|19486413|P2|Overall Study|Not treated|0
5642306|NCT00617890|19486414|P1|Overall Study|Not treated|1
5642307|NCT00617890|19486411|P4|Overall Study|Adverse Event|8
5642308|NCT00617890|19486412|P3|Overall Study|Adverse Event|3
5642309|NCT00617890|19486413|P2|Overall Study|Adverse Event|0
5642310|NCT00617890|19486414|P1|Overall Study|Adverse Event|1
5642311|NCT00617890|19486411|P4|Overall Study|Protocol Violation|0
5642312|NCT00617890|19486412|P3|Overall Study|Protocol Violation|0
5642313|NCT00617890|19486413|P2|Overall Study|Protocol Violation|1
5642314|NCT00617890|19486414|P1|Overall Study|Protocol Violation|2
5642315|NCT00617890|19486411|P4|Overall Study|Withdrawal by Subject|2
5642316|NCT00617890|19486412|P3|Overall Study|Withdrawal by Subject|0
5642317|NCT00617890|19486413|P2|Overall Study|Withdrawal by Subject|1
5642318|NCT00617890|19486414|P1|Overall Study|Withdrawal by Subject|4
5642319|NCT00617890|19486411|P4|Overall Study|Lost to Follow-up|2
5642320|NCT00617890|19486412|P3|Overall Study|Lost to Follow-up|1
5642321|NCT00617890|19486413|P2|Overall Study|Lost to Follow-up|0
5642322|NCT00617890|19486414|P1|Overall Study|Lost to Follow-up|0
5642323|NCT00617890|19486411|P4|Overall Study|Lack of Efficacy|97
5642324|NCT00617890|19486412|P3|Overall Study|Lack of Efficacy|30
5642325|NCT00617890|19486413|P2|Overall Study|Lack of Efficacy|26
5642326|NCT00617890|19486414|P1|Overall Study|Lack of Efficacy|23
5642327|NCT00617890|19486411|P4|Overall Study|Treatment ongoing at data cut-off|5
5642328|NCT00617890|19486412|P3|Overall Study|Treatment ongoing at data cut-off|0
5642329|NCT00617890|19486413|P2|Overall Study|Treatment ongoing at data cut-off|0
5642330|NCT00617890|19486414|P1|Overall Study|Treatment ongoing at data cut-off|0
5642331|NCT00617851|19486450|P4|Overall Study|Unable to classify|0
5642332|NCT00617851|19486451|P3|Overall Study|Unable to classify|1
5642333|NCT00617851|19486452|P2|Overall Study|Unable to classify|0
5642334|NCT00617851|19486453|P1|Overall Study|Unable to classify|1
5642335|NCT00617851|19486450|P4|Overall Study|Inappropriate Enrollment|1
5642336|NCT00617851|19486451|P3|Overall Study|Inappropriate Enrollment|1
5642337|NCT00617851|19486452|P2|Overall Study|Inappropriate Enrollment|4
5642338|NCT00617851|19486453|P1|Overall Study|Inappropriate Enrollment|5
5642339|NCT00617851|19486450|P4|Overall Study|Lost to Follow-up|19
5642340|NCT00617851|19486451|P3|Overall Study|Lost to Follow-up|31
5642341|NCT00617851|19486452|P2|Overall Study|Lost to Follow-up|29
5642342|NCT00617851|19486453|P1|Overall Study|Lost to Follow-up|27
5642343|NCT00617851|19486450|P4|Overall Study|Withdrawal by Subject|4
5642344|NCT00617851|19486451|P3|Overall Study|Withdrawal by Subject|12
5642345|NCT00617851|19486452|P2|Overall Study|Withdrawal by Subject|7
5642346|NCT00617851|19486453|P1|Overall Study|Withdrawal by Subject|14
5642347|NCT00617851|19486450|P4|Overall Study|Death|1
5642348|NCT00617851|19486451|P3|Overall Study|Death|0
5642349|NCT00617851|19486452|P2|Overall Study|Death|0
5642350|NCT00617851|19486453|P1|Overall Study|Death|0
5642351|NCT00617773|19486491|P1|Overall Study|Protocol Violation|1
5642352|NCT00617773|19486491|P1|Overall Study|Progressive disease|19
5642353|NCT00617773|19486491|P1|Overall Study|Death|1
5642354|NCT00617773|19486491|P1|Overall Study|Withdrawal by Subject|1
5642355|NCT00617773|19486491|P1|Overall Study|Lack of compliance with the protocol|1
5642356|NCT00617773|19486491|P1|Overall Study|Physician Decision|1
5642357|NCT00617734|19486508|P2|Overall Study|Lost to Follow-up|1
5642358|NCT00617734|19486509|P1|Overall Study|Lost to Follow-up|0
5642359|NCT00617734|19486508|P2|Overall Study|Found Ineligible After Randomization|4
5642360|NCT00617734|19486509|P1|Overall Study|Found Ineligible After Randomization|1
5642361|NCT00617734|19486508|P2|Overall Study|Protocol Violation|0
5642362|NCT00617734|19486509|P1|Overall Study|Protocol Violation|1
5642363|NCT00617734|19486508|P2|Overall Study|Adverse Event|1
5642364|NCT00617734|19486509|P1|Overall Study|Adverse Event|4
5642365|NCT00617734|19486508|P2|Overall Study|Withdrew Consent|0
5642366|NCT00617734|19486509|P1|Overall Study|Withdrew Consent|2
5642367|NCT00617708|19486530|P3|Overall Study|Not eligible|5
5642368|NCT00617708|19486531|P2|Overall Study|Not eligible|3
5642369|NCT00617708|19486532|P1|Overall Study|Not eligible|1
5642370|NCT00617708|19486530|P3|Overall Study|Not protocol specified|2
5642371|NCT00617708|19486531|P2|Overall Study|Not protocol specified|4
5642372|NCT00617708|19486532|P1|Overall Study|Not protocol specified|1
5642373|NCT00617708|19486530|P3|Overall Study|Progression/Relapse|36
5642374|NCT00617708|19486531|P2|Overall Study|Progression/Relapse|40
5642375|NCT00617708|19486532|P1|Overall Study|Progression/Relapse|7
5642376|NCT00617708|19486530|P3|Overall Study|Death|5
5642377|NCT00617708|19486531|P2|Overall Study|Death|6
5642378|NCT00617708|19486532|P1|Overall Study|Death|0
5642379|NCT00617708|19486530|P3|Overall Study|Withdrawal by Subject|7
5642380|NCT00617708|19486531|P2|Overall Study|Withdrawal by Subject|1
5642381|NCT00617708|19486532|P1|Overall Study|Withdrawal by Subject|1
5642382|NCT00617708|19486530|P3|Overall Study|Adverse Event|9
5642383|NCT00617708|19486531|P2|Overall Study|Adverse Event|6
5642384|NCT00617708|19486532|P1|Overall Study|Adverse Event|0
5642385|NCT00617669|19486549|P2|Overall Study|Patients randomized but not treated|3
5642386|NCT00617669|19486550|P1|Overall Study|Patients randomized but not treated|2
5642387|NCT00617669|19486549|P2|Overall Study|Reason not otherwise captured, eg; death|290
5642388|NCT00617669|19486550|P1|Overall Study|Reason not otherwise captured, eg; death|265
5642389|NCT00617669|19486549|P2|Overall Study|Protocol Violation|3
5642390|NCT00617669|19486550|P1|Overall Study|Protocol Violation|2
5642391|NCT00617669|19486549|P2|Overall Study|Adverse Event|76
5642392|NCT00617669|19486550|P1|Overall Study|Adverse Event|87
5642393|NCT00617669|19486549|P2|Overall Study|Lost to Follow-up|2
5642394|NCT00617669|19486550|P1|Overall Study|Lost to Follow-up|3
5642395|NCT00617669|19486549|P2|Overall Study|Withdrawal by Subject|77
5642396|NCT00617669|19486550|P1|Overall Study|Withdrawal by Subject|71
5642397|NCT00617604|19486572|P2|Overall Study|Randomized but Never Received Study Drug|3
5642398|NCT00617604|19486573|P1|Overall Study|Randomized but Never Received Study Drug|3
5642399|NCT00617604|19486572|P2|Overall Study|Withdrawal by Subject|6
5642400|NCT00617604|19486573|P1|Overall Study|Withdrawal by Subject|4
5642401|NCT00617604|19486572|P2|Overall Study|Miscellaneous Reasons|10
5642402|NCT00617604|19486573|P1|Overall Study|Miscellaneous Reasons|8
5642403|NCT00617604|19486572|P2|Overall Study|Lost to Follow-up|0
5642404|NCT00617604|19486573|P1|Overall Study|Lost to Follow-up|1
5642405|NCT00617604|19486572|P2|Overall Study|Death|1
5642406|NCT00617604|19486573|P1|Overall Study|Death|2
5642407|NCT00617591|19486617|P1|Overall Study|Withdrew consent during Maintenance|6
5642408|NCT00617591|19486617|P1|Overall Study|Withdrew consent during Induction|4
5642409|NCT00617461|19486633|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
5642410|NCT00617461|19486634|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
5642411|NCT00617461|19486633|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
5642412|NCT00617461|19486634|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
5642413|NCT00617461|19486633|P2|Second Treatment Intervention Period|Lack of Efficacy|3
5642414|NCT00617461|19486634|P1|Second Treatment Intervention Period|Lack of Efficacy|0
5642415|NCT00617461|19486633|P2|Second Treatment Intervention Period|Adverse Event|1
5642416|NCT00617461|19486634|P1|Second Treatment Intervention Period|Adverse Event|0
5642417|NCT00617461|19486633|P2|4-Day Crossover Period|Withdrawal by Subject|0
5642418|NCT00617461|19486634|P1|4-Day Crossover Period|Withdrawal by Subject|1
5642419|NCT00617461|19486633|P2|First Treatment Intervention Period|Withdrawal by Subject|0
5642420|NCT00617461|19486634|P1|First Treatment Intervention Period|Withdrawal by Subject|4
5642421|NCT00617461|19486633|P2|First Treatment Intervention Period|Investigator Discretion|1
5642422|NCT00617461|19486634|P1|First Treatment Intervention Period|Investigator Discretion|1
5642423|NCT00617461|19486633|P2|First Treatment Intervention Period|Lost to Follow-up|1
5642424|NCT00617461|19486634|P1|First Treatment Intervention Period|Lost to Follow-up|0
5642425|NCT00617461|19486633|P2|First Treatment Intervention Period|Protocol Violation|1
5642426|NCT00617461|19486634|P1|First Treatment Intervention Period|Protocol Violation|2
5642427|NCT00617461|19486633|P2|First Treatment Intervention Period|Lack of Efficacy|0
5642428|NCT00617461|19486634|P1|First Treatment Intervention Period|Lack of Efficacy|1
5642429|NCT00617461|19486633|P2|First Treatment Intervention Period|Adverse Event|0
5642430|NCT00617461|19486634|P1|First Treatment Intervention Period|Adverse Event|2
5642431|NCT00617409|19486690|P3|Overall Study|Alternative Therapy|0
5642432|NCT00617409|19486691|P2|Overall Study|Alternative Therapy|2
5642433|NCT00617409|19486692|P1|Overall Study|Alternative Therapy|1
5642434|NCT00617409|19486690|P3|Overall Study|Death|4
5642435|NCT00617409|19486691|P2|Overall Study|Death|5
5642436|NCT00617409|19486692|P1|Overall Study|Death|3
5642437|NCT00617409|19486690|P3|Overall Study|Disease Progression|18
5642438|NCT00617409|19486691|P2|Overall Study|Disease Progression|8
5642439|NCT00617409|19486692|P1|Overall Study|Disease Progression|8
5642440|NCT00617409|19486690|P3|Overall Study|Adverse Event|3
5642441|NCT00617409|19486691|P2|Overall Study|Adverse Event|2
5642442|NCT00617409|19486692|P1|Overall Study|Adverse Event|0
5642443|NCT00617409|19486690|P3|Overall Study|Withdrawal by Subject|2
5642444|NCT00617409|19486691|P2|Overall Study|Withdrawal by Subject|1
5642445|NCT00617409|19486692|P1|Overall Study|Withdrawal by Subject|4
5642446|NCT00617357|19486707|P1|Overall Study|Physician Decision|1
5642447|NCT00617357|19486707|P1|Overall Study|Withdrawal by Subject|1
5642448|NCT00617357|19486707|P1|Overall Study|insurance concerns|2
5642449|NCT00617357|19486707|P1|Overall Study|Death|5
5642450|NCT00617357|19486707|P1|Overall Study|Lost to Follow-up|7
5642451|NCT00617344|19486720|P3|Overall Study|Withdrawal by Subject|2
5642452|NCT00617344|19486721|P2|Overall Study|Withdrawal by Subject|9
5642453|NCT00617344|19486722|P1|Overall Study|Withdrawal by Subject|8
5642454|NCT00617344|19486720|P3|Overall Study|Lost to Follow-up|1
5642455|NCT00617344|19486721|P2|Overall Study|Lost to Follow-up|4
5642456|NCT00617344|19486722|P1|Overall Study|Lost to Follow-up|5
5642457|NCT00617344|19486720|P3|Overall Study|Protocol Violation|5
5642458|NCT00617344|19486721|P2|Overall Study|Protocol Violation|8
5642459|NCT00617344|19486722|P1|Overall Study|Protocol Violation|10
5642460|NCT00617344|19486720|P3|Overall Study|Other Adverse Event|0
5642461|NCT00617344|19486721|P2|Overall Study|Other Adverse Event|1
5642462|NCT00617344|19486722|P1|Overall Study|Other Adverse Event|1
5642463|NCT00617344|19486720|P3|Overall Study|Serious adverse event|0
5642464|NCT00617344|19486721|P2|Overall Study|Serious adverse event|0
5642465|NCT00617344|19486722|P1|Overall Study|Serious adverse event|1
5642466|NCT00617305|19486750|P3|Overall Study|Withdrawal by Subject|0
5642467|NCT00617305|19486751|P2|Overall Study|Withdrawal by Subject|0
5642468|NCT00617305|19486752|P1|Overall Study|Withdrawal by Subject|1
5642469|NCT00617305|19486750|P3|Overall Study|Protocol Violation|1
5642470|NCT00617305|19486751|P2|Overall Study|Protocol Violation|0
5642471|NCT00617305|19486752|P1|Overall Study|Protocol Violation|1
5642472|NCT00617305|19486750|P3|Overall Study|Physician Decision|0
5642473|NCT00617305|19486751|P2|Overall Study|Physician Decision|0
5642474|NCT00617305|19486752|P1|Overall Study|Physician Decision|1
5642475|NCT00617305|19486750|P3|Overall Study|Death|0
5642476|NCT00617305|19486751|P2|Overall Study|Death|0
5642477|NCT00617305|19486752|P1|Overall Study|Death|1
5642478|NCT00617305|19486750|P3|Overall Study|Adverse Event|0
5642479|NCT00617305|19486751|P2|Overall Study|Adverse Event|0
5642480|NCT00617305|19486752|P1|Overall Study|Adverse Event|4
5642481|NCT00617279|19486808|P2|Overall Study|Death|2
5642482|NCT00617279|19486809|P1|Overall Study|Death|1
5642483|NCT00617279|19486808|P2|Overall Study|Lost to Follow-up|0
5642484|NCT00617279|19486809|P1|Overall Study|Lost to Follow-up|1
5642485|NCT00617279|19486808|P2|Overall Study|Graft abandonment|0
5642486|NCT00617279|19486809|P1|Overall Study|Graft abandonment|2
5642487|NCT00617279|19486808|P2|Overall Study|Study terminated by Sponsor|15
5642488|NCT00617279|19486809|P1|Overall Study|Study terminated by Sponsor|10
5642489|NCT00617240|19486865|P2|Overall Study|Lack of Efficacy|0
5642490|NCT00617240|19486866|P1|Overall Study|Lack of Efficacy|1
5642491|NCT00617201|19486886|P2|Overall Study|Lost to Follow-up|13
5642492|NCT00617201|19486887|P1|Overall Study|Lost to Follow-up|9
5642493|NCT00617123|19486915|P2|Study Treatment Period|Noncompliance with Protocol|1
5642494|NCT00617123|19486916|P1|Study Treatment Period|Noncompliance with Protocol|0
5642495|NCT00617123|19486915|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
5642496|NCT00617123|19486916|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
5642497|NCT00617123|19486915|P2|Study Treatment Period|Adverse Event|3
5642498|NCT00617123|19486916|P1|Study Treatment Period|Adverse Event|7
5642499|NCT00617123|19486915|P2|Study Treatment Period|Withdrawal by Subject|12
5642500|NCT00617123|19486916|P1|Study Treatment Period|Withdrawal by Subject|8
5642501|NCT00617123|19486915|P2|Referral Screening Period|Adverse Event|1
5642502|NCT00617123|19486916|P1|Referral Screening Period|Adverse Event|0
5642503|NCT00617123|19486915|P2|Referral Screening Period|Did Not Wish To Continue|1
5642504|NCT00617123|19486916|P1|Referral Screening Period|Did Not Wish To Continue|3
5642505|NCT00617123|19486915|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
5642506|NCT00617123|19486916|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
5642507|NCT00617084|19486947|P2|Overall Study|Missed 12 Months visit|19
5642508|NCT00617084|19486948|P1|Overall Study|Missed 12 Months visit|16
5642509|NCT00617084|19486947|P2|Overall Study|Withdrawal by Subject|7
5642510|NCT00617084|19486948|P1|Overall Study|Withdrawal by Subject|5
5642511|NCT00616967|19487001|P3|Overall Study|Withdrawal by Subject|1
5642512|NCT00616967|19487002|P2|Overall Study|Withdrawal by Subject|0
5642513|NCT00616967|19487003|P1|Overall Study|Withdrawal by Subject|0
5642514|NCT00616941|19487028|P3|Overall Study|Vaccination Suspended|3
5642515|NCT00616941|19487029|P2|Overall Study|Vaccination Suspended|0
5642516|NCT00616941|19487030|P1|Overall Study|Vaccination Suspended|0
5642517|NCT00616941|19487028|P3|Overall Study|Unrelated Medical Illness/Complication|0
5642518|NCT00616941|19487029|P2|Overall Study|Unrelated Medical Illness/Complication|2
5642519|NCT00616941|19487030|P1|Overall Study|Unrelated Medical Illness/Complication|0
5642520|NCT00616941|19487028|P3|Overall Study|Subject Non-compliance|1
5642521|NCT00616941|19487029|P2|Overall Study|Subject Non-compliance|0
5642522|NCT00616941|19487030|P1|Overall Study|Subject Non-compliance|0
5642523|NCT00616941|19487028|P3|Overall Study|Adverse Event|1
5642524|NCT00616941|19487029|P2|Overall Study|Adverse Event|1
5642525|NCT00616941|19487030|P1|Overall Study|Adverse Event|0
5642526|NCT00616941|19487028|P3|Overall Study|Progressive Disease|1
5642527|NCT00616941|19487029|P2|Overall Study|Progressive Disease|2
5642528|NCT00616941|19487030|P1|Overall Study|Progressive Disease|1
5642529|NCT00616928|19487057|P4|Overall Study|Lost to Follow-up|0
5642530|NCT00616928|19487058|P3|Overall Study|Lost to Follow-up|0
5642531|NCT00616928|19487059|P2|Overall Study|Lost to Follow-up|7
5642532|NCT00616928|19487060|P1|Overall Study|Lost to Follow-up|5
5642533|NCT00616928|19487057|P4|Overall Study|Other|5
5642534|NCT00616928|19487058|P3|Overall Study|Other|15
5642535|NCT00616928|19487059|P2|Overall Study|Other|8
5642536|NCT00616928|19487060|P1|Overall Study|Other|51
5642537|NCT00616928|19487057|P4|Overall Study|Adverse Event|2
5642538|NCT00616928|19487058|P3|Overall Study|Adverse Event|2
5642539|NCT00616928|19487059|P2|Overall Study|Adverse Event|3
5642540|NCT00616928|19487060|P1|Overall Study|Adverse Event|6
5642541|NCT00616902|19487124|P2|Overall Study|Termination of study|6
5642542|NCT00616902|19487125|P1|Overall Study|Termination of study|6
5642543|NCT00616759|19487168|P2|Overall Study|Withdrawal by Subject|2
5642544|NCT00616759|19487169|P1|Overall Study|Withdrawal by Subject|1
5642545|NCT00616759|19487168|P2|Overall Study|Physician Decision|0
5642546|NCT00616759|19487169|P1|Overall Study|Physician Decision|2
5642547|NCT00616655|19487178|P3|Overall Study|Other|5
5642548|NCT00616655|19487179|P2|Overall Study|Other|6
5642549|NCT00616655|19487180|P1|Overall Study|Other|6
5642550|NCT00616655|19487178|P3|Overall Study|Does not meet in/ex criteria|2
5642551|NCT00616655|19487179|P2|Overall Study|Does not meet in/ex criteria|0
5642552|NCT00616655|19487180|P1|Overall Study|Does not meet in/ex criteria|0
5642553|NCT00616655|19487178|P3|Overall Study|Withdrawal by Subject|11
5642554|NCT00616655|19487179|P2|Overall Study|Withdrawal by Subject|7
5642555|NCT00616655|19487180|P1|Overall Study|Withdrawal by Subject|9
5642556|NCT00616655|19487178|P3|Overall Study|Protocol Violation|3
5642557|NCT00616655|19487179|P2|Overall Study|Protocol Violation|4
5642558|NCT00616655|19487180|P1|Overall Study|Protocol Violation|2
5642559|NCT00616655|19487178|P3|Overall Study|Lost to Follow-up|10
5642560|NCT00616655|19487179|P2|Overall Study|Lost to Follow-up|12
5642561|NCT00616655|19487180|P1|Overall Study|Lost to Follow-up|3
5642562|NCT00616655|19487178|P3|Overall Study|Lack of Efficacy|5
5642563|NCT00616655|19487179|P2|Overall Study|Lack of Efficacy|5
5642564|NCT00616655|19487180|P1|Overall Study|Lack of Efficacy|5
5642565|NCT00616655|19487178|P3|Overall Study|Adverse Event|12
5642566|NCT00616655|19487179|P2|Overall Study|Adverse Event|7
5642567|NCT00616655|19487180|P1|Overall Study|Adverse Event|10
5642568|NCT00616642|19487220|P2|Overall Study|Withdrawal by Subject|1
5642569|NCT00616642|19487221|P1|Overall Study|Withdrawal by Subject|0
5642570|NCT00616629|19487232|P5|Overall Study|AV-block|0
5642571|NCT00616629|19487233|P4|Overall Study|AV-block|0
5642572|NCT00616629|19487234|P3|Overall Study|AV-block|0
5642573|NCT00616629|19487235|P2|Overall Study|AV-block|0
5642574|NCT00616629|19487236|P1|Overall Study|AV-block|1
5642575|NCT00616629|19487232|P5|Overall Study|Protocol Violation|0
5642576|NCT00616629|19487233|P4|Overall Study|Protocol Violation|0
5642577|NCT00616629|19487234|P3|Overall Study|Protocol Violation|1
5642578|NCT00616629|19487235|P2|Overall Study|Protocol Violation|2
5642579|NCT00616629|19487236|P1|Overall Study|Protocol Violation|1
5642580|NCT00616603|19487281|P3|Overall Study|Physician Decision|2
5642581|NCT00616603|19487282|P2|Overall Study|Physician Decision|0
5642582|NCT00616603|19487283|P1|Overall Study|Physician Decision|2
5642583|NCT00616434|19487306|P2|Overall Study|Protocol deviation|1
5642584|NCT00616434|19487307|P1|Overall Study|Protocol deviation|0
5642585|NCT00616434|19487306|P2|Overall Study|Withdrawal by Subject|1
5642586|NCT00616434|19487307|P1|Overall Study|Withdrawal by Subject|1
5642587|NCT00616434|19487306|P2|Overall Study|Physician Decision|4
5642588|NCT00616434|19487307|P1|Overall Study|Physician Decision|0
5642589|NCT00616434|19487306|P2|Overall Study|Adverse Event|2
5642590|NCT00616434|19487307|P1|Overall Study|Adverse Event|5
5642591|NCT00616421|19487320|P3|Overall Study|Unable to classify|0
5642592|NCT00616421|19487321|P2|Overall Study|Unable to classify|0
5642593|NCT00616421|19487322|P1|Overall Study|Unable to classify|1
5642594|NCT00616421|19487320|P3|Overall Study|Protocol Violation|2
5642595|NCT00616421|19487321|P2|Overall Study|Protocol Violation|1
5642596|NCT00616421|19487322|P1|Overall Study|Protocol Violation|0
5642597|NCT00616421|19487320|P3|Overall Study|Administrative reason|0
5642598|NCT00616421|19487321|P2|Overall Study|Administrative reason|0
5642599|NCT00616421|19487322|P1|Overall Study|Administrative reason|1
5642600|NCT00616421|19487320|P3|Overall Study|Inappropriate enrollment|1
5642601|NCT00616421|19487321|P2|Overall Study|Inappropriate enrollment|0
5642602|NCT00616421|19487322|P1|Overall Study|Inappropriate enrollment|3
5642603|NCT00616421|19487320|P3|Overall Study|Lost to Follow-up|30
5642604|NCT00616421|19487321|P2|Overall Study|Lost to Follow-up|26
5642605|NCT00616421|19487322|P1|Overall Study|Lost to Follow-up|12
5642606|NCT00616421|19487320|P3|Overall Study|Withdrawal by Subject|8
5642607|NCT00616421|19487321|P2|Overall Study|Withdrawal by Subject|11
5642608|NCT00616421|19487322|P1|Overall Study|Withdrawal by Subject|9
5642609|NCT00616239|19487363|P1|Overall Study|Withdrawal by Subject|2
5642610|NCT00616018|19487393|P1|Overall Study|Protocol Violation|3
5642611|NCT00615992|19487398|P1|Overall Study|Protocol Violation|67
5642612|NCT00615914|19487424|P1|Overall Study|Irregularly enrolled patients|10
5642613|NCT00615914|19487424|P1|Overall Study|No treatment|2
5642614|NCT00615914|19487424|P1|Overall Study|No data was collected.|65
5642615|NCT00615914|19487424|P1|Overall Study|Physician Decision|4
5642616|NCT00615914|19487424|P1|Overall Study|Withdrawal by Subject|16
5642617|NCT00615914|19487424|P1|Overall Study|Lost to Follow-up|187
5642618|NCT00615914|19487424|P1|Overall Study|Lack of Efficacy|59
5642619|NCT00615914|19487424|P1|Overall Study|Death|20
5642620|NCT00615914|19487424|P1|Overall Study|Adverse Event|274
5642621|NCT00615901|19487431|P1|Overall Study|Adverse Event|7
5642622|NCT00615901|19487431|P1|Overall Study|Withdrawal by Subject|2
5642623|NCT00615836|19487439|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
5642624|NCT00615836|19487440|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
5642625|NCT00615836|19487441|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
5642626|NCT00615836|19487442|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
5642627|NCT00615836|19487443|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
5642628|NCT00615836|19487439|P5|Extension Study (FE992026 CS31)|Not reported|0
5642629|NCT00615836|19487440|P4|Extension Study (FE992026 CS31)|Not reported|4
5642630|NCT00615836|19487441|P3|Extension Study (FE992026 CS31)|Not reported|1
5642631|NCT00615836|19487442|P2|Extension Study (FE992026 CS31)|Not reported|4
5642632|NCT00615836|19487443|P1|Extension Study (FE992026 CS31)|Not reported|6
5642633|NCT00615836|19487439|P5|Extension Study (FE992026 CS31)|Other|0
5642634|NCT00615836|19487440|P4|Extension Study (FE992026 CS31)|Other|8
5642635|NCT00615836|19487441|P3|Extension Study (FE992026 CS31)|Other|8
5642636|NCT00615836|19487442|P2|Extension Study (FE992026 CS31)|Other|7
5642637|NCT00615836|19487443|P1|Extension Study (FE992026 CS31)|Other|10
5642638|NCT00615836|19487439|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
5642639|NCT00615836|19487440|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
5642640|NCT00615836|19487441|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
5642641|NCT00615836|19487442|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
5642642|NCT00615836|19487443|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
5642643|NCT00615836|19487439|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
5642644|NCT00615836|19487440|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
5642645|NCT00615836|19487441|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
5642646|NCT00615836|19487442|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
5642647|NCT00615836|19487443|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
5642648|NCT00615836|19487439|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
5642649|NCT00615836|19487440|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
5642650|NCT00615836|19487441|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
5642651|NCT00615836|19487442|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
5642652|NCT00615836|19487443|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
5642653|NCT00615836|19487439|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
5642654|NCT00615836|19487440|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
5642655|NCT00615836|19487441|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
5642656|NCT00615836|19487442|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
5642657|NCT00615836|19487443|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
5642658|NCT00615836|19487439|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
5642659|NCT00615836|19487440|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
5642660|NCT00615836|19487441|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
5642661|NCT00615836|19487442|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
5642662|NCT00615836|19487443|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
5642663|NCT00615836|19487439|P5|Extension Study (FE992026 CS31)|Adverse Event|0
5642664|NCT00615836|19487440|P4|Extension Study (FE992026 CS31)|Adverse Event|13
5642665|NCT00615836|19487441|P3|Extension Study (FE992026 CS31)|Adverse Event|15
5642666|NCT00615836|19487442|P2|Extension Study (FE992026 CS31)|Adverse Event|12
5642667|NCT00615836|19487443|P1|Extension Study (FE992026 CS31)|Adverse Event|7
5642668|NCT00615719|19487508|P1|Overall Study|Physician Decision|5
5642669|NCT00615550|19487522|P2|Overall Study|Lost to Follow-up|1
5642670|NCT00615550|19487523|P1|Overall Study|Lost to Follow-up|6
5642671|NCT00615459|19487546|P4|Period III|Unsatisfactory therapeutic effect|0
5642672|NCT00615459|19487547|P3|Period III|Unsatisfactory therapeutic effect|0
5642673|NCT00615459|19487548|P2|Period III|Unsatisfactory therapeutic effect|1
5642674|NCT00615459|19487549|P1|Period III|Unsatisfactory therapeutic effect|0
5642675|NCT00615459|19487546|P4|Period III|Administrative problems|0
5642676|NCT00615459|19487547|P3|Period III|Administrative problems|1
5642677|NCT00615459|19487548|P2|Period III|Administrative problems|1
5642678|NCT00615459|19487549|P1|Period III|Administrative problems|0
5642679|NCT00615459|19487546|P4|Period III|Adverse Event|0
5642680|NCT00615459|19487547|P3|Period III|Adverse Event|0
5642681|NCT00615459|19487548|P2|Period III|Adverse Event|1
5642682|NCT00615459|19487549|P1|Period III|Adverse Event|0
5642683|NCT00615459|19487546|P4|Period II|Lost to Follow-up|1
5642684|NCT00615459|19487547|P3|Period II|Lost to Follow-up|0
5642685|NCT00615459|19487548|P2|Period II|Lost to Follow-up|0
5642686|NCT00615459|19487549|P1|Period II|Lost to Follow-up|0
5642687|NCT00615459|19487546|P4|Period II|Adverse Event|0
5642688|NCT00615459|19487547|P3|Period II|Adverse Event|0
5642689|NCT00615459|19487548|P2|Period II|Adverse Event|0
5642690|NCT00615459|19487549|P1|Period II|Adverse Event|1
5642691|NCT00615459|19487546|P4|Period I|Abnormal test procedure results|0
5642692|NCT00615459|19487547|P3|Period I|Abnormal test procedure results|1
5642693|NCT00615459|19487548|P2|Period I|Abnormal test procedure results|1
5642694|NCT00615459|19487549|P1|Period I|Abnormal test procedure results|1
5642695|NCT00615459|19487546|P4|Period I|Subject withdrew consent|1
5642696|NCT00615459|19487547|P3|Period I|Subject withdrew consent|0
5642697|NCT00615459|19487548|P2|Period I|Subject withdrew consent|0
5642698|NCT00615459|19487549|P1|Period I|Subject withdrew consent|1
5642699|NCT00615459|19487546|P4|Period I|Adverse Event|0
5642700|NCT00615459|19487547|P3|Period I|Adverse Event|1
5642701|NCT00615459|19487548|P2|Period I|Adverse Event|0
5642702|NCT00615459|19487549|P1|Period I|Adverse Event|2
5642703|NCT00615290|19487595|P1|Overall Study|Other|2
5642704|NCT00615290|19487595|P1|Overall Study|Withdrawal by Subject|1
5642705|NCT00615290|19487595|P1|Overall Study|Lost to Follow-up|3
5642706|NCT00615290|19487595|P1|Overall Study|Adverse Event|2
5642707|NCT00615264|19487609|P2|Overall Study|Dermal Hypersensitivity|3
5642708|NCT00615264|19487610|P1|Overall Study|Dermal Hypersensitivity|0
5642709|NCT00615264|19487609|P2|Overall Study|Not defined|4
5642710|NCT00615264|19487610|P1|Overall Study|Not defined|7
5642711|NCT00615264|19487609|P2|Overall Study|Protocol Violation|7
5642712|NCT00615264|19487610|P1|Overall Study|Protocol Violation|11
5642713|NCT00615264|19487609|P2|Overall Study|Death|1
5642714|NCT00615264|19487610|P1|Overall Study|Death|1
5642715|NCT00615264|19487609|P2|Overall Study|Adverse Event|5
5642716|NCT00615264|19487610|P1|Overall Study|Adverse Event|8
5642717|NCT00615264|19487609|P2|Overall Study|Lost to Follow-up|13
5642718|NCT00615264|19487610|P1|Overall Study|Lost to Follow-up|6
5642719|NCT00615264|19487609|P2|Overall Study|Withdrawal by Subject|19
5642720|NCT00615264|19487610|P1|Overall Study|Withdrawal by Subject|17
5642721|NCT00615199|19487622|P4|Overall Study|Withdrawal by Subject|0
5642722|NCT00615199|19487623|P3|Overall Study|Withdrawal by Subject|0
5642723|NCT00615199|19487624|P2|Overall Study|Withdrawal by Subject|1
5642724|NCT00615199|19487625|P1|Overall Study|Withdrawal by Subject|2
5642725|NCT00615199|19487622|P4|Overall Study|Other|1
5642726|NCT00615199|19487623|P3|Overall Study|Other|0
5642727|NCT00615199|19487624|P2|Overall Study|Other|0
5642728|NCT00615199|19487625|P1|Overall Study|Other|0
5642729|NCT00615199|19487622|P4|Overall Study|Lost to Follow-up|0
5642730|NCT00615199|19487623|P3|Overall Study|Lost to Follow-up|0
5642731|NCT00615199|19487624|P2|Overall Study|Lost to Follow-up|0
5642732|NCT00615199|19487625|P1|Overall Study|Lost to Follow-up|1
5642733|NCT00615199|19487622|P4|Overall Study|Lack of Efficacy|1
5642734|NCT00615199|19487623|P3|Overall Study|Lack of Efficacy|0
5642735|NCT00615199|19487624|P2|Overall Study|Lack of Efficacy|0
5642736|NCT00615199|19487625|P1|Overall Study|Lack of Efficacy|2
5642737|NCT00615199|19487622|P4|Overall Study|Adverse Event|0
5642738|NCT00615199|19487623|P3|Overall Study|Adverse Event|1
5642739|NCT00615199|19487624|P2|Overall Study|Adverse Event|1
5642740|NCT00615199|19487625|P1|Overall Study|Adverse Event|3
5642741|NCT00615108|19487659|P1|Overall Study|Lost to Follow-up|15
5642742|NCT00615108|19487659|P1|Overall Study|Other|370
5642743|NCT00615108|19487659|P1|Overall Study|Adverse Event|122
5642744|NCT00615069|19487674|P1|Overall Study|Withdrawal by Subject|4
5642745|NCT00615069|19487674|P1|Overall Study|Physician Decision|2
5642746|NCT00615069|19487674|P1|Overall Study|Death|10
5642747|NCT00615056|19487683|P4|Overall Study|Randomized but not treated|0
5642748|NCT00615056|19487684|P3|Overall Study|Randomized but not treated|0
5642749|NCT00615056|19487685|P2|Overall Study|Randomized but not treated|0
5642750|NCT00615056|19487686|P1|Overall Study|Randomized but not treated|3
5642751|NCT00615056|19487683|P4|Overall Study|Discontinued by Sponsor|0
5642752|NCT00615056|19487684|P3|Overall Study|Discontinued by Sponsor|0
5642753|NCT00615056|19487685|P2|Overall Study|Discontinued by Sponsor|0
5642754|NCT00615056|19487686|P1|Overall Study|Discontinued by Sponsor|1
5642755|NCT00615056|19487683|P4|Overall Study|Withdrawal by Subject|0
5642756|NCT00615056|19487684|P3|Overall Study|Withdrawal by Subject|1
5642757|NCT00615056|19487685|P2|Overall Study|Withdrawal by Subject|1
5642758|NCT00615056|19487686|P1|Overall Study|Withdrawal by Subject|0
5642759|NCT00615056|19487683|P4|Overall Study|Objective progression or relapse|0
5642760|NCT00615056|19487684|P3|Overall Study|Objective progression or relapse|0
5642761|NCT00615056|19487685|P2|Overall Study|Objective progression or relapse|2
5642762|NCT00615056|19487686|P1|Overall Study|Objective progression or relapse|0
5642763|NCT00615056|19487683|P4|Overall Study|Other|7
5642764|NCT00615056|19487684|P3|Overall Study|Other|10
5642765|NCT00615056|19487685|P2|Overall Study|Other|15
5642766|NCT00615056|19487686|P1|Overall Study|Other|13
5642767|NCT00615056|19487683|P4|Overall Study|Lost to Follow-up|5
5642768|NCT00615056|19487684|P3|Overall Study|Lost to Follow-up|4
5642769|NCT00615056|19487685|P2|Overall Study|Lost to Follow-up|2
5642770|NCT00615056|19487686|P1|Overall Study|Lost to Follow-up|1
5642771|NCT00615056|19487683|P4|Overall Study|Death|23
5642772|NCT00615056|19487684|P3|Overall Study|Death|21
5642773|NCT00615056|19487685|P2|Overall Study|Death|31
5642774|NCT00615056|19487686|P1|Overall Study|Death|31
5642775|NCT00615030|19487716|P12|Period III|Administrative problems|0
5642776|NCT00615030|19487717|P11|Period III|Administrative problems|0
5642777|NCT00615030|19487718|P10|Period III|Administrative problems|0
5642778|NCT00615030|19487719|P9|Period III|Administrative problems|0
5642779|NCT00615030|19487720|P8|Period III|Administrative problems|0
5642780|NCT00615030|19487721|P7|Period III|Administrative problems|0
5642781|NCT00615030|19487722|P6|Period III|Administrative problems|0
5642782|NCT00615030|19487723|P5|Period III|Administrative problems|0
5642783|NCT00615030|19487724|P4|Period III|Administrative problems|1
5642784|NCT00615030|19487725|P3|Period III|Administrative problems|0
5642785|NCT00615030|19487726|P2|Period III|Administrative problems|0
5642786|NCT00615030|19487727|P1|Period III|Administrative problems|1
5642787|NCT00615030|19487716|P12|Period II|Subject withdrew consent|0
5642788|NCT00615030|19487717|P11|Period II|Subject withdrew consent|0
5642789|NCT00615030|19487718|P10|Period II|Subject withdrew consent|0
5642790|NCT00615030|19487719|P9|Period II|Subject withdrew consent|0
5642791|NCT00615030|19487720|P8|Period II|Subject withdrew consent|0
5642792|NCT00615030|19487721|P7|Period II|Subject withdrew consent|1
5642793|NCT00615030|19487722|P6|Period II|Subject withdrew consent|0
5642794|NCT00615030|19487723|P5|Period II|Subject withdrew consent|0
5642795|NCT00615030|19487724|P4|Period II|Subject withdrew consent|1
5642796|NCT00615030|19487725|P3|Period II|Subject withdrew consent|0
5642797|NCT00615030|19487726|P2|Period II|Subject withdrew consent|0
5642798|NCT00615030|19487727|P1|Period II|Subject withdrew consent|0
5642799|NCT00615030|19487716|P12|Period II|Adverse Event|0
5642800|NCT00615030|19487717|P11|Period II|Adverse Event|0
5642801|NCT00615030|19487718|P10|Period II|Adverse Event|0
5642802|NCT00615030|19487719|P9|Period II|Adverse Event|1
5642803|NCT00615030|19487720|P8|Period II|Adverse Event|0
5642804|NCT00615030|19487721|P7|Period II|Adverse Event|0
5642805|NCT00615030|19487722|P6|Period II|Adverse Event|0
5642806|NCT00615030|19487723|P5|Period II|Adverse Event|0
5642807|NCT00615030|19487724|P4|Period II|Adverse Event|0
5642808|NCT00615030|19487725|P3|Period II|Adverse Event|1
5642809|NCT00615030|19487726|P2|Period II|Adverse Event|0
5642810|NCT00615030|19487727|P1|Period II|Adverse Event|0
5642811|NCT00615030|19487716|P12|Period I|Abnormal laboratory value(s)|0
5642812|NCT00615030|19487717|P11|Period I|Abnormal laboratory value(s)|0
5642813|NCT00615030|19487718|P10|Period I|Abnormal laboratory value(s)|0
5642814|NCT00615030|19487719|P9|Period I|Abnormal laboratory value(s)|0
5642815|NCT00615030|19487720|P8|Period I|Abnormal laboratory value(s)|0
5642816|NCT00615030|19487721|P7|Period I|Abnormal laboratory value(s)|0
5642817|NCT00615030|19487722|P6|Period I|Abnormal laboratory value(s)|1
5642818|NCT00615030|19487723|P5|Period I|Abnormal laboratory value(s)|0
5642819|NCT00615030|19487724|P4|Period I|Abnormal laboratory value(s)|0
5642820|NCT00615030|19487725|P3|Period I|Abnormal laboratory value(s)|0
5642821|NCT00615030|19487726|P2|Period I|Abnormal laboratory value(s)|0
5642822|NCT00615030|19487727|P1|Period I|Abnormal laboratory value(s)|0
5642823|NCT00615030|19487716|P12|Period I|Subject withdrew consent|1
5642824|NCT00615030|19487717|P11|Period I|Subject withdrew consent|1
5642825|NCT00615030|19487718|P10|Period I|Subject withdrew consent|0
5642826|NCT00615030|19487719|P9|Period I|Subject withdrew consent|1
5642827|NCT00615030|19487720|P8|Period I|Subject withdrew consent|0
5642828|NCT00615030|19487721|P7|Period I|Subject withdrew consent|0
5642829|NCT00615030|19487722|P6|Period I|Subject withdrew consent|0
5642830|NCT00615030|19487723|P5|Period I|Subject withdrew consent|0
5642831|NCT00615030|19487724|P4|Period I|Subject withdrew consent|0
5642832|NCT00615030|19487725|P3|Period I|Subject withdrew consent|0
5642833|NCT00615030|19487726|P2|Period I|Subject withdrew consent|0
5642834|NCT00615030|19487727|P1|Period I|Subject withdrew consent|0
5642835|NCT00615030|19487716|P12|Period I|Protocol deviation|0
5642836|NCT00615030|19487717|P11|Period I|Protocol deviation|0
5642837|NCT00615030|19487718|P10|Period I|Protocol deviation|0
5642838|NCT00615030|19487719|P9|Period I|Protocol deviation|0
5642839|NCT00615030|19487720|P8|Period I|Protocol deviation|0
5642840|NCT00615030|19487721|P7|Period I|Protocol deviation|0
5642841|NCT00615030|19487722|P6|Period I|Protocol deviation|0
5642842|NCT00615030|19487723|P5|Period I|Protocol deviation|0
5642843|NCT00615030|19487724|P4|Period I|Protocol deviation|0
5642844|NCT00615030|19487725|P3|Period I|Protocol deviation|0
5642845|NCT00615030|19487726|P2|Period I|Protocol deviation|0
5642846|NCT00615030|19487727|P1|Period I|Protocol deviation|1
5642847|NCT00615030|19487716|P12|Period I|Administrative problem|0
5642848|NCT00615030|19487717|P11|Period I|Administrative problem|0
5642849|NCT00615030|19487718|P10|Period I|Administrative problem|0
5642850|NCT00615030|19487719|P9|Period I|Administrative problem|0
5642851|NCT00615030|19487720|P8|Period I|Administrative problem|0
5642852|NCT00615030|19487721|P7|Period I|Administrative problem|0
5642853|NCT00615030|19487722|P6|Period I|Administrative problem|0
5642854|NCT00615030|19487723|P5|Period I|Administrative problem|1
5642855|NCT00615030|19487724|P4|Period I|Administrative problem|0
5642856|NCT00615030|19487725|P3|Period I|Administrative problem|0
5642857|NCT00615030|19487726|P2|Period I|Administrative problem|0
5642858|NCT00615030|19487727|P1|Period I|Administrative problem|0
5642859|NCT00615017|19487747|P6|Overall Study|Physician discontinued drug|1
5642860|NCT00615017|19487748|P5|Overall Study|Physician discontinued drug|0
5642861|NCT00615017|19487749|P4|Overall Study|Physician discontinued drug|0
5642862|NCT00615017|19487750|P3|Overall Study|Physician discontinued drug|0
5642863|NCT00615017|19487751|P2|Overall Study|Physician discontinued drug|0
5642864|NCT00615017|19487752|P1|Overall Study|Physician discontinued drug|0
5642865|NCT00615017|19487747|P6|Overall Study|Transferred out of Intensive Care Unit|0
5642866|NCT00615017|19487748|P5|Overall Study|Transferred out of Intensive Care Unit|0
5642867|NCT00615017|19487749|P4|Overall Study|Transferred out of Intensive Care Unit|1
5642868|NCT00615017|19487750|P3|Overall Study|Transferred out of Intensive Care Unit|0
5642869|NCT00615017|19487751|P2|Overall Study|Transferred out of Intensive Care Unit|0
5642870|NCT00615017|19487752|P1|Overall Study|Transferred out of Intensive Care Unit|0
5642871|NCT00615017|19487747|P6|Overall Study|Sepsis resolved|0
5642872|NCT00615017|19487748|P5|Overall Study|Sepsis resolved|0
5642873|NCT00615017|19487749|P4|Overall Study|Sepsis resolved|0
5642874|NCT00615017|19487750|P3|Overall Study|Sepsis resolved|1
5642875|NCT00615017|19487751|P2|Overall Study|Sepsis resolved|0
5642876|NCT00615017|19487752|P1|Overall Study|Sepsis resolved|0
5642877|NCT00615017|19487747|P6|Overall Study|Death|1
5642878|NCT00615017|19487748|P5|Overall Study|Death|1
5642879|NCT00615017|19487749|P4|Overall Study|Death|0
5642880|NCT00615017|19487750|P3|Overall Study|Death|2
5642881|NCT00615017|19487751|P2|Overall Study|Death|0
5642882|NCT00615017|19487752|P1|Overall Study|Death|0
5642883|NCT00615017|19487747|P6|Overall Study|Adverse Event|1
5642884|NCT00615017|19487748|P5|Overall Study|Adverse Event|0
5642885|NCT00615017|19487749|P4|Overall Study|Adverse Event|0
5642886|NCT00615017|19487750|P3|Overall Study|Adverse Event|2
5642887|NCT00615017|19487751|P2|Overall Study|Adverse Event|1
5642888|NCT00615017|19487752|P1|Overall Study|Adverse Event|0
5642889|NCT00614991|19487910|P6|Overall Study|Adverse Event|0
5642890|NCT00614991|19487911|P5|Overall Study|Adverse Event|1
5642891|NCT00614991|19487912|P4|Overall Study|Adverse Event|0
5642892|NCT00614991|19487913|P3|Overall Study|Adverse Event|0
5642893|NCT00614991|19487914|P2|Overall Study|Adverse Event|3
5642894|NCT00614991|19487915|P1|Overall Study|Adverse Event|3
5642895|NCT00614939|19487949|P2|Overall Study|Hospitalized due to kidney transplant|0
5642896|NCT00614939|19487950|P1|Overall Study|Hospitalized due to kidney transplant|1
5642897|NCT00614939|19487949|P2|Overall Study|Poor/non-compliance|0
5642898|NCT00614939|19487950|P1|Overall Study|Poor/non-compliance|4
5642899|NCT00614939|19487949|P2|Overall Study|Death|3
5642900|NCT00614939|19487950|P1|Overall Study|Death|4
5642901|NCT00614939|19487949|P2|Overall Study|Incorrect enrollment|2
5642902|NCT00614939|19487950|P1|Overall Study|Incorrect enrollment|1
5642903|NCT00614939|19487949|P2|Overall Study|Adverse Event|5
5642904|NCT00614939|19487950|P1|Overall Study|Adverse Event|2
5642905|NCT00614939|19487949|P2|Overall Study|Study specific discontinuation criteris|16
5642906|NCT00614939|19487950|P1|Overall Study|Study specific discontinuation criteris|13
5642907|NCT00614939|19487949|P2|Overall Study|Withdrawal by Subject|17
5642908|NCT00614939|19487950|P1|Overall Study|Withdrawal by Subject|10
5642909|NCT00614926|19487984|P2|Overall Study|Adverse Event|0
5642910|NCT00614926|19487985|P1|Overall Study|Adverse Event|3
5642911|NCT00614926|19487984|P2|Overall Study|Burden of travel|0
5642912|NCT00614926|19487985|P1|Overall Study|Burden of travel|1
5642913|NCT00614874|19487998|P1|Overall Study|Withdrawal by Subject|1
5642914|NCT00614874|19487998|P1|Overall Study|Protocol Violation|1
5642915|NCT00614822|19488005|P1|Overall Study|Adverse Event|3
5642916|NCT00614744|19488014|P2|Overall Study|Incomplete for Behavior Issues|2
5642917|NCT00614744|19488015|P1|Overall Study|Incomplete for Behavior Issues|0
5642918|NCT00614744|19488014|P2|Overall Study|Lost to Follow-up|4
5642919|NCT00614744|19488015|P1|Overall Study|Lost to Follow-up|5
5642920|NCT00614614|19488041|P5|Booster Vaccination Phase|Other|1
5642921|NCT00614614|19488042|P4|Booster Vaccination Phase|Other|2
5642922|NCT00614614|19488043|P3|Booster Vaccination Phase|Other|3
5642923|NCT00614614|19488044|P2|Booster Vaccination Phase|Other|1
5642924|NCT00614614|19488045|P1|Booster Vaccination Phase|Other|0
5642925|NCT00614614|19488041|P5|Booster Vaccination Phase|Protocol Violation|0
5642926|NCT00614614|19488042|P4|Booster Vaccination Phase|Protocol Violation|3
5642927|NCT00614614|19488043|P3|Booster Vaccination Phase|Protocol Violation|2
5642928|NCT00614614|19488044|P2|Booster Vaccination Phase|Protocol Violation|0
5642929|NCT00614614|19488045|P1|Booster Vaccination Phase|Protocol Violation|0
5642930|NCT00614614|19488041|P5|Booster Vaccination Phase|Lost to Follow-up|8
5642931|NCT00614614|19488042|P4|Booster Vaccination Phase|Lost to Follow-up|10
5642932|NCT00614614|19488043|P3|Booster Vaccination Phase|Lost to Follow-up|17
5642933|NCT00614614|19488044|P2|Booster Vaccination Phase|Lost to Follow-up|5
5642934|NCT00614614|19488045|P1|Booster Vaccination Phase|Lost to Follow-up|0
5642935|NCT00614614|19488041|P5|Booster Vaccination Phase|Withdrawal by Subject|4
5642936|NCT00614614|19488042|P4|Booster Vaccination Phase|Withdrawal by Subject|3
5642937|NCT00614614|19488043|P3|Booster Vaccination Phase|Withdrawal by Subject|4
5642938|NCT00614614|19488044|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5642939|NCT00614614|19488045|P1|Booster Vaccination Phase|Withdrawal by Subject|0
5642940|NCT00614614|19488041|P5|Booster Vaccination Phase|Adverse Event|0
5642941|NCT00614614|19488042|P4|Booster Vaccination Phase|Adverse Event|1
5642942|NCT00614614|19488043|P3|Booster Vaccination Phase|Adverse Event|1
5642943|NCT00614614|19488044|P2|Booster Vaccination Phase|Adverse Event|0
5642944|NCT00614614|19488045|P1|Booster Vaccination Phase|Adverse Event|0
5642945|NCT00614614|19488041|P5|Primary Vaccination Phase|Other|0
5642946|NCT00614614|19488042|P4|Primary Vaccination Phase|Other|0
5642947|NCT00614614|19488043|P3|Primary Vaccination Phase|Other|0
5642948|NCT00614614|19488044|P2|Primary Vaccination Phase|Other|0
5642949|NCT00614614|19488045|P1|Primary Vaccination Phase|Other|4
5642950|NCT00614614|19488041|P5|Primary Vaccination Phase|Protocol Violation|0
5642951|NCT00614614|19488042|P4|Primary Vaccination Phase|Protocol Violation|0
5642952|NCT00614614|19488043|P3|Primary Vaccination Phase|Protocol Violation|0
5642953|NCT00614614|19488044|P2|Primary Vaccination Phase|Protocol Violation|3
5642954|NCT00614614|19488045|P1|Primary Vaccination Phase|Protocol Violation|9
5642955|NCT00614614|19488041|P5|Primary Vaccination Phase|Lost to Follow-up|0
5642956|NCT00614614|19488042|P4|Primary Vaccination Phase|Lost to Follow-up|0
5642957|NCT00614614|19488043|P3|Primary Vaccination Phase|Lost to Follow-up|0
5642958|NCT00614614|19488044|P2|Primary Vaccination Phase|Lost to Follow-up|8
5642959|NCT00614614|19488045|P1|Primary Vaccination Phase|Lost to Follow-up|26
5642960|NCT00614614|19488041|P5|Primary Vaccination Phase|Withdrawal by Subject|0
5642961|NCT00614614|19488042|P4|Primary Vaccination Phase|Withdrawal by Subject|0
5642962|NCT00614614|19488043|P3|Primary Vaccination Phase|Withdrawal by Subject|0
5642963|NCT00614614|19488044|P2|Primary Vaccination Phase|Withdrawal by Subject|6
5642964|NCT00614614|19488045|P1|Primary Vaccination Phase|Withdrawal by Subject|45
5642965|NCT00614614|19488041|P5|Primary Vaccination Phase|Adverse Event|0
5642966|NCT00614614|19488042|P4|Primary Vaccination Phase|Adverse Event|0
5642967|NCT00614614|19488043|P3|Primary Vaccination Phase|Adverse Event|0
5642968|NCT00614614|19488044|P2|Primary Vaccination Phase|Adverse Event|0
5642969|NCT00614614|19488045|P1|Primary Vaccination Phase|Adverse Event|6
5642970|NCT00614575|19488168|P1|Overall Study|No treatment|1
5642971|NCT00614575|19488168|P1|Overall Study|Irregularly enrolled patients|23
5642972|NCT00614575|19488168|P1|Overall Study|No data were collected.|18
5642973|NCT00614575|19488168|P1|Overall Study|Physician Decision|2
5642974|NCT00614575|19488168|P1|Overall Study|Death|3
5642975|NCT00614575|19488168|P1|Overall Study|Withdrawal by Subject|6
5642976|NCT00614575|19488168|P1|Overall Study|Lack of Efficacy|14
5642977|NCT00614575|19488168|P1|Overall Study|Lost to Follow-up|55
5642978|NCT00614575|19488168|P1|Overall Study|Adverse Event|106
5642979|NCT00614523|19488179|P2|Overall Study|Administrative Decision|46
5642980|NCT00614523|19488180|P1|Overall Study|Administrative Decision|23
5642981|NCT00614523|19488179|P2|Overall Study|Disease Progression|8
5642982|NCT00614523|19488180|P1|Overall Study|Disease Progression|0
5642983|NCT00614523|19488179|P2|Overall Study|Ineligibility Determined|2
5642984|NCT00614523|19488180|P1|Overall Study|Ineligibility Determined|1
5642985|NCT00614523|19488179|P2|Overall Study|Other|11
5642986|NCT00614523|19488180|P1|Overall Study|Other|6
5642987|NCT00614523|19488179|P2|Overall Study|Withdrawal by Subject|22
5642988|NCT00614523|19488180|P1|Overall Study|Withdrawal by Subject|12
5642989|NCT00614523|19488179|P2|Overall Study|Protocol Violation|2
5642990|NCT00614523|19488180|P1|Overall Study|Protocol Violation|3
5642991|NCT00614523|19488179|P2|Overall Study|Lost to Follow-up|1
5642992|NCT00614523|19488180|P1|Overall Study|Lost to Follow-up|0
5642993|NCT00614523|19488179|P2|Overall Study|Lack of Efficacy|11
5642994|NCT00614523|19488180|P1|Overall Study|Lack of Efficacy|9
5642995|NCT00614523|19488179|P2|Overall Study|Death|8
5642996|NCT00614523|19488180|P1|Overall Study|Death|5
5642997|NCT00614523|19488179|P2|Overall Study|Adverse Event|20
5642998|NCT00614523|19488180|P1|Overall Study|Adverse Event|4
5642999|NCT00614393|19488245|P5|Overall Study|Not Treated|2
5643000|NCT00614393|19488246|P4|Overall Study|Not Treated|0
5643001|NCT00614393|19488247|P3|Overall Study|Not Treated|0
5643002|NCT00614393|19488248|P2|Overall Study|Not Treated|0
5643003|NCT00614393|19488249|P1|Overall Study|Not Treated|0
5643004|NCT00614393|19488245|P5|Overall Study|Other|2
5643005|NCT00614393|19488246|P4|Overall Study|Other|4
5643006|NCT00614393|19488247|P3|Overall Study|Other|0
5643007|NCT00614393|19488248|P2|Overall Study|Other|0
5643008|NCT00614393|19488249|P1|Overall Study|Other|4
5643009|NCT00614393|19488245|P5|Overall Study|Withdrawal by Subject|13
5643010|NCT00614393|19488246|P4|Overall Study|Withdrawal by Subject|16
5643011|NCT00614393|19488247|P3|Overall Study|Withdrawal by Subject|1
5643012|NCT00614393|19488248|P2|Overall Study|Withdrawal by Subject|1
5643013|NCT00614393|19488249|P1|Overall Study|Withdrawal by Subject|20
5643014|NCT00614393|19488245|P5|Overall Study|Terminated by Sponsor|1
5643015|NCT00614393|19488246|P4|Overall Study|Terminated by Sponsor|0
5643016|NCT00614393|19488247|P3|Overall Study|Terminated by Sponsor|0
5643017|NCT00614393|19488248|P2|Overall Study|Terminated by Sponsor|0
5643018|NCT00614393|19488249|P1|Overall Study|Terminated by Sponsor|0
5643019|NCT00614393|19488245|P5|Overall Study|Protocol Violation|0
5643020|NCT00614393|19488246|P4|Overall Study|Protocol Violation|0
5643021|NCT00614393|19488247|P3|Overall Study|Protocol Violation|0
5643022|NCT00614393|19488248|P2|Overall Study|Protocol Violation|0
5643023|NCT00614393|19488249|P1|Overall Study|Protocol Violation|1
5643024|NCT00614393|19488245|P5|Overall Study|Progressive Disease|130
5643025|NCT00614393|19488246|P4|Overall Study|Progressive Disease|138
5643026|NCT00614393|19488247|P3|Overall Study|Progressive Disease|5
5643027|NCT00614393|19488248|P2|Overall Study|Progressive Disease|5
5643028|NCT00614393|19488249|P1|Overall Study|Progressive Disease|118
5643029|NCT00614393|19488245|P5|Overall Study|Physician Decision|9
5643030|NCT00614393|19488246|P4|Overall Study|Physician Decision|8
5643031|NCT00614393|19488247|P3|Overall Study|Physician Decision|1
5643032|NCT00614393|19488248|P2|Overall Study|Physician Decision|0
5643033|NCT00614393|19488249|P1|Overall Study|Physician Decision|17
5643034|NCT00614393|19488245|P5|Overall Study|Lost to Follow-up|2
5643035|NCT00614393|19488246|P4|Overall Study|Lost to Follow-up|1
5643036|NCT00614393|19488247|P3|Overall Study|Lost to Follow-up|0
5643037|NCT00614393|19488248|P2|Overall Study|Lost to Follow-up|0
5643038|NCT00614393|19488249|P1|Overall Study|Lost to Follow-up|0
5643039|NCT00614393|19488245|P5|Overall Study|Adverse Event|21
5643040|NCT00614393|19488246|P4|Overall Study|Adverse Event|13
5643041|NCT00614393|19488247|P3|Overall Study|Adverse Event|3
5643042|NCT00614393|19488248|P2|Overall Study|Adverse Event|2
5643043|NCT00614393|19488249|P1|Overall Study|Adverse Event|20
5643044|NCT00614380|19488295|P4|Overall Study|Consent withdrawn|0
5643045|NCT00614380|19488296|P3|Overall Study|Consent withdrawn|0
5643046|NCT00614380|19488297|P2|Overall Study|Consent withdrawn|1
5643047|NCT00614380|19488298|P1|Overall Study|Consent withdrawn|3
5643048|NCT00614380|19488295|P4|Overall Study|Non compliant with the protocol|2
5643049|NCT00614380|19488296|P3|Overall Study|Non compliant with the protocol|1
5643050|NCT00614380|19488297|P2|Overall Study|Non compliant with the protocol|2
5643051|NCT00614380|19488298|P1|Overall Study|Non compliant with the protocol|12
5643052|NCT00614380|19488295|P4|Overall Study|Lost to Follow-up|0
5643053|NCT00614380|19488296|P3|Overall Study|Lost to Follow-up|0
5643054|NCT00614380|19488297|P2|Overall Study|Lost to Follow-up|1
5643055|NCT00614380|19488298|P1|Overall Study|Lost to Follow-up|6
5643056|NCT00614380|19488295|P4|Overall Study|Adverse Event|0
5643057|NCT00614380|19488296|P3|Overall Study|Adverse Event|0
5643058|NCT00614380|19488297|P2|Overall Study|Adverse Event|4
5643059|NCT00614380|19488298|P1|Overall Study|Adverse Event|14
5643060|NCT00614120|19488365|P4|Overall Study|Lost to Follow-up|4
5643061|NCT00614120|19488366|P3|Overall Study|Lost to Follow-up|3
5643062|NCT00614120|19488367|P2|Overall Study|Lost to Follow-up|2
5643063|NCT00614120|19488368|P1|Overall Study|Lost to Follow-up|1
5643064|NCT00614120|19488365|P4|Overall Study|Taken inhibition medication eg Prandin|1
5643065|NCT00614120|19488366|P3|Overall Study|Taken inhibition medication eg Prandin|1
5643066|NCT00614120|19488367|P2|Overall Study|Taken inhibition medication eg Prandin|0
5643067|NCT00614120|19488368|P1|Overall Study|Taken inhibition medication eg Prandin|0
5643068|NCT00614120|19488365|P4|Overall Study|Late syphilis, latent|0
5643069|NCT00614120|19488366|P3|Overall Study|Late syphilis, latent|0
5643070|NCT00614120|19488367|P2|Overall Study|Late syphilis, latent|0
5643071|NCT00614120|19488368|P1|Overall Study|Late syphilis, latent|1
5643072|NCT00614120|19488365|P4|Overall Study|Lack of trial product|0
5643073|NCT00614120|19488366|P3|Overall Study|Lack of trial product|2
5643074|NCT00614120|19488367|P2|Overall Study|Lack of trial product|3
5643075|NCT00614120|19488368|P1|Overall Study|Lack of trial product|3
5643076|NCT00614120|19488365|P4|Overall Study|Hypoglycaemia|1
5643077|NCT00614120|19488366|P3|Overall Study|Hypoglycaemia|0
5643078|NCT00614120|19488367|P2|Overall Study|Hypoglycaemia|0
5643079|NCT00614120|19488368|P1|Overall Study|Hypoglycaemia|0
5643080|NCT00614120|19488365|P4|Overall Study|hCG positive (not pregnant)|0
5643081|NCT00614120|19488366|P3|Overall Study|hCG positive (not pregnant)|1
5643082|NCT00614120|19488367|P2|Overall Study|hCG positive (not pregnant)|0
5643083|NCT00614120|19488368|P1|Overall Study|hCG positive (not pregnant)|0
5643084|NCT00614120|19488365|P4|Overall Study|Did not meet trial criteria|1
5643085|NCT00614120|19488366|P3|Overall Study|Did not meet trial criteria|1
5643086|NCT00614120|19488367|P2|Overall Study|Did not meet trial criteria|1
5643087|NCT00614120|19488368|P1|Overall Study|Did not meet trial criteria|0
5643088|NCT00614120|19488365|P4|Overall Study|Withdrawal by Subject|3
5643089|NCT00614120|19488366|P3|Overall Study|Withdrawal by Subject|16
5643090|NCT00614120|19488367|P2|Overall Study|Withdrawal by Subject|10
5643091|NCT00614120|19488368|P1|Overall Study|Withdrawal by Subject|9
5643092|NCT00614120|19488365|P4|Overall Study|Withdrawal criteria|0
5643093|NCT00614120|19488366|P3|Overall Study|Withdrawal criteria|0
5643094|NCT00614120|19488367|P2|Overall Study|Withdrawal criteria|0
5643095|NCT00614120|19488368|P1|Overall Study|Withdrawal criteria|1
5643096|NCT00614120|19488365|P4|Overall Study|Protocol Violation|1
5643097|NCT00614120|19488366|P3|Overall Study|Protocol Violation|3
5643098|NCT00614120|19488367|P2|Overall Study|Protocol Violation|5
5643099|NCT00614120|19488368|P1|Overall Study|Protocol Violation|2
5643100|NCT00614120|19488365|P4|Overall Study|Lack of Efficacy|2
5643101|NCT00614120|19488366|P3|Overall Study|Lack of Efficacy|2
5643102|NCT00614120|19488367|P2|Overall Study|Lack of Efficacy|3
5643103|NCT00614120|19488368|P1|Overall Study|Lack of Efficacy|3
5643104|NCT00614120|19488365|P4|Overall Study|Adverse Event|3
5643105|NCT00614120|19488366|P3|Overall Study|Adverse Event|30
5643106|NCT00614120|19488367|P2|Overall Study|Adverse Event|22
5643107|NCT00614120|19488368|P1|Overall Study|Adverse Event|9
5643108|NCT00614055|19488409|P3|Overall Study|Unclassified|2
5643109|NCT00614055|19488410|P2|Overall Study|Unclassified|4
5643110|NCT00614055|19488411|P1|Overall Study|Unclassified|1
5643111|NCT00614055|19488409|P3|Overall Study|Lack of Efficacy|2
5643112|NCT00614055|19488410|P2|Overall Study|Lack of Efficacy|0
5643113|NCT00614055|19488411|P1|Overall Study|Lack of Efficacy|0
5643114|NCT00614055|19488409|P3|Overall Study|Protocol Violation|1
5643115|NCT00614055|19488410|P2|Overall Study|Protocol Violation|2
5643116|NCT00614055|19488411|P1|Overall Study|Protocol Violation|2
5643117|NCT00614055|19488409|P3|Overall Study|Adverse Event|0
5643118|NCT00614055|19488410|P2|Overall Study|Adverse Event|0
5643119|NCT00614055|19488411|P1|Overall Study|Adverse Event|1
5643120|NCT00613951|19488458|P3|Overall Study|Unclassified|2
5643121|NCT00613951|19488459|P2|Overall Study|Unclassified|3
5643122|NCT00613951|19488460|P1|Overall Study|Unclassified|5
5643123|NCT00613951|19488458|P3|Overall Study|Protocol Violation|1
5643124|NCT00613951|19488459|P2|Overall Study|Protocol Violation|1
5643125|NCT00613951|19488460|P1|Overall Study|Protocol Violation|1
5643126|NCT00613951|19488458|P3|Overall Study|Lack of Efficacy|1
5643127|NCT00613951|19488459|P2|Overall Study|Lack of Efficacy|1
5643128|NCT00613951|19488460|P1|Overall Study|Lack of Efficacy|0
5643129|NCT00613951|19488458|P3|Overall Study|Adverse Event|1
5643130|NCT00613951|19488459|P2|Overall Study|Adverse Event|0
5643131|NCT00613951|19488460|P1|Overall Study|Adverse Event|1
5643132|NCT00613938|19488505|P4|Overall Study|Other|3
5643133|NCT00613938|19488506|P3|Overall Study|Other|1
5643134|NCT00613938|19488507|P2|Overall Study|Other|2
5643135|NCT00613938|19488508|P1|Overall Study|Other|1
5643136|NCT00613938|19488505|P4|Overall Study|Lack of Efficacy|9
5643137|NCT00613938|19488506|P3|Overall Study|Lack of Efficacy|5
5643138|NCT00613938|19488507|P2|Overall Study|Lack of Efficacy|18
5643139|NCT00613938|19488508|P1|Overall Study|Lack of Efficacy|16
5643140|NCT00613938|19488505|P4|Overall Study|Adverse Event|5
5643141|NCT00613938|19488506|P3|Overall Study|Adverse Event|8
5643142|NCT00613938|19488507|P2|Overall Study|Adverse Event|4
5643143|NCT00613938|19488508|P1|Overall Study|Adverse Event|1
5643144|NCT00613938|19488505|P4|Overall Study|Withdrawal by Subject|9
5643145|NCT00613938|19488506|P3|Overall Study|Withdrawal by Subject|9
5643146|NCT00613938|19488507|P2|Overall Study|Withdrawal by Subject|4
5643147|NCT00613938|19488508|P1|Overall Study|Withdrawal by Subject|2
5643148|NCT00613925|19488540|P2|Overall Study|1 did not tolerate outpatient biopsy|1
5643149|NCT00613925|19488541|P1|Overall Study|1 did not tolerate outpatient biopsy|0
5643150|NCT00613834|19488551|P2|Overall Study|Withdrawal by Subject|3
5643151|NCT00613834|19488552|P1|Overall Study|Withdrawal by Subject|0
5643152|NCT00613821|19488564|P2|Overall Study|Physician Decision|1
5643153|NCT00613821|19488565|P1|Overall Study|Physician Decision|1
5643154|NCT00613821|19488564|P2|Overall Study|Withdrawal by Subject|0
5643155|NCT00613821|19488565|P1|Overall Study|Withdrawal by Subject|1
5643156|NCT00613730|19488571|P1|Overall Study|Administrative decision|1
5643157|NCT00613730|19488571|P1|Overall Study|Disease progression|2
5643158|NCT00613626|19488580|P3|Overall Study|Ineligible|0
5643159|NCT00613626|19488581|P2|Overall Study|Ineligible|1
5643160|NCT00613626|19488582|P1|Overall Study|Ineligible|0
5643161|NCT00613574|19488598|P1|Overall Study|Other|1
5643162|NCT00613574|19488598|P1|Overall Study|Lost to Follow-up|2
5643163|NCT00613574|19488598|P1|Overall Study|Adverse Event|3
5643164|NCT00613509|19488610|P2|Cycle 1|Other administrative reason|1
5643165|NCT00613509|19488611|P1|Cycle 1|Other administrative reason|0
5643166|NCT00613509|19488610|P2|Cycle 1|Unacceptable Toxicity|0
5643167|NCT00613509|19488611|P1|Cycle 1|Unacceptable Toxicity|1
5643168|NCT00613509|19488610|P2|Cycle 1|Disease Progression|6
5643169|NCT00613509|19488611|P1|Cycle 1|Disease Progression|2
5643170|NCT00613509|19488610|P2|Cycle 1|Adverse Event|1
5643171|NCT00613509|19488611|P1|Cycle 1|Adverse Event|2
5643172|NCT00613366|19488657|P2|Overall Study|Withdrawal by Subject|2
5643173|NCT00613366|19488658|P1|Overall Study|Withdrawal by Subject|3
5643174|NCT00613327|19488666|P1|Overall Study|Other|47
5643175|NCT00613327|19488666|P1|Overall Study|Protocol Violation|2
5643176|NCT00613327|19488666|P1|Overall Study|Withdrawal by Subject|6
5643177|NCT00613327|19488666|P1|Overall Study|Lost to Follow-up|8
5643178|NCT00613327|19488666|P1|Overall Study|Adverse Event|38
5643179|NCT00613314|19488685|P1|Overall Study|Other reason not defined above|90
5643180|NCT00613314|19488685|P1|Overall Study|Lost to Follow-up|46
5643181|NCT00613314|19488685|P1|Overall Study|Protocol Violation|14
5643182|NCT00613314|19488685|P1|Overall Study|Adverse Event|5
5643183|NCT00613301|19488693|P1|Overall Study|Irregularly enrolled patients|12
5643184|NCT00613301|19488693|P1|Overall Study|No data was collected|53
5643185|NCT00613301|19488693|P1|Overall Study|Physician Decision|2
5643186|NCT00613301|19488693|P1|Overall Study|Lack of Efficacy|13
5643187|NCT00613301|19488693|P1|Overall Study|Death|6
5643188|NCT00613301|19488693|P1|Overall Study|Withdrawal by Subject|5
5643189|NCT00613301|19488693|P1|Overall Study|Lost to Follow-up|88
5643190|NCT00613301|19488693|P1|Overall Study|Adverse Event|49
5643191|NCT00613106|19488702|P2|Overall Study|misc|3
5643192|NCT00613106|19488703|P1|Overall Study|misc|4
5643193|NCT00613106|19488702|P2|Overall Study|Lost to Follow-up|2
5643194|NCT00613106|19488703|P1|Overall Study|Lost to Follow-up|7
5643195|NCT00613106|19488702|P2|Overall Study|Withdrawal by Subject|3
5643196|NCT00613106|19488703|P1|Overall Study|Withdrawal by Subject|6
5643197|NCT00613106|19488702|P2|Overall Study|Adverse Event|1
5643198|NCT00613106|19488703|P1|Overall Study|Adverse Event|3
5643199|NCT00613080|19488709|P1|Overall Study|Ineligible / no protocol treatment|11
5643200|NCT00613015|19488744|P6|Overall Study|Lost to Follow-up|3
5643201|NCT00613015|19488745|P5|Overall Study|Lost to Follow-up|2
5643202|NCT00613015|19488746|P4|Overall Study|Lost to Follow-up|3
5643203|NCT00613015|19488747|P3|Overall Study|Lost to Follow-up|3
5643204|NCT00613015|19488748|P2|Overall Study|Lost to Follow-up|1
5643205|NCT00613015|19488749|P1|Overall Study|Lost to Follow-up|0
5643206|NCT00612807|19488785|P2|Overall Study|Withdrawal by Subject|0
5643207|NCT00612807|19488786|P1|Overall Study|Withdrawal by Subject|2
5643208|NCT00612690|19488833|P2|Overall Study|Withdrawal by Site|0
5643209|NCT00612690|19488834|P1|Overall Study|Withdrawal by Site|11
5643210|NCT00612690|19488833|P2|Overall Study|Withdrawal by Subject|20
5643211|NCT00612690|19488834|P1|Overall Study|Withdrawal by Subject|32
5643212|NCT00612690|19488833|P2|Overall Study|Lost to Follow-up|98
5643213|NCT00612690|19488834|P1|Overall Study|Lost to Follow-up|72
5643214|NCT00612677|19488842|P1|Overall Study|study closed before treatment started|1
5643215|NCT00612586|19488850|P2|Overall Study|Randomized and Not Treated|1
5643216|NCT00612586|19488851|P1|Overall Study|Randomized and Not Treated|1
5643217|NCT00612586|19488850|P2|Overall Study|Progressive Disease|24
5643218|NCT00612586|19488851|P1|Overall Study|Progressive Disease|26
5643219|NCT00612586|19488850|P2|Overall Study|Sponsor Decision|1
5643220|NCT00612586|19488851|P1|Overall Study|Sponsor Decision|1
5643221|NCT00612586|19488850|P2|Overall Study|Physician Decision|2
5643222|NCT00612586|19488851|P1|Overall Study|Physician Decision|1
5643223|NCT00612586|19488850|P2|Overall Study|Withdrawal by Subject|9
5643224|NCT00612586|19488851|P1|Overall Study|Withdrawal by Subject|7
5643225|NCT00612586|19488850|P2|Overall Study|Entry Criteria Not Met|2
5643226|NCT00612586|19488851|P1|Overall Study|Entry Criteria Not Met|0
5643227|NCT00612586|19488850|P2|Overall Study|Death|0
5643228|NCT00612586|19488851|P1|Overall Study|Death|1
5643229|NCT00612586|19488850|P2|Overall Study|Adverse Event|2
5643230|NCT00612586|19488851|P1|Overall Study|Adverse Event|6
5643231|NCT00612534|19488927|P4|Overall Study|Other Reason|0
5643232|NCT00612534|19488928|P3|Overall Study|Other Reason|0
5643233|NCT00612534|19488929|P2|Overall Study|Other Reason|1
5643234|NCT00612534|19488930|P1|Overall Study|Other Reason|0
5643235|NCT00612534|19488927|P4|Overall Study|Lack of Efficacy|16
5643236|NCT00612534|19488928|P3|Overall Study|Lack of Efficacy|5
5643237|NCT00612534|19488929|P2|Overall Study|Lack of Efficacy|12
5643238|NCT00612534|19488930|P1|Overall Study|Lack of Efficacy|13
5643239|NCT00612534|19488927|P4|Overall Study|Adverse Event|1
5643240|NCT00612534|19488928|P3|Overall Study|Adverse Event|2
5643241|NCT00612534|19488929|P2|Overall Study|Adverse Event|4
5643242|NCT00612534|19488930|P1|Overall Study|Adverse Event|0
5643243|NCT00612508|19488942|P2|Overall Study|Withdrawal by Subject|4
5643244|NCT00612508|19488943|P1|Overall Study|Withdrawal by Subject|3
5643245|NCT00612456|19488954|P3|Overall Study|Withdrawal by Subject|0
5643246|NCT00612456|19488955|P2|Overall Study|Withdrawal by Subject|1
5643247|NCT00612456|19488956|P1|Overall Study|Withdrawal by Subject|0
5643248|NCT00612456|19488954|P3|Overall Study|Lack of Efficacy|0
5643249|NCT00612456|19488955|P2|Overall Study|Lack of Efficacy|1
5643250|NCT00612456|19488956|P1|Overall Study|Lack of Efficacy|1
5643251|NCT00612456|19488954|P3|Overall Study|Adverse Event|0
5643252|NCT00612456|19488955|P2|Overall Study|Adverse Event|0
5643253|NCT00612456|19488956|P1|Overall Study|Adverse Event|1
5643254|NCT00612352|19489019|P2|Overall Study|didn't return calls/show up on test date|1
5643255|NCT00612352|19489020|P1|Overall Study|didn't return calls/show up on test date|4
5643256|NCT00612352|19489019|P2|Overall Study|moved out of state|0
5643257|NCT00612352|19489020|P1|Overall Study|moved out of state|1
5643258|NCT00612352|19489019|P2|Overall Study|Withdrawal by Subject|5
5643259|NCT00612352|19489020|P1|Overall Study|Withdrawal by Subject|3
5643260|NCT00612352|19489019|P2|Overall Study|Adverse Event|0
5643261|NCT00612352|19489020|P1|Overall Study|Adverse Event|1
5643262|NCT00612313|19489140|P2|Overall Study|Lost to Follow-up|4
5643263|NCT00612313|19489141|P1|Overall Study|Lost to Follow-up|11
5643264|NCT00612313|19489140|P2|Overall Study|Withdrawal by Subject|9
5643265|NCT00612313|19489141|P1|Overall Study|Withdrawal by Subject|6
5643266|NCT00612105|19489183|P2|Period Title 3: 3-Week Taper Phase|Other|0
5643267|NCT00612105|19489184|P1|Period Title 3: 3-Week Taper Phase|Other|1
5643268|NCT00612105|19489183|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
5643269|NCT00612105|19489184|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
5643270|NCT00612105|19489183|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
5643271|NCT00612105|19489184|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
5643272|NCT00612105|19489183|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
5643273|NCT00612105|19489184|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
5643274|NCT00612105|19489183|P2|Period Title 1: 6-Week Titration Phase|Other|1
5643275|NCT00612105|19489184|P1|Period Title 1: 6-Week Titration Phase|Other|0
5643276|NCT00612105|19489183|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
5643277|NCT00612105|19489184|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
5643278|NCT00612105|19489183|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
5643279|NCT00612105|19489184|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
5643280|NCT00612105|19489183|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
5643281|NCT00612105|19489184|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
5643282|NCT00612105|19489183|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
5643283|NCT00612105|19489184|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
5643284|NCT00612105|19489183|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
5643285|NCT00612105|19489184|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
5643286|NCT00612105|19489183|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
5643287|NCT00612105|19489184|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
5643288|NCT00612105|19489183|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
5643289|NCT00612105|19489184|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
5643290|NCT00612066|19489234|P1|Overall Study|Adverse Event|1
5643291|NCT00612040|19489241|P3|Overall Study|Unclassified|5
5643292|NCT00612040|19489242|P2|Overall Study|Unclassified|2
5643293|NCT00612040|19489243|P1|Overall Study|Unclassified|2
5643294|NCT00612040|19489241|P3|Overall Study|Lack of Efficacy|0
5643295|NCT00612040|19489242|P2|Overall Study|Lack of Efficacy|1
5643296|NCT00612040|19489243|P1|Overall Study|Lack of Efficacy|2
5643297|NCT00612040|19489241|P3|Overall Study|Protocol Violation|1
5643298|NCT00612040|19489242|P2|Overall Study|Protocol Violation|2
5643299|NCT00612040|19489243|P1|Overall Study|Protocol Violation|1
5643300|NCT00612040|19489241|P3|Overall Study|Adverse Event|1
5643301|NCT00612040|19489242|P2|Overall Study|Adverse Event|2
5643302|NCT00612040|19489243|P1|Overall Study|Adverse Event|0
5643303|NCT00611975|19489289|P2|Overall Study|Pregnancy|1
5643304|NCT00611975|19489290|P1|Overall Study|Pregnancy|2
5643305|NCT00611975|19489289|P2|Overall Study|Withdrawal by Subject|7
5643306|NCT00611975|19489290|P1|Overall Study|Withdrawal by Subject|3
5643307|NCT00611923|19489318|P2|Overall Study|Withdrawal by Subject|2
5643308|NCT00611923|19489319|P1|Overall Study|Withdrawal by Subject|2
5643309|NCT00611884|19489364|P4|Overall Study|Unclassified|3
5643310|NCT00611884|19489365|P3|Overall Study|Unclassified|2
5643311|NCT00611884|19489366|P2|Overall Study|Unclassified|4
5643312|NCT00611884|19489367|P1|Overall Study|Unclassified|7
5643313|NCT00611884|19489364|P4|Overall Study|Lack of Efficacy|0
5643314|NCT00611884|19489365|P3|Overall Study|Lack of Efficacy|0
5643315|NCT00611884|19489366|P2|Overall Study|Lack of Efficacy|1
5643316|NCT00611884|19489367|P1|Overall Study|Lack of Efficacy|0
5643317|NCT00611884|19489364|P4|Overall Study|Non-Compliance|2
5643318|NCT00611884|19489365|P3|Overall Study|Non-Compliance|2
5643319|NCT00611884|19489366|P2|Overall Study|Non-Compliance|4
5643320|NCT00611884|19489367|P1|Overall Study|Non-Compliance|1
5643321|NCT00611884|19489364|P4|Overall Study|Adverse Event|1
5643322|NCT00611884|19489365|P3|Overall Study|Adverse Event|0
5643323|NCT00611884|19489366|P2|Overall Study|Adverse Event|0
5643324|NCT00611884|19489367|P1|Overall Study|Adverse Event|1
5643325|NCT00611858|19489421|P1|Overall Study|Withdrawal by Subject|2
5643326|NCT00611858|19489421|P1|Overall Study|Adverse Event|2
5643327|NCT00611806|19489433|P2|Overall Study|Lost to Follow-up|0
5643328|NCT00611806|19489434|P1|Overall Study|Lost to Follow-up|6
5643329|NCT00611806|19489433|P2|Overall Study|Adverse Event|1
5643330|NCT00611806|19489434|P1|Overall Study|Adverse Event|2
5643331|NCT00611806|19489433|P2|Overall Study|Withdrawal by Subject|2
5643332|NCT00611806|19489434|P1|Overall Study|Withdrawal by Subject|8
5643333|NCT00611767|19489448|P2|Overall Study|Physician Decision|0
5643334|NCT00611767|19489449|P1|Overall Study|Physician Decision|1
5643335|NCT00611767|19489448|P2|Overall Study|didn't like the medication|1
5643336|NCT00611767|19489449|P1|Overall Study|didn't like the medication|1
5643337|NCT00611767|19489448|P2|Overall Study|Thiopental not available|0
5643338|NCT00611767|19489449|P1|Overall Study|Thiopental not available|3
5643339|NCT00611767|19489448|P2|Overall Study|Withdrawal by Subject|1
5643340|NCT00611767|19489449|P1|Overall Study|Withdrawal by Subject|4
5643341|NCT00611715|19489611|P2|Overall Study|two patients are still on treatment|0
5643342|NCT00611715|19489612|P1|Overall Study|two patients are still on treatment|2
5643343|NCT00611715|19489611|P2|Overall Study|Death|0
5643344|NCT00611715|19489612|P1|Overall Study|Death|1
5643345|NCT00611715|19489611|P2|Overall Study|Adverse Event|1
5643346|NCT00611715|19489612|P1|Overall Study|Adverse Event|9
5643347|NCT00611715|19489611|P2|Overall Study|Withdrawal by Subject|1
5643348|NCT00611715|19489612|P1|Overall Study|Withdrawal by Subject|5
5643349|NCT00611715|19489611|P2|Overall Study|Disease Progression|4
5643350|NCT00611715|19489612|P1|Overall Study|Disease Progression|24
5643351|NCT00611559|19489632|P3|Overall Study|Protocol Violation|1
5643352|NCT00611559|19489633|P2|Overall Study|Protocol Violation|0
5643353|NCT00611559|19489634|P1|Overall Study|Protocol Violation|1
5643354|NCT00611559|19489632|P3|Overall Study|Lost to Follow-up|0
5643355|NCT00611559|19489633|P2|Overall Study|Lost to Follow-up|1
5643356|NCT00611559|19489634|P1|Overall Study|Lost to Follow-up|0
5643357|NCT00611533|19489693|P2|Second Intervention (6 Weeks)|Adverse Event|2
5643358|NCT00611533|19489694|P1|Second Intervention (6 Weeks)|Adverse Event|0
5643359|NCT00611533|19489693|P2|First Intervention (6 Weeks)|Adverse Event|1
5643360|NCT00611533|19489694|P1|First Intervention (6 Weeks)|Adverse Event|0
5643361|NCT00611533|19489693|P2|First Intervention (6 Weeks)|Never started study|1
5643362|NCT00611533|19489694|P1|First Intervention (6 Weeks)|Never started study|0
5643363|NCT00611455|19489728|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
5643364|NCT00611455|19489729|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
5643365|NCT00611455|19489730|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
5643366|NCT00611455|19489728|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
5643367|NCT00611455|19489729|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
5643368|NCT00611455|19489730|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
5643369|NCT00611455|19489728|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
5643370|NCT00611455|19489729|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
5643371|NCT00611455|19489730|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
5643372|NCT00611455|19489728|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
5643373|NCT00611455|19489729|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
5643374|NCT00611455|19489730|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
5643375|NCT00611455|19489728|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
5643376|NCT00611455|19489729|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
5643377|NCT00611455|19489730|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
5643378|NCT00611455|19489728|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
5643379|NCT00611455|19489729|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
5643380|NCT00611455|19489730|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
5643381|NCT00611455|19489728|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
5643382|NCT00611455|19489729|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
5643383|NCT00611455|19489730|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
5643384|NCT00611455|19489728|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
5643385|NCT00611455|19489729|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
5643386|NCT00611455|19489730|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
5643387|NCT00611455|19489728|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
5643388|NCT00611455|19489729|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
5643389|NCT00611455|19489730|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
5643390|NCT00611455|19489728|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
5643391|NCT00611455|19489729|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
5643392|NCT00611455|19489730|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
5643393|NCT00611455|19489728|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
5643394|NCT00611455|19489729|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
5643395|NCT00611455|19489730|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
5643396|NCT00611455|19489728|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
5643397|NCT00611455|19489729|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
5643398|NCT00611455|19489730|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
5643399|NCT00611455|19489728|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
5643400|NCT00611455|19489729|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
5643401|NCT00611455|19489730|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
5643402|NCT00611455|19489728|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
5643403|NCT00611455|19489729|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
5643404|NCT00611455|19489730|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
5643405|NCT00611455|19489728|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
5643406|NCT00611455|19489729|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
5643407|NCT00611455|19489730|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
5643408|NCT00611455|19489728|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
5643409|NCT00611455|19489729|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
5643410|NCT00611455|19489730|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
5643411|NCT00611455|19489728|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
5643412|NCT00611455|19489729|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
5643413|NCT00611455|19489730|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
5643414|NCT00611455|19489728|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
5643415|NCT00611455|19489729|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
5643416|NCT00611455|19489730|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
5643417|NCT00611455|19489728|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
5643418|NCT00611455|19489729|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
5643419|NCT00611455|19489730|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
5643420|NCT00611455|19489728|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
5643421|NCT00611455|19489729|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
5643422|NCT00611455|19489730|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
5643423|NCT00611455|19489728|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
5643424|NCT00611455|19489729|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
5643425|NCT00611455|19489730|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
5643426|NCT00611247|19489910|P2|Overall Study|Lack of Efficacy|16
5643427|NCT00611247|19489911|P1|Overall Study|Lack of Efficacy|1
5643428|NCT00611247|19489910|P2|Overall Study|Death|5
5643429|NCT00611247|19489911|P1|Overall Study|Death|1
5643430|NCT00611130|19489923|P2|Overall Study|Death|0
5643431|NCT00611130|19489924|P1|Overall Study|Death|1
5643432|NCT00611130|19489923|P2|Overall Study|Adverse Event|0
5643433|NCT00611130|19489924|P1|Overall Study|Adverse Event|1
5643434|NCT00611130|19489923|P2|Overall Study|Administrative|1
5643435|NCT00611130|19489924|P1|Overall Study|Administrative|1
5643436|NCT00611130|19489923|P2|Overall Study|Incarceration|2
5643437|NCT00611130|19489924|P1|Overall Study|Incarceration|3
5643438|NCT00611130|19489923|P2|Overall Study|Other|4
5643439|NCT00611130|19489924|P1|Overall Study|Other|5
5643440|NCT00611130|19489923|P2|Overall Study|Withdrawal by Subject|5
5643441|NCT00611130|19489924|P1|Overall Study|Withdrawal by Subject|6
5643442|NCT00611130|19489923|P2|Overall Study|Protocol noncompliance|6
5643443|NCT00611130|19489924|P1|Overall Study|Protocol noncompliance|7
5643444|NCT00611130|19489923|P2|Overall Study|Lost to Follow-up|29
5643445|NCT00611130|19489924|P1|Overall Study|Lost to Follow-up|25
5643446|NCT00611026|19489934|P3|Double-blind Treatment Period|Other|18
5643447|NCT00611026|19489935|P2|Double-blind Treatment Period|Other|20
5643448|NCT00611026|19489936|P1|Double-blind Treatment Period|Other|13
5643449|NCT00611026|19489934|P3|Double-blind Treatment Period|Withdrawal by Subject|16
5643450|NCT00611026|19489935|P2|Double-blind Treatment Period|Withdrawal by Subject|19
5643451|NCT00611026|19489936|P1|Double-blind Treatment Period|Withdrawal by Subject|7
5643452|NCT00611026|19489934|P3|Double-blind Treatment Period|Lost to Follow-up|14
5643453|NCT00611026|19489935|P2|Double-blind Treatment Period|Lost to Follow-up|11
5643454|NCT00611026|19489936|P1|Double-blind Treatment Period|Lost to Follow-up|6
5643455|NCT00611026|19489934|P3|Double-blind Treatment Period|Lack of Efficacy|4
5643456|NCT00611026|19489935|P2|Double-blind Treatment Period|Lack of Efficacy|10
5643457|NCT00611026|19489936|P1|Double-blind Treatment Period|Lack of Efficacy|11
5643458|NCT00611026|19489934|P3|Double-blind Treatment Period|Adverse Event|46
5643459|NCT00611026|19489935|P2|Double-blind Treatment Period|Adverse Event|28
5643460|NCT00611026|19489936|P1|Double-blind Treatment Period|Adverse Event|9
5643461|NCT00611026|19489934|P3|Double-blind Treatment Period|Death|0
5643462|NCT00611026|19489935|P2|Double-blind Treatment Period|Death|0
5643463|NCT00611026|19489936|P1|Double-blind Treatment Period|Death|1
5643464|NCT00611026|19489934|P3|Randomized to Double-blind Treatment|Not treated|3
5643465|NCT00611026|19489935|P2|Randomized to Double-blind Treatment|Not treated|1
5643466|NCT00611026|19489936|P1|Randomized to Double-blind Treatment|Not treated|2
5643467|NCT00610857|19490013|P1|Overall Study|Not evaluable for response|2
5643468|NCT00610714|19490057|P2|Overall Study|Study completion at 120 PFS events|2
5643469|NCT00610714|19490058|P1|Overall Study|Study completion at 120 PFS events|2
5643470|NCT00610714|19490057|P2|Overall Study|Withdrawal by Subject|3
5643471|NCT00610714|19490058|P1|Overall Study|Withdrawal by Subject|9
5643472|NCT00610714|19490057|P2|Overall Study|Death|18
5643473|NCT00610714|19490058|P1|Overall Study|Death|12
5643474|NCT00610714|19490057|P2|Overall Study|Adverse Event|1
5643475|NCT00610714|19490058|P1|Overall Study|Adverse Event|3
5643476|NCT00610675|19490096|P1|Overall Study|Other reason (not specified)|25
5643477|NCT00610675|19490096|P1|Overall Study|Lost to Follow-up|31
5643478|NCT00610675|19490096|P1|Overall Study|Lack of Compliance|7
5643479|NCT00610675|19490096|P1|Overall Study|Reasons unrelated to trial|27
5643480|NCT00610675|19490096|P1|Overall Study|Withdrawal by Subject|28
5643481|NCT00610675|19490096|P1|Overall Study|Insufficient Effect|31
5643482|NCT00610675|19490096|P1|Overall Study|Adverse Event|67
5643483|NCT00610675|19490096|P1|Overall Study|Untreated|4
5643484|NCT00610649|19490118|P11|Overall Study|Withdrawal by Subject|0
5643485|NCT00610649|19490119|P10|Overall Study|Withdrawal by Subject|1
5643486|NCT00610649|19490120|P9|Overall Study|Withdrawal by Subject|0
5643487|NCT00610649|19490121|P8|Overall Study|Withdrawal by Subject|0
5643488|NCT00610649|19490122|P7|Overall Study|Withdrawal by Subject|0
5643489|NCT00610649|19490123|P6|Overall Study|Withdrawal by Subject|0
5643490|NCT00610649|19490124|P5|Overall Study|Withdrawal by Subject|0
5643491|NCT00610649|19490125|P4|Overall Study|Withdrawal by Subject|0
5643492|NCT00610649|19490126|P3|Overall Study|Withdrawal by Subject|0
5643493|NCT00610649|19490127|P2|Overall Study|Withdrawal by Subject|0
5643494|NCT00610649|19490128|P1|Overall Study|Withdrawal by Subject|0
5643495|NCT00610649|19490118|P11|Overall Study|Family Emergency|0
5643496|NCT00610649|19490119|P10|Overall Study|Family Emergency|0
5643497|NCT00610649|19490120|P9|Overall Study|Family Emergency|0
5643498|NCT00610649|19490121|P8|Overall Study|Family Emergency|0
5643499|NCT00610649|19490122|P7|Overall Study|Family Emergency|0
5643500|NCT00610649|19490123|P6|Overall Study|Family Emergency|0
5643501|NCT00610649|19490124|P5|Overall Study|Family Emergency|0
5643502|NCT00610649|19490125|P4|Overall Study|Family Emergency|0
5643503|NCT00610649|19490126|P3|Overall Study|Family Emergency|0
5643504|NCT00610649|19490127|P2|Overall Study|Family Emergency|1
5643505|NCT00610649|19490128|P1|Overall Study|Family Emergency|0
5643506|NCT00610649|19490118|P11|Overall Study|Adverse Event|1
5643507|NCT00610649|19490119|P10|Overall Study|Adverse Event|0
5643508|NCT00610649|19490120|P9|Overall Study|Adverse Event|0
5643509|NCT00610649|19490121|P8|Overall Study|Adverse Event|0
5643510|NCT00610649|19490122|P7|Overall Study|Adverse Event|0
5643511|NCT00610649|19490123|P6|Overall Study|Adverse Event|0
5643512|NCT00610649|19490124|P5|Overall Study|Adverse Event|0
5643513|NCT00610649|19490125|P4|Overall Study|Adverse Event|0
5643514|NCT00610649|19490126|P3|Overall Study|Adverse Event|0
5643515|NCT00610649|19490127|P2|Overall Study|Adverse Event|0
5643516|NCT00610649|19490128|P1|Overall Study|Adverse Event|1
5643517|NCT00610441|19490223|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
5643518|NCT00610441|19490224|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
5643519|NCT00610441|19490225|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
5643520|NCT00610441|19490226|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
5643521|NCT00610441|19490223|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
5643522|NCT00610441|19490224|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
5643523|NCT00610441|19490225|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
5643524|NCT00610441|19490226|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
5643525|NCT00610441|19490223|P4|Treatment Period 2 - 3 Weeks|Other|1
5643526|NCT00610441|19490224|P3|Treatment Period 2 - 3 Weeks|Other|0
5643527|NCT00610441|19490225|P2|Treatment Period 2 - 3 Weeks|Other|1
5643528|NCT00610441|19490226|P1|Treatment Period 2 - 3 Weeks|Other|1
5643529|NCT00610441|19490223|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
5643530|NCT00610441|19490224|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
5643531|NCT00610441|19490225|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
5643532|NCT00610441|19490226|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
5643533|NCT00610441|19490223|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
5643534|NCT00610441|19490224|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
5643535|NCT00610441|19490225|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
5643536|NCT00610441|19490226|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
5643537|NCT00610441|19490223|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
5643538|NCT00610441|19490224|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
5643539|NCT00610441|19490225|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
5643540|NCT00610441|19490226|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
5643541|NCT00610441|19490223|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
5643542|NCT00610441|19490224|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
5643543|NCT00610441|19490225|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
5643544|NCT00610441|19490226|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
5643545|NCT00610441|19490223|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
5643546|NCT00610441|19490224|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
5643547|NCT00610441|19490225|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
5643548|NCT00610441|19490226|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
5643549|NCT00610441|19490223|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
5643550|NCT00610441|19490224|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
5643551|NCT00610441|19490225|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
5643552|NCT00610441|19490226|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
5643553|NCT00610363|19490335|P2|Overall Study|Other than specified above|1
5643554|NCT00610363|19490336|P1|Overall Study|Other than specified above|1
5643555|NCT00610363|19490335|P2|Overall Study|Withdrawal by Subject|0
5643556|NCT00610363|19490336|P1|Overall Study|Withdrawal by Subject|1
5643557|NCT00610363|19490335|P2|Overall Study|Lost to Follow-up|0
5643558|NCT00610363|19490336|P1|Overall Study|Lost to Follow-up|4
5643559|NCT00610363|19490335|P2|Overall Study|Lack of Efficacy|0
5643560|NCT00610363|19490336|P1|Overall Study|Lack of Efficacy|2
5643561|NCT00610363|19490335|P2|Overall Study|Adverse Event|1
5643562|NCT00610363|19490336|P1|Overall Study|Adverse Event|3
5643563|NCT00610363|19490335|P2|Overall Study|Non-compliance with protocol|1
5643564|NCT00610363|19490336|P1|Overall Study|Non-compliance with protocol|0
5643565|NCT00610207|19490361|P1|Overall Study|Lost to Follow-up|3
5643566|NCT00610168|19490368|P2|Overall Study|Withdrawal by Subject|0
5643567|NCT00610168|19490369|P1|Overall Study|Withdrawal by Subject|2
5643568|NCT00610155|19490388|P6|Period 3|Adverse Event|0
5643569|NCT00610155|19490389|P5|Period 3|Adverse Event|0
5643570|NCT00610155|19490390|P4|Period 3|Adverse Event|0
5643571|NCT00610155|19490391|P3|Period 3|Adverse Event|0
5643572|NCT00610155|19490392|P2|Period 3|Adverse Event|0
5643573|NCT00610155|19490393|P1|Period 3|Adverse Event|1
5643574|NCT00610155|19490388|P6|Period 1|Withdrawal by Subject|0
5643575|NCT00610155|19490389|P5|Period 1|Withdrawal by Subject|0
5643576|NCT00610155|19490390|P4|Period 1|Withdrawal by Subject|0
5643577|NCT00610155|19490391|P3|Period 1|Withdrawal by Subject|1
5643578|NCT00610155|19490392|P2|Period 1|Withdrawal by Subject|0
5643579|NCT00610155|19490393|P1|Period 1|Withdrawal by Subject|0
5643580|NCT00610129|19490440|P1|Overall Study|Not treated since patients ineligible|3
5643581|NCT00609986|19490446|P2|Overall Study|Did not receive transplant or treatment|3
5643582|NCT00609986|19490447|P1|Overall Study|Did not receive transplant or treatment|8
5643583|NCT00609973|19490461|P2|Overall Study|Withdrawal by Subject|1
5643584|NCT00609973|19490462|P1|Overall Study|Withdrawal by Subject|0
5643585|NCT00609973|19490461|P2|Overall Study|Lost to Follow-up|1
5643586|NCT00609973|19490462|P1|Overall Study|Lost to Follow-up|2
5643587|NCT00609973|19490461|P2|Overall Study|Protocol Violation|3
5643588|NCT00609973|19490462|P1|Overall Study|Protocol Violation|4
5643589|NCT00609973|19490461|P2|Overall Study|Adverse Event|1
5643590|NCT00609973|19490462|P1|Overall Study|Adverse Event|2
5643591|NCT00609947|19490470|P1|Overall Study|Death|1
5643592|NCT00609869|19490475|P1|Overall Study|Mantle cell: not evaluable|4
5643593|NCT00609869|19490475|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
5643594|NCT00609869|19490475|P1|Overall Study|Hepatitis B infection|1
5643595|NCT00609869|19490475|P1|Overall Study|Severe tumor flare reaction|1
5643596|NCT00609869|19490475|P1|Overall Study|Seizures|1
5643597|NCT00609869|19490475|P1|Overall Study|Withdrawal by Subject|1
5643598|NCT00609869|19490475|P1|Overall Study|Severe hematologic toxicity|1
5643599|NCT00609869|19490475|P1|Overall Study|Withdrawn, ischemic stroke|1
5643600|NCT00609765|19490494|P1|Overall Study|Study ended prior to 12 months|1
5643601|NCT00609674|19490508|P2|Overall Study|Withdrew consent|1
5643602|NCT00609674|19490509|P1|Overall Study|Withdrew consent|2
5643603|NCT00609674|19490508|P2|Overall Study|Lost to Follow-up|0
5643604|NCT00609674|19490509|P1|Overall Study|Lost to Follow-up|1
5643605|NCT00609674|19490508|P2|Overall Study|Protocol Violation|5
5643606|NCT00609674|19490509|P1|Overall Study|Protocol Violation|3
5643607|NCT00609674|19490508|P2|Overall Study|Adverse Event|1
5643608|NCT00609674|19490509|P1|Overall Study|Adverse Event|1
5643609|NCT00609622|19490545|P2|Overall Study|Global deterioration of health status|2
5643610|NCT00609622|19490546|P1|Overall Study|Global deterioration of health status|6
5643611|NCT00609622|19490545|P2|Overall Study|Other|14
5643612|NCT00609622|19490546|P1|Overall Study|Other|7
5643613|NCT00609622|19490545|P2|Overall Study|Study terminated by sponsor|3
5643614|NCT00609622|19490546|P1|Overall Study|Study terminated by sponsor|16
5643615|NCT00609622|19490545|P2|Overall Study|Objective progression or relapse|41
5643616|NCT00609622|19490546|P1|Overall Study|Objective progression or relapse|47
5643617|NCT00609622|19490545|P2|Overall Study|Protocol Violation|1
5643618|NCT00609622|19490546|P1|Overall Study|Protocol Violation|1
5643619|NCT00609622|19490545|P2|Overall Study|Death|4
5643620|NCT00609622|19490546|P1|Overall Study|Death|1
5643621|NCT00609622|19490545|P2|Overall Study|Withdrawal by Subject|20
5643622|NCT00609622|19490546|P1|Overall Study|Withdrawal by Subject|4
5643623|NCT00609622|19490545|P2|Overall Study|Adverse Event|10
5643624|NCT00609622|19490546|P1|Overall Study|Adverse Event|14
5643625|NCT00609609|19490568|P2|Overall Study|Progression|2
5643626|NCT00609609|19490569|P1|Overall Study|Progression|4
5643627|NCT00609609|19490568|P2|Overall Study|Withdrawal by Subject|0
5643628|NCT00609609|19490569|P1|Overall Study|Withdrawal by Subject|2
5643629|NCT00609518|19490581|P2|Overall Study|Death from Adverse Event|2
5643630|NCT00609518|19490582|P1|Overall Study|Death from Adverse Event|2
5643631|NCT00609518|19490581|P2|Overall Study|Physician Decision|3
5643632|NCT00609518|19490582|P1|Overall Study|Physician Decision|1
5643633|NCT00609518|19490581|P2|Overall Study|Lost to Follow-up|0
5643634|NCT00609518|19490582|P1|Overall Study|Lost to Follow-up|3
5643635|NCT00609518|19490581|P2|Overall Study|Withdrawal by Subject|3
5643636|NCT00609518|19490582|P1|Overall Study|Withdrawal by Subject|5
5643637|NCT00609518|19490581|P2|Overall Study|Death from Study Disease|32
5643638|NCT00609518|19490582|P1|Overall Study|Death from Study Disease|32
5643639|NCT00609492|19490597|P3|Overall Study|Lost to Follow-up|4
5643640|NCT00609492|19490598|P2|Overall Study|Lost to Follow-up|1
5643641|NCT00609492|19490599|P1|Overall Study|Lost to Follow-up|1
5643642|NCT00609492|19490597|P3|Overall Study|Withdrawal by Subject|3
5643643|NCT00609492|19490598|P2|Overall Study|Withdrawal by Subject|2
5643644|NCT00609492|19490599|P1|Overall Study|Withdrawal by Subject|0
5643645|NCT00609466|19490684|P3|Overall Study|Lack of Efficacy|2
5643646|NCT00609466|19490685|P2|Overall Study|Lack of Efficacy|2
5643647|NCT00609466|19490686|P1|Overall Study|Lack of Efficacy|0
5643648|NCT00609466|19490684|P3|Overall Study|Adverse Event|1
5643649|NCT00609466|19490685|P2|Overall Study|Adverse Event|3
5643650|NCT00609466|19490686|P1|Overall Study|Adverse Event|2
5643651|NCT00609466|19490684|P3|Overall Study|Withdrawal by Subject|1
5643652|NCT00609466|19490685|P2|Overall Study|Withdrawal by Subject|1
5643653|NCT00609466|19490686|P1|Overall Study|Withdrawal by Subject|0
5643654|NCT00609362|19490714|P2|Overall Study|Adverse Event|0
5643655|NCT00609362|19490715|P1|Overall Study|Adverse Event|1
5643656|NCT00609362|19490714|P2|Overall Study|Withdrawal by Subject|1
5643657|NCT00609362|19490715|P1|Overall Study|Withdrawal by Subject|2
5643658|NCT00609336|19490725|P1|Overall Study|LA or Met at Surgery|9
5643659|NCT00609336|19490725|P1|Overall Study|Death|1
5643660|NCT00609336|19490725|P1|Overall Study|Protocol Violation|3
5643661|NCT00609245|19490776|P1|Overall Study|Adverse Event|1
5643662|NCT00609167|19490784|P2|Overall Study|Stem Cell Transplant|6
5643663|NCT00609167|19490785|P1|Overall Study|Stem Cell Transplant|0
5643664|NCT00609167|19490784|P2|Overall Study|Disease Progression|0
5643665|NCT00609167|19490785|P1|Overall Study|Disease Progression|1
5643666|NCT00609167|19490784|P2|Overall Study|Adverse Event|1
5643667|NCT00609167|19490785|P1|Overall Study|Adverse Event|5
5643668|NCT00609167|19490784|P2|Overall Study|Lack of Efficacy|0
5643669|NCT00609167|19490785|P1|Overall Study|Lack of Efficacy|1
5643670|NCT00609167|19490784|P2|Overall Study|Withdrawal by Subject|0
5643671|NCT00609167|19490785|P1|Overall Study|Withdrawal by Subject|1
5643672|NCT00608985|19490816|P4|Overall Study|Lost to Follow-up|0
5643673|NCT00608985|19490817|P3|Overall Study|Lost to Follow-up|0
5643674|NCT00608985|19490818|P2|Overall Study|Lost to Follow-up|1
5643675|NCT00608985|19490819|P1|Overall Study|Lost to Follow-up|2
5643676|NCT00608985|19490816|P4|Overall Study|Withdrawal of Consent|1
5643677|NCT00608985|19490817|P3|Overall Study|Withdrawal of Consent|1
5643678|NCT00608985|19490818|P2|Overall Study|Withdrawal of Consent|1
5643679|NCT00608985|19490819|P1|Overall Study|Withdrawal of Consent|5
5643680|NCT00608985|19490816|P4|Overall Study|Administrative/Other|2
5643681|NCT00608985|19490817|P3|Overall Study|Administrative/Other|1
5643682|NCT00608985|19490818|P2|Overall Study|Administrative/Other|4
5643683|NCT00608985|19490819|P1|Overall Study|Administrative/Other|7
5643684|NCT00608985|19490816|P4|Overall Study|Adverse Event|6
5643685|NCT00608985|19490817|P3|Overall Study|Adverse Event|4
5643686|NCT00608985|19490818|P2|Overall Study|Adverse Event|7
5643687|NCT00608985|19490819|P1|Overall Study|Adverse Event|2
5643688|NCT00608959|19490851|P1|Part 1|Did not meet eligibility criteria|1
5643689|NCT00608907|19490864|P3|Overall Study|Progressive Disease|0
5643690|NCT00608907|19490865|P2|Overall Study|Progressive Disease|0
5643691|NCT00608907|19490866|P1|Overall Study|Progressive Disease|1
5643692|NCT00608907|19490864|P3|Overall Study|Withdrawal by Subject|0
5643693|NCT00608907|19490865|P2|Overall Study|Withdrawal by Subject|0
5643694|NCT00608907|19490866|P1|Overall Study|Withdrawal by Subject|4
5643695|NCT00608907|19490864|P3|Overall Study|Death|0
5643696|NCT00608907|19490865|P2|Overall Study|Death|0
5643697|NCT00608907|19490866|P1|Overall Study|Death|1
5643698|NCT00608907|19490864|P3|Overall Study|Adverse Event|1
5643699|NCT00608907|19490865|P2|Overall Study|Adverse Event|0
5643700|NCT00608907|19490866|P1|Overall Study|Adverse Event|6
5643701|NCT00608894|19490876|P2|Overall Study|Withdrawal by Subject|2
5643702|NCT00608894|19490877|P1|Overall Study|Withdrawal by Subject|0
5643703|NCT00608881|19490889|P2|Overall Study|Institutionalized|2
5643704|NCT00608881|19490890|P1|Overall Study|Institutionalized|1
5643705|NCT00608881|19490889|P2|Overall Study|Physician Decision|5
5643706|NCT00608881|19490890|P1|Overall Study|Physician Decision|5
5643707|NCT00608881|19490889|P2|Overall Study|Withdrawal by Subject|29
5643708|NCT00608881|19490890|P1|Overall Study|Withdrawal by Subject|18
5643709|NCT00608881|19490889|P2|Overall Study|Lost to Follow-up|14
5643710|NCT00608881|19490890|P1|Overall Study|Lost to Follow-up|28
5643711|NCT00608881|19490889|P2|Overall Study|Adverse Event|3
5643712|NCT00608881|19490890|P1|Overall Study|Adverse Event|5
5643713|NCT00608881|19490889|P2|Overall Study|Death|13
5643714|NCT00608881|19490890|P1|Overall Study|Death|22
5643715|NCT00608868|19490924|P1|Overall Study|Physician Decision|2
5643716|NCT00608868|19490924|P1|Overall Study|Adverse Event|1
5643717|NCT00608868|19490924|P1|Overall Study|Lost to Follow-up|2
5643718|NCT00608868|19490924|P1|Overall Study|Protocol Violation|3
5643719|NCT00608868|19490924|P1|Overall Study|Withdrawal by Subject|7
5643720|NCT00608842|19490935|P4|Overall Study|Lost to Follow-up|0
5643721|NCT00608842|19490936|P3|Overall Study|Lost to Follow-up|0
5643722|NCT00608842|19490937|P2|Overall Study|Lost to Follow-up|0
5643723|NCT00608842|19490938|P1|Overall Study|Lost to Follow-up|1
5643724|NCT00608842|19490935|P4|Overall Study|Participant's Request|1
5643725|NCT00608842|19490936|P3|Overall Study|Participant's Request|2
5643726|NCT00608842|19490937|P2|Overall Study|Participant's Request|1
5643727|NCT00608842|19490938|P1|Overall Study|Participant's Request|0
5643728|NCT00608829|19490972|P1|Overall Study|Subject refuses to follow up or return.|5
5643729|NCT00608829|19490972|P1|Overall Study|Withdrawal by Subject|4
5643730|NCT00608829|19490972|P1|Overall Study|Death|6
5643731|NCT00608582|19490998|P2|Overall Study|Early stage Design Change|3
5643732|NCT00608582|19490999|P1|Overall Study|Early stage Design Change|0
5643733|NCT00608582|19490998|P2|Overall Study|Illicit Drug Use|0
5643734|NCT00608582|19490999|P1|Overall Study|Illicit Drug Use|1
5643735|NCT00608582|19490998|P2|Overall Study|No Best Response in Phase 1 located|1
5643736|NCT00608582|19490999|P1|Overall Study|No Best Response in Phase 1 located|1
5643737|NCT00608582|19490998|P2|Overall Study|Lost to Follow-up|0
5643738|NCT00608582|19490999|P1|Overall Study|Lost to Follow-up|2
5643739|NCT00608569|19491009|P2|Overall Study|Unable to adhere with study requirements|1
5643740|NCT00608569|19491010|P1|Overall Study|Unable to adhere with study requirements|0
5643741|NCT00608569|19491009|P2|Overall Study|Adverse Event|0
5643742|NCT00608569|19491010|P1|Overall Study|Adverse Event|1
5643743|NCT00608569|19491009|P2|Overall Study|Withdrawal by Subject|0
5643744|NCT00608569|19491010|P1|Overall Study|Withdrawal by Subject|1
5643745|NCT00608569|19491009|P2|Overall Study|Lost to Follow-up|5
5643746|NCT00608569|19491010|P1|Overall Study|Lost to Follow-up|4
5643747|NCT00608569|19491009|P2|Overall Study|Death|3
5643748|NCT00608569|19491010|P1|Overall Study|Death|4
5643749|NCT00608543|19491030|P1|Overall Study|Adverse Event|4
5643750|NCT00608530|19491043|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
5643751|NCT00608530|19491044|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
5643752|NCT00608530|19491045|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
5643753|NCT00608530|19491046|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
5643754|NCT00608530|19491043|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
5643755|NCT00608530|19491044|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
5643756|NCT00608530|19491045|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
5643757|NCT00608530|19491046|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
5643758|NCT00608530|19491043|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
5643759|NCT00608530|19491044|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
5643760|NCT00608530|19491045|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
5643761|NCT00608530|19491046|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
5643762|NCT00608530|19491043|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
5643763|NCT00608530|19491044|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
5643764|NCT00608530|19491045|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
5643765|NCT00608530|19491046|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
5643766|NCT00608530|19491043|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
5643767|NCT00608530|19491044|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
5643768|NCT00608530|19491045|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
5643769|NCT00608530|19491046|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
5643770|NCT00608530|19491043|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
5643771|NCT00608530|19491044|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
5643772|NCT00608530|19491045|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
5643773|NCT00608530|19491046|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
5643774|NCT00608517|19491067|P3|Overall Study|Death|0
5643775|NCT00608517|19491068|P2|Overall Study|Death|0
5643776|NCT00608517|19491069|P1|Overall Study|Death|1
5643777|NCT00608426|19491249|P2|Overall Study|refused, health issues, wrong address|348
5643778|NCT00608426|19491250|P1|Overall Study|refused, health issues, wrong address|319
5643779|NCT00608426|19491249|P2|Overall Study|Lost to Follow-up|521
5643780|NCT00608426|19491250|P1|Overall Study|Lost to Follow-up|485
5643781|NCT00608426|19491249|P2|Overall Study|Death|36
5643782|NCT00608426|19491250|P1|Overall Study|Death|32
5643783|NCT00608322|19491262|P2|Overall Study|Death|1
5643784|NCT00608322|19491263|P1|Overall Study|Death|2
5643785|NCT00608244|19491269|P1|Overall Study|Low trough levels|1
5643786|NCT00608244|19491269|P1|Overall Study|Adverse Event|1
5643787|NCT00608205|19491280|P2|Overall Study|Patient non-compliant|1
5643788|NCT00608205|19491281|P1|Overall Study|Patient non-compliant|0
5643789|NCT00608205|19491280|P2|Overall Study|Adverse Event|2
5643790|NCT00608205|19491281|P1|Overall Study|Adverse Event|3
5643791|NCT00608023|19491465|P3|Overall Study|Unknown reason|0
5643792|NCT00608023|19491466|P2|Overall Study|Unknown reason|3
5643793|NCT00608023|19491467|P1|Overall Study|Unknown reason|0
5643794|NCT00608023|19491465|P3|Overall Study|Protocol Violation|1
5643795|NCT00608023|19491466|P2|Overall Study|Protocol Violation|3
5643796|NCT00608023|19491467|P1|Overall Study|Protocol Violation|1
5643797|NCT00608023|19491465|P3|Overall Study|Lost to Follow-up|1
5643798|NCT00608023|19491466|P2|Overall Study|Lost to Follow-up|2
5643799|NCT00608023|19491467|P1|Overall Study|Lost to Follow-up|2
5643800|NCT00608023|19491465|P3|Overall Study|Adverse Event|5
5643801|NCT00608023|19491466|P2|Overall Study|Adverse Event|4
5643802|NCT00608023|19491467|P1|Overall Study|Adverse Event|1
5643803|NCT00608023|19491465|P3|Overall Study|Withdrawal by Subject|7
5643804|NCT00608023|19491466|P2|Overall Study|Withdrawal by Subject|10
5643805|NCT00608023|19491467|P1|Overall Study|Withdrawal by Subject|8
5643806|NCT00607997|19491491|P4|Overall Study|Other without explanation|1
5643807|NCT00607997|19491492|P3|Overall Study|Other without explanation|4
5643808|NCT00607997|19491493|P2|Overall Study|Other without explanation|0
5643809|NCT00607997|19491494|P1|Overall Study|Other without explanation|2
5643810|NCT00607997|19491491|P4|Overall Study|Relapse, recurrent illness|0
5643811|NCT00607997|19491492|P3|Overall Study|Relapse, recurrent illness|2
5643812|NCT00607997|19491493|P2|Overall Study|Relapse, recurrent illness|0
5643813|NCT00607997|19491494|P1|Overall Study|Relapse, recurrent illness|4
5643814|NCT00607997|19491491|P4|Overall Study|Physician Decision|0
5643815|NCT00607997|19491492|P3|Overall Study|Physician Decision|0
5643816|NCT00607997|19491493|P2|Overall Study|Physician Decision|1
5643817|NCT00607997|19491494|P1|Overall Study|Physician Decision|4
5643818|NCT00607997|19491491|P4|Overall Study|Adverse Event|0
5643819|NCT00607997|19491492|P3|Overall Study|Adverse Event|2
5643820|NCT00607997|19491493|P2|Overall Study|Adverse Event|1
5643821|NCT00607997|19491494|P1|Overall Study|Adverse Event|3
5643822|NCT00607997|19491491|P4|Overall Study|Death|5
5643823|NCT00607997|19491492|P3|Overall Study|Death|2
5643824|NCT00607997|19491493|P2|Overall Study|Death|5
5643825|NCT00607997|19491494|P1|Overall Study|Death|8
5643826|NCT00607997|19491491|P4|Overall Study|Lack of Efficacy|10
5643827|NCT00607997|19491492|P3|Overall Study|Lack of Efficacy|14
5643828|NCT00607997|19491493|P2|Overall Study|Lack of Efficacy|20
5643829|NCT00607997|19491494|P1|Overall Study|Lack of Efficacy|6
5643830|NCT00607919|19491552|P2|Open-Label Phase|Parent/Caregiver Decision|2
5643831|NCT00607919|19491553|P1|Open-Label Phase|Parent/Caregiver Decision|1
5643832|NCT00607919|19491552|P2|Open-Label Phase|Withdrawal by Subject|2
5643833|NCT00607919|19491553|P1|Open-Label Phase|Withdrawal by Subject|2
5643834|NCT00607919|19491552|P2|Open-Label Phase|Protocol Violation|2
5643835|NCT00607919|19491553|P1|Open-Label Phase|Protocol Violation|2
5643836|NCT00607919|19491552|P2|Open-Label Phase|Lost to Follow-up|1
5643837|NCT00607919|19491553|P1|Open-Label Phase|Lost to Follow-up|4
5643838|NCT00607919|19491552|P2|Open-Label Phase|Adverse Event|5
5643839|NCT00607919|19491553|P1|Open-Label Phase|Adverse Event|1
5643840|NCT00607919|19491552|P2|Acute Phase|Withdrawal by Subject|3
5643841|NCT00607919|19491553|P1|Acute Phase|Withdrawal by Subject|3
5643842|NCT00607919|19491552|P2|Acute Phase|Protocol Violation|1
5643843|NCT00607919|19491553|P1|Acute Phase|Protocol Violation|5
5643844|NCT00607919|19491552|P2|Acute Phase|Parent/Caregiver Decision|4
5643845|NCT00607919|19491553|P1|Acute Phase|Parent/Caregiver Decision|6
5643846|NCT00607919|19491552|P2|Acute Phase|Lost to Follow-up|3
5643847|NCT00607919|19491553|P1|Acute Phase|Lost to Follow-up|9
5643848|NCT00607919|19491552|P2|Acute Phase|Lack of Efficacy|2
5643849|NCT00607919|19491553|P1|Acute Phase|Lack of Efficacy|1
5643850|NCT00607919|19491552|P2|Acute Phase|Entry Criteria Not Met|1
5643851|NCT00607919|19491553|P1|Acute Phase|Entry Criteria Not Met|1
5643852|NCT00607919|19491552|P2|Acute Phase|Adverse Event|2
5643853|NCT00607919|19491553|P1|Acute Phase|Adverse Event|9
5643854|NCT00607893|19491611|P2|Overall Study|Withdrew due to hypertensive urgency|1
5643855|NCT00607893|19491612|P1|Overall Study|Withdrew due to hypertensive urgency|1
5643856|NCT00607893|19491611|P2|Overall Study|Declined to be treated|0
5643857|NCT00607893|19491612|P1|Overall Study|Declined to be treated|1
5643858|NCT00607893|19491611|P2|Overall Study|withdrew could not tolerate CPAP|1
5643859|NCT00607893|19491612|P1|Overall Study|withdrew could not tolerate CPAP|0
5643860|NCT00607893|19491611|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
5643861|NCT00607893|19491612|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
5643862|NCT00607893|19491611|P2|Overall Study|withdrew due to loss of interest|1
5643863|NCT00607893|19491612|P1|Overall Study|withdrew due to loss of interest|0
5643864|NCT00607893|19491611|P2|Overall Study|Lost to Follow-up|0
5643865|NCT00607893|19491612|P1|Overall Study|Lost to Follow-up|4
5643866|NCT00607880|19491640|P2|Overall Study|Unable to place port due to occlusion|0
5643867|NCT00607880|19491641|P1|Overall Study|Unable to place port due to occlusion|1
5643868|NCT00607789|19491691|P2|Overall Study|Withdrawal by Subject|0
5643869|NCT00607789|19491692|P1|Overall Study|Withdrawal by Subject|1
5643870|NCT00607789|19491691|P2|Overall Study|Lost to Follow-up|5
5643871|NCT00607789|19491692|P1|Overall Study|Lost to Follow-up|0
5643872|NCT00607789|19491691|P2|Overall Study|Inadequate adherence|0
5643873|NCT00607789|19491692|P1|Overall Study|Inadequate adherence|3
5643874|NCT00607789|19491691|P2|Overall Study|Lack of Efficacy|1
5643875|NCT00607789|19491692|P1|Overall Study|Lack of Efficacy|0
5643876|NCT00607789|19491691|P2|Overall Study|Adverse Event|0
5643877|NCT00607789|19491692|P1|Overall Study|Adverse Event|3
5643878|NCT00607724|19491707|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5643879|NCT00607724|19491708|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5643880|NCT00607724|19491709|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5643881|NCT00607724|19491710|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
5643882|NCT00607724|19491711|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5643883|NCT00607724|19491712|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5643884|NCT00607724|19491713|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
5643885|NCT00607724|19491707|P7|Stage 2: Expanded Cohort|Physician Decision|0
5643886|NCT00607724|19491708|P6|Stage 2: Expanded Cohort|Physician Decision|1
5643887|NCT00607724|19491709|P5|Stage 2: Expanded Cohort|Physician Decision|1
5643888|NCT00607724|19491710|P4|Stage 2: Expanded Cohort|Physician Decision|0
5643889|NCT00607724|19491711|P3|Stage 2: Expanded Cohort|Physician Decision|0
5643890|NCT00607724|19491712|P2|Stage 2: Expanded Cohort|Physician Decision|0
5643891|NCT00607724|19491713|P1|Stage 2: Expanded Cohort|Physician Decision|0
5643892|NCT00607724|19491707|P7|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
5643893|NCT00607724|19491708|P6|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
5643894|NCT00607724|19491709|P5|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
5643895|NCT00607724|19491710|P4|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
5643896|NCT00607724|19491711|P3|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
5643897|NCT00607724|19491712|P2|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
5643898|NCT00607724|19491713|P1|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
5643899|NCT00607724|19491707|P7|Stage 2: Expanded Cohort|Adverse Event|1
5643900|NCT00607724|19491708|P6|Stage 2: Expanded Cohort|Adverse Event|0
5643901|NCT00607724|19491709|P5|Stage 2: Expanded Cohort|Adverse Event|0
5643902|NCT00607724|19491710|P4|Stage 2: Expanded Cohort|Adverse Event|0
5643903|NCT00607724|19491711|P3|Stage 2: Expanded Cohort|Adverse Event|0
5643904|NCT00607724|19491712|P2|Stage 2: Expanded Cohort|Adverse Event|0
5643905|NCT00607724|19491713|P1|Stage 2: Expanded Cohort|Adverse Event|0
5643906|NCT00607724|19491707|P7|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
5643907|NCT00607724|19491708|P6|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
5643908|NCT00607724|19491709|P5|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
5643909|NCT00607724|19491710|P4|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
5643910|NCT00607724|19491711|P3|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
5643911|NCT00607724|19491712|P2|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
5643912|NCT00607724|19491713|P1|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
5643913|NCT00607386|19491876|P1|Overall Study|Physician Decision|1
5643914|NCT00607373|19491891|P2|Follow-up Period|Withdrawal by Subject|3
5643915|NCT00607373|19491892|P1|Follow-up Period|Withdrawal by Subject|1
5643916|NCT00607373|19491891|P2|Follow-up Period|Protocol Violation|1
5643917|NCT00607373|19491892|P1|Follow-up Period|Protocol Violation|0
5643918|NCT00607373|19491891|P2|Follow-up Period|Other|1
5643919|NCT00607373|19491892|P1|Follow-up Period|Other|0
5643920|NCT00607373|19491891|P2|Treatment Period|Withdrawal by Subject|1
5643921|NCT00607373|19491892|P1|Treatment Period|Withdrawal by Subject|0
5643922|NCT00607373|19491891|P2|Treatment Period|Physician Decision|1
5643923|NCT00607373|19491892|P1|Treatment Period|Physician Decision|0
5643924|NCT00607373|19491891|P2|Treatment Period|Adverse Event|4
5643925|NCT00607373|19491892|P1|Treatment Period|Adverse Event|0
5643926|NCT00607087|19491994|P3|Period 3|Adverse Event|0
5643927|NCT00607087|19491995|P2|Period 3|Adverse Event|1
5643928|NCT00607087|19491996|P1|Period 3|Adverse Event|0
5643929|NCT00607087|19491994|P3|Period 3|Withdrawal by Subject|0
5643930|NCT00607087|19491995|P2|Period 3|Withdrawal by Subject|1
5643931|NCT00607087|19491996|P1|Period 3|Withdrawal by Subject|2
5643932|NCT00607087|19491994|P3|Period 2|Poor compliance to protocol|1
5643933|NCT00607087|19491995|P2|Period 2|Poor compliance to protocol|0
5643934|NCT00607087|19491996|P1|Period 2|Poor compliance to protocol|0
5643935|NCT00607087|19491994|P3|Period 2|Adverse Event|3
5643936|NCT00607087|19491995|P2|Period 2|Adverse Event|1
5643937|NCT00607087|19491996|P1|Period 2|Adverse Event|0
5643938|NCT00607087|19491994|P3|Period 2|Other reason|0
5643939|NCT00607087|19491995|P2|Period 2|Other reason|1
5643940|NCT00607087|19491996|P1|Period 2|Other reason|1
5643941|NCT00607087|19491994|P3|Period 2|Withdrawal by Subject|1
5643942|NCT00607087|19491995|P2|Period 2|Withdrawal by Subject|1
5643943|NCT00607087|19491996|P1|Period 2|Withdrawal by Subject|0
5643944|NCT00607087|19491994|P3|Period 1|Other reason|2
5643945|NCT00607087|19491995|P2|Period 1|Other reason|4
5643946|NCT00607087|19491996|P1|Period 1|Other reason|0
5643947|NCT00607087|19491994|P3|Period 1|Lost to Follow-up|0
5643948|NCT00607087|19491995|P2|Period 1|Lost to Follow-up|0
5643949|NCT00607087|19491996|P1|Period 1|Lost to Follow-up|1
5643950|NCT00607087|19491994|P3|Period 1|Poor compliance to protocol|0
5643951|NCT00607087|19491995|P2|Period 1|Poor compliance to protocol|0
5643952|NCT00607087|19491996|P1|Period 1|Poor compliance to protocol|1
5643953|NCT00607087|19491994|P3|Period 1|Adverse Event|0
5643954|NCT00607087|19491995|P2|Period 1|Adverse Event|0
5643955|NCT00607087|19491996|P1|Period 1|Adverse Event|3
5643956|NCT00607087|19491994|P3|Period 1|Withdrawal by Subject|3
5643957|NCT00607087|19491995|P2|Period 1|Withdrawal by Subject|2
5643958|NCT00607087|19491996|P1|Period 1|Withdrawal by Subject|7
5643959|NCT00607087|19491994|P3|Overall Study|Lost to Follow-up|0
5643960|NCT00607087|19491995|P2|Overall Study|Lost to Follow-up|0
5643961|NCT00607087|19491996|P1|Overall Study|Lost to Follow-up|1
5643962|NCT00607087|19491994|P3|Overall Study|Poor compliance to protocol|1
5643963|NCT00607087|19491995|P2|Overall Study|Poor compliance to protocol|0
5643964|NCT00607087|19491996|P1|Overall Study|Poor compliance to protocol|1
5643965|NCT00607087|19491994|P3|Overall Study|Other reason|2
5643966|NCT00607087|19491995|P2|Overall Study|Other reason|5
5643967|NCT00607087|19491996|P1|Overall Study|Other reason|1
5643968|NCT00607087|19491994|P3|Overall Study|Adverse Event|3
5643969|NCT00607087|19491995|P2|Overall Study|Adverse Event|2
5643970|NCT00607087|19491996|P1|Overall Study|Adverse Event|3
5643971|NCT00607087|19491994|P3|Overall Study|Withdrawal by Subject|4
5643972|NCT00607087|19491995|P2|Overall Study|Withdrawal by Subject|4
5643973|NCT00607087|19491996|P1|Overall Study|Withdrawal by Subject|9
5643974|NCT00607048|19492054|P6|Overall Study|Other|1
5643975|NCT00607048|19492055|P5|Overall Study|Other|0
5643976|NCT00607048|19492056|P4|Overall Study|Other|0
5643977|NCT00607048|19492057|P3|Overall Study|Other|0
5643978|NCT00607048|19492058|P2|Overall Study|Other|1
5643979|NCT00607048|19492059|P1|Overall Study|Other|1
5643980|NCT00607048|19492054|P6|Overall Study|Withdrawal by Subject|2
5643981|NCT00607048|19492055|P5|Overall Study|Withdrawal by Subject|0
5643982|NCT00607048|19492056|P4|Overall Study|Withdrawal by Subject|1
5643983|NCT00607048|19492057|P3|Overall Study|Withdrawal by Subject|0
5643984|NCT00607048|19492058|P2|Overall Study|Withdrawal by Subject|0
5643985|NCT00607048|19492059|P1|Overall Study|Withdrawal by Subject|0
5643986|NCT00607048|19492054|P6|Overall Study|Objective disease progression - relapse|2
5643987|NCT00607048|19492055|P5|Overall Study|Objective disease progression - relapse|2
5643988|NCT00607048|19492056|P4|Overall Study|Objective disease progression - relapse|2
5643989|NCT00607048|19492057|P3|Overall Study|Objective disease progression - relapse|4
5643990|NCT00607048|19492058|P2|Overall Study|Objective disease progression - relapse|2
5643991|NCT00607048|19492059|P1|Overall Study|Objective disease progression - relapse|1
5643992|NCT00607048|19492054|P6|Overall Study|Global deterioration of health|0
5643993|NCT00607048|19492055|P5|Overall Study|Global deterioration of health|0
5643994|NCT00607048|19492056|P4|Overall Study|Global deterioration of health|0
5643995|NCT00607048|19492057|P3|Overall Study|Global deterioration of health|0
5643996|NCT00607048|19492058|P2|Overall Study|Global deterioration of health|0
5643997|NCT00607048|19492059|P1|Overall Study|Global deterioration of health|1
5643998|NCT00607048|19492054|P6|Overall Study|Adverse Event|0
5643999|NCT00607048|19492055|P5|Overall Study|Adverse Event|4
5644000|NCT00607048|19492056|P4|Overall Study|Adverse Event|0
5644001|NCT00607048|19492057|P3|Overall Study|Adverse Event|0
5644002|NCT00607048|19492058|P2|Overall Study|Adverse Event|1
5644003|NCT00607048|19492059|P1|Overall Study|Adverse Event|0
5644004|NCT00607022|19492144|P3|Overall Study|Withdrawal by Subject|0
5644005|NCT00607022|19492145|P2|Overall Study|Withdrawal by Subject|0
5644006|NCT00607022|19492146|P1|Overall Study|Withdrawal by Subject|1
5644007|NCT00606931|19492163|P1|Overall Study|Withdrawal by Subject|3
5644008|NCT00606905|19492171|P2|Overall Study|Withdrew|5
5644009|NCT00606905|19492172|P1|Overall Study|Withdrew|5
5644010|NCT00606905|19492171|P2|Overall Study|Non-Index Pregnancy|4
5644011|NCT00606905|19492172|P1|Overall Study|Non-Index Pregnancy|1
5644012|NCT00606905|19492171|P2|Overall Study|No Pregnancy|6
5644013|NCT00606905|19492172|P1|Overall Study|No Pregnancy|9
5644014|NCT00606892|19492178|P2|First Intervention|Protocol Violation|4
5644015|NCT00606892|19492179|P1|First Intervention|Protocol Violation|1
5644016|NCT00606801|19492213|P2|Intervention|Protocol Violation|3
5644017|NCT00606801|19492214|P1|Intervention|Protocol Violation|3
5644018|NCT00606684|19492242|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
5644019|NCT00606684|19492243|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
5644020|NCT00606684|19492244|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
5644021|NCT00606684|19492245|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
5644022|NCT00606684|19492246|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
5644023|NCT00606684|19492247|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
5644024|NCT00606684|19492248|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
5644025|NCT00606684|19492242|P7|Double-Blind Treatment Period|Physician Decision|2
5644026|NCT00606684|19492243|P6|Double-Blind Treatment Period|Physician Decision|1
5644027|NCT00606684|19492244|P5|Double-Blind Treatment Period|Physician Decision|3
5644028|NCT00606684|19492245|P4|Double-Blind Treatment Period|Physician Decision|0
5644029|NCT00606684|19492246|P3|Double-Blind Treatment Period|Physician Decision|1
5644030|NCT00606684|19492247|P2|Double-Blind Treatment Period|Physician Decision|5
5644031|NCT00606684|19492248|P1|Double-Blind Treatment Period|Physician Decision|0
5644032|NCT00606684|19492242|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
5644033|NCT00606684|19492243|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
5644034|NCT00606684|19492244|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
5644035|NCT00606684|19492245|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
5644036|NCT00606684|19492246|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
5644037|NCT00606684|19492247|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
5644038|NCT00606684|19492248|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
5644039|NCT00606684|19492242|P7|Double-Blind Treatment Period|Protocol Violation|4
5644040|NCT00606684|19492243|P6|Double-Blind Treatment Period|Protocol Violation|3
5644041|NCT00606684|19492244|P5|Double-Blind Treatment Period|Protocol Violation|0
5644042|NCT00606684|19492245|P4|Double-Blind Treatment Period|Protocol Violation|3
5644043|NCT00606684|19492246|P3|Double-Blind Treatment Period|Protocol Violation|5
5644044|NCT00606684|19492247|P2|Double-Blind Treatment Period|Protocol Violation|5
5644045|NCT00606684|19492248|P1|Double-Blind Treatment Period|Protocol Violation|0
5644046|NCT00606684|19492242|P7|Double-Blind Treatment Period|Lack of Efficacy|0
5644047|NCT00606684|19492243|P6|Double-Blind Treatment Period|Lack of Efficacy|0
5644048|NCT00606684|19492244|P5|Double-Blind Treatment Period|Lack of Efficacy|1
5644049|NCT00606684|19492245|P4|Double-Blind Treatment Period|Lack of Efficacy|0
5644050|NCT00606684|19492246|P3|Double-Blind Treatment Period|Lack of Efficacy|0
5644051|NCT00606684|19492247|P2|Double-Blind Treatment Period|Lack of Efficacy|1
5644052|NCT00606684|19492248|P1|Double-Blind Treatment Period|Lack of Efficacy|0
5644053|NCT00606684|19492242|P7|Double-Blind Treatment Period|Adverse Event|1
5644054|NCT00606684|19492243|P6|Double-Blind Treatment Period|Adverse Event|0
5644055|NCT00606684|19492244|P5|Double-Blind Treatment Period|Adverse Event|2
5644056|NCT00606684|19492245|P4|Double-Blind Treatment Period|Adverse Event|4
5644057|NCT00606684|19492246|P3|Double-Blind Treatment Period|Adverse Event|2
5644058|NCT00606684|19492247|P2|Double-Blind Treatment Period|Adverse Event|3
5644059|NCT00606684|19492248|P1|Double-Blind Treatment Period|Adverse Event|0
5644060|NCT00606684|19492242|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5644061|NCT00606684|19492243|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5644062|NCT00606684|19492244|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5644063|NCT00606684|19492245|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5644064|NCT00606684|19492246|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5644065|NCT00606684|19492247|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
5644066|NCT00606684|19492248|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
5644067|NCT00606684|19492242|P7|2-week Single-Blind Run-in Period|Adverse Event|0
5644068|NCT00606684|19492243|P6|2-week Single-Blind Run-in Period|Adverse Event|0
5644069|NCT00606684|19492244|P5|2-week Single-Blind Run-in Period|Adverse Event|0
5644070|NCT00606684|19492245|P4|2-week Single-Blind Run-in Period|Adverse Event|0
5644071|NCT00606684|19492246|P3|2-week Single-Blind Run-in Period|Adverse Event|0
5644072|NCT00606684|19492247|P2|2-week Single-Blind Run-in Period|Adverse Event|0
5644073|NCT00606684|19492248|P1|2-week Single-Blind Run-in Period|Adverse Event|2
5644074|NCT00606684|19492242|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5644075|NCT00606684|19492243|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5644076|NCT00606684|19492244|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5644077|NCT00606684|19492245|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5644078|NCT00606684|19492246|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5644079|NCT00606684|19492247|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
5644080|NCT00606684|19492248|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
5644081|NCT00606684|19492242|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5644082|NCT00606684|19492243|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5644083|NCT00606684|19492244|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5644084|NCT00606684|19492245|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5644085|NCT00606684|19492246|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5644086|NCT00606684|19492247|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
5644087|NCT00606684|19492248|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
5644088|NCT00606684|19492242|P7|2-week Single-Blind Run-in Period|Physician Decision|0
5644089|NCT00606684|19492243|P6|2-week Single-Blind Run-in Period|Physician Decision|0
5644090|NCT00606684|19492244|P5|2-week Single-Blind Run-in Period|Physician Decision|0
5644091|NCT00606684|19492245|P4|2-week Single-Blind Run-in Period|Physician Decision|0
5644092|NCT00606684|19492246|P3|2-week Single-Blind Run-in Period|Physician Decision|0
5644093|NCT00606684|19492247|P2|2-week Single-Blind Run-in Period|Physician Decision|0
5644094|NCT00606684|19492248|P1|2-week Single-Blind Run-in Period|Physician Decision|18
5644095|NCT00606684|19492242|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5644096|NCT00606684|19492243|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5644097|NCT00606684|19492244|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5644098|NCT00606684|19492245|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5644099|NCT00606684|19492246|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5644100|NCT00606684|19492247|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
5644101|NCT00606684|19492248|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
5644102|NCT00606684|19492242|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5644103|NCT00606684|19492243|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5644104|NCT00606684|19492244|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5644105|NCT00606684|19492245|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5644106|NCT00606684|19492246|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5644107|NCT00606684|19492247|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
5644108|NCT00606684|19492248|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
5644109|NCT00606632|19492280|P1|Overall Study|Miscellaneous reasons|9
5644110|NCT00606632|19492280|P1|Overall Study|Withdrawal by Subject|13
5644111|NCT00606593|19492293|P10|Overall Study|Administrative/Other|0
5644112|NCT00606593|19492294|P9|Overall Study|Administrative/Other|0
5644113|NCT00606593|19492295|P8|Overall Study|Administrative/Other|0
5644114|NCT00606593|19492296|P7|Overall Study|Administrative/Other|0
5644115|NCT00606593|19492297|P6|Overall Study|Administrative/Other|0
5644116|NCT00606593|19492298|P5|Overall Study|Administrative/Other|0
5644117|NCT00606593|19492299|P4|Overall Study|Administrative/Other|0
5644118|NCT00606593|19492300|P3|Overall Study|Administrative/Other|1
5644119|NCT00606593|19492301|P2|Overall Study|Administrative/Other|0
5644120|NCT00606593|19492302|P1|Overall Study|Administrative/Other|0
5644121|NCT00606593|19492293|P10|Overall Study|Withdrawal of consent|0
5644122|NCT00606593|19492294|P9|Overall Study|Withdrawal of consent|0
5644123|NCT00606593|19492295|P8|Overall Study|Withdrawal of consent|0
5644124|NCT00606593|19492296|P7|Overall Study|Withdrawal of consent|0
5644125|NCT00606593|19492297|P6|Overall Study|Withdrawal of consent|0
5644126|NCT00606593|19492298|P5|Overall Study|Withdrawal of consent|0
5644127|NCT00606593|19492299|P4|Overall Study|Withdrawal of consent|0
5644128|NCT00606593|19492300|P3|Overall Study|Withdrawal of consent|1
5644129|NCT00606593|19492301|P2|Overall Study|Withdrawal of consent|0
5644130|NCT00606593|19492302|P1|Overall Study|Withdrawal of consent|1
5644131|NCT00606593|19492293|P10|Overall Study|Adverse Event|0
5644132|NCT00606593|19492294|P9|Overall Study|Adverse Event|1
5644133|NCT00606593|19492295|P8|Overall Study|Adverse Event|2
5644134|NCT00606593|19492296|P7|Overall Study|Adverse Event|1
5644135|NCT00606593|19492297|P6|Overall Study|Adverse Event|0
5644136|NCT00606593|19492298|P5|Overall Study|Adverse Event|1
5644137|NCT00606593|19492299|P4|Overall Study|Adverse Event|1
5644138|NCT00606593|19492300|P3|Overall Study|Adverse Event|0
5644139|NCT00606593|19492301|P2|Overall Study|Adverse Event|0
5644140|NCT00606593|19492302|P1|Overall Study|Adverse Event|0
5644141|NCT00606580|19492323|P3|Overall Study|Withdrawal by Subject|0
5644142|NCT00606580|19492324|P2|Overall Study|Withdrawal by Subject|1
5644143|NCT00606580|19492325|P1|Overall Study|Withdrawal by Subject|0
5644144|NCT00606580|19492323|P3|Overall Study|Withdrawal by investigator|6
5644145|NCT00606580|19492324|P2|Overall Study|Withdrawal by investigator|1
5644146|NCT00606580|19492325|P1|Overall Study|Withdrawal by investigator|0
5644147|NCT00606580|19492323|P3|Overall Study|Clinical failures|12
5644148|NCT00606580|19492324|P2|Overall Study|Clinical failures|0
5644149|NCT00606580|19492325|P1|Overall Study|Clinical failures|1
5644150|NCT00606580|19492323|P3|Overall Study|Lost to Follow-up|4
5644151|NCT00606580|19492324|P2|Overall Study|Lost to Follow-up|1
5644152|NCT00606580|19492325|P1|Overall Study|Lost to Follow-up|1
5644153|NCT00606502|19492391|P2|Treatment|Treatment ongoing at time of data cutoff|3
5644154|NCT00606502|19492392|P1|Treatment|Treatment ongoing at time of data cutoff|0
5644155|NCT00606502|19492391|P2|Randomization|Randomized but not treated|0
5644156|NCT00606502|19492392|P1|Randomization|Randomized but not treated|3
5644157|NCT00606320|19492413|P1|Overall Study|Progression to depressive phase|4
5644158|NCT00606320|19492413|P1|Overall Study|Withdrawal by Subject|10
5644159|NCT00606320|19492413|P1|Overall Study|Protocol Violation|8
5644160|NCT00606320|19492413|P1|Overall Study|Physician Decision|7
5644161|NCT00606320|19492413|P1|Overall Study|Lack of Efficacy|5
5644162|NCT00606320|19492413|P1|Overall Study|Adverse Event|3
5644163|NCT00606307|19492418|P1|Overall Study|QTc prolongation|1
5644164|NCT00606307|19492418|P1|Overall Study|Disease progression|6
5644165|NCT00606307|19492418|P1|Overall Study|Withdrawal by Subject|2
5644166|NCT00606307|19492418|P1|Overall Study|Adverse Event|2
5644167|NCT00606294|19492426|P2|Overall Study|Withdrawal by Subject|0
5644168|NCT00606294|19492427|P1|Overall Study|Withdrawal by Subject|36
5644169|NCT00606281|19492441|P2|Overall Study|Change of residence or other commitments|1
5644170|NCT00606281|19492442|P1|Overall Study|Change of residence or other commitments|1
5644171|NCT00606281|19492441|P2|Overall Study|Progression to depressive phase|1
5644172|NCT00606281|19492442|P1|Overall Study|Progression to depressive phase|1
5644173|NCT00606281|19492441|P2|Overall Study|Withdrawal by Subject|13
5644174|NCT00606281|19492442|P1|Overall Study|Withdrawal by Subject|11
5644175|NCT00606281|19492441|P2|Overall Study|Protocol Violation|3
5644176|NCT00606281|19492442|P1|Overall Study|Protocol Violation|3
5644177|NCT00606281|19492441|P2|Overall Study|Physician Decision|1
5644178|NCT00606281|19492442|P1|Overall Study|Physician Decision|0
5644179|NCT00606281|19492441|P2|Overall Study|Lack of Efficacy|35
5644180|NCT00606281|19492442|P1|Overall Study|Lack of Efficacy|28
5644181|NCT00606281|19492441|P2|Overall Study|Death|0
5644182|NCT00606281|19492442|P1|Overall Study|Death|1
5644183|NCT00606281|19492441|P2|Overall Study|Adverse Event|12
5644184|NCT00606281|19492442|P1|Overall Study|Adverse Event|11
5644185|NCT00606229|19492450|P1|Overall Study|change of residence or other commitments|2
5644186|NCT00606229|19492450|P1|Overall Study|does not meet inclusion criterion 1-3|4
5644187|NCT00606229|19492450|P1|Overall Study|Withdrawal by Subject|4
5644188|NCT00606229|19492450|P1|Overall Study|Lack of Efficacy|1
5644189|NCT00606229|19492450|P1|Overall Study|Adverse Event|11
5644190|NCT00606177|19492457|P2|Overall Study|Change of residence or other commitments|1
5644191|NCT00606177|19492458|P1|Overall Study|Change of residence or other commitments|1
5644192|NCT00606177|19492457|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
5644193|NCT00606177|19492458|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
5644194|NCT00606177|19492457|P2|Overall Study|Progression to depressive phase|1
5644195|NCT00606177|19492458|P1|Overall Study|Progression to depressive phase|6
5644196|NCT00606177|19492457|P2|Overall Study|Withdrawal by Subject|6
5644197|NCT00606177|19492458|P1|Overall Study|Withdrawal by Subject|5
5644198|NCT00606177|19492457|P2|Overall Study|Protocol Violation|4
5644199|NCT00606177|19492458|P1|Overall Study|Protocol Violation|1
5644200|NCT00606177|19492457|P2|Overall Study|Physician Decision|0
5644201|NCT00606177|19492458|P1|Overall Study|Physician Decision|1
5644202|NCT00606177|19492457|P2|Overall Study|Lack of Efficacy|7
5644203|NCT00606177|19492458|P1|Overall Study|Lack of Efficacy|3
5644204|NCT00606177|19492457|P2|Overall Study|Adverse Event|5
5644205|NCT00606177|19492458|P1|Overall Study|Adverse Event|9
5644206|NCT00606086|19492485|P2|Overall Study|Randomized, not treated|2
5644207|NCT00606086|19492486|P1|Overall Study|Randomized, not treated|1
5644208|NCT00606086|19492485|P2|Overall Study|Non-compliance|1
5644209|NCT00606086|19492486|P1|Overall Study|Non-compliance|0
5644210|NCT00606086|19492485|P2|Overall Study|Withdrawal by Subject|3
5644211|NCT00606086|19492486|P1|Overall Study|Withdrawal by Subject|5
5644212|NCT00606086|19492485|P2|Overall Study|Protocol Violation|0
5644213|NCT00606086|19492486|P1|Overall Study|Protocol Violation|1
5644214|NCT00606086|19492485|P2|Overall Study|Lost to Follow-up|8
5644215|NCT00606086|19492486|P1|Overall Study|Lost to Follow-up|4
5644216|NCT00606086|19492485|P2|Overall Study|Adverse Event|1
5644217|NCT00606086|19492486|P1|Overall Study|Adverse Event|1
5644218|NCT00606034|19492496|P1|Overall Study|incarceration|1
5644219|NCT00606021|19492504|P3|Maintenance Phase|Lost to Follow-up|2
5644220|NCT00606021|19492505|P2|Maintenance Phase|Lost to Follow-up|5
5644221|NCT00606021|19492506|P1|Maintenance Phase|Lost to Follow-up|0
5644222|NCT00606021|19492504|P3|Maintenance Phase|Physician Decision|0
5644223|NCT00606021|19492505|P2|Maintenance Phase|Physician Decision|1
5644224|NCT00606021|19492506|P1|Maintenance Phase|Physician Decision|0
5644225|NCT00606021|19492504|P3|Maintenance Phase|Death|15
5644226|NCT00606021|19492505|P2|Maintenance Phase|Death|17
5644227|NCT00606021|19492506|P1|Maintenance Phase|Death|0
5644228|NCT00606021|19492504|P3|Induction Phase|Lost to Follow-up|0
5644229|NCT00606021|19492505|P2|Induction Phase|Lost to Follow-up|0
5644230|NCT00606021|19492506|P1|Induction Phase|Lost to Follow-up|10
5644231|NCT00606021|19492504|P3|Induction Phase|Withdrawal by Subject|0
5644232|NCT00606021|19492505|P2|Induction Phase|Withdrawal by Subject|0
5644233|NCT00606021|19492506|P1|Induction Phase|Withdrawal by Subject|2
5644234|NCT00606021|19492504|P3|Induction Phase|Physician Decision|0
5644235|NCT00606021|19492505|P2|Induction Phase|Physician Decision|0
5644236|NCT00606021|19492506|P1|Induction Phase|Physician Decision|2
5644237|NCT00606021|19492504|P3|Induction Phase|Death|0
5644238|NCT00606021|19492505|P2|Induction Phase|Death|0
5644239|NCT00606021|19492506|P1|Induction Phase|Death|73
5644240|NCT00606008|19492524|P1|Overall Study|Withdrawal by Subject|4
5644241|NCT00606008|19492524|P1|Overall Study|Adverse Event|1
5644242|NCT00605917|19492538|P1|Overall Study|Protocol Violation|79
5644243|NCT00605865|19492590|P1|Overall Study|Protocol Violation|115
5644244|NCT00605839|19492632|P3|Overall Study|Protocol Violation|0
5644245|NCT00605839|19492633|P2|Overall Study|Protocol Violation|0
5644246|NCT00605839|19492634|P1|Overall Study|Protocol Violation|1
5644247|NCT00605813|19492657|P1|Overall Study|Protocol Violation|25
5644248|NCT00605722|19492670|P1|Overall Study|Failure to return|1
5644249|NCT00605722|19492670|P1|Overall Study|Insufficient therapeutic response|44
5644250|NCT00605722|19492670|P1|Overall Study|Adverse Event|6
5644251|NCT00605657|19492691|P1|Overall Study|Protocol Violation|1
5644252|NCT00605657|19492691|P1|Overall Study|Adverse Event|1
5644253|NCT00605566|19492717|P1|Overall Study|Poor compliance in run-in period|1
5644254|NCT00605566|19492717|P1|Overall Study|Clinical deterioration|1
5644255|NCT00605566|19492717|P1|Overall Study|Adverse Event|1
5644256|NCT00605540|19492725|P1|Overall Study|Lost to Follow-up|23
5644257|NCT00605540|19492725|P1|Overall Study|Death|15
5644258|NCT00605475|19492743|P10|Overall Study|Withdrawal by Subject|1
5644259|NCT00605475|19492744|P9|Overall Study|Withdrawal by Subject|0
5644260|NCT00605475|19492745|P8|Overall Study|Withdrawal by Subject|0
5644261|NCT00605475|19492746|P7|Overall Study|Withdrawal by Subject|0
5644262|NCT00605475|19492747|P6|Overall Study|Withdrawal by Subject|2
5644263|NCT00605475|19492748|P5|Overall Study|Withdrawal by Subject|0
5644264|NCT00605475|19492749|P4|Overall Study|Withdrawal by Subject|0
5644265|NCT00605475|19492750|P3|Overall Study|Withdrawal by Subject|0
5644266|NCT00605475|19492751|P2|Overall Study|Withdrawal by Subject|0
5644267|NCT00605475|19492752|P1|Overall Study|Withdrawal by Subject|0
5644268|NCT00605475|19492743|P10|Overall Study|Protocol Violation|0
5644269|NCT00605475|19492744|P9|Overall Study|Protocol Violation|0
5644270|NCT00605475|19492745|P8|Overall Study|Protocol Violation|0
5644271|NCT00605475|19492746|P7|Overall Study|Protocol Violation|0
5644272|NCT00605475|19492747|P6|Overall Study|Protocol Violation|0
5644273|NCT00605475|19492748|P5|Overall Study|Protocol Violation|1
5644274|NCT00605475|19492749|P4|Overall Study|Protocol Violation|0
5644275|NCT00605475|19492750|P3|Overall Study|Protocol Violation|0
5644276|NCT00605475|19492751|P2|Overall Study|Protocol Violation|0
5644277|NCT00605475|19492752|P1|Overall Study|Protocol Violation|0
5644278|NCT00605475|19492743|P10|Overall Study|Lost to Follow-up|1
5644279|NCT00605475|19492744|P9|Overall Study|Lost to Follow-up|1
5644280|NCT00605475|19492745|P8|Overall Study|Lost to Follow-up|0
5644281|NCT00605475|19492746|P7|Overall Study|Lost to Follow-up|0
5644282|NCT00605475|19492747|P6|Overall Study|Lost to Follow-up|0
5644283|NCT00605475|19492748|P5|Overall Study|Lost to Follow-up|0
5644284|NCT00605475|19492749|P4|Overall Study|Lost to Follow-up|0
5644285|NCT00605475|19492750|P3|Overall Study|Lost to Follow-up|0
5644286|NCT00605475|19492751|P2|Overall Study|Lost to Follow-up|0
5644287|NCT00605475|19492752|P1|Overall Study|Lost to Follow-up|0
5644288|NCT00605475|19492743|P10|Overall Study|Administrative problems|0
5644289|NCT00605475|19492744|P9|Overall Study|Administrative problems|0
5644290|NCT00605475|19492745|P8|Overall Study|Administrative problems|0
5644291|NCT00605475|19492746|P7|Overall Study|Administrative problems|1
5644292|NCT00605475|19492747|P6|Overall Study|Administrative problems|0
5644293|NCT00605475|19492748|P5|Overall Study|Administrative problems|0
5644294|NCT00605475|19492749|P4|Overall Study|Administrative problems|0
5644295|NCT00605475|19492750|P3|Overall Study|Administrative problems|0
5644296|NCT00605475|19492751|P2|Overall Study|Administrative problems|0
5644297|NCT00605475|19492752|P1|Overall Study|Administrative problems|0
5644298|NCT00605475|19492743|P10|Overall Study|Abnormal Laboratory Values|0
5644299|NCT00605475|19492744|P9|Overall Study|Abnormal Laboratory Values|1
5644300|NCT00605475|19492745|P8|Overall Study|Abnormal Laboratory Values|0
5644301|NCT00605475|19492746|P7|Overall Study|Abnormal Laboratory Values|0
5644302|NCT00605475|19492747|P6|Overall Study|Abnormal Laboratory Values|0
5644303|NCT00605475|19492748|P5|Overall Study|Abnormal Laboratory Values|0
5644304|NCT00605475|19492749|P4|Overall Study|Abnormal Laboratory Values|0
5644305|NCT00605475|19492750|P3|Overall Study|Abnormal Laboratory Values|0
5644306|NCT00605475|19492751|P2|Overall Study|Abnormal Laboratory Values|0
5644307|NCT00605475|19492752|P1|Overall Study|Abnormal Laboratory Values|0
5644308|NCT00605345|19492929|P2|Overall Study|Protocol Violation|2
5644309|NCT00605345|19492930|P1|Overall Study|Protocol Violation|0
5644310|NCT00605345|19492929|P2|Overall Study|Adverse Event|1
5644311|NCT00605345|19492930|P1|Overall Study|Adverse Event|0
5644312|NCT00605345|19492929|P2|Overall Study|Withdrawal by Subject|0
5644313|NCT00605345|19492930|P1|Overall Study|Withdrawal by Subject|1
5644314|NCT00605319|19492946|P1|Overall Study|Adverse Event|6
5644315|NCT00605306|19492958|P2|Overall Study|Adverse Event|1
5644316|NCT00605306|19492959|P1|Overall Study|Adverse Event|0
5644317|NCT00605293|19492973|P2|Overall Study|Principal Investigator Decision|1
5644318|NCT00605293|19492974|P1|Overall Study|Principal Investigator Decision|0
5644319|NCT00605293|19492973|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
5644320|NCT00605293|19492974|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
5644321|NCT00605293|19492973|P2|Overall Study|Incorrect Epoetin Beta Administration|0
5644322|NCT00605293|19492974|P1|Overall Study|Incorrect Epoetin Beta Administration|1
5644323|NCT00605293|19492973|P2|Overall Study|Renal Transplantation|1
5644324|NCT00605293|19492974|P1|Overall Study|Renal Transplantation|3
5644325|NCT00605293|19492973|P2|Overall Study|Blood Transfusion|1
5644326|NCT00605293|19492974|P1|Overall Study|Blood Transfusion|7
5644327|NCT00605293|19492973|P2|Overall Study|Holidays Dialysis Out|0
5644328|NCT00605293|19492974|P1|Overall Study|Holidays Dialysis Out|1
5644329|NCT00605293|19492973|P2|Overall Study|Adverse Event|0
5644330|NCT00605293|19492974|P1|Overall Study|Adverse Event|1
5644331|NCT00605293|19492973|P2|Overall Study|Insufficient Therapeutic Response|0
5644332|NCT00605293|19492974|P1|Overall Study|Insufficient Therapeutic Response|2
5644333|NCT00605293|19492973|P2|Overall Study|Death|1
5644334|NCT00605293|19492974|P1|Overall Study|Death|2
5644335|NCT00605280|19492994|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
5644336|NCT00605280|19492995|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
5644337|NCT00605280|19492996|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
5644338|NCT00605280|19492997|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
5644339|NCT00605280|19492994|P4|Year 3 Extension|Other|0
5644340|NCT00605280|19492995|P3|Year 3 Extension|Other|0
5644341|NCT00605280|19492996|P2|Year 3 Extension|Other|0
5644342|NCT00605280|19492997|P1|Year 3 Extension|Other|2
5644343|NCT00605280|19492994|P4|Year 3 Extension|Withdrawal by Subject|5
5644344|NCT00605280|19492995|P3|Year 3 Extension|Withdrawal by Subject|0
5644345|NCT00605280|19492996|P2|Year 3 Extension|Withdrawal by Subject|0
5644346|NCT00605280|19492997|P1|Year 3 Extension|Withdrawal by Subject|2
5644347|NCT00605280|19492994|P4|Year 3 Extension|Physician Decision|2
5644348|NCT00605280|19492995|P3|Year 3 Extension|Physician Decision|0
5644349|NCT00605280|19492996|P2|Year 3 Extension|Physician Decision|0
5644350|NCT00605280|19492997|P1|Year 3 Extension|Physician Decision|0
5644351|NCT00605280|19492994|P4|Year 3 Extension|Adverse Event|2
5644352|NCT00605280|19492995|P3|Year 3 Extension|Adverse Event|0
5644353|NCT00605280|19492996|P2|Year 3 Extension|Adverse Event|0
5644354|NCT00605280|19492997|P1|Year 3 Extension|Adverse Event|2
5644355|NCT00605280|19492994|P4|Year 2|Lost to Follow-up or Patient non-comply|2
5644356|NCT00605280|19492995|P3|Year 2|Lost to Follow-up or Patient non-comply|0
5644357|NCT00605280|19492996|P2|Year 2|Lost to Follow-up or Patient non-comply|0
5644358|NCT00605280|19492997|P1|Year 2|Lost to Follow-up or Patient non-comply|4
5644359|NCT00605280|19492994|P4|Year 2|Other|1
5644360|NCT00605280|19492995|P3|Year 2|Other|0
5644361|NCT00605280|19492996|P2|Year 2|Other|0
5644362|NCT00605280|19492997|P1|Year 2|Other|1
5644363|NCT00605280|19492994|P4|Year 2|Withdrawal by Subject|4
5644364|NCT00605280|19492995|P3|Year 2|Withdrawal by Subject|0
5644365|NCT00605280|19492996|P2|Year 2|Withdrawal by Subject|0
5644366|NCT00605280|19492997|P1|Year 2|Withdrawal by Subject|4
5644367|NCT00605280|19492994|P4|Year 2|Physician Decision|11
5644368|NCT00605280|19492995|P3|Year 2|Physician Decision|4
5644369|NCT00605280|19492996|P2|Year 2|Physician Decision|6
5644370|NCT00605280|19492997|P1|Year 2|Physician Decision|11
5644371|NCT00605280|19492994|P4|Year 2|Adverse Event|4
5644372|NCT00605280|19492995|P3|Year 2|Adverse Event|2
5644373|NCT00605280|19492996|P2|Year 2|Adverse Event|0
5644374|NCT00605280|19492997|P1|Year 2|Adverse Event|4
5644375|NCT00605280|19492994|P4|Year 1|Lost to Follow-up or Patient non-comply|2
5644376|NCT00605280|19492995|P3|Year 1|Lost to Follow-up or Patient non-comply|0
5644377|NCT00605280|19492996|P2|Year 1|Lost to Follow-up or Patient non-comply|1
5644378|NCT00605280|19492997|P1|Year 1|Lost to Follow-up or Patient non-comply|5
5644379|NCT00605280|19492994|P4|Year 1|Other|1
5644380|NCT00605280|19492995|P3|Year 1|Other|0
5644381|NCT00605280|19492996|P2|Year 1|Other|1
5644382|NCT00605280|19492997|P1|Year 1|Other|2
5644383|NCT00605280|19492994|P4|Year 1|Withdrawal by Subject|4
5644384|NCT00605280|19492995|P3|Year 1|Withdrawal by Subject|0
5644385|NCT00605280|19492996|P2|Year 1|Withdrawal by Subject|4
5644386|NCT00605280|19492997|P1|Year 1|Withdrawal by Subject|2
5644387|NCT00605280|19492994|P4|Year 1|Physician Decision|6
5644388|NCT00605280|19492995|P3|Year 1|Physician Decision|0
5644389|NCT00605280|19492996|P2|Year 1|Physician Decision|4
5644390|NCT00605280|19492997|P1|Year 1|Physician Decision|7
5644391|NCT00605280|19492994|P4|Year 1|Adverse Event|5
5644392|NCT00605280|19492995|P3|Year 1|Adverse Event|1
5644393|NCT00605280|19492996|P2|Year 1|Adverse Event|1
5644394|NCT00605280|19492997|P1|Year 1|Adverse Event|3
5644395|NCT00605280|19492994|P4|Year 1|Protocol Violation|1
5644396|NCT00605280|19492995|P3|Year 1|Protocol Violation|0
5644397|NCT00605280|19492996|P2|Year 1|Protocol Violation|0
5644398|NCT00605280|19492997|P1|Year 1|Protocol Violation|0
5644399|NCT00605267|19493031|P2|Overall Study|Withdrawal by Subject|3
5644400|NCT00605267|19493032|P1|Overall Study|Withdrawal by Subject|2
5644401|NCT00605267|19493031|P2|Overall Study|Lack of Efficacy|5
5644402|NCT00605267|19493032|P1|Overall Study|Lack of Efficacy|1
5644403|NCT00605267|19493031|P2|Overall Study|Adverse Event|1
5644404|NCT00605267|19493032|P1|Overall Study|Adverse Event|0
5644405|NCT00605189|19493080|P3|Overall Study|Other|0
5644406|NCT00605189|19493081|P2|Overall Study|Other|2
5644407|NCT00605189|19493082|P1|Overall Study|Other|2
5644408|NCT00605189|19493080|P3|Overall Study|Adverse Event|0
5644409|NCT00605189|19493081|P2|Overall Study|Adverse Event|0
5644410|NCT00605189|19493082|P1|Overall Study|Adverse Event|1
5644411|NCT00605176|19493093|P3|Overall Study|Other (not due to AE)|0
5644412|NCT00605176|19493094|P2|Overall Study|Other (not due to AE)|1
5644413|NCT00605176|19493095|P1|Overall Study|Other (not due to AE)|1
5644414|NCT00605176|19493093|P3|Overall Study|Use of concomitant therapy|1
5644415|NCT00605176|19493094|P2|Overall Study|Use of concomitant therapy|0
5644416|NCT00605176|19493095|P1|Overall Study|Use of concomitant therapy|1
5644417|NCT00605176|19493093|P3|Overall Study|Non-complicance with study procedures|0
5644418|NCT00605176|19493094|P2|Overall Study|Non-complicance with study procedures|0
5644419|NCT00605176|19493095|P1|Overall Study|Non-complicance with study procedures|1
5644420|NCT00605176|19493093|P3|Overall Study|Lost to Follow-up|1
5644421|NCT00605176|19493094|P2|Overall Study|Lost to Follow-up|2
5644422|NCT00605176|19493095|P1|Overall Study|Lost to Follow-up|2
5644423|NCT00605176|19493093|P3|Overall Study|Withdrawal by Subject|4
5644424|NCT00605176|19493094|P2|Overall Study|Withdrawal by Subject|2
5644425|NCT00605176|19493095|P1|Overall Study|Withdrawal by Subject|4
5644426|NCT00605176|19493093|P3|Overall Study|Adverse Event|3
5644427|NCT00605176|19493094|P2|Overall Study|Adverse Event|1
5644428|NCT00605176|19493095|P1|Overall Study|Adverse Event|2
5644429|NCT00605085|19493119|P2|Overall Study|administrative reasons|8
5644430|NCT00605085|19493120|P1|Overall Study|administrative reasons|18
5644431|NCT00605085|19493119|P2|Overall Study|Lost to Follow-up|5
5644432|NCT00605085|19493120|P1|Overall Study|Lost to Follow-up|10
5644433|NCT00605085|19493119|P2|Overall Study|Protocol Violation|2
5644434|NCT00605085|19493120|P1|Overall Study|Protocol Violation|3
5644435|NCT00605085|19493119|P2|Overall Study|Pregnancy|0
5644436|NCT00605085|19493120|P1|Overall Study|Pregnancy|2
5644437|NCT00605085|19493119|P2|Overall Study|Adverse Event|5
5644438|NCT00605085|19493120|P1|Overall Study|Adverse Event|9
5644439|NCT00605085|19493119|P2|Overall Study|Withdrawal by Subject|5
5644440|NCT00605085|19493120|P1|Overall Study|Withdrawal by Subject|8
5644441|NCT00605033|19493153|P2|Overall Study|Protocol Violation|1
5644442|NCT00605033|19493154|P1|Overall Study|Protocol Violation|1
5644443|NCT00605033|19493153|P2|Overall Study|Withdrawal by Subject|4
5644444|NCT00605033|19493154|P1|Overall Study|Withdrawal by Subject|3
5644445|NCT00605033|19493153|P2|Overall Study|Lost to Follow-up|1
5644446|NCT00605033|19493154|P1|Overall Study|Lost to Follow-up|1
5644447|NCT00605033|19493153|P2|Overall Study|Adverse Event|2
5644448|NCT00605033|19493154|P1|Overall Study|Adverse Event|2
5644449|NCT00604825|19493198|P4|Overall Study|Exclusion criterion met|1
5644450|NCT00604825|19493199|P3|Overall Study|Exclusion criterion met|0
5644451|NCT00604825|19493200|P2|Overall Study|Exclusion criterion met|0
5644452|NCT00604825|19493201|P1|Overall Study|Exclusion criterion met|0
5644453|NCT00604825|19493198|P4|Overall Study|Physician Decision|1
5644454|NCT00604825|19493199|P3|Overall Study|Physician Decision|0
5644455|NCT00604825|19493200|P2|Overall Study|Physician Decision|0
5644456|NCT00604825|19493201|P1|Overall Study|Physician Decision|0
5644457|NCT00604825|19493198|P4|Overall Study|Did not meet eligibility criteria|0
5644458|NCT00604825|19493199|P3|Overall Study|Did not meet eligibility criteria|2
5644459|NCT00604825|19493200|P2|Overall Study|Did not meet eligibility criteria|0
5644460|NCT00604825|19493201|P1|Overall Study|Did not meet eligibility criteria|0
5644461|NCT00604825|19493198|P4|Overall Study|Lack of Efficacy|0
5644462|NCT00604825|19493199|P3|Overall Study|Lack of Efficacy|1
5644463|NCT00604825|19493200|P2|Overall Study|Lack of Efficacy|2
5644464|NCT00604825|19493201|P1|Overall Study|Lack of Efficacy|3
5644465|NCT00604825|19493198|P4|Overall Study|Withdrawal by Subject|5
5644466|NCT00604825|19493199|P3|Overall Study|Withdrawal by Subject|5
5644467|NCT00604825|19493200|P2|Overall Study|Withdrawal by Subject|3
5644468|NCT00604825|19493201|P1|Overall Study|Withdrawal by Subject|4
5644469|NCT00604825|19493198|P4|Overall Study|Protocol Violation|0
5644470|NCT00604825|19493199|P3|Overall Study|Protocol Violation|0
5644471|NCT00604825|19493200|P2|Overall Study|Protocol Violation|1
5644472|NCT00604825|19493201|P1|Overall Study|Protocol Violation|0
5644473|NCT00604825|19493198|P4|Overall Study|Lost to Follow-up|0
5644474|NCT00604825|19493199|P3|Overall Study|Lost to Follow-up|1
5644475|NCT00604825|19493200|P2|Overall Study|Lost to Follow-up|3
5644476|NCT00604825|19493201|P1|Overall Study|Lost to Follow-up|0
5644477|NCT00604825|19493198|P4|Overall Study|Adverse Event|4
5644478|NCT00604825|19493199|P3|Overall Study|Adverse Event|7
5644479|NCT00604825|19493200|P2|Overall Study|Adverse Event|6
5644480|NCT00604825|19493201|P1|Overall Study|Adverse Event|2
5644481|NCT00604786|19493429|P2|Overall Study|Lost to Follow-up|0
5644482|NCT00604786|19493430|P1|Overall Study|Lost to Follow-up|2
5644483|NCT00604721|19493436|P1|Overall Study|Withdrawal by Subject|1
5644484|NCT00604721|19493436|P1|Overall Study|Physician Decision|1
5644485|NCT00604708|19493444|P2|Overall Study|Adverse Event|6
5644486|NCT00604708|19493445|P1|Overall Study|Adverse Event|6
5644487|NCT00604708|19493444|P2|Overall Study|administrative reasons|11
5644488|NCT00604708|19493445|P1|Overall Study|administrative reasons|9
5644489|NCT00604708|19493444|P2|Overall Study|Lost to Follow-up|5
5644490|NCT00604708|19493445|P1|Overall Study|Lost to Follow-up|5
5644491|NCT00604708|19493444|P2|Overall Study|Protocol Violation|8
5644492|NCT00604708|19493445|P1|Overall Study|Protocol Violation|2
5644493|NCT00604708|19493444|P2|Overall Study|Withdrawal by Subject|10
5644494|NCT00604708|19493445|P1|Overall Study|Withdrawal by Subject|9
5644495|NCT00604695|19493455|P2|Overall Study|Did not receive first bolus.|4
5644496|NCT00604695|19493456|P1|Overall Study|Did not receive first bolus.|0
5644497|NCT00604669|19493478|P1|Overall Study|lack of information in chart|7
5644498|NCT00604565|19493484|P2|Overall Study|Study terminated|3
5644499|NCT00604565|19493485|P1|Overall Study|Study terminated|0
5644500|NCT00604500|19493504|P1|Overall Study|Did not meet protocol eligibility|1
5644501|NCT00604500|19493504|P1|Overall Study|Administrative|1
5644502|NCT00604500|19493504|P1|Overall Study|Withdrawal by Subject|4
5644503|NCT00604500|19493504|P1|Overall Study|Treatment Failure|1
5644504|NCT00604500|19493504|P1|Overall Study|Protocol Violation|2
5644505|NCT00604500|19493504|P1|Overall Study|Adverse Event|2
5644506|NCT00604383|19493518|P2|Overall Study|Physician Decision|3
5644507|NCT00604383|19493519|P1|Overall Study|Physician Decision|0
5644508|NCT00604383|19493518|P2|Overall Study|Adverse Event|9
5644509|NCT00604383|19493519|P1|Overall Study|Adverse Event|16
5644510|NCT00604383|19493518|P2|Overall Study|Death|22
5644511|NCT00604383|19493519|P1|Overall Study|Death|14
5644512|NCT00604383|19493518|P2|Overall Study|Lost to Follow-up|19
5644513|NCT00604383|19493519|P1|Overall Study|Lost to Follow-up|24
5644514|NCT00604383|19493518|P2|Overall Study|Withdrawal by Subject|31
5644515|NCT00604383|19493519|P1|Overall Study|Withdrawal by Subject|33
5644516|NCT00604279|19493535|P2|Overall Study|Other|4
5644517|NCT00604279|19493536|P1|Overall Study|Other|8
5644518|NCT00604279|19493535|P2|Overall Study|Adverse Event|5
5644519|NCT00604279|19493536|P1|Overall Study|Adverse Event|4
5644520|NCT00604279|19493535|P2|Overall Study|Withdrawal by Subject|5
5644521|NCT00604279|19493536|P1|Overall Study|Withdrawal by Subject|16
5644522|NCT00604279|19493535|P2|Overall Study|Protocol Violation|1
5644523|NCT00604279|19493536|P1|Overall Study|Protocol Violation|3
5644524|NCT00604279|19493535|P2|Overall Study|Pregnancy|0
5644525|NCT00604279|19493536|P1|Overall Study|Pregnancy|2
5644526|NCT00604279|19493535|P2|Overall Study|Lost to Follow-up|14
5644527|NCT00604279|19493536|P1|Overall Study|Lost to Follow-up|9
5644528|NCT00604279|19493535|P2|Overall Study|Lack of Efficacy|9
5644529|NCT00604279|19493536|P1|Overall Study|Lack of Efficacy|22
5644530|NCT00604214|19493552|P2|Day 91 to Day 180|Withdrawal by Subject|1
5644531|NCT00604214|19493553|P1|Day 91 to Day 180|Withdrawal by Subject|1
5644532|NCT00604214|19493552|P2|Day 91 to Day 180|Lost to Follow-up|8
5644533|NCT00604214|19493553|P1|Day 91 to Day 180|Lost to Follow-up|6
5644534|NCT00604214|19493552|P2|Day 91 to Day 180|Death|23
5644535|NCT00604214|19493553|P1|Day 91 to Day 180|Death|19
5644536|NCT00604214|19493552|P2|Day 29 to Day 90|Withdrawal by Subject|6
5644537|NCT00604214|19493553|P1|Day 29 to Day 90|Withdrawal by Subject|0
5644538|NCT00604214|19493552|P2|Day 29 to Day 90|Lost to Follow-up|6
5644539|NCT00604214|19493553|P1|Day 29 to Day 90|Lost to Follow-up|4
5644540|NCT00604214|19493552|P2|Day 29 to Day 90|Death|67
5644541|NCT00604214|19493553|P1|Day 29 to Day 90|Death|64
5644542|NCT00604214|19493552|P2|Baseline to Day 28|Withdrawal by Subject|7
5644543|NCT00604214|19493553|P1|Baseline to Day 28|Withdrawal by Subject|3
5644544|NCT00604214|19493552|P2|Baseline to Day 28|Lost to Follow-up|4
5644545|NCT00604214|19493553|P1|Baseline to Day 28|Lost to Follow-up|2
5644546|NCT00604214|19493552|P2|Baseline to Day 28|Death|202
5644547|NCT00604214|19493553|P1|Baseline to Day 28|Death|223
5644548|NCT00604188|19493601|P2|Overall Study|Did not receive study drug|1
5644549|NCT00604188|19493602|P1|Overall Study|Did not receive study drug|0
5644550|NCT00604188|19493601|P2|Overall Study|Non-compliance with protocol|4
5644551|NCT00604188|19493602|P1|Overall Study|Non-compliance with protocol|4
5644552|NCT00604188|19493601|P2|Overall Study|Withdrawal by Subject|1
5644553|NCT00604188|19493602|P1|Overall Study|Withdrawal by Subject|5
5644554|NCT00604188|19493601|P2|Overall Study|Lost to Follow-up|15
5644555|NCT00604188|19493602|P1|Overall Study|Lost to Follow-up|17
5644556|NCT00604188|19493601|P2|Overall Study|Adverse Event|4
5644557|NCT00604188|19493602|P1|Overall Study|Adverse Event|1
5644558|NCT00604175|19493625|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
5644559|NCT00604175|19493626|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
5644560|NCT00604175|19493627|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
5644561|NCT00604175|19493625|P3|Week 29 Through Week 72|Site closure|0
5644562|NCT00604175|19493626|P2|Week 29 Through Week 72|Site closure|1
5644563|NCT00604175|19493627|P1|Week 29 Through Week 72|Site closure|0
5644564|NCT00604175|19493625|P3|Week 29 Through Week 72|Lost to Follow-up|2
5644565|NCT00604175|19493626|P2|Week 29 Through Week 72|Lost to Follow-up|6
5644566|NCT00604175|19493627|P1|Week 29 Through Week 72|Lost to Follow-up|12
5644567|NCT00604175|19493625|P3|Week 29 Through Week 72|Death|1
5644568|NCT00604175|19493626|P2|Week 29 Through Week 72|Death|0
5644569|NCT00604175|19493627|P1|Week 29 Through Week 72|Death|0
5644570|NCT00604175|19493625|P3|Entry Through Week 28|Did not start intervention|1
5644571|NCT00604175|19493626|P2|Entry Through Week 28|Did not start intervention|0
5644572|NCT00604175|19493627|P1|Entry Through Week 28|Did not start intervention|2
5644573|NCT00604175|19493625|P3|Entry Through Week 28|Ineligible|0
5644574|NCT00604175|19493626|P2|Entry Through Week 28|Ineligible|0
5644575|NCT00604175|19493627|P1|Entry Through Week 28|Ineligible|1
5644576|NCT00604175|19493625|P3|Entry Through Week 28|Lost to Follow-up|0
5644577|NCT00604175|19493626|P2|Entry Through Week 28|Lost to Follow-up|3
5644578|NCT00604175|19493627|P1|Entry Through Week 28|Lost to Follow-up|4
5644579|NCT00604175|19493625|P3|Entry Through Week 28|Withdrawal by Subject|0
5644580|NCT00604175|19493626|P2|Entry Through Week 28|Withdrawal by Subject|0
5644581|NCT00604175|19493627|P1|Entry Through Week 28|Withdrawal by Subject|1
5644582|NCT00604175|19493625|P3|Entry Through Week 28|Death|0
5644583|NCT00604175|19493626|P2|Entry Through Week 28|Death|0
5644584|NCT00604175|19493627|P1|Entry Through Week 28|Death|2
5644585|NCT00604162|19493680|P1|Overall Study|Withdrawal by Subject|1
5644586|NCT00604162|19493680|P1|Overall Study|Physician Decision|3
5644587|NCT00603980|19493722|P1|Main Study|14th subject completed trial|1
5644588|NCT00603980|19493722|P1|Study Qualification|Inconsistent data reporting|13
5644589|NCT00603980|19493722|P1|Study Qualification|Protocol Violation|3
5644590|NCT00603941|19493841|P3|Overall Study|Withdrawal by Subject|0
5644591|NCT00603941|19493842|P2|Overall Study|Withdrawal by Subject|2
5644592|NCT00603941|19493843|P1|Overall Study|Withdrawal by Subject|0
5644593|NCT00603941|19493841|P3|Overall Study|Physician Decision|0
5644594|NCT00603941|19493842|P2|Overall Study|Physician Decision|1
5644595|NCT00603941|19493843|P1|Overall Study|Physician Decision|0
5644596|NCT00603941|19493841|P3|Overall Study|Adverse Event|1
5644597|NCT00603941|19493842|P2|Overall Study|Adverse Event|0
5644598|NCT00603941|19493843|P1|Overall Study|Adverse Event|1
5644599|NCT00603941|19493841|P3|Overall Study|Disease progression|1
5644600|NCT00603941|19493842|P2|Overall Study|Disease progression|7
5644601|NCT00603941|19493843|P1|Overall Study|Disease progression|6
5644602|NCT00603915|19493854|P1|Overall Study|Physician Decision|1
5644603|NCT00603837|19493884|P2|Overall Study|Physician Decision|0
5644604|NCT00603837|19493885|P1|Overall Study|Physician Decision|3
5644605|NCT00603798|19493894|P3|Overall Study|Not due to AE|4
5644606|NCT00603798|19493895|P2|Overall Study|Not due to AE|1
5644607|NCT00603798|19493896|P1|Overall Study|Not due to AE|1
5644608|NCT00603798|19493894|P3|Overall Study|Non-compliance with study procedures|0
5644609|NCT00603798|19493895|P2|Overall Study|Non-compliance with study procedures|1
5644610|NCT00603798|19493896|P1|Overall Study|Non-compliance with study procedures|0
5644611|NCT00603798|19493894|P3|Overall Study|Lost to Follow-up|1
5644612|NCT00603798|19493895|P2|Overall Study|Lost to Follow-up|0
5644613|NCT00603798|19493896|P1|Overall Study|Lost to Follow-up|1
5644614|NCT00603798|19493894|P3|Overall Study|Withdrawal by Subject|4
5644615|NCT00603798|19493895|P2|Overall Study|Withdrawal by Subject|3
5644616|NCT00603798|19493896|P1|Overall Study|Withdrawal by Subject|4
5644617|NCT00603798|19493894|P3|Overall Study|Adverse Event|1
5644618|NCT00603798|19493895|P2|Overall Study|Adverse Event|2
5644619|NCT00603798|19493896|P1|Overall Study|Adverse Event|4
5644620|NCT00603746|19493919|P6|Overall Study|Withdrawal by Subject|1
5644621|NCT00603746|19493920|P5|Overall Study|Withdrawal by Subject|3
5644622|NCT00603746|19493921|P4|Overall Study|Withdrawal by Subject|1
5644623|NCT00603746|19493922|P3|Overall Study|Withdrawal by Subject|0
5644624|NCT00603746|19493923|P2|Overall Study|Withdrawal by Subject|0
5644625|NCT00603746|19493924|P1|Overall Study|Withdrawal by Subject|1
5644626|NCT00603746|19493919|P6|Overall Study|Physician Decision|0
5644627|NCT00603746|19493920|P5|Overall Study|Physician Decision|1
5644628|NCT00603746|19493921|P4|Overall Study|Physician Decision|0
5644629|NCT00603746|19493922|P3|Overall Study|Physician Decision|0
5644630|NCT00603746|19493923|P2|Overall Study|Physician Decision|0
5644631|NCT00603746|19493924|P1|Overall Study|Physician Decision|1
5644632|NCT00603746|19493919|P6|Overall Study|Lost to Follow-up|0
5644633|NCT00603746|19493920|P5|Overall Study|Lost to Follow-up|0
5644634|NCT00603746|19493921|P4|Overall Study|Lost to Follow-up|0
5644635|NCT00603746|19493922|P3|Overall Study|Lost to Follow-up|1
5644636|NCT00603746|19493923|P2|Overall Study|Lost to Follow-up|1
5644637|NCT00603746|19493924|P1|Overall Study|Lost to Follow-up|0
5644638|NCT00603746|19493919|P6|Overall Study|Protocol Violation|0
5644639|NCT00603746|19493920|P5|Overall Study|Protocol Violation|1
5644640|NCT00603746|19493921|P4|Overall Study|Protocol Violation|0
5644641|NCT00603746|19493922|P3|Overall Study|Protocol Violation|1
5644642|NCT00603746|19493923|P2|Overall Study|Protocol Violation|3
5644643|NCT00603746|19493924|P1|Overall Study|Protocol Violation|0
5644644|NCT00603746|19493919|P6|Overall Study|Lack of Efficacy|8
5644645|NCT00603746|19493920|P5|Overall Study|Lack of Efficacy|12
5644646|NCT00603746|19493921|P4|Overall Study|Lack of Efficacy|11
5644647|NCT00603746|19493922|P3|Overall Study|Lack of Efficacy|6
5644648|NCT00603746|19493923|P2|Overall Study|Lack of Efficacy|11
5644649|NCT00603746|19493924|P1|Overall Study|Lack of Efficacy|34
5644650|NCT00603746|19493919|P6|Overall Study|Adverse Event|4
5644651|NCT00603746|19493920|P5|Overall Study|Adverse Event|0
5644652|NCT00603746|19493921|P4|Overall Study|Adverse Event|1
5644653|NCT00603746|19493922|P3|Overall Study|Adverse Event|0
5644654|NCT00603746|19493923|P2|Overall Study|Adverse Event|3
5644655|NCT00603746|19493924|P1|Overall Study|Adverse Event|2
5644656|NCT00603733|19494072|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
5644657|NCT00603733|19494073|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
5644658|NCT00603733|19494072|P2|Maintenance Phase ITT|Physician Decision|1
5644659|NCT00603733|19494073|P1|Maintenance Phase ITT|Physician Decision|0
5644660|NCT00603733|19494072|P2|Maintenance Phase ITT|Lack of Efficacy|2
5644661|NCT00603733|19494073|P1|Maintenance Phase ITT|Lack of Efficacy|2
5644662|NCT00603733|19494072|P2|Maintenance Phase ITT|Lost to Follow-up|1
5644663|NCT00603733|19494073|P1|Maintenance Phase ITT|Lost to Follow-up|0
5644664|NCT00603733|19494072|P2|Maintenance Phase ITT|Protocol Violation|1
5644665|NCT00603733|19494073|P1|Maintenance Phase ITT|Protocol Violation|1
5644666|NCT00603733|19494072|P2|Maintenance Phase ITT|Withdrawal by Subject|0
5644667|NCT00603733|19494073|P1|Maintenance Phase ITT|Withdrawal by Subject|1
5644668|NCT00603733|19494072|P2|Maintenance Phase ITT|Adverse Event|6
5644669|NCT00603733|19494073|P1|Maintenance Phase ITT|Adverse Event|3
5644670|NCT00603733|19494072|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
5644671|NCT00603733|19494073|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
5644672|NCT00603733|19494072|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
5644673|NCT00603733|19494073|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
5644674|NCT00603733|19494072|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
5644675|NCT00603733|19494073|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
5644676|NCT00603733|19494072|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
5644677|NCT00603733|19494073|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
5644678|NCT00603733|19494072|P2|Run-In Phase - 4 Weeks|Adverse Event|1
5644679|NCT00603733|19494073|P1|Run-In Phase - 4 Weeks|Adverse Event|2
5644680|NCT00603733|19494072|P2|Active Phase ITT|Subject moved, site closed|1
5644681|NCT00603733|19494073|P1|Active Phase ITT|Subject moved, site closed|1
5644682|NCT00603733|19494072|P2|Active Phase ITT|Lack of Efficacy|2
5644683|NCT00603733|19494073|P1|Active Phase ITT|Lack of Efficacy|1
5644684|NCT00603733|19494072|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
5644685|NCT00603733|19494073|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
5644686|NCT00603733|19494072|P2|Active Phase ITT|Lost to Follow-up|1
5644687|NCT00603733|19494073|P1|Active Phase ITT|Lost to Follow-up|0
5644688|NCT00603733|19494072|P2|Active Phase ITT|Withdrawal by Subject|3
5644689|NCT00603733|19494073|P1|Active Phase ITT|Withdrawal by Subject|0
5644690|NCT00603733|19494072|P2|Active Phase ITT|Adverse Event|7
5644691|NCT00603733|19494073|P1|Active Phase ITT|Adverse Event|8
5644692|NCT00603590|19494123|P2|Overall Study|Cardiovascular event|1
5644693|NCT00603590|19494124|P1|Overall Study|Cardiovascular event|0
5644694|NCT00603590|19494123|P2|Overall Study|Lost to Follow-up|4
5644695|NCT00603590|19494124|P1|Overall Study|Lost to Follow-up|8
5644696|NCT00603590|19494123|P2|Overall Study|Adverse Event|0
5644697|NCT00603590|19494124|P1|Overall Study|Adverse Event|2
5644698|NCT00603590|19494123|P2|Overall Study|Patient discontinued study drug|15
5644699|NCT00603590|19494124|P1|Overall Study|Patient discontinued study drug|22
5644700|NCT00603590|19494123|P2|Overall Study|Refused blood test|1
5644701|NCT00603590|19494124|P1|Overall Study|Refused blood test|5
5644702|NCT00603590|19494123|P2|Overall Study|Did not attend study clinic|30
5644703|NCT00603590|19494124|P1|Overall Study|Did not attend study clinic|39
5644704|NCT00603538|19494148|P3|Overall Study|Objective progression or relapse|0
5644705|NCT00603538|19494149|P2|Overall Study|Objective progression or relapse|0
5644706|NCT00603538|19494150|P1|Overall Study|Objective progression or relapse|3
5644707|NCT00603538|19494148|P3|Overall Study|Adverse Event|2
5644708|NCT00603538|19494149|P2|Overall Study|Adverse Event|4
5644709|NCT00603538|19494150|P1|Overall Study|Adverse Event|0
5644710|NCT00603525|19494190|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
5644711|NCT00603525|19494191|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
5644712|NCT00603525|19494192|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
5644713|NCT00603525|19494190|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
5644714|NCT00603525|19494191|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
5644715|NCT00603525|19494192|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
5644716|NCT00603525|19494190|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
5644717|NCT00603525|19494191|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
5644718|NCT00603525|19494192|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
5644719|NCT00603525|19494190|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
5644720|NCT00603525|19494191|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
5644721|NCT00603525|19494192|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
5644722|NCT00603525|19494190|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
5644723|NCT00603525|19494191|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
5644724|NCT00603525|19494192|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
5644725|NCT00603525|19494190|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
5644726|NCT00603525|19494191|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
5644727|NCT00603525|19494192|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
5644728|NCT00603525|19494190|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
5644729|NCT00603525|19494191|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
5644730|NCT00603525|19494192|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
5644731|NCT00603525|19494190|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
5644732|NCT00603525|19494191|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
5644733|NCT00603525|19494192|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
5644734|NCT00603525|19494190|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
5644735|NCT00603525|19494191|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
5644736|NCT00603525|19494192|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
5644737|NCT00603525|19494190|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
5644738|NCT00603525|19494191|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
5644739|NCT00603525|19494192|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
5644740|NCT00603525|19494190|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
5644741|NCT00603525|19494191|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
5644742|NCT00603525|19494192|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
5644743|NCT00603525|19494190|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
5644744|NCT00603525|19494191|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
5644745|NCT00603525|19494192|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
5644746|NCT00603525|19494190|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
5644747|NCT00603525|19494191|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
5644748|NCT00603525|19494192|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
5644749|NCT00603525|19494190|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
5644750|NCT00603525|19494191|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
5644751|NCT00603525|19494192|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
5644752|NCT00603525|19494190|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
5644753|NCT00603525|19494191|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
5644754|NCT00603525|19494192|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
5644755|NCT00603512|19494324|P5|Overall Study|Randomized but not treated|0
5644756|NCT00603512|19494325|P4|Overall Study|Randomized but not treated|2
5644757|NCT00603512|19494326|P3|Overall Study|Randomized but not treated|1
5644758|NCT00603512|19494327|P2|Overall Study|Randomized but not treated|1
5644759|NCT00603512|19494328|P1|Overall Study|Randomized but not treated|0
5644760|NCT00603512|19494324|P5|Overall Study|Withdrawal by Subject|1
5644761|NCT00603512|19494325|P4|Overall Study|Withdrawal by Subject|0
5644762|NCT00603512|19494326|P3|Overall Study|Withdrawal by Subject|0
5644763|NCT00603512|19494327|P2|Overall Study|Withdrawal by Subject|0
5644764|NCT00603512|19494328|P1|Overall Study|Withdrawal by Subject|0
5644765|NCT00603512|19494324|P5|Overall Study|Other|1
5644766|NCT00603512|19494325|P4|Overall Study|Other|1
5644767|NCT00603512|19494326|P3|Overall Study|Other|0
5644768|NCT00603512|19494327|P2|Overall Study|Other|1
5644769|NCT00603512|19494328|P1|Overall Study|Other|2
5644770|NCT00603512|19494324|P5|Overall Study|Lack of Efficacy|1
5644771|NCT00603512|19494325|P4|Overall Study|Lack of Efficacy|0
5644772|NCT00603512|19494326|P3|Overall Study|Lack of Efficacy|0
5644773|NCT00603512|19494327|P2|Overall Study|Lack of Efficacy|1
5644774|NCT00603512|19494328|P1|Overall Study|Lack of Efficacy|0
5644775|NCT00603512|19494324|P5|Overall Study|Adverse Event|2
5644776|NCT00603512|19494325|P4|Overall Study|Adverse Event|4
5644777|NCT00603512|19494326|P3|Overall Study|Adverse Event|4
5644778|NCT00603512|19494327|P2|Overall Study|Adverse Event|2
5644779|NCT00603512|19494328|P1|Overall Study|Adverse Event|0
5644780|NCT00603473|19494470|P1|Overall Study|Protocol Violation|1
5644781|NCT00603473|19494470|P1|Overall Study|Lack of Efficacy|4
5644782|NCT00603473|19494470|P1|Overall Study|Adverse Event|4
5644783|NCT00603447|19494483|P7|Overall Study|Withdrew Consent|1
5644784|NCT00603447|19494484|P6|Overall Study|Withdrew Consent|0
5644785|NCT00603447|19494485|P5|Overall Study|Withdrew Consent|1
5644786|NCT00603447|19494486|P4|Overall Study|Withdrew Consent|0
5644787|NCT00603447|19494487|P3|Overall Study|Withdrew Consent|0
5644788|NCT00603447|19494488|P2|Overall Study|Withdrew Consent|2
5644789|NCT00603447|19494489|P1|Overall Study|Withdrew Consent|0
5644790|NCT00603447|19494483|P7|Overall Study|Other|13
5644791|NCT00603447|19494484|P6|Overall Study|Other|0
5644792|NCT00603447|19494485|P5|Overall Study|Other|3
5644793|NCT00603447|19494486|P4|Overall Study|Other|0
5644794|NCT00603447|19494487|P3|Overall Study|Other|1
5644795|NCT00603447|19494488|P2|Overall Study|Other|0
5644796|NCT00603447|19494489|P1|Overall Study|Other|0
5644797|NCT00603447|19494483|P7|Overall Study|Adverse Event|10
5644798|NCT00603447|19494484|P6|Overall Study|Adverse Event|2
5644799|NCT00603447|19494485|P5|Overall Study|Adverse Event|1
5644800|NCT00603447|19494486|P4|Overall Study|Adverse Event|2
5644801|NCT00603447|19494487|P3|Overall Study|Adverse Event|1
5644802|NCT00603447|19494488|P2|Overall Study|Adverse Event|1
5644803|NCT00603447|19494489|P1|Overall Study|Adverse Event|0
5644804|NCT00603382|19494528|P6|Overall Study|Withdrawal by Subject|1
5644805|NCT00603382|19494529|P5|Overall Study|Withdrawal by Subject|0
5644806|NCT00603382|19494530|P4|Overall Study|Withdrawal by Subject|1
5644807|NCT00603382|19494531|P3|Overall Study|Withdrawal by Subject|1
5644808|NCT00603382|19494532|P2|Overall Study|Withdrawal by Subject|3
5644809|NCT00603382|19494533|P1|Overall Study|Withdrawal by Subject|3
5644810|NCT00603382|19494528|P6|Overall Study|Physician Decision|3
5644811|NCT00603382|19494529|P5|Overall Study|Physician Decision|1
5644812|NCT00603382|19494530|P4|Overall Study|Physician Decision|0
5644813|NCT00603382|19494531|P3|Overall Study|Physician Decision|2
5644814|NCT00603382|19494532|P2|Overall Study|Physician Decision|0
5644815|NCT00603382|19494533|P1|Overall Study|Physician Decision|0
5644816|NCT00603382|19494528|P6|Overall Study|Lost to Follow-up|1
5644817|NCT00603382|19494529|P5|Overall Study|Lost to Follow-up|0
5644818|NCT00603382|19494530|P4|Overall Study|Lost to Follow-up|1
5644819|NCT00603382|19494531|P3|Overall Study|Lost to Follow-up|1
5644820|NCT00603382|19494532|P2|Overall Study|Lost to Follow-up|1
5644821|NCT00603382|19494533|P1|Overall Study|Lost to Follow-up|0
5644822|NCT00603382|19494528|P6|Overall Study|Protocol Violation|0
5644823|NCT00603382|19494529|P5|Overall Study|Protocol Violation|1
5644824|NCT00603382|19494530|P4|Overall Study|Protocol Violation|2
5644825|NCT00603382|19494531|P3|Overall Study|Protocol Violation|1
5644826|NCT00603382|19494532|P2|Overall Study|Protocol Violation|0
5644827|NCT00603382|19494533|P1|Overall Study|Protocol Violation|1
5644828|NCT00603382|19494528|P6|Overall Study|Lack of Efficacy|11
5644829|NCT00603382|19494529|P5|Overall Study|Lack of Efficacy|6
5644830|NCT00603382|19494530|P4|Overall Study|Lack of Efficacy|6
5644831|NCT00603382|19494531|P3|Overall Study|Lack of Efficacy|3
5644832|NCT00603382|19494532|P2|Overall Study|Lack of Efficacy|9
5644833|NCT00603382|19494533|P1|Overall Study|Lack of Efficacy|14
5644834|NCT00603382|19494528|P6|Overall Study|Adverse Event|2
5644835|NCT00603382|19494529|P5|Overall Study|Adverse Event|1
5644836|NCT00603382|19494530|P4|Overall Study|Adverse Event|2
5644837|NCT00603382|19494531|P3|Overall Study|Adverse Event|1
5644838|NCT00603382|19494532|P2|Overall Study|Adverse Event|1
5644839|NCT00603382|19494533|P1|Overall Study|Adverse Event|0
5644840|NCT00603304|19494681|P2|Overall Study|Patient Decision|0
5644841|NCT00603304|19494682|P1|Overall Study|Patient Decision|2
5644842|NCT00603304|19494681|P2|Overall Study|Other|0
5644843|NCT00603304|19494682|P1|Overall Study|Other|2
5644844|NCT00603304|19494681|P2|Overall Study|Moved Away|2
5644845|NCT00603304|19494682|P1|Overall Study|Moved Away|0
5644846|NCT00603304|19494681|P2|Overall Study|Non-Compliant|1
5644847|NCT00603304|19494682|P1|Overall Study|Non-Compliant|0
5644848|NCT00603304|19494681|P2|Overall Study|Exclusionary Medication|3
5644849|NCT00603304|19494682|P1|Overall Study|Exclusionary Medication|2
5644850|NCT00603304|19494681|P2|Overall Study|Crossed Over to Open Label Therapy|3
5644851|NCT00603304|19494682|P1|Overall Study|Crossed Over to Open Label Therapy|3
5644852|NCT00603304|19494681|P2|Overall Study|Unacceptable Treatment Toxicity|8
5644853|NCT00603304|19494682|P1|Overall Study|Unacceptable Treatment Toxicity|5
5644854|NCT00603304|19494681|P2|Overall Study|Adverse Event|2
5644855|NCT00603304|19494682|P1|Overall Study|Adverse Event|4
5644856|NCT00603304|19494681|P2|Overall Study|Protocol Violation|0
5644857|NCT00603304|19494682|P1|Overall Study|Protocol Violation|1
5644858|NCT00603304|19494681|P2|Overall Study|Withdrawal by Subject|5
5644859|NCT00603304|19494682|P1|Overall Study|Withdrawal by Subject|8
5644860|NCT00603304|19494681|P2|Overall Study|Lost to Follow-up|7
5644861|NCT00603304|19494682|P1|Overall Study|Lost to Follow-up|5
5644862|NCT00603278|19494738|P6|Overall Study|Lost to Follow-up|0
5644863|NCT00603278|19494739|P5|Overall Study|Lost to Follow-up|1
5644864|NCT00603278|19494740|P4|Overall Study|Lost to Follow-up|0
5644865|NCT00603278|19494741|P3|Overall Study|Lost to Follow-up|0
5644866|NCT00603278|19494742|P2|Overall Study|Lost to Follow-up|0
5644867|NCT00603278|19494743|P1|Overall Study|Lost to Follow-up|1
5644868|NCT00603278|19494738|P6|Overall Study|Physician Decision|1
5644869|NCT00603278|19494739|P5|Overall Study|Physician Decision|2
5644870|NCT00603278|19494740|P4|Overall Study|Physician Decision|0
5644871|NCT00603278|19494741|P3|Overall Study|Physician Decision|0
5644872|NCT00603278|19494742|P2|Overall Study|Physician Decision|1
5644873|NCT00603278|19494743|P1|Overall Study|Physician Decision|0
5644874|NCT00603278|19494738|P6|Overall Study|Protocol Violation|1
5644875|NCT00603278|19494739|P5|Overall Study|Protocol Violation|0
5644876|NCT00603278|19494740|P4|Overall Study|Protocol Violation|1
5644877|NCT00603278|19494741|P3|Overall Study|Protocol Violation|1
5644878|NCT00603278|19494742|P2|Overall Study|Protocol Violation|0
5644879|NCT00603278|19494743|P1|Overall Study|Protocol Violation|3
5644880|NCT00603278|19494738|P6|Overall Study|Withdrawal by Subject|2
5644881|NCT00603278|19494739|P5|Overall Study|Withdrawal by Subject|1
5644882|NCT00603278|19494740|P4|Overall Study|Withdrawal by Subject|2
5644883|NCT00603278|19494741|P3|Overall Study|Withdrawal by Subject|1
5644884|NCT00603278|19494742|P2|Overall Study|Withdrawal by Subject|3
5644885|NCT00603278|19494743|P1|Overall Study|Withdrawal by Subject|2
5644886|NCT00603278|19494738|P6|Overall Study|Adverse Event|1
5644887|NCT00603278|19494739|P5|Overall Study|Adverse Event|2
5644888|NCT00603278|19494740|P4|Overall Study|Adverse Event|0
5644889|NCT00603278|19494741|P3|Overall Study|Adverse Event|1
5644890|NCT00603278|19494742|P2|Overall Study|Adverse Event|3
5644891|NCT00603278|19494743|P1|Overall Study|Adverse Event|0
5644892|NCT00603278|19494738|P6|Overall Study|Lack of Efficacy|14
5644893|NCT00603278|19494739|P5|Overall Study|Lack of Efficacy|7
5644894|NCT00603278|19494740|P4|Overall Study|Lack of Efficacy|8
5644895|NCT00603278|19494741|P3|Overall Study|Lack of Efficacy|11
5644896|NCT00603278|19494742|P2|Overall Study|Lack of Efficacy|10
5644897|NCT00603278|19494743|P1|Overall Study|Lack of Efficacy|35
5644898|NCT00603265|19494892|P3|Overall Study|Protocol Violation|0
5644899|NCT00603265|19494893|P2|Overall Study|Protocol Violation|0
5644900|NCT00603265|19494894|P1|Overall Study|Protocol Violation|1
5644901|NCT00603265|19494892|P3|Overall Study|Participant Left Country, No Responses|0
5644902|NCT00603265|19494893|P2|Overall Study|Participant Left Country, No Responses|1
5644903|NCT00603265|19494894|P1|Overall Study|Participant Left Country, No Responses|0
5644904|NCT00603265|19494892|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
5644905|NCT00603265|19494893|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
5644906|NCT00603265|19494894|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
5644907|NCT00603265|19494892|P3|Overall Study|Lost to Follow-up|0
5644908|NCT00603265|19494893|P2|Overall Study|Lost to Follow-up|1
5644909|NCT00603265|19494894|P1|Overall Study|Lost to Follow-up|0
5644910|NCT00603265|19494892|P3|Overall Study|Lack of Efficacy|3
5644911|NCT00603265|19494893|P2|Overall Study|Lack of Efficacy|0
5644912|NCT00603265|19494894|P1|Overall Study|Lack of Efficacy|3
5644913|NCT00603265|19494892|P3|Overall Study|Withdrawal by Subject|1
5644914|NCT00603265|19494893|P2|Overall Study|Withdrawal by Subject|2
5644915|NCT00603265|19494894|P1|Overall Study|Withdrawal by Subject|1
5644916|NCT00603265|19494892|P3|Overall Study|Adverse Event|1
5644917|NCT00603265|19494893|P2|Overall Study|Adverse Event|11
5644918|NCT00603265|19494894|P1|Overall Study|Adverse Event|2
5644919|NCT00603239|19494922|P2|Overall Study|Subject decision|1
5644920|NCT00603239|19494923|P1|Overall Study|Subject decision|2
5644921|NCT00603239|19494922|P2|Overall Study|Protocol Violation|0
5644922|NCT00603239|19494923|P1|Overall Study|Protocol Violation|2
5644923|NCT00603239|19494922|P2|Overall Study|Physician Decision|0
5644924|NCT00603239|19494923|P1|Overall Study|Physician Decision|2
5644925|NCT00603239|19494922|P2|Overall Study|Lost to Follow-up|1
5644926|NCT00603239|19494923|P1|Overall Study|Lost to Follow-up|2
5644927|NCT00603239|19494922|P2|Overall Study|Loss of glucose control|0
5644928|NCT00603239|19494923|P1|Overall Study|Loss of glucose control|3
5644929|NCT00603239|19494922|P2|Overall Study|Entry criteria not met|1
5644930|NCT00603239|19494923|P1|Overall Study|Entry criteria not met|0
5644931|NCT00603239|19494922|P2|Overall Study|Adverse Event|1
5644932|NCT00603239|19494923|P1|Overall Study|Adverse Event|4
5644933|NCT00602979|19494984|P5|Overall Study|Failed Intubation|0
5644934|NCT00602979|19494985|P4|Overall Study|Failed Intubation|1
5644935|NCT00602979|19494986|P3|Overall Study|Failed Intubation|0
5644936|NCT00602979|19494987|P2|Overall Study|Failed Intubation|1
5644937|NCT00602979|19494988|P1|Overall Study|Failed Intubation|0
5644938|NCT00602979|19494984|P5|Overall Study|Lost to Follow-up|3
5644939|NCT00602979|19494985|P4|Overall Study|Lost to Follow-up|2
5644940|NCT00602979|19494986|P3|Overall Study|Lost to Follow-up|3
5644941|NCT00602979|19494987|P2|Overall Study|Lost to Follow-up|2
5644942|NCT00602979|19494988|P1|Overall Study|Lost to Follow-up|3
5644943|NCT00602927|19495038|P2|Period 3: 13 Days|MRI data quality|2
5644944|NCT00602927|19495039|P1|Period 3: 13 Days|MRI data quality|2
5644945|NCT00602927|19495038|P2|Period 3: 13 Days|Protocol Violation|1
5644946|NCT00602927|19495039|P1|Period 3: 13 Days|Protocol Violation|0
5644947|NCT00602927|19495038|P2|Period 2: 14 Days|Protocol Violation|2
5644948|NCT00602927|19495039|P1|Period 2: 14 Days|Protocol Violation|0
5644949|NCT00602927|19495038|P2|Period 1: 13 Days|Claustrophobia|1
5644950|NCT00602927|19495039|P1|Period 1: 13 Days|Claustrophobia|0
5644951|NCT00602927|19495038|P2|Period 1: 13 Days|Time|0
5644952|NCT00602927|19495039|P1|Period 1: 13 Days|Time|1
5644953|NCT00602927|19495038|P2|Period 1: 13 Days|MRI scanner technical issue|0
5644954|NCT00602927|19495039|P1|Period 1: 13 Days|MRI scanner technical issue|1
5644955|NCT00602927|19495038|P2|Period 1: 13 Days|Protocol Violation|4
5644956|NCT00602927|19495039|P1|Period 1: 13 Days|Protocol Violation|2
5644957|NCT00602797|19495056|P1|Overall Study|Adverse Event|1
5644958|NCT00602667|19495074|P3|Overall Study|Progressive disease prior to therapy|1
5644959|NCT00602667|19495075|P2|Overall Study|Progressive disease prior to therapy|0
5644960|NCT00602667|19495076|P1|Overall Study|Progressive disease prior to therapy|0
5644961|NCT00602667|19495074|P3|Overall Study|Progressive disease|45
5644962|NCT00602667|19495075|P2|Overall Study|Progressive disease|48
5644963|NCT00602667|19495076|P1|Overall Study|Progressive disease|13
5644964|NCT00602667|19495074|P3|Overall Study|Physician Decision|8
5644965|NCT00602667|19495075|P2|Overall Study|Physician Decision|3
5644966|NCT00602667|19495076|P1|Overall Study|Physician Decision|2
5644967|NCT00602667|19495074|P3|Overall Study|Second malignancy|0
5644968|NCT00602667|19495075|P2|Overall Study|Second malignancy|1
5644969|NCT00602667|19495076|P1|Overall Study|Second malignancy|0
5644970|NCT00602667|19495074|P3|Overall Study|Excessive toxicity|0
5644971|NCT00602667|19495075|P2|Overall Study|Excessive toxicity|1
5644972|NCT00602667|19495076|P1|Overall Study|Excessive toxicity|1
5644973|NCT00602667|19495074|P3|Overall Study|Family request|6
5644974|NCT00602667|19495075|P2|Overall Study|Family request|25
5644975|NCT00602667|19495076|P1|Overall Study|Family request|3
5644976|NCT00602667|19495074|P3|Overall Study|Death|1
5644977|NCT00602667|19495075|P2|Overall Study|Death|1
5644978|NCT00602667|19495076|P1|Overall Study|Death|0
5644979|NCT00602667|19495074|P3|Overall Study|Still on Therapy|2
5644980|NCT00602667|19495075|P2|Overall Study|Still on Therapy|2
5644981|NCT00602667|19495076|P1|Overall Study|Still on Therapy|0
5644982|NCT00602641|19495255|P2|Overall Study|Other|1
5644983|NCT00602641|19495256|P1|Overall Study|Other|3
5644984|NCT00602641|19495255|P2|Overall Study|Administrative Closure|1
5644985|NCT00602641|19495256|P1|Overall Study|Administrative Closure|1
5644986|NCT00602641|19495255|P2|Overall Study|Physician Decision|4
5644987|NCT00602641|19495256|P1|Overall Study|Physician Decision|5
5644988|NCT00602641|19495255|P2|Overall Study|Other Complicating Disease|2
5644989|NCT00602641|19495256|P1|Overall Study|Other Complicating Disease|5
5644990|NCT00602641|19495255|P2|Overall Study|Alternative therapy|2
5644991|NCT00602641|19495256|P1|Overall Study|Alternative therapy|5
5644992|NCT00602641|19495255|P2|Overall Study|Withdrawal by Subject|12
5644993|NCT00602641|19495256|P1|Overall Study|Withdrawal by Subject|15
5644994|NCT00602641|19495255|P2|Overall Study|Death|5
5644995|NCT00602641|19495256|P1|Overall Study|Death|6
5644996|NCT00602641|19495255|P2|Overall Study|Disease progression|55
5644997|NCT00602641|19495256|P1|Overall Study|Disease progression|38
5644998|NCT00602641|19495255|P2|Overall Study|Adverse Event|53
5644999|NCT00602641|19495256|P1|Overall Study|Adverse Event|62
5645000|NCT00602641|19495255|P2|Overall Study|Still on treatment at time of analysis|15
5645001|NCT00602641|19495256|P1|Overall Study|Still on treatment at time of analysis|8
5645002|NCT00602641|19495255|P2|Overall Study|Never started protocol therapy|2
5645003|NCT00602641|19495256|P1|Overall Study|Never started protocol therapy|6
5645004|NCT00602537|19495270|P2|Follow Up Study Comparison|Withdrawal by Subject|2
5645005|NCT00602537|19495271|P1|Follow Up Study Comparison|Withdrawal by Subject|2
5645006|NCT00602537|19495270|P2|Follow Up Study Comparison|Lost to Follow-up|1
5645007|NCT00602537|19495271|P1|Follow Up Study Comparison|Lost to Follow-up|8
5645008|NCT00602537|19495270|P2|Follow Up Study Comparison|Adverse Event|0
5645009|NCT00602537|19495271|P1|Follow Up Study Comparison|Adverse Event|1
5645010|NCT00602537|19495270|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
5645187|NCT00600886|19495888|P1|Extension - After Crossover (CAS)|Death|1
5645011|NCT00602537|19495271|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
5645012|NCT00602537|19495270|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
5645013|NCT00602537|19495271|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
5645014|NCT00602537|19495270|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
5645015|NCT00602537|19495271|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
5645016|NCT00602537|19495270|P2|12 Week Double Blind Comparison|Adverse Event|5
5645017|NCT00602537|19495271|P1|12 Week Double Blind Comparison|Adverse Event|2
5645018|NCT00602472|19495281|P2|Overall Study|Other incl. lack of efficacy|2
5645019|NCT00602472|19495282|P1|Overall Study|Other incl. lack of efficacy|4
5645020|NCT00602472|19495281|P2|Overall Study|Withdrawal by Subject|14
5645021|NCT00602472|19495282|P1|Overall Study|Withdrawal by Subject|8
5645022|NCT00602472|19495281|P2|Overall Study|Protocol Violation|19
5645023|NCT00602472|19495282|P1|Overall Study|Protocol Violation|4
5645024|NCT00602472|19495281|P2|Overall Study|Adverse Event|23
5645025|NCT00602472|19495282|P1|Overall Study|Adverse Event|5
5645026|NCT00602420|19495347|P2|Overall Study|Adverse Event|0
5645027|NCT00602420|19495348|P1|Overall Study|Adverse Event|1
5645028|NCT00602420|19495347|P2|Overall Study|Withdrawal by Subject|17
5645029|NCT00602420|19495348|P1|Overall Study|Withdrawal by Subject|18
5645030|NCT00602420|19495347|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
5645031|NCT00602420|19495348|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
5645032|NCT00602420|19495347|P2|Overall Study|Death|4
5645033|NCT00602420|19495348|P1|Overall Study|Death|1
5645034|NCT00601900|19495456|P2|Overall Study|Withdrawal by Subject|3
5645035|NCT00601900|19495457|P1|Overall Study|Withdrawal by Subject|0
5645036|NCT00601835|19495481|P2|Overall Study|Relocate|2
5645037|NCT00601835|19495482|P1|Overall Study|Relocate|12
5645038|NCT00601835|19495481|P2|Overall Study|Adverse Event|1
5645039|NCT00601835|19495482|P1|Overall Study|Adverse Event|1
5645040|NCT00601835|19495481|P2|Overall Study|Lost to Follow-up|5
5645041|NCT00601835|19495482|P1|Overall Study|Lost to Follow-up|37
5645042|NCT00601835|19495481|P2|Overall Study|Physician Decision|0
5645043|NCT00601835|19495482|P1|Overall Study|Physician Decision|1
5645044|NCT00601835|19495481|P2|Overall Study|Withdrawal by Subject|6
5645045|NCT00601835|19495482|P1|Overall Study|Withdrawal by Subject|9
5645046|NCT00601705|19495571|P1|Overall Study|Withdrawal by Subject|1
5645047|NCT00601640|19495583|P3|Overall Study|change in eligibility status|1
5645048|NCT00601640|19495584|P2|Overall Study|change in eligibility status|1
5645049|NCT00601640|19495585|P1|Overall Study|change in eligibility status|0
5645050|NCT00601640|19495583|P3|Overall Study|intercurrent illness|0
5645051|NCT00601640|19495584|P2|Overall Study|intercurrent illness|0
5645052|NCT00601640|19495585|P1|Overall Study|intercurrent illness|1
5645053|NCT00601640|19495583|P3|Overall Study|Adverse Event|2
5645054|NCT00601640|19495584|P2|Overall Study|Adverse Event|4
5645055|NCT00601640|19495585|P1|Overall Study|Adverse Event|0
5645056|NCT00601640|19495583|P3|Overall Study|Death|0
5645057|NCT00601640|19495584|P2|Overall Study|Death|0
5645058|NCT00601640|19495585|P1|Overall Study|Death|1
5645059|NCT00601640|19495583|P3|Overall Study|Withdrawal by Subject|7
5645060|NCT00601640|19495584|P2|Overall Study|Withdrawal by Subject|0
5645061|NCT00601640|19495585|P1|Overall Study|Withdrawal by Subject|3
5645062|NCT00601523|19495610|P2|Overall Study|Other|1
5645063|NCT00601523|19495611|P1|Overall Study|Other|9
5645064|NCT00601523|19495610|P2|Overall Study|Withdrawal by Subject|9
5645065|NCT00601523|19495611|P1|Overall Study|Withdrawal by Subject|18
5645066|NCT00601523|19495610|P2|Overall Study|Lost to Follow-up|1
5645067|NCT00601523|19495611|P1|Overall Study|Lost to Follow-up|0
5645068|NCT00601523|19495610|P2|Overall Study|Protocol Violation|1
5645069|NCT00601523|19495611|P1|Overall Study|Protocol Violation|5
5645070|NCT00601523|19495610|P2|Overall Study|Lack of Efficacy|0
5645071|NCT00601523|19495611|P1|Overall Study|Lack of Efficacy|3
5645072|NCT00601523|19495610|P2|Overall Study|Adverse Event|14
5645073|NCT00601523|19495611|P1|Overall Study|Adverse Event|42
5645074|NCT00601458|19495646|P3|Overall Study|Early Termination|1
5645075|NCT00601458|19495647|P2|Overall Study|Early Termination|1
5645076|NCT00601458|19495648|P1|Overall Study|Early Termination|0
5645077|NCT00601458|19495646|P3|Overall Study|Protocol Violation|1
5645078|NCT00601458|19495647|P2|Overall Study|Protocol Violation|2
5645079|NCT00601458|19495648|P1|Overall Study|Protocol Violation|3
5645080|NCT00601458|19495646|P3|Overall Study|Incomplete Data|0
5645081|NCT00601458|19495647|P2|Overall Study|Incomplete Data|2
5645082|NCT00601458|19495648|P1|Overall Study|Incomplete Data|0
5645083|NCT00601458|19495646|P3|Overall Study|Dosing Error|0
5645084|NCT00601458|19495647|P2|Overall Study|Dosing Error|0
5645085|NCT00601458|19495648|P1|Overall Study|Dosing Error|1
5645086|NCT00601419|19495659|P1|Overall Study|Missed Visits|1
5645087|NCT00601419|19495659|P1|Overall Study|Lost to Follow-up|3
5645088|NCT00601354|19495689|P2|Overall Study|Lost to Follow-up|5
5645089|NCT00601354|19495690|P1|Overall Study|Lost to Follow-up|4
5645090|NCT00601250|19495702|P2|Overall Study|Other incl. lack of efficacy|9
5645091|NCT00601250|19495703|P1|Overall Study|Other incl. lack of efficacy|2
5645092|NCT00601250|19495702|P2|Overall Study|Withdrawal by Subject|13
5645093|NCT00601250|19495703|P1|Overall Study|Withdrawal by Subject|4
5645094|NCT00601250|19495702|P2|Overall Study|Lost to Follow-up|6
5645095|NCT00601250|19495703|P1|Overall Study|Lost to Follow-up|2
5645096|NCT00601250|19495702|P2|Overall Study|Protocol Violation|2
5645097|NCT00601250|19495703|P1|Overall Study|Protocol Violation|3
5645098|NCT00601250|19495702|P2|Overall Study|Adverse Event|9
5645099|NCT00601250|19495703|P1|Overall Study|Adverse Event|3
5645100|NCT00601172|19495739|P2|Overall Study|Did not meet continuation criteria|20
5645101|NCT00601172|19495740|P1|Overall Study|Did not meet continuation criteria|19
5645102|NCT00601172|19495739|P2|Overall Study|Withdrawal by Subject|27
5645103|NCT00601172|19495740|P1|Overall Study|Withdrawal by Subject|35
5645104|NCT00601172|19495739|P2|Overall Study|Physician Decision|28
5645105|NCT00601172|19495740|P1|Overall Study|Physician Decision|27
5645106|NCT00601172|19495739|P2|Overall Study|Lost to Follow-up|3
5645107|NCT00601172|19495740|P1|Overall Study|Lost to Follow-up|4
5645108|NCT00601172|19495739|P2|Overall Study|Protocol Violation|5
5645109|NCT00601172|19495740|P1|Overall Study|Protocol Violation|2
5645110|NCT00601172|19495739|P2|Overall Study|Lack of Efficacy|12
5645111|NCT00601172|19495740|P1|Overall Study|Lack of Efficacy|11
5645112|NCT00601172|19495739|P2|Overall Study|Adverse Event|32
5645113|NCT00601172|19495740|P1|Overall Study|Adverse Event|43
5645114|NCT00601107|19495797|P4|Overall Study|Undefined|0
5645115|NCT00601107|19495798|P3|Overall Study|Undefined|1
5645116|NCT00601107|19495799|P2|Overall Study|Undefined|0
5645117|NCT00601107|19495800|P1|Overall Study|Undefined|1
5645118|NCT00601107|19495797|P4|Overall Study|Worsening of Psoriasis|4
5645119|NCT00601107|19495798|P3|Overall Study|Worsening of Psoriasis|1
5645120|NCT00601107|19495799|P2|Overall Study|Worsening of Psoriasis|1
5645121|NCT00601107|19495800|P1|Overall Study|Worsening of Psoriasis|4
5645122|NCT00601107|19495797|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
5645123|NCT00601107|19495798|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
5645124|NCT00601107|19495799|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
5645125|NCT00601107|19495800|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
5645126|NCT00601107|19495797|P4|Overall Study|Lost to Follow-up|3
5645127|NCT00601107|19495798|P3|Overall Study|Lost to Follow-up|0
5645128|NCT00601107|19495799|P2|Overall Study|Lost to Follow-up|3
5645129|NCT00601107|19495800|P1|Overall Study|Lost to Follow-up|3
5645130|NCT00601107|19495797|P4|Overall Study|Withdrawal by Subject|4
5645131|NCT00601107|19495798|P3|Overall Study|Withdrawal by Subject|7
5645132|NCT00601107|19495799|P2|Overall Study|Withdrawal by Subject|4
5645133|NCT00601107|19495800|P1|Overall Study|Withdrawal by Subject|5
5645134|NCT00601107|19495797|P4|Overall Study|Adverse Event|0
5645135|NCT00601107|19495798|P3|Overall Study|Adverse Event|3
5645136|NCT00601107|19495799|P2|Overall Study|Adverse Event|1
5645137|NCT00601107|19495800|P1|Overall Study|Adverse Event|0
5645138|NCT00600938|19495820|P4|Extension Study|Death|0
5645139|NCT00600938|19495821|P3|Extension Study|Death|0
5645140|NCT00600938|19495822|P2|Extension Study|Death|0
5645141|NCT00600938|19495823|P1|Extension Study|Death|1
5645142|NCT00600938|19495820|P4|Extension Study|Lost to Follow-up|0
5645143|NCT00600938|19495821|P3|Extension Study|Lost to Follow-up|2
5645144|NCT00600938|19495822|P2|Extension Study|Lost to Follow-up|1
5645145|NCT00600938|19495823|P1|Extension Study|Lost to Follow-up|1
5645146|NCT00600938|19495820|P4|Extension Study|Withdrawal by Subject|0
5645147|NCT00600938|19495821|P3|Extension Study|Withdrawal by Subject|3
5645148|NCT00600938|19495822|P2|Extension Study|Withdrawal by Subject|2
5645149|NCT00600938|19495823|P1|Extension Study|Withdrawal by Subject|2
5645150|NCT00600938|19495820|P4|Extension Study|Unsatisfactory therapeutic effect|0
5645151|NCT00600938|19495821|P3|Extension Study|Unsatisfactory therapeutic effect|1
5645152|NCT00600938|19495822|P2|Extension Study|Unsatisfactory therapeutic effect|1
5645153|NCT00600938|19495823|P1|Extension Study|Unsatisfactory therapeutic effect|4
5645154|NCT00600938|19495820|P4|Extension Study|Abnormal test procedure results|1
5645155|NCT00600938|19495821|P3|Extension Study|Abnormal test procedure results|1
5645156|NCT00600938|19495822|P2|Extension Study|Abnormal test procedure results|1
5645157|NCT00600938|19495823|P1|Extension Study|Abnormal test procedure results|0
5645158|NCT00600938|19495820|P4|Extension Study|Adverse Event|0
5645159|NCT00600938|19495821|P3|Extension Study|Adverse Event|2
5645160|NCT00600938|19495822|P2|Extension Study|Adverse Event|0
5645161|NCT00600938|19495823|P1|Extension Study|Adverse Event|1
5645162|NCT00600938|19495820|P4|Core Study|Protocol Violation|0
5645163|NCT00600938|19495821|P3|Core Study|Protocol Violation|0
5645164|NCT00600938|19495822|P2|Core Study|Protocol Violation|2
5645165|NCT00600938|19495823|P1|Core Study|Protocol Violation|1
5645166|NCT00600938|19495820|P4|Core Study|Death|0
5645167|NCT00600938|19495821|P3|Core Study|Death|0
5645168|NCT00600938|19495822|P2|Core Study|Death|1
5645169|NCT00600938|19495823|P1|Core Study|Death|1
5645170|NCT00600938|19495820|P4|Core Study|Lost to Follow-up|0
5645171|NCT00600938|19495821|P3|Core Study|Lost to Follow-up|0
5645172|NCT00600938|19495822|P2|Core Study|Lost to Follow-up|2
5645173|NCT00600938|19495823|P1|Core Study|Lost to Follow-up|3
5645174|NCT00600938|19495820|P4|Core Study|Patient withdrew consent|0
5645175|NCT00600938|19495821|P3|Core Study|Patient withdrew consent|0
5645176|NCT00600938|19495822|P2|Core Study|Patient withdrew consent|12
5645177|NCT00600938|19495823|P1|Core Study|Patient withdrew consent|7
5645178|NCT00600938|19495820|P4|Core Study|Unsatisfactory therapeutic effect|0
5645179|NCT00600938|19495821|P3|Core Study|Unsatisfactory therapeutic effect|0
5645180|NCT00600938|19495822|P2|Core Study|Unsatisfactory therapeutic effect|2
5645181|NCT00600938|19495823|P1|Core Study|Unsatisfactory therapeutic effect|1
5645182|NCT00600938|19495820|P4|Core Study|Abnormal test procedure result(s)|0
5645183|NCT00600938|19495821|P3|Core Study|Abnormal test procedure result(s)|0
5645184|NCT00600938|19495822|P2|Core Study|Abnormal test procedure result(s)|2
5645185|NCT00600938|19495823|P1|Core Study|Abnormal test procedure result(s)|3
5645186|NCT00600886|19495887|P2|Extension - After Crossover (CAS)|Death|0
5645188|NCT00600886|19495887|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
5645189|NCT00600886|19495888|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
5645190|NCT00600886|19495887|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
5645191|NCT00600886|19495888|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
5645192|NCT00600886|19495887|P2|Extension - After Crossover (CAS)|Administrative Problems|4
5645193|NCT00600886|19495888|P1|Extension - After Crossover (CAS)|Administrative Problems|4
5645194|NCT00600886|19495887|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
5645195|NCT00600886|19495888|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
5645196|NCT00600886|19495887|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
5645197|NCT00600886|19495888|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
5645198|NCT00600886|19495887|P2|Extension - After Crossover (CAS)|Adverse Event|1
5645199|NCT00600886|19495888|P1|Extension - After Crossover (CAS)|Adverse Event|19
5645200|NCT00600886|19495887|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
5645201|NCT00600886|19495888|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
5645202|NCT00600886|19495887|P2|Extension - Same Treatment (FAS)|Death|1
5645203|NCT00600886|19495888|P1|Extension - Same Treatment (FAS)|Death|1
5645204|NCT00600886|19495887|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
5645205|NCT00600886|19495888|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
5645206|NCT00600886|19495887|P2|Extension - Same Treatment (FAS)|Adverse Event|1
5645207|NCT00600886|19495888|P1|Extension - Same Treatment (FAS)|Adverse Event|4
5645208|NCT00600886|19495887|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
5645209|NCT00600886|19495888|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
5645210|NCT00600886|19495887|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
5645211|NCT00600886|19495888|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
5645212|NCT00600886|19495887|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
5645213|NCT00600886|19495888|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
5645214|NCT00600886|19495887|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
5645215|NCT00600886|19495888|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
5645216|NCT00600886|19495887|P2|Core Phase - Full Analysis Set (FAS)|Death|1
5645217|NCT00600886|19495888|P1|Core Phase - Full Analysis Set (FAS)|Death|0
5645218|NCT00600886|19495887|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
5645219|NCT00600886|19495888|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
5645220|NCT00600886|19495887|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
5645221|NCT00600886|19495888|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
5645222|NCT00600886|19495887|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
5645223|NCT00600886|19495888|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
5645224|NCT00600886|19495887|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
5645225|NCT00600886|19495888|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
5645226|NCT00600886|19495887|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
5645227|NCT00600886|19495888|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
5645228|NCT00600886|19495887|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
5645229|NCT00600886|19495888|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
5645230|NCT00600886|19495887|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
5645231|NCT00600886|19495888|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
5645232|NCT00600821|19495952|P2|Overall Study|Other|3
5645233|NCT00600821|19495953|P1|Overall Study|Other|2
5645234|NCT00600821|19495952|P2|Overall Study|Randomized but not treated|1
5645235|NCT00600821|19495953|P1|Overall Study|Randomized but not treated|0
5645236|NCT00600821|19495952|P2|Overall Study|Objective progression or relapse|1
5645237|NCT00600821|19495953|P1|Overall Study|Objective progression or relapse|0
5645238|NCT00600821|19495952|P2|Overall Study|Terminated by sponsor|6
5645239|NCT00600821|19495953|P1|Overall Study|Terminated by sponsor|8
5645240|NCT00600821|19495952|P2|Overall Study|Withdrawal by Subject|1
5645241|NCT00600821|19495953|P1|Overall Study|Withdrawal by Subject|1
5645242|NCT00600821|19495952|P2|Overall Study|Lost to Follow-up|2
5645243|NCT00600821|19495953|P1|Overall Study|Lost to Follow-up|2
5645244|NCT00600821|19495952|P2|Overall Study|Death|46
5645245|NCT00600821|19495953|P1|Overall Study|Death|45
5645246|NCT00600756|19495981|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
5645247|NCT00600756|19495982|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
5645248|NCT00600756|19495981|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
5645249|NCT00600756|19495982|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
5645250|NCT00600756|19495981|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
5645251|NCT00600756|19495982|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
5645252|NCT00600756|19495981|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
5645253|NCT00600756|19495982|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
5645254|NCT00600756|19495981|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
5645255|NCT00600756|19495982|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
5645256|NCT00600756|19495981|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
5645257|NCT00600756|19495982|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
5645258|NCT00600756|19495981|P2|Overall Study Analysis After 12 Months|Adverse Event|44
5645259|NCT00600756|19495982|P1|Overall Study Analysis After 12 Months|Adverse Event|53
5645260|NCT00600756|19495981|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
5645261|NCT00600756|19495982|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
5645262|NCT00600756|19495981|P2|Analysis After 6 Months|Lost to Follow-up|8
5645263|NCT00600756|19495982|P1|Analysis After 6 Months|Lost to Follow-up|10
5645264|NCT00600756|19495981|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
5645265|NCT00600756|19495982|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
5645266|NCT00600756|19495981|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
5645267|NCT00600756|19495982|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
5645268|NCT00600756|19495981|P2|Analysis After 6 Months|Incorrect Enrollment|21
5645269|NCT00600756|19495982|P1|Analysis After 6 Months|Incorrect Enrollment|12
5645270|NCT00600756|19495981|P2|Analysis After 6 Months|Withdrawal by Subject|30
5645271|NCT00600756|19495982|P1|Analysis After 6 Months|Withdrawal by Subject|38
5645272|NCT00600756|19495981|P2|Analysis After 6 Months|Adverse Event|33
5645273|NCT00600756|19495982|P1|Analysis After 6 Months|Adverse Event|43
5645274|NCT00600613|19496091|P1|Overall Study|Protocol Deviation|1
5645275|NCT00600353|19496097|P2|Overall Study|History of prepartive regimen|1
5645276|NCT00600353|19496098|P1|Overall Study|History of prepartive regimen|0
5645277|NCT00600353|19496097|P2|Overall Study|history of malignancy within 5 years|0
5645278|NCT00600353|19496098|P1|Overall Study|history of malignancy within 5 years|1
5645279|NCT00600171|19496161|P6|Overall Study|Lost to Follow-up|0
5645280|NCT00600171|19496162|P5|Overall Study|Lost to Follow-up|0
5645281|NCT00600171|19496163|P4|Overall Study|Lost to Follow-up|1
5645282|NCT00600171|19496164|P3|Overall Study|Lost to Follow-up|0
5645283|NCT00600171|19496165|P2|Overall Study|Lost to Follow-up|0
5645284|NCT00600171|19496166|P1|Overall Study|Lost to Follow-up|0
5645285|NCT00600171|19496161|P6|Overall Study|Physician Decision|2
5645286|NCT00600171|19496162|P5|Overall Study|Physician Decision|0
5645287|NCT00600171|19496163|P4|Overall Study|Physician Decision|1
5645288|NCT00600171|19496164|P3|Overall Study|Physician Decision|0
5645289|NCT00600171|19496165|P2|Overall Study|Physician Decision|1
5645290|NCT00600171|19496166|P1|Overall Study|Physician Decision|0
5645291|NCT00600171|19496161|P6|Overall Study|Withdrawal by Subject|1
5645292|NCT00600171|19496162|P5|Overall Study|Withdrawal by Subject|1
5645293|NCT00600171|19496163|P4|Overall Study|Withdrawal by Subject|1
5645294|NCT00600171|19496164|P3|Overall Study|Withdrawal by Subject|0
5645295|NCT00600171|19496165|P2|Overall Study|Withdrawal by Subject|0
5645296|NCT00600171|19496166|P1|Overall Study|Withdrawal by Subject|3
5645297|NCT00600171|19496161|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
5645298|NCT00600171|19496162|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
5645299|NCT00600171|19496163|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
5645300|NCT00600171|19496164|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
5645301|NCT00600171|19496165|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
5645302|NCT00600171|19496166|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
5645303|NCT00600171|19496161|P6|Overall Study|Protocol Violation|0
5645304|NCT00600171|19496162|P5|Overall Study|Protocol Violation|0
5645305|NCT00600171|19496163|P4|Overall Study|Protocol Violation|1
5645306|NCT00600171|19496164|P3|Overall Study|Protocol Violation|0
5645307|NCT00600171|19496165|P2|Overall Study|Protocol Violation|2
5645308|NCT00600171|19496166|P1|Overall Study|Protocol Violation|1
5645309|NCT00600171|19496161|P6|Overall Study|Lack of Efficacy|0
5645310|NCT00600171|19496162|P5|Overall Study|Lack of Efficacy|4
5645311|NCT00600171|19496163|P4|Overall Study|Lack of Efficacy|5
5645312|NCT00600171|19496164|P3|Overall Study|Lack of Efficacy|3
5645313|NCT00600171|19496165|P2|Overall Study|Lack of Efficacy|12
5645314|NCT00600171|19496166|P1|Overall Study|Lack of Efficacy|9
5645315|NCT00600171|19496161|P6|Overall Study|Adverse Event|0
5645316|NCT00600171|19496162|P5|Overall Study|Adverse Event|1
5645317|NCT00600171|19496163|P4|Overall Study|Adverse Event|0
5645318|NCT00600171|19496164|P3|Overall Study|Adverse Event|0
5645319|NCT00600171|19496165|P2|Overall Study|Adverse Event|1
5645320|NCT00600171|19496166|P1|Overall Study|Adverse Event|0
5645321|NCT00600119|19496240|P6|Follow-up Period|Other|0
5645322|NCT00600119|19496241|P5|Follow-up Period|Other|0
5645323|NCT00600119|19496242|P4|Follow-up Period|Other|0
5645324|NCT00600119|19496243|P3|Follow-up Period|Other|0
5645325|NCT00600119|19496244|P2|Follow-up Period|Other|0
5645326|NCT00600119|19496245|P1|Follow-up Period|Other|1
5645327|NCT00600119|19496240|P6|Follow-up Period|Adverse Event|1
5645328|NCT00600119|19496241|P5|Follow-up Period|Adverse Event|0
5645329|NCT00600119|19496242|P4|Follow-up Period|Adverse Event|0
5645330|NCT00600119|19496243|P3|Follow-up Period|Adverse Event|0
5645331|NCT00600119|19496244|P2|Follow-up Period|Adverse Event|0
5645332|NCT00600119|19496245|P1|Follow-up Period|Adverse Event|0
5645333|NCT00600119|19496240|P6|Double-blind Treatment Period|Adverse Event|10
5645334|NCT00600119|19496241|P5|Double-blind Treatment Period|Adverse Event|2
5645335|NCT00600119|19496242|P4|Double-blind Treatment Period|Adverse Event|1
5645336|NCT00600119|19496243|P3|Double-blind Treatment Period|Adverse Event|0
5645337|NCT00600119|19496244|P2|Double-blind Treatment Period|Adverse Event|1
5645338|NCT00600119|19496245|P1|Double-blind Treatment Period|Adverse Event|1
5645339|NCT00600119|19496240|P6|Double-blind Treatment Period|Lost to Follow-up|0
5645340|NCT00600119|19496241|P5|Double-blind Treatment Period|Lost to Follow-up|0
5645341|NCT00600119|19496242|P4|Double-blind Treatment Period|Lost to Follow-up|0
5645342|NCT00600119|19496243|P3|Double-blind Treatment Period|Lost to Follow-up|0
5645343|NCT00600119|19496244|P2|Double-blind Treatment Period|Lost to Follow-up|1
5645344|NCT00600119|19496245|P1|Double-blind Treatment Period|Lost to Follow-up|0
5645345|NCT00600119|19496240|P6|Double-blind Treatment Period|Physician Decision|0
5645346|NCT00600119|19496241|P5|Double-blind Treatment Period|Physician Decision|0
5645347|NCT00600119|19496242|P4|Double-blind Treatment Period|Physician Decision|0
5645348|NCT00600119|19496243|P3|Double-blind Treatment Period|Physician Decision|0
5645349|NCT00600119|19496244|P2|Double-blind Treatment Period|Physician Decision|0
5645350|NCT00600119|19496245|P1|Double-blind Treatment Period|Physician Decision|2
5645351|NCT00600119|19496240|P6|Double-blind Treatment Period|Sponsor Decision|0
5645352|NCT00600119|19496241|P5|Double-blind Treatment Period|Sponsor Decision|1
5645353|NCT00600119|19496242|P4|Double-blind Treatment Period|Sponsor Decision|0
5645354|NCT00600119|19496243|P3|Double-blind Treatment Period|Sponsor Decision|0
5645355|NCT00600119|19496244|P2|Double-blind Treatment Period|Sponsor Decision|1
5645356|NCT00600119|19496245|P1|Double-blind Treatment Period|Sponsor Decision|0
5645357|NCT00600119|19496240|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5645358|NCT00600119|19496241|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5645359|NCT00600119|19496242|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5645360|NCT00600119|19496243|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5645361|NCT00600119|19496244|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
5645362|NCT00600119|19496245|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
5645363|NCT00600119|19496240|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
5645364|NCT00600119|19496241|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
5645365|NCT00600119|19496242|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
5645366|NCT00600119|19496243|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
5645367|NCT00600119|19496244|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
5645368|NCT00600119|19496245|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
5645369|NCT00600119|19496240|P6|Double-blind Treatment Period|Other|1
5645370|NCT00600119|19496241|P5|Double-blind Treatment Period|Other|2
5645371|NCT00600119|19496242|P4|Double-blind Treatment Period|Other|0
5645372|NCT00600119|19496243|P3|Double-blind Treatment Period|Other|0
5645373|NCT00600119|19496244|P2|Double-blind Treatment Period|Other|0
5645374|NCT00600119|19496245|P1|Double-blind Treatment Period|Other|0
5645375|NCT00600119|19496240|P6|Double-blind Treatment Period|Withdrawal by Subject|3
5645376|NCT00600119|19496241|P5|Double-blind Treatment Period|Withdrawal by Subject|0
5645377|NCT00600119|19496242|P4|Double-blind Treatment Period|Withdrawal by Subject|1
5645378|NCT00600119|19496243|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5645379|NCT00600119|19496244|P2|Double-blind Treatment Period|Withdrawal by Subject|0
5645380|NCT00600119|19496245|P1|Double-blind Treatment Period|Withdrawal by Subject|2
5645381|NCT00600119|19496240|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
5645382|NCT00600119|19496241|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
5645383|NCT00600119|19496242|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
5645384|NCT00600119|19496243|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
5645385|NCT00600119|19496244|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
5645386|NCT00600119|19496245|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
5645387|NCT00600119|19496240|P6|Single-blind Placebo run-in Period|Adverse Event|1
5645388|NCT00600119|19496241|P5|Single-blind Placebo run-in Period|Adverse Event|0
5645389|NCT00600119|19496242|P4|Single-blind Placebo run-in Period|Adverse Event|1
5645390|NCT00600119|19496243|P3|Single-blind Placebo run-in Period|Adverse Event|0
5645391|NCT00600119|19496244|P2|Single-blind Placebo run-in Period|Adverse Event|0
5645392|NCT00600119|19496245|P1|Single-blind Placebo run-in Period|Adverse Event|0
5645393|NCT00600119|19496240|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
5645394|NCT00600119|19496241|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
5645395|NCT00600119|19496242|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
5645396|NCT00600119|19496243|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
5645397|NCT00600119|19496244|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
5645398|NCT00600119|19496245|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
5645399|NCT00600119|19496240|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
5645400|NCT00600119|19496241|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
5645401|NCT00600119|19496242|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
5645402|NCT00600119|19496243|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
5645403|NCT00600119|19496244|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
5645404|NCT00600119|19496245|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
5645405|NCT00600119|19496240|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
5645406|NCT00600119|19496241|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
5645407|NCT00600119|19496242|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
5645408|NCT00600119|19496243|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
5645409|NCT00600119|19496244|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
5645410|NCT00600119|19496245|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
5645411|NCT00600119|19496240|P6|Single-blind Placebo run-in Period|Other - Not specified|1
5645412|NCT00600119|19496241|P5|Single-blind Placebo run-in Period|Other - Not specified|1
5645413|NCT00600119|19496242|P4|Single-blind Placebo run-in Period|Other - Not specified|0
5645414|NCT00600119|19496243|P3|Single-blind Placebo run-in Period|Other - Not specified|0
5645415|NCT00600119|19496244|P2|Single-blind Placebo run-in Period|Other - Not specified|0
5645416|NCT00600119|19496245|P1|Single-blind Placebo run-in Period|Other - Not specified|1
5645417|NCT00600106|19496279|P2|Overall Study|Withdrawal by Subject|1
5645418|NCT00600106|19496280|P1|Overall Study|Withdrawal by Subject|1
5645419|NCT00600067|19496327|P2|Overall Study|Lack of Efficacy|0
5645420|NCT00600067|19496328|P1|Overall Study|Lack of Efficacy|1
5645421|NCT00600067|19496327|P2|Overall Study|protocol non-compliance|3
5645422|NCT00600067|19496328|P1|Overall Study|protocol non-compliance|0
5645423|NCT00600067|19496327|P2|Overall Study|Lost to Follow-up|3
5645424|NCT00600067|19496328|P1|Overall Study|Lost to Follow-up|2
5645425|NCT00600067|19496327|P2|Overall Study|Adverse Event|1
5645426|NCT00600067|19496328|P1|Overall Study|Adverse Event|0
5645427|NCT00600028|19496338|P2|Second Intervention (12 Weeks)|Adverse Event|2
5645428|NCT00600028|19496339|P1|Second Intervention (12 Weeks)|Adverse Event|0
5645429|NCT00600028|19496338|P2|First Intervention (12 Weeks)|Adverse Event|1
5645430|NCT00600028|19496339|P1|First Intervention (12 Weeks)|Adverse Event|0
5645431|NCT00600028|19496338|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
5645432|NCT00600028|19496339|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
5645433|NCT00599924|19496369|P7|Overall Study|Other|2
5645434|NCT00599924|19496370|P6|Overall Study|Other|0
5645435|NCT00599924|19496371|P5|Overall Study|Other|2
5645436|NCT00599924|19496372|P4|Overall Study|Other|1
5645437|NCT00599924|19496373|P3|Overall Study|Other|0
5645438|NCT00599924|19496374|P2|Overall Study|Other|0
5645439|NCT00599924|19496375|P1|Overall Study|Other|0
5645440|NCT00599924|19496369|P7|Overall Study|Withdrawal by Subject|0
5645441|NCT00599924|19496370|P6|Overall Study|Withdrawal by Subject|0
5645442|NCT00599924|19496371|P5|Overall Study|Withdrawal by Subject|1
5645443|NCT00599924|19496372|P4|Overall Study|Withdrawal by Subject|0
5645444|NCT00599924|19496373|P3|Overall Study|Withdrawal by Subject|1
5645445|NCT00599924|19496374|P2|Overall Study|Withdrawal by Subject|0
5645446|NCT00599924|19496375|P1|Overall Study|Withdrawal by Subject|0
5645447|NCT00599924|19496369|P7|Overall Study|Protocol Violation|0
5645448|NCT00599924|19496370|P6|Overall Study|Protocol Violation|0
5645449|NCT00599924|19496371|P5|Overall Study|Protocol Violation|0
5645450|NCT00599924|19496372|P4|Overall Study|Protocol Violation|1
5645451|NCT00599924|19496373|P3|Overall Study|Protocol Violation|0
5645452|NCT00599924|19496374|P2|Overall Study|Protocol Violation|0
5645453|NCT00599924|19496375|P1|Overall Study|Protocol Violation|0
5645454|NCT00599924|19496369|P7|Overall Study|Death|1
5645455|NCT00599924|19496370|P6|Overall Study|Death|2
5645456|NCT00599924|19496371|P5|Overall Study|Death|0
5645457|NCT00599924|19496372|P4|Overall Study|Death|2
5645458|NCT00599924|19496373|P3|Overall Study|Death|0
5645459|NCT00599924|19496374|P2|Overall Study|Death|0
5645460|NCT00599924|19496375|P1|Overall Study|Death|0
5645461|NCT00599924|19496369|P7|Overall Study|Adverse Event|2
5645462|NCT00599924|19496370|P6|Overall Study|Adverse Event|0
5645463|NCT00599924|19496371|P5|Overall Study|Adverse Event|0
5645464|NCT00599924|19496372|P4|Overall Study|Adverse Event|2
5645465|NCT00599924|19496373|P3|Overall Study|Adverse Event|0
5645466|NCT00599924|19496374|P2|Overall Study|Adverse Event|0
5645467|NCT00599924|19496375|P1|Overall Study|Adverse Event|0
5645468|NCT00599924|19496369|P7|Overall Study|Lack of Efficacy|0
5645469|NCT00599924|19496370|P6|Overall Study|Lack of Efficacy|2
5645470|NCT00599924|19496371|P5|Overall Study|Lack of Efficacy|3
5645471|NCT00599924|19496372|P4|Overall Study|Lack of Efficacy|2
5645472|NCT00599924|19496373|P3|Overall Study|Lack of Efficacy|1
5645473|NCT00599924|19496374|P2|Overall Study|Lack of Efficacy|5
5645474|NCT00599924|19496375|P1|Overall Study|Lack of Efficacy|3
5645475|NCT00599755|19496479|P1|Overall Study|No data available|1
5645476|NCT00599755|19496479|P1|Overall Study|Other Reason|2
5645477|NCT00599755|19496479|P1|Overall Study|Progression of Disease|3
5645478|NCT00599755|19496479|P1|Overall Study|Withdrawal by Subject|2
5645479|NCT00599755|19496479|P1|Overall Study|Adverse Event|11
5645480|NCT00599521|19496490|P2|Overall Study|Pregnancy|2
5645481|NCT00599521|19496491|P1|Overall Study|Pregnancy|0
5645482|NCT00599521|19496490|P2|Overall Study|Lost to Follow-up|23
5645483|NCT00599521|19496491|P1|Overall Study|Lost to Follow-up|23
5645484|NCT00599521|19496490|P2|Overall Study|Protocol Violation|1
5645485|NCT00599521|19496491|P1|Overall Study|Protocol Violation|1
5645486|NCT00599521|19496490|P2|Overall Study|Withdrawal by Subject|34
5645487|NCT00599521|19496491|P1|Overall Study|Withdrawal by Subject|28
5645488|NCT00599521|19496490|P2|Overall Study|Adverse Event|1
5645489|NCT00599521|19496491|P1|Overall Study|Adverse Event|4
5645490|NCT00599521|19496490|P2|Overall Study|Lack of Efficacy|8
5645491|NCT00599521|19496491|P1|Overall Study|Lack of Efficacy|4
5645492|NCT00599339|19496505|P1|Overall Study|Study Termination Status Unknown|12
5645493|NCT00599339|19496505|P1|Overall Study|No valid data consent|36
5645494|NCT00599339|19496505|P1|Overall Study|Lost to Follow-up|221
5645495|NCT00599339|19496505|P1|Overall Study|Other Reason|179
5645496|NCT00599339|19496505|P1|Overall Study|Withdrawal by Subject|137
5645497|NCT00599339|19496505|P1|Overall Study|Adverse Event|79
5645498|NCT00599326|19496607|P1|Overall Study|Noncompliant|1
5645499|NCT00599326|19496607|P1|Overall Study|Lost to Follow-up|1
5645500|NCT00599313|19496612|P1|Overall Study|Ineligible|1
5645501|NCT00599313|19496612|P1|Overall Study|Patient Request|4
5645502|NCT00599313|19496612|P1|Overall Study|Disease Progression|12
5645503|NCT00599313|19496612|P1|Overall Study|Adverse Event|19
5645504|NCT00599196|19496654|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
5645505|NCT00599196|19496654|P1|Overall Study|Other: Patient Stopped Due To Moving|1
5645506|NCT00599196|19496654|P1|Overall Study|Other: Pt Moved To Australia|1
5645507|NCT00599196|19496654|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
5645508|NCT00599196|19496654|P1|Overall Study|Other: Spouse Withdrew Consent|1
5645509|NCT00599196|19496654|P1|Overall Study|Other: Patient Leaving For Israel|1
5645510|NCT00599196|19496654|P1|Overall Study|Lost to Follow-up|17
5645511|NCT00599196|19496654|P1|Overall Study|Study ended per sponsor|197
5645512|NCT00599196|19496654|P1|Overall Study|Subject withdrew consent|43
5645513|NCT00599196|19496654|P1|Overall Study|Unsatisfactory compliance of subject|3
5645514|NCT00599196|19496654|P1|Overall Study|Adverse Event|93
5645515|NCT00599196|19496654|P1|Overall Study|Lack of Efficacy|22
5645516|NCT00599027|19496685|P2|Overall Study|Treatment Failure|1
5645517|NCT00599027|19496686|P1|Overall Study|Treatment Failure|0
5645518|NCT00599027|19496685|P2|Overall Study|Adverse Event|1
5645519|NCT00599027|19496686|P1|Overall Study|Adverse Event|0
5645520|NCT00599027|19496685|P2|Overall Study|Withdrawal by Subject|1
5645521|NCT00599027|19496686|P1|Overall Study|Withdrawal by Subject|1
5645522|NCT00598871|19496699|P2|Overall Study|Adverse Event|1
5645523|NCT00598871|19496700|P1|Overall Study|Adverse Event|0
5645524|NCT00598832|19496710|P2|Overall Study|Non compliance|0
5645525|NCT00598832|19496711|P1|Overall Study|Non compliance|1
5645526|NCT00598832|19496710|P2|Overall Study|Physician Decision|4
5645527|NCT00598832|19496711|P1|Overall Study|Physician Decision|1
5645528|NCT00598832|19496710|P2|Overall Study|Pregnancy|2
5645529|NCT00598832|19496711|P1|Overall Study|Pregnancy|2
5645530|NCT00598832|19496710|P2|Overall Study|Lost to Follow-up|29
5645531|NCT00598832|19496711|P1|Overall Study|Lost to Follow-up|24
5645532|NCT00598832|19496710|P2|Overall Study|Protocol Violation|2
5645533|NCT00598832|19496711|P1|Overall Study|Protocol Violation|0
5645534|NCT00598832|19496710|P2|Overall Study|Withdrawal by Subject|36
5645535|NCT00598832|19496711|P1|Overall Study|Withdrawal by Subject|25
5645536|NCT00598832|19496710|P2|Overall Study|Adverse Event|2
5645537|NCT00598832|19496711|P1|Overall Study|Adverse Event|6
5645538|NCT00598832|19496710|P2|Overall Study|Lack of Efficacy|7
5645539|NCT00598832|19496711|P1|Overall Study|Lack of Efficacy|3
5645540|NCT00598702|19496764|P8|Overall Study|Dose limiting toxicity|0
5645541|NCT00598702|19496765|P7|Overall Study|Dose limiting toxicity|0
5645542|NCT00598702|19496766|P6|Overall Study|Dose limiting toxicity|1
5645543|NCT00598702|19496767|P5|Overall Study|Dose limiting toxicity|1
5645544|NCT00598702|19496768|P4|Overall Study|Dose limiting toxicity|1
5645545|NCT00598702|19496769|P3|Overall Study|Dose limiting toxicity|0
5645546|NCT00598702|19496770|P2|Overall Study|Dose limiting toxicity|0
5645547|NCT00598702|19496771|P1|Overall Study|Dose limiting toxicity|0
5645548|NCT00598702|19496764|P8|Overall Study|Physician Decision|0
5645549|NCT00598702|19496765|P7|Overall Study|Physician Decision|0
5645550|NCT00598702|19496766|P6|Overall Study|Physician Decision|0
5645551|NCT00598702|19496767|P5|Overall Study|Physician Decision|1
5645552|NCT00598702|19496768|P4|Overall Study|Physician Decision|0
5645553|NCT00598702|19496769|P3|Overall Study|Physician Decision|0
5645554|NCT00598702|19496770|P2|Overall Study|Physician Decision|0
5645555|NCT00598702|19496771|P1|Overall Study|Physician Decision|0
5645556|NCT00598702|19496764|P8|Overall Study|Withdrawal by Subject|0
5645557|NCT00598702|19496765|P7|Overall Study|Withdrawal by Subject|0
5645558|NCT00598702|19496766|P6|Overall Study|Withdrawal by Subject|0
5645559|NCT00598702|19496767|P5|Overall Study|Withdrawal by Subject|1
5645560|NCT00598702|19496768|P4|Overall Study|Withdrawal by Subject|1
5645561|NCT00598702|19496769|P3|Overall Study|Withdrawal by Subject|0
5645562|NCT00598702|19496770|P2|Overall Study|Withdrawal by Subject|0
5645563|NCT00598702|19496771|P1|Overall Study|Withdrawal by Subject|0
5645564|NCT00598702|19496764|P8|Overall Study|Adverse Event|0
5645565|NCT00598702|19496765|P7|Overall Study|Adverse Event|0
5645566|NCT00598702|19496766|P6|Overall Study|Adverse Event|0
5645567|NCT00598702|19496767|P5|Overall Study|Adverse Event|0
5645568|NCT00598702|19496768|P4|Overall Study|Adverse Event|1
5645569|NCT00598702|19496769|P3|Overall Study|Adverse Event|0
5645570|NCT00598702|19496770|P2|Overall Study|Adverse Event|0
5645571|NCT00598702|19496771|P1|Overall Study|Adverse Event|0
5645572|NCT00598702|19496764|P8|Overall Study|Early discharge from hospital|0
5645573|NCT00598702|19496765|P7|Overall Study|Early discharge from hospital|1
5645574|NCT00598702|19496766|P6|Overall Study|Early discharge from hospital|10
5645575|NCT00598702|19496767|P5|Overall Study|Early discharge from hospital|0
5645576|NCT00598702|19496768|P4|Overall Study|Early discharge from hospital|5
5645577|NCT00598702|19496769|P3|Overall Study|Early discharge from hospital|2
5645578|NCT00598702|19496770|P2|Overall Study|Early discharge from hospital|0
5645579|NCT00598702|19496771|P1|Overall Study|Early discharge from hospital|0
5645580|NCT00598702|19496764|P8|Overall Study|Other|0
5645581|NCT00598702|19496765|P7|Overall Study|Other|0
5645582|NCT00598702|19496766|P6|Overall Study|Other|1
5645583|NCT00598702|19496767|P5|Overall Study|Other|0
5645584|NCT00598702|19496768|P4|Overall Study|Other|0
5645585|NCT00598702|19496769|P3|Overall Study|Other|0
5645586|NCT00598702|19496770|P2|Overall Study|Other|2
5645587|NCT00598702|19496771|P1|Overall Study|Other|0
5645588|NCT00598650|19496847|P1|Overall Study|Physician Decision|2
5645589|NCT00598650|19496847|P1|Overall Study|Prohibited Concomitant Medication|2
5645590|NCT00598650|19496847|P1|Overall Study|Not eligible|1
5645591|NCT00598650|19496847|P1|Overall Study|No treatment for 3 weeks|1
5645592|NCT00598650|19496847|P1|Overall Study|Adverse Event|18
5645593|NCT00598650|19496847|P1|Overall Study|Withdrawal by Subject|3
5645594|NCT00598585|19496856|P2|Overall Study|Lost to Follow-up|0
5645595|NCT00598585|19496857|P1|Overall Study|Lost to Follow-up|1
5645596|NCT00598559|19496866|P3|Overall Study|Subject unable/unwilling to attend visit|0
5645687|NCT00597753|19497103|P1|Overall Study|Relocation|17
5645597|NCT00598559|19496867|P2|Overall Study|Subject unable/unwilling to attend visit|7
5645598|NCT00598559|19496868|P1|Overall Study|Subject unable/unwilling to attend visit|4
5645599|NCT00598559|19496866|P3|Overall Study|Early discharge from hospital|3
5645600|NCT00598559|19496867|P2|Overall Study|Early discharge from hospital|12
5645601|NCT00598559|19496868|P1|Overall Study|Early discharge from hospital|9
5645602|NCT00598559|19496866|P3|Overall Study|Protocol Non-compliance|0
5645603|NCT00598559|19496867|P2|Overall Study|Protocol Non-compliance|0
5645604|NCT00598559|19496868|P1|Overall Study|Protocol Non-compliance|1
5645605|NCT00598559|19496866|P3|Overall Study|Withdrawal by Subject|0
5645606|NCT00598559|19496867|P2|Overall Study|Withdrawal by Subject|2
5645607|NCT00598559|19496868|P1|Overall Study|Withdrawal by Subject|2
5645608|NCT00598559|19496866|P3|Overall Study|Adverse Event|0
5645609|NCT00598559|19496867|P2|Overall Study|Adverse Event|7
5645610|NCT00598559|19496868|P1|Overall Study|Adverse Event|11
5645611|NCT00598481|19496892|P1|Treatment|Physician Decision|1
5645612|NCT00598442|19496902|P3|Overall Study|Started dialysis|0
5645613|NCT00598442|19496903|P2|Overall Study|Started dialysis|0
5645614|NCT00598442|19496904|P1|Overall Study|Started dialysis|1
5645615|NCT00598442|19496902|P3|Overall Study|Site closed by sponsor|1
5645616|NCT00598442|19496903|P2|Overall Study|Site closed by sponsor|2
5645617|NCT00598442|19496904|P1|Overall Study|Site closed by sponsor|5
5645618|NCT00598442|19496902|P3|Overall Study|Renal transplant|1
5645619|NCT00598442|19496903|P2|Overall Study|Renal transplant|0
5645620|NCT00598442|19496904|P1|Overall Study|Renal transplant|0
5645621|NCT00598442|19496902|P3|Overall Study|Relocation|0
5645622|NCT00598442|19496903|P2|Overall Study|Relocation|4
5645623|NCT00598442|19496904|P1|Overall Study|Relocation|1
5645624|NCT00598442|19496902|P3|Overall Study|Noncompliance|1
5645625|NCT00598442|19496903|P2|Overall Study|Noncompliance|2
5645626|NCT00598442|19496904|P1|Overall Study|Noncompliance|0
5645627|NCT00598442|19496902|P3|Overall Study|Withdrawal by Subject|6
5645628|NCT00598442|19496903|P2|Overall Study|Withdrawal by Subject|16
5645629|NCT00598442|19496904|P1|Overall Study|Withdrawal by Subject|8
5645630|NCT00598442|19496902|P3|Overall Study|Physician Decision|1
5645631|NCT00598442|19496903|P2|Overall Study|Physician Decision|1
5645632|NCT00598442|19496904|P1|Overall Study|Physician Decision|2
5645633|NCT00598442|19496902|P3|Overall Study|Lost to Follow-up|3
5645634|NCT00598442|19496903|P2|Overall Study|Lost to Follow-up|3
5645635|NCT00598442|19496904|P1|Overall Study|Lost to Follow-up|4
5645636|NCT00598442|19496902|P3|Overall Study|Death|11
5645637|NCT00598442|19496903|P2|Overall Study|Death|11
5645638|NCT00598442|19496904|P1|Overall Study|Death|19
5645639|NCT00598442|19496902|P3|Overall Study|Adverse Event|0
5645640|NCT00598442|19496903|P2|Overall Study|Adverse Event|0
5645641|NCT00598442|19496904|P1|Overall Study|Adverse Event|3
5645642|NCT00598273|19496921|P3|Overall Study|Started dialysis|5
5645643|NCT00598273|19496922|P2|Overall Study|Started dialysis|4
5645644|NCT00598273|19496923|P1|Overall Study|Started dialysis|6
5645645|NCT00598273|19496921|P3|Overall Study|Site elected to close|0
5645646|NCT00598273|19496922|P2|Overall Study|Site elected to close|0
5645647|NCT00598273|19496923|P1|Overall Study|Site elected to close|1
5645648|NCT00598273|19496921|P3|Overall Study|Renal transplant|1
5645649|NCT00598273|19496922|P2|Overall Study|Renal transplant|0
5645650|NCT00598273|19496923|P1|Overall Study|Renal transplant|1
5645651|NCT00598273|19496921|P3|Overall Study|Relocation|4
5645652|NCT00598273|19496922|P2|Overall Study|Relocation|2
5645653|NCT00598273|19496923|P1|Overall Study|Relocation|0
5645654|NCT00598273|19496921|P3|Overall Study|Noncompliance|3
5645655|NCT00598273|19496922|P2|Overall Study|Noncompliance|2
5645656|NCT00598273|19496923|P1|Overall Study|Noncompliance|3
5645657|NCT00598273|19496921|P3|Overall Study|Withdrawal by Subject|10
5645658|NCT00598273|19496922|P2|Overall Study|Withdrawal by Subject|10
5645659|NCT00598273|19496923|P1|Overall Study|Withdrawal by Subject|12
5645660|NCT00598273|19496921|P3|Overall Study|Physician Decision|1
5645661|NCT00598273|19496922|P2|Overall Study|Physician Decision|0
5645662|NCT00598273|19496923|P1|Overall Study|Physician Decision|0
5645663|NCT00598273|19496921|P3|Overall Study|Lost to Follow-up|5
5645664|NCT00598273|19496922|P2|Overall Study|Lost to Follow-up|3
5645665|NCT00598273|19496923|P1|Overall Study|Lost to Follow-up|8
5645666|NCT00598273|19496921|P3|Overall Study|Death|8
5645667|NCT00598273|19496922|P2|Overall Study|Death|12
5645668|NCT00598273|19496923|P1|Overall Study|Death|6
5645669|NCT00598273|19496921|P3|Overall Study|Adverse Event|2
5645670|NCT00598273|19496922|P2|Overall Study|Adverse Event|5
5645671|NCT00598273|19496923|P1|Overall Study|Adverse Event|4
5645672|NCT00598078|19496937|P2|Period 2 (Day 2)|Adverse Event|0
5645673|NCT00598078|19496938|P1|Period 2 (Day 2)|Adverse Event|1
5645674|NCT00597766|19497081|P3|Follow-up 2, Week 8|Lost to Follow-up|1
5645675|NCT00597766|19497082|P2|Follow-up 2, Week 8|Lost to Follow-up|0
5645676|NCT00597766|19497083|P1|Follow-up 2, Week 8|Lost to Follow-up|0
5645677|NCT00597766|19497081|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
5645678|NCT00597766|19497082|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
5645679|NCT00597766|19497083|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
5645680|NCT00597753|19497102|P2|Overall Study|Site elected to close|4
5645681|NCT00597753|19497103|P1|Overall Study|Site elected to close|2
5645682|NCT00597753|19497102|P2|Overall Study|Site closed by sponsor|7
5645683|NCT00597753|19497103|P1|Overall Study|Site closed by sponsor|19
5645684|NCT00597753|19497102|P2|Overall Study|Renal transplant|3
5645685|NCT00597753|19497103|P1|Overall Study|Renal transplant|10
5645686|NCT00597753|19497102|P2|Overall Study|Relocation|6
5645688|NCT00597753|19497102|P2|Overall Study|Noncompliance|1
5645689|NCT00597753|19497103|P1|Overall Study|Noncompliance|2
5645690|NCT00597753|19497102|P2|Overall Study|Never dosed|0
5645691|NCT00597753|19497103|P1|Overall Study|Never dosed|2
5645692|NCT00597753|19497102|P2|Overall Study|Discontinued Dialysis|1
5645693|NCT00597753|19497103|P1|Overall Study|Discontinued Dialysis|0
5645694|NCT00597753|19497102|P2|Overall Study|Withdrawal by Subject|12
5645695|NCT00597753|19497103|P1|Overall Study|Withdrawal by Subject|35
5645696|NCT00597753|19497102|P2|Overall Study|Pregnancy|0
5645697|NCT00597753|19497103|P1|Overall Study|Pregnancy|1
5645698|NCT00597753|19497102|P2|Overall Study|Physician Decision|1
5645699|NCT00597753|19497103|P1|Overall Study|Physician Decision|5
5645700|NCT00597753|19497102|P2|Overall Study|Lost to Follow-up|3
5645701|NCT00597753|19497103|P1|Overall Study|Lost to Follow-up|10
5645702|NCT00597753|19497102|P2|Overall Study|Lack of Efficacy|0
5645703|NCT00597753|19497103|P1|Overall Study|Lack of Efficacy|2
5645704|NCT00597753|19497102|P2|Overall Study|Death|29
5645705|NCT00597753|19497103|P1|Overall Study|Death|55
5645706|NCT00597753|19497102|P2|Overall Study|Adverse Event|2
5645707|NCT00597753|19497103|P1|Overall Study|Adverse Event|6
5645708|NCT00597714|19497137|P3|Overall Study|Recipient death|10
5645709|NCT00597714|19497138|P2|Overall Study|Recipient death|0
5645710|NCT00597714|19497139|P1|Overall Study|Recipient death|0
5645711|NCT00597714|19497137|P3|Overall Study|Death|0
5645712|NCT00597714|19497138|P2|Overall Study|Death|46
5645713|NCT00597714|19497139|P1|Overall Study|Death|56
5645714|NCT00597701|19497151|P2|Overall Study|Did not start intervention (pharmacy er)|2
5645715|NCT00597701|19497152|P1|Overall Study|Did not start intervention (pharmacy er)|0
5645716|NCT00597701|19497151|P2|Overall Study|Physician Decision|0
5645717|NCT00597701|19497152|P1|Overall Study|Physician Decision|2
5645718|NCT00597701|19497151|P2|Overall Study|Death|1
5645719|NCT00597701|19497152|P1|Overall Study|Death|0
5645720|NCT00597701|19497151|P2|Overall Study|Withdrawal by Subject|5
5645721|NCT00597701|19497152|P1|Overall Study|Withdrawal by Subject|5
5645722|NCT00597584|19497174|P2|Overall Study|Renal transplant|7
5645723|NCT00597584|19497175|P1|Overall Study|Renal transplant|9
5645724|NCT00597584|19497174|P2|Overall Study|Relocation|6
5645725|NCT00597584|19497175|P1|Overall Study|Relocation|8
5645726|NCT00597584|19497174|P2|Overall Study|Never dosed|0
5645727|NCT00597584|19497175|P1|Overall Study|Never dosed|1
5645728|NCT00597584|19497174|P2|Overall Study|Lost ability to consent|1
5645729|NCT00597584|19497175|P1|Overall Study|Lost ability to consent|1
5645730|NCT00597584|19497174|P2|Overall Study|Discontinued Dialysis|1
5645731|NCT00597584|19497175|P1|Overall Study|Discontinued Dialysis|0
5645732|NCT00597584|19497174|P2|Overall Study|Withdrawal by Subject|12
5645733|NCT00597584|19497175|P1|Overall Study|Withdrawal by Subject|44
5645734|NCT00597584|19497174|P2|Overall Study|Pregnancy|0
5645735|NCT00597584|19497175|P1|Overall Study|Pregnancy|2
5645736|NCT00597584|19497174|P2|Overall Study|Physician Decision|0
5645737|NCT00597584|19497175|P1|Overall Study|Physician Decision|3
5645738|NCT00597584|19497174|P2|Overall Study|Lost to Follow-up|4
5645739|NCT00597584|19497175|P1|Overall Study|Lost to Follow-up|2
5645740|NCT00597584|19497174|P2|Overall Study|Lack of Efficacy|0
5645741|NCT00597584|19497175|P1|Overall Study|Lack of Efficacy|1
5645742|NCT00597584|19497174|P2|Overall Study|Death|30
5645743|NCT00597584|19497175|P1|Overall Study|Death|53
5645744|NCT00597584|19497174|P2|Overall Study|Adverse Event|2
5645745|NCT00597584|19497175|P1|Overall Study|Adverse Event|4
5645746|NCT00597519|19497200|P1|Overall Study|Death|1
5645747|NCT00597506|19497204|P1|Overall Study|Subject is being followed for survival|1
5645748|NCT00597376|19497254|P2|Overall Study|Adverse Event|1
5645749|NCT00597376|19497255|P1|Overall Study|Adverse Event|4
5645750|NCT00597376|19497254|P2|Overall Study|Withdrawal by Subject|3
5645751|NCT00597376|19497255|P1|Overall Study|Withdrawal by Subject|4
5645752|NCT00597207|19497301|P2|Overall Study|Lost to Follow-up|7
5645753|NCT00597207|19497302|P1|Overall Study|Lost to Follow-up|5
5645754|NCT00597116|19497310|P2|Overall Study|Progressive disease|6
5645755|NCT00597116|19497311|P1|Overall Study|Progressive disease|11
5645756|NCT00597116|19497310|P2|Overall Study|Lost to Follow-up|0
5645757|NCT00597116|19497311|P1|Overall Study|Lost to Follow-up|1
5645758|NCT00597116|19497310|P2|Overall Study|Death|1
5645759|NCT00597116|19497311|P1|Overall Study|Death|0
5645760|NCT00597116|19497310|P2|Overall Study|Physician Decision|1
5645761|NCT00597116|19497311|P1|Overall Study|Physician Decision|0
5645762|NCT00597116|19497310|P2|Overall Study|Withdrawal by Subject|2
5645763|NCT00597116|19497311|P1|Overall Study|Withdrawal by Subject|0
5645764|NCT00597116|19497310|P2|Overall Study|Adverse Event|1
5645765|NCT00597116|19497311|P1|Overall Study|Adverse Event|2
5645766|NCT00597012|19497337|P2|Overall Study|Lost to Follow-up|2
5645767|NCT00597012|19497338|P1|Overall Study|Lost to Follow-up|0
5645768|NCT00597012|19497337|P2|Overall Study|Ineligible|0
5645769|NCT00597012|19497338|P1|Overall Study|Ineligible|2
5645770|NCT00597012|19497337|P2|Overall Study|Withdrawal by Subject|4
5645771|NCT00597012|19497338|P1|Overall Study|Withdrawal by Subject|7
5645772|NCT00597012|19497337|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
5645773|NCT00597012|19497338|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
5645774|NCT00597012|19497337|P2|Overall Study|Death|1
5645775|NCT00597012|19497338|P1|Overall Study|Death|1
5645776|NCT00596960|19497354|P2|Overall Study|No alcohol use data|1
5645777|NCT00596960|19497355|P1|Overall Study|No alcohol use data|0
5645778|NCT00596960|19497354|P2|Overall Study|Protocol Violation|1
5645779|NCT00596960|19497355|P1|Overall Study|Protocol Violation|0
5645780|NCT00596960|19497354|P2|Overall Study|Physician Decision|0
5645781|NCT00596960|19497355|P1|Overall Study|Physician Decision|1
5645782|NCT00596960|19497354|P2|Overall Study|Incarcerated|0
5645783|NCT00596960|19497355|P1|Overall Study|Incarcerated|2
5645784|NCT00596960|19497354|P2|Overall Study|Withdrawal by Subject|0
5645785|NCT00596960|19497355|P1|Overall Study|Withdrawal by Subject|1
5645786|NCT00596960|19497354|P2|Overall Study|Lost to Follow-up|5
5645787|NCT00596960|19497355|P1|Overall Study|Lost to Follow-up|6
5645788|NCT00596960|19497354|P2|Overall Study|Death|2
5645789|NCT00596960|19497355|P1|Overall Study|Death|1
5645790|NCT00596947|19497367|P2|Overall Study|Lost to Follow-up|0
5645791|NCT00596947|19497368|P1|Overall Study|Lost to Follow-up|1
5645792|NCT00596947|19497367|P2|Overall Study|study halted due to low enrollment|3
5645793|NCT00596947|19497368|P1|Overall Study|study halted due to low enrollment|5
5645794|NCT00596934|19497408|P1|Overall Study|Withdrawal by Subject|1
5645795|NCT00596934|19497408|P1|Overall Study|Protocol Violation|1
5645796|NCT00596830|19497421|P2|Overall Study|Randomized but not treated|7
5645797|NCT00596830|19497422|P1|Overall Study|Randomized but not treated|3
5645798|NCT00596830|19497421|P2|Overall Study|Follow-up was discontinued|0
5645799|NCT00596830|19497422|P1|Overall Study|Follow-up was discontinued|1
5645800|NCT00596830|19497421|P2|Overall Study|Study terminated by sponsor|62
5645801|NCT00596830|19497422|P1|Overall Study|Study terminated by sponsor|51
5645802|NCT00596830|19497421|P2|Overall Study|Withdrawal by Subject|12
5645803|NCT00596830|19497422|P1|Overall Study|Withdrawal by Subject|22
5645804|NCT00596830|19497421|P2|Overall Study|Lost to Follow-up|11
5645805|NCT00596830|19497422|P1|Overall Study|Lost to Follow-up|7
5645806|NCT00596830|19497421|P2|Overall Study|Death|247
5645807|NCT00596830|19497422|P1|Overall Study|Death|258
5645808|NCT00596817|19497448|P2|Double-blind Period|Other Reasons|18
5645809|NCT00596817|19497449|P1|Double-blind Period|Other Reasons|10
5645810|NCT00596817|19497448|P2|Double-blind Period|Lost to Follow-up|2
5645811|NCT00596817|19497449|P1|Double-blind Period|Lost to Follow-up|0
5645812|NCT00596817|19497448|P2|Double-blind Period|Withdrawal of Consent|3
5645813|NCT00596817|19497449|P1|Double-blind Period|Withdrawal of Consent|7
5645814|NCT00596817|19497448|P2|Double-blind Period|Protocol Violation|8
5645815|NCT00596817|19497449|P1|Double-blind Period|Protocol Violation|11
5645816|NCT00596817|19497448|P2|Double-blind Period|Non-compliance With Study Product|4
5645817|NCT00596817|19497449|P1|Double-blind Period|Non-compliance With Study Product|3
5645818|NCT00596817|19497448|P2|Double-blind Period|Lack of Efficacy|28
5645819|NCT00596817|19497449|P1|Double-blind Period|Lack of Efficacy|52
5645820|NCT00596817|19497448|P2|Double-blind Period|Adverse Event|16
5645821|NCT00596817|19497449|P1|Double-blind Period|Adverse Event|5
5645822|NCT00596817|19497448|P2|Open-label Period to Double-blind Period|Other Reasons|14
5645823|NCT00596817|19497449|P1|Open-label Period to Double-blind Period|Other Reasons|0
5645824|NCT00596817|19497448|P2|Open-label Period to Double-blind Period|Not Eligible|49
5645825|NCT00596817|19497449|P1|Open-label Period to Double-blind Period|Not Eligible|0
5645826|NCT00596817|19497448|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
5645827|NCT00596817|19497449|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
5645828|NCT00596817|19497448|P2|Open-label Period to Double-blind Period|Adverse Event|5
5645829|NCT00596817|19497449|P1|Open-label Period to Double-blind Period|Adverse Event|0
5645830|NCT00596817|19497448|P2|Open-label Period|Other Reasons|65
5645831|NCT00596817|19497449|P1|Open-label Period|Other Reasons|0
5645832|NCT00596817|19497448|P2|Open-label Period|Lack of Efficacy|33
5645833|NCT00596817|19497449|P1|Open-label Period|Lack of Efficacy|0
5645834|NCT00596817|19497448|P2|Open-label Period|Adverse Event|49
5645835|NCT00596817|19497449|P1|Open-label Period|Adverse Event|0
5645836|NCT00596752|19497474|P2|Overall Study|Protocol Violation|0
5645837|NCT00596752|19497475|P1|Overall Study|Protocol Violation|1
5645838|NCT00596752|19497474|P2|Overall Study|Lack of Efficacy|7
5645839|NCT00596752|19497475|P1|Overall Study|Lack of Efficacy|4
5645840|NCT00596752|19497474|P2|Overall Study|Unsatisfactory Compliance|6
5645841|NCT00596752|19497475|P1|Overall Study|Unsatisfactory Compliance|9
5645842|NCT00596752|19497474|P2|Overall Study|Withdrawal by Subject|9
5645843|NCT00596752|19497475|P1|Overall Study|Withdrawal by Subject|12
5645844|NCT00596752|19497474|P2|Overall Study|Lost to Follow-up|38
5645845|NCT00596752|19497475|P1|Overall Study|Lost to Follow-up|22
5645846|NCT00596752|19497474|P2|Overall Study|Adverse Event|34
5645847|NCT00596752|19497475|P1|Overall Study|Adverse Event|34
5645848|NCT00596752|19497474|P2|Overall Study|Other Reason|49
5645849|NCT00596752|19497475|P1|Overall Study|Other Reason|44
5645850|NCT00596687|19497505|P2|Overall Study|cancelled surgery|1
5645851|NCT00596687|19497506|P1|Overall Study|cancelled surgery|1
5645852|NCT00596687|19497505|P2|Overall Study|Withdrawal by Subject|1
5645853|NCT00596687|19497506|P1|Overall Study|Withdrawal by Subject|3
5645854|NCT00596687|19497505|P2|Overall Study|continuous insulin infusion during TPN|1
5645855|NCT00596687|19497506|P1|Overall Study|continuous insulin infusion during TPN|2
5645856|NCT00596687|19497505|P2|Overall Study|< 24 hours of insulin treatment|6
5645857|NCT00596687|19497506|P1|Overall Study|< 24 hours of insulin treatment|8
5645858|NCT00596635|19497517|P3|Overall Study|Could not provide urine specimen|2
5645859|NCT00596635|19497518|P2|Overall Study|Could not provide urine specimen|2
5645860|NCT00596635|19497519|P1|Overall Study|Could not provide urine specimen|1
5645861|NCT00596635|19497517|P3|Overall Study|Hip fracture|3
5645862|NCT00596635|19497518|P2|Overall Study|Hip fracture|3
5645863|NCT00596635|19497519|P1|Overall Study|Hip fracture|2
5645864|NCT00596635|19497517|P3|Overall Study|Treatment for symptomatic UTI|3
5645865|NCT00596635|19497518|P2|Overall Study|Treatment for symptomatic UTI|6
5645866|NCT00596635|19497519|P1|Overall Study|Treatment for symptomatic UTI|4
5645867|NCT00596635|19497517|P3|Overall Study|Lost to Follow-up|0
5645868|NCT00596635|19497518|P2|Overall Study|Lost to Follow-up|2
5645869|NCT00596635|19497519|P1|Overall Study|Lost to Follow-up|0
5645870|NCT00596466|19497545|P1|Overall Study|Enrolled, not treated|2
5645871|NCT00596466|19497545|P1|Overall Study|Unpecified|2
5645872|NCT00596466|19497545|P1|Overall Study|Protocol Violation|2
5645873|NCT00596466|19497545|P1|Overall Study|Withdrawal by Subject|2
5645874|NCT00596466|19497545|P1|Overall Study|Adverse Event|4
5645875|NCT00596466|19497545|P1|Overall Study|Lack of Efficacy|5
5645876|NCT00596427|19497575|P2|Overall Study|Protocol Violation|0
5645877|NCT00596427|19497576|P1|Overall Study|Protocol Violation|1
5645878|NCT00596427|19497575|P2|Overall Study|Increased Fasting Triacylglycerol level|0
5645879|NCT00596427|19497576|P1|Overall Study|Increased Fasting Triacylglycerol level|1
5645880|NCT00596427|19497575|P2|Overall Study|Withdrawal by Subject|2
5645881|NCT00596427|19497576|P1|Overall Study|Withdrawal by Subject|2
5645882|NCT00596362|19497604|P1|Overall Study|Progressive Disease|1
5645883|NCT00596011|19497640|P2|Overall Study|Adverse Event|7
5645884|NCT00596011|19497641|P1|Overall Study|Adverse Event|11
5645885|NCT00596011|19497640|P2|Overall Study|Withdrawal by Subject|3
5645886|NCT00596011|19497641|P1|Overall Study|Withdrawal by Subject|2
5645887|NCT00595959|19497657|P1|Overall Study|Lost to Follow-up|1
5645888|NCT00595959|19497657|P1|Overall Study|Withdrawal by Subject|1
5645889|NCT00595920|19497691|P1|Overall Study|The OLTERMS study was discontinued by th|116
5645890|NCT00595868|19497702|P2|Overall Study|Lost to Follow-up|50
5645891|NCT00595868|19497703|P1|Overall Study|Lost to Follow-up|45
5645892|NCT00595764|19497726|P2|Overall Study|Withdrawal by Subject|0
5645893|NCT00595764|19497727|P1|Overall Study|Withdrawal by Subject|4
5645894|NCT00595764|19497726|P2|Overall Study|Missed 3 PM visits|7
5645895|NCT00595764|19497727|P1|Overall Study|Missed 3 PM visits|1
5645896|NCT00595764|19497726|P2|Overall Study|Missed Medication >1 week|17
5645897|NCT00595764|19497727|P1|Overall Study|Missed Medication >1 week|10
5645898|NCT00595764|19497726|P2|Overall Study|Protocol Violation|19
5645899|NCT00595764|19497727|P1|Overall Study|Protocol Violation|24
5645900|NCT00595621|19497743|P2|Randomization and Study|Withdrawal by Subject|1
5645901|NCT00595621|19497744|P1|Randomization and Study|Withdrawal by Subject|0
5645902|NCT00595621|19497743|P2|Randomization and Study|Adverse Event|0
5645903|NCT00595621|19497744|P1|Randomization and Study|Adverse Event|2
5645904|NCT00595621|19497743|P2|Open Label Run in|Withdrawal by Subject|0
5645905|NCT00595621|19497744|P1|Open Label Run in|Withdrawal by Subject|1
5645906|NCT00595621|19497743|P2|Open Label Run in|Physician Decision|0
5645907|NCT00595621|19497744|P1|Open Label Run in|Physician Decision|1
5645908|NCT00595621|19497743|P2|Open Label Run in|Adverse Event|0
5645909|NCT00595621|19497744|P1|Open Label Run in|Adverse Event|1
5645910|NCT00595582|19497761|P1|Overall Study|Physician Decision|5
5645911|NCT00595582|19497761|P1|Overall Study|Adverse Event|2
5645912|NCT00595582|19497761|P1|Overall Study|Lost to Follow-up|1
5645913|NCT00595582|19497761|P1|Overall Study|Pilot study that PI terminated|2
5645914|NCT00595517|19497787|P1|Overall Study|No intention to attend regularly|1
5645915|NCT00595517|19497787|P1|Overall Study|usage of prohibited treatment|1
5645916|NCT00595517|19497787|P1|Overall Study|Recurrence of ulcer|5
5645917|NCT00595517|19497787|P1|Overall Study|Protocol Violation|2
5645918|NCT00595517|19497787|P1|Overall Study|Withdrawal by Subject|4
5645919|NCT00595517|19497787|P1|Overall Study|Adverse Event|6
5645920|NCT00595504|19497796|P2|Overall Study|Physician Decision|0
5645921|NCT00595504|19497797|P1|Overall Study|Physician Decision|1
5645922|NCT00595504|19497796|P2|Overall Study|Withdrawal by Subject|3
5645923|NCT00595504|19497797|P1|Overall Study|Withdrawal by Subject|1
5645924|NCT00595478|19497809|P2|36-week Follow-up Period|Withdrawal by Subject|4
5645925|NCT00595478|19497810|P1|36-week Follow-up Period|Withdrawal by Subject|4
5645926|NCT00595478|19497809|P2|36-week Follow-up Period|Lost to Follow-up|4
5645927|NCT00595478|19497810|P1|36-week Follow-up Period|Lost to Follow-up|5
5645928|NCT00595465|19497821|P3|Overall Study|administrative reason|1
5645929|NCT00595465|19497822|P2|Overall Study|administrative reason|0
5645930|NCT00595465|19497823|P1|Overall Study|administrative reason|0
5645931|NCT00595465|19497821|P3|Overall Study|Lost to Follow-up|2
5645932|NCT00595465|19497822|P2|Overall Study|Lost to Follow-up|0
5645933|NCT00595465|19497823|P1|Overall Study|Lost to Follow-up|0
5645934|NCT00595465|19497821|P3|Overall Study|Protocol Violation|0
5645935|NCT00595465|19497822|P2|Overall Study|Protocol Violation|1
5645936|NCT00595465|19497823|P1|Overall Study|Protocol Violation|2
5645937|NCT00595465|19497821|P3|Overall Study|Pregnancy|1
5645938|NCT00595465|19497822|P2|Overall Study|Pregnancy|0
5645939|NCT00595465|19497823|P1|Overall Study|Pregnancy|0
5645940|NCT00595465|19497821|P3|Overall Study|Adverse Event|3
5645941|NCT00595465|19497822|P2|Overall Study|Adverse Event|3
5645942|NCT00595465|19497823|P1|Overall Study|Adverse Event|4
5645943|NCT00595413|19497835|P4|Overall Study|Other|0
5645944|NCT00595413|19497836|P3|Overall Study|Other|5
5645945|NCT00595413|19497837|P2|Overall Study|Other|1
5645946|NCT00595413|19497838|P1|Overall Study|Other|5
5645947|NCT00595413|19497835|P4|Overall Study|Death|0
5645948|NCT00595413|19497836|P3|Overall Study|Death|1
5645949|NCT00595413|19497837|P2|Overall Study|Death|0
5645950|NCT00595413|19497838|P1|Overall Study|Death|0
5645951|NCT00595413|19497835|P4|Overall Study|Lost to Follow-up|3
5645952|NCT00595413|19497836|P3|Overall Study|Lost to Follow-up|1
5645953|NCT00595413|19497837|P2|Overall Study|Lost to Follow-up|2
5645954|NCT00595413|19497838|P1|Overall Study|Lost to Follow-up|2
5645955|NCT00595413|19497835|P4|Overall Study|Adverse Event|1
5645956|NCT00595413|19497836|P3|Overall Study|Adverse Event|1
5645957|NCT00595413|19497837|P2|Overall Study|Adverse Event|2
5645958|NCT00595413|19497838|P1|Overall Study|Adverse Event|0
5645959|NCT00595335|19497879|P2|Six Months to Twelve Months|Disease Progression|0
5645960|NCT00595335|19497880|P1|Six Months to Twelve Months|Disease Progression|1
5645961|NCT00595335|19497879|P2|Six Months to Twelve Months|Withdrawal by Subject|1
5645962|NCT00595335|19497880|P1|Six Months to Twelve Months|Withdrawal by Subject|0
5645963|NCT00595335|19497879|P2|Baseline to Six Months|Adverse Event|0
5645964|NCT00595335|19497880|P1|Baseline to Six Months|Adverse Event|1
5645965|NCT00595335|19497879|P2|Baseline to Six Months|Disease Progression|1
5645966|NCT00595335|19497880|P1|Baseline to Six Months|Disease Progression|1
5645967|NCT00595335|19497879|P2|Baseline to Six Months|Withdrawal by Subject|1
5645968|NCT00595335|19497880|P1|Baseline to Six Months|Withdrawal by Subject|0
5645969|NCT00595309|19497900|P1|Overall Study|personal reason|1
5645970|NCT00595309|19497900|P1|Overall Study|acute infection after V0|1
5645971|NCT00595309|19497900|P1|Overall Study|planned vaccination against yellow fever|1
5645972|NCT00595309|19497900|P1|Overall Study|Lost to Follow-up|1
5645973|NCT00595127|19497949|P1|Overall Study|joined another trial|1
5645974|NCT00595127|19497949|P1|Overall Study|Relapsed|3
5645975|NCT00595127|19497949|P1|Overall Study|Death|6
5645976|NCT00595075|19497995|P2|Overall Study|Withdrawal by Subject|0
5645977|NCT00595075|19497996|P1|Overall Study|Withdrawal by Subject|1
5645978|NCT00594958|19498017|P3|Overall Study|administrative|2
5645979|NCT00594958|19498018|P2|Overall Study|administrative|0
5645980|NCT00594958|19498019|P1|Overall Study|administrative|3
5645981|NCT00594958|19498017|P3|Overall Study|Lost to Follow-up|3
5645982|NCT00594958|19498018|P2|Overall Study|Lost to Follow-up|0
5645983|NCT00594958|19498019|P1|Overall Study|Lost to Follow-up|5
5645984|NCT00594958|19498017|P3|Overall Study|Protocol Violation|2
5645985|NCT00594958|19498018|P2|Overall Study|Protocol Violation|0
5645986|NCT00594958|19498019|P1|Overall Study|Protocol Violation|1
5645987|NCT00594958|19498017|P3|Overall Study|Pregnancy|0
5645988|NCT00594958|19498018|P2|Overall Study|Pregnancy|2
5645989|NCT00594958|19498019|P1|Overall Study|Pregnancy|0
5645990|NCT00594958|19498017|P3|Overall Study|Adverse Event|2
5645991|NCT00594958|19498018|P2|Overall Study|Adverse Event|1
5645992|NCT00594958|19498019|P1|Overall Study|Adverse Event|4
5645993|NCT00594958|19498017|P3|Overall Study|Withdrawal by Subject|1
5645994|NCT00594958|19498018|P2|Overall Study|Withdrawal by Subject|0
5645995|NCT00594958|19498019|P1|Overall Study|Withdrawal by Subject|1
5645996|NCT00594932|19498040|P2|Final 3 Months|Withdrawal by Subject|3
5645997|NCT00594932|19498041|P1|Final 3 Months|Withdrawal by Subject|4
5645998|NCT00594932|19498040|P2|First 3 Months|Withdrawal by Subject|3
5645999|NCT00594932|19498041|P1|First 3 Months|Withdrawal by Subject|1
5646000|NCT00594906|19498053|P2|Overall Study|Death|1
5646001|NCT00594906|19498054|P1|Overall Study|Death|0
5646002|NCT00594906|19498053|P2|Overall Study|Physician Decision|1
5646003|NCT00594906|19498054|P1|Overall Study|Physician Decision|0
5646004|NCT00594906|19498053|P2|Overall Study|Physician Decision|0
5646005|NCT00594906|19498054|P1|Overall Study|Physician Decision|1
5646006|NCT00594880|19498062|P2|Overall Study|Lost to Follow-up|0
5646007|NCT00594880|19498063|P1|Overall Study|Lost to Follow-up|1
5646008|NCT00594880|19498062|P2|Overall Study|Withdrawal by Subject|1
5646009|NCT00594880|19498063|P1|Overall Study|Withdrawal by Subject|1
5646010|NCT00594854|19498075|P2|Overall Study|Study terminated|10
5646011|NCT00594854|19498076|P1|Overall Study|Study terminated|7
5646012|NCT00594815|19498086|P1|Overall Study|Toxicity|4
5646013|NCT00594815|19498086|P1|Overall Study|Withdrawal by Subject|2
5646014|NCT00594815|19498086|P1|Overall Study|Never Treated|3
5646015|NCT00594659|19498111|P3|Overall Study|Lost to Follow-up|7
5646016|NCT00594659|19498112|P2|Overall Study|Lost to Follow-up|9
5646017|NCT00594659|19498113|P1|Overall Study|Lost to Follow-up|13
5646018|NCT00594646|19498124|P1|Overall Study|Lost to Follow-up|15
5646019|NCT00594646|19498124|P1|Overall Study|Withdrawal by Subject|1
5646020|NCT00594568|19498132|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
5646021|NCT00594568|19498133|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
5646022|NCT00594568|19498134|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
5646023|NCT00594568|19498132|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
5646024|NCT00594568|19498133|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
5646025|NCT00594568|19498134|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
5646026|NCT00594568|19498132|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
5646027|NCT00594568|19498133|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
5646028|NCT00594568|19498134|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
5646029|NCT00594568|19498132|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
5646030|NCT00594568|19498133|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
5646031|NCT00594568|19498134|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
5646032|NCT00594568|19498132|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
5646033|NCT00594568|19498133|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
5646034|NCT00594568|19498134|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
5646035|NCT00594568|19498132|P3|Safety Follow Up (SFU)-Optional|Death|0
5646036|NCT00594568|19498133|P2|Safety Follow Up (SFU)-Optional|Death|1
5646037|NCT00594568|19498134|P1|Safety Follow Up (SFU)-Optional|Death|0
5646038|NCT00594568|19498132|P3|Delayed Start|Sponsor Decision|59
5646039|NCT00594568|19498133|P2|Delayed Start|Sponsor Decision|66
5646040|NCT00594568|19498134|P1|Delayed Start|Sponsor Decision|77
5646041|NCT00594568|19498132|P3|Delayed Start|Caregiver Decision|2
5646042|NCT00594568|19498133|P2|Delayed Start|Caregiver Decision|6
5646043|NCT00594568|19498134|P1|Delayed Start|Caregiver Decision|5
5646044|NCT00594568|19498132|P3|Delayed Start|Lost to Follow-up|1
5646045|NCT00594568|19498133|P2|Delayed Start|Lost to Follow-up|0
5646046|NCT00594568|19498134|P1|Delayed Start|Lost to Follow-up|0
5646047|NCT00594568|19498132|P3|Delayed Start|Physician Decision|1
5646048|NCT00594568|19498133|P2|Delayed Start|Physician Decision|0
5646049|NCT00594568|19498134|P1|Delayed Start|Physician Decision|0
5646050|NCT00594568|19498132|P3|Delayed Start|Withdrawal by Subject|0
5646051|NCT00594568|19498133|P2|Delayed Start|Withdrawal by Subject|3
5646052|NCT00594568|19498134|P1|Delayed Start|Withdrawal by Subject|4
5646053|NCT00594568|19498132|P3|Delayed Start|Adverse Event|2
5646054|NCT00594568|19498133|P2|Delayed Start|Adverse Event|2
5646055|NCT00594568|19498134|P1|Delayed Start|Adverse Event|12
5646056|NCT00594568|19498132|P3|Delayed Start|Death|1
5646057|NCT00594568|19498133|P2|Delayed Start|Death|0
5646058|NCT00594568|19498134|P1|Delayed Start|Death|0
5646059|NCT00594568|19498132|P3|Initial Treatment|Entry criteria exclusion|1
5646060|NCT00594568|19498133|P2|Initial Treatment|Entry criteria exclusion|1
5646061|NCT00594568|19498134|P1|Initial Treatment|Entry criteria exclusion|0
5646062|NCT00594568|19498132|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
5646063|NCT00594568|19498133|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
5646064|NCT00594568|19498134|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
5646065|NCT00594568|19498132|P3|Initial Treatment|Caregiver decision|36
5646066|NCT00594568|19498133|P2|Initial Treatment|Caregiver decision|36
5646067|NCT00594568|19498134|P1|Initial Treatment|Caregiver decision|21
5646068|NCT00594568|19498132|P3|Initial Treatment|Sponsor decision|147
5646069|NCT00594568|19498133|P2|Initial Treatment|Sponsor decision|142
5646070|NCT00594568|19498134|P1|Initial Treatment|Sponsor decision|193
5646071|NCT00594568|19498132|P3|Initial Treatment|Withdrawal by Subject|46
5646072|NCT00594568|19498133|P2|Initial Treatment|Withdrawal by Subject|31
5646073|NCT00594568|19498134|P1|Initial Treatment|Withdrawal by Subject|25
5646074|NCT00594568|19498132|P3|Initial Treatment|Protocol Violation|5
5646075|NCT00594568|19498133|P2|Initial Treatment|Protocol Violation|2
5646076|NCT00594568|19498134|P1|Initial Treatment|Protocol Violation|2
5646077|NCT00594568|19498132|P3|Initial Treatment|Physician Decision|4
5646078|NCT00594568|19498133|P2|Initial Treatment|Physician Decision|2
5646079|NCT00594568|19498134|P1|Initial Treatment|Physician Decision|3
5646080|NCT00594568|19498132|P3|Initial Treatment|Lost to Follow-up|4
5646081|NCT00594568|19498133|P2|Initial Treatment|Lost to Follow-up|1
5646082|NCT00594568|19498134|P1|Initial Treatment|Lost to Follow-up|4
5646083|NCT00594568|19498132|P3|Initial Treatment|Death|15
5646084|NCT00594568|19498133|P2|Initial Treatment|Death|11
5646085|NCT00594568|19498134|P1|Initial Treatment|Death|6
5646086|NCT00594568|19498132|P3|Initial Treatment|Adverse Event|144
5646087|NCT00594568|19498133|P2|Initial Treatment|Adverse Event|121
5646088|NCT00594568|19498134|P1|Initial Treatment|Adverse Event|51
5646089|NCT00594516|19498222|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
5646090|NCT00594516|19498223|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
5646091|NCT00594516|19498224|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
5646092|NCT00594516|19498222|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
5646093|NCT00594516|19498223|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
5646094|NCT00594516|19498224|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
5646095|NCT00594516|19498222|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
5646096|NCT00594516|19498223|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
5646097|NCT00594516|19498224|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
5646098|NCT00594516|19498222|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
5646099|NCT00594516|19498223|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
5646100|NCT00594516|19498224|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
5646101|NCT00594516|19498222|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
5646102|NCT00594516|19498223|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
5646103|NCT00594516|19498224|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
5646104|NCT00594516|19498222|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
5646105|NCT00594516|19498223|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
5646106|NCT00594516|19498224|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
5646107|NCT00594516|19498222|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
5646108|NCT00594516|19498223|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
5646109|NCT00594516|19498224|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
5646110|NCT00594516|19498222|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
5646111|NCT00594516|19498223|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
5646112|NCT00594516|19498224|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
5646113|NCT00594516|19498222|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
5646114|NCT00594516|19498223|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
5646115|NCT00594516|19498224|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
5646116|NCT00594464|19498232|P1|Overall Study|Delay in operation|2
5646117|NCT00594464|19498232|P1|Overall Study|Withdrawal by Subject|1
5646118|NCT00594399|19498361|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
5646119|NCT00594399|19498362|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
5646120|NCT00594399|19498363|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
5646121|NCT00594399|19498361|P3|Rerandomization Arm 1 Only|Death|0
5646122|NCT00594399|19498362|P2|Rerandomization Arm 1 Only|Death|1
5646123|NCT00594399|19498363|P1|Rerandomization Arm 1 Only|Death|2
5646124|NCT00594399|19498361|P3|Initial 3 Month Counseling|Family illness|0
5646125|NCT00594399|19498362|P2|Initial 3 Month Counseling|Family illness|0
5646126|NCT00594399|19498363|P1|Initial 3 Month Counseling|Family illness|1
5646127|NCT00594399|19498361|P3|Initial 3 Month Counseling|Moved|0
5646128|NCT00594399|19498362|P2|Initial 3 Month Counseling|Moved|0
5646129|NCT00594399|19498363|P1|Initial 3 Month Counseling|Moved|1
5646130|NCT00594399|19498361|P3|Initial 3 Month Counseling|Pain|0
5646131|NCT00594399|19498362|P2|Initial 3 Month Counseling|Pain|0
5646132|NCT00594399|19498363|P1|Initial 3 Month Counseling|Pain|2
5646133|NCT00594399|19498361|P3|Initial 3 Month Counseling|Too busy|0
5646134|NCT00594399|19498362|P2|Initial 3 Month Counseling|Too busy|1
5646135|NCT00594399|19498363|P1|Initial 3 Month Counseling|Too busy|7
5646136|NCT00594399|19498361|P3|Initial 3 Month Counseling|Personal issues|0
5646137|NCT00594399|19498362|P2|Initial 3 Month Counseling|Personal issues|0
5646138|NCT00594399|19498363|P1|Initial 3 Month Counseling|Personal issues|2
5646139|NCT00594399|19498361|P3|Initial 3 Month Counseling|Lack of Interest|0
5646140|NCT00594399|19498362|P2|Initial 3 Month Counseling|Lack of Interest|3
5646141|NCT00594399|19498363|P1|Initial 3 Month Counseling|Lack of Interest|3
5646142|NCT00594399|19498361|P3|Initial 3 Month Counseling|Not ready to exercise|0
5646143|NCT00594399|19498362|P2|Initial 3 Month Counseling|Not ready to exercise|0
5646144|NCT00594399|19498363|P1|Initial 3 Month Counseling|Not ready to exercise|1
5646145|NCT00594386|19498385|P1|Overall Study|Other: Loss of drivers license|1
5646146|NCT00594386|19498385|P1|Overall Study|Other: Patient wants prescription Neupro|1
5646147|NCT00594386|19498385|P1|Overall Study|Other: Site terminated participation|1
5646148|NCT00594386|19498385|P1|Overall Study|Other: Sponsor closure of study|1
5646149|NCT00594386|19498385|P1|Overall Study|Other: Study terminated per investigator|2
5646150|NCT00594386|19498385|P1|Overall Study|Other: Subject admitted to nursing home|1
5646151|NCT00594386|19498385|P1|Overall Study|Other: Subject moved to Seattle|1
5646152|NCT00594386|19498385|P1|Overall Study|Other: Patient went off patch (hospital)|1
5646153|NCT00594386|19498385|P1|Overall Study|Lost to Follow-up|6
5646154|NCT00594386|19498385|P1|Overall Study|Study ended per sponsor|115
5646155|NCT00594386|19498385|P1|Overall Study|Subject withdrew consent|35
5646156|NCT00594386|19498385|P1|Overall Study|Unsatisfactory compliance of subject|11
5646157|NCT00594386|19498385|P1|Overall Study|Adverse Event|68
5646158|NCT00594386|19498385|P1|Overall Study|Lack of Efficacy|12
5646159|NCT00594386|19498385|P1|Overall Study|Major protocol violation|2
5646160|NCT00594204|19498418|P2|Overall Study|Randomized but not treated|1
5646161|NCT00594204|19498419|P1|Overall Study|Randomized but not treated|4
5646162|NCT00594204|19498418|P2|Overall Study|Lack of Efficacy|4
5646163|NCT00594204|19498419|P1|Overall Study|Lack of Efficacy|3
5646164|NCT00594204|19498418|P2|Overall Study|Other|3
5646165|NCT00594204|19498419|P1|Overall Study|Other|4
5646166|NCT00594204|19498418|P2|Overall Study|Withdrawal by Subject|29
5646167|NCT00594204|19498419|P1|Overall Study|Withdrawal by Subject|23
5646168|NCT00594204|19498418|P2|Overall Study|Lost to Follow-up|5
5646169|NCT00594204|19498419|P1|Overall Study|Lost to Follow-up|9
5646170|NCT00594204|19498418|P2|Overall Study|Adverse Event|3
5646171|NCT00594204|19498419|P1|Overall Study|Adverse Event|15
5646172|NCT00594178|19498429|P1|Overall Study|Physician Decision|5
5646173|NCT00594165|19498434|P1|Overall Study|Other: Site terminated participation|2
5646174|NCT00594165|19498434|P1|Overall Study|Other: Subject enrolled in other trial|1
5646175|NCT00594165|19498434|P1|Overall Study|Other: House bound; can't get to clinic|1
5646176|NCT00594165|19498434|P1|Overall Study|Other: Brain surgery controlled symptoms|1
5646177|NCT00594165|19498434|P1|Overall Study|Other: Subject moving|3
5646178|NCT00594165|19498434|P1|Overall Study|Other: PI discretion|5
5646179|NCT00594165|19498434|P1|Overall Study|Lost to Follow-up|4
5646180|NCT00594165|19498434|P1|Overall Study|Study ended per sponsor|102
5646181|NCT00594165|19498434|P1|Overall Study|Subject withdrew consent|27
5646182|NCT00594165|19498434|P1|Overall Study|Unsatisfactory compliance of subject|6
5646183|NCT00594165|19498434|P1|Overall Study|Adverse Event|52
5646184|NCT00594165|19498434|P1|Overall Study|Lack of Efficacy|12
5646185|NCT00594165|19498434|P1|Overall Study|Major protocol violation|1
5646186|NCT00594100|19498440|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
5646187|NCT00594100|19498440|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
5646188|NCT00594100|19498440|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
5646189|NCT00594100|19498440|P1|Procedure|Technical Failure|9
5646190|NCT00594035|19498456|P2|Overall Study|Subject couldn't return due to job|1
5646191|NCT00594035|19498457|P1|Overall Study|Subject couldn't return due to job|0
5646192|NCT00594035|19498456|P2|Overall Study|Subject transferred to nursing home|1
5646193|NCT00594035|19498457|P1|Overall Study|Subject transferred to nursing home|0
5646194|NCT00594035|19498456|P2|Overall Study|Withdrawal by Subject|0
5646195|NCT00594035|19498457|P1|Overall Study|Withdrawal by Subject|1
5646196|NCT00594035|19498456|P2|Overall Study|Lost to Follow-up|1
5646197|NCT00594035|19498457|P1|Overall Study|Lost to Follow-up|1
5646198|NCT00593957|19498487|P3|Overall Study|Physician Decision|2
5646199|NCT00593957|19498488|P2|Overall Study|Physician Decision|1
5646200|NCT00593957|19498489|P1|Overall Study|Physician Decision|0
5646201|NCT00593918|19498513|P2|Overall Study|Withdrawal by Subject|24
5646202|NCT00593918|19498514|P1|Overall Study|Withdrawal by Subject|5
5646203|NCT00593840|19498527|P1|Overall Study|Withdrawal by Subject|1
5646204|NCT00593827|19498539|P2|Overall Study|On Active Treatment/Pending|2
5646205|NCT00593827|19498540|P1|Overall Study|On Active Treatment/Pending|0
5646206|NCT00593814|19498564|P2|Overall Study|Physician Decision|0
5646207|NCT00593814|19498565|P1|Overall Study|Physician Decision|3
5646208|NCT00593814|19498564|P2|Overall Study|Lost to Follow-up|0
5646209|NCT00593814|19498565|P1|Overall Study|Lost to Follow-up|7
5646210|NCT00593814|19498564|P2|Overall Study|Withdrawal by Subject|0
5646211|NCT00593814|19498565|P1|Overall Study|Withdrawal by Subject|7
5646212|NCT00593814|19498564|P2|Overall Study|Death|0
5646213|NCT00593814|19498565|P1|Overall Study|Death|7
5646214|NCT00593736|19498577|P4|Treatment Period and Placebo Run-out|Various|0
5646215|NCT00593736|19498578|P3|Treatment Period and Placebo Run-out|Various|1
5646216|NCT00593736|19498579|P2|Treatment Period and Placebo Run-out|Various|1
5646217|NCT00593736|19498580|P1|Treatment Period and Placebo Run-out|Various|1
5646218|NCT00593736|19498577|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
5646219|NCT00593736|19498578|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
5646220|NCT00593736|19498579|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
5646221|NCT00593736|19498580|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
5646222|NCT00593736|19498577|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
5646223|NCT00593736|19498578|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
5646224|NCT00593736|19498579|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
5646225|NCT00593736|19498580|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
5646226|NCT00593736|19498577|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
5646227|NCT00593736|19498578|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
5646228|NCT00593736|19498579|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
5646229|NCT00593736|19498580|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
5646230|NCT00593736|19498577|P4|Screening Period and Placebo Run-in|Various|25
5646231|NCT00593736|19498578|P3|Screening Period and Placebo Run-in|Various|0
5646232|NCT00593736|19498579|P2|Screening Period and Placebo Run-in|Various|0
5646233|NCT00593736|19498580|P1|Screening Period and Placebo Run-in|Various|0
5646234|NCT00593736|19498577|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
5646235|NCT00593736|19498578|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
5646236|NCT00593736|19498579|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
5646237|NCT00593736|19498580|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
5646238|NCT00593736|19498577|P4|Screening Period and Placebo Run-in|Study Termination|15
5646239|NCT00593736|19498578|P3|Screening Period and Placebo Run-in|Study Termination|0
5646240|NCT00593736|19498579|P2|Screening Period and Placebo Run-in|Study Termination|0
5646241|NCT00593736|19498580|P1|Screening Period and Placebo Run-in|Study Termination|0
5646242|NCT00593736|19498577|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
5646243|NCT00593736|19498578|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
5646244|NCT00593736|19498579|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
5646245|NCT00593736|19498580|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
5646246|NCT00593736|19498577|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
5646247|NCT00593736|19498578|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
5646248|NCT00593736|19498579|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
5646249|NCT00593736|19498580|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
5646250|NCT00593736|19498577|P4|Screening Period and Placebo Run-in|Adverse Event|3
5646251|NCT00593736|19498578|P3|Screening Period and Placebo Run-in|Adverse Event|0
5646252|NCT00593736|19498579|P2|Screening Period and Placebo Run-in|Adverse Event|0
5646253|NCT00593736|19498580|P1|Screening Period and Placebo Run-in|Adverse Event|0
5646254|NCT00593684|19498828|P2|Overall Study|Death|1
5646255|NCT00593684|19498829|P1|Overall Study|Death|2
5646256|NCT00593606|19498855|P1|Overall Study|Screen Failure|3
5646257|NCT00593606|19498855|P1|Overall Study|Run-In Failure|5
5646258|NCT00593606|19498855|P1|Overall Study|Lost to Follow-up|2
5646259|NCT00593606|19498855|P1|Overall Study|Protocol Violation|3
5646260|NCT00593606|19498855|P1|Overall Study|Withdrawal by Subject|1
5646261|NCT00593606|19498855|P1|Overall Study|Adverse Event|13
5646262|NCT00593554|19498953|P2|Overall Study|Disease Progression|2
5646263|NCT00593554|19498954|P1|Overall Study|Disease Progression|1
5646264|NCT00593554|19498953|P2|Overall Study|Withdrawal by Subject|0
5646265|NCT00593554|19498954|P1|Overall Study|Withdrawal by Subject|1
5646266|NCT00593554|19498953|P2|Overall Study|Physician Decision|1
5646267|NCT00593554|19498954|P1|Overall Study|Physician Decision|0
5646268|NCT00593554|19498953|P2|Overall Study|Death|2
5646269|NCT00593554|19498954|P1|Overall Study|Death|1
5646270|NCT00593489|19498974|P2|Allocation|did not attend workshop; allocation not|1
5646271|NCT00593489|19498975|P1|Allocation|did not attend workshop; allocation not|2
5646272|NCT00593385|19499078|P1|Overall Study|Withdrawal by Subject|9
5646273|NCT00593385|19499078|P1|Overall Study|Lost to Follow-up|17
5646274|NCT00593385|19499078|P1|Overall Study|Death|14
5646275|NCT00593333|19499139|P2|Overall Study|Lost to Follow-up|11
5646276|NCT00593333|19499140|P1|Overall Study|Lost to Follow-up|10
5646277|NCT00593112|19499163|P2|Overall Study|Withdrawal by Subject|0
5646278|NCT00593112|19499164|P1|Overall Study|Withdrawal by Subject|5
5646279|NCT00593112|19499163|P2|Overall Study|Unreadable Scan|0
5646280|NCT00593112|19499164|P1|Overall Study|Unreadable Scan|1
5646281|NCT00593112|19499163|P2|Overall Study|Abnormal Scan|0
5646282|NCT00593112|19499164|P1|Overall Study|Abnormal Scan|1
5646283|NCT00593112|19499163|P2|Overall Study|Scan Anxiety|0
5646284|NCT00593112|19499164|P1|Overall Study|Scan Anxiety|3
5646285|NCT00592904|19499191|P4|Overall Study|Other|0
5646286|NCT00592904|19499192|P3|Overall Study|Other|0
5646287|NCT00592904|19499193|P2|Overall Study|Other|3
5646288|NCT00592904|19499194|P1|Overall Study|Other|3
5646289|NCT00592904|19499191|P4|Overall Study|Physician Decision|0
5646290|NCT00592904|19499192|P3|Overall Study|Physician Decision|1
5646291|NCT00592904|19499193|P2|Overall Study|Physician Decision|3
5646292|NCT00592904|19499194|P1|Overall Study|Physician Decision|0
5646293|NCT00592904|19499191|P4|Overall Study|Lack of Efficacy|3
5646294|NCT00592904|19499192|P3|Overall Study|Lack of Efficacy|2
5646295|NCT00592904|19499193|P2|Overall Study|Lack of Efficacy|7
5646296|NCT00592904|19499194|P1|Overall Study|Lack of Efficacy|2
5646297|NCT00592904|19499191|P4|Overall Study|Withdrawal by Subject|2
5646298|NCT00592904|19499192|P3|Overall Study|Withdrawal by Subject|1
5646299|NCT00592904|19499193|P2|Overall Study|Withdrawal by Subject|16
5646300|NCT00592904|19499194|P1|Overall Study|Withdrawal by Subject|4
5646301|NCT00592904|19499191|P4|Overall Study|Protocol Violation|1
5646302|NCT00592904|19499192|P3|Overall Study|Protocol Violation|0
5646303|NCT00592904|19499193|P2|Overall Study|Protocol Violation|1
5646304|NCT00592904|19499194|P1|Overall Study|Protocol Violation|1
5646305|NCT00592904|19499191|P4|Overall Study|Adverse Event|5
5646306|NCT00592904|19499192|P3|Overall Study|Adverse Event|13
5646307|NCT00592904|19499193|P2|Overall Study|Adverse Event|25
5646308|NCT00592904|19499194|P1|Overall Study|Adverse Event|15
5646309|NCT00592852|19499220|P1|Overall Study|Withdrawal by Subject|1
5646310|NCT00592852|19499220|P1|Overall Study|Found ineligible|1
5646311|NCT00592852|19499220|P1|Overall Study|Adverse Event|3
5646312|NCT00592852|19499220|P1|Overall Study|Non-compliance|1
5646313|NCT00592839|19499228|P3|Overall Study|Lost to Follow-up|1
5646314|NCT00592839|19499229|P2|Overall Study|Lost to Follow-up|1
5646315|NCT00592839|19499230|P1|Overall Study|Lost to Follow-up|0
5646316|NCT00592839|19499228|P3|Overall Study|Adverse Event|0
5646317|NCT00592839|19499229|P2|Overall Study|Adverse Event|1
5646318|NCT00592839|19499230|P1|Overall Study|Adverse Event|0
5646319|NCT00592839|19499228|P3|Overall Study|Protocol Violation|2
5646320|NCT00592839|19499229|P2|Overall Study|Protocol Violation|1
5646321|NCT00592839|19499230|P1|Overall Study|Protocol Violation|1
5646322|NCT00592839|19499228|P3|Overall Study|Withdrawal by Subject|3
5646323|NCT00592839|19499229|P2|Overall Study|Withdrawal by Subject|1
5646324|NCT00592839|19499230|P1|Overall Study|Withdrawal by Subject|1
5646325|NCT00592774|19499258|P5|Overall Study|Other|2
5646326|NCT00592774|19499259|P4|Overall Study|Other|0
5646327|NCT00592774|19499260|P3|Overall Study|Other|1
5646328|NCT00592774|19499261|P2|Overall Study|Other|1
5646329|NCT00592774|19499262|P1|Overall Study|Other|0
5646330|NCT00592774|19499258|P5|Overall Study|Physician Decision|1
5646331|NCT00592774|19499259|P4|Overall Study|Physician Decision|0
5646332|NCT00592774|19499260|P3|Overall Study|Physician Decision|1
5646333|NCT00592774|19499261|P2|Overall Study|Physician Decision|1
5646334|NCT00592774|19499262|P1|Overall Study|Physician Decision|0
5646335|NCT00592774|19499258|P5|Overall Study|Lack of Efficacy|2
5646336|NCT00592774|19499259|P4|Overall Study|Lack of Efficacy|0
5646337|NCT00592774|19499260|P3|Overall Study|Lack of Efficacy|0
5646338|NCT00592774|19499261|P2|Overall Study|Lack of Efficacy|3
5646339|NCT00592774|19499262|P1|Overall Study|Lack of Efficacy|3
5646340|NCT00592774|19499258|P5|Overall Study|Withdrawal by Subject|0
5646341|NCT00592774|19499259|P4|Overall Study|Withdrawal by Subject|0
5646342|NCT00592774|19499260|P3|Overall Study|Withdrawal by Subject|0
5646343|NCT00592774|19499261|P2|Overall Study|Withdrawal by Subject|7
5646344|NCT00592774|19499262|P1|Overall Study|Withdrawal by Subject|3
5646345|NCT00592774|19499258|P5|Overall Study|Protocol Violation|1
5646346|NCT00592774|19499259|P4|Overall Study|Protocol Violation|0
5646347|NCT00592774|19499260|P3|Overall Study|Protocol Violation|0
5646348|NCT00592774|19499261|P2|Overall Study|Protocol Violation|1
5646349|NCT00592774|19499262|P1|Overall Study|Protocol Violation|0
5646350|NCT00592774|19499258|P5|Overall Study|Adverse Event|8
5646351|NCT00592774|19499259|P4|Overall Study|Adverse Event|14
5646352|NCT00592774|19499260|P3|Overall Study|Adverse Event|2
5646353|NCT00592774|19499261|P2|Overall Study|Adverse Event|19
5646354|NCT00592774|19499262|P1|Overall Study|Adverse Event|5
5646355|NCT00592683|19499334|P2|Overall Study|Lost to Follow-up|1
5646356|NCT00592683|19499335|P1|Overall Study|Lost to Follow-up|0
5646357|NCT00592683|19499334|P2|Overall Study|Other|0
5646358|NCT00592683|19499335|P1|Overall Study|Other|1
5646359|NCT00592683|19499334|P2|Overall Study|Study drug expired|0
5646360|NCT00592683|19499335|P1|Overall Study|Study drug expired|1
5646361|NCT00592683|19499334|P2|Overall Study|Protocol Violation|0
5646362|NCT00592683|19499335|P1|Overall Study|Protocol Violation|1
5646363|NCT00592683|19499334|P2|Overall Study|Adverse Event|2
5646364|NCT00592683|19499335|P1|Overall Study|Adverse Event|0
5646365|NCT00592683|19499334|P2|Overall Study|Withdrawal by Subject|0
5646366|NCT00592683|19499335|P1|Overall Study|Withdrawal by Subject|1
5646367|NCT00592683|19499334|P2|Overall Study|Found ineligible|1
5646368|NCT00592683|19499335|P1|Overall Study|Found ineligible|0
5646369|NCT00592631|19499345|P2|Overall Study|Lost to Follow-up|2
5646370|NCT00592631|19499346|P1|Overall Study|Lost to Follow-up|0
5646371|NCT00592553|19499355|P3|Overall Study|Protocol Noncompliance|0
5646372|NCT00592553|19499356|P2|Overall Study|Protocol Noncompliance|0
5646373|NCT00592553|19499357|P1|Overall Study|Protocol Noncompliance|1
5646374|NCT00592384|19499474|P2|Overall Study|Withdrawal by Subject|6
5646375|NCT00592384|19499475|P1|Overall Study|Withdrawal by Subject|5
5646376|NCT00592358|19499483|P1|Overall Study|Inability to swallow pills|1
5646377|NCT00592358|19499483|P1|Overall Study|Lack of Efficacy|2
5646378|NCT00592358|19499483|P1|Overall Study|Adverse Event|1
5646379|NCT00592358|19499483|P1|Overall Study|Withdrawal by Subject|2
5646380|NCT00592319|19499490|P2|Overall Study|Lost to Follow-up|3
5646381|NCT00592319|19499491|P1|Overall Study|Lost to Follow-up|0
5646382|NCT00592072|19499566|P2|Wash Out Period|Lost to Follow-up|1
5646383|NCT00592072|19499567|P1|Wash Out Period|Lost to Follow-up|1
5646384|NCT00592007|19499589|P1|Overall Study|patient ineligible (out of lab range)|1
5646385|NCT00592007|19499589|P1|Overall Study|Withdrawal by Subject|1
5646386|NCT00591864|19499601|P1|Overall Study|Incomplete Imaging|5
5646387|NCT00591851|19499607|P1|Overall Study|Progressive Disease|1
5646388|NCT00591851|19499607|P1|Overall Study|Adverse Event|2
5646389|NCT00591851|19499607|P1|Overall Study|Withdrawal by Subject|3
5646390|NCT00591838|19499616|P5|Overall Study|Withdrawal by Subject|0
5646391|NCT00591838|19499617|P4|Overall Study|Withdrawal by Subject|1
5646392|NCT00591838|19499618|P3|Overall Study|Withdrawal by Subject|0
5646393|NCT00591838|19499619|P2|Overall Study|Withdrawal by Subject|0
5646394|NCT00591838|19499620|P1|Overall Study|Withdrawal by Subject|0
5646395|NCT00591786|19499684|P10|Overall Study|Withdrawal of Informed Consent|0
5646396|NCT00591786|19499685|P9|Overall Study|Withdrawal of Informed Consent|0
5646397|NCT00591786|19499686|P8|Overall Study|Withdrawal of Informed Consent|0
5646398|NCT00591786|19499687|P7|Overall Study|Withdrawal of Informed Consent|0
5646399|NCT00591786|19499688|P6|Overall Study|Withdrawal of Informed Consent|0
5646400|NCT00591786|19499689|P5|Overall Study|Withdrawal of Informed Consent|0
5646401|NCT00591786|19499690|P4|Overall Study|Withdrawal of Informed Consent|0
5646402|NCT00591786|19499691|P3|Overall Study|Withdrawal of Informed Consent|1
5646403|NCT00591786|19499692|P2|Overall Study|Withdrawal of Informed Consent|0
5646404|NCT00591786|19499693|P1|Overall Study|Withdrawal of Informed Consent|0
5646405|NCT00591773|19499738|P3|Overall Study|Other|4
5646406|NCT00591773|19499739|P2|Overall Study|Other|1
5646407|NCT00591773|19499740|P1|Overall Study|Other|1
5646408|NCT00591773|19499738|P3|Overall Study|Lack of Efficacy|2
5646409|NCT00591773|19499739|P2|Overall Study|Lack of Efficacy|2
5646410|NCT00591773|19499740|P1|Overall Study|Lack of Efficacy|1
5646411|NCT00591773|19499738|P3|Overall Study|Withdrawal by Subject|3
5646412|NCT00591773|19499739|P2|Overall Study|Withdrawal by Subject|5
5646413|NCT00591773|19499740|P1|Overall Study|Withdrawal by Subject|2
5646414|NCT00591773|19499738|P3|Overall Study|Lost to Follow-up|1
5646415|NCT00591773|19499739|P2|Overall Study|Lost to Follow-up|4
5646416|NCT00591773|19499740|P1|Overall Study|Lost to Follow-up|1
5646417|NCT00591773|19499738|P3|Overall Study|Protocol Violation|0
5646418|NCT00591773|19499739|P2|Overall Study|Protocol Violation|3
5646419|NCT00591773|19499740|P1|Overall Study|Protocol Violation|2
5646420|NCT00591773|19499738|P3|Overall Study|Adverse Event|6
5646421|NCT00591773|19499739|P2|Overall Study|Adverse Event|9
5646422|NCT00591773|19499740|P1|Overall Study|Adverse Event|9
5646423|NCT00591734|19499799|P1|Overall Study|Intercurrent Illness|8
5646424|NCT00591734|19499799|P1|Overall Study|Physician Decision|5
5646425|NCT00591734|19499799|P1|Overall Study|Adverse Event|5
5646426|NCT00591734|19499799|P1|Overall Study|Lack of Efficacy|35
5646427|NCT00591721|19499805|P2|Overall Study|Intervention not received|8
5646428|NCT00591721|19499806|P1|Overall Study|Intervention not received|10
5646429|NCT00591721|19499805|P2|Overall Study|Lost to Follow-up|4
5646430|NCT00591721|19499806|P1|Overall Study|Lost to Follow-up|1
5646431|NCT00591721|19499805|P2|Overall Study|Withdrawal by Subject|10
5646432|NCT00591721|19499806|P1|Overall Study|Withdrawal by Subject|10
5646433|NCT00591591|19499814|P2|Overall Study|Lack of Efficacy|2
5646434|NCT00591591|19499815|P1|Overall Study|Lack of Efficacy|10
5646435|NCT00591591|19499814|P2|Overall Study|Withdrawal by Subject|37
5646436|NCT00591591|19499815|P1|Overall Study|Withdrawal by Subject|1
5646437|NCT00591578|19499832|P3|Open-Label Extension Phase|Other|0
5646438|NCT00591578|19499833|P2|Open-Label Extension Phase|Other|0
5646439|NCT00591578|19499834|P1|Open-Label Extension Phase|Other|1
5646440|NCT00591578|19499832|P3|Open-Label Extension Phase|Withdrawal by Subject|0
5646441|NCT00591578|19499833|P2|Open-Label Extension Phase|Withdrawal by Subject|1
5646442|NCT00591578|19499834|P1|Open-Label Extension Phase|Withdrawal by Subject|1
5646443|NCT00591578|19499832|P3|Open-Label Extension Phase|Lost to Follow-up|0
5646444|NCT00591578|19499833|P2|Open-Label Extension Phase|Lost to Follow-up|4
5646445|NCT00591578|19499834|P1|Open-Label Extension Phase|Lost to Follow-up|1
5646446|NCT00591578|19499832|P3|Open-Label Extension Phase|Adverse Event|0
5646447|NCT00591578|19499833|P2|Open-Label Extension Phase|Adverse Event|5
5646448|NCT00591578|19499834|P1|Open-Label Extension Phase|Adverse Event|3
5646449|NCT00591578|19499832|P3|Double-Blind Treatment Phase|Other|4
5646450|NCT00591578|19499833|P2|Double-Blind Treatment Phase|Other|9
5646451|NCT00591578|19499834|P1|Double-Blind Treatment Phase|Other|4
5646452|NCT00591578|19499832|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
5646453|NCT00591578|19499833|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
5646454|NCT00591578|19499834|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
5646455|NCT00591578|19499832|P3|Double-Blind Treatment Phase|Pregnancy|0
5646456|NCT00591578|19499833|P2|Double-Blind Treatment Phase|Pregnancy|0
5646457|NCT00591578|19499834|P1|Double-Blind Treatment Phase|Pregnancy|1
5646458|NCT00591578|19499832|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
5646459|NCT00591578|19499833|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
5646460|NCT00591578|19499834|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
5646461|NCT00591578|19499832|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
5646462|NCT00591578|19499833|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
5646463|NCT00591578|19499834|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
5646464|NCT00591578|19499832|P3|Double-Blind Treatment Phase|Protocol Violation|3
5646465|NCT00591578|19499833|P2|Double-Blind Treatment Phase|Protocol Violation|2
5646466|NCT00591578|19499834|P1|Double-Blind Treatment Phase|Protocol Violation|3
5646467|NCT00591578|19499832|P3|Double-Blind Treatment Phase|Adverse Event|19
5646468|NCT00591578|19499833|P2|Double-Blind Treatment Phase|Adverse Event|26
5646469|NCT00591578|19499834|P1|Double-Blind Treatment Phase|Adverse Event|20
5646470|NCT00591565|19499885|P1|Overall Study|lost follow up, withdrawn|5
5646471|NCT00591409|19499899|P10|Overall Study|Not Treated|1
5646472|NCT00591409|19499900|P9|Overall Study|Not Treated|0
5646473|NCT00591409|19499901|P8|Overall Study|Not Treated|0
5646474|NCT00591409|19499902|P7|Overall Study|Not Treated|0
5646475|NCT00591409|19499903|P6|Overall Study|Not Treated|0
5646476|NCT00591409|19499904|P5|Overall Study|Not Treated|1
5646477|NCT00591409|19499905|P4|Overall Study|Not Treated|0
5646478|NCT00591409|19499906|P3|Overall Study|Not Treated|0
5646479|NCT00591409|19499907|P2|Overall Study|Not Treated|0
5646480|NCT00591409|19499908|P1|Overall Study|Not Treated|0
5646481|NCT00591370|19499950|P1|Overall Study|Not Treated|2
5646482|NCT00591344|19499958|P2|Overall Study|Did not want to come off medication|1
5646483|NCT00591344|19499959|P1|Overall Study|Did not want to come off medication|0
5646484|NCT00591344|19499958|P2|Overall Study|Lost to Follow-up|1
5646485|NCT00591344|19499959|P1|Overall Study|Lost to Follow-up|0
5646486|NCT00591344|19499958|P2|Overall Study|Death|1
5646487|NCT00591344|19499959|P1|Overall Study|Death|0
5646488|NCT00591344|19499958|P2|Overall Study|Underwent DBS|2
5646489|NCT00591344|19499959|P1|Overall Study|Underwent DBS|2
5646490|NCT00591344|19499958|P2|Overall Study|Medical complications|3
5646491|NCT00591344|19499959|P1|Overall Study|Medical complications|1
5646492|NCT00591344|19499958|P2|Overall Study|Moved out of state|0
5646493|NCT00591344|19499959|P1|Overall Study|Moved out of state|1
5646494|NCT00591344|19499958|P2|Overall Study|Transportation issues|0
5646495|NCT00591344|19499959|P1|Overall Study|Transportation issues|1
5646496|NCT00591266|19499985|P3|Overall Study|Other|5
5646497|NCT00591266|19499986|P2|Overall Study|Other|4
5646498|NCT00591266|19499987|P1|Overall Study|Other|1
5646499|NCT00591266|19499985|P3|Overall Study|Lack of Efficacy|0
5646500|NCT00591266|19499986|P2|Overall Study|Lack of Efficacy|2
5646501|NCT00591266|19499987|P1|Overall Study|Lack of Efficacy|0
5646502|NCT00591266|19499985|P3|Overall Study|Withdrawal by Subject|5
5646503|NCT00591266|19499986|P2|Overall Study|Withdrawal by Subject|2
5646504|NCT00591266|19499987|P1|Overall Study|Withdrawal by Subject|6
5646505|NCT00591266|19499985|P3|Overall Study|Protocol Violation|1
5646506|NCT00591266|19499986|P2|Overall Study|Protocol Violation|0
5646507|NCT00591266|19499987|P1|Overall Study|Protocol Violation|0
5646508|NCT00591266|19499985|P3|Overall Study|Lost to Follow-up|0
5646509|NCT00591266|19499986|P2|Overall Study|Lost to Follow-up|1
5646510|NCT00591266|19499987|P1|Overall Study|Lost to Follow-up|0
5646511|NCT00591266|19499985|P3|Overall Study|Adverse Event|3
5646512|NCT00591266|19499986|P2|Overall Study|Adverse Event|2
5646513|NCT00591266|19499987|P1|Overall Study|Adverse Event|2
5646514|NCT00591253|19500040|P3|Overall Study|Other|3
5646515|NCT00591253|19500041|P2|Overall Study|Other|5
5646516|NCT00591253|19500042|P1|Overall Study|Other|5
5646517|NCT00591253|19500040|P3|Overall Study|Lack of Efficacy|3
5646518|NCT00591253|19500041|P2|Overall Study|Lack of Efficacy|0
5646519|NCT00591253|19500042|P1|Overall Study|Lack of Efficacy|1
5646520|NCT00591253|19500040|P3|Overall Study|Withdrawal by Subject|6
5646521|NCT00591253|19500041|P2|Overall Study|Withdrawal by Subject|7
5646522|NCT00591253|19500042|P1|Overall Study|Withdrawal by Subject|1
5646523|NCT00591253|19500040|P3|Overall Study|Lost to Follow-up|0
5646524|NCT00591253|19500041|P2|Overall Study|Lost to Follow-up|4
5646525|NCT00591253|19500042|P1|Overall Study|Lost to Follow-up|2
5646526|NCT00591253|19500040|P3|Overall Study|Protocol Violation|2
5646527|NCT00591253|19500041|P2|Overall Study|Protocol Violation|2
5646528|NCT00591253|19500042|P1|Overall Study|Protocol Violation|2
5646529|NCT00591253|19500040|P3|Overall Study|Adverse Event|1
5646530|NCT00591253|19500041|P2|Overall Study|Adverse Event|3
5646531|NCT00591253|19500042|P1|Overall Study|Adverse Event|3
5646532|NCT00591214|19500110|P1|Overall Study|Withdrawal by Subject|1
5646533|NCT00591214|19500110|P1|Overall Study|Physician Decision|7
5646534|NCT00591149|19500119|P1|Overall Study|Withdrawal by Subject|1
5646535|NCT00591149|19500119|P1|Overall Study|Adverse Event|4
5646536|NCT00591006|19500135|P24|Overall Study|Adverse Event|0
5646537|NCT00591006|19500136|P23|Overall Study|Adverse Event|1
5646538|NCT00591006|19500137|P22|Overall Study|Adverse Event|0
5646539|NCT00591006|19500138|P21|Overall Study|Adverse Event|0
5646540|NCT00591006|19500139|P20|Overall Study|Adverse Event|0
5646541|NCT00591006|19500140|P19|Overall Study|Adverse Event|0
5646542|NCT00591006|19500141|P18|Overall Study|Adverse Event|0
5646543|NCT00591006|19500142|P17|Overall Study|Adverse Event|0
5646544|NCT00591006|19500143|P16|Overall Study|Adverse Event|0
5646545|NCT00591006|19500144|P15|Overall Study|Adverse Event|0
5646546|NCT00591006|19500145|P14|Overall Study|Adverse Event|0
5646547|NCT00591006|19500146|P13|Overall Study|Adverse Event|0
5646548|NCT00591006|19500147|P12|Overall Study|Adverse Event|0
5646549|NCT00591006|19500148|P11|Overall Study|Adverse Event|0
5646550|NCT00591006|19500149|P10|Overall Study|Adverse Event|0
5646551|NCT00591006|19500150|P9|Overall Study|Adverse Event|0
5646552|NCT00591006|19500151|P8|Overall Study|Adverse Event|0
5646553|NCT00591006|19500152|P7|Overall Study|Adverse Event|0
5646554|NCT00591006|19500153|P6|Overall Study|Adverse Event|0
5646555|NCT00591006|19500154|P5|Overall Study|Adverse Event|0
5646556|NCT00591006|19500155|P4|Overall Study|Adverse Event|0
5646557|NCT00591006|19500156|P3|Overall Study|Adverse Event|0
5646558|NCT00591006|19500157|P2|Overall Study|Adverse Event|0
5646559|NCT00591006|19500158|P1|Overall Study|Adverse Event|0
5646560|NCT00591006|19500135|P24|Overall Study|Withdrawal by Subject|1
5646561|NCT00591006|19500136|P23|Overall Study|Withdrawal by Subject|0
5646562|NCT00591006|19500137|P22|Overall Study|Withdrawal by Subject|0
5646563|NCT00591006|19500138|P21|Overall Study|Withdrawal by Subject|0
5646564|NCT00591006|19500139|P20|Overall Study|Withdrawal by Subject|0
5646565|NCT00591006|19500140|P19|Overall Study|Withdrawal by Subject|0
5646566|NCT00591006|19500141|P18|Overall Study|Withdrawal by Subject|0
5646567|NCT00591006|19500142|P17|Overall Study|Withdrawal by Subject|0
5646568|NCT00591006|19500143|P16|Overall Study|Withdrawal by Subject|1
5646569|NCT00591006|19500144|P15|Overall Study|Withdrawal by Subject|0
5646570|NCT00591006|19500145|P14|Overall Study|Withdrawal by Subject|0
5646571|NCT00591006|19500146|P13|Overall Study|Withdrawal by Subject|0
5646572|NCT00591006|19500147|P12|Overall Study|Withdrawal by Subject|0
5646573|NCT00591006|19500148|P11|Overall Study|Withdrawal by Subject|0
5646574|NCT00591006|19500149|P10|Overall Study|Withdrawal by Subject|0
5646575|NCT00591006|19500150|P9|Overall Study|Withdrawal by Subject|0
5646576|NCT00591006|19500151|P8|Overall Study|Withdrawal by Subject|0
5646577|NCT00591006|19500152|P7|Overall Study|Withdrawal by Subject|0
5646578|NCT00591006|19500153|P6|Overall Study|Withdrawal by Subject|0
5646579|NCT00591006|19500154|P5|Overall Study|Withdrawal by Subject|0
5646580|NCT00591006|19500155|P4|Overall Study|Withdrawal by Subject|0
5646581|NCT00591006|19500156|P3|Overall Study|Withdrawal by Subject|0
5646582|NCT00591006|19500157|P2|Overall Study|Withdrawal by Subject|0
5646583|NCT00591006|19500158|P1|Overall Study|Withdrawal by Subject|0
5646584|NCT00590980|19500176|P1|Overall Study|Did not meet all inclusion criteria|10
5646585|NCT00590967|19500182|P2|Overall Study|Did not receive chemo per protocol|0
5646586|NCT00590967|19500183|P1|Overall Study|Did not receive chemo per protocol|1
5646587|NCT00590967|19500182|P2|Overall Study|Did not sign consent form|1
5646588|NCT00590967|19500183|P1|Overall Study|Did not sign consent form|0
5646589|NCT00590967|19500182|P2|Overall Study|Non-compliant|2
5646590|NCT00590967|19500183|P1|Overall Study|Non-compliant|0
5646591|NCT00590967|19500182|P2|Overall Study|Poor performance status|1
5646592|NCT00590967|19500183|P1|Overall Study|Poor performance status|0
5646593|NCT00590967|19500182|P2|Overall Study|Ineligible|0
5646594|NCT00590967|19500183|P1|Overall Study|Ineligible|1
5646595|NCT00590967|19500182|P2|Overall Study|Withdrawal by Subject|1
5646596|NCT00590967|19500183|P1|Overall Study|Withdrawal by Subject|1
5646597|NCT00590954|19500195|P1|Overall Study|Inevaluable|2
5646598|NCT00590902|19500201|P1|Overall Study|Death|1
5646599|NCT00590824|19500234|P4|Overall Study|Adverse Event|1
5646600|NCT00590824|19500235|P3|Overall Study|Adverse Event|0
5646601|NCT00590824|19500236|P2|Overall Study|Adverse Event|0
5646602|NCT00590824|19500237|P1|Overall Study|Adverse Event|0
5646603|NCT00590824|19500234|P4|Overall Study|Disease could not be resected|0
5646604|NCT00590824|19500235|P3|Overall Study|Disease could not be resected|1
5646605|NCT00590824|19500236|P2|Overall Study|Disease could not be resected|2
5646606|NCT00590824|19500237|P1|Overall Study|Disease could not be resected|0
5646607|NCT00590759|19500263|P1|Overall Study|Lost to Follow-up|28
5646608|NCT00590759|19500263|P1|Overall Study|Death|52
5646609|NCT00590720|19500270|P2|Overall Study|Withdrawal by Subject|1
5646610|NCT00590720|19500271|P1|Overall Study|Withdrawal by Subject|0
5646611|NCT00590720|19500270|P2|Overall Study|Lost to Follow-up|0
5646612|NCT00590720|19500271|P1|Overall Study|Lost to Follow-up|1
5646613|NCT00590590|19500333|P3|Overall Study|Did not complete study|0
5646614|NCT00590590|19500334|P2|Overall Study|Did not complete study|1
5646615|NCT00590590|19500335|P1|Overall Study|Did not complete study|0
5646616|NCT00590590|19500333|P3|Overall Study|Did not complete due to study closure|1
5646617|NCT00590590|19500334|P2|Overall Study|Did not complete due to study closure|1
5646618|NCT00590590|19500335|P1|Overall Study|Did not complete due to study closure|1
5646619|NCT00590590|19500333|P3|Overall Study|Withdrawal by Subject|1
5646620|NCT00590590|19500334|P2|Overall Study|Withdrawal by Subject|1
5646621|NCT00590590|19500335|P1|Overall Study|Withdrawal by Subject|0
5646622|NCT00590590|19500333|P3|Overall Study|Lost to Follow-up|2
5646623|NCT00590590|19500334|P2|Overall Study|Lost to Follow-up|1
5646624|NCT00590590|19500335|P1|Overall Study|Lost to Follow-up|4
5646625|NCT00590590|19500333|P3|Overall Study|Protocol Violation|2
5646626|NCT00590590|19500334|P2|Overall Study|Protocol Violation|0
5646627|NCT00590590|19500335|P1|Overall Study|Protocol Violation|0
5646628|NCT00590590|19500333|P3|Overall Study|Adverse Event|0
5646629|NCT00590590|19500334|P2|Overall Study|Adverse Event|0
5646630|NCT00590590|19500335|P1|Overall Study|Adverse Event|1
5646631|NCT00590590|19500333|P3|Overall Study|Lack of Efficacy|0
5646632|NCT00590590|19500334|P2|Overall Study|Lack of Efficacy|2
5646633|NCT00590590|19500335|P1|Overall Study|Lack of Efficacy|1
5646634|NCT00590577|19500362|P4|Overall Study|Various reasons|2
5646635|NCT00590577|19500363|P3|Overall Study|Various reasons|1
5646636|NCT00590577|19500364|P2|Overall Study|Various reasons|3
5646637|NCT00590577|19500365|P1|Overall Study|Various reasons|1
5646638|NCT00590577|19500362|P4|Overall Study|Pregnancy|0
5646639|NCT00590577|19500363|P3|Overall Study|Pregnancy|0
5646640|NCT00590577|19500364|P2|Overall Study|Pregnancy|1
5646641|NCT00590577|19500365|P1|Overall Study|Pregnancy|0
5646642|NCT00590577|19500362|P4|Overall Study|Lost to Follow-up|9
5646643|NCT00590577|19500363|P3|Overall Study|Lost to Follow-up|6
5646644|NCT00590577|19500364|P2|Overall Study|Lost to Follow-up|6
5646645|NCT00590577|19500365|P1|Overall Study|Lost to Follow-up|12
5646646|NCT00590577|19500362|P4|Overall Study|Adverse Event|11
5646647|NCT00590577|19500363|P3|Overall Study|Adverse Event|13
5646648|NCT00590577|19500364|P2|Overall Study|Adverse Event|10
5646649|NCT00590577|19500365|P1|Overall Study|Adverse Event|10
5646650|NCT00590577|19500362|P4|Overall Study|Withdrawal by Subject|26
5646651|NCT00590577|19500363|P3|Overall Study|Withdrawal by Subject|30
5646652|NCT00590577|19500364|P2|Overall Study|Withdrawal by Subject|28
5646653|NCT00590577|19500365|P1|Overall Study|Withdrawal by Subject|23
5646654|NCT00590577|19500362|P4|Overall Study|Lack of Efficacy|45
5646655|NCT00590577|19500363|P3|Overall Study|Lack of Efficacy|23
5646656|NCT00590577|19500364|P2|Overall Study|Lack of Efficacy|28
5646657|NCT00590577|19500365|P1|Overall Study|Lack of Efficacy|31
5646658|NCT00590564|19500383|P1|Overall Study|Patient Non-compliance|6
5646659|NCT00590564|19500383|P1|Overall Study|Patient Found to be Ineligible|1
5646660|NCT00590564|19500383|P1|Overall Study|Protocol Violation|1
5646661|NCT00590564|19500383|P1|Overall Study|Lost to Follow-up|6
5646662|NCT00590564|19500383|P1|Overall Study|Withdrawal by Subject|4
5646663|NCT00590538|19500387|P1|Overall Study|Study terminated before completed|2
5646664|NCT00590317|19500433|P2|Overall Study|Lack of Efficacy|5
5646665|NCT00590317|19500434|P1|Overall Study|Lack of Efficacy|1
5646666|NCT00590135|19500464|P1|Overall Study|Primary endpoint measure not obtainable|59
5646667|NCT00590044|19500474|P2|Overall Study|Protocol Violation|0
5646668|NCT00590044|19500475|P1|Overall Study|Protocol Violation|1
5646669|NCT00590044|19500474|P2|Overall Study|wrong insulin arm assigned|0
5646670|NCT00590044|19500475|P1|Overall Study|wrong insulin arm assigned|1
5646671|NCT00590044|19500474|P2|Overall Study|Withdrawal by Subject|2
5646672|NCT00590044|19500475|P1|Overall Study|Withdrawal by Subject|2
5646673|NCT00590031|19500487|P1|Overall Study|Admin Hold|1
5646674|NCT00590031|19500487|P1|Overall Study|Metastatic Disease|1
5646675|NCT00590031|19500487|P1|Overall Study|Withdrawal by Subject|1
5646676|NCT00590031|19500487|P1|Overall Study|Adverse Event|3
5646677|NCT00589979|19500514|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
5646678|NCT00589979|19500515|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
5646679|NCT00589979|19500516|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
5646680|NCT00589979|19500514|P3|Double-Blind Treatment Period 3|Protocol Violation|0
5646681|NCT00589979|19500515|P2|Double-Blind Treatment Period 3|Protocol Violation|1
5646682|NCT00589979|19500516|P1|Double-Blind Treatment Period 3|Protocol Violation|0
5646683|NCT00589979|19500514|P3|Double-Blind Treatment Period 2|Other|1
5646684|NCT00589979|19500515|P2|Double-Blind Treatment Period 2|Other|0
5646685|NCT00589979|19500516|P1|Double-Blind Treatment Period 2|Other|0
5646686|NCT00589979|19500514|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
5646687|NCT00589979|19500515|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
5646688|NCT00589979|19500516|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
5646689|NCT00589979|19500514|P3|Double-Blind Treatment Period 2|Adverse Event|0
5646690|NCT00589979|19500515|P2|Double-Blind Treatment Period 2|Adverse Event|1
5646691|NCT00589979|19500516|P1|Double-Blind Treatment Period 2|Adverse Event|0
5646692|NCT00589979|19500514|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
5646693|NCT00589979|19500515|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
5646694|NCT00589979|19500516|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
5646695|NCT00589979|19500514|P3|Double-Blind Treatment Period 1|Protocol Violation|1
5646696|NCT00589979|19500515|P2|Double-Blind Treatment Period 1|Protocol Violation|1
5646697|NCT00589979|19500516|P1|Double-Blind Treatment Period 1|Protocol Violation|0
5646698|NCT00589979|19500514|P3|Double-Blind Treatment Period 1|Adverse Event|0
5646699|NCT00589979|19500515|P2|Double-Blind Treatment Period 1|Adverse Event|1
5646700|NCT00589979|19500516|P1|Double-Blind Treatment Period 1|Adverse Event|0
5646701|NCT00589979|19500514|P3|Run-In Period|Informed Consent Withdrawn|0
5646702|NCT00589979|19500515|P2|Run-In Period|Informed Consent Withdrawn|0
5646703|NCT00589979|19500516|P1|Run-In Period|Informed Consent Withdrawn|4
5646704|NCT00589979|19500514|P3|Run-In Period|Withdrawal by Subject|0
5646705|NCT00589979|19500515|P2|Run-In Period|Withdrawal by Subject|0
5646706|NCT00589979|19500516|P1|Run-In Period|Withdrawal by Subject|10
5646707|NCT00589979|19500514|P3|Run-In Period|Did not qualify for randomization|0
5646708|NCT00589979|19500515|P2|Run-In Period|Did not qualify for randomization|0
5646709|NCT00589979|19500516|P1|Run-In Period|Did not qualify for randomization|54
5646710|NCT00589979|19500514|P3|Run-In Period|Protocol Violation|0
5646711|NCT00589979|19500515|P2|Run-In Period|Protocol Violation|0
5646712|NCT00589979|19500516|P1|Run-In Period|Protocol Violation|3
5646713|NCT00589979|19500514|P3|Run-In Period|Adverse Event|0
5646714|NCT00589979|19500515|P2|Run-In Period|Adverse Event|0
5646715|NCT00589979|19500516|P1|Run-In Period|Adverse Event|5
5646716|NCT00589914|19500555|P2|Overall Study|Other|17
5646717|NCT00589914|19500556|P1|Overall Study|Other|22
5646718|NCT00589914|19500555|P2|Overall Study|Withdrawal by Subject|49
5646719|NCT00589914|19500556|P1|Overall Study|Withdrawal by Subject|55
5646720|NCT00589914|19500555|P2|Overall Study|Pregnancy|0
5646721|NCT00589914|19500556|P1|Overall Study|Pregnancy|1
5646722|NCT00589914|19500555|P2|Overall Study|Lost to Follow-up|18
5646723|NCT00589914|19500556|P1|Overall Study|Lost to Follow-up|11
5646724|NCT00589914|19500555|P2|Overall Study|Lack of Efficacy|43
5646725|NCT00589914|19500556|P1|Overall Study|Lack of Efficacy|40
5646726|NCT00589914|19500555|P2|Overall Study|Death|0
5646727|NCT00589914|19500556|P1|Overall Study|Death|2
5646728|NCT00589914|19500555|P2|Overall Study|Adverse Event|10
5646729|NCT00589914|19500556|P1|Overall Study|Adverse Event|19
5646730|NCT00589797|19500612|P2|Overall Study|Non-Randomized Training Subjects|6
5646731|NCT00589797|19500613|P1|Overall Study|Non-Randomized Training Subjects|46
5646732|NCT00589797|19500612|P2|Overall Study|Withdrawal by Subject|5
5646733|NCT00589797|19500613|P1|Overall Study|Withdrawal by Subject|6
5646734|NCT00589797|19500612|P2|Overall Study|Physician Decision|3
5646735|NCT00589797|19500613|P1|Overall Study|Physician Decision|8
5646736|NCT00589797|19500612|P2|Overall Study|Lost to Follow-up|9
5646737|NCT00589797|19500613|P1|Overall Study|Lost to Follow-up|12
5646738|NCT00589797|19500612|P2|Overall Study|Death|0
5646739|NCT00589797|19500613|P1|Overall Study|Death|1
5646740|NCT00589784|19500637|P2|Overall Study|Adverse Event|4
5646741|NCT00589784|19500638|P1|Overall Study|Adverse Event|0
5646742|NCT00589784|19500637|P2|Overall Study|Patient inevaluable|0
5646743|NCT00589784|19500638|P1|Overall Study|Patient inevaluable|1
5646744|NCT00589784|19500637|P2|Overall Study|Withdrawal by Subject|6
5646745|NCT00589784|19500638|P1|Overall Study|Withdrawal by Subject|0
5646746|NCT00589693|19500645|P2|Overall Study|Protocol Violation|1
5646747|NCT00589693|19500646|P1|Overall Study|Protocol Violation|1
5646748|NCT00589693|19500645|P2|Overall Study|Physician Decision|1
5646749|NCT00589693|19500646|P1|Overall Study|Physician Decision|0
5646750|NCT00589693|19500645|P2|Overall Study|Lost to Follow-up|0
5646751|NCT00589693|19500646|P1|Overall Study|Lost to Follow-up|1
5646752|NCT00589693|19500645|P2|Overall Study|Lack of Efficacy|1
5646753|NCT00589693|19500646|P1|Overall Study|Lack of Efficacy|0
5646754|NCT00589693|19500645|P2|Overall Study|Death|16
5646755|NCT00589693|19500646|P1|Overall Study|Death|26
5646756|NCT00589693|19500645|P2|Overall Study|Adverse Event|4
5646757|NCT00589693|19500646|P1|Overall Study|Adverse Event|4
5646758|NCT00589693|19500645|P2|Overall Study|randomized in error|6
5646759|NCT00589693|19500646|P1|Overall Study|randomized in error|12
5646760|NCT00589667|19500660|P1|Overall Study|Withdrawal by Subject|1
5646761|NCT00589667|19500660|P1|Overall Study|Adverse Event|2
5646762|NCT00589628|19500667|P2|Overall Study|Lost to Follow-up|1
5646763|NCT00589628|19500668|P1|Overall Study|Lost to Follow-up|0
5646764|NCT00589602|19500674|P1|Overall Study|Did not collect enough CD34+ cells|1
5646765|NCT00589472|19500709|P1|Overall Study|Adverse Event|1
5646766|NCT00589303|19500732|P2|Overall Study|Withdrawal by Subject|1
5646767|NCT00589303|19500733|P1|Overall Study|Withdrawal by Subject|2
5646768|NCT00589290|19500739|P1|Overall Study|Withdrawal by Subject|1
5646769|NCT00589121|19500762|P2|Overall Study|No protocol treatment received|1
5646770|NCT00589121|19500763|P1|Overall Study|No protocol treatment received|0
5646771|NCT00589121|19500762|P2|Overall Study|Protocol Violation|6
5646772|NCT00589121|19500763|P1|Overall Study|Protocol Violation|2
5646773|NCT00589108|19500785|P3|Overall Study|Death|4
5646774|NCT00589108|19500786|P2|Overall Study|Death|3
5646775|NCT00589108|19500787|P1|Overall Study|Death|3
5646776|NCT00589108|19500785|P3|Overall Study|Lost to Follow-up|1
5646777|NCT00589108|19500786|P2|Overall Study|Lost to Follow-up|1
5646778|NCT00589108|19500787|P1|Overall Study|Lost to Follow-up|1
5646779|NCT00588952|19500823|P2|Overall Study|Withdrawal by Subject|5
5646780|NCT00588952|19500824|P1|Overall Study|Withdrawal by Subject|3
5646781|NCT00588952|19500823|P2|Overall Study|Adverse Event|2
5646782|NCT00588952|19500824|P1|Overall Study|Adverse Event|0
5646783|NCT00588861|19500852|P2|10 Years|Incomplete due to study termination|114
5646784|NCT00588861|19500853|P1|10 Years|Incomplete due to study termination|107
5646785|NCT00588861|19500852|P2|8 Years|Patients did not return for follow-up|114
5646786|NCT00588861|19500853|P1|8 Years|Patients did not return for follow-up|105
5646787|NCT00588861|19500852|P2|6 Years|Patients did not return for follow-up|109
5646788|NCT00588861|19500853|P1|6 Years|Patients did not return for follow-up|104
5646789|NCT00588861|19500852|P2|4 Years|Patients did not return for follow-up|103
5646790|NCT00588861|19500853|P1|4 Years|Patients did not return for follow-up|91
5646791|NCT00588861|19500852|P2|2 Years|Patients did not return for follow-up|87
5646792|NCT00588861|19500853|P1|2 Years|Patients did not return for follow-up|92
5646793|NCT00588861|19500852|P2|1 Year|Patients did not return for follow-up|82
5646794|NCT00588861|19500853|P1|1 Year|Patients did not return for follow-up|89
5646795|NCT00588861|19500852|P2|6 Months|Patients did not return for follow-up|73
5646796|NCT00588861|19500853|P1|6 Months|Patients did not return for follow-up|98
5646797|NCT00588861|19500852|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
5646798|NCT00588861|19500853|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
5646799|NCT00588848|19500863|P2|Overall Study|Physician Decision|3
5646800|NCT00588848|19500864|P1|Overall Study|Physician Decision|0
5646801|NCT00588822|19500874|P1|Overall Study|progression of disease|8
5646802|NCT00588770|19500894|P2|Overall Study|Patient non-compliance|2
5646803|NCT00588770|19500895|P1|Overall Study|Patient non-compliance|2
5646804|NCT00588770|19500894|P2|Overall Study|Physician discretion|0
5646805|NCT00588770|19500895|P1|Overall Study|Physician discretion|2
5646806|NCT00588770|19500894|P2|Overall Study|Lack of Efficacy|10
5646807|NCT00588770|19500895|P1|Overall Study|Lack of Efficacy|8
5646808|NCT00588770|19500894|P2|Overall Study|Not start protocol therapy|9
5646809|NCT00588770|19500895|P1|Overall Study|Not start protocol therapy|0
5646810|NCT00588770|19500894|P2|Overall Study|Other complicating disease|2
5646811|NCT00588770|19500895|P1|Overall Study|Other complicating disease|3
5646812|NCT00588770|19500894|P2|Overall Study|Alternative therapy|4
5646813|NCT00588770|19500895|P1|Overall Study|Alternative therapy|2
5646814|NCT00588770|19500894|P2|Overall Study|Withdrawal by Subject|25
5646815|NCT00588770|19500895|P1|Overall Study|Withdrawal by Subject|15
5646816|NCT00588770|19500894|P2|Overall Study|Death|22
5646817|NCT00588770|19500895|P1|Overall Study|Death|13
5646818|NCT00588770|19500894|P2|Overall Study|Adverse Event|58
5646819|NCT00588770|19500895|P1|Overall Study|Adverse Event|29
5646820|NCT00588770|19500894|P2|Overall Study|Disease progression|68
5646821|NCT00588770|19500895|P1|Overall Study|Disease progression|85
5646822|NCT00588731|19500907|P2|Overall Study|Withdrawal by Subject|2
5646823|NCT00588731|19500908|P1|Overall Study|Withdrawal by Subject|3
5646824|NCT00588692|19500918|P2|Overall Study|Death|0
5646825|NCT00588692|19500919|P1|Overall Study|Death|1
5646826|NCT00588692|19500918|P2|Overall Study|Cancer|0
5646827|NCT00588692|19500919|P1|Overall Study|Cancer|1
5646828|NCT00588692|19500918|P2|Overall Study|Severe Peptic Ulcer Disease|0
5646829|NCT00588692|19500919|P1|Overall Study|Severe Peptic Ulcer Disease|1
5646830|NCT00588692|19500918|P2|Overall Study|Hip Surgery|1
5646831|NCT00588692|19500919|P1|Overall Study|Hip Surgery|0
5646832|NCT00588692|19500918|P2|Overall Study|Withdrawal by Subject|2
5646833|NCT00588692|19500919|P1|Overall Study|Withdrawal by Subject|4
5646834|NCT00588666|19500955|P1|Overall Study|Adverse Event|4
5646835|NCT00588640|19500960|P1|Overall Study|Ineligible Patient|1
5646836|NCT00588640|19500960|P1|Overall Study|Physician Decision|1
5646837|NCT00588445|19500979|P1|Overall Study|Not Treated|10
5646838|NCT00588445|19500979|P1|Overall Study|Disease Progression|1
5646839|NCT00588445|19500979|P1|Overall Study|Withdrawal by Subject|3
5646840|NCT00588445|19500979|P1|Overall Study|Protocol Violation|1
5646841|NCT00588354|19501003|P2|Baseline to 4 Weeks|Lost to Follow-up|1
5646842|NCT00588354|19501004|P1|Baseline to 4 Weeks|Lost to Follow-up|0
5646843|NCT00588354|19501003|P2|Baseline to 2 Weeks|Lack of Efficacy|0
5646844|NCT00588354|19501004|P1|Baseline to 2 Weeks|Lack of Efficacy|1
5646845|NCT00588354|19501003|P2|Baseline to 2 Weeks|Adverse Event|0
5646846|NCT00588354|19501004|P1|Baseline to 2 Weeks|Adverse Event|1
5646847|NCT00588341|19501024|P1|Overall Study|Patient ineligible|1
5646848|NCT00588341|19501024|P1|Overall Study|Not treated due to metastatic disease|1
5646849|NCT00588341|19501024|P1|Overall Study|Withdrawal by Subject|3
5646850|NCT00588237|19501028|P1|Overall Study|Patien not treated|1
5646851|NCT00588237|19501028|P1|Overall Study|Evaluable for toxicity only|3
5646852|NCT00588146|19501051|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
5646853|NCT00588146|19501052|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
5646854|NCT00588094|19501058|P1|Overall Study|Progression of Disease|2
5646855|NCT00588094|19501058|P1|Overall Study|Adverse Event|3
5646856|NCT00587990|19501065|P3|Overall Study|Death|1
5646857|NCT00587990|19501066|P2|Overall Study|Death|0
5646858|NCT00587990|19501067|P1|Overall Study|Death|0
5646859|NCT00587964|19501110|P1|Overall Study|Progression of Disease|4
5646860|NCT00587964|19501110|P1|Overall Study|Patient did not receive intervention|5
5646861|NCT00587964|19501110|P1|Overall Study|Patient found to be ineligible|1
5646862|NCT00587964|19501110|P1|Overall Study|Lost to Follow-up|1
5646863|NCT00587964|19501110|P1|Overall Study|Withdrawal by Subject|1
5646864|NCT00587860|19501116|P2|Overall Study|Withdrawal by Subject|3
5646865|NCT00587860|19501117|P1|Overall Study|Withdrawal by Subject|3
5646866|NCT00587860|19501116|P2|Overall Study|Lost to Follow-up|2
5646867|NCT00587860|19501117|P1|Overall Study|Lost to Follow-up|2
5646868|NCT00587847|19501137|P1|Overall Study|Adverse Event|2
5646869|NCT00587847|19501137|P1|Overall Study|Lack of Efficacy|5
5646870|NCT00587795|19501160|P2|Overall Study|Withdrawal by Subject|0
5646871|NCT00587795|19501161|P1|Overall Study|Withdrawal by Subject|1
5646872|NCT00587639|19501215|P1|Overall Study|Withdrawal by Subject|1
5646873|NCT00587587|19501222|P2|Overall Study|Lost to Follow-up|1
5646874|NCT00587587|19501223|P1|Overall Study|Lost to Follow-up|6
5646875|NCT00587457|19501277|P3|Overall Study|Development of neutralizing Abs|1
5646876|NCT00587457|19501278|P2|Overall Study|Development of neutralizing Abs|0
5646877|NCT00587457|19501279|P1|Overall Study|Development of neutralizing Abs|0
5646878|NCT00587457|19501277|P3|Overall Study|Undefined|1
5646879|NCT00587457|19501278|P2|Overall Study|Undefined|0
5646880|NCT00587457|19501279|P1|Overall Study|Undefined|0
5646881|NCT00587457|19501277|P3|Overall Study|Initiation of alternative therapy|0
5646882|NCT00587457|19501278|P2|Overall Study|Initiation of alternative therapy|1
5646883|NCT00587457|19501279|P1|Overall Study|Initiation of alternative therapy|0
5646884|NCT00587457|19501277|P3|Overall Study|Disease progression|2
5646885|NCT00587457|19501278|P2|Overall Study|Disease progression|0
5646886|NCT00587457|19501279|P1|Overall Study|Disease progression|2
5646887|NCT00587457|19501277|P3|Overall Study|Adverse Event|1
5646888|NCT00587457|19501278|P2|Overall Study|Adverse Event|2
5646889|NCT00587457|19501279|P1|Overall Study|Adverse Event|1
5646890|NCT00587431|19501316|P2|Overall Study|Withdrawal by Subject|1
5646891|NCT00587431|19501317|P1|Overall Study|Withdrawal by Subject|0
5646892|NCT00587431|19501316|P2|Overall Study|Adverse Event|0
5646893|NCT00587431|19501317|P1|Overall Study|Adverse Event|1
5646894|NCT00587288|19501328|P2|Overall Study|Protocol Violation|0
5646895|NCT00587288|19501329|P1|Overall Study|Protocol Violation|1
5646896|NCT00587288|19501328|P2|Overall Study|Lack of Efficacy|8
5646897|NCT00587288|19501329|P1|Overall Study|Lack of Efficacy|2
5646898|NCT00587288|19501328|P2|Overall Study|Adverse Event|1
5646899|NCT00587288|19501329|P1|Overall Study|Adverse Event|0
5646900|NCT00587223|19501347|P1|Overall Study|Adverse Event|1
5646901|NCT00587171|19501364|P2|Overall Study|Lost to Follow-up|1
5646902|NCT00587171|19501365|P1|Overall Study|Lost to Follow-up|1
5646903|NCT00587158|19501395|P2|Overall Study|Subject did not want to take study med|1
5646904|NCT00587158|19501396|P1|Overall Study|Subject did not want to take study med|0
5646905|NCT00587158|19501395|P2|Overall Study|Death|1
5646906|NCT00587158|19501396|P1|Overall Study|Death|0
5646907|NCT00587158|19501395|P2|Overall Study|Lost to Follow-up|2
5646908|NCT00587158|19501396|P1|Overall Study|Lost to Follow-up|1
5646909|NCT00587158|19501395|P2|Overall Study|Physician Decision|1
5646910|NCT00587158|19501396|P1|Overall Study|Physician Decision|0
5646911|NCT00587158|19501395|P2|Overall Study|Did not want to do 24 hr urine collect.|3
5646912|NCT00587158|19501396|P1|Overall Study|Did not want to do 24 hr urine collect.|4
5646913|NCT00587054|19501449|P1|Overall Study|Patient not treated|9
5646914|NCT00586924|19501475|P6|Overall Study|Other|6
5646915|NCT00586924|19501476|P5|Overall Study|Other|1
5646916|NCT00586924|19501477|P4|Overall Study|Other|1
5646917|NCT00586924|19501478|P3|Overall Study|Other|1
5646918|NCT00586924|19501479|P2|Overall Study|Other|0
5646919|NCT00586924|19501480|P1|Overall Study|Other|1
5646920|NCT00586924|19501475|P6|Overall Study|Complete response|2
5646921|NCT00586924|19501476|P5|Overall Study|Complete response|2
5646922|NCT00586924|19501477|P4|Overall Study|Complete response|0
5646923|NCT00586924|19501478|P3|Overall Study|Complete response|0
5646924|NCT00586924|19501479|P2|Overall Study|Complete response|1
5646925|NCT00586924|19501480|P1|Overall Study|Complete response|0
5646926|NCT00586924|19501475|P6|Overall Study|Development of neutralizing antibodies|22
5646927|NCT00586924|19501476|P5|Overall Study|Development of neutralizing antibodies|0
5646928|NCT00586924|19501477|P4|Overall Study|Development of neutralizing antibodies|0
5646929|NCT00586924|19501478|P3|Overall Study|Development of neutralizing antibodies|2
5646930|NCT00586924|19501479|P2|Overall Study|Development of neutralizing antibodies|2
5646931|NCT00586924|19501480|P1|Overall Study|Development of neutralizing antibodies|2
5646932|NCT00586924|19501475|P6|Overall Study|Disease progression|0
5646933|NCT00586924|19501476|P5|Overall Study|Disease progression|1
5646934|NCT00586924|19501477|P4|Overall Study|Disease progression|1
5646935|NCT00586924|19501478|P3|Overall Study|Disease progression|0
5646936|NCT00586924|19501479|P2|Overall Study|Disease progression|0
5646937|NCT00586924|19501480|P1|Overall Study|Disease progression|0
5646938|NCT00586924|19501475|P6|Overall Study|Initiation of alternative cancer therapy|1
5646939|NCT00586924|19501476|P5|Overall Study|Initiation of alternative cancer therapy|0
5646940|NCT00586924|19501477|P4|Overall Study|Initiation of alternative cancer therapy|0
5646941|NCT00586924|19501478|P3|Overall Study|Initiation of alternative cancer therapy|0
5646942|NCT00586924|19501479|P2|Overall Study|Initiation of alternative cancer therapy|0
5646943|NCT00586924|19501480|P1|Overall Study|Initiation of alternative cancer therapy|0
5646944|NCT00586924|19501475|P6|Overall Study|Adverse event/serious adverse event|2
5646945|NCT00586924|19501476|P5|Overall Study|Adverse event/serious adverse event|0
5646946|NCT00586924|19501477|P4|Overall Study|Adverse event/serious adverse event|1
5646947|NCT00586924|19501478|P3|Overall Study|Adverse event/serious adverse event|0
5646948|NCT00586924|19501479|P2|Overall Study|Adverse event/serious adverse event|0
5646949|NCT00586924|19501480|P1|Overall Study|Adverse event/serious adverse event|0
5646950|NCT00586898|19501680|P1|Overall Study|Evaluable for Toxicity Only|5
5646951|NCT00586898|19501680|P1|Overall Study|Patiemt Non-compliance|1
5646952|NCT00586898|19501680|P1|Overall Study|Adverse Event|1
5646953|NCT00586846|19501684|P1|Overall Study|Evaluable for Toxicity Only|4
5646954|NCT00586846|19501684|P1|Overall Study|Death|1
5646955|NCT00586846|19501684|P1|Overall Study|Physician Decision|1
5646956|NCT00586820|19501690|P2|Overall Study|Unsuccessful PCI|0
5646957|NCT00586820|19501691|P1|Overall Study|Unsuccessful PCI|1
5646958|NCT00586703|19501722|P1|Overall Study|Death|12
5646959|NCT00586690|19501729|P2|Overall Study|Lab can't accommodate|0
5646960|NCT00586690|19501730|P1|Overall Study|Lab can't accommodate|1
5646961|NCT00586690|19501729|P2|Overall Study|Lack of Efficacy|0
5646962|NCT00586690|19501730|P1|Overall Study|Lack of Efficacy|2
5646963|NCT00586690|19501729|P2|Overall Study|Adverse Event|0
5646964|NCT00586690|19501730|P1|Overall Study|Adverse Event|1
5646965|NCT00586690|19501729|P2|Overall Study|Disease Progression|0
5646966|NCT00586690|19501730|P1|Overall Study|Disease Progression|10
5646967|NCT00586690|19501729|P2|Overall Study|Death|0
5646968|NCT00586690|19501730|P1|Overall Study|Death|2
5646969|NCT00586664|19501740|P3|Overall Study|Exclusion criteria met|0
5646970|NCT00586664|19501741|P2|Overall Study|Exclusion criteria met|0
5646971|NCT00586664|19501742|P1|Overall Study|Exclusion criteria met|2
5646972|NCT00586664|19501740|P3|Overall Study|Withdrawal by Subject|1
5646973|NCT00586664|19501741|P2|Overall Study|Withdrawal by Subject|7
5646974|NCT00586664|19501742|P1|Overall Study|Withdrawal by Subject|3
5646975|NCT00586625|19501788|P2|Overall Study|Subject unable to return for visit|0
5646976|NCT00586625|19501789|P1|Overall Study|Subject unable to return for visit|2
5646977|NCT00586625|19501788|P2|Overall Study|Subject non-compliance|1
5646978|NCT00586625|19501789|P1|Overall Study|Subject non-compliance|0
5646979|NCT00586625|19501788|P2|Overall Study|Withdrawal by Subject|10
5646980|NCT00586625|19501789|P1|Overall Study|Withdrawal by Subject|32
5646981|NCT00586625|19501788|P2|Overall Study|Protocol Violation|0
5646982|NCT00586625|19501789|P1|Overall Study|Protocol Violation|3
5646983|NCT00586625|19501788|P2|Overall Study|Adverse Event|6
5646984|NCT00586625|19501789|P1|Overall Study|Adverse Event|6
5646985|NCT00586612|19501797|P2|Booster Phase|Lost to Follow-up|1
5646986|NCT00586612|19501798|P1|Booster Phase|Lost to Follow-up|3
5646987|NCT00586612|19501797|P2|Primary Phase|Withdrawal by Subject|2
5646988|NCT00586612|19501798|P1|Primary Phase|Withdrawal by Subject|0
5646989|NCT00586612|19501797|P2|Primary Phase|Lost to Follow-up|1
5646990|NCT00586612|19501798|P1|Primary Phase|Lost to Follow-up|0
5646991|NCT00586612|19501797|P2|Primary Phase|Protocol Violation|0
5646992|NCT00586612|19501798|P1|Primary Phase|Protocol Violation|1
5646993|NCT00586521|19501868|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
5646994|NCT00586508|19501877|P2|Overall Study|Withdrawal by Subject|0
5646995|NCT00586508|19501878|P1|Overall Study|Withdrawal by Subject|4
5646996|NCT00586508|19501877|P2|Overall Study|Adverse Event|4
5646997|NCT00586508|19501878|P1|Overall Study|Adverse Event|12
5646998|NCT00586508|19501877|P2|Overall Study|Death|1
5646999|NCT00586508|19501878|P1|Overall Study|Death|0
5647000|NCT00586508|19501877|P2|Overall Study|Progressive disease|8
5647001|NCT00586508|19501878|P1|Overall Study|Progressive disease|52
5647002|NCT00586495|19501894|P1|Follow-up|Switch to commercial drug|10
5647003|NCT00586495|19501894|P1|Follow-up|Protocol driven decision point|37
5647004|NCT00586495|19501894|P1|Follow-up|Withdrawal by Subject|4
5647005|NCT00586495|19501894|P1|Follow-up|Lost to Follow-up|1
5647006|NCT00586495|19501894|P1|Follow-up|Death|40
5647007|NCT00586495|19501894|P1|Treatment Period|Switch to commercial drug|10
5647008|NCT00586495|19501894|P1|Treatment Period|Disease progression, recurrence/relapse|71
5647009|NCT00586495|19501894|P1|Treatment Period|Withdrawal by Subject|1
5647010|NCT00586495|19501894|P1|Treatment Period|Protocol Violation|1
5647011|NCT00586495|19501894|P1|Treatment Period|Death|1
5647012|NCT00586495|19501894|P1|Treatment Period|Adverse Event|11
5647013|NCT00586469|19501923|P2|Overall Study|Adverse Event|1
5647014|NCT00586469|19501924|P1|Overall Study|Adverse Event|0
5647015|NCT00586339|19501951|P3|Overall Study|Lost to Follow-up|1
5647016|NCT00586339|19501952|P2|Overall Study|Lost to Follow-up|2
5647017|NCT00586339|19501953|P1|Overall Study|Lost to Follow-up|3
5647018|NCT00586339|19501951|P3|Overall Study|Migrated/moved from study area|4
5647019|NCT00586339|19501952|P2|Overall Study|Migrated/moved from study area|2
5647020|NCT00586339|19501953|P1|Overall Study|Migrated/moved from study area|3
5647021|NCT00586339|19501951|P3|Overall Study|Withdrawal by Subject|1
5647022|NCT00586339|19501952|P2|Overall Study|Withdrawal by Subject|3
5647023|NCT00586339|19501953|P1|Overall Study|Withdrawal by Subject|1
5647024|NCT00586326|19502054|P1|Treated Through 5-yr Follow Up-Treated|Other|2
5647025|NCT00586326|19502054|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
5647026|NCT00586326|19502054|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
5647027|NCT00586326|19502054|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
5647028|NCT00586326|19502054|P1|Treated Through 5-yr Follow Up-Treated|Death|2
5647029|NCT00586326|19502054|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
5647030|NCT00586326|19502054|P1|Device Placed toTreatment-ITT|Physician Decision|1
5647031|NCT00586326|19502054|P1|Device Placed toTreatment-ITT|Positive Margins|3
5647032|NCT00586326|19502054|P1|Device Placed toTreatment-ITT|Microinvasion|1
5647033|NCT00586326|19502054|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
5647034|NCT00586326|19502054|P1|Device Placed toTreatment-ITT|Skin Distance|7
5647035|NCT00586326|19502054|P1|Enrollment to Device Placement-Enrolled|Other|1
5647036|NCT00586326|19502054|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
5647037|NCT00586326|19502054|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
5647038|NCT00586326|19502054|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
5647039|NCT00586326|19502054|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
5647040|NCT00586326|19502054|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
5647041|NCT00586313|19502065|P1|Overall Study|Lack of Efficacy|2
5647042|NCT00586157|19502101|P2|Second Intervention|Adverse Event|1
5647043|NCT00586157|19502102|P1|Second Intervention|Adverse Event|0
5647044|NCT00586157|19502101|P2|Second Intervention|Worsening behavior|0
5647045|NCT00586157|19502102|P1|Second Intervention|Worsening behavior|1
5647046|NCT00586157|19502101|P2|Second Intervention|Withdrawal by Subject|0
5647047|NCT00586157|19502102|P1|Second Intervention|Withdrawal by Subject|1
5647048|NCT00586157|19502101|P2|First Intervention|Worsening behavior|0
5647049|NCT00586157|19502102|P1|First Intervention|Worsening behavior|1
5647050|NCT00586105|19502112|P1|Overall Study|Reason not reported|1
5647051|NCT00586105|19502112|P1|Overall Study|Switched to commercial drug|9
5647052|NCT00586105|19502112|P1|Overall Study|Disease progression|19
5647053|NCT00586105|19502112|P1|Overall Study|Withdrawal by Subject|3
5647054|NCT00586105|19502112|P1|Overall Study|Protocol Violation|1
5647055|NCT00586105|19502112|P1|Overall Study|Death|2
5647056|NCT00586105|19502112|P1|Overall Study|Adverse Event|4
5647057|NCT00586066|19502127|P2|Overall Study|Withdrawal of consent|2
5647058|NCT00586066|19502128|P1|Overall Study|Withdrawal of consent|4
5647059|NCT00586066|19502127|P2|Overall Study|Physician Decision|0
5647060|NCT00586066|19502128|P1|Overall Study|Physician Decision|1
5647061|NCT00586066|19502127|P2|Overall Study|Adverse Event|2
5647062|NCT00586066|19502128|P1|Overall Study|Adverse Event|2
5647063|NCT00586066|19502127|P2|Overall Study|Lack of Efficacy|3
5647064|NCT00586066|19502128|P1|Overall Study|Lack of Efficacy|5
5647065|NCT00586066|19502127|P2|Overall Study|Lost to Follow-up|3
5647066|NCT00586066|19502128|P1|Overall Study|Lost to Follow-up|6
5647067|NCT00585975|19502185|P2|Overall Study|Enrollment met/over-enrolled|9
5647068|NCT00585975|19502186|P1|Overall Study|Enrollment met/over-enrolled|10
5647069|NCT00585975|19502185|P2|Overall Study|Lost to Follow-up|1
5647070|NCT00585975|19502186|P1|Overall Study|Lost to Follow-up|2
5647071|NCT00585975|19502185|P2|Overall Study|Withdrawal by Subject|3
5647072|NCT00585975|19502186|P1|Overall Study|Withdrawal by Subject|3
5647073|NCT00585923|19502196|P2|Overall Study|Physician decided not to continue|33
5647074|NCT00585923|19502197|P1|Overall Study|Physician decided not to continue|31
5647075|NCT00585689|19502249|P1|Overall Study|Death|1
5647076|NCT00585689|19502249|P1|Overall Study|Patient had unresectable disease|1
5647077|NCT00585689|19502249|P1|Overall Study|Patient Declined Surgery|1
5647078|NCT00585689|19502249|P1|Overall Study|Adverse Event|1
5647079|NCT00585689|19502249|P1|Overall Study|Received different ABI-007 schedule|3
5647080|NCT00585585|19502308|P1|Overall Study|Adverse Event|1
5647081|NCT00585546|19502312|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
5647082|NCT00585546|19502312|P1|Clenbuterol Treatment - up to 12 Months|Death|1
5647083|NCT00585533|19502326|P1|Overall Study|objective or symptomatic progression|9
5647084|NCT00585468|19502335|P2|First Intervention|Withdrawal by Subject|1
5647085|NCT00585468|19502336|P1|First Intervention|Withdrawal by Subject|1
5647086|NCT00585351|19502368|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5647087|NCT00585351|19502369|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5647088|NCT00585351|19502370|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
5647089|NCT00585351|19502371|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
5647090|NCT00585351|19502372|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5647091|NCT00585351|19502373|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5647092|NCT00585351|19502374|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5647093|NCT00585351|19502375|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
5647094|NCT00585351|19502368|P8|Enrollment Period (Intervention)|Death|0
5647095|NCT00585351|19502369|P7|Enrollment Period (Intervention)|Death|1
5647096|NCT00585351|19502370|P6|Enrollment Period (Intervention)|Death|0
5647097|NCT00585351|19502371|P5|Enrollment Period (Intervention)|Death|1
5647098|NCT00585351|19502372|P4|Enrollment Period (Intervention)|Death|0
5647099|NCT00585351|19502373|P3|Enrollment Period (Intervention)|Death|0
5647100|NCT00585351|19502374|P2|Enrollment Period (Intervention)|Death|0
5647101|NCT00585351|19502375|P1|Enrollment Period (Intervention)|Death|0
5647102|NCT00585351|19502368|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
5647103|NCT00585351|19502369|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
5647104|NCT00585351|19502370|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
5647105|NCT00585351|19502371|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
5647106|NCT00585351|19502372|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
5647107|NCT00585351|19502373|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
5647108|NCT00585351|19502374|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
5647109|NCT00585351|19502375|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
5647110|NCT00585351|19502368|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5647111|NCT00585351|19502369|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5647112|NCT00585351|19502370|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5647113|NCT00585351|19502371|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5647114|NCT00585351|19502372|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5647115|NCT00585351|19502373|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
5647116|NCT00585351|19502374|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
5647117|NCT00585351|19502375|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
5647118|NCT00585351|19502368|P8|Notification Period (Informed Consent)|No study medication on flight|0
5647119|NCT00585351|19502369|P7|Notification Period (Informed Consent)|No study medication on flight|0
5647120|NCT00585351|19502370|P6|Notification Period (Informed Consent)|No study medication on flight|0
5647121|NCT00585351|19502371|P5|Notification Period (Informed Consent)|No study medication on flight|0
5647122|NCT00585351|19502372|P4|Notification Period (Informed Consent)|No study medication on flight|0
5647123|NCT00585351|19502373|P3|Notification Period (Informed Consent)|No study medication on flight|0
5647124|NCT00585351|19502374|P2|Notification Period (Informed Consent)|No study medication on flight|1
5647125|NCT00585351|19502375|P1|Notification Period (Informed Consent)|No study medication on flight|0
5647126|NCT00585351|19502368|P8|Notification Period (Informed Consent)|Flight aborted|0
5647127|NCT00585351|19502369|P7|Notification Period (Informed Consent)|Flight aborted|0
5647128|NCT00585351|19502370|P6|Notification Period (Informed Consent)|Flight aborted|0
5647129|NCT00585351|19502371|P5|Notification Period (Informed Consent)|Flight aborted|0
5647130|NCT00585351|19502372|P4|Notification Period (Informed Consent)|Flight aborted|0
5647131|NCT00585351|19502373|P3|Notification Period (Informed Consent)|Flight aborted|0
5647132|NCT00585351|19502374|P2|Notification Period (Informed Consent)|Flight aborted|1
5647133|NCT00585351|19502375|P1|Notification Period (Informed Consent)|Flight aborted|2
5647134|NCT00585351|19502368|P8|Notification Period (Informed Consent)|Physician Decision|0
5647135|NCT00585351|19502369|P7|Notification Period (Informed Consent)|Physician Decision|0
5647136|NCT00585351|19502370|P6|Notification Period (Informed Consent)|Physician Decision|0
5647137|NCT00585351|19502371|P5|Notification Period (Informed Consent)|Physician Decision|0
5647138|NCT00585351|19502372|P4|Notification Period (Informed Consent)|Physician Decision|0
5647139|NCT00585351|19502373|P3|Notification Period (Informed Consent)|Physician Decision|0
5647140|NCT00585351|19502374|P2|Notification Period (Informed Consent)|Physician Decision|2
5647141|NCT00585351|19502375|P1|Notification Period (Informed Consent)|Physician Decision|0
5647142|NCT00585325|19502391|P2|Overall Study|Withdrawal by Subject|1
5647143|NCT00585325|19502392|P1|Overall Study|Withdrawal by Subject|1
5647144|NCT00585312|19502400|P2|Overall Study|Study terminated by the sponsor|31
5647145|NCT00585312|19502401|P1|Overall Study|Study terminated by the sponsor|34
5647146|NCT00585312|19502400|P2|Overall Study|Withdrawal by Subject|1
5647147|NCT00585312|19502401|P1|Overall Study|Withdrawal by Subject|5
5647148|NCT00585312|19502400|P2|Overall Study|Reason not specified|0
5647149|NCT00585312|19502401|P1|Overall Study|Reason not specified|2
5647150|NCT00585312|19502400|P2|Overall Study|Lost to Follow-up|1
5647151|NCT00585312|19502401|P1|Overall Study|Lost to Follow-up|1
5647152|NCT00585312|19502400|P2|Overall Study|Lack of Efficacy|11
5647153|NCT00585312|19502401|P1|Overall Study|Lack of Efficacy|6
5647154|NCT00585312|19502400|P2|Overall Study|Adverse Event|0
5647155|NCT00585312|19502401|P1|Overall Study|Adverse Event|3
5647156|NCT00585286|19502413|P1|Overall Study|Lost to Follow-up|1
5647157|NCT00585221|19502429|P1|Overall Study|Protocol Violation|8
5647158|NCT00585169|19502439|P1|Overall Study|Withdrawal by Subject|1
5647159|NCT00585078|19502449|P1|Overall Study|Death|1
5647160|NCT00585078|19502449|P1|Overall Study|Adverse Event|10
5647161|NCT00585078|19502449|P1|Overall Study|Disease Progression|24
5647162|NCT00585078|19502449|P1|Overall Study|Poor performance status|1
5647163|NCT00585078|19502449|P1|Overall Study|Withdrawal by Subject|4
5647164|NCT00585052|19502456|P1|Overall Study|Withdrawal by Subject|1
5647165|NCT00585039|19502463|P2|Overall Study|medication spilled|0
5647166|NCT00585039|19502464|P1|Overall Study|medication spilled|2
5647167|NCT00584987|19502493|P4|Overall Study|Adverse Event|1
5647168|NCT00584987|19502494|P3|Overall Study|Adverse Event|0
5647169|NCT00584987|19502495|P2|Overall Study|Adverse Event|0
5647170|NCT00584987|19502496|P1|Overall Study|Adverse Event|0
5647171|NCT00584987|19502493|P4|Overall Study|Protocol Violation|0
5647172|NCT00584987|19502494|P3|Overall Study|Protocol Violation|1
5647173|NCT00584987|19502495|P2|Overall Study|Protocol Violation|1
5647174|NCT00584987|19502496|P1|Overall Study|Protocol Violation|1
5647175|NCT00584909|19502548|P1|Overall Study|Adverse Event|4
5647176|NCT00584844|19502558|P1|Overall Study|Screen Failure|20
5647177|NCT00584844|19502558|P1|Overall Study|Withdrawal by Subject|59
5647178|NCT00584805|19502608|P1|Overall Study|Screen failures|2
5647179|NCT00584805|19502608|P1|Overall Study|Lost to follow up|3
5647180|NCT00584805|19502608|P1|Overall Study|Non-compliance|1
5647181|NCT00584805|19502608|P1|Overall Study|Withdrawal by Subject|18
5647182|NCT00584805|19502608|P1|Overall Study|Relocation|36
5647183|NCT00584805|19502608|P1|Overall Study|No longer at risk of exposure|39
5647184|NCT00584740|19502621|P2|Overall Study|Lost to Follow-up|1
5647185|NCT00584740|19502622|P1|Overall Study|Lost to Follow-up|0
5647186|NCT00584740|19502621|P2|Overall Study|Withdrawal by Subject|2
5647187|NCT00584740|19502622|P1|Overall Study|Withdrawal by Subject|3
5647188|NCT00584740|19502621|P2|Overall Study|Lack of Efficacy|2
5647189|NCT00584740|19502622|P1|Overall Study|Lack of Efficacy|8
5647190|NCT00584740|19502621|P2|Overall Study|Adverse Event|1
5647191|NCT00584740|19502622|P1|Overall Study|Adverse Event|1
5647192|NCT00584727|19502640|P6|Third Intervention|Protocol Violation|2
5647193|NCT00584727|19502641|P5|Third Intervention|Protocol Violation|4
5647194|NCT00584727|19502642|P4|Third Intervention|Protocol Violation|0
5647195|NCT00584727|19502643|P3|Third Intervention|Protocol Violation|1
5647196|NCT00584727|19502644|P2|Third Intervention|Protocol Violation|0
5647197|NCT00584727|19502645|P1|Third Intervention|Protocol Violation|0
5647198|NCT00584727|19502640|P6|First Intervention|Discontinuation|0
5647199|NCT00584727|19502641|P5|First Intervention|Discontinuation|0
5647200|NCT00584727|19502642|P4|First Intervention|Discontinuation|0
5647201|NCT00584727|19502643|P3|First Intervention|Discontinuation|1
5647202|NCT00584727|19502644|P2|First Intervention|Discontinuation|0
5647203|NCT00584727|19502645|P1|First Intervention|Discontinuation|0
5647204|NCT00584454|19502683|P1|Overall Study|Clinical Hold|2
5647205|NCT00584454|19502683|P1|Overall Study|Relocation|1
5647206|NCT00584454|19502683|P1|Overall Study|Adverse Event|1
5647207|NCT00584415|19502687|P1|Overall Study|Adverse Event|7
5647208|NCT00584194|19502710|P1|Overall Study|Other|135
5647209|NCT00584012|19502723|P1|Overall Study|Withdrawal by Subject|1
5647210|NCT00583947|19502729|P2|Cross-over Period|Other|1
5647211|NCT00583947|19502730|P1|Cross-over Period|Other|1
5647212|NCT00583947|19502729|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
5647213|NCT00583947|19502730|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
5647214|NCT00583947|19502729|P2|Cross-over Period|Withdrawal by Subject|0
5647215|NCT00583947|19502730|P1|Cross-over Period|Withdrawal by Subject|2
5647216|NCT00583947|19502729|P2|Cross-over Period|Adverse Event|0
5647217|NCT00583947|19502730|P1|Cross-over Period|Adverse Event|2
5647218|NCT00583791|19502851|P1|Overall Study|Death|6
5647219|NCT00583791|19502851|P1|Overall Study|Other|67
5647220|NCT00583596|19502906|P1|Overall Study|Outside f-up window|26
5647221|NCT00583596|19502906|P1|Overall Study|Not consented|15
5647222|NCT00583596|19502906|P1|Overall Study|Data not complete|1
5647223|NCT00583596|19502906|P1|Overall Study|Lost to Follow-up|94
5647224|NCT00583596|19502906|P1|Overall Study|Withdrawal by Subject|6
5647225|NCT00583596|19502906|P1|Overall Study|Death|2
5647226|NCT00583596|19502906|P1|Overall Study|Excluded due to Hurricane Katrina|30
5647227|NCT00583596|19502906|P1|Overall Study|Lost to Follow-up|110
5647228|NCT00583557|19502911|P1|Overall Study|Did not receive belimumab in LBRA99|2
5647229|NCT00583557|19502911|P1|Overall Study|Other|5
5647230|NCT00583557|19502911|P1|Overall Study|Lack of Compliance|5
5647231|NCT00583557|19502911|P1|Overall Study|Lack of Efficacy|31
5647232|NCT00583557|19502911|P1|Overall Study|Adverse Event|9
5647233|NCT00583557|19502911|P1|Overall Study|Withdrawal by Subject|18
5647234|NCT00583453|19502942|P2|Overall Study|discontinued intervention|2
5647235|NCT00583453|19502943|P1|Overall Study|discontinued intervention|0
5647236|NCT00583362|19502980|P1|Overall Study|Withdrawal by Subject|57
5647237|NCT00583362|19502980|P1|Overall Study|Protocol Violation|2
5647238|NCT00583362|19502980|P1|Overall Study|Physician Decision|19
5647239|NCT00583362|19502980|P1|Overall Study|Sponsor request due to missed doses|1
5647240|NCT00583362|19502980|P1|Overall Study|Behavioral problems and non-compliance|1
5647241|NCT00583362|19502980|P1|Overall Study|Misunderstanding of protocol|1
5647242|NCT00583362|19502980|P1|Overall Study|Missed visits due to staff changes|1
5647243|NCT00583362|19502980|P1|Overall Study|Subject moved out of the country/state|2
5647244|NCT00583362|19502980|P1|Overall Study|Subject not dosed in LBSL99|1
5647245|NCT00583362|19502980|P1|Overall Study|Current site closed|7
5647246|NCT00583362|19502980|P1|Overall Study|Miscommunication of visit window|5
5647247|NCT00583362|19502980|P1|Overall Study|Pregnancy|7
5647248|NCT00583362|19502980|P1|Overall Study|Non-compliance with study drug|28
5647249|NCT00583362|19502980|P1|Overall Study|Lost to Follow-up|4
5647250|NCT00583362|19502980|P1|Overall Study|Lack of Efficacy|22
5647251|NCT00583362|19502980|P1|Overall Study|Adverse Event|44
5647252|NCT00583219|19503004|P1|Phase 2|Withdrawal by Subject|1
5647253|NCT00583115|19503021|P1|Overall Study|Death|1
5647254|NCT00583102|19503026|P1|Overall Study|Adverse Event|3
5647255|NCT00582972|19503043|P1|Overall Study|Protocol Violation|2
5647256|NCT00582933|19503052|P1|Overall Study|Physician Decision|3
5647257|NCT00582907|19503056|P4|2nd Course|Lack of Efficacy|0
5647258|NCT00582907|19503057|P3|2nd Course|Lack of Efficacy|0
5647259|NCT00582907|19503058|P2|2nd Course|Lack of Efficacy|0
5647260|NCT00582907|19503059|P1|2nd Course|Lack of Efficacy|1
5647261|NCT00582907|19503056|P4|1st Course|Lost to Follow-up|1
5647262|NCT00582907|19503057|P3|1st Course|Lost to Follow-up|0
5647263|NCT00582907|19503058|P2|1st Course|Lost to Follow-up|0
5647264|NCT00582907|19503059|P1|1st Course|Lost to Follow-up|0
5647265|NCT00582907|19503056|P4|1st Course|Withdrawal by Subject|0
5647266|NCT00582907|19503057|P3|1st Course|Withdrawal by Subject|0
5647267|NCT00582907|19503058|P2|1st Course|Withdrawal by Subject|0
5647268|NCT00582907|19503059|P1|1st Course|Withdrawal by Subject|1
5647269|NCT00582816|19503098|P1|Overall Study|Engraftment Failure|3
5647270|NCT00582790|19503108|P1|Overall Study|Rapid progression of disease|1
5647271|NCT00582738|19503117|P2|Overall Study|Withdrawal by Subject|3
5647272|NCT00582738|19503118|P1|Overall Study|Withdrawal by Subject|0
5647273|NCT00582738|19503117|P2|Overall Study|Protocol Violation|1
5647274|NCT00582738|19503118|P1|Overall Study|Protocol Violation|1
5647275|NCT00582738|19503117|P2|Overall Study|Other|0
5647276|NCT00582738|19503118|P1|Overall Study|Other|1
5647277|NCT00582738|19503117|P2|Overall Study|Graft Lost|1
5647278|NCT00582738|19503118|P1|Overall Study|Graft Lost|0
5647279|NCT00582738|19503117|P2|Overall Study|Adverse Event|5
5647280|NCT00582738|19503118|P1|Overall Study|Adverse Event|0
5647281|NCT00582738|19503117|P2|Overall Study|Administrative Problems|8
5647282|NCT00582738|19503118|P1|Overall Study|Administrative Problems|7
5647283|NCT00582712|19503142|P1|Overall Study|Complicating disease requiring treatment|1
5647284|NCT00582712|19503142|P1|Overall Study|Withdrawal by Subject|1
5647285|NCT00582712|19503142|P1|Overall Study|Lack of Efficacy|1
5647286|NCT00582712|19503142|P1|Overall Study|Adverse Event|1
5647287|NCT00582608|19503157|P1|Overall Study|Lack of accrual|4
5647288|NCT00582608|19503157|P1|Overall Study|Patient Ineligible|1
5647289|NCT00582608|19503157|P1|Overall Study|Not Treated|7
5647290|NCT00582556|19503164|P3|Overall Study|Physician Decision|1
5647291|NCT00582556|19503165|P2|Overall Study|Physician Decision|0
5647292|NCT00582556|19503166|P1|Overall Study|Physician Decision|0
5647293|NCT00582556|19503164|P3|Overall Study|Withdrawal by Subject|1
5647294|NCT00582556|19503165|P2|Overall Study|Withdrawal by Subject|1
5647295|NCT00582556|19503166|P1|Overall Study|Withdrawal by Subject|0
5647296|NCT00582491|19503194|P2|Overall Study|Withdrawal by Subject|0
5647297|NCT00582491|19503195|P1|Overall Study|Withdrawal by Subject|1
5647298|NCT00582426|19503219|P2|Overall Study|Use of illicit drugs|0
5647299|NCT00582426|19503220|P1|Overall Study|Use of illicit drugs|1
5647300|NCT00582426|19503219|P2|Overall Study|Disease Progression|2
5647301|NCT00582426|19503220|P1|Overall Study|Disease Progression|2
5647302|NCT00582426|19503219|P2|Overall Study|Withdrawal by Subject|2
5647303|NCT00582426|19503220|P1|Overall Study|Withdrawal by Subject|3
5647304|NCT00582426|19503219|P2|Overall Study|Death|3
5647305|NCT00582426|19503220|P1|Overall Study|Death|4
5647306|NCT00582426|19503219|P2|Overall Study|Protocol Violation|2
5647307|NCT00582426|19503220|P1|Overall Study|Protocol Violation|6
5647308|NCT00582426|19503219|P2|Overall Study|Adverse Event|2
5647309|NCT00582426|19503220|P1|Overall Study|Adverse Event|4
5647310|NCT00582426|19503219|P2|Overall Study|Lost to Follow-up|2
5647311|NCT00582426|19503220|P1|Overall Study|Lost to Follow-up|0
5647312|NCT00582309|19503267|P3|Overall Study|Protocol Violation|2
5647313|NCT00582309|19503268|P2|Overall Study|Protocol Violation|0
5647314|NCT00582309|19503269|P1|Overall Study|Protocol Violation|0
5647315|NCT00582166|19503282|P1|Overall Study|Ineligible pathology|1
5647316|NCT00582166|19503282|P1|Overall Study|Death|1
5647317|NCT00582114|19503292|P2|Overall Study|Stopped by data safety monitoring board|20
5647318|NCT00582114|19503293|P1|Overall Study|Stopped by data safety monitoring board|19
5647319|NCT00582114|19503292|P2|Overall Study|Physician Decision|6
5647320|NCT00582114|19503293|P1|Overall Study|Physician Decision|0
5647321|NCT00582114|19503292|P2|Overall Study|Adverse Event|1
5647322|NCT00582114|19503293|P1|Overall Study|Adverse Event|1
5647323|NCT00582114|19503292|P2|Overall Study|Withdrawal by Subject|16
5647324|NCT00582114|19503293|P1|Overall Study|Withdrawal by Subject|8
5647325|NCT00582114|19503292|P2|Overall Study|Lost to Follow-up|6
5647326|NCT00582114|19503293|P1|Overall Study|Lost to Follow-up|7
5647327|NCT00582114|19503292|P2|Overall Study|Kidney Transplant|1
5647328|NCT00582114|19503293|P1|Overall Study|Kidney Transplant|3
5647329|NCT00582114|19503292|P2|Overall Study|Death|4
5647330|NCT00582114|19503293|P1|Overall Study|Death|4
5647331|NCT00582036|19503308|P2|Overall Study|Withdrawal by Subject|1
5647332|NCT00582036|19503309|P1|Overall Study|Withdrawal by Subject|0
5647333|NCT00582010|19503317|P2|Overall Study|Death|1
5647334|NCT00582010|19503318|P1|Overall Study|Death|0
5647335|NCT00581945|19503347|P2|Overall Study|Death|0
5647336|NCT00581945|19503348|P1|Overall Study|Death|1
5647337|NCT00581945|19503347|P2|Overall Study|Withdrawal by Subject|6
5647338|NCT00581945|19503348|P1|Overall Study|Withdrawal by Subject|2
5647339|NCT00581945|19503347|P2|Overall Study|Unsatisfactory therapeutic effect|0
5647340|NCT00581945|19503348|P1|Overall Study|Unsatisfactory therapeutic effect|2
5647341|NCT00581945|19503347|P2|Overall Study|Adverse Event|4
5647342|NCT00581945|19503348|P1|Overall Study|Adverse Event|4
5647343|NCT00581919|19503364|P1|Overall Study|Withdrawal by Subject|1
5647344|NCT00581919|19503364|P1|Overall Study|Started Non-Protocol Therapy|2
5647345|NCT00581919|19503364|P1|Overall Study|Other Complicating Disease|1
5647346|NCT00581919|19503364|P1|Overall Study|Physician Decision|1
5647347|NCT00581919|19503364|P1|Overall Study|Disease Progression|10
5647348|NCT00581919|19503364|P1|Overall Study|Death|1
5647349|NCT00581919|19503364|P1|Overall Study|Adverse Event|8
5647350|NCT00581828|19503383|P1|Overall Study|Protocol Violation|1
5647351|NCT00581776|19503387|P1|Overall Study|Disease progression or no response|3
5647352|NCT00581555|19503405|P2|Overall Study|Other reasons|4
5647353|NCT00581555|19503406|P1|Overall Study|Other reasons|16
5647354|NCT00581555|19503405|P2|Overall Study|Lost to Follow-up|2
5647355|NCT00581555|19503406|P1|Overall Study|Lost to Follow-up|2
5647356|NCT00581555|19503405|P2|Overall Study|Withdrawal by Subject|9
5647357|NCT00581555|19503406|P1|Overall Study|Withdrawal by Subject|18
5647358|NCT00581555|19503405|P2|Overall Study|Physician Decision|2
5647359|NCT00581555|19503406|P1|Overall Study|Physician Decision|3
5647360|NCT00581555|19503405|P2|Overall Study|Adverse Event|3
5647361|NCT00581555|19503406|P1|Overall Study|Adverse Event|4
5647362|NCT00581542|19503430|P2|Overall Study|Lost to Follow-up|21
5647363|NCT00581542|19503431|P1|Overall Study|Lost to Follow-up|9
5647364|NCT00581542|19503430|P2|Overall Study|they met an exclusion criteria|2
5647365|NCT00581542|19503431|P1|Overall Study|they met an exclusion criteria|2
5647366|NCT00581360|19503485|P1|Overall Study|Withdrawal by Subject|1
5647367|NCT00581308|19503504|P1|Month 12|Other|1
5647368|NCT00581308|19503504|P1|Month 12|Device Removed|1
5647369|NCT00581308|19503504|P1|Month 12|Withdrawal by Subject|3
5647370|NCT00581308|19503504|P1|Month 12|Lost to Follow-up|14
5647371|NCT00581308|19503504|P1|Month 12|Death|1
5647372|NCT00581308|19503504|P1|Month 6|Withdrawal by Subject|2
5647373|NCT00581308|19503504|P1|Month 6|Lost to Follow-up|1
5647374|NCT00581308|19503504|P1|Month 1|Uknown|1
5647375|NCT00581308|19503504|P1|Month 1|Device Removed|2
5647376|NCT00581308|19503504|P1|Month 1|Withdrawal by Subject|2
5647377|NCT00581308|19503504|P1|Month 1|Lost to Follow-up|3
5647378|NCT00581308|19503504|P1|Pre Discharge|Device Removed|1
5647379|NCT00581308|19503504|P1|Pre Discharge|Lost to Follow-up|1
5647380|NCT00581113|19503535|P2|Overall Study|Withdrawal by Subject|1
5647381|NCT00581113|19503536|P1|Overall Study|Withdrawal by Subject|0
5647382|NCT00581100|19503546|P2|Overall Study|Other|0
5647383|NCT00581100|19503547|P1|Overall Study|Other|3
5647384|NCT00581100|19503546|P2|Overall Study|Withdrawal by Subject|4
5647385|NCT00581100|19503547|P1|Overall Study|Withdrawal by Subject|1
5647386|NCT00581100|19503546|P2|Overall Study|Adverse Event|1
5647387|NCT00581100|19503547|P1|Overall Study|Adverse Event|2
5647388|NCT00581100|19503546|P2|Overall Study|Death|0
5647389|NCT00581100|19503547|P1|Overall Study|Death|1
5647390|NCT00580983|19503600|P1|Overall Study|Did not complete 12 mon post RT studies|7
5647391|NCT00580970|19503607|P1|Treatment (Lovastatin)|Death|1
5647392|NCT00580970|19503607|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
5647393|NCT00580970|19503607|P1|Treatment (Lovastatin)|Physician Decision|4
5647394|NCT00580970|19503607|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
5647395|NCT00580970|19503607|P1|Treatment (Lovastatin)|Non-compliance|6
5647396|NCT00580970|19503607|P1|Pre-treatment|Non-compliance|1
5647397|NCT00580866|19503622|P2|Overall Study|Lost to Follow-up|2
5647398|NCT00580866|19503623|P1|Overall Study|Lost to Follow-up|2
5647399|NCT00580840|19503647|P4|Double-Blind|Other: Forbidden Medication|0
5647400|NCT00580840|19503648|P3|Double-Blind|Other: Forbidden Medication|1
5647401|NCT00580840|19503649|P2|Double-Blind|Other: Forbidden Medication|0
5647402|NCT00580840|19503650|P1|Double-Blind|Other: Forbidden Medication|0
5647403|NCT00580840|19503647|P4|Double-Blind|Other: Discontinued Methotrexate|0
5647404|NCT00580840|19503648|P3|Double-Blind|Other: Discontinued Methotrexate|0
5647405|NCT00580840|19503649|P2|Double-Blind|Other: Discontinued Methotrexate|1
5647406|NCT00580840|19503650|P1|Double-Blind|Other: Discontinued Methotrexate|0
5647407|NCT00580840|19503647|P4|Double-Blind|Withdrawal by Subject|2
5647408|NCT00580840|19503648|P3|Double-Blind|Withdrawal by Subject|2
5647409|NCT00580840|19503649|P2|Double-Blind|Withdrawal by Subject|1
5647410|NCT00580840|19503650|P1|Double-Blind|Withdrawal by Subject|0
5647411|NCT00580840|19503647|P4|Double-Blind|Lost to Follow-up|2
5647412|NCT00580840|19503648|P3|Double-Blind|Lost to Follow-up|0
5647413|NCT00580840|19503649|P2|Double-Blind|Lost to Follow-up|1
5647414|NCT00580840|19503650|P1|Double-Blind|Lost to Follow-up|0
5647415|NCT00580840|19503647|P4|Double-Blind|Loss of Efficacy|10
5647416|NCT00580840|19503648|P3|Double-Blind|Loss of Efficacy|2
5647417|NCT00580840|19503649|P2|Double-Blind|Loss of Efficacy|1
5647418|NCT00580840|19503650|P1|Double-Blind|Loss of Efficacy|0
5647419|NCT00580840|19503647|P4|Double-Blind|Adverse Event|1
5647420|NCT00580840|19503648|P3|Double-Blind|Adverse Event|4
5647421|NCT00580840|19503649|P2|Double-Blind|Adverse Event|3
5647422|NCT00580840|19503650|P1|Double-Blind|Adverse Event|0
5647423|NCT00580840|19503647|P4|Run-in|Other: Exclusionary Lab Value|0
5647424|NCT00580840|19503648|P3|Run-in|Other: Exclusionary Lab Value|0
5647425|NCT00580840|19503649|P2|Run-in|Other: Exclusionary Lab Value|0
5647426|NCT00580840|19503650|P1|Run-in|Other: Exclusionary Lab Value|1
5647427|NCT00580840|19503647|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
5647428|NCT00580840|19503648|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
5647429|NCT00580840|19503649|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
5647430|NCT00580840|19503650|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
5647431|NCT00580840|19503647|P4|Run-in|Other: Per Sponsor Request|0
5647432|NCT00580840|19503648|P3|Run-in|Other: Per Sponsor Request|0
5647433|NCT00580840|19503649|P2|Run-in|Other: Per Sponsor Request|0
5647434|NCT00580840|19503650|P1|Run-in|Other: Per Sponsor Request|2
5647435|NCT00580840|19503647|P4|Run-in|Withdrawal by Subject|0
5647436|NCT00580840|19503648|P3|Run-in|Withdrawal by Subject|0
5647437|NCT00580840|19503649|P2|Run-in|Withdrawal by Subject|0
5647438|NCT00580840|19503650|P1|Run-in|Withdrawal by Subject|5
5647439|NCT00580840|19503647|P4|Run-in|Lost to Follow-up|0
5647440|NCT00580840|19503648|P3|Run-in|Lost to Follow-up|0
5647441|NCT00580840|19503649|P2|Run-in|Lost to Follow-up|0
5647442|NCT00580840|19503650|P1|Run-in|Lost to Follow-up|4
5647443|NCT00580840|19503647|P4|Run-in|Loss of Efficacy|0
5647444|NCT00580840|19503648|P3|Run-in|Loss of Efficacy|0
5647445|NCT00580840|19503649|P2|Run-in|Loss of Efficacy|0
5647446|NCT00580840|19503650|P1|Run-in|Loss of Efficacy|1
5647447|NCT00580840|19503647|P4|Run-in|Lack of Efficacy|0
5647448|NCT00580840|19503648|P3|Run-in|Lack of Efficacy|0
5647449|NCT00580840|19503649|P2|Run-in|Lack of Efficacy|0
5647450|NCT00580840|19503650|P1|Run-in|Lack of Efficacy|93
5647451|NCT00580840|19503647|P4|Run-in|Adverse Event|0
5647452|NCT00580840|19503648|P3|Run-in|Adverse Event|0
5647453|NCT00580840|19503649|P2|Run-in|Adverse Event|0
5647454|NCT00580840|19503650|P1|Run-in|Adverse Event|17
5647455|NCT00580801|19503758|P3|Overall Study|Travel|0
5647456|NCT00580801|19503759|P2|Overall Study|Travel|0
5647457|NCT00580801|19503760|P1|Overall Study|Travel|1
5647458|NCT00580801|19503758|P3|Overall Study|Participant non-compliant|1
5647459|NCT00580801|19503759|P2|Overall Study|Participant non-compliant|0
5647460|NCT00580801|19503760|P1|Overall Study|Participant non-compliant|0
5647461|NCT00580801|19503758|P3|Overall Study|Reached a virologic endpoint|2
5647462|NCT00580801|19503759|P2|Overall Study|Reached a virologic endpoint|1
5647463|NCT00580801|19503760|P1|Overall Study|Reached a virologic endpoint|0
5647464|NCT00580801|19503758|P3|Overall Study|Lost to Follow-up|0
5647465|NCT00580801|19503759|P2|Overall Study|Lost to Follow-up|0
5647466|NCT00580801|19503760|P1|Overall Study|Lost to Follow-up|2
5647467|NCT00580801|19503758|P3|Overall Study|Adverse Event|0
5647468|NCT00580801|19503759|P2|Overall Study|Adverse Event|0
5647469|NCT00580801|19503760|P1|Overall Study|Adverse Event|2
5647470|NCT00580801|19503758|P3|Overall Study|Physician Decision|0
5647471|NCT00580801|19503759|P2|Overall Study|Physician Decision|0
5647472|NCT00580801|19503760|P1|Overall Study|Physician Decision|1
5647473|NCT00580788|19503799|P4|Overall Study|Adverse Event|1
5647474|NCT00580788|19503800|P3|Overall Study|Adverse Event|0
5647475|NCT00580788|19503801|P2|Overall Study|Adverse Event|0
5647476|NCT00580788|19503802|P1|Overall Study|Adverse Event|0
5647477|NCT00580723|19503860|P1|Overall Study|Lost to Follow-up|5
5647478|NCT00580723|19503860|P1|Overall Study|Did not want to participate in extension|3
5647479|NCT00580606|19503903|P2|Open Label (OL)|Needed Prohibited Medication|1
5647480|NCT00580606|19503904|P1|Open Label (OL)|Needed Prohibited Medication|0
5647481|NCT00580606|19503903|P2|Open Label (OL)|Physician Decision|1
5647482|NCT00580606|19503904|P1|Open Label (OL)|Physician Decision|1
5647483|NCT00580606|19503903|P2|Open Label (OL)|Non-compliance|0
5647484|NCT00580606|19503904|P1|Open Label (OL)|Non-compliance|2
5647485|NCT00580606|19503903|P2|Open Label (OL)|Pregnancy|1
5647486|NCT00580606|19503904|P1|Open Label (OL)|Pregnancy|0
5647487|NCT00580606|19503903|P2|Open Label (OL)|Lost to Follow-up|1
5647488|NCT00580606|19503904|P1|Open Label (OL)|Lost to Follow-up|0
5647489|NCT00580606|19503903|P2|Open Label (OL)|Dosing Symptoms|1
5647490|NCT00580606|19503904|P1|Open Label (OL)|Dosing Symptoms|0
5647491|NCT00580606|19503903|P2|Open Label (OL)|Withdrawal by Subject|6
5647492|NCT00580606|19503904|P1|Open Label (OL)|Withdrawal by Subject|4
5647493|NCT00580606|19503903|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
5647494|NCT00580606|19503904|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
5647495|NCT00580047|19503985|P3|Overall Study|Withdrawal by Subject|0
5647496|NCT00580047|19503986|P2|Overall Study|Withdrawal by Subject|0
5647497|NCT00580047|19503987|P1|Overall Study|Withdrawal by Subject|1
5647498|NCT00580047|19503985|P3|Overall Study|Withdrawal by Subject|2
5647499|NCT00580047|19503986|P2|Overall Study|Withdrawal by Subject|1
5647500|NCT00580047|19503987|P1|Overall Study|Withdrawal by Subject|1
5647501|NCT00580047|19503985|P3|Overall Study|Lost to Follow-up|0
5647502|NCT00580047|19503986|P2|Overall Study|Lost to Follow-up|1
5647503|NCT00580047|19503987|P1|Overall Study|Lost to Follow-up|1
5647504|NCT00580034|19503998|P2|Overall Study|Toxicity|0
5647505|NCT00580034|19503999|P1|Overall Study|Toxicity|10
5647506|NCT00579982|19504005|P1|Overall Study|Protocol Violation|4
5647507|NCT00579982|19504005|P1|Overall Study|Adverse Event|4
5647508|NCT00579826|19504039|P2|Overall Study|Withdrawal by Subject|3
5647509|NCT00579826|19504040|P1|Overall Study|Withdrawal by Subject|5
5647510|NCT00579670|19504074|P5|Overall Study|Withdrawal by Subject|0
5647511|NCT00579670|19504075|P4|Overall Study|Withdrawal by Subject|0
5647512|NCT00579670|19504076|P3|Overall Study|Withdrawal by Subject|1
5647513|NCT00579670|19504077|P2|Overall Study|Withdrawal by Subject|0
5647514|NCT00579670|19504078|P1|Overall Study|Withdrawal by Subject|0
5647515|NCT00579670|19504074|P5|Overall Study|Other|0
5647516|NCT00579670|19504075|P4|Overall Study|Other|2
5647517|NCT00579670|19504076|P3|Overall Study|Other|1
5647518|NCT00579670|19504077|P2|Overall Study|Other|0
5647519|NCT00579670|19504078|P1|Overall Study|Other|0
5647520|NCT00579670|19504074|P5|Overall Study|Lost to Follow-up|0
5647521|NCT00579670|19504075|P4|Overall Study|Lost to Follow-up|4
5647522|NCT00579670|19504076|P3|Overall Study|Lost to Follow-up|0
5647523|NCT00579670|19504077|P2|Overall Study|Lost to Follow-up|1
5647524|NCT00579670|19504078|P1|Overall Study|Lost to Follow-up|0
5647525|NCT00579670|19504074|P5|Overall Study|Lack of Efficacy|0
5647526|NCT00579670|19504075|P4|Overall Study|Lack of Efficacy|14
5647527|NCT00579670|19504076|P3|Overall Study|Lack of Efficacy|1
5647528|NCT00579670|19504077|P2|Overall Study|Lack of Efficacy|0
5647529|NCT00579670|19504078|P1|Overall Study|Lack of Efficacy|0
5647530|NCT00579670|19504074|P5|Overall Study|Adverse Event|0
5647531|NCT00579670|19504075|P4|Overall Study|Adverse Event|2
5647532|NCT00579670|19504076|P3|Overall Study|Adverse Event|1
5647533|NCT00579670|19504077|P2|Overall Study|Adverse Event|0
5647534|NCT00579670|19504078|P1|Overall Study|Adverse Event|1
5647535|NCT00579670|19504074|P5|Overall Study|Death|0
5647536|NCT00579670|19504075|P4|Overall Study|Death|0
5647537|NCT00579670|19504076|P3|Overall Study|Death|0
5647538|NCT00579670|19504077|P2|Overall Study|Death|0
5647539|NCT00579670|19504078|P1|Overall Study|Death|1
5647540|NCT00579527|19504290|P1|Overall Study|Death|4
5647541|NCT00579501|19504302|P1|Overall Study|Radiation therapy before surgery|1
5647542|NCT00579501|19504302|P1|Overall Study|Secondary lesion|1
5647543|NCT00579501|19504302|P1|Overall Study|toxicity|1
5647544|NCT00579501|19504302|P1|Overall Study|End of neoadjuvant therapy|25
5647545|NCT00579501|19504302|P1|Overall Study|Death|1
5647546|NCT00579345|19504330|P8|Overall Study|Death|0
5647547|NCT00579345|19504331|P7|Overall Study|Death|0
5647548|NCT00579345|19504332|P6|Overall Study|Death|0
5647549|NCT00579345|19504333|P5|Overall Study|Death|0
5647550|NCT00579345|19504334|P4|Overall Study|Death|1
5647551|NCT00579345|19504335|P3|Overall Study|Death|1
5647552|NCT00579345|19504336|P2|Overall Study|Death|1
5647553|NCT00579345|19504337|P1|Overall Study|Death|1
5647554|NCT00579345|19504330|P8|Overall Study|Protocol Violation|1
5647555|NCT00579345|19504331|P7|Overall Study|Protocol Violation|0
5647556|NCT00579345|19504332|P6|Overall Study|Protocol Violation|0
5647557|NCT00579345|19504333|P5|Overall Study|Protocol Violation|0
5647558|NCT00579345|19504334|P4|Overall Study|Protocol Violation|0
5647559|NCT00579345|19504335|P3|Overall Study|Protocol Violation|0
5647560|NCT00579345|19504336|P2|Overall Study|Protocol Violation|0
5647561|NCT00579345|19504337|P1|Overall Study|Protocol Violation|1
5647562|NCT00579345|19504330|P8|Overall Study|Adverse Event|0
5647563|NCT00579345|19504331|P7|Overall Study|Adverse Event|0
5647564|NCT00579345|19504332|P6|Overall Study|Adverse Event|0
5647565|NCT00579345|19504333|P5|Overall Study|Adverse Event|0
5647566|NCT00579345|19504334|P4|Overall Study|Adverse Event|0
5647567|NCT00579345|19504335|P3|Overall Study|Adverse Event|1
5647568|NCT00579345|19504336|P2|Overall Study|Adverse Event|0
5647569|NCT00579345|19504337|P1|Overall Study|Adverse Event|0
5647570|NCT00579345|19504330|P8|Overall Study|Lost to Follow-up|0
5647571|NCT00579345|19504331|P7|Overall Study|Lost to Follow-up|0
5647572|NCT00579345|19504332|P6|Overall Study|Lost to Follow-up|0
5647573|NCT00579345|19504333|P5|Overall Study|Lost to Follow-up|0
5647574|NCT00579345|19504334|P4|Overall Study|Lost to Follow-up|0
5647575|NCT00579345|19504335|P3|Overall Study|Lost to Follow-up|0
5647576|NCT00579345|19504336|P2|Overall Study|Lost to Follow-up|0
5647577|NCT00579345|19504337|P1|Overall Study|Lost to Follow-up|1
5647578|NCT00579345|19504330|P8|Overall Study|Withdrawal by Subject|1
5647579|NCT00579345|19504331|P7|Overall Study|Withdrawal by Subject|0
5647580|NCT00579345|19504332|P6|Overall Study|Withdrawal by Subject|0
5647581|NCT00579345|19504333|P5|Overall Study|Withdrawal by Subject|0
5647582|NCT00579345|19504334|P4|Overall Study|Withdrawal by Subject|0
5647583|NCT00579345|19504335|P3|Overall Study|Withdrawal by Subject|0
5647584|NCT00579345|19504336|P2|Overall Study|Withdrawal by Subject|0
5647585|NCT00579345|19504337|P1|Overall Study|Withdrawal by Subject|2
5647586|NCT00579254|19504412|P1|Overall Study|Discontinued when study terminated|73
5647587|NCT00579254|19504412|P1|Overall Study|Lost to Follow-up|39
5647588|NCT00579098|19504436|P2|Overall Study|AF returned after ablation|2
5647589|NCT00579098|19504437|P1|Overall Study|AF returned after ablation|3
5647590|NCT00579098|19504436|P2|Overall Study|Withdrawal by Subject|3
5647591|NCT00579098|19504437|P1|Overall Study|Withdrawal by Subject|2
5647592|NCT00579098|19504436|P2|Overall Study|Adverse Event|3
5647593|NCT00579098|19504437|P1|Overall Study|Adverse Event|2
5647594|NCT00579098|19504436|P2|Overall Study|Lost to Follow-up|0
5647595|NCT00579098|19504437|P1|Overall Study|Lost to Follow-up|2
5647596|NCT00579059|19504453|P2|Overall Study|Study Canceled at 1 Year|10
5647597|NCT00579059|19504454|P1|Overall Study|Study Canceled at 1 Year|21
5647598|NCT00578942|19504528|P1|Overall Study|Lost to Follow-up|1
5647599|NCT00578877|19504567|P2|Overall Study|did not provide follow-up data|17
5647600|NCT00578877|19504568|P1|Overall Study|did not provide follow-up data|12
5647601|NCT00578877|19504567|P2|Overall Study|early discontinue|101
5647602|NCT00578877|19504568|P1|Overall Study|early discontinue|61
5647603|NCT00578877|19504567|P2|Overall Study|Lost to Follow-up|10
5647604|NCT00578877|19504568|P1|Overall Study|Lost to Follow-up|8
5647605|NCT00578864|19504576|P2|Overall Study|Death|0
5647606|NCT00578864|19504577|P1|Overall Study|Death|1
5647607|NCT00578812|19504593|P2|Overall Study|Not treated|7
5647608|NCT00578812|19504594|P1|Overall Study|Not treated|6
5647609|NCT00578786|19504633|P3|Overall Study|Qualified but Not Enrolled in Extension|0
5647610|NCT00578786|19504634|P2|Overall Study|Qualified but Not Enrolled in Extension|3
5647611|NCT00578786|19504635|P1|Overall Study|Qualified but Not Enrolled in Extension|0
5647612|NCT00578786|19504633|P3|Overall Study|Not Otherwise Specified|1
5647613|NCT00578786|19504634|P2|Overall Study|Not Otherwise Specified|4
5647614|NCT00578786|19504635|P1|Overall Study|Not Otherwise Specified|0
5647615|NCT00578786|19504633|P3|Overall Study|Pregnancy|0
5647616|NCT00578786|19504634|P2|Overall Study|Pregnancy|1
5647617|NCT00578786|19504635|P1|Overall Study|Pregnancy|0
5647618|NCT00578786|19504633|P3|Overall Study|Lost to Follow-up|0
5647619|NCT00578786|19504634|P2|Overall Study|Lost to Follow-up|4
5647620|NCT00578786|19504635|P1|Overall Study|Lost to Follow-up|0
5647621|NCT00578786|19504633|P3|Overall Study|Sponsor Decision|1
5647622|NCT00578786|19504634|P2|Overall Study|Sponsor Decision|0
5647623|NCT00578786|19504635|P1|Overall Study|Sponsor Decision|0
5647624|NCT00578786|19504633|P3|Overall Study|Physician Decision|1
5647625|NCT00578786|19504634|P2|Overall Study|Physician Decision|0
5647626|NCT00578786|19504635|P1|Overall Study|Physician Decision|1
5647627|NCT00578786|19504633|P3|Overall Study|Protocol Violation|1
5647628|NCT00578786|19504634|P2|Overall Study|Protocol Violation|3
5647629|NCT00578786|19504635|P1|Overall Study|Protocol Violation|0
5647630|NCT00578786|19504633|P3|Overall Study|Withdrawal by Subject|5
5647631|NCT00578786|19504634|P2|Overall Study|Withdrawal by Subject|8
5647632|NCT00578786|19504635|P1|Overall Study|Withdrawal by Subject|7
5647633|NCT00578786|19504633|P3|Overall Study|Early Escape from Prior Study|2
5647634|NCT00578786|19504634|P2|Overall Study|Early Escape from Prior Study|1
5647635|NCT00578786|19504635|P1|Overall Study|Early Escape from Prior Study|2
5647636|NCT00578786|19504633|P3|Overall Study|Lack of Efficacy|2
5647637|NCT00578786|19504634|P2|Overall Study|Lack of Efficacy|5
5647638|NCT00578786|19504635|P1|Overall Study|Lack of Efficacy|2
5647639|NCT00578786|19504633|P3|Overall Study|Adverse Event|17
5647640|NCT00578786|19504634|P2|Overall Study|Adverse Event|37
5647641|NCT00578786|19504635|P1|Overall Study|Adverse Event|27
5647642|NCT00578643|19504736|P1|Overall Study|Lost to Follow-up|1
5647643|NCT00578643|19504736|P1|Overall Study|Death|1
5647644|NCT00578565|19504752|P1|Overall Study|Adverse Event|3
5647645|NCT00578448|19504782|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
5647646|NCT00578448|19504782|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
5647647|NCT00578448|19504782|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
5647648|NCT00578448|19504782|P1|Day 1 up to 3 Years of Planned Study|Death|1
5647649|NCT00578344|19504833|P1|Overall Study|Graft failure|1
5647650|NCT00578344|19504833|P1|Overall Study|Insurance problems|1
5647651|NCT00578318|19504852|P2|Overall Study|Physician Decision|0
5647652|NCT00578318|19504853|P1|Overall Study|Physician Decision|1
5647653|NCT00578318|19504852|P2|Overall Study|Lost to Follow-up|0
5647654|NCT00578318|19504853|P1|Overall Study|Lost to Follow-up|2
5647655|NCT00578292|19504923|P1|Overall Study|Graft failure|2
5647656|NCT00578292|19504923|P1|Overall Study|Death|1
5647657|NCT00578227|19504947|P3|Overall Study|Withdrawal by Subject|3
5647658|NCT00578227|19504948|P2|Overall Study|Withdrawal by Subject|1
5647659|NCT00578227|19504949|P1|Overall Study|Withdrawal by Subject|5
5647660|NCT00578227|19504947|P3|Overall Study|Lost to Follow-up|1
5647661|NCT00578227|19504948|P2|Overall Study|Lost to Follow-up|1
5647662|NCT00578227|19504949|P1|Overall Study|Lost to Follow-up|0
5647663|NCT00578175|19505074|P3|Overall Study|Other reasons|23
5647664|NCT00578175|19505075|P2|Overall Study|Other reasons|42
5647665|NCT00578175|19505076|P1|Overall Study|Other reasons|70
5647666|NCT00578175|19505074|P3|Overall Study|Adverse Event|1
5647667|NCT00578175|19505075|P2|Overall Study|Adverse Event|1
5647668|NCT00578175|19505076|P1|Overall Study|Adverse Event|0
5647669|NCT00578136|19505155|P2|Overall Study|Not given intervention|1
5647670|NCT00578136|19505156|P1|Overall Study|Not given intervention|1
5647671|NCT00577993|19505174|P3|Overall Study|Uninsured|0
5647672|NCT00577993|19505175|P2|Overall Study|Uninsured|0
5647673|NCT00577993|19505176|P1|Overall Study|Uninsured|1
5647674|NCT00577993|19505174|P3|Overall Study|Conversion|0
5647675|NCT00577993|19505175|P2|Overall Study|Conversion|5
5647676|NCT00577993|19505176|P1|Overall Study|Conversion|2
5647677|NCT00577993|19505174|P3|Overall Study|Withdrawal by Subject|2
5647678|NCT00577993|19505175|P2|Overall Study|Withdrawal by Subject|0
5647679|NCT00577993|19505176|P1|Overall Study|Withdrawal by Subject|1
5647680|NCT00577993|19505174|P3|Overall Study|Protocol Violation|0
5647681|NCT00577993|19505175|P2|Overall Study|Protocol Violation|3
5647682|NCT00577993|19505176|P1|Overall Study|Protocol Violation|2
5647683|NCT00577993|19505174|P3|Overall Study|Lack of Efficacy|0
5647684|NCT00577993|19505175|P2|Overall Study|Lack of Efficacy|1
5647685|NCT00577993|19505176|P1|Overall Study|Lack of Efficacy|0
5647686|NCT00577993|19505174|P3|Overall Study|Death|1
5647687|NCT00577993|19505175|P2|Overall Study|Death|1
5647688|NCT00577993|19505176|P1|Overall Study|Death|0
5647689|NCT00577993|19505174|P3|Overall Study|Adverse Event|0
5647690|NCT00577993|19505175|P2|Overall Study|Adverse Event|0
5647691|NCT00577993|19505176|P1|Overall Study|Adverse Event|1
5647692|NCT00577889|19505187|P3|Overall Study|Withdrawal by Subject|0
5647693|NCT00577889|19505188|P2|Overall Study|Withdrawal by Subject|0
5647694|NCT00577889|19505189|P1|Overall Study|Withdrawal by Subject|1
5647695|NCT00577863|19505208|P2|Overall Study|Did Not Receive at Least One Injection|1
5647696|NCT00577863|19505209|P1|Overall Study|Did Not Receive at Least One Injection|0
5647697|NCT00577863|19505208|P2|Overall Study|Sponsor Decision|7
5647698|NCT00577863|19505209|P1|Overall Study|Sponsor Decision|2
5647699|NCT00577863|19505208|P2|Overall Study|Withdrawal by Subject|2
5647700|NCT00577863|19505209|P1|Overall Study|Withdrawal by Subject|0
5647701|NCT00577863|19505208|P2|Overall Study|Entry Criteria Exclusion|0
5647702|NCT00577863|19505209|P1|Overall Study|Entry Criteria Exclusion|1
5647703|NCT00577863|19505208|P2|Overall Study|Lost to Follow-up|2
5647704|NCT00577863|19505209|P1|Overall Study|Lost to Follow-up|2
5647705|NCT00577863|19505208|P2|Overall Study|Death|0
5647706|NCT00577863|19505209|P1|Overall Study|Death|1
5647707|NCT00577863|19505208|P2|Overall Study|Adverse Event|2
5647708|NCT00577863|19505209|P1|Overall Study|Adverse Event|4
5647709|NCT00577824|19505251|P3|Overall Study|Protocol Violation|0
5647710|NCT00577824|19505252|P2|Overall Study|Protocol Violation|1
5647711|NCT00577824|19505253|P1|Overall Study|Protocol Violation|1
5647712|NCT00577824|19505251|P3|Overall Study|Patient decision|1
5647713|NCT00577824|19505252|P2|Overall Study|Patient decision|1
5647714|NCT00577824|19505253|P1|Overall Study|Patient decision|0
5647715|NCT00577824|19505251|P3|Overall Study|Adverse Event|1
5647716|NCT00577824|19505252|P2|Overall Study|Adverse Event|18
5647717|NCT00577824|19505253|P1|Overall Study|Adverse Event|6
5647718|NCT00577772|19505311|P2|Overall Study|Lost to Follow-up|1
5647719|NCT00577772|19505312|P1|Overall Study|Lost to Follow-up|0
5647720|NCT00577720|19505322|P4|Overall Study|Withdrawal by Subject|2
5647721|NCT00577720|19505323|P3|Overall Study|Withdrawal by Subject|0
5647722|NCT00577720|19505324|P2|Overall Study|Withdrawal by Subject|0
5647723|NCT00577720|19505325|P1|Overall Study|Withdrawal by Subject|2
5647724|NCT00577720|19505322|P4|Overall Study|Protocol Violation|1
5647725|NCT00577720|19505323|P3|Overall Study|Protocol Violation|0
5647726|NCT00577720|19505324|P2|Overall Study|Protocol Violation|0
5647727|NCT00577720|19505325|P1|Overall Study|Protocol Violation|0
5647728|NCT00577720|19505322|P4|Overall Study|Lost to Follow-up|0
5647729|NCT00577720|19505323|P3|Overall Study|Lost to Follow-up|1
5647730|NCT00577720|19505324|P2|Overall Study|Lost to Follow-up|0
5647731|NCT00577720|19505325|P1|Overall Study|Lost to Follow-up|0
5647732|NCT00577720|19505322|P4|Overall Study|Adverse Event|4
5647733|NCT00577720|19505323|P3|Overall Study|Adverse Event|0
5647734|NCT00577720|19505324|P2|Overall Study|Adverse Event|1
5647735|NCT00577720|19505325|P1|Overall Study|Adverse Event|2
5647736|NCT00577707|19505343|P1|Overall Study|Withdrawal by Subject|3
5647737|NCT00577655|19505351|P2|Overall Study|Lost to Follow-up|1
5647738|NCT00577655|19505352|P1|Overall Study|Lost to Follow-up|1
5647739|NCT00577655|19505351|P2|Overall Study|Protocol Violation|1
5647740|NCT00577655|19505352|P1|Overall Study|Protocol Violation|0
5647741|NCT00577655|19505351|P2|Overall Study|Patient Request|2
5647742|NCT00577655|19505352|P1|Overall Study|Patient Request|0
5647743|NCT00577642|19505390|P1|Overall Study|Clinical Disease Progression|1
5647744|NCT00577629|19505394|P1|Long Term Follow-Up|Physician Decision|1
5647745|NCT00577629|19505394|P1|Long Term Follow-Up|Withdrawal by Subject|4
5647746|NCT00577629|19505394|P1|Long Term Follow-Up|Lost to Follow-up|5
5647747|NCT00577629|19505394|P1|Long Term Follow-Up|Death|15
5647748|NCT00577629|19505394|P1|Treatment Period|Death|1
5647749|NCT00577473|19505421|P2|Overall Study|Lack of Efficacy|7
5647750|NCT00577473|19505422|P1|Overall Study|Lack of Efficacy|8
5647751|NCT00577473|19505421|P2|Overall Study|Physician Decision|2
5647752|NCT00577473|19505422|P1|Overall Study|Physician Decision|2
5647753|NCT00577473|19505421|P2|Overall Study|Withdrawal by Subject|6
5647754|NCT00577473|19505422|P1|Overall Study|Withdrawal by Subject|2
5647755|NCT00577473|19505421|P2|Overall Study|Adverse Event|5
5647756|NCT00577473|19505422|P1|Overall Study|Adverse Event|8
5647757|NCT00577473|19505421|P2|Overall Study|Protocol Violation|4
5647758|NCT00577473|19505422|P1|Overall Study|Protocol Violation|1
5647759|NCT00577460|19505453|P3|Overall Study|Other|2
5647760|NCT00577460|19505454|P2|Overall Study|Other|3
5647761|NCT00577460|19505455|P1|Overall Study|Other|0
5647762|NCT00577460|19505453|P3|Overall Study|Withdrawal by Subject|6
5647763|NCT00577460|19505454|P2|Overall Study|Withdrawal by Subject|5
5647764|NCT00577460|19505455|P1|Overall Study|Withdrawal by Subject|5
5647765|NCT00577460|19505453|P3|Overall Study|Lost to Follow-up|4
5647766|NCT00577460|19505454|P2|Overall Study|Lost to Follow-up|3
5647767|NCT00577460|19505455|P1|Overall Study|Lost to Follow-up|0
5647768|NCT00577460|19505453|P3|Overall Study|Protocol Violation|1
5647769|NCT00577460|19505454|P2|Overall Study|Protocol Violation|1
5647770|NCT00577460|19505455|P1|Overall Study|Protocol Violation|0
5647771|NCT00577460|19505453|P3|Overall Study|Adverse Event|14
5647772|NCT00577460|19505454|P2|Overall Study|Adverse Event|7
5647773|NCT00577460|19505455|P1|Overall Study|Adverse Event|11
5647774|NCT00577408|19505564|P2|Overall Study|Psychiatric hospitalization|1
5647775|NCT00577408|19505565|P1|Overall Study|Psychiatric hospitalization|0
5647776|NCT00577408|19505564|P2|Overall Study|Death|1
5647777|NCT00577408|19505565|P1|Overall Study|Death|0
5647778|NCT00577408|19505564|P2|Overall Study|Scheduling Issues|3
5647779|NCT00577408|19505565|P1|Overall Study|Scheduling Issues|0
5647780|NCT00577408|19505564|P2|Overall Study|Moved out of state|1
5647781|NCT00577408|19505565|P1|Overall Study|Moved out of state|0
5647782|NCT00577408|19505564|P2|Overall Study|Refused Oral Naltrexone|1
5647783|NCT00577408|19505565|P1|Overall Study|Refused Oral Naltrexone|0
5647784|NCT00577408|19505564|P2|Overall Study|Non-compliance with study meds|3
5647785|NCT00577408|19505565|P1|Overall Study|Non-compliance with study meds|0
5647786|NCT00577408|19505564|P2|Overall Study|Continued opioid use|2
5647787|NCT00577408|19505565|P1|Overall Study|Continued opioid use|3
5647788|NCT00577408|19505564|P2|Overall Study|Stopped attending study visits|11
5647789|NCT00577408|19505565|P1|Overall Study|Stopped attending study visits|9
5647790|NCT00577395|19505573|P2|Overall Study|Study was terminated early by Sponsor|6
5647791|NCT00577395|19505574|P1|Overall Study|Study was terminated early by Sponsor|7
5647792|NCT00577382|19505584|P2|Overall Study|Lost to Follow-up|2
5647793|NCT00577382|19505585|P1|Overall Study|Lost to Follow-up|2
5647794|NCT00577382|19505584|P2|Overall Study|Death|1
5647795|NCT00577382|19505585|P1|Overall Study|Death|1
5647796|NCT00577382|19505584|P2|Overall Study|Intercurrent Illness|2
5647797|NCT00577382|19505585|P1|Overall Study|Intercurrent Illness|1
5647798|NCT00577382|19505584|P2|Overall Study|Progressive Disease|19
5647799|NCT00577382|19505585|P1|Overall Study|Progressive Disease|17
5647800|NCT00577382|19505584|P2|Overall Study|Withdrawal by Subject|1
5647801|NCT00577382|19505585|P1|Overall Study|Withdrawal by Subject|0
5647802|NCT00577382|19505584|P2|Overall Study|Adverse Event|6
5647803|NCT00577382|19505585|P1|Overall Study|Adverse Event|0
5647804|NCT00577122|19505728|P2|Overall Study|Alternative Therapy|1
5647805|NCT00577122|19505729|P1|Overall Study|Alternative Therapy|0
5647806|NCT00577122|19505728|P2|Overall Study|Prog, refract disease during active trt|5
5647807|NCT00577122|19505729|P1|Overall Study|Prog, refract disease during active trt|8
5647808|NCT00577122|19505728|P2|Overall Study|Progression, relapse during active trt|8
5647809|NCT00577122|19505729|P1|Overall Study|Progression, relapse during active trt|6
5647810|NCT00577122|19505728|P2|Overall Study|Adverse Event|2
5647811|NCT00577122|19505729|P1|Overall Study|Adverse Event|0
5647812|NCT00577096|19505743|P2|Short Term Participation|Death|1
5647813|NCT00577096|19505744|P1|Short Term Participation|Death|1
5647814|NCT00577096|19505743|P2|Short Term Participation|Withdrawal by Subject|5
5647815|NCT00577096|19505744|P1|Short Term Participation|Withdrawal by Subject|3
5647816|NCT00577096|19505743|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
5647817|NCT00577096|19505744|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
5647818|NCT00577031|19505783|P1|Overall Study|Death|6
5647819|NCT00577031|19505783|P1|Overall Study|Medical decision|14
5647820|NCT00577031|19505783|P1|Overall Study|Need for surgery|17
5647821|NCT00577031|19505783|P1|Overall Study|Participant non-compliance|5
5647822|NCT00577031|19505783|P1|Overall Study|Participant withdrew consent|13
5647823|NCT00577031|19505783|P1|Overall Study|Protocol Violation|5
5647824|NCT00577031|19505783|P1|Overall Study|Progression of disease|93
5647825|NCT00577031|19505783|P1|Overall Study|Adverse Event|52
5647826|NCT00577005|19505804|P2|Overall Study|Withdrawal by Subject|1
5647827|NCT00577005|19505805|P1|Overall Study|Withdrawal by Subject|2
5647828|NCT00577005|19505804|P2|Overall Study|Lost to Follow-up|2
5647829|NCT00577005|19505805|P1|Overall Study|Lost to Follow-up|3
5647830|NCT00576927|19505819|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
5647831|NCT00576927|19505819|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
5647832|NCT00576927|19505819|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
5647833|NCT00576927|19505819|P1|Sleep Hygiene Behavioral Intervention|Death|1
5647834|NCT00576927|19505819|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
5647835|NCT00576927|19505819|P1|Baseline|Withdrawal by Subject|3
5647836|NCT00576927|19505819|P1|Baseline|Medication Change by PCP of subject|1
5647837|NCT00576927|19505819|P1|Baseline|Physician Decision|9
5647838|NCT00576927|19505819|P1|Clinical Assessment|Physician Decision|1
5647839|NCT00576927|19505819|P1|Clinical Assessment|Withdrawal by Subject|10
5647840|NCT00576927|19505819|P1|Clinical Assessment|Death|1
5647841|NCT00576927|19505819|P1|Clinical Assessment|Lack of Efficacy|24
5647842|NCT00576901|19505831|P1|Overall Study|Protocol Violation|1
5647843|NCT00576901|19505831|P1|Overall Study|Disease course|1
5647844|NCT00576901|19505831|P1|Overall Study|Withdrawal by Subject|1
5647845|NCT00576836|19505839|P2|Overall Study|Physician Decision|1
5647846|NCT00576836|19505840|P1|Overall Study|Physician Decision|0
5647847|NCT00576836|19505839|P2|Overall Study|Death|1
5647848|NCT00576836|19505840|P1|Overall Study|Death|0
5647849|NCT00576823|19505855|P3|40-week Safety Extension Phase|Lack of Efficacy|0
5647850|NCT00576823|19505856|P2|40-week Safety Extension Phase|Lack of Efficacy|0
5647851|NCT00576823|19505857|P1|40-week Safety Extension Phase|Lack of Efficacy|1
5647852|NCT00576823|19505855|P3|12-week Efficacy Phase|Parent's schedule issue|0
5647853|NCT00576823|19505856|P2|12-week Efficacy Phase|Parent's schedule issue|0
5647854|NCT00576823|19505857|P1|12-week Efficacy Phase|Parent's schedule issue|1
5647855|NCT00576758|19505873|P2|Follow-up Period|Withdrew consent|1
5647856|NCT00576758|19505874|P1|Follow-up Period|Withdrew consent|2
5647857|NCT00576758|19505873|P2|Follow-up Period|Insufficient therapeutic response|5
5647858|NCT00576758|19505874|P1|Follow-up Period|Insufficient therapeutic response|16
5647859|NCT00576758|19505873|P2|Follow-up Period|Death|3
5647860|NCT00576758|19505874|P1|Follow-up Period|Death|3
5647861|NCT00576758|19505873|P2|Follow-up Period|Administrative/Other|8
5647862|NCT00576758|19505874|P1|Follow-up Period|Administrative/Other|6
5647863|NCT00576758|19505873|P2|Extension Treatment Period|Administrative/Other|1
5647864|NCT00576758|19505874|P1|Extension Treatment Period|Administrative/Other|3
5647865|NCT00576758|19505873|P2|Extension Treatment Period|Insufficient therapeutic response|33
5647866|NCT00576758|19505874|P1|Extension Treatment Period|Insufficient therapeutic response|30
5647867|NCT00576758|19505873|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
5647868|NCT00576758|19505874|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
5647869|NCT00576758|19505873|P2|Extension Treatment Period|Death|1
5647870|NCT00576758|19505874|P1|Extension Treatment Period|Death|1
5647871|NCT00576758|19505873|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
5647872|NCT00576758|19505874|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
5647873|NCT00576758|19505873|P2|Induction Treatment Period|Withdrew consent|0
5647874|NCT00576758|19505874|P1|Induction Treatment Period|Withdrew consent|1
5647875|NCT00576758|19505873|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
5647876|NCT00576758|19505874|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
5647877|NCT00576758|19505873|P2|Induction Treatment Period|Death|0
5647878|NCT00576758|19505874|P1|Induction Treatment Period|Death|1
5647879|NCT00576758|19505873|P2|Induction Treatment Period|Violation of selection criteria at entry|1
5647880|NCT00576758|19505874|P1|Induction Treatment Period|Violation of selection criteria at entry|1
5647881|NCT00576758|19505873|P2|Induction Treatment Period|Insufficient therapeutic response|0
5647882|NCT00576758|19505874|P1|Induction Treatment Period|Insufficient therapeutic response|2
5647883|NCT00576758|19505873|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
5647884|NCT00576758|19505874|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
5647885|NCT00576732|19505920|P6|OPEN LABEL|Protocol Violation|0
5647886|NCT00576732|19505921|P5|OPEN LABEL|Protocol Violation|1
5647887|NCT00576732|19505922|P4|OPEN LABEL|Protocol Violation|2
5647888|NCT00576732|19505923|P3|OPEN LABEL|Protocol Violation|0
5647889|NCT00576732|19505924|P2|OPEN LABEL|Protocol Violation|0
5647890|NCT00576732|19505925|P1|OPEN LABEL|Protocol Violation|0
5647891|NCT00576732|19505920|P6|OPEN LABEL|Lack of Efficacy|3
5647892|NCT00576732|19505921|P5|OPEN LABEL|Lack of Efficacy|2
5647893|NCT00576732|19505922|P4|OPEN LABEL|Lack of Efficacy|2
5647894|NCT00576732|19505923|P3|OPEN LABEL|Lack of Efficacy|0
5647895|NCT00576732|19505924|P2|OPEN LABEL|Lack of Efficacy|0
5647896|NCT00576732|19505925|P1|OPEN LABEL|Lack of Efficacy|0
5647897|NCT00576732|19505920|P6|OPEN LABEL|OTHER|2
5647898|NCT00576732|19505921|P5|OPEN LABEL|OTHER|0
5647899|NCT00576732|19505922|P4|OPEN LABEL|OTHER|0
5647900|NCT00576732|19505923|P3|OPEN LABEL|OTHER|0
5647901|NCT00576732|19505924|P2|OPEN LABEL|OTHER|0
5647902|NCT00576732|19505925|P1|OPEN LABEL|OTHER|0
5647903|NCT00576732|19505920|P6|OPEN LABEL|Withdrawal by Subject|1
5647904|NCT00576732|19505921|P5|OPEN LABEL|Withdrawal by Subject|0
5647905|NCT00576732|19505922|P4|OPEN LABEL|Withdrawal by Subject|1
5647906|NCT00576732|19505923|P3|OPEN LABEL|Withdrawal by Subject|0
5647907|NCT00576732|19505924|P2|OPEN LABEL|Withdrawal by Subject|0
5647908|NCT00576732|19505925|P1|OPEN LABEL|Withdrawal by Subject|0
5647909|NCT00576732|19505920|P6|OPEN LABEL|Lost to Follow-up|1
5647910|NCT00576732|19505921|P5|OPEN LABEL|Lost to Follow-up|1
5647911|NCT00576732|19505922|P4|OPEN LABEL|Lost to Follow-up|2
5647912|NCT00576732|19505923|P3|OPEN LABEL|Lost to Follow-up|0
5647913|NCT00576732|19505924|P2|OPEN LABEL|Lost to Follow-up|0
5647914|NCT00576732|19505925|P1|OPEN LABEL|Lost to Follow-up|0
5647915|NCT00576732|19505920|P6|OPEN LABEL|Adverse Event|1
5647916|NCT00576732|19505921|P5|OPEN LABEL|Adverse Event|0
5647917|NCT00576732|19505922|P4|OPEN LABEL|Adverse Event|4
5647918|NCT00576732|19505923|P3|OPEN LABEL|Adverse Event|0
5647919|NCT00576732|19505924|P2|OPEN LABEL|Adverse Event|0
5647920|NCT00576732|19505925|P1|OPEN LABEL|Adverse Event|0
5647921|NCT00576732|19505920|P6|DOUBLE BLIND|Protocol Violation|0
5647922|NCT00576732|19505921|P5|DOUBLE BLIND|Protocol Violation|0
5647923|NCT00576732|19505922|P4|DOUBLE BLIND|Protocol Violation|0
5647924|NCT00576732|19505923|P3|DOUBLE BLIND|Protocol Violation|0
5647925|NCT00576732|19505924|P2|DOUBLE BLIND|Protocol Violation|0
5647926|NCT00576732|19505925|P1|DOUBLE BLIND|Protocol Violation|1
5647927|NCT00576732|19505920|P6|DOUBLE BLIND|Lack of Efficacy|0
5647928|NCT00576732|19505921|P5|DOUBLE BLIND|Lack of Efficacy|0
5647929|NCT00576732|19505922|P4|DOUBLE BLIND|Lack of Efficacy|0
5647930|NCT00576732|19505923|P3|DOUBLE BLIND|Lack of Efficacy|0
5647931|NCT00576732|19505924|P2|DOUBLE BLIND|Lack of Efficacy|1
5647932|NCT00576732|19505925|P1|DOUBLE BLIND|Lack of Efficacy|6
5647933|NCT00576732|19505920|P6|DOUBLE BLIND|OTHER|0
5647934|NCT00576732|19505921|P5|DOUBLE BLIND|OTHER|0
5647935|NCT00576732|19505922|P4|DOUBLE BLIND|OTHER|0
5647936|NCT00576732|19505923|P3|DOUBLE BLIND|OTHER|1
5647937|NCT00576732|19505924|P2|DOUBLE BLIND|OTHER|2
5647938|NCT00576732|19505925|P1|DOUBLE BLIND|OTHER|0
5647939|NCT00576732|19505920|P6|DOUBLE BLIND|Withdrawal by Subject|0
5647940|NCT00576732|19505921|P5|DOUBLE BLIND|Withdrawal by Subject|0
5647941|NCT00576732|19505922|P4|DOUBLE BLIND|Withdrawal by Subject|0
5647942|NCT00576732|19505923|P3|DOUBLE BLIND|Withdrawal by Subject|3
5647943|NCT00576732|19505924|P2|DOUBLE BLIND|Withdrawal by Subject|1
5647944|NCT00576732|19505925|P1|DOUBLE BLIND|Withdrawal by Subject|1
5647945|NCT00576732|19505920|P6|DOUBLE BLIND|Lost to Follow-up|0
5647946|NCT00576732|19505921|P5|DOUBLE BLIND|Lost to Follow-up|0
5647947|NCT00576732|19505922|P4|DOUBLE BLIND|Lost to Follow-up|0
5647948|NCT00576732|19505923|P3|DOUBLE BLIND|Lost to Follow-up|1
5647949|NCT00576732|19505924|P2|DOUBLE BLIND|Lost to Follow-up|1
5647950|NCT00576732|19505925|P1|DOUBLE BLIND|Lost to Follow-up|0
5647951|NCT00576732|19505920|P6|DOUBLE BLIND|Adverse Event|0
5647952|NCT00576732|19505921|P5|DOUBLE BLIND|Adverse Event|0
5647953|NCT00576732|19505922|P4|DOUBLE BLIND|Adverse Event|0
5647954|NCT00576732|19505923|P3|DOUBLE BLIND|Adverse Event|1
5647955|NCT00576732|19505924|P2|DOUBLE BLIND|Adverse Event|0
5647956|NCT00576732|19505925|P1|DOUBLE BLIND|Adverse Event|0
5647957|NCT00576693|19505957|P2|Overall Study|Withdrawal by Subject|13
5647958|NCT00576693|19505958|P1|Overall Study|Withdrawal by Subject|3
5647959|NCT00576693|19505957|P2|Overall Study|Lost to Follow-up|11
5647960|NCT00576693|19505958|P1|Overall Study|Lost to Follow-up|7
5647961|NCT00576628|19505970|P1|Overall Study|Dialysis|15
5647962|NCT00576628|19505970|P1|Overall Study|Transplantation|1
5647963|NCT00576628|19505970|P1|Overall Study|The patient move into other town|1
5647964|NCT00576628|19505970|P1|Overall Study|Progression of Renal Failure|1
5647965|NCT00576628|19505970|P1|Overall Study|Progression of Kidney Disease|1
5647966|NCT00576628|19505970|P1|Overall Study|RBC transfusion|1
5647967|NCT00576628|19505970|P1|Overall Study|Pregnancy|1
5647968|NCT00576628|19505970|P1|Overall Study|Refused Treatment|8
5647969|NCT00576628|19505970|P1|Overall Study|Failure to return|1
5647970|NCT00576628|19505970|P1|Overall Study|Death|2
5647971|NCT00576628|19505970|P1|Overall Study|Adverse Event|11
5647972|NCT00576576|19505990|P1|Overall Study|Protocol Violation|1
5647973|NCT00576576|19505990|P1|Overall Study|Lost to Follow-up|6
5647974|NCT00576472|19506024|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
5647975|NCT00576472|19506025|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
5647976|NCT00576472|19506026|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
5647977|NCT00576472|19506027|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
5647978|NCT00576472|19506028|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
5647979|NCT00576472|19506029|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
5647980|NCT00576472|19506030|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
5647981|NCT00576472|19506031|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
5647982|NCT00576472|19506032|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
5647983|NCT00576472|19506033|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
5647984|NCT00576472|19506034|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
5647985|NCT00576472|19506035|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
5647986|NCT00576472|19506036|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
5647987|NCT00576472|19506037|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
5647988|NCT00576472|19506038|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
5647989|NCT00576472|19506024|P15|MPH Home Maintenance Phase|Medical reasons|6
5647990|NCT00576472|19506025|P14|MPH Home Maintenance Phase|Medical reasons|0
5647991|NCT00576472|19506026|P13|MPH Home Maintenance Phase|Medical reasons|0
5647992|NCT00576472|19506027|P12|MPH Home Maintenance Phase|Medical reasons|0
5647993|NCT00576472|19506028|P11|MPH Home Maintenance Phase|Medical reasons|0
5647994|NCT00576472|19506029|P10|MPH Home Maintenance Phase|Medical reasons|0
5647995|NCT00576472|19506030|P9|MPH Home Maintenance Phase|Medical reasons|0
5647996|NCT00576472|19506031|P8|MPH Home Maintenance Phase|Medical reasons|0
5647997|NCT00576472|19506032|P7|MPH Home Maintenance Phase|Medical reasons|0
5647998|NCT00576472|19506033|P6|MPH Home Maintenance Phase|Medical reasons|0
5647999|NCT00576472|19506034|P5|MPH Home Maintenance Phase|Medical reasons|0
5648000|NCT00576472|19506035|P4|MPH Home Maintenance Phase|Medical reasons|0
5648001|NCT00576472|19506036|P3|MPH Home Maintenance Phase|Medical reasons|0
5648002|NCT00576472|19506037|P2|MPH Home Maintenance Phase|Medical reasons|0
5648003|NCT00576472|19506038|P1|MPH Home Maintenance Phase|Medical reasons|0
5648004|NCT00576472|19506024|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
5648005|NCT00576472|19506025|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648006|NCT00576472|19506026|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648007|NCT00576472|19506027|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648008|NCT00576472|19506028|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648009|NCT00576472|19506029|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648010|NCT00576472|19506030|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648011|NCT00576472|19506031|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648012|NCT00576472|19506032|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648013|NCT00576472|19506033|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648014|NCT00576472|19506034|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648015|NCT00576472|19506035|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648016|NCT00576472|19506036|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648017|NCT00576472|19506037|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648018|NCT00576472|19506038|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
5648019|NCT00576472|19506024|P15|MPH Home Maintenance Phase|Side effects|8
5648020|NCT00576472|19506025|P14|MPH Home Maintenance Phase|Side effects|0
5648021|NCT00576472|19506026|P13|MPH Home Maintenance Phase|Side effects|0
5648022|NCT00576472|19506027|P12|MPH Home Maintenance Phase|Side effects|0
5648023|NCT00576472|19506028|P11|MPH Home Maintenance Phase|Side effects|0
5648024|NCT00576472|19506029|P10|MPH Home Maintenance Phase|Side effects|0
5648025|NCT00576472|19506030|P9|MPH Home Maintenance Phase|Side effects|0
5648026|NCT00576472|19506031|P8|MPH Home Maintenance Phase|Side effects|0
5648027|NCT00576472|19506032|P7|MPH Home Maintenance Phase|Side effects|0
5648028|NCT00576472|19506033|P6|MPH Home Maintenance Phase|Side effects|0
5648029|NCT00576472|19506034|P5|MPH Home Maintenance Phase|Side effects|0
5648030|NCT00576472|19506035|P4|MPH Home Maintenance Phase|Side effects|0
5648031|NCT00576472|19506036|P3|MPH Home Maintenance Phase|Side effects|0
5648032|NCT00576472|19506037|P2|MPH Home Maintenance Phase|Side effects|0
5648033|NCT00576472|19506038|P1|MPH Home Maintenance Phase|Side effects|0
5648034|NCT00576472|19506024|P15|MPH Home Maintenance Phase|Insufficient data|0
5648035|NCT00576472|19506025|P14|MPH Home Maintenance Phase|Insufficient data|4
5648036|NCT00576472|19506026|P13|MPH Home Maintenance Phase|Insufficient data|0
5648037|NCT00576472|19506027|P12|MPH Home Maintenance Phase|Insufficient data|0
5648038|NCT00576472|19506028|P11|MPH Home Maintenance Phase|Insufficient data|0
5648039|NCT00576472|19506029|P10|MPH Home Maintenance Phase|Insufficient data|0
5648040|NCT00576472|19506030|P9|MPH Home Maintenance Phase|Insufficient data|0
5648041|NCT00576472|19506031|P8|MPH Home Maintenance Phase|Insufficient data|0
5648042|NCT00576472|19506032|P7|MPH Home Maintenance Phase|Insufficient data|0
5648043|NCT00576472|19506033|P6|MPH Home Maintenance Phase|Insufficient data|0
5648044|NCT00576472|19506034|P5|MPH Home Maintenance Phase|Insufficient data|0
5648045|NCT00576472|19506035|P4|MPH Home Maintenance Phase|Insufficient data|0
5648046|NCT00576472|19506036|P3|MPH Home Maintenance Phase|Insufficient data|0
5648047|NCT00576472|19506037|P2|MPH Home Maintenance Phase|Insufficient data|0
5648048|NCT00576472|19506038|P1|MPH Home Maintenance Phase|Insufficient data|0
5648049|NCT00576472|19506024|P15|MPH Home Maintenance Phase|Declined to participate|0
5648050|NCT00576472|19506025|P14|MPH Home Maintenance Phase|Declined to participate|7
5648051|NCT00576472|19506026|P13|MPH Home Maintenance Phase|Declined to participate|0
5648052|NCT00576472|19506027|P12|MPH Home Maintenance Phase|Declined to participate|0
5648053|NCT00576472|19506028|P11|MPH Home Maintenance Phase|Declined to participate|0
5648054|NCT00576472|19506029|P10|MPH Home Maintenance Phase|Declined to participate|0
5648055|NCT00576472|19506030|P9|MPH Home Maintenance Phase|Declined to participate|0
5648056|NCT00576472|19506031|P8|MPH Home Maintenance Phase|Declined to participate|0
5648057|NCT00576472|19506032|P7|MPH Home Maintenance Phase|Declined to participate|0
5648058|NCT00576472|19506033|P6|MPH Home Maintenance Phase|Declined to participate|0
5648059|NCT00576472|19506034|P5|MPH Home Maintenance Phase|Declined to participate|0
5648060|NCT00576472|19506035|P4|MPH Home Maintenance Phase|Declined to participate|0
5648061|NCT00576472|19506036|P3|MPH Home Maintenance Phase|Declined to participate|0
5648062|NCT00576472|19506037|P2|MPH Home Maintenance Phase|Declined to participate|0
5648063|NCT00576472|19506038|P1|MPH Home Maintenance Phase|Declined to participate|0
5648064|NCT00576472|19506024|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
5648065|NCT00576472|19506025|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
5648066|NCT00576472|19506026|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
5648067|NCT00576472|19506027|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
5648068|NCT00576472|19506028|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
5648069|NCT00576472|19506029|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
5648070|NCT00576472|19506030|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
5648071|NCT00576472|19506031|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
5648072|NCT00576472|19506032|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
5648073|NCT00576472|19506033|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
5648074|NCT00576472|19506034|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
5648075|NCT00576472|19506035|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
5648076|NCT00576472|19506036|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
5648077|NCT00576472|19506037|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
5648078|NCT00576472|19506038|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
5648079|NCT00576472|19506024|P15|MPH Cross Over Phase|Did not complete cross over phase|0
5648080|NCT00576472|19506025|P14|MPH Cross Over Phase|Did not complete cross over phase|0
5648081|NCT00576472|19506026|P13|MPH Cross Over Phase|Did not complete cross over phase|0
5648082|NCT00576472|19506027|P12|MPH Cross Over Phase|Did not complete cross over phase|1
5648083|NCT00576472|19506028|P11|MPH Cross Over Phase|Did not complete cross over phase|1
5648084|NCT00576472|19506029|P10|MPH Cross Over Phase|Did not complete cross over phase|0
5648085|NCT00576472|19506030|P9|MPH Cross Over Phase|Did not complete cross over phase|2
5648086|NCT00576472|19506031|P8|MPH Cross Over Phase|Did not complete cross over phase|0
5648087|NCT00576472|19506032|P7|MPH Cross Over Phase|Did not complete cross over phase|0
5648088|NCT00576472|19506033|P6|MPH Cross Over Phase|Did not complete cross over phase|0
5648089|NCT00576472|19506034|P5|MPH Cross Over Phase|Did not complete cross over phase|0
5648090|NCT00576472|19506035|P4|MPH Cross Over Phase|Did not complete cross over phase|0
5648091|NCT00576472|19506036|P3|MPH Cross Over Phase|Did not complete cross over phase|0
5648092|NCT00576472|19506037|P2|MPH Cross Over Phase|Did not complete cross over phase|0
5648093|NCT00576472|19506038|P1|MPH Cross Over Phase|Did not complete cross over phase|0
5648094|NCT00576472|19506024|P15|MPH Cross Over Phase|Physician Decision|0
5648095|NCT00576472|19506025|P14|MPH Cross Over Phase|Physician Decision|0
5648096|NCT00576472|19506026|P13|MPH Cross Over Phase|Physician Decision|0
5648097|NCT00576472|19506027|P12|MPH Cross Over Phase|Physician Decision|0
5648098|NCT00576472|19506028|P11|MPH Cross Over Phase|Physician Decision|0
5648099|NCT00576472|19506029|P10|MPH Cross Over Phase|Physician Decision|0
5648100|NCT00576472|19506030|P9|MPH Cross Over Phase|Physician Decision|0
5648101|NCT00576472|19506031|P8|MPH Cross Over Phase|Physician Decision|0
5648102|NCT00576472|19506032|P7|MPH Cross Over Phase|Physician Decision|4
5648103|NCT00576472|19506033|P6|MPH Cross Over Phase|Physician Decision|0
5648104|NCT00576472|19506034|P5|MPH Cross Over Phase|Physician Decision|0
5648105|NCT00576472|19506035|P4|MPH Cross Over Phase|Physician Decision|0
5648106|NCT00576472|19506036|P3|MPH Cross Over Phase|Physician Decision|0
5648107|NCT00576472|19506037|P2|MPH Cross Over Phase|Physician Decision|0
5648108|NCT00576472|19506038|P1|MPH Cross Over Phase|Physician Decision|0
5648109|NCT00576472|19506024|P15|MPH Cross Over Phase|Ineligible due to disease|0
5648110|NCT00576472|19506025|P14|MPH Cross Over Phase|Ineligible due to disease|0
5648111|NCT00576472|19506026|P13|MPH Cross Over Phase|Ineligible due to disease|0
5648112|NCT00576472|19506027|P12|MPH Cross Over Phase|Ineligible due to disease|0
5648113|NCT00576472|19506028|P11|MPH Cross Over Phase|Ineligible due to disease|0
5648114|NCT00576472|19506029|P10|MPH Cross Over Phase|Ineligible due to disease|0
5648115|NCT00576472|19506030|P9|MPH Cross Over Phase|Ineligible due to disease|0
5648116|NCT00576472|19506031|P8|MPH Cross Over Phase|Ineligible due to disease|0
5648117|NCT00576472|19506032|P7|MPH Cross Over Phase|Ineligible due to disease|2
5648118|NCT00576472|19506033|P6|MPH Cross Over Phase|Ineligible due to disease|0
5648119|NCT00576472|19506034|P5|MPH Cross Over Phase|Ineligible due to disease|0
5648120|NCT00576472|19506035|P4|MPH Cross Over Phase|Ineligible due to disease|0
5648121|NCT00576472|19506036|P3|MPH Cross Over Phase|Ineligible due to disease|0
5648122|NCT00576472|19506037|P2|MPH Cross Over Phase|Ineligible due to disease|0
5648123|NCT00576472|19506038|P1|MPH Cross Over Phase|Ineligible due to disease|0
5648124|NCT00576472|19506024|P15|MPH Cross Over Phase|Withdrawal by Subject|0
5648125|NCT00576472|19506025|P14|MPH Cross Over Phase|Withdrawal by Subject|0
5648126|NCT00576472|19506026|P13|MPH Cross Over Phase|Withdrawal by Subject|0
5648127|NCT00576472|19506027|P12|MPH Cross Over Phase|Withdrawal by Subject|0
5648128|NCT00576472|19506028|P11|MPH Cross Over Phase|Withdrawal by Subject|0
5648129|NCT00576472|19506029|P10|MPH Cross Over Phase|Withdrawal by Subject|0
5648130|NCT00576472|19506030|P9|MPH Cross Over Phase|Withdrawal by Subject|0
5648131|NCT00576472|19506031|P8|MPH Cross Over Phase|Withdrawal by Subject|0
5648132|NCT00576472|19506032|P7|MPH Cross Over Phase|Withdrawal by Subject|6
5648133|NCT00576472|19506033|P6|MPH Cross Over Phase|Withdrawal by Subject|0
5648134|NCT00576472|19506034|P5|MPH Cross Over Phase|Withdrawal by Subject|0
5648135|NCT00576472|19506035|P4|MPH Cross Over Phase|Withdrawal by Subject|0
5648136|NCT00576472|19506036|P3|MPH Cross Over Phase|Withdrawal by Subject|0
5648137|NCT00576472|19506037|P2|MPH Cross Over Phase|Withdrawal by Subject|0
5648138|NCT00576472|19506038|P1|MPH Cross Over Phase|Withdrawal by Subject|0
5648139|NCT00576472|19506024|P15|MPH In-Lab Phase|Psychiatric exclusion|0
5648140|NCT00576472|19506025|P14|MPH In-Lab Phase|Psychiatric exclusion|0
5648141|NCT00576472|19506026|P13|MPH In-Lab Phase|Psychiatric exclusion|0
5648142|NCT00576472|19506027|P12|MPH In-Lab Phase|Psychiatric exclusion|0
5648143|NCT00576472|19506028|P11|MPH In-Lab Phase|Psychiatric exclusion|0
5648144|NCT00576472|19506029|P10|MPH In-Lab Phase|Psychiatric exclusion|0
5648145|NCT00576472|19506030|P9|MPH In-Lab Phase|Psychiatric exclusion|0
5648146|NCT00576472|19506031|P8|MPH In-Lab Phase|Psychiatric exclusion|0
5648147|NCT00576472|19506032|P7|MPH In-Lab Phase|Psychiatric exclusion|0
5648148|NCT00576472|19506033|P6|MPH In-Lab Phase|Psychiatric exclusion|0
5648149|NCT00576472|19506034|P5|MPH In-Lab Phase|Psychiatric exclusion|0
5648150|NCT00576472|19506035|P4|MPH In-Lab Phase|Psychiatric exclusion|10
5648151|NCT00576472|19506036|P3|MPH In-Lab Phase|Psychiatric exclusion|0
5648152|NCT00576472|19506037|P2|MPH In-Lab Phase|Psychiatric exclusion|0
5648153|NCT00576472|19506038|P1|MPH In-Lab Phase|Psychiatric exclusion|0
5648154|NCT00576472|19506024|P15|MPH In-Lab Phase|No attention/academic problems|0
5648155|NCT00576472|19506025|P14|MPH In-Lab Phase|No attention/academic problems|0
5648156|NCT00576472|19506026|P13|MPH In-Lab Phase|No attention/academic problems|0
5648157|NCT00576472|19506027|P12|MPH In-Lab Phase|No attention/academic problems|0
5648158|NCT00576472|19506028|P11|MPH In-Lab Phase|No attention/academic problems|0
5648159|NCT00576472|19506029|P10|MPH In-Lab Phase|No attention/academic problems|0
5648160|NCT00576472|19506030|P9|MPH In-Lab Phase|No attention/academic problems|0
5648161|NCT00576472|19506031|P8|MPH In-Lab Phase|No attention/academic problems|0
5648162|NCT00576472|19506032|P7|MPH In-Lab Phase|No attention/academic problems|0
5648163|NCT00576472|19506033|P6|MPH In-Lab Phase|No attention/academic problems|0
5648164|NCT00576472|19506034|P5|MPH In-Lab Phase|No attention/academic problems|0
5648165|NCT00576472|19506035|P4|MPH In-Lab Phase|No attention/academic problems|245
5648166|NCT00576472|19506036|P3|MPH In-Lab Phase|No attention/academic problems|0
5648167|NCT00576472|19506037|P2|MPH In-Lab Phase|No attention/academic problems|0
5648168|NCT00576472|19506038|P1|MPH In-Lab Phase|No attention/academic problems|0
5648169|NCT00576472|19506024|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648170|NCT00576472|19506025|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648171|NCT00576472|19506026|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648172|NCT00576472|19506027|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648173|NCT00576472|19506028|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648174|NCT00576472|19506029|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648175|NCT00576472|19506030|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648176|NCT00576472|19506031|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648177|NCT00576472|19506032|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648178|NCT00576472|19506033|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648179|NCT00576472|19506034|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648180|NCT00576472|19506035|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
5648181|NCT00576472|19506036|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648182|NCT00576472|19506037|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648183|NCT00576472|19506038|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
5648184|NCT00576472|19506024|P15|MPH In-Lab Phase|Lost to Follow-up|0
5648185|NCT00576472|19506025|P14|MPH In-Lab Phase|Lost to Follow-up|0
5648186|NCT00576472|19506026|P13|MPH In-Lab Phase|Lost to Follow-up|0
5648187|NCT00576472|19506027|P12|MPH In-Lab Phase|Lost to Follow-up|0
5648188|NCT00576472|19506028|P11|MPH In-Lab Phase|Lost to Follow-up|0
5648189|NCT00576472|19506029|P10|MPH In-Lab Phase|Lost to Follow-up|0
5648190|NCT00576472|19506030|P9|MPH In-Lab Phase|Lost to Follow-up|0
5648191|NCT00576472|19506031|P8|MPH In-Lab Phase|Lost to Follow-up|0
5648192|NCT00576472|19506032|P7|MPH In-Lab Phase|Lost to Follow-up|0
5648193|NCT00576472|19506033|P6|MPH In-Lab Phase|Lost to Follow-up|0
5648194|NCT00576472|19506034|P5|MPH In-Lab Phase|Lost to Follow-up|0
5648195|NCT00576472|19506035|P4|MPH In-Lab Phase|Lost to Follow-up|1
5648196|NCT00576472|19506036|P3|MPH In-Lab Phase|Lost to Follow-up|0
5648197|NCT00576472|19506037|P2|MPH In-Lab Phase|Lost to Follow-up|0
5648198|NCT00576472|19506038|P1|MPH In-Lab Phase|Lost to Follow-up|0
5648199|NCT00576472|19506024|P15|MPH In-Lab Phase|Declined participation in medication pha|0
5648200|NCT00576472|19506025|P14|MPH In-Lab Phase|Declined participation in medication pha|0
5648201|NCT00576472|19506026|P13|MPH In-Lab Phase|Declined participation in medication pha|0
5648202|NCT00576472|19506027|P12|MPH In-Lab Phase|Declined participation in medication pha|0
5648203|NCT00576472|19506028|P11|MPH In-Lab Phase|Declined participation in medication pha|0
5648204|NCT00576472|19506029|P10|MPH In-Lab Phase|Declined participation in medication pha|0
5648205|NCT00576472|19506030|P9|MPH In-Lab Phase|Declined participation in medication pha|0
5648206|NCT00576472|19506031|P8|MPH In-Lab Phase|Declined participation in medication pha|0
5648207|NCT00576472|19506032|P7|MPH In-Lab Phase|Declined participation in medication pha|0
5648208|NCT00576472|19506033|P6|MPH In-Lab Phase|Declined participation in medication pha|0
5648209|NCT00576472|19506034|P5|MPH In-Lab Phase|Declined participation in medication pha|0
5648210|NCT00576472|19506035|P4|MPH In-Lab Phase|Declined participation in medication pha|75
5648211|NCT00576472|19506036|P3|MPH In-Lab Phase|Declined participation in medication pha|0
5648212|NCT00576472|19506037|P2|MPH In-Lab Phase|Declined participation in medication pha|0
5648213|NCT00576472|19506038|P1|MPH In-Lab Phase|Declined participation in medication pha|0
5648214|NCT00576420|19506131|P3|Overall Study|Death|1
5648215|NCT00576420|19506132|P2|Overall Study|Death|0
5648216|NCT00576420|19506133|P1|Overall Study|Death|0
5648217|NCT00576407|19506298|P1|Overall Study|Physician Decision|1
5648218|NCT00576407|19506298|P1|Overall Study|Death|7
5648219|NCT00576381|19506310|P1|Overall Study|Adverse Event|4
5648220|NCT00576381|19506310|P1|Overall Study|Reoperation|3
5648221|NCT00576316|19506314|P1|Overall Study|Protocol Violation|9
5648222|NCT00576316|19506314|P1|Overall Study|Withdrawal by Subject|2
5648223|NCT00576316|19506314|P1|Overall Study|Adverse Event|9
5648224|NCT00576303|19506319|P1|Long Term Safety Period|Early withdrawal|16
5648225|NCT00576303|19506319|P1|Efficacy Evaluation Period|Early withdrawal|5
5648226|NCT00576303|19506319|P1|Dose Titration Period|Early withdrawal|17
5648227|NCT00576199|19506337|P1|Overall Study|Reason Unspecified|2
5648228|NCT00576199|19506337|P1|Overall Study|Refused Treatment|2
5648229|NCT00576199|19506337|P1|Overall Study|Insufficient Therapeutic Response|14
5648230|NCT00576199|19506337|P1|Overall Study|Adverse Event|12
5648231|NCT00576056|19506350|P1|Overall Study|Physician Decision|1
5648232|NCT00576056|19506350|P1|Overall Study|did not meet eligibility criteria|8
5648233|NCT00576056|19506350|P1|Overall Study|Withdrawal by Subject|2
5648234|NCT00576056|19506350|P1|Overall Study|Lack of Efficacy|1
5648235|NCT00576056|19506350|P1|Overall Study|Death|1
5648236|NCT00576056|19506350|P1|Overall Study|Adverse Event|1
5648237|NCT00575666|19506366|P2|Overall Study|Physician Decision|1
5648238|NCT00575666|19506367|P1|Overall Study|Physician Decision|1
5648239|NCT00575666|19506366|P2|Overall Study|Withdrawal by Subject|2
5648240|NCT00575666|19506367|P1|Overall Study|Withdrawal by Subject|3
5648241|NCT00575588|19506407|P2|Overall Study|Impossible to determine HbA1c|1
5648242|NCT00575588|19506408|P1|Overall Study|Impossible to determine HbA1c|0
5648243|NCT00575588|19506407|P2|Overall Study|Patient moved|3
5648244|NCT00575588|19506408|P1|Overall Study|Patient moved|1
5648245|NCT00575588|19506407|P2|Overall Study|Elevated triglyceride|0
5648246|NCT00575588|19506408|P1|Overall Study|Elevated triglyceride|1
5648247|NCT00575588|19506407|P2|Overall Study|Safety reasons|1
5648248|NCT00575588|19506408|P1|Overall Study|Safety reasons|2
5648249|NCT00575588|19506407|P2|Overall Study|Severe non-compliance to protocol|7
5648250|NCT00575588|19506408|P1|Overall Study|Severe non-compliance to protocol|5
5648251|NCT00575588|19506407|P2|Overall Study|Study specific discontinuation criteria|218
5648252|NCT00575588|19506408|P1|Overall Study|Study specific discontinuation criteria|203
5648253|NCT00575588|19506407|P2|Overall Study|Incorrect enrollment|4
5648254|NCT00575588|19506408|P1|Overall Study|Incorrect enrollment|8
5648255|NCT00575588|19506407|P2|Overall Study|Death|2
5648256|NCT00575588|19506408|P1|Overall Study|Death|4
5648257|NCT00575588|19506407|P2|Overall Study|Lost to Follow-up|3
5648258|NCT00575588|19506408|P1|Overall Study|Lost to Follow-up|1
5648259|NCT00575588|19506407|P2|Overall Study|Withdrawal by Subject|31
5648260|NCT00575588|19506408|P1|Overall Study|Withdrawal by Subject|27
5648261|NCT00575588|19506407|P2|Overall Study|Adverse Event|13
5648262|NCT00575588|19506408|P1|Overall Study|Adverse Event|11
5648263|NCT00575510|19506431|P3|Overall Study|Pregnancy|1
5648264|NCT00575510|19506432|P2|Overall Study|Pregnancy|0
5648265|NCT00575510|19506433|P1|Overall Study|Pregnancy|0
5648266|NCT00575510|19506431|P3|Overall Study|Clinic Called Patient|7
5648267|NCT00575510|19506432|P2|Overall Study|Clinic Called Patient|7
5648268|NCT00575510|19506433|P1|Overall Study|Clinic Called Patient|7
5648269|NCT00575510|19506431|P3|Overall Study|Withdrawal by Subject|0
5648270|NCT00575510|19506432|P2|Overall Study|Withdrawal by Subject|0
5648271|NCT00575510|19506433|P1|Overall Study|Withdrawal by Subject|1
5648272|NCT00575510|19506431|P3|Overall Study|Lost to Follow-up|9
5648273|NCT00575510|19506432|P2|Overall Study|Lost to Follow-up|6
5648274|NCT00575510|19506433|P1|Overall Study|Lost to Follow-up|4
5648275|NCT00575380|19506446|P2|Overall Study|Various|2
5648276|NCT00575380|19506447|P1|Overall Study|Various|0
5648277|NCT00575380|19506446|P2|Overall Study|Adverse Event|1
5648278|NCT00575380|19506447|P1|Overall Study|Adverse Event|0
5648279|NCT00575380|19506446|P2|Overall Study|Withdrawal by Subject|0
5648280|NCT00575380|19506447|P1|Overall Study|Withdrawal by Subject|1
5648281|NCT00575328|19506466|P2|Overall Study|Lost to Follow-up|1
5648282|NCT00575328|19506467|P1|Overall Study|Lost to Follow-up|2
5648283|NCT00575328|19506466|P2|Overall Study|Adverse Event|1
5648284|NCT00575328|19506467|P1|Overall Study|Adverse Event|1
5648285|NCT00575094|19506600|P1|Overall Study|Withdrawal by Subject|1
5648286|NCT00575094|19506600|P1|Overall Study|Adverse Event|2
5648287|NCT00575042|19506604|P1|Overall Study|Lost to Follow-up|1
5648288|NCT00575042|19506604|P1|Overall Study|Adverse Event|2
5648289|NCT00574951|19506655|P1|Overall Study|Ineligible - improper prior treatment|1
5648290|NCT00574912|19506663|P1|Overall Study|Physician Decision|2
5648291|NCT00574912|19506663|P1|Overall Study|scheduling conflicts|3
5648292|NCT00574912|19506663|P1|Overall Study|Could not place IV lines.|3
5648293|NCT00574873|19506677|P2|Overall Study|Extension Study|0
5648294|NCT00574873|19506678|P1|Overall Study|Extension Study|126
5648295|NCT00574873|19506677|P2|Overall Study|Blank, site closed per local regulations|2
5648296|NCT00574873|19506678|P1|Overall Study|Blank, site closed per local regulations|2
5648297|NCT00574873|19506677|P2|Overall Study|Discontinuation of study by sponsor|199
5648298|NCT00574873|19506678|P1|Overall Study|Discontinuation of study by sponsor|5
5648299|NCT00574873|19506677|P2|Overall Study|Other|4
5648300|NCT00574873|19506678|P1|Overall Study|Other|40
5648301|NCT00574873|19506677|P2|Overall Study|Lost to Follow-up|5
5648302|NCT00574873|19506678|P1|Overall Study|Lost to Follow-up|14
5648303|NCT00574873|19506677|P2|Overall Study|Death|14
5648304|NCT00574873|19506678|P1|Overall Study|Death|15
5648305|NCT00574873|19506677|P2|Overall Study|Investigator request|8
5648306|NCT00574873|19506678|P1|Overall Study|Investigator request|18
5648307|NCT00574873|19506677|P2|Overall Study|Withdrawal by Subject|19
5648308|NCT00574873|19506678|P1|Overall Study|Withdrawal by Subject|18
5648309|NCT00574847|19506696|P2|Overall Study|Did not receive medication (declined)|5
5648310|NCT00574847|19506697|P1|Overall Study|Did not receive medication (declined)|2
5648311|NCT00574847|19506696|P2|Overall Study|Physician Decision|0
5648312|NCT00574847|19506697|P1|Overall Study|Physician Decision|1
5648313|NCT00574847|19506696|P2|Overall Study|Withdrawal by Subject|2
5648314|NCT00574847|19506697|P1|Overall Study|Withdrawal by Subject|2
5648315|NCT00574847|19506696|P2|Overall Study|Death|0
5648316|NCT00574847|19506697|P1|Overall Study|Death|1
5648317|NCT00574847|19506696|P2|Overall Study|Adverse Event|0
5648318|NCT00574847|19506697|P1|Overall Study|Adverse Event|2
5648319|NCT00574795|19506742|P1|Toddler Dose|Withdrawal by Subject|1
5648320|NCT00574795|19506742|P1|After Infant Series|Adverse Event|2
5648321|NCT00574795|19506742|P1|After Infant Series|Withdrawal by Subject|1
5648322|NCT00574795|19506742|P1|Infant Series|Adverse Event|1
5648323|NCT00574795|19506742|P1|Infant Series|Protocol Violation|2
5648324|NCT00574795|19506742|P1|Infant Series|Withdrawal by Subject|2
5648325|NCT00574405|19506843|P2|Overall Study|Withdrawal by Subject|2
5648326|NCT00574405|19506844|P1|Overall Study|Withdrawal by Subject|3
5648327|NCT00574288|19506864|P7|Overall Study|Other|0
5648328|NCT00574288|19506865|P6|Overall Study|Other|0
5648329|NCT00574288|19506866|P5|Overall Study|Other|0
5648330|NCT00574288|19506867|P4|Overall Study|Other|0
5648331|NCT00574288|19506868|P3|Overall Study|Other|0
5648332|NCT00574288|19506869|P2|Overall Study|Other|1
5648333|NCT00574288|19506870|P1|Overall Study|Other|1
5648334|NCT00574288|19506864|P7|Overall Study|Progressive Disease|0
5648335|NCT00574288|19506865|P6|Overall Study|Progressive Disease|0
5648336|NCT00574288|19506866|P5|Overall Study|Progressive Disease|1
5648337|NCT00574288|19506867|P4|Overall Study|Progressive Disease|2
5648338|NCT00574288|19506868|P3|Overall Study|Progressive Disease|3
5648339|NCT00574288|19506869|P2|Overall Study|Progressive Disease|2
5648340|NCT00574288|19506870|P1|Overall Study|Progressive Disease|17
5648341|NCT00574288|19506864|P7|Overall Study|Study Terminated By Sponsor|5
5648342|NCT00574288|19506865|P6|Overall Study|Study Terminated By Sponsor|0
5648343|NCT00574288|19506866|P5|Overall Study|Study Terminated By Sponsor|0
5648344|NCT00574288|19506867|P4|Overall Study|Study Terminated By Sponsor|0
5648345|NCT00574288|19506868|P3|Overall Study|Study Terminated By Sponsor|0
5648346|NCT00574288|19506869|P2|Overall Study|Study Terminated By Sponsor|0
5648347|NCT00574288|19506870|P1|Overall Study|Study Terminated By Sponsor|0
5648348|NCT00574288|19506864|P7|Overall Study|Lost to Follow-up|2
5648349|NCT00574288|19506865|P6|Overall Study|Lost to Follow-up|1
5648350|NCT00574288|19506866|P5|Overall Study|Lost to Follow-up|0
5648351|NCT00574288|19506867|P4|Overall Study|Lost to Follow-up|0
5648352|NCT00574288|19506868|P3|Overall Study|Lost to Follow-up|0
5648353|NCT00574288|19506869|P2|Overall Study|Lost to Follow-up|0
5648354|NCT00574288|19506870|P1|Overall Study|Lost to Follow-up|0
5648355|NCT00574288|19506864|P7|Overall Study|Death|21
5648356|NCT00574288|19506865|P6|Overall Study|Death|25
5648357|NCT00574288|19506866|P5|Overall Study|Death|0
5648358|NCT00574288|19506867|P4|Overall Study|Death|0
5648359|NCT00574288|19506868|P3|Overall Study|Death|0
5648360|NCT00574288|19506869|P2|Overall Study|Death|0
5648361|NCT00574288|19506870|P1|Overall Study|Death|0
5648362|NCT00574288|19506864|P7|Overall Study|Adverse Event|0
5648363|NCT00574288|19506865|P6|Overall Study|Adverse Event|0
5648364|NCT00574288|19506866|P5|Overall Study|Adverse Event|1
5648365|NCT00574288|19506867|P4|Overall Study|Adverse Event|0
5648366|NCT00574288|19506868|P3|Overall Study|Adverse Event|0
5648367|NCT00574288|19506869|P2|Overall Study|Adverse Event|0
5648368|NCT00574288|19506870|P1|Overall Study|Adverse Event|2
5648369|NCT00574275|19506908|P2|Overall Study|Operation for curative intent|1
5648370|NCT00574275|19506909|P1|Overall Study|Operation for curative intent|0
5648371|NCT00574275|19506908|P2|Overall Study|Insurance change|1
5648372|NCT00574275|19506909|P1|Overall Study|Insurance change|0
5648373|NCT00574275|19506908|P2|Overall Study|Patient and Investigator decision|1
5648374|NCT00574275|19506909|P1|Overall Study|Patient and Investigator decision|0
5648375|NCT00574275|19506908|P2|Overall Study|Protocol Violation|1
5648376|NCT00574275|19506909|P1|Overall Study|Protocol Violation|0
5648377|NCT00574275|19506908|P2|Overall Study|Physician Decision|1
5648378|NCT00574275|19506909|P1|Overall Study|Physician Decision|1
5648379|NCT00574275|19506908|P2|Overall Study|Error calculating tumor measurement|0
5648380|NCT00574275|19506909|P1|Overall Study|Error calculating tumor measurement|1
5648381|NCT00574275|19506908|P2|Overall Study|Withdrawal by Subject|17
5648382|NCT00574275|19506909|P1|Overall Study|Withdrawal by Subject|15
5648383|NCT00574275|19506908|P2|Overall Study|Study stopped based on DMC decision|23
5648384|NCT00574275|19506909|P1|Overall Study|Study stopped based on DMC decision|62
5648385|NCT00574275|19506908|P2|Overall Study|Lost to Follow-up|1
5648386|NCT00574275|19506909|P1|Overall Study|Lost to Follow-up|2
5648387|NCT00574275|19506908|P2|Overall Study|Disease progression|146
5648388|NCT00574275|19506909|P1|Overall Study|Disease progression|160
5648389|NCT00574275|19506908|P2|Overall Study|Adverse Event|76
5648390|NCT00574275|19506909|P1|Overall Study|Adverse Event|32
5648391|NCT00574275|19506908|P2|Overall Study|Randomized but not treated|3
5648392|NCT00574275|19506909|P1|Overall Study|Randomized but not treated|2
5648393|NCT00574249|19506927|P2|Overall Study|PPD test taken twice|1
5648394|NCT00574249|19506928|P1|Overall Study|PPD test taken twice|0
5648395|NCT00574249|19506927|P2|Overall Study|Excluded by company|1
5648396|NCT00574249|19506928|P1|Overall Study|Excluded by company|0
5648397|NCT00574249|19506927|P2|Overall Study|Pregnancy|0
5648398|NCT00574249|19506928|P1|Overall Study|Pregnancy|1
5648399|NCT00574249|19506927|P2|Overall Study|Physician Decision|0
5648400|NCT00574249|19506928|P1|Overall Study|Physician Decision|1
5648401|NCT00574249|19506927|P2|Overall Study|Withdrawal by Subject|0
5648402|NCT00574249|19506928|P1|Overall Study|Withdrawal by Subject|3
5648403|NCT00574249|19506927|P2|Overall Study|History of carcinoma|0
5648404|NCT00574249|19506928|P1|Overall Study|History of carcinoma|1
5648405|NCT00574249|19506927|P2|Overall Study|Protocol Violation|2
5648406|NCT00574249|19506928|P1|Overall Study|Protocol Violation|5
5648407|NCT00574249|19506927|P2|Overall Study|Lost to Follow-up|3
5648408|NCT00574249|19506928|P1|Overall Study|Lost to Follow-up|4
5648409|NCT00574249|19506927|P2|Overall Study|Lack of Efficacy|3
5648410|NCT00574249|19506928|P1|Overall Study|Lack of Efficacy|5
5648411|NCT00574249|19506927|P2|Overall Study|Adverse Event|18
5648412|NCT00574249|19506928|P1|Overall Study|Adverse Event|6
5648413|NCT00574145|19506984|P2|Overall Study|Withdrawal by Subject|1
5648414|NCT00574145|19506985|P1|Overall Study|Withdrawal by Subject|2
5648415|NCT00574119|19506995|P1|Overall Study|Physician Decision|1
5648416|NCT00574119|19506995|P1|Overall Study|Withdrawal by Subject|1
5648417|NCT00574119|19506995|P1|Overall Study|Protocol Violation|1
5648418|NCT00574119|19506995|P1|Overall Study|Adverse Event|1
5648419|NCT00574080|19507009|P2|Overall Study|Death|10
5648420|NCT00574080|19507010|P1|Overall Study|Death|10
5648421|NCT00573937|19507079|P2|Overall Study|Study Terminated|1
5648422|NCT00573937|19507080|P1|Overall Study|Study Terminated|0
5648423|NCT00573859|19507094|P1|Smoking Versus Abstinence|Scheduling conflicts|12
5648424|NCT00573859|19507094|P1|Medication Versus Placebo|Scheduling conflicts|12
5648425|NCT00573833|19507100|P1|Overall Study|Not Treated|2
5648426|NCT00573794|19507107|P1|Overall Study|Other|46
5648427|NCT00573794|19507107|P1|Overall Study|Lack of Efficacy|94
5648428|NCT00573794|19507107|P1|Overall Study|Protocol Violation|6
5648429|NCT00573794|19507107|P1|Overall Study|Lost to Follow-up|13
5648430|NCT00573794|19507107|P1|Overall Study|Withdrew Consent|90
5648431|NCT00573794|19507107|P1|Overall Study|Adverse Event|81
5648432|NCT00573768|19507138|P3|Overall Study|Lost to Follow-up|1
5648433|NCT00573768|19507139|P2|Overall Study|Lost to Follow-up|0
5648434|NCT00573768|19507140|P1|Overall Study|Lost to Follow-up|0
5648435|NCT00573768|19507138|P3|Overall Study|Withdrawal by Subject|0
5648436|NCT00573768|19507139|P2|Overall Study|Withdrawal by Subject|1
5648437|NCT00573768|19507140|P1|Overall Study|Withdrawal by Subject|0
5648438|NCT00573768|19507138|P3|Overall Study|Protocol Violation|1
5648439|NCT00573768|19507139|P2|Overall Study|Protocol Violation|0
5648440|NCT00573768|19507140|P1|Overall Study|Protocol Violation|1
5648441|NCT00573768|19507138|P3|Overall Study|Adverse Event|2
5648442|NCT00573768|19507139|P2|Overall Study|Adverse Event|1
5648443|NCT00573768|19507140|P1|Overall Study|Adverse Event|1
5648444|NCT00573755|19507150|P2|Overall Study|Still receiving treatment|0
5648445|NCT00573755|19507151|P1|Overall Study|Still receiving treatment|1
5648446|NCT00573534|19507167|P1|Overall Study|oppositional behavior|3
5648447|NCT00573469|19507208|P3|Overall Study|Other|3
5648448|NCT00573469|19507209|P2|Overall Study|Other|1
5648449|NCT00573469|19507210|P1|Overall Study|Other|5
5648450|NCT00573469|19507208|P3|Overall Study|Withdrawal by Subject|0
5648451|NCT00573469|19507209|P2|Overall Study|Withdrawal by Subject|2
5648452|NCT00573469|19507210|P1|Overall Study|Withdrawal by Subject|0
5648453|NCT00573469|19507208|P3|Overall Study|Adverse Event|1
5648454|NCT00573469|19507209|P2|Overall Study|Adverse Event|1
5648455|NCT00573469|19507210|P1|Overall Study|Adverse Event|1
5648456|NCT00573443|19507233|P3|Open-Label Extension Phase|Other|0
5648457|NCT00573443|19507234|P2|Open-Label Extension Phase|Other|0
5648458|NCT00573443|19507235|P1|Open-Label Extension Phase|Other|2
5648459|NCT00573443|19507233|P3|Open-Label Extension Phase|Protocol Violation|0
5648460|NCT00573443|19507234|P2|Open-Label Extension Phase|Protocol Violation|0
5648461|NCT00573443|19507235|P1|Open-Label Extension Phase|Protocol Violation|2
5648462|NCT00573443|19507233|P3|Open-Label Extension Phase|Withdrawal by Subject|0
5648463|NCT00573443|19507234|P2|Open-Label Extension Phase|Withdrawal by Subject|0
5648464|NCT00573443|19507235|P1|Open-Label Extension Phase|Withdrawal by Subject|3
5648465|NCT00573443|19507233|P3|Open-Label Extension Phase|Serious Adverse Event|0
5648466|NCT00573443|19507234|P2|Open-Label Extension Phase|Serious Adverse Event|0
5648467|NCT00573443|19507235|P1|Open-Label Extension Phase|Serious Adverse Event|5
5648468|NCT00573443|19507233|P3|Open-Label Extension Phase|Adverse Event|0
5648469|NCT00573443|19507234|P2|Open-Label Extension Phase|Adverse Event|0
5648470|NCT00573443|19507235|P1|Open-Label Extension Phase|Adverse Event|3
5648471|NCT00573443|19507233|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
5648472|NCT00573443|19507234|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
5648473|NCT00573443|19507235|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
5648474|NCT00573443|19507233|P3|Open-Label Extension Phase|Lost to Follow-up|0
5648475|NCT00573443|19507234|P2|Open-Label Extension Phase|Lost to Follow-up|0
5648476|NCT00573443|19507235|P1|Open-Label Extension Phase|Lost to Follow-up|1
5648477|NCT00573443|19507233|P3|Double-Blind Phase|Other|3
5648478|NCT00573443|19507234|P2|Double-Blind Phase|Other|2
5648479|NCT00573443|19507235|P1|Double-Blind Phase|Other|0
5648480|NCT00573443|19507233|P3|Double-Blind Phase|Protocol Violation|1
5648481|NCT00573443|19507234|P2|Double-Blind Phase|Protocol Violation|2
5648482|NCT00573443|19507235|P1|Double-Blind Phase|Protocol Violation|0
5648483|NCT00573443|19507233|P3|Double-Blind Phase|Withdrawal by Subject|7
5648484|NCT00573443|19507234|P2|Double-Blind Phase|Withdrawal by Subject|2
5648485|NCT00573443|19507235|P1|Double-Blind Phase|Withdrawal by Subject|2
5648486|NCT00573443|19507233|P3|Double-Blind Phase|Medication refusal due to AE|0
5648487|NCT00573443|19507234|P2|Double-Blind Phase|Medication refusal due to AE|2
5648488|NCT00573443|19507235|P1|Double-Blind Phase|Medication refusal due to AE|2
5648489|NCT00573443|19507233|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
5648490|NCT00573443|19507234|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
5648491|NCT00573443|19507235|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
5648492|NCT00573443|19507233|P3|Double-Blind Phase|Adverse Event|0
5648493|NCT00573443|19507234|P2|Double-Blind Phase|Adverse Event|5
5648494|NCT00573443|19507235|P1|Double-Blind Phase|Adverse Event|1
5648495|NCT00573443|19507233|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
5648496|NCT00573443|19507234|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
5648497|NCT00573443|19507235|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
5648498|NCT00573443|19507233|P3|Double-Blind Phase|Lost to Follow-up|2
5648499|NCT00573443|19507234|P2|Double-Blind Phase|Lost to Follow-up|3
5648500|NCT00573443|19507235|P1|Double-Blind Phase|Lost to Follow-up|1
5648501|NCT00573430|19507265|P3|Overall Study|Eligibility criteria not fulfilled|3
5648502|NCT00573430|19507266|P2|Overall Study|Eligibility criteria not fulfilled|0
5648503|NCT00573430|19507267|P1|Overall Study|Eligibility criteria not fulfilled|0
5648504|NCT00573430|19507265|P3|Overall Study|Protocol Violation|1
5648505|NCT00573430|19507266|P2|Overall Study|Protocol Violation|1
5648506|NCT00573430|19507267|P1|Overall Study|Protocol Violation|0
5648507|NCT00573430|19507265|P3|Overall Study|Withdrawal by Subject|1
5648508|NCT00573430|19507266|P2|Overall Study|Withdrawal by Subject|0
5648509|NCT00573430|19507267|P1|Overall Study|Withdrawal by Subject|1
5648510|NCT00573430|19507265|P3|Overall Study|Adverse Event|2
5648511|NCT00573430|19507266|P2|Overall Study|Adverse Event|0
5648512|NCT00573430|19507267|P1|Overall Study|Adverse Event|0
5648513|NCT00573430|19507265|P3|Overall Study|Incorrect enrollment of randomization|3
5648514|NCT00573430|19507266|P2|Overall Study|Incorrect enrollment of randomization|4
5648515|NCT00573430|19507267|P1|Overall Study|Incorrect enrollment of randomization|0
5648516|NCT00573391|19507289|P2|Overall Study|Death|0
5648517|NCT00573391|19507290|P1|Overall Study|Death|1
5648518|NCT00573391|19507289|P2|Overall Study|study stopped|2
5648519|NCT00573391|19507290|P1|Overall Study|study stopped|2
5648520|NCT00573313|19507300|P4|Overall Study|Protocol Violation|0
5648521|NCT00573313|19507301|P3|Overall Study|Protocol Violation|6
5648522|NCT00573313|19507302|P2|Overall Study|Protocol Violation|0
5648523|NCT00573313|19507303|P1|Overall Study|Protocol Violation|5
5648524|NCT00573248|19507353|P2|Overall Study|scheduling conflicts|11
5648525|NCT00573248|19507354|P1|Overall Study|scheduling conflicts|15
5648526|NCT00573183|19507368|P2|Overall Study|Other|2
5648527|NCT00573183|19507369|P1|Overall Study|Other|5
5648528|NCT00573183|19507368|P2|Overall Study|Incarceration|8
5648529|NCT00573183|19507369|P1|Overall Study|Incarceration|5
5648530|NCT00573183|19507368|P2|Overall Study|Adverse Event|0
5648531|NCT00573183|19507369|P1|Overall Study|Adverse Event|2
5648532|NCT00573183|19507368|P2|Overall Study|Death|1
5648533|NCT00573183|19507369|P1|Overall Study|Death|0
5648534|NCT00573183|19507368|P2|Overall Study|Withdrawal by Subject|2
5648535|NCT00573183|19507369|P1|Overall Study|Withdrawal by Subject|8
5648536|NCT00573183|19507368|P2|Overall Study|Lost to Follow-up|50
5648537|NCT00573183|19507369|P1|Overall Study|Lost to Follow-up|52
5648538|NCT00573170|19507377|P6|Third Treatment Period|Lost to Follow-up|2
5648539|NCT00573170|19507378|P5|Third Treatment Period|Lost to Follow-up|0
5648540|NCT00573170|19507379|P4|Third Treatment Period|Lost to Follow-up|0
5648541|NCT00573170|19507380|P3|Third Treatment Period|Lost to Follow-up|0
5648542|NCT00573170|19507381|P2|Third Treatment Period|Lost to Follow-up|0
5648543|NCT00573170|19507382|P1|Third Treatment Period|Lost to Follow-up|0
5648544|NCT00573170|19507377|P6|Third Treatment Period|Withdrawal by Subject|0
5648545|NCT00573170|19507378|P5|Third Treatment Period|Withdrawal by Subject|0
5648546|NCT00573170|19507379|P4|Third Treatment Period|Withdrawal by Subject|0
5648547|NCT00573170|19507380|P3|Third Treatment Period|Withdrawal by Subject|0
5648548|NCT00573170|19507381|P2|Third Treatment Period|Withdrawal by Subject|0
5648549|NCT00573170|19507382|P1|Third Treatment Period|Withdrawal by Subject|1
5648550|NCT00573170|19507377|P6|Second Washout Period|Other|2
5648551|NCT00573170|19507378|P5|Second Washout Period|Other|6
5648552|NCT00573170|19507379|P4|Second Washout Period|Other|4
5648553|NCT00573170|19507380|P3|Second Washout Period|Other|1
5648554|NCT00573170|19507381|P2|Second Washout Period|Other|2
5648555|NCT00573170|19507382|P1|Second Washout Period|Other|1
5648556|NCT00573170|19507377|P6|Second Washout Period|Lost to Follow-up|0
5648557|NCT00573170|19507378|P5|Second Washout Period|Lost to Follow-up|0
5648558|NCT00573170|19507379|P4|Second Washout Period|Lost to Follow-up|1
5648559|NCT00573170|19507380|P3|Second Washout Period|Lost to Follow-up|0
5648560|NCT00573170|19507381|P2|Second Washout Period|Lost to Follow-up|0
5648561|NCT00573170|19507382|P1|Second Washout Period|Lost to Follow-up|0
5648562|NCT00573170|19507377|P6|Second Washout Period|Withdrawal by Subject|0
5648563|NCT00573170|19507378|P5|Second Washout Period|Withdrawal by Subject|1
5648564|NCT00573170|19507379|P4|Second Washout Period|Withdrawal by Subject|0
5648565|NCT00573170|19507380|P3|Second Washout Period|Withdrawal by Subject|2
5648566|NCT00573170|19507381|P2|Second Washout Period|Withdrawal by Subject|1
5648567|NCT00573170|19507382|P1|Second Washout Period|Withdrawal by Subject|1
5648568|NCT00573170|19507377|P6|Second Washout Period|Protocol Violation|0
5648569|NCT00573170|19507378|P5|Second Washout Period|Protocol Violation|0
5648570|NCT00573170|19507379|P4|Second Washout Period|Protocol Violation|0
5648571|NCT00573170|19507380|P3|Second Washout Period|Protocol Violation|1
5648572|NCT00573170|19507381|P2|Second Washout Period|Protocol Violation|1
5648573|NCT00573170|19507382|P1|Second Washout Period|Protocol Violation|2
5648574|NCT00573170|19507377|P6|Second Washout Period|Adverse Event|0
5648575|NCT00573170|19507378|P5|Second Washout Period|Adverse Event|1
5648576|NCT00573170|19507379|P4|Second Washout Period|Adverse Event|0
5648577|NCT00573170|19507380|P3|Second Washout Period|Adverse Event|0
5648578|NCT00573170|19507381|P2|Second Washout Period|Adverse Event|0
5648579|NCT00573170|19507382|P1|Second Washout Period|Adverse Event|1
5648580|NCT00573170|19507377|P6|First Washout Period|Other|0
5648581|NCT00573170|19507378|P5|First Washout Period|Other|0
5648582|NCT00573170|19507379|P4|First Washout Period|Other|1
5648583|NCT00573170|19507380|P3|First Washout Period|Other|1
5648584|NCT00573170|19507381|P2|First Washout Period|Other|0
5648585|NCT00573170|19507382|P1|First Washout Period|Other|4
5648586|NCT00573170|19507377|P6|First Washout Period|Withdrawal by Subject|3
5648587|NCT00573170|19507378|P5|First Washout Period|Withdrawal by Subject|3
5648588|NCT00573170|19507379|P4|First Washout Period|Withdrawal by Subject|2
5648589|NCT00573170|19507380|P3|First Washout Period|Withdrawal by Subject|0
5648590|NCT00573170|19507381|P2|First Washout Period|Withdrawal by Subject|0
5648591|NCT00573170|19507382|P1|First Washout Period|Withdrawal by Subject|2
5648592|NCT00573170|19507377|P6|First Washout Period|Lost to Follow-up|2
5648593|NCT00573170|19507378|P5|First Washout Period|Lost to Follow-up|0
5648594|NCT00573170|19507379|P4|First Washout Period|Lost to Follow-up|2
5648595|NCT00573170|19507380|P3|First Washout Period|Lost to Follow-up|0
5648596|NCT00573170|19507381|P2|First Washout Period|Lost to Follow-up|1
5648597|NCT00573170|19507382|P1|First Washout Period|Lost to Follow-up|1
5648598|NCT00573170|19507377|P6|First Washout Period|Lack of Efficacy|1
5648599|NCT00573170|19507378|P5|First Washout Period|Lack of Efficacy|0
5648600|NCT00573170|19507379|P4|First Washout Period|Lack of Efficacy|0
5648601|NCT00573170|19507380|P3|First Washout Period|Lack of Efficacy|0
5648602|NCT00573170|19507381|P2|First Washout Period|Lack of Efficacy|0
5648603|NCT00573170|19507382|P1|First Washout Period|Lack of Efficacy|0
5648604|NCT00573170|19507377|P6|First Washout Period|Adverse Event|1
5648605|NCT00573170|19507378|P5|First Washout Period|Adverse Event|0
5648606|NCT00573170|19507379|P4|First Washout Period|Adverse Event|0
5648607|NCT00573170|19507380|P3|First Washout Period|Adverse Event|0
5648608|NCT00573170|19507381|P2|First Washout Period|Adverse Event|1
5648609|NCT00573170|19507382|P1|First Washout Period|Adverse Event|1
5648610|NCT00573170|19507377|P6|First Treatment Period|Did Not Treat Attack 1|0
5648611|NCT00573170|19507378|P5|First Treatment Period|Did Not Treat Attack 1|1
5648612|NCT00573170|19507379|P4|First Treatment Period|Did Not Treat Attack 1|0
5648613|NCT00573170|19507380|P3|First Treatment Period|Did Not Treat Attack 1|0
5648614|NCT00573170|19507381|P2|First Treatment Period|Did Not Treat Attack 1|0
5648615|NCT00573170|19507382|P1|First Treatment Period|Did Not Treat Attack 1|0
5648616|NCT00573157|19507458|P2|Overall Study|Other|1
5648617|NCT00573157|19507459|P1|Overall Study|Other|1
5648618|NCT00573157|19507458|P2|Overall Study|Adverse Event|1
5648619|NCT00573157|19507459|P1|Overall Study|Adverse Event|3
5648620|NCT00573144|19507471|P2|Overall Study|Withdrawal by Subject|3
5648621|NCT00573144|19507472|P1|Overall Study|Withdrawal by Subject|2
5648622|NCT00573131|19507484|P2|Overall Study|Withdrawal by Subject|8
5648623|NCT00573131|19507485|P1|Overall Study|Withdrawal by Subject|10
5648624|NCT00573066|19507491|P1|Overall Study|Postoperative bleeding|1
5648625|NCT00573066|19507491|P1|Overall Study|IV malfunction|1
5648626|NCT00573066|19507491|P1|Overall Study|Exclusion criteria|18
5648627|NCT00572910|19507535|P11|Overall Study|Withdrawal by Subject|1
5648628|NCT00572910|19507536|P10|Overall Study|Withdrawal by Subject|2
5648629|NCT00572910|19507537|P9|Overall Study|Withdrawal by Subject|2
5648630|NCT00572910|19507538|P8|Overall Study|Withdrawal by Subject|2
5648631|NCT00572910|19507539|P7|Overall Study|Withdrawal by Subject|0
5648632|NCT00572910|19507540|P6|Overall Study|Withdrawal by Subject|3
5648633|NCT00572910|19507541|P5|Overall Study|Withdrawal by Subject|1
5648634|NCT00572910|19507542|P4|Overall Study|Withdrawal by Subject|0
5648635|NCT00572910|19507543|P3|Overall Study|Withdrawal by Subject|1
5648636|NCT00572910|19507544|P2|Overall Study|Withdrawal by Subject|0
5648637|NCT00572910|19507545|P1|Overall Study|Withdrawal by Subject|3
5648638|NCT00572910|19507535|P11|Overall Study|Lost to Follow-up|0
5648639|NCT00572910|19507536|P10|Overall Study|Lost to Follow-up|1
5648640|NCT00572910|19507537|P9|Overall Study|Lost to Follow-up|0
5648641|NCT00572910|19507538|P8|Overall Study|Lost to Follow-up|0
5648642|NCT00572910|19507539|P7|Overall Study|Lost to Follow-up|0
5648643|NCT00572910|19507540|P6|Overall Study|Lost to Follow-up|0
5648644|NCT00572910|19507541|P5|Overall Study|Lost to Follow-up|1
5648645|NCT00572910|19507542|P4|Overall Study|Lost to Follow-up|2
5648646|NCT00572910|19507543|P3|Overall Study|Lost to Follow-up|1
5648647|NCT00572910|19507544|P2|Overall Study|Lost to Follow-up|1
5648648|NCT00572910|19507545|P1|Overall Study|Lost to Follow-up|0
5648649|NCT00572910|19507535|P11|Overall Study|Adverse Event|2
5648650|NCT00572910|19507536|P10|Overall Study|Adverse Event|3
5648651|NCT00572910|19507537|P9|Overall Study|Adverse Event|1
5648652|NCT00572910|19507538|P8|Overall Study|Adverse Event|2
5648653|NCT00572910|19507539|P7|Overall Study|Adverse Event|4
5648654|NCT00572910|19507540|P6|Overall Study|Adverse Event|0
5648655|NCT00572910|19507541|P5|Overall Study|Adverse Event|0
5648656|NCT00572910|19507542|P4|Overall Study|Adverse Event|2
5648657|NCT00572910|19507543|P3|Overall Study|Adverse Event|0
5648658|NCT00572910|19507544|P2|Overall Study|Adverse Event|2
5648659|NCT00572910|19507545|P1|Overall Study|Adverse Event|1
5648660|NCT00572832|19507612|P2|Overall Study|Pregnancy|1
5648661|NCT00572832|19507613|P1|Overall Study|Pregnancy|0
5648662|NCT00572832|19507612|P2|Overall Study|Lost to Follow-up|11
5648663|NCT00572832|19507613|P1|Overall Study|Lost to Follow-up|0
5648664|NCT00572728|19507619|P1|Overall Study|Pathology missing|1
5648665|NCT00572728|19507619|P1|Overall Study|FLT2 after second chemotherapy initiated|7
5648666|NCT00572728|19507619|P1|Overall Study|Second chemotherapy not initiated|1
5648667|NCT00572728|19507619|P1|Overall Study|FLT2 not completed|5
5648668|NCT00572728|19507619|P1|Overall Study|First Chemotherapy not initiated|2
5648669|NCT00572728|19507619|P1|Overall Study|FLT1 not completed|4
5648670|NCT00572728|19507619|P1|Overall Study|Offstudy due to complicating disease|1
5648671|NCT00572728|19507619|P1|Overall Study|Enrolled under Amendment 4|5
5648672|NCT00572728|19507619|P1|Overall Study|Ineligible|3
5648673|NCT00572728|19507619|P1|Overall Study|Withdrawal by Subject|10
5648674|NCT00572624|19507633|P2|Overall Study|Health issues unrelated to the study|0
5648675|NCT00572624|19507634|P1|Overall Study|Health issues unrelated to the study|1
5648676|NCT00572624|19507633|P2|Overall Study|Problem with vascular access|0
5648677|NCT00572624|19507634|P1|Overall Study|Problem with vascular access|1
5648678|NCT00572624|19507633|P2|Overall Study|Refused to do the stress test|0
5648679|NCT00572624|19507634|P1|Overall Study|Refused to do the stress test|1
5648680|NCT00572624|19507633|P2|Overall Study|Admitted to being a smoker|0
5648681|NCT00572624|19507634|P1|Overall Study|Admitted to being a smoker|1
5648682|NCT00572624|19507633|P2|Overall Study|Started a new job-- no time for study|0
5648683|NCT00572624|19507634|P1|Overall Study|Started a new job-- no time for study|1
5648684|NCT00572624|19507633|P2|Overall Study|Medication change|0
5648685|NCT00572624|19507634|P1|Overall Study|Medication change|1
5648686|NCT00572624|19507633|P2|Overall Study|Wanted to do a different diet program|0
5648687|NCT00572624|19507634|P1|Overall Study|Wanted to do a different diet program|1
5648688|NCT00572624|19507633|P2|Overall Study|Lost to Follow-up|4
5648689|NCT00572624|19507634|P1|Overall Study|Lost to Follow-up|10
5648690|NCT00572572|19507662|P2|Overall Study|Withdrawal by Subject|6
5648691|NCT00572572|19507663|P1|Overall Study|Withdrawal by Subject|3
5648692|NCT00572533|19507681|P2|Overall Study|Transfer out of Facility|1
5648693|NCT00572533|19507682|P1|Overall Study|Transfer out of Facility|0
5648694|NCT00572533|19507681|P2|Overall Study|Social Issues|0
5648695|NCT00572533|19507682|P1|Overall Study|Social Issues|1
5648696|NCT00572533|19507681|P2|Overall Study|Received Kidney Transplant|1
5648697|NCT00572533|19507682|P1|Overall Study|Received Kidney Transplant|2
5648698|NCT00572533|19507681|P2|Overall Study|Death|1
5648699|NCT00572533|19507682|P1|Overall Study|Death|4
5648700|NCT00572195|19507726|P1|Overall Study|Lost to Follow-up|5
5648701|NCT00572195|19507726|P1|Overall Study|Adverse Event|4
5648702|NCT00572195|19507726|P1|Overall Study|Death|9
5648703|NCT00572195|19507726|P1|Overall Study|Withdrawal by Subject|50
5648704|NCT00572156|19507738|P4|Overall Study|Sponsor Decision|19
5648705|NCT00572156|19507739|P3|Overall Study|Sponsor Decision|17
5648706|NCT00572156|19507740|P2|Overall Study|Sponsor Decision|16
5648707|NCT00572156|19507741|P1|Overall Study|Sponsor Decision|20
5648708|NCT00572156|19507738|P4|Overall Study|Patient/Parent Decision|3
5648709|NCT00572156|19507739|P3|Overall Study|Patient/Parent Decision|4
5648710|NCT00572156|19507740|P2|Overall Study|Patient/Parent Decision|6
5648711|NCT00572156|19507741|P1|Overall Study|Patient/Parent Decision|1
5648712|NCT00572156|19507738|P4|Overall Study|Protocol Violation|2
5648713|NCT00572156|19507739|P3|Overall Study|Protocol Violation|0
5648714|NCT00572156|19507740|P2|Overall Study|Protocol Violation|2
5648715|NCT00572156|19507741|P1|Overall Study|Protocol Violation|1
5648716|NCT00572156|19507738|P4|Overall Study|Lost to Follow-up|0
5648717|NCT00572156|19507739|P3|Overall Study|Lost to Follow-up|1
5648718|NCT00572156|19507740|P2|Overall Study|Lost to Follow-up|1
5648719|NCT00572156|19507741|P1|Overall Study|Lost to Follow-up|1
5648720|NCT00572156|19507738|P4|Overall Study|Adverse Event|1
5648721|NCT00572156|19507739|P3|Overall Study|Adverse Event|5
5648722|NCT00572156|19507740|P2|Overall Study|Adverse Event|1
5648723|NCT00572156|19507741|P1|Overall Study|Adverse Event|3
5648724|NCT00572039|19507812|P2|Overall Study|Ill|1
5648725|NCT00572039|19507813|P1|Overall Study|Ill|5
5648726|NCT00572039|19507812|P2|Overall Study|Death|3
5648727|NCT00572039|19507813|P1|Overall Study|Death|2
5648728|NCT00572039|19507812|P2|Overall Study|Withdrawal by Subject|6
5648729|NCT00572039|19507813|P1|Overall Study|Withdrawal by Subject|9
5648730|NCT00571948|19507845|P2|Overall Study|Parent were afraid of blood colection|5
5648731|NCT00571948|19507846|P1|Overall Study|Parent were afraid of blood colection|2
5648732|NCT00571948|19507845|P2|Overall Study|infant refused study meal|4
5648733|NCT00571948|19507846|P1|Overall Study|infant refused study meal|3
5648734|NCT00571948|19507845|P2|Overall Study|Protocol Violation|3
5648735|NCT00571948|19507846|P1|Overall Study|Protocol Violation|3
5648736|NCT00571948|19507845|P2|Overall Study|Withdrawal by Subject|2
5648737|NCT00571948|19507846|P1|Overall Study|Withdrawal by Subject|1
5648738|NCT00571948|19507845|P2|Overall Study|Lost to Follow-up|0
5648739|NCT00571948|19507846|P1|Overall Study|Lost to Follow-up|2
5648740|NCT00571922|19507854|P2|Overall Study|Completion unknown|36
5648741|NCT00571922|19507855|P1|Overall Study|Completion unknown|36
5648742|NCT00571701|19507865|P2|Second Intervention 12 Months|Withdrawal by Subject|0
5648743|NCT00571701|19507866|P1|Second Intervention 12 Months|Withdrawal by Subject|3
5648744|NCT00571701|19507865|P2|Second Intervention 12 Months|Adverse Event|1
5648745|NCT00571701|19507866|P1|Second Intervention 12 Months|Adverse Event|0
5648746|NCT00571701|19507865|P2|First Intervention 12 Months|Death|0
5648747|NCT00571701|19507866|P1|First Intervention 12 Months|Death|1
5648748|NCT00571701|19507865|P2|First Intervention 12 Months|Withdrawal by Subject|1
5648749|NCT00571701|19507866|P1|First Intervention 12 Months|Withdrawal by Subject|2
5648750|NCT00571688|19507892|P2|Overall Study|subject moved out of the area|0
5648751|NCT00571688|19507893|P1|Overall Study|subject moved out of the area|1
5648752|NCT00571688|19507892|P2|Overall Study|subject did not tolerate Consta|0
5648753|NCT00571688|19507893|P1|Overall Study|subject did not tolerate Consta|1
5648754|NCT00571688|19507892|P2|Overall Study|Lost to Follow-up|6
5648755|NCT00571688|19507893|P1|Overall Study|Lost to Follow-up|3
5648756|NCT00571662|19507899|P1|Overall Study|Adverse Event|5
5648757|NCT00571662|19507899|P1|Overall Study|psychiatric instability|1
5648758|NCT00571662|19507899|P1|Overall Study|Withdrawal by Subject|2
5648759|NCT00571649|19507910|P2|Follow-up Period|Protocol Violation|12
5648760|NCT00571649|19507911|P1|Follow-up Period|Protocol Violation|5
5648761|NCT00571649|19507910|P2|Follow-up Period|Patient convenience|121
5648762|NCT00571649|19507911|P1|Follow-up Period|Patient convenience|136
5648763|NCT00571649|19507910|P2|Follow-up Period|Lost to Follow-up|92
5648764|NCT00571649|19507911|P1|Follow-up Period|Lost to Follow-up|95
5648765|NCT00571649|19507910|P2|Follow-up Period|Physician Decision|13
5648766|NCT00571649|19507911|P1|Follow-up Period|Physician Decision|7
5648767|NCT00571649|19507910|P2|Follow-up Period|Death|133
5648768|NCT00571649|19507911|P1|Follow-up Period|Death|132
5648769|NCT00571649|19507910|P2|Follow-up Period|Withdrawal by Subject|115
5648770|NCT00571649|19507911|P1|Follow-up Period|Withdrawal by Subject|119
5648771|NCT00571649|19507910|P2|Follow-up Period|Clinical endpoint reached|2
5648772|NCT00571649|19507911|P1|Follow-up Period|Clinical endpoint reached|5
5648773|NCT00571649|19507910|P2|Follow-up Period|Adverse Event|40
5648774|NCT00571649|19507911|P1|Follow-up Period|Adverse Event|46
5648775|NCT00571649|19507910|P2|Treatment Period|Technical problems|5
5648776|NCT00571649|19507911|P1|Treatment Period|Technical problems|3
5648777|NCT00571649|19507910|P2|Treatment Period|Protocol Violation|92
5648778|NCT00571649|19507911|P1|Treatment Period|Protocol Violation|90
5648779|NCT00571649|19507910|P2|Treatment Period|Patient convenience|13
5648780|NCT00571649|19507911|P1|Treatment Period|Patient convenience|11
5648781|NCT00571649|19507910|P2|Treatment Period|Non-compliant with study medication|89
5648782|NCT00571649|19507911|P1|Treatment Period|Non-compliant with study medication|88
5648783|NCT00571649|19507910|P2|Treatment Period|Lost to Follow-up|41
5648784|NCT00571649|19507911|P1|Treatment Period|Lost to Follow-up|43
5648785|NCT00571649|19507910|P2|Treatment Period|Physician Decision|9
5648786|NCT00571649|19507911|P1|Treatment Period|Physician Decision|8
5648787|NCT00571649|19507910|P2|Treatment Period|Death|59
5648788|NCT00571649|19507911|P1|Treatment Period|Death|76
5648789|NCT00571649|19507910|P2|Treatment Period|Withdrawal by Subject|255
5648790|NCT00571649|19507911|P1|Treatment Period|Withdrawal by Subject|285
5648791|NCT00571649|19507910|P2|Treatment Period|Clinical endpoint reached|56
5648792|NCT00571649|19507911|P1|Treatment Period|Clinical endpoint reached|50
5648793|NCT00571649|19507910|P2|Treatment Period|Adverse Event|385
5648794|NCT00571649|19507911|P1|Treatment Period|Adverse Event|438
5648795|NCT00571103|19508009|P1|Overall Study|Lost to Follow-up|1
5648796|NCT00571103|19508009|P1|Overall Study|Withdrawal by Subject|1
5648797|NCT00571064|19508014|P1|Overall Study|Other|2
5648798|NCT00571064|19508014|P1|Overall Study|Withdrawal by Subject|2
5648799|NCT00571064|19508014|P1|Overall Study|Protocol Violation|4
5648800|NCT00571064|19508014|P1|Overall Study|Adverse Event|13
5648801|NCT00571038|19508029|P2|Overall Study|Moved out of state|2
5648802|NCT00571038|19508030|P1|Overall Study|Moved out of state|2
5648803|NCT00571038|19508029|P2|Overall Study|Withdrawal by Subject|3
5648804|NCT00571038|19508030|P1|Overall Study|Withdrawal by Subject|1
5648805|NCT00571038|19508029|P2|Overall Study|Death|5
5648806|NCT00571038|19508030|P1|Overall Study|Death|7
5648807|NCT00571038|19508029|P2|Overall Study|Lost to Follow-up|4
5648808|NCT00571038|19508030|P1|Overall Study|Lost to Follow-up|1
5648809|NCT00570921|19508085|P1|Overall Study|Physician Decision|1
5648810|NCT00570921|19508085|P1|Overall Study|Protocol Violation|1
5648811|NCT00570908|19508091|P1|Overall Study|Withdrawal by Subject|2
5648812|NCT00570908|19508091|P1|Overall Study|Adverse Event|5
5648813|NCT00570778|19508095|P4|Overall Study|Subject no longer requires study drug|0
5648814|NCT00570778|19508096|P3|Overall Study|Subject no longer requires study drug|0
5648815|NCT00570778|19508097|P2|Overall Study|Subject no longer requires study drug|1
5648816|NCT00570778|19508098|P1|Overall Study|Subject no longer requires study drug|0
5648817|NCT00570778|19508095|P4|Overall Study|Lost to Follow-up|0
5648818|NCT00570778|19508096|P3|Overall Study|Lost to Follow-up|1
5648819|NCT00570778|19508097|P2|Overall Study|Lost to Follow-up|0
5648820|NCT00570778|19508098|P1|Overall Study|Lost to Follow-up|0
5648821|NCT00570778|19508095|P4|Overall Study|Unsatisfactory therapeutic effect|0
5648822|NCT00570778|19508096|P3|Overall Study|Unsatisfactory therapeutic effect|0
5648823|NCT00570778|19508097|P2|Overall Study|Unsatisfactory therapeutic effect|0
5648824|NCT00570778|19508098|P1|Overall Study|Unsatisfactory therapeutic effect|1
5648825|NCT00570778|19508095|P4|Overall Study|Abnormal test procedure|0
5648826|NCT00570778|19508096|P3|Overall Study|Abnormal test procedure|0
5648827|NCT00570778|19508097|P2|Overall Study|Abnormal test procedure|0
5648828|NCT00570778|19508098|P1|Overall Study|Abnormal test procedure|1
5648829|NCT00570778|19508095|P4|Overall Study|Subject withdrew consent|1
5648830|NCT00570778|19508096|P3|Overall Study|Subject withdrew consent|0
5648831|NCT00570778|19508097|P2|Overall Study|Subject withdrew consent|1
5648832|NCT00570778|19508098|P1|Overall Study|Subject withdrew consent|0
5648833|NCT00570778|19508095|P4|Overall Study|Adverse Event|1
5648834|NCT00570778|19508096|P3|Overall Study|Adverse Event|4
5648835|NCT00570778|19508097|P2|Overall Study|Adverse Event|1
5648836|NCT00570778|19508098|P1|Overall Study|Adverse Event|0
5648837|NCT00570778|19508095|P4|Overall Study|Protocol deviation|2
5648838|NCT00570778|19508096|P3|Overall Study|Protocol deviation|2
5648839|NCT00570778|19508097|P2|Overall Study|Protocol deviation|1
5648840|NCT00570778|19508098|P1|Overall Study|Protocol deviation|2
5648841|NCT00570739|19508139|P4|Overall Study|Other|3
5648842|NCT00570739|19508140|P3|Overall Study|Other|5
5648843|NCT00570739|19508141|P2|Overall Study|Other|2
5648844|NCT00570739|19508142|P1|Overall Study|Other|0
5648845|NCT00570739|19508139|P4|Overall Study|Met discontinuation criteria|1
5648846|NCT00570739|19508140|P3|Overall Study|Met discontinuation criteria|1
5648847|NCT00570739|19508141|P2|Overall Study|Met discontinuation criteria|0
5648848|NCT00570739|19508142|P1|Overall Study|Met discontinuation criteria|1
5648849|NCT00570739|19508139|P4|Overall Study|Required restricted medication|0
5648850|NCT00570739|19508140|P3|Overall Study|Required restricted medication|1
5648851|NCT00570739|19508141|P2|Overall Study|Required restricted medication|0
5648852|NCT00570739|19508142|P1|Overall Study|Required restricted medication|0
5648853|NCT00570739|19508139|P4|Overall Study|Withdrawal by Subject|5
5648854|NCT00570739|19508140|P3|Overall Study|Withdrawal by Subject|3
5648855|NCT00570739|19508141|P2|Overall Study|Withdrawal by Subject|7
5648856|NCT00570739|19508142|P1|Overall Study|Withdrawal by Subject|7
5648857|NCT00570739|19508139|P4|Overall Study|Physician Decision|0
5648858|NCT00570739|19508140|P3|Overall Study|Physician Decision|0
5648859|NCT00570739|19508141|P2|Overall Study|Physician Decision|1
5648860|NCT00570739|19508142|P1|Overall Study|Physician Decision|1
5648861|NCT00570739|19508139|P4|Overall Study|Lost to Follow-up|1
5648862|NCT00570739|19508140|P3|Overall Study|Lost to Follow-up|4
5648863|NCT00570739|19508141|P2|Overall Study|Lost to Follow-up|5
5648864|NCT00570739|19508142|P1|Overall Study|Lost to Follow-up|4
5648865|NCT00570739|19508139|P4|Overall Study|Adverse Event|2
5648866|NCT00570739|19508140|P3|Overall Study|Adverse Event|2
5648867|NCT00570739|19508141|P2|Overall Study|Adverse Event|6
5648868|NCT00570739|19508142|P1|Overall Study|Adverse Event|8
5648869|NCT00570713|19508294|P2|Overall Study|Discontinuation of Study by the Sponsor|7
5648870|NCT00570713|19508295|P1|Overall Study|Discontinuation of Study by the Sponsor|10
5648871|NCT00570713|19508294|P2|Overall Study|Withdrawal by Subject|3
5648872|NCT00570713|19508295|P1|Overall Study|Withdrawal by Subject|3
5648873|NCT00570713|19508294|P2|Overall Study|Physician Decision|2
5648874|NCT00570713|19508295|P1|Overall Study|Physician Decision|2
5648875|NCT00570713|19508294|P2|Overall Study|Lack of Efficacy|49
5648876|NCT00570713|19508295|P1|Overall Study|Lack of Efficacy|40
5648877|NCT00570713|19508294|P2|Overall Study|Death|7
5648878|NCT00570713|19508295|P1|Overall Study|Death|7
5648879|NCT00570713|19508294|P2|Overall Study|Adverse Event|9
5648880|NCT00570713|19508295|P1|Overall Study|Adverse Event|16
5648881|NCT00570687|19508313|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648882|NCT00570687|19508314|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648883|NCT00570687|19508315|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648884|NCT00570687|19508316|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
5648885|NCT00570687|19508317|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648886|NCT00570687|19508318|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648887|NCT00570687|19508319|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648888|NCT00570687|19508320|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648889|NCT00570687|19508321|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648890|NCT00570687|19508322|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648891|NCT00570687|19508313|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648892|NCT00570687|19508314|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
5648893|NCT00570687|19508315|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648894|NCT00570687|19508316|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648895|NCT00570687|19508317|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648896|NCT00570687|19508318|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648897|NCT00570687|19508319|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648898|NCT00570687|19508320|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648899|NCT00570687|19508321|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648900|NCT00570687|19508322|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648901|NCT00570687|19508313|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
5648902|NCT00570687|19508314|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
5648903|NCT00570687|19508315|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
5648904|NCT00570687|19508316|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
5648905|NCT00570687|19508317|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
5648906|NCT00570687|19508318|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
5648907|NCT00570687|19508319|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648908|NCT00570687|19508320|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648909|NCT00570687|19508321|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648910|NCT00570687|19508322|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
5648911|NCT00570674|19508348|P7|Overall Study|Withdrawal by Subject|0
5648912|NCT00570674|19508349|P6|Overall Study|Withdrawal by Subject|0
5648913|NCT00570674|19508350|P5|Overall Study|Withdrawal by Subject|0
5648914|NCT00570674|19508351|P4|Overall Study|Withdrawal by Subject|0
5648915|NCT00570674|19508352|P3|Overall Study|Withdrawal by Subject|1
5648916|NCT00570674|19508353|P2|Overall Study|Withdrawal by Subject|0
5648917|NCT00570674|19508354|P1|Overall Study|Withdrawal by Subject|0
5648918|NCT00570505|19508377|P1|Overall Study|Other loss to follow-up|4
5648919|NCT00570505|19508377|P1|Overall Study|Lost to Follow-up|23
5648920|NCT00570505|19508377|P1|Overall Study|Withdrawal by Subject|7
5648921|NCT00570505|19508377|P1|Overall Study|Adverse Event|7
5648922|NCT00570492|19508390|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
5648923|NCT00570492|19508391|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
5648924|NCT00570492|19508392|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
5648925|NCT00570492|19508390|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
5648926|NCT00570492|19508391|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
5648927|NCT00570492|19508392|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
5648928|NCT00570492|19508390|P3|52-week Double-blind Treatment Period|Physician Decision|4
5648929|NCT00570492|19508391|P2|52-week Double-blind Treatment Period|Physician Decision|2
5648930|NCT00570492|19508392|P1|52-week Double-blind Treatment Period|Physician Decision|0
5648931|NCT00570492|19508390|P3|52-week Double-blind Treatment Period|Adverse Event|5
5648932|NCT00570492|19508391|P2|52-week Double-blind Treatment Period|Adverse Event|5
5648933|NCT00570492|19508392|P1|52-week Double-blind Treatment Period|Adverse Event|0
5648934|NCT00570492|19508390|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
5648935|NCT00570492|19508391|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
5648936|NCT00570492|19508392|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
5648937|NCT00570492|19508390|P3|52-week Double-blind Treatment Period|Protocol Violation|15
5648938|NCT00570492|19508391|P2|52-week Double-blind Treatment Period|Protocol Violation|12
5648939|NCT00570492|19508392|P1|52-week Double-blind Treatment Period|Protocol Violation|0
5648940|NCT00570492|19508390|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
5648941|NCT00570492|19508391|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
5648942|NCT00570492|19508392|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
5648943|NCT00570492|19508390|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
5648944|NCT00570492|19508391|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
5648945|NCT00570492|19508392|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
5648946|NCT00570492|19508390|P3|16-week Single-blind Baseline Period|Adverse Event|0
5648947|NCT00570492|19508391|P2|16-week Single-blind Baseline Period|Adverse Event|0
5648948|NCT00570492|19508392|P1|16-week Single-blind Baseline Period|Adverse Event|1
5648949|NCT00570492|19508390|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
5648950|NCT00570492|19508391|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
5648951|NCT00570492|19508392|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
5648952|NCT00570492|19508390|P3|16-week Single-blind Baseline Period|Protocol Violation|0
5648953|NCT00570492|19508391|P2|16-week Single-blind Baseline Period|Protocol Violation|0
5648954|NCT00570492|19508392|P1|16-week Single-blind Baseline Period|Protocol Violation|15
5648955|NCT00570492|19508390|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
5648956|NCT00570492|19508391|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
5648957|NCT00570492|19508392|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
5648958|NCT00570492|19508390|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
5648959|NCT00570492|19508391|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
5648960|NCT00570492|19508392|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
5648961|NCT00570492|19508390|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
5648962|NCT00570492|19508391|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
5648963|NCT00570492|19508392|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
5648964|NCT00570401|19508430|P1|Overall Study|Adverse Event|2
5648965|NCT00570323|19508464|P2|Complete Study After Start|Physician Decision|0
5648966|NCT00570323|19508465|P1|Complete Study After Start|Physician Decision|1
5648967|NCT00570323|19508464|P2|Complete Study After Start|Withdrawal by Subject|0
5648968|NCT00570323|19508465|P1|Complete Study After Start|Withdrawal by Subject|2
5648969|NCT00570323|19508464|P2|Complete Study After Start|Lost to Follow-up|1
5648970|NCT00570323|19508465|P1|Complete Study After Start|Lost to Follow-up|0
5648971|NCT00570323|19508464|P2|Started Treatment After Randomization|Physician Decision|0
5648972|NCT00570323|19508465|P1|Started Treatment After Randomization|Physician Decision|1
5648973|NCT00570323|19508464|P2|Started Treatment After Randomization|Protocol Violation|0
5648974|NCT00570323|19508465|P1|Started Treatment After Randomization|Protocol Violation|1
5648975|NCT00570323|19508464|P2|Started Treatment After Randomization|Withdrawal by Subject|1
5648976|NCT00570323|19508465|P1|Started Treatment After Randomization|Withdrawal by Subject|0
5648977|NCT00570310|19508477|P2|Overall Study|Lack of Efficacy|4
5648978|NCT00570310|19508478|P1|Overall Study|Lack of Efficacy|1
5648979|NCT00570310|19508477|P2|Overall Study|Adverse Event|2
5648980|NCT00570310|19508478|P1|Overall Study|Adverse Event|1
5648981|NCT00570232|19508497|P1|Overall Study|discontinued due to noncompliance|2
5648982|NCT00570232|19508497|P1|Overall Study|discontinued due to recurrence|8
5648983|NCT00570232|19508497|P1|Overall Study|discontinued due to medical condition|3
5648984|NCT00570232|19508497|P1|Overall Study|Adverse Event|10
5648985|NCT00570141|19508503|P1|Overall Study|Lost to Follow-up|1
5648986|NCT00570141|19508503|P1|Overall Study|Missed visits|1
5648987|NCT00570141|19508503|P1|Overall Study|Adverse Event|1
5648988|NCT00570063|19508519|P2|Overall Study|Sponsor's Decision|3
5648989|NCT00570063|19508520|P1|Overall Study|Sponsor's Decision|7
5648990|NCT00570063|19508519|P2|Overall Study|Withdrawal by Subject|3
5648991|NCT00570063|19508520|P1|Overall Study|Withdrawal by Subject|4
5648992|NCT00570063|19508519|P2|Overall Study|Lack of Efficacy|1
5648993|NCT00570063|19508520|P1|Overall Study|Lack of Efficacy|0
5648994|NCT00570063|19508519|P2|Overall Study|Adverse Event|1
5648995|NCT00570063|19508520|P1|Overall Study|Adverse Event|4
5648996|NCT00570037|19508586|P2|Overall Study|Could not reach for 6-8 week contact|69
5648997|NCT00570037|19508587|P1|Overall Study|Could not reach for 6-8 week contact|44
5648998|NCT00569946|19508597|P1|Overall Study|Global Deterioration of Health Status|1
5648999|NCT00569946|19508597|P1|Overall Study|Objective Progression or Relapse|42
5649000|NCT00569946|19508597|P1|Overall Study|Adverse Event|16
5649001|NCT00569803|19508629|P8|Overall Study|Withdrawal by Subject|1
5649002|NCT00569803|19508630|P7|Overall Study|Withdrawal by Subject|0
5649003|NCT00569803|19508631|P6|Overall Study|Withdrawal by Subject|0
5649004|NCT00569803|19508632|P5|Overall Study|Withdrawal by Subject|0
5649005|NCT00569803|19508633|P4|Overall Study|Withdrawal by Subject|0
5649006|NCT00569803|19508634|P3|Overall Study|Withdrawal by Subject|0
5649007|NCT00569803|19508635|P2|Overall Study|Withdrawal by Subject|0
5649008|NCT00569803|19508636|P1|Overall Study|Withdrawal by Subject|0
5649009|NCT00569803|19508629|P8|Overall Study|injection syringe leaked during dosing|0
5649010|NCT00569803|19508630|P7|Overall Study|injection syringe leaked during dosing|0
5649011|NCT00569803|19508631|P6|Overall Study|injection syringe leaked during dosing|0
5649012|NCT00569803|19508632|P5|Overall Study|injection syringe leaked during dosing|0
5649013|NCT00569803|19508633|P4|Overall Study|injection syringe leaked during dosing|1
5649014|NCT00569803|19508634|P3|Overall Study|injection syringe leaked during dosing|0
5649015|NCT00569803|19508635|P2|Overall Study|injection syringe leaked during dosing|0
5649016|NCT00569803|19508636|P1|Overall Study|injection syringe leaked during dosing|0
5649017|NCT00569803|19508629|P8|Overall Study|Lost to Follow-up|0
5649018|NCT00569803|19508630|P7|Overall Study|Lost to Follow-up|0
5649019|NCT00569803|19508631|P6|Overall Study|Lost to Follow-up|0
5649020|NCT00569803|19508632|P5|Overall Study|Lost to Follow-up|0
5649021|NCT00569803|19508633|P4|Overall Study|Lost to Follow-up|0
5649022|NCT00569803|19508634|P3|Overall Study|Lost to Follow-up|0
5649023|NCT00569803|19508635|P2|Overall Study|Lost to Follow-up|0
5649024|NCT00569803|19508636|P1|Overall Study|Lost to Follow-up|1
5649025|NCT00569777|19508763|P2|Overall Study|pregnant|0
5649026|NCT00569777|19508764|P1|Overall Study|pregnant|1
5649027|NCT00569777|19508763|P2|Overall Study|did not meet exclusion criteria|2
5649028|NCT00569777|19508764|P1|Overall Study|did not meet exclusion criteria|1
5649029|NCT00569777|19508763|P2|Overall Study|scheduled eye surgery|1
5649030|NCT00569777|19508764|P1|Overall Study|scheduled eye surgery|0
5649031|NCT00569777|19508763|P2|Overall Study|Lost to Follow-up|0
5649032|NCT00569777|19508764|P1|Overall Study|Lost to Follow-up|1
5649033|NCT00569777|19508763|P2|Overall Study|Adverse Event|0
5649034|NCT00569777|19508764|P1|Overall Study|Adverse Event|3
5649035|NCT00569777|19508763|P2|Overall Study|Withdrawal by Subject|0
5649036|NCT00569777|19508764|P1|Overall Study|Withdrawal by Subject|4
5649037|NCT00569582|19508815|P1|Overall Study|Subject was non-compliant.|1
5649038|NCT00569582|19508815|P1|Overall Study|Subject was too ill to travel.|1
5649039|NCT00569582|19508815|P1|Overall Study|Adverse Event|7
5649040|NCT00569582|19508815|P1|Overall Study|Death|2
5649041|NCT00569582|19508815|P1|Overall Study|Withdrawal by Subject|5
5649042|NCT00569374|19508831|P1|Overall Study|Withdrawal by Subject|4
5649043|NCT00569270|19508850|P2|Period: First Intervention|Protocol Violation|1
5649044|NCT00569270|19508851|P1|Period: First Intervention|Protocol Violation|0
5649045|NCT00569231|19508886|P1|Overall Study|Non-compliance|2
5649046|NCT00569231|19508886|P1|Overall Study|Car accident injury|1
5649047|NCT00569231|19508886|P1|Overall Study|Withdrawal by Subject|1
5649048|NCT00569231|19508886|P1|Overall Study|Airfare expense|2
5649049|NCT00569231|19508886|P1|Overall Study|Study unrelated surgery|1
5649050|NCT00569166|19508924|P3|Overall Study|Lost to Follow-up|1
5649051|NCT00569166|19508925|P2|Overall Study|Lost to Follow-up|1
5649052|NCT00569166|19508926|P1|Overall Study|Lost to Follow-up|2
5649053|NCT00569166|19508924|P3|Overall Study|Withdrawal by Subject|3
5649054|NCT00569166|19508925|P2|Overall Study|Withdrawal by Subject|5
5649055|NCT00569166|19508926|P1|Overall Study|Withdrawal by Subject|7
5649056|NCT00569127|19508960|P2|Overall Study|Still on Treatment|3
5649057|NCT00569127|19508961|P1|Overall Study|Still on Treatment|7
5649058|NCT00569127|19508960|P2|Overall Study|Not Eligible|11
5649059|NCT00569127|19508961|P1|Overall Study|Not Eligible|14
5649060|NCT00569127|19508960|P2|Overall Study|Lost to Follow-up|3
5649061|NCT00569127|19508961|P1|Overall Study|Lost to Follow-up|0
5649062|NCT00569127|19508960|P2|Overall Study|Other|19
5649063|NCT00569127|19508961|P1|Overall Study|Other|20
5649064|NCT00569127|19508960|P2|Overall Study|Death|3
5649065|NCT00569127|19508961|P1|Overall Study|Death|4
5649066|NCT00569127|19508960|P2|Overall Study|Progression|100
5649067|NCT00569127|19508961|P1|Overall Study|Progression|99
5649068|NCT00569127|19508960|P2|Overall Study|Withdrawal by Subject|27
5649069|NCT00569127|19508961|P1|Overall Study|Withdrawal by Subject|13
5649070|NCT00569127|19508960|P2|Overall Study|Adverse Event|47
5649071|NCT00569127|19508961|P1|Overall Study|Adverse Event|57
5649072|NCT00568958|19508996|P2|Follow-Up|Adverse Event|0
5649073|NCT00568958|19508997|P1|Follow-Up|Adverse Event|1
5649074|NCT00568958|19508996|P2|Follow-Up|Family Emergency|0
5649075|NCT00568958|19508997|P1|Follow-Up|Family Emergency|1
5649076|NCT00568958|19508996|P2|Follow-Up|Physician Decision|1
5649077|NCT00568958|19508997|P1|Follow-Up|Physician Decision|1
5649078|NCT00568958|19508996|P2|Follow-Up|Withdrawal by Subject|6
5649079|NCT00568958|19508997|P1|Follow-Up|Withdrawal by Subject|6
5649080|NCT00568958|19508996|P2|Allocation|Physician Decision|0
5649081|NCT00568958|19508997|P1|Allocation|Physician Decision|2
5649082|NCT00568958|19508996|P2|Allocation|Withdrawal by Subject|3
5649083|NCT00568958|19508997|P1|Allocation|Withdrawal by Subject|7
5649084|NCT00568776|19509044|P4|Overall Study|Miscellaeneous|4
5649085|NCT00568776|19509045|P3|Overall Study|Miscellaeneous|1
5649086|NCT00568776|19509046|P2|Overall Study|Miscellaeneous|3
5649087|NCT00568776|19509047|P1|Overall Study|Miscellaeneous|3
5649088|NCT00568776|19509044|P4|Overall Study|Sponsor Decision|42
5649089|NCT00568776|19509045|P3|Overall Study|Sponsor Decision|41
5649090|NCT00568776|19509046|P2|Overall Study|Sponsor Decision|2
5649091|NCT00568776|19509047|P1|Overall Study|Sponsor Decision|2
5649092|NCT00568776|19509044|P4|Overall Study|Loss of Caregiver|2
5649093|NCT00568776|19509045|P3|Overall Study|Loss of Caregiver|1
5649094|NCT00568776|19509046|P2|Overall Study|Loss of Caregiver|2
5649095|NCT00568776|19509047|P1|Overall Study|Loss of Caregiver|0
5649096|NCT00568776|19509044|P4|Overall Study|Withdrawal by Subject|7
5649097|NCT00568776|19509045|P3|Overall Study|Withdrawal by Subject|13
5649098|NCT00568776|19509046|P2|Overall Study|Withdrawal by Subject|15
5649099|NCT00568776|19509047|P1|Overall Study|Withdrawal by Subject|13
5649100|NCT00568776|19509044|P4|Overall Study|Protocol Violation|1
5649101|NCT00568776|19509045|P3|Overall Study|Protocol Violation|1
5649102|NCT00568776|19509046|P2|Overall Study|Protocol Violation|0
5649103|NCT00568776|19509047|P1|Overall Study|Protocol Violation|1
5649104|NCT00568776|19509044|P4|Overall Study|Lost to Follow-up|1
5649105|NCT00568776|19509045|P3|Overall Study|Lost to Follow-up|1
5649106|NCT00568776|19509046|P2|Overall Study|Lost to Follow-up|1
5649107|NCT00568776|19509047|P1|Overall Study|Lost to Follow-up|1
5649108|NCT00568776|19509044|P4|Overall Study|Lack of Efficacy|4
5649109|NCT00568776|19509045|P3|Overall Study|Lack of Efficacy|2
5649110|NCT00568776|19509046|P2|Overall Study|Lack of Efficacy|2
5649111|NCT00568776|19509047|P1|Overall Study|Lack of Efficacy|2
5649112|NCT00568776|19509044|P4|Overall Study|Physician Decision|0
5649113|NCT00568776|19509045|P3|Overall Study|Physician Decision|0
5649114|NCT00568776|19509046|P2|Overall Study|Physician Decision|2
5649115|NCT00568776|19509047|P1|Overall Study|Physician Decision|0
5649116|NCT00568776|19509044|P4|Overall Study|Death|3
5649117|NCT00568776|19509045|P3|Overall Study|Death|4
5649118|NCT00568776|19509046|P2|Overall Study|Death|1
5649119|NCT00568776|19509047|P1|Overall Study|Death|0
5649120|NCT00568776|19509044|P4|Overall Study|Adverse Event|8
5649121|NCT00568776|19509045|P3|Overall Study|Adverse Event|10
5649122|NCT00568776|19509046|P2|Overall Study|Adverse Event|8
5649123|NCT00568776|19509047|P1|Overall Study|Adverse Event|8
5649124|NCT00568685|19509096|P3|Overall Study|Protocol Violation|0
5649125|NCT00568685|19509097|P2|Overall Study|Protocol Violation|0
5649126|NCT00568685|19509098|P1|Overall Study|Protocol Violation|1
5649127|NCT00568685|19509096|P3|Overall Study|Withdrawal by Subject|2
5649128|NCT00568685|19509097|P2|Overall Study|Withdrawal by Subject|2
5649129|NCT00568685|19509098|P1|Overall Study|Withdrawal by Subject|7
5649130|NCT00568685|19509096|P3|Overall Study|Adverse Event|3
5649131|NCT00568685|19509097|P2|Overall Study|Adverse Event|3
5649132|NCT00568685|19509098|P1|Overall Study|Adverse Event|2
5649133|NCT00568555|19509155|P2|Overall Study|Withdrawal by Subject|1
5649134|NCT00568555|19509156|P1|Overall Study|Withdrawal by Subject|1
5649135|NCT00568451|19509174|P4|Overall Study|Disease Progression|7
5649136|NCT00568451|19509175|P3|Overall Study|Disease Progression|2
5649137|NCT00568451|19509176|P2|Overall Study|Disease Progression|0
5649138|NCT00568451|19509177|P1|Overall Study|Disease Progression|0
5649139|NCT00568399|19509193|P1|Overall Study|Withdrawal by Subject|8
5649140|NCT00568399|19509193|P1|Overall Study|Adverse Event|5
5649141|NCT00568399|19509193|P1|Overall Study|Death|2
5649142|NCT00568334|19509208|P2|Overall Study|Lost to Follow-up|0
5649143|NCT00568334|19509209|P1|Overall Study|Lost to Follow-up|1
5649144|NCT00568334|19509208|P2|Overall Study|Withdrawal by Subject|1
5649145|NCT00568334|19509209|P1|Overall Study|Withdrawal by Subject|0
5649146|NCT00568178|19509235|P6|Open Label Extension|Withdrawal by Subject|4
5649147|NCT00568178|19509236|P5|Open Label Extension|Withdrawal by Subject|4
5649148|NCT00568178|19509237|P4|Open Label Extension|Withdrawal by Subject|0
5649149|NCT00568178|19509238|P3|Open Label Extension|Withdrawal by Subject|0
5649150|NCT00568178|19509239|P2|Open Label Extension|Withdrawal by Subject|0
5649151|NCT00568178|19509240|P1|Open Label Extension|Withdrawal by Subject|0
5649152|NCT00568178|19509235|P6|Open Label Extension|Termination of Trial|47
5649153|NCT00568178|19509236|P5|Open Label Extension|Termination of Trial|45
5649154|NCT00568178|19509237|P4|Open Label Extension|Termination of Trial|0
5649155|NCT00568178|19509238|P3|Open Label Extension|Termination of Trial|0
5649156|NCT00568178|19509239|P2|Open Label Extension|Termination of Trial|0
5649157|NCT00568178|19509240|P1|Open Label Extension|Termination of Trial|0
5649158|NCT00568178|19509235|P6|Open Label Extension|Progressive Disease|1
5649159|NCT00568178|19509236|P5|Open Label Extension|Progressive Disease|3
5649160|NCT00568178|19509237|P4|Open Label Extension|Progressive Disease|0
5649161|NCT00568178|19509238|P3|Open Label Extension|Progressive Disease|0
5649162|NCT00568178|19509239|P2|Open Label Extension|Progressive Disease|0
5649163|NCT00568178|19509240|P1|Open Label Extension|Progressive Disease|0
5649164|NCT00568178|19509235|P6|Open Label Extension|Pregnancy|1
5649165|NCT00568178|19509236|P5|Open Label Extension|Pregnancy|0
5649166|NCT00568178|19509237|P4|Open Label Extension|Pregnancy|0
5649167|NCT00568178|19509238|P3|Open Label Extension|Pregnancy|0
5649168|NCT00568178|19509239|P2|Open Label Extension|Pregnancy|0
5649169|NCT00568178|19509240|P1|Open Label Extension|Pregnancy|0
5649170|NCT00568178|19509235|P6|Open Label Extension|Physician Decision|8
5649171|NCT00568178|19509236|P5|Open Label Extension|Physician Decision|9
5649172|NCT00568178|19509237|P4|Open Label Extension|Physician Decision|0
5649173|NCT00568178|19509238|P3|Open Label Extension|Physician Decision|0
5649174|NCT00568178|19509239|P2|Open Label Extension|Physician Decision|0
5649175|NCT00568178|19509240|P1|Open Label Extension|Physician Decision|0
5649176|NCT00568178|19509235|P6|Open Label Extension|Lost to Follow-up|11
5649177|NCT00568178|19509236|P5|Open Label Extension|Lost to Follow-up|6
5649178|NCT00568178|19509237|P4|Open Label Extension|Lost to Follow-up|0
5649179|NCT00568178|19509238|P3|Open Label Extension|Lost to Follow-up|0
5649180|NCT00568178|19509239|P2|Open Label Extension|Lost to Follow-up|0
5649181|NCT00568178|19509240|P1|Open Label Extension|Lost to Follow-up|0
5649182|NCT00568178|19509235|P6|Open Label Extension|Protocol Violation|0
5649183|NCT00568178|19509236|P5|Open Label Extension|Protocol Violation|1
5649184|NCT00568178|19509237|P4|Open Label Extension|Protocol Violation|0
5649185|NCT00568178|19509238|P3|Open Label Extension|Protocol Violation|0
5649186|NCT00568178|19509239|P2|Open Label Extension|Protocol Violation|0
5649187|NCT00568178|19509240|P1|Open Label Extension|Protocol Violation|0
5649188|NCT00568178|19509235|P6|Open Label Extension|Adverse Event|8
5649189|NCT00568178|19509236|P5|Open Label Extension|Adverse Event|11
5649190|NCT00568178|19509237|P4|Open Label Extension|Adverse Event|0
5649191|NCT00568178|19509238|P3|Open Label Extension|Adverse Event|0
5649192|NCT00568178|19509239|P2|Open Label Extension|Adverse Event|0
5649193|NCT00568178|19509240|P1|Open Label Extension|Adverse Event|0
5649194|NCT00568178|19509235|P6|Double Blind Base Study|Progressive Disease|0
5649195|NCT00568178|19509236|P5|Double Blind Base Study|Progressive Disease|0
5649196|NCT00568178|19509237|P4|Double Blind Base Study|Progressive Disease|1
5649197|NCT00568178|19509238|P3|Double Blind Base Study|Progressive Disease|0
5649198|NCT00568178|19509239|P2|Double Blind Base Study|Progressive Disease|0
5649199|NCT00568178|19509240|P1|Double Blind Base Study|Progressive Disease|0
5649200|NCT00568178|19509235|P6|Double Blind Base Study|Withdrawal by Subject|0
5649201|NCT00568178|19509236|P5|Double Blind Base Study|Withdrawal by Subject|0
5649202|NCT00568178|19509237|P4|Double Blind Base Study|Withdrawal by Subject|0
5649203|NCT00568178|19509238|P3|Double Blind Base Study|Withdrawal by Subject|0
5649204|NCT00568178|19509239|P2|Double Blind Base Study|Withdrawal by Subject|1
5649205|NCT00568178|19509240|P1|Double Blind Base Study|Withdrawal by Subject|1
5649206|NCT00568178|19509235|P6|Double Blind Base Study|Protocol Violation|0
5649207|NCT00568178|19509236|P5|Double Blind Base Study|Protocol Violation|0
5649208|NCT00568178|19509237|P4|Double Blind Base Study|Protocol Violation|0
5649209|NCT00568178|19509238|P3|Double Blind Base Study|Protocol Violation|0
5649210|NCT00568178|19509239|P2|Double Blind Base Study|Protocol Violation|2
5649211|NCT00568178|19509240|P1|Double Blind Base Study|Protocol Violation|3
5649212|NCT00568178|19509235|P6|Double Blind Base Study|Physician Decision|0
5649213|NCT00568178|19509236|P5|Double Blind Base Study|Physician Decision|0
5649214|NCT00568178|19509237|P4|Double Blind Base Study|Physician Decision|1
5649215|NCT00568178|19509238|P3|Double Blind Base Study|Physician Decision|0
5649216|NCT00568178|19509239|P2|Double Blind Base Study|Physician Decision|1
5649217|NCT00568178|19509240|P1|Double Blind Base Study|Physician Decision|1
5649218|NCT00568178|19509235|P6|Double Blind Base Study|Lost to Follow-up|0
5649219|NCT00568178|19509236|P5|Double Blind Base Study|Lost to Follow-up|0
5649220|NCT00568178|19509237|P4|Double Blind Base Study|Lost to Follow-up|1
5649221|NCT00568178|19509238|P3|Double Blind Base Study|Lost to Follow-up|0
5649222|NCT00568178|19509239|P2|Double Blind Base Study|Lost to Follow-up|0
5649223|NCT00568178|19509240|P1|Double Blind Base Study|Lost to Follow-up|1
5649224|NCT00568178|19509235|P6|Double Blind Base Study|Adverse Event|0
5649225|NCT00568178|19509236|P5|Double Blind Base Study|Adverse Event|0
5649226|NCT00568178|19509237|P4|Double Blind Base Study|Adverse Event|2
5649227|NCT00568178|19509238|P3|Double Blind Base Study|Adverse Event|1
5649228|NCT00568178|19509239|P2|Double Blind Base Study|Adverse Event|2
5649229|NCT00568178|19509240|P1|Double Blind Base Study|Adverse Event|0
5649230|NCT00568126|19509258|P2|Overall Study|Physician Decision|2
5649231|NCT00568126|19509259|P1|Overall Study|Physician Decision|2
5649232|NCT00568126|19509258|P2|Overall Study|Lack of Efficacy|1
5649233|NCT00568126|19509259|P1|Overall Study|Lack of Efficacy|0
5649234|NCT00568126|19509258|P2|Overall Study|Lost to Follow-up|3
5649235|NCT00568126|19509259|P1|Overall Study|Lost to Follow-up|4
5649236|NCT00568126|19509258|P2|Overall Study|Withdrawal by Subject|3
5649237|NCT00568126|19509259|P1|Overall Study|Withdrawal by Subject|2
5649238|NCT00568126|19509258|P2|Overall Study|Adverse Event|0
5649239|NCT00568126|19509259|P1|Overall Study|Adverse Event|3
5649240|NCT00568061|19509284|P2|Overall Study|Adverse Event|1
5649241|NCT00568061|19509285|P1|Overall Study|Adverse Event|0
5649242|NCT00568061|19509284|P2|Overall Study|Inclusion / exclusion criteria|1
5649243|NCT00568061|19509285|P1|Overall Study|Inclusion / exclusion criteria|5
5649244|NCT00567996|19509348|P3|Overall Study|Patient's inability to use the device|0
5649245|NCT00567996|19509349|P2|Overall Study|Patient's inability to use the device|1
5649246|NCT00567996|19509350|P1|Overall Study|Patient's inability to use the device|0
5649247|NCT00567996|19509348|P3|Overall Study|Death|2
5649248|NCT00567996|19509349|P2|Overall Study|Death|0
5649249|NCT00567996|19509350|P1|Overall Study|Death|1
5649250|NCT00567996|19509348|P3|Overall Study|Administrative problems|0
5649251|NCT00567996|19509349|P2|Overall Study|Administrative problems|1
5649252|NCT00567996|19509350|P1|Overall Study|Administrative problems|1
5649253|NCT00567996|19509348|P3|Overall Study|Unsatisfactory therapeutic effect|15
5649254|NCT00567996|19509349|P2|Overall Study|Unsatisfactory therapeutic effect|2
5649255|NCT00567996|19509350|P1|Overall Study|Unsatisfactory therapeutic effect|1
5649256|NCT00567996|19509348|P3|Overall Study|Lost to Follow-up|2
5649257|NCT00567996|19509349|P2|Overall Study|Lost to Follow-up|5
5649258|NCT00567996|19509350|P1|Overall Study|Lost to Follow-up|2
5649259|NCT00567996|19509348|P3|Overall Study|Abnormal test procedure result(s)|1
5649260|NCT00567996|19509349|P2|Overall Study|Abnormal test procedure result(s)|1
5649261|NCT00567996|19509350|P1|Overall Study|Abnormal test procedure result(s)|2
5649262|NCT00567996|19509348|P3|Overall Study|Abnormal Lab value(s)|2
5649263|NCT00567996|19509349|P2|Overall Study|Abnormal Lab value(s)|1
5649264|NCT00567996|19509350|P1|Overall Study|Abnormal Lab value(s)|2
5649265|NCT00567996|19509348|P3|Overall Study|Withdrawal by Subject|22
5649266|NCT00567996|19509349|P2|Overall Study|Withdrawal by Subject|12
5649267|NCT00567996|19509350|P1|Overall Study|Withdrawal by Subject|8
5649268|NCT00567996|19509348|P3|Overall Study|Protocol Deviation|13
5649269|NCT00567996|19509349|P2|Overall Study|Protocol Deviation|11
5649270|NCT00567996|19509350|P1|Overall Study|Protocol Deviation|9
5649271|NCT00567996|19509348|P3|Overall Study|Adverse Event|13
5649272|NCT00567996|19509349|P2|Overall Study|Adverse Event|16
5649273|NCT00567996|19509350|P1|Overall Study|Adverse Event|18
5649274|NCT00567892|19509366|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
5649275|NCT00567892|19509367|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5649276|NCT00567892|19509368|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5649277|NCT00567892|19509369|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5649278|NCT00567892|19509366|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
5649279|NCT00567892|19509367|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
5649280|NCT00567892|19509368|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5649281|NCT00567892|19509369|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
5649282|NCT00567879|19509387|P6|Overall Study|Disease progression|3
5649283|NCT00567879|19509388|P5|Overall Study|Disease progression|11
5649284|NCT00567879|19509389|P4|Overall Study|Disease progression|5
5649285|NCT00567879|19509390|P3|Overall Study|Disease progression|15
5649286|NCT00567879|19509391|P2|Overall Study|Disease progression|7
5649287|NCT00567879|19509392|P1|Overall Study|Disease progression|5
5649288|NCT00567879|19509387|P6|Overall Study|New cancer therapy|0
5649289|NCT00567879|19509388|P5|Overall Study|New cancer therapy|0
5649290|NCT00567879|19509389|P4|Overall Study|New cancer therapy|0
5649291|NCT00567879|19509390|P3|Overall Study|New cancer therapy|1
5649292|NCT00567879|19509391|P2|Overall Study|New cancer therapy|0
5649293|NCT00567879|19509392|P1|Overall Study|New cancer therapy|0
5649294|NCT00567879|19509387|P6|Overall Study|Withdrawal by Subject|0
5649295|NCT00567879|19509388|P5|Overall Study|Withdrawal by Subject|0
5649296|NCT00567879|19509389|P4|Overall Study|Withdrawal by Subject|1
5649297|NCT00567879|19509390|P3|Overall Study|Withdrawal by Subject|3
5649298|NCT00567879|19509391|P2|Overall Study|Withdrawal by Subject|0
5649299|NCT00567879|19509392|P1|Overall Study|Withdrawal by Subject|0
5649300|NCT00567879|19509387|P6|Overall Study|Abnormal test procedure(s)|0
5649301|NCT00567879|19509388|P5|Overall Study|Abnormal test procedure(s)|0
5649302|NCT00567879|19509389|P4|Overall Study|Abnormal test procedure(s)|0
5649303|NCT00567879|19509390|P3|Overall Study|Abnormal test procedure(s)|1
5649304|NCT00567879|19509391|P2|Overall Study|Abnormal test procedure(s)|0
5649305|NCT00567879|19509392|P1|Overall Study|Abnormal test procedure(s)|0
5649306|NCT00567879|19509387|P6|Overall Study|Adverse Event|0
5649307|NCT00567879|19509388|P5|Overall Study|Adverse Event|1
5649308|NCT00567879|19509389|P4|Overall Study|Adverse Event|0
5649309|NCT00567879|19509390|P3|Overall Study|Adverse Event|1
5649310|NCT00567879|19509391|P2|Overall Study|Adverse Event|0
5649311|NCT00567879|19509392|P1|Overall Study|Adverse Event|2
5649312|NCT00567593|19509459|P1|Overall Study|Physician Decision|1
5649313|NCT00567593|19509459|P1|Overall Study|Adverse Event|1
5649314|NCT00567567|19509466|P3|Overall Study|Unable adequate stem cell for transplant|2
5649315|NCT00567567|19509467|P2|Overall Study|Unable adequate stem cell for transplant|0
5649316|NCT00567567|19509468|P1|Overall Study|Unable adequate stem cell for transplant|0
5649317|NCT00567567|19509466|P3|Overall Study|Enrolled another COG therapeutic study|0
5649318|NCT00567567|19509467|P2|Overall Study|Enrolled another COG therapeutic study|80
5649319|NCT00567567|19509468|P1|Overall Study|Enrolled another COG therapeutic study|99
5649320|NCT00567567|19509466|P3|Overall Study|Refusal by patient/parent/guardian|122
5649321|NCT00567567|19509467|P2|Overall Study|Refusal by patient/parent/guardian|16
5649322|NCT00567567|19509468|P1|Overall Study|Refusal by patient/parent/guardian|9
5649323|NCT00567567|19509466|P3|Overall Study|Ineligible|9
5649324|NCT00567567|19509467|P2|Overall Study|Ineligible|0
5649325|NCT00567567|19509468|P1|Overall Study|Ineligible|4
5649326|NCT00567567|19509466|P3|Overall Study|Withdrawal by Subject|2
5649327|NCT00567567|19509467|P2|Overall Study|Withdrawal by Subject|0
5649328|NCT00567567|19509468|P1|Overall Study|Withdrawal by Subject|0
5649329|NCT00567567|19509466|P3|Overall Study|Physician Decision|84
5649330|NCT00567567|19509467|P2|Overall Study|Physician Decision|18
5649331|NCT00567567|19509468|P1|Overall Study|Physician Decision|16
5649332|NCT00567567|19509466|P3|Overall Study|Lost to Follow-up|1
5649333|NCT00567567|19509467|P2|Overall Study|Lost to Follow-up|0
5649334|NCT00567567|19509468|P1|Overall Study|Lost to Follow-up|0
5649335|NCT00567567|19509466|P3|Overall Study|Lack of Efficacy|48
5649336|NCT00567567|19509467|P2|Overall Study|Lack of Efficacy|17
5649337|NCT00567567|19509468|P1|Overall Study|Lack of Efficacy|16
5649338|NCT00567567|19509466|P3|Overall Study|Death|5
5649339|NCT00567567|19509467|P2|Overall Study|Death|1
5649340|NCT00567567|19509468|P1|Overall Study|Death|8
5649341|NCT00567567|19509466|P3|Overall Study|Adverse Event|5
5649342|NCT00567567|19509467|P2|Overall Study|Adverse Event|2
5649343|NCT00567567|19509468|P1|Overall Study|Adverse Event|0
5649344|NCT00567541|19509516|P2|Overall Study|Adverse Event|1
5649345|NCT00567541|19509517|P1|Overall Study|Adverse Event|0
5649346|NCT00567502|19509527|P4|Overall Study|Never Initiated Treatment|72
5649347|NCT00567502|19509528|P3|Overall Study|Never Initiated Treatment|0
5649348|NCT00567502|19509529|P2|Overall Study|Never Initiated Treatment|0
5649349|NCT00567502|19509530|P1|Overall Study|Never Initiated Treatment|0
5649350|NCT00567502|19509527|P4|Overall Study|Sponsor request|1
5649351|NCT00567502|19509528|P3|Overall Study|Sponsor request|30
5649352|NCT00567502|19509529|P2|Overall Study|Sponsor request|0
5649353|NCT00567502|19509530|P1|Overall Study|Sponsor request|9
5649354|NCT00567502|19509527|P4|Overall Study|Participant request|1
5649355|NCT00567502|19509528|P3|Overall Study|Participant request|33
5649356|NCT00567502|19509529|P2|Overall Study|Participant request|1
5649357|NCT00567502|19509530|P1|Overall Study|Participant request|12
5649358|NCT00567502|19509527|P4|Overall Study|Other|6
5649359|NCT00567502|19509528|P3|Overall Study|Other|134
5649360|NCT00567502|19509529|P2|Overall Study|Other|2
5649361|NCT00567502|19509530|P1|Overall Study|Other|64
5649362|NCT00567502|19509527|P4|Overall Study|Death|5
5649363|NCT00567502|19509528|P3|Overall Study|Death|360
5649364|NCT00567502|19509529|P2|Overall Study|Death|16
5649365|NCT00567502|19509530|P1|Overall Study|Death|65
5649366|NCT00567502|19509527|P4|Overall Study|Lost to Follow-up|2
5649367|NCT00567502|19509528|P3|Overall Study|Lost to Follow-up|351
5649368|NCT00567502|19509529|P2|Overall Study|Lost to Follow-up|14
5649369|NCT00567502|19509530|P1|Overall Study|Lost to Follow-up|91
5649370|NCT00567489|19509567|P2|Overall Study|Other|0
5649371|NCT00567489|19509568|P1|Overall Study|Other|1
5649372|NCT00567489|19509567|P2|Overall Study|Renal Transplantation|3
5649373|NCT00567489|19509568|P1|Overall Study|Renal Transplantation|0
5649374|NCT00567489|19509567|P2|Overall Study|Withdrawal by Subject|2
5649375|NCT00567489|19509568|P1|Overall Study|Withdrawal by Subject|0
5649376|NCT00567489|19509567|P2|Overall Study|Physician Decision|4
5649377|NCT00567489|19509568|P1|Overall Study|Physician Decision|0
5649378|NCT00567489|19509567|P2|Overall Study|Adverse Event|14
5649379|NCT00567489|19509568|P1|Overall Study|Adverse Event|6
5649380|NCT00567476|19509618|P2|Overall Study|Non-adherence to protocol|1
5649381|NCT00567476|19509619|P1|Overall Study|Non-adherence to protocol|0
5649382|NCT00567476|19509618|P2|Overall Study|Medical Decision|1
5649383|NCT00567476|19509619|P1|Overall Study|Medical Decision|0
5649384|NCT00567476|19509618|P2|Overall Study|Administrative issues|0
5649385|NCT00567476|19509619|P1|Overall Study|Administrative issues|1
5649386|NCT00567476|19509618|P2|Overall Study|Lost to Follow-up|1
5649387|NCT00567476|19509619|P1|Overall Study|Lost to Follow-up|0
5649388|NCT00567476|19509618|P2|Overall Study|Protocol Violation|1
5649389|NCT00567476|19509619|P1|Overall Study|Protocol Violation|4
5649390|NCT00567476|19509618|P2|Overall Study|Pregnancy|0
5649391|NCT00567476|19509619|P1|Overall Study|Pregnancy|1
5649392|NCT00567476|19509618|P2|Overall Study|Adverse Event|0
5649393|NCT00567476|19509619|P1|Overall Study|Adverse Event|2
5649394|NCT00567398|19509645|P2|Overall Study|Other|0
5649395|NCT00567398|19509646|P1|Overall Study|Other|1
5649396|NCT00567398|19509645|P2|Overall Study|Renal Transplantation|3
5649397|NCT00567398|19509646|P1|Overall Study|Renal Transplantation|0
5649398|NCT00567398|19509645|P2|Overall Study|Withdrawal by Subject|2
5649399|NCT00567398|19509646|P1|Overall Study|Withdrawal by Subject|0
5649400|NCT00567398|19509645|P2|Overall Study|Physician Decision|4
5649401|NCT00567398|19509646|P1|Overall Study|Physician Decision|0
5649402|NCT00567398|19509645|P2|Overall Study|Adverse Event|14
5649403|NCT00567398|19509646|P1|Overall Study|Adverse Event|6
5649404|NCT00567359|19509694|P1|Overall Study|Withdrawal by Subject|1
5649405|NCT00567268|19509719|P1|Overall Study|"Safety Evaluation Not Assessable"|1
5649406|NCT00567268|19509719|P1|Overall Study|No Drug Administration|4
5649407|NCT00567268|19509719|P1|Overall Study|No Visit After First Day of Treatment|2
5649408|NCT00567268|19509719|P1|Overall Study|Lost to Follow-up|36
5649409|NCT00567268|19509719|P1|Overall Study|Protocol Violation|7
5649410|NCT00567255|19509770|P2|Overall Study|Drug noncompliance,moved,other|15
5649411|NCT00567255|19509771|P1|Overall Study|Drug noncompliance,moved,other|25
5649412|NCT00567255|19509770|P2|Overall Study|Pregnancy|0
5649413|NCT00567255|19509771|P1|Overall Study|Pregnancy|6
5649414|NCT00567255|19509770|P2|Overall Study|Protocol Violation|8
5649415|NCT00567255|19509771|P1|Overall Study|Protocol Violation|20
5649416|NCT00567255|19509770|P2|Overall Study|Lack of Efficacy|33
5649417|NCT00567255|19509771|P1|Overall Study|Lack of Efficacy|19
5649418|NCT00567255|19509770|P2|Overall Study|Withdrawal by Subject|56
5649419|NCT00567255|19509771|P1|Overall Study|Withdrawal by Subject|75
5649420|NCT00567255|19509770|P2|Overall Study|Lost to Follow-up|48
5649421|NCT00567255|19509771|P1|Overall Study|Lost to Follow-up|77
5649422|NCT00567255|19509770|P2|Overall Study|Adverse Event|68
5649423|NCT00567255|19509771|P1|Overall Study|Adverse Event|241
5649424|NCT00567190|19509834|P2|Overall Study|Withdrew Consent or Lost to Follow-up|53
5649425|NCT00567190|19509835|P1|Overall Study|Withdrew Consent or Lost to Follow-up|48
5649426|NCT00567190|19509834|P2|Overall Study|Death|280
5649427|NCT00567190|19509835|P1|Overall Study|Death|235
5649428|NCT00567164|19509886|P3|Overall Study|Missing|0
5649429|NCT00567164|19509887|P2|Overall Study|Missing|0
5649430|NCT00567164|19509888|P1|Overall Study|Missing|1
5649431|NCT00567164|19509886|P3|Overall Study|Primary Reason coded as 'Other'|16
5649432|NCT00567164|19509887|P2|Overall Study|Primary Reason coded as 'Other'|8
5649433|NCT00567164|19509888|P1|Overall Study|Primary Reason coded as 'Other'|37
5649434|NCT00567164|19509886|P3|Overall Study|Pregnancy|6
5649435|NCT00567164|19509887|P2|Overall Study|Pregnancy|4
5649436|NCT00567164|19509888|P1|Overall Study|Pregnancy|20
5649437|NCT00567164|19509886|P3|Overall Study|Lost to Follow-up|21
5649438|NCT00567164|19509887|P2|Overall Study|Lost to Follow-up|23
5649439|NCT00567164|19509888|P1|Overall Study|Lost to Follow-up|202
5649440|NCT00567164|19509886|P3|Overall Study|Death|1
5649441|NCT00567164|19509887|P2|Overall Study|Death|0
5649442|NCT00567164|19509888|P1|Overall Study|Death|0
5649443|NCT00567164|19509886|P3|Overall Study|Adverse Event|9
5649444|NCT00567164|19509887|P2|Overall Study|Adverse Event|13
5649445|NCT00567164|19509888|P1|Overall Study|Adverse Event|92
5649446|NCT00567164|19509886|P3|Overall Study|Protocol Violation|2
5649447|NCT00567164|19509887|P2|Overall Study|Protocol Violation|4
5649448|NCT00567164|19509888|P1|Overall Study|Protocol Violation|23
5649449|NCT00567164|19509886|P3|Overall Study|Withdrawal by Subject|17
5649450|NCT00567164|19509887|P2|Overall Study|Withdrawal by Subject|21
5649451|NCT00567164|19509888|P1|Overall Study|Withdrawal by Subject|171
5649452|NCT00567112|19509960|P3|Washout Period 3 (3 Days)|Protocol Violation|0
5649453|NCT00567112|19509961|P2|Washout Period 3 (3 Days)|Protocol Violation|0
5649454|NCT00567112|19509962|P1|Washout Period 3 (3 Days)|Protocol Violation|1
5649455|NCT00567112|19509960|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
5649456|NCT00567112|19509961|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
5649457|NCT00567112|19509962|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
5649458|NCT00567112|19509960|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
5649459|NCT00567112|19509961|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
5649460|NCT00567112|19509962|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
5649461|NCT00566995|19509993|P1|Overall Study|Withdrew consent|3
5649462|NCT00566995|19509993|P1|Overall Study|Toxicity|4
5649463|NCT00566982|19510008|P2|Overall Study|Other-family problems & doctor's request|2
5649464|NCT00566982|19510009|P1|Overall Study|Other-family problems & doctor's request|0
5649465|NCT00566982|19510008|P2|Overall Study|Lost to Follow-up|1
5649466|NCT00566982|19510009|P1|Overall Study|Lost to Follow-up|0
5649467|NCT00566982|19510008|P2|Overall Study|Protocol Violation|4
5649468|NCT00566982|19510009|P1|Overall Study|Protocol Violation|1
5649469|NCT00566982|19510008|P2|Overall Study|Withdrawal by Subject|14
5649470|NCT00566982|19510009|P1|Overall Study|Withdrawal by Subject|1
5649471|NCT00566982|19510008|P2|Overall Study|Adverse Event|48
5649472|NCT00566982|19510009|P1|Overall Study|Adverse Event|6
5649473|NCT00566852|19510074|P2|Overall Study|Missing reason not reported|20
5649474|NCT00566852|19510075|P1|Overall Study|Missing reason not reported|16
5649475|NCT00566852|19510074|P2|Overall Study|Missing reason not specified|2
5649476|NCT00566852|19510075|P1|Overall Study|Missing reason not specified|1
5649477|NCT00566852|19510074|P2|Overall Study|Not tested due to disability|12
5649478|NCT00566852|19510075|P1|Overall Study|Not tested due to disability|6
5649479|NCT00566852|19510074|P2|Overall Study|Patient refusal|37
5649480|NCT00566852|19510075|P1|Overall Study|Patient refusal|37
5649481|NCT00566852|19510074|P2|Overall Study|Withdrawal by Subject|25
5649482|NCT00566852|19510075|P1|Overall Study|Withdrawal by Subject|30
5649483|NCT00566852|19510074|P2|Overall Study|Death|78
5649484|NCT00566852|19510075|P1|Overall Study|Death|95
5649485|NCT00566852|19510074|P2|Overall Study|Protocol Violation|24
5649486|NCT00566852|19510075|P1|Overall Study|Protocol Violation|22
5649487|NCT00566735|19510106|P2|Overall Study|Switched into a manic episode|1
5649488|NCT00566735|19510107|P1|Overall Study|Switched into a manic episode|0
5649489|NCT00566735|19510106|P2|Overall Study|Refused neuropsychological testing|5
5649490|NCT00566735|19510107|P1|Overall Study|Refused neuropsychological testing|2
5649491|NCT00566735|19510106|P2|Overall Study|Withdrawal by Subject|1
5649492|NCT00566735|19510107|P1|Overall Study|Withdrawal by Subject|0
5649493|NCT00566722|19510120|P3|Overall Study|Noncompliant with drug administration|1
5649494|NCT00566722|19510121|P2|Overall Study|Noncompliant with drug administration|0
5649495|NCT00566722|19510122|P1|Overall Study|Noncompliant with drug administration|0
5649496|NCT00566722|19510120|P3|Overall Study|Serious adverse event|0
5649497|NCT00566722|19510121|P2|Overall Study|Serious adverse event|1
5649498|NCT00566722|19510122|P1|Overall Study|Serious adverse event|0
5649499|NCT00566722|19510120|P3|Overall Study|Did not meet exclusion criteria|2
5649500|NCT00566722|19510121|P2|Overall Study|Did not meet exclusion criteria|0
5649501|NCT00566722|19510122|P1|Overall Study|Did not meet exclusion criteria|0
5649502|NCT00566722|19510120|P3|Overall Study|Lack of Efficacy|4
5649503|NCT00566722|19510121|P2|Overall Study|Lack of Efficacy|2
5649504|NCT00566722|19510122|P1|Overall Study|Lack of Efficacy|1
5649505|NCT00566722|19510120|P3|Overall Study|Lost to Follow-up|1
5649506|NCT00566722|19510121|P2|Overall Study|Lost to Follow-up|1
5649507|NCT00566722|19510122|P1|Overall Study|Lost to Follow-up|1
5649508|NCT00566722|19510120|P3|Overall Study|Withdrawal by Subject|1
5649509|NCT00566722|19510121|P2|Overall Study|Withdrawal by Subject|0
5649510|NCT00566722|19510122|P1|Overall Study|Withdrawal by Subject|0
5649511|NCT00566722|19510120|P3|Overall Study|Adverse Event|0
5649512|NCT00566722|19510121|P2|Overall Study|Adverse Event|1
5649513|NCT00566722|19510122|P1|Overall Study|Adverse Event|0
5649514|NCT00566709|19510168|P2|Overall Study|Protocol Violation|0
5649515|NCT00566709|19510169|P1|Overall Study|Protocol Violation|5
5649516|NCT00566696|19510185|P1|Overall Study|Non-Patient Donors|37
5649517|NCT00566696|19510185|P1|Overall Study|Physician Decision|1
5649518|NCT00566696|19510185|P1|Overall Study|Health Status Change|1
5649519|NCT00566696|19510185|P1|Overall Study|Muromonab not available|1
5649520|NCT00566696|19510185|P1|Overall Study|Met Exclusion Criteria|2
5649521|NCT00566631|19510195|P1|Part 2: Extension Phase|Other|5
5649522|NCT00566631|19510195|P1|Part 2: Extension Phase|Death|1
5649523|NCT00566631|19510195|P1|Part 2: Extension Phase|Lost to Follow-up|6
5649524|NCT00566631|19510195|P1|Part 2: Extension Phase|Adverse Event|11
5649525|NCT00566631|19510195|P1|Part 2: Extension Phase|Withdrawal by Subject|34
5649526|NCT00566631|19510195|P1|Part 2: Extension Phase|Lack of Efficacy|25
5649527|NCT00566631|19510195|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
5649528|NCT00566631|19510195|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
5649529|NCT00566631|19510195|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
5649530|NCT00566631|19510195|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
5649531|NCT00566631|19510195|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
5649532|NCT00566631|19510195|P1|Part 1: Core Treatment Phase|Adverse Event|9
5649533|NCT00566631|19510195|P1|Part 1: Core Treatment Phase|Physician Decision|1
5649534|NCT00566631|19510195|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
5649535|NCT00566527|19510222|P3|Overall Study|Withdrawal by Subject|43
5649536|NCT00566527|19510223|P2|Overall Study|Withdrawal by Subject|43
5649537|NCT00566527|19510224|P1|Overall Study|Withdrawal by Subject|6
5649538|NCT00566527|19510222|P3|Overall Study|Lost to Follow-up|4
5649539|NCT00566527|19510223|P2|Overall Study|Lost to Follow-up|4
5649540|NCT00566527|19510224|P1|Overall Study|Lost to Follow-up|3
5649541|NCT00566527|19510222|P3|Overall Study|Physician Decision|20
5649542|NCT00566527|19510223|P2|Overall Study|Physician Decision|8
5649543|NCT00566527|19510224|P1|Overall Study|Physician Decision|3
5649544|NCT00566527|19510222|P3|Overall Study|Adverse Event|1
5649545|NCT00566527|19510223|P2|Overall Study|Adverse Event|0
5649546|NCT00566527|19510224|P1|Overall Study|Adverse Event|2
5649547|NCT00566527|19510222|P3|Overall Study|Reason not provided|10
5649548|NCT00566527|19510223|P2|Overall Study|Reason not provided|11
5649549|NCT00566527|19510224|P1|Overall Study|Reason not provided|3
5649550|NCT00566254|19510285|P2|Overall Study|Other|2
5649551|NCT00566254|19510286|P1|Overall Study|Other|0
5649552|NCT00566254|19510285|P2|Overall Study|Lack of Efficacy|6
5649553|NCT00566254|19510286|P1|Overall Study|Lack of Efficacy|5
5649554|NCT00566254|19510285|P2|Overall Study|Withdrawal by Subject|2
5649555|NCT00566254|19510286|P1|Overall Study|Withdrawal by Subject|1
5649556|NCT00566254|19510285|P2|Overall Study|Protocol Violation|3
5649557|NCT00566254|19510286|P1|Overall Study|Protocol Violation|1
5649558|NCT00566254|19510285|P2|Overall Study|Adverse Event|1
5649559|NCT00566254|19510286|P1|Overall Study|Adverse Event|3
5649560|NCT00566228|19510300|P2|Overall Study|progressed before infusion could occur|1
5649561|NCT00566228|19510301|P1|Overall Study|progressed before infusion could occur|0
5649562|NCT00566228|19510300|P2|Overall Study|Unable to collect sufficient CD34 cells|2
5649563|NCT00566228|19510301|P1|Overall Study|Unable to collect sufficient CD34 cells|3
5649564|NCT00566228|19510300|P2|Overall Study|Attempt to mobilize stem cells failed|2
5649565|NCT00566228|19510301|P1|Overall Study|Attempt to mobilize stem cells failed|2
5649566|NCT00566228|19510300|P2|Overall Study|Withdrawal by Subject|0
5649567|NCT00566228|19510301|P1|Overall Study|Withdrawal by Subject|1
5649568|NCT00566111|19510334|P2|Overall Study|Adverse Event|2
5649569|NCT00566111|19510335|P1|Overall Study|Adverse Event|0
5649570|NCT00566098|19510349|P1|Administration of ASCT+MILs|Lack of Efficacy|8
5649571|NCT00566098|19510349|P1|Administration of ASCT+MILs|Death|10
5649572|NCT00566098|19510349|P1|Generation of MILs Product|Relapsed|1
5649573|NCT00566098|19510349|P1|Collection of MILs|Relapsed|1
5649574|NCT00566098|19510349|P1|Collection of MILs|Withdrawal by Subject|1
5649575|NCT00566020|19510359|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
5649576|NCT00566020|19510360|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
5649577|NCT00566020|19510359|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
5649578|NCT00566020|19510360|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
5649579|NCT00566020|19510359|P2|46-week Long-term Administration Phase|Physician Decision|7
5649580|NCT00566020|19510360|P1|46-week Long-term Administration Phase|Physician Decision|0
5649581|NCT00566020|19510359|P2|46-week Long-term Administration Phase|Adverse Event|7
5649582|NCT00566020|19510360|P1|46-week Long-term Administration Phase|Adverse Event|0
5649583|NCT00566020|19510359|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
5649584|NCT00566020|19510360|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
5649585|NCT00566020|19510359|P2|6-week Dosage Adjustment Phase|Adverse Event|0
5649586|NCT00566020|19510360|P1|6-week Dosage Adjustment Phase|Adverse Event|5
5649587|NCT00565851|19510454|P8|Chemotherapy Assignment|Still On Chemotherapy|1
5649588|NCT00565851|19510455|P7|Chemotherapy Assignment|Still On Chemotherapy|0
5649589|NCT00565851|19510456|P6|Chemotherapy Assignment|Still On Chemotherapy|1
5649590|NCT00565851|19510457|P5|Chemotherapy Assignment|Still On Chemotherapy|0
5649591|NCT00565851|19510458|P4|Chemotherapy Assignment|Still On Chemotherapy|18
5649592|NCT00565851|19510459|P3|Chemotherapy Assignment|Still On Chemotherapy|0
5649593|NCT00565851|19510460|P2|Chemotherapy Assignment|Still On Chemotherapy|14
5649594|NCT00565851|19510461|P1|Chemotherapy Assignment|Still On Chemotherapy|0
5649595|NCT00565851|19510454|P8|Chemotherapy Assignment|Never Initiated Chemotherapy|2
5649596|NCT00565851|19510455|P7|Chemotherapy Assignment|Never Initiated Chemotherapy|0
5649597|NCT00565851|19510456|P6|Chemotherapy Assignment|Never Initiated Chemotherapy|2
5649598|NCT00565851|19510457|P5|Chemotherapy Assignment|Never Initiated Chemotherapy|0
5649599|NCT00565851|19510458|P4|Chemotherapy Assignment|Never Initiated Chemotherapy|18
5649600|NCT00565851|19510459|P3|Chemotherapy Assignment|Never Initiated Chemotherapy|3
5649601|NCT00565851|19510460|P2|Chemotherapy Assignment|Never Initiated Chemotherapy|9
5649602|NCT00565851|19510461|P1|Chemotherapy Assignment|Never Initiated Chemotherapy|9
5649603|NCT00565812|19510498|P3|Overall Study|Physician Decision|0
5649604|NCT00565812|19510499|P2|Overall Study|Physician Decision|0
5649605|NCT00565812|19510500|P1|Overall Study|Physician Decision|2
5649606|NCT00565812|19510498|P3|Overall Study|Follow-up Visit Not Completed|1
5649607|NCT00565812|19510499|P2|Overall Study|Follow-up Visit Not Completed|0
5649608|NCT00565812|19510500|P1|Overall Study|Follow-up Visit Not Completed|2
5649609|NCT00565812|19510498|P3|Overall Study|Low Compliance|1
5649610|NCT00565812|19510499|P2|Overall Study|Low Compliance|0
5649611|NCT00565812|19510500|P1|Overall Study|Low Compliance|1
5649612|NCT00565812|19510498|P3|Overall Study|Surgical Intervention|2
5649613|NCT00565812|19510499|P2|Overall Study|Surgical Intervention|1
5649614|NCT00565812|19510500|P1|Overall Study|Surgical Intervention|0
5649615|NCT00565812|19510498|P3|Overall Study|Research Site Closure|8
5649616|NCT00565812|19510499|P2|Overall Study|Research Site Closure|1
5649617|NCT00565812|19510500|P1|Overall Study|Research Site Closure|6
5649618|NCT00565812|19510498|P3|Overall Study|Domestic Reasons|3
5649619|NCT00565812|19510499|P2|Overall Study|Domestic Reasons|1
5649620|NCT00565812|19510500|P1|Overall Study|Domestic Reasons|7
5649621|NCT00565812|19510498|P3|Overall Study|Sponsor Decision|1
5649622|NCT00565812|19510499|P2|Overall Study|Sponsor Decision|5
5649623|NCT00565812|19510500|P1|Overall Study|Sponsor Decision|1
5649624|NCT00565812|19510498|P3|Overall Study|Relocated Out of Area|9
5649625|NCT00565812|19510499|P2|Overall Study|Relocated Out of Area|8
5649626|NCT00565812|19510500|P1|Overall Study|Relocated Out of Area|5
5649627|NCT00565812|19510498|P3|Overall Study|Jury Duty|0
5649628|NCT00565812|19510499|P2|Overall Study|Jury Duty|0
5649629|NCT00565812|19510500|P1|Overall Study|Jury Duty|1
5649630|NCT00565812|19510498|P3|Overall Study|Adverse Event|40
5649631|NCT00565812|19510499|P2|Overall Study|Adverse Event|54
5649632|NCT00565812|19510500|P1|Overall Study|Adverse Event|41
5649633|NCT00565812|19510498|P3|Overall Study|Protocol Violation|4
5649634|NCT00565812|19510499|P2|Overall Study|Protocol Violation|6
5649635|NCT00565812|19510500|P1|Overall Study|Protocol Violation|2
5649636|NCT00565812|19510498|P3|Overall Study|Work Schedule|1
5649637|NCT00565812|19510499|P2|Overall Study|Work Schedule|3
5649638|NCT00565812|19510500|P1|Overall Study|Work Schedule|5
5649639|NCT00565812|19510498|P3|Overall Study|Withdrawal by Subject|48
5649640|NCT00565812|19510499|P2|Overall Study|Withdrawal by Subject|47
5649641|NCT00565812|19510500|P1|Overall Study|Withdrawal by Subject|58
5649642|NCT00565812|19510498|P3|Overall Study|Lost to Follow-up|8
5649643|NCT00565812|19510499|P2|Overall Study|Lost to Follow-up|8
5649644|NCT00565812|19510500|P1|Overall Study|Lost to Follow-up|10
5649645|NCT00565812|19510498|P3|Overall Study|Did not Meet Entrance Criteria|1
5649646|NCT00565812|19510499|P2|Overall Study|Did not Meet Entrance Criteria|0
5649647|NCT00565812|19510500|P1|Overall Study|Did not Meet Entrance Criteria|1
5649648|NCT00565812|19510498|P3|Overall Study|Death|3
5649649|NCT00565812|19510499|P2|Overall Study|Death|1
5649650|NCT00565812|19510500|P1|Overall Study|Death|2
5649651|NCT00565773|19510637|P1|Overall Study|Physician Decision|1
5649652|NCT00565773|19510637|P1|Overall Study|Withdrawal by Subject|1
5649653|NCT00565747|19510649|P2|Overall Study|No embryo transfer|73
5649654|NCT00565747|19510650|P1|Overall Study|No embryo transfer|67
5649655|NCT00565721|19510660|P1|Overall Study|Other reasons|6
5649656|NCT00565721|19510660|P1|Overall Study|Physician Decision|2
5649657|NCT00565721|19510660|P1|Overall Study|Technical Problems|1
5649658|NCT00565721|19510660|P1|Overall Study|Lost to Follow-up|6
5649659|NCT00565721|19510660|P1|Overall Study|Screen Failure|2
5649660|NCT00565617|19510709|P1|Overall Study|Withdrawal by Subject|1
5649661|NCT00565604|19510713|P1|Overall Study|Lost to Follow-up|2
5649662|NCT00565604|19510713|P1|Overall Study|Failure to treat|2
5649663|NCT00565448|19510759|P2|Overall Study|Withdrawal by Subject|0
5649664|NCT00565448|19510760|P1|Overall Study|Withdrawal by Subject|1
5649665|NCT00565448|19510759|P2|Overall Study|Disease progression|0
5649666|NCT00565448|19510760|P1|Overall Study|Disease progression|1
5649667|NCT00565448|19510759|P2|Overall Study|Adverse Event|2
5649668|NCT00565448|19510760|P1|Overall Study|Adverse Event|1
5649669|NCT00565409|19510771|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
5649670|NCT00565409|19510772|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
5649671|NCT00565409|19510773|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
5649672|NCT00565409|19510774|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
5649673|NCT00565409|19510771|P4|Period 2 Double-Blind|Other|9
5649674|NCT00565409|19510772|P3|Period 2 Double-Blind|Other|5
5649675|NCT00565409|19510773|P2|Period 2 Double-Blind|Other|4
5649676|NCT00565409|19510774|P1|Period 2 Double-Blind|Other|0
5649677|NCT00565409|19510771|P4|Period 2 Double-Blind|Lost to Follow-up|0
5649678|NCT00565409|19510772|P3|Period 2 Double-Blind|Lost to Follow-up|1
5649679|NCT00565409|19510773|P2|Period 2 Double-Blind|Lost to Follow-up|0
5649680|NCT00565409|19510774|P1|Period 2 Double-Blind|Lost to Follow-up|0
5649681|NCT00565409|19510771|P4|Period 2 Double-Blind|Protocol Violation|2
5649682|NCT00565409|19510772|P3|Period 2 Double-Blind|Protocol Violation|6
5649683|NCT00565409|19510773|P2|Period 2 Double-Blind|Protocol Violation|4
5649684|NCT00565409|19510774|P1|Period 2 Double-Blind|Protocol Violation|0
5649685|NCT00565409|19510771|P4|Period 2 Double-Blind|Death|0
5649686|NCT00565409|19510772|P3|Period 2 Double-Blind|Death|0
5649687|NCT00565409|19510773|P2|Period 2 Double-Blind|Death|2
5649688|NCT00565409|19510774|P1|Period 2 Double-Blind|Death|0
5649689|NCT00565409|19510771|P4|Period 2 Double-Blind|Adverse Event|5
5649690|NCT00565409|19510772|P3|Period 2 Double-Blind|Adverse Event|4
5649691|NCT00565409|19510773|P2|Period 2 Double-Blind|Adverse Event|7
5649692|NCT00565409|19510774|P1|Period 2 Double-Blind|Adverse Event|0
5649693|NCT00565409|19510771|P4|After Period 1, Prior to Period 2|did not meet criteria|0
5649694|NCT00565409|19510772|P3|After Period 1, Prior to Period 2|did not meet criteria|0
5649695|NCT00565409|19510773|P2|After Period 1, Prior to Period 2|did not meet criteria|0
5649696|NCT00565409|19510774|P1|After Period 1, Prior to Period 2|did not meet criteria|152
5649697|NCT00565409|19510771|P4|Period 1 Open Label|no conclusion of participation record|0
5649698|NCT00565409|19510772|P3|Period 1 Open Label|no conclusion of participation record|0
5649699|NCT00565409|19510773|P2|Period 1 Open Label|no conclusion of participation record|0
5649700|NCT00565409|19510774|P1|Period 1 Open Label|no conclusion of participation record|1
5649701|NCT00565409|19510771|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
5649702|NCT00565409|19510772|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
5649703|NCT00565409|19510773|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
5649704|NCT00565409|19510774|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
5649705|NCT00565409|19510771|P4|Period 1 Open Label|Protocol Violation|0
5649706|NCT00565409|19510772|P3|Period 1 Open Label|Protocol Violation|0
5649707|NCT00565409|19510773|P2|Period 1 Open Label|Protocol Violation|0
5649708|NCT00565409|19510774|P1|Period 1 Open Label|Protocol Violation|14
5649709|NCT00565409|19510771|P4|Period 1 Open Label|Other|0
5649710|NCT00565409|19510772|P3|Period 1 Open Label|Other|0
5649711|NCT00565409|19510773|P2|Period 1 Open Label|Other|0
5649712|NCT00565409|19510774|P1|Period 1 Open Label|Other|21
5649713|NCT00565409|19510771|P4|Period 1 Open Label|Lost to Follow-up|0
5649714|NCT00565409|19510772|P3|Period 1 Open Label|Lost to Follow-up|0
5649715|NCT00565409|19510773|P2|Period 1 Open Label|Lost to Follow-up|0
5649716|NCT00565409|19510774|P1|Period 1 Open Label|Lost to Follow-up|1
5649717|NCT00565409|19510771|P4|Period 1 Open Label|Death|0
5649718|NCT00565409|19510772|P3|Period 1 Open Label|Death|0
5649719|NCT00565409|19510773|P2|Period 1 Open Label|Death|0
5649720|NCT00565409|19510774|P1|Period 1 Open Label|Death|2
5649721|NCT00565409|19510771|P4|Period 1 Open Label|Adverse Event|0
5649722|NCT00565409|19510772|P3|Period 1 Open Label|Adverse Event|0
5649723|NCT00565409|19510773|P2|Period 1 Open Label|Adverse Event|0
5649724|NCT00565409|19510774|P1|Period 1 Open Label|Adverse Event|17
5649725|NCT00565136|19510910|P1|Overall Study|Protocol Violation|1
5649726|NCT00565136|19510910|P1|Overall Study|Withdrawal by Subject|1
5649727|NCT00565136|19510910|P1|Overall Study|Lost to Follow-up|1
5649728|NCT00565058|19510951|P2|Overall Study|Adverse Event|0
5649729|NCT00565058|19510952|P1|Overall Study|Adverse Event|1
5649730|NCT00564902|19510999|P3|Overall Study|Death|0
5649731|NCT00564902|19511000|P2|Overall Study|Death|1
5649732|NCT00564902|19511001|P1|Overall Study|Death|1
5649733|NCT00564902|19510999|P3|Overall Study|Withdrawal by Subject|4
5649734|NCT00564902|19511000|P2|Overall Study|Withdrawal by Subject|3
5649735|NCT00564902|19511001|P1|Overall Study|Withdrawal by Subject|0
5649736|NCT00564889|19511033|P1|Overall Study|Other, not specified|4
5649737|NCT00564889|19511033|P1|Overall Study|Disease progression|3
5649738|NCT00564889|19511033|P1|Overall Study|Alternative treatment|3
5649739|NCT00564889|19511033|P1|Overall Study|Adverse Event|12
5649740|NCT00564889|19511033|P1|Overall Study|Death|7
5649741|NCT00564850|19511048|P1|Overall Study|Protocol Violation|2
5649742|NCT00564733|19511066|P1|Overall Study|Ineligible|5
5649743|NCT00564733|19511066|P1|Overall Study|Withdrawal by Subject|4
5649744|NCT00564629|19511100|P2|Overall Study|Vomited within 2 hours of receiving drug|9
5649745|NCT00564629|19511101|P1|Overall Study|Vomited within 2 hours of receiving drug|15
5649746|NCT00564486|19511126|P4|Overall Study|Lost to Follow-up|2
5649747|NCT00564486|19511127|P3|Overall Study|Lost to Follow-up|2
5649748|NCT00564486|19511128|P2|Overall Study|Lost to Follow-up|0
5649749|NCT00564486|19511129|P1|Overall Study|Lost to Follow-up|3
5649750|NCT00564486|19511126|P4|Overall Study|Subject refused to have blood drawn|0
5649751|NCT00564486|19511127|P3|Overall Study|Subject refused to have blood drawn|1
5649752|NCT00564486|19511128|P2|Overall Study|Subject refused to have blood drawn|0
5649753|NCT00564486|19511129|P1|Overall Study|Subject refused to have blood drawn|0
5649754|NCT00564486|19511126|P4|Overall Study|Withdrawal by Subject|5
5649755|NCT00564486|19511127|P3|Overall Study|Withdrawal by Subject|0
5649756|NCT00564486|19511128|P2|Overall Study|Withdrawal by Subject|0
5649757|NCT00564486|19511129|P1|Overall Study|Withdrawal by Subject|4
5649758|NCT00564486|19511126|P4|Overall Study|Adverse Event|0
5649759|NCT00564486|19511127|P3|Overall Study|Adverse Event|0
5649760|NCT00564486|19511128|P2|Overall Study|Adverse Event|1
5649761|NCT00564486|19511129|P1|Overall Study|Adverse Event|0
5649762|NCT00564395|19511178|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
5649763|NCT00564395|19511179|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
5649764|NCT00564395|19511178|P2|First Intervention (10 Days)|Withdrawal by Subject|0
5649765|NCT00564395|19511179|P1|First Intervention (10 Days)|Withdrawal by Subject|1
5649766|NCT00564278|19511187|P2|Overall Study|Withdrawal by Subject|7
5649767|NCT00564278|19511188|P1|Overall Study|Withdrawal by Subject|11
5649768|NCT00564278|19511187|P2|Overall Study|Physician Decision|2
5649769|NCT00564278|19511188|P1|Overall Study|Physician Decision|1
5649770|NCT00564278|19511187|P2|Overall Study|Lost to Follow-up|33
5649771|NCT00564278|19511188|P1|Overall Study|Lost to Follow-up|35
5649772|NCT00564070|19511210|P2|Overall Study|Worsening depression, referred to care|0
5649773|NCT00564070|19511211|P1|Overall Study|Worsening depression, referred to care|3
5649774|NCT00564070|19511210|P2|Overall Study|Lost to Follow-up|7
5649775|NCT00564070|19511211|P1|Overall Study|Lost to Follow-up|9
5649776|NCT00564018|19511238|P3|Overall Study|Withdrawal by Subject|1
5649777|NCT00564018|19511239|P2|Overall Study|Withdrawal by Subject|3
5649778|NCT00564018|19511240|P1|Overall Study|Withdrawal by Subject|2
5649779|NCT00563797|19511253|P2|Overall Study|Lost to Follow-up|2
5649780|NCT00563797|19511254|P1|Overall Study|Lost to Follow-up|7
5649781|NCT00563784|19511266|P1|Overall Study|Screen Failures|20
5649782|NCT00563784|19511266|P1|Overall Study|Withdrawal by Subject|2
5649783|NCT00563706|19511280|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
5649784|NCT00563706|19511281|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
5649785|NCT00563706|19511282|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
5649786|NCT00563706|19511283|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
5649787|NCT00563706|19511284|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
5649788|NCT00563706|19511285|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
5649789|NCT00563706|19511286|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
5649790|NCT00563706|19511287|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
5649791|NCT00563706|19511288|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
5649792|NCT00563706|19511280|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5649793|NCT00563706|19511281|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
5649794|NCT00563706|19511282|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5649795|NCT00563706|19511283|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5649796|NCT00563706|19511284|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5649797|NCT00563706|19511285|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5649798|NCT00563706|19511286|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5649799|NCT00563706|19511287|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
5649800|NCT00563706|19511288|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
5649801|NCT00563706|19511280|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
5649802|NCT00563706|19511281|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
5649803|NCT00563706|19511282|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
5649804|NCT00563706|19511283|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
5649805|NCT00563706|19511284|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
5649806|NCT00563706|19511285|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
5649807|NCT00563706|19511286|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
5649808|NCT00563706|19511287|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
5649809|NCT00563706|19511288|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
5649810|NCT00563706|19511280|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
5649811|NCT00563706|19511281|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
5649812|NCT00563706|19511282|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
5649813|NCT00563706|19511283|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
5649814|NCT00563706|19511284|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
5649815|NCT00563706|19511285|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
5649816|NCT00563706|19511286|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
5649817|NCT00563706|19511287|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
5649818|NCT00563706|19511288|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
5649819|NCT00563706|19511280|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
5649820|NCT00563706|19511281|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
5649821|NCT00563706|19511282|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
5649822|NCT00563706|19511283|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
5649823|NCT00563706|19511284|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
5649824|NCT00563706|19511285|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
5649825|NCT00563706|19511286|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
5649826|NCT00563706|19511287|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
5649827|NCT00563706|19511288|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
5649828|NCT00563381|19511406|P2|Overall Study|Individual different reasons|34
5649829|NCT00563381|19511407|P1|Overall Study|Individual different reasons|24
5649830|NCT00563381|19511406|P2|Overall Study|Lack of Efficacy|24
5649831|NCT00563381|19511407|P1|Overall Study|Lack of Efficacy|32
5649832|NCT00563381|19511406|P2|Overall Study|Withdrawal by Subject|209
5649833|NCT00563381|19511407|P1|Overall Study|Withdrawal by Subject|192
5649834|NCT00563381|19511406|P2|Overall Study|Lost to Follow-up|15
5649835|NCT00563381|19511407|P1|Overall Study|Lost to Follow-up|7
5649836|NCT00563381|19511406|P2|Overall Study|Protocol Violation|74
5649837|NCT00563381|19511407|P1|Overall Study|Protocol Violation|66
5649838|NCT00563381|19511406|P2|Overall Study|Adverse Event|292
5649839|NCT00563381|19511407|P1|Overall Study|Adverse Event|264
5649840|NCT00563368|19511480|P7|Overall Study|Other|0
5649841|NCT00563368|19511481|P6|Overall Study|Other|4
5649842|NCT00563368|19511482|P5|Overall Study|Other|4
5649843|NCT00563368|19511483|P4|Overall Study|Other|4
5649844|NCT00563368|19511484|P3|Overall Study|Other|3
5649845|NCT00563368|19511485|P2|Overall Study|Other|5
5649846|NCT00563368|19511486|P1|Overall Study|Other|5
5649847|NCT00563368|19511480|P7|Overall Study|requirement for restricted medication|0
5649848|NCT00563368|19511481|P6|Overall Study|requirement for restricted medication|0
5649849|NCT00563368|19511482|P5|Overall Study|requirement for restricted medication|0
5649850|NCT00563368|19511483|P4|Overall Study|requirement for restricted medication|0
5649851|NCT00563368|19511484|P3|Overall Study|requirement for restricted medication|2
5649852|NCT00563368|19511485|P2|Overall Study|requirement for restricted medication|0
5649853|NCT00563368|19511486|P1|Overall Study|requirement for restricted medication|0
5649854|NCT00563368|19511480|P7|Overall Study|Pregnancy|0
5649855|NCT00563368|19511481|P6|Overall Study|Pregnancy|2
5649856|NCT00563368|19511482|P5|Overall Study|Pregnancy|1
5649857|NCT00563368|19511483|P4|Overall Study|Pregnancy|2
5649858|NCT00563368|19511484|P3|Overall Study|Pregnancy|1
5649859|NCT00563368|19511485|P2|Overall Study|Pregnancy|0
5649860|NCT00563368|19511486|P1|Overall Study|Pregnancy|1
5649861|NCT00563368|19511480|P7|Overall Study|protocol non-compliance|3
5649862|NCT00563368|19511481|P6|Overall Study|protocol non-compliance|1
5649863|NCT00563368|19511482|P5|Overall Study|protocol non-compliance|0
5649864|NCT00563368|19511483|P4|Overall Study|protocol non-compliance|1
5649865|NCT00563368|19511484|P3|Overall Study|protocol non-compliance|2
5649866|NCT00563368|19511485|P2|Overall Study|protocol non-compliance|1
5649867|NCT00563368|19511486|P1|Overall Study|protocol non-compliance|1
5649868|NCT00563368|19511480|P7|Overall Study|Withdrawal by Subject|4
5649869|NCT00563368|19511481|P6|Overall Study|Withdrawal by Subject|5
5649870|NCT00563368|19511482|P5|Overall Study|Withdrawal by Subject|8
5649871|NCT00563368|19511483|P4|Overall Study|Withdrawal by Subject|7
5649872|NCT00563368|19511484|P3|Overall Study|Withdrawal by Subject|5
5649873|NCT00563368|19511485|P2|Overall Study|Withdrawal by Subject|6
5649874|NCT00563368|19511486|P1|Overall Study|Withdrawal by Subject|11
5649875|NCT00563368|19511480|P7|Overall Study|Adverse Event|17
5649876|NCT00563368|19511481|P6|Overall Study|Adverse Event|10
5649877|NCT00563368|19511482|P5|Overall Study|Adverse Event|6
5649878|NCT00563368|19511483|P4|Overall Study|Adverse Event|9
5649879|NCT00563368|19511484|P3|Overall Study|Adverse Event|5
5649880|NCT00563368|19511485|P2|Overall Study|Adverse Event|4
5649881|NCT00563368|19511486|P1|Overall Study|Adverse Event|3
5649882|NCT00563368|19511480|P7|Overall Study|Lost to Follow-up|9
5649883|NCT00563368|19511481|P6|Overall Study|Lost to Follow-up|8
5649884|NCT00563368|19511482|P5|Overall Study|Lost to Follow-up|9
5649885|NCT00563368|19511483|P4|Overall Study|Lost to Follow-up|6
5649886|NCT00563368|19511484|P3|Overall Study|Lost to Follow-up|12
5649887|NCT00563368|19511485|P2|Overall Study|Lost to Follow-up|14
5649888|NCT00563368|19511486|P1|Overall Study|Lost to Follow-up|14
5649889|NCT00563316|19511509|P1|Overall Study|Other|1
5649890|NCT00563316|19511509|P1|Overall Study|On-going in study as of 16 July 2009.|5
5649891|NCT00563316|19511509|P1|Overall Study|Death|1
5649892|NCT00563316|19511509|P1|Overall Study|Lost to Follow-up|2
5649893|NCT00563316|19511509|P1|Overall Study|Physician Decision|1
5649894|NCT00563316|19511509|P1|Overall Study|Adverse Event|2
5649895|NCT00563186|19511534|P2|Overall Study|Incomplete data|1
5649896|NCT00563186|19511535|P1|Overall Study|Incomplete data|1
5649897|NCT00563186|19511534|P2|Overall Study|LOS<48 hours|74
5649898|NCT00563186|19511535|P1|Overall Study|LOS<48 hours|97
5649899|NCT00562965|19511546|P2|Overall Study|Other|1
5649900|NCT00562965|19511547|P1|Overall Study|Other|0
5649901|NCT00562965|19511546|P2|Overall Study|Lost to Follow-up|0
5649902|NCT00562965|19511547|P1|Overall Study|Lost to Follow-up|1
5649903|NCT00562965|19511546|P2|Overall Study|Death|4
5649904|NCT00562965|19511547|P1|Overall Study|Death|2
5649905|NCT00562965|19511546|P2|Overall Study|Withdrawal by Subject|1
5649906|NCT00562965|19511547|P1|Overall Study|Withdrawal by Subject|0
5649907|NCT00562861|19511568|P2|Overall Study|Lost to Follow-up|3
5649908|NCT00562861|19511569|P1|Overall Study|Lost to Follow-up|7
5649909|NCT00562861|19511568|P2|Overall Study|noncompliance, moved|2
5649910|NCT00562861|19511569|P1|Overall Study|noncompliance, moved|7
5649911|NCT00562861|19511568|P2|Overall Study|Lack of Efficacy|5
5649912|NCT00562861|19511569|P1|Overall Study|Lack of Efficacy|5
5649913|NCT00562861|19511568|P2|Overall Study|Adverse Event|1
5649914|NCT00562861|19511569|P1|Overall Study|Adverse Event|1
5649915|NCT00562718|19511575|P1|Overall Study|not stated|1
5649916|NCT00562718|19511575|P1|Overall Study|Lack of Efficacy|2
5649917|NCT00562718|19511575|P1|Overall Study|Adverse Event|4
5649918|NCT00562718|19511575|P1|Overall Study|Withdrawal by Subject|3
5649919|NCT00562718|19511575|P1|Overall Study|Death|1
5649920|NCT00562627|19511584|P3|Overall Study|Protocol Violation|1
5649921|NCT00562627|19511585|P2|Overall Study|Protocol Violation|1
5649922|NCT00562627|19511586|P1|Overall Study|Protocol Violation|1
5649923|NCT00562588|19511602|P2|Overall Study|Other|2
5649924|NCT00562588|19511603|P1|Overall Study|Other|0
5649925|NCT00562588|19511602|P2|Overall Study|Withdrawal by Subject|9
5649926|NCT00562588|19511603|P1|Overall Study|Withdrawal by Subject|10
5649927|NCT00562588|19511602|P2|Overall Study|Lost to Follow-up|4
5649928|NCT00562588|19511603|P1|Overall Study|Lost to Follow-up|12
5649929|NCT00562588|19511602|P2|Overall Study|Protocol Violation|26
5649930|NCT00562588|19511603|P1|Overall Study|Protocol Violation|30
5649931|NCT00562588|19511602|P2|Overall Study|Adverse Event|58
5649932|NCT00562588|19511603|P1|Overall Study|Adverse Event|40
5649933|NCT00562484|19511633|P2|Overall Study|Reason not provided or not specified|12
5649934|NCT00562484|19511634|P1|Overall Study|Reason not provided or not specified|25
5649935|NCT00562484|19511633|P2|Overall Study|Lost to Follow-up|71
5649936|NCT00562484|19511634|P1|Overall Study|Lost to Follow-up|132
5649937|NCT00562484|19511633|P2|Overall Study|Moved away from the study area|9
5649938|NCT00562484|19511634|P1|Overall Study|Moved away from the study area|20
5649939|NCT00562484|19511633|P2|Overall Study|Withdrawal by Subject|9
5649940|NCT00562484|19511634|P1|Overall Study|Withdrawal by Subject|12
5649941|NCT00562484|19511633|P2|Overall Study|Protocol Violation|2
5649942|NCT00562484|19511634|P1|Overall Study|Protocol Violation|11
5649943|NCT00562484|19511633|P2|Overall Study|Adverse Event|1
5649944|NCT00562484|19511634|P1|Overall Study|Adverse Event|6
5649945|NCT00562354|19511666|P2|Overall Study|Lost to Follow-up|1
5649946|NCT00562354|19511667|P1|Overall Study|Lost to Follow-up|0
5649947|NCT00562354|19511666|P2|Overall Study|Physician Decision|1
5649948|NCT00562354|19511667|P1|Overall Study|Physician Decision|0
5649949|NCT00562302|19511733|P2|Overall Study|Not stated|4
5649950|NCT00562302|19511734|P1|Overall Study|Not stated|1
5649951|NCT00562302|19511733|P2|Overall Study|Lung resection prior to study completion|7
5649952|NCT00562302|19511734|P1|Overall Study|Lung resection prior to study completion|7
5649953|NCT00562302|19511733|P2|Overall Study|Death|2
5649954|NCT00562302|19511734|P1|Overall Study|Death|1
5649955|NCT00562302|19511733|P2|Overall Study|Withdrawal by Subject|8
5649956|NCT00562302|19511734|P1|Overall Study|Withdrawal by Subject|7
5649957|NCT00562302|19511733|P2|Overall Study|Non-compliance|2
5649958|NCT00562302|19511734|P1|Overall Study|Non-compliance|1
5649959|NCT00562302|19511733|P2|Overall Study|Adverse Event|6
5649960|NCT00562302|19511734|P1|Overall Study|Adverse Event|0
5649961|NCT00562302|19511733|P2|Overall Study|Lost to Follow-up|3
5649962|NCT00562302|19511734|P1|Overall Study|Lost to Follow-up|3
5649963|NCT00562159|19511756|P2|Overall Study|Did not meet protocol eligibility|1
5649964|NCT00562159|19511757|P1|Overall Study|Did not meet protocol eligibility|1
5649965|NCT00562159|19511756|P2|Overall Study|Protocol Violation|12
5649966|NCT00562159|19511757|P1|Overall Study|Protocol Violation|12
5649967|NCT00562159|19511756|P2|Overall Study|Withdrawal by Subject|8
5649968|NCT00562159|19511757|P1|Overall Study|Withdrawal by Subject|9
5649969|NCT00562159|19511756|P2|Overall Study|Lost to Follow-up|4
5649970|NCT00562159|19511757|P1|Overall Study|Lost to Follow-up|5
5649971|NCT00562159|19511756|P2|Overall Study|Adverse Event|8
5649972|NCT00562159|19511757|P1|Overall Study|Adverse Event|11
5649973|NCT00562120|19511769|P4|First Intervention Period|Randomized but not Treated|0
5649974|NCT00562120|19511770|P3|First Intervention Period|Randomized but not Treated|0
5649975|NCT00562120|19511771|P2|First Intervention Period|Randomized but not Treated|0
5649976|NCT00562120|19511772|P1|First Intervention Period|Randomized but not Treated|1
5649977|NCT00562120|19511769|P4|First Intervention Period|Adverse Event|0
5649978|NCT00562120|19511770|P3|First Intervention Period|Adverse Event|0
5649979|NCT00562120|19511771|P2|First Intervention Period|Adverse Event|0
5649980|NCT00562120|19511772|P1|First Intervention Period|Adverse Event|1
5649981|NCT00562094|19511804|P1|Overall Study|Lost to Follow-up|62
5649982|NCT00561977|19511819|P3|Overall Study|Pregnancy|1
5649983|NCT00561977|19511820|P2|Overall Study|Pregnancy|1
5649984|NCT00561977|19511821|P1|Overall Study|Pregnancy|0
5649985|NCT00561977|19511819|P3|Overall Study|Withdrawal by Subject|1
5649986|NCT00561977|19511820|P2|Overall Study|Withdrawal by Subject|2
5649987|NCT00561977|19511821|P1|Overall Study|Withdrawal by Subject|0
5649988|NCT00561951|19511847|P3|Overall Study|Adverse Event Occured Before Treatment|1
5649989|NCT00561951|19511848|P2|Overall Study|Adverse Event Occured Before Treatment|2
5649990|NCT00561951|19511849|P1|Overall Study|Adverse Event Occured Before Treatment|1
5649991|NCT00561951|19511847|P3|Overall Study|Meet Withdrawal Criterion|1
5649992|NCT00561951|19511848|P2|Overall Study|Meet Withdrawal Criterion|1
5649993|NCT00561951|19511849|P1|Overall Study|Meet Withdrawal Criterion|0
5649994|NCT00561951|19511847|P3|Overall Study|Pregnancy|0
5649995|NCT00561951|19511848|P2|Overall Study|Pregnancy|1
5649996|NCT00561951|19511849|P1|Overall Study|Pregnancy|0
5649997|NCT00561951|19511847|P3|Overall Study|Physician Decision|0
5649998|NCT00561951|19511848|P2|Overall Study|Physician Decision|0
5649999|NCT00561951|19511849|P1|Overall Study|Physician Decision|1
5650000|NCT00561951|19511847|P3|Overall Study|Protocol Violation|4
5650001|NCT00561951|19511848|P2|Overall Study|Protocol Violation|3
5650002|NCT00561951|19511849|P1|Overall Study|Protocol Violation|4
5650003|NCT00561951|19511847|P3|Overall Study|Withdrawal by Subject|10
5650004|NCT00561951|19511848|P2|Overall Study|Withdrawal by Subject|9
5650005|NCT00561951|19511849|P1|Overall Study|Withdrawal by Subject|10
5650006|NCT00561951|19511847|P3|Overall Study|Lost to Follow-up|0
5650007|NCT00561951|19511848|P2|Overall Study|Lost to Follow-up|1
5650008|NCT00561951|19511849|P1|Overall Study|Lost to Follow-up|1
5650009|NCT00561951|19511847|P3|Overall Study|Lack of Efficacy|2
5650010|NCT00561951|19511848|P2|Overall Study|Lack of Efficacy|3
5650011|NCT00561951|19511849|P1|Overall Study|Lack of Efficacy|5
5650012|NCT00561951|19511847|P3|Overall Study|Adverse Event|14
5650013|NCT00561951|19511848|P2|Overall Study|Adverse Event|14
5650014|NCT00561951|19511849|P1|Overall Study|Adverse Event|11
5650015|NCT00561925|19511905|P5|Open-Label Extension Period|Declined entry into extension period|50
5650016|NCT00561925|19511906|P4|Open-Label Extension Period|Declined entry into extension period|43
5650017|NCT00561925|19511907|P3|Open-Label Extension Period|Declined entry into extension period|0
5650018|NCT00561925|19511908|P2|Open-Label Extension Period|Declined entry into extension period|0
5650019|NCT00561925|19511909|P1|Open-Label Extension Period|Declined entry into extension period|0
5650020|NCT00561925|19511905|P5|144-week Double-blind, Double-dummy|Other|0
5650021|NCT00561925|19511906|P4|144-week Double-blind, Double-dummy|Other|0
5650022|NCT00561925|19511907|P3|144-week Double-blind, Double-dummy|Other|11
5650023|NCT00561925|19511908|P2|144-week Double-blind, Double-dummy|Other|8
5650024|NCT00561925|19511909|P1|144-week Double-blind, Double-dummy|Other|0
5650025|NCT00561925|19511905|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
5650026|NCT00561925|19511906|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
5650027|NCT00561925|19511907|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
5650028|NCT00561925|19511908|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
5650029|NCT00561925|19511909|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
5650030|NCT00561925|19511905|P5|144-week Double-blind, Double-dummy|Death|0
5650031|NCT00561925|19511906|P4|144-week Double-blind, Double-dummy|Death|0
5650032|NCT00561925|19511907|P3|144-week Double-blind, Double-dummy|Death|3
5650033|NCT00561925|19511908|P2|144-week Double-blind, Double-dummy|Death|6
5650034|NCT00561925|19511909|P1|144-week Double-blind, Double-dummy|Death|0
5650035|NCT00561925|19511905|P5|144-week Double-blind, Double-dummy|Pregnancy|0
5650036|NCT00561925|19511906|P4|144-week Double-blind, Double-dummy|Pregnancy|0
5650037|NCT00561925|19511907|P3|144-week Double-blind, Double-dummy|Pregnancy|9
5650038|NCT00561925|19511908|P2|144-week Double-blind, Double-dummy|Pregnancy|1
5650039|NCT00561925|19511909|P1|144-week Double-blind, Double-dummy|Pregnancy|0
5650040|NCT00561925|19511905|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
5650041|NCT00561925|19511906|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
5650042|NCT00561925|19511907|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
5650043|NCT00561925|19511908|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
5650044|NCT00561925|19511909|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
5650045|NCT00561925|19511905|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
5650046|NCT00561925|19511906|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
5650047|NCT00561925|19511907|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
5650048|NCT00561925|19511908|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
5650049|NCT00561925|19511909|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
5650050|NCT00561925|19511905|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
5650051|NCT00561925|19511906|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
5650052|NCT00561925|19511907|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
5650053|NCT00561925|19511908|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
5650054|NCT00561925|19511909|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
5650055|NCT00561925|19511905|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
5650056|NCT00561925|19511906|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
5650057|NCT00561925|19511907|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
5650058|NCT00561925|19511908|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
5650059|NCT00561925|19511909|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
5650060|NCT00561925|19511905|P5|144-week Double-blind, Double-dummy|Adverse Event|0
5650061|NCT00561925|19511906|P4|144-week Double-blind, Double-dummy|Adverse Event|0
5650062|NCT00561925|19511907|P3|144-week Double-blind, Double-dummy|Adverse Event|43
5650063|NCT00561925|19511908|P2|144-week Double-blind, Double-dummy|Adverse Event|48
5650064|NCT00561925|19511909|P1|144-week Double-blind, Double-dummy|Adverse Event|0
5650065|NCT00561925|19511905|P5|14 Day Lead-In Period|Other|0
5650066|NCT00561925|19511906|P4|14 Day Lead-In Period|Other|0
5650067|NCT00561925|19511907|P3|14 Day Lead-In Period|Other|0
5650068|NCT00561925|19511908|P2|14 Day Lead-In Period|Other|0
5650069|NCT00561925|19511909|P1|14 Day Lead-In Period|Other|5
5650070|NCT00561925|19511905|P5|14 Day Lead-In Period|Withdrawal by Subject|0
5650071|NCT00561925|19511906|P4|14 Day Lead-In Period|Withdrawal by Subject|0
5650072|NCT00561925|19511907|P3|14 Day Lead-In Period|Withdrawal by Subject|0
5650073|NCT00561925|19511908|P2|14 Day Lead-In Period|Withdrawal by Subject|0
5650074|NCT00561925|19511909|P1|14 Day Lead-In Period|Withdrawal by Subject|4
5650075|NCT00561925|19511905|P5|14 Day Lead-In Period|Lost to Follow-up|0
5650076|NCT00561925|19511906|P4|14 Day Lead-In Period|Lost to Follow-up|0
5650077|NCT00561925|19511907|P3|14 Day Lead-In Period|Lost to Follow-up|0
5650078|NCT00561925|19511908|P2|14 Day Lead-In Period|Lost to Follow-up|0
5650079|NCT00561925|19511909|P1|14 Day Lead-In Period|Lost to Follow-up|4
5650080|NCT00561925|19511905|P5|14 Day Lead-In Period|In/Exclusion criteria|0
5650081|NCT00561925|19511906|P4|14 Day Lead-In Period|In/Exclusion criteria|0
5650082|NCT00561925|19511907|P3|14 Day Lead-In Period|In/Exclusion criteria|0
5650083|NCT00561925|19511908|P2|14 Day Lead-In Period|In/Exclusion criteria|0
5650084|NCT00561925|19511909|P1|14 Day Lead-In Period|In/Exclusion criteria|4
5650085|NCT00561925|19511905|P5|14 Day Lead-In Period|Adverse Event|0
5650086|NCT00561925|19511906|P4|14 Day Lead-In Period|Adverse Event|0
5650087|NCT00561925|19511907|P3|14 Day Lead-In Period|Adverse Event|0
5650088|NCT00561925|19511908|P2|14 Day Lead-In Period|Adverse Event|0
5650089|NCT00561925|19511909|P1|14 Day Lead-In Period|Adverse Event|38
5650090|NCT00561912|19511958|P1|Overall Study|ineligible|1
5650091|NCT00561821|19511970|P4|Overall Study|Adverse Event|1
5650092|NCT00561821|19511971|P3|Overall Study|Adverse Event|1
5650093|NCT00561821|19511972|P2|Overall Study|Adverse Event|3
5650094|NCT00561821|19511973|P1|Overall Study|Adverse Event|2
5650095|NCT00561821|19511970|P4|Overall Study|Other (reason not specified)|0
5650096|NCT00561821|19511971|P3|Overall Study|Other (reason not specified)|0
5650097|NCT00561821|19511972|P2|Overall Study|Other (reason not specified)|1
5650098|NCT00561821|19511973|P1|Overall Study|Other (reason not specified)|1
5650099|NCT00561821|19511970|P4|Overall Study|Reasons not related to trial|0
5650100|NCT00561821|19511971|P3|Overall Study|Reasons not related to trial|0
5650101|NCT00561821|19511972|P2|Overall Study|Reasons not related to trial|1
5650102|NCT00561821|19511973|P1|Overall Study|Reasons not related to trial|2
5650103|NCT00561821|19511970|P4|Overall Study|Withdrawal by Subject|2
5650104|NCT00561821|19511971|P3|Overall Study|Withdrawal by Subject|0
5650105|NCT00561821|19511972|P2|Overall Study|Withdrawal by Subject|1
5650106|NCT00561821|19511973|P1|Overall Study|Withdrawal by Subject|0
5650107|NCT00561821|19511970|P4|Overall Study|Not treated|0
5650108|NCT00561821|19511971|P3|Overall Study|Not treated|1
5650109|NCT00561821|19511972|P2|Overall Study|Not treated|0
5650110|NCT00561821|19511973|P1|Overall Study|Not treated|0
5650111|NCT00561795|19512049|P4|Overall Study|Physician Decision|0
5650112|NCT00561795|19512050|P3|Overall Study|Physician Decision|0
5650113|NCT00561795|19512051|P2|Overall Study|Physician Decision|0
5650114|NCT00561795|19512052|P1|Overall Study|Physician Decision|1
5650115|NCT00561795|19512049|P4|Overall Study|Study Closed/Terminated|0
5650116|NCT00561795|19512050|P3|Overall Study|Study Closed/Terminated|0
5650117|NCT00561795|19512051|P2|Overall Study|Study Closed/Terminated|3
5650118|NCT00561795|19512052|P1|Overall Study|Study Closed/Terminated|0
5650119|NCT00561795|19512049|P4|Overall Study|Adverse Event|0
5650120|NCT00561795|19512050|P3|Overall Study|Adverse Event|0
5650121|NCT00561795|19512051|P2|Overall Study|Adverse Event|3
5650122|NCT00561795|19512052|P1|Overall Study|Adverse Event|3
5650123|NCT00561730|19512072|P1|Overall Study|Not specified reasons|1
5650124|NCT00561730|19512072|P1|Overall Study|Lost to Follow-up|5
5650125|NCT00561730|19512072|P1|Overall Study|Handling of the drug|1
5650126|NCT00561730|19512072|P1|Overall Study|Adverse Event|2
5650127|NCT00561678|19512088|P2|Overall Study|anesthesia provider refusal|0
5650128|NCT00561678|19512089|P1|Overall Study|anesthesia provider refusal|1
5650129|NCT00561678|19512088|P2|Overall Study|surgery rescheduled to different site|2
5650130|NCT00561678|19512089|P1|Overall Study|surgery rescheduled to different site|2
5650131|NCT00561678|19512088|P2|Overall Study|surgery cancelled|1
5650132|NCT00561678|19512089|P1|Overall Study|surgery cancelled|1
5650133|NCT00561678|19512088|P2|Overall Study|Withdrawal by Subject|3
5650134|NCT00561678|19512089|P1|Overall Study|Withdrawal by Subject|4
5650135|NCT00561652|19512107|P2|Overall Study|Withdrawal by Subject|1
5650136|NCT00561652|19512108|P1|Overall Study|Withdrawal by Subject|0
5650137|NCT00561574|19512191|P2|Overall Study|Other|7
5650138|NCT00561574|19512192|P1|Overall Study|Other|5
5650139|NCT00561574|19512191|P2|Overall Study|Lost to Follow-up|0
5650140|NCT00561574|19512192|P1|Overall Study|Lost to Follow-up|1
5650141|NCT00561574|19512191|P2|Overall Study|Reason Unrelated to Trial|2
5650142|NCT00561574|19512192|P1|Overall Study|Reason Unrelated to Trial|6
5650143|NCT00561574|19512191|P2|Overall Study|Withdrawal by Subject|4
5650144|NCT00561574|19512192|P1|Overall Study|Withdrawal by Subject|4
5650145|NCT00561574|19512191|P2|Overall Study|Lack of Efficacy|21
5650146|NCT00561574|19512192|P1|Overall Study|Lack of Efficacy|11
5650147|NCT00561574|19512191|P2|Overall Study|Adverse Event|24
5650148|NCT00561574|19512192|P1|Overall Study|Adverse Event|21
5650149|NCT00561470|19512218|P2|Overall Study|Ongoing Treatment|14
5650150|NCT00561470|19512219|P1|Overall Study|Ongoing Treatment|11
5650151|NCT00561470|19512218|P2|Overall Study|Planning surgery|1
5650152|NCT00561470|19512219|P1|Overall Study|Planning surgery|1
5650153|NCT00561470|19512218|P2|Overall Study|Missed visit window|4
5650154|NCT00561470|19512219|P1|Overall Study|Missed visit window|1
5650155|NCT00561470|19512218|P2|Overall Study|Randomized but not treated|5
5650156|NCT00561470|19512219|P1|Overall Study|Randomized but not treated|5
5650157|NCT00561470|19512218|P2|Overall Study|Unauthorized procedure|1
5650158|NCT00561470|19512219|P1|Overall Study|Unauthorized procedure|3
5650159|NCT00561470|19512218|P2|Overall Study|Metastatic surgery|12
5650160|NCT00561470|19512219|P1|Overall Study|Metastatic surgery|10
5650161|NCT00561470|19512218|P2|Overall Study|Subject request|77
5650162|NCT00561470|19512219|P1|Overall Study|Subject request|43
5650163|NCT00561470|19512218|P2|Overall Study|Consent Withdrawn|6
5650164|NCT00561470|19512219|P1|Overall Study|Consent Withdrawn|2
5650165|NCT00561470|19512218|P2|Overall Study|Physician Decision|20
5650166|NCT00561470|19512219|P1|Overall Study|Physician Decision|21
5650167|NCT00561470|19512218|P2|Overall Study|Lost to Follow-up|0
5650168|NCT00561470|19512219|P1|Overall Study|Lost to Follow-up|2
5650169|NCT00561470|19512218|P2|Overall Study|poor compliance to protocol|4
5650170|NCT00561470|19512219|P1|Overall Study|poor compliance to protocol|4
5650171|NCT00561470|19512218|P2|Overall Study|Disease progression|305
5650172|NCT00561470|19512219|P1|Overall Study|Disease progression|437
5650173|NCT00561470|19512218|P2|Overall Study|Adverse Event|163
5650174|NCT00561470|19512219|P1|Overall Study|Adverse Event|74
5650175|NCT00561392|19512255|P1|Overall Study|Administrative problems|4
5650176|NCT00561392|19512255|P1|Overall Study|Withdrawal by Subject|8
5650177|NCT00561392|19512255|P1|Overall Study|Protocol Violation|1
5650178|NCT00561392|19512255|P1|Overall Study|Lack of Efficacy|2
5650179|NCT00561392|19512255|P1|Overall Study|Adverse Event|38
5650180|NCT00561353|19512277|P10|Overall Study|Withdrawal by Subject|0
5650181|NCT00561353|19512278|P9|Overall Study|Withdrawal by Subject|0
5650182|NCT00561353|19512279|P8|Overall Study|Withdrawal by Subject|0
5650183|NCT00561353|19512280|P7|Overall Study|Withdrawal by Subject|0
5650184|NCT00561353|19512281|P6|Overall Study|Withdrawal by Subject|0
5650185|NCT00561353|19512282|P5|Overall Study|Withdrawal by Subject|0
5650186|NCT00561353|19512283|P4|Overall Study|Withdrawal by Subject|0
5650187|NCT00561353|19512284|P3|Overall Study|Withdrawal by Subject|0
5650188|NCT00561353|19512285|P2|Overall Study|Withdrawal by Subject|2
5650189|NCT00561353|19512286|P1|Overall Study|Withdrawal by Subject|0
5650190|NCT00561353|19512277|P10|Overall Study|Lost to Follow-up|0
5650191|NCT00561353|19512278|P9|Overall Study|Lost to Follow-up|0
5650192|NCT00561353|19512279|P8|Overall Study|Lost to Follow-up|0
5650193|NCT00561353|19512280|P7|Overall Study|Lost to Follow-up|0
5650194|NCT00561353|19512281|P6|Overall Study|Lost to Follow-up|0
5650195|NCT00561353|19512282|P5|Overall Study|Lost to Follow-up|0
5650196|NCT00561353|19512283|P4|Overall Study|Lost to Follow-up|0
5650197|NCT00561353|19512284|P3|Overall Study|Lost to Follow-up|1
5650198|NCT00561353|19512285|P2|Overall Study|Lost to Follow-up|0
5650199|NCT00561353|19512286|P1|Overall Study|Lost to Follow-up|2
5650200|NCT00561353|19512277|P10|Overall Study|Adverse Event|1
5650201|NCT00561353|19512278|P9|Overall Study|Adverse Event|0
5650202|NCT00561353|19512279|P8|Overall Study|Adverse Event|0
5650203|NCT00561353|19512280|P7|Overall Study|Adverse Event|1
5650204|NCT00561353|19512281|P6|Overall Study|Adverse Event|0
5650205|NCT00561353|19512282|P5|Overall Study|Adverse Event|0
5650206|NCT00561353|19512283|P4|Overall Study|Adverse Event|2
5650207|NCT00561353|19512284|P3|Overall Study|Adverse Event|0
5650208|NCT00561353|19512285|P2|Overall Study|Adverse Event|0
5650209|NCT00561353|19512286|P1|Overall Study|Adverse Event|0
5650210|NCT00561353|19512277|P10|Overall Study|Other|0
5650211|NCT00561353|19512278|P9|Overall Study|Other|0
5650212|NCT00561353|19512279|P8|Overall Study|Other|0
5650213|NCT00561353|19512280|P7|Overall Study|Other|0
5650214|NCT00561353|19512281|P6|Overall Study|Other|2
5650215|NCT00561353|19512282|P5|Overall Study|Other|0
5650216|NCT00561353|19512283|P4|Overall Study|Other|0
5650217|NCT00561353|19512284|P3|Overall Study|Other|1
5650218|NCT00561353|19512285|P2|Overall Study|Other|0
5650219|NCT00561353|19512286|P1|Overall Study|Other|1
5650220|NCT00561353|19512277|P10|Overall Study|Subject ineligible to continue the trial|1
5650221|NCT00561353|19512278|P9|Overall Study|Subject ineligible to continue the trial|2
5650222|NCT00561353|19512279|P8|Overall Study|Subject ineligible to continue the trial|0
5650223|NCT00561353|19512280|P7|Overall Study|Subject ineligible to continue the trial|1
5650224|NCT00561353|19512281|P6|Overall Study|Subject ineligible to continue the trial|1
5650225|NCT00561353|19512282|P5|Overall Study|Subject ineligible to continue the trial|0
5650226|NCT00561353|19512283|P4|Overall Study|Subject ineligible to continue the trial|0
5650227|NCT00561353|19512284|P3|Overall Study|Subject ineligible to continue the trial|0
5650228|NCT00561353|19512285|P2|Overall Study|Subject ineligible to continue the trial|0
5650229|NCT00561353|19512286|P1|Overall Study|Subject ineligible to continue the trial|0
5650230|NCT00561353|19512277|P10|Overall Study|Subject reached a virologic endpoint|0
5650231|NCT00561353|19512278|P9|Overall Study|Subject reached a virologic endpoint|5
5650232|NCT00561353|19512279|P8|Overall Study|Subject reached a virologic endpoint|4
5650233|NCT00561353|19512280|P7|Overall Study|Subject reached a virologic endpoint|4
5650234|NCT00561353|19512281|P6|Overall Study|Subject reached a virologic endpoint|3
5650235|NCT00561353|19512282|P5|Overall Study|Subject reached a virologic endpoint|1
5650236|NCT00561353|19512283|P4|Overall Study|Subject reached a virologic endpoint|4
5650237|NCT00561353|19512284|P3|Overall Study|Subject reached a virologic endpoint|1
5650238|NCT00561353|19512285|P2|Overall Study|Subject reached a virologic endpoint|1
5650239|NCT00561353|19512286|P1|Overall Study|Subject reached a virologic endpoint|2
5650240|NCT00561340|19512441|P2|Overall Study|refused to drink pediasure|0
5650241|NCT00561340|19512442|P1|Overall Study|refused to drink pediasure|6
5650242|NCT00561080|19512462|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
5650243|NCT00561080|19512463|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
5650244|NCT00561080|19512464|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
5650245|NCT00561080|19512462|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
5650246|NCT00561080|19512463|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
5650247|NCT00561080|19512464|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
5650248|NCT00561080|19512462|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
5650249|NCT00561080|19512463|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
5650250|NCT00561080|19512464|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
5650251|NCT00561080|19512462|P3|12-month Post Last Dose Follow-up|Adverse Event|1
5650252|NCT00561080|19512463|P2|12-month Post Last Dose Follow-up|Adverse Event|3
5650253|NCT00561080|19512464|P1|12-month Post Last Dose Follow-up|Adverse Event|3
5650254|NCT00561080|19512462|P3|Vaccination Period (up to Month 4)|Other|1
5650255|NCT00561080|19512463|P2|Vaccination Period (up to Month 4)|Other|2
5650256|NCT00561080|19512464|P1|Vaccination Period (up to Month 4)|Other|0
5650257|NCT00561080|19512462|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
5650258|NCT00561080|19512463|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
5650259|NCT00561080|19512464|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
5650260|NCT00561080|19512462|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
5650261|NCT00561080|19512463|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
5650262|NCT00561080|19512464|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
5650263|NCT00561080|19512462|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
5650264|NCT00561080|19512463|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
5650265|NCT00561080|19512464|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
5650266|NCT00561080|19512462|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
5650267|NCT00561080|19512463|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
5650268|NCT00561080|19512464|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
5650269|NCT00561080|19512462|P3|Vaccination Period (up to Month 4)|Adverse Event|6
5650270|NCT00561080|19512463|P2|Vaccination Period (up to Month 4)|Adverse Event|4
5650271|NCT00561080|19512464|P1|Vaccination Period (up to Month 4)|Adverse Event|0
5650272|NCT00561015|19512541|P6|Overall Study|Participant non-compliance|0
5650273|NCT00561015|19512542|P5|Overall Study|Participant non-compliance|0
5650274|NCT00561015|19512543|P4|Overall Study|Participant non-compliance|0
5650275|NCT00561015|19512544|P3|Overall Study|Participant non-compliance|0
5650276|NCT00561015|19512545|P2|Overall Study|Participant non-compliance|0
5650277|NCT00561015|19512546|P1|Overall Study|Participant non-compliance|2
5650278|NCT00561015|19512541|P6|Overall Study|Lost to Follow-up|3
5650279|NCT00561015|19512542|P5|Overall Study|Lost to Follow-up|0
5650280|NCT00561015|19512543|P4|Overall Study|Lost to Follow-up|1
5650281|NCT00561015|19512544|P3|Overall Study|Lost to Follow-up|0
5650282|NCT00561015|19512545|P2|Overall Study|Lost to Follow-up|0
5650283|NCT00561015|19512546|P1|Overall Study|Lost to Follow-up|2
5650284|NCT00561015|19512541|P6|Overall Study|Adverse Event|0
5650285|NCT00561015|19512542|P5|Overall Study|Adverse Event|1
5650286|NCT00561015|19512543|P4|Overall Study|Adverse Event|0
5650287|NCT00561015|19512544|P3|Overall Study|Adverse Event|0
5650288|NCT00561015|19512545|P2|Overall Study|Adverse Event|0
5650289|NCT00561015|19512546|P1|Overall Study|Adverse Event|0
5650290|NCT00560950|19512637|P2|Overall Study|Lost to Follow-up|0
5650291|NCT00560950|19512638|P1|Overall Study|Lost to Follow-up|1
5650292|NCT00560937|19512676|P2|Overall Study|Physician Decision|1
5650293|NCT00560937|19512677|P1|Overall Study|Physician Decision|1
5650294|NCT00560937|19512676|P2|Overall Study|Withdrawal by Subject|1
5650295|NCT00560937|19512677|P1|Overall Study|Withdrawal by Subject|0
5650296|NCT00560885|19512693|P1|Overall Study|Withdrawal by Subject|1
5650297|NCT00560885|19512693|P1|Overall Study|Death|7
5650298|NCT00560833|19512718|P5|Overall Study|Never received drug|1
5650299|NCT00560833|19512719|P4|Overall Study|Never received drug|0
5650300|NCT00560833|19512720|P3|Overall Study|Never received drug|0
5650301|NCT00560833|19512721|P2|Overall Study|Never received drug|1
5650302|NCT00560833|19512722|P1|Overall Study|Never received drug|0
5650303|NCT00560833|19512718|P5|Overall Study|Other|0
5650304|NCT00560833|19512719|P4|Overall Study|Other|0
5650305|NCT00560833|19512720|P3|Overall Study|Other|3
5650306|NCT00560833|19512721|P2|Overall Study|Other|1
5650307|NCT00560833|19512722|P1|Overall Study|Other|1
5650308|NCT00560833|19512718|P5|Overall Study|Participant uncooperative|2
5650309|NCT00560833|19512719|P4|Overall Study|Participant uncooperative|4
5650310|NCT00560833|19512720|P3|Overall Study|Participant uncooperative|4
5650311|NCT00560833|19512721|P2|Overall Study|Participant uncooperative|5
5650312|NCT00560833|19512722|P1|Overall Study|Participant uncooperative|5
5650313|NCT00560833|19512718|P5|Overall Study|Lack of Efficacy|4
5650314|NCT00560833|19512719|P4|Overall Study|Lack of Efficacy|4
5650315|NCT00560833|19512720|P3|Overall Study|Lack of Efficacy|6
5650316|NCT00560833|19512721|P2|Overall Study|Lack of Efficacy|9
5650317|NCT00560833|19512722|P1|Overall Study|Lack of Efficacy|22
5650318|NCT00560833|19512718|P5|Overall Study|Lost to Follow-up|0
5650319|NCT00560833|19512719|P4|Overall Study|Lost to Follow-up|0
5650320|NCT00560833|19512720|P3|Overall Study|Lost to Follow-up|1
5650321|NCT00560833|19512721|P2|Overall Study|Lost to Follow-up|0
5650322|NCT00560833|19512722|P1|Overall Study|Lost to Follow-up|0
5650323|NCT00560833|19512718|P5|Overall Study|Adverse Event|35
5650324|NCT00560833|19512719|P4|Overall Study|Adverse Event|23
5650325|NCT00560833|19512720|P3|Overall Study|Adverse Event|25
5650326|NCT00560833|19512721|P2|Overall Study|Adverse Event|10
5650327|NCT00560833|19512722|P1|Overall Study|Adverse Event|16
5650328|NCT00560794|19512754|P1|Overall Study|Received Bone Marrow Transplant|6
5650329|NCT00560794|19512754|P1|Overall Study|Hematological Relapse|1
5650330|NCT00560794|19512754|P1|Overall Study|Minimal Residual Disease Relapse|1
5650331|NCT00560794|19512754|P1|Overall Study|Patient was not Compliant|1
5650332|NCT00560794|19512754|P1|Overall Study|Adverse Event|2
5650333|NCT00560755|19512771|P1|Overall Study|Physician Decision|2
5650334|NCT00560755|19512771|P1|Overall Study|Adverse Event|8
5650335|NCT00560755|19512771|P1|Overall Study|Lost to Follow-up|9
5650336|NCT00560755|19512771|P1|Overall Study|Withdrawal by Subject|26
5650337|NCT00560755|19512771|P1|Overall Study|Protocol Violation|15
5650338|NCT00560703|19512792|P2|Overall Study|non-compliance|1
5650339|NCT00560703|19512793|P1|Overall Study|non-compliance|0
5650340|NCT00560703|19512792|P2|Overall Study|Withdrawal by Subject|1
5650341|NCT00560703|19512793|P1|Overall Study|Withdrawal by Subject|0
5650342|NCT00560703|19512792|P2|Overall Study|Protocol Violation|2
5650343|NCT00560703|19512793|P1|Overall Study|Protocol Violation|0
5650344|NCT00560703|19512792|P2|Overall Study|Adverse Event|2
5650345|NCT00560703|19512793|P1|Overall Study|Adverse Event|0
5650346|NCT00560573|19512816|P6|Overall Study|Enrolled, not treated|0
5650347|NCT00560573|19512817|P5|Overall Study|Enrolled, not treated|1
5650348|NCT00560573|19512818|P4|Overall Study|Enrolled, not treated|0
5650349|NCT00560573|19512819|P3|Overall Study|Enrolled, not treated|0
5650350|NCT00560573|19512820|P2|Overall Study|Enrolled, not treated|0
5650351|NCT00560573|19512821|P1|Overall Study|Enrolled, not treated|0
5650352|NCT00560573|19512816|P6|Overall Study|Other|3
5650353|NCT00560573|19512817|P5|Overall Study|Other|3
5650354|NCT00560573|19512818|P4|Overall Study|Other|3
5650355|NCT00560573|19512819|P3|Overall Study|Other|2
5650356|NCT00560573|19512820|P2|Overall Study|Other|2
5650357|NCT00560573|19512821|P1|Overall Study|Other|2
5650358|NCT00560573|19512816|P6|Overall Study|Withdrawal by Subject|0
5650359|NCT00560573|19512817|P5|Overall Study|Withdrawal by Subject|1
5650360|NCT00560573|19512818|P4|Overall Study|Withdrawal by Subject|1
5650361|NCT00560573|19512819|P3|Overall Study|Withdrawal by Subject|0
5650362|NCT00560573|19512820|P2|Overall Study|Withdrawal by Subject|0
5650363|NCT00560573|19512821|P1|Overall Study|Withdrawal by Subject|0
5650364|NCT00560573|19512816|P6|Overall Study|Lost to Follow-up|0
5650365|NCT00560573|19512817|P5|Overall Study|Lost to Follow-up|1
5650366|NCT00560573|19512818|P4|Overall Study|Lost to Follow-up|1
5650367|NCT00560573|19512819|P3|Overall Study|Lost to Follow-up|0
5650368|NCT00560573|19512820|P2|Overall Study|Lost to Follow-up|0
5650369|NCT00560573|19512821|P1|Overall Study|Lost to Follow-up|0
5650370|NCT00560573|19512816|P6|Overall Study|Death|10
5650371|NCT00560573|19512817|P5|Overall Study|Death|1
5650372|NCT00560573|19512818|P4|Overall Study|Death|5
5650373|NCT00560573|19512819|P3|Overall Study|Death|4
5650374|NCT00560573|19512820|P2|Overall Study|Death|1
5650375|NCT00560573|19512821|P1|Overall Study|Death|4
5650376|NCT00560508|19512898|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
5650377|NCT00560508|19512899|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
5650378|NCT00560508|19512898|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
5650379|NCT00560508|19512899|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
5650380|NCT00560508|19512898|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
5650381|NCT00560508|19512899|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
5650382|NCT00560508|19512898|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
5650383|NCT00560508|19512899|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
5650384|NCT00560508|19512898|P2|12 Week Double-blind Period|Withdrawal by Subject|1
5650385|NCT00560508|19512899|P1|12 Week Double-blind Period|Withdrawal by Subject|1
5650386|NCT00560508|19512898|P2|12 Week Double-blind Period|Protocol Violation|0
5650387|NCT00560508|19512899|P1|12 Week Double-blind Period|Protocol Violation|1
5650388|NCT00560508|19512898|P2|12 Week Double-blind Period|Adverse Event|2
5650389|NCT00560508|19512899|P1|12 Week Double-blind Period|Adverse Event|3
5650390|NCT00560417|19512958|P2|Overall Study|Withdrawal by Subject|3
5650391|NCT00560417|19512959|P1|Overall Study|Withdrawal by Subject|3
5650392|NCT00560417|19512958|P2|Overall Study|Sponsor Decision|0
5650393|NCT00560417|19512959|P1|Overall Study|Sponsor Decision|2
5650394|NCT00560417|19512958|P2|Overall Study|Protocol Violation|5
5650395|NCT00560417|19512959|P1|Overall Study|Protocol Violation|6
5650396|NCT00560417|19512958|P2|Overall Study|Physician Decision|6
5650397|NCT00560417|19512959|P1|Overall Study|Physician Decision|2
5650398|NCT00560417|19512958|P2|Overall Study|Lost to Follow-up|1
5650399|NCT00560417|19512959|P1|Overall Study|Lost to Follow-up|0
5650400|NCT00560417|19512958|P2|Overall Study|Entry Criteria Not Met|0
5650401|NCT00560417|19512959|P1|Overall Study|Entry Criteria Not Met|1
5650402|NCT00560417|19512958|P2|Overall Study|Adverse Event|2
5650403|NCT00560417|19512959|P1|Overall Study|Adverse Event|3
5650404|NCT00560404|19512987|P2|Overall Study|Other withdrawal reason|5
5650405|NCT00560404|19512988|P1|Overall Study|Other withdrawal reason|13
5650406|NCT00560404|19512987|P2|Overall Study|Failure to return|2
5650407|NCT00560404|19512988|P1|Overall Study|Failure to return|1
5650408|NCT00560404|19512987|P2|Overall Study|Withdrew Consent|0
5650409|NCT00560404|19512988|P1|Overall Study|Withdrew Consent|4
5650410|NCT00560404|19512987|P2|Overall Study|Administrative Reasons|1
5650411|NCT00560404|19512988|P1|Overall Study|Administrative Reasons|1
5650412|NCT00560404|19512987|P2|Overall Study|Protocol Violation|7
5650413|NCT00560404|19512988|P1|Overall Study|Protocol Violation|12
5650414|NCT00560404|19512987|P2|Overall Study|Death|3
5650415|NCT00560404|19512988|P1|Overall Study|Death|3
5650416|NCT00560404|19512987|P2|Overall Study|Adverse Event|3
5650417|NCT00560404|19512988|P1|Overall Study|Adverse Event|2
5650418|NCT00560391|19513035|P5|Overall Study|Still on treatment|2
5650419|NCT00560391|19513036|P4|Overall Study|Still on treatment|1
5650420|NCT00560391|19513037|P3|Overall Study|Still on treatment|0
5650421|NCT00560391|19513038|P2|Overall Study|Still on treatment|0
5650422|NCT00560391|19513039|P1|Overall Study|Still on treatment|0
5650423|NCT00560352|19513095|P3|Overall Study|Maximum clinical benefit|0
5650424|NCT00560352|19513096|P2|Overall Study|Maximum clinical benefit|0
5650425|NCT00560352|19513097|P1|Overall Study|Maximum clinical benefit|1
5650426|NCT00560352|19513095|P3|Overall Study|Withdrawal by Subject|1
5650427|NCT00560352|19513096|P2|Overall Study|Withdrawal by Subject|1
5650428|NCT00560352|19513097|P1|Overall Study|Withdrawal by Subject|1
5650429|NCT00560352|19513095|P3|Overall Study|Disease progression|1
5650430|NCT00560352|19513096|P2|Overall Study|Disease progression|1
5650431|NCT00560352|19513097|P1|Overall Study|Disease progression|0
5650432|NCT00560352|19513095|P3|Overall Study|Study drug toxicity|1
5650433|NCT00560352|19513096|P2|Overall Study|Study drug toxicity|0
5650434|NCT00560352|19513097|P1|Overall Study|Study drug toxicity|3
5650435|NCT00560352|19513095|P3|Overall Study|Adverse event unrelated to study drug|1
5650436|NCT00560352|19513096|P2|Overall Study|Adverse event unrelated to study drug|1
5650437|NCT00560352|19513097|P1|Overall Study|Adverse event unrelated to study drug|2
5650438|NCT00560313|19513114|P1|Overall Study|Protocol Violation|1
5650439|NCT00560313|19513114|P1|Overall Study|Lost to Follow-up|1
5650440|NCT00560313|19513114|P1|Overall Study|Withdrawal by Subject|2
5650441|NCT00560313|19513114|P1|Overall Study|Adverse Events or Death|2
5650442|NCT00560235|19513141|P3|Phase 2|Ongoing at Date of Cut-Off|1
5650443|NCT00560235|19513142|P2|Phase 2|Ongoing at Date of Cut-Off|0
5650444|NCT00560235|19513143|P1|Phase 2|Ongoing at Date of Cut-Off|0
5650445|NCT00560235|19513141|P3|Phase 2|Discontinued|96
5650446|NCT00560235|19513142|P2|Phase 2|Discontinued|0
5650447|NCT00560235|19513143|P1|Phase 2|Discontinued|0
5650448|NCT00560235|19513141|P3|Phase 1B|Discontinued|0
5650449|NCT00560235|19513142|P2|Phase 1B|Discontinued|19
5650450|NCT00560235|19513143|P1|Phase 1B|Discontinued|0
5650451|NCT00560235|19513141|P3|Phase 1|Discontinued|0
5650452|NCT00560235|19513142|P2|Phase 1|Discontinued|0
5650453|NCT00560235|19513143|P1|Phase 1|Discontinued|8
5650454|NCT00560105|19513174|P2|Overall Study|musculoskeletal chest discomfort with us|2
5650455|NCT00560105|19513175|P1|Overall Study|musculoskeletal chest discomfort with us|1
5650456|NCT00560066|19513189|P2|Overall Study|Missing primary reason|2
5650457|NCT00560066|19513190|P1|Overall Study|Missing primary reason|0
5650458|NCT00560066|19513189|P2|Overall Study|Administrative reason|5
5650459|NCT00560066|19513190|P1|Overall Study|Administrative reason|0
5650460|NCT00560066|19513189|P2|Overall Study|Protocol Violation|1
5650461|NCT00560066|19513190|P1|Overall Study|Protocol Violation|0
5650462|NCT00560066|19513189|P2|Overall Study|Lost to Follow-up|10
5650463|NCT00560066|19513190|P1|Overall Study|Lost to Follow-up|4
5650464|NCT00560066|19513189|P2|Overall Study|Withdrawal by Subject|3
5650465|NCT00560066|19513190|P1|Overall Study|Withdrawal by Subject|0
5650466|NCT00560066|19513189|P2|Overall Study|Death|1
5650467|NCT00560066|19513190|P1|Overall Study|Death|2
5650468|NCT00559988|19513222|P2|Overall Study|ICD device explanted|17
5650469|NCT00559988|19513223|P1|Overall Study|ICD device explanted|10
5650470|NCT00559988|19513222|P2|Overall Study|Lost to Follow-up|56
5650471|NCT00559988|19513223|P1|Overall Study|Lost to Follow-up|42
5650472|NCT00559988|19513222|P2|Overall Study|Withdrawal by Subject|139
5650473|NCT00559988|19513223|P1|Overall Study|Withdrawal by Subject|152
5650474|NCT00559988|19513222|P2|Overall Study|Death|140
5650475|NCT00559988|19513223|P1|Overall Study|Death|147
5650476|NCT00559962|19513253|P8|Overall Study|Inclusion/exclusion criteria not met|0
5650477|NCT00559962|19513254|P7|Overall Study|Inclusion/exclusion criteria not met|1
5650478|NCT00559962|19513255|P6|Overall Study|Inclusion/exclusion criteria not met|0
5650479|NCT00559962|19513256|P5|Overall Study|Inclusion/exclusion criteria not met|0
5650480|NCT00559962|19513257|P4|Overall Study|Inclusion/exclusion criteria not met|0
5650481|NCT00559962|19513258|P3|Overall Study|Inclusion/exclusion criteria not met|0
5650482|NCT00559962|19513259|P2|Overall Study|Inclusion/exclusion criteria not met|0
5650483|NCT00559962|19513260|P1|Overall Study|Inclusion/exclusion criteria not met|0
5650484|NCT00559962|19513253|P8|Overall Study|Withdrawal by Subject|2
5650485|NCT00559962|19513254|P7|Overall Study|Withdrawal by Subject|0
5650486|NCT00559962|19513255|P6|Overall Study|Withdrawal by Subject|1
5650487|NCT00559962|19513256|P5|Overall Study|Withdrawal by Subject|3
5650488|NCT00559962|19513257|P4|Overall Study|Withdrawal by Subject|0
5650489|NCT00559962|19513258|P3|Overall Study|Withdrawal by Subject|2
5650490|NCT00559962|19513259|P2|Overall Study|Withdrawal by Subject|1
5650491|NCT00559962|19513260|P1|Overall Study|Withdrawal by Subject|1
5650492|NCT00559962|19513253|P8|Overall Study|Lost to Follow-up|0
5650493|NCT00559962|19513254|P7|Overall Study|Lost to Follow-up|0
5650494|NCT00559962|19513255|P6|Overall Study|Lost to Follow-up|0
5650495|NCT00559962|19513256|P5|Overall Study|Lost to Follow-up|0
5650496|NCT00559962|19513257|P4|Overall Study|Lost to Follow-up|0
5650497|NCT00559962|19513258|P3|Overall Study|Lost to Follow-up|0
5650498|NCT00559962|19513259|P2|Overall Study|Lost to Follow-up|1
5650499|NCT00559962|19513260|P1|Overall Study|Lost to Follow-up|0
5650500|NCT00559962|19513253|P8|Overall Study|Adverse Event|2
5650501|NCT00559962|19513254|P7|Overall Study|Adverse Event|4
5650502|NCT00559962|19513255|P6|Overall Study|Adverse Event|4
5650503|NCT00559962|19513256|P5|Overall Study|Adverse Event|11
5650504|NCT00559962|19513257|P4|Overall Study|Adverse Event|5
5650505|NCT00559962|19513258|P3|Overall Study|Adverse Event|8
5650506|NCT00559962|19513259|P2|Overall Study|Adverse Event|7
5650507|NCT00559962|19513260|P1|Overall Study|Adverse Event|1
5650508|NCT00559949|19513280|P1|Overall Study|No disease evaluation per protocol|1
5650509|NCT00559949|19513280|P1|Overall Study|Withdrawal by Subject|4
5650510|NCT00559949|19513280|P1|Overall Study|Adverse Event|1
5650511|NCT00559949|19513280|P1|Overall Study|Progressive Disease during cycle 1|1
5650512|NCT00559845|19513296|P1|Overall Study|Premature Surgery-Investigator Decision|1
5650513|NCT00559845|19513296|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
5650514|NCT00559845|19513296|P1|Overall Study|Adverse Event|3
5650515|NCT00559845|19513296|P1|Overall Study|Disease Progression|1
5650516|NCT00559845|19513296|P1|Overall Study|Withdrew Consent|1
5650517|NCT00559754|19513305|P1|Overall Study|Withdrawal by Subject|2
5650518|NCT00559754|19513305|P1|Overall Study|Investigator criteria|2
5650519|NCT00559754|19513305|P1|Overall Study|Protocol Violation|1
5650520|NCT00559754|19513305|P1|Overall Study|Adverse Event|5
5650521|NCT00559754|19513305|P1|Overall Study|Disease progression|1
5650522|NCT00559637|19513329|P1|Overall Study|Inclusion or exclusion criteria violated|2
5650523|NCT00559637|19513329|P1|Overall Study|Change of home|1
5650524|NCT00559637|19513329|P1|Overall Study|Change of center|1
5650525|NCT00559637|19513329|P1|Overall Study|Delayed administration of C.E.R.A|1
5650526|NCT00559637|19513329|P1|Overall Study|Participation in another study|1
5650527|NCT00559637|19513329|P1|Overall Study|Suspected lung cancer|1
5650528|NCT00559637|19513329|P1|Overall Study|Started requiring dialysis after month 7|2
5650529|NCT00559637|19513329|P1|Overall Study|Insufficient response|3
5650530|NCT00559637|19513329|P1|Overall Study|Failure to return|6
5650531|NCT00559637|19513329|P1|Overall Study|Withdrawal criteria fulfilled|4
5650532|NCT00559637|19513329|P1|Overall Study|Protocol Violation|6
5650533|NCT00559637|19513329|P1|Overall Study|Withdrawal by Subject|4
5650534|NCT00559637|19513329|P1|Overall Study|Adverse Event|22
5650535|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
5650536|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
5650537|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|non-specified|0
5650538|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|non-specified|71
5650539|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
5650540|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
5650541|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
5650542|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
5650543|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
5650544|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
5650545|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|Death|0
5650546|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|Death|20
5650547|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
5650548|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
5650549|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
5650550|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
5650551|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
5650552|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
5650553|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
5650554|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
5650555|NCT00559585|19513342|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
5650556|NCT00559585|19513343|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
5650557|NCT00559585|19513342|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
5650558|NCT00559585|19513343|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
5650559|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
5650560|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
5650561|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Investigator Decision|1
5650562|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Investigator Decision|0
5650563|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
5650564|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
5650565|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
5650566|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
5650567|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Early Discontinuation|1
5650568|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Early Discontinuation|0
5650569|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
5650570|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
5650571|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
5650572|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
5650573|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Missed Doses|1
5650574|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Missed Doses|0
5650575|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
5650576|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
5650577|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
5650578|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
5650579|NCT00559585|19513342|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
5650580|NCT00559585|19513343|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
5650581|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Death|1
5650582|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Death|1
5650583|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
5650584|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
5650585|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
5650586|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
5650587|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
5650588|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
5650589|NCT00559585|19513342|P2|Double Blind ST Period Main Study|Adverse Event|25
5650590|NCT00559585|19513343|P1|Double Blind ST Period Main Study|Adverse Event|17
5650591|NCT00559507|19513403|P1|Overall Study|Not treated, patient ineligible|3
5650592|NCT00559377|19513422|P1|Overall Study|Withdrawal by Subject|9
5650593|NCT00559364|19513432|P2|Overall Study|Inclusion/exclusion criteria failure|0
5650594|NCT00559364|19513433|P1|Overall Study|Inclusion/exclusion criteria failure|1
5650595|NCT00559273|19513445|P2|Evaluation Period (8 Weeks)|Physician Decision|1
5650596|NCT00559273|19513446|P1|Evaluation Period (8 Weeks)|Physician Decision|0
5650597|NCT00559273|19513445|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
5650598|NCT00559273|19513446|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
5650599|NCT00559273|19513445|P2|Evaluation Period (8 Weeks)|Adverse Event|1
5650600|NCT00559273|19513446|P1|Evaluation Period (8 Weeks)|Adverse Event|0
5650601|NCT00559273|19513445|P2|Evaluation Period (8 Weeks)|Death|3
5650602|NCT00559273|19513446|P1|Evaluation Period (8 Weeks)|Death|1
5650603|NCT00559273|19513445|P2|Correction Period (20 Weeks)|Did not received study treatment|0
5650604|NCT00559273|19513446|P1|Correction Period (20 Weeks)|Did not received study treatment|2
5650605|NCT00559273|19513445|P2|Correction Period (20 Weeks)|Participant treated by another center|1
5650606|NCT00559273|19513446|P1|Correction Period (20 Weeks)|Participant treated by another center|0
5650607|NCT00559273|19513445|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
5650608|NCT00559273|19513446|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
5650609|NCT00559273|19513445|P2|Correction Period (20 Weeks)|Adverse Event|1
5650610|NCT00559273|19513446|P1|Correction Period (20 Weeks)|Adverse Event|2
5650611|NCT00559273|19513445|P2|Correction Period (20 Weeks)|Death|4
5650612|NCT00559273|19513446|P1|Correction Period (20 Weeks)|Death|3
5650613|NCT00559104|19513468|P2|Overall Study|Lack of Efficacy|0
5650614|NCT00559104|19513469|P1|Overall Study|Lack of Efficacy|9
5650615|NCT00558896|19513490|P7|Overall Study|Continues on treatment|6
5650616|NCT00558896|19513491|P6|Overall Study|Continues on treatment|25
5650617|NCT00558896|19513492|P5|Overall Study|Continues on treatment|9
5650618|NCT00558896|19513493|P4|Overall Study|Continues on treatment|1
5650619|NCT00558896|19513494|P3|Overall Study|Continues on treatment|0
5650620|NCT00558896|19513495|P2|Overall Study|Continues on treatment|1
5650621|NCT00558896|19513496|P1|Overall Study|Continues on treatment|10
5650622|NCT00558896|19513490|P7|Overall Study|Physician discretion|3
5650623|NCT00558896|19513491|P6|Overall Study|Physician discretion|3
5650624|NCT00558896|19513492|P5|Overall Study|Physician discretion|1
5650625|NCT00558896|19513493|P4|Overall Study|Physician discretion|2
5650626|NCT00558896|19513494|P3|Overall Study|Physician discretion|1
5650627|NCT00558896|19513495|P2|Overall Study|Physician discretion|2
5650628|NCT00558896|19513496|P1|Overall Study|Physician discretion|3
5650629|NCT00558896|19513490|P7|Overall Study|Alternative Treatment|1
5650630|NCT00558896|19513491|P6|Overall Study|Alternative Treatment|7
5650631|NCT00558896|19513492|P5|Overall Study|Alternative Treatment|6
5650632|NCT00558896|19513493|P4|Overall Study|Alternative Treatment|2
5650633|NCT00558896|19513494|P3|Overall Study|Alternative Treatment|0
5650634|NCT00558896|19513495|P2|Overall Study|Alternative Treatment|2
5650635|NCT00558896|19513496|P1|Overall Study|Alternative Treatment|2
5650636|NCT00558896|19513490|P7|Overall Study|Withdrawal by Subject|5
5650637|NCT00558896|19513491|P6|Overall Study|Withdrawal by Subject|5
5650638|NCT00558896|19513492|P5|Overall Study|Withdrawal by Subject|1
5650639|NCT00558896|19513493|P4|Overall Study|Withdrawal by Subject|1
5650640|NCT00558896|19513494|P3|Overall Study|Withdrawal by Subject|1
5650641|NCT00558896|19513495|P2|Overall Study|Withdrawal by Subject|1
5650642|NCT00558896|19513496|P1|Overall Study|Withdrawal by Subject|2
5650643|NCT00558896|19513490|P7|Overall Study|Death|6
5650644|NCT00558896|19513491|P6|Overall Study|Death|2
5650645|NCT00558896|19513492|P5|Overall Study|Death|2
5650646|NCT00558896|19513493|P4|Overall Study|Death|3
5650647|NCT00558896|19513494|P3|Overall Study|Death|2
5650648|NCT00558896|19513495|P2|Overall Study|Death|0
5650649|NCT00558896|19513496|P1|Overall Study|Death|3
5650650|NCT00558896|19513490|P7|Overall Study|Adverse Event|3
5650651|NCT00558896|19513491|P6|Overall Study|Adverse Event|10
5650652|NCT00558896|19513492|P5|Overall Study|Adverse Event|4
5650653|NCT00558896|19513493|P4|Overall Study|Adverse Event|3
5650654|NCT00558896|19513494|P3|Overall Study|Adverse Event|1
5650655|NCT00558896|19513495|P2|Overall Study|Adverse Event|1
5650656|NCT00558896|19513496|P1|Overall Study|Adverse Event|1
5650657|NCT00558831|19513598|P1|Overall Study|Lost to Follow-up|1
5650658|NCT00558753|19513655|P2|Overall Study|Lost to Follow-up|7
5650659|NCT00558753|19513656|P1|Overall Study|Lost to Follow-up|5
5650660|NCT00558701|19513668|P2|Overall Study|Protocol Deviations|4
5650661|NCT00558701|19513669|P1|Overall Study|Protocol Deviations|1
5650662|NCT00558636|19513677|P2|Follow-up|Premature termination of the study|7
5650663|NCT00558636|19513678|P1|Follow-up|Premature termination of the study|12
5650664|NCT00558636|19513677|P2|Treatment|Disease progression|5
5650665|NCT00558636|19513678|P1|Treatment|Disease progression|1
5650666|NCT00558636|19513677|P2|Treatment|Premature termination of the study|37
5650667|NCT00558636|19513678|P1|Treatment|Premature termination of the study|35
5650668|NCT00558636|19513677|P2|Treatment|Withdrawal by Subject|0
5650669|NCT00558636|19513678|P1|Treatment|Withdrawal by Subject|2
5650670|NCT00558636|19513677|P2|Treatment|Adverse Event|2
5650671|NCT00558636|19513678|P1|Treatment|Adverse Event|9
5650672|NCT00558558|19513778|P1|Overall Study|Lack of Efficacy|4
5650673|NCT00558558|19513778|P1|Overall Study|Withdrawal by Subject|1
5650674|NCT00558558|19513778|P1|Overall Study|Unable to swallow|1
5650675|NCT00558519|19513782|P1|Overall Study|Never received treatment|1
5650676|NCT00558519|19513782|P1|Overall Study|Insufficient data|1
5650677|NCT00558519|19513782|P1|Overall Study|Ineligible|1
5650678|NCT00558519|19513782|P1|Overall Study|Ph+|20
5650679|NCT00558467|19513792|P2|Overall Study|Patient moving out of state|1
5650680|NCT00558467|19513793|P1|Overall Study|Patient moving out of state|0
5650681|NCT00558467|19513792|P2|Overall Study|Lack of Efficacy|1
5650682|NCT00558467|19513793|P1|Overall Study|Lack of Efficacy|0
5650683|NCT00558467|19513792|P2|Overall Study|Adverse Event|2
5650684|NCT00558467|19513793|P1|Overall Study|Adverse Event|1
5650685|NCT00558428|19513853|P4|Overall Study|Other|1
5650686|NCT00558428|19513854|P3|Overall Study|Other|0
5650687|NCT00558428|19513855|P2|Overall Study|Other|0
5650688|NCT00558428|19513856|P1|Overall Study|Other|3
5650689|NCT00558428|19513853|P4|Overall Study|Consent withdrawn|1
5650690|NCT00558428|19513854|P3|Overall Study|Consent withdrawn|0
5650691|NCT00558428|19513855|P2|Overall Study|Consent withdrawn|1
5650692|NCT00558428|19513856|P1|Overall Study|Consent withdrawn|2
5650693|NCT00558428|19513853|P4|Overall Study|Non compliant with protocol|3
5650694|NCT00558428|19513854|P3|Overall Study|Non compliant with protocol|0
5650695|NCT00558428|19513855|P2|Overall Study|Non compliant with protocol|0
5650696|NCT00558428|19513856|P1|Overall Study|Non compliant with protocol|1
5650697|NCT00558428|19513853|P4|Overall Study|Lack of Efficacy|2
5650698|NCT00558428|19513854|P3|Overall Study|Lack of Efficacy|1
5650699|NCT00558428|19513855|P2|Overall Study|Lack of Efficacy|0
5650700|NCT00558428|19513856|P1|Overall Study|Lack of Efficacy|0
5650701|NCT00558428|19513853|P4|Overall Study|Lost to Follow-up|0
5650702|NCT00558428|19513854|P3|Overall Study|Lost to Follow-up|0
5650703|NCT00558428|19513855|P2|Overall Study|Lost to Follow-up|1
5650704|NCT00558428|19513856|P1|Overall Study|Lost to Follow-up|0
5650705|NCT00558428|19513853|P4|Overall Study|Adverse Event|4
5650706|NCT00558428|19513854|P3|Overall Study|Adverse Event|3
5650707|NCT00558428|19513855|P2|Overall Study|Adverse Event|22
5650708|NCT00558428|19513856|P1|Overall Study|Adverse Event|6
5650709|NCT00558363|19513896|P2|Overall Study|Hospitalized; Unable to Continue|1
5650710|NCT00558363|19513897|P1|Overall Study|Hospitalized; Unable to Continue|0
5650711|NCT00558363|19513896|P2|Overall Study|Randomized in Error|2
5650712|NCT00558363|19513897|P1|Overall Study|Randomized in Error|1
5650713|NCT00558363|19513896|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
5650714|NCT00558363|19513897|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
5650715|NCT00558363|19513896|P2|Overall Study|Lost to Follow-up|1
5650716|NCT00558363|19513897|P1|Overall Study|Lost to Follow-up|0
5650717|NCT00558363|19513896|P2|Overall Study|Protocol Violation|1
5650718|NCT00558363|19513897|P1|Overall Study|Protocol Violation|2
5650719|NCT00558363|19513896|P2|Overall Study|Lack of Efficacy|2
5650720|NCT00558363|19513897|P1|Overall Study|Lack of Efficacy|2
5650721|NCT00558363|19513896|P2|Overall Study|Adverse Event|5
5650722|NCT00558363|19513897|P1|Overall Study|Adverse Event|5
5650723|NCT00558363|19513896|P2|Overall Study|Withdrawal by Subject|4
5650724|NCT00558363|19513897|P1|Overall Study|Withdrawal by Subject|11
5650725|NCT00558363|19513896|P2|Overall Study|Physician Decision|4
5650726|NCT00558363|19513897|P1|Overall Study|Physician Decision|18
5650727|NCT00558285|19513952|P5|Overall Study|Protocol deviation|0
5650728|NCT00558285|19513953|P4|Overall Study|Protocol deviation|1
5650729|NCT00558285|19513954|P3|Overall Study|Protocol deviation|0
5650730|NCT00558285|19513955|P2|Overall Study|Protocol deviation|1
5650731|NCT00558285|19513956|P1|Overall Study|Protocol deviation|1
5650732|NCT00558285|19513952|P5|Overall Study|Administrative problems|1
5650733|NCT00558285|19513953|P4|Overall Study|Administrative problems|1
5650734|NCT00558285|19513954|P3|Overall Study|Administrative problems|0
5650735|NCT00558285|19513955|P2|Overall Study|Administrative problems|0
5650736|NCT00558285|19513956|P1|Overall Study|Administrative problems|0
5650737|NCT00558285|19513952|P5|Overall Study|Lost to Follow-up|0
5650738|NCT00558285|19513953|P4|Overall Study|Lost to Follow-up|0
5650739|NCT00558285|19513954|P3|Overall Study|Lost to Follow-up|0
5650740|NCT00558285|19513955|P2|Overall Study|Lost to Follow-up|1
5650741|NCT00558285|19513956|P1|Overall Study|Lost to Follow-up|1
5650742|NCT00558285|19513952|P5|Overall Study|Subject withdrew consent|1
5650743|NCT00558285|19513953|P4|Overall Study|Subject withdrew consent|1
5650744|NCT00558285|19513954|P3|Overall Study|Subject withdrew consent|1
5650745|NCT00558285|19513955|P2|Overall Study|Subject withdrew consent|0
5650746|NCT00558285|19513956|P1|Overall Study|Subject withdrew consent|2
5650747|NCT00558285|19513952|P5|Overall Study|Abnormal test procedure result(s)|0
5650748|NCT00558285|19513953|P4|Overall Study|Abnormal test procedure result(s)|0
5650749|NCT00558285|19513954|P3|Overall Study|Abnormal test procedure result(s)|0
5650750|NCT00558285|19513955|P2|Overall Study|Abnormal test procedure result(s)|0
5650751|NCT00558285|19513956|P1|Overall Study|Abnormal test procedure result(s)|1
5650752|NCT00558285|19513952|P5|Overall Study|Adverse Event|2
5650753|NCT00558285|19513953|P4|Overall Study|Adverse Event|1
5650754|NCT00558285|19513954|P3|Overall Study|Adverse Event|4
5650755|NCT00558285|19513955|P2|Overall Study|Adverse Event|1
5650756|NCT00558285|19513956|P1|Overall Study|Adverse Event|1
5650757|NCT00558272|19514000|P2|Overall Study|Withdrawal by Subject|1
5650758|NCT00558272|19514001|P1|Overall Study|Withdrawal by Subject|0
5650759|NCT00558272|19514000|P2|Overall Study|Incorrectly enrolled|0
5650760|NCT00558272|19514001|P1|Overall Study|Incorrectly enrolled|1
5650761|NCT00558272|19514000|P2|Overall Study|AZ study team decision|1
5650762|NCT00558272|19514001|P1|Overall Study|AZ study team decision|0
5650763|NCT00558272|19514000|P2|Overall Study|Dev. of study specific discon. criteria|0
5650764|NCT00558272|19514001|P1|Overall Study|Dev. of study specific discon. criteria|1
5650765|NCT00558272|19514000|P2|Overall Study|Death|0
5650766|NCT00558272|19514001|P1|Overall Study|Death|1
5650767|NCT00558272|19514000|P2|Overall Study|Adverse Event|0
5650768|NCT00558272|19514001|P1|Overall Study|Adverse Event|10
5650769|NCT00558259|19514041|P2|Overall Study|Withdrawal by Subject|13
5650770|NCT00558259|19514042|P1|Overall Study|Withdrawal by Subject|12
5650771|NCT00558259|19514041|P2|Overall Study|Protocol Violation|5
5650772|NCT00558259|19514042|P1|Overall Study|Protocol Violation|9
5650773|NCT00558259|19514041|P2|Overall Study|Adverse Event|81
5650774|NCT00558259|19514042|P1|Overall Study|Adverse Event|50
5650775|NCT00558103|19514082|P6|Monotherapy Extension Phase|Disease Progression|8
5650776|NCT00558103|19514083|P5|Monotherapy Extension Phase|Disease Progression|0
5650777|NCT00558103|19514084|P4|Monotherapy Extension Phase|Disease Progression|0
5650778|NCT00558103|19514085|P3|Monotherapy Extension Phase|Disease Progression|0
5650779|NCT00558103|19514086|P2|Monotherapy Extension Phase|Disease Progression|0
5650780|NCT00558103|19514087|P1|Monotherapy Extension Phase|Disease Progression|0
5650781|NCT00558103|19514082|P6|Monotherapy Extension Phase|Protocol Violation|1
5650782|NCT00558103|19514083|P5|Monotherapy Extension Phase|Protocol Violation|0
5650783|NCT00558103|19514084|P4|Monotherapy Extension Phase|Protocol Violation|0
5650784|NCT00558103|19514085|P3|Monotherapy Extension Phase|Protocol Violation|0
5650785|NCT00558103|19514086|P2|Monotherapy Extension Phase|Protocol Violation|0
5650786|NCT00558103|19514087|P1|Monotherapy Extension Phase|Protocol Violation|0
5650787|NCT00558103|19514082|P6|Randomized Treatment Phase|Adverse Event|0
5650788|NCT00558103|19514083|P5|Randomized Treatment Phase|Adverse Event|1
5650789|NCT00558103|19514084|P4|Randomized Treatment Phase|Adverse Event|1
5650790|NCT00558103|19514085|P3|Randomized Treatment Phase|Adverse Event|0
5650791|NCT00558103|19514086|P2|Randomized Treatment Phase|Adverse Event|0
5650792|NCT00558103|19514087|P1|Randomized Treatment Phase|Adverse Event|0
5650793|NCT00558103|19514082|P6|Randomized Treatment Phase|Disease Progression|0
5650794|NCT00558103|19514083|P5|Randomized Treatment Phase|Disease Progression|0
5650795|NCT00558103|19514084|P4|Randomized Treatment Phase|Disease Progression|0
5650796|NCT00558103|19514085|P3|Randomized Treatment Phase|Disease Progression|1
5650797|NCT00558103|19514086|P2|Randomized Treatment Phase|Disease Progression|0
5650798|NCT00558103|19514087|P1|Randomized Treatment Phase|Disease Progression|1
5650799|NCT00558103|19514082|P6|Randomized Treatment Phase|Withdrawal by Subject|0
5650800|NCT00558103|19514083|P5|Randomized Treatment Phase|Withdrawal by Subject|1
5650801|NCT00558103|19514084|P4|Randomized Treatment Phase|Withdrawal by Subject|0
5650802|NCT00558103|19514085|P3|Randomized Treatment Phase|Withdrawal by Subject|0
5650803|NCT00558103|19514086|P2|Randomized Treatment Phase|Withdrawal by Subject|2
5650804|NCT00558103|19514087|P1|Randomized Treatment Phase|Withdrawal by Subject|2
5650805|NCT00558103|19514082|P6|Randomized Treatment Phase|Lost to Follow-up|0
5650806|NCT00558103|19514083|P5|Randomized Treatment Phase|Lost to Follow-up|3
5650807|NCT00558103|19514084|P4|Randomized Treatment Phase|Lost to Follow-up|1
5650808|NCT00558103|19514085|P3|Randomized Treatment Phase|Lost to Follow-up|2
5650809|NCT00558103|19514086|P2|Randomized Treatment Phase|Lost to Follow-up|2
5650810|NCT00558103|19514087|P1|Randomized Treatment Phase|Lost to Follow-up|2
5650811|NCT00558064|19514117|P2|Overall Study|No visit within allowance period|0
5650812|NCT00558064|19514118|P1|Overall Study|No visit within allowance period|1
5650813|NCT00558064|19514117|P2|Overall Study|Withdrawal by Subject|1
5650814|NCT00558064|19514118|P1|Overall Study|Withdrawal by Subject|0
5650815|NCT00558064|19514117|P2|Overall Study|Lost to Follow-up|1
5650816|NCT00558064|19514118|P1|Overall Study|Lost to Follow-up|0
5650817|NCT00558064|19514117|P2|Overall Study|Protocol Violation|0
5650818|NCT00558064|19514118|P1|Overall Study|Protocol Violation|1
5650819|NCT00558064|19514117|P2|Overall Study|Lack of Efficacy|1
5650820|NCT00558064|19514118|P1|Overall Study|Lack of Efficacy|0
5650821|NCT00558064|19514117|P2|Overall Study|Adverse Event|2
5650822|NCT00558064|19514118|P1|Overall Study|Adverse Event|3
5650823|NCT00558025|19514140|P2|Overall Study|Protocol Violation|0
5650824|NCT00558025|19514141|P1|Overall Study|Protocol Violation|1
5650825|NCT00558025|19514140|P2|Overall Study|Withdrawal by Subject|2
5650826|NCT00558025|19514141|P1|Overall Study|Withdrawal by Subject|2
5650827|NCT00558025|19514140|P2|Overall Study|Adverse Event|1
5650828|NCT00558025|19514141|P1|Overall Study|Adverse Event|1
5650829|NCT00557856|19514197|P9|Part 2: Exploratory Phase|global deterioration of health status|1
5650830|NCT00557856|19514198|P8|Part 2: Exploratory Phase|global deterioration of health status|0
5650831|NCT00557856|19514199|P7|Part 2: Exploratory Phase|global deterioration of health status|0
5650832|NCT00557856|19514200|P6|Part 2: Exploratory Phase|global deterioration of health status|0
5650833|NCT00557856|19514201|P5|Part 2: Exploratory Phase|global deterioration of health status|0
5650834|NCT00557856|19514202|P4|Part 2: Exploratory Phase|global deterioration of health status|0
5650835|NCT00557856|19514203|P3|Part 2: Exploratory Phase|global deterioration of health status|0
5650836|NCT00557856|19514204|P2|Part 2: Exploratory Phase|global deterioration of health status|0
5650837|NCT00557856|19514205|P1|Part 2: Exploratory Phase|global deterioration of health status|0
5650838|NCT00557856|19514197|P9|Part 2: Exploratory Phase|Death|2
5650839|NCT00557856|19514198|P8|Part 2: Exploratory Phase|Death|0
5650840|NCT00557856|19514199|P7|Part 2: Exploratory Phase|Death|0
5650841|NCT00557856|19514200|P6|Part 2: Exploratory Phase|Death|0
5650842|NCT00557856|19514201|P5|Part 2: Exploratory Phase|Death|0
5650843|NCT00557856|19514202|P4|Part 2: Exploratory Phase|Death|0
5650844|NCT00557856|19514203|P3|Part 2: Exploratory Phase|Death|0
5650845|NCT00557856|19514204|P2|Part 2: Exploratory Phase|Death|0
5650846|NCT00557856|19514205|P1|Part 2: Exploratory Phase|Death|0
5650847|NCT00557856|19514197|P9|Part 2: Exploratory Phase|Other|1
5650848|NCT00557856|19514198|P8|Part 2: Exploratory Phase|Other|0
5650849|NCT00557856|19514199|P7|Part 2: Exploratory Phase|Other|0
5650850|NCT00557856|19514200|P6|Part 2: Exploratory Phase|Other|0
5650851|NCT00557856|19514201|P5|Part 2: Exploratory Phase|Other|0
5650852|NCT00557856|19514202|P4|Part 2: Exploratory Phase|Other|0
5650853|NCT00557856|19514203|P3|Part 2: Exploratory Phase|Other|0
5650854|NCT00557856|19514204|P2|Part 2: Exploratory Phase|Other|0
5650855|NCT00557856|19514205|P1|Part 2: Exploratory Phase|Other|0
5650856|NCT00557856|19514197|P9|Part 2: Exploratory Phase|Adverse Event|4
5650857|NCT00557856|19514198|P8|Part 2: Exploratory Phase|Adverse Event|0
5650858|NCT00557856|19514199|P7|Part 2: Exploratory Phase|Adverse Event|0
5650859|NCT00557856|19514200|P6|Part 2: Exploratory Phase|Adverse Event|0
5650860|NCT00557856|19514201|P5|Part 2: Exploratory Phase|Adverse Event|0
5650861|NCT00557856|19514202|P4|Part 2: Exploratory Phase|Adverse Event|0
5650862|NCT00557856|19514203|P3|Part 2: Exploratory Phase|Adverse Event|0
5650863|NCT00557856|19514204|P2|Part 2: Exploratory Phase|Adverse Event|0
5650864|NCT00557856|19514205|P1|Part 2: Exploratory Phase|Adverse Event|0
5650865|NCT00557856|19514197|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
5650866|NCT00557856|19514198|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
5650867|NCT00557856|19514199|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
5650868|NCT00557856|19514200|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
5650869|NCT00557856|19514201|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
5650870|NCT00557856|19514202|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
5650871|NCT00557856|19514203|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
5650872|NCT00557856|19514204|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
5650873|NCT00557856|19514205|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
5650874|NCT00557856|19514197|P9|Part 2: Exploratory Phase|objective progression or relapse|15
5650875|NCT00557856|19514198|P8|Part 2: Exploratory Phase|objective progression or relapse|0
5650876|NCT00557856|19514199|P7|Part 2: Exploratory Phase|objective progression or relapse|0
5650877|NCT00557856|19514200|P6|Part 2: Exploratory Phase|objective progression or relapse|0
5650878|NCT00557856|19514201|P5|Part 2: Exploratory Phase|objective progression or relapse|0
5650879|NCT00557856|19514202|P4|Part 2: Exploratory Phase|objective progression or relapse|0
5650880|NCT00557856|19514203|P3|Part 2: Exploratory Phase|objective progression or relapse|0
5650881|NCT00557856|19514204|P2|Part 2: Exploratory Phase|objective progression or relapse|0
5650882|NCT00557856|19514205|P1|Part 2: Exploratory Phase|objective progression or relapse|0
5650883|NCT00557856|19514197|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
5650884|NCT00557856|19514198|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
5650885|NCT00557856|19514199|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
5650886|NCT00557856|19514200|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
5650887|NCT00557856|19514201|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
5650888|NCT00557856|19514202|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
5650889|NCT00557856|19514203|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
5650890|NCT00557856|19514204|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
5650891|NCT00557856|19514205|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
5650892|NCT00557856|19514197|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
5650893|NCT00557856|19514198|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
5650894|NCT00557856|19514199|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
5650895|NCT00557856|19514200|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
5650896|NCT00557856|19514201|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
5650897|NCT00557856|19514202|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
5650898|NCT00557856|19514203|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
5650899|NCT00557856|19514204|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
5650900|NCT00557856|19514205|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
5650901|NCT00557856|19514197|P9|Part 1: Dose Escalation Phase|Death|0
5650902|NCT00557856|19514198|P8|Part 1: Dose Escalation Phase|Death|0
5650903|NCT00557856|19514199|P7|Part 1: Dose Escalation Phase|Death|0
5650904|NCT00557856|19514200|P6|Part 1: Dose Escalation Phase|Death|1
5650905|NCT00557856|19514201|P5|Part 1: Dose Escalation Phase|Death|0
5650906|NCT00557856|19514202|P4|Part 1: Dose Escalation Phase|Death|0
5650907|NCT00557856|19514203|P3|Part 1: Dose Escalation Phase|Death|0
5650908|NCT00557856|19514204|P2|Part 1: Dose Escalation Phase|Death|0
5650909|NCT00557856|19514205|P1|Part 1: Dose Escalation Phase|Death|0
5650910|NCT00557856|19514197|P9|Part 1: Dose Escalation Phase|Other|0
5650911|NCT00557856|19514198|P8|Part 1: Dose Escalation Phase|Other|1
5650912|NCT00557856|19514199|P7|Part 1: Dose Escalation Phase|Other|0
5650913|NCT00557856|19514200|P6|Part 1: Dose Escalation Phase|Other|0
5650914|NCT00557856|19514201|P5|Part 1: Dose Escalation Phase|Other|0
5650915|NCT00557856|19514202|P4|Part 1: Dose Escalation Phase|Other|1
5650916|NCT00557856|19514203|P3|Part 1: Dose Escalation Phase|Other|1
5650917|NCT00557856|19514204|P2|Part 1: Dose Escalation Phase|Other|0
5650918|NCT00557856|19514205|P1|Part 1: Dose Escalation Phase|Other|0
5650919|NCT00557856|19514197|P9|Part 1: Dose Escalation Phase|Adverse Event|0
5650920|NCT00557856|19514198|P8|Part 1: Dose Escalation Phase|Adverse Event|2
5650921|NCT00557856|19514199|P7|Part 1: Dose Escalation Phase|Adverse Event|1
5650922|NCT00557856|19514200|P6|Part 1: Dose Escalation Phase|Adverse Event|3
5650923|NCT00557856|19514201|P5|Part 1: Dose Escalation Phase|Adverse Event|1
5650924|NCT00557856|19514202|P4|Part 1: Dose Escalation Phase|Adverse Event|1
5650925|NCT00557856|19514203|P3|Part 1: Dose Escalation Phase|Adverse Event|1
5650926|NCT00557856|19514204|P2|Part 1: Dose Escalation Phase|Adverse Event|0
5650927|NCT00557856|19514205|P1|Part 1: Dose Escalation Phase|Adverse Event|1
5650928|NCT00557856|19514197|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5650929|NCT00557856|19514198|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5650930|NCT00557856|19514199|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5650931|NCT00557856|19514200|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5650932|NCT00557856|19514201|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5650933|NCT00557856|19514202|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5650934|NCT00557856|19514203|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
5650935|NCT00557856|19514204|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
5650936|NCT00557856|19514205|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
5650937|NCT00557856|19514197|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
5650938|NCT00557856|19514198|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
5650939|NCT00557856|19514199|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
5650940|NCT00557856|19514200|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
5650941|NCT00557856|19514201|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
5650942|NCT00557856|19514202|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
5650943|NCT00557856|19514203|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
5650944|NCT00557856|19514204|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
5650945|NCT00557856|19514205|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
5650946|NCT00557830|19514404|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
5650947|NCT00557830|19514405|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
5650948|NCT00557830|19514406|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
5650949|NCT00557830|19514404|P3|Screening Treatment Phase|Adverse Event|0
5650950|NCT00557830|19514405|P2|Screening Treatment Phase|Adverse Event|0
5650951|NCT00557830|19514406|P1|Screening Treatment Phase|Adverse Event|2
5650952|NCT00557830|19514404|P3|Screening Treatment Phase|Withdrawal by Subject|0
5650953|NCT00557830|19514405|P2|Screening Treatment Phase|Withdrawal by Subject|0
5650954|NCT00557830|19514406|P1|Screening Treatment Phase|Withdrawal by Subject|1
5650955|NCT00557622|19514428|P2|12-Week Treatment Phase|Lost to Follow-up|1
5650956|NCT00557622|19514429|P1|12-Week Treatment Phase|Lost to Follow-up|0
5650957|NCT00557622|19514428|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
5650958|NCT00557622|19514429|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
5650959|NCT00557622|19514428|P2|4-Week Run-in Phase|Withdrawal by Subject|0
5650960|NCT00557622|19514429|P1|4-Week Run-in Phase|Withdrawal by Subject|1
5650961|NCT00557505|19514458|P9|Overall Study|Withdrawal by Subject|1
5650962|NCT00557505|19514459|P8|Overall Study|Withdrawal by Subject|0
5650963|NCT00557505|19514460|P7|Overall Study|Withdrawal by Subject|0
5650964|NCT00557505|19514461|P6|Overall Study|Withdrawal by Subject|0
5650965|NCT00557505|19514462|P5|Overall Study|Withdrawal by Subject|0
5650966|NCT00557505|19514463|P4|Overall Study|Withdrawal by Subject|1
5650967|NCT00557505|19514464|P3|Overall Study|Withdrawal by Subject|0
5650968|NCT00557505|19514465|P2|Overall Study|Withdrawal by Subject|0
5650969|NCT00557505|19514466|P1|Overall Study|Withdrawal by Subject|0
5650970|NCT00557505|19514458|P9|Overall Study|Objective progression or relapse|15
5650971|NCT00557505|19514459|P8|Overall Study|Objective progression or relapse|5
5650972|NCT00557505|19514460|P7|Overall Study|Objective progression or relapse|2
5650973|NCT00557505|19514461|P6|Overall Study|Objective progression or relapse|3
5650974|NCT00557505|19514462|P5|Overall Study|Objective progression or relapse|2
5650975|NCT00557505|19514463|P4|Overall Study|Objective progression or relapse|2
5650976|NCT00557505|19514464|P3|Overall Study|Objective progression or relapse|3
5650977|NCT00557505|19514465|P2|Overall Study|Objective progression or relapse|3
5650978|NCT00557505|19514466|P1|Overall Study|Objective progression or relapse|2
5650979|NCT00557505|19514458|P9|Overall Study|Global deterioration of health|0
5650980|NCT00557505|19514459|P8|Overall Study|Global deterioration of health|0
5650981|NCT00557505|19514460|P7|Overall Study|Global deterioration of health|0
5650982|NCT00557505|19514461|P6|Overall Study|Global deterioration of health|0
5650983|NCT00557505|19514462|P5|Overall Study|Global deterioration of health|0
5650984|NCT00557505|19514463|P4|Overall Study|Global deterioration of health|0
5650985|NCT00557505|19514464|P3|Overall Study|Global deterioration of health|0
5650986|NCT00557505|19514465|P2|Overall Study|Global deterioration of health|0
5650987|NCT00557505|19514466|P1|Overall Study|Global deterioration of health|1
5650988|NCT00557505|19514458|P9|Overall Study|Adverse Event|0
5650989|NCT00557505|19514459|P8|Overall Study|Adverse Event|0
5650990|NCT00557505|19514460|P7|Overall Study|Adverse Event|1
5650991|NCT00557505|19514461|P6|Overall Study|Adverse Event|0
5650992|NCT00557505|19514462|P5|Overall Study|Adverse Event|0
5650993|NCT00557505|19514463|P4|Overall Study|Adverse Event|0
5650994|NCT00557505|19514464|P3|Overall Study|Adverse Event|1
5650995|NCT00557505|19514465|P2|Overall Study|Adverse Event|0
5650996|NCT00557505|19514466|P1|Overall Study|Adverse Event|0
5650997|NCT00557505|19514458|P9|Overall Study|Death|1
5650998|NCT00557505|19514459|P8|Overall Study|Death|0
5650999|NCT00557505|19514460|P7|Overall Study|Death|0
5651000|NCT00557505|19514461|P6|Overall Study|Death|0
5651001|NCT00557505|19514462|P5|Overall Study|Death|0
5651002|NCT00557505|19514463|P4|Overall Study|Death|0
5651003|NCT00557505|19514464|P3|Overall Study|Death|0
5651004|NCT00557505|19514465|P2|Overall Study|Death|0
5651005|NCT00557505|19514466|P1|Overall Study|Death|0
5651006|NCT00557492|19514630|P1|Overall Study|Change in health insurance|1
5651007|NCT00557466|19514648|P6|Overall Study|Lost to Follow-up|0
5651008|NCT00557466|19514649|P5|Overall Study|Lost to Follow-up|0
5651009|NCT00557466|19514650|P4|Overall Study|Lost to Follow-up|1
5651010|NCT00557466|19514651|P3|Overall Study|Lost to Follow-up|0
5651011|NCT00557466|19514652|P2|Overall Study|Lost to Follow-up|0
5651012|NCT00557466|19514653|P1|Overall Study|Lost to Follow-up|0
5651013|NCT00557466|19514648|P6|Overall Study|Abnormal test procedure results|0
5651014|NCT00557466|19514649|P5|Overall Study|Abnormal test procedure results|0
5651015|NCT00557466|19514650|P4|Overall Study|Abnormal test procedure results|0
5651016|NCT00557466|19514651|P3|Overall Study|Abnormal test procedure results|1
5651017|NCT00557466|19514652|P2|Overall Study|Abnormal test procedure results|0
5651018|NCT00557466|19514653|P1|Overall Study|Abnormal test procedure results|0
5651019|NCT00557466|19514648|P6|Overall Study|Administrative problems|0
5651020|NCT00557466|19514649|P5|Overall Study|Administrative problems|0
5651021|NCT00557466|19514650|P4|Overall Study|Administrative problems|0
5651022|NCT00557466|19514651|P3|Overall Study|Administrative problems|1
5651023|NCT00557466|19514652|P2|Overall Study|Administrative problems|1
5651024|NCT00557466|19514653|P1|Overall Study|Administrative problems|0
5651025|NCT00557466|19514648|P6|Overall Study|Subject withdrew consent|2
5651026|NCT00557466|19514649|P5|Overall Study|Subject withdrew consent|1
5651027|NCT00557466|19514650|P4|Overall Study|Subject withdrew consent|0
5651028|NCT00557466|19514651|P3|Overall Study|Subject withdrew consent|0
5651029|NCT00557466|19514652|P2|Overall Study|Subject withdrew consent|0
5651030|NCT00557466|19514653|P1|Overall Study|Subject withdrew consent|0
5651031|NCT00557466|19514648|P6|Overall Study|Protocol deviation|0
5651032|NCT00557466|19514649|P5|Overall Study|Protocol deviation|0
5651033|NCT00557466|19514650|P4|Overall Study|Protocol deviation|2
5651034|NCT00557466|19514651|P3|Overall Study|Protocol deviation|0
5651035|NCT00557466|19514652|P2|Overall Study|Protocol deviation|1
5651036|NCT00557466|19514653|P1|Overall Study|Protocol deviation|0
5651037|NCT00557466|19514648|P6|Overall Study|Abnormal laboratory value(s)|0
5651038|NCT00557466|19514649|P5|Overall Study|Abnormal laboratory value(s)|0
5651039|NCT00557466|19514650|P4|Overall Study|Abnormal laboratory value(s)|0
5651040|NCT00557466|19514651|P3|Overall Study|Abnormal laboratory value(s)|0
5651041|NCT00557466|19514652|P2|Overall Study|Abnormal laboratory value(s)|2
5651042|NCT00557466|19514653|P1|Overall Study|Abnormal laboratory value(s)|1
5651043|NCT00557466|19514648|P6|Overall Study|Adverse Event|4
5651044|NCT00557466|19514649|P5|Overall Study|Adverse Event|2
5651045|NCT00557466|19514650|P4|Overall Study|Adverse Event|1
5651046|NCT00557466|19514651|P3|Overall Study|Adverse Event|4
5651047|NCT00557466|19514652|P2|Overall Study|Adverse Event|1
5651048|NCT00557466|19514653|P1|Overall Study|Adverse Event|3
5651049|NCT00557440|19514706|P3|Treatment Period 1|Adverse Event|1
5651050|NCT00557440|19514707|P2|Treatment Period 1|Adverse Event|0
5651051|NCT00557440|19514708|P1|Treatment Period 1|Adverse Event|0
5651052|NCT00557323|19514762|P1|Overall Study|Administrative change|2
5651053|NCT00557323|19514762|P1|Overall Study|Withdrawal by Subject|2
5651054|NCT00557323|19514762|P1|Overall Study|Death|3
5651055|NCT00557310|19514767|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
5651056|NCT00557310|19514767|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
5651057|NCT00557310|19514767|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
5651058|NCT00557310|19514767|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
5651059|NCT00557310|19514767|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
5651060|NCT00557310|19514767|P1|Main Study (0 - 18 Months)|Adverse Event|4
5651061|NCT00557245|19514813|P3|Overall Study|Ineligible|2
5651062|NCT00557245|19514814|P2|Overall Study|Ineligible|4
5651063|NCT00557245|19514815|P1|Overall Study|Ineligible|5
5651064|NCT00557245|19514813|P3|Overall Study|Lost to Follow-up|10
5651065|NCT00557245|19514814|P2|Overall Study|Lost to Follow-up|8
5651066|NCT00557245|19514815|P1|Overall Study|Lost to Follow-up|7
5651067|NCT00557193|19514853|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
5651068|NCT00557193|19514854|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
5651069|NCT00557193|19514855|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
5651070|NCT00557193|19514856|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
5651071|NCT00557193|19514857|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
5651072|NCT00557193|19514858|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
5651073|NCT00557193|19514853|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5651074|NCT00557193|19514854|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5651075|NCT00557193|19514855|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5651076|NCT00557193|19514856|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
5651077|NCT00557193|19514857|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5651078|NCT00557193|19514858|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
5651079|NCT00557193|19514853|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5651080|NCT00557193|19514854|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5651081|NCT00557193|19514855|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5651082|NCT00557193|19514856|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
5651083|NCT00557193|19514857|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5651084|NCT00557193|19514858|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
5651085|NCT00557193|19514853|P6|Post Induction Therapy by Tx Assignment|Relapse|20
5651086|NCT00557193|19514854|P5|Post Induction Therapy by Tx Assignment|Relapse|1
5651087|NCT00557193|19514855|P4|Post Induction Therapy by Tx Assignment|Relapse|3
5651088|NCT00557193|19514856|P3|Post Induction Therapy by Tx Assignment|Relapse|16
5651089|NCT00557193|19514857|P2|Post Induction Therapy by Tx Assignment|Relapse|5
5651090|NCT00557193|19514858|P1|Post Induction Therapy by Tx Assignment|Relapse|0
5651091|NCT00557193|19514853|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
5651092|NCT00557193|19514854|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
5651093|NCT00557193|19514855|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
5651094|NCT00557193|19514856|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
5651095|NCT00557193|19514857|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
5651096|NCT00557193|19514858|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
5651097|NCT00557193|19514853|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
5651098|NCT00557193|19514854|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
5651099|NCT00557193|19514855|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
5651100|NCT00557193|19514856|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
5651101|NCT00557193|19514857|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
5651102|NCT00557193|19514858|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
5651103|NCT00557193|19514853|P6|Post Induction Therapy by Tx Assignment|Death|2
5651104|NCT00557193|19514854|P5|Post Induction Therapy by Tx Assignment|Death|2
5651105|NCT00557193|19514855|P4|Post Induction Therapy by Tx Assignment|Death|0
5651106|NCT00557193|19514856|P3|Post Induction Therapy by Tx Assignment|Death|2
5651107|NCT00557193|19514857|P2|Post Induction Therapy by Tx Assignment|Death|0
5651108|NCT00557193|19514858|P1|Post Induction Therapy by Tx Assignment|Death|0
5651109|NCT00557193|19514853|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
5651110|NCT00557193|19514854|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
5651111|NCT00557193|19514855|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
5651112|NCT00557193|19514856|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
5651113|NCT00557193|19514857|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
5651114|NCT00557193|19514858|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
5651115|NCT00557193|19514853|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
5651116|NCT00557193|19514854|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
5651117|NCT00557193|19514855|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
5651118|NCT00557193|19514856|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
5651119|NCT00557193|19514857|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
5651120|NCT00557193|19514858|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
5651121|NCT00557193|19514853|P6|Induction|Inevaluable for post Induction|0
5651122|NCT00557193|19514854|P5|Induction|Inevaluable for post Induction|0
5651123|NCT00557193|19514855|P4|Induction|Inevaluable for post Induction|0
5651124|NCT00557193|19514856|P3|Induction|Inevaluable for post Induction|0
5651125|NCT00557193|19514857|P2|Induction|Inevaluable for post Induction|0
5651126|NCT00557193|19514858|P1|Induction|Inevaluable for post Induction|2
5651127|NCT00557193|19514853|P6|Induction|Ineligible|0
5651128|NCT00557193|19514854|P5|Induction|Ineligible|0
5651129|NCT00557193|19514855|P4|Induction|Ineligible|0
5651130|NCT00557193|19514856|P3|Induction|Ineligible|0
5651131|NCT00557193|19514857|P2|Induction|Ineligible|0
5651132|NCT00557193|19514858|P1|Induction|Ineligible|8
5651133|NCT00557193|19514853|P6|Induction|Refusal of Further Protocol Therapy|0
5651134|NCT00557193|19514854|P5|Induction|Refusal of Further Protocol Therapy|0
5651135|NCT00557193|19514855|P4|Induction|Refusal of Further Protocol Therapy|0
5651136|NCT00557193|19514856|P3|Induction|Refusal of Further Protocol Therapy|0
5651137|NCT00557193|19514857|P2|Induction|Refusal of Further Protocol Therapy|0
5651138|NCT00557193|19514858|P1|Induction|Refusal of Further Protocol Therapy|2
5651139|NCT00557193|19514853|P6|Induction|Withdrawal by Subject|0
5651140|NCT00557193|19514854|P5|Induction|Withdrawal by Subject|0
5651141|NCT00557193|19514855|P4|Induction|Withdrawal by Subject|0
5651142|NCT00557193|19514856|P3|Induction|Withdrawal by Subject|0
5651143|NCT00557193|19514857|P2|Induction|Withdrawal by Subject|0
5651144|NCT00557193|19514858|P1|Induction|Withdrawal by Subject|1
5651145|NCT00557193|19514853|P6|Induction|Physician Decision|0
5651146|NCT00557193|19514854|P5|Induction|Physician Decision|0
5651147|NCT00557193|19514855|P4|Induction|Physician Decision|0
5651148|NCT00557193|19514856|P3|Induction|Physician Decision|0
5651149|NCT00557193|19514857|P2|Induction|Physician Decision|0
5651150|NCT00557193|19514858|P1|Induction|Physician Decision|3
5651151|NCT00557193|19514853|P6|Induction|Death|0
5651152|NCT00557193|19514854|P5|Induction|Death|0
5651153|NCT00557193|19514855|P4|Induction|Death|0
5651154|NCT00557193|19514856|P3|Induction|Death|0
5651155|NCT00557193|19514857|P2|Induction|Death|0
5651156|NCT00557193|19514858|P1|Induction|Death|6
5651157|NCT00557193|19514853|P6|Induction|Adverse Event|0
5651158|NCT00557193|19514854|P5|Induction|Adverse Event|0
5651159|NCT00557193|19514855|P4|Induction|Adverse Event|0
5651160|NCT00557193|19514856|P3|Induction|Adverse Event|0
5651161|NCT00557193|19514857|P2|Induction|Adverse Event|0
5651162|NCT00557193|19514858|P1|Induction|Adverse Event|2
5651163|NCT00557076|19514898|P2|Overall Study|Unblinding|1
5651164|NCT00557076|19514899|P1|Overall Study|Unblinding|0
5651165|NCT00556998|19514907|P1|Voriconazole Oral|Intolerant of oral treatment|1
5651166|NCT00556998|19514907|P1|Voriconazole Oral|Adverse Event|1
5651167|NCT00556998|19514907|P1|Voriconazole Intravenous (IV)|Other|4
5651168|NCT00556998|19514907|P1|Voriconazole Intravenous (IV)|Adverse Event|1
5651169|NCT00556933|19514942|P4|CNI Withdrawal vs. Minimization|Death|1
5651170|NCT00556933|19514943|P3|CNI Withdrawal vs. Minimization|Death|0
5651171|NCT00556933|19514944|P2|CNI Withdrawal vs. Minimization|Death|0
5651172|NCT00556933|19514945|P1|CNI Withdrawal vs. Minimization|Death|0
5651173|NCT00556933|19514942|P4|CNI Withdrawal vs. Minimization|Graft loss|0
5651174|NCT00556933|19514943|P3|CNI Withdrawal vs. Minimization|Graft loss|2
5651175|NCT00556933|19514944|P2|CNI Withdrawal vs. Minimization|Graft loss|1
5651176|NCT00556933|19514945|P1|CNI Withdrawal vs. Minimization|Graft loss|0
5651177|NCT00556933|19514942|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
5651178|NCT00556933|19514943|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
5651179|NCT00556933|19514944|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
5651180|NCT00556933|19514945|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
5651181|NCT00556933|19514942|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
5651182|NCT00556933|19514943|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
5651183|NCT00556933|19514944|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
5651184|NCT00556933|19514945|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
5651185|NCT00556933|19514942|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
5651186|NCT00556933|19514943|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
5651187|NCT00556933|19514944|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
5651188|NCT00556933|19514945|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
5651189|NCT00556933|19514942|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
5651190|NCT00556933|19514943|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
5651191|NCT00556933|19514944|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
5651192|NCT00556933|19514945|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
5651193|NCT00556933|19514942|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
5651194|NCT00556933|19514943|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
5651195|NCT00556933|19514944|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
5651196|NCT00556933|19514945|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
5651197|NCT00556933|19514942|P4|Single vs. Divided-dose rATG Induction|Death|0
5651198|NCT00556933|19514943|P3|Single vs. Divided-dose rATG Induction|Death|0
5651199|NCT00556933|19514944|P2|Single vs. Divided-dose rATG Induction|Death|1
5651200|NCT00556933|19514945|P1|Single vs. Divided-dose rATG Induction|Death|0
5651201|NCT00556933|19514942|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
5651202|NCT00556933|19514943|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
5651203|NCT00556933|19514944|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
5651204|NCT00556933|19514945|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
5651205|NCT00556933|19514942|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
5651206|NCT00556933|19514943|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
5651290|NCT00556322|19515305|P2|Overall Study|Death|14
5651207|NCT00556933|19514944|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
5651208|NCT00556933|19514945|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
5651209|NCT00556933|19514942|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
5651210|NCT00556933|19514943|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
5651211|NCT00556933|19514944|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
5651212|NCT00556933|19514945|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
5651213|NCT00556894|19515002|P3|Overall Study|Withdrawal by Subject|1
5651214|NCT00556894|19515003|P2|Overall Study|Withdrawal by Subject|1
5651215|NCT00556894|19515004|P1|Overall Study|Withdrawal by Subject|1
5651216|NCT00556894|19515002|P3|Overall Study|Change in therapy|2
5651217|NCT00556894|19515003|P2|Overall Study|Change in therapy|1
5651218|NCT00556894|19515004|P1|Overall Study|Change in therapy|2
5651219|NCT00556894|19515002|P3|Overall Study|regulatory decision in Bulgaria|13
5651220|NCT00556894|19515003|P2|Overall Study|regulatory decision in Bulgaria|14
5651221|NCT00556894|19515004|P1|Overall Study|regulatory decision in Bulgaria|10
5651222|NCT00556894|19515002|P3|Overall Study|Death|0
5651223|NCT00556894|19515003|P2|Overall Study|Death|0
5651224|NCT00556894|19515004|P1|Overall Study|Death|1
5651225|NCT00556894|19515002|P3|Overall Study|Adverse Event|3
5651226|NCT00556894|19515003|P2|Overall Study|Adverse Event|3
5651227|NCT00556894|19515004|P1|Overall Study|Adverse Event|2
5651228|NCT00556712|19515033|P2|Overall Study|Ongoing at Data Cutoff|66
5651229|NCT00556712|19515034|P1|Overall Study|Ongoing at Data Cutoff|32
5651230|NCT00556712|19515033|P2|Overall Study|Other|2
5651231|NCT00556712|19515034|P1|Overall Study|Other|2
5651232|NCT00556712|19515033|P2|Overall Study|Failure to Return|3
5651233|NCT00556712|19515034|P1|Overall Study|Failure to Return|2
5651234|NCT00556712|19515033|P2|Overall Study|Refused Treatment|16
5651235|NCT00556712|19515034|P1|Overall Study|Refused Treatment|17
5651236|NCT00556712|19515033|P2|Overall Study|Protocol Violation|2
5651237|NCT00556712|19515034|P1|Overall Study|Protocol Violation|3
5651238|NCT00556712|19515033|P2|Overall Study|Progressive Disease|320
5651239|NCT00556712|19515034|P1|Overall Study|Progressive Disease|383
5651240|NCT00556712|19515033|P2|Overall Study|Death|10
5651241|NCT00556712|19515034|P1|Overall Study|Death|5
5651242|NCT00556712|19515033|P2|Overall Study|Adverse Event|19
5651243|NCT00556712|19515034|P1|Overall Study|Adverse Event|7
5651244|NCT00556673|19515112|P2|Overall Study|Protocol deviation|2
5651245|NCT00556673|19515113|P1|Overall Study|Protocol deviation|3
5651246|NCT00556439|19515249|P4|After Week 12 (Randomized Study Period)|Severe infection|0
5651247|NCT00556439|19515250|P3|After Week 12 (Randomized Study Period)|Severe infection|0
5651248|NCT00556439|19515251|P2|After Week 12 (Randomized Study Period)|Severe infection|0
5651249|NCT00556439|19515252|P1|After Week 12 (Randomized Study Period)|Severe infection|1
5651250|NCT00556439|19515249|P4|After Week 12 (Randomized Study Period)|Malignancy|1
5651251|NCT00556439|19515250|P3|After Week 12 (Randomized Study Period)|Malignancy|0
5651252|NCT00556439|19515251|P2|After Week 12 (Randomized Study Period)|Malignancy|1
5651253|NCT00556439|19515252|P1|After Week 12 (Randomized Study Period)|Malignancy|0
5651254|NCT00556439|19515249|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
5651255|NCT00556439|19515250|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
5651256|NCT00556439|19515251|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
5651257|NCT00556439|19515252|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
5651258|NCT00556439|19515249|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
5651259|NCT00556439|19515250|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
5651260|NCT00556439|19515251|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
5651261|NCT00556439|19515252|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
5651262|NCT00556439|19515249|P4|Study Entry to Week 12|Malignancy|0
5651263|NCT00556439|19515250|P3|Study Entry to Week 12|Malignancy|1
5651264|NCT00556439|19515251|P2|Study Entry to Week 12|Malignancy|0
5651265|NCT00556439|19515252|P1|Study Entry to Week 12|Malignancy|0
5651266|NCT00556439|19515249|P4|Study Entry to Week 12|Recurrent infection|0
5651267|NCT00556439|19515250|P3|Study Entry to Week 12|Recurrent infection|0
5651268|NCT00556439|19515251|P2|Study Entry to Week 12|Recurrent infection|0
5651269|NCT00556439|19515252|P1|Study Entry to Week 12|Recurrent infection|1
5651270|NCT00556439|19515249|P4|Study Entry to Week 12|Withdrawal by Subject|0
5651271|NCT00556439|19515250|P3|Study Entry to Week 12|Withdrawal by Subject|1
5651272|NCT00556439|19515251|P2|Study Entry to Week 12|Withdrawal by Subject|0
5651273|NCT00556439|19515252|P1|Study Entry to Week 12|Withdrawal by Subject|1
5651274|NCT00556439|19515249|P4|Study Entry to Week 12|Physician Decision|0
5651275|NCT00556439|19515250|P3|Study Entry to Week 12|Physician Decision|0
5651276|NCT00556439|19515251|P2|Study Entry to Week 12|Physician Decision|0
5651277|NCT00556439|19515252|P1|Study Entry to Week 12|Physician Decision|1
5651278|NCT00556439|19515249|P4|Study Entry to Week 12|Lack of Efficacy|0
5651279|NCT00556439|19515250|P3|Study Entry to Week 12|Lack of Efficacy|6
5651280|NCT00556439|19515251|P2|Study Entry to Week 12|Lack of Efficacy|0
5651281|NCT00556439|19515252|P1|Study Entry to Week 12|Lack of Efficacy|5
5651282|NCT00556426|19515262|P1|Overall Study|Death|6
5651283|NCT00556426|19515262|P1|Overall Study|Withdrawal by Subject|3
5651284|NCT00556374|19515284|P2|Overall Study|Lost to Follow-up|5
5651285|NCT00556374|19515285|P1|Overall Study|Lost to Follow-up|7
5651286|NCT00556374|19515284|P2|Overall Study|Death|43
5651287|NCT00556374|19515285|P1|Overall Study|Death|50
5651288|NCT00556374|19515284|P2|Overall Study|Withdrawal by Subject|172
5651289|NCT00556374|19515285|P1|Overall Study|Withdrawal by Subject|190
5651291|NCT00556322|19515306|P1|Overall Study|Death|20
5651292|NCT00556322|19515305|P2|Overall Study|Ongoing at data cutoff|5
5651293|NCT00556322|19515306|P1|Overall Study|Ongoing at data cutoff|3
5651294|NCT00556322|19515305|P2|Overall Study|Protocol Violation|1
5651295|NCT00556322|19515306|P1|Overall Study|Protocol Violation|5
5651296|NCT00556322|19515305|P2|Overall Study|Withdrawal by Subject|7
5651297|NCT00556322|19515306|P1|Overall Study|Withdrawal by Subject|19
5651298|NCT00556322|19515305|P2|Overall Study|Lost to Follow-up|3
5651299|NCT00556322|19515306|P1|Overall Study|Lost to Follow-up|5
5651300|NCT00556322|19515305|P2|Overall Study|Other|1
5651301|NCT00556322|19515306|P1|Overall Study|Other|4
5651302|NCT00556322|19515305|P2|Overall Study|Adverse Event|4
5651303|NCT00556322|19515306|P1|Overall Study|Adverse Event|7
5651304|NCT00556322|19515305|P2|Overall Study|Insufficient therapeutic response|168
5651305|NCT00556322|19515306|P1|Overall Study|Insufficient therapeutic response|158
5651306|NCT00556166|19515354|P1|Overall Study|Withdrawal by Subject|1
5651307|NCT00556075|19515367|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
5651308|NCT00556075|19515368|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
5651309|NCT00556075|19515369|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
5651310|NCT00556075|19515367|P3|Overall Study|Personal issues|0
5651311|NCT00556075|19515368|P2|Overall Study|Personal issues|1
5651312|NCT00556075|19515369|P1|Overall Study|Personal issues|4
5651313|NCT00556075|19515367|P3|Overall Study|Adverse Event|0
5651314|NCT00556075|19515368|P2|Overall Study|Adverse Event|2
5651315|NCT00556075|19515369|P1|Overall Study|Adverse Event|1
5651316|NCT00556075|19515367|P3|Overall Study|Not eligible|2
5651317|NCT00556075|19515368|P2|Overall Study|Not eligible|1
5651318|NCT00556075|19515369|P1|Overall Study|Not eligible|1
5651319|NCT00556075|19515367|P3|Overall Study|Protocol Violation|3
5651320|NCT00556075|19515368|P2|Overall Study|Protocol Violation|1
5651321|NCT00556075|19515369|P1|Overall Study|Protocol Violation|1
5651322|NCT00556075|19515367|P3|Overall Study|Withdrawal by Subject|0
5651323|NCT00556075|19515368|P2|Overall Study|Withdrawal by Subject|3
5651324|NCT00556075|19515369|P1|Overall Study|Withdrawal by Subject|3
5651325|NCT00556075|19515367|P3|Overall Study|Lost to Follow-up|3
5651326|NCT00556075|19515368|P2|Overall Study|Lost to Follow-up|0
5651327|NCT00556075|19515369|P1|Overall Study|Lost to Follow-up|3
5651328|NCT00555971|19515420|P2|Overall Study|Adverse Event|1
5651329|NCT00555971|19515421|P1|Overall Study|Adverse Event|1
5651330|NCT00555906|19515432|P5|Phase 2|Randomized but not Treated|2
5651331|NCT00555906|19515433|P4|Phase 2|Randomized but not Treated|0
5651332|NCT00555906|19515434|P3|Phase 2|Randomized but not Treated|0
5651333|NCT00555906|19515435|P2|Phase 2|Randomized but not Treated|0
5651334|NCT00555906|19515436|P1|Phase 2|Randomized but not Treated|0
5651335|NCT00555906|19515432|P5|Phase 2|Other|6
5651336|NCT00555906|19515433|P4|Phase 2|Other|0
5651337|NCT00555906|19515434|P3|Phase 2|Other|0
5651338|NCT00555906|19515435|P2|Phase 2|Other|0
5651339|NCT00555906|19515436|P1|Phase 2|Other|0
5651340|NCT00555906|19515432|P5|Phase 2|Withdrawal by Subject|2
5651341|NCT00555906|19515433|P4|Phase 2|Withdrawal by Subject|0
5651342|NCT00555906|19515434|P3|Phase 2|Withdrawal by Subject|0
5651343|NCT00555906|19515435|P2|Phase 2|Withdrawal by Subject|0
5651344|NCT00555906|19515436|P1|Phase 2|Withdrawal by Subject|0
5651345|NCT00555906|19515432|P5|Phase 2|Objective Progression or Relapse|16
5651346|NCT00555906|19515433|P4|Phase 2|Objective Progression or Relapse|0
5651347|NCT00555906|19515434|P3|Phase 2|Objective Progression or Relapse|0
5651348|NCT00555906|19515435|P2|Phase 2|Objective Progression or Relapse|0
5651349|NCT00555906|19515436|P1|Phase 2|Objective Progression or Relapse|0
5651350|NCT00555906|19515432|P5|Phase 2|Global Deterioration of Health Status|2
5651351|NCT00555906|19515433|P4|Phase 2|Global Deterioration of Health Status|0
5651352|NCT00555906|19515434|P3|Phase 2|Global Deterioration of Health Status|0
5651353|NCT00555906|19515435|P2|Phase 2|Global Deterioration of Health Status|0
5651354|NCT00555906|19515436|P1|Phase 2|Global Deterioration of Health Status|0
5651355|NCT00555906|19515432|P5|Phase 2|Adverse Event|4
5651356|NCT00555906|19515433|P4|Phase 2|Adverse Event|0
5651357|NCT00555906|19515434|P3|Phase 2|Adverse Event|0
5651358|NCT00555906|19515435|P2|Phase 2|Adverse Event|0
5651359|NCT00555906|19515436|P1|Phase 2|Adverse Event|0
5651360|NCT00555906|19515432|P5|Phase 1|Withdrawal by Subject|0
5651361|NCT00555906|19515433|P4|Phase 1|Withdrawal by Subject|1
5651362|NCT00555906|19515434|P3|Phase 1|Withdrawal by Subject|0
5651363|NCT00555906|19515435|P2|Phase 1|Withdrawal by Subject|0
5651364|NCT00555906|19515436|P1|Phase 1|Withdrawal by Subject|0
5651365|NCT00555906|19515432|P5|Phase 1|Adverse Event|0
5651366|NCT00555906|19515433|P4|Phase 1|Adverse Event|2
5651367|NCT00555906|19515434|P3|Phase 1|Adverse Event|3
5651368|NCT00555906|19515435|P2|Phase 1|Adverse Event|0
5651369|NCT00555906|19515436|P1|Phase 1|Adverse Event|0
5651370|NCT00555906|19515432|P5|Phase 1|Global Deterioration of Health Status|0
5651371|NCT00555906|19515433|P4|Phase 1|Global Deterioration of Health Status|1
5651372|NCT00555906|19515434|P3|Phase 1|Global Deterioration of Health Status|1
5651373|NCT00555906|19515435|P2|Phase 1|Global Deterioration of Health Status|1
5651374|NCT00555906|19515436|P1|Phase 1|Global Deterioration of Health Status|0
5651375|NCT00555906|19515432|P5|Phase 1|Objective Progression or Relapse|0
5651376|NCT00555906|19515433|P4|Phase 1|Objective Progression or Relapse|1
5651377|NCT00555906|19515434|P3|Phase 1|Objective Progression or Relapse|3
5651378|NCT00555906|19515435|P2|Phase 1|Objective Progression or Relapse|5
5651379|NCT00555906|19515436|P1|Phase 1|Objective Progression or Relapse|3
5651380|NCT00555672|19515558|P2|Overall Study|Participant refused|0
5651381|NCT00555672|19515559|P1|Overall Study|Participant refused|2
5651382|NCT00555672|19515558|P2|Overall Study|Other|1
5651383|NCT00555672|19515559|P1|Overall Study|Other|3
5651384|NCT00555672|19515558|P2|Overall Study|Objective progression or relapse|5
5651385|NCT00555672|19515559|P1|Overall Study|Objective progression or relapse|11
5651386|NCT00555672|19515558|P2|Overall Study|Adverse Event|2
5651387|NCT00555672|19515559|P1|Overall Study|Adverse Event|8
5651388|NCT00555672|19515558|P2|Overall Study|Death|2
5651389|NCT00555672|19515559|P1|Overall Study|Death|0
5651390|NCT00555620|19515584|P6|Overall Study|Other|3
5651391|NCT00555620|19515585|P5|Overall Study|Other|0
5651392|NCT00555620|19515586|P4|Overall Study|Other|1
5651393|NCT00555620|19515587|P3|Overall Study|Other|0
5651394|NCT00555620|19515588|P2|Overall Study|Other|0
5651395|NCT00555620|19515589|P1|Overall Study|Other|0
5651396|NCT00555620|19515584|P6|Overall Study|Participant refused treatment|1
5651397|NCT00555620|19515585|P5|Overall Study|Participant refused treatment|0
5651398|NCT00555620|19515586|P4|Overall Study|Participant refused treatment|0
5651399|NCT00555620|19515587|P3|Overall Study|Participant refused treatment|1
5651400|NCT00555620|19515588|P2|Overall Study|Participant refused treatment|1
5651401|NCT00555620|19515589|P1|Overall Study|Participant refused treatment|0
5651402|NCT00555620|19515584|P6|Overall Study|Objective progression or relapse|16
5651403|NCT00555620|19515585|P5|Overall Study|Objective progression or relapse|3
5651404|NCT00555620|19515586|P4|Overall Study|Objective progression or relapse|17
5651405|NCT00555620|19515587|P3|Overall Study|Objective progression or relapse|12
5651406|NCT00555620|19515588|P2|Overall Study|Objective progression or relapse|5
5651407|NCT00555620|19515589|P1|Overall Study|Objective progression or relapse|6
5651408|NCT00555620|19515584|P6|Overall Study|Adverse Event|1
5651409|NCT00555620|19515585|P5|Overall Study|Adverse Event|0
5651410|NCT00555620|19515586|P4|Overall Study|Adverse Event|5
5651411|NCT00555620|19515587|P3|Overall Study|Adverse Event|1
5651412|NCT00555620|19515588|P2|Overall Study|Adverse Event|0
5651413|NCT00555620|19515589|P1|Overall Study|Adverse Event|0
5651414|NCT00555620|19515584|P6|Overall Study|Study terminated by sponsor|0
5651415|NCT00555620|19515585|P5|Overall Study|Study terminated by sponsor|0
5651416|NCT00555620|19515586|P4|Overall Study|Study terminated by sponsor|0
5651417|NCT00555620|19515587|P3|Overall Study|Study terminated by sponsor|1
5651418|NCT00555620|19515588|P2|Overall Study|Study terminated by sponsor|0
5651419|NCT00555620|19515589|P1|Overall Study|Study terminated by sponsor|0
5651420|NCT00555620|19515584|P6|Overall Study|Death|1
5651421|NCT00555620|19515585|P5|Overall Study|Death|0
5651422|NCT00555620|19515586|P4|Overall Study|Death|0
5651423|NCT00555620|19515587|P3|Overall Study|Death|0
5651424|NCT00555620|19515588|P2|Overall Study|Death|1
5651425|NCT00555620|19515589|P1|Overall Study|Death|0
5651426|NCT00555568|19515713|P3|Overall Study|Lost to Follow-up|16
5651427|NCT00555568|19515714|P2|Overall Study|Lost to Follow-up|16
5651428|NCT00555568|19515715|P1|Overall Study|Lost to Follow-up|26
5651429|NCT00555477|19515737|P2|Overall Study|Physician Decision|2
5651430|NCT00555477|19515738|P1|Overall Study|Physician Decision|1
5651431|NCT00555477|19515737|P2|Overall Study|Withdrawal by Subject|2
5651432|NCT00555477|19515738|P1|Overall Study|Withdrawal by Subject|1
5651433|NCT00555477|19515737|P2|Overall Study|Adverse Event|9
5651434|NCT00555477|19515738|P1|Overall Study|Adverse Event|0
5651435|NCT00555438|19515754|P1|Between 10 Days and 30 Days Postoperativ|Death|5
5651436|NCT00555438|19515754|P1|10 Days Post-operative|Death|4
5651437|NCT00555425|19515764|P2|Overall Study|Became pregnant and transferred care|1
5651438|NCT00555425|19515765|P1|Overall Study|Became pregnant and transferred care|0
5651439|NCT00555425|19515764|P2|Overall Study|Met criteria for protective transfer|3
5651440|NCT00555425|19515765|P1|Overall Study|Met criteria for protective transfer|16
5651441|NCT00555425|19515764|P2|Overall Study|Missed 3 physician management visits|0
5651442|NCT00555425|19515765|P1|Overall Study|Missed 3 physician management visits|1
5651443|NCT00555425|19515764|P2|Overall Study|Missed Medication > 1 wk|15
5651444|NCT00555425|19515765|P1|Overall Study|Missed Medication > 1 wk|34
5651445|NCT00555321|19515801|P5|Long-term Extension Phase|Other Reason|0
5651446|NCT00555321|19515802|P4|Long-term Extension Phase|Other Reason|0
5651447|NCT00555321|19515803|P3|Long-term Extension Phase|Other Reason|2
5651448|NCT00555321|19515804|P2|Long-term Extension Phase|Other Reason|0
5651449|NCT00555321|19515805|P1|Long-term Extension Phase|Other Reason|1
5651450|NCT00555321|19515801|P5|Long-term Extension Phase|Participant did not meet study criteria|1
5651451|NCT00555321|19515802|P4|Long-term Extension Phase|Participant did not meet study criteria|0
5651452|NCT00555321|19515803|P3|Long-term Extension Phase|Participant did not meet study criteria|0
5651453|NCT00555321|19515804|P2|Long-term Extension Phase|Participant did not meet study criteria|0
5651454|NCT00555321|19515805|P1|Long-term Extension Phase|Participant did not meet study criteria|0
5651455|NCT00555321|19515801|P5|Long-term Extension Phase|Death|0
5651456|NCT00555321|19515802|P4|Long-term Extension Phase|Death|3
5651457|NCT00555321|19515803|P3|Long-term Extension Phase|Death|0
5651458|NCT00555321|19515804|P2|Long-term Extension Phase|Death|0
5651459|NCT00555321|19515805|P1|Long-term Extension Phase|Death|2
5651460|NCT00555321|19515801|P5|Long-term Extension Phase|Administrative reason by sponsor|23
5651461|NCT00555321|19515802|P4|Long-term Extension Phase|Administrative reason by sponsor|31
5651462|NCT00555321|19515803|P3|Long-term Extension Phase|Administrative reason by sponsor|18
5651463|NCT00555321|19515804|P2|Long-term Extension Phase|Administrative reason by sponsor|21
5651464|NCT00555321|19515805|P1|Long-term Extension Phase|Administrative reason by sponsor|23
5651465|NCT00555321|19515801|P5|Long-term Extension Phase|Withdrawal by Subject|2
5651466|NCT00555321|19515802|P4|Long-term Extension Phase|Withdrawal by Subject|3
5651467|NCT00555321|19515803|P3|Long-term Extension Phase|Withdrawal by Subject|2
5651468|NCT00555321|19515804|P2|Long-term Extension Phase|Withdrawal by Subject|1
5651469|NCT00555321|19515805|P1|Long-term Extension Phase|Withdrawal by Subject|2
5651470|NCT00555321|19515801|P5|Long-term Extension Phase|Adverse Event|0
5651471|NCT00555321|19515802|P4|Long-term Extension Phase|Adverse Event|1
5651472|NCT00555321|19515803|P3|Long-term Extension Phase|Adverse Event|2
5651473|NCT00555321|19515804|P2|Long-term Extension Phase|Adverse Event|5
5651474|NCT00555321|19515805|P1|Long-term Extension Phase|Adverse Event|2
5651475|NCT00555321|19515801|P5|Treatment Phase up to 12-months|Never treated|4
5651476|NCT00555321|19515802|P4|Treatment Phase up to 12-months|Never treated|0
5651477|NCT00555321|19515803|P3|Treatment Phase up to 12-months|Never treated|1
5651478|NCT00555321|19515804|P2|Treatment Phase up to 12-months|Never treated|3
5651479|NCT00555321|19515805|P1|Treatment Phase up to 12-months|Never treated|2
5651480|NCT00555321|19515801|P5|Treatment Phase up to 12-months|Other Reason|0
5651481|NCT00555321|19515802|P4|Treatment Phase up to 12-months|Other Reason|0
5651482|NCT00555321|19515803|P3|Treatment Phase up to 12-months|Other Reason|2
5651483|NCT00555321|19515804|P2|Treatment Phase up to 12-months|Other Reason|3
5651484|NCT00555321|19515805|P1|Treatment Phase up to 12-months|Other Reason|1
5651485|NCT00555321|19515801|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
5651486|NCT00555321|19515802|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
5651487|NCT00555321|19515803|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
5651488|NCT00555321|19515804|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
5651489|NCT00555321|19515805|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
5651490|NCT00555321|19515801|P5|Treatment Phase up to 12-months|Death|0
5651491|NCT00555321|19515802|P4|Treatment Phase up to 12-months|Death|0
5651492|NCT00555321|19515803|P3|Treatment Phase up to 12-months|Death|4
5651493|NCT00555321|19515804|P2|Treatment Phase up to 12-months|Death|1
5651494|NCT00555321|19515805|P1|Treatment Phase up to 12-months|Death|2
5651495|NCT00555321|19515801|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
5651496|NCT00555321|19515802|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
5651497|NCT00555321|19515803|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
5651498|NCT00555321|19515804|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
5651499|NCT00555321|19515805|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
5651500|NCT00555321|19515801|P5|Treatment Phase up to 12-months|Adverse Event|18
5651501|NCT00555321|19515802|P4|Treatment Phase up to 12-months|Adverse Event|7
5651502|NCT00555321|19515803|P3|Treatment Phase up to 12-months|Adverse Event|11
5651503|NCT00555321|19515804|P2|Treatment Phase up to 12-months|Adverse Event|7
5651504|NCT00555321|19515805|P1|Treatment Phase up to 12-months|Adverse Event|6
5651505|NCT00555217|19516109|P2|Overall Study|close out sites|17
5651506|NCT00555217|19516110|P1|Overall Study|close out sites|21
5651507|NCT00555217|19516109|P2|Overall Study|Lost to Follow-up|20
5651508|NCT00555217|19516110|P1|Overall Study|Lost to Follow-up|19
5651509|NCT00555217|19516109|P2|Overall Study|Withdrawal by Subject|31
5651510|NCT00555217|19516110|P1|Overall Study|Withdrawal by Subject|35
5651511|NCT00555061|19516147|P1|Overall Study|Participant enrolled, but never treated|1
5651512|NCT00555061|19516147|P1|Overall Study|Withdrawal by Subject|2
5651513|NCT00555061|19516147|P1|Overall Study|Lost to Follow-up|2
5651514|NCT00555061|19516147|P1|Overall Study|Protocol Violation|1
5651515|NCT00555061|19516147|P1|Overall Study|Adverse Event|3
5651516|NCT00555009|19516166|P2|Overall Study|Terminated by Sponsor|5
5651517|NCT00555009|19516167|P1|Overall Study|Terminated by Sponsor|2
5651518|NCT00555009|19516166|P2|Overall Study|Withdrawal by Subject|1
5651519|NCT00555009|19516167|P1|Overall Study|Withdrawal by Subject|0
5651520|NCT00554840|19516247|P2|Overall Study|Physician Decision|1
5651521|NCT00554840|19516248|P1|Overall Study|Physician Decision|0
5651522|NCT00554801|19516266|P2|Overall Study|Withdrawal by Subject|0
5651523|NCT00554801|19516267|P1|Overall Study|Withdrawal by Subject|14
5651524|NCT00554801|19516266|P2|Overall Study|left area before completion|0
5651525|NCT00554801|19516267|P1|Overall Study|left area before completion|5
5651526|NCT00554788|19516278|P3|Overall Study|Ineligible|1
5651527|NCT00554788|19516279|P2|Overall Study|Ineligible|0
5651528|NCT00554788|19516280|P1|Overall Study|Ineligible|2
5651529|NCT00554788|19516278|P3|Overall Study|Progressive disease|3
5651530|NCT00554788|19516279|P2|Overall Study|Progressive disease|0
5651531|NCT00554788|19516280|P1|Overall Study|Progressive disease|0
5651532|NCT00554788|19516278|P3|Overall Study|Refusal of further protocol therapy|1
5651533|NCT00554788|19516279|P2|Overall Study|Refusal of further protocol therapy|1
5651534|NCT00554788|19516280|P1|Overall Study|Refusal of further protocol therapy|0
5651535|NCT00554788|19516278|P3|Overall Study|Withdrawal by Subject|1
5651536|NCT00554788|19516279|P2|Overall Study|Withdrawal by Subject|0
5651537|NCT00554788|19516280|P1|Overall Study|Withdrawal by Subject|0
5651538|NCT00554788|19516278|P3|Overall Study|Physician Decision|3
5651539|NCT00554788|19516279|P2|Overall Study|Physician Decision|1
5651540|NCT00554788|19516280|P1|Overall Study|Physician Decision|1
5651541|NCT00554788|19516278|P3|Overall Study|Lost to Follow-up|3
5651542|NCT00554788|19516279|P2|Overall Study|Lost to Follow-up|3
5651543|NCT00554788|19516280|P1|Overall Study|Lost to Follow-up|4
5651544|NCT00554788|19516278|P3|Overall Study|Adverse Event|2
5651545|NCT00554788|19516279|P2|Overall Study|Adverse Event|1
5651546|NCT00554788|19516280|P1|Overall Study|Adverse Event|0
5651547|NCT00554619|19516312|P1|Overall Study|Liver Function Test Abnormality|1
5651548|NCT00554619|19516312|P1|Overall Study|Physician Decision|1
5651549|NCT00554619|19516312|P1|Overall Study|Adverse Event|1
5651550|NCT00554515|19516324|P1|Overall Study|Misc|15
5651551|NCT00554515|19516324|P1|Overall Study|Other|1
5651552|NCT00554515|19516324|P1|Overall Study|Achieved Stable Disease|7
5651553|NCT00554515|19516324|P1|Overall Study|Death|2
5651554|NCT00554515|19516324|P1|Overall Study|Adverse Event|9
5651555|NCT00554515|19516324|P1|Overall Study|Withdrawal by Subject|11
5651556|NCT00554515|19516324|P1|Overall Study|Physician Decision|18
5651557|NCT00554515|19516324|P1|Overall Study|Disease progression|52
5651558|NCT00554515|19516324|P1|Overall Study|Withdrawal by Subject|3
5651559|NCT00554229|19516387|P2|Overall Study|Randomised but no treatment received|0
5651560|NCT00554229|19516388|P1|Overall Study|Randomised but no treatment received|1
5651561|NCT00554229|19516387|P2|Overall Study|Reason not otherwise captured, eg; death|140
5651562|NCT00554229|19516388|P1|Overall Study|Reason not otherwise captured, eg; death|119
5651563|NCT00554229|19516387|P2|Overall Study|Protocol Violation|3
5651564|NCT00554229|19516388|P1|Overall Study|Protocol Violation|3
5651565|NCT00554229|19516387|P2|Overall Study|Adverse Event|39
5651566|NCT00554229|19516388|P1|Overall Study|Adverse Event|71
5651567|NCT00554229|19516387|P2|Overall Study|Withdrawal by Subject|37
5651568|NCT00554229|19516388|P1|Overall Study|Withdrawal by Subject|29
5651569|NCT00554229|19516387|P2|Overall Study|Lost to Follow-up|6
5651570|NCT00554229|19516388|P1|Overall Study|Lost to Follow-up|3
5651571|NCT00554216|19516413|P3|Overall Study|Lack of Efficacy|0
5651572|NCT00554216|19516414|P2|Overall Study|Lack of Efficacy|3
5651573|NCT00554216|19516415|P1|Overall Study|Lack of Efficacy|15
5651574|NCT00554216|19516413|P3|Overall Study|Other|10
5651575|NCT00554216|19516414|P2|Overall Study|Other|7
5651576|NCT00554216|19516415|P1|Overall Study|Other|12
5651577|NCT00554216|19516413|P3|Overall Study|Restricted med|1
5651578|NCT00554216|19516414|P2|Overall Study|Restricted med|1
5651579|NCT00554216|19516415|P1|Overall Study|Restricted med|3
5651580|NCT00554216|19516413|P3|Overall Study|Pregnancy|14
5651581|NCT00554216|19516414|P2|Overall Study|Pregnancy|1
5651582|NCT00554216|19516415|P1|Overall Study|Pregnancy|2
5651583|NCT00554216|19516413|P3|Overall Study|Non compliance|5
5651584|NCT00554216|19516414|P2|Overall Study|Non compliance|4
5651585|NCT00554216|19516415|P1|Overall Study|Non compliance|10
5651586|NCT00554216|19516413|P3|Overall Study|Withdrawal by Subject|43
5651587|NCT00554216|19516414|P2|Overall Study|Withdrawal by Subject|31
5651588|NCT00554216|19516415|P1|Overall Study|Withdrawal by Subject|92
5651589|NCT00554216|19516413|P3|Overall Study|Adverse Event|36
5651590|NCT00554216|19516414|P2|Overall Study|Adverse Event|16
5651591|NCT00554216|19516415|P1|Overall Study|Adverse Event|16
5651592|NCT00554216|19516413|P3|Overall Study|Lost to Follow-up|63
5651593|NCT00554216|19516414|P2|Overall Study|Lost to Follow-up|31
5651594|NCT00554216|19516415|P1|Overall Study|Lost to Follow-up|92
5651595|NCT00554190|19516426|P1|Overall Study|Termination forms not completed|10
5651596|NCT00554099|19516435|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
5651597|NCT00554099|19516436|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
5651598|NCT00554099|19516437|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
5651599|NCT00554099|19516435|P3|Non-Treatment Phase (9 Months)|Relapse|1
5651600|NCT00554099|19516436|P2|Non-Treatment Phase (9 Months)|Relapse|1
5651601|NCT00554099|19516437|P1|Non-Treatment Phase (9 Months)|Relapse|2
5651602|NCT00554099|19516435|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
5651603|NCT00554099|19516436|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
5651604|NCT00554099|19516437|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
5651605|NCT00554099|19516435|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
5651606|NCT00554099|19516436|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
5651607|NCT00554099|19516437|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
5651608|NCT00554099|19516435|P3|Treatment Period (12 Weeks)|Protocol Violation|2
5651609|NCT00554099|19516436|P2|Treatment Period (12 Weeks)|Protocol Violation|0
5651610|NCT00554099|19516437|P1|Treatment Period (12 Weeks)|Protocol Violation|0
5651611|NCT00554099|19516435|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
5651612|NCT00554099|19516436|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
5651613|NCT00554099|19516437|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
5651614|NCT00554099|19516435|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
5651615|NCT00554099|19516436|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
5651616|NCT00554099|19516437|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
5651617|NCT00554099|19516435|P3|Treatment Period (12 Weeks)|Physician Decision|0
5651618|NCT00554099|19516436|P2|Treatment Period (12 Weeks)|Physician Decision|0
5651619|NCT00554099|19516437|P1|Treatment Period (12 Weeks)|Physician Decision|3
5651620|NCT00554099|19516435|P3|Treatment Period (12 Weeks)|Adverse Event|1
5651621|NCT00554099|19516436|P2|Treatment Period (12 Weeks)|Adverse Event|5
5651622|NCT00554099|19516437|P1|Treatment Period (12 Weeks)|Adverse Event|3
5651623|NCT00553787|19516492|P3|Overall Study|Other|13
5651624|NCT00553787|19516493|P2|Overall Study|Other|10
5651625|NCT00553787|19516494|P1|Overall Study|Other|18
5651626|NCT00553787|19516492|P3|Overall Study|Requirement for restricted medication|5
5651627|NCT00553787|19516493|P2|Overall Study|Requirement for restricted medication|7
5651628|NCT00553787|19516494|P1|Overall Study|Requirement for restricted medication|8
5651629|NCT00553787|19516492|P3|Overall Study|non compliance|11
5651630|NCT00553787|19516493|P2|Overall Study|non compliance|0
5651631|NCT00553787|19516494|P1|Overall Study|non compliance|4
5651632|NCT00553787|19516492|P3|Overall Study|Pregnancy|2
5651633|NCT00553787|19516493|P2|Overall Study|Pregnancy|1
5651634|NCT00553787|19516494|P1|Overall Study|Pregnancy|0
5651635|NCT00553787|19516492|P3|Overall Study|Lack of Efficacy|3
5651636|NCT00553787|19516493|P2|Overall Study|Lack of Efficacy|1
5651637|NCT00553787|19516494|P1|Overall Study|Lack of Efficacy|31
5651638|NCT00553787|19516492|P3|Overall Study|Withdrawal by Subject|83
5651639|NCT00553787|19516493|P2|Overall Study|Withdrawal by Subject|40
5651640|NCT00553787|19516494|P1|Overall Study|Withdrawal by Subject|151
5651641|NCT00553787|19516492|P3|Overall Study|Lost to Follow-up|78
5651642|NCT00553787|19516493|P2|Overall Study|Lost to Follow-up|44
5651643|NCT00553787|19516494|P1|Overall Study|Lost to Follow-up|132
5651644|NCT00553787|19516492|P3|Overall Study|Adverse Event|67
5651645|NCT00553787|19516493|P2|Overall Study|Adverse Event|21
5651646|NCT00553787|19516494|P1|Overall Study|Adverse Event|34
5651647|NCT00553696|19516526|P4|Overall Study|Withdrawal by Subject|0
5651648|NCT00553696|19516527|P3|Overall Study|Withdrawal by Subject|0
5651649|NCT00553696|19516528|P2|Overall Study|Withdrawal by Subject|1
5651650|NCT00553696|19516529|P1|Overall Study|Withdrawal by Subject|0
5651651|NCT00553696|19516526|P4|Overall Study|Objective progression or relapse|0
5651652|NCT00553696|19516527|P3|Overall Study|Objective progression or relapse|6
5651653|NCT00553696|19516528|P2|Overall Study|Objective progression or relapse|9
5651654|NCT00553696|19516529|P1|Overall Study|Objective progression or relapse|2
5651655|NCT00553696|19516526|P4|Overall Study|Global deterioration of health status|0
5651656|NCT00553696|19516527|P3|Overall Study|Global deterioration of health status|0
5651657|NCT00553696|19516528|P2|Overall Study|Global deterioration of health status|2
5651658|NCT00553696|19516529|P1|Overall Study|Global deterioration of health status|0
5651659|NCT00553696|19516526|P4|Overall Study|Adverse Event|1
5651660|NCT00553696|19516527|P3|Overall Study|Adverse Event|0
5651661|NCT00553696|19516528|P2|Overall Study|Adverse Event|4
5651662|NCT00553696|19516529|P1|Overall Study|Adverse Event|2
5651663|NCT00553644|19516567|P1|Overall Study|Alternative therapy|6
5651664|NCT00553644|19516567|P1|Overall Study|Physician Decision|1
5651665|NCT00553644|19516567|P1|Overall Study|Withdrawal by Subject|4
5651666|NCT00553644|19516567|P1|Overall Study|Adverse Event|17
5651667|NCT00553631|19516576|P2|Overall Study|Lost to Follow-up|0
5651668|NCT00553631|19516577|P1|Overall Study|Lost to Follow-up|1
5651669|NCT00553631|19516576|P2|Overall Study|Withdrawal by Subject|1
5651670|NCT00553631|19516577|P1|Overall Study|Withdrawal by Subject|0
5651671|NCT00553605|19516599|P2|Overall Study|Randomized but not treated|0
5651672|NCT00553605|19516600|P1|Overall Study|Randomized but not treated|2
5651673|NCT00553605|19516599|P2|Overall Study|Did not receive full dose|0
5651674|NCT00553605|19516600|P1|Overall Study|Did not receive full dose|1
5651675|NCT00553605|19516599|P2|Overall Study|Did not meet entrance criteria|3
5651676|NCT00553605|19516600|P1|Overall Study|Did not meet entrance criteria|1
5651677|NCT00553540|19516626|P2|Overall Study|discharged after first visit|5
5651678|NCT00553540|19516627|P1|Overall Study|discharged after first visit|2
5651679|NCT00553514|19516638|P5|Overall Study|Other|1
5651680|NCT00553514|19516639|P4|Overall Study|Other|0
5651681|NCT00553514|19516640|P3|Overall Study|Other|0
5651682|NCT00553514|19516641|P2|Overall Study|Other|1
5651683|NCT00553514|19516642|P1|Overall Study|Other|1
5651684|NCT00553514|19516638|P5|Overall Study|Risk of multiple pregnancy|0
5651685|NCT00553514|19516639|P4|Overall Study|Risk of multiple pregnancy|1
5651686|NCT00553514|19516640|P3|Overall Study|Risk of multiple pregnancy|0
5651687|NCT00553514|19516641|P2|Overall Study|Risk of multiple pregnancy|2
5651688|NCT00553514|19516642|P1|Overall Study|Risk of multiple pregnancy|0
5651689|NCT00553514|19516638|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
5651690|NCT00553514|19516639|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
5651691|NCT00553514|19516640|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
5651692|NCT00553514|19516641|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
5651693|NCT00553514|19516642|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
5651694|NCT00553514|19516638|P5|Overall Study|Lack of ovarian response|6
5651695|NCT00553514|19516639|P4|Overall Study|Lack of ovarian response|5
5651696|NCT00553514|19516640|P3|Overall Study|Lack of ovarian response|5
5651697|NCT00553514|19516641|P2|Overall Study|Lack of ovarian response|5
5651698|NCT00553514|19516642|P1|Overall Study|Lack of ovarian response|4
5651699|NCT00553514|19516638|P5|Overall Study|Protocol deviation|0
5651700|NCT00553514|19516639|P4|Overall Study|Protocol deviation|1
5651701|NCT00553514|19516640|P3|Overall Study|Protocol deviation|0
5651702|NCT00553514|19516641|P2|Overall Study|Protocol deviation|0
5651703|NCT00553514|19516642|P1|Overall Study|Protocol deviation|0
5651704|NCT00553501|19516679|P1|Overall Study|Progression|1
5651705|NCT00553501|19516679|P1|Overall Study|Death|1
5651706|NCT00553501|19516679|P1|Overall Study|Adverse Event|2
5651707|NCT00553475|19516688|P3|Overall Study|Due to moving|0
5651708|NCT00553475|19516689|P2|Overall Study|Due to moving|1
5651709|NCT00553475|19516690|P1|Overall Study|Due to moving|0
5651710|NCT00553475|19516688|P3|Overall Study|Physician Decision|0
5651711|NCT00553475|19516689|P2|Overall Study|Physician Decision|0
5651712|NCT00553475|19516690|P1|Overall Study|Physician Decision|1
5651713|NCT00553475|19516688|P3|Overall Study|Withdrawal by Subject|0
5651714|NCT00553475|19516689|P2|Overall Study|Withdrawal by Subject|1
5651715|NCT00553475|19516690|P1|Overall Study|Withdrawal by Subject|1
5651716|NCT00553475|19516688|P3|Overall Study|Lack of Efficacy|0
5651717|NCT00553475|19516689|P2|Overall Study|Lack of Efficacy|1
5651718|NCT00553475|19516690|P1|Overall Study|Lack of Efficacy|7
5651719|NCT00553475|19516688|P3|Overall Study|Adverse Event|13
5651720|NCT00553475|19516689|P2|Overall Study|Adverse Event|17
5651721|NCT00553475|19516690|P1|Overall Study|Adverse Event|7
5651722|NCT00553462|19516812|P1|Overall Study|Physician Decision|1
5651723|NCT00553462|19516812|P1|Overall Study|Withdrawal by Subject|5
5651724|NCT00553462|19516812|P1|Overall Study|Progression|4
5651725|NCT00553462|19516812|P1|Overall Study|Adverse Event|4
5651726|NCT00553436|19516818|P1|Overall Study|Conversion to another procedure|1
5651727|NCT00553358|19516842|P3|Overall Study|Other: Reason Not Specified|20
5651728|NCT00553358|19516843|P2|Overall Study|Other: Reason Not Specified|4
5651729|NCT00553358|19516844|P1|Overall Study|Other: Reason Not Specified|15
5651730|NCT00553358|19516842|P3|Overall Study|Missing|1
5651731|NCT00553358|19516843|P2|Overall Study|Missing|1
5651732|NCT00553358|19516844|P1|Overall Study|Missing|1
5651733|NCT00553358|19516842|P3|Overall Study|Participant Withdrawal from Drug|3
5651734|NCT00553358|19516843|P2|Overall Study|Participant Withdrawal from Drug|0
5651735|NCT00553358|19516844|P1|Overall Study|Participant Withdrawal from Drug|0
5651736|NCT00553358|19516842|P3|Overall Study|Recurrence of Disease|1
5651737|NCT00553358|19516843|P2|Overall Study|Recurrence of Disease|4
5651738|NCT00553358|19516844|P1|Overall Study|Recurrence of Disease|3
5651739|NCT00553358|19516842|P3|Overall Study|Withdrawal by Subject|1
5651740|NCT00553358|19516843|P2|Overall Study|Withdrawal by Subject|0
5651741|NCT00553358|19516844|P1|Overall Study|Withdrawal by Subject|5
5651742|NCT00553358|19516842|P3|Overall Study|Protocol Violation|1
5651743|NCT00553358|19516843|P2|Overall Study|Protocol Violation|1
5651744|NCT00553358|19516844|P1|Overall Study|Protocol Violation|0
5651745|NCT00553358|19516842|P3|Overall Study|Lost to Follow-up|1
5651746|NCT00553358|19516843|P2|Overall Study|Lost to Follow-up|0
5651747|NCT00553358|19516844|P1|Overall Study|Lost to Follow-up|0
5651748|NCT00553358|19516842|P3|Overall Study|Adverse Event|32
5651749|NCT00553358|19516843|P2|Overall Study|Adverse Event|2
5651750|NCT00553358|19516844|P1|Overall Study|Adverse Event|29
5651751|NCT00553332|19516870|P1|Overall Study|ineligible, incorrect diagnosis|1
5651752|NCT00553319|19516882|P3|Overall Study|moved|1
5651753|NCT00553319|19516883|P2|Overall Study|moved|0
5651754|NCT00553319|19516884|P1|Overall Study|moved|1
5651755|NCT00553319|19516882|P3|Overall Study|incarceration|0
5651756|NCT00553319|19516883|P2|Overall Study|incarceration|0
5651757|NCT00553319|19516884|P1|Overall Study|incarceration|1
5651758|NCT00553319|19516882|P3|Overall Study|non-compliance|2
5651759|NCT00553319|19516883|P2|Overall Study|non-compliance|0
5651760|NCT00553319|19516884|P1|Overall Study|non-compliance|0
5651761|NCT00553319|19516882|P3|Overall Study|wanted treatment elsewhere|1
5651762|NCT00553319|19516883|P2|Overall Study|wanted treatment elsewhere|1
5651763|NCT00553319|19516884|P1|Overall Study|wanted treatment elsewhere|2
5651764|NCT00553319|19516882|P3|Overall Study|Lost to Follow-up|5
5651765|NCT00553319|19516883|P2|Overall Study|Lost to Follow-up|9
5651766|NCT00553319|19516884|P1|Overall Study|Lost to Follow-up|10
5651767|NCT00553280|19516895|P1|Overall Study|Physician Decision|1
5651768|NCT00553280|19516895|P1|Overall Study|Withdrawal by Subject|3
5651769|NCT00553280|19516895|P1|Overall Study|Lack of Efficacy|3
5651770|NCT00553280|19516895|P1|Overall Study|Adverse Event|19
5651771|NCT00553267|19516907|P3|Overall Study|Specified category|1
5651772|NCT00553267|19516908|P2|Overall Study|Specified category|2
5651773|NCT00553267|19516909|P1|Overall Study|Specified category|1
5651774|NCT00553267|19516907|P3|Overall Study|Consent withdrawn|1
5651775|NCT00553267|19516908|P2|Overall Study|Consent withdrawn|3
5651776|NCT00553267|19516909|P1|Overall Study|Consent withdrawn|2
5651777|NCT00553267|19516907|P3|Overall Study|Lost to Follow-up|1
5651778|NCT00553267|19516908|P2|Overall Study|Lost to Follow-up|0
5651779|NCT00553267|19516909|P1|Overall Study|Lost to Follow-up|0
5651780|NCT00553267|19516907|P3|Overall Study|Non compliant with protocol|2
5651781|NCT00553267|19516908|P2|Overall Study|Non compliant with protocol|3
5651782|NCT00553267|19516909|P1|Overall Study|Non compliant with protocol|3
5651783|NCT00553267|19516907|P3|Overall Study|Adverse Event|5
5651784|NCT00553267|19516908|P2|Overall Study|Adverse Event|10
5651785|NCT00553267|19516909|P1|Overall Study|Adverse Event|8
5651786|NCT00553254|19516946|P3|Overall Study|Other|13
5651787|NCT00553254|19516947|P2|Overall Study|Other|0
5651788|NCT00553254|19516948|P1|Overall Study|Other|1
5651789|NCT00553254|19516946|P3|Overall Study|Study terminated by Sponsor|1
5651790|NCT00553254|19516947|P2|Overall Study|Study terminated by Sponsor|0
5651791|NCT00553254|19516948|P1|Overall Study|Study terminated by Sponsor|0
5651792|NCT00553254|19516946|P3|Overall Study|Withdrawal by Subject|2
5651793|NCT00553254|19516947|P2|Overall Study|Withdrawal by Subject|0
5651794|NCT00553254|19516948|P1|Overall Study|Withdrawal by Subject|2
5651795|NCT00553254|19516946|P3|Overall Study|Lost to Follow-up|2
5651796|NCT00553254|19516947|P2|Overall Study|Lost to Follow-up|0
5651797|NCT00553254|19516948|P1|Overall Study|Lost to Follow-up|0
5651798|NCT00553254|19516946|P3|Overall Study|Death|25
5651799|NCT00553254|19516947|P2|Overall Study|Death|6
5651800|NCT00553254|19516948|P1|Overall Study|Death|3
5651801|NCT00553202|19516990|P1|Overall Study|Fails to meet organ function|6
5651802|NCT00553202|19516990|P1|Overall Study|No donor identified|16
5651803|NCT00553202|19516990|P1|Overall Study|Withdrawal by Subject|1
5651804|NCT00553202|19516990|P1|Overall Study|Physician Decision|28
5651805|NCT00553202|19516990|P1|Overall Study|Lost to Follow-up|1
5651806|NCT00553202|19516990|P1|Overall Study|Death|16
5651807|NCT00553150|19517017|P4|Overall Study|Ineligible|1
5651808|NCT00553150|19517018|P3|Overall Study|Ineligible|0
5651809|NCT00553150|19517019|P2|Overall Study|Ineligible|0
5651810|NCT00553150|19517020|P1|Overall Study|Ineligible|0
5651811|NCT00553150|19517017|P4|Overall Study|Protocol Violation|1
5651812|NCT00553150|19517018|P3|Overall Study|Protocol Violation|0
5651813|NCT00553150|19517019|P2|Overall Study|Protocol Violation|0
5651814|NCT00553150|19517020|P1|Overall Study|Protocol Violation|0
5651815|NCT00553150|19517017|P4|Overall Study|Withdrawal by Subject|2
5651816|NCT00553150|19517018|P3|Overall Study|Withdrawal by Subject|0
5651817|NCT00553150|19517019|P2|Overall Study|Withdrawal by Subject|0
5651818|NCT00553150|19517020|P1|Overall Study|Withdrawal by Subject|0
5651819|NCT00553059|19517048|P2|Overall Study|Drug supply not available|1
5651820|NCT00553059|19517049|P1|Overall Study|Drug supply not available|0
5651821|NCT00553059|19517048|P2|Overall Study|Deemed ineligible|1
5651822|NCT00553059|19517049|P1|Overall Study|Deemed ineligible|1
5651823|NCT00552929|19517077|P10|Overall Study|Not Eligible|0
5651824|NCT00552929|19517078|P9|Overall Study|Not Eligible|0
5651825|NCT00552929|19517079|P8|Overall Study|Not Eligible|0
5651826|NCT00552929|19517080|P7|Overall Study|Not Eligible|0
5651827|NCT00552929|19517081|P6|Overall Study|Not Eligible|1
5651828|NCT00552929|19517082|P5|Overall Study|Not Eligible|0
5651829|NCT00552929|19517083|P4|Overall Study|Not Eligible|0
5651830|NCT00552929|19517084|P3|Overall Study|Not Eligible|0
5651831|NCT00552929|19517085|P2|Overall Study|Not Eligible|0
5651832|NCT00552929|19517086|P1|Overall Study|Not Eligible|0
5651833|NCT00552929|19517077|P10|Overall Study|Lost to Follow-up|0
5651834|NCT00552929|19517078|P9|Overall Study|Lost to Follow-up|1
5651835|NCT00552929|19517079|P8|Overall Study|Lost to Follow-up|0
5651836|NCT00552929|19517080|P7|Overall Study|Lost to Follow-up|0
5651837|NCT00552929|19517081|P6|Overall Study|Lost to Follow-up|0
5651838|NCT00552929|19517082|P5|Overall Study|Lost to Follow-up|0
5651839|NCT00552929|19517083|P4|Overall Study|Lost to Follow-up|0
5651840|NCT00552929|19517084|P3|Overall Study|Lost to Follow-up|0
5651841|NCT00552929|19517085|P2|Overall Study|Lost to Follow-up|0
5651842|NCT00552929|19517086|P1|Overall Study|Lost to Follow-up|0
5651843|NCT00552760|19517157|P2|Overall Study|Medication Change|0
5651844|NCT00552760|19517158|P1|Overall Study|Medication Change|1
5651845|NCT00552760|19517157|P2|Overall Study|Withdrawal by Subject|0
5651846|NCT00552760|19517158|P1|Overall Study|Withdrawal by Subject|3
5651847|NCT00552760|19517157|P2|Overall Study|Medical Condition|1
5651848|NCT00552760|19517158|P1|Overall Study|Medical Condition|1
5651849|NCT00552760|19517157|P2|Overall Study|Non-compliance|1
5651850|NCT00552760|19517158|P1|Overall Study|Non-compliance|1
5651851|NCT00552760|19517157|P2|Overall Study|Lost to Follow-up|1
5651852|NCT00552760|19517158|P1|Overall Study|Lost to Follow-up|1
5651853|NCT00552760|19517157|P2|Overall Study|Protocol Violation|1
5651854|NCT00552760|19517158|P1|Overall Study|Protocol Violation|0
5651855|NCT00552760|19517157|P2|Overall Study|Relapsed- Mixed Event|5
5651856|NCT00552760|19517158|P1|Overall Study|Relapsed- Mixed Event|3
5651857|NCT00552760|19517157|P2|Overall Study|Relapse- Manic Event|3
5651858|NCT00552760|19517158|P1|Overall Study|Relapse- Manic Event|3
5651859|NCT00552760|19517157|P2|Overall Study|Relapsed- Depressed Event|16
5651860|NCT00552760|19517158|P1|Overall Study|Relapsed- Depressed Event|10
5651861|NCT00552760|19517157|P2|Overall Study|Adverse Event|5
5651862|NCT00552760|19517158|P1|Overall Study|Adverse Event|3
5651863|NCT00552669|19517185|P2|Overall Study|Death|7
5651864|NCT00552669|19517186|P1|Overall Study|Death|3
5651865|NCT00552617|19517206|P10|Overall Study|Lost to Follow-up|0
5651866|NCT00552617|19517207|P9|Overall Study|Lost to Follow-up|2
5651867|NCT00552617|19517208|P8|Overall Study|Lost to Follow-up|0
5651868|NCT00552617|19517209|P7|Overall Study|Lost to Follow-up|0
5651869|NCT00552617|19517210|P6|Overall Study|Lost to Follow-up|2
5651870|NCT00552617|19517211|P5|Overall Study|Lost to Follow-up|0
5651871|NCT00552617|19517212|P4|Overall Study|Lost to Follow-up|1
5651872|NCT00552617|19517213|P3|Overall Study|Lost to Follow-up|0
5651873|NCT00552617|19517214|P2|Overall Study|Lost to Follow-up|0
5651874|NCT00552617|19517215|P1|Overall Study|Lost to Follow-up|0
5651875|NCT00552617|19517206|P10|Overall Study|Not Treated|1
5651876|NCT00552617|19517207|P9|Overall Study|Not Treated|0
5651877|NCT00552617|19517208|P8|Overall Study|Not Treated|0
5651878|NCT00552617|19517209|P7|Overall Study|Not Treated|0
5651879|NCT00552617|19517210|P6|Overall Study|Not Treated|0
5651880|NCT00552617|19517211|P5|Overall Study|Not Treated|0
5651881|NCT00552617|19517212|P4|Overall Study|Not Treated|0
5651882|NCT00552617|19517213|P3|Overall Study|Not Treated|1
5651883|NCT00552617|19517214|P2|Overall Study|Not Treated|0
5651884|NCT00552617|19517215|P1|Overall Study|Not Treated|0
5651885|NCT00552578|19517259|P2|Overall Study|Lost to Follow-up|1
5651886|NCT00552578|19517260|P1|Overall Study|Lost to Follow-up|1
5651887|NCT00552513|19517272|P2|Overall Study|Lost to Follow-up|1
5651888|NCT00552513|19517273|P1|Overall Study|Lost to Follow-up|5
5651889|NCT00552396|19517318|P7|Overall Study|protocol withdrawal criteria|9
5651890|NCT00552396|19517319|P6|Overall Study|protocol withdrawal criteria|3
5651891|NCT00552396|19517320|P5|Overall Study|protocol withdrawal criteria|3
5651892|NCT00552396|19517321|P4|Overall Study|protocol withdrawal criteria|6
5651893|NCT00552396|19517322|P3|Overall Study|protocol withdrawal criteria|3
5651894|NCT00552396|19517323|P2|Overall Study|protocol withdrawal criteria|3
5651895|NCT00552396|19517324|P1|Overall Study|protocol withdrawal criteria|3
5651896|NCT00552344|19517361|P1|Overall Study|Other Reason|22
5651897|NCT00552344|19517361|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
5651898|NCT00552344|19517361|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
5651899|NCT00552344|19517361|P1|Overall Study|AE, non-serious non-fatal|38
5651900|NCT00552344|19517361|P1|Overall Study|SAE, non-fatal|6
5651901|NCT00552344|19517361|P1|Overall Study|Withdrawal by Subject|48
5651902|NCT00552344|19517361|P1|Overall Study|Lost to Follow-up|8
5651903|NCT00552344|19517361|P1|Overall Study|Loss of efficacy|75
5651904|NCT00552344|19517361|P1|Overall Study|Lack of Efficacy|55
5651905|NCT00552305|19517370|P1|Overall Study|Other: Subject went to rehab|1
5651906|NCT00552305|19517370|P1|Overall Study|Other: Subject incarcerated|1
5651907|NCT00552305|19517370|P1|Overall Study|Other: Subject moved from area|2
5651908|NCT00552305|19517370|P1|Overall Study|Other: Health problems, not drug related|1
5651909|NCT00552305|19517370|P1|Overall Study|Other: Subject became pregnant|1
5651910|NCT00552305|19517370|P1|Overall Study|Other: Subject underwent surgery|4
5651911|NCT00552305|19517370|P1|Overall Study|Other: Unable to attend visits|1
5651912|NCT00552305|19517370|P1|Overall Study|Other: Personal problems|1
5651913|NCT00552305|19517370|P1|Overall Study|Other: Site closed|4
5651914|NCT00552305|19517370|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
5651915|NCT00552305|19517370|P1|Overall Study|AE/Other: prohibited drug required|1
5651916|NCT00552305|19517370|P1|Overall Study|Poor compliance/lost to follow-up|1
5651917|NCT00552305|19517370|P1|Overall Study|Unsatisfactory compliance|11
5651918|NCT00552305|19517370|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
5651919|NCT00552305|19517370|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
5651920|NCT00552305|19517370|P1|Overall Study|Lack of efficacy/withdrew consent|1
5651921|NCT00552305|19517370|P1|Overall Study|Withdrawal by Subject|44
5651922|NCT00552305|19517370|P1|Overall Study|Protocol Violation|3
5651923|NCT00552305|19517370|P1|Overall Study|Lost to Follow-up|4
5651924|NCT00552305|19517370|P1|Overall Study|Lack of Efficacy|120
5651925|NCT00552305|19517370|P1|Overall Study|Adverse Event|43
5651926|NCT00552279|19517380|P2|Overall Study|Other|1
5651927|NCT00552279|19517381|P1|Overall Study|Other|1
5651928|NCT00552279|19517380|P2|Overall Study|Lost to Follow-up|0
5651929|NCT00552279|19517381|P1|Overall Study|Lost to Follow-up|1
5651930|NCT00552279|19517380|P2|Overall Study|Withdrawal by Subject|1
5651931|NCT00552279|19517381|P1|Overall Study|Withdrawal by Subject|12
5651932|NCT00552279|19517380|P2|Overall Study|Adverse Event|1
5651933|NCT00552279|19517381|P1|Overall Study|Adverse Event|0
5651934|NCT00552240|19517407|P2|Overall Study|Other|0
5651935|NCT00552240|19517408|P1|Overall Study|Other|1
5651936|NCT00552240|19517407|P2|Overall Study|Lack of Efficacy|0
5651937|NCT00552240|19517408|P1|Overall Study|Lack of Efficacy|6
5651938|NCT00552240|19517407|P2|Overall Study|Withdrawal by Subject|2
5651939|NCT00552240|19517408|P1|Overall Study|Withdrawal by Subject|2
5651940|NCT00552240|19517407|P2|Overall Study|Lost to Follow-up|6
5651941|NCT00552240|19517408|P1|Overall Study|Lost to Follow-up|5
5651942|NCT00552240|19517407|P2|Overall Study|Protocol Violation|1
5651943|NCT00552240|19517408|P1|Overall Study|Protocol Violation|1
5651944|NCT00552240|19517407|P2|Overall Study|Adverse Event|9
5651945|NCT00552240|19517408|P1|Overall Study|Adverse Event|9
5651946|NCT00552188|19517510|P2|Overall Study|Subject returned to home country|1
5651947|NCT00552188|19517511|P1|Overall Study|Subject returned to home country|0
5651948|NCT00552188|19517510|P2|Overall Study|Withdrawal of consent|1
5651949|NCT00552188|19517511|P1|Overall Study|Withdrawal of consent|0
5651950|NCT00552188|19517510|P2|Overall Study|Lost to Follow-up|1
5651951|NCT00552188|19517511|P1|Overall Study|Lost to Follow-up|2
5651952|NCT00552188|19517510|P2|Overall Study|Adverse Event|2
5651953|NCT00552188|19517511|P1|Overall Study|Adverse Event|0
5651954|NCT00552175|19517522|P3|Overall Study|Reason Not Specified|1
5651955|NCT00552175|19517523|P2|Overall Study|Reason Not Specified|1
5651956|NCT00552175|19517524|P1|Overall Study|Reason Not Specified|3
5651957|NCT00552175|19517522|P3|Overall Study|Entry Criteria Not Met|0
5651958|NCT00552175|19517523|P2|Overall Study|Entry Criteria Not Met|1
5651959|NCT00552175|19517524|P1|Overall Study|Entry Criteria Not Met|1
5651960|NCT00552175|19517522|P3|Overall Study|Lost to Follow-up|1
5651961|NCT00552175|19517523|P2|Overall Study|Lost to Follow-up|0
5651962|NCT00552175|19517524|P1|Overall Study|Lost to Follow-up|0
5651963|NCT00552175|19517522|P3|Overall Study|Withdrawal by Subject|1
5651964|NCT00552175|19517523|P2|Overall Study|Withdrawal by Subject|2
5651965|NCT00552175|19517524|P1|Overall Study|Withdrawal by Subject|2
5651966|NCT00552175|19517522|P3|Overall Study|Adverse Event|10
5651967|NCT00552175|19517523|P2|Overall Study|Adverse Event|9
5651968|NCT00552175|19517524|P1|Overall Study|Adverse Event|9
5651969|NCT00552175|19517522|P3|Overall Study|Lack of Efficacy|1
5651970|NCT00552175|19517523|P2|Overall Study|Lack of Efficacy|0
5651971|NCT00552175|19517524|P1|Overall Study|Lack of Efficacy|2
5651972|NCT00552110|19517564|P5|Overall Study|Nonserious Adverse Event (AE)|0
5651973|NCT00552110|19517565|P4|Overall Study|Nonserious Adverse Event (AE)|1
5651974|NCT00552110|19517566|P3|Overall Study|Nonserious Adverse Event (AE)|0
5651975|NCT00552110|19517567|P2|Overall Study|Nonserious Adverse Event (AE)|0
5651976|NCT00552110|19517568|P1|Overall Study|Nonserious Adverse Event (AE)|1
5651977|NCT00552110|19517564|P5|Overall Study|Increased Blood Pressure at Visit 2|0
5651978|NCT00552110|19517565|P4|Overall Study|Increased Blood Pressure at Visit 2|1
5651979|NCT00552110|19517566|P3|Overall Study|Increased Blood Pressure at Visit 2|0
5651980|NCT00552110|19517567|P2|Overall Study|Increased Blood Pressure at Visit 2|0
5651981|NCT00552110|19517568|P1|Overall Study|Increased Blood Pressure at Visit 2|0
5651982|NCT00552110|19517564|P5|Overall Study|Delay of Study due to Relabeling|0
5652068|NCT00552032|19517648|P2|Overall Study|Protocol Violation|12
5651983|NCT00552110|19517565|P4|Overall Study|Delay of Study due to Relabeling|1
5651984|NCT00552110|19517566|P3|Overall Study|Delay of Study due to Relabeling|0
5651985|NCT00552110|19517567|P2|Overall Study|Delay of Study due to Relabeling|0
5651986|NCT00552110|19517568|P1|Overall Study|Delay of Study due to Relabeling|0
5651987|NCT00552110|19517564|P5|Overall Study|Use of Prohibited Medication|0
5651988|NCT00552110|19517565|P4|Overall Study|Use of Prohibited Medication|0
5651989|NCT00552110|19517566|P3|Overall Study|Use of Prohibited Medication|0
5651990|NCT00552110|19517567|P2|Overall Study|Use of Prohibited Medication|1
5651991|NCT00552110|19517568|P1|Overall Study|Use of Prohibited Medication|1
5651992|NCT00552110|19517564|P5|Overall Study|Withdrawn per Sponsor|1
5651993|NCT00552110|19517565|P4|Overall Study|Withdrawn per Sponsor|0
5651994|NCT00552110|19517566|P3|Overall Study|Withdrawn per Sponsor|0
5651995|NCT00552110|19517567|P2|Overall Study|Withdrawn per Sponsor|1
5651996|NCT00552110|19517568|P1|Overall Study|Withdrawn per Sponsor|0
5651997|NCT00552110|19517564|P5|Overall Study|Failed to Comply With Study Requirements|1
5651998|NCT00552110|19517565|P4|Overall Study|Failed to Comply With Study Requirements|0
5651999|NCT00552110|19517566|P3|Overall Study|Failed to Comply With Study Requirements|1
5652000|NCT00552110|19517567|P2|Overall Study|Failed to Comply With Study Requirements|1
5652001|NCT00552110|19517568|P1|Overall Study|Failed to Comply With Study Requirements|1
5652002|NCT00552110|19517564|P5|Overall Study|Lost to Follow-up|1
5652003|NCT00552110|19517565|P4|Overall Study|Lost to Follow-up|1
5652004|NCT00552110|19517566|P3|Overall Study|Lost to Follow-up|0
5652005|NCT00552110|19517567|P2|Overall Study|Lost to Follow-up|0
5652006|NCT00552110|19517568|P1|Overall Study|Lost to Follow-up|0
5652007|NCT00552110|19517564|P5|Overall Study|Withdrawal by Subject|2
5652008|NCT00552110|19517565|P4|Overall Study|Withdrawal by Subject|3
5652009|NCT00552110|19517566|P3|Overall Study|Withdrawal by Subject|0
5652010|NCT00552110|19517567|P2|Overall Study|Withdrawal by Subject|2
5652011|NCT00552110|19517568|P1|Overall Study|Withdrawal by Subject|0
5652012|NCT00552110|19517564|P5|Overall Study|Lack of Efficacy|4
5652013|NCT00552110|19517565|P4|Overall Study|Lack of Efficacy|1
5652014|NCT00552110|19517566|P3|Overall Study|Lack of Efficacy|0
5652015|NCT00552110|19517567|P2|Overall Study|Lack of Efficacy|0
5652016|NCT00552110|19517568|P1|Overall Study|Lack of Efficacy|1
5652017|NCT00552110|19517564|P5|Overall Study|Serious or Life-Threatening AE|0
5652018|NCT00552110|19517565|P4|Overall Study|Serious or Life-Threatening AE|0
5652019|NCT00552110|19517566|P3|Overall Study|Serious or Life-Threatening AE|1
5652020|NCT00552110|19517567|P2|Overall Study|Serious or Life-Threatening AE|0
5652021|NCT00552110|19517568|P1|Overall Study|Serious or Life-Threatening AE|0
5652022|NCT00552084|19517587|P2|Overall Study|change in anti-arrythmic drug|1
5652023|NCT00552084|19517588|P1|Overall Study|change in anti-arrythmic drug|1
5652024|NCT00552084|19517587|P2|Overall Study|Protocol Violation|0
5652025|NCT00552084|19517588|P1|Overall Study|Protocol Violation|1
5652026|NCT00552084|19517587|P2|Overall Study|Withdrawal by Subject|5
5652027|NCT00552084|19517588|P1|Overall Study|Withdrawal by Subject|4
5652028|NCT00552084|19517587|P2|Overall Study|Adverse Event|3
5652029|NCT00552084|19517588|P1|Overall Study|Adverse Event|2
5652030|NCT00552071|19517596|P2|Overall Study|Withdrawal by Subject|1
5652031|NCT00552071|19517597|P1|Overall Study|Withdrawal by Subject|0
5652032|NCT00552071|19517596|P2|Overall Study|Death|1
5652033|NCT00552071|19517597|P1|Overall Study|Death|0
5652034|NCT00552071|19517596|P2|Overall Study|Pregnancy|0
5652035|NCT00552071|19517597|P1|Overall Study|Pregnancy|1
5652036|NCT00552071|19517596|P2|Overall Study|Physician Decision|0
5652037|NCT00552071|19517597|P1|Overall Study|Physician Decision|1
5652038|NCT00552071|19517596|P2|Overall Study|Lack of Efficacy|0
5652039|NCT00552071|19517597|P1|Overall Study|Lack of Efficacy|1
5652040|NCT00552071|19517596|P2|Overall Study|Adverse Event|0
5652041|NCT00552071|19517597|P1|Overall Study|Adverse Event|1
5652042|NCT00552058|19517607|P2|Overall Study|Other: Early Roll Over|0
5652043|NCT00552058|19517608|P1|Overall Study|Other: Early Roll Over|1
5652044|NCT00552058|19517607|P2|Overall Study|Other: Sponsors Decision|1
5652045|NCT00552058|19517608|P1|Overall Study|Other: Sponsors Decision|0
5652046|NCT00552058|19517607|P2|Overall Study|Other: Randomized in error|1
5652047|NCT00552058|19517608|P1|Overall Study|Other: Randomized in error|0
5652048|NCT00552058|19517607|P2|Overall Study|Other: Positive Stool Result|1
5652049|NCT00552058|19517608|P1|Overall Study|Other: Positive Stool Result|0
5652050|NCT00552058|19517607|P2|Overall Study|Other: Low CDAI score, entry violation|1
5652051|NCT00552058|19517608|P1|Overall Study|Other: Low CDAI score, entry violation|0
5652052|NCT00552058|19517607|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
5652053|NCT00552058|19517608|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
5652054|NCT00552058|19517607|P2|Overall Study|Other: Non Compliance|2
5652055|NCT00552058|19517608|P1|Overall Study|Other: Non Compliance|1
5652056|NCT00552058|19517607|P2|Overall Study|Other: Protocol Violation|1
5652057|NCT00552058|19517608|P1|Overall Study|Other: Protocol Violation|0
5652058|NCT00552058|19517607|P2|Overall Study|Withdrawal by Subject|4
5652059|NCT00552058|19517608|P1|Overall Study|Withdrawal by Subject|4
5652060|NCT00552058|19517607|P2|Overall Study|Lost to Follow-up|0
5652061|NCT00552058|19517608|P1|Overall Study|Lost to Follow-up|1
5652062|NCT00552058|19517607|P2|Overall Study|Lack of Efficacy|5
5652063|NCT00552058|19517608|P1|Overall Study|Lack of Efficacy|1
5652064|NCT00552058|19517607|P2|Overall Study|Adverse Event|7
5652065|NCT00552058|19517608|P1|Overall Study|Adverse Event|8
5652066|NCT00552032|19517648|P2|Overall Study|Lost to Follow-up|5
5652067|NCT00552032|19517649|P1|Overall Study|Lost to Follow-up|8
5652069|NCT00552032|19517649|P1|Overall Study|Protocol Violation|7
5652070|NCT00552032|19517648|P2|Overall Study|Withdrawal by Subject|2
5652071|NCT00552032|19517649|P1|Overall Study|Withdrawal by Subject|2
5652072|NCT00551759|19517693|P1|Overall Study|Ineligible|1
5652073|NCT00551759|19517693|P1|Overall Study|Death|5
5652074|NCT00551759|19517693|P1|Overall Study|Adverse Event|7
5652075|NCT00551642|19517734|P2|Overall Study|Inclusion/Exclusion criteria|4
5652076|NCT00551642|19517735|P1|Overall Study|Inclusion/Exclusion criteria|4
5652077|NCT00551642|19517734|P2|Overall Study|Delivery device failure|3
5652078|NCT00551642|19517735|P1|Overall Study|Delivery device failure|1
5652079|NCT00551642|19517734|P2|Overall Study|Physician Decision|1
5652080|NCT00551642|19517735|P1|Overall Study|Physician Decision|0
5652081|NCT00551642|19517734|P2|Overall Study|Protocol Violation|11
5652082|NCT00551642|19517735|P1|Overall Study|Protocol Violation|6
5652083|NCT00551642|19517734|P2|Overall Study|Death|31
5652084|NCT00551642|19517735|P1|Overall Study|Death|33
5652085|NCT00551642|19517734|P2|Overall Study|Adverse Event|12
5652086|NCT00551642|19517735|P1|Overall Study|Adverse Event|15
5652087|NCT00551642|19517734|P2|Overall Study|Withdrawal by Subject|1
5652088|NCT00551642|19517735|P1|Overall Study|Withdrawal by Subject|2
5652089|NCT00551525|19517741|P1|Overall Study|Protocol Violation|5
5652090|NCT00551460|19517750|P1|Overall Study|Not analyzable (did not start treatment)|4
5652091|NCT00551460|19517750|P1|Overall Study|Ineligible|4
5652092|NCT00551460|19517750|P1|Overall Study|Death|7
5652093|NCT00551460|19517750|P1|Overall Study|Physician Decision|1
5652094|NCT00551460|19517750|P1|Overall Study|Withdrawal by Subject|1
5652095|NCT00551460|19517750|P1|Overall Study|Adverse Event|1
5652096|NCT00551421|19517756|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
5652097|NCT00551369|19517763|P1|Overall Study|Not treated per protocol and re|1
5652098|NCT00551369|19517763|P1|Overall Study|Withdrawal by Subject|1
5652099|NCT00551369|19517763|P1|Overall Study|Protocol Violation|5
5652100|NCT00551291|19517772|P1|Overall Study|Physician Decision|1
5652101|NCT00551213|19517780|P2|Overall Study|Not Treated|2
5652102|NCT00551213|19517781|P1|Overall Study|Not Treated|1
5652103|NCT00551213|19517780|P2|Overall Study|Withdrawal by Subject|0
5652104|NCT00551213|19517781|P1|Overall Study|Withdrawal by Subject|2
5652105|NCT00551213|19517780|P2|Overall Study|Progressive Disease|12
5652106|NCT00551213|19517781|P1|Overall Study|Progressive Disease|41
5652107|NCT00551213|19517780|P2|Overall Study|Adverse Event|3
5652108|NCT00551213|19517781|P1|Overall Study|Adverse Event|6
5652109|NCT00551161|19517825|P1|Overall Study|Withdrawal by Subject|1
5652110|NCT00551135|19517833|P4|Overall Study|Withdrawal by Subject|1
5652111|NCT00551135|19517834|P3|Overall Study|Withdrawal by Subject|3
5652112|NCT00551135|19517835|P2|Overall Study|Withdrawal by Subject|0
5652113|NCT00551135|19517836|P1|Overall Study|Withdrawal by Subject|1
5652114|NCT00551135|19517833|P4|Overall Study|Other|2
5652115|NCT00551135|19517834|P3|Overall Study|Other|1
5652116|NCT00551135|19517835|P2|Overall Study|Other|2
5652117|NCT00551135|19517836|P1|Overall Study|Other|3
5652118|NCT00551135|19517833|P4|Overall Study|Lost to Follow-up|1
5652119|NCT00551135|19517834|P3|Overall Study|Lost to Follow-up|0
5652120|NCT00551135|19517835|P2|Overall Study|Lost to Follow-up|0
5652121|NCT00551135|19517836|P1|Overall Study|Lost to Follow-up|0
5652122|NCT00551135|19517833|P4|Overall Study|Adverse Event|1
5652123|NCT00551135|19517834|P3|Overall Study|Adverse Event|1
5652124|NCT00551135|19517835|P2|Overall Study|Adverse Event|0
5652125|NCT00551135|19517836|P1|Overall Study|Adverse Event|1
5652126|NCT00551031|19517965|P5|Overall Study|Did not receive vaccine|0
5652127|NCT00551031|19517966|P4|Overall Study|Did not receive vaccine|0
5652128|NCT00551031|19517967|P3|Overall Study|Did not receive vaccine|0
5652129|NCT00551031|19517968|P2|Overall Study|Did not receive vaccine|2
5652130|NCT00551031|19517969|P1|Overall Study|Did not receive vaccine|1
5652131|NCT00551031|19517965|P5|Overall Study|Serious Adverse Event|0
5652132|NCT00551031|19517966|P4|Overall Study|Serious Adverse Event|0
5652133|NCT00551031|19517967|P3|Overall Study|Serious Adverse Event|1
5652134|NCT00551031|19517968|P2|Overall Study|Serious Adverse Event|2
5652135|NCT00551031|19517969|P1|Overall Study|Serious Adverse Event|0
5652136|NCT00551031|19517965|P5|Overall Study|Withdrawal by Subject|0
5652137|NCT00551031|19517966|P4|Overall Study|Withdrawal by Subject|2
5652138|NCT00551031|19517967|P3|Overall Study|Withdrawal by Subject|1
5652139|NCT00551031|19517968|P2|Overall Study|Withdrawal by Subject|4
5652140|NCT00551031|19517969|P1|Overall Study|Withdrawal by Subject|0
5652141|NCT00551031|19517965|P5|Overall Study|Lost to Follow-up|1
5652142|NCT00551031|19517966|P4|Overall Study|Lost to Follow-up|1
5652143|NCT00551031|19517967|P3|Overall Study|Lost to Follow-up|0
5652144|NCT00551031|19517968|P2|Overall Study|Lost to Follow-up|1
5652145|NCT00551031|19517969|P1|Overall Study|Lost to Follow-up|0
5652146|NCT00551031|19517965|P5|Overall Study|Protocol Violation|0
5652147|NCT00551031|19517966|P4|Overall Study|Protocol Violation|0
5652148|NCT00551031|19517967|P3|Overall Study|Protocol Violation|0
5652149|NCT00551031|19517968|P2|Overall Study|Protocol Violation|1
5652150|NCT00551031|19517969|P1|Overall Study|Protocol Violation|1
5652151|NCT00551031|19517965|P5|Overall Study|Adverse Event|0
5652152|NCT00551031|19517966|P4|Overall Study|Adverse Event|0
5652153|NCT00551031|19517967|P3|Overall Study|Adverse Event|0
5652154|NCT00551031|19517968|P2|Overall Study|Adverse Event|1
5652155|NCT00551031|19517969|P1|Overall Study|Adverse Event|0
5652156|NCT00550953|19517998|P2|Overall Study|Not able to visit the site|3
5652157|NCT00550953|19517999|P1|Overall Study|Not able to visit the site|2
5652158|NCT00550953|19517998|P2|Overall Study|Adverse Event|3
5652159|NCT00550953|19517999|P1|Overall Study|Adverse Event|4
5652160|NCT00550836|19518046|P2|Overall Study|Withdrawal by Subject|9
5652161|NCT00550836|19518047|P1|Overall Study|Withdrawal by Subject|3
5652162|NCT00550771|19518063|P2|Overall Study|Protocol Violation|5
5652163|NCT00550771|19518064|P1|Overall Study|Protocol Violation|4
5652164|NCT00550771|19518063|P2|Overall Study|Withdrawal by Subject|1
5652165|NCT00550771|19518064|P1|Overall Study|Withdrawal by Subject|0
5652166|NCT00550771|19518063|P2|Overall Study|Physician Decision|0
5652167|NCT00550771|19518064|P1|Overall Study|Physician Decision|2
5652168|NCT00550771|19518063|P2|Overall Study|Discontinued for study-related reasons|1
5652169|NCT00550771|19518064|P1|Overall Study|Discontinued for study-related reasons|0
5652170|NCT00550771|19518063|P2|Overall Study|Adverse Event|3
5652171|NCT00550771|19518064|P1|Overall Study|Adverse Event|11
5652172|NCT00550745|19518078|P2|Overall Study|Screen failure|0
5652173|NCT00550745|19518079|P1|Overall Study|Screen failure|1
5652174|NCT00550745|19518078|P2|Overall Study|Withdrawal by Subject|10
5652175|NCT00550745|19518079|P1|Overall Study|Withdrawal by Subject|17
5652176|NCT00550745|19518078|P2|Overall Study|Protocol Violation|2
5652177|NCT00550745|19518079|P1|Overall Study|Protocol Violation|4
5652178|NCT00550745|19518078|P2|Overall Study|Physician Decision|2
5652179|NCT00550745|19518079|P1|Overall Study|Physician Decision|0
5652180|NCT00550745|19518078|P2|Overall Study|Lost to Follow-up|30
5652181|NCT00550745|19518079|P1|Overall Study|Lost to Follow-up|45
5652182|NCT00550745|19518078|P2|Overall Study|Death|16
5652183|NCT00550745|19518079|P1|Overall Study|Death|20
5652184|NCT00550732|19518087|P1|Overall Study|Adverse Event|1
5652185|NCT00550732|19518087|P1|Overall Study|Palliative care|1
5652186|NCT00550732|19518087|P1|Overall Study|Lost to Follow-up|1
5652187|NCT00550732|19518087|P1|Overall Study|Physician Decision|2
5652188|NCT00550732|19518087|P1|Overall Study|Withdrawal by Subject|2
5652189|NCT00550732|19518087|P1|Overall Study|Death|4
5652190|NCT00550680|19518098|P1|Overall Study|Screen Failure|6
5652191|NCT00550680|19518098|P1|Overall Study|Refused Treatment|19
5652192|NCT00550680|19518098|P1|Overall Study|Protocol Violation|7
5652193|NCT00550680|19518098|P1|Overall Study|Other|10
5652194|NCT00550680|19518098|P1|Overall Study|Lack of Efficacy|1
5652195|NCT00550680|19518098|P1|Overall Study|Lost to Follow-up|3
5652196|NCT00550680|19518098|P1|Overall Study|Early Improvement|1
5652197|NCT00550680|19518098|P1|Overall Study|Death|3
5652198|NCT00550680|19518098|P1|Overall Study|Adverse Event|5
5652199|NCT00550680|19518098|P1|Overall Study|Administrative Reasons|1
5652200|NCT00550615|19518119|P4|Overall Study|Not evaluable|7
5652201|NCT00550615|19518120|P3|Overall Study|Not evaluable|2
5652202|NCT00550615|19518121|P2|Overall Study|Not evaluable|0
5652203|NCT00550615|19518122|P1|Overall Study|Not evaluable|0
5652204|NCT00550615|19518119|P4|Overall Study|Withdrawal by Subject|3
5652205|NCT00550615|19518120|P3|Overall Study|Withdrawal by Subject|2
5652206|NCT00550615|19518121|P2|Overall Study|Withdrawal by Subject|0
5652207|NCT00550615|19518122|P1|Overall Study|Withdrawal by Subject|0
5652208|NCT00550550|19518141|P2|Overall Study|Randomized But Not Treated|0
5652209|NCT00550550|19518142|P1|Overall Study|Randomized But Not Treated|1
5652210|NCT00550550|19518141|P2|Overall Study|Did Not Meet Protocol Eligibility|1
5652211|NCT00550550|19518142|P1|Overall Study|Did Not Meet Protocol Eligibility|1
5652212|NCT00550550|19518141|P2|Overall Study|Protocol Violation|14
5652213|NCT00550550|19518142|P1|Overall Study|Protocol Violation|5
5652214|NCT00550550|19518141|P2|Overall Study|Withdrawal by Subject|8
5652215|NCT00550550|19518142|P1|Overall Study|Withdrawal by Subject|10
5652216|NCT00550550|19518141|P2|Overall Study|Lost to Follow-up|0
5652217|NCT00550550|19518142|P1|Overall Study|Lost to Follow-up|4
5652218|NCT00550550|19518141|P2|Overall Study|Treatment Failure|1
5652219|NCT00550550|19518142|P1|Overall Study|Treatment Failure|0
5652220|NCT00550550|19518141|P2|Overall Study|Adverse Event|5
5652221|NCT00550550|19518142|P1|Overall Study|Adverse Event|13
5652222|NCT00550537|19518154|P1|Overall Study|Treated closer to home|4
5652223|NCT00550537|19518154|P1|Overall Study|Declining performance status|2
5652224|NCT00550537|19518154|P1|Overall Study|Other complicating ilness|3
5652225|NCT00550537|19518154|P1|Overall Study|Change in treatment plan|4
5652226|NCT00550537|19518154|P1|Overall Study|Withdrawal by Subject|7
5652227|NCT00550537|19518154|P1|Overall Study|Disease progression before|46
5652228|NCT00550537|19518154|P1|Overall Study|Adverse Event|20
5652229|NCT00550537|19518154|P1|Overall Study|Death|18
5652230|NCT00550459|19518171|P2|Overall Study|Withdrawal by Subject|1
5652231|NCT00550459|19518172|P1|Overall Study|Withdrawal by Subject|1
5652232|NCT00550459|19518171|P2|Overall Study|Adverse Event|2
5652233|NCT00550459|19518172|P1|Overall Study|Adverse Event|0
5652234|NCT00550446|19518241|P11|Post Week 12|Other|0
5652235|NCT00550446|19518242|P10|Post Week 12|Other|1
5652236|NCT00550446|19518243|P9|Post Week 12|Other|1
5652237|NCT00550446|19518244|P8|Post Week 12|Other|0
5652238|NCT00550446|19518245|P7|Post Week 12|Other|1
5652239|NCT00550446|19518246|P6|Post Week 12|Other|0
5652240|NCT00550446|19518247|P5|Post Week 12|Other|0
5652241|NCT00550446|19518248|P4|Post Week 12|Other|1
5652242|NCT00550446|19518249|P3|Post Week 12|Other|0
5652243|NCT00550446|19518250|P2|Post Week 12|Other|1
5652244|NCT00550446|19518251|P1|Post Week 12|Other|1
5652245|NCT00550446|19518241|P11|Post Week 12|Withdrawal by Subject|0
5652246|NCT00550446|19518242|P10|Post Week 12|Withdrawal by Subject|0
5652247|NCT00550446|19518243|P9|Post Week 12|Withdrawal by Subject|0
5652248|NCT00550446|19518244|P8|Post Week 12|Withdrawal by Subject|0
5652249|NCT00550446|19518245|P7|Post Week 12|Withdrawal by Subject|0
5652250|NCT00550446|19518246|P6|Post Week 12|Withdrawal by Subject|0
5652251|NCT00550446|19518247|P5|Post Week 12|Withdrawal by Subject|1
5652252|NCT00550446|19518248|P4|Post Week 12|Withdrawal by Subject|0
5652253|NCT00550446|19518249|P3|Post Week 12|Withdrawal by Subject|0
5652254|NCT00550446|19518250|P2|Post Week 12|Withdrawal by Subject|0
5652255|NCT00550446|19518251|P1|Post Week 12|Withdrawal by Subject|0
5652256|NCT00550446|19518241|P11|Post Week 12|Lost to Follow-up|0
5652257|NCT00550446|19518242|P10|Post Week 12|Lost to Follow-up|0
5652258|NCT00550446|19518243|P9|Post Week 12|Lost to Follow-up|0
5652259|NCT00550446|19518244|P8|Post Week 12|Lost to Follow-up|0
5652260|NCT00550446|19518245|P7|Post Week 12|Lost to Follow-up|1
5652261|NCT00550446|19518246|P6|Post Week 12|Lost to Follow-up|0
5652262|NCT00550446|19518247|P5|Post Week 12|Lost to Follow-up|0
5652263|NCT00550446|19518248|P4|Post Week 12|Lost to Follow-up|1
5652264|NCT00550446|19518249|P3|Post Week 12|Lost to Follow-up|1
5652265|NCT00550446|19518250|P2|Post Week 12|Lost to Follow-up|0
5652266|NCT00550446|19518251|P1|Post Week 12|Lost to Follow-up|0
5652267|NCT00550446|19518241|P11|Post Week 12|Lack of Efficacy|1
5652268|NCT00550446|19518242|P10|Post Week 12|Lack of Efficacy|2
5652269|NCT00550446|19518243|P9|Post Week 12|Lack of Efficacy|1
5652270|NCT00550446|19518244|P8|Post Week 12|Lack of Efficacy|1
5652271|NCT00550446|19518245|P7|Post Week 12|Lack of Efficacy|0
5652272|NCT00550446|19518246|P6|Post Week 12|Lack of Efficacy|0
5652273|NCT00550446|19518247|P5|Post Week 12|Lack of Efficacy|0
5652274|NCT00550446|19518248|P4|Post Week 12|Lack of Efficacy|0
5652275|NCT00550446|19518249|P3|Post Week 12|Lack of Efficacy|1
5652276|NCT00550446|19518250|P2|Post Week 12|Lack of Efficacy|0
5652277|NCT00550446|19518251|P1|Post Week 12|Lack of Efficacy|0
5652278|NCT00550446|19518241|P11|Post Week 12|Adverse Event|0
5652279|NCT00550446|19518242|P10|Post Week 12|Adverse Event|4
5652280|NCT00550446|19518243|P9|Post Week 12|Adverse Event|0
5652281|NCT00550446|19518244|P8|Post Week 12|Adverse Event|0
5652282|NCT00550446|19518245|P7|Post Week 12|Adverse Event|0
5652283|NCT00550446|19518246|P6|Post Week 12|Adverse Event|1
5652284|NCT00550446|19518247|P5|Post Week 12|Adverse Event|1
5652285|NCT00550446|19518248|P4|Post Week 12|Adverse Event|1
5652286|NCT00550446|19518249|P3|Post Week 12|Adverse Event|1
5652287|NCT00550446|19518250|P2|Post Week 12|Adverse Event|1
5652288|NCT00550446|19518251|P1|Post Week 12|Adverse Event|2
5652289|NCT00550446|19518241|P11|Up To Week 12|Randomized not treated|0
5652290|NCT00550446|19518242|P10|Up To Week 12|Randomized not treated|0
5652291|NCT00550446|19518243|P9|Up To Week 12|Randomized not treated|0
5652292|NCT00550446|19518244|P8|Up To Week 12|Randomized not treated|0
5652293|NCT00550446|19518245|P7|Up To Week 12|Randomized not treated|0
5652294|NCT00550446|19518246|P6|Up To Week 12|Randomized not treated|0
5652295|NCT00550446|19518247|P5|Up To Week 12|Randomized not treated|0
5652296|NCT00550446|19518248|P4|Up To Week 12|Randomized not treated|0
5652297|NCT00550446|19518249|P3|Up To Week 12|Randomized not treated|1
5652298|NCT00550446|19518250|P2|Up To Week 12|Randomized not treated|1
5652299|NCT00550446|19518251|P1|Up To Week 12|Randomized not treated|0
5652300|NCT00550446|19518241|P11|Up To Week 12|Other|0
5652301|NCT00550446|19518242|P10|Up To Week 12|Other|0
5652302|NCT00550446|19518243|P9|Up To Week 12|Other|0
5652303|NCT00550446|19518244|P8|Up To Week 12|Other|0
5652304|NCT00550446|19518245|P7|Up To Week 12|Other|4
5652305|NCT00550446|19518246|P6|Up To Week 12|Other|1
5652306|NCT00550446|19518247|P5|Up To Week 12|Other|0
5652307|NCT00550446|19518248|P4|Up To Week 12|Other|0
5652308|NCT00550446|19518249|P3|Up To Week 12|Other|0
5652309|NCT00550446|19518250|P2|Up To Week 12|Other|0
5652310|NCT00550446|19518251|P1|Up To Week 12|Other|3
5652311|NCT00550446|19518241|P11|Up To Week 12|Withdrawal by Subject|0
5652312|NCT00550446|19518242|P10|Up To Week 12|Withdrawal by Subject|0
5652313|NCT00550446|19518243|P9|Up To Week 12|Withdrawal by Subject|0
5652314|NCT00550446|19518244|P8|Up To Week 12|Withdrawal by Subject|0
5652315|NCT00550446|19518245|P7|Up To Week 12|Withdrawal by Subject|3
5652316|NCT00550446|19518246|P6|Up To Week 12|Withdrawal by Subject|1
5652317|NCT00550446|19518247|P5|Up To Week 12|Withdrawal by Subject|0
5652318|NCT00550446|19518248|P4|Up To Week 12|Withdrawal by Subject|2
5652319|NCT00550446|19518249|P3|Up To Week 12|Withdrawal by Subject|3
5652320|NCT00550446|19518250|P2|Up To Week 12|Withdrawal by Subject|0
5652321|NCT00550446|19518251|P1|Up To Week 12|Withdrawal by Subject|2
5652322|NCT00550446|19518241|P11|Up To Week 12|Lost to Follow-up|0
5652323|NCT00550446|19518242|P10|Up To Week 12|Lost to Follow-up|0
5652324|NCT00550446|19518243|P9|Up To Week 12|Lost to Follow-up|0
5652325|NCT00550446|19518244|P8|Up To Week 12|Lost to Follow-up|0
5652326|NCT00550446|19518245|P7|Up To Week 12|Lost to Follow-up|2
5652327|NCT00550446|19518246|P6|Up To Week 12|Lost to Follow-up|1
5652328|NCT00550446|19518247|P5|Up To Week 12|Lost to Follow-up|1
5652329|NCT00550446|19518248|P4|Up To Week 12|Lost to Follow-up|0
5652330|NCT00550446|19518249|P3|Up To Week 12|Lost to Follow-up|0
5652331|NCT00550446|19518250|P2|Up To Week 12|Lost to Follow-up|1
5652332|NCT00550446|19518251|P1|Up To Week 12|Lost to Follow-up|0
5652333|NCT00550446|19518241|P11|Up To Week 12|Lack of Efficacy|0
5652334|NCT00550446|19518242|P10|Up To Week 12|Lack of Efficacy|0
5652335|NCT00550446|19518243|P9|Up To Week 12|Lack of Efficacy|0
5652336|NCT00550446|19518244|P8|Up To Week 12|Lack of Efficacy|0
5652337|NCT00550446|19518245|P7|Up To Week 12|Lack of Efficacy|3
5652338|NCT00550446|19518246|P6|Up To Week 12|Lack of Efficacy|3
5652339|NCT00550446|19518247|P5|Up To Week 12|Lack of Efficacy|0
5652340|NCT00550446|19518248|P4|Up To Week 12|Lack of Efficacy|1
5652341|NCT00550446|19518249|P3|Up To Week 12|Lack of Efficacy|0
5652342|NCT00550446|19518250|P2|Up To Week 12|Lack of Efficacy|1
5652343|NCT00550446|19518251|P1|Up To Week 12|Lack of Efficacy|3
5652344|NCT00550446|19518241|P11|Up To Week 12|Adverse Event|0
5652345|NCT00550446|19518242|P10|Up To Week 12|Adverse Event|0
5652346|NCT00550446|19518243|P9|Up To Week 12|Adverse Event|0
5652347|NCT00550446|19518244|P8|Up To Week 12|Adverse Event|0
5652348|NCT00550446|19518245|P7|Up To Week 12|Adverse Event|1
5652349|NCT00550446|19518246|P6|Up To Week 12|Adverse Event|2
5652350|NCT00550446|19518247|P5|Up To Week 12|Adverse Event|2
5652351|NCT00550446|19518248|P4|Up To Week 12|Adverse Event|0
5652352|NCT00550446|19518249|P3|Up To Week 12|Adverse Event|0
5652353|NCT00550446|19518250|P2|Up To Week 12|Adverse Event|2
5652354|NCT00550446|19518251|P1|Up To Week 12|Adverse Event|2
5652355|NCT00550420|19518683|P1|Overall Study|Prohibited medicine|1
5652356|NCT00550420|19518683|P1|Overall Study|Exclusion criteria|1
5652357|NCT00550420|19518683|P1|Overall Study|Out of Electrocardiogram criteria|1
5652358|NCT00550420|19518683|P1|Overall Study|Caregiver's decision to withdraw|1
5652359|NCT00550420|19518683|P1|Overall Study|Unethical stop of enrollment|2
5652360|NCT00550420|19518683|P1|Overall Study|Lack of curative effect|1
5652361|NCT00550420|19518683|P1|Overall Study|Investigators opinion|1
5652362|NCT00550420|19518683|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
5652363|NCT00550420|19518683|P1|Overall Study|Missing|2
5652364|NCT00550420|19518683|P1|Overall Study|Still in study at termination|206
5652365|NCT00550420|19518683|P1|Overall Study|Withdrawal by Subject|30
5652366|NCT00550420|19518683|P1|Overall Study|Protocol Violation|11
5652367|NCT00550420|19518683|P1|Overall Study|Lost to Follow-up|8
5652368|NCT00550420|19518683|P1|Overall Study|Adverse Event|28
5652369|NCT00550407|19518706|P3|26-Week Randomized Phase|Withdrawal by Subject|3
5652370|NCT00550407|19518707|P2|26-Week Randomized Phase|Withdrawal by Subject|1
5652371|NCT00550407|19518708|P1|26-Week Randomized Phase|Withdrawal by Subject|0
5652372|NCT00550407|19518706|P3|26-Week Randomized Phase|Investigator Discretion|0
5652373|NCT00550407|19518707|P2|26-Week Randomized Phase|Investigator Discretion|1
5652374|NCT00550407|19518708|P1|26-Week Randomized Phase|Investigator Discretion|0
5652375|NCT00550407|19518706|P3|26-Week Randomized Phase|Lack of Efficacy|19
5652376|NCT00550407|19518707|P2|26-Week Randomized Phase|Lack of Efficacy|36
5652377|NCT00550407|19518708|P1|26-Week Randomized Phase|Lack of Efficacy|0
5652378|NCT00550407|19518706|P3|26-Week Randomized Phase|Adverse Event|2
5652379|NCT00550407|19518707|P2|26-Week Randomized Phase|Adverse Event|5
5652380|NCT00550407|19518708|P1|26-Week Randomized Phase|Adverse Event|0
5652381|NCT00550407|19518706|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
5652382|NCT00550407|19518707|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
5652383|NCT00550407|19518708|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
5652384|NCT00550407|19518706|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
5652385|NCT00550407|19518707|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
5652386|NCT00550407|19518708|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
5652387|NCT00550407|19518706|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
5652388|NCT00550407|19518707|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
5652389|NCT00550407|19518708|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
5652390|NCT00550407|19518706|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
5652391|NCT00550407|19518707|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
5652392|NCT00550407|19518708|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
5652393|NCT00550407|19518706|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
5652394|NCT00550407|19518707|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
5652395|NCT00550407|19518708|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
5652396|NCT00550407|19518706|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
5652397|NCT00550407|19518707|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
5652398|NCT00550407|19518708|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
5652399|NCT00550407|19518706|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
5652400|NCT00550407|19518707|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
5652401|NCT00550407|19518708|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
5652402|NCT00550407|19518706|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
5652403|NCT00550407|19518707|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
5652404|NCT00550407|19518708|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
5652405|NCT00550238|19518780|P1|Overall Study|Sponsor decision|55
5652406|NCT00550238|19518780|P1|Overall Study|Lost to Follow-up|13
5652407|NCT00550238|19518780|P1|Overall Study|Patient noncompliance|25
5652408|NCT00550238|19518780|P1|Overall Study|Physician Decision|31
5652409|NCT00550238|19518780|P1|Overall Study|Withdrawal by Subject|167
5652410|NCT00550238|19518780|P1|Overall Study|Disease progression|46
5652411|NCT00550238|19518780|P1|Overall Study|Death|34
5652412|NCT00550238|19518780|P1|Overall Study|Adverse Event|88
5652413|NCT00550173|19518787|P3|Overall Study|Lost to Follow-up|3
5652414|NCT00550173|19518788|P2|Overall Study|Lost to Follow-up|4
5652415|NCT00550173|19518789|P1|Overall Study|Lost to Follow-up|4
5652416|NCT00550173|19518787|P3|Overall Study|Sponsor Decision|1
5652417|NCT00550173|19518788|P2|Overall Study|Sponsor Decision|7
5652418|NCT00550173|19518789|P1|Overall Study|Sponsor Decision|13
5652419|NCT00550173|19518787|P3|Overall Study|Withdrawal by Subject|17
5652420|NCT00550173|19518788|P2|Overall Study|Withdrawal by Subject|12
5652421|NCT00550173|19518789|P1|Overall Study|Withdrawal by Subject|9
5652422|NCT00550173|19518787|P3|Overall Study|Physician Decision|2
5652423|NCT00550173|19518788|P2|Overall Study|Physician Decision|2
5652424|NCT00550173|19518789|P1|Overall Study|Physician Decision|1
5652425|NCT00550173|19518787|P3|Overall Study|Death|50
5652426|NCT00550173|19518788|P2|Overall Study|Death|38
5652427|NCT00550173|19518789|P1|Overall Study|Death|45
5652428|NCT00550147|19518818|P1|Quetiapine Addition Treatment Period|Moved out of state|1
5652429|NCT00550147|19518818|P1|Quetiapine Addition Treatment Period|Noncompliance|2
5652430|NCT00550147|19518818|P1|Quetiapine Addition Treatment Period|Adverse Event|3
5652431|NCT00550147|19518818|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
5652432|NCT00550147|19518818|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
5652433|NCT00550043|19518841|P5|Overall Study|Other Reasons- Unspecified|0
5652434|NCT00550043|19518842|P4|Overall Study|Other Reasons- Unspecified|1
5652435|NCT00550043|19518843|P3|Overall Study|Other Reasons- Unspecified|0
5652436|NCT00550043|19518844|P2|Overall Study|Other Reasons- Unspecified|1
5652437|NCT00550043|19518845|P1|Overall Study|Other Reasons- Unspecified|0
5652438|NCT00550043|19518841|P5|Overall Study|Subject Withdrew Consent|0
5652439|NCT00550043|19518842|P4|Overall Study|Subject Withdrew Consent|0
5652440|NCT00550043|19518843|P3|Overall Study|Subject Withdrew Consent|1
5652441|NCT00550043|19518844|P2|Overall Study|Subject Withdrew Consent|2
5652442|NCT00550043|19518845|P1|Overall Study|Subject Withdrew Consent|0
5652443|NCT00550043|19518841|P5|Overall Study|Adverse Event|1
5652444|NCT00550043|19518842|P4|Overall Study|Adverse Event|1
5652445|NCT00550043|19518843|P3|Overall Study|Adverse Event|0
5652446|NCT00550043|19518844|P2|Overall Study|Adverse Event|0
5652447|NCT00550043|19518845|P1|Overall Study|Adverse Event|0
5652448|NCT00549939|19518900|P3|40-week Open Label Treatment Period|Other|4
5652449|NCT00549939|19518901|P2|40-week Open Label Treatment Period|Other|1
5652450|NCT00549939|19518902|P1|40-week Open Label Treatment Period|Other|0
5652451|NCT00549939|19518900|P3|40-week Open Label Treatment Period|Protocol Violation|0
5652452|NCT00549939|19518901|P2|40-week Open Label Treatment Period|Protocol Violation|1
5652453|NCT00549939|19518902|P1|40-week Open Label Treatment Period|Protocol Violation|0
5652454|NCT00549939|19518900|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
5652455|NCT00549939|19518901|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
5652456|NCT00549939|19518902|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
5652457|NCT00549939|19518900|P3|40-week Open Label Treatment Period|Adverse Event|1
5652458|NCT00549939|19518901|P2|40-week Open Label Treatment Period|Adverse Event|2
5652459|NCT00549939|19518902|P1|40-week Open Label Treatment Period|Adverse Event|0
5652460|NCT00549939|19518900|P3|12-week Double Blind Treatment Period|Too many blood draws|0
5652461|NCT00549939|19518901|P2|12-week Double Blind Treatment Period|Too many blood draws|1
5652462|NCT00549939|19518902|P1|12-week Double Blind Treatment Period|Too many blood draws|0
5652463|NCT00549939|19518900|P3|12-week Double Blind Treatment Period|Adverse Event|2
5652464|NCT00549939|19518901|P2|12-week Double Blind Treatment Period|Adverse Event|1
5652465|NCT00549939|19518902|P1|12-week Double Blind Treatment Period|Adverse Event|1
5652466|NCT00549900|19518929|P1|Overall Study|Adverse Event|1
5652467|NCT00549770|19518985|P8|Overall Study|Adverse Event|4
5652468|NCT00549770|19518986|P7|Overall Study|Adverse Event|5
5652469|NCT00549770|19518987|P6|Overall Study|Adverse Event|0
5652470|NCT00549770|19518988|P5|Overall Study|Adverse Event|1
5652471|NCT00549770|19518989|P4|Overall Study|Adverse Event|2
5652472|NCT00549770|19518990|P3|Overall Study|Adverse Event|1
5652473|NCT00549770|19518991|P2|Overall Study|Adverse Event|3
5652474|NCT00549770|19518992|P1|Overall Study|Adverse Event|1
5652475|NCT00549770|19518985|P8|Overall Study|Abnormal laboratory values|0
5652476|NCT00549770|19518986|P7|Overall Study|Abnormal laboratory values|0
5652477|NCT00549770|19518987|P6|Overall Study|Abnormal laboratory values|1
5652478|NCT00549770|19518988|P5|Overall Study|Abnormal laboratory values|0
5652479|NCT00549770|19518989|P4|Overall Study|Abnormal laboratory values|0
5652480|NCT00549770|19518990|P3|Overall Study|Abnormal laboratory values|0
5652481|NCT00549770|19518991|P2|Overall Study|Abnormal laboratory values|0
5652482|NCT00549770|19518992|P1|Overall Study|Abnormal laboratory values|0
5652483|NCT00549770|19518985|P8|Overall Study|Abnormal test procedure results|1
5652484|NCT00549770|19518986|P7|Overall Study|Abnormal test procedure results|1
5652485|NCT00549770|19518987|P6|Overall Study|Abnormal test procedure results|1
5652486|NCT00549770|19518988|P5|Overall Study|Abnormal test procedure results|0
5652487|NCT00549770|19518989|P4|Overall Study|Abnormal test procedure results|2
5652488|NCT00549770|19518990|P3|Overall Study|Abnormal test procedure results|0
5652489|NCT00549770|19518991|P2|Overall Study|Abnormal test procedure results|0
5652490|NCT00549770|19518992|P1|Overall Study|Abnormal test procedure results|0
5652491|NCT00549770|19518985|P8|Overall Study|Lack of Efficacy|8
5652492|NCT00549770|19518986|P7|Overall Study|Lack of Efficacy|3
5652493|NCT00549770|19518987|P6|Overall Study|Lack of Efficacy|1
5652494|NCT00549770|19518988|P5|Overall Study|Lack of Efficacy|5
5652495|NCT00549770|19518989|P4|Overall Study|Lack of Efficacy|3
5652496|NCT00549770|19518990|P3|Overall Study|Lack of Efficacy|2
5652497|NCT00549770|19518991|P2|Overall Study|Lack of Efficacy|0
5652498|NCT00549770|19518992|P1|Overall Study|Lack of Efficacy|1
5652499|NCT00549770|19518985|P8|Overall Study|Withdrawal by Subject|9
5652500|NCT00549770|19518986|P7|Overall Study|Withdrawal by Subject|4
5652501|NCT00549770|19518987|P6|Overall Study|Withdrawal by Subject|6
5652502|NCT00549770|19518988|P5|Overall Study|Withdrawal by Subject|6
5652503|NCT00549770|19518989|P4|Overall Study|Withdrawal by Subject|5
5652504|NCT00549770|19518990|P3|Overall Study|Withdrawal by Subject|4
5652505|NCT00549770|19518991|P2|Overall Study|Withdrawal by Subject|6
5652506|NCT00549770|19518992|P1|Overall Study|Withdrawal by Subject|4
5652507|NCT00549770|19518985|P8|Overall Study|Lost to Follow-up|0
5652508|NCT00549770|19518986|P7|Overall Study|Lost to Follow-up|0
5652509|NCT00549770|19518987|P6|Overall Study|Lost to Follow-up|2
5652510|NCT00549770|19518988|P5|Overall Study|Lost to Follow-up|3
5652511|NCT00549770|19518989|P4|Overall Study|Lost to Follow-up|2
5652512|NCT00549770|19518990|P3|Overall Study|Lost to Follow-up|2
5652513|NCT00549770|19518991|P2|Overall Study|Lost to Follow-up|0
5652514|NCT00549770|19518992|P1|Overall Study|Lost to Follow-up|0
5652515|NCT00549770|19518985|P8|Overall Study|Administrative problems|1
5652516|NCT00549770|19518986|P7|Overall Study|Administrative problems|0
5652517|NCT00549770|19518987|P6|Overall Study|Administrative problems|0
5652518|NCT00549770|19518988|P5|Overall Study|Administrative problems|0
5652519|NCT00549770|19518989|P4|Overall Study|Administrative problems|0
5652520|NCT00549770|19518990|P3|Overall Study|Administrative problems|0
5652521|NCT00549770|19518991|P2|Overall Study|Administrative problems|1
5652522|NCT00549770|19518992|P1|Overall Study|Administrative problems|0
5652523|NCT00549770|19518985|P8|Overall Study|Protocol deviation|2
5652524|NCT00549770|19518986|P7|Overall Study|Protocol deviation|1
5652525|NCT00549770|19518987|P6|Overall Study|Protocol deviation|2
5652526|NCT00549770|19518988|P5|Overall Study|Protocol deviation|2
5652527|NCT00549770|19518989|P4|Overall Study|Protocol deviation|2
5652528|NCT00549770|19518990|P3|Overall Study|Protocol deviation|1
5652529|NCT00549770|19518991|P2|Overall Study|Protocol deviation|1
5652530|NCT00549770|19518992|P1|Overall Study|Protocol deviation|1
5652531|NCT00549757|19519076|P2|Extension Period (in Average 9 Months)|Patient's request|436
5652532|NCT00549757|19519077|P1|Extension Period (in Average 9 Months)|Patient's request|421
5652533|NCT00549757|19519076|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
5652534|NCT00549757|19519077|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
5652535|NCT00549757|19519076|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
5652536|NCT00549757|19519077|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
5652537|NCT00549757|19519076|P2|Extension Period (in Average 9 Months)|Death|136
5652538|NCT00549757|19519077|P1|Extension Period (in Average 9 Months)|Death|143
5652539|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
5652540|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
5652541|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
5652542|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
5652543|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
5652544|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
5652545|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Death|200
5652546|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Death|188
5652547|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
5652548|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
5652549|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
5652550|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
5652551|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
5652552|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
5652553|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
5652554|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
5652555|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
5652556|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
5652557|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
5652558|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
5652559|NCT00549757|19519076|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
5652560|NCT00549757|19519077|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
5652561|NCT00549718|19519139|P4|Overall Study|Administrative|1
5652562|NCT00549718|19519140|P3|Overall Study|Administrative|2
5652563|NCT00549718|19519141|P2|Overall Study|Administrative|2
5652564|NCT00549718|19519142|P1|Overall Study|Administrative|2
5652565|NCT00549718|19519139|P4|Overall Study|Withdrawal by Subject|13
5652566|NCT00549718|19519140|P3|Overall Study|Withdrawal by Subject|12
5652567|NCT00549718|19519141|P2|Overall Study|Withdrawal by Subject|18
5652568|NCT00549718|19519142|P1|Overall Study|Withdrawal by Subject|9
5652569|NCT00549718|19519139|P4|Overall Study|Lost to Follow-up|6
5652570|NCT00549718|19519140|P3|Overall Study|Lost to Follow-up|0
5652571|NCT00549718|19519141|P2|Overall Study|Lost to Follow-up|2
5652572|NCT00549718|19519142|P1|Overall Study|Lost to Follow-up|4
5652573|NCT00549718|19519139|P4|Overall Study|Adverse Event|3
5652574|NCT00549718|19519140|P3|Overall Study|Adverse Event|7
5652575|NCT00549718|19519141|P2|Overall Study|Adverse Event|8
5652576|NCT00549718|19519142|P1|Overall Study|Adverse Event|6
5652577|NCT00549718|19519139|P4|Overall Study|Insufficient clinical response|32
5652578|NCT00549718|19519140|P3|Overall Study|Insufficient clinical response|18
5652579|NCT00549718|19519141|P2|Overall Study|Insufficient clinical response|7
5652580|NCT00549718|19519142|P1|Overall Study|Insufficient clinical response|20
5652581|NCT00549640|19519158|P2|Overall Study|Lost to Follow-up|4
5652582|NCT00549640|19519159|P1|Overall Study|Lost to Follow-up|7
5652583|NCT00549640|19519158|P2|Overall Study|Adverse Event|0
5652584|NCT00549640|19519159|P1|Overall Study|Adverse Event|5
5652585|NCT00549640|19519158|P2|Overall Study|Withdrawal by Subject|12
5652586|NCT00549640|19519159|P1|Overall Study|Withdrawal by Subject|6
5652587|NCT00549601|19519172|P3|Received Study Drug|Withdrawal by Subject|1
5652588|NCT00549601|19519173|P2|Received Study Drug|Withdrawal by Subject|0
5652589|NCT00549601|19519174|P1|Received Study Drug|Withdrawal by Subject|2
5652590|NCT00549601|19519172|P3|Received Study Drug|Protocol Violation|1
5652591|NCT00549601|19519173|P2|Received Study Drug|Protocol Violation|4
5652592|NCT00549601|19519174|P1|Received Study Drug|Protocol Violation|3
5652593|NCT00549601|19519172|P3|Received Study Drug|Lost to Follow-up|1
5652594|NCT00549601|19519173|P2|Received Study Drug|Lost to Follow-up|1
5652595|NCT00549601|19519174|P1|Received Study Drug|Lost to Follow-up|0
5652596|NCT00549601|19519172|P3|Received Study Drug|Death|0
5652597|NCT00549601|19519173|P2|Received Study Drug|Death|1
5652598|NCT00549601|19519174|P1|Received Study Drug|Death|0
5652599|NCT00549601|19519172|P3|Received Study Drug|Adverse Event|1
5652600|NCT00549601|19519173|P2|Received Study Drug|Adverse Event|5
5652601|NCT00549601|19519174|P1|Received Study Drug|Adverse Event|2
5652602|NCT00549601|19519172|P3|Randomized|Withdrawal by Subject|1
5652603|NCT00549601|19519173|P2|Randomized|Withdrawal by Subject|1
5652604|NCT00549601|19519174|P1|Randomized|Withdrawal by Subject|0
5652605|NCT00549601|19519172|P3|Randomized|Protocol Violation|1
5652606|NCT00549601|19519173|P2|Randomized|Protocol Violation|0
5652607|NCT00549601|19519174|P1|Randomized|Protocol Violation|0
5652608|NCT00549562|19519196|P1|Overall Study|Lack of Efficacy|1
5652609|NCT00549562|19519196|P1|Overall Study|Adverse Event|1
5652610|NCT00549549|19519208|P4|Overall Study|Randomized but not treated|1
5652611|NCT00549549|19519209|P3|Overall Study|Randomized but not treated|1
5652612|NCT00549549|19519210|P2|Overall Study|Randomized but not treated|0
5652613|NCT00549549|19519211|P1|Overall Study|Randomized but not treated|0
5652614|NCT00549549|19519208|P4|Overall Study|Other|11
5652615|NCT00549549|19519209|P3|Overall Study|Other|9
5652616|NCT00549549|19519210|P2|Overall Study|Other|9
5652617|NCT00549549|19519211|P1|Overall Study|Other|9
5652618|NCT00549549|19519208|P4|Overall Study|Withdrawal by Subject|0
5652619|NCT00549549|19519209|P3|Overall Study|Withdrawal by Subject|1
5652620|NCT00549549|19519210|P2|Overall Study|Withdrawal by Subject|4
5652621|NCT00549549|19519211|P1|Overall Study|Withdrawal by Subject|0
5652622|NCT00549549|19519208|P4|Overall Study|Lost to Follow-up|2
5652623|NCT00549549|19519209|P3|Overall Study|Lost to Follow-up|1
5652624|NCT00549549|19519210|P2|Overall Study|Lost to Follow-up|0
5652625|NCT00549549|19519211|P1|Overall Study|Lost to Follow-up|1
5652626|NCT00549549|19519208|P4|Overall Study|Lack of Efficacy|2
5652627|NCT00549549|19519209|P3|Overall Study|Lack of Efficacy|4
5652628|NCT00549549|19519210|P2|Overall Study|Lack of Efficacy|6
5652629|NCT00549549|19519211|P1|Overall Study|Lack of Efficacy|9
5652630|NCT00549549|19519208|P4|Overall Study|Adverse Event|9
5652631|NCT00549549|19519209|P3|Overall Study|Adverse Event|1
5652632|NCT00549549|19519210|P2|Overall Study|Adverse Event|3
5652633|NCT00549549|19519211|P1|Overall Study|Adverse Event|5
5652634|NCT00549445|19519279|P2|Overall Study|Sputum & Blood Samples Not Available|17
5652635|NCT00549445|19519280|P1|Overall Study|Sputum & Blood Samples Not Available|15
5652636|NCT00549328|19519299|P1|Overall Study|Use of Prohibited Medication|1
5652637|NCT00549328|19519299|P1|Overall Study|Death|1
5652638|NCT00549328|19519299|P1|Overall Study|Disease Progression|10
5652639|NCT00549328|19519299|P1|Overall Study|Adverse Event|2
5652640|NCT00549302|19519310|P3|Open-Label|Withdrawal by Subject|6
5652641|NCT00549302|19519311|P2|Open-Label|Withdrawal by Subject|0
5652642|NCT00549302|19519312|P1|Open-Label|Withdrawal by Subject|0
5652643|NCT00549302|19519310|P3|Open-Label|New drug pulmonary atrial hypertension|2
5652644|NCT00549302|19519311|P2|Open-Label|New drug pulmonary atrial hypertension|0
5652645|NCT00549302|19519312|P1|Open-Label|New drug pulmonary atrial hypertension|0
5652646|NCT00549302|19519310|P3|Open-Label|Other|3
5652647|NCT00549302|19519311|P2|Open-Label|Other|0
5652648|NCT00549302|19519312|P1|Open-Label|Other|0
5652649|NCT00549302|19519310|P3|Open-Label|Lost to Follow-up|2
5652650|NCT00549302|19519311|P2|Open-Label|Lost to Follow-up|0
5652651|NCT00549302|19519312|P1|Open-Label|Lost to Follow-up|0
5652652|NCT00549302|19519310|P3|Open-Label|Investigator Decision|5
5652653|NCT00549302|19519311|P2|Open-Label|Investigator Decision|0
5652654|NCT00549302|19519312|P1|Open-Label|Investigator Decision|0
5652655|NCT00549302|19519310|P3|Open-Label|Death|40
5652656|NCT00549302|19519311|P2|Open-Label|Death|0
5652657|NCT00549302|19519312|P1|Open-Label|Death|0
5652658|NCT00549302|19519310|P3|Open-Label|Adverse Event|11
5652659|NCT00549302|19519311|P2|Open-Label|Adverse Event|0
5652660|NCT00549302|19519312|P1|Open-Label|Adverse Event|0
5652661|NCT00549302|19519310|P3|Double-Blind|New condition or starts new therapy|0
5652662|NCT00549302|19519311|P2|Double-Blind|New condition or starts new therapy|2
5652663|NCT00549302|19519312|P1|Double-Blind|New condition or starts new therapy|0
5652664|NCT00549302|19519310|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
5652665|NCT00549302|19519311|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
5652666|NCT00549302|19519312|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
5652667|NCT00549302|19519310|P3|Double-Blind|Lost to Follow-up|0
5652668|NCT00549302|19519311|P2|Double-Blind|Lost to Follow-up|2
5652669|NCT00549302|19519312|P1|Double-Blind|Lost to Follow-up|1
5652670|NCT00549302|19519310|P3|Double-Blind|Sponsor Decision|0
5652671|NCT00549302|19519311|P2|Double-Blind|Sponsor Decision|1
5652672|NCT00549302|19519312|P1|Double-Blind|Sponsor Decision|0
5652673|NCT00549302|19519310|P3|Double-Blind|Investigator Decision|0
5652674|NCT00549302|19519311|P2|Double-Blind|Investigator Decision|5
5652675|NCT00549302|19519312|P1|Double-Blind|Investigator Decision|1
5652676|NCT00549302|19519310|P3|Double-Blind|Withdrawal by Subject|0
5652677|NCT00549302|19519311|P2|Double-Blind|Withdrawal by Subject|8
5652678|NCT00549302|19519312|P1|Double-Blind|Withdrawal by Subject|3
5652679|NCT00549302|19519310|P3|Double-Blind|Adverse Event|0
5652680|NCT00549302|19519311|P2|Double-Blind|Adverse Event|16
5652681|NCT00549302|19519312|P1|Double-Blind|Adverse Event|3
5652682|NCT00549302|19519310|P3|Double-Blind|Death|0
5652683|NCT00549302|19519311|P2|Double-Blind|Death|9
5652684|NCT00549302|19519312|P1|Double-Blind|Death|2
5652685|NCT00549198|19519324|P2|Overall Study|Not Exposed to Study Drug|4
5652686|NCT00549198|19519325|P1|Overall Study|Not Exposed to Study Drug|3
5652687|NCT00549198|19519324|P2|Overall Study|Pregnancy|3
5652688|NCT00549198|19519325|P1|Overall Study|Pregnancy|0
5652689|NCT00549198|19519324|P2|Overall Study|No scan facilities|2
5652690|NCT00549198|19519325|P1|Overall Study|No scan facilities|0
5652691|NCT00549198|19519324|P2|Overall Study|Participant overweight, no scan possible|0
5652692|NCT00549198|19519325|P1|Overall Study|Participant overweight, no scan possible|1
5652693|NCT00549198|19519324|P2|Overall Study|Participant planning pregnancy|0
5652694|NCT00549198|19519325|P1|Overall Study|Participant planning pregnancy|1
5652695|NCT00549198|19519324|P2|Overall Study|Prohibited Medication|2
5652696|NCT00549198|19519325|P1|Overall Study|Prohibited Medication|1
5652697|NCT00549198|19519324|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
5652698|NCT00549198|19519325|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
5652699|NCT00549198|19519324|P2|Overall Study|Participant not able to perform Week 96|0
5652700|NCT00549198|19519325|P1|Overall Study|Participant not able to perform Week 96|1
5652701|NCT00549198|19519324|P2|Overall Study|Participant Moved|0
5652702|NCT00549198|19519325|P1|Overall Study|Participant Moved|2
5652703|NCT00549198|19519324|P2|Overall Study|Disease Progression|0
5652704|NCT00549198|19519325|P1|Overall Study|Disease Progression|1
5652705|NCT00549198|19519324|P2|Overall Study|Withdrawal by Subject|7
5652706|NCT00549198|19519325|P1|Overall Study|Withdrawal by Subject|7
5652707|NCT00549198|19519324|P2|Overall Study|Investigator Decision|3
5652708|NCT00549198|19519325|P1|Overall Study|Investigator Decision|4
5652709|NCT00549198|19519324|P2|Overall Study|Protocol Violation|2
5652710|NCT00549198|19519325|P1|Overall Study|Protocol Violation|7
5652711|NCT00549198|19519324|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
5652712|NCT00549198|19519325|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
5652713|NCT00549198|19519324|P2|Overall Study|Lost to Follow-up|8
5652714|NCT00549198|19519325|P1|Overall Study|Lost to Follow-up|7
5652715|NCT00549198|19519324|P2|Overall Study|Non-compliance|4
5652716|NCT00549198|19519325|P1|Overall Study|Non-compliance|2
5652717|NCT00549198|19519324|P2|Overall Study|Protocol-defined Virological Failure|0
5652718|NCT00549198|19519325|P1|Overall Study|Protocol-defined Virological Failure|7
5652719|NCT00549198|19519324|P2|Overall Study|Insufficient Viral Load Response|2
5652720|NCT00549198|19519325|P1|Overall Study|Insufficient Viral Load Response|4
5652721|NCT00549198|19519324|P2|Overall Study|Adverse Event|26
5652722|NCT00549198|19519325|P1|Overall Study|Adverse Event|28
5652723|NCT00549055|19519462|P1|Overall Study|Very low visual acuity (VA)|1
5652724|NCT00549055|19519462|P1|Overall Study|Choroidal neovascularization|1
5652725|NCT00549055|19519462|P1|Overall Study|Growth choroidal neovascularisation|1
5652726|NCT00549055|19519462|P1|Overall Study|Vitreous hemorrhage|1
5652727|NCT00549055|19519462|P1|Overall Study|Active choroidal neovascula increased|1
5652728|NCT00549055|19519462|P1|Overall Study|Decrease of size|1
5652729|NCT00549055|19519462|P1|Overall Study|Progression to fibrosis|2
5652730|NCT00549055|19519462|P1|Overall Study|Stabilization|5
5652731|NCT00549055|19519462|P1|Overall Study|Lack of Efficacy|18
5652732|NCT00549055|19519462|P1|Overall Study|Adverse Event|4
5652733|NCT00548847|19519506|P1|Overall Study|Disease progression|7
5652734|NCT00548808|19519513|P2|Overall Study|Sponsor Decision|1
5652735|NCT00548808|19519514|P1|Overall Study|Sponsor Decision|1
5652736|NCT00548808|19519513|P2|Overall Study|Lack of Efficacy|0
5652737|NCT00548808|19519514|P1|Overall Study|Lack of Efficacy|2
5652738|NCT00548808|19519513|P2|Overall Study|Entry Criteria Not Met|2
5652739|NCT00548808|19519514|P1|Overall Study|Entry Criteria Not Met|2
5652740|NCT00548808|19519513|P2|Overall Study|Death|0
5652741|NCT00548808|19519514|P1|Overall Study|Death|2
5652742|NCT00548808|19519513|P2|Overall Study|Adverse Event|5
5652743|NCT00548808|19519514|P1|Overall Study|Adverse Event|4
5652744|NCT00548808|19519513|P2|Overall Study|Physician Decision|3
5652745|NCT00548808|19519514|P1|Overall Study|Physician Decision|6
5652746|NCT00548808|19519513|P2|Overall Study|Withdrawal by Subject|4
5652747|NCT00548808|19519514|P1|Overall Study|Withdrawal by Subject|8
5652748|NCT00548808|19519513|P2|Overall Study|Protocol Violation|8
5652749|NCT00548808|19519514|P1|Overall Study|Protocol Violation|8
5652750|NCT00548808|19519513|P2|Overall Study|Lost to Follow-up|3
5652751|NCT00548808|19519514|P1|Overall Study|Lost to Follow-up|9
5652752|NCT00548717|19519538|P2|Overall Study|Alternative treatment for GVHD|0
5652753|NCT00548717|19519539|P1|Overall Study|Alternative treatment for GVHD|1
5652754|NCT00548717|19519538|P2|Overall Study|Relapse|0
5652755|NCT00548717|19519539|P1|Overall Study|Relapse|3
5652756|NCT00548717|19519538|P2|Overall Study|Death|2
5652757|NCT00548717|19519539|P1|Overall Study|Death|5
5652758|NCT00548548|19519583|P2|Overall Study|Lost to Follow-up|18
5652759|NCT00548548|19519584|P1|Overall Study|Lost to Follow-up|17
5652760|NCT00548548|19519583|P2|Overall Study|Death|348
5652761|NCT00548548|19519584|P1|Overall Study|Death|345
5652762|NCT00548405|19519627|P3|Overall Study|Randomized but not treated|0
5652763|NCT00548405|19519628|P2|Overall Study|Randomized but not treated|0
5652764|NCT00548405|19519629|P1|Overall Study|Randomized but not treated|1
5652765|NCT00548405|19519627|P3|Overall Study|Sponsor decision|0
5652766|NCT00548405|19519628|P2|Overall Study|Sponsor decision|0
5652767|NCT00548405|19519629|P1|Overall Study|Sponsor decision|1
5652768|NCT00548405|19519627|P3|Overall Study|Death|1
5652769|NCT00548405|19519628|P2|Overall Study|Death|1
5652770|NCT00548405|19519629|P1|Overall Study|Death|0
5652771|NCT00548405|19519627|P3|Overall Study|Lost to Follow-up|2
5652772|NCT00548405|19519628|P2|Overall Study|Lost to Follow-up|1
5652773|NCT00548405|19519629|P1|Overall Study|Lost to Follow-up|1
5652774|NCT00548405|19519627|P3|Overall Study|Withdrawal by Subject|5
5652775|NCT00548405|19519628|P2|Overall Study|Withdrawal by Subject|12
5652776|NCT00548405|19519629|P1|Overall Study|Withdrawal by Subject|36
5652777|NCT00548405|19519627|P3|Overall Study|Protocol Violation|0
5652778|NCT00548405|19519628|P2|Overall Study|Protocol Violation|0
5652779|NCT00548405|19519629|P1|Overall Study|Protocol Violation|1
5652780|NCT00548405|19519627|P3|Overall Study|Pregnancy|0
5652781|NCT00548405|19519628|P2|Overall Study|Pregnancy|0
5652782|NCT00548405|19519629|P1|Overall Study|Pregnancy|1
5652783|NCT00548405|19519627|P3|Overall Study|Physician Decision|1
5652784|NCT00548405|19519628|P2|Overall Study|Physician Decision|4
5652785|NCT00548405|19519629|P1|Overall Study|Physician Decision|3
5652786|NCT00548405|19519627|P3|Overall Study|Lack of Efficacy|0
5652787|NCT00548405|19519628|P2|Overall Study|Lack of Efficacy|0
5652788|NCT00548405|19519629|P1|Overall Study|Lack of Efficacy|6
5652789|NCT00548405|19519627|P3|Overall Study|Adverse Event|0
5652790|NCT00548405|19519628|P2|Overall Study|Adverse Event|2
5652791|NCT00548405|19519629|P1|Overall Study|Adverse Event|6
5652792|NCT00548340|19519650|P3|Overall Study|Other|1
5652793|NCT00548340|19519651|P2|Overall Study|Other|1
5652794|NCT00548340|19519652|P1|Overall Study|Other|1
5652795|NCT00548340|19519650|P3|Overall Study|Withdrawal by Subject|3
5652796|NCT00548340|19519651|P2|Overall Study|Withdrawal by Subject|4
5652797|NCT00548340|19519652|P1|Overall Study|Withdrawal by Subject|2
5652798|NCT00548340|19519650|P3|Overall Study|Lost to Follow-up|0
5652799|NCT00548340|19519651|P2|Overall Study|Lost to Follow-up|1
5652800|NCT00548340|19519652|P1|Overall Study|Lost to Follow-up|1
5652801|NCT00548340|19519650|P3|Overall Study|Adverse Event|2
5652802|NCT00548340|19519651|P2|Overall Study|Adverse Event|2
5652803|NCT00548340|19519652|P1|Overall Study|Adverse Event|2
5652804|NCT00548340|19519650|P3|Overall Study|Protocol Violation|3
5652805|NCT00548340|19519651|P2|Overall Study|Protocol Violation|3
5652806|NCT00548340|19519652|P1|Overall Study|Protocol Violation|2
5652807|NCT00548327|19519671|P2|Overall Study|Adverse Event|1
5652808|NCT00548327|19519672|P1|Overall Study|Adverse Event|0
5652809|NCT00548262|19519690|P1|Overall Study|Withdrawal by Subject|1
5652810|NCT00548262|19519690|P1|Overall Study|Other|3
5652811|NCT00548262|19519690|P1|Overall Study|Lost to Follow-up|1
5652812|NCT00548262|19519690|P1|Overall Study|Lack of Efficacy|4
5652813|NCT00548262|19519690|P1|Overall Study|Adverse Event|2
5652814|NCT00548262|19519690|P1|Overall Study|Death|21
5652815|NCT00548249|19519720|P5|Overall Study|Sponsor's request|0
5652816|NCT00548249|19519721|P4|Overall Study|Sponsor's request|1
5652817|NCT00548249|19519722|P3|Overall Study|Sponsor's request|0
5652818|NCT00548249|19519723|P2|Overall Study|Sponsor's request|0
5652819|NCT00548249|19519724|P1|Overall Study|Sponsor's request|0
5652820|NCT00548249|19519720|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
5652821|NCT00548249|19519721|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
5652822|NCT00548249|19519722|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
5652823|NCT00548249|19519723|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
5652824|NCT00548249|19519724|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
5652825|NCT00548249|19519720|P5|Overall Study|Withdrawal by Subject|0
5652826|NCT00548249|19519721|P4|Overall Study|Withdrawal by Subject|0
5652827|NCT00548249|19519722|P3|Overall Study|Withdrawal by Subject|0
5652828|NCT00548249|19519723|P2|Overall Study|Withdrawal by Subject|0
5652829|NCT00548249|19519724|P1|Overall Study|Withdrawal by Subject|2
5652830|NCT00548249|19519720|P5|Overall Study|Prolonged hospitalization|0
5652831|NCT00548249|19519721|P4|Overall Study|Prolonged hospitalization|1
5652832|NCT00548249|19519722|P3|Overall Study|Prolonged hospitalization|2
5652833|NCT00548249|19519723|P2|Overall Study|Prolonged hospitalization|0
5652834|NCT00548249|19519724|P1|Overall Study|Prolonged hospitalization|0
5652835|NCT00548249|19519720|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
5652836|NCT00548249|19519721|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
5652837|NCT00548249|19519722|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
5652838|NCT00548249|19519723|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
5652839|NCT00548249|19519724|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
5652840|NCT00548249|19519720|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
5652841|NCT00548249|19519721|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
5652842|NCT00548249|19519722|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
5652843|NCT00548249|19519723|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
5652844|NCT00548249|19519724|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
5652845|NCT00548249|19519720|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
5652930|NCT00547521|19519990|P1|Short Term Study (4 Months)|Adverse Event|1
5652846|NCT00548249|19519721|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
5652847|NCT00548249|19519722|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
5652848|NCT00548249|19519723|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
5652849|NCT00548249|19519724|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
5652850|NCT00548249|19519720|P5|Overall Study|Adverse Event|1
5652851|NCT00548249|19519721|P4|Overall Study|Adverse Event|1
5652852|NCT00548249|19519722|P3|Overall Study|Adverse Event|0
5652853|NCT00548249|19519723|P2|Overall Study|Adverse Event|2
5652854|NCT00548249|19519724|P1|Overall Study|Adverse Event|2
5652855|NCT00548249|19519720|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
5652856|NCT00548249|19519721|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
5652857|NCT00548249|19519722|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
5652858|NCT00548249|19519723|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
5652859|NCT00548249|19519724|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
5652860|NCT00548249|19519720|P5|Overall Study|Miscellaneous|2
5652861|NCT00548249|19519721|P4|Overall Study|Miscellaneous|0
5652862|NCT00548249|19519722|P3|Overall Study|Miscellaneous|2
5652863|NCT00548249|19519723|P2|Overall Study|Miscellaneous|3
5652864|NCT00548249|19519724|P1|Overall Study|Miscellaneous|2
5652865|NCT00548249|19519720|P5|Overall Study|Protocol Violation|3
5652866|NCT00548249|19519721|P4|Overall Study|Protocol Violation|0
5652867|NCT00548249|19519722|P3|Overall Study|Protocol Violation|4
5652868|NCT00548249|19519723|P2|Overall Study|Protocol Violation|1
5652869|NCT00548249|19519724|P1|Overall Study|Protocol Violation|1
5652870|NCT00548249|19519720|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
5652871|NCT00548249|19519721|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
5652872|NCT00548249|19519722|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
5652873|NCT00548249|19519723|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
5652874|NCT00548249|19519724|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
5652875|NCT00548249|19519720|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
5652876|NCT00548249|19519721|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
5652877|NCT00548249|19519722|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
5652878|NCT00548249|19519723|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
5652879|NCT00548249|19519724|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
5652880|NCT00548184|19519772|P1|Overall Study|Found Her2 negative|1
5652881|NCT00548184|19519772|P1|Overall Study|took other drug|1
5652882|NCT00548184|19519772|P1|Overall Study|Adverse Event|3
5652883|NCT00548145|19519820|P2|Overall Study|Physician Decision|1
5652884|NCT00548145|19519821|P1|Overall Study|Physician Decision|1
5652885|NCT00548145|19519820|P2|Overall Study|Withdrawal by Subject|2
5652886|NCT00548145|19519821|P1|Overall Study|Withdrawal by Subject|0
5652887|NCT00548145|19519820|P2|Overall Study|Death|1
5652888|NCT00548145|19519821|P1|Overall Study|Death|0
5652889|NCT00548093|19519840|P2|Overall Study|Completed post-treatment follow-up|0
5652890|NCT00548093|19519841|P1|Overall Study|Completed post-treatment follow-up|1
5652891|NCT00548093|19519840|P2|Overall Study|Withdrawal by Subject|0
5652892|NCT00548093|19519841|P1|Overall Study|Withdrawal by Subject|1
5652893|NCT00548093|19519840|P2|Overall Study|Other|1
5652894|NCT00548093|19519841|P1|Overall Study|Other|11
5652895|NCT00548093|19519840|P2|Overall Study|Objective progression or relapse|1
5652896|NCT00548093|19519841|P1|Overall Study|Objective progression or relapse|1
5652897|NCT00548093|19519840|P2|Overall Study|Lost to Follow-up|1
5652898|NCT00548093|19519841|P1|Overall Study|Lost to Follow-up|3
5652899|NCT00548093|19519840|P2|Overall Study|Death|13
5652900|NCT00548093|19519841|P1|Overall Study|Death|33
5652901|NCT00547911|19519879|P6|Overall Study|Adverse Event|0
5652902|NCT00547911|19519880|P5|Overall Study|Adverse Event|0
5652903|NCT00547911|19519881|P4|Overall Study|Adverse Event|1
5652904|NCT00547911|19519882|P3|Overall Study|Adverse Event|0
5652905|NCT00547911|19519883|P2|Overall Study|Adverse Event|0
5652906|NCT00547911|19519884|P1|Overall Study|Adverse Event|0
5652907|NCT00547703|19519934|P2|Overall Study|Lost to Follow-up|0
5652908|NCT00547703|19519935|P1|Overall Study|Lost to Follow-up|1
5652909|NCT00547534|19519981|P1|Overall Study|Disease Progression|4
5652910|NCT00547534|19519981|P1|Overall Study|Adverse Event|7
5652911|NCT00547521|19519989|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
5652912|NCT00547521|19519990|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
5652913|NCT00547521|19519989|P2|Long Term Extension (LTE) Study|Other|2
5652914|NCT00547521|19519990|P1|Long Term Extension (LTE) Study|Other|0
5652915|NCT00547521|19519989|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
5652916|NCT00547521|19519990|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
5652917|NCT00547521|19519989|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
5652918|NCT00547521|19519990|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
5652919|NCT00547521|19519989|P2|Long Term Extension (LTE) Study|Adverse Event|9
5652920|NCT00547521|19519990|P1|Long Term Extension (LTE) Study|Adverse Event|0
5652921|NCT00547521|19519989|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
5652922|NCT00547521|19519990|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
5652923|NCT00547521|19519989|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
5652924|NCT00547521|19519990|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
5652925|NCT00547521|19519989|P2|Short Term Study (4 Months)|Withdrawal of consent|1
5652926|NCT00547521|19519990|P1|Short Term Study (4 Months)|Withdrawal of consent|0
5652927|NCT00547521|19519989|P2|Short Term Study (4 Months)|Lack of Efficacy|2
5652928|NCT00547521|19519990|P1|Short Term Study (4 Months)|Lack of Efficacy|0
5652929|NCT00547521|19519989|P2|Short Term Study (4 Months)|Adverse Event|0
5652931|NCT00547378|19520067|P3|All Implanted Cohort|Other reasons|1
5652932|NCT00547378|19520068|P2|All Implanted Cohort|Other reasons|0
5652933|NCT00547378|19520069|P1|All Implanted Cohort|Other reasons|1
5652934|NCT00547378|19520067|P3|All Implanted Cohort|Site closure|1
5652935|NCT00547378|19520068|P2|All Implanted Cohort|Site closure|0
5652936|NCT00547378|19520069|P1|All Implanted Cohort|Site closure|2
5652937|NCT00547378|19520067|P3|All Implanted Cohort|Physician Decision|6
5652938|NCT00547378|19520068|P2|All Implanted Cohort|Physician Decision|2
5652939|NCT00547378|19520069|P1|All Implanted Cohort|Physician Decision|0
5652940|NCT00547378|19520067|P3|All Implanted Cohort|Death|4
5652941|NCT00547378|19520068|P2|All Implanted Cohort|Death|1
5652942|NCT00547378|19520069|P1|All Implanted Cohort|Death|3
5652943|NCT00547378|19520067|P3|All Implanted Cohort|Lost to Follow-up|14
5652944|NCT00547378|19520068|P2|All Implanted Cohort|Lost to Follow-up|1
5652945|NCT00547378|19520069|P1|All Implanted Cohort|Lost to Follow-up|0
5652946|NCT00547378|19520067|P3|All Implanted Cohort|Adverse Event|17
5652947|NCT00547378|19520068|P2|All Implanted Cohort|Adverse Event|10
5652948|NCT00547378|19520069|P1|All Implanted Cohort|Adverse Event|4
5652949|NCT00547378|19520067|P3|All Implanted Cohort|Withdrawal by Subject|27
5652950|NCT00547378|19520068|P2|All Implanted Cohort|Withdrawal by Subject|4
5652951|NCT00547378|19520069|P1|All Implanted Cohort|Withdrawal by Subject|5
5652952|NCT00547378|19520067|P3|Randomized Cohort|Other reasons|0
5652953|NCT00547378|19520068|P2|Randomized Cohort|Other reasons|0
5652954|NCT00547378|19520069|P1|Randomized Cohort|Other reasons|2
5652955|NCT00547378|19520067|P3|Randomized Cohort|Adverse Event|0
5652956|NCT00547378|19520068|P2|Randomized Cohort|Adverse Event|0
5652957|NCT00547378|19520069|P1|Randomized Cohort|Adverse Event|1
5652958|NCT00547378|19520067|P3|Randomized Cohort|Lost to Follow-up|0
5652959|NCT00547378|19520068|P2|Randomized Cohort|Lost to Follow-up|0
5652960|NCT00547378|19520069|P1|Randomized Cohort|Lost to Follow-up|1
5652961|NCT00547378|19520067|P3|Randomized Cohort|Death|0
5652962|NCT00547378|19520068|P2|Randomized Cohort|Death|1
5652963|NCT00547378|19520069|P1|Randomized Cohort|Death|0
5652964|NCT00547378|19520067|P3|Randomized Cohort|Withdrawal by Subject|0
5652965|NCT00547378|19520068|P2|Randomized Cohort|Withdrawal by Subject|5
5652966|NCT00547378|19520069|P1|Randomized Cohort|Withdrawal by Subject|7
5652967|NCT00547365|19520079|P1|Overall Study|death (not related to study)|4
5652968|NCT00547365|19520079|P1|Overall Study|Protocol Violation|2
5652969|NCT00547365|19520079|P1|Overall Study|Lost to Follow-up|1
5652970|NCT00547365|19520079|P1|Overall Study|Physician Decision|1
5652971|NCT00547300|19520086|P2|Overall Study|Did not Meet Entry Criteria|2
5652972|NCT00547300|19520087|P1|Overall Study|Did not Meet Entry Criteria|0
5652973|NCT00547300|19520086|P2|Overall Study|Study was Administratively Terminated|24
5652974|NCT00547300|19520087|P1|Overall Study|Study was Administratively Terminated|25
5652975|NCT00547248|19520101|P4|Overall Study|Withdrawal by Subject|1
5652976|NCT00547248|19520102|P3|Overall Study|Withdrawal by Subject|7
5652977|NCT00547248|19520103|P2|Overall Study|Withdrawal by Subject|0
5652978|NCT00547248|19520104|P1|Overall Study|Withdrawal by Subject|0
5652979|NCT00547248|19520101|P4|Overall Study|Migrated/moved from study area|0
5652980|NCT00547248|19520102|P3|Overall Study|Migrated/moved from study area|2
5652981|NCT00547248|19520103|P2|Overall Study|Migrated/moved from study area|0
5652982|NCT00547248|19520104|P1|Overall Study|Migrated/moved from study area|0
5652983|NCT00547248|19520101|P4|Overall Study|Protocol Violation|1
5652984|NCT00547248|19520102|P3|Overall Study|Protocol Violation|1
5652985|NCT00547248|19520103|P2|Overall Study|Protocol Violation|0
5652986|NCT00547248|19520104|P1|Overall Study|Protocol Violation|0
5652987|NCT00547157|19520222|P2|Overall Study|Lost to Follow-up|2
5652988|NCT00547157|19520223|P1|Overall Study|Lost to Follow-up|4
5652989|NCT00547157|19520222|P2|Overall Study|Administrative decision|2
5652990|NCT00547157|19520223|P1|Overall Study|Administrative decision|3
5652991|NCT00547157|19520222|P2|Overall Study|Withdrawal by Subject|1
5652992|NCT00547157|19520223|P1|Overall Study|Withdrawal by Subject|3
5652993|NCT00547157|19520222|P2|Overall Study|Death|18
5652994|NCT00547157|19520223|P1|Overall Study|Death|38
5652995|NCT00547157|19520222|P2|Overall Study|Other|0
5652996|NCT00547157|19520223|P1|Overall Study|Other|1
5652997|NCT00547118|19520241|P2|Overall Study|Study suspended|8
5652998|NCT00547118|19520242|P1|Overall Study|Study suspended|7
5652999|NCT00547118|19520241|P2|Overall Study|Did not qualify prior to starting drug|1
5653000|NCT00547118|19520242|P1|Overall Study|Did not qualify prior to starting drug|1
5653001|NCT00546910|19520286|P2|Overall Study|Withdrawal by Subject|0
5653002|NCT00546910|19520287|P1|Overall Study|Withdrawal by Subject|2
5653003|NCT00546910|19520286|P2|Overall Study|Physician Decision|1
5653004|NCT00546910|19520287|P1|Overall Study|Physician Decision|0
5653005|NCT00546910|19520286|P2|Overall Study|Lack of Efficacy|7
5653006|NCT00546910|19520287|P1|Overall Study|Lack of Efficacy|5
5653007|NCT00546910|19520286|P2|Overall Study|Adverse Event|3
5653008|NCT00546910|19520287|P1|Overall Study|Adverse Event|2
5653009|NCT00546871|19520353|P2|Study Extension Period|Withdrawal by Subject|1
5653010|NCT00546871|19520354|P1|Study Extension Period|Withdrawal by Subject|0
5653011|NCT00546871|19520353|P2|Study Extension Period|Protocol Violation|0
5653012|NCT00546871|19520354|P1|Study Extension Period|Protocol Violation|1
5653013|NCT00546871|19520353|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
5653014|NCT00546871|19520354|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
5653015|NCT00546871|19520353|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
5653016|NCT00546871|19520354|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
5653017|NCT00546871|19520353|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
5653018|NCT00546871|19520354|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
5653019|NCT00546819|19520459|P2|Overall Study|Withdrawal by Subject|2
5653020|NCT00546819|19520460|P1|Overall Study|Withdrawal by Subject|4
5653021|NCT00546819|19520459|P2|Overall Study|Lost to Follow-up|1
5653022|NCT00546819|19520460|P1|Overall Study|Lost to Follow-up|2
5653023|NCT00546819|19520459|P2|Overall Study|Adverse Event|3
5653024|NCT00546819|19520460|P1|Overall Study|Adverse Event|2
5653025|NCT00546754|19520472|P2|Overall Study|Missing|7
5653026|NCT00546754|19520473|P1|Overall Study|Missing|14
5653027|NCT00546754|19520472|P2|Overall Study|Patient's Decision|1
5653028|NCT00546754|19520473|P1|Overall Study|Patient's Decision|0
5653029|NCT00546754|19520472|P2|Overall Study|Elevated Creatinine and Potassium levels|1
5653030|NCT00546754|19520473|P1|Overall Study|Elevated Creatinine and Potassium levels|0
5653031|NCT00546754|19520472|P2|Overall Study|Missing Cooperation|0
5653032|NCT00546754|19520473|P1|Overall Study|Missing Cooperation|1
5653033|NCT00546754|19520472|P2|Overall Study|Suicide|0
5653034|NCT00546754|19520473|P1|Overall Study|Suicide|1
5653035|NCT00546754|19520472|P2|Overall Study|Hip Replacement|0
5653036|NCT00546754|19520473|P1|Overall Study|Hip Replacement|1
5653037|NCT00546754|19520472|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
5653038|NCT00546754|19520473|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
5653039|NCT00546754|19520472|P2|Overall Study|Dyspnea|0
5653040|NCT00546754|19520473|P1|Overall Study|Dyspnea|1
5653041|NCT00546754|19520472|P2|Overall Study|Withdrawal by Subject|7
5653042|NCT00546754|19520473|P1|Overall Study|Withdrawal by Subject|6
5653043|NCT00546754|19520472|P2|Overall Study|Protocol Violation|0
5653044|NCT00546754|19520473|P1|Overall Study|Protocol Violation|3
5653045|NCT00546754|19520472|P2|Overall Study|Lost to Follow-up|15
5653046|NCT00546754|19520473|P1|Overall Study|Lost to Follow-up|9
5653047|NCT00546754|19520472|P2|Overall Study|Lack of Efficacy|1
5653048|NCT00546754|19520473|P1|Overall Study|Lack of Efficacy|1
5653049|NCT00546754|19520472|P2|Overall Study|Adverse Event|16
5653050|NCT00546754|19520473|P1|Overall Study|Adverse Event|11
5653051|NCT00546754|19520472|P2|Overall Study|Serious Adverse Event|1
5653052|NCT00546754|19520473|P1|Overall Study|Serious Adverse Event|1
5653053|NCT00546715|19520516|P4|Overall Study|Withdrawal by Subject|0
5653054|NCT00546715|19520517|P3|Overall Study|Withdrawal by Subject|0
5653055|NCT00546715|19520518|P2|Overall Study|Withdrawal by Subject|1
5653056|NCT00546715|19520519|P1|Overall Study|Withdrawal by Subject|0
5653057|NCT00546637|19520574|P2|Overall Study|Randomized, but not treated|1
5653058|NCT00546637|19520575|P1|Overall Study|Randomized, but not treated|3
5653059|NCT00546637|19520574|P2|Overall Study|Withdrawal by Subject|9
5653060|NCT00546637|19520575|P1|Overall Study|Withdrawal by Subject|7
5653061|NCT00546637|19520574|P2|Overall Study|Other|12
5653062|NCT00546637|19520575|P1|Overall Study|Other|10
5653063|NCT00546637|19520574|P2|Overall Study|Lost to Follow-up|2
5653064|NCT00546637|19520575|P1|Overall Study|Lost to Follow-up|2
5653065|NCT00546637|19520574|P2|Overall Study|Lack of Efficacy|5
5653066|NCT00546637|19520575|P1|Overall Study|Lack of Efficacy|5
5653067|NCT00546637|19520574|P2|Overall Study|Adverse Event|20
5653068|NCT00546637|19520575|P1|Overall Study|Adverse Event|46
5653069|NCT00546572|19520649|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
5653070|NCT00546572|19520650|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
5653071|NCT00546572|19520649|P2|Vax 2 / Year 1|Adverse Event|0
5653072|NCT00546572|19520650|P1|Vax 2 / Year 1|Adverse Event|1
5653073|NCT00546572|19520649|P2|Vax 2 / Year 1|Other|1
5653074|NCT00546572|19520650|P1|Vax 2 / Year 1|Other|1
5653075|NCT00546572|19520649|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
5653076|NCT00546572|19520650|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
5653077|NCT00546572|19520649|P2|Vax 1 / Year 0|Lost to Follow-up|1
5653078|NCT00546572|19520650|P1|Vax 1 / Year 0|Lost to Follow-up|0
5653079|NCT00546572|19520649|P2|Vax 1 / Year 0|Adverse Event|1
5653080|NCT00546572|19520650|P1|Vax 1 / Year 0|Adverse Event|0
5653081|NCT00546572|19520649|P2|Vax 1 / Year 0|Death|2
5653082|NCT00546572|19520650|P1|Vax 1 / Year 0|Death|2
5653083|NCT00546572|19520649|P2|Vax 1 / Year 0|Protocol Violation|4
5653084|NCT00546572|19520650|P1|Vax 1 / Year 0|Protocol Violation|3
5653085|NCT00546572|19520649|P2|Vax 1 / Year 0|Withdrawal by Subject|2
5653086|NCT00546572|19520650|P1|Vax 1 / Year 0|Withdrawal by Subject|3
5653087|NCT00546572|19520649|P2|Vax 1 / Year 0|Randomized, not treated|1
5653088|NCT00546572|19520650|P1|Vax 1 / Year 0|Randomized, not treated|1
5653089|NCT00546481|19520694|P3|Maintenance Phase (CERA)|Other Reason|1
5653090|NCT00546481|19520695|P2|Maintenance Phase (CERA)|Other Reason|0
5653091|NCT00546481|19520696|P1|Maintenance Phase (CERA)|Other Reason|0
5653092|NCT00546481|19520694|P3|Maintenance Phase (CERA)|Kidney transplantation|1
5653093|NCT00546481|19520695|P2|Maintenance Phase (CERA)|Kidney transplantation|0
5653094|NCT00546481|19520696|P1|Maintenance Phase (CERA)|Kidney transplantation|0
5653095|NCT00546481|19520694|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
5653096|NCT00546481|19520695|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
5653097|NCT00546481|19520696|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
5653098|NCT00546481|19520694|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
5653099|NCT00546481|19520695|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
5653100|NCT00546481|19520696|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
5653101|NCT00546481|19520694|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
5653102|NCT00546481|19520695|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
5653103|NCT00546481|19520696|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
5653104|NCT00546481|19520694|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
5653105|NCT00546481|19520695|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
5653106|NCT00546481|19520696|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
5653107|NCT00546481|19520694|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
5653108|NCT00546481|19520695|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
5653109|NCT00546481|19520696|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
5653110|NCT00546481|19520694|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
5653111|NCT00546481|19520695|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
5653112|NCT00546481|19520696|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
5653113|NCT00546481|19520694|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
5653114|NCT00546481|19520695|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
5653115|NCT00546481|19520696|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
5653116|NCT00546377|19520734|P1|Overall Study|Adverse Event|6
5653117|NCT00546377|19520734|P1|Overall Study|Deemed ineligible|1
5653118|NCT00546364|19520742|P3|Overall Study|Sponsor decision|1
5653119|NCT00546364|19520743|P2|Overall Study|Sponsor decision|0
5653120|NCT00546364|19520744|P1|Overall Study|Sponsor decision|0
5653121|NCT00546364|19520742|P3|Overall Study|Physician Decision|1
5653122|NCT00546364|19520743|P2|Overall Study|Physician Decision|0
5653123|NCT00546364|19520744|P1|Overall Study|Physician Decision|0
5653124|NCT00546364|19520742|P3|Overall Study|Target lesions resected|0
5653125|NCT00546364|19520743|P2|Overall Study|Target lesions resected|0
5653126|NCT00546364|19520744|P1|Overall Study|Target lesions resected|1
5653127|NCT00546364|19520742|P3|Overall Study|Palliative treatment|1
5653128|NCT00546364|19520743|P2|Overall Study|Palliative treatment|0
5653129|NCT00546364|19520744|P1|Overall Study|Palliative treatment|1
5653130|NCT00546364|19520742|P3|Overall Study|Mixed response|0
5653131|NCT00546364|19520743|P2|Overall Study|Mixed response|0
5653132|NCT00546364|19520744|P1|Overall Study|Mixed response|1
5653133|NCT00546364|19520742|P3|Overall Study|Prior taxotere|0
5653134|NCT00546364|19520743|P2|Overall Study|Prior taxotere|0
5653135|NCT00546364|19520744|P1|Overall Study|Prior taxotere|1
5653136|NCT00546364|19520742|P3|Overall Study|Withdrawal by Subject|3
5653137|NCT00546364|19520743|P2|Overall Study|Withdrawal by Subject|6
5653138|NCT00546364|19520744|P1|Overall Study|Withdrawal by Subject|5
5653139|NCT00546364|19520742|P3|Overall Study|No longer meets study criteria|0
5653140|NCT00546364|19520743|P2|Overall Study|No longer meets study criteria|1
5653141|NCT00546364|19520744|P1|Overall Study|No longer meets study criteria|1
5653142|NCT00546364|19520742|P3|Overall Study|Poor compliance/noncompliance|1
5653143|NCT00546364|19520743|P2|Overall Study|Poor compliance/noncompliance|0
5653144|NCT00546364|19520744|P1|Overall Study|Poor compliance/noncompliance|0
5653145|NCT00546364|19520742|P3|Overall Study|Administrative reason by sponsor|0
5653146|NCT00546364|19520743|P2|Overall Study|Administrative reason by sponsor|0
5653147|NCT00546364|19520744|P1|Overall Study|Administrative reason by sponsor|1
5653148|NCT00546364|19520742|P3|Overall Study|Completed and off treatment|2
5653149|NCT00546364|19520743|P2|Overall Study|Completed and off treatment|0
5653150|NCT00546364|19520744|P1|Overall Study|Completed and off treatment|1
5653151|NCT00546364|19520742|P3|Overall Study|Disease progression|8
5653152|NCT00546364|19520743|P2|Overall Study|Disease progression|11
5653153|NCT00546364|19520744|P1|Overall Study|Disease progression|5
5653154|NCT00546351|19520779|P1|Overall Study|Other reasons for premature termination|17
5653155|NCT00546351|19520779|P1|Overall Study|Unsatisfactory compliance|9
5653156|NCT00546351|19520779|P1|Overall Study|Protocol Deviation|1
5653157|NCT00546351|19520779|P1|Overall Study|Lost to Follow-up|9
5653158|NCT00546351|19520779|P1|Overall Study|Withdrawal by Subject|109
5653159|NCT00546351|19520779|P1|Overall Study|Lack of Efficacy|15
5653160|NCT00546351|19520779|P1|Overall Study|Adverse Event|76
5653161|NCT00546260|19520825|P2|Overall Study|Drug not given pre diagnostic angiogr|2
5653162|NCT00546260|19520826|P1|Overall Study|Drug not given pre diagnostic angiogr|8
5653163|NCT00546117|19520848|P2|Overall Study|Inability to schedule follow-up visit|0
5653164|NCT00546117|19520849|P1|Overall Study|Inability to schedule follow-up visit|1
5653165|NCT00546117|19520848|P2|Overall Study|Withdrawal by Subject|0
5653166|NCT00546117|19520849|P1|Overall Study|Withdrawal by Subject|3
5653167|NCT00546078|19520874|P2|Overall Study|Other reason|1
5653168|NCT00546078|19520875|P1|Overall Study|Other reason|1
5653169|NCT00546078|19520874|P2|Overall Study|Withdrawal by Subject|3
5653170|NCT00546078|19520875|P1|Overall Study|Withdrawal by Subject|2
5653171|NCT00546078|19520874|P2|Overall Study|Lost to Follow-up|3
5653172|NCT00546078|19520875|P1|Overall Study|Lost to Follow-up|1
5653173|NCT00546052|19520913|P1|Overall Study|Non Compliance|7
5653174|NCT00546052|19520913|P1|Overall Study|Withdrawal by Subject|20
5653175|NCT00546052|19520913|P1|Overall Study|Protocol Violation|9
5653176|NCT00546052|19520913|P1|Overall Study|Lost to Follow-up|144
5653177|NCT00546052|19520913|P1|Overall Study|Adverse Event|47
5653178|NCT00546000|19520931|P1|Overall Study|Baseline HPA Axis Supression|2
5653179|NCT00546000|19520931|P1|Overall Study|Lost to Follow-up|1
5653180|NCT00546000|19520931|P1|Overall Study|Adverse Event|1
5653181|NCT00545948|19520956|P3|Overall Study|Not Treated|7
5653182|NCT00545948|19520957|P2|Overall Study|Not Treated|1
5653183|NCT00545948|19520958|P1|Overall Study|Not Treated|1
5653184|NCT00545844|19520968|P1|Overall Study|Withdrawal by Subject|2
5653185|NCT00545844|19520968|P1|Overall Study|Protocol Violation|1
5653186|NCT00545844|19520968|P1|Overall Study|Lost to Follow-up|9
5653187|NCT00545818|19520984|P2|Overall Study|Lost to Follow-up|6
5653188|NCT00545818|19520985|P1|Overall Study|Lost to Follow-up|1
5653189|NCT00545818|19520984|P2|Overall Study|Adverse Event|1
5653190|NCT00545818|19520985|P1|Overall Study|Adverse Event|1
5653191|NCT00545818|19520984|P2|Overall Study|Protocol Violation|0
5653192|NCT00545818|19520985|P1|Overall Study|Protocol Violation|1
5653193|NCT00545792|19520999|P1|Overall Study|Withdrawal by Subject|1
5653194|NCT00545779|19521004|P1|Overall Study|Failure to return|3
5653195|NCT00545779|19521004|P1|Overall Study|Adverse Event/intercurrent illness|5
5653196|NCT00545779|19521004|P1|Overall Study|Withdrawal by Subject|20
5653197|NCT00545779|19521004|P1|Overall Study|Did not cooperate|7
5653198|NCT00545779|19521004|P1|Overall Study|Other protocol violation|1
5653199|NCT00545779|19521004|P1|Overall Study|Violation of selection criteria at entry|8
5653200|NCT00545753|19521024|P3|Overall Study|Protocol Violation|4
5653201|NCT00545753|19521025|P2|Overall Study|Protocol Violation|1
5653202|NCT00545753|19521026|P1|Overall Study|Protocol Violation|3
5653203|NCT00545753|19521024|P3|Overall Study|Lost to Follow-up|12
5653204|NCT00545753|19521025|P2|Overall Study|Lost to Follow-up|3
5653205|NCT00545753|19521026|P1|Overall Study|Lost to Follow-up|13
5653206|NCT00545753|19521024|P3|Overall Study|Withdrawal by Subject|10
5653207|NCT00545753|19521025|P2|Overall Study|Withdrawal by Subject|1
5653208|NCT00545753|19521026|P1|Overall Study|Withdrawal by Subject|0
5653209|NCT00545740|19521039|P4|Overall Study|Husband against study|0
5653210|NCT00545740|19521040|P3|Overall Study|Husband against study|1
5653211|NCT00545740|19521041|P2|Overall Study|Husband against study|0
5653212|NCT00545740|19521042|P1|Overall Study|Husband against study|0
5653213|NCT00545740|19521039|P4|Overall Study|Patient difficulties|0
5653214|NCT00545740|19521040|P3|Overall Study|Patient difficulties|0
5653215|NCT00545740|19521041|P2|Overall Study|Patient difficulties|1
5653216|NCT00545740|19521042|P1|Overall Study|Patient difficulties|0
5653217|NCT00545740|19521039|P4|Overall Study|Non-adherence to visits|0
5653218|NCT00545740|19521040|P3|Overall Study|Non-adherence to visits|0
5653219|NCT00545740|19521041|P2|Overall Study|Non-adherence to visits|1
5653220|NCT00545740|19521042|P1|Overall Study|Non-adherence to visits|0
5653221|NCT00545740|19521039|P4|Overall Study|Lack of time|0
5653222|NCT00545740|19521040|P3|Overall Study|Lack of time|0
5653223|NCT00545740|19521041|P2|Overall Study|Lack of time|1
5653224|NCT00545740|19521042|P1|Overall Study|Lack of time|0
5653225|NCT00545740|19521039|P4|Overall Study|Sponsor decision|0
5653226|NCT00545740|19521040|P3|Overall Study|Sponsor decision|0
5653227|NCT00545740|19521041|P2|Overall Study|Sponsor decision|1
5653228|NCT00545740|19521042|P1|Overall Study|Sponsor decision|0
5653229|NCT00545740|19521039|P4|Overall Study|Accepted only monthly telephone calls|0
5653230|NCT00545740|19521040|P3|Overall Study|Accepted only monthly telephone calls|0
5653231|NCT00545740|19521041|P2|Overall Study|Accepted only monthly telephone calls|0
5653232|NCT00545740|19521042|P1|Overall Study|Accepted only monthly telephone calls|1
5653233|NCT00545740|19521039|P4|Overall Study|Physician Decision|0
5653234|NCT00545740|19521040|P3|Overall Study|Physician Decision|3
5653235|NCT00545740|19521041|P2|Overall Study|Physician Decision|0
5653236|NCT00545740|19521042|P1|Overall Study|Physician Decision|0
5653237|NCT00545740|19521039|P4|Overall Study|Missed visit|0
5653238|NCT00545740|19521040|P3|Overall Study|Missed visit|0
5653239|NCT00545740|19521041|P2|Overall Study|Missed visit|0
5653240|NCT00545740|19521042|P1|Overall Study|Missed visit|1
5653241|NCT00545740|19521039|P4|Overall Study|Site closure|0
5653242|NCT00545740|19521040|P3|Overall Study|Site closure|0
5653243|NCT00545740|19521041|P2|Overall Study|Site closure|0
5653244|NCT00545740|19521042|P1|Overall Study|Site closure|1
5653245|NCT00545740|19521039|P4|Overall Study|Suspected Diverticulitis Recurrence|1
5653246|NCT00545740|19521040|P3|Overall Study|Suspected Diverticulitis Recurrence|1
5653247|NCT00545740|19521041|P2|Overall Study|Suspected Diverticulitis Recurrence|1
5653248|NCT00545740|19521042|P1|Overall Study|Suspected Diverticulitis Recurrence|1
5653249|NCT00545740|19521039|P4|Overall Study|Diverticulitis attack|1
5653250|NCT00545740|19521040|P3|Overall Study|Diverticulitis attack|1
5653251|NCT00545740|19521041|P2|Overall Study|Diverticulitis attack|0
5653252|NCT00545740|19521042|P1|Overall Study|Diverticulitis attack|0
5653253|NCT00545740|19521039|P4|Overall Study|Moved|0
5653254|NCT00545740|19521040|P3|Overall Study|Moved|1
5653255|NCT00545740|19521041|P2|Overall Study|Moved|0
5653256|NCT00545740|19521042|P1|Overall Study|Moved|2
5653257|NCT00545740|19521039|P4|Overall Study|Non-compliance|0
5653258|NCT00545740|19521040|P3|Overall Study|Non-compliance|1
5653259|NCT00545740|19521041|P2|Overall Study|Non-compliance|2
5653260|NCT00545740|19521042|P1|Overall Study|Non-compliance|0
5653261|NCT00545740|19521039|P4|Overall Study|Protocol Violation|0
5653262|NCT00545740|19521040|P3|Overall Study|Protocol Violation|1
5653263|NCT00545740|19521041|P2|Overall Study|Protocol Violation|3
5653264|NCT00545740|19521042|P1|Overall Study|Protocol Violation|1
5653265|NCT00545740|19521039|P4|Overall Study|Lost to Follow-up|6
5653266|NCT00545740|19521040|P3|Overall Study|Lost to Follow-up|5
5653267|NCT00545740|19521041|P2|Overall Study|Lost to Follow-up|5
5653268|NCT00545740|19521042|P1|Overall Study|Lost to Follow-up|7
5653269|NCT00545740|19521039|P4|Overall Study|Adverse Event|9
5653270|NCT00545740|19521040|P3|Overall Study|Adverse Event|19
5653271|NCT00545740|19521041|P2|Overall Study|Adverse Event|18
5653272|NCT00545740|19521042|P1|Overall Study|Adverse Event|10
5653273|NCT00545740|19521039|P4|Overall Study|Withdrawal by Subject|18
5653274|NCT00545740|19521040|P3|Overall Study|Withdrawal by Subject|16
5653275|NCT00545740|19521041|P2|Overall Study|Withdrawal by Subject|15
5653276|NCT00545740|19521042|P1|Overall Study|Withdrawal by Subject|17
5653277|NCT00545740|19521039|P4|Overall Study|Lack of Efficacy|36
5653278|NCT00545740|19521040|P3|Overall Study|Lack of Efficacy|47
5653279|NCT00545740|19521041|P2|Overall Study|Lack of Efficacy|35
5653280|NCT00545740|19521042|P1|Overall Study|Lack of Efficacy|34
5653281|NCT00545714|19521076|P1|Maintenance Phase (36 Months)|Death|2
5653282|NCT00545714|19521076|P1|Maintenance Phase (36 Months)|Withdrawal by Subject|3
5653283|NCT00545714|19521076|P1|Maintenance Phase (36 Months)|Protocol Violation|1
5653284|NCT00545714|19521076|P1|Maintenance Phase (36 Months)|Physician Decision|1
5653285|NCT00545714|19521076|P1|Maintenance Phase (36 Months)|Disease Progression|9
5653286|NCT00545714|19521076|P1|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
5653287|NCT00545714|19521076|P1|Induction Phase (6 Months)|Eligibility Criteria Violation|2
5653288|NCT00545714|19521076|P1|Induction Phase (6 Months)|Disease Progression|1
5653289|NCT00545714|19521076|P1|Induction Phase (6 Months)|Unacceptable Toxicity|6
5653290|NCT00545714|19521076|P1|Induction Phase (6 Months)|Physician Decision|3
5653291|NCT00545688|19521097|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
5653292|NCT00545688|19521098|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
5653293|NCT00545688|19521099|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
5653294|NCT00545688|19521100|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
5653295|NCT00545688|19521097|P4|Follow-Up Period|Unspecified Reason|8
5653296|NCT00545688|19521098|P3|Follow-Up Period|Unspecified Reason|6
5653297|NCT00545688|19521099|P2|Follow-Up Period|Unspecified Reason|5
5653298|NCT00545688|19521100|P1|Follow-Up Period|Unspecified Reason|2
5653299|NCT00545688|19521097|P4|Follow-Up Period|Lost to Follow-up|1
5653300|NCT00545688|19521098|P3|Follow-Up Period|Lost to Follow-up|3
5653301|NCT00545688|19521099|P2|Follow-Up Period|Lost to Follow-up|3
5653302|NCT00545688|19521100|P1|Follow-Up Period|Lost to Follow-up|3
5653303|NCT00545688|19521097|P4|Follow-Up Period|Refused Treatment|2
5653304|NCT00545688|19521098|P3|Follow-Up Period|Refused Treatment|0
5653305|NCT00545688|19521099|P2|Follow-Up Period|Refused Treatment|2
5653306|NCT00545688|19521100|P1|Follow-Up Period|Refused Treatment|6
5653307|NCT00545688|19521097|P4|Follow-Up Period|Disease Progression|9
5653308|NCT00545688|19521098|P3|Follow-Up Period|Disease Progression|9
5653309|NCT00545688|19521099|P2|Follow-Up Period|Disease Progression|5
5653310|NCT00545688|19521100|P1|Follow-Up Period|Disease Progression|6
5653311|NCT00545688|19521097|P4|Follow-Up Period|Death|6
5653312|NCT00545688|19521098|P3|Follow-Up Period|Death|2
5653313|NCT00545688|19521099|P2|Follow-Up Period|Death|2
5653314|NCT00545688|19521100|P1|Follow-Up Period|Death|4
5653315|NCT00545688|19521097|P4|Adjuvant Treatment Period|Unknown Reason|0
5653316|NCT00545688|19521098|P3|Adjuvant Treatment Period|Unknown Reason|0
5653317|NCT00545688|19521099|P2|Adjuvant Treatment Period|Unknown Reason|1
5653318|NCT00545688|19521100|P1|Adjuvant Treatment Period|Unknown Reason|0
5653319|NCT00545688|19521097|P4|Adjuvant Treatment Period|Adverse Event|2
5653320|NCT00545688|19521098|P3|Adjuvant Treatment Period|Adverse Event|2
5653321|NCT00545688|19521099|P2|Adjuvant Treatment Period|Adverse Event|3
5653322|NCT00545688|19521100|P1|Adjuvant Treatment Period|Adverse Event|0
5653323|NCT00545688|19521097|P4|Adjuvant Treatment Period|Lost to Follow-up|0
5653324|NCT00545688|19521098|P3|Adjuvant Treatment Period|Lost to Follow-up|1
5653325|NCT00545688|19521099|P2|Adjuvant Treatment Period|Lost to Follow-up|0
5653326|NCT00545688|19521100|P1|Adjuvant Treatment Period|Lost to Follow-up|1
5653327|NCT00545688|19521097|P4|Adjuvant Treatment Period|Refused Treatment|5
5653328|NCT00545688|19521098|P3|Adjuvant Treatment Period|Refused Treatment|1
5653329|NCT00545688|19521099|P2|Adjuvant Treatment Period|Refused Treatment|1
5653330|NCT00545688|19521100|P1|Adjuvant Treatment Period|Refused Treatment|1
5653331|NCT00545688|19521097|P4|Adjuvant Treatment Period|Disease Progression|7
5653332|NCT00545688|19521098|P3|Adjuvant Treatment Period|Disease Progression|0
5653333|NCT00545688|19521099|P2|Adjuvant Treatment Period|Disease Progression|3
5653334|NCT00545688|19521100|P1|Adjuvant Treatment Period|Disease Progression|3
5653335|NCT00545688|19521097|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
5653336|NCT00545688|19521098|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
5653337|NCT00545688|19521099|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
5653338|NCT00545688|19521100|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
5653339|NCT00545688|19521097|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
5653340|NCT00545688|19521098|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
5653341|NCT00545688|19521099|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
5653342|NCT00545688|19521100|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
5653343|NCT00545688|19521097|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
5653344|NCT00545688|19521098|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
5653345|NCT00545688|19521099|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
5653346|NCT00545688|19521100|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
5653347|NCT00545688|19521097|P4|Neo-Adjuvant Treatment Period|Death|0
5653348|NCT00545688|19521098|P3|Neo-Adjuvant Treatment Period|Death|0
5653349|NCT00545688|19521099|P2|Neo-Adjuvant Treatment Period|Death|1
5653350|NCT00545688|19521100|P1|Neo-Adjuvant Treatment Period|Death|0
5653351|NCT00545688|19521097|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
5653352|NCT00545688|19521098|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
5653353|NCT00545688|19521099|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
5653354|NCT00545688|19521100|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
5653355|NCT00545688|19521097|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
5653356|NCT00545688|19521098|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
5653357|NCT00545688|19521099|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
5653358|NCT00545688|19521100|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
5653359|NCT00545688|19521097|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
5653360|NCT00545688|19521098|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
5653361|NCT00545688|19521099|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
5653362|NCT00545688|19521100|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
5653363|NCT00545584|19521199|P3|Overall Study|Two or more reasons for discontinuation|8
5653364|NCT00545584|19521200|P2|Overall Study|Two or more reasons for discontinuation|19
5653365|NCT00545584|19521201|P1|Overall Study|Two or more reasons for discontinuation|17
5653366|NCT00545584|19521199|P3|Overall Study|Only one reason for discontinuation|48
5653367|NCT00545584|19521200|P2|Overall Study|Only one reason for discontinuation|61
5653368|NCT00545584|19521201|P1|Overall Study|Only one reason for discontinuation|62
5653369|NCT00545571|19521212|P1|Overall Study|Kidney Transplantation|3
5653370|NCT00545571|19521212|P1|Overall Study|Early Termination of Study|24
5653371|NCT00545571|19521212|P1|Overall Study|Transfusion|12
5653372|NCT00545571|19521212|P1|Overall Study|Screen Failure|16
5653373|NCT00545571|19521212|P1|Overall Study|Refused Treatment|1
5653374|NCT00545571|19521212|P1|Overall Study|Protocol Violation|2
5653375|NCT00545571|19521212|P1|Overall Study|Lack of Efficacy|1
5653376|NCT00545571|19521212|P1|Overall Study|Death|5
5653377|NCT00545571|19521212|P1|Overall Study|Adverse Event|2
5653378|NCT00545571|19521212|P1|Overall Study|Administrative Reasons|1
5653379|NCT00545532|19521227|P2|Overall Study|Death|1
5653380|NCT00545532|19521228|P1|Overall Study|Death|0
5653381|NCT00545532|19521227|P2|Overall Study|Lost to Follow-up|6
5653382|NCT00545532|19521228|P1|Overall Study|Lost to Follow-up|5
5653383|NCT00545532|19521227|P2|Overall Study|Withdrawal by Subject|3
5653384|NCT00545532|19521228|P1|Overall Study|Withdrawal by Subject|1
5653385|NCT00545441|19521319|P2|Overall Study|Patients were not treated|3
5653386|NCT00545441|19521320|P1|Overall Study|Patients were not treated|1
5653387|NCT00545441|19521319|P2|Overall Study|Persistence or recurrence of fistula|2
5653388|NCT00545441|19521320|P1|Overall Study|Persistence or recurrence of fistula|5
5653389|NCT00545441|19521319|P2|Overall Study|Withdrawal by Subject|1
5653390|NCT00545441|19521320|P1|Overall Study|Withdrawal by Subject|1
5653391|NCT00545441|19521319|P2|Overall Study|Technical failure|1
5653392|NCT00545441|19521320|P1|Overall Study|Technical failure|0
5653393|NCT00545441|19521319|P2|Overall Study|Lost to Follow-up|5
5653394|NCT00545441|19521320|P1|Overall Study|Lost to Follow-up|9
5653395|NCT00545441|19521319|P2|Overall Study|Fistula draining at 6 months|4
5653396|NCT00545441|19521320|P1|Overall Study|Fistula draining at 6 months|2
5653397|NCT00545402|19521328|P2|Overall Study|Reason not specified|1
5653398|NCT00545402|19521329|P1|Overall Study|Reason not specified|1
5653399|NCT00545402|19521328|P2|Overall Study|Protocol Violation|0
5653400|NCT00545402|19521329|P1|Overall Study|Protocol Violation|1
5653401|NCT00545402|19521328|P2|Overall Study|Withdrawal by Subject|1
5653402|NCT00545402|19521329|P1|Overall Study|Withdrawal by Subject|0
5653403|NCT00545402|19521328|P2|Overall Study|Graft loss|4
5653404|NCT00545402|19521329|P1|Overall Study|Graft loss|2
5653405|NCT00545402|19521328|P2|Overall Study|Death|7
5653406|NCT00545402|19521329|P1|Overall Study|Death|5
5653407|NCT00545402|19521328|P2|Overall Study|Use of unauthorized immunosuppressant|7
5653408|NCT00545402|19521329|P1|Overall Study|Use of unauthorized immunosuppressant|8
5653409|NCT00545402|19521328|P2|Overall Study|Discontinuation of treatment|9
5653410|NCT00545402|19521329|P1|Overall Study|Discontinuation of treatment|17
5653411|NCT00545363|19521347|P2|Overall Study|Other|1
5653412|NCT00545363|19521348|P1|Overall Study|Other|1
5653413|NCT00545363|19521347|P2|Overall Study|Lost to Follow-up|0
5653414|NCT00545363|19521348|P1|Overall Study|Lost to Follow-up|2
5653415|NCT00545363|19521347|P2|Overall Study|Did not meet entry criteria|1
5653416|NCT00545363|19521348|P1|Overall Study|Did not meet entry criteria|1
5653417|NCT00545363|19521347|P2|Overall Study|Non-compliance|1
5653418|NCT00545363|19521348|P1|Overall Study|Non-compliance|3
5653419|NCT00545363|19521347|P2|Overall Study|Withdrawal by Subject|5
5653420|NCT00545363|19521348|P1|Overall Study|Withdrawal by Subject|6
5653421|NCT00545363|19521347|P2|Overall Study|Adverse Event|7
5653422|NCT00545363|19521348|P1|Overall Study|Adverse Event|6
5653423|NCT00545298|19521363|P3|Overall Study|Issues with Standard of Care|1
5653424|NCT00545298|19521364|P2|Overall Study|Issues with Standard of Care|0
5653425|NCT00545298|19521365|P1|Overall Study|Issues with Standard of Care|2
5653426|NCT00545272|19521382|P6|Overall Study|Lost to Follow-up|0
5653427|NCT00545272|19521383|P5|Overall Study|Lost to Follow-up|1
5653428|NCT00545272|19521384|P4|Overall Study|Lost to Follow-up|0
5653429|NCT00545272|19521385|P3|Overall Study|Lost to Follow-up|0
5653430|NCT00545272|19521386|P2|Overall Study|Lost to Follow-up|0
5653431|NCT00545272|19521387|P1|Overall Study|Lost to Follow-up|0
5653432|NCT00545272|19521382|P6|Overall Study|Abnormal test procedure result(s)|0
5653433|NCT00545272|19521383|P5|Overall Study|Abnormal test procedure result(s)|1
5653434|NCT00545272|19521384|P4|Overall Study|Abnormal test procedure result(s)|0
5653435|NCT00545272|19521385|P3|Overall Study|Abnormal test procedure result(s)|0
5653436|NCT00545272|19521386|P2|Overall Study|Abnormal test procedure result(s)|0
5653437|NCT00545272|19521387|P1|Overall Study|Abnormal test procedure result(s)|0
5653438|NCT00545272|19521382|P6|Overall Study|Abnormal laboratory value(s)|1
5653439|NCT00545272|19521383|P5|Overall Study|Abnormal laboratory value(s)|0
5653440|NCT00545272|19521384|P4|Overall Study|Abnormal laboratory value(s)|0
5653441|NCT00545272|19521385|P3|Overall Study|Abnormal laboratory value(s)|0
5653442|NCT00545272|19521386|P2|Overall Study|Abnormal laboratory value(s)|0
5653443|NCT00545272|19521387|P1|Overall Study|Abnormal laboratory value(s)|0
5653444|NCT00545272|19521382|P6|Overall Study|Adverse Event|1
5653445|NCT00545272|19521383|P5|Overall Study|Adverse Event|0
5653446|NCT00545272|19521384|P4|Overall Study|Adverse Event|0
5653447|NCT00545272|19521385|P3|Overall Study|Adverse Event|1
5653448|NCT00545272|19521386|P2|Overall Study|Adverse Event|0
5653449|NCT00545272|19521387|P1|Overall Study|Adverse Event|0
5653450|NCT00545272|19521382|P6|Overall Study|Protocol deviation|1
5653451|NCT00545272|19521383|P5|Overall Study|Protocol deviation|0
5653452|NCT00545272|19521384|P4|Overall Study|Protocol deviation|1
5653453|NCT00545272|19521385|P3|Overall Study|Protocol deviation|0
5653454|NCT00545272|19521386|P2|Overall Study|Protocol deviation|1
5653455|NCT00545272|19521387|P1|Overall Study|Protocol deviation|0
5653456|NCT00545233|19521439|P2|Overall Study|Physician Decision|1
5653457|NCT00545233|19521440|P1|Overall Study|Physician Decision|2
5653458|NCT00545233|19521439|P2|Overall Study|Insufficient response|15
5653459|NCT00545233|19521440|P1|Overall Study|Insufficient response|14
5653460|NCT00545233|19521439|P2|Overall Study|Failure to Return|6
5653461|NCT00545233|19521440|P1|Overall Study|Failure to Return|4
5653462|NCT00545233|19521439|P2|Overall Study|Refused Treatment|7
5653463|NCT00545233|19521440|P1|Overall Study|Refused Treatment|9
5653464|NCT00545233|19521439|P2|Overall Study|Protocol Violation|0
5653465|NCT00545233|19521440|P1|Overall Study|Protocol Violation|2
5653466|NCT00545233|19521439|P2|Overall Study|Violation of Selection Criteria at Entry|1
5653467|NCT00545233|19521440|P1|Overall Study|Violation of Selection Criteria at Entry|5
5653468|NCT00545233|19521439|P2|Overall Study|Adverse Event|5
5653469|NCT00545233|19521440|P1|Overall Study|Adverse Event|10
5653470|NCT00545168|19521499|P3|Overall Study|Visit for Day 21 was not done in error|2
5653471|NCT00545168|19521500|P2|Overall Study|Visit for Day 21 was not done in error|0
5653472|NCT00545168|19521501|P1|Overall Study|Visit for Day 21 was not done in error|1
5653473|NCT00545168|19521499|P3|Overall Study|Protocol Violation|1
5653474|NCT00545168|19521500|P2|Overall Study|Protocol Violation|0
5653475|NCT00545168|19521501|P1|Overall Study|Protocol Violation|1
5653476|NCT00545168|19521499|P3|Overall Study|Withdrawal by Subject|13
5653477|NCT00545168|19521500|P2|Overall Study|Withdrawal by Subject|0
5653478|NCT00545168|19521501|P1|Overall Study|Withdrawal by Subject|9
5653479|NCT00545168|19521499|P3|Overall Study|Lost to Follow-up|5
5653480|NCT00545168|19521500|P2|Overall Study|Lost to Follow-up|5
5653481|NCT00545168|19521501|P1|Overall Study|Lost to Follow-up|5
5653482|NCT00545103|19521527|P4|Overall Study|Death|0
5653483|NCT00545103|19521528|P3|Overall Study|Death|0
5653484|NCT00545103|19521529|P2|Overall Study|Death|1
5653485|NCT00545103|19521530|P1|Overall Study|Death|0
5653486|NCT00545103|19521527|P4|Overall Study|Subject met endpoint under protocol v. 1|0
5653487|NCT00545103|19521528|P3|Overall Study|Subject met endpoint under protocol v. 1|1
5653488|NCT00545103|19521529|P2|Overall Study|Subject met endpoint under protocol v. 1|0
5653489|NCT00545103|19521530|P1|Overall Study|Subject met endpoint under protocol v. 1|0
5653490|NCT00545103|19521527|P4|Overall Study|Does not want to take study drug anymore|0
5653491|NCT00545103|19521528|P3|Overall Study|Does not want to take study drug anymore|1
5653492|NCT00545103|19521529|P2|Overall Study|Does not want to take study drug anymore|0
5653493|NCT00545103|19521530|P1|Overall Study|Does not want to take study drug anymore|1
5653494|NCT00545103|19521527|P4|Overall Study|Use of prohibited medication|0
5653495|NCT00545103|19521528|P3|Overall Study|Use of prohibited medication|1
5653496|NCT00545103|19521529|P2|Overall Study|Use of prohibited medication|0
5653497|NCT00545103|19521530|P1|Overall Study|Use of prohibited medication|0
5653498|NCT00545103|19521527|P4|Overall Study|Subject moved|0
5653499|NCT00545103|19521528|P3|Overall Study|Subject moved|0
5653500|NCT00545103|19521529|P2|Overall Study|Subject moved|1
5653501|NCT00545103|19521530|P1|Overall Study|Subject moved|0
5653502|NCT00545103|19521527|P4|Overall Study|Investigator decision|0
5653503|NCT00545103|19521528|P3|Overall Study|Investigator decision|1
5653504|NCT00545103|19521529|P2|Overall Study|Investigator decision|0
5653505|NCT00545103|19521530|P1|Overall Study|Investigator decision|0
5653506|NCT00545103|19521527|P4|Overall Study|Noncompliance|0
5653507|NCT00545103|19521528|P3|Overall Study|Noncompliance|0
5653508|NCT00545103|19521529|P2|Overall Study|Noncompliance|1
5653509|NCT00545103|19521530|P1|Overall Study|Noncompliance|0
5653510|NCT00545103|19521527|P4|Overall Study|Subject's decision|0
5653511|NCT00545103|19521528|P3|Overall Study|Subject's decision|0
5653512|NCT00545103|19521529|P2|Overall Study|Subject's decision|0
5653513|NCT00545103|19521530|P1|Overall Study|Subject's decision|1
5653514|NCT00545103|19521527|P4|Overall Study|Personal reasons|0
5653515|NCT00545103|19521528|P3|Overall Study|Personal reasons|0
5653516|NCT00545103|19521529|P2|Overall Study|Personal reasons|0
5653517|NCT00545103|19521530|P1|Overall Study|Personal reasons|1
5653518|NCT00545103|19521527|P4|Overall Study|Diverticulitis crisis|1
5653519|NCT00545103|19521528|P3|Overall Study|Diverticulitis crisis|0
5653520|NCT00545103|19521529|P2|Overall Study|Diverticulitis crisis|0
5653521|NCT00545103|19521530|P1|Overall Study|Diverticulitis crisis|0
5653522|NCT00545103|19521527|P4|Overall Study|Wish to start a family|1
5653523|NCT00545103|19521528|P3|Overall Study|Wish to start a family|0
5653524|NCT00545103|19521529|P2|Overall Study|Wish to start a family|0
5653525|NCT00545103|19521530|P1|Overall Study|Wish to start a family|0
5653526|NCT00545103|19521527|P4|Overall Study|Investigational product not taken|1
5653527|NCT00545103|19521528|P3|Overall Study|Investigational product not taken|0
5653528|NCT00545103|19521529|P2|Overall Study|Investigational product not taken|0
5653529|NCT00545103|19521530|P1|Overall Study|Investigational product not taken|1
5653530|NCT00545103|19521527|P4|Overall Study|Difficult to open package|1
5653531|NCT00545103|19521528|P3|Overall Study|Difficult to open package|0
5653532|NCT00545103|19521529|P2|Overall Study|Difficult to open package|0
5653533|NCT00545103|19521530|P1|Overall Study|Difficult to open package|0
5653534|NCT00545103|19521527|P4|Overall Study|Suspected recurrence of diverticulitis|3
5653535|NCT00545103|19521528|P3|Overall Study|Suspected recurrence of diverticulitis|0
5653536|NCT00545103|19521529|P2|Overall Study|Suspected recurrence of diverticulitis|0
5653537|NCT00545103|19521530|P1|Overall Study|Suspected recurrence of diverticulitis|1
5653538|NCT00545103|19521527|P4|Overall Study|Protocol Violation|0
5653539|NCT00545103|19521528|P3|Overall Study|Protocol Violation|3
5653540|NCT00545103|19521529|P2|Overall Study|Protocol Violation|2
5653541|NCT00545103|19521530|P1|Overall Study|Protocol Violation|1
5653542|NCT00545103|19521527|P4|Overall Study|Lost to Follow-up|4
5653543|NCT00545103|19521528|P3|Overall Study|Lost to Follow-up|3
5653544|NCT00545103|19521529|P2|Overall Study|Lost to Follow-up|6
5653545|NCT00545103|19521530|P1|Overall Study|Lost to Follow-up|4
5653546|NCT00545103|19521527|P4|Overall Study|Adverse Event|10
5653547|NCT00545103|19521528|P3|Overall Study|Adverse Event|17
5653548|NCT00545103|19521529|P2|Overall Study|Adverse Event|12
5653549|NCT00545103|19521530|P1|Overall Study|Adverse Event|11
5653550|NCT00545103|19521527|P4|Overall Study|Withdrawal by Subject|22
5653551|NCT00545103|19521528|P3|Overall Study|Withdrawal by Subject|18
5653552|NCT00545103|19521529|P2|Overall Study|Withdrawal by Subject|10
5653553|NCT00545103|19521530|P1|Overall Study|Withdrawal by Subject|6
5653554|NCT00545103|19521527|P4|Overall Study|Lack of Efficacy|27
5653555|NCT00545103|19521528|P3|Overall Study|Lack of Efficacy|31
5653556|NCT00545103|19521529|P2|Overall Study|Lack of Efficacy|45
5653557|NCT00545103|19521530|P1|Overall Study|Lack of Efficacy|48
5653558|NCT00545077|19521566|P2|Overall Study|Death|8
5653559|NCT00545077|19521567|P1|Overall Study|Death|0
5653560|NCT00545077|19521566|P2|Overall Study|Adverse Event|31
5653561|NCT00545077|19521567|P1|Overall Study|Adverse Event|0
5653562|NCT00545077|19521566|P2|Overall Study|Protocol Violation|0
5653563|NCT00545077|19521567|P1|Overall Study|Protocol Violation|1
5653564|NCT00545077|19521566|P2|Overall Study|Lost to Follow-up|0
5653565|NCT00545077|19521567|P1|Overall Study|Lost to Follow-up|2
5653566|NCT00545077|19521566|P2|Overall Study|Physician Decision|3
5653567|NCT00545077|19521567|P1|Overall Study|Physician Decision|6
5653568|NCT00545077|19521566|P2|Overall Study|Withdrawal by Subject|14
5653569|NCT00545077|19521567|P1|Overall Study|Withdrawal by Subject|3
5653570|NCT00545077|19521566|P2|Overall Study|Disease Progression|98
5653571|NCT00545077|19521567|P1|Overall Study|Disease Progression|131
5653572|NCT00545077|19521566|P2|Overall Study|Treatment not received|1
5653573|NCT00545077|19521567|P1|Overall Study|Treatment not received|5
5653574|NCT00545064|19521583|P1|Overall Study|inclement weather|1
5653575|NCT00545064|19521583|P1|Overall Study|cancel all appointments, no rebooking|1
5653576|NCT00545064|19521583|P1|Overall Study|did not complete course of treatment|1
5653577|NCT00545064|19521583|P1|Overall Study|Withdrawal by Subject|2
5653578|NCT00545064|19521583|P1|Overall Study|Lost to Follow-up|3
5653579|NCT00545051|19521594|P2|Overall Study|Administrative reasons|1
5653580|NCT00545051|19521595|P1|Overall Study|Administrative reasons|0
5653581|NCT00545051|19521594|P2|Overall Study|Withdrawal by Subject|1
5653582|NCT00545051|19521595|P1|Overall Study|Withdrawal by Subject|0
5653583|NCT00545051|19521594|P2|Overall Study|Protocol Violation|0
5653584|NCT00545051|19521595|P1|Overall Study|Protocol Violation|1
5653585|NCT00545051|19521594|P2|Overall Study|Violation of inclusion/exclusion|2
5653586|NCT00545051|19521595|P1|Overall Study|Violation of inclusion/exclusion|0
5653587|NCT00545051|19521594|P2|Overall Study|Death|0
5653588|NCT00545051|19521595|P1|Overall Study|Death|1
5653589|NCT00545051|19521594|P2|Overall Study|Adverse Event|3
5653590|NCT00545051|19521595|P1|Overall Study|Adverse Event|7
5653591|NCT00544882|19521639|P3|Cycle 3: Follow-up|Pregnancy|0
5653592|NCT00544882|19521640|P2|Cycle 3: Follow-up|Pregnancy|1
5653593|NCT00544882|19521641|P1|Cycle 3: Follow-up|Pregnancy|0
5653594|NCT00544882|19521639|P3|Cycle 3: Follow-up|Noncompliance|0
5653595|NCT00544882|19521640|P2|Cycle 3: Follow-up|Noncompliance|1
5653596|NCT00544882|19521641|P1|Cycle 3: Follow-up|Noncompliance|0
5653597|NCT00544882|19521639|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
5653598|NCT00544882|19521640|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
5653599|NCT00544882|19521641|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
5653600|NCT00544882|19521639|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
5653601|NCT00544882|19521640|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
5653602|NCT00544882|19521641|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
5653603|NCT00544882|19521639|P3|Cycle 1: Run-in Cycle|Adverse Event|0
5653604|NCT00544882|19521640|P2|Cycle 1: Run-in Cycle|Adverse Event|0
5653605|NCT00544882|19521641|P1|Cycle 1: Run-in Cycle|Adverse Event|1
5653606|NCT00544882|19521639|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
5653607|NCT00544882|19521640|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
5653608|NCT00544882|19521641|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
5653609|NCT00544869|19521666|P3|Overall Study|Physician Decision|0
5653610|NCT00544869|19521667|P2|Overall Study|Physician Decision|0
5653611|NCT00544869|19521668|P1|Overall Study|Physician Decision|2
5653612|NCT00544869|19521666|P3|Overall Study|Lack of Efficacy|0
5653613|NCT00544869|19521667|P2|Overall Study|Lack of Efficacy|1
5653614|NCT00544869|19521668|P1|Overall Study|Lack of Efficacy|1
5653615|NCT00544869|19521666|P3|Overall Study|Adverse Event|0
5653616|NCT00544869|19521667|P2|Overall Study|Adverse Event|1
5653617|NCT00544869|19521668|P1|Overall Study|Adverse Event|6
5653618|NCT00544869|19521666|P3|Overall Study|Rsolution of congenitive symptoms|0
5653619|NCT00544869|19521667|P2|Overall Study|Rsolution of congenitive symptoms|0
5653620|NCT00544869|19521668|P1|Overall Study|Rsolution of congenitive symptoms|3
5653621|NCT00544817|19521676|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
5653622|NCT00544817|19521676|P1|Follow-up Systemic Therapy|Physician Decision|3
5653623|NCT00544817|19521676|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
5653624|NCT00544817|19521676|P1|No Treatment Interval|Adverse Event|1
5653625|NCT00544817|19521676|P1|No Treatment Interval|Physician Decision|3
5653626|NCT00544817|19521676|P1|No Treatment Interval|Lack of Efficacy|8
5653627|NCT00544817|19521676|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
5653628|NCT00544817|19521676|P1|Combined Modality|Adverse Event|2
5653629|NCT00544817|19521676|P1|Combined Modality|Worsening Neurologic Symptoms|2
5653630|NCT00544817|19521676|P1|Combined Modality|Lack of Efficacy|2
5653631|NCT00544648|19521725|P2|Overall Study|progression of disease|0
5653632|NCT00544648|19521726|P1|Overall Study|progression of disease|1
5653633|NCT00544648|19521725|P2|Overall Study|Adverse Event|1
5653634|NCT00544648|19521726|P1|Overall Study|Adverse Event|1
5653635|NCT00544648|19521725|P2|Overall Study|Withdrawal by Subject|0
5653636|NCT00544648|19521726|P1|Overall Study|Withdrawal by Subject|1
5653637|NCT00544557|19521740|P1|Overall Study|Other|98
5653638|NCT00544557|19521740|P1|Overall Study|Lack of Efficacy|196
5653639|NCT00544557|19521740|P1|Overall Study|Adverse Event|140
5653640|NCT00544544|19521771|P1|Overall Study|Lost to Follow-up|1
5653641|NCT00544544|19521771|P1|Overall Study|Adverse Event|1
5653642|NCT00544544|19521771|P1|Overall Study|Withdrawal by Subject|1
5653643|NCT00544440|19521778|P1|Overall Study|Other|5
5653644|NCT00544440|19521778|P1|Overall Study|Progressive Disease|47
5653645|NCT00544440|19521778|P1|Overall Study|Subject Non-compliance|1
5653646|NCT00544440|19521778|P1|Overall Study|Withdrawal by Subject|2
5653647|NCT00544440|19521778|P1|Overall Study|Adverse Event|1
5653648|NCT00544440|19521778|P1|Overall Study|Other|1
5653649|NCT00544167|19521785|P1|Overall Study|Physician Decision|8
5653650|NCT00544167|19521785|P1|Overall Study|Adverse Event|21
5653651|NCT00543985|19521811|P1|Overall Study|Withdrawal by Subject|4
5653652|NCT00543855|19521822|P4|Overall Study|Protocol Violation|0
5653653|NCT00543855|19521823|P3|Overall Study|Protocol Violation|0
5653654|NCT00543855|19521824|P2|Overall Study|Protocol Violation|0
5653655|NCT00543855|19521825|P1|Overall Study|Protocol Violation|1
5653656|NCT00543855|19521822|P4|Overall Study|Withdrawal by Subject|0
5653657|NCT00543855|19521823|P3|Overall Study|Withdrawal by Subject|2
5653658|NCT00543855|19521824|P2|Overall Study|Withdrawal by Subject|1
5653659|NCT00543855|19521825|P1|Overall Study|Withdrawal by Subject|0
5653660|NCT00543855|19521822|P4|Overall Study|Lost to Follow-up|0
5653661|NCT00543855|19521823|P3|Overall Study|Lost to Follow-up|1
5653662|NCT00543855|19521824|P2|Overall Study|Lost to Follow-up|0
5653663|NCT00543855|19521825|P1|Overall Study|Lost to Follow-up|0
5653664|NCT00543855|19521822|P4|Overall Study|Adverse Event|4
5653665|NCT00543855|19521823|P3|Overall Study|Adverse Event|3
5653666|NCT00543855|19521824|P2|Overall Study|Adverse Event|1
5653667|NCT00543855|19521825|P1|Overall Study|Adverse Event|3
5653668|NCT00543803|19521847|P1|Overall Study|Other|86
5653669|NCT00543803|19521847|P1|Overall Study|Lost to Follow-up|20
5653670|NCT00543803|19521847|P1|Overall Study|Lack of Efficacy|22
5653671|NCT00543803|19521847|P1|Overall Study|Adverse Event|14
5653672|NCT00543725|19521875|P2|Overall Study|Other|3
5653673|NCT00543725|19521876|P1|Overall Study|Other|3
5653674|NCT00543725|19521875|P2|Overall Study|Lost to Follow-up|11
5653675|NCT00543725|19521876|P1|Overall Study|Lost to Follow-up|15
5653676|NCT00543725|19521875|P2|Overall Study|Withdrawal by Subject|13
5653677|NCT00543725|19521876|P1|Overall Study|Withdrawal by Subject|4
5653678|NCT00543725|19521875|P2|Overall Study|Protocol Violation|1
5653679|NCT00543725|19521876|P1|Overall Study|Protocol Violation|0
5653680|NCT00543725|19521875|P2|Overall Study|Subject Reached A Virologic Endpoint|14
5653681|NCT00543725|19521876|P1|Overall Study|Subject Reached A Virologic Endpoint|22
5653682|NCT00543725|19521875|P2|Overall Study|Subject Ineligible To Continue The Trial|0
5653683|NCT00543725|19521876|P1|Overall Study|Subject Ineligible To Continue The Trial|2
5653684|NCT00543725|19521875|P2|Overall Study|Subject Non-Compliant|4
5653685|NCT00543725|19521876|P1|Overall Study|Subject Non-Compliant|4
5653686|NCT00543725|19521875|P2|Overall Study|Sponsor's Decision|1
5653687|NCT00543725|19521876|P1|Overall Study|Sponsor's Decision|0
5653688|NCT00543725|19521875|P2|Overall Study|Adverse Event|27
5653689|NCT00543725|19521876|P1|Overall Study|Adverse Event|18
5653690|NCT00543569|19521902|P4|Overall Study|Randomized but never received study drug|3
5653691|NCT00543569|19521903|P3|Overall Study|Randomized but never received study drug|5
5653692|NCT00543569|19521904|P2|Overall Study|Randomized but never received study drug|3
5653693|NCT00543569|19521905|P1|Overall Study|Randomized but never received study drug|3
5653694|NCT00543569|19521902|P4|Overall Study|Miscellaneous Reasons|4
5653695|NCT00543569|19521903|P3|Overall Study|Miscellaneous Reasons|11
5653696|NCT00543569|19521904|P2|Overall Study|Miscellaneous Reasons|3
5653697|NCT00543569|19521905|P1|Overall Study|Miscellaneous Reasons|7
5653698|NCT00543569|19521902|P4|Overall Study|Lost to Follow-up|1
5653699|NCT00543569|19521903|P3|Overall Study|Lost to Follow-up|1
5653700|NCT00543569|19521904|P2|Overall Study|Lost to Follow-up|0
5653701|NCT00543569|19521905|P1|Overall Study|Lost to Follow-up|0
5653702|NCT00543569|19521902|P4|Overall Study|Death|1
5653703|NCT00543569|19521903|P3|Overall Study|Death|3
5653704|NCT00543569|19521904|P2|Overall Study|Death|2
5653705|NCT00543569|19521905|P1|Overall Study|Death|2
5653706|NCT00543543|19522011|P4|Extension Study|Withdrawal by Subject|120
5653707|NCT00543543|19522012|P3|Extension Study|Withdrawal by Subject|0
5653708|NCT00543543|19522013|P2|Extension Study|Withdrawal by Subject|0
5653709|NCT00543543|19522014|P1|Extension Study|Withdrawal by Subject|0
5653710|NCT00543543|19522011|P4|Extension Study|Protocol Violation|11
5653711|NCT00543543|19522012|P3|Extension Study|Protocol Violation|0
5653712|NCT00543543|19522013|P2|Extension Study|Protocol Violation|0
5653713|NCT00543543|19522014|P1|Extension Study|Protocol Violation|0
5653714|NCT00543543|19522011|P4|Extension Study|Pregnancy|6
5653715|NCT00543543|19522012|P3|Extension Study|Pregnancy|0
5653716|NCT00543543|19522013|P2|Extension Study|Pregnancy|0
5653717|NCT00543543|19522014|P1|Extension Study|Pregnancy|0
5653718|NCT00543543|19522011|P4|Extension Study|Physician Decision|7
5653719|NCT00543543|19522012|P3|Extension Study|Physician Decision|0
5653720|NCT00543543|19522013|P2|Extension Study|Physician Decision|0
5653721|NCT00543543|19522014|P1|Extension Study|Physician Decision|0
5653722|NCT00543543|19522011|P4|Extension Study|Lost to Follow-up|77
5653723|NCT00543543|19522012|P3|Extension Study|Lost to Follow-up|0
5653724|NCT00543543|19522013|P2|Extension Study|Lost to Follow-up|0
5653725|NCT00543543|19522014|P1|Extension Study|Lost to Follow-up|0
5653726|NCT00543543|19522011|P4|Extension Study|Adverse Event|5
5653727|NCT00543543|19522012|P3|Extension Study|Adverse Event|0
5653728|NCT00543543|19522013|P2|Extension Study|Adverse Event|0
5653729|NCT00543543|19522014|P1|Extension Study|Adverse Event|0
5653730|NCT00543543|19522011|P4|Base Study|Withdrawal by Subject|503
5653731|NCT00543543|19522012|P3|Base Study|Withdrawal by Subject|5
5653732|NCT00543543|19522013|P2|Base Study|Withdrawal by Subject|482
5653733|NCT00543543|19522014|P1|Base Study|Withdrawal by Subject|7
5653734|NCT00543543|19522011|P4|Base Study|Protocol Violation|6
5653735|NCT00543543|19522012|P3|Base Study|Protocol Violation|0
5653736|NCT00543543|19522013|P2|Base Study|Protocol Violation|6
5653737|NCT00543543|19522014|P1|Base Study|Protocol Violation|0
5653738|NCT00543543|19522011|P4|Base Study|Physician Decision|7
5653739|NCT00543543|19522012|P3|Base Study|Physician Decision|0
5653740|NCT00543543|19522013|P2|Base Study|Physician Decision|4
5653741|NCT00543543|19522014|P1|Base Study|Physician Decision|0
5653742|NCT00543543|19522011|P4|Base Study|Lost to Follow-up|701
5653743|NCT00543543|19522012|P3|Base Study|Lost to Follow-up|9
5653744|NCT00543543|19522013|P2|Base Study|Lost to Follow-up|749
5653745|NCT00543543|19522014|P1|Base Study|Lost to Follow-up|12
5653746|NCT00543543|19522011|P4|Base Study|Adverse Event|5
5653747|NCT00543543|19522012|P3|Base Study|Adverse Event|0
5653748|NCT00543543|19522013|P2|Base Study|Adverse Event|11
5653749|NCT00543543|19522014|P1|Base Study|Adverse Event|1
5653750|NCT00543439|19522058|P3|Period 2|Adverse Event|1
5653751|NCT00543439|19522059|P2|Period 2|Adverse Event|1
5653752|NCT00543439|19522060|P1|Period 2|Adverse Event|0
5653753|NCT00543439|19522058|P3|Period 2|Protocol Violation|1
5653754|NCT00543439|19522059|P2|Period 2|Protocol Violation|0
5653755|NCT00543439|19522060|P1|Period 2|Protocol Violation|1
5653756|NCT00543439|19522058|P3|Period 1|Physician Decision|1
5653757|NCT00543439|19522059|P2|Period 1|Physician Decision|0
5653758|NCT00543439|19522060|P1|Period 1|Physician Decision|0
5653759|NCT00543439|19522058|P3|Period 1|Withdrawal by Subject|0
5653760|NCT00543439|19522059|P2|Period 1|Withdrawal by Subject|1
5653761|NCT00543439|19522060|P1|Period 1|Withdrawal by Subject|1
5653762|NCT00543439|19522058|P3|Period 1|Adverse Event|1
5653763|NCT00543439|19522059|P2|Period 1|Adverse Event|2
5653764|NCT00543439|19522060|P1|Period 1|Adverse Event|0
5653765|NCT00543387|19522129|P11|Crossover Participants|Study Terminated by Sponsor|1
5653766|NCT00543387|19522130|P10|Crossover Participants|Study Terminated by Sponsor|0
5653767|NCT00543387|19522131|P9|Crossover Participants|Study Terminated by Sponsor|0
5653768|NCT00543387|19522132|P8|Crossover Participants|Study Terminated by Sponsor|0
5653769|NCT00543387|19522133|P7|Crossover Participants|Study Terminated by Sponsor|0
5653770|NCT00543387|19522134|P6|Crossover Participants|Study Terminated by Sponsor|0
5653771|NCT00543387|19522135|P5|Crossover Participants|Study Terminated by Sponsor|0
5653772|NCT00543387|19522136|P4|Crossover Participants|Study Terminated by Sponsor|0
5653773|NCT00543387|19522137|P3|Crossover Participants|Study Terminated by Sponsor|0
5653774|NCT00543387|19522138|P2|Crossover Participants|Study Terminated by Sponsor|0
5653775|NCT00543387|19522139|P1|Crossover Participants|Study Terminated by Sponsor|0
5653776|NCT00543387|19522129|P11|Crossover Participants|Progressive Disease|2
5653777|NCT00543387|19522130|P10|Crossover Participants|Progressive Disease|1
5653778|NCT00543387|19522131|P9|Crossover Participants|Progressive Disease|0
5653779|NCT00543387|19522132|P8|Crossover Participants|Progressive Disease|0
5653780|NCT00543387|19522133|P7|Crossover Participants|Progressive Disease|0
5653781|NCT00543387|19522134|P6|Crossover Participants|Progressive Disease|0
5653782|NCT00543387|19522135|P5|Crossover Participants|Progressive Disease|0
5653783|NCT00543387|19522136|P4|Crossover Participants|Progressive Disease|0
5653784|NCT00543387|19522137|P3|Crossover Participants|Progressive Disease|0
5653785|NCT00543387|19522138|P2|Crossover Participants|Progressive Disease|0
5653786|NCT00543387|19522139|P1|Crossover Participants|Progressive Disease|0
5653787|NCT00543387|19522129|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
5653788|NCT00543387|19522130|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
5653789|NCT00543387|19522131|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
5653790|NCT00543387|19522132|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
5653791|NCT00543387|19522133|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
5653792|NCT00543387|19522134|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
5653793|NCT00543387|19522135|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
5653794|NCT00543387|19522136|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
5653795|NCT00543387|19522137|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
5653796|NCT00543387|19522138|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
5653797|NCT00543387|19522139|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
5653798|NCT00543387|19522129|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
5653799|NCT00543387|19522130|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
5653800|NCT00543387|19522131|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
5653801|NCT00543387|19522132|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
5653802|NCT00543387|19522133|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
5653803|NCT00543387|19522134|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
5653804|NCT00543387|19522135|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
5653805|NCT00543387|19522136|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
5653806|NCT00543387|19522137|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
5653807|NCT00543387|19522138|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
5653808|NCT00543387|19522139|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
5653809|NCT00543387|19522129|P11|Panel 1 + Panel 2|Physician Decision|0
5653810|NCT00543387|19522130|P10|Panel 1 + Panel 2|Physician Decision|0
5653811|NCT00543387|19522131|P9|Panel 1 + Panel 2|Physician Decision|0
5653812|NCT00543387|19522132|P8|Panel 1 + Panel 2|Physician Decision|1
5653813|NCT00543387|19522133|P7|Panel 1 + Panel 2|Physician Decision|0
5653814|NCT00543387|19522134|P6|Panel 1 + Panel 2|Physician Decision|0
5653815|NCT00543387|19522135|P5|Panel 1 + Panel 2|Physician Decision|0
5653816|NCT00543387|19522136|P4|Panel 1 + Panel 2|Physician Decision|0
5653817|NCT00543387|19522137|P3|Panel 1 + Panel 2|Physician Decision|1
5653818|NCT00543387|19522138|P2|Panel 1 + Panel 2|Physician Decision|0
5653819|NCT00543387|19522139|P1|Panel 1 + Panel 2|Physician Decision|0
5653820|NCT00543387|19522129|P11|Panel 1 + Panel 2|Adverse Event|0
5653821|NCT00543387|19522130|P10|Panel 1 + Panel 2|Adverse Event|0
5653822|NCT00543387|19522131|P9|Panel 1 + Panel 2|Adverse Event|1
5653823|NCT00543387|19522132|P8|Panel 1 + Panel 2|Adverse Event|1
5653824|NCT00543387|19522133|P7|Panel 1 + Panel 2|Adverse Event|0
5653825|NCT00543387|19522134|P6|Panel 1 + Panel 2|Adverse Event|0
5653826|NCT00543387|19522135|P5|Panel 1 + Panel 2|Adverse Event|0
5653827|NCT00543387|19522136|P4|Panel 1 + Panel 2|Adverse Event|0
5653828|NCT00543387|19522137|P3|Panel 1 + Panel 2|Adverse Event|0
5653829|NCT00543387|19522138|P2|Panel 1 + Panel 2|Adverse Event|1
5653830|NCT00543387|19522139|P1|Panel 1 + Panel 2|Adverse Event|0
5653831|NCT00543309|19522177|P3|Overall Study|Physician Decision|0
5653832|NCT00543309|19522178|P2|Overall Study|Physician Decision|1
5653833|NCT00543309|19522179|P1|Overall Study|Physician Decision|0
5653834|NCT00543296|19522229|P1|Overall Study|Physician Decision|7
5653835|NCT00543140|19522236|P1|Overall Study|Conversion to different procedure|1
5653836|NCT00543140|19522236|P1|Overall Study|Subject moved|1
5653837|NCT00543140|19522236|P1|Overall Study|Death|1
5653838|NCT00543140|19522236|P1|Overall Study|SAE leading to explant of SAGB|3
5653839|NCT00543140|19522236|P1|Overall Study|Insufficient weight loss|10
5653840|NCT00543140|19522236|P1|Overall Study|Protocol Violation|10
5653841|NCT00543140|19522236|P1|Overall Study|Withdrawal by Subject|13
5653842|NCT00543140|19522236|P1|Overall Study|Lost to Follow-up|33
5653843|NCT00543062|19522274|P4|Overall Study|Protocol Violation|0
5653844|NCT00543062|19522275|P3|Overall Study|Protocol Violation|0
5653845|NCT00543062|19522276|P2|Overall Study|Protocol Violation|0
5653846|NCT00543062|19522277|P1|Overall Study|Protocol Violation|1
5653847|NCT00543062|19522274|P4|Overall Study|Adverse Event|1
5653848|NCT00543062|19522275|P3|Overall Study|Adverse Event|1
5653849|NCT00543062|19522276|P2|Overall Study|Adverse Event|1
5653850|NCT00543062|19522277|P1|Overall Study|Adverse Event|0
5653851|NCT00543062|19522274|P4|Overall Study|Withdrawal by Subject|0
5653852|NCT00543062|19522275|P3|Overall Study|Withdrawal by Subject|2
5653853|NCT00543062|19522276|P2|Overall Study|Withdrawal by Subject|0
5653854|NCT00543062|19522277|P1|Overall Study|Withdrawal by Subject|1
5653855|NCT00542997|19522299|P1|Efficacy Period|Adverse Event|3
5653856|NCT00542997|19522299|P1|Wash in / Wash Out Period|Adverse Event|3
5653857|NCT00542997|19522299|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
5653858|NCT00542919|19522322|P3|Overall Study|Lost to Follow-up|1
5653859|NCT00542919|19522323|P2|Overall Study|Lost to Follow-up|0
5653860|NCT00542919|19522324|P1|Overall Study|Lost to Follow-up|2
5653861|NCT00542919|19522322|P3|Overall Study|Sponsor Decision|0
5653862|NCT00542919|19522323|P2|Overall Study|Sponsor Decision|0
5653863|NCT00542919|19522324|P1|Overall Study|Sponsor Decision|1
5653864|NCT00542919|19522322|P3|Overall Study|Physician Decision|1
5653865|NCT00542919|19522323|P2|Overall Study|Physician Decision|2
5653866|NCT00542919|19522324|P1|Overall Study|Physician Decision|2
5653867|NCT00542919|19522322|P3|Overall Study|Withdrawal by Subject|3
5653868|NCT00542919|19522323|P2|Overall Study|Withdrawal by Subject|0
5653869|NCT00542919|19522324|P1|Overall Study|Withdrawal by Subject|1
5653870|NCT00542919|19522322|P3|Overall Study|Adverse Event|1
5653871|NCT00542919|19522323|P2|Overall Study|Adverse Event|5
5653872|NCT00542919|19522324|P1|Overall Study|Adverse Event|1
5653873|NCT00542880|19522369|P2|Period 3|Adverse Event|2
5653874|NCT00542880|19522370|P1|Period 3|Adverse Event|0
5653875|NCT00542880|19522369|P2|Period 2|Other|1
5653876|NCT00542880|19522370|P1|Period 2|Other|0
5653877|NCT00542880|19522369|P2|Period 2|Severe non-compliance|1
5653878|NCT00542880|19522370|P1|Period 2|Severe non-compliance|0
5653879|NCT00542880|19522369|P2|Period 2|Discontinuation criteria|0
5653880|NCT00542880|19522370|P1|Period 2|Discontinuation criteria|2
5653881|NCT00542880|19522369|P2|Period 2|Eligibility not fulfilled|1
5653882|NCT00542880|19522370|P1|Period 2|Eligibility not fulfilled|0
5653883|NCT00542880|19522369|P2|Period 2|Adverse Event|7
5653884|NCT00542880|19522370|P1|Period 2|Adverse Event|5
5653885|NCT00542880|19522369|P2|Period 1|Protocol Violation|1
5653886|NCT00542880|19522370|P1|Period 1|Protocol Violation|0
5653887|NCT00542880|19522369|P2|Period 1|Withdrawal by Subject|1
5653888|NCT00542880|19522370|P1|Period 1|Withdrawal by Subject|1
5653889|NCT00542880|19522369|P2|Period 1|Development of study-specific criteria|2
5653890|NCT00542880|19522370|P1|Period 1|Development of study-specific criteria|1
5653891|NCT00542880|19522369|P2|Period 1|Adverse Event|2
5653892|NCT00542880|19522370|P1|Period 1|Adverse Event|2
5653893|NCT00542880|19522369|P2|Period 1|Eligibility criteria not fulfilled|6
5653894|NCT00542880|19522370|P1|Period 1|Eligibility criteria not fulfilled|2
5653895|NCT00542828|19522406|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
5653896|NCT00542828|19522406|P1|Overall Study|Study Prematurely Discontinued|7
5653897|NCT00542828|19522406|P1|Overall Study|Need for Prohibited Treatment|3
5653898|NCT00542828|19522406|P1|Overall Study|Physician Decision|1
5653899|NCT00542815|19522424|P3|Overall Study|Other reasons|10
5653900|NCT00542815|19522425|P2|Overall Study|Other reasons|10
5653901|NCT00542815|19522426|P1|Overall Study|Other reasons|24
5653902|NCT00542815|19522424|P3|Overall Study|Withdrawal by Subject|8
5653903|NCT00542815|19522425|P2|Overall Study|Withdrawal by Subject|5
5653904|NCT00542815|19522426|P1|Overall Study|Withdrawal by Subject|41
5653905|NCT00542815|19522424|P3|Overall Study|Protocol Violation|2
5653906|NCT00542815|19522425|P2|Overall Study|Protocol Violation|1
5653907|NCT00542815|19522426|P1|Overall Study|Protocol Violation|1
5653908|NCT00542815|19522424|P3|Overall Study|Physician Decision|0
5653909|NCT00542815|19522425|P2|Overall Study|Physician Decision|1
5653910|NCT00542815|19522426|P1|Overall Study|Physician Decision|2
5653911|NCT00542815|19522424|P3|Overall Study|Lack of Efficacy|0
5653912|NCT00542815|19522425|P2|Overall Study|Lack of Efficacy|2
5653913|NCT00542815|19522426|P1|Overall Study|Lack of Efficacy|9
5653914|NCT00542815|19522424|P3|Overall Study|Death|3
5653915|NCT00542815|19522425|P2|Overall Study|Death|7
5653916|NCT00542815|19522426|P1|Overall Study|Death|10
5653917|NCT00542815|19522424|P3|Overall Study|Adverse Event|9
5653918|NCT00542815|19522425|P2|Overall Study|Adverse Event|6
5653919|NCT00542815|19522426|P1|Overall Study|Adverse Event|19
5653920|NCT00542789|19522439|P2|Overall Study|Recurrence of Gastric Ulcer|57
5653921|NCT00542789|19522440|P1|Overall Study|Recurrence of Gastric Ulcer|8
5653922|NCT00542789|19522439|P2|Overall Study|Protocol Violation|1
5653923|NCT00542789|19522440|P1|Overall Study|Protocol Violation|8
5653924|NCT00542789|19522439|P2|Overall Study|Withdrawal by Subject|3
5653925|NCT00542789|19522440|P1|Overall Study|Withdrawal by Subject|7
5653926|NCT00542789|19522439|P2|Overall Study|Adverse Event|17
5653927|NCT00542789|19522440|P1|Overall Study|Adverse Event|18
5653928|NCT00542425|19522540|P5|Extended 24 Weeks of Treatment|Other|1
5653929|NCT00542425|19522541|P4|Extended 24 Weeks of Treatment|Other|0
5653930|NCT00542425|19522542|P3|Extended 24 Weeks of Treatment|Other|0
5653931|NCT00542425|19522543|P2|Extended 24 Weeks of Treatment|Other|1
5653932|NCT00542425|19522544|P1|Extended 24 Weeks of Treatment|Other|1
5653933|NCT00542425|19522540|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
5653934|NCT00542425|19522541|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
5653935|NCT00542425|19522542|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
5653936|NCT00542425|19522543|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
5653937|NCT00542425|19522544|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
5653938|NCT00542425|19522540|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
5653939|NCT00542425|19522541|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
5653940|NCT00542425|19522542|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
5653941|NCT00542425|19522543|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
5653942|NCT00542425|19522544|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
5653943|NCT00542425|19522540|P5|Extended 24 Weeks of Treatment|Adverse Event|0
5653944|NCT00542425|19522541|P4|Extended 24 Weeks of Treatment|Adverse Event|1
5653945|NCT00542425|19522542|P3|Extended 24 Weeks of Treatment|Adverse Event|1
5653946|NCT00542425|19522543|P2|Extended 24 Weeks of Treatment|Adverse Event|0
5653947|NCT00542425|19522544|P1|Extended 24 Weeks of Treatment|Adverse Event|0
5653948|NCT00542425|19522540|P5|Initial 24 Weeks|Other|0
5653949|NCT00542425|19522541|P4|Initial 24 Weeks|Other|0
5653950|NCT00542425|19522542|P3|Initial 24 Weeks|Other|1
5653951|NCT00542425|19522543|P2|Initial 24 Weeks|Other|2
5653952|NCT00542425|19522544|P1|Initial 24 Weeks|Other|0
5653953|NCT00542425|19522540|P5|Initial 24 Weeks|Refusal of treatment|1
5653954|NCT00542425|19522541|P4|Initial 24 Weeks|Refusal of treatment|4
5653955|NCT00542425|19522542|P3|Initial 24 Weeks|Refusal of treatment|1
5653956|NCT00542425|19522543|P2|Initial 24 Weeks|Refusal of treatment|2
5653957|NCT00542425|19522544|P1|Initial 24 Weeks|Refusal of treatment|2
5653958|NCT00542425|19522540|P5|Initial 24 Weeks|Protocol Violation|0
5653959|NCT00542425|19522541|P4|Initial 24 Weeks|Protocol Violation|1
5653960|NCT00542425|19522542|P3|Initial 24 Weeks|Protocol Violation|0
5653961|NCT00542425|19522543|P2|Initial 24 Weeks|Protocol Violation|0
5653962|NCT00542425|19522544|P1|Initial 24 Weeks|Protocol Violation|0
5653963|NCT00542425|19522540|P5|Initial 24 Weeks|Non-compliance|1
5653964|NCT00542425|19522541|P4|Initial 24 Weeks|Non-compliance|1
5653965|NCT00542425|19522542|P3|Initial 24 Weeks|Non-compliance|0
5653966|NCT00542425|19522543|P2|Initial 24 Weeks|Non-compliance|0
5653967|NCT00542425|19522544|P1|Initial 24 Weeks|Non-compliance|0
5653968|NCT00542425|19522540|P5|Initial 24 Weeks|Lost to Follow-up|0
5653969|NCT00542425|19522541|P4|Initial 24 Weeks|Lost to Follow-up|0
5653970|NCT00542425|19522542|P3|Initial 24 Weeks|Lost to Follow-up|1
5653971|NCT00542425|19522543|P2|Initial 24 Weeks|Lost to Follow-up|2
5653972|NCT00542425|19522544|P1|Initial 24 Weeks|Lost to Follow-up|2
5653973|NCT00542425|19522540|P5|Initial 24 Weeks|Inability to complete procedures|2
5653974|NCT00542425|19522541|P4|Initial 24 Weeks|Inability to complete procedures|1
5653975|NCT00542425|19522542|P3|Initial 24 Weeks|Inability to complete procedures|2
5653976|NCT00542425|19522543|P2|Initial 24 Weeks|Inability to complete procedures|3
5653977|NCT00542425|19522544|P1|Initial 24 Weeks|Inability to complete procedures|0
5653978|NCT00542425|19522540|P5|Initial 24 Weeks|Adverse Event|2
5653979|NCT00542425|19522541|P4|Initial 24 Weeks|Adverse Event|3
5653980|NCT00542425|19522542|P3|Initial 24 Weeks|Adverse Event|1
5653981|NCT00542425|19522543|P2|Initial 24 Weeks|Adverse Event|1
5653982|NCT00542425|19522544|P1|Initial 24 Weeks|Adverse Event|0
5653983|NCT00542425|19522540|P5|Initial 24 Weeks|Administrative reasons|0
5653984|NCT00542425|19522541|P4|Initial 24 Weeks|Administrative reasons|1
5653985|NCT00542425|19522542|P3|Initial 24 Weeks|Administrative reasons|1
5653986|NCT00542425|19522543|P2|Initial 24 Weeks|Administrative reasons|0
5653987|NCT00542425|19522544|P1|Initial 24 Weeks|Administrative reasons|0
5653988|NCT00542386|19522582|P6|Overall Study|Other Reasons|2
5653989|NCT00542386|19522583|P5|Overall Study|Other Reasons|4
5653990|NCT00542386|19522584|P4|Overall Study|Other Reasons|3
5653991|NCT00542386|19522585|P3|Overall Study|Other Reasons|4
5653992|NCT00542386|19522586|P2|Overall Study|Other Reasons|1
5653993|NCT00542386|19522587|P1|Overall Study|Other Reasons|4
5653994|NCT00542386|19522582|P6|Overall Study|Withdrawal by Subject|7
5653995|NCT00542386|19522583|P5|Overall Study|Withdrawal by Subject|15
5653996|NCT00542386|19522584|P4|Overall Study|Withdrawal by Subject|11
5653997|NCT00542386|19522585|P3|Overall Study|Withdrawal by Subject|10
5653998|NCT00542386|19522586|P2|Overall Study|Withdrawal by Subject|8
5653999|NCT00542386|19522587|P1|Overall Study|Withdrawal by Subject|5
5654000|NCT00542386|19522582|P6|Overall Study|Protocol Violation|4
5654001|NCT00542386|19522583|P5|Overall Study|Protocol Violation|0
5654002|NCT00542386|19522584|P4|Overall Study|Protocol Violation|0
5654003|NCT00542386|19522585|P3|Overall Study|Protocol Violation|1
5654004|NCT00542386|19522586|P2|Overall Study|Protocol Violation|0
5654005|NCT00542386|19522587|P1|Overall Study|Protocol Violation|0
5654006|NCT00542386|19522582|P6|Overall Study|Physician Decision|0
5654007|NCT00542386|19522583|P5|Overall Study|Physician Decision|0
5654008|NCT00542386|19522584|P4|Overall Study|Physician Decision|1
5654009|NCT00542386|19522585|P3|Overall Study|Physician Decision|0
5654010|NCT00542386|19522586|P2|Overall Study|Physician Decision|0
5654011|NCT00542386|19522587|P1|Overall Study|Physician Decision|1
5654012|NCT00542386|19522582|P6|Overall Study|Lack of Efficacy|31
5654013|NCT00542386|19522583|P5|Overall Study|Lack of Efficacy|7
5654014|NCT00542386|19522584|P4|Overall Study|Lack of Efficacy|13
5654015|NCT00542386|19522585|P3|Overall Study|Lack of Efficacy|10
5654016|NCT00542386|19522586|P2|Overall Study|Lack of Efficacy|12
5654017|NCT00542386|19522587|P1|Overall Study|Lack of Efficacy|32
5654018|NCT00542386|19522582|P6|Overall Study|Death|2
5654019|NCT00542386|19522583|P5|Overall Study|Death|1
5654020|NCT00542386|19522584|P4|Overall Study|Death|2
5654021|NCT00542386|19522585|P3|Overall Study|Death|1
5654022|NCT00542386|19522586|P2|Overall Study|Death|0
5654023|NCT00542386|19522587|P1|Overall Study|Death|0
5654024|NCT00542386|19522582|P6|Overall Study|Adverse Event|4
5654025|NCT00542386|19522583|P5|Overall Study|Adverse Event|13
5654026|NCT00542386|19522584|P4|Overall Study|Adverse Event|8
5654027|NCT00542386|19522585|P3|Overall Study|Adverse Event|7
5654028|NCT00542386|19522586|P2|Overall Study|Adverse Event|7
5654029|NCT00542386|19522587|P1|Overall Study|Adverse Event|1
5654030|NCT00542321|19522609|P2|Overall Study|Death|1
5654031|NCT00542321|19522610|P1|Overall Study|Death|0
5654032|NCT00542269|19522632|P3|Overall Study|Administrative problems|1
5654033|NCT00542269|19522633|P2|Overall Study|Administrative problems|1
5654034|NCT00542269|19522634|P1|Overall Study|Administrative problems|1
5654035|NCT00542269|19522632|P3|Overall Study|Withdrawal by Subject|0
5654036|NCT00542269|19522633|P2|Overall Study|Withdrawal by Subject|0
5654037|NCT00542269|19522634|P1|Overall Study|Withdrawal by Subject|1
5654038|NCT00542269|19522632|P3|Overall Study|Protocol Violation|0
5654039|NCT00542269|19522633|P2|Overall Study|Protocol Violation|1
5654040|NCT00542269|19522634|P1|Overall Study|Protocol Violation|1
5654041|NCT00542269|19522632|P3|Overall Study|Adverse Event|5
5654042|NCT00542269|19522633|P2|Overall Study|Adverse Event|4
5654043|NCT00542269|19522634|P1|Overall Study|Adverse Event|10
5654044|NCT00542191|19522663|P1|Overall Study|Death|3
5654045|NCT00542178|19522673|P8|Overall Study|did not complete year 4 follow-up|85
5654046|NCT00542178|19522674|P7|Overall Study|did not complete year 4 follow-up|87
5654047|NCT00542178|19522675|P6|Overall Study|did not complete year 4 follow-up|89
5654048|NCT00542178|19522676|P5|Overall Study|did not complete year 4 follow-up|64
5654049|NCT00542178|19522677|P4|Overall Study|did not complete year 4 follow-up|62
5654050|NCT00542178|19522678|P3|Overall Study|did not complete year 4 follow-up|74
5654051|NCT00542178|19522679|P2|Overall Study|did not complete year 4 follow-up|80
5654052|NCT00542178|19522680|P1|Overall Study|did not complete year 4 follow-up|75
5654053|NCT00541970|19522716|P4|Month 60|Protocol Violation|72
5654054|NCT00541970|19522717|P3|Month 60|Protocol Violation|82
5654055|NCT00541970|19522718|P2|Month 60|Protocol Violation|77
5654056|NCT00541970|19522719|P1|Month 60|Protocol Violation|78
5654057|NCT00541970|19522716|P4|Month 48|Lost to Follow-up|73
5654058|NCT00541970|19522717|P3|Month 48|Lost to Follow-up|68
5654059|NCT00541970|19522718|P2|Month 48|Lost to Follow-up|68
5654060|NCT00541970|19522719|P1|Month 48|Lost to Follow-up|66
5654061|NCT00541970|19522716|P4|Month 48|Other|0
5654062|NCT00541970|19522717|P3|Month 48|Other|1
5654063|NCT00541970|19522718|P2|Month 48|Other|1
5654064|NCT00541970|19522719|P1|Month 48|Other|3
5654065|NCT00541970|19522716|P4|Month 48|Withdrawal by Subject|2
5654066|NCT00541970|19522717|P3|Month 48|Withdrawal by Subject|4
5654067|NCT00541970|19522718|P2|Month 48|Withdrawal by Subject|4
5654068|NCT00541970|19522719|P1|Month 48|Withdrawal by Subject|2
5654069|NCT00541970|19522716|P4|Month 36|Protocol Violation|60
5654070|NCT00541970|19522717|P3|Month 36|Protocol Violation|66
5654071|NCT00541970|19522718|P2|Month 36|Protocol Violation|66
5654072|NCT00541970|19522719|P1|Month 36|Protocol Violation|61
5654073|NCT00541970|19522716|P4|Month 24|Protocol Violation|21
5654074|NCT00541970|19522717|P3|Month 24|Protocol Violation|31
5654075|NCT00541970|19522718|P2|Month 24|Protocol Violation|31
5654076|NCT00541970|19522719|P1|Month 24|Protocol Violation|29
5654077|NCT00541970|19522716|P4|Month 24|Adverse Event|1
5654078|NCT00541970|19522717|P3|Month 24|Adverse Event|1
5654079|NCT00541970|19522718|P2|Month 24|Adverse Event|1
5654080|NCT00541970|19522719|P1|Month 24|Adverse Event|0
5654081|NCT00541970|19522716|P4|Month 18|Protocol Violation|16
5654082|NCT00541970|19522717|P3|Month 18|Protocol Violation|24
5654083|NCT00541970|19522718|P2|Month 18|Protocol Violation|23
5654084|NCT00541970|19522719|P1|Month 18|Protocol Violation|14
5654085|NCT00541970|19522716|P4|Month 18|Adverse Event|1
5654086|NCT00541970|19522717|P3|Month 18|Adverse Event|1
5654087|NCT00541970|19522718|P2|Month 18|Adverse Event|1
5654088|NCT00541970|19522719|P1|Month 18|Adverse Event|0
5654089|NCT00541970|19522716|P4|Month 12|Protocol Violation|15
5654090|NCT00541970|19522717|P3|Month 12|Protocol Violation|20
5654091|NCT00541970|19522718|P2|Month 12|Protocol Violation|21
5654092|NCT00541970|19522719|P1|Month 12|Protocol Violation|12
5654093|NCT00541970|19522716|P4|Month 12|Adverse Event|1
5654094|NCT00541970|19522717|P3|Month 12|Adverse Event|1
5654095|NCT00541970|19522718|P2|Month 12|Adverse Event|1
5654096|NCT00541970|19522719|P1|Month 12|Adverse Event|0
5654097|NCT00541970|19522716|P4|Month 7|Protocol Violation|5
5654098|NCT00541970|19522717|P3|Month 7|Protocol Violation|11
5654099|NCT00541970|19522718|P2|Month 7|Protocol Violation|13
5654100|NCT00541970|19522719|P1|Month 7|Protocol Violation|9
5654101|NCT00541931|19522870|P2|Overall Study|Transportation Issue|1
5654102|NCT00541931|19522871|P1|Overall Study|Transportation Issue|0
5654103|NCT00541931|19522870|P2|Overall Study|Withdrawal by Subject|0
5654104|NCT00541931|19522871|P1|Overall Study|Withdrawal by Subject|1
5654105|NCT00541931|19522870|P2|Overall Study|Lost to Follow-up|3
5654106|NCT00541931|19522871|P1|Overall Study|Lost to Follow-up|3
5654107|NCT00541931|19522870|P2|Overall Study|Adverse Event|0
5654108|NCT00541931|19522871|P1|Overall Study|Adverse Event|1
5654109|NCT00541866|19522884|P5|Overall Study|Physician Decision|0
5654110|NCT00541866|19522885|P4|Overall Study|Physician Decision|1
5654111|NCT00541866|19522886|P3|Overall Study|Physician Decision|2
5654112|NCT00541866|19522887|P2|Overall Study|Physician Decision|0
5654113|NCT00541866|19522888|P1|Overall Study|Physician Decision|0
5654114|NCT00541866|19522884|P5|Overall Study|Not Reported or Other|1
5654115|NCT00541866|19522885|P4|Overall Study|Not Reported or Other|3
5654116|NCT00541866|19522886|P3|Overall Study|Not Reported or Other|3
5654117|NCT00541866|19522887|P2|Overall Study|Not Reported or Other|3
5654118|NCT00541866|19522888|P1|Overall Study|Not Reported or Other|11
5654119|NCT00541866|19522884|P5|Overall Study|Lack of Efficacy|14
5654120|NCT00541866|19522885|P4|Overall Study|Lack of Efficacy|12
5654121|NCT00541866|19522886|P3|Overall Study|Lack of Efficacy|10
5654122|NCT00541866|19522887|P2|Overall Study|Lack of Efficacy|15
5654123|NCT00541866|19522888|P1|Overall Study|Lack of Efficacy|19
5654124|NCT00541866|19522884|P5|Overall Study|Death|0
5654125|NCT00541866|19522885|P4|Overall Study|Death|0
5654126|NCT00541866|19522886|P3|Overall Study|Death|0
5654127|NCT00541866|19522887|P2|Overall Study|Death|0
5654128|NCT00541866|19522888|P1|Overall Study|Death|1
5654129|NCT00541866|19522884|P5|Overall Study|Adverse Event|0
5654130|NCT00541866|19522885|P4|Overall Study|Adverse Event|0
5654131|NCT00541866|19522886|P3|Overall Study|Adverse Event|0
5654132|NCT00541866|19522887|P2|Overall Study|Adverse Event|0
5654133|NCT00541866|19522888|P1|Overall Study|Adverse Event|3
5654134|NCT00541775|19522929|P3|Overall Study|Withdrawal by Subject and Other|2
5654135|NCT00541775|19522930|P2|Overall Study|Withdrawal by Subject and Other|0
5654136|NCT00541775|19522931|P1|Overall Study|Withdrawal by Subject and Other|5
5654137|NCT00541775|19522929|P3|Overall Study|Protocol Violation|0
5654138|NCT00541775|19522930|P2|Overall Study|Protocol Violation|0
5654139|NCT00541775|19522931|P1|Overall Study|Protocol Violation|1
5654140|NCT00541775|19522929|P3|Overall Study|Lost to Follow-up|2
5654141|NCT00541775|19522930|P2|Overall Study|Lost to Follow-up|0
5654142|NCT00541775|19522931|P1|Overall Study|Lost to Follow-up|0
5654143|NCT00541775|19522929|P3|Overall Study|Lack of Efficacy|3
5654144|NCT00541775|19522930|P2|Overall Study|Lack of Efficacy|0
5654145|NCT00541775|19522931|P1|Overall Study|Lack of Efficacy|0
5654146|NCT00541775|19522929|P3|Overall Study|Adverse Event|1
5654147|NCT00541775|19522930|P2|Overall Study|Adverse Event|2
5654148|NCT00541775|19522931|P1|Overall Study|Adverse Event|3
5654149|NCT00541658|19522957|P3|Overall Study|Took No Study Drug|0
5654150|NCT00541658|19522958|P2|Overall Study|Took No Study Drug|0
5654151|NCT00541658|19522959|P1|Overall Study|Took No Study Drug|1
5654152|NCT00541658|19522957|P3|Overall Study|Withdrawal by Subject|32
5654153|NCT00541658|19522958|P2|Overall Study|Withdrawal by Subject|32
5654154|NCT00541658|19522959|P1|Overall Study|Withdrawal by Subject|28
5654155|NCT00541658|19522957|P3|Overall Study|Protocol Violation|1
5654156|NCT00541658|19522958|P2|Overall Study|Protocol Violation|1
5654157|NCT00541658|19522959|P1|Overall Study|Protocol Violation|0
5654158|NCT00541658|19522957|P3|Overall Study|Lost to Follow-up|6
5654159|NCT00541658|19522958|P2|Overall Study|Lost to Follow-up|3
5654160|NCT00541658|19522959|P1|Overall Study|Lost to Follow-up|3
5654161|NCT00541658|19522957|P3|Overall Study|Physician Decision|4
5654162|NCT00541658|19522958|P2|Overall Study|Physician Decision|0
5654163|NCT00541658|19522959|P1|Overall Study|Physician Decision|0
5654164|NCT00541658|19522957|P3|Overall Study|Adverse Event|25
5654165|NCT00541658|19522958|P2|Overall Study|Adverse Event|37
5654166|NCT00541658|19522959|P1|Overall Study|Adverse Event|28
5654167|NCT00541450|19523122|P2|Phase B|Withdrawal by Subject|6
5654168|NCT00541450|19523123|P1|Phase B|Withdrawal by Subject|8
5654169|NCT00541450|19523122|P2|Phase B|Protocol Violation|3
5654170|NCT00541450|19523123|P1|Phase B|Protocol Violation|3
5654171|NCT00541450|19523122|P2|Phase B|Pregnancy|1
5654172|NCT00541450|19523123|P1|Phase B|Pregnancy|0
5654173|NCT00541450|19523122|P2|Phase B|Physician Decision|2
5654174|NCT00541450|19523123|P1|Phase B|Physician Decision|4
5654175|NCT00541450|19523122|P2|Phase B|Lost to Follow-up|4
5654176|NCT00541450|19523123|P1|Phase B|Lost to Follow-up|6
5654177|NCT00541450|19523122|P2|Phase B|Hyperglycemia|9
5654178|NCT00541450|19523123|P1|Phase B|Hyperglycemia|10
5654179|NCT00541450|19523122|P2|Phase B|Adverse Event|6
5654180|NCT00541450|19523123|P1|Phase B|Adverse Event|6
5654181|NCT00541450|19523122|P2|Phase A|Withdrawal by Subject|7
5654182|NCT00541450|19523123|P1|Phase A|Withdrawal by Subject|7
5654183|NCT00541450|19523122|P2|Phase A|Protocol Violation|3
5654184|NCT00541450|19523123|P1|Phase A|Protocol Violation|2
5654185|NCT00541450|19523122|P2|Phase A|Physician Decision|0
5654186|NCT00541450|19523123|P1|Phase A|Physician Decision|2
5654187|NCT00541450|19523122|P2|Phase A|Lost to Follow-up|4
5654188|NCT00541450|19523123|P1|Phase A|Lost to Follow-up|6
5654189|NCT00541450|19523122|P2|Phase A|Hyperglycemia|1
5654190|NCT00541450|19523123|P1|Phase A|Hyperglycemia|0
5654191|NCT00541450|19523122|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
5654192|NCT00541450|19523123|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
5654193|NCT00541450|19523122|P2|Phase A|Adverse Event|0
5654194|NCT00541450|19523123|P1|Phase A|Adverse Event|3
5654195|NCT00541346|19523141|P1|Follow-up|Adverse Event|1
5654196|NCT00541307|19523155|P1|Overall Study|Surgical Bypass|5
5654197|NCT00541307|19523155|P1|Overall Study|Subject returned early (outside window)|1
5654198|NCT00541307|19523155|P1|Overall Study|Lost to Follow-up|4
5654199|NCT00541307|19523155|P1|Overall Study|Withdrawal by Subject|6
5654200|NCT00541307|19523155|P1|Overall Study|Physician Decision|3
5654201|NCT00541307|19523155|P1|Overall Study|Death|5
5654202|NCT00541229|19523180|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5654203|NCT00541229|19523181|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5654204|NCT00541229|19523182|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5654205|NCT00541229|19523183|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
5654206|NCT00541229|19523184|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5654207|NCT00541229|19523185|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
5654208|NCT00541229|19523180|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
5654209|NCT00541229|19523181|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5654210|NCT00541229|19523182|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5654211|NCT00541229|19523183|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5654212|NCT00541229|19523184|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5654213|NCT00541229|19523185|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
5654214|NCT00541229|19523180|P6|Treatment Period III (Week 11)|Adverse Event|0
5654215|NCT00541229|19523181|P5|Treatment Period III (Week 11)|Adverse Event|1
5654216|NCT00541229|19523182|P4|Treatment Period III (Week 11)|Adverse Event|0
5654217|NCT00541229|19523183|P3|Treatment Period III (Week 11)|Adverse Event|0
5654218|NCT00541229|19523184|P2|Treatment Period III (Week 11)|Adverse Event|0
5654219|NCT00541229|19523185|P1|Treatment Period III (Week 11)|Adverse Event|0
5654220|NCT00541229|19523180|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
5654221|NCT00541229|19523181|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
5654222|NCT00541229|19523182|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
5654223|NCT00541229|19523183|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
5654224|NCT00541229|19523184|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
5654225|NCT00541229|19523185|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
5654226|NCT00541229|19523180|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5654227|NCT00541229|19523181|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
5654228|NCT00541229|19523182|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5654229|NCT00541229|19523183|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5654230|NCT00541229|19523184|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5654231|NCT00541229|19523185|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
5654232|NCT00541229|19523180|P6|Washout Period II (Week 7-10)|Protocol Violation|0
5654233|NCT00541229|19523181|P5|Washout Period II (Week 7-10)|Protocol Violation|0
5654234|NCT00541229|19523182|P4|Washout Period II (Week 7-10)|Protocol Violation|0
5654235|NCT00541229|19523183|P3|Washout Period II (Week 7-10)|Protocol Violation|0
5654236|NCT00541229|19523184|P2|Washout Period II (Week 7-10)|Protocol Violation|0
5654237|NCT00541229|19523185|P1|Washout Period II (Week 7-10)|Protocol Violation|1
5654238|NCT00541229|19523180|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
5654239|NCT00541229|19523181|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
5654240|NCT00541229|19523182|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
5654241|NCT00541229|19523183|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
5654242|NCT00541229|19523184|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
5654243|NCT00541229|19523185|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
5654244|NCT00541229|19523180|P6|Treatment Period II (Week 6)|Protocol Violation|1
5654245|NCT00541229|19523181|P5|Treatment Period II (Week 6)|Protocol Violation|1
5654246|NCT00541229|19523182|P4|Treatment Period II (Week 6)|Protocol Violation|0
5654247|NCT00541229|19523183|P3|Treatment Period II (Week 6)|Protocol Violation|0
5654248|NCT00541229|19523184|P2|Treatment Period II (Week 6)|Protocol Violation|0
5654249|NCT00541229|19523185|P1|Treatment Period II (Week 6)|Protocol Violation|0
5654250|NCT00541229|19523180|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
5654251|NCT00541229|19523181|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
5654252|NCT00541229|19523182|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
5654253|NCT00541229|19523183|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
5654254|NCT00541229|19523184|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
5654255|NCT00541229|19523185|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
5654256|NCT00541229|19523180|P6|Washout Period I (Week 2-5)|Protocol Violation|1
5654257|NCT00541229|19523181|P5|Washout Period I (Week 2-5)|Protocol Violation|0
5654258|NCT00541229|19523182|P4|Washout Period I (Week 2-5)|Protocol Violation|0
5654259|NCT00541229|19523183|P3|Washout Period I (Week 2-5)|Protocol Violation|0
5654260|NCT00541229|19523184|P2|Washout Period I (Week 2-5)|Protocol Violation|0
5654261|NCT00541229|19523185|P1|Washout Period I (Week 2-5)|Protocol Violation|0
5654262|NCT00541229|19523180|P6|Washout Period I (Week 2-5)|Physician Decision|0
5654263|NCT00541229|19523181|P5|Washout Period I (Week 2-5)|Physician Decision|0
5654264|NCT00541229|19523182|P4|Washout Period I (Week 2-5)|Physician Decision|1
5654265|NCT00541229|19523183|P3|Washout Period I (Week 2-5)|Physician Decision|0
5654266|NCT00541229|19523184|P2|Washout Period I (Week 2-5)|Physician Decision|0
5654267|NCT00541229|19523185|P1|Washout Period I (Week 2-5)|Physician Decision|0
5654268|NCT00541229|19523180|P6|Washout Period I (Week 2-5)|Adverse Event|0
5654269|NCT00541229|19523181|P5|Washout Period I (Week 2-5)|Adverse Event|0
5654270|NCT00541229|19523182|P4|Washout Period I (Week 2-5)|Adverse Event|0
5654271|NCT00541229|19523183|P3|Washout Period I (Week 2-5)|Adverse Event|1
5654272|NCT00541229|19523184|P2|Washout Period I (Week 2-5)|Adverse Event|0
5654273|NCT00541229|19523185|P1|Washout Period I (Week 2-5)|Adverse Event|1
5654274|NCT00541229|19523180|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
5654275|NCT00541229|19523181|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
5654276|NCT00541229|19523182|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
5654277|NCT00541229|19523183|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
5654278|NCT00541229|19523184|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
5654279|NCT00541229|19523185|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
5654280|NCT00541229|19523180|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
5654281|NCT00541229|19523181|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5654282|NCT00541229|19523182|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5654283|NCT00541229|19523183|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5654284|NCT00541229|19523184|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5654285|NCT00541229|19523185|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
5654286|NCT00541229|19523180|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
5654287|NCT00541229|19523181|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
5654288|NCT00541229|19523182|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
5654289|NCT00541229|19523183|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
5654290|NCT00541229|19523184|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
5654291|NCT00541229|19523185|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
5654292|NCT00541229|19523180|P6|Treatment Period I (Week 1)|Physician Decision|0
5654293|NCT00541229|19523181|P5|Treatment Period I (Week 1)|Physician Decision|0
5654294|NCT00541229|19523182|P4|Treatment Period I (Week 1)|Physician Decision|0
5654295|NCT00541229|19523183|P3|Treatment Period I (Week 1)|Physician Decision|1
5654296|NCT00541229|19523184|P2|Treatment Period I (Week 1)|Physician Decision|0
5654297|NCT00541229|19523185|P1|Treatment Period I (Week 1)|Physician Decision|0
5654298|NCT00541099|19523204|P1|Overall Study|Ineligible|3
5654299|NCT00541034|19523212|P1|Overall Study|Non-Compliance|3
5654300|NCT00540644|19523261|P2|Overall Study|Noncomplilance|0
5654301|NCT00540644|19523262|P1|Overall Study|Noncomplilance|1
5654302|NCT00540644|19523261|P2|Overall Study|Withdrawal by Subject|2
5654303|NCT00540644|19523262|P1|Overall Study|Withdrawal by Subject|2
5654304|NCT00540644|19523261|P2|Overall Study|Physician Decision|5
5654305|NCT00540644|19523262|P1|Overall Study|Physician Decision|0
5654306|NCT00540644|19523261|P2|Overall Study|Disease Progression|1
5654307|NCT00540644|19523262|P1|Overall Study|Disease Progression|3
5654308|NCT00540644|19523261|P2|Overall Study|Adverse Event|1
5654309|NCT00540644|19523262|P1|Overall Study|Adverse Event|3
5654310|NCT00540592|19523282|P10|Overall Study|Withdrawal by Subject|0
5654311|NCT00540592|19523283|P9|Overall Study|Withdrawal by Subject|0
5654312|NCT00540592|19523284|P8|Overall Study|Withdrawal by Subject|0
5654313|NCT00540592|19523285|P7|Overall Study|Withdrawal by Subject|0
5654314|NCT00540592|19523286|P6|Overall Study|Withdrawal by Subject|0
5654315|NCT00540592|19523287|P5|Overall Study|Withdrawal by Subject|0
5654316|NCT00540592|19523288|P4|Overall Study|Withdrawal by Subject|1
5654317|NCT00540592|19523289|P3|Overall Study|Withdrawal by Subject|1
5654318|NCT00540592|19523290|P2|Overall Study|Withdrawal by Subject|0
5654319|NCT00540592|19523291|P1|Overall Study|Withdrawal by Subject|0
5654320|NCT00540592|19523282|P10|Overall Study|Lost to Follow-up|0
5654321|NCT00540592|19523283|P9|Overall Study|Lost to Follow-up|0
5654322|NCT00540592|19523284|P8|Overall Study|Lost to Follow-up|0
5654323|NCT00540592|19523285|P7|Overall Study|Lost to Follow-up|0
5654324|NCT00540592|19523286|P6|Overall Study|Lost to Follow-up|0
5654325|NCT00540592|19523287|P5|Overall Study|Lost to Follow-up|0
5654326|NCT00540592|19523288|P4|Overall Study|Lost to Follow-up|0
5654327|NCT00540592|19523289|P3|Overall Study|Lost to Follow-up|0
5654328|NCT00540592|19523290|P2|Overall Study|Lost to Follow-up|0
5654329|NCT00540592|19523291|P1|Overall Study|Lost to Follow-up|2
5654330|NCT00540592|19523282|P10|Overall Study|Adverse Event|2
5654331|NCT00540592|19523283|P9|Overall Study|Adverse Event|1
5654332|NCT00540592|19523284|P8|Overall Study|Adverse Event|1
5654333|NCT00540592|19523285|P7|Overall Study|Adverse Event|0
5654334|NCT00540592|19523286|P6|Overall Study|Adverse Event|0
5654335|NCT00540592|19523287|P5|Overall Study|Adverse Event|1
5654336|NCT00540592|19523288|P4|Overall Study|Adverse Event|0
5654337|NCT00540592|19523289|P3|Overall Study|Adverse Event|0
5654338|NCT00540592|19523290|P2|Overall Study|Adverse Event|1
5654339|NCT00540592|19523291|P1|Overall Study|Adverse Event|0
5654340|NCT00540514|19523530|P2|Overall Study|Paclitaxel not available|2
5654341|NCT00540514|19523531|P1|Overall Study|Paclitaxel not available|0
5654342|NCT00540514|19523530|P2|Overall Study|Excluded prior to treatment|7
5654343|NCT00540514|19523531|P1|Overall Study|Excluded prior to treatment|7
5654344|NCT00540514|19523530|P2|Overall Study|Withdrawal by Subject|67
5654345|NCT00540514|19523531|P1|Overall Study|Withdrawal by Subject|65
5654346|NCT00540514|19523530|P2|Overall Study|Lost to Follow-up|1
5654347|NCT00540514|19523531|P1|Overall Study|Lost to Follow-up|1
5654348|NCT00540514|19523530|P2|Overall Study|Protocol Deviation|4
5654349|NCT00540514|19523531|P1|Overall Study|Protocol Deviation|3
5654350|NCT00540514|19523530|P2|Overall Study|Physician Decision|99
5654351|NCT00540514|19523531|P1|Overall Study|Physician Decision|86
5654352|NCT00540514|19523530|P2|Overall Study|Adverse Event|24
5654353|NCT00540514|19523531|P1|Overall Study|Adverse Event|20
5654354|NCT00540514|19523530|P2|Overall Study|Unacceptable Toxicity|62
5654355|NCT00540514|19523531|P1|Overall Study|Unacceptable Toxicity|61
5654356|NCT00540514|19523530|P2|Overall Study|Still on treatment|0
5654357|NCT00540514|19523531|P1|Overall Study|Still on treatment|3
5654358|NCT00540449|19523563|P2|Overall Study|Other|4
5654359|NCT00540449|19523564|P1|Overall Study|Other|1
5654360|NCT00540449|19523563|P2|Overall Study|Withdrawal by Subject|10
5654361|NCT00540449|19523564|P1|Overall Study|Withdrawal by Subject|10
5654362|NCT00540449|19523563|P2|Overall Study|Subject Reached A Virologic Endpoint|8
5654363|NCT00540449|19523564|P1|Overall Study|Subject Reached A Virologic Endpoint|32
5654364|NCT00540449|19523563|P2|Overall Study|Subject Non-Compliant|5
5654365|NCT00540449|19523564|P1|Overall Study|Subject Non-Compliant|7
5654366|NCT00540449|19523563|P2|Overall Study|Lost to Follow-up|17
5654367|NCT00540449|19523564|P1|Overall Study|Lost to Follow-up|19
5654368|NCT00540449|19523563|P2|Overall Study|Subject Ineligible To Continue The Trial|1
5654369|NCT00540449|19523564|P1|Overall Study|Subject Ineligible To Continue The Trial|2
5654370|NCT00540449|19523563|P2|Overall Study|Sponsor's Decision|1
5654371|NCT00540449|19523564|P1|Overall Study|Sponsor's Decision|1
5654372|NCT00540449|19523563|P2|Overall Study|Adverse Event|32
5654373|NCT00540449|19523564|P1|Overall Study|Adverse Event|12
5654374|NCT00540436|19523586|P1|Second 12-Week Treatment Period|Adverse Event|1
5654375|NCT00540436|19523586|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
5654376|NCT00540436|19523586|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
5654377|NCT00540436|19523586|P1|First 12-Week Treatment Period|Adverse Event|1
5654378|NCT00540423|19523601|P3|Open-Label Treatment Period|Lack of Efficacy|2
5654379|NCT00540423|19523602|P2|Open-Label Treatment Period|Lack of Efficacy|0
5654380|NCT00540423|19523603|P1|Open-Label Treatment Period|Lack of Efficacy|0
5654381|NCT00540423|19523601|P3|Double-Blind Treatment Period|Adverse Event|0
5654382|NCT00540423|19523602|P2|Double-Blind Treatment Period|Adverse Event|1
5654383|NCT00540423|19523603|P1|Double-Blind Treatment Period|Adverse Event|0
5654384|NCT00540293|19523653|P1|Overall Study|Protocol violation, & subject schedule|12
5654385|NCT00540293|19523653|P1|Overall Study|Withdrawal by Subject|6
5654386|NCT00540293|19523653|P1|Overall Study|Adverse event not related to study drug|7
5654387|NCT00540293|19523653|P1|Overall Study|Adverse event related to study drug|10
5654388|NCT00540228|19523701|P5|Overall Study|Lost to Follow-up|0
5654389|NCT00540228|19523702|P4|Overall Study|Lost to Follow-up|0
5654390|NCT00540228|19523703|P3|Overall Study|Lost to Follow-up|0
5654391|NCT00540228|19523704|P2|Overall Study|Lost to Follow-up|1
5654392|NCT00540228|19523705|P1|Overall Study|Lost to Follow-up|1
5654393|NCT00540228|19523701|P5|Overall Study|Adverse Event|0
5654394|NCT00540228|19523702|P4|Overall Study|Adverse Event|0
5654395|NCT00540228|19523703|P3|Overall Study|Adverse Event|0
5654396|NCT00540228|19523704|P2|Overall Study|Adverse Event|0
5654397|NCT00540228|19523705|P1|Overall Study|Adverse Event|2
5654398|NCT00540124|19523775|P3|Overall Study|Withdrawal by Subject|0
5654399|NCT00540124|19523776|P2|Overall Study|Withdrawal by Subject|1
5654400|NCT00540124|19523777|P1|Overall Study|Withdrawal by Subject|1
5654401|NCT00540124|19523775|P3|Overall Study|Lack of Efficacy|0
5654402|NCT00540124|19523776|P2|Overall Study|Lack of Efficacy|0
5654403|NCT00540124|19523777|P1|Overall Study|Lack of Efficacy|1
5654404|NCT00540124|19523775|P3|Overall Study|Entry Criteria Not Met|0
5654405|NCT00540124|19523776|P2|Overall Study|Entry Criteria Not Met|0
5654406|NCT00540124|19523777|P1|Overall Study|Entry Criteria Not Met|2
5654407|NCT00540124|19523775|P3|Overall Study|Adverse Event|1
5654408|NCT00540124|19523776|P2|Overall Study|Adverse Event|2
5654409|NCT00540124|19523777|P1|Overall Study|Adverse Event|0
5654410|NCT00540046|19523823|P2|Overall Study|Lost to Follow-up|23
5654411|NCT00540046|19523824|P1|Overall Study|Lost to Follow-up|33
5654412|NCT00539994|19523860|P3|Overall Study|Physician Decision|1
5654413|NCT00539994|19523861|P2|Overall Study|Physician Decision|0
5654414|NCT00539994|19523862|P1|Overall Study|Physician Decision|0
5654415|NCT00539994|19523860|P3|Overall Study|Withdrawal by Subject|1
5654416|NCT00539994|19523861|P2|Overall Study|Withdrawal by Subject|0
5654417|NCT00539994|19523862|P1|Overall Study|Withdrawal by Subject|1
5654418|NCT00539994|19523860|P3|Overall Study|Lost to Follow-up|0
5654419|NCT00539994|19523861|P2|Overall Study|Lost to Follow-up|1
5654420|NCT00539994|19523862|P1|Overall Study|Lost to Follow-up|2
5654421|NCT00539864|19523912|P2|Overall Study|Withdrawal by Subject|1
5654422|NCT00539864|19523913|P1|Overall Study|Withdrawal by Subject|1
5654423|NCT00539864|19523912|P2|Overall Study|Lost to Follow-up|1
5654424|NCT00539864|19523913|P1|Overall Study|Lost to Follow-up|0
5654425|NCT00539838|19523928|P3|Overall Study|Administrative|8
5654426|NCT00539838|19523929|P2|Overall Study|Administrative|0
5654427|NCT00539838|19523930|P1|Overall Study|Administrative|4
5654428|NCT00539838|19523928|P3|Overall Study|Did not cooperate|1
5654429|NCT00539838|19523929|P2|Overall Study|Did not cooperate|0
5654430|NCT00539838|19523930|P1|Overall Study|Did not cooperate|1
5654431|NCT00539838|19523928|P3|Overall Study|Death|0
5654432|NCT00539838|19523929|P2|Overall Study|Death|2
5654433|NCT00539838|19523930|P1|Overall Study|Death|0
5654434|NCT00539838|19523928|P3|Overall Study|Withdrawal by Subject|0
5654435|NCT00539838|19523929|P2|Overall Study|Withdrawal by Subject|4
5654436|NCT00539838|19523930|P1|Overall Study|Withdrawal by Subject|0
5654437|NCT00539838|19523928|P3|Overall Study|Fail to return|0
5654438|NCT00539838|19523929|P2|Overall Study|Fail to return|0
5654439|NCT00539838|19523930|P1|Overall Study|Fail to return|2
5654440|NCT00539734|19523980|P1|Overall Study|Protocol Violation|1
5654441|NCT00539591|19524006|P3|Overall Study|Disease progression|3
5654442|NCT00539591|19524007|P2|Overall Study|Disease progression|2
5654443|NCT00539591|19524008|P1|Overall Study|Disease progression|2
5654444|NCT00539591|19524006|P3|Overall Study|Toxicity|0
5654445|NCT00539591|19524007|P2|Overall Study|Toxicity|0
5654446|NCT00539591|19524008|P1|Overall Study|Toxicity|3
5654447|NCT00539513|19524160|P2|Overall Study|Lost to Follow-up|1
5654448|NCT00539513|19524161|P1|Overall Study|Lost to Follow-up|0
5654449|NCT00539513|19524160|P2|Overall Study|Withdrawal by Subject|1
5654450|NCT00539513|19524161|P1|Overall Study|Withdrawal by Subject|2
5654451|NCT00539500|19524173|P1|Overall Study|Lost to Follow-up|2
5654452|NCT00539500|19524173|P1|Overall Study|Disease Progression|1
5654453|NCT00539305|19524181|P2|Overall Study|Withdrawal by Subject|1
5654454|NCT00539305|19524182|P1|Overall Study|Withdrawal by Subject|0
5654455|NCT00539305|19524181|P2|Overall Study|Substance Use|1
5654456|NCT00539305|19524182|P1|Overall Study|Substance Use|0
5654457|NCT00539305|19524181|P2|Overall Study|Adverse Event|0
5654458|NCT00539305|19524182|P1|Overall Study|Adverse Event|1
5654459|NCT00539279|19524196|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
5654460|NCT00539279|19524197|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
5654461|NCT00539279|19524196|P2|Post-Treatment Assessment|Lost to Follow-up|9
5654462|NCT00539279|19524197|P1|Post-Treatment Assessment|Lost to Follow-up|12
5654463|NCT00539279|19524196|P2|Treatment|Death|0
5654464|NCT00539279|19524197|P1|Treatment|Death|1
5654465|NCT00539279|19524196|P2|Treatment|Withdrawal by Subject|8
5654466|NCT00539279|19524197|P1|Treatment|Withdrawal by Subject|10
5654467|NCT00539240|19524223|P3|Overall Study|Adverse Event|10
5654468|NCT00539240|19524224|P2|Overall Study|Adverse Event|1
5654469|NCT00539240|19524225|P1|Overall Study|Adverse Event|3
5654470|NCT00539240|19524223|P3|Overall Study|Lost to Follow-up|1
5654471|NCT00539240|19524224|P2|Overall Study|Lost to Follow-up|3
5654472|NCT00539240|19524225|P1|Overall Study|Lost to Follow-up|2
5654473|NCT00539240|19524223|P3|Overall Study|Protocol Violation|4
5654474|NCT00539240|19524224|P2|Overall Study|Protocol Violation|1
5654475|NCT00539240|19524225|P1|Overall Study|Protocol Violation|1
5654476|NCT00539240|19524223|P3|Overall Study|Withdrawal by Subject|0
5654477|NCT00539240|19524224|P2|Overall Study|Withdrawal by Subject|2
5654478|NCT00539240|19524225|P1|Overall Study|Withdrawal by Subject|0
5654479|NCT00539188|19524244|P2|Overall Study|Lost to Follow-up|1
5654480|NCT00539188|19524245|P1|Overall Study|Lost to Follow-up|2
5654481|NCT00539188|19524244|P2|Overall Study|Withdrawal by Subject|0
5654482|NCT00539188|19524245|P1|Overall Study|Withdrawal by Subject|1
5654483|NCT00539032|19524268|P2|Overall Study|Withdrawal by Subject|1
5654484|NCT00539032|19524269|P1|Overall Study|Withdrawal by Subject|2
5654485|NCT00539006|19524283|P4|Treatment Period 2|Other|0
5654486|NCT00539006|19524284|P3|Treatment Period 2|Other|0
5654487|NCT00539006|19524285|P2|Treatment Period 2|Other|1
5654488|NCT00539006|19524286|P1|Treatment Period 2|Other|0
5654489|NCT00539006|19524283|P4|Treatment Period 2|Protocol Violation|0
5654490|NCT00539006|19524284|P3|Treatment Period 2|Protocol Violation|0
5654491|NCT00539006|19524285|P2|Treatment Period 2|Protocol Violation|0
5654492|NCT00539006|19524286|P1|Treatment Period 2|Protocol Violation|1
5654493|NCT00539006|19524283|P4|Washout|Other|3
5654494|NCT00539006|19524284|P3|Washout|Other|2
5654495|NCT00539006|19524285|P2|Washout|Other|1
5654496|NCT00539006|19524286|P1|Washout|Other|1
5654497|NCT00539006|19524283|P4|Washout|Failed to meet continuation criteria|6
5654498|NCT00539006|19524284|P3|Washout|Failed to meet continuation criteria|14
5654499|NCT00539006|19524285|P2|Washout|Failed to meet continuation criteria|5
5654500|NCT00539006|19524286|P1|Washout|Failed to meet continuation criteria|16
5654501|NCT00539006|19524283|P4|Washout|Withdrawal by Subject|0
5654502|NCT00539006|19524284|P3|Washout|Withdrawal by Subject|0
5654503|NCT00539006|19524285|P2|Washout|Withdrawal by Subject|2
5654504|NCT00539006|19524286|P1|Washout|Withdrawal by Subject|0
5654505|NCT00539006|19524283|P4|Washout|Protocol Violation|0
5654506|NCT00539006|19524284|P3|Washout|Protocol Violation|0
5654507|NCT00539006|19524285|P2|Washout|Protocol Violation|1
5654508|NCT00539006|19524286|P1|Washout|Protocol Violation|1
5654509|NCT00539006|19524283|P4|Washout|Adverse Event|0
5654510|NCT00539006|19524284|P3|Washout|Adverse Event|0
5654511|NCT00539006|19524285|P2|Washout|Adverse Event|1
5654512|NCT00539006|19524286|P1|Washout|Adverse Event|2
5654513|NCT00539006|19524283|P4|Treatment Period 1|Lack of Efficacy|1
5654514|NCT00539006|19524284|P3|Treatment Period 1|Lack of Efficacy|0
5654515|NCT00539006|19524285|P2|Treatment Period 1|Lack of Efficacy|0
5654516|NCT00539006|19524286|P1|Treatment Period 1|Lack of Efficacy|0
5654517|NCT00539006|19524283|P4|Treatment Period 1|Protocol Violation|0
5654518|NCT00539006|19524284|P3|Treatment Period 1|Protocol Violation|1
5654519|NCT00539006|19524285|P2|Treatment Period 1|Protocol Violation|0
5654520|NCT00539006|19524286|P1|Treatment Period 1|Protocol Violation|0
5654521|NCT00539006|19524283|P4|Treatment Period 1|Lost to Follow-up|0
5654522|NCT00539006|19524284|P3|Treatment Period 1|Lost to Follow-up|1
5654523|NCT00539006|19524285|P2|Treatment Period 1|Lost to Follow-up|0
5654524|NCT00539006|19524286|P1|Treatment Period 1|Lost to Follow-up|0
5654525|NCT00539006|19524283|P4|Pre-treatment|Other|0
5654526|NCT00539006|19524284|P3|Pre-treatment|Other|0
5654527|NCT00539006|19524285|P2|Pre-treatment|Other|1
5654528|NCT00539006|19524286|P1|Pre-treatment|Other|0
5654529|NCT00538902|19524331|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
5654530|NCT00538902|19524332|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
5654531|NCT00538902|19524333|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
5654532|NCT00538902|19524331|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
5654533|NCT00538902|19524332|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
5654534|NCT00538902|19524333|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
5654535|NCT00538902|19524331|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
5654536|NCT00538902|19524332|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
5654537|NCT00538902|19524333|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
5654538|NCT00538902|19524331|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
5654539|NCT00538902|19524332|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
5654540|NCT00538902|19524333|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
5654541|NCT00538902|19524331|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
5654542|NCT00538902|19524332|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
5654543|NCT00538902|19524333|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
5654544|NCT00538902|19524331|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
5654545|NCT00538902|19524332|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
5654546|NCT00538902|19524333|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
5654547|NCT00538902|19524331|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
5654548|NCT00538902|19524332|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
5654549|NCT00538902|19524333|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
5654550|NCT00538902|19524331|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
5654551|NCT00538902|19524332|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
5654552|NCT00538902|19524333|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
5654553|NCT00538785|19524394|P2|Overall Study|Lost to Follow-up|0
5654554|NCT00538785|19524395|P1|Overall Study|Lost to Follow-up|1
5654555|NCT00538785|19524394|P2|Overall Study|Withdrawal of consent|7
5654556|NCT00538785|19524395|P1|Overall Study|Withdrawal of consent|9
5654557|NCT00538785|19524394|P2|Overall Study|Death|10
5654558|NCT00538785|19524395|P1|Overall Study|Death|9
5654559|NCT00538733|19524437|P1|Overall Study|still on therapy|1
5654560|NCT00538733|19524437|P1|Overall Study|declined to participate|2
5654561|NCT00538733|19524437|P1|Overall Study|Death|1
5654562|NCT00538733|19524437|P1|Overall Study|Adverse Event|8
5654563|NCT00538681|19524449|P4|Overall Study|Investigator Decision|1
5654564|NCT00538681|19524450|P3|Overall Study|Investigator Decision|0
5654565|NCT00538681|19524451|P2|Overall Study|Investigator Decision|0
5654566|NCT00538681|19524452|P1|Overall Study|Investigator Decision|0
5654567|NCT00538681|19524449|P4|Overall Study|Death|1
5654568|NCT00538681|19524450|P3|Overall Study|Death|1
5654569|NCT00538681|19524451|P2|Overall Study|Death|0
5654570|NCT00538681|19524452|P1|Overall Study|Death|0
5654571|NCT00538681|19524449|P4|Overall Study|Adverse Event|0
5654572|NCT00538681|19524450|P3|Overall Study|Adverse Event|1
5654573|NCT00538681|19524451|P2|Overall Study|Adverse Event|1
5654574|NCT00538681|19524452|P1|Overall Study|Adverse Event|1
5654575|NCT00538681|19524449|P4|Overall Study|Sponsor Decision|9
5654576|NCT00538681|19524450|P3|Overall Study|Sponsor Decision|8
5654577|NCT00538681|19524451|P2|Overall Study|Sponsor Decision|3
5654578|NCT00538681|19524452|P1|Overall Study|Sponsor Decision|1
5654579|NCT00538681|19524449|P4|Overall Study|Progressive Disease|0
5654580|NCT00538681|19524450|P3|Overall Study|Progressive Disease|1
5654581|NCT00538681|19524451|P2|Overall Study|Progressive Disease|0
5654582|NCT00538681|19524452|P1|Overall Study|Progressive Disease|7
5654583|NCT00538629|19524518|P1|Overall Study|Subject's untimely distrust of medicine|1
5654584|NCT00538629|19524518|P1|Overall Study|Lost to Follow-up|6
5654585|NCT00538629|19524518|P1|Overall Study|Lack of Efficacy|12
5654586|NCT00538629|19524518|P1|Overall Study|Adverse Event|2
5654587|NCT00538629|19524518|P1|Overall Study|At subject's request|1
5654588|NCT00538590|19524574|P2|Overall Study|Death|0
5654589|NCT00538590|19524575|P1|Overall Study|Death|1
5654590|NCT00538473|19524613|P2|Overall Study|Adverse Event|0
5654591|NCT00538473|19524614|P1|Overall Study|Adverse Event|1
5654592|NCT00538291|19524694|P1|Overall Study|Withdrawal by Subject|1
5654593|NCT00538291|19524694|P1|Overall Study|Adverse Event|2
5654594|NCT00537979|19524752|P2|Overall Study|Heart failure|1
5654595|NCT00537979|19524753|P1|Overall Study|Heart failure|0
5654596|NCT00537979|19524752|P2|Overall Study|Kidney transplant|3
5654597|NCT00537979|19524753|P1|Overall Study|Kidney transplant|0
5654598|NCT00537979|19524752|P2|Overall Study|Death|3
5654599|NCT00537979|19524753|P1|Overall Study|Death|0
5654600|NCT00537979|19524752|P2|Overall Study|Non-compliance with treatment/procedure|2
5654601|NCT00537979|19524753|P1|Overall Study|Non-compliance with treatment/procedure|2
5654602|NCT00537979|19524752|P2|Overall Study|Lack of Efficacy|1
5654603|NCT00537979|19524753|P1|Overall Study|Lack of Efficacy|0
5654604|NCT00537979|19524752|P2|Overall Study|Lost to Follow-up|4
5654605|NCT00537979|19524753|P1|Overall Study|Lost to Follow-up|1
5654606|NCT00537979|19524752|P2|Overall Study|Withdrawal by Subject|4
5654607|NCT00537979|19524753|P1|Overall Study|Withdrawal by Subject|1
5654608|NCT00537979|19524752|P2|Overall Study|Adverse Event|2
5654609|NCT00537979|19524753|P1|Overall Study|Adverse Event|2
5654610|NCT00537940|19524769|P2|Overall Study|Other|12
5654611|NCT00537940|19524770|P1|Overall Study|Other|10
5654612|NCT00537940|19524769|P2|Overall Study|Study terminated by sponsor|3
5654613|NCT00537940|19524770|P1|Overall Study|Study terminated by sponsor|2
5654614|NCT00537940|19524769|P2|Overall Study|Pregnancy|1
5654615|NCT00537940|19524770|P1|Overall Study|Pregnancy|1
5654616|NCT00537940|19524769|P2|Overall Study|Protocol Violation|4
5654617|NCT00537940|19524770|P1|Overall Study|Protocol Violation|6
5654618|NCT00537940|19524769|P2|Overall Study|Withdrawal by Subject|95
5654619|NCT00537940|19524770|P1|Overall Study|Withdrawal by Subject|113
5654620|NCT00537940|19524769|P2|Overall Study|Lost to Follow-up|29
5654621|NCT00537940|19524770|P1|Overall Study|Lost to Follow-up|23
5654622|NCT00537940|19524769|P2|Overall Study|Lack of Efficacy|16
5654623|NCT00537940|19524770|P1|Overall Study|Lack of Efficacy|8
5654624|NCT00537940|19524769|P2|Overall Study|Adverse Event|19
5654625|NCT00537940|19524770|P1|Overall Study|Adverse Event|20
5654626|NCT00537823|19524794|P2|Overall Study|Adverse Event|0
5654627|NCT00537823|19524795|P1|Overall Study|Adverse Event|2
5654628|NCT00537810|19524821|P4|Overall Study|Medically withdrawn|1
5654629|NCT00537810|19524822|P3|Overall Study|Medically withdrawn|0
5654630|NCT00537810|19524823|P2|Overall Study|Medically withdrawn|2
5654631|NCT00537810|19524824|P1|Overall Study|Medically withdrawn|2
5654632|NCT00537810|19524821|P4|Overall Study|Withdrawal by Subject|3
5654633|NCT00537810|19524822|P3|Overall Study|Withdrawal by Subject|4
5654634|NCT00537810|19524823|P2|Overall Study|Withdrawal by Subject|11
5654635|NCT00537810|19524824|P1|Overall Study|Withdrawal by Subject|4
5654636|NCT00537771|19524840|P2|Overall Study|Severe Non-Compliance to Protocol|2
5654637|NCT00537771|19524841|P1|Overall Study|Severe Non-Compliance to Protocol|4
5654638|NCT00537771|19524840|P2|Overall Study|Protocol Violation|6
5654639|NCT00537771|19524841|P1|Overall Study|Protocol Violation|2
5654640|NCT00537771|19524840|P2|Overall Study|Lost to Follow-up|15
5654641|NCT00537771|19524841|P1|Overall Study|Lost to Follow-up|9
5654642|NCT00537771|19524840|P2|Overall Study|Adverse Event|15
5654643|NCT00537771|19524841|P1|Overall Study|Adverse Event|8
5654644|NCT00537771|19524840|P2|Overall Study|Withdrawal by Subject|23
5654645|NCT00537771|19524841|P1|Overall Study|Withdrawal by Subject|6
5654646|NCT00537745|19524851|P1|Overall Study|Subject unable to provide Interlock info|1
5654647|NCT00537745|19524851|P1|Overall Study|Withdrawal by Subject|2
5654648|NCT00537745|19524851|P1|Overall Study|Did not meet eligibility criteria|2
5654649|NCT00537485|19524933|P2|Overall Study|Physician Decision|0
5654650|NCT00537485|19524934|P1|Overall Study|Physician Decision|1
5654651|NCT00537485|19524933|P2|Overall Study|Withdrawal by Subject|3
5654652|NCT00537485|19524934|P1|Overall Study|Withdrawal by Subject|1
5654653|NCT00537485|19524933|P2|Overall Study|Withdrawal by Subject|2
5654654|NCT00537485|19524934|P1|Overall Study|Withdrawal by Subject|3
5654655|NCT00537485|19524933|P2|Overall Study|Adverse Event|5
5654656|NCT00537485|19524934|P1|Overall Study|Adverse Event|10
5654657|NCT00537394|19525017|P3|2nd Year of Follow-up|Clinic site closure|0
5654658|NCT00537394|19525018|P2|2nd Year of Follow-up|Clinic site closure|0
5654659|NCT00537394|19525019|P1|2nd Year of Follow-up|Clinic site closure|1
5654660|NCT00537394|19525017|P3|2nd Year of Follow-up|Lost to Follow-up|2
5654661|NCT00537394|19525018|P2|2nd Year of Follow-up|Lost to Follow-up|7
5654662|NCT00537394|19525019|P1|2nd Year of Follow-up|Lost to Follow-up|6
5654663|NCT00537394|19525017|P3|2nd Year of Follow-up|Withdrawal by Subject|2
5654664|NCT00537394|19525018|P2|2nd Year of Follow-up|Withdrawal by Subject|1
5654665|NCT00537394|19525019|P1|2nd Year of Follow-up|Withdrawal by Subject|0
5654666|NCT00537394|19525017|P3|2nd Year of Follow-up|Death|2
5654667|NCT00537394|19525018|P2|2nd Year of Follow-up|Death|1
5654668|NCT00537394|19525019|P1|2nd Year of Follow-up|Death|4
5654669|NCT00537394|19525017|P3|First Year of Follow-up|Lost to Follow-up|1
5654670|NCT00537394|19525018|P2|First Year of Follow-up|Lost to Follow-up|5
5654671|NCT00537394|19525019|P1|First Year of Follow-up|Lost to Follow-up|1
5654672|NCT00537394|19525017|P3|First Year of Follow-up|Withdrawal by Subject|1
5654673|NCT00537394|19525018|P2|First Year of Follow-up|Withdrawal by Subject|6
5654674|NCT00537394|19525019|P1|First Year of Follow-up|Withdrawal by Subject|3
5654675|NCT00537394|19525017|P3|First Year of Follow-up|Severe debilitation|1
5654676|NCT00537394|19525018|P2|First Year of Follow-up|Severe debilitation|0
5654677|NCT00537394|19525019|P1|First Year of Follow-up|Severe debilitation|1
5654678|NCT00537394|19525017|P3|First Year of Follow-up|Death|0
5654679|NCT00537394|19525018|P2|First Year of Follow-up|Death|0
5654680|NCT00537394|19525019|P1|First Year of Follow-up|Death|7
5654681|NCT00537381|19525055|P2|Overall Study|Other|3
5654682|NCT00537381|19525056|P1|Overall Study|Other|5
5654683|NCT00537381|19525055|P2|Overall Study|Sponsor decision|9
5654684|NCT00537381|19525056|P1|Overall Study|Sponsor decision|14
5654685|NCT00537381|19525055|P2|Overall Study|Disease Progression|18
5654686|NCT00537381|19525056|P1|Overall Study|Disease Progression|9
5654687|NCT00537381|19525055|P2|Overall Study|Physician Decision|6
5654688|NCT00537381|19525056|P1|Overall Study|Physician Decision|7
5654689|NCT00537381|19525055|P2|Overall Study|Withdrawal by Subject|14
5654690|NCT00537381|19525056|P1|Overall Study|Withdrawal by Subject|5
5654691|NCT00537381|19525055|P2|Overall Study|Death|3
5654692|NCT00537381|19525056|P1|Overall Study|Death|3
5654693|NCT00537381|19525055|P2|Overall Study|Adverse Event|9
5654694|NCT00537381|19525056|P1|Overall Study|Adverse Event|13
5654695|NCT00537329|19525076|P1|Overall Study|Other|1
5654696|NCT00537329|19525076|P1|Overall Study|Withdrawal by Subject|4
5654697|NCT00537329|19525076|P1|Overall Study|Lost to Follow-up|6
5654698|NCT00537329|19525076|P1|Overall Study|Lack of Efficacy|2
5654699|NCT00537329|19525076|P1|Overall Study|Adverse Event|3
5654700|NCT00537329|19525076|P1|Overall Study|Death|10
5654701|NCT00537316|19525096|P7|Part 2|Administrative|1
5654702|NCT00537316|19525097|P6|Part 2|Administrative|4
5654703|NCT00537316|19525098|P5|Part 2|Administrative|1
5654704|NCT00537316|19525099|P4|Part 2|Administrative|3
5654705|NCT00537316|19525100|P3|Part 2|Administrative|24
5654706|NCT00537316|19525101|P2|Part 2|Administrative|8
5654707|NCT00537316|19525102|P1|Part 2|Administrative|16
5654708|NCT00537316|19525096|P7|Part 2|Withdrawal by Subject|0
5654709|NCT00537316|19525097|P6|Part 2|Withdrawal by Subject|0
5654710|NCT00537316|19525098|P5|Part 2|Withdrawal by Subject|0
5654711|NCT00537316|19525099|P4|Part 2|Withdrawal by Subject|0
5654712|NCT00537316|19525100|P3|Part 2|Withdrawal by Subject|4
5654713|NCT00537316|19525101|P2|Part 2|Withdrawal by Subject|1
5654714|NCT00537316|19525102|P1|Part 2|Withdrawal by Subject|5
5654715|NCT00537316|19525096|P7|Part 2|Lost to Follow-up|0
5654716|NCT00537316|19525097|P6|Part 2|Lost to Follow-up|0
5654717|NCT00537316|19525098|P5|Part 2|Lost to Follow-up|0
5654718|NCT00537316|19525099|P4|Part 2|Lost to Follow-up|0
5654719|NCT00537316|19525100|P3|Part 2|Lost to Follow-up|2
5654720|NCT00537316|19525101|P2|Part 2|Lost to Follow-up|0
5654721|NCT00537316|19525102|P1|Part 2|Lost to Follow-up|1
5654722|NCT00537316|19525096|P7|Part 2|Adverse Event|0
5654723|NCT00537316|19525097|P6|Part 2|Adverse Event|0
5654724|NCT00537316|19525098|P5|Part 2|Adverse Event|0
5654725|NCT00537316|19525099|P4|Part 2|Adverse Event|0
5654726|NCT00537316|19525100|P3|Part 2|Adverse Event|2
5654727|NCT00537316|19525101|P2|Part 2|Adverse Event|0
5654728|NCT00537316|19525102|P1|Part 2|Adverse Event|4
5654729|NCT00537316|19525096|P7|Part 2|Never entered follow-up|1
5654730|NCT00537316|19525097|P6|Part 2|Never entered follow-up|0
5654731|NCT00537316|19525098|P5|Part 2|Never entered follow-up|0
5654732|NCT00537316|19525099|P4|Part 2|Never entered follow-up|0
5654733|NCT00537316|19525100|P3|Part 2|Never entered follow-up|0
5654734|NCT00537316|19525101|P2|Part 2|Never entered follow-up|0
5654735|NCT00537316|19525102|P1|Part 2|Never entered follow-up|0
5654736|NCT00537316|19525096|P7|Part 1|Administrative|0
5654737|NCT00537316|19525097|P6|Part 1|Administrative|0
5654738|NCT00537316|19525098|P5|Part 1|Administrative|0
5654739|NCT00537316|19525099|P4|Part 1|Administrative|0
5654740|NCT00537316|19525100|P3|Part 1|Administrative|2
5654741|NCT00537316|19525101|P2|Part 1|Administrative|0
5654742|NCT00537316|19525102|P1|Part 1|Administrative|0
5654743|NCT00537316|19525096|P7|Part 1|Did not meet protocol eligibility|0
5654744|NCT00537316|19525097|P6|Part 1|Did not meet protocol eligibility|0
5654745|NCT00537316|19525098|P5|Part 1|Did not meet protocol eligibility|0
5654746|NCT00537316|19525099|P4|Part 1|Did not meet protocol eligibility|0
5654747|NCT00537316|19525100|P3|Part 1|Did not meet protocol eligibility|2
5654748|NCT00537316|19525101|P2|Part 1|Did not meet protocol eligibility|3
5654749|NCT00537316|19525102|P1|Part 1|Did not meet protocol eligibility|1
5654750|NCT00537316|19525096|P7|Part 1|Protocol Violation|0
5654751|NCT00537316|19525097|P6|Part 1|Protocol Violation|0
5654752|NCT00537316|19525098|P5|Part 1|Protocol Violation|0
5654753|NCT00537316|19525099|P4|Part 1|Protocol Violation|0
5654754|NCT00537316|19525100|P3|Part 1|Protocol Violation|1
5654755|NCT00537316|19525101|P2|Part 1|Protocol Violation|5
5654756|NCT00537316|19525102|P1|Part 1|Protocol Violation|1
5654757|NCT00537316|19525096|P7|Part 1|Withdrawal by Subject|0
5654758|NCT00537316|19525097|P6|Part 1|Withdrawal by Subject|0
5654759|NCT00537316|19525098|P5|Part 1|Withdrawal by Subject|0
5654760|NCT00537316|19525099|P4|Part 1|Withdrawal by Subject|0
5654761|NCT00537316|19525100|P3|Part 1|Withdrawal by Subject|4
5654762|NCT00537316|19525101|P2|Part 1|Withdrawal by Subject|8
5654763|NCT00537316|19525102|P1|Part 1|Withdrawal by Subject|3
5654764|NCT00537316|19525096|P7|Part 1|Lost to Follow-up|0
5654765|NCT00537316|19525097|P6|Part 1|Lost to Follow-up|0
5654766|NCT00537316|19525098|P5|Part 1|Lost to Follow-up|0
5654767|NCT00537316|19525099|P4|Part 1|Lost to Follow-up|0
5654768|NCT00537316|19525100|P3|Part 1|Lost to Follow-up|0
5654769|NCT00537316|19525101|P2|Part 1|Lost to Follow-up|0
5654770|NCT00537316|19525102|P1|Part 1|Lost to Follow-up|1
5654771|NCT00537316|19525096|P7|Part 1|Protocol defined clinical event|0
5654772|NCT00537316|19525097|P6|Part 1|Protocol defined clinical event|0
5654773|NCT00537316|19525098|P5|Part 1|Protocol defined clinical event|0
5654774|NCT00537316|19525099|P4|Part 1|Protocol defined clinical event|0
5654775|NCT00537316|19525100|P3|Part 1|Protocol defined clinical event|0
5654776|NCT00537316|19525101|P2|Part 1|Protocol defined clinical event|0
5654777|NCT00537316|19525102|P1|Part 1|Protocol defined clinical event|1
5654778|NCT00537316|19525096|P7|Part 1|Adverse Event|0
5654779|NCT00537316|19525097|P6|Part 1|Adverse Event|0
5654780|NCT00537316|19525098|P5|Part 1|Adverse Event|0
5654781|NCT00537316|19525099|P4|Part 1|Adverse Event|0
5654782|NCT00537316|19525100|P3|Part 1|Adverse Event|8
5654783|NCT00537316|19525101|P2|Part 1|Adverse Event|11
5654784|NCT00537316|19525102|P1|Part 1|Adverse Event|7
5654785|NCT00537303|19525129|P2|Overall Study|Unclassified|7
5654786|NCT00537303|19525130|P1|Overall Study|Unclassified|8
5654787|NCT00537303|19525129|P2|Overall Study|Withdrawal criteria|3
5654788|NCT00537303|19525130|P1|Overall Study|Withdrawal criteria|3
5654789|NCT00537303|19525129|P2|Overall Study|Protocol Violation|4
5654790|NCT00537303|19525130|P1|Overall Study|Protocol Violation|8
5654791|NCT00537303|19525129|P2|Overall Study|Lack of Efficacy|7
5654792|NCT00537303|19525130|P1|Overall Study|Lack of Efficacy|6
5654793|NCT00537303|19525129|P2|Overall Study|Adverse Event|4
5654794|NCT00537303|19525130|P1|Overall Study|Adverse Event|1
5654795|NCT00537277|19525151|P1|Overall Study|Non-compliance with trial procedures|15
5654796|NCT00537277|19525151|P1|Overall Study|Inability to tolerate trial medication|4
5654797|NCT00537277|19525151|P1|Overall Study|Unclassified|4
5654798|NCT00537277|19525151|P1|Overall Study|Protocol Violation|11
5654799|NCT00537277|19525151|P1|Overall Study|Lost to Follow-up|12
5654800|NCT00537277|19525151|P1|Overall Study|Lack of Efficacy|2
5654801|NCT00537277|19525151|P1|Overall Study|Adverse Event|1
5654802|NCT00537238|19525162|P2|Overall Study|Other|52
5654803|NCT00537238|19525163|P1|Overall Study|Other|44
5654804|NCT00537238|19525162|P2|Overall Study|Does not meet entrance criteria|2
5654805|NCT00537238|19525163|P1|Overall Study|Does not meet entrance criteria|0
5654806|NCT00537238|19525162|P2|Overall Study|Protocol Violation|19
5654807|NCT00537238|19525163|P1|Overall Study|Protocol Violation|15
5654808|NCT00537238|19525162|P2|Overall Study|Withdrawal by Subject|47
5654809|NCT00537238|19525163|P1|Overall Study|Withdrawal by Subject|51
5654810|NCT00537238|19525162|P2|Overall Study|Lost to Follow-up|8
5654811|NCT00537238|19525163|P1|Overall Study|Lost to Follow-up|12
5654812|NCT00537238|19525162|P2|Overall Study|Lack of Efficacy|21
5654813|NCT00537238|19525163|P1|Overall Study|Lack of Efficacy|20
5654814|NCT00537238|19525162|P2|Overall Study|Adverse Event|22
5654815|NCT00537238|19525163|P1|Overall Study|Adverse Event|31
5654816|NCT00537238|19525162|P2|Overall Study|Death|2
5654817|NCT00537238|19525163|P1|Overall Study|Death|1
5654818|NCT00537199|19525183|P1|Overall Study|Study Terminated|1
5654819|NCT00537095|19525189|P2|Overall Study|Incorrect enrolment|1
5654820|NCT00537095|19525190|P1|Overall Study|Incorrect enrolment|0
5654821|NCT00537095|19525189|P2|Overall Study|subjective disease progression|1
5654822|NCT00537095|19525190|P1|Overall Study|subjective disease progression|0
5654823|NCT00537095|19525189|P2|Overall Study|Withdrawal by Subject|2
5654824|NCT00537095|19525190|P1|Overall Study|Withdrawal by Subject|2
5654825|NCT00537095|19525189|P2|Overall Study|Death|1
5654826|NCT00537095|19525190|P1|Overall Study|Death|3
5654827|NCT00537095|19525189|P2|Overall Study|disease progression|48
5654828|NCT00537095|19525190|P1|Overall Study|disease progression|21
5654829|NCT00537095|19525189|P2|Overall Study|Adverse Event|4
5654830|NCT00537095|19525190|P1|Overall Study|Adverse Event|24
5654831|NCT00537095|19525189|P2|Overall Study|surgery|0
5654832|NCT00537095|19525190|P1|Overall Study|surgery|1
5654833|NCT00537082|19525205|P3|Overall Study|Discontinued before initiating treatment|0
5654834|NCT00537082|19525206|P2|Overall Study|Discontinued before initiating treatment|0
5654835|NCT00537082|19525207|P1|Overall Study|Discontinued before initiating treatment|3
5654836|NCT00537082|19525205|P3|Overall Study|Withdrawal by Subject|0
5654837|NCT00537082|19525206|P2|Overall Study|Withdrawal by Subject|1
5654838|NCT00537082|19525207|P1|Overall Study|Withdrawal by Subject|0
5654839|NCT00537082|19525205|P3|Overall Study|Lack of Efficacy|2
5654840|NCT00537082|19525206|P2|Overall Study|Lack of Efficacy|0
5654841|NCT00537082|19525207|P1|Overall Study|Lack of Efficacy|0
5654842|NCT00537082|19525205|P3|Overall Study|Protocol Violation|1
5654843|NCT00537082|19525206|P2|Overall Study|Protocol Violation|2
5654844|NCT00537082|19525207|P1|Overall Study|Protocol Violation|0
5654845|NCT00537082|19525205|P3|Overall Study|Adverse Event|3
5654846|NCT00537082|19525206|P2|Overall Study|Adverse Event|6
5654847|NCT00537082|19525207|P1|Overall Study|Adverse Event|6
5654848|NCT00537056|19525224|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
5654849|NCT00537030|19525236|P1|Overall Study|Inevaluable|2
5654850|NCT00537030|19525236|P1|Overall Study|Ineligible|2
5654851|NCT00537030|19525236|P1|Overall Study|Disease progression/ relapse during Tx|1
5654852|NCT00537030|19525236|P1|Overall Study|≥ Grade 2 allergy|7
5654853|NCT00537030|19525236|P1|Overall Study|Withdrawal by Subject|2
5654854|NCT00537030|19525236|P1|Overall Study|Physician Decision|2
5654855|NCT00537017|19525243|P1|Follow-up Phase|Withdrawal by Subject|9
5654856|NCT00537017|19525243|P1|Treatment Phase|Protocol Violation|2
5654857|NCT00537017|19525243|P1|Treatment Phase|Withdrawal by Subject|13
5654858|NCT00537017|19525243|P1|Treatment Phase|Adverse Event|19
5654859|NCT00536991|19525254|P1|Overall Study|patient ineligible|2
5654860|NCT00536991|19525254|P1|Overall Study|Physician Decision|1
5654861|NCT00536991|19525254|P1|Overall Study|Withdrawal by Subject|10
5654862|NCT00536978|19525261|P1|Overall Study|Not eligible for Adback Infusion|22
5654863|NCT00536939|19525265|P2|Overall Study|Other Complicating Disease|0
5654864|NCT00536939|19525266|P1|Overall Study|Other Complicating Disease|1
5654865|NCT00536939|19525265|P2|Overall Study|Withdrawal by Subject|0
5654866|NCT00536939|19525266|P1|Overall Study|Withdrawal by Subject|1
5654867|NCT00536874|19525297|P1|Overall Study|Withdrawal by Subject|1
5654868|NCT00536874|19525297|P1|Overall Study|Death|2
5654869|NCT00536874|19525297|P1|Overall Study|Adverse Event|1
5654870|NCT00536809|19525307|P1|Phase II|Referred for surgical resection|1
5654871|NCT00536809|19525307|P1|Phase II|Adverse Event|1
5654872|NCT00536744|19525330|P2|Overall Study|PI tried alternative treatment|3
5654873|NCT00536744|19525331|P1|Overall Study|PI tried alternative treatment|1
5654874|NCT00536744|19525330|P2|Overall Study|Withdrawal by Subject|8
5654875|NCT00536744|19525331|P1|Overall Study|Withdrawal by Subject|7
5654876|NCT00536744|19525330|P2|Overall Study|Lost to Follow-up|5
5654877|NCT00536744|19525331|P1|Overall Study|Lost to Follow-up|3
5654878|NCT00536744|19525330|P2|Overall Study|Physician Decision|1
5654879|NCT00536744|19525331|P1|Overall Study|Physician Decision|3
5654880|NCT00536744|19525330|P2|Overall Study|Death|1
5654881|NCT00536744|19525331|P1|Overall Study|Death|2
5654882|NCT00536744|19525330|P2|Overall Study|Adverse Event|10
5654883|NCT00536744|19525331|P1|Overall Study|Adverse Event|13
5654884|NCT00536731|19525340|P3|Overall Study|Other|0
5654885|NCT00536731|19525341|P2|Overall Study|Other|1
5654886|NCT00536731|19525342|P1|Overall Study|Other|1
5654887|NCT00536731|19525340|P3|Overall Study|Safety reasons|1
5654888|NCT00536731|19525341|P2|Overall Study|Safety reasons|0
5654889|NCT00536731|19525342|P1|Overall Study|Safety reasons|0
5654890|NCT00536731|19525340|P3|Overall Study|Intake of prohibited conc. medication|1
5654891|NCT00536731|19525341|P2|Overall Study|Intake of prohibited conc. medication|0
5654892|NCT00536731|19525342|P1|Overall Study|Intake of prohibited conc. medication|0
5654893|NCT00536731|19525340|P3|Overall Study|Withdrawal by Subject|0
5654894|NCT00536731|19525341|P2|Overall Study|Withdrawal by Subject|2
5654895|NCT00536731|19525342|P1|Overall Study|Withdrawal by Subject|0
5654896|NCT00536731|19525340|P3|Overall Study|Adverse Event|3
5654897|NCT00536731|19525341|P2|Overall Study|Adverse Event|2
5654898|NCT00536731|19525342|P1|Overall Study|Adverse Event|3
5654899|NCT00536575|19525386|P1|Overall Study|Death|1
5654900|NCT00536575|19525386|P1|Overall Study|Withdrawal by Subject|1
5654901|NCT00536510|19525392|P2|Overall Study|Patient Discontinued for Other Reasons|2
5654902|NCT00536510|19525393|P1|Overall Study|Patient Discontinued for Other Reasons|2
5654903|NCT00536510|19525392|P2|Overall Study|Laboratory Adverse Event|1
5654904|NCT00536510|19525393|P1|Overall Study|Laboratory Adverse Event|2
5654905|NCT00536510|19525392|P2|Overall Study|Flushing with Product|0
5654906|NCT00536510|19525393|P1|Overall Study|Flushing with Product|20
5654907|NCT00536510|19525392|P2|Overall Study|Withdrawal by Subject|9
5654908|NCT00536510|19525393|P1|Overall Study|Withdrawal by Subject|16
5654909|NCT00536510|19525392|P2|Overall Study|Protocol Violation|5
5654910|NCT00536510|19525393|P1|Overall Study|Protocol Violation|4
5654911|NCT00536510|19525392|P2|Overall Study|Lost to Follow-up|8
5654912|NCT00536510|19525393|P1|Overall Study|Lost to Follow-up|11
5654913|NCT00536510|19525392|P2|Overall Study|Adverse Event|4
5654914|NCT00536510|19525393|P1|Overall Study|Adverse Event|27
5654915|NCT00536484|19525403|P2|Overall Study|Other|0
5654916|NCT00536484|19525404|P1|Overall Study|Other|4
5654917|NCT00536484|19525403|P2|Overall Study|Lack of Efficacy|5
5654918|NCT00536484|19525404|P1|Overall Study|Lack of Efficacy|16
5654919|NCT00536484|19525403|P2|Overall Study|Lost to Follow-up|6
5654920|NCT00536484|19525404|P1|Overall Study|Lost to Follow-up|8
5654921|NCT00536484|19525403|P2|Overall Study|Withdrawal by Subject|11
5654922|NCT00536484|19525404|P1|Overall Study|Withdrawal by Subject|11
5654923|NCT00536484|19525403|P2|Overall Study|Adverse Event|34
5654924|NCT00536484|19525404|P1|Overall Study|Adverse Event|21
5654925|NCT00536471|19525438|P4|Overall Study|Sponsor Decision|2
5654926|NCT00536471|19525439|P3|Overall Study|Sponsor Decision|3
5654927|NCT00536471|19525440|P2|Overall Study|Sponsor Decision|1
5654928|NCT00536471|19525441|P1|Overall Study|Sponsor Decision|0
5654929|NCT00536471|19525438|P4|Overall Study|Death|2
5654930|NCT00536471|19525439|P3|Overall Study|Death|1
5654931|NCT00536471|19525440|P2|Overall Study|Death|0
5654932|NCT00536471|19525441|P1|Overall Study|Death|0
5654933|NCT00536471|19525438|P4|Overall Study|Physician Decision|2
5654934|NCT00536471|19525439|P3|Overall Study|Physician Decision|3
5654935|NCT00536471|19525440|P2|Overall Study|Physician Decision|1
5654936|NCT00536471|19525441|P1|Overall Study|Physician Decision|11
5654937|NCT00536471|19525438|P4|Overall Study|Protocol Violation|3
5654938|NCT00536471|19525439|P3|Overall Study|Protocol Violation|2
5654939|NCT00536471|19525440|P2|Overall Study|Protocol Violation|1
5654940|NCT00536471|19525441|P1|Overall Study|Protocol Violation|8
5654941|NCT00536471|19525438|P4|Overall Study|Lack of Efficacy|9
5654942|NCT00536471|19525439|P3|Overall Study|Lack of Efficacy|11
5654943|NCT00536471|19525440|P2|Overall Study|Lack of Efficacy|18
5654944|NCT00536471|19525441|P1|Overall Study|Lack of Efficacy|17
5654945|NCT00536471|19525438|P4|Overall Study|Withdrawal by Subject|21
5654946|NCT00536471|19525439|P3|Overall Study|Withdrawal by Subject|43
5654947|NCT00536471|19525440|P2|Overall Study|Withdrawal by Subject|24
5654948|NCT00536471|19525441|P1|Overall Study|Withdrawal by Subject|40
5654949|NCT00536471|19525438|P4|Overall Study|Adverse Event|13
5654950|NCT00536471|19525439|P3|Overall Study|Adverse Event|28
5654951|NCT00536471|19525440|P2|Overall Study|Adverse Event|16
5654952|NCT00536471|19525441|P1|Overall Study|Adverse Event|32
5654953|NCT00536471|19525438|P4|Overall Study|Lost to Follow-up|22
5654954|NCT00536471|19525439|P3|Overall Study|Lost to Follow-up|48
5654955|NCT00536471|19525440|P2|Overall Study|Lost to Follow-up|23
5654956|NCT00536471|19525441|P1|Overall Study|Lost to Follow-up|48
5654957|NCT00536380|19525686|P3|Overall Study|Administrative|1
5654958|NCT00536380|19525687|P2|Overall Study|Administrative|0
5654959|NCT00536380|19525688|P1|Overall Study|Administrative|0
5654960|NCT00536380|19525686|P3|Overall Study|Did not meet protocol eligibility|1
5654961|NCT00536380|19525687|P2|Overall Study|Did not meet protocol eligibility|0
5654962|NCT00536380|19525688|P1|Overall Study|Did not meet protocol eligibility|0
5654963|NCT00536380|19525686|P3|Overall Study|Noncompliance with protocol|2
5654964|NCT00536380|19525687|P2|Overall Study|Noncompliance with protocol|2
5654965|NCT00536380|19525688|P1|Overall Study|Noncompliance with protocol|3
5654966|NCT00536380|19525686|P3|Overall Study|Withdrawal related to study drug|2
5654967|NCT00536380|19525687|P2|Overall Study|Withdrawal related to study drug|5
5654968|NCT00536380|19525688|P1|Overall Study|Withdrawal related to study drug|7
5654969|NCT00536380|19525686|P3|Overall Study|Withdrawal unrelated to study drug|1
5654970|NCT00536380|19525687|P2|Overall Study|Withdrawal unrelated to study drug|0
5654971|NCT00536380|19525688|P1|Overall Study|Withdrawal unrelated to study drug|2
5654972|NCT00536380|19525686|P3|Overall Study|Lost to Follow-up|1
5654973|NCT00536380|19525687|P2|Overall Study|Lost to Follow-up|0
5654974|NCT00536380|19525688|P1|Overall Study|Lost to Follow-up|0
5654975|NCT00536380|19525686|P3|Overall Study|Adverse Event|2
5654976|NCT00536380|19525687|P2|Overall Study|Adverse Event|2
5654977|NCT00536380|19525688|P1|Overall Study|Adverse Event|0
5654978|NCT00536263|19525712|P3|Overall Study|Did not meet protocol eligibility|2
5654979|NCT00536263|19525713|P2|Overall Study|Did not meet protocol eligibility|2
5654980|NCT00536263|19525714|P1|Overall Study|Did not meet protocol eligibility|1
5654981|NCT00536263|19525712|P3|Overall Study|Noncompliance with protocol|1
5654982|NCT00536263|19525713|P2|Overall Study|Noncompliance with protocol|0
5654983|NCT00536263|19525714|P1|Overall Study|Noncompliance with protocol|0
5654984|NCT00536263|19525712|P3|Overall Study|Subject withdrew - treatment related|2
5654985|NCT00536263|19525713|P2|Overall Study|Subject withdrew - treatment related|3
5654986|NCT00536263|19525714|P1|Overall Study|Subject withdrew - treatment related|0
5654987|NCT00536263|19525712|P3|Overall Study|Subject withdrew - not treatment related|5
5654988|NCT00536263|19525713|P2|Overall Study|Subject withdrew - not treatment related|0
5654989|NCT00536263|19525714|P1|Overall Study|Subject withdrew - not treatment related|2
5654990|NCT00536263|19525712|P3|Overall Study|Lost to Follow-up|4
5654991|NCT00536263|19525713|P2|Overall Study|Lost to Follow-up|4
5654992|NCT00536263|19525714|P1|Overall Study|Lost to Follow-up|3
5654993|NCT00536263|19525712|P3|Overall Study|Adverse Event|7
5654994|NCT00536263|19525713|P2|Overall Study|Adverse Event|5
5654995|NCT00536263|19525714|P1|Overall Study|Adverse Event|5
5654996|NCT00536198|19525754|P2|Overall Study|Protocol Violation|1
5654997|NCT00536198|19525755|P1|Overall Study|Protocol Violation|0
5654998|NCT00536198|19525754|P2|Overall Study|Pregnancy|1
5654999|NCT00536198|19525755|P1|Overall Study|Pregnancy|1
5655000|NCT00536198|19525754|P2|Overall Study|Rescue|9
5655001|NCT00536198|19525755|P1|Overall Study|Rescue|3
5655002|NCT00536198|19525754|P2|Overall Study|Adverse Event|2
5655003|NCT00536198|19525755|P1|Overall Study|Adverse Event|2
5655004|NCT00536198|19525754|P2|Overall Study|Withdrawal by Subject|12
5655005|NCT00536198|19525755|P1|Overall Study|Withdrawal by Subject|16
5655006|NCT00536198|19525754|P2|Overall Study|Lost to Follow-up|14
5655007|NCT00536198|19525755|P1|Overall Study|Lost to Follow-up|15
5655008|NCT00536120|19525794|P2|Overall Study|Missed Study Visit|1
5655009|NCT00536120|19525795|P1|Overall Study|Missed Study Visit|0
5655010|NCT00536120|19525794|P2|Overall Study|Steroid Use|2
5655011|NCT00536120|19525795|P1|Overall Study|Steroid Use|0
5655012|NCT00536120|19525794|P2|Overall Study|Sponsor Decision Due to Lab Values|0
5655013|NCT00536120|19525795|P1|Overall Study|Sponsor Decision Due to Lab Values|1
5655014|NCT00536120|19525794|P2|Overall Study|Non-compliance|0
5655015|NCT00536120|19525795|P1|Overall Study|Non-compliance|1
5655016|NCT00536120|19525794|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
5655017|NCT00536120|19525795|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
5655018|NCT00536120|19525794|P2|Overall Study|Lost to Follow-up|0
5655019|NCT00536120|19525795|P1|Overall Study|Lost to Follow-up|1
5655020|NCT00536107|19525809|P2|Overall Study|Study Termination|4
5655021|NCT00536107|19525810|P1|Overall Study|Study Termination|2
5655022|NCT00536107|19525809|P2|Overall Study|Withdrawal by Subject|1
5655023|NCT00536107|19525810|P1|Overall Study|Withdrawal by Subject|0
5655024|NCT00536107|19525809|P2|Overall Study|Incorrect enrolment|0
5655025|NCT00536107|19525810|P1|Overall Study|Incorrect enrolment|1
5655026|NCT00536107|19525809|P2|Overall Study|Death|1
5655027|NCT00536107|19525810|P1|Overall Study|Death|5
5655028|NCT00535847|19525875|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
5655029|NCT00535847|19525876|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
5655030|NCT00535847|19525877|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
5655031|NCT00535847|19525875|P3|Overall Study|Non compliance|0
5655032|NCT00535847|19525876|P2|Overall Study|Non compliance|1
5655033|NCT00535847|19525877|P1|Overall Study|Non compliance|1
5655034|NCT00535847|19525875|P3|Overall Study|Adverse Event|2
5655035|NCT00535847|19525876|P2|Overall Study|Adverse Event|3
5655036|NCT00535847|19525877|P1|Overall Study|Adverse Event|5
5655037|NCT00535730|19526112|P2|Overall Study|Withdrawal by Subject|4
5655038|NCT00535730|19526113|P1|Overall Study|Withdrawal by Subject|0
5655039|NCT00535730|19526112|P2|Overall Study|Protocol Violation|0
5655040|NCT00535730|19526113|P1|Overall Study|Protocol Violation|1
5655041|NCT00535730|19526112|P2|Overall Study|Physician Decision|1
5655042|NCT00535730|19526113|P1|Overall Study|Physician Decision|0
5655043|NCT00535730|19526112|P2|Overall Study|Lost to Follow-up|1
5655044|NCT00535730|19526113|P1|Overall Study|Lost to Follow-up|0
5655045|NCT00535730|19526112|P2|Overall Study|Adverse Event|1
5655046|NCT00535730|19526113|P1|Overall Study|Adverse Event|1
5655047|NCT00535626|19526134|P1|Overall Study|Unable to return|2
5655048|NCT00535626|19526134|P1|Overall Study|Subject terminated|31
5655049|NCT00535626|19526134|P1|Overall Study|Removal/revision of study component|8
5655050|NCT00535626|19526134|P1|Overall Study|Withdrawal by Subject|20
5655051|NCT00535626|19526134|P1|Overall Study|Lost to Follow-up|29
5655052|NCT00535626|19526134|P1|Overall Study|Death|15
5655053|NCT00535496|19526174|P4|Overall Study|Not treated with sugammadex|0
5655054|NCT00535496|19526175|P3|Overall Study|Not treated with sugammadex|0
5655055|NCT00535496|19526176|P2|Overall Study|Not treated with sugammadex|1
5655056|NCT00535496|19526177|P1|Overall Study|Not treated with sugammadex|0
5655057|NCT00535496|19526174|P4|Overall Study|Lost to Follow-up|0
5655058|NCT00535496|19526175|P3|Overall Study|Lost to Follow-up|0
5655059|NCT00535496|19526176|P2|Overall Study|Lost to Follow-up|1
5655060|NCT00535496|19526177|P1|Overall Study|Lost to Follow-up|0
5655061|NCT00535405|19526197|P5|Overall Study|Withdrawal by Subject|8
5655062|NCT00535405|19526198|P4|Overall Study|Withdrawal by Subject|10
5655063|NCT00535405|19526199|P3|Overall Study|Withdrawal by Subject|10
5655064|NCT00535405|19526200|P2|Overall Study|Withdrawal by Subject|11
5655065|NCT00535405|19526201|P1|Overall Study|Withdrawal by Subject|5
5655066|NCT00535405|19526197|P5|Overall Study|Protocol Violation|0
5655067|NCT00535405|19526198|P4|Overall Study|Protocol Violation|1
5655068|NCT00535405|19526199|P3|Overall Study|Protocol Violation|2
5655069|NCT00535405|19526200|P2|Overall Study|Protocol Violation|2
5655070|NCT00535405|19526201|P1|Overall Study|Protocol Violation|2
5655071|NCT00535405|19526197|P5|Overall Study|Physician Decision|1
5655072|NCT00535405|19526198|P4|Overall Study|Physician Decision|1
5655073|NCT00535405|19526199|P3|Overall Study|Physician Decision|0
5655074|NCT00535405|19526200|P2|Overall Study|Physician Decision|2
5655075|NCT00535405|19526201|P1|Overall Study|Physician Decision|3
5655076|NCT00535405|19526197|P5|Overall Study|Lost to Follow-up|1
5655077|NCT00535405|19526198|P4|Overall Study|Lost to Follow-up|2
5655078|NCT00535405|19526199|P3|Overall Study|Lost to Follow-up|3
5655079|NCT00535405|19526200|P2|Overall Study|Lost to Follow-up|3
5655080|NCT00535405|19526201|P1|Overall Study|Lost to Follow-up|1
5655081|NCT00535405|19526197|P5|Overall Study|Adverse Event|6
5655082|NCT00535405|19526198|P4|Overall Study|Adverse Event|8
5655083|NCT00535405|19526199|P3|Overall Study|Adverse Event|3
5655084|NCT00535405|19526200|P2|Overall Study|Adverse Event|8
5655085|NCT00535405|19526201|P1|Overall Study|Adverse Event|6
5655086|NCT00535288|19526262|P5|Overall Study|Other|1
5655087|NCT00535288|19526263|P4|Overall Study|Other|2
5655088|NCT00535288|19526264|P3|Overall Study|Other|1
5655089|NCT00535288|19526265|P2|Overall Study|Other|1
5655090|NCT00535288|19526266|P1|Overall Study|Other|2
5655091|NCT00535288|19526262|P5|Overall Study|Unwilling to cooperate|4
5655092|NCT00535288|19526263|P4|Overall Study|Unwilling to cooperate|3
5655093|NCT00535288|19526264|P3|Overall Study|Unwilling to cooperate|3
5655094|NCT00535288|19526265|P2|Overall Study|Unwilling to cooperate|6
5655095|NCT00535288|19526266|P1|Overall Study|Unwilling to cooperate|6
5655096|NCT00535288|19526262|P5|Overall Study|Lack of Efficacy|7
5655097|NCT00535288|19526263|P4|Overall Study|Lack of Efficacy|4
5655098|NCT00535288|19526264|P3|Overall Study|Lack of Efficacy|4
5655099|NCT00535288|19526265|P2|Overall Study|Lack of Efficacy|3
5655100|NCT00535288|19526266|P1|Overall Study|Lack of Efficacy|26
5655101|NCT00535288|19526262|P5|Overall Study|Lost to Follow-up|0
5655102|NCT00535288|19526263|P4|Overall Study|Lost to Follow-up|0
5655103|NCT00535288|19526264|P3|Overall Study|Lost to Follow-up|0
5655104|NCT00535288|19526265|P2|Overall Study|Lost to Follow-up|3
5655105|NCT00535288|19526266|P1|Overall Study|Lost to Follow-up|0
5655106|NCT00535288|19526262|P5|Overall Study|Adverse Event|30
5655107|NCT00535288|19526263|P4|Overall Study|Adverse Event|20
5655108|NCT00535288|19526264|P3|Overall Study|Adverse Event|25
5655109|NCT00535288|19526265|P2|Overall Study|Adverse Event|19
5655110|NCT00535288|19526266|P1|Overall Study|Adverse Event|20
5655111|NCT00535262|19526343|P1|Overall Study|No funding|3
5655112|NCT00535236|19526357|P10|Overall Study|Withdrawal by Subject|2
5655113|NCT00535236|19526358|P9|Overall Study|Withdrawal by Subject|4
5655114|NCT00535236|19526359|P8|Overall Study|Withdrawal by Subject|0
5655115|NCT00535236|19526360|P7|Overall Study|Withdrawal by Subject|5
5655116|NCT00535236|19526361|P6|Overall Study|Withdrawal by Subject|1
5655117|NCT00535236|19526362|P5|Overall Study|Withdrawal by Subject|6
5655118|NCT00535236|19526363|P4|Overall Study|Withdrawal by Subject|1
5655119|NCT00535236|19526364|P3|Overall Study|Withdrawal by Subject|2
5655120|NCT00535236|19526365|P2|Overall Study|Withdrawal by Subject|0
5655121|NCT00535236|19526366|P1|Overall Study|Withdrawal by Subject|3
5655122|NCT00535236|19526357|P10|Overall Study|Protocol Violation|0
5655123|NCT00535236|19526358|P9|Overall Study|Protocol Violation|1
5655124|NCT00535236|19526359|P8|Overall Study|Protocol Violation|0
5655125|NCT00535236|19526360|P7|Overall Study|Protocol Violation|0
5655126|NCT00535236|19526361|P6|Overall Study|Protocol Violation|0
5655127|NCT00535236|19526362|P5|Overall Study|Protocol Violation|0
5655128|NCT00535236|19526363|P4|Overall Study|Protocol Violation|0
5655129|NCT00535236|19526364|P3|Overall Study|Protocol Violation|1
5655130|NCT00535236|19526365|P2|Overall Study|Protocol Violation|0
5655131|NCT00535236|19526366|P1|Overall Study|Protocol Violation|2
5655132|NCT00535236|19526357|P10|Overall Study|Physician Decision|0
5655133|NCT00535236|19526358|P9|Overall Study|Physician Decision|0
5655134|NCT00535236|19526359|P8|Overall Study|Physician Decision|0
5655135|NCT00535236|19526360|P7|Overall Study|Physician Decision|1
5655136|NCT00535236|19526361|P6|Overall Study|Physician Decision|0
5655137|NCT00535236|19526362|P5|Overall Study|Physician Decision|1
5655138|NCT00535236|19526363|P4|Overall Study|Physician Decision|0
5655139|NCT00535236|19526364|P3|Overall Study|Physician Decision|0
5655140|NCT00535236|19526365|P2|Overall Study|Physician Decision|0
5655141|NCT00535236|19526366|P1|Overall Study|Physician Decision|0
5655142|NCT00535236|19526357|P10|Overall Study|Lost to Follow-up|1
5655143|NCT00535236|19526358|P9|Overall Study|Lost to Follow-up|6
5655144|NCT00535236|19526359|P8|Overall Study|Lost to Follow-up|0
5655145|NCT00535236|19526360|P7|Overall Study|Lost to Follow-up|0
5655146|NCT00535236|19526361|P6|Overall Study|Lost to Follow-up|0
5655147|NCT00535236|19526362|P5|Overall Study|Lost to Follow-up|2
5655148|NCT00535236|19526363|P4|Overall Study|Lost to Follow-up|0
5655149|NCT00535236|19526364|P3|Overall Study|Lost to Follow-up|0
5655150|NCT00535236|19526365|P2|Overall Study|Lost to Follow-up|2
5655151|NCT00535236|19526366|P1|Overall Study|Lost to Follow-up|1
5655152|NCT00535236|19526357|P10|Overall Study|Adverse Event|1
5655153|NCT00535236|19526358|P9|Overall Study|Adverse Event|2
5655154|NCT00535236|19526359|P8|Overall Study|Adverse Event|1
5655155|NCT00535236|19526360|P7|Overall Study|Adverse Event|5
5655156|NCT00535236|19526361|P6|Overall Study|Adverse Event|0
5655157|NCT00535236|19526362|P5|Overall Study|Adverse Event|3
5655158|NCT00535236|19526363|P4|Overall Study|Adverse Event|3
5655159|NCT00535236|19526364|P3|Overall Study|Adverse Event|9
5655160|NCT00535236|19526365|P2|Overall Study|Adverse Event|0
5655161|NCT00535236|19526366|P1|Overall Study|Adverse Event|1
5655162|NCT00535223|19526426|P2|Overall Study|Withdrawal by Subject|1
5655163|NCT00535223|19526427|P1|Overall Study|Withdrawal by Subject|4
5655164|NCT00535145|19526435|P1|Phase II|Subject non-compliance|2
5655165|NCT00535145|19526435|P1|Phase II|Withdrawal by Subject|5
5655166|NCT00535145|19526435|P1|Phase II|Lost to Follow-up|5
5655167|NCT00535145|19526435|P1|Phase II|Lack of Efficacy|1
5655168|NCT00535145|19526435|P1|Phase II|Adverse Event|2
5655169|NCT00535145|19526435|P1|Phase I|(diagnosis)|3
5655170|NCT00535145|19526435|P1|Phase I|(PI decision)|1
5655171|NCT00535145|19526435|P1|Phase I|(protocol violation)|1
5655172|NCT00535145|19526435|P1|Phase I|(eligibility)|8
5655173|NCT00535145|19526435|P1|Phase I|Withdrawal by Subject|6
5655174|NCT00535145|19526435|P1|Phase I|Lost to Follow-up|7
5655175|NCT00535145|19526435|P1|Phase I|Adverse Event|3
5655176|NCT00535132|19526447|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
5655177|NCT00535132|19526448|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
5655178|NCT00535132|19526447|P2|Safety Analysis Set|Did Not Receive Study Medication|2
5655179|NCT00535132|19526448|P1|Safety Analysis Set|Did Not Receive Study Medication|2
5655180|NCT00534976|19526529|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
5655181|NCT00534976|19526530|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
5655182|NCT00534976|19526529|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
5655183|NCT00534976|19526530|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
5655184|NCT00534976|19526529|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
5655185|NCT00534976|19526530|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
5655186|NCT00534638|19526610|P2|Overall Study|Other|902
5655187|NCT00534638|19526611|P1|Overall Study|Other|1685
5655188|NCT00534638|19526610|P2|Overall Study|Lost to follow-up, complete vaccination|10757
5655189|NCT00534638|19526611|P1|Overall Study|Lost to follow-up, complete vaccination|4707
5655354|NCT00533897|19527190|P1|Long Term Extension (LTE)|Lost to Follow-up|0
5655190|NCT00534638|19526610|P2|Overall Study|Lost to follow-up,incomplete vaccination|117
5655191|NCT00534638|19526611|P1|Overall Study|Lost to follow-up,incomplete vaccination|83
5655192|NCT00534638|19526610|P2|Overall Study|Migrated/moved from study area|11
5655193|NCT00534638|19526611|P1|Overall Study|Migrated/moved from study area|13
5655194|NCT00534638|19526610|P2|Overall Study|Withdrawal by Subject|4
5655195|NCT00534638|19526611|P1|Overall Study|Withdrawal by Subject|3
5655196|NCT00534599|19526649|P2|Overall Study|Other|0
5655197|NCT00534599|19526650|P1|Overall Study|Other|7
5655198|NCT00534599|19526649|P2|Overall Study|Withdrawal by Subject|6
5655199|NCT00534599|19526650|P1|Overall Study|Withdrawal by Subject|4
5655200|NCT00534599|19526649|P2|Overall Study|Lost to Follow-up|14
5655201|NCT00534599|19526650|P1|Overall Study|Lost to Follow-up|11
5655202|NCT00534599|19526649|P2|Overall Study|Protocol Violation|3
5655203|NCT00534599|19526650|P1|Overall Study|Protocol Violation|1
5655204|NCT00534599|19526649|P2|Overall Study|Generalized anxiety disorder worsened|1
5655205|NCT00534599|19526650|P1|Overall Study|Generalized anxiety disorder worsened|0
5655206|NCT00534599|19526649|P2|Overall Study|Lack of Efficacy|1
5655207|NCT00534599|19526650|P1|Overall Study|Lack of Efficacy|0
5655208|NCT00534599|19526649|P2|Overall Study|Developed study-specific d/c criteria|0
5655209|NCT00534599|19526650|P1|Overall Study|Developed study-specific d/c criteria|5
5655210|NCT00534599|19526649|P2|Overall Study|Mis-randomization|2
5655211|NCT00534599|19526650|P1|Overall Study|Mis-randomization|2
5655212|NCT00534599|19526649|P2|Overall Study|Incorrect enrollment|1
5655213|NCT00534599|19526650|P1|Overall Study|Incorrect enrollment|2
5655214|NCT00534599|19526649|P2|Overall Study|Adverse Event|4
5655215|NCT00534599|19526650|P1|Overall Study|Adverse Event|25
5655216|NCT00534495|19526686|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
5655217|NCT00534495|19526687|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
5655218|NCT00534495|19526688|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
5655219|NCT00534495|19526686|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
5655220|NCT00534495|19526687|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
5655221|NCT00534495|19526688|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
5655222|NCT00534495|19526686|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
5655223|NCT00534495|19526687|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
5655224|NCT00534495|19526688|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
5655225|NCT00534495|19526686|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
5655226|NCT00534495|19526687|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
5655227|NCT00534495|19526688|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
5655228|NCT00534495|19526686|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
5655229|NCT00534495|19526687|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
5655230|NCT00534495|19526688|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
5655231|NCT00534495|19526686|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
5655232|NCT00534495|19526687|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
5655233|NCT00534495|19526688|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
5655234|NCT00534495|19526686|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
5655235|NCT00534495|19526687|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
5655236|NCT00534495|19526688|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
5655237|NCT00534495|19526686|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
5655238|NCT00534495|19526687|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
5655239|NCT00534495|19526688|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
5655240|NCT00534495|19526686|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
5655241|NCT00534495|19526687|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
5655242|NCT00534495|19526688|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
5655243|NCT00534404|19526726|P3|Overall Study|Lost to Follow-up|201
5655244|NCT00534404|19526727|P2|Overall Study|Lost to Follow-up|138
5655245|NCT00534404|19526728|P1|Overall Study|Lost to Follow-up|170
5655246|NCT00534404|19526726|P3|Overall Study|Removed by study staff|1
5655247|NCT00534404|19526727|P2|Overall Study|Removed by study staff|3
5655248|NCT00534404|19526728|P1|Overall Study|Removed by study staff|2
5655249|NCT00534404|19526726|P3|Overall Study|Withdrawal by Subject|38
5655250|NCT00534404|19526727|P2|Overall Study|Withdrawal by Subject|2
5655251|NCT00534404|19526728|P1|Overall Study|Withdrawal by Subject|8
5655252|NCT00534404|19526726|P3|Overall Study|Death|2
5655253|NCT00534404|19526727|P2|Overall Study|Death|0
5655254|NCT00534404|19526728|P1|Overall Study|Death|0
5655255|NCT00534352|19526759|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
5655256|NCT00534352|19526759|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
5655257|NCT00534352|19526759|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
5655258|NCT00534352|19526759|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
5655259|NCT00534352|19526759|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
5655260|NCT00534352|19526759|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
5655261|NCT00534313|19526803|P4|Long-term Period|Other|2
5655262|NCT00534313|19526804|P3|Long-term Period|Other|2
5655263|NCT00534313|19526805|P2|Long-term Period|Other|2
5655264|NCT00534313|19526806|P1|Long-term Period|Other|1
5655265|NCT00534313|19526803|P4|Long-term Period|Administrative reason by sponsor|18
5655266|NCT00534313|19526804|P3|Long-term Period|Administrative reason by sponsor|26
5655267|NCT00534313|19526805|P2|Long-term Period|Administrative reason by sponsor|15
5655268|NCT00534313|19526806|P1|Long-term Period|Administrative reason by sponsor|17
5655269|NCT00534313|19526803|P4|Long-term Period|Poor compliance/noncompliance|0
5655270|NCT00534313|19526804|P3|Long-term Period|Poor compliance/noncompliance|1
5655271|NCT00534313|19526805|P2|Long-term Period|Poor compliance/noncompliance|1
5655272|NCT00534313|19526806|P1|Long-term Period|Poor compliance/noncompliance|0
5655273|NCT00534313|19526803|P4|Long-term Period|No longer meets study criteria|0
5655274|NCT00534313|19526804|P3|Long-term Period|No longer meets study criteria|0
5655275|NCT00534313|19526805|P2|Long-term Period|No longer meets study criteria|1
5655276|NCT00534313|19526806|P1|Long-term Period|No longer meets study criteria|0
5655277|NCT00534313|19526803|P4|Long-term Period|Withdrawal by Subject|0
5655278|NCT00534313|19526804|P3|Long-term Period|Withdrawal by Subject|0
5655279|NCT00534313|19526805|P2|Long-term Period|Withdrawal by Subject|2
5655280|NCT00534313|19526806|P1|Long-term Period|Withdrawal by Subject|2
5655281|NCT00534313|19526803|P4|Long-term Period|Lost to Follow-up|0
5655282|NCT00534313|19526804|P3|Long-term Period|Lost to Follow-up|0
5655283|NCT00534313|19526805|P2|Long-term Period|Lost to Follow-up|2
5655284|NCT00534313|19526806|P1|Long-term Period|Lost to Follow-up|1
5655285|NCT00534313|19526803|P4|Long-term Period|Lack of Efficacy|12
5655286|NCT00534313|19526804|P3|Long-term Period|Lack of Efficacy|14
5655287|NCT00534313|19526805|P2|Long-term Period|Lack of Efficacy|10
5655288|NCT00534313|19526806|P1|Long-term Period|Lack of Efficacy|14
5655289|NCT00534313|19526803|P4|Long-term Period|Adverse Event|1
5655290|NCT00534313|19526804|P3|Long-term Period|Adverse Event|0
5655291|NCT00534313|19526805|P2|Long-term Period|Adverse Event|1
5655292|NCT00534313|19526806|P1|Long-term Period|Adverse Event|2
5655293|NCT00534313|19526803|P4|Short-term Period|Pregnancy|0
5655294|NCT00534313|19526804|P3|Short-term Period|Pregnancy|1
5655295|NCT00534313|19526805|P2|Short-term Period|Pregnancy|0
5655296|NCT00534313|19526806|P1|Short-term Period|Pregnancy|0
5655297|NCT00534313|19526803|P4|Short-term Period|Participant withdrew consent|2
5655298|NCT00534313|19526804|P3|Short-term Period|Participant withdrew consent|0
5655299|NCT00534313|19526805|P2|Short-term Period|Participant withdrew consent|0
5655300|NCT00534313|19526806|P1|Short-term Period|Participant withdrew consent|2
5655301|NCT00534313|19526803|P4|Short-term Period|Participant not meeting study criteria|1
5655302|NCT00534313|19526804|P3|Short-term Period|Participant not meeting study criteria|0
5655303|NCT00534313|19526805|P2|Short-term Period|Participant not meeting study criteria|0
5655304|NCT00534313|19526806|P1|Short-term Period|Participant not meeting study criteria|0
5655305|NCT00534313|19526803|P4|Short-term Period|Lack of Efficacy|3
5655306|NCT00534313|19526804|P3|Short-term Period|Lack of Efficacy|0
5655307|NCT00534313|19526805|P2|Short-term Period|Lack of Efficacy|4
5655308|NCT00534313|19526806|P1|Short-term Period|Lack of Efficacy|3
5655309|NCT00534313|19526803|P4|Short-term Period|Adverse Event|3
5655310|NCT00534313|19526804|P3|Short-term Period|Adverse Event|1
5655311|NCT00534313|19526805|P2|Short-term Period|Adverse Event|2
5655312|NCT00534313|19526806|P1|Short-term Period|Adverse Event|1
5655313|NCT00534248|19526901|P2|Overall Study|Withdrawal by Subject|255
5655314|NCT00534248|19526902|P1|Overall Study|Withdrawal by Subject|263
5655315|NCT00534248|19526901|P2|Overall Study|Protocol Violation|4
5655316|NCT00534248|19526902|P1|Overall Study|Protocol Violation|3
5655317|NCT00534248|19526901|P2|Overall Study|Physician Decision|7
5655318|NCT00534248|19526902|P1|Overall Study|Physician Decision|10
5655319|NCT00534248|19526901|P2|Overall Study|Other protocol specified criteria|3
5655320|NCT00534248|19526902|P1|Overall Study|Other protocol specified criteria|13
5655321|NCT00534248|19526901|P2|Overall Study|Lost to Follow-up|375
5655322|NCT00534248|19526902|P1|Overall Study|Lost to Follow-up|353
5655323|NCT00534248|19526901|P2|Overall Study|Adverse Event|29
5655324|NCT00534248|19526902|P1|Overall Study|Adverse Event|19
5655325|NCT00534105|19527072|P2|Overall Study|Lost to Follow-up|39
5655326|NCT00534105|19527073|P1|Overall Study|Lost to Follow-up|23
5655327|NCT00534092|19527087|P2|Overall Study|personal reasons/family concerns|0
5655328|NCT00534092|19527088|P1|Overall Study|personal reasons/family concerns|1
5655329|NCT00534092|19527087|P2|Overall Study|Lost to Follow-up|0
5655330|NCT00534092|19527088|P1|Overall Study|Lost to Follow-up|1
5655331|NCT00533949|19527126|P4|Overall Study|Withdrawal by Subject|1
5655332|NCT00533949|19527127|P3|Overall Study|Withdrawal by Subject|1
5655333|NCT00533949|19527128|P2|Overall Study|Withdrawal by Subject|2
5655334|NCT00533949|19527129|P1|Overall Study|Withdrawal by Subject|3
5655335|NCT00533949|19527126|P4|Overall Study|Protocol Violation|9
5655336|NCT00533949|19527127|P3|Overall Study|Protocol Violation|9
5655337|NCT00533949|19527128|P2|Overall Study|Protocol Violation|12
5655338|NCT00533949|19527129|P1|Overall Study|Protocol Violation|12
5655339|NCT00533897|19527183|P8|Long Term Extension (LTE)|Other|6
5655340|NCT00533897|19527184|P7|Long Term Extension (LTE)|Other|1
5655341|NCT00533897|19527185|P6|Long Term Extension (LTE)|Other|0
5655342|NCT00533897|19527186|P5|Long Term Extension (LTE)|Other|0
5655343|NCT00533897|19527187|P4|Long Term Extension (LTE)|Other|0
5655344|NCT00533897|19527188|P3|Long Term Extension (LTE)|Other|0
5655345|NCT00533897|19527189|P2|Long Term Extension (LTE)|Other|0
5655346|NCT00533897|19527190|P1|Long Term Extension (LTE)|Other|0
5655347|NCT00533897|19527183|P8|Long Term Extension (LTE)|Lost to Follow-up|1
5655348|NCT00533897|19527184|P7|Long Term Extension (LTE)|Lost to Follow-up|1
5655349|NCT00533897|19527185|P6|Long Term Extension (LTE)|Lost to Follow-up|0
5655350|NCT00533897|19527186|P5|Long Term Extension (LTE)|Lost to Follow-up|0
5655351|NCT00533897|19527187|P4|Long Term Extension (LTE)|Lost to Follow-up|0
5655352|NCT00533897|19527188|P3|Long Term Extension (LTE)|Lost to Follow-up|0
5655353|NCT00533897|19527189|P2|Long Term Extension (LTE)|Lost to Follow-up|0
5655355|NCT00533897|19527183|P8|Long Term Extension (LTE)|Pregnancy|2
5655356|NCT00533897|19527184|P7|Long Term Extension (LTE)|Pregnancy|0
5655357|NCT00533897|19527185|P6|Long Term Extension (LTE)|Pregnancy|0
5655358|NCT00533897|19527186|P5|Long Term Extension (LTE)|Pregnancy|0
5655359|NCT00533897|19527187|P4|Long Term Extension (LTE)|Pregnancy|0
5655360|NCT00533897|19527188|P3|Long Term Extension (LTE)|Pregnancy|0
5655361|NCT00533897|19527189|P2|Long Term Extension (LTE)|Pregnancy|0
5655362|NCT00533897|19527190|P1|Long Term Extension (LTE)|Pregnancy|0
5655363|NCT00533897|19527183|P8|Long Term Extension (LTE)|Adverse Event|5
5655364|NCT00533897|19527184|P7|Long Term Extension (LTE)|Adverse Event|2
5655365|NCT00533897|19527185|P6|Long Term Extension (LTE)|Adverse Event|0
5655366|NCT00533897|19527186|P5|Long Term Extension (LTE)|Adverse Event|0
5655367|NCT00533897|19527187|P4|Long Term Extension (LTE)|Adverse Event|0
5655368|NCT00533897|19527188|P3|Long Term Extension (LTE)|Adverse Event|0
5655369|NCT00533897|19527189|P2|Long Term Extension (LTE)|Adverse Event|0
5655370|NCT00533897|19527190|P1|Long Term Extension (LTE)|Adverse Event|0
5655371|NCT00533897|19527183|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
5655372|NCT00533897|19527184|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
5655373|NCT00533897|19527185|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
5655374|NCT00533897|19527186|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
5655375|NCT00533897|19527187|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
5655376|NCT00533897|19527188|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
5655377|NCT00533897|19527189|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
5655378|NCT00533897|19527190|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
5655379|NCT00533897|19527183|P8|Long Term Extension (LTE)|Lack of Efficacy|3
5655380|NCT00533897|19527184|P7|Long Term Extension (LTE)|Lack of Efficacy|5
5655381|NCT00533897|19527185|P6|Long Term Extension (LTE)|Lack of Efficacy|0
5655382|NCT00533897|19527186|P5|Long Term Extension (LTE)|Lack of Efficacy|0
5655383|NCT00533897|19527187|P4|Long Term Extension (LTE)|Lack of Efficacy|0
5655384|NCT00533897|19527188|P3|Long Term Extension (LTE)|Lack of Efficacy|0
5655385|NCT00533897|19527189|P2|Long Term Extension (LTE)|Lack of Efficacy|0
5655386|NCT00533897|19527190|P1|Long Term Extension (LTE)|Lack of Efficacy|0
5655387|NCT00533897|19527183|P8|Long Term Extension (LTE)|Death|3
5655388|NCT00533897|19527184|P7|Long Term Extension (LTE)|Death|1
5655389|NCT00533897|19527185|P6|Long Term Extension (LTE)|Death|0
5655390|NCT00533897|19527186|P5|Long Term Extension (LTE)|Death|0
5655391|NCT00533897|19527187|P4|Long Term Extension (LTE)|Death|0
5655392|NCT00533897|19527188|P3|Long Term Extension (LTE)|Death|0
5655393|NCT00533897|19527189|P2|Long Term Extension (LTE)|Death|0
5655394|NCT00533897|19527190|P1|Long Term Extension (LTE)|Death|0
5655395|NCT00533897|19527183|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
5655396|NCT00533897|19527184|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
5655397|NCT00533897|19527185|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
5655398|NCT00533897|19527186|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
5655399|NCT00533897|19527187|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
5655400|NCT00533897|19527188|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
5655401|NCT00533897|19527189|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
5655402|NCT00533897|19527190|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
5655403|NCT00533897|19527183|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5655404|NCT00533897|19527184|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5655405|NCT00533897|19527185|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
5655406|NCT00533897|19527186|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5655407|NCT00533897|19527187|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5655408|NCT00533897|19527188|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5655409|NCT00533897|19527189|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5655410|NCT00533897|19527190|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
5655411|NCT00533897|19527183|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5655412|NCT00533897|19527184|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5655413|NCT00533897|19527185|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
5655414|NCT00533897|19527186|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5655415|NCT00533897|19527187|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5655416|NCT00533897|19527188|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5655417|NCT00533897|19527189|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5655418|NCT00533897|19527190|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
5655419|NCT00533897|19527183|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5655420|NCT00533897|19527184|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5655421|NCT00533897|19527185|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5655422|NCT00533897|19527186|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5655423|NCT00533897|19527187|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5655424|NCT00533897|19527188|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
5655425|NCT00533897|19527189|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5655426|NCT00533897|19527190|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
5655427|NCT00533897|19527183|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5655428|NCT00533897|19527184|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5655429|NCT00533897|19527185|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5655430|NCT00533897|19527186|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5655431|NCT00533897|19527187|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5655432|NCT00533897|19527188|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
5655433|NCT00533897|19527189|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
5655434|NCT00533897|19527190|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
5655435|NCT00533897|19527183|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5655436|NCT00533897|19527184|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5655437|NCT00533897|19527185|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5655438|NCT00533897|19527186|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5655439|NCT00533897|19527187|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5655440|NCT00533897|19527188|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5655441|NCT00533897|19527189|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
5655442|NCT00533897|19527190|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
5655443|NCT00533897|19527183|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
5655444|NCT00533897|19527184|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
5655445|NCT00533897|19527185|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
5655446|NCT00533897|19527186|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
5655447|NCT00533897|19527187|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
5655448|NCT00533897|19527188|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
5655449|NCT00533897|19527189|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
5655450|NCT00533897|19527190|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
5655451|NCT00533897|19527183|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5655452|NCT00533897|19527184|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5655453|NCT00533897|19527185|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5655454|NCT00533897|19527186|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5655455|NCT00533897|19527187|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5655456|NCT00533897|19527188|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5655457|NCT00533897|19527189|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
5655458|NCT00533897|19527190|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
5655459|NCT00533897|19527183|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
5655460|NCT00533897|19527184|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
5655461|NCT00533897|19527185|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
5655462|NCT00533897|19527186|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
5655463|NCT00533897|19527187|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
5655464|NCT00533897|19527188|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
5655465|NCT00533897|19527189|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
5655466|NCT00533897|19527190|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
5655467|NCT00533897|19527183|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5655468|NCT00533897|19527184|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5655469|NCT00533897|19527185|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5655470|NCT00533897|19527186|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5655471|NCT00533897|19527187|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5655472|NCT00533897|19527188|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5655473|NCT00533897|19527189|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
5655474|NCT00533897|19527190|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
5655475|NCT00533897|19527183|P8|Lead-in (LI) Period 1|Adverse Event|0
5655476|NCT00533897|19527184|P7|Lead-in (LI) Period 1|Adverse Event|0
5655477|NCT00533897|19527185|P6|Lead-in (LI) Period 1|Adverse Event|0
5655478|NCT00533897|19527186|P5|Lead-in (LI) Period 1|Adverse Event|0
5655479|NCT00533897|19527187|P4|Lead-in (LI) Period 1|Adverse Event|0
5655480|NCT00533897|19527188|P3|Lead-in (LI) Period 1|Adverse Event|0
5655481|NCT00533897|19527189|P2|Lead-in (LI) Period 1|Adverse Event|0
5655482|NCT00533897|19527190|P1|Lead-in (LI) Period 1|Adverse Event|1
5655483|NCT00533845|19527330|P2|Overall Study|Physician Decision|0
5655484|NCT00533845|19527331|P1|Overall Study|Physician Decision|1
5655485|NCT00533702|19527339|P2|Overall Study|Found ineligible after randomization|1
5655486|NCT00533702|19527340|P1|Overall Study|Found ineligible after randomization|2
5655487|NCT00533702|19527339|P2|Overall Study|Withdrawal by Subject|1
5655488|NCT00533702|19527340|P1|Overall Study|Withdrawal by Subject|3
5655489|NCT00533507|19527371|P1|Overall Study|Withdrawal by Subject|1
5655490|NCT00533273|19527416|P2|Open-label|Withdrawal by Subject|0
5655491|NCT00533273|19527417|P1|Open-label|Withdrawal by Subject|6
5655492|NCT00533273|19527416|P2|Double-blind|Withdrew consent|2
5655493|NCT00533273|19527417|P1|Double-blind|Withdrew consent|0
5655494|NCT00532948|19527468|P3|Overall Study|Failure to return|0
5655495|NCT00532948|19527469|P2|Overall Study|Failure to return|1
5655496|NCT00532948|19527470|P1|Overall Study|Failure to return|0
5655497|NCT00532948|19527468|P3|Overall Study|Violation of selection criteria at entry|0
5655498|NCT00532948|19527469|P2|Overall Study|Violation of selection criteria at entry|1
5655499|NCT00532948|19527470|P1|Overall Study|Violation of selection criteria at entry|0
5655500|NCT00532948|19527468|P3|Overall Study|Death|4
5655501|NCT00532948|19527469|P2|Overall Study|Death|3
5655502|NCT00532948|19527470|P1|Overall Study|Death|3
5655503|NCT00532948|19527468|P3|Overall Study|Protocol Violation|0
5655504|NCT00532948|19527469|P2|Overall Study|Protocol Violation|0
5655505|NCT00532948|19527470|P1|Overall Study|Protocol Violation|1
5655506|NCT00532935|19527502|P2|Overall Study|Protocol Specific Criteria|15
5655507|NCT00532935|19527503|P1|Overall Study|Protocol Specific Criteria|11
5655508|NCT00532935|19527502|P2|Overall Study|Withdrawal by Subject|9
5655509|NCT00532935|19527503|P1|Overall Study|Withdrawal by Subject|10
5655510|NCT00532935|19527502|P2|Overall Study|Protocol Violation|2
5655511|NCT00532935|19527503|P1|Overall Study|Protocol Violation|4
5655512|NCT00532935|19527502|P2|Overall Study|Pregnancy|0
5655513|NCT00532935|19527503|P1|Overall Study|Pregnancy|1
5655514|NCT00532935|19527502|P2|Overall Study|Physician Decision|5
5655515|NCT00532935|19527503|P1|Overall Study|Physician Decision|4
5655516|NCT00532935|19527502|P2|Overall Study|Lost to Follow-up|6
5655517|NCT00532935|19527503|P1|Overall Study|Lost to Follow-up|10
5655518|NCT00532935|19527502|P2|Overall Study|Lack of Efficacy|3
5655519|NCT00532935|19527503|P1|Overall Study|Lack of Efficacy|0
5655520|NCT00532935|19527502|P2|Overall Study|Adverse Event|12
5655521|NCT00532935|19527503|P1|Overall Study|Adverse Event|11
5655522|NCT00532883|19527521|P4|Overall Study|Early Study Termination|4
5655523|NCT00532883|19527522|P3|Overall Study|Early Study Termination|1
5655524|NCT00532883|19527523|P2|Overall Study|Early Study Termination|4
5655525|NCT00532883|19527524|P1|Overall Study|Early Study Termination|4
5655526|NCT00532883|19527521|P4|Overall Study|Subject was Nonadherent|0
5655527|NCT00532883|19527522|P3|Overall Study|Subject was Nonadherent|1
5655528|NCT00532883|19527523|P2|Overall Study|Subject was Nonadherent|1
5655529|NCT00532883|19527524|P1|Overall Study|Subject was Nonadherent|0
5655530|NCT00532883|19527521|P4|Overall Study|Withdrawal by Subject|0
5655531|NCT00532883|19527522|P3|Overall Study|Withdrawal by Subject|1
5655532|NCT00532883|19527523|P2|Overall Study|Withdrawal by Subject|1
5655533|NCT00532883|19527524|P1|Overall Study|Withdrawal by Subject|0
5655534|NCT00532883|19527521|P4|Overall Study|Lost to Follow-up|0
5655535|NCT00532883|19527522|P3|Overall Study|Lost to Follow-up|1
5655536|NCT00532883|19527523|P2|Overall Study|Lost to Follow-up|1
5655537|NCT00532883|19527524|P1|Overall Study|Lost to Follow-up|1
5655538|NCT00532883|19527521|P4|Overall Study|Adverse Event|1
5655539|NCT00532883|19527522|P3|Overall Study|Adverse Event|0
5655540|NCT00532883|19527523|P2|Overall Study|Adverse Event|0
5655541|NCT00532883|19527524|P1|Overall Study|Adverse Event|1
5655542|NCT00532779|19527537|P3|Overall Study|Drug noncompliance, moved, other|29
5655543|NCT00532779|19527538|P2|Overall Study|Drug noncompliance, moved, other|23
5655544|NCT00532779|19527539|P1|Overall Study|Drug noncompliance, moved, other|14
5655545|NCT00532779|19527537|P3|Overall Study|Death|0
5655546|NCT00532779|19527538|P2|Overall Study|Death|1
5655547|NCT00532779|19527539|P1|Overall Study|Death|0
5655548|NCT00532779|19527537|P3|Overall Study|Pregnancy|3
5655549|NCT00532779|19527538|P2|Overall Study|Pregnancy|5
5655550|NCT00532779|19527539|P1|Overall Study|Pregnancy|2
5655551|NCT00532779|19527537|P3|Overall Study|Protocol Violation|7
5655552|NCT00532779|19527538|P2|Overall Study|Protocol Violation|9
5655553|NCT00532779|19527539|P1|Overall Study|Protocol Violation|5
5655554|NCT00532779|19527537|P3|Overall Study|Lack of Efficacy|40
5655555|NCT00532779|19527538|P2|Overall Study|Lack of Efficacy|12
5655556|NCT00532779|19527539|P1|Overall Study|Lack of Efficacy|12
5655557|NCT00532779|19527537|P3|Overall Study|Withdrawal by Subject|90
5655558|NCT00532779|19527538|P2|Overall Study|Withdrawal by Subject|60
5655559|NCT00532779|19527539|P1|Overall Study|Withdrawal by Subject|63
5655560|NCT00532779|19527537|P3|Overall Study|Lost to Follow-up|66
5655561|NCT00532779|19527538|P2|Overall Study|Lost to Follow-up|65
5655562|NCT00532779|19527539|P1|Overall Study|Lost to Follow-up|76
5655563|NCT00532779|19527537|P3|Overall Study|Adverse Event|56
5655564|NCT00532779|19527538|P2|Overall Study|Adverse Event|112
5655565|NCT00532779|19527539|P1|Overall Study|Adverse Event|122
5655566|NCT00532493|19527600|P2|Overall Study|Contraindicative Medication|0
5655567|NCT00532493|19527601|P1|Overall Study|Contraindicative Medication|1
5655568|NCT00532493|19527600|P2|Overall Study|Subject Moved Away|1
5655569|NCT00532493|19527601|P1|Overall Study|Subject Moved Away|3
5655570|NCT00532493|19527600|P2|Overall Study|Protocol Deviation|0
5655571|NCT00532493|19527601|P1|Overall Study|Protocol Deviation|1
5655572|NCT00532493|19527600|P2|Overall Study|Adverse Event|5
5655573|NCT00532493|19527601|P1|Overall Study|Adverse Event|6
5655574|NCT00532493|19527600|P2|Overall Study|Physician Decision|6
5655575|NCT00532493|19527601|P1|Overall Study|Physician Decision|1
5655576|NCT00532493|19527600|P2|Overall Study|Withdrawal by Subject|9
5655577|NCT00532493|19527601|P1|Overall Study|Withdrawal by Subject|7
5655578|NCT00532493|19527600|P2|Overall Study|Lost to Follow-up|7
5655579|NCT00532493|19527601|P1|Overall Study|Lost to Follow-up|10
5655580|NCT00532493|19527600|P2|Overall Study|Death|1
5655581|NCT00532493|19527601|P1|Overall Study|Death|1
5655582|NCT00532441|19527635|P2|Overall Study|Death|0
5655583|NCT00532441|19527636|P1|Overall Study|Death|1
5655584|NCT00532298|19527651|P6|Overall Study|Lost to Follow-up|1
5655585|NCT00532298|19527652|P5|Overall Study|Lost to Follow-up|0
5655586|NCT00532298|19527653|P4|Overall Study|Lost to Follow-up|0
5655587|NCT00532298|19527654|P3|Overall Study|Lost to Follow-up|1
5655588|NCT00532298|19527655|P2|Overall Study|Lost to Follow-up|1
5655589|NCT00532298|19527656|P1|Overall Study|Lost to Follow-up|1
5655590|NCT00532298|19527651|P6|Overall Study|Adverse Event|1
5655591|NCT00532298|19527652|P5|Overall Study|Adverse Event|1
5655592|NCT00532298|19527653|P4|Overall Study|Adverse Event|0
5655593|NCT00532298|19527654|P3|Overall Study|Adverse Event|0
5655594|NCT00532298|19527655|P2|Overall Study|Adverse Event|0
5655595|NCT00532298|19527656|P1|Overall Study|Adverse Event|1
5655596|NCT00532259|19527736|P1|Overall Study|Protocol Violation|1
5655597|NCT00532259|19527736|P1|Overall Study|Physician Decision|3
5655598|NCT00532259|19527736|P1|Overall Study|Lost to Follow-up|3
5655599|NCT00532259|19527736|P1|Overall Study|Lack of Efficacy|21
5655600|NCT00532259|19527736|P1|Overall Study|Death|1
5655601|NCT00532259|19527736|P1|Overall Study|Adverse Event|1
5655602|NCT00532259|19527736|P1|Overall Study|Withdrawal by Subject|2
5655603|NCT00532155|19527743|P2|Overall Study|Did not receive study medication|6
5655604|NCT00532155|19527744|P1|Overall Study|Did not receive study medication|2
5655605|NCT00532155|19527743|P2|Overall Study|Study termination stop further treatment|0
5655606|NCT00532155|19527744|P1|Overall Study|Study termination stop further treatment|4
5655607|NCT00532155|19527743|P2|Overall Study|Study terminated by sponsor|0
5655608|NCT00532155|19527744|P1|Overall Study|Study terminated by sponsor|1
5655609|NCT00532155|19527743|P2|Overall Study|Study stopped|0
5655610|NCT00532155|19527744|P1|Overall Study|Study stopped|1
5655611|NCT00532155|19527743|P2|Overall Study|Had brain metastasis, was mis-randomized|0
5655612|NCT00532155|19527744|P1|Overall Study|Had brain metastasis, was mis-randomized|1
5655613|NCT00532155|19527743|P2|Overall Study|Progressive disease (by incorrect scan)|1
5655614|NCT00532155|19527744|P1|Overall Study|Progressive disease (by incorrect scan)|0
5655615|NCT00532155|19527743|P2|Overall Study|Promotor ended study|0
5655616|NCT00532155|19527744|P1|Overall Study|Promotor ended study|1
5655617|NCT00532155|19527743|P2|Overall Study|Occurence of a secondary cancer|1
5655618|NCT00532155|19527744|P1|Overall Study|Occurence of a secondary cancer|0
5655619|NCT00532155|19527743|P2|Overall Study|Occurence of a second cancer|1
5655620|NCT00532155|19527744|P1|Overall Study|Occurence of a second cancer|0
5655621|NCT00532155|19527743|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
5655622|NCT00532155|19527744|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
5655623|NCT00532155|19527743|P2|Overall Study|Moved|0
5655624|NCT00532155|19527744|P1|Overall Study|Moved|1
5655625|NCT00532155|19527743|P2|Overall Study|Consent withdrawn|7
5655626|NCT00532155|19527744|P1|Overall Study|Consent withdrawn|5
5655627|NCT00532155|19527743|P2|Overall Study|Withdrawal by Subject|44
5655628|NCT00532155|19527744|P1|Overall Study|Withdrawal by Subject|23
5655629|NCT00532155|19527743|P2|Overall Study|Physician Decision|15
5655630|NCT00532155|19527744|P1|Overall Study|Physician Decision|16
5655631|NCT00532155|19527743|P2|Overall Study|Lost to Follow-up|0
5655632|NCT00532155|19527744|P1|Overall Study|Lost to Follow-up|2
5655633|NCT00532155|19527743|P2|Overall Study|Protocol Violation|3
5655634|NCT00532155|19527744|P1|Overall Study|Protocol Violation|1
5655635|NCT00532155|19527743|P2|Overall Study|Lack of Efficacy|255
5655636|NCT00532155|19527744|P1|Overall Study|Lack of Efficacy|332
5655637|NCT00532155|19527743|P2|Overall Study|Adverse Event|123
5655638|NCT00532155|19527744|P1|Overall Study|Adverse Event|66
5655639|NCT00532129|19527758|P1|Follow-up Period|Other|6
5655640|NCT00532129|19527758|P1|Follow-up Period|Lost to Follow-up|1
5655641|NCT00532129|19527758|P1|Follow-up Period|Disease progression|57
5655642|NCT00532129|19527758|P1|Follow-up Period|Adverse event/Serious adverse event|1
5655643|NCT00532129|19527758|P1|Treatment Period|Other|5
5655644|NCT00532129|19527758|P1|Treatment Period|Protocol Violation|1
5655645|NCT00532129|19527758|P1|Treatment Period|Disease progression|3
5655646|NCT00532129|19527758|P1|Treatment Period|Physician Decision|15
5655647|NCT00532129|19527758|P1|Treatment Period|Adverse event/Serious adverse event|25
5655648|NCT00531960|19527778|P2|Overall Study|Other|10
5655649|NCT00531960|19527779|P1|Overall Study|Other|4
5655650|NCT00531960|19527778|P2|Overall Study|Refused Treatment|6
5655651|NCT00531960|19527779|P1|Overall Study|Refused Treatment|5
5655652|NCT00531960|19527778|P2|Overall Study|Violation of Selection Criteria|0
5655653|NCT00531960|19527779|P1|Overall Study|Violation of Selection Criteria|2
5655654|NCT00531960|19527778|P2|Overall Study|Lack of Efficacy|41
5655655|NCT00531960|19527779|P1|Overall Study|Lack of Efficacy|42
5655656|NCT00531960|19527778|P2|Overall Study|Death|2
5655657|NCT00531960|19527779|P1|Overall Study|Death|3
5655658|NCT00531960|19527778|P2|Overall Study|Adverse Event|4
5655659|NCT00531960|19527779|P1|Overall Study|Adverse Event|5
5655660|NCT00531947|19527797|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
5655661|NCT00531947|19527798|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
5655662|NCT00531947|19527797|P2|Overall Study|Non-Compliance|7
5655663|NCT00531947|19527798|P1|Overall Study|Non-Compliance|4
5655664|NCT00531947|19527797|P2|Overall Study|Protocol Violation|1
5655665|NCT00531947|19527798|P1|Overall Study|Protocol Violation|2
5655666|NCT00531947|19527797|P2|Overall Study|Withdrawal by Subject|19
5655667|NCT00531947|19527798|P1|Overall Study|Withdrawal by Subject|14
5655668|NCT00531947|19527797|P2|Overall Study|Lost to Follow-up|9
5655669|NCT00531947|19527798|P1|Overall Study|Lost to Follow-up|12
5655670|NCT00531947|19527797|P2|Overall Study|Adverse Event|10
5655671|NCT00531947|19527798|P1|Overall Study|Adverse Event|5
5655672|NCT00531934|19527842|P2|Overall Study|Other|2
5655673|NCT00531934|19527843|P1|Overall Study|Other|2
5655674|NCT00531934|19527842|P2|Overall Study|Withdrawal by Subject|1
5655675|NCT00531934|19527843|P1|Overall Study|Withdrawal by Subject|1
5655676|NCT00531934|19527842|P2|Overall Study|Death|10
5655677|NCT00531934|19527843|P1|Overall Study|Death|7
5655678|NCT00531934|19527842|P2|Overall Study|Progression|42
5655679|NCT00531934|19527843|P1|Overall Study|Progression|52
5655680|NCT00531934|19527842|P2|Overall Study|Adverse Event|8
5655681|NCT00531934|19527843|P1|Overall Study|Adverse Event|4
5655682|NCT00531752|19527971|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
5655683|NCT00531752|19527972|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
5655684|NCT00531752|19527973|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
5655685|NCT00531752|19527974|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
5655770|NCT00531284|19528161|P2|Overall Study|Withdrawal by Subject|0
5655686|NCT00531752|19527971|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
5655687|NCT00531752|19527972|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
5655688|NCT00531752|19527973|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
5655689|NCT00531752|19527974|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
5655690|NCT00531752|19527971|P4|Second Double-blind Intervention Period|Other|0
5655691|NCT00531752|19527972|P3|Second Double-blind Intervention Period|Other|0
5655692|NCT00531752|19527973|P2|Second Double-blind Intervention Period|Other|1
5655693|NCT00531752|19527974|P1|Second Double-blind Intervention Period|Other|1
5655694|NCT00531752|19527971|P4|Second Double-blind Intervention Period|Adverse Event|0
5655695|NCT00531752|19527972|P3|Second Double-blind Intervention Period|Adverse Event|0
5655696|NCT00531752|19527973|P2|Second Double-blind Intervention Period|Adverse Event|1
5655697|NCT00531752|19527974|P1|Second Double-blind Intervention Period|Adverse Event|1
5655698|NCT00531752|19527971|P4|First Double-blind Intervention Period|Randomized but not treated|0
5655699|NCT00531752|19527972|P3|First Double-blind Intervention Period|Randomized but not treated|0
5655700|NCT00531752|19527973|P2|First Double-blind Intervention Period|Randomized but not treated|0
5655701|NCT00531752|19527974|P1|First Double-blind Intervention Period|Randomized but not treated|1
5655702|NCT00531752|19527971|P4|First Double-blind Intervention Period|Lost to Follow-up|1
5655703|NCT00531752|19527972|P3|First Double-blind Intervention Period|Lost to Follow-up|1
5655704|NCT00531752|19527973|P2|First Double-blind Intervention Period|Lost to Follow-up|0
5655705|NCT00531752|19527974|P1|First Double-blind Intervention Period|Lost to Follow-up|0
5655706|NCT00531752|19527971|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
5655707|NCT00531752|19527972|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
5655708|NCT00531752|19527973|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
5655709|NCT00531752|19527974|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
5655710|NCT00531752|19527971|P4|First Double-blind Intervention Period|Other|0
5655711|NCT00531752|19527972|P3|First Double-blind Intervention Period|Other|4
5655712|NCT00531752|19527973|P2|First Double-blind Intervention Period|Other|4
5655713|NCT00531752|19527974|P1|First Double-blind Intervention Period|Other|1
5655714|NCT00531752|19527971|P4|First Double-blind Intervention Period|Adverse Event|1
5655715|NCT00531752|19527972|P3|First Double-blind Intervention Period|Adverse Event|1
5655716|NCT00531752|19527973|P2|First Double-blind Intervention Period|Adverse Event|0
5655717|NCT00531752|19527974|P1|First Double-blind Intervention Period|Adverse Event|2
5655718|NCT00531479|19528085|P2|Overall Study|Did not receive treatment|3
5655719|NCT00531479|19528086|P1|Overall Study|Did not receive treatment|2
5655720|NCT00531479|19528085|P2|Overall Study|Withdrawal by Subject|6
5655721|NCT00531479|19528086|P1|Overall Study|Withdrawal by Subject|6
5655722|NCT00531479|19528085|P2|Overall Study|Other|1
5655723|NCT00531479|19528086|P1|Overall Study|Other|0
5655724|NCT00531479|19528085|P2|Overall Study|Lost to Follow-up|2
5655725|NCT00531479|19528086|P1|Overall Study|Lost to Follow-up|0
5655726|NCT00531479|19528085|P2|Overall Study|Death|71
5655727|NCT00531479|19528086|P1|Overall Study|Death|68
5655728|NCT00531427|19528117|P2|Overall Study|Administrative|9
5655729|NCT00531427|19528118|P1|Overall Study|Administrative|4
5655730|NCT00531427|19528117|P2|Overall Study|Lack of Efficacy|39
5655731|NCT00531427|19528118|P1|Overall Study|Lack of Efficacy|14
5655732|NCT00531427|19528117|P2|Overall Study|Lost to Follow-up|3
5655733|NCT00531427|19528118|P1|Overall Study|Lost to Follow-up|4
5655734|NCT00531427|19528117|P2|Overall Study|Adverse Event|30
5655735|NCT00531427|19528118|P1|Overall Study|Adverse Event|44
5655736|NCT00531427|19528117|P2|Overall Study|Withdrawal by Subject|13
5655737|NCT00531427|19528118|P1|Overall Study|Withdrawal by Subject|7
5655738|NCT00531284|19528146|P17|Overall Study|Other|0
5655739|NCT00531284|19528147|P16|Overall Study|Other|0
5655740|NCT00531284|19528148|P15|Overall Study|Other|1
5655741|NCT00531284|19528149|P14|Overall Study|Other|0
5655742|NCT00531284|19528150|P13|Overall Study|Other|0
5655743|NCT00531284|19528151|P12|Overall Study|Other|2
5655744|NCT00531284|19528152|P11|Overall Study|Other|0
5655745|NCT00531284|19528153|P10|Overall Study|Other|1
5655746|NCT00531284|19528154|P9|Overall Study|Other|2
5655747|NCT00531284|19528155|P8|Overall Study|Other|0
5655748|NCT00531284|19528156|P7|Overall Study|Other|0
5655749|NCT00531284|19528157|P6|Overall Study|Other|1
5655750|NCT00531284|19528158|P5|Overall Study|Other|2
5655751|NCT00531284|19528159|P4|Overall Study|Other|10
5655752|NCT00531284|19528160|P3|Overall Study|Other|0
5655753|NCT00531284|19528161|P2|Overall Study|Other|0
5655754|NCT00531284|19528162|P1|Overall Study|Other|1
5655755|NCT00531284|19528146|P17|Overall Study|Withdrawal by Subject|1
5655756|NCT00531284|19528147|P16|Overall Study|Withdrawal by Subject|1
5655757|NCT00531284|19528148|P15|Overall Study|Withdrawal by Subject|0
5655758|NCT00531284|19528149|P14|Overall Study|Withdrawal by Subject|1
5655759|NCT00531284|19528150|P13|Overall Study|Withdrawal by Subject|0
5655760|NCT00531284|19528151|P12|Overall Study|Withdrawal by Subject|3
5655761|NCT00531284|19528152|P11|Overall Study|Withdrawal by Subject|0
5655762|NCT00531284|19528153|P10|Overall Study|Withdrawal by Subject|0
5655763|NCT00531284|19528154|P9|Overall Study|Withdrawal by Subject|0
5655764|NCT00531284|19528155|P8|Overall Study|Withdrawal by Subject|0
5655765|NCT00531284|19528156|P7|Overall Study|Withdrawal by Subject|0
5655766|NCT00531284|19528157|P6|Overall Study|Withdrawal by Subject|0
5655767|NCT00531284|19528158|P5|Overall Study|Withdrawal by Subject|0
5655768|NCT00531284|19528159|P4|Overall Study|Withdrawal by Subject|4
5655769|NCT00531284|19528160|P3|Overall Study|Withdrawal by Subject|0
5655771|NCT00531284|19528162|P1|Overall Study|Withdrawal by Subject|1
5655772|NCT00531284|19528146|P17|Overall Study|Adverse Event|2
5655773|NCT00531284|19528147|P16|Overall Study|Adverse Event|0
5655774|NCT00531284|19528148|P15|Overall Study|Adverse Event|1
5655775|NCT00531284|19528149|P14|Overall Study|Adverse Event|1
5655776|NCT00531284|19528150|P13|Overall Study|Adverse Event|0
5655777|NCT00531284|19528151|P12|Overall Study|Adverse Event|5
5655778|NCT00531284|19528152|P11|Overall Study|Adverse Event|0
5655779|NCT00531284|19528153|P10|Overall Study|Adverse Event|0
5655780|NCT00531284|19528154|P9|Overall Study|Adverse Event|3
5655781|NCT00531284|19528155|P8|Overall Study|Adverse Event|2
5655782|NCT00531284|19528156|P7|Overall Study|Adverse Event|3
5655783|NCT00531284|19528157|P6|Overall Study|Adverse Event|2
5655784|NCT00531284|19528158|P5|Overall Study|Adverse Event|0
5655785|NCT00531284|19528159|P4|Overall Study|Adverse Event|7
5655786|NCT00531284|19528160|P3|Overall Study|Adverse Event|1
5655787|NCT00531284|19528161|P2|Overall Study|Adverse Event|1
5655788|NCT00531284|19528162|P1|Overall Study|Adverse Event|0
5655789|NCT00531284|19528146|P17|Overall Study|Progressive Disease|5
5655790|NCT00531284|19528147|P16|Overall Study|Progressive Disease|11
5655791|NCT00531284|19528148|P15|Overall Study|Progressive Disease|2
5655792|NCT00531284|19528149|P14|Overall Study|Progressive Disease|1
5655793|NCT00531284|19528150|P13|Overall Study|Progressive Disease|2
5655794|NCT00531284|19528151|P12|Overall Study|Progressive Disease|14
5655795|NCT00531284|19528152|P11|Overall Study|Progressive Disease|3
5655796|NCT00531284|19528153|P10|Overall Study|Progressive Disease|3
5655797|NCT00531284|19528154|P9|Overall Study|Progressive Disease|6
5655798|NCT00531284|19528155|P8|Overall Study|Progressive Disease|8
5655799|NCT00531284|19528156|P7|Overall Study|Progressive Disease|3
5655800|NCT00531284|19528157|P6|Overall Study|Progressive Disease|4
5655801|NCT00531284|19528158|P5|Overall Study|Progressive Disease|4
5655802|NCT00531284|19528159|P4|Overall Study|Progressive Disease|42
5655803|NCT00531284|19528160|P3|Overall Study|Progressive Disease|5
5655804|NCT00531284|19528161|P2|Overall Study|Progressive Disease|3
5655805|NCT00531284|19528162|P1|Overall Study|Progressive Disease|1
5655806|NCT00531206|19528312|P1|Overall Study|including non-related adverse events|8
5655807|NCT00531206|19528312|P1|Overall Study|Lost to Follow-up|5
5655808|NCT00531206|19528312|P1|Overall Study|Lack of Efficacy|2
5655809|NCT00531206|19528312|P1|Overall Study|Adverse Event related|5
5655810|NCT00531050|19528342|P6|Part 2: Period 3|Abnormal test procedure|1
5655811|NCT00531050|19528343|P5|Part 2: Period 3|Abnormal test procedure|0
5655812|NCT00531050|19528344|P4|Part 2: Period 3|Abnormal test procedure|0
5655813|NCT00531050|19528345|P3|Part 2: Period 3|Abnormal test procedure|0
5655814|NCT00531050|19528346|P2|Part 2: Period 3|Abnormal test procedure|0
5655815|NCT00531050|19528347|P1|Part 2: Period 3|Abnormal test procedure|1
5655816|NCT00531050|19528342|P6|Part 2: Period 1|Adverse Event|1
5655817|NCT00531050|19528343|P5|Part 2: Period 1|Adverse Event|0
5655818|NCT00531050|19528344|P4|Part 2: Period 1|Adverse Event|0
5655819|NCT00531050|19528345|P3|Part 2: Period 1|Adverse Event|0
5655820|NCT00531050|19528346|P2|Part 2: Period 1|Adverse Event|0
5655821|NCT00531050|19528347|P1|Part 2: Period 1|Adverse Event|0
5655822|NCT00531050|19528342|P6|Part 1: Period 3|Adverse Event|0
5655823|NCT00531050|19528343|P5|Part 1: Period 3|Adverse Event|0
5655824|NCT00531050|19528344|P4|Part 1: Period 3|Adverse Event|0
5655825|NCT00531050|19528345|P3|Part 1: Period 3|Adverse Event|0
5655826|NCT00531050|19528346|P2|Part 1: Period 3|Adverse Event|0
5655827|NCT00531050|19528347|P1|Part 1: Period 3|Adverse Event|1
5655828|NCT00531050|19528342|P6|Part 1: Period 1|Protocol Deviation|0
5655829|NCT00531050|19528343|P5|Part 1: Period 1|Protocol Deviation|0
5655830|NCT00531050|19528344|P4|Part 1: Period 1|Protocol Deviation|1
5655831|NCT00531050|19528345|P3|Part 1: Period 1|Protocol Deviation|0
5655832|NCT00531050|19528346|P2|Part 1: Period 1|Protocol Deviation|0
5655833|NCT00531050|19528347|P1|Part 1: Period 1|Protocol Deviation|0
5655834|NCT00531050|19528342|P6|Part 1: Period 1|Adverse Event|0
5655835|NCT00531050|19528343|P5|Part 1: Period 1|Adverse Event|0
5655836|NCT00531050|19528344|P4|Part 1: Period 1|Adverse Event|0
5655837|NCT00531050|19528345|P3|Part 1: Period 1|Adverse Event|0
5655838|NCT00531050|19528346|P2|Part 1: Period 1|Adverse Event|1
5655839|NCT00531050|19528347|P1|Part 1: Period 1|Adverse Event|0
5655840|NCT00531011|19528376|P2|Overall Study|Physician Decision|3
5655841|NCT00531011|19528377|P1|Overall Study|Physician Decision|0
5655842|NCT00531011|19528376|P2|Overall Study|Lost to Follow-up|0
5655843|NCT00531011|19528377|P1|Overall Study|Lost to Follow-up|1
5655844|NCT00531011|19528376|P2|Overall Study|Death|0
5655845|NCT00531011|19528377|P1|Overall Study|Death|1
5655846|NCT00531011|19528376|P2|Overall Study|Withdrawal by Subject|4
5655847|NCT00531011|19528377|P1|Overall Study|Withdrawal by Subject|2
5655848|NCT00530946|19528423|P4|Overall Study|Noncompliance|0
5655849|NCT00530946|19528424|P3|Overall Study|Noncompliance|0
5655850|NCT00530946|19528425|P2|Overall Study|Noncompliance|0
5655851|NCT00530946|19528426|P1|Overall Study|Noncompliance|1
5655852|NCT00530946|19528423|P4|Overall Study|Protocol Violation|1
5655853|NCT00530946|19528424|P3|Overall Study|Protocol Violation|0
5655854|NCT00530946|19528425|P2|Overall Study|Protocol Violation|0
5655855|NCT00530946|19528426|P1|Overall Study|Protocol Violation|0
5655856|NCT00530946|19528423|P4|Overall Study|Adverse Event|1
5655857|NCT00530946|19528424|P3|Overall Study|Adverse Event|1
5655858|NCT00530946|19528425|P2|Overall Study|Adverse Event|2
5655859|NCT00530946|19528426|P1|Overall Study|Adverse Event|1
5655860|NCT00530920|19528479|P3|Overall Study|Withdrawal by Subject|1
5655861|NCT00530920|19528480|P2|Overall Study|Withdrawal by Subject|0
5655862|NCT00530920|19528481|P1|Overall Study|Withdrawal by Subject|0
5655863|NCT00530920|19528479|P3|Overall Study|Adverse Event|3
5655864|NCT00530920|19528480|P2|Overall Study|Adverse Event|0
5655865|NCT00530920|19528481|P1|Overall Study|Adverse Event|0
5655866|NCT00530920|19528479|P3|Overall Study|Randomized but not treated|0
5655867|NCT00530920|19528480|P2|Overall Study|Randomized but not treated|2
5655868|NCT00530920|19528481|P1|Overall Study|Randomized but not treated|0
5655869|NCT00530894|19528541|P4|Overall Study|Alive and censored prior to 1 year|0
5655870|NCT00530894|19528542|P3|Overall Study|Alive and censored prior to 1 year|0
5655871|NCT00530894|19528543|P2|Overall Study|Alive and censored prior to 1 year|0
5655872|NCT00530894|19528544|P1|Overall Study|Alive and censored prior to 1 year|2
5655873|NCT00530894|19528541|P4|Overall Study|Withdrawal by Subject|5
5655874|NCT00530894|19528542|P3|Overall Study|Withdrawal by Subject|0
5655875|NCT00530894|19528543|P2|Overall Study|Withdrawal by Subject|23
5655876|NCT00530894|19528544|P1|Overall Study|Withdrawal by Subject|1
5655877|NCT00530894|19528541|P4|Overall Study|Lost to Follow-up|0
5655878|NCT00530894|19528542|P3|Overall Study|Lost to Follow-up|0
5655879|NCT00530894|19528543|P2|Overall Study|Lost to Follow-up|3
5655880|NCT00530894|19528544|P1|Overall Study|Lost to Follow-up|1
5655881|NCT00530894|19528541|P4|Overall Study|Death|89
5655882|NCT00530894|19528542|P3|Overall Study|Death|55
5655883|NCT00530894|19528543|P2|Overall Study|Death|89
5655884|NCT00530894|19528544|P1|Overall Study|Death|84
5655885|NCT00530855|19528572|P1|Overall Study|Other reason for premature termination|17
5655886|NCT00530855|19528572|P1|Overall Study|Lost to Follow-up|9
5655887|NCT00530855|19528572|P1|Overall Study|Unsatisfactory compliance of subject|11
5655888|NCT00530855|19528572|P1|Overall Study|Protocol Violation|3
5655889|NCT00530855|19528572|P1|Overall Study|Non Fatal Non Serious AE|12
5655890|NCT00530855|19528572|P1|Overall Study|Non Fatal Serious AE|7
5655891|NCT00530855|19528572|P1|Overall Study|Fatal Serious AE|3
5655892|NCT00530855|19528572|P1|Overall Study|Withdrawal by Subject|30
5655893|NCT00530855|19528572|P1|Overall Study|Lack of Efficacy|20
5655894|NCT00530842|19528581|P2|Period 2|Individual different reasons|0
5655895|NCT00530842|19528582|P1|Period 2|Individual different reasons|2
5655896|NCT00530842|19528581|P2|Period 2|Withdrawal by Subject|2
5655897|NCT00530842|19528582|P1|Period 2|Withdrawal by Subject|1
5655898|NCT00530842|19528581|P2|Period 2|Protocol Violation|0
5655899|NCT00530842|19528582|P1|Period 2|Protocol Violation|1
5655900|NCT00530842|19528581|P2|Period 2|Lost to Follow-up|4
5655901|NCT00530842|19528582|P1|Period 2|Lost to Follow-up|0
5655902|NCT00530842|19528581|P2|Period 2|Lack of Efficacy|0
5655903|NCT00530842|19528582|P1|Period 2|Lack of Efficacy|1
5655904|NCT00530842|19528581|P2|Period 2|Adverse Event|3
5655905|NCT00530842|19528582|P1|Period 2|Adverse Event|3
5655906|NCT00530842|19528581|P2|Period 1|Individual different reasons|3
5655907|NCT00530842|19528582|P1|Period 1|Individual different reasons|2
5655908|NCT00530842|19528581|P2|Period 1|Withdrawal by Subject|3
5655909|NCT00530842|19528582|P1|Period 1|Withdrawal by Subject|2
5655910|NCT00530842|19528581|P2|Period 1|Protocol Violation|1
5655911|NCT00530842|19528582|P1|Period 1|Protocol Violation|2
5655912|NCT00530842|19528581|P2|Period 1|Lack of Efficacy|1
5655913|NCT00530842|19528582|P1|Period 1|Lack of Efficacy|1
5655914|NCT00530842|19528581|P2|Period 1|Adverse Event|3
5655915|NCT00530842|19528582|P1|Period 1|Adverse Event|7
5655916|NCT00530842|19528581|P2|Overall Study|Individual different reasons|3
5655917|NCT00530842|19528582|P1|Overall Study|Individual different reasons|4
5655918|NCT00530842|19528581|P2|Overall Study|Withdrawal by Subject|5
5655919|NCT00530842|19528582|P1|Overall Study|Withdrawal by Subject|4
5655920|NCT00530842|19528581|P2|Overall Study|Protocol Violation|2
5655921|NCT00530842|19528582|P1|Overall Study|Protocol Violation|3
5655922|NCT00530842|19528581|P2|Overall Study|Lost to Follow-up|4
5655923|NCT00530842|19528582|P1|Overall Study|Lost to Follow-up|0
5655924|NCT00530842|19528581|P2|Overall Study|Lack of Efficacy|1
5655925|NCT00530842|19528582|P1|Overall Study|Lack of Efficacy|2
5655926|NCT00530842|19528581|P2|Overall Study|Adverse Event|6
5655927|NCT00530842|19528582|P1|Overall Study|Adverse Event|10
5655928|NCT00530816|19528709|P3|Overall Study|Withdrawal by Subject|6
5655929|NCT00530816|19528710|P2|Overall Study|Withdrawal by Subject|2
5655930|NCT00530816|19528711|P1|Overall Study|Withdrawal by Subject|1
5655931|NCT00530816|19528709|P3|Overall Study|Other|4
5655932|NCT00530816|19528710|P2|Overall Study|Other|3
5655933|NCT00530816|19528711|P1|Overall Study|Other|3
5655934|NCT00530816|19528709|P3|Overall Study|Adverse Event|7
5655935|NCT00530816|19528710|P2|Overall Study|Adverse Event|13
5655936|NCT00530816|19528711|P1|Overall Study|Adverse Event|6
5655937|NCT00530816|19528709|P3|Overall Study|Progressive Disease|24
5655938|NCT00530816|19528710|P2|Overall Study|Progressive Disease|24
5655939|NCT00530816|19528711|P1|Overall Study|Progressive Disease|16
5655940|NCT00530790|19528754|P1|Overall Study|Physician Decision|1
5655941|NCT00530790|19528754|P1|Overall Study|Withdrawal by Subject|2
5655942|NCT00530790|19528754|P1|Overall Study|Adverse Event|2
5655943|NCT00530777|19528776|P2|Overall Study|Unable to adhere to visit schedule|1
5655944|NCT00530777|19528777|P1|Overall Study|Unable to adhere to visit schedule|5
5655945|NCT00530777|19528776|P2|Overall Study|Withdrawal by Subject|1
5655946|NCT00530777|19528777|P1|Overall Study|Withdrawal by Subject|0
5655947|NCT00530777|19528776|P2|Overall Study|Physician Decision|0
5655948|NCT00530777|19528777|P1|Overall Study|Physician Decision|1
5655949|NCT00530777|19528776|P2|Overall Study|Death|2
5655950|NCT00530777|19528777|P1|Overall Study|Death|1
5655951|NCT00530777|19528776|P2|Overall Study|Lost to Follow-up|1
5655952|NCT00530777|19528777|P1|Overall Study|Lost to Follow-up|0
5655953|NCT00530712|19528834|P1|12 Month Follow-up Visit|Death|9
5655954|NCT00530712|19528834|P1|12 Month Follow-up Visit|Lost to Follow-up|7
5655955|NCT00530712|19528834|P1|12 Month Follow-up Visit|Missed Visit|3
5655956|NCT00530712|19528834|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
5655957|NCT00530712|19528834|P1|6 Month Follow-up Visit|Death|2
5655958|NCT00530712|19528834|P1|6 Month Follow-up Visit|Lost to Follow-up|3
5655959|NCT00530712|19528834|P1|6 Month Follow-up Visit|Missed Visit|3
5655960|NCT00530712|19528834|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
5655961|NCT00530712|19528834|P1|30 Day Follow-up Visit|Missed Visit|5
5655962|NCT00530712|19528834|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
5655963|NCT00530621|19528857|P2|Overall Study|Not Treated Due to PD Prior to Dosing|0
5655964|NCT00530621|19528858|P1|Overall Study|Not Treated Due to PD Prior to Dosing|1
5655965|NCT00530621|19528857|P2|Overall Study|Death|6
5655966|NCT00530621|19528858|P1|Overall Study|Death|3
5655967|NCT00530621|19528857|P2|Overall Study|Subject Decision|7
5655968|NCT00530621|19528858|P1|Overall Study|Subject Decision|4
5655969|NCT00530621|19528857|P2|Overall Study|Sponsor Decision|15
5655970|NCT00530621|19528858|P1|Overall Study|Sponsor Decision|12
5655971|NCT00530621|19528857|P2|Overall Study|Progressive Disease (PD)|40
5655972|NCT00530621|19528858|P1|Overall Study|Progressive Disease (PD)|47
5655973|NCT00530621|19528857|P2|Overall Study|Physician Decision|4
5655974|NCT00530621|19528858|P1|Overall Study|Physician Decision|2
5655975|NCT00530621|19528857|P2|Overall Study|Adverse Event|8
5655976|NCT00530621|19528858|P1|Overall Study|Adverse Event|11
5655977|NCT00530504|19528879|P1|Overall Study|Exited study due to other reasons|33
5655978|NCT00530504|19528879|P1|Overall Study|Withdrawal by Subject|39
5655979|NCT00530504|19528879|P1|Overall Study|Lost to Follow-up|26
5655980|NCT00530504|19528879|P1|Overall Study|Death|54
5655981|NCT00530439|19528885|P2|Overall Study|Severe malformation/abortion|3
5655982|NCT00530439|19528886|P1|Overall Study|Severe malformation/abortion|0
5655983|NCT00530439|19528885|P2|Overall Study|Twin pregnancy|2
5655984|NCT00530439|19528886|P1|Overall Study|Twin pregnancy|0
5655985|NCT00530439|19528885|P2|Overall Study|Misclassification|0
5655986|NCT00530439|19528886|P1|Overall Study|Misclassification|2
5655987|NCT00530439|19528885|P2|Overall Study|Missed abortion|4
5655988|NCT00530439|19528886|P1|Overall Study|Missed abortion|1
5655989|NCT00530439|19528885|P2|Overall Study|Withdraw|14
5655990|NCT00530439|19528886|P1|Overall Study|Withdraw|18
5655991|NCT00530439|19528885|P2|Overall Study|GDM|3
5655992|NCT00530439|19528886|P1|Overall Study|GDM|9
5655993|NCT00530348|19528894|P2|Overall Study|Noncompliance with inclusion criterion 3|1
5655994|NCT00530348|19528895|P1|Overall Study|Noncompliance with inclusion criterion 3|0
5655995|NCT00530348|19528894|P2|Overall Study|Randomised in error|0
5655996|NCT00530348|19528895|P1|Overall Study|Randomised in error|1
5655997|NCT00530348|19528894|P2|Overall Study|Withdrawal by Subject|12
5655998|NCT00530348|19528895|P1|Overall Study|Withdrawal by Subject|12
5655999|NCT00530348|19528894|P2|Overall Study|Pregnancy|0
5656000|NCT00530348|19528895|P1|Overall Study|Pregnancy|1
5656001|NCT00530348|19528894|P2|Overall Study|Physician Decision|2
5656002|NCT00530348|19528895|P1|Overall Study|Physician Decision|1
5656003|NCT00530348|19528894|P2|Overall Study|Lost to Follow-up|2
5656004|NCT00530348|19528895|P1|Overall Study|Lost to Follow-up|0
5656005|NCT00530348|19528894|P2|Overall Study|Lack of Efficacy|0
5656006|NCT00530348|19528895|P1|Overall Study|Lack of Efficacy|2
5656007|NCT00530348|19528894|P2|Overall Study|Death|1
5656008|NCT00530348|19528895|P1|Overall Study|Death|0
5656009|NCT00530348|19528894|P2|Overall Study|Adverse Event|1
5656010|NCT00530348|19528895|P1|Overall Study|Adverse Event|5
5656011|NCT00530335|19528911|P1|Overall Study|Physician Decision|1
5656012|NCT00530335|19528911|P1|Overall Study|Withdrawal by Subject|1
5656013|NCT00530335|19528911|P1|Overall Study|Protocol Violation|1
5656014|NCT00530335|19528911|P1|Overall Study|Adverse Event|3
5656015|NCT00530270|19528928|P2|Overall Study|Protocol Violation|0
5656016|NCT00530270|19528929|P1|Overall Study|Protocol Violation|1
5656017|NCT00530257|19528943|P1|Overall Study|Lost to Follow-up|1
5656018|NCT00530218|19528971|P1|Overall Study|Death|12
5656019|NCT00530218|19528971|P1|Overall Study|CMV Not Detected|13
5656020|NCT00530088|19528978|P1|Overall Study|Other Not Specified|2
5656021|NCT00530088|19528978|P1|Overall Study|Physician Decision|4
5656022|NCT00530088|19528978|P1|Overall Study|Disease Progression|4
5656023|NCT00530075|19528983|P1|Overall Study|Withdrawal by Subject|1
5656024|NCT00530075|19528983|P1|Overall Study|Protocol Violation|1
5656025|NCT00530075|19528983|P1|Overall Study|Lack of Efficacy|3
5656026|NCT00530075|19528983|P1|Overall Study|Death|1
5656027|NCT00530075|19528983|P1|Overall Study|Adverse Event|1
5656028|NCT00530023|19528996|P2|Overall Study|Withdrawal by Subject|1
5656029|NCT00530023|19528997|P1|Overall Study|Withdrawal by Subject|0
5656030|NCT00529958|19529014|P3|5-Year Follow-up|Withdrawal by Subject|0
5656031|NCT00529958|19529015|P2|5-Year Follow-up|Withdrawal by Subject|0
5656032|NCT00529958|19529016|P1|5-Year Follow-up|Withdrawal by Subject|1
5656033|NCT00529958|19529014|P3|5-Year Follow-up|Lost to Follow-up|1
5656034|NCT00529958|19529015|P2|5-Year Follow-up|Lost to Follow-up|3
5656035|NCT00529958|19529016|P1|5-Year Follow-up|Lost to Follow-up|2
5656036|NCT00529958|19529014|P3|2-Year Follow-up|Withdrawal by Subject|0
5656037|NCT00529958|19529015|P2|2-Year Follow-up|Withdrawal by Subject|0
5656038|NCT00529958|19529016|P1|2-Year Follow-up|Withdrawal by Subject|3
5656039|NCT00529958|19529014|P3|2-Year Follow-up|Lost to Follow-up|2
5656040|NCT00529958|19529015|P2|2-Year Follow-up|Lost to Follow-up|2
5656041|NCT00529958|19529016|P1|2-Year Follow-up|Lost to Follow-up|1
5656042|NCT00529802|19529057|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
5656043|NCT00529802|19529057|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
5656044|NCT00529802|19529057|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
5656045|NCT00529802|19529057|P1|Evaluable for Primary Endpoint|Death|1
5656046|NCT00529802|19529057|P1|Evaluable for Primary Endpoint|Adverse Event|2
5656047|NCT00529802|19529057|P1|Evaluable for Primary Endpoint|Worsening performance status|2
5656048|NCT00529802|19529057|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
5656049|NCT00529789|19529063|P1|Study Period IV|Lost to Follow-up|3
5656050|NCT00529789|19529063|P1|Study Period IV|Lack of Efficacy|1
5656051|NCT00529789|19529063|P1|Study Period IV|Adverse Event|1
5656052|NCT00529789|19529063|P1|Study Period IV|Parent/Caregiver Decision|1
5656053|NCT00529789|19529063|P1|Study Period II/III|Lost to Follow-up|3
5656054|NCT00529789|19529063|P1|Study Period II/III|Physician Decision|3
5656055|NCT00529789|19529063|P1|Study Period II/III|Protocol Violation|3
5656056|NCT00529789|19529063|P1|Study Period II/III|Withdrawal by Subject|1
5656057|NCT00529789|19529063|P1|Study Period II/III|Lack of Efficacy|2
5656058|NCT00529789|19529063|P1|Study Period II/III|Adverse Event|3
5656059|NCT00529789|19529063|P1|Study Period II/III|Parent/Caregiver Decision|9
5656060|NCT00529763|19529088|P3|Overall Study|Patient Withdrew Consent|2
5656061|NCT00529763|19529089|P2|Overall Study|Patient Withdrew Consent|3
5656062|NCT00529763|19529090|P1|Overall Study|Patient Withdrew Consent|2
5656063|NCT00529763|19529088|P3|Overall Study|Study Drug Toxicity|1
5656064|NCT00529763|19529089|P2|Overall Study|Study Drug Toxicity|6
5656065|NCT00529763|19529090|P1|Overall Study|Study Drug Toxicity|1
5656066|NCT00529763|19529088|P3|Overall Study|Stem Cell Transplant|0
5656067|NCT00529763|19529089|P2|Overall Study|Stem Cell Transplant|3
5656068|NCT00529763|19529090|P1|Overall Study|Stem Cell Transplant|0
5656069|NCT00529763|19529088|P3|Overall Study|Lost to Follow-up|1
5656070|NCT00529763|19529089|P2|Overall Study|Lost to Follow-up|1
5656071|NCT00529763|19529090|P1|Overall Study|Lost to Follow-up|0
5656072|NCT00529763|19529088|P3|Overall Study|Disease Progression|1
5656073|NCT00529763|19529089|P2|Overall Study|Disease Progression|16
5656074|NCT00529763|19529090|P1|Overall Study|Disease Progression|6
5656075|NCT00529763|19529088|P3|Overall Study|Death|1
5656076|NCT00529763|19529089|P2|Overall Study|Death|1
5656077|NCT00529763|19529090|P1|Overall Study|Death|0
5656078|NCT00529763|19529088|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
5656079|NCT00529763|19529089|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
5656080|NCT00529763|19529090|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
5656081|NCT00529659|19529128|P2|Overall Study|Withdrawal by Subject|6
5656082|NCT00529659|19529129|P1|Overall Study|Withdrawal by Subject|1
5656083|NCT00529659|19529128|P2|Overall Study|Protocol Violation|6
5656084|NCT00529659|19529129|P1|Overall Study|Protocol Violation|2
5656085|NCT00529659|19529128|P2|Overall Study|Physician Decision|2
5656086|NCT00529659|19529129|P1|Overall Study|Physician Decision|0
5656087|NCT00529659|19529128|P2|Overall Study|Lost to Follow-up|2
5656088|NCT00529659|19529129|P1|Overall Study|Lost to Follow-up|0
5656089|NCT00529659|19529128|P2|Overall Study|Adverse Event|7
5656090|NCT00529659|19529129|P1|Overall Study|Adverse Event|8
5656091|NCT00529633|19529147|P2|Overall Study|Withdrawal by Subject|1
5656092|NCT00529633|19529148|P1|Overall Study|Withdrawal by Subject|1
5656093|NCT00529568|19529160|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
5656094|NCT00529568|19529161|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
5656095|NCT00529568|19529162|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
5656096|NCT00529568|19529160|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
5656097|NCT00529568|19529161|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
5656098|NCT00529568|19529162|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
5656099|NCT00529568|19529160|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
5656100|NCT00529568|19529161|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
5656101|NCT00529568|19529162|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
5656102|NCT00529568|19529160|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
5656103|NCT00529568|19529161|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
5656104|NCT00529568|19529162|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
5656105|NCT00529568|19529160|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
5656106|NCT00529568|19529161|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
5656107|NCT00529568|19529162|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
5656108|NCT00529568|19529160|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
5656109|NCT00529568|19529161|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
5656110|NCT00529568|19529162|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
5656111|NCT00529568|19529160|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
5656112|NCT00529568|19529161|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
5656113|NCT00529568|19529162|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
5656114|NCT00529568|19529160|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
5656115|NCT00529568|19529161|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
5656116|NCT00529568|19529162|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
5656117|NCT00529568|19529160|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
5656118|NCT00529568|19529161|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
5656119|NCT00529568|19529162|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
5656120|NCT00529568|19529160|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
5656121|NCT00529568|19529161|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
5656122|NCT00529568|19529162|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
5656123|NCT00529568|19529160|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
5656124|NCT00529568|19529161|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
5656125|NCT00529568|19529162|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
5656126|NCT00529542|19529225|P2|Overall Study|Lost to Follow-up|1
5656127|NCT00529542|19529226|P1|Overall Study|Lost to Follow-up|0
5656128|NCT00529542|19529225|P2|Overall Study|Withdrawal by Subject|0
5656129|NCT00529542|19529226|P1|Overall Study|Withdrawal by Subject|1
5656130|NCT00529529|19529269|P3|Overall Study|Administrative problems|3
5656131|NCT00529529|19529270|P2|Overall Study|Administrative problems|0
5656132|NCT00529529|19529271|P1|Overall Study|Administrative problems|1
5656133|NCT00529529|19529269|P3|Overall Study|Abnormal test procedure result(s)|0
5656134|NCT00529529|19529270|P2|Overall Study|Abnormal test procedure result(s)|0
5656135|NCT00529529|19529271|P1|Overall Study|Abnormal test procedure result(s)|1
5656136|NCT00529529|19529269|P3|Overall Study|Death|0
5656137|NCT00529529|19529270|P2|Overall Study|Death|0
5656138|NCT00529529|19529271|P1|Overall Study|Death|2
5656139|NCT00529529|19529269|P3|Overall Study|Unsatisfactory therapeutic effect|2
5656140|NCT00529529|19529270|P2|Overall Study|Unsatisfactory therapeutic effect|2
5656141|NCT00529529|19529271|P1|Overall Study|Unsatisfactory therapeutic effect|2
5656142|NCT00529529|19529269|P3|Overall Study|Lost to Follow-up|1
5656143|NCT00529529|19529270|P2|Overall Study|Lost to Follow-up|3
5656144|NCT00529529|19529271|P1|Overall Study|Lost to Follow-up|5
5656145|NCT00529529|19529269|P3|Overall Study|Protocol deviation|5
5656146|NCT00529529|19529270|P2|Overall Study|Protocol deviation|12
5656147|NCT00529529|19529271|P1|Overall Study|Protocol deviation|8
5656148|NCT00529529|19529269|P3|Overall Study|Subject withdrew consent|12
5656149|NCT00529529|19529270|P2|Overall Study|Subject withdrew consent|9
5656150|NCT00529529|19529271|P1|Overall Study|Subject withdrew consent|12
5656151|NCT00529529|19529269|P3|Overall Study|Adverse Event|8
5656152|NCT00529529|19529270|P2|Overall Study|Adverse Event|17
5656153|NCT00529529|19529271|P1|Overall Study|Adverse Event|12
5656154|NCT00529516|19529330|P3|Overall Study|Lost to Follow-up|1
5656155|NCT00529516|19529331|P2|Overall Study|Lost to Follow-up|0
5656156|NCT00529516|19529332|P1|Overall Study|Lost to Follow-up|0
5656157|NCT00529516|19529330|P3|Overall Study|Withdrawal by Subject|0
5656158|NCT00529516|19529331|P2|Overall Study|Withdrawal by Subject|1
5656159|NCT00529516|19529332|P1|Overall Study|Withdrawal by Subject|1
5656160|NCT00529516|19529330|P3|Overall Study|Adverse Event|0
5656161|NCT00529516|19529331|P2|Overall Study|Adverse Event|1
5656162|NCT00529516|19529332|P1|Overall Study|Adverse Event|2
5656163|NCT00529451|19529417|P4|Overall Study|Administrative problems|2
5656164|NCT00529451|19529418|P3|Overall Study|Administrative problems|0
5656165|NCT00529451|19529419|P2|Overall Study|Administrative problems|1
5656166|NCT00529451|19529420|P1|Overall Study|Administrative problems|1
5656167|NCT00529451|19529417|P4|Overall Study|Protocol deviation|1
5656168|NCT00529451|19529418|P3|Overall Study|Protocol deviation|4
5656169|NCT00529451|19529419|P2|Overall Study|Protocol deviation|1
5656170|NCT00529451|19529420|P1|Overall Study|Protocol deviation|1
5656171|NCT00529451|19529417|P4|Overall Study|Lost to Follow-up|4
5656172|NCT00529451|19529418|P3|Overall Study|Lost to Follow-up|4
5656173|NCT00529451|19529419|P2|Overall Study|Lost to Follow-up|7
5656174|NCT00529451|19529420|P1|Overall Study|Lost to Follow-up|4
5656175|NCT00529451|19529417|P4|Overall Study|Unsatisfactory therapeutic response|4
5656176|NCT00529451|19529418|P3|Overall Study|Unsatisfactory therapeutic response|5
5656177|NCT00529451|19529419|P2|Overall Study|Unsatisfactory therapeutic response|2
5656178|NCT00529451|19529420|P1|Overall Study|Unsatisfactory therapeutic response|6
5656179|NCT00529451|19529417|P4|Overall Study|Adverse Event|8
5656180|NCT00529451|19529418|P3|Overall Study|Adverse Event|14
5656181|NCT00529451|19529419|P2|Overall Study|Adverse Event|16
5656182|NCT00529451|19529420|P1|Overall Study|Adverse Event|9
5656183|NCT00529451|19529417|P4|Overall Study|Subject withdrew consent|12
5656184|NCT00529451|19529418|P3|Overall Study|Subject withdrew consent|13
5656185|NCT00529451|19529419|P2|Overall Study|Subject withdrew consent|21
5656186|NCT00529451|19529420|P1|Overall Study|Subject withdrew consent|16
5656187|NCT00529399|19529447|P3|Overall Study|Non-compliant|0
5656188|NCT00529399|19529448|P2|Overall Study|Non-compliant|1
5656189|NCT00529399|19529449|P1|Overall Study|Non-compliant|0
5656190|NCT00529399|19529447|P3|Overall Study|Withdrawal by Subject|1
5656191|NCT00529399|19529448|P2|Overall Study|Withdrawal by Subject|0
5656192|NCT00529399|19529449|P1|Overall Study|Withdrawal by Subject|1
5656193|NCT00529399|19529447|P3|Overall Study|Lost to Follow-up|1
5656194|NCT00529399|19529448|P2|Overall Study|Lost to Follow-up|0
5656195|NCT00529399|19529449|P1|Overall Study|Lost to Follow-up|1
5656196|NCT00529386|19529457|P1|Overall Study|Lost to Follow-up|1
5656197|NCT00529373|19529463|P2|Second Extension Study|Status Missing|5
5656198|NCT00529373|19529464|P1|Second Extension Study|Status Missing|5
5656199|NCT00529373|19529463|P2|Second Extension Study|Withdrawal by Subject|75
5656200|NCT00529373|19529464|P1|Second Extension Study|Withdrawal by Subject|97
5656201|NCT00529373|19529463|P2|Second Extension Study|Protocol Violation|1
5656202|NCT00529373|19529464|P1|Second Extension Study|Protocol Violation|2
5656203|NCT00529373|19529463|P2|Second Extension Study|Physician Decision|26
5656204|NCT00529373|19529464|P1|Second Extension Study|Physician Decision|63
5656205|NCT00529373|19529463|P2|Second Extension Study|Other|12
5656206|NCT00529373|19529464|P1|Second Extension Study|Other|7
5656207|NCT00529373|19529463|P2|Second Extension Study|Lost to Follow-up|12
5656208|NCT00529373|19529464|P1|Second Extension Study|Lost to Follow-up|18
5656209|NCT00529373|19529463|P2|Second Extension Study|Lack of Efficacy|15
5656210|NCT00529373|19529464|P1|Second Extension Study|Lack of Efficacy|7
5656211|NCT00529373|19529463|P2|Second Extension Study|Adverse Event|51
5656212|NCT00529373|19529464|P1|Second Extension Study|Adverse Event|101
5656213|NCT00529373|19529463|P2|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
5656214|NCT00529373|19529464|P1|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
5656215|NCT00529373|19529463|P2|First Extension Study|Did not cont. into 2nd Ext (verified)|281
5656216|NCT00529373|19529464|P1|First Extension Study|Did not cont. into 2nd Ext (verified)|256
5656217|NCT00529373|19529463|P2|First Extension Study|Discontinued after 5 years completion|346
5656218|NCT00529373|19529464|P1|First Extension Study|Discontinued after 5 years completion|208
5656219|NCT00529373|19529463|P2|First Extension Study|Disposition record non-existing|1
5656220|NCT00529373|19529464|P1|First Extension Study|Disposition record non-existing|0
5656221|NCT00529373|19529463|P2|First Extension Study|Withdrawal by Subject|287
5656222|NCT00529373|19529464|P1|First Extension Study|Withdrawal by Subject|296
5656223|NCT00529373|19529463|P2|First Extension Study|Protocol Violation|13
5656224|NCT00529373|19529464|P1|First Extension Study|Protocol Violation|16
5656225|NCT00529373|19529463|P2|First Extension Study|Physician Decision|45
5656226|NCT00529373|19529464|P1|First Extension Study|Physician Decision|50
5656227|NCT00529373|19529463|P2|First Extension Study|Other|47
5656228|NCT00529373|19529464|P1|First Extension Study|Other|27
5656229|NCT00529373|19529463|P2|First Extension Study|Lost to Follow-up|37
5656230|NCT00529373|19529464|P1|First Extension Study|Lost to Follow-up|41
5656231|NCT00529373|19529463|P2|First Extension Study|Lack of Efficacy|427
5656232|NCT00529373|19529464|P1|First Extension Study|Lack of Efficacy|65
5656233|NCT00529373|19529463|P2|First Extension Study|Adverse Event|142
5656234|NCT00529373|19529464|P1|First Extension Study|Adverse Event|162
5656235|NCT00529373|19529463|P2|Base Study|Did not continue into Extension|2238
5656236|NCT00529373|19529464|P1|Base Study|Did not continue into Extension|1795
5656237|NCT00529373|19529463|P2|Base Study|Withdrawal by Subject|967
5656238|NCT00529373|19529464|P1|Base Study|Withdrawal by Subject|1062
5656239|NCT00529373|19529463|P2|Base Study|Protocol Violation|38
5656240|NCT00529373|19529464|P1|Base Study|Protocol Violation|48
5656241|NCT00529373|19529463|P2|Base Study|Physician Decision|52
5656242|NCT00529373|19529464|P1|Base Study|Physician Decision|60
5656243|NCT00529373|19529463|P2|Base Study|Other Protocol Specified Criteria|20
5656244|NCT00529373|19529464|P1|Base Study|Other Protocol Specified Criteria|19
5656245|NCT00529373|19529463|P2|Base Study|Lost to Follow-up|208
5656246|NCT00529373|19529464|P1|Base Study|Lost to Follow-up|221
5656247|NCT00529373|19529463|P2|Base Study|Lack of Efficacy|75
5656248|NCT00529373|19529464|P1|Base Study|Lack of Efficacy|16
5656249|NCT00529373|19529463|P2|Base Study|Adverse Event|470
5656250|NCT00529373|19529464|P1|Base Study|Adverse Event|525
5656251|NCT00529308|19529658|P2|Overall Study|Withdrawal by Subject|1
5656252|NCT00529308|19529659|P1|Overall Study|Withdrawal by Subject|1
5656253|NCT00529243|19529688|P1|Overall Study|Relocated|1
5656254|NCT00529243|19529688|P1|Overall Study|Death|1
5656255|NCT00529243|19529688|P1|Overall Study|Adverse Event|1
5656256|NCT00529217|19529693|P1|Overall Study|Unable to adhere to study schedule|2
5656257|NCT00529217|19529693|P1|Overall Study|Lack of Efficacy|2
5656258|NCT00529152|19529729|P1|Overall Study|Lost to Follow-up|1
5656259|NCT00529152|19529729|P1|Overall Study|Withdrawal by Subject|2
5656260|NCT00529152|19529729|P1|Overall Study|Adverse Event|2
5656261|NCT00529100|19529753|P2|Overall Study|Participant Ineligibility|1
5656262|NCT00529100|19529754|P1|Overall Study|Participant Ineligibility|0
5656263|NCT00529100|19529753|P2|Overall Study|Withdrawal by Subject|1
5656264|NCT00529100|19529754|P1|Overall Study|Withdrawal by Subject|0
5656265|NCT00529100|19529753|P2|Overall Study|Progressive Disease|1
5656266|NCT00529100|19529754|P1|Overall Study|Progressive Disease|0
5656267|NCT00529100|19529753|P2|Overall Study|Protocol Violation|1
5656268|NCT00529100|19529754|P1|Overall Study|Protocol Violation|0
5656269|NCT00529100|19529753|P2|Overall Study|Adverse Event|5
5656270|NCT00529100|19529754|P1|Overall Study|Adverse Event|0
5656271|NCT00529087|19529771|P3|Overall Study|Protocol deviation|2
5656272|NCT00529087|19529772|P2|Overall Study|Protocol deviation|1
5656273|NCT00529087|19529773|P1|Overall Study|Protocol deviation|1
5656274|NCT00529087|19529771|P3|Overall Study|Withdrawal by Subject|3
5656275|NCT00529087|19529772|P2|Overall Study|Withdrawal by Subject|3
5656276|NCT00529087|19529773|P1|Overall Study|Withdrawal by Subject|3
5656277|NCT00529087|19529771|P3|Overall Study|Protocol Violation|6
5656278|NCT00529087|19529772|P2|Overall Study|Protocol Violation|7
5656279|NCT00529087|19529773|P1|Overall Study|Protocol Violation|8
5656280|NCT00529087|19529771|P3|Overall Study|Lost to Follow-up|1
5656281|NCT00529087|19529772|P2|Overall Study|Lost to Follow-up|4
5656282|NCT00529087|19529773|P1|Overall Study|Lost to Follow-up|6
5656283|NCT00529087|19529771|P3|Overall Study|Adverse Event|4
5656284|NCT00529087|19529772|P2|Overall Study|Adverse Event|13
5656285|NCT00529087|19529773|P1|Overall Study|Adverse Event|10
5656286|NCT00529035|19529837|P1|Overall Study|Withdrawal by Subject|1
5656287|NCT00528970|19529851|P3|Overall Study|Randomized but not treated|1
5656288|NCT00528970|19529852|P2|Overall Study|Randomized but not treated|0
5656289|NCT00528970|19529853|P1|Overall Study|Randomized but not treated|0
5656290|NCT00528970|19529851|P3|Overall Study|Withdrawal by Subject|5
5656291|NCT00528970|19529852|P2|Overall Study|Withdrawal by Subject|3
5656292|NCT00528970|19529853|P1|Overall Study|Withdrawal by Subject|4
5656293|NCT00528970|19529851|P3|Overall Study|Lack of Efficacy|1
5656294|NCT00528970|19529852|P2|Overall Study|Lack of Efficacy|0
5656295|NCT00528970|19529853|P1|Overall Study|Lack of Efficacy|0
5656296|NCT00528970|19529851|P3|Overall Study|Protocol Violation|4
5656297|NCT00528970|19529852|P2|Overall Study|Protocol Violation|1
5656298|NCT00528970|19529853|P1|Overall Study|Protocol Violation|2
5656299|NCT00528970|19529851|P3|Overall Study|Other than specified|3
5656300|NCT00528970|19529852|P2|Overall Study|Other than specified|3
5656301|NCT00528970|19529853|P1|Overall Study|Other than specified|2
5656302|NCT00528970|19529851|P3|Overall Study|Lost to Follow-up|1
5656303|NCT00528970|19529852|P2|Overall Study|Lost to Follow-up|0
5656304|NCT00528970|19529853|P1|Overall Study|Lost to Follow-up|0
5656305|NCT00528970|19529851|P3|Overall Study|Adverse Event|5
5656306|NCT00528970|19529852|P2|Overall Study|Adverse Event|8
5656307|NCT00528970|19529853|P1|Overall Study|Adverse Event|6
5656308|NCT00528957|19529872|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
5656309|NCT00528957|19529873|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
5656310|NCT00528957|19529872|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
5656311|NCT00528957|19529873|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
5656312|NCT00528957|19529872|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
5656313|NCT00528957|19529873|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
5656314|NCT00528957|19529872|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
5656315|NCT00528957|19529873|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
5656316|NCT00528957|19529872|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
5656317|NCT00528957|19529873|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
5656318|NCT00528957|19529872|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
5656319|NCT00528957|19529873|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
5656320|NCT00528957|19529872|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
5656321|NCT00528957|19529873|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
5656322|NCT00528957|19529872|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
5656323|NCT00528957|19529873|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
5656324|NCT00528957|19529872|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
5656325|NCT00528957|19529873|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
5656326|NCT00528957|19529872|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
5656327|NCT00528957|19529873|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
5656328|NCT00528957|19529872|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
5656329|NCT00528957|19529873|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
5656330|NCT00528957|19529872|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
5656331|NCT00528957|19529873|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
5656332|NCT00528957|19529872|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
5656333|NCT00528957|19529873|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
5656334|NCT00528957|19529872|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
5656335|NCT00528957|19529873|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
5656336|NCT00528957|19529872|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
5656337|NCT00528957|19529873|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
5656338|NCT00528957|19529872|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
5656339|NCT00528957|19529873|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
5656340|NCT00528931|19530014|P1|Overall Study|Lost to Follow-up|1
5656341|NCT00528879|19530026|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
5656342|NCT00528879|19530027|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
5656343|NCT00528879|19530028|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
5656344|NCT00528879|19530029|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
5656345|NCT00528879|19530026|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
5656346|NCT00528879|19530027|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
5656347|NCT00528879|19530028|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
5656348|NCT00528879|19530029|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
5656349|NCT00528879|19530026|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
5656350|NCT00528879|19530027|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
5656351|NCT00528879|19530028|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
5656352|NCT00528879|19530029|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
5656353|NCT00528879|19530026|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
5656354|NCT00528879|19530027|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
5656355|NCT00528879|19530028|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
5656356|NCT00528879|19530029|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
5656357|NCT00528879|19530026|P4|Long-term Period (Weeks 24 to 102)|Death|0
5656358|NCT00528879|19530027|P3|Long-term Period (Weeks 24 to 102)|Death|0
5656359|NCT00528879|19530028|P2|Long-term Period (Weeks 24 to 102)|Death|1
5656360|NCT00528879|19530029|P1|Long-term Period (Weeks 24 to 102)|Death|0
5656361|NCT00528879|19530026|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
5656362|NCT00528879|19530027|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
5656363|NCT00528879|19530028|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
5656364|NCT00528879|19530029|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
5656365|NCT00528879|19530026|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
5656366|NCT00528879|19530027|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
5656367|NCT00528879|19530028|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
5656368|NCT00528879|19530029|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
5656369|NCT00528879|19530026|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
5656370|NCT00528879|19530027|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
5656371|NCT00528879|19530028|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
5656372|NCT00528879|19530029|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
5656373|NCT00528879|19530026|P4|Short-term Period (Day 1 to Week 24)|Other|1
5656374|NCT00528879|19530027|P3|Short-term Period (Day 1 to Week 24)|Other|1
5656375|NCT00528879|19530028|P2|Short-term Period (Day 1 to Week 24)|Other|0
5656376|NCT00528879|19530029|P1|Short-term Period (Day 1 to Week 24)|Other|0
5656377|NCT00528879|19530026|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
5656378|NCT00528879|19530027|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
5656379|NCT00528879|19530028|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
5656380|NCT00528879|19530029|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
5656381|NCT00528879|19530026|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
5656382|NCT00528879|19530027|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
5656383|NCT00528879|19530028|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
5656384|NCT00528879|19530029|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
5656385|NCT00528879|19530026|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
5656386|NCT00528879|19530027|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
5656387|NCT00528879|19530028|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
5656388|NCT00528879|19530029|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
5656389|NCT00528879|19530026|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
5656390|NCT00528879|19530027|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5656391|NCT00528879|19530028|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
5656392|NCT00528879|19530029|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
5656393|NCT00528879|19530026|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
5656394|NCT00528879|19530027|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
5656395|NCT00528879|19530028|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
5656396|NCT00528879|19530029|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
5656397|NCT00528879|19530026|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
5656398|NCT00528879|19530027|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
5656399|NCT00528879|19530028|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
5656400|NCT00528879|19530029|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
5656401|NCT00528879|19530026|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
5656402|NCT00528879|19530027|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
5656403|NCT00528879|19530028|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
5656404|NCT00528879|19530029|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
5656405|NCT00528866|19530095|P1|Overall Study|Protocol Violation|6
5656406|NCT00528840|19530108|P1|Overall Study|Other|2
5656407|NCT00528840|19530108|P1|Overall Study|Administrative Reasons|1
5656408|NCT00528840|19530108|P1|Overall Study|Death|2
5656409|NCT00528840|19530108|P1|Overall Study|Withdrawal by Subject|17
5656410|NCT00528840|19530108|P1|Overall Study|Adverse Event|1
5656411|NCT00528840|19530108|P1|Overall Study|Lost to Follow-up|10
5656412|NCT00528801|19530122|P2|Overall Study|Administrative Reasons|1
5656413|NCT00528801|19530123|P1|Overall Study|Administrative Reasons|0
5656414|NCT00528801|19530122|P2|Overall Study|Lost to Follow-up|4
5656415|NCT00528801|19530123|P1|Overall Study|Lost to Follow-up|15
5656416|NCT00528801|19530122|P2|Overall Study|Protocol Violation|5
5656417|NCT00528801|19530123|P1|Overall Study|Protocol Violation|11
5656418|NCT00528801|19530122|P2|Overall Study|Withdrawal by Subject|1
5656419|NCT00528801|19530123|P1|Overall Study|Withdrawal by Subject|1
5656420|NCT00528775|19530137|P1|Overall Study|Other not specified|1
5656421|NCT00528645|19530145|P1|Overall Study|Adverse Event|3
5656422|NCT00528606|19530154|P2|Overall Study|Other|0
5656423|NCT00528606|19530155|P1|Overall Study|Other|2
5656424|NCT00528606|19530154|P2|Overall Study|Adverse Event|0
5656425|NCT00528606|19530155|P1|Overall Study|Adverse Event|3
5656426|NCT00528606|19530154|P2|Overall Study|Lost to Follow-up|1
5656427|NCT00528606|19530155|P1|Overall Study|Lost to Follow-up|4
5656428|NCT00528606|19530154|P2|Overall Study|Withdrew consent|3
5656429|NCT00528606|19530155|P1|Overall Study|Withdrew consent|4
5656430|NCT00528567|19530188|P2|Overall Study|Administrative/Other|75
5656431|NCT00528567|19530189|P1|Overall Study|Administrative/Other|22
5656432|NCT00528567|19530188|P2|Overall Study|Other Protocol Violation|21
5656433|NCT00528567|19530189|P1|Overall Study|Other Protocol Violation|5
5656434|NCT00528567|19530188|P2|Overall Study|Failure to Return|4
5656435|NCT00528567|19530189|P1|Overall Study|Failure to Return|1
5656436|NCT00528567|19530188|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
5656437|NCT00528567|19530189|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
5656438|NCT00528567|19530188|P2|Overall Study|Withdrew Consent|55
5656439|NCT00528567|19530189|P1|Overall Study|Withdrew Consent|59
5656440|NCT00528567|19530188|P2|Overall Study|Violation Criteria at Entry|17
5656441|NCT00528567|19530189|P1|Overall Study|Violation Criteria at Entry|3
5656442|NCT00528567|19530188|P2|Overall Study|Adverse Event/Intermittent Illness|29
5656443|NCT00528567|19530189|P1|Overall Study|Adverse Event/Intermittent Illness|255
5656444|NCT00528567|19530188|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
5656445|NCT00528567|19530189|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
5656446|NCT00528567|19530188|P2|Overall Study|Death|5
5656447|NCT00528567|19530189|P1|Overall Study|Death|4
5656448|NCT00528528|19530256|P4|Overall Study|Ongoing participant|0
5656449|NCT00528528|19530257|P3|Overall Study|Ongoing participant|1
5656450|NCT00528528|19530258|P2|Overall Study|Ongoing participant|0
5656451|NCT00528528|19530259|P1|Overall Study|Ongoing participant|0
5656452|NCT00528528|19530256|P4|Overall Study|Withdrawal by Subject|1
5656453|NCT00528528|19530257|P3|Overall Study|Withdrawal by Subject|1
5656454|NCT00528528|19530258|P2|Overall Study|Withdrawal by Subject|2
5656455|NCT00528528|19530259|P1|Overall Study|Withdrawal by Subject|3
5656456|NCT00528528|19530256|P4|Overall Study|Other|0
5656457|NCT00528528|19530257|P3|Overall Study|Other|0
5656458|NCT00528528|19530258|P2|Overall Study|Other|1
5656459|NCT00528528|19530259|P1|Overall Study|Other|0
5656460|NCT00528528|19530256|P4|Overall Study|Ineligible to continue the trial|1
5656461|NCT00528528|19530257|P3|Overall Study|Ineligible to continue the trial|0
5656462|NCT00528528|19530258|P2|Overall Study|Ineligible to continue the trial|0
5656463|NCT00528528|19530259|P1|Overall Study|Ineligible to continue the trial|0
5656464|NCT00528528|19530256|P4|Overall Study|Lost to Follow-up|1
5656465|NCT00528528|19530257|P3|Overall Study|Lost to Follow-up|1
5656466|NCT00528528|19530258|P2|Overall Study|Lost to Follow-up|0
5656467|NCT00528528|19530259|P1|Overall Study|Lost to Follow-up|0
5656468|NCT00528424|19530297|P1|Overall Study|Other|12
5656469|NCT00528424|19530297|P1|Overall Study|Administrative reason|2
5656470|NCT00528424|19530297|P1|Overall Study|Withdrew consent|2
5656471|NCT00528424|19530297|P1|Overall Study|Lost to Follow-up|13
5656472|NCT00528411|19530312|P3|Overall Study|Prior commitment medication|0
5656473|NCT00528411|19530313|P2|Overall Study|Prior commitment medication|1
5656474|NCT00528411|19530314|P1|Overall Study|Prior commitment medication|0
5656475|NCT00528411|19530312|P3|Overall Study|Severe non-compliance to protocol|0
5656476|NCT00528411|19530313|P2|Overall Study|Severe non-compliance to protocol|1
5656477|NCT00528411|19530314|P1|Overall Study|Severe non-compliance to protocol|0
5656478|NCT00528411|19530312|P3|Overall Study|Incorrect Enrolment|0
5656479|NCT00528411|19530313|P2|Overall Study|Incorrect Enrolment|1
5656480|NCT00528411|19530314|P1|Overall Study|Incorrect Enrolment|1
5656481|NCT00528411|19530312|P3|Overall Study|Adverse Event|1
5656482|NCT00528411|19530313|P2|Overall Study|Adverse Event|0
5656483|NCT00528411|19530314|P1|Overall Study|Adverse Event|4
5656484|NCT00528372|19530451|P9|Long-term (LT) Period (Weeks 24-102)|Other|0
5656485|NCT00528372|19530452|P8|Long-term (LT) Period (Weeks 24-102)|Other|1
5656486|NCT00528372|19530453|P7|Long-term (LT) Period (Weeks 24-102)|Other|3
5656487|NCT00528372|19530454|P6|Long-term (LT) Period (Weeks 24-102)|Other|0
5656488|NCT00528372|19530455|P5|Long-term (LT) Period (Weeks 24-102)|Other|3
5656489|NCT00528372|19530456|P4|Long-term (LT) Period (Weeks 24-102)|Other|2
5656490|NCT00528372|19530457|P3|Long-term (LT) Period (Weeks 24-102)|Other|1
5656491|NCT00528372|19530458|P2|Long-term (LT) Period (Weeks 24-102)|Other|2
5656492|NCT00528372|19530459|P1|Long-term (LT) Period (Weeks 24-102)|Other|2
5656493|NCT00528372|19530451|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
5656494|NCT00528372|19530452|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5656495|NCT00528372|19530453|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
5656496|NCT00528372|19530454|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5656497|NCT00528372|19530455|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5656498|NCT00528372|19530456|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5656499|NCT00528372|19530457|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5656500|NCT00528372|19530458|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
5656501|NCT00528372|19530459|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
5656502|NCT00528372|19530451|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5656503|NCT00528372|19530452|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5656504|NCT00528372|19530453|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5656505|NCT00528372|19530454|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
5656506|NCT00528372|19530455|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
5656507|NCT00528372|19530456|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5656508|NCT00528372|19530457|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5656509|NCT00528372|19530458|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5656510|NCT00528372|19530459|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
5656511|NCT00528372|19530451|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5656512|NCT00528372|19530452|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5656513|NCT00528372|19530453|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
5656514|NCT00528372|19530454|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5656664|NCT00527826|19530727|P1|Overall Study|Inclusion Criteria Not Met|3
5656515|NCT00528372|19530455|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5656516|NCT00528372|19530456|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
5656517|NCT00528372|19530457|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
5656518|NCT00528372|19530458|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
5656519|NCT00528372|19530459|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
5656520|NCT00528372|19530451|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
5656521|NCT00528372|19530452|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
5656522|NCT00528372|19530453|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
5656523|NCT00528372|19530454|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
5656524|NCT00528372|19530455|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
5656525|NCT00528372|19530456|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
5656526|NCT00528372|19530457|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
5656527|NCT00528372|19530458|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
5656528|NCT00528372|19530459|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
5656529|NCT00528372|19530451|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
5656530|NCT00528372|19530452|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
5656531|NCT00528372|19530453|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
5656532|NCT00528372|19530454|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
5656533|NCT00528372|19530455|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
5656534|NCT00528372|19530456|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
5656535|NCT00528372|19530457|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
5656536|NCT00528372|19530458|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
5656537|NCT00528372|19530459|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
5656538|NCT00528372|19530451|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
5656539|NCT00528372|19530452|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
5656540|NCT00528372|19530453|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
5656541|NCT00528372|19530454|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
5656542|NCT00528372|19530455|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
5656543|NCT00528372|19530456|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
5656544|NCT00528372|19530457|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
5656545|NCT00528372|19530458|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
5656546|NCT00528372|19530459|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
5656547|NCT00528372|19530451|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
5656548|NCT00528372|19530452|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
5656549|NCT00528372|19530453|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
5656550|NCT00528372|19530454|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
5656551|NCT00528372|19530455|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
5656552|NCT00528372|19530456|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
5656553|NCT00528372|19530457|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
5656554|NCT00528372|19530458|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
5656555|NCT00528372|19530459|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
5656556|NCT00528372|19530451|P9|Short-term (ST) Period (Day 1-Week 24)|Other|0
5656557|NCT00528372|19530452|P8|Short-term (ST) Period (Day 1-Week 24)|Other|1
5656558|NCT00528372|19530453|P7|Short-term (ST) Period (Day 1-Week 24)|Other|0
5656559|NCT00528372|19530454|P6|Short-term (ST) Period (Day 1-Week 24)|Other|0
5656560|NCT00528372|19530455|P5|Short-term (ST) Period (Day 1-Week 24)|Other|0
5656561|NCT00528372|19530456|P4|Short-term (ST) Period (Day 1-Week 24)|Other|1
5656562|NCT00528372|19530457|P3|Short-term (ST) Period (Day 1-Week 24)|Other|0
5656563|NCT00528372|19530458|P2|Short-term (ST) Period (Day 1-Week 24)|Other|0
5656564|NCT00528372|19530459|P1|Short-term (ST) Period (Day 1-Week 24)|Other|3
5656565|NCT00528372|19530451|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5656566|NCT00528372|19530452|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5656567|NCT00528372|19530453|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5656568|NCT00528372|19530454|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
5656569|NCT00528372|19530455|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5656570|NCT00528372|19530456|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5656571|NCT00528372|19530457|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
5656572|NCT00528372|19530458|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
5656573|NCT00528372|19530459|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
5656574|NCT00528372|19530451|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5656575|NCT00528372|19530452|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5656576|NCT00528372|19530453|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5656577|NCT00528372|19530454|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
5656578|NCT00528372|19530455|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5656579|NCT00528372|19530456|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
5656580|NCT00528372|19530457|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5656581|NCT00528372|19530458|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5656582|NCT00528372|19530459|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
5656583|NCT00528372|19530451|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
5656584|NCT00528372|19530452|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
5656585|NCT00528372|19530453|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
5656586|NCT00528372|19530454|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
5656587|NCT00528372|19530455|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
5656588|NCT00528372|19530456|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
5656589|NCT00528372|19530457|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
5656590|NCT00528372|19530458|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
5656591|NCT00528372|19530459|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
5656592|NCT00528372|19530451|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
5656593|NCT00528372|19530452|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
5656594|NCT00528372|19530453|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
5656595|NCT00528372|19530454|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
5656596|NCT00528372|19530455|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
5656597|NCT00528372|19530456|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
5656598|NCT00528372|19530457|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
5656599|NCT00528372|19530458|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
5656600|NCT00528372|19530459|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
5656601|NCT00528372|19530451|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
5656602|NCT00528372|19530452|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
5656603|NCT00528372|19530453|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
5656604|NCT00528372|19530454|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
5656605|NCT00528372|19530455|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
5656606|NCT00528372|19530456|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
5656607|NCT00528372|19530457|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
5656608|NCT00528372|19530458|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
5656609|NCT00528372|19530459|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
5656610|NCT00528372|19530451|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5656611|NCT00528372|19530452|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5656612|NCT00528372|19530453|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5656613|NCT00528372|19530454|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5656614|NCT00528372|19530455|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5656615|NCT00528372|19530456|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5656616|NCT00528372|19530457|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5656617|NCT00528372|19530458|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
5656618|NCT00528372|19530459|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
5656619|NCT00528112|19530591|P2|Extension Phase|Protocol Violation|2
5656620|NCT00528112|19530592|P1|Extension Phase|Protocol Violation|0
5656621|NCT00528112|19530591|P2|Extension Phase|Adverse Event|36
5656622|NCT00528112|19530592|P1|Extension Phase|Adverse Event|0
5656623|NCT00528112|19530591|P2|Extension Phase|Death|1
5656624|NCT00528112|19530592|P1|Extension Phase|Death|0
5656625|NCT00528112|19530591|P2|Extension Phase|Lost to Follow-up|12
5656626|NCT00528112|19530592|P1|Extension Phase|Lost to Follow-up|0
5656627|NCT00528112|19530591|P2|Extension Phase|Pregnancy|3
5656628|NCT00528112|19530592|P1|Extension Phase|Pregnancy|0
5656629|NCT00528112|19530591|P2|Extension Phase|Other reasons|100
5656630|NCT00528112|19530592|P1|Extension Phase|Other reasons|0
5656631|NCT00528112|19530591|P2|Extension Phase|Withdrawal by Subject|3
5656632|NCT00528112|19530592|P1|Extension Phase|Withdrawal by Subject|0
5656633|NCT00528112|19530591|P2|Treatment up to 3 Years|Other reasons|186
5656634|NCT00528112|19530592|P1|Treatment up to 3 Years|Other reasons|186
5656635|NCT00528112|19530591|P2|Treatment up to 3 Years|Pregnancy|10
5656636|NCT00528112|19530592|P1|Treatment up to 3 Years|Pregnancy|9
5656637|NCT00528112|19530591|P2|Treatment up to 3 Years|Lost to Follow-up|61
5656638|NCT00528112|19530592|P1|Treatment up to 3 Years|Lost to Follow-up|63
5656639|NCT00528112|19530591|P2|Treatment up to 3 Years|Death|1
5656640|NCT00528112|19530592|P1|Treatment up to 3 Years|Death|0
5656641|NCT00528112|19530591|P2|Treatment up to 3 Years|Protocol Violation|16
5656642|NCT00528112|19530592|P1|Treatment up to 3 Years|Protocol Violation|16
5656643|NCT00528112|19530591|P2|Treatment up to 3 Years|Withdrawal by Subject|31
5656644|NCT00528112|19530592|P1|Treatment up to 3 Years|Withdrawal by Subject|26
5656645|NCT00528112|19530591|P2|Treatment up to 3 Years|Adverse Event|278
5656646|NCT00528112|19530592|P1|Treatment up to 3 Years|Adverse Event|313
5656647|NCT00528021|19530650|P4|Overall Study|Lack of Efficacy|9
5656648|NCT00528021|19530651|P3|Overall Study|Lack of Efficacy|7
5656649|NCT00528021|19530652|P2|Overall Study|Lack of Efficacy|13
5656650|NCT00528021|19530653|P1|Overall Study|Lack of Efficacy|17
5656651|NCT00527982|19530665|P2|Overall Study|Physician Decision|0
5656652|NCT00527982|19530666|P1|Overall Study|Physician Decision|1
5656653|NCT00527904|19530707|P1|Overall Study|misc|22
5656654|NCT00527904|19530707|P1|Overall Study|Lost to Follow-up|8
5656655|NCT00527904|19530707|P1|Overall Study|Withdrawal by Subject|21
5656656|NCT00527904|19530707|P1|Overall Study|Adverse Event|45
5656657|NCT00527826|19530726|P2|Overall Study|Participant moved away|1
5656658|NCT00527826|19530727|P1|Overall Study|Participant moved away|0
5656659|NCT00527826|19530726|P2|Overall Study|Additional Intake of Viani forte|1
5656660|NCT00527826|19530727|P1|Overall Study|Additional Intake of Viani forte|0
5656661|NCT00527826|19530726|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
5656662|NCT00527826|19530727|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
5656663|NCT00527826|19530726|P2|Overall Study|Inclusion Criteria Not Met|3
5656665|NCT00527826|19530726|P2|Overall Study|Withdrawal by Subject|8
5656666|NCT00527826|19530727|P1|Overall Study|Withdrawal by Subject|5
5656667|NCT00527826|19530726|P2|Overall Study|Lost to Follow-up|2
5656668|NCT00527826|19530727|P1|Overall Study|Lost to Follow-up|3
5656669|NCT00527826|19530726|P2|Overall Study|Adverse Event|10
5656670|NCT00527826|19530727|P1|Overall Study|Adverse Event|10
5656671|NCT00527787|19530776|P2|Overall Study|misc|2
5656672|NCT00527787|19530777|P1|Overall Study|misc|5
5656673|NCT00527787|19530776|P2|Overall Study|Duodenal Ulcer|10
5656674|NCT00527787|19530777|P1|Overall Study|Duodenal Ulcer|1
5656675|NCT00527787|19530776|P2|Overall Study|Lost to Follow-up|2
5656676|NCT00527787|19530777|P1|Overall Study|Lost to Follow-up|5
5656677|NCT00527787|19530776|P2|Overall Study|Withdrawal by Subject|25
5656678|NCT00527787|19530777|P1|Overall Study|Withdrawal by Subject|13
5656679|NCT00527787|19530776|P2|Overall Study|Adverse Event|24
5656680|NCT00527787|19530777|P1|Overall Study|Adverse Event|14
5656681|NCT00527748|19530799|P1|Overall Study|Other|3
5656682|NCT00527735|19530806|P3|Overall Study|Completed treatment during maintenance|1
5656683|NCT00527735|19530807|P2|Overall Study|Completed treatment during maintenance|2
5656684|NCT00527735|19530808|P1|Overall Study|Completed treatment during maintenance|2
5656685|NCT00527735|19530806|P3|Overall Study|Poor compliance or noncompliance|1
5656686|NCT00527735|19530807|P2|Overall Study|Poor compliance or noncompliance|1
5656687|NCT00527735|19530808|P1|Overall Study|Poor compliance or noncompliance|0
5656688|NCT00527735|19530806|P3|Overall Study|Lost to Follow-up|3
5656689|NCT00527735|19530807|P2|Overall Study|Lost to Follow-up|0
5656690|NCT00527735|19530808|P1|Overall Study|Lost to Follow-up|0
5656691|NCT00527735|19530806|P3|Overall Study|No longer met study criteria|1
5656692|NCT00527735|19530807|P2|Overall Study|No longer met study criteria|2
5656693|NCT00527735|19530808|P1|Overall Study|No longer met study criteria|2
5656694|NCT00527735|19530806|P3|Overall Study|Withdrawal by Subject|3
5656695|NCT00527735|19530807|P2|Overall Study|Withdrawal by Subject|4
5656696|NCT00527735|19530808|P1|Overall Study|Withdrawal by Subject|5
5656697|NCT00527735|19530806|P3|Overall Study|Not identified|5
5656698|NCT00527735|19530807|P2|Overall Study|Not identified|5
5656699|NCT00527735|19530808|P1|Overall Study|Not identified|5
5656700|NCT00527735|19530806|P3|Overall Study|Adverse Event|7
5656701|NCT00527735|19530807|P2|Overall Study|Adverse Event|6
5656702|NCT00527735|19530808|P1|Overall Study|Adverse Event|10
5656703|NCT00527735|19530806|P3|Overall Study|Completed treatment in treatment phase|18
5656704|NCT00527735|19530807|P2|Overall Study|Completed treatment in treatment phase|13
5656705|NCT00527735|19530808|P1|Overall Study|Completed treatment in treatment phase|14
5656706|NCT00527735|19530806|P3|Overall Study|Death|15
5656707|NCT00527735|19530807|P2|Overall Study|Death|13
5656708|NCT00527735|19530808|P1|Overall Study|Death|23
5656709|NCT00527735|19530806|P3|Overall Study|Disease progression|53
5656710|NCT00527735|19530807|P2|Overall Study|Disease progression|61
5656711|NCT00527735|19530808|P1|Overall Study|Disease progression|47
5656712|NCT00527618|19530894|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
5656713|NCT00527618|19530895|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
5656714|NCT00527618|19530894|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
5656715|NCT00527618|19530895|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
5656716|NCT00527618|19530894|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
5656717|NCT00527618|19530895|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
5656718|NCT00527618|19530894|P2|Week 13-14 (Washout)|Lost to Follow-up|0
5656719|NCT00527618|19530895|P1|Week 13-14 (Washout)|Lost to Follow-up|1
5656720|NCT00527618|19530894|P2|Week 1-12 (First Intervention)|Adverse Event|1
5656721|NCT00527618|19530895|P1|Week 1-12 (First Intervention)|Adverse Event|0
5656722|NCT00527618|19530894|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
5656723|NCT00527618|19530895|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
5656724|NCT00527605|19530910|P2|Overall Study|Protocol Violation|2
5656725|NCT00527605|19530911|P1|Overall Study|Protocol Violation|1
5656726|NCT00527605|19530910|P2|Overall Study|Lost to Follow-up|2
5656727|NCT00527605|19530911|P1|Overall Study|Lost to Follow-up|6
5656728|NCT00527605|19530910|P2|Overall Study|Withdrawal by Subject|7
5656729|NCT00527605|19530911|P1|Overall Study|Withdrawal by Subject|3
5656730|NCT00527605|19530910|P2|Overall Study|Adverse Event|0
5656731|NCT00527605|19530911|P1|Overall Study|Adverse Event|3
5656732|NCT00527514|19530962|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
5656733|NCT00527514|19530962|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
5656734|NCT00527514|19530962|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
5656735|NCT00527514|19530962|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
5656736|NCT00527514|19530962|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
5656737|NCT00527514|19530962|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
5656738|NCT00527514|19530962|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
5656739|NCT00527488|19530978|P4|Overall Study|Withdrawn prior to dosing|0
5656740|NCT00527488|19530979|P3|Overall Study|Withdrawn prior to dosing|1
5656741|NCT00527488|19530980|P2|Overall Study|Withdrawn prior to dosing|1
5656742|NCT00527488|19530981|P1|Overall Study|Withdrawn prior to dosing|0
5656743|NCT00527423|19531064|P1|Overall Study|Death|9
5656744|NCT00527423|19531064|P1|Overall Study|OTHER|4
5656745|NCT00527423|19531064|P1|Overall Study|Lost to Follow-up|4
5656746|NCT00527423|19531064|P1|Overall Study|Withdrawal by Subject|10
5656747|NCT00527423|19531064|P1|Overall Study|Physician Decision|4
5656748|NCT00527423|19531064|P1|Overall Study|Adverse Event|5
5656749|NCT00527423|19531064|P1|Overall Study|Protocol Violation|1
5656750|NCT00527397|19531070|P1|Overall Study|Study terminated by sponsor|13
5656751|NCT00527397|19531070|P1|Overall Study|Withdrawal by Subject|6
5656752|NCT00527397|19531070|P1|Overall Study|Protocol Violation|1
5656753|NCT00527397|19531070|P1|Overall Study|Lack of Efficacy|1
5656754|NCT00527397|19531070|P1|Overall Study|Adverse Event|3
5656755|NCT00527332|19531096|P2|Overall Study|Withdrew consent|1
5656756|NCT00527332|19531097|P1|Overall Study|Withdrew consent|5
5656757|NCT00527332|19531096|P2|Overall Study|Protocol Violation|8
5656758|NCT00527332|19531097|P1|Overall Study|Protocol Violation|4
5656759|NCT00527319|19531106|P3|Overall Study|Adverse Event|1
5656760|NCT00527319|19531107|P2|Overall Study|Adverse Event|0
5656761|NCT00527319|19531108|P1|Overall Study|Adverse Event|0
5656762|NCT00527319|19531106|P3|Overall Study|Intercurrent Medical Illness|3
5656763|NCT00527319|19531107|P2|Overall Study|Intercurrent Medical Illness|1
5656764|NCT00527319|19531108|P1|Overall Study|Intercurrent Medical Illness|0
5656765|NCT00527319|19531106|P3|Overall Study|Death|1
5656766|NCT00527319|19531107|P2|Overall Study|Death|3
5656767|NCT00527319|19531108|P1|Overall Study|Death|0
5656768|NCT00527319|19531106|P3|Overall Study|Lost to Follow-up|0
5656769|NCT00527319|19531107|P2|Overall Study|Lost to Follow-up|0
5656770|NCT00527319|19531108|P1|Overall Study|Lost to Follow-up|1
5656771|NCT00527319|19531106|P3|Overall Study|Withdrawal by Subject|1
5656772|NCT00527319|19531107|P2|Overall Study|Withdrawal by Subject|0
5656773|NCT00527319|19531108|P1|Overall Study|Withdrawal by Subject|5
5656774|NCT00527111|19531138|P2|Overall Study|Other|2
5656775|NCT00527111|19531139|P1|Overall Study|Other|2
5656776|NCT00527111|19531138|P2|Overall Study|Patient Request|5
5656777|NCT00527111|19531139|P1|Overall Study|Patient Request|2
5656778|NCT00527111|19531138|P2|Overall Study|Investigator Request|1
5656779|NCT00527111|19531139|P1|Overall Study|Investigator Request|2
5656780|NCT00527111|19531138|P2|Overall Study|Death|1
5656781|NCT00527111|19531139|P1|Overall Study|Death|0
5656782|NCT00527111|19531138|P2|Overall Study|Adverse Event|13
5656783|NCT00527111|19531139|P1|Overall Study|Adverse Event|14
5656784|NCT00527072|19531161|P1|Overall Study|Withdrawal by Subject|7
5656785|NCT00527072|19531161|P1|Overall Study|Protocol Violation|2
5656786|NCT00527072|19531161|P1|Overall Study|Lost to Follow-up|3
5656787|NCT00527072|19531161|P1|Overall Study|Lack of Efficacy|11
5656788|NCT00527072|19531161|P1|Overall Study|Adverse Event|13
5656789|NCT00526994|19531170|P3|Overall Study|incarcerated, impaired, incomplete|3
5656790|NCT00526994|19531171|P2|Overall Study|incarcerated, impaired, incomplete|3
5656791|NCT00526994|19531172|P1|Overall Study|incarcerated, impaired, incomplete|4
5656792|NCT00526994|19531170|P3|Overall Study|Withdrawal by Subject|5
5656793|NCT00526994|19531171|P2|Overall Study|Withdrawal by Subject|7
5656794|NCT00526994|19531172|P1|Overall Study|Withdrawal by Subject|2
5656795|NCT00526994|19531170|P3|Overall Study|Death|3
5656796|NCT00526994|19531171|P2|Overall Study|Death|3
5656797|NCT00526994|19531172|P1|Overall Study|Death|4
5656798|NCT00526994|19531170|P3|Overall Study|Lost to Follow-up|96
5656799|NCT00526994|19531171|P2|Overall Study|Lost to Follow-up|108
5656800|NCT00526994|19531172|P1|Overall Study|Lost to Follow-up|98
5656801|NCT00526890|19531189|P1|Overall Study|Adverse Event|2
5656802|NCT00526799|19531201|P2|Overall Study|Intercurrent Complicating Disease|1
5656803|NCT00526799|19531202|P1|Overall Study|Intercurrent Complicating Disease|0
5656804|NCT00526799|19531201|P2|Overall Study|Withdrawal by Subject|0
5656805|NCT00526799|19531202|P1|Overall Study|Withdrawal by Subject|1
5656806|NCT00526669|19531210|P2|Combined Treatment Phase|Death|2
5656807|NCT00526669|19531211|P1|Combined Treatment Phase|Death|0
5656808|NCT00526669|19531210|P2|Combined Treatment Phase|Sponsor Terminated Study|2
5656809|NCT00526669|19531211|P1|Combined Treatment Phase|Sponsor Terminated Study|0
5656810|NCT00526669|19531210|P2|Combined Treatment Phase|Withdrawal by Subject|2
5656811|NCT00526669|19531211|P1|Combined Treatment Phase|Withdrawal by Subject|0
5656812|NCT00526669|19531210|P2|Combined Treatment Phase|Lost to Follow-up|2
5656813|NCT00526669|19531211|P1|Combined Treatment Phase|Lost to Follow-up|0
5656814|NCT00526656|19531240|P1|Overall Study|Refused surgery|1
5656815|NCT00526656|19531240|P1|Overall Study|Death|1
5656816|NCT00526630|19531246|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
5656817|NCT00526630|19531247|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
5656818|NCT00526630|19531246|P2|First Intervention Period - 12 Weeks|Withdrawn|3
5656819|NCT00526630|19531247|P1|First Intervention Period - 12 Weeks|Withdrawn|0
5656820|NCT00526331|19531359|P1|Overall Study|Sponsor Termination|55
5656821|NCT00526227|19531367|P1|Overall Study|Death|1
5656822|NCT00526227|19531367|P1|Overall Study|Device not implanted|1
5656823|NCT00526162|19531380|P1|Overall Study|Device not implanted|3
5656824|NCT00526110|19531413|P2|Overall Study|Poor Tolerance|5
5656825|NCT00526110|19531414|P1|Overall Study|Poor Tolerance|0
5656826|NCT00526110|19531413|P2|Overall Study|Withdrawal by Subject|2
5656827|NCT00526110|19531414|P1|Overall Study|Withdrawal by Subject|0
5656828|NCT00526110|19531413|P2|Overall Study|Maximal Response|6
5656829|NCT00526110|19531414|P1|Overall Study|Maximal Response|0
5656830|NCT00526110|19531413|P2|Overall Study|Disease Progression|19
5656831|NCT00526110|19531414|P1|Overall Study|Disease Progression|0
5656832|NCT00526110|19531413|P2|Overall Study|Adverse Event|9
5656833|NCT00526110|19531414|P1|Overall Study|Adverse Event|2
5656834|NCT00526097|19531423|P2|Overall Study|Other|1
5656835|NCT00526097|19531424|P1|Overall Study|Other|2
5656836|NCT00526097|19531423|P2|Overall Study|Withdrawal by Subject|1
5656837|NCT00526097|19531424|P1|Overall Study|Withdrawal by Subject|3
5656838|NCT00526097|19531423|P2|Overall Study|Protocol Violation|10
5656839|NCT00526097|19531424|P1|Overall Study|Protocol Violation|4
5656840|NCT00526097|19531423|P2|Overall Study|Adverse Event|44
5656841|NCT00526097|19531424|P1|Overall Study|Adverse Event|6
5656842|NCT00526071|19531600|P1|Overall Study|Lack of Response to Study Drug|4
5656843|NCT00526071|19531600|P1|Overall Study|Withdrawal by Subject|1
5656844|NCT00526071|19531600|P1|Overall Study|Adverse Event|1
5656845|NCT00525915|19531626|P2|Overall Study|Unrelated illness|0
5656846|NCT00525915|19531627|P1|Overall Study|Unrelated illness|1
5656847|NCT00525915|19531626|P2|Overall Study|Refused Surgery|2
5656848|NCT00525915|19531627|P1|Overall Study|Refused Surgery|1
5656849|NCT00525915|19531626|P2|Overall Study|Withdrawal by Subject|0
5656850|NCT00525915|19531627|P1|Overall Study|Withdrawal by Subject|1
5656851|NCT00525915|19531626|P2|Overall Study|Disease Progression|6
5656852|NCT00525915|19531627|P1|Overall Study|Disease Progression|5
5656853|NCT00525915|19531626|P2|Overall Study|Non-Compliance|1
5656854|NCT00525915|19531627|P1|Overall Study|Non-Compliance|0
5656855|NCT00525902|19531633|P1|Overall Study|Lack of Efficacy|1
5656856|NCT00525824|19531657|P4|Overall Study|Other|1
5656857|NCT00525824|19531658|P3|Overall Study|Other|3
5656858|NCT00525824|19531659|P2|Overall Study|Other|3
5656859|NCT00525824|19531660|P1|Overall Study|Other|1
5656860|NCT00525824|19531657|P4|Overall Study|Safety reasons|0
5656861|NCT00525824|19531658|P3|Overall Study|Safety reasons|1
5656862|NCT00525824|19531659|P2|Overall Study|Safety reasons|0
5656863|NCT00525824|19531660|P1|Overall Study|Safety reasons|1
5656864|NCT00525824|19531657|P4|Overall Study|Severe non-compliance|1
5656865|NCT00525824|19531658|P3|Overall Study|Severe non-compliance|1
5656866|NCT00525824|19531659|P2|Overall Study|Severe non-compliance|1
5656867|NCT00525824|19531660|P1|Overall Study|Severe non-compliance|0
5656868|NCT00525824|19531657|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
5656869|NCT00525824|19531658|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
5656870|NCT00525824|19531659|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
5656871|NCT00525824|19531660|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
5656872|NCT00525824|19531657|P4|Overall Study|Lost to Follow-up|0
5656873|NCT00525824|19531658|P3|Overall Study|Lost to Follow-up|4
5656874|NCT00525824|19531659|P2|Overall Study|Lost to Follow-up|2
5656875|NCT00525824|19531660|P1|Overall Study|Lost to Follow-up|4
5656876|NCT00525824|19531657|P4|Overall Study|Withdrawal by Subject|4
5656877|NCT00525824|19531658|P3|Overall Study|Withdrawal by Subject|3
5656878|NCT00525824|19531659|P2|Overall Study|Withdrawal by Subject|9
5656879|NCT00525824|19531660|P1|Overall Study|Withdrawal by Subject|5
5656880|NCT00525824|19531657|P4|Overall Study|Adverse Event|7
5656881|NCT00525824|19531658|P3|Overall Study|Adverse Event|6
5656882|NCT00525824|19531659|P2|Overall Study|Adverse Event|11
5656883|NCT00525824|19531660|P1|Overall Study|Adverse Event|7
5656884|NCT00525785|19531733|P1|Overall Study|Physician Decision|1
5656885|NCT00525785|19531733|P1|Overall Study|Lack of Efficacy|1
5656886|NCT00525785|19531733|P1|Overall Study|Withdrawal by Subject|1
5656887|NCT00525590|19531757|P1|Overall Study|Other|13
5656888|NCT00525590|19531757|P1|Overall Study|Death|9
5656889|NCT00525590|19531757|P1|Overall Study|Lost to Follow-up|1
5656890|NCT00525590|19531757|P1|Overall Study|Withdrawal by Subject|16
5656891|NCT00525590|19531757|P1|Overall Study|Physician Decision|3
5656892|NCT00525590|19531757|P1|Overall Study|Adverse Event|3
5656893|NCT00525512|19531785|P4|Open-Label Phase|Other reason (not specified)|5
5656894|NCT00525512|19531786|P3|Open-Label Phase|Other reason (not specified)|4
5656895|NCT00525512|19531787|P2|Open-Label Phase|Other reason (not specified)|0
5656896|NCT00525512|19531788|P1|Open-Label Phase|Other reason (not specified)|0
5656897|NCT00525512|19531785|P4|Open-Label Phase|Lost to Follow-up|0
5656898|NCT00525512|19531786|P3|Open-Label Phase|Lost to Follow-up|1
5656899|NCT00525512|19531787|P2|Open-Label Phase|Lost to Follow-up|0
5656900|NCT00525512|19531788|P1|Open-Label Phase|Lost to Follow-up|0
5656901|NCT00525512|19531785|P4|Open-Label Phase|Adverse Event|0
5656902|NCT00525512|19531786|P3|Open-Label Phase|Adverse Event|1
5656903|NCT00525512|19531787|P2|Open-Label Phase|Adverse Event|0
5656904|NCT00525512|19531788|P1|Open-Label Phase|Adverse Event|0
5656905|NCT00525512|19531785|P4|Double-Blind Phase|Other reason (not specified)|0
5656906|NCT00525512|19531786|P3|Double-Blind Phase|Other reason (not specified)|0
5656907|NCT00525512|19531787|P2|Double-Blind Phase|Other reason (not specified)|13
5656908|NCT00525512|19531788|P1|Double-Blind Phase|Other reason (not specified)|12
5656909|NCT00525512|19531785|P4|Double-Blind Phase|Lack of Efficacy|0
5656910|NCT00525512|19531786|P3|Double-Blind Phase|Lack of Efficacy|0
5656911|NCT00525512|19531787|P2|Double-Blind Phase|Lack of Efficacy|5
5656912|NCT00525512|19531788|P1|Double-Blind Phase|Lack of Efficacy|13
5656913|NCT00525512|19531785|P4|Double-Blind Phase|Withdrawal by Subject|0
5656914|NCT00525512|19531786|P3|Double-Blind Phase|Withdrawal by Subject|0
5656915|NCT00525512|19531787|P2|Double-Blind Phase|Withdrawal by Subject|12
5656916|NCT00525512|19531788|P1|Double-Blind Phase|Withdrawal by Subject|17
5656917|NCT00525512|19531785|P4|Double-Blind Phase|Lost to Follow-up|0
5656918|NCT00525512|19531786|P3|Double-Blind Phase|Lost to Follow-up|0
5656919|NCT00525512|19531787|P2|Double-Blind Phase|Lost to Follow-up|7
5656920|NCT00525512|19531788|P1|Double-Blind Phase|Lost to Follow-up|3
5656921|NCT00525512|19531785|P4|Double-Blind Phase|Protocol Violation|0
5656922|NCT00525512|19531786|P3|Double-Blind Phase|Protocol Violation|0
5656923|NCT00525512|19531787|P2|Double-Blind Phase|Protocol Violation|1
5656924|NCT00525512|19531788|P1|Double-Blind Phase|Protocol Violation|3
5656925|NCT00525512|19531785|P4|Double-Blind Phase|Adverse Event|0
5656926|NCT00525512|19531786|P3|Double-Blind Phase|Adverse Event|0
5656927|NCT00525512|19531787|P2|Double-Blind Phase|Adverse Event|28
5656928|NCT00525512|19531788|P1|Double-Blind Phase|Adverse Event|48
5656929|NCT00525499|19531930|P4|Overall Study|Protocol Violation|0
5656930|NCT00525499|19531931|P3|Overall Study|Protocol Violation|1
5656931|NCT00525499|19531932|P2|Overall Study|Protocol Violation|1
5656932|NCT00525499|19531933|P1|Overall Study|Protocol Violation|0
5656933|NCT00525499|19531930|P4|Overall Study|Withdrawal by Subject|2
5656934|NCT00525499|19531931|P3|Overall Study|Withdrawal by Subject|5
5656935|NCT00525499|19531932|P2|Overall Study|Withdrawal by Subject|1
5656936|NCT00525499|19531933|P1|Overall Study|Withdrawal by Subject|5
5656937|NCT00525499|19531930|P4|Overall Study|Adverse Event|1
5656938|NCT00525499|19531931|P3|Overall Study|Adverse Event|0
5656939|NCT00525499|19531932|P2|Overall Study|Adverse Event|1
5656940|NCT00525499|19531933|P1|Overall Study|Adverse Event|0
5656941|NCT00525499|19531930|P4|Overall Study|Lost to Follow-up|4
5656942|NCT00525499|19531931|P3|Overall Study|Lost to Follow-up|1
5656943|NCT00525499|19531932|P2|Overall Study|Lost to Follow-up|4
5656944|NCT00525499|19531933|P1|Overall Study|Lost to Follow-up|2
5656945|NCT00525265|19531960|P2|Overall Study|Protocol Violation|0
5656946|NCT00525265|19531961|P1|Overall Study|Protocol Violation|1
5656947|NCT00525161|19532018|P1|Overall Study|Adverse Event|1
5656948|NCT00525148|19532028|P4|Overall Study|Other than stated|3
5656949|NCT00525148|19532029|P3|Overall Study|Other than stated|0
5656950|NCT00525148|19532030|P2|Overall Study|Other than stated|1
5656951|NCT00525148|19532031|P1|Overall Study|Other than stated|2
5656952|NCT00525148|19532028|P4|Overall Study|Refused continuation of study medication|1
5656953|NCT00525148|19532029|P3|Overall Study|Refused continuation of study medication|0
5656954|NCT00525148|19532030|P2|Overall Study|Refused continuation of study medication|2
5656955|NCT00525148|19532031|P1|Overall Study|Refused continuation of study medication|0
5656956|NCT00525148|19532028|P4|Overall Study|Progressive disease|49
5656957|NCT00525148|19532029|P3|Overall Study|Progressive disease|6
5656958|NCT00525148|19532030|P2|Overall Study|Progressive disease|30
5656959|NCT00525148|19532031|P1|Overall Study|Progressive disease|18
5656960|NCT00525148|19532028|P4|Overall Study|Other Adverse Event|8
5656961|NCT00525148|19532029|P3|Overall Study|Other Adverse Event|1
5656962|NCT00525148|19532030|P2|Overall Study|Other Adverse Event|5
5656963|NCT00525148|19532031|P1|Overall Study|Other Adverse Event|3
5656964|NCT00525044|19532059|P2|Overall Study|Lost to Follow-up|1
5656965|NCT00525044|19532060|P1|Overall Study|Lost to Follow-up|0
5656966|NCT00525031|19532076|P2|Overall Study|Disease Progression|1
5656967|NCT00525031|19532077|P1|Overall Study|Disease Progression|1
5656968|NCT00524771|19532091|P2|Overall Study|Protocol Violation|585
5656969|NCT00524771|19532092|P1|Overall Study|Protocol Violation|220
5656970|NCT00524745|19532106|P4|Overall Study|subject withdrawal or lost to follow up|22
5656971|NCT00524745|19532107|P3|Overall Study|subject withdrawal or lost to follow up|29
5656972|NCT00524745|19532108|P2|Overall Study|subject withdrawal or lost to follow up|13
5656973|NCT00524745|19532109|P1|Overall Study|subject withdrawal or lost to follow up|34
5656974|NCT00524680|19532135|P4|Overall Study|Withdrawal by Subject|1
5656975|NCT00524680|19532136|P3|Overall Study|Withdrawal by Subject|1
5656976|NCT00524680|19532137|P2|Overall Study|Withdrawal by Subject|0
5656977|NCT00524680|19532138|P1|Overall Study|Withdrawal by Subject|1
5656978|NCT00524680|19532135|P4|Overall Study|Other|3
5656979|NCT00524680|19532136|P3|Overall Study|Other|2
5656980|NCT00524680|19532137|P2|Overall Study|Other|1
5656981|NCT00524680|19532138|P1|Overall Study|Other|0
5656982|NCT00524680|19532135|P4|Overall Study|Adverse Event|1
5656983|NCT00524680|19532136|P3|Overall Study|Adverse Event|0
5656984|NCT00524680|19532137|P2|Overall Study|Adverse Event|0
5656985|NCT00524680|19532138|P1|Overall Study|Adverse Event|2
5656986|NCT00524680|19532135|P4|Overall Study|progression|1
5656987|NCT00524680|19532136|P3|Overall Study|progression|0
5656988|NCT00524680|19532137|P2|Overall Study|progression|0
5656989|NCT00524680|19532138|P1|Overall Study|progression|0
5656990|NCT00524589|19532160|P1|Overall Study|Disease Progression|16
5656991|NCT00524589|19532160|P1|Overall Study|Withdrawal by Subject|2
5656992|NCT00524485|19532211|P1|Overall Study|Withdrawal by Subject|5
5656993|NCT00524459|19532240|P1|Overall Study|Other|1
5656994|NCT00524459|19532240|P1|Overall Study|Withdrawal by Subject|1
5656995|NCT00524420|19532250|P2|Overall Study|Lack of Efficacy|0
5656996|NCT00524420|19532251|P1|Overall Study|Lack of Efficacy|1
5656997|NCT00524368|19532269|P2|Overall Study|Other|2
5656998|NCT00524368|19532270|P1|Overall Study|Other|3
5656999|NCT00524368|19532269|P2|Overall Study|Ineligible to Continue the study|5
5657000|NCT00524368|19532270|P1|Overall Study|Ineligible to Continue the study|2
5657001|NCT00524368|19532269|P2|Overall Study|Sponsor's Decision|0
5657002|NCT00524368|19532270|P1|Overall Study|Sponsor's Decision|2
5657003|NCT00524368|19532269|P2|Overall Study|Reached a Virologic Endpoint|2
5657004|NCT00524368|19532270|P1|Overall Study|Reached a Virologic Endpoint|3
5657005|NCT00524368|19532269|P2|Overall Study|Non-compliant|9
5657006|NCT00524368|19532270|P1|Overall Study|Non-compliant|8
5657007|NCT00524368|19532269|P2|Overall Study|Withdrawal by Subject|5
5657008|NCT00524368|19532270|P1|Overall Study|Withdrawal by Subject|4
5657009|NCT00524368|19532269|P2|Overall Study|Lost to Follow-up|13
5657010|NCT00524368|19532270|P1|Overall Study|Lost to Follow-up|9
5657011|NCT00524368|19532269|P2|Overall Study|Adverse Event|12
5657012|NCT00524368|19532270|P1|Overall Study|Adverse Event|10
5657013|NCT00524316|19532304|P1|Overall Study|Disease Progression|7
5657014|NCT00524316|19532304|P1|Overall Study|Adverse Event|7
5657015|NCT00524316|19532304|P1|Overall Study|Withdrawal by Subject|2
5657016|NCT00524303|19532316|P3|Overall Study|Completed 5 years|1
5657017|NCT00524303|19532317|P2|Overall Study|Completed 5 years|0
5657018|NCT00524303|19532318|P1|Overall Study|Completed 5 years|0
5657019|NCT00524303|19532316|P3|Overall Study|Physician Decision|1
5657020|NCT00524303|19532317|P2|Overall Study|Physician Decision|0
5657021|NCT00524303|19532318|P1|Overall Study|Physician Decision|0
5657022|NCT00524303|19532316|P3|Overall Study|Sponsor Request|1
5657023|NCT00524303|19532317|P2|Overall Study|Sponsor Request|0
5657024|NCT00524303|19532318|P1|Overall Study|Sponsor Request|0
5657025|NCT00524303|19532316|P3|Overall Study|Disease Recurrence|0
5657026|NCT00524303|19532317|P2|Overall Study|Disease Recurrence|1
5657027|NCT00524303|19532318|P1|Overall Study|Disease Recurrence|0
5657028|NCT00524303|19532316|P3|Overall Study|Disease Progression|1
5657029|NCT00524303|19532317|P2|Overall Study|Disease Progression|4
5657030|NCT00524303|19532318|P1|Overall Study|Disease Progression|0
5657031|NCT00524303|19532316|P3|Overall Study|Worsening Peripheral Neuropathy|0
5657032|NCT00524303|19532317|P2|Overall Study|Worsening Peripheral Neuropathy|0
5657033|NCT00524303|19532318|P1|Overall Study|Worsening Peripheral Neuropathy|1
5657034|NCT00524303|19532316|P3|Overall Study|Did not Complete Study Dosing|0
5657035|NCT00524303|19532317|P2|Overall Study|Did not Complete Study Dosing|0
5657036|NCT00524303|19532318|P1|Overall Study|Did not Complete Study Dosing|1
5657037|NCT00524303|19532316|P3|Overall Study|Adverse Event|3
5657038|NCT00524303|19532317|P2|Overall Study|Adverse Event|2
5657039|NCT00524303|19532318|P1|Overall Study|Adverse Event|1
5657040|NCT00524303|19532316|P3|Overall Study|Death|3
5657041|NCT00524303|19532317|P2|Overall Study|Death|2
5657042|NCT00524303|19532318|P1|Overall Study|Death|0
5657043|NCT00524303|19532316|P3|Overall Study|Withdrawal by Subject|4
5657044|NCT00524303|19532317|P2|Overall Study|Withdrawal by Subject|0
5657045|NCT00524303|19532318|P1|Overall Study|Withdrawal by Subject|3
5657046|NCT00524303|19532316|P3|Overall Study|Protocol Violation|1
5657047|NCT00524303|19532317|P2|Overall Study|Protocol Violation|1
5657048|NCT00524303|19532318|P1|Overall Study|Protocol Violation|0
5657049|NCT00524303|19532316|P3|Overall Study|Lost to Follow-up|3
5657050|NCT00524303|19532317|P2|Overall Study|Lost to Follow-up|0
5657051|NCT00524303|19532318|P1|Overall Study|Lost to Follow-up|6
5657052|NCT00524173|19532370|P2|Overall Study|Had not reached endpoint at study close|1
5657053|NCT00524173|19532371|P1|Overall Study|Had not reached endpoint at study close|4
5657054|NCT00524173|19532370|P2|Overall Study|Death|0
5657055|NCT00524173|19532371|P1|Overall Study|Death|1
5657056|NCT00524173|19532370|P2|Overall Study|Lost to Follow-up|1
5657057|NCT00524173|19532371|P1|Overall Study|Lost to Follow-up|0
5657058|NCT00524134|19532383|P1|Overall Study|Physician Decision|1
5657059|NCT00524134|19532383|P1|Overall Study|Withdrawal by Subject|1
5657060|NCT00524121|19532390|P1|Overall Study|Not treated (changed mind)|1
5657061|NCT00524121|19532390|P1|Overall Study|Not treated (became ineligible)|4
5657062|NCT00524121|19532390|P1|Overall Study|Death|1
5657063|NCT00524121|19532390|P1|Overall Study|Other|1
5657064|NCT00524121|19532390|P1|Overall Study|Patient refused|2
5657065|NCT00524121|19532390|P1|Overall Study|Adverse Event|4
5657066|NCT00524121|19532390|P1|Overall Study|Disease progression|6
5657067|NCT00524043|19532410|P3|Overall Study|Various (eg, incarceration)|0
5657068|NCT00524043|19532411|P2|Overall Study|Various (eg, incarceration)|1
5657069|NCT00524043|19532412|P1|Overall Study|Various (eg, incarceration)|2
5657070|NCT00524043|19532410|P3|Overall Study|Lost to Follow-up|3
5657071|NCT00524043|19532411|P2|Overall Study|Lost to Follow-up|5
5657072|NCT00524043|19532412|P1|Overall Study|Lost to Follow-up|3
5657073|NCT00524043|19532410|P3|Overall Study|Adverse Event|7
5657074|NCT00524043|19532411|P2|Overall Study|Adverse Event|2
5657075|NCT00524043|19532412|P1|Overall Study|Adverse Event|5
5657076|NCT00524043|19532410|P3|Overall Study|Withdrawal by Subject|7
5657077|NCT00524043|19532411|P2|Overall Study|Withdrawal by Subject|7
5657078|NCT00524043|19532412|P1|Overall Study|Withdrawal by Subject|5
5657079|NCT00524043|19532410|P3|Overall Study|Lack of Efficacy|14
5657080|NCT00524043|19532411|P2|Overall Study|Lack of Efficacy|13
5657081|NCT00524043|19532412|P1|Overall Study|Lack of Efficacy|15
5657082|NCT00524030|19532434|P2|Overall Study|Death|1
5657083|NCT00524030|19532435|P1|Overall Study|Death|0
5657084|NCT00524030|19532434|P2|Overall Study|Adverse Event|21
5657085|NCT00524030|19532435|P1|Overall Study|Adverse Event|3
5657086|NCT00524030|19532434|P2|Overall Study|Pregnancy|0
5657087|NCT00524030|19532435|P1|Overall Study|Pregnancy|1
5657088|NCT00524030|19532434|P2|Overall Study|Protocol Violation|1
5657089|NCT00524030|19532435|P1|Overall Study|Protocol Violation|0
5657090|NCT00524030|19532434|P2|Overall Study|Noncompliance/Investigator discretion|2
5657091|NCT00524030|19532435|P1|Overall Study|Noncompliance/Investigator discretion|0
5657092|NCT00524030|19532434|P2|Overall Study|Withdrawal by Subject|8
5657093|NCT00524030|19532435|P1|Overall Study|Withdrawal by Subject|3
5657094|NCT00524030|19532434|P2|Overall Study|Lost to Follow-up|2
5657095|NCT00524030|19532435|P1|Overall Study|Lost to Follow-up|0
5657096|NCT00524030|19532434|P2|Overall Study|Lack of Efficacy|24
5657097|NCT00524030|19532435|P1|Overall Study|Lack of Efficacy|10
5657098|NCT00523991|19532474|P2|Overall Study|Other reason (not specified)|0
5657099|NCT00523991|19532475|P1|Overall Study|Other reason (not specified)|3
5657100|NCT00523991|19532474|P2|Overall Study|Withdrawal by Subject|17
5657101|NCT00523991|19532475|P1|Overall Study|Withdrawal by Subject|7
5657102|NCT00523991|19532474|P2|Overall Study|Lost to Follow-up|1
5657103|NCT00523991|19532475|P1|Overall Study|Lost to Follow-up|4
5657104|NCT00523991|19532474|P2|Overall Study|Protocol Violation|4
5657105|NCT00523991|19532475|P1|Overall Study|Protocol Violation|1
5657106|NCT00523991|19532474|P2|Overall Study|Adverse Event|5
5657107|NCT00523991|19532475|P1|Overall Study|Adverse Event|6
5657108|NCT00523978|19532755|P2|Overall Study|Death|0
5657109|NCT00523978|19532756|P1|Overall Study|Death|1
5657110|NCT00523978|19532755|P2|Overall Study|Screen Failures|1
5657111|NCT00523978|19532756|P1|Overall Study|Screen Failures|5
5657112|NCT00523978|19532755|P2|Overall Study|Withdrawal by Subject|7
5657113|NCT00523978|19532756|P1|Overall Study|Withdrawal by Subject|3
5657114|NCT00523848|19532778|P1|Overall Study|Other, unspecified|4
5657115|NCT00523848|19532778|P1|Overall Study|Disease Progression|5
5657116|NCT00523848|19532778|P1|Overall Study|NOT TREATED (Became ineligible)|2
5657117|NCT00523848|19532778|P1|Overall Study|Withdrawal by Subject|2
5657118|NCT00523848|19532778|P1|Overall Study|Adverse Event|11
5657119|NCT00523744|19532788|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
5657120|NCT00523744|19532788|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
5657121|NCT00523744|19532788|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
5657122|NCT00523744|19532788|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
5657123|NCT00523744|19532788|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
5657124|NCT00523744|19532788|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
5657125|NCT00523718|19532807|P2|Overall Study|Protocol Violation|0
5657126|NCT00523718|19532808|P1|Overall Study|Protocol Violation|2
5657127|NCT00523718|19532807|P2|Overall Study|Withdrawal by Subject|0
5657128|NCT00523718|19532808|P1|Overall Study|Withdrawal by Subject|1
5657129|NCT00523705|19532822|P2|Overall Study|No time for study.|1
5657130|NCT00523705|19532823|P1|Overall Study|No time for study.|0
5657131|NCT00523640|19532835|P1|Overall Study|Death|1
5657132|NCT00523549|19532852|P2|Overall Study|Lost to Follow-up|5
5657133|NCT00523549|19532853|P1|Overall Study|Lost to Follow-up|3
5657134|NCT00523549|19532852|P2|Overall Study|Patient withdrew consent|6
5657135|NCT00523549|19532853|P1|Overall Study|Patient withdrew consent|7
5657136|NCT00523549|19532852|P2|Overall Study|Protocol Deviation|1
5657137|NCT00523549|19532853|P1|Overall Study|Protocol Deviation|3
5657138|NCT00523549|19532852|P2|Overall Study|Unsatisfactory therapeutic effect|1
5657139|NCT00523549|19532853|P1|Overall Study|Unsatisfactory therapeutic effect|0
5657140|NCT00523549|19532852|P2|Overall Study|Adverse Event|3
5657141|NCT00523549|19532853|P1|Overall Study|Adverse Event|6
5657142|NCT00523419|19532871|P1|Overall Study|Death due to Adverse Event|2
5657143|NCT00523419|19532871|P1|Overall Study|Death due to Study Disease|4
5657144|NCT00523419|19532871|P1|Overall Study|Progressive Disease|22
5657145|NCT00523419|19532871|P1|Overall Study|Physician Decision|2
5657146|NCT00523419|19532871|P1|Overall Study|Withdrawal by Subject|1
5657147|NCT00523419|19532871|P1|Overall Study|Adverse Event|1
5657148|NCT00523367|19532881|P1|Overall Study|4 Withdrawn by PI|4
5657149|NCT00523367|19532881|P1|Overall Study|19 screen failures|19
5657150|NCT00523341|19532887|P2|Overall Study|Disease Progression|0
5657151|NCT00523341|19532888|P1|Overall Study|Disease Progression|1
5657152|NCT00523341|19532887|P2|Overall Study|Ineligibility Determined|4
5657153|NCT00523341|19532888|P1|Overall Study|Ineligibility Determined|3
5657154|NCT00523341|19532887|P2|Overall Study|Protocol Deviation|5
5657155|NCT00523341|19532888|P1|Overall Study|Protocol Deviation|6
5657156|NCT00523341|19532887|P2|Overall Study|Requirement for Alternative Therapy|14
5657157|NCT00523341|19532888|P1|Overall Study|Requirement for Alternative Therapy|4
5657158|NCT00523341|19532887|P2|Overall Study|Physician Decision|13
5657159|NCT00523341|19532888|P1|Overall Study|Physician Decision|14
5657160|NCT00523341|19532887|P2|Overall Study|Non-compliance|13
5657161|NCT00523341|19532888|P1|Overall Study|Non-compliance|20
5657162|NCT00523341|19532887|P2|Overall Study|Lost to Follow-up|61
5657163|NCT00523341|19532888|P1|Overall Study|Lost to Follow-up|73
5657164|NCT00523341|19532887|P2|Overall Study|Death|110
5657165|NCT00523341|19532888|P1|Overall Study|Death|101
5657166|NCT00523341|19532887|P2|Overall Study|Adverse Event|155
5657167|NCT00523341|19532888|P1|Overall Study|Adverse Event|122
5657168|NCT00523341|19532887|P2|Overall Study|Other|198
5657169|NCT00523341|19532888|P1|Overall Study|Other|181
5657170|NCT00523341|19532887|P2|Overall Study|Withdrawal by Subject|427
5657171|NCT00523341|19532888|P1|Overall Study|Withdrawal by Subject|399
5657172|NCT00522951|19533005|P2|Period 2|residual contrast medium|1
5657173|NCT00522951|19533006|P1|Period 2|residual contrast medium|1
5657174|NCT00522951|19533005|P2|Period 2|Withdrawal by Subject|0
5657175|NCT00522951|19533006|P1|Period 2|Withdrawal by Subject|1
5657176|NCT00522951|19533005|P2|Washout Period|Death|1
5657177|NCT00522951|19533006|P1|Washout Period|Death|0
5657178|NCT00522951|19533005|P2|Washout Period|Adverse Event|1
5657179|NCT00522951|19533006|P1|Washout Period|Adverse Event|0
5657180|NCT00522951|19533005|P2|Period 1|body motion|1
5657181|NCT00522951|19533006|P1|Period 1|body motion|0
5657182|NCT00522873|19533061|P2|Overall Study|Never Received Medication|0
5657183|NCT00522873|19533062|P1|Overall Study|Never Received Medication|1
5657184|NCT00522873|19533061|P2|Overall Study|Medication Errors|1
5657185|NCT00522873|19533062|P1|Overall Study|Medication Errors|1
5657186|NCT00522873|19533061|P2|Overall Study|Personal Reasons|1
5657187|NCT00522873|19533062|P1|Overall Study|Personal Reasons|8
5657188|NCT00522873|19533061|P2|Overall Study|Lost to Follow-up|3
5657189|NCT00522873|19533062|P1|Overall Study|Lost to Follow-up|11
5657190|NCT00522873|19533061|P2|Overall Study|Protocol Violation|4
5657191|NCT00522873|19533062|P1|Overall Study|Protocol Violation|14
5657192|NCT00522873|19533061|P2|Overall Study|Withdrawal by Subject|9
5657193|NCT00522873|19533062|P1|Overall Study|Withdrawal by Subject|20
5657194|NCT00522873|19533061|P2|Overall Study|Adverse Event|26
5657195|NCT00522873|19533062|P1|Overall Study|Adverse Event|41
5657196|NCT00522626|19533075|P1|Overall Study|Lost to Follow-up|7
5657197|NCT00522548|19533081|P2|Overall Study|Withdrawal by Subject|2
5657198|NCT00522548|19533082|P1|Overall Study|Withdrawal by Subject|0
5657199|NCT00522548|19533081|P2|Overall Study|Adverse Event|2
5657200|NCT00522548|19533082|P1|Overall Study|Adverse Event|2
5657201|NCT00522457|19533110|P1|Overall Study|Adverse Event|2
5657202|NCT00522457|19533110|P1|Overall Study|Due to disease progression|16
5657203|NCT00522431|19533116|P1|Overall Study|Other/unknown|1
5657204|NCT00522431|19533116|P1|Overall Study|Subject non-compliance|1
5657205|NCT00522431|19533116|P1|Overall Study|Withdrawal by Subject|2
5657206|NCT00522431|19533116|P1|Overall Study|Protocol Violation|2
5657207|NCT00522431|19533116|P1|Overall Study|Adverse Event|5
5657208|NCT00522418|19533123|P2|Overall Study|Lack of Efficacy|1
5657209|NCT00522418|19533124|P1|Overall Study|Lack of Efficacy|0
5657210|NCT00522418|19533123|P2|Overall Study|Consent Withdraw|2
5657211|NCT00522418|19533124|P1|Overall Study|Consent Withdraw|1
5657212|NCT00522418|19533123|P2|Overall Study|Reason Not Specified|1
5657213|NCT00522418|19533124|P1|Overall Study|Reason Not Specified|3
5657214|NCT00522418|19533123|P2|Overall Study|Noncompliance|2
5657215|NCT00522418|19533124|P1|Overall Study|Noncompliance|2
5657216|NCT00522418|19533123|P2|Overall Study|Early Study Termination|47
5657217|NCT00522418|19533124|P1|Overall Study|Early Study Termination|46
5657218|NCT00522418|19533123|P2|Overall Study|Local IRB Consent Violation|5
5657219|NCT00522418|19533124|P1|Overall Study|Local IRB Consent Violation|5
5657220|NCT00522392|19533172|P2|Overall Study|Non-compliance|1
5657221|NCT00522392|19533173|P1|Overall Study|Non-compliance|0
5657222|NCT00522392|19533172|P2|Overall Study|Physician Decision|1
5657223|NCT00522392|19533173|P1|Overall Study|Physician Decision|0
5657224|NCT00522392|19533172|P2|Overall Study|Withdrawal by Subject|1
5657225|NCT00522392|19533173|P1|Overall Study|Withdrawal by Subject|1
5657226|NCT00522392|19533172|P2|Overall Study|Adverse Event|7
5657227|NCT00522392|19533173|P1|Overall Study|Adverse Event|7
5657228|NCT00522392|19533172|P2|Overall Study|Disease progression|3
5657229|NCT00522392|19533173|P1|Overall Study|Disease progression|0
5657230|NCT00522379|19533190|P5|Overall Study|Subject Withdrawal|0
5657231|NCT00522379|19533191|P4|Overall Study|Subject Withdrawal|1
5657232|NCT00522379|19533192|P3|Overall Study|Subject Withdrawal|0
5657233|NCT00522379|19533193|P2|Overall Study|Subject Withdrawal|0
5657234|NCT00522379|19533194|P1|Overall Study|Subject Withdrawal|0
5657235|NCT00522379|19533190|P5|Overall Study|Site Closed|0
5657236|NCT00522379|19533191|P4|Overall Study|Site Closed|1
5657237|NCT00522379|19533192|P3|Overall Study|Site Closed|0
5657238|NCT00522379|19533193|P2|Overall Study|Site Closed|0
5657239|NCT00522379|19533194|P1|Overall Study|Site Closed|0
5657240|NCT00522379|19533190|P5|Overall Study|Family Problem|0
5657241|NCT00522379|19533191|P4|Overall Study|Family Problem|0
5657242|NCT00522379|19533192|P3|Overall Study|Family Problem|1
5657243|NCT00522379|19533193|P2|Overall Study|Family Problem|0
5657244|NCT00522379|19533194|P1|Overall Study|Family Problem|0
5657245|NCT00522379|19533190|P5|Overall Study|Sponsor Request|0
5657246|NCT00522379|19533191|P4|Overall Study|Sponsor Request|0
5657247|NCT00522379|19533192|P3|Overall Study|Sponsor Request|0
5657248|NCT00522379|19533193|P2|Overall Study|Sponsor Request|1
5657249|NCT00522379|19533194|P1|Overall Study|Sponsor Request|0
5657250|NCT00522379|19533190|P5|Overall Study|Subject Moved|0
5657251|NCT00522379|19533191|P4|Overall Study|Subject Moved|0
5657252|NCT00522379|19533192|P3|Overall Study|Subject Moved|0
5657253|NCT00522379|19533193|P2|Overall Study|Subject Moved|1
5657254|NCT00522379|19533194|P1|Overall Study|Subject Moved|1
5657255|NCT00522379|19533190|P5|Overall Study|Dispensing error|0
5657256|NCT00522379|19533191|P4|Overall Study|Dispensing error|1
5657257|NCT00522379|19533192|P3|Overall Study|Dispensing error|0
5657258|NCT00522379|19533193|P2|Overall Study|Dispensing error|0
5657259|NCT00522379|19533194|P1|Overall Study|Dispensing error|1
5657260|NCT00522379|19533190|P5|Overall Study|Randomization error|1
5657261|NCT00522379|19533191|P4|Overall Study|Randomization error|0
5657262|NCT00522379|19533192|P3|Overall Study|Randomization error|0
5657263|NCT00522379|19533193|P2|Overall Study|Randomization error|0
5657264|NCT00522379|19533194|P1|Overall Study|Randomization error|0
5657265|NCT00522379|19533190|P5|Overall Study|Lost to Follow-up|2
5657266|NCT00522379|19533191|P4|Overall Study|Lost to Follow-up|2
5657267|NCT00522379|19533192|P3|Overall Study|Lost to Follow-up|4
5657268|NCT00522379|19533193|P2|Overall Study|Lost to Follow-up|0
5657269|NCT00522379|19533194|P1|Overall Study|Lost to Follow-up|1
5657270|NCT00522379|19533190|P5|Overall Study|Unsatisfactory Subject Compliance|0
5657271|NCT00522379|19533191|P4|Overall Study|Unsatisfactory Subject Compliance|0
5657272|NCT00522379|19533192|P3|Overall Study|Unsatisfactory Subject Compliance|0
5657273|NCT00522379|19533193|P2|Overall Study|Unsatisfactory Subject Compliance|2
5657274|NCT00522379|19533194|P1|Overall Study|Unsatisfactory Subject Compliance|1
5657275|NCT00522379|19533190|P5|Overall Study|Protocol Violation|0
5657276|NCT00522379|19533191|P4|Overall Study|Protocol Violation|0
5657277|NCT00522379|19533192|P3|Overall Study|Protocol Violation|2
5657278|NCT00522379|19533193|P2|Overall Study|Protocol Violation|1
5657279|NCT00522379|19533194|P1|Overall Study|Protocol Violation|1
5657280|NCT00522379|19533190|P5|Overall Study|Withdrawal by Subject|0
5657281|NCT00522379|19533191|P4|Overall Study|Withdrawal by Subject|2
5657282|NCT00522379|19533192|P3|Overall Study|Withdrawal by Subject|1
5657283|NCT00522379|19533193|P2|Overall Study|Withdrawal by Subject|3
5657284|NCT00522379|19533194|P1|Overall Study|Withdrawal by Subject|2
5657285|NCT00522379|19533190|P5|Overall Study|Lack of Efficacy|7
5657286|NCT00522379|19533191|P4|Overall Study|Lack of Efficacy|2
5657287|NCT00522379|19533192|P3|Overall Study|Lack of Efficacy|2
5657288|NCT00522379|19533193|P2|Overall Study|Lack of Efficacy|0
5657289|NCT00522379|19533194|P1|Overall Study|Lack of Efficacy|3
5657290|NCT00522379|19533190|P5|Overall Study|Adverse Event|17
5657291|NCT00522379|19533191|P4|Overall Study|Adverse Event|5
5657292|NCT00522379|19533192|P3|Overall Study|Adverse Event|12
5657293|NCT00522379|19533193|P2|Overall Study|Adverse Event|15
5657294|NCT00522379|19533194|P1|Overall Study|Adverse Event|12
5657295|NCT00522301|19533296|P1|Overall Study|Adverse Event|5
5657296|NCT00522301|19533296|P1|Overall Study|Withdrawal by Subject|1
5657297|NCT00522275|19533300|P1|Overall Study|Other: Subject had surgery for epilepsy|2
5657298|NCT00522275|19533300|P1|Overall Study|Other: Subject ran out of medication|1
5657299|NCT00522275|19533300|P1|Overall Study|Other: Sponsor request|2
5657300|NCT00522275|19533300|P1|Overall Study|Other: Travel to / from site difficulty|3
5657301|NCT00522275|19533300|P1|Overall Study|Other: Site / clinic closed|4
5657302|NCT00522275|19533300|P1|Overall Study|Other: Subject arrested|1
5657303|NCT00522275|19533300|P1|Overall Study|Other: Subject relocated|2
5657304|NCT00522275|19533300|P1|Overall Study|Other: Subject is pregnant|2
5657305|NCT00522275|19533300|P1|Overall Study|Other: Subject wants to become pregnant|2
5657306|NCT00522275|19533300|P1|Overall Study|Lost to Follow-up|8
5657307|NCT00522275|19533300|P1|Overall Study|Unsatisfactory compliance|11
5657308|NCT00522275|19533300|P1|Overall Study|Protocol deviation|1
5657309|NCT00522275|19533300|P1|Overall Study|Subject withdrew consent|16
5657310|NCT00522275|19533300|P1|Overall Study|Lack of Efficacy|80
5657311|NCT00522275|19533300|P1|Overall Study|Adverse Event|35
5657312|NCT00522041|19533321|P2|Overall Study|Did not receive treatment|1
5657313|NCT00522041|19533322|P1|Overall Study|Did not receive treatment|0
5657314|NCT00522041|19533321|P2|Overall Study|Voluntary withdrawal|4
5657315|NCT00522041|19533322|P1|Overall Study|Voluntary withdrawal|5
5657316|NCT00522041|19533321|P2|Overall Study|Lost to Follow-up|4
5657317|NCT00522041|19533322|P1|Overall Study|Lost to Follow-up|1
5657318|NCT00522041|19533321|P2|Overall Study|Protocol Violation|0
5657319|NCT00522041|19533322|P1|Overall Study|Protocol Violation|2
5657320|NCT00522041|19533321|P2|Overall Study|Adverse Event|3
5657321|NCT00522041|19533322|P1|Overall Study|Adverse Event|9
5657322|NCT00521599|19533381|P3|Overall Study|Did not meet protocol eligibility|1
5657323|NCT00521599|19533382|P2|Overall Study|Did not meet protocol eligibility|2
5657324|NCT00521599|19533383|P1|Overall Study|Did not meet protocol eligibility|2
5657325|NCT00521599|19533381|P3|Overall Study|Protocol Violation|2
5657326|NCT00521599|19533382|P2|Overall Study|Protocol Violation|4
5657327|NCT00521599|19533383|P1|Overall Study|Protocol Violation|2
5657328|NCT00521599|19533381|P3|Overall Study|Withdrawal by subject treatment related|2
5657329|NCT00521599|19533382|P2|Overall Study|Withdrawal by subject treatment related|1
5657330|NCT00521599|19533383|P1|Overall Study|Withdrawal by subject treatment related|3
5657331|NCT00521599|19533381|P3|Overall Study|Withdrawal by Subject|1
5657332|NCT00521599|19533382|P2|Overall Study|Withdrawal by Subject|5
5657333|NCT00521599|19533383|P1|Overall Study|Withdrawal by Subject|3
5657334|NCT00521599|19533381|P3|Overall Study|Lost to Follow-up|2
5657335|NCT00521599|19533382|P2|Overall Study|Lost to Follow-up|1
5657336|NCT00521599|19533383|P1|Overall Study|Lost to Follow-up|2
5657337|NCT00521599|19533381|P3|Overall Study|Treatment Failure|22
5657338|NCT00521599|19533382|P2|Overall Study|Treatment Failure|9
5657339|NCT00521599|19533383|P1|Overall Study|Treatment Failure|8
5657340|NCT00521599|19533381|P3|Overall Study|Adverse Event|6
5657341|NCT00521599|19533382|P2|Overall Study|Adverse Event|7
5657342|NCT00521599|19533383|P1|Overall Study|Adverse Event|5
5657343|NCT00521586|19533394|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
5657344|NCT00521586|19533395|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
5657345|NCT00521586|19533394|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
5657346|NCT00521586|19533395|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
5657347|NCT00521586|19533394|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
5657348|NCT00521586|19533395|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
5657349|NCT00521586|19533394|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
5657350|NCT00521586|19533395|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
5657351|NCT00521586|19533394|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
5657352|NCT00521586|19533395|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
5657353|NCT00521586|19533394|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
5657354|NCT00521586|19533395|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
5657355|NCT00521586|19533394|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
5657356|NCT00521586|19533395|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
5657357|NCT00521586|19533394|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
5657358|NCT00521586|19533395|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
5657359|NCT00521586|19533394|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
5657360|NCT00521586|19533395|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
5657361|NCT00521586|19533394|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
5657362|NCT00521586|19533395|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
5657363|NCT00521586|19533394|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
5657364|NCT00521586|19533395|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
5657365|NCT00521586|19533394|P2|Initial Vaccination (Year 0)|Failed to return|1
5657366|NCT00521586|19533395|P1|Initial Vaccination (Year 0)|Failed to return|0
5657367|NCT00521586|19533394|P2|Initial Vaccination (Year 0)|Death|0
5657368|NCT00521586|19533395|P1|Initial Vaccination (Year 0)|Death|1
5657369|NCT00521586|19533394|P2|Initial Vaccination (Year 0)|Adverse Event|1
5657370|NCT00521586|19533395|P1|Initial Vaccination (Year 0)|Adverse Event|0
5657371|NCT00521586|19533394|P2|Initial Vaccination (Year 0)|Investigator request|0
5657372|NCT00521586|19533395|P1|Initial Vaccination (Year 0)|Investigator request|2
5657373|NCT00521586|19533394|P2|Initial Vaccination (Year 0)|Other, unspecified|1
5657374|NCT00521586|19533395|P1|Initial Vaccination (Year 0)|Other, unspecified|3
5657375|NCT00521586|19533394|P2|Initial Vaccination (Year 0)|Protocol Violation|5
5657376|NCT00521586|19533395|P1|Initial Vaccination (Year 0)|Protocol Violation|2
5657377|NCT00521586|19533394|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
5657378|NCT00521586|19533395|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
5657379|NCT00521586|19533394|P2|Initial Vaccination (Year 0)|Subject request|11
5657380|NCT00521586|19533395|P1|Initial Vaccination (Year 0)|Subject request|8
5657381|NCT00521404|19533468|P1|Overall Study|Other|7
5657382|NCT00521404|19533468|P1|Overall Study|Noncompliance or lack of cooperation|1
5657383|NCT00521404|19533468|P1|Overall Study|Withdrawal of consent|3
5657384|NCT00521404|19533468|P1|Overall Study|Investigator decision|5
5657385|NCT00521404|19533468|P1|Overall Study|Disease Progression|33
5657386|NCT00521404|19533468|P1|Overall Study|Adverse Event|13
5657387|NCT00521365|19533477|P1|Overall Study|Usage of not allowed drugs|6
5657388|NCT00521365|19533477|P1|Overall Study|Drug compliance|3
5657389|NCT00521365|19533477|P1|Overall Study|Protocol deviation|2
5657390|NCT00521365|19533477|P1|Overall Study|Lost to Follow-up|6
5657391|NCT00521365|19533477|P1|Overall Study|Adverse Event|3
5657392|NCT00521339|19533507|P3|Treatment Extension Phase|Death|1
5657393|NCT00521339|19533508|P2|Treatment Extension Phase|Death|0
5657394|NCT00521339|19533509|P1|Treatment Extension Phase|Death|0
5657395|NCT00521339|19533507|P3|Treatment Extension Phase|Withdrawal by Subject|2
5657396|NCT00521339|19533508|P2|Treatment Extension Phase|Withdrawal by Subject|0
5657397|NCT00521339|19533509|P1|Treatment Extension Phase|Withdrawal by Subject|0
5657398|NCT00521339|19533507|P3|Treatment Phase|Protocol Violation|0
5657399|NCT00521339|19533508|P2|Treatment Phase|Protocol Violation|0
5657400|NCT00521339|19533509|P1|Treatment Phase|Protocol Violation|1
5657401|NCT00521339|19533507|P3|Treatment Phase|Lost to Follow-up|0
5657402|NCT00521339|19533508|P2|Treatment Phase|Lost to Follow-up|0
5657403|NCT00521339|19533509|P1|Treatment Phase|Lost to Follow-up|1
5657404|NCT00521339|19533507|P3|Treatment Phase|Withdrawal by Subject|0
5657405|NCT00521339|19533508|P2|Treatment Phase|Withdrawal by Subject|0
5657406|NCT00521339|19533509|P1|Treatment Phase|Withdrawal by Subject|3
5657407|NCT00521339|19533507|P3|Treatment Phase|Lack of Efficacy|0
5657408|NCT00521339|19533508|P2|Treatment Phase|Lack of Efficacy|0
5657409|NCT00521339|19533509|P1|Treatment Phase|Lack of Efficacy|3
5657410|NCT00521339|19533507|P3|Treatment Phase|Intolerability to study drug|0
5657411|NCT00521339|19533508|P2|Treatment Phase|Intolerability to study drug|0
5657412|NCT00521339|19533509|P1|Treatment Phase|Intolerability to study drug|2
5657413|NCT00521339|19533507|P3|Treatment Phase|Adverse Event|0
5657414|NCT00521339|19533508|P2|Treatment Phase|Adverse Event|0
5657415|NCT00521339|19533509|P1|Treatment Phase|Adverse Event|2
5657416|NCT00521144|19533577|P5|Overall Study|Progressive Disease|6
5657417|NCT00521144|19533578|P4|Overall Study|Progressive Disease|0
5657418|NCT00521144|19533579|P3|Overall Study|Progressive Disease|2
5657419|NCT00521144|19533580|P2|Overall Study|Progressive Disease|2
5657420|NCT00521144|19533581|P1|Overall Study|Progressive Disease|4
5657421|NCT00521144|19533577|P5|Overall Study|Adverse Event|1
5657422|NCT00521144|19533578|P4|Overall Study|Adverse Event|0
5657423|NCT00521144|19533579|P3|Overall Study|Adverse Event|0
5657424|NCT00521144|19533580|P2|Overall Study|Adverse Event|1
5657425|NCT00521144|19533581|P1|Overall Study|Adverse Event|0
5657426|NCT00521144|19533577|P5|Overall Study|Not Treated|0
5657427|NCT00521144|19533578|P4|Overall Study|Not Treated|1
5657428|NCT00521144|19533579|P3|Overall Study|Not Treated|0
5657429|NCT00521144|19533580|P2|Overall Study|Not Treated|0
5657430|NCT00521144|19533581|P1|Overall Study|Not Treated|0
5657431|NCT00521079|19533595|P2|Overall Study|Withdrawal by Subject|3
5657432|NCT00521079|19533596|P1|Overall Study|Withdrawal by Subject|5
5657433|NCT00521079|19533595|P2|Overall Study|Lost to Follow-up|1
5657434|NCT00521079|19533596|P1|Overall Study|Lost to Follow-up|2
5657435|NCT00521079|19533595|P2|Overall Study|Adverse Event|1
5657436|NCT00521079|19533596|P1|Overall Study|Adverse Event|7
5657437|NCT00521053|19533606|P1|Observation Phase|Physician Decision|1
5657438|NCT00521053|19533606|P1|Observation Phase|Other non-study melanoma treatment|1
5657439|NCT00521053|19533606|P1|Observation Phase|Adverse Event|1
5657440|NCT00521053|19533606|P1|Observation Phase|Death|2
5657441|NCT00521053|19533606|P1|Observation Phase|Additional PV-10 via alternate protocol|8
5657442|NCT00521053|19533606|P1|Observation Phase|Disease Progression|55
5657443|NCT00521014|19533616|P1|Overall Study|Inevaluable, not treated|1
5657444|NCT00521001|19533620|P1|Overall Study|Ineligible|1
5657445|NCT00520975|19533629|P2|Overall Study|Not start protocol therapy|2
5657446|NCT00520975|19533630|P1|Overall Study|Not start protocol therapy|1
5657447|NCT00520975|19533629|P2|Overall Study|Other reasons|2
5657448|NCT00520975|19533630|P1|Overall Study|Other reasons|4
5657449|NCT00520975|19533629|P2|Overall Study|Other therapy|4
5657450|NCT00520975|19533630|P1|Overall Study|Other therapy|2
5657451|NCT00520975|19533629|P2|Overall Study|Withdrawal by Subject|5
5657452|NCT00520975|19533630|P1|Overall Study|Withdrawal by Subject|3
5657453|NCT00520975|19533629|P2|Overall Study|Death|2
5657454|NCT00520975|19533630|P1|Overall Study|Death|0
5657455|NCT00520975|19533629|P2|Overall Study|Adverse Event|10
5657456|NCT00520975|19533630|P1|Overall Study|Adverse Event|7
5657457|NCT00520975|19533629|P2|Overall Study|Disease progression|23
5657458|NCT00520975|19533630|P1|Overall Study|Disease progression|31
5657459|NCT00520936|19533662|P8|Overall Study|Protocol Violation|0
5657460|NCT00520936|19533663|P7|Overall Study|Protocol Violation|1
5657461|NCT00520936|19533664|P6|Overall Study|Protocol Violation|0
5657462|NCT00520936|19533665|P5|Overall Study|Protocol Violation|1
5657463|NCT00520936|19533666|P4|Overall Study|Protocol Violation|0
5657464|NCT00520936|19533667|P3|Overall Study|Protocol Violation|1
5657465|NCT00520936|19533668|P2|Overall Study|Protocol Violation|1
5657466|NCT00520936|19533669|P1|Overall Study|Protocol Violation|0
5657467|NCT00520936|19533662|P8|Overall Study|Death|0
5657468|NCT00520936|19533663|P7|Overall Study|Death|1
5657469|NCT00520936|19533664|P6|Overall Study|Death|0
5657470|NCT00520936|19533665|P5|Overall Study|Death|0
5657471|NCT00520936|19533666|P4|Overall Study|Death|0
5657472|NCT00520936|19533667|P3|Overall Study|Death|0
5657473|NCT00520936|19533668|P2|Overall Study|Death|0
5657474|NCT00520936|19533669|P1|Overall Study|Death|0
5657475|NCT00520936|19533662|P8|Overall Study|Toxicity Requiring Removal from Study|0
5657476|NCT00520936|19533663|P7|Overall Study|Toxicity Requiring Removal from Study|2
5657477|NCT00520936|19533664|P6|Overall Study|Toxicity Requiring Removal from Study|0
5657478|NCT00520936|19533665|P5|Overall Study|Toxicity Requiring Removal from Study|0
5657479|NCT00520936|19533666|P4|Overall Study|Toxicity Requiring Removal from Study|0
5657480|NCT00520936|19533667|P3|Overall Study|Toxicity Requiring Removal from Study|0
5657481|NCT00520936|19533668|P2|Overall Study|Toxicity Requiring Removal from Study|1
5657482|NCT00520936|19533669|P1|Overall Study|Toxicity Requiring Removal from Study|0
5657483|NCT00520936|19533662|P8|Overall Study|Withdrawal by Subject|1
5657484|NCT00520936|19533663|P7|Overall Study|Withdrawal by Subject|0
5657485|NCT00520936|19533664|P6|Overall Study|Withdrawal by Subject|0
5657486|NCT00520936|19533665|P5|Overall Study|Withdrawal by Subject|0
5657487|NCT00520936|19533666|P4|Overall Study|Withdrawal by Subject|0
5657488|NCT00520936|19533667|P3|Overall Study|Withdrawal by Subject|0
5657489|NCT00520936|19533668|P2|Overall Study|Withdrawal by Subject|0
5657490|NCT00520936|19533669|P1|Overall Study|Withdrawal by Subject|0
5657491|NCT00520936|19533662|P8|Overall Study|Physician Decision|0
5657492|NCT00520936|19533663|P7|Overall Study|Physician Decision|0
5657493|NCT00520936|19533664|P6|Overall Study|Physician Decision|0
5657494|NCT00520936|19533665|P5|Overall Study|Physician Decision|0
5657495|NCT00520936|19533666|P4|Overall Study|Physician Decision|0
5657496|NCT00520936|19533667|P3|Overall Study|Physician Decision|1
5657497|NCT00520936|19533668|P2|Overall Study|Physician Decision|2
5657498|NCT00520936|19533669|P1|Overall Study|Physician Decision|0
5657499|NCT00520845|19533724|P1|Overall Study|Alternative Therapy|1
5657500|NCT00520845|19533724|P1|Overall Study|Withdrawal by Subject|1
5657501|NCT00520845|19533724|P1|Overall Study|Disease Progression, relapse|13
5657502|NCT00520845|19533724|P1|Overall Study|Adverse Event|4
5657503|NCT00520845|19533724|P1|Overall Study|Death|3
5657504|NCT00520767|19533732|P1|Overall Study|Death|2
5657505|NCT00520741|19533738|P2|Overall Study|Other reasons for premature termination|6
5657506|NCT00520741|19533739|P1|Overall Study|Other reasons for premature termination|0
5657507|NCT00520741|19533738|P2|Overall Study|Lost to Follow-up|4
5657508|NCT00520741|19533739|P1|Overall Study|Lost to Follow-up|4
5657509|NCT00520741|19533738|P2|Overall Study|Unsatisfactory compliance of subject|3
5657510|NCT00520741|19533739|P1|Overall Study|Unsatisfactory compliance of subject|4
5657511|NCT00520741|19533738|P2|Overall Study|Protocol Violation|15
5657512|NCT00520741|19533739|P1|Overall Study|Protocol Violation|2
5657513|NCT00520741|19533738|P2|Overall Study|Withdrawal by Subject|11
5657514|NCT00520741|19533739|P1|Overall Study|Withdrawal by Subject|0
5657515|NCT00520741|19533738|P2|Overall Study|Lack of Efficacy|30
5657516|NCT00520741|19533739|P1|Overall Study|Lack of Efficacy|11
5657517|NCT00520741|19533738|P2|Overall Study|Adverse Event|56
5657518|NCT00520741|19533739|P1|Overall Study|Adverse Event|16
5657519|NCT00520676|19533757|P2|Overall Study|Withdrawal by Subject|11
5657520|NCT00520676|19533758|P1|Overall Study|Withdrawal by Subject|7
5657521|NCT00520676|19533757|P2|Overall Study|Physician Decision|1
5657522|NCT00520676|19533758|P1|Overall Study|Physician Decision|4
5657523|NCT00520676|19533757|P2|Overall Study|Lost to Follow-up|10
5657524|NCT00520676|19533758|P1|Overall Study|Lost to Follow-up|6
5657525|NCT00520676|19533757|P2|Overall Study|Death|81
5657526|NCT00520676|19533758|P1|Overall Study|Death|84
5657527|NCT00520572|19533784|P6|Overall Study|Did not receive Treatment|0
5657528|NCT00520572|19533785|P5|Overall Study|Did not receive Treatment|0
5657529|NCT00520572|19533786|P4|Overall Study|Did not receive Treatment|0
5657530|NCT00520572|19533787|P3|Overall Study|Did not receive Treatment|1
5657531|NCT00520572|19533788|P2|Overall Study|Did not receive Treatment|0
5657532|NCT00520572|19533789|P1|Overall Study|Did not receive Treatment|1
5657533|NCT00520572|19533784|P6|Overall Study|Long break in taking Medication|0
5657534|NCT00520572|19533785|P5|Overall Study|Long break in taking Medication|0
5657535|NCT00520572|19533786|P4|Overall Study|Long break in taking Medication|1
5657536|NCT00520572|19533787|P3|Overall Study|Long break in taking Medication|0
5657537|NCT00520572|19533788|P2|Overall Study|Long break in taking Medication|0
5657538|NCT00520572|19533789|P1|Overall Study|Long break in taking Medication|0
5657539|NCT00520572|19533784|P6|Overall Study|Oral corticotherapy for acute urticaria|0
5657540|NCT00520572|19533785|P5|Overall Study|Oral corticotherapy for acute urticaria|0
5657541|NCT00520572|19533786|P4|Overall Study|Oral corticotherapy for acute urticaria|0
5657542|NCT00520572|19533787|P3|Overall Study|Oral corticotherapy for acute urticaria|0
5657543|NCT00520572|19533788|P2|Overall Study|Oral corticotherapy for acute urticaria|1
5657544|NCT00520572|19533789|P1|Overall Study|Oral corticotherapy for acute urticaria|0
5657545|NCT00520572|19533784|P6|Overall Study|Incorrect enrollment|0
5657546|NCT00520572|19533785|P5|Overall Study|Incorrect enrollment|1
5657547|NCT00520572|19533786|P4|Overall Study|Incorrect enrollment|0
5657548|NCT00520572|19533787|P3|Overall Study|Incorrect enrollment|1
5657549|NCT00520572|19533788|P2|Overall Study|Incorrect enrollment|0
5657550|NCT00520572|19533789|P1|Overall Study|Incorrect enrollment|1
5657551|NCT00520572|19533784|P6|Overall Study|Lost to Follow-up|0
5657552|NCT00520572|19533785|P5|Overall Study|Lost to Follow-up|1
5657553|NCT00520572|19533786|P4|Overall Study|Lost to Follow-up|0
5657554|NCT00520572|19533787|P3|Overall Study|Lost to Follow-up|0
5657555|NCT00520572|19533788|P2|Overall Study|Lost to Follow-up|0
5657556|NCT00520572|19533789|P1|Overall Study|Lost to Follow-up|0
5657557|NCT00520572|19533784|P6|Overall Study|Lack of Efficacy|0
5657558|NCT00520572|19533785|P5|Overall Study|Lack of Efficacy|1
5657559|NCT00520572|19533786|P4|Overall Study|Lack of Efficacy|2
5657560|NCT00520572|19533787|P3|Overall Study|Lack of Efficacy|1
5657561|NCT00520572|19533788|P2|Overall Study|Lack of Efficacy|1
5657562|NCT00520572|19533789|P1|Overall Study|Lack of Efficacy|1
5657563|NCT00520572|19533784|P6|Overall Study|Protocol Violation|0
5657564|NCT00520572|19533785|P5|Overall Study|Protocol Violation|0
5657565|NCT00520572|19533786|P4|Overall Study|Protocol Violation|0
5657566|NCT00520572|19533787|P3|Overall Study|Protocol Violation|1
5657567|NCT00520572|19533788|P2|Overall Study|Protocol Violation|0
5657568|NCT00520572|19533789|P1|Overall Study|Protocol Violation|0
5657569|NCT00520572|19533784|P6|Overall Study|Withdrawal by Subject|0
5657570|NCT00520572|19533785|P5|Overall Study|Withdrawal by Subject|2
5657571|NCT00520572|19533786|P4|Overall Study|Withdrawal by Subject|2
5657572|NCT00520572|19533787|P3|Overall Study|Withdrawal by Subject|5
5657573|NCT00520572|19533788|P2|Overall Study|Withdrawal by Subject|9
5657574|NCT00520572|19533789|P1|Overall Study|Withdrawal by Subject|0
5657575|NCT00520572|19533784|P6|Overall Study|Adverse Event|2
5657576|NCT00520572|19533785|P5|Overall Study|Adverse Event|7
5657577|NCT00520572|19533786|P4|Overall Study|Adverse Event|9
5657578|NCT00520572|19533787|P3|Overall Study|Adverse Event|6
5657579|NCT00520572|19533788|P2|Overall Study|Adverse Event|3
5657580|NCT00520572|19533789|P1|Overall Study|Adverse Event|9
5657581|NCT00520546|19533827|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
5657582|NCT00520546|19533827|P1|Overall Study|Withdrawal by Subject|1
5657583|NCT00520494|19533842|P1|Overall Study|Withdrawal by Subject|1
5657584|NCT00520481|19533867|P2|Overall Study|Withdrawal by Subject|0
5657585|NCT00520481|19533868|P1|Overall Study|Withdrawal by Subject|3
5657586|NCT00520481|19533867|P2|Overall Study|Adverse Event|1
5657587|NCT00520481|19533868|P1|Overall Study|Adverse Event|4
5657588|NCT00520403|19533892|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
5657589|NCT00520403|19533892|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
5657590|NCT00520403|19533892|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
5657591|NCT00520403|19533892|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
5657592|NCT00520403|19533892|P1|Bevacizumab + IFN/Vinblastine|Death|2
5657593|NCT00520403|19533892|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
5657594|NCT00520403|19533892|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
5657595|NCT00520403|19533892|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
5657596|NCT00520351|19533901|P2|First Intervention|Withdrawal by Subject|1
5657597|NCT00520351|19533902|P1|First Intervention|Withdrawal by Subject|1
5657598|NCT00520299|19533917|P3|Overall Study|Progressive disease|4
5657599|NCT00520299|19533918|P2|Overall Study|Progressive disease|3
5657600|NCT00520299|19533919|P1|Overall Study|Progressive disease|0
5657601|NCT00520299|19533917|P3|Overall Study|Withdrawal by Subject|2
5657602|NCT00520299|19533918|P2|Overall Study|Withdrawal by Subject|0
5657603|NCT00520299|19533919|P1|Overall Study|Withdrawal by Subject|0
5657604|NCT00520130|19533974|P2|Overall Study|Physician Decision|1
5657605|NCT00520130|19533975|P1|Overall Study|Physician Decision|1
5657606|NCT00520130|19533974|P2|Overall Study|Disease progression on study|0
5657607|NCT00520130|19533975|P1|Overall Study|Disease progression on study|4
5657608|NCT00520039|19534017|P2|Overall Study|Exclusion criteria met at first visit|5
5657609|NCT00520039|19534018|P1|Overall Study|Exclusion criteria met at first visit|7
5657610|NCT00520013|19534031|P3|Overall Study|Physician Decision|3
5657611|NCT00520013|19534032|P2|Overall Study|Physician Decision|0
5657612|NCT00520013|19534033|P1|Overall Study|Physician Decision|0
5657613|NCT00520013|19534031|P3|Overall Study|Death|0
5657614|NCT00520013|19534032|P2|Overall Study|Death|1
5657615|NCT00520013|19534033|P1|Overall Study|Death|0
5657616|NCT00520013|19534031|P3|Overall Study|Clinical Progression|0
5657617|NCT00520013|19534032|P2|Overall Study|Clinical Progression|1
5657618|NCT00520013|19534033|P1|Overall Study|Clinical Progression|3
5657619|NCT00520013|19534031|P3|Overall Study|Progressive Disease|0
5657620|NCT00520013|19534032|P2|Overall Study|Progressive Disease|3
5657621|NCT00520013|19534033|P1|Overall Study|Progressive Disease|7
5657622|NCT00520013|19534031|P3|Overall Study|Adverse Event|7
5657623|NCT00520013|19534032|P2|Overall Study|Adverse Event|10
5657624|NCT00520013|19534033|P1|Overall Study|Adverse Event|2
5657625|NCT00520013|19534031|P3|Overall Study|Withdrawal by Subject|1
5657626|NCT00520013|19534032|P2|Overall Study|Withdrawal by Subject|0
5657627|NCT00520013|19534033|P1|Overall Study|Withdrawal by Subject|0
5657628|NCT00519896|19534043|P1|Overall Study|Adverse Event|1
5657629|NCT00519896|19534043|P1|Overall Study|Protocol Violation|1
5657630|NCT00519831|19534049|P1|Overall Study|Adverse Event|3
5657631|NCT00519779|19534066|P2|Overall Study|Withdrawal by Subject|1
5657632|NCT00519779|19534067|P1|Overall Study|Withdrawal by Subject|0
5657633|NCT00519649|19534083|P1|Overall Study|Withdrawal by Subject|1
5657634|NCT00519636|19534096|P4|Post Study Period|Subject randomized in error|1
5657635|NCT00519636|19534097|P3|Post Study Period|Subject randomized in error|0
5657636|NCT00519636|19534098|P2|Post Study Period|Subject randomized in error|0
5657637|NCT00519636|19534099|P1|Post Study Period|Subject randomized in error|0
5657638|NCT00519636|19534096|P4|Treatment Period 2|Subject misrandomized|1
5657639|NCT00519636|19534097|P3|Treatment Period 2|Subject misrandomized|0
5657640|NCT00519636|19534098|P2|Treatment Period 2|Subject misrandomized|0
5657641|NCT00519636|19534099|P1|Treatment Period 2|Subject misrandomized|0
5657642|NCT00519636|19534096|P4|Treatment Period 2|Per doctors request|0
5657643|NCT00519636|19534097|P3|Treatment Period 2|Per doctors request|1
5657644|NCT00519636|19534098|P2|Treatment Period 2|Per doctors request|0
5657645|NCT00519636|19534099|P1|Treatment Period 2|Per doctors request|0
5657646|NCT00519636|19534096|P4|Treatment Period 2|Subject randomized in error|0
5657647|NCT00519636|19534097|P3|Treatment Period 2|Subject randomized in error|0
5657648|NCT00519636|19534098|P2|Treatment Period 2|Subject randomized in error|1
5657649|NCT00519636|19534099|P1|Treatment Period 2|Subject randomized in error|0
5657650|NCT00519636|19534096|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
5657651|NCT00519636|19534097|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
5657652|NCT00519636|19534098|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
5657653|NCT00519636|19534099|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
5657654|NCT00519636|19534096|P4|Washout Period|Prohibited medications|0
5657655|NCT00519636|19534097|P3|Washout Period|Prohibited medications|1
5657656|NCT00519636|19534098|P2|Washout Period|Prohibited medications|0
5657657|NCT00519636|19534099|P1|Washout Period|Prohibited medications|0
5657658|NCT00519636|19534096|P4|Washout Period|Subject randomized in error|0
5657659|NCT00519636|19534097|P3|Washout Period|Subject randomized in error|1
5657660|NCT00519636|19534098|P2|Washout Period|Subject randomized in error|0
5657661|NCT00519636|19534099|P1|Washout Period|Subject randomized in error|0
5657662|NCT00519636|19534096|P4|Washout Period|Per doctors request|0
5657663|NCT00519636|19534097|P3|Washout Period|Per doctors request|0
5657664|NCT00519636|19534098|P2|Washout Period|Per doctors request|1
5657665|NCT00519636|19534099|P1|Washout Period|Per doctors request|0
5657666|NCT00519636|19534096|P4|Washout Period|Non-compliant|0
5657667|NCT00519636|19534097|P3|Washout Period|Non-compliant|0
5657668|NCT00519636|19534098|P2|Washout Period|Non-compliant|1
5657669|NCT00519636|19534099|P1|Washout Period|Non-compliant|0
5657670|NCT00519636|19534096|P4|Washout Period|Participating in study at another site|0
5657671|NCT00519636|19534097|P3|Washout Period|Participating in study at another site|0
5657672|NCT00519636|19534098|P2|Washout Period|Participating in study at another site|0
5657673|NCT00519636|19534099|P1|Washout Period|Participating in study at another site|1
5657674|NCT00519636|19534096|P4|Washout Period|Out of pollen area > 48 hours|0
5657675|NCT00519636|19534097|P3|Washout Period|Out of pollen area > 48 hours|0
5657676|NCT00519636|19534098|P2|Washout Period|Out of pollen area > 48 hours|0
5657677|NCT00519636|19534099|P1|Washout Period|Out of pollen area > 48 hours|1
5657678|NCT00519636|19534096|P4|Washout Period|Failed to meet continuation criteria|3
5657679|NCT00519636|19534097|P3|Washout Period|Failed to meet continuation criteria|9
5657680|NCT00519636|19534098|P2|Washout Period|Failed to meet continuation criteria|11
5657681|NCT00519636|19534099|P1|Washout Period|Failed to meet continuation criteria|14
5657682|NCT00519636|19534096|P4|Washout Period|Withdrawal by Subject|0
5657683|NCT00519636|19534097|P3|Washout Period|Withdrawal by Subject|1
5657684|NCT00519636|19534098|P2|Washout Period|Withdrawal by Subject|0
5657685|NCT00519636|19534099|P1|Washout Period|Withdrawal by Subject|1
5657686|NCT00519636|19534096|P4|Washout Period|Protocol Violation|2
5657687|NCT00519636|19534097|P3|Washout Period|Protocol Violation|1
5657688|NCT00519636|19534098|P2|Washout Period|Protocol Violation|0
5657689|NCT00519636|19534099|P1|Washout Period|Protocol Violation|0
5657690|NCT00519636|19534096|P4|Washout Period|Lost to Follow-up|0
5657691|NCT00519636|19534097|P3|Washout Period|Lost to Follow-up|0
5657692|NCT00519636|19534098|P2|Washout Period|Lost to Follow-up|0
5657693|NCT00519636|19534099|P1|Washout Period|Lost to Follow-up|1
5657694|NCT00519636|19534096|P4|Washout Period|Adverse Event|0
5657695|NCT00519636|19534097|P3|Washout Period|Adverse Event|1
5657696|NCT00519636|19534098|P2|Washout Period|Adverse Event|1
5657697|NCT00519636|19534099|P1|Washout Period|Adverse Event|2
5657698|NCT00519636|19534096|P4|Treatment Period 1|Sponsor request due to missed visit|0
5657699|NCT00519636|19534097|P3|Treatment Period 1|Sponsor request due to missed visit|0
5657700|NCT00519636|19534098|P2|Treatment Period 1|Sponsor request due to missed visit|0
5657701|NCT00519636|19534099|P1|Treatment Period 1|Sponsor request due to missed visit|1
5657702|NCT00519636|19534096|P4|Treatment Period 1|Adverse Event|0
5657703|NCT00519636|19534097|P3|Treatment Period 1|Adverse Event|1
5657704|NCT00519636|19534098|P2|Treatment Period 1|Adverse Event|0
5657705|NCT00519636|19534099|P1|Treatment Period 1|Adverse Event|1
5657706|NCT00519623|19534129|P1|Overall Study|Adverse Event|1
5657707|NCT00519532|19534163|P1|Overall Study|Lost to Follow-up|2
5657708|NCT00519532|19534163|P1|Overall Study|Withdrawal by Subject|5
5657709|NCT00519532|19534163|P1|Overall Study|Adverse Event|11
5657710|NCT00519428|19534173|P3|Overall Study|unstated|2
5657711|NCT00519428|19534174|P2|Overall Study|unstated|3
5657712|NCT00519428|19534175|P1|Overall Study|unstated|1
5657713|NCT00519428|19534173|P3|Overall Study|Withdrawal by Subject|7
5657714|NCT00519428|19534174|P2|Overall Study|Withdrawal by Subject|3
5657715|NCT00519428|19534175|P1|Overall Study|Withdrawal by Subject|8
5657716|NCT00519428|19534173|P3|Overall Study|Lost to Follow-up|6
5657717|NCT00519428|19534174|P2|Overall Study|Lost to Follow-up|7
5657718|NCT00519428|19534175|P1|Overall Study|Lost to Follow-up|7
5657719|NCT00519428|19534173|P3|Overall Study|Adverse Event|10
5657720|NCT00519428|19534174|P2|Overall Study|Adverse Event|2
5657721|NCT00519428|19534175|P1|Overall Study|Adverse Event|5
5657722|NCT00519376|19534195|P16|Treatment Period 4|Lost to Follow-up|0
5657723|NCT00519376|19534196|P15|Treatment Period 4|Lost to Follow-up|0
5657724|NCT00519376|19534197|P14|Treatment Period 4|Lost to Follow-up|0
5657725|NCT00519376|19534198|P13|Treatment Period 4|Lost to Follow-up|0
5657726|NCT00519376|19534199|P12|Treatment Period 4|Lost to Follow-up|0
5657727|NCT00519376|19534200|P11|Treatment Period 4|Lost to Follow-up|0
5657728|NCT00519376|19534201|P10|Treatment Period 4|Lost to Follow-up|0
5657729|NCT00519376|19534202|P9|Treatment Period 4|Lost to Follow-up|0
5657730|NCT00519376|19534203|P8|Treatment Period 4|Lost to Follow-up|0
5657731|NCT00519376|19534204|P7|Treatment Period 4|Lost to Follow-up|0
5657732|NCT00519376|19534205|P6|Treatment Period 4|Lost to Follow-up|0
5657733|NCT00519376|19534206|P5|Treatment Period 4|Lost to Follow-up|0
5657734|NCT00519376|19534207|P4|Treatment Period 4|Lost to Follow-up|0
5657735|NCT00519376|19534208|P3|Treatment Period 4|Lost to Follow-up|1
5657736|NCT00519376|19534209|P2|Treatment Period 4|Lost to Follow-up|0
5657737|NCT00519376|19534210|P1|Treatment Period 4|Lost to Follow-up|0
5657738|NCT00519376|19534195|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657739|NCT00519376|19534196|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657740|NCT00519376|19534197|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657741|NCT00519376|19534198|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
5657742|NCT00519376|19534199|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657743|NCT00519376|19534200|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657744|NCT00519376|19534201|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657745|NCT00519376|19534202|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657746|NCT00519376|19534203|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657747|NCT00519376|19534204|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657748|NCT00519376|19534205|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657749|NCT00519376|19534206|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657750|NCT00519376|19534207|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657751|NCT00519376|19534208|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657752|NCT00519376|19534209|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657753|NCT00519376|19534210|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
5657754|NCT00519285|19534334|P2|Overall Study|Treatment ongoing|2
5657755|NCT00519285|19534335|P1|Overall Study|Treatment ongoing|1
5657756|NCT00519285|19534334|P2|Overall Study|Not treated|7
5657757|NCT00519285|19534335|P1|Overall Study|Not treated|8
5657758|NCT00519285|19534334|P2|Overall Study|Reason unspecified|8
5657759|NCT00519285|19534335|P1|Overall Study|Reason unspecified|5
5657760|NCT00519285|19534334|P2|Overall Study|Poor compliance to protocol|7
5657761|NCT00519285|19534335|P1|Overall Study|Poor compliance to protocol|5
5657762|NCT00519285|19534334|P2|Overall Study|Consent withdrawn|5
5657763|NCT00519285|19534335|P1|Overall Study|Consent withdrawn|4
5657764|NCT00519285|19534334|P2|Overall Study|Participant's request|84
5657765|NCT00519285|19534335|P1|Overall Study|Participant's request|53
5657766|NCT00519285|19534334|P2|Overall Study|Physician Decision|47
5657767|NCT00519285|19534335|P1|Overall Study|Physician Decision|75
5657768|NCT00519285|19534334|P2|Overall Study|Disease progression|186
5657769|NCT00519285|19534335|P1|Overall Study|Disease progression|334
5657770|NCT00519285|19534334|P2|Overall Study|Adverse Event|266
5657771|NCT00519285|19534335|P1|Overall Study|Adverse Event|127
5657772|NCT00519194|19534361|P1|Overall Study|Lost to Follow-up|3
5657773|NCT00519194|19534361|P1|Overall Study|Death|9
5657774|NCT00519194|19534361|P1|Overall Study|Withdrawal by Subject|9
5657775|NCT00519077|19534376|P1|Overall Study|Other|2
5657776|NCT00519077|19534376|P1|Overall Study|Death|6
5657777|NCT00518986|19534383|P2|Overall Study|Non-Specific|1
5657778|NCT00518986|19534384|P1|Overall Study|Non-Specific|2
5657779|NCT00518986|19534383|P2|Overall Study|Withdrawal by Subject|4
5657780|NCT00518986|19534384|P1|Overall Study|Withdrawal by Subject|4
5657781|NCT00518986|19534383|P2|Overall Study|Protocol Violation|7
5657782|NCT00518986|19534384|P1|Overall Study|Protocol Violation|5
5657783|NCT00518986|19534383|P2|Overall Study|Physician Decision|3
5657784|NCT00518986|19534384|P1|Overall Study|Physician Decision|0
5657785|NCT00518986|19534383|P2|Overall Study|Lost to Follow-up|2
5657786|NCT00518986|19534384|P1|Overall Study|Lost to Follow-up|3
5657787|NCT00518986|19534383|P2|Overall Study|Lack of Efficacy|2
5657788|NCT00518986|19534384|P1|Overall Study|Lack of Efficacy|0
5657789|NCT00518986|19534383|P2|Overall Study|Adverse Event|7
5657790|NCT00518986|19534384|P1|Overall Study|Adverse Event|12
5657791|NCT00518973|19534510|P2|Overall Study|Withdrawal by Subject|2
5657792|NCT00518973|19534511|P1|Overall Study|Withdrawal by Subject|3
5657793|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
5657794|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
5657795|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Subject decision|0
5657796|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Subject decision|2
5657797|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
5657798|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
5657799|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
5657800|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
5657801|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Creatine increased|0
5657802|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Creatine increased|1
5657803|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Change in treatment|1
5657804|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Change in treatment|1
5657805|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
5657806|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
5657807|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
5657808|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
5657809|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
5657810|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
5657811|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
5657812|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
5657813|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
5657814|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
5657815|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
5657816|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
5657817|NCT00518882|19534527|P2|Open-Label Extension, Week 26-78|Adverse Event|9
5657818|NCT00518882|19534528|P1|Open-Label Extension, Week 26-78|Adverse Event|3
5657819|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Mutual consent|1
5657820|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Mutual consent|0
5657821|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
5657822|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
5657823|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
5657824|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
5657825|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Loss of trust|1
5657826|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Loss of trust|0
5657827|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
5657828|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
5657829|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Subject decision|1
5657830|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Subject decision|1
5657831|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Lost to follow up|1
5657832|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Lost to follow up|2
5657833|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
5657834|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
5657835|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Protocol Violation|3
5657836|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Protocol Violation|4
5657837|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
5657838|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
5657839|NCT00518882|19534527|P2|Double-Blind, Week 0-26|Adverse Event|31
5657840|NCT00518882|19534528|P1|Double-Blind, Week 0-26|Adverse Event|23
5657841|NCT00518687|19534709|P2|Overall Study|Withdrawal by Subject|110
5657842|NCT00518687|19534710|P1|Overall Study|Withdrawal by Subject|110
5657843|NCT00518687|19534709|P2|Overall Study|Study terminated by sponsor|918
5657844|NCT00518687|19534710|P1|Overall Study|Study terminated by sponsor|930
5657845|NCT00518687|19534709|P2|Overall Study|Protocol Violation|10
5657846|NCT00518687|19534710|P1|Overall Study|Protocol Violation|8
5657847|NCT00518687|19534709|P2|Overall Study|Progressive disease|2
5657848|NCT00518687|19534710|P1|Overall Study|Progressive disease|2
5657849|NCT00518687|19534709|P2|Overall Study|Physician Decision|48
5657850|NCT00518687|19534710|P1|Overall Study|Physician Decision|42
5657851|NCT00518687|19534709|P2|Overall Study|Lost to Follow-up|155
5657852|NCT00518687|19534710|P1|Overall Study|Lost to Follow-up|144
5657853|NCT00518687|19534709|P2|Overall Study|Adverse Event|177
5657854|NCT00518687|19534710|P1|Overall Study|Adverse Event|201
5657855|NCT00518622|19534730|P8|Overall Study|Study medication taken incorrectly|0
5657856|NCT00518622|19534731|P7|Overall Study|Study medication taken incorrectly|0
5657857|NCT00518622|19534732|P6|Overall Study|Study medication taken incorrectly|0
5657858|NCT00518622|19534733|P5|Overall Study|Study medication taken incorrectly|0
5657859|NCT00518622|19534734|P4|Overall Study|Study medication taken incorrectly|0
5657860|NCT00518622|19534735|P3|Overall Study|Study medication taken incorrectly|0
5657861|NCT00518622|19534736|P2|Overall Study|Study medication taken incorrectly|1
5657862|NCT00518622|19534737|P1|Overall Study|Study medication taken incorrectly|0
5657863|NCT00518622|19534730|P8|Overall Study|Lost to Follow-up|0
5657864|NCT00518622|19534731|P7|Overall Study|Lost to Follow-up|0
5657865|NCT00518622|19534732|P6|Overall Study|Lost to Follow-up|0
5657866|NCT00518622|19534733|P5|Overall Study|Lost to Follow-up|0
5657867|NCT00518622|19534734|P4|Overall Study|Lost to Follow-up|0
5657868|NCT00518622|19534735|P3|Overall Study|Lost to Follow-up|1
5657869|NCT00518622|19534736|P2|Overall Study|Lost to Follow-up|0
5657870|NCT00518622|19534737|P1|Overall Study|Lost to Follow-up|0
5657871|NCT00518531|19534765|P2|Treatment Period 2|Non-compliance|2
5657872|NCT00518531|19534766|P1|Treatment Period 2|Non-compliance|1
5657873|NCT00518531|19534765|P2|Treatment Period 2|Protocol-specified criteria|1
5657874|NCT00518531|19534766|P1|Treatment Period 2|Protocol-specified criteria|0
5657875|NCT00518531|19534765|P2|Treatment Period 2|Adverse Event|7
5657876|NCT00518531|19534766|P1|Treatment Period 2|Adverse Event|1
5657877|NCT00518531|19534765|P2|Treatment Period 2|Complete out of scheduled visit window|2
5657878|NCT00518531|19534766|P1|Treatment Period 2|Complete out of scheduled visit window|1
5657879|NCT00518531|19534765|P2|Treatment Period 2|Withdrawal by Subject|8
5657880|NCT00518531|19534766|P1|Treatment Period 2|Withdrawal by Subject|0
5657881|NCT00518531|19534765|P2|Treatment Period 1|Early crossover|3
5657882|NCT00518531|19534766|P1|Treatment Period 1|Early crossover|1
5657883|NCT00518531|19534765|P2|Treatment Period 1|Withdrawal by Subject|6
5657884|NCT00518531|19534766|P1|Treatment Period 1|Withdrawal by Subject|4
5657885|NCT00518531|19534765|P2|Treatment Period 1|Protocol Violation|0
5657886|NCT00518531|19534766|P1|Treatment Period 1|Protocol Violation|2
5657887|NCT00518531|19534765|P2|Treatment Period 1|Physician Decision|0
5657888|NCT00518531|19534766|P1|Treatment Period 1|Physician Decision|1
5657889|NCT00518531|19534765|P2|Treatment Period 1|Lost to Follow-up|3
5657890|NCT00518531|19534766|P1|Treatment Period 1|Lost to Follow-up|5
5657891|NCT00518531|19534765|P2|Treatment Period 1|Adverse Event|0
5657892|NCT00518531|19534766|P1|Treatment Period 1|Adverse Event|5
5657893|NCT00518336|19534811|P2|Year 9|Personal reasons|0
5657894|NCT00518336|19534812|P1|Year 9|Personal reasons|1
5657895|NCT00518336|19534811|P2|Year 9|Lost to Follow-up|0
5657896|NCT00518336|19534812|P1|Year 9|Lost to Follow-up|3
5657897|NCT00518336|19534811|P2|Year 9|Migrated/moved from study area|1
5657898|NCT00518336|19534812|P1|Year 9|Migrated/moved from study area|1
5657899|NCT00518336|19534811|P2|Year 8|Could not attend in time|1
5657900|NCT00518336|19534812|P1|Year 8|Could not attend in time|0
5657901|NCT00518336|19534811|P2|Year 8|Lost to Follow-up|1
5657902|NCT00518336|19534812|P1|Year 8|Lost to Follow-up|1
5657903|NCT00518336|19534811|P2|Year 7|Could not attend in time|3
5657904|NCT00518336|19534812|P1|Year 7|Could not attend in time|0
5657905|NCT00518336|19534811|P2|Year 7|Lost to Follow-up|0
5657906|NCT00518336|19534812|P1|Year 7|Lost to Follow-up|2
5657907|NCT00518323|19534978|P4|Overall Study|Prohibited medication and others|0
5657908|NCT00518323|19534979|P3|Overall Study|Prohibited medication and others|1
5657909|NCT00518323|19534980|P2|Overall Study|Prohibited medication and others|1
5657910|NCT00518323|19534981|P1|Overall Study|Prohibited medication and others|3
5657911|NCT00518323|19534978|P4|Overall Study|Adverse Event|0
5657912|NCT00518323|19534979|P3|Overall Study|Adverse Event|1
5657913|NCT00518323|19534980|P2|Overall Study|Adverse Event|1
5657914|NCT00518323|19534981|P1|Overall Study|Adverse Event|1
5657915|NCT00518323|19534978|P4|Overall Study|Lost to Follow-up|3
5657916|NCT00518323|19534979|P3|Overall Study|Lost to Follow-up|1
5657917|NCT00518323|19534980|P2|Overall Study|Lost to Follow-up|2
5657918|NCT00518323|19534981|P1|Overall Study|Lost to Follow-up|0
5657919|NCT00518323|19534978|P4|Overall Study|Withdrawal by Subject|2
5657920|NCT00518323|19534979|P3|Overall Study|Withdrawal by Subject|4
5657921|NCT00518323|19534980|P2|Overall Study|Withdrawal by Subject|2
5657922|NCT00518323|19534981|P1|Overall Study|Withdrawal by Subject|1
5657923|NCT00518323|19534978|P4|Overall Study|Lack of Efficacy|20
5657924|NCT00518323|19534979|P3|Overall Study|Lack of Efficacy|4
5657925|NCT00518323|19534980|P2|Overall Study|Lack of Efficacy|2
5657926|NCT00518323|19534981|P1|Overall Study|Lack of Efficacy|14
5657927|NCT00518284|19535011|P4|Overall Study|Study Termination|2
5657928|NCT00518284|19535012|P3|Overall Study|Study Termination|1
5657929|NCT00518284|19535013|P2|Overall Study|Study Termination|2
5657930|NCT00518284|19535014|P1|Overall Study|Study Termination|0
5657931|NCT00518284|19535011|P4|Overall Study|Adverse Event|0
5657932|NCT00518284|19535012|P3|Overall Study|Adverse Event|0
5657933|NCT00518284|19535013|P2|Overall Study|Adverse Event|1
5657934|NCT00518284|19535014|P1|Overall Study|Adverse Event|0
5657935|NCT00518206|19535070|P2|Overall Study|Completion Status Unknown|0
5657936|NCT00518206|19535071|P1|Overall Study|Completion Status Unknown|1
5657937|NCT00518206|19535070|P2|Overall Study|Reason Unknown|0
5657938|NCT00518206|19535071|P1|Overall Study|Reason Unknown|1
5657939|NCT00518206|19535070|P2|Overall Study|Drug Supply Issue|0
5657940|NCT00518206|19535071|P1|Overall Study|Drug Supply Issue|1
5657941|NCT00518206|19535070|P2|Overall Study|Withdrawal by Subject|0
5657942|NCT00518206|19535071|P1|Overall Study|Withdrawal by Subject|2
5657943|NCT00518206|19535070|P2|Overall Study|Disease Progression Requiring Therapy|6
5657944|NCT00518206|19535071|P1|Overall Study|Disease Progression Requiring Therapy|6
5657945|NCT00518180|19535088|P3|Overall Study|Adverse Event|0
5657946|NCT00518180|19535089|P2|Overall Study|Adverse Event|0
5657947|NCT00518180|19535090|P1|Overall Study|Adverse Event|1
5657948|NCT00518180|19535088|P3|Overall Study|Unable to classify|0
5657949|NCT00518180|19535089|P2|Overall Study|Unable to classify|2
5657950|NCT00518180|19535090|P1|Overall Study|Unable to classify|0
5657951|NCT00518180|19535088|P3|Overall Study|Protocol Violation|4
5657952|NCT00518180|19535089|P2|Overall Study|Protocol Violation|7
5657953|NCT00518180|19535090|P1|Overall Study|Protocol Violation|5
5657954|NCT00518180|19535088|P3|Overall Study|Administrative reason|2
5657955|NCT00518180|19535089|P2|Overall Study|Administrative reason|2
5657956|NCT00518180|19535090|P1|Overall Study|Administrative reason|0
5657957|NCT00518180|19535088|P3|Overall Study|Lost to Follow-up|34
5657958|NCT00518180|19535089|P2|Overall Study|Lost to Follow-up|28
5657959|NCT00518180|19535090|P1|Overall Study|Lost to Follow-up|30
5657960|NCT00518180|19535088|P3|Overall Study|Withdrawal by Subject|42
5657961|NCT00518180|19535089|P2|Overall Study|Withdrawal by Subject|30
5657962|NCT00518180|19535090|P1|Overall Study|Withdrawal by Subject|29
5657963|NCT00518115|19535146|P10|Overall Study|Moved Out of State|1
5657964|NCT00518115|19535147|P9|Overall Study|Moved Out of State|0
5657965|NCT00518115|19535148|P8|Overall Study|Moved Out of State|0
5657966|NCT00518115|19535149|P7|Overall Study|Moved Out of State|0
5657967|NCT00518115|19535150|P6|Overall Study|Moved Out of State|0
5657968|NCT00518115|19535151|P5|Overall Study|Moved Out of State|0
5657969|NCT00518115|19535152|P4|Overall Study|Moved Out of State|0
5657970|NCT00518115|19535153|P3|Overall Study|Moved Out of State|0
5657971|NCT00518115|19535154|P2|Overall Study|Moved Out of State|0
5657972|NCT00518115|19535155|P1|Overall Study|Moved Out of State|0
5657973|NCT00518115|19535146|P10|Overall Study|Withdrew Consent|0
5657974|NCT00518115|19535147|P9|Overall Study|Withdrew Consent|0
5657975|NCT00518115|19535148|P8|Overall Study|Withdrew Consent|0
5657976|NCT00518115|19535149|P7|Overall Study|Withdrew Consent|0
5657977|NCT00518115|19535150|P6|Overall Study|Withdrew Consent|1
5657978|NCT00518115|19535151|P5|Overall Study|Withdrew Consent|0
5657979|NCT00518115|19535152|P4|Overall Study|Withdrew Consent|0
5657980|NCT00518115|19535153|P3|Overall Study|Withdrew Consent|0
5657981|NCT00518115|19535154|P2|Overall Study|Withdrew Consent|0
5657982|NCT00518115|19535155|P1|Overall Study|Withdrew Consent|0
5657983|NCT00518115|19535146|P10|Overall Study|Family Emergency; Had to Go to England|0
5657984|NCT00518115|19535147|P9|Overall Study|Family Emergency; Had to Go to England|0
5657985|NCT00518115|19535148|P8|Overall Study|Family Emergency; Had to Go to England|0
5657986|NCT00518115|19535149|P7|Overall Study|Family Emergency; Had to Go to England|0
5657987|NCT00518115|19535150|P6|Overall Study|Family Emergency; Had to Go to England|0
5657988|NCT00518115|19535151|P5|Overall Study|Family Emergency; Had to Go to England|1
5657989|NCT00518115|19535152|P4|Overall Study|Family Emergency; Had to Go to England|0
5657990|NCT00518115|19535153|P3|Overall Study|Family Emergency; Had to Go to England|0
5657991|NCT00518115|19535154|P2|Overall Study|Family Emergency; Had to Go to England|0
5657992|NCT00518115|19535155|P1|Overall Study|Family Emergency; Had to Go to England|0
5657993|NCT00518115|19535146|P10|Overall Study|Violation of Exclusion Criteria|0
5657994|NCT00518115|19535147|P9|Overall Study|Violation of Exclusion Criteria|0
5657995|NCT00518115|19535148|P8|Overall Study|Violation of Exclusion Criteria|0
5657996|NCT00518115|19535149|P7|Overall Study|Violation of Exclusion Criteria|1
5657997|NCT00518115|19535150|P6|Overall Study|Violation of Exclusion Criteria|0
5657998|NCT00518115|19535151|P5|Overall Study|Violation of Exclusion Criteria|0
5657999|NCT00518115|19535152|P4|Overall Study|Violation of Exclusion Criteria|1
5658000|NCT00518115|19535153|P3|Overall Study|Violation of Exclusion Criteria|0
5658001|NCT00518115|19535154|P2|Overall Study|Violation of Exclusion Criteria|0
5658002|NCT00518115|19535155|P1|Overall Study|Violation of Exclusion Criteria|0
5658003|NCT00518115|19535146|P10|Overall Study|Wrong Monotherapy Administered|0
5658004|NCT00518115|19535147|P9|Overall Study|Wrong Monotherapy Administered|0
5658005|NCT00518115|19535148|P8|Overall Study|Wrong Monotherapy Administered|0
5658006|NCT00518115|19535149|P7|Overall Study|Wrong Monotherapy Administered|1
5658007|NCT00518115|19535150|P6|Overall Study|Wrong Monotherapy Administered|0
5658008|NCT00518115|19535151|P5|Overall Study|Wrong Monotherapy Administered|0
5658009|NCT00518115|19535152|P4|Overall Study|Wrong Monotherapy Administered|0
5658010|NCT00518115|19535153|P3|Overall Study|Wrong Monotherapy Administered|1
5658011|NCT00518115|19535154|P2|Overall Study|Wrong Monotherapy Administered|0
5658012|NCT00518115|19535155|P1|Overall Study|Wrong Monotherapy Administered|0
5658013|NCT00518115|19535146|P10|Overall Study|Different Monotherapy Diabetic Drug|0
5658014|NCT00518115|19535147|P9|Overall Study|Different Monotherapy Diabetic Drug|1
5658015|NCT00518115|19535148|P8|Overall Study|Different Monotherapy Diabetic Drug|0
5658016|NCT00518115|19535149|P7|Overall Study|Different Monotherapy Diabetic Drug|0
5658017|NCT00518115|19535150|P6|Overall Study|Different Monotherapy Diabetic Drug|0
5658018|NCT00518115|19535151|P5|Overall Study|Different Monotherapy Diabetic Drug|0
5658019|NCT00518115|19535152|P4|Overall Study|Different Monotherapy Diabetic Drug|0
5658020|NCT00518115|19535153|P3|Overall Study|Different Monotherapy Diabetic Drug|1
5658021|NCT00518115|19535154|P2|Overall Study|Different Monotherapy Diabetic Drug|0
5658022|NCT00518115|19535155|P1|Overall Study|Different Monotherapy Diabetic Drug|0
5658023|NCT00518115|19535146|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
5658024|NCT00518115|19535147|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
5658025|NCT00518115|19535148|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
5658026|NCT00518115|19535149|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
5658027|NCT00518115|19535150|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
5658028|NCT00518115|19535151|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
5658029|NCT00518115|19535152|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
5658030|NCT00518115|19535153|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
5658031|NCT00518115|19535154|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
5658032|NCT00518115|19535155|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
5658033|NCT00518115|19535146|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
5658034|NCT00518115|19535147|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
5658035|NCT00518115|19535148|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
5658036|NCT00518115|19535149|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
5658037|NCT00518115|19535150|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
5658038|NCT00518115|19535151|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
5658039|NCT00518115|19535152|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
5658040|NCT00518115|19535153|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
5658041|NCT00518115|19535154|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
5658042|NCT00518115|19535155|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
5658043|NCT00518115|19535146|P10|Overall Study|Non-Compliance|1
5658044|NCT00518115|19535147|P9|Overall Study|Non-Compliance|0
5658045|NCT00518115|19535148|P8|Overall Study|Non-Compliance|1
5658046|NCT00518115|19535149|P7|Overall Study|Non-Compliance|1
5658047|NCT00518115|19535150|P6|Overall Study|Non-Compliance|1
5658048|NCT00518115|19535151|P5|Overall Study|Non-Compliance|1
5658049|NCT00518115|19535152|P4|Overall Study|Non-Compliance|0
5658050|NCT00518115|19535153|P3|Overall Study|Non-Compliance|1
5658051|NCT00518115|19535154|P2|Overall Study|Non-Compliance|0
5658052|NCT00518115|19535155|P1|Overall Study|Non-Compliance|1
5658053|NCT00518115|19535146|P10|Overall Study|Lack of Efficacy|0
5658054|NCT00518115|19535147|P9|Overall Study|Lack of Efficacy|0
5658055|NCT00518115|19535148|P8|Overall Study|Lack of Efficacy|1
5658056|NCT00518115|19535149|P7|Overall Study|Lack of Efficacy|0
5658057|NCT00518115|19535150|P6|Overall Study|Lack of Efficacy|0
5658058|NCT00518115|19535151|P5|Overall Study|Lack of Efficacy|0
5658059|NCT00518115|19535152|P4|Overall Study|Lack of Efficacy|1
5658060|NCT00518115|19535153|P3|Overall Study|Lack of Efficacy|1
5658061|NCT00518115|19535154|P2|Overall Study|Lack of Efficacy|0
5658062|NCT00518115|19535155|P1|Overall Study|Lack of Efficacy|1
5658063|NCT00518115|19535146|P10|Overall Study|Withdrawal by Subject|3
5658064|NCT00518115|19535147|P9|Overall Study|Withdrawal by Subject|1
5658065|NCT00518115|19535148|P8|Overall Study|Withdrawal by Subject|2
5658066|NCT00518115|19535149|P7|Overall Study|Withdrawal by Subject|0
5658067|NCT00518115|19535150|P6|Overall Study|Withdrawal by Subject|1
5658068|NCT00518115|19535151|P5|Overall Study|Withdrawal by Subject|2
5658069|NCT00518115|19535152|P4|Overall Study|Withdrawal by Subject|0
5658070|NCT00518115|19535153|P3|Overall Study|Withdrawal by Subject|5
5658071|NCT00518115|19535154|P2|Overall Study|Withdrawal by Subject|1
5658072|NCT00518115|19535155|P1|Overall Study|Withdrawal by Subject|1
5658073|NCT00518115|19535146|P10|Overall Study|Protocol Violation|0
5658074|NCT00518115|19535147|P9|Overall Study|Protocol Violation|0
5658075|NCT00518115|19535148|P8|Overall Study|Protocol Violation|0
5658076|NCT00518115|19535149|P7|Overall Study|Protocol Violation|0
5658077|NCT00518115|19535150|P6|Overall Study|Protocol Violation|0
5658078|NCT00518115|19535151|P5|Overall Study|Protocol Violation|0
5658079|NCT00518115|19535152|P4|Overall Study|Protocol Violation|0
5658080|NCT00518115|19535153|P3|Overall Study|Protocol Violation|1
5658081|NCT00518115|19535154|P2|Overall Study|Protocol Violation|3
5658082|NCT00518115|19535155|P1|Overall Study|Protocol Violation|1
5658083|NCT00518115|19535146|P10|Overall Study|Lost to Follow-up|1
5658084|NCT00518115|19535147|P9|Overall Study|Lost to Follow-up|1
5658085|NCT00518115|19535148|P8|Overall Study|Lost to Follow-up|1
5658086|NCT00518115|19535149|P7|Overall Study|Lost to Follow-up|0
5658087|NCT00518115|19535150|P6|Overall Study|Lost to Follow-up|3
5658088|NCT00518115|19535151|P5|Overall Study|Lost to Follow-up|1
5658089|NCT00518115|19535152|P4|Overall Study|Lost to Follow-up|3
5658090|NCT00518115|19535153|P3|Overall Study|Lost to Follow-up|2
5658091|NCT00518115|19535154|P2|Overall Study|Lost to Follow-up|0
5658092|NCT00518115|19535155|P1|Overall Study|Lost to Follow-up|0
5658093|NCT00518115|19535146|P10|Overall Study|Adverse Event|9
5658094|NCT00518115|19535147|P9|Overall Study|Adverse Event|2
5658095|NCT00518115|19535148|P8|Overall Study|Adverse Event|10
5658096|NCT00518115|19535149|P7|Overall Study|Adverse Event|5
5658097|NCT00518115|19535150|P6|Overall Study|Adverse Event|5
5658098|NCT00518115|19535151|P5|Overall Study|Adverse Event|5
5658099|NCT00518115|19535152|P4|Overall Study|Adverse Event|6
5658100|NCT00518115|19535153|P3|Overall Study|Adverse Event|5
5658101|NCT00518115|19535154|P2|Overall Study|Adverse Event|1
5658102|NCT00518115|19535155|P1|Overall Study|Adverse Event|6
5658103|NCT00518011|19535330|P2|Overall Study|Withdrawal by Subject|0
5658104|NCT00518011|19535331|P1|Overall Study|Withdrawal by Subject|1
5658105|NCT00518011|19535330|P2|Overall Study|Other Reasons|2
5658106|NCT00518011|19535331|P1|Overall Study|Other Reasons|3
5658107|NCT00518011|19535330|P2|Overall Study|Disease Progression|2
5658108|NCT00518011|19535331|P1|Overall Study|Disease Progression|2
5658109|NCT00518011|19535330|P2|Overall Study|Adverse Event|3
5658110|NCT00518011|19535331|P1|Overall Study|Adverse Event|2
5658111|NCT00518011|19535330|P2|Overall Study|Death|1
5658112|NCT00518011|19535331|P1|Overall Study|Death|1
5658113|NCT00517933|19535353|P2|Period 2|Underwent lung transplant|2
5658114|NCT00517933|19535354|P1|Period 2|Underwent lung transplant|0
5658115|NCT00517933|19535353|P2|Period 2|Withdrawal by Subject|3
5658116|NCT00517933|19535354|P1|Period 2|Withdrawal by Subject|1
5658117|NCT00517933|19535353|P2|Period 2|Physician Decision|0
5658118|NCT00517933|19535354|P1|Period 2|Physician Decision|1
5658119|NCT00517933|19535353|P2|Period 2|Adverse Event|4
5658120|NCT00517933|19535354|P1|Period 2|Adverse Event|2
5658121|NCT00517933|19535353|P2|Period 2|Death|4
5658122|NCT00517933|19535354|P1|Period 2|Death|2
5658123|NCT00517933|19535353|P2|Period 1|Underwent lung transplant|1
5658124|NCT00517933|19535354|P1|Period 1|Underwent lung transplant|0
5658125|NCT00517933|19535353|P2|Period 1|Lost to Follow-up|0
5658126|NCT00517933|19535354|P1|Period 1|Lost to Follow-up|2
5658127|NCT00517933|19535353|P2|Period 1|Adverse Event|4
5658128|NCT00517933|19535354|P1|Period 1|Adverse Event|4
5658129|NCT00517933|19535353|P2|Period 1|Death|1
5658130|NCT00517933|19535354|P1|Period 1|Death|2
5658131|NCT00517881|19535418|P1|Overall Study|Renal transplantation|2
5658132|NCT00517881|19535418|P1|Overall Study|Adverse Event|1
5658133|NCT00517881|19535418|P1|Overall Study|Protocol Violation|2
5658134|NCT00517829|19535430|P2|Overall Study|Other|1
5658135|NCT00517829|19535431|P1|Overall Study|Other|3
5658136|NCT00517829|19535430|P2|Overall Study|Investigator Request|3
5658137|NCT00517829|19535431|P1|Overall Study|Investigator Request|5
5658138|NCT00517829|19535430|P2|Overall Study|Patient Request|5
5658139|NCT00517829|19535431|P1|Overall Study|Patient Request|6
5658140|NCT00517829|19535430|P2|Overall Study|Disease Progression|32
5658141|NCT00517829|19535431|P1|Overall Study|Disease Progression|39
5658142|NCT00517829|19535430|P2|Overall Study|Adverse Event|34
5658143|NCT00517829|19535431|P1|Overall Study|Adverse Event|22
5658144|NCT00517751|19535445|P1|Overall Study|Missing|3
5658145|NCT00517751|19535445|P1|Overall Study|Patient not due for visit|76
5658146|NCT00517751|19535445|P1|Overall Study|patient not over due|6
5658147|NCT00517751|19535445|P1|Overall Study|Lost to Follow-up|4
5658148|NCT00517751|19535445|P1|Overall Study|Withdrawal by Subject|37
5658149|NCT00517751|19535445|P1|Overall Study|Death|3
5658150|NCT00517699|19535468|P1|Overall Study|Study terminated by Sponsor|2
5658151|NCT00517699|19535468|P1|Overall Study|Administrative error|1
5658152|NCT00517699|19535468|P1|Overall Study|Lack of Efficacy|1
5658153|NCT00517699|19535468|P1|Overall Study|Withdrawal by Subject|1
5658154|NCT00517634|19535476|P6|Second Treatment Period|Withdrawal by Subject|0
5658155|NCT00517634|19535477|P5|Second Treatment Period|Withdrawal by Subject|1
5658156|NCT00517634|19535478|P4|Second Treatment Period|Withdrawal by Subject|0
5658157|NCT00517634|19535479|P3|Second Treatment Period|Withdrawal by Subject|0
5658158|NCT00517634|19535480|P2|Second Treatment Period|Withdrawal by Subject|0
5658159|NCT00517634|19535481|P1|Second Treatment Period|Withdrawal by Subject|0
5658160|NCT00517413|19535583|P1|Overall Study|Other-Reasons|23
5658161|NCT00517413|19535583|P1|Overall Study|Failure to return|1
5658162|NCT00517413|19535583|P1|Overall Study|Withdrawal by Subject|2
5658163|NCT00517413|19535583|P1|Overall Study|Protocol Violation|15
5658164|NCT00517413|19535583|P1|Overall Study|Death|13
5658165|NCT00517413|19535583|P1|Overall Study|Adverse Event|7
5658166|NCT00517361|19535604|P1|Overall Study|The study was terminated|5
5658167|NCT00517361|19535604|P1|Overall Study|Death|6
5658168|NCT00517296|19535613|P2|Overall Study|Withdrawal by Subject|0
5658169|NCT00517296|19535614|P1|Overall Study|Withdrawal by Subject|1
5658170|NCT00517192|19535626|P2|Overall Study|Early termination of the trial|18
5658171|NCT00517192|19535627|P1|Overall Study|Early termination of the trial|16
5658172|NCT00517192|19535626|P2|Overall Study|Withdrawal by Subject|0
5658173|NCT00517192|19535627|P1|Overall Study|Withdrawal by Subject|1
5658174|NCT00517192|19535626|P2|Overall Study|Lost to Follow-up|1
5658175|NCT00517192|19535627|P1|Overall Study|Lost to Follow-up|1
5658176|NCT00517192|19535626|P2|Overall Study|Adverse Event|1
5658177|NCT00517192|19535627|P1|Overall Study|Adverse Event|1
5658178|NCT00516906|19535734|P2|Overall Study|Final Dressing Removal Data not captured|2
5658179|NCT00516906|19535735|P1|Overall Study|Final Dressing Removal Data not captured|6
5658180|NCT00516893|19535745|P1|Overall Study|Received Medication From Another Study|1
5658181|NCT00516893|19535745|P1|Overall Study|Pregnancy|1
5658182|NCT00516893|19535745|P1|Overall Study|Relocated|1
5658183|NCT00516893|19535745|P1|Overall Study|Persistent Antibodies per Protocol|6
5658184|NCT00516893|19535745|P1|Overall Study|Death|1
5658185|NCT00516893|19535745|P1|Overall Study|Noncompliance|2
5658186|NCT00516893|19535745|P1|Overall Study|Withdrawal by Subject|2
5658187|NCT00516893|19535745|P1|Overall Study|Adverse Event|3
5658188|NCT00516893|19535745|P1|Overall Study|Lost to Follow-up|4
5658189|NCT00516737|19535754|P2|Overall Study|Lack of Qualifying Event|6
5658190|NCT00516737|19535755|P1|Overall Study|Lack of Qualifying Event|9
5658191|NCT00516737|19535754|P2|Overall Study|Withdrawal by Subject|1
5658192|NCT00516737|19535755|P1|Overall Study|Withdrawal by Subject|0
5658193|NCT00516737|19535754|P2|Overall Study|Physician Decision|1
5658194|NCT00516737|19535755|P1|Overall Study|Physician Decision|0
5658195|NCT00516737|19535754|P2|Overall Study|Lost to Follow-up|0
5658196|NCT00516737|19535755|P1|Overall Study|Lost to Follow-up|2
5658197|NCT00516386|19535794|P1|Overall Study|Lost to Follow-up|2
5658198|NCT00516386|19535794|P1|Overall Study|not interested in the study|4
5658199|NCT00516321|19535801|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
5658200|NCT00516321|19535802|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
5658201|NCT00516321|19535803|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
5658202|NCT00516321|19535801|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
5658203|NCT00516321|19535802|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
5658204|NCT00516321|19535803|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
5658205|NCT00516321|19535801|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
5658206|NCT00516321|19535802|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
5658207|NCT00516321|19535803|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
5658208|NCT00516321|19535801|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
5658209|NCT00516321|19535802|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
5658210|NCT00516321|19535803|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
5658211|NCT00516321|19535801|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
5658212|NCT00516321|19535802|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
5658213|NCT00516321|19535803|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
5658214|NCT00516321|19535801|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
5658215|NCT00516321|19535802|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
5658216|NCT00516321|19535803|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
5658217|NCT00516321|19535801|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
5658218|NCT00516321|19535802|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
5658219|NCT00516321|19535803|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
5658220|NCT00516321|19535801|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
5658221|NCT00516321|19535802|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
5658222|NCT00516321|19535803|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
5658223|NCT00516321|19535801|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
5658224|NCT00516321|19535802|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
5658225|NCT00516321|19535803|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
5658226|NCT00516321|19535801|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
5658227|NCT00516321|19535802|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
5658228|NCT00516321|19535803|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
5658229|NCT00516321|19535801|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
5658230|NCT00516321|19535802|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
5658231|NCT00516321|19535803|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
5658232|NCT00516295|19535854|P3|Overall Study|Ineligible|0
5658233|NCT00516295|19535855|P2|Overall Study|Ineligible|0
5658234|NCT00516295|19535856|P1|Overall Study|Ineligible|1
5658235|NCT00516295|19535854|P3|Overall Study|Lack of Efficacy|0
5658236|NCT00516295|19535855|P2|Overall Study|Lack of Efficacy|0
5658237|NCT00516295|19535856|P1|Overall Study|Lack of Efficacy|2
5658238|NCT00516269|19535869|P2|Overall Study|Protocol Violation|1
5658239|NCT00516269|19535870|P1|Overall Study|Protocol Violation|0
5658240|NCT00516269|19535869|P2|Overall Study|Lost to Follow-up|1
5658241|NCT00516269|19535870|P1|Overall Study|Lost to Follow-up|0
5658242|NCT00516269|19535869|P2|Overall Study|Adverse Event|1
5658243|NCT00516269|19535870|P1|Overall Study|Adverse Event|2
5658244|NCT00516139|19535891|P1|Overall Study|Lack of Efficacy|1
5658245|NCT00516139|19535891|P1|Overall Study|Withdrawal by Subject|8
5658246|NCT00516139|19535891|P1|Overall Study|Protocol Violation|1
5658247|NCT00516139|19535891|P1|Overall Study|Lost to Follow-up|1
5658248|NCT00516139|19535891|P1|Overall Study|Adverse Event|27
5658249|NCT00516074|19535922|P2|Overall Study|Loss of Glucose Control|0
5658250|NCT00516074|19535923|P1|Overall Study|Loss of Glucose Control|2
5658251|NCT00516074|19535922|P2|Overall Study|Subject Decision|2
5658252|NCT00516074|19535923|P1|Overall Study|Subject Decision|4
5658253|NCT00516074|19535922|P2|Overall Study|Adverse Event|1
5658254|NCT00516074|19535923|P1|Overall Study|Adverse Event|0
5658255|NCT00516048|19535941|P3|Overall Study|Subject Decision|0
5658256|NCT00516048|19535942|P2|Overall Study|Subject Decision|2
5658257|NCT00516048|19535943|P1|Overall Study|Subject Decision|0
5658258|NCT00516048|19535941|P3|Overall Study|Death|1
5658259|NCT00516048|19535942|P2|Overall Study|Death|0
5658260|NCT00516048|19535943|P1|Overall Study|Death|0
5658261|NCT00515827|19535978|P2|Second Intervention (12 Weeks)|Consent withdraw|0
5658262|NCT00515827|19535979|P1|Second Intervention (12 Weeks)|Consent withdraw|1
5658263|NCT00515827|19535978|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
5658264|NCT00515827|19535979|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
5658265|NCT00515671|19536037|P2|Overall Study|incarcerated|2
5658266|NCT00515671|19536038|P1|Overall Study|incarcerated|1
5658267|NCT00515671|19536037|P2|Overall Study|Withdrawal by Subject|5
5658268|NCT00515671|19536038|P1|Overall Study|Withdrawal by Subject|3
5658269|NCT00515671|19536037|P2|Overall Study|Lost to Follow-up|10
5658270|NCT00515671|19536038|P1|Overall Study|Lost to Follow-up|13
5658271|NCT00515619|19536046|P1|Overall Study|Other: Subject interested in other AED|1
5658272|NCT00515619|19536046|P1|Overall Study|Other: Drug available on license|1
5658273|NCT00515619|19536046|P1|Overall Study|Other: Request from sponsor|1
5658274|NCT00515619|19536046|P1|Overall Study|Other: Subject became pregnant|1
5658275|NCT00515619|19536046|P1|Overall Study|Other: Investigator decision|1
5658276|NCT00515619|19536046|P1|Overall Study|Other: Subject moved to another country|1
5658277|NCT00515619|19536046|P1|Overall Study|Other: Subject required surgery|1
5658278|NCT00515619|19536046|P1|Overall Study|Other: Subject cannot attend visits|2
5658279|NCT00515619|19536046|P1|Overall Study|Other: Site discontinuing trials|2
5658280|NCT00515619|19536046|P1|Overall Study|Unsatisfactory compliance|6
5658281|NCT00515619|19536046|P1|Overall Study|Lost to Follow-up|4
5658282|NCT00515619|19536046|P1|Overall Study|Protocol Violation|3
5658283|NCT00515619|19536046|P1|Overall Study|Withdrawal by Subject|66
5658284|NCT00515619|19536046|P1|Overall Study|Lack of Efficacy|92
5658285|NCT00515619|19536046|P1|Overall Study|Adverse Event|34
5658286|NCT00515541|19536058|P4|Overall Study|Withdrawal by Subject|2
5658287|NCT00515541|19536059|P3|Overall Study|Withdrawal by Subject|0
5658288|NCT00515541|19536060|P2|Overall Study|Withdrawal by Subject|2
5658289|NCT00515541|19536061|P1|Overall Study|Withdrawal by Subject|0
5658290|NCT00515541|19536058|P4|Overall Study|No show for appointments|2
5658291|NCT00515541|19536059|P3|Overall Study|No show for appointments|0
5658292|NCT00515541|19536060|P2|Overall Study|No show for appointments|1
5658293|NCT00515541|19536061|P1|Overall Study|No show for appointments|0
5658294|NCT00515541|19536058|P4|Overall Study|Physician Decision|1
5658295|NCT00515541|19536059|P3|Overall Study|Physician Decision|0
5658296|NCT00515541|19536060|P2|Overall Study|Physician Decision|2
5658297|NCT00515541|19536061|P1|Overall Study|Physician Decision|0
5658298|NCT00515502|19536092|P12|Treatment Period 2|Adverse Event|0
5658299|NCT00515502|19536093|P11|Treatment Period 2|Adverse Event|0
5658300|NCT00515502|19536094|P10|Treatment Period 2|Adverse Event|0
5658301|NCT00515502|19536095|P9|Treatment Period 2|Adverse Event|0
5658302|NCT00515502|19536096|P8|Treatment Period 2|Adverse Event|0
5658303|NCT00515502|19536097|P7|Treatment Period 2|Adverse Event|0
5658304|NCT00515502|19536098|P6|Treatment Period 2|Adverse Event|0
5658305|NCT00515502|19536099|P5|Treatment Period 2|Adverse Event|0
5658306|NCT00515502|19536100|P4|Treatment Period 2|Adverse Event|0
5658307|NCT00515502|19536101|P3|Treatment Period 2|Adverse Event|0
5658308|NCT00515502|19536102|P2|Treatment Period 2|Adverse Event|1
5658309|NCT00515502|19536103|P1|Treatment Period 2|Adverse Event|0
5658310|NCT00515502|19536092|P12|Treatment Period 1|Adverse Event|1
5658311|NCT00515502|19536093|P11|Treatment Period 1|Adverse Event|0
5658312|NCT00515502|19536094|P10|Treatment Period 1|Adverse Event|0
5658313|NCT00515502|19536095|P9|Treatment Period 1|Adverse Event|1
5658314|NCT00515502|19536096|P8|Treatment Period 1|Adverse Event|0
5658315|NCT00515502|19536097|P7|Treatment Period 1|Adverse Event|1
5658316|NCT00515502|19536098|P6|Treatment Period 1|Adverse Event|0
5658317|NCT00515502|19536099|P5|Treatment Period 1|Adverse Event|0
5658318|NCT00515502|19536100|P4|Treatment Period 1|Adverse Event|0
5658319|NCT00515502|19536101|P3|Treatment Period 1|Adverse Event|0
5658320|NCT00515502|19536102|P2|Treatment Period 1|Adverse Event|0
5658321|NCT00515502|19536103|P1|Treatment Period 1|Adverse Event|0
5658322|NCT00515463|19536263|P2|Overall Study|Other|1
5658323|NCT00515463|19536264|P1|Overall Study|Other|0
5658324|NCT00515463|19536263|P2|Overall Study|Lost to Follow-up|5
5658325|NCT00515463|19536264|P1|Overall Study|Lost to Follow-up|6
5658326|NCT00515463|19536263|P2|Overall Study|Withdrawal by Subject|4
5658327|NCT00515463|19536264|P1|Overall Study|Withdrawal by Subject|3
5658328|NCT00515463|19536263|P2|Overall Study|Adverse Event|2
5658329|NCT00515463|19536264|P1|Overall Study|Adverse Event|1
5658330|NCT00515463|19536263|P2|Overall Study|Physician Decision|2
5658331|NCT00515463|19536264|P1|Overall Study|Physician Decision|4
5658332|NCT00515294|19536463|P4|Overall Study|Caffeine amount inaccurate|0
5658333|NCT00515294|19536464|P3|Overall Study|Caffeine amount inaccurate|7
5658334|NCT00515294|19536465|P2|Overall Study|Caffeine amount inaccurate|0
5658335|NCT00515294|19536466|P1|Overall Study|Caffeine amount inaccurate|5
5658336|NCT00515294|19536463|P4|Overall Study|Driver simulator problems|3
5658337|NCT00515294|19536464|P3|Overall Study|Driver simulator problems|1
5658338|NCT00515294|19536465|P2|Overall Study|Driver simulator problems|1
5658339|NCT00515294|19536466|P1|Overall Study|Driver simulator problems|1
5658340|NCT00515294|19536463|P4|Overall Study|Lost to Follow-up|1
5658341|NCT00515294|19536464|P3|Overall Study|Lost to Follow-up|3
5658342|NCT00515294|19536465|P2|Overall Study|Lost to Follow-up|2
5658343|NCT00515294|19536466|P1|Overall Study|Lost to Follow-up|3
5658344|NCT00515216|19536480|P1|Overall Study|Withdrawal by Subject|1
5658345|NCT00515112|19536542|P2|Overall Study|The study was terminated|2
5658346|NCT00515112|19536543|P1|Overall Study|The study was terminated|3
5658347|NCT00515112|19536542|P2|Overall Study|Death|1
5658348|NCT00515112|19536543|P1|Overall Study|Death|0
5658349|NCT00515099|19536553|P2|Overall Study|IRB Recommendation|0
5658350|NCT00515099|19536554|P1|Overall Study|IRB Recommendation|1
5658351|NCT00515099|19536553|P2|Overall Study|Withdrawal by Subject|0
5658352|NCT00515099|19536554|P1|Overall Study|Withdrawal by Subject|2
5658353|NCT00515099|19536553|P2|Overall Study|Lost to Follow-up|4
5658354|NCT00515099|19536554|P1|Overall Study|Lost to Follow-up|0
5658355|NCT00515086|19536576|P4|Overall Study|Death|0
5658356|NCT00515086|19536577|P3|Overall Study|Death|0
5658357|NCT00515086|19536578|P2|Overall Study|Death|0
5658358|NCT00515086|19536579|P1|Overall Study|Death|2
5658359|NCT00515086|19536576|P4|Overall Study|Study drug no longer required|0
5658360|NCT00515086|19536577|P3|Overall Study|Study drug no longer required|0
5658361|NCT00515086|19536578|P2|Overall Study|Study drug no longer required|1
5658362|NCT00515086|19536579|P1|Overall Study|Study drug no longer required|0
5658363|NCT00515086|19536576|P4|Overall Study|Lost to Follow-up|0
5658364|NCT00515086|19536577|P3|Overall Study|Lost to Follow-up|0
5658365|NCT00515086|19536578|P2|Overall Study|Lost to Follow-up|0
5658366|NCT00515086|19536579|P1|Overall Study|Lost to Follow-up|1
5658367|NCT00515086|19536576|P4|Overall Study|Unsatisfactory therapeutic effect|2
5658368|NCT00515086|19536577|P3|Overall Study|Unsatisfactory therapeutic effect|3
5658369|NCT00515086|19536578|P2|Overall Study|Unsatisfactory therapeutic effect|3
5658370|NCT00515086|19536579|P1|Overall Study|Unsatisfactory therapeutic effect|18
5658371|NCT00515086|19536576|P4|Overall Study|Withdrawal by Subject|1
5658372|NCT00515086|19536577|P3|Overall Study|Withdrawal by Subject|0
5658373|NCT00515086|19536578|P2|Overall Study|Withdrawal by Subject|0
5658374|NCT00515086|19536579|P1|Overall Study|Withdrawal by Subject|1
5658375|NCT00515086|19536576|P4|Overall Study|Administrative|0
5658376|NCT00515086|19536577|P3|Overall Study|Administrative|0
5658377|NCT00515086|19536578|P2|Overall Study|Administrative|1
5658378|NCT00515086|19536579|P1|Overall Study|Administrative|1
5658379|NCT00515086|19536576|P4|Overall Study|Adverse Event|3
5658380|NCT00515086|19536577|P3|Overall Study|Adverse Event|2
5658381|NCT00515086|19536578|P2|Overall Study|Adverse Event|1
5658382|NCT00515086|19536579|P1|Overall Study|Adverse Event|1
5658383|NCT00515073|19536606|P1|Overall Study|Physician Decision|1
5658384|NCT00515073|19536606|P1|Overall Study|Withdrawal by Subject|1
5658385|NCT00515034|19536614|P4|Overall Study|Other|1
5658386|NCT00515034|19536615|P3|Overall Study|Other|2
5658387|NCT00515034|19536616|P2|Overall Study|Other|0
5658388|NCT00515034|19536617|P1|Overall Study|Other|1
5658389|NCT00515034|19536614|P4|Overall Study|Physician Decision|1
5658390|NCT00515034|19536615|P3|Overall Study|Physician Decision|1
5658391|NCT00515034|19536616|P2|Overall Study|Physician Decision|0
5658392|NCT00515034|19536617|P1|Overall Study|Physician Decision|0
5658393|NCT00515034|19536614|P4|Overall Study|Withdrawal by Subject|0
5658394|NCT00515034|19536615|P3|Overall Study|Withdrawal by Subject|3
5658395|NCT00515034|19536616|P2|Overall Study|Withdrawal by Subject|0
5658396|NCT00515034|19536617|P1|Overall Study|Withdrawal by Subject|1
5658397|NCT00515034|19536614|P4|Overall Study|Death|3
5658398|NCT00515034|19536615|P3|Overall Study|Death|1
5658399|NCT00515034|19536616|P2|Overall Study|Death|2
5658400|NCT00515034|19536617|P1|Overall Study|Death|4
5658401|NCT00515034|19536614|P4|Overall Study|Adverse Event|0
5658402|NCT00515034|19536615|P3|Overall Study|Adverse Event|1
5658403|NCT00515034|19536616|P2|Overall Study|Adverse Event|0
5658404|NCT00515034|19536617|P1|Overall Study|Adverse Event|2
5658405|NCT00515008|19536648|P2|Overall Study|Scheduling conflict|0
5658406|NCT00515008|19536649|P1|Overall Study|Scheduling conflict|1
5658407|NCT00515008|19536648|P2|Overall Study|Left the Boston Area|1
5658408|NCT00515008|19536649|P1|Overall Study|Left the Boston Area|1
5658409|NCT00515008|19536648|P2|Overall Study|Declined|3
5658410|NCT00515008|19536649|P1|Overall Study|Declined|0
5658411|NCT00515008|19536648|P2|Overall Study|Lost to Follow-up|0
5658412|NCT00515008|19536649|P1|Overall Study|Lost to Follow-up|1
5658413|NCT00514943|19536673|P2|Stage 2|Other than stated above|2
5658414|NCT00514943|19536674|P1|Stage 2|Other than stated above|0
5658415|NCT00514943|19536673|P2|Stage 2|Patient refused to continue study meds|0
5658416|NCT00514943|19536674|P1|Stage 2|Patient refused to continue study meds|2
5658417|NCT00514943|19536673|P2|Stage 2|Other Adverse Event|10
5658418|NCT00514943|19536674|P1|Stage 2|Other Adverse Event|3
5658419|NCT00514943|19536673|P2|Stage 2|Progressive disease|24
5658420|NCT00514943|19536674|P1|Stage 2|Progressive disease|27
5658421|NCT00514943|19536673|P2|Stage 1|Other than stated above|7
5658422|NCT00514943|19536674|P1|Stage 1|Other than stated above|1
5658423|NCT00514943|19536673|P2|Stage 1|Patient refused to continue study meds|3
5658424|NCT00514943|19536674|P1|Stage 1|Patient refused to continue study meds|8
5658425|NCT00514943|19536673|P2|Stage 1|Not treated|2
5658426|NCT00514943|19536674|P1|Stage 1|Not treated|1
5658427|NCT00514943|19536673|P2|Stage 1|Other Adverse Event|6
5658428|NCT00514943|19536674|P1|Stage 1|Other Adverse Event|16
5658429|NCT00514943|19536673|P2|Stage 1|Progressive disease|8
5658430|NCT00514943|19536674|P1|Stage 1|Progressive disease|4
5658431|NCT00514917|19536732|P2|Overall Study|Undefined|5
5658432|NCT00514917|19536733|P1|Overall Study|Undefined|11
5658433|NCT00514917|19536732|P2|Overall Study|Discontinued due to study closure|81
5658434|NCT00514917|19536733|P1|Overall Study|Discontinued due to study closure|88
5658435|NCT00514917|19536732|P2|Overall Study|Withdrawal by Subject|16
5658436|NCT00514917|19536733|P1|Overall Study|Withdrawal by Subject|18
5658437|NCT00514917|19536732|P2|Overall Study|Lost to Follow-up|3
5658438|NCT00514917|19536733|P1|Overall Study|Lost to Follow-up|4
5658439|NCT00514917|19536732|P2|Overall Study|Protocol Violation|0
5658440|NCT00514917|19536733|P1|Overall Study|Protocol Violation|1
5658441|NCT00514917|19536732|P2|Overall Study|Death|10
5658442|NCT00514917|19536733|P1|Overall Study|Death|4
5658443|NCT00514904|19536761|P2|Overall Study|Lost to Follow-up|3
5658444|NCT00514904|19536762|P1|Overall Study|Lost to Follow-up|21
5658445|NCT00514904|19536761|P2|Overall Study|Withdrawal by Subject|2
5658446|NCT00514904|19536762|P1|Overall Study|Withdrawal by Subject|3
5658447|NCT00514813|19536827|P4|Overall Study|Death|2
5658448|NCT00514813|19536828|P3|Overall Study|Death|3
5658449|NCT00514813|19536829|P2|Overall Study|Death|2
5658450|NCT00514813|19536830|P1|Overall Study|Death|0
5658451|NCT00514813|19536827|P4|Overall Study|Kidney transplant|0
5658452|NCT00514813|19536828|P3|Overall Study|Kidney transplant|2
5658453|NCT00514813|19536829|P2|Overall Study|Kidney transplant|6
5658454|NCT00514813|19536830|P1|Overall Study|Kidney transplant|0
5658455|NCT00514813|19536827|P4|Overall Study|Lack of Efficacy|0
5658456|NCT00514813|19536828|P3|Overall Study|Lack of Efficacy|0
5658457|NCT00514813|19536829|P2|Overall Study|Lack of Efficacy|1
5658458|NCT00514813|19536830|P1|Overall Study|Lack of Efficacy|0
5658459|NCT00514813|19536827|P4|Overall Study|Withdrawal by Subject|0
5658460|NCT00514813|19536828|P3|Overall Study|Withdrawal by Subject|0
5658461|NCT00514813|19536829|P2|Overall Study|Withdrawal by Subject|1
5658462|NCT00514813|19536830|P1|Overall Study|Withdrawal by Subject|0
5658463|NCT00514813|19536827|P4|Overall Study|Protocol Violation|0
5658464|NCT00514813|19536828|P3|Overall Study|Protocol Violation|0
5658465|NCT00514813|19536829|P2|Overall Study|Protocol Violation|0
5658466|NCT00514813|19536830|P1|Overall Study|Protocol Violation|1
5658467|NCT00514813|19536827|P4|Overall Study|Adverse Event|0
5658468|NCT00514813|19536828|P3|Overall Study|Adverse Event|2
5658469|NCT00514813|19536829|P2|Overall Study|Adverse Event|2
5658470|NCT00514813|19536830|P1|Overall Study|Adverse Event|0
5658471|NCT00514813|19536827|P4|Overall Study|Study terminated|2
5658472|NCT00514813|19536828|P3|Overall Study|Study terminated|40
5658473|NCT00514813|19536829|P2|Overall Study|Study terminated|74
5658474|NCT00514813|19536830|P1|Overall Study|Study terminated|14
5658475|NCT00514735|19536850|P2|Overall Study|Lost to Follow-up|1
5658476|NCT00514735|19536851|P1|Overall Study|Lost to Follow-up|0
5658477|NCT00514735|19536850|P2|Overall Study|Death|0
5658478|NCT00514735|19536851|P1|Overall Study|Death|1
5658479|NCT00514735|19536850|P2|Overall Study|Withdrawal by Subject|5
5658480|NCT00514735|19536851|P1|Overall Study|Withdrawal by Subject|13
5658481|NCT00514683|19536887|P5|Overall Study|Reason other than listed above|1
5658482|NCT00514683|19536888|P4|Overall Study|Reason other than listed above|0
5658483|NCT00514683|19536889|P3|Overall Study|Reason other than listed above|2
5658484|NCT00514683|19536890|P2|Overall Study|Reason other than listed above|1
5658485|NCT00514683|19536891|P1|Overall Study|Reason other than listed above|0
5658486|NCT00514683|19536887|P5|Overall Study|Withdrawal by Subject|4
5658487|NCT00514683|19536888|P4|Overall Study|Withdrawal by Subject|0
5658488|NCT00514683|19536889|P3|Overall Study|Withdrawal by Subject|1
5658489|NCT00514683|19536890|P2|Overall Study|Withdrawal by Subject|2
5658490|NCT00514683|19536891|P1|Overall Study|Withdrawal by Subject|2
5658491|NCT00514683|19536887|P5|Overall Study|Protocol Violation|0
5658492|NCT00514683|19536888|P4|Overall Study|Protocol Violation|1
5658493|NCT00514683|19536889|P3|Overall Study|Protocol Violation|0
5658494|NCT00514683|19536890|P2|Overall Study|Protocol Violation|1
5658495|NCT00514683|19536891|P1|Overall Study|Protocol Violation|1
5658496|NCT00514683|19536887|P5|Overall Study|Adverse Event|27
5658497|NCT00514683|19536888|P4|Overall Study|Adverse Event|13
5658498|NCT00514683|19536889|P3|Overall Study|Adverse Event|15
5658499|NCT00514683|19536890|P2|Overall Study|Adverse Event|20
5658500|NCT00514683|19536891|P1|Overall Study|Adverse Event|21
5658501|NCT00514683|19536887|P5|Overall Study|Not treated|1
5658502|NCT00514683|19536888|P4|Overall Study|Not treated|0
5658503|NCT00514683|19536889|P3|Overall Study|Not treated|0
5658504|NCT00514683|19536890|P2|Overall Study|Not treated|1
5658505|NCT00514683|19536891|P1|Overall Study|Not treated|2
5658506|NCT00514540|19537087|P1|Second-Line|Physician/Patient Decision|31
5658507|NCT00514540|19537087|P1|First-Line Chemo|Protocol Violation|7
5658508|NCT00514540|19537087|P1|First-Line Chemo|Withdrawal by Subject|1
5658509|NCT00514514|19537098|P3|Extension - 4 Years|Adverse Event|3
5658510|NCT00514514|19537099|P2|Extension - 4 Years|Adverse Event|6
5658511|NCT00514514|19537100|P1|Extension - 4 Years|Adverse Event|9
5658512|NCT00514514|19537098|P3|Extension - 4 Years|Death|6
5658513|NCT00514514|19537099|P2|Extension - 4 Years|Death|3
5658514|NCT00514514|19537100|P1|Extension - 4 Years|Death|8
5658515|NCT00514514|19537098|P3|Extension - 4 Years|Administrative problems|1
5658516|NCT00514514|19537099|P2|Extension - 4 Years|Administrative problems|1
5658517|NCT00514514|19537100|P1|Extension - 4 Years|Administrative problems|3
5658518|NCT00514514|19537098|P3|Extension - 4 Years|Lost to Follow-up|9
5658519|NCT00514514|19537099|P2|Extension - 4 Years|Lost to Follow-up|10
5658520|NCT00514514|19537100|P1|Extension - 4 Years|Lost to Follow-up|12
5658521|NCT00514514|19537098|P3|Extension - 4 Years|Withdrawal by Subject|2
5658522|NCT00514514|19537099|P2|Extension - 4 Years|Withdrawal by Subject|2
5658523|NCT00514514|19537100|P1|Extension - 4 Years|Withdrawal by Subject|5
5658524|NCT00514514|19537098|P3|Randomized - 9 Month|Adverse Event|27
5658525|NCT00514514|19537099|P2|Randomized - 9 Month|Adverse Event|44
5658526|NCT00514514|19537100|P1|Randomized - 9 Month|Adverse Event|25
5658527|NCT00514514|19537098|P3|Randomized - 9 Month|Abnormal laboratory values|1
5658528|NCT00514514|19537099|P2|Randomized - 9 Month|Abnormal laboratory values|3
5658529|NCT00514514|19537100|P1|Randomized - 9 Month|Abnormal laboratory values|0
5658530|NCT00514514|19537098|P3|Randomized - 9 Month|Lack of Efficacy|1
5658531|NCT00514514|19537099|P2|Randomized - 9 Month|Lack of Efficacy|3
5658532|NCT00514514|19537100|P1|Randomized - 9 Month|Lack of Efficacy|2
5658533|NCT00514514|19537098|P3|Randomized - 9 Month|Protocol Violation|0
5658534|NCT00514514|19537099|P2|Randomized - 9 Month|Protocol Violation|1
5658535|NCT00514514|19537100|P1|Randomized - 9 Month|Protocol Violation|1
5658536|NCT00514514|19537098|P3|Randomized - 9 Month|Withdrawal by Subject|5
5658537|NCT00514514|19537099|P2|Randomized - 9 Month|Withdrawal by Subject|7
5658538|NCT00514514|19537100|P1|Randomized - 9 Month|Withdrawal by Subject|7
5658539|NCT00514514|19537098|P3|Randomized - 9 Month|Administrative problems|2
5658540|NCT00514514|19537099|P2|Randomized - 9 Month|Administrative problems|1
5658541|NCT00514514|19537100|P1|Randomized - 9 Month|Administrative problems|1
5658542|NCT00514514|19537098|P3|Randomized - 9 Month|Death|2
5658543|NCT00514514|19537099|P2|Randomized - 9 Month|Death|2
5658544|NCT00514514|19537100|P1|Randomized - 9 Month|Death|3
5658545|NCT00514514|19537098|P3|Pre-phase|Withdrawal by Subject|0
5658546|NCT00514514|19537099|P2|Pre-phase|Withdrawal by Subject|0
5658547|NCT00514514|19537100|P1|Pre-phase|Withdrawal by Subject|66
5658548|NCT00514514|19537098|P3|Pre-phase|Adverse Event|0
5658549|NCT00514514|19537099|P2|Pre-phase|Adverse Event|0
5658550|NCT00514514|19537100|P1|Pre-phase|Adverse Event|137
5658551|NCT00514514|19537098|P3|Pre-phase|Lack of Efficacy|0
5658552|NCT00514514|19537099|P2|Pre-phase|Lack of Efficacy|0
5658553|NCT00514514|19537100|P1|Pre-phase|Lack of Efficacy|35
5658554|NCT00514514|19537098|P3|Pre-phase|abnormal lab values|0
5658555|NCT00514514|19537099|P2|Pre-phase|abnormal lab values|0
5658556|NCT00514514|19537100|P1|Pre-phase|abnormal lab values|23
5658557|NCT00514514|19537098|P3|Pre-phase|Lost to Follow-up|0
5658558|NCT00514514|19537099|P2|Pre-phase|Lost to Follow-up|0
5658559|NCT00514514|19537100|P1|Pre-phase|Lost to Follow-up|2
5658560|NCT00514514|19537098|P3|Pre-phase|abnormal test procedure results|0
5658561|NCT00514514|19537099|P2|Pre-phase|abnormal test procedure results|0
5658562|NCT00514514|19537100|P1|Pre-phase|abnormal test procedure results|15
5658563|NCT00514514|19537098|P3|Pre-phase|condition no longer requires study drug|0
5658564|NCT00514514|19537099|P2|Pre-phase|condition no longer requires study drug|0
5658565|NCT00514514|19537100|P1|Pre-phase|condition no longer requires study drug|7
5658566|NCT00514514|19537098|P3|Pre-phase|Protocol Violation|0
5658567|NCT00514514|19537099|P2|Pre-phase|Protocol Violation|0
5658568|NCT00514514|19537100|P1|Pre-phase|Protocol Violation|6
5658569|NCT00514514|19537098|P3|Pre-phase|administrative problems|0
5658570|NCT00514514|19537099|P2|Pre-phase|administrative problems|0
5658571|NCT00514514|19537100|P1|Pre-phase|administrative problems|2
5658572|NCT00514514|19537098|P3|Pre-phase|Death|0
5658573|NCT00514514|19537099|P2|Pre-phase|Death|0
5658574|NCT00514514|19537100|P1|Pre-phase|Death|10
5658575|NCT00514449|19537152|P2|Overall Study|Lost to Follow-up|0
5658576|NCT00514449|19537153|P1|Overall Study|Lost to Follow-up|1
5658577|NCT00514449|19537152|P2|Overall Study|Protocol Violation|2
5658578|NCT00514449|19537153|P1|Overall Study|Protocol Violation|1
5658579|NCT00514449|19537152|P2|Overall Study|Withdrawal by Subject|2
5658580|NCT00514449|19537153|P1|Overall Study|Withdrawal by Subject|1
5658581|NCT00514046|19537186|P9|Overall Study|Disease progression on study|0
5658582|NCT00514046|19537187|P8|Overall Study|Disease progression on study|0
5658583|NCT00514046|19537188|P7|Overall Study|Disease progression on study|0
5658584|NCT00514046|19537189|P6|Overall Study|Disease progression on study|1
5658585|NCT00514046|19537190|P5|Overall Study|Disease progression on study|0
5658586|NCT00514046|19537191|P4|Overall Study|Disease progression on study|0
5658587|NCT00514046|19537192|P3|Overall Study|Disease progression on study|2
5658588|NCT00514046|19537193|P2|Overall Study|Disease progression on study|0
5658589|NCT00514046|19537194|P1|Overall Study|Disease progression on study|0
5658590|NCT00514046|19537186|P9|Overall Study|Getting vandetanib via the REMS program|1
5658591|NCT00514046|19537187|P8|Overall Study|Getting vandetanib via the REMS program|1
5658592|NCT00514046|19537188|P7|Overall Study|Getting vandetanib via the REMS program|0
5658593|NCT00514046|19537189|P6|Overall Study|Getting vandetanib via the REMS program|0
5658594|NCT00514046|19537190|P5|Overall Study|Getting vandetanib via the REMS program|0
5658595|NCT00514046|19537191|P4|Overall Study|Getting vandetanib via the REMS program|0
5658596|NCT00514046|19537192|P3|Overall Study|Getting vandetanib via the REMS program|0
5658597|NCT00514046|19537193|P2|Overall Study|Getting vandetanib via the REMS program|0
5658598|NCT00514046|19537194|P1|Overall Study|Getting vandetanib via the REMS program|1
5658599|NCT00514046|19537186|P9|Overall Study|transferred to another protocol|0
5658600|NCT00514046|19537187|P8|Overall Study|transferred to another protocol|0
5658601|NCT00514046|19537188|P7|Overall Study|transferred to another protocol|0
5658602|NCT00514046|19537189|P6|Overall Study|transferred to another protocol|0
5658603|NCT00514046|19537190|P5|Overall Study|transferred to another protocol|1
5658604|NCT00514046|19537191|P4|Overall Study|transferred to another protocol|0
5658605|NCT00514046|19537192|P3|Overall Study|transferred to another protocol|3
5658606|NCT00514046|19537193|P2|Overall Study|transferred to another protocol|1
5658607|NCT00514046|19537194|P1|Overall Study|transferred to another protocol|2
5658608|NCT00514020|19537236|P1|Overall Study|"patients moved to the no tx group"|6
5658609|NCT00514020|19537236|P1|Overall Study|patient went to radiation treatment|1
5658610|NCT00514020|19537236|P1|Overall Study|other complicating disease|2
5658611|NCT00514020|19537236|P1|Overall Study|disease progression|9
5658612|NCT00514020|19537236|P1|Overall Study|Physician Decision|1
5658613|NCT00514020|19537236|P1|Overall Study|Withdrawal by Subject|3
5658614|NCT00514020|19537236|P1|Overall Study|Adverse Event|6
5658615|NCT00513708|19537290|P3|Overall Study|Lost to Follow-up|4
5658616|NCT00513708|19537291|P2|Overall Study|Lost to Follow-up|4
5658617|NCT00513708|19537292|P1|Overall Study|Lost to Follow-up|4
5658618|NCT00513695|19537306|P1|Overall Study|Progression prior to surgery|3
5658619|NCT00513695|19537306|P1|Overall Study|Discontinued therapy|2
5658620|NCT00513682|19537315|P1|Washout Phase|Adverse Event|2
5658621|NCT00513604|19537345|P5|Overall Study|Death during treatment|0
5658622|NCT00513604|19537346|P4|Overall Study|Death during treatment|0
5658623|NCT00513604|19537347|P3|Overall Study|Death during treatment|2
5658624|NCT00513604|19537348|P2|Overall Study|Death during treatment|3
5658625|NCT00513604|19537349|P1|Overall Study|Death during treatment|0
5658626|NCT00513604|19537345|P5|Overall Study|Not treated|0
5658627|NCT00513604|19537346|P4|Overall Study|Not treated|0
5658628|NCT00513604|19537347|P3|Overall Study|Not treated|1
5658629|NCT00513604|19537348|P2|Overall Study|Not treated|0
5658630|NCT00513604|19537349|P1|Overall Study|Not treated|2
5658631|NCT00513500|19537383|P2|Overall Study|Hospitalized|14
5658632|NCT00513500|19537384|P1|Overall Study|Hospitalized|4
5658633|NCT00513500|19537383|P2|Overall Study|Death|1
5658634|NCT00513500|19537384|P1|Overall Study|Death|2
5658635|NCT00513500|19537383|P2|Overall Study|Lost to Follow-up|39
5658636|NCT00513500|19537384|P1|Overall Study|Lost to Follow-up|35
5658637|NCT00513474|19537396|P2|Overall Study|Participant Withdrew Consent|0
5658638|NCT00513474|19537397|P1|Overall Study|Participant Withdrew Consent|1
5658639|NCT00513474|19537396|P2|Overall Study|Death|9
5658640|NCT00513474|19537397|P1|Overall Study|Death|6
5658641|NCT00513409|19537453|P2|Overall Study|Visit 3 not done|2
5658642|NCT00513409|19537454|P1|Overall Study|Visit 3 not done|1
5658643|NCT00513409|19537453|P2|Overall Study|Physician Decision|0
5658644|NCT00513409|19537454|P1|Overall Study|Physician Decision|1
5658645|NCT00513409|19537453|P2|Overall Study|Lost to Follow-up|1
5658646|NCT00513409|19537454|P1|Overall Study|Lost to Follow-up|0
5658647|NCT00513409|19537453|P2|Overall Study|Withdrawal by Subject|2
5658648|NCT00513409|19537454|P1|Overall Study|Withdrawal by Subject|0
5658649|NCT00513409|19537453|P2|Overall Study|Adverse Event|1
5658650|NCT00513409|19537454|P1|Overall Study|Adverse Event|0
5658651|NCT00513357|19537510|P2|Overall Study|Disease Progression|1
5658652|NCT00513357|19537511|P1|Overall Study|Disease Progression|2
5658653|NCT00513357|19537510|P2|Overall Study|Withdrawal by Subject|4
5658654|NCT00513357|19537511|P1|Overall Study|Withdrawal by Subject|5
5658655|NCT00513357|19537510|P2|Overall Study|Death|0
5658656|NCT00513357|19537511|P1|Overall Study|Death|2
5658657|NCT00513357|19537510|P2|Overall Study|Adverse Event|2
5658658|NCT00513357|19537511|P1|Overall Study|Adverse Event|4
5658659|NCT00513357|19537510|P2|Overall Study|did not receive allocated placebo|3
5658660|NCT00513357|19537511|P1|Overall Study|did not receive allocated placebo|2
5658661|NCT00513305|19537530|P2|Overall Study|Sponsor Decision|2
5658662|NCT00513305|19537531|P1|Overall Study|Sponsor Decision|0
5658663|NCT00513305|19537530|P2|Overall Study|Persistent hypocellularity|1
5658664|NCT00513305|19537531|P1|Overall Study|Persistent hypocellularity|0
5658665|NCT00513305|19537530|P2|Overall Study|Physician Decision|0
5658666|NCT00513305|19537531|P1|Overall Study|Physician Decision|1
5658667|NCT00513305|19537530|P2|Overall Study|Hematologic counts did not recover|0
5658668|NCT00513305|19537531|P1|Overall Study|Hematologic counts did not recover|1
5658669|NCT00513305|19537530|P2|Overall Study|Eligible for stem cell transplant|0
5658670|NCT00513305|19537531|P1|Overall Study|Eligible for stem cell transplant|1
5658671|NCT00513305|19537530|P2|Overall Study|Disease progression|5
5658672|NCT00513305|19537531|P1|Overall Study|Disease progression|8
5658673|NCT00513305|19537530|P2|Overall Study|Withdrawal by Subject|2
5658674|NCT00513305|19537531|P1|Overall Study|Withdrawal by Subject|1
5658675|NCT00513305|19537530|P2|Overall Study|Lack of Efficacy|13
5658676|NCT00513305|19537531|P1|Overall Study|Lack of Efficacy|8
5658677|NCT00513305|19537530|P2|Overall Study|Death (through Consolidation Treatment)|2
5658678|NCT00513305|19537531|P1|Overall Study|Death (through Consolidation Treatment)|2
5658679|NCT00513305|19537530|P2|Overall Study|Adverse Event|2
5658680|NCT00513305|19537531|P1|Overall Study|Adverse Event|6
5658681|NCT00513240|19537574|P2|Overall Study|Withdrawal by Subject|4
5658682|NCT00513240|19537575|P1|Overall Study|Withdrawal by Subject|7
5658683|NCT00513240|19537574|P2|Overall Study|Death|3
5658684|NCT00513240|19537575|P1|Overall Study|Death|3
5658685|NCT00513240|19537574|P2|Overall Study|Did not have intended surgery|0
5658686|NCT00513240|19537575|P1|Overall Study|Did not have intended surgery|3
5658687|NCT00513071|19537588|P1|Overall Study|Physician Decision|3
5658688|NCT00513071|19537588|P1|Overall Study|Withdrawal by Subject|1
5658689|NCT00513071|19537588|P1|Overall Study|Adverse Event|1
5658690|NCT00513019|19537600|P2|Overall Study|Withdrawal by Subject|5
5658691|NCT00513019|19537601|P1|Overall Study|Withdrawal by Subject|4
5658692|NCT00513019|19537600|P2|Overall Study|Adverse Event|0
5658693|NCT00513019|19537601|P1|Overall Study|Adverse Event|1
5658694|NCT00512902|19537607|P1|Overall Study|Lost to Follow-up|1
5658695|NCT00512902|19537607|P1|Overall Study|Adverse Event|7
5658696|NCT00512798|19537622|P2|Overall Study|Withdrawal by Subject|0
5658697|NCT00512798|19537623|P1|Overall Study|Withdrawal by Subject|3
5658698|NCT00512798|19537622|P2|Overall Study|Progression of disease|20
5658699|NCT00512798|19537623|P1|Overall Study|Progression of disease|14
5658700|NCT00512798|19537622|P2|Overall Study|Adverse Event|4
5658701|NCT00512798|19537623|P1|Overall Study|Adverse Event|2
5658702|NCT00512798|19537622|P2|Overall Study|Death|3
5658703|NCT00512798|19537623|P1|Overall Study|Death|0
5658704|NCT00512707|19537634|P2|Overall Study|Unable to tolerate the smell of the gel|0
5658705|NCT00512707|19537635|P1|Overall Study|Unable to tolerate the smell of the gel|1
5658706|NCT00512707|19537634|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
5658707|NCT00512707|19537635|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
5658708|NCT00512707|19537634|P2|Overall Study|Developed skin irritation|1
5658709|NCT00512707|19537635|P1|Overall Study|Developed skin irritation|2
5658710|NCT00512707|19537634|P2|Overall Study|Lost to Follow-up|11
5658711|NCT00512707|19537635|P1|Overall Study|Lost to Follow-up|5
5658712|NCT00512252|19537685|P3|Overall Study|Death|1
5658713|NCT00512252|19537686|P2|Overall Study|Death|0
5658714|NCT00512252|19537687|P1|Overall Study|Death|0
5658715|NCT00512252|19537685|P3|Overall Study|Protocol Violation|1
5658716|NCT00512252|19537686|P2|Overall Study|Protocol Violation|0
5658717|NCT00512252|19537687|P1|Overall Study|Protocol Violation|0
5658718|NCT00512252|19537685|P3|Overall Study|Lost to Follow-up|1
5658719|NCT00512252|19537686|P2|Overall Study|Lost to Follow-up|0
5658720|NCT00512252|19537687|P1|Overall Study|Lost to Follow-up|0
5658721|NCT00512148|19537715|P1|Primay Study Period|Withdrawal by Subject|1
5658722|NCT00512096|19537721|P1|Overall Study|Lack of Efficacy|3
5658723|NCT00512096|19537721|P1|Overall Study|Withdrawal by Subject|2
5658724|NCT00512096|19537721|P1|Overall Study|Adverse Event|2
5658725|NCT00511901|19537749|P2|Overall Study|Withdrawal by Subject|3
5658726|NCT00511901|19537750|P1|Overall Study|Withdrawal by Subject|1
5658727|NCT00511875|19537772|P2|Overall Study|Missing variables|0
5658728|NCT00511875|19537773|P1|Overall Study|Missing variables|1
5658729|NCT00511875|19537772|P2|Overall Study|Lost to Follow-up|0
5658730|NCT00511875|19537773|P1|Overall Study|Lost to Follow-up|4
5658731|NCT00511836|19537813|P2|Double-blind Period|Lost to Follow-up|0
5658732|NCT00511836|19537814|P1|Double-blind Period|Lost to Follow-up|1
5658733|NCT00511810|19537831|P2|Overall Study|Refused second scn|1
5658734|NCT00511810|19537832|P1|Overall Study|Refused second scn|0
5658735|NCT00511810|19537831|P2|Overall Study|Lack of Efficacy|2
5658736|NCT00511810|19537832|P1|Overall Study|Lack of Efficacy|0
5658737|NCT00511810|19537831|P2|Overall Study|Lost to Follow-up|2
5658738|NCT00511810|19537832|P1|Overall Study|Lost to Follow-up|1
5658739|NCT00511797|19537842|P4|Overall Study|Other (moving etc)|2
5658740|NCT00511797|19537843|P3|Overall Study|Other (moving etc)|1
5658741|NCT00511797|19537844|P2|Overall Study|Other (moving etc)|0
5658742|NCT00511797|19537845|P1|Overall Study|Other (moving etc)|1
5658743|NCT00511797|19537842|P4|Overall Study|Partially missing diary|0
5658744|NCT00511797|19537843|P3|Overall Study|Partially missing diary|1
5658745|NCT00511797|19537844|P2|Overall Study|Partially missing diary|0
5658746|NCT00511797|19537845|P1|Overall Study|Partially missing diary|0
5658747|NCT00511797|19537842|P4|Overall Study|Study drug not taken|1
5658748|NCT00511797|19537843|P3|Overall Study|Study drug not taken|0
5658749|NCT00511797|19537844|P2|Overall Study|Study drug not taken|1
5658750|NCT00511797|19537845|P1|Overall Study|Study drug not taken|0
5658751|NCT00511797|19537842|P4|Overall Study|Never dispensed|3
5658752|NCT00511797|19537843|P3|Overall Study|Never dispensed|1
5658753|NCT00511797|19537844|P2|Overall Study|Never dispensed|0
5658754|NCT00511797|19537845|P1|Overall Study|Never dispensed|1
5658755|NCT00511797|19537842|P4|Overall Study|Withdrawal by Subject|2
5658756|NCT00511797|19537843|P3|Overall Study|Withdrawal by Subject|4
5658757|NCT00511797|19537844|P2|Overall Study|Withdrawal by Subject|3
5658758|NCT00511797|19537845|P1|Overall Study|Withdrawal by Subject|3
5658759|NCT00511797|19537842|P4|Overall Study|Protocol Violation|3
5658760|NCT00511797|19537843|P3|Overall Study|Protocol Violation|2
5658761|NCT00511797|19537844|P2|Overall Study|Protocol Violation|2
5658762|NCT00511797|19537845|P1|Overall Study|Protocol Violation|0
5658763|NCT00511797|19537842|P4|Overall Study|Pregnancy|1
5658764|NCT00511797|19537843|P3|Overall Study|Pregnancy|0
5658765|NCT00511797|19537844|P2|Overall Study|Pregnancy|0
5658766|NCT00511797|19537845|P1|Overall Study|Pregnancy|0
5658767|NCT00511797|19537842|P4|Overall Study|Lost to Follow-up|1
5658768|NCT00511797|19537843|P3|Overall Study|Lost to Follow-up|0
5658769|NCT00511797|19537844|P2|Overall Study|Lost to Follow-up|0
5658770|NCT00511797|19537845|P1|Overall Study|Lost to Follow-up|1
5658771|NCT00511797|19537842|P4|Overall Study|Adverse Event|2
5658772|NCT00511797|19537843|P3|Overall Study|Adverse Event|2
5658773|NCT00511797|19537844|P2|Overall Study|Adverse Event|2
5658774|NCT00511797|19537845|P1|Overall Study|Adverse Event|1
5658775|NCT00511667|19537964|P2|Overall Study|Other|1
5658776|NCT00511667|19537965|P1|Overall Study|Other|2
5658777|NCT00511667|19537964|P2|Overall Study|Site terminated|1
5658778|NCT00511667|19537965|P1|Overall Study|Site terminated|6
5658779|NCT00511667|19537964|P2|Overall Study|Withdrawal by Subject|0
5658780|NCT00511667|19537965|P1|Overall Study|Withdrawal by Subject|2
5658781|NCT00511667|19537964|P2|Overall Study|Protocol Violation|1
5658782|NCT00511667|19537965|P1|Overall Study|Protocol Violation|1
5658783|NCT00511667|19537964|P2|Overall Study|Adverse Event|0
5658784|NCT00511667|19537965|P1|Overall Study|Adverse Event|1
5658785|NCT00511472|19538000|P2|Overall Study|Not reported|2
5658786|NCT00511472|19538001|P1|Overall Study|Not reported|2
5658787|NCT00511472|19538000|P2|Overall Study|Laboratory Adverse Event|2
5658788|NCT00511472|19538001|P1|Overall Study|Laboratory Adverse Event|0
5658789|NCT00511472|19538000|P2|Overall Study|Clinical Adverse Event|2
5658790|NCT00511472|19538001|P1|Overall Study|Clinical Adverse Event|1
5658791|NCT00511433|19538020|P2|Overall Study|Other Reason|1
5658792|NCT00511433|19538021|P1|Overall Study|Other Reason|1
5658793|NCT00511433|19538020|P2|Overall Study|Adverse Event|0
5658794|NCT00511433|19538021|P1|Overall Study|Adverse Event|5
5658795|NCT00511355|19538061|P2|Overall Study|Other reason pre-treatment|1
5658796|NCT00511355|19538062|P1|Overall Study|Other reason pre-treatment|0
5658797|NCT00511355|19538061|P2|Overall Study|Withdrawal of informed consent|1
5658798|NCT00511355|19538062|P1|Overall Study|Withdrawal of informed consent|0
5658799|NCT00511355|19538061|P2|Overall Study|Pre-treatment (serious) adverse event|1
5658800|NCT00511355|19538062|P1|Overall Study|Pre-treatment (serious) adverse event|0
5658801|NCT00511355|19538061|P2|Overall Study|Other Reason|1
5658802|NCT00511355|19538062|P1|Overall Study|Other Reason|0
5658803|NCT00511355|19538061|P2|Overall Study|Lost to Follow-up|1
5658804|NCT00511355|19538062|P1|Overall Study|Lost to Follow-up|2
5658805|NCT00511355|19538061|P2|Overall Study|Pregnancy Wish|0
5658806|NCT00511355|19538062|P1|Overall Study|Pregnancy Wish|1
5658807|NCT00511355|19538061|P2|Overall Study|Adverse Event|4
5658808|NCT00511355|19538062|P1|Overall Study|Adverse Event|4
5658809|NCT00511342|19538162|P2|Overall Study|Other Reason|2
5658810|NCT00511342|19538163|P1|Overall Study|Other Reason|2
5658811|NCT00511342|19538162|P2|Overall Study|Lost to Follow-up|5
5658812|NCT00511342|19538163|P1|Overall Study|Lost to Follow-up|1
5658813|NCT00511342|19538162|P2|Overall Study|Pregnancy wish|1
5658814|NCT00511342|19538163|P1|Overall Study|Pregnancy wish|0
5658815|NCT00511342|19538162|P2|Overall Study|Pregnancy|1
5658816|NCT00511342|19538163|P1|Overall Study|Pregnancy|0
5658817|NCT00511342|19538162|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
5658818|NCT00511342|19538163|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
5658819|NCT00511342|19538162|P2|Overall Study|Unacceptable vaginal bleeding|1
5658820|NCT00511342|19538163|P1|Overall Study|Unacceptable vaginal bleeding|2
5658821|NCT00511238|19538194|P2|Overall Study|various reasons|14
5658822|NCT00511238|19538195|P1|Overall Study|various reasons|4
5658823|NCT00511238|19538194|P2|Overall Study|Progressive Disease|157
5658824|NCT00511238|19538195|P1|Overall Study|Progressive Disease|23
5658825|NCT00511238|19538194|P2|Overall Study|Withdrawal by Subject|22
5658826|NCT00511238|19538195|P1|Overall Study|Withdrawal by Subject|2
5658827|NCT00511238|19538194|P2|Overall Study|Adverse Event|33
5658828|NCT00511238|19538195|P1|Overall Study|Adverse Event|13
5658829|NCT00511199|19538214|P2|Overall Study|Other Reason|37
5658830|NCT00511199|19538215|P1|Overall Study|Other Reason|78
5658831|NCT00511199|19538214|P2|Overall Study|Lost to Follow-up|17
5658832|NCT00511199|19538215|P1|Overall Study|Lost to Follow-up|40
5658833|NCT00511199|19538214|P2|Overall Study|Pregnancy Wish|8
5658834|NCT00511199|19538215|P1|Overall Study|Pregnancy Wish|16
5658835|NCT00511199|19538214|P2|Overall Study|Pregnancy|3
5658836|NCT00511199|19538215|P1|Overall Study|Pregnancy|6
5658837|NCT00511199|19538214|P2|Overall Study|Withdrawal of Informed Consent|4
5658838|NCT00511199|19538215|P1|Overall Study|Withdrawal of Informed Consent|19
5658839|NCT00511199|19538214|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
5658840|NCT00511199|19538215|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
5658841|NCT00511199|19538214|P2|Overall Study|Unacceptable Vaginal Bleeding|4
5658842|NCT00511199|19538215|P1|Overall Study|Unacceptable Vaginal Bleeding|63
5658843|NCT00511147|19538244|P1|Overall Study|Required platelet transfusion|1
5658844|NCT00511147|19538244|P1|Overall Study|Disease progression|5
5658845|NCT00511147|19538244|P1|Overall Study|Withdrawal by Subject|1
5658846|NCT00511134|19538253|P2|Overall Study|Withdrawal by Subject|2
5658847|NCT00511134|19538254|P1|Overall Study|Withdrawal by Subject|0
5658848|NCT00511108|19538266|P4|Overall Study|Withdrawal by Subject|2
5658849|NCT00511108|19538267|P3|Overall Study|Withdrawal by Subject|3
5658850|NCT00511108|19538268|P2|Overall Study|Withdrawal by Subject|0
5658851|NCT00511108|19538269|P1|Overall Study|Withdrawal by Subject|4
5658852|NCT00511108|19538266|P4|Overall Study|Physician Decision|1
5658853|NCT00511108|19538267|P3|Overall Study|Physician Decision|0
5658854|NCT00511108|19538268|P2|Overall Study|Physician Decision|0
5658855|NCT00511108|19538269|P1|Overall Study|Physician Decision|0
5658856|NCT00511108|19538266|P4|Overall Study|Lost to Follow-up|0
5658857|NCT00511108|19538267|P3|Overall Study|Lost to Follow-up|1
5658858|NCT00511108|19538268|P2|Overall Study|Lost to Follow-up|2
5658859|NCT00511108|19538269|P1|Overall Study|Lost to Follow-up|0
5658860|NCT00511108|19538266|P4|Overall Study|Adverse Event|2
5658861|NCT00511108|19538267|P3|Overall Study|Adverse Event|1
5658862|NCT00511108|19538268|P2|Overall Study|Adverse Event|0
5658863|NCT00511108|19538269|P1|Overall Study|Adverse Event|2
5658864|NCT00511004|19538300|P3|Overall Study|Lost to Follow-up|4
5658865|NCT00511004|19538301|P2|Overall Study|Lost to Follow-up|0
5658866|NCT00511004|19538302|P1|Overall Study|Lost to Follow-up|0
5658867|NCT00510952|19538321|P2|Overall Study|Did Not Receive Study Drug|0
5658868|NCT00510952|19538322|P1|Overall Study|Did Not Receive Study Drug|2
5658869|NCT00510952|19538321|P2|Overall Study|Withdrawal by Subject|7
5658870|NCT00510952|19538322|P1|Overall Study|Withdrawal by Subject|6
5658871|NCT00510952|19538321|P2|Overall Study|Sponsor Decision|0
5658872|NCT00510952|19538322|P1|Overall Study|Sponsor Decision|1
5658873|NCT00510952|19538321|P2|Overall Study|Protocol Violation|4
5658874|NCT00510952|19538322|P1|Overall Study|Protocol Violation|7
5658875|NCT00510952|19538321|P2|Overall Study|Physician Decision|1
5658876|NCT00510952|19538322|P1|Overall Study|Physician Decision|1
5658877|NCT00510952|19538321|P2|Overall Study|Lost to Follow-up|3
5658878|NCT00510952|19538322|P1|Overall Study|Lost to Follow-up|5
5658879|NCT00510952|19538321|P2|Overall Study|Entry Criteria Not Met|1
5658880|NCT00510952|19538322|P1|Overall Study|Entry Criteria Not Met|3
5658881|NCT00510952|19538321|P2|Overall Study|Adverse Event|0
5658882|NCT00510952|19538322|P1|Overall Study|Adverse Event|1
5658883|NCT00510887|19538348|P1|Overall Study|Lost to Follow-up|1
5658884|NCT00510874|19538364|P7|Overall Study|Lost to Follow-up|1
5658885|NCT00510874|19538365|P6|Overall Study|Lost to Follow-up|0
5658886|NCT00510874|19538366|P5|Overall Study|Lost to Follow-up|4
5658887|NCT00510874|19538367|P4|Overall Study|Lost to Follow-up|3
5658888|NCT00510874|19538368|P3|Overall Study|Lost to Follow-up|1
5658889|NCT00510874|19538369|P2|Overall Study|Lost to Follow-up|3
5658890|NCT00510874|19538370|P1|Overall Study|Lost to Follow-up|2
5658891|NCT00510874|19538364|P7|Overall Study|Withdrawal by Subject|0
5658892|NCT00510874|19538365|P6|Overall Study|Withdrawal by Subject|0
5658893|NCT00510874|19538366|P5|Overall Study|Withdrawal by Subject|3
5658894|NCT00510874|19538367|P4|Overall Study|Withdrawal by Subject|0
5658895|NCT00510874|19538368|P3|Overall Study|Withdrawal by Subject|0
5658896|NCT00510874|19538369|P2|Overall Study|Withdrawal by Subject|1
5658897|NCT00510874|19538370|P1|Overall Study|Withdrawal by Subject|1
5658898|NCT00510835|19538473|P3|Overall Study|Withdrawal by Subject|2
5658899|NCT00510835|19538474|P2|Overall Study|Withdrawal by Subject|2
5658900|NCT00510835|19538475|P1|Overall Study|Withdrawal by Subject|6
5658901|NCT00510783|19538501|P2|Overall Study|Protocol Violation|1
5658902|NCT00510783|19538502|P1|Overall Study|Protocol Violation|0
5658903|NCT00510783|19538501|P2|Overall Study|Withdrawal by Subject|3
5658904|NCT00510783|19538502|P1|Overall Study|Withdrawal by Subject|2
5658905|NCT00510783|19538501|P2|Overall Study|Lost to Follow-up|25
5658906|NCT00510783|19538502|P1|Overall Study|Lost to Follow-up|29
5658907|NCT00510718|19538519|P2|Multiple Dose Period: 12 Weeks|Other|1
5658908|NCT00510718|19538520|P1|Multiple Dose Period: 12 Weeks|Other|1
5658909|NCT00510718|19538519|P2|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
5658910|NCT00510718|19538520|P1|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
5658911|NCT00510718|19538519|P2|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
5658912|NCT00510718|19538520|P1|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
5658913|NCT00510718|19538519|P2|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
5658914|NCT00510718|19538520|P1|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
5658915|NCT00510718|19538519|P2|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
5658916|NCT00510718|19538520|P1|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
5658917|NCT00510718|19538519|P2|Multiple Dose Period: 12 Weeks|Adverse Event|8
5658918|NCT00510718|19538520|P1|Multiple Dose Period: 12 Weeks|Adverse Event|1
5658919|NCT00510692|19538646|P2|Overall Study|Withdrawal by Subject|0
5658920|NCT00510692|19538647|P1|Overall Study|Withdrawal by Subject|1
5658921|NCT00510692|19538646|P2|Overall Study|Adverse Event|3
5658922|NCT00510692|19538647|P1|Overall Study|Adverse Event|1
5658923|NCT00510653|19538661|P1|Overall Study|Monetary|3
5658924|NCT00510653|19538661|P1|Overall Study|Withdrawal by Subject|8
5658925|NCT00510510|19538668|P3|Overall Study|Protocol Violation|4
5658926|NCT00510510|19538669|P2|Overall Study|Protocol Violation|3
5658927|NCT00510510|19538670|P1|Overall Study|Protocol Violation|0
5658928|NCT00510510|19538668|P3|Overall Study|Lost to Follow-up|1
5658929|NCT00510510|19538669|P2|Overall Study|Lost to Follow-up|0
5658930|NCT00510510|19538670|P1|Overall Study|Lost to Follow-up|0
5658931|NCT00510510|19538668|P3|Overall Study|Withdrawal by Subject|3
5658932|NCT00510510|19538669|P2|Overall Study|Withdrawal by Subject|2
5658933|NCT00510510|19538670|P1|Overall Study|Withdrawal by Subject|1
5658934|NCT00510510|19538668|P3|Overall Study|Subjects no longer requires study drug|2
5658935|NCT00510510|19538669|P2|Overall Study|Subjects no longer requires study drug|0
5658936|NCT00510510|19538670|P1|Overall Study|Subjects no longer requires study drug|0
5658937|NCT00510510|19538668|P3|Overall Study|Lack of Efficacy|1
5658938|NCT00510510|19538669|P2|Overall Study|Lack of Efficacy|1
5658939|NCT00510510|19538670|P1|Overall Study|Lack of Efficacy|0
5658940|NCT00510510|19538668|P3|Overall Study|Adverse Event|6
5658941|NCT00510510|19538669|P2|Overall Study|Adverse Event|3
5658942|NCT00510510|19538670|P1|Overall Study|Adverse Event|4
5658943|NCT00510484|19538688|P2|Wash-out Period|Adverse Event|1
5658944|NCT00510484|19538689|P1|Wash-out Period|Adverse Event|0
5658945|NCT00510458|19538709|P1|Overall Study|Revision|2
5658946|NCT00510458|19538709|P1|Overall Study|Withdrawal by Subject|3
5658947|NCT00510458|19538709|P1|Overall Study|Lost to Follow-up|6
5658948|NCT00510458|19538709|P1|Overall Study|Terminated|14
5658949|NCT00510458|19538709|P1|Overall Study|Death|1
5658950|NCT00510458|19538709|P1|Overall Study|5 year not evaluable/missed|21
5658951|NCT00510289|19538722|P1|Overall Study|Progressed prior to starting drug|2
5658952|NCT00510289|19538722|P1|Overall Study|Lost to Follow-up|1
5658953|NCT00510289|19538722|P1|Overall Study|Refused bone marrow biopsy|2
5658954|NCT00510289|19538722|P1|Overall Study|Withdrawal by Subject|7
5658955|NCT00510276|19538732|P2|Extension Open-Label Phase|Subject Decision|9
5658956|NCT00510276|19538733|P1|Extension Open-Label Phase|Subject Decision|7
5658957|NCT00510276|19538732|P2|Extension Open-Label Phase|Sponsor Decision|0
5658958|NCT00510276|19538733|P1|Extension Open-Label Phase|Sponsor Decision|1
5658959|NCT00510276|19538732|P2|Extension Open-Label Phase|Protocol Violation|1
5658960|NCT00510276|19538733|P1|Extension Open-Label Phase|Protocol Violation|0
5658961|NCT00510276|19538732|P2|Extension Open-Label Phase|Physician Decision|3
5658962|NCT00510276|19538733|P1|Extension Open-Label Phase|Physician Decision|2
5658963|NCT00510276|19538732|P2|Extension Open-Label Phase|Lost to Follow-up|10
5658964|NCT00510276|19538733|P1|Extension Open-Label Phase|Lost to Follow-up|12
5658965|NCT00510276|19538732|P2|Extension Open-Label Phase|Lack of Efficacy|7
5658966|NCT00510276|19538733|P1|Extension Open-Label Phase|Lack of Efficacy|2
5658967|NCT00510276|19538732|P2|Extension Open-Label Phase|Adverse Event|18
5658968|NCT00510276|19538733|P1|Extension Open-Label Phase|Adverse Event|9
5658969|NCT00510276|19538732|P2|Acute Double-Blind Phase|Subject Decision|28
5658970|NCT00510276|19538733|P1|Acute Double-Blind Phase|Subject Decision|26
5658971|NCT00510276|19538732|P2|Acute Double-Blind Phase|Sponsor Decision|1
5658972|NCT00510276|19538733|P1|Acute Double-Blind Phase|Sponsor Decision|2
5658973|NCT00510276|19538732|P2|Acute Double-Blind Phase|Protocol Violation|3
5658974|NCT00510276|19538733|P1|Acute Double-Blind Phase|Protocol Violation|4
5658975|NCT00510276|19538732|P2|Acute Double-Blind Phase|Physician Decision|3
5658976|NCT00510276|19538733|P1|Acute Double-Blind Phase|Physician Decision|0
5658977|NCT00510276|19538732|P2|Acute Double-Blind Phase|Lost to Follow-up|49
5658978|NCT00510276|19538733|P1|Acute Double-Blind Phase|Lost to Follow-up|48
5658979|NCT00510276|19538732|P2|Acute Double-Blind Phase|Lack of Efficacy|4
5658980|NCT00510276|19538733|P1|Acute Double-Blind Phase|Lack of Efficacy|3
5658981|NCT00510276|19538732|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
5658982|NCT00510276|19538733|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
5658983|NCT00510276|19538732|P2|Acute Double-Blind Phase|Adverse Event|6
5658984|NCT00510276|19538733|P1|Acute Double-Blind Phase|Adverse Event|21
5658985|NCT00510198|19538827|P2|Overall Study|Withdrawal by Subject|4
5658986|NCT00510198|19538828|P1|Overall Study|Withdrawal by Subject|5
5658987|NCT00510146|19538842|P2|Open-Label Treatment|Sponsor Decision|0
5658988|NCT00510146|19538843|P1|Open-Label Treatment|Sponsor Decision|2
5658989|NCT00510146|19538842|P2|Open-Label Treatment|Clinical Relapse|1
5658990|NCT00510146|19538843|P1|Open-Label Treatment|Clinical Relapse|1
5658991|NCT00510146|19538842|P2|Open-Label Treatment|Withdrawal by Subject|12
5658992|NCT00510146|19538843|P1|Open-Label Treatment|Withdrawal by Subject|24
5658993|NCT00510146|19538842|P2|Open-Label Treatment|Protocol Violation|2
5658994|NCT00510146|19538843|P1|Open-Label Treatment|Protocol Violation|4
5658995|NCT00510146|19538842|P2|Open-Label Treatment|Physician Decision|1
5658996|NCT00510146|19538843|P1|Open-Label Treatment|Physician Decision|3
5658997|NCT00510146|19538842|P2|Open-Label Treatment|Lost to Follow-up|1
5658998|NCT00510146|19538843|P1|Open-Label Treatment|Lost to Follow-up|10
5658999|NCT00510146|19538842|P2|Open-Label Treatment|Lack of Efficacy|0
5659000|NCT00510146|19538843|P1|Open-Label Treatment|Lack of Efficacy|4
5659001|NCT00510146|19538842|P2|Open-Label Treatment|Death|1
5659002|NCT00510146|19538843|P1|Open-Label Treatment|Death|1
5659003|NCT00510146|19538842|P2|Open-Label Treatment|Adverse Event|8
5659004|NCT00510146|19538843|P1|Open-Label Treatment|Adverse Event|22
5659005|NCT00510146|19538842|P2|Double-Blind Treatment|Entry Criteria Not Met|0
5659006|NCT00510146|19538843|P1|Double-Blind Treatment|Entry Criteria Not Met|3
5659007|NCT00510146|19538842|P2|Double-Blind Treatment|Clinical Relapse|1
5659008|NCT00510146|19538843|P1|Double-Blind Treatment|Clinical Relapse|0
5659009|NCT00510146|19538842|P2|Double-Blind Treatment|Withdrawal by Subject|13
5659010|NCT00510146|19538843|P1|Double-Blind Treatment|Withdrawal by Subject|27
5659011|NCT00510146|19538842|P2|Double-Blind Treatment|Protocol Violation|2
5659012|NCT00510146|19538843|P1|Double-Blind Treatment|Protocol Violation|1
5659013|NCT00510146|19538842|P2|Double-Blind Treatment|Physician Decision|0
5659014|NCT00510146|19538843|P1|Double-Blind Treatment|Physician Decision|6
5659015|NCT00510146|19538842|P2|Double-Blind Treatment|Lost to Follow-up|7
5659016|NCT00510146|19538843|P1|Double-Blind Treatment|Lost to Follow-up|3
5659017|NCT00510146|19538842|P2|Double-Blind Treatment|Lack of Efficacy|13
5659018|NCT00510146|19538843|P1|Double-Blind Treatment|Lack of Efficacy|6
5659019|NCT00510146|19538842|P2|Double-Blind Treatment|Adverse Event|13
5659020|NCT00510146|19538843|P1|Double-Blind Treatment|Adverse Event|30
5659021|NCT00510068|19538932|P2|Open-label Period|Abnormal laboratory value (s)|0
5659022|NCT00510068|19538933|P1|Open-label Period|Abnormal laboratory value (s)|1
5659023|NCT00510068|19538932|P2|Open-label Period|Protocol Violation|0
5659024|NCT00510068|19538933|P1|Open-label Period|Protocol Violation|2
5659025|NCT00510068|19538932|P2|Open-label Period|New cancer therapy|0
5659026|NCT00510068|19538933|P1|Open-label Period|New cancer therapy|7
5659027|NCT00510068|19538932|P2|Open-label Period|Death|0
5659028|NCT00510068|19538933|P1|Open-label Period|Death|7
5659029|NCT00510068|19538932|P2|Open-label Period|Administrative problems|0
5659030|NCT00510068|19538933|P1|Open-label Period|Administrative problems|17
5659031|NCT00510068|19538932|P2|Open-label Period|Withdrawal by Subject|0
5659032|NCT00510068|19538933|P1|Open-label Period|Withdrawal by Subject|21
5659033|NCT00510068|19538932|P2|Open-label Period|Adverse Event|0
5659034|NCT00510068|19538933|P1|Open-label Period|Adverse Event|46
5659035|NCT00510068|19538932|P2|Open-label Period|Disease Progression|0
5659036|NCT00510068|19538933|P1|Open-label Period|Disease Progression|124
5659037|NCT00510068|19538932|P2|Double-blind Period|Protocol Violation|0
5659038|NCT00510068|19538933|P1|Double-blind Period|Protocol Violation|6
5659039|NCT00510068|19538932|P2|Double-blind Period|Lost to Follow-up|0
5659040|NCT00510068|19538933|P1|Double-blind Period|Lost to Follow-up|1
5659041|NCT00510068|19538932|P2|Double-blind Period|Abnormal test result (s)|0
5659042|NCT00510068|19538933|P1|Double-blind Period|Abnormal test result (s)|1
5659043|NCT00510068|19538932|P2|Double-blind Period|Death|3
5659044|NCT00510068|19538933|P1|Double-blind Period|Death|4
5659045|NCT00510068|19538932|P2|Double-blind Period|Withdrawal by Subject|6
5659046|NCT00510068|19538933|P1|Double-blind Period|Withdrawal by Subject|8
5659047|NCT00510068|19538932|P2|Double-blind Period|Adverse Event|7
5659048|NCT00510068|19538933|P1|Double-blind Period|Adverse Event|37
5659049|NCT00510068|19538932|P2|Double-blind Period|Final primary analysis|18
5659050|NCT00510068|19538933|P1|Double-blind Period|Final primary analysis|52
5659051|NCT00510068|19538932|P2|Double-blind Period|Disease progression|169
5659052|NCT00510068|19538933|P1|Double-blind Period|Disease progression|98
5659053|NCT00509925|19538974|P2|Overall Study|Personal reasons|1
5659054|NCT00509925|19538975|P1|Overall Study|Personal reasons|0
5659055|NCT00509899|19539023|P8|Overall Study|Lack of Efficacy|0
5659056|NCT00509899|19539024|P7|Overall Study|Lack of Efficacy|0
5659057|NCT00509899|19539025|P6|Overall Study|Lack of Efficacy|1
5659058|NCT00509899|19539026|P5|Overall Study|Lack of Efficacy|0
5659059|NCT00509899|19539027|P4|Overall Study|Lack of Efficacy|0
5659060|NCT00509899|19539028|P3|Overall Study|Lack of Efficacy|2
5659061|NCT00509899|19539029|P2|Overall Study|Lack of Efficacy|0
5659062|NCT00509899|19539030|P1|Overall Study|Lack of Efficacy|1
5659063|NCT00509899|19539023|P8|Overall Study|Death|1
5659064|NCT00509899|19539024|P7|Overall Study|Death|1
5659065|NCT00509899|19539025|P6|Overall Study|Death|1
5659066|NCT00509899|19539026|P5|Overall Study|Death|1
5659067|NCT00509899|19539027|P4|Overall Study|Death|0
5659068|NCT00509899|19539028|P3|Overall Study|Death|3
5659069|NCT00509899|19539029|P2|Overall Study|Death|2
5659070|NCT00509899|19539030|P1|Overall Study|Death|2
5659071|NCT00509899|19539023|P8|Overall Study|Intercurrent Illness|0
5659072|NCT00509899|19539024|P7|Overall Study|Intercurrent Illness|0
5659073|NCT00509899|19539025|P6|Overall Study|Intercurrent Illness|1
5659074|NCT00509899|19539026|P5|Overall Study|Intercurrent Illness|0
5659075|NCT00509899|19539027|P4|Overall Study|Intercurrent Illness|1
5659076|NCT00509899|19539028|P3|Overall Study|Intercurrent Illness|0
5659077|NCT00509899|19539029|P2|Overall Study|Intercurrent Illness|0
5659078|NCT00509899|19539030|P1|Overall Study|Intercurrent Illness|1
5659079|NCT00509899|19539023|P8|Overall Study|Physician Decision|0
5659080|NCT00509899|19539024|P7|Overall Study|Physician Decision|0
5659081|NCT00509899|19539025|P6|Overall Study|Physician Decision|4
5659082|NCT00509899|19539026|P5|Overall Study|Physician Decision|1
5659083|NCT00509899|19539027|P4|Overall Study|Physician Decision|0
5659084|NCT00509899|19539028|P3|Overall Study|Physician Decision|7
5659085|NCT00509899|19539029|P2|Overall Study|Physician Decision|2
5659086|NCT00509899|19539030|P1|Overall Study|Physician Decision|4
5659087|NCT00509899|19539023|P8|Overall Study|Withdrawal by Subject|0
5659088|NCT00509899|19539024|P7|Overall Study|Withdrawal by Subject|0
5659089|NCT00509899|19539025|P6|Overall Study|Withdrawal by Subject|2
5659090|NCT00509899|19539026|P5|Overall Study|Withdrawal by Subject|3
5659091|NCT00509899|19539027|P4|Overall Study|Withdrawal by Subject|0
5659092|NCT00509899|19539028|P3|Overall Study|Withdrawal by Subject|3
5659093|NCT00509899|19539029|P2|Overall Study|Withdrawal by Subject|2
5659094|NCT00509899|19539030|P1|Overall Study|Withdrawal by Subject|6
5659095|NCT00509899|19539023|P8|Overall Study|Unacceptable Toxicity|0
5659096|NCT00509899|19539024|P7|Overall Study|Unacceptable Toxicity|0
5659097|NCT00509899|19539025|P6|Overall Study|Unacceptable Toxicity|0
5659098|NCT00509899|19539026|P5|Overall Study|Unacceptable Toxicity|0
5659099|NCT00509899|19539027|P4|Overall Study|Unacceptable Toxicity|2
5659100|NCT00509899|19539028|P3|Overall Study|Unacceptable Toxicity|0
5659101|NCT00509899|19539029|P2|Overall Study|Unacceptable Toxicity|0
5659102|NCT00509899|19539030|P1|Overall Study|Unacceptable Toxicity|1
5659103|NCT00509899|19539023|P8|Overall Study|Progressive disease|0
5659104|NCT00509899|19539024|P7|Overall Study|Progressive disease|0
5659105|NCT00509899|19539025|P6|Overall Study|Progressive disease|1
5659106|NCT00509899|19539026|P5|Overall Study|Progressive disease|0
5659107|NCT00509899|19539027|P4|Overall Study|Progressive disease|1
5659108|NCT00509899|19539028|P3|Overall Study|Progressive disease|5
5659109|NCT00509899|19539029|P2|Overall Study|Progressive disease|3
5659110|NCT00509899|19539030|P1|Overall Study|Progressive disease|1
5659111|NCT00509821|19539087|P2|Study Period 1 (Induction)|Progressive Disease|1
5659112|NCT00509821|19539088|P1|Study Period 1 (Induction)|Progressive Disease|0
5659113|NCT00509821|19539087|P2|Study Period 1 (Induction)|Adverse Event|2
5659114|NCT00509821|19539088|P1|Study Period 1 (Induction)|Adverse Event|0
5659115|NCT00509821|19539087|P2|Study Period 1 (Induction)|Death|1
5659116|NCT00509821|19539088|P1|Study Period 1 (Induction)|Death|0
5659117|NCT00509795|19539106|P4|Overall Study|Withdrawal by Subject|8
5659118|NCT00509795|19539107|P3|Overall Study|Withdrawal by Subject|7
5659119|NCT00509795|19539108|P2|Overall Study|Withdrawal by Subject|5
5659120|NCT00509795|19539109|P1|Overall Study|Withdrawal by Subject|10
5659121|NCT00509795|19539106|P4|Overall Study|Protocol Violation|1
5659122|NCT00509795|19539107|P3|Overall Study|Protocol Violation|3
5659123|NCT00509795|19539108|P2|Overall Study|Protocol Violation|0
5659124|NCT00509795|19539109|P1|Overall Study|Protocol Violation|3
5659125|NCT00509795|19539106|P4|Overall Study|OTHER|1
5659126|NCT00509795|19539107|P3|Overall Study|OTHER|4
5659127|NCT00509795|19539108|P2|Overall Study|OTHER|0
5659128|NCT00509795|19539109|P1|Overall Study|OTHER|1
5659129|NCT00509795|19539106|P4|Overall Study|Lost to Follow-up|4
5659130|NCT00509795|19539107|P3|Overall Study|Lost to Follow-up|4
5659131|NCT00509795|19539108|P2|Overall Study|Lost to Follow-up|2
5659132|NCT00509795|19539109|P1|Overall Study|Lost to Follow-up|1
5659133|NCT00509795|19539106|P4|Overall Study|Lack of Efficacy|2
5659134|NCT00509795|19539107|P3|Overall Study|Lack of Efficacy|2
5659135|NCT00509795|19539108|P2|Overall Study|Lack of Efficacy|0
5659136|NCT00509795|19539109|P1|Overall Study|Lack of Efficacy|0
5659137|NCT00509795|19539106|P4|Overall Study|Death|7
5659138|NCT00509795|19539107|P3|Overall Study|Death|2
5659139|NCT00509795|19539108|P2|Overall Study|Death|1
5659140|NCT00509795|19539109|P1|Overall Study|Death|3
5659141|NCT00509795|19539106|P4|Overall Study|Adverse Event|4
5659142|NCT00509795|19539107|P3|Overall Study|Adverse Event|5
5659143|NCT00509795|19539108|P2|Overall Study|Adverse Event|3
5659144|NCT00509795|19539109|P1|Overall Study|Adverse Event|4
5659145|NCT00509769|19539140|P1|Overall Study|Use of prohibited therapies during study|1
5659146|NCT00509769|19539140|P1|Overall Study|Physician Decision|8
5659147|NCT00509769|19539140|P1|Overall Study|Patient's decision|1
5659148|NCT00509769|19539140|P1|Overall Study|Adverse Event|4
5659149|NCT00509769|19539140|P1|Overall Study|Progressive disease|77
5659150|NCT00509600|19539159|P1|Overall Study|Adverse Event|1
5659151|NCT00509366|19539238|P5|Overall Study|Not Treated (Screen Failure)|0
5659152|NCT00509366|19539239|P4|Overall Study|Not Treated (Screen Failure)|0
5659153|NCT00509366|19539240|P3|Overall Study|Not Treated (Screen Failure)|1
5659154|NCT00509366|19539241|P2|Overall Study|Not Treated (Screen Failure)|1
5659155|NCT00509366|19539242|P1|Overall Study|Not Treated (Screen Failure)|1
5659156|NCT00509262|19539266|P2|Overall Study|Withdrawal by Subject|11
5659157|NCT00509262|19539267|P1|Overall Study|Withdrawal by Subject|24
5659158|NCT00509262|19539266|P2|Overall Study|Protocol Violation|2
5659159|NCT00509262|19539267|P1|Overall Study|Protocol Violation|2
5659160|NCT00509262|19539266|P2|Overall Study|Physician Decision|3
5659161|NCT00509262|19539267|P1|Overall Study|Physician Decision|1
5659162|NCT00509262|19539266|P2|Overall Study|Lost to Follow-up|6
5659163|NCT00509262|19539267|P1|Overall Study|Lost to Follow-up|1
5659164|NCT00509262|19539266|P2|Overall Study|Lack of Efficacy|0
5659165|NCT00509262|19539267|P1|Overall Study|Lack of Efficacy|1
5659166|NCT00509262|19539266|P2|Overall Study|Other|2
5659167|NCT00509262|19539267|P1|Overall Study|Other|2
5659168|NCT00509262|19539266|P2|Overall Study|Adverse Event|18
5659169|NCT00509262|19539267|P1|Overall Study|Adverse Event|16
5659170|NCT00509236|19539285|P2|Overall Study|Scheduled Kidney Transplant|0
5659171|NCT00509236|19539286|P1|Overall Study|Scheduled Kidney Transplant|1
5659172|NCT00509236|19539285|P2|Overall Study|Excluded Medication|1
5659173|NCT00509236|19539286|P1|Overall Study|Excluded Medication|1
5659174|NCT00509236|19539285|P2|Overall Study|Protocol Violation|0
5659175|NCT00509236|19539286|P1|Overall Study|Protocol Violation|3
5659176|NCT00509236|19539285|P2|Overall Study|Withdrawal by Subject|10
5659177|NCT00509236|19539286|P1|Overall Study|Withdrawal by Subject|5
5659178|NCT00509236|19539285|P2|Overall Study|Adverse Event|9
5659179|NCT00509236|19539286|P1|Overall Study|Adverse Event|7
5659180|NCT00509223|19539301|P2|Overall Study|Did not meet revised inclusion criteria|62
5659181|NCT00509223|19539302|P1|Overall Study|Did not meet revised inclusion criteria|56
5659182|NCT00509223|19539301|P2|Overall Study|Including: subject change of address|2
5659183|NCT00509223|19539302|P1|Overall Study|Including: subject change of address|5
5659184|NCT00509223|19539301|P2|Overall Study|Withdrawal by Subject|6
5659185|NCT00509223|19539302|P1|Overall Study|Withdrawal by Subject|25
5659186|NCT00509223|19539301|P2|Overall Study|Adverse Event|1
5659187|NCT00509223|19539302|P1|Overall Study|Adverse Event|1
5659188|NCT00509223|19539301|P2|Overall Study|Lost to Follow-up|1
5659189|NCT00509223|19539302|P1|Overall Study|Lost to Follow-up|1
5659190|NCT00509106|19539334|P2|Overall Study|Death|6
5659191|NCT00509106|19539335|P1|Overall Study|Death|6
5659192|NCT00509106|19539334|P2|Overall Study|Other|0
5659193|NCT00509106|19539335|P1|Overall Study|Other|1
5659194|NCT00509106|19539334|P2|Overall Study|Lost to Follow-up|10
5659195|NCT00509106|19539335|P1|Overall Study|Lost to Follow-up|16
5659196|NCT00509106|19539334|P2|Overall Study|Withdrew consent|8
5659197|NCT00509106|19539335|P1|Overall Study|Withdrew consent|4
5659198|NCT00509106|19539334|P2|Overall Study|At the request of sponsor/investigator|2
5659199|NCT00509106|19539335|P1|Overall Study|At the request of sponsor/investigator|1
5659200|NCT00509106|19539334|P2|Overall Study|Noncompliance|1
5659201|NCT00509106|19539335|P1|Overall Study|Noncompliance|0
5659202|NCT00509106|19539334|P2|Overall Study|Adverse Event|2
5659203|NCT00509106|19539335|P1|Overall Study|Adverse Event|3
5659204|NCT00509093|19539341|P1|Overall Study|Physician Decision|1
5659205|NCT00509093|19539341|P1|Overall Study|Withdrawal by Subject|3
5659206|NCT00509093|19539341|P1|Overall Study|Transformed into MDS|1
5659207|NCT00509093|19539341|P1|Overall Study|Disease Progression|9
5659208|NCT00509093|19539341|P1|Overall Study|Adverse Event|10
5659209|NCT00509067|19539351|P2|Overall Study|Protocol Violation|3
5659210|NCT00509067|19539352|P1|Overall Study|Protocol Violation|0
5659211|NCT00509067|19539351|P2|Overall Study|Adverse Event|1
5659212|NCT00509067|19539352|P1|Overall Study|Adverse Event|3
5659213|NCT00509067|19539351|P2|Overall Study|Lost to Follow-up|1
5659214|NCT00509067|19539352|P1|Overall Study|Lost to Follow-up|1
5659215|NCT00509028|19539371|P2|Overall Study|Non-compliance|1
5659216|NCT00509028|19539372|P1|Overall Study|Non-compliance|2
5659217|NCT00509028|19539371|P2|Overall Study|Protocol Violation|2
5659218|NCT00509028|19539372|P1|Overall Study|Protocol Violation|4
5659219|NCT00509028|19539371|P2|Overall Study|Lost to Follow-up|1
5659220|NCT00509028|19539372|P1|Overall Study|Lost to Follow-up|0
5659221|NCT00509028|19539371|P2|Overall Study|Withdrawal by Subject|3
5659222|NCT00509028|19539372|P1|Overall Study|Withdrawal by Subject|4
5659223|NCT00509028|19539371|P2|Overall Study|Adverse Event|0
5659224|NCT00509028|19539372|P1|Overall Study|Adverse Event|2
5659225|NCT00508924|19539412|P4|Overall Study|Protocol Violation|1
5659226|NCT00508924|19539413|P3|Overall Study|Protocol Violation|1
5659227|NCT00508924|19539414|P2|Overall Study|Protocol Violation|0
5659228|NCT00508924|19539415|P1|Overall Study|Protocol Violation|0
5659229|NCT00508872|19539429|P1|Overall Study|Physician Decision|1
5659230|NCT00508872|19539429|P1|Overall Study|Lost to Follow-up|1
5659231|NCT00508820|19539435|P2|Overall Study|Protocol-specified Criteria|12
5659232|NCT00508820|19539436|P1|Overall Study|Protocol-specified Criteria|3
5659233|NCT00508820|19539435|P2|Overall Study|Requirement for alternative therapy|15
5659234|NCT00508820|19539436|P1|Overall Study|Requirement for alternative therapy|7
5659235|NCT00508820|19539435|P2|Overall Study|Noncompliance|0
5659236|NCT00508820|19539436|P1|Overall Study|Noncompliance|1
5659237|NCT00508820|19539435|P2|Overall Study|Other|2
5659238|NCT00508820|19539436|P1|Overall Study|Other|11
5659239|NCT00508820|19539435|P2|Overall Study|Withdrawal by Subject|12
5659240|NCT00508820|19539436|P1|Overall Study|Withdrawal by Subject|10
5659241|NCT00508820|19539435|P2|Overall Study|Protocol Violation|0
5659242|NCT00508820|19539436|P1|Overall Study|Protocol Violation|2
5659243|NCT00508820|19539435|P2|Overall Study|Pregnancy|2
5659244|NCT00508820|19539436|P1|Overall Study|Pregnancy|0
5659245|NCT00508820|19539435|P2|Overall Study|Physician Decision|2
5659246|NCT00508820|19539436|P1|Overall Study|Physician Decision|8
5659247|NCT00508820|19539435|P2|Overall Study|Lost to Follow-up|1
5659248|NCT00508820|19539436|P1|Overall Study|Lost to Follow-up|1
5659249|NCT00508820|19539435|P2|Overall Study|Death|8
5659250|NCT00508820|19539436|P1|Overall Study|Death|6
5659251|NCT00508820|19539435|P2|Overall Study|Adverse Event|10
5659252|NCT00508820|19539436|P1|Overall Study|Adverse Event|6
5659253|NCT00508755|19539446|P1|Overall Study|Withdrawal by Subject|1
5659254|NCT00508742|19539454|P2|Period 3: Toddler Dose|Other|4
5659255|NCT00508742|19539455|P1|Period 3: Toddler Dose|Other|5
5659256|NCT00508742|19539454|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
5659257|NCT00508742|19539455|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
5659258|NCT00508742|19539454|P2|Period 3: Toddler Dose|Lost to Follow-up|3
5659259|NCT00508742|19539455|P1|Period 3: Toddler Dose|Lost to Follow-up|2
5659260|NCT00508742|19539454|P2|Period 3: Toddler Dose|Adverse Event|0
5659261|NCT00508742|19539455|P1|Period 3: Toddler Dose|Adverse Event|1
5659262|NCT00508742|19539454|P2|Period 2: After Infant Series|Other|1
5659263|NCT00508742|19539455|P1|Period 2: After Infant Series|Other|2
5659264|NCT00508742|19539454|P2|Period 2: After Infant Series|Failed to Return|0
5659265|NCT00508742|19539455|P1|Period 2: After Infant Series|Failed to Return|1
5659266|NCT00508742|19539454|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
5659267|NCT00508742|19539455|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
5659268|NCT00508742|19539454|P2|Period 2: After Infant Series|Protocol Violation|0
5659269|NCT00508742|19539455|P1|Period 2: After Infant Series|Protocol Violation|1
5659270|NCT00508742|19539454|P2|Period 2: After Infant Series|Lost to Follow-up|1
5659271|NCT00508742|19539455|P1|Period 2: After Infant Series|Lost to Follow-up|1
5659272|NCT00508742|19539454|P2|Period 2: After Infant Series|Adverse Event|6
5659273|NCT00508742|19539455|P1|Period 2: After Infant Series|Adverse Event|2
5659274|NCT00508742|19539454|P2|Period 1: Infant Series|Other|1
5659275|NCT00508742|19539455|P1|Period 1: Infant Series|Other|4
5659276|NCT00508742|19539454|P2|Period 1: Infant Series|Physician Decision|0
5659277|NCT00508742|19539455|P1|Period 1: Infant Series|Physician Decision|1
5659278|NCT00508742|19539454|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
5659279|NCT00508742|19539455|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
5659280|NCT00508742|19539454|P2|Period 1: Infant Series|Protocol Violation|0
5659281|NCT00508742|19539455|P1|Period 1: Infant Series|Protocol Violation|1
5659282|NCT00508742|19539454|P2|Period 1: Infant Series|Adverse Event|4
5659283|NCT00508742|19539455|P1|Period 1: Infant Series|Adverse Event|5
5659284|NCT00508651|19539480|P2|Overall Study|Withdrawal by Subject|1
5659285|NCT00508651|19539481|P1|Overall Study|Withdrawal by Subject|1
5659286|NCT00508651|19539480|P2|Overall Study|Lost to Follow-up|1
5659287|NCT00508651|19539481|P1|Overall Study|Lost to Follow-up|3
5659288|NCT00508482|19539562|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
5659289|NCT00508482|19539563|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
5659290|NCT00508482|19539564|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
5659291|NCT00508482|19539562|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
5659292|NCT00508482|19539563|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
5659293|NCT00508482|19539564|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
5659294|NCT00508482|19539562|P3|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
5659295|NCT00508482|19539563|P2|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
5659296|NCT00508482|19539564|P1|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
5659297|NCT00508404|19539608|P1|Overall Study|Other - Not Specified|3
5659298|NCT00508404|19539608|P1|Overall Study|Lost to Follow-up|2
5659299|NCT00508404|19539608|P1|Overall Study|Protocol-specified Criteria|2
5659300|NCT00508404|19539608|P1|Overall Study|Withdrawal by Subject|3
5659301|NCT00508404|19539608|P1|Overall Study|Physician Decision|2
5659302|NCT00508404|19539608|P1|Overall Study|Death|16
5659303|NCT00508404|19539608|P1|Overall Study|Adverse Event|2
5659304|NCT00508404|19539608|P1|Overall Study|Ongoing at Data Cut-off|12
5659305|NCT00508391|19539635|P2|Second Treatment|Withdrawal by Subject|0
5659306|NCT00508391|19539636|P1|Second Treatment|Withdrawal by Subject|2
5659307|NCT00508391|19539635|P2|First Treatment|Withdrawal by Subject|3
5659308|NCT00508391|19539636|P1|First Treatment|Withdrawal by Subject|6
5659309|NCT00508274|19539656|P1|Overall Study|Withdrawal by Subject|1
5659310|NCT00508274|19539656|P1|Overall Study|Adverse Event|1
5659311|NCT00508261|19539669|P4|Overall Study|Lost to Follow-up|1
5659312|NCT00508261|19539670|P3|Overall Study|Lost to Follow-up|1
5659313|NCT00508261|19539671|P2|Overall Study|Lost to Follow-up|1
5659314|NCT00508261|19539672|P1|Overall Study|Lost to Follow-up|0
5659315|NCT00508261|19539669|P4|Overall Study|Migrated/ moved from study area|0
5659316|NCT00508261|19539670|P3|Overall Study|Migrated/ moved from study area|0
5659317|NCT00508261|19539671|P2|Overall Study|Migrated/ moved from study area|1
5659318|NCT00508261|19539672|P1|Overall Study|Migrated/ moved from study area|0
5659319|NCT00508261|19539669|P4|Overall Study|Withdrawal by Subject|0
5659320|NCT00508261|19539670|P3|Overall Study|Withdrawal by Subject|4
5659321|NCT00508261|19539671|P2|Overall Study|Withdrawal by Subject|4
5659322|NCT00508261|19539672|P1|Overall Study|Withdrawal by Subject|3
5659323|NCT00508261|19539669|P4|Overall Study|Serious Adverse Event|0
5659324|NCT00508261|19539670|P3|Overall Study|Serious Adverse Event|0
5659325|NCT00508261|19539671|P2|Overall Study|Serious Adverse Event|1
5659326|NCT00508261|19539672|P1|Overall Study|Serious Adverse Event|0
5659327|NCT00508261|19539669|P4|Overall Study|Other|0
5659328|NCT00508261|19539670|P3|Overall Study|Other|1
5659329|NCT00508261|19539671|P2|Overall Study|Other|1
5659330|NCT00508261|19539672|P1|Overall Study|Other|0
5659331|NCT00508157|19539812|P2|Overall Study|Other known cause|1
5659332|NCT00508157|19539813|P1|Overall Study|Other known cause|0
5659333|NCT00508157|19539812|P2|Overall Study|Subject no longer met study criteria|1
5659334|NCT00508157|19539813|P1|Overall Study|Subject no longer met study criteria|0
5659335|NCT00508157|19539812|P2|Overall Study|Lost to Follow-up|0
5659336|NCT00508157|19539813|P1|Overall Study|Lost to Follow-up|1
5659337|NCT00508157|19539812|P2|Overall Study|Subject Withdrew Consent|0
5659338|NCT00508157|19539813|P1|Overall Study|Subject Withdrew Consent|1
5659339|NCT00508157|19539812|P2|Overall Study|Adverse Event|1
5659340|NCT00508157|19539813|P1|Overall Study|Adverse Event|0
5659341|NCT00508144|19539835|P1|Overall Study|Death|5
5659342|NCT00508144|19539835|P1|Overall Study|Not eligible|6
5659343|NCT00508027|19539874|P1|Dose Level 2|Withdrawal by Subject|2
5659344|NCT00508027|19539874|P1|Dose Level 2|Lost to Follow-up|2
5659345|NCT00508027|19539874|P1|Dose Level 1|Physician Decision|2
5659346|NCT00508027|19539874|P1|Dose Level 1|Withdrawal by Subject|2
5659347|NCT00508027|19539874|P1|Dose Level 1|Lost to Follow-up|4
5659348|NCT00508001|19539915|P3|Overall Study|Withdrawal by Subject|1
5659349|NCT00508001|19539916|P2|Overall Study|Withdrawal by Subject|4
5659350|NCT00508001|19539917|P1|Overall Study|Withdrawal by Subject|4
5659351|NCT00508001|19539915|P3|Overall Study|Death|1
5659352|NCT00508001|19539916|P2|Overall Study|Death|1
5659353|NCT00508001|19539917|P1|Overall Study|Death|0
5659354|NCT00508001|19539915|P3|Overall Study|condition under investigation worsened|1
5659355|NCT00508001|19539916|P2|Overall Study|condition under investigation worsened|7
5659356|NCT00508001|19539917|P1|Overall Study|condition under investigation worsened|13
5659357|NCT00508001|19539915|P3|Overall Study|Adverse Event|4
5659358|NCT00508001|19539916|P2|Overall Study|Adverse Event|0
5659359|NCT00508001|19539917|P1|Overall Study|Adverse Event|2
5659360|NCT00507819|19539934|P2|Washout (6 Weeks)|Withdrawal by Subject|0
5659361|NCT00507819|19539935|P1|Washout (6 Weeks)|Withdrawal by Subject|1
5659362|NCT00507689|19539954|P2|Randomized Period|Withdrawal by Subject|1
5659363|NCT00507689|19539955|P1|Randomized Period|Withdrawal by Subject|0
5659364|NCT00507689|19539954|P2|Randomized Period|Adverse Event|1
5659365|NCT00507689|19539955|P1|Randomized Period|Adverse Event|1
5659366|NCT00507689|19539954|P2|Pre-Randomization Period|Withdrawal by Subject|0
5659367|NCT00507689|19539955|P1|Pre-Randomization Period|Withdrawal by Subject|1
5659368|NCT00507689|19539954|P2|Pre-Randomization Period|Physician Decision|0
5659369|NCT00507689|19539955|P1|Pre-Randomization Period|Physician Decision|1
5659370|NCT00507689|19539954|P2|Pre-Randomization Period|Adverse Event|0
5659371|NCT00507689|19539955|P1|Pre-Randomization Period|Adverse Event|1
5659372|NCT00507546|19539987|P2|Overall Study|Physician Decision|1
5659373|NCT00507546|19539988|P1|Overall Study|Physician Decision|0
5659374|NCT00507546|19539987|P2|Overall Study|Protocol Violation|0
5659375|NCT00507546|19539988|P1|Overall Study|Protocol Violation|1
5659376|NCT00507546|19539987|P2|Overall Study|Withdrawal by Subject|0
5659377|NCT00507546|19539988|P1|Overall Study|Withdrawal by Subject|1
5659378|NCT00507507|19539998|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
5659379|NCT00507507|19539999|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
5659380|NCT00507507|19539998|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
5659381|NCT00507507|19539999|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
5659382|NCT00507507|19539998|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
5659383|NCT00507507|19539999|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
5659384|NCT00507507|19539998|P2|Treatment Period|Withdrawal by Subject|47
5659385|NCT00507507|19539999|P1|Treatment Period|Withdrawal by Subject|46
5659386|NCT00507507|19539998|P2|Treatment Period|Adverse Event|1
5659387|NCT00507507|19539999|P1|Treatment Period|Adverse Event|1
5659388|NCT00507507|19539998|P2|Treatment Period|Protocol Violation|2
5659389|NCT00507507|19539999|P1|Treatment Period|Protocol Violation|1
5659390|NCT00507507|19539998|P2|Treatment Period|Physician Decision|1
5659391|NCT00507507|19539999|P1|Treatment Period|Physician Decision|4
5659392|NCT00507507|19539998|P2|Treatment Period|Lost to Follow-up|2
5659393|NCT00507507|19539999|P1|Treatment Period|Lost to Follow-up|0
5659394|NCT00507455|19540034|P3|Overall Study|Other - miscellaneous reason|1
5659395|NCT00507455|19540035|P2|Overall Study|Other - miscellaneous reason|0
5659396|NCT00507455|19540036|P1|Overall Study|Other - miscellaneous reason|1
5659397|NCT00507455|19540034|P3|Overall Study|Lack of Efficacy|0
5659398|NCT00507455|19540035|P2|Overall Study|Lack of Efficacy|1
5659399|NCT00507455|19540036|P1|Overall Study|Lack of Efficacy|0
5659400|NCT00507455|19540034|P3|Overall Study|Lost to Follow-up|2
5659401|NCT00507455|19540035|P2|Overall Study|Lost to Follow-up|0
5659402|NCT00507455|19540036|P1|Overall Study|Lost to Follow-up|2
5659403|NCT00507455|19540034|P3|Overall Study|Protocol Violation|1
5659404|NCT00507455|19540035|P2|Overall Study|Protocol Violation|1
5659405|NCT00507455|19540036|P1|Overall Study|Protocol Violation|4
5659406|NCT00507455|19540034|P3|Overall Study|Withdrawal by Subject|2
5659407|NCT00507455|19540035|P2|Overall Study|Withdrawal by Subject|1
5659408|NCT00507455|19540036|P1|Overall Study|Withdrawal by Subject|2
5659409|NCT00507455|19540034|P3|Overall Study|Adverse Event|6
5659410|NCT00507455|19540035|P2|Overall Study|Adverse Event|3
5659411|NCT00507455|19540036|P1|Overall Study|Adverse Event|3
5659412|NCT00507442|19540099|P4|Overall Study|Other|2
5659413|NCT00507442|19540100|P3|Overall Study|Other|2
5659414|NCT00507442|19540101|P2|Overall Study|Other|5
5659415|NCT00507442|19540102|P1|Overall Study|Other|2
5659416|NCT00507442|19540099|P4|Overall Study|Withdrawal by Subject|1
5659417|NCT00507442|19540100|P3|Overall Study|Withdrawal by Subject|2
5659418|NCT00507442|19540101|P2|Overall Study|Withdrawal by Subject|4
5659419|NCT00507442|19540102|P1|Overall Study|Withdrawal by Subject|4
5659420|NCT00507442|19540099|P4|Overall Study|Progressive Disease|0
5659421|NCT00507442|19540100|P3|Overall Study|Progressive Disease|2
5659422|NCT00507442|19540101|P2|Overall Study|Progressive Disease|4
5659423|NCT00507442|19540102|P1|Overall Study|Progressive Disease|2
5659424|NCT00507442|19540099|P4|Overall Study|Physician Decision|1
5659425|NCT00507442|19540100|P3|Overall Study|Physician Decision|4
5659426|NCT00507442|19540101|P2|Overall Study|Physician Decision|2
5659427|NCT00507442|19540102|P1|Overall Study|Physician Decision|0
5659428|NCT00507442|19540099|P4|Overall Study|Lost to Follow-up|0
5659429|NCT00507442|19540100|P3|Overall Study|Lost to Follow-up|1
5659430|NCT00507442|19540101|P2|Overall Study|Lost to Follow-up|0
5659431|NCT00507442|19540102|P1|Overall Study|Lost to Follow-up|0
5659432|NCT00507442|19540099|P4|Overall Study|Protocol Violation|0
5659433|NCT00507442|19540100|P3|Overall Study|Protocol Violation|0
5659434|NCT00507442|19540101|P2|Overall Study|Protocol Violation|1
5659435|NCT00507442|19540102|P1|Overall Study|Protocol Violation|0
5659436|NCT00507442|19540099|P4|Overall Study|Adverse Event|1
5659437|NCT00507442|19540100|P3|Overall Study|Adverse Event|4
5659438|NCT00507442|19540101|P2|Overall Study|Adverse Event|11
5659439|NCT00507442|19540102|P1|Overall Study|Adverse Event|8
5659440|NCT00507429|19540154|P2|Maintenance Phase|Progressive Disease|0
5659441|NCT00507429|19540155|P1|Maintenance Phase|Progressive Disease|14
5659442|NCT00507429|19540154|P2|Treatment Phase|Other|3
5659443|NCT00507429|19540155|P1|Treatment Phase|Other|6
5659444|NCT00507429|19540154|P2|Treatment Phase|Physician Decision|2
5659445|NCT00507429|19540155|P1|Treatment Phase|Physician Decision|4
5659446|NCT00507429|19540154|P2|Treatment Phase|Withdrawal by Subject|3
5659447|NCT00507429|19540155|P1|Treatment Phase|Withdrawal by Subject|3
5659448|NCT00507429|19540154|P2|Treatment Phase|Adverse Event|5
5659449|NCT00507429|19540155|P1|Treatment Phase|Adverse Event|12
5659450|NCT00507429|19540154|P2|Treatment Phase|Disease Progression|5
5659451|NCT00507429|19540155|P1|Treatment Phase|Disease Progression|12
5659452|NCT00507416|19540166|P3|Overall Study|Did not Receive Study Treatment|4
5659453|NCT00507416|19540167|P2|Overall Study|Did not Receive Study Treatment|9
5659454|NCT00507416|19540168|P1|Overall Study|Did not Receive Study Treatment|3
5659455|NCT00507416|19540166|P3|Overall Study|Other|13
5659456|NCT00507416|19540167|P2|Overall Study|Other|16
5659457|NCT00507416|19540168|P1|Overall Study|Other|11
5659458|NCT00507416|19540166|P3|Overall Study|Patient declined further treatment|11
5659459|NCT00507416|19540167|P2|Overall Study|Patient declined further treatment|14
5659460|NCT00507416|19540168|P1|Overall Study|Patient declined further treatment|18
5659461|NCT00507416|19540166|P3|Overall Study|Progressive Disease|13
5659462|NCT00507416|19540167|P2|Overall Study|Progressive Disease|10
5659463|NCT00507416|19540168|P1|Overall Study|Progressive Disease|20
5659464|NCT00507416|19540166|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
5659465|NCT00507416|19540167|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
5659466|NCT00507416|19540168|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
5659467|NCT00507416|19540166|P3|Overall Study|Protocol Violation|0
5659468|NCT00507416|19540167|P2|Overall Study|Protocol Violation|2
5659469|NCT00507416|19540168|P1|Overall Study|Protocol Violation|1
5659470|NCT00507416|19540166|P3|Overall Study|Adverse Event|65
5659471|NCT00507416|19540167|P2|Overall Study|Adverse Event|67
5659472|NCT00507416|19540168|P1|Overall Study|Adverse Event|58
5659473|NCT00507130|19540210|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
5659474|NCT00507130|19540211|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
5659475|NCT00507130|19540212|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
5659476|NCT00507130|19540213|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
5659477|NCT00507130|19540210|P4|Overall Study|Lost to Follow-up|1
5659478|NCT00507130|19540211|P3|Overall Study|Lost to Follow-up|1
5659479|NCT00507130|19540212|P2|Overall Study|Lost to Follow-up|0
5659480|NCT00507130|19540213|P1|Overall Study|Lost to Follow-up|0
5659481|NCT00506948|19540255|P1|Overall Study|Physician Decision|1
5659482|NCT00506948|19540255|P1|Overall Study|Adverse Event|5
5659483|NCT00506948|19540255|P1|Overall Study|Death|4
5659484|NCT00506922|19540264|P5|Overall Study|Withdrawal by Subject|1
5659485|NCT00506922|19540265|P4|Overall Study|Withdrawal by Subject|0
5659486|NCT00506922|19540266|P3|Overall Study|Withdrawal by Subject|0
5659487|NCT00506922|19540267|P2|Overall Study|Withdrawal by Subject|0
5659488|NCT00506922|19540268|P1|Overall Study|Withdrawal by Subject|0
5659489|NCT00506922|19540264|P5|Overall Study|Physician Decision|0
5659490|NCT00506922|19540265|P4|Overall Study|Physician Decision|2
5659491|NCT00506922|19540266|P3|Overall Study|Physician Decision|0
5659492|NCT00506922|19540267|P2|Overall Study|Physician Decision|0
5659493|NCT00506922|19540268|P1|Overall Study|Physician Decision|0
5659494|NCT00506883|19540295|P3|Overall Study|Other|1
5659495|NCT00506883|19540296|P2|Overall Study|Other|1
5659496|NCT00506883|19540297|P1|Overall Study|Other|5
5659497|NCT00506883|19540295|P3|Overall Study|Lack of Efficacy|1
5659498|NCT00506883|19540296|P2|Overall Study|Lack of Efficacy|1
5659499|NCT00506883|19540297|P1|Overall Study|Lack of Efficacy|0
5659500|NCT00506883|19540295|P3|Overall Study|Withdrawal by Subject|1
5659501|NCT00506883|19540296|P2|Overall Study|Withdrawal by Subject|0
5659502|NCT00506883|19540297|P1|Overall Study|Withdrawal by Subject|1
5659503|NCT00506883|19540295|P3|Overall Study|Lost to Follow-up|1
5659504|NCT00506883|19540296|P2|Overall Study|Lost to Follow-up|1
5659505|NCT00506883|19540297|P1|Overall Study|Lost to Follow-up|1
5659506|NCT00506831|19540310|P1|Overall Study|Withdrawal by Subject|1
5659507|NCT00506831|19540310|P1|Overall Study|Death|1
5659508|NCT00506779|19540323|P4|Overall Study|Adverse Event|1
5659509|NCT00506779|19540324|P3|Overall Study|Adverse Event|1
5659510|NCT00506779|19540325|P2|Overall Study|Adverse Event|1
5659511|NCT00506779|19540326|P1|Overall Study|Adverse Event|0
5659512|NCT00506779|19540323|P4|Overall Study|Withdrawal by Subject|0
5659513|NCT00506779|19540324|P3|Overall Study|Withdrawal by Subject|1
5659514|NCT00506779|19540325|P2|Overall Study|Withdrawal by Subject|0
5659515|NCT00506779|19540326|P1|Overall Study|Withdrawal by Subject|1
5659516|NCT00506753|19540341|P2|Overall Study|Lost to Follow-up|15
5659517|NCT00506753|19540342|P1|Overall Study|Lost to Follow-up|21
5659518|NCT00506662|19540380|P2|Overall Study|Not recorded|6
5659519|NCT00506662|19540381|P1|Overall Study|Not recorded|4
5659520|NCT00506662|19540380|P2|Overall Study|Trial terminated|16
5659521|NCT00506662|19540381|P1|Overall Study|Trial terminated|10
5659522|NCT00506662|19540380|P2|Overall Study|Protocol Violation|4
5659523|NCT00506662|19540381|P1|Overall Study|Protocol Violation|2
5659524|NCT00506662|19540380|P2|Overall Study|Lack of Efficacy|0
5659525|NCT00506662|19540381|P1|Overall Study|Lack of Efficacy|1
5659526|NCT00506662|19540380|P2|Overall Study|Adverse Event|2
5659527|NCT00506662|19540381|P1|Overall Study|Adverse Event|0
5659528|NCT00506493|19540415|P1|Overall Study|Withdrawal by Subject|5
5659529|NCT00506493|19540415|P1|Overall Study|Death|6
5659530|NCT00506454|19540424|P2|Overall Study|Withdrawal by Subject|1
5659531|NCT00506454|19540425|P1|Overall Study|Withdrawal by Subject|1
5659532|NCT00506441|19540431|P2|Period 2; Double-blind Period|Other Reason|1
5659533|NCT00506441|19540432|P1|Period 2; Double-blind Period|Other Reason|1
5659534|NCT00506441|19540431|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
5659535|NCT00506441|19540432|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
5659536|NCT00506441|19540431|P2|Period 2; Double-blind Period|Physician Decision|1
5659537|NCT00506441|19540432|P1|Period 2; Double-blind Period|Physician Decision|1
5659538|NCT00506441|19540431|P2|Period 2; Double-blind Period|Lack of Efficacy|2
5659539|NCT00506441|19540432|P1|Period 2; Double-blind Period|Lack of Efficacy|0
5659540|NCT00506441|19540431|P2|Period 2; Double-blind Period|Adverse Event|1
5659541|NCT00506441|19540432|P1|Period 2; Double-blind Period|Adverse Event|0
5659542|NCT00506441|19540431|P2|Period 1; Open-label Period|Other Reasons|0
5659543|NCT00506441|19540432|P1|Period 1; Open-label Period|Other Reasons|13
5659544|NCT00506441|19540431|P2|Period 1; Open-label Period|Withdrawal by Subject|0
5659545|NCT00506441|19540432|P1|Period 1; Open-label Period|Withdrawal by Subject|13
5659546|NCT00506441|19540431|P2|Period 1; Open-label Period|Protocol Violation|0
5659547|NCT00506441|19540432|P1|Period 1; Open-label Period|Protocol Violation|9
5659548|NCT00506441|19540431|P2|Period 1; Open-label Period|Physician Decision|0
5659549|NCT00506441|19540432|P1|Period 1; Open-label Period|Physician Decision|5
5659550|NCT00506441|19540431|P2|Period 1; Open-label Period|Lost to Follow-up|0
5659551|NCT00506441|19540432|P1|Period 1; Open-label Period|Lost to Follow-up|2
5659552|NCT00506441|19540431|P2|Period 1; Open-label Period|Lack of Efficacy|0
5659553|NCT00506441|19540432|P1|Period 1; Open-label Period|Lack of Efficacy|13
5659554|NCT00506441|19540431|P2|Period 1; Open-label Period|Adverse Event|0
5659555|NCT00506441|19540432|P1|Period 1; Open-label Period|Adverse Event|21
5659556|NCT00506415|19540440|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
5659557|NCT00506415|19540441|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
5659558|NCT00506415|19540442|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
5659559|NCT00506415|19540443|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
5659560|NCT00506415|19540440|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
5659561|NCT00506415|19540441|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5659562|NCT00506415|19540442|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5659563|NCT00506415|19540443|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5659564|NCT00506415|19540440|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
5659565|NCT00506415|19540441|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
5659566|NCT00506415|19540442|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
5659567|NCT00506415|19540443|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
5659568|NCT00506415|19540440|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
5659569|NCT00506415|19540441|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5659570|NCT00506415|19540442|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5659571|NCT00506415|19540443|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5659572|NCT00506415|19540440|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
5659573|NCT00506415|19540441|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5659574|NCT00506415|19540442|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5659575|NCT00506415|19540443|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5659576|NCT00506415|19540440|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
5659577|NCT00506415|19540441|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
5659578|NCT00506415|19540442|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
5659579|NCT00506415|19540443|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
5659580|NCT00506415|19540440|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
5659581|NCT00506415|19540441|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
5659582|NCT00506415|19540442|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
5659583|NCT00506415|19540443|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
5659584|NCT00506415|19540440|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
5659585|NCT00506415|19540441|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
5659586|NCT00506415|19540442|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
5659587|NCT00506415|19540443|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
5659588|NCT00506415|19540440|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
5659589|NCT00506415|19540441|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
5659590|NCT00506415|19540442|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
5659591|NCT00506415|19540443|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
5659592|NCT00506415|19540440|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
5659593|NCT00506415|19540441|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
5659594|NCT00506415|19540442|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
5659595|NCT00506415|19540443|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
5659596|NCT00506415|19540440|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
5659597|NCT00506415|19540441|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
5659598|NCT00506415|19540442|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
5659599|NCT00506415|19540443|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
5659600|NCT00506415|19540440|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
5659601|NCT00506415|19540441|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
5659602|NCT00506415|19540442|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
5659603|NCT00506415|19540443|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
5659604|NCT00506415|19540440|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
5659605|NCT00506415|19540441|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
5659606|NCT00506415|19540442|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
5659607|NCT00506415|19540443|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
5659608|NCT00506415|19540440|P4|Double Blind (Maximum 48 Weeks )|Death|0
5659609|NCT00506415|19540441|P3|Double Blind (Maximum 48 Weeks )|Death|3
5659610|NCT00506415|19540442|P2|Double Blind (Maximum 48 Weeks )|Death|5
5659611|NCT00506415|19540443|P1|Double Blind (Maximum 48 Weeks )|Death|0
5659612|NCT00506415|19540440|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
5659613|NCT00506415|19540441|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
5659614|NCT00506415|19540442|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
5659615|NCT00506415|19540443|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
5659616|NCT00506415|19540440|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
5659617|NCT00506415|19540441|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
5659618|NCT00506415|19540442|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
5659619|NCT00506415|19540443|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
5659620|NCT00506415|19540440|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
5659621|NCT00506415|19540441|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
5659622|NCT00506415|19540442|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
5659623|NCT00506415|19540443|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
5659624|NCT00506415|19540440|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
5659625|NCT00506415|19540441|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
5659626|NCT00506415|19540442|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
5659627|NCT00506415|19540443|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
5659628|NCT00506415|19540440|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5659629|NCT00506415|19540441|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5659630|NCT00506415|19540442|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
5659631|NCT00506415|19540443|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
5659632|NCT00506415|19540440|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5659633|NCT00506415|19540441|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5659634|NCT00506415|19540442|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
5659635|NCT00506415|19540443|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
5659636|NCT00506415|19540440|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5659637|NCT00506415|19540441|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5659638|NCT00506415|19540442|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
5659639|NCT00506415|19540443|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
5659640|NCT00506415|19540440|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
5659641|NCT00506415|19540441|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
5659642|NCT00506415|19540442|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
5659643|NCT00506415|19540443|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
5659644|NCT00506415|19540440|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
5659645|NCT00506415|19540441|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
5659646|NCT00506415|19540442|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
5659647|NCT00506415|19540443|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
5659648|NCT00506415|19540440|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
5659649|NCT00506415|19540441|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
5659650|NCT00506415|19540442|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
5659651|NCT00506415|19540443|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
5659652|NCT00506389|19540468|P3|In-treatment Period|Randomized but not treated|1
5659653|NCT00506389|19540469|P2|In-treatment Period|Randomized but not treated|1
5659654|NCT00506389|19540470|P1|In-treatment Period|Randomized but not treated|4
5659655|NCT00506389|19540468|P3|In-treatment Period|Adverse Event|2
5659656|NCT00506389|19540469|P2|In-treatment Period|Adverse Event|5
5659657|NCT00506389|19540470|P1|In-treatment Period|Adverse Event|11
5659658|NCT00506389|19540468|P3|In-treatment Period|Lack of Efficacy|0
5659659|NCT00506389|19540469|P2|In-treatment Period|Lack of Efficacy|2
5659660|NCT00506389|19540470|P1|In-treatment Period|Lack of Efficacy|0
5659661|NCT00506389|19540468|P3|In-treatment Period|Withdrawal by Subject|4
5659662|NCT00506389|19540469|P2|In-treatment Period|Withdrawal by Subject|3
5659663|NCT00506389|19540470|P1|In-treatment Period|Withdrawal by Subject|3
5659664|NCT00506389|19540468|P3|In-treatment Period|Reasons not related to trial|0
5659665|NCT00506389|19540469|P2|In-treatment Period|Reasons not related to trial|1
5659666|NCT00506389|19540470|P1|In-treatment Period|Reasons not related to trial|4
5659667|NCT00506389|19540468|P3|In-treatment Period|Lack of compliance|0
5659668|NCT00506389|19540469|P2|In-treatment Period|Lack of compliance|0
5659669|NCT00506389|19540470|P1|In-treatment Period|Lack of compliance|1
5659670|NCT00506389|19540468|P3|In-treatment Period|Lost to Follow-up|1
5659671|NCT00506389|19540469|P2|In-treatment Period|Lost to Follow-up|0
5659672|NCT00506389|19540470|P1|In-treatment Period|Lost to Follow-up|0
5659673|NCT00506389|19540468|P3|In-treatment Period|Other|4
5659674|NCT00506389|19540469|P2|In-treatment Period|Other|3
5659675|NCT00506389|19540470|P1|In-treatment Period|Other|3
5659676|NCT00506350|19540496|P9|Overall Study|Other|2
5659677|NCT00506350|19540497|P8|Overall Study|Other|2
5659678|NCT00506350|19540498|P7|Overall Study|Other|0
5659679|NCT00506350|19540499|P6|Overall Study|Other|0
5659680|NCT00506350|19540500|P5|Overall Study|Other|3
5659681|NCT00506350|19540501|P4|Overall Study|Other|0
5659682|NCT00506350|19540502|P3|Overall Study|Other|3
5659683|NCT00506350|19540503|P2|Overall Study|Other|1
5659684|NCT00506350|19540504|P1|Overall Study|Other|1
5659685|NCT00506350|19540496|P9|Overall Study|Medical Reason|0
5659686|NCT00506350|19540497|P8|Overall Study|Medical Reason|0
5659687|NCT00506350|19540498|P7|Overall Study|Medical Reason|0
5659688|NCT00506350|19540499|P6|Overall Study|Medical Reason|0
5659689|NCT00506350|19540500|P5|Overall Study|Medical Reason|1
5659690|NCT00506350|19540501|P4|Overall Study|Medical Reason|0
5659691|NCT00506350|19540502|P3|Overall Study|Medical Reason|0
5659692|NCT00506350|19540503|P2|Overall Study|Medical Reason|0
5659693|NCT00506350|19540504|P1|Overall Study|Medical Reason|0
5659694|NCT00506350|19540496|P9|Overall Study|Lost to Follow-up|2
5659695|NCT00506350|19540497|P8|Overall Study|Lost to Follow-up|0
5659696|NCT00506350|19540498|P7|Overall Study|Lost to Follow-up|0
5659697|NCT00506350|19540499|P6|Overall Study|Lost to Follow-up|1
5659698|NCT00506350|19540500|P5|Overall Study|Lost to Follow-up|2
5659699|NCT00506350|19540501|P4|Overall Study|Lost to Follow-up|1
5659700|NCT00506350|19540502|P3|Overall Study|Lost to Follow-up|1
5659701|NCT00506350|19540503|P2|Overall Study|Lost to Follow-up|1
5659702|NCT00506350|19540504|P1|Overall Study|Lost to Follow-up|1
5659703|NCT00506350|19540496|P9|Overall Study|Withdrawal by Subject|0
5659704|NCT00506350|19540497|P8|Overall Study|Withdrawal by Subject|2
5659705|NCT00506350|19540498|P7|Overall Study|Withdrawal by Subject|1
5659706|NCT00506350|19540499|P6|Overall Study|Withdrawal by Subject|1
5659707|NCT00506350|19540500|P5|Overall Study|Withdrawal by Subject|4
5659708|NCT00506350|19540501|P4|Overall Study|Withdrawal by Subject|1
5659709|NCT00506350|19540502|P3|Overall Study|Withdrawal by Subject|1
5659710|NCT00506350|19540503|P2|Overall Study|Withdrawal by Subject|1
5659711|NCT00506350|19540504|P1|Overall Study|Withdrawal by Subject|0
5659712|NCT00506350|19540496|P9|Overall Study|Protocol Violation|0
5659713|NCT00506350|19540497|P8|Overall Study|Protocol Violation|0
5659714|NCT00506350|19540498|P7|Overall Study|Protocol Violation|1
5659715|NCT00506350|19540499|P6|Overall Study|Protocol Violation|0
5659716|NCT00506350|19540500|P5|Overall Study|Protocol Violation|0
5659717|NCT00506350|19540501|P4|Overall Study|Protocol Violation|0
5659718|NCT00506350|19540502|P3|Overall Study|Protocol Violation|1
5659719|NCT00506350|19540503|P2|Overall Study|Protocol Violation|0
5659720|NCT00506350|19540504|P1|Overall Study|Protocol Violation|0
5659721|NCT00506350|19540496|P9|Overall Study|Adverse Event|1
5659722|NCT00506350|19540497|P8|Overall Study|Adverse Event|1
5659723|NCT00506350|19540498|P7|Overall Study|Adverse Event|0
5659724|NCT00506350|19540499|P6|Overall Study|Adverse Event|0
5659725|NCT00506350|19540500|P5|Overall Study|Adverse Event|0
5659726|NCT00506350|19540501|P4|Overall Study|Adverse Event|0
5659727|NCT00506350|19540502|P3|Overall Study|Adverse Event|0
5659728|NCT00506350|19540503|P2|Overall Study|Adverse Event|0
5659729|NCT00506350|19540504|P1|Overall Study|Adverse Event|0
5659730|NCT00506350|19540496|P9|Overall Study|Serious Adverse Event|0
5659731|NCT00506350|19540497|P8|Overall Study|Serious Adverse Event|0
5659732|NCT00506350|19540498|P7|Overall Study|Serious Adverse Event|0
5659733|NCT00506350|19540499|P6|Overall Study|Serious Adverse Event|0
5659734|NCT00506350|19540500|P5|Overall Study|Serious Adverse Event|0
5659735|NCT00506350|19540501|P4|Overall Study|Serious Adverse Event|0
5659736|NCT00506350|19540502|P3|Overall Study|Serious Adverse Event|0
5659737|NCT00506350|19540503|P2|Overall Study|Serious Adverse Event|0
5659738|NCT00506350|19540504|P1|Overall Study|Serious Adverse Event|1
5659739|NCT00506285|19540651|P2|6-month Open Label Phase|Withdrawal by Subject|5
5659740|NCT00506285|19540652|P1|6-month Open Label Phase|Withdrawal by Subject|9
5659741|NCT00506285|19540651|P2|6-month Open Label Phase|Lost to Follow-up|7
5659742|NCT00506285|19540652|P1|6-month Open Label Phase|Lost to Follow-up|1
5659743|NCT00506285|19540651|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
5659744|NCT00506285|19540652|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
5659745|NCT00506285|19540651|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
5659746|NCT00506285|19540652|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
5659747|NCT00506285|19540651|P2|3 Week Screening Phase|Withdrawal by Subject|10
5659748|NCT00506285|19540652|P1|3 Week Screening Phase|Withdrawal by Subject|17
5659749|NCT00506142|19540667|P2|Overall Study|New health condition|0
5659750|NCT00506142|19540668|P1|Overall Study|New health condition|1
5659751|NCT00506142|19540667|P2|Overall Study|Physician Decision|0
5659752|NCT00506142|19540668|P1|Overall Study|Physician Decision|1
5659753|NCT00506142|19540667|P2|Overall Study|Withdrawal by Subject|5
5659754|NCT00506142|19540668|P1|Overall Study|Withdrawal by Subject|4
5659755|NCT00506142|19540667|P2|Overall Study|Lack of Efficacy|7
5659756|NCT00506142|19540668|P1|Overall Study|Lack of Efficacy|21
5659757|NCT00506142|19540667|P2|Overall Study|Adverse Event|7
5659758|NCT00506142|19540668|P1|Overall Study|Adverse Event|8
5659759|NCT00506129|19540674|P1|Overall Study|Death|7
5659760|NCT00506129|19540674|P1|Overall Study|Disease Progression/Relapse|15
5659761|NCT00506077|19540681|P2|Treatment Period 2|Withdrawal by Subject|0
5659762|NCT00506077|19540682|P1|Treatment Period 2|Withdrawal by Subject|1
5659763|NCT00506077|19540681|P2|Treatment Period 2|Adverse Event|1
5659764|NCT00506077|19540682|P1|Treatment Period 2|Adverse Event|0
5659765|NCT00506077|19540681|P2|Treatment Period 1|Withdrawal by Subject|0
5659766|NCT00506077|19540682|P1|Treatment Period 1|Withdrawal by Subject|2
5659767|NCT00506077|19540681|P2|Treatment Period 1|Lost to Follow-up|2
5659768|NCT00506077|19540682|P1|Treatment Period 1|Lost to Follow-up|0
5659769|NCT00506077|19540681|P2|Treatment Period 1|Adverse Event|1
5659770|NCT00506077|19540682|P1|Treatment Period 1|Adverse Event|2
5659771|NCT00505934|19540724|P1|Overall Study|Other: IV dose needed to be changed|1
5659772|NCT00505934|19540724|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
5659773|NCT00505934|19540724|P1|Overall Study|Adverse Event|1
5659774|NCT00505921|19540730|P1|Overall Study|Failed to Mobilize|8
5659775|NCT00505921|19540730|P1|Overall Study|Ineligible|1
5659776|NCT00505778|19540747|P2|Overall Study|Took No Study Drug|2
5659777|NCT00505778|19540748|P1|Overall Study|Took No Study Drug|2
5659778|NCT00505778|19540747|P2|Overall Study|Relapse|65
5659779|NCT00505778|19540748|P1|Overall Study|Relapse|65
5659780|NCT00505778|19540747|P2|Overall Study|Withdrawal by Subject|14
5659781|NCT00505778|19540748|P1|Overall Study|Withdrawal by Subject|29
5659782|NCT00505778|19540747|P2|Overall Study|Protocol Violation|9
5659783|NCT00505778|19540748|P1|Overall Study|Protocol Violation|7
5659784|NCT00505778|19540747|P2|Overall Study|Unable to Meet Protocol Criteria|1
5659785|NCT00505778|19540748|P1|Overall Study|Unable to Meet Protocol Criteria|4
5659786|NCT00505778|19540747|P2|Overall Study|Lost to Follow-up|23
5659787|NCT00505778|19540748|P1|Overall Study|Lost to Follow-up|17
5659788|NCT00505778|19540747|P2|Overall Study|Physician Decision|14
5659789|NCT00505778|19540748|P1|Overall Study|Physician Decision|8
5659790|NCT00505778|19540747|P2|Overall Study|Adverse Event|7
5659791|NCT00505778|19540748|P1|Overall Study|Adverse Event|2
5659792|NCT00505765|19540767|P3|Overall Study|Noncompliance|3
5659793|NCT00505765|19540768|P2|Overall Study|Noncompliance|1
5659794|NCT00505765|19540769|P1|Overall Study|Noncompliance|0
5659795|NCT00505765|19540767|P3|Overall Study|Adverse Event|0
5659796|NCT00505765|19540768|P2|Overall Study|Adverse Event|2
5659797|NCT00505765|19540769|P1|Overall Study|Adverse Event|1
5659798|NCT00505765|19540767|P3|Overall Study|Withdrawal by Subject|0
5659799|NCT00505765|19540768|P2|Overall Study|Withdrawal by Subject|0
5659800|NCT00505765|19540769|P1|Overall Study|Withdrawal by Subject|1
5659801|NCT00505752|19540796|P4|Overall Study|Other|2
5659802|NCT00505752|19540797|P3|Overall Study|Other|1
5659803|NCT00505752|19540798|P2|Overall Study|Other|2
5659804|NCT00505752|19540799|P1|Overall Study|Other|1
5659805|NCT00505752|19540796|P4|Overall Study|All embryos/blastocysts discarded|1
5659806|NCT00505752|19540797|P3|Overall Study|All embryos/blastocysts discarded|1
5659807|NCT00505752|19540798|P2|Overall Study|All embryos/blastocysts discarded|0
5659808|NCT00505752|19540799|P1|Overall Study|All embryos/blastocysts discarded|0
5659809|NCT00505752|19540796|P4|Overall Study|No Fertilization|1
5659810|NCT00505752|19540797|P3|Overall Study|No Fertilization|2
5659811|NCT00505752|19540798|P2|Overall Study|No Fertilization|1
5659812|NCT00505752|19540799|P1|Overall Study|No Fertilization|1
5659813|NCT00505752|19540796|P4|Overall Study|No oocytes retrieved|1
5659814|NCT00505752|19540797|P3|Overall Study|No oocytes retrieved|0
5659815|NCT00505752|19540798|P2|Overall Study|No oocytes retrieved|2
5659816|NCT00505752|19540799|P1|Overall Study|No oocytes retrieved|0
5659817|NCT00505752|19540796|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
5659818|NCT00505752|19540797|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
5659819|NCT00505752|19540798|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
5659820|NCT00505752|19540799|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
5659821|NCT00505752|19540796|P4|Overall Study|Lack of ovarian response|0
5659822|NCT00505752|19540797|P3|Overall Study|Lack of ovarian response|0
5659823|NCT00505752|19540798|P2|Overall Study|Lack of ovarian response|3
5659824|NCT00505752|19540799|P1|Overall Study|Lack of ovarian response|1
5659825|NCT00505752|19540796|P4|Overall Study|Lost to Follow-up|0
5659826|NCT00505752|19540797|P3|Overall Study|Lost to Follow-up|0
5659827|NCT00505752|19540798|P2|Overall Study|Lost to Follow-up|0
5659828|NCT00505752|19540799|P1|Overall Study|Lost to Follow-up|1
5659829|NCT00505752|19540796|P4|Overall Study|Adverse Event|0
5659830|NCT00505752|19540797|P3|Overall Study|Adverse Event|1
5659831|NCT00505752|19540798|P2|Overall Study|Adverse Event|0
5659832|NCT00505752|19540799|P1|Overall Study|Adverse Event|1
5659833|NCT00505687|19540813|P1|Overall Study|Other: As Per Sponsor|8
5659834|NCT00505687|19540813|P1|Overall Study|Other: Disease Progression|1
5659835|NCT00505687|19540813|P1|Overall Study|Other: Neupro Given In Hospital|1
5659836|NCT00505687|19540813|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
5659837|NCT00505687|19540813|P1|Overall Study|Other: Prolonged Hospitalization|1
5659838|NCT00505687|19540813|P1|Overall Study|Other: Scheduled DBS Surgery|1
5659839|NCT00505687|19540813|P1|Overall Study|Other: Underwent Implantation Of DBS|1
5659840|NCT00505687|19540813|P1|Overall Study|Lost to Follow-up|1
5659841|NCT00505687|19540813|P1|Overall Study|Subject withdrew consent|15
5659842|NCT00505687|19540813|P1|Overall Study|Adverse Event|48
5659843|NCT00505687|19540813|P1|Overall Study|Lack of Efficacy|15
5659844|NCT00505687|19540813|P1|Overall Study|Important protocol violation|2
5659845|NCT00505661|19540819|P1|Overall Study|Not Eligible|4
5659846|NCT00505622|19540830|P3|Overall Study|Study termination by sponsor|90
5659847|NCT00505622|19540831|P2|Overall Study|Study termination by sponsor|98
5659848|NCT00505622|19540832|P1|Overall Study|Study termination by sponsor|115
5659849|NCT00505622|19540830|P3|Overall Study|Withdrawal by Subject|2
5659850|NCT00505622|19540831|P2|Overall Study|Withdrawal by Subject|3
5659851|NCT00505622|19540832|P1|Overall Study|Withdrawal by Subject|0
5659852|NCT00505622|19540830|P3|Overall Study|Protocol Violation|0
5659853|NCT00505622|19540831|P2|Overall Study|Protocol Violation|1
5659854|NCT00505622|19540832|P1|Overall Study|Protocol Violation|1
5659855|NCT00505622|19540830|P3|Overall Study|Adverse Event|4
5659856|NCT00505622|19540831|P2|Overall Study|Adverse Event|6
5659857|NCT00505622|19540832|P1|Overall Study|Adverse Event|5
5659858|NCT00505414|19540857|P5|Maintenance Phase|underlying disease and therapy required|0
5659859|NCT00505414|19540858|P4|Maintenance Phase|underlying disease and therapy required|0
5659860|NCT00505414|19540859|P3|Maintenance Phase|underlying disease and therapy required|2
5659861|NCT00505414|19540860|P2|Maintenance Phase|underlying disease and therapy required|2
5659862|NCT00505414|19540861|P1|Maintenance Phase|underlying disease and therapy required|0
5659863|NCT00505414|19540857|P5|Maintenance Phase|Withdrawal by Subject|0
5659864|NCT00505414|19540858|P4|Maintenance Phase|Withdrawal by Subject|0
5659865|NCT00505414|19540859|P3|Maintenance Phase|Withdrawal by Subject|1
5659866|NCT00505414|19540860|P2|Maintenance Phase|Withdrawal by Subject|0
5659867|NCT00505414|19540861|P1|Maintenance Phase|Withdrawal by Subject|0
5659868|NCT00505414|19540857|P5|Maintenance Phase|Lack of Efficacy|0
5659869|NCT00505414|19540858|P4|Maintenance Phase|Lack of Efficacy|0
5659870|NCT00505414|19540859|P3|Maintenance Phase|Lack of Efficacy|1
5659871|NCT00505414|19540860|P2|Maintenance Phase|Lack of Efficacy|1
5659872|NCT00505414|19540861|P1|Maintenance Phase|Lack of Efficacy|2
5659873|NCT00505414|19540857|P5|Maintenance Phase|Death|0
5659874|NCT00505414|19540858|P4|Maintenance Phase|Death|0
5659875|NCT00505414|19540859|P3|Maintenance Phase|Death|1
5659876|NCT00505414|19540860|P2|Maintenance Phase|Death|0
5659877|NCT00505414|19540861|P1|Maintenance Phase|Death|2
5659878|NCT00505414|19540857|P5|Maintenance Phase|Adverse Event|0
5659879|NCT00505414|19540858|P4|Maintenance Phase|Adverse Event|0
5659880|NCT00505414|19540859|P3|Maintenance Phase|Adverse Event|3
5659881|NCT00505414|19540860|P2|Maintenance Phase|Adverse Event|2
5659882|NCT00505414|19540861|P1|Maintenance Phase|Adverse Event|2
5659883|NCT00505414|19540857|P5|Titration Phase|Underlying disease and therapy required|3
5659884|NCT00505414|19540858|P4|Titration Phase|Underlying disease and therapy required|7
5659885|NCT00505414|19540859|P3|Titration Phase|Underlying disease and therapy required|0
5659886|NCT00505414|19540860|P2|Titration Phase|Underlying disease and therapy required|0
5659887|NCT00505414|19540861|P1|Titration Phase|Underlying disease and therapy required|0
5659888|NCT00505414|19540857|P5|Titration Phase|Withdrawal by Subject|4
5659889|NCT00505414|19540858|P4|Titration Phase|Withdrawal by Subject|3
5659890|NCT00505414|19540859|P3|Titration Phase|Withdrawal by Subject|0
5659891|NCT00505414|19540860|P2|Titration Phase|Withdrawal by Subject|0
5659892|NCT00505414|19540861|P1|Titration Phase|Withdrawal by Subject|0
5659893|NCT00505414|19540857|P5|Titration Phase|Protocol Violation|1
5659894|NCT00505414|19540858|P4|Titration Phase|Protocol Violation|0
5659895|NCT00505414|19540859|P3|Titration Phase|Protocol Violation|0
5659896|NCT00505414|19540860|P2|Titration Phase|Protocol Violation|0
5659897|NCT00505414|19540861|P1|Titration Phase|Protocol Violation|0
5659898|NCT00505414|19540857|P5|Titration Phase|Lack of Efficacy|1
5659899|NCT00505414|19540858|P4|Titration Phase|Lack of Efficacy|10
5659900|NCT00505414|19540859|P3|Titration Phase|Lack of Efficacy|0
5659901|NCT00505414|19540860|P2|Titration Phase|Lack of Efficacy|0
5659902|NCT00505414|19540861|P1|Titration Phase|Lack of Efficacy|0
5659903|NCT00505414|19540857|P5|Titration Phase|Death|0
5659904|NCT00505414|19540858|P4|Titration Phase|Death|2
5659905|NCT00505414|19540859|P3|Titration Phase|Death|0
5659906|NCT00505414|19540860|P2|Titration Phase|Death|0
5659907|NCT00505414|19540861|P1|Titration Phase|Death|0
5659908|NCT00505414|19540857|P5|Titration Phase|Adverse Event|3
5659909|NCT00505414|19540858|P4|Titration Phase|Adverse Event|8
5659910|NCT00505414|19540859|P3|Titration Phase|Adverse Event|0
5659911|NCT00505414|19540860|P2|Titration Phase|Adverse Event|0
5659912|NCT00505414|19540861|P1|Titration Phase|Adverse Event|0
5659913|NCT00505375|19540878|P2|Overall Study|Travel issues|1
5659914|NCT00505375|19540879|P1|Overall Study|Travel issues|0
5659915|NCT00505375|19540878|P2|Overall Study|Pregnancy|0
5659916|NCT00505375|19540879|P1|Overall Study|Pregnancy|1
5659917|NCT00505375|19540878|P2|Overall Study|Lost to Follow-up|2
5659918|NCT00505375|19540879|P1|Overall Study|Lost to Follow-up|0
5659919|NCT00505375|19540878|P2|Overall Study|Withdrawal by Subject|2
5659920|NCT00505375|19540879|P1|Overall Study|Withdrawal by Subject|2
5659921|NCT00505375|19540878|P2|Overall Study|Death|0
5659922|NCT00505375|19540879|P1|Overall Study|Death|1
5659923|NCT00505284|19540901|P5|Overall Study|Other|4
5659924|NCT00505284|19540902|P4|Overall Study|Other|4
5659925|NCT00505284|19540903|P3|Overall Study|Other|0
5659926|NCT00505284|19540904|P2|Overall Study|Other|0
5659927|NCT00505284|19540905|P1|Overall Study|Other|5
5659928|NCT00505284|19540901|P5|Overall Study|Physician Decision|0
5659929|NCT00505284|19540902|P4|Overall Study|Physician Decision|0
5659930|NCT00505284|19540903|P3|Overall Study|Physician Decision|0
5659931|NCT00505284|19540904|P2|Overall Study|Physician Decision|1
5659932|NCT00505284|19540905|P1|Overall Study|Physician Decision|0
5659933|NCT00505284|19540901|P5|Overall Study|Lack of Efficacy|1
5659934|NCT00505284|19540902|P4|Overall Study|Lack of Efficacy|1
5659935|NCT00505284|19540903|P3|Overall Study|Lack of Efficacy|1
5659936|NCT00505284|19540904|P2|Overall Study|Lack of Efficacy|1
5659937|NCT00505284|19540905|P1|Overall Study|Lack of Efficacy|0
5659938|NCT00505284|19540901|P5|Overall Study|Withdrawal by Subject|6
5659939|NCT00505284|19540902|P4|Overall Study|Withdrawal by Subject|0
5659940|NCT00505284|19540903|P3|Overall Study|Withdrawal by Subject|1
5659941|NCT00505284|19540904|P2|Overall Study|Withdrawal by Subject|6
5659942|NCT00505284|19540905|P1|Overall Study|Withdrawal by Subject|2
5659943|NCT00505284|19540901|P5|Overall Study|Protocol Violation|0
5659944|NCT00505284|19540902|P4|Overall Study|Protocol Violation|0
5659945|NCT00505284|19540903|P3|Overall Study|Protocol Violation|1
5659946|NCT00505284|19540904|P2|Overall Study|Protocol Violation|1
5659947|NCT00505284|19540905|P1|Overall Study|Protocol Violation|0
5659948|NCT00505284|19540901|P5|Overall Study|Adverse Event|22
5659949|NCT00505284|19540902|P4|Overall Study|Adverse Event|14
5659950|NCT00505284|19540903|P3|Overall Study|Adverse Event|9
5659951|NCT00505284|19540904|P2|Overall Study|Adverse Event|7
5659952|NCT00505284|19540905|P1|Overall Study|Adverse Event|3
5659953|NCT00505076|19540975|P3|Overall Study|Withdrawal by Subject|2
5659954|NCT00505076|19540976|P2|Overall Study|Withdrawal by Subject|1
5659955|NCT00505076|19540977|P1|Overall Study|Withdrawal by Subject|0
5659956|NCT00505076|19540975|P3|Overall Study|Protocol Violation|2
5659957|NCT00505076|19540976|P2|Overall Study|Protocol Violation|1
5659958|NCT00505076|19540977|P1|Overall Study|Protocol Violation|2
5659959|NCT00505076|19540975|P3|Overall Study|Adverse Event|1
5659960|NCT00505076|19540976|P2|Overall Study|Adverse Event|0
5659961|NCT00505076|19540977|P1|Overall Study|Adverse Event|1
5659962|NCT00504881|19541006|P2|Overall Study|AE of unknown type|0
5659963|NCT00504881|19541007|P1|Overall Study|AE of unknown type|1
5659964|NCT00504881|19541006|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
5659965|NCT00504881|19541007|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5659966|NCT00504881|19541006|P2|Overall Study|AE, non-serious non-fatal|14
5659967|NCT00504881|19541007|P1|Overall Study|AE, non-serious non-fatal|4
5659968|NCT00504881|19541006|P2|Overall Study|SAE, non-fatal|6
5659969|NCT00504881|19541007|P1|Overall Study|SAE, non-fatal|2
5659970|NCT00504881|19541006|P2|Overall Study|AE, serious fatal|1
5659971|NCT00504881|19541007|P1|Overall Study|AE, serious fatal|0
5659972|NCT00504881|19541006|P2|Overall Study|Safety Visit not performed|1
5659973|NCT00504881|19541007|P1|Overall Study|Safety Visit not performed|0
5659974|NCT00504881|19541006|P2|Overall Study|No Birth Control|1
5659975|NCT00504881|19541007|P1|Overall Study|No Birth Control|0
5659976|NCT00504881|19541006|P2|Overall Study|Non-Compliance|0
5659977|NCT00504881|19541007|P1|Overall Study|Non-Compliance|1
5659978|NCT00504881|19541006|P2|Overall Study|Withdrawal by Subject|4
5659979|NCT00504881|19541007|P1|Overall Study|Withdrawal by Subject|1
5659980|NCT00504881|19541006|P2|Overall Study|Lost to Follow-up|2
5659981|NCT00504881|19541007|P1|Overall Study|Lost to Follow-up|0
5659982|NCT00504881|19541006|P2|Overall Study|Lack of Efficacy|5
5659983|NCT00504881|19541007|P1|Overall Study|Lack of Efficacy|1
5659984|NCT00504829|19541060|P3|Overall Study|Protocol Violation|10
5659985|NCT00504829|19541061|P2|Overall Study|Protocol Violation|4
5659986|NCT00504829|19541062|P1|Overall Study|Protocol Violation|6
5659987|NCT00504777|19541071|P1|Overall Study|Adverse Event|1
5659988|NCT00504725|19541084|P2|Overall Study|Protocol Violation|0
5659989|NCT00504725|19541085|P1|Overall Study|Protocol Violation|1
5659990|NCT00504595|19541108|P4|Overall Study|Other|0
5659991|NCT00504595|19541109|P3|Overall Study|Other|2
5659992|NCT00504595|19541110|P2|Overall Study|Other|0
5659993|NCT00504595|19541111|P1|Overall Study|Other|0
5659994|NCT00504595|19541108|P4|Overall Study|Lack of Efficacy|0
5659995|NCT00504595|19541109|P3|Overall Study|Lack of Efficacy|0
5659996|NCT00504595|19541110|P2|Overall Study|Lack of Efficacy|0
5659997|NCT00504595|19541111|P1|Overall Study|Lack of Efficacy|1
5659998|NCT00504556|19541128|P5|Overall Study|not in safety analysis set|1
5659999|NCT00504556|19541129|P4|Overall Study|not in safety analysis set|0
5660000|NCT00504556|19541130|P3|Overall Study|not in safety analysis set|1
5660001|NCT00504556|19541131|P2|Overall Study|not in safety analysis set|1
5660002|NCT00504556|19541132|P1|Overall Study|not in safety analysis set|0
5660003|NCT00504556|19541128|P5|Overall Study|Other|0
5660004|NCT00504556|19541129|P4|Overall Study|Other|3
5660005|NCT00504556|19541130|P3|Overall Study|Other|2
5660006|NCT00504556|19541131|P2|Overall Study|Other|2
5660007|NCT00504556|19541132|P1|Overall Study|Other|2
5660008|NCT00504556|19541128|P5|Overall Study|data monitor committee decision|0
5660009|NCT00504556|19541129|P4|Overall Study|data monitor committee decision|100
5660010|NCT00504556|19541130|P3|Overall Study|data monitor committee decision|0
5660011|NCT00504556|19541131|P2|Overall Study|data monitor committee decision|0
5660012|NCT00504556|19541132|P1|Overall Study|data monitor committee decision|0
5660013|NCT00504556|19541128|P5|Overall Study|did not meet entry criteria|0
5660014|NCT00504556|19541129|P4|Overall Study|did not meet entry criteria|1
5660015|NCT00504556|19541130|P3|Overall Study|did not meet entry criteria|1
5660016|NCT00504556|19541131|P2|Overall Study|did not meet entry criteria|0
5660017|NCT00504556|19541132|P1|Overall Study|did not meet entry criteria|2
5660018|NCT00504556|19541128|P5|Overall Study|administrative reasons|2
5660019|NCT00504556|19541129|P4|Overall Study|administrative reasons|1
5660020|NCT00504556|19541130|P3|Overall Study|administrative reasons|2
5660021|NCT00504556|19541131|P2|Overall Study|administrative reasons|2
5660022|NCT00504556|19541132|P1|Overall Study|administrative reasons|0
5660023|NCT00504556|19541128|P5|Overall Study|Withdrawal by Subject|12
5660024|NCT00504556|19541129|P4|Overall Study|Withdrawal by Subject|8
5660025|NCT00504556|19541130|P3|Overall Study|Withdrawal by Subject|7
5660026|NCT00504556|19541131|P2|Overall Study|Withdrawal by Subject|16
5660027|NCT00504556|19541132|P1|Overall Study|Withdrawal by Subject|16
5660028|NCT00504556|19541128|P5|Overall Study|Lost to Follow-up|1
5660029|NCT00504556|19541129|P4|Overall Study|Lost to Follow-up|1
5660030|NCT00504556|19541130|P3|Overall Study|Lost to Follow-up|1
5660031|NCT00504556|19541131|P2|Overall Study|Lost to Follow-up|0
5660032|NCT00504556|19541132|P1|Overall Study|Lost to Follow-up|0
5660033|NCT00504556|19541128|P5|Overall Study|Protocol Violation|2
5660034|NCT00504556|19541129|P4|Overall Study|Protocol Violation|1
5660035|NCT00504556|19541130|P3|Overall Study|Protocol Violation|2
5660036|NCT00504556|19541131|P2|Overall Study|Protocol Violation|3
5660037|NCT00504556|19541132|P1|Overall Study|Protocol Violation|1
5660038|NCT00504556|19541128|P5|Overall Study|Death|2
5660039|NCT00504556|19541129|P4|Overall Study|Death|0
5660040|NCT00504556|19541130|P3|Overall Study|Death|1
5660041|NCT00504556|19541131|P2|Overall Study|Death|3
5660042|NCT00504556|19541132|P1|Overall Study|Death|3
5660043|NCT00504556|19541128|P5|Overall Study|Adverse Event|5
5660044|NCT00504556|19541129|P4|Overall Study|Adverse Event|13
5660045|NCT00504556|19541130|P3|Overall Study|Adverse Event|14
5660046|NCT00504556|19541131|P2|Overall Study|Adverse Event|11
5660047|NCT00504556|19541132|P1|Overall Study|Adverse Event|11
5660048|NCT00504426|19541200|P4|Overall Study|Withdrawal by Subject|0
5660049|NCT00504426|19541201|P3|Overall Study|Withdrawal by Subject|0
5660050|NCT00504426|19541202|P2|Overall Study|Withdrawal by Subject|0
5660051|NCT00504426|19541203|P1|Overall Study|Withdrawal by Subject|2
5660052|NCT00504426|19541200|P4|Overall Study|Protocol Violation|0
5660053|NCT00504426|19541201|P3|Overall Study|Protocol Violation|2
5660054|NCT00504426|19541202|P2|Overall Study|Protocol Violation|1
5660055|NCT00504426|19541203|P1|Overall Study|Protocol Violation|1
5660056|NCT00504426|19541200|P4|Overall Study|Adverse Event|0
5660057|NCT00504426|19541201|P3|Overall Study|Adverse Event|2
5660058|NCT00504426|19541202|P2|Overall Study|Adverse Event|0
5660059|NCT00504426|19541203|P1|Overall Study|Adverse Event|0
5660060|NCT00504348|19541217|P1|Overall Study|Physician Decision|1
5660061|NCT00504348|19541217|P1|Overall Study|Lack of Efficacy|4
5660062|NCT00504348|19541217|P1|Overall Study|Adverse Event|3
5660063|NCT00504309|19541228|P6|Overall Study|Withdrawal by Subject|0
5660064|NCT00504309|19541229|P5|Overall Study|Withdrawal by Subject|0
5660065|NCT00504309|19541230|P4|Overall Study|Withdrawal by Subject|0
5660066|NCT00504309|19541231|P3|Overall Study|Withdrawal by Subject|1
5660067|NCT00504309|19541232|P2|Overall Study|Withdrawal by Subject|0
5660068|NCT00504309|19541233|P1|Overall Study|Withdrawal by Subject|0
5660069|NCT00504309|19541228|P6|Overall Study|Death|0
5660070|NCT00504309|19541229|P5|Overall Study|Death|1
5660071|NCT00504309|19541230|P4|Overall Study|Death|0
5660072|NCT00504309|19541231|P3|Overall Study|Death|0
5660073|NCT00504309|19541232|P2|Overall Study|Death|0
5660074|NCT00504309|19541233|P1|Overall Study|Death|0
5660075|NCT00504257|19541271|P1|Overall Study|ineligible histology|2
5660076|NCT00504257|19541271|P1|Overall Study|Withdrawal by Subject|2
5660077|NCT00504231|19541283|P4|Overall Study|Discrepant chart documentation re route|0
5660078|NCT00504231|19541284|P3|Overall Study|Discrepant chart documentation re route|1
5660079|NCT00504231|19541285|P2|Overall Study|Discrepant chart documentation re route|0
5660080|NCT00504231|19541286|P1|Overall Study|Discrepant chart documentation re route|0
5660081|NCT00504166|19541306|P2|Overall Study|Lost to Follow-up|3
5660082|NCT00504166|19541307|P1|Overall Study|Lost to Follow-up|1
5660083|NCT00504166|19541306|P2|Overall Study|Physician Decision|1
5660084|NCT00504166|19541307|P1|Overall Study|Physician Decision|1
5660085|NCT00504166|19541306|P2|Overall Study|Withdrawal by Subject|6
5660086|NCT00504166|19541307|P1|Overall Study|Withdrawal by Subject|3
5660087|NCT00504166|19541306|P2|Overall Study|Adverse Event|4
5660088|NCT00504166|19541307|P1|Overall Study|Adverse Event|1
5660089|NCT00504153|19541313|P1|Overall Study|Death|1
5660090|NCT00504153|19541313|P1|Overall Study|Adverse Event|4
5660091|NCT00504153|19541313|P1|Overall Study|Withdrawal by Subject|1
5660092|NCT00504075|19541321|P1|Overall Study|Required other therapeutic intervention|1
5660093|NCT00504075|19541321|P1|Overall Study|Withdrawal by Subject|1
5660094|NCT00504075|19541321|P1|Overall Study|Lost to Follow-up|5
5660095|NCT00504075|19541321|P1|Overall Study|Adverse Event|1
5660096|NCT00503997|19541331|P1|Overall Study|Withdrawal by Subject|1
5660097|NCT00503997|19541331|P1|Overall Study|Death|1
5660098|NCT00503997|19541331|P1|Overall Study|Adverse Event|5
5660099|NCT00503997|19541331|P1|Overall Study|disease progression|1
5660100|NCT00503984|19541337|P6|Overall Study|Death|0
5660101|NCT00503984|19541338|P5|Overall Study|Death|1
5660102|NCT00503984|19541339|P4|Overall Study|Death|0
5660103|NCT00503984|19541340|P3|Overall Study|Death|0
5660104|NCT00503984|19541341|P2|Overall Study|Death|0
5660105|NCT00503984|19541342|P1|Overall Study|Death|0
5660106|NCT00503984|19541337|P6|Overall Study|Adverse Event|0
5660107|NCT00503984|19541338|P5|Overall Study|Adverse Event|0
5660108|NCT00503984|19541339|P4|Overall Study|Adverse Event|0
5660109|NCT00503984|19541340|P3|Overall Study|Adverse Event|0
5660110|NCT00503984|19541341|P2|Overall Study|Adverse Event|1
5660111|NCT00503984|19541342|P1|Overall Study|Adverse Event|0
5660112|NCT00503984|19541337|P6|Overall Study|Protocol Violation|0
5660113|NCT00503984|19541338|P5|Overall Study|Protocol Violation|0
5660114|NCT00503984|19541339|P4|Overall Study|Protocol Violation|0
5660115|NCT00503984|19541340|P3|Overall Study|Protocol Violation|0
5660116|NCT00503984|19541341|P2|Overall Study|Protocol Violation|1
5660117|NCT00503984|19541342|P1|Overall Study|Protocol Violation|0
5660118|NCT00503906|19541368|P1|Overall Study|Withdrawal by Subject|1
5660119|NCT00503867|19541390|P1|Overall Study|Adverse Event|1
5660120|NCT00503867|19541390|P1|Overall Study|Lost to Follow-up|1
5660121|NCT00503841|19541398|P1|Overall Study|All screen failures|44
5660122|NCT00503776|19541409|P4|Overall Study|Physician Decision|1
5660123|NCT00503776|19541410|P3|Overall Study|Physician Decision|1
5660124|NCT00503776|19541411|P2|Overall Study|Physician Decision|0
5660125|NCT00503776|19541412|P1|Overall Study|Physician Decision|0
5660126|NCT00503776|19541409|P4|Overall Study|Withdrawal by Subject|1
5660127|NCT00503776|19541410|P3|Overall Study|Withdrawal by Subject|1
5660128|NCT00503776|19541411|P2|Overall Study|Withdrawal by Subject|0
5660129|NCT00503776|19541412|P1|Overall Study|Withdrawal by Subject|1
5660130|NCT00503698|19541445|P2|Overall Study|Not exposed to trial drug|6
5660131|NCT00503698|19541446|P1|Overall Study|Not exposed to trial drug|11
5660132|NCT00503698|19541445|P2|Overall Study|Unclassified|32
5660133|NCT00503698|19541446|P1|Overall Study|Unclassified|48
5660134|NCT00503698|19541445|P2|Overall Study|Critically ill|0
5660135|NCT00503698|19541446|P1|Overall Study|Critically ill|2
5660136|NCT00503698|19541445|P2|Overall Study|Move to nonparticipating dialysis center|1
5660137|NCT00503698|19541446|P1|Overall Study|Move to nonparticipating dialysis center|2
5660138|NCT00503698|19541445|P2|Overall Study|Switch to peritoneal or home dialysis|2
5660139|NCT00503698|19541446|P1|Overall Study|Switch to peritoneal or home dialysis|2
5660140|NCT00503698|19541445|P2|Overall Study|Any condition in exclusion criteria|6
5660141|NCT00503698|19541446|P1|Overall Study|Any condition in exclusion criteria|4
5660142|NCT00503698|19541445|P2|Overall Study|Pregnancy/intention to become pregnant|0
5660143|NCT00503698|19541446|P1|Overall Study|Pregnancy/intention to become pregnant|1
5660144|NCT00503698|19541445|P2|Overall Study|End hemodialysis due to renal transplant|4
5660145|NCT00503698|19541446|P1|Overall Study|End hemodialysis due to renal transplant|10
5660146|NCT00503698|19541445|P2|Overall Study|Trial terminated|253
5660147|NCT00503698|19541446|P1|Overall Study|Trial terminated|216
5660148|NCT00503698|19541445|P2|Overall Study|Lack of Efficacy|4
5660149|NCT00503698|19541446|P1|Overall Study|Lack of Efficacy|3
5660150|NCT00503698|19541445|P2|Overall Study|Death|0
5660151|NCT00503698|19541446|P1|Overall Study|Death|1
5660152|NCT00503698|19541445|P2|Overall Study|Adverse Event|41
5660153|NCT00503698|19541446|P1|Overall Study|Adverse Event|52
5660154|NCT00503698|19541445|P2|Overall Study|Protocol Violation|6
5660155|NCT00503698|19541446|P1|Overall Study|Protocol Violation|5
5660156|NCT00503685|19541463|P3|Overall Study|Eligibility Criteria Not Met|0
5660157|NCT00503685|19541464|P2|Overall Study|Eligibility Criteria Not Met|1
5660158|NCT00503685|19541465|P1|Overall Study|Eligibility Criteria Not Met|0
5660159|NCT00503685|19541463|P3|Overall Study|Protocol Violation|0
5660160|NCT00503685|19541464|P2|Overall Study|Protocol Violation|1
5660161|NCT00503685|19541465|P1|Overall Study|Protocol Violation|0
5660162|NCT00503685|19541463|P3|Overall Study|Withdrawal by Subject|0
5660163|NCT00503685|19541464|P2|Overall Study|Withdrawal by Subject|1
5660164|NCT00503685|19541465|P1|Overall Study|Withdrawal by Subject|0
5660165|NCT00503685|19541463|P3|Overall Study|Adverse Event|2
5660166|NCT00503685|19541464|P2|Overall Study|Adverse Event|0
5660167|NCT00503685|19541465|P1|Overall Study|Adverse Event|0
5660168|NCT00503581|19541510|P3|Overall Study|Study closed|2
5660169|NCT00503581|19541511|P2|Overall Study|Study closed|4
5660170|NCT00503581|19541512|P1|Overall Study|Study closed|3
5660171|NCT00503425|19541523|P1|Overall Study|Missing Data/Unknown|4
5660172|NCT00503425|19541523|P1|Overall Study|Death|3
5660173|NCT00503425|19541523|P1|Overall Study|Lost to Follow-up|3
5660174|NCT00503425|19541523|P1|Overall Study|Withdrawal by Subject|8
5660175|NCT00503425|19541523|P1|Overall Study|Lack of Efficacy|25
5660176|NCT00503425|19541523|P1|Overall Study|Adverse Event|5
5660177|NCT00503425|19541523|P1|Overall Study|Participant files lost|6
5660178|NCT00503399|19541533|P2|Overall Study|Lost to Follow-up|2
5660179|NCT00503399|19541534|P1|Overall Study|Lost to Follow-up|0
5660180|NCT00503399|19541533|P2|Overall Study|Adverse Event|3
5660181|NCT00503399|19541534|P1|Overall Study|Adverse Event|0
5660182|NCT00503399|19541533|P2|Overall Study|Withdrawal by Subject|2
5660183|NCT00503399|19541534|P1|Overall Study|Withdrawal by Subject|4
5660184|NCT00503399|19541533|P2|Overall Study|Protocol Violation|0
5660185|NCT00503399|19541534|P1|Overall Study|Protocol Violation|1
5660186|NCT00503399|19541533|P2|Overall Study|Death|1
5660187|NCT00503399|19541534|P1|Overall Study|Death|2
5660188|NCT00503308|19541558|P2|Overall Study|Protocol Violation|1
5660189|NCT00503308|19541559|P1|Overall Study|Protocol Violation|2
5660190|NCT00503139|19541565|P1|Overall Study|Protocol Violation|4
5660191|NCT00503139|19541565|P1|Overall Study|Case Report Forms were not collected|4
5660192|NCT00503009|19541613|P3|Overall Study|Physician Decision|1
5660193|NCT00503009|19541614|P2|Overall Study|Physician Decision|1
5660194|NCT00503009|19541615|P1|Overall Study|Physician Decision|0
5660195|NCT00503009|19541613|P3|Overall Study|Withdrawal by Subject|1
5660196|NCT00503009|19541614|P2|Overall Study|Withdrawal by Subject|1
5660197|NCT00503009|19541615|P1|Overall Study|Withdrawal by Subject|0
5660198|NCT00503009|19541613|P3|Overall Study|Protocol Violation|1
5660199|NCT00503009|19541614|P2|Overall Study|Protocol Violation|0
5660200|NCT00503009|19541615|P1|Overall Study|Protocol Violation|1
5660201|NCT00502996|19541632|P1|Overall Study|Adverse Event|2
5660202|NCT00502996|19541632|P1|Overall Study|Withdrawal Informed Consent|6
5660203|NCT00502996|19541632|P1|Overall Study|Treatment failure|25
5660204|NCT00502996|19541632|P1|Overall Study|Protocol Violation|2
5660205|NCT00502996|19541632|P1|Overall Study|Lost to Follow-up|9
5660206|NCT00502840|19541700|P1|Overall Study|Other|20
5660207|NCT00502840|19541700|P1|Overall Study|Administrative problems|1
5660208|NCT00502840|19541700|P1|Overall Study|Lost to Follow-up|6
5660209|NCT00502840|19541700|P1|Overall Study|Withdrawal by Subject|5
5660210|NCT00502840|19541700|P1|Overall Study|Protocol Violation|4
5660211|NCT00502840|19541700|P1|Overall Study|Lack of Efficacy|11
5660212|NCT00502840|19541700|P1|Overall Study|Additional or changed therapy|48
5660213|NCT00502840|19541700|P1|Overall Study|Adverse Event|5
5660214|NCT00502801|19541728|P1|End of Therapy to Test of Cure|OTHER|2
5660215|NCT00502801|19541728|P1|End of Therapy to Test of Cure|Death|3
5660216|NCT00502801|19541728|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
5660217|NCT00502801|19541728|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
5660218|NCT00502801|19541728|P1|Treatment Period|OTHER|30
5660219|NCT00502801|19541728|P1|Treatment Period|Death|14
5660220|NCT00502801|19541728|P1|Treatment Period|Adverse Event|7
5660221|NCT00502801|19541728|P1|Treatment Period|Withdrawal by Subject|3
5660222|NCT00502775|19541736|P3|Overall Study|Subject took disallowed drug|1
5660223|NCT00502775|19541737|P2|Overall Study|Subject took disallowed drug|0
5660224|NCT00502775|19541738|P1|Overall Study|Subject took disallowed drug|0
5660225|NCT00502775|19541736|P3|Overall Study|Subject in jail|0
5660226|NCT00502775|19541737|P2|Overall Study|Subject in jail|1
5660227|NCT00502775|19541738|P1|Overall Study|Subject in jail|0
5660228|NCT00502775|19541736|P3|Overall Study|Declining pollen counts|1
5660229|NCT00502775|19541737|P2|Overall Study|Declining pollen counts|1
5660230|NCT00502775|19541738|P1|Overall Study|Declining pollen counts|0
5660231|NCT00502775|19541736|P3|Overall Study|Outside pollen area more than 48 hours|0
5660232|NCT00502775|19541737|P2|Overall Study|Outside pollen area more than 48 hours|1
5660233|NCT00502775|19541738|P1|Overall Study|Outside pollen area more than 48 hours|0
5660234|NCT00502775|19541736|P3|Overall Study|Non-compliance|2
5660235|NCT00502775|19541737|P2|Overall Study|Non-compliance|2
5660236|NCT00502775|19541738|P1|Overall Study|Non-compliance|0
5660237|NCT00502775|19541736|P3|Overall Study|Randomized in error|1
5660238|NCT00502775|19541737|P2|Overall Study|Randomized in error|1
5660239|NCT00502775|19541738|P1|Overall Study|Randomized in error|0
5660240|NCT00502775|19541736|P3|Overall Study|Logpad compliance <80%|0
5660241|NCT00502775|19541737|P2|Overall Study|Logpad compliance <80%|0
5660242|NCT00502775|19541738|P1|Overall Study|Logpad compliance <80%|1
5660243|NCT00502775|19541736|P3|Overall Study|Subject unable to swallow capsule|1
5660244|NCT00502775|19541737|P2|Overall Study|Subject unable to swallow capsule|0
5660245|NCT00502775|19541738|P1|Overall Study|Subject unable to swallow capsule|1
5660246|NCT00502775|19541736|P3|Overall Study|Non-compliance with eDiary|1
5660247|NCT00502775|19541737|P2|Overall Study|Non-compliance with eDiary|1
5660248|NCT00502775|19541738|P1|Overall Study|Non-compliance with eDiary|4
5660249|NCT00502775|19541736|P3|Overall Study|Sponsor Terminated Study|1
5660250|NCT00502775|19541737|P2|Overall Study|Sponsor Terminated Study|0
5660251|NCT00502775|19541738|P1|Overall Study|Sponsor Terminated Study|1
5660252|NCT00502775|19541736|P3|Overall Study|Withdrawal by Subject|2
5660253|NCT00502775|19541737|P2|Overall Study|Withdrawal by Subject|1
5660254|NCT00502775|19541738|P1|Overall Study|Withdrawal by Subject|1
5660255|NCT00502775|19541736|P3|Overall Study|Protocol Violation|2
5660256|NCT00502775|19541737|P2|Overall Study|Protocol Violation|5
5660257|NCT00502775|19541738|P1|Overall Study|Protocol Violation|1
5660258|NCT00502775|19541736|P3|Overall Study|Adverse Event|1
5660259|NCT00502775|19541737|P2|Overall Study|Adverse Event|2
5660260|NCT00502775|19541738|P1|Overall Study|Adverse Event|1
5660261|NCT00502697|19541781|P2|Overall Study|did not meet assignment criteria|2
5660262|NCT00502697|19541782|P1|Overall Study|did not meet assignment criteria|4
5660263|NCT00502697|19541781|P2|Overall Study|found not to meet eligibility criteria|4
5660264|NCT00502697|19541782|P1|Overall Study|found not to meet eligibility criteria|3
5660265|NCT00502697|19541781|P2|Overall Study|disenrolled due to pregnancy loss|5
5660266|NCT00502697|19541782|P1|Overall Study|disenrolled due to pregnancy loss|3
5660267|NCT00502697|19541781|P2|Overall Study|Withdrawal by Subject|1
5660268|NCT00502697|19541782|P1|Overall Study|Withdrawal by Subject|3
5660269|NCT00502671|19541790|P1|Overall Study|Adverse Event|19
5660270|NCT00502671|19541790|P1|Overall Study|Protocol Violation|16
5660271|NCT00502671|19541790|P1|Overall Study|Lost to Follow-up|7
5660272|NCT00502671|19541790|P1|Overall Study|Personal Reasons|22
5660273|NCT00502671|19541790|P1|Overall Study|Disease Progression|13
5660274|NCT00502593|19541807|P12|Overall Study|Lost to Follow-up|0
5660275|NCT00502593|19541808|P11|Overall Study|Lost to Follow-up|1
5660276|NCT00502593|19541809|P10|Overall Study|Lost to Follow-up|0
5660277|NCT00502593|19541810|P9|Overall Study|Lost to Follow-up|3
5660278|NCT00502593|19541811|P8|Overall Study|Lost to Follow-up|0
5660279|NCT00502593|19541812|P7|Overall Study|Lost to Follow-up|0
5660280|NCT00502593|19541813|P6|Overall Study|Lost to Follow-up|0
5660281|NCT00502593|19541814|P5|Overall Study|Lost to Follow-up|0
5660282|NCT00502593|19541815|P4|Overall Study|Lost to Follow-up|1
5660283|NCT00502593|19541816|P3|Overall Study|Lost to Follow-up|1
5660284|NCT00502593|19541817|P2|Overall Study|Lost to Follow-up|1
5660285|NCT00502593|19541818|P1|Overall Study|Lost to Follow-up|2
5660286|NCT00502593|19541807|P12|Overall Study|Withdrawal by Subject|0
5660287|NCT00502593|19541808|P11|Overall Study|Withdrawal by Subject|1
5660288|NCT00502593|19541809|P10|Overall Study|Withdrawal by Subject|0
5660289|NCT00502593|19541810|P9|Overall Study|Withdrawal by Subject|3
5660290|NCT00502593|19541811|P8|Overall Study|Withdrawal by Subject|0
5660291|NCT00502593|19541812|P7|Overall Study|Withdrawal by Subject|3
5660292|NCT00502593|19541813|P6|Overall Study|Withdrawal by Subject|0
5660293|NCT00502593|19541814|P5|Overall Study|Withdrawal by Subject|2
5660294|NCT00502593|19541815|P4|Overall Study|Withdrawal by Subject|2
5660295|NCT00502593|19541816|P3|Overall Study|Withdrawal by Subject|6
5660296|NCT00502593|19541817|P2|Overall Study|Withdrawal by Subject|0
5660297|NCT00502593|19541818|P1|Overall Study|Withdrawal by Subject|0
5660298|NCT00502593|19541807|P12|Overall Study|Withdrawn unspecified reason|0
5660299|NCT00502593|19541808|P11|Overall Study|Withdrawn unspecified reason|0
5660300|NCT00502593|19541809|P10|Overall Study|Withdrawn unspecified reason|0
5660301|NCT00502593|19541810|P9|Overall Study|Withdrawn unspecified reason|0
5660302|NCT00502593|19541811|P8|Overall Study|Withdrawn unspecified reason|0
5660303|NCT00502593|19541812|P7|Overall Study|Withdrawn unspecified reason|2
5660304|NCT00502593|19541813|P6|Overall Study|Withdrawn unspecified reason|0
5660305|NCT00502593|19541814|P5|Overall Study|Withdrawn unspecified reason|2
5660306|NCT00502593|19541815|P4|Overall Study|Withdrawn unspecified reason|1
5660307|NCT00502593|19541816|P3|Overall Study|Withdrawn unspecified reason|3
5660308|NCT00502593|19541817|P2|Overall Study|Withdrawn unspecified reason|1
5660309|NCT00502593|19541818|P1|Overall Study|Withdrawn unspecified reason|1
5660310|NCT00502320|19542334|P2|Overall Study|Adverse Event|5
5660311|NCT00502320|19542335|P1|Overall Study|Adverse Event|3
5660312|NCT00502320|19542334|P2|Overall Study|Screen Failure|1
5660313|NCT00502320|19542335|P1|Overall Study|Screen Failure|0
5660314|NCT00502320|19542334|P2|Overall Study|No longer met criteria|0
5660315|NCT00502320|19542335|P1|Overall Study|No longer met criteria|1
5660316|NCT00502320|19542334|P2|Overall Study|Withdrew Consent|0
5660317|NCT00502320|19542335|P1|Overall Study|Withdrew Consent|1
5660318|NCT00502320|19542334|P2|Overall Study|Lost to Follow-up|1
5660319|NCT00502320|19542335|P1|Overall Study|Lost to Follow-up|1
5660320|NCT00502307|19542345|P3|Maintenance Period|Discontinued due to other reasons|0
5660321|NCT00502307|19542346|P2|Maintenance Period|Discontinued due to other reasons|0
5660322|NCT00502307|19542347|P1|Maintenance Period|Discontinued due to other reasons|68
5660323|NCT00502307|19542345|P3|Maintenance Period|Progressive disease|0
5660324|NCT00502307|19542346|P2|Maintenance Period|Progressive disease|0
5660325|NCT00502307|19542347|P1|Maintenance Period|Progressive disease|80
5660326|NCT00502307|19542345|P3|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
5660327|NCT00502307|19542346|P2|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
5660328|NCT00502307|19542347|P1|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
5660329|NCT00502307|19542345|P3|Double-Blind Period (12 Weeks)|Progressive disease|2
5660330|NCT00502307|19542346|P2|Double-Blind Period (12 Weeks)|Progressive disease|23
5660331|NCT00502307|19542347|P1|Double-Blind Period (12 Weeks)|Progressive disease|0
5660332|NCT00502307|19542345|P3|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
5660333|NCT00502307|19542346|P2|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
5660334|NCT00502307|19542347|P1|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
5660335|NCT00502307|19542345|P3|Open Label Period (16 Weeks)|Progressive disease|0
5660336|NCT00502307|19542346|P2|Open Label Period (16 Weeks)|Progressive disease|0
5660337|NCT00502307|19542347|P1|Open Label Period (16 Weeks)|Progressive disease|50
5660338|NCT00502242|19542374|P2|Overall Study|Withdrawal by Subject|7
5660339|NCT00502242|19542375|P1|Overall Study|Withdrawal by Subject|6
5660340|NCT00502242|19542374|P2|Overall Study|Protocol Violation|1
5660341|NCT00502242|19542375|P1|Overall Study|Protocol Violation|3
5660342|NCT00502242|19542374|P2|Overall Study|Other - Unspecified|14
5660343|NCT00502242|19542375|P1|Overall Study|Other - Unspecified|8
5660344|NCT00502242|19542374|P2|Overall Study|Physician Decision|3
5660345|NCT00502242|19542375|P1|Overall Study|Physician Decision|2
5660346|NCT00502242|19542374|P2|Overall Study|Adverse Event|20
5660347|NCT00502242|19542375|P1|Overall Study|Adverse Event|31
5660348|NCT00502242|19542374|P2|Overall Study|Lack of Efficacy|11
5660349|NCT00502242|19542375|P1|Overall Study|Lack of Efficacy|1
5660350|NCT00502203|19542439|P1|Overall Study|Inevaluable|1
5660351|NCT00501969|19542448|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
5660352|NCT00501969|19542448|P1|Overall Study|Other: Admin Request from the Sponsor|3
5660353|NCT00501969|19542448|P1|Overall Study|Other: As Required by Local EC|2
5660354|NCT00501969|19542448|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
5660355|NCT00501969|19542448|P1|Overall Study|Other: Pat Pending Surgery for PD|1
5660356|NCT00501969|19542448|P1|Overall Study|Other: Patient is Going to Have DBS|1
5660357|NCT00501969|19542448|P1|Overall Study|Other: Patients + Investigator Agreement|1
5660358|NCT00501969|19542448|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
5660359|NCT00501969|19542448|P1|Overall Study|Other: Sponsor Stopped Study|12
5660360|NCT00501969|19542448|P1|Overall Study|Other: Sponsor Termination at Site|1
5660361|NCT00501969|19542448|P1|Overall Study|Other: Sponsors Request|10
5660362|NCT00501969|19542448|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
5660363|NCT00501969|19542448|P1|Overall Study|Lost to Follow-up|4
5660364|NCT00501969|19542448|P1|Overall Study|Subject withdrew consent|51
5660365|NCT00501969|19542448|P1|Overall Study|Unsatisfactory compliance of subject|7
5660366|NCT00501969|19542448|P1|Overall Study|Adverse Event|76
5660367|NCT00501969|19542448|P1|Overall Study|Lack of Efficacy|29
5660368|NCT00501969|19542448|P1|Overall Study|Major Protocol Violation|4
5660369|NCT00501852|19542480|P1|Overall Study|Withdrawal by Subject|2
5660370|NCT00501852|19542480|P1|Overall Study|Adverse Event|3
5660371|NCT00501644|19542500|P1|Overall Study|Withdrawal by Subject|1
5660372|NCT00501644|19542500|P1|Overall Study|Adverse Event|4
5660373|NCT00501540|19542529|P1|Overall Study|Death|5
5660374|NCT00501293|19542541|P2|Maintenance Period|Application site reaction|0
5660375|NCT00501293|19542542|P1|Maintenance Period|Application site reaction|1
5660376|NCT00501293|19542541|P2|Maintenance Period|Would not wear patch|0
5660377|NCT00501293|19542542|P1|Maintenance Period|Would not wear patch|1
5660378|NCT00501293|19542541|P2|Maintenance Period|Went into rehabilitation|0
5660379|NCT00501293|19542542|P1|Maintenance Period|Went into rehabilitation|1
5660380|NCT00501293|19542541|P2|Maintenance Period|Noncompliant with study medication|0
5660381|NCT00501293|19542542|P1|Maintenance Period|Noncompliant with study medication|5
5660382|NCT00501293|19542541|P2|Maintenance Period|Lack of Efficacy|1
5660383|NCT00501293|19542542|P1|Maintenance Period|Lack of Efficacy|4
5660384|NCT00501293|19542541|P2|Maintenance Period|Protocol Violation|1
5660385|NCT00501293|19542542|P1|Maintenance Period|Protocol Violation|2
5660386|NCT00501293|19542541|P2|Maintenance Period|Adverse Event|6
5660387|NCT00501293|19542542|P1|Maintenance Period|Adverse Event|6
5660388|NCT00501293|19542541|P2|Maintenance Period|Lost to Follow-up|7
5660389|NCT00501293|19542542|P1|Maintenance Period|Lost to Follow-up|12
5660390|NCT00501293|19542541|P2|Maintenance Period|Withdrawal by Subject|13
5660391|NCT00501293|19542542|P1|Maintenance Period|Withdrawal by Subject|14
5660392|NCT00501293|19542541|P2|Optimization Period|Enrolled in error|0
5660393|NCT00501293|19542542|P1|Optimization Period|Enrolled in error|1
5660394|NCT00501228|19542569|P1|Overall Study|Withdrawal by Subject|1
5660395|NCT00501085|19542573|P1|Overall Study|Other loss to follow-up|32
5660396|NCT00501085|19542573|P1|Overall Study|Study closed by sponsor|109
5660397|NCT00501085|19542573|P1|Overall Study|Non-Compliance|24
5660398|NCT00501085|19542573|P1|Overall Study|Adverse Event|4
5660399|NCT00501085|19542573|P1|Overall Study|Explantation Surgery|26
5660400|NCT00501085|19542573|P1|Overall Study|Revision Surgery|7
5660401|NCT00501085|19542573|P1|Overall Study|Subject Decision|1
5660402|NCT00501085|19542573|P1|Overall Study|Withdrawal by Subject|34
5660403|NCT00501085|19542573|P1|Overall Study|Lost to Follow-up|195
5660404|NCT00501059|19542583|P2|Overall Study|Not treated|17
5660405|NCT00501059|19542584|P1|Overall Study|Not treated|25
5660406|NCT00501059|19542583|P2|Overall Study|Lost to Follow-up|198
5660407|NCT00501059|19542584|P1|Overall Study|Lost to Follow-up|210
5660408|NCT00501059|19542583|P2|Overall Study|Adverse Event|122
5660409|NCT00501059|19542584|P1|Overall Study|Adverse Event|129
5660410|NCT00501059|19542583|P2|Overall Study|Reason not given|1
5660411|NCT00501059|19542584|P1|Overall Study|Reason not given|3
5660412|NCT00501059|19542583|P2|Overall Study|Non-compliant with study treatment|16
5660413|NCT00501059|19542584|P1|Overall Study|Non-compliant with study treatment|23
5660414|NCT00501059|19542583|P2|Overall Study|Consent withdrawn by subject|873
5660415|NCT00501059|19542584|P1|Overall Study|Consent withdrawn by subject|817
5660416|NCT00501059|19542583|P2|Overall Study|Insufficient therapeutic effect|5
5660417|NCT00501059|19542584|P1|Overall Study|Insufficient therapeutic effect|4
5660418|NCT00501059|19542583|P2|Overall Study|Clinical endpoint reached|123
5660419|NCT00501059|19542584|P1|Overall Study|Clinical endpoint reached|110
5660420|NCT00501059|19542583|P2|Overall Study|Missing end-of-study page|92
5660421|NCT00501059|19542584|P1|Overall Study|Missing end-of-study page|91
5660422|NCT00501059|19542583|P2|Overall Study|Other|239
5660423|NCT00501059|19542584|P1|Overall Study|Other|236
5660424|NCT00501059|19542583|P2|Overall Study|Death|137
5660425|NCT00501059|19542584|P1|Overall Study|Death|140
5660426|NCT00501059|19542583|P2|Overall Study|Protocol Violation|69
5660427|NCT00501059|19542584|P1|Overall Study|Protocol Violation|80
5660428|NCT00501046|19542608|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
5660429|NCT00501046|19542609|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
5660430|NCT00501046|19542608|P2|Overall Study|Withdrawal by Subject|83
5660431|NCT00501046|19542609|P1|Overall Study|Withdrawal by Subject|84
5660432|NCT00501046|19542608|P2|Overall Study|Protocol Violation|1
5660433|NCT00501046|19542609|P1|Overall Study|Protocol Violation|2
5660434|NCT00501046|19542608|P2|Overall Study|Pregnancy|3
5660435|NCT00501046|19542609|P1|Overall Study|Pregnancy|0
5660436|NCT00501046|19542608|P2|Overall Study|Physician Decision|2
5660437|NCT00501046|19542609|P1|Overall Study|Physician Decision|7
5660438|NCT00501046|19542608|P2|Overall Study|Lost to Follow-up|13
5660439|NCT00501046|19542609|P1|Overall Study|Lost to Follow-up|14
5660440|NCT00501046|19542608|P2|Overall Study|Death|30
5660441|NCT00501046|19542609|P1|Overall Study|Death|23
5660442|NCT00501046|19542608|P2|Overall Study|Adverse Event|25
5660443|NCT00501046|19542609|P1|Overall Study|Adverse Event|21
5660444|NCT00501007|19542615|P2|Overall Study|Inclusion criteria not met.|25
5660445|NCT00501007|19542616|P1|Overall Study|Inclusion criteria not met.|29
5660446|NCT00500903|19542625|P3|Overall Study|Reason Not Specified|2
5660447|NCT00500903|19542626|P2|Overall Study|Reason Not Specified|0
5660448|NCT00500903|19542627|P1|Overall Study|Reason Not Specified|10
5660449|NCT00500903|19542625|P3|Overall Study|Symptomatic Deterioration|0
5660450|NCT00500903|19542626|P2|Overall Study|Symptomatic Deterioration|0
5660451|NCT00500903|19542627|P1|Overall Study|Symptomatic Deterioration|2
5660452|NCT00500903|19542625|P3|Overall Study|Patient Declined Further Treatment|3
5660453|NCT00500903|19542626|P2|Overall Study|Patient Declined Further Treatment|0
5660454|NCT00500903|19542627|P1|Overall Study|Patient Declined Further Treatment|0
5660455|NCT00500903|19542625|P3|Overall Study|Progressive Disease|15
5660456|NCT00500903|19542626|P2|Overall Study|Progressive Disease|2
5660457|NCT00500903|19542627|P1|Overall Study|Progressive Disease|41
5660458|NCT00500903|19542625|P3|Overall Study|Unsatisfactory Therapeutic Response|0
5660459|NCT00500903|19542626|P2|Overall Study|Unsatisfactory Therapeutic Response|0
5660460|NCT00500903|19542627|P1|Overall Study|Unsatisfactory Therapeutic Response|2
5660461|NCT00500903|19542625|P3|Overall Study|Occurrence of Adverse Event(s)|0
5660462|NCT00500903|19542626|P2|Overall Study|Occurrence of Adverse Event(s)|0
5660463|NCT00500903|19542627|P1|Overall Study|Occurrence of Adverse Event(s)|10
5660464|NCT00500760|19542823|P2|Overall Study|Other|2
5660465|NCT00500760|19542824|P1|Overall Study|Other|1
5660466|NCT00500760|19542823|P2|Overall Study|Lost to Follow-up|0
5660467|NCT00500760|19542824|P1|Overall Study|Lost to Follow-up|3
5660468|NCT00500760|19542823|P2|Overall Study|Administrative decision|0
5660469|NCT00500760|19542824|P1|Overall Study|Administrative decision|2
5660470|NCT00500760|19542823|P2|Overall Study|Withdrawal by Subject|7
5660471|NCT00500760|19542824|P1|Overall Study|Withdrawal by Subject|5
5660472|NCT00500760|19542823|P2|Overall Study|Death|15
5660473|NCT00500760|19542824|P1|Overall Study|Death|32
5660474|NCT00500682|19542844|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
5660475|NCT00500682|19542845|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
5660476|NCT00500682|19542844|P2|Overall Study|Withdrawal by Subject|74
5660477|NCT00500682|19542845|P1|Overall Study|Withdrawal by Subject|80
5660478|NCT00500682|19542844|P2|Overall Study|Protocol Violation|3
5660479|NCT00500682|19542845|P1|Overall Study|Protocol Violation|1
5660480|NCT00500682|19542844|P2|Overall Study|Pregnancy|0
5660481|NCT00500682|19542845|P1|Overall Study|Pregnancy|2
5660482|NCT00500682|19542844|P2|Overall Study|Physician Decision|10
5660483|NCT00500682|19542845|P1|Overall Study|Physician Decision|6
5660484|NCT00500682|19542844|P2|Overall Study|Lost to Follow-up|11
5660485|NCT00500682|19542845|P1|Overall Study|Lost to Follow-up|11
5660486|NCT00500682|19542844|P2|Overall Study|Death|16
5660487|NCT00500682|19542845|P1|Overall Study|Death|25
5660488|NCT00500682|19542844|P2|Overall Study|Adverse Event|29
5660489|NCT00500682|19542845|P1|Overall Study|Adverse Event|37
5660490|NCT00500539|19542879|P1|Follow-up Period (16 Weeks)|Missing|3
5660491|NCT00500539|19542879|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
5660492|NCT00500539|19542879|P1|Follow-up Period (16 Weeks)|Death|1
5660493|NCT00500539|19542879|P1|Follow-up Period (16 Weeks)|Administrative problems|1
5660494|NCT00500539|19542879|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
5660495|NCT00500539|19542879|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
5660496|NCT00500539|19542879|P1|Follow-up Period (16 Weeks)|Adverse Event|1
5660497|NCT00500539|19542879|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
5660498|NCT00500539|19542879|P1|Treatment Period (24 Weeks)|Administrative problems|2
5660499|NCT00500539|19542879|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
5660500|NCT00500539|19542879|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
5660501|NCT00500539|19542879|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
5660502|NCT00500539|19542879|P1|Treatment Period (24 Weeks)|Adverse Event|4
5660503|NCT00500370|19542905|P2|Overall Study|Subject Decision|17
5660504|NCT00500370|19542906|P1|Overall Study|Subject Decision|10
5660505|NCT00500370|19542905|P2|Overall Study|Sponsor Decision|0
5660506|NCT00500370|19542906|P1|Overall Study|Sponsor Decision|2
5660507|NCT00500370|19542905|P2|Overall Study|Protocol Violation|4
5660508|NCT00500370|19542906|P1|Overall Study|Protocol Violation|2
5660509|NCT00500370|19542905|P2|Overall Study|Lost to Follow-up|10
5660510|NCT00500370|19542906|P1|Overall Study|Lost to Follow-up|10
5660511|NCT00500370|19542905|P2|Overall Study|Adverse Event|3
5660512|NCT00500370|19542906|P1|Overall Study|Adverse Event|9
5660513|NCT00500357|19542942|P1|Overall Study|Death|1
5660514|NCT00500331|19542968|P7|Overall Study|Protocol violated|0
5660515|NCT00500331|19542969|P6|Overall Study|Protocol violated|0
5660516|NCT00500331|19542970|P5|Overall Study|Protocol violated|0
5660517|NCT00500331|19542971|P4|Overall Study|Protocol violated|1
5660518|NCT00500331|19542972|P3|Overall Study|Protocol violated|0
5660519|NCT00500331|19542973|P2|Overall Study|Protocol violated|0
5660520|NCT00500331|19542974|P1|Overall Study|Protocol violated|0
5660521|NCT00500331|19542968|P7|Overall Study|State ban of biological samples export|0
5660522|NCT00500331|19542969|P6|Overall Study|State ban of biological samples export|0
5660523|NCT00500331|19542970|P5|Overall Study|State ban of biological samples export|0
5660524|NCT00500331|19542971|P4|Overall Study|State ban of biological samples export|1
5660525|NCT00500331|19542972|P3|Overall Study|State ban of biological samples export|0
5660526|NCT00500331|19542973|P2|Overall Study|State ban of biological samples export|0
5660527|NCT00500331|19542974|P1|Overall Study|State ban of biological samples export|0
5660528|NCT00500331|19542968|P7|Overall Study|Diabetologist nurse in the study|0
5660529|NCT00500331|19542969|P6|Overall Study|Diabetologist nurse in the study|0
5660530|NCT00500331|19542970|P5|Overall Study|Diabetologist nurse in the study|0
5660531|NCT00500331|19542971|P4|Overall Study|Diabetologist nurse in the study|0
5660532|NCT00500331|19542972|P3|Overall Study|Diabetologist nurse in the study|1
5660533|NCT00500331|19542973|P2|Overall Study|Diabetologist nurse in the study|0
5660534|NCT00500331|19542974|P1|Overall Study|Diabetologist nurse in the study|0
5660535|NCT00500331|19542968|P7|Overall Study|Participant was randomized by mistake|0
5660536|NCT00500331|19542969|P6|Overall Study|Participant was randomized by mistake|0
5660537|NCT00500331|19542970|P5|Overall Study|Participant was randomized by mistake|0
5660538|NCT00500331|19542971|P4|Overall Study|Participant was randomized by mistake|0
5660539|NCT00500331|19542972|P3|Overall Study|Participant was randomized by mistake|0
5660540|NCT00500331|19542973|P2|Overall Study|Participant was randomized by mistake|0
5660541|NCT00500331|19542974|P1|Overall Study|Participant was randomized by mistake|1
5660542|NCT00500331|19542968|P7|Overall Study|Sponsor decided to withdraw participant|0
5660543|NCT00500331|19542969|P6|Overall Study|Sponsor decided to withdraw participant|0
5660544|NCT00500331|19542970|P5|Overall Study|Sponsor decided to withdraw participant|0
5660545|NCT00500331|19542971|P4|Overall Study|Sponsor decided to withdraw participant|0
5660546|NCT00500331|19542972|P3|Overall Study|Sponsor decided to withdraw participant|0
5660547|NCT00500331|19542973|P2|Overall Study|Sponsor decided to withdraw participant|0
5660548|NCT00500331|19542974|P1|Overall Study|Sponsor decided to withdraw participant|1
5660549|NCT00500331|19542968|P7|Overall Study|Exclusion citeria not met on Visit 4|0
5660550|NCT00500331|19542969|P6|Overall Study|Exclusion citeria not met on Visit 4|0
5660551|NCT00500331|19542970|P5|Overall Study|Exclusion citeria not met on Visit 4|0
5660552|NCT00500331|19542971|P4|Overall Study|Exclusion citeria not met on Visit 4|0
5660553|NCT00500331|19542972|P3|Overall Study|Exclusion citeria not met on Visit 4|0
5660554|NCT00500331|19542973|P2|Overall Study|Exclusion citeria not met on Visit 4|0
5660555|NCT00500331|19542974|P1|Overall Study|Exclusion citeria not met on Visit 4|1
5660556|NCT00500331|19542968|P7|Overall Study|Didn't return for continuation of study|0
5660557|NCT00500331|19542969|P6|Overall Study|Didn't return for continuation of study|0
5660558|NCT00500331|19542970|P5|Overall Study|Didn't return for continuation of study|0
5660559|NCT00500331|19542971|P4|Overall Study|Didn't return for continuation of study|0
5660560|NCT00500331|19542972|P3|Overall Study|Didn't return for continuation of study|0
5660561|NCT00500331|19542973|P2|Overall Study|Didn't return for continuation of study|0
5660562|NCT00500331|19542974|P1|Overall Study|Didn't return for continuation of study|1
5660563|NCT00500331|19542968|P7|Overall Study|Increased serum creatinine from Baseline|0
5660564|NCT00500331|19542969|P6|Overall Study|Increased serum creatinine from Baseline|1
5660565|NCT00500331|19542970|P5|Overall Study|Increased serum creatinine from Baseline|0
5660566|NCT00500331|19542971|P4|Overall Study|Increased serum creatinine from Baseline|0
5660567|NCT00500331|19542972|P3|Overall Study|Increased serum creatinine from Baseline|0
5660568|NCT00500331|19542973|P2|Overall Study|Increased serum creatinine from Baseline|0
5660569|NCT00500331|19542974|P1|Overall Study|Increased serum creatinine from Baseline|0
5660570|NCT00500331|19542968|P7|Overall Study|Liver function test abnormality|0
5660571|NCT00500331|19542969|P6|Overall Study|Liver function test abnormality|0
5660572|NCT00500331|19542970|P5|Overall Study|Liver function test abnormality|0
5660573|NCT00500331|19542971|P4|Overall Study|Liver function test abnormality|0
5660574|NCT00500331|19542972|P3|Overall Study|Liver function test abnormality|1
5660575|NCT00500331|19542973|P2|Overall Study|Liver function test abnormality|0
5660576|NCT00500331|19542974|P1|Overall Study|Liver function test abnormality|0
5660577|NCT00500331|19542968|P7|Overall Study|Lack of Efficacy|0
5660578|NCT00500331|19542969|P6|Overall Study|Lack of Efficacy|0
5660579|NCT00500331|19542970|P5|Overall Study|Lack of Efficacy|0
5660580|NCT00500331|19542971|P4|Overall Study|Lack of Efficacy|0
5660581|NCT00500331|19542972|P3|Overall Study|Lack of Efficacy|0
5660582|NCT00500331|19542973|P2|Overall Study|Lack of Efficacy|1
5660583|NCT00500331|19542974|P1|Overall Study|Lack of Efficacy|3
5660584|NCT00500331|19542968|P7|Overall Study|Withdrawal by Subject|1
5660585|NCT00500331|19542969|P6|Overall Study|Withdrawal by Subject|1
5660586|NCT00500331|19542970|P5|Overall Study|Withdrawal by Subject|0
5660587|NCT00500331|19542971|P4|Overall Study|Withdrawal by Subject|5
5660588|NCT00500331|19542972|P3|Overall Study|Withdrawal by Subject|1
5660589|NCT00500331|19542973|P2|Overall Study|Withdrawal by Subject|0
5660590|NCT00500331|19542974|P1|Overall Study|Withdrawal by Subject|4
5660591|NCT00500331|19542968|P7|Overall Study|Protocol Violation|1
5660592|NCT00500331|19542969|P6|Overall Study|Protocol Violation|1
5660593|NCT00500331|19542970|P5|Overall Study|Protocol Violation|1
5660594|NCT00500331|19542971|P4|Overall Study|Protocol Violation|0
5660595|NCT00500331|19542972|P3|Overall Study|Protocol Violation|1
5660596|NCT00500331|19542973|P2|Overall Study|Protocol Violation|1
5660597|NCT00500331|19542974|P1|Overall Study|Protocol Violation|3
5660598|NCT00500331|19542968|P7|Overall Study|Lost to Follow-up|0
5660599|NCT00500331|19542969|P6|Overall Study|Lost to Follow-up|0
5660600|NCT00500331|19542970|P5|Overall Study|Lost to Follow-up|1
5660601|NCT00500331|19542971|P4|Overall Study|Lost to Follow-up|2
5660602|NCT00500331|19542972|P3|Overall Study|Lost to Follow-up|1
5660603|NCT00500331|19542973|P2|Overall Study|Lost to Follow-up|1
5660604|NCT00500331|19542974|P1|Overall Study|Lost to Follow-up|1
5660605|NCT00500331|19542968|P7|Overall Study|Adverse Event|0
5660606|NCT00500331|19542969|P6|Overall Study|Adverse Event|2
5660607|NCT00500331|19542970|P5|Overall Study|Adverse Event|2
5660608|NCT00500331|19542971|P4|Overall Study|Adverse Event|1
5660609|NCT00500331|19542972|P3|Overall Study|Adverse Event|0
5660610|NCT00500331|19542973|P2|Overall Study|Adverse Event|2
5660611|NCT00500331|19542974|P1|Overall Study|Adverse Event|0
5660612|NCT00500318|19543111|P2|Overall Study|Other Reason|1
5660613|NCT00500318|19543112|P1|Overall Study|Other Reason|0
5660614|NCT00500318|19543111|P2|Overall Study|Lack of Efficacy|3
5660615|NCT00500318|19543112|P1|Overall Study|Lack of Efficacy|0
5660616|NCT00500318|19543111|P2|Overall Study|Withdrawal by Subject|2
5660617|NCT00500318|19543112|P1|Overall Study|Withdrawal by Subject|1
5660618|NCT00500318|19543111|P2|Overall Study|Protocol Violation|3
5660619|NCT00500318|19543112|P1|Overall Study|Protocol Violation|1
5660620|NCT00500318|19543111|P2|Overall Study|Adverse Event|8
5660621|NCT00500318|19543112|P1|Overall Study|Adverse Event|3
5660622|NCT00500292|19543129|P3|Overall Study|Other|4
5660623|NCT00500292|19543130|P2|Overall Study|Other|1
5660624|NCT00500292|19543131|P1|Overall Study|Other|1
5660625|NCT00500292|19543129|P3|Overall Study|Withdrawal by Subject|0
5660626|NCT00500292|19543130|P2|Overall Study|Withdrawal by Subject|1
5660627|NCT00500292|19543131|P1|Overall Study|Withdrawal by Subject|0
5660628|NCT00500292|19543129|P3|Overall Study|Condition under investigation worsened|19
5660629|NCT00500292|19543130|P2|Overall Study|Condition under investigation worsened|23
5660630|NCT00500292|19543131|P1|Overall Study|Condition under investigation worsened|21
5660631|NCT00500292|19543129|P3|Overall Study|Adverse Event|4
5660632|NCT00500292|19543130|P2|Overall Study|Adverse Event|6
5660633|NCT00500292|19543131|P1|Overall Study|Adverse Event|3
5660634|NCT00500149|19543152|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
5660635|NCT00500149|19543153|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
5660636|NCT00500149|19543152|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
5660637|NCT00500149|19543153|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
5660638|NCT00500149|19543152|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
5660639|NCT00500149|19543153|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
5660640|NCT00500149|19543152|P2|First Intervention (Cross-over Phase)|Adverse Event|1
5660641|NCT00500149|19543153|P1|First Intervention (Cross-over Phase)|Adverse Event|0
5660642|NCT00500149|19543152|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
5660643|NCT00500149|19543153|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
5660644|NCT00500149|19543152|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
5660645|NCT00500149|19543153|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
5660646|NCT00500149|19543152|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
5660647|NCT00500149|19543153|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
5660648|NCT00500110|19543161|P1|Overall Study|Withdrawal by Subject|3
5660649|NCT00500071|19543165|P1|30-day Safety Follow-up|Lost to Follow-up|17
5660650|NCT00500071|19543165|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
5660651|NCT00500071|19543165|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
5660652|NCT00500071|19543165|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
5660653|NCT00500071|19543165|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
5660654|NCT00500071|19543165|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
5660655|NCT00500071|19543165|P1|Screening and Washout Phase|Protocol Violation|1
5660656|NCT00499889|19543188|P1|Overall Study|Infection prior to treatment|1
5660657|NCT00499863|19543196|P2|Overall Study|Lost to Follow-up|1
5660658|NCT00499863|19543197|P1|Overall Study|Lost to Follow-up|1
5660659|NCT00499863|19543196|P2|Overall Study|Sponsor decision|2
5660660|NCT00499863|19543197|P1|Overall Study|Sponsor decision|2
5660661|NCT00499863|19543196|P2|Overall Study|Adverse Event|2
5660662|NCT00499863|19543197|P1|Overall Study|Adverse Event|8
5660663|NCT00499863|19543196|P2|Overall Study|Withdrawal by Subject|4
5660664|NCT00499863|19543197|P1|Overall Study|Withdrawal by Subject|6
5660665|NCT00499863|19543196|P2|Overall Study|Protocol Violation|7
5660666|NCT00499863|19543197|P1|Overall Study|Protocol Violation|12
5660667|NCT00499863|19543196|P2|Overall Study|Lack of Efficacy|27
5660668|NCT00499863|19543197|P1|Overall Study|Lack of Efficacy|21
5660669|NCT00500266|19543225|P1|Overall Study|Assigned, not treated|4
5660670|NCT00500266|19543225|P1|Overall Study|Withdrawal by Subject|3
5660671|NCT00500266|19543225|P1|Overall Study|Lost to Follow-up|3
5660672|NCT00500266|19543225|P1|Overall Study|Death|3
5660673|NCT00499746|19543232|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
5660674|NCT00499746|19543232|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
5660675|NCT00499746|19543232|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
5660676|NCT00499746|19543232|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
5660677|NCT00499694|19543301|P1|Overall Study|Patient never received treatment.|1
5660678|NCT00499681|19543310|P2|Overall Study|disease progression|1
5660679|NCT00499681|19543311|P1|Overall Study|disease progression|0
5660680|NCT00499681|19543310|P2|Overall Study|toxicity|1
5660681|NCT00499681|19543311|P1|Overall Study|toxicity|0
5660682|NCT00499616|19543338|P4|Overall Study|Patient/Parent Refusal|0
5660683|NCT00499616|19543339|P3|Overall Study|Patient/Parent Refusal|3
5660684|NCT00499616|19543340|P2|Overall Study|Patient/Parent Refusal|5
5660685|NCT00499616|19543341|P1|Overall Study|Patient/Parent Refusal|1
5660686|NCT00499616|19543338|P4|Overall Study|Not evaluable|41
5660687|NCT00499616|19543339|P3|Overall Study|Not evaluable|0
5660688|NCT00499616|19543340|P2|Overall Study|Not evaluable|0
5660689|NCT00499616|19543341|P1|Overall Study|Not evaluable|0
5660690|NCT00499616|19543338|P4|Overall Study|Ineligible|15
5660691|NCT00499616|19543339|P3|Overall Study|Ineligible|0
5660692|NCT00499616|19543340|P2|Overall Study|Ineligible|2
5660693|NCT00499616|19543341|P1|Overall Study|Ineligible|1
5660694|NCT00499616|19543338|P4|Overall Study|Withdrawal by Subject|0
5660695|NCT00499616|19543339|P3|Overall Study|Withdrawal by Subject|1
5660696|NCT00499616|19543340|P2|Overall Study|Withdrawal by Subject|0
5660697|NCT00499616|19543341|P1|Overall Study|Withdrawal by Subject|1
5660698|NCT00499616|19543338|P4|Overall Study|Physician Decision|0
5660699|NCT00499616|19543339|P3|Overall Study|Physician Decision|9
5660700|NCT00499616|19543340|P2|Overall Study|Physician Decision|16
5660701|NCT00499616|19543341|P1|Overall Study|Physician Decision|6
5660702|NCT00499616|19543338|P4|Overall Study|Lost to Follow-up|0
5660703|NCT00499616|19543339|P3|Overall Study|Lost to Follow-up|1
5660704|NCT00499616|19543340|P2|Overall Study|Lost to Follow-up|0
5660705|NCT00499616|19543341|P1|Overall Study|Lost to Follow-up|0
5660706|NCT00499616|19543338|P4|Overall Study|Lack of Efficacy|0
5660707|NCT00499616|19543339|P3|Overall Study|Lack of Efficacy|19
5660708|NCT00499616|19543340|P2|Overall Study|Lack of Efficacy|0
5660709|NCT00499616|19543341|P1|Overall Study|Lack of Efficacy|5
5660710|NCT00499616|19543338|P4|Overall Study|Death|1
5660711|NCT00499616|19543339|P3|Overall Study|Death|3
5660712|NCT00499616|19543340|P2|Overall Study|Death|5
5660713|NCT00499616|19543341|P1|Overall Study|Death|1
5660714|NCT00499603|19543386|P2|Overall Study|Adverse Event|1
5660715|NCT00499603|19543387|P1|Overall Study|Adverse Event|0
5660716|NCT00499590|19543400|P3|Overall Study|Not treated|1
5660717|NCT00499590|19543401|P2|Overall Study|Not treated|0
5660718|NCT00499590|19543402|P1|Overall Study|Not treated|1
5660719|NCT00499590|19543400|P3|Overall Study|Study Terminated|112
5660720|NCT00499590|19543401|P2|Overall Study|Study Terminated|112
5660721|NCT00499590|19543402|P1|Overall Study|Study Terminated|112
5660722|NCT00499486|19543413|P1|Overall Study|Withdrawal by Subject|16
5660723|NCT00499460|19543440|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
5660724|NCT00499460|19543441|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
5660725|NCT00499460|19543440|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
5660726|NCT00499460|19543441|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
5660727|NCT00499460|19543440|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
5660728|NCT00499460|19543441|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
5660729|NCT00499369|19543474|P5|Overall Study|Ineligible|0
5660730|NCT00499369|19543475|P4|Overall Study|Ineligible|1
5660731|NCT00499369|19543476|P3|Overall Study|Ineligible|1
5660732|NCT00499369|19543477|P2|Overall Study|Ineligible|2
5660733|NCT00499369|19543478|P1|Overall Study|Ineligible|2
5660734|NCT00499369|19543474|P5|Overall Study|Not protocol specified|0
5660735|NCT00499369|19543475|P4|Overall Study|Not protocol specified|1
5660736|NCT00499369|19543476|P3|Overall Study|Not protocol specified|3
5660737|NCT00499369|19543477|P2|Overall Study|Not protocol specified|0
5660738|NCT00499369|19543478|P1|Overall Study|Not protocol specified|2
5660739|NCT00499369|19543474|P5|Overall Study|Death|0
5660740|NCT00499369|19543475|P4|Overall Study|Death|0
5660741|NCT00499369|19543476|P3|Overall Study|Death|0
5660742|NCT00499369|19543477|P2|Overall Study|Death|1
5660743|NCT00499369|19543478|P1|Overall Study|Death|0
5660744|NCT00499369|19543474|P5|Overall Study|Progression|10
5660745|NCT00499369|19543475|P4|Overall Study|Progression|6
5660746|NCT00499369|19543476|P3|Overall Study|Progression|9
5660747|NCT00499369|19543477|P2|Overall Study|Progression|12
5660748|NCT00499369|19543478|P1|Overall Study|Progression|10
5660749|NCT00499369|19543474|P5|Overall Study|Withdrawal by Subject|0
5660750|NCT00499369|19543475|P4|Overall Study|Withdrawal by Subject|0
5660751|NCT00499369|19543476|P3|Overall Study|Withdrawal by Subject|1
5660752|NCT00499369|19543477|P2|Overall Study|Withdrawal by Subject|1
5660753|NCT00499369|19543478|P1|Overall Study|Withdrawal by Subject|0
5660754|NCT00499369|19543474|P5|Overall Study|Adverse Event|2
5660755|NCT00499369|19543475|P4|Overall Study|Adverse Event|1
5660756|NCT00499369|19543476|P3|Overall Study|Adverse Event|3
5660757|NCT00499369|19543477|P2|Overall Study|Adverse Event|2
5660758|NCT00499369|19543478|P1|Overall Study|Adverse Event|2
5660759|NCT00499252|19543514|P1|Overall Study|<no further label>|3
5660760|NCT00499252|19543514|P1|Overall Study|Ineligible|4
5660761|NCT00499252|19543514|P1|Overall Study|Refused further treatment|2
5660762|NCT00499252|19543514|P1|Overall Study|Adverse Event|3
5660763|NCT00499122|19543524|P1|Overall Study|Withdrawal by Subject|2
5660764|NCT00499083|19543567|P1|Overall Study|Not evaluable|3
5660765|NCT00499031|19543574|P1|Overall Study|Never treated|1
5660766|NCT00499031|19543574|P1|Overall Study|Required test not done|1
5660767|NCT00499031|19543574|P1|Overall Study|Improper pre-protocol treatment|1
5660768|NCT00498797|19543597|P2|Overall Study|Other|1
5660769|NCT00498797|19543598|P1|Overall Study|Other|3
5660770|NCT00498797|19543597|P2|Overall Study|Condition under investigation worsened|21
5660771|NCT00498797|19543598|P1|Overall Study|Condition under investigation worsened|19
5660772|NCT00498797|19543597|P2|Overall Study|Adverse Event|5
5660773|NCT00498797|19543598|P1|Overall Study|Adverse Event|12
5660774|NCT00498797|19543597|P2|Overall Study|Withdrawal by Subject|2
5660775|NCT00498797|19543598|P1|Overall Study|Withdrawal by Subject|4
5660776|NCT00498602|19543682|P7|Overall Study|Other|0
5660777|NCT00498602|19543683|P6|Overall Study|Other|3
5660778|NCT00498602|19543684|P5|Overall Study|Other|0
5660779|NCT00498602|19543685|P4|Overall Study|Other|0
5660780|NCT00498602|19543686|P3|Overall Study|Other|1
5660781|NCT00498602|19543687|P2|Overall Study|Other|3
5660782|NCT00498602|19543688|P1|Overall Study|Other|2
5660783|NCT00498602|19543682|P7|Overall Study|Subject Request|1
5660784|NCT00498602|19543683|P6|Overall Study|Subject Request|4
5660785|NCT00498602|19543684|P5|Overall Study|Subject Request|1
5660786|NCT00498602|19543685|P4|Overall Study|Subject Request|1
5660787|NCT00498602|19543686|P3|Overall Study|Subject Request|1
5660788|NCT00498602|19543687|P2|Overall Study|Subject Request|0
5660789|NCT00498602|19543688|P1|Overall Study|Subject Request|3
5660790|NCT00498602|19543682|P7|Overall Study|Investigator Request|0
5660791|NCT00498602|19543683|P6|Overall Study|Investigator Request|0
5660792|NCT00498602|19543684|P5|Overall Study|Investigator Request|0
5660793|NCT00498602|19543685|P4|Overall Study|Investigator Request|0
5660794|NCT00498602|19543686|P3|Overall Study|Investigator Request|1
5660795|NCT00498602|19543687|P2|Overall Study|Investigator Request|0
5660796|NCT00498602|19543688|P1|Overall Study|Investigator Request|0
5660797|NCT00498602|19543682|P7|Overall Study|Caregiver Request|0
5660798|NCT00498602|19543683|P6|Overall Study|Caregiver Request|2
5660799|NCT00498602|19543684|P5|Overall Study|Caregiver Request|1
5660800|NCT00498602|19543685|P4|Overall Study|Caregiver Request|0
5660801|NCT00498602|19543686|P3|Overall Study|Caregiver Request|2
5660802|NCT00498602|19543687|P2|Overall Study|Caregiver Request|2
5660803|NCT00498602|19543688|P1|Overall Study|Caregiver Request|2
5660804|NCT00498602|19543682|P7|Overall Study|AE not related to Study Drug|1
5660805|NCT00498602|19543683|P6|Overall Study|AE not related to Study Drug|2
5660806|NCT00498602|19543684|P5|Overall Study|AE not related to Study Drug|2
5660807|NCT00498602|19543685|P4|Overall Study|AE not related to Study Drug|0
5660808|NCT00498602|19543686|P3|Overall Study|AE not related to Study Drug|0
5660809|NCT00498602|19543687|P2|Overall Study|AE not related to Study Drug|3
5660810|NCT00498602|19543688|P1|Overall Study|AE not related to Study Drug|1
5660811|NCT00498602|19543682|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
5660812|NCT00498602|19543683|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
5660813|NCT00498602|19543684|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
5660814|NCT00498602|19543685|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
5660815|NCT00498602|19543686|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
5660816|NCT00498602|19543687|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
5660817|NCT00498602|19543688|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
5660818|NCT00498602|19543682|P7|Overall Study|Lost to Follow-up|0
5660819|NCT00498602|19543683|P6|Overall Study|Lost to Follow-up|0
5660820|NCT00498602|19543684|P5|Overall Study|Lost to Follow-up|0
5660821|NCT00498602|19543685|P4|Overall Study|Lost to Follow-up|2
5660822|NCT00498602|19543686|P3|Overall Study|Lost to Follow-up|0
5660823|NCT00498602|19543687|P2|Overall Study|Lost to Follow-up|2
5660824|NCT00498602|19543688|P1|Overall Study|Lost to Follow-up|0
5660825|NCT00498602|19543682|P7|Overall Study|Lack of Efficacy|0
5660826|NCT00498602|19543683|P6|Overall Study|Lack of Efficacy|0
5660827|NCT00498602|19543684|P5|Overall Study|Lack of Efficacy|0
5660828|NCT00498602|19543685|P4|Overall Study|Lack of Efficacy|0
5660829|NCT00498602|19543686|P3|Overall Study|Lack of Efficacy|0
5660830|NCT00498602|19543687|P2|Overall Study|Lack of Efficacy|0
5660831|NCT00498602|19543688|P1|Overall Study|Lack of Efficacy|1
5660832|NCT00498602|19543682|P7|Overall Study|Death|0
5660833|NCT00498602|19543683|P6|Overall Study|Death|1
5660834|NCT00498602|19543684|P5|Overall Study|Death|0
5660835|NCT00498602|19543685|P4|Overall Study|Death|0
5660836|NCT00498602|19543686|P3|Overall Study|Death|0
5660837|NCT00498602|19543687|P2|Overall Study|Death|0
5660838|NCT00498602|19543688|P1|Overall Study|Death|0
5660839|NCT00498485|19543736|P2|Overall Study|Adverse Event|5
5660840|NCT00498485|19543737|P1|Overall Study|Adverse Event|1
5660841|NCT00498433|19543748|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
5660842|NCT00498433|19543749|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
5660843|NCT00498433|19543750|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
5660844|NCT00498433|19543748|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
5660845|NCT00498433|19543749|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
5660846|NCT00498433|19543750|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
5660847|NCT00498433|19543748|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
5660848|NCT00498433|19543749|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
5660849|NCT00498433|19543750|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
5660850|NCT00498433|19543748|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
5660851|NCT00498433|19543749|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
5660852|NCT00498433|19543750|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
5660853|NCT00498368|19543795|P2|Overall Study|Withdrawal by Subject|2
5660854|NCT00498368|19543796|P1|Overall Study|Withdrawal by Subject|3
5660855|NCT00498355|19543808|P1|Overall Study|Lost to Follow-up|1
5660856|NCT00498186|19543816|P1|Overall Study|Other|10
5660857|NCT00498186|19543816|P1|Overall Study|Lost to Follow-up|3
5660858|NCT00498186|19543816|P1|Overall Study|Withdrawal by Subject|18
5660859|NCT00498186|19543816|P1|Overall Study|Unsatisfactory compliance of subject|12
5660860|NCT00498186|19543816|P1|Overall Study|Adverse Event|89
5660861|NCT00498186|19543816|P1|Overall Study|Lack of Efficacy|31
5660862|NCT00498186|19543816|P1|Overall Study|Protocol Violation|10
5660863|NCT00498173|19543823|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
5660864|NCT00498173|19543824|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
5660865|NCT00498173|19543825|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
5660866|NCT00497874|19543855|P2|Overall Study|Unable to schedule|24
5660867|NCT00497874|19543856|P1|Overall Study|Unable to schedule|37
5660868|NCT00497874|19543855|P2|Overall Study|Unable to contact|67
5660869|NCT00497874|19543856|P1|Overall Study|Unable to contact|52
5660870|NCT00497874|19543855|P2|Overall Study|Death|4
5660871|NCT00497874|19543856|P1|Overall Study|Death|2
5660872|NCT00497874|19543855|P2|Overall Study|Illness|4
5660873|NCT00497874|19543856|P1|Overall Study|Illness|8
5660874|NCT00497874|19543855|P2|Overall Study|Withdrawal by Subject|17
5660875|NCT00497874|19543856|P1|Overall Study|Withdrawal by Subject|48
5660876|NCT00497796|19543874|P2|Overall Study|Not applicable (randomized not treated)|4
5660877|NCT00497796|19543875|P1|Overall Study|Not applicable (randomized not treated)|0
5660878|NCT00497796|19543874|P2|Overall Study|Lost to Follow-up|1
5660879|NCT00497796|19543875|P1|Overall Study|Lost to Follow-up|0
5660880|NCT00497796|19543874|P2|Overall Study|Investigator/sponsor discretion|34
5660881|NCT00497796|19543875|P1|Overall Study|Investigator/sponsor discretion|31
5660882|NCT00497796|19543874|P2|Overall Study|Consent withdrawn|3
5660883|NCT00497796|19543875|P1|Overall Study|Consent withdrawn|10
5660884|NCT00497796|19543874|P2|Overall Study|CMV infection or disease treatment|4
5660885|NCT00497796|19543875|P1|Overall Study|CMV infection or disease treatment|30
5660886|NCT00497796|19543874|P2|Overall Study|Adverse event (related)|4
5660887|NCT00497796|19543875|P1|Overall Study|Adverse event (related)|5
5660888|NCT00497796|19543874|P2|Overall Study|Adverse event (not related)|9
5660889|NCT00497796|19543875|P1|Overall Study|Adverse event (not related)|9
5660890|NCT00497198|19543962|P2|Overall Study|Withdrawal by Subject|1
5660891|NCT00497198|19543963|P1|Overall Study|Withdrawal by Subject|0
5660892|NCT00497198|19543962|P2|Overall Study|Physician Decision|2
5660893|NCT00497198|19543963|P1|Overall Study|Physician Decision|1
5660894|NCT00497198|19543962|P2|Overall Study|Adverse Event|2
5660895|NCT00497198|19543963|P1|Overall Study|Adverse Event|4
5660896|NCT00497146|19543979|P2|Long-term Follow-up Period|Other|1
5660897|NCT00497146|19543980|P1|Long-term Follow-up Period|Other|0
5660898|NCT00497146|19543979|P2|Long-term Follow-up Period|Lost to Follow-up|1
5660899|NCT00497146|19543980|P1|Long-term Follow-up Period|Lost to Follow-up|5
5660900|NCT00497146|19543979|P2|Long-term Follow-up Period|Withdrawal by Subject|2
5660901|NCT00497146|19543980|P1|Long-term Follow-up Period|Withdrawal by Subject|8
5660902|NCT00497146|19543979|P2|Long-term Follow-up Period|Adverse Event|2
5660903|NCT00497146|19543980|P1|Long-term Follow-up Period|Adverse Event|2
5660904|NCT00497146|19543979|P2|Treatment Period|Other Reason|3
5660905|NCT00497146|19543980|P1|Treatment Period|Other Reason|2
5660906|NCT00497146|19543979|P2|Treatment Period|Unable to dose reduce per protocol|1
5660907|NCT00497146|19543980|P1|Treatment Period|Unable to dose reduce per protocol|4
5660908|NCT00497146|19543979|P2|Treatment Period|Change in RAAS inhibitor therapy|2
5660909|NCT00497146|19543980|P1|Treatment Period|Change in RAAS inhibitor therapy|5
5660910|NCT00497146|19543979|P2|Treatment Period|Required dialysis|1
5660911|NCT00497146|19543980|P1|Treatment Period|Required dialysis|4
5660912|NCT00497146|19543979|P2|Treatment Period|Lost to Follow-up|3
5660913|NCT00497146|19543980|P1|Treatment Period|Lost to Follow-up|1
5660914|NCT00497146|19543979|P2|Treatment Period|Withdrawal by Subject|9
5660915|NCT00497146|19543980|P1|Treatment Period|Withdrawal by Subject|5
5660916|NCT00497146|19543979|P2|Treatment Period|Adverse Event|2
5660917|NCT00497146|19543980|P1|Treatment Period|Adverse Event|6
5660918|NCT00496964|19544048|P2|Overall Study|Withdrawal by Subject|1
5660919|NCT00496964|19544049|P1|Overall Study|Withdrawal by Subject|0
5660920|NCT00496873|19544067|P1|Overall Study|Withdrawal by Subject|3
5660921|NCT00496873|19544067|P1|Overall Study|Death|2
5660922|NCT00496873|19544067|P1|Overall Study|Ineligible|2
5660923|NCT00496834|19544100|P2|Overall Study|Blood Pressure control failure|1
5660924|NCT00496834|19544101|P1|Overall Study|Blood Pressure control failure|2
5660925|NCT00496834|19544100|P2|Overall Study|Lost to Follow-up|0
5660926|NCT00496834|19544101|P1|Overall Study|Lost to Follow-up|2
5660927|NCT00496834|19544100|P2|Overall Study|IP administration violation|0
5660928|NCT00496834|19544101|P1|Overall Study|IP administration violation|2
5660929|NCT00496834|19544100|P2|Overall Study|Adverse Event|3
5660930|NCT00496834|19544101|P1|Overall Study|Adverse Event|5
5660931|NCT00496834|19544100|P2|Overall Study|Inclusion/exclusion criteria not met|2
5660932|NCT00496834|19544101|P1|Overall Study|Inclusion/exclusion criteria not met|3
5660933|NCT00496834|19544100|P2|Overall Study|Contraindicated medication administered|1
5660934|NCT00496834|19544101|P1|Overall Study|Contraindicated medication administered|0
5660935|NCT00496834|19544100|P2|Overall Study|Withdrawal by Subject|6
5660936|NCT00496834|19544101|P1|Overall Study|Withdrawal by Subject|4
5660937|NCT00496782|19544120|P2|Overall Study|Protocol Violation|2
5660938|NCT00496782|19544121|P1|Overall Study|Protocol Violation|1
5660939|NCT00496769|19544155|P3|Open Label|>=1 reason assigned per patient|1011
5660940|NCT00496769|19544156|P2|Open Label|>=1 reason assigned per patient|0
5660941|NCT00496769|19544157|P1|Open Label|>=1 reason assigned per patient|0
5660942|NCT00496769|19544155|P3|Double Blind|>=1 reason assigned per patient|0
5660943|NCT00496769|19544156|P2|Double Blind|>=1 reason assigned per patient|649
5660944|NCT00496769|19544157|P1|Double Blind|>=1 reason assigned per patient|558
5660945|NCT00496730|19544187|P2|Overall Study|Withdrawal by Subject|2
5660946|NCT00496730|19544188|P1|Overall Study|Withdrawal by Subject|2
5660947|NCT00496730|19544187|P2|Overall Study|Lost to Follow-up|3
5660948|NCT00496730|19544188|P1|Overall Study|Lost to Follow-up|4
5660949|NCT00496626|19544200|P2|Overall Study|Relocated|1
5660950|NCT00496626|19544201|P1|Overall Study|Relocated|0
5660951|NCT00496626|19544200|P2|Overall Study|Withdrawal by Subject|4
5660952|NCT00496626|19544201|P1|Overall Study|Withdrawal by Subject|5
5660953|NCT00496626|19544200|P2|Overall Study|Protocol Violation|0
5660954|NCT00496626|19544201|P1|Overall Study|Protocol Violation|1
5660955|NCT00496626|19544200|P2|Overall Study|Lost to Follow-up|1
5660956|NCT00496626|19544201|P1|Overall Study|Lost to Follow-up|0
5660957|NCT00496587|19544213|P1|Overall Study|Complications unrelated|2
5660958|NCT00496587|19544213|P1|Overall Study|Death|1
5660959|NCT00496587|19544213|P1|Overall Study|Withdrawal by Subject|2
5660960|NCT00496587|19544213|P1|Overall Study|Progressive Disease|24
5660961|NCT00496587|19544213|P1|Overall Study|Adverse Event|2
5660962|NCT00496483|19544219|P1|Overall Study|Lack of Efficacy|1
5660963|NCT00496483|19544219|P1|Overall Study|Adverse Event|2
5660964|NCT00496483|19544219|P1|Overall Study|Not dosed|9
5660965|NCT00496470|19544236|P2|Overall Study|Other reason|2
5660966|NCT00496470|19544237|P1|Overall Study|Other reason|0
5660967|NCT00496470|19544236|P2|Overall Study|Incorrectly enrolled|5
5660968|NCT00496470|19544237|P1|Overall Study|Incorrectly enrolled|13
5660969|NCT00496470|19544236|P2|Overall Study|Withdrawal by Subject|12
5660970|NCT00496470|19544237|P1|Overall Study|Withdrawal by Subject|5
5660971|NCT00496470|19544236|P2|Overall Study|Adverse Event|10
5660972|NCT00496470|19544237|P1|Overall Study|Adverse Event|8
5660973|NCT00496366|19544323|P1|Overall Study|Death|1
5660974|NCT00496197|19544354|P1|Overall Study|Protocol Violation|8
5660975|NCT00496197|19544354|P1|Overall Study|Other|14
5660976|NCT00496197|19544354|P1|Overall Study|Pathogen not isolated baseline specimen|4
5660977|NCT00496197|19544354|P1|Overall Study|Withdrawal by Subject|11
5660978|NCT00496197|19544354|P1|Overall Study|Lost to Follow-up|11
5660979|NCT00496197|19544354|P1|Overall Study|Insufficient bacteriological response|10
5660980|NCT00496197|19544354|P1|Overall Study|Insufficient clinical response|3
5660981|NCT00496197|19544354|P1|Overall Study|Does not meet entrance criteria|5
5660982|NCT00496197|19544354|P1|Overall Study|Adverse Event|13
5660983|NCT00496197|19544354|P1|Overall Study|Discontinued study due to death|43
5660984|NCT00496080|19544381|P1|Overall Study|Physician Decision|6
5660985|NCT00496080|19544381|P1|Overall Study|Withdrawal by Subject|5
5660986|NCT00496080|19544381|P1|Overall Study|Surgical re-intervention|7
5660987|NCT00496080|19544381|P1|Overall Study|Lost to Follow-up|9
5660988|NCT00496054|19544391|P1|Overall Study|Lost to Follow-up|7
5660989|NCT00496054|19544391|P1|Overall Study|Adverse Event|1
5660990|NCT00496015|19544423|P5|Overall Study|Other|0
5660991|NCT00496015|19544424|P4|Overall Study|Other|1
5660992|NCT00496015|19544425|P3|Overall Study|Other|0
5660993|NCT00496015|19544426|P2|Overall Study|Other|0
5660994|NCT00496015|19544427|P1|Overall Study|Other|1
5660995|NCT00495820|19544551|P2|Overall Study|Adverse Event|1
5660996|NCT00495820|19544552|P1|Overall Study|Adverse Event|1
5660997|NCT00495794|19544564|P2|Overall Study|Pharmacist did not activate patient|0
5660998|NCT00495794|19544565|P1|Overall Study|Pharmacist did not activate patient|522
5660999|NCT00495755|19544575|P1|Overall Study|Adverse Event|3
5661000|NCT00495677|19544596|P7|Stage 1 (25 Days)|Adverse Event|0
5661001|NCT00495677|19544597|P6|Stage 1 (25 Days)|Adverse Event|0
5661002|NCT00495677|19544598|P5|Stage 1 (25 Days)|Adverse Event|0
5661003|NCT00495677|19544599|P4|Stage 1 (25 Days)|Adverse Event|0
5661004|NCT00495677|19544600|P3|Stage 1 (25 Days)|Adverse Event|1
5661005|NCT00495677|19544601|P2|Stage 1 (25 Days)|Adverse Event|0
5661006|NCT00495677|19544602|P1|Stage 1 (25 Days)|Adverse Event|0
5661007|NCT00495625|19544657|P1|Overall Study|Did not complete at least 1 42 day cycle|10
5661008|NCT00495612|19544668|P2|Overall Study|Subject's Decision to Withdraw|0
5661009|NCT00495612|19544669|P1|Overall Study|Subject's Decision to Withdraw|3
5661010|NCT00495612|19544668|P2|Overall Study|Lost to Follow-up|0
5661011|NCT00495612|19544669|P1|Overall Study|Lost to Follow-up|1
5661012|NCT00495586|19544687|P2|Overall Study|Withdrawal by Subject|4
5661013|NCT00495586|19544688|P1|Overall Study|Withdrawal by Subject|4
5661014|NCT00495521|19544698|P2|Overall Study|Physician Decision|1
5661015|NCT00495521|19544699|P1|Overall Study|Physician Decision|0
5661016|NCT00495495|19544729|P1|Overall Study|Protocol Violation|99
5661017|NCT00495469|19544749|P7|Overall Study|ST depression at randomisation in ECG|0
5661018|NCT00495469|19544750|P6|Overall Study|ST depression at randomisation in ECG|0
5661019|NCT00495469|19544751|P5|Overall Study|ST depression at randomisation in ECG|0
5661020|NCT00495469|19544752|P4|Overall Study|ST depression at randomisation in ECG|0
5661021|NCT00495469|19544753|P3|Overall Study|ST depression at randomisation in ECG|0
5661022|NCT00495469|19544754|P2|Overall Study|ST depression at randomisation in ECG|1
5661023|NCT00495469|19544755|P1|Overall Study|ST depression at randomisation in ECG|0
5661024|NCT00495469|19544749|P7|Overall Study|Liver function test abnormality|0
5661025|NCT00495469|19544750|P6|Overall Study|Liver function test abnormality|0
5661026|NCT00495469|19544751|P5|Overall Study|Liver function test abnormality|0
5661027|NCT00495469|19544752|P4|Overall Study|Liver function test abnormality|0
5661028|NCT00495469|19544753|P3|Overall Study|Liver function test abnormality|0
5661029|NCT00495469|19544754|P2|Overall Study|Liver function test abnormality|1
5661030|NCT00495469|19544755|P1|Overall Study|Liver function test abnormality|0
5661031|NCT00495469|19544749|P7|Overall Study|Lack of Efficacy|1
5661032|NCT00495469|19544750|P6|Overall Study|Lack of Efficacy|0
5661033|NCT00495469|19544751|P5|Overall Study|Lack of Efficacy|0
5661034|NCT00495469|19544752|P4|Overall Study|Lack of Efficacy|0
5661035|NCT00495469|19544753|P3|Overall Study|Lack of Efficacy|0
5661036|NCT00495469|19544754|P2|Overall Study|Lack of Efficacy|0
5661037|NCT00495469|19544755|P1|Overall Study|Lack of Efficacy|0
5661038|NCT00495469|19544749|P7|Overall Study|Withdrawal by Subject|3
5661039|NCT00495469|19544750|P6|Overall Study|Withdrawal by Subject|2
5661040|NCT00495469|19544751|P5|Overall Study|Withdrawal by Subject|3
5661041|NCT00495469|19544752|P4|Overall Study|Withdrawal by Subject|3
5661042|NCT00495469|19544753|P3|Overall Study|Withdrawal by Subject|1
5661043|NCT00495469|19544754|P2|Overall Study|Withdrawal by Subject|3
5661044|NCT00495469|19544755|P1|Overall Study|Withdrawal by Subject|5
5661045|NCT00495469|19544749|P7|Overall Study|Protocol Violation|0
5661046|NCT00495469|19544750|P6|Overall Study|Protocol Violation|2
5661047|NCT00495469|19544751|P5|Overall Study|Protocol Violation|1
5661048|NCT00495469|19544752|P4|Overall Study|Protocol Violation|0
5661049|NCT00495469|19544753|P3|Overall Study|Protocol Violation|0
5661050|NCT00495469|19544754|P2|Overall Study|Protocol Violation|0
5661051|NCT00495469|19544755|P1|Overall Study|Protocol Violation|0
5661052|NCT00495469|19544749|P7|Overall Study|Lost to Follow-up|0
5661053|NCT00495469|19544750|P6|Overall Study|Lost to Follow-up|0
5661054|NCT00495469|19544751|P5|Overall Study|Lost to Follow-up|0
5661055|NCT00495469|19544752|P4|Overall Study|Lost to Follow-up|1
5661056|NCT00495469|19544753|P3|Overall Study|Lost to Follow-up|3
5661057|NCT00495469|19544754|P2|Overall Study|Lost to Follow-up|1
5661058|NCT00495469|19544755|P1|Overall Study|Lost to Follow-up|1
5661059|NCT00495469|19544749|P7|Overall Study|Adverse Event|1
5661060|NCT00495469|19544750|P6|Overall Study|Adverse Event|1
5661061|NCT00495469|19544751|P5|Overall Study|Adverse Event|1
5661062|NCT00495469|19544752|P4|Overall Study|Adverse Event|0
5661063|NCT00495469|19544753|P3|Overall Study|Adverse Event|3
5661064|NCT00495469|19544754|P2|Overall Study|Adverse Event|1
5661065|NCT00495469|19544755|P1|Overall Study|Adverse Event|0
5661066|NCT00495391|19544899|P2|Overall Study|Withdrawal by Subject|3
5661067|NCT00495391|19544900|P1|Overall Study|Withdrawal by Subject|2
5661068|NCT00495391|19544899|P2|Overall Study|Lack of Efficacy|18
5661069|NCT00495391|19544900|P1|Overall Study|Lack of Efficacy|34
5661070|NCT00495170|19544923|P1|Overall Study|Inappropriate staging|8
5661071|NCT00495170|19544923|P1|Overall Study|Withdrawal by Subject|3
5661072|NCT00495170|19544923|P1|Overall Study|Lost to Follow-up|9
5661073|NCT00495131|19544942|P2|Overall Study|Withdrawal by Subject|0
5661074|NCT00495131|19544943|P1|Overall Study|Withdrawal by Subject|1
5661075|NCT00495131|19544942|P2|Overall Study|Lost to Follow-up|2
5661076|NCT00495131|19544943|P1|Overall Study|Lost to Follow-up|0
5661077|NCT00495131|19544942|P2|Overall Study|Lack of Efficacy|2
5661078|NCT00495131|19544943|P1|Overall Study|Lack of Efficacy|0
5661079|NCT00495131|19544942|P2|Overall Study|Adverse Event|2
5661080|NCT00495131|19544943|P1|Overall Study|Adverse Event|6
5661081|NCT00495040|19544960|P1|Overall Study|Withdrawal by Subject|3
5661082|NCT00494871|19544975|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
5661083|NCT00494871|19544976|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
5661084|NCT00494871|19544975|P2|Follow-up (FU) Period|Withdrawal by Subject|5
5661085|NCT00494871|19544976|P1|Follow-up (FU) Period|Withdrawal by Subject|5
5661086|NCT00494871|19544975|P2|Follow-up (FU) Period|Protocol Violation|0
5661087|NCT00494871|19544976|P1|Follow-up (FU) Period|Protocol Violation|1
5661088|NCT00494871|19544975|P2|Follow-up (FU) Period|Physician Decision|1
5661089|NCT00494871|19544976|P1|Follow-up (FU) Period|Physician Decision|0
5661090|NCT00494871|19544975|P2|Follow-up (FU) Period|Lost to Follow-up|2
5661091|NCT00494871|19544976|P1|Follow-up (FU) Period|Lost to Follow-up|6
5661092|NCT00494871|19544975|P2|Follow-up (FU) Period|Death|12
5661093|NCT00494871|19544976|P1|Follow-up (FU) Period|Death|13
5661094|NCT00494871|19544975|P2|Follow-up (FU) Period|Adverse Event|1
5661095|NCT00494871|19544976|P1|Follow-up (FU) Period|Adverse Event|1
5661096|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
5661097|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
5661098|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
5661099|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
5661100|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
5661101|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
5661102|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
5661103|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
5661104|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
5661105|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
5661106|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
5661107|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
5661108|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
5661109|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
5661110|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
5661111|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
5661112|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Physician Decision|13
5661113|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Physician Decision|4
5661114|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Death|3
5661115|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Death|8
5661116|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
5661117|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
5661118|NCT00494871|19544975|P2|Double-blind (DB) Treatment Period|Adverse Event|70
5661119|NCT00494871|19544976|P1|Double-blind (DB) Treatment Period|Adverse Event|73
5661120|NCT00494780|19545017|P2|Overall Study|Insurance Issues|1
5661121|NCT00494780|19545018|P1|Overall Study|Insurance Issues|0
5661122|NCT00494780|19545017|P2|Overall Study|Residual Tumour Mass|1
5661123|NCT00494780|19545018|P1|Overall Study|Residual Tumour Mass|0
5661124|NCT00494780|19545017|P2|Overall Study|Non-compliance|0
5661125|NCT00494780|19545018|P1|Overall Study|Non-compliance|1
5661126|NCT00494780|19545017|P2|Overall Study|New Treatment|2
5661127|NCT00494780|19545018|P1|Overall Study|New Treatment|2
5661128|NCT00494780|19545017|P2|Overall Study|Progression of Study Disease|8
5661129|NCT00494780|19545018|P1|Overall Study|Progression of Study Disease|7
5661130|NCT00494780|19545017|P2|Overall Study|Withdrew before Dosed|1
5661131|NCT00494780|19545018|P1|Overall Study|Withdrew before Dosed|0
5661132|NCT00494780|19545017|P2|Overall Study|Adverse Event|0
5661133|NCT00494780|19545018|P1|Overall Study|Adverse Event|1
5661134|NCT00494676|19545056|P2|Second Intervention|Withdrawal by Subject|1
5661135|NCT00494676|19545057|P1|Second Intervention|Withdrawal by Subject|1
5661136|NCT00494676|19545056|P2|First Intervention|Withdrawal by Subject|3
5661137|NCT00494676|19545057|P1|First Intervention|Withdrawal by Subject|1
5661138|NCT00494676|19545056|P2|Allocation|Withdrawal by Subject|4
5661139|NCT00494676|19545057|P1|Allocation|Withdrawal by Subject|2
5661140|NCT00494507|19545072|P4|Open-Label Phase|Worsening Disease|2
5661141|NCT00494507|19545073|P3|Open-Label Phase|Worsening Disease|0
5661142|NCT00494507|19545074|P2|Open-Label Phase|Worsening Disease|0
5661143|NCT00494507|19545075|P1|Open-Label Phase|Worsening Disease|0
5661144|NCT00494507|19545072|P4|Open-Label Phase|Adverse Event|3
5661145|NCT00494507|19545073|P3|Open-Label Phase|Adverse Event|5
5661146|NCT00494507|19545074|P2|Open-Label Phase|Adverse Event|1
5661147|NCT00494507|19545075|P1|Open-Label Phase|Adverse Event|0
5661148|NCT00494507|19545072|P4|Double-Blind Phase|Negative DNA test|1
5661149|NCT00494507|19545073|P3|Double-Blind Phase|Negative DNA test|0
5661150|NCT00494507|19545074|P2|Double-Blind Phase|Negative DNA test|0
5661151|NCT00494507|19545075|P1|Double-Blind Phase|Negative DNA test|0
5661152|NCT00494507|19545072|P4|Double-Blind Phase|Subject Non-compliance|0
5661153|NCT00494507|19545073|P3|Double-Blind Phase|Subject Non-compliance|1
5661154|NCT00494507|19545074|P2|Double-Blind Phase|Subject Non-compliance|0
5661155|NCT00494507|19545075|P1|Double-Blind Phase|Subject Non-compliance|0
5661156|NCT00494507|19545072|P4|Double-Blind Phase|Withdrawal by Subject|0
5661157|NCT00494507|19545073|P3|Double-Blind Phase|Withdrawal by Subject|0
5661158|NCT00494507|19545074|P2|Double-Blind Phase|Withdrawal by Subject|0
5661159|NCT00494507|19545075|P1|Double-Blind Phase|Withdrawal by Subject|1
5661160|NCT00494507|19545072|P4|Double-Blind Phase|Adverse Event|0
5661161|NCT00494507|19545073|P3|Double-Blind Phase|Adverse Event|1
5661162|NCT00494507|19545074|P2|Double-Blind Phase|Adverse Event|0
5661163|NCT00494507|19545075|P1|Double-Blind Phase|Adverse Event|2
5661164|NCT00494481|19545142|P2|Overall Study|Never received IP|0
5661165|NCT00494481|19545143|P1|Overall Study|Never received IP|2
5661166|NCT00494481|19545142|P2|Overall Study|Other|0
5661167|NCT00494481|19545143|P1|Overall Study|Other|1
5661168|NCT00494481|19545142|P2|Overall Study|Adverse Event|11
5661169|NCT00494481|19545143|P1|Overall Study|Adverse Event|15
5661170|NCT00494481|19545142|P2|Overall Study|Condition under investigation worsened|13
5661171|NCT00494481|19545143|P1|Overall Study|Condition under investigation worsened|11
5661172|NCT00494442|19545151|P2|Overall Study|Intercurrent illness|1
5661173|NCT00494442|19545152|P1|Overall Study|Intercurrent illness|0
5661174|NCT00494442|19545151|P2|Overall Study|Non-compliance|1
5661175|NCT00494442|19545152|P1|Overall Study|Non-compliance|0
5661176|NCT00494442|19545151|P2|Overall Study|Physician Decision|1
5661177|NCT00494442|19545152|P1|Overall Study|Physician Decision|0
5661178|NCT00494442|19545151|P2|Overall Study|Adverse Event|2
5661179|NCT00494442|19545152|P1|Overall Study|Adverse Event|0
5661180|NCT00494442|19545151|P2|Overall Study|Lack of Efficacy|10
5661181|NCT00494442|19545152|P1|Overall Study|Lack of Efficacy|16
5661182|NCT00494442|19545151|P2|Overall Study|Death|1
5661183|NCT00494442|19545152|P1|Overall Study|Death|1
5661184|NCT00494299|19545168|P2|Overall Study|Protocol Driven Decision Point|22
5661185|NCT00494299|19545169|P1|Overall Study|Protocol Driven Decision Point|11
5661186|NCT00494299|19545168|P2|Overall Study|Site Closed by Sponsor|0
5661187|NCT00494299|19545169|P1|Overall Study|Site Closed by Sponsor|6
5661188|NCT00494299|19545168|P2|Overall Study|Participant Did Not Take Study Drug|2
5661189|NCT00494299|19545169|P1|Overall Study|Participant Did Not Take Study Drug|0
5661190|NCT00494299|19545168|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
5661191|NCT00494299|19545169|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
5661192|NCT00494299|19545168|P2|Overall Study|Withdrawal by Subject|3
5661193|NCT00494299|19545169|P1|Overall Study|Withdrawal by Subject|8
5661194|NCT00494299|19545168|P2|Overall Study|Protocol Violation|2
5661195|NCT00494299|19545169|P1|Overall Study|Protocol Violation|1
5661196|NCT00494299|19545168|P2|Overall Study|Physician Decision|2
5661197|NCT00494299|19545169|P1|Overall Study|Physician Decision|0
5661198|NCT00494299|19545168|P2|Overall Study|Lost to Follow-up|0
5661199|NCT00494299|19545169|P1|Overall Study|Lost to Follow-up|1
5661200|NCT00494299|19545168|P2|Overall Study|Adverse Event|13
5661201|NCT00494299|19545169|P1|Overall Study|Adverse Event|93
5661202|NCT00494234|19545181|P2|Overall Study|Death|1
5661203|NCT00494234|19545182|P1|Overall Study|Death|2
5661204|NCT00494234|19545181|P2|Overall Study|Withdrawal by Subject|0
5661205|NCT00494234|19545182|P1|Overall Study|Withdrawal by Subject|1
5661206|NCT00494234|19545181|P2|Overall Study|Lack of Efficacy|9
5661207|NCT00494234|19545182|P1|Overall Study|Lack of Efficacy|12
5661208|NCT00494221|19545201|P3|Overall Study|Withdrawal by Subject|0
5661209|NCT00494221|19545202|P2|Overall Study|Withdrawal by Subject|2
5661210|NCT00494221|19545203|P1|Overall Study|Withdrawal by Subject|1
5661211|NCT00494221|19545201|P3|Overall Study|Death|14
5661212|NCT00494221|19545202|P2|Overall Study|Death|9
5661213|NCT00494221|19545203|P1|Overall Study|Death|15
5661214|NCT00494091|19545244|P2|Overall Study|Withdrawal by Subject|7
5661215|NCT00494091|19545245|P1|Overall Study|Withdrawal by Subject|0
5661216|NCT00494091|19545244|P2|Overall Study|Other|11
5661217|NCT00494091|19545245|P1|Overall Study|Other|1
5661218|NCT00494091|19545244|P2|Overall Study|Lost to Follow-up|4
5661219|NCT00494091|19545245|P1|Overall Study|Lost to Follow-up|0
5661220|NCT00494091|19545244|P2|Overall Study|Death|54
5661221|NCT00494091|19545245|P1|Overall Study|Death|5
5661222|NCT00494026|19545267|P1|Overall Study|Sponsor Decision|4
5661223|NCT00494013|19545277|P2|Overall Study|Sponsor Decision|1
5661224|NCT00494013|19545278|P1|Overall Study|Sponsor Decision|0
5661225|NCT00494013|19545277|P2|Overall Study|Withdrawal by Subject|14
5661226|NCT00494013|19545278|P1|Overall Study|Withdrawal by Subject|13
5661227|NCT00494013|19545277|P2|Overall Study|Protocol Violation|5
5661228|NCT00494013|19545278|P1|Overall Study|Protocol Violation|8
5661229|NCT00494013|19545277|P2|Overall Study|Physician Decision|5
5661230|NCT00494013|19545278|P1|Overall Study|Physician Decision|3
5661231|NCT00494013|19545277|P2|Overall Study|Lost to Follow-up|6
5661232|NCT00494013|19545278|P1|Overall Study|Lost to Follow-up|5
5661233|NCT00494013|19545277|P2|Overall Study|Entry Criteria Not Met|4
5661234|NCT00494013|19545278|P1|Overall Study|Entry Criteria Not Met|1
5661235|NCT00494013|19545277|P2|Overall Study|Adverse Event|1
5661236|NCT00494013|19545278|P1|Overall Study|Adverse Event|0
5661237|NCT00493974|19545308|P2|Overall Study|Lost to Follow-up|6
5661238|NCT00493974|19545309|P1|Overall Study|Lost to Follow-up|4
5661239|NCT00493974|19545308|P2|Overall Study|Withdrawal by Subject|6
5661240|NCT00493974|19545309|P1|Overall Study|Withdrawal by Subject|8
5661241|NCT00493974|19545308|P2|Overall Study|Death|2
5661242|NCT00493974|19545309|P1|Overall Study|Death|1
5661243|NCT00493779|19545336|P1|Overall Study|Logistical issue at site|1
5661244|NCT00493649|19545343|P1|Overall Study|Other|13
5661245|NCT00493649|19545343|P1|Overall Study|Lost to Follow-up|1
5661246|NCT00493649|19545343|P1|Overall Study|Disease Progression|1
5661247|NCT00493649|19545343|P1|Overall Study|Investigator Request|2
5661248|NCT00493649|19545343|P1|Overall Study|Patient Request|21
5661249|NCT00493649|19545343|P1|Overall Study|Adverse Event|44
5661250|NCT00493636|19545356|P2|Overall Study|Mis-randomization|1
5661251|NCT00493636|19545357|P1|Overall Study|Mis-randomization|1
5661252|NCT00493636|19545356|P2|Overall Study|Disease progression/recurrence/relapse|1
5661253|NCT00493636|19545357|P1|Overall Study|Disease progression/recurrence/relapse|0
5661254|NCT00493636|19545356|P2|Overall Study|Withdrawal by Subject|0
5661255|NCT00493636|19545357|P1|Overall Study|Withdrawal by Subject|1
5661256|NCT00493467|19545371|P1|Overall Study|Death|1
5661257|NCT00493454|19545376|P1|Overall Study|Withdrawal by Subject|1
5661258|NCT00493311|19545382|P2|Overall Study|Need for rescue medication|2
5661259|NCT00493311|19545383|P1|Overall Study|Need for rescue medication|2
5661260|NCT00493285|19545403|P6|Overall Study|Lost to Follow-up|0
5661261|NCT00493285|19545404|P5|Overall Study|Lost to Follow-up|1
5661262|NCT00493285|19545405|P4|Overall Study|Lost to Follow-up|0
5661263|NCT00493285|19545406|P3|Overall Study|Lost to Follow-up|0
5661264|NCT00493285|19545407|P2|Overall Study|Lost to Follow-up|0
5661265|NCT00493285|19545408|P1|Overall Study|Lost to Follow-up|0
5661266|NCT00493246|19545640|P8|Overall Study|Lost to Follow-up|0
5661267|NCT00493246|19545641|P7|Overall Study|Lost to Follow-up|1
5661268|NCT00493246|19545642|P6|Overall Study|Lost to Follow-up|0
5661269|NCT00493246|19545643|P5|Overall Study|Lost to Follow-up|0
5661270|NCT00493246|19545644|P4|Overall Study|Lost to Follow-up|0
5661271|NCT00493246|19545645|P3|Overall Study|Lost to Follow-up|0
5661272|NCT00493246|19545646|P2|Overall Study|Lost to Follow-up|0
5661273|NCT00493246|19545647|P1|Overall Study|Lost to Follow-up|0
5661274|NCT00493246|19545640|P8|Overall Study|No access to draw blood|0
5661275|NCT00493246|19545641|P7|Overall Study|No access to draw blood|0
5661276|NCT00493246|19545642|P6|Overall Study|No access to draw blood|1
5661277|NCT00493246|19545643|P5|Overall Study|No access to draw blood|0
5661278|NCT00493246|19545644|P4|Overall Study|No access to draw blood|0
5661279|NCT00493246|19545645|P3|Overall Study|No access to draw blood|0
5661280|NCT00493246|19545646|P2|Overall Study|No access to draw blood|0
5661281|NCT00493246|19545647|P1|Overall Study|No access to draw blood|0
5661282|NCT00493246|19545640|P8|Overall Study|Withdrawal by Subject|0
5661283|NCT00493246|19545641|P7|Overall Study|Withdrawal by Subject|0
5661284|NCT00493246|19545642|P6|Overall Study|Withdrawal by Subject|0
5661285|NCT00493246|19545643|P5|Overall Study|Withdrawal by Subject|1
5661286|NCT00493246|19545644|P4|Overall Study|Withdrawal by Subject|0
5661287|NCT00493246|19545645|P3|Overall Study|Withdrawal by Subject|0
5661288|NCT00493246|19545646|P2|Overall Study|Withdrawal by Subject|0
5661289|NCT00493246|19545647|P1|Overall Study|Withdrawal by Subject|0
5661290|NCT00493220|19545711|P6|Third Intervention|Withdrawal by Subject|0
5661291|NCT00493220|19545712|P5|Third Intervention|Withdrawal by Subject|0
5661292|NCT00493220|19545713|P4|Third Intervention|Withdrawal by Subject|0
5661293|NCT00493220|19545714|P3|Third Intervention|Withdrawal by Subject|0
5661294|NCT00493220|19545715|P2|Third Intervention|Withdrawal by Subject|0
5661295|NCT00493220|19545716|P1|Third Intervention|Withdrawal by Subject|1
5661296|NCT00493038|19545744|P2|Follow-up|Lost to Follow-up|0
5661297|NCT00493038|19545745|P1|Follow-up|Lost to Follow-up|1
5661298|NCT00493038|19545744|P2|Treatment|Other|1
5661299|NCT00493038|19545745|P1|Treatment|Other|0
5661300|NCT00493038|19545744|P2|Treatment|Withdrawal by Subject|12
5661301|NCT00493038|19545745|P1|Treatment|Withdrawal by Subject|11
5661302|NCT00493038|19545744|P2|Treatment|Lost to Follow-up|3
5661303|NCT00493038|19545745|P1|Treatment|Lost to Follow-up|5
5661304|NCT00493038|19545744|P2|Treatment|Adverse Event|4
5661305|NCT00493038|19545745|P1|Treatment|Adverse Event|8
5661306|NCT00493025|19545759|P1|Overall Study|Physician Decision|19
5661307|NCT00493012|19545770|P2|Overall Study|Lost to Follow-up|17
5661308|NCT00493012|19545771|P1|Overall Study|Lost to Follow-up|18
5661309|NCT00492921|19545814|P3|Overall Study|Death|1
5661310|NCT00492921|19545815|P2|Overall Study|Death|0
5661311|NCT00492921|19545816|P1|Overall Study|Death|1
5661312|NCT00492856|19545827|P4|Post-consolidation|Observation Arm|0
5661313|NCT00492856|19545828|P3|Post-consolidation|Observation Arm|27
5661314|NCT00492856|19545829|P2|Post-consolidation|Observation Arm|0
5661315|NCT00492856|19545830|P1|Post-consolidation|Observation Arm|0
5661316|NCT00492856|19545827|P4|Post-consolidation|Lost to Follow-up|0
5661317|NCT00492856|19545828|P3|Post-consolidation|Lost to Follow-up|0
5661318|NCT00492856|19545829|P2|Post-consolidation|Lost to Follow-up|2
5661319|NCT00492856|19545830|P1|Post-consolidation|Lost to Follow-up|0
5661320|NCT00492856|19545827|P4|Post-consolidation|Not protocol specified|0
5661321|NCT00492856|19545828|P3|Post-consolidation|Not protocol specified|0
5661322|NCT00492856|19545829|P2|Post-consolidation|Not protocol specified|1
5661323|NCT00492856|19545830|P1|Post-consolidation|Not protocol specified|0
5661324|NCT00492856|19545827|P4|Post-consolidation|Death|0
5661325|NCT00492856|19545828|P3|Post-consolidation|Death|0
5661326|NCT00492856|19545829|P2|Post-consolidation|Death|1
5661327|NCT00492856|19545830|P1|Post-consolidation|Death|0
5661328|NCT00492856|19545827|P4|Post-consolidation|Withdrawal by Subject|0
5661329|NCT00492856|19545828|P3|Post-consolidation|Withdrawal by Subject|0
5661330|NCT00492856|19545829|P2|Post-consolidation|Withdrawal by Subject|4
5661331|NCT00492856|19545830|P1|Post-consolidation|Withdrawal by Subject|0
5661332|NCT00492856|19545827|P4|Post-consolidation|Adverse Event|1
5661333|NCT00492856|19545828|P3|Post-consolidation|Adverse Event|0
5661334|NCT00492856|19545829|P2|Post-consolidation|Adverse Event|4
5661335|NCT00492856|19545830|P1|Post-consolidation|Adverse Event|0
5661336|NCT00492856|19545827|P4|Consolidation|Lost to Follow-up|0
5661337|NCT00492856|19545828|P3|Consolidation|Lost to Follow-up|0
5661338|NCT00492856|19545829|P2|Consolidation|Lost to Follow-up|0
5661339|NCT00492856|19545830|P1|Consolidation|Lost to Follow-up|1
5661340|NCT00492856|19545827|P4|Consolidation|Not protocol specified|0
5661341|NCT00492856|19545828|P3|Consolidation|Not protocol specified|0
5661342|NCT00492856|19545829|P2|Consolidation|Not protocol specified|0
5661343|NCT00492856|19545830|P1|Consolidation|Not protocol specified|2
5661344|NCT00492856|19545827|P4|Consolidation|Adverse Event|0
5661345|NCT00492856|19545828|P3|Consolidation|Adverse Event|0
5661346|NCT00492856|19545829|P2|Consolidation|Adverse Event|0
5661347|NCT00492856|19545830|P1|Consolidation|Adverse Event|6
5661348|NCT00492856|19545827|P4|Induction|Death|0
5661349|NCT00492856|19545828|P3|Induction|Death|0
5661350|NCT00492856|19545829|P2|Induction|Death|0
5661351|NCT00492856|19545830|P1|Induction|Death|3
5661352|NCT00492856|19545827|P4|Induction|Withdrawal by Subject|0
5661353|NCT00492856|19545828|P3|Induction|Withdrawal by Subject|0
5661354|NCT00492856|19545829|P2|Induction|Withdrawal by Subject|0
5661355|NCT00492856|19545830|P1|Induction|Withdrawal by Subject|1
5661356|NCT00492856|19545827|P4|Induction|Adverse Event|0
5661357|NCT00492856|19545828|P3|Induction|Adverse Event|0
5661358|NCT00492856|19545829|P2|Induction|Adverse Event|0
5661359|NCT00492856|19545830|P1|Induction|Adverse Event|2
5661360|NCT00492752|19545844|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
5661361|NCT00492752|19545845|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
5661362|NCT00492752|19545846|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
5661363|NCT00492752|19545847|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
5661364|NCT00492752|19545844|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
5661365|NCT00492752|19545845|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
5661366|NCT00492752|19545846|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
5661367|NCT00492752|19545847|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
5661368|NCT00492752|19545844|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
5661369|NCT00492752|19545845|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
5661370|NCT00492752|19545846|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
5661371|NCT00492752|19545847|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
5661372|NCT00492752|19545844|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
5661373|NCT00492752|19545845|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
5661374|NCT00492752|19545846|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
5661375|NCT00492752|19545847|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
5661376|NCT00492752|19545844|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
5661377|NCT00492752|19545845|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
5661378|NCT00492752|19545846|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
5661379|NCT00492752|19545847|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
5661380|NCT00492752|19545844|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
5661381|NCT00492752|19545845|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
5661382|NCT00492752|19545846|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
5661383|NCT00492752|19545847|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
5661384|NCT00492752|19545844|P4|Follow-up and/or Open Label Sorafenib|Death|1
5661385|NCT00492752|19545845|P3|Follow-up and/or Open Label Sorafenib|Death|45
5661386|NCT00492752|19545846|P2|Follow-up and/or Open Label Sorafenib|Death|5
5661387|NCT00492752|19545847|P1|Follow-up and/or Open Label Sorafenib|Death|75
5661388|NCT00492752|19545844|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
5661389|NCT00492752|19545845|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
5661390|NCT00492752|19545846|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
5661391|NCT00492752|19545847|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
5661392|NCT00492752|19545844|P4|Double Blind Treatment|Protocol Violation|0
5661393|NCT00492752|19545845|P3|Double Blind Treatment|Protocol Violation|1
5661394|NCT00492752|19545846|P2|Double Blind Treatment|Protocol Violation|0
5661395|NCT00492752|19545847|P1|Double Blind Treatment|Protocol Violation|0
5661396|NCT00492752|19545844|P4|Double Blind Treatment|Adverse Event|0
5661397|NCT00492752|19545845|P3|Double Blind Treatment|Adverse Event|0
5661398|NCT00492752|19545846|P2|Double Blind Treatment|Adverse Event|0
5661399|NCT00492752|19545847|P1|Double Blind Treatment|Adverse Event|1
5661400|NCT00492752|19545844|P4|Double Blind Treatment|Death|0
5661401|NCT00492752|19545845|P3|Double Blind Treatment|Death|2
5661402|NCT00492752|19545846|P2|Double Blind Treatment|Death|0
5661403|NCT00492752|19545847|P1|Double Blind Treatment|Death|13
5661404|NCT00492726|19545882|P2|Overall Study|Non compliant with study medication|3
5661405|NCT00492726|19545883|P1|Overall Study|Non compliant with study medication|0
5661406|NCT00492726|19545882|P2|Overall Study|Withdrawal by Subject|3
5661407|NCT00492726|19545883|P1|Overall Study|Withdrawal by Subject|6
5661408|NCT00492726|19545882|P2|Overall Study|Physician Decision|1
5661409|NCT00492726|19545883|P1|Overall Study|Physician Decision|0
5661410|NCT00492726|19545882|P2|Overall Study|Lost to Follow-up|19
5661411|NCT00492726|19545883|P1|Overall Study|Lost to Follow-up|27
5661412|NCT00492726|19545882|P2|Overall Study|Lack of Efficacy|2
5661413|NCT00492726|19545883|P1|Overall Study|Lack of Efficacy|0
5661414|NCT00492726|19545882|P2|Overall Study|Death|2
5661415|NCT00492726|19545883|P1|Overall Study|Death|7
5661416|NCT00492726|19545882|P2|Overall Study|Adverse Event|6
5661417|NCT00492726|19545883|P1|Overall Study|Adverse Event|10
5661418|NCT00492648|19545909|P2|Month 30 (109671 Study)|Protocol Violation|1
5661419|NCT00492648|19545910|P1|Month 30 (109671 Study)|Protocol Violation|0
5661420|NCT00492557|19545957|P2|Overall Study|Lost to Follow-up|1
5661421|NCT00492557|19545958|P1|Overall Study|Lost to Follow-up|0
5661422|NCT00492557|19545957|P2|Overall Study|Failed to return|0
5661423|NCT00492557|19545958|P1|Overall Study|Failed to return|1
5661424|NCT00492557|19545957|P2|Overall Study|Adverse Event|0
5661425|NCT00492557|19545958|P1|Overall Study|Adverse Event|1
5661426|NCT00492557|19545957|P2|Overall Study|Death|1
5661427|NCT00492557|19545958|P1|Overall Study|Death|1
5661428|NCT00492557|19545957|P2|Overall Study|Other|2
5661429|NCT00492557|19545958|P1|Overall Study|Other|2
5661430|NCT00492557|19545957|P2|Overall Study|Protocol Violation|8
5661431|NCT00492557|19545958|P1|Overall Study|Protocol Violation|7
5661432|NCT00492557|19545957|P2|Overall Study|Subject request|11
5661433|NCT00492557|19545958|P1|Overall Study|Subject request|12
5661434|NCT00492531|19545988|P2|Overall Study|Withdrawn(More than one reason selected)|23
5661435|NCT00492531|19545989|P1|Overall Study|Withdrawn(More than one reason selected)|22
5661436|NCT00492297|19546062|P1|Survival Only Follow-up|Study terminated by sponsor|12
5661437|NCT00492297|19546062|P1|Survival Only Follow-up|Lack of Efficacy|1
5661438|NCT00492297|19546062|P1|Survival Only Follow-up|Death|46
5661439|NCT00492297|19546062|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
5661440|NCT00492297|19546062|P1|Active Follow-up 30(+4) Days Duration|Death|17
5661441|NCT00492297|19546062|P1|Treatment|Study terminated by sponsor|3
5661442|NCT00492297|19546062|P1|Treatment|Death|2
5661443|NCT00492284|19546080|P4|Overall Study|Withdrawal by Subject|2
5661444|NCT00492284|19546081|P3|Overall Study|Withdrawal by Subject|0
5661445|NCT00492284|19546082|P2|Overall Study|Withdrawal by Subject|0
5661446|NCT00492284|19546083|P1|Overall Study|Withdrawal by Subject|1
5661447|NCT00492284|19546080|P4|Overall Study|Death|5
5661448|NCT00492284|19546081|P3|Overall Study|Death|2
5661449|NCT00492284|19546082|P2|Overall Study|Death|3
5661450|NCT00492284|19546083|P1|Overall Study|Death|0
5661451|NCT00492284|19546080|P4|Overall Study|Lost to Follow-up|1
5661452|NCT00492284|19546081|P3|Overall Study|Lost to Follow-up|3
5661453|NCT00492284|19546082|P2|Overall Study|Lost to Follow-up|0
5661454|NCT00492284|19546083|P1|Overall Study|Lost to Follow-up|0
5661455|NCT00492284|19546080|P4|Overall Study|Adverse Event|2
5661456|NCT00492284|19546081|P3|Overall Study|Adverse Event|1
5661457|NCT00492284|19546082|P2|Overall Study|Adverse Event|1
5661458|NCT00492284|19546083|P1|Overall Study|Adverse Event|0
5661459|NCT00492232|19546127|P2|Open-Label Treatment|Withdrawal by Subject|0
5661460|NCT00492232|19546128|P1|Open-Label Treatment|Withdrawal by Subject|1
5661461|NCT00492232|19546127|P2|Double-Blind Treatment|Randomized not treated|0
5661462|NCT00492232|19546128|P1|Double-Blind Treatment|Randomized not treated|1
5661463|NCT00492232|19546127|P2|Double-Blind Treatment|Other|5
5661464|NCT00492232|19546128|P1|Double-Blind Treatment|Other|6
5661465|NCT00492232|19546127|P2|Double-Blind Treatment|Lack of Efficacy|0
5661466|NCT00492232|19546128|P1|Double-Blind Treatment|Lack of Efficacy|1
5661467|NCT00492232|19546127|P2|Double-Blind Treatment|Withdrawal by Subject|8
5661468|NCT00492232|19546128|P1|Double-Blind Treatment|Withdrawal by Subject|4
5661469|NCT00492232|19546127|P2|Double-Blind Treatment|Lost to Follow-up|3
5661470|NCT00492232|19546128|P1|Double-Blind Treatment|Lost to Follow-up|2
5661471|NCT00492232|19546127|P2|Double-Blind Treatment|Protocol Violation|7
5661472|NCT00492232|19546128|P1|Double-Blind Treatment|Protocol Violation|3
5661473|NCT00492232|19546127|P2|Double-Blind Treatment|Adverse Event|2
5661474|NCT00492232|19546128|P1|Double-Blind Treatment|Adverse Event|1
5661475|NCT00492232|19546127|P2|Placebo Run-in|Missing|2
5661476|NCT00492232|19546128|P1|Placebo Run-in|Missing|0
5661477|NCT00492232|19546127|P2|Placebo Run-in|Other|6
5661478|NCT00492232|19546128|P1|Placebo Run-in|Other|0
5661479|NCT00492232|19546127|P2|Placebo Run-in|Entrance criteria not met|45
5661480|NCT00492232|19546128|P1|Placebo Run-in|Entrance criteria not met|0
5661481|NCT00492232|19546127|P2|Placebo Run-in|Pregnancy|1
5661482|NCT00492232|19546128|P1|Placebo Run-in|Pregnancy|0
5661483|NCT00492232|19546127|P2|Placebo Run-in|Withdrawal by Subject|8
5661484|NCT00492232|19546128|P1|Placebo Run-in|Withdrawal by Subject|0
5661485|NCT00492232|19546127|P2|Placebo Run-in|Lost to Follow-up|3
5661486|NCT00492232|19546128|P1|Placebo Run-in|Lost to Follow-up|0
5661487|NCT00492232|19546127|P2|Placebo Run-in|Protocol Violation|3
5661488|NCT00492232|19546128|P1|Placebo Run-in|Protocol Violation|0
5661489|NCT00492232|19546127|P2|Placebo Run-in|Adverse Event|2
5661490|NCT00492232|19546128|P1|Placebo Run-in|Adverse Event|0
5661491|NCT00492115|19546169|P2|Overall Study|Withdrawal by Subject|4
5661492|NCT00492115|19546170|P1|Overall Study|Withdrawal by Subject|3
5661493|NCT00492063|19546191|P4|Overall Study|Protocol Violation|1
5661494|NCT00492063|19546192|P3|Overall Study|Protocol Violation|0
5661495|NCT00492063|19546193|P2|Overall Study|Protocol Violation|0
5661496|NCT00492063|19546194|P1|Overall Study|Protocol Violation|0
5661497|NCT00492063|19546191|P4|Overall Study|Lost to Follow-up|3
5661498|NCT00492063|19546192|P3|Overall Study|Lost to Follow-up|5
5661499|NCT00492063|19546193|P2|Overall Study|Lost to Follow-up|11
5661500|NCT00492063|19546194|P1|Overall Study|Lost to Follow-up|6
5661501|NCT00492063|19546191|P4|Overall Study|Withdrawal by Subject|4
5661502|NCT00492063|19546192|P3|Overall Study|Withdrawal by Subject|5
5661503|NCT00492063|19546193|P2|Overall Study|Withdrawal by Subject|3
5661504|NCT00492063|19546194|P1|Overall Study|Withdrawal by Subject|4
5661505|NCT00492063|19546191|P4|Overall Study|Death|2
5661506|NCT00492063|19546192|P3|Overall Study|Death|1
5661507|NCT00492063|19546193|P2|Overall Study|Death|0
5661508|NCT00492063|19546194|P1|Overall Study|Death|0
5661509|NCT00492024|19546218|P2|Follow up|Lost to Follow-up|1
5661510|NCT00492024|19546219|P1|Follow up|Lost to Follow-up|1
5661511|NCT00492024|19546218|P2|Follow up|Lack of Efficacy|1
5661512|NCT00492024|19546219|P1|Follow up|Lack of Efficacy|0
5661513|NCT00492024|19546218|P2|Treatment|Withdrawal by Subject|0
5661514|NCT00492024|19546219|P1|Treatment|Withdrawal by Subject|2
5661515|NCT00492024|19546218|P2|Treatment|Lost to Follow-up|1
5661516|NCT00492024|19546219|P1|Treatment|Lost to Follow-up|3
5661517|NCT00492024|19546218|P2|Treatment|Lack of Efficacy|20
5661518|NCT00492024|19546219|P1|Treatment|Lack of Efficacy|21
5661519|NCT00492024|19546218|P2|Treatment|Adverse Event|1
5661520|NCT00492024|19546219|P1|Treatment|Adverse Event|3
5661521|NCT00491894|19546235|P1|Overall Study|Other-Intake of prohibited medication|1
5661522|NCT00491894|19546235|P1|Overall Study|Protocol Violation|2
5661523|NCT00491894|19546235|P1|Overall Study|Physician Decision|2
5661524|NCT00491894|19546235|P1|Overall Study|Other-Failed to meet any criteria|2
5661525|NCT00491894|19546235|P1|Overall Study|Lack of Efficacy|2
5661526|NCT00491894|19546235|P1|Overall Study|Lost to Follow-up|3
5661527|NCT00491894|19546235|P1|Overall Study|Death|3
5661528|NCT00491894|19546235|P1|Overall Study|Withdrawal by Subject|5
5661529|NCT00491894|19546235|P1|Overall Study|Adverse Event|14
5661530|NCT00491764|19546262|P6|Overall Study|Administrative|0
5661531|NCT00491764|19546263|P5|Overall Study|Administrative|0
5661532|NCT00491764|19546264|P4|Overall Study|Administrative|1
5661533|NCT00491764|19546265|P3|Overall Study|Administrative|2
5661534|NCT00491764|19546266|P2|Overall Study|Administrative|0
5661535|NCT00491764|19546267|P1|Overall Study|Administrative|1
5661536|NCT00491764|19546262|P6|Overall Study|Did not Meet Protocol Eligibility|1
5661537|NCT00491764|19546263|P5|Overall Study|Did not Meet Protocol Eligibility|1
5661538|NCT00491764|19546264|P4|Overall Study|Did not Meet Protocol Eligibility|0
5661539|NCT00491764|19546265|P3|Overall Study|Did not Meet Protocol Eligibility|1
5661540|NCT00491764|19546266|P2|Overall Study|Did not Meet Protocol Eligibility|1
5661541|NCT00491764|19546267|P1|Overall Study|Did not Meet Protocol Eligibility|0
5661542|NCT00491764|19546262|P6|Overall Study|Non Compliance with the Protocol|0
5661543|NCT00491764|19546263|P5|Overall Study|Non Compliance with the Protocol|0
5661544|NCT00491764|19546264|P4|Overall Study|Non Compliance with the Protocol|0
5661545|NCT00491764|19546265|P3|Overall Study|Non Compliance with the Protocol|0
5661546|NCT00491764|19546266|P2|Overall Study|Non Compliance with the Protocol|0
5661547|NCT00491764|19546267|P1|Overall Study|Non Compliance with the Protocol|1
5661548|NCT00491764|19546262|P6|Overall Study|Withdrawal by Subject|4
5661549|NCT00491764|19546263|P5|Overall Study|Withdrawal by Subject|2
5661550|NCT00491764|19546264|P4|Overall Study|Withdrawal by Subject|2
5661551|NCT00491764|19546265|P3|Overall Study|Withdrawal by Subject|1
5661552|NCT00491764|19546266|P2|Overall Study|Withdrawal by Subject|3
5661553|NCT00491764|19546267|P1|Overall Study|Withdrawal by Subject|2
5661554|NCT00491764|19546262|P6|Overall Study|Lost to Follow-up|3
5661555|NCT00491764|19546263|P5|Overall Study|Lost to Follow-up|0
5661556|NCT00491764|19546264|P4|Overall Study|Lost to Follow-up|1
5661557|NCT00491764|19546265|P3|Overall Study|Lost to Follow-up|0
5661558|NCT00491764|19546266|P2|Overall Study|Lost to Follow-up|1
5661559|NCT00491764|19546267|P1|Overall Study|Lost to Follow-up|0
5661560|NCT00491764|19546262|P6|Overall Study|Adverse Event|1
5661561|NCT00491764|19546263|P5|Overall Study|Adverse Event|0
5661562|NCT00491764|19546264|P4|Overall Study|Adverse Event|4
5661563|NCT00491764|19546265|P3|Overall Study|Adverse Event|4
5661564|NCT00491764|19546266|P2|Overall Study|Adverse Event|2
5661565|NCT00491764|19546267|P1|Overall Study|Adverse Event|1
5661566|NCT00491608|19546315|P1|Overall Study|Withdrawal by Subject|1
5661567|NCT00491608|19546315|P1|Overall Study|Death|2
5661568|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
5661569|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
5661570|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
5661571|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
5661572|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
5661573|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
5661574|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
5661575|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
5661576|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
5661577|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
5661578|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
5661579|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
5661580|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
5661581|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
5661582|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
5661583|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
5661584|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
5661585|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
5661586|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
5661587|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
5661588|NCT00491556|19546326|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
5661589|NCT00491556|19546327|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
5661590|NCT00491556|19546326|P2|Entry-Week (WK) 48: EXP/Standard Care|Other|0
5661591|NCT00491556|19546327|P1|Entry-Week (WK) 48: EXP/Standard Care|Other|3
5661592|NCT00491556|19546326|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
5661593|NCT00491556|19546327|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
5661594|NCT00491556|19546326|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
5661595|NCT00491556|19546327|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
5661596|NCT00491556|19546326|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
5661597|NCT00491556|19546327|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
5661598|NCT00491556|19546326|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
5661599|NCT00491556|19546327|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
5661600|NCT00491556|19546326|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
5661601|NCT00491556|19546327|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
5661602|NCT00491556|19546326|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
5661603|NCT00491556|19546327|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
5661604|NCT00491556|19546326|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
5661605|NCT00491556|19546327|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
5661606|NCT00491556|19546326|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
5661607|NCT00491556|19546327|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
5661608|NCT00491530|19546386|P3|Overall Study|Use of Prohibited Medication|1
5661609|NCT00491530|19546387|P2|Overall Study|Use of Prohibited Medication|0
5661610|NCT00491530|19546388|P1|Overall Study|Use of Prohibited Medication|0
5661611|NCT00491530|19546386|P3|Overall Study|Patient Request|0
5661612|NCT00491530|19546387|P2|Overall Study|Patient Request|1
5661613|NCT00491530|19546388|P1|Overall Study|Patient Request|0
5661614|NCT00491530|19546386|P3|Overall Study|Investigator Discretion|0
5661615|NCT00491530|19546387|P2|Overall Study|Investigator Discretion|1
5661616|NCT00491530|19546388|P1|Overall Study|Investigator Discretion|0
5661617|NCT00491530|19546386|P3|Overall Study|Lack of Efficacy|0
5661618|NCT00491530|19546387|P2|Overall Study|Lack of Efficacy|1
5661619|NCT00491530|19546388|P1|Overall Study|Lack of Efficacy|0
5661620|NCT00491530|19546386|P3|Overall Study|Lost to Follow-up|2
5661621|NCT00491530|19546387|P2|Overall Study|Lost to Follow-up|2
5661622|NCT00491530|19546388|P1|Overall Study|Lost to Follow-up|3
5661623|NCT00491530|19546386|P3|Overall Study|Withdrawal by Subject|0
5661624|NCT00491530|19546387|P2|Overall Study|Withdrawal by Subject|0
5661625|NCT00491530|19546388|P1|Overall Study|Withdrawal by Subject|3
5661626|NCT00491530|19546386|P3|Overall Study|Adverse Event|2
5661627|NCT00491530|19546387|P2|Overall Study|Adverse Event|1
5661628|NCT00491530|19546388|P1|Overall Study|Adverse Event|6
5661629|NCT00491504|19546418|P4|Overall Study|Protocol Violation|2
5661630|NCT00491504|19546419|P3|Overall Study|Protocol Violation|3
5661631|NCT00491504|19546420|P2|Overall Study|Protocol Violation|0
5661632|NCT00491504|19546421|P1|Overall Study|Protocol Violation|0
5661633|NCT00491504|19546418|P4|Overall Study|Withdrawal by Subject|2
5661634|NCT00491504|19546419|P3|Overall Study|Withdrawal by Subject|1
5661635|NCT00491504|19546420|P2|Overall Study|Withdrawal by Subject|0
5661636|NCT00491504|19546421|P1|Overall Study|Withdrawal by Subject|0
5661637|NCT00491504|19546418|P4|Overall Study|Adverse Event|0
5661638|NCT00491504|19546419|P3|Overall Study|Adverse Event|0
5661639|NCT00491504|19546420|P2|Overall Study|Adverse Event|1
5661640|NCT00491504|19546421|P1|Overall Study|Adverse Event|0
5661641|NCT00491400|19546450|P2|Overall Study|Withdrawal by Subject|4
5661642|NCT00491400|19546451|P1|Overall Study|Withdrawal by Subject|5
5661643|NCT00491387|19546459|P1|Overall Study|study terminated|20
5661644|NCT00491322|19546474|P2|Overall Study|Pregnancy|1
5661645|NCT00491322|19546475|P1|Overall Study|Pregnancy|0
5661646|NCT00491322|19546474|P2|Overall Study|Protocol Violation|0
5661647|NCT00491322|19546475|P1|Overall Study|Protocol Violation|1
5661648|NCT00491179|19546494|P2|Overall Study|Withdrawal by Subject|1
5661649|NCT00491179|19546495|P1|Overall Study|Withdrawal by Subject|2
5661650|NCT00491179|19546494|P2|Overall Study|Adverse Event|1
5661651|NCT00491179|19546495|P1|Overall Study|Adverse Event|5
5661652|NCT00491075|19546503|P1|Overall Study|Physician Decision|1
5661653|NCT00491075|19546503|P1|Overall Study|Withdrawal by Subject|1
5661654|NCT00490971|19546509|P5|Maintenance|Other|3
5661655|NCT00490971|19546510|P4|Maintenance|Other|9
5661656|NCT00490971|19546511|P3|Maintenance|Other|11
5661657|NCT00490971|19546512|P2|Maintenance|Other|0
5661658|NCT00490971|19546513|P1|Maintenance|Other|0
5661659|NCT00490971|19546509|P5|Maintenance|Withdrawal by Subject|18
5661660|NCT00490971|19546510|P4|Maintenance|Withdrawal by Subject|28
5661661|NCT00490971|19546511|P3|Maintenance|Withdrawal by Subject|26
5661662|NCT00490971|19546512|P2|Maintenance|Withdrawal by Subject|0
5661663|NCT00490971|19546513|P1|Maintenance|Withdrawal by Subject|0
5661664|NCT00490971|19546509|P5|Maintenance|Protocol Violation|1
5661665|NCT00490971|19546510|P4|Maintenance|Protocol Violation|1
5661666|NCT00490971|19546511|P3|Maintenance|Protocol Violation|4
5661667|NCT00490971|19546512|P2|Maintenance|Protocol Violation|0
5661668|NCT00490971|19546513|P1|Maintenance|Protocol Violation|0
5661669|NCT00490971|19546509|P5|Maintenance|Pregnancy|0
5661670|NCT00490971|19546510|P4|Maintenance|Pregnancy|0
5661671|NCT00490971|19546511|P3|Maintenance|Pregnancy|1
5661672|NCT00490971|19546512|P2|Maintenance|Pregnancy|0
5661673|NCT00490971|19546513|P1|Maintenance|Pregnancy|0
5661674|NCT00490971|19546509|P5|Maintenance|Lost to Follow-up|10
5661675|NCT00490971|19546510|P4|Maintenance|Lost to Follow-up|8
5661676|NCT00490971|19546511|P3|Maintenance|Lost to Follow-up|5
5661677|NCT00490971|19546512|P2|Maintenance|Lost to Follow-up|0
5661678|NCT00490971|19546513|P1|Maintenance|Lost to Follow-up|0
5661679|NCT00490971|19546509|P5|Maintenance|Death|0
5661680|NCT00490971|19546510|P4|Maintenance|Death|2
5661681|NCT00490971|19546511|P3|Maintenance|Death|0
5661682|NCT00490971|19546512|P2|Maintenance|Death|0
5661683|NCT00490971|19546513|P1|Maintenance|Death|0
5661684|NCT00490971|19546509|P5|Maintenance|Adverse Event|7
5661685|NCT00490971|19546510|P4|Maintenance|Adverse Event|5
5661686|NCT00490971|19546511|P3|Maintenance|Adverse Event|4
5661687|NCT00490971|19546512|P2|Maintenance|Adverse Event|0
5661688|NCT00490971|19546513|P1|Maintenance|Adverse Event|0
5661689|NCT00490971|19546509|P5|Acute/Continuation|Other|0
5661690|NCT00490971|19546510|P4|Acute/Continuation|Other|0
5661691|NCT00490971|19546511|P3|Acute/Continuation|Other|0
5661692|NCT00490971|19546512|P2|Acute/Continuation|Other|4
5661693|NCT00490971|19546513|P1|Acute/Continuation|Other|11
5661694|NCT00490971|19546509|P5|Acute/Continuation|Withdrawal by Subject|0
5661695|NCT00490971|19546510|P4|Acute/Continuation|Withdrawal by Subject|0
5661696|NCT00490971|19546511|P3|Acute/Continuation|Withdrawal by Subject|0
5661697|NCT00490971|19546512|P2|Acute/Continuation|Withdrawal by Subject|24
5661698|NCT00490971|19546513|P1|Acute/Continuation|Withdrawal by Subject|92
5661699|NCT00490971|19546509|P5|Acute/Continuation|Protocol Violation|0
5661700|NCT00490971|19546510|P4|Acute/Continuation|Protocol Violation|0
5661701|NCT00490971|19546511|P3|Acute/Continuation|Protocol Violation|0
5661702|NCT00490971|19546512|P2|Acute/Continuation|Protocol Violation|2
5661703|NCT00490971|19546513|P1|Acute/Continuation|Protocol Violation|10
5661704|NCT00490971|19546509|P5|Acute/Continuation|Lost to Follow-up|0
5661705|NCT00490971|19546510|P4|Acute/Continuation|Lost to Follow-up|0
5661706|NCT00490971|19546511|P3|Acute/Continuation|Lost to Follow-up|0
5661707|NCT00490971|19546512|P2|Acute/Continuation|Lost to Follow-up|7
5661708|NCT00490971|19546513|P1|Acute/Continuation|Lost to Follow-up|23
5661709|NCT00490971|19546509|P5|Acute/Continuation|Lack of Efficacy|0
5661710|NCT00490971|19546510|P4|Acute/Continuation|Lack of Efficacy|0
5661711|NCT00490971|19546511|P3|Acute/Continuation|Lack of Efficacy|0
5661712|NCT00490971|19546512|P2|Acute/Continuation|Lack of Efficacy|12
5661713|NCT00490971|19546513|P1|Acute/Continuation|Lack of Efficacy|106
5661714|NCT00490971|19546509|P5|Acute/Continuation|Death|0
5661715|NCT00490971|19546510|P4|Acute/Continuation|Death|0
5661716|NCT00490971|19546511|P3|Acute/Continuation|Death|0
5661717|NCT00490971|19546512|P2|Acute/Continuation|Death|0
5661718|NCT00490971|19546513|P1|Acute/Continuation|Death|2
5661719|NCT00490971|19546509|P5|Acute/Continuation|Adverse Event|0
5661720|NCT00490971|19546510|P4|Acute/Continuation|Adverse Event|0
5661721|NCT00490971|19546511|P3|Acute/Continuation|Adverse Event|0
5661722|NCT00490971|19546512|P2|Acute/Continuation|Adverse Event|13
5661723|NCT00490971|19546513|P1|Acute/Continuation|Adverse Event|62
5661724|NCT00490945|19546560|P5|Overall Study|Adverse Event|0
5661725|NCT00490945|19546561|P4|Overall Study|Adverse Event|0
5661726|NCT00490945|19546562|P3|Overall Study|Adverse Event|0
5661727|NCT00490945|19546563|P2|Overall Study|Adverse Event|1
5661728|NCT00490945|19546564|P1|Overall Study|Adverse Event|0
5661729|NCT00490919|19546600|P3|Double-blind Phase|Administrative|6
5661730|NCT00490919|19546601|P2|Double-blind Phase|Administrative|6
5661731|NCT00490919|19546602|P1|Double-blind Phase|Administrative|0
5661732|NCT00490919|19546600|P3|Double-blind Phase|Lack of Efficacy|36
5661733|NCT00490919|19546601|P2|Double-blind Phase|Lack of Efficacy|22
5661734|NCT00490919|19546602|P1|Double-blind Phase|Lack of Efficacy|0
5661735|NCT00490919|19546600|P3|Double-blind Phase|Lost to Follow-up|11
5661736|NCT00490919|19546601|P2|Double-blind Phase|Lost to Follow-up|8
5661737|NCT00490919|19546602|P1|Double-blind Phase|Lost to Follow-up|0
5661738|NCT00490919|19546600|P3|Double-blind Phase|Withdrawal by Subject|11
5661739|NCT00490919|19546601|P2|Double-blind Phase|Withdrawal by Subject|10
5661740|NCT00490919|19546602|P1|Double-blind Phase|Withdrawal by Subject|0
5661741|NCT00490919|19546600|P3|Double-blind Phase|Adverse Event|20
5661742|NCT00490919|19546601|P2|Double-blind Phase|Adverse Event|40
5661743|NCT00490919|19546602|P1|Double-blind Phase|Adverse Event|0
5661744|NCT00490919|19546600|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
5661745|NCT00490919|19546601|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
5661746|NCT00490919|19546602|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
5661747|NCT00490919|19546600|P3|Open-label Run-in Period|Administrative|0
5661748|NCT00490919|19546601|P2|Open-label Run-in Period|Administrative|0
5661749|NCT00490919|19546602|P1|Open-label Run-in Period|Administrative|40
5661750|NCT00490919|19546600|P3|Open-label Run-in Period|Lack of Efficacy|0
5661751|NCT00490919|19546601|P2|Open-label Run-in Period|Lack of Efficacy|0
5661752|NCT00490919|19546602|P1|Open-label Run-in Period|Lack of Efficacy|143
5661753|NCT00490919|19546600|P3|Open-label Run-in Period|Lost to Follow-up|0
5661754|NCT00490919|19546601|P2|Open-label Run-in Period|Lost to Follow-up|0
5661755|NCT00490919|19546602|P1|Open-label Run-in Period|Lost to Follow-up|21
5661756|NCT00490919|19546600|P3|Open-label Run-in Period|Withdrawal by Subject|0
5661757|NCT00490919|19546601|P2|Open-label Run-in Period|Withdrawal by Subject|0
5661758|NCT00490919|19546602|P1|Open-label Run-in Period|Withdrawal by Subject|37
5661759|NCT00490919|19546600|P3|Open-label Run-in Period|Adverse Event|0
5661760|NCT00490919|19546601|P2|Open-label Run-in Period|Adverse Event|0
5661761|NCT00490919|19546602|P1|Open-label Run-in Period|Adverse Event|239
5661762|NCT00490841|19546613|P1|Overall Study|30 day f/u, only non-study stent used|3
5661763|NCT00490841|19546613|P1|Overall Study|Lost to Follow-up|1
5661764|NCT00490841|19546613|P1|Overall Study|Withdrawal by Subject|4
5661765|NCT00490841|19546613|P1|Overall Study|Death|5
5661766|NCT00490815|19546635|P2|Overall Study|Death|3
5661767|NCT00490815|19546636|P1|Overall Study|Death|1
5661768|NCT00490815|19546635|P2|Overall Study|Lost to Follow-up|3
5661769|NCT00490815|19546636|P1|Overall Study|Lost to Follow-up|1
5661770|NCT00490815|19546635|P2|Overall Study|Withdrawal by Subject|0
5661771|NCT00490815|19546636|P1|Overall Study|Withdrawal by Subject|4
5661772|NCT00490815|19546635|P2|Overall Study|Adverse Event|3
5661773|NCT00490815|19546636|P1|Overall Study|Adverse Event|2
5661774|NCT00490724|19546664|P3|Period II|Treatment Discontinuation|3
5661775|NCT00490724|19546665|P2|Period II|Treatment Discontinuation|1
5661776|NCT00490724|19546666|P1|Period II|Treatment Discontinuation|3
5661777|NCT00490724|19546664|P3|Period I|Physician Decision|1
5661778|NCT00490724|19546665|P2|Period I|Physician Decision|0
5661779|NCT00490724|19546666|P1|Period I|Physician Decision|0
5661780|NCT00490698|19546731|P1|Overall Study|Physician Decision|2
5661781|NCT00490698|19546731|P1|Overall Study|Disease Progression|7
5661782|NCT00490698|19546731|P1|Overall Study|Withdrawal by Subject|1
5661783|NCT00490646|19546737|P2|Overall Study|Never Treated (withdrew consent)|1
5661784|NCT00490646|19546738|P1|Overall Study|Never Treated (withdrew consent)|0
5661785|NCT00490646|19546737|P2|Overall Study|Never Treated (had an adverse event)|0
5661786|NCT00490646|19546738|P1|Overall Study|Never Treated (had an adverse event)|1
5661787|NCT00490646|19546737|P2|Overall Study|Still on trastuzumab monotherapy|1
5661788|NCT00490646|19546738|P1|Overall Study|Still on trastuzumab monotherapy|1
5661789|NCT00490568|19546758|P1|Overall Study|Participant withdrawal due to surgery|1
5661790|NCT00490568|19546758|P1|Overall Study|Participant died|1
5661791|NCT00490568|19546758|P1|Overall Study|Efficacy related|3
5661792|NCT00490568|19546758|P1|Overall Study|Non-Compliance|7
5661793|NCT00490568|19546758|P1|Overall Study|Investigator decision|3
5661794|NCT00490568|19546758|P1|Overall Study|Unmet inclusion-exclusion criteria|5
5661795|NCT00490568|19546758|P1|Overall Study|Disease progression|4
5661796|NCT00490568|19546758|P1|Overall Study|Legal representative withdrew consent|1
5661797|NCT00490568|19546758|P1|Overall Study|Participant refused follow-up|9
5661798|NCT00490568|19546758|P1|Overall Study|Abnormal ECG|25
5661799|NCT00490568|19546758|P1|Overall Study|Caregiver related|20
5661800|NCT00490568|19546758|P1|Overall Study|Exclusion criteria met|1
5661801|NCT00490568|19546758|P1|Overall Study|Other|1
5661802|NCT00490568|19546758|P1|Overall Study|Still in the study at termination|974
5661803|NCT00490568|19546758|P1|Overall Study|Withdrawal by Subject|135
5661804|NCT00490568|19546758|P1|Overall Study|Protocol Violation|45
5661805|NCT00490568|19546758|P1|Overall Study|Lost to Follow-up|13
5661806|NCT00490568|19546758|P1|Overall Study|Adverse Event|116
5661807|NCT00490555|19546782|P4|Overall Study|noncompliant with drug administration|0
5661808|NCT00490555|19546783|P3|Overall Study|noncompliant with drug administration|2
5661809|NCT00490555|19546784|P2|Overall Study|noncompliant with drug administration|0
5661810|NCT00490555|19546785|P1|Overall Study|noncompliant with drug administration|0
5661811|NCT00490542|19546813|P2|Overall Study|Lack of Efficacy|1
5661812|NCT00490542|19546814|P1|Overall Study|Lack of Efficacy|1
5661813|NCT00490542|19546813|P2|Overall Study|Adverse Event|3
5661814|NCT00490542|19546814|P1|Overall Study|Adverse Event|3
5661815|NCT00490542|19546813|P2|Overall Study|Lost to Follow-up|0
5661816|NCT00490542|19546814|P1|Overall Study|Lost to Follow-up|3
5661817|NCT00490529|19546820|P1|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
5661818|NCT00490529|19546820|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
5661819|NCT00490529|19546820|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
5661820|NCT00490529|19546820|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
5661821|NCT00490529|19546820|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
5661822|NCT00490529|19546820|P1|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
5661823|NCT00490490|19546828|P1|Completed Assessment for TTP|Lost to Follow-up|2
5661824|NCT00490490|19546828|P1|Completed Assessment for TTP|Withdrawal by Subject|1
5661825|NCT00490451|19546845|P2|Overall Study|Progressive Disease|34
5661826|NCT00490451|19546846|P1|Overall Study|Progressive Disease|53
5661827|NCT00490451|19546845|P2|Overall Study|Protocol Violation|0
5661828|NCT00490451|19546846|P1|Overall Study|Protocol Violation|1
5661829|NCT00490451|19546845|P2|Overall Study|Investigator Decision|0
5661830|NCT00490451|19546846|P1|Overall Study|Investigator Decision|1
5661831|NCT00490451|19546845|P2|Overall Study|Withdrawal by Subject|0
5661832|NCT00490451|19546846|P1|Overall Study|Withdrawal by Subject|2
5661833|NCT00490451|19546845|P2|Overall Study|Death|1
5661834|NCT00490451|19546846|P1|Overall Study|Death|3
5661835|NCT00490451|19546845|P2|Overall Study|Adverse Event|3
5661836|NCT00490451|19546846|P1|Overall Study|Adverse Event|3
5661837|NCT00490282|19546866|P1|Overall Study|Withdrawal by Subject|3
5661838|NCT00490139|19546894|P4|Overall Study|Participant Withdrew Consent|116
5661839|NCT00490139|19546895|P3|Overall Study|Participant Withdrew Consent|208
5661840|NCT00490139|19546896|P2|Overall Study|Participant Withdrew Consent|110
5661841|NCT00490139|19546897|P1|Overall Study|Participant Withdrew Consent|146
5661842|NCT00490139|19546894|P4|Overall Study|Lost to Follow-up|56
5661843|NCT00490139|19546895|P3|Overall Study|Lost to Follow-up|58
5661844|NCT00490139|19546896|P2|Overall Study|Lost to Follow-up|46
5661845|NCT00490139|19546897|P1|Overall Study|Lost to Follow-up|56
5661846|NCT00490139|19546894|P4|Overall Study|Death|135
5661847|NCT00490139|19546895|P3|Overall Study|Death|168
5661848|NCT00490139|19546896|P2|Overall Study|Death|119
5661849|NCT00490139|19546897|P1|Overall Study|Death|106
5661850|NCT00490061|19546932|P1|Overall Study|Physician Decision|1
5661851|NCT00490035|19546941|P4|Overall Study|AE of unknown type|0
5661852|NCT00490035|19546942|P3|Overall Study|AE of unknown type|2
5661853|NCT00490035|19546943|P2|Overall Study|AE of unknown type|0
5661854|NCT00490035|19546944|P1|Overall Study|AE of unknown type|0
5661855|NCT00490035|19546941|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
5661856|NCT00490035|19546942|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
5661857|NCT00490035|19546943|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
5661858|NCT00490035|19546944|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
5661859|NCT00490035|19546941|P4|Overall Study|AE, serious fatal|0
5661860|NCT00490035|19546942|P3|Overall Study|AE, serious fatal|0
5661861|NCT00490035|19546943|P2|Overall Study|AE, serious fatal|0
5661862|NCT00490035|19546944|P1|Overall Study|AE, serious fatal|1
5661863|NCT00490035|19546941|P4|Overall Study|Other reason|1
5661864|NCT00490035|19546942|P3|Overall Study|Other reason|3
5661865|NCT00490035|19546943|P2|Overall Study|Other reason|1
5661866|NCT00490035|19546944|P1|Overall Study|Other reason|0
5661867|NCT00490035|19546941|P4|Overall Study|Withdrawal by Subject|0
5661868|NCT00490035|19546942|P3|Overall Study|Withdrawal by Subject|1
5661869|NCT00490035|19546943|P2|Overall Study|Withdrawal by Subject|1
5661870|NCT00490035|19546944|P1|Overall Study|Withdrawal by Subject|2
5661871|NCT00490035|19546941|P4|Overall Study|Lost to Follow-up|0
5661872|NCT00490035|19546942|P3|Overall Study|Lost to Follow-up|1
5661873|NCT00490035|19546943|P2|Overall Study|Lost to Follow-up|0
5661874|NCT00490035|19546944|P1|Overall Study|Lost to Follow-up|2
5661875|NCT00490035|19546941|P4|Overall Study|AE, non-serious non-fatal|5
5661876|NCT00490035|19546942|P3|Overall Study|AE, non-serious non-fatal|4
5661877|NCT00490035|19546943|P2|Overall Study|AE, non-serious non-fatal|4
5661878|NCT00490035|19546944|P1|Overall Study|AE, non-serious non-fatal|3
5661879|NCT00490022|19547044|P2|Overall Study|Subject failed to disclose concommitant|1
5661880|NCT00490022|19547045|P1|Overall Study|Subject failed to disclose concommitant|0
5661881|NCT00490022|19547044|P2|Overall Study|Withdrawal by Subject|0
5661882|NCT00490022|19547045|P1|Overall Study|Withdrawal by Subject|1
5661883|NCT00490022|19547044|P2|Overall Study|Adverse Event|2
5661884|NCT00490022|19547045|P1|Overall Study|Adverse Event|0
5661885|NCT00489970|19547062|P3|Persistence Year 9|Other|2
5661886|NCT00489970|19547063|P2|Persistence Year 9|Other|0
5661887|NCT00489970|19547064|P1|Persistence Year 9|Other|1
5661888|NCT00489970|19547062|P3|Persistence Year 9|Lost to Follow-up|3
5661889|NCT00489970|19547063|P2|Persistence Year 9|Lost to Follow-up|2
5661890|NCT00489970|19547064|P1|Persistence Year 9|Lost to Follow-up|2
5661891|NCT00489918|19547168|P5|Overall Study|Physician Decision|0
5661892|NCT00489918|19547169|P4|Overall Study|Physician Decision|0
5661893|NCT00489918|19547170|P3|Overall Study|Physician Decision|1
5661894|NCT00489918|19547171|P2|Overall Study|Physician Decision|0
5661895|NCT00489918|19547172|P1|Overall Study|Physician Decision|0
5661896|NCT00489918|19547168|P5|Overall Study|Lost to Follow-up|0
5661897|NCT00489918|19547169|P4|Overall Study|Lost to Follow-up|1
5661898|NCT00489918|19547170|P3|Overall Study|Lost to Follow-up|1
5661899|NCT00489918|19547171|P2|Overall Study|Lost to Follow-up|0
5661900|NCT00489918|19547172|P1|Overall Study|Lost to Follow-up|0
5661901|NCT00489918|19547168|P5|Overall Study|Adverse Event|0
5661902|NCT00489918|19547169|P4|Overall Study|Adverse Event|0
5661903|NCT00489918|19547170|P3|Overall Study|Adverse Event|1
5661904|NCT00489918|19547171|P2|Overall Study|Adverse Event|1
5661905|NCT00489918|19547172|P1|Overall Study|Adverse Event|0
5661906|NCT00489918|19547168|P5|Overall Study|Withdrawal by Subject|1
5661907|NCT00489918|19547169|P4|Overall Study|Withdrawal by Subject|0
5661908|NCT00489918|19547170|P3|Overall Study|Withdrawal by Subject|1
5661909|NCT00489918|19547171|P2|Overall Study|Withdrawal by Subject|1
5661910|NCT00489918|19547172|P1|Overall Study|Withdrawal by Subject|2
5661911|NCT00489853|19547221|P3|Treatment Period 3|Study specific discontinuation criteria|0
5661912|NCT00489853|19547222|P2|Treatment Period 3|Study specific discontinuation criteria|1
5661913|NCT00489853|19547223|P1|Treatment Period 3|Study specific discontinuation criteria|0
5661914|NCT00489853|19547221|P3|Wash-out Period 2|Study specific discontinuation criteria|2
5661915|NCT00489853|19547222|P2|Wash-out Period 2|Study specific discontinuation criteria|2
5661916|NCT00489853|19547223|P1|Wash-out Period 2|Study specific discontinuation criteria|3
5661917|NCT00489853|19547221|P3|Wash-out Period 2|Adverse Event|0
5661918|NCT00489853|19547222|P2|Wash-out Period 2|Adverse Event|1
5661919|NCT00489853|19547223|P1|Wash-out Period 2|Adverse Event|1
5661920|NCT00489853|19547221|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
5661921|NCT00489853|19547222|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
5661922|NCT00489853|19547223|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
5661923|NCT00489853|19547221|P3|Wash-out Period 1|Protocol Violation|1
5661924|NCT00489853|19547222|P2|Wash-out Period 1|Protocol Violation|1
5661925|NCT00489853|19547223|P1|Wash-out Period 1|Protocol Violation|0
5661926|NCT00489853|19547221|P3|Wash-out Period 1|Adverse Event|1
5661927|NCT00489853|19547222|P2|Wash-out Period 1|Adverse Event|1
5661928|NCT00489853|19547223|P1|Wash-out Period 1|Adverse Event|0
5661929|NCT00489853|19547221|P3|Wash-out Period 1|Withdrawal by Subject|0
5661930|NCT00489853|19547222|P2|Wash-out Period 1|Withdrawal by Subject|0
5661931|NCT00489853|19547223|P1|Wash-out Period 1|Withdrawal by Subject|1
5661932|NCT00489827|19547320|P2|Overall Study|Intraoperative exclusion criteria|1
5661933|NCT00489827|19547321|P1|Overall Study|Intraoperative exclusion criteria|1
5661934|NCT00489827|19547320|P2|Overall Study|Intraoperative exclusion criteria|1
5661935|NCT00489827|19547321|P1|Overall Study|Intraoperative exclusion criteria|1
5661936|NCT00489736|19547345|P2|Overall Study|Not coded/ Not pre-specified|8
5661937|NCT00489736|19547346|P1|Overall Study|Not coded/ Not pre-specified|5
5661938|NCT00489736|19547345|P2|Overall Study|Poor compliance|2
5661939|NCT00489736|19547346|P1|Overall Study|Poor compliance|6
5661940|NCT00489736|19547345|P2|Overall Study|Adverse Event|45
5661941|NCT00489736|19547346|P1|Overall Study|Adverse Event|32
5661942|NCT00489736|19547345|P2|Overall Study|Lack of Efficacy|14
5661943|NCT00489736|19547346|P1|Overall Study|Lack of Efficacy|53
5661944|NCT00489554|19547356|P1|Overall Study|Lost to Follow-up|1
5661945|NCT00489554|19547356|P1|Overall Study|Withdrawal by Subject|1
5661946|NCT00489554|19547356|P1|Overall Study|Adverse Event|2
5661947|NCT00489541|19547376|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
5661948|NCT00489541|19547377|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
5661949|NCT00489541|19547376|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
5661950|NCT00489541|19547377|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
5661951|NCT00489541|19547376|P2|12-Month Clinical Follow-up|Death|2
5661952|NCT00489541|19547377|P1|12-Month Clinical Follow-up|Death|3
5661953|NCT00489541|19547376|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
5661954|NCT00489541|19547377|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
5661955|NCT00489541|19547376|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
5661956|NCT00489541|19547377|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
5661957|NCT00489541|19547376|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
5661958|NCT00489541|19547377|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
5661959|NCT00489489|19547388|P3|Overall Study|Other than above|0
5661960|NCT00489489|19547389|P2|Overall Study|Other than above|1
5661961|NCT00489489|19547390|P1|Overall Study|Other than above|0
5661962|NCT00489489|19547388|P3|Overall Study|Participant did not wish to continue|0
5661963|NCT00489489|19547389|P2|Overall Study|Participant did not wish to continue|1
5661964|NCT00489489|19547390|P1|Overall Study|Participant did not wish to continue|1
5661965|NCT00489489|19547388|P3|Overall Study|Progressive disease|0
5661966|NCT00489489|19547389|P2|Overall Study|Progressive disease|1
5661967|NCT00489489|19547390|P1|Overall Study|Progressive disease|0
5661968|NCT00489489|19547388|P3|Overall Study|Protocol Violation|1
5661969|NCT00489489|19547389|P2|Overall Study|Protocol Violation|0
5661970|NCT00489489|19547390|P1|Overall Study|Protocol Violation|1
5661971|NCT00489489|19547388|P3|Overall Study|Adverse Event|1
5661972|NCT00489489|19547389|P2|Overall Study|Adverse Event|1
5661973|NCT00489489|19547390|P1|Overall Study|Adverse Event|1
5661974|NCT00489489|19547388|P3|Overall Study|Not treated due to protocol violation|1
5661975|NCT00489489|19547389|P2|Overall Study|Not treated due to protocol violation|1
5661976|NCT00489489|19547390|P1|Overall Study|Not treated due to protocol violation|0
5661977|NCT00489476|19547422|P4|Overall Study|Lost to Follow-up|0
5661978|NCT00489476|19547423|P3|Overall Study|Lost to Follow-up|0
5661979|NCT00489476|19547424|P2|Overall Study|Lost to Follow-up|1
5661980|NCT00489476|19547425|P1|Overall Study|Lost to Follow-up|0
5661981|NCT00489424|19547446|P3|Overall Study|Administrative problems|1
5661982|NCT00489424|19547447|P2|Overall Study|Administrative problems|2
5661983|NCT00489424|19547448|P1|Overall Study|Administrative problems|0
5661984|NCT00489424|19547446|P3|Overall Study|Lack of Efficacy|0
5661985|NCT00489424|19547447|P2|Overall Study|Lack of Efficacy|0
5661986|NCT00489424|19547448|P1|Overall Study|Lack of Efficacy|1
5661987|NCT00489424|19547446|P3|Overall Study|Adverse Event|4
5661988|NCT00489424|19547447|P2|Overall Study|Adverse Event|3
5661989|NCT00489424|19547448|P1|Overall Study|Adverse Event|3
5661990|NCT00489411|19547479|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
5661991|NCT00489411|19547480|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
5661992|NCT00489411|19547479|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
5661993|NCT00489411|19547480|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
5661994|NCT00489411|19547479|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
5661995|NCT00489411|19547480|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
5661996|NCT00489411|19547479|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
5661997|NCT00489411|19547480|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
5661998|NCT00489411|19547479|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
5661999|NCT00489411|19547480|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
5662000|NCT00489359|19547494|P2|Overall Study|Adverse Event|16
5662001|NCT00489359|19547495|P1|Overall Study|Adverse Event|0
5662002|NCT00489359|19547494|P2|Overall Study|Withdrawal by Subject|5
5662003|NCT00489359|19547495|P1|Overall Study|Withdrawal by Subject|1
5662004|NCT00489359|19547494|P2|Overall Study|Lost to Follow-up|0
5662005|NCT00489359|19547495|P1|Overall Study|Lost to Follow-up|1
5662006|NCT00489359|19547494|P2|Overall Study|Progressive Disease|6
5662007|NCT00489359|19547495|P1|Overall Study|Progressive Disease|5
5662008|NCT00489359|19547494|P2|Overall Study|Death|2
5662009|NCT00489359|19547495|P1|Overall Study|Death|0
5662010|NCT00489255|19547571|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
5662011|NCT00489255|19547572|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
5662012|NCT00489255|19547571|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
5662013|NCT00489255|19547572|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
5662014|NCT00489255|19547571|P2|Period 3: Days 57 to 84|Adverse Event|3
5662015|NCT00489255|19547572|P1|Period 3: Days 57 to 84|Adverse Event|3
5662016|NCT00489255|19547571|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
5662017|NCT00489255|19547572|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
5662018|NCT00489255|19547571|P2|Period 2: Days 29 to 56|Adverse Event|1
5662019|NCT00489255|19547572|P1|Period 2: Days 29 to 56|Adverse Event|3
5662020|NCT00489255|19547571|P2|Period 1: Days 1 to 28|Noncompliance|0
5662021|NCT00489255|19547572|P1|Period 1: Days 1 to 28|Noncompliance|2
5662022|NCT00489255|19547571|P2|Period 1: Days 1 to 28|Physician Decision|4
5662023|NCT00489255|19547572|P1|Period 1: Days 1 to 28|Physician Decision|1
5662024|NCT00489255|19547571|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
5662025|NCT00489255|19547572|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
5662026|NCT00489255|19547571|P2|Period 1: Days 1 to 28|Adverse Event|8
5662027|NCT00489255|19547572|P1|Period 1: Days 1 to 28|Adverse Event|21
5662028|NCT00489255|19547571|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
5662029|NCT00489255|19547572|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
5662030|NCT00489216|19547620|P1|Overall Study|Adverse Event|1
5662031|NCT00488982|19547637|P3|Course 1|Adverse Event|6
5662032|NCT00488982|19547638|P2|Course 1|Adverse Event|0
5662033|NCT00488982|19547639|P1|Course 1|Adverse Event|0
5662034|NCT00488982|19547637|P3|Course 1|nonprotocol therapy|2
5662035|NCT00488982|19547638|P2|Course 1|nonprotocol therapy|2
5662036|NCT00488982|19547639|P1|Course 1|nonprotocol therapy|0
5662037|NCT00488982|19547637|P3|Course 1|Withdrawal by Subject|2
5662038|NCT00488982|19547638|P2|Course 1|Withdrawal by Subject|8
5662039|NCT00488982|19547639|P1|Course 1|Withdrawal by Subject|0
5662040|NCT00488982|19547637|P3|Course 1|Physician Decision|4
5662041|NCT00488982|19547638|P2|Course 1|Physician Decision|2
5662042|NCT00488982|19547639|P1|Course 1|Physician Decision|0
5662043|NCT00488826|19547662|P3|Overall Study|Protocol Deviations|1
5662044|NCT00488826|19547663|P2|Overall Study|Protocol Deviations|1
5662045|NCT00488826|19547664|P1|Overall Study|Protocol Deviations|2
5662046|NCT00488826|19547662|P3|Overall Study|Lost to Follow-up|0
5662047|NCT00488826|19547663|P2|Overall Study|Lost to Follow-up|1
5662048|NCT00488826|19547664|P1|Overall Study|Lost to Follow-up|5
5662049|NCT00488826|19547662|P3|Overall Study|Adverse Event|4
5662050|NCT00488826|19547663|P2|Overall Study|Adverse Event|15
5662051|NCT00488826|19547664|P1|Overall Study|Adverse Event|9
5662052|NCT00488826|19547662|P3|Overall Study|Protocol Violation|2
5662053|NCT00488826|19547663|P2|Overall Study|Protocol Violation|0
5662054|NCT00488826|19547664|P1|Overall Study|Protocol Violation|0
5662055|NCT00488826|19547662|P3|Overall Study|Withdrawal by Subject|19
5662056|NCT00488826|19547663|P2|Overall Study|Withdrawal by Subject|35
5662057|NCT00488826|19547664|P1|Overall Study|Withdrawal by Subject|40
5662058|NCT00488774|19547679|P4|Overall Study|Lost to Follow-up|1
5662059|NCT00488774|19547680|P3|Overall Study|Lost to Follow-up|1
5662060|NCT00488774|19547681|P2|Overall Study|Lost to Follow-up|0
5662061|NCT00488774|19547682|P1|Overall Study|Lost to Follow-up|0
5662062|NCT00488774|19547679|P4|Overall Study|Other|2
5662063|NCT00488774|19547680|P3|Overall Study|Other|2
5662064|NCT00488774|19547681|P2|Overall Study|Other|3
5662065|NCT00488774|19547682|P1|Overall Study|Other|6
5662066|NCT00488774|19547679|P4|Overall Study|Withdrawal of consent|0
5662067|NCT00488774|19547680|P3|Overall Study|Withdrawal of consent|2
5662068|NCT00488774|19547681|P2|Overall Study|Withdrawal of consent|2
5662069|NCT00488774|19547682|P1|Overall Study|Withdrawal of consent|2
5662070|NCT00488683|19547699|P3|Overall Study|Unable to Classify|0
5662071|NCT00488683|19547700|P2|Overall Study|Unable to Classify|0
5662072|NCT00488683|19547701|P1|Overall Study|Unable to Classify|1
5662073|NCT00488683|19547699|P3|Overall Study|Protocol Violation|0
5662074|NCT00488683|19547700|P2|Overall Study|Protocol Violation|1
5662075|NCT00488683|19547701|P1|Overall Study|Protocol Violation|5
5662076|NCT00488683|19547699|P3|Overall Study|Lost to Follow-up|0
5662077|NCT00488683|19547700|P2|Overall Study|Lost to Follow-up|3
5662078|NCT00488683|19547701|P1|Overall Study|Lost to Follow-up|5
5662079|NCT00488683|19547699|P3|Overall Study|Withdrawal by Subject|2
5662080|NCT00488683|19547700|P2|Overall Study|Withdrawal by Subject|2
5662081|NCT00488683|19547701|P1|Overall Study|Withdrawal by Subject|1
5662082|NCT00488644|19547760|P1|Overall Study|Not Evaluable|1
5662083|NCT00488644|19547760|P1|Overall Study|Not Eligible|1
5662084|NCT00488631|19547770|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5662085|NCT00488631|19547771|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
5662086|NCT00488631|19547772|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
5662087|NCT00488631|19547773|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
5662088|NCT00488631|19547774|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5662089|NCT00488631|19547775|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5662090|NCT00488631|19547776|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5662091|NCT00488631|19547777|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5662092|NCT00488631|19547778|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5662093|NCT00488631|19547779|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
5662094|NCT00488631|19547770|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5662095|NCT00488631|19547771|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
5662096|NCT00488631|19547772|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5662097|NCT00488631|19547773|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
5662098|NCT00488631|19547774|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5662099|NCT00488631|19547775|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5662100|NCT00488631|19547776|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5662101|NCT00488631|19547777|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5662102|NCT00488631|19547778|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5662103|NCT00488631|19547779|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
5662104|NCT00488631|19547770|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
5662105|NCT00488631|19547771|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
5662106|NCT00488631|19547772|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
5662107|NCT00488631|19547773|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
5662108|NCT00488631|19547774|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5662109|NCT00488631|19547775|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5662110|NCT00488631|19547776|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5662111|NCT00488631|19547777|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5662112|NCT00488631|19547778|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5662113|NCT00488631|19547779|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
5662114|NCT00488631|19547770|P10|Open Label Study Extension (Week 54-228)|Death|0
5662115|NCT00488631|19547771|P9|Open Label Study Extension (Week 54-228)|Death|1
5662116|NCT00488631|19547772|P8|Open Label Study Extension (Week 54-228)|Death|0
5662117|NCT00488631|19547773|P7|Open Label Study Extension (Week 54-228)|Death|0
5662118|NCT00488631|19547774|P6|Open Label Study Extension (Week 54-228)|Death|0
5662119|NCT00488631|19547775|P5|Open Label Study Extension (Week 54-228)|Death|0
5662120|NCT00488631|19547776|P4|Open Label Study Extension (Week 54-228)|Death|0
5662121|NCT00488631|19547777|P3|Open Label Study Extension (Week 54-228)|Death|0
5662122|NCT00488631|19547778|P2|Open Label Study Extension (Week 54-228)|Death|0
5662123|NCT00488631|19547779|P1|Open Label Study Extension (Week 54-228)|Death|0
5662124|NCT00488631|19547770|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
5662125|NCT00488631|19547771|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
5662126|NCT00488631|19547772|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
5662127|NCT00488631|19547773|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
5662128|NCT00488631|19547774|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
5662129|NCT00488631|19547775|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
5662130|NCT00488631|19547776|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
5662131|NCT00488631|19547777|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
5662132|NCT00488631|19547778|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
5662133|NCT00488631|19547779|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
5662134|NCT00488631|19547770|P10|Double Blind Period (Week 0-54)|Other|0
5662135|NCT00488631|19547771|P9|Double Blind Period (Week 0-54)|Other|0
5662136|NCT00488631|19547772|P8|Double Blind Period (Week 0-54)|Other|0
5662137|NCT00488631|19547773|P7|Double Blind Period (Week 0-54)|Other|0
5662138|NCT00488631|19547774|P6|Double Blind Period (Week 0-54)|Other|34
5662139|NCT00488631|19547775|P5|Double Blind Period (Week 0-54)|Other|14
5662140|NCT00488631|19547776|P4|Double Blind Period (Week 0-54)|Other|11
5662141|NCT00488631|19547777|P3|Double Blind Period (Week 0-54)|Other|10
5662142|NCT00488631|19547778|P2|Double Blind Period (Week 0-54)|Other|12
5662143|NCT00488631|19547779|P1|Double Blind Period (Week 0-54)|Other|6
5662144|NCT00488631|19547770|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5662145|NCT00488631|19547771|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5662146|NCT00488631|19547772|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5662147|NCT00488631|19547773|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5662148|NCT00488631|19547774|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
5662149|NCT00488631|19547775|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
5662150|NCT00488631|19547776|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
5662151|NCT00488631|19547777|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
5662152|NCT00488631|19547778|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
5662153|NCT00488631|19547779|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
5662154|NCT00488631|19547770|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
5662155|NCT00488631|19547771|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
5662156|NCT00488631|19547772|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
5662157|NCT00488631|19547773|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
5662158|NCT00488631|19547774|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
5662159|NCT00488631|19547775|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
5662160|NCT00488631|19547776|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
5662161|NCT00488631|19547777|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
5662162|NCT00488631|19547778|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
5662163|NCT00488631|19547779|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
5662164|NCT00488631|19547770|P10|Double Blind Period (Week 0-54)|Death|0
5662165|NCT00488631|19547771|P9|Double Blind Period (Week 0-54)|Death|0
5662166|NCT00488631|19547772|P8|Double Blind Period (Week 0-54)|Death|0
5662167|NCT00488631|19547773|P7|Double Blind Period (Week 0-54)|Death|0
5662168|NCT00488631|19547774|P6|Double Blind Period (Week 0-54)|Death|1
5662169|NCT00488631|19547775|P5|Double Blind Period (Week 0-54)|Death|0
5662170|NCT00488631|19547776|P4|Double Blind Period (Week 0-54)|Death|0
5662171|NCT00488631|19547777|P3|Double Blind Period (Week 0-54)|Death|0
5662172|NCT00488631|19547778|P2|Double Blind Period (Week 0-54)|Death|0
5662173|NCT00488631|19547779|P1|Double Blind Period (Week 0-54)|Death|0
5662174|NCT00488631|19547770|P10|Double Blind Period (Week 0-54)|Adverse Event|0
5662175|NCT00488631|19547771|P9|Double Blind Period (Week 0-54)|Adverse Event|0
5662176|NCT00488631|19547772|P8|Double Blind Period (Week 0-54)|Adverse Event|0
5662177|NCT00488631|19547773|P7|Double Blind Period (Week 0-54)|Adverse Event|0
5662178|NCT00488631|19547774|P6|Double Blind Period (Week 0-54)|Adverse Event|50
5662179|NCT00488631|19547775|P5|Double Blind Period (Week 0-54)|Adverse Event|30
5662180|NCT00488631|19547776|P4|Double Blind Period (Week 0-54)|Adverse Event|12
5662181|NCT00488631|19547777|P3|Double Blind Period (Week 0-54)|Adverse Event|12
5662182|NCT00488631|19547778|P2|Double Blind Period (Week 0-54)|Adverse Event|12
5662183|NCT00488631|19547779|P1|Double Blind Period (Week 0-54)|Adverse Event|17
5662184|NCT00488618|19547816|P2|Overall Study|Lost to Follow-up|0
5662185|NCT00488618|19547817|P1|Overall Study|Lost to Follow-up|1
5662186|NCT00488618|19547816|P2|Overall Study|Withdrawal of Consent|13
5662187|NCT00488618|19547817|P1|Overall Study|Withdrawal of Consent|15
5662188|NCT00488618|19547816|P2|Overall Study|Protocol Violation|2
5662189|NCT00488618|19547817|P1|Overall Study|Protocol Violation|0
5662190|NCT00488618|19547816|P2|Overall Study|Insufficient Therapeutic Response|11
5662191|NCT00488618|19547817|P1|Overall Study|Insufficient Therapeutic Response|18
5662192|NCT00488618|19547816|P2|Overall Study|Adverse Event|17
5662193|NCT00488618|19547817|P1|Overall Study|Adverse Event|13
5662194|NCT00488592|19547825|P1|Overall Study|Enrolled but not treated|1
5662195|NCT00488592|19547825|P1|Overall Study|Disease progression|1
5662196|NCT00488592|19547825|P1|Overall Study|Withdrawal by Subject|1
5662197|NCT00488514|19547829|P1|Overall Study|Increased use of concomitant medication|1
5662198|NCT00488514|19547829|P1|Overall Study|Increase in number of migraines|2
5662199|NCT00488514|19547829|P1|Overall Study|Participant had too few migraines|5
5662200|NCT00488514|19547829|P1|Overall Study|Investigator decision|1
5662201|NCT00488514|19547829|P1|Overall Study|Withdrawn per medical monitor decision|2
5662202|NCT00488514|19547829|P1|Overall Study|Postive drug screen|1
5662203|NCT00488514|19547829|P1|Overall Study|Did not meet criteria for treatment|30
5662204|NCT00488514|19547829|P1|Overall Study|Lack of Efficacy|28
5662205|NCT00488514|19547829|P1|Overall Study|Withdrawal by Subject|106
5662206|NCT00488514|19547829|P1|Overall Study|Protocol Violation|32
5662207|NCT00488514|19547829|P1|Overall Study|Lost to Follow-up|44
5662208|NCT00488514|19547829|P1|Overall Study|Adverse Event|41
5662209|NCT00488475|19547917|P1|Overall Study|Other|1754
5662210|NCT00488345|19547946|P3|Overall Study|Parent/legal guardian request|1
5662211|NCT00488345|19547947|P2|Overall Study|Parent/legal guardian request|1
5662212|NCT00488345|19547948|P1|Overall Study|Parent/legal guardian request|0
5662213|NCT00488345|19547946|P3|Overall Study|Surgical team recommendation|0
5662214|NCT00488345|19547947|P2|Overall Study|Surgical team recommendation|1
5662215|NCT00488345|19547948|P1|Overall Study|Surgical team recommendation|0
5662216|NCT00488345|19547946|P3|Overall Study|Institutional Review Board review|1
5662217|NCT00488345|19547947|P2|Overall Study|Institutional Review Board review|0
5662218|NCT00488345|19547948|P1|Overall Study|Institutional Review Board review|0
5662219|NCT00488345|19547946|P3|Overall Study|Unable to administer antibiotics at home|0
5662220|NCT00488345|19547947|P2|Overall Study|Unable to administer antibiotics at home|1
5662221|NCT00488345|19547948|P1|Overall Study|Unable to administer antibiotics at home|0
5662222|NCT00488345|19547946|P3|Overall Study|Adverse Event|1
5662223|NCT00488345|19547947|P2|Overall Study|Adverse Event|1
5662224|NCT00488345|19547948|P1|Overall Study|Adverse Event|0
5662225|NCT00488319|19547974|P3|Overall Study|Other reasons for withdrawal|12
5662226|NCT00488319|19547975|P2|Overall Study|Other reasons for withdrawal|4
5662227|NCT00488319|19547976|P1|Overall Study|Other reasons for withdrawal|0
5662228|NCT00488319|19547974|P3|Overall Study|Withdrawal by Subject|44
5662229|NCT00488319|19547975|P2|Overall Study|Withdrawal by Subject|20
5662230|NCT00488319|19547976|P1|Overall Study|Withdrawal by Subject|5
5662231|NCT00488319|19547974|P3|Overall Study|Lost to Follow-up|16
5662232|NCT00488319|19547975|P2|Overall Study|Lost to Follow-up|5
5662233|NCT00488319|19547976|P1|Overall Study|Lost to Follow-up|3
5662234|NCT00488319|19547974|P3|Overall Study|Lack of Efficacy|27
5662235|NCT00488319|19547975|P2|Overall Study|Lack of Efficacy|12
5662236|NCT00488319|19547976|P1|Overall Study|Lack of Efficacy|6
5662237|NCT00488319|19547974|P3|Overall Study|Adverse Event|23
5662238|NCT00488319|19547975|P2|Overall Study|Adverse Event|2
5662239|NCT00488319|19547976|P1|Overall Study|Adverse Event|1
5662240|NCT00488293|19548063|P2|Overall Study|Misrandomization/Other Unspecified|1
5662241|NCT00488293|19548064|P1|Overall Study|Misrandomization/Other Unspecified|1
5662242|NCT00488293|19548063|P2|Overall Study|Death|1
5662243|NCT00488293|19548064|P1|Overall Study|Death|2
5662244|NCT00488293|19548063|P2|Overall Study|Withdrawal by Subject|3
5662245|NCT00488293|19548064|P1|Overall Study|Withdrawal by Subject|5
5662246|NCT00488293|19548063|P2|Overall Study|Lost to Follow-up|25
5662247|NCT00488293|19548064|P1|Overall Study|Lost to Follow-up|28
5662248|NCT00488033|19548109|P2|Overall Study|Withdrawal by Subject|0
5662249|NCT00488033|19548110|P1|Overall Study|Withdrawal by Subject|1
5662250|NCT00487981|19548126|P1|Overall Study|Hypothyroidism diagnosis|1
5662251|NCT00487942|19548134|P4|Overall Study|Withdrawal by Subject|0
5662252|NCT00487942|19548135|P3|Overall Study|Withdrawal by Subject|2
5662253|NCT00487942|19548136|P2|Overall Study|Withdrawal by Subject|1
5662254|NCT00487942|19548137|P1|Overall Study|Withdrawal by Subject|0
5662255|NCT00487942|19548134|P4|Overall Study|Protocol Violation|0
5662256|NCT00487942|19548135|P3|Overall Study|Protocol Violation|0
5662257|NCT00487942|19548136|P2|Overall Study|Protocol Violation|1
5662258|NCT00487942|19548137|P1|Overall Study|Protocol Violation|1
5662259|NCT00487942|19548134|P4|Overall Study|Lost to Follow-up|1
5662260|NCT00487942|19548135|P3|Overall Study|Lost to Follow-up|0
5662261|NCT00487942|19548136|P2|Overall Study|Lost to Follow-up|0
5662262|NCT00487942|19548137|P1|Overall Study|Lost to Follow-up|1
5662263|NCT00487942|19548134|P4|Overall Study|Adverse Event|1
5662264|NCT00487942|19548135|P3|Overall Study|Adverse Event|1
5662265|NCT00487942|19548136|P2|Overall Study|Adverse Event|1
5662266|NCT00487942|19548137|P1|Overall Study|Adverse Event|1
5662267|NCT00487825|19548521|P2|Overall Study|Other|2
5662268|NCT00487825|19548522|P1|Overall Study|Other|3
5662269|NCT00487825|19548521|P2|Overall Study|Lack of Efficacy|1
5662270|NCT00487825|19548522|P1|Overall Study|Lack of Efficacy|1
5662271|NCT00487825|19548521|P2|Overall Study|Adverse Event|2
5662272|NCT00487825|19548522|P1|Overall Study|Adverse Event|2
5662273|NCT00487747|19548534|P1|Overall Study|Lack of Efficacy|1
5662274|NCT00487747|19548534|P1|Overall Study|Lost to Follow-up|9
5662275|NCT00487747|19548534|P1|Overall Study|Adverse Event|1
5662276|NCT00487695|19548551|P2|Second Procedure|Withdrawal by Subject|2
5662277|NCT00487695|19548552|P1|Second Procedure|Withdrawal by Subject|1
5662278|NCT00487695|19548551|P2|Second Procedure|active wheezing|1
5662279|NCT00487695|19548552|P1|Second Procedure|active wheezing|0
5662280|NCT00487695|19548551|P2|First Procedure|esophageal stricture found (excl crit)|0
5662281|NCT00487695|19548552|P1|First Procedure|esophageal stricture found (excl crit)|1
5662282|NCT00487695|19548551|P2|First Procedure|active wheezing (did not have procedure)|0
5662283|NCT00487695|19548552|P1|First Procedure|active wheezing (did not have procedure)|1
5662284|NCT00487695|19548551|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
5662285|NCT00487695|19548552|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
5662286|NCT00487578|19548580|P2|Overall Study|Lost to Follow-up|1
5662287|NCT00487578|19548581|P1|Overall Study|Lost to Follow-up|0
5662288|NCT00487578|19548580|P2|Overall Study|Lack of Efficacy|1
5662289|NCT00487578|19548581|P1|Overall Study|Lack of Efficacy|0
5662290|NCT00487578|19548580|P2|Overall Study|Adverse Event|2
5662291|NCT00487578|19548581|P1|Overall Study|Adverse Event|1
5662292|NCT00487552|19548601|P1|Overall Study|Stent not placed|1
5662293|NCT00487552|19548601|P1|Overall Study|Death due to progressive malignancy|2
5662294|NCT00487552|19548601|P1|Overall Study|Unsuccessful magnet placements|3
5662295|NCT00487539|19548610|P4|Overall Study|Other|2
5662296|NCT00487539|19548611|P3|Overall Study|Other|2
5662297|NCT00487539|19548612|P2|Overall Study|Other|1
5662298|NCT00487539|19548613|P1|Overall Study|Other|3
5662299|NCT00487539|19548610|P4|Overall Study|Unsatisfactory therapeutic effect|1
5662300|NCT00487539|19548611|P3|Overall Study|Unsatisfactory therapeutic effect|0
5662301|NCT00487539|19548612|P2|Overall Study|Unsatisfactory therapeutic effect|0
5662302|NCT00487539|19548613|P1|Overall Study|Unsatisfactory therapeutic effect|1
5662303|NCT00487539|19548610|P4|Overall Study|Adverse Event|1
5662304|NCT00487539|19548611|P3|Overall Study|Adverse Event|1
5662305|NCT00487539|19548612|P2|Overall Study|Adverse Event|2
5662306|NCT00487539|19548613|P1|Overall Study|Adverse Event|3
5662307|NCT00487435|19548647|P1|Overall Study|Other|83
5662308|NCT00487435|19548647|P1|Overall Study|Study Medication Non-Compliant|32
5662309|NCT00487435|19548647|P1|Overall Study|Resolution Of Pain|1
5662310|NCT00487435|19548647|P1|Overall Study|Withdrawal by Subject|132
5662311|NCT00487435|19548647|P1|Overall Study|Pregnancy|2
5662312|NCT00487435|19548647|P1|Overall Study|Lost to Follow-up|54
5662313|NCT00487435|19548647|P1|Overall Study|Lack of Efficacy|33
5662314|NCT00487435|19548647|P1|Overall Study|Death|2
5662315|NCT00487435|19548647|P1|Overall Study|Adverse Event|146
5662316|NCT00487279|19548663|P2|Overall Study|Withdrawal by Subject|2
5662317|NCT00487279|19548664|P1|Overall Study|Withdrawal by Subject|0
5662318|NCT00487279|19548663|P2|Overall Study|Death|0
5662319|NCT00487279|19548664|P1|Overall Study|Death|1
5662320|NCT00487240|19548674|P2|Overall Study|Physician Decision|0
5662321|NCT00487240|19548675|P1|Overall Study|Physician Decision|2
5662322|NCT00487240|19548674|P2|Overall Study|Sponsor Decision|1
5662323|NCT00487240|19548675|P1|Overall Study|Sponsor Decision|2
5662324|NCT00487240|19548674|P2|Overall Study|Entry Criteria Not Met|4
5662325|NCT00487240|19548675|P1|Overall Study|Entry Criteria Not Met|3
5662326|NCT00487240|19548674|P2|Overall Study|Protocol Violation|5
5662327|NCT00487240|19548675|P1|Overall Study|Protocol Violation|5
5662328|NCT00487240|19548674|P2|Overall Study|Adverse Event|4
5662329|NCT00487240|19548675|P1|Overall Study|Adverse Event|0
5662330|NCT00487240|19548674|P2|Overall Study|Lost to Follow-up|6
5662331|NCT00487240|19548675|P1|Overall Study|Lost to Follow-up|7
5662332|NCT00487240|19548674|P2|Overall Study|Withdrawal by Subject|6
5662333|NCT00487240|19548675|P1|Overall Study|Withdrawal by Subject|12
5662334|NCT00487188|19548703|P3|Maintenance Phase|Administrative|1
5662335|NCT00487188|19548704|P2|Maintenance Phase|Administrative|0
5662336|NCT00487188|19548705|P1|Maintenance Phase|Administrative|0
5662337|NCT00487188|19548703|P3|Maintenance Phase|Lost to Follow-up|0
5662338|NCT00487188|19548704|P2|Maintenance Phase|Lost to Follow-up|0
5662339|NCT00487188|19548705|P1|Maintenance Phase|Lost to Follow-up|1
5662340|NCT00487188|19548703|P3|Maintenance Phase|Death|0
5662341|NCT00487188|19548704|P2|Maintenance Phase|Death|0
5662342|NCT00487188|19548705|P1|Maintenance Phase|Death|1
5662343|NCT00487188|19548703|P3|Maintenance Phase|Adverse Event|0
5662344|NCT00487188|19548704|P2|Maintenance Phase|Adverse Event|0
5662345|NCT00487188|19548705|P1|Maintenance Phase|Adverse Event|1
5662346|NCT00487188|19548703|P3|Induction Phase|Administrative|0
5662347|NCT00487188|19548704|P2|Induction Phase|Administrative|1
5662348|NCT00487188|19548705|P1|Induction Phase|Administrative|0
5662349|NCT00487188|19548703|P3|Induction Phase|Lost to Follow-up|0
5662350|NCT00487188|19548704|P2|Induction Phase|Lost to Follow-up|2
5662351|NCT00487188|19548705|P1|Induction Phase|Lost to Follow-up|2
5662352|NCT00487188|19548703|P3|Induction Phase|Refused Treatment|0
5662353|NCT00487188|19548704|P2|Induction Phase|Refused Treatment|2
5662354|NCT00487188|19548705|P1|Induction Phase|Refused Treatment|1
5662355|NCT00487188|19548703|P3|Induction Phase|Protocol Violation|0
5662356|NCT00487188|19548704|P2|Induction Phase|Protocol Violation|0
5662357|NCT00487188|19548705|P1|Induction Phase|Protocol Violation|1
5662358|NCT00487188|19548703|P3|Induction Phase|Lack of Efficacy|0
5662359|NCT00487188|19548704|P2|Induction Phase|Lack of Efficacy|1
5662360|NCT00487188|19548705|P1|Induction Phase|Lack of Efficacy|0
5662361|NCT00487188|19548703|P3|Induction Phase|Adverse Event|0
5662362|NCT00487188|19548704|P2|Induction Phase|Adverse Event|0
5662363|NCT00487188|19548705|P1|Induction Phase|Adverse Event|5
5662364|NCT00487188|19548703|P3|Induction Phase|Abnormality of Laboratory Test|0
5662365|NCT00487188|19548704|P2|Induction Phase|Abnormality of Laboratory Test|1
5662366|NCT00487188|19548705|P1|Induction Phase|Abnormality of Laboratory Test|0
5662367|NCT00487162|19548744|P2|Overall Study|Withdrawal by Subject|3
5662368|NCT00487162|19548745|P1|Overall Study|Withdrawal by Subject|2
5662369|NCT00487162|19548744|P2|Overall Study|Physician Decision|1
5662370|NCT00487162|19548745|P1|Overall Study|Physician Decision|0
5662371|NCT00487162|19548744|P2|Overall Study|Adverse Event|1
5662372|NCT00487162|19548745|P1|Overall Study|Adverse Event|0
5662373|NCT00487084|19548756|P3|Overall Study|Did not receive intervention|5
5662374|NCT00487084|19548757|P2|Overall Study|Did not receive intervention|3
5662375|NCT00487084|19548758|P1|Overall Study|Did not receive intervention|4
5662376|NCT00486954|19548779|P5|Randomized Part|Sponsor Terminated Study|13
5662377|NCT00486954|19548780|P4|Randomized Part|Sponsor Terminated Study|19
5662378|NCT00486954|19548781|P3|Randomized Part|Sponsor Terminated Study|0
5662379|NCT00486954|19548782|P2|Randomized Part|Sponsor Terminated Study|0
5662380|NCT00486954|19548783|P1|Randomized Part|Sponsor Terminated Study|0
5662381|NCT00486954|19548779|P5|Randomized Part|Withdrawal by Subject|0
5662382|NCT00486954|19548780|P4|Randomized Part|Withdrawal by Subject|1
5662383|NCT00486954|19548781|P3|Randomized Part|Withdrawal by Subject|0
5662384|NCT00486954|19548782|P2|Randomized Part|Withdrawal by Subject|0
5662385|NCT00486954|19548783|P1|Randomized Part|Withdrawal by Subject|0
5662386|NCT00486954|19548779|P5|Randomized Part|Lost to Follow-up|1
5662387|NCT00486954|19548780|P4|Randomized Part|Lost to Follow-up|0
5662388|NCT00486954|19548781|P3|Randomized Part|Lost to Follow-up|0
5662389|NCT00486954|19548782|P2|Randomized Part|Lost to Follow-up|0
5662390|NCT00486954|19548783|P1|Randomized Part|Lost to Follow-up|0
5662391|NCT00486954|19548779|P5|Pilot Part|Disease Progression|0
5662392|NCT00486954|19548780|P4|Pilot Part|Disease Progression|0
5662393|NCT00486954|19548781|P3|Pilot Part|Disease Progression|1
5662394|NCT00486954|19548782|P2|Pilot Part|Disease Progression|0
5662395|NCT00486954|19548783|P1|Pilot Part|Disease Progression|2
5662396|NCT00486954|19548779|P5|Pilot Part|Adverse Event|0
5662397|NCT00486954|19548780|P4|Pilot Part|Adverse Event|0
5662398|NCT00486954|19548781|P3|Pilot Part|Adverse Event|5
5662399|NCT00486954|19548782|P2|Pilot Part|Adverse Event|0
5662400|NCT00486954|19548783|P1|Pilot Part|Adverse Event|4
5662401|NCT00486902|19548881|P2|Overall Study|No toradol due to hemmorhage or allergy|1
5662402|NCT00486902|19548882|P1|Overall Study|No toradol due to hemmorhage or allergy|3
5662403|NCT00486902|19548881|P2|Overall Study|Did not meet inclusion criteria|0
5662404|NCT00486902|19548882|P1|Overall Study|Did not meet inclusion criteria|1
5662405|NCT00486902|19548881|P2|Overall Study|spinal anesthetic protocal violation|1
5662406|NCT00486902|19548882|P1|Overall Study|spinal anesthetic protocal violation|1
5662407|NCT00486902|19548881|P2|Overall Study|decision for postpartum tubal ligation|1
5662408|NCT00486902|19548882|P1|Overall Study|decision for postpartum tubal ligation|3
5662409|NCT00486902|19548881|P2|Overall Study|Withdrawal by Subject|2
5662410|NCT00486902|19548882|P1|Overall Study|Withdrawal by Subject|1
5662411|NCT00486837|19548949|P2|Overall Study|No sputum, devise issues, exacerbation|4
5662412|NCT00486837|19548950|P1|Overall Study|No sputum, devise issues, exacerbation|3
5662413|NCT00486837|19548949|P2|Overall Study|Protocol Violation|2
5662414|NCT00486837|19548950|P1|Overall Study|Protocol Violation|4
5662415|NCT00486837|19548949|P2|Overall Study|Adverse Event|1
5662416|NCT00486837|19548950|P1|Overall Study|Adverse Event|1
5662417|NCT00486837|19548949|P2|Overall Study|Withdrawal by Subject|0
5662418|NCT00486837|19548950|P1|Overall Study|Withdrawal by Subject|1
5662419|NCT00486811|19548990|P3|Overall Study|All other|7
5662420|NCT00486811|19548991|P2|Overall Study|All other|11
5662421|NCT00486811|19548992|P1|Overall Study|All other|18
5662422|NCT00486811|19548990|P3|Overall Study|Study drug non-compliant|3
5662423|NCT00486811|19548991|P2|Overall Study|Study drug non-compliant|6
5662424|NCT00486811|19548992|P1|Overall Study|Study drug non-compliant|5
5662425|NCT00486811|19548990|P3|Overall Study|Withdrawal by Subject|58
5662426|NCT00486811|19548991|P2|Overall Study|Withdrawal by Subject|44
5662427|NCT00486811|19548992|P1|Overall Study|Withdrawal by Subject|33
5662428|NCT00486811|19548990|P3|Overall Study|Lost to Follow-up|4
5662429|NCT00486811|19548991|P2|Overall Study|Lost to Follow-up|6
5662430|NCT00486811|19548992|P1|Overall Study|Lost to Follow-up|4
5662431|NCT00486811|19548990|P3|Overall Study|Lack of Efficacy|7
5662432|NCT00486811|19548991|P2|Overall Study|Lack of Efficacy|14
5662433|NCT00486811|19548992|P1|Overall Study|Lack of Efficacy|34
5662434|NCT00486811|19548990|P3|Overall Study|Adverse Event|135
5662435|NCT00486811|19548991|P2|Overall Study|Adverse Event|60
5662436|NCT00486811|19548992|P1|Overall Study|Adverse Event|28
5662437|NCT00486759|19549035|P2|Safety Follow-up|Adverse event/intercurrent illness|0
5662438|NCT00486759|19549036|P1|Safety Follow-up|Adverse event/intercurrent illness|4
5662439|NCT00486759|19549035|P2|Safety Follow-up|Refused treatment/did not cooperate|4
5662440|NCT00486759|19549036|P1|Safety Follow-up|Refused treatment/did not cooperate|6
5662441|NCT00486759|19549035|P2|Safety Follow-up|Administrative/not specified|6
5662442|NCT00486759|19549036|P1|Safety Follow-up|Administrative/not specified|8
5662443|NCT00486759|19549035|P2|Safety Follow-up|Failure to return|6
5662444|NCT00486759|19549036|P1|Safety Follow-up|Failure to return|9
5662445|NCT00486759|19549035|P2|Safety Follow-up|Withdrew consent|23
5662446|NCT00486759|19549036|P1|Safety Follow-up|Withdrew consent|32
5662447|NCT00486759|19549035|P2|Safety Follow-up|Death|29
5662448|NCT00486759|19549036|P1|Safety Follow-up|Death|40
5662449|NCT00486759|19549035|P2|Safety Follow-up|Insufficient therapeutic response|50
5662450|NCT00486759|19549036|P1|Safety Follow-up|Insufficient therapeutic response|40
5662451|NCT00486759|19549035|P2|Treatment|Failure to return|1
5662452|NCT00486759|19549036|P1|Treatment|Failure to return|1
5662453|NCT00486759|19549035|P2|Treatment|Other protocol violation|5
5662454|NCT00486759|19549036|P1|Treatment|Other protocol violation|1
5662455|NCT00486759|19549035|P2|Treatment|Violation of selection criteria at entry|3
5662456|NCT00486759|19549036|P1|Treatment|Violation of selection criteria at entry|3
5662457|NCT00486759|19549035|P2|Treatment|Refused treatment|7
5662458|NCT00486759|19549036|P1|Treatment|Refused treatment|10
5662459|NCT00486759|19549035|P2|Treatment|Administrative/reason not specified|21
5662460|NCT00486759|19549036|P1|Treatment|Administrative/reason not specified|17
5662461|NCT00486759|19549035|P2|Treatment|Withdrew consent|12
5662462|NCT00486759|19549036|P1|Treatment|Withdrew consent|15
5662463|NCT00486759|19549035|P2|Treatment|Death|10
5662464|NCT00486759|19549036|P1|Treatment|Death|17
5662465|NCT00486759|19549035|P2|Treatment|Insufficient therapeutic response|39
5662466|NCT00486759|19549036|P1|Treatment|Insufficient therapeutic response|37
5662467|NCT00486759|19549035|P2|Treatment|Adverse event/intercurrent illness|39
5662468|NCT00486759|19549036|P1|Treatment|Adverse event/intercurrent illness|86
5662469|NCT00486720|19549048|P2|Overall Study|Progressive Disease|1
5662470|NCT00486720|19549049|P1|Overall Study|Progressive Disease|0
5662471|NCT00486720|19549048|P2|Overall Study|Withdrawal by Subject|1
5662472|NCT00486720|19549049|P1|Overall Study|Withdrawal by Subject|3
5662473|NCT00486720|19549048|P2|Overall Study|Protocol Violation|0
5662474|NCT00486720|19549049|P1|Overall Study|Protocol Violation|1
5662475|NCT00486720|19549048|P2|Overall Study|Physician Decision|2
5662476|NCT00486720|19549049|P1|Overall Study|Physician Decision|1
5662477|NCT00486720|19549048|P2|Overall Study|Lack of Efficacy|6
5662478|NCT00486720|19549049|P1|Overall Study|Lack of Efficacy|4
5662479|NCT00486720|19549048|P2|Overall Study|Adverse Event|2
5662480|NCT00486720|19549049|P1|Overall Study|Adverse Event|1
5662481|NCT00486603|19549084|P5|Overall Study|Physician Decision|0
5662482|NCT00486603|19549085|P4|Overall Study|Physician Decision|0
5662483|NCT00486603|19549086|P3|Overall Study|Physician Decision|0
5662484|NCT00486603|19549087|P2|Overall Study|Physician Decision|1
5662485|NCT00486603|19549088|P1|Overall Study|Physician Decision|0
5662486|NCT00486603|19549084|P5|Overall Study|Withdrawal by Subject|0
5662487|NCT00486603|19549085|P4|Overall Study|Withdrawal by Subject|0
5662488|NCT00486603|19549086|P3|Overall Study|Withdrawal by Subject|0
5662489|NCT00486603|19549087|P2|Overall Study|Withdrawal by Subject|0
5662490|NCT00486603|19549088|P1|Overall Study|Withdrawal by Subject|1
5662491|NCT00486434|19549136|P2|Overall Study|Personal reasons|6
5662492|NCT00486434|19549137|P1|Overall Study|Personal reasons|5
5662493|NCT00486434|19549136|P2|Overall Study|Death|2
5662494|NCT00486434|19549137|P1|Overall Study|Death|1
5662495|NCT00486434|19549136|P2|Overall Study|Lost to Follow-up|3
5662496|NCT00486434|19549137|P1|Overall Study|Lost to Follow-up|2
5662497|NCT00486434|19549136|P2|Overall Study|Lack of Efficacy|19
5662498|NCT00486434|19549137|P1|Overall Study|Lack of Efficacy|12
5662499|NCT00486434|19549136|P2|Overall Study|Protocol Violation|21
5662500|NCT00486434|19549137|P1|Overall Study|Protocol Violation|22
5662501|NCT00486434|19549136|P2|Overall Study|Adverse Event|44
5662502|NCT00486434|19549137|P1|Overall Study|Adverse Event|118
5662503|NCT00486434|19549136|P2|Overall Study|Withdrawal by Subject|39
5662504|NCT00486434|19549137|P1|Overall Study|Withdrawal by Subject|34
5662505|NCT00486330|19549156|P1|Overall Study|Adverse Event|2
5662506|NCT00486291|19549162|P2|Overall Study|requirement for restricted medication|3
5662507|NCT00486291|19549163|P1|Overall Study|requirement for restricted medication|0
5662508|NCT00486291|19549162|P2|Overall Study|protocol non-compliance|15
5662509|NCT00486291|19549163|P1|Overall Study|protocol non-compliance|10
5662510|NCT00486291|19549162|P2|Overall Study|Lost to Follow-up|7
5662511|NCT00486291|19549163|P1|Overall Study|Lost to Follow-up|3
5662512|NCT00486291|19549162|P2|Overall Study|Adverse Event|4
5662513|NCT00486291|19549163|P1|Overall Study|Adverse Event|3
5662514|NCT00486278|19549171|P1|Overall Study|Physician Decision|2
5662515|NCT00486278|19549171|P1|Overall Study|Withdrawal by Subject|2
5662516|NCT00486278|19549171|P1|Overall Study|Adverse Event|5
5662517|NCT00486265|19549305|P1|Overall Study|Lack of Efficacy|8
5662518|NCT00486265|19549305|P1|Overall Study|Adverse Event|1
5662519|NCT00486252|19549309|P1|Overall Study|Other|18
5662520|NCT00486252|19549309|P1|Overall Study|Lost to Follow-up|24
5662521|NCT00486252|19549309|P1|Overall Study|Lack of Efficacy|9
5662522|NCT00486252|19549309|P1|Overall Study|Adverse Event|7
5662523|NCT00486226|19549324|P1|Overall Study|Lost to Follow-up|8
5662524|NCT00486226|19549324|P1|Overall Study|Withdrawal by Subject|1
5662525|NCT00486226|19549324|P1|Overall Study|Adverse Event|1
5662526|NCT00486226|19549324|P1|Overall Study|Death|3
5662527|NCT00486044|19549334|P2|Overall Study|Lost to Follow-up|1
5662528|NCT00486044|19549335|P1|Overall Study|Lost to Follow-up|0
5662529|NCT00486044|19549334|P2|Overall Study|Adverse Event|1
5662530|NCT00486044|19549335|P1|Overall Study|Adverse Event|0
5662531|NCT00486044|19549334|P2|Overall Study|Withdrawal by Subject|1
5662532|NCT00486044|19549335|P1|Overall Study|Withdrawal by Subject|2
5662533|NCT00485758|19549429|P2|Overall Study|Study Terminated by Sponsor|0
5662534|NCT00485758|19549430|P1|Overall Study|Study Terminated by Sponsor|3
5662535|NCT00485758|19549429|P2|Overall Study|Withdrawal by Subject|27
5662536|NCT00485758|19549430|P1|Overall Study|Withdrawal by Subject|32
5662537|NCT00485758|19549429|P2|Overall Study|Protocol Violation|2
5662538|NCT00485758|19549430|P1|Overall Study|Protocol Violation|11
5662539|NCT00485758|19549429|P2|Overall Study|Physician Decision|3
5662540|NCT00485758|19549430|P1|Overall Study|Physician Decision|3
5662541|NCT00485758|19549429|P2|Overall Study|Lost to Follow-up|1
5662542|NCT00485758|19549430|P1|Overall Study|Lost to Follow-up|5
5662543|NCT00485758|19549429|P2|Overall Study|Death|1
5662544|NCT00485758|19549430|P1|Overall Study|Death|0
5662545|NCT00485758|19549429|P2|Overall Study|Adverse Event|31
5662546|NCT00485758|19549430|P1|Overall Study|Adverse Event|102
5662547|NCT00485732|19549442|P2|Overall Study|Lost to Follow-up|2
5662548|NCT00485732|19549443|P1|Overall Study|Lost to Follow-up|2
5662549|NCT00485732|19549442|P2|Overall Study|Withdrawal by Subject|4
5662550|NCT00485732|19549443|P1|Overall Study|Withdrawal by Subject|5
5662551|NCT00485732|19549442|P2|Overall Study|Protocol Violation|3
5662552|NCT00485732|19549443|P1|Overall Study|Protocol Violation|1
5662553|NCT00485589|19549478|P3|Overall Study|Adverse Event|10
5662554|NCT00485589|19549479|P2|Overall Study|Adverse Event|3
5662555|NCT00485589|19549480|P1|Overall Study|Adverse Event|3
5662556|NCT00485589|19549478|P3|Overall Study|Withdrawal by Subject|2
5662557|NCT00485589|19549479|P2|Overall Study|Withdrawal by Subject|2
5662558|NCT00485589|19549480|P1|Overall Study|Withdrawal by Subject|3
5662559|NCT00485589|19549478|P3|Overall Study|Refused treatment/did not cooperate|2
5662560|NCT00485589|19549479|P2|Overall Study|Refused treatment/did not cooperate|0
5662561|NCT00485589|19549480|P1|Overall Study|Refused treatment/did not cooperate|1
5662562|NCT00485589|19549478|P3|Overall Study|Insufficient therapeutic response|1
5662563|NCT00485589|19549479|P2|Overall Study|Insufficient therapeutic response|3
5662564|NCT00485589|19549480|P1|Overall Study|Insufficient therapeutic response|10
5662565|NCT00485589|19549478|P3|Overall Study|Administrative/Other|1
5662566|NCT00485589|19549479|P2|Overall Study|Administrative/Other|2
5662567|NCT00485589|19549480|P1|Overall Study|Administrative/Other|1
5662568|NCT00485589|19549478|P3|Overall Study|Violation of selection criteria at entry|1
5662569|NCT00485589|19549479|P2|Overall Study|Violation of selection criteria at entry|3
5662570|NCT00485589|19549480|P1|Overall Study|Violation of selection criteria at entry|0
5662571|NCT00485589|19549478|P3|Overall Study|Protocol Violation|0
5662572|NCT00485589|19549479|P2|Overall Study|Protocol Violation|0
5662573|NCT00485589|19549480|P1|Overall Study|Protocol Violation|1
5662574|NCT00485589|19549478|P3|Overall Study|Failure to return|1
5662575|NCT00485589|19549479|P2|Overall Study|Failure to return|5
5662576|NCT00485589|19549480|P1|Overall Study|Failure to return|6
5662577|NCT00485589|19549478|P3|Overall Study|Death|0
5662578|NCT00485589|19549479|P2|Overall Study|Death|2
5662579|NCT00485589|19549480|P1|Overall Study|Death|2
5662580|NCT00485472|19549512|P2|Overall Study|Lost to Follow-up|1
5662581|NCT00485472|19549513|P1|Overall Study|Lost to Follow-up|0
5662582|NCT00485472|19549512|P2|Overall Study|Other|1
5662583|NCT00485472|19549513|P1|Overall Study|Other|2
5662584|NCT00485472|19549512|P2|Overall Study|Protocol Violation|1
5662585|NCT00485472|19549513|P1|Overall Study|Protocol Violation|0
5662586|NCT00485472|19549512|P2|Overall Study|Withdrawal by Subject|0
5662587|NCT00485472|19549513|P1|Overall Study|Withdrawal by Subject|1
5662588|NCT00485472|19549512|P2|Overall Study|Lack of Efficacy|4
5662589|NCT00485472|19549513|P1|Overall Study|Lack of Efficacy|5
5662590|NCT00485472|19549512|P2|Overall Study|Adverse Event|5
5662591|NCT00485472|19549513|P1|Overall Study|Adverse Event|8
5662592|NCT00485303|19549550|P1|Overall Study|Treatment ongoing at cutoff date|2
5662593|NCT00485303|19549550|P1|Overall Study|Initiation of new anti-cancer treatment|2
5662594|NCT00485303|19549550|P1|Overall Study|Other|3
5662595|NCT00485303|19549550|P1|Overall Study|Progressive Disease|44
5662596|NCT00485303|19549550|P1|Overall Study|Adverse Event|5
5662597|NCT00485264|19549568|P6|Overall Study|Other Reason|0
5662598|NCT00485264|19549569|P5|Overall Study|Other Reason|0
5662599|NCT00485264|19549570|P4|Overall Study|Other Reason|0
5662600|NCT00485264|19549571|P3|Overall Study|Other Reason|0
5662601|NCT00485264|19549572|P2|Overall Study|Other Reason|0
5662602|NCT00485264|19549573|P1|Overall Study|Other Reason|3
5662603|NCT00485264|19549568|P6|Overall Study|Lost to Follow-up|1
5662604|NCT00485264|19549569|P5|Overall Study|Lost to Follow-up|0
5662605|NCT00485264|19549570|P4|Overall Study|Lost to Follow-up|0
5662606|NCT00485264|19549571|P3|Overall Study|Lost to Follow-up|1
5662607|NCT00485264|19549572|P2|Overall Study|Lost to Follow-up|1
5662608|NCT00485264|19549573|P1|Overall Study|Lost to Follow-up|2
5662609|NCT00485264|19549568|P6|Overall Study|Non-Compliant|0
5662610|NCT00485264|19549569|P5|Overall Study|Non-Compliant|1
5662611|NCT00485264|19549570|P4|Overall Study|Non-Compliant|0
5662612|NCT00485264|19549571|P3|Overall Study|Non-Compliant|1
5662613|NCT00485264|19549572|P2|Overall Study|Non-Compliant|2
5662614|NCT00485264|19549573|P1|Overall Study|Non-Compliant|17
5662615|NCT00485264|19549568|P6|Overall Study|Not Able to Attend Clinic|2
5662616|NCT00485264|19549569|P5|Overall Study|Not Able to Attend Clinic|1
5662617|NCT00485264|19549570|P4|Overall Study|Not Able to Attend Clinic|1
5662618|NCT00485264|19549571|P3|Overall Study|Not Able to Attend Clinic|0
5662619|NCT00485264|19549572|P2|Overall Study|Not Able to Attend Clinic|0
5662620|NCT00485264|19549573|P1|Overall Study|Not Able to Attend Clinic|5
5662621|NCT00485264|19549568|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
5662622|NCT00485264|19549569|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
5662623|NCT00485264|19549570|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
5662624|NCT00485264|19549571|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
5662625|NCT00485264|19549572|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
5662626|NCT00485264|19549573|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
5662627|NCT00485264|19549568|P6|Overall Study|Physician Decision|0
5662628|NCT00485264|19549569|P5|Overall Study|Physician Decision|0
5662629|NCT00485264|19549570|P4|Overall Study|Physician Decision|0
5662630|NCT00485264|19549571|P3|Overall Study|Physician Decision|0
5662631|NCT00485264|19549572|P2|Overall Study|Physician Decision|2
5662632|NCT00485264|19549573|P1|Overall Study|Physician Decision|0
5662633|NCT00485264|19549568|P6|Overall Study|Guardian Consent Withdrawn|0
5662634|NCT00485264|19549569|P5|Overall Study|Guardian Consent Withdrawn|1
5662635|NCT00485264|19549570|P4|Overall Study|Guardian Consent Withdrawn|0
5662636|NCT00485264|19549571|P3|Overall Study|Guardian Consent Withdrawn|0
5662637|NCT00485264|19549572|P2|Overall Study|Guardian Consent Withdrawn|0
5662638|NCT00485264|19549573|P1|Overall Study|Guardian Consent Withdrawn|1
5662639|NCT00485264|19549568|P6|Overall Study|Lack of Efficacy|0
5662640|NCT00485264|19549569|P5|Overall Study|Lack of Efficacy|0
5662641|NCT00485264|19549570|P4|Overall Study|Lack of Efficacy|0
5662642|NCT00485264|19549571|P3|Overall Study|Lack of Efficacy|0
5662643|NCT00485264|19549572|P2|Overall Study|Lack of Efficacy|1
5662644|NCT00485264|19549573|P1|Overall Study|Lack of Efficacy|0
5662645|NCT00485264|19549568|P6|Overall Study|Number/Volume/Timing of Study Meds|0
5662646|NCT00485264|19549569|P5|Overall Study|Number/Volume/Timing of Study Meds|0
5662647|NCT00485264|19549570|P4|Overall Study|Number/Volume/Timing of Study Meds|0
5662648|NCT00485264|19549571|P3|Overall Study|Number/Volume/Timing of Study Meds|1
5662649|NCT00485264|19549572|P2|Overall Study|Number/Volume/Timing of Study Meds|1
5662650|NCT00485264|19549573|P1|Overall Study|Number/Volume/Timing of Study Meds|2
5662651|NCT00485264|19549568|P6|Overall Study|Disallowed Medication|1
5662652|NCT00485264|19549569|P5|Overall Study|Disallowed Medication|0
5662653|NCT00485264|19549570|P4|Overall Study|Disallowed Medication|0
5662654|NCT00485264|19549571|P3|Overall Study|Disallowed Medication|0
5662655|NCT00485264|19549572|P2|Overall Study|Disallowed Medication|0
5662656|NCT00485264|19549573|P1|Overall Study|Disallowed Medication|0
5662657|NCT00485264|19549568|P6|Overall Study|Pregnancy|0
5662658|NCT00485264|19549569|P5|Overall Study|Pregnancy|0
5662659|NCT00485264|19549570|P4|Overall Study|Pregnancy|0
5662660|NCT00485264|19549571|P3|Overall Study|Pregnancy|0
5662661|NCT00485264|19549572|P2|Overall Study|Pregnancy|0
5662662|NCT00485264|19549573|P1|Overall Study|Pregnancy|4
5662663|NCT00485264|19549568|P6|Overall Study|Adverse Event|3
5662664|NCT00485264|19549569|P5|Overall Study|Adverse Event|1
5662665|NCT00485264|19549570|P4|Overall Study|Adverse Event|3
5662666|NCT00485264|19549571|P3|Overall Study|Adverse Event|2
5662667|NCT00485264|19549572|P2|Overall Study|Adverse Event|0
5662668|NCT00485264|19549573|P1|Overall Study|Adverse Event|1
5662669|NCT00485264|19549568|P6|Overall Study|Death|0
5662670|NCT00485264|19549569|P5|Overall Study|Death|1
5662671|NCT00485264|19549570|P4|Overall Study|Death|0
5662672|NCT00485264|19549571|P3|Overall Study|Death|0
5662673|NCT00485264|19549572|P2|Overall Study|Death|0
5662674|NCT00485264|19549573|P1|Overall Study|Death|1
5662675|NCT00485264|19549568|P6|Overall Study|Enrolled But Not Given Treatment|0
5662676|NCT00485264|19549569|P5|Overall Study|Enrolled But Not Given Treatment|1
5662677|NCT00485264|19549570|P4|Overall Study|Enrolled But Not Given Treatment|0
5662678|NCT00485264|19549571|P3|Overall Study|Enrolled But Not Given Treatment|0
5662679|NCT00485264|19549572|P2|Overall Study|Enrolled But Not Given Treatment|0
5662680|NCT00485264|19549573|P1|Overall Study|Enrolled But Not Given Treatment|0
5662681|NCT00485173|19549661|P2|Overall Study|Lost to Follow-up|61
5662682|NCT00485173|19549662|P1|Overall Study|Lost to Follow-up|32
5662683|NCT00485173|19549661|P2|Overall Study|Death|3
5662684|NCT00485173|19549662|P1|Overall Study|Death|4
5662685|NCT00485134|19549710|P8|Overall Study|Pregnancy|0
5662686|NCT00485134|19549711|P7|Overall Study|Pregnancy|1
5662687|NCT00485134|19549712|P6|Overall Study|Pregnancy|0
5662688|NCT00485134|19549713|P5|Overall Study|Pregnancy|0
5662689|NCT00485134|19549714|P4|Overall Study|Pregnancy|0
5662690|NCT00485134|19549715|P3|Overall Study|Pregnancy|0
5662691|NCT00485134|19549716|P2|Overall Study|Pregnancy|0
5662692|NCT00485134|19549717|P1|Overall Study|Pregnancy|0
5662693|NCT00485134|19549710|P8|Overall Study|Unable to comply with study schedule|1
5662694|NCT00485134|19549711|P7|Overall Study|Unable to comply with study schedule|0
5662695|NCT00485134|19549712|P6|Overall Study|Unable to comply with study schedule|0
5662696|NCT00485134|19549713|P5|Overall Study|Unable to comply with study schedule|0
5662697|NCT00485134|19549714|P4|Overall Study|Unable to comply with study schedule|0
5662698|NCT00485134|19549715|P3|Overall Study|Unable to comply with study schedule|0
5662699|NCT00485134|19549716|P2|Overall Study|Unable to comply with study schedule|0
5662700|NCT00485134|19549717|P1|Overall Study|Unable to comply with study schedule|0
5662701|NCT00485134|19549710|P8|Overall Study|Non-compliance|0
5662702|NCT00485134|19549711|P7|Overall Study|Non-compliance|2
5662703|NCT00485134|19549712|P6|Overall Study|Non-compliance|2
5662704|NCT00485134|19549713|P5|Overall Study|Non-compliance|1
5662705|NCT00485134|19549714|P4|Overall Study|Non-compliance|0
5662706|NCT00485134|19549715|P3|Overall Study|Non-compliance|0
5662707|NCT00485134|19549716|P2|Overall Study|Non-compliance|0
5662708|NCT00485134|19549717|P1|Overall Study|Non-compliance|0
5662709|NCT00485134|19549710|P8|Overall Study|Positive drug test|0
5662710|NCT00485134|19549711|P7|Overall Study|Positive drug test|0
5662711|NCT00485134|19549712|P6|Overall Study|Positive drug test|1
5662712|NCT00485134|19549713|P5|Overall Study|Positive drug test|2
5662713|NCT00485134|19549714|P4|Overall Study|Positive drug test|0
5662714|NCT00485134|19549715|P3|Overall Study|Positive drug test|0
5662715|NCT00485134|19549716|P2|Overall Study|Positive drug test|0
5662716|NCT00485134|19549717|P1|Overall Study|Positive drug test|0
5662717|NCT00485134|19549710|P8|Overall Study|Withdrew for adverse event|0
5662718|NCT00485134|19549711|P7|Overall Study|Withdrew for adverse event|0
5662719|NCT00485134|19549712|P6|Overall Study|Withdrew for adverse event|0
5662720|NCT00485134|19549713|P5|Overall Study|Withdrew for adverse event|0
5662721|NCT00485134|19549714|P4|Overall Study|Withdrew for adverse event|0
5662722|NCT00485134|19549715|P3|Overall Study|Withdrew for adverse event|1
5662723|NCT00485134|19549716|P2|Overall Study|Withdrew for adverse event|0
5662724|NCT00485134|19549717|P1|Overall Study|Withdrew for adverse event|0
5662725|NCT00485134|19549710|P8|Overall Study|Change in health status|0
5662726|NCT00485134|19549711|P7|Overall Study|Change in health status|0
5662727|NCT00485134|19549712|P6|Overall Study|Change in health status|1
5662728|NCT00485134|19549713|P5|Overall Study|Change in health status|0
5662729|NCT00485134|19549714|P4|Overall Study|Change in health status|1
5662730|NCT00485134|19549715|P3|Overall Study|Change in health status|2
5662731|NCT00485134|19549716|P2|Overall Study|Change in health status|1
5662732|NCT00485134|19549717|P1|Overall Study|Change in health status|0
5662733|NCT00485134|19549710|P8|Overall Study|Withdrawal by Subject|0
5662734|NCT00485134|19549711|P7|Overall Study|Withdrawal by Subject|0
5662735|NCT00485134|19549712|P6|Overall Study|Withdrawal by Subject|0
5662736|NCT00485134|19549713|P5|Overall Study|Withdrawal by Subject|0
5662737|NCT00485134|19549714|P4|Overall Study|Withdrawal by Subject|0
5662738|NCT00485134|19549715|P3|Overall Study|Withdrawal by Subject|0
5662739|NCT00485134|19549716|P2|Overall Study|Withdrawal by Subject|1
5662740|NCT00485134|19549717|P1|Overall Study|Withdrawal by Subject|0
5662741|NCT00485134|19549710|P8|Overall Study|Lost to Follow-up|0
5662742|NCT00485134|19549711|P7|Overall Study|Lost to Follow-up|0
5662743|NCT00485134|19549712|P6|Overall Study|Lost to Follow-up|0
5662744|NCT00485134|19549713|P5|Overall Study|Lost to Follow-up|0
5662745|NCT00485134|19549714|P4|Overall Study|Lost to Follow-up|0
5662746|NCT00485134|19549715|P3|Overall Study|Lost to Follow-up|0
5662747|NCT00485134|19549716|P2|Overall Study|Lost to Follow-up|0
5662748|NCT00485134|19549717|P1|Overall Study|Lost to Follow-up|1
5662749|NCT00485069|19549739|P2|Overall Study|Withdrawal by Subject|6
5662750|NCT00485069|19549740|P1|Overall Study|Withdrawal by Subject|6
5662751|NCT00485069|19549739|P2|Overall Study|Protocol Violation|1
5662752|NCT00485069|19549740|P1|Overall Study|Protocol Violation|0
5662753|NCT00485069|19549739|P2|Overall Study|Lack of Efficacy|1
5662754|NCT00485069|19549740|P1|Overall Study|Lack of Efficacy|2
5662755|NCT00485069|19549739|P2|Overall Study|Adverse Event|4
5662756|NCT00485069|19549740|P1|Overall Study|Adverse Event|10
5662757|NCT00484939|19549785|P2|Overall Study|Reason Not Specified|6
5662758|NCT00484939|19549786|P1|Overall Study|Reason Not Specified|11
5662759|NCT00484939|19549785|P2|Overall Study|Screen Failure|2
5662760|NCT00484939|19549786|P1|Overall Study|Screen Failure|2
5662761|NCT00484939|19549785|P2|Overall Study|Disease progression|88
5662762|NCT00484939|19549786|P1|Overall Study|Disease progression|67
5662763|NCT00484939|19549785|P2|Overall Study|Discretion of Investigator or Sponsor|3
5662764|NCT00484939|19549786|P1|Overall Study|Discretion of Investigator or Sponsor|7
5662765|NCT00484939|19549785|P2|Overall Study|Lost to Follow-up|3
5662766|NCT00484939|19549786|P1|Overall Study|Lost to Follow-up|0
5662767|NCT00484939|19549785|P2|Overall Study|Protocol Violation|3
5662768|NCT00484939|19549786|P1|Overall Study|Protocol Violation|3
5662769|NCT00484939|19549785|P2|Overall Study|Patient Withdrew Consent|10
5662770|NCT00484939|19549786|P1|Overall Study|Patient Withdrew Consent|19
5662771|NCT00484939|19549785|P2|Overall Study|Adverse Event|12
5662772|NCT00484939|19549786|P1|Overall Study|Adverse Event|22
5662773|NCT00484939|19549785|P2|Overall Study|Death|13
5662774|NCT00484939|19549786|P1|Overall Study|Death|9
5662775|NCT00484679|19549813|P1|Overall Study|Withdrawal by Subject|3
5662776|NCT00484419|19549820|P3|Overall Study|sponsor decision, randomized in error|2
5662777|NCT00484419|19549821|P2|Overall Study|sponsor decision, randomized in error|0
5662778|NCT00484419|19549822|P1|Overall Study|sponsor decision, randomized in error|0
5662779|NCT00484419|19549820|P3|Overall Study|subject relocated|0
5662780|NCT00484419|19549821|P2|Overall Study|subject relocated|1
5662781|NCT00484419|19549822|P1|Overall Study|subject relocated|0
5662782|NCT00484419|19549820|P3|Overall Study|subject unable to receive medication|0
5662783|NCT00484419|19549821|P2|Overall Study|subject unable to receive medication|0
5662784|NCT00484419|19549822|P1|Overall Study|subject unable to receive medication|1
5662785|NCT00484419|19549820|P3|Overall Study|Physician Decision|1
5662786|NCT00484419|19549821|P2|Overall Study|Physician Decision|1
5662787|NCT00484419|19549822|P1|Overall Study|Physician Decision|1
5662788|NCT00484419|19549820|P3|Overall Study|required restricted medication|1
5662789|NCT00484419|19549821|P2|Overall Study|required restricted medication|0
5662790|NCT00484419|19549822|P1|Overall Study|required restricted medication|1
5662791|NCT00484419|19549820|P3|Overall Study|subject met discontinuation criteria|4
5662792|NCT00484419|19549821|P2|Overall Study|subject met discontinuation criteria|2
5662793|NCT00484419|19549822|P1|Overall Study|subject met discontinuation criteria|2
5662794|NCT00484419|19549820|P3|Overall Study|Withdrawal by Subject|1
5662795|NCT00484419|19549821|P2|Overall Study|Withdrawal by Subject|1
5662796|NCT00484419|19549822|P1|Overall Study|Withdrawal by Subject|3
5662797|NCT00484419|19549820|P3|Overall Study|Lost to Follow-up|2
5662798|NCT00484419|19549821|P2|Overall Study|Lost to Follow-up|0
5662799|NCT00484419|19549822|P1|Overall Study|Lost to Follow-up|1
5662800|NCT00484419|19549820|P3|Overall Study|Adverse Event|0
5662801|NCT00484419|19549821|P2|Overall Study|Adverse Event|0
5662802|NCT00484419|19549822|P1|Overall Study|Adverse Event|3
5662803|NCT00484315|19549906|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
5662804|NCT00484315|19549907|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
5662805|NCT00484315|19549906|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
5662806|NCT00484315|19549907|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
5662807|NCT00484315|19549906|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
5662808|NCT00484315|19549907|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
5662809|NCT00484315|19549906|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
5662810|NCT00484315|19549907|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
5662811|NCT00484315|19549906|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
5662812|NCT00484315|19549907|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
5662813|NCT00484315|19549906|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
5662814|NCT00484315|19549907|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
5662815|NCT00484315|19549906|P2|12-Month Clinical Follow-up|Death|2
5662816|NCT00484315|19549907|P1|12-Month Clinical Follow-up|Death|6
5662817|NCT00484289|19549918|P3|Post Marketing Phase|Adverse Event|0
5662818|NCT00484289|19549919|P2|Post Marketing Phase|Adverse Event|1
5662819|NCT00484289|19549920|P1|Post Marketing Phase|Adverse Event|0
5662820|NCT00484289|19549918|P3|Long Term Phase|Other Reason|1
5662821|NCT00484289|19549919|P2|Long Term Phase|Other Reason|5
5662822|NCT00484289|19549920|P1|Long Term Phase|Other Reason|0
5662823|NCT00484289|19549918|P3|Long Term Phase|Inadequate response|4
5662824|NCT00484289|19549919|P2|Long Term Phase|Inadequate response|7
5662825|NCT00484289|19549920|P1|Long Term Phase|Inadequate response|2
5662826|NCT00484289|19549918|P3|Long Term Phase|Withdrawal by Subject|6
5662827|NCT00484289|19549919|P2|Long Term Phase|Withdrawal by Subject|7
5662828|NCT00484289|19549920|P1|Long Term Phase|Withdrawal by Subject|0
5662829|NCT00484289|19549918|P3|Long Term Phase|Adverse Event|5
5662830|NCT00484289|19549919|P2|Long Term Phase|Adverse Event|17
5662831|NCT00484289|19549920|P1|Long Term Phase|Adverse Event|1
5662832|NCT00484185|19549992|P1|Overall Study|Death|2
5662833|NCT00484185|19549992|P1|Overall Study|Randomized but not treated|5
5662834|NCT00484185|19549992|P1|Overall Study|Other|20
5662835|NCT00484185|19549992|P1|Overall Study|Lost to Follow-up|44
5662836|NCT00484159|19550014|P3|Overall Study|Lost to Follow-up|0
5662837|NCT00484159|19550015|P2|Overall Study|Lost to Follow-up|1
5662838|NCT00484159|19550016|P1|Overall Study|Lost to Follow-up|1
5662839|NCT00484094|19550027|P1|Overall Study|Other|3
5662840|NCT00484094|19550027|P1|Overall Study|Discontinued|39
5662841|NCT00483938|19550043|P7|Overall Study|Other|32
5662842|NCT00483938|19550044|P6|Overall Study|Other|4
5662843|NCT00483938|19550045|P5|Overall Study|Other|0
5662844|NCT00483938|19550046|P4|Overall Study|Other|4
5662845|NCT00483938|19550047|P3|Overall Study|Other|0
5662846|NCT00483938|19550048|P2|Overall Study|Other|9
5662847|NCT00483938|19550049|P1|Overall Study|Other|3
5662848|NCT00483938|19550043|P7|Overall Study|Death|0
5662849|NCT00483938|19550044|P6|Overall Study|Death|0
5662850|NCT00483938|19550045|P5|Overall Study|Death|0
5662851|NCT00483938|19550046|P4|Overall Study|Death|0
5662852|NCT00483938|19550047|P3|Overall Study|Death|0
5662853|NCT00483938|19550048|P2|Overall Study|Death|2
5662854|NCT00483938|19550049|P1|Overall Study|Death|0
5662855|NCT00483938|19550043|P7|Overall Study|Lost to Follow-up|3
5662856|NCT00483938|19550044|P6|Overall Study|Lost to Follow-up|1
5662857|NCT00483938|19550045|P5|Overall Study|Lost to Follow-up|1
5662858|NCT00483938|19550046|P4|Overall Study|Lost to Follow-up|2
5662859|NCT00483938|19550047|P3|Overall Study|Lost to Follow-up|0
5662860|NCT00483938|19550048|P2|Overall Study|Lost to Follow-up|2
5662861|NCT00483938|19550049|P1|Overall Study|Lost to Follow-up|1
5662862|NCT00483938|19550043|P7|Overall Study|Withdrawal by Subject|2
5662863|NCT00483938|19550044|P6|Overall Study|Withdrawal by Subject|3
5662864|NCT00483938|19550045|P5|Overall Study|Withdrawal by Subject|1
5662865|NCT00483938|19550046|P4|Overall Study|Withdrawal by Subject|0
5662866|NCT00483938|19550047|P3|Overall Study|Withdrawal by Subject|0
5662867|NCT00483938|19550048|P2|Overall Study|Withdrawal by Subject|6
5662868|NCT00483938|19550049|P1|Overall Study|Withdrawal by Subject|1
5662869|NCT00483938|19550043|P7|Overall Study|Protocol Violation|3
5662870|NCT00483938|19550044|P6|Overall Study|Protocol Violation|0
5662871|NCT00483938|19550045|P5|Overall Study|Protocol Violation|0
5662872|NCT00483938|19550046|P4|Overall Study|Protocol Violation|0
5662873|NCT00483938|19550047|P3|Overall Study|Protocol Violation|0
5662874|NCT00483938|19550048|P2|Overall Study|Protocol Violation|0
5662875|NCT00483938|19550049|P1|Overall Study|Protocol Violation|0
5662876|NCT00483756|19550073|P3|Overall Study|Randomized, Not Treated|4
5662877|NCT00483756|19550074|P2|Overall Study|Randomized, Not Treated|4
5662878|NCT00483756|19550075|P1|Overall Study|Randomized, Not Treated|1
5662879|NCT00483756|19550073|P3|Overall Study|Other|3
5662880|NCT00483756|19550074|P2|Overall Study|Other|4
5662881|NCT00483756|19550075|P1|Overall Study|Other|2
5662882|NCT00483756|19550073|P3|Overall Study|Withdrawal by Subject|4
5662883|NCT00483756|19550074|P2|Overall Study|Withdrawal by Subject|3
5662884|NCT00483756|19550075|P1|Overall Study|Withdrawal by Subject|5
5662885|NCT00483756|19550073|P3|Overall Study|Lost to Follow-up|0
5662886|NCT00483756|19550074|P2|Overall Study|Lost to Follow-up|1
5662887|NCT00483756|19550075|P1|Overall Study|Lost to Follow-up|3
5662888|NCT00483756|19550073|P3|Overall Study|Lack of Efficacy|0
5662889|NCT00483756|19550074|P2|Overall Study|Lack of Efficacy|0
5662890|NCT00483756|19550075|P1|Overall Study|Lack of Efficacy|1
5662891|NCT00483756|19550073|P3|Overall Study|Adverse Event|40
5662892|NCT00483756|19550074|P2|Overall Study|Adverse Event|38
5662893|NCT00483756|19550075|P1|Overall Study|Adverse Event|19
5662894|NCT00483756|19550073|P3|Overall Study|Death|1
5662895|NCT00483756|19550074|P2|Overall Study|Death|0
5662896|NCT00483756|19550075|P1|Overall Study|Death|2
5662897|NCT00483717|19550139|P2|Overall Study|Withdrawal by Subject|0
5662898|NCT00483717|19550140|P1|Overall Study|Withdrawal by Subject|1
5662899|NCT00483717|19550139|P2|Overall Study|Lost to Follow-up|0
5662900|NCT00483717|19550140|P1|Overall Study|Lost to Follow-up|1
5662901|NCT00483717|19550139|P2|Overall Study|No treatment for migraine|13
5662902|NCT00483717|19550140|P1|Overall Study|No treatment for migraine|16
5662903|NCT00483717|19550139|P2|Overall Study|Time of dosing missing|1
5662904|NCT00483717|19550140|P1|Overall Study|Time of dosing missing|1
5662905|NCT00483717|19550139|P2|Overall Study|Protocol Violation|7
5662906|NCT00483717|19550140|P1|Overall Study|Protocol Violation|5
5662907|NCT00483704|19550163|P3|Treatment|Physician Decision|4
5662908|NCT00483704|19550164|P2|Treatment|Physician Decision|1
5662909|NCT00483704|19550165|P1|Treatment|Physician Decision|0
5662910|NCT00483704|19550163|P3|Treatment|Pregnancy|0
5662911|NCT00483704|19550164|P2|Treatment|Pregnancy|1
5662912|NCT00483704|19550165|P1|Treatment|Pregnancy|0
5662913|NCT00483704|19550163|P3|Treatment|Lack of Efficacy|1
5662914|NCT00483704|19550164|P2|Treatment|Lack of Efficacy|1
5662915|NCT00483704|19550165|P1|Treatment|Lack of Efficacy|1
5662916|NCT00483704|19550163|P3|Treatment|Lost to Follow-up|5
5662917|NCT00483704|19550164|P2|Treatment|Lost to Follow-up|7
5662918|NCT00483704|19550165|P1|Treatment|Lost to Follow-up|2
5662919|NCT00483704|19550163|P3|Treatment|Protocol Violation|5
5662920|NCT00483704|19550164|P2|Treatment|Protocol Violation|3
5662921|NCT00483704|19550165|P1|Treatment|Protocol Violation|6
5662922|NCT00483704|19550163|P3|Treatment|Withdrawal by Subject|21
5662923|NCT00483704|19550164|P2|Treatment|Withdrawal by Subject|12
5662924|NCT00483704|19550165|P1|Treatment|Withdrawal by Subject|16
5662925|NCT00483704|19550163|P3|Treatment|Adverse Event|4
5662926|NCT00483704|19550164|P2|Treatment|Adverse Event|5
5662927|NCT00483704|19550165|P1|Treatment|Adverse Event|3
5662928|NCT00483704|19550163|P3|Treatment|Lack of qualifying migraines|116
5662929|NCT00483704|19550164|P2|Treatment|Lack of qualifying migraines|99
5662930|NCT00483704|19550165|P1|Treatment|Lack of qualifying migraines|101
5662931|NCT00483704|19550163|P3|Randomization|Lack of qualifying migraines|31
5662932|NCT00483704|19550164|P2|Randomization|Lack of qualifying migraines|25
5662933|NCT00483704|19550165|P1|Randomization|Lack of qualifying migraines|21
5662934|NCT00483704|19550163|P3|Randomization|Progressive disease|1
5662935|NCT00483704|19550164|P2|Randomization|Progressive disease|0
5662936|NCT00483704|19550165|P1|Randomization|Progressive disease|0
5662937|NCT00483704|19550163|P3|Randomization|Physician Decision|0
5662938|NCT00483704|19550164|P2|Randomization|Physician Decision|4
5662939|NCT00483704|19550165|P1|Randomization|Physician Decision|2
5662940|NCT00483704|19550163|P3|Randomization|Pregnancy|0
5662941|NCT00483704|19550164|P2|Randomization|Pregnancy|0
5662942|NCT00483704|19550165|P1|Randomization|Pregnancy|1
5662943|NCT00483704|19550163|P3|Randomization|Lost to Follow-up|19
5662944|NCT00483704|19550164|P2|Randomization|Lost to Follow-up|14
5662945|NCT00483704|19550165|P1|Randomization|Lost to Follow-up|14
5662946|NCT00483704|19550163|P3|Randomization|Protocol Violation|22
5662947|NCT00483704|19550164|P2|Randomization|Protocol Violation|25
5662948|NCT00483704|19550165|P1|Randomization|Protocol Violation|14
5662949|NCT00483704|19550163|P3|Randomization|Withdrawal by Subject|18
5662950|NCT00483704|19550164|P2|Randomization|Withdrawal by Subject|28
5662951|NCT00483704|19550165|P1|Randomization|Withdrawal by Subject|19
5662952|NCT00483652|19550211|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
5662953|NCT00483652|19550212|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
5662954|NCT00483652|19550211|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
5662955|NCT00483652|19550212|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
5662956|NCT00483652|19550211|P2|Double-blind Treatment Period|Adverse Event|4
5662957|NCT00483652|19550212|P1|Double-blind Treatment Period|Adverse Event|3
5662958|NCT00483652|19550211|P2|Double-blind Treatment Period|Protocol Violation|1
5662959|NCT00483652|19550212|P1|Double-blind Treatment Period|Protocol Violation|2
5662960|NCT00483574|19550222|P2|Overall Study|Withdrawal by Subject|0
5662961|NCT00483574|19550223|P1|Overall Study|Withdrawal by Subject|52
5662962|NCT00483574|19550222|P2|Overall Study|Lost to Follow-up|4
5662963|NCT00483574|19550223|P1|Overall Study|Lost to Follow-up|16
5662964|NCT00483574|19550222|P2|Overall Study|Protocol Violation|9
5662965|NCT00483574|19550223|P1|Overall Study|Protocol Violation|28
5662966|NCT00483574|19550222|P2|Overall Study|Adverse Event|0
5662967|NCT00483574|19550223|P1|Overall Study|Adverse Event|6
5662968|NCT00483548|19550238|P2|Overall Study|Withdrawal by Subject|2
5662969|NCT00483548|19550239|P1|Overall Study|Withdrawal by Subject|5
5662970|NCT00483548|19550238|P2|Overall Study|Lost to Follow-up|4
5662971|NCT00483548|19550239|P1|Overall Study|Lost to Follow-up|3
5662972|NCT00483548|19550238|P2|Overall Study|Non-compliance with medication|0
5662973|NCT00483548|19550239|P1|Overall Study|Non-compliance with medication|2
5662974|NCT00483548|19550238|P2|Overall Study|Unable to comply with protocol schedule|0
5662975|NCT00483548|19550239|P1|Overall Study|Unable to comply with protocol schedule|1
5662976|NCT00483548|19550238|P2|Overall Study|Protocol required discontinuation|6
5662977|NCT00483548|19550239|P1|Overall Study|Protocol required discontinuation|6
5662978|NCT00483548|19550238|P2|Overall Study|Pregnancy|0
5662979|NCT00483548|19550239|P1|Overall Study|Pregnancy|1
5662980|NCT00483548|19550238|P2|Overall Study|Protocol Violation|7
5662981|NCT00483548|19550239|P1|Overall Study|Protocol Violation|11
5662982|NCT00483548|19550238|P2|Overall Study|Lack of Efficacy|8
5662983|NCT00483548|19550239|P1|Overall Study|Lack of Efficacy|4
5662984|NCT00483548|19550238|P2|Overall Study|Laboratory abnormality|2
5662985|NCT00483548|19550239|P1|Overall Study|Laboratory abnormality|1
5662986|NCT00483548|19550238|P2|Overall Study|Adverse Event|14
5662987|NCT00483548|19550239|P1|Overall Study|Adverse Event|25
5662988|NCT00483548|19550238|P2|Overall Study|Randomized; not treated with study drug|3
5662989|NCT00483548|19550239|P1|Overall Study|Randomized; not treated with study drug|1
5662990|NCT00483405|19550297|P1|Overall Study|Other complicating disease|1
5662991|NCT00483405|19550297|P1|Overall Study|Withdrawal by Subject|2
5662992|NCT00483405|19550297|P1|Overall Study|Death|3
5662993|NCT00483405|19550297|P1|Overall Study|Lack of Efficacy|14
5662994|NCT00483405|19550297|P1|Overall Study|Adverse Event|8
5662995|NCT00483379|19550306|P2|Treatment Period|Withdrawal by Subject|0
5662996|NCT00483379|19550307|P1|Treatment Period|Withdrawal by Subject|1
5662997|NCT00483379|19550306|P2|Treatment Period|Adverse Event|0
5662998|NCT00483379|19550307|P1|Treatment Period|Adverse Event|1
5662999|NCT00483327|19550343|P1|Overall Study|Patient Non Compliance|2
5663000|NCT00483327|19550343|P1|Overall Study|Lost to Follow-up|4
5663001|NCT00483327|19550343|P1|Overall Study|Withdrawal by Subject|3
5663002|NCT00483327|19550343|P1|Overall Study|Adverse Event|1
5663003|NCT00483184|19550375|P3|Overall Study|Protocol Violation|1
5663004|NCT00483184|19550376|P2|Overall Study|Protocol Violation|0
5663005|NCT00483184|19550377|P1|Overall Study|Protocol Violation|1
5663006|NCT00483184|19550375|P3|Overall Study|Adverse Event|2
5663007|NCT00483184|19550376|P2|Overall Study|Adverse Event|2
5663008|NCT00483184|19550377|P1|Overall Study|Adverse Event|1
5663009|NCT00483184|19550375|P3|Overall Study|Lost to Follow-up|0
5663010|NCT00483184|19550376|P2|Overall Study|Lost to Follow-up|0
5663011|NCT00483184|19550377|P1|Overall Study|Lost to Follow-up|1
5663012|NCT00483184|19550375|P3|Overall Study|Withdrawal by Subject|0
5663013|NCT00483184|19550376|P2|Overall Study|Withdrawal by Subject|2
5663014|NCT00483184|19550377|P1|Overall Study|Withdrawal by Subject|2
5663015|NCT00483119|19550387|P2|Overall Study|Physician Decision|0
5663016|NCT00483119|19550388|P1|Overall Study|Physician Decision|1
5663017|NCT00483119|19550387|P2|Overall Study|Adverse Event|1
5663018|NCT00483119|19550388|P1|Overall Study|Adverse Event|0
5663019|NCT00483041|19550402|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
5663020|NCT00483041|19550403|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
5663021|NCT00483002|19550433|P1|Overall Study|Other|967
5663022|NCT00483002|19550433|P1|Overall Study|Other|2
5663023|NCT00483002|19550433|P1|Overall Study|Lost to Follow-up|962
5663024|NCT00483002|19550433|P1|Overall Study|Lack of Efficacy|555
5663025|NCT00483002|19550433|P1|Overall Study|Adverse Event|68
5663026|NCT00482729|19550458|P2|Overall Study|Withdrawal by Subject|69
5663027|NCT00482729|19550459|P1|Overall Study|Withdrawal by Subject|67
5663028|NCT00482729|19550458|P2|Overall Study|Protocol Violation|18
5663029|NCT00482729|19550459|P1|Overall Study|Protocol Violation|10
5663030|NCT00482729|19550458|P2|Overall Study|Pregnancy|2
5663031|NCT00482729|19550459|P1|Overall Study|Pregnancy|4
5663032|NCT00482729|19550458|P2|Overall Study|Physician Decision|7
5663033|NCT00482729|19550459|P1|Overall Study|Physician Decision|10
5663034|NCT00482729|19550458|P2|Overall Study|Lost to Follow-up|66
5663035|NCT00482729|19550459|P1|Overall Study|Lost to Follow-up|86
5663036|NCT00482729|19550458|P2|Overall Study|Lack of Efficacy|16
5663037|NCT00482729|19550459|P1|Overall Study|Lack of Efficacy|4
5663038|NCT00482729|19550458|P2|Overall Study|Hyperglycemia Criteria|5
5663039|NCT00482729|19550459|P1|Overall Study|Hyperglycemia Criteria|7
5663040|NCT00482729|19550458|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
5663041|NCT00482729|19550459|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
5663042|NCT00482729|19550458|P2|Overall Study|Adverse Event|33
5663043|NCT00482729|19550459|P1|Overall Study|Adverse Event|29
5663044|NCT00482703|19550475|P2|Overall Study|Poor compliance|0
5663045|NCT00482703|19550476|P1|Overall Study|Poor compliance|1
5663046|NCT00482612|19550547|P4|Follow-up Period|Reasons not related to trial|3
5663047|NCT00482612|19550548|P3|Follow-up Period|Reasons not related to trial|1
5663048|NCT00482612|19550549|P2|Follow-up Period|Reasons not related to trial|0
5663049|NCT00482612|19550550|P1|Follow-up Period|Reasons not related to trial|1
5663050|NCT00482612|19550547|P4|Follow-up Period|Withdrawal by Subject|2
5663051|NCT00482612|19550548|P3|Follow-up Period|Withdrawal by Subject|7
5663052|NCT00482612|19550549|P2|Follow-up Period|Withdrawal by Subject|5
5663053|NCT00482612|19550550|P1|Follow-up Period|Withdrawal by Subject|3
5663054|NCT00482612|19550547|P4|Follow-up Period|Lack of Efficacy|0
5663055|NCT00482612|19550548|P3|Follow-up Period|Lack of Efficacy|1
5663056|NCT00482612|19550549|P2|Follow-up Period|Lack of Efficacy|0
5663057|NCT00482612|19550550|P1|Follow-up Period|Lack of Efficacy|2
5663058|NCT00482612|19550547|P4|Follow-up Period|Adverse Event|0
5663059|NCT00482612|19550548|P3|Follow-up Period|Adverse Event|9
5663060|NCT00482612|19550549|P2|Follow-up Period|Adverse Event|7
5663061|NCT00482612|19550550|P1|Follow-up Period|Adverse Event|4
5663062|NCT00482612|19550547|P4|Follow-up Period|Lost to Follow-up|1
5663063|NCT00482612|19550548|P3|Follow-up Period|Lost to Follow-up|2
5663064|NCT00482612|19550549|P2|Follow-up Period|Lost to Follow-up|4
5663065|NCT00482612|19550550|P1|Follow-up Period|Lost to Follow-up|0
5663066|NCT00482612|19550547|P4|Follow-up Period|Lack of compliance|0
5663067|NCT00482612|19550548|P3|Follow-up Period|Lack of compliance|1
5663068|NCT00482612|19550549|P2|Follow-up Period|Lack of compliance|0
5663069|NCT00482612|19550550|P1|Follow-up Period|Lack of compliance|0
5663070|NCT00482612|19550547|P4|Follow-up Period|Other|2
5663071|NCT00482612|19550548|P3|Follow-up Period|Other|1
5663072|NCT00482612|19550549|P2|Follow-up Period|Other|2
5663073|NCT00482612|19550550|P1|Follow-up Period|Other|4
5663074|NCT00482612|19550547|P4|In-treatment Period|No study medication administered|0
5663075|NCT00482612|19550548|P3|In-treatment Period|No study medication administered|1
5663076|NCT00482612|19550549|P2|In-treatment Period|No study medication administered|0
5663077|NCT00482612|19550550|P1|In-treatment Period|No study medication administered|0
5663078|NCT00482391|19550599|P1|Overall Study|Death|1
5663079|NCT00482391|19550599|P1|Overall Study|Adverse Event|1
5663080|NCT00482391|19550599|P1|Overall Study|Withdrawal by Subject|1
5663081|NCT00482274|19550604|P1|Overall Study|Adverse Event|1
5663082|NCT00482170|19550614|P2|Overall Study|Unspecified reason|2
5663083|NCT00482170|19550615|P1|Overall Study|Unspecified reason|0
5663084|NCT00482170|19550614|P2|Overall Study|Lost to Follow-up|0
5663085|NCT00482170|19550615|P1|Overall Study|Lost to Follow-up|2
5663086|NCT00482170|19550614|P2|Overall Study|Protocol Violation|3
5663087|NCT00482170|19550615|P1|Overall Study|Protocol Violation|2
5663088|NCT00482170|19550614|P2|Overall Study|Withdrawal by Subject|1
5663089|NCT00482170|19550615|P1|Overall Study|Withdrawal by Subject|6
5663090|NCT00482170|19550614|P2|Overall Study|Adverse Event|14
5663091|NCT00482170|19550615|P1|Overall Study|Adverse Event|5
5663092|NCT00482053|19550733|P1|Inter-treatment Period|Disease progression|1
5663093|NCT00482014|19550747|P4|Overall Study|Sponsor Decision|1
5663094|NCT00482014|19550748|P3|Overall Study|Sponsor Decision|1
5663095|NCT00482014|19550749|P2|Overall Study|Sponsor Decision|2
5663096|NCT00482014|19550750|P1|Overall Study|Sponsor Decision|1
5663097|NCT00482014|19550747|P4|Overall Study|Lack of Efficacy|6
5663098|NCT00482014|19550748|P3|Overall Study|Lack of Efficacy|4
5663099|NCT00482014|19550749|P2|Overall Study|Lack of Efficacy|0
5663100|NCT00482014|19550750|P1|Overall Study|Lack of Efficacy|1
5663101|NCT00482014|19550747|P4|Overall Study|Death|4
5663102|NCT00482014|19550748|P3|Overall Study|Death|1
5663103|NCT00482014|19550749|P2|Overall Study|Death|2
5663104|NCT00482014|19550750|P1|Overall Study|Death|1
5663105|NCT00482014|19550747|P4|Overall Study|Adverse Event|8
5663106|NCT00482014|19550748|P3|Overall Study|Adverse Event|2
5663107|NCT00482014|19550749|P2|Overall Study|Adverse Event|0
5663108|NCT00482014|19550750|P1|Overall Study|Adverse Event|3
5663109|NCT00482014|19550747|P4|Overall Study|Withdrawal by Subject|4
5663110|NCT00482014|19550748|P3|Overall Study|Withdrawal by Subject|3
5663111|NCT00482014|19550749|P2|Overall Study|Withdrawal by Subject|2
5663112|NCT00482014|19550750|P1|Overall Study|Withdrawal by Subject|1
5663113|NCT00482001|19550774|P2|Overall Study|Protocol Violation|1
5663114|NCT00482001|19550775|P1|Overall Study|Protocol Violation|1
5663115|NCT00481988|19550795|P2|Overall Study|Withdrawal by Subject|1
5663116|NCT00481988|19550796|P1|Overall Study|Withdrawal by Subject|1
5663117|NCT00481871|19550809|P5|Overall Study|Progressive Disease - pt withdrew|0
5663118|NCT00481871|19550810|P4|Overall Study|Progressive Disease - pt withdrew|0
5663119|NCT00481871|19550811|P3|Overall Study|Progressive Disease - pt withdrew|1
5663120|NCT00481871|19550812|P2|Overall Study|Progressive Disease - pt withdrew|0
5663121|NCT00481871|19550813|P1|Overall Study|Progressive Disease - pt withdrew|0
5663122|NCT00481832|19550838|P1|Inter-transplant Period|Lack of allogeneic donor|5
5663123|NCT00481832|19550838|P1|Inter-transplant Period|Disease relapse|11
5663124|NCT00481832|19550838|P1|Inter-transplant Period|Physician Decision|4
5663125|NCT00481832|19550838|P1|Inter-transplant Period|Death|3
5663126|NCT00481832|19550838|P1|Inter-transplant Period|Adverse Event|4
5663127|NCT00481832|19550838|P1|Enrollment|Unable to collect enough stem cells|2
5663128|NCT00481832|19550838|P1|Enrollment|Physician Decision|8
5663129|NCT00481767|19550853|P2|Overall Study|Lost to Follow-up|10
5663130|NCT00481767|19550854|P1|Overall Study|Lost to Follow-up|16
5663131|NCT00481767|19550853|P2|Overall Study|Withdrawal by Subject|11
5663132|NCT00481767|19550854|P1|Overall Study|Withdrawal by Subject|16
5663133|NCT00481676|19550888|P2|Overall Study|Administrative problem|0
5663134|NCT00481676|19550889|P1|Overall Study|Administrative problem|1
5663135|NCT00481676|19550888|P2|Overall Study|Unsatisfactory therapeutic effect|4
5663136|NCT00481676|19550889|P1|Overall Study|Unsatisfactory therapeutic effect|1
5663137|NCT00481676|19550888|P2|Overall Study|Adverse Event|1
5663138|NCT00481676|19550889|P1|Overall Study|Adverse Event|0
5663139|NCT00481247|19550941|P2|Overall Study|Did not receive treatment|2
5663140|NCT00481247|19550942|P1|Overall Study|Did not receive treatment|1
5663141|NCT00481247|19550941|P2|Overall Study|Varied|15
5663142|NCT00481247|19550942|P1|Overall Study|Varied|6
5663143|NCT00481247|19550941|P2|Overall Study|Administrative reason by sponsor|162
5663144|NCT00481247|19550942|P1|Overall Study|Administrative reason by sponsor|157
5663145|NCT00481247|19550941|P2|Overall Study|Poor compliance/noncompliance|7
5663146|NCT00481247|19550942|P1|Overall Study|Poor compliance/noncompliance|1
5663147|NCT00481247|19550941|P2|Overall Study|Lost to Follow-up|2
5663148|NCT00481247|19550942|P1|Overall Study|Lost to Follow-up|1
5663149|NCT00481247|19550941|P2|Overall Study|Pregnancy|1
5663150|NCT00481247|19550942|P1|Overall Study|Pregnancy|2
5663151|NCT00481247|19550941|P2|Overall Study|Withdrawal by Subject|13
5663152|NCT00481247|19550942|P1|Overall Study|Withdrawal by Subject|8
5663153|NCT00481247|19550941|P2|Overall Study|AE unrelated to study drug|4
5663154|NCT00481247|19550942|P1|Overall Study|AE unrelated to study drug|13
5663155|NCT00481247|19550941|P2|Overall Study|Treatment failure|14
5663156|NCT00481247|19550942|P1|Overall Study|Treatment failure|10
5663157|NCT00481247|19550941|P2|Overall Study|Intolerance|17
5663158|NCT00481247|19550942|P1|Overall Study|Intolerance|42
5663159|NCT00481247|19550941|P2|Overall Study|Disease progression|22
5663160|NCT00481247|19550942|P1|Overall Study|Disease progression|18
5663161|NCT00481247|19550941|P2|Overall Study|Death|1
5663162|NCT00481247|19550942|P1|Overall Study|Death|0
5663163|NCT00481195|19550966|P2|Overall Study|Miscellaneous|2
5663164|NCT00481195|19550967|P1|Overall Study|Miscellaneous|2
5663165|NCT00481195|19550966|P2|Overall Study|Withdrawal by Subject|9
5663166|NCT00481195|19550967|P1|Overall Study|Withdrawal by Subject|3
5663167|NCT00481195|19550966|P2|Overall Study|Protocol Violation|7
5663168|NCT00481195|19550967|P1|Overall Study|Protocol Violation|10
5663169|NCT00481195|19550966|P2|Overall Study|Physician Decision|1
5663170|NCT00481195|19550967|P1|Overall Study|Physician Decision|3
5663171|NCT00481195|19550966|P2|Overall Study|Lost to Follow-up|6
5663172|NCT00481195|19550967|P1|Overall Study|Lost to Follow-up|4
5663173|NCT00481195|19550966|P2|Overall Study|Lack of Efficacy|3
5663174|NCT00481195|19550967|P1|Overall Study|Lack of Efficacy|1
5663175|NCT00481195|19550966|P2|Overall Study|Adverse Event|11
5663176|NCT00481195|19550967|P1|Overall Study|Adverse Event|16
5663177|NCT00481078|19551053|P2|Overall Study|Brain metastasis|1
5663178|NCT00481078|19551054|P1|Overall Study|Brain metastasis|0
5663179|NCT00481078|19551053|P2|Overall Study|Received other treatment|1
5663180|NCT00481078|19551054|P1|Overall Study|Received other treatment|2
5663181|NCT00481078|19551053|P2|Overall Study|Information not available|0
5663182|NCT00481078|19551054|P1|Overall Study|Information not available|1
5663183|NCT00481078|19551053|P2|Overall Study|Withdrawal by Subject|1
5663184|NCT00481078|19551054|P1|Overall Study|Withdrawal by Subject|7
5663185|NCT00481078|19551053|P2|Overall Study|Intercurrent illness|0
5663186|NCT00481078|19551054|P1|Overall Study|Intercurrent illness|1
5663187|NCT00481078|19551053|P2|Overall Study|Death|3
5663188|NCT00481078|19551054|P1|Overall Study|Death|5
5663189|NCT00481078|19551053|P2|Overall Study|Adverse Event|3
5663190|NCT00481078|19551054|P1|Overall Study|Adverse Event|15
5663191|NCT00481078|19551053|P2|Overall Study|Progression of disease|11
5663192|NCT00481078|19551054|P1|Overall Study|Progression of disease|11
5663193|NCT00481065|19551072|P8|Overall Study|Unable to classify|0
5663194|NCT00481065|19551073|P7|Overall Study|Unable to classify|0
5663195|NCT00481065|19551074|P6|Overall Study|Unable to classify|0
5663196|NCT00481065|19551075|P5|Overall Study|Unable to classify|1
5663197|NCT00481065|19551076|P4|Overall Study|Unable to classify|0
5663198|NCT00481065|19551077|P3|Overall Study|Unable to classify|2
5663199|NCT00481065|19551078|P2|Overall Study|Unable to classify|1
5663200|NCT00481065|19551079|P1|Overall Study|Unable to classify|0
5663201|NCT00481065|19551072|P8|Overall Study|Protocol Violation|2
5663202|NCT00481065|19551073|P7|Overall Study|Protocol Violation|3
5663203|NCT00481065|19551074|P6|Overall Study|Protocol Violation|6
5663204|NCT00481065|19551075|P5|Overall Study|Protocol Violation|2
5663205|NCT00481065|19551076|P4|Overall Study|Protocol Violation|1
5663206|NCT00481065|19551077|P3|Overall Study|Protocol Violation|1
5663207|NCT00481065|19551078|P2|Overall Study|Protocol Violation|1
5663208|NCT00481065|19551079|P1|Overall Study|Protocol Violation|2
5663209|NCT00481065|19551072|P8|Overall Study|Administrative reason|0
5663210|NCT00481065|19551073|P7|Overall Study|Administrative reason|1
5663211|NCT00481065|19551074|P6|Overall Study|Administrative reason|2
5663212|NCT00481065|19551075|P5|Overall Study|Administrative reason|0
5663213|NCT00481065|19551076|P4|Overall Study|Administrative reason|0
5663214|NCT00481065|19551077|P3|Overall Study|Administrative reason|0
5663215|NCT00481065|19551078|P2|Overall Study|Administrative reason|0
5663216|NCT00481065|19551079|P1|Overall Study|Administrative reason|0
5663217|NCT00481065|19551072|P8|Overall Study|Inappropriate enrollment|1
5663218|NCT00481065|19551073|P7|Overall Study|Inappropriate enrollment|0
5663219|NCT00481065|19551074|P6|Overall Study|Inappropriate enrollment|1
5663220|NCT00481065|19551075|P5|Overall Study|Inappropriate enrollment|2
5663221|NCT00481065|19551076|P4|Overall Study|Inappropriate enrollment|0
5663222|NCT00481065|19551077|P3|Overall Study|Inappropriate enrollment|2
5663223|NCT00481065|19551078|P2|Overall Study|Inappropriate enrollment|0
5663224|NCT00481065|19551079|P1|Overall Study|Inappropriate enrollment|4
5663225|NCT00481065|19551072|P8|Overall Study|Lost to Follow-up|5
5663226|NCT00481065|19551073|P7|Overall Study|Lost to Follow-up|2
5663227|NCT00481065|19551074|P6|Overall Study|Lost to Follow-up|3
5663228|NCT00481065|19551075|P5|Overall Study|Lost to Follow-up|3
5663229|NCT00481065|19551076|P4|Overall Study|Lost to Follow-up|3
5663230|NCT00481065|19551077|P3|Overall Study|Lost to Follow-up|4
5663231|NCT00481065|19551078|P2|Overall Study|Lost to Follow-up|2
5663232|NCT00481065|19551079|P1|Overall Study|Lost to Follow-up|4
5663233|NCT00481065|19551072|P8|Overall Study|Withdrawal by Subject|10
5663234|NCT00481065|19551073|P7|Overall Study|Withdrawal by Subject|9
5663235|NCT00481065|19551074|P6|Overall Study|Withdrawal by Subject|12
5663236|NCT00481065|19551075|P5|Overall Study|Withdrawal by Subject|13
5663237|NCT00481065|19551076|P4|Overall Study|Withdrawal by Subject|11
5663238|NCT00481065|19551077|P3|Overall Study|Withdrawal by Subject|7
5663239|NCT00481065|19551078|P2|Overall Study|Withdrawal by Subject|12
5663240|NCT00481065|19551079|P1|Overall Study|Withdrawal by Subject|11
5663241|NCT00481065|19551072|P8|Overall Study|Adverse event or death|1
5663242|NCT00481065|19551073|P7|Overall Study|Adverse event or death|1
5663243|NCT00481065|19551074|P6|Overall Study|Adverse event or death|0
5663244|NCT00481065|19551075|P5|Overall Study|Adverse event or death|2
5663245|NCT00481065|19551076|P4|Overall Study|Adverse event or death|0
5663246|NCT00481065|19551077|P3|Overall Study|Adverse event or death|3
5663247|NCT00481065|19551078|P2|Overall Study|Adverse event or death|1
5663248|NCT00481065|19551079|P1|Overall Study|Adverse event or death|1
5663249|NCT00480857|19551169|P1|Overall Study|Lack of Efficacy|2
5663250|NCT00480779|19551179|P2|Overall Study|Job and Health-related|3
5663251|NCT00480779|19551180|P1|Overall Study|Job and Health-related|0
5663252|NCT00480779|19551179|P2|Overall Study|Other|0
5663253|NCT00480779|19551180|P1|Overall Study|Other|2
5663254|NCT00480636|19551217|P1|Overall Study|Lost to follow-up; subsequently died|1
5663255|NCT00480636|19551217|P1|Overall Study|Other|2
5663256|NCT00480636|19551217|P1|Overall Study|Lost to Follow-up|4
5663257|NCT00480636|19551217|P1|Overall Study|Death|12
5663258|NCT00480532|19551229|P4|Overall Study|Protocol Violation|0
5663259|NCT00480532|19551230|P3|Overall Study|Protocol Violation|1
5663260|NCT00480532|19551231|P2|Overall Study|Protocol Violation|0
5663261|NCT00480532|19551232|P1|Overall Study|Protocol Violation|0
5663262|NCT00480532|19551229|P4|Overall Study|Withdrawal by Subject|1
5663263|NCT00480532|19551230|P3|Overall Study|Withdrawal by Subject|3
5663264|NCT00480532|19551231|P2|Overall Study|Withdrawal by Subject|4
5663265|NCT00480532|19551232|P1|Overall Study|Withdrawal by Subject|2
5663266|NCT00480493|19551252|P2|Overall Study|moved|7
5663267|NCT00480493|19551253|P1|Overall Study|moved|2
5663268|NCT00480441|19551265|P3|Randomization|Lost to Follow-up|2
5663269|NCT00480441|19551266|P2|Randomization|Lost to Follow-up|7
5663270|NCT00480441|19551267|P1|Randomization|Lost to Follow-up|0
5663271|NCT00480441|19551265|P3|Baseline Functional MRI|physical contraindication|0
5663272|NCT00480441|19551266|P2|Baseline Functional MRI|physical contraindication|0
5663434|NCT00479557|19551577|P5|Overall Study|Lack of Efficacy|0
5663273|NCT00480441|19551267|P1|Baseline Functional MRI|physical contraindication|4
5663274|NCT00480441|19551265|P3|Baseline Functional MRI|Lost to Follow-up|0
5663275|NCT00480441|19551266|P2|Baseline Functional MRI|Lost to Follow-up|0
5663276|NCT00480441|19551267|P1|Baseline Functional MRI|Lost to Follow-up|4
5663277|NCT00480441|19551265|P3|Baseline Functional MRI|Functional MRI data not usable|0
5663278|NCT00480441|19551266|P2|Baseline Functional MRI|Functional MRI data not usable|0
5663279|NCT00480441|19551267|P1|Baseline Functional MRI|Functional MRI data not usable|4
5663280|NCT00480441|19551265|P3|Screening|Not Eligible|0
5663281|NCT00480441|19551266|P2|Screening|Not Eligible|0
5663282|NCT00480441|19551267|P1|Screening|Not Eligible|37
5663283|NCT00480324|19551276|P2|Overall Study|Subject's mother pregnant|1
5663284|NCT00480324|19551277|P1|Overall Study|Subject's mother pregnant|0
5663285|NCT00480324|19551276|P2|Overall Study|Lost to Follow-up|8
5663286|NCT00480324|19551277|P1|Overall Study|Lost to Follow-up|17
5663287|NCT00480324|19551276|P2|Overall Study|Withdrawal by Subject|5
5663288|NCT00480324|19551277|P1|Overall Study|Withdrawal by Subject|14
5663289|NCT00480324|19551276|P2|Overall Study|Protocol Violation|1
5663290|NCT00480324|19551277|P1|Overall Study|Protocol Violation|0
5663291|NCT00480324|19551276|P2|Overall Study|Adverse Event|1
5663292|NCT00480324|19551277|P1|Overall Study|Adverse Event|1
5663293|NCT00480077|19551305|P2|Overall Study|early exit|11
5663294|NCT00480077|19551306|P1|Overall Study|early exit|12
5663295|NCT00480077|19551305|P2|Overall Study|Death|15
5663296|NCT00480077|19551306|P1|Overall Study|Death|19
5663297|NCT00480025|19551314|P2|Overall Study|SAE including intercurrent illness|42
5663298|NCT00480025|19551315|P1|Overall Study|SAE including intercurrent illness|76
5663299|NCT00480025|19551314|P2|Overall Study|Other|29
5663300|NCT00480025|19551315|P1|Overall Study|Other|70
5663301|NCT00480025|19551314|P2|Overall Study|Adverse Event|12
5663302|NCT00480025|19551315|P1|Overall Study|Adverse Event|44
5663303|NCT00480025|19551314|P2|Overall Study|Disease Progression / Recurrence|224
5663304|NCT00480025|19551315|P1|Overall Study|Disease Progression / Recurrence|449
5663305|NCT00480025|19551314|P2|Overall Study|Patients remaining ongoing at Data Lock|55
5663306|NCT00480025|19551315|P1|Overall Study|Patients remaining ongoing at Data Lock|101
5663307|NCT00480025|19551314|P2|Overall Study|Protocol Violation|7
5663308|NCT00480025|19551315|P1|Overall Study|Protocol Violation|12
5663309|NCT00479882|19551387|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
5663310|NCT00479882|19551388|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
5663311|NCT00479882|19551389|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
5663312|NCT00479882|19551390|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
5663313|NCT00479882|19551387|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
5663314|NCT00479882|19551388|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
5663315|NCT00479882|19551389|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
5663316|NCT00479882|19551390|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
5663317|NCT00479882|19551387|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
5663318|NCT00479882|19551388|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
5663319|NCT00479882|19551389|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
5663320|NCT00479882|19551390|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
5663321|NCT00479882|19551387|P4|Crossover: Period III (Weeks 13-20)|Other|2
5663322|NCT00479882|19551388|P3|Crossover: Period III (Weeks 13-20)|Other|2
5663323|NCT00479882|19551389|P2|Crossover: Period III (Weeks 13-20)|Other|0
5663324|NCT00479882|19551390|P1|Crossover: Period III (Weeks 13-20)|Other|5
5663325|NCT00479882|19551387|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
5663326|NCT00479882|19551388|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
5663327|NCT00479882|19551389|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
5663328|NCT00479882|19551390|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
5663329|NCT00479882|19551387|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
5663330|NCT00479882|19551388|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
5663331|NCT00479882|19551389|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
5663332|NCT00479882|19551390|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
5663333|NCT00479882|19551387|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
5663334|NCT00479882|19551388|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
5663335|NCT00479882|19551389|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
5663336|NCT00479882|19551390|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
5663337|NCT00479882|19551387|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
5663338|NCT00479882|19551388|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
5663339|NCT00479882|19551389|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
5663340|NCT00479882|19551390|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
5663341|NCT00479882|19551387|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
5663342|NCT00479882|19551388|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
5663343|NCT00479882|19551389|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
5663344|NCT00479882|19551390|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
5663345|NCT00479882|19551387|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
5663346|NCT00479882|19551388|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
5663347|NCT00479882|19551389|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
5663348|NCT00479882|19551390|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
5663349|NCT00479882|19551387|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
5663350|NCT00479882|19551388|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
5663351|NCT00479882|19551389|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
5663352|NCT00479882|19551390|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
5663353|NCT00479882|19551387|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
5663354|NCT00479882|19551388|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
5663355|NCT00479882|19551389|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
5663356|NCT00479882|19551390|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
5663357|NCT00479882|19551387|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
5663358|NCT00479882|19551388|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
5663359|NCT00479882|19551389|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
5663360|NCT00479882|19551390|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
5663361|NCT00479882|19551387|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
5663362|NCT00479882|19551388|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
5663363|NCT00479882|19551389|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
5663364|NCT00479882|19551390|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
5663365|NCT00479856|19551520|P1|Overall Study|Physician Decision|1
5663366|NCT00479856|19551520|P1|Overall Study|Withdrawal by Subject|1
5663367|NCT00479856|19551520|P1|Overall Study|Adverse Event|1
5663368|NCT00479765|19551529|P1|Overall Study|study terminated|4
5663369|NCT00479713|19551535|P2|Overall Study|Withdrawal by Subject|1
5663370|NCT00479713|19551536|P1|Overall Study|Withdrawal by Subject|4
5663371|NCT00479713|19551535|P2|Overall Study|Protocol Violation|1
5663372|NCT00479713|19551536|P1|Overall Study|Protocol Violation|0
5663373|NCT00479713|19551535|P2|Overall Study|Lost to Follow-up|1
5663374|NCT00479713|19551536|P1|Overall Study|Lost to Follow-up|0
5663375|NCT00479713|19551535|P2|Overall Study|Death|0
5663376|NCT00479713|19551536|P1|Overall Study|Death|1
5663377|NCT00479713|19551535|P2|Overall Study|Adverse Event|6
5663378|NCT00479713|19551536|P1|Overall Study|Adverse Event|8
5663379|NCT00479674|19551560|P1|Overall Study|none provided|3
5663380|NCT00479674|19551560|P1|Overall Study|Physician Decision|14
5663381|NCT00479674|19551560|P1|Overall Study|Withdrawal by Subject|6
5663382|NCT00479674|19551560|P1|Overall Study|Adverse Event|18
5663383|NCT00479557|19551575|P7|Overall Study|Other|0
5663384|NCT00479557|19551576|P6|Overall Study|Other|3
5663385|NCT00479557|19551577|P5|Overall Study|Other|0
5663386|NCT00479557|19551578|P4|Overall Study|Other|0
5663387|NCT00479557|19551579|P3|Overall Study|Other|1
5663388|NCT00479557|19551580|P2|Overall Study|Other|3
5663389|NCT00479557|19551581|P1|Overall Study|Other|2
5663390|NCT00479557|19551575|P7|Overall Study|Subject Request|1
5663391|NCT00479557|19551576|P6|Overall Study|Subject Request|4
5663392|NCT00479557|19551577|P5|Overall Study|Subject Request|1
5663393|NCT00479557|19551578|P4|Overall Study|Subject Request|1
5663394|NCT00479557|19551579|P3|Overall Study|Subject Request|1
5663395|NCT00479557|19551580|P2|Overall Study|Subject Request|0
5663396|NCT00479557|19551581|P1|Overall Study|Subject Request|3
5663397|NCT00479557|19551575|P7|Overall Study|Investigator Request|0
5663398|NCT00479557|19551576|P6|Overall Study|Investigator Request|0
5663399|NCT00479557|19551577|P5|Overall Study|Investigator Request|0
5663400|NCT00479557|19551578|P4|Overall Study|Investigator Request|0
5663401|NCT00479557|19551579|P3|Overall Study|Investigator Request|1
5663402|NCT00479557|19551580|P2|Overall Study|Investigator Request|0
5663403|NCT00479557|19551581|P1|Overall Study|Investigator Request|0
5663404|NCT00479557|19551575|P7|Overall Study|Caregiver Request|0
5663405|NCT00479557|19551576|P6|Overall Study|Caregiver Request|2
5663406|NCT00479557|19551577|P5|Overall Study|Caregiver Request|1
5663407|NCT00479557|19551578|P4|Overall Study|Caregiver Request|0
5663408|NCT00479557|19551579|P3|Overall Study|Caregiver Request|2
5663409|NCT00479557|19551580|P2|Overall Study|Caregiver Request|2
5663410|NCT00479557|19551581|P1|Overall Study|Caregiver Request|2
5663411|NCT00479557|19551575|P7|Overall Study|AE not related to Study Drug|1
5663412|NCT00479557|19551576|P6|Overall Study|AE not related to Study Drug|2
5663413|NCT00479557|19551577|P5|Overall Study|AE not related to Study Drug|2
5663414|NCT00479557|19551578|P4|Overall Study|AE not related to Study Drug|0
5663415|NCT00479557|19551579|P3|Overall Study|AE not related to Study Drug|0
5663416|NCT00479557|19551580|P2|Overall Study|AE not related to Study Drug|3
5663417|NCT00479557|19551581|P1|Overall Study|AE not related to Study Drug|1
5663418|NCT00479557|19551575|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
5663419|NCT00479557|19551576|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
5663420|NCT00479557|19551577|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
5663421|NCT00479557|19551578|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
5663422|NCT00479557|19551579|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
5663423|NCT00479557|19551580|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
5663424|NCT00479557|19551581|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
5663425|NCT00479557|19551575|P7|Overall Study|Lost to Follow-up|0
5663426|NCT00479557|19551576|P6|Overall Study|Lost to Follow-up|0
5663427|NCT00479557|19551577|P5|Overall Study|Lost to Follow-up|0
5663428|NCT00479557|19551578|P4|Overall Study|Lost to Follow-up|2
5663429|NCT00479557|19551579|P3|Overall Study|Lost to Follow-up|0
5663430|NCT00479557|19551580|P2|Overall Study|Lost to Follow-up|2
5663431|NCT00479557|19551581|P1|Overall Study|Lost to Follow-up|0
5663432|NCT00479557|19551575|P7|Overall Study|Lack of Efficacy|0
5663433|NCT00479557|19551576|P6|Overall Study|Lack of Efficacy|0
5663435|NCT00479557|19551578|P4|Overall Study|Lack of Efficacy|0
5663436|NCT00479557|19551579|P3|Overall Study|Lack of Efficacy|0
5663437|NCT00479557|19551580|P2|Overall Study|Lack of Efficacy|0
5663438|NCT00479557|19551581|P1|Overall Study|Lack of Efficacy|1
5663439|NCT00479557|19551575|P7|Overall Study|Death|0
5663440|NCT00479557|19551576|P6|Overall Study|Death|1
5663441|NCT00479557|19551577|P5|Overall Study|Death|0
5663442|NCT00479557|19551578|P4|Overall Study|Death|0
5663443|NCT00479557|19551579|P3|Overall Study|Death|0
5663444|NCT00479557|19551580|P2|Overall Study|Death|0
5663445|NCT00479557|19551581|P1|Overall Study|Death|0
5663446|NCT00479466|19551624|P6|Overall Study|Withdrawal by Subject|1
5663447|NCT00479466|19551625|P5|Overall Study|Withdrawal by Subject|3
5663448|NCT00479466|19551626|P4|Overall Study|Withdrawal by Subject|2
5663449|NCT00479466|19551627|P3|Overall Study|Withdrawal by Subject|0
5663450|NCT00479466|19551628|P2|Overall Study|Withdrawal by Subject|5
5663451|NCT00479466|19551629|P1|Overall Study|Withdrawal by Subject|3
5663452|NCT00479466|19551624|P6|Overall Study|Protocol Violation|0
5663453|NCT00479466|19551625|P5|Overall Study|Protocol Violation|0
5663454|NCT00479466|19551626|P4|Overall Study|Protocol Violation|0
5663455|NCT00479466|19551627|P3|Overall Study|Protocol Violation|0
5663456|NCT00479466|19551628|P2|Overall Study|Protocol Violation|0
5663457|NCT00479466|19551629|P1|Overall Study|Protocol Violation|1
5663458|NCT00479466|19551624|P6|Overall Study|Pregnancy|0
5663459|NCT00479466|19551625|P5|Overall Study|Pregnancy|1
5663460|NCT00479466|19551626|P4|Overall Study|Pregnancy|0
5663461|NCT00479466|19551627|P3|Overall Study|Pregnancy|0
5663462|NCT00479466|19551628|P2|Overall Study|Pregnancy|0
5663463|NCT00479466|19551629|P1|Overall Study|Pregnancy|0
5663464|NCT00479466|19551624|P6|Overall Study|Physician Decision|0
5663465|NCT00479466|19551625|P5|Overall Study|Physician Decision|0
5663466|NCT00479466|19551626|P4|Overall Study|Physician Decision|0
5663467|NCT00479466|19551627|P3|Overall Study|Physician Decision|1
5663468|NCT00479466|19551628|P2|Overall Study|Physician Decision|1
5663469|NCT00479466|19551629|P1|Overall Study|Physician Decision|2
5663470|NCT00479466|19551624|P6|Overall Study|Lost to Follow-up|2
5663471|NCT00479466|19551625|P5|Overall Study|Lost to Follow-up|2
5663472|NCT00479466|19551626|P4|Overall Study|Lost to Follow-up|0
5663473|NCT00479466|19551627|P3|Overall Study|Lost to Follow-up|1
5663474|NCT00479466|19551628|P2|Overall Study|Lost to Follow-up|1
5663475|NCT00479466|19551629|P1|Overall Study|Lost to Follow-up|0
5663476|NCT00479466|19551624|P6|Overall Study|Lack of Efficacy|0
5663477|NCT00479466|19551625|P5|Overall Study|Lack of Efficacy|0
5663478|NCT00479466|19551626|P4|Overall Study|Lack of Efficacy|0
5663479|NCT00479466|19551627|P3|Overall Study|Lack of Efficacy|1
5663480|NCT00479466|19551628|P2|Overall Study|Lack of Efficacy|0
5663481|NCT00479466|19551629|P1|Overall Study|Lack of Efficacy|2
5663482|NCT00479466|19551624|P6|Overall Study|Hyperglycemia|1
5663483|NCT00479466|19551625|P5|Overall Study|Hyperglycemia|0
5663484|NCT00479466|19551626|P4|Overall Study|Hyperglycemia|0
5663485|NCT00479466|19551627|P3|Overall Study|Hyperglycemia|0
5663486|NCT00479466|19551628|P2|Overall Study|Hyperglycemia|0
5663487|NCT00479466|19551629|P1|Overall Study|Hyperglycemia|0
5663488|NCT00479466|19551624|P6|Overall Study|Adverse Event|0
5663489|NCT00479466|19551625|P5|Overall Study|Adverse Event|2
5663490|NCT00479466|19551626|P4|Overall Study|Adverse Event|1
5663491|NCT00479466|19551627|P3|Overall Study|Adverse Event|0
5663492|NCT00479466|19551628|P2|Overall Study|Adverse Event|1
5663493|NCT00479466|19551629|P1|Overall Study|Adverse Event|5
5663494|NCT00479401|19551658|P3|Overall Study|Exclusion criteria, relocation|0
5663495|NCT00479401|19551659|P2|Overall Study|Exclusion criteria, relocation|3
5663496|NCT00479401|19551660|P1|Overall Study|Exclusion criteria, relocation|4
5663497|NCT00479401|19551658|P3|Overall Study|Withdrawal by Subject|2
5663498|NCT00479401|19551659|P2|Overall Study|Withdrawal by Subject|10
5663499|NCT00479401|19551660|P1|Overall Study|Withdrawal by Subject|16
5663500|NCT00479401|19551658|P3|Overall Study|Lost to Follow-up|1
5663501|NCT00479401|19551659|P2|Overall Study|Lost to Follow-up|1
5663502|NCT00479401|19551660|P1|Overall Study|Lost to Follow-up|1
5663503|NCT00479401|19551658|P3|Overall Study|Protocol Violation|1
5663504|NCT00479401|19551659|P2|Overall Study|Protocol Violation|1
5663505|NCT00479401|19551660|P1|Overall Study|Protocol Violation|2
5663506|NCT00479401|19551658|P3|Overall Study|Lack of Efficacy|4
5663507|NCT00479401|19551659|P2|Overall Study|Lack of Efficacy|2
5663508|NCT00479401|19551660|P1|Overall Study|Lack of Efficacy|2
5663509|NCT00479401|19551658|P3|Overall Study|Adverse Event|4
5663510|NCT00479401|19551659|P2|Overall Study|Adverse Event|20
5663511|NCT00479401|19551660|P1|Overall Study|Adverse Event|24
5663512|NCT00479388|19551715|P2|Overall Study|Withdrawal by Subject|17
5663513|NCT00479388|19551716|P1|Overall Study|Withdrawal by Subject|32
5663514|NCT00479388|19551715|P2|Overall Study|Protocol Violation|9
5663515|NCT00479388|19551716|P1|Overall Study|Protocol Violation|10
5663516|NCT00479388|19551715|P2|Overall Study|Lost to Follow-up|2
5663517|NCT00479388|19551716|P1|Overall Study|Lost to Follow-up|0
5663518|NCT00479388|19551715|P2|Overall Study|Adverse Event|45
5663519|NCT00479388|19551716|P1|Overall Study|Adverse Event|90
5663520|NCT00479336|19551730|P4|Overall Study|Resolution of all hepatic edema findings|0
5663521|NCT00479336|19551731|P3|Overall Study|Resolution of all hepatic edema findings|0
5663522|NCT00479336|19551732|P2|Overall Study|Resolution of all hepatic edema findings|1
5663523|NCT00479336|19551733|P1|Overall Study|Resolution of all hepatic edema findings|1
5663524|NCT00479336|19551730|P4|Overall Study|Physician Decision|2
5663525|NCT00479336|19551731|P3|Overall Study|Physician Decision|0
5663526|NCT00479336|19551732|P2|Overall Study|Physician Decision|1
5663527|NCT00479336|19551733|P1|Overall Study|Physician Decision|0
5663528|NCT00479336|19551730|P4|Overall Study|Withdrawal by Subject|0
5663529|NCT00479336|19551731|P3|Overall Study|Withdrawal by Subject|0
5663530|NCT00479336|19551732|P2|Overall Study|Withdrawal by Subject|2
5663531|NCT00479336|19551733|P1|Overall Study|Withdrawal by Subject|1
5663532|NCT00479336|19551730|P4|Overall Study|Protocol Violation|0
5663533|NCT00479336|19551731|P3|Overall Study|Protocol Violation|0
5663534|NCT00479336|19551732|P2|Overall Study|Protocol Violation|1
5663535|NCT00479336|19551733|P1|Overall Study|Protocol Violation|0
5663536|NCT00479336|19551730|P4|Overall Study|Lack of Efficacy|0
5663537|NCT00479336|19551731|P3|Overall Study|Lack of Efficacy|0
5663538|NCT00479336|19551732|P2|Overall Study|Lack of Efficacy|0
5663539|NCT00479336|19551733|P1|Overall Study|Lack of Efficacy|1
5663540|NCT00479336|19551730|P4|Overall Study|Adverse Event|3
5663541|NCT00479336|19551731|P3|Overall Study|Adverse Event|1
5663542|NCT00479336|19551732|P2|Overall Study|Adverse Event|1
5663543|NCT00479336|19551733|P1|Overall Study|Adverse Event|1
5663544|NCT00479232|19551756|P6|Overall Study|Withdrew Consent|3
5663545|NCT00479232|19551757|P5|Overall Study|Withdrew Consent|1
5663546|NCT00479232|19551758|P4|Overall Study|Withdrew Consent|0
5663547|NCT00479232|19551759|P3|Overall Study|Withdrew Consent|6
5663548|NCT00479232|19551760|P2|Overall Study|Withdrew Consent|2
5663549|NCT00479232|19551761|P1|Overall Study|Withdrew Consent|0
5663550|NCT00479232|19551756|P6|Overall Study|Progressive Disease|12
5663551|NCT00479232|19551757|P5|Overall Study|Progressive Disease|3
5663552|NCT00479232|19551758|P4|Overall Study|Progressive Disease|3
5663553|NCT00479232|19551759|P3|Overall Study|Progressive Disease|12
5663554|NCT00479232|19551760|P2|Overall Study|Progressive Disease|1
5663555|NCT00479232|19551761|P1|Overall Study|Progressive Disease|3
5663556|NCT00479232|19551756|P6|Overall Study|Physician Decision|1
5663557|NCT00479232|19551757|P5|Overall Study|Physician Decision|0
5663558|NCT00479232|19551758|P4|Overall Study|Physician Decision|0
5663559|NCT00479232|19551759|P3|Overall Study|Physician Decision|2
5663560|NCT00479232|19551760|P2|Overall Study|Physician Decision|0
5663561|NCT00479232|19551761|P1|Overall Study|Physician Decision|0
5663562|NCT00479232|19551756|P6|Overall Study|Lack of Efficacy|4
5663563|NCT00479232|19551757|P5|Overall Study|Lack of Efficacy|0
5663564|NCT00479232|19551758|P4|Overall Study|Lack of Efficacy|0
5663565|NCT00479232|19551759|P3|Overall Study|Lack of Efficacy|2
5663566|NCT00479232|19551760|P2|Overall Study|Lack of Efficacy|0
5663567|NCT00479232|19551761|P1|Overall Study|Lack of Efficacy|0
5663568|NCT00479232|19551756|P6|Overall Study|Deviation from Protocol|0
5663569|NCT00479232|19551757|P5|Overall Study|Deviation from Protocol|0
5663570|NCT00479232|19551758|P4|Overall Study|Deviation from Protocol|0
5663571|NCT00479232|19551759|P3|Overall Study|Deviation from Protocol|1
5663572|NCT00479232|19551760|P2|Overall Study|Deviation from Protocol|0
5663573|NCT00479232|19551761|P1|Overall Study|Deviation from Protocol|0
5663574|NCT00479232|19551756|P6|Overall Study|Adverse Event|10
5663575|NCT00479232|19551757|P5|Overall Study|Adverse Event|0
5663576|NCT00479232|19551758|P4|Overall Study|Adverse Event|0
5663577|NCT00479232|19551759|P3|Overall Study|Adverse Event|5
5663578|NCT00479232|19551760|P2|Overall Study|Adverse Event|0
5663579|NCT00479232|19551761|P1|Overall Study|Adverse Event|0
5663580|NCT00478933|19551823|P1|Overall Study|Inadequate data available|53
5663581|NCT00478933|19551823|P1|Overall Study|Informed consent not verified|3
5663582|NCT00478933|19551823|P1|Overall Study|Protocol Violation|22
5663583|NCT00478881|19551849|P2|Overall Study|Non-Compliance with Study Medication|2
5663584|NCT00478881|19551850|P1|Overall Study|Non-Compliance with Study Medication|0
5663585|NCT00478881|19551849|P2|Overall Study|Withdrawal by Subject|2
5663586|NCT00478881|19551850|P1|Overall Study|Withdrawal by Subject|6
5663587|NCT00478881|19551849|P2|Overall Study|Protocol Violation|2
5663588|NCT00478881|19551850|P1|Overall Study|Protocol Violation|2
5663589|NCT00478881|19551849|P2|Overall Study|Lost to Follow-up|1
5663590|NCT00478881|19551850|P1|Overall Study|Lost to Follow-up|0
5663591|NCT00478881|19551849|P2|Overall Study|Lack of Efficacy|3
5663592|NCT00478881|19551850|P1|Overall Study|Lack of Efficacy|0
5663593|NCT00478881|19551849|P2|Overall Study|Adverse Event|12
5663594|NCT00478881|19551850|P1|Overall Study|Adverse Event|31
5663595|NCT00478777|19551874|P1|Overall Study|Not treated with lenalidomide|6
5663596|NCT00478777|19551874|P1|Overall Study|End of therapy|2
5663597|NCT00478777|19551874|P1|Overall Study|Lymphocytes infusion|1
5663598|NCT00478777|19551874|P1|Overall Study|Lack of compliance|1
5663599|NCT00478777|19551874|P1|Overall Study|Intolerance of therapy|1
5663600|NCT00478777|19551874|P1|Overall Study|Physician Decision|1
5663601|NCT00478777|19551874|P1|Overall Study|Lost to Follow-up|3
5663602|NCT00478777|19551874|P1|Overall Study|Protocol Violation|3
5663603|NCT00478777|19551874|P1|Overall Study|Death|3
5663604|NCT00478777|19551874|P1|Overall Study|Withdrawal by Subject|4
5663605|NCT00478777|19551874|P1|Overall Study|Lack of Efficacy|23
5663606|NCT00478777|19551874|P1|Overall Study|Adverse Event|29
5663607|NCT00478673|19551881|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
5663608|NCT00478673|19551881|P1|12-Months Post-Procedure|Missed Visit|25
5663609|NCT00478673|19551881|P1|12-Months Post-Procedure|Withdrawal by Subject|6
5663610|NCT00478673|19551881|P1|12-Months Post-Procedure|Lost to Follow-up|4
5663611|NCT00478673|19551881|P1|12-Months Post-Procedure|Death|23
5663612|NCT00478673|19551881|P1|30-Days Post-Procedure|Missed Visit|7
5663613|NCT00478673|19551881|P1|30-Days Post-Procedure|Withdrawal by Subject|1
5663614|NCT00478673|19551881|P1|30-Days Post-Procedure|Death|2
5663615|NCT00478647|19551886|P1|Overall Study|Withdrawal by Subject|1
5663616|NCT00478647|19551886|P1|Overall Study|Adverse Event|1
5663617|NCT00478608|19551894|P1|Overall Study|Protocol Violation|3
5663618|NCT00478608|19551894|P1|Overall Study|Withdrawal by Subject|2
5663619|NCT00478608|19551894|P1|Overall Study|Serious Adverse Event|14
5663620|NCT00478608|19551894|P1|Overall Study|Adverse Event|1
5663621|NCT00478426|19551927|P1|Overall Study|Withdrawal by Subject|1
5663622|NCT00478257|19551952|P2|Overall Study|Withdrawal by Subject|3
5663623|NCT00478257|19551953|P1|Overall Study|Withdrawal by Subject|8
5663624|NCT00478244|19551959|P1|Overall Study|Did not receive transplant|1
5663625|NCT00478231|19551972|P1|Overall Study|Randomized, not treated|3
5663626|NCT00478231|19551972|P1|Overall Study|Adverse Event|5
5663627|NCT00478231|19551972|P1|Overall Study|Other|9
5663628|NCT00478231|19551972|P1|Overall Study|Withdrawal by Subject|6
5663629|NCT00478231|19551972|P1|Overall Study|Lost to Follow-up|7
5663630|NCT00478231|19551972|P1|Overall Study|Lack of Efficacy|47
5663631|NCT00478231|19551972|P1|Overall Study|Death|7
5663632|NCT00478205|19552008|P2|Overall Study|Other|12
5663633|NCT00478205|19552009|P1|Overall Study|Other|24
5663634|NCT00478205|19552008|P2|Overall Study|Lack of Efficacy|0
5663635|NCT00478205|19552009|P1|Overall Study|Lack of Efficacy|1
5663636|NCT00478205|19552008|P2|Overall Study|Withdrawal by Subject|22
5663637|NCT00478205|19552009|P1|Overall Study|Withdrawal by Subject|61
5663638|NCT00478205|19552008|P2|Overall Study|Request of Investigator or Sponsor|5
5663639|NCT00478205|19552009|P1|Overall Study|Request of Investigator or Sponsor|4
5663640|NCT00478205|19552008|P2|Overall Study|Protocol Violation|5
5663641|NCT00478205|19552009|P1|Overall Study|Protocol Violation|15
5663642|NCT00478205|19552008|P2|Overall Study|Medication Non-compliance|4
5663643|NCT00478205|19552009|P1|Overall Study|Medication Non-compliance|9
5663644|NCT00478205|19552008|P2|Overall Study|Adverse Event|39
5663645|NCT00478205|19552009|P1|Overall Study|Adverse Event|182
5663646|NCT00478140|19552053|P1|Overall Study|Clinical Disease Progression|1
5663647|NCT00478023|19552085|P5|Overall Study|Lack of pain, Technical difficulties|3
5663648|NCT00478023|19552086|P4|Overall Study|Lack of pain, Technical difficulties|6
5663649|NCT00478023|19552087|P3|Overall Study|Lack of pain, Technical difficulties|5
5663650|NCT00478023|19552088|P2|Overall Study|Lack of pain, Technical difficulties|3
5663651|NCT00478023|19552089|P1|Overall Study|Lack of pain, Technical difficulties|7
5663652|NCT00478023|19552085|P5|Overall Study|Withdrawal by Subject|5
5663653|NCT00478023|19552086|P4|Overall Study|Withdrawal by Subject|4
5663654|NCT00478023|19552087|P3|Overall Study|Withdrawal by Subject|2
5663655|NCT00478023|19552088|P2|Overall Study|Withdrawal by Subject|3
5663656|NCT00478023|19552089|P1|Overall Study|Withdrawal by Subject|2
5663657|NCT00478023|19552085|P5|Overall Study|Lost to Follow-up|0
5663658|NCT00478023|19552086|P4|Overall Study|Lost to Follow-up|1
5663659|NCT00478023|19552087|P3|Overall Study|Lost to Follow-up|1
5663660|NCT00478023|19552088|P2|Overall Study|Lost to Follow-up|1
5663661|NCT00478023|19552089|P1|Overall Study|Lost to Follow-up|3
5663662|NCT00478023|19552085|P5|Overall Study|Lack of Efficacy|41
5663663|NCT00478023|19552086|P4|Overall Study|Lack of Efficacy|5
5663664|NCT00478023|19552087|P3|Overall Study|Lack of Efficacy|4
5663665|NCT00478023|19552088|P2|Overall Study|Lack of Efficacy|10
5663666|NCT00478023|19552089|P1|Overall Study|Lack of Efficacy|11
5663667|NCT00478023|19552085|P5|Overall Study|Death|0
5663668|NCT00478023|19552086|P4|Overall Study|Death|0
5663669|NCT00478023|19552087|P3|Overall Study|Death|0
5663670|NCT00478023|19552088|P2|Overall Study|Death|0
5663671|NCT00478023|19552089|P1|Overall Study|Death|1
5663672|NCT00478023|19552085|P5|Overall Study|Adverse Event|6
5663673|NCT00478023|19552086|P4|Overall Study|Adverse Event|14
5663674|NCT00478023|19552087|P3|Overall Study|Adverse Event|8
5663675|NCT00478023|19552088|P2|Overall Study|Adverse Event|7
5663676|NCT00478023|19552089|P1|Overall Study|Adverse Event|11
5663677|NCT00477971|19552108|P2|Overall Study|Alternative treatment|1
5663678|NCT00477971|19552109|P1|Overall Study|Alternative treatment|3
5663679|NCT00477971|19552108|P2|Overall Study|Death|4
5663680|NCT00477971|19552109|P1|Overall Study|Death|2
5663681|NCT00477971|19552108|P2|Overall Study|Adverse Event|0
5663682|NCT00477971|19552109|P1|Overall Study|Adverse Event|3
5663683|NCT00477971|19552108|P2|Overall Study|Withdrawal by Subject|1
5663684|NCT00477971|19552109|P1|Overall Study|Withdrawal by Subject|3
5663685|NCT00477971|19552108|P2|Overall Study|Disease progression|0
5663686|NCT00477971|19552109|P1|Overall Study|Disease progression|6
5663687|NCT00477750|19552121|P1|Overall Study|Currently Receiving Treatment|11
5663688|NCT00477672|19552137|P3|Overall Study|Discretion of Sponsor|0
5663689|NCT00477672|19552138|P2|Overall Study|Discretion of Sponsor|2
5663690|NCT00477672|19552139|P1|Overall Study|Discretion of Sponsor|1
5663691|NCT00477672|19552137|P3|Overall Study|Consent withdrawn|10
5663692|NCT00477672|19552138|P2|Overall Study|Consent withdrawn|5
5663693|NCT00477672|19552139|P1|Overall Study|Consent withdrawn|2
5663694|NCT00477672|19552137|P3|Overall Study|Protocol noncompliance|0
5663695|NCT00477672|19552138|P2|Overall Study|Protocol noncompliance|2
5663696|NCT00477672|19552139|P1|Overall Study|Protocol noncompliance|0
5663697|NCT00477672|19552137|P3|Overall Study|Physician Decision|0
5663698|NCT00477672|19552138|P2|Overall Study|Physician Decision|0
5663699|NCT00477672|19552139|P1|Overall Study|Physician Decision|1
5663700|NCT00477672|19552137|P3|Overall Study|Disease progression|0
5663701|NCT00477672|19552138|P2|Overall Study|Disease progression|1
5663702|NCT00477672|19552139|P1|Overall Study|Disease progression|0
5663703|NCT00477672|19552137|P3|Overall Study|Death|0
5663704|NCT00477672|19552138|P2|Overall Study|Death|1
5663705|NCT00477672|19552139|P1|Overall Study|Death|0
5663706|NCT00477672|19552137|P3|Overall Study|Adverse Event|6
5663707|NCT00477672|19552138|P2|Overall Study|Adverse Event|5
5663708|NCT00477672|19552139|P1|Overall Study|Adverse Event|3
5663709|NCT00477633|19552150|P1|Overall Study|Various (Moving, Enrollment closed)|75
5663710|NCT00477633|19552150|P1|Overall Study|Protocol Violation|25
5663711|NCT00477633|19552150|P1|Overall Study|Withdrawal by Subject|149
5663712|NCT00477633|19552150|P1|Overall Study|Lost to Follow-up|271
5663713|NCT00477633|19552150|P1|Overall Study|Pregnancy|23
5663714|NCT00477633|19552150|P1|Overall Study|Adverse Event|143
5663715|NCT00477633|19552150|P1|Overall Study|Did not receive treatment|23
5663716|NCT00477607|19552158|P2|Overall Study|Lost to Follow-up|7
5663717|NCT00477607|19552159|P1|Overall Study|Lost to Follow-up|7
5663718|NCT00477594|19552171|P2|Follow-up Period|Other|0
5663719|NCT00477594|19552172|P1|Follow-up Period|Other|1
5663720|NCT00477594|19552171|P2|Follow-up Period|Withdrawal by Subject|1
5663721|NCT00477594|19552172|P1|Follow-up Period|Withdrawal by Subject|2
5663722|NCT00477594|19552171|P2|Year 3|Withdrawal by Subject|0
5663723|NCT00477594|19552172|P1|Year 3|Withdrawal by Subject|1
5663724|NCT00477594|19552171|P2|Year 3|Adverse Event|0
5663725|NCT00477594|19552172|P1|Year 3|Adverse Event|1
5663726|NCT00477594|19552171|P2|Year 1 and Year 2|Other|0
5663727|NCT00477594|19552172|P1|Year 1 and Year 2|Other|1
5663728|NCT00477594|19552171|P2|Year 1 and Year 2|Withdrawal by Subject|1
5663729|NCT00477594|19552172|P1|Year 1 and Year 2|Withdrawal by Subject|2
5663730|NCT00477594|19552171|P2|Year 1 and Year 2|Physician Decision|1
5663731|NCT00477594|19552172|P1|Year 1 and Year 2|Physician Decision|2
5663732|NCT00477594|19552171|P2|Year 1 and Year 2|Adverse Event|2
5663733|NCT00477594|19552172|P1|Year 1 and Year 2|Adverse Event|4
5663734|NCT00477490|19552233|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
5663735|NCT00477490|19552234|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
5663736|NCT00477490|19552235|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
5663737|NCT00477490|19552236|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
5663738|NCT00477490|19552237|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
5663739|NCT00477490|19552238|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
5663740|NCT00477490|19552239|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
5663741|NCT00477490|19552240|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
5663742|NCT00477490|19552241|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
5663743|NCT00477490|19552233|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
5663744|NCT00477490|19552234|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
5663745|NCT00477490|19552235|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
5663746|NCT00477490|19552236|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
5663747|NCT00477490|19552237|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
5663748|NCT00477490|19552238|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
5663749|NCT00477490|19552239|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
5663750|NCT00477490|19552240|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
5663751|NCT00477490|19552241|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
5663752|NCT00477490|19552233|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5663753|NCT00477490|19552234|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5663754|NCT00477490|19552235|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5663755|NCT00477490|19552236|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5663756|NCT00477490|19552237|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5663757|NCT00477490|19552238|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5663758|NCT00477490|19552239|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5663759|NCT00477490|19552240|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
5663760|NCT00477490|19552241|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
5663761|NCT00477490|19552233|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
5663762|NCT00477490|19552234|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
5663763|NCT00477490|19552235|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5663764|NCT00477490|19552236|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5663765|NCT00477490|19552237|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
5663766|NCT00477490|19552238|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5663767|NCT00477490|19552239|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5663768|NCT00477490|19552240|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5663769|NCT00477490|19552241|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
5663770|NCT00477490|19552233|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5663771|NCT00477490|19552234|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5663772|NCT00477490|19552235|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
5663773|NCT00477490|19552236|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5663774|NCT00477490|19552237|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
5663775|NCT00477490|19552238|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5663776|NCT00477490|19552239|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
5663777|NCT00477490|19552240|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
5663778|NCT00477490|19552241|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
5663779|NCT00477490|19552233|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
5663780|NCT00477490|19552234|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5663781|NCT00477490|19552235|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5663782|NCT00477490|19552236|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5663783|NCT00477490|19552237|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5663784|NCT00477490|19552238|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
5663785|NCT00477490|19552239|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
5663786|NCT00477490|19552240|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
5663787|NCT00477490|19552241|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
5663788|NCT00477490|19552233|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
5663789|NCT00477490|19552234|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
5663790|NCT00477490|19552235|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
5663791|NCT00477490|19552236|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
5663792|NCT00477490|19552237|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
5663793|NCT00477490|19552238|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
5663794|NCT00477490|19552239|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
5663795|NCT00477490|19552240|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
5663796|NCT00477490|19552241|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
5663797|NCT00477490|19552233|P9|Part I: 4 Week Efficacy|Not Reported|0
5663798|NCT00477490|19552234|P8|Part I: 4 Week Efficacy|Not Reported|0
5663799|NCT00477490|19552235|P7|Part I: 4 Week Efficacy|Not Reported|0
5663800|NCT00477490|19552236|P6|Part I: 4 Week Efficacy|Not Reported|0
5663801|NCT00477490|19552237|P5|Part I: 4 Week Efficacy|Not Reported|1
5663802|NCT00477490|19552238|P4|Part I: 4 Week Efficacy|Not Reported|0
5663803|NCT00477490|19552239|P3|Part I: 4 Week Efficacy|Not Reported|3
5663804|NCT00477490|19552240|P2|Part I: 4 Week Efficacy|Not Reported|2
5663805|NCT00477490|19552241|P1|Part I: 4 Week Efficacy|Not Reported|1
5663806|NCT00477490|19552233|P9|Part I: 4 Week Efficacy|Other, not specified|0
5663807|NCT00477490|19552234|P8|Part I: 4 Week Efficacy|Other, not specified|0
5663808|NCT00477490|19552235|P7|Part I: 4 Week Efficacy|Other, not specified|0
5663809|NCT00477490|19552236|P6|Part I: 4 Week Efficacy|Other, not specified|0
5663810|NCT00477490|19552237|P5|Part I: 4 Week Efficacy|Other, not specified|1
5663811|NCT00477490|19552238|P4|Part I: 4 Week Efficacy|Other, not specified|1
5663812|NCT00477490|19552239|P3|Part I: 4 Week Efficacy|Other, not specified|0
5663813|NCT00477490|19552240|P2|Part I: 4 Week Efficacy|Other, not specified|4
5663814|NCT00477490|19552241|P1|Part I: 4 Week Efficacy|Other, not specified|2
5663815|NCT00477490|19552233|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
5663816|NCT00477490|19552234|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
5663817|NCT00477490|19552235|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
5663818|NCT00477490|19552236|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
5663819|NCT00477490|19552237|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
5663820|NCT00477490|19552238|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
5663821|NCT00477490|19552239|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
5663822|NCT00477490|19552240|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
5663823|NCT00477490|19552241|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
5663824|NCT00477490|19552233|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
5663825|NCT00477490|19552234|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
5663826|NCT00477490|19552235|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
5663827|NCT00477490|19552236|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
5663828|NCT00477490|19552237|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
5663829|NCT00477490|19552238|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
5663830|NCT00477490|19552239|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
5663831|NCT00477490|19552240|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
5663832|NCT00477490|19552241|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
5663833|NCT00477490|19552233|P9|Part I: 4 Week Efficacy|Protocol Violation|0
5663834|NCT00477490|19552234|P8|Part I: 4 Week Efficacy|Protocol Violation|0
5663835|NCT00477490|19552235|P7|Part I: 4 Week Efficacy|Protocol Violation|0
5663836|NCT00477490|19552236|P6|Part I: 4 Week Efficacy|Protocol Violation|0
5663837|NCT00477490|19552237|P5|Part I: 4 Week Efficacy|Protocol Violation|1
5663838|NCT00477490|19552238|P4|Part I: 4 Week Efficacy|Protocol Violation|0
5663839|NCT00477490|19552239|P3|Part I: 4 Week Efficacy|Protocol Violation|0
5663840|NCT00477490|19552240|P2|Part I: 4 Week Efficacy|Protocol Violation|0
5663841|NCT00477490|19552241|P1|Part I: 4 Week Efficacy|Protocol Violation|2
5663842|NCT00477490|19552233|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5663843|NCT00477490|19552234|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5663844|NCT00477490|19552235|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5663845|NCT00477490|19552236|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5663846|NCT00477490|19552237|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
5663847|NCT00477490|19552238|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
5663848|NCT00477490|19552239|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5663849|NCT00477490|19552240|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
5663850|NCT00477490|19552241|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
5663851|NCT00477490|19552233|P9|Part I: 4 Week Efficacy|Adverse Event|0
5663852|NCT00477490|19552234|P8|Part I: 4 Week Efficacy|Adverse Event|0
5663853|NCT00477490|19552235|P7|Part I: 4 Week Efficacy|Adverse Event|0
5663854|NCT00477490|19552236|P6|Part I: 4 Week Efficacy|Adverse Event|0
5663855|NCT00477490|19552237|P5|Part I: 4 Week Efficacy|Adverse Event|6
5663856|NCT00477490|19552238|P4|Part I: 4 Week Efficacy|Adverse Event|5
5663857|NCT00477490|19552239|P3|Part I: 4 Week Efficacy|Adverse Event|0
5663858|NCT00477490|19552240|P2|Part I: 4 Week Efficacy|Adverse Event|4
5663859|NCT00477490|19552241|P1|Part I: 4 Week Efficacy|Adverse Event|1
5663860|NCT00477464|19552325|P1|Overall Study|Completion of protocol-defined follow-up|14
5663861|NCT00477464|19552325|P1|Overall Study|Death|36
5663862|NCT00477464|19552325|P1|Overall Study|Lost to Follow-up|1
5663863|NCT00477386|19552369|P2|Overall Study|Withdrawal by Subject|0
5663864|NCT00477386|19552370|P1|Overall Study|Withdrawal by Subject|1
5663865|NCT00477386|19552369|P2|Overall Study|Physician Decision|0
5663866|NCT00477386|19552370|P1|Overall Study|Physician Decision|1
5663867|NCT00477386|19552369|P2|Overall Study|Other|2
5663868|NCT00477386|19552370|P1|Overall Study|Other|1
5663869|NCT00477386|19552369|P2|Overall Study|Disease progression, refractory|3
5663870|NCT00477386|19552370|P1|Overall Study|Disease progression, refractory|1
5663871|NCT00477386|19552369|P2|Overall Study|Disease progression, relapse|4
5663872|NCT00477386|19552370|P1|Overall Study|Disease progression, relapse|3
5663873|NCT00477386|19552369|P2|Overall Study|Adverse Event|8
5663874|NCT00477386|19552370|P1|Overall Study|Adverse Event|4
5663875|NCT00477334|19552380|P2|Overall Study|Protocol Violation|1
5663876|NCT00477334|19552381|P1|Overall Study|Protocol Violation|7
5663877|NCT00477334|19552380|P2|Overall Study|Administrative Problems|15
5663878|NCT00477334|19552381|P1|Overall Study|Administrative Problems|39
5663879|NCT00477334|19552380|P2|Overall Study|Lost to Follow-up|4
5663880|NCT00477334|19552381|P1|Overall Study|Lost to Follow-up|15
5663881|NCT00477334|19552380|P2|Overall Study|Withdrawal by Subject|1
5663882|NCT00477334|19552381|P1|Overall Study|Withdrawal by Subject|2
5663883|NCT00477334|19552380|P2|Overall Study|Adverse Event|2
5663884|NCT00477334|19552381|P1|Overall Study|Adverse Event|1
5663885|NCT00477334|19552380|P2|Overall Study|Discontinued prior to taking study drug|53
5663886|NCT00477334|19552381|P1|Overall Study|Discontinued prior to taking study drug|106
5663887|NCT00477295|19552407|P2|Overall Study|Other|3
5663888|NCT00477295|19552408|P1|Overall Study|Other|4
5663889|NCT00477295|19552407|P2|Overall Study|Lost to Follow-up|11
5663890|NCT00477295|19552408|P1|Overall Study|Lost to Follow-up|21
5663891|NCT00477295|19552407|P2|Overall Study|Physician Decision|5
5663892|NCT00477295|19552408|P1|Overall Study|Physician Decision|4
5663893|NCT00477295|19552407|P2|Overall Study|Protocol Violation|8
5663894|NCT00477295|19552408|P1|Overall Study|Protocol Violation|3
5663895|NCT00477295|19552407|P2|Overall Study|Lack of Efficacy|23
5663896|NCT00477295|19552408|P1|Overall Study|Lack of Efficacy|23
5663897|NCT00477295|19552407|P2|Overall Study|Withdrawal by Subject|24
5663898|NCT00477295|19552408|P1|Overall Study|Withdrawal by Subject|35
5663899|NCT00477295|19552407|P2|Overall Study|Adverse Event|35
5663900|NCT00477295|19552408|P1|Overall Study|Adverse Event|31
5663901|NCT00477269|19552436|P3|Open Label Extension|Death|4
5663902|NCT00477269|19552437|P2|Open Label Extension|Death|0
5663903|NCT00477269|19552438|P1|Open Label Extension|Death|0
5663904|NCT00477269|19552436|P3|Open Label Extension|Adminiatrative problems|2
5663905|NCT00477269|19552437|P2|Open Label Extension|Adminiatrative problems|0
5663906|NCT00477269|19552438|P1|Open Label Extension|Adminiatrative problems|0
5663907|NCT00477269|19552436|P3|Open Label Extension|unsatisfactory therapeutic effects|2
5663908|NCT00477269|19552437|P2|Open Label Extension|unsatisfactory therapeutic effects|0
5663909|NCT00477269|19552438|P1|Open Label Extension|unsatisfactory therapeutic effects|0
5663910|NCT00477269|19552436|P3|Open Label Extension|Abnormal laboratory values|1
5663911|NCT00477269|19552437|P2|Open Label Extension|Abnormal laboratory values|0
5663912|NCT00477269|19552438|P1|Open Label Extension|Abnormal laboratory values|0
5663913|NCT00477269|19552436|P3|Open Label Extension|Adverse Event|4
5663914|NCT00477269|19552437|P2|Open Label Extension|Adverse Event|0
5663915|NCT00477269|19552438|P1|Open Label Extension|Adverse Event|0
5663916|NCT00477269|19552436|P3|Core Study|Withdrawn Consent|0
5663917|NCT00477269|19552437|P2|Core Study|Withdrawn Consent|1
5663918|NCT00477269|19552438|P1|Core Study|Withdrawn Consent|0
5663919|NCT00477269|19552436|P3|Core Study|Death|0
5663920|NCT00477269|19552437|P2|Core Study|Death|3
5663921|NCT00477269|19552438|P1|Core Study|Death|3
5663922|NCT00477269|19552436|P3|Core Study|Adverse Event|0
5663923|NCT00477269|19552437|P2|Core Study|Adverse Event|4
5663924|NCT00477269|19552438|P1|Core Study|Adverse Event|6
5663925|NCT00477165|19552517|P2|Overall Study|Adverse Event|2
5663926|NCT00477165|19552518|P1|Overall Study|Adverse Event|7
5663927|NCT00477152|19552530|P1|Overall Study|Adverse Event|1
5663928|NCT00477152|19552530|P1|Overall Study|Parent withdrew consent|2
5663929|NCT00476996|19552546|P4|OLE Phase (From Week 48)|Early termination of the study|578
5663930|NCT00476996|19552547|P3|OLE Phase (From Week 48)|Early termination of the study|0
5663931|NCT00476996|19552548|P2|OLE Phase (From Week 48)|Early termination of the study|0
5663932|NCT00476996|19552549|P1|OLE Phase (From Week 48)|Early termination of the study|0
5663933|NCT00476996|19552546|P4|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
5663934|NCT00476996|19552547|P3|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
5663935|NCT00476996|19552548|P2|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
5663936|NCT00476996|19552549|P1|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
5663937|NCT00476996|19552546|P4|OLE Phase (From Week 48)|Lost to Follow-up|4
5663938|NCT00476996|19552547|P3|OLE Phase (From Week 48)|Lost to Follow-up|0
5663939|NCT00476996|19552548|P2|OLE Phase (From Week 48)|Lost to Follow-up|0
5663940|NCT00476996|19552549|P1|OLE Phase (From Week 48)|Lost to Follow-up|0
5663941|NCT00476996|19552546|P4|OLE Phase (From Week 48)|Lack of Efficacy|13
5663942|NCT00476996|19552547|P3|OLE Phase (From Week 48)|Lack of Efficacy|0
5663943|NCT00476996|19552548|P2|OLE Phase (From Week 48)|Lack of Efficacy|0
5663944|NCT00476996|19552549|P1|OLE Phase (From Week 48)|Lack of Efficacy|0
5663945|NCT00476996|19552546|P4|OLE Phase (From Week 48)|Death|7
5663946|NCT00476996|19552547|P3|OLE Phase (From Week 48)|Death|0
5663947|NCT00476996|19552548|P2|OLE Phase (From Week 48)|Death|0
5663948|NCT00476996|19552549|P1|OLE Phase (From Week 48)|Death|0
5663949|NCT00476996|19552546|P4|OLE Phase (From Week 48)|Adverse Event|8
5663950|NCT00476996|19552547|P3|OLE Phase (From Week 48)|Adverse Event|0
5663951|NCT00476996|19552548|P2|OLE Phase (From Week 48)|Adverse Event|0
5663952|NCT00476996|19552549|P1|OLE Phase (From Week 48)|Adverse Event|0
5663953|NCT00476996|19552546|P4|OLE Phase (From Week 48)|Withdrawal by Subject|50
5663954|NCT00476996|19552547|P3|OLE Phase (From Week 48)|Withdrawal by Subject|0
5663955|NCT00476996|19552548|P2|OLE Phase (From Week 48)|Withdrawal by Subject|0
5663956|NCT00476996|19552549|P1|OLE Phase (From Week 48)|Withdrawal by Subject|0
5663957|NCT00476996|19552546|P4|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
5663958|NCT00476996|19552547|P3|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
5663959|NCT00476996|19552548|P2|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
5663960|NCT00476996|19552549|P1|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
5663961|NCT00476996|19552546|P4|Blinded Treatment Phase (up to Week 48)|Death|0
5663962|NCT00476996|19552547|P3|Blinded Treatment Phase (up to Week 48)|Death|1
5663963|NCT00476996|19552548|P2|Blinded Treatment Phase (up to Week 48)|Death|1
5663964|NCT00476996|19552549|P1|Blinded Treatment Phase (up to Week 48)|Death|2
5663965|NCT00476996|19552546|P4|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
5663966|NCT00476996|19552547|P3|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
5663967|NCT00476996|19552548|P2|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
5663968|NCT00476996|19552549|P1|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
5663969|NCT00476996|19552546|P4|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
5663970|NCT00476996|19552547|P3|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
5663971|NCT00476996|19552548|P2|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
5663972|NCT00476996|19552549|P1|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
5663973|NCT00476996|19552546|P4|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
5663974|NCT00476996|19552547|P3|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
5663975|NCT00476996|19552548|P2|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
5663976|NCT00476996|19552549|P1|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
5663977|NCT00476996|19552546|P4|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
5663978|NCT00476996|19552547|P3|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
5663979|NCT00476996|19552548|P2|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
5663980|NCT00476996|19552549|P1|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
5663981|NCT00476996|19552546|P4|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
5663982|NCT00476996|19552547|P3|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
5663983|NCT00476996|19552548|P2|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
5663984|NCT00476996|19552549|P1|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
5663985|NCT00476996|19552546|P4|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
5663986|NCT00476996|19552547|P3|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
5663987|NCT00476996|19552548|P2|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
5663988|NCT00476996|19552549|P1|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
5663989|NCT00476957|19552581|P2|Overall Study|Lost to Follow-up|193
5663990|NCT00476957|19552582|P1|Overall Study|Lost to Follow-up|176
5663991|NCT00476593|19552646|P4|Overall Study|Lost to Follow-up|22
5663992|NCT00476593|19552647|P3|Overall Study|Lost to Follow-up|8
5663993|NCT00476593|19552648|P2|Overall Study|Lost to Follow-up|2
5663994|NCT00476593|19552649|P1|Overall Study|Lost to Follow-up|10
5663995|NCT00476476|19552661|P2|Overall Study|Progressive Disease|17
5663996|NCT00476476|19552662|P1|Overall Study|Progressive Disease|0
5663997|NCT00476476|19552661|P2|Overall Study|Adverse Event|7
5663998|NCT00476476|19552662|P1|Overall Study|Adverse Event|2
5663999|NCT00476229|19552680|P1|Overall Study|Progressive shortness of breath|1
5664000|NCT00476151|19552686|P2|Overall Study|Physician Decision|2
5664001|NCT00476151|19552687|P1|Overall Study|Physician Decision|0
5664002|NCT00476151|19552686|P2|Overall Study|Withdrawal by Subject|0
5664003|NCT00476151|19552687|P1|Overall Study|Withdrawal by Subject|2
5664004|NCT00476151|19552686|P2|Overall Study|Protocol Violation|3
5664005|NCT00476151|19552687|P1|Overall Study|Protocol Violation|1
5664006|NCT00476151|19552686|P2|Overall Study|Adverse Event|2
5664007|NCT00476151|19552687|P1|Overall Study|Adverse Event|0
5664008|NCT00476086|19552693|P1|Overall Study|Progressive Disease|4
5664009|NCT00476086|19552693|P1|Overall Study|Alternative therapy|1
5664010|NCT00476047|19552699|P1|Overall Study|Lost to Follow-up|1
5664011|NCT00476008|19552725|P2|Overall Study|Death|0
5664012|NCT00476008|19552726|P1|Overall Study|Death|1
5664013|NCT00476008|19552725|P2|Overall Study|Withdrawal by Subject|1
5664014|NCT00476008|19552726|P1|Overall Study|Withdrawal by Subject|0
5664015|NCT00476008|19552725|P2|Overall Study|Physician Decision: Medication Noncompli|1
5664016|NCT00476008|19552726|P1|Overall Study|Physician Decision: Medication Noncompli|2
5664017|NCT00476008|19552725|P2|Overall Study|Placebo concerns|2
5664018|NCT00476008|19552726|P1|Overall Study|Placebo concerns|2
5664019|NCT00476008|19552725|P2|Overall Study|Adverse Event|4
5664020|NCT00476008|19552726|P1|Overall Study|Adverse Event|4
5664021|NCT00475982|19552752|P2|Overall Study|surgery rescheduled|3
5664022|NCT00475982|19552753|P1|Overall Study|surgery rescheduled|7
5664023|NCT00475865|19552801|P3|Overall Study|Other than above|0
5664024|NCT00475865|19552802|P2|Overall Study|Other than above|1
5664025|NCT00475865|19552803|P1|Overall Study|Other than above|0
5664026|NCT00475865|19552801|P3|Overall Study|Participant did not wish to continue|0
5664027|NCT00475865|19552802|P2|Overall Study|Participant did not wish to continue|0
5664028|NCT00475865|19552803|P1|Overall Study|Participant did not wish to continue|1
5664029|NCT00475865|19552801|P3|Overall Study|Progressive disease|2
5664030|NCT00475865|19552802|P2|Overall Study|Progressive disease|1
5664031|NCT00475865|19552803|P1|Overall Study|Progressive disease|0
5664032|NCT00475865|19552801|P3|Overall Study|Lack of Efficacy|0
5664033|NCT00475865|19552802|P2|Overall Study|Lack of Efficacy|0
5664034|NCT00475865|19552803|P1|Overall Study|Lack of Efficacy|1
5664035|NCT00475865|19552801|P3|Overall Study|Adverse Event|4
5664036|NCT00475865|19552802|P2|Overall Study|Adverse Event|3
5664037|NCT00475865|19552803|P1|Overall Study|Adverse Event|0
5664038|NCT00475852|19552833|P2|Overall Study|Lost to Follow-up|68
5664039|NCT00475852|19552834|P1|Overall Study|Lost to Follow-up|54
5664040|NCT00475852|19552833|P2|Overall Study|Withdrawal by Subject|24
5664041|NCT00475852|19552834|P1|Overall Study|Withdrawal by Subject|19
5664042|NCT00475852|19552833|P2|Overall Study|Death|456
5664043|NCT00475852|19552834|P1|Overall Study|Death|444
5664044|NCT00475735|19552885|P6|Treatment Period 2|Withdrawal by Subject|0
5664045|NCT00475735|19552886|P5|Treatment Period 2|Withdrawal by Subject|1
5664046|NCT00475735|19552887|P4|Treatment Period 2|Withdrawal by Subject|0
5664047|NCT00475735|19552888|P3|Treatment Period 2|Withdrawal by Subject|0
5664048|NCT00475735|19552889|P2|Treatment Period 2|Withdrawal by Subject|0
5664049|NCT00475735|19552890|P1|Treatment Period 2|Withdrawal by Subject|0
5664050|NCT00475735|19552885|P6|Treatment Period 2|Lack of Efficacy|1
5664051|NCT00475735|19552886|P5|Treatment Period 2|Lack of Efficacy|0
5664052|NCT00475735|19552887|P4|Treatment Period 2|Lack of Efficacy|0
5664053|NCT00475735|19552888|P3|Treatment Period 2|Lack of Efficacy|0
5664054|NCT00475735|19552889|P2|Treatment Period 2|Lack of Efficacy|0
5664055|NCT00475735|19552890|P1|Treatment Period 2|Lack of Efficacy|0
5664056|NCT00475735|19552885|P6|Treatment Period 2|Adverse Event|0
5664057|NCT00475735|19552886|P5|Treatment Period 2|Adverse Event|0
5664058|NCT00475735|19552887|P4|Treatment Period 2|Adverse Event|2
5664059|NCT00475735|19552888|P3|Treatment Period 2|Adverse Event|0
5664060|NCT00475735|19552889|P2|Treatment Period 2|Adverse Event|1
5664061|NCT00475735|19552890|P1|Treatment Period 2|Adverse Event|0
5664062|NCT00475735|19552885|P6|Treatment Washout|Protocol Violation|0
5664063|NCT00475735|19552886|P5|Treatment Washout|Protocol Violation|0
5664064|NCT00475735|19552887|P4|Treatment Washout|Protocol Violation|0
5664065|NCT00475735|19552888|P3|Treatment Washout|Protocol Violation|0
5664066|NCT00475735|19552889|P2|Treatment Washout|Protocol Violation|1
5664067|NCT00475735|19552890|P1|Treatment Washout|Protocol Violation|0
5664068|NCT00475735|19552885|P6|Treatment Washout|Lost to Follow-up|0
5664069|NCT00475735|19552886|P5|Treatment Washout|Lost to Follow-up|0
5664070|NCT00475735|19552887|P4|Treatment Washout|Lost to Follow-up|0
5664071|NCT00475735|19552888|P3|Treatment Washout|Lost to Follow-up|0
5664072|NCT00475735|19552889|P2|Treatment Washout|Lost to Follow-up|1
5664073|NCT00475735|19552890|P1|Treatment Washout|Lost to Follow-up|0
5664074|NCT00475735|19552885|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
5664075|NCT00475735|19552886|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
5664076|NCT00475735|19552887|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
5664077|NCT00475735|19552888|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
5664078|NCT00475735|19552889|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
5664079|NCT00475735|19552890|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
5664080|NCT00475735|19552885|P6|Treatment Period 1|DC due to AE but continuing|2
5664081|NCT00475735|19552886|P5|Treatment Period 1|DC due to AE but continuing|2
5664082|NCT00475735|19552887|P4|Treatment Period 1|DC due to AE but continuing|1
5664083|NCT00475735|19552888|P3|Treatment Period 1|DC due to AE but continuing|0
5664084|NCT00475735|19552889|P2|Treatment Period 1|DC due to AE but continuing|0
5664085|NCT00475735|19552890|P1|Treatment Period 1|DC due to AE but continuing|0
5664086|NCT00475735|19552885|P6|Treatment Period 1|Withdrawal by Subject|0
5664087|NCT00475735|19552886|P5|Treatment Period 1|Withdrawal by Subject|0
5664088|NCT00475735|19552887|P4|Treatment Period 1|Withdrawal by Subject|0
5664089|NCT00475735|19552888|P3|Treatment Period 1|Withdrawal by Subject|0
5664090|NCT00475735|19552889|P2|Treatment Period 1|Withdrawal by Subject|1
5664091|NCT00475735|19552890|P1|Treatment Period 1|Withdrawal by Subject|1
5664092|NCT00475735|19552885|P6|Treatment Period 1|Protocol Violation|0
5664093|NCT00475735|19552886|P5|Treatment Period 1|Protocol Violation|0
5664094|NCT00475735|19552887|P4|Treatment Period 1|Protocol Violation|1
5664095|NCT00475735|19552888|P3|Treatment Period 1|Protocol Violation|0
5664096|NCT00475735|19552889|P2|Treatment Period 1|Protocol Violation|0
5664097|NCT00475735|19552890|P1|Treatment Period 1|Protocol Violation|0
5664098|NCT00475735|19552885|P6|Treatment Period 1|Lost to Follow-up|1
5664099|NCT00475735|19552886|P5|Treatment Period 1|Lost to Follow-up|0
5664100|NCT00475735|19552887|P4|Treatment Period 1|Lost to Follow-up|0
5664101|NCT00475735|19552888|P3|Treatment Period 1|Lost to Follow-up|0
5664102|NCT00475735|19552889|P2|Treatment Period 1|Lost to Follow-up|0
5664103|NCT00475735|19552890|P1|Treatment Period 1|Lost to Follow-up|0
5664104|NCT00475735|19552885|P6|Treatment Period 1|Lack of Efficacy|0
5664105|NCT00475735|19552886|P5|Treatment Period 1|Lack of Efficacy|0
5664106|NCT00475735|19552887|P4|Treatment Period 1|Lack of Efficacy|0
5664107|NCT00475735|19552888|P3|Treatment Period 1|Lack of Efficacy|0
5664108|NCT00475735|19552889|P2|Treatment Period 1|Lack of Efficacy|0
5664109|NCT00475735|19552890|P1|Treatment Period 1|Lack of Efficacy|1
5664110|NCT00475735|19552885|P6|Treatment Period 1|Adverse Event|0
5664111|NCT00475735|19552886|P5|Treatment Period 1|Adverse Event|0
5664112|NCT00475735|19552887|P4|Treatment Period 1|Adverse Event|0
5664113|NCT00475735|19552888|P3|Treatment Period 1|Adverse Event|0
5664114|NCT00475735|19552889|P2|Treatment Period 1|Adverse Event|0
5664115|NCT00475735|19552890|P1|Treatment Period 1|Adverse Event|2
5664116|NCT00475722|19552903|P2|Overall Study|Protocol Violation|0
5664117|NCT00475722|19552904|P1|Overall Study|Protocol Violation|3
5664118|NCT00475722|19552903|P2|Overall Study|Withdrawal by Subject|12
5664119|NCT00475722|19552904|P1|Overall Study|Withdrawal by Subject|12
5664120|NCT00475709|19552910|P1|Overall Study|Lost to Follow-up|21
5664121|NCT00475709|19552910|P1|Overall Study|Device Explant|6
5664122|NCT00475709|19552910|P1|Overall Study|Death|41
5664123|NCT00475709|19552910|P1|Overall Study|Did not meet eligibility criteria|8
5664124|NCT00475670|19552918|P2|Overall Study|Other|3
5664125|NCT00475670|19552919|P1|Overall Study|Other|0
5664126|NCT00475670|19552918|P2|Overall Study|Failure to Return|1
5664127|NCT00475670|19552919|P1|Overall Study|Failure to Return|0
5664128|NCT00475670|19552918|P2|Overall Study|Refused treatment|2
5664129|NCT00475670|19552919|P1|Overall Study|Refused treatment|0
5664130|NCT00475670|19552918|P2|Overall Study|Lack of Efficacy|34
5664131|NCT00475670|19552919|P1|Overall Study|Lack of Efficacy|3
5664132|NCT00475670|19552918|P2|Overall Study|Death|1
5664133|NCT00475670|19552919|P1|Overall Study|Death|0
5664134|NCT00475657|19552943|P1|Overall Study|Sponsor's Decision|3
5664135|NCT00475657|19552943|P1|Overall Study|Death|1
5664136|NCT00475644|19552951|P1|Overall Study|Protocol Violation|13
5664137|NCT00475423|19553016|P1|Overall Study|Lost to Follow-up|7
5664138|NCT00475423|19553016|P1|Overall Study|Reason not specified|1
5664139|NCT00475423|19553016|P1|Overall Study|Death|1
5664140|NCT00475423|19553016|P1|Overall Study|Lack of Efficacy|8
5664141|NCT00475423|19553016|P1|Overall Study|Withdrawal by Subject|6
5664142|NCT00475423|19553016|P1|Overall Study|Adverse Event|4
5664143|NCT00475423|19553016|P1|Overall Study|Protocol Violation|5
5664144|NCT00475306|19553062|P4|Overall Study|Protocol Violation|1
5664145|NCT00475306|19553063|P3|Overall Study|Protocol Violation|0
5664146|NCT00475306|19553064|P2|Overall Study|Protocol Violation|1
5664147|NCT00475306|19553065|P1|Overall Study|Protocol Violation|1
5664148|NCT00475228|19553096|P2|Overall Study|Lost to Follow-up|17
5664149|NCT00475228|19553097|P1|Overall Study|Lost to Follow-up|17
5664150|NCT00475176|19553136|P1|Overall Study|Protocol Violation|1
5664151|NCT00475176|19553136|P1|Overall Study|Withdrawal by Subject|1
5664152|NCT00475176|19553136|P1|Overall Study|Adverse Event|2
5664153|NCT00475033|19553176|P2|Toddler Dose|Lost to Follow-up|0
5664154|NCT00475033|19553177|P1|Toddler Dose|Lost to Follow-up|1
5664155|NCT00475033|19553176|P2|Toddler Dose|Failed to return|0
5664156|NCT00475033|19553177|P1|Toddler Dose|Failed to return|1
5664157|NCT00475033|19553176|P2|Toddler Dose|Parent or legal guardian request|0
5664158|NCT00475033|19553177|P1|Toddler Dose|Parent or legal guardian request|2
5664159|NCT00475033|19553176|P2|After the Infant Series|Other|1
5664160|NCT00475033|19553177|P1|After the Infant Series|Other|0
5664161|NCT00475033|19553176|P2|After the Infant Series|Lost to Follow-up|0
5664162|NCT00475033|19553177|P1|After the Infant Series|Lost to Follow-up|1
5664163|NCT00475033|19553176|P2|After the Infant Series|Protocol Violation|0
5664164|NCT00475033|19553177|P1|After the Infant Series|Protocol Violation|1
5664165|NCT00475033|19553176|P2|After the Infant Series|Failed to return|1
5664166|NCT00475033|19553177|P1|After the Infant Series|Failed to return|2
5664167|NCT00475033|19553176|P2|After the Infant Series|Parent or legal guardian request|2
5664168|NCT00475033|19553177|P1|After the Infant Series|Parent or legal guardian request|2
5664169|NCT00475033|19553176|P2|After the Infant Series|Adverse Event|4
5664170|NCT00475033|19553177|P1|After the Infant Series|Adverse Event|0
5664171|NCT00475033|19553176|P2|Infant Series|Adverse Event|2
5664172|NCT00475033|19553177|P1|Infant Series|Adverse Event|0
5664173|NCT00475033|19553176|P2|Infant Series|Lost to Follow-up|0
5664174|NCT00475033|19553177|P1|Infant Series|Lost to Follow-up|2
5664175|NCT00475033|19553176|P2|Infant Series|Protocol Violation|2
5664176|NCT00475033|19553177|P1|Infant Series|Protocol Violation|1
5664177|NCT00475033|19553176|P2|Infant Series|Parent or legal guardian request|5
5664178|NCT00475033|19553177|P1|Infant Series|Parent or legal guardian request|1
5664179|NCT00475033|19553176|P2|Infant Series|Failed to return|4
5664180|NCT00475033|19553177|P1|Infant Series|Failed to return|3
5664181|NCT00475020|19553225|P1|Overall Study|Donor not able to donate the last minute|1
5664182|NCT00475020|19553225|P1|Overall Study|Insurance Denial|1
5664183|NCT00475020|19553225|P1|Overall Study|Physician Decision|3
5664184|NCT00474994|19553230|P1|Overall Study|Patient found to be ineligible|1
5664185|NCT00474994|19553230|P1|Overall Study|Patient evaluable for toxicity only|3
5664186|NCT00474994|19553230|P1|Overall Study|Patient Not treated|1
5664187|NCT00474968|19553236|P2|Overall Study|Sample not collected|1
5664188|NCT00474968|19553237|P1|Overall Study|Sample not collected|1
5664189|NCT00474968|19553236|P2|Overall Study|Protocol Violation|8
5664190|NCT00474968|19553237|P1|Overall Study|Protocol Violation|9
5664191|NCT00474968|19553236|P2|Overall Study|Withdrawal by Subject|7
5664192|NCT00474968|19553237|P1|Overall Study|Withdrawal by Subject|8
5664193|NCT00474955|19553247|P1|Overall Study|Personal reasons|5
5664194|NCT00474955|19553247|P1|Overall Study|Drug unavailability|1
5664195|NCT00474955|19553247|P1|Overall Study|Adverse Event|2
5664196|NCT00474929|19553263|P5|Overall Study|Physician Decision|0
5664197|NCT00474929|19553264|P4|Overall Study|Physician Decision|2
5664198|NCT00474929|19553265|P3|Overall Study|Physician Decision|1
5664199|NCT00474929|19553266|P2|Overall Study|Physician Decision|0
5664200|NCT00474929|19553267|P1|Overall Study|Physician Decision|0
5664201|NCT00474929|19553263|P5|Overall Study|Unrelated medical condition|0
5664202|NCT00474929|19553264|P4|Overall Study|Unrelated medical condition|0
5664203|NCT00474929|19553265|P3|Overall Study|Unrelated medical condition|1
5664204|NCT00474929|19553266|P2|Overall Study|Unrelated medical condition|0
5664205|NCT00474929|19553267|P1|Overall Study|Unrelated medical condition|0
5664206|NCT00474929|19553263|P5|Overall Study|Withdrawal by Subject|0
5664207|NCT00474929|19553264|P4|Overall Study|Withdrawal by Subject|0
5664208|NCT00474929|19553265|P3|Overall Study|Withdrawal by Subject|0
5664209|NCT00474929|19553266|P2|Overall Study|Withdrawal by Subject|1
5664210|NCT00474929|19553267|P1|Overall Study|Withdrawal by Subject|0
5664211|NCT00474903|19553284|P3|Overall Study|Protocol Violation|2
5664212|NCT00474903|19553285|P2|Overall Study|Protocol Violation|5
5664213|NCT00474903|19553286|P1|Overall Study|Protocol Violation|1
5664214|NCT00474812|19553308|P1|Overall Study|No Initiation of treatment|2
5664215|NCT00474812|19553308|P1|Overall Study|Withdrawal by Subject|5
5664216|NCT00474786|19553318|P2|Overall Study|Other|0
5664217|NCT00474786|19553319|P1|Overall Study|Other|5
5664218|NCT00474786|19553318|P2|Overall Study|Withdrawal by Subject|15
5664219|NCT00474786|19553319|P1|Overall Study|Withdrawal by Subject|15
5664220|NCT00474786|19553318|P2|Overall Study|Protocol Violation|0
5664221|NCT00474786|19553319|P1|Overall Study|Protocol Violation|2
5664222|NCT00474786|19553318|P2|Overall Study|Lost to Follow-up|7
5664223|NCT00474786|19553319|P1|Overall Study|Lost to Follow-up|4
5664224|NCT00474786|19553318|P2|Overall Study|Discontinuation of Study by Sponsor|59
5664225|NCT00474786|19553319|P1|Overall Study|Discontinuation of Study by Sponsor|42
5664226|NCT00474786|19553318|P2|Overall Study|Death|170
5664227|NCT00474786|19553319|P1|Overall Study|Death|189
5664228|NCT00474786|19553318|P2|Overall Study|Investigator Request|1
5664229|NCT00474786|19553319|P1|Overall Study|Investigator Request|2
5664230|NCT00474786|19553318|P2|Overall Study|Not Meeting Study Criteria|1
5664231|NCT00474786|19553319|P1|Overall Study|Not Meeting Study Criteria|0
5664232|NCT00474760|19553344|P7|Overall Study|Terminated by sponsor|2
5664233|NCT00474760|19553345|P6|Overall Study|Terminated by sponsor|0
5664234|NCT00474760|19553346|P5|Overall Study|Terminated by sponsor|0
5664235|NCT00474760|19553347|P4|Overall Study|Terminated by sponsor|0
5664236|NCT00474760|19553348|P3|Overall Study|Terminated by sponsor|0
5664237|NCT00474760|19553349|P2|Overall Study|Terminated by sponsor|0
5664238|NCT00474760|19553350|P1|Overall Study|Terminated by sponsor|0
5664239|NCT00474760|19553344|P7|Overall Study|Progressive disease|7
5664240|NCT00474760|19553345|P6|Overall Study|Progressive disease|20
5664241|NCT00474760|19553346|P5|Overall Study|Progressive disease|8
5664242|NCT00474760|19553347|P4|Overall Study|Progressive disease|2
5664243|NCT00474760|19553348|P3|Overall Study|Progressive disease|3
5664244|NCT00474760|19553349|P2|Overall Study|Progressive disease|2
5664245|NCT00474760|19553350|P1|Overall Study|Progressive disease|3
5664246|NCT00474760|19553344|P7|Overall Study|Other|0
5664247|NCT00474760|19553345|P6|Overall Study|Other|0
5664248|NCT00474760|19553346|P5|Overall Study|Other|1
5664249|NCT00474760|19553347|P4|Overall Study|Other|0
5664250|NCT00474760|19553348|P3|Overall Study|Other|0
5664251|NCT00474760|19553349|P2|Overall Study|Other|1
5664252|NCT00474760|19553350|P1|Overall Study|Other|0
5664253|NCT00474760|19553344|P7|Overall Study|Withdrawal by Subject|1
5664254|NCT00474760|19553345|P6|Overall Study|Withdrawal by Subject|1
5664255|NCT00474760|19553346|P5|Overall Study|Withdrawal by Subject|0
5664256|NCT00474760|19553347|P4|Overall Study|Withdrawal by Subject|1
5664257|NCT00474760|19553348|P3|Overall Study|Withdrawal by Subject|0
5664258|NCT00474760|19553349|P2|Overall Study|Withdrawal by Subject|0
5664259|NCT00474760|19553350|P1|Overall Study|Withdrawal by Subject|0
5664260|NCT00474760|19553344|P7|Overall Study|Laboratory abnormality|0
5664261|NCT00474760|19553345|P6|Overall Study|Laboratory abnormality|1
5664262|NCT00474760|19553346|P5|Overall Study|Laboratory abnormality|0
5664263|NCT00474760|19553347|P4|Overall Study|Laboratory abnormality|0
5664264|NCT00474760|19553348|P3|Overall Study|Laboratory abnormality|0
5664265|NCT00474760|19553349|P2|Overall Study|Laboratory abnormality|0
5664266|NCT00474760|19553350|P1|Overall Study|Laboratory abnormality|0
5664267|NCT00474760|19553344|P7|Overall Study|Adverse Event|0
5664268|NCT00474760|19553345|P6|Overall Study|Adverse Event|7
5664269|NCT00474760|19553346|P5|Overall Study|Adverse Event|1
5664270|NCT00474760|19553347|P4|Overall Study|Adverse Event|0
5664271|NCT00474760|19553348|P3|Overall Study|Adverse Event|0
5664272|NCT00474760|19553349|P2|Overall Study|Adverse Event|0
5664273|NCT00474760|19553350|P1|Overall Study|Adverse Event|0
5664274|NCT00474760|19553344|P7|Overall Study|Death|0
5664275|NCT00474760|19553345|P6|Overall Study|Death|0
5664276|NCT00474760|19553346|P5|Overall Study|Death|2
5664277|NCT00474760|19553347|P4|Overall Study|Death|0
5664278|NCT00474760|19553348|P3|Overall Study|Death|0
5664279|NCT00474760|19553349|P2|Overall Study|Death|0
5664280|NCT00474760|19553350|P1|Overall Study|Death|0
5664281|NCT00474708|19553457|P2|Overall Study|Physician Decision|6
5664282|NCT00474708|19553458|P1|Overall Study|Physician Decision|9
5664283|NCT00474708|19553457|P2|Overall Study|Lost to Follow-up|9
5664284|NCT00474708|19553458|P1|Overall Study|Lost to Follow-up|18
5664285|NCT00474708|19553457|P2|Overall Study|Lack of compliance|4
5664286|NCT00474708|19553458|P1|Overall Study|Lack of compliance|12
5664287|NCT00474708|19553457|P2|Overall Study|Withdrawal by Subject|0
5664288|NCT00474708|19553458|P1|Overall Study|Withdrawal by Subject|7
5664289|NCT00474708|19553457|P2|Overall Study|Suicide ideation/behavior|1
5664290|NCT00474708|19553458|P1|Overall Study|Suicide ideation/behavior|0
5664291|NCT00474708|19553457|P2|Overall Study|Lack of Efficacy|5
5664292|NCT00474708|19553458|P1|Overall Study|Lack of Efficacy|11
5664293|NCT00474630|19553468|P2|Overall Study|Drug noncompliance, other|4
5664294|NCT00474630|19553469|P1|Overall Study|Drug noncompliance, other|11
5664295|NCT00474630|19553468|P2|Overall Study|Lack of Efficacy|6
5664296|NCT00474630|19553469|P1|Overall Study|Lack of Efficacy|5
5664297|NCT00474630|19553468|P2|Overall Study|Protocol Violation|4
5664298|NCT00474630|19553469|P1|Overall Study|Protocol Violation|3
5664299|NCT00474630|19553468|P2|Overall Study|Withdrawal by Subject|15
5664300|NCT00474630|19553469|P1|Overall Study|Withdrawal by Subject|21
5664301|NCT00474630|19553468|P2|Overall Study|Lost to Follow-up|15
5664302|NCT00474630|19553469|P1|Overall Study|Lost to Follow-up|22
5664303|NCT00474630|19553468|P2|Overall Study|Adverse Event|26
5664304|NCT00474630|19553469|P1|Overall Study|Adverse Event|98
5664305|NCT00474539|19553562|P2|Toddler Dose|Protocol Violation|0
5664306|NCT00474539|19553563|P1|Toddler Dose|Protocol Violation|1
5664307|NCT00474539|19553562|P2|After Infant Series|Withdrawal by Subject|0
5664308|NCT00474539|19553563|P1|After Infant Series|Withdrawal by Subject|1
5664309|NCT00474539|19553562|P2|After Infant Series|Lost to Follow-up|0
5664310|NCT00474539|19553563|P1|After Infant Series|Lost to Follow-up|3
5664311|NCT00474539|19553562|P2|Infant Series|Protocol Violation|1
5664312|NCT00474539|19553563|P1|Infant Series|Protocol Violation|0
5664313|NCT00474539|19553562|P2|Infant Series|Lost to Follow-up|1
5664314|NCT00474539|19553563|P1|Infant Series|Lost to Follow-up|2
5664315|NCT00474539|19553562|P2|Infant Series|Randomization error|0
5664316|NCT00474539|19553563|P1|Infant Series|Randomization error|5
5664317|NCT00474539|19553562|P2|Infant Series|Withdrawal by Subject|4
5664318|NCT00474539|19553563|P1|Infant Series|Withdrawal by Subject|3
5664319|NCT00474526|19553628|P17|Overall Study|Withdrawal by Subject|1
5664320|NCT00474526|19553629|P16|Overall Study|Withdrawal by Subject|1
5664321|NCT00474526|19553630|P15|Overall Study|Withdrawal by Subject|22
5664322|NCT00474526|19553631|P14|Overall Study|Withdrawal by Subject|37
5664323|NCT00474526|19553632|P13|Overall Study|Withdrawal by Subject|4
5664324|NCT00474526|19553633|P12|Overall Study|Withdrawal by Subject|4
5664325|NCT00474526|19553634|P11|Overall Study|Withdrawal by Subject|5
5664326|NCT00474526|19553635|P10|Overall Study|Withdrawal by Subject|13
5664327|NCT00474526|19553636|P9|Overall Study|Withdrawal by Subject|4
5664328|NCT00474526|19553637|P8|Overall Study|Withdrawal by Subject|4
5664329|NCT00474526|19553638|P7|Overall Study|Withdrawal by Subject|12
5664330|NCT00474526|19553639|P6|Overall Study|Withdrawal by Subject|6
5664331|NCT00474526|19553640|P5|Overall Study|Withdrawal by Subject|38
5664332|NCT00474526|19553641|P4|Overall Study|Withdrawal by Subject|52
5664333|NCT00474526|19553642|P3|Overall Study|Withdrawal by Subject|21
5664334|NCT00474526|19553643|P2|Overall Study|Withdrawal by Subject|24
5664335|NCT00474526|19553644|P1|Overall Study|Withdrawal by Subject|9
5664336|NCT00474526|19553628|P17|Overall Study|UNABLE TO CLASSIFY|1
5664337|NCT00474526|19553629|P16|Overall Study|UNABLE TO CLASSIFY|6
5664338|NCT00474526|19553630|P15|Overall Study|UNABLE TO CLASSIFY|12
5664339|NCT00474526|19553631|P14|Overall Study|UNABLE TO CLASSIFY|20
5664340|NCT00474526|19553632|P13|Overall Study|UNABLE TO CLASSIFY|0
5664341|NCT00474526|19553633|P12|Overall Study|UNABLE TO CLASSIFY|0
5664342|NCT00474526|19553634|P11|Overall Study|UNABLE TO CLASSIFY|0
5664343|NCT00474526|19553635|P10|Overall Study|UNABLE TO CLASSIFY|3
5664344|NCT00474526|19553636|P9|Overall Study|UNABLE TO CLASSIFY|0
5664345|NCT00474526|19553637|P8|Overall Study|UNABLE TO CLASSIFY|1
5664346|NCT00474526|19553638|P7|Overall Study|UNABLE TO CLASSIFY|0
5664347|NCT00474526|19553639|P6|Overall Study|UNABLE TO CLASSIFY|2
5664348|NCT00474526|19553640|P5|Overall Study|UNABLE TO CLASSIFY|3
5664349|NCT00474526|19553641|P4|Overall Study|UNABLE TO CLASSIFY|1
5664350|NCT00474526|19553642|P3|Overall Study|UNABLE TO CLASSIFY|0
5664351|NCT00474526|19553643|P2|Overall Study|UNABLE TO CLASSIFY|0
5664352|NCT00474526|19553644|P1|Overall Study|UNABLE TO CLASSIFY|1
5664353|NCT00474526|19553628|P17|Overall Study|Protocol Violation|2
5664354|NCT00474526|19553629|P16|Overall Study|Protocol Violation|6
5664355|NCT00474526|19553630|P15|Overall Study|Protocol Violation|9
5664356|NCT00474526|19553631|P14|Overall Study|Protocol Violation|19
5664357|NCT00474526|19553632|P13|Overall Study|Protocol Violation|4
5664358|NCT00474526|19553633|P12|Overall Study|Protocol Violation|2
5664359|NCT00474526|19553634|P11|Overall Study|Protocol Violation|2
5664360|NCT00474526|19553635|P10|Overall Study|Protocol Violation|4
5664361|NCT00474526|19553636|P9|Overall Study|Protocol Violation|0
5664362|NCT00474526|19553637|P8|Overall Study|Protocol Violation|0
5664363|NCT00474526|19553638|P7|Overall Study|Protocol Violation|3
5664364|NCT00474526|19553639|P6|Overall Study|Protocol Violation|1
5664365|NCT00474526|19553640|P5|Overall Study|Protocol Violation|3
5664366|NCT00474526|19553641|P4|Overall Study|Protocol Violation|12
5664367|NCT00474526|19553642|P3|Overall Study|Protocol Violation|4
5664368|NCT00474526|19553643|P2|Overall Study|Protocol Violation|6
5664369|NCT00474526|19553644|P1|Overall Study|Protocol Violation|2
5664370|NCT00474526|19553628|P17|Overall Study|Lost to Follow-up|5
5664371|NCT00474526|19553629|P16|Overall Study|Lost to Follow-up|4
5664372|NCT00474526|19553630|P15|Overall Study|Lost to Follow-up|29
5664373|NCT00474526|19553631|P14|Overall Study|Lost to Follow-up|74
5664374|NCT00474526|19553632|P13|Overall Study|Lost to Follow-up|6
5664375|NCT00474526|19553633|P12|Overall Study|Lost to Follow-up|4
5664376|NCT00474526|19553634|P11|Overall Study|Lost to Follow-up|2
5664377|NCT00474526|19553635|P10|Overall Study|Lost to Follow-up|6
5664378|NCT00474526|19553636|P9|Overall Study|Lost to Follow-up|0
5664379|NCT00474526|19553637|P8|Overall Study|Lost to Follow-up|1
5664380|NCT00474526|19553638|P7|Overall Study|Lost to Follow-up|8
5664381|NCT00474526|19553639|P6|Overall Study|Lost to Follow-up|5
5664382|NCT00474526|19553640|P5|Overall Study|Lost to Follow-up|11
5664383|NCT00474526|19553641|P4|Overall Study|Lost to Follow-up|29
5664384|NCT00474526|19553642|P3|Overall Study|Lost to Follow-up|13
5664385|NCT00474526|19553643|P2|Overall Study|Lost to Follow-up|6
5664386|NCT00474526|19553644|P1|Overall Study|Lost to Follow-up|8
5664387|NCT00474526|19553628|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664388|NCT00474526|19553629|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664389|NCT00474526|19553630|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
5664390|NCT00474526|19553631|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
5664391|NCT00474526|19553632|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664392|NCT00474526|19553633|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664393|NCT00474526|19553634|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664394|NCT00474526|19553635|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664395|NCT00474526|19553636|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664396|NCT00474526|19553637|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664397|NCT00474526|19553638|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664398|NCT00474526|19553639|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664399|NCT00474526|19553640|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
5664400|NCT00474526|19553641|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
5664401|NCT00474526|19553642|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664402|NCT00474526|19553643|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
5664403|NCT00474526|19553644|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
5664404|NCT00474526|19553628|P17|Overall Study|Death|0
5664405|NCT00474526|19553629|P16|Overall Study|Death|0
5664406|NCT00474526|19553630|P15|Overall Study|Death|0
5664407|NCT00474526|19553631|P14|Overall Study|Death|3
5664408|NCT00474526|19553632|P13|Overall Study|Death|0
5664409|NCT00474526|19553633|P12|Overall Study|Death|0
5664410|NCT00474526|19553634|P11|Overall Study|Death|0
5664411|NCT00474526|19553635|P10|Overall Study|Death|0
5664412|NCT00474526|19553636|P9|Overall Study|Death|0
5664413|NCT00474526|19553637|P8|Overall Study|Death|0
5664414|NCT00474526|19553638|P7|Overall Study|Death|0
5664415|NCT00474526|19553639|P6|Overall Study|Death|0
5664416|NCT00474526|19553640|P5|Overall Study|Death|0
5664417|NCT00474526|19553641|P4|Overall Study|Death|0
5664418|NCT00474526|19553642|P3|Overall Study|Death|0
5664419|NCT00474526|19553643|P2|Overall Study|Death|0
5664420|NCT00474526|19553644|P1|Overall Study|Death|0
5664421|NCT00474526|19553628|P17|Overall Study|Adverse Event|0
5664422|NCT00474526|19553629|P16|Overall Study|Adverse Event|1
5664423|NCT00474526|19553630|P15|Overall Study|Adverse Event|1
5664424|NCT00474526|19553631|P14|Overall Study|Adverse Event|0
5664425|NCT00474526|19553632|P13|Overall Study|Adverse Event|0
5664426|NCT00474526|19553633|P12|Overall Study|Adverse Event|0
5664427|NCT00474526|19553634|P11|Overall Study|Adverse Event|0
5664428|NCT00474526|19553635|P10|Overall Study|Adverse Event|0
5664429|NCT00474526|19553636|P9|Overall Study|Adverse Event|0
5664430|NCT00474526|19553637|P8|Overall Study|Adverse Event|0
5664431|NCT00474526|19553638|P7|Overall Study|Adverse Event|1
5664432|NCT00474526|19553639|P6|Overall Study|Adverse Event|1
5664433|NCT00474526|19553640|P5|Overall Study|Adverse Event|2
5664434|NCT00474526|19553641|P4|Overall Study|Adverse Event|4
5664435|NCT00474526|19553642|P3|Overall Study|Adverse Event|2
5664436|NCT00474526|19553643|P2|Overall Study|Adverse Event|0
5664437|NCT00474526|19553644|P1|Overall Study|Adverse Event|2
5664438|NCT00474526|19553628|P17|Overall Study|ADMINISTRATIVE REASON|0
5664439|NCT00474526|19553629|P16|Overall Study|ADMINISTRATIVE REASON|0
5664440|NCT00474526|19553630|P15|Overall Study|ADMINISTRATIVE REASON|2
5664441|NCT00474526|19553631|P14|Overall Study|ADMINISTRATIVE REASON|1
5664442|NCT00474526|19553632|P13|Overall Study|ADMINISTRATIVE REASON|1
5664443|NCT00474526|19553633|P12|Overall Study|ADMINISTRATIVE REASON|1
5664444|NCT00474526|19553634|P11|Overall Study|ADMINISTRATIVE REASON|1
5664445|NCT00474526|19553635|P10|Overall Study|ADMINISTRATIVE REASON|1
5664446|NCT00474526|19553636|P9|Overall Study|ADMINISTRATIVE REASON|2
5664447|NCT00474526|19553637|P8|Overall Study|ADMINISTRATIVE REASON|0
5664448|NCT00474526|19553638|P7|Overall Study|ADMINISTRATIVE REASON|1
5664449|NCT00474526|19553639|P6|Overall Study|ADMINISTRATIVE REASON|1
5664450|NCT00474526|19553640|P5|Overall Study|ADMINISTRATIVE REASON|9
5664451|NCT00474526|19553641|P4|Overall Study|ADMINISTRATIVE REASON|20
5664452|NCT00474526|19553642|P3|Overall Study|ADMINISTRATIVE REASON|9
5664453|NCT00474526|19553643|P2|Overall Study|ADMINISTRATIVE REASON|9
5664454|NCT00474526|19553644|P1|Overall Study|ADMINISTRATIVE REASON|11
5664455|NCT00474487|19553809|P4|Overall Study|Death|0
5664456|NCT00474487|19553810|P3|Overall Study|Death|0
5664457|NCT00474487|19553811|P2|Overall Study|Death|1
5664458|NCT00474487|19553812|P1|Overall Study|Death|0
5664459|NCT00474487|19553809|P4|Overall Study|Inappropriate enrollment|0
5664460|NCT00474487|19553810|P3|Overall Study|Inappropriate enrollment|7
5664461|NCT00474487|19553811|P2|Overall Study|Inappropriate enrollment|0
5664462|NCT00474487|19553812|P1|Overall Study|Inappropriate enrollment|4
5664463|NCT00474487|19553809|P4|Overall Study|Lost to Follow-up|0
5664464|NCT00474487|19553810|P3|Overall Study|Lost to Follow-up|7
5664465|NCT00474487|19553811|P2|Overall Study|Lost to Follow-up|1
5664466|NCT00474487|19553812|P1|Overall Study|Lost to Follow-up|20
5664467|NCT00474487|19553809|P4|Overall Study|Withdrawal by Subject|0
5664468|NCT00474487|19553810|P3|Overall Study|Withdrawal by Subject|0
5664469|NCT00474487|19553811|P2|Overall Study|Withdrawal by Subject|0
5664470|NCT00474487|19553812|P1|Overall Study|Withdrawal by Subject|6
5664471|NCT00474383|19553832|P2|Extension|Progressive Disease|5
5664472|NCT00474383|19553833|P1|Extension|Progressive Disease|0
5664473|NCT00474383|19553832|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
5664474|NCT00474383|19553833|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
5664475|NCT00474383|19553832|P2|Main Study|Other|0
5664476|NCT00474383|19553833|P1|Main Study|Other|1
5664477|NCT00474383|19553832|P2|Main Study|Progressive Disease|0
5664478|NCT00474383|19553833|P1|Main Study|Progressive Disease|23
5664479|NCT00474383|19553832|P2|Main Study|Symptomatic Deterioration|0
5664480|NCT00474383|19553833|P1|Main Study|Symptomatic Deterioration|1
5664481|NCT00474383|19553832|P2|Main Study|Adverse Event|0
5664482|NCT00474383|19553833|P1|Main Study|Adverse Event|11
5664483|NCT00474266|19553848|P4|Overall Study|Withdrawal by Subject|7
5664484|NCT00474266|19553849|P3|Overall Study|Withdrawal by Subject|4
5664485|NCT00474266|19553850|P2|Overall Study|Withdrawal by Subject|20
5664486|NCT00474266|19553851|P1|Overall Study|Withdrawal by Subject|7
5664487|NCT00474253|19553955|P2|Overall Study|Discharged prior to study completion|1
5664488|NCT00474253|19553956|P1|Overall Study|Discharged prior to study completion|0
5664489|NCT00474253|19553955|P2|Overall Study|Lost to Follow-up|0
5664490|NCT00474253|19553956|P1|Overall Study|Lost to Follow-up|1
5664491|NCT00474253|19553955|P2|Overall Study|Withdrew due to surgery-related issues|3
5664492|NCT00474253|19553956|P1|Overall Study|Withdrew due to surgery-related issues|0
5664493|NCT00474253|19553955|P2|Overall Study|Withdrew consent|0
5664494|NCT00474253|19553956|P1|Overall Study|Withdrew consent|2
5664495|NCT00474240|19553980|P6|Overall Study|Removed due to lab value|1
5664496|NCT00474240|19553981|P5|Overall Study|Removed due to lab value|0
5664497|NCT00474240|19553982|P4|Overall Study|Removed due to lab value|0
5664498|NCT00474240|19553983|P3|Overall Study|Removed due to lab value|0
5664499|NCT00474240|19553984|P2|Overall Study|Removed due to lab value|0
5664500|NCT00474240|19553985|P1|Overall Study|Removed due to lab value|0
5664501|NCT00474240|19553980|P6|Overall Study|Adverse Event|16
5664502|NCT00474240|19553981|P5|Overall Study|Adverse Event|5
5664503|NCT00474240|19553982|P4|Overall Study|Adverse Event|14
5664504|NCT00474240|19553983|P3|Overall Study|Adverse Event|9
5664505|NCT00474240|19553984|P2|Overall Study|Adverse Event|0
5664506|NCT00474240|19553985|P1|Overall Study|Adverse Event|0
5664507|NCT00474240|19553980|P6|Overall Study|Withdrawal by Subject|1
5664508|NCT00474240|19553981|P5|Overall Study|Withdrawal by Subject|3
5664509|NCT00474240|19553982|P4|Overall Study|Withdrawal by Subject|2
5664510|NCT00474240|19553983|P3|Overall Study|Withdrawal by Subject|0
5664511|NCT00474240|19553984|P2|Overall Study|Withdrawal by Subject|1
5664512|NCT00474240|19553985|P1|Overall Study|Withdrawal by Subject|1
5664513|NCT00474188|19554010|P1|Overall Study|Study discontinued by sponsor|5
5664514|NCT00474188|19554010|P1|Overall Study|Withdrawal by Subject|1
5664515|NCT00474175|19554020|P3|Overall Study|Administrative|0
5664516|NCT00474175|19554021|P2|Overall Study|Administrative|1
5664517|NCT00474175|19554022|P1|Overall Study|Administrative|0
5664518|NCT00474175|19554020|P3|Overall Study|Protocol Violation|1
5664519|NCT00474175|19554021|P2|Overall Study|Protocol Violation|2
5664520|NCT00474175|19554022|P1|Overall Study|Protocol Violation|0
5664521|NCT00474175|19554020|P3|Overall Study|Ineligible|1
5664522|NCT00474175|19554021|P2|Overall Study|Ineligible|3
5664523|NCT00474175|19554022|P1|Overall Study|Ineligible|1
5664524|NCT00474175|19554020|P3|Overall Study|Withdrawal by Subject|1
5664525|NCT00474175|19554021|P2|Overall Study|Withdrawal by Subject|1
5664526|NCT00474175|19554022|P1|Overall Study|Withdrawal by Subject|0
5664527|NCT00474175|19554020|P3|Overall Study|Lack of Efficacy|1
5664528|NCT00474175|19554021|P2|Overall Study|Lack of Efficacy|0
5664529|NCT00474175|19554022|P1|Overall Study|Lack of Efficacy|0
5664530|NCT00474058|19554086|P2|Overall Study|Other|0
5664531|NCT00474058|19554087|P1|Overall Study|Other|2
5664532|NCT00474058|19554086|P2|Overall Study|Withdrawal by Subject|7
5664533|NCT00474058|19554087|P1|Overall Study|Withdrawal by Subject|11
5664534|NCT00474058|19554086|P2|Overall Study|Lack of Efficacy|4
5664535|NCT00474058|19554087|P1|Overall Study|Lack of Efficacy|0
5664536|NCT00474058|19554086|P2|Overall Study|Adverse Event|6
5664537|NCT00474058|19554087|P1|Overall Study|Adverse Event|11
5664538|NCT00474045|19554101|P2|Overall Study|Withdrawal criteria|50
5664539|NCT00474045|19554102|P1|Overall Study|Withdrawal criteria|60
5664540|NCT00474045|19554101|P2|Overall Study|Withdrawal by Subject|18
5664541|NCT00474045|19554102|P1|Overall Study|Withdrawal by Subject|16
5664542|NCT00474045|19554101|P2|Overall Study|Protocol Violation|12
5664543|NCT00474045|19554102|P1|Overall Study|Protocol Violation|10
5664544|NCT00474045|19554101|P2|Overall Study|Lost to Follow-up|1
5664545|NCT00474045|19554102|P1|Overall Study|Lost to Follow-up|1
5664546|NCT00474045|19554101|P2|Overall Study|Lack of Efficacy|9
5664547|NCT00474045|19554102|P1|Overall Study|Lack of Efficacy|0
5664548|NCT00474045|19554101|P2|Overall Study|Unclassified|3
5664549|NCT00474045|19554102|P1|Overall Study|Unclassified|1
5664550|NCT00474045|19554101|P2|Overall Study|Adverse Event|8
5664551|NCT00474045|19554102|P1|Overall Study|Adverse Event|18
5664552|NCT00473889|19554202|P2|Overall Study|Withdrawal by Subject|0
5664553|NCT00473889|19554203|P1|Overall Study|Withdrawal by Subject|5
5664554|NCT00473889|19554202|P2|Overall Study|Trial Terminated|6
5664555|NCT00473889|19554203|P1|Overall Study|Trial Terminated|3
5664556|NCT00473889|19554202|P2|Overall Study|Physician Decision|5
5664557|NCT00473889|19554203|P1|Overall Study|Physician Decision|10
5664558|NCT00473889|19554202|P2|Overall Study|Lost to Follow-up|1
5664559|NCT00473889|19554203|P1|Overall Study|Lost to Follow-up|2
5664560|NCT00473889|19554202|P2|Overall Study|Lack of Efficacy|29
5664561|NCT00473889|19554203|P1|Overall Study|Lack of Efficacy|28
5664562|NCT00473889|19554202|P2|Overall Study|Protocol Violation|2
5664563|NCT00473889|19554203|P1|Overall Study|Protocol Violation|4
5664564|NCT00473889|19554202|P2|Overall Study|Adverse Event|17
5664565|NCT00473889|19554203|P1|Overall Study|Adverse Event|30
5664566|NCT00473889|19554202|P2|Overall Study|Did not receive study medication|4
5664567|NCT00473889|19554203|P1|Overall Study|Did not receive study medication|1
5664568|NCT00473876|19554215|P2|Overall Study|Lost to Follow-up|1
5664569|NCT00473876|19554216|P1|Overall Study|Lost to Follow-up|3
5664570|NCT00473824|19554235|P2|Overall Study|Withdrawal by physician|0
5664571|NCT00473824|19554236|P1|Overall Study|Withdrawal by physician|1
5664572|NCT00473824|19554235|P2|Overall Study|Lost to Follow-up|0
5664573|NCT00473824|19554236|P1|Overall Study|Lost to Follow-up|1
5664574|NCT00473824|19554235|P2|Overall Study|Death|0
5664575|NCT00473824|19554236|P1|Overall Study|Death|1
5664576|NCT00473824|19554235|P2|Overall Study|Adverse Event|0
5664577|NCT00473824|19554236|P1|Overall Study|Adverse Event|1
5664578|NCT00473824|19554235|P2|Overall Study|Virologic Breakthrough|0
5664579|NCT00473824|19554236|P1|Overall Study|Virologic Breakthrough|1
5664580|NCT00473746|19554247|P5|Period 2 (Phase 2)|Reason not specified|3
5664581|NCT00473746|19554248|P4|Period 2 (Phase 2)|Reason not specified|0
5664582|NCT00473746|19554249|P3|Period 2 (Phase 2)|Reason not specified|0
5664583|NCT00473746|19554250|P2|Period 2 (Phase 2)|Reason not specified|0
5664584|NCT00473746|19554251|P1|Period 2 (Phase 2)|Reason not specified|0
5664585|NCT00473746|19554247|P5|Period 2 (Phase 2)|Progressive Disease|20
5664586|NCT00473746|19554248|P4|Period 2 (Phase 2)|Progressive Disease|0
5664587|NCT00473746|19554249|P3|Period 2 (Phase 2)|Progressive Disease|0
5664588|NCT00473746|19554250|P2|Period 2 (Phase 2)|Progressive Disease|0
5664589|NCT00473746|19554251|P1|Period 2 (Phase 2)|Progressive Disease|0
5664590|NCT00473746|19554247|P5|Period 2 (Phase 2)|Death|1
5664591|NCT00473746|19554248|P4|Period 2 (Phase 2)|Death|0
5664592|NCT00473746|19554249|P3|Period 2 (Phase 2)|Death|0
5664593|NCT00473746|19554250|P2|Period 2 (Phase 2)|Death|0
5664594|NCT00473746|19554251|P1|Period 2 (Phase 2)|Death|0
5664595|NCT00473746|19554247|P5|Period 2 (Phase 2)|Adverse Event|3
5664596|NCT00473746|19554248|P4|Period 2 (Phase 2)|Adverse Event|0
5664597|NCT00473746|19554249|P3|Period 2 (Phase 2)|Adverse Event|0
5664598|NCT00473746|19554250|P2|Period 2 (Phase 2)|Adverse Event|0
5664599|NCT00473746|19554251|P1|Period 2 (Phase 2)|Adverse Event|0
5664600|NCT00473746|19554247|P5|Period 1 (Phase 1)|Reason not specified|0
5664601|NCT00473746|19554248|P4|Period 1 (Phase 1)|Reason not specified|0
5664602|NCT00473746|19554249|P3|Period 1 (Phase 1)|Reason not specified|0
5664603|NCT00473746|19554250|P2|Period 1 (Phase 1)|Reason not specified|1
5664604|NCT00473746|19554251|P1|Period 1 (Phase 1)|Reason not specified|0
5664605|NCT00473746|19554247|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
5664606|NCT00473746|19554248|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
5664607|NCT00473746|19554249|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
5664608|NCT00473746|19554250|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
5664609|NCT00473746|19554251|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
5664610|NCT00473746|19554247|P5|Period 1 (Phase 1)|Progressive Disease|0
5664611|NCT00473746|19554248|P4|Period 1 (Phase 1)|Progressive Disease|10
5664612|NCT00473746|19554249|P3|Period 1 (Phase 1)|Progressive Disease|6
5664613|NCT00473746|19554250|P2|Period 1 (Phase 1)|Progressive Disease|6
5664614|NCT00473746|19554251|P1|Period 1 (Phase 1)|Progressive Disease|5
5664615|NCT00473746|19554247|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
5664616|NCT00473746|19554248|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
5664617|NCT00473746|19554249|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
5664618|NCT00473746|19554250|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
5664619|NCT00473746|19554251|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
5664620|NCT00473746|19554247|P5|Period 1 (Phase 1)|Adverse Event|0
5664621|NCT00473746|19554248|P4|Period 1 (Phase 1)|Adverse Event|0
5664622|NCT00473746|19554249|P3|Period 1 (Phase 1)|Adverse Event|0
5664623|NCT00473746|19554250|P2|Period 1 (Phase 1)|Adverse Event|0
5664624|NCT00473746|19554251|P1|Period 1 (Phase 1)|Adverse Event|1
5664625|NCT00473694|19554300|P4|Overall Study|Lost to Follow-up|1
5664626|NCT00473694|19554301|P3|Overall Study|Lost to Follow-up|0
5664627|NCT00473694|19554302|P2|Overall Study|Lost to Follow-up|0
5664628|NCT00473694|19554303|P1|Overall Study|Lost to Follow-up|0
5664629|NCT00473694|19554300|P4|Overall Study|Participants did not receive treatment|6
5664630|NCT00473694|19554301|P3|Overall Study|Participants did not receive treatment|5
5664631|NCT00473694|19554302|P2|Overall Study|Participants did not receive treatment|3
5664632|NCT00473694|19554303|P1|Overall Study|Participants did not receive treatment|11
5664633|NCT00473694|19554300|P4|Overall Study|Adverse Event|0
5664634|NCT00473694|19554301|P3|Overall Study|Adverse Event|0
5664635|NCT00473694|19554302|P2|Overall Study|Adverse Event|1
5664636|NCT00473694|19554303|P1|Overall Study|Adverse Event|0
5664637|NCT00473668|19554344|P3|Overall Study|Other|4
5664638|NCT00473668|19554345|P2|Overall Study|Other|3
5664639|NCT00473668|19554346|P1|Overall Study|Other|2
5664640|NCT00473668|19554344|P3|Overall Study|Lost to Follow-up|6
5664641|NCT00473668|19554345|P2|Overall Study|Lost to Follow-up|4
5664642|NCT00473668|19554346|P1|Overall Study|Lost to Follow-up|0
5664643|NCT00473668|19554344|P3|Overall Study|Migrated/moved from study area|0
5664644|NCT00473668|19554345|P2|Overall Study|Migrated/moved from study area|2
5664645|NCT00473668|19554346|P1|Overall Study|Migrated/moved from study area|3
5664646|NCT00473668|19554344|P3|Overall Study|Withdrawal by Subject|0
5664647|NCT00473668|19554345|P2|Overall Study|Withdrawal by Subject|2
5664648|NCT00473668|19554346|P1|Overall Study|Withdrawal by Subject|0
5664649|NCT00473655|19554399|P3|Overall Study|Lost to Follow-up|8
5664650|NCT00473655|19554400|P2|Overall Study|Lost to Follow-up|5
5664651|NCT00473655|19554401|P1|Overall Study|Lost to Follow-up|9
5664652|NCT00473590|19554462|P2|Overall Study|Other|1
5664653|NCT00473590|19554463|P1|Overall Study|Other|0
5664654|NCT00473590|19554462|P2|Overall Study|Withdrawal by Subject|3
5664655|NCT00473590|19554463|P1|Overall Study|Withdrawal by Subject|5
5664656|NCT00473590|19554462|P2|Overall Study|Physician Decision|4
5664657|NCT00473590|19554463|P1|Overall Study|Physician Decision|2
5664658|NCT00473590|19554462|P2|Overall Study|Non-protocol-specified therapy|5
5664659|NCT00473590|19554463|P1|Overall Study|Non-protocol-specified therapy|7
5664660|NCT00473590|19554462|P2|Overall Study|Progression not resulting in death|20
5664661|NCT00473590|19554463|P1|Overall Study|Progression not resulting in death|24
5664662|NCT00473590|19554462|P2|Overall Study|Death|2
5664663|NCT00473590|19554463|P1|Overall Study|Death|4
5664664|NCT00473590|19554462|P2|Overall Study|Adverse Event|3
5664665|NCT00473590|19554463|P1|Overall Study|Adverse Event|3
5664666|NCT00473564|19554479|P1|Overall Study|robot surgery aborted in OR|23
5664667|NCT00473512|19554489|P5|Period 2 (Phase 2)|Other|0
5664668|NCT00473512|19554490|P4|Period 2 (Phase 2)|Other|3
5664669|NCT00473512|19554491|P3|Period 2 (Phase 2)|Other|0
5664670|NCT00473512|19554492|P2|Period 2 (Phase 2)|Other|0
5664671|NCT00473512|19554493|P1|Period 2 (Phase 2)|Other|1
5664672|NCT00473512|19554489|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
5664673|NCT00473512|19554490|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
5664674|NCT00473512|19554491|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
5664675|NCT00473512|19554492|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
5664676|NCT00473512|19554493|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
5664677|NCT00473512|19554489|P5|Period 2 (Phase 2)|Disease Progression|1
5664678|NCT00473512|19554490|P4|Period 2 (Phase 2)|Disease Progression|17
5664679|NCT00473512|19554491|P3|Period 2 (Phase 2)|Disease Progression|2
5664680|NCT00473512|19554492|P2|Period 2 (Phase 2)|Disease Progression|2
5664681|NCT00473512|19554493|P1|Period 2 (Phase 2)|Disease Progression|0
5664682|NCT00473512|19554489|P5|Period 2 (Phase 2)|Death|1
5664683|NCT00473512|19554490|P4|Period 2 (Phase 2)|Death|1
5664684|NCT00473512|19554491|P3|Period 2 (Phase 2)|Death|0
5664685|NCT00473512|19554492|P2|Period 2 (Phase 2)|Death|0
5664686|NCT00473512|19554493|P1|Period 2 (Phase 2)|Death|0
5664687|NCT00473512|19554489|P5|Period 2 (Phase 2)|Adverse Event|0
5664688|NCT00473512|19554490|P4|Period 2 (Phase 2)|Adverse Event|1
5664689|NCT00473512|19554491|P3|Period 2 (Phase 2)|Adverse Event|0
5664690|NCT00473512|19554492|P2|Period 2 (Phase 2)|Adverse Event|0
5664691|NCT00473512|19554493|P1|Period 2 (Phase 2)|Adverse Event|0
5664692|NCT00473512|19554489|P5|Period 1 (Phase 1)|Other|0
5664693|NCT00473512|19554490|P4|Period 1 (Phase 1)|Other|1
5664694|NCT00473512|19554491|P3|Period 1 (Phase 1)|Other|0
5664695|NCT00473512|19554492|P2|Period 1 (Phase 1)|Other|0
5664696|NCT00473512|19554493|P1|Period 1 (Phase 1)|Other|0
5664697|NCT00473512|19554489|P5|Period 1 (Phase 1)|Disease Progression|1
5664698|NCT00473512|19554490|P4|Period 1 (Phase 1)|Disease Progression|10
5664699|NCT00473512|19554491|P3|Period 1 (Phase 1)|Disease Progression|0
5664700|NCT00473512|19554492|P2|Period 1 (Phase 1)|Disease Progression|1
5664701|NCT00473512|19554493|P1|Period 1 (Phase 1)|Disease Progression|1
5664702|NCT00473512|19554489|P5|Period 1 (Phase 1)|Death|0
5664703|NCT00473512|19554490|P4|Period 1 (Phase 1)|Death|1
5664704|NCT00473512|19554491|P3|Period 1 (Phase 1)|Death|0
5664705|NCT00473512|19554492|P2|Period 1 (Phase 1)|Death|0
5664706|NCT00473512|19554493|P1|Period 1 (Phase 1)|Death|0
5664707|NCT00473512|19554489|P5|Period 1 (Phase 1)|Adverse Event|0
5664708|NCT00473512|19554490|P4|Period 1 (Phase 1)|Adverse Event|5
5664709|NCT00473512|19554491|P3|Period 1 (Phase 1)|Adverse Event|0
5664710|NCT00473512|19554492|P2|Period 1 (Phase 1)|Adverse Event|0
5664711|NCT00473512|19554493|P1|Period 1 (Phase 1)|Adverse Event|0
5664712|NCT00473434|19554551|P1|Overall Study|No longer required|1
5664713|NCT00473434|19554551|P1|Overall Study|Switching to trial medication|1
5664714|NCT00473434|19554551|P1|Overall Study|Ceased in favor of Paliperidone|1
5664715|NCT00473434|19554551|P1|Overall Study|Reason not specified|6
5664716|NCT00473434|19554551|P1|Overall Study|Safety evaluation|1
5664717|NCT00473434|19554551|P1|Overall Study|Patient was selling medication to others|1
5664718|NCT00473434|19554551|P1|Overall Study|Adverse Event|3
5664719|NCT00473434|19554551|P1|Overall Study|Lack of Efficacy|3
5664720|NCT00473434|19554551|P1|Overall Study|Compliance|3
5664721|NCT00473434|19554551|P1|Overall Study|Withdrawal by Subject|9
5664722|NCT00473434|19554551|P1|Overall Study|Physician Decision|3
5664723|NCT00473382|19554616|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
5664724|NCT00473382|19554617|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
5664799|NCT00473330|19554677|P2|Open-label Extension Through Month 60|Death|2
5664725|NCT00473382|19554618|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
5664726|NCT00473382|19554616|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
5664727|NCT00473382|19554617|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
5664728|NCT00473382|19554618|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
5664729|NCT00473382|19554616|P3|Open-label Extension Through Month 60|Subject's Decision|6
5664730|NCT00473382|19554617|P2|Open-label Extension Through Month 60|Subject's Decision|1
5664731|NCT00473382|19554618|P1|Open-label Extension Through Month 60|Subject's Decision|7
5664732|NCT00473382|19554616|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
5664733|NCT00473382|19554617|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
5664734|NCT00473382|19554618|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
5664735|NCT00473382|19554616|P3|Open-label Extension Through Month 60|Death|4
5664736|NCT00473382|19554617|P2|Open-label Extension Through Month 60|Death|7
5664737|NCT00473382|19554618|P1|Open-label Extension Through Month 60|Death|1
5664738|NCT00473382|19554616|P3|Open-label Extension Through Month 60|Adverse Event|2
5664739|NCT00473382|19554617|P2|Open-label Extension Through Month 60|Adverse Event|0
5664740|NCT00473382|19554618|P1|Open-label Extension Through Month 60|Adverse Event|0
5664741|NCT00473382|19554616|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
5664742|NCT00473382|19554617|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
5664743|NCT00473382|19554618|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
5664744|NCT00473382|19554616|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
5664745|NCT00473382|19554617|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
5664746|NCT00473382|19554618|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
5664747|NCT00473382|19554616|P3|Open-label Extension Through Month 48|Subject's Decision|6
5664748|NCT00473382|19554617|P2|Open-label Extension Through Month 48|Subject's Decision|1
5664749|NCT00473382|19554618|P1|Open-label Extension Through Month 48|Subject's Decision|5
5664750|NCT00473382|19554616|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
5664751|NCT00473382|19554617|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
5664752|NCT00473382|19554618|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
5664753|NCT00473382|19554616|P3|Open-label Extension Through Month 48|Death|3
5664754|NCT00473382|19554617|P2|Open-label Extension Through Month 48|Death|3
5664755|NCT00473382|19554618|P1|Open-label Extension Through Month 48|Death|1
5664756|NCT00473382|19554616|P3|Open-label Extension Through Month 48|Adverse Event|1
5664757|NCT00473382|19554617|P2|Open-label Extension Through Month 48|Adverse Event|0
5664758|NCT00473382|19554618|P1|Open-label Extension Through Month 48|Adverse Event|0
5664759|NCT00473382|19554616|P3|Core Study|Subject's decision|10
5664760|NCT00473382|19554617|P2|Core Study|Subject's decision|11
5664761|NCT00473382|19554618|P1|Core Study|Subject's decision|12
5664762|NCT00473382|19554616|P3|Core Study|Subject needed other treatment|2
5664763|NCT00473382|19554617|P2|Core Study|Subject needed other treatment|3
5664764|NCT00473382|19554618|P1|Core Study|Subject needed other treatment|1
5664765|NCT00473382|19554616|P3|Core Study|Subject non-compliance|1
5664766|NCT00473382|19554617|P2|Core Study|Subject non-compliance|2
5664767|NCT00473382|19554618|P1|Core Study|Subject non-compliance|5
5664768|NCT00473382|19554616|P3|Core Study|Physician Decision|2
5664769|NCT00473382|19554617|P2|Core Study|Physician Decision|2
5664770|NCT00473382|19554618|P1|Core Study|Physician Decision|1
5664771|NCT00473382|19554616|P3|Core Study|Lost to Follow-up|3
5664772|NCT00473382|19554617|P2|Core Study|Lost to Follow-up|3
5664773|NCT00473382|19554618|P1|Core Study|Lost to Follow-up|3
5664774|NCT00473382|19554616|P3|Core Study|Death|10
5664775|NCT00473382|19554617|P2|Core Study|Death|5
5664776|NCT00473382|19554618|P1|Core Study|Death|3
5664777|NCT00473382|19554616|P3|Core Study|Adverse Event|1
5664778|NCT00473382|19554617|P2|Core Study|Adverse Event|1
5664779|NCT00473382|19554618|P1|Core Study|Adverse Event|3
5664780|NCT00473330|19554676|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
5664781|NCT00473330|19554677|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
5664782|NCT00473330|19554678|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
5664783|NCT00473330|19554676|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
5664784|NCT00473330|19554677|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
5664785|NCT00473330|19554678|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
5664786|NCT00473330|19554676|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
5664787|NCT00473330|19554677|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
5664788|NCT00473330|19554678|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
5664789|NCT00473330|19554676|P3|Open-label Extension Through Month 60|Subject's Decision|4
5664790|NCT00473330|19554677|P2|Open-label Extension Through Month 60|Subject's Decision|3
5664791|NCT00473330|19554678|P1|Open-label Extension Through Month 60|Subject's Decision|1
5664792|NCT00473330|19554676|P3|Open-label Extension Through Month 60|Physician's Decision|3
5664793|NCT00473330|19554677|P2|Open-label Extension Through Month 60|Physician's Decision|1
5664794|NCT00473330|19554678|P1|Open-label Extension Through Month 60|Physician's Decision|2
5664795|NCT00473330|19554676|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
5664796|NCT00473330|19554677|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
5664797|NCT00473330|19554678|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
5664798|NCT00473330|19554676|P3|Open-label Extension Through Month 60|Death|1
5664800|NCT00473330|19554678|P1|Open-label Extension Through Month 60|Death|2
5664801|NCT00473330|19554676|P3|Open-label Extension Through Month 60|Adverse Event|2
5664802|NCT00473330|19554677|P2|Open-label Extension Through Month 60|Adverse Event|0
5664803|NCT00473330|19554678|P1|Open-label Extension Through Month 60|Adverse Event|0
5664804|NCT00473330|19554676|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
5664805|NCT00473330|19554677|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
5664806|NCT00473330|19554678|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
5664807|NCT00473330|19554676|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
5664808|NCT00473330|19554677|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
5664809|NCT00473330|19554678|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
5664810|NCT00473330|19554676|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
5664811|NCT00473330|19554677|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
5664812|NCT00473330|19554678|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
5664813|NCT00473330|19554676|P3|Open-label Extension Through Month 48|Subject's Decision|3
5664814|NCT00473330|19554677|P2|Open-label Extension Through Month 48|Subject's Decision|3
5664815|NCT00473330|19554678|P1|Open-label Extension Through Month 48|Subject's Decision|1
5664816|NCT00473330|19554676|P3|Open-label Extension Through Month 48|Physician's Decision|3
5664817|NCT00473330|19554677|P2|Open-label Extension Through Month 48|Physician's Decision|1
5664818|NCT00473330|19554678|P1|Open-label Extension Through Month 48|Physician's Decision|2
5664819|NCT00473330|19554676|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
5664820|NCT00473330|19554677|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
5664821|NCT00473330|19554678|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
5664822|NCT00473330|19554676|P3|Open-label Extension Through Month 48|Death|0
5664823|NCT00473330|19554677|P2|Open-label Extension Through Month 48|Death|0
5664824|NCT00473330|19554678|P1|Open-label Extension Through Month 48|Death|2
5664825|NCT00473330|19554676|P3|Open-label Extension Through Month 48|Adverse Event|2
5664826|NCT00473330|19554677|P2|Open-label Extension Through Month 48|Adverse Event|0
5664827|NCT00473330|19554678|P1|Open-label Extension Through Month 48|Adverse Event|0
5664828|NCT00473330|19554676|P3|Core Study|Subject's Decision|19
5664829|NCT00473330|19554677|P2|Core Study|Subject's Decision|8
5664830|NCT00473330|19554678|P1|Core Study|Subject's Decision|9
5664831|NCT00473330|19554676|P3|Core Study|Subject Required Other Therapy|3
5664832|NCT00473330|19554677|P2|Core Study|Subject Required Other Therapy|1
5664833|NCT00473330|19554678|P1|Core Study|Subject Required Other Therapy|0
5664834|NCT00473330|19554676|P3|Core Study|Subject Non-compliance|1
5664835|NCT00473330|19554677|P2|Core Study|Subject Non-compliance|2
5664836|NCT00473330|19554678|P1|Core Study|Subject Non-compliance|1
5664837|NCT00473330|19554676|P3|Core Study|Physician Decision|3
5664838|NCT00473330|19554677|P2|Core Study|Physician Decision|1
5664839|NCT00473330|19554678|P1|Core Study|Physician Decision|2
5664840|NCT00473330|19554676|P3|Core Study|Lost to Follow-up|10
5664841|NCT00473330|19554677|P2|Core Study|Lost to Follow-up|5
5664842|NCT00473330|19554678|P1|Core Study|Lost to Follow-up|5
5664843|NCT00473330|19554676|P3|Core Study|Death|4
5664844|NCT00473330|19554677|P2|Core Study|Death|4
5664845|NCT00473330|19554678|P1|Core Study|Death|6
5664846|NCT00473330|19554676|P3|Core Study|Adverse Event|1
5664847|NCT00473330|19554677|P2|Core Study|Adverse Event|4
5664848|NCT00473330|19554678|P1|Core Study|Adverse Event|4
5664849|NCT00473265|19554733|P1|Overall Study|Off treatment early|15
5664850|NCT00473265|19554733|P1|Overall Study|Unrelated adverse event|5
5664851|NCT00473083|19554745|P3|Overall Study|Adverse Event|0
5664852|NCT00473083|19554746|P2|Overall Study|Adverse Event|0
5664853|NCT00473083|19554747|P1|Overall Study|Adverse Event|1
5664854|NCT00472641|19554822|P1|Overall Study|Lost to Follow-up|1
5664855|NCT00472641|19554822|P1|Overall Study|Adverse Event|3
5664856|NCT00472641|19554822|P1|Overall Study|Lack of Efficacy|3
5664857|NCT00472446|19554842|P4|Overall Study|Questionnaires not returned|4
5664858|NCT00472446|19554843|P3|Overall Study|Questionnaires not returned|6
5664859|NCT00472446|19554844|P2|Overall Study|Questionnaires not returned|6
5664860|NCT00472446|19554845|P1|Overall Study|Questionnaires not returned|5
5664861|NCT00472446|19554842|P4|Overall Study|Reintervention|1
5664862|NCT00472446|19554843|P3|Overall Study|Reintervention|1
5664863|NCT00472446|19554844|P2|Overall Study|Reintervention|0
5664864|NCT00472446|19554845|P1|Overall Study|Reintervention|0
5664865|NCT00472446|19554842|P4|Overall Study|Protocol Violation|1
5664866|NCT00472446|19554843|P3|Overall Study|Protocol Violation|0
5664867|NCT00472446|19554844|P2|Overall Study|Protocol Violation|0
5664868|NCT00472446|19554845|P1|Overall Study|Protocol Violation|0
5664869|NCT00472420|19554875|P1|Follow-up Period|Protocol Violation|1
5664870|NCT00472420|19554875|P1|Follow-up Period|Lost to Follow-up|2
5664871|NCT00472420|19554875|P1|Follow-up Period|Physician Decision|9
5664872|NCT00472420|19554875|P1|Follow-up Period|Death|5
5664873|NCT00472420|19554875|P1|Induction Treatment Period|Death|3
5664874|NCT00472420|19554875|P1|Induction Treatment Period|Non-compliance|1
5664875|NCT00472420|19554875|P1|Induction Treatment Period|Adverse Event|3
5664876|NCT00472420|19554875|P1|Induction Treatment Period|Physician Decision|9
5664877|NCT00472303|19554883|P3|Maintenance Phase|Other|0
5664878|NCT00472303|19554884|P2|Maintenance Phase|Other|1
5664879|NCT00472303|19554885|P1|Maintenance Phase|Other|1
5664880|NCT00472303|19554883|P3|Maintenance Phase|Resolution of pain|1
5664881|NCT00472303|19554884|P2|Maintenance Phase|Resolution of pain|0
5664882|NCT00472303|19554885|P1|Maintenance Phase|Resolution of pain|0
5664883|NCT00472303|19554883|P3|Maintenance Phase|Trial medication non-compliant|1
5664884|NCT00472303|19554884|P2|Maintenance Phase|Trial medication non-compliant|0
5664885|NCT00472303|19554885|P1|Maintenance Phase|Trial medication non-compliant|0
5664886|NCT00472303|19554883|P3|Maintenance Phase|Withdrawal by Subject|3
5664887|NCT00472303|19554884|P2|Maintenance Phase|Withdrawal by Subject|7
5664888|NCT00472303|19554885|P1|Maintenance Phase|Withdrawal by Subject|6
5664889|NCT00472303|19554883|P3|Maintenance Phase|Lack of Efficacy|4
5664890|NCT00472303|19554884|P2|Maintenance Phase|Lack of Efficacy|2
5664891|NCT00472303|19554885|P1|Maintenance Phase|Lack of Efficacy|2
5664892|NCT00472303|19554883|P3|Maintenance Phase|Death|2
5664893|NCT00472303|19554884|P2|Maintenance Phase|Death|0
5664894|NCT00472303|19554885|P1|Maintenance Phase|Death|3
5664895|NCT00472303|19554883|P3|Maintenance Phase|Adverse Event|6
5664896|NCT00472303|19554884|P2|Maintenance Phase|Adverse Event|6
5664897|NCT00472303|19554885|P1|Maintenance Phase|Adverse Event|5
5664898|NCT00472303|19554883|P3|Discontinuations After Titration Phase|Other|0
5664899|NCT00472303|19554884|P2|Discontinuations After Titration Phase|Other|0
5664900|NCT00472303|19554885|P1|Discontinuations After Titration Phase|Other|5
5664901|NCT00472303|19554883|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
5664902|NCT00472303|19554884|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
5664903|NCT00472303|19554885|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
5664904|NCT00472303|19554883|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
5664905|NCT00472303|19554884|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
5664906|NCT00472303|19554885|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
5664907|NCT00472303|19554883|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
5664908|NCT00472303|19554884|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
5664909|NCT00472303|19554885|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
5664910|NCT00472303|19554883|P3|Discontinuations After Titration Phase|Adverse Event|0
5664911|NCT00472303|19554884|P2|Discontinuations After Titration Phase|Adverse Event|0
5664912|NCT00472303|19554885|P1|Discontinuations After Titration Phase|Adverse Event|6
5664913|NCT00472303|19554883|P3|Titration Phase|Other|0
5664914|NCT00472303|19554884|P2|Titration Phase|Other|1
5664915|NCT00472303|19554885|P1|Titration Phase|Other|3
5664916|NCT00472303|19554883|P3|Titration Phase|Trial Medication non-compliant|0
5664917|NCT00472303|19554884|P2|Titration Phase|Trial Medication non-compliant|1
5664918|NCT00472303|19554885|P1|Titration Phase|Trial Medication non-compliant|4
5664919|NCT00472303|19554883|P3|Titration Phase|Withdrawal by Subject|0
5664920|NCT00472303|19554884|P2|Titration Phase|Withdrawal by Subject|13
5664921|NCT00472303|19554885|P1|Titration Phase|Withdrawal by Subject|16
5664922|NCT00472303|19554883|P3|Titration Phase|Lack of Efficacy|0
5664923|NCT00472303|19554884|P2|Titration Phase|Lack of Efficacy|0
5664924|NCT00472303|19554885|P1|Titration Phase|Lack of Efficacy|10
5664925|NCT00472303|19554883|P3|Titration Phase|Death|0
5664926|NCT00472303|19554884|P2|Titration Phase|Death|2
5664927|NCT00472303|19554885|P1|Titration Phase|Death|4
5664928|NCT00472303|19554883|P3|Titration Phase|Adverse Event|0
5664929|NCT00472303|19554884|P2|Titration Phase|Adverse Event|12
5664930|NCT00472303|19554885|P1|Titration Phase|Adverse Event|22
5664931|NCT00472290|19554948|P1|Overall Study|Requirement for alternative therapy|7
5664932|NCT00472290|19554948|P1|Overall Study|Adverse Event|6
5664933|NCT00472290|19554948|P1|Overall Study|Withdrawal by Subject|5
5664934|NCT00472290|19554948|P1|Overall Study|Disease Progression|4
5664935|NCT00472290|19554948|P1|Overall Study|Lack of Efficacy|1
5664936|NCT00472290|19554948|P1|Overall Study|Lost to Follow-up|1
5664937|NCT00472290|19554948|P1|Overall Study|Death|3
5664938|NCT00472290|19554948|P1|Overall Study|Administrative Decision|37
5664939|NCT00472290|19554948|P1|Overall Study|Protocol Specified Criteria|7
5664940|NCT00472290|19554948|P1|Overall Study|Progression of Therapy-Related MDS|1
5664941|NCT00472199|19554960|P2|Overall Study|patient was asymptomatic|0
5664942|NCT00472199|19554961|P1|Overall Study|patient was asymptomatic|1
5664943|NCT00472199|19554960|P2|Overall Study|personal reason|1
5664944|NCT00472199|19554961|P1|Overall Study|personal reason|0
5664945|NCT00472199|19554960|P2|Overall Study|Withdrawal by Subject|5
5664946|NCT00472199|19554961|P1|Overall Study|Withdrawal by Subject|6
5664947|NCT00472199|19554960|P2|Overall Study|Protocol Violation|2
5664948|NCT00472199|19554961|P1|Overall Study|Protocol Violation|3
5664949|NCT00472199|19554960|P2|Overall Study|Lost to Follow-up|4
5664950|NCT00472199|19554961|P1|Overall Study|Lost to Follow-up|2
5664951|NCT00472199|19554960|P2|Overall Study|Lack of Efficacy|25
5664952|NCT00472199|19554961|P1|Overall Study|Lack of Efficacy|4
5664953|NCT00472199|19554960|P2|Overall Study|Adverse Event|23
5664954|NCT00472199|19554961|P1|Overall Study|Adverse Event|19
5664955|NCT00472082|19555027|P1|Overall Study|Study prematurely terminated|5
5664956|NCT00472030|19555049|P2|Overall Study|Physician Decision|0
5664957|NCT00472030|19555050|P1|Overall Study|Physician Decision|1
5664958|NCT00471887|19555066|P1|Overall Study|Adverse Event|9
5664959|NCT00471822|19555075|P1|Overall Study|Protocol Violation|2
5664960|NCT00471718|19555083|P1|Overall Study|Withdrawal by Subject|1
5664961|NCT00471718|19555083|P1|Overall Study|disease progression|22
5664962|NCT00471718|19555083|P1|Overall Study|other complicating disease|1
5664963|NCT00471718|19555083|P1|Overall Study|Adverse Event|3
5664964|NCT00471536|19555111|P1|Overall Study|Withdrawal by Subject|1
5664965|NCT00471497|19555123|P3|Extension Phase|Protocol Violation|0
5664966|NCT00471497|19555124|P2|Extension Phase|Protocol Violation|2
5664967|NCT00471497|19555125|P1|Extension Phase|Protocol Violation|2
5664968|NCT00471497|19555123|P3|Extension Phase|Disease progression|0
5664969|NCT00471497|19555124|P2|Extension Phase|Disease progression|0
5664970|NCT00471497|19555125|P1|Extension Phase|Disease progression|2
5664971|NCT00471497|19555123|P3|Extension Phase|Death|0
5664972|NCT00471497|19555124|P2|Extension Phase|Death|0
5664973|NCT00471497|19555125|P1|Extension Phase|Death|1
5664974|NCT00471497|19555123|P3|Extension Phase|Lost to Follow-up|0
5664975|NCT00471497|19555124|P2|Extension Phase|Lost to Follow-up|0
5664976|NCT00471497|19555125|P1|Extension Phase|Lost to Follow-up|2
5664977|NCT00471497|19555123|P3|Extension Phase|Withdrawal by Subject|0
5664978|NCT00471497|19555124|P2|Extension Phase|Withdrawal by Subject|1
5664979|NCT00471497|19555125|P1|Extension Phase|Withdrawal by Subject|3
5664980|NCT00471497|19555123|P3|Extension Phase|Unsatisfactory therapeutic effect|0
5664981|NCT00471497|19555124|P2|Extension Phase|Unsatisfactory therapeutic effect|6
5664982|NCT00471497|19555125|P1|Extension Phase|Unsatisfactory therapeutic effect|8
5664983|NCT00471497|19555123|P3|Extension Phase|Adverse Event|1
5664984|NCT00471497|19555124|P2|Extension Phase|Adverse Event|5
5664985|NCT00471497|19555125|P1|Extension Phase|Adverse Event|9
5664986|NCT00471497|19555123|P3|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
5664987|NCT00471497|19555124|P2|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
5664988|NCT00471497|19555125|P1|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
5664989|NCT00471497|19555123|P3|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
5664990|NCT00471497|19555124|P2|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
5664991|NCT00471497|19555125|P1|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
5664992|NCT00471497|19555123|P3|Core Treatment Phase|Adverse Event|89
5664993|NCT00471497|19555124|P2|Core Treatment Phase|Adverse Event|53
5664994|NCT00471497|19555125|P1|Core Treatment Phase|Adverse Event|43
5664995|NCT00471497|19555123|P3|Core Treatment Phase|Administrative problems|12
5664996|NCT00471497|19555124|P2|Core Treatment Phase|Administrative problems|14
5664997|NCT00471497|19555125|P1|Core Treatment Phase|Administrative problems|14
5664998|NCT00471497|19555123|P3|Core Treatment Phase|Sub optimal response or treat. failure|13
5664999|NCT00471497|19555124|P2|Core Treatment Phase|Sub optimal response or treat. failure|11
5665000|NCT00471497|19555125|P1|Core Treatment Phase|Sub optimal response or treat. failure|19
5665001|NCT00471497|19555123|P3|Core Treatment Phase|Protocol Violation|11
5665002|NCT00471497|19555124|P2|Core Treatment Phase|Protocol Violation|15
5665003|NCT00471497|19555125|P1|Core Treatment Phase|Protocol Violation|6
5665004|NCT00471497|19555123|P3|Core Treatment Phase|Disease Progression|4
5665005|NCT00471497|19555124|P2|Core Treatment Phase|Disease Progression|2
5665006|NCT00471497|19555125|P1|Core Treatment Phase|Disease Progression|10
5665007|NCT00471497|19555123|P3|Core Treatment Phase|Death|3
5665008|NCT00471497|19555124|P2|Core Treatment Phase|Death|9
5665009|NCT00471497|19555125|P1|Core Treatment Phase|Death|3
5665010|NCT00471497|19555123|P3|Core Treatment Phase|Lost to Follow-up|3
5665011|NCT00471497|19555124|P2|Core Treatment Phase|Lost to Follow-up|6
5665012|NCT00471497|19555125|P1|Core Treatment Phase|Lost to Follow-up|6
5665013|NCT00471497|19555123|P3|Core Treatment Phase|Withdrawal by Subject|34
5665014|NCT00471497|19555124|P2|Core Treatment Phase|Withdrawal by Subject|29
5665015|NCT00471497|19555125|P1|Core Treatment Phase|Withdrawal by Subject|31
5665016|NCT00471497|19555123|P3|Core Treatment Phase|Condition no longer requires study drug|0
5665017|NCT00471497|19555124|P2|Core Treatment Phase|Condition no longer requires study drug|1
5665018|NCT00471497|19555125|P1|Core Treatment Phase|Condition no longer requires study drug|0
5665019|NCT00471497|19555123|P3|Core Treatment Phase|Abnormal Test Procedures|1
5665020|NCT00471497|19555124|P2|Core Treatment Phase|Abnormal Test Procedures|0
5665021|NCT00471497|19555125|P1|Core Treatment Phase|Abnormal Test Procedures|1
5665022|NCT00471497|19555123|P3|Core Treatment Phase|Abnormal Laboratory Values|9
5665023|NCT00471497|19555124|P2|Core Treatment Phase|Abnormal Laboratory Values|9
5665024|NCT00471497|19555125|P1|Core Treatment Phase|Abnormal Laboratory Values|3
5665025|NCT00471445|19555221|P2|Overall Study|Protocol Violation|1
5665026|NCT00471445|19555222|P1|Overall Study|Protocol Violation|0
5665027|NCT00471445|19555221|P2|Overall Study|Ineligible|0
5665028|NCT00471445|19555222|P1|Overall Study|Ineligible|1
5665029|NCT00471445|19555221|P2|Overall Study|Withdrawal by Subject|1
5665030|NCT00471445|19555222|P1|Overall Study|Withdrawal by Subject|1
5665031|NCT00471354|19555235|P1|Overall Study|Patient/Caregiver Decision|12
5665032|NCT00471354|19555235|P1|Overall Study|Lack of Efficacy|5
5665033|NCT00471354|19555235|P1|Overall Study|Lost to Follow-up|3
5665034|NCT00471354|19555235|P1|Overall Study|Sponsor Decision|1
5665035|NCT00471354|19555235|P1|Overall Study|Physician Decision|4
5665036|NCT00471354|19555235|P1|Overall Study|Withdrawal by Subject|1
5665037|NCT00471354|19555235|P1|Overall Study|Protocol Violation|12
5665038|NCT00471354|19555235|P1|Overall Study|Adverse Event|13
5665039|NCT00471354|19555235|P1|Overall Study|Protocol Entry Criteria Not Met|1
5665040|NCT00471328|19555247|P2|Extension Phase|Administrative Problem|0
5665041|NCT00471328|19555248|P1|Extension Phase|Administrative Problem|1
5665042|NCT00471328|19555247|P2|Extension Phase|New cancer Therapy|0
5665043|NCT00471328|19555248|P1|Extension Phase|New cancer Therapy|1
5665044|NCT00471328|19555247|P2|Extension Phase|Disease Progression|44
5665045|NCT00471328|19555248|P1|Extension Phase|Disease Progression|32
5665046|NCT00471328|19555247|P2|Extension Phase|Treatment duration as per protocol|1
5665047|NCT00471328|19555248|P1|Extension Phase|Treatment duration as per protocol|0
5665048|NCT00471328|19555247|P2|Extension Phase|Protocol Deviation|1
5665049|NCT00471328|19555248|P1|Extension Phase|Protocol Deviation|3
5665050|NCT00471328|19555247|P2|Extension Phase|Death|7
5665051|NCT00471328|19555248|P1|Extension Phase|Death|1
5665052|NCT00471328|19555247|P2|Extension Phase|Withdrawal by Subject|2
5665053|NCT00471328|19555248|P1|Extension Phase|Withdrawal by Subject|0
5665054|NCT00471328|19555247|P2|Extension Phase|Adverse Event|12
5665055|NCT00471328|19555248|P1|Extension Phase|Adverse Event|3
5665056|NCT00471328|19555247|P2|Core Phase|Protocol Deviation|1
5665057|NCT00471328|19555248|P1|Core Phase|Protocol Deviation|0
5665058|NCT00471328|19555247|P2|Core Phase|Administrative Problem|1
5665059|NCT00471328|19555248|P1|Core Phase|Administrative Problem|0
5665060|NCT00471328|19555247|P2|Core Phase|Disease Progression|53
5665061|NCT00471328|19555248|P1|Core Phase|Disease Progression|78
5665062|NCT00471328|19555247|P2|Core Phase|Abnormal laboratory value|0
5665063|NCT00471328|19555248|P1|Core Phase|Abnormal laboratory value|1
5665064|NCT00471328|19555247|P2|Core Phase|Withdrawal by Subject|2
5665065|NCT00471328|19555248|P1|Core Phase|Withdrawal by Subject|2
5665066|NCT00471328|19555247|P2|Core Phase|Death|4
5665067|NCT00471328|19555248|P1|Core Phase|Death|8
5665068|NCT00471328|19555247|P2|Core Phase|Adverse Event|6
5665069|NCT00471328|19555248|P1|Core Phase|Adverse Event|18
5665070|NCT00471315|19555267|P1|Overall Study|Withdrawal by Subject|1
5665071|NCT00471315|19555267|P1|Overall Study|Adverse Event|7
5665072|NCT00471276|19555272|P1|Overall Study|Refused treatment|6
5665073|NCT00471276|19555272|P1|Overall Study|Other|3
5665074|NCT00471276|19555272|P1|Overall Study|Global deterioration of health status|1
5665075|NCT00471276|19555272|P1|Overall Study|Objective progression or relapse|54
5665076|NCT00471276|19555272|P1|Overall Study|Protocol Violation|1
5665077|NCT00471276|19555272|P1|Overall Study|Adverse Event|16
5665078|NCT00471276|19555272|P1|Overall Study|Death|2
5665079|NCT00471237|19555302|P7|Overall Study|Participant's decision|0
5665080|NCT00471237|19555303|P6|Overall Study|Participant's decision|1
5665081|NCT00471237|19555304|P5|Overall Study|Participant's decision|0
5665082|NCT00471237|19555305|P4|Overall Study|Participant's decision|0
5665083|NCT00471237|19555306|P3|Overall Study|Participant's decision|0
5665084|NCT00471237|19555307|P2|Overall Study|Participant's decision|0
5665085|NCT00471237|19555308|P1|Overall Study|Participant's decision|0
5665086|NCT00471237|19555302|P7|Overall Study|Participant shifted residence|0
5665087|NCT00471237|19555303|P6|Overall Study|Participant shifted residence|0
5665088|NCT00471237|19555304|P5|Overall Study|Participant shifted residence|1
5665089|NCT00471237|19555305|P4|Overall Study|Participant shifted residence|0
5665090|NCT00471237|19555306|P3|Overall Study|Participant shifted residence|0
5665091|NCT00471237|19555307|P2|Overall Study|Participant shifted residence|0
5665092|NCT00471237|19555308|P1|Overall Study|Participant shifted residence|0
5665093|NCT00471237|19555302|P7|Overall Study|Administration of prohibited medicine|0
5665094|NCT00471237|19555303|P6|Overall Study|Administration of prohibited medicine|0
5665095|NCT00471237|19555304|P5|Overall Study|Administration of prohibited medicine|1
5665096|NCT00471237|19555305|P4|Overall Study|Administration of prohibited medicine|0
5665097|NCT00471237|19555306|P3|Overall Study|Administration of prohibited medicine|0
5665098|NCT00471237|19555307|P2|Overall Study|Administration of prohibited medicine|0
5665099|NCT00471237|19555308|P1|Overall Study|Administration of prohibited medicine|0
5665100|NCT00471237|19555302|P7|Overall Study|Participant lost medication|0
5665101|NCT00471237|19555303|P6|Overall Study|Participant lost medication|0
5665102|NCT00471237|19555304|P5|Overall Study|Participant lost medication|1
5665103|NCT00471237|19555305|P4|Overall Study|Participant lost medication|0
5665104|NCT00471237|19555306|P3|Overall Study|Participant lost medication|0
5665105|NCT00471237|19555307|P2|Overall Study|Participant lost medication|0
5665106|NCT00471237|19555308|P1|Overall Study|Participant lost medication|0
5665107|NCT00471237|19555302|P7|Overall Study|High parathyroid hormone|0
5665108|NCT00471237|19555303|P6|Overall Study|High parathyroid hormone|0
5665109|NCT00471237|19555304|P5|Overall Study|High parathyroid hormone|0
5665110|NCT00471237|19555305|P4|Overall Study|High parathyroid hormone|0
5665111|NCT00471237|19555306|P3|Overall Study|High parathyroid hormone|1
5665112|NCT00471237|19555307|P2|Overall Study|High parathyroid hormone|0
5665113|NCT00471237|19555308|P1|Overall Study|High parathyroid hormone|0
5665114|NCT00471237|19555302|P7|Overall Study|Participant planned to travel to abraod|0
5665115|NCT00471237|19555303|P6|Overall Study|Participant planned to travel to abraod|1
5665116|NCT00471237|19555304|P5|Overall Study|Participant planned to travel to abraod|0
5665117|NCT00471237|19555305|P4|Overall Study|Participant planned to travel to abraod|0
5665118|NCT00471237|19555306|P3|Overall Study|Participant planned to travel to abraod|0
5665119|NCT00471237|19555307|P2|Overall Study|Participant planned to travel to abraod|0
5665120|NCT00471237|19555308|P1|Overall Study|Participant planned to travel to abraod|1
5665121|NCT00471237|19555302|P7|Overall Study|Early stopping due to non-efficacy|0
5665122|NCT00471237|19555303|P6|Overall Study|Early stopping due to non-efficacy|0
5665123|NCT00471237|19555304|P5|Overall Study|Early stopping due to non-efficacy|1
5665124|NCT00471237|19555305|P4|Overall Study|Early stopping due to non-efficacy|0
5665125|NCT00471237|19555306|P3|Overall Study|Early stopping due to non-efficacy|0
5665126|NCT00471237|19555307|P2|Overall Study|Early stopping due to non-efficacy|0
5665127|NCT00471237|19555308|P1|Overall Study|Early stopping due to non-efficacy|1
5665128|NCT00471237|19555302|P7|Overall Study|Met serum creatinine withdrawal criteria|0
5665129|NCT00471237|19555303|P6|Overall Study|Met serum creatinine withdrawal criteria|0
5665130|NCT00471237|19555304|P5|Overall Study|Met serum creatinine withdrawal criteria|0
5665131|NCT00471237|19555305|P4|Overall Study|Met serum creatinine withdrawal criteria|2
5665132|NCT00471237|19555306|P3|Overall Study|Met serum creatinine withdrawal criteria|2
5665133|NCT00471237|19555307|P2|Overall Study|Met serum creatinine withdrawal criteria|0
5665134|NCT00471237|19555308|P1|Overall Study|Met serum creatinine withdrawal criteria|1
5665135|NCT00471237|19555302|P7|Overall Study|Non-compliance|0
5665136|NCT00471237|19555303|P6|Overall Study|Non-compliance|0
5665137|NCT00471237|19555304|P5|Overall Study|Non-compliance|0
5665138|NCT00471237|19555305|P4|Overall Study|Non-compliance|1
5665139|NCT00471237|19555306|P3|Overall Study|Non-compliance|0
5665140|NCT00471237|19555307|P2|Overall Study|Non-compliance|1
5665141|NCT00471237|19555308|P1|Overall Study|Non-compliance|0
5665142|NCT00471237|19555302|P7|Overall Study|Sponsor terminated study|0
5665143|NCT00471237|19555303|P6|Overall Study|Sponsor terminated study|24
5665144|NCT00471237|19555304|P5|Overall Study|Sponsor terminated study|18
5665145|NCT00471237|19555305|P4|Overall Study|Sponsor terminated study|22
5665146|NCT00471237|19555306|P3|Overall Study|Sponsor terminated study|19
5665147|NCT00471237|19555307|P2|Overall Study|Sponsor terminated study|23
5665148|NCT00471237|19555308|P1|Overall Study|Sponsor terminated study|20
5665149|NCT00471237|19555302|P7|Overall Study|Withdrawal by Subject|2
5665150|NCT00471237|19555303|P6|Overall Study|Withdrawal by Subject|4
5665151|NCT00471237|19555304|P5|Overall Study|Withdrawal by Subject|7
5665152|NCT00471237|19555305|P4|Overall Study|Withdrawal by Subject|8
5665153|NCT00471237|19555306|P3|Overall Study|Withdrawal by Subject|5
5665154|NCT00471237|19555307|P2|Overall Study|Withdrawal by Subject|6
5665155|NCT00471237|19555308|P1|Overall Study|Withdrawal by Subject|8
5665156|NCT00471237|19555302|P7|Overall Study|Protocol Violation|1
5665157|NCT00471237|19555303|P6|Overall Study|Protocol Violation|4
5665158|NCT00471237|19555304|P5|Overall Study|Protocol Violation|2
5665159|NCT00471237|19555305|P4|Overall Study|Protocol Violation|2
5665160|NCT00471237|19555306|P3|Overall Study|Protocol Violation|3
5665161|NCT00471237|19555307|P2|Overall Study|Protocol Violation|6
5665162|NCT00471237|19555308|P1|Overall Study|Protocol Violation|3
5665163|NCT00471237|19555302|P7|Overall Study|Lost to Follow-up|0
5665164|NCT00471237|19555303|P6|Overall Study|Lost to Follow-up|0
5665165|NCT00471237|19555304|P5|Overall Study|Lost to Follow-up|3
5665166|NCT00471237|19555305|P4|Overall Study|Lost to Follow-up|2
5665167|NCT00471237|19555306|P3|Overall Study|Lost to Follow-up|0
5665168|NCT00471237|19555307|P2|Overall Study|Lost to Follow-up|1
5665169|NCT00471237|19555308|P1|Overall Study|Lost to Follow-up|1
5665170|NCT00471237|19555302|P7|Overall Study|Adverse Event|0
5665171|NCT00471237|19555303|P6|Overall Study|Adverse Event|5
5665172|NCT00471237|19555304|P5|Overall Study|Adverse Event|7
5665173|NCT00471237|19555305|P4|Overall Study|Adverse Event|8
5665174|NCT00471237|19555306|P3|Overall Study|Adverse Event|4
5665175|NCT00471237|19555307|P2|Overall Study|Adverse Event|5
5665176|NCT00471237|19555308|P1|Overall Study|Adverse Event|6
5665177|NCT00471146|19555458|P2|Overall Study|Other|5
5665178|NCT00471146|19555459|P1|Overall Study|Other|4
5665179|NCT00471146|19555458|P2|Overall Study|Randomized but not treated|8
5665180|NCT00471146|19555459|P1|Overall Study|Randomized but not treated|9
5665181|NCT00471146|19555458|P2|Overall Study|Global deterioration of health status|14
5665182|NCT00471146|19555459|P1|Overall Study|Global deterioration of health status|12
5665183|NCT00471146|19555458|P2|Overall Study|Objective progression or relapse|87
5665184|NCT00471146|19555459|P1|Overall Study|Objective progression or relapse|84
5665185|NCT00471146|19555458|P2|Overall Study|Protocol Violation|2
5665186|NCT00471146|19555459|P1|Overall Study|Protocol Violation|2
5665187|NCT00471146|19555458|P2|Overall Study|Lost to Follow-up|2
5665188|NCT00471146|19555459|P1|Overall Study|Lost to Follow-up|4
5665189|NCT00471146|19555458|P2|Overall Study|Death|12
5665190|NCT00471146|19555459|P1|Overall Study|Death|11
5665191|NCT00471146|19555458|P2|Overall Study|Withdrawal by Subject|11
5665192|NCT00471146|19555459|P1|Overall Study|Withdrawal by Subject|14
5665193|NCT00471146|19555458|P2|Overall Study|Adverse Event|33
5665194|NCT00471146|19555459|P1|Overall Study|Adverse Event|32
5665195|NCT00471107|19555484|P3|Overall Study|Technical problems/data loss|3
5665196|NCT00471107|19555485|P2|Overall Study|Technical problems/data loss|1
5665197|NCT00471107|19555486|P1|Overall Study|Technical problems/data loss|3
5665198|NCT00471081|19555496|P2|Extended Safety Follow-Up|Missing confirmed|1
5665199|NCT00471081|19555497|P1|Extended Safety Follow-Up|Missing confirmed|0
5665200|NCT00471081|19555496|P2|Extended Safety Follow-Up|Lost to Follow-up|8
5665201|NCT00471081|19555497|P1|Extended Safety Follow-Up|Lost to Follow-up|1
5665202|NCT00471081|19555496|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
5665203|NCT00471081|19555497|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
5665204|NCT00471081|19555496|P2|Active Phase|Lost health plan/insurance|8
5665205|NCT00471081|19555497|P1|Active Phase|Lost health plan/insurance|1
5665206|NCT00471081|19555496|P2|Active Phase|Lost to Follow-up|1
5665207|NCT00471081|19555497|P1|Active Phase|Lost to Follow-up|0
5665208|NCT00471081|19555496|P2|Active Phase|Withdrawal by Subject|3
5665209|NCT00471081|19555497|P1|Active Phase|Withdrawal by Subject|0
5665210|NCT00471081|19555496|P2|Active Phase|Protocol Violation|1
5665211|NCT00471081|19555497|P1|Active Phase|Protocol Violation|1
5665212|NCT00470847|19555543|P1|Overall Study|Pt still receiving treatment|1
5665213|NCT00470834|19555556|P2|Extension Period (24 Months)|Disease Progression|1
5665214|NCT00470834|19555557|P1|Extension Period (24 Months)|Disease Progression|0
5665215|NCT00470834|19555556|P2|Extension Period (24 Months)|Non-compliance|1
5665216|NCT00470834|19555557|P1|Extension Period (24 Months)|Non-compliance|0
5665217|NCT00470834|19555556|P2|Extension Period (24 Months)|Lost to Follow-up|1
5665218|NCT00470834|19555557|P1|Extension Period (24 Months)|Lost to Follow-up|0
5665219|NCT00470834|19555556|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
5665220|NCT00470834|19555557|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
5665221|NCT00470834|19555556|P2|Extension Period (24 Months)|Physician Decision|3
5665222|NCT00470834|19555557|P1|Extension Period (24 Months)|Physician Decision|4
5665223|NCT00470834|19555556|P2|Extension Period (24 Months)|Withdrawal by Subject|5
5665224|NCT00470834|19555557|P1|Extension Period (24 Months)|Withdrawal by Subject|2
5665225|NCT00470834|19555556|P2|Extension Period (24 Months)|Adverse Event|4
5665226|NCT00470834|19555557|P1|Extension Period (24 Months)|Adverse Event|3
5665227|NCT00470834|19555556|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
5665228|NCT00470834|19555557|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
5665229|NCT00470834|19555556|P2|Treatment Period (18 Months)|Lack of Efficacy|0
5665230|NCT00470834|19555557|P1|Treatment Period (18 Months)|Lack of Efficacy|1
5665231|NCT00470834|19555556|P2|Treatment Period (18 Months)|Non-compliance|0
5665232|NCT00470834|19555557|P1|Treatment Period (18 Months)|Non-compliance|1
5665233|NCT00470834|19555556|P2|Treatment Period (18 Months)|Lost to Follow-up|0
5665234|NCT00470834|19555557|P1|Treatment Period (18 Months)|Lost to Follow-up|1
5665235|NCT00470834|19555556|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
5665236|NCT00470834|19555557|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
5665237|NCT00470834|19555556|P2|Treatment Period (18 Months)|Protocol Violation|1
5665238|NCT00470834|19555557|P1|Treatment Period (18 Months)|Protocol Violation|3
5665239|NCT00470834|19555556|P2|Treatment Period (18 Months)|Physician Decision|4
5665240|NCT00470834|19555557|P1|Treatment Period (18 Months)|Physician Decision|4
5665241|NCT00470834|19555556|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
5665242|NCT00470834|19555557|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
5665243|NCT00470834|19555556|P2|Treatment Period (18 Months)|Adverse Event|6
5665244|NCT00470834|19555557|P1|Treatment Period (18 Months)|Adverse Event|7
5665245|NCT00470834|19555556|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
5665246|NCT00470834|19555557|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
5665247|NCT00470626|19555571|P1|Overall Study|Withdrawal by Subject|7
5665248|NCT00470626|19555571|P1|Overall Study|Lost to Follow-up|10
5665249|NCT00470535|19555619|P1|Overall Study|Other|2
5665250|NCT00470535|19555619|P1|Overall Study|Death|1
5665251|NCT00470535|19555619|P1|Overall Study|Adverse Event|1
5665252|NCT00470535|19555619|P1|Overall Study|Withdrawal by Subject|1
5665253|NCT00470535|19555619|P1|Overall Study|Disease Progression|13
5665254|NCT00470470|19555628|P1|Overall Study|Not treated|1
5665255|NCT00470470|19555628|P1|Overall Study|Death|2
5665256|NCT00470470|19555628|P1|Overall Study|Adverse Event|2
5665257|NCT00470418|19555635|P2|Overall Study|Withdrawal by Subject|0
5665258|NCT00470418|19555636|P1|Overall Study|Withdrawal by Subject|1
5665259|NCT00470366|19555657|P1|Overall Study|Poor compliance|1
5665260|NCT00470366|19555657|P1|Overall Study|Adverse Event|3
5665261|NCT00470275|19555668|P1|Overall Study|Withdrawal by Subject|2
5665262|NCT00470275|19555668|P1|Overall Study|Lack of Efficacy|7
5665263|NCT00470275|19555668|P1|Overall Study|Death|1
5665264|NCT00470262|19555674|P2|Overall Study|Withdrawal by Subject|0
5665265|NCT00470262|19555675|P1|Overall Study|Withdrawal by Subject|2
5665266|NCT00470184|19555683|P1|Overall Study|recurrence|1
5665267|NCT00470184|19555683|P1|Overall Study|other|5
5665268|NCT00470184|19555683|P1|Overall Study|Withdrawal by Subject|4
5665269|NCT00470184|19555683|P1|Overall Study|Adverse Event|3
5665270|NCT00470184|19555683|P1|Overall Study|disease Progression|4
5665271|NCT00470184|19555683|P1|Overall Study|Not treated (other)|1
5665272|NCT00470184|19555683|P1|Overall Study|Not Treated(became ineligible)|4
5665273|NCT00470158|19555695|P5|Overall Study|Protocol Violation|0
5665274|NCT00470158|19555696|P4|Overall Study|Protocol Violation|0
5665275|NCT00470158|19555697|P3|Overall Study|Protocol Violation|0
5665276|NCT00470158|19555698|P2|Overall Study|Protocol Violation|0
5665277|NCT00470158|19555699|P1|Overall Study|Protocol Violation|1
5665278|NCT00470158|19555695|P5|Overall Study|Lost to Follow-up|4
5665279|NCT00470158|19555696|P4|Overall Study|Lost to Follow-up|5
5665280|NCT00470158|19555697|P3|Overall Study|Lost to Follow-up|8
5665281|NCT00470158|19555698|P2|Overall Study|Lost to Follow-up|8
5665282|NCT00470158|19555699|P1|Overall Study|Lost to Follow-up|7
5665283|NCT00470158|19555695|P5|Overall Study|Death|2
5665284|NCT00470158|19555696|P4|Overall Study|Death|0
5665285|NCT00470158|19555697|P3|Overall Study|Death|0
5665286|NCT00470158|19555698|P2|Overall Study|Death|0
5665287|NCT00470158|19555699|P1|Overall Study|Death|0
5665288|NCT00470093|19555732|P1|Overall Study|Adverse Event|2
5665289|NCT00470067|19555739|P1|Overall Study|Disease Progression|6
5665290|NCT00470067|19555739|P1|Overall Study|Death|1
5665291|NCT00470054|19555743|P1|Overall Study|Ineligible|1
5665292|NCT00469898|19555759|P1|Overall Study|Decreased performance status|1
5665293|NCT00469898|19555759|P1|Overall Study|Disease progression|9
5665294|NCT00469898|19555759|P1|Overall Study|Death|4
5665295|NCT00469898|19555759|P1|Overall Study|Withdrawal by Subject|4
5665296|NCT00469898|19555759|P1|Overall Study|Adverse Event|7
5665297|NCT00469859|19555768|P2|Overall Study|Inevaluable|2
5665298|NCT00469859|19555769|P1|Overall Study|Inevaluable|0
5665299|NCT00469833|19555777|P1|Overall Study|No IV access|2
5665300|NCT00469612|19555789|P2|Overall Study|Study terminated before data collected|0
5665301|NCT00469612|19555790|P1|Overall Study|Study terminated before data collected|2
5665302|NCT00469456|19555817|P2|Overall Study|Withdrawal by Subject|1
5665303|NCT00469456|19555818|P1|Overall Study|Withdrawal by Subject|4
5665304|NCT00469456|19555817|P2|Overall Study|Protocol Violation|0
5665305|NCT00469456|19555818|P1|Overall Study|Protocol Violation|1
5665306|NCT00469456|19555817|P2|Overall Study|Adverse Event|3
5665307|NCT00469456|19555818|P1|Overall Study|Adverse Event|4
5665308|NCT00469209|19555847|P3|Overall Study|Adverse Event|1
5665309|NCT00469209|19555848|P2|Overall Study|Adverse Event|0
5665310|NCT00469209|19555849|P1|Overall Study|Adverse Event|1
5665311|NCT00469092|19555859|P2|Overall Study|Use of Corticosteroid|0
5665312|NCT00469092|19555860|P1|Overall Study|Use of Corticosteroid|1
5665313|NCT00469092|19555859|P2|Overall Study|Abnormal lab value|0
5665314|NCT00469092|19555860|P1|Overall Study|Abnormal lab value|1
5665315|NCT00469092|19555859|P2|Overall Study|Hypoglycaemic Episodes|1
5665316|NCT00469092|19555860|P1|Overall Study|Hypoglycaemic Episodes|1
5665317|NCT00469092|19555859|P2|Overall Study|Use of lipid lowering drug|0
5665318|NCT00469092|19555860|P1|Overall Study|Use of lipid lowering drug|1
5665319|NCT00469092|19555859|P2|Overall Study|Contraindication metformin/glimepiride|0
5665320|NCT00469092|19555860|P1|Overall Study|Contraindication metformin/glimepiride|1
5665321|NCT00469092|19555859|P2|Overall Study|Incorrectly Randomised|3
5665322|NCT00469092|19555860|P1|Overall Study|Incorrectly Randomised|4
5665323|NCT00469092|19555859|P2|Overall Study|Withdrawal Criteria|4
5665324|NCT00469092|19555860|P1|Overall Study|Withdrawal Criteria|3
5665325|NCT00469092|19555859|P2|Overall Study|Withdrawal by Subject|4
5665326|NCT00469092|19555860|P1|Overall Study|Withdrawal by Subject|4
5665327|NCT00469092|19555859|P2|Overall Study|Protocol Violation|3
5665328|NCT00469092|19555860|P1|Overall Study|Protocol Violation|3
5665329|NCT00469092|19555859|P2|Overall Study|Lost to Follow-up|2
5665330|NCT00469092|19555860|P1|Overall Study|Lost to Follow-up|1
5665331|NCT00469092|19555859|P2|Overall Study|Lack of Efficacy|0
5665332|NCT00469092|19555860|P1|Overall Study|Lack of Efficacy|1
5665333|NCT00469092|19555859|P2|Overall Study|Adverse Event|4
5665334|NCT00469092|19555860|P1|Overall Study|Adverse Event|5
5665335|NCT00469079|19555879|P3|Overall Study|Ineligible|0
5665336|NCT00469079|19555880|P2|Overall Study|Ineligible|1
5665337|NCT00469079|19555881|P1|Overall Study|Ineligible|0
5665338|NCT00469079|19555879|P3|Overall Study|Withdrawal by Subject|2
5665339|NCT00469079|19555880|P2|Overall Study|Withdrawal by Subject|2
5665340|NCT00469079|19555881|P1|Overall Study|Withdrawal by Subject|1
5665341|NCT00469079|19555879|P3|Overall Study|Lost to Follow-up|10
5665342|NCT00469079|19555880|P2|Overall Study|Lost to Follow-up|8
5665343|NCT00469079|19555881|P1|Overall Study|Lost to Follow-up|4
5665344|NCT00469079|19555879|P3|Overall Study|Adverse Event|2
5665345|NCT00469079|19555880|P2|Overall Study|Adverse Event|3
5665346|NCT00469079|19555881|P1|Overall Study|Adverse Event|1
5665347|NCT00469079|19555879|P3|Overall Study|Lack of Efficacy|5
5665348|NCT00469079|19555880|P2|Overall Study|Lack of Efficacy|8
5665349|NCT00469079|19555881|P1|Overall Study|Lack of Efficacy|3
5665350|NCT00468910|19555900|P2|Overall Study|Medical Contraindication|1
5665351|NCT00468910|19555901|P1|Overall Study|Medical Contraindication|0
5665352|NCT00468910|19555900|P2|Overall Study|Withdrawal by Subject|1
5665353|NCT00468910|19555901|P1|Overall Study|Withdrawal by Subject|2
5665354|NCT00468910|19555900|P2|Overall Study|Lost to Follow-up|1
5665355|NCT00468910|19555901|P1|Overall Study|Lost to Follow-up|2
5665356|NCT00468858|19555920|P3|Overall Study|Other|1
5665357|NCT00468858|19555921|P2|Overall Study|Other|0
5665358|NCT00468858|19555922|P1|Overall Study|Other|0
5665359|NCT00468858|19555920|P3|Overall Study|Lost to Follow-up|5
5665360|NCT00468858|19555921|P2|Overall Study|Lost to Follow-up|2
5665361|NCT00468858|19555922|P1|Overall Study|Lost to Follow-up|1
5665362|NCT00468858|19555920|P3|Overall Study|Relocation|3
5665363|NCT00468858|19555921|P2|Overall Study|Relocation|3
5665364|NCT00468858|19555922|P1|Overall Study|Relocation|1
5665365|NCT00468858|19555920|P3|Overall Study|Withdrawal by Subject|5
5665366|NCT00468858|19555921|P2|Overall Study|Withdrawal by Subject|4
5665367|NCT00468858|19555922|P1|Overall Study|Withdrawal by Subject|7
5665368|NCT00468858|19555920|P3|Overall Study|Adverse Event|0
5665369|NCT00468858|19555921|P2|Overall Study|Adverse Event|1
5665370|NCT00468858|19555922|P1|Overall Study|Adverse Event|0
5665371|NCT00468845|19556043|P3|Overall Study|Randomized, not treated|2
5665372|NCT00468845|19556044|P2|Overall Study|Randomized, not treated|4
5665373|NCT00468845|19556045|P1|Overall Study|Randomized, not treated|1
5665374|NCT00468845|19556043|P3|Overall Study|No longer willing to participate|10
5665375|NCT00468845|19556044|P2|Overall Study|No longer willing to participate|6
5665376|NCT00468845|19556045|P1|Overall Study|No longer willing to participate|5
5665377|NCT00468845|19556043|P3|Overall Study|Other|5
5665378|NCT00468845|19556044|P2|Overall Study|Other|9
5665379|NCT00468845|19556045|P1|Overall Study|Other|4
5665380|NCT00468845|19556043|P3|Overall Study|Lost to Follow-up|2
5665381|NCT00468845|19556044|P2|Overall Study|Lost to Follow-up|1
5665382|NCT00468845|19556045|P1|Overall Study|Lost to Follow-up|2
5665383|NCT00468845|19556043|P3|Overall Study|Adverse Event|11
5665384|NCT00468845|19556044|P2|Overall Study|Adverse Event|14
5665385|NCT00468845|19556045|P1|Overall Study|Adverse Event|9
5665386|NCT00468819|19556182|P3|Overall Study|Drop-outs (Treatment never received)|0
5665387|NCT00468819|19556183|P2|Overall Study|Drop-outs (Treatment never received)|0
5665388|NCT00468819|19556184|P1|Overall Study|Drop-outs (Treatment never received)|2
5665389|NCT00468819|19556182|P3|Overall Study|Lost to Follow-up|1
5665390|NCT00468819|19556183|P2|Overall Study|Lost to Follow-up|0
5665391|NCT00468819|19556184|P1|Overall Study|Lost to Follow-up|0
5665392|NCT00468819|19556182|P3|Overall Study|Withdrawal by Subject|1
5665393|NCT00468819|19556183|P2|Overall Study|Withdrawal by Subject|0
5665394|NCT00468819|19556184|P1|Overall Study|Withdrawal by Subject|4
5665395|NCT00468728|19556264|P2|Follow-up|mITT failure|31
5665396|NCT00468728|19556265|P1|Follow-up|mITT failure|34
5665397|NCT00468728|19556264|P2|Treatment|criteria for mITT population|11
5665398|NCT00468728|19556265|P1|Treatment|criteria for mITT population|4
5665399|NCT00468676|19556277|P2|Overall Study|Death|1
5665400|NCT00468676|19556278|P1|Overall Study|Death|2
5665401|NCT00468676|19556277|P2|Overall Study|Lost to Follow-up|11
5665402|NCT00468676|19556278|P1|Overall Study|Lost to Follow-up|14
5665403|NCT00468650|19556295|P1|Overall Study|Protocol Violation|1
5665404|NCT00468650|19556295|P1|Overall Study|Withdrawal by Subject|2
5665405|NCT00468650|19556295|P1|Overall Study|Lost to Follow-up|4
5665406|NCT00468585|19556343|P4|Overall Study|Withdrawal by Subject|1
5665407|NCT00468585|19556344|P3|Overall Study|Withdrawal by Subject|2
5665408|NCT00468585|19556345|P2|Overall Study|Withdrawal by Subject|0
5665409|NCT00468585|19556346|P1|Overall Study|Withdrawal by Subject|0
5665410|NCT00468585|19556343|P4|Overall Study|Adverse Event|0
5665411|NCT00468585|19556344|P3|Overall Study|Adverse Event|1
5665412|NCT00468585|19556345|P2|Overall Study|Adverse Event|0
5665413|NCT00468585|19556346|P1|Overall Study|Adverse Event|0
5665414|NCT00468585|19556343|P4|Overall Study|Patient found to be ineligible|0
5665415|NCT00468585|19556344|P3|Overall Study|Patient found to be ineligible|1
5665416|NCT00468585|19556345|P2|Overall Study|Patient found to be ineligible|0
5665417|NCT00468585|19556346|P1|Overall Study|Patient found to be ineligible|0
5665418|NCT00468585|19556343|P4|Overall Study|Patient not treated|0
5665419|NCT00468585|19556344|P3|Overall Study|Patient not treated|1
5665420|NCT00468585|19556345|P2|Overall Study|Patient not treated|0
5665421|NCT00468585|19556346|P1|Overall Study|Patient not treated|1
5665422|NCT00468559|19556358|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
5665423|NCT00468559|19556359|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
5665424|NCT00468559|19556360|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
5665425|NCT00468559|19556358|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
5665426|NCT00468559|19556359|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
5665427|NCT00468559|19556360|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
5665428|NCT00468559|19556358|P3|Open-label Treatment Phase|Withdrawal by Subject|0
5665429|NCT00468559|19556359|P2|Open-label Treatment Phase|Withdrawal by Subject|0
5665430|NCT00468559|19556360|P1|Open-label Treatment Phase|Withdrawal by Subject|4
5665431|NCT00468559|19556358|P3|Open-label Treatment Phase|Lack of Efficacy|0
5665432|NCT00468559|19556359|P2|Open-label Treatment Phase|Lack of Efficacy|0
5665433|NCT00468559|19556360|P1|Open-label Treatment Phase|Lack of Efficacy|9
5665434|NCT00468559|19556358|P3|Open-label Treatment Phase|Adverse Event|0
5665435|NCT00468559|19556359|P2|Open-label Treatment Phase|Adverse Event|0
5665436|NCT00468559|19556360|P1|Open-label Treatment Phase|Adverse Event|5
5665437|NCT00468546|19556388|P2|Week 24 to Week 104 Analysis|Other|14
5665438|NCT00468546|19556389|P1|Week 24 to Week 104 Analysis|Other|17
5665439|NCT00468546|19556388|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
5665440|NCT00468546|19556389|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
5665441|NCT00468546|19556388|P2|Week 24 to Week 104 Analysis|Failure to return|2
5665442|NCT00468546|19556389|P1|Week 24 to Week 104 Analysis|Failure to return|1
5665443|NCT00468546|19556388|P2|Week 24 to Week 104 Analysis|Refused treatment|7
5665444|NCT00468546|19556389|P1|Week 24 to Week 104 Analysis|Refused treatment|4
5665445|NCT00468546|19556388|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
5665446|NCT00468546|19556389|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
5665447|NCT00468546|19556388|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
5665448|NCT00468546|19556389|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
5665449|NCT00468546|19556388|P2|Week 24 to Week 104 Analysis|Death|0
5665450|NCT00468546|19556389|P1|Week 24 to Week 104 Analysis|Death|1
5665451|NCT00468546|19556388|P2|Week 24 to Week 104 Analysis|Adverse Event|5
5665452|NCT00468546|19556389|P1|Week 24 to Week 104 Analysis|Adverse Event|2
5665453|NCT00468546|19556388|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
5665454|NCT00468546|19556389|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
5665455|NCT00468546|19556388|P2|Week 24 Analysis|Went onto rescue therapy|0
5665456|NCT00468546|19556389|P1|Week 24 Analysis|Went onto rescue therapy|1
5665457|NCT00468546|19556388|P2|Week 24 Analysis|Due to clinical hold|0
5665458|NCT00468546|19556389|P1|Week 24 Analysis|Due to clinical hold|1
5665459|NCT00468546|19556388|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
5665460|NCT00468546|19556389|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
5665461|NCT00468546|19556388|P2|Week 24 Analysis|Rescue therapy|0
5665462|NCT00468546|19556389|P1|Week 24 Analysis|Rescue therapy|2
5665463|NCT00468546|19556388|P2|Week 24 Analysis|Failure to return|4
5665464|NCT00468546|19556389|P1|Week 24 Analysis|Failure to return|3
5665465|NCT00468546|19556388|P2|Week 24 Analysis|Adverse Event|8
5665466|NCT00468546|19556389|P1|Week 24 Analysis|Adverse Event|1
5665467|NCT00468546|19556388|P2|Week 24 Analysis|Refused treatment|5
5665468|NCT00468546|19556389|P1|Week 24 Analysis|Refused treatment|5
5665469|NCT00468546|19556388|P2|Week 24 Analysis|Lack of Efficacy|37
5665470|NCT00468546|19556389|P1|Week 24 Analysis|Lack of Efficacy|83
5665471|NCT00468481|19556419|P2|Overall Study|Other|0
5665472|NCT00468481|19556420|P1|Overall Study|Other|6
5665473|NCT00468481|19556419|P2|Overall Study|Non-Compliance|0
5665474|NCT00468481|19556420|P1|Overall Study|Non-Compliance|5
5665475|NCT00468481|19556419|P2|Overall Study|Moved out of area|1
5665476|NCT00468481|19556420|P1|Overall Study|Moved out of area|4
5665477|NCT00468481|19556419|P2|Overall Study|Egg Donor|0
5665478|NCT00468481|19556420|P1|Overall Study|Egg Donor|1
5665479|NCT00468481|19556419|P2|Overall Study|Prohibited Medication|1
5665480|NCT00468481|19556420|P1|Overall Study|Prohibited Medication|1
5665481|NCT00468481|19556419|P2|Overall Study|susp/diag malignant/premalignant disease|0
5665482|NCT00468481|19556420|P1|Overall Study|susp/diag malignant/premalignant disease|1
5665483|NCT00468481|19556419|P2|Overall Study|Withdrawal by Subject|3
5665484|NCT00468481|19556420|P1|Overall Study|Withdrawal by Subject|12
5665485|NCT00468481|19556419|P2|Overall Study|Protocol Violation|8
5665486|NCT00468481|19556420|P1|Overall Study|Protocol Violation|18
5665487|NCT00468481|19556419|P2|Overall Study|Pregnancy|0
5665488|NCT00468481|19556420|P1|Overall Study|Pregnancy|2
5665489|NCT00468481|19556419|P2|Overall Study|Lost to Follow-up|8
5665490|NCT00468481|19556420|P1|Overall Study|Lost to Follow-up|25
5665491|NCT00468481|19556419|P2|Overall Study|Adverse Event|3
5665492|NCT00468481|19556420|P1|Overall Study|Adverse Event|13
5665493|NCT00468312|19556520|P2|Overall Study|Did not meet protocol eligibility|1
5665494|NCT00468312|19556521|P1|Overall Study|Did not meet protocol eligibility|0
5665495|NCT00468312|19556520|P2|Overall Study|Protocol Violation|1
5665496|NCT00468312|19556521|P1|Overall Study|Protocol Violation|2
5665497|NCT00468312|19556520|P2|Overall Study|Withdrawal by Subject|1
5665498|NCT00468312|19556521|P1|Overall Study|Withdrawal by Subject|0
5665499|NCT00468312|19556520|P2|Overall Study|Lack of Efficacy|1
5665500|NCT00468312|19556521|P1|Overall Study|Lack of Efficacy|0
5665501|NCT00468312|19556520|P2|Overall Study|Adverse Event|1
5665502|NCT00468312|19556521|P1|Overall Study|Adverse Event|2
5665503|NCT00468299|19556537|P2|Overall Study|Withdrawal by Subject|1
5665504|NCT00468299|19556538|P1|Overall Study|Withdrawal by Subject|0
5665505|NCT00468286|19556548|P2|Overall Study|Physician Decision|1
5665506|NCT00468286|19556549|P1|Overall Study|Physician Decision|0
5665507|NCT00468286|19556548|P2|Overall Study|Withdrawal by Subject|3
5665508|NCT00468286|19556549|P1|Overall Study|Withdrawal by Subject|4
5665509|NCT00468286|19556548|P2|Overall Study|Protocol Violation|2
5665510|NCT00468286|19556549|P1|Overall Study|Protocol Violation|2
5665511|NCT00468286|19556548|P2|Overall Study|Adverse Event|6
5665512|NCT00468286|19556549|P1|Overall Study|Adverse Event|1
5665513|NCT00468169|19556581|P2|Overall Study|Withdrawal by Subject|0
5665514|NCT00468169|19556582|P1|Overall Study|Withdrawal by Subject|1
5665515|NCT00468143|19556598|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
5665516|NCT00468143|19556599|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
5665517|NCT00468143|19556598|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
5665518|NCT00468143|19556599|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
5665519|NCT00468104|19556613|P2|Second Intervention|discarded for malposition of chest tube|2
5665520|NCT00468104|19556614|P1|Second Intervention|discarded for malposition of chest tube|0
5665521|NCT00468104|19556613|P2|Second Intervention|Withdrawal by Subject|2
5665522|NCT00468104|19556614|P1|Second Intervention|Withdrawal by Subject|5
5665523|NCT00468104|19556613|P2|First Intervention|trapped lung|0
5665524|NCT00468104|19556614|P1|First Intervention|trapped lung|1
5665525|NCT00468104|19556613|P2|First Intervention|associated prolonged pneumothorax|0
5665526|NCT00468104|19556614|P1|First Intervention|associated prolonged pneumothorax|1
5665527|NCT00468104|19556613|P2|First Intervention|large lung mass with minimal effusion|0
5665528|NCT00468104|19556614|P1|First Intervention|large lung mass with minimal effusion|1
5665529|NCT00468104|19556613|P2|First Intervention|malposition/blocked chest tube tube|0
5665530|NCT00468104|19556614|P1|First Intervention|malposition/blocked chest tube tube|2
5665531|NCT00468104|19556613|P2|First Intervention|died within 3 weeks|0
5665532|NCT00468104|19556614|P1|First Intervention|died within 3 weeks|1
5665533|NCT00468104|19556613|P2|First Intervention|bleeding at chest tube site--first dose|0
5665534|NCT00468104|19556614|P1|First Intervention|bleeding at chest tube site--first dose|1
5665535|NCT00468104|19556613|P2|First Intervention|Protocol Violation|1
5665536|NCT00468104|19556614|P1|First Intervention|Protocol Violation|2
5665537|NCT00468052|19556631|P2|Overall Study|Protocol Violation|8
5665538|NCT00468052|19556632|P1|Overall Study|Protocol Violation|7
5665539|NCT00467961|19556650|P1|Overall Study|Disease Progression|2
5665540|NCT00467961|19556650|P1|Overall Study|Technical Failures|5
5665541|NCT00467896|19556654|P1|Overall Study|Patient had no improvement|1
5665542|NCT00467896|19556654|P1|Overall Study|Started inhaled Remodulin|1
5665543|NCT00467896|19556654|P1|Overall Study|Started intravenous prostacyclin|1
5665544|NCT00467896|19556654|P1|Overall Study|Mainly used Prodose not I-neb® device|1
5665545|NCT00467896|19556654|P1|Overall Study|Patient weaned off iloprost|1
5665546|NCT00467896|19556654|P1|Overall Study|Patient had atrial septostomy|1
5665547|NCT00467896|19556654|P1|Overall Study|Patient received transplant|2
5665548|NCT00467896|19556654|P1|Overall Study|Changed therapy|2
5665549|NCT00467896|19556654|P1|Overall Study|Non-compliance|3
5665550|NCT00467896|19556654|P1|Overall Study|Serious Adverse Event|13
5665551|NCT00467896|19556654|P1|Overall Study|Adverse Event|7
5665552|NCT00467896|19556654|P1|Overall Study|Consent Withdrawal|18
5665553|NCT00467870|19556680|P6|Overall Study|Other/Unknown|0
5665554|NCT00467870|19556681|P5|Overall Study|Other/Unknown|4
5665555|NCT00467870|19556682|P4|Overall Study|Other/Unknown|5
5665556|NCT00467870|19556683|P3|Overall Study|Other/Unknown|1
5665557|NCT00467870|19556684|P2|Overall Study|Other/Unknown|5
5665558|NCT00467870|19556685|P1|Overall Study|Other/Unknown|8
5665559|NCT00467870|19556680|P6|Overall Study|Subject Non-compliance|0
5665560|NCT00467870|19556681|P5|Overall Study|Subject Non-compliance|5
5665561|NCT00467870|19556682|P4|Overall Study|Subject Non-compliance|1
5665562|NCT00467870|19556683|P3|Overall Study|Subject Non-compliance|0
5665563|NCT00467870|19556684|P2|Overall Study|Subject Non-compliance|4
5665564|NCT00467870|19556685|P1|Overall Study|Subject Non-compliance|3
5665565|NCT00467870|19556680|P6|Overall Study|Lost to Follow-up|0
5665566|NCT00467870|19556681|P5|Overall Study|Lost to Follow-up|3
5665567|NCT00467870|19556682|P4|Overall Study|Lost to Follow-up|1
5665568|NCT00467870|19556683|P3|Overall Study|Lost to Follow-up|1
5665569|NCT00467870|19556684|P2|Overall Study|Lost to Follow-up|3
5665570|NCT00467870|19556685|P1|Overall Study|Lost to Follow-up|5
5665571|NCT00467870|19556680|P6|Overall Study|Withdrawal by Subject|1
5665572|NCT00467870|19556681|P5|Overall Study|Withdrawal by Subject|10
5665573|NCT00467870|19556682|P4|Overall Study|Withdrawal by Subject|9
5665574|NCT00467870|19556683|P3|Overall Study|Withdrawal by Subject|0
5665575|NCT00467870|19556684|P2|Overall Study|Withdrawal by Subject|21
5665576|NCT00467870|19556685|P1|Overall Study|Withdrawal by Subject|14
5665577|NCT00467870|19556680|P6|Overall Study|Protocol Violation|0
5665578|NCT00467870|19556681|P5|Overall Study|Protocol Violation|0
5665579|NCT00467870|19556682|P4|Overall Study|Protocol Violation|2
5665580|NCT00467870|19556683|P3|Overall Study|Protocol Violation|1
5665581|NCT00467870|19556684|P2|Overall Study|Protocol Violation|1
5665582|NCT00467870|19556685|P1|Overall Study|Protocol Violation|2
5665583|NCT00467870|19556680|P6|Overall Study|Adverse Event|1
5665584|NCT00467870|19556681|P5|Overall Study|Adverse Event|15
5665585|NCT00467870|19556682|P4|Overall Study|Adverse Event|15
5665586|NCT00467870|19556683|P3|Overall Study|Adverse Event|1
5665587|NCT00467870|19556684|P2|Overall Study|Adverse Event|9
5665588|NCT00467870|19556685|P1|Overall Study|Adverse Event|13
5665589|NCT00467857|19556728|P2|Overall Study|Discontinuation reason missing|3
5665590|NCT00467857|19556729|P1|Overall Study|Discontinuation reason missing|0
5665591|NCT00467857|19556728|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
5665592|NCT00467857|19556729|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
5665593|NCT00467857|19556728|P2|Overall Study|Emergency care required|1
5665594|NCT00467857|19556729|P1|Overall Study|Emergency care required|0
5665595|NCT00467857|19556728|P2|Overall Study|Discharged from court service|1
5665596|NCT00467857|19556729|P1|Overall Study|Discharged from court service|0
5665597|NCT00467857|19556728|P2|Overall Study|Death|1
5665598|NCT00467857|19556729|P1|Overall Study|Death|0
5665599|NCT00467857|19556728|P2|Overall Study|Withdrew consent|0
5665600|NCT00467857|19556729|P1|Overall Study|Withdrew consent|2
5665601|NCT00467857|19556728|P2|Overall Study|Adverse Event|0
5665602|NCT00467857|19556729|P1|Overall Study|Adverse Event|1
5665603|NCT00467831|19556777|P1|Overall Study|Withdrawal by Subject|1
5665604|NCT00467831|19556777|P1|Overall Study|Death|2
5665605|NCT00467818|19556783|P2|Overall Study|Lost to Follow-up|2
5665606|NCT00467818|19556784|P1|Overall Study|Lost to Follow-up|2
5665607|NCT00467818|19556783|P2|Overall Study|Adverse Event|0
5665608|NCT00467818|19556784|P1|Overall Study|Adverse Event|1
5665609|NCT00467779|19556813|P15|Stage 3|Unspecified Reason|5
5665610|NCT00467779|19556814|P14|Stage 3|Unspecified Reason|0
5665611|NCT00467779|19556815|P13|Stage 3|Unspecified Reason|0
5665612|NCT00467779|19556816|P12|Stage 3|Unspecified Reason|0
5665613|NCT00467779|19556817|P11|Stage 3|Unspecified Reason|0
5665614|NCT00467779|19556818|P10|Stage 3|Unspecified Reason|0
5665615|NCT00467779|19556819|P9|Stage 3|Unspecified Reason|0
5665616|NCT00467779|19556820|P8|Stage 3|Unspecified Reason|0
5665617|NCT00467779|19556821|P7|Stage 3|Unspecified Reason|0
5665618|NCT00467779|19556822|P6|Stage 3|Unspecified Reason|0
5665619|NCT00467779|19556823|P5|Stage 3|Unspecified Reason|0
5665620|NCT00467779|19556824|P4|Stage 3|Unspecified Reason|0
5665621|NCT00467779|19556825|P3|Stage 3|Unspecified Reason|0
5665622|NCT00467779|19556826|P2|Stage 3|Unspecified Reason|0
5665623|NCT00467779|19556827|P1|Stage 3|Unspecified Reason|0
5665624|NCT00467779|19556813|P15|Stage 3|Disease Progression|9
5665625|NCT00467779|19556814|P14|Stage 3|Disease Progression|0
5665626|NCT00467779|19556815|P13|Stage 3|Disease Progression|0
5665627|NCT00467779|19556816|P12|Stage 3|Disease Progression|0
5665628|NCT00467779|19556817|P11|Stage 3|Disease Progression|0
5665629|NCT00467779|19556818|P10|Stage 3|Disease Progression|0
5665630|NCT00467779|19556819|P9|Stage 3|Disease Progression|0
5665631|NCT00467779|19556820|P8|Stage 3|Disease Progression|0
5665632|NCT00467779|19556821|P7|Stage 3|Disease Progression|0
5665633|NCT00467779|19556822|P6|Stage 3|Disease Progression|0
5665634|NCT00467779|19556823|P5|Stage 3|Disease Progression|0
5665635|NCT00467779|19556824|P4|Stage 3|Disease Progression|0
5665636|NCT00467779|19556825|P3|Stage 3|Disease Progression|0
5665637|NCT00467779|19556826|P2|Stage 3|Disease Progression|0
5665638|NCT00467779|19556827|P1|Stage 3|Disease Progression|0
5665639|NCT00467779|19556813|P15|Stage 3|Death|1
5665640|NCT00467779|19556814|P14|Stage 3|Death|0
5665641|NCT00467779|19556815|P13|Stage 3|Death|0
5665642|NCT00467779|19556816|P12|Stage 3|Death|0
5665643|NCT00467779|19556817|P11|Stage 3|Death|0
5665644|NCT00467779|19556818|P10|Stage 3|Death|0
5665645|NCT00467779|19556819|P9|Stage 3|Death|0
5665646|NCT00467779|19556820|P8|Stage 3|Death|0
5665647|NCT00467779|19556821|P7|Stage 3|Death|0
5665648|NCT00467779|19556822|P6|Stage 3|Death|0
5665649|NCT00467779|19556823|P5|Stage 3|Death|0
5665650|NCT00467779|19556824|P4|Stage 3|Death|0
5665651|NCT00467779|19556825|P3|Stage 3|Death|0
5665652|NCT00467779|19556826|P2|Stage 3|Death|0
5665653|NCT00467779|19556827|P1|Stage 3|Death|0
5665654|NCT00467779|19556813|P15|Stage 3|Adverse Event|2
5665655|NCT00467779|19556814|P14|Stage 3|Adverse Event|0
5665656|NCT00467779|19556815|P13|Stage 3|Adverse Event|0
5665657|NCT00467779|19556816|P12|Stage 3|Adverse Event|0
5665658|NCT00467779|19556817|P11|Stage 3|Adverse Event|0
5665659|NCT00467779|19556818|P10|Stage 3|Adverse Event|0
5665660|NCT00467779|19556819|P9|Stage 3|Adverse Event|0
5665661|NCT00467779|19556820|P8|Stage 3|Adverse Event|0
5665662|NCT00467779|19556821|P7|Stage 3|Adverse Event|0
5665663|NCT00467779|19556822|P6|Stage 3|Adverse Event|0
5665664|NCT00467779|19556823|P5|Stage 3|Adverse Event|0
5665665|NCT00467779|19556824|P4|Stage 3|Adverse Event|0
5665666|NCT00467779|19556825|P3|Stage 3|Adverse Event|0
5665667|NCT00467779|19556826|P2|Stage 3|Adverse Event|0
5665668|NCT00467779|19556827|P1|Stage 3|Adverse Event|0
5665669|NCT00467779|19556813|P15|Stage 2A|Withdrawal by Subject|0
5665670|NCT00467779|19556814|P14|Stage 2A|Withdrawal by Subject|1
5665671|NCT00467779|19556815|P13|Stage 2A|Withdrawal by Subject|0
5665672|NCT00467779|19556816|P12|Stage 2A|Withdrawal by Subject|0
5665673|NCT00467779|19556817|P11|Stage 2A|Withdrawal by Subject|0
5665674|NCT00467779|19556818|P10|Stage 2A|Withdrawal by Subject|0
5665675|NCT00467779|19556819|P9|Stage 2A|Withdrawal by Subject|0
5665676|NCT00467779|19556820|P8|Stage 2A|Withdrawal by Subject|0
5665677|NCT00467779|19556821|P7|Stage 2A|Withdrawal by Subject|0
5665678|NCT00467779|19556822|P6|Stage 2A|Withdrawal by Subject|0
5665679|NCT00467779|19556823|P5|Stage 2A|Withdrawal by Subject|0
5665680|NCT00467779|19556824|P4|Stage 2A|Withdrawal by Subject|0
5665681|NCT00467779|19556825|P3|Stage 2A|Withdrawal by Subject|0
5665682|NCT00467779|19556826|P2|Stage 2A|Withdrawal by Subject|0
5665683|NCT00467779|19556827|P1|Stage 2A|Withdrawal by Subject|0
5665684|NCT00467779|19556813|P15|Stage 2A|Unspecified Reason|0
5665685|NCT00467779|19556814|P14|Stage 2A|Unspecified Reason|7
5665686|NCT00467779|19556815|P13|Stage 2A|Unspecified Reason|0
5665687|NCT00467779|19556816|P12|Stage 2A|Unspecified Reason|0
5665688|NCT00467779|19556817|P11|Stage 2A|Unspecified Reason|0
5665689|NCT00467779|19556818|P10|Stage 2A|Unspecified Reason|0
5665690|NCT00467779|19556819|P9|Stage 2A|Unspecified Reason|0
5665691|NCT00467779|19556820|P8|Stage 2A|Unspecified Reason|0
5665692|NCT00467779|19556821|P7|Stage 2A|Unspecified Reason|0
5665693|NCT00467779|19556822|P6|Stage 2A|Unspecified Reason|0
5665694|NCT00467779|19556823|P5|Stage 2A|Unspecified Reason|0
5665695|NCT00467779|19556824|P4|Stage 2A|Unspecified Reason|0
5665696|NCT00467779|19556825|P3|Stage 2A|Unspecified Reason|0
5665697|NCT00467779|19556826|P2|Stage 2A|Unspecified Reason|0
5665698|NCT00467779|19556827|P1|Stage 2A|Unspecified Reason|0
5665699|NCT00467779|19556813|P15|Stage 2A|Disease Progression|0
5665700|NCT00467779|19556814|P14|Stage 2A|Disease Progression|10
5665701|NCT00467779|19556815|P13|Stage 2A|Disease Progression|0
5665702|NCT00467779|19556816|P12|Stage 2A|Disease Progression|0
5665703|NCT00467779|19556817|P11|Stage 2A|Disease Progression|0
5665704|NCT00467779|19556818|P10|Stage 2A|Disease Progression|0
5665705|NCT00467779|19556819|P9|Stage 2A|Disease Progression|0
5665706|NCT00467779|19556820|P8|Stage 2A|Disease Progression|0
5665707|NCT00467779|19556821|P7|Stage 2A|Disease Progression|0
5665708|NCT00467779|19556822|P6|Stage 2A|Disease Progression|0
5665709|NCT00467779|19556823|P5|Stage 2A|Disease Progression|0
5665710|NCT00467779|19556824|P4|Stage 2A|Disease Progression|0
5665711|NCT00467779|19556825|P3|Stage 2A|Disease Progression|0
5665712|NCT00467779|19556826|P2|Stage 2A|Disease Progression|0
5665713|NCT00467779|19556827|P1|Stage 2A|Disease Progression|0
5665714|NCT00467779|19556813|P15|Stage 2A|Death|0
5665715|NCT00467779|19556814|P14|Stage 2A|Death|1
5665716|NCT00467779|19556815|P13|Stage 2A|Death|0
5665717|NCT00467779|19556816|P12|Stage 2A|Death|0
5665718|NCT00467779|19556817|P11|Stage 2A|Death|0
5665719|NCT00467779|19556818|P10|Stage 2A|Death|0
5665720|NCT00467779|19556819|P9|Stage 2A|Death|0
5665721|NCT00467779|19556820|P8|Stage 2A|Death|0
5665722|NCT00467779|19556821|P7|Stage 2A|Death|0
5665723|NCT00467779|19556822|P6|Stage 2A|Death|0
5665724|NCT00467779|19556823|P5|Stage 2A|Death|0
5665725|NCT00467779|19556824|P4|Stage 2A|Death|0
5665726|NCT00467779|19556825|P3|Stage 2A|Death|0
5665727|NCT00467779|19556826|P2|Stage 2A|Death|0
5665728|NCT00467779|19556827|P1|Stage 2A|Death|0
5665729|NCT00467779|19556813|P15|Stage 2A|Adverse Event|0
5665730|NCT00467779|19556814|P14|Stage 2A|Adverse Event|2
5665731|NCT00467779|19556815|P13|Stage 2A|Adverse Event|0
5665732|NCT00467779|19556816|P12|Stage 2A|Adverse Event|0
5665733|NCT00467779|19556817|P11|Stage 2A|Adverse Event|0
5665734|NCT00467779|19556818|P10|Stage 2A|Adverse Event|0
5665735|NCT00467779|19556819|P9|Stage 2A|Adverse Event|0
5665736|NCT00467779|19556820|P8|Stage 2A|Adverse Event|0
5665737|NCT00467779|19556821|P7|Stage 2A|Adverse Event|0
5665738|NCT00467779|19556822|P6|Stage 2A|Adverse Event|0
5665739|NCT00467779|19556823|P5|Stage 2A|Adverse Event|0
5665740|NCT00467779|19556824|P4|Stage 2A|Adverse Event|0
5665741|NCT00467779|19556825|P3|Stage 2A|Adverse Event|0
5665742|NCT00467779|19556826|P2|Stage 2A|Adverse Event|0
5665743|NCT00467779|19556827|P1|Stage 2A|Adverse Event|0
5665744|NCT00467779|19556813|P15|Stage 2|Unspecified Reason|0
5665745|NCT00467779|19556814|P14|Stage 2|Unspecified Reason|0
5665746|NCT00467779|19556815|P13|Stage 2|Unspecified Reason|0
5665747|NCT00467779|19556816|P12|Stage 2|Unspecified Reason|0
5665748|NCT00467779|19556817|P11|Stage 2|Unspecified Reason|0
5665749|NCT00467779|19556818|P10|Stage 2|Unspecified Reason|0
5665750|NCT00467779|19556819|P9|Stage 2|Unspecified Reason|3
5665751|NCT00467779|19556820|P8|Stage 2|Unspecified Reason|0
5665752|NCT00467779|19556821|P7|Stage 2|Unspecified Reason|0
5665753|NCT00467779|19556822|P6|Stage 2|Unspecified Reason|0
5665754|NCT00467779|19556823|P5|Stage 2|Unspecified Reason|0
5665755|NCT00467779|19556824|P4|Stage 2|Unspecified Reason|0
5665756|NCT00467779|19556825|P3|Stage 2|Unspecified Reason|0
5665757|NCT00467779|19556826|P2|Stage 2|Unspecified Reason|0
5665758|NCT00467779|19556827|P1|Stage 2|Unspecified Reason|0
5665759|NCT00467779|19556813|P15|Stage 2|Disease Progression|0
5665760|NCT00467779|19556814|P14|Stage 2|Disease Progression|0
5665761|NCT00467779|19556815|P13|Stage 2|Disease Progression|0
5665762|NCT00467779|19556816|P12|Stage 2|Disease Progression|0
5665763|NCT00467779|19556817|P11|Stage 2|Disease Progression|0
5665764|NCT00467779|19556818|P10|Stage 2|Disease Progression|0
5665765|NCT00467779|19556819|P9|Stage 2|Disease Progression|16
5665766|NCT00467779|19556820|P8|Stage 2|Disease Progression|0
5665767|NCT00467779|19556821|P7|Stage 2|Disease Progression|0
5665768|NCT00467779|19556822|P6|Stage 2|Disease Progression|0
5665769|NCT00467779|19556823|P5|Stage 2|Disease Progression|0
5665770|NCT00467779|19556824|P4|Stage 2|Disease Progression|0
5665771|NCT00467779|19556825|P3|Stage 2|Disease Progression|0
5665772|NCT00467779|19556826|P2|Stage 2|Disease Progression|0
5665773|NCT00467779|19556827|P1|Stage 2|Disease Progression|0
5665774|NCT00467779|19556813|P15|Stage 2|Death|0
5665775|NCT00467779|19556814|P14|Stage 2|Death|0
5665776|NCT00467779|19556815|P13|Stage 2|Death|0
5665777|NCT00467779|19556816|P12|Stage 2|Death|0
5665778|NCT00467779|19556817|P11|Stage 2|Death|0
5665779|NCT00467779|19556818|P10|Stage 2|Death|0
5665780|NCT00467779|19556819|P9|Stage 2|Death|1
5665781|NCT00467779|19556820|P8|Stage 2|Death|0
5665782|NCT00467779|19556821|P7|Stage 2|Death|0
5665783|NCT00467779|19556822|P6|Stage 2|Death|0
5665784|NCT00467779|19556823|P5|Stage 2|Death|0
5665785|NCT00467779|19556824|P4|Stage 2|Death|0
5665786|NCT00467779|19556825|P3|Stage 2|Death|0
5665787|NCT00467779|19556826|P2|Stage 2|Death|0
5665788|NCT00467779|19556827|P1|Stage 2|Death|0
5665789|NCT00467779|19556813|P15|Stage 2|Adverse Event|0
5665790|NCT00467779|19556814|P14|Stage 2|Adverse Event|0
5665791|NCT00467779|19556815|P13|Stage 2|Adverse Event|0
5665792|NCT00467779|19556816|P12|Stage 2|Adverse Event|0
5665793|NCT00467779|19556817|P11|Stage 2|Adverse Event|0
5665794|NCT00467779|19556818|P10|Stage 2|Adverse Event|0
5665795|NCT00467779|19556819|P9|Stage 2|Adverse Event|1
5665796|NCT00467779|19556820|P8|Stage 2|Adverse Event|0
5665797|NCT00467779|19556821|P7|Stage 2|Adverse Event|0
5665798|NCT00467779|19556822|P6|Stage 2|Adverse Event|0
5665799|NCT00467779|19556823|P5|Stage 2|Adverse Event|0
5665800|NCT00467779|19556824|P4|Stage 2|Adverse Event|0
5665801|NCT00467779|19556825|P3|Stage 2|Adverse Event|0
5665802|NCT00467779|19556826|P2|Stage 2|Adverse Event|0
5665803|NCT00467779|19556827|P1|Stage 2|Adverse Event|0
5665804|NCT00467779|19556813|P15|Stage 1A|Unspecified Reason|0
5665805|NCT00467779|19556814|P14|Stage 1A|Unspecified Reason|0
5665806|NCT00467779|19556815|P13|Stage 1A|Unspecified Reason|1
5665807|NCT00467779|19556816|P12|Stage 1A|Unspecified Reason|1
5665808|NCT00467779|19556817|P11|Stage 1A|Unspecified Reason|0
5665809|NCT00467779|19556818|P10|Stage 1A|Unspecified Reason|0
5665810|NCT00467779|19556819|P9|Stage 1A|Unspecified Reason|0
5665811|NCT00467779|19556820|P8|Stage 1A|Unspecified Reason|0
5665812|NCT00467779|19556821|P7|Stage 1A|Unspecified Reason|0
5665813|NCT00467779|19556822|P6|Stage 1A|Unspecified Reason|0
5665814|NCT00467779|19556823|P5|Stage 1A|Unspecified Reason|0
5665815|NCT00467779|19556824|P4|Stage 1A|Unspecified Reason|0
5665816|NCT00467779|19556825|P3|Stage 1A|Unspecified Reason|0
5665817|NCT00467779|19556826|P2|Stage 1A|Unspecified Reason|0
5665818|NCT00467779|19556827|P1|Stage 1A|Unspecified Reason|0
5665819|NCT00467779|19556813|P15|Stage 1A|Withdrawal by Subject|0
5665820|NCT00467779|19556814|P14|Stage 1A|Withdrawal by Subject|0
5665821|NCT00467779|19556815|P13|Stage 1A|Withdrawal by Subject|1
5665822|NCT00467779|19556816|P12|Stage 1A|Withdrawal by Subject|1
5665823|NCT00467779|19556817|P11|Stage 1A|Withdrawal by Subject|1
5665824|NCT00467779|19556818|P10|Stage 1A|Withdrawal by Subject|0
5665825|NCT00467779|19556819|P9|Stage 1A|Withdrawal by Subject|0
5665826|NCT00467779|19556820|P8|Stage 1A|Withdrawal by Subject|0
5665827|NCT00467779|19556821|P7|Stage 1A|Withdrawal by Subject|0
5665828|NCT00467779|19556822|P6|Stage 1A|Withdrawal by Subject|0
5665829|NCT00467779|19556823|P5|Stage 1A|Withdrawal by Subject|0
5665830|NCT00467779|19556824|P4|Stage 1A|Withdrawal by Subject|0
5665831|NCT00467779|19556825|P3|Stage 1A|Withdrawal by Subject|0
5665832|NCT00467779|19556826|P2|Stage 1A|Withdrawal by Subject|0
5665833|NCT00467779|19556827|P1|Stage 1A|Withdrawal by Subject|0
5665834|NCT00467779|19556813|P15|Stage 1A|Physician Decision|0
5665835|NCT00467779|19556814|P14|Stage 1A|Physician Decision|0
5665836|NCT00467779|19556815|P13|Stage 1A|Physician Decision|0
5665837|NCT00467779|19556816|P12|Stage 1A|Physician Decision|0
5665838|NCT00467779|19556817|P11|Stage 1A|Physician Decision|0
5665839|NCT00467779|19556818|P10|Stage 1A|Physician Decision|1
5665840|NCT00467779|19556819|P9|Stage 1A|Physician Decision|0
5665841|NCT00467779|19556820|P8|Stage 1A|Physician Decision|0
5665842|NCT00467779|19556821|P7|Stage 1A|Physician Decision|0
5665843|NCT00467779|19556822|P6|Stage 1A|Physician Decision|0
5665844|NCT00467779|19556823|P5|Stage 1A|Physician Decision|0
5665845|NCT00467779|19556824|P4|Stage 1A|Physician Decision|0
5665846|NCT00467779|19556825|P3|Stage 1A|Physician Decision|0
5665847|NCT00467779|19556826|P2|Stage 1A|Physician Decision|0
5665848|NCT00467779|19556827|P1|Stage 1A|Physician Decision|0
5665849|NCT00467779|19556813|P15|Stage 1A|Disease Progression|0
5665850|NCT00467779|19556814|P14|Stage 1A|Disease Progression|0
5665851|NCT00467779|19556815|P13|Stage 1A|Disease Progression|2
5665852|NCT00467779|19556816|P12|Stage 1A|Disease Progression|5
5665853|NCT00467779|19556817|P11|Stage 1A|Disease Progression|2
5665854|NCT00467779|19556818|P10|Stage 1A|Disease Progression|2
5665855|NCT00467779|19556819|P9|Stage 1A|Disease Progression|0
5665856|NCT00467779|19556820|P8|Stage 1A|Disease Progression|0
5665857|NCT00467779|19556821|P7|Stage 1A|Disease Progression|0
5665858|NCT00467779|19556822|P6|Stage 1A|Disease Progression|0
5665859|NCT00467779|19556823|P5|Stage 1A|Disease Progression|0
5665860|NCT00467779|19556824|P4|Stage 1A|Disease Progression|0
5665861|NCT00467779|19556825|P3|Stage 1A|Disease Progression|0
5665862|NCT00467779|19556826|P2|Stage 1A|Disease Progression|0
5665863|NCT00467779|19556827|P1|Stage 1A|Disease Progression|0
5665864|NCT00467779|19556813|P15|Stage 1A|Death|0
5665865|NCT00467779|19556814|P14|Stage 1A|Death|0
5665866|NCT00467779|19556815|P13|Stage 1A|Death|1
5665867|NCT00467779|19556816|P12|Stage 1A|Death|1
5665868|NCT00467779|19556817|P11|Stage 1A|Death|0
5665869|NCT00467779|19556818|P10|Stage 1A|Death|0
5665870|NCT00467779|19556819|P9|Stage 1A|Death|0
5665871|NCT00467779|19556820|P8|Stage 1A|Death|0
5665872|NCT00467779|19556821|P7|Stage 1A|Death|0
5665873|NCT00467779|19556822|P6|Stage 1A|Death|0
5665874|NCT00467779|19556823|P5|Stage 1A|Death|0
5665875|NCT00467779|19556824|P4|Stage 1A|Death|0
5665876|NCT00467779|19556825|P3|Stage 1A|Death|0
5665877|NCT00467779|19556826|P2|Stage 1A|Death|0
5665878|NCT00467779|19556827|P1|Stage 1A|Death|0
5665879|NCT00467779|19556813|P15|Stage 1A|Adverse Event|0
5665880|NCT00467779|19556814|P14|Stage 1A|Adverse Event|0
5665881|NCT00467779|19556815|P13|Stage 1A|Adverse Event|1
5665882|NCT00467779|19556816|P12|Stage 1A|Adverse Event|0
5665883|NCT00467779|19556817|P11|Stage 1A|Adverse Event|0
5665884|NCT00467779|19556818|P10|Stage 1A|Adverse Event|0
5665885|NCT00467779|19556819|P9|Stage 1A|Adverse Event|0
5665886|NCT00467779|19556820|P8|Stage 1A|Adverse Event|0
5665887|NCT00467779|19556821|P7|Stage 1A|Adverse Event|0
5665888|NCT00467779|19556822|P6|Stage 1A|Adverse Event|0
5665889|NCT00467779|19556823|P5|Stage 1A|Adverse Event|0
5665890|NCT00467779|19556824|P4|Stage 1A|Adverse Event|0
5665891|NCT00467779|19556825|P3|Stage 1A|Adverse Event|0
5665892|NCT00467779|19556826|P2|Stage 1A|Adverse Event|0
5665893|NCT00467779|19556827|P1|Stage 1A|Adverse Event|0
5665894|NCT00467779|19556813|P15|Stage 1|Withdrawal by Subject|0
5665895|NCT00467779|19556814|P14|Stage 1|Withdrawal by Subject|0
5665896|NCT00467779|19556815|P13|Stage 1|Withdrawal by Subject|0
5665897|NCT00467779|19556816|P12|Stage 1|Withdrawal by Subject|0
5665898|NCT00467779|19556817|P11|Stage 1|Withdrawal by Subject|0
5665899|NCT00467779|19556818|P10|Stage 1|Withdrawal by Subject|0
5665900|NCT00467779|19556819|P9|Stage 1|Withdrawal by Subject|0
5665901|NCT00467779|19556820|P8|Stage 1|Withdrawal by Subject|1
5665902|NCT00467779|19556821|P7|Stage 1|Withdrawal by Subject|1
5665903|NCT00467779|19556822|P6|Stage 1|Withdrawal by Subject|0
5665904|NCT00467779|19556823|P5|Stage 1|Withdrawal by Subject|0
5665905|NCT00467779|19556824|P4|Stage 1|Withdrawal by Subject|0
5665906|NCT00467779|19556825|P3|Stage 1|Withdrawal by Subject|0
5665907|NCT00467779|19556826|P2|Stage 1|Withdrawal by Subject|0
5665908|NCT00467779|19556827|P1|Stage 1|Withdrawal by Subject|0
5665909|NCT00467779|19556813|P15|Stage 1|Physician Decision|0
5665910|NCT00467779|19556814|P14|Stage 1|Physician Decision|0
5665911|NCT00467779|19556815|P13|Stage 1|Physician Decision|0
5665912|NCT00467779|19556816|P12|Stage 1|Physician Decision|0
5665913|NCT00467779|19556817|P11|Stage 1|Physician Decision|0
5665914|NCT00467779|19556818|P10|Stage 1|Physician Decision|0
5665915|NCT00467779|19556819|P9|Stage 1|Physician Decision|0
5665916|NCT00467779|19556820|P8|Stage 1|Physician Decision|0
5665917|NCT00467779|19556821|P7|Stage 1|Physician Decision|0
5665918|NCT00467779|19556822|P6|Stage 1|Physician Decision|0
5665919|NCT00467779|19556823|P5|Stage 1|Physician Decision|0
5665920|NCT00467779|19556824|P4|Stage 1|Physician Decision|0
5665921|NCT00467779|19556825|P3|Stage 1|Physician Decision|0
5665922|NCT00467779|19556826|P2|Stage 1|Physician Decision|1
5665923|NCT00467779|19556827|P1|Stage 1|Physician Decision|0
5665924|NCT00467779|19556813|P15|Stage 1|Unspecified Reason|0
5665925|NCT00467779|19556814|P14|Stage 1|Unspecified Reason|0
5665926|NCT00467779|19556815|P13|Stage 1|Unspecified Reason|0
5665927|NCT00467779|19556816|P12|Stage 1|Unspecified Reason|0
5665928|NCT00467779|19556817|P11|Stage 1|Unspecified Reason|0
5665929|NCT00467779|19556818|P10|Stage 1|Unspecified Reason|0
5665930|NCT00467779|19556819|P9|Stage 1|Unspecified Reason|0
5665931|NCT00467779|19556820|P8|Stage 1|Unspecified Reason|0
5665932|NCT00467779|19556821|P7|Stage 1|Unspecified Reason|0
5665933|NCT00467779|19556822|P6|Stage 1|Unspecified Reason|2
5665934|NCT00467779|19556823|P5|Stage 1|Unspecified Reason|1
5665935|NCT00467779|19556824|P4|Stage 1|Unspecified Reason|0
5665936|NCT00467779|19556825|P3|Stage 1|Unspecified Reason|1
5665937|NCT00467779|19556826|P2|Stage 1|Unspecified Reason|0
5665938|NCT00467779|19556827|P1|Stage 1|Unspecified Reason|1
5665939|NCT00467779|19556813|P15|Stage 1|Disease Progression|0
5665940|NCT00467779|19556814|P14|Stage 1|Disease Progression|0
5665941|NCT00467779|19556815|P13|Stage 1|Disease Progression|0
5665942|NCT00467779|19556816|P12|Stage 1|Disease Progression|0
5665943|NCT00467779|19556817|P11|Stage 1|Disease Progression|0
5665944|NCT00467779|19556818|P10|Stage 1|Disease Progression|0
5665945|NCT00467779|19556819|P9|Stage 1|Disease Progression|0
5665946|NCT00467779|19556820|P8|Stage 1|Disease Progression|5
5665947|NCT00467779|19556821|P7|Stage 1|Disease Progression|4
5665948|NCT00467779|19556822|P6|Stage 1|Disease Progression|2
5665949|NCT00467779|19556823|P5|Stage 1|Disease Progression|2
5665950|NCT00467779|19556824|P4|Stage 1|Disease Progression|3
5665951|NCT00467779|19556825|P3|Stage 1|Disease Progression|2
5665952|NCT00467779|19556826|P2|Stage 1|Disease Progression|2
5665953|NCT00467779|19556827|P1|Stage 1|Disease Progression|2
5665954|NCT00467779|19556813|P15|Stage 1|Adverse Event|0
5665955|NCT00467779|19556814|P14|Stage 1|Adverse Event|0
5665956|NCT00467779|19556815|P13|Stage 1|Adverse Event|0
5665957|NCT00467779|19556816|P12|Stage 1|Adverse Event|0
5665958|NCT00467779|19556817|P11|Stage 1|Adverse Event|0
5665959|NCT00467779|19556818|P10|Stage 1|Adverse Event|0
5665960|NCT00467779|19556819|P9|Stage 1|Adverse Event|0
5665961|NCT00467779|19556820|P8|Stage 1|Adverse Event|1
5665962|NCT00467779|19556821|P7|Stage 1|Adverse Event|2
5665963|NCT00467779|19556822|P6|Stage 1|Adverse Event|1
5665964|NCT00467779|19556823|P5|Stage 1|Adverse Event|0
5665965|NCT00467779|19556824|P4|Stage 1|Adverse Event|0
5665966|NCT00467779|19556825|P3|Stage 1|Adverse Event|0
5665967|NCT00467779|19556826|P2|Stage 1|Adverse Event|0
5665968|NCT00467779|19556827|P1|Stage 1|Adverse Event|1
5665969|NCT00467753|19557001|P2|Overall Study|Adverse Event|0
5665970|NCT00467753|19557002|P1|Overall Study|Adverse Event|2
5665971|NCT00467753|19557001|P2|Overall Study|Lost to Follow-up|2
5665972|NCT00467753|19557002|P1|Overall Study|Lost to Follow-up|1
5665973|NCT00467740|19557013|P5|Overall Study|Lack of Efficacy|0
5665974|NCT00467740|19557014|P4|Overall Study|Lack of Efficacy|0
5665975|NCT00467740|19557015|P3|Overall Study|Lack of Efficacy|0
5665976|NCT00467740|19557016|P2|Overall Study|Lack of Efficacy|1
5665977|NCT00467740|19557017|P1|Overall Study|Lack of Efficacy|0
5665978|NCT00467740|19557013|P5|Overall Study|Withdrawal by Subject|0
5665979|NCT00467740|19557014|P4|Overall Study|Withdrawal by Subject|1
5665980|NCT00467740|19557015|P3|Overall Study|Withdrawal by Subject|0
5665981|NCT00467740|19557016|P2|Overall Study|Withdrawal by Subject|1
5665982|NCT00467740|19557017|P1|Overall Study|Withdrawal by Subject|1
5665983|NCT00467740|19557013|P5|Overall Study|Lost to Follow-up|0
5665984|NCT00467740|19557014|P4|Overall Study|Lost to Follow-up|0
5665985|NCT00467740|19557015|P3|Overall Study|Lost to Follow-up|0
5665986|NCT00467740|19557016|P2|Overall Study|Lost to Follow-up|1
5665987|NCT00467740|19557017|P1|Overall Study|Lost to Follow-up|0
5665988|NCT00467740|19557013|P5|Overall Study|Protocol Violation|0
5665989|NCT00467740|19557014|P4|Overall Study|Protocol Violation|0
5665990|NCT00467740|19557015|P3|Overall Study|Protocol Violation|1
5665991|NCT00467740|19557016|P2|Overall Study|Protocol Violation|0
5665992|NCT00467740|19557017|P1|Overall Study|Protocol Violation|0
5665993|NCT00467740|19557013|P5|Overall Study|Adverse Event|0
5665994|NCT00467740|19557014|P4|Overall Study|Adverse Event|0
5665995|NCT00467740|19557015|P3|Overall Study|Adverse Event|1
5665996|NCT00467740|19557016|P2|Overall Study|Adverse Event|0
5665997|NCT00467740|19557017|P1|Overall Study|Adverse Event|0
5665998|NCT00467649|19557206|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
5665999|NCT00467649|19557207|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5666000|NCT00467649|19557208|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5666001|NCT00467649|19557209|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5666002|NCT00467649|19557210|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5666003|NCT00467649|19557211|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
5666004|NCT00467649|19557206|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5666005|NCT00467649|19557207|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5666006|NCT00467649|19557208|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
5666007|NCT00467649|19557209|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5666008|NCT00467649|19557210|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5666009|NCT00467649|19557211|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
5666010|NCT00467649|19557206|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5666011|NCT00467649|19557207|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5666012|NCT00467649|19557208|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
5666013|NCT00467649|19557209|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5666014|NCT00467649|19557210|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5666015|NCT00467649|19557211|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
5666016|NCT00467649|19557206|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
5666017|NCT00467649|19557207|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
5666018|NCT00467649|19557208|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
5666019|NCT00467649|19557209|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
5666020|NCT00467649|19557210|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
5666021|NCT00467649|19557211|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
5666022|NCT00467649|19557206|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
5666023|NCT00467649|19557207|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
5666024|NCT00467649|19557208|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
5666025|NCT00467649|19557209|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
5666026|NCT00467649|19557210|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
5666027|NCT00467649|19557211|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
5666028|NCT00467649|19557206|P6|Phase 1 (Randomized Population)|Investigator Decision|0
5666029|NCT00467649|19557207|P5|Phase 1 (Randomized Population)|Investigator Decision|0
5666030|NCT00467649|19557208|P4|Phase 1 (Randomized Population)|Investigator Decision|0
5666031|NCT00467649|19557209|P3|Phase 1 (Randomized Population)|Investigator Decision|0
5666032|NCT00467649|19557210|P2|Phase 1 (Randomized Population)|Investigator Decision|0
5666033|NCT00467649|19557211|P1|Phase 1 (Randomized Population)|Investigator Decision|1
5666034|NCT00467649|19557206|P6|Phase 1 (Randomized Population)|Adverse Event|0
5666035|NCT00467649|19557207|P5|Phase 1 (Randomized Population)|Adverse Event|0
5666036|NCT00467649|19557208|P4|Phase 1 (Randomized Population)|Adverse Event|0
5666037|NCT00467649|19557209|P3|Phase 1 (Randomized Population)|Adverse Event|0
5666038|NCT00467649|19557210|P2|Phase 1 (Randomized Population)|Adverse Event|0
5666039|NCT00467649|19557211|P1|Phase 1 (Randomized Population)|Adverse Event|2
5666040|NCT00467610|19557251|P1|Overall Study|Withdrawal by Subject|1
5666041|NCT00467597|19557262|P2|Overall Study|Withdrawal by Subject|0
5666042|NCT00467597|19557263|P1|Overall Study|Withdrawal by Subject|2
5666043|NCT00467584|19557276|P3|Overall Study|Withdrawal by Subject|1
5666044|NCT00467584|19557277|P2|Overall Study|Withdrawal by Subject|5
5666045|NCT00467584|19557278|P1|Overall Study|Withdrawal by Subject|4
5666046|NCT00467558|19557288|P2|Overall Study|Lost to Follow-up|0
5666047|NCT00467558|19557289|P1|Overall Study|Lost to Follow-up|2
5666048|NCT00467519|19557299|P2|Overall Study|Withdrawal by Subject|10
5666049|NCT00467519|19557300|P1|Overall Study|Withdrawal by Subject|4
5666050|NCT00467519|19557299|P2|Overall Study|Lost to Follow-up|9
5666051|NCT00467519|19557300|P1|Overall Study|Lost to Follow-up|2
5666052|NCT00467519|19557299|P2|Overall Study|Protocol Violation|4
5666053|NCT00467519|19557300|P1|Overall Study|Protocol Violation|8
5666054|NCT00467363|19557329|P2|Overall Study|Lost to Follow-up|70
5666055|NCT00467363|19557330|P1|Overall Study|Lost to Follow-up|80
5666056|NCT00467285|19557386|P2|Overall Study|Lost to Follow-up|4
5666057|NCT00467285|19557387|P1|Overall Study|Lost to Follow-up|4
5666058|NCT00467259|19557407|P2|Overall Study|Site Closed|1
5666059|NCT00467259|19557408|P1|Overall Study|Site Closed|2
5666060|NCT00467259|19557407|P2|Overall Study|Lost to Follow-up|34
5666061|NCT00467259|19557408|P1|Overall Study|Lost to Follow-up|14
5666062|NCT00467259|19557407|P2|Overall Study|Physician Decision|2
5666063|NCT00467259|19557408|P1|Overall Study|Physician Decision|0
5666064|NCT00467259|19557407|P2|Overall Study|Withdrawal by Subject|108
5666065|NCT00467259|19557408|P1|Overall Study|Withdrawal by Subject|34
5666066|NCT00467259|19557407|P2|Overall Study|Protocol Violation|7
5666067|NCT00467259|19557408|P1|Overall Study|Protocol Violation|1
5666068|NCT00467259|19557407|P2|Overall Study|Adverse Event|90
5666069|NCT00467259|19557408|P1|Overall Study|Adverse Event|24
5666070|NCT00467051|19557425|P1|Overall Study|Adverse Event|2
5666071|NCT00466947|19557452|P2|Study End Analysis Period|Other - Unconformity in team's treatment|1
5666072|NCT00466947|19557453|P1|Study End Analysis Period|Other - Unconformity in team's treatment|0
5666073|NCT00466947|19557452|P2|Study End Analysis Period|Other - Subject without a legal guardian|0
5666074|NCT00466947|19557453|P1|Study End Analysis Period|Other - Subject without a legal guardian|1
5666075|NCT00466947|19557452|P2|Study End Analysis Period|Other - Forbidden vaccination|10
5666076|NCT00466947|19557453|P1|Study End Analysis Period|Other - Forbidden vaccination|21
5666077|NCT00466947|19557452|P2|Study End Analysis Period|Withdrawal by Subject|1267
5666078|NCT00466947|19557453|P1|Study End Analysis Period|Withdrawal by Subject|1264
5666079|NCT00466947|19557452|P2|Study End Analysis Period|Protocol Violation|17
5666080|NCT00466947|19557453|P1|Study End Analysis Period|Protocol Violation|9
5666081|NCT00466947|19557452|P2|Study End Analysis Period|Physician Decision|29
5666082|NCT00466947|19557453|P1|Study End Analysis Period|Physician Decision|29
5666083|NCT00466947|19557452|P2|Study End Analysis Period|Lost to Follow-up|1167
5666084|NCT00466947|19557453|P1|Study End Analysis Period|Lost to Follow-up|1137
5666085|NCT00466947|19557452|P2|Study End Analysis Period|Adverse Event|43
5666086|NCT00466947|19557453|P1|Study End Analysis Period|Adverse Event|35
5666087|NCT00466947|19557452|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
5666088|NCT00466947|19557453|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
5666089|NCT00466921|19557575|P1|Follow up for a Minimum of 1 Year|Death|6
5666090|NCT00466921|19557575|P1|Completed 4 Cycles/Reached 1st Response|Other|1
5666091|NCT00466921|19557575|P1|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
5666092|NCT00466921|19557575|P1|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
5666093|NCT00466921|19557575|P1|First 3 Cycles of Treatment|Withdrawal by Subject|5
5666094|NCT00466921|19557575|P1|First 3 Cycles of Treatment|Adverse Event|2
5666095|NCT00466726|19557651|P1|Overall Study|Not evaluable for response|14
5666096|NCT00466687|19557657|P1|Overall Study|Disease progression|29
5666097|NCT00466687|19557657|P1|Overall Study|Withdrawal by Subject|1
5666098|NCT00466687|19557657|P1|Overall Study|Other complicating illness|3
5666099|NCT00466687|19557657|P1|Overall Study|Adverse Event|1
5666100|NCT00466505|19557689|P1|Overall Study|Adverse Event|4
5666101|NCT00466505|19557689|P1|Overall Study|disease progression|13
5666102|NCT00466440|19557704|P3|Overall Study|Sponsor decision|1
5666103|NCT00466440|19557705|P2|Overall Study|Sponsor decision|0
5666104|NCT00466440|19557706|P1|Overall Study|Sponsor decision|0
5666105|NCT00466440|19557704|P3|Overall Study|Withdrawal by Subject|0
5666106|NCT00466440|19557705|P2|Overall Study|Withdrawal by Subject|1
5666107|NCT00466440|19557706|P1|Overall Study|Withdrawal by Subject|0
5666108|NCT00466440|19557704|P3|Overall Study|Protocol entry criteria not met|4
5666109|NCT00466440|19557705|P2|Overall Study|Protocol entry criteria not met|0
5666110|NCT00466440|19557706|P1|Overall Study|Protocol entry criteria not met|0
5666111|NCT00466440|19557704|P3|Overall Study|Physician Decision|2
5666112|NCT00466440|19557705|P2|Overall Study|Physician Decision|1
5666113|NCT00466440|19557706|P1|Overall Study|Physician Decision|0
5666114|NCT00466440|19557704|P3|Overall Study|Lost to Follow-up|0
5666115|NCT00466440|19557705|P2|Overall Study|Lost to Follow-up|1
5666116|NCT00466440|19557706|P1|Overall Study|Lost to Follow-up|0
5666117|NCT00466440|19557704|P3|Overall Study|Progressive disease|4
5666118|NCT00466440|19557705|P2|Overall Study|Progressive disease|5
5666119|NCT00466440|19557706|P1|Overall Study|Progressive disease|13
5666120|NCT00466440|19557704|P3|Overall Study|Death|0
5666121|NCT00466440|19557705|P2|Overall Study|Death|1
5666122|NCT00466440|19557706|P1|Overall Study|Death|1
5666123|NCT00466440|19557704|P3|Overall Study|Adverse Event|1
5666124|NCT00466440|19557705|P2|Overall Study|Adverse Event|3
5666125|NCT00466440|19557706|P1|Overall Study|Adverse Event|0
5666126|NCT00466193|19557781|P2|Overall Study|Patient refused Visit 4 procedures|0
5666127|NCT00466193|19557782|P1|Overall Study|Patient refused Visit 4 procedures|1
5666128|NCT00466193|19557781|P2|Overall Study|Withdrawal by Subject|2
5666129|NCT00466193|19557782|P1|Overall Study|Withdrawal by Subject|7
5666130|NCT00466193|19557781|P2|Overall Study|Protocol Violation|1
5666131|NCT00466193|19557782|P1|Overall Study|Protocol Violation|1
5666132|NCT00466193|19557781|P2|Overall Study|Physician Decision|0
5666133|NCT00466193|19557782|P1|Overall Study|Physician Decision|1
5666134|NCT00466193|19557781|P2|Overall Study|Lost to Follow-up|4
5666135|NCT00466193|19557782|P1|Overall Study|Lost to Follow-up|2
5666136|NCT00466193|19557781|P2|Overall Study|Adverse Event|1
5666137|NCT00466193|19557782|P1|Overall Study|Adverse Event|0
5666138|NCT00466167|19557809|P3|Overall Study|Not treated|0
5666139|NCT00466167|19557810|P2|Overall Study|Not treated|0
5666140|NCT00466167|19557811|P1|Overall Study|Not treated|1
5666141|NCT00466167|19557809|P3|Overall Study|patient did not meet inclusion criteria|1
5666142|NCT00466167|19557810|P2|Overall Study|patient did not meet inclusion criteria|0
5666143|NCT00466167|19557811|P1|Overall Study|patient did not meet inclusion criteria|1
5666144|NCT00466167|19557809|P3|Overall Study|Withdrawal by Subject|6
5666145|NCT00466167|19557810|P2|Overall Study|Withdrawal by Subject|1
5666146|NCT00466167|19557811|P1|Overall Study|Withdrawal by Subject|4
5666147|NCT00466167|19557809|P3|Overall Study|Lost to Follow-up|2
5666148|NCT00466167|19557810|P2|Overall Study|Lost to Follow-up|2
5666149|NCT00466167|19557811|P1|Overall Study|Lost to Follow-up|3
5666150|NCT00466167|19557809|P3|Overall Study|Protocol Violation|2
5666151|NCT00466167|19557810|P2|Overall Study|Protocol Violation|1
5666152|NCT00466167|19557811|P1|Overall Study|Protocol Violation|1
5666153|NCT00466167|19557809|P3|Overall Study|Lack of Efficacy|3
5666154|NCT00466167|19557810|P2|Overall Study|Lack of Efficacy|0
5666155|NCT00466167|19557811|P1|Overall Study|Lack of Efficacy|2
5666156|NCT00466167|19557809|P3|Overall Study|Adverse Event|7
5666157|NCT00466167|19557810|P2|Overall Study|Adverse Event|8
5666158|NCT00466167|19557811|P1|Overall Study|Adverse Event|8
5666159|NCT00465985|19557872|P2|Part III - Open-label Treatment Period|Adverse Event|0
5666160|NCT00465985|19557873|P1|Part III - Open-label Treatment Period|Adverse Event|1
5666161|NCT00465985|19557872|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
5666162|NCT00465985|19557873|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
5666163|NCT00465985|19557872|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
5666164|NCT00465985|19557873|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
5666165|NCT00465985|19557872|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
5666166|NCT00465985|19557873|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
5666167|NCT00465972|19557896|P2|Overall Study|Withdrawal by Subject|1
5666168|NCT00465972|19557897|P1|Overall Study|Withdrawal by Subject|2
5666169|NCT00465894|19557907|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
5666170|NCT00465894|19557908|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
5666171|NCT00465894|19557907|P2|Treatment For 12 Weeks|Family Issues|1
5666172|NCT00465894|19557908|P1|Treatment For 12 Weeks|Family Issues|1
5666173|NCT00465894|19557907|P2|Treatment For 12 Weeks|Lost to Follow-up|1
5666174|NCT00465894|19557908|P1|Treatment For 12 Weeks|Lost to Follow-up|4
5666175|NCT00465816|19557941|P3|Overall Study|Lost to Follow-up|2
5666176|NCT00465816|19557942|P2|Overall Study|Lost to Follow-up|0
5666177|NCT00465816|19557943|P1|Overall Study|Lost to Follow-up|0
5666178|NCT00465738|19558006|P2|Overall Study|Other|5
5666179|NCT00465738|19558007|P1|Overall Study|Other|2
5666180|NCT00465738|19558006|P2|Overall Study|Withdrawal by Subject|0
5666181|NCT00465738|19558007|P1|Overall Study|Withdrawal by Subject|2
5666182|NCT00465738|19558006|P2|Overall Study|Adverse Event|1
5666183|NCT00465738|19558007|P1|Overall Study|Adverse Event|0
5666184|NCT00465738|19558006|P2|Overall Study|Lost to Follow-up|0
5666185|NCT00465738|19558007|P1|Overall Study|Lost to Follow-up|2
5666186|NCT00465647|19558101|P4|Overall Study|"The other reasons included loss of IV"|2
5666187|NCT00465647|19558102|P3|Overall Study|"The other reasons included loss of IV"|3
5666188|NCT00465647|19558103|P2|Overall Study|"The other reasons included loss of IV"|4
5666189|NCT00465647|19558104|P1|Overall Study|"The other reasons included loss of IV"|8
5666190|NCT00465647|19558101|P4|Overall Study|Withdrawal by Subject|7
5666191|NCT00465647|19558102|P3|Overall Study|Withdrawal by Subject|2
5666192|NCT00465647|19558103|P2|Overall Study|Withdrawal by Subject|2
5666193|NCT00465647|19558104|P1|Overall Study|Withdrawal by Subject|1
5666194|NCT00465647|19558101|P4|Overall Study|Adverse Event|2
5666195|NCT00465647|19558102|P3|Overall Study|Adverse Event|3
5666196|NCT00465647|19558103|P2|Overall Study|Adverse Event|0
5666197|NCT00465647|19558104|P1|Overall Study|Adverse Event|2
5666198|NCT00465647|19558101|P4|Overall Study|Administrative|2
5666199|NCT00465647|19558102|P3|Overall Study|Administrative|3
5666200|NCT00465647|19558103|P2|Overall Study|Administrative|2
5666201|NCT00465647|19558104|P1|Overall Study|Administrative|2
5666202|NCT00465569|19558152|P2|Overall Study|persistent eczema during dose escalation|0
5666203|NCT00465569|19558153|P1|Overall Study|persistent eczema during dose escalation|1
5666204|NCT00465361|19558176|P1|Baseline Assessment|Personal Issues/Scheduling|4
5666205|NCT00465270|19558182|P2|Overall Study|Investigator request|4
5666206|NCT00465270|19558183|P1|Overall Study|Investigator request|3
5666207|NCT00465270|19558182|P2|Overall Study|Lost to Follow-up|67
5666208|NCT00465270|19558183|P1|Overall Study|Lost to Follow-up|60
5666209|NCT00465270|19558182|P2|Overall Study|Withdrawal by Subject|78
5666210|NCT00465270|19558183|P1|Overall Study|Withdrawal by Subject|34
5666211|NCT00465270|19558182|P2|Overall Study|Death|11
5666212|NCT00465270|19558183|P1|Overall Study|Death|7
5666213|NCT00465179|19558192|P1|Overall Study|Progression of Disease|47
5666214|NCT00465179|19558192|P1|Overall Study|Withdrawal by Subject|2
5666215|NCT00465179|19558192|P1|Overall Study|Adverse Event|4
5666216|NCT00465101|19558198|P1|Overall Study|Withdrew consent prior to procedure|3
5666217|NCT00465101|19558198|P1|Overall Study|Physician Decision|1
5666218|NCT00465101|19558198|P1|Overall Study|Withdrawal by Subject|25
5666219|NCT00465101|19558198|P1|Overall Study|Death|3
5666220|NCT00465101|19558198|P1|Overall Study|Unable to obtain IRB approval|1
5666221|NCT00465101|19558198|P1|Overall Study|Site closed due to IRB expiration|1
5666222|NCT00465101|19558198|P1|Overall Study|Patient postponed procedure|1
5666223|NCT00465101|19558198|P1|Overall Study|Pt. Insurance not accepted at center|2
5666224|NCT00465101|19558198|P1|Overall Study|Other|6
5666225|NCT00465101|19558198|P1|Overall Study|Lost to Follow-up|5
5666226|NCT00465101|19558198|P1|Overall Study|Did not meet study criteria|4
5666227|NCT00465101|19558198|P1|Overall Study|Change in health precluded follow up|4
5666228|NCT00465101|19558198|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
5666229|NCT00464945|19558268|P2|Toddler Dose|Lost to Follow-up|1
5666230|NCT00464945|19558269|P1|Toddler Dose|Lost to Follow-up|0
5666231|NCT00464945|19558268|P2|After Infant Series|Withdrawal by Subject|2
5666232|NCT00464945|19558269|P1|After Infant Series|Withdrawal by Subject|0
5666233|NCT00464945|19558268|P2|Infant Series|Lost to Follow-up|0
5666234|NCT00464945|19558269|P1|Infant Series|Lost to Follow-up|1
5666235|NCT00464945|19558268|P2|Infant Series|Protocol Violation|0
5666236|NCT00464945|19558269|P1|Infant Series|Protocol Violation|1
5666237|NCT00464945|19558268|P2|Infant Series|Withdrawal by parent/guardian request|1
5666238|NCT00464945|19558269|P1|Infant Series|Withdrawal by parent/guardian request|2
5666239|NCT00464815|19558299|P2|Overall Study|Withdrawal by Subject|3
5666240|NCT00464815|19558300|P1|Overall Study|Withdrawal by Subject|6
5666241|NCT00464737|19558333|P3|Overall Study|Other: Subject's disability per sponsor|1
5666242|NCT00464737|19558334|P2|Overall Study|Other: Subject's disability per sponsor|0
5666243|NCT00464737|19558335|P1|Overall Study|Other: Subject's disability per sponsor|0
5666244|NCT00464737|19558333|P3|Overall Study|Other: Personal family reasons|1
5666245|NCT00464737|19558334|P2|Overall Study|Other: Personal family reasons|0
5666246|NCT00464737|19558335|P1|Overall Study|Other: Personal family reasons|0
5666247|NCT00464737|19558333|P3|Overall Study|Other: Study demands too great|0
5666248|NCT00464737|19558334|P2|Overall Study|Other: Study demands too great|1
5666249|NCT00464737|19558335|P1|Overall Study|Other: Study demands too great|0
5666250|NCT00464737|19558333|P3|Overall Study|Other: Subject left town; family illness|0
5666251|NCT00464737|19558334|P2|Overall Study|Other: Subject left town; family illness|0
5666252|NCT00464737|19558335|P1|Overall Study|Other: Subject left town; family illness|1
5666253|NCT00464737|19558333|P3|Overall Study|Other: Subject's schedule doesn't permit|0
5666254|NCT00464737|19558334|P2|Overall Study|Other: Subject's schedule doesn't permit|0
5666255|NCT00464737|19558335|P1|Overall Study|Other: Subject's schedule doesn't permit|1
5666256|NCT00464737|19558333|P3|Overall Study|Lost to Follow-up|5
5666257|NCT00464737|19558334|P2|Overall Study|Lost to Follow-up|2
5666258|NCT00464737|19558335|P1|Overall Study|Lost to Follow-up|5
5666259|NCT00464737|19558333|P3|Overall Study|Non-compliance|1
5666260|NCT00464737|19558334|P2|Overall Study|Non-compliance|1
5666261|NCT00464737|19558335|P1|Overall Study|Non-compliance|0
5666262|NCT00464737|19558333|P3|Overall Study|Protocol Violation|5
5666263|NCT00464737|19558334|P2|Overall Study|Protocol Violation|1
5666264|NCT00464737|19558335|P1|Overall Study|Protocol Violation|1
5666265|NCT00464737|19558333|P3|Overall Study|Withdrawal by Subject|5
5666266|NCT00464737|19558334|P2|Overall Study|Withdrawal by Subject|3
5666267|NCT00464737|19558335|P1|Overall Study|Withdrawal by Subject|5
5666268|NCT00464737|19558333|P3|Overall Study|Lack of Efficacy|4
5666269|NCT00464737|19558334|P2|Overall Study|Lack of Efficacy|7
5666270|NCT00464737|19558335|P1|Overall Study|Lack of Efficacy|7
5666271|NCT00464737|19558333|P3|Overall Study|Adverse Event|33
5666272|NCT00464737|19558334|P2|Overall Study|Adverse Event|17
5666273|NCT00464737|19558335|P1|Overall Study|Adverse Event|12
5666274|NCT00464672|19558415|P6|Overall Study|Lost to Follow-up|0
5666275|NCT00464672|19558416|P5|Overall Study|Lost to Follow-up|1
5666276|NCT00464672|19558417|P4|Overall Study|Lost to Follow-up|0
5666277|NCT00464672|19558418|P3|Overall Study|Lost to Follow-up|0
5666278|NCT00464672|19558419|P2|Overall Study|Lost to Follow-up|10
5666279|NCT00464672|19558420|P1|Overall Study|Lost to Follow-up|25
5666280|NCT00464672|19558415|P6|Overall Study|withdrawal of consent|4
5666281|NCT00464672|19558416|P5|Overall Study|withdrawal of consent|9
5666282|NCT00464672|19558417|P4|Overall Study|withdrawal of consent|1
5666283|NCT00464672|19558418|P3|Overall Study|withdrawal of consent|0
5666284|NCT00464672|19558419|P2|Overall Study|withdrawal of consent|0
5666285|NCT00464672|19558420|P1|Overall Study|withdrawal of consent|0
5666286|NCT00464620|19558499|P3|Overall Study|Use of prohibited concomitant medication|2
5666287|NCT00464620|19558500|P2|Overall Study|Use of prohibited concomitant medication|0
5666288|NCT00464620|19558501|P1|Overall Study|Use of prohibited concomitant medication|0
5666289|NCT00464620|19558499|P3|Overall Study|Ineligible sarcoma subtype|2
5666290|NCT00464620|19558500|P2|Overall Study|Ineligible sarcoma subtype|2
5666291|NCT00464620|19558501|P1|Overall Study|Ineligible sarcoma subtype|0
5666292|NCT00464620|19558499|P3|Overall Study|Withdrawal by Subject|3
5666293|NCT00464620|19558500|P2|Overall Study|Withdrawal by Subject|0
5666294|NCT00464620|19558501|P1|Overall Study|Withdrawal by Subject|1
5666295|NCT00464620|19558499|P3|Overall Study|Physician Decision|0
5666296|NCT00464620|19558500|P2|Overall Study|Physician Decision|0
5666297|NCT00464620|19558501|P1|Overall Study|Physician Decision|1
5666298|NCT00464568|19558528|P1|Overall Study|Adverse Event|2
5666299|NCT00464542|19558601|P1|Pre-treatment|Withdrawal by Subject|2
5666300|NCT00464490|19558608|P2|Overall Study|Physician Decision|11
5666301|NCT00464490|19558609|P1|Overall Study|Physician Decision|11
5666302|NCT00464334|19558656|P11|Overall Study|Withdrawal by Subject|0
5666303|NCT00464334|19558657|P10|Overall Study|Withdrawal by Subject|0
5666304|NCT00464334|19558658|P9|Overall Study|Withdrawal by Subject|3
5666305|NCT00464334|19558659|P8|Overall Study|Withdrawal by Subject|1
5666306|NCT00464334|19558660|P7|Overall Study|Withdrawal by Subject|2
5666307|NCT00464334|19558661|P6|Overall Study|Withdrawal by Subject|2
5666308|NCT00464334|19558662|P5|Overall Study|Withdrawal by Subject|2
5666309|NCT00464334|19558663|P4|Overall Study|Withdrawal by Subject|2
5666310|NCT00464334|19558664|P3|Overall Study|Withdrawal by Subject|4
5666311|NCT00464334|19558665|P2|Overall Study|Withdrawal by Subject|7
5666312|NCT00464334|19558666|P1|Overall Study|Withdrawal by Subject|1
5666313|NCT00464334|19558656|P11|Overall Study|Study Terminated by Sponsor|0
5666314|NCT00464334|19558657|P10|Overall Study|Study Terminated by Sponsor|0
5666315|NCT00464334|19558658|P9|Overall Study|Study Terminated by Sponsor|0
5666316|NCT00464334|19558659|P8|Overall Study|Study Terminated by Sponsor|0
5666317|NCT00464334|19558660|P7|Overall Study|Study Terminated by Sponsor|0
5666318|NCT00464334|19558661|P6|Overall Study|Study Terminated by Sponsor|0
5666319|NCT00464334|19558662|P5|Overall Study|Study Terminated by Sponsor|0
5666320|NCT00464334|19558663|P4|Overall Study|Study Terminated by Sponsor|1
5666321|NCT00464334|19558664|P3|Overall Study|Study Terminated by Sponsor|0
5666322|NCT00464334|19558665|P2|Overall Study|Study Terminated by Sponsor|0
5666323|NCT00464334|19558666|P1|Overall Study|Study Terminated by Sponsor|0
5666324|NCT00464334|19558656|P11|Overall Study|Progressive Disease|0
5666325|NCT00464334|19558657|P10|Overall Study|Progressive Disease|0
5666326|NCT00464334|19558658|P9|Overall Study|Progressive Disease|1
5666327|NCT00464334|19558659|P8|Overall Study|Progressive Disease|0
5666328|NCT00464334|19558660|P7|Overall Study|Progressive Disease|0
5666329|NCT00464334|19558661|P6|Overall Study|Progressive Disease|1
5666330|NCT00464334|19558662|P5|Overall Study|Progressive Disease|0
5666331|NCT00464334|19558663|P4|Overall Study|Progressive Disease|0
5666332|NCT00464334|19558664|P3|Overall Study|Progressive Disease|0
5666333|NCT00464334|19558665|P2|Overall Study|Progressive Disease|0
5666334|NCT00464334|19558666|P1|Overall Study|Progressive Disease|0
5666335|NCT00464334|19558656|P11|Overall Study|Lost to Follow-up|2
5666336|NCT00464334|19558657|P10|Overall Study|Lost to Follow-up|0
5666337|NCT00464334|19558658|P9|Overall Study|Lost to Follow-up|0
5666338|NCT00464334|19558659|P8|Overall Study|Lost to Follow-up|0
5666339|NCT00464334|19558660|P7|Overall Study|Lost to Follow-up|1
5666340|NCT00464334|19558661|P6|Overall Study|Lost to Follow-up|0
5666341|NCT00464334|19558662|P5|Overall Study|Lost to Follow-up|1
5666342|NCT00464334|19558663|P4|Overall Study|Lost to Follow-up|0
5666343|NCT00464334|19558664|P3|Overall Study|Lost to Follow-up|1
5666344|NCT00464334|19558665|P2|Overall Study|Lost to Follow-up|0
5666345|NCT00464334|19558666|P1|Overall Study|Lost to Follow-up|0
5666346|NCT00464334|19558656|P11|Overall Study|Lack of Efficacy|0
5666347|NCT00464334|19558657|P10|Overall Study|Lack of Efficacy|0
5666348|NCT00464334|19558658|P9|Overall Study|Lack of Efficacy|0
5666349|NCT00464334|19558659|P8|Overall Study|Lack of Efficacy|0
5666350|NCT00464334|19558660|P7|Overall Study|Lack of Efficacy|0
5666351|NCT00464334|19558661|P6|Overall Study|Lack of Efficacy|0
5666352|NCT00464334|19558662|P5|Overall Study|Lack of Efficacy|0
5666353|NCT00464334|19558663|P4|Overall Study|Lack of Efficacy|0
5666354|NCT00464334|19558664|P3|Overall Study|Lack of Efficacy|0
5666355|NCT00464334|19558665|P2|Overall Study|Lack of Efficacy|1
5666356|NCT00464334|19558666|P1|Overall Study|Lack of Efficacy|0
5666357|NCT00464334|19558656|P11|Overall Study|Adverse Event|2
5666358|NCT00464334|19558657|P10|Overall Study|Adverse Event|1
5666359|NCT00464334|19558658|P9|Overall Study|Adverse Event|2
5666360|NCT00464334|19558659|P8|Overall Study|Adverse Event|0
5666361|NCT00464334|19558660|P7|Overall Study|Adverse Event|0
5666362|NCT00464334|19558661|P6|Overall Study|Adverse Event|1
5666363|NCT00464334|19558662|P5|Overall Study|Adverse Event|1
5666364|NCT00464334|19558663|P4|Overall Study|Adverse Event|1
5666365|NCT00464334|19558664|P3|Overall Study|Adverse Event|0
5666366|NCT00464334|19558665|P2|Overall Study|Adverse Event|0
5666367|NCT00464334|19558666|P1|Overall Study|Adverse Event|0
5666368|NCT00464308|19558726|P3|Overall Study|Physician Decision|0
5666369|NCT00464308|19558727|P2|Overall Study|Physician Decision|0
5666370|NCT00464308|19558728|P1|Overall Study|Physician Decision|1
5666371|NCT00464308|19558726|P3|Overall Study|Patient discontinued and other reasons|23
5666372|NCT00464308|19558727|P2|Overall Study|Patient discontinued and other reasons|17
5666373|NCT00464308|19558728|P1|Overall Study|Patient discontinued and other reasons|17
5666374|NCT00464308|19558726|P3|Overall Study|Lost to Follow-up|20
5666375|NCT00464308|19558727|P2|Overall Study|Lost to Follow-up|19
5666376|NCT00464308|19558728|P1|Overall Study|Lost to Follow-up|29
5666377|NCT00464308|19558726|P3|Overall Study|Adverse Event|16
5666378|NCT00464308|19558727|P2|Overall Study|Adverse Event|27
5666379|NCT00464308|19558728|P1|Overall Study|Adverse Event|22
5666380|NCT00464269|19558758|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5666381|NCT00464269|19558759|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
5666382|NCT00464269|19558760|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5666383|NCT00464269|19558761|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
5666384|NCT00464269|19558758|P4|Overall Study|AE, non-serious non-fatal|4
5666385|NCT00464269|19558759|P3|Overall Study|AE, non-serious non-fatal|3
5666386|NCT00464269|19558760|P2|Overall Study|AE, non-serious non-fatal|8
5666387|NCT00464269|19558761|P1|Overall Study|AE, non-serious non-fatal|2
5666388|NCT00464269|19558758|P4|Overall Study|SAE, non-fatal|1
5666389|NCT00464269|19558759|P3|Overall Study|SAE, non-fatal|0
5666390|NCT00464269|19558760|P2|Overall Study|SAE, non-fatal|0
5666391|NCT00464269|19558761|P1|Overall Study|SAE, non-fatal|0
5666392|NCT00464269|19558758|P4|Overall Study|AE, serious fatal|1
5666393|NCT00464269|19558759|P3|Overall Study|AE, serious fatal|1
5666394|NCT00464269|19558760|P2|Overall Study|AE, serious fatal|0
5666395|NCT00464269|19558761|P1|Overall Study|AE, serious fatal|0
5666396|NCT00464269|19558758|P4|Overall Study|Other reason|1
5666397|NCT00464269|19558759|P3|Overall Study|Other reason|1
5666398|NCT00464269|19558760|P2|Overall Study|Other reason|3
5666399|NCT00464269|19558761|P1|Overall Study|Other reason|3
5666400|NCT00464269|19558758|P4|Overall Study|Withdrawal by Subject|1
5666401|NCT00464269|19558759|P3|Overall Study|Withdrawal by Subject|1
5666402|NCT00464269|19558760|P2|Overall Study|Withdrawal by Subject|2
5666403|NCT00464269|19558761|P1|Overall Study|Withdrawal by Subject|0
5666404|NCT00464269|19558758|P4|Overall Study|Lost to Follow-up|1
5666405|NCT00464269|19558759|P3|Overall Study|Lost to Follow-up|0
5666406|NCT00464269|19558760|P2|Overall Study|Lost to Follow-up|4
5666407|NCT00464269|19558761|P1|Overall Study|Lost to Follow-up|0
5666408|NCT00464269|19558758|P4|Overall Study|Lack of Efficacy|0
5666409|NCT00464269|19558759|P3|Overall Study|Lack of Efficacy|0
5666410|NCT00464269|19558760|P2|Overall Study|Lack of Efficacy|0
5666411|NCT00464269|19558761|P1|Overall Study|Lack of Efficacy|1
5666412|NCT00464087|19558899|P3|Overall Study|No PCI per inclusion criteria|29
5666413|NCT00464087|19558900|P2|Overall Study|No PCI per inclusion criteria|0
5666414|NCT00464087|19558901|P1|Overall Study|No PCI per inclusion criteria|0
5666415|NCT00463866|19558919|P2|Overall Study|Other|22
5666416|NCT00463866|19558920|P1|Overall Study|Other|22
5666417|NCT00463866|19558919|P2|Overall Study|Mis-Randomization of subject|1
5666418|NCT00463866|19558920|P1|Overall Study|Mis-Randomization of subject|0
5666419|NCT00463866|19558919|P2|Overall Study|Safety Reason|3
5666420|NCT00463866|19558920|P1|Overall Study|Safety Reason|1
5666421|NCT00463866|19558919|P2|Overall Study|Severe Non-Compliance to Protocol|21
5666422|NCT00463866|19558920|P1|Overall Study|Severe Non-Compliance to Protocol|25
5666423|NCT00463866|19558919|P2|Overall Study|Incorrect Enrolment|66
5666424|NCT00463866|19558920|P1|Overall Study|Incorrect Enrolment|64
5666425|NCT00463866|19558919|P2|Overall Study|Lost to Follow-up|55
5666426|NCT00463866|19558920|P1|Overall Study|Lost to Follow-up|46
5666427|NCT00463866|19558919|P2|Overall Study|Withdrawal by Subject|79
5666428|NCT00463866|19558920|P1|Overall Study|Withdrawal by Subject|81
5666429|NCT00463866|19558919|P2|Overall Study|Adverse Event|93
5666430|NCT00463866|19558920|P1|Overall Study|Adverse Event|70
5666431|NCT00463840|19558940|P1|Overall Study|Adverse Event|3
5666432|NCT00463840|19558940|P1|Overall Study|Withdrawal by Subject|2
5666433|NCT00463840|19558940|P1|Overall Study|Disease progression|7
5666434|NCT00463801|19558945|P1|Overall Study|No longer require therapy|1
5666435|NCT00463801|19558945|P1|Overall Study|Lost to Follow-up|5
5666436|NCT00463801|19558945|P1|Overall Study|Adverse Event|4
5666437|NCT00463801|19558945|P1|Overall Study|Lack of Efficacy|2
5666438|NCT00463801|19558945|P1|Overall Study|Protocol Violation|1
5666439|NCT00463788|19558951|P2|Overall Study|Randomized but not treated|1
5666440|NCT00463788|19558952|P1|Overall Study|Randomized but not treated|1
5666441|NCT00463788|19558951|P2|Overall Study|Other|0
5666442|NCT00463788|19558952|P1|Overall Study|Other|3
5666443|NCT00463788|19558951|P2|Overall Study|Protocol Violation|1
5666444|NCT00463788|19558952|P1|Overall Study|Protocol Violation|0
5666445|NCT00463788|19558951|P2|Overall Study|Lost to Follow-up|0
5666446|NCT00463788|19558952|P1|Overall Study|Lost to Follow-up|1
5666447|NCT00463788|19558951|P2|Overall Study|Symptomatic Deterioration|3
5666448|NCT00463788|19558952|P1|Overall Study|Symptomatic Deterioration|2
5666449|NCT00463788|19558951|P2|Overall Study|Death|3
5666450|NCT00463788|19558952|P1|Overall Study|Death|4
5666451|NCT00463788|19558951|P2|Overall Study|Withdrawal by Subject|2
5666452|NCT00463788|19558952|P1|Overall Study|Withdrawal by Subject|6
5666453|NCT00463788|19558951|P2|Overall Study|Adverse Event|2
5666454|NCT00463788|19558952|P1|Overall Study|Adverse Event|6
5666455|NCT00463788|19558951|P2|Overall Study|Progressive Disease|42
5666456|NCT00463788|19558952|P1|Overall Study|Progressive Disease|86
5666457|NCT00463684|19558967|P1|Overall Study|Lost to Follow-up|3
5666458|NCT00463684|19558967|P1|Overall Study|Withdrawal by Subject|1
5666459|NCT00463606|19558985|P3|Overall Study|Protocol Violation|1
5666460|NCT00463606|19558986|P2|Overall Study|Protocol Violation|0
5666461|NCT00463606|19558987|P1|Overall Study|Protocol Violation|0
5666462|NCT00463606|19558985|P3|Overall Study|Participation in another ABT-335 trial|0
5666463|NCT00463606|19558986|P2|Overall Study|Participation in another ABT-335 trial|0
5666464|NCT00463606|19558987|P1|Overall Study|Participation in another ABT-335 trial|1
5666465|NCT00463606|19558985|P3|Overall Study|Patient randomized in error|0
5666466|NCT00463606|19558986|P2|Overall Study|Patient randomized in error|0
5666467|NCT00463606|19558987|P1|Overall Study|Patient randomized in error|1
5666468|NCT00463606|19558985|P3|Overall Study|Coordinator error|0
5666469|NCT00463606|19558986|P2|Overall Study|Coordinator error|0
5666470|NCT00463606|19558987|P1|Overall Study|Coordinator error|1
5666471|NCT00463606|19558985|P3|Overall Study|Exclusion criteria violation|0
5666472|NCT00463606|19558986|P2|Overall Study|Exclusion criteria violation|0
5666473|NCT00463606|19558987|P1|Overall Study|Exclusion criteria violation|2
5666474|NCT00463606|19558985|P3|Overall Study|Sponsor request|0
5666475|NCT00463606|19558986|P2|Overall Study|Sponsor request|1
5666476|NCT00463606|19558987|P1|Overall Study|Sponsor request|0
5666477|NCT00463606|19558985|P3|Overall Study|Physician Decision|0
5666478|NCT00463606|19558986|P2|Overall Study|Physician Decision|1
5666479|NCT00463606|19558987|P1|Overall Study|Physician Decision|0
5666480|NCT00463606|19558985|P3|Overall Study|Subject moved out of town|0
5666481|NCT00463606|19558986|P2|Overall Study|Subject moved out of town|0
5666482|NCT00463606|19558987|P1|Overall Study|Subject moved out of town|1
5666483|NCT00463606|19558985|P3|Overall Study|Subject noncompliance|0
5666484|NCT00463606|19558986|P2|Overall Study|Subject noncompliance|1
5666485|NCT00463606|19558987|P1|Overall Study|Subject noncompliance|1
5666486|NCT00463606|19558985|P3|Overall Study|Lost to Follow-up|3
5666487|NCT00463606|19558986|P2|Overall Study|Lost to Follow-up|2
5666488|NCT00463606|19558987|P1|Overall Study|Lost to Follow-up|2
5666489|NCT00463606|19558985|P3|Overall Study|Withdrawal by Subject|5
5666490|NCT00463606|19558986|P2|Overall Study|Withdrawal by Subject|11
5666491|NCT00463606|19558987|P1|Overall Study|Withdrawal by Subject|11
5666492|NCT00463606|19558985|P3|Overall Study|Adverse Event|11
5666493|NCT00463606|19558986|P2|Overall Study|Adverse Event|18
5666494|NCT00463606|19558987|P1|Overall Study|Adverse Event|21
5666495|NCT00463580|19559012|P2|Overall Study|Medical/psychiatric complications|2
5666496|NCT00463580|19559013|P1|Overall Study|Medical/psychiatric complications|0
5666497|NCT00463580|19559012|P2|Overall Study|Schedule conflict|0
5666498|NCT00463580|19559013|P1|Overall Study|Schedule conflict|2
5666499|NCT00463580|19559012|P2|Overall Study|Lost to Follow-up|0
5666500|NCT00463580|19559013|P1|Overall Study|Lost to Follow-up|1
5666501|NCT00463567|19559046|P7|Overall Study|Death|0
5666502|NCT00463567|19559047|P6|Overall Study|Death|0
5666503|NCT00463567|19559048|P5|Overall Study|Death|0
5666504|NCT00463567|19559049|P4|Overall Study|Death|0
5666505|NCT00463567|19559050|P3|Overall Study|Death|2
5666506|NCT00463567|19559051|P2|Overall Study|Death|0
5666507|NCT00463567|19559052|P1|Overall Study|Death|1
5666508|NCT00463567|19559046|P7|Overall Study|Abnormal test procedure result(s)|0
5666509|NCT00463567|19559047|P6|Overall Study|Abnormal test procedure result(s)|2
5666510|NCT00463567|19559048|P5|Overall Study|Abnormal test procedure result(s)|0
5666511|NCT00463567|19559049|P4|Overall Study|Abnormal test procedure result(s)|2
5666512|NCT00463567|19559050|P3|Overall Study|Abnormal test procedure result(s)|6
5666513|NCT00463567|19559051|P2|Overall Study|Abnormal test procedure result(s)|1
5666514|NCT00463567|19559052|P1|Overall Study|Abnormal test procedure result(s)|1
5666515|NCT00463567|19559046|P7|Overall Study|Abnormal lab value(s)|0
5666516|NCT00463567|19559047|P6|Overall Study|Abnormal lab value(s)|0
5666517|NCT00463567|19559048|P5|Overall Study|Abnormal lab value(s)|1
5666518|NCT00463567|19559049|P4|Overall Study|Abnormal lab value(s)|1
5666519|NCT00463567|19559050|P3|Overall Study|Abnormal lab value(s)|2
5666520|NCT00463567|19559051|P2|Overall Study|Abnormal lab value(s)|1
5666521|NCT00463567|19559052|P1|Overall Study|Abnormal lab value(s)|1
5666522|NCT00463567|19559046|P7|Overall Study|Lack of Efficacy|1
5666523|NCT00463567|19559047|P6|Overall Study|Lack of Efficacy|0
5666524|NCT00463567|19559048|P5|Overall Study|Lack of Efficacy|1
5666525|NCT00463567|19559049|P4|Overall Study|Lack of Efficacy|17
5666526|NCT00463567|19559050|P3|Overall Study|Lack of Efficacy|9
5666527|NCT00463567|19559051|P2|Overall Study|Lack of Efficacy|9
5666528|NCT00463567|19559052|P1|Overall Study|Lack of Efficacy|4
5666529|NCT00463567|19559046|P7|Overall Study|Administrative problems|2
5666530|NCT00463567|19559047|P6|Overall Study|Administrative problems|2
5666531|NCT00463567|19559048|P5|Overall Study|Administrative problems|3
5666532|NCT00463567|19559049|P4|Overall Study|Administrative problems|9
5666533|NCT00463567|19559050|P3|Overall Study|Administrative problems|6
5666534|NCT00463567|19559051|P2|Overall Study|Administrative problems|3
5666535|NCT00463567|19559052|P1|Overall Study|Administrative problems|5
5666536|NCT00463567|19559046|P7|Overall Study|Lost to Follow-up|1
5666537|NCT00463567|19559047|P6|Overall Study|Lost to Follow-up|1
5666538|NCT00463567|19559048|P5|Overall Study|Lost to Follow-up|1
5666539|NCT00463567|19559049|P4|Overall Study|Lost to Follow-up|8
5666540|NCT00463567|19559050|P3|Overall Study|Lost to Follow-up|13
5666541|NCT00463567|19559051|P2|Overall Study|Lost to Follow-up|6
5666542|NCT00463567|19559052|P1|Overall Study|Lost to Follow-up|12
5666543|NCT00463567|19559046|P7|Overall Study|Protocol Deviation|2
5666544|NCT00463567|19559047|P6|Overall Study|Protocol Deviation|1
5666545|NCT00463567|19559048|P5|Overall Study|Protocol Deviation|1
5666546|NCT00463567|19559049|P4|Overall Study|Protocol Deviation|11
5666547|NCT00463567|19559050|P3|Overall Study|Protocol Deviation|14
5666548|NCT00463567|19559051|P2|Overall Study|Protocol Deviation|9
5666549|NCT00463567|19559052|P1|Overall Study|Protocol Deviation|13
5666550|NCT00463567|19559046|P7|Overall Study|Withdrawal by Subject|1
5666551|NCT00463567|19559047|P6|Overall Study|Withdrawal by Subject|5
5666552|NCT00463567|19559048|P5|Overall Study|Withdrawal by Subject|6
5666553|NCT00463567|19559049|P4|Overall Study|Withdrawal by Subject|37
5666554|NCT00463567|19559050|P3|Overall Study|Withdrawal by Subject|20
5666555|NCT00463567|19559051|P2|Overall Study|Withdrawal by Subject|22
5666556|NCT00463567|19559052|P1|Overall Study|Withdrawal by Subject|29
5666557|NCT00463567|19559046|P7|Overall Study|Adverse Event|4
5666558|NCT00463567|19559047|P6|Overall Study|Adverse Event|10
5666559|NCT00463567|19559048|P5|Overall Study|Adverse Event|10
5666560|NCT00463567|19559049|P4|Overall Study|Adverse Event|46
5666561|NCT00463567|19559050|P3|Overall Study|Adverse Event|17
5666562|NCT00463567|19559051|P2|Overall Study|Adverse Event|26
5666563|NCT00463567|19559052|P1|Overall Study|Adverse Event|29
5666564|NCT00463476|19559085|P2|Overall Study|Lost to Follow-up|1
5666565|NCT00463476|19559086|P1|Overall Study|Lost to Follow-up|1
5666566|NCT00463476|19559085|P2|Overall Study|Withdrawal by Subject|2
5666567|NCT00463476|19559086|P1|Overall Study|Withdrawal by Subject|1
5666568|NCT00463385|19559175|P4|Overall Study|1 participant received commercial drug|0
5666569|NCT00463385|19559176|P3|Overall Study|1 participant received commercial drug|0
5666570|NCT00463385|19559177|P2|Overall Study|1 participant received commercial drug|1
5666571|NCT00463385|19559178|P1|Overall Study|1 participant received commercial drug|0
5666572|NCT00463385|19559175|P4|Overall Study|Missing|2
5666573|NCT00463385|19559176|P3|Overall Study|Missing|0
5666574|NCT00463385|19559177|P2|Overall Study|Missing|0
5666575|NCT00463385|19559178|P1|Overall Study|Missing|2
5666576|NCT00463385|19559175|P4|Overall Study|Death|0
5666577|NCT00463385|19559176|P3|Overall Study|Death|2
5666578|NCT00463385|19559177|P2|Overall Study|Death|1
5666579|NCT00463385|19559178|P1|Overall Study|Death|2
5666580|NCT00463385|19559175|P4|Overall Study|Lost to Follow-up|1
5666581|NCT00463385|19559176|P3|Overall Study|Lost to Follow-up|0
5666582|NCT00463385|19559177|P2|Overall Study|Lost to Follow-up|0
5666583|NCT00463385|19559178|P1|Overall Study|Lost to Follow-up|0
5666584|NCT00463385|19559175|P4|Overall Study|Withdrawal by Subject|4
5666585|NCT00463385|19559176|P3|Overall Study|Withdrawal by Subject|3
5666586|NCT00463385|19559177|P2|Overall Study|Withdrawal by Subject|3
5666587|NCT00463385|19559178|P1|Overall Study|Withdrawal by Subject|3
5666588|NCT00463385|19559175|P4|Overall Study|Lack of Efficacy|9
5666589|NCT00463385|19559176|P3|Overall Study|Lack of Efficacy|7
5666590|NCT00463385|19559177|P2|Overall Study|Lack of Efficacy|6
5666591|NCT00463385|19559178|P1|Overall Study|Lack of Efficacy|6
5666592|NCT00463385|19559175|P4|Overall Study|Adverse Event|2
5666593|NCT00463385|19559176|P3|Overall Study|Adverse Event|4
5666594|NCT00463385|19559177|P2|Overall Study|Adverse Event|8
5666595|NCT00463385|19559178|P1|Overall Study|Adverse Event|5
5666596|NCT00463385|19559175|P4|Overall Study|Other|4
5666597|NCT00463385|19559176|P3|Overall Study|Other|6
5666598|NCT00463385|19559177|P2|Overall Study|Other|3
5666599|NCT00463385|19559178|P1|Overall Study|Other|4
5666600|NCT00463346|19559230|P2|Overall Study|Withdrawal by Subject|3
5666601|NCT00463346|19559231|P1|Overall Study|Withdrawal by Subject|3
5666602|NCT00463229|19559241|P2|Overall Study|Death|3
5666603|NCT00463229|19559242|P1|Overall Study|Death|4
5666604|NCT00463229|19559241|P2|Overall Study|Lost to Follow-up|7
5666605|NCT00463229|19559242|P1|Overall Study|Lost to Follow-up|5
5666606|NCT00463060|19559262|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
5666607|NCT00463060|19559262|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
5666608|NCT00463047|19559276|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
5666609|NCT00463047|19559277|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
5666610|NCT00463047|19559276|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
5666611|NCT00463047|19559277|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
5666612|NCT00463047|19559276|P2|Double-Blind Treatment Period 2|Adverse Event|1
5666613|NCT00463047|19559277|P1|Double-Blind Treatment Period 2|Adverse Event|0
5666614|NCT00463047|19559276|P2|Double-Blind Treatment Period 1|Other|0
5666615|NCT00463047|19559277|P1|Double-Blind Treatment Period 1|Other|1
5666616|NCT00463047|19559276|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
5666617|NCT00463047|19559277|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
5666618|NCT00463047|19559276|P2|Double-Blind Treatment Period 1|Protocol Violation|2
5666619|NCT00463047|19559277|P1|Double-Blind Treatment Period 1|Protocol Violation|1
5666620|NCT00463047|19559276|P2|Double-Blind Treatment Period 1|Adverse Event|2
5666621|NCT00463047|19559277|P1|Double-Blind Treatment Period 1|Adverse Event|0
5666622|NCT00463047|19559276|P2|Titration Period 2|Other|2
5666623|NCT00463047|19559277|P1|Titration Period 2|Other|3
5666624|NCT00463047|19559276|P2|Titration Period 2|Non-compliance procedures|1
5666625|NCT00463047|19559277|P1|Titration Period 2|Non-compliance procedures|4
5666626|NCT00463047|19559276|P2|Titration Period 2|Non-compliance study medication|2
5666627|NCT00463047|19559277|P1|Titration Period 2|Non-compliance study medication|4
5666628|NCT00463047|19559276|P2|Titration Period 2|Lost to Follow-up|2
5666629|NCT00463047|19559277|P1|Titration Period 2|Lost to Follow-up|1
5666630|NCT00463047|19559276|P2|Titration Period 2|Protocol Violation|3
5666631|NCT00463047|19559277|P1|Titration Period 2|Protocol Violation|2
5666632|NCT00463047|19559276|P2|Titration Period 2|Withdrawal by Subject|0
5666633|NCT00463047|19559277|P1|Titration Period 2|Withdrawal by Subject|1
5666634|NCT00463047|19559276|P2|Titration Period 2|Lack of Efficacy|4
5666635|NCT00463047|19559277|P1|Titration Period 2|Lack of Efficacy|6
5666636|NCT00463047|19559276|P2|Titration Period 2|Adverse Event|9
5666637|NCT00463047|19559277|P1|Titration Period 2|Adverse Event|9
5666638|NCT00463047|19559276|P2|Titration Period 1|Other|2
5666639|NCT00463047|19559277|P1|Titration Period 1|Other|0
5666640|NCT00463047|19559276|P2|Titration Period 1|Non-compliance procedures|10
5666641|NCT00463047|19559277|P1|Titration Period 1|Non-compliance procedures|4
5666642|NCT00463047|19559276|P2|Titration Period 1|Withdrawal by Subject|5
5666643|NCT00463047|19559277|P1|Titration Period 1|Withdrawal by Subject|3
5666644|NCT00463047|19559276|P2|Titration Period 1|Protocol Violation|5
5666645|NCT00463047|19559277|P1|Titration Period 1|Protocol Violation|5
5666646|NCT00463047|19559276|P2|Titration Period 1|Non-compliance with study medication|5
5666647|NCT00463047|19559277|P1|Titration Period 1|Non-compliance with study medication|3
5666648|NCT00463047|19559276|P2|Titration Period 1|Lost to Follow-up|0
5666649|NCT00463047|19559277|P1|Titration Period 1|Lost to Follow-up|2
5666650|NCT00463047|19559276|P2|Titration Period 1|Lack of Efficacy|4
5666651|NCT00463047|19559277|P1|Titration Period 1|Lack of Efficacy|10
5666652|NCT00463047|19559276|P2|Titration Period 1|Adverse Event|8
5666653|NCT00463047|19559277|P1|Titration Period 1|Adverse Event|10
5666654|NCT00462982|19559362|P1|Overall Study|Patient Not Treated|2
5666655|NCT00462982|19559362|P1|Overall Study|Adverse Event|1
5666656|NCT00462943|19559369|P3|Overall Study|Withdrawal by Subject|0
5666657|NCT00462943|19559370|P2|Overall Study|Withdrawal by Subject|1
5666658|NCT00462943|19559371|P1|Overall Study|Withdrawal by Subject|0
5666659|NCT00462943|19559369|P3|Overall Study|Physician Decision|0
5666660|NCT00462943|19559370|P2|Overall Study|Physician Decision|0
5666661|NCT00462943|19559371|P1|Overall Study|Physician Decision|1
5666662|NCT00462943|19559369|P3|Overall Study|Transplant - not specified|1
5666663|NCT00462943|19559370|P2|Overall Study|Transplant - not specified|0
5666664|NCT00462943|19559371|P1|Overall Study|Transplant - not specified|1
5666665|NCT00462943|19559369|P3|Overall Study|Required Lymphocyte Infusion|0
5666666|NCT00462943|19559370|P2|Overall Study|Required Lymphocyte Infusion|0
5666667|NCT00462943|19559371|P1|Overall Study|Required Lymphocyte Infusion|1
5666668|NCT00462943|19559369|P3|Overall Study|Bone Marrow Transplant|0
5666669|NCT00462943|19559370|P2|Overall Study|Bone Marrow Transplant|0
5666670|NCT00462943|19559371|P1|Overall Study|Bone Marrow Transplant|1
5666671|NCT00462943|19559369|P3|Overall Study|Stem Cell Transplant|0
5666672|NCT00462943|19559370|P2|Overall Study|Stem Cell Transplant|1
5666673|NCT00462943|19559371|P1|Overall Study|Stem Cell Transplant|1
5666674|NCT00462943|19559369|P3|Overall Study|Death|7
5666675|NCT00462943|19559370|P2|Overall Study|Death|2
5666676|NCT00462943|19559371|P1|Overall Study|Death|5
5666677|NCT00462943|19559369|P3|Overall Study|Disease Progression|9
5666678|NCT00462943|19559370|P2|Overall Study|Disease Progression|15
5666679|NCT00462943|19559371|P1|Overall Study|Disease Progression|15
5666680|NCT00462943|19559369|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
5666681|NCT00462943|19559370|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
5666682|NCT00462943|19559371|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
5666683|NCT00462943|19559369|P3|Overall Study|Protocol Violation|0
5666684|NCT00462943|19559370|P2|Overall Study|Protocol Violation|0
5666685|NCT00462943|19559371|P1|Overall Study|Protocol Violation|1
5666686|NCT00462943|19559369|P3|Overall Study|Adverse Event|1
5666687|NCT00462943|19559370|P2|Overall Study|Adverse Event|4
5666688|NCT00462943|19559371|P1|Overall Study|Adverse Event|6
5666689|NCT00462943|19559369|P3|Overall Study|Failure to achieve a response|1
5666690|NCT00462943|19559370|P2|Overall Study|Failure to achieve a response|5
5666691|NCT00462943|19559371|P1|Overall Study|Failure to achieve a response|5
5666692|NCT00462904|19559463|P1|Overall Study|Lost to Follow-up|1
5666693|NCT00462865|19559468|P1|Overall Study|Adverse Event|1
5666694|NCT00462826|19559488|P1|Overall Study|Never treated|1
5666695|NCT00462826|19559488|P1|Overall Study|Ineligible - wrong primary|2
5666696|NCT00462826|19559488|P1|Overall Study|Ineligible - wrong cell type|1
5666697|NCT00462826|19559488|P1|Overall Study|Ineligible - second primary|1
5666698|NCT00462761|19559501|P1|Overall Study|Other|1
5666699|NCT00462761|19559501|P1|Overall Study|Death|12
5666700|NCT00462761|19559501|P1|Overall Study|Disease progression|43
5666701|NCT00462761|19559501|P1|Overall Study|Physician Decision|5
5666702|NCT00462761|19559501|P1|Overall Study|Withdrawal by Subject|9
5666703|NCT00462761|19559501|P1|Overall Study|Adverse Event|6
5666704|NCT00462748|19559576|P3|Overall Study|Discontinued after 41 days Rx|0
5666705|NCT00462748|19559577|P2|Overall Study|Discontinued after 41 days Rx|0
5666706|NCT00462748|19559578|P1|Overall Study|Discontinued after 41 days Rx|1
5666707|NCT00462748|19559576|P3|Overall Study|Lost to Follow-up|1
5666708|NCT00462748|19559577|P2|Overall Study|Lost to Follow-up|1
5666709|NCT00462748|19559578|P1|Overall Study|Lost to Follow-up|1
5666710|NCT00462748|19559576|P3|Overall Study|Withdrew consent|0
5666711|NCT00462748|19559577|P2|Overall Study|Withdrew consent|3
5666712|NCT00462748|19559578|P1|Overall Study|Withdrew consent|3
5666713|NCT00462748|19559576|P3|Overall Study|Protocol Violation|1
5666714|NCT00462748|19559577|P2|Overall Study|Protocol Violation|2
5666715|NCT00462748|19559578|P1|Overall Study|Protocol Violation|0
5666716|NCT00462748|19559576|P3|Overall Study|Adverse Event|9
5666717|NCT00462748|19559577|P2|Overall Study|Adverse Event|5
5666718|NCT00462748|19559578|P1|Overall Study|Adverse Event|7
5666719|NCT00462709|19559631|P1|Overall Study|Withdrew to start treatment with Cetor|1
5666720|NCT00462709|19559631|P1|Overall Study|Physician Decision|1
5666721|NCT00462709|19559631|P1|Overall Study|Logistical reasons|2
5666722|NCT00462709|19559631|P1|Overall Study|Death|2
5666723|NCT00462709|19559631|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
5666724|NCT00462709|19559631|P1|Overall Study|Withdrawal by Subject|8
5666725|NCT00462709|19559631|P1|Overall Study|Lost to Follow-up|10
5666726|NCT00462709|19559631|P1|Overall Study|Transitioned to commercial C1INH-nf|40
5666727|NCT00462670|19559640|P2|Overall Study|Resolution of signs and symptoms|2
5666728|NCT00462670|19559641|P1|Overall Study|Resolution of signs and symptoms|0
5666729|NCT00462670|19559640|P2|Overall Study|Protocol Violation|0
5666730|NCT00462670|19559641|P1|Overall Study|Protocol Violation|1
5666731|NCT00462670|19559640|P2|Overall Study|Lack of Efficacy|0
5666732|NCT00462670|19559641|P1|Overall Study|Lack of Efficacy|1
5666733|NCT00462670|19559640|P2|Overall Study|Adverse Event|5
5666734|NCT00462670|19559641|P1|Overall Study|Adverse Event|3
5666735|NCT00462501|19559678|P1|Overall Study|Adverse Event|2
5666736|NCT00462501|19559678|P1|Overall Study|Not treated|3
5666737|NCT00462488|19559684|P2|Overall Study|Lack of Efficacy|17
5666738|NCT00462488|19559685|P1|Overall Study|Lack of Efficacy|19
5666739|NCT00462488|19559684|P2|Overall Study|Protocol Violation|0
5666740|NCT00462488|19559685|P1|Overall Study|Protocol Violation|1
5666741|NCT00462462|19559693|P2|Overall Study|Physician Decision|1
5666742|NCT00462462|19559694|P1|Overall Study|Physician Decision|0
5666743|NCT00462384|19559722|P1|Overall Study|Other|4
5666744|NCT00462384|19559722|P1|Overall Study|Withdrawal by Subject|1
5666745|NCT00462384|19559722|P1|Overall Study|Death|2
5666746|NCT00462384|19559722|P1|Overall Study|Adverse Event|2
5666747|NCT00462345|19559730|P1|Overall Study|Did not complete second course|1
5666748|NCT00462345|19559730|P1|Overall Study|Withdrawal by Subject|2
5666749|NCT00462306|19559765|P2|Overall Study|insufficient data|13
5666750|NCT00462306|19559766|P1|Overall Study|insufficient data|0
5666751|NCT00461981|19559897|P2|Overall Study|Withdrawal by Subject|3
5666752|NCT00461981|19559898|P1|Overall Study|Withdrawal by Subject|2
5666753|NCT00461981|19559897|P2|Overall Study|Lost to Follow-up|6
5666754|NCT00461981|19559898|P1|Overall Study|Lost to Follow-up|9
5666755|NCT00461812|19560014|P1|Overall Study|study terminated|10
5666756|NCT00461786|19560019|P1|Overall Study|Inevaluable (Never Treated)|1
5666757|NCT00461786|19560019|P1|Overall Study|Entry Criteria Not Met|2
5666758|NCT00461708|19560064|P2|Overall Study|Death|1
5666759|NCT00461708|19560065|P1|Overall Study|Death|8
5666760|NCT00461708|19560064|P2|Overall Study|Other|4
5666761|NCT00461708|19560065|P1|Overall Study|Other|4
5666762|NCT00461708|19560064|P2|Overall Study|Withdrawal by Subject|2
5666763|NCT00461708|19560065|P1|Overall Study|Withdrawal by Subject|8
5666764|NCT00461708|19560064|P2|Overall Study|Physician Decision|4
5666765|NCT00461708|19560065|P1|Overall Study|Physician Decision|10
5666766|NCT00461708|19560064|P2|Overall Study|Lack of Efficacy|20
5666767|NCT00461708|19560065|P1|Overall Study|Lack of Efficacy|68
5666768|NCT00461708|19560064|P2|Overall Study|Adverse Event|7
5666769|NCT00461708|19560065|P1|Overall Study|Adverse Event|17
5666770|NCT00461682|19560091|P1|Overall Study|Protocol Violation|1
5666771|NCT00461630|19560119|P2|Overall Study|Lost to Follow-up|95
5666772|NCT00461630|19560120|P1|Overall Study|Lost to Follow-up|108
5666773|NCT00461630|19560119|P2|Overall Study|Death|732
5666774|NCT00461630|19560120|P1|Overall Study|Death|798
5666775|NCT00461552|19560159|P2|Overall Study|Drug Dispensing error|2
5666776|NCT00461552|19560160|P1|Overall Study|Drug Dispensing error|0
5666777|NCT00461500|19560183|P2|Overall Study|Lost to Follow-up|2
5666778|NCT00461500|19560184|P1|Overall Study|Lost to Follow-up|2
5666779|NCT00461500|19560183|P2|Overall Study|No Longer Willing to Take Part in Study|0
5666780|NCT00461500|19560184|P1|Overall Study|No Longer Willing to Take Part in Study|1
5666781|NCT00461500|19560183|P2|Overall Study|Drug Treatment Misuse|0
5666782|NCT00461500|19560184|P1|Overall Study|Drug Treatment Misuse|1
5666783|NCT00461500|19560183|P2|Overall Study|Study Stopped|2
5666784|NCT00461500|19560184|P1|Overall Study|Study Stopped|1
5666785|NCT00461500|19560183|P2|Overall Study|Expired Drug Treatment|1
5666786|NCT00461500|19560184|P1|Overall Study|Expired Drug Treatment|1
5666787|NCT00461500|19560183|P2|Overall Study|Lack of Efficacy|1
5666788|NCT00461500|19560184|P1|Overall Study|Lack of Efficacy|0
5666789|NCT00461500|19560183|P2|Overall Study|Adverse Event|0
5666790|NCT00461500|19560184|P1|Overall Study|Adverse Event|1
5666791|NCT00461305|19560227|P2|Continued Treatment|Other (missing drug etc)|0
5666792|NCT00461305|19560228|P1|Continued Treatment|Other (missing drug etc)|2
5666793|NCT00461305|19560227|P2|Continued Treatment|Partially missing diary|0
5666794|NCT00461305|19560228|P1|Continued Treatment|Partially missing diary|2
5666795|NCT00461305|19560227|P2|Continued Treatment|Withdrawal by Subject|0
5666796|NCT00461305|19560228|P1|Continued Treatment|Withdrawal by Subject|48
5666797|NCT00461305|19560227|P2|Continued Treatment|Protocol Violation|0
5666798|NCT00461305|19560228|P1|Continued Treatment|Protocol Violation|13
5666799|NCT00461305|19560227|P2|Continued Treatment|Lost to Follow-up|0
5666800|NCT00461305|19560228|P1|Continued Treatment|Lost to Follow-up|4
5666801|NCT00461305|19560227|P2|Continued Treatment|Adverse Event|0
5666802|NCT00461305|19560228|P1|Continued Treatment|Adverse Event|26
5666803|NCT00461305|19560227|P2|Treatment|Other (missing drug etc)|0
5666804|NCT00461305|19560228|P1|Treatment|Other (missing drug etc)|2
5666805|NCT00461305|19560227|P2|Treatment|Partially missing diary|0
5666806|NCT00461305|19560228|P1|Treatment|Partially missing diary|2
5666807|NCT00461305|19560227|P2|Treatment|Study drug not taken|0
5666808|NCT00461305|19560228|P1|Treatment|Study drug not taken|1
5666809|NCT00461305|19560227|P2|Treatment|Never dispensed|0
5666810|NCT00461305|19560228|P1|Treatment|Never dispensed|5
5666811|NCT00461305|19560227|P2|Treatment|Withdrawal by Subject|2
5666812|NCT00461305|19560228|P1|Treatment|Withdrawal by Subject|48
5666813|NCT00461305|19560227|P2|Treatment|Protocol Violation|2
5666814|NCT00461305|19560228|P1|Treatment|Protocol Violation|13
5666815|NCT00461305|19560227|P2|Treatment|Lost to Follow-up|2
5666816|NCT00461305|19560228|P1|Treatment|Lost to Follow-up|4
5666817|NCT00461305|19560227|P2|Treatment|Adverse Event|3
5666818|NCT00461305|19560228|P1|Treatment|Adverse Event|26
5666819|NCT00461253|19560312|P2|Overall Study|administrative|7773
5666820|NCT00461253|19560313|P1|Overall Study|administrative|773
5666821|NCT00461253|19560312|P2|Overall Study|no response|11789
5666822|NCT00461253|19560313|P1|Overall Study|no response|2609
5666823|NCT00461253|19560312|P2|Overall Study|Protocol Violation|236
5666824|NCT00461253|19560313|P1|Overall Study|Protocol Violation|613
5666825|NCT00461253|19560312|P2|Overall Study|Death|0
5666826|NCT00461253|19560313|P1|Overall Study|Death|985
5666827|NCT00461175|19560321|P2|Overall Study|Protocol Violation|365
5666828|NCT00461175|19560322|P1|Overall Study|Protocol Violation|522
5666829|NCT00461123|19560332|P2|Overall Study|Withdrawal by Subject|3
5666830|NCT00461123|19560333|P1|Overall Study|Withdrawal by Subject|1
5666831|NCT00461123|19560332|P2|Overall Study|Protocol Violation|2
5666832|NCT00461123|19560333|P1|Overall Study|Protocol Violation|3
5666833|NCT00461123|19560332|P2|Overall Study|Lost to Follow-up|1
5666834|NCT00461123|19560333|P1|Overall Study|Lost to Follow-up|1
5666835|NCT00461123|19560332|P2|Overall Study|Adverse Event|0
5666836|NCT00461123|19560333|P1|Overall Study|Adverse Event|1
5666837|NCT00461032|19560378|P2|Overall Study|Other|5
5666838|NCT00461032|19560379|P1|Overall Study|Other|7
5666839|NCT00461032|19560378|P2|Overall Study|Patient Moved or Relocated|1
5666840|NCT00461032|19560379|P1|Overall Study|Patient Moved or Relocated|2
5666841|NCT00461032|19560378|P2|Overall Study|Withdrawal by Subject|15
5666842|NCT00461032|19560379|P1|Overall Study|Withdrawal by Subject|7
5666843|NCT00461032|19560378|P2|Overall Study|Protocol Violation|4
5666844|NCT00461032|19560379|P1|Overall Study|Protocol Violation|4
5666845|NCT00461032|19560378|P2|Overall Study|Lost to Follow-up|12
5666846|NCT00461032|19560379|P1|Overall Study|Lost to Follow-up|7
5666847|NCT00461032|19560378|P2|Overall Study|Lack of Efficacy|1
5666848|NCT00461032|19560379|P1|Overall Study|Lack of Efficacy|5
5666849|NCT00461032|19560378|P2|Overall Study|Adverse Event|6
5666850|NCT00461032|19560379|P1|Overall Study|Adverse Event|5
5666851|NCT00460811|19560405|P5|Overall Study|Lost to Follow-up|6
5666852|NCT00460811|19560406|P4|Overall Study|Lost to Follow-up|3
5666853|NCT00460811|19560407|P3|Overall Study|Lost to Follow-up|5
5666854|NCT00460811|19560408|P2|Overall Study|Lost to Follow-up|2
5666855|NCT00460811|19560409|P1|Overall Study|Lost to Follow-up|3
5666856|NCT00460811|19560405|P5|Overall Study|Physician Decision|0
5666857|NCT00460811|19560406|P4|Overall Study|Physician Decision|0
5666858|NCT00460811|19560407|P3|Overall Study|Physician Decision|0
5666859|NCT00460811|19560408|P2|Overall Study|Physician Decision|0
5666860|NCT00460811|19560409|P1|Overall Study|Physician Decision|1
5666861|NCT00460811|19560405|P5|Overall Study|Withdrawal by Subject|11
5666862|NCT00460811|19560406|P4|Overall Study|Withdrawal by Subject|3
5666863|NCT00460811|19560407|P3|Overall Study|Withdrawal by Subject|6
5666864|NCT00460811|19560408|P2|Overall Study|Withdrawal by Subject|7
5666865|NCT00460811|19560409|P1|Overall Study|Withdrawal by Subject|7
5666866|NCT00460811|19560405|P5|Overall Study|Noncompliance|1
5666867|NCT00460811|19560406|P4|Overall Study|Noncompliance|2
5666868|NCT00460811|19560407|P3|Overall Study|Noncompliance|0
5666869|NCT00460811|19560408|P2|Overall Study|Noncompliance|0
5666870|NCT00460811|19560409|P1|Overall Study|Noncompliance|1
5666871|NCT00460811|19560405|P5|Overall Study|Adverse Event|2
5666872|NCT00460811|19560406|P4|Overall Study|Adverse Event|10
5666873|NCT00460811|19560407|P3|Overall Study|Adverse Event|3
5666874|NCT00460811|19560408|P2|Overall Study|Adverse Event|6
5666875|NCT00460811|19560409|P1|Overall Study|Adverse Event|4
5666876|NCT00460798|19560451|P1|Overall Study|Missing/Incomplete Dosing Information|27
5666877|NCT00460798|19560451|P1|Overall Study|Ongoing at Date of Cut-Off|82
5666878|NCT00460798|19560451|P1|Overall Study|Other|27
5666879|NCT00460798|19560451|P1|Overall Study|Progressive Disease|99
5666880|NCT00460798|19560451|P1|Overall Study|Lost to Follow-up|19
5666881|NCT00460798|19560451|P1|Overall Study|Adverse Event|27
5666882|NCT00460798|19560451|P1|Overall Study|Death|59
5666883|NCT00460746|19560459|P1|Overall Study|Lost to Follow-up|1
5666884|NCT00460746|19560459|P1|Overall Study|Adverse Event|1
5666885|NCT00460655|19560474|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
5666886|NCT00460655|19560475|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
5666887|NCT00460655|19560476|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
5666888|NCT00460655|19560477|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
5666889|NCT00460655|19560474|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
5666890|NCT00460655|19560475|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
5666891|NCT00460655|19560476|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5666892|NCT00460655|19560477|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5666893|NCT00460655|19560474|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
5666894|NCT00460655|19560475|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
5666895|NCT00460655|19560476|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
5666896|NCT00460655|19560477|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
5666897|NCT00460655|19560474|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
5666898|NCT00460655|19560475|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
5666899|NCT00460655|19560476|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
5666900|NCT00460655|19560477|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
5666901|NCT00460655|19560474|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5666902|NCT00460655|19560475|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5666903|NCT00460655|19560476|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5666904|NCT00460655|19560477|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
5666905|NCT00460655|19560474|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
5666906|NCT00460655|19560475|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
5666907|NCT00460655|19560476|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
5666908|NCT00460655|19560477|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
5666909|NCT00460603|19560521|P12|Phase 2|Randomized, but not treated|0
5666910|NCT00460603|19560522|P11|Phase 2|Randomized, but not treated|0
5666911|NCT00460603|19560523|P10|Phase 2|Randomized, but not treated|3
5666912|NCT00460603|19560524|P9|Phase 2|Randomized, but not treated|0
5666913|NCT00460603|19560525|P8|Phase 2|Randomized, but not treated|0
5666914|NCT00460603|19560526|P7|Phase 2|Randomized, but not treated|0
5666915|NCT00460603|19560527|P6|Phase 2|Randomized, but not treated|0
5666916|NCT00460603|19560528|P5|Phase 2|Randomized, but not treated|0
5666917|NCT00460603|19560529|P4|Phase 2|Randomized, but not treated|0
5666918|NCT00460603|19560530|P3|Phase 2|Randomized, but not treated|0
5666919|NCT00460603|19560531|P2|Phase 2|Randomized, but not treated|0
5666920|NCT00460603|19560532|P1|Phase 2|Randomized, but not treated|0
5666921|NCT00460603|19560521|P12|Phase 2|Withdrawal by Subject|5
5666922|NCT00460603|19560522|P11|Phase 2|Withdrawal by Subject|4
5666923|NCT00460603|19560523|P10|Phase 2|Withdrawal by Subject|5
5666924|NCT00460603|19560524|P9|Phase 2|Withdrawal by Subject|0
5666925|NCT00460603|19560525|P8|Phase 2|Withdrawal by Subject|0
5666926|NCT00460603|19560526|P7|Phase 2|Withdrawal by Subject|0
5666927|NCT00460603|19560527|P6|Phase 2|Withdrawal by Subject|0
5666928|NCT00460603|19560528|P5|Phase 2|Withdrawal by Subject|0
5666929|NCT00460603|19560529|P4|Phase 2|Withdrawal by Subject|0
5666930|NCT00460603|19560530|P3|Phase 2|Withdrawal by Subject|0
5666931|NCT00460603|19560531|P2|Phase 2|Withdrawal by Subject|0
5666932|NCT00460603|19560532|P1|Phase 2|Withdrawal by Subject|0
5666933|NCT00460603|19560521|P12|Phase 2|Global Deterioration of Health Status|0
5666934|NCT00460603|19560522|P11|Phase 2|Global Deterioration of Health Status|1
5666935|NCT00460603|19560523|P10|Phase 2|Global Deterioration of Health Status|0
5666936|NCT00460603|19560524|P9|Phase 2|Global Deterioration of Health Status|0
5666937|NCT00460603|19560525|P8|Phase 2|Global Deterioration of Health Status|0
5666938|NCT00460603|19560526|P7|Phase 2|Global Deterioration of Health Status|0
5666939|NCT00460603|19560527|P6|Phase 2|Global Deterioration of Health Status|0
5666940|NCT00460603|19560528|P5|Phase 2|Global Deterioration of Health Status|0
5666941|NCT00460603|19560529|P4|Phase 2|Global Deterioration of Health Status|0
5666942|NCT00460603|19560530|P3|Phase 2|Global Deterioration of Health Status|0
5666943|NCT00460603|19560531|P2|Phase 2|Global Deterioration of Health Status|0
5666944|NCT00460603|19560532|P1|Phase 2|Global Deterioration of Health Status|0
5666945|NCT00460603|19560521|P12|Phase 2|Objective Progression or Relapse|17
5666946|NCT00460603|19560522|P11|Phase 2|Objective Progression or Relapse|10
5666947|NCT00460603|19560523|P10|Phase 2|Objective Progression or Relapse|9
5666948|NCT00460603|19560524|P9|Phase 2|Objective Progression or Relapse|0
5666949|NCT00460603|19560525|P8|Phase 2|Objective Progression or Relapse|0
5666950|NCT00460603|19560526|P7|Phase 2|Objective Progression or Relapse|0
5666951|NCT00460603|19560527|P6|Phase 2|Objective Progression or Relapse|0
5666952|NCT00460603|19560528|P5|Phase 2|Objective Progression or Relapse|0
5666953|NCT00460603|19560529|P4|Phase 2|Objective Progression or Relapse|0
5666954|NCT00460603|19560530|P3|Phase 2|Objective Progression or Relapse|0
5666955|NCT00460603|19560531|P2|Phase 2|Objective Progression or Relapse|0
5666956|NCT00460603|19560532|P1|Phase 2|Objective Progression or Relapse|0
5666957|NCT00460603|19560521|P12|Phase 2|Other|7
5666958|NCT00460603|19560522|P11|Phase 2|Other|16
5666959|NCT00460603|19560523|P10|Phase 2|Other|6
5666960|NCT00460603|19560524|P9|Phase 2|Other|0
5666961|NCT00460603|19560525|P8|Phase 2|Other|0
5666962|NCT00460603|19560526|P7|Phase 2|Other|0
5666963|NCT00460603|19560527|P6|Phase 2|Other|0
5666964|NCT00460603|19560528|P5|Phase 2|Other|0
5666965|NCT00460603|19560529|P4|Phase 2|Other|0
5666966|NCT00460603|19560530|P3|Phase 2|Other|0
5666967|NCT00460603|19560531|P2|Phase 2|Other|0
5666968|NCT00460603|19560532|P1|Phase 2|Other|0
5666969|NCT00460603|19560521|P12|Phase 2|Lost to Follow-up|0
5666970|NCT00460603|19560522|P11|Phase 2|Lost to Follow-up|0
5666971|NCT00460603|19560523|P10|Phase 2|Lost to Follow-up|1
5666972|NCT00460603|19560524|P9|Phase 2|Lost to Follow-up|0
5666973|NCT00460603|19560525|P8|Phase 2|Lost to Follow-up|0
5666974|NCT00460603|19560526|P7|Phase 2|Lost to Follow-up|0
5666975|NCT00460603|19560527|P6|Phase 2|Lost to Follow-up|0
5666976|NCT00460603|19560528|P5|Phase 2|Lost to Follow-up|0
5666977|NCT00460603|19560529|P4|Phase 2|Lost to Follow-up|0
5666978|NCT00460603|19560530|P3|Phase 2|Lost to Follow-up|0
5666979|NCT00460603|19560531|P2|Phase 2|Lost to Follow-up|0
5666980|NCT00460603|19560532|P1|Phase 2|Lost to Follow-up|0
5666981|NCT00460603|19560521|P12|Phase 2|Protocol Violation|0
5666982|NCT00460603|19560522|P11|Phase 2|Protocol Violation|1
5666983|NCT00460603|19560523|P10|Phase 2|Protocol Violation|1
5666984|NCT00460603|19560524|P9|Phase 2|Protocol Violation|0
5666985|NCT00460603|19560525|P8|Phase 2|Protocol Violation|0
5666986|NCT00460603|19560526|P7|Phase 2|Protocol Violation|0
5666987|NCT00460603|19560527|P6|Phase 2|Protocol Violation|0
5666988|NCT00460603|19560528|P5|Phase 2|Protocol Violation|0
5666989|NCT00460603|19560529|P4|Phase 2|Protocol Violation|0
5666990|NCT00460603|19560530|P3|Phase 2|Protocol Violation|0
5666991|NCT00460603|19560531|P2|Phase 2|Protocol Violation|0
5666992|NCT00460603|19560532|P1|Phase 2|Protocol Violation|0
5666993|NCT00460603|19560521|P12|Phase 2|Death|2
5666994|NCT00460603|19560522|P11|Phase 2|Death|2
5666995|NCT00460603|19560523|P10|Phase 2|Death|4
5666996|NCT00460603|19560524|P9|Phase 2|Death|0
5666997|NCT00460603|19560525|P8|Phase 2|Death|0
5666998|NCT00460603|19560526|P7|Phase 2|Death|0
5666999|NCT00460603|19560527|P6|Phase 2|Death|0
5667000|NCT00460603|19560528|P5|Phase 2|Death|0
5667001|NCT00460603|19560529|P4|Phase 2|Death|0
5667002|NCT00460603|19560530|P3|Phase 2|Death|0
5667003|NCT00460603|19560531|P2|Phase 2|Death|0
5667004|NCT00460603|19560532|P1|Phase 2|Death|0
5667005|NCT00460603|19560521|P12|Phase 2|Adverse Event|10
5667006|NCT00460603|19560522|P11|Phase 2|Adverse Event|9
5667007|NCT00460603|19560523|P10|Phase 2|Adverse Event|12
5667008|NCT00460603|19560524|P9|Phase 2|Adverse Event|0
5667009|NCT00460603|19560525|P8|Phase 2|Adverse Event|0
5667010|NCT00460603|19560526|P7|Phase 2|Adverse Event|0
5667011|NCT00460603|19560527|P6|Phase 2|Adverse Event|0
5667012|NCT00460603|19560528|P5|Phase 2|Adverse Event|0
5667013|NCT00460603|19560529|P4|Phase 2|Adverse Event|0
5667014|NCT00460603|19560530|P3|Phase 2|Adverse Event|0
5667015|NCT00460603|19560531|P2|Phase 2|Adverse Event|0
5667016|NCT00460603|19560532|P1|Phase 2|Adverse Event|0
5667017|NCT00460603|19560521|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667018|NCT00460603|19560522|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667019|NCT00460603|19560523|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
5667020|NCT00460603|19560524|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667021|NCT00460603|19560525|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667022|NCT00460603|19560526|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667023|NCT00460603|19560527|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667024|NCT00460603|19560528|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667025|NCT00460603|19560529|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667026|NCT00460603|19560530|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667027|NCT00460603|19560531|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667028|NCT00460603|19560532|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
5667029|NCT00460603|19560521|P12|Phase 1|Other|0
5667030|NCT00460603|19560522|P11|Phase 1|Other|0
5667031|NCT00460603|19560523|P10|Phase 1|Other|0
5667032|NCT00460603|19560524|P9|Phase 1|Other|0
5667033|NCT00460603|19560525|P8|Phase 1|Other|1
5667034|NCT00460603|19560526|P7|Phase 1|Other|0
5667035|NCT00460603|19560527|P6|Phase 1|Other|2
5667036|NCT00460603|19560528|P5|Phase 1|Other|1
5667037|NCT00460603|19560529|P4|Phase 1|Other|1
5667038|NCT00460603|19560530|P3|Phase 1|Other|1
5667039|NCT00460603|19560531|P2|Phase 1|Other|3
5667040|NCT00460603|19560532|P1|Phase 1|Other|0
5667041|NCT00460603|19560521|P12|Phase 1|Withdrawal by Subject|0
5667042|NCT00460603|19560522|P11|Phase 1|Withdrawal by Subject|0
5667043|NCT00460603|19560523|P10|Phase 1|Withdrawal by Subject|0
5667044|NCT00460603|19560524|P9|Phase 1|Withdrawal by Subject|2
5667045|NCT00460603|19560525|P8|Phase 1|Withdrawal by Subject|0
5667046|NCT00460603|19560526|P7|Phase 1|Withdrawal by Subject|1
5667047|NCT00460603|19560527|P6|Phase 1|Withdrawal by Subject|0
5667048|NCT00460603|19560528|P5|Phase 1|Withdrawal by Subject|3
5667049|NCT00460603|19560529|P4|Phase 1|Withdrawal by Subject|1
5667050|NCT00460603|19560530|P3|Phase 1|Withdrawal by Subject|1
5667051|NCT00460603|19560531|P2|Phase 1|Withdrawal by Subject|2
5667052|NCT00460603|19560532|P1|Phase 1|Withdrawal by Subject|1
5667053|NCT00460603|19560521|P12|Phase 1|Lack of Efficacy|0
5667054|NCT00460603|19560522|P11|Phase 1|Lack of Efficacy|0
5667055|NCT00460603|19560523|P10|Phase 1|Lack of Efficacy|0
5667056|NCT00460603|19560524|P9|Phase 1|Lack of Efficacy|11
5667057|NCT00460603|19560525|P8|Phase 1|Lack of Efficacy|2
5667058|NCT00460603|19560526|P7|Phase 1|Lack of Efficacy|2
5667059|NCT00460603|19560527|P6|Phase 1|Lack of Efficacy|2
5667060|NCT00460603|19560528|P5|Phase 1|Lack of Efficacy|2
5667061|NCT00460603|19560529|P4|Phase 1|Lack of Efficacy|2
5667062|NCT00460603|19560530|P3|Phase 1|Lack of Efficacy|1
5667063|NCT00460603|19560531|P2|Phase 1|Lack of Efficacy|0
5667064|NCT00460603|19560532|P1|Phase 1|Lack of Efficacy|1
5667065|NCT00460603|19560521|P12|Phase 1|Adverse Event|0
5667066|NCT00460603|19560522|P11|Phase 1|Adverse Event|0
5667067|NCT00460603|19560523|P10|Phase 1|Adverse Event|0
5667068|NCT00460603|19560524|P9|Phase 1|Adverse Event|4
5667069|NCT00460603|19560525|P8|Phase 1|Adverse Event|0
5667070|NCT00460603|19560526|P7|Phase 1|Adverse Event|3
5667071|NCT00460603|19560527|P6|Phase 1|Adverse Event|0
5667072|NCT00460603|19560528|P5|Phase 1|Adverse Event|0
5667073|NCT00460603|19560529|P4|Phase 1|Adverse Event|2
5667074|NCT00460603|19560530|P3|Phase 1|Adverse Event|1
5667075|NCT00460603|19560531|P2|Phase 1|Adverse Event|1
5667076|NCT00460603|19560532|P1|Phase 1|Adverse Event|3
5667077|NCT00460603|19560521|P12|Phase 1|Death|0
5667078|NCT00460603|19560522|P11|Phase 1|Death|0
5667079|NCT00460603|19560523|P10|Phase 1|Death|0
5667080|NCT00460603|19560524|P9|Phase 1|Death|1
5667081|NCT00460603|19560525|P8|Phase 1|Death|0
5667082|NCT00460603|19560526|P7|Phase 1|Death|0
5667083|NCT00460603|19560527|P6|Phase 1|Death|0
5667084|NCT00460603|19560528|P5|Phase 1|Death|0
5667085|NCT00460603|19560529|P4|Phase 1|Death|2
5667086|NCT00460603|19560530|P3|Phase 1|Death|0
5667087|NCT00460603|19560531|P2|Phase 1|Death|0
5667088|NCT00460603|19560532|P1|Phase 1|Death|1
5667089|NCT00460577|19560626|P2|Overall Study|Protocol Violation|6
5667090|NCT00460577|19560627|P1|Overall Study|Protocol Violation|2
5667091|NCT00460564|19560645|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5667092|NCT00460564|19560646|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5667093|NCT00460564|19560647|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5667094|NCT00460564|19560648|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
5667095|NCT00460564|19560649|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5667096|NCT00460564|19560650|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5667097|NCT00460564|19560651|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5667098|NCT00460564|19560652|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
5667099|NCT00460564|19560645|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5667100|NCT00460564|19560646|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5667101|NCT00460564|19560647|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
5667102|NCT00460564|19560648|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
5667103|NCT00460564|19560649|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5667104|NCT00460564|19560650|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5667105|NCT00460564|19560651|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5667106|NCT00460564|19560652|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
5667107|NCT00460564|19560645|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
5667108|NCT00460564|19560646|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
5667109|NCT00460564|19560647|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
5667110|NCT00460564|19560648|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
5667111|NCT00460564|19560649|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
5667112|NCT00460564|19560650|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
5667113|NCT00460564|19560651|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
5667114|NCT00460564|19560652|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
5667115|NCT00460564|19560645|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5667116|NCT00460564|19560646|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5667117|NCT00460564|19560647|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5667118|NCT00460564|19560648|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5667119|NCT00460564|19560649|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5667120|NCT00460564|19560650|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5667121|NCT00460564|19560651|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
5667122|NCT00460564|19560652|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
5667123|NCT00460564|19560645|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
5667124|NCT00460564|19560646|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
5667125|NCT00460564|19560647|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
5667126|NCT00460564|19560648|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
5667127|NCT00460564|19560649|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
5667128|NCT00460564|19560650|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
5667129|NCT00460564|19560651|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
5667130|NCT00460564|19560652|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
5667131|NCT00460434|19560796|P2|Overall Study|Lost to Follow-up|7
5667132|NCT00460434|19560797|P1|Overall Study|Lost to Follow-up|3
5667133|NCT00460408|19560876|P4|Overall Study|Other|0
5667134|NCT00460408|19560877|P3|Overall Study|Other|0
5667135|NCT00460408|19560878|P2|Overall Study|Other|2
5667136|NCT00460408|19560879|P1|Overall Study|Other|12
5667137|NCT00460408|19560876|P4|Overall Study|Insufficient clinical response|0
5667138|NCT00460408|19560877|P3|Overall Study|Insufficient clinical response|5
5667139|NCT00460408|19560878|P2|Overall Study|Insufficient clinical response|1
5667140|NCT00460408|19560879|P1|Overall Study|Insufficient clinical response|5
5667141|NCT00460408|19560876|P4|Overall Study|Withdrawal by Subject|0
5667142|NCT00460408|19560877|P3|Overall Study|Withdrawal by Subject|0
5667143|NCT00460408|19560878|P2|Overall Study|Withdrawal by Subject|0
5667144|NCT00460408|19560879|P1|Overall Study|Withdrawal by Subject|31
5667145|NCT00460408|19560876|P4|Overall Study|Lost to Follow-up|0
5667146|NCT00460408|19560877|P3|Overall Study|Lost to Follow-up|1
5667147|NCT00460408|19560878|P2|Overall Study|Lost to Follow-up|0
5667148|NCT00460408|19560879|P1|Overall Study|Lost to Follow-up|11
5667149|NCT00460408|19560876|P4|Overall Study|Death|0
5667150|NCT00460408|19560877|P3|Overall Study|Death|0
5667151|NCT00460408|19560878|P2|Overall Study|Death|0
5667152|NCT00460408|19560879|P1|Overall Study|Death|7
5667153|NCT00460408|19560876|P4|Overall Study|Adverse Event|0
5667154|NCT00460408|19560877|P3|Overall Study|Adverse Event|0
5667155|NCT00460408|19560878|P2|Overall Study|Adverse Event|0
5667156|NCT00460408|19560879|P1|Overall Study|Adverse Event|1
5667157|NCT00460265|19560916|P2|Overall Study|Ongoing|47
5667158|NCT00460265|19560917|P1|Overall Study|Ongoing|60
5667159|NCT00460265|19560916|P2|Overall Study|Withdrawal by Subject|25
5667160|NCT00460265|19560917|P1|Overall Study|Withdrawal by Subject|10
5667161|NCT00460265|19560916|P2|Overall Study|Physician Decision|2
5667162|NCT00460265|19560917|P1|Overall Study|Physician Decision|1
5667163|NCT00460265|19560916|P2|Overall Study|Lost to Follow-up|15
5667164|NCT00460265|19560917|P1|Overall Study|Lost to Follow-up|14
5667165|NCT00460239|19560933|P9|Overall Study|Withdrawal by Subject|0
5667166|NCT00460239|19560934|P8|Overall Study|Withdrawal by Subject|0
5667167|NCT00460239|19560935|P7|Overall Study|Withdrawal by Subject|0
5667168|NCT00460239|19560936|P6|Overall Study|Withdrawal by Subject|1
5667169|NCT00460239|19560937|P5|Overall Study|Withdrawal by Subject|0
5667170|NCT00460239|19560938|P4|Overall Study|Withdrawal by Subject|0
5667171|NCT00460239|19560939|P3|Overall Study|Withdrawal by Subject|0
5667172|NCT00460239|19560940|P2|Overall Study|Withdrawal by Subject|0
5667173|NCT00460239|19560941|P1|Overall Study|Withdrawal by Subject|0
5667174|NCT00460239|19560933|P9|Overall Study|Physician Decision|0
5667175|NCT00460239|19560934|P8|Overall Study|Physician Decision|0
5667176|NCT00460239|19560935|P7|Overall Study|Physician Decision|0
5667177|NCT00460239|19560936|P6|Overall Study|Physician Decision|2
5667178|NCT00460239|19560937|P5|Overall Study|Physician Decision|0
5667179|NCT00460239|19560938|P4|Overall Study|Physician Decision|0
5667180|NCT00460239|19560939|P3|Overall Study|Physician Decision|0
5667181|NCT00460239|19560940|P2|Overall Study|Physician Decision|1
5667182|NCT00460239|19560941|P1|Overall Study|Physician Decision|0
5667183|NCT00460109|19561010|P1|Overall Study|Death|1
5667184|NCT00460031|19561018|P1|Overall Study|Death|1
5667185|NCT00460031|19561018|P1|Overall Study|Withdrawal by Subject|5
5667186|NCT00460031|19561018|P1|Overall Study|Adverse Event|5
5667187|NCT00459979|19561026|P1|Overall Study|Protocol Violation|1
5667188|NCT00459979|19561026|P1|Overall Study|Withdrawal by Subject|1
5667189|NCT00459953|19561038|P2|Overall Study|not analyzed-household member in study|1
5667190|NCT00459953|19561039|P1|Overall Study|not analyzed-household member in study|1
5667191|NCT00459875|19561045|P1|Overall Study|Adverse Event|2
5667192|NCT00459875|19561045|P1|Overall Study|Ineligible participant|1
5667193|NCT00459706|19561081|P2|Overall Study|Other|1
5667194|NCT00459706|19561082|P1|Overall Study|Other|0
5667195|NCT00459706|19561081|P2|Overall Study|Failed to Return|0
5667196|NCT00459706|19561082|P1|Overall Study|Failed to Return|1
5667197|NCT00459706|19561081|P2|Overall Study|Protocol Violation|1
5667198|NCT00459706|19561082|P1|Overall Study|Protocol Violation|2
5667199|NCT00459706|19561081|P2|Overall Study|Discontinuation of Study by Sponsor|0
5667200|NCT00459706|19561082|P1|Overall Study|Discontinuation of Study by Sponsor|1
5667201|NCT00459706|19561081|P2|Overall Study|Physician Decision|0
5667202|NCT00459706|19561082|P1|Overall Study|Physician Decision|2
5667203|NCT00459706|19561081|P2|Overall Study|Withdrawal by Subject|6
5667204|NCT00459706|19561082|P1|Overall Study|Withdrawal by Subject|1
5667205|NCT00459706|19561081|P2|Overall Study|Adverse Event|13
5667206|NCT00459706|19561082|P1|Overall Study|Adverse Event|19
5667207|NCT00459667|19561225|P3|Overall Study|No treatment administered|1
5667208|NCT00459667|19561226|P2|Overall Study|No treatment administered|3
5667209|NCT00459667|19561227|P1|Overall Study|No treatment administered|6
5667210|NCT00459667|19561225|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
5667211|NCT00459667|19561226|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
5667212|NCT00459667|19561227|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
5667213|NCT00459667|19561225|P3|Overall Study|Other disease modifying treatment|1
5667214|NCT00459667|19561226|P2|Overall Study|Other disease modifying treatment|2
5667215|NCT00459667|19561227|P1|Overall Study|Other disease modifying treatment|1
5667216|NCT00459667|19561225|P3|Overall Study|Withdrawal by Subject|5
5667217|NCT00459667|19561226|P2|Overall Study|Withdrawal by Subject|5
5667218|NCT00459667|19561227|P1|Overall Study|Withdrawal by Subject|3
5667219|NCT00459667|19561225|P3|Overall Study|Protocol Violation|0
5667220|NCT00459667|19561226|P2|Overall Study|Protocol Violation|0
5667221|NCT00459667|19561227|P1|Overall Study|Protocol Violation|1
5667222|NCT00459667|19561225|P3|Overall Study|Pregnancy|1
5667223|NCT00459667|19561226|P2|Overall Study|Pregnancy|1
5667224|NCT00459667|19561227|P1|Overall Study|Pregnancy|1
5667225|NCT00459667|19561225|P3|Overall Study|Lost to Follow-up|3
5667226|NCT00459667|19561226|P2|Overall Study|Lost to Follow-up|9
5667227|NCT00459667|19561227|P1|Overall Study|Lost to Follow-up|5
5667228|NCT00459667|19561225|P3|Overall Study|Adverse Event|8
5667229|NCT00459667|19561226|P2|Overall Study|Adverse Event|12
5667230|NCT00459667|19561227|P1|Overall Study|Adverse Event|9
5667231|NCT00459537|19561249|P2|Overall Study|Missing|0
5667232|NCT00459537|19561250|P1|Overall Study|Missing|1
5667233|NCT00459537|19561249|P2|Overall Study|Protocol Violation|3
5667234|NCT00459537|19561250|P1|Overall Study|Protocol Violation|4
5667235|NCT00459537|19561249|P2|Overall Study|Administrative problems|0
5667236|NCT00459537|19561250|P1|Overall Study|Administrative problems|3
5667237|NCT00459537|19561249|P2|Overall Study|Lost to Follow-up|30
5667238|NCT00459537|19561250|P1|Overall Study|Lost to Follow-up|27
5667239|NCT00459537|19561249|P2|Overall Study|Withdrawal by Subject|26
5667240|NCT00459537|19561250|P1|Overall Study|Withdrawal by Subject|20
5667241|NCT00459537|19561249|P2|Overall Study|Lack of Efficacy|11
5667242|NCT00459537|19561250|P1|Overall Study|Lack of Efficacy|10
5667243|NCT00459537|19561249|P2|Overall Study|Adverse Event|6
5667244|NCT00459537|19561250|P1|Overall Study|Adverse Event|1
5667245|NCT00459355|19561285|P2|Overall Study|Subject no longer met inc criteria|18
5667246|NCT00459355|19561286|P1|Overall Study|Subject no longer met inc criteria|20
5667247|NCT00459342|19561298|P1|Overall Study|Not eligible|1
5667248|NCT00459316|19561311|P3|Step 3|Withdrawal by Subject|1
5667249|NCT00459316|19561312|P2|Step 3|Withdrawal by Subject|0
5667250|NCT00459316|19561313|P1|Step 3|Withdrawal by Subject|3
5667251|NCT00459316|19561311|P3|Steps 1 & 2|Lost to Follow-up|2
5667252|NCT00459316|19561312|P2|Steps 1 & 2|Lost to Follow-up|0
5667253|NCT00459316|19561313|P1|Steps 1 & 2|Lost to Follow-up|5
5667254|NCT00459316|19561311|P3|Steps 1 & 2|Not willing to adhere to regulations|0
5667255|NCT00459316|19561312|P2|Steps 1 & 2|Not willing to adhere to regulations|0
5667256|NCT00459316|19561313|P1|Steps 1 & 2|Not willing to adhere to regulations|1
5667257|NCT00459316|19561311|P3|Steps 1 & 2|Withdrawal by Subject|0
5667258|NCT00459316|19561312|P2|Steps 1 & 2|Withdrawal by Subject|1
5667259|NCT00459316|19561313|P1|Steps 1 & 2|Withdrawal by Subject|6
5667260|NCT00459316|19561311|P3|Steps 1 & 2|Not able to get to clinic|0
5667261|NCT00459316|19561312|P2|Steps 1 & 2|Not able to get to clinic|4
5667262|NCT00459316|19561313|P1|Steps 1 & 2|Not able to get to clinic|7
5667263|NCT00459316|19561311|P3|Steps 1 & 2|Death|0
5667264|NCT00459316|19561312|P2|Steps 1 & 2|Death|1
5667265|NCT00459316|19561313|P1|Steps 1 & 2|Death|1
5667266|NCT00459316|19561311|P3|Steps 1 & 2|Other eligibility failure|0
5667267|NCT00459316|19561312|P2|Steps 1 & 2|Other eligibility failure|1
5667268|NCT00459316|19561313|P1|Steps 1 & 2|Other eligibility failure|1
5667269|NCT00459290|19561378|P1|Overall Study|Ineligible|2
5667270|NCT00459290|19561378|P1|Overall Study|Adverse Event|3
5667271|NCT00459186|19561393|P1|PET Imaging and Assessment|Adverse Event|3
5667272|NCT00459186|19561393|P1|Single Agent RAD001|Withdrawal by Subject|1
5667273|NCT00459134|19561400|P2|Overall Study|Multiple Reasons|3
5667274|NCT00459134|19561401|P1|Overall Study|Multiple Reasons|2
5667275|NCT00459134|19561400|P2|Overall Study|Progression|0
5667276|NCT00459134|19561401|P1|Overall Study|Progression|1
5667277|NCT00459134|19561400|P2|Overall Study|Toxicity|5
5667278|NCT00459134|19561401|P1|Overall Study|Toxicity|4
5667279|NCT00459134|19561400|P2|Overall Study|Surgery|2
5667280|NCT00459134|19561401|P1|Overall Study|Surgery|1
5667281|NCT00459134|19561400|P2|Overall Study|Lost to Follow-up|7
5667282|NCT00459134|19561401|P1|Overall Study|Lost to Follow-up|6
5667283|NCT00459134|19561400|P2|Overall Study|Withdrawal by Subject|7
5667284|NCT00459134|19561401|P1|Overall Study|Withdrawal by Subject|8
5667285|NCT00459134|19561400|P2|Overall Study|Physician Decision|1
5667286|NCT00459134|19561401|P1|Overall Study|Physician Decision|1
5667287|NCT00459108|19561417|P1|Overall Study|Progression|1
5667288|NCT00459108|19561417|P1|Overall Study|Death|2
5667289|NCT00459108|19561417|P1|Overall Study|Adverse Event|3
5667290|NCT00459108|19561417|P1|Overall Study|Withdrawal by Subject|5
5667291|NCT00459056|19561427|P2|First Intervention (First Three Months)|Lost to Follow-up|1
5667292|NCT00459056|19561428|P1|First Intervention (First Three Months)|Lost to Follow-up|1
5667293|NCT00459043|19561436|P2|Overall Study|Withdrawal by Subject|0
5667294|NCT00459043|19561437|P1|Overall Study|Withdrawal by Subject|1
5667295|NCT00458705|19561464|P1|Overall Study|Not Treated|1
5667296|NCT00458705|19561464|P1|Overall Study|Adverse Event|4
5667297|NCT00458536|19561468|P1|Overall Study|Progressive disease during treatment|2
5667298|NCT00458536|19561468|P1|Overall Study|Withdrawal by Subject|1
5667299|NCT00458536|19561468|P1|Overall Study|Ineligible due to toxicity|1
5667300|NCT00458536|19561468|P1|Overall Study|Patient did not have surgery|1
5667301|NCT00458536|19561468|P1|Overall Study|Did not have renal cell carcinoma|2
5667302|NCT00458536|19561468|P1|Overall Study|No measurable disease after surgery|2
5667303|NCT00458536|19561468|P1|Overall Study|Unable to make vaccine|3
5667304|NCT00458536|19561468|P1|Overall Study|Disease progression prior to treatment|7
5667305|NCT00458484|19561479|P7|Overall Study|Not eligible b/c prior radiation history|0
5667306|NCT00458484|19561480|P6|Overall Study|Not eligible b/c prior radiation history|1
5667307|NCT00458484|19561481|P5|Overall Study|Not eligible b/c prior radiation history|0
5667308|NCT00458484|19561482|P4|Overall Study|Not eligible b/c prior radiation history|0
5667309|NCT00458484|19561483|P3|Overall Study|Not eligible b/c prior radiation history|0
5667310|NCT00458484|19561484|P2|Overall Study|Not eligible b/c prior radiation history|0
5667311|NCT00458484|19561485|P1|Overall Study|Not eligible b/c prior radiation history|0
5667312|NCT00458393|19561551|P2|Overall Study|Sites marked other on the form.|20
5667313|NCT00458393|19561552|P1|Overall Study|Sites marked other on the form.|19
5667314|NCT00458393|19561551|P2|Overall Study|Lost to Follow-up|92
5667315|NCT00458393|19561552|P1|Overall Study|Lost to Follow-up|115
5667316|NCT00458393|19561551|P2|Overall Study|Relocated|81
5667317|NCT00458393|19561552|P1|Overall Study|Relocated|77
5667318|NCT00458393|19561551|P2|Overall Study|Physician Decision|22
5667319|NCT00458393|19561552|P1|Overall Study|Physician Decision|31
5667320|NCT00458393|19561551|P2|Overall Study|Withdrawal by Subject|80
5667321|NCT00458393|19561552|P1|Overall Study|Withdrawal by Subject|67
5667322|NCT00458341|19561600|P2|Cycle 1|Adverse Event|0
5667323|NCT00458341|19561601|P1|Cycle 1|Adverse Event|1
5667324|NCT00458302|19561641|P2|Overall Study|Other|2
5667325|NCT00458302|19561642|P1|Overall Study|Other|4
5667326|NCT00458302|19561641|P2|Overall Study|Lost to Follow-up|0
5667327|NCT00458302|19561642|P1|Overall Study|Lost to Follow-up|2
5667328|NCT00458302|19561641|P2|Overall Study|Study Termination By Sponsor|0
5667329|NCT00458302|19561642|P1|Overall Study|Study Termination By Sponsor|1
5667330|NCT00458302|19561641|P2|Overall Study|Inc/Exc Criteria Not Met|1
5667331|NCT00458302|19561642|P1|Overall Study|Inc/Exc Criteria Not Met|1
5667332|NCT00458302|19561641|P2|Overall Study|Withdrawal by Subject|4
5667333|NCT00458302|19561642|P1|Overall Study|Withdrawal by Subject|6
5667334|NCT00458302|19561641|P2|Overall Study|Protocol Violation|2
5667335|NCT00458302|19561642|P1|Overall Study|Protocol Violation|0
5667336|NCT00458302|19561641|P2|Overall Study|Pregnancy|1
5667337|NCT00458302|19561642|P1|Overall Study|Pregnancy|2
5667338|NCT00458302|19561641|P2|Overall Study|Adverse Event|14
5667339|NCT00458302|19561642|P1|Overall Study|Adverse Event|4
5667340|NCT00458211|19561687|P1|Overall Study|Protocol Violation|2
5667341|NCT00458211|19561687|P1|Overall Study|Withdrawal by Subject|2
5667342|NCT00458211|19561687|P1|Overall Study|Lack of Efficacy|12
5667343|NCT00457821|19561737|P8|Part 2|Withdrawal by Subject|1
5667344|NCT00457821|19561738|P7|Part 2|Withdrawal by Subject|0
5667345|NCT00457821|19561739|P6|Part 2|Withdrawal by Subject|0
5667346|NCT00457821|19561740|P5|Part 2|Withdrawal by Subject|0
5667347|NCT00457821|19561741|P4|Part 2|Withdrawal by Subject|0
5667348|NCT00457821|19561742|P3|Part 2|Withdrawal by Subject|0
5667349|NCT00457821|19561743|P2|Part 2|Withdrawal by Subject|0
5667350|NCT00457821|19561744|P1|Part 2|Withdrawal by Subject|0
5667351|NCT00457743|19561783|P3|Overall Study|Lack of Efficacy|3
5667352|NCT00457743|19561784|P2|Overall Study|Lack of Efficacy|23
5667353|NCT00457743|19561785|P1|Overall Study|Lack of Efficacy|3
5667354|NCT00457743|19561783|P3|Overall Study|Adverse Event|0
5667355|NCT00457743|19561784|P2|Overall Study|Adverse Event|4
5667356|NCT00457743|19561785|P1|Overall Study|Adverse Event|0
5667357|NCT00457691|19561842|P2|Overall Study|Disease progression, study terminated|196
5667358|NCT00457691|19561843|P1|Overall Study|Disease progression, study terminated|180
5667359|NCT00457691|19561842|P2|Overall Study|Subject refused (reason other than AE)|19
5667360|NCT00457691|19561843|P1|Overall Study|Subject refused (reason other than AE)|14
5667361|NCT00457691|19561842|P2|Overall Study|Study terminated by Sponsor|1
5667362|NCT00457691|19561843|P1|Overall Study|Study terminated by Sponsor|1
5667363|NCT00457691|19561842|P2|Overall Study|Lost to Follow-up|14
5667364|NCT00457691|19561843|P1|Overall Study|Lost to Follow-up|23
5667365|NCT00457691|19561842|P2|Overall Study|Protocol Violation|3
5667366|NCT00457691|19561843|P1|Overall Study|Protocol Violation|1
5667367|NCT00457691|19561842|P2|Overall Study|Death|148
5667368|NCT00457691|19561843|P1|Overall Study|Death|163
5667369|NCT00457691|19561842|P2|Overall Study|Adverse Event|1
5667370|NCT00457691|19561843|P1|Overall Study|Adverse Event|4
5667371|NCT00457665|19561865|P2|24 Months|Abnormal liver function tests|5
5667372|NCT00457665|19561866|P1|24 Months|Abnormal liver function tests|1
5667373|NCT00457665|19561865|P2|24 Months|Lipodystrophy|1
5667374|NCT00457665|19561866|P1|24 Months|Lipodystrophy|1
5667375|NCT00457665|19561865|P2|24 Months|Withdrawal by Subject|2
5667376|NCT00457665|19561866|P1|24 Months|Withdrawal by Subject|3
5667377|NCT00457665|19561865|P2|12 Months|Abnormal Liver function tests|5
5667378|NCT00457665|19561866|P1|12 Months|Abnormal Liver function tests|0
5667379|NCT00457665|19561865|P2|12 Months|Withdrawal by Subject|2
5667380|NCT00457665|19561866|P1|12 Months|Withdrawal by Subject|0
5667381|NCT00457665|19561865|P2|12 Months|Lipodystrophy|0
5667382|NCT00457665|19561866|P1|12 Months|Lipodystrophy|2
5667383|NCT00457665|19561865|P2|12 Months|High HIV viral load|1
5667384|NCT00457665|19561866|P1|12 Months|High HIV viral load|5
5667385|NCT00457665|19561865|P2|12 Months|Drug allergy|1
5667386|NCT00457665|19561866|P1|12 Months|Drug allergy|1
5667387|NCT00457639|19561872|P2|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
5667388|NCT00457639|19561873|P1|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
5667389|NCT00457639|19561872|P2|Intervention 1 (6 Months)|unrelated illness|2
5667390|NCT00457639|19561873|P1|Intervention 1 (6 Months)|unrelated illness|0
5667391|NCT00457639|19561872|P2|Intervention 1 (6 Months)|Lost to Follow-up|0
5667392|NCT00457639|19561873|P1|Intervention 1 (6 Months)|Lost to Follow-up|3
5667393|NCT00457418|19561881|P1|Post PK Maintenance|Lost to Follow-up|1
5667394|NCT00457418|19561881|P1|Post PK Maintenance|Withdrawal by Subject|11
5667395|NCT00457418|19561881|P1|Post PK Maintenance|Progression of Disease|6
5667396|NCT00457418|19561881|P1|Post PK Maintenance|Adverse Event|10
5667397|NCT00457418|19561881|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
5667398|NCT00457418|19561881|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
5667399|NCT00457418|19561881|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
5667400|NCT00457392|19561893|P2|Overall Study|Randomized, Not Treated|3
5667401|NCT00457392|19561894|P1|Overall Study|Randomized, Not Treated|7
5667402|NCT00457392|19561893|P2|Overall Study|Study Terminated by Sponsor|4
5667403|NCT00457392|19561894|P1|Overall Study|Study Terminated by Sponsor|1
5667404|NCT00457392|19561893|P2|Overall Study|Other|4
5667405|NCT00457392|19561894|P1|Overall Study|Other|7
5667406|NCT00457392|19561893|P2|Overall Study|Protocol Violation|3
5667407|NCT00457392|19561894|P1|Overall Study|Protocol Violation|4
5667408|NCT00457392|19561893|P2|Overall Study|Lost to Follow-up|7
5667409|NCT00457392|19561894|P1|Overall Study|Lost to Follow-up|6
5667410|NCT00457392|19561893|P2|Overall Study|Withdrawal by Subject|8
5667411|NCT00457392|19561894|P1|Overall Study|Withdrawal by Subject|14
5667412|NCT00457392|19561893|P2|Overall Study|Global Deterioration of Health Status|8
5667413|NCT00457392|19561894|P1|Overall Study|Global Deterioration of Health Status|22
5667414|NCT00457392|19561893|P2|Overall Study|Adverse Event|41
5667415|NCT00457392|19561894|P1|Overall Study|Adverse Event|84
5667416|NCT00457392|19561893|P2|Overall Study|Death|106
5667417|NCT00457392|19561894|P1|Overall Study|Death|106
5667418|NCT00457392|19561893|P2|Overall Study|Objective Progression or Relapse|296
5667419|NCT00457392|19561894|P1|Overall Study|Objective Progression or Relapse|229
5667420|NCT00457301|19561921|P2|Overall Study|Death|7
5667421|NCT00457301|19561922|P1|Overall Study|Death|5
5667422|NCT00457301|19561921|P2|Overall Study|Censored out of the study|14
5667423|NCT00457301|19561922|P1|Overall Study|Censored out of the study|15
5667424|NCT00457301|19561921|P2|Overall Study|Withdrawal by Subject|3
5667425|NCT00457301|19561922|P1|Overall Study|Withdrawal by Subject|3
5667426|NCT00457249|19561936|P2|Overall Study|Serious Adverse Events|0
5667427|NCT00457249|19561937|P1|Overall Study|Serious Adverse Events|2
5667428|NCT00457249|19561936|P2|Overall Study|Withdrawal by Subject|1
5667429|NCT00457249|19561937|P1|Overall Study|Withdrawal by Subject|3
5667430|NCT00457249|19561936|P2|Overall Study|Protocol Violation|1
5667431|NCT00457249|19561937|P1|Overall Study|Protocol Violation|4
5667432|NCT00457249|19561936|P2|Overall Study|Lost to Follow-up|0
5667433|NCT00457249|19561937|P1|Overall Study|Lost to Follow-up|3
5667434|NCT00457015|19561976|P2|Overall Study|Left study site against medical advice|1
5667435|NCT00457015|19561977|P1|Overall Study|Left study site against medical advice|0
5667436|NCT00457002|19561993|P2|Overall Study|treated for 1 day; missing status/reason|0
5667437|NCT00457002|19561994|P1|Overall Study|treated for 1 day; missing status/reason|1
5667438|NCT00457002|19561993|P2|Overall Study|non-specified|38
5667439|NCT00457002|19561994|P1|Overall Study|non-specified|29
5667440|NCT00457002|19561993|P2|Overall Study|Administrative reason by Sponsor|0
5667441|NCT00457002|19561994|P1|Overall Study|Administrative reason by Sponsor|1
5667442|NCT00457002|19561993|P2|Overall Study|No longer met criteria|37
5667443|NCT00457002|19561994|P1|Overall Study|No longer met criteria|41
5667444|NCT00457002|19561993|P2|Overall Study|Poor/Non-compliance|33
5667445|NCT00457002|19561994|P1|Overall Study|Poor/Non-compliance|46
5667446|NCT00457002|19561993|P2|Overall Study|Lost to Follow-up|71
5667447|NCT00457002|19561994|P1|Overall Study|Lost to Follow-up|72
5667448|NCT00457002|19561993|P2|Overall Study|Withdrawal by Subject|271
5667449|NCT00457002|19561994|P1|Overall Study|Withdrawal by Subject|299
5667450|NCT00457002|19561993|P2|Overall Study|Adverse Event|260
5667451|NCT00457002|19561994|P1|Overall Study|Adverse Event|284
5667452|NCT00457002|19561993|P2|Overall Study|Death|47
5667453|NCT00457002|19561994|P1|Overall Study|Death|40
5667454|NCT00456846|19562099|P2|Overall Study|Other|2
5667455|NCT00456846|19562100|P1|Overall Study|Other|0
5667456|NCT00456846|19562099|P2|Overall Study|Participant Discretion|5
5667457|NCT00456846|19562100|P1|Overall Study|Participant Discretion|1
5667458|NCT00456846|19562099|P2|Overall Study|Protocol Deviation|0
5667459|NCT00456846|19562100|P1|Overall Study|Protocol Deviation|2
5667460|NCT00456846|19562099|P2|Overall Study|Physician Decision|6
5667461|NCT00456846|19562100|P1|Overall Study|Physician Decision|11
5667462|NCT00456846|19562099|P2|Overall Study|Adverse Event|15
5667463|NCT00456846|19562100|P1|Overall Study|Adverse Event|2
5667464|NCT00456755|19562141|P2|Overall Study|Lost to Follow-up|1
5667465|NCT00456755|19562142|P1|Overall Study|Lost to Follow-up|2
5667466|NCT00456612|19562156|P1|Overall Study|Withdrawal by Subject|3
5667467|NCT00456599|19562161|P1|Overall Study|Withdrawal by Subject|2
5667468|NCT00456599|19562161|P1|Overall Study|Non-compliance|1
5667469|NCT00456521|19562184|P2|Overall Study|Drug non-compliance, moved, other|11
5667470|NCT00456521|19562185|P1|Overall Study|Drug non-compliance, moved, other|26
5667471|NCT00456521|19562184|P2|Overall Study|Pregnancy|1
5667472|NCT00456521|19562185|P1|Overall Study|Pregnancy|1
5667473|NCT00456521|19562184|P2|Overall Study|Protocol Violation|0
5667474|NCT00456521|19562185|P1|Overall Study|Protocol Violation|4
5667475|NCT00456521|19562184|P2|Overall Study|Lack of Efficacy|6
5667476|NCT00456521|19562185|P1|Overall Study|Lack of Efficacy|3
5667477|NCT00456521|19562184|P2|Overall Study|Lost to Follow-up|17
5667478|NCT00456521|19562185|P1|Overall Study|Lost to Follow-up|22
5667479|NCT00456521|19562184|P2|Overall Study|Withdrawal by Subject|24
5667480|NCT00456521|19562185|P1|Overall Study|Withdrawal by Subject|43
5667481|NCT00456521|19562184|P2|Overall Study|Adverse Event|25
5667482|NCT00456521|19562185|P1|Overall Study|Adverse Event|150
5667483|NCT00456495|19562231|P1|Overall Study|Physician Decision|2
5667484|NCT00456365|19562238|P2|Overall Study|oncologic diagnosis|1
5667485|NCT00456365|19562239|P1|Overall Study|oncologic diagnosis|1
5667486|NCT00456365|19562238|P2|Overall Study|Pregnancy|1
5667487|NCT00456365|19562239|P1|Overall Study|Pregnancy|1
5667488|NCT00456365|19562238|P2|Overall Study|Withdrawal by Subject|7
5667489|NCT00456365|19562239|P1|Overall Study|Withdrawal by Subject|4
5667490|NCT00456365|19562238|P2|Overall Study|Lost to Follow-up|3
5667491|NCT00456365|19562239|P1|Overall Study|Lost to Follow-up|1
5667492|NCT00456300|19562251|P2|Overall Study|Adverse Event|0
5667493|NCT00456300|19562252|P1|Overall Study|Adverse Event|1
5667494|NCT00456092|19562276|P5|Treatment Phase (12 Weeks)|Other|0
5667495|NCT00456092|19562277|P4|Treatment Phase (12 Weeks)|Other|0
5667496|NCT00456092|19562278|P3|Treatment Phase (12 Weeks)|Other|1
5667497|NCT00456092|19562279|P2|Treatment Phase (12 Weeks)|Other|0
5667498|NCT00456092|19562280|P1|Treatment Phase (12 Weeks)|Other|1
5667499|NCT00456092|19562276|P5|Treatment Phase (12 Weeks)|Lost to Follow-up|0
5667500|NCT00456092|19562277|P4|Treatment Phase (12 Weeks)|Lost to Follow-up|0
5667501|NCT00456092|19562278|P3|Treatment Phase (12 Weeks)|Lost to Follow-up|1
5667502|NCT00456092|19562279|P2|Treatment Phase (12 Weeks)|Lost to Follow-up|1
5667503|NCT00456092|19562280|P1|Treatment Phase (12 Weeks)|Lost to Follow-up|0
5667504|NCT00456092|19562276|P5|Treatment Phase (12 Weeks)|Withdrew Consent|0
5667505|NCT00456092|19562277|P4|Treatment Phase (12 Weeks)|Withdrew Consent|0
5667506|NCT00456092|19562278|P3|Treatment Phase (12 Weeks)|Withdrew Consent|2
5667507|NCT00456092|19562279|P2|Treatment Phase (12 Weeks)|Withdrew Consent|1
5667508|NCT00456092|19562280|P1|Treatment Phase (12 Weeks)|Withdrew Consent|0
5667509|NCT00456092|19562276|P5|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
5667510|NCT00456092|19562277|P4|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
5667511|NCT00456092|19562278|P3|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
5667512|NCT00456092|19562279|P2|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
5667513|NCT00456092|19562280|P1|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
5667514|NCT00456092|19562276|P5|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
5667515|NCT00456092|19562277|P4|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
5667516|NCT00456092|19562278|P3|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
5667517|NCT00456092|19562279|P2|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
5667518|NCT00456092|19562280|P1|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
5667519|NCT00456092|19562276|P5|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
5667520|NCT00456092|19562277|P4|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
5667521|NCT00456092|19562278|P3|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
5667522|NCT00456092|19562279|P2|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
5667523|NCT00456092|19562280|P1|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
5667524|NCT00456092|19562276|P5|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
5667525|NCT00456092|19562277|P4|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
5667526|NCT00456092|19562278|P3|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
5667527|NCT00456092|19562279|P2|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
5667528|NCT00456092|19562280|P1|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
5667529|NCT00456092|19562276|P5|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
5667530|NCT00456092|19562277|P4|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
5667531|NCT00456092|19562278|P3|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
5667532|NCT00456092|19562279|P2|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
5667533|NCT00456092|19562280|P1|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
5667534|NCT00456092|19562276|P5|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
5667535|NCT00456092|19562277|P4|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
5667536|NCT00456092|19562278|P3|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
5667537|NCT00456092|19562279|P2|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
5667538|NCT00456092|19562280|P1|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
5667539|NCT00456092|19562276|P5|Extension Phase|Other|1
5667540|NCT00456092|19562277|P4|Extension Phase|Other|1
5667541|NCT00456092|19562278|P3|Extension Phase|Other|0
5667542|NCT00456092|19562279|P2|Extension Phase|Other|0
5667543|NCT00456092|19562280|P1|Extension Phase|Other|2
5667544|NCT00456092|19562276|P5|Extension Phase|Lost to Follow-up|1
5667545|NCT00456092|19562277|P4|Extension Phase|Lost to Follow-up|0
5667546|NCT00456092|19562278|P3|Extension Phase|Lost to Follow-up|0
5667547|NCT00456092|19562279|P2|Extension Phase|Lost to Follow-up|1
5667548|NCT00456092|19562280|P1|Extension Phase|Lost to Follow-up|1
5667549|NCT00456092|19562276|P5|Extension Phase|Withdrew Consent|0
5667550|NCT00456092|19562277|P4|Extension Phase|Withdrew Consent|0
5667551|NCT00456092|19562278|P3|Extension Phase|Withdrew Consent|0
5667552|NCT00456092|19562279|P2|Extension Phase|Withdrew Consent|0
5667553|NCT00456092|19562280|P1|Extension Phase|Withdrew Consent|2
5667554|NCT00456092|19562276|P5|Extension Phase|Worsening / Not Responding to Study Drug|2
5667555|NCT00456092|19562277|P4|Extension Phase|Worsening / Not Responding to Study Drug|0
5667556|NCT00456092|19562278|P3|Extension Phase|Worsening / Not Responding to Study Drug|0
5667557|NCT00456092|19562279|P2|Extension Phase|Worsening / Not Responding to Study Drug|1
5667558|NCT00456092|19562280|P1|Extension Phase|Worsening / Not Responding to Study Drug|3
5667559|NCT00456092|19562276|P5|Extension Phase|Flare of Psoriatic Arthritis|1
5667560|NCT00456092|19562277|P4|Extension Phase|Flare of Psoriatic Arthritis|0
5667561|NCT00456092|19562278|P3|Extension Phase|Flare of Psoriatic Arthritis|0
5667562|NCT00456092|19562279|P2|Extension Phase|Flare of Psoriatic Arthritis|0
5667563|NCT00456092|19562280|P1|Extension Phase|Flare of Psoriatic Arthritis|1
5667564|NCT00456092|19562276|P5|Extension Phase|Grade 2 or Greater AE|2
5667565|NCT00456092|19562277|P4|Extension Phase|Grade 2 or Greater AE|0
5667566|NCT00456092|19562278|P3|Extension Phase|Grade 2 or Greater AE|0
5667567|NCT00456092|19562279|P2|Extension Phase|Grade 2 or Greater AE|2
5667568|NCT00456092|19562280|P1|Extension Phase|Grade 2 or Greater AE|2
5667569|NCT00455923|19562462|P2|Overall Study|Other|1
5667570|NCT00455923|19562463|P1|Overall Study|Other|3
5667571|NCT00455923|19562462|P2|Overall Study|Pregnancy|2
5667572|NCT00455923|19562463|P1|Overall Study|Pregnancy|0
5667573|NCT00455858|19562479|P1|Overall Study|Withdrawal|1
5667574|NCT00455858|19562479|P1|Overall Study|Well controlled FPG without insulin|1
5667575|NCT00455858|19562479|P1|Overall Study|Lack of Efficacy|1
5667576|NCT00455858|19562479|P1|Overall Study|Protocol Violation|1
5667577|NCT00455858|19562479|P1|Overall Study|Lost to Follow-up|2
5667578|NCT00455741|19562489|P2|Overall Study|Physician Decision|1
5667579|NCT00455741|19562490|P1|Overall Study|Physician Decision|0
5667580|NCT00455533|19562586|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
5667581|NCT00455533|19562587|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
5667582|NCT00455533|19562588|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
5667583|NCT00455533|19562586|P3|Period Two: Randomized Period|Study Drug Toxicity|0
5667584|NCT00455533|19562587|P2|Period Two: Randomized Period|Study Drug Toxicity|2
5667585|NCT00455533|19562588|P1|Period Two: Randomized Period|Study Drug Toxicity|0
5667586|NCT00455533|19562586|P3|Period Two: Randomized Period|Other - need reasons|0
5667587|NCT00455533|19562587|P2|Period Two: Randomized Period|Other - need reasons|1
5667588|NCT00455533|19562588|P1|Period Two: Randomized Period|Other - need reasons|0
5667589|NCT00455533|19562586|P3|Period Two: Randomized Period|Lost to Follow-up|1
5667590|NCT00455533|19562587|P2|Period Two: Randomized Period|Lost to Follow-up|0
5667591|NCT00455533|19562588|P1|Period Two: Randomized Period|Lost to Follow-up|0
5667592|NCT00455533|19562586|P3|Period Two: Randomized Period|Disease Progression|1
5667593|NCT00455533|19562587|P2|Period Two: Randomized Period|Disease Progression|1
5667594|NCT00455533|19562588|P1|Period Two: Randomized Period|Disease Progression|0
5667595|NCT00455533|19562586|P3|Period Two: Randomized Period|Death|3
5667596|NCT00455533|19562587|P2|Period Two: Randomized Period|Death|0
5667597|NCT00455533|19562588|P1|Period Two: Randomized Period|Death|0
5667598|NCT00455533|19562586|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
5667599|NCT00455533|19562587|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
5667600|NCT00455533|19562588|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
5667601|NCT00455533|19562586|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
5667602|NCT00455533|19562587|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
5667603|NCT00455533|19562588|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
5667604|NCT00455533|19562586|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
5667605|NCT00455533|19562587|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
5667606|NCT00455533|19562588|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
5667607|NCT00455533|19562586|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
5667608|NCT00455533|19562587|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
5667609|NCT00455533|19562588|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
5667610|NCT00455533|19562586|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
5667611|NCT00455533|19562587|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
5667612|NCT00455533|19562588|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
5667613|NCT00455533|19562586|P3|Period One: Initial Chemotherapy|Not Reported|0
5667614|NCT00455533|19562587|P2|Period One: Initial Chemotherapy|Not Reported|0
5667615|NCT00455533|19562588|P1|Period One: Initial Chemotherapy|Not Reported|1
5667616|NCT00455533|19562586|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
5667617|NCT00455533|19562587|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
5667618|NCT00455533|19562588|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
5667619|NCT00455533|19562586|P3|Period One: Initial Chemotherapy|Disease Progression|0
5667620|NCT00455533|19562587|P2|Period One: Initial Chemotherapy|Disease Progression|0
5667621|NCT00455533|19562588|P1|Period One: Initial Chemotherapy|Disease Progression|5
5667622|NCT00455533|19562586|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
5667623|NCT00455533|19562587|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
5667624|NCT00455533|19562588|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
5667625|NCT00455520|19562637|P2|Double Blind Tapentadol ER vs Placebo|All other|6
5667626|NCT00455520|19562638|P1|Double Blind Tapentadol ER vs Placebo|All other|4
5667627|NCT00455520|19562637|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
5667628|NCT00455520|19562638|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
5667629|NCT00455520|19562637|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
5667630|NCT00455520|19562638|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
5667631|NCT00455520|19562637|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
5667632|NCT00455520|19562638|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
5667633|NCT00455520|19562637|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
5667634|NCT00455520|19562638|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
5667635|NCT00455520|19562637|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
5667636|NCT00455520|19562638|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
5667637|NCT00455520|19562637|P2|Open Label Tapentadol Extended Release|All other|0
5667638|NCT00455520|19562638|P1|Open Label Tapentadol Extended Release|All other|33
5667639|NCT00455520|19562637|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
5667640|NCT00455520|19562638|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
5667641|NCT00455520|19562637|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
5667642|NCT00455520|19562638|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
5667643|NCT00455520|19562637|P2|Open Label Tapentadol Extended Release|Adverse Event|0
5667644|NCT00455520|19562638|P1|Open Label Tapentadol Extended Release|Adverse Event|100
5667645|NCT00455520|19562637|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
5667646|NCT00455520|19562638|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
5667647|NCT00455520|19562637|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
5667648|NCT00455520|19562638|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
5667649|NCT00455455|19562654|P2|Washout|Withdrawal by Subject|0
5667650|NCT00455455|19562655|P1|Washout|Withdrawal by Subject|1
5667651|NCT00455455|19562654|P2|Washout|Withdrawal by Subject|1
5667652|NCT00455455|19562655|P1|Washout|Withdrawal by Subject|0
5667653|NCT00455429|19562675|P4|Overall Study|Other|1
5667654|NCT00455429|19562676|P3|Overall Study|Other|0
5667655|NCT00455429|19562677|P2|Overall Study|Other|2
5667656|NCT00455429|19562678|P1|Overall Study|Other|0
5667657|NCT00455429|19562675|P4|Overall Study|Non-compliance|1
5667658|NCT00455429|19562676|P3|Overall Study|Non-compliance|0
5667659|NCT00455429|19562677|P2|Overall Study|Non-compliance|0
5667660|NCT00455429|19562678|P1|Overall Study|Non-compliance|0
5667661|NCT00455429|19562675|P4|Overall Study|Personal Reason|0
5667662|NCT00455429|19562676|P3|Overall Study|Personal Reason|0
5667663|NCT00455429|19562677|P2|Overall Study|Personal Reason|0
5667664|NCT00455429|19562678|P1|Overall Study|Personal Reason|1
5667665|NCT00455429|19562675|P4|Overall Study|Randomly assigned but not treated|2
5667666|NCT00455429|19562676|P3|Overall Study|Randomly assigned but not treated|0
5667667|NCT00455429|19562677|P2|Overall Study|Randomly assigned but not treated|0
5667668|NCT00455429|19562678|P1|Overall Study|Randomly assigned but not treated|0
5667669|NCT00455429|19562675|P4|Overall Study|Adverse Event|3
5667670|NCT00455429|19562676|P3|Overall Study|Adverse Event|0
5667671|NCT00455429|19562677|P2|Overall Study|Adverse Event|1
5667672|NCT00455429|19562678|P1|Overall Study|Adverse Event|0
5667673|NCT00455429|19562675|P4|Overall Study|Lack of Efficacy|1
5667674|NCT00455429|19562676|P3|Overall Study|Lack of Efficacy|0
5667675|NCT00455429|19562677|P2|Overall Study|Lack of Efficacy|1
5667676|NCT00455429|19562678|P1|Overall Study|Lack of Efficacy|0
5667677|NCT00455429|19562675|P4|Overall Study|Withdrawal by Subject|0
5667678|NCT00455429|19562676|P3|Overall Study|Withdrawal by Subject|1
5667679|NCT00455429|19562677|P2|Overall Study|Withdrawal by Subject|1
5667680|NCT00455429|19562678|P1|Overall Study|Withdrawal by Subject|0
5667681|NCT00455429|19562675|P4|Overall Study|Lost to Follow-up|3
5667682|NCT00455429|19562676|P3|Overall Study|Lost to Follow-up|0
5667683|NCT00455429|19562677|P2|Overall Study|Lost to Follow-up|0
5667684|NCT00455429|19562678|P1|Overall Study|Lost to Follow-up|1
5667685|NCT00455429|19562675|P4|Overall Study|Study Terminated by Sponsor|3
5667686|NCT00455429|19562676|P3|Overall Study|Study Terminated by Sponsor|0
5667687|NCT00455429|19562677|P2|Overall Study|Study Terminated by Sponsor|0
5667688|NCT00455429|19562678|P1|Overall Study|Study Terminated by Sponsor|0
5667689|NCT00455312|19562737|P2|Overall Study|Death|1
5667690|NCT00455312|19562738|P1|Overall Study|Death|0
5667691|NCT00455195|19562764|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
5667692|NCT00455195|19562765|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
5667693|NCT00455195|19562764|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
5667694|NCT00455195|19562765|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
5667695|NCT00455195|19562764|P2|Double-blind Study AGLU02704|Death|0
5667696|NCT00455195|19562765|P1|Double-blind Study AGLU02704|Death|1
5667697|NCT00455195|19562764|P2|Double-blind Study AGLU02704|Adverse Event|1
5667698|NCT00455195|19562765|P1|Double-blind Study AGLU02704|Adverse Event|2
5667699|NCT00455143|19562779|P1|Overall Study|Surgical time, staff not available|1
5667700|NCT00455143|19562779|P1|Overall Study|No longer met Inclusion Criteria|1
5667701|NCT00455143|19562779|P1|Overall Study|Staff was not avail to follow patient|2
5667702|NCT00455143|19562779|P1|Overall Study|Withdrawal by Subject|1
5667703|NCT00455143|19562779|P1|Overall Study|Physician Decision|1
5667704|NCT00455013|19562803|P3|Long Term Extension (LTE)|non-specified|1
5667705|NCT00455013|19562804|P2|Long Term Extension (LTE)|non-specified|0
5667706|NCT00455013|19562805|P1|Long Term Extension (LTE)|non-specified|0
5667707|NCT00455013|19562803|P3|Long Term Extension (LTE)|Poor non-compliance|0
5667708|NCT00455013|19562804|P2|Long Term Extension (LTE)|Poor non-compliance|1
5667709|NCT00455013|19562805|P1|Long Term Extension (LTE)|Poor non-compliance|0
5667710|NCT00455013|19562803|P3|Long Term Extension (LTE)|Subject Request or refused|3
5667711|NCT00455013|19562804|P2|Long Term Extension (LTE)|Subject Request or refused|0
5667712|NCT00455013|19562805|P1|Long Term Extension (LTE)|Subject Request or refused|0
5667713|NCT00455013|19562803|P3|Long Term Extension (LTE)|No longer met criteria|1
5667714|NCT00455013|19562804|P2|Long Term Extension (LTE)|No longer met criteria|0
5667715|NCT00455013|19562805|P1|Long Term Extension (LTE)|No longer met criteria|0
5667716|NCT00455013|19562803|P3|Long Term Extension (LTE)|Death|0
5667717|NCT00455013|19562804|P2|Long Term Extension (LTE)|Death|1
5667718|NCT00455013|19562805|P1|Long Term Extension (LTE)|Death|1
5667719|NCT00455013|19562803|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
5667720|NCT00455013|19562804|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
5667721|NCT00455013|19562805|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
5667722|NCT00455013|19562803|P3|Long Term Extension (LTE)|Adverse Event|1
5667723|NCT00455013|19562804|P2|Long Term Extension (LTE)|Adverse Event|1
5667724|NCT00455013|19562805|P1|Long Term Extension (LTE)|Adverse Event|0
5667725|NCT00455013|19562803|P3|Short Term Period|Other|1
5667726|NCT00455013|19562804|P2|Short Term Period|Other|0
5667727|NCT00455013|19562805|P1|Short Term Period|Other|0
5667728|NCT00455013|19562803|P3|Short Term Period|Lack of Efficacy|0
5667729|NCT00455013|19562804|P2|Short Term Period|Lack of Efficacy|0
5667730|NCT00455013|19562805|P1|Short Term Period|Lack of Efficacy|4
5667731|NCT00455013|19562803|P3|Short Term Period|Withdrawal by Subject|1
5667732|NCT00455013|19562804|P2|Short Term Period|Withdrawal by Subject|0
5667733|NCT00455013|19562805|P1|Short Term Period|Withdrawal by Subject|0
5667734|NCT00455013|19562803|P3|Short Term Period|Adverse Event|0
5667735|NCT00455013|19562804|P2|Short Term Period|Adverse Event|5
5667736|NCT00455013|19562805|P1|Short Term Period|Adverse Event|2
5667737|NCT00454987|19562873|P3|Booster Period (NCT00258700)|Lost to Follow-up|0
5667738|NCT00454987|19562874|P2|Booster Period (NCT00258700)|Lost to Follow-up|0
5667739|NCT00454987|19562875|P1|Booster Period (NCT00258700)|Lost to Follow-up|1
5667740|NCT00454987|19562873|P3|Booster Period (NCT00258700)|Withdrawal by Subject|0
5667741|NCT00454987|19562874|P2|Booster Period (NCT00258700)|Withdrawal by Subject|1
5667742|NCT00454987|19562875|P1|Booster Period (NCT00258700)|Withdrawal by Subject|0
5667743|NCT00454987|19562873|P3|Booster Period (NCT00258700)|Adverse Event|0
5667744|NCT00454987|19562874|P2|Booster Period (NCT00258700)|Adverse Event|0
5667745|NCT00454987|19562875|P1|Booster Period (NCT00258700)|Adverse Event|1
5667746|NCT00454909|19562949|P3|Overall Study|Others|0
5667747|NCT00454909|19562950|P2|Overall Study|Others|0
5667748|NCT00454909|19562951|P1|Overall Study|Others|1
5667749|NCT00454909|19562949|P3|Overall Study|Lost to follow-up (complete vaccination)|1
5667750|NCT00454909|19562950|P2|Overall Study|Lost to follow-up (complete vaccination)|3
5667751|NCT00454909|19562951|P1|Overall Study|Lost to follow-up (complete vaccination)|5
5667752|NCT00454909|19562949|P3|Overall Study|Migrated/moved from study area|1
5667753|NCT00454909|19562950|P2|Overall Study|Migrated/moved from study area|0
5667754|NCT00454909|19562951|P1|Overall Study|Migrated/moved from study area|0
5667755|NCT00454909|19562949|P3|Overall Study|Withdrawal by Subject|0
5667756|NCT00454909|19562950|P2|Overall Study|Withdrawal by Subject|0
5667757|NCT00454909|19562951|P1|Overall Study|Withdrawal by Subject|1
5667758|NCT00454857|19562989|P1|Overall Study|Reason unknown|1
5667759|NCT00454857|19562989|P1|Overall Study|Other|11
5667760|NCT00454857|19562989|P1|Overall Study|Death|5
5667761|NCT00454857|19562989|P1|Overall Study|Noncompliance|6
5667762|NCT00454857|19562989|P1|Overall Study|Lost to Follow-up|16
5667763|NCT00454857|19562989|P1|Overall Study|Withdrawal by Subject|15
5667764|NCT00454818|19563014|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
5667765|NCT00454818|19563015|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
5667766|NCT00454818|19563016|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
5667767|NCT00454818|19563017|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
5667768|NCT00454818|19563018|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
5667769|NCT00454818|19563014|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
5667770|NCT00454818|19563015|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
5667771|NCT00454818|19563016|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
5667772|NCT00454818|19563017|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
5667773|NCT00454818|19563018|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
5667774|NCT00454818|19563014|P5|Phase 2: Randomized Double-blind|Death|1
5667775|NCT00454818|19563015|P4|Phase 2: Randomized Double-blind|Death|0
5667776|NCT00454818|19563016|P3|Phase 2: Randomized Double-blind|Death|0
5667777|NCT00454818|19563017|P2|Phase 2: Randomized Double-blind|Death|1
5667778|NCT00454818|19563018|P1|Phase 2: Randomized Double-blind|Death|0
5667779|NCT00454818|19563014|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
5667780|NCT00454818|19563015|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
5667781|NCT00454818|19563016|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
5667782|NCT00454818|19563017|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
5667783|NCT00454818|19563018|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
5667784|NCT00454818|19563014|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
5667785|NCT00454818|19563015|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
5667786|NCT00454818|19563016|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
5667787|NCT00454818|19563017|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
5667788|NCT00454818|19563018|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
5667789|NCT00454818|19563014|P5|Phase I: Open-label Dose-escalation|Death|0
5667790|NCT00454818|19563015|P4|Phase I: Open-label Dose-escalation|Death|0
5667791|NCT00454818|19563016|P3|Phase I: Open-label Dose-escalation|Death|0
5667792|NCT00454818|19563017|P2|Phase I: Open-label Dose-escalation|Death|1
5667793|NCT00454818|19563018|P1|Phase I: Open-label Dose-escalation|Death|0
5667794|NCT00454818|19563014|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
5667795|NCT00454818|19563015|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
5667796|NCT00454818|19563016|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
5667797|NCT00454818|19563017|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
5667798|NCT00454818|19563018|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
5667799|NCT00454805|19563097|P2|Overall Study|In order to begin radiotherapy|0
5667800|NCT00454805|19563098|P1|Overall Study|In order to begin radiotherapy|1
5667801|NCT00454805|19563097|P2|Overall Study|Disease progression|19
5667802|NCT00454805|19563098|P1|Overall Study|Disease progression|16
5667803|NCT00454805|19563097|P2|Overall Study|Death|2
5667804|NCT00454805|19563098|P1|Overall Study|Death|0
5667805|NCT00454805|19563097|P2|Overall Study|Withdrawal by Subject|2
5667806|NCT00454805|19563098|P1|Overall Study|Withdrawal by Subject|9
5667807|NCT00454779|19563114|P2|Second-line Treatment Phase|Ongoing|1
5667808|NCT00454779|19563115|P1|Second-line Treatment Phase|Ongoing|0
5667809|NCT00454779|19563114|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
5667810|NCT00454779|19563115|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
5667811|NCT00454779|19563114|P2|Second-line Treatment Phase|Withdrawal by Subject|1
5667812|NCT00454779|19563115|P1|Second-line Treatment Phase|Withdrawal by Subject|0
5667813|NCT00454779|19563114|P2|First-line Treatment Phase|Ongoing|0
5667814|NCT00454779|19563115|P1|First-line Treatment Phase|Ongoing|1
5667815|NCT00454779|19563114|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
5667816|NCT00454779|19563115|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
5667817|NCT00454779|19563114|P2|First-line Treatment Phase|Protocol Violation|1
5667818|NCT00454779|19563115|P1|First-line Treatment Phase|Protocol Violation|0
5667819|NCT00454779|19563114|P2|First-line Treatment Phase|Lost to Follow-up|0
5667820|NCT00454779|19563115|P1|First-line Treatment Phase|Lost to Follow-up|1
5667821|NCT00454779|19563114|P2|First-line Treatment Phase|Withdrawal by Subject|4
5667822|NCT00454779|19563115|P1|First-line Treatment Phase|Withdrawal by Subject|2
5667823|NCT00454779|19563114|P2|First-line Treatment Phase|Lack of Efficacy|2
5667824|NCT00454779|19563115|P1|First-line Treatment Phase|Lack of Efficacy|0
5667825|NCT00454649|19563153|P10|Overall Study|Withdrawal by Subject|0
5667826|NCT00454649|19563154|P9|Overall Study|Withdrawal by Subject|1
5667827|NCT00454649|19563155|P8|Overall Study|Withdrawal by Subject|2
5667828|NCT00454649|19563156|P7|Overall Study|Withdrawal by Subject|0
5667829|NCT00454649|19563157|P6|Overall Study|Withdrawal by Subject|1
5667830|NCT00454649|19563158|P5|Overall Study|Withdrawal by Subject|0
5667831|NCT00454649|19563159|P4|Overall Study|Withdrawal by Subject|0
5667832|NCT00454649|19563160|P3|Overall Study|Withdrawal by Subject|0
5667833|NCT00454649|19563161|P2|Overall Study|Withdrawal by Subject|0
5667834|NCT00454649|19563162|P1|Overall Study|Withdrawal by Subject|0
5667835|NCT00454649|19563153|P10|Overall Study|Other|1
5667836|NCT00454649|19563154|P9|Overall Study|Other|3
5667837|NCT00454649|19563155|P8|Overall Study|Other|0
5667838|NCT00454649|19563156|P7|Overall Study|Other|0
5667839|NCT00454649|19563157|P6|Overall Study|Other|0
5667840|NCT00454649|19563158|P5|Overall Study|Other|0
5667841|NCT00454649|19563159|P4|Overall Study|Other|3
5667842|NCT00454649|19563160|P3|Overall Study|Other|5
5667843|NCT00454649|19563161|P2|Overall Study|Other|1
5667844|NCT00454649|19563162|P1|Overall Study|Other|1
5667845|NCT00454649|19563153|P10|Overall Study|Lost to Follow-up|0
5667846|NCT00454649|19563154|P9|Overall Study|Lost to Follow-up|0
5667847|NCT00454649|19563155|P8|Overall Study|Lost to Follow-up|0
5667848|NCT00454649|19563156|P7|Overall Study|Lost to Follow-up|1
5667849|NCT00454649|19563157|P6|Overall Study|Lost to Follow-up|0
5667850|NCT00454649|19563158|P5|Overall Study|Lost to Follow-up|0
5667851|NCT00454649|19563159|P4|Overall Study|Lost to Follow-up|0
5667852|NCT00454649|19563160|P3|Overall Study|Lost to Follow-up|1
5667853|NCT00454649|19563161|P2|Overall Study|Lost to Follow-up|0
5667854|NCT00454649|19563162|P1|Overall Study|Lost to Follow-up|0
5667855|NCT00454649|19563153|P10|Overall Study|Adverse Event|2
5667856|NCT00454649|19563154|P9|Overall Study|Adverse Event|6
5667857|NCT00454649|19563155|P8|Overall Study|Adverse Event|4
5667858|NCT00454649|19563156|P7|Overall Study|Adverse Event|3
5667859|NCT00454649|19563157|P6|Overall Study|Adverse Event|2
5667860|NCT00454649|19563158|P5|Overall Study|Adverse Event|1
5667861|NCT00454649|19563159|P4|Overall Study|Adverse Event|0
5667862|NCT00454649|19563160|P3|Overall Study|Adverse Event|3
5667863|NCT00454649|19563161|P2|Overall Study|Adverse Event|1
5667864|NCT00454649|19563162|P1|Overall Study|Adverse Event|0
5667865|NCT00454649|19563153|P10|Overall Study|Lack of Efficacy|2
5667866|NCT00454649|19563154|P9|Overall Study|Lack of Efficacy|10
5667867|NCT00454649|19563155|P8|Overall Study|Lack of Efficacy|13
5667868|NCT00454649|19563156|P7|Overall Study|Lack of Efficacy|5
5667869|NCT00454649|19563157|P6|Overall Study|Lack of Efficacy|4
5667870|NCT00454649|19563158|P5|Overall Study|Lack of Efficacy|0
5667871|NCT00454649|19563159|P4|Overall Study|Lack of Efficacy|3
5667872|NCT00454649|19563160|P3|Overall Study|Lack of Efficacy|10
5667873|NCT00454649|19563161|P2|Overall Study|Lack of Efficacy|2
5667874|NCT00454649|19563162|P1|Overall Study|Lack of Efficacy|2
5667875|NCT00454636|19563291|P4|Overall Study|Lost to Follow-up|0
5667876|NCT00454636|19563292|P3|Overall Study|Lost to Follow-up|0
5667877|NCT00454636|19563293|P2|Overall Study|Lost to Follow-up|1
5667878|NCT00454636|19563294|P1|Overall Study|Lost to Follow-up|0
5667879|NCT00454636|19563291|P4|Overall Study|Patient refusal|2
5667880|NCT00454636|19563292|P3|Overall Study|Patient refusal|3
5667881|NCT00454636|19563293|P2|Overall Study|Patient refusal|1
5667882|NCT00454636|19563294|P1|Overall Study|Patient refusal|1
5667883|NCT00454636|19563291|P4|Overall Study|Death|1
5667884|NCT00454636|19563292|P3|Overall Study|Death|1
5667885|NCT00454636|19563293|P2|Overall Study|Death|1
5667886|NCT00454636|19563294|P1|Overall Study|Death|6
5667887|NCT00454636|19563291|P4|Overall Study|Protocol Violation|3
5667888|NCT00454636|19563292|P3|Overall Study|Protocol Violation|3
5667889|NCT00454636|19563293|P2|Overall Study|Protocol Violation|2
5667890|NCT00454636|19563294|P1|Overall Study|Protocol Violation|3
5667891|NCT00454636|19563291|P4|Overall Study|Disease Progression|11
5667892|NCT00454636|19563292|P3|Overall Study|Disease Progression|4
5667893|NCT00454636|19563293|P2|Overall Study|Disease Progression|12
5667894|NCT00454636|19563294|P1|Overall Study|Disease Progression|11
5667895|NCT00454636|19563291|P4|Overall Study|Adverse Event|15
5667896|NCT00454636|19563292|P3|Overall Study|Adverse Event|9
5667897|NCT00454636|19563293|P2|Overall Study|Adverse Event|6
5667898|NCT00454636|19563294|P1|Overall Study|Adverse Event|10
5667899|NCT00454584|19563327|P6|After Controlled Period|Other|17
5667900|NCT00454584|19563328|P5|After Controlled Period|Other|5
5667901|NCT00454584|19563329|P4|After Controlled Period|Other|13
5667902|NCT00454584|19563330|P3|After Controlled Period|Other|0
5667903|NCT00454584|19563331|P2|After Controlled Period|Other|0
5667904|NCT00454584|19563332|P1|After Controlled Period|Other|0
5667905|NCT00454584|19563327|P6|After Controlled Period|Other|0
5667906|NCT00454584|19563328|P5|After Controlled Period|Other|0
5667907|NCT00454584|19563329|P4|After Controlled Period|Other|1
5667908|NCT00454584|19563330|P3|After Controlled Period|Other|0
5667909|NCT00454584|19563331|P2|After Controlled Period|Other|0
5667910|NCT00454584|19563332|P1|After Controlled Period|Other|0
5667911|NCT00454584|19563327|P6|After Controlled Period|Lost to Follow-up|6
5667912|NCT00454584|19563328|P5|After Controlled Period|Lost to Follow-up|4
5667913|NCT00454584|19563329|P4|After Controlled Period|Lost to Follow-up|2
5667914|NCT00454584|19563330|P3|After Controlled Period|Lost to Follow-up|0
5667915|NCT00454584|19563331|P2|After Controlled Period|Lost to Follow-up|0
5667916|NCT00454584|19563332|P1|After Controlled Period|Lost to Follow-up|0
5667917|NCT00454584|19563327|P6|After Controlled Period|Lack of Efficacy|0
5667918|NCT00454584|19563328|P5|After Controlled Period|Lack of Efficacy|0
5667919|NCT00454584|19563329|P4|After Controlled Period|Lack of Efficacy|1
5667920|NCT00454584|19563330|P3|After Controlled Period|Lack of Efficacy|0
5667921|NCT00454584|19563331|P2|After Controlled Period|Lack of Efficacy|0
5667922|NCT00454584|19563332|P1|After Controlled Period|Lack of Efficacy|0
5667923|NCT00454584|19563327|P6|After Controlled Period|Adverse Event|9
5667924|NCT00454584|19563328|P5|After Controlled Period|Adverse Event|3
5667925|NCT00454584|19563329|P4|After Controlled Period|Adverse Event|9
5667926|NCT00454584|19563330|P3|After Controlled Period|Adverse Event|0
5667927|NCT00454584|19563331|P2|After Controlled Period|Adverse Event|0
5667928|NCT00454584|19563332|P1|After Controlled Period|Adverse Event|0
5667929|NCT00454584|19563327|P6|Controlled Period|Other|0
5667930|NCT00454584|19563328|P5|Controlled Period|Other|0
5667931|NCT00454584|19563329|P4|Controlled Period|Other|0
5667932|NCT00454584|19563330|P3|Controlled Period|Other|2
5667933|NCT00454584|19563331|P2|Controlled Period|Other|4
5667934|NCT00454584|19563332|P1|Controlled Period|Other|5
5667935|NCT00454584|19563327|P6|Controlled Period|Lost to Follow-up|0
5667936|NCT00454584|19563328|P5|Controlled Period|Lost to Follow-up|0
5667937|NCT00454584|19563329|P4|Controlled Period|Lost to Follow-up|0
5667938|NCT00454584|19563330|P3|Controlled Period|Lost to Follow-up|2
5667939|NCT00454584|19563331|P2|Controlled Period|Lost to Follow-up|2
5667940|NCT00454584|19563332|P1|Controlled Period|Lost to Follow-up|1
5667941|NCT00454584|19563327|P6|Controlled Period|Adverse Event|0
5667942|NCT00454584|19563328|P5|Controlled Period|Adverse Event|0
5667943|NCT00454584|19563329|P4|Controlled Period|Adverse Event|0
5667944|NCT00454584|19563330|P3|Controlled Period|Adverse Event|1
5667945|NCT00454584|19563331|P2|Controlled Period|Adverse Event|2
5667946|NCT00454584|19563332|P1|Controlled Period|Adverse Event|5
5667947|NCT00454571|19563354|P2|Overall Study|Withdrawal by Subject|5
5667948|NCT00454571|19563355|P1|Overall Study|Withdrawal by Subject|10
5667949|NCT00454571|19563354|P2|Overall Study|Protocol Violation|0
5667950|NCT00454571|19563355|P1|Overall Study|Protocol Violation|1
5667951|NCT00454571|19563354|P2|Overall Study|Physician Decision|1
5667952|NCT00454571|19563355|P1|Overall Study|Physician Decision|0
5667953|NCT00454571|19563354|P2|Overall Study|Adverse Event|0
5667954|NCT00454571|19563355|P1|Overall Study|Adverse Event|2
5667955|NCT00454363|19563390|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
5667956|NCT00454363|19563391|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
5667957|NCT00454363|19563390|P2|Overall Study|Adverse Event|2
5667958|NCT00454363|19563391|P1|Overall Study|Adverse Event|1
5667959|NCT00454246|19563420|P3|Overall Study|Early termination of study|9
5667960|NCT00454246|19563421|P2|Overall Study|Early termination of study|26
5667961|NCT00454246|19563422|P1|Overall Study|Early termination of study|62
5667962|NCT00454246|19563420|P3|Overall Study|Failure to return|0
5667963|NCT00454246|19563421|P2|Overall Study|Failure to return|0
5667964|NCT00454246|19563422|P1|Overall Study|Failure to return|1
5667965|NCT00454246|19563420|P3|Overall Study|Refused Treatment|0
5667966|NCT00454246|19563421|P2|Overall Study|Refused Treatment|1
5667967|NCT00454246|19563422|P1|Overall Study|Refused Treatment|1
5667968|NCT00454246|19563420|P3|Overall Study|Protocol Violation|0
5667969|NCT00454246|19563421|P2|Overall Study|Protocol Violation|0
5667970|NCT00454246|19563422|P1|Overall Study|Protocol Violation|1
5667971|NCT00454246|19563420|P3|Overall Study|Violation of selection criteria at entry|0
5667972|NCT00454246|19563421|P2|Overall Study|Violation of selection criteria at entry|0
5667973|NCT00454246|19563422|P1|Overall Study|Violation of selection criteria at entry|6
5667974|NCT00454246|19563420|P3|Overall Study|Adverse Event|0
5667975|NCT00454246|19563421|P2|Overall Study|Adverse Event|2
5667976|NCT00454246|19563422|P1|Overall Study|Adverse Event|2
5667977|NCT00454207|19563438|P2|Overall Study|Protocol Violation|1
5667978|NCT00454207|19563439|P1|Overall Study|Protocol Violation|0
5667979|NCT00454207|19563438|P2|Overall Study|Lack of Efficacy|0
5667980|NCT00454207|19563439|P1|Overall Study|Lack of Efficacy|1
5667981|NCT00454207|19563438|P2|Overall Study|Adverse Event|1
5667982|NCT00454207|19563439|P1|Overall Study|Adverse Event|3
5667983|NCT00454194|19563484|P2|Overall Study|Other Unspecified Reason|2
5667984|NCT00454194|19563485|P1|Overall Study|Other Unspecified Reason|2
5667985|NCT00454194|19563484|P2|Overall Study|Other Medical Problems|2
5667986|NCT00454194|19563485|P1|Overall Study|Other Medical Problems|1
5667987|NCT00454194|19563484|P2|Overall Study|Withdrawal by Subject|8
5667988|NCT00454194|19563485|P1|Overall Study|Withdrawal by Subject|12
5667989|NCT00454194|19563484|P2|Overall Study|Adverse Event|2
5667990|NCT00454194|19563485|P1|Overall Study|Adverse Event|7
5667991|NCT00454181|19563503|P2|Overall Study|Withdrawal by Subject|0
5667992|NCT00454181|19563504|P1|Overall Study|Withdrawal by Subject|2
5667993|NCT00454181|19563503|P2|Overall Study|Protocol Violation|1
5667994|NCT00454181|19563504|P1|Overall Study|Protocol Violation|1
5667995|NCT00454181|19563503|P2|Overall Study|Lost to Follow-up|1
5667996|NCT00454181|19563504|P1|Overall Study|Lost to Follow-up|11
5667997|NCT00454181|19563503|P2|Overall Study|Adverse Event|1
5667998|NCT00454181|19563504|P1|Overall Study|Adverse Event|1
5667999|NCT00454142|19563520|P1|Overall Study|Withdrawal by Subject|1
5668000|NCT00454116|19563538|P3|Overall Study|Other|0
5668001|NCT00454116|19563539|P2|Overall Study|Other|2
5668002|NCT00454116|19563540|P1|Overall Study|Other|2
5668003|NCT00454116|19563538|P3|Overall Study|Withdrawal by Subject|1
5668004|NCT00454116|19563539|P2|Overall Study|Withdrawal by Subject|3
5668005|NCT00454116|19563540|P1|Overall Study|Withdrawal by Subject|3
5668006|NCT00454116|19563538|P3|Overall Study|Condition under investigation worsened|18
5668007|NCT00454116|19563539|P2|Overall Study|Condition under investigation worsened|13
5668008|NCT00454116|19563540|P1|Overall Study|Condition under investigation worsened|17
5668009|NCT00454116|19563538|P3|Overall Study|Adverse Event|9
5668010|NCT00454116|19563539|P2|Overall Study|Adverse Event|11
5668011|NCT00454116|19563540|P1|Overall Study|Adverse Event|5
5668012|NCT00454051|19563550|P2|Overall Study|Protocol Violation|1
5668013|NCT00454051|19563551|P1|Overall Study|Protocol Violation|1
5668014|NCT00454051|19563550|P2|Overall Study|Withdrawal by Subject|0
5668015|NCT00454051|19563551|P1|Overall Study|Withdrawal by Subject|1
5668016|NCT00454051|19563550|P2|Overall Study|Adverse Event|2
5668017|NCT00454051|19563551|P1|Overall Study|Adverse Event|1
5668018|NCT00453999|19563584|P3|Overall Study|Subject Request|0
5668019|NCT00453999|19563585|P2|Overall Study|Subject Request|1
5668020|NCT00453999|19563586|P1|Overall Study|Subject Request|2
5668021|NCT00453999|19563584|P3|Overall Study|Withdrawal by Subject|1
5668022|NCT00453999|19563585|P2|Overall Study|Withdrawal by Subject|1
5668023|NCT00453999|19563586|P1|Overall Study|Withdrawal by Subject|2
5668024|NCT00453999|19563584|P3|Overall Study|Lost to Follow-up|1
5668025|NCT00453999|19563585|P2|Overall Study|Lost to Follow-up|1
5668026|NCT00453999|19563586|P1|Overall Study|Lost to Follow-up|0
5668027|NCT00453999|19563584|P3|Overall Study|Adverse Event|1
5668028|NCT00453999|19563585|P2|Overall Study|Adverse Event|2
5668029|NCT00453999|19563586|P1|Overall Study|Adverse Event|1
5668030|NCT00453986|19563614|P5|Overall Study|Lost to Follow-up|0
5668031|NCT00453986|19563615|P4|Overall Study|Lost to Follow-up|2
5668032|NCT00453986|19563616|P3|Overall Study|Lost to Follow-up|6
5668033|NCT00453986|19563617|P2|Overall Study|Lost to Follow-up|5
5668034|NCT00453986|19563618|P1|Overall Study|Lost to Follow-up|6
5668035|NCT00453973|19563711|P2|Overall Study|Sponsor Decision to Terminate Study|30
5668036|NCT00453973|19563712|P1|Overall Study|Sponsor Decision to Terminate Study|35
5668037|NCT00453973|19563711|P2|Overall Study|Site closed by sponsor|0
5668038|NCT00453973|19563712|P1|Overall Study|Site closed by sponsor|3
5668039|NCT00453973|19563711|P2|Overall Study|Renal transplant|1
5668040|NCT00453973|19563712|P1|Overall Study|Renal transplant|1
5668041|NCT00453973|19563711|P2|Overall Study|Relocation|0
5668042|NCT00453973|19563712|P1|Overall Study|Relocation|1
5668043|NCT00453973|19563711|P2|Overall Study|PI Decision|2
5668044|NCT00453973|19563712|P1|Overall Study|PI Decision|0
5668045|NCT00453973|19563711|P2|Overall Study|Withdrawal by Subject|6
5668046|NCT00453973|19563712|P1|Overall Study|Withdrawal by Subject|7
5668047|NCT00453973|19563711|P2|Overall Study|Adverse Event|9
5668048|NCT00453973|19563712|P1|Overall Study|Adverse Event|4
5668049|NCT00453921|19563722|P4|Overall Study|Lost to Follow-up|0
5668050|NCT00453921|19563723|P3|Overall Study|Lost to Follow-up|1
5668051|NCT00453921|19563724|P2|Overall Study|Lost to Follow-up|0
5668052|NCT00453921|19563725|P1|Overall Study|Lost to Follow-up|0
5668053|NCT00453921|19563722|P4|Overall Study|Withdrawal by Subject|1
5668054|NCT00453921|19563723|P3|Overall Study|Withdrawal by Subject|1
5668055|NCT00453921|19563724|P2|Overall Study|Withdrawal by Subject|1
5668056|NCT00453921|19563725|P1|Overall Study|Withdrawal by Subject|1
5668057|NCT00453362|19563872|P1|Overall Study|Screening Failure|14
5668058|NCT00453362|19563872|P1|Overall Study|Progression of disease|56
5668059|NCT00453362|19563872|P1|Overall Study|Withdrawal by Subject|3
5668060|NCT00453362|19563872|P1|Overall Study|Physician Decision|2
5668061|NCT00453362|19563872|P1|Overall Study|Death|7
5668062|NCT00453362|19563872|P1|Overall Study|Adverse Event|5
5668063|NCT00453349|19563898|P2|Completed Study|Lost to follow up after study treatment|11
5668064|NCT00453349|19563899|P1|Completed Study|Lost to follow up after study treatment|2
5668065|NCT00453349|19563898|P2|Completed Study|Withdrawal by Subject|5
5668066|NCT00453349|19563899|P1|Completed Study|Withdrawal by Subject|3
5668067|NCT00453349|19563898|P2|Completed Study|Protocol Violation|1
5668068|NCT00453349|19563899|P1|Completed Study|Protocol Violation|1
5668069|NCT00453349|19563898|P2|Completed Study|Lost to Follow-up|5
5668070|NCT00453349|19563899|P1|Completed Study|Lost to Follow-up|7
5668071|NCT00453349|19563898|P2|Completed Study|Lack of Efficacy|1
5668072|NCT00453349|19563899|P1|Completed Study|Lack of Efficacy|2
5668073|NCT00453349|19563898|P2|Completed Study|Adverse Event|11
5668074|NCT00453349|19563899|P1|Completed Study|Adverse Event|12
5668075|NCT00453349|19563898|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
5668076|NCT00453349|19563899|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
5668077|NCT00453349|19563898|P2|Randomized|Withdrawal by Subject|5
5668078|NCT00453349|19563899|P1|Randomized|Withdrawal by Subject|3
5668079|NCT00453349|19563898|P2|Randomized|Protocol Violation|1
5668080|NCT00453349|19563899|P1|Randomized|Protocol Violation|1
5668081|NCT00453349|19563898|P2|Randomized|Lost to Follow-up|5
5668082|NCT00453349|19563899|P1|Randomized|Lost to Follow-up|7
5668083|NCT00453349|19563898|P2|Randomized|Lack of Efficacy|1
5668084|NCT00453349|19563899|P1|Randomized|Lack of Efficacy|2
5668085|NCT00453349|19563898|P2|Randomized|Adverse Event|11
5668086|NCT00453349|19563899|P1|Randomized|Adverse Event|12
5668087|NCT00453310|19563930|P1|Overall Study|Progression of Disease|10
5668088|NCT00453206|19563934|P1|Overall Study|Death|1
5668089|NCT00453180|19563944|P2|Overall Study|Adverse Event|2
5668090|NCT00453180|19563945|P1|Overall Study|Adverse Event|1
5668091|NCT00453180|19563944|P2|Overall Study|Lost to Follow-up|1
5668092|NCT00453180|19563945|P1|Overall Study|Lost to Follow-up|2
5668093|NCT00453154|19563964|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
5668094|NCT00453154|19563965|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
5668095|NCT00453154|19563966|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
5668096|NCT00453154|19563967|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
5668097|NCT00453154|19563964|P4|Double BIind Maintenance|Medical Issues|1
5668098|NCT00453154|19563965|P3|Double BIind Maintenance|Medical Issues|3
5668099|NCT00453154|19563966|P2|Double BIind Maintenance|Medical Issues|0
5668100|NCT00453154|19563967|P1|Double BIind Maintenance|Medical Issues|0
5668101|NCT00453154|19563964|P4|Double BIind Maintenance|Progression|26
5668102|NCT00453154|19563965|P3|Double BIind Maintenance|Progression|29
5668103|NCT00453154|19563966|P2|Double BIind Maintenance|Progression|0
5668104|NCT00453154|19563967|P1|Double BIind Maintenance|Progression|0
5668105|NCT00453154|19563964|P4|Double BIind Maintenance|Withdrawal by Subject|4
5668106|NCT00453154|19563965|P3|Double BIind Maintenance|Withdrawal by Subject|4
5668107|NCT00453154|19563966|P2|Double BIind Maintenance|Withdrawal by Subject|0
5668108|NCT00453154|19563967|P1|Double BIind Maintenance|Withdrawal by Subject|0
5668109|NCT00453154|19563964|P4|Double BIind Maintenance|Death|1
5668110|NCT00453154|19563965|P3|Double BIind Maintenance|Death|2
5668111|NCT00453154|19563966|P2|Double BIind Maintenance|Death|0
5668112|NCT00453154|19563967|P1|Double BIind Maintenance|Death|0
5668113|NCT00453154|19563964|P4|Double BIind Maintenance|Adverse Event|12
5668114|NCT00453154|19563965|P3|Double BIind Maintenance|Adverse Event|3
5668115|NCT00453154|19563966|P2|Double BIind Maintenance|Adverse Event|0
5668116|NCT00453154|19563967|P1|Double BIind Maintenance|Adverse Event|0
5668117|NCT00453102|19563980|P1|Overall Study|Withdrawal by Subject|2
5668118|NCT00453063|19563991|P2|Overall Study|Protocol Violation|0
5668119|NCT00453063|19563992|P1|Overall Study|Protocol Violation|1
5668120|NCT00453063|19563991|P2|Overall Study|Withdrawal by Subject|1
5668121|NCT00453063|19563992|P1|Overall Study|Withdrawal by Subject|1
5668122|NCT00453063|19563991|P2|Overall Study|Adverse Event|2
5668123|NCT00453063|19563992|P1|Overall Study|Adverse Event|1
5668124|NCT00452790|19564012|P2|Toddler Dose|Parent/legal guardian request|1
5668125|NCT00452790|19564013|P1|Toddler Dose|Parent/legal guardian request|0
5668126|NCT00452790|19564012|P2|Toddler Dose|Failed to return|1
5668127|NCT00452790|19564013|P1|Toddler Dose|Failed to return|0
5668128|NCT00452790|19564012|P2|After Infant Series|Other reasons|0
5668129|NCT00452790|19564013|P1|After Infant Series|Other reasons|1
5668130|NCT00452790|19564012|P2|After Infant Series|Failed to return|0
5668131|NCT00452790|19564013|P1|After Infant Series|Failed to return|1
5668132|NCT00452790|19564012|P2|After Infant Series|Lost to Follow-up|0
5668133|NCT00452790|19564013|P1|After Infant Series|Lost to Follow-up|4
5668134|NCT00452790|19564012|P2|After Infant Series|Parent/legal guardian request|3
5668135|NCT00452790|19564013|P1|After Infant Series|Parent/legal guardian request|1
5668136|NCT00452790|19564012|P2|After Infant Series|Adverse Event|1
5668137|NCT00452790|19564013|P1|After Infant Series|Adverse Event|4
5668138|NCT00452790|19564012|P2|After Infant Series|Investigator request|10
5668139|NCT00452790|19564013|P1|After Infant Series|Investigator request|10
5668140|NCT00452790|19564012|P2|Infant Series|Death|1
5668141|NCT00452790|19564013|P1|Infant Series|Death|0
5668142|NCT00452790|19564012|P2|Infant Series|Investigator request|1
5668143|NCT00452790|19564013|P1|Infant Series|Investigator request|0
5668144|NCT00452790|19564012|P2|Infant Series|Other reasons|2
5668145|NCT00452790|19564013|P1|Infant Series|Other reasons|1
5668146|NCT00452790|19564012|P2|Infant Series|Adverse Event|2
5668147|NCT00452790|19564013|P1|Infant Series|Adverse Event|1
5668148|NCT00452790|19564012|P2|Infant Series|Lost to Follow-up|2
5668149|NCT00452790|19564013|P1|Infant Series|Lost to Follow-up|2
5668150|NCT00452790|19564012|P2|Infant Series|Protocol Violation|3
5668151|NCT00452790|19564013|P1|Infant Series|Protocol Violation|1
5668152|NCT00452790|19564012|P2|Infant Series|Failed to return|1
5668153|NCT00452790|19564013|P1|Infant Series|Failed to return|4
5668154|NCT00452790|19564012|P2|Infant Series|Parent/legal guardian request|6
5668155|NCT00452790|19564013|P1|Infant Series|Parent/legal guardian request|8
5668156|NCT00452790|19564012|P2|Infant Series|Clinical hold - consent withdrawn|123
5668157|NCT00452790|19564013|P1|Infant Series|Clinical hold - consent withdrawn|118
5668158|NCT00452699|19564049|P2|Overall Study|Other|7
5668159|NCT00452699|19564050|P1|Overall Study|Other|12
5668160|NCT00452699|19564049|P2|Overall Study|Withdrawal by Subject|25
5668161|NCT00452699|19564050|P1|Overall Study|Withdrawal by Subject|26
5668162|NCT00452699|19564049|P2|Overall Study|Protocol Violation|25
5668163|NCT00452699|19564050|P1|Overall Study|Protocol Violation|21
5668164|NCT00452699|19564049|P2|Overall Study|Lost to Follow-up|9
5668165|NCT00452699|19564050|P1|Overall Study|Lost to Follow-up|6
5668166|NCT00452699|19564049|P2|Overall Study|Lack of Efficacy|4
5668167|NCT00452699|19564050|P1|Overall Study|Lack of Efficacy|6
5668168|NCT00452699|19564049|P2|Overall Study|Adverse Event|3
5668169|NCT00452699|19564050|P1|Overall Study|Adverse Event|10
5668170|NCT00452673|19564066|P5|Dose Expansion Period|Other|2
5668171|NCT00452673|19564067|P4|Dose Expansion Period|Other|0
5668172|NCT00452673|19564068|P3|Dose Expansion Period|Other|0
5668173|NCT00452673|19564069|P2|Dose Expansion Period|Other|0
5668174|NCT00452673|19564070|P1|Dose Expansion Period|Other|0
5668175|NCT00452673|19564066|P5|Dose Expansion Period|Disease Progression|19
5668176|NCT00452673|19564067|P4|Dose Expansion Period|Disease Progression|0
5668177|NCT00452673|19564068|P3|Dose Expansion Period|Disease Progression|0
5668178|NCT00452673|19564069|P2|Dose Expansion Period|Disease Progression|0
5668179|NCT00452673|19564070|P1|Dose Expansion Period|Disease Progression|0
5668180|NCT00452673|19564066|P5|Dose Escalation Period|Withdrawal by Subject|0
5668181|NCT00452673|19564067|P4|Dose Escalation Period|Withdrawal by Subject|1
5668182|NCT00452673|19564068|P3|Dose Escalation Period|Withdrawal by Subject|0
5668183|NCT00452673|19564069|P2|Dose Escalation Period|Withdrawal by Subject|0
5668184|NCT00452673|19564070|P1|Dose Escalation Period|Withdrawal by Subject|0
5668185|NCT00452673|19564066|P5|Dose Escalation Period|Adverse Event|0
5668186|NCT00452673|19564067|P4|Dose Escalation Period|Adverse Event|1
5668187|NCT00452673|19564068|P3|Dose Escalation Period|Adverse Event|0
5668188|NCT00452673|19564069|P2|Dose Escalation Period|Adverse Event|0
5668189|NCT00452673|19564070|P1|Dose Escalation Period|Adverse Event|0
5668190|NCT00452673|19564066|P5|Dose Escalation Period|Other|0
5668191|NCT00452673|19564067|P4|Dose Escalation Period|Other|0
5668192|NCT00452673|19564068|P3|Dose Escalation Period|Other|1
5668193|NCT00452673|19564069|P2|Dose Escalation Period|Other|0
5668194|NCT00452673|19564070|P1|Dose Escalation Period|Other|0
5668195|NCT00452673|19564066|P5|Dose Escalation Period|study drug toxicity|0
5668196|NCT00452673|19564067|P4|Dose Escalation Period|study drug toxicity|1
5668197|NCT00452673|19564068|P3|Dose Escalation Period|study drug toxicity|3
5668198|NCT00452673|19564069|P2|Dose Escalation Period|study drug toxicity|3
5668199|NCT00452673|19564070|P1|Dose Escalation Period|study drug toxicity|1
5668200|NCT00452673|19564066|P5|Dose Escalation Period|Disease Progression|0
5668201|NCT00452673|19564067|P4|Dose Escalation Period|Disease Progression|6
5668202|NCT00452673|19564068|P3|Dose Escalation Period|Disease Progression|2
5668203|NCT00452673|19564069|P2|Dose Escalation Period|Disease Progression|6
5668204|NCT00452673|19564070|P1|Dose Escalation Period|Disease Progression|6
5668205|NCT00452530|19564117|P2|Overall Study|Other|11
5668206|NCT00452530|19564118|P1|Overall Study|Other|7
5668207|NCT00452530|19564117|P2|Overall Study|No longer met study criteria|22
5668208|NCT00452530|19564118|P1|Overall Study|No longer met study criteria|18
5668209|NCT00452530|19564117|P2|Overall Study|Poor compliance/noncompliance|2
5668210|NCT00452530|19564118|P1|Overall Study|Poor compliance/noncompliance|1
5668211|NCT00452530|19564117|P2|Overall Study|Lost to Follow-up|0
5668212|NCT00452530|19564118|P1|Overall Study|Lost to Follow-up|1
5668213|NCT00452530|19564117|P2|Overall Study|Withdrawal by Subject|57
5668214|NCT00452530|19564118|P1|Overall Study|Withdrawal by Subject|68
5668215|NCT00452530|19564117|P2|Overall Study|Adverse Event|44
5668216|NCT00452530|19564118|P1|Overall Study|Adverse Event|40
5668217|NCT00452530|19564117|P2|Overall Study|Death|0
5668218|NCT00452530|19564118|P1|Overall Study|Death|1
5668219|NCT00452452|19564139|P3|Overall Study|Lost to Follow-up|0
5668220|NCT00452452|19564140|P2|Overall Study|Lost to Follow-up|0
5668221|NCT00452452|19564141|P1|Overall Study|Lost to Follow-up|1
5668222|NCT00452452|19564139|P3|Overall Study|Withdrawal by Subject|0
5668223|NCT00452452|19564140|P2|Overall Study|Withdrawal by Subject|0
5668224|NCT00452452|19564141|P1|Overall Study|Withdrawal by Subject|1
5668225|NCT00452452|19564139|P3|Overall Study|Protocol Violation|1
5668226|NCT00452452|19564140|P2|Overall Study|Protocol Violation|0
5668227|NCT00452452|19564141|P1|Overall Study|Protocol Violation|0
5668228|NCT00452439|19564166|P2|Overall Study|Fracture|0
5668229|NCT00452439|19564167|P1|Overall Study|Fracture|1
5668230|NCT00452439|19564166|P2|Overall Study|Relapse|0
5668231|NCT00452439|19564167|P1|Overall Study|Relapse|3
5668232|NCT00452439|19564166|P2|Overall Study|Failed to achieve complete response|0
5668233|NCT00452439|19564167|P1|Overall Study|Failed to achieve complete response|2
5668234|NCT00452439|19564166|P2|Overall Study|Too Ill to Continue|1
5668235|NCT00452439|19564167|P1|Overall Study|Too Ill to Continue|0
5668236|NCT00452439|19564166|P2|Overall Study|Bone Marrow Transplant|1
5668237|NCT00452439|19564167|P1|Overall Study|Bone Marrow Transplant|0
5668238|NCT00452439|19564166|P2|Overall Study|Death|1
5668239|NCT00452439|19564167|P1|Overall Study|Death|3
5668240|NCT00452439|19564166|P2|Overall Study|Refused Treatment|3
5668241|NCT00452439|19564167|P1|Overall Study|Refused Treatment|4
5668242|NCT00452439|19564166|P2|Overall Study|Lost to Follow-up|1
5668243|NCT00452439|19564167|P1|Overall Study|Lost to Follow-up|1
5668244|NCT00452400|19564197|P5|Overall Study|Other reasons not listed above|1
5668245|NCT00452400|19564198|P4|Overall Study|Other reasons not listed above|1
5668246|NCT00452400|19564199|P3|Overall Study|Other reasons not listed above|0
5668247|NCT00452400|19564200|P2|Overall Study|Other reasons not listed above|0
5668248|NCT00452400|19564201|P1|Overall Study|Other reasons not listed above|0
5668249|NCT00452400|19564197|P5|Overall Study|Lack of Efficacy|0
5668250|NCT00452400|19564198|P4|Overall Study|Lack of Efficacy|0
5668251|NCT00452400|19564199|P3|Overall Study|Lack of Efficacy|0
5668252|NCT00452400|19564200|P2|Overall Study|Lack of Efficacy|0
5668253|NCT00452400|19564201|P1|Overall Study|Lack of Efficacy|2
5668254|NCT00452400|19564197|P5|Overall Study|Withdrawal by Subject|0
5668255|NCT00452400|19564198|P4|Overall Study|Withdrawal by Subject|0
5668256|NCT00452400|19564199|P3|Overall Study|Withdrawal by Subject|1
5668257|NCT00452400|19564200|P2|Overall Study|Withdrawal by Subject|0
5668258|NCT00452400|19564201|P1|Overall Study|Withdrawal by Subject|1
5668259|NCT00452400|19564197|P5|Overall Study|Lost to Follow-up|0
5668260|NCT00452400|19564198|P4|Overall Study|Lost to Follow-up|0
5668261|NCT00452400|19564199|P3|Overall Study|Lost to Follow-up|0
5668262|NCT00452400|19564200|P2|Overall Study|Lost to Follow-up|0
5668263|NCT00452400|19564201|P1|Overall Study|Lost to Follow-up|1
5668264|NCT00452400|19564197|P5|Overall Study|Protocol Violation|0
5668265|NCT00452400|19564198|P4|Overall Study|Protocol Violation|0
5668266|NCT00452400|19564199|P3|Overall Study|Protocol Violation|1
5668267|NCT00452400|19564200|P2|Overall Study|Protocol Violation|0
5668268|NCT00452400|19564201|P1|Overall Study|Protocol Violation|0
5668269|NCT00452400|19564197|P5|Overall Study|Adverse Event|2
5668270|NCT00452400|19564198|P4|Overall Study|Adverse Event|0
5668271|NCT00452400|19564199|P3|Overall Study|Adverse Event|5
5668272|NCT00452400|19564200|P2|Overall Study|Adverse Event|1
5668273|NCT00452400|19564201|P1|Overall Study|Adverse Event|1
5668274|NCT00452361|19564388|P2|Overall Study|Premature termination|9
5668275|NCT00452361|19564389|P1|Overall Study|Premature termination|13
5668276|NCT00452361|19564388|P2|Overall Study|Withdrawal by Subject|1
5668277|NCT00452361|19564389|P1|Overall Study|Withdrawal by Subject|0
5668278|NCT00452361|19564388|P2|Overall Study|Adverse Event|0
5668279|NCT00452361|19564389|P1|Overall Study|Adverse Event|8
5668280|NCT00452348|19564433|P2|Overall Study|Other|9
5668281|NCT00452348|19564434|P1|Overall Study|Other|9
5668282|NCT00452348|19564433|P2|Overall Study|Withdrawal by Subject|21
5668283|NCT00452348|19564434|P1|Overall Study|Withdrawal by Subject|18
5668284|NCT00452348|19564433|P2|Overall Study|Protocol Violation|28
5668285|NCT00452348|19564434|P1|Overall Study|Protocol Violation|22
5668286|NCT00452348|19564433|P2|Overall Study|Lost to Follow-up|8
5668287|NCT00452348|19564434|P1|Overall Study|Lost to Follow-up|14
5668288|NCT00452348|19564433|P2|Overall Study|Lack of Efficacy|9
5668289|NCT00452348|19564434|P1|Overall Study|Lack of Efficacy|10
5668290|NCT00452348|19564433|P2|Overall Study|Adverse Event|9
5668291|NCT00452348|19564434|P1|Overall Study|Adverse Event|6
5668292|NCT00452114|19564488|P2|Overall Study|Physician Decision|3
5668293|NCT00452114|19564489|P1|Overall Study|Physician Decision|3
5668294|NCT00451958|19564505|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
5668295|NCT00451958|19564506|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
5668296|NCT00451958|19564507|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
5668297|NCT00451958|19564508|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
5668298|NCT00451958|19564509|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
5668299|NCT00451958|19564505|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
5668300|NCT00451958|19564506|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
5668301|NCT00451958|19564507|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
5668302|NCT00451958|19564508|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
5668303|NCT00451958|19564509|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
5668304|NCT00451958|19564505|P5|CS21A (NCT00451958)|Physician Decision|0
5668305|NCT00451958|19564506|P4|CS21A (NCT00451958)|Physician Decision|4
5668306|NCT00451958|19564507|P3|CS21A (NCT00451958)|Physician Decision|4
5668307|NCT00451958|19564508|P2|CS21A (NCT00451958)|Physician Decision|4
5668308|NCT00451958|19564509|P1|CS21A (NCT00451958)|Physician Decision|2
5668309|NCT00451958|19564505|P5|CS21A (NCT00451958)|Protocol Violation|0
5668310|NCT00451958|19564506|P4|CS21A (NCT00451958)|Protocol Violation|0
5668311|NCT00451958|19564507|P3|CS21A (NCT00451958)|Protocol Violation|2
5668312|NCT00451958|19564508|P2|CS21A (NCT00451958)|Protocol Violation|3
5668313|NCT00451958|19564509|P1|CS21A (NCT00451958)|Protocol Violation|1
5668314|NCT00451958|19564505|P5|CS21A (NCT00451958)|Lost to Follow-up|0
5668315|NCT00451958|19564506|P4|CS21A (NCT00451958)|Lost to Follow-up|1
5668316|NCT00451958|19564507|P3|CS21A (NCT00451958)|Lost to Follow-up|1
5668317|NCT00451958|19564508|P2|CS21A (NCT00451958)|Lost to Follow-up|5
5668318|NCT00451958|19564509|P1|CS21A (NCT00451958)|Lost to Follow-up|6
5668319|NCT00451958|19564505|P5|CS21A (NCT00451958)|Adverse Event|0
5668320|NCT00451958|19564506|P4|CS21A (NCT00451958)|Adverse Event|17
5668321|NCT00451958|19564507|P3|CS21A (NCT00451958)|Adverse Event|14
5668322|NCT00451958|19564508|P2|CS21A (NCT00451958)|Adverse Event|34
5668323|NCT00451958|19564509|P1|CS21A (NCT00451958)|Adverse Event|21
5668324|NCT00451906|19564539|P1|Overall Study|Did not complete final visit|4
5668325|NCT00451906|19564539|P1|Overall Study|Other Reasons|121
5668326|NCT00451906|19564539|P1|Overall Study|Termination of the study|108
5668327|NCT00451906|19564539|P1|Overall Study|Progressive disease|1328
5668328|NCT00451906|19564539|P1|Overall Study|Protocol Violation|21
5668329|NCT00451906|19564539|P1|Overall Study|Withdrawal by Subject|111
5668330|NCT00451906|19564539|P1|Overall Study|Lost to Follow-up|31
5668331|NCT00451906|19564539|P1|Overall Study|Adverse Event|515
5668332|NCT00451555|19564567|P2|Overall Study|Physician Decision|1
5668333|NCT00451555|19564568|P1|Overall Study|Physician Decision|2
5668334|NCT00451555|19564567|P2|Overall Study|Withdrawal by Subject|0
5668335|NCT00451555|19564568|P1|Overall Study|Withdrawal by Subject|6
5668336|NCT00451555|19564567|P2|Overall Study|Adverse Event|1
5668337|NCT00451555|19564568|P1|Overall Study|Adverse Event|3
5668338|NCT00451555|19564567|P2|Overall Study|Protocol Violation|2
5668339|NCT00451555|19564568|P1|Overall Study|Protocol Violation|2
5668340|NCT00451451|19564602|P4|Overall Study|Other Reasons for Not Completing Study|14
5668341|NCT00451451|19564603|P3|Overall Study|Other Reasons for Not Completing Study|17
5668342|NCT00451451|19564604|P2|Overall Study|Other Reasons for Not Completing Study|30
5668343|NCT00451451|19564605|P1|Overall Study|Other Reasons for Not Completing Study|34
5668344|NCT00451451|19564602|P4|Overall Study|Death|1
5668345|NCT00451451|19564603|P3|Overall Study|Death|0
5668346|NCT00451451|19564604|P2|Overall Study|Death|0
5668347|NCT00451451|19564605|P1|Overall Study|Death|1
5668348|NCT00451451|19564602|P4|Overall Study|Subject Non-Compliance|3
5668349|NCT00451451|19564603|P3|Overall Study|Subject Non-Compliance|3
5668350|NCT00451451|19564604|P2|Overall Study|Subject Non-Compliance|4
5668351|NCT00451451|19564605|P1|Overall Study|Subject Non-Compliance|8
5668352|NCT00451451|19564602|P4|Overall Study|Investigator Decision|2
5668353|NCT00451451|19564603|P3|Overall Study|Investigator Decision|1
5668354|NCT00451451|19564604|P2|Overall Study|Investigator Decision|2
5668355|NCT00451451|19564605|P1|Overall Study|Investigator Decision|6
5668356|NCT00451451|19564602|P4|Overall Study|Consent Withdrawn|17
5668357|NCT00451451|19564603|P3|Overall Study|Consent Withdrawn|17
5668358|NCT00451451|19564604|P2|Overall Study|Consent Withdrawn|9
5668359|NCT00451451|19564605|P1|Overall Study|Consent Withdrawn|14
5668360|NCT00451451|19564602|P4|Overall Study|Lost to Follow-up|11
5668361|NCT00451451|19564603|P3|Overall Study|Lost to Follow-up|8
5668362|NCT00451451|19564604|P2|Overall Study|Lost to Follow-up|9
5668363|NCT00451451|19564605|P1|Overall Study|Lost to Follow-up|11
5668364|NCT00451451|19564602|P4|Overall Study|Adverse Event|10
5668365|NCT00451451|19564603|P3|Overall Study|Adverse Event|26
5668366|NCT00451451|19564604|P2|Overall Study|Adverse Event|21
5668367|NCT00451451|19564605|P1|Overall Study|Adverse Event|11
5668368|NCT00451321|19564640|P8|Overall Study|Sponsor decision to amend protocol|3
5668369|NCT00451321|19564641|P7|Overall Study|Sponsor decision to amend protocol|1
5668370|NCT00451321|19564642|P6|Overall Study|Sponsor decision to amend protocol|1
5668371|NCT00451321|19564643|P5|Overall Study|Sponsor decision to amend protocol|0
5668372|NCT00451321|19564644|P4|Overall Study|Sponsor decision to amend protocol|0
5668373|NCT00451321|19564645|P3|Overall Study|Sponsor decision to amend protocol|0
5668374|NCT00451321|19564646|P2|Overall Study|Sponsor decision to amend protocol|0
5668375|NCT00451321|19564647|P1|Overall Study|Sponsor decision to amend protocol|0
5668376|NCT00451321|19564640|P8|Overall Study|Study closed/terminated|3
5668377|NCT00451321|19564641|P7|Overall Study|Study closed/terminated|5
5668378|NCT00451321|19564642|P6|Overall Study|Study closed/terminated|7
5668379|NCT00451321|19564643|P5|Overall Study|Study closed/terminated|7
5668380|NCT00451321|19564644|P4|Overall Study|Study closed/terminated|5
5668381|NCT00451321|19564645|P3|Overall Study|Study closed/terminated|17
5668382|NCT00451321|19564646|P2|Overall Study|Study closed/terminated|1
5668383|NCT00451321|19564647|P1|Overall Study|Study closed/terminated|1
5668384|NCT00451321|19564640|P8|Overall Study|Withdrawal by Subject|0
5668385|NCT00451321|19564641|P7|Overall Study|Withdrawal by Subject|0
5668386|NCT00451321|19564642|P6|Overall Study|Withdrawal by Subject|0
5668387|NCT00451321|19564643|P5|Overall Study|Withdrawal by Subject|0
5668388|NCT00451321|19564644|P4|Overall Study|Withdrawal by Subject|4
5668389|NCT00451321|19564645|P3|Overall Study|Withdrawal by Subject|0
5668390|NCT00451321|19564646|P2|Overall Study|Withdrawal by Subject|1
5668391|NCT00451321|19564647|P1|Overall Study|Withdrawal by Subject|3
5668392|NCT00451321|19564640|P8|Overall Study|Lost to Follow-up|0
5668393|NCT00451321|19564641|P7|Overall Study|Lost to Follow-up|0
5668394|NCT00451321|19564642|P6|Overall Study|Lost to Follow-up|1
5668395|NCT00451321|19564643|P5|Overall Study|Lost to Follow-up|0
5668396|NCT00451321|19564644|P4|Overall Study|Lost to Follow-up|3
5668397|NCT00451321|19564645|P3|Overall Study|Lost to Follow-up|1
5668398|NCT00451321|19564646|P2|Overall Study|Lost to Follow-up|3
5668399|NCT00451321|19564647|P1|Overall Study|Lost to Follow-up|3
5668400|NCT00451282|19564819|P2|Overall Study|Lost to Follow-up|5
5668401|NCT00451282|19564820|P1|Overall Study|Lost to Follow-up|6
5668402|NCT00451217|19564836|P4|Overall Study|Not Treated|4
5668403|NCT00451217|19564837|P3|Overall Study|Not Treated|3
5668404|NCT00451217|19564838|P2|Overall Study|Not Treated|1
5668405|NCT00451217|19564839|P1|Overall Study|Not Treated|1
5668406|NCT00451217|19564836|P4|Overall Study|Withdrawal by Subject|0
5668407|NCT00451217|19564837|P3|Overall Study|Withdrawal by Subject|0
5668408|NCT00451217|19564838|P2|Overall Study|Withdrawal by Subject|0
5668409|NCT00451217|19564839|P1|Overall Study|Withdrawal by Subject|1
5668410|NCT00451217|19564836|P4|Overall Study|Lost to Follow-up|1
5668411|NCT00451217|19564837|P3|Overall Study|Lost to Follow-up|1
5668412|NCT00451217|19564838|P2|Overall Study|Lost to Follow-up|1
5668413|NCT00451217|19564839|P1|Overall Study|Lost to Follow-up|0
5668414|NCT00451204|19564867|P2|Overall Study|Other|2
5668415|NCT00451204|19564868|P1|Overall Study|Other|1
5668416|NCT00451204|19564867|P2|Overall Study|Patient refusal|4
5668417|NCT00451204|19564868|P1|Overall Study|Patient refusal|8
5668418|NCT00451204|19564867|P2|Overall Study|Protocol Violation|0
5668419|NCT00451204|19564868|P1|Overall Study|Protocol Violation|1
5668420|NCT00451204|19564867|P2|Overall Study|Lost to Follow-up|4
5668421|NCT00451204|19564868|P1|Overall Study|Lost to Follow-up|4
5668422|NCT00451204|19564867|P2|Overall Study|Lack of Efficacy|4
5668423|NCT00451204|19564868|P1|Overall Study|Lack of Efficacy|4
5668424|NCT00451204|19564867|P2|Overall Study|Adverse Event|6
5668425|NCT00451204|19564868|P1|Overall Study|Adverse Event|4
5668426|NCT00451191|19564886|P2|Overall Study|withdrawal or received alternate tx|11
5668427|NCT00451191|19564887|P1|Overall Study|withdrawal or received alternate tx|15
5668428|NCT00451178|19564895|P2|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
5668429|NCT00451178|19564896|P1|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
5668430|NCT00451178|19564895|P2|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
5668431|NCT00451178|19564896|P1|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
5668432|NCT00451178|19564895|P2|Maintenance Therapy (up to 3 Years)|PD|0
5668433|NCT00451178|19564896|P1|Maintenance Therapy (up to 3 Years)|PD|10
5668434|NCT00451178|19564895|P2|Maintenance Therapy (up to 3 Years)|Death|0
5668435|NCT00451178|19564896|P1|Maintenance Therapy (up to 3 Years)|Death|1
5668436|NCT00451178|19564895|P2|Maintenance Therapy (up to 3 Years)|Physician Decision|0
5668437|NCT00451178|19564896|P1|Maintenance Therapy (up to 3 Years)|Physician Decision|1
5668438|NCT00451178|19564895|P2|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
5668439|NCT00451178|19564896|P1|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
5668440|NCT00451178|19564895|P2|Maintenance Therapy (up to 3 Years)|Adverse Event|0
5668441|NCT00451178|19564896|P1|Maintenance Therapy (up to 3 Years)|Adverse Event|4
5668442|NCT00451178|19564895|P2|Prior to Maintenance Therapy|PD|0
5668443|NCT00451178|19564896|P1|Prior to Maintenance Therapy|PD|2
5668444|NCT00451178|19564895|P2|Prior to Maintenance Therapy|Physician Decision|0
5668445|NCT00451178|19564896|P1|Prior to Maintenance Therapy|Physician Decision|2
5668446|NCT00451178|19564895|P2|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
5668447|NCT00451178|19564896|P1|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
5668448|NCT00451178|19564895|P2|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
5668449|NCT00451178|19564896|P1|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
5668450|NCT00451178|19564895|P2|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
5668451|NCT00451178|19564896|P1|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
5668452|NCT00451178|19564895|P2|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
5668453|NCT00451178|19564896|P1|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
5668454|NCT00451178|19564895|P2|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
5668455|NCT00451178|19564896|P1|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
5668456|NCT00451178|19564895|P2|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
5668457|NCT00451178|19564896|P1|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
5668458|NCT00450866|19564943|P2|Overall Study|Physician Decision|0
5668459|NCT00450866|19564944|P1|Overall Study|Physician Decision|1
5668460|NCT00450866|19564943|P2|Overall Study|Death|0
5668461|NCT00450866|19564944|P1|Overall Study|Death|1
5668462|NCT00450866|19564943|P2|Overall Study|Withdrawal by Subject|2
5668463|NCT00450866|19564944|P1|Overall Study|Withdrawal by Subject|5
5668464|NCT00450866|19564943|P2|Overall Study|Adverse Event|1
5668465|NCT00450866|19564944|P1|Overall Study|Adverse Event|0
5668466|NCT00450814|19564964|P11|Overall Study|Patient withdrawal prior to treatment|0
5668467|NCT00450814|19564965|P10|Overall Study|Patient withdrawal prior to treatment|1
5668468|NCT00450814|19564966|P9|Overall Study|Patient withdrawal prior to treatment|0
5668469|NCT00450814|19564967|P8|Overall Study|Patient withdrawal prior to treatment|0
5668470|NCT00450814|19564968|P7|Overall Study|Patient withdrawal prior to treatment|0
5668471|NCT00450814|19564969|P6|Overall Study|Patient withdrawal prior to treatment|0
5668472|NCT00450814|19564970|P5|Overall Study|Patient withdrawal prior to treatment|0
5668473|NCT00450814|19564971|P4|Overall Study|Patient withdrawal prior to treatment|0
5668474|NCT00450814|19564972|P3|Overall Study|Patient withdrawal prior to treatment|0
5668475|NCT00450814|19564973|P2|Overall Study|Patient withdrawal prior to treatment|0
5668476|NCT00450814|19564974|P1|Overall Study|Patient withdrawal prior to treatment|0
5668477|NCT00450814|19564964|P11|Overall Study|Failed to complete the initial therapy|0
5668478|NCT00450814|19564965|P10|Overall Study|Failed to complete the initial therapy|0
5668479|NCT00450814|19564966|P9|Overall Study|Failed to complete the initial therapy|0
5668480|NCT00450814|19564967|P8|Overall Study|Failed to complete the initial therapy|0
5668481|NCT00450814|19564968|P7|Overall Study|Failed to complete the initial therapy|0
5668482|NCT00450814|19564969|P6|Overall Study|Failed to complete the initial therapy|1
5668483|NCT00450814|19564970|P5|Overall Study|Failed to complete the initial therapy|1
5668484|NCT00450814|19564971|P4|Overall Study|Failed to complete the initial therapy|1
5668485|NCT00450814|19564972|P3|Overall Study|Failed to complete the initial therapy|0
5668486|NCT00450814|19564973|P2|Overall Study|Failed to complete the initial therapy|0
5668487|NCT00450814|19564974|P1|Overall Study|Failed to complete the initial therapy|0
5668488|NCT00450801|19565008|P1|Overall Study|Death|1
5668489|NCT00450749|19565022|P3|Overall Study|Noncompliant|0
5668490|NCT00450749|19565023|P2|Overall Study|Noncompliant|1
5668491|NCT00450749|19565024|P1|Overall Study|Noncompliant|0
5668492|NCT00450749|19565022|P3|Overall Study|Withdrawal by Subject|2
5668493|NCT00450749|19565023|P2|Overall Study|Withdrawal by Subject|0
5668494|NCT00450749|19565024|P1|Overall Study|Withdrawal by Subject|0
5668495|NCT00450723|19565062|P1|Overall Study|Physician Decision|5
5668496|NCT00450658|19565070|P2|Overall Study|misc|10
5668497|NCT00450658|19565071|P1|Overall Study|misc|21
5668498|NCT00450658|19565070|P2|Overall Study|UGI ulcer|34
5668499|NCT00450658|19565071|P1|Overall Study|UGI ulcer|33
5668500|NCT00450658|19565070|P2|Overall Study|Lost to Follow-up|5
5668501|NCT00450658|19565071|P1|Overall Study|Lost to Follow-up|22
5668502|NCT00450658|19565070|P2|Overall Study|Withdrawal by Subject|26
5668503|NCT00450658|19565071|P1|Overall Study|Withdrawal by Subject|43
5668504|NCT00450658|19565070|P2|Overall Study|Adverse Event|15
5668505|NCT00450658|19565071|P1|Overall Study|Adverse Event|24
5668506|NCT00450619|19565085|P2|Overall Study|Adverse Event|0
5668507|NCT00450619|19565086|P1|Overall Study|Adverse Event|1
5668508|NCT00450619|19565085|P2|Overall Study|did not progress; refused further trmt|1
5668509|NCT00450619|19565086|P1|Overall Study|did not progress; refused further trmt|1
5668510|NCT00450619|19565085|P2|Overall Study|refused treatment after randomization|0
5668511|NCT00450619|19565086|P1|Overall Study|refused treatment after randomization|2
5668512|NCT00450580|19565112|P2|Overall Study|Withdrawal due to pregnancy|1
5668513|NCT00450580|19565113|P1|Overall Study|Withdrawal due to pregnancy|0
5668514|NCT00450580|19565112|P2|Overall Study|Patient could not swallow Norvir|0
5668515|NCT00450580|19565113|P1|Overall Study|Patient could not swallow Norvir|1
5668516|NCT00450580|19565112|P2|Overall Study|Patient went to Brazil|0
5668517|NCT00450580|19565113|P1|Overall Study|Patient went to Brazil|1
5668518|NCT00450580|19565112|P2|Overall Study|Could not comply with scheduled visits|0
5668519|NCT00450580|19565113|P1|Overall Study|Could not comply with scheduled visits|1
5668520|NCT00450580|19565112|P2|Overall Study|Protocol-defined virologic failure|0
5668521|NCT00450580|19565113|P1|Overall Study|Protocol-defined virologic failure|1
5668522|NCT00450580|19565112|P2|Overall Study|Protocol Violation|1
5668523|NCT00450580|19565113|P1|Overall Study|Protocol Violation|1
5668524|NCT00450580|19565112|P2|Overall Study|Withdrawal by Subject|2
5668525|NCT00450580|19565113|P1|Overall Study|Withdrawal by Subject|2
5668526|NCT00450580|19565112|P2|Overall Study|Lost to Follow-up|5
5668527|NCT00450580|19565113|P1|Overall Study|Lost to Follow-up|4
5668528|NCT00450580|19565112|P2|Overall Study|Adverse Event|7
5668529|NCT00450580|19565113|P1|Overall Study|Adverse Event|5
5668530|NCT00450450|19565150|P2|Overall Study|Missing Data|0
5668531|NCT00450450|19565151|P1|Overall Study|Missing Data|2
5668532|NCT00450450|19565150|P2|Overall Study|Relapse|0
5668533|NCT00450450|19565151|P1|Overall Study|Relapse|2
5668534|NCT00450450|19565150|P2|Overall Study|Death|3
5668535|NCT00450450|19565151|P1|Overall Study|Death|1
5668536|NCT00450437|19565175|P4|Overall Study|Unable to Classify|0
5668537|NCT00450437|19565176|P3|Overall Study|Unable to Classify|1
5668538|NCT00450437|19565177|P2|Overall Study|Unable to Classify|0
5668539|NCT00450437|19565178|P1|Overall Study|Unable to Classify|1
5668540|NCT00450437|19565175|P4|Overall Study|Administrative reason|0
5668541|NCT00450437|19565176|P3|Overall Study|Administrative reason|1
5668542|NCT00450437|19565177|P2|Overall Study|Administrative reason|0
5668543|NCT00450437|19565178|P1|Overall Study|Administrative reason|0
5668544|NCT00450437|19565175|P4|Overall Study|Inappropriate enrollment|0
5668545|NCT00450437|19565176|P3|Overall Study|Inappropriate enrollment|3
5668546|NCT00450437|19565177|P2|Overall Study|Inappropriate enrollment|1
5668547|NCT00450437|19565178|P1|Overall Study|Inappropriate enrollment|4
5668548|NCT00450437|19565175|P4|Overall Study|Protocol Violation|1
5668549|NCT00450437|19565176|P3|Overall Study|Protocol Violation|0
5668550|NCT00450437|19565177|P2|Overall Study|Protocol Violation|1
5668551|NCT00450437|19565178|P1|Overall Study|Protocol Violation|0
5668552|NCT00450437|19565175|P4|Overall Study|Lost to Follow-up|9
5668553|NCT00450437|19565176|P3|Overall Study|Lost to Follow-up|19
5668554|NCT00450437|19565177|P2|Overall Study|Lost to Follow-up|12
5668555|NCT00450437|19565178|P1|Overall Study|Lost to Follow-up|31
5668556|NCT00450437|19565175|P4|Overall Study|Withdrawal by Subject|1
5668557|NCT00450437|19565176|P3|Overall Study|Withdrawal by Subject|0
5668558|NCT00450437|19565177|P2|Overall Study|Withdrawal by Subject|2
5668559|NCT00450437|19565178|P1|Overall Study|Withdrawal by Subject|10
5668560|NCT00450411|19565209|P1|Overall Study|No protocol treatment|2
5668561|NCT00450411|19565209|P1|Overall Study|Protocol Violation|6
5668562|NCT00450385|19565214|P1|Overall Study|Other|3
5668563|NCT00450385|19565214|P1|Overall Study|Physician Decision|1
5668564|NCT00450385|19565214|P1|Overall Study|Adverse Event|1
5668565|NCT00450385|19565214|P1|Overall Study|Lack of Efficacy|2
5668566|NCT00450385|19565214|P1|Overall Study|Withdrawal by Subject|2
5668567|NCT00450385|19565214|P1|Overall Study|Protocol Violation|1
5668568|NCT00450385|19565214|P1|Overall Study|Death|3
5668569|NCT00450372|19565223|P1|Overall Study|Physician Decision|1
5668570|NCT00450333|19565236|P4|Overall Study|Death|2
5668571|NCT00450333|19565237|P3|Overall Study|Death|2
5668572|NCT00450333|19565238|P2|Overall Study|Death|2
5668573|NCT00450333|19565239|P1|Overall Study|Death|3
5668574|NCT00450333|19565236|P4|Overall Study|Kidney transplant|3
5668575|NCT00450333|19565237|P3|Overall Study|Kidney transplant|1
5668576|NCT00450333|19565238|P2|Overall Study|Kidney transplant|0
5668577|NCT00450333|19565239|P1|Overall Study|Kidney transplant|1
5668578|NCT00450333|19565236|P4|Overall Study|Withdrawal by Subject|0
5668579|NCT00450333|19565237|P3|Overall Study|Withdrawal by Subject|3
5668580|NCT00450333|19565238|P2|Overall Study|Withdrawal by Subject|0
5668581|NCT00450333|19565239|P1|Overall Study|Withdrawal by Subject|1
5668582|NCT00450333|19565236|P4|Overall Study|Protocol Violation|0
5668583|NCT00450333|19565237|P3|Overall Study|Protocol Violation|1
5668584|NCT00450333|19565238|P2|Overall Study|Protocol Violation|0
5668585|NCT00450333|19565239|P1|Overall Study|Protocol Violation|1
5668586|NCT00450333|19565236|P4|Overall Study|Adverse Event|2
5668587|NCT00450333|19565237|P3|Overall Study|Adverse Event|2
5668588|NCT00450333|19565238|P2|Overall Study|Adverse Event|7
5668589|NCT00450333|19565239|P1|Overall Study|Adverse Event|1
5668590|NCT00450333|19565236|P4|Overall Study|Study terminated|21
5668591|NCT00450333|19565237|P3|Overall Study|Study terminated|16
5668592|NCT00450333|19565238|P2|Overall Study|Study terminated|54
5668593|NCT00450333|19565239|P1|Overall Study|Study terminated|47
5668594|NCT00450255|19565262|P1|Overall Study|Prior RFA ablation of liver|1
5668595|NCT00450216|19565287|P2|Overall Study|misc|20
5668596|NCT00450216|19565288|P1|Overall Study|misc|21
5668597|NCT00450216|19565287|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
5668598|NCT00450216|19565288|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
5668599|NCT00450216|19565287|P2|Overall Study|Lost to Follow-up|9
5668600|NCT00450216|19565288|P1|Overall Study|Lost to Follow-up|16
5668601|NCT00450216|19565287|P2|Overall Study|Withdrawal by Subject|26
5668602|NCT00450216|19565288|P1|Overall Study|Withdrawal by Subject|48
5668603|NCT00450216|19565287|P2|Overall Study|Adverse Event|23
5668604|NCT00450216|19565288|P1|Overall Study|Adverse Event|38
5668605|NCT00450190|19565300|P1|Overall Study|Withdrawal by Subject|2
5668606|NCT00450177|19565310|P2|Overall Study|Withdrawal by Primary Team|1
5668607|NCT00450177|19565311|P1|Overall Study|Withdrawal by Primary Team|1
5668608|NCT00450177|19565310|P2|Overall Study|Withdrawal by Subject|6
5668609|NCT00450177|19565311|P1|Overall Study|Withdrawal by Subject|1
5668610|NCT00450177|19565310|P2|Overall Study|Adverse Event|4
5668611|NCT00450177|19565311|P1|Overall Study|Adverse Event|7
5668612|NCT00450112|19565337|P2|Overall Study|Others|3
5668613|NCT00450112|19565338|P1|Overall Study|Others|2
5668614|NCT00450112|19565337|P2|Overall Study|Lost to Follow-up|1
5668615|NCT00450112|19565338|P1|Overall Study|Lost to Follow-up|2
5668616|NCT00450112|19565337|P2|Overall Study|Withdrawal by Subject|1
5668617|NCT00450112|19565338|P1|Overall Study|Withdrawal by Subject|4
5668618|NCT00450112|19565337|P2|Overall Study|Other Treatment Required|1
5668619|NCT00450112|19565338|P1|Overall Study|Other Treatment Required|5
5668620|NCT00449956|19565376|P3|Overall Study|Physician Decision|1
5668621|NCT00449956|19565377|P2|Overall Study|Physician Decision|1
5668622|NCT00449956|19565378|P1|Overall Study|Physician Decision|2
5668623|NCT00449956|19565376|P3|Overall Study|Withdrawal by Subject|0
5668624|NCT00449956|19565377|P2|Overall Study|Withdrawal by Subject|1
5668625|NCT00449956|19565378|P1|Overall Study|Withdrawal by Subject|0
5668626|NCT00449956|19565376|P3|Overall Study|Protocol Violation|1
5668627|NCT00449956|19565377|P2|Overall Study|Protocol Violation|1
5668628|NCT00449956|19565378|P1|Overall Study|Protocol Violation|1
5668629|NCT00449956|19565376|P3|Overall Study|Lack of Efficacy|1
5668630|NCT00449956|19565377|P2|Overall Study|Lack of Efficacy|0
5668631|NCT00449956|19565378|P1|Overall Study|Lack of Efficacy|0
5668632|NCT00449956|19565376|P3|Overall Study|Adverse Event|6
5668633|NCT00449956|19565377|P2|Overall Study|Adverse Event|1
5668634|NCT00449956|19565378|P1|Overall Study|Adverse Event|7
5668635|NCT00449930|19565394|P2|Overall Study|Glycemic discontinuation criteria|1
5668636|NCT00449930|19565395|P1|Overall Study|Glycemic discontinuation criteria|1
5668637|NCT00449930|19565394|P2|Overall Study|Withdrawal by Subject|23
5668638|NCT00449930|19565395|P1|Overall Study|Withdrawal by Subject|16
5668639|NCT00449930|19565394|P2|Overall Study|Protocol Violation|15
5668640|NCT00449930|19565395|P1|Overall Study|Protocol Violation|14
5668641|NCT00449930|19565394|P2|Overall Study|Physician Decision|2
5668642|NCT00449930|19565395|P1|Overall Study|Physician Decision|1
5668643|NCT00449930|19565394|P2|Overall Study|Lost to Follow-up|14
5668644|NCT00449930|19565395|P1|Overall Study|Lost to Follow-up|9
5668645|NCT00449930|19565394|P2|Overall Study|Lack of Efficacy|1
5668646|NCT00449930|19565395|P1|Overall Study|Lack of Efficacy|10
5668647|NCT00449930|19565394|P2|Overall Study|Trial Terminated ( Site Closed)|0
5668648|NCT00449930|19565395|P1|Overall Study|Trial Terminated ( Site Closed)|1
5668649|NCT00449930|19565394|P2|Overall Study|Adverse Event|19
5668650|NCT00449930|19565395|P1|Overall Study|Adverse Event|9
5668651|NCT00449865|19565411|P2|Overall Study|Study was stopped|328
5668652|NCT00449865|19565412|P1|Overall Study|Study was stopped|324
5668653|NCT00449865|19565411|P2|Overall Study|Protocol Violation|7
5668654|NCT00449865|19565412|P1|Overall Study|Protocol Violation|8
5668655|NCT00449865|19565411|P2|Overall Study|Death|40
5668656|NCT00449865|19565412|P1|Overall Study|Death|31
5668657|NCT00449865|19565411|P2|Overall Study|Physician Decision|12
5668658|NCT00449865|19565412|P1|Overall Study|Physician Decision|13
5668659|NCT00449865|19565411|P2|Overall Study|Lost to Follow-up|37
5668660|NCT00449865|19565412|P1|Overall Study|Lost to Follow-up|36
5668661|NCT00449865|19565411|P2|Overall Study|Withdrawal by Subject|110
5668662|NCT00449865|19565412|P1|Overall Study|Withdrawal by Subject|110
5668663|NCT00449787|19565420|P2|Overall Study|Did not require medication|92
5668664|NCT00449787|19565421|P1|Overall Study|Did not require medication|95
5668665|NCT00449787|19565420|P2|Overall Study|Lost to Follow-up|8
5668666|NCT00449787|19565421|P1|Overall Study|Lost to Follow-up|10
5668667|NCT00449696|19565437|P2|Overall Study|Others|0
5668668|NCT00449696|19565438|P1|Overall Study|Others|7
5668669|NCT00449696|19565437|P2|Overall Study|Lost to Follow-up|3
5668670|NCT00449696|19565438|P1|Overall Study|Lost to Follow-up|2
5668671|NCT00449696|19565437|P2|Overall Study|Withdrawal by Subject|5
5668672|NCT00449696|19565438|P1|Overall Study|Withdrawal by Subject|5
5668673|NCT00449696|19565437|P2|Overall Study|Other Treatment Required|1
5668674|NCT00449696|19565438|P1|Overall Study|Other Treatment Required|6
5668675|NCT00449670|19565462|P2|Booster Phase (Study no.109873)|Other|2
5668676|NCT00449670|19565463|P1|Booster Phase (Study no.109873)|Other|0
5668677|NCT00449670|19565462|P2|Booster Phase (Study no.109873)|Migrated/moved from study area|1
5668678|NCT00449670|19565463|P1|Booster Phase (Study no.109873)|Migrated/moved from study area|0
5668679|NCT00449670|19565462|P2|Primary Phase (Study no.109630)|Lost to Follow-up|1
5668680|NCT00449670|19565463|P1|Primary Phase (Study no.109630)|Lost to Follow-up|5
5668681|NCT00449670|19565462|P2|Primary Phase (Study no.109630)|Withdrawal by Subject|1
5668682|NCT00449670|19565463|P1|Primary Phase (Study no.109630)|Withdrawal by Subject|4
5668772|NCT00449072|19565672|P1|Overall Study|Not treated|0
5668683|NCT00449670|19565462|P2|Primary Phase (Study no.109630)|Non-serious adverse event|0
5668684|NCT00449670|19565463|P1|Primary Phase (Study no.109630)|Non-serious adverse event|4
5668685|NCT00449670|19565462|P2|Primary Phase (Study no.109630)|Serious Adverse Event|0
5668686|NCT00449670|19565463|P1|Primary Phase (Study no.109630)|Serious Adverse Event|1
5668687|NCT00449644|19565576|P4|Overall Study|Rolled-over to treatment with TMC207|1
5668688|NCT00449644|19565577|P3|Overall Study|Rolled-over to treatment with TMC207|0
5668689|NCT00449644|19565578|P2|Overall Study|Rolled-over to treatment with TMC207|0
5668690|NCT00449644|19565579|P1|Overall Study|Rolled-over to treatment with TMC207|0
5668691|NCT00449644|19565576|P4|Overall Study|Other|0
5668692|NCT00449644|19565577|P3|Overall Study|Other|1
5668693|NCT00449644|19565578|P2|Overall Study|Other|4
5668694|NCT00449644|19565579|P1|Overall Study|Other|1
5668695|NCT00449644|19565576|P4|Overall Study|Inclusion/exclusion criteria not met|6
5668696|NCT00449644|19565577|P3|Overall Study|Inclusion/exclusion criteria not met|2
5668697|NCT00449644|19565578|P2|Overall Study|Inclusion/exclusion criteria not met|0
5668698|NCT00449644|19565579|P1|Overall Study|Inclusion/exclusion criteria not met|0
5668699|NCT00449644|19565576|P4|Overall Study|Withdrawal by Subject|7
5668700|NCT00449644|19565577|P3|Overall Study|Withdrawal by Subject|6
5668701|NCT00449644|19565578|P2|Overall Study|Withdrawal by Subject|4
5668702|NCT00449644|19565579|P1|Overall Study|Withdrawal by Subject|3
5668703|NCT00449644|19565576|P4|Overall Study|Protocol Violation|7
5668704|NCT00449644|19565577|P3|Overall Study|Protocol Violation|3
5668705|NCT00449644|19565578|P2|Overall Study|Protocol Violation|4
5668706|NCT00449644|19565579|P1|Overall Study|Protocol Violation|4
5668707|NCT00449644|19565576|P4|Overall Study|Pregnancy|2
5668708|NCT00449644|19565577|P3|Overall Study|Pregnancy|3
5668709|NCT00449644|19565578|P2|Overall Study|Pregnancy|0
5668710|NCT00449644|19565579|P1|Overall Study|Pregnancy|0
5668711|NCT00449644|19565576|P4|Overall Study|Lost to Follow-up|3
5668712|NCT00449644|19565577|P3|Overall Study|Lost to Follow-up|5
5668713|NCT00449644|19565578|P2|Overall Study|Lost to Follow-up|1
5668714|NCT00449644|19565579|P1|Overall Study|Lost to Follow-up|1
5668715|NCT00449644|19565576|P4|Overall Study|Death|1
5668716|NCT00449644|19565577|P3|Overall Study|Death|6
5668717|NCT00449644|19565578|P2|Overall Study|Death|0
5668718|NCT00449644|19565579|P1|Overall Study|Death|1
5668719|NCT00449644|19565576|P4|Overall Study|Adverse Event|5
5668720|NCT00449644|19565577|P3|Overall Study|Adverse Event|3
5668721|NCT00449644|19565578|P2|Overall Study|Adverse Event|0
5668722|NCT00449644|19565579|P1|Overall Study|Adverse Event|0
5668723|NCT00449540|19565599|P3|Treatment Phase|did not experience or treat migraine|17
5668724|NCT00449540|19565600|P2|Treatment Phase|did not experience or treat migraine|20
5668725|NCT00449540|19565601|P1|Treatment Phase|did not experience or treat migraine|0
5668726|NCT00449540|19565599|P3|Pretreatment Phase|No migraine experienced|0
5668727|NCT00449540|19565600|P2|Pretreatment Phase|No migraine experienced|0
5668728|NCT00449540|19565601|P1|Pretreatment Phase|No migraine experienced|66
5668729|NCT00449176|19565618|P3|Overall Study|all other|20
5668730|NCT00449176|19565619|P2|Overall Study|all other|19
5668731|NCT00449176|19565620|P1|Overall Study|all other|22
5668732|NCT00449176|19565618|P3|Overall Study|Study drug non-compliant|11
5668733|NCT00449176|19565619|P2|Overall Study|Study drug non-compliant|11
5668734|NCT00449176|19565620|P1|Overall Study|Study drug non-compliant|14
5668735|NCT00449176|19565618|P3|Overall Study|Lack of Efficacy|50
5668736|NCT00449176|19565619|P2|Overall Study|Lack of Efficacy|7
5668737|NCT00449176|19565620|P1|Overall Study|Lack of Efficacy|13
5668738|NCT00449176|19565618|P3|Overall Study|Adverse Event|15
5668739|NCT00449176|19565619|P2|Overall Study|Adverse Event|107
5668740|NCT00449176|19565620|P1|Overall Study|Adverse Event|51
5668741|NCT00449176|19565618|P3|Overall Study|Lost to Follow-up|12
5668742|NCT00449176|19565619|P2|Overall Study|Lost to Follow-up|8
5668743|NCT00449176|19565620|P1|Overall Study|Lost to Follow-up|13
5668744|NCT00449176|19565618|P3|Overall Study|Withdrawal by Subject|59
5668745|NCT00449176|19565619|P2|Overall Study|Withdrawal by Subject|43
5668746|NCT00449176|19565620|P1|Overall Study|Withdrawal by Subject|39
5668747|NCT00449163|19565646|P1|Overall Study|Physician Decision|3
5668748|NCT00449150|19565656|P3|Overall Study|Protocol Violation|1
5668749|NCT00449150|19565657|P2|Overall Study|Protocol Violation|2
5668750|NCT00449150|19565658|P1|Overall Study|Protocol Violation|1
5668751|NCT00449150|19565656|P3|Overall Study|Withdrawal by Subject|21
5668752|NCT00449150|19565657|P2|Overall Study|Withdrawal by Subject|18
5668753|NCT00449150|19565658|P1|Overall Study|Withdrawal by Subject|17
5668754|NCT00449150|19565656|P3|Overall Study|Other|14
5668755|NCT00449150|19565657|P2|Overall Study|Other|13
5668756|NCT00449150|19565658|P1|Overall Study|Other|16
5668757|NCT00449150|19565656|P3|Overall Study|Lack of Efficacy|2
5668758|NCT00449150|19565657|P2|Overall Study|Lack of Efficacy|2
5668759|NCT00449150|19565658|P1|Overall Study|Lack of Efficacy|1
5668760|NCT00449150|19565656|P3|Overall Study|Adverse Event|9
5668761|NCT00449150|19565657|P2|Overall Study|Adverse Event|18
5668762|NCT00449150|19565658|P1|Overall Study|Adverse Event|11
5668763|NCT00449072|19565671|P2|Overall Study|Relocation|2
5668764|NCT00449072|19565672|P1|Overall Study|Relocation|3
5668765|NCT00449072|19565671|P2|Overall Study|Sponsor decision|3
5668766|NCT00449072|19565672|P1|Overall Study|Sponsor decision|1
5668767|NCT00449072|19565671|P2|Overall Study|Non-compliance|5
5668768|NCT00449072|19565672|P1|Overall Study|Non-compliance|2
5668769|NCT00449072|19565671|P2|Overall Study|Excluded medication|2
5668770|NCT00449072|19565672|P1|Overall Study|Excluded medication|0
5668771|NCT00449072|19565671|P2|Overall Study|Not treated|1
5668773|NCT00449072|19565671|P2|Overall Study|Physician Decision|0
5668774|NCT00449072|19565672|P1|Overall Study|Physician Decision|1
5668775|NCT00449072|19565671|P2|Overall Study|Lack of Efficacy|1
5668776|NCT00449072|19565672|P1|Overall Study|Lack of Efficacy|1
5668777|NCT00449072|19565671|P2|Overall Study|Withdrawal by Subject|8
5668778|NCT00449072|19565672|P1|Overall Study|Withdrawal by Subject|11
5668779|NCT00449072|19565671|P2|Overall Study|Lost to Follow-up|7
5668780|NCT00449072|19565672|P1|Overall Study|Lost to Follow-up|5
5668781|NCT00449072|19565671|P2|Overall Study|Protocol Violation|12
5668782|NCT00449072|19565672|P1|Overall Study|Protocol Violation|14
5668783|NCT00449072|19565671|P2|Overall Study|Adverse Event|1
5668784|NCT00449072|19565672|P1|Overall Study|Adverse Event|3
5668785|NCT00449033|19565709|P2|Follow-up Period|Reason Missing|113
5668786|NCT00449033|19565710|P1|Follow-up Period|Reason Missing|120
5668787|NCT00449033|19565709|P2|Follow-up Period|Lost to Follow-up|10
5668788|NCT00449033|19565710|P1|Follow-up Period|Lost to Follow-up|6
5668789|NCT00449033|19565709|P2|Follow-up Period|Death|311
5668790|NCT00449033|19565710|P1|Follow-up Period|Death|299
5668791|NCT00449033|19565709|P2|Treatment Period|Treatment Ongoing|4
5668792|NCT00449033|19565710|P1|Treatment Period|Treatment Ongoing|6
5668793|NCT00449033|19565709|P2|Treatment Period|Reason Missing|4
5668794|NCT00449033|19565710|P1|Treatment Period|Reason Missing|0
5668795|NCT00449033|19565709|P2|Treatment Period|Second Malignancy|1
5668796|NCT00449033|19565710|P1|Treatment Period|Second Malignancy|0
5668797|NCT00449033|19565709|P2|Treatment Period|Non-compliance|8
5668798|NCT00449033|19565710|P1|Treatment Period|Non-compliance|7
5668799|NCT00449033|19565709|P2|Treatment Period|Amended Protocol Criteria|18
5668800|NCT00449033|19565710|P1|Treatment Period|Amended Protocol Criteria|22
5668801|NCT00449033|19565709|P2|Treatment Period|Consent Withdrawn|20
5668802|NCT00449033|19565710|P1|Treatment Period|Consent Withdrawn|36
5668803|NCT00449033|19565709|P2|Treatment Period|Disease Progression|288
5668804|NCT00449033|19565710|P1|Treatment Period|Disease Progression|231
5668805|NCT00449033|19565709|P2|Treatment Period|Protocol Violation|7
5668806|NCT00449033|19565710|P1|Treatment Period|Protocol Violation|8
5668807|NCT00449033|19565709|P2|Treatment Period|Physician Decision|5
5668808|NCT00449033|19565710|P1|Treatment Period|Physician Decision|4
5668809|NCT00449033|19565709|P2|Treatment Period|Lost to Follow-up|2
5668810|NCT00449033|19565710|P1|Treatment Period|Lost to Follow-up|0
5668811|NCT00449033|19565709|P2|Treatment Period|Death|12
5668812|NCT00449033|19565710|P1|Treatment Period|Death|21
5668813|NCT00449033|19565709|P2|Treatment Period|Adverse Event|83
5668814|NCT00449033|19565710|P1|Treatment Period|Adverse Event|117
5668815|NCT00448916|19565748|P4|Overall Study|Protocol Violation|1
5668816|NCT00448916|19565749|P3|Overall Study|Protocol Violation|0
5668817|NCT00448916|19565750|P2|Overall Study|Protocol Violation|0
5668818|NCT00448916|19565751|P1|Overall Study|Protocol Violation|0
5668819|NCT00448916|19565748|P4|Overall Study|Lost to Follow-up|1
5668820|NCT00448916|19565749|P3|Overall Study|Lost to Follow-up|0
5668821|NCT00448916|19565750|P2|Overall Study|Lost to Follow-up|1
5668822|NCT00448916|19565751|P1|Overall Study|Lost to Follow-up|0
5668823|NCT00448916|19565748|P4|Overall Study|Other|0
5668824|NCT00448916|19565749|P3|Overall Study|Other|0
5668825|NCT00448916|19565750|P2|Overall Study|Other|0
5668826|NCT00448916|19565751|P1|Overall Study|Other|1
5668827|NCT00448916|19565748|P4|Overall Study|Withdrawal by Subject|1
5668828|NCT00448916|19565749|P3|Overall Study|Withdrawal by Subject|1
5668829|NCT00448916|19565750|P2|Overall Study|Withdrawal by Subject|3
5668830|NCT00448916|19565751|P1|Overall Study|Withdrawal by Subject|3
5668831|NCT00448916|19565748|P4|Overall Study|Lack of Efficacy|1
5668832|NCT00448916|19565749|P3|Overall Study|Lack of Efficacy|2
5668833|NCT00448916|19565750|P2|Overall Study|Lack of Efficacy|0
5668834|NCT00448916|19565751|P1|Overall Study|Lack of Efficacy|1
5668835|NCT00448916|19565748|P4|Overall Study|Adverse Event|2
5668836|NCT00448916|19565749|P3|Overall Study|Adverse Event|3
5668837|NCT00448916|19565750|P2|Overall Study|Adverse Event|2
5668838|NCT00448916|19565751|P1|Overall Study|Adverse Event|2
5668839|NCT00448864|19565825|P3|Overall Study|Protocol Violation|0
5668840|NCT00448864|19565826|P2|Overall Study|Protocol Violation|2
5668841|NCT00448864|19565827|P1|Overall Study|Protocol Violation|0
5668842|NCT00448864|19565825|P3|Overall Study|Withdrawal by Subject|0
5668843|NCT00448864|19565826|P2|Overall Study|Withdrawal by Subject|2
5668844|NCT00448864|19565827|P1|Overall Study|Withdrawal by Subject|0
5668845|NCT00448864|19565825|P3|Overall Study|Physician Decision|1
5668846|NCT00448864|19565826|P2|Overall Study|Physician Decision|0
5668847|NCT00448864|19565827|P1|Overall Study|Physician Decision|1
5668848|NCT00448864|19565825|P3|Overall Study|Lost to Follow-up|0
5668849|NCT00448864|19565826|P2|Overall Study|Lost to Follow-up|1
5668850|NCT00448864|19565827|P1|Overall Study|Lost to Follow-up|3
5668851|NCT00448864|19565825|P3|Overall Study|Death|0
5668852|NCT00448864|19565826|P2|Overall Study|Death|0
5668853|NCT00448864|19565827|P1|Overall Study|Death|1
5668854|NCT00448760|19565843|P1|Overall Study|Death|3
5668855|NCT00448747|19565852|P2|Overall Study|collapsed veins|0
5668856|NCT00448747|19565853|P1|Overall Study|collapsed veins|1
5668857|NCT00448708|19565871|P2|Overall Study|not listed|2
5668858|NCT00448708|19565872|P1|Overall Study|not listed|0
5668859|NCT00448708|19565871|P2|Overall Study|Lost to Follow-up|8
5668860|NCT00448708|19565872|P1|Overall Study|Lost to Follow-up|6
5668861|NCT00448708|19565871|P2|Overall Study|Withdrawal by Subject|4
5668862|NCT00448708|19565872|P1|Overall Study|Withdrawal by Subject|8
5668863|NCT00448708|19565871|P2|Overall Study|Death|17
5668864|NCT00448708|19565872|P1|Overall Study|Death|21
5668865|NCT00448669|19565888|P2|Overall Study|Never started drug|7
5668866|NCT00448669|19565889|P1|Overall Study|Never started drug|9
5668867|NCT00448669|19565888|P2|Overall Study|HIV-infected at enrollment|2
5668868|NCT00448669|19565889|P1|Overall Study|HIV-infected at enrollment|1
5668869|NCT00448669|19565888|P2|Overall Study|Had other reasons|6
5668870|NCT00448669|19565889|P1|Overall Study|Had other reasons|5
5668871|NCT00448669|19565888|P2|Overall Study|Death|4
5668872|NCT00448669|19565889|P1|Overall Study|Death|2
5668873|NCT00448669|19565888|P2|Overall Study|Were withdrawn by investigator|6
5668874|NCT00448669|19565889|P1|Overall Study|Were withdrawn by investigator|10
5668875|NCT00448669|19565888|P2|Overall Study|Relocated|36
5668876|NCT00448669|19565889|P1|Overall Study|Relocated|49
5668877|NCT00448669|19565888|P2|Overall Study|Withdrawal by Subject|74
5668878|NCT00448669|19565889|P1|Overall Study|Withdrawal by Subject|90
5668879|NCT00448669|19565888|P2|Overall Study|Lost to Follow-up|63
5668880|NCT00448669|19565889|P1|Overall Study|Lost to Follow-up|52
5668881|NCT00448591|19565950|P1|Overall Study|Termination of Study|70
5668882|NCT00448591|19565950|P1|Overall Study|Other|154
5668883|NCT00448591|19565950|P1|Overall Study|Treatment Regimen Completed|70
5668884|NCT00448591|19565950|P1|Overall Study|Lost to Follow-up|19
5668885|NCT00448591|19565950|P1|Overall Study|Protocol Violation|41
5668886|NCT00448591|19565950|P1|Overall Study|Adverse Event|382
5668887|NCT00448591|19565950|P1|Overall Study|Progressive Disease|1382
5668888|NCT00448591|19565950|P1|Overall Study|Withdrawal by Subject|178
5668889|NCT00448539|19565961|P2|Overall Study|Lost to Follow-up|3
5668890|NCT00448539|19565962|P1|Overall Study|Lost to Follow-up|1
5668891|NCT00448539|19565961|P2|Overall Study|Change of meds|3
5668892|NCT00448539|19565962|P1|Overall Study|Change of meds|2
5668893|NCT00448539|19565961|P2|Overall Study|Miscellaneous|1
5668894|NCT00448539|19565962|P1|Overall Study|Miscellaneous|2
5668895|NCT00448539|19565961|P2|Overall Study|Lack of Efficacy|40
5668896|NCT00448539|19565962|P1|Overall Study|Lack of Efficacy|27
5668897|NCT00448539|19565961|P2|Overall Study|Adverse Event|26
5668898|NCT00448539|19565962|P1|Overall Study|Adverse Event|9
5668899|NCT00448539|19565961|P2|Overall Study|Diary non-compliance|0
5668900|NCT00448539|19565962|P1|Overall Study|Diary non-compliance|1
5668901|NCT00448539|19565961|P2|Overall Study|Withdrawal by Subject|24
5668902|NCT00448539|19565962|P1|Overall Study|Withdrawal by Subject|20
5668903|NCT00448539|19565961|P2|Overall Study|Request of the investigator or sponsor|54
5668904|NCT00448539|19565962|P1|Overall Study|Request of the investigator or sponsor|67
5668905|NCT00448539|19565961|P2|Overall Study|Protocol Violation|0
5668906|NCT00448539|19565962|P1|Overall Study|Protocol Violation|1
5668907|NCT00448539|19565961|P2|Overall Study|Medication non-compliance|1
5668908|NCT00448539|19565962|P1|Overall Study|Medication non-compliance|4
5668909|NCT00448448|19565970|P2|Overall Study|Signed consent lost|1
5668910|NCT00448448|19565971|P1|Overall Study|Signed consent lost|0
5668911|NCT00448448|19565970|P2|Overall Study|Wrong diagnosis (n=3) or other|1
5668912|NCT00448448|19565971|P1|Overall Study|Wrong diagnosis (n=3) or other|2
5668913|NCT00448448|19565970|P2|Overall Study|Lost to Follow-up|1
5668914|NCT00448448|19565971|P1|Overall Study|Lost to Follow-up|2
5668915|NCT00448448|19565970|P2|Overall Study|On protocol when study ended|36
5668916|NCT00448448|19565971|P1|Overall Study|On protocol when study ended|83
5668917|NCT00448448|19565970|P2|Overall Study|Withdrawal by Subject|2
5668918|NCT00448448|19565971|P1|Overall Study|Withdrawal by Subject|13
5668919|NCT00448435|19565977|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
5668920|NCT00448435|19565978|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
5668921|NCT00448344|19566029|P2|Overall Study|Physician Decision|2
5668922|NCT00448344|19566030|P1|Overall Study|Physician Decision|1
5668923|NCT00448344|19566029|P2|Overall Study|Death|4
5668924|NCT00448344|19566030|P1|Overall Study|Death|3
5668925|NCT00448344|19566029|P2|Overall Study|Withdrawal by Subject|8
5668926|NCT00448344|19566030|P1|Overall Study|Withdrawal by Subject|6
5668927|NCT00448344|19566029|P2|Overall Study|Lost to Follow-up|22
5668928|NCT00448344|19566030|P1|Overall Study|Lost to Follow-up|20
5668929|NCT00448279|19566040|P2|Overall Study|Protocol Violation|1
5668930|NCT00448279|19566041|P1|Overall Study|Protocol Violation|0
5668931|NCT00448279|19566040|P2|Overall Study|Other|4
5668932|NCT00448279|19566041|P1|Overall Study|Other|6
5668933|NCT00448279|19566040|P2|Overall Study|Withdrawal by Subject|3
5668934|NCT00448279|19566041|P1|Overall Study|Withdrawal by Subject|4
5668935|NCT00448279|19566040|P2|Overall Study|Disease progression|18
5668936|NCT00448279|19566041|P1|Overall Study|Disease progression|16
5668937|NCT00448279|19566040|P2|Overall Study|Adverse Event|1
5668938|NCT00448279|19566041|P1|Overall Study|Adverse Event|1
5668939|NCT00448279|19566040|P2|Overall Study|Lost to Follow-up|2
5668940|NCT00448279|19566041|P1|Overall Study|Lost to Follow-up|2
5668941|NCT00448136|19566104|P2|Overall Study|Investigator's decision (progression)|0
5668942|NCT00448136|19566105|P1|Overall Study|Investigator's decision (progression)|1
5668943|NCT00448136|19566104|P2|Overall Study|Death|8
5668944|NCT00448136|19566105|P1|Overall Study|Death|3
5668945|NCT00448123|19566143|P2|Overall Study|Physician Decision|6
5668946|NCT00448123|19566144|P1|Overall Study|Physician Decision|6
5668947|NCT00448123|19566143|P2|Overall Study|Lost to Follow-up|6
5668948|NCT00448123|19566144|P1|Overall Study|Lost to Follow-up|9
5668949|NCT00448019|19566154|P1|Overall Study|Insurance Issues|1
5668950|NCT00448019|19566154|P1|Overall Study|Death|2
5668951|NCT00448019|19566154|P1|Overall Study|Disease progression|1
5668952|NCT00448019|19566154|P1|Overall Study|Withdrawal by Subject|3
5668953|NCT00447902|19566162|P2|Overall Study|Lack of Efficacy|1
5668954|NCT00447902|19566163|P1|Overall Study|Lack of Efficacy|2
5668955|NCT00447902|19566162|P2|Overall Study|included patients who discontinued|1
5668956|NCT00447902|19566163|P1|Overall Study|included patients who discontinued|1
5668957|NCT00447902|19566162|P2|Overall Study|Withdrawal by Subject|1
5668958|NCT00447902|19566163|P1|Overall Study|Withdrawal by Subject|0
5668959|NCT00447902|19566162|P2|Overall Study|Protocol Violation|0
5668960|NCT00447902|19566163|P1|Overall Study|Protocol Violation|1
5668961|NCT00447902|19566162|P2|Overall Study|Adverse Event|3
5668962|NCT00447902|19566163|P1|Overall Study|Adverse Event|0
5668963|NCT00447876|19566205|P2|Overall Study|Deterioration of symptomology|0
5668964|NCT00447876|19566206|P1|Overall Study|Deterioration of symptomology|1
5668965|NCT00447876|19566205|P2|Overall Study|Lost to Follow-up|0
5668966|NCT00447876|19566206|P1|Overall Study|Lost to Follow-up|1
5668967|NCT00447876|19566205|P2|Overall Study|Withdrawal by Subject|4
5668968|NCT00447876|19566206|P1|Overall Study|Withdrawal by Subject|1
5668969|NCT00447772|19566236|P1|Overall Study|Premature re-injection required|1
5668970|NCT00447772|19566236|P1|Overall Study|Chemotherapy for lung cancer|1
5668971|NCT00447772|19566236|P1|Overall Study|Incomplete documentation at visit 1|1
5668972|NCT00447772|19566236|P1|Overall Study|Patient relocated|1
5668973|NCT00447772|19566236|P1|Overall Study|Adverse Event|1
5668974|NCT00447772|19566236|P1|Overall Study|Unable to attend all study visits|2
5668975|NCT00447772|19566236|P1|Overall Study|Withdrawal by Subject|1
5668976|NCT00447772|19566236|P1|Overall Study|Lost to Follow-up|9
5668977|NCT00447772|19566236|P1|Overall Study|Discontinuation of drug therapy|1
5668978|NCT00447772|19566236|P1|Overall Study|Insufficient compliance|6
5668979|NCT00447772|19566236|P1|Overall Study|Lack of Efficacy|3
5668980|NCT00447603|19566256|P3|Filter Period|Study terminated by Sponsor|10
5668981|NCT00447603|19566257|P2|Filter Period|Study terminated by Sponsor|1
5668982|NCT00447603|19566258|P1|Filter Period|Study terminated by Sponsor|0
5668983|NCT00447603|19566256|P3|Filter Period|Screen Failure|4
5668984|NCT00447603|19566257|P2|Filter Period|Screen Failure|3
5668985|NCT00447603|19566258|P1|Filter Period|Screen Failure|0
5668986|NCT00447603|19566256|P3|Filter Period|Adverse Event|1
5668987|NCT00447603|19566257|P2|Filter Period|Adverse Event|0
5668988|NCT00447603|19566258|P1|Filter Period|Adverse Event|0
5668989|NCT00447603|19566256|P3|Screening|Study Terminated by Sponsor|0
5668990|NCT00447603|19566257|P2|Screening|Study Terminated by Sponsor|0
5668991|NCT00447603|19566258|P1|Screening|Study Terminated by Sponsor|15
5668992|NCT00447603|19566256|P3|Screening|Screen Failure|0
5668993|NCT00447603|19566257|P2|Screening|Screen Failure|0
5668994|NCT00447603|19566258|P1|Screening|Screen Failure|4
5668995|NCT00447603|19566256|P3|Screening|Protocol Violation|0
5668996|NCT00447603|19566257|P2|Screening|Protocol Violation|0
5668997|NCT00447603|19566258|P1|Screening|Protocol Violation|1
5668998|NCT00447603|19566256|P3|Screening|Withdrawal by Subject|0
5668999|NCT00447603|19566257|P2|Screening|Withdrawal by Subject|0
5669000|NCT00447603|19566258|P1|Screening|Withdrawal by Subject|1
5669001|NCT00447590|19566278|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
5669002|NCT00447590|19566278|P1|Overall Study|Lost to Follow-up|24
5669003|NCT00447590|19566278|P1|Overall Study|Withdrawal by Subject|26
5669004|NCT00447499|19566287|P1|Overall Study|Physician Decision|1
5669005|NCT00447499|19566287|P1|Overall Study|Sponsor Decision|1
5669006|NCT00447499|19566287|P1|Overall Study|Patient Decision|4
5669007|NCT00447499|19566287|P1|Overall Study|Adverse Event|1
5669008|NCT00447421|19566297|P1|Overall Study|Sponsor Decision|2
5669009|NCT00447421|19566297|P1|Overall Study|Adverse Event|3
5669010|NCT00447421|19566297|P1|Overall Study|Lack of Efficacy|1
5669011|NCT00447382|19566309|P2|Overall Study|Unclassified|5
5669012|NCT00447382|19566310|P1|Overall Study|Unclassified|2
5669013|NCT00447382|19566309|P2|Overall Study|Protocol Violation|0
5669014|NCT00447382|19566310|P1|Overall Study|Protocol Violation|2
5669015|NCT00447382|19566309|P2|Overall Study|Lack of Efficacy|0
5669016|NCT00447382|19566310|P1|Overall Study|Lack of Efficacy|1
5669017|NCT00447382|19566309|P2|Overall Study|Adverse Event|1
5669018|NCT00447382|19566310|P1|Overall Study|Adverse Event|1
5669019|NCT00447278|19566371|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
5669020|NCT00447278|19566372|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
5669021|NCT00447278|19566371|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
5669022|NCT00447278|19566372|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
5669023|NCT00447278|19566371|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
5669024|NCT00447278|19566372|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
5669025|NCT00447278|19566371|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
5669026|NCT00447278|19566372|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
5669027|NCT00447278|19566371|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
5669028|NCT00447278|19566372|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
5669029|NCT00447278|19566371|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
5669030|NCT00447278|19566372|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
5669031|NCT00447278|19566371|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
5669032|NCT00447278|19566372|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
5669033|NCT00447278|19566371|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
5669034|NCT00447278|19566372|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
5669035|NCT00447278|19566371|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
5669036|NCT00447278|19566372|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
5669037|NCT00447278|19566371|P2|Period II (6 Month Open-Label)|Physician Decision|1
5669038|NCT00447278|19566372|P1|Period II (6 Month Open-Label)|Physician Decision|4
5669039|NCT00447278|19566371|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
5669040|NCT00447278|19566372|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
5669041|NCT00447278|19566371|P2|Period II (6 Month Open-Label)|Protocol Violation|7
5669042|NCT00447278|19566372|P1|Period II (6 Month Open-Label)|Protocol Violation|10
5669043|NCT00447278|19566371|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
5669044|NCT00447278|19566372|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
5669045|NCT00447278|19566371|P2|Period II (6 Month Open-Label)|Adverse Event|3
5669046|NCT00447278|19566372|P1|Period II (6 Month Open-Label)|Adverse Event|7
5669047|NCT00447265|19566393|P2|Overall Study|Physician Decision|0
5669048|NCT00447265|19566394|P1|Overall Study|Physician Decision|1
5669049|NCT00447226|19566407|P2|Double-blind Phase|Disease Progression|3
5669050|NCT00447226|19566408|P1|Double-blind Phase|Disease Progression|4
5669051|NCT00447226|19566407|P2|12-Week Open-label Phase|Physician Decision|1
5669052|NCT00447226|19566408|P1|12-Week Open-label Phase|Physician Decision|0
5669053|NCT00447226|19566407|P2|12-Week Open-label Phase|Disease Progression|20
5669054|NCT00447226|19566408|P1|12-Week Open-label Phase|Disease Progression|0
5669055|NCT00447226|19566407|P2|12-Week Open-label Phase|Protocol Violation|1
5669056|NCT00447226|19566408|P1|12-Week Open-label Phase|Protocol Violation|0
5669057|NCT00447226|19566407|P2|12-Week Open-label Phase|Adverse Event|3
5669058|NCT00447226|19566408|P1|12-Week Open-label Phase|Adverse Event|0
5669059|NCT00447057|19566451|P4|Overall Study|Death, study drug related|0
5669060|NCT00447057|19566452|P3|Overall Study|Death, study drug related|0
5669061|NCT00447057|19566453|P2|Overall Study|Death, study drug related|1
5669062|NCT00447057|19566454|P1|Overall Study|Death, study drug related|0
5669063|NCT00447057|19566451|P4|Overall Study|Death due to adverse event|2
5669064|NCT00447057|19566452|P3|Overall Study|Death due to adverse event|1
5669065|NCT00447057|19566453|P2|Overall Study|Death due to adverse event|0
5669066|NCT00447057|19566454|P1|Overall Study|Death due to adverse event|0
5669067|NCT00447057|19566451|P4|Overall Study|Progressive disease|18
5669068|NCT00447057|19566452|P3|Overall Study|Progressive disease|13
5669069|NCT00447057|19566453|P2|Overall Study|Progressive disease|43
5669070|NCT00447057|19566454|P1|Overall Study|Progressive disease|58
5669071|NCT00447057|19566451|P4|Overall Study|Sponsor decision|0
5669072|NCT00447057|19566452|P3|Overall Study|Sponsor decision|0
5669073|NCT00447057|19566453|P2|Overall Study|Sponsor decision|1
5669074|NCT00447057|19566454|P1|Overall Study|Sponsor decision|1
5669075|NCT00447057|19566451|P4|Overall Study|Physician Decision|1
5669076|NCT00447057|19566452|P3|Overall Study|Physician Decision|3
5669077|NCT00447057|19566453|P2|Overall Study|Physician Decision|6
5669078|NCT00447057|19566454|P1|Overall Study|Physician Decision|9
5669079|NCT00447057|19566451|P4|Overall Study|Withdrawal by Subject|1
5669080|NCT00447057|19566452|P3|Overall Study|Withdrawal by Subject|1
5669081|NCT00447057|19566453|P2|Overall Study|Withdrawal by Subject|5
5669082|NCT00447057|19566454|P1|Overall Study|Withdrawal by Subject|4
5669083|NCT00447057|19566451|P4|Overall Study|Protocol Violation|0
5669084|NCT00447057|19566452|P3|Overall Study|Protocol Violation|0
5669085|NCT00447057|19566453|P2|Overall Study|Protocol Violation|1
5669086|NCT00447057|19566454|P1|Overall Study|Protocol Violation|0
5669087|NCT00447057|19566451|P4|Overall Study|Entry criteria not met|0
5669088|NCT00447057|19566452|P3|Overall Study|Entry criteria not met|0
5669089|NCT00447057|19566453|P2|Overall Study|Entry criteria not met|1
5669090|NCT00447057|19566454|P1|Overall Study|Entry criteria not met|1
5669091|NCT00447057|19566451|P4|Overall Study|Lost to Follow-up|0
5669092|NCT00447057|19566452|P3|Overall Study|Lost to Follow-up|0
5669093|NCT00447057|19566453|P2|Overall Study|Lost to Follow-up|1
5669094|NCT00447057|19566454|P1|Overall Study|Lost to Follow-up|0
5669095|NCT00447057|19566451|P4|Overall Study|Death due to study disease|1
5669096|NCT00447057|19566452|P3|Overall Study|Death due to study disease|1
5669097|NCT00447057|19566453|P2|Overall Study|Death due to study disease|4
5669098|NCT00447057|19566454|P1|Overall Study|Death due to study disease|6
5669099|NCT00447057|19566451|P4|Overall Study|Adverse Event|3
5669100|NCT00447057|19566452|P3|Overall Study|Adverse Event|0
5669101|NCT00447057|19566453|P2|Overall Study|Adverse Event|10
5669102|NCT00447057|19566454|P1|Overall Study|Adverse Event|4
5669103|NCT00447005|19566472|P1|Overall Study|Lack of Efficacy|11
5669104|NCT00447005|19566472|P1|Overall Study|Adverse Event|1
5669105|NCT00446992|19566486|P1|Overall Study|Lost to Follow-up|5
5669106|NCT00446992|19566486|P1|Overall Study|Adverse Event|11
5669107|NCT00446966|19566500|P2|Overall Study|Lost to Follow-up|7
5669108|NCT00446966|19566501|P1|Overall Study|Lost to Follow-up|10
5669109|NCT00446849|19566507|P1|Maintenance Phase|concomitant medication use|1
5669110|NCT00446849|19566507|P1|Maintenance Phase|hydrocodone use|1
5669111|NCT00446849|19566507|P1|Maintenance Phase|study closure|1
5669112|NCT00446849|19566507|P1|Maintenance Phase|antibiotic use|1
5669113|NCT00446849|19566507|P1|Maintenance Phase|prohibited medication use|2
5669114|NCT00446849|19566507|P1|Maintenance Phase|noncompliance|2
5669115|NCT00446849|19566507|P1|Maintenance Phase|Pregnancy|1
5669116|NCT00446849|19566507|P1|Maintenance Phase|Lost to Follow-up|3
5669117|NCT00446849|19566507|P1|Maintenance Phase|Consent withdrawn|5
5669118|NCT00446849|19566507|P1|Maintenance Phase|Adverse Event|6
5669119|NCT00446849|19566507|P1|Maintenance Phase|Protocol Violation|7
5669120|NCT00446849|19566507|P1|Maintenance Phase|Lack of Efficacy|40
5669121|NCT00446849|19566507|P1|Acute Phase|noncompliance|1
5669122|NCT00446849|19566507|P1|Acute Phase|Physician Decision|1
5669123|NCT00446849|19566507|P1|Acute Phase|Lost to Follow-up|2
5669124|NCT00446849|19566507|P1|Acute Phase|Consent withdrawn|4
5669125|NCT00446849|19566507|P1|Acute Phase|Protocol Violation|10
5669126|NCT00446849|19566507|P1|Acute Phase|Lack of Efficacy|64
5669127|NCT00446797|19566519|P2|Overall Study|did not meet entrance criteria|1
5669128|NCT00446797|19566520|P1|Overall Study|did not meet entrance criteria|0
5669129|NCT00446797|19566519|P2|Overall Study|subject entered at another site|1
5669130|NCT00446797|19566520|P1|Overall Study|subject entered at another site|0
5669131|NCT00446797|19566519|P2|Overall Study|Protocol Violation|3
5669132|NCT00446797|19566520|P1|Overall Study|Protocol Violation|1
5669133|NCT00446797|19566519|P2|Overall Study|Withdrawal by Subject|2
5669134|NCT00446797|19566520|P1|Overall Study|Withdrawal by Subject|2
5669135|NCT00446797|19566519|P2|Overall Study|Lost to Follow-up|3
5669136|NCT00446797|19566520|P1|Overall Study|Lost to Follow-up|5
5669137|NCT00446797|19566519|P2|Overall Study|Lack of Efficacy|2
5669138|NCT00446797|19566520|P1|Overall Study|Lack of Efficacy|0
5669139|NCT00446654|19566566|P2|Overall Study|Adverse Event|0
5669140|NCT00446654|19566567|P1|Overall Study|Adverse Event|1
5669141|NCT00446654|19566566|P2|Overall Study|Withdrawal by Subject|0
5669142|NCT00446654|19566567|P1|Overall Study|Withdrawal by Subject|1
5669143|NCT00446641|19566575|P2|Overall Study|Lost to Follow-up|1
5669144|NCT00446641|19566576|P1|Overall Study|Lost to Follow-up|1
5669145|NCT00446641|19566575|P2|Overall Study|poor compliance|6
5669146|NCT00446641|19566576|P1|Overall Study|poor compliance|8
5669147|NCT00446641|19566575|P2|Overall Study|Withdrawal by Subject|3
5669148|NCT00446641|19566576|P1|Overall Study|Withdrawal by Subject|8
5669149|NCT00446563|19566596|P2|Overall Study|Administrative problems|1
5669150|NCT00446563|19566597|P1|Overall Study|Administrative problems|0
5669151|NCT00446563|19566596|P2|Overall Study|Withdrawal by Subject|1
5669152|NCT00446563|19566597|P1|Overall Study|Withdrawal by Subject|2
5669153|NCT00446563|19566596|P2|Overall Study|Unsatisfactory therapeutic effect|3
5669154|NCT00446563|19566597|P1|Overall Study|Unsatisfactory therapeutic effect|0
5669155|NCT00446563|19566596|P2|Overall Study|Abnormal test procedure result(s)|0
5669156|NCT00446563|19566597|P1|Overall Study|Abnormal test procedure result(s)|1
5669157|NCT00446563|19566596|P2|Overall Study|Abnormal laboratory value(s)|1
5669158|NCT00446563|19566597|P1|Overall Study|Abnormal laboratory value(s)|0
5669159|NCT00446563|19566596|P2|Overall Study|Adverse Event|3
5669160|NCT00446563|19566597|P1|Overall Study|Adverse Event|4
5669161|NCT00446550|19566633|P2|Overall Study|Adverse Event|0
5669162|NCT00446550|19566634|P1|Overall Study|Adverse Event|1
5669163|NCT00446511|19566646|P4|Overall Study|Administrative Problems|1
5669164|NCT00446511|19566647|P3|Overall Study|Administrative Problems|4
5669165|NCT00446511|19566648|P2|Overall Study|Administrative Problems|0
5669166|NCT00446511|19566649|P1|Overall Study|Administrative Problems|3
5669167|NCT00446511|19566646|P4|Overall Study|Withdrawal by Subject|3
5669168|NCT00446511|19566647|P3|Overall Study|Withdrawal by Subject|0
5669169|NCT00446511|19566648|P2|Overall Study|Withdrawal by Subject|0
5669170|NCT00446511|19566649|P1|Overall Study|Withdrawal by Subject|0
5669171|NCT00446511|19566646|P4|Overall Study|Protocol Violation|1
5669172|NCT00446511|19566647|P3|Overall Study|Protocol Violation|0
5669173|NCT00446511|19566648|P2|Overall Study|Protocol Violation|0
5669174|NCT00446511|19566649|P1|Overall Study|Protocol Violation|0
5669175|NCT00446511|19566646|P4|Overall Study|Adverse Event|1
5669176|NCT00446511|19566647|P3|Overall Study|Adverse Event|3
5669177|NCT00446511|19566648|P2|Overall Study|Adverse Event|2
5669178|NCT00446511|19566649|P1|Overall Study|Adverse Event|7
5669179|NCT00446459|19566673|P1|12 Months|14 subjects to MMF + Rituximab Study|14
5669180|NCT00446459|19566673|P1|12 Months|Protocol Violation|4
5669181|NCT00446459|19566673|P1|8 Months|Protocol Violation|12
5669182|NCT00446446|19566681|P1|Overall Study|On Treatment at Time of Data Cut-off|1
5669183|NCT00446446|19566681|P1|Overall Study|Adverse Event|1
5669184|NCT00446446|19566681|P1|Overall Study|Disease Progession|2
5669185|NCT00446446|19566681|P1|Overall Study|Other|4
5669186|NCT00446446|19566681|P1|Overall Study|Withdrawal by Subject|6
5669187|NCT00446446|19566681|P1|Overall Study|Death|10
5669188|NCT00446251|19566705|P1|Overall Study|Lost to Follow-up|1
5669189|NCT00446251|19566705|P1|Overall Study|Rituximab Infusion Reaction|2
5669190|NCT00446251|19566705|P1|Overall Study|On-study Transplants|2
5669191|NCT00446199|19566715|P4|Overall Study|Move|0
5669192|NCT00446199|19566716|P3|Overall Study|Move|0
5669193|NCT00446199|19566717|P2|Overall Study|Move|1
5669194|NCT00446199|19566718|P1|Overall Study|Move|0
5669195|NCT00446199|19566715|P4|Overall Study|In-/Exclusion criterion violated|1
5669196|NCT00446199|19566716|P3|Overall Study|In-/Exclusion criterion violated|2
5669197|NCT00446199|19566717|P2|Overall Study|In-/Exclusion criterion violated|1
5669198|NCT00446199|19566718|P1|Overall Study|In-/Exclusion criterion violated|2
5669199|NCT00446199|19566715|P4|Overall Study|Lost interest in study participation|0
5669200|NCT00446199|19566716|P3|Overall Study|Lost interest in study participation|0
5669201|NCT00446199|19566717|P2|Overall Study|Lost interest in study participation|1
5669202|NCT00446199|19566718|P1|Overall Study|Lost interest in study participation|0
5669203|NCT00446199|19566715|P4|Overall Study|Hormone fear|1
5669204|NCT00446199|19566716|P3|Overall Study|Hormone fear|0
5669205|NCT00446199|19566717|P2|Overall Study|Hormone fear|0
5669206|NCT00446199|19566718|P1|Overall Study|Hormone fear|0
5669207|NCT00446199|19566715|P4|Overall Study|Non-compliant with visit schedule|2
5669208|NCT00446199|19566716|P3|Overall Study|Non-compliant with visit schedule|1
5669209|NCT00446199|19566717|P2|Overall Study|Non-compliant with visit schedule|1
5669210|NCT00446199|19566718|P1|Overall Study|Non-compliant with visit schedule|1
5669211|NCT00446199|19566715|P4|Overall Study|Non-compliant with study drug|0
5669212|NCT00446199|19566716|P3|Overall Study|Non-compliant with study drug|5
5669213|NCT00446199|19566717|P2|Overall Study|Non-compliant with study drug|0
5669214|NCT00446199|19566718|P1|Overall Study|Non-compliant with study drug|1
5669215|NCT00446199|19566715|P4|Overall Study|Lack of Efficacy|1
5669216|NCT00446199|19566716|P3|Overall Study|Lack of Efficacy|0
5669217|NCT00446199|19566717|P2|Overall Study|Lack of Efficacy|0
5669218|NCT00446199|19566718|P1|Overall Study|Lack of Efficacy|1
5669219|NCT00446199|19566715|P4|Overall Study|Randomization in Error|1
5669220|NCT00446199|19566716|P3|Overall Study|Randomization in Error|1
5669221|NCT00446199|19566717|P2|Overall Study|Randomization in Error|0
5669222|NCT00446199|19566718|P1|Overall Study|Randomization in Error|2
5669223|NCT00446199|19566715|P4|Overall Study|Site termination|1
5669224|NCT00446199|19566716|P3|Overall Study|Site termination|0
5669225|NCT00446199|19566717|P2|Overall Study|Site termination|0
5669226|NCT00446199|19566718|P1|Overall Study|Site termination|2
5669227|NCT00446199|19566715|P4|Overall Study|Withdrawal by Subject|10
5669228|NCT00446199|19566716|P3|Overall Study|Withdrawal by Subject|9
5669229|NCT00446199|19566717|P2|Overall Study|Withdrawal by Subject|5
5669230|NCT00446199|19566718|P1|Overall Study|Withdrawal by Subject|2
5669231|NCT00446199|19566715|P4|Overall Study|Protocol Violation|3
5669232|NCT00446199|19566716|P3|Overall Study|Protocol Violation|1
5669233|NCT00446199|19566717|P2|Overall Study|Protocol Violation|2
5669234|NCT00446199|19566718|P1|Overall Study|Protocol Violation|1
5669235|NCT00446199|19566715|P4|Overall Study|Lost to Follow-up|6
5669236|NCT00446199|19566716|P3|Overall Study|Lost to Follow-up|2
5669237|NCT00446199|19566717|P2|Overall Study|Lost to Follow-up|5
5669238|NCT00446199|19566718|P1|Overall Study|Lost to Follow-up|4
5669239|NCT00446199|19566715|P4|Overall Study|Adverse Event|4
5669240|NCT00446199|19566716|P3|Overall Study|Adverse Event|6
5669241|NCT00446199|19566717|P2|Overall Study|Adverse Event|4
5669242|NCT00446199|19566718|P1|Overall Study|Adverse Event|7
5669243|NCT00446134|19566811|P4|Overall Study|Reason Not Completed|2
5669244|NCT00446134|19566812|P3|Overall Study|Reason Not Completed|1
5669245|NCT00446134|19566813|P2|Overall Study|Reason Not Completed|0
5669246|NCT00446134|19566814|P1|Overall Study|Reason Not Completed|3
5669247|NCT00446134|19566811|P4|Overall Study|Adverse Event-Diarrhea|0
5669248|NCT00446134|19566812|P3|Overall Study|Adverse Event-Diarrhea|2
5669249|NCT00446134|19566813|P2|Overall Study|Adverse Event-Diarrhea|1
5669250|NCT00446134|19566814|P1|Overall Study|Adverse Event-Diarrhea|1
5669251|NCT00446134|19566811|P4|Overall Study|Physician Decision|2
5669252|NCT00446134|19566812|P3|Overall Study|Physician Decision|0
5669253|NCT00446134|19566813|P2|Overall Study|Physician Decision|0
5669254|NCT00446134|19566814|P1|Overall Study|Physician Decision|0
5669255|NCT00446134|19566811|P4|Overall Study|Withdrawal by Subject|3
5669256|NCT00446134|19566812|P3|Overall Study|Withdrawal by Subject|1
5669257|NCT00446134|19566813|P2|Overall Study|Withdrawal by Subject|3
5669258|NCT00446134|19566814|P1|Overall Study|Withdrawal by Subject|3
5669259|NCT00446134|19566811|P4|Overall Study|Lost to Follow-up|1
5669260|NCT00446134|19566812|P3|Overall Study|Lost to Follow-up|1
5669261|NCT00446134|19566813|P2|Overall Study|Lost to Follow-up|3
5669262|NCT00446134|19566814|P1|Overall Study|Lost to Follow-up|1
5669263|NCT00446134|19566811|P4|Overall Study|Protocol Violation|0
5669264|NCT00446134|19566812|P3|Overall Study|Protocol Violation|1
5669265|NCT00446134|19566813|P2|Overall Study|Protocol Violation|2
5669266|NCT00446134|19566814|P1|Overall Study|Protocol Violation|0
5669267|NCT00446134|19566811|P4|Overall Study|Lack of Efficacy|19
5669268|NCT00446134|19566812|P3|Overall Study|Lack of Efficacy|24
5669269|NCT00446134|19566813|P2|Overall Study|Lack of Efficacy|19
5669270|NCT00446134|19566814|P1|Overall Study|Lack of Efficacy|19
5669271|NCT00446134|19566811|P4|Overall Study|Adverse Event|18
5669272|NCT00446134|19566812|P3|Overall Study|Adverse Event|13
5669273|NCT00446134|19566813|P2|Overall Study|Adverse Event|17
5669274|NCT00446134|19566814|P1|Overall Study|Adverse Event|7
5669275|NCT00446095|19566841|P5|Phase I (28 Days)|Lack of Efficacy|3
5669276|NCT00446095|19566842|P4|Phase I (28 Days)|Lack of Efficacy|0
5669277|NCT00446095|19566843|P3|Phase I (28 Days)|Lack of Efficacy|0
5669278|NCT00446095|19566844|P2|Phase I (28 Days)|Lack of Efficacy|0
5669279|NCT00446095|19566845|P1|Phase I (28 Days)|Lack of Efficacy|0
5669280|NCT00446095|19566841|P5|Phase I (28 Days)|Adverse Event|0
5669281|NCT00446095|19566842|P4|Phase I (28 Days)|Adverse Event|1
5669282|NCT00446095|19566843|P3|Phase I (28 Days)|Adverse Event|0
5669283|NCT00446095|19566844|P2|Phase I (28 Days)|Adverse Event|0
5669284|NCT00446095|19566845|P1|Phase I (28 Days)|Adverse Event|0
5669285|NCT00446095|19566841|P5|Phase II (8 Weeks)|Ongoing|0
5669286|NCT00446095|19566842|P4|Phase II (8 Weeks)|Ongoing|0
5669287|NCT00446095|19566843|P3|Phase II (8 Weeks)|Ongoing|1
5669288|NCT00446095|19566844|P2|Phase II (8 Weeks)|Ongoing|0
5669289|NCT00446095|19566845|P1|Phase II (8 Weeks)|Ongoing|0
5669290|NCT00446095|19566841|P5|Phase II (8 Weeks)|Lack of Efficacy|0
5669291|NCT00446095|19566842|P4|Phase II (8 Weeks)|Lack of Efficacy|0
5669292|NCT00446095|19566843|P3|Phase II (8 Weeks)|Lack of Efficacy|1
5669293|NCT00446095|19566844|P2|Phase II (8 Weeks)|Lack of Efficacy|2
5669294|NCT00446095|19566845|P1|Phase II (8 Weeks)|Lack of Efficacy|9
5669295|NCT00446095|19566841|P5|Phase II (8 Weeks)|Physician Decision|0
5669296|NCT00446095|19566842|P4|Phase II (8 Weeks)|Physician Decision|0
5669297|NCT00446095|19566843|P3|Phase II (8 Weeks)|Physician Decision|0
5669298|NCT00446095|19566844|P2|Phase II (8 Weeks)|Physician Decision|0
5669299|NCT00446095|19566845|P1|Phase II (8 Weeks)|Physician Decision|1
5669300|NCT00446095|19566841|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
5669301|NCT00446095|19566842|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
5669302|NCT00446095|19566843|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
5669303|NCT00446095|19566844|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
5669304|NCT00446095|19566845|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
5669305|NCT00446095|19566841|P5|Phase II (8 Weeks)|Adverse Event|0
5669306|NCT00446095|19566842|P4|Phase II (8 Weeks)|Adverse Event|0
5669307|NCT00446095|19566843|P3|Phase II (8 Weeks)|Adverse Event|1
5669308|NCT00446095|19566844|P2|Phase II (8 Weeks)|Adverse Event|1
5669309|NCT00446095|19566845|P1|Phase II (8 Weeks)|Adverse Event|0
5669310|NCT00446095|19566841|P5|Phase II (8 Weeks)|Lost to Follow-up|0
5669311|NCT00446095|19566842|P4|Phase II (8 Weeks)|Lost to Follow-up|0
5669312|NCT00446095|19566843|P3|Phase II (8 Weeks)|Lost to Follow-up|0
5669313|NCT00446095|19566844|P2|Phase II (8 Weeks)|Lost to Follow-up|0
5669314|NCT00446095|19566845|P1|Phase II (8 Weeks)|Lost to Follow-up|1
5669315|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
5669316|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
5669317|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
5669318|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
5669319|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
5669320|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
5669321|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
5669322|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
5669323|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
5669324|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
5669325|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
5669326|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
5669327|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
5669328|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
5669329|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Death|2
5669330|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Death|2
5669331|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
5669332|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
5669333|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
5669334|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
5669335|NCT00446030|19566868|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
5669336|NCT00446030|19566869|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
5669337|NCT00446030|19566868|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
5669338|NCT00446030|19566869|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
5669339|NCT00446030|19566868|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
5669340|NCT00446030|19566869|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
5669341|NCT00446030|19566868|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
5669342|NCT00446030|19566869|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
5669343|NCT00446030|19566868|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
5669344|NCT00446030|19566869|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
5669345|NCT00446030|19566868|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
5669346|NCT00446030|19566869|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
5669347|NCT00446030|19566868|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
5669348|NCT00446030|19566869|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
5669349|NCT00446030|19566868|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
5669350|NCT00446030|19566869|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
5669351|NCT00446030|19566868|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
5669352|NCT00446030|19566869|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
5669353|NCT00445939|19566880|P4|Period B - Week 4 - Week 8|Adverse Event|1
5669354|NCT00445939|19566881|P3|Period B - Week 4 - Week 8|Adverse Event|0
5669355|NCT00445939|19566882|P2|Period B - Week 4 - Week 8|Adverse Event|0
5669356|NCT00445939|19566883|P1|Period B - Week 4 - Week 8|Adverse Event|2
5669357|NCT00445939|19566880|P4|Period A - Week 0 - Week 4|Adverse Event|0
5669358|NCT00445939|19566881|P3|Period A - Week 0 - Week 4|Adverse Event|0
5669359|NCT00445939|19566882|P2|Period A - Week 0 - Week 4|Adverse Event|2
5669360|NCT00445939|19566883|P1|Period A - Week 0 - Week 4|Adverse Event|1
5669361|NCT00445848|19566931|P1|Overall Study|Other-Not protocol specified|5
5669362|NCT00445848|19566931|P1|Overall Study|Progression|62
5669363|NCT00445848|19566931|P1|Overall Study|Withdrawal by Subject|4
5669364|NCT00445848|19566931|P1|Overall Study|Adverse Event|14
5669365|NCT00445770|19566941|P3|Overall Study|Other|6
5669366|NCT00445770|19566942|P2|Overall Study|Other|5
5669367|NCT00445770|19566943|P1|Overall Study|Other|6
5669368|NCT00445770|19566941|P3|Overall Study|Lost to Follow-up|0
5669369|NCT00445770|19566942|P2|Overall Study|Lost to Follow-up|2
5669370|NCT00445770|19566943|P1|Overall Study|Lost to Follow-up|0
5669371|NCT00445770|19566941|P3|Overall Study|Lack of Efficacy|6
5669372|NCT00445770|19566942|P2|Overall Study|Lack of Efficacy|13
5669373|NCT00445770|19566943|P1|Overall Study|Lack of Efficacy|38
5669374|NCT00445770|19566941|P3|Overall Study|Adverse Event|19
5669375|NCT00445770|19566942|P2|Overall Study|Adverse Event|15
5669376|NCT00445770|19566943|P1|Overall Study|Adverse Event|9
5669377|NCT00445692|19567044|P1|Overall Study|Lack of Efficacy|5
5669378|NCT00445692|19567044|P1|Overall Study|Adverse Event|11
5669379|NCT00445679|19567054|P4|Overall Study|Lack of Efficacy|0
5669380|NCT00445679|19567055|P3|Overall Study|Lack of Efficacy|2
5669381|NCT00445679|19567056|P2|Overall Study|Lack of Efficacy|6
5669382|NCT00445679|19567057|P1|Overall Study|Lack of Efficacy|2
5669383|NCT00445679|19567054|P4|Overall Study|Withdrawal by Subject|18
5669384|NCT00445679|19567055|P3|Overall Study|Withdrawal by Subject|20
5669385|NCT00445679|19567056|P2|Overall Study|Withdrawal by Subject|14
5669386|NCT00445679|19567057|P1|Overall Study|Withdrawal by Subject|8
5669387|NCT00445679|19567054|P4|Overall Study|Protocol Violation|1
5669388|NCT00445679|19567055|P3|Overall Study|Protocol Violation|3
5669389|NCT00445679|19567056|P2|Overall Study|Protocol Violation|3
5669390|NCT00445679|19567057|P1|Overall Study|Protocol Violation|2
5669391|NCT00445679|19567054|P4|Overall Study|Withdrawal of Informed Consent|0
5669392|NCT00445679|19567055|P3|Overall Study|Withdrawal of Informed Consent|1
5669393|NCT00445679|19567056|P2|Overall Study|Withdrawal of Informed Consent|0
5669394|NCT00445679|19567057|P1|Overall Study|Withdrawal of Informed Consent|0
5669395|NCT00445679|19567054|P4|Overall Study|Compliance|2
5669396|NCT00445679|19567055|P3|Overall Study|Compliance|1
5669397|NCT00445679|19567056|P2|Overall Study|Compliance|2
5669398|NCT00445679|19567057|P1|Overall Study|Compliance|3
5669399|NCT00445679|19567054|P4|Overall Study|Lost to Follow-up|5
5669400|NCT00445679|19567055|P3|Overall Study|Lost to Follow-up|6
5669401|NCT00445679|19567056|P2|Overall Study|Lost to Follow-up|6
5669402|NCT00445679|19567057|P1|Overall Study|Lost to Follow-up|10
5669403|NCT00445679|19567054|P4|Overall Study|Physician Decision|0
5669404|NCT00445679|19567055|P3|Overall Study|Physician Decision|1
5669405|NCT00445679|19567056|P2|Overall Study|Physician Decision|0
5669406|NCT00445679|19567057|P1|Overall Study|Physician Decision|0
5669407|NCT00445679|19567054|P4|Overall Study|Failed to return|2
5669408|NCT00445679|19567055|P3|Overall Study|Failed to return|2
5669409|NCT00445679|19567056|P2|Overall Study|Failed to return|3
5669410|NCT00445679|19567057|P1|Overall Study|Failed to return|1
5669411|NCT00445679|19567054|P4|Overall Study|Adverse Event|19
5669412|NCT00445679|19567055|P3|Overall Study|Adverse Event|30
5669413|NCT00445679|19567056|P2|Overall Study|Adverse Event|12
5669414|NCT00445679|19567057|P1|Overall Study|Adverse Event|22
5669415|NCT00445601|19567093|P2|Overall Study|Death prior to TURBT|1
5669416|NCT00445601|19567094|P1|Overall Study|Death prior to TURBT|0
5669417|NCT00445601|19567093|P2|Overall Study|Adverse Event|0
5669418|NCT00445601|19567094|P1|Overall Study|Adverse Event|2
5669419|NCT00445601|19567093|P2|Overall Study|Drug Delivery Issue|2
5669420|NCT00445601|19567094|P1|Overall Study|Drug Delivery Issue|2
5669421|NCT00445601|19567093|P2|Overall Study|Incorrect Disease Status|6
5669422|NCT00445601|19567094|P1|Overall Study|Incorrect Disease Status|6
5669423|NCT00445601|19567093|P2|Overall Study|TURBT Complication|8
5669424|NCT00445601|19567094|P1|Overall Study|TURBT Complication|12
5669425|NCT00445601|19567093|P2|Overall Study|Withdrawal by Subject|11
5669426|NCT00445601|19567094|P1|Overall Study|Withdrawal by Subject|11
5669427|NCT00445549|19567111|P1|Overall Study|progressive disease|12
5669428|NCT00445458|19567135|P4|Overall Study|Surgery|0
5669429|NCT00445458|19567136|P3|Overall Study|Surgery|1
5669430|NCT00445458|19567137|P2|Overall Study|Surgery|0
5669431|NCT00445458|19567138|P1|Overall Study|Surgery|0
5669432|NCT00445458|19567135|P4|Overall Study|Physician Decision|1
5669433|NCT00445458|19567136|P3|Overall Study|Physician Decision|1
5669434|NCT00445458|19567137|P2|Overall Study|Physician Decision|0
5669435|NCT00445458|19567138|P1|Overall Study|Physician Decision|0
5669436|NCT00445458|19567135|P4|Overall Study|Death|0
5669437|NCT00445458|19567136|P3|Overall Study|Death|2
5669438|NCT00445458|19567137|P2|Overall Study|Death|1
5669439|NCT00445458|19567138|P1|Overall Study|Death|0
5669440|NCT00445458|19567135|P4|Overall Study|Adverse Event|0
5669441|NCT00445458|19567136|P3|Overall Study|Adverse Event|3
5669442|NCT00445458|19567137|P2|Overall Study|Adverse Event|0
5669443|NCT00445458|19567138|P1|Overall Study|Adverse Event|0
5669444|NCT00445458|19567135|P4|Overall Study|Withdrawal by Subject|0
5669445|NCT00445458|19567136|P3|Overall Study|Withdrawal by Subject|7
5669446|NCT00445458|19567137|P2|Overall Study|Withdrawal by Subject|0
5669447|NCT00445458|19567138|P1|Overall Study|Withdrawal by Subject|0
5669448|NCT00445458|19567135|P4|Overall Study|Disease Progression|27
5669449|NCT00445458|19567136|P3|Overall Study|Disease Progression|54
5669450|NCT00445458|19567137|P2|Overall Study|Disease Progression|4
5669451|NCT00445458|19567138|P1|Overall Study|Disease Progression|3
5669452|NCT00445432|19567156|P4|148 Weeks of Adalimumab Treatment|Other|9
5669453|NCT00445432|19567157|P3|148 Weeks of Adalimumab Treatment|Other|0
5669454|NCT00445432|19567158|P2|148 Weeks of Adalimumab Treatment|Other|0
5669455|NCT00445432|19567159|P1|148 Weeks of Adalimumab Treatment|Other|0
5669456|NCT00445432|19567156|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
5669457|NCT00445432|19567157|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
5669458|NCT00445432|19567158|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
5669459|NCT00445432|19567159|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
5669460|NCT00445432|19567156|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
5669461|NCT00445432|19567157|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
5669462|NCT00445432|19567158|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
5669463|NCT00445432|19567159|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
5669464|NCT00445432|19567156|P4|Through Week 52 of NCT00445432 (M06-837)|Other|0
5669465|NCT00445432|19567157|P3|Through Week 52 of NCT00445432 (M06-837)|Other|2
5669466|NCT00445432|19567158|P2|Through Week 52 of NCT00445432 (M06-837)|Other|1
5669467|NCT00445432|19567159|P1|Through Week 52 of NCT00445432 (M06-837)|Other|0
5669468|NCT00445432|19567156|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
5669469|NCT00445432|19567157|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
5669470|NCT00445432|19567158|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
5669471|NCT00445432|19567159|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
5669472|NCT00445432|19567156|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
5669473|NCT00445432|19567157|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
5669474|NCT00445432|19567158|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
5669475|NCT00445432|19567159|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
5669476|NCT00445432|19567156|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
5669477|NCT00445432|19567157|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
5669478|NCT00445432|19567158|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
5669479|NCT00445432|19567159|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
5669480|NCT00445341|19567192|P1|Overall Study|taken off treatment too early|1
5669481|NCT00445341|19567192|P1|Overall Study|refused further treatment|1
5669482|NCT00445328|19567199|P2|Overall Study|Protocol Violation|0
5669483|NCT00445328|19567200|P1|Overall Study|Protocol Violation|1
5669484|NCT00445328|19567199|P2|Overall Study|Withdrawal by Subject|0
5669485|NCT00445328|19567200|P1|Overall Study|Withdrawal by Subject|2
5669486|NCT00445328|19567199|P2|Overall Study|Other|2
5669487|NCT00445328|19567200|P1|Overall Study|Other|0
5669488|NCT00445328|19567199|P2|Overall Study|Adverse Event|3
5669489|NCT00445328|19567200|P1|Overall Study|Adverse Event|0
5669490|NCT00445328|19567199|P2|Overall Study|Death|1
5669491|NCT00445328|19567200|P1|Overall Study|Death|0
5669492|NCT00445224|19567361|P2|Specific Exercises|Withdrawal by Subject|0
5669493|NCT00445224|19567362|P1|Specific Exercises|Withdrawal by Subject|1
5669494|NCT00445224|19567361|P2|Specific Exercises|Withdrawal by Subject|3
5669495|NCT00445224|19567362|P1|Specific Exercises|Withdrawal by Subject|3
5669496|NCT00445146|19567389|P1|Overall Study|Pregnancy|1
5669497|NCT00445146|19567389|P1|Overall Study|Protocol Violation|4
5669498|NCT00445146|19567389|P1|Overall Study|Death|9
5669499|NCT00445146|19567389|P1|Overall Study|Lost to Follow-up|13
5669500|NCT00445146|19567389|P1|Overall Study|Adverse Event|13
5669501|NCT00445146|19567389|P1|Overall Study|Investigator's Discretion|22
5669502|NCT00445146|19567389|P1|Overall Study|Lack of Efficacy|28
5669503|NCT00445146|19567389|P1|Overall Study|Withdrew Consent|29
5669504|NCT00445003|19567411|P3|Overall Study|Dropped|2
5669505|NCT00445003|19567412|P2|Overall Study|Dropped|3
5669506|NCT00445003|19567413|P1|Overall Study|Dropped|1
5669507|NCT00445003|19567411|P3|Overall Study|Missed Visit|1
5669508|NCT00445003|19567412|P2|Overall Study|Missed Visit|5
5669509|NCT00445003|19567413|P1|Overall Study|Missed Visit|3
5669510|NCT00445003|19567411|P3|Overall Study|Death|1
5669511|NCT00445003|19567412|P2|Overall Study|Death|2
5669512|NCT00445003|19567413|P1|Overall Study|Death|1
5669513|NCT00444951|19567445|P3|Overall Study|Withdrawal by Subject|3
5669514|NCT00444951|19567446|P2|Overall Study|Withdrawal by Subject|5
5669515|NCT00444951|19567447|P1|Overall Study|Withdrawal by Subject|4
5669516|NCT00444951|19567445|P3|Overall Study|Lost to Follow-up|0
5669517|NCT00444951|19567446|P2|Overall Study|Lost to Follow-up|1
5669518|NCT00444951|19567447|P1|Overall Study|Lost to Follow-up|1
5669519|NCT00444925|19567464|P3|Double-blind Treatment Period|Other|12
5669520|NCT00444925|19567465|P2|Double-blind Treatment Period|Other|7
5669521|NCT00444925|19567466|P1|Double-blind Treatment Period|Other|7
5669522|NCT00444925|19567464|P3|Double-blind Treatment Period|Withdrawal by Subject|7
5669523|NCT00444925|19567465|P2|Double-blind Treatment Period|Withdrawal by Subject|8
5669524|NCT00444925|19567466|P1|Double-blind Treatment Period|Withdrawal by Subject|6
5669525|NCT00444925|19567464|P3|Double-blind Treatment Period|Lost to Follow-up|5
5669526|NCT00444925|19567465|P2|Double-blind Treatment Period|Lost to Follow-up|8
5669527|NCT00444925|19567466|P1|Double-blind Treatment Period|Lost to Follow-up|4
5669528|NCT00444925|19567464|P3|Double-blind Treatment Period|Lack of Efficacy|13
5669529|NCT00444925|19567465|P2|Double-blind Treatment Period|Lack of Efficacy|5
5669530|NCT00444925|19567466|P1|Double-blind Treatment Period|Lack of Efficacy|5
5669531|NCT00444925|19567464|P3|Double-blind Treatment Period|Adverse Event|44
5669532|NCT00444925|19567465|P2|Double-blind Treatment Period|Adverse Event|28
5669533|NCT00444925|19567466|P1|Double-blind Treatment Period|Adverse Event|6
5669534|NCT00444925|19567464|P3|Double-blind Treatment Period|Death|0
5669535|NCT00444925|19567465|P2|Double-blind Treatment Period|Death|0
5669536|NCT00444925|19567466|P1|Double-blind Treatment Period|Death|2
5669537|NCT00444925|19567464|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
5669538|NCT00444925|19567465|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
5669539|NCT00444925|19567466|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
5669540|NCT00444912|19567530|P2|Overall Study|Participant Failed Mobilization|0
5669541|NCT00444912|19567531|P1|Overall Study|Participant Failed Mobilization|1
5669542|NCT00444912|19567530|P2|Overall Study|Lost to Follow-up|0
5669543|NCT00444912|19567531|P1|Overall Study|Lost to Follow-up|1
5669544|NCT00444912|19567530|P2|Overall Study|Death|2
5669545|NCT00444912|19567531|P1|Overall Study|Death|1
5669546|NCT00444795|19567572|P1|Overall Study|Treated Prior to the Contract Date|2
5669547|NCT00444795|19567572|P1|Overall Study|Not Treated|1
5669548|NCT00444678|19567577|P1|Overall Study|Withdrawal by Subject|2
5669549|NCT00444678|19567577|P1|Overall Study|Physician Decision|3
5669550|NCT00444678|19567577|P1|Overall Study|Death|3
5669551|NCT00444678|19567577|P1|Overall Study|Disease Progression|12
5669552|NCT00444678|19567577|P1|Overall Study|Toxicity|11
5669553|NCT00444626|19567584|P1|Initial Treatment Period|Lost to Follow-up|9
5669554|NCT00444626|19567584|P1|Initial Treatment Period|Adverse Event|1
5669555|NCT00444626|19567584|P1|Initial Treatment Period|Withdrawal by Subject|2
5669556|NCT00444600|19567614|P4|Overall Study|Missed visit|1
5669557|NCT00444600|19567615|P3|Overall Study|Missed visit|0
5669558|NCT00444600|19567616|P2|Overall Study|Missed visit|0
5669559|NCT00444600|19567617|P1|Overall Study|Missed visit|1
5669560|NCT00444600|19567614|P4|Overall Study|Dropped|7
5669561|NCT00444600|19567615|P3|Overall Study|Dropped|7
5669562|NCT00444600|19567616|P2|Overall Study|Dropped|11
5669563|NCT00444600|19567617|P1|Overall Study|Dropped|11
5669564|NCT00444600|19567614|P4|Overall Study|Death|2
5669565|NCT00444600|19567615|P3|Overall Study|Death|3
5669566|NCT00444600|19567616|P2|Overall Study|Death|5
5669567|NCT00444600|19567617|P1|Overall Study|Death|7
5669568|NCT00444587|19567709|P2|Overall Study|Missing|5
5669569|NCT00444587|19567710|P1|Overall Study|Missing|0
5669570|NCT00444587|19567709|P2|Overall Study|Protocol Violation|0
5669571|NCT00444587|19567710|P1|Overall Study|Protocol Violation|1
5669572|NCT00444587|19567709|P2|Overall Study|Investigator decision|0
5669573|NCT00444587|19567710|P1|Overall Study|Investigator decision|3
5669574|NCT00444587|19567709|P2|Overall Study|Refused treatment/did not cooperate|1
5669575|NCT00444587|19567710|P1|Overall Study|Refused treatment/did not cooperate|4
5669576|NCT00444587|19567709|P2|Overall Study|Progression of the disease|8
5669577|NCT00444587|19567710|P1|Overall Study|Progression of the disease|73
5669578|NCT00444587|19567709|P2|Overall Study|Death|1
5669579|NCT00444587|19567710|P1|Overall Study|Death|2
5669580|NCT00444535|19567731|P1|Overall Study|Adverse Event|3
5669581|NCT00444535|19567731|P1|Overall Study|Investigator decision|2
5669582|NCT00444535|19567731|P1|Overall Study|Withdrawal by Subject|3
5669583|NCT00444535|19567731|P1|Overall Study|Treatment is ongoing|16
5669584|NCT00444457|19567742|P4|Toddler Dose|Protocol Violation|1
5669585|NCT00444457|19567743|P3|Toddler Dose|Protocol Violation|0
5669586|NCT00444457|19567744|P2|Toddler Dose|Protocol Violation|0
5669587|NCT00444457|19567745|P1|Toddler Dose|Protocol Violation|1
5669588|NCT00444457|19567742|P4|Toddler Dose|Parent or legal guardian request|1
5669589|NCT00444457|19567743|P3|Toddler Dose|Parent or legal guardian request|2
5669590|NCT00444457|19567744|P2|Toddler Dose|Parent or legal guardian request|3
5669591|NCT00444457|19567745|P1|Toddler Dose|Parent or legal guardian request|0
5669592|NCT00444457|19567742|P4|Toddler Dose|Failed to return|3
5669593|NCT00444457|19567743|P3|Toddler Dose|Failed to return|1
5669594|NCT00444457|19567744|P2|Toddler Dose|Failed to return|2
5669595|NCT00444457|19567745|P1|Toddler Dose|Failed to return|2
5669596|NCT00444457|19567742|P4|Toddler Dose|Lost to Follow-up|3
5669597|NCT00444457|19567743|P3|Toddler Dose|Lost to Follow-up|1
5669598|NCT00444457|19567744|P2|Toddler Dose|Lost to Follow-up|1
5669599|NCT00444457|19567745|P1|Toddler Dose|Lost to Follow-up|4
5669600|NCT00444457|19567742|P4|After Infant Series|Other|0
5669601|NCT00444457|19567743|P3|After Infant Series|Other|0
5669602|NCT00444457|19567744|P2|After Infant Series|Other|1
5669603|NCT00444457|19567745|P1|After Infant Series|Other|0
5669604|NCT00444457|19567742|P4|After Infant Series|Investigator request|1
5669605|NCT00444457|19567743|P3|After Infant Series|Investigator request|0
5669606|NCT00444457|19567744|P2|After Infant Series|Investigator request|0
5669607|NCT00444457|19567745|P1|After Infant Series|Investigator request|0
5669608|NCT00444457|19567742|P4|After Infant Series|Adverse Event|0
5669609|NCT00444457|19567743|P3|After Infant Series|Adverse Event|0
5669610|NCT00444457|19567744|P2|After Infant Series|Adverse Event|2
5669611|NCT00444457|19567745|P1|After Infant Series|Adverse Event|2
5669612|NCT00444457|19567742|P4|After Infant Series|Protocol Violation|2
5669613|NCT00444457|19567743|P3|After Infant Series|Protocol Violation|2
5669614|NCT00444457|19567744|P2|After Infant Series|Protocol Violation|4
5669615|NCT00444457|19567745|P1|After Infant Series|Protocol Violation|2
5669616|NCT00444457|19567742|P4|After Infant Series|Lost to Follow-up|2
5669617|NCT00444457|19567743|P3|After Infant Series|Lost to Follow-up|5
5669618|NCT00444457|19567744|P2|After Infant Series|Lost to Follow-up|5
5669619|NCT00444457|19567745|P1|After Infant Series|Lost to Follow-up|5
5669620|NCT00444457|19567742|P4|After Infant Series|Failed to return|1
5669621|NCT00444457|19567743|P3|After Infant Series|Failed to return|5
5669622|NCT00444457|19567744|P2|After Infant Series|Failed to return|6
5669623|NCT00444457|19567745|P1|After Infant Series|Failed to return|7
5669624|NCT00444457|19567742|P4|After Infant Series|Parent or legal guardian request|3
5669625|NCT00444457|19567743|P3|After Infant Series|Parent or legal guardian request|6
5669626|NCT00444457|19567744|P2|After Infant Series|Parent or legal guardian request|11
5669627|NCT00444457|19567745|P1|After Infant Series|Parent or legal guardian request|4
5669628|NCT00444457|19567742|P4|After Infant Series|Other|1
5669629|NCT00444457|19567743|P3|After Infant Series|Other|1
5669630|NCT00444457|19567744|P2|After Infant Series|Other|1
5669631|NCT00444457|19567745|P1|After Infant Series|Other|0
5669632|NCT00444457|19567742|P4|Infant Series|Death|1
5669633|NCT00444457|19567743|P3|Infant Series|Death|1
5669634|NCT00444457|19567744|P2|Infant Series|Death|1
5669635|NCT00444457|19567745|P1|Infant Series|Death|0
5669636|NCT00444457|19567742|P4|Infant Series|Adverse Event|0
5669637|NCT00444457|19567743|P3|Infant Series|Adverse Event|2
5669638|NCT00444457|19567744|P2|Infant Series|Adverse Event|2
5669639|NCT00444457|19567745|P1|Infant Series|Adverse Event|1
5669640|NCT00444457|19567742|P4|Infant Series|Other|0
5669641|NCT00444457|19567743|P3|Infant Series|Other|4
5669642|NCT00444457|19567744|P2|Infant Series|Other|2
5669643|NCT00444457|19567745|P1|Infant Series|Other|0
5669644|NCT00444457|19567742|P4|Infant Series|Investigator request|2
5669645|NCT00444457|19567743|P3|Infant Series|Investigator request|3
5669646|NCT00444457|19567744|P2|Infant Series|Investigator request|3
5669647|NCT00444457|19567745|P1|Infant Series|Investigator request|4
5669648|NCT00444457|19567742|P4|Infant Series|Failed to return|2
5669649|NCT00444457|19567743|P3|Infant Series|Failed to return|4
5669650|NCT00444457|19567744|P2|Infant Series|Failed to return|4
5669651|NCT00444457|19567745|P1|Infant Series|Failed to return|5
5669652|NCT00444457|19567742|P4|Infant Series|Protocol Violation|3
5669653|NCT00444457|19567743|P3|Infant Series|Protocol Violation|6
5669654|NCT00444457|19567744|P2|Infant Series|Protocol Violation|8
5669655|NCT00444457|19567745|P1|Infant Series|Protocol Violation|16
5669656|NCT00444457|19567742|P4|Infant Series|Lost to Follow-up|6
5669657|NCT00444457|19567743|P3|Infant Series|Lost to Follow-up|7
5669658|NCT00444457|19567744|P2|Infant Series|Lost to Follow-up|11
5669659|NCT00444457|19567745|P1|Infant Series|Lost to Follow-up|10
5669660|NCT00444457|19567742|P4|Infant Series|Parent or legal guardian request|14
5669661|NCT00444457|19567743|P3|Infant Series|Parent or legal guardian request|34
5669662|NCT00444457|19567744|P2|Infant Series|Parent or legal guardian request|29
5669663|NCT00444457|19567745|P1|Infant Series|Parent or legal guardian request|18
5669664|NCT00444457|19567742|P4|Infant Series|Other|0
5669665|NCT00444457|19567743|P3|Infant Series|Other|0
5669666|NCT00444457|19567744|P2|Infant Series|Other|1
5669667|NCT00444457|19567745|P1|Infant Series|Other|0
5669668|NCT00444275|19567810|P5|Maintenance Treatment Phase|Ineffectiveness|14
5669669|NCT00444275|19567811|P4|Maintenance Treatment Phase|Ineffectiveness|3
5669670|NCT00444275|19567812|P3|Maintenance Treatment Phase|Ineffectiveness|5
5669671|NCT00444275|19567813|P2|Maintenance Treatment Phase|Ineffectiveness|0
5669672|NCT00444275|19567814|P1|Maintenance Treatment Phase|Ineffectiveness|0
5669673|NCT00444275|19567810|P5|Maintenance Treatment Phase|Protocol Violation|87
5669674|NCT00444275|19567811|P4|Maintenance Treatment Phase|Protocol Violation|88
5669675|NCT00444275|19567812|P3|Maintenance Treatment Phase|Protocol Violation|103
5669676|NCT00444275|19567813|P2|Maintenance Treatment Phase|Protocol Violation|0
5669677|NCT00444275|19567814|P1|Maintenance Treatment Phase|Protocol Violation|0
5669678|NCT00444275|19567810|P5|Maintenance Treatment Phase|Patient's wish|20
5669679|NCT00444275|19567811|P4|Maintenance Treatment Phase|Patient's wish|9
5669680|NCT00444275|19567812|P3|Maintenance Treatment Phase|Patient's wish|19
5669681|NCT00444275|19567813|P2|Maintenance Treatment Phase|Patient's wish|0
5669682|NCT00444275|19567814|P1|Maintenance Treatment Phase|Patient's wish|0
5669683|NCT00444275|19567810|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
5669684|NCT00444275|19567811|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
5669685|NCT00444275|19567812|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
5669686|NCT00444275|19567813|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
5669687|NCT00444275|19567814|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
5669688|NCT00444275|19567810|P5|Maintenance Treatment Phase|Adverse Event|13
5669689|NCT00444275|19567811|P4|Maintenance Treatment Phase|Adverse Event|2
5669690|NCT00444275|19567812|P3|Maintenance Treatment Phase|Adverse Event|3
5669691|NCT00444275|19567813|P2|Maintenance Treatment Phase|Adverse Event|0
5669692|NCT00444275|19567814|P1|Maintenance Treatment Phase|Adverse Event|0
5669693|NCT00444275|19567810|P5|Maintenance Treatment Phase|Lost to Follow-up|10
5669694|NCT00444275|19567811|P4|Maintenance Treatment Phase|Lost to Follow-up|14
5669695|NCT00444275|19567812|P3|Maintenance Treatment Phase|Lost to Follow-up|8
5669696|NCT00444275|19567813|P2|Maintenance Treatment Phase|Lost to Follow-up|0
5669697|NCT00444275|19567814|P1|Maintenance Treatment Phase|Lost to Follow-up|0
5669698|NCT00444275|19567810|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
5669699|NCT00444275|19567811|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
5669700|NCT00444275|19567812|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
5669701|NCT00444275|19567813|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
5669702|NCT00444275|19567814|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
5669703|NCT00444145|19567864|P1|Overall Study|Screen Failures|5
5669704|NCT00444145|19567864|P1|Overall Study|non-compliant|11
5669705|NCT00444145|19567864|P1|Overall Study|Lost to Follow-up|1
5669706|NCT00444145|19567864|P1|Overall Study|Withdrawal by Subject|2
5669707|NCT00444106|19567871|P3|Overall Study|Abnormal Test Procedure Results|1
5669708|NCT00444106|19567872|P2|Overall Study|Abnormal Test Procedure Results|0
5669709|NCT00444106|19567873|P1|Overall Study|Abnormal Test Procedure Results|0
5669710|NCT00444106|19567871|P3|Overall Study|Lost to Follow-up|0
5669711|NCT00444106|19567872|P2|Overall Study|Lost to Follow-up|1
5669712|NCT00444106|19567873|P1|Overall Study|Lost to Follow-up|2
5669713|NCT00444067|19567905|P2|Overall Study|Lost to Follow-up|1
5669714|NCT00444067|19567906|P1|Overall Study|Lost to Follow-up|0
5669715|NCT00443898|19567969|P4|Overall Study|Death|0
5669716|NCT00443898|19567970|P3|Overall Study|Death|0
5669717|NCT00443898|19567971|P2|Overall Study|Death|1
5669718|NCT00443898|19567972|P1|Overall Study|Death|0
5669719|NCT00443898|19567969|P4|Overall Study|Lost to Follow-up|10
5669720|NCT00443898|19567970|P3|Overall Study|Lost to Follow-up|14
5669721|NCT00443898|19567971|P2|Overall Study|Lost to Follow-up|10
5669722|NCT00443898|19567972|P1|Overall Study|Lost to Follow-up|10
5669723|NCT00443898|19567969|P4|Overall Study|Withdrawal by Subject|6
5669724|NCT00443898|19567970|P3|Overall Study|Withdrawal by Subject|10
5669725|NCT00443898|19567971|P2|Overall Study|Withdrawal by Subject|10
5669726|NCT00443898|19567972|P1|Overall Study|Withdrawal by Subject|11
5669727|NCT00443898|19567969|P4|Overall Study|Protocol Violation|0
5669728|NCT00443898|19567970|P3|Overall Study|Protocol Violation|1
5669729|NCT00443898|19567971|P2|Overall Study|Protocol Violation|1
5669730|NCT00443898|19567972|P1|Overall Study|Protocol Violation|1
5669731|NCT00443898|19567969|P4|Overall Study|Lack of Efficacy|1
5669732|NCT00443898|19567970|P3|Overall Study|Lack of Efficacy|3
5669733|NCT00443898|19567971|P2|Overall Study|Lack of Efficacy|3
5669734|NCT00443898|19567972|P1|Overall Study|Lack of Efficacy|2
5669735|NCT00443898|19567969|P4|Overall Study|Adverse Event|1
5669736|NCT00443898|19567970|P3|Overall Study|Adverse Event|1
5669737|NCT00443898|19567971|P2|Overall Study|Adverse Event|0
5669738|NCT00443898|19567972|P1|Overall Study|Adverse Event|0
5669739|NCT00443872|19567994|P1|Overall Study|Adverse Event|8
5669740|NCT00443872|19567994|P1|Overall Study|Lost to Follow-up|2
5669741|NCT00443872|19567994|P1|Overall Study|Protocol Violation|7
5669742|NCT00443846|19568009|P2|Overall Study|Lost to Follow-up|2
5669743|NCT00443846|19568010|P1|Overall Study|Lost to Follow-up|1
5669744|NCT00443846|19568009|P2|Overall Study|Personal reason|3
5669745|NCT00443846|19568010|P1|Overall Study|Personal reason|8
5669746|NCT00443846|19568009|P2|Overall Study|Adverse Event|1
5669747|NCT00443846|19568010|P1|Overall Study|Adverse Event|0
5669748|NCT00443846|19568009|P2|Overall Study|Not vaccinated, no blood sample drawn|0
5669749|NCT00443846|19568010|P1|Overall Study|Not vaccinated, no blood sample drawn|1
5669750|NCT00443846|19568009|P2|Overall Study|Withdrawn due to intercurrent disease|0
5669751|NCT00443846|19568010|P1|Overall Study|Withdrawn due to intercurrent disease|1
5669752|NCT00443820|19568020|P4|Overall Study|Death|0
5669753|NCT00443820|19568021|P3|Overall Study|Death|1
5669754|NCT00443820|19568022|P2|Overall Study|Death|0
5669755|NCT00443820|19568023|P1|Overall Study|Death|0
5669756|NCT00443820|19568020|P4|Overall Study|Administrative problems|1
5669757|NCT00443820|19568021|P3|Overall Study|Administrative problems|0
5669758|NCT00443820|19568022|P2|Overall Study|Administrative problems|0
5669759|NCT00443820|19568023|P1|Overall Study|Administrative problems|0
5669760|NCT00443820|19568020|P4|Overall Study|Lost to Follow-up|5
5669761|NCT00443820|19568021|P3|Overall Study|Lost to Follow-up|6
5669762|NCT00443820|19568022|P2|Overall Study|Lost to Follow-up|8
5669763|NCT00443820|19568023|P1|Overall Study|Lost to Follow-up|9
5669764|NCT00443820|19568020|P4|Overall Study|Withdrawal by Subject|9
5669765|NCT00443820|19568021|P3|Overall Study|Withdrawal by Subject|8
5669766|NCT00443820|19568022|P2|Overall Study|Withdrawal by Subject|7
5669767|NCT00443820|19568023|P1|Overall Study|Withdrawal by Subject|6
5669768|NCT00443820|19568020|P4|Overall Study|Protocol Violation|1
5669769|NCT00443820|19568021|P3|Overall Study|Protocol Violation|2
5669770|NCT00443820|19568022|P2|Overall Study|Protocol Violation|1
5669771|NCT00443820|19568023|P1|Overall Study|Protocol Violation|2
5669772|NCT00443820|19568020|P4|Overall Study|Lack of Efficacy|1
5669773|NCT00443820|19568021|P3|Overall Study|Lack of Efficacy|1
5669774|NCT00443820|19568022|P2|Overall Study|Lack of Efficacy|2
5669775|NCT00443820|19568023|P1|Overall Study|Lack of Efficacy|3
5669776|NCT00443820|19568020|P4|Overall Study|Adverse Event|0
5669777|NCT00443820|19568021|P3|Overall Study|Adverse Event|0
5669778|NCT00443820|19568022|P2|Overall Study|Adverse Event|1
5669779|NCT00443820|19568023|P1|Overall Study|Adverse Event|1
5669780|NCT00443781|19568045|P1|Overall Study|PD/FAD not done|1
5669781|NCT00443781|19568045|P1|Overall Study|Insurance not covered|2
5669782|NCT00443781|19568045|P1|Overall Study|Investigator terminated participation|1
5669783|NCT00443781|19568045|P1|Overall Study|Unable to comply with study follow up|2
5669784|NCT00443781|19568045|P1|Overall Study|Withdrawal by Subject|6
5669785|NCT00443781|19568045|P1|Overall Study|Protocol Violation|1
5669786|NCT00443781|19568045|P1|Overall Study|Physician Decision|2
5669787|NCT00443781|19568045|P1|Overall Study|Lost to Follow-up|10
5669788|NCT00443755|19568051|P2|Overall Study|Withdrawal by Subject|1
5669789|NCT00443755|19568052|P1|Overall Study|Withdrawal by Subject|2
5669790|NCT00443729|19568086|P2|Overall Study|Withdrawal by Subject|1
5669791|NCT00443729|19568087|P1|Overall Study|Withdrawal by Subject|3
5669792|NCT00443729|19568086|P2|Overall Study|Protocol Violation|1
5669793|NCT00443729|19568087|P1|Overall Study|Protocol Violation|1
5669794|NCT00443729|19568086|P2|Overall Study|Physician Decision|1
5669795|NCT00443729|19568087|P1|Overall Study|Physician Decision|2
5669796|NCT00443729|19568086|P2|Overall Study|Lost to Follow-up|1
5669797|NCT00443729|19568087|P1|Overall Study|Lost to Follow-up|0
5669798|NCT00443729|19568086|P2|Overall Study|Lack of Efficacy|2
5669799|NCT00443729|19568087|P1|Overall Study|Lack of Efficacy|4
5669800|NCT00443729|19568086|P2|Overall Study|Never Treated|1
5669801|NCT00443729|19568087|P1|Overall Study|Never Treated|0
5669802|NCT00443703|19568135|P2|Overall Study|Progressive Disease|0
5669803|NCT00443703|19568136|P1|Overall Study|Progressive Disease|1
5669804|NCT00443703|19568135|P2|Overall Study|Withdrawal by Subject|6
5669805|NCT00443703|19568136|P1|Overall Study|Withdrawal by Subject|9
5669806|NCT00443703|19568135|P2|Overall Study|Protocol Violation|1
5669807|NCT00443703|19568136|P1|Overall Study|Protocol Violation|1
5669808|NCT00443703|19568135|P2|Overall Study|Physician Decision|2
5669809|NCT00443703|19568136|P1|Overall Study|Physician Decision|4
5669810|NCT00443703|19568135|P2|Overall Study|Lost to Follow-up|4
5669811|NCT00443703|19568136|P1|Overall Study|Lost to Follow-up|0
5669812|NCT00443703|19568135|P2|Overall Study|Lack of Efficacy|1
5669813|NCT00443703|19568136|P1|Overall Study|Lack of Efficacy|3
5669814|NCT00443703|19568135|P2|Overall Study|Adverse Event|3
5669815|NCT00443703|19568136|P1|Overall Study|Adverse Event|7
5669816|NCT00443703|19568135|P2|Overall Study|Never Treated|1
5669817|NCT00443703|19568136|P1|Overall Study|Never Treated|3
5669818|NCT00443651|19568188|P2|Overall Study|Pregnancy|1
5669819|NCT00443651|19568189|P1|Overall Study|Pregnancy|0
5669820|NCT00443651|19568188|P2|Overall Study|Physician Decision|4
5669821|NCT00443651|19568189|P1|Overall Study|Physician Decision|13
5669822|NCT00443651|19568188|P2|Overall Study|Patient's/Guardian's Decision|30
5669823|NCT00443651|19568189|P1|Overall Study|Patient's/Guardian's Decision|58
5669824|NCT00443651|19568188|P2|Overall Study|Lost to Follow-up|12
5669825|NCT00443651|19568189|P1|Overall Study|Lost to Follow-up|18
5669826|NCT00443651|19568188|P2|Overall Study|Adverse Event|6
5669827|NCT00443651|19568189|P1|Overall Study|Adverse Event|5
5669828|NCT00443651|19568188|P2|Overall Study|Death|5
5669829|NCT00443651|19568189|P1|Overall Study|Death|1
5669830|NCT00443599|19568209|P2|Overall Study|Cardiopulmonary bypass canceled|1
5669831|NCT00443599|19568210|P1|Overall Study|Cardiopulmonary bypass canceled|3
5669832|NCT00443599|19568209|P2|Overall Study|Death|1
5669833|NCT00443599|19568210|P1|Overall Study|Death|1
5669834|NCT00443599|19568209|P2|Overall Study|Physician Decision|1
5669835|NCT00443599|19568210|P1|Overall Study|Physician Decision|2
5669836|NCT00443560|19568244|P2|Overall Study|Multiple pregnancies or fetal demise|4
5669837|NCT00443560|19568245|P1|Overall Study|Multiple pregnancies or fetal demise|2
5669838|NCT00443560|19568244|P2|Overall Study|No intrathecal dose|26
5669839|NCT00443560|19568245|P1|Overall Study|No intrathecal dose|58
5669840|NCT00443534|19568280|P1|Overall Study|Enrolled, Not Treated|1
5669841|NCT00443534|19568280|P1|Overall Study|Other|10
5669842|NCT00443534|19568280|P1|Overall Study|Study Terminated by Sponsor|12
5669843|NCT00443534|19568280|P1|Overall Study|Withdrawal by Subject|8
5669844|NCT00443534|19568280|P1|Overall Study|Death|9
5669845|NCT00443534|19568280|P1|Overall Study|Adverse Event|16
5669846|NCT00443534|19568280|P1|Overall Study|Lack of Efficacy|67
5669847|NCT00443456|19568287|P1|Overall Study|Withdrawal by Subject|1
5669848|NCT00443456|19568287|P1|Overall Study|Move|1
5669849|NCT00443456|19568287|P1|Overall Study|Adverse Event|16
5669850|NCT00443430|19568322|P2|Overall Study|Adverse Event|1
5669851|NCT00443430|19568323|P1|Overall Study|Adverse Event|1
5669852|NCT00443430|19568322|P2|Overall Study|Lack of Efficacy|3
5669853|NCT00443430|19568323|P1|Overall Study|Lack of Efficacy|3
5669854|NCT00443261|19568337|P1|Overall Study|Death|1
5669855|NCT00443209|19568343|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
5669856|NCT00443209|19568344|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
5669857|NCT00443209|19568343|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
5669858|NCT00443209|19568344|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
5669859|NCT00443209|19568343|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
5669860|NCT00443209|19568344|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
5669861|NCT00443209|19568343|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
5669862|NCT00443209|19568344|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
5669863|NCT00443209|19568343|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
5669864|NCT00443209|19568344|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
5669865|NCT00443209|19568343|P2|Months 13 to 18 Treatment Period|Adverse Event|0
5669866|NCT00443209|19568344|P1|Months 13 to 18 Treatment Period|Adverse Event|1
5669867|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Not Treated|43
5669868|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Not Treated|71
5669869|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Missing|1
5669870|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Missing|2
5669871|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
5669872|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
5669873|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
5669874|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
5669875|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Pregnancy|4
5669876|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Pregnancy|3
5669877|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Physician Decision|4
5669878|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Physician Decision|8
5669879|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
5669880|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
5669881|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
5669882|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
5669883|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
5669884|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
5669885|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
5669886|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
5669887|NCT00443209|19568343|P2|Months 1 to 12 Treatment Period|Adverse Event|11
5669888|NCT00443209|19568344|P1|Months 1 to 12 Treatment Period|Adverse Event|22
5669889|NCT00443118|19568361|P3|Overall Study|Withdrawal by Subject|0
5669890|NCT00443118|19568362|P2|Overall Study|Withdrawal by Subject|0
5669891|NCT00443118|19568363|P1|Overall Study|Withdrawal by Subject|1
5669892|NCT00443118|19568361|P3|Overall Study|unknown primary outcome|0
5669893|NCT00443118|19568362|P2|Overall Study|unknown primary outcome|1
5669894|NCT00443118|19568363|P1|Overall Study|unknown primary outcome|3
5669895|NCT00443053|19568412|P2|Overall Study|Physician Decision|4
5669896|NCT00443053|19568413|P1|Overall Study|Physician Decision|0
5669897|NCT00443053|19568412|P2|Overall Study|Other|4
5669898|NCT00443053|19568413|P1|Overall Study|Other|3
5669899|NCT00443053|19568412|P2|Overall Study|Noncompliance|1
5669900|NCT00443053|19568413|P1|Overall Study|Noncompliance|2
5669901|NCT00443053|19568412|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5669902|NCT00443053|19568413|P1|Overall Study|Did Not Meet Eligibility Criteria|1
5669903|NCT00443053|19568412|P2|Overall Study|Lost to Follow-up|5
5669904|NCT00443053|19568413|P1|Overall Study|Lost to Follow-up|4
5669905|NCT00443053|19568412|P2|Overall Study|Withdrawal by Subject|18
5669906|NCT00443053|19568413|P1|Overall Study|Withdrawal by Subject|9
5669907|NCT00443053|19568412|P2|Overall Study|Adverse Event|1
5669908|NCT00443053|19568413|P1|Overall Study|Adverse Event|2
5669909|NCT00443040|19568434|P3|Overall Study|Converted to an open laparotomy|1
5669910|NCT00443040|19568435|P2|Overall Study|Converted to an open laparotomy|0
5669911|NCT00443040|19568436|P1|Overall Study|Converted to an open laparotomy|3
5669912|NCT00443040|19568434|P3|Overall Study|Withdrawal by Subject|0
5669913|NCT00443040|19568435|P2|Overall Study|Withdrawal by Subject|0
5669914|NCT00443040|19568436|P1|Overall Study|Withdrawal by Subject|1
5669915|NCT00442962|19568444|P1|Overall Study|Lost to Follow-up|7
5669916|NCT00442962|19568444|P1|Overall Study|Pregnancy|1
5669917|NCT00442936|19568462|P4|Overall Study|Protocol Violation|1
5669918|NCT00442936|19568463|P3|Overall Study|Protocol Violation|1
5669919|NCT00442936|19568464|P2|Overall Study|Protocol Violation|0
5669920|NCT00442936|19568465|P1|Overall Study|Protocol Violation|1
5669921|NCT00442897|19568513|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
5669922|NCT00442897|19568514|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
5669923|NCT00442897|19568513|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
5669924|NCT00442897|19568514|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
5669925|NCT00442897|19568513|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
5669926|NCT00442897|19568514|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
5669927|NCT00442897|19568513|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
5669928|NCT00442897|19568514|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
5669929|NCT00442897|19568513|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
5669930|NCT00442897|19568514|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
5669931|NCT00442897|19568513|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
5669932|NCT00442897|19568514|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
5669933|NCT00442897|19568513|P2|Base Study (12 Week Follow-up)|Death|1
5669934|NCT00442897|19568514|P1|Base Study (12 Week Follow-up)|Death|0
5669935|NCT00442897|19568513|P2|Base Study (12 Week Follow-up)|Adverse Event|0
5669936|NCT00442897|19568514|P1|Base Study (12 Week Follow-up)|Adverse Event|1
5669937|NCT00442702|19568532|P2|Evaluation Period|Site closure|1
5669938|NCT00442702|19568533|P1|Evaluation Period|Site closure|0
5669939|NCT00442702|19568532|P2|Evaluation Period|Failure to return|0
5669940|NCT00442702|19568533|P1|Evaluation Period|Failure to return|1
5669941|NCT00442702|19568532|P2|Evaluation Period|Renal transplant|1
5669942|NCT00442702|19568533|P1|Evaluation Period|Renal transplant|0
5669943|NCT00442702|19568532|P2|Evaluation Period|Refused treatment|1
5669944|NCT00442702|19568533|P1|Evaluation Period|Refused treatment|1
5669945|NCT00442702|19568532|P2|Evaluation Period|Insufficient Therapeutic Response|0
5669946|NCT00442702|19568533|P1|Evaluation Period|Insufficient Therapeutic Response|1
5669947|NCT00442702|19568532|P2|Evaluation Period|Death|1
5669948|NCT00442702|19568533|P1|Evaluation Period|Death|1
5669949|NCT00442702|19568532|P2|Evaluation Period|Adverse Event|0
5669950|NCT00442702|19568533|P1|Evaluation Period|Adverse Event|1
5669951|NCT00442702|19568532|P2|Titration Period|Hospitalized in another hospital|0
5669952|NCT00442702|19568533|P1|Titration Period|Hospitalized in another hospital|1
5669953|NCT00442702|19568532|P2|Titration Period|Failure to return|0
5669954|NCT00442702|19568533|P1|Titration Period|Failure to return|1
5669955|NCT00442702|19568532|P2|Titration Period|Refused Treatment|1
5669956|NCT00442702|19568533|P1|Titration Period|Refused Treatment|4
5669957|NCT00442702|19568532|P2|Titration Period|Insufficient Therapeutic Response|0
5669958|NCT00442702|19568533|P1|Titration Period|Insufficient Therapeutic Response|1
5669959|NCT00442702|19568532|P2|Titration Period|Death|2
5669960|NCT00442702|19568533|P1|Titration Period|Death|3
5669961|NCT00442702|19568532|P2|Titration Period|Adverse Event|0
5669962|NCT00442702|19568533|P1|Titration Period|Adverse Event|2
5669963|NCT00442598|19568598|P3|Overall Study|Death|0
5669964|NCT00442598|19568599|P2|Overall Study|Death|1
5669965|NCT00442598|19568600|P1|Overall Study|Death|0
5669966|NCT00442598|19568598|P3|Overall Study|Reduced creatinine clearance|0
5669967|NCT00442598|19568599|P2|Overall Study|Reduced creatinine clearance|0
5669968|NCT00442598|19568600|P1|Overall Study|Reduced creatinine clearance|1
5669969|NCT00442598|19568598|P3|Overall Study|CA125 progression|0
5669970|NCT00442598|19568599|P2|Overall Study|CA125 progression|1
5669971|NCT00442598|19568600|P1|Overall Study|CA125 progression|0
5669972|NCT00442598|19568598|P3|Overall Study|Clinical deterioration|0
5669973|NCT00442598|19568599|P2|Overall Study|Clinical deterioration|2
5669974|NCT00442598|19568600|P1|Overall Study|Clinical deterioration|1
5669975|NCT00442598|19568598|P3|Overall Study|Tumor progression|0
5669976|NCT00442598|19568599|P2|Overall Study|Tumor progression|4
5669977|NCT00442598|19568600|P1|Overall Study|Tumor progression|3
5669978|NCT00442598|19568598|P3|Overall Study|Adverse Event|0
5669979|NCT00442598|19568599|P2|Overall Study|Adverse Event|0
5669980|NCT00442598|19568600|P1|Overall Study|Adverse Event|1
5669981|NCT00442572|19568618|P2|Overall Study|Withdrawal by Subject|1
5669982|NCT00442572|19568619|P1|Overall Study|Withdrawal by Subject|0
5669983|NCT00442572|19568618|P2|Overall Study|Lost to Follow-up|1
5669984|NCT00442572|19568619|P1|Overall Study|Lost to Follow-up|0
5669985|NCT00442572|19568618|P2|Overall Study|Relapse|1
5669986|NCT00442572|19568619|P1|Overall Study|Relapse|8
5669987|NCT00442559|19568659|P2|Overall Study|Withdrawal by Subject|0
5669988|NCT00442559|19568660|P1|Overall Study|Withdrawal by Subject|1
5669989|NCT00442559|19568659|P2|Overall Study|Protocol Violation|1
5669990|NCT00442559|19568660|P1|Overall Study|Protocol Violation|1
5669991|NCT00442559|19568659|P2|Overall Study|Lost to Follow-up|34
5669992|NCT00442559|19568660|P1|Overall Study|Lost to Follow-up|32
5669993|NCT00442546|19568675|P3|Overall Study|Randomized But Not Treated|6
5669994|NCT00442546|19568676|P2|Overall Study|Randomized But Not Treated|4
5669995|NCT00442546|19568677|P1|Overall Study|Randomized But Not Treated|5
5669996|NCT00442546|19568675|P3|Overall Study|Withdrawal by Subject|7
5669997|NCT00442546|19568676|P2|Overall Study|Withdrawal by Subject|5
5669998|NCT00442546|19568677|P1|Overall Study|Withdrawal by Subject|5
5669999|NCT00442546|19568675|P3|Overall Study|Other|6
5670000|NCT00442546|19568676|P2|Overall Study|Other|9
5670001|NCT00442546|19568677|P1|Overall Study|Other|4
5670002|NCT00442546|19568675|P3|Overall Study|Lost to Follow-up|1
5670003|NCT00442546|19568676|P2|Overall Study|Lost to Follow-up|2
5670004|NCT00442546|19568677|P1|Overall Study|Lost to Follow-up|1
5670005|NCT00442546|19568675|P3|Overall Study|Adverse Event|13
5670006|NCT00442546|19568676|P2|Overall Study|Adverse Event|17
5670007|NCT00442546|19568677|P1|Overall Study|Adverse Event|11
5670008|NCT00442468|19568806|P1|Overall Study|Did not complete all study procedures|88
5670009|NCT00442468|19568806|P1|Overall Study|Withdrawal by Subject|91
5670010|NCT00442468|19568806|P1|Overall Study|Adverse Event|4
5670011|NCT00442416|19568836|P2|Overall Study|Administrative/Other|33
5670012|NCT00442416|19568837|P1|Overall Study|Administrative/Other|27
5670013|NCT00442416|19568836|P2|Overall Study|Withdrew consent|2
5670014|NCT00442416|19568837|P1|Overall Study|Withdrew consent|1
5670015|NCT00442416|19568836|P2|Overall Study|Protocol Violation|3
5670016|NCT00442416|19568837|P1|Overall Study|Protocol Violation|2
5670017|NCT00442416|19568836|P2|Overall Study|Lack of Efficacy|0
5670018|NCT00442416|19568837|P1|Overall Study|Lack of Efficacy|2
5670019|NCT00442416|19568836|P2|Overall Study|Death|0
5670020|NCT00442416|19568837|P1|Overall Study|Death|1
5670021|NCT00442416|19568836|P2|Overall Study|Adverse Event|1
5670022|NCT00442416|19568837|P1|Overall Study|Adverse Event|4
5670023|NCT00442351|19568876|P2|Overall Study|Other|1
5670024|NCT00442351|19568877|P1|Overall Study|Other|0
5670025|NCT00442351|19568876|P2|Overall Study|Did not meet protocol eligibility|0
5670026|NCT00442351|19568877|P1|Overall Study|Did not meet protocol eligibility|1
5670027|NCT00442351|19568876|P2|Overall Study|Administrative|5
5670028|NCT00442351|19568877|P1|Overall Study|Administrative|6
5670029|NCT00442286|19568899|P2|Overall Study|Patient Injury|0
5670030|NCT00442286|19568900|P1|Overall Study|Patient Injury|1
5670031|NCT00442286|19568899|P2|Overall Study|System explanted|0
5670032|NCT00442286|19568900|P1|Overall Study|System explanted|1
5670033|NCT00442286|19568899|P2|Overall Study|Withdrawal by Subject|0
5670034|NCT00442286|19568900|P1|Overall Study|Withdrawal by Subject|2
5670035|NCT00442286|19568899|P2|Overall Study|Lost to Follow-up|0
5670036|NCT00442286|19568900|P1|Overall Study|Lost to Follow-up|1
5670037|NCT00442286|19568899|P2|Overall Study|Death|2
5670038|NCT00442286|19568900|P1|Overall Study|Death|2
5670039|NCT00442117|19568962|P2|Overall Study|Met Withdrawal Criteria|1
5670040|NCT00442117|19568963|P1|Overall Study|Met Withdrawal Criteria|2
5670041|NCT00442117|19568962|P2|Overall Study|Non compliance with protocol|5
5670042|NCT00442117|19568963|P1|Overall Study|Non compliance with protocol|3
5670043|NCT00442117|19568962|P2|Overall Study|Major Deviation|20
5670044|NCT00442117|19568963|P1|Overall Study|Major Deviation|25
5670045|NCT00442117|19568962|P2|Overall Study|Withdrawal by Subject|2
5670046|NCT00442117|19568963|P1|Overall Study|Withdrawal by Subject|2
5670047|NCT00442117|19568962|P2|Overall Study|Lost to Follow-up|2
5670048|NCT00442117|19568963|P1|Overall Study|Lost to Follow-up|1
5670049|NCT00442117|19568962|P2|Overall Study|Lack of Efficacy|6
5670050|NCT00442117|19568963|P1|Overall Study|Lack of Efficacy|2
5670051|NCT00442117|19568962|P2|Overall Study|Adverse Event|2
5670052|NCT00442117|19568963|P1|Overall Study|Adverse Event|3
5670053|NCT00441974|19568994|P1|Overall Study|Protocol Violation|7
5670054|NCT00441974|19568994|P1|Overall Study|Lost to Follow-up|80
5670055|NCT00441974|19568994|P1|Overall Study|Consent Withdrawn|35
5670056|NCT00441974|19568994|P1|Overall Study|Adverse Event|6
5670057|NCT00441792|19569041|P2|Overall Study|Lost to Follow-up|2
5670058|NCT00441792|19569042|P1|Overall Study|Lost to Follow-up|0
5670059|NCT00441727|19569082|P3|Overall Study|Various reason specified|5
5670060|NCT00441727|19569083|P2|Overall Study|Various reason specified|8
5670061|NCT00441727|19569084|P1|Overall Study|Various reason specified|6
5670062|NCT00441727|19569082|P3|Overall Study|Safety Reasons|3
5670063|NCT00441727|19569083|P2|Overall Study|Safety Reasons|1
5670064|NCT00441727|19569084|P1|Overall Study|Safety Reasons|3
5670065|NCT00441727|19569082|P3|Overall Study|Lost to Follow-up|5
5670066|NCT00441727|19569083|P2|Overall Study|Lost to Follow-up|6
5670067|NCT00441727|19569084|P1|Overall Study|Lost to Follow-up|5
5670068|NCT00441727|19569082|P3|Overall Study|Withdrawal by Subject|47
5670069|NCT00441727|19569083|P2|Overall Study|Withdrawal by Subject|34
5670070|NCT00441727|19569084|P1|Overall Study|Withdrawal by Subject|40
5670071|NCT00441727|19569082|P3|Overall Study|Lack of Efficacy|48
5670072|NCT00441727|19569083|P2|Overall Study|Lack of Efficacy|8
5670073|NCT00441727|19569084|P1|Overall Study|Lack of Efficacy|7
5670074|NCT00441727|19569082|P3|Overall Study|Adverse Event|28
5670075|NCT00441727|19569083|P2|Overall Study|Adverse Event|33
5670076|NCT00441727|19569084|P1|Overall Study|Adverse Event|26
5670077|NCT00441727|19569082|P3|Overall Study|Protocol Violation|32
5670078|NCT00441727|19569083|P2|Overall Study|Protocol Violation|28
5670079|NCT00441727|19569084|P1|Overall Study|Protocol Violation|19
5670080|NCT00441701|19569117|P10|Overall Study|Withdrawal by Subject|0
5670081|NCT00441701|19569118|P9|Overall Study|Withdrawal by Subject|0
5670082|NCT00441701|19569119|P8|Overall Study|Withdrawal by Subject|0
5670083|NCT00441701|19569120|P7|Overall Study|Withdrawal by Subject|0
5670084|NCT00441701|19569121|P6|Overall Study|Withdrawal by Subject|0
5670085|NCT00441701|19569122|P5|Overall Study|Withdrawal by Subject|0
5670086|NCT00441701|19569123|P4|Overall Study|Withdrawal by Subject|1
5670087|NCT00441701|19569124|P3|Overall Study|Withdrawal by Subject|1
5670088|NCT00441701|19569125|P2|Overall Study|Withdrawal by Subject|2
5670089|NCT00441701|19569126|P1|Overall Study|Withdrawal by Subject|0
5670090|NCT00441701|19569117|P10|Overall Study|Lack of Efficacy|0
5670091|NCT00441701|19569118|P9|Overall Study|Lack of Efficacy|0
5670092|NCT00441701|19569119|P8|Overall Study|Lack of Efficacy|0
5670093|NCT00441701|19569120|P7|Overall Study|Lack of Efficacy|0
5670094|NCT00441701|19569121|P6|Overall Study|Lack of Efficacy|1
5670095|NCT00441701|19569122|P5|Overall Study|Lack of Efficacy|0
5670096|NCT00441701|19569123|P4|Overall Study|Lack of Efficacy|2
5670097|NCT00441701|19569124|P3|Overall Study|Lack of Efficacy|2
5670098|NCT00441701|19569125|P2|Overall Study|Lack of Efficacy|0
5670099|NCT00441701|19569126|P1|Overall Study|Lack of Efficacy|2
5670100|NCT00441701|19569117|P10|Overall Study|Adverse Event|0
5670101|NCT00441701|19569118|P9|Overall Study|Adverse Event|0
5670102|NCT00441701|19569119|P8|Overall Study|Adverse Event|0
5670103|NCT00441701|19569120|P7|Overall Study|Adverse Event|0
5670104|NCT00441701|19569121|P6|Overall Study|Adverse Event|2
5670105|NCT00441701|19569122|P5|Overall Study|Adverse Event|2
5670106|NCT00441701|19569123|P4|Overall Study|Adverse Event|0
5670107|NCT00441701|19569124|P3|Overall Study|Adverse Event|1
5670108|NCT00441701|19569125|P2|Overall Study|Adverse Event|2
5670109|NCT00441701|19569126|P1|Overall Study|Adverse Event|3
5670110|NCT00441584|19569208|P1|Overall Study|Failure to meet eligibility criteria|3
5670111|NCT00441584|19569208|P1|Overall Study|Lost to Follow-up|4
5670112|NCT00441584|19569208|P1|Overall Study|Protocol Violation|5
5670113|NCT00441584|19569208|P1|Overall Study|Adverse Event|6
5670114|NCT00441584|19569208|P1|Overall Study|Withdrawal by Subject|8
5670115|NCT00441584|19569208|P1|Overall Study|Lack of Efficacy|79
5670116|NCT00441545|19569216|P2|Second Intervention|Subject moved|1
5670117|NCT00441545|19569217|P1|Second Intervention|Subject moved|0
5670118|NCT00441545|19569216|P2|Second Intervention|Subject exceeded safety criteria|0
5670119|NCT00441545|19569217|P1|Second Intervention|Subject exceeded safety criteria|1
5670120|NCT00441545|19569216|P2|Second Intervention|Lack of Efficacy|1
5670121|NCT00441545|19569217|P1|Second Intervention|Lack of Efficacy|0
5670122|NCT00441545|19569216|P2|Second Intervention|Kidney Transplant|1
5670123|NCT00441545|19569217|P1|Second Intervention|Kidney Transplant|1
5670124|NCT00441545|19569216|P2|Second Intervention|Withdrawal by Subject|1
5670125|NCT00441545|19569217|P1|Second Intervention|Withdrawal by Subject|1
5670126|NCT00441545|19569216|P2|Second Intervention|Protocol Violation|1
5670127|NCT00441545|19569217|P1|Second Intervention|Protocol Violation|4
5670128|NCT00441545|19569216|P2|Second Intervention|Adverse Event|2
5670129|NCT00441545|19569217|P1|Second Intervention|Adverse Event|5
5670130|NCT00441545|19569216|P2|First Intervention|Sponsor's request|0
5670131|NCT00441545|19569217|P1|First Intervention|Sponsor's request|1
5670132|NCT00441545|19569216|P2|First Intervention|Site error|0
5670133|NCT00441545|19569217|P1|First Intervention|Site error|1
5670134|NCT00441545|19569216|P2|First Intervention|Extended hospitalization|0
5670135|NCT00441545|19569217|P1|First Intervention|Extended hospitalization|1
5670136|NCT00441545|19569216|P2|First Intervention|Subject met an exclusionary criteria|0
5670137|NCT00441545|19569217|P1|First Intervention|Subject met an exclusionary criteria|1
5670138|NCT00441545|19569216|P2|First Intervention|Subject exceeded safety criteria|1
5670139|NCT00441545|19569217|P1|First Intervention|Subject exceeded safety criteria|0
5670140|NCT00441545|19569216|P2|First Intervention|Lack of Efficacy|0
5670141|NCT00441545|19569217|P1|First Intervention|Lack of Efficacy|2
5670142|NCT00441545|19569216|P2|First Intervention|Kidney transplant|1
5670143|NCT00441545|19569217|P1|First Intervention|Kidney transplant|1
5670144|NCT00441545|19569216|P2|First Intervention|Withdrawal by Subject|3
5670145|NCT00441545|19569217|P1|First Intervention|Withdrawal by Subject|3
5670146|NCT00441545|19569216|P2|First Intervention|Protocol Violation|2
5670147|NCT00441545|19569217|P1|First Intervention|Protocol Violation|2
5670148|NCT00441545|19569216|P2|First Intervention|Adverse Event|5
5670149|NCT00441545|19569217|P1|First Intervention|Adverse Event|6
5670150|NCT00441480|19569231|P2|Overall Study|Withdrawal by Subject|3
5670151|NCT00441480|19569232|P1|Overall Study|Withdrawal by Subject|2
5670152|NCT00441480|19569231|P2|Overall Study|Protocol Violation|1
5670153|NCT00441480|19569232|P1|Overall Study|Protocol Violation|1
5670154|NCT00441467|19569264|P1|Overall Study|Progressive disease|9
5670155|NCT00441467|19569264|P1|Overall Study|Withdrawal by Subject|3
5670156|NCT00441467|19569264|P1|Overall Study|Adverse Event|6
5670157|NCT00441441|19569272|P2|Overall Study|Other|3
5670158|NCT00441441|19569273|P1|Overall Study|Other|3
5670159|NCT00441441|19569272|P2|Overall Study|Withdrawal by Subject|2
5670160|NCT00441441|19569273|P1|Overall Study|Withdrawal by Subject|1
5670161|NCT00441441|19569272|P2|Overall Study|Exacerbation of asthma|2
5670162|NCT00441441|19569273|P1|Overall Study|Exacerbation of asthma|1
5670163|NCT00441441|19569272|P2|Overall Study|Protocol Violation|6
5670164|NCT00441441|19569273|P1|Overall Study|Protocol Violation|4
5670165|NCT00441441|19569272|P2|Overall Study|Adverse Event|1
5670166|NCT00441441|19569273|P1|Overall Study|Adverse Event|2
5670167|NCT00441363|19569333|P2|Overall Study|Other|0
5670168|NCT00441363|19569334|P1|Overall Study|Other|2
5670169|NCT00441363|19569333|P2|Overall Study|Lost to Follow-up|2
5670170|NCT00441363|19569334|P1|Overall Study|Lost to Follow-up|2
5670171|NCT00441363|19569333|P2|Overall Study|Physician Decision|7
5670172|NCT00441363|19569334|P1|Overall Study|Physician Decision|6
5670173|NCT00441363|19569333|P2|Overall Study|Withdrawal by Subject|4
5670174|NCT00441363|19569334|P1|Overall Study|Withdrawal by Subject|3
5670175|NCT00441363|19569333|P2|Overall Study|Adverse Event|2
5670176|NCT00441363|19569334|P1|Overall Study|Adverse Event|4
5670177|NCT00441337|19569346|P4|Overall Study|Did not meet inclusion criteria|0
5670178|NCT00441337|19569347|P3|Overall Study|Did not meet inclusion criteria|1
5670179|NCT00441337|19569348|P2|Overall Study|Did not meet inclusion criteria|0
5670180|NCT00441337|19569349|P1|Overall Study|Did not meet inclusion criteria|0
5670181|NCT00441337|19569346|P4|Overall Study|Sponsor Decision|2
5670182|NCT00441337|19569347|P3|Overall Study|Sponsor Decision|1
5670183|NCT00441337|19569348|P2|Overall Study|Sponsor Decision|0
5670184|NCT00441337|19569349|P1|Overall Study|Sponsor Decision|0
5670185|NCT00441337|19569346|P4|Overall Study|Lost to Follow-up|1
5670186|NCT00441337|19569347|P3|Overall Study|Lost to Follow-up|0
5670187|NCT00441337|19569348|P2|Overall Study|Lost to Follow-up|0
5670188|NCT00441337|19569349|P1|Overall Study|Lost to Follow-up|0
5670189|NCT00441337|19569346|P4|Overall Study|Disease Progression|18
5670190|NCT00441337|19569347|P3|Overall Study|Disease Progression|4
5670191|NCT00441337|19569348|P2|Overall Study|Disease Progression|6
5670192|NCT00441337|19569349|P1|Overall Study|Disease Progression|6
5670193|NCT00441272|19569462|P2|Overall Study|Study terminated prior to enrollment|25
5670194|NCT00441272|19569463|P1|Overall Study|Study terminated prior to enrollment|25
5670195|NCT00441168|19569490|P2|Follow-up Period|Other|3
5670196|NCT00441168|19569491|P1|Follow-up Period|Other|1
5670197|NCT00441168|19569490|P2|Follow-up Period|Withdrawal by Subject|0
5670198|NCT00441168|19569491|P1|Follow-up Period|Withdrawal by Subject|3
5670199|NCT00441168|19569490|P2|Follow-up Period|Lost to Follow-up|6
5670200|NCT00441168|19569491|P1|Follow-up Period|Lost to Follow-up|5
5670201|NCT00441168|19569490|P2|Follow-up Period|Death|0
5670202|NCT00441168|19569491|P1|Follow-up Period|Death|3
5670203|NCT00441168|19569490|P2|Treatment Period|refractory disease|0
5670204|NCT00441168|19569491|P1|Treatment Period|refractory disease|1
5670205|NCT00441168|19569490|P2|Treatment Period|qualified for stem-cell transplantation|0
5670206|NCT00441168|19569491|P1|Treatment Period|qualified for stem-cell transplantation|3
5670207|NCT00441168|19569490|P2|Treatment Period|Withdrawal by Subject|0
5670208|NCT00441168|19569491|P1|Treatment Period|Withdrawal by Subject|3
5670209|NCT00441168|19569490|P2|Treatment Period|Lost to Follow-up|1
5670210|NCT00441168|19569491|P1|Treatment Period|Lost to Follow-up|0
5670211|NCT00441168|19569490|P2|Treatment Period|Protocol Violation|1
5670212|NCT00441168|19569491|P1|Treatment Period|Protocol Violation|0
5670213|NCT00441168|19569490|P2|Treatment Period|Progressive Disease|2
5670214|NCT00441168|19569491|P1|Treatment Period|Progressive Disease|0
5670215|NCT00441168|19569490|P2|Treatment Period|Adverse Event|2
5670216|NCT00441168|19569491|P1|Treatment Period|Adverse Event|1
5670217|NCT00441168|19569490|P2|Treatment Period|Death|0
5670218|NCT00441168|19569491|P1|Treatment Period|Death|3
5670219|NCT00441142|19569505|P4|Overall Study|Death|1
5670220|NCT00441142|19569506|P3|Overall Study|Death|0
5670221|NCT00441142|19569507|P2|Overall Study|Death|0
5670222|NCT00441142|19569508|P1|Overall Study|Death|0
5670223|NCT00441142|19569505|P4|Overall Study|Physician Decision|1
5670224|NCT00441142|19569506|P3|Overall Study|Physician Decision|0
5670225|NCT00441142|19569507|P2|Overall Study|Physician Decision|1
5670226|NCT00441142|19569508|P1|Overall Study|Physician Decision|0
5670227|NCT00441142|19569505|P4|Overall Study|Patient still receiving active study tx|2
5670228|NCT00441142|19569506|P3|Overall Study|Patient still receiving active study tx|0
5670229|NCT00441142|19569507|P2|Overall Study|Patient still receiving active study tx|0
5670230|NCT00441142|19569508|P1|Overall Study|Patient still receiving active study tx|1
5670231|NCT00441142|19569505|P4|Overall Study|Withdrawal by Subject|10
5670232|NCT00441142|19569506|P3|Overall Study|Withdrawal by Subject|2
5670233|NCT00441142|19569507|P2|Overall Study|Withdrawal by Subject|0
5670234|NCT00441142|19569508|P1|Overall Study|Withdrawal by Subject|0
5670235|NCT00441142|19569505|P4|Overall Study|Lack of Efficacy|32
5670236|NCT00441142|19569506|P3|Overall Study|Lack of Efficacy|17
5670237|NCT00441142|19569507|P2|Overall Study|Lack of Efficacy|3
5670238|NCT00441142|19569508|P1|Overall Study|Lack of Efficacy|3
5670239|NCT00441142|19569505|P4|Overall Study|Adverse Event|22
5670240|NCT00441142|19569506|P3|Overall Study|Adverse Event|3
5670241|NCT00441142|19569507|P2|Overall Study|Adverse Event|3
5670242|NCT00441142|19569508|P1|Overall Study|Adverse Event|2
5670243|NCT00441129|19569530|P2|Overall Study|Withdrawal by Subject|14
5670244|NCT00441129|19569531|P1|Overall Study|Withdrawal by Subject|6
5670245|NCT00441116|19569543|P2|Overall Study|Did not meet Eligibility Criteria|1
5670246|NCT00441116|19569544|P1|Overall Study|Did not meet Eligibility Criteria|1
5670247|NCT00441116|19569543|P2|Overall Study|Withdrawal by Subject|0
5670248|NCT00441116|19569544|P1|Overall Study|Withdrawal by Subject|1
5670249|NCT00441116|19569543|P2|Overall Study|Adverse Event|1
5670250|NCT00441116|19569544|P1|Overall Study|Adverse Event|1
5670251|NCT00441103|19569612|P2|Overall Study|Participant decided to stop|1
5670252|NCT00441103|19569613|P1|Overall Study|Participant decided to stop|0
5670253|NCT00441103|19569612|P2|Overall Study|Participant's reason|1
5670254|NCT00441103|19569613|P1|Overall Study|Participant's reason|0
5670255|NCT00441103|19569612|P2|Overall Study|Participant decided to withdraw|0
5670256|NCT00441103|19569613|P1|Overall Study|Participant decided to withdraw|1
5670257|NCT00441103|19569612|P2|Overall Study|Non-compliant|1
5670258|NCT00441103|19569613|P1|Overall Study|Non-compliant|0
5670259|NCT00441103|19569612|P2|Overall Study|Inclusion criteria absent|0
5670260|NCT00441103|19569613|P1|Overall Study|Inclusion criteria absent|1
5670261|NCT00441103|19569612|P2|Overall Study|Participant refused MRI|0
5670262|NCT00441103|19569613|P1|Overall Study|Participant refused MRI|1
5670263|NCT00441103|19569612|P2|Overall Study|Participant unable to use Rebiject II|0
5670264|NCT00441103|19569613|P1|Overall Study|Participant unable to use Rebiject II|1
5670265|NCT00441103|19569612|P2|Overall Study|Protocol Violation|0
5670266|NCT00441103|19569613|P1|Overall Study|Protocol Violation|1
5670267|NCT00441103|19569612|P2|Overall Study|Lost to Follow-up|0
5670268|NCT00441103|19569613|P1|Overall Study|Lost to Follow-up|1
5670269|NCT00441103|19569612|P2|Overall Study|Disease Progression|0
5670270|NCT00441103|19569613|P1|Overall Study|Disease Progression|2
5670271|NCT00441103|19569612|P2|Overall Study|Death|0
5670272|NCT00441103|19569613|P1|Overall Study|Death|1
5670273|NCT00441103|19569612|P2|Overall Study|Adverse Event|1
5670274|NCT00441103|19569613|P1|Overall Study|Adverse Event|2
5670275|NCT00441090|19569629|P5|Overall Study|Lack of Efficacy|0
5670276|NCT00441090|19569630|P4|Overall Study|Lack of Efficacy|0
5670277|NCT00441090|19569631|P3|Overall Study|Lack of Efficacy|0
5670278|NCT00441090|19569632|P2|Overall Study|Lack of Efficacy|0
5670279|NCT00441090|19569633|P1|Overall Study|Lack of Efficacy|1
5670280|NCT00441090|19569629|P5|Overall Study|Withdrawal by Subject|0
5670281|NCT00441090|19569630|P4|Overall Study|Withdrawal by Subject|0
5670282|NCT00441090|19569631|P3|Overall Study|Withdrawal by Subject|1
5670283|NCT00441090|19569632|P2|Overall Study|Withdrawal by Subject|0
5670284|NCT00441090|19569633|P1|Overall Study|Withdrawal by Subject|1
5670285|NCT00441090|19569629|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
5670286|NCT00441090|19569630|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
5670287|NCT00441090|19569631|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
5670288|NCT00441090|19569632|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
5670289|NCT00441090|19569633|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
5670290|NCT00441090|19569629|P5|Overall Study|Adverse Event|0
5670291|NCT00441090|19569630|P4|Overall Study|Adverse Event|0
5670292|NCT00441090|19569631|P3|Overall Study|Adverse Event|1
5670293|NCT00441090|19569632|P2|Overall Study|Adverse Event|1
5670294|NCT00441090|19569633|P1|Overall Study|Adverse Event|0
5670295|NCT00441064|19569677|P2|Overall Study|Patient withdrew consent|2
5670296|NCT00441064|19569678|P1|Overall Study|Patient withdrew consent|5
5670297|NCT00441064|19569677|P2|Overall Study|Protocol Deviation|2
5670298|NCT00441064|19569678|P1|Overall Study|Protocol Deviation|3
5670299|NCT00441064|19569677|P2|Overall Study|Unsatisfactory therapeutic effect|0
5670300|NCT00441064|19569678|P1|Overall Study|Unsatisfactory therapeutic effect|1
5670301|NCT00441064|19569677|P2|Overall Study|Abnormal test procedure results|1
5670302|NCT00441064|19569678|P1|Overall Study|Abnormal test procedure results|0
5670303|NCT00441064|19569677|P2|Overall Study|Abnormal laboratory values|2
5670304|NCT00441064|19569678|P1|Overall Study|Abnormal laboratory values|0
5670305|NCT00441064|19569677|P2|Overall Study|Adverse Event|0
5670306|NCT00441064|19569678|P1|Overall Study|Adverse Event|1
5670307|NCT00441012|19569690|P2|Overall Study|Subject Randomized but Not Vaccinated|0
5670308|NCT00441012|19569691|P1|Overall Study|Subject Randomized but Not Vaccinated|1
5670309|NCT00441012|19569690|P2|Overall Study|Withdrawal by Subject|0
5670310|NCT00441012|19569691|P1|Overall Study|Withdrawal by Subject|4
5670311|NCT00441012|19569690|P2|Overall Study|Protocol Violation|9
5670312|NCT00441012|19569691|P1|Overall Study|Protocol Violation|10
5670313|NCT00441012|19569690|P2|Overall Study|Lost to Follow-up|3
5670314|NCT00441012|19569691|P1|Overall Study|Lost to Follow-up|3
5670315|NCT00441012|19569690|P2|Overall Study|Adverse Event|1
5670316|NCT00441012|19569691|P1|Overall Study|Adverse Event|0
5670317|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
5670318|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
5670319|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
5670320|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
5670321|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
5670322|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Physician Decision|1
5670323|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Physician Decision|0
5670324|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Physician Decision|0
5670325|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Physician Decision|0
5670326|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Physician Decision|0
5670327|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Other|0
5670328|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Other|1
5670329|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Other|0
5670330|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Other|0
5670331|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Other|0
5670332|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
5670333|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
5670334|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
5670335|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
5670336|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
5670337|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Sponsor Request|1
5670338|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Sponsor Request|1
5670339|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Sponsor Request|0
5670340|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Sponsor Request|0
5670341|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Sponsor Request|0
5670342|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Participant Moved|1
5670343|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Participant Moved|1
5670344|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Participant Moved|0
5670345|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Participant Moved|0
5670346|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Participant Moved|0
5670347|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Pregnancy|0
5670348|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Pregnancy|3
5670349|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Pregnancy|0
5670350|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Pregnancy|0
5670351|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Pregnancy|0
5670352|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
5670353|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
5670354|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
5670355|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
5670356|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
5670357|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Protocol Violation|0
5670358|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Protocol Violation|1
5670359|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Protocol Violation|0
5670360|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Protocol Violation|0
5670361|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Protocol Violation|0
5670362|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
5670363|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
5670364|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
5670365|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
5670366|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
5670367|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Non-compliance|1
5670368|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Non-compliance|1
5670369|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Non-compliance|0
5670370|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Non-compliance|0
5670371|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Non-compliance|0
5670372|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
5670373|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
5670374|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
5670375|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
5670376|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
5670377|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
5670378|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
5670379|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
5670380|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
5670381|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
5670382|NCT00440947|19569705|P5|Optional 60-Week Extension Phase|Adverse Event|3
5670383|NCT00440947|19569706|P4|Optional 60-Week Extension Phase|Adverse Event|1
5670384|NCT00440947|19569707|P3|Optional 60-Week Extension Phase|Adverse Event|0
5670385|NCT00440947|19569708|P2|Optional 60-Week Extension Phase|Adverse Event|0
5670386|NCT00440947|19569709|P1|Optional 60-Week Extension Phase|Adverse Event|0
5670387|NCT00440947|19569705|P5|48-Week Randomization Phase|Physician Decision|0
5670388|NCT00440947|19569706|P4|48-Week Randomization Phase|Physician Decision|0
5670389|NCT00440947|19569707|P3|48-Week Randomization Phase|Physician Decision|0
5670390|NCT00440947|19569708|P2|48-Week Randomization Phase|Physician Decision|2
5670391|NCT00440947|19569709|P1|48-Week Randomization Phase|Physician Decision|0
5670392|NCT00440947|19569705|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
5670393|NCT00440947|19569706|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
5670394|NCT00440947|19569707|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
5670395|NCT00440947|19569708|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
5670396|NCT00440947|19569709|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
5670397|NCT00440947|19569705|P5|48-Week Randomization Phase|Incarceration|0
5670398|NCT00440947|19569706|P4|48-Week Randomization Phase|Incarceration|0
5670399|NCT00440947|19569707|P3|48-Week Randomization Phase|Incarceration|0
5670400|NCT00440947|19569708|P2|48-Week Randomization Phase|Incarceration|3
5670401|NCT00440947|19569709|P1|48-Week Randomization Phase|Incarceration|0
5670402|NCT00440947|19569705|P5|48-Week Randomization Phase|Pregnancy|0
5670403|NCT00440947|19569706|P4|48-Week Randomization Phase|Pregnancy|0
5670404|NCT00440947|19569707|P3|48-Week Randomization Phase|Pregnancy|1
5670405|NCT00440947|19569708|P2|48-Week Randomization Phase|Pregnancy|0
5670406|NCT00440947|19569709|P1|48-Week Randomization Phase|Pregnancy|0
5670407|NCT00440947|19569705|P5|48-Week Randomization Phase|Withdrawal by Subject|0
5670408|NCT00440947|19569706|P4|48-Week Randomization Phase|Withdrawal by Subject|0
5670409|NCT00440947|19569707|P3|48-Week Randomization Phase|Withdrawal by Subject|4
5670410|NCT00440947|19569708|P2|48-Week Randomization Phase|Withdrawal by Subject|2
5670411|NCT00440947|19569709|P1|48-Week Randomization Phase|Withdrawal by Subject|0
5670412|NCT00440947|19569705|P5|48-Week Randomization Phase|Protocol Violation|0
5670413|NCT00440947|19569706|P4|48-Week Randomization Phase|Protocol Violation|0
5670414|NCT00440947|19569707|P3|48-Week Randomization Phase|Protocol Violation|1
5670415|NCT00440947|19569708|P2|48-Week Randomization Phase|Protocol Violation|0
5670416|NCT00440947|19569709|P1|48-Week Randomization Phase|Protocol Violation|0
5670417|NCT00440947|19569705|P5|48-Week Randomization Phase|Lost to Follow-up|0
5670418|NCT00440947|19569706|P4|48-Week Randomization Phase|Lost to Follow-up|0
5670419|NCT00440947|19569707|P3|48-Week Randomization Phase|Lost to Follow-up|8
5670420|NCT00440947|19569708|P2|48-Week Randomization Phase|Lost to Follow-up|2
5670421|NCT00440947|19569709|P1|48-Week Randomization Phase|Lost to Follow-up|0
5670422|NCT00440947|19569705|P5|48-Week Randomization Phase|Non-compliance|0
5670423|NCT00440947|19569706|P4|48-Week Randomization Phase|Non-compliance|0
5670424|NCT00440947|19569707|P3|48-Week Randomization Phase|Non-compliance|4
5670425|NCT00440947|19569708|P2|48-Week Randomization Phase|Non-compliance|3
5670426|NCT00440947|19569709|P1|48-Week Randomization Phase|Non-compliance|0
5670427|NCT00440947|19569705|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
5670428|NCT00440947|19569706|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
5670429|NCT00440947|19569707|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
5670430|NCT00440947|19569708|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
5670431|NCT00440947|19569709|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
5670432|NCT00440947|19569705|P5|48-Week Randomization Phase|Adverse Event|0
5670433|NCT00440947|19569706|P4|48-Week Randomization Phase|Adverse Event|0
5670434|NCT00440947|19569707|P3|48-Week Randomization Phase|Adverse Event|5
5670435|NCT00440947|19569708|P2|48-Week Randomization Phase|Adverse Event|2
5670436|NCT00440947|19569709|P1|48-Week Randomization Phase|Adverse Event|0
5670437|NCT00440947|19569705|P5|36-Week Induction Phase|Pregnancy|0
5670438|NCT00440947|19569706|P4|36-Week Induction Phase|Pregnancy|0
5670439|NCT00440947|19569707|P3|36-Week Induction Phase|Pregnancy|0
5670440|NCT00440947|19569708|P2|36-Week Induction Phase|Pregnancy|0
5670441|NCT00440947|19569709|P1|36-Week Induction Phase|Pregnancy|1
5670442|NCT00440947|19569705|P5|36-Week Induction Phase|Incarceration|0
5670443|NCT00440947|19569706|P4|36-Week Induction Phase|Incarceration|0
5670444|NCT00440947|19569707|P3|36-Week Induction Phase|Incarceration|0
5670445|NCT00440947|19569708|P2|36-Week Induction Phase|Incarceration|0
5670446|NCT00440947|19569709|P1|36-Week Induction Phase|Incarceration|3
5670447|NCT00440947|19569705|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
5670448|NCT00440947|19569706|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
5670449|NCT00440947|19569707|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
5670450|NCT00440947|19569708|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
5670451|NCT00440947|19569709|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
5670452|NCT00440947|19569705|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
5670453|NCT00440947|19569706|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
5670454|NCT00440947|19569707|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
5670455|NCT00440947|19569708|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
5670456|NCT00440947|19569709|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
5670457|NCT00440947|19569705|P5|36-Week Induction Phase|Took Exclusionary Medications|0
5670458|NCT00440947|19569706|P4|36-Week Induction Phase|Took Exclusionary Medications|0
5670459|NCT00440947|19569707|P3|36-Week Induction Phase|Took Exclusionary Medications|0
5670460|NCT00440947|19569708|P2|36-Week Induction Phase|Took Exclusionary Medications|0
5670461|NCT00440947|19569709|P1|36-Week Induction Phase|Took Exclusionary Medications|1
5670462|NCT00440947|19569705|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
5670463|NCT00440947|19569706|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
5670464|NCT00440947|19569707|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
5670465|NCT00440947|19569708|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
5670466|NCT00440947|19569709|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
5670467|NCT00440947|19569705|P5|36-Week Induction Phase|Withdrawal by Subject|0
5670468|NCT00440947|19569706|P4|36-Week Induction Phase|Withdrawal by Subject|0
5670469|NCT00440947|19569707|P3|36-Week Induction Phase|Withdrawal by Subject|0
5670470|NCT00440947|19569708|P2|36-Week Induction Phase|Withdrawal by Subject|0
5670471|NCT00440947|19569709|P1|36-Week Induction Phase|Withdrawal by Subject|7
5670472|NCT00440947|19569705|P5|36-Week Induction Phase|Lost to Follow-up|0
5670473|NCT00440947|19569706|P4|36-Week Induction Phase|Lost to Follow-up|0
5670474|NCT00440947|19569707|P3|36-Week Induction Phase|Lost to Follow-up|0
5670475|NCT00440947|19569708|P2|36-Week Induction Phase|Lost to Follow-up|0
5670476|NCT00440947|19569709|P1|36-Week Induction Phase|Lost to Follow-up|16
5670477|NCT00440947|19569705|P5|36-Week Induction Phase|Non-compliance|0
5670478|NCT00440947|19569706|P4|36-Week Induction Phase|Non-compliance|0
5670479|NCT00440947|19569707|P3|36-Week Induction Phase|Non-compliance|0
5670480|NCT00440947|19569708|P2|36-Week Induction Phase|Non-compliance|0
5670481|NCT00440947|19569709|P1|36-Week Induction Phase|Non-compliance|10
5670482|NCT00440947|19569705|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
5670483|NCT00440947|19569706|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
5670484|NCT00440947|19569707|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
5670485|NCT00440947|19569708|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
5670486|NCT00440947|19569709|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
5670487|NCT00440947|19569705|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
5670488|NCT00440947|19569706|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
5670489|NCT00440947|19569707|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
5670490|NCT00440947|19569708|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
5670491|NCT00440947|19569709|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
5670492|NCT00440947|19569705|P5|36-Week Induction Phase|Adverse Event|0
5670493|NCT00440947|19569706|P4|36-Week Induction Phase|Adverse Event|0
5670494|NCT00440947|19569707|P3|36-Week Induction Phase|Adverse Event|0
5670495|NCT00440947|19569708|P2|36-Week Induction Phase|Adverse Event|0
5670496|NCT00440947|19569709|P1|36-Week Induction Phase|Adverse Event|16
5670497|NCT00440726|19569784|P3|Phase 2|Adverse Event|1
5670498|NCT00440726|19569785|P2|Phase 2|Adverse Event|0
5670499|NCT00440726|19569786|P1|Phase 2|Adverse Event|0
5670500|NCT00440726|19569784|P3|Phase 2|Death|1
5670501|NCT00440726|19569785|P2|Phase 2|Death|0
5670502|NCT00440726|19569786|P1|Phase 2|Death|0
5670503|NCT00440726|19569784|P3|Phase 1|Physician Decision|0
5670504|NCT00440726|19569785|P2|Phase 1|Physician Decision|0
5670505|NCT00440726|19569786|P1|Phase 1|Physician Decision|1
5670506|NCT00440726|19569784|P3|Phase 1|Dose-Limiting Toxicity|0
5670507|NCT00440726|19569785|P2|Phase 1|Dose-Limiting Toxicity|1
5670508|NCT00440726|19569786|P1|Phase 1|Dose-Limiting Toxicity|0
5670509|NCT00440700|19569800|P3|Overall Study|Withdrawal by Subject|4
5670510|NCT00440700|19569801|P2|Overall Study|Withdrawal by Subject|8
5670511|NCT00440700|19569802|P1|Overall Study|Withdrawal by Subject|8
5670512|NCT00440557|19569836|P3|Overall Study|Patient had surgery|0
5670513|NCT00440557|19569837|P2|Overall Study|Patient had surgery|0
5670514|NCT00440557|19569838|P1|Overall Study|Patient had surgery|1
5670515|NCT00440557|19569836|P3|Overall Study|Patient transferred to nursing home|0
5670516|NCT00440557|19569837|P2|Overall Study|Patient transferred to nursing home|1
5670517|NCT00440557|19569838|P1|Overall Study|Patient transferred to nursing home|0
5670518|NCT00440557|19569836|P3|Overall Study|Principal Investigator's office closed|4
5670519|NCT00440557|19569837|P2|Overall Study|Principal Investigator's office closed|6
5670520|NCT00440557|19569838|P1|Overall Study|Principal Investigator's office closed|3
5670521|NCT00440557|19569836|P3|Overall Study|Patient moved|1
5670522|NCT00440557|19569837|P2|Overall Study|Patient moved|2
5670523|NCT00440557|19569838|P1|Overall Study|Patient moved|1
5670524|NCT00440557|19569836|P3|Overall Study|Principal Investigator decision|1
5670525|NCT00440557|19569837|P2|Overall Study|Principal Investigator decision|3
5670526|NCT00440557|19569838|P1|Overall Study|Principal Investigator decision|0
5670527|NCT00440557|19569836|P3|Overall Study|Began Dialysis|4
5670528|NCT00440557|19569837|P2|Overall Study|Began Dialysis|1
5670529|NCT00440557|19569838|P1|Overall Study|Began Dialysis|4
5670530|NCT00440557|19569836|P3|Overall Study|Death|3
5670531|NCT00440557|19569837|P2|Overall Study|Death|6
5670532|NCT00440557|19569838|P1|Overall Study|Death|2
5670533|NCT00440557|19569836|P3|Overall Study|Adverse Event|5
5670534|NCT00440557|19569837|P2|Overall Study|Adverse Event|3
5670535|NCT00440557|19569838|P1|Overall Study|Adverse Event|3
5670536|NCT00440557|19569836|P3|Overall Study|Lost to Follow-up|6
5670537|NCT00440557|19569837|P2|Overall Study|Lost to Follow-up|2
5670538|NCT00440557|19569838|P1|Overall Study|Lost to Follow-up|1
5670539|NCT00440557|19569836|P3|Overall Study|Withdrawal by Subject|11
5670540|NCT00440557|19569837|P2|Overall Study|Withdrawal by Subject|5
5670541|NCT00440557|19569838|P1|Overall Study|Withdrawal by Subject|10
5670542|NCT00440531|19569870|P3|Overall Study|see pre-assignment details|0
5670543|NCT00440531|19569871|P2|Overall Study|see pre-assignment details|0
5670544|NCT00440531|19569872|P1|Overall Study|see pre-assignment details|2
5670545|NCT00440531|19569870|P3|Overall Study|Lost to Follow-up|5
5670546|NCT00440531|19569871|P2|Overall Study|Lost to Follow-up|3
5670547|NCT00440531|19569872|P1|Overall Study|Lost to Follow-up|4
5670548|NCT00440531|19569870|P3|Overall Study|Protocol Violation|0
5670549|NCT00440531|19569871|P2|Overall Study|Protocol Violation|2
5670550|NCT00440531|19569872|P1|Overall Study|Protocol Violation|1
5670551|NCT00440531|19569870|P3|Overall Study|Withdrawal by Subject|0
5670552|NCT00440531|19569871|P2|Overall Study|Withdrawal by Subject|0
5670553|NCT00440531|19569872|P1|Overall Study|Withdrawal by Subject|2
5670554|NCT00440531|19569870|P3|Overall Study|Adverse Event|2
5670555|NCT00440531|19569871|P2|Overall Study|Adverse Event|0
5670556|NCT00440531|19569872|P1|Overall Study|Adverse Event|1
5670557|NCT00440518|19569889|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
5670558|NCT00440518|19569890|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
5670559|NCT00440518|19569891|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
5670560|NCT00440518|19569889|P3|Maintenance and Safety Follow-up Periods|Other|2
5670561|NCT00440518|19569890|P2|Maintenance and Safety Follow-up Periods|Other|0
5670562|NCT00440518|19569891|P1|Maintenance and Safety Follow-up Periods|Other|0
5670563|NCT00440518|19569889|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
5670564|NCT00440518|19569890|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
5670565|NCT00440518|19569891|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
5670566|NCT00440518|19569889|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
5670567|NCT00440518|19569890|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
5670568|NCT00440518|19569891|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
5670569|NCT00440518|19569889|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
5670570|NCT00440518|19569890|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
5670571|NCT00440518|19569891|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
5670572|NCT00440518|19569889|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
5670573|NCT00440518|19569890|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
5670574|NCT00440518|19569891|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
5670575|NCT00440518|19569889|P3|Randomized /Titration Period|Adverse Event|0
5670576|NCT00440518|19569890|P2|Randomized /Titration Period|Adverse Event|3
5670577|NCT00440518|19569891|P1|Randomized /Titration Period|Adverse Event|2
5670578|NCT00440518|19569889|P3|Randomized /Titration Period|Lost to Follow-up|1
5670579|NCT00440518|19569890|P2|Randomized /Titration Period|Lost to Follow-up|2
5670580|NCT00440518|19569891|P1|Randomized /Titration Period|Lost to Follow-up|2
5670581|NCT00440518|19569889|P3|Randomized /Titration Period|Other|0
5670582|NCT00440518|19569890|P2|Randomized /Titration Period|Other|0
5670583|NCT00440518|19569891|P1|Randomized /Titration Period|Other|1
5670584|NCT00440518|19569889|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
5670585|NCT00440518|19569890|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
5670586|NCT00440518|19569891|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
5670587|NCT00440518|19569889|P3|Randomized /Titration Period|Protocol Deviation|0
5670588|NCT00440518|19569890|P2|Randomized /Titration Period|Protocol Deviation|0
5670589|NCT00440518|19569891|P1|Randomized /Titration Period|Protocol Deviation|1
5670590|NCT00440518|19569889|P3|Randomized /Titration Period|Subject Withdrew Consent|0
5670591|NCT00440518|19569890|P2|Randomized /Titration Period|Subject Withdrew Consent|1
5670592|NCT00440518|19569891|P1|Randomized /Titration Period|Subject Withdrew Consent|4
5670593|NCT00440518|19569889|P3|Randomized /Titration Period|Lack of Efficacy|1
5670594|NCT00440518|19569890|P2|Randomized /Titration Period|Lack of Efficacy|0
5670595|NCT00440518|19569891|P1|Randomized /Titration Period|Lack of Efficacy|1
5670596|NCT00440466|19569936|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
5670597|NCT00440466|19569937|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
5670598|NCT00440466|19569938|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
5670599|NCT00440466|19569936|P3|Overall Study|Began Dialysis|1
5670600|NCT00440466|19569937|P2|Overall Study|Began Dialysis|0
5670601|NCT00440466|19569938|P1|Overall Study|Began Dialysis|0
5670602|NCT00440466|19569936|P3|Overall Study|Withdrawal by Subject|9
5670603|NCT00440466|19569937|P2|Overall Study|Withdrawal by Subject|5
5670604|NCT00440466|19569938|P1|Overall Study|Withdrawal by Subject|2
5670605|NCT00440466|19569936|P3|Overall Study|Protocol Violation|4
5670606|NCT00440466|19569937|P2|Overall Study|Protocol Violation|0
5670607|NCT00440466|19569938|P1|Overall Study|Protocol Violation|2
5670608|NCT00440466|19569936|P3|Overall Study|Physician Decision|1
5670609|NCT00440466|19569937|P2|Overall Study|Physician Decision|0
5670610|NCT00440466|19569938|P1|Overall Study|Physician Decision|2
5670611|NCT00440466|19569936|P3|Overall Study|Lost to Follow-up|2
5670612|NCT00440466|19569937|P2|Overall Study|Lost to Follow-up|0
5670613|NCT00440466|19569938|P1|Overall Study|Lost to Follow-up|1
5670614|NCT00440466|19569936|P3|Overall Study|Adverse Event|11
5670615|NCT00440466|19569937|P2|Overall Study|Adverse Event|4
5670616|NCT00440466|19569938|P1|Overall Study|Adverse Event|3
5670617|NCT00440466|19569936|P3|Overall Study|Death|9
5670618|NCT00440466|19569937|P2|Overall Study|Death|2
5670619|NCT00440466|19569938|P1|Overall Study|Death|3
5670620|NCT00440401|19569972|P2|Overall Study|Other|5
5670621|NCT00440401|19569973|P1|Overall Study|Other|2
5670622|NCT00440401|19569972|P2|Overall Study|Adverse Event|1
5670623|NCT00440401|19569973|P1|Overall Study|Adverse Event|2
5670624|NCT00440310|19569983|P2|Overall Study|Status Unknown|3
5670625|NCT00440310|19569984|P1|Overall Study|Status Unknown|1
5670626|NCT00440310|19569983|P2|Overall Study|Other|0
5670627|NCT00440310|19569984|P1|Overall Study|Other|1
5670628|NCT00440310|19569983|P2|Overall Study|No Reply at EOS|7
5670629|NCT00440310|19569984|P1|Overall Study|No Reply at EOS|7
5670630|NCT00440310|19569983|P2|Overall Study|Withdrawal by Subject|14
5670631|NCT00440310|19569984|P1|Overall Study|Withdrawal by Subject|15
5670632|NCT00440310|19569983|P2|Overall Study|Protocol Violation|1
5670633|NCT00440310|19569984|P1|Overall Study|Protocol Violation|0
5670634|NCT00440310|19569983|P2|Overall Study|Lost to Follow-up|5
5670635|NCT00440310|19569984|P1|Overall Study|Lost to Follow-up|4
5670636|NCT00440297|19569992|P2|Overall Study|Randomized by mistake|0
5670637|NCT00440297|19569993|P1|Overall Study|Randomized by mistake|1
5670638|NCT00440297|19569992|P2|Overall Study|Withdrawal by Subject|6
5670639|NCT00440297|19569993|P1|Overall Study|Withdrawal by Subject|1
5670640|NCT00440297|19569992|P2|Overall Study|Protocol Violation|7
5670641|NCT00440297|19569993|P1|Overall Study|Protocol Violation|11
5670642|NCT00440297|19569992|P2|Overall Study|Physician Decision|0
5670643|NCT00440297|19569993|P1|Overall Study|Physician Decision|1
5670644|NCT00440297|19569992|P2|Overall Study|Lost to Follow-up|0
5670645|NCT00440297|19569993|P1|Overall Study|Lost to Follow-up|1
5670646|NCT00440297|19569992|P2|Overall Study|Adverse Event|5
5670647|NCT00440297|19569993|P1|Overall Study|Adverse Event|8
5670648|NCT00440271|19570009|P2|Overall Study|Other|0
5670649|NCT00440271|19570010|P1|Overall Study|Other|2
5670650|NCT00440271|19570009|P2|Overall Study|Due to closure of trial|10
5670651|NCT00440271|19570010|P1|Overall Study|Due to closure of trial|8
5670652|NCT00440271|19570009|P2|Overall Study|Lack of Efficacy|1
5670653|NCT00440271|19570010|P1|Overall Study|Lack of Efficacy|0
5670654|NCT00440271|19570009|P2|Overall Study|Withdrawal by Subject|2
5670655|NCT00440271|19570010|P1|Overall Study|Withdrawal by Subject|0
5670656|NCT00440271|19570009|P2|Overall Study|Lost to Follow-up|0
5670657|NCT00440271|19570010|P1|Overall Study|Lost to Follow-up|1
5670658|NCT00440271|19570009|P2|Overall Study|Adverse Event|1
5670659|NCT00440271|19570010|P1|Overall Study|Adverse Event|0
5670660|NCT00440271|19570009|P2|Overall Study|Protocol Violation|1
5670661|NCT00440271|19570010|P1|Overall Study|Protocol Violation|1
5670662|NCT00440232|19570044|P2|Overall Study|Onset of headache within 4 hours of fast|2
5670663|NCT00440232|19570045|P1|Overall Study|Onset of headache within 4 hours of fast|2
5670664|NCT00440232|19570044|P2|Overall Study|Unable to treat within allowed time|1
5670665|NCT00440232|19570045|P1|Overall Study|Unable to treat within allowed time|0
5670666|NCT00440232|19570044|P2|Overall Study|Lost to Follow-up|1
5670667|NCT00440232|19570045|P1|Overall Study|Lost to Follow-up|1
5670668|NCT00440193|19570055|P2|Observational Period|Participant convenience|0
5670669|NCT00440193|19570056|P1|Observational Period|Participant convenience|2
5670670|NCT00440193|19570055|P2|Observational Period|Clinical endpoint reached|0
5670671|NCT00440193|19570056|P1|Observational Period|Clinical endpoint reached|1
5670672|NCT00440193|19570055|P2|Observational Period|Physician Decision|0
5670673|NCT00440193|19570056|P1|Observational Period|Physician Decision|1
5670674|NCT00440193|19570055|P2|Observational Period|Withdrawal by Subject|8
5670675|NCT00440193|19570056|P1|Observational Period|Withdrawal by Subject|11
5670676|NCT00440193|19570055|P2|Observational Period|Protocol Violation|0
5670677|NCT00440193|19570056|P1|Observational Period|Protocol Violation|1
5670678|NCT00440193|19570055|P2|Observational Period|Lost to Follow-up|8
5670679|NCT00440193|19570056|P1|Observational Period|Lost to Follow-up|12
5670680|NCT00440193|19570055|P2|Observational Period|Death|20
5670681|NCT00440193|19570056|P1|Observational Period|Death|15
5670682|NCT00440193|19570055|P2|Observational Period|Adverse Event|2
5670683|NCT00440193|19570056|P1|Observational Period|Adverse Event|2
5670684|NCT00440193|19570055|P2|Treatment Period|Site closed by investigator|2
5670685|NCT00440193|19570056|P1|Treatment Period|Site closed by investigator|0
5670686|NCT00440193|19570055|P2|Treatment Period|Participant did not receive treatment|13
5670687|NCT00440193|19570056|P1|Treatment Period|Participant did not receive treatment|7
5670688|NCT00440193|19570055|P2|Treatment Period|Participant convenience|2
5670689|NCT00440193|19570056|P1|Treatment Period|Participant convenience|5
5670690|NCT00440193|19570055|P2|Treatment Period|Technical problems|1
5670691|NCT00440193|19570056|P1|Treatment Period|Technical problems|1
5670692|NCT00440193|19570055|P2|Treatment Period|Switch to commercial drug|2
5670693|NCT00440193|19570056|P1|Treatment Period|Switch to commercial drug|0
5670694|NCT00440193|19570055|P2|Treatment Period|Protocol driven decision point|2
5670695|NCT00440193|19570056|P1|Treatment Period|Protocol driven decision point|2
5670696|NCT00440193|19570055|P2|Treatment Period|Study terminated by sponsor|94
5670697|NCT00440193|19570056|P1|Treatment Period|Study terminated by sponsor|102
5670698|NCT00440193|19570055|P2|Treatment Period|Clinical endpoint reached|25
5670699|NCT00440193|19570056|P1|Treatment Period|Clinical endpoint reached|28
5670700|NCT00440193|19570055|P2|Treatment Period|Withdrawal by Subject|77
5670701|NCT00440193|19570056|P1|Treatment Period|Withdrawal by Subject|36
5670702|NCT00440193|19570055|P2|Treatment Period|Protocol Violation|19
5670703|NCT00440193|19570056|P1|Treatment Period|Protocol Violation|16
5670704|NCT00440193|19570055|P2|Treatment Period|Physician Decision|6
5670705|NCT00440193|19570056|P1|Treatment Period|Physician Decision|3
5670706|NCT00440193|19570055|P2|Treatment Period|Lost to Follow-up|18
5670707|NCT00440193|19570056|P1|Treatment Period|Lost to Follow-up|12
5670708|NCT00440193|19570055|P2|Treatment Period|Lack of Efficacy|1
5670709|NCT00440193|19570056|P1|Treatment Period|Lack of Efficacy|0
5670710|NCT00440193|19570055|P2|Treatment Period|Death|22
5670711|NCT00440193|19570056|P1|Treatment Period|Death|19
5670712|NCT00440193|19570055|P2|Treatment Period|Adverse Event|67
5670713|NCT00440193|19570056|P1|Treatment Period|Adverse Event|74
5670714|NCT00440115|19570102|P3|Overall Study|Incarceration|1
5670715|NCT00440115|19570103|P2|Overall Study|Incarceration|2
5670716|NCT00440115|19570104|P1|Overall Study|Incarceration|0
5670717|NCT00440115|19570102|P3|Overall Study|Death|5
5670718|NCT00440115|19570103|P2|Overall Study|Death|9
5670719|NCT00440115|19570104|P1|Overall Study|Death|7
5670720|NCT00440037|19570133|P1|Overall Study|Administrative decision|3
5670721|NCT00440037|19570133|P1|Overall Study|Withdrawal by Subject|6
5670722|NCT00440011|19570143|P2|Overall Study|Withdrawal by Subject|0
5670723|NCT00440011|19570144|P1|Overall Study|Withdrawal by Subject|1
5670724|NCT00440011|19570143|P2|Overall Study|Protocol Violation|1
5670725|NCT00440011|19570144|P1|Overall Study|Protocol Violation|1
5670726|NCT00440011|19570143|P2|Overall Study|Lost to Follow-up|2
5670727|NCT00440011|19570144|P1|Overall Study|Lost to Follow-up|0
5670728|NCT00440011|19570143|P2|Overall Study|Adverse Event|0
5670729|NCT00440011|19570144|P1|Overall Study|Adverse Event|2
5670730|NCT00439777|19570171|P2|Observational Period|Technical problems|1
5670731|NCT00439777|19570172|P1|Observational Period|Technical problems|0
5670732|NCT00439777|19570171|P2|Observational Period|Lack of Efficacy|0
5670733|NCT00439777|19570172|P1|Observational Period|Lack of Efficacy|1
5670734|NCT00439777|19570171|P2|Observational Period|Protocol driven decision point|1
5670735|NCT00439777|19570172|P1|Observational Period|Protocol driven decision point|0
5670736|NCT00439777|19570171|P2|Observational Period|Study terminated by sponsor|1
5670737|NCT00439777|19570172|P1|Observational Period|Study terminated by sponsor|3
5670738|NCT00439777|19570171|P2|Observational Period|Death|20
5670739|NCT00439777|19570172|P1|Observational Period|Death|27
5670740|NCT00439777|19570171|P2|Observational Period|Lost to Follow-up|11
5670741|NCT00439777|19570172|P1|Observational Period|Lost to Follow-up|1
5670742|NCT00439777|19570171|P2|Observational Period|Withdrawal by Subject|5
5670743|NCT00439777|19570172|P1|Observational Period|Withdrawal by Subject|9
5670744|NCT00439777|19570171|P2|Observational Period|Protocol Violation|2
5670745|NCT00439777|19570172|P1|Observational Period|Protocol Violation|0
5670746|NCT00439777|19570171|P2|Treatment Period|Participant convenience|8
5670747|NCT00439777|19570172|P1|Treatment Period|Participant convenience|12
5670748|NCT00439777|19570171|P2|Treatment Period|Technical problems|1
5670749|NCT00439777|19570172|P1|Treatment Period|Technical problems|3
5670750|NCT00439777|19570171|P2|Treatment Period|Clinical endpoint reached|13
5670751|NCT00439777|19570172|P1|Treatment Period|Clinical endpoint reached|26
5670752|NCT00439777|19570171|P2|Treatment Period|Physician Decision|18
5670753|NCT00439777|19570172|P1|Treatment Period|Physician Decision|7
5670754|NCT00439777|19570171|P2|Treatment Period|Protocol driven decision point|3
5670755|NCT00439777|19570172|P1|Treatment Period|Protocol driven decision point|1
5670756|NCT00439777|19570171|P2|Treatment Period|Lost to Follow-up|10
5670757|NCT00439777|19570172|P1|Treatment Period|Lost to Follow-up|8
5670758|NCT00439777|19570171|P2|Treatment Period|Lack of Efficacy|4
5670759|NCT00439777|19570172|P1|Treatment Period|Lack of Efficacy|1
5670760|NCT00439777|19570171|P2|Treatment Period|Withdrawal by Subject|118
5670761|NCT00439777|19570172|P1|Treatment Period|Withdrawal by Subject|66
5670762|NCT00439777|19570171|P2|Treatment Period|Protocol Violation|30
5670763|NCT00439777|19570172|P1|Treatment Period|Protocol Violation|23
5670764|NCT00439777|19570171|P2|Treatment Period|Adverse Event|92
5670765|NCT00439777|19570172|P1|Treatment Period|Adverse Event|111
5670766|NCT00439777|19570171|P2|Treatment Period|Did not take study treatment|8
5670767|NCT00439777|19570172|P1|Treatment Period|Did not take study treatment|7
5670768|NCT00439777|19570171|P2|Treatment Period|Site closed by investigator|1
5670769|NCT00439777|19570172|P1|Treatment Period|Site closed by investigator|0
5670770|NCT00439777|19570171|P2|Treatment Period|Study terminated by sponsor|132
5670771|NCT00439777|19570172|P1|Treatment Period|Study terminated by sponsor|125
5670772|NCT00439777|19570171|P2|Treatment Period|Death|21
5670773|NCT00439777|19570172|P1|Treatment Period|Death|29
5670774|NCT00439738|19570210|P2|Overall Study|Abnormal Lab Values|0
5670775|NCT00439738|19570211|P1|Overall Study|Abnormal Lab Values|1
5670776|NCT00439738|19570210|P2|Overall Study|Lack of Efficacy|2
5670777|NCT00439738|19570211|P1|Overall Study|Lack of Efficacy|2
5670778|NCT00439738|19570210|P2|Overall Study|Protocol Violation|3
5670779|NCT00439738|19570211|P1|Overall Study|Protocol Violation|6
5670780|NCT00439738|19570210|P2|Overall Study|Lost to Follow-up|6
5670781|NCT00439738|19570211|P1|Overall Study|Lost to Follow-up|5
5670782|NCT00439738|19570210|P2|Overall Study|Adverse Event|4
5670783|NCT00439738|19570211|P1|Overall Study|Adverse Event|6
5670784|NCT00439738|19570210|P2|Overall Study|Withdrawal by Subject|13
5670785|NCT00439738|19570211|P1|Overall Study|Withdrawal by Subject|16
5670786|NCT00439725|19570229|P2|Observational Period|Participant convenience|0
5670787|NCT00439725|19570230|P1|Observational Period|Participant convenience|1
5670788|NCT00439725|19570229|P2|Observational Period|Technical problems|0
5670789|NCT00439725|19570230|P1|Observational Period|Technical problems|1
5670790|NCT00439725|19570229|P2|Observational Period|Clinical endpoint reached|1
5670791|NCT00439725|19570230|P1|Observational Period|Clinical endpoint reached|3
5670792|NCT00439725|19570229|P2|Observational Period|Study termination by sponsor|1
5670793|NCT00439725|19570230|P1|Observational Period|Study termination by sponsor|1
5670794|NCT00439725|19570229|P2|Observational Period|Death|2
5670795|NCT00439725|19570230|P1|Observational Period|Death|0
5670796|NCT00439725|19570229|P2|Observational Period|Lost to Follow-up|1
5670797|NCT00439725|19570230|P1|Observational Period|Lost to Follow-up|0
5670798|NCT00439725|19570229|P2|Observational Period|Withdrawal by Subject|2
5670799|NCT00439725|19570230|P1|Observational Period|Withdrawal by Subject|2
5670800|NCT00439725|19570229|P2|Treatment Period|Participant did not receive treatment|4
5670801|NCT00439725|19570230|P1|Treatment Period|Participant did not receive treatment|4
5670802|NCT00439725|19570229|P2|Treatment Period|Death|1
5670803|NCT00439725|19570230|P1|Treatment Period|Death|1
5670804|NCT00439725|19570229|P2|Treatment Period|Protocol driven decision point|1
5670805|NCT00439725|19570230|P1|Treatment Period|Protocol driven decision point|1
5670806|NCT00439725|19570229|P2|Treatment Period|Participant convenience|0
5670807|NCT00439725|19570230|P1|Treatment Period|Participant convenience|1
5670808|NCT00439725|19570229|P2|Treatment Period|Lost to Follow-up|1
5670809|NCT00439725|19570230|P1|Treatment Period|Lost to Follow-up|1
5670810|NCT00439725|19570229|P2|Treatment Period|Technical problems|0
5670811|NCT00439725|19570230|P1|Treatment Period|Technical problems|1
5670812|NCT00439725|19570229|P2|Treatment Period|Clinical endpoint reached|50
5670813|NCT00439725|19570230|P1|Treatment Period|Clinical endpoint reached|6
5670814|NCT00439725|19570229|P2|Treatment Period|Protocol Violation|1
5670815|NCT00439725|19570230|P1|Treatment Period|Protocol Violation|2
5670816|NCT00439725|19570229|P2|Treatment Period|Physician Decision|1
5670817|NCT00439725|19570230|P1|Treatment Period|Physician Decision|1
5670818|NCT00439725|19570229|P2|Treatment Period|Adverse Event|18
5670819|NCT00439725|19570230|P1|Treatment Period|Adverse Event|39
5670820|NCT00439725|19570229|P2|Treatment Period|Site closed by investigator|2
5670821|NCT00439725|19570230|P1|Treatment Period|Site closed by investigator|1
5670822|NCT00439725|19570229|P2|Treatment Period|Study terminated by sponsor|148
5670823|NCT00439725|19570230|P1|Treatment Period|Study terminated by sponsor|156
5670824|NCT00439725|19570229|P2|Treatment Period|Withdrawal by Subject|19
5670825|NCT00439725|19570230|P1|Treatment Period|Withdrawal by Subject|22
5670826|NCT00439647|19570281|P2|Overall Study|Lack of Efficacy|4
5670827|NCT00439647|19570282|P1|Overall Study|Lack of Efficacy|0
5670828|NCT00439647|19570281|P2|Overall Study|Protocol Violation|4
5670829|NCT00439647|19570282|P1|Overall Study|Protocol Violation|3
5670830|NCT00439647|19570281|P2|Overall Study|Lost to Follow-up|12
5670831|NCT00439647|19570282|P1|Overall Study|Lost to Follow-up|4
5670832|NCT00439647|19570281|P2|Overall Study|Adverse Event|11
5670833|NCT00439647|19570282|P1|Overall Study|Adverse Event|11
5670834|NCT00439647|19570281|P2|Overall Study|Death|18
5670835|NCT00439647|19570282|P1|Overall Study|Death|15
5670836|NCT00439647|19570281|P2|Overall Study|Withdrawal by Subject|22
5670837|NCT00439647|19570282|P1|Overall Study|Withdrawal by Subject|25
5670838|NCT00439569|19570319|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
5670839|NCT00439569|19570319|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
5670840|NCT00439569|19570319|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
5670841|NCT00439556|19570333|P3|Overall Study|Patient was taken off study for non-comp|0
5670842|NCT00439556|19570334|P2|Overall Study|Patient was taken off study for non-comp|1
5670843|NCT00439556|19570335|P1|Overall Study|Patient was taken off study for non-comp|0
5670844|NCT00439517|19570348|P2|Overall Study|Subject in survival follow-up|0
5670845|NCT00439517|19570349|P1|Overall Study|Subject in survival follow-up|1
5670846|NCT00439517|19570348|P2|Overall Study|Subject on treatment|0
5670847|NCT00439517|19570349|P1|Overall Study|Subject on treatment|1
5670848|NCT00439309|19570488|P2|Follow-Up|Late response by subject|1
5670849|NCT00439309|19570489|P1|Follow-Up|Late response by subject|0
5670850|NCT00439309|19570488|P2|Follow-Up|Withdrawal by Subject|1
5670851|NCT00439309|19570489|P1|Follow-Up|Withdrawal by Subject|0
5670852|NCT00439309|19570488|P2|Follow-Up|Lost to Follow-up|0
5670853|NCT00439309|19570489|P1|Follow-Up|Lost to Follow-up|2
5670854|NCT00439309|19570488|P2|Follow-Up|Death|0
5670855|NCT00439309|19570489|P1|Follow-Up|Death|1
5670856|NCT00439270|19570521|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
5670857|NCT00439270|19570522|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
5670858|NCT00439270|19570523|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
5670859|NCT00439270|19570524|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
5670860|NCT00439270|19570525|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
5670861|NCT00439270|19570521|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
5670862|NCT00439270|19570522|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
5670863|NCT00439270|19570523|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
5670864|NCT00439270|19570524|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
5670865|NCT00439270|19570525|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
5670866|NCT00439270|19570521|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
5670867|NCT00439270|19570522|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
5670868|NCT00439270|19570523|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
5670869|NCT00439270|19570524|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
5670870|NCT00439270|19570525|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
5670871|NCT00439270|19570521|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
5670872|NCT00439270|19570522|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
5670873|NCT00439270|19570523|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
5670874|NCT00439270|19570524|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
5670875|NCT00439270|19570525|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
5670876|NCT00439270|19570521|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
5670877|NCT00439270|19570522|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
5670878|NCT00439270|19570523|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
5670879|NCT00439270|19570524|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
5670880|NCT00439270|19570525|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
5670881|NCT00439270|19570521|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
5670882|NCT00439270|19570522|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
5670883|NCT00439270|19570523|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
5670884|NCT00439270|19570524|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
5670885|NCT00439270|19570525|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
5670886|NCT00439270|19570521|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
5670887|NCT00439270|19570522|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
5670888|NCT00439270|19570523|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
5670889|NCT00439270|19570524|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
5670890|NCT00439270|19570525|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
5670891|NCT00439270|19570521|P5|Phase 2 (51.6 Months)|Disease progression|0
5670892|NCT00439270|19570522|P4|Phase 2 (51.6 Months)|Disease progression|18
5670893|NCT00439270|19570523|P3|Phase 2 (51.6 Months)|Disease progression|0
5670894|NCT00439270|19570524|P2|Phase 2 (51.6 Months)|Disease progression|0
5670895|NCT00439270|19570525|P1|Phase 2 (51.6 Months)|Disease progression|0
5670896|NCT00439270|19570521|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
5670897|NCT00439270|19570522|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
5670898|NCT00439270|19570523|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
5670899|NCT00439270|19570524|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
5670900|NCT00439270|19570525|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
5670901|NCT00439270|19570521|P5|Phase 1 (18.1 Months)|Disease progression|3
5670902|NCT00439270|19570522|P4|Phase 1 (18.1 Months)|Disease progression|0
5670903|NCT00439270|19570523|P3|Phase 1 (18.1 Months)|Disease progression|3
5670904|NCT00439270|19570524|P2|Phase 1 (18.1 Months)|Disease progression|2
5670905|NCT00439270|19570525|P1|Phase 1 (18.1 Months)|Disease progression|3
5670906|NCT00439244|19570567|P3|Overall Study|Administrative problems|0
5670907|NCT00439244|19570568|P2|Overall Study|Administrative problems|0
5670908|NCT00439244|19570569|P1|Overall Study|Administrative problems|1
5670909|NCT00439244|19570567|P3|Overall Study|Protocol Violation|0
5670910|NCT00439244|19570568|P2|Overall Study|Protocol Violation|1
5670911|NCT00439244|19570569|P1|Overall Study|Protocol Violation|0
5670912|NCT00439244|19570567|P3|Overall Study|Death|0
5670913|NCT00439244|19570568|P2|Overall Study|Death|1
5670914|NCT00439244|19570569|P1|Overall Study|Death|0
5670915|NCT00439244|19570567|P3|Overall Study|Lost to Follow-up|2
5670916|NCT00439244|19570568|P2|Overall Study|Lost to Follow-up|1
5670917|NCT00439244|19570569|P1|Overall Study|Lost to Follow-up|2
5670918|NCT00439244|19570567|P3|Overall Study|Withdrawal by Subject|2
5670919|NCT00439244|19570568|P2|Overall Study|Withdrawal by Subject|1
5670920|NCT00439244|19570569|P1|Overall Study|Withdrawal by Subject|3
5670921|NCT00439244|19570567|P3|Overall Study|Adverse Event|3
5670922|NCT00439244|19570568|P2|Overall Study|Adverse Event|2
5670923|NCT00439244|19570569|P1|Overall Study|Adverse Event|5
5670924|NCT00439231|19570589|P1|Overall Study|Lack of Efficacy|28
5670925|NCT00439218|19570593|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
5670926|NCT00439179|19570608|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
5670927|NCT00439179|19570609|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
5670928|NCT00439179|19570610|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
5670929|NCT00439179|19570611|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
5670930|NCT00439140|19570628|P3|Treatment Cycle 2|Lost to Follow-up|0
5670931|NCT00439140|19570629|P2|Treatment Cycle 2|Lost to Follow-up|1
5670932|NCT00439140|19570630|P1|Treatment Cycle 2|Lost to Follow-up|1
5670933|NCT00439140|19570628|P3|Treatment Cycle 2|Withdrawal by Subject|0
5670934|NCT00439140|19570629|P2|Treatment Cycle 2|Withdrawal by Subject|0
5670935|NCT00439140|19570630|P1|Treatment Cycle 2|Withdrawal by Subject|1
5670936|NCT00439140|19570628|P3|Treatment Cycle 1|Withdrawal by Subject|0
5670937|NCT00439140|19570629|P2|Treatment Cycle 1|Withdrawal by Subject|1
5670938|NCT00439140|19570630|P1|Treatment Cycle 1|Withdrawal by Subject|0
5670939|NCT00439140|19570628|P3|Treatment Cycle 1|Personal reasons|0
5670940|NCT00439140|19570629|P2|Treatment Cycle 1|Personal reasons|2
5670941|NCT00439140|19570630|P1|Treatment Cycle 1|Personal reasons|0
5670942|NCT00439140|19570628|P3|Treatment Cycle 1|Lost to Follow-up|1
5670943|NCT00439140|19570629|P2|Treatment Cycle 1|Lost to Follow-up|1
5670944|NCT00439140|19570630|P1|Treatment Cycle 1|Lost to Follow-up|1
5670945|NCT00438815|19570713|P1|Overall Study|Death|1
5670946|NCT00438815|19570713|P1|Overall Study|Withdrawal by Subject|6
5670947|NCT00438815|19570713|P1|Overall Study|Lost to Follow-up|6
5670948|NCT00438815|19570713|P1|Overall Study|Transitioned to commercial C1INH-nf|6
5670949|NCT00438815|19570713|P1|Overall Study|Noncompliance with protocol requirements|9
5670950|NCT00438815|19570713|P1|Overall Study|3-month follow-up no longer required|12
5670951|NCT00438815|19570713|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
5670952|NCT00438672|19570763|P2|Overall Study|Lost to Follow-up|9
5670953|NCT00438672|19570764|P1|Overall Study|Lost to Follow-up|7
5670954|NCT00438659|19570774|P2|Overall Study|Cancel|2
5670955|NCT00438659|19570775|P1|Overall Study|Cancel|5
5670956|NCT00438659|19570774|P2|Overall Study|Discontinued Mometasone/Placebo|2
5670957|NCT00438659|19570775|P1|Overall Study|Discontinued Mometasone/Placebo|1
5670958|NCT00438633|19570799|P2|Overall Study|Lost to Follow-up|17
5670959|NCT00438633|19570800|P1|Overall Study|Lost to Follow-up|15
5670960|NCT00438633|19570799|P2|Overall Study|Withdrawal by Subject|0
5670961|NCT00438633|19570800|P1|Overall Study|Withdrawal by Subject|1
5670962|NCT00438464|19570831|P2|Overall Study|Incomplete data submission|2
5670963|NCT00438464|19570832|P1|Overall Study|Incomplete data submission|0
5670964|NCT00438464|19570831|P2|Overall Study|Terminated Early|5
5670965|NCT00438464|19570832|P1|Overall Study|Terminated Early|14
5670966|NCT00438399|19570933|P6|Overall Study|Patien stopped study at visit 4 by error|0
5670967|NCT00438399|19570934|P5|Overall Study|Patien stopped study at visit 4 by error|0
5670968|NCT00438399|19570935|P4|Overall Study|Patien stopped study at visit 4 by error|0
5670969|NCT00438399|19570936|P3|Overall Study|Patien stopped study at visit 4 by error|0
5670970|NCT00438399|19570937|P2|Overall Study|Patien stopped study at visit 4 by error|0
5670971|NCT00438399|19570938|P1|Overall Study|Patien stopped study at visit 4 by error|1
5670972|NCT00438399|19570933|P6|Overall Study|Pregnancy|1
5670973|NCT00438399|19570934|P5|Overall Study|Pregnancy|0
5670974|NCT00438399|19570935|P4|Overall Study|Pregnancy|0
5670975|NCT00438399|19570936|P3|Overall Study|Pregnancy|0
5670976|NCT00438399|19570937|P2|Overall Study|Pregnancy|0
5670977|NCT00438399|19570938|P1|Overall Study|Pregnancy|0
5670978|NCT00438399|19570933|P6|Overall Study|Subje stopped study|0
5670979|NCT00438399|19570934|P5|Overall Study|Subje stopped study|0
5670980|NCT00438399|19570935|P4|Overall Study|Subje stopped study|0
5670981|NCT00438399|19570936|P3|Overall Study|Subje stopped study|1
5670982|NCT00438399|19570937|P2|Overall Study|Subje stopped study|0
5670983|NCT00438399|19570938|P1|Overall Study|Subje stopped study|0
5670984|NCT00438399|19570933|P6|Overall Study|Protocol Violation|1
5670985|NCT00438399|19570934|P5|Overall Study|Protocol Violation|0
5670986|NCT00438399|19570935|P4|Overall Study|Protocol Violation|0
5670987|NCT00438399|19570936|P3|Overall Study|Protocol Violation|1
5670988|NCT00438399|19570937|P2|Overall Study|Protocol Violation|0
5670989|NCT00438399|19570938|P1|Overall Study|Protocol Violation|0
5670990|NCT00438399|19570933|P6|Overall Study|Withdrawal by Subject|2
5670991|NCT00438399|19570934|P5|Overall Study|Withdrawal by Subject|2
5670992|NCT00438399|19570935|P4|Overall Study|Withdrawal by Subject|2
5670993|NCT00438399|19570936|P3|Overall Study|Withdrawal by Subject|3
5670994|NCT00438399|19570937|P2|Overall Study|Withdrawal by Subject|6
5670995|NCT00438399|19570938|P1|Overall Study|Withdrawal by Subject|5
5670996|NCT00438399|19570933|P6|Overall Study|Adverse Event|1
5670997|NCT00438399|19570934|P5|Overall Study|Adverse Event|0
5670998|NCT00438399|19570935|P4|Overall Study|Adverse Event|1
5670999|NCT00438399|19570936|P3|Overall Study|Adverse Event|1
5671000|NCT00438399|19570937|P2|Overall Study|Adverse Event|0
5671001|NCT00438399|19570938|P1|Overall Study|Adverse Event|0
5671002|NCT00438399|19570933|P6|Overall Study|Lost to Follow-up|1
5671003|NCT00438399|19570934|P5|Overall Study|Lost to Follow-up|1
5671004|NCT00438399|19570935|P4|Overall Study|Lost to Follow-up|1
5671005|NCT00438399|19570936|P3|Overall Study|Lost to Follow-up|1
5671006|NCT00438399|19570937|P2|Overall Study|Lost to Follow-up|2
5671007|NCT00438399|19570938|P1|Overall Study|Lost to Follow-up|2
5671008|NCT00438360|19570949|P2|Overall Study|Other|15
5671009|NCT00438360|19570950|P1|Overall Study|Other|24
5671010|NCT00438360|19570949|P2|Overall Study|Lack of Efficacy|27
5671011|NCT00438360|19570950|P1|Overall Study|Lack of Efficacy|42
5671012|NCT00438360|19570949|P2|Overall Study|Adverse Event|1
5671013|NCT00438360|19570950|P1|Overall Study|Adverse Event|6
5671014|NCT00438256|19570964|P4|Overall Study|Excluded final Diagnosis|2
5671015|NCT00438256|19570965|P3|Overall Study|Excluded final Diagnosis|0
5671016|NCT00438256|19570966|P2|Overall Study|Excluded final Diagnosis|0
5671017|NCT00438256|19570967|P1|Overall Study|Excluded final Diagnosis|0
5671018|NCT00438256|19570964|P4|Overall Study|Ineligible for Resection|7
5671019|NCT00438256|19570965|P3|Overall Study|Ineligible for Resection|1
5671020|NCT00438256|19570966|P2|Overall Study|Ineligible for Resection|1
5671021|NCT00438256|19570967|P1|Overall Study|Ineligible for Resection|2
5671022|NCT00437983|19571017|P2|Overall Study|Withdrawal by Subject|6
5671023|NCT00437983|19571018|P1|Overall Study|Withdrawal by Subject|5
5671024|NCT00437983|19571017|P2|Overall Study|Protocol Violation|1
5671025|NCT00437983|19571018|P1|Overall Study|Protocol Violation|2
5671026|NCT00437983|19571017|P2|Overall Study|Adverse Event|6
5671027|NCT00437983|19571018|P1|Overall Study|Adverse Event|6
5671028|NCT00437658|19571031|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
5671029|NCT00437658|19571032|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
5671030|NCT00437658|19571033|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
5671031|NCT00437658|19571031|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
5671032|NCT00437658|19571032|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
5671033|NCT00437658|19571033|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
5671034|NCT00437658|19571031|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
5671035|NCT00437658|19571032|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
5671036|NCT00437658|19571033|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
5671037|NCT00437658|19571031|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
5671038|NCT00437658|19571032|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
5671039|NCT00437658|19571033|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
5671040|NCT00437658|19571031|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
5671041|NCT00437658|19571032|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
5671042|NCT00437658|19571033|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
5671043|NCT00437658|19571031|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
5671044|NCT00437658|19571032|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
5671045|NCT00437658|19571033|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
5671046|NCT00437658|19571031|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
5671047|NCT00437658|19571032|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
5671048|NCT00437658|19571033|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
5671049|NCT00437658|19571031|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
5671050|NCT00437658|19571032|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
5671051|NCT00437658|19571033|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
5671052|NCT00437658|19571031|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
5671053|NCT00437658|19571032|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
5671054|NCT00437658|19571033|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
5671055|NCT00437658|19571031|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
5671056|NCT00437658|19571032|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
5671057|NCT00437658|19571033|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
5671058|NCT00437658|19571031|P3|Treatment Period (24 Weeks)|Non-compliance|4
5671059|NCT00437658|19571032|P2|Treatment Period (24 Weeks)|Non-compliance|1
5671060|NCT00437658|19571033|P1|Treatment Period (24 Weeks)|Non-compliance|1
5671061|NCT00437658|19571031|P3|Treatment Period (24 Weeks)|Adverse Event|14
5671062|NCT00437658|19571032|P2|Treatment Period (24 Weeks)|Adverse Event|7
5671063|NCT00437658|19571033|P1|Treatment Period (24 Weeks)|Adverse Event|4
5671064|NCT00437645|19571127|P2|Overall Study|Condition no longer requires study drug|1
5671065|NCT00437645|19571128|P1|Overall Study|Condition no longer requires study drug|1
5671066|NCT00437645|19571127|P2|Overall Study|Lack of Efficacy|1
5671067|NCT00437645|19571128|P1|Overall Study|Lack of Efficacy|2
5671068|NCT00437645|19571127|P2|Overall Study|Administrative problems|1
5671069|NCT00437645|19571128|P1|Overall Study|Administrative problems|2
5671070|NCT00437645|19571127|P2|Overall Study|Lost to Follow-up|3
5671071|NCT00437645|19571128|P1|Overall Study|Lost to Follow-up|2
5671072|NCT00437645|19571127|P2|Overall Study|Protocol Violation|3
5671073|NCT00437645|19571128|P1|Overall Study|Protocol Violation|3
5671074|NCT00437645|19571127|P2|Overall Study|Withdrawal by Subject|22
5671075|NCT00437645|19571128|P1|Overall Study|Withdrawal by Subject|10
5671076|NCT00437645|19571127|P2|Overall Study|Adverse Event|84
5671077|NCT00437645|19571128|P1|Overall Study|Adverse Event|15
5671078|NCT00437489|19571144|P2|Overall Study|Lost to Follow-up|1
5671079|NCT00437489|19571145|P1|Overall Study|Lost to Follow-up|0
5671080|NCT00437489|19571144|P2|Overall Study|Study terminated by sponsor|21
5671081|NCT00437489|19571145|P1|Overall Study|Study terminated by sponsor|23
5671082|NCT00437294|19571164|P2|Overall Study|Entry criteria not met|1
5671083|NCT00437294|19571165|P1|Overall Study|Entry criteria not met|1
5671084|NCT00437294|19571164|P2|Overall Study|Protocol Violation|1
5671085|NCT00437294|19571165|P1|Overall Study|Protocol Violation|0
5671086|NCT00437294|19571164|P2|Overall Study|Sponsor Decision|9
5671087|NCT00437294|19571165|P1|Overall Study|Sponsor Decision|8
5671088|NCT00437294|19571164|P2|Overall Study|Progressive Disease|23
5671089|NCT00437294|19571165|P1|Overall Study|Progressive Disease|19
5671090|NCT00437294|19571164|P2|Overall Study|Withdrawal by Subject|0
5671091|NCT00437294|19571165|P1|Overall Study|Withdrawal by Subject|5
5671092|NCT00437294|19571164|P2|Overall Study|Physician Decision|3
5671093|NCT00437294|19571165|P1|Overall Study|Physician Decision|0
5671094|NCT00437294|19571164|P2|Overall Study|Death|2
5671095|NCT00437294|19571165|P1|Overall Study|Death|5
5671096|NCT00437294|19571164|P2|Overall Study|Adverse Event|4
5671097|NCT00437294|19571165|P1|Overall Study|Adverse Event|5
5671098|NCT00437281|19571206|P20|Overall Study|Lost to Follow-up|1
5671099|NCT00437281|19571207|P19|Overall Study|Lost to Follow-up|0
5671100|NCT00437281|19571208|P18|Overall Study|Lost to Follow-up|0
5671101|NCT00437281|19571209|P17|Overall Study|Lost to Follow-up|0
5671102|NCT00437281|19571210|P16|Overall Study|Lost to Follow-up|0
5671103|NCT00437281|19571211|P15|Overall Study|Lost to Follow-up|0
5671104|NCT00437281|19571212|P14|Overall Study|Lost to Follow-up|0
5671105|NCT00437281|19571213|P13|Overall Study|Lost to Follow-up|0
5671106|NCT00437281|19571214|P12|Overall Study|Lost to Follow-up|0
5671107|NCT00437281|19571215|P11|Overall Study|Lost to Follow-up|0
5671108|NCT00437281|19571216|P10|Overall Study|Lost to Follow-up|0
5671109|NCT00437281|19571217|P9|Overall Study|Lost to Follow-up|0
5671110|NCT00437281|19571218|P8|Overall Study|Lost to Follow-up|0
5671111|NCT00437281|19571219|P7|Overall Study|Lost to Follow-up|0
5671112|NCT00437281|19571220|P6|Overall Study|Lost to Follow-up|0
5671113|NCT00437281|19571221|P5|Overall Study|Lost to Follow-up|0
5671114|NCT00437281|19571222|P4|Overall Study|Lost to Follow-up|0
5671115|NCT00437281|19571223|P3|Overall Study|Lost to Follow-up|0
5671116|NCT00437281|19571224|P2|Overall Study|Lost to Follow-up|0
5671117|NCT00437281|19571225|P1|Overall Study|Lost to Follow-up|0
5671118|NCT00437281|19571206|P20|Overall Study|Adverse Event|0
5671119|NCT00437281|19571207|P19|Overall Study|Adverse Event|1
5671120|NCT00437281|19571208|P18|Overall Study|Adverse Event|0
5671121|NCT00437281|19571209|P17|Overall Study|Adverse Event|0
5671122|NCT00437281|19571210|P16|Overall Study|Adverse Event|0
5671123|NCT00437281|19571211|P15|Overall Study|Adverse Event|1
5671124|NCT00437281|19571212|P14|Overall Study|Adverse Event|1
5671125|NCT00437281|19571213|P13|Overall Study|Adverse Event|0
5671126|NCT00437281|19571214|P12|Overall Study|Adverse Event|0
5671127|NCT00437281|19571215|P11|Overall Study|Adverse Event|0
5671128|NCT00437281|19571216|P10|Overall Study|Adverse Event|1
5671129|NCT00437281|19571217|P9|Overall Study|Adverse Event|0
5671130|NCT00437281|19571218|P8|Overall Study|Adverse Event|0
5671131|NCT00437281|19571219|P7|Overall Study|Adverse Event|0
5671132|NCT00437281|19571220|P6|Overall Study|Adverse Event|1
5671133|NCT00437281|19571221|P5|Overall Study|Adverse Event|0
5671134|NCT00437281|19571222|P4|Overall Study|Adverse Event|1
5671135|NCT00437281|19571223|P3|Overall Study|Adverse Event|0
5671136|NCT00437281|19571224|P2|Overall Study|Adverse Event|0
5671137|NCT00437281|19571225|P1|Overall Study|Adverse Event|0
5671138|NCT00437268|19571521|P2|Overall Study|Death|1
5671139|NCT00437268|19571522|P1|Overall Study|Death|0
5671140|NCT00437268|19571521|P2|Overall Study|Physician Decision|0
5671141|NCT00437268|19571522|P1|Overall Study|Physician Decision|1
5671142|NCT00437268|19571521|P2|Overall Study|Progressive disease|9
5671143|NCT00437268|19571522|P1|Overall Study|Progressive disease|9
5671144|NCT00437268|19571521|P2|Overall Study|Withdrawal by Subject|2
5671145|NCT00437268|19571522|P1|Overall Study|Withdrawal by Subject|2
5671146|NCT00437268|19571521|P2|Overall Study|Adverse Event|1
5671147|NCT00437268|19571522|P1|Overall Study|Adverse Event|1
5671148|NCT00437203|19571548|P10|Overall Study|Other|0
5671149|NCT00437203|19571549|P9|Overall Study|Other|0
5671150|NCT00437203|19571550|P8|Overall Study|Other|0
5671151|NCT00437203|19571551|P7|Overall Study|Other|1
5671152|NCT00437203|19571552|P6|Overall Study|Other|0
5671153|NCT00437203|19571553|P5|Overall Study|Other|0
5671154|NCT00437203|19571554|P4|Overall Study|Other|0
5671155|NCT00437203|19571555|P3|Overall Study|Other|0
5671156|NCT00437203|19571556|P2|Overall Study|Other|1
5671157|NCT00437203|19571557|P1|Overall Study|Other|0
5671158|NCT00437203|19571548|P10|Overall Study|Objective progression or relapse|2
5671159|NCT00437203|19571549|P9|Overall Study|Objective progression or relapse|2
5671160|NCT00437203|19571550|P8|Overall Study|Objective progression or relapse|1
5671161|NCT00437203|19571551|P7|Overall Study|Objective progression or relapse|6
5671162|NCT00437203|19571552|P6|Overall Study|Objective progression or relapse|3
5671163|NCT00437203|19571553|P5|Overall Study|Objective progression or relapse|3
5671164|NCT00437203|19571554|P4|Overall Study|Objective progression or relapse|3
5671165|NCT00437203|19571555|P3|Overall Study|Objective progression or relapse|2
5671166|NCT00437203|19571556|P2|Overall Study|Objective progression or relapse|6
5671167|NCT00437203|19571557|P1|Overall Study|Objective progression or relapse|5
5671168|NCT00437203|19571548|P10|Overall Study|Study terminated by sponsor|0
5671169|NCT00437203|19571549|P9|Overall Study|Study terminated by sponsor|1
5671170|NCT00437203|19571550|P8|Overall Study|Study terminated by sponsor|0
5671171|NCT00437203|19571551|P7|Overall Study|Study terminated by sponsor|0
5671172|NCT00437203|19571552|P6|Overall Study|Study terminated by sponsor|0
5671173|NCT00437203|19571553|P5|Overall Study|Study terminated by sponsor|0
5671174|NCT00437203|19571554|P4|Overall Study|Study terminated by sponsor|0
5671175|NCT00437203|19571555|P3|Overall Study|Study terminated by sponsor|0
5671176|NCT00437203|19571556|P2|Overall Study|Study terminated by sponsor|0
5671177|NCT00437203|19571557|P1|Overall Study|Study terminated by sponsor|0
5671178|NCT00437203|19571548|P10|Overall Study|Adverse Event|1
5671179|NCT00437203|19571549|P9|Overall Study|Adverse Event|0
5671180|NCT00437203|19571550|P8|Overall Study|Adverse Event|1
5671181|NCT00437203|19571551|P7|Overall Study|Adverse Event|0
5671182|NCT00437203|19571552|P6|Overall Study|Adverse Event|0
5671183|NCT00437203|19571553|P5|Overall Study|Adverse Event|0
5671184|NCT00437203|19571554|P4|Overall Study|Adverse Event|0
5671185|NCT00437203|19571555|P3|Overall Study|Adverse Event|0
5671186|NCT00437203|19571556|P2|Overall Study|Adverse Event|1
5671187|NCT00437203|19571557|P1|Overall Study|Adverse Event|1
5671188|NCT00437203|19571548|P10|Overall Study|Death|1
5671189|NCT00437203|19571549|P9|Overall Study|Death|0
5671190|NCT00437203|19571550|P8|Overall Study|Death|1
5671191|NCT00437203|19571551|P7|Overall Study|Death|0
5671192|NCT00437203|19571552|P6|Overall Study|Death|0
5671193|NCT00437203|19571553|P5|Overall Study|Death|0
5671194|NCT00437203|19571554|P4|Overall Study|Death|0
5671195|NCT00437203|19571555|P3|Overall Study|Death|1
5671196|NCT00437203|19571556|P2|Overall Study|Death|0
5671197|NCT00437203|19571557|P1|Overall Study|Death|0
5671198|NCT00437125|19571661|P1|Overall Study|Physician Decision|1
5671199|NCT00437125|19571661|P1|Overall Study|Withdrawal by Caregiver|2
5671200|NCT00437125|19571661|P1|Overall Study|Withdrawal by Subject|13
5671201|NCT00437125|19571661|P1|Overall Study|Lost to Follow-up|1
5671202|NCT00437125|19571661|P1|Overall Study|Lack of Efficacy|1
5671203|NCT00437125|19571661|P1|Overall Study|Clinical Relapse|1
5671204|NCT00437125|19571661|P1|Overall Study|Death|1
5671205|NCT00437125|19571661|P1|Overall Study|Adverse Event|12
5671206|NCT00437073|19571682|P2|Overall Study|Physician Decision|1
5671207|NCT00437073|19571683|P1|Overall Study|Physician Decision|0
5671208|NCT00437073|19571682|P2|Overall Study|Sponsor Terminated Study|0
5671209|NCT00437073|19571683|P1|Overall Study|Sponsor Terminated Study|1
5671210|NCT00437034|19571711|P1|Overall Study|Disease progression during treatment|5
5671211|NCT00437034|19571711|P1|Overall Study|Adverse Event|1
5671212|NCT00436982|19571717|P2|Overall Study|no RSA data|2
5671213|NCT00436982|19571718|P1|Overall Study|no RSA data|1
5671214|NCT00436982|19571717|P2|Overall Study|Did not receive allocated intervention|1
5671215|NCT00436982|19571718|P1|Overall Study|Did not receive allocated intervention|0
5671216|NCT00436982|19571717|P2|Overall Study|Withdrawal by Subject|1
5671217|NCT00436982|19571718|P1|Overall Study|Withdrawal by Subject|3
5671218|NCT00436956|19571789|P2|Overall Study|Not evaluable|0
5671219|NCT00436956|19571790|P1|Overall Study|Not evaluable|1
5671220|NCT00436917|19571804|P1|Overall Study|Personal conflicts of patient|1
5671221|NCT00436917|19571804|P1|Overall Study|Increased creatinine|1
5671222|NCT00436917|19571804|P1|Overall Study|Treatment for polymyalgia rheumatic|1
5671223|NCT00436917|19571804|P1|Overall Study|Lost to Follow-up|1
5671224|NCT00436917|19571804|P1|Overall Study|Death|1
5671225|NCT00436917|19571804|P1|Overall Study|Physician Decision|1
5671226|NCT00436917|19571804|P1|Overall Study|Adverse Event|2
5671227|NCT00436917|19571804|P1|Overall Study|Withdrawal by Subject|13
5671228|NCT00436852|19571830|P2|Overall Study|Ineligible|0
5671229|NCT00436852|19571831|P1|Overall Study|Ineligible|1
5671230|NCT00436852|19571830|P2|Overall Study|Withdrawal by Subject|4
5671231|NCT00436852|19571831|P1|Overall Study|Withdrawal by Subject|2
5671232|NCT00436852|19571830|P2|Overall Study|Lack of Efficacy|7
5671233|NCT00436852|19571831|P1|Overall Study|Lack of Efficacy|9
5671234|NCT00436852|19571830|P2|Overall Study|Death|34
5671235|NCT00436852|19571831|P1|Overall Study|Death|23
5671236|NCT00436826|19571850|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
5671237|NCT00436826|19571851|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
5671238|NCT00436826|19571852|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
5671323|NCT00436553|19572031|P1|Overall Study|Death|3
5671239|NCT00436826|19571853|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
5671240|NCT00436826|19571854|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
5671241|NCT00436826|19571855|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
5671242|NCT00436826|19571850|P6|Ext. Period (With Cladribine Treatment)|Other un-specified|0
5671243|NCT00436826|19571851|P5|Ext. Period (With Cladribine Treatment)|Other un-specified|0
5671244|NCT00436826|19571852|P4|Ext. Period (With Cladribine Treatment)|Other un-specified|25
5671245|NCT00436826|19571853|P3|Ext. Period (With Cladribine Treatment)|Other un-specified|46
5671246|NCT00436826|19571854|P2|Ext. Period (With Cladribine Treatment)|Other un-specified|0
5671247|NCT00436826|19571855|P1|Ext. Period (With Cladribine Treatment)|Other un-specified|0
5671248|NCT00436826|19571850|P6|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5671249|NCT00436826|19571851|P5|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5671250|NCT00436826|19571852|P4|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
5671251|NCT00436826|19571853|P3|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5671252|NCT00436826|19571854|P2|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5671253|NCT00436826|19571855|P1|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
5671254|NCT00436826|19571850|P6|Double Blind Period (DBP)|Other|0
5671255|NCT00436826|19571851|P5|Double Blind Period (DBP)|Other|0
5671256|NCT00436826|19571852|P4|Double Blind Period (DBP)|Other|0
5671257|NCT00436826|19571853|P3|Double Blind Period (DBP)|Other|0
5671258|NCT00436826|19571854|P2|Double Blind Period (DBP)|Other|11
5671259|NCT00436826|19571855|P1|Double Blind Period (DBP)|Other|10
5671260|NCT00436826|19571850|P6|Double Blind Period (DBP)|Protocol Violation|0
5671261|NCT00436826|19571851|P5|Double Blind Period (DBP)|Protocol Violation|0
5671262|NCT00436826|19571852|P4|Double Blind Period (DBP)|Protocol Violation|0
5671263|NCT00436826|19571853|P3|Double Blind Period (DBP)|Protocol Violation|0
5671264|NCT00436826|19571854|P2|Double Blind Period (DBP)|Protocol Violation|0
5671265|NCT00436826|19571855|P1|Double Blind Period (DBP)|Protocol Violation|1
5671266|NCT00436826|19571850|P6|Double Blind Period (DBP)|Adverse Event|0
5671267|NCT00436826|19571851|P5|Double Blind Period (DBP)|Adverse Event|0
5671268|NCT00436826|19571852|P4|Double Blind Period (DBP)|Adverse Event|0
5671269|NCT00436826|19571853|P3|Double Blind Period (DBP)|Adverse Event|0
5671270|NCT00436826|19571854|P2|Double Blind Period (DBP)|Adverse Event|0
5671271|NCT00436826|19571855|P1|Double Blind Period (DBP)|Adverse Event|2
5671272|NCT00436748|19571953|P2|Overall Study|Other|0
5671273|NCT00436748|19571954|P1|Overall Study|Other|3
5671274|NCT00436748|19571953|P2|Overall Study|Protocol-specified Criteria|4
5671275|NCT00436748|19571954|P1|Overall Study|Protocol-specified Criteria|5
5671276|NCT00436748|19571953|P2|Overall Study|Lost to Follow-up|1
5671277|NCT00436748|19571954|P1|Overall Study|Lost to Follow-up|0
5671278|NCT00436748|19571953|P2|Overall Study|Administrative Decision|0
5671279|NCT00436748|19571954|P1|Overall Study|Administrative Decision|1
5671280|NCT00436748|19571953|P2|Overall Study|Consent Withdrawn|4
5671281|NCT00436748|19571954|P1|Overall Study|Consent Withdrawn|1
5671282|NCT00436748|19571953|P2|Overall Study|Adverse Event|2
5671283|NCT00436748|19571954|P1|Overall Study|Adverse Event|0
5671284|NCT00436748|19571953|P2|Overall Study|Ineligibility Determined|1
5671285|NCT00436748|19571954|P1|Overall Study|Ineligibility Determined|1
5671286|NCT00436644|19571988|P1|Overall Study|Death|1
5671287|NCT00436644|19571988|P1|Overall Study|Adverse Event|2
5671288|NCT00436618|19571998|P3|Overall Study|Still on treatment|7
5671289|NCT00436618|19571999|P2|Overall Study|Still on treatment|2
5671290|NCT00436618|19572000|P1|Overall Study|Still on treatment|1
5671291|NCT00436618|19571998|P3|Overall Study|New Primary or Other Reasons|12
5671292|NCT00436618|19571999|P2|Overall Study|New Primary or Other Reasons|2
5671293|NCT00436618|19572000|P1|Overall Study|New Primary or Other Reasons|6
5671294|NCT00436618|19571998|P3|Overall Study|Death|3
5671295|NCT00436618|19571999|P2|Overall Study|Death|2
5671296|NCT00436618|19572000|P1|Overall Study|Death|4
5671297|NCT00436618|19571998|P3|Overall Study|Other Medical Problems|7
5671298|NCT00436618|19571999|P2|Overall Study|Other Medical Problems|1
5671299|NCT00436618|19572000|P1|Overall Study|Other Medical Problems|3
5671300|NCT00436618|19571998|P3|Overall Study|Alternate Treatment|12
5671301|NCT00436618|19571999|P2|Overall Study|Alternate Treatment|4
5671302|NCT00436618|19572000|P1|Overall Study|Alternate Treatment|3
5671303|NCT00436618|19571998|P3|Overall Study|Adverse Event|9
5671304|NCT00436618|19571999|P2|Overall Study|Adverse Event|8
5671305|NCT00436618|19572000|P1|Overall Study|Adverse Event|8
5671306|NCT00436618|19571998|P3|Overall Study|Withdrawal by Subject|11
5671307|NCT00436618|19571999|P2|Overall Study|Withdrawal by Subject|8
5671308|NCT00436618|19572000|P1|Overall Study|Withdrawal by Subject|5
5671309|NCT00436605|19572017|P1|Overall Study|Protocol Violation|3
5671310|NCT00436566|19572022|P1|Overall Study|Protocol Violation|1
5671311|NCT00436566|19572022|P1|Overall Study|Withdrawal by Subject|2
5671312|NCT00436553|19572029|P3|Overall Study|Withdrawal by Subject|3
5671313|NCT00436553|19572030|P2|Overall Study|Withdrawal by Subject|6
5671314|NCT00436553|19572031|P1|Overall Study|Withdrawal by Subject|5
5671315|NCT00436553|19572029|P3|Overall Study|Protocol Violation|0
5671316|NCT00436553|19572030|P2|Overall Study|Protocol Violation|0
5671317|NCT00436553|19572031|P1|Overall Study|Protocol Violation|1
5671318|NCT00436553|19572029|P3|Overall Study|Lost to Follow-up|0
5671319|NCT00436553|19572030|P2|Overall Study|Lost to Follow-up|2
5671320|NCT00436553|19572031|P1|Overall Study|Lost to Follow-up|0
5671321|NCT00436553|19572029|P3|Overall Study|Death|3
5671322|NCT00436553|19572030|P2|Overall Study|Death|1
5671324|NCT00436553|19572029|P3|Overall Study|Adverse Event|4
5671325|NCT00436553|19572030|P2|Overall Study|Adverse Event|3
5671326|NCT00436553|19572031|P1|Overall Study|Adverse Event|4
5671327|NCT00436501|19572052|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
5671328|NCT00436501|19572053|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
5671329|NCT00436501|19572052|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
5671330|NCT00436501|19572053|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
5671331|NCT00436436|19572089|P1|Overall Study|Death|6
5671332|NCT00436436|19572089|P1|Overall Study|Adverse Event|2
5671333|NCT00436436|19572089|P1|Overall Study|Progression|4
5671334|NCT00436345|19572100|P2|Overall Study|ICU resident beyond follow-up period|0
5671335|NCT00436345|19572101|P1|Overall Study|ICU resident beyond follow-up period|3
5671336|NCT00436332|19572154|P1|Overall Study|Never Received Treatment|3
5671337|NCT00436332|19572154|P1|Overall Study|Ineligible|2
5671338|NCT00436332|19572154|P1|Overall Study|Not Protocol Specified|6
5671339|NCT00436332|19572154|P1|Overall Study|Death|2
5671340|NCT00436332|19572154|P1|Overall Study|Progression|59
5671341|NCT00436332|19572154|P1|Overall Study|Withdrawal by Subject|2
5671342|NCT00436332|19572154|P1|Overall Study|Adverse Event|9
5671343|NCT00436280|19572161|P1|Period 3: Maintenance|Progressive Disease|12
5671344|NCT00436280|19572161|P1|Period 3: Maintenance|Adverse Event|6
5671345|NCT00436280|19572161|P1|Period 2: Consolidation|Death|1
5671346|NCT00436280|19572161|P1|Period 2: Consolidation|Withdrawal by Subject|2
5671347|NCT00436280|19572161|P1|Period 2: Consolidation|Physician Decision|2
5671348|NCT00436280|19572161|P1|Period 2: Consolidation|Stable Disease|1
5671349|NCT00436280|19572161|P1|Period 2: Consolidation|Progressive Disease|10
5671350|NCT00436280|19572161|P1|Period 2: Consolidation|Adverse Event|1
5671351|NCT00436280|19572161|P1|Period 1: Induction|Death|1
5671352|NCT00436280|19572161|P1|Period 1: Induction|Withdrawal by Subject|1
5671353|NCT00436280|19572161|P1|Period 1: Induction|Stable Disease|6
5671354|NCT00436280|19572161|P1|Period 1: Induction|Progressive Disease|12
5671355|NCT00436280|19572161|P1|Period 1: Induction|Adverse Event|8
5671356|NCT00436215|19572175|P1|Overall Study|Small bowel obstruction|1
5671357|NCT00436215|19572175|P1|Overall Study|Refused further treatment|3
5671358|NCT00436163|19572181|P1|Overall Study|Adverse Event|1
5671359|NCT00436163|19572181|P1|Overall Study|Lost to Follow-up|2
5671360|NCT00436007|19572229|P3|Overall Study|Other|1
5671361|NCT00436007|19572230|P2|Overall Study|Other|0
5671362|NCT00436007|19572231|P1|Overall Study|Other|0
5671363|NCT00436007|19572229|P3|Overall Study|Death|3
5671364|NCT00436007|19572230|P2|Overall Study|Death|1
5671365|NCT00436007|19572231|P1|Overall Study|Death|0
5671366|NCT00436007|19572229|P3|Overall Study|Physician Decision|2
5671367|NCT00436007|19572230|P2|Overall Study|Physician Decision|0
5671368|NCT00436007|19572231|P1|Overall Study|Physician Decision|0
5671369|NCT00436007|19572229|P3|Overall Study|Lost to Follow-up|13
5671370|NCT00436007|19572230|P2|Overall Study|Lost to Follow-up|10
5671371|NCT00436007|19572231|P1|Overall Study|Lost to Follow-up|14
5671372|NCT00436007|19572229|P3|Overall Study|Withdrawal by Subject|4
5671373|NCT00436007|19572230|P2|Overall Study|Withdrawal by Subject|3
5671374|NCT00436007|19572231|P1|Overall Study|Withdrawal by Subject|5
5671375|NCT00435994|19572279|P3|Overall Study|Lost to Follow-up|0
5671376|NCT00435994|19572280|P2|Overall Study|Lost to Follow-up|0
5671377|NCT00435994|19572281|P1|Overall Study|Lost to Follow-up|7
5671378|NCT00435942|19572292|P2|Overall Study|Other|1
5671379|NCT00435942|19572293|P1|Overall Study|Other|0
5671380|NCT00435942|19572292|P2|Overall Study|Technical Failure|0
5671381|NCT00435942|19572293|P1|Overall Study|Technical Failure|3
5671382|NCT00435942|19572292|P2|Overall Study|Conversion to Open Repair|0
5671383|NCT00435942|19572293|P1|Overall Study|Conversion to Open Repair|1
5671384|NCT00435942|19572292|P2|Overall Study|Lost to Follow-up|16
5671385|NCT00435942|19572293|P1|Overall Study|Lost to Follow-up|0
5671386|NCT00435942|19572292|P2|Overall Study|Withdrawal by Subject|0
5671387|NCT00435942|19572293|P1|Overall Study|Withdrawal by Subject|2
5671388|NCT00435942|19572292|P2|Overall Study|Death|10
5671389|NCT00435942|19572293|P1|Overall Study|Death|17
5671390|NCT00435825|19572333|P4|Overall Study|Did not complete full follow-up period|5
5671391|NCT00435825|19572334|P3|Overall Study|Did not complete full follow-up period|4
5671392|NCT00435825|19572335|P2|Overall Study|Did not complete full follow-up period|6
5671393|NCT00435825|19572336|P1|Overall Study|Did not complete full follow-up period|6
5671394|NCT00435825|19572333|P4|Overall Study|Did not enter follow-up|3
5671395|NCT00435825|19572334|P3|Overall Study|Did not enter follow-up|1
5671396|NCT00435825|19572335|P2|Overall Study|Did not enter follow-up|4
5671397|NCT00435825|19572336|P1|Overall Study|Did not enter follow-up|0
5671398|NCT00435825|19572333|P4|Overall Study|Did not receive study drug|0
5671399|NCT00435825|19572334|P3|Overall Study|Did not receive study drug|2
5671400|NCT00435825|19572335|P2|Overall Study|Did not receive study drug|0
5671401|NCT00435825|19572336|P1|Overall Study|Did not receive study drug|1
5671402|NCT00435825|19572333|P4|Overall Study|Failure to return|0
5671403|NCT00435825|19572334|P3|Overall Study|Failure to return|4
5671404|NCT00435825|19572335|P2|Overall Study|Failure to return|0
5671405|NCT00435825|19572336|P1|Overall Study|Failure to return|5
5671406|NCT00435825|19572333|P4|Overall Study|Refused treatment|5
5671407|NCT00435825|19572334|P3|Overall Study|Refused treatment|0
5671408|NCT00435825|19572335|P2|Overall Study|Refused treatment|0
5671409|NCT00435825|19572336|P1|Overall Study|Refused treatment|2
5671410|NCT00435825|19572333|P4|Overall Study|Other Protocol Violation|0
5671411|NCT00435825|19572334|P3|Overall Study|Other Protocol Violation|0
5671412|NCT00435825|19572335|P2|Overall Study|Other Protocol Violation|0
5671413|NCT00435825|19572336|P1|Overall Study|Other Protocol Violation|1
5671414|NCT00435825|19572333|P4|Overall Study|Insufficient Therapeutic Response|3
5671415|NCT00435825|19572334|P3|Overall Study|Insufficient Therapeutic Response|0
5671416|NCT00435825|19572335|P2|Overall Study|Insufficient Therapeutic Response|1
5671417|NCT00435825|19572336|P1|Overall Study|Insufficient Therapeutic Response|3
5671418|NCT00435825|19572333|P4|Overall Study|Abnormality of Laboratory Test|0
5671419|NCT00435825|19572334|P3|Overall Study|Abnormality of Laboratory Test|0
5671420|NCT00435825|19572335|P2|Overall Study|Abnormality of Laboratory Test|1
5671421|NCT00435825|19572336|P1|Overall Study|Abnormality of Laboratory Test|0
5671422|NCT00435487|19572459|P2|Overall Study|Received Drug in Other Treatment Group|1
5671423|NCT00435487|19572460|P1|Overall Study|Received Drug in Other Treatment Group|0
5671424|NCT00435487|19572459|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
5671425|NCT00435487|19572460|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
5671426|NCT00435487|19572459|P2|Overall Study|Withdrawal by Subject|1
5671427|NCT00435487|19572460|P1|Overall Study|Withdrawal by Subject|2
5671428|NCT00435487|19572459|P2|Overall Study|Other|2
5671429|NCT00435487|19572460|P1|Overall Study|Other|5
5671430|NCT00435487|19572459|P2|Overall Study|Lost to Follow-up|2
5671431|NCT00435487|19572460|P1|Overall Study|Lost to Follow-up|2
5671432|NCT00435487|19572459|P2|Overall Study|Adverse Event|3
5671433|NCT00435487|19572460|P1|Overall Study|Adverse Event|0
5671434|NCT00435487|19572459|P2|Overall Study|Death|4
5671435|NCT00435487|19572460|P1|Overall Study|Death|3
5671436|NCT00435461|19572479|P3|Overall Study|Lost to Follow-up|2
5671437|NCT00435461|19572480|P2|Overall Study|Lost to Follow-up|1
5671438|NCT00435461|19572481|P1|Overall Study|Lost to Follow-up|1
5671439|NCT00435461|19572479|P3|Overall Study|Non-Compliance of diary|1
5671440|NCT00435461|19572480|P2|Overall Study|Non-Compliance of diary|0
5671441|NCT00435461|19572481|P1|Overall Study|Non-Compliance of diary|2
5671442|NCT00435461|19572479|P3|Overall Study|Adverse Event|6
5671443|NCT00435461|19572480|P2|Overall Study|Adverse Event|2
5671444|NCT00435461|19572481|P1|Overall Study|Adverse Event|1
5671445|NCT00435461|19572479|P3|Overall Study|Noncompliance with study requirements|1
5671446|NCT00435461|19572480|P2|Overall Study|Noncompliance with study requirements|1
5671447|NCT00435461|19572481|P1|Overall Study|Noncompliance with study requirements|1
5671448|NCT00435461|19572479|P3|Overall Study|Participant ended study one day early|0
5671449|NCT00435461|19572480|P2|Overall Study|Participant ended study one day early|0
5671450|NCT00435461|19572481|P1|Overall Study|Participant ended study one day early|1
5671451|NCT00435461|19572479|P3|Overall Study|Participant moved eDiary,studymedication|0
5671452|NCT00435461|19572480|P2|Overall Study|Participant moved eDiary,studymedication|0
5671453|NCT00435461|19572481|P1|Overall Study|Participant moved eDiary,studymedication|1
5671454|NCT00435461|19572479|P3|Overall Study|Pregnancy|0
5671455|NCT00435461|19572480|P2|Overall Study|Pregnancy|0
5671456|NCT00435461|19572481|P1|Overall Study|Pregnancy|2
5671457|NCT00435461|19572479|P3|Overall Study|Participant could not swallow capsule|1
5671458|NCT00435461|19572480|P2|Overall Study|Participant could not swallow capsule|0
5671459|NCT00435461|19572481|P1|Overall Study|Participant could not swallow capsule|0
5671460|NCT00435461|19572479|P3|Overall Study|Participant could not tolerate symptoms|1
5671461|NCT00435461|19572480|P2|Overall Study|Participant could not tolerate symptoms|0
5671462|NCT00435461|19572481|P1|Overall Study|Participant could not tolerate symptoms|0
5671463|NCT00435461|19572479|P3|Overall Study|Randomized in error|0
5671464|NCT00435461|19572480|P2|Overall Study|Randomized in error|0
5671465|NCT00435461|19572481|P1|Overall Study|Randomized in error|1
5671466|NCT00435461|19572479|P3|Overall Study|Withdrawal by Subject|2
5671467|NCT00435461|19572480|P2|Overall Study|Withdrawal by Subject|0
5671468|NCT00435461|19572481|P1|Overall Study|Withdrawal by Subject|1
5671469|NCT00435461|19572479|P3|Overall Study|Lack of Efficacy|0
5671470|NCT00435461|19572480|P2|Overall Study|Lack of Efficacy|1
5671471|NCT00435461|19572481|P1|Overall Study|Lack of Efficacy|2
5671472|NCT00435461|19572479|P3|Overall Study|In error, two study medications switched|0
5671473|NCT00435461|19572480|P2|Overall Study|In error, two study medications switched|0
5671474|NCT00435461|19572481|P1|Overall Study|In error, two study medications switched|1
5671475|NCT00435461|19572479|P3|Overall Study|Compliance less than 80 percent|0
5671476|NCT00435461|19572480|P2|Overall Study|Compliance less than 80 percent|0
5671477|NCT00435461|19572481|P1|Overall Study|Compliance less than 80 percent|1
5671478|NCT00435461|19572479|P3|Overall Study|Participant randomized(inadequate score)|0
5671479|NCT00435461|19572480|P2|Overall Study|Participant randomized(inadequate score)|0
5671480|NCT00435461|19572481|P1|Overall Study|Participant randomized(inadequate score)|1
5671481|NCT00435461|19572479|P3|Overall Study|Protocol Violation|10
5671482|NCT00435461|19572480|P2|Overall Study|Protocol Violation|9
5671483|NCT00435461|19572481|P1|Overall Study|Protocol Violation|6
5671484|NCT00435461|19572479|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
5671485|NCT00435461|19572480|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
5671486|NCT00435461|19572481|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
5671487|NCT00435409|19572518|P3|Overall Study|Sponsor decision|0
5671488|NCT00435409|19572519|P2|Overall Study|Sponsor decision|3
5671489|NCT00435409|19572520|P1|Overall Study|Sponsor decision|0
5671490|NCT00435409|19572518|P3|Overall Study|Adverse Event|8
5671491|NCT00435409|19572519|P2|Overall Study|Adverse Event|0
5671492|NCT00435409|19572520|P1|Overall Study|Adverse Event|0
5671493|NCT00435409|19572518|P3|Overall Study|Other|1
5671494|NCT00435409|19572519|P2|Overall Study|Other|30
5671495|NCT00435409|19572520|P1|Overall Study|Other|45
5671496|NCT00435409|19572518|P3|Overall Study|Withdrawal by Subject|1
5671497|NCT00435409|19572519|P2|Overall Study|Withdrawal by Subject|7
5671498|NCT00435409|19572520|P1|Overall Study|Withdrawal by Subject|8
5671499|NCT00435409|19572518|P3|Overall Study|Global deterioration of health status|4
5671500|NCT00435409|19572519|P2|Overall Study|Global deterioration of health status|0
5671501|NCT00435409|19572520|P1|Overall Study|Global deterioration of health status|0
5671502|NCT00435409|19572518|P3|Overall Study|Objective progression or relapse|58
5671503|NCT00435409|19572519|P2|Overall Study|Objective progression or relapse|93
5671504|NCT00435409|19572520|P1|Overall Study|Objective progression or relapse|158
5671505|NCT00435409|19572518|P3|Overall Study|Death|6
5671506|NCT00435409|19572519|P2|Overall Study|Death|6
5671507|NCT00435409|19572520|P1|Overall Study|Death|8
5671508|NCT00435409|19572518|P3|Overall Study|Lost to Follow-up|0
5671509|NCT00435409|19572519|P2|Overall Study|Lost to Follow-up|2
5671510|NCT00435409|19572520|P1|Overall Study|Lost to Follow-up|1
5671511|NCT00435409|19572518|P3|Overall Study|Protocol Violation|0
5671512|NCT00435409|19572519|P2|Overall Study|Protocol Violation|2
5671513|NCT00435409|19572520|P1|Overall Study|Protocol Violation|1
5671514|NCT00435370|19572542|P2|Overall Study|Antipsychotic medication changed|2
5671515|NCT00435370|19572543|P1|Overall Study|Antipsychotic medication changed|4
5671516|NCT00435370|19572542|P2|Overall Study|Withdrawal by Subject|10
5671517|NCT00435370|19572543|P1|Overall Study|Withdrawal by Subject|10
5671518|NCT00435370|19572542|P2|Overall Study|Adverse Event|8
5671519|NCT00435370|19572543|P1|Overall Study|Adverse Event|8
5671520|NCT00435188|19572551|P2|Overall Study|Lost to Follow-up|6
5671521|NCT00435188|19572552|P1|Overall Study|Lost to Follow-up|5
5671522|NCT00435188|19572551|P2|Overall Study|Withdrawal by Subject|11
5671523|NCT00435188|19572552|P1|Overall Study|Withdrawal by Subject|16
5671524|NCT00435188|19572551|P2|Overall Study|Death|6
5671525|NCT00435188|19572552|P1|Overall Study|Death|1
5671526|NCT00435162|19572595|P6|Period 2 (2 Weeks)|Adverse Event|0
5671527|NCT00435162|19572596|P5|Period 2 (2 Weeks)|Adverse Event|0
5671528|NCT00435162|19572597|P4|Period 2 (2 Weeks)|Adverse Event|0
5671529|NCT00435162|19572598|P3|Period 2 (2 Weeks)|Adverse Event|0
5671530|NCT00435162|19572599|P2|Period 2 (2 Weeks)|Adverse Event|1
5671531|NCT00435162|19572600|P1|Period 2 (2 Weeks)|Adverse Event|0
5671532|NCT00435045|19572620|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
5671533|NCT00435045|19572621|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
5671534|NCT00435045|19572620|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
5671535|NCT00435045|19572621|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
5671536|NCT00435045|19572620|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
5671537|NCT00435045|19572621|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
5671538|NCT00435045|19572620|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
5671539|NCT00435045|19572621|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
5671540|NCT00435045|19572620|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
5671541|NCT00435045|19572621|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
5671542|NCT00435045|19572620|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
5671543|NCT00435045|19572621|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
5671544|NCT00435045|19572620|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
5671545|NCT00435045|19572621|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
5671546|NCT00435045|19572620|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
5671547|NCT00435045|19572621|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
5671548|NCT00435045|19572620|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
5671549|NCT00435045|19572621|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
5671550|NCT00435045|19572620|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
5671551|NCT00435045|19572621|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
5671552|NCT00435045|19572620|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
5671553|NCT00435045|19572621|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
5671554|NCT00435019|19572677|P2|Overall Study|Personal reasons for withdrawal|7
5671555|NCT00435019|19572678|P1|Overall Study|Personal reasons for withdrawal|8
5671556|NCT00435019|19572677|P2|Overall Study|Protocol Violation|1
5671557|NCT00435019|19572678|P1|Overall Study|Protocol Violation|3
5671558|NCT00435019|19572677|P2|Overall Study|Lack of Efficacy|2
5671559|NCT00435019|19572678|P1|Overall Study|Lack of Efficacy|1
5671560|NCT00435019|19572677|P2|Overall Study|Adverse Event|0
5671561|NCT00435019|19572678|P1|Overall Study|Adverse Event|1
5671562|NCT00434967|19572719|P4|Overall Study|Patient Disposition Challenges|3
5671563|NCT00434967|19572720|P3|Overall Study|Patient Disposition Challenges|0
5671564|NCT00434967|19572721|P2|Overall Study|Patient Disposition Challenges|0
5671565|NCT00434967|19572722|P1|Overall Study|Patient Disposition Challenges|2
5671566|NCT00434967|19572719|P4|Overall Study|Physician Decision|0
5671567|NCT00434967|19572720|P3|Overall Study|Physician Decision|1
5671568|NCT00434967|19572721|P2|Overall Study|Physician Decision|1
5671569|NCT00434967|19572722|P1|Overall Study|Physician Decision|1
5671570|NCT00434967|19572719|P4|Overall Study|Protocol Violation|1
5671571|NCT00434967|19572720|P3|Overall Study|Protocol Violation|0
5671572|NCT00434967|19572721|P2|Overall Study|Protocol Violation|1
5671573|NCT00434967|19572722|P1|Overall Study|Protocol Violation|0
5671574|NCT00434967|19572719|P4|Overall Study|Randomized in error|1
5671575|NCT00434967|19572720|P3|Overall Study|Randomized in error|0
5671576|NCT00434967|19572721|P2|Overall Study|Randomized in error|0
5671577|NCT00434967|19572722|P1|Overall Study|Randomized in error|0
5671578|NCT00434967|19572719|P4|Overall Study|Withdrawal by Subject|6
5671579|NCT00434967|19572720|P3|Overall Study|Withdrawal by Subject|4
5671580|NCT00434967|19572721|P2|Overall Study|Withdrawal by Subject|2
5671581|NCT00434967|19572722|P1|Overall Study|Withdrawal by Subject|2
5671582|NCT00434967|19572719|P4|Overall Study|Lost to Follow-up|0
5671583|NCT00434967|19572720|P3|Overall Study|Lost to Follow-up|1
5671584|NCT00434967|19572721|P2|Overall Study|Lost to Follow-up|0
5671585|NCT00434967|19572722|P1|Overall Study|Lost to Follow-up|0
5671586|NCT00434967|19572719|P4|Overall Study|Adverse Event|3
5671587|NCT00434967|19572720|P3|Overall Study|Adverse Event|3
5671588|NCT00434967|19572721|P2|Overall Study|Adverse Event|4
5671589|NCT00434967|19572722|P1|Overall Study|Adverse Event|2
5671590|NCT00434954|19572742|P2|Overall Study|Subject decision|22
5671591|NCT00434954|19572743|P1|Overall Study|Subject decision|8
5671592|NCT00434954|19572742|P2|Overall Study|Sponsor decision|0
5671593|NCT00434954|19572743|P1|Overall Study|Sponsor decision|1
5671594|NCT00434954|19572742|P2|Overall Study|Protocol Violation|27
5671595|NCT00434954|19572743|P1|Overall Study|Protocol Violation|36
5671596|NCT00434954|19572742|P2|Overall Study|Physician Decision|3
5671597|NCT00434954|19572743|P1|Overall Study|Physician Decision|6
5671598|NCT00434954|19572742|P2|Overall Study|Lost to Follow-up|1
5671599|NCT00434954|19572743|P1|Overall Study|Lost to Follow-up|0
5671600|NCT00434954|19572742|P2|Overall Study|Entry criteria not met|16
5671601|NCT00434954|19572743|P1|Overall Study|Entry criteria not met|14
5671602|NCT00434954|19572742|P2|Overall Study|Adverse Event|2
5671603|NCT00434954|19572743|P1|Overall Study|Adverse Event|17
5671604|NCT00434876|19572773|P2|Overall Study|Lost to Follow-up|1
5671605|NCT00434876|19572774|P1|Overall Study|Lost to Follow-up|1
5671606|NCT00434759|19572788|P2|Overall Study|family affairs|0
5671607|NCT00434759|19572789|P1|Overall Study|family affairs|2
5671608|NCT00434759|19572788|P2|Overall Study|Withdrawal by Subject|1
5671609|NCT00434759|19572789|P1|Overall Study|Withdrawal by Subject|17
5671610|NCT00434759|19572788|P2|Overall Study|Lack of Efficacy|4
5671611|NCT00434759|19572789|P1|Overall Study|Lack of Efficacy|5
5671612|NCT00434642|19572805|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
5671613|NCT00434642|19572806|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
5671614|NCT00434642|19572805|P2|Open-label Treatment Phase|Adverse Event|5
5671615|NCT00434642|19572806|P1|Open-label Treatment Phase|Adverse Event|0
5671616|NCT00434642|19572805|P2|Blinded Treatment Phase|Did not Receive Treatment|1
5671617|NCT00434642|19572806|P1|Blinded Treatment Phase|Did not Receive Treatment|4
5671618|NCT00434642|19572805|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
5671619|NCT00434642|19572806|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
5671620|NCT00434642|19572805|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
5671621|NCT00434642|19572806|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
5671622|NCT00434642|19572805|P2|Blinded Treatment Phase|Physician Decision|27
5671623|NCT00434642|19572806|P1|Blinded Treatment Phase|Physician Decision|19
5671624|NCT00434642|19572805|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
5671625|NCT00434642|19572806|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
5671626|NCT00434642|19572805|P2|Blinded Treatment Phase|Clinical Disease Progression|5
5671627|NCT00434642|19572806|P1|Blinded Treatment Phase|Clinical Disease Progression|4
5671628|NCT00434642|19572805|P2|Blinded Treatment Phase|Adverse Event|58
5671629|NCT00434642|19572806|P1|Blinded Treatment Phase|Adverse Event|12
5671630|NCT00434590|19572824|P2|Overall Study|Administrative problems|5
5671631|NCT00434590|19572825|P1|Overall Study|Administrative problems|5
5671632|NCT00434577|19572836|P5|Months 0-3|Withdrawal by Subject|1
5671633|NCT00434577|19572837|P4|Months 0-3|Withdrawal by Subject|1
5671634|NCT00434577|19572838|P3|Months 0-3|Withdrawal by Subject|1
5671635|NCT00434577|19572839|P2|Months 0-3|Withdrawal by Subject|1
5671636|NCT00434577|19572840|P1|Months 0-3|Withdrawal by Subject|2
5671637|NCT00434577|19572836|P5|Months 0-3|Protocol Violation|0
5671638|NCT00434577|19572837|P4|Months 0-3|Protocol Violation|0
5671639|NCT00434577|19572838|P3|Months 0-3|Protocol Violation|1
5671640|NCT00434577|19572839|P2|Months 0-3|Protocol Violation|0
5671641|NCT00434577|19572840|P1|Months 0-3|Protocol Violation|1
5671642|NCT00434577|19572836|P5|Months 0-3|Lost to Follow-up|2
5671643|NCT00434577|19572837|P4|Months 0-3|Lost to Follow-up|0
5671644|NCT00434577|19572838|P3|Months 0-3|Lost to Follow-up|0
5671645|NCT00434577|19572839|P2|Months 0-3|Lost to Follow-up|0
5671646|NCT00434577|19572840|P1|Months 0-3|Lost to Follow-up|0
5671647|NCT00434577|19572836|P5|Months 0-3|Adverse Event|0
5671648|NCT00434577|19572837|P4|Months 0-3|Adverse Event|0
5671649|NCT00434577|19572838|P3|Months 0-3|Adverse Event|1
5671650|NCT00434577|19572839|P2|Months 0-3|Adverse Event|1
5671651|NCT00434577|19572840|P1|Months 0-3|Adverse Event|0
5671652|NCT00434577|19572836|P5|Months 0-3|Serious Adverse Event|0
5671653|NCT00434577|19572837|P4|Months 0-3|Serious Adverse Event|0
5671654|NCT00434577|19572838|P3|Months 0-3|Serious Adverse Event|1
5671655|NCT00434577|19572839|P2|Months 0-3|Serious Adverse Event|0
5671656|NCT00434577|19572840|P1|Months 0-3|Serious Adverse Event|0
5671657|NCT00434512|19573018|P6|Overall Study|Other|0
5671658|NCT00434512|19573019|P5|Overall Study|Other|0
5671659|NCT00434512|19573020|P4|Overall Study|Other|0
5671660|NCT00434512|19573021|P3|Overall Study|Other|0
5671661|NCT00434512|19573022|P2|Overall Study|Other|1
5671662|NCT00434512|19573023|P1|Overall Study|Other|0
5671663|NCT00434512|19573018|P6|Overall Study|Migrated/moved from study area|1
5671664|NCT00434512|19573019|P5|Overall Study|Migrated/moved from study area|1
5671665|NCT00434512|19573020|P4|Overall Study|Migrated/moved from study area|1
5671666|NCT00434512|19573021|P3|Overall Study|Migrated/moved from study area|0
5671667|NCT00434512|19573022|P2|Overall Study|Migrated/moved from study area|0
5671668|NCT00434512|19573023|P1|Overall Study|Migrated/moved from study area|0
5671669|NCT00434421|19573137|P1|Overall Study|Non-compliance with study treatment|1
5671670|NCT00434421|19573137|P1|Overall Study|Withdrawal by Subject|1
5671671|NCT00434330|19573165|P6|Overall Study|Subject Not Compliant With Study|0
5671672|NCT00434330|19573166|P5|Overall Study|Subject Not Compliant With Study|0
5671673|NCT00434330|19573167|P4|Overall Study|Subject Not Compliant With Study|0
5671674|NCT00434330|19573168|P3|Overall Study|Subject Not Compliant With Study|1
5671675|NCT00434330|19573169|P2|Overall Study|Subject Not Compliant With Study|0
5671676|NCT00434330|19573170|P1|Overall Study|Subject Not Compliant With Study|0
5671677|NCT00434330|19573165|P6|Overall Study|Renal transplant|0
5671678|NCT00434330|19573166|P5|Overall Study|Renal transplant|0
5671679|NCT00434330|19573167|P4|Overall Study|Renal transplant|1
5671680|NCT00434330|19573168|P3|Overall Study|Renal transplant|0
5671681|NCT00434330|19573169|P2|Overall Study|Renal transplant|0
5671682|NCT00434330|19573170|P1|Overall Study|Renal transplant|0
5671683|NCT00434330|19573165|P6|Overall Study|Withdrawal by Subject|0
5671684|NCT00434330|19573166|P5|Overall Study|Withdrawal by Subject|0
5671685|NCT00434330|19573167|P4|Overall Study|Withdrawal by Subject|1
5671686|NCT00434330|19573168|P3|Overall Study|Withdrawal by Subject|1
5671687|NCT00434330|19573169|P2|Overall Study|Withdrawal by Subject|0
5671688|NCT00434330|19573170|P1|Overall Study|Withdrawal by Subject|0
5671689|NCT00434330|19573165|P6|Overall Study|Death|1
5671690|NCT00434330|19573166|P5|Overall Study|Death|1
5671691|NCT00434330|19573167|P4|Overall Study|Death|0
5671692|NCT00434330|19573168|P3|Overall Study|Death|0
5671693|NCT00434330|19573169|P2|Overall Study|Death|0
5671694|NCT00434330|19573170|P1|Overall Study|Death|1
5671695|NCT00434330|19573165|P6|Overall Study|Adverse Event|0
5671696|NCT00434330|19573166|P5|Overall Study|Adverse Event|0
5671697|NCT00434330|19573167|P4|Overall Study|Adverse Event|0
5671698|NCT00434330|19573168|P3|Overall Study|Adverse Event|1
5671699|NCT00434330|19573169|P2|Overall Study|Adverse Event|0
5671700|NCT00434330|19573170|P1|Overall Study|Adverse Event|0
5671701|NCT00434304|19573202|P1|Overall Study|Withdrawal by Subject|4
5671702|NCT00434304|19573202|P1|Overall Study|Lack of Efficacy|2
5671703|NCT00434304|19573202|P1|Overall Study|Adverse Event|14
5671704|NCT00434252|19573251|P2|Overall Study|Withdrawal by Subject|7
5671705|NCT00434252|19573252|P1|Overall Study|Withdrawal by Subject|3
5671706|NCT00434252|19573251|P2|Overall Study|Physician Decision|8
5671707|NCT00434252|19573252|P1|Overall Study|Physician Decision|4
5671708|NCT00434252|19573251|P2|Overall Study|Lost to Follow-up|1
5671709|NCT00434252|19573252|P1|Overall Study|Lost to Follow-up|0
5671710|NCT00434252|19573251|P2|Overall Study|Death|2
5671711|NCT00434252|19573252|P1|Overall Study|Death|1
5671712|NCT00434252|19573251|P2|Overall Study|Adverse Event|13
5671713|NCT00434252|19573252|P1|Overall Study|Adverse Event|6
5671714|NCT00434252|19573251|P2|Overall Study|Lack of Efficacy|100
5671715|NCT00434252|19573252|P1|Overall Study|Lack of Efficacy|50
5671716|NCT00434213|19573286|P1|Overall Study|Non-compliant to study schedule|1
5671717|NCT00434213|19573286|P1|Overall Study|Application site reaction|1
5671718|NCT00434213|19573286|P1|Overall Study|Unable to comply with study visit window|2
5671719|NCT00434213|19573286|P1|Overall Study|Protocol Violation|3
5671720|NCT00434213|19573286|P1|Overall Study|Withdrawal by Subject|7
5671721|NCT00434213|19573286|P1|Overall Study|Lost to Follow-up|14
5671722|NCT00434213|19573286|P1|Overall Study|Lack of Efficacy|9
5671723|NCT00434213|19573286|P1|Overall Study|Adverse Event|12
5671724|NCT00434161|19573294|P3|Overall Study|Logistical error study assessments|3
5671725|NCT00434161|19573295|P2|Overall Study|Logistical error study assessments|0
5671726|NCT00434161|19573296|P1|Overall Study|Logistical error study assessments|1
5671727|NCT00434161|19573294|P3|Overall Study|Withdrawal by Subject|3
5671728|NCT00434161|19573295|P2|Overall Study|Withdrawal by Subject|0
5671729|NCT00434161|19573296|P1|Overall Study|Withdrawal by Subject|2
5671730|NCT00434161|19573294|P3|Overall Study|Non-Compliance|0
5671731|NCT00434161|19573295|P2|Overall Study|Non-Compliance|1
5671732|NCT00434161|19573296|P1|Overall Study|Non-Compliance|1
5671733|NCT00434161|19573294|P3|Overall Study|Death|1
5671734|NCT00434161|19573295|P2|Overall Study|Death|0
5671735|NCT00434161|19573296|P1|Overall Study|Death|1
5671736|NCT00434161|19573294|P3|Overall Study|Lost to Follow-up|0
5671737|NCT00434161|19573295|P2|Overall Study|Lost to Follow-up|1
5671738|NCT00434161|19573296|P1|Overall Study|Lost to Follow-up|0
5671739|NCT00434161|19573294|P3|Overall Study|Adverse Event|4
5671740|NCT00434161|19573295|P2|Overall Study|Adverse Event|1
5671741|NCT00434161|19573296|P1|Overall Study|Adverse Event|5
5671742|NCT00434148|19573340|P2|Overall Study|Abnormal test procedure result|1
5671743|NCT00434148|19573341|P1|Overall Study|Abnormal test procedure result|0
5671744|NCT00434148|19573340|P2|Overall Study|Condition no longer requires study drug|0
5671745|NCT00434148|19573341|P1|Overall Study|Condition no longer requires study drug|1
5671746|NCT00434148|19573340|P2|Overall Study|Lost to Follow-up|1
5671747|NCT00434148|19573341|P1|Overall Study|Lost to Follow-up|0
5671748|NCT00434148|19573340|P2|Overall Study|Administrative problems|10
5671749|NCT00434148|19573341|P1|Overall Study|Administrative problems|6
5671750|NCT00434148|19573340|P2|Overall Study|Protocol Violation|0
5671751|NCT00434148|19573341|P1|Overall Study|Protocol Violation|4
5671752|NCT00434148|19573340|P2|Overall Study|Withdrawal by Subject|15
5671753|NCT00434148|19573341|P1|Overall Study|Withdrawal by Subject|15
5671754|NCT00434148|19573340|P2|Overall Study|Lack of Efficacy|28
5671755|NCT00434148|19573341|P1|Overall Study|Lack of Efficacy|25
5671756|NCT00434148|19573340|P2|Overall Study|Adverse Event|18
5671757|NCT00434148|19573341|P1|Overall Study|Adverse Event|18
5671758|NCT00434122|19573377|P2|Overall Study|Travelling of subject.|0
5671759|NCT00434122|19573378|P1|Overall Study|Travelling of subject.|1
5671760|NCT00434122|19573377|P2|Overall Study|Low follicular response.|2
5671761|NCT00434122|19573378|P1|Overall Study|Low follicular response.|1
5671762|NCT00434122|19573377|P2|Overall Study|Large follicle size|2
5671763|NCT00434122|19573378|P1|Overall Study|Large follicle size|2
5671764|NCT00434122|19573377|P2|Overall Study|Personal reasons|1
5671765|NCT00434122|19573378|P1|Overall Study|Personal reasons|1
5671766|NCT00434122|19573377|P2|Overall Study|loss of subject contact|1
5671767|NCT00434122|19573378|P1|Overall Study|loss of subject contact|1
5671768|NCT00434122|19573377|P2|Overall Study|Non-compliance with protocol|1
5671769|NCT00434122|19573378|P1|Overall Study|Non-compliance with protocol|0
5671770|NCT00434109|19573387|P1|Overall Study|had embolism, did not receive sunitinib|3
5671771|NCT00434109|19573387|P1|Overall Study|Protocol Violation|1
5671772|NCT00434109|19573387|P1|Overall Study|Adverse Event|5
5671773|NCT00434109|19573387|P1|Overall Study|Physician Decision|9
5671774|NCT00434057|19573396|P1|Overall Study|Withdrawal by Subject|1
5671775|NCT00433966|19573434|P4|Stent Intervention/Randomization|Lost to Follow-up|47
5671776|NCT00433966|19573435|P3|Stent Intervention/Randomization|Lost to Follow-up|113
5671777|NCT00433966|19573436|P2|Stent Intervention/Randomization|Lost to Follow-up|0
5671778|NCT00433966|19573437|P1|Stent Intervention/Randomization|Lost to Follow-up|0
5671779|NCT00433966|19573434|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
5671780|NCT00433966|19573435|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
5671781|NCT00433966|19573436|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
5671782|NCT00433966|19573437|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
5671783|NCT00433966|19573434|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
5671784|NCT00433966|19573435|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
5671785|NCT00433966|19573436|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
5671786|NCT00433966|19573437|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
5671787|NCT00433966|19573434|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
5671788|NCT00433966|19573435|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
5671789|NCT00433966|19573436|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
5671790|NCT00433966|19573437|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
5671791|NCT00433966|19573434|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
5671792|NCT00433966|19573435|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
5671793|NCT00433966|19573436|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
5671794|NCT00433966|19573437|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
5671795|NCT00433914|19573459|P2|Overall Study|Lost to Follow-up|1
5671796|NCT00433914|19573460|P1|Overall Study|Lost to Follow-up|0
5671797|NCT00433914|19573459|P2|Overall Study|Withdrawal by Subject|2
5671798|NCT00433914|19573460|P1|Overall Study|Withdrawal by Subject|0
5671799|NCT00433836|19573480|P2|Overall Study|Abnormal laboratory values|1
5671800|NCT00433836|19573481|P1|Overall Study|Abnormal laboratory values|0
5671801|NCT00433836|19573480|P2|Overall Study|Condition no longer requires study drug|1
5671802|NCT00433836|19573481|P1|Overall Study|Condition no longer requires study drug|0
5671803|NCT00433836|19573480|P2|Overall Study|Protocol Violation|2
5671804|NCT00433836|19573481|P1|Overall Study|Protocol Violation|0
5671805|NCT00433836|19573480|P2|Overall Study|Unsatisfactory therapeutic effect|1
5671806|NCT00433836|19573481|P1|Overall Study|Unsatisfactory therapeutic effect|1
5671807|NCT00433836|19573480|P2|Overall Study|Withdrawal by Subject|1
5671808|NCT00433836|19573481|P1|Overall Study|Withdrawal by Subject|2
5671809|NCT00433836|19573480|P2|Overall Study|Lost to Follow-up|0
5671810|NCT00433836|19573481|P1|Overall Study|Lost to Follow-up|3
5671811|NCT00433836|19573480|P2|Overall Study|Adverse Event|0
5671812|NCT00433836|19573481|P1|Overall Study|Adverse Event|7
5671813|NCT00433771|19573493|P1|Overall Study|Failure to deploy stent|1
5671814|NCT00433771|19573493|P1|Overall Study|Death|2
5671815|NCT00433771|19573493|P1|Overall Study|Treated and later found to be ineligible|2
5671816|NCT00433771|19573493|P1|Overall Study|screen fail|14
5671817|NCT00433654|19573516|P2|Overall Study|Withdrawal by Subject|2
5671818|NCT00433654|19573517|P1|Overall Study|Withdrawal by Subject|1
5671819|NCT00433654|19573516|P2|Overall Study|Subject not yet due for visit|0
5671820|NCT00433654|19573517|P1|Overall Study|Subject not yet due for visit|4
5671821|NCT00433654|19573516|P2|Overall Study|Missed visit|3
5671822|NCT00433654|19573517|P1|Overall Study|Missed visit|6
5671823|NCT00433654|19573516|P2|Overall Study|Death|0
5671824|NCT00433654|19573517|P1|Overall Study|Death|4
5671825|NCT00433537|19573563|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
5671826|NCT00433537|19573564|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
5671827|NCT00433537|19573565|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
5671828|NCT00433537|19573563|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
5671829|NCT00433537|19573564|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
5671830|NCT00433537|19573565|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
5671831|NCT00433537|19573563|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
5671832|NCT00433537|19573564|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
5671833|NCT00433537|19573565|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
5671834|NCT00433537|19573563|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
5671835|NCT00433537|19573564|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
5671836|NCT00433537|19573565|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
5671837|NCT00433537|19573563|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
5671838|NCT00433537|19573564|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
5671839|NCT00433537|19573565|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
5671840|NCT00433537|19573563|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
5671841|NCT00433537|19573564|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
5671842|NCT00433537|19573565|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
5671843|NCT00433537|19573563|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
5671844|NCT00433537|19573564|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
5671845|NCT00433537|19573565|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
5671846|NCT00433537|19573563|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
5671847|NCT00433537|19573564|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
5671848|NCT00433537|19573565|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
5671849|NCT00433537|19573563|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
5671850|NCT00433537|19573564|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
5671851|NCT00433537|19573565|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
5671852|NCT00433511|19573577|P3|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
5671853|NCT00433511|19573578|P2|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
5671854|NCT00433511|19573579|P1|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
5671855|NCT00433511|19573577|P3|Step 2 (Arm D)|Insurance/drug distribution issues|4
5671856|NCT00433511|19573578|P2|Step 2 (Arm D)|Insurance/drug distribution issues|0
5671857|NCT00433511|19573579|P1|Step 2 (Arm D)|Insurance/drug distribution issues|0
5671858|NCT00433511|19573577|P3|Step 2 (Arm D)|Suspected recurrence|1
5671859|NCT00433511|19573578|P2|Step 2 (Arm D)|Suspected recurrence|0
5671860|NCT00433511|19573579|P1|Step 2 (Arm D)|Suspected recurrence|0
5671861|NCT00433511|19573577|P3|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
5671862|NCT00433511|19573578|P2|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
5671863|NCT00433511|19573579|P1|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
5671864|NCT00433511|19573577|P3|Step 2 (Arm D)|Other complicating disease|3
5671865|NCT00433511|19573578|P2|Step 2 (Arm D)|Other complicating disease|0
5671866|NCT00433511|19573579|P1|Step 2 (Arm D)|Other complicating disease|0
5671867|NCT00433511|19573577|P3|Step 2 (Arm D)|Disease progression, relapse|7
5671868|NCT00433511|19573578|P2|Step 2 (Arm D)|Disease progression, relapse|0
5671869|NCT00433511|19573579|P1|Step 2 (Arm D)|Disease progression, relapse|0
5671870|NCT00433511|19573577|P3|Step 2 (Arm D)|Physician Decision|9
5671871|NCT00433511|19573578|P2|Step 2 (Arm D)|Physician Decision|0
5671872|NCT00433511|19573579|P1|Step 2 (Arm D)|Physician Decision|0
5671873|NCT00433511|19573577|P3|Step 2 (Arm D)|Never started protocol therapy|148
5671874|NCT00433511|19573578|P2|Step 2 (Arm D)|Never started protocol therapy|0
5671875|NCT00433511|19573579|P1|Step 2 (Arm D)|Never started protocol therapy|0
5671876|NCT00433511|19573577|P3|Step 2 (Arm D)|Withdrawal by Subject|181
5671877|NCT00433511|19573578|P2|Step 2 (Arm D)|Withdrawal by Subject|0
5671878|NCT00433511|19573579|P1|Step 2 (Arm D)|Withdrawal by Subject|0
5671879|NCT00433511|19573577|P3|Step 2 (Arm D)|Adverse Event|135
5671880|NCT00433511|19573578|P2|Step 2 (Arm D)|Adverse Event|0
5671881|NCT00433511|19573579|P1|Step 2 (Arm D)|Adverse Event|0
5671882|NCT00433511|19573577|P3|Step 1|Patient moved|1
5671883|NCT00433511|19573578|P2|Step 1|Patient moved|0
5671884|NCT00433511|19573579|P1|Step 1|Patient moved|0
5671885|NCT00433511|19573577|P3|Step 1|Insurance/drug distribution issues|2
5671886|NCT00433511|19573578|P2|Step 1|Insurance/drug distribution issues|1
5671887|NCT00433511|19573579|P1|Step 1|Insurance/drug distribution issues|0
5671888|NCT00433511|19573577|P3|Step 1|Suspected recurrence|0
5671889|NCT00433511|19573578|P2|Step 1|Suspected recurrence|1
5671890|NCT00433511|19573579|P1|Step 1|Suspected recurrence|0
5671891|NCT00433511|19573577|P3|Step 1|Non-breast cancer surgery/wound issues|1
5671892|NCT00433511|19573578|P2|Step 1|Non-breast cancer surgery/wound issues|4
5671893|NCT00433511|19573579|P1|Step 1|Non-breast cancer surgery/wound issues|0
5671894|NCT00433511|19573577|P3|Step 1|Other complicating disease|3
5671895|NCT00433511|19573578|P2|Step 1|Other complicating disease|6
5671896|NCT00433511|19573579|P1|Step 1|Other complicating disease|2
5671897|NCT00433511|19573577|P3|Step 1|Disease progression, relapse|3
5671898|NCT00433511|19573578|P2|Step 1|Disease progression, relapse|3
5671899|NCT00433511|19573579|P1|Step 1|Disease progression, relapse|5
5671900|NCT00433511|19573577|P3|Step 1|Alternative therapy|3
5671901|NCT00433511|19573578|P2|Step 1|Alternative therapy|1
5671902|NCT00433511|19573579|P1|Step 1|Alternative therapy|2
5671903|NCT00433511|19573577|P3|Step 1|Never started protocol therapy|66
5671904|NCT00433511|19573578|P2|Step 1|Never started protocol therapy|64
5671905|NCT00433511|19573579|P1|Step 1|Never started protocol therapy|28
5671906|NCT00433511|19573577|P3|Step 1|Physician Decision|3
5671907|NCT00433511|19573578|P2|Step 1|Physician Decision|4
5671908|NCT00433511|19573579|P1|Step 1|Physician Decision|1
5671909|NCT00433511|19573577|P3|Step 1|Death|1
5671910|NCT00433511|19573578|P2|Step 1|Death|1
5671911|NCT00433511|19573579|P1|Step 1|Death|3
5671912|NCT00433511|19573577|P3|Step 1|Withdrawal by Subject|154
5671913|NCT00433511|19573578|P2|Step 1|Withdrawal by Subject|143
5671914|NCT00433511|19573579|P1|Step 1|Withdrawal by Subject|45
5671915|NCT00433511|19573577|P3|Step 1|Adverse Event|153
5671916|NCT00433511|19573578|P2|Step 1|Adverse Event|157
5671917|NCT00433511|19573579|P1|Step 1|Adverse Event|50
5671918|NCT00433446|19573593|P1|Overall Study|Ineligible|9
5671919|NCT00433446|19573593|P1|Overall Study|Other - Not Protocol specified|3
5671920|NCT00433446|19573593|P1|Overall Study|Progression|44
5671921|NCT00433446|19573593|P1|Overall Study|Refusal Unrelated to Adverse Event|1
5671922|NCT00433446|19573593|P1|Overall Study|Adverse Event|4
5671923|NCT00433381|19573603|P2|Overall Study|Ineligible / no protocol treatment|3
5671924|NCT00433381|19573604|P1|Overall Study|Ineligible / no protocol treatment|3
5671925|NCT00433329|19573623|P1|Overall Study|Physician Decision|1
5671926|NCT00433329|19573623|P1|Overall Study|Lost to Follow-up|1
5671927|NCT00433329|19573623|P1|Overall Study|Moved out of state|1
5671928|NCT00433329|19573623|P1|Overall Study|Discontinued sildenafil|2
5671929|NCT00433329|19573623|P1|Overall Study|Withdrew consent|3
5671930|NCT00433329|19573623|P1|Overall Study|Death|4
5671931|NCT00433329|19573623|P1|Overall Study|Adverse Event|9
5671932|NCT00433290|19573629|P2|Overall Study|Lost to Follow-up|0
5671933|NCT00433290|19573630|P1|Overall Study|Lost to Follow-up|1
5671934|NCT00433290|19573629|P2|Overall Study|Entry Criteria Not Met|1
5671935|NCT00433290|19573630|P1|Overall Study|Entry Criteria Not Met|0
5671936|NCT00433290|19573629|P2|Overall Study|Physician Decision|0
5671937|NCT00433290|19573630|P1|Overall Study|Physician Decision|2
5671938|NCT00433290|19573629|P2|Overall Study|Protocol Violation|2
5671939|NCT00433290|19573630|P1|Overall Study|Protocol Violation|3
5671940|NCT00433290|19573629|P2|Overall Study|Withdrawal by Subject|2
5671941|NCT00433290|19573630|P1|Overall Study|Withdrawal by Subject|4
5671942|NCT00433290|19573629|P2|Overall Study|Lack of Efficacy|5
5671943|NCT00433290|19573630|P1|Overall Study|Lack of Efficacy|1
5671944|NCT00433290|19573629|P2|Overall Study|Adverse Event|7
5671945|NCT00433290|19573630|P1|Overall Study|Adverse Event|24
5671946|NCT00433199|19573699|P2|Open-Label Period|Administrative|1
5671947|NCT00433199|19573700|P1|Open-Label Period|Administrative|0
5671948|NCT00433199|19573699|P2|Open-Label Period|Protocol Violation|2
5671949|NCT00433199|19573700|P1|Open-Label Period|Protocol Violation|0
5671950|NCT00433199|19573699|P2|Open-Label Period|Withdrawal by Subject|7
5671951|NCT00433199|19573700|P1|Open-Label Period|Withdrawal by Subject|0
5671952|NCT00433199|19573699|P2|Open-Label Period|Lost to Follow-up|3
5671953|NCT00433199|19573700|P1|Open-Label Period|Lost to Follow-up|0
5671954|NCT00433199|19573699|P2|Open-Label Period|Lack of Efficacy|2
5671955|NCT00433199|19573700|P1|Open-Label Period|Lack of Efficacy|0
5671956|NCT00433199|19573699|P2|Open-Label Period|Adverse Event|19
5671957|NCT00433199|19573700|P1|Open-Label Period|Adverse Event|0
5671958|NCT00433199|19573699|P2|Double-Blind Period|Administrative|5
5671959|NCT00433199|19573700|P1|Double-Blind Period|Administrative|1
5671960|NCT00433199|19573699|P2|Double-Blind Period|Protocol Violation|10
5671961|NCT00433199|19573700|P1|Double-Blind Period|Protocol Violation|1
5671962|NCT00433199|19573699|P2|Double-Blind Period|Withdrawal by Subject|19
5671963|NCT00433199|19573700|P1|Double-Blind Period|Withdrawal by Subject|8
5671964|NCT00433199|19573699|P2|Double-Blind Period|Lost to Follow-up|5
5671965|NCT00433199|19573700|P1|Double-Blind Period|Lost to Follow-up|2
5671966|NCT00433199|19573699|P2|Double-Blind Period|Lack of Efficacy|2
5671967|NCT00433199|19573700|P1|Double-Blind Period|Lack of Efficacy|0
5671968|NCT00433199|19573699|P2|Double-Blind Period|Adverse Event|25
5671969|NCT00433199|19573700|P1|Double-Blind Period|Adverse Event|0
5671970|NCT00433160|19573720|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
5671971|NCT00433160|19573721|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
5671972|NCT00433160|19573720|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
5671973|NCT00433160|19573721|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
5671974|NCT00433160|19573720|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
5671975|NCT00433160|19573721|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
5671976|NCT00433160|19573720|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
5671977|NCT00433160|19573721|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
5671978|NCT00433160|19573720|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
5671979|NCT00433160|19573721|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
5671980|NCT00433160|19573720|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
5671981|NCT00433160|19573721|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
5671982|NCT00433160|19573720|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
5671983|NCT00433160|19573721|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
5671984|NCT00433160|19573720|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
5671985|NCT00433160|19573721|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
5671986|NCT00433160|19573720|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
5671987|NCT00433160|19573721|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
5671988|NCT00433160|19573720|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
5671989|NCT00433160|19573721|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
5671990|NCT00433160|19573720|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
5671991|NCT00433160|19573721|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
5671992|NCT00433160|19573720|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
5671993|NCT00433160|19573721|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
5671994|NCT00433160|19573720|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
5671995|NCT00433160|19573721|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
5671996|NCT00433160|19573720|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
5671997|NCT00433160|19573721|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
5671998|NCT00433160|19573720|P2|52-Week Double-Blind (DB) Period|Death|0
5671999|NCT00433160|19573721|P1|52-Week Double-Blind (DB) Period|Death|0
5672000|NCT00433160|19573720|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
5672001|NCT00433160|19573721|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
5672002|NCT00433147|19573773|P4|Overall Study|Adverse Event|0
5672003|NCT00433147|19573774|P3|Overall Study|Adverse Event|0
5672004|NCT00433147|19573775|P2|Overall Study|Adverse Event|1
5672005|NCT00433147|19573776|P1|Overall Study|Adverse Event|0
5672006|NCT00433017|19573792|P2|Overall Study|Subject no longer requires study drug|1
5672007|NCT00433017|19573793|P1|Overall Study|Subject no longer requires study drug|1
5672008|NCT00433017|19573792|P2|Overall Study|Death|2
5672009|NCT00433017|19573793|P1|Overall Study|Death|2
5672010|NCT00433017|19573792|P2|Overall Study|Protocol Violation|0
5672011|NCT00433017|19573793|P1|Overall Study|Protocol Violation|1
5672012|NCT00433017|19573792|P2|Overall Study|Administrative problems|86
5672013|NCT00433017|19573793|P1|Overall Study|Administrative problems|80
5672014|NCT00433017|19573792|P2|Overall Study|Lost to Follow-up|4
5672015|NCT00433017|19573793|P1|Overall Study|Lost to Follow-up|3
5672016|NCT00433017|19573792|P2|Overall Study|Withdrawal by Subject|5
5672017|NCT00433017|19573793|P1|Overall Study|Withdrawal by Subject|4
5672018|NCT00433017|19573792|P2|Overall Study|Adverse Event|3
5672019|NCT00433017|19573793|P1|Overall Study|Adverse Event|5
5672020|NCT00433004|19573809|P2|Overall Study|Lost to Follow-up|7
5672021|NCT00433004|19573810|P1|Overall Study|Lost to Follow-up|5
5672022|NCT00432991|19573822|P2|Overall Study|Protocol Violation|12
5672023|NCT00432991|19573823|P1|Overall Study|Protocol Violation|7
5672024|NCT00432965|19573835|P2|Overall Study|Incomplete Data|3
5672025|NCT00432965|19573836|P1|Overall Study|Incomplete Data|4
5672026|NCT00432965|19573835|P2|Overall Study|Exclusionary Methods|2
5672027|NCT00432965|19573836|P1|Overall Study|Exclusionary Methods|1
5672028|NCT00432965|19573835|P2|Overall Study|Death|4
5672029|NCT00432965|19573836|P1|Overall Study|Death|3
5672030|NCT00432965|19573835|P2|Overall Study|Adverse Event|19
5672031|NCT00432965|19573836|P1|Overall Study|Adverse Event|22
5672032|NCT00432965|19573835|P2|Overall Study|Non-compliance|0
5672033|NCT00432965|19573836|P1|Overall Study|Non-compliance|7
5672034|NCT00432965|19573835|P2|Overall Study|Lack of Efficacy|13
5672035|NCT00432965|19573836|P1|Overall Study|Lack of Efficacy|8
5672036|NCT00432965|19573835|P2|Overall Study|Physician Decision|13
5672037|NCT00432965|19573836|P1|Overall Study|Physician Decision|14
5672038|NCT00432965|19573835|P2|Overall Study|Withdrawal by Subject|13
5672039|NCT00432965|19573836|P1|Overall Study|Withdrawal by Subject|13
5672040|NCT00432965|19573835|P2|Overall Study|Lost to Follow-up|19
5672041|NCT00432965|19573836|P1|Overall Study|Lost to Follow-up|22
5672042|NCT00432835|19573844|P2|Overall Study|Adverse event: lead dislodgement.|7
5672043|NCT00432835|19573845|P1|Overall Study|Adverse event: lead dislodgement.|6
5672044|NCT00432809|19573858|P3|1 Year Follow-up|Withdrawal by Subject|1
5672045|NCT00432809|19573859|P2|1 Year Follow-up|Withdrawal by Subject|0
5672046|NCT00432809|19573860|P1|1 Year Follow-up|Withdrawal by Subject|7
5672047|NCT00432809|19573858|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
5672048|NCT00432809|19573859|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
5672049|NCT00432809|19573860|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
5672050|NCT00432744|19573933|P2|Months 7 - 12|Too disabled to score|1
5672051|NCT00432744|19573934|P1|Months 7 - 12|Too disabled to score|0
5672052|NCT00432744|19573933|P2|Months 7 - 12|Withdrawal by Subject|0
5672053|NCT00432744|19573934|P1|Months 7 - 12|Withdrawal by Subject|1
5672054|NCT00432744|19573933|P2|Months 0-6|Too disabled to score|0
5672055|NCT00432744|19573934|P1|Months 0-6|Too disabled to score|1
5672056|NCT00432744|19573933|P2|Months 0-6|Withdrawal by Subject|4
5672057|NCT00432744|19573934|P1|Months 0-6|Withdrawal by Subject|4
5672058|NCT00432679|19573946|P2|Overall Study|Withdrawal by Subject|2
5672059|NCT00432679|19573947|P1|Overall Study|Withdrawal by Subject|3
5672060|NCT00432679|19573946|P2|Overall Study|Adverse Event|1
5672061|NCT00432679|19573947|P1|Overall Study|Adverse Event|2
5672062|NCT00432666|19573971|P2|Open-Label Extension Period|Physician Decision|0
5672063|NCT00432666|19573972|P1|Open-Label Extension Period|Physician Decision|3
5672064|NCT00432666|19573971|P2|Open-Label Extension Period|Consent withdrawn|0
5672065|NCT00432666|19573972|P1|Open-Label Extension Period|Consent withdrawn|10
5672066|NCT00432666|19573971|P2|Open-Label Extension Period|Adverse Event|0
5672067|NCT00432666|19573972|P1|Open-Label Extension Period|Adverse Event|5
5672068|NCT00432666|19573971|P2|Open-Label Extension Period|Lack of Efficacy|0
5672069|NCT00432666|19573972|P1|Open-Label Extension Period|Lack of Efficacy|6
5672070|NCT00432666|19573971|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
5672071|NCT00432666|19573972|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
5672072|NCT00432666|19573971|P2|Main Period|Consent Withdrawn|0
5672073|NCT00432666|19573972|P1|Main Period|Consent Withdrawn|1
5672074|NCT00432666|19573971|P2|Main Period|Adverse Event|1
5672075|NCT00432666|19573972|P1|Main Period|Adverse Event|1
5672076|NCT00432562|19574145|P2|Overall Study|Death|0
5672077|NCT00432562|19574146|P1|Overall Study|Death|3
5672078|NCT00432380|19574198|P3|Overall Study|Adverse Event|0
5672079|NCT00432380|19574199|P2|Overall Study|Adverse Event|0
5672080|NCT00432380|19574200|P1|Overall Study|Adverse Event|1
5672081|NCT00432380|19574198|P3|Overall Study|Migrated/moved from study area|1
5672082|NCT00432380|19574199|P2|Overall Study|Migrated/moved from study area|4
5672083|NCT00432380|19574200|P1|Overall Study|Migrated/moved from study area|3
5672084|NCT00432276|19574253|P2|Overall Study|Other|3
5672085|NCT00432276|19574254|P1|Overall Study|Other|2
5672086|NCT00432276|19574253|P2|Overall Study|Physician Decision|8
5672087|NCT00432276|19574254|P1|Overall Study|Physician Decision|6
5672088|NCT00432276|19574253|P2|Overall Study|Withdrawal by Subject|20
5672089|NCT00432276|19574254|P1|Overall Study|Withdrawal by Subject|25
5672090|NCT00432276|19574253|P2|Overall Study|Lost to Follow-up|2
5672091|NCT00432276|19574254|P1|Overall Study|Lost to Follow-up|6
5672092|NCT00432276|19574253|P2|Overall Study|Protocol Violation|20
5672093|NCT00432276|19574254|P1|Overall Study|Protocol Violation|25
5672094|NCT00432276|19574253|P2|Overall Study|Adverse Event|16
5672095|NCT00432276|19574254|P1|Overall Study|Adverse Event|13
5672096|NCT00432276|19574253|P2|Overall Study|Hyperglycemic Rescue|87
5672097|NCT00432276|19574254|P1|Overall Study|Hyperglycemic Rescue|44
5672098|NCT00432237|19574344|P4|Overall Study|Lack of Qualifying Event|84
5672099|NCT00432237|19574345|P3|Overall Study|Lack of Qualifying Event|69
5672100|NCT00432237|19574346|P2|Overall Study|Lack of Qualifying Event|71
5672101|NCT00432237|19574347|P1|Overall Study|Lack of Qualifying Event|38
5672102|NCT00432237|19574344|P4|Overall Study|Withdrawal by Subject|11
5672103|NCT00432237|19574345|P3|Overall Study|Withdrawal by Subject|9
5672104|NCT00432237|19574346|P2|Overall Study|Withdrawal by Subject|6
5672105|NCT00432237|19574347|P1|Overall Study|Withdrawal by Subject|5
5672106|NCT00432237|19574344|P4|Overall Study|Protocol Violation|8
5672107|NCT00432237|19574345|P3|Overall Study|Protocol Violation|11
5672108|NCT00432237|19574346|P2|Overall Study|Protocol Violation|10
5672109|NCT00432237|19574347|P1|Overall Study|Protocol Violation|13
5672110|NCT00432237|19574344|P4|Overall Study|Pregnancy|0
5672111|NCT00432237|19574345|P3|Overall Study|Pregnancy|0
5672112|NCT00432237|19574346|P2|Overall Study|Pregnancy|1
5672113|NCT00432237|19574347|P1|Overall Study|Pregnancy|0
5672114|NCT00432237|19574344|P4|Overall Study|Physician Decision|1
5672115|NCT00432237|19574345|P3|Overall Study|Physician Decision|2
5672116|NCT00432237|19574346|P2|Overall Study|Physician Decision|3
5672117|NCT00432237|19574347|P1|Overall Study|Physician Decision|1
5672118|NCT00432237|19574344|P4|Overall Study|Lost to Follow-up|18
5672119|NCT00432237|19574345|P3|Overall Study|Lost to Follow-up|18
5672120|NCT00432237|19574346|P2|Overall Study|Lost to Follow-up|10
5672121|NCT00432237|19574347|P1|Overall Study|Lost to Follow-up|10
5672122|NCT00432237|19574344|P4|Overall Study|Lack of Efficacy|1
5672123|NCT00432237|19574345|P3|Overall Study|Lack of Efficacy|0
5672124|NCT00432237|19574346|P2|Overall Study|Lack of Efficacy|0
5672125|NCT00432237|19574347|P1|Overall Study|Lack of Efficacy|0
5672126|NCT00432237|19574344|P4|Overall Study|Adverse Event|1
5672127|NCT00432237|19574345|P3|Overall Study|Adverse Event|0
5672128|NCT00432237|19574346|P2|Overall Study|Adverse Event|0
5672129|NCT00432237|19574347|P1|Overall Study|Adverse Event|0
5672130|NCT00432172|19574389|P4|Overall Study|No treatment received|1
5672131|NCT00432172|19574390|P3|Overall Study|No treatment received|0
5672132|NCT00432172|19574391|P2|Overall Study|No treatment received|2
5672133|NCT00432172|19574392|P1|Overall Study|No treatment received|2
5672134|NCT00432172|19574389|P4|Overall Study|Withdrawal by Subject|2
5672135|NCT00432172|19574390|P3|Overall Study|Withdrawal by Subject|0
5672136|NCT00432172|19574391|P2|Overall Study|Withdrawal by Subject|1
5672137|NCT00432172|19574392|P1|Overall Study|Withdrawal by Subject|0
5672138|NCT00432172|19574389|P4|Overall Study|Disease progression|1
5672139|NCT00432172|19574390|P3|Overall Study|Disease progression|5
5672140|NCT00432172|19574391|P2|Overall Study|Disease progression|2
5672141|NCT00432172|19574392|P1|Overall Study|Disease progression|0
5672142|NCT00432172|19574389|P4|Overall Study|Adverse Event|3
5672143|NCT00432172|19574390|P3|Overall Study|Adverse Event|4
5672144|NCT00432172|19574391|P2|Overall Study|Adverse Event|2
5672145|NCT00432172|19574392|P1|Overall Study|Adverse Event|4
5672146|NCT00432172|19574389|P4|Overall Study|Physician Decision|0
5672147|NCT00432172|19574390|P3|Overall Study|Physician Decision|2
5672148|NCT00432172|19574391|P2|Overall Study|Physician Decision|0
5672149|NCT00432172|19574392|P1|Overall Study|Physician Decision|0
5672150|NCT00432159|19574417|P5|Overall Study|Missing NDI and/or neuro. assessment|7
5672151|NCT00432159|19574418|P4|Overall Study|Missing NDI and/or neuro. assessment|3
5672152|NCT00432159|19574419|P3|Overall Study|Missing NDI and/or neuro. assessment|1
5672153|NCT00432159|19574420|P2|Overall Study|Missing NDI and/or neuro. assessment|24
5672154|NCT00432159|19574421|P1|Overall Study|Missing NDI and/or neuro. assessment|13
5672155|NCT00432159|19574417|P5|Overall Study|Failure|3
5672156|NCT00432159|19574418|P4|Overall Study|Failure|2
5672157|NCT00432159|19574419|P3|Overall Study|Failure|3
5672158|NCT00432159|19574420|P2|Overall Study|Failure|5
5672159|NCT00432159|19574421|P1|Overall Study|Failure|9
5672160|NCT00432159|19574417|P5|Overall Study|Death|0
5672161|NCT00432159|19574418|P4|Overall Study|Death|0
5672162|NCT00432159|19574419|P3|Overall Study|Death|0
5672163|NCT00432159|19574420|P2|Overall Study|Death|1
5672164|NCT00432159|19574421|P1|Overall Study|Death|0
5672165|NCT00432042|19574528|P3|Overall Study|Lost to Follow-up|0
5672166|NCT00432042|19574529|P2|Overall Study|Lost to Follow-up|1
5672167|NCT00432042|19574530|P1|Overall Study|Lost to Follow-up|5
5672168|NCT00432042|19574528|P3|Overall Study|Withdrawal by Subject|2
5672169|NCT00432042|19574529|P2|Overall Study|Withdrawal by Subject|0
5672170|NCT00432042|19574530|P1|Overall Study|Withdrawal by Subject|0
5672171|NCT00432042|19574528|P3|Overall Study|Protocol Violation|0
5672172|NCT00432042|19574529|P2|Overall Study|Protocol Violation|0
5672173|NCT00432042|19574530|P1|Overall Study|Protocol Violation|2
5672174|NCT00431964|19574543|P2|Overall Study|Due to Unstable Health|1
5672175|NCT00431964|19574544|P1|Overall Study|Due to Unstable Health|0
5672176|NCT00431964|19574543|P2|Overall Study|Parental Consent Withdrawn|2
5672177|NCT00431964|19574544|P1|Overall Study|Parental Consent Withdrawn|0
5672178|NCT00431964|19574543|P2|Overall Study|Withdrawal by Subject|1
5672179|NCT00431964|19574544|P1|Overall Study|Withdrawal by Subject|2
5672180|NCT00431964|19574543|P2|Overall Study|Physician Decision|2
5672181|NCT00431964|19574544|P1|Overall Study|Physician Decision|2
5672182|NCT00431964|19574543|P2|Overall Study|Lost to Follow-up|2
5672183|NCT00431964|19574544|P1|Overall Study|Lost to Follow-up|1
5672184|NCT00431964|19574543|P2|Overall Study|Adverse Event|0
5672185|NCT00431964|19574544|P1|Overall Study|Adverse Event|1
5672186|NCT00431951|19574554|P4|Overall Study|Adverse Event|0
5672187|NCT00431951|19574555|P3|Overall Study|Adverse Event|1
5672188|NCT00431951|19574556|P2|Overall Study|Adverse Event|0
5672189|NCT00431951|19574557|P1|Overall Study|Adverse Event|0
5672190|NCT00431951|19574554|P4|Overall Study|Withdrawal by Subject|0
5672191|NCT00431951|19574555|P3|Overall Study|Withdrawal by Subject|0
5672192|NCT00431951|19574556|P2|Overall Study|Withdrawal by Subject|1
5672193|NCT00431951|19574557|P1|Overall Study|Withdrawal by Subject|0
5672194|NCT00431951|19574554|P4|Overall Study|Lost to Follow-up|0
5672195|NCT00431951|19574555|P3|Overall Study|Lost to Follow-up|0
5672196|NCT00431951|19574556|P2|Overall Study|Lost to Follow-up|1
5672197|NCT00431951|19574557|P1|Overall Study|Lost to Follow-up|0
5672198|NCT00431951|19574554|P4|Overall Study|Inability to follow study procedures|2
5672199|NCT00431951|19574555|P3|Overall Study|Inability to follow study procedures|1
5672200|NCT00431951|19574556|P2|Overall Study|Inability to follow study procedures|0
5672201|NCT00431951|19574557|P1|Overall Study|Inability to follow study procedures|1
5672202|NCT00431847|19574619|P5|Overall Study|Protocol Violation|1
5672203|NCT00431847|19574620|P4|Overall Study|Protocol Violation|0
5672204|NCT00431847|19574621|P3|Overall Study|Protocol Violation|0
5672205|NCT00431847|19574622|P2|Overall Study|Protocol Violation|0
5672206|NCT00431847|19574623|P1|Overall Study|Protocol Violation|0
5672207|NCT00431847|19574619|P5|Overall Study|completion of less than two study visits|0
5672208|NCT00431847|19574620|P4|Overall Study|completion of less than two study visits|14
5672209|NCT00431847|19574621|P3|Overall Study|completion of less than two study visits|4
5672210|NCT00431847|19574622|P2|Overall Study|completion of less than two study visits|3
5672211|NCT00431847|19574623|P1|Overall Study|completion of less than two study visits|6
5672212|NCT00431834|19574697|P1|Overall Study|Lost to Follow-up|1
5672213|NCT00431834|19574697|P1|Overall Study|Missed Endpoint Visit|2
5672214|NCT00431834|19574697|P1|Overall Study|Death|3
5672215|NCT00431834|19574697|P1|Overall Study|Withdrawal by Subject|7
5672216|NCT00431496|19574713|P1|Overall Study|Protocol-specified criteria|5
5672217|NCT00431496|19574713|P1|Overall Study|Withdrawal by Subject|2
5672218|NCT00431496|19574713|P1|Overall Study|Lost to Follow-up|1
5672219|NCT00431496|19574713|P1|Overall Study|Adverse Event|3
5672220|NCT00431444|19574724|P2|Overall Study|Administrative Problems|1
5672221|NCT00431444|19574725|P1|Overall Study|Administrative Problems|0
5672222|NCT00431444|19574724|P2|Overall Study|Lost to Follow-up|0
5672223|NCT00431444|19574725|P1|Overall Study|Lost to Follow-up|1
5672224|NCT00431444|19574724|P2|Overall Study|Withdrawal by Subject|1
5672225|NCT00431444|19574725|P1|Overall Study|Withdrawal by Subject|1
5672226|NCT00431444|19574724|P2|Overall Study|Adverse Event|1
5672227|NCT00431444|19574725|P1|Overall Study|Adverse Event|2
5672228|NCT00431444|19574724|P2|Overall Study|Protocol Violation|4
5672229|NCT00431444|19574725|P1|Overall Study|Protocol Violation|1
5672230|NCT00431067|19574765|P1|Overall Study|Non-compliance,lost to follow-up|2
5672231|NCT00431067|19574765|P1|Overall Study|Progressive disease|30
5672232|NCT00431067|19574765|P1|Overall Study|Other Adverse Event|9
5672233|NCT00430989|19574790|P2|Overall Study|Not eligible|6
5672234|NCT00430989|19574791|P1|Overall Study|Not eligible|13
5672235|NCT00430989|19574790|P2|Overall Study|Protocol Violation|37
5672236|NCT00430989|19574791|P1|Overall Study|Protocol Violation|30
5672237|NCT00430989|19574790|P2|Overall Study|Withdrawal by Subject|14
5672238|NCT00430989|19574791|P1|Overall Study|Withdrawal by Subject|15
5672239|NCT00430989|19574790|P2|Overall Study|Lost to Follow-up|3
5672240|NCT00430989|19574791|P1|Overall Study|Lost to Follow-up|2
5672241|NCT00430950|19574811|P2|Overall Study|concomitant medication,etc.|7
5672242|NCT00430950|19574812|P1|Overall Study|concomitant medication,etc.|5
5672243|NCT00430950|19574811|P2|Overall Study|Withdrawal by Subject|0
5672244|NCT00430950|19574812|P1|Overall Study|Withdrawal by Subject|1
5672245|NCT00430950|19574811|P2|Overall Study|Adverse Event|6
5672246|NCT00430950|19574812|P1|Overall Study|Adverse Event|7
5672247|NCT00430937|19574826|P2|Overall Study|Unable to classify|1
5672248|NCT00430937|19574827|P1|Overall Study|Unable to classify|0
5672249|NCT00430937|19574826|P2|Overall Study|Protocol discontinuation criteria met|2
5672250|NCT00430937|19574827|P1|Overall Study|Protocol discontinuation criteria met|1
5672251|NCT00430937|19574826|P2|Overall Study|Administrative reasons|0
5672252|NCT00430937|19574827|P1|Overall Study|Administrative reasons|1
5672253|NCT00430937|19574826|P2|Overall Study|Inappropriate enrollment|1
5672254|NCT00430937|19574827|P1|Overall Study|Inappropriate enrollment|2
5672255|NCT00430937|19574826|P2|Overall Study|Lack of Efficacy|5
5672256|NCT00430937|19574827|P1|Overall Study|Lack of Efficacy|6
5672257|NCT00430937|19574826|P2|Overall Study|Protocol Violation|2
5672258|NCT00430937|19574827|P1|Overall Study|Protocol Violation|3
5672259|NCT00430937|19574826|P2|Overall Study|Withdrawal by Subject|2
5672260|NCT00430937|19574827|P1|Overall Study|Withdrawal by Subject|5
5672261|NCT00430937|19574826|P2|Overall Study|Lost to Follow-up|6
5672262|NCT00430937|19574827|P1|Overall Study|Lost to Follow-up|6
5672263|NCT00430937|19574826|P2|Overall Study|Death|1
5672264|NCT00430937|19574827|P1|Overall Study|Death|0
5672265|NCT00430937|19574826|P2|Overall Study|Adverse Event|8
5672266|NCT00430937|19574827|P1|Overall Study|Adverse Event|3
5672267|NCT00430781|19574838|P3|End-of-Study Analysis; 28 July 2011|Other|0
5672268|NCT00430781|19574839|P2|End-of-Study Analysis; 28 July 2011|Other|1
5672269|NCT00430781|19574840|P1|End-of-Study Analysis; 28 July 2011|Other|4
5672270|NCT00430781|19574838|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
5672271|NCT00430781|19574839|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
5672272|NCT00430781|19574840|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
5672273|NCT00430781|19574838|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
5672274|NCT00430781|19574839|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
5672275|NCT00430781|19574840|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
5672276|NCT00430781|19574838|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
5672277|NCT00430781|19574839|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
5672278|NCT00430781|19574840|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
5672279|NCT00430781|19574838|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
5672280|NCT00430781|19574839|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
5672281|NCT00430781|19574840|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
5672282|NCT00430781|19574838|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
5672283|NCT00430781|19574839|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
5672284|NCT00430781|19574840|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
5672285|NCT00430781|19574838|P3|Final Analysis; 31 July 2008|Ongoing|32
5672286|NCT00430781|19574839|P2|Final Analysis; 31 July 2008|Ongoing|29
5672287|NCT00430781|19574840|P1|Final Analysis; 31 July 2008|Ongoing|0
5672288|NCT00430781|19574838|P3|Final Analysis; 31 July 2008|Other|0
5672289|NCT00430781|19574839|P2|Final Analysis; 31 July 2008|Other|1
5672290|NCT00430781|19574840|P1|Final Analysis; 31 July 2008|Other|0
5672291|NCT00430781|19574838|P3|Final Analysis; 31 July 2008|Physician Decision|6
5672292|NCT00430781|19574839|P2|Final Analysis; 31 July 2008|Physician Decision|6
5672293|NCT00430781|19574840|P1|Final Analysis; 31 July 2008|Physician Decision|0
5672294|NCT00430781|19574838|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
5672295|NCT00430781|19574839|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
5672296|NCT00430781|19574840|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
5672297|NCT00430781|19574838|P3|Final Analysis; 31 July 2008|Protocol Violation|0
5672298|NCT00430781|19574839|P2|Final Analysis; 31 July 2008|Protocol Violation|1
5672299|NCT00430781|19574840|P1|Final Analysis; 31 July 2008|Protocol Violation|0
5672300|NCT00430781|19574838|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
5672301|NCT00430781|19574839|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
5672302|NCT00430781|19574840|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
5672303|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Ongoing|25
5672304|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Ongoing|20
5672305|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Ongoing|23
5672306|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Physician Decision|3
5672307|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Physician Decision|3
5672308|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Physician Decision|2
5672309|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
5672310|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
5672311|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
5672312|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Death|0
5672313|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Death|1
5672314|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Death|0
5672315|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Disease Progression|22
5672316|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Disease Progression|30
5672317|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Disease Progression|16
5672318|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
5672319|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
5672320|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
5672321|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
5672322|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
5672323|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
5672324|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
5672325|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
5672326|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
5672327|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
5672328|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
5672329|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
5672330|NCT00430781|19574838|P3|Interim Analysis; 11 February 2008|Adverse Event|7
5672331|NCT00430781|19574839|P2|Interim Analysis; 11 February 2008|Adverse Event|3
5672332|NCT00430781|19574840|P1|Interim Analysis; 11 February 2008|Adverse Event|10
5672333|NCT00430755|19574882|P1|Overall Study|Withdrawal by Subject|53
5672334|NCT00430716|19574889|P3|Open Label Phase|Study terminated by sponsor|4
5672335|NCT00430716|19574890|P2|Open Label Phase|Study terminated by sponsor|5
5672336|NCT00430716|19574891|P1|Open Label Phase|Study terminated by sponsor|4
5672337|NCT00430716|19574889|P3|Open Label Phase|Protocol Violation|0
5672338|NCT00430716|19574890|P2|Open Label Phase|Protocol Violation|0
5672339|NCT00430716|19574891|P1|Open Label Phase|Protocol Violation|1
5672340|NCT00430716|19574889|P3|Open Label Phase|Other|1
5672341|NCT00430716|19574890|P2|Open Label Phase|Other|1
5672342|NCT00430716|19574891|P1|Open Label Phase|Other|3
5672343|NCT00430716|19574889|P3|Open Label Phase|No longer willing to participate|1
5672344|NCT00430716|19574890|P2|Open Label Phase|No longer willing to participate|1
5672345|NCT00430716|19574891|P1|Open Label Phase|No longer willing to participate|0
5672346|NCT00430716|19574889|P3|Open Label Phase|Lost to Follow-up|1
5672347|NCT00430716|19574890|P2|Open Label Phase|Lost to Follow-up|0
5672348|NCT00430716|19574891|P1|Open Label Phase|Lost to Follow-up|1
5672349|NCT00430716|19574889|P3|Double Blind Phase|Not treated|0
5672350|NCT00430716|19574890|P2|Double Blind Phase|Not treated|0
5672351|NCT00430716|19574891|P1|Double Blind Phase|Not treated|1
5672352|NCT00430716|19574889|P3|Double Blind Phase|Adverse Event|3
5672353|NCT00430716|19574890|P2|Double Blind Phase|Adverse Event|1
5672354|NCT00430716|19574891|P1|Double Blind Phase|Adverse Event|1
5672355|NCT00430716|19574889|P3|Double Blind Phase|Study terminated by sponsor|2
5672356|NCT00430716|19574890|P2|Double Blind Phase|Study terminated by sponsor|1
5672357|NCT00430716|19574891|P1|Double Blind Phase|Study terminated by sponsor|1
5672358|NCT00430716|19574889|P3|Double Blind Phase|Other|0
5672359|NCT00430716|19574890|P2|Double Blind Phase|Other|2
5672360|NCT00430716|19574891|P1|Double Blind Phase|Other|0
5672361|NCT00430716|19574889|P3|Double Blind Phase|No longer willing to participate|1
5672362|NCT00430716|19574890|P2|Double Blind Phase|No longer willing to participate|1
5672363|NCT00430716|19574891|P1|Double Blind Phase|No longer willing to participate|2
5672364|NCT00430716|19574889|P3|Double Blind Phase|Death|0
5672365|NCT00430716|19574890|P2|Double Blind Phase|Death|0
5672366|NCT00430716|19574891|P1|Double Blind Phase|Death|1
5672367|NCT00430677|19574923|P3|Long-term Extension Period|Poor compliance/noncompliance|0
5672368|NCT00430677|19574924|P2|Long-term Extension Period|Poor compliance/noncompliance|0
5672369|NCT00430677|19574925|P1|Long-term Extension Period|Poor compliance/noncompliance|1
5672370|NCT00430677|19574923|P3|Long-term Extension Period|Other|1
5672371|NCT00430677|19574924|P2|Long-term Extension Period|Other|1
5672372|NCT00430677|19574925|P1|Long-term Extension Period|Other|2
5672373|NCT00430677|19574923|P3|Long-term Extension Period|Administrative reason by sponsor|46
5672374|NCT00430677|19574924|P2|Long-term Extension Period|Administrative reason by sponsor|49
5672375|NCT00430677|19574925|P1|Long-term Extension Period|Administrative reason by sponsor|41
5672376|NCT00430677|19574923|P3|Long-term Extension Period|Pregnancy|0
5672377|NCT00430677|19574924|P2|Long-term Extension Period|Pregnancy|1
5672378|NCT00430677|19574925|P1|Long-term Extension Period|Pregnancy|1
5672379|NCT00430677|19574923|P3|Long-term Extension Period|Withdrawal by Subject|2
5672380|NCT00430677|19574924|P2|Long-term Extension Period|Withdrawal by Subject|1
5672381|NCT00430677|19574925|P1|Long-term Extension Period|Withdrawal by Subject|5
5672382|NCT00430677|19574923|P3|Long-term Extension Period|Lost to Follow-up|1
5672383|NCT00430677|19574924|P2|Long-term Extension Period|Lost to Follow-up|1
5672384|NCT00430677|19574925|P1|Long-term Extension Period|Lost to Follow-up|1
5672385|NCT00430677|19574923|P3|Long-term Extension Period|Lack of Efficacy|8
5672386|NCT00430677|19574924|P2|Long-term Extension Period|Lack of Efficacy|3
5672387|NCT00430677|19574925|P1|Long-term Extension Period|Lack of Efficacy|5
5672388|NCT00430677|19574923|P3|Long-term Extension Period|Adverse Event|5
5672389|NCT00430677|19574924|P2|Long-term Extension Period|Adverse Event|2
5672390|NCT00430677|19574925|P1|Long-term Extension Period|Adverse Event|3
5672391|NCT00430677|19574923|P3|Long-term Extension Period|Death|0
5672392|NCT00430677|19574924|P2|Long-term Extension Period|Death|0
5672393|NCT00430677|19574925|P1|Long-term Extension Period|Death|1
5672394|NCT00430677|19574923|P3|Short-term Period|Pregnancy|0
5672395|NCT00430677|19574924|P2|Short-term Period|Pregnancy|2
5672396|NCT00430677|19574925|P1|Short-term Period|Pregnancy|0
5672397|NCT00430677|19574923|P3|Short-term Period|Poor compliance/ noncompliance|0
5672398|NCT00430677|19574924|P2|Short-term Period|Poor compliance/ noncompliance|1
5672399|NCT00430677|19574925|P1|Short-term Period|Poor compliance/ noncompliance|0
5672400|NCT00430677|19574923|P3|Short-term Period|Participant no longer met study criteria|2
5672401|NCT00430677|19574924|P2|Short-term Period|Participant no longer met study criteria|1
5672402|NCT00430677|19574925|P1|Short-term Period|Participant no longer met study criteria|1
5672403|NCT00430677|19574923|P3|Short-term Period|Withdrawal by Subject|2
5672404|NCT00430677|19574924|P2|Short-term Period|Withdrawal by Subject|1
5672405|NCT00430677|19574925|P1|Short-term Period|Withdrawal by Subject|1
5672406|NCT00430677|19574923|P3|Short-term Period|Lack of Efficacy|4
5672407|NCT00430677|19574924|P2|Short-term Period|Lack of Efficacy|6
5672408|NCT00430677|19574925|P1|Short-term Period|Lack of Efficacy|5
5672409|NCT00430677|19574923|P3|Short-term Period|Adverse Event|9
5672410|NCT00430677|19574924|P2|Short-term Period|Adverse Event|13
5672411|NCT00430677|19574925|P1|Short-term Period|Adverse Event|15
5672412|NCT00430677|19574923|P3|Short-term Period|Death|5
5672413|NCT00430677|19574924|P2|Short-term Period|Death|1
5672414|NCT00430677|19574925|P1|Short-term Period|Death|1
5672415|NCT00430638|19575048|P2|Overall Study|Other|2
5672416|NCT00430638|19575049|P1|Overall Study|Other|2
5672417|NCT00430638|19575048|P2|Overall Study|Non-compliant|1
5672418|NCT00430638|19575049|P1|Overall Study|Non-compliant|2
5672419|NCT00430638|19575048|P2|Overall Study|Withdrawal by Subject|6
5672420|NCT00430638|19575049|P1|Overall Study|Withdrawal by Subject|4
5672421|NCT00430638|19575048|P2|Overall Study|Protocol Violation|4
5672422|NCT00430638|19575049|P1|Overall Study|Protocol Violation|6
5672423|NCT00430638|19575048|P2|Overall Study|Lost to Follow-up|7
5672424|NCT00430638|19575049|P1|Overall Study|Lost to Follow-up|1
5672425|NCT00430638|19575048|P2|Overall Study|Uncontrolled blood pressure|13
5672426|NCT00430638|19575049|P1|Overall Study|Uncontrolled blood pressure|48
5672427|NCT00430638|19575048|P2|Overall Study|Adverse Event|15
5672428|NCT00430638|19575049|P1|Overall Study|Adverse Event|15
5672429|NCT00430573|19575084|P1|Overall Study|Withdrawal by Subject|5
5672430|NCT00430521|19575097|P8|Overall Study|Withdrawal by Subject|2
5672431|NCT00430521|19575098|P7|Overall Study|Withdrawal by Subject|0
5672432|NCT00430521|19575099|P6|Overall Study|Withdrawal by Subject|0
5672433|NCT00430521|19575100|P5|Overall Study|Withdrawal by Subject|0
5672434|NCT00430521|19575101|P4|Overall Study|Withdrawal by Subject|3
5672435|NCT00430521|19575102|P3|Overall Study|Withdrawal by Subject|0
5672436|NCT00430521|19575103|P2|Overall Study|Withdrawal by Subject|1
5672437|NCT00430521|19575104|P1|Overall Study|Withdrawal by Subject|3
5672438|NCT00430521|19575097|P8|Overall Study|Protocol Violation|0
5672439|NCT00430521|19575098|P7|Overall Study|Protocol Violation|0
5672440|NCT00430521|19575099|P6|Overall Study|Protocol Violation|0
5672441|NCT00430521|19575100|P5|Overall Study|Protocol Violation|0
5672442|NCT00430521|19575101|P4|Overall Study|Protocol Violation|0
5672443|NCT00430521|19575102|P3|Overall Study|Protocol Violation|0
5672444|NCT00430521|19575103|P2|Overall Study|Protocol Violation|0
5672445|NCT00430521|19575104|P1|Overall Study|Protocol Violation|1
5672446|NCT00430521|19575097|P8|Overall Study|Vaccine Expired|0
5672447|NCT00430521|19575098|P7|Overall Study|Vaccine Expired|0
5672448|NCT00430521|19575099|P6|Overall Study|Vaccine Expired|1
5672449|NCT00430521|19575100|P5|Overall Study|Vaccine Expired|0
5672450|NCT00430521|19575101|P4|Overall Study|Vaccine Expired|0
5672451|NCT00430521|19575102|P3|Overall Study|Vaccine Expired|0
5672452|NCT00430521|19575103|P2|Overall Study|Vaccine Expired|0
5672453|NCT00430521|19575104|P1|Overall Study|Vaccine Expired|0
5672454|NCT00430521|19575097|P8|Overall Study|Pregnancy|0
5672455|NCT00430521|19575098|P7|Overall Study|Pregnancy|1
5672456|NCT00430521|19575099|P6|Overall Study|Pregnancy|0
5672457|NCT00430521|19575100|P5|Overall Study|Pregnancy|0
5672458|NCT00430521|19575101|P4|Overall Study|Pregnancy|0
5672459|NCT00430521|19575102|P3|Overall Study|Pregnancy|0
5672460|NCT00430521|19575103|P2|Overall Study|Pregnancy|0
5672461|NCT00430521|19575104|P1|Overall Study|Pregnancy|0
5672462|NCT00430521|19575097|P8|Overall Study|Lost to Follow-up|10
5672463|NCT00430521|19575098|P7|Overall Study|Lost to Follow-up|8
5672464|NCT00430521|19575099|P6|Overall Study|Lost to Follow-up|2
5672465|NCT00430521|19575100|P5|Overall Study|Lost to Follow-up|5
5672466|NCT00430521|19575101|P4|Overall Study|Lost to Follow-up|5
5672467|NCT00430521|19575102|P3|Overall Study|Lost to Follow-up|3
5672468|NCT00430521|19575103|P2|Overall Study|Lost to Follow-up|8
5672469|NCT00430521|19575104|P1|Overall Study|Lost to Follow-up|7
5672470|NCT00430521|19575097|P8|Overall Study|Adverse Event|0
5672471|NCT00430521|19575098|P7|Overall Study|Adverse Event|1
5672472|NCT00430521|19575099|P6|Overall Study|Adverse Event|2
5672473|NCT00430521|19575100|P5|Overall Study|Adverse Event|0
5672474|NCT00430521|19575101|P4|Overall Study|Adverse Event|0
5672475|NCT00430521|19575102|P3|Overall Study|Adverse Event|0
5672476|NCT00430521|19575103|P2|Overall Study|Adverse Event|0
5672477|NCT00430521|19575104|P1|Overall Study|Adverse Event|0
5672478|NCT00430508|19575346|P4|Overall Study|Other|0
5672479|NCT00430508|19575347|P3|Overall Study|Other|3
5672480|NCT00430508|19575348|P2|Overall Study|Other|1
5672481|NCT00430508|19575349|P1|Overall Study|Other|1
5672482|NCT00430508|19575346|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
5672483|NCT00430508|19575347|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
5672484|NCT00430508|19575348|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
5672485|NCT00430508|19575349|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
5672486|NCT00430508|19575346|P4|Overall Study|responder at visit 4|0
5672487|NCT00430508|19575347|P3|Overall Study|responder at visit 4|2
5672488|NCT00430508|19575348|P2|Overall Study|responder at visit 4|0
5672489|NCT00430508|19575349|P1|Overall Study|responder at visit 4|0
5672490|NCT00430508|19575346|P4|Overall Study|Withdrawal by Subject|1
5672491|NCT00430508|19575347|P3|Overall Study|Withdrawal by Subject|1
5672492|NCT00430508|19575348|P2|Overall Study|Withdrawal by Subject|1
5672493|NCT00430508|19575349|P1|Overall Study|Withdrawal by Subject|0
5672494|NCT00430508|19575346|P4|Overall Study|Adverse Event|3
5672495|NCT00430508|19575347|P3|Overall Study|Adverse Event|5
5672496|NCT00430508|19575348|P2|Overall Study|Adverse Event|3
5672497|NCT00430508|19575349|P1|Overall Study|Adverse Event|2
5672498|NCT00430495|19575387|P4|Overall Study|Randomized but not Treated|0
5672499|NCT00430495|19575388|P3|Overall Study|Randomized but not Treated|0
5672500|NCT00430495|19575389|P2|Overall Study|Randomized but not Treated|0
5672501|NCT00430495|19575390|P1|Overall Study|Randomized but not Treated|2
5672502|NCT00430495|19575387|P4|Overall Study|Other|4
5672503|NCT00430495|19575388|P3|Overall Study|Other|5
5672504|NCT00430495|19575389|P2|Overall Study|Other|2
5672505|NCT00430495|19575390|P1|Overall Study|Other|8
5672506|NCT00430495|19575387|P4|Overall Study|Disease Progression|0
5672507|NCT00430495|19575388|P3|Overall Study|Disease Progression|0
5672508|NCT00430495|19575389|P2|Overall Study|Disease Progression|1
5672509|NCT00430495|19575390|P1|Overall Study|Disease Progression|1
5672510|NCT00430495|19575387|P4|Overall Study|Protocol Violation|0
5672511|NCT00430495|19575388|P3|Overall Study|Protocol Violation|1
5672512|NCT00430495|19575389|P2|Overall Study|Protocol Violation|0
5672513|NCT00430495|19575390|P1|Overall Study|Protocol Violation|1
5672514|NCT00430495|19575387|P4|Overall Study|Lost to Follow-up|0
5672515|NCT00430495|19575388|P3|Overall Study|Lost to Follow-up|4
5672516|NCT00430495|19575389|P2|Overall Study|Lost to Follow-up|1
5672517|NCT00430495|19575390|P1|Overall Study|Lost to Follow-up|0
5672518|NCT00430495|19575387|P4|Overall Study|Death|0
5672519|NCT00430495|19575388|P3|Overall Study|Death|1
5672520|NCT00430495|19575389|P2|Overall Study|Death|0
5672521|NCT00430495|19575390|P1|Overall Study|Death|0
5672522|NCT00430495|19575387|P4|Overall Study|Adverse Event|0
5672523|NCT00430495|19575388|P3|Overall Study|Adverse Event|2
5672524|NCT00430495|19575389|P2|Overall Study|Adverse Event|3
5672525|NCT00430495|19575390|P1|Overall Study|Adverse Event|2
5672526|NCT00430482|19575430|P2|Completed Treatment|Insufficient Treatment|11
5672527|NCT00430482|19575431|P1|Completed Treatment|Insufficient Treatment|7
5672528|NCT00430352|19575439|P1|Overall Study|Other|48
5672529|NCT00430352|19575439|P1|Overall Study|Death|5
5672530|NCT00430352|19575439|P1|Overall Study|Adverse Event|16
5672531|NCT00430352|19575439|P1|Overall Study|Withdrawal by Subject|11
5672532|NCT00430352|19575439|P1|Overall Study|Disease progression|58
5672533|NCT00430300|19575457|P4|Overall Study|Other|1
5672534|NCT00430300|19575458|P3|Overall Study|Other|0
5672535|NCT00430300|19575459|P2|Overall Study|Other|0
5672536|NCT00430300|19575460|P1|Overall Study|Other|0
5672537|NCT00430300|19575457|P4|Overall Study|Laboratory abnormality|0
5672538|NCT00430300|19575458|P3|Overall Study|Laboratory abnormality|0
5672539|NCT00430300|19575459|P2|Overall Study|Laboratory abnormality|0
5672540|NCT00430300|19575460|P1|Overall Study|Laboratory abnormality|1
5672541|NCT00430300|19575457|P4|Overall Study|Withdrawal by Subject|0
5672542|NCT00430300|19575458|P3|Overall Study|Withdrawal by Subject|5
5672543|NCT00430300|19575459|P2|Overall Study|Withdrawal by Subject|0
5672544|NCT00430300|19575460|P1|Overall Study|Withdrawal by Subject|1
5672545|NCT00430300|19575457|P4|Overall Study|Adverse Event|1
5672546|NCT00430300|19575458|P3|Overall Study|Adverse Event|1
5672547|NCT00430300|19575459|P2|Overall Study|Adverse Event|2
5672548|NCT00430300|19575460|P1|Overall Study|Adverse Event|0
5672549|NCT00430248|19575565|P3|Overall Study|Reason Not Specified|11
5672550|NCT00430248|19575566|P2|Overall Study|Reason Not Specified|8
5672551|NCT00430248|19575567|P1|Overall Study|Reason Not Specified|8
5672552|NCT00430248|19575565|P3|Overall Study|Gout Flare|2
5672553|NCT00430248|19575566|P2|Overall Study|Gout Flare|7
5672554|NCT00430248|19575567|P1|Overall Study|Gout Flare|3
5672555|NCT00430248|19575565|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5672556|NCT00430248|19575566|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
5672557|NCT00430248|19575567|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5672558|NCT00430248|19575565|P3|Overall Study|Withdrawal by Subject|16
5672559|NCT00430248|19575566|P2|Overall Study|Withdrawal by Subject|20
5672560|NCT00430248|19575567|P1|Overall Study|Withdrawal by Subject|14
5672561|NCT00430248|19575565|P3|Overall Study|Therapeutic Failure|1
5672562|NCT00430248|19575566|P2|Overall Study|Therapeutic Failure|1
5672563|NCT00430248|19575567|P1|Overall Study|Therapeutic Failure|1
5672564|NCT00430248|19575565|P3|Overall Study|Lost to Follow-up|28
5672565|NCT00430248|19575566|P2|Overall Study|Lost to Follow-up|33
5672566|NCT00430248|19575567|P1|Overall Study|Lost to Follow-up|28
5672567|NCT00430248|19575565|P3|Overall Study|Personal Reasons|9
5672568|NCT00430248|19575566|P2|Overall Study|Personal Reasons|24
5672569|NCT00430248|19575567|P1|Overall Study|Personal Reasons|12
5672570|NCT00430248|19575565|P3|Overall Study|Protocol Violation|4
5672571|NCT00430248|19575566|P2|Overall Study|Protocol Violation|2
5672572|NCT00430248|19575567|P1|Overall Study|Protocol Violation|10
5672573|NCT00430248|19575565|P3|Overall Study|Adverse Event|64
5672574|NCT00430248|19575566|P2|Overall Study|Adverse Event|61
5672575|NCT00430248|19575567|P1|Overall Study|Adverse Event|49
5672576|NCT00430092|19575635|P3|Overall Study|Withdrawal by Subject|1
5672577|NCT00430092|19575636|P2|Overall Study|Withdrawal by Subject|1
5672578|NCT00430092|19575637|P1|Overall Study|Withdrawal by Subject|0
5672579|NCT00430092|19575635|P3|Overall Study|Protocol Violation|1
5672580|NCT00430092|19575636|P2|Overall Study|Protocol Violation|1
5672581|NCT00430092|19575637|P1|Overall Study|Protocol Violation|0
5672582|NCT00430092|19575635|P3|Overall Study|Lost to Follow-up|0
5672583|NCT00430092|19575636|P2|Overall Study|Lost to Follow-up|0
5672584|NCT00430092|19575637|P1|Overall Study|Lost to Follow-up|1
5672585|NCT00430092|19575635|P3|Overall Study|Lack of Efficacy|54
5672586|NCT00430092|19575636|P2|Overall Study|Lack of Efficacy|2
5672587|NCT00430092|19575637|P1|Overall Study|Lack of Efficacy|5
5672588|NCT00430092|19575635|P3|Overall Study|Adverse Event|1
5672589|NCT00430092|19575636|P2|Overall Study|Adverse Event|0
5672590|NCT00430092|19575637|P1|Overall Study|Adverse Event|0
5672591|NCT00430027|19575642|P1|Overall Study|Study terminated|8
5672592|NCT00429923|19575659|P3|Overall Study|Early Termination|0
5672593|NCT00429923|19575660|P2|Overall Study|Early Termination|1
5672594|NCT00429923|19575661|P1|Overall Study|Early Termination|0
5672595|NCT00429923|19575659|P3|Overall Study|Withdrew Consent|1
5672596|NCT00429923|19575660|P2|Overall Study|Withdrew Consent|0
5672597|NCT00429923|19575661|P1|Overall Study|Withdrew Consent|1
5672598|NCT00429923|19575659|P3|Overall Study|Lost to Follow-up|2
5672599|NCT00429923|19575660|P2|Overall Study|Lost to Follow-up|0
5672600|NCT00429923|19575661|P1|Overall Study|Lost to Follow-up|0
5672601|NCT00429923|19575659|P3|Overall Study|Lack of Efficacy|33
5672602|NCT00429923|19575660|P2|Overall Study|Lack of Efficacy|1
5672603|NCT00429923|19575661|P1|Overall Study|Lack of Efficacy|4
5672604|NCT00429923|19575659|P3|Overall Study|Adverse Event|3
5672605|NCT00429923|19575660|P2|Overall Study|Adverse Event|2
5672606|NCT00429923|19575661|P1|Overall Study|Adverse Event|0
5672607|NCT00429858|19575666|P1|Overall Study|Study Termination|1
5672608|NCT00429858|19575666|P1|Overall Study|Withdrawal by Subject|1
5672609|NCT00429793|19575677|P1|Overall Study|Non-measurable|1
5672610|NCT00429793|19575677|P1|Overall Study|Never treated|1
5672611|NCT00429793|19575677|P1|Overall Study|Required test not done|1
5672612|NCT00429793|19575677|P1|Overall Study|Improper pre-protocol treatment|3
5672613|NCT00429663|19575704|P2|Overall Study|Death|0
5672614|NCT00429663|19575705|P1|Overall Study|Death|4
5672615|NCT00429663|19575704|P2|Overall Study|Withdrawal by Subject|5
5672616|NCT00429663|19575705|P1|Overall Study|Withdrawal by Subject|2
5672617|NCT00429663|19575704|P2|Overall Study|Physician Decision|3
5672618|NCT00429663|19575705|P1|Overall Study|Physician Decision|6
5672619|NCT00429663|19575704|P2|Overall Study|Lost to Follow-up|31
5672620|NCT00429663|19575705|P1|Overall Study|Lost to Follow-up|24
5672621|NCT00429572|19575719|P1|Overall Study|Disease progression|1
5672622|NCT00429494|19575731|P1|Overall Study|Death|6
5672623|NCT00429494|19575731|P1|Overall Study|Withdrawal by Subject|9
5672624|NCT00429416|19575735|P1|Overall Study|Death|1
5672625|NCT00429364|19575754|P2|Overall Study|Pregnancy|1
5672626|NCT00429364|19575755|P1|Overall Study|Pregnancy|0
5672627|NCT00429364|19575754|P2|Overall Study|Underwent aortic root surgery|18
5672628|NCT00429364|19575755|P1|Overall Study|Underwent aortic root surgery|10
5672629|NCT00429364|19575754|P2|Overall Study|Death|1
5672630|NCT00429364|19575755|P1|Overall Study|Death|0
5672631|NCT00429364|19575754|P2|Overall Study|Lost to Follow-up|6
5672632|NCT00429364|19575755|P1|Overall Study|Lost to Follow-up|7
5672633|NCT00429364|19575754|P2|Overall Study|Physician Decision|2
5672634|NCT00429364|19575755|P1|Overall Study|Physician Decision|4
5672635|NCT00429364|19575754|P2|Overall Study|Withdrawal by Subject|5
5672636|NCT00429364|19575755|P1|Overall Study|Withdrawal by Subject|11
5672637|NCT00429299|19575814|P3|Overall Study|Withdrawal by Subject|3
5672638|NCT00429299|19575815|P2|Overall Study|Withdrawal by Subject|1
5672639|NCT00429299|19575816|P1|Overall Study|Withdrawal by Subject|0
5672640|NCT00429299|19575814|P3|Overall Study|Protocol Violation|0
5672641|NCT00429299|19575815|P2|Overall Study|Protocol Violation|0
5672642|NCT00429299|19575816|P1|Overall Study|Protocol Violation|1
5672643|NCT00429299|19575814|P3|Overall Study|Adverse Event|1
5672644|NCT00429299|19575815|P2|Overall Study|Adverse Event|5
5672645|NCT00429299|19575816|P1|Overall Study|Adverse Event|2
5672646|NCT00429299|19575814|P3|Overall Study|Disease Progression|0
5672647|NCT00429299|19575815|P2|Overall Study|Disease Progression|1
5672648|NCT00429299|19575816|P1|Overall Study|Disease Progression|1
5672649|NCT00429273|19575848|P3|Overall Study|Adverse Event|2
5672650|NCT00429273|19575849|P2|Overall Study|Adverse Event|1
5672651|NCT00429273|19575850|P1|Overall Study|Adverse Event|1
5672652|NCT00429273|19575848|P3|Overall Study|Physician Decision|5
5672653|NCT00429273|19575849|P2|Overall Study|Physician Decision|5
5672654|NCT00429273|19575850|P1|Overall Study|Physician Decision|6
5672655|NCT00429273|19575848|P3|Overall Study|Lost to Follow-up|2
5672656|NCT00429273|19575849|P2|Overall Study|Lost to Follow-up|2
5672657|NCT00429273|19575850|P1|Overall Study|Lost to Follow-up|1
5672658|NCT00429182|19575858|P1|Overall Study|Not eligible|5
5672659|NCT00429182|19575858|P1|Overall Study|Not evaluable, Disease Progression|2
5672660|NCT00429169|19575865|P2|Overall Study|Ineligibility discovered after entry|1
5672661|NCT00429169|19575866|P1|Overall Study|Ineligibility discovered after entry|2
5672662|NCT00429169|19575865|P2|Overall Study|Lost to Follow-up|1
5672663|NCT00429169|19575866|P1|Overall Study|Lost to Follow-up|0
5672664|NCT00429104|19575886|P1|Overall Study|Protocol Violation|1
5672665|NCT00429026|19575891|P1|Overall Study|Inevaluable for response.|40
5672666|NCT00428948|19575918|P2|Overall Study|Protocol Deviation|1
5672667|NCT00428948|19575919|P1|Overall Study|Protocol Deviation|1
5672668|NCT00428948|19575918|P2|Overall Study|Subject Withdrew Consent|30
5672669|NCT00428948|19575919|P1|Overall Study|Subject Withdrew Consent|50
5672670|NCT00428948|19575918|P2|Overall Study|Investigator Withdrew Subject|4
5672671|NCT00428948|19575919|P1|Overall Study|Investigator Withdrew Subject|3
5672672|NCT00428948|19575918|P2|Overall Study|Subject Met Withdrawal Criteria|0
5672673|NCT00428948|19575919|P1|Overall Study|Subject Met Withdrawal Criteria|4
5672674|NCT00428948|19575918|P2|Overall Study|Adverse Event|24
5672675|NCT00428948|19575919|P1|Overall Study|Adverse Event|148
5672676|NCT00428948|19575918|P2|Overall Study|Lost to Follow-up|8
5672677|NCT00428948|19575919|P1|Overall Study|Lost to Follow-up|15
5672678|NCT00428844|19575947|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
5672679|NCT00428844|19575948|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
5672680|NCT00428844|19575949|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
5672681|NCT00428844|19575947|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
5672682|NCT00428844|19575948|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
5672683|NCT00428844|19575949|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
5672684|NCT00428844|19575947|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
5672685|NCT00428844|19575948|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
5672686|NCT00428844|19575949|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
5672687|NCT00428844|19575947|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
5672688|NCT00428844|19575948|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
5672689|NCT00428844|19575949|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
5672690|NCT00428844|19575947|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
5672691|NCT00428844|19575948|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
5672692|NCT00428844|19575949|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
5672693|NCT00428844|19575947|P3|Completed Study Drug Treatment|Randomized Not Treated|1
5672694|NCT00428844|19575948|P2|Completed Study Drug Treatment|Randomized Not Treated|0
5672695|NCT00428844|19575949|P1|Completed Study Drug Treatment|Randomized Not Treated|0
5672696|NCT00428844|19575947|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
5672697|NCT00428844|19575948|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
5672698|NCT00428844|19575949|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
5672699|NCT00428844|19575947|P3|Completed Study Drug Treatment|Protocol Violation|1
5672700|NCT00428844|19575948|P2|Completed Study Drug Treatment|Protocol Violation|1
5672701|NCT00428844|19575949|P1|Completed Study Drug Treatment|Protocol Violation|0
5672702|NCT00428844|19575947|P3|Completed Study Drug Treatment|Adverse Event|4
5672703|NCT00428844|19575948|P2|Completed Study Drug Treatment|Adverse Event|4
5672704|NCT00428844|19575949|P1|Completed Study Drug Treatment|Adverse Event|2
5672705|NCT00428792|19575972|P2|Overall Study|Lost to Follow-up|1
5672706|NCT00428792|19575973|P1|Overall Study|Lost to Follow-up|0
5672707|NCT00428792|19575972|P2|Overall Study|Lack of Efficacy|3
5672708|NCT00428792|19575973|P1|Overall Study|Lack of Efficacy|1
5672709|NCT00428714|19575999|P2|Overall Study|Death due to other then PD|0
5672710|NCT00428714|19576000|P1|Overall Study|Death due to other then PD|1
5672711|NCT00428714|19575999|P2|Overall Study|Death due to Progressive Disease (PD)|0
5672712|NCT00428714|19576000|P1|Overall Study|Death due to Progressive Disease (PD)|1
5672713|NCT00428714|19575999|P2|Overall Study|Physician Decision|1
5672714|NCT00428714|19576000|P1|Overall Study|Physician Decision|1
5672715|NCT00428714|19575999|P2|Overall Study|Adverse Event|2
5672716|NCT00428714|19576000|P1|Overall Study|Adverse Event|0
5672717|NCT00428714|19575999|P2|Overall Study|Withdrawal by Subject|3
5672718|NCT00428714|19576000|P1|Overall Study|Withdrawal by Subject|0
5672719|NCT00428714|19575999|P2|Overall Study|Progressive Disease|36
5672720|NCT00428714|19576000|P1|Overall Study|Progressive Disease|28
5672721|NCT00428610|19576019|P3|Overall Study|Withdrawal by Subject|0
5672722|NCT00428610|19576020|P2|Overall Study|Withdrawal by Subject|0
5672723|NCT00428610|19576021|P1|Overall Study|Withdrawal by Subject|4
5672724|NCT00428610|19576019|P3|Overall Study|Progressive Disease|22
5672725|NCT00428610|19576020|P2|Overall Study|Progressive Disease|14
5672726|NCT00428610|19576021|P1|Overall Study|Progressive Disease|42
5672727|NCT00428610|19576019|P3|Overall Study|Investigator Decision|1
5672728|NCT00428610|19576020|P2|Overall Study|Investigator Decision|1
5672729|NCT00428610|19576021|P1|Overall Study|Investigator Decision|2
5672730|NCT00428610|19576019|P3|Overall Study|Adverse Event|2
5672731|NCT00428610|19576020|P2|Overall Study|Adverse Event|3
5672732|NCT00428610|19576021|P1|Overall Study|Adverse Event|2
5672733|NCT00428610|19576019|P3|Overall Study|Death Due to Progressive Disease|2
5672734|NCT00428610|19576020|P2|Overall Study|Death Due to Progressive Disease|0
5672735|NCT00428610|19576021|P1|Overall Study|Death Due to Progressive Disease|0
5672736|NCT00428610|19576019|P3|Overall Study|Death Due to Adverse Event|5
5672737|NCT00428610|19576020|P2|Overall Study|Death Due to Adverse Event|0
5672738|NCT00428610|19576021|P1|Overall Study|Death Due to Adverse Event|3
5672739|NCT00428597|19576055|P2|Overall Study|Death|3
5672740|NCT00428597|19576056|P1|Overall Study|Death|1
5672741|NCT00428597|19576055|P2|Overall Study|Pregnancy|0
5672742|NCT00428597|19576056|P1|Overall Study|Pregnancy|1
5672743|NCT00428597|19576055|P2|Overall Study|Lost to Follow-up|1
5672744|NCT00428597|19576056|P1|Overall Study|Lost to Follow-up|0
5672745|NCT00428597|19576055|P2|Overall Study|Other|1
5672746|NCT00428597|19576056|P1|Overall Study|Other|1
5672747|NCT00428597|19576055|P2|Overall Study|Withdrawal by Subject|1
5672748|NCT00428597|19576056|P1|Overall Study|Withdrawal by Subject|2
5672749|NCT00428597|19576055|P2|Overall Study|Protocol Violation|1
5672750|NCT00428597|19576056|P1|Overall Study|Protocol Violation|2
5672751|NCT00428597|19576055|P2|Overall Study|Global Deterioration of Health Status|5
5672752|NCT00428597|19576056|P1|Overall Study|Global Deterioration of Health Status|1
5672753|NCT00428597|19576055|P2|Overall Study|Adverse Event|7
5672754|NCT00428597|19576056|P1|Overall Study|Adverse Event|15
5672755|NCT00428597|19576055|P2|Overall Study|Study Terminated by Sponsor|16
5672756|NCT00428597|19576056|P1|Overall Study|Study Terminated by Sponsor|41
5672757|NCT00428597|19576055|P2|Overall Study|Objective Progression or Relapse|47
5672758|NCT00428597|19576056|P1|Overall Study|Objective Progression or Relapse|19
5672759|NCT00428597|19576055|P2|Overall Study|Randomized but not treated|3
5672760|NCT00428597|19576056|P1|Overall Study|Randomized but not treated|3
5672761|NCT00428441|19576123|P1|Overall Study|Lost to Follow-up|1
5672762|NCT00428389|19576129|P2|Extension Phase|Administrative problems|1
5672763|NCT00428389|19576130|P1|Extension Phase|Administrative problems|1
5672764|NCT00428389|19576129|P2|Extension Phase|Protocol Violation|2
5672765|NCT00428389|19576130|P1|Extension Phase|Protocol Violation|3
5672766|NCT00428389|19576129|P2|Extension Phase|Death|0
5672767|NCT00428389|19576130|P1|Extension Phase|Death|1
5672768|NCT00428389|19576129|P2|Extension Phase|Lost to Follow-up|3
5672769|NCT00428389|19576130|P1|Extension Phase|Lost to Follow-up|0
5672770|NCT00428389|19576129|P2|Extension Phase|Withdrawal by Subject|6
5672771|NCT00428389|19576130|P1|Extension Phase|Withdrawal by Subject|6
5672772|NCT00428389|19576129|P2|Extension Phase|Lack of Efficacy|3
5672773|NCT00428389|19576130|P1|Extension Phase|Lack of Efficacy|4
5672774|NCT00428389|19576129|P2|Extension Phase|Adverse Event|11
5672775|NCT00428389|19576130|P1|Extension Phase|Adverse Event|17
5672776|NCT00428389|19576129|P2|Core Phase|Protocol deviation|2
5672777|NCT00428389|19576130|P1|Core Phase|Protocol deviation|0
5672778|NCT00428389|19576129|P2|Core Phase|Withdrawal by Subject|4
5672779|NCT00428389|19576130|P1|Core Phase|Withdrawal by Subject|3
5672780|NCT00428389|19576129|P2|Core Phase|Abnormal test procedure result(s)|1
5672781|NCT00428389|19576130|P1|Core Phase|Abnormal test procedure result(s)|0
5672782|NCT00428389|19576129|P2|Core Phase|Lack of Efficacy|0
5672783|NCT00428389|19576130|P1|Core Phase|Lack of Efficacy|2
5672784|NCT00428389|19576129|P2|Core Phase|Adverse Event|4
5672785|NCT00428389|19576130|P1|Core Phase|Adverse Event|6
5672786|NCT00428246|19576164|P3|Overall Study|Adverse Event|0
5672787|NCT00428246|19576165|P2|Overall Study|Adverse Event|0
5672788|NCT00428246|19576166|P1|Overall Study|Adverse Event|1
5672789|NCT00428246|19576164|P3|Overall Study|Withdrawal by Subject|1
5672790|NCT00428246|19576165|P2|Overall Study|Withdrawal by Subject|0
5672791|NCT00428246|19576166|P1|Overall Study|Withdrawal by Subject|0
5672792|NCT00428220|19576174|P1|Overall Study|Other|23
5672793|NCT00428220|19576174|P1|Overall Study|Adverse Event|51
5672794|NCT00428220|19576174|P1|Overall Study|Participant refused continued treatment|7
5672795|NCT00428220|19576174|P1|Overall Study|Objective progression or relapse|123
5672796|NCT00428220|19576174|P1|Overall Study|Lost to Follow-up|4
5672797|NCT00428220|19576174|P1|Overall Study|Global deterioration of health status|7
5672798|NCT00428220|19576174|P1|Overall Study|Participant died|8
5672799|NCT00428116|19576199|P2|Overall Study|Lost to Follow-up|0
5672800|NCT00428116|19576200|P1|Overall Study|Lost to Follow-up|1
5672801|NCT00428116|19576199|P2|Overall Study|Withdrawal by Subject|0
5672802|NCT00428116|19576200|P1|Overall Study|Withdrawal by Subject|1
5672803|NCT00428116|19576199|P2|Overall Study|Death|0
5672804|NCT00428116|19576200|P1|Overall Study|Death|1
5672805|NCT00428090|19576212|P4|Overall Study|Raised Creatinine Value|1
5672806|NCT00428090|19576213|P3|Overall Study|Raised Creatinine Value|0
5672807|NCT00428090|19576214|P2|Overall Study|Raised Creatinine Value|0
5672808|NCT00428090|19576215|P1|Overall Study|Raised Creatinine Value|0
5672809|NCT00428090|19576212|P4|Overall Study|Excluded for heart insufficiency|0
5672810|NCT00428090|19576213|P3|Overall Study|Excluded for heart insufficiency|1
5672811|NCT00428090|19576214|P2|Overall Study|Excluded for heart insufficiency|0
5672812|NCT00428090|19576215|P1|Overall Study|Excluded for heart insufficiency|0
5672813|NCT00428090|19576212|P4|Overall Study|Serious adverse event|0
5672814|NCT00428090|19576213|P3|Overall Study|Serious adverse event|1
5672815|NCT00428090|19576214|P2|Overall Study|Serious adverse event|0
5672816|NCT00428090|19576215|P1|Overall Study|Serious adverse event|0
5672817|NCT00428090|19576212|P4|Overall Study|Deterioration of cognitive status|0
5672818|NCT00428090|19576213|P3|Overall Study|Deterioration of cognitive status|1
5672819|NCT00428090|19576214|P2|Overall Study|Deterioration of cognitive status|0
5672820|NCT00428090|19576215|P1|Overall Study|Deterioration of cognitive status|0
5672821|NCT00428090|19576212|P4|Overall Study|High MMSE scores|0
5672822|NCT00428090|19576213|P3|Overall Study|High MMSE scores|1
5672823|NCT00428090|19576214|P2|Overall Study|High MMSE scores|0
5672824|NCT00428090|19576215|P1|Overall Study|High MMSE scores|0
5672825|NCT00428090|19576212|P4|Overall Study|Insufficient AD documentation|0
5672826|NCT00428090|19576213|P3|Overall Study|Insufficient AD documentation|1
5672827|NCT00428090|19576214|P2|Overall Study|Insufficient AD documentation|0
5672828|NCT00428090|19576215|P1|Overall Study|Insufficient AD documentation|0
5672829|NCT00428090|19576212|P4|Overall Study|Excluded for concerning QTc value|0
5672830|NCT00428090|19576213|P3|Overall Study|Excluded for concerning QTc value|1
5672831|NCT00428090|19576214|P2|Overall Study|Excluded for concerning QTc value|0
5672832|NCT00428090|19576215|P1|Overall Study|Excluded for concerning QTc value|0
5672833|NCT00428090|19576212|P4|Overall Study|Worsening of AD|0
5672834|NCT00428090|19576213|P3|Overall Study|Worsening of AD|1
5672835|NCT00428090|19576214|P2|Overall Study|Worsening of AD|0
5672836|NCT00428090|19576215|P1|Overall Study|Worsening of AD|0
5672837|NCT00428090|19576212|P4|Overall Study|Mental status of par. was|0
5672838|NCT00428090|19576213|P3|Overall Study|Mental status of par. was|0
5672839|NCT00428090|19576214|P2|Overall Study|Mental status of par. was|1
5672840|NCT00428090|19576215|P1|Overall Study|Mental status of par. was|0
5672841|NCT00428090|19576212|P4|Overall Study|Medical monitor terminated par.|0
5672842|NCT00428090|19576213|P3|Overall Study|Medical monitor terminated par.|0
5672843|NCT00428090|19576214|P2|Overall Study|Medical monitor terminated par.|1
5672844|NCT00428090|19576215|P1|Overall Study|Medical monitor terminated par.|0
5672845|NCT00428090|19576212|P4|Overall Study|Visit 7 exceed the visit window|0
5672846|NCT00428090|19576213|P3|Overall Study|Visit 7 exceed the visit window|0
5672847|NCT00428090|19576214|P2|Overall Study|Visit 7 exceed the visit window|1
5672848|NCT00428090|19576215|P1|Overall Study|Visit 7 exceed the visit window|0
5672849|NCT00428090|19576212|P4|Overall Study|Death of par.|0
5672850|NCT00428090|19576213|P3|Overall Study|Death of par.|1
5672851|NCT00428090|19576214|P2|Overall Study|Death of par.|0
5672852|NCT00428090|19576215|P1|Overall Study|Death of par.|1
5672853|NCT00428090|19576212|P4|Overall Study|Prohibited medication used for SAE|0
5672854|NCT00428090|19576213|P3|Overall Study|Prohibited medication used for SAE|0
5672855|NCT00428090|19576214|P2|Overall Study|Prohibited medication used for SAE|0
5672856|NCT00428090|19576215|P1|Overall Study|Prohibited medication used for SAE|1
5672857|NCT00428090|19576212|P4|Overall Study|Follow-Up visit not possible|0
5672858|NCT00428090|19576213|P3|Overall Study|Follow-Up visit not possible|0
5672859|NCT00428090|19576214|P2|Overall Study|Follow-Up visit not possible|0
5672860|NCT00428090|19576215|P1|Overall Study|Follow-Up visit not possible|1
5672861|NCT00428090|19576212|P4|Overall Study|Par. did not returned to visit|1
5672862|NCT00428090|19576213|P3|Overall Study|Par. did not returned to visit|0
5672863|NCT00428090|19576214|P2|Overall Study|Par. did not returned to visit|0
5672864|NCT00428090|19576215|P1|Overall Study|Par. did not returned to visit|1
5672865|NCT00428090|19576212|P4|Overall Study|Non-compliance|3
5672866|NCT00428090|19576213|P3|Overall Study|Non-compliance|1
5672867|NCT00428090|19576214|P2|Overall Study|Non-compliance|0
5672868|NCT00428090|19576215|P1|Overall Study|Non-compliance|4
5672869|NCT00428090|19576212|P4|Overall Study|Sponsor terminated study|0
5672870|NCT00428090|19576213|P3|Overall Study|Sponsor terminated study|0
5672871|NCT00428090|19576214|P2|Overall Study|Sponsor terminated study|1
5672872|NCT00428090|19576215|P1|Overall Study|Sponsor terminated study|0
5672873|NCT00428090|19576212|P4|Overall Study|Withdrawal by Subject|5
5672874|NCT00428090|19576213|P3|Overall Study|Withdrawal by Subject|15
5672875|NCT00428090|19576214|P2|Overall Study|Withdrawal by Subject|12
5672876|NCT00428090|19576215|P1|Overall Study|Withdrawal by Subject|10
5672877|NCT00428090|19576212|P4|Overall Study|Protocol Violation|3
5672878|NCT00428090|19576213|P3|Overall Study|Protocol Violation|3
5672879|NCT00428090|19576214|P2|Overall Study|Protocol Violation|1
5672880|NCT00428090|19576215|P1|Overall Study|Protocol Violation|3
5672881|NCT00428090|19576212|P4|Overall Study|Lost to Follow-up|4
5672882|NCT00428090|19576213|P3|Overall Study|Lost to Follow-up|1
5672883|NCT00428090|19576214|P2|Overall Study|Lost to Follow-up|6
5672884|NCT00428090|19576215|P1|Overall Study|Lost to Follow-up|3
5672885|NCT00428090|19576212|P4|Overall Study|Adverse Event|11
5672886|NCT00428090|19576213|P3|Overall Study|Adverse Event|10
5672887|NCT00428090|19576214|P2|Overall Study|Adverse Event|8
5672888|NCT00428090|19576215|P1|Overall Study|Adverse Event|10
5672889|NCT00427999|19576333|P1|Overall Study|Death|1
5672890|NCT00427999|19576333|P1|Overall Study|Withdrawal by Subject|9
5672891|NCT00427999|19576333|P1|Overall Study|Protocol Violation|2
5672892|NCT00427999|19576333|P1|Overall Study|Unsatisfactory therapeutic effect|13
5672893|NCT00427999|19576333|P1|Overall Study|Abnormal laboratory values|1
5672894|NCT00427999|19576333|P1|Overall Study|Adverse Event|6
5672895|NCT00427960|19576351|P2|Overall Study|Other|1
5672896|NCT00427960|19576352|P1|Overall Study|Other|0
5672897|NCT00427960|19576351|P2|Overall Study|Withdrawal by Subject|3
5672898|NCT00427960|19576352|P1|Overall Study|Withdrawal by Subject|0
5672899|NCT00427960|19576351|P2|Overall Study|Adverse Event|0
5672900|NCT00427960|19576352|P1|Overall Study|Adverse Event|2
5672901|NCT00427934|19576390|P4|Overall Study|Withdrawal by Subject|3
5672902|NCT00427934|19576391|P3|Overall Study|Withdrawal by Subject|1
5672903|NCT00427934|19576392|P2|Overall Study|Withdrawal by Subject|0
5672904|NCT00427934|19576393|P1|Overall Study|Withdrawal by Subject|0
5672905|NCT00427934|19576390|P4|Overall Study|Other|5
5672906|NCT00427934|19576391|P3|Overall Study|Other|11
5672907|NCT00427934|19576392|P2|Overall Study|Other|0
5672908|NCT00427934|19576393|P1|Overall Study|Other|0
5672909|NCT00427934|19576390|P4|Overall Study|Randomized But Did Not Receive Treatment|1
5672910|NCT00427934|19576391|P3|Overall Study|Randomized But Did Not Receive Treatment|1
5672911|NCT00427934|19576392|P2|Overall Study|Randomized But Did Not Receive Treatment|0
5672912|NCT00427934|19576393|P1|Overall Study|Randomized But Did Not Receive Treatment|0
5672913|NCT00427934|19576390|P4|Overall Study|Lack of Efficacy|2
5672914|NCT00427934|19576391|P3|Overall Study|Lack of Efficacy|5
5672915|NCT00427934|19576392|P2|Overall Study|Lack of Efficacy|0
5672916|NCT00427934|19576393|P1|Overall Study|Lack of Efficacy|0
5672917|NCT00427934|19576390|P4|Overall Study|Adverse Event|4
5672918|NCT00427934|19576391|P3|Overall Study|Adverse Event|5
5672919|NCT00427934|19576392|P2|Overall Study|Adverse Event|0
5672920|NCT00427934|19576393|P1|Overall Study|Adverse Event|1
5672921|NCT00427921|19576461|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
5672922|NCT00427921|19576461|P1|Overall Study|Adverse Event + Withdrawn from Study|1
5672923|NCT00427921|19576461|P1|Overall Study|Adverse Event + Lost Response|1
5672924|NCT00427921|19576461|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
5672925|NCT00427921|19576461|P1|Overall Study|Adverse Event + Worsening of CD|1
5672926|NCT00427921|19576461|P1|Overall Study|Adverse Event + No Response|1
5672927|NCT00427921|19576461|P1|Overall Study|Adverse Event + Withdrew Consent|1
5672928|NCT00427921|19576461|P1|Overall Study|Adverse Event + Hospitalization|1
5672929|NCT00427921|19576461|P1|Overall Study|Other reason not specified|10
5672930|NCT00427921|19576461|P1|Overall Study|Lost to Follow-up|2
5672931|NCT00427921|19576461|P1|Overall Study|Withdrawal by Subject|4
5672932|NCT00427921|19576461|P1|Overall Study|Adverse Event|26
5672933|NCT00427908|19576484|P4|Primary Phase|Adverse Event|0
5672934|NCT00427908|19576485|P3|Primary Phase|Adverse Event|0
5672935|NCT00427908|19576486|P2|Primary Phase|Adverse Event|1
5672936|NCT00427908|19576487|P1|Primary Phase|Adverse Event|0
5672937|NCT00427908|19576484|P4|Primary Phase|Withdrawal by Subject|0
5672938|NCT00427908|19576485|P3|Primary Phase|Withdrawal by Subject|1
5672939|NCT00427908|19576486|P2|Primary Phase|Withdrawal by Subject|2
5672940|NCT00427908|19576487|P1|Primary Phase|Withdrawal by Subject|1
5672941|NCT00427908|19576484|P4|Primary Phase|Lost to Follow-up|0
5672942|NCT00427908|19576485|P3|Primary Phase|Lost to Follow-up|2
5672943|NCT00427908|19576486|P2|Primary Phase|Lost to Follow-up|0
5672944|NCT00427908|19576487|P1|Primary Phase|Lost to Follow-up|4
5672945|NCT00427895|19576687|P8|Vax 2/Year 3 to 4|Failed to Return|0
5672946|NCT00427895|19576688|P7|Vax 2/Year 3 to 4|Failed to Return|0
5672947|NCT00427895|19576689|P6|Vax 2/Year 3 to 4|Failed to Return|0
5672948|NCT00427895|19576690|P5|Vax 2/Year 3 to 4|Failed to Return|1
5672949|NCT00427895|19576691|P4|Vax 2/Year 3 to 4|Failed to Return|0
5672950|NCT00427895|19576692|P3|Vax 2/Year 3 to 4|Failed to Return|0
5672951|NCT00427895|19576693|P2|Vax 2/Year 3 to 4|Failed to Return|0
5672952|NCT00427895|19576694|P1|Vax 2/Year 3 to 4|Failed to Return|0
5672953|NCT00427895|19576687|P8|Vax 2/Year 3 to 4|Protocol Violation|1
5672954|NCT00427895|19576688|P7|Vax 2/Year 3 to 4|Protocol Violation|0
5672955|NCT00427895|19576689|P6|Vax 2/Year 3 to 4|Protocol Violation|0
5672956|NCT00427895|19576690|P5|Vax 2/Year 3 to 4|Protocol Violation|0
5672957|NCT00427895|19576691|P4|Vax 2/Year 3 to 4|Protocol Violation|0
5672958|NCT00427895|19576692|P3|Vax 2/Year 3 to 4|Protocol Violation|0
5672959|NCT00427895|19576693|P2|Vax 2/Year 3 to 4|Protocol Violation|0
5672960|NCT00427895|19576694|P1|Vax 2/Year 3 to 4|Protocol Violation|0
5672961|NCT00427895|19576687|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
5672962|NCT00427895|19576688|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
5672963|NCT00427895|19576689|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
5672964|NCT00427895|19576690|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
5672965|NCT00427895|19576691|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
5672966|NCT00427895|19576692|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
5672967|NCT00427895|19576693|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
5672968|NCT00427895|19576694|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
5672969|NCT00427895|19576687|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
5672970|NCT00427895|19576688|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
5672971|NCT00427895|19576689|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
5672972|NCT00427895|19576690|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
5672973|NCT00427895|19576691|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
5672974|NCT00427895|19576692|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
5672975|NCT00427895|19576693|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
5672976|NCT00427895|19576694|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
5672977|NCT00427895|19576687|P8|Vax 1/Year 1 Follow-up|Other|0
5672978|NCT00427895|19576688|P7|Vax 1/Year 1 Follow-up|Other|0
5672979|NCT00427895|19576689|P6|Vax 1/Year 1 Follow-up|Other|0
5672980|NCT00427895|19576690|P5|Vax 1/Year 1 Follow-up|Other|0
5672981|NCT00427895|19576691|P4|Vax 1/Year 1 Follow-up|Other|2
5672982|NCT00427895|19576692|P3|Vax 1/Year 1 Follow-up|Other|0
5672983|NCT00427895|19576693|P2|Vax 1/Year 1 Follow-up|Other|0
5672984|NCT00427895|19576694|P1|Vax 1/Year 1 Follow-up|Other|0
5672985|NCT00427895|19576687|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
5672986|NCT00427895|19576688|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
5672987|NCT00427895|19576689|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
5672988|NCT00427895|19576690|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
5672989|NCT00427895|19576691|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
5672990|NCT00427895|19576692|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
5672991|NCT00427895|19576693|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
5672992|NCT00427895|19576694|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
5672993|NCT00427895|19576687|P8|Vax 1/Year 1 Follow-up|Death|0
5672994|NCT00427895|19576688|P7|Vax 1/Year 1 Follow-up|Death|0
5672995|NCT00427895|19576689|P6|Vax 1/Year 1 Follow-up|Death|0
5672996|NCT00427895|19576690|P5|Vax 1/Year 1 Follow-up|Death|0
5672997|NCT00427895|19576691|P4|Vax 1/Year 1 Follow-up|Death|0
5672998|NCT00427895|19576692|P3|Vax 1/Year 1 Follow-up|Death|0
5672999|NCT00427895|19576693|P2|Vax 1/Year 1 Follow-up|Death|0
5673000|NCT00427895|19576694|P1|Vax 1/Year 1 Follow-up|Death|1
5673001|NCT00427895|19576687|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
5673002|NCT00427895|19576688|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
5673003|NCT00427895|19576689|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
5673004|NCT00427895|19576690|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
5673005|NCT00427895|19576691|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
5673006|NCT00427895|19576692|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
5673007|NCT00427895|19576693|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
5673008|NCT00427895|19576694|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
5673009|NCT00427895|19576687|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
5673010|NCT00427895|19576688|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
5673011|NCT00427895|19576689|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
5673012|NCT00427895|19576690|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
5673013|NCT00427895|19576691|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
5673014|NCT00427895|19576692|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
5673015|NCT00427895|19576693|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
5673016|NCT00427895|19576694|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
5673017|NCT00427895|19576687|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
5673018|NCT00427895|19576688|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
5673019|NCT00427895|19576689|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
5673020|NCT00427895|19576690|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
5673021|NCT00427895|19576691|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
5673022|NCT00427895|19576692|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
5673023|NCT00427895|19576693|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
5673024|NCT00427895|19576694|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
5673025|NCT00427895|19576687|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5673026|NCT00427895|19576688|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5673027|NCT00427895|19576689|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5673028|NCT00427895|19576690|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5673029|NCT00427895|19576691|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
5673030|NCT00427895|19576692|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
5673031|NCT00427895|19576693|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
5673032|NCT00427895|19576694|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
5673033|NCT00427895|19576687|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5673034|NCT00427895|19576688|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5673035|NCT00427895|19576689|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5673036|NCT00427895|19576690|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5673037|NCT00427895|19576691|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
5673038|NCT00427895|19576692|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5673039|NCT00427895|19576693|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5673040|NCT00427895|19576694|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
5673041|NCT00427895|19576687|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
5673042|NCT00427895|19576688|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
5673043|NCT00427895|19576689|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
5673044|NCT00427895|19576690|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
5673045|NCT00427895|19576691|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
5673046|NCT00427895|19576692|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
5673047|NCT00427895|19576693|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
5673048|NCT00427895|19576694|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
5673049|NCT00427895|19576687|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
5673050|NCT00427895|19576688|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
5673051|NCT00427895|19576689|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
5673052|NCT00427895|19576690|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
5673053|NCT00427895|19576691|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
5673054|NCT00427895|19576692|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
5673055|NCT00427895|19576693|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
5673056|NCT00427895|19576694|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
5673057|NCT00427895|19576687|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5673058|NCT00427895|19576688|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5673059|NCT00427895|19576689|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5673060|NCT00427895|19576690|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5673061|NCT00427895|19576691|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
5673062|NCT00427895|19576692|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5673063|NCT00427895|19576693|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5673064|NCT00427895|19576694|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
5673065|NCT00427895|19576687|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
5673066|NCT00427895|19576688|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
5673067|NCT00427895|19576689|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
5673068|NCT00427895|19576690|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
5673069|NCT00427895|19576691|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
5673070|NCT00427895|19576692|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
5673071|NCT00427895|19576693|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
5673072|NCT00427895|19576694|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
5673073|NCT00427895|19576687|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5673074|NCT00427895|19576688|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5673075|NCT00427895|19576689|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5673076|NCT00427895|19576690|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5673077|NCT00427895|19576691|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5673078|NCT00427895|19576692|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
5673079|NCT00427895|19576693|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
5673080|NCT00427895|19576694|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
5673081|NCT00427895|19576687|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5673082|NCT00427895|19576688|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5673083|NCT00427895|19576689|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5673084|NCT00427895|19576690|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5673085|NCT00427895|19576691|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
5673086|NCT00427895|19576692|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
5673087|NCT00427895|19576693|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
5673088|NCT00427895|19576694|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
5673089|NCT00427895|19576687|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5673090|NCT00427895|19576688|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5673091|NCT00427895|19576689|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5673092|NCT00427895|19576690|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5673093|NCT00427895|19576691|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
5673094|NCT00427895|19576692|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
5673095|NCT00427895|19576693|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
5673096|NCT00427895|19576694|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
5673097|NCT00427778|19576769|P2|First Intervention (4 Weeks)|anxious about using ring|0
5673098|NCT00427778|19576770|P1|First Intervention (4 Weeks)|anxious about using ring|1
5673099|NCT00427778|19576769|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
5673100|NCT00427778|19576770|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
5673101|NCT00427778|19576769|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
5673102|NCT00427778|19576770|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
5673103|NCT00427778|19576769|P2|First Intervention (4 Weeks)|no longer interested|0
5673104|NCT00427778|19576770|P1|First Intervention (4 Weeks)|no longer interested|1
5673105|NCT00427700|19576795|P2|Overall Study|Pregnancy|2
5673106|NCT00427700|19576796|P1|Overall Study|Pregnancy|0
5673107|NCT00427700|19576795|P2|Overall Study|no induction of menses|4
5673108|NCT00427700|19576796|P1|Overall Study|no induction of menses|1
5673109|NCT00427700|19576795|P2|Overall Study|Lost to Follow-up|5
5673110|NCT00427700|19576796|P1|Overall Study|Lost to Follow-up|2
5673111|NCT00427648|19576812|P2|Overall Study|Adverse Event|1
5673112|NCT00427648|19576813|P1|Overall Study|Adverse Event|0
5673113|NCT00427648|19576812|P2|Overall Study|Protocol Violation|2
5673114|NCT00427648|19576813|P1|Overall Study|Protocol Violation|1
5673115|NCT00427635|19576833|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
5673116|NCT00427635|19576834|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
5673117|NCT00427635|19576833|P2|Treatment Phase|Withdrawal by Subject|0
5673118|NCT00427635|19576834|P1|Treatment Phase|Withdrawal by Subject|1
5673119|NCT00427349|19576866|P1|Overall Study|Never started therapy|1
5673120|NCT00427349|19576866|P1|Overall Study|Ineligible|1
5673121|NCT00427349|19576866|P1|Overall Study|Other|2
5673122|NCT00427349|19576866|P1|Overall Study|Alternative therapy|1
5673123|NCT00427349|19576866|P1|Overall Study|Withdrawal by Subject|3
5673124|NCT00427349|19576866|P1|Overall Study|Death|1
5673125|NCT00427349|19576866|P1|Overall Study|Adverse Event|14
5673126|NCT00427349|19576866|P1|Overall Study|Lack of Efficacy|23
5673127|NCT00427011|19576923|P1|Overall Study|Other|12
5673128|NCT00427011|19576923|P1|Overall Study|Lack of Efficacy|2
5673129|NCT00427011|19576923|P1|Overall Study|Withdrawal by Subject|1
5673130|NCT00427011|19576923|P1|Overall Study|Adverse Event|10
5673131|NCT00426842|19576938|P1|Overall Study|Lost to Follow-up|1
5673132|NCT00426764|19576944|P1|Overall Study|Other Reasons (Miscellaneous)|10
5673133|NCT00426764|19576944|P1|Overall Study|Death|1
5673134|NCT00426764|19576944|P1|Overall Study|Other|1
5673135|NCT00426764|19576944|P1|Overall Study|Adverse Event|24
5673136|NCT00426764|19576944|P1|Overall Study|Progressive Disease|83
5673137|NCT00426764|19576944|P1|Overall Study|Compassionate Use|1
5673138|NCT00426764|19576944|P1|Overall Study|Physician Decision|6
5673139|NCT00426764|19576944|P1|Overall Study|Withdrawal by Subject|4
5673140|NCT00426764|19576944|P1|Overall Study|Protocol Violation|1
5673141|NCT00426751|19576961|P2|Overall Study|Other Reasons|12
5673142|NCT00426751|19576962|P1|Overall Study|Other Reasons|7
5673143|NCT00426751|19576961|P2|Overall Study|Consent Withdrawn|1
5673144|NCT00426751|19576962|P1|Overall Study|Consent Withdrawn|0
5673145|NCT00426751|19576961|P2|Overall Study|Lost to Follow-up|6
5673146|NCT00426751|19576962|P1|Overall Study|Lost to Follow-up|7
5673147|NCT00426751|19576961|P2|Overall Study|Adverse Event|1
5673148|NCT00426751|19576962|P1|Overall Study|Adverse Event|8
5673149|NCT00426660|19577006|P1|Overall Study|Enrolled Not Treated|15
5673150|NCT00426660|19577006|P1|Overall Study|Protocol Violation|1
5673151|NCT00426660|19577006|P1|Overall Study|Withdrawal by Subject|18
5673152|NCT00426660|19577006|P1|Overall Study|Other|23
5673153|NCT00426660|19577006|P1|Overall Study|Lost to Follow-up|15
5673154|NCT00426660|19577006|P1|Overall Study|Insufficient Clinical Response|22
5673155|NCT00426660|19577006|P1|Overall Study|Adverse Event|23
5673156|NCT00426660|19577006|P1|Overall Study|Death|14
5673157|NCT00426556|19577037|P4|Phase II - Extension Phase|Adverse Event|2
5673158|NCT00426556|19577038|P3|Phase II - Extension Phase|Adverse Event|0
5673159|NCT00426556|19577039|P2|Phase II - Extension Phase|Adverse Event|0
5673160|NCT00426556|19577040|P1|Phase II - Extension Phase|Adverse Event|0
5673161|NCT00426556|19577037|P4|Phase II - Extension Phase|Disease Progression|21
5673162|NCT00426556|19577038|P3|Phase II - Extension Phase|Disease Progression|0
5673163|NCT00426556|19577039|P2|Phase II - Extension Phase|Disease Progression|0
5673164|NCT00426556|19577040|P1|Phase II - Extension Phase|Disease Progression|0
5673165|NCT00426556|19577037|P4|Phase II - Core Phase|Adverse Event|8
5673166|NCT00426556|19577038|P3|Phase II - Core Phase|Adverse Event|0
5673167|NCT00426556|19577039|P2|Phase II - Core Phase|Adverse Event|0
5673168|NCT00426556|19577040|P1|Phase II - Core Phase|Adverse Event|0
5673169|NCT00426556|19577037|P4|Phase II - Core Phase|Disease Progression|16
5673170|NCT00426556|19577038|P3|Phase II - Core Phase|Disease Progression|0
5673171|NCT00426556|19577039|P2|Phase II - Core Phase|Disease Progression|0
5673172|NCT00426556|19577040|P1|Phase II - Core Phase|Disease Progression|0
5673173|NCT00426556|19577037|P4|Phase II - Core Phase|Withdrawal by Subject|3
5673174|NCT00426556|19577038|P3|Phase II - Core Phase|Withdrawal by Subject|0
5673175|NCT00426556|19577039|P2|Phase II - Core Phase|Withdrawal by Subject|0
5673176|NCT00426556|19577040|P1|Phase II - Core Phase|Withdrawal by Subject|0
5673177|NCT00426556|19577037|P4|Phase I - Extension Phase|Disease Progression|0
5673178|NCT00426556|19577038|P3|Phase I - Extension Phase|Disease Progression|6
5673179|NCT00426556|19577039|P2|Phase I - Extension Phase|Disease Progression|5
5673180|NCT00426556|19577040|P1|Phase I - Extension Phase|Disease Progression|5
5673181|NCT00426556|19577037|P4|Phase I - Extension Phase|Adverse Event|0
5673182|NCT00426556|19577038|P3|Phase I - Extension Phase|Adverse Event|1
5673183|NCT00426556|19577039|P2|Phase I - Extension Phase|Adverse Event|1
5673184|NCT00426556|19577040|P1|Phase I - Extension Phase|Adverse Event|0
5673185|NCT00426556|19577037|P4|Phase I - Core Phase|Death|0
5673186|NCT00426556|19577038|P3|Phase I - Core Phase|Death|0
5673187|NCT00426556|19577039|P2|Phase I - Core Phase|Death|1
5673188|NCT00426556|19577040|P1|Phase I - Core Phase|Death|0
5673189|NCT00426556|19577037|P4|Phase I - Core Phase|Adverse Event|0
5673190|NCT00426556|19577038|P3|Phase I - Core Phase|Adverse Event|1
5673191|NCT00426556|19577039|P2|Phase I - Core Phase|Adverse Event|3
5673192|NCT00426556|19577040|P1|Phase I - Core Phase|Adverse Event|1
5673193|NCT00426556|19577037|P4|Phase I - Core Phase|Disease Progression|0
5673194|NCT00426556|19577038|P3|Phase I - Core Phase|Disease Progression|2
5673195|NCT00426556|19577039|P2|Phase I - Core Phase|Disease Progression|6
5673196|NCT00426556|19577040|P1|Phase I - Core Phase|Disease Progression|0
5673197|NCT00426361|19577065|P3|Overall Study|Withdrawal by Subject|0
5673198|NCT00426361|19577066|P2|Overall Study|Withdrawal by Subject|3
5673199|NCT00426361|19577067|P1|Overall Study|Withdrawal by Subject|1
5673200|NCT00426361|19577065|P3|Overall Study|Lost to Follow-up|5
5673201|NCT00426361|19577066|P2|Overall Study|Lost to Follow-up|2
5673202|NCT00426361|19577067|P1|Overall Study|Lost to Follow-up|3
5673203|NCT00426270|19577134|P1|Overall Study|Adverse Event|5
5673204|NCT00426270|19577134|P1|Overall Study|Incorrectly Enrolled in the Study|1
5673205|NCT00426231|19577144|P2|Overall Study|Withdrawal by Subject|12
5673206|NCT00426231|19577145|P1|Overall Study|Withdrawal by Subject|9
5673207|NCT00426127|19577168|P1|Overall Study|Removed due to disease progression|1
5673208|NCT00426127|19577168|P1|Overall Study|Adverse Event|1
5673209|NCT00425945|19577176|P2|Overall Study|Moved from area|1
5673210|NCT00425945|19577177|P1|Overall Study|Moved from area|0
5673211|NCT00425945|19577176|P2|Overall Study|Began cancer treatments|0
5673212|NCT00425945|19577177|P1|Overall Study|Began cancer treatments|1
5673213|NCT00425945|19577176|P2|Overall Study|Began hypertension medication|0
5673214|NCT00425945|19577177|P1|Overall Study|Began hypertension medication|1
5673215|NCT00425945|19577176|P2|Overall Study|Lost to Follow-up|2
5673216|NCT00425945|19577177|P1|Overall Study|Lost to Follow-up|0
5673217|NCT00425945|19577176|P2|Overall Study|Inconvenience|2
5673218|NCT00425945|19577177|P1|Overall Study|Inconvenience|0
5673219|NCT00425945|19577176|P2|Overall Study|Concern about Supplement|0
5673220|NCT00425945|19577177|P1|Overall Study|Concern about Supplement|2
5673221|NCT00425854|19577215|P2|Overall Study|Other Adverse Event|2
5673222|NCT00425854|19577216|P1|Overall Study|Other Adverse Event|2
5673223|NCT00425854|19577215|P2|Overall Study|Dose reduction toxicity AE|7
5673224|NCT00425854|19577216|P1|Overall Study|Dose reduction toxicity AE|8
5673225|NCT00425854|19577215|P2|Overall Study|Progressive Disease|12
5673226|NCT00425854|19577216|P1|Overall Study|Progressive Disease|19
5673227|NCT00425750|19577249|P1|Overall Study|Progression of disease|18
5673228|NCT00425750|19577249|P1|Overall Study|Adverse Event|3
5673229|NCT00425750|19577249|P1|Overall Study|Withdrawal by Subject|3
5673230|NCT00425750|19577249|P1|Overall Study|Death|1
5673231|NCT00425698|19577257|P2|Overall Study|Withdrawal by Subject|1
5673232|NCT00425698|19577258|P1|Overall Study|Withdrawal by Subject|0
5673233|NCT00425698|19577257|P2|Overall Study|Adverse Event|1
5673234|NCT00425698|19577258|P1|Overall Study|Adverse Event|3
5673235|NCT00425607|19577273|P1|Overall Study|Withdrawal by Subject|1
5673236|NCT00425607|19577273|P1|Overall Study|Death|1
5673237|NCT00425503|19577277|P1|Overall Study|Protocol Violation|1
5673238|NCT00425503|19577277|P1|Overall Study|Adverse Event|2
5673239|NCT00425438|19577289|P2|Overall Study|Termination by Sponsor|27
5673240|NCT00425438|19577290|P1|Overall Study|Termination by Sponsor|25
5673241|NCT00425373|19577324|P9|Overall Study|Lack of Efficacy|5
5673242|NCT00425373|19577325|P8|Overall Study|Lack of Efficacy|0
5673243|NCT00425373|19577326|P7|Overall Study|Lack of Efficacy|3
5673244|NCT00425373|19577327|P6|Overall Study|Lack of Efficacy|3
5673245|NCT00425373|19577328|P5|Overall Study|Lack of Efficacy|1
5673246|NCT00425373|19577329|P4|Overall Study|Lack of Efficacy|0
5673247|NCT00425373|19577330|P3|Overall Study|Lack of Efficacy|0
5673248|NCT00425373|19577331|P2|Overall Study|Lack of Efficacy|0
5673249|NCT00425373|19577332|P1|Overall Study|Lack of Efficacy|0
5673250|NCT00425373|19577324|P9|Overall Study|Withdrawal by Subject|2
5673251|NCT00425373|19577325|P8|Overall Study|Withdrawal by Subject|2
5673252|NCT00425373|19577326|P7|Overall Study|Withdrawal by Subject|2
5673253|NCT00425373|19577327|P6|Overall Study|Withdrawal by Subject|0
5673254|NCT00425373|19577328|P5|Overall Study|Withdrawal by Subject|4
5673255|NCT00425373|19577329|P4|Overall Study|Withdrawal by Subject|1
5673256|NCT00425373|19577330|P3|Overall Study|Withdrawal by Subject|2
5673257|NCT00425373|19577331|P2|Overall Study|Withdrawal by Subject|0
5673258|NCT00425373|19577332|P1|Overall Study|Withdrawal by Subject|2
5673259|NCT00425373|19577324|P9|Overall Study|Protocol Violation|3
5673260|NCT00425373|19577325|P8|Overall Study|Protocol Violation|5
5673261|NCT00425373|19577326|P7|Overall Study|Protocol Violation|0
5673262|NCT00425373|19577327|P6|Overall Study|Protocol Violation|0
5673263|NCT00425373|19577328|P5|Overall Study|Protocol Violation|0
5673264|NCT00425373|19577329|P4|Overall Study|Protocol Violation|0
5673265|NCT00425373|19577330|P3|Overall Study|Protocol Violation|1
5673266|NCT00425373|19577331|P2|Overall Study|Protocol Violation|0
5673267|NCT00425373|19577332|P1|Overall Study|Protocol Violation|1
5673268|NCT00425373|19577324|P9|Overall Study|Lost to Follow-up|0
5673269|NCT00425373|19577325|P8|Overall Study|Lost to Follow-up|0
5673270|NCT00425373|19577326|P7|Overall Study|Lost to Follow-up|0
5673271|NCT00425373|19577327|P6|Overall Study|Lost to Follow-up|0
5673272|NCT00425373|19577328|P5|Overall Study|Lost to Follow-up|1
5673273|NCT00425373|19577329|P4|Overall Study|Lost to Follow-up|0
5673274|NCT00425373|19577330|P3|Overall Study|Lost to Follow-up|0
5673275|NCT00425373|19577331|P2|Overall Study|Lost to Follow-up|1
5673276|NCT00425373|19577332|P1|Overall Study|Lost to Follow-up|0
5673277|NCT00425373|19577324|P9|Overall Study|Adverse Event|8
5673278|NCT00425373|19577325|P8|Overall Study|Adverse Event|3
5673279|NCT00425373|19577326|P7|Overall Study|Adverse Event|2
5673280|NCT00425373|19577327|P6|Overall Study|Adverse Event|6
5673281|NCT00425373|19577328|P5|Overall Study|Adverse Event|4
5673282|NCT00425373|19577329|P4|Overall Study|Adverse Event|1
5673283|NCT00425373|19577330|P3|Overall Study|Adverse Event|0
5673284|NCT00425373|19577331|P2|Overall Study|Adverse Event|2
5673285|NCT00425373|19577332|P1|Overall Study|Adverse Event|2
5673286|NCT00425308|19577390|P2|Overall Study|Death|0
5673287|NCT00425308|19577391|P1|Overall Study|Death|1
5673288|NCT00425308|19577390|P2|Overall Study|Withdrawal by Subject|0
5673289|NCT00425308|19577391|P1|Overall Study|Withdrawal by Subject|1
5673290|NCT00425308|19577390|P2|Overall Study|Adverse Event|1
5673291|NCT00425308|19577391|P1|Overall Study|Adverse Event|2
5673292|NCT00425269|19577421|P2|Overall Study|moved or medical reason|4
5673293|NCT00425269|19577422|P1|Overall Study|moved or medical reason|5
5673294|NCT00425269|19577421|P2|Overall Study|Lost to Follow-up|9
5673295|NCT00425269|19577422|P1|Overall Study|Lost to Follow-up|9
5673296|NCT00425269|19577421|P2|Overall Study|Pregnancy|7
5673297|NCT00425269|19577422|P1|Overall Study|Pregnancy|5
5673298|NCT00425113|19577500|P2|Overall Study|Withdrawal by Subject|0
5673299|NCT00425113|19577501|P1|Overall Study|Withdrawal by Subject|1
5673300|NCT00425113|19577500|P2|Overall Study|missing study drug more than 14 days|1
5673301|NCT00425113|19577501|P1|Overall Study|missing study drug more than 14 days|0
5673302|NCT00425113|19577500|P2|Overall Study|diagnosis of abdominal TB|1
5673303|NCT00425113|19577501|P1|Overall Study|diagnosis of abdominal TB|0
5673304|NCT00425113|19577500|P2|Overall Study|uncontrolled diabetes mellitus|0
5673305|NCT00425113|19577501|P1|Overall Study|uncontrolled diabetes mellitus|1
5673306|NCT00425100|19577509|P1|Overall Study|Withdrawal by Subject|7
5673307|NCT00425100|19577509|P1|Overall Study|Protocol Violation|4
5673308|NCT00425100|19577509|P1|Overall Study|Lost to Follow-up|2
5673309|NCT00425100|19577509|P1|Overall Study|Lack of Efficacy|4
5673310|NCT00425100|19577509|P1|Overall Study|Adverse Event|36
5673311|NCT00425061|19577553|P7|Overall Study|Other|1
5673312|NCT00425061|19577554|P6|Overall Study|Other|0
5673313|NCT00425061|19577555|P5|Overall Study|Other|3
5673314|NCT00425061|19577556|P4|Overall Study|Other|0
5673315|NCT00425061|19577557|P3|Overall Study|Other|0
5673316|NCT00425061|19577558|P2|Overall Study|Other|0
5673317|NCT00425061|19577559|P1|Overall Study|Other|0
5673318|NCT00425061|19577553|P7|Overall Study|Physician Decision|0
5673319|NCT00425061|19577554|P6|Overall Study|Physician Decision|0
5673320|NCT00425061|19577555|P5|Overall Study|Physician Decision|1
5673321|NCT00425061|19577556|P4|Overall Study|Physician Decision|0
5673322|NCT00425061|19577557|P3|Overall Study|Physician Decision|0
5673323|NCT00425061|19577558|P2|Overall Study|Physician Decision|0
5673324|NCT00425061|19577559|P1|Overall Study|Physician Decision|0
5673325|NCT00425061|19577553|P7|Overall Study|Sponsor's request|15
5673326|NCT00425061|19577554|P6|Overall Study|Sponsor's request|4
5673327|NCT00425061|19577555|P5|Overall Study|Sponsor's request|19
5673328|NCT00425061|19577556|P4|Overall Study|Sponsor's request|0
5673329|NCT00425061|19577557|P3|Overall Study|Sponsor's request|0
5673330|NCT00425061|19577558|P2|Overall Study|Sponsor's request|0
5673331|NCT00425061|19577559|P1|Overall Study|Sponsor's request|0
5673332|NCT00425061|19577553|P7|Overall Study|Withdrawal by Subject|3
5673333|NCT00425061|19577554|P6|Overall Study|Withdrawal by Subject|0
5673334|NCT00425061|19577555|P5|Overall Study|Withdrawal by Subject|1
5673335|NCT00425061|19577556|P4|Overall Study|Withdrawal by Subject|0
5673336|NCT00425061|19577557|P3|Overall Study|Withdrawal by Subject|0
5673337|NCT00425061|19577558|P2|Overall Study|Withdrawal by Subject|1
5673338|NCT00425061|19577559|P1|Overall Study|Withdrawal by Subject|0
5673339|NCT00425061|19577553|P7|Overall Study|Protocol Violation|0
5673340|NCT00425061|19577554|P6|Overall Study|Protocol Violation|0
5673341|NCT00425061|19577555|P5|Overall Study|Protocol Violation|0
5673342|NCT00425061|19577556|P4|Overall Study|Protocol Violation|0
5673343|NCT00425061|19577557|P3|Overall Study|Protocol Violation|0
5673344|NCT00425061|19577558|P2|Overall Study|Protocol Violation|0
5673345|NCT00425061|19577559|P1|Overall Study|Protocol Violation|1
5673346|NCT00425061|19577553|P7|Overall Study|Lost to Follow-up|0
5673347|NCT00425061|19577554|P6|Overall Study|Lost to Follow-up|0
5673348|NCT00425061|19577555|P5|Overall Study|Lost to Follow-up|0
5673349|NCT00425061|19577556|P4|Overall Study|Lost to Follow-up|0
5673350|NCT00425061|19577557|P3|Overall Study|Lost to Follow-up|0
5673351|NCT00425061|19577558|P2|Overall Study|Lost to Follow-up|1
5673352|NCT00425061|19577559|P1|Overall Study|Lost to Follow-up|0
5673353|NCT00425061|19577553|P7|Overall Study|Adverse Event|0
5673354|NCT00425061|19577554|P6|Overall Study|Adverse Event|0
5673355|NCT00425061|19577555|P5|Overall Study|Adverse Event|2
5673356|NCT00425061|19577556|P4|Overall Study|Adverse Event|2
5673357|NCT00425061|19577557|P3|Overall Study|Adverse Event|0
5673358|NCT00425061|19577558|P2|Overall Study|Adverse Event|0
5673359|NCT00425061|19577559|P1|Overall Study|Adverse Event|1
5673360|NCT00424827|19577683|P1|Overall Study|Adverse Event|1
5673361|NCT00424775|19577691|P2|Overall Study|Lack of Efficacy|0
5673362|NCT00424775|19577692|P1|Overall Study|Lack of Efficacy|1
5673363|NCT00424775|19577691|P2|Overall Study|Adverse Event|0
5673364|NCT00424775|19577692|P1|Overall Study|Adverse Event|2
5673365|NCT00424762|19577702|P2|Overall Study|Lost to Follow-up|3
5673366|NCT00424762|19577703|P1|Overall Study|Lost to Follow-up|2
5673367|NCT00424762|19577702|P2|Overall Study|Withdrawal by Subject|19
5673368|NCT00424762|19577703|P1|Overall Study|Withdrawal by Subject|18
5673369|NCT00424749|19577713|P1|Overall Study|Withdrawal by Subject|1
5673370|NCT00424645|19577720|P2|Overall Study|Death|0
5673371|NCT00424645|19577721|P1|Overall Study|Death|1
5673372|NCT00424632|19577729|P10|Overall Study|Other|0
5673373|NCT00424632|19577730|P9|Overall Study|Other|1
5673374|NCT00424632|19577731|P8|Overall Study|Other|0
5673375|NCT00424632|19577732|P7|Overall Study|Other|0
5673376|NCT00424632|19577733|P6|Overall Study|Other|0
5673377|NCT00424632|19577734|P5|Overall Study|Other|0
5673378|NCT00424632|19577735|P4|Overall Study|Other|1
5673379|NCT00424632|19577736|P3|Overall Study|Other|0
5673380|NCT00424632|19577737|P2|Overall Study|Other|0
5673381|NCT00424632|19577738|P1|Overall Study|Other|0
5673382|NCT00424632|19577729|P10|Overall Study|Objective progression or relapse|4
5673383|NCT00424632|19577730|P9|Overall Study|Objective progression or relapse|12
5673384|NCT00424632|19577731|P8|Overall Study|Objective progression or relapse|3
5673385|NCT00424632|19577732|P7|Overall Study|Objective progression or relapse|7
5673386|NCT00424632|19577733|P6|Overall Study|Objective progression or relapse|13
5673387|NCT00424632|19577734|P5|Overall Study|Objective progression or relapse|2
5673388|NCT00424632|19577735|P4|Overall Study|Objective progression or relapse|2
5673389|NCT00424632|19577736|P3|Overall Study|Objective progression or relapse|1
5673390|NCT00424632|19577737|P2|Overall Study|Objective progression or relapse|1
5673391|NCT00424632|19577738|P1|Overall Study|Objective progression or relapse|1
5673392|NCT00424632|19577729|P10|Overall Study|Global deterioration of health status|0
5673393|NCT00424632|19577730|P9|Overall Study|Global deterioration of health status|0
5673394|NCT00424632|19577731|P8|Overall Study|Global deterioration of health status|0
5673395|NCT00424632|19577732|P7|Overall Study|Global deterioration of health status|0
5673396|NCT00424632|19577733|P6|Overall Study|Global deterioration of health status|0
5673397|NCT00424632|19577734|P5|Overall Study|Global deterioration of health status|1
5673398|NCT00424632|19577735|P4|Overall Study|Global deterioration of health status|1
5673399|NCT00424632|19577736|P3|Overall Study|Global deterioration of health status|0
5673400|NCT00424632|19577737|P2|Overall Study|Global deterioration of health status|0
5673401|NCT00424632|19577738|P1|Overall Study|Global deterioration of health status|0
5673402|NCT00424632|19577729|P10|Overall Study|Adverse Event|2
5673403|NCT00424632|19577730|P9|Overall Study|Adverse Event|3
5673404|NCT00424632|19577731|P8|Overall Study|Adverse Event|0
5673405|NCT00424632|19577732|P7|Overall Study|Adverse Event|0
5673406|NCT00424632|19577733|P6|Overall Study|Adverse Event|0
5673407|NCT00424632|19577734|P5|Overall Study|Adverse Event|0
5673408|NCT00424632|19577735|P4|Overall Study|Adverse Event|0
5673409|NCT00424632|19577736|P3|Overall Study|Adverse Event|0
5673410|NCT00424632|19577737|P2|Overall Study|Adverse Event|0
5673411|NCT00424632|19577738|P1|Overall Study|Adverse Event|0
5673412|NCT00424632|19577729|P10|Overall Study|Death|0
5673413|NCT00424632|19577730|P9|Overall Study|Death|0
5673414|NCT00424632|19577731|P8|Overall Study|Death|0
5673415|NCT00424632|19577732|P7|Overall Study|Death|0
5673416|NCT00424632|19577733|P6|Overall Study|Death|2
5673417|NCT00424632|19577734|P5|Overall Study|Death|0
5673418|NCT00424632|19577735|P4|Overall Study|Death|0
5673419|NCT00424632|19577736|P3|Overall Study|Death|0
5673420|NCT00424632|19577737|P2|Overall Study|Death|0
5673421|NCT00424632|19577738|P1|Overall Study|Death|0
5673422|NCT00424593|19577908|P2|Dose-Blind Extension Period|Physician Decision|0
5673423|NCT00424593|19577909|P1|Dose-Blind Extension Period|Physician Decision|3
5673424|NCT00424593|19577908|P2|Dose-Blind Extension Period|Lost to Follow-up|0
5673425|NCT00424593|19577909|P1|Dose-Blind Extension Period|Lost to Follow-up|6
5673426|NCT00424593|19577908|P2|Dose-Blind Extension Period|Protocol Violation|0
5673427|NCT00424593|19577909|P1|Dose-Blind Extension Period|Protocol Violation|9
5673428|NCT00424593|19577908|P2|Dose-Blind Extension Period|Lack of Efficacy|0
5673429|NCT00424593|19577909|P1|Dose-Blind Extension Period|Lack of Efficacy|9
5673430|NCT00424593|19577908|P2|Dose-Blind Extension Period|Adverse Event|0
5673431|NCT00424593|19577909|P1|Dose-Blind Extension Period|Adverse Event|18
5673432|NCT00424593|19577908|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
5673433|NCT00424593|19577909|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
5673434|NCT00424593|19577908|P2|Acute Double-Blind Period|Lack of Efficacy|1
5673435|NCT00424593|19577909|P1|Acute Double-Blind Period|Lack of Efficacy|0
5673436|NCT00424593|19577908|P2|Acute Double-Blind Period|Lost to Follow-up|1
5673437|NCT00424593|19577909|P1|Acute Double-Blind Period|Lost to Follow-up|1
5673438|NCT00424593|19577908|P2|Acute Double-Blind Period|Physician Decision|2
5673439|NCT00424593|19577909|P1|Acute Double-Blind Period|Physician Decision|1
5673440|NCT00424593|19577908|P2|Acute Double-Blind Period|Protocol Violation|2
5673441|NCT00424593|19577909|P1|Acute Double-Blind Period|Protocol Violation|2
5673442|NCT00424593|19577908|P2|Acute Double-Blind Period|Withdrawal by Subject|10
5673443|NCT00424593|19577909|P1|Acute Double-Blind Period|Withdrawal by Subject|11
5673444|NCT00424593|19577908|P2|Acute Double-Blind Period|Adverse Event|7
5673445|NCT00424593|19577909|P1|Acute Double-Blind Period|Adverse Event|16
5673446|NCT00424528|19577973|P3|Overall Study|noncompliance with study requirements|2
5673447|NCT00424528|19577974|P2|Overall Study|noncompliance with study requirements|1
5673448|NCT00424528|19577975|P1|Overall Study|noncompliance with study requirements|2
5673449|NCT00424528|19577973|P3|Overall Study|Lost to Follow-up|0
5673450|NCT00424528|19577974|P2|Overall Study|Lost to Follow-up|1
5673451|NCT00424528|19577975|P1|Overall Study|Lost to Follow-up|0
5673452|NCT00424528|19577973|P3|Overall Study|Protocol Violation|0
5673453|NCT00424528|19577974|P2|Overall Study|Protocol Violation|1
5673454|NCT00424528|19577975|P1|Overall Study|Protocol Violation|1
5673455|NCT00424528|19577973|P3|Overall Study|Adverse Event|2
5673456|NCT00424528|19577974|P2|Overall Study|Adverse Event|1
5673457|NCT00424528|19577975|P1|Overall Study|Adverse Event|2
5673458|NCT00424515|19578030|P2|Overall Study|Withdrawal by Subject|0
5673459|NCT00424515|19578031|P1|Overall Study|Withdrawal by Subject|1
5673460|NCT00424515|19578030|P2|Overall Study|Intercurrent Illness|1
5673461|NCT00424515|19578031|P1|Overall Study|Intercurrent Illness|0
5673462|NCT00424515|19578030|P2|Overall Study|Adverse Event|1
5673463|NCT00424515|19578031|P1|Overall Study|Adverse Event|0
5673464|NCT00424515|19578030|P2|Overall Study|Progressive Disease|11
5673465|NCT00424515|19578031|P1|Overall Study|Progressive Disease|10
5673466|NCT00424489|19578050|P1|Overall Study|Death|3
5673467|NCT00424476|19578057|P3|Overall Study|Other|9
5673468|NCT00424476|19578058|P2|Overall Study|Other|3
5673469|NCT00424476|19578059|P1|Overall Study|Other|4
5673470|NCT00424476|19578057|P3|Overall Study|Physician Decision|3
5673471|NCT00424476|19578058|P2|Overall Study|Physician Decision|2
5673472|NCT00424476|19578059|P1|Overall Study|Physician Decision|3
5673473|NCT00424476|19578057|P3|Overall Study|Protocol Violation|3
5673474|NCT00424476|19578058|P2|Overall Study|Protocol Violation|2
5673475|NCT00424476|19578059|P1|Overall Study|Protocol Violation|7
5673476|NCT00424476|19578057|P3|Overall Study|Lost to Follow-up|3
5673477|NCT00424476|19578058|P2|Overall Study|Lost to Follow-up|6
5673478|NCT00424476|19578059|P1|Overall Study|Lost to Follow-up|4
5673479|NCT00424476|19578057|P3|Overall Study|Lack of Compliance|1
5673480|NCT00424476|19578058|P2|Overall Study|Lack of Compliance|1
5673481|NCT00424476|19578059|P1|Overall Study|Lack of Compliance|1
5673482|NCT00424476|19578057|P3|Overall Study|Lack of Efficacy|12
5673483|NCT00424476|19578058|P2|Overall Study|Lack of Efficacy|12
5673484|NCT00424476|19578059|P1|Overall Study|Lack of Efficacy|16
5673485|NCT00424476|19578057|P3|Overall Study|Adverse Event|15
5673486|NCT00424476|19578058|P2|Overall Study|Adverse Event|16
5673487|NCT00424476|19578059|P1|Overall Study|Adverse Event|19
5673488|NCT00424476|19578057|P3|Overall Study|Withdrawal by Subject|3
5673489|NCT00424476|19578058|P2|Overall Study|Withdrawal by Subject|6
5673490|NCT00424476|19578059|P1|Overall Study|Withdrawal by Subject|7
5673491|NCT00424463|19578085|P3|Overall Study|Patient's convenience|1
5673492|NCT00424463|19578086|P2|Overall Study|Patient's convenience|0
5673493|NCT00424463|19578087|P1|Overall Study|Patient's convenience|0
5673494|NCT00424463|19578085|P3|Overall Study|Tracheotomy due to worsening of ALS|6
5673495|NCT00424463|19578086|P2|Overall Study|Tracheotomy due to worsening of ALS|7
5673496|NCT00424463|19578087|P1|Overall Study|Tracheotomy due to worsening of ALS|1
5673497|NCT00424463|19578085|P3|Overall Study|Withdrawal by Subject|5
5673498|NCT00424463|19578086|P2|Overall Study|Withdrawal by Subject|2
5673499|NCT00424463|19578087|P1|Overall Study|Withdrawal by Subject|4
5673500|NCT00424463|19578085|P3|Overall Study|Physician Decision|2
5673501|NCT00424463|19578086|P2|Overall Study|Physician Decision|2
5673502|NCT00424463|19578087|P1|Overall Study|Physician Decision|0
5673503|NCT00424463|19578085|P3|Overall Study|Adverse Event|2
5673504|NCT00424463|19578086|P2|Overall Study|Adverse Event|3
5673505|NCT00424463|19578087|P1|Overall Study|Adverse Event|2
5673506|NCT00424398|19578116|P3|Overall Study|Subject met exclusion criteria|0
5673507|NCT00424398|19578117|P2|Overall Study|Subject met exclusion criteria|0
5673508|NCT00424398|19578118|P1|Overall Study|Subject met exclusion criteria|1
5673509|NCT00424398|19578116|P3|Overall Study|Withdrawal by Subject|0
5673510|NCT00424398|19578117|P2|Overall Study|Withdrawal by Subject|1
5673511|NCT00424398|19578118|P1|Overall Study|Withdrawal by Subject|2
5673512|NCT00424385|19578162|P1|Cohort 1|Withdrawal by Subject|1
5673513|NCT00424385|19578162|P1|Cohort 0|Physician Decision|1
5673514|NCT00424385|19578162|P1|Cohort 0|Withdrawal by Subject|5
5673515|NCT00424372|19578169|P1|Overall Study|Lack of Efficacy|6
5673516|NCT00424372|19578169|P1|Overall Study|Protocol Violation|1
5673517|NCT00424372|19578169|P1|Overall Study|Withdrawal by Subject|4
5673518|NCT00424372|19578169|P1|Overall Study|Health deterioration|1
5673519|NCT00424372|19578169|P1|Overall Study|Adverse Event|18
5673520|NCT00424372|19578169|P1|Overall Study|Death|1
5673521|NCT00424346|19578181|P4|Extension Phase|Protocol Violation|0
5673522|NCT00424346|19578182|P3|Extension Phase|Protocol Violation|1
5673523|NCT00424346|19578183|P2|Extension Phase|Protocol Violation|1
5673524|NCT00424346|19578184|P1|Extension Phase|Protocol Violation|0
5673525|NCT00424346|19578181|P4|Extension Phase|Death|1
5673526|NCT00424346|19578182|P3|Extension Phase|Death|0
5673527|NCT00424346|19578183|P2|Extension Phase|Death|0
5673528|NCT00424346|19578184|P1|Extension Phase|Death|0
5673529|NCT00424346|19578181|P4|Extension Phase|Administrative Problems|35
5673530|NCT00424346|19578182|P3|Extension Phase|Administrative Problems|32
5673531|NCT00424346|19578183|P2|Extension Phase|Administrative Problems|69
5673532|NCT00424346|19578184|P1|Extension Phase|Administrative Problems|0
5673533|NCT00424346|19578181|P4|Extension Phase|Lost to Follow-up|0
5673534|NCT00424346|19578182|P3|Extension Phase|Lost to Follow-up|0
5673535|NCT00424346|19578183|P2|Extension Phase|Lost to Follow-up|2
5673536|NCT00424346|19578184|P1|Extension Phase|Lost to Follow-up|0
5673537|NCT00424346|19578181|P4|Extension Phase|Withdrawal by Subject|4
5673538|NCT00424346|19578182|P3|Extension Phase|Withdrawal by Subject|3
5673539|NCT00424346|19578183|P2|Extension Phase|Withdrawal by Subject|5
5673540|NCT00424346|19578184|P1|Extension Phase|Withdrawal by Subject|0
5673541|NCT00424346|19578181|P4|Extension Phase|Lack of Efficacy|11
5673542|NCT00424346|19578182|P3|Extension Phase|Lack of Efficacy|14
5673543|NCT00424346|19578183|P2|Extension Phase|Lack of Efficacy|16
5673544|NCT00424346|19578184|P1|Extension Phase|Lack of Efficacy|0
5673545|NCT00424346|19578181|P4|Extension Phase|Adverse Event|4
5673546|NCT00424346|19578182|P3|Extension Phase|Adverse Event|5
5673547|NCT00424346|19578183|P2|Extension Phase|Adverse Event|9
5673548|NCT00424346|19578184|P1|Extension Phase|Adverse Event|0
5673549|NCT00424346|19578181|P4|Core Study|Protocol Violation|0
5673550|NCT00424346|19578182|P3|Core Study|Protocol Violation|2
5673551|NCT00424346|19578183|P2|Core Study|Protocol Violation|0
5673552|NCT00424346|19578184|P1|Core Study|Protocol Violation|0
5673553|NCT00424346|19578181|P4|Core Study|Administrative Problems|0
5673554|NCT00424346|19578182|P3|Core Study|Administrative Problems|1
5673555|NCT00424346|19578183|P2|Core Study|Administrative Problems|0
5673556|NCT00424346|19578184|P1|Core Study|Administrative Problems|1
5673557|NCT00424346|19578181|P4|Core Study|Lost to Follow-up|0
5673558|NCT00424346|19578182|P3|Core Study|Lost to Follow-up|0
5673559|NCT00424346|19578183|P2|Core Study|Lost to Follow-up|1
5673560|NCT00424346|19578184|P1|Core Study|Lost to Follow-up|1
5673561|NCT00424346|19578181|P4|Core Study|Withdrawal by Subject|2
5673562|NCT00424346|19578182|P3|Core Study|Withdrawal by Subject|0
5673563|NCT00424346|19578183|P2|Core Study|Withdrawal by Subject|0
5673564|NCT00424346|19578184|P1|Core Study|Withdrawal by Subject|1
5673565|NCT00424346|19578181|P4|Core Study|Lack of Efficacy|4
5673566|NCT00424346|19578182|P3|Core Study|Lack of Efficacy|0
5673567|NCT00424346|19578183|P2|Core Study|Lack of Efficacy|3
5673568|NCT00424346|19578184|P1|Core Study|Lack of Efficacy|1
5673569|NCT00424346|19578181|P4|Core Study|Abnormal Laboratory Values|0
5673570|NCT00424346|19578182|P3|Core Study|Abnormal Laboratory Values|0
5673571|NCT00424346|19578183|P2|Core Study|Abnormal Laboratory Values|1
5673572|NCT00424346|19578184|P1|Core Study|Abnormal Laboratory Values|0
5673573|NCT00424346|19578181|P4|Core Study|Adverse Event|1
5673574|NCT00424346|19578182|P3|Core Study|Adverse Event|1
5673575|NCT00424346|19578183|P2|Core Study|Adverse Event|3
5673576|NCT00424346|19578184|P1|Core Study|Adverse Event|5
5673577|NCT00424294|19578299|P2|Overall Study|Randomized but not Treated|0
5673578|NCT00424294|19578300|P1|Overall Study|Randomized but not Treated|1
5673579|NCT00424294|19578299|P2|Overall Study|Other|2
5673580|NCT00424294|19578300|P1|Overall Study|Other|0
5673581|NCT00424294|19578299|P2|Overall Study|Withdrawal by Subject|2
5673582|NCT00424294|19578300|P1|Overall Study|Withdrawal by Subject|1
5673583|NCT00424294|19578299|P2|Overall Study|Lack of Efficacy|1
5673584|NCT00424294|19578300|P1|Overall Study|Lack of Efficacy|2
5673585|NCT00424294|19578299|P2|Overall Study|Adverse Event|10
5673586|NCT00424294|19578300|P1|Overall Study|Adverse Event|4
5673587|NCT00424255|19578367|P2|Overall Study|Sponsor Terminated Study|167
5673588|NCT00424255|19578368|P1|Overall Study|Sponsor Terminated Study|161
5673589|NCT00424255|19578367|P2|Overall Study|Disease Progression|2
5673590|NCT00424255|19578368|P1|Overall Study|Disease Progression|0
5673591|NCT00424255|19578367|P2|Overall Study|Fatigue|0
5673592|NCT00424255|19578368|P1|Overall Study|Fatigue|1
5673593|NCT00424255|19578367|P2|Overall Study|Non-compliance by Participants|0
5673594|NCT00424255|19578368|P1|Overall Study|Non-compliance by Participants|1
5673595|NCT00424255|19578367|P2|Overall Study|Cognitive Disturbance|0
5673596|NCT00424255|19578368|P1|Overall Study|Cognitive Disturbance|1
5673597|NCT00424255|19578367|P2|Overall Study|Physician Decision|7
5673598|NCT00424255|19578368|P1|Overall Study|Physician Decision|3
5673599|NCT00424255|19578367|P2|Overall Study|Withdrawal by Subject|38
5673600|NCT00424255|19578368|P1|Overall Study|Withdrawal by Subject|34
5673601|NCT00424255|19578367|P2|Overall Study|Protocol Violation|1
5673602|NCT00424255|19578368|P1|Overall Study|Protocol Violation|0
5673603|NCT00424255|19578367|P2|Overall Study|Lost to Follow-up|20
5673604|NCT00424255|19578368|P1|Overall Study|Lost to Follow-up|26
5673605|NCT00424255|19578367|P2|Overall Study|Death|111
5673606|NCT00424255|19578368|P1|Overall Study|Death|115
5673607|NCT00424190|19578416|P2|Overall Study|Other|21
5673608|NCT00424190|19578417|P1|Overall Study|Other|15
5673609|NCT00424190|19578416|P2|Overall Study|Diagnosis of osteomyelitis|1
5673610|NCT00424190|19578417|P1|Overall Study|Diagnosis of osteomyelitis|0
5673611|NCT00424190|19578416|P2|Overall Study|Request of sponsor or investigator|2
5673612|NCT00424190|19578417|P1|Overall Study|Request of sponsor or investigator|0
5673613|NCT00424190|19578416|P2|Overall Study|Noncompliance|2
5673614|NCT00424190|19578417|P1|Overall Study|Noncompliance|1
5673615|NCT00424190|19578416|P2|Overall Study|Death|0
5673616|NCT00424190|19578417|P1|Overall Study|Death|3
5673617|NCT00424190|19578416|P2|Overall Study|Withdrew consent|4
5673618|NCT00424190|19578417|P1|Overall Study|Withdrew consent|3
5673619|NCT00424177|19578423|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
5673620|NCT00424177|19578423|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
5673621|NCT00424177|19578423|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
5673622|NCT00424177|19578423|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
5673623|NCT00424177|19578423|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
5673624|NCT00424177|19578423|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
5673625|NCT00424177|19578423|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
5673626|NCT00424177|19578423|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
5673627|NCT00424177|19578423|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
5673628|NCT00424177|19578423|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
5673629|NCT00424047|19578452|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
5673630|NCT00424047|19578453|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
5673631|NCT00424047|19578452|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
5673632|NCT00424047|19578453|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
5673633|NCT00424047|19578452|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
5673634|NCT00424047|19578453|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
5673635|NCT00424047|19578452|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
5673636|NCT00424047|19578453|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
5673637|NCT00424047|19578452|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
5673638|NCT00424047|19578453|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
5673639|NCT00424047|19578452|P2|On Study at Time of Unblinding|Other|4
5673640|NCT00424047|19578453|P1|On Study at Time of Unblinding|Other|5
5673641|NCT00424047|19578452|P2|On Study at Time of Unblinding|Death|11
5673642|NCT00424047|19578453|P1|On Study at Time of Unblinding|Death|11
5673643|NCT00424047|19578452|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
5673644|NCT00424047|19578453|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
5673645|NCT00424047|19578452|P2|On Study at Time of Unblinding|Lack of Efficacy|3
5673646|NCT00424047|19578453|P1|On Study at Time of Unblinding|Lack of Efficacy|1
5673647|NCT00424047|19578452|P2|On Study at Time of Unblinding|Progression of disease|128
5673648|NCT00424047|19578453|P1|On Study at Time of Unblinding|Progression of disease|92
5673649|NCT00424047|19578452|P2|On Study at Time of Unblinding|Adverse Event|12
5673650|NCT00424047|19578453|P1|On Study at Time of Unblinding|Adverse Event|22
5673651|NCT00424047|19578452|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
5673652|NCT00424047|19578453|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
5673653|NCT00424047|19578452|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
5673654|NCT00424047|19578453|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
5673655|NCT00424047|19578452|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
5673656|NCT00424047|19578453|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
5673657|NCT00424047|19578452|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
5673658|NCT00424047|19578453|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
5673659|NCT00424047|19578452|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
5673660|NCT00424047|19578453|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
5673661|NCT00424047|19578452|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
5673662|NCT00424047|19578453|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
5673663|NCT00424021|19578485|P4|AMB-220-E Study Period|Physician Decision|1
5673664|NCT00424021|19578486|P3|AMB-220-E Study Period|Physician Decision|0
5673665|NCT00424021|19578487|P2|AMB-220-E Study Period|Physician Decision|0
5673666|NCT00424021|19578488|P1|AMB-220-E Study Period|Physician Decision|0
5673667|NCT00424021|19578485|P4|AMB-220-E Study Period|Lost to Follow-up|1
5673668|NCT00424021|19578486|P3|AMB-220-E Study Period|Lost to Follow-up|1
5673669|NCT00424021|19578487|P2|AMB-220-E Study Period|Lost to Follow-up|1
5673670|NCT00424021|19578488|P1|AMB-220-E Study Period|Lost to Follow-up|0
5673671|NCT00424021|19578485|P4|AMB-220-E Study Period|Death|1
5673672|NCT00424021|19578486|P3|AMB-220-E Study Period|Death|1
5673673|NCT00424021|19578487|P2|AMB-220-E Study Period|Death|0
5673674|NCT00424021|19578488|P1|AMB-220-E Study Period|Death|0
5673675|NCT00424021|19578485|P4|AMB-220-E Study Period|Adverse Event|7
5673676|NCT00424021|19578486|P3|AMB-220-E Study Period|Adverse Event|3
5673677|NCT00424021|19578487|P2|AMB-220-E Study Period|Adverse Event|1
5673678|NCT00424021|19578488|P1|AMB-220-E Study Period|Adverse Event|1
5673679|NCT00424021|19578485|P4|NCT00046319 Study Period|Lost to Follow-up|0
5673680|NCT00424021|19578486|P3|NCT00046319 Study Period|Lost to Follow-up|0
5673681|NCT00424021|19578487|P2|NCT00046319 Study Period|Lost to Follow-up|1
5673682|NCT00424021|19578488|P1|NCT00046319 Study Period|Lost to Follow-up|0
5673683|NCT00424021|19578485|P4|NCT00046319 Study Period|Sponsor discretion|0
5673684|NCT00424021|19578486|P3|NCT00046319 Study Period|Sponsor discretion|0
5673685|NCT00424021|19578487|P2|NCT00046319 Study Period|Sponsor discretion|1
5673686|NCT00424021|19578488|P1|NCT00046319 Study Period|Sponsor discretion|0
5673687|NCT00424021|19578485|P4|NCT00046319 Study Period|Withdrawal by Subject|0
5673688|NCT00424021|19578486|P3|NCT00046319 Study Period|Withdrawal by Subject|0
5673689|NCT00424021|19578487|P2|NCT00046319 Study Period|Withdrawal by Subject|1
5673690|NCT00424021|19578488|P1|NCT00046319 Study Period|Withdrawal by Subject|0
5673691|NCT00424021|19578485|P4|NCT00046319 Study Period|Adverse Event|1
5673692|NCT00424021|19578486|P3|NCT00046319 Study Period|Adverse Event|1
5673693|NCT00424021|19578487|P2|NCT00046319 Study Period|Adverse Event|0
5673694|NCT00424021|19578488|P1|NCT00046319 Study Period|Adverse Event|1
5673695|NCT00424008|19578531|P2|Overall Study|Administrative|257
5673696|NCT00424008|19578532|P1|Overall Study|Administrative|266
5673697|NCT00424008|19578531|P2|Overall Study|Did not meet protocol eligibility|21
5673698|NCT00424008|19578532|P1|Overall Study|Did not meet protocol eligibility|16
5673699|NCT00424008|19578531|P2|Overall Study|Noncompliance with protocol|7
5673700|NCT00424008|19578532|P1|Overall Study|Noncompliance with protocol|13
5673701|NCT00424008|19578531|P2|Overall Study|Withdrawal by Subject|8
5673702|NCT00424008|19578532|P1|Overall Study|Withdrawal by Subject|5
5673703|NCT00424008|19578531|P2|Overall Study|Lost to Follow-up|2
5673704|NCT00424008|19578532|P1|Overall Study|Lost to Follow-up|1
5673705|NCT00424008|19578531|P2|Overall Study|Lack of Efficacy|34
5673706|NCT00424008|19578532|P1|Overall Study|Lack of Efficacy|40
5673707|NCT00424008|19578531|P2|Overall Study|Adverse Event|6
5673708|NCT00424008|19578532|P1|Overall Study|Adverse Event|8
5673709|NCT00423943|19578547|P2|Overall Study|Withdrawal by Subject|1
5673710|NCT00423943|19578548|P1|Overall Study|Withdrawal by Subject|3
5673711|NCT00423930|19578562|P1|Overall Study|Withdrawal by Subject|2
5673712|NCT00423917|19578567|P1|Overall Study|Ineligible|1
5673713|NCT00423917|19578567|P1|Overall Study|Cancel|2
5673714|NCT00423891|19578580|P3|Post-Dosing Follow Up|Lost to Follow-up|0
5673715|NCT00423891|19578581|P2|Post-Dosing Follow Up|Lost to Follow-up|0
5673716|NCT00423891|19578582|P1|Post-Dosing Follow Up|Lost to Follow-up|2
5673717|NCT00423891|19578580|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
5673718|NCT00423891|19578581|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
5673719|NCT00423891|19578582|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
5673720|NCT00423891|19578580|P3|Treatment|Lost to Follow-up|0
5673721|NCT00423891|19578581|P2|Treatment|Lost to Follow-up|0
5673722|NCT00423891|19578582|P1|Treatment|Lost to Follow-up|1
5673723|NCT00423891|19578580|P3|Treatment|Withdrawal by Subject|0
5673724|NCT00423891|19578581|P2|Treatment|Withdrawal by Subject|0
5673725|NCT00423891|19578582|P1|Treatment|Withdrawal by Subject|1
5673726|NCT00423891|19578580|P3|Enrolled|No longer met criteria|1
5673727|NCT00423891|19578581|P2|Enrolled|No longer met criteria|2
5673728|NCT00423891|19578582|P1|Enrolled|No longer met criteria|11
5673729|NCT00423891|19578580|P3|Enrolled|Lost to Follow-up|1
5673730|NCT00423891|19578581|P2|Enrolled|Lost to Follow-up|0
5673731|NCT00423891|19578582|P1|Enrolled|Lost to Follow-up|0
5673732|NCT00423891|19578580|P3|Enrolled|Withdrawal by Subject|1
5673733|NCT00423891|19578581|P2|Enrolled|Withdrawal by Subject|0
5673734|NCT00423891|19578582|P1|Enrolled|Withdrawal by Subject|0
5673735|NCT00423852|19578660|P1|Overall Study|Removed pior to the high-dose portion|3
5673736|NCT00423813|19578668|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
5673737|NCT00423813|19578669|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
5673738|NCT00423813|19578670|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
5673739|NCT00423813|19578668|P3|Overall Study|Will start exclusionary medications|0
5673740|NCT00423813|19578669|P2|Overall Study|Will start exclusionary medications|1
5673741|NCT00423813|19578670|P1|Overall Study|Will start exclusionary medications|0
5673742|NCT00423813|19578668|P3|Overall Study|Subject started night shift work|0
5673743|NCT00423813|19578669|P2|Overall Study|Subject started night shift work|0
5673744|NCT00423813|19578670|P1|Overall Study|Subject started night shift work|1
5673745|NCT00423813|19578668|P3|Overall Study|Pregnancy|1
5673746|NCT00423813|19578669|P2|Overall Study|Pregnancy|0
5673747|NCT00423813|19578670|P1|Overall Study|Pregnancy|0
5673748|NCT00423813|19578668|P3|Overall Study|Protocol Violation|4
5673749|NCT00423813|19578669|P2|Overall Study|Protocol Violation|4
5673750|NCT00423813|19578670|P1|Overall Study|Protocol Violation|9
5673751|NCT00423813|19578668|P3|Overall Study|Sponsor Decision|0
5673752|NCT00423813|19578669|P2|Overall Study|Sponsor Decision|1
5673753|NCT00423813|19578670|P1|Overall Study|Sponsor Decision|0
5673754|NCT00423813|19578668|P3|Overall Study|Physician Decision|0
5673755|NCT00423813|19578669|P2|Overall Study|Physician Decision|0
5673756|NCT00423813|19578670|P1|Overall Study|Physician Decision|2
5673757|NCT00423813|19578668|P3|Overall Study|Lack of Efficacy|19
5673758|NCT00423813|19578669|P2|Overall Study|Lack of Efficacy|18
5673759|NCT00423813|19578670|P1|Overall Study|Lack of Efficacy|23
5673760|NCT00423813|19578668|P3|Overall Study|Lost to Follow-up|4
5673761|NCT00423813|19578669|P2|Overall Study|Lost to Follow-up|4
5673762|NCT00423813|19578670|P1|Overall Study|Lost to Follow-up|5
5673763|NCT00423813|19578668|P3|Overall Study|Withdrawal by Subject|5
5673764|NCT00423813|19578669|P2|Overall Study|Withdrawal by Subject|8
5673765|NCT00423813|19578670|P1|Overall Study|Withdrawal by Subject|6
5673766|NCT00423813|19578668|P3|Overall Study|Adverse Event|40
5673767|NCT00423813|19578669|P2|Overall Study|Adverse Event|30
5673768|NCT00423813|19578670|P1|Overall Study|Adverse Event|11
5673769|NCT00423800|19578680|P2|Overall Study|Protocol Violation|1
5673770|NCT00423800|19578681|P1|Overall Study|Protocol Violation|0
5673771|NCT00423735|19578693|P3|Overall Study|Ineligible / No protocol treatment|0
5673772|NCT00423735|19578694|P2|Overall Study|Ineligible / No protocol treatment|6
5673773|NCT00423735|19578695|P1|Overall Study|Ineligible / No protocol treatment|8
5673774|NCT00423722|19578718|P2|Overall Study|Withdrawal by Subject|2
5673775|NCT00423722|19578719|P1|Overall Study|Withdrawal by Subject|4
5673776|NCT00423722|19578718|P2|Overall Study|Unable to complete questionnaires|4
5673777|NCT00423722|19578719|P1|Overall Study|Unable to complete questionnaires|4
5673778|NCT00423722|19578718|P2|Overall Study|Declined to participate|3
5673779|NCT00423722|19578719|P1|Overall Study|Declined to participate|2
5673780|NCT00423722|19578718|P2|Overall Study|Death|4
5673781|NCT00423722|19578719|P1|Overall Study|Death|4
5673782|NCT00423670|19578761|P8|Follow-up Period|Non-compliance with protocol|2
5673783|NCT00423670|19578762|P7|Follow-up Period|Non-compliance with protocol|3
5673784|NCT00423670|19578763|P6|Follow-up Period|Non-compliance with protocol|0
5673785|NCT00423670|19578764|P5|Follow-up Period|Non-compliance with protocol|0
5673786|NCT00423670|19578765|P4|Follow-up Period|Non-compliance with protocol|1
5673787|NCT00423670|19578766|P3|Follow-up Period|Non-compliance with protocol|1
5673788|NCT00423670|19578767|P2|Follow-up Period|Non-compliance with protocol|0
5673789|NCT00423670|19578768|P1|Follow-up Period|Non-compliance with protocol|2
5673790|NCT00423670|19578761|P8|Follow-up Period|Subject withdrew (not treatment related)|1
5673791|NCT00423670|19578762|P7|Follow-up Period|Subject withdrew (not treatment related)|1
5673792|NCT00423670|19578763|P6|Follow-up Period|Subject withdrew (not treatment related)|0
5673793|NCT00423670|19578764|P5|Follow-up Period|Subject withdrew (not treatment related)|1
5673794|NCT00423670|19578765|P4|Follow-up Period|Subject withdrew (not treatment related)|1
5673795|NCT00423670|19578766|P3|Follow-up Period|Subject withdrew (not treatment related)|2
5673796|NCT00423670|19578767|P2|Follow-up Period|Subject withdrew (not treatment related)|4
5673797|NCT00423670|19578768|P1|Follow-up Period|Subject withdrew (not treatment related)|1
5673798|NCT00423670|19578761|P8|Follow-up Period|Lost to Follow-up|0
5673799|NCT00423670|19578762|P7|Follow-up Period|Lost to Follow-up|5
5673800|NCT00423670|19578763|P6|Follow-up Period|Lost to Follow-up|0
5673801|NCT00423670|19578764|P5|Follow-up Period|Lost to Follow-up|1
5673802|NCT00423670|19578765|P4|Follow-up Period|Lost to Follow-up|3
5673803|NCT00423670|19578766|P3|Follow-up Period|Lost to Follow-up|8
5673804|NCT00423670|19578767|P2|Follow-up Period|Lost to Follow-up|12
5673805|NCT00423670|19578768|P1|Follow-up Period|Lost to Follow-up|0
5673806|NCT00423670|19578761|P8|Treatment Period|Non-compliance with protocol|2
5673807|NCT00423670|19578762|P7|Treatment Period|Non-compliance with protocol|2
5673808|NCT00423670|19578763|P6|Treatment Period|Non-compliance with protocol|0
5673809|NCT00423670|19578764|P5|Treatment Period|Non-compliance with protocol|2
5673810|NCT00423670|19578765|P4|Treatment Period|Non-compliance with protocol|3
5673811|NCT00423670|19578766|P3|Treatment Period|Non-compliance with protocol|1
5673812|NCT00423670|19578767|P2|Treatment Period|Non-compliance with protocol|1
5673813|NCT00423670|19578768|P1|Treatment Period|Non-compliance with protocol|3
5673814|NCT00423670|19578761|P8|Treatment Period|Investigator decision|1
5673815|NCT00423670|19578762|P7|Treatment Period|Investigator decision|0
5673816|NCT00423670|19578763|P6|Treatment Period|Investigator decision|0
5673817|NCT00423670|19578764|P5|Treatment Period|Investigator decision|0
5673818|NCT00423670|19578765|P4|Treatment Period|Investigator decision|0
5673819|NCT00423670|19578766|P3|Treatment Period|Investigator decision|0
5673820|NCT00423670|19578767|P2|Treatment Period|Investigator decision|0
5673821|NCT00423670|19578768|P1|Treatment Period|Investigator decision|0
5673822|NCT00423670|19578761|P8|Treatment Period|Subject withdrew (not treatment related)|0
5673823|NCT00423670|19578762|P7|Treatment Period|Subject withdrew (not treatment related)|3
5673824|NCT00423670|19578763|P6|Treatment Period|Subject withdrew (not treatment related)|0
5673825|NCT00423670|19578764|P5|Treatment Period|Subject withdrew (not treatment related)|5
5673826|NCT00423670|19578765|P4|Treatment Period|Subject withdrew (not treatment related)|4
5673827|NCT00423670|19578766|P3|Treatment Period|Subject withdrew (not treatment related)|4
5673828|NCT00423670|19578767|P2|Treatment Period|Subject withdrew (not treatment related)|9
5673829|NCT00423670|19578768|P1|Treatment Period|Subject withdrew (not treatment related)|3
5673830|NCT00423670|19578761|P8|Treatment Period|Lost to Follow-up|1
5673831|NCT00423670|19578762|P7|Treatment Period|Lost to Follow-up|3
5673832|NCT00423670|19578763|P6|Treatment Period|Lost to Follow-up|0
5673833|NCT00423670|19578764|P5|Treatment Period|Lost to Follow-up|6
5673834|NCT00423670|19578765|P4|Treatment Period|Lost to Follow-up|1
5673835|NCT00423670|19578766|P3|Treatment Period|Lost to Follow-up|3
5673836|NCT00423670|19578767|P2|Treatment Period|Lost to Follow-up|1
5673837|NCT00423670|19578768|P1|Treatment Period|Lost to Follow-up|2
5673838|NCT00423670|19578761|P8|Treatment Period|Protocol-defined clinical event|15
5673839|NCT00423670|19578762|P7|Treatment Period|Protocol-defined clinical event|16
5673840|NCT00423670|19578763|P6|Treatment Period|Protocol-defined clinical event|4
5673841|NCT00423670|19578764|P5|Treatment Period|Protocol-defined clinical event|5
5673842|NCT00423670|19578765|P4|Treatment Period|Protocol-defined clinical event|12
5673843|NCT00423670|19578766|P3|Treatment Period|Protocol-defined clinical event|4
5673844|NCT00423670|19578767|P2|Treatment Period|Protocol-defined clinical event|7
5673845|NCT00423670|19578768|P1|Treatment Period|Protocol-defined clinical event|0
5673846|NCT00423670|19578761|P8|Treatment Period|Adverse Event|2
5673847|NCT00423670|19578762|P7|Treatment Period|Adverse Event|7
5673848|NCT00423670|19578763|P6|Treatment Period|Adverse Event|4
5673849|NCT00423670|19578764|P5|Treatment Period|Adverse Event|9
5673850|NCT00423670|19578765|P4|Treatment Period|Adverse Event|20
5673851|NCT00423670|19578766|P3|Treatment Period|Adverse Event|15
5673852|NCT00423670|19578767|P2|Treatment Period|Adverse Event|12
5673853|NCT00423670|19578768|P1|Treatment Period|Adverse Event|8
5673854|NCT00423670|19578761|P8|Treatment Period|Switched to Arm 8 at TW 24|0
5673855|NCT00423670|19578762|P7|Treatment Period|Switched to Arm 8 at TW 24|0
5673856|NCT00423670|19578763|P6|Treatment Period|Switched to Arm 8 at TW 24|0
5673857|NCT00423670|19578764|P5|Treatment Period|Switched to Arm 8 at TW 24|0
5673858|NCT00423670|19578765|P4|Treatment Period|Switched to Arm 8 at TW 24|0
5673859|NCT00423670|19578766|P3|Treatment Period|Switched to Arm 8 at TW 24|0
5673860|NCT00423670|19578767|P2|Treatment Period|Switched to Arm 8 at TW 24|0
5673861|NCT00423670|19578768|P1|Treatment Period|Switched to Arm 8 at TW 24|36
5673862|NCT00423657|19578826|P2|Overall Study|Request of sponsor/investigator|0
5673863|NCT00423657|19578827|P1|Overall Study|Request of sponsor/investigator|1
5673864|NCT00423657|19578826|P2|Overall Study|Other|16
5673865|NCT00423657|19578827|P1|Overall Study|Other|15
5673866|NCT00423657|19578826|P2|Overall Study|Non-compliance|1
5673867|NCT00423657|19578827|P1|Overall Study|Non-compliance|0
5673868|NCT00423657|19578826|P2|Overall Study|Withdrew consent|8
5673869|NCT00423657|19578827|P1|Overall Study|Withdrew consent|10
5673870|NCT00423605|19578833|P1|Overall Study|Not one of the pre-specified options|5
5673871|NCT00423605|19578833|P1|Overall Study|Protocol Violation|7
5673872|NCT00423605|19578833|P1|Overall Study|Physician Decision|8
5673873|NCT00423605|19578833|P1|Overall Study|Sponsor Decision|3
5673874|NCT00423605|19578833|P1|Overall Study|Lack of Efficacy|38
5673875|NCT00423605|19578833|P1|Overall Study|Lost to Follow-up|15
5673876|NCT00423605|19578833|P1|Overall Study|Withdrawal by Subject|36
5673877|NCT00423605|19578833|P1|Overall Study|Adverse Event|129
5673878|NCT00423592|19578837|P1|Overall Study|Adverse Event (post Week 12)|5
5673879|NCT00423592|19578837|P1|Overall Study|Adverse Event (through Week 12)|2
5673880|NCT00423579|19578858|P2|Overall Study|Diagnosis of diabetes|1
5673881|NCT00423579|19578859|P1|Overall Study|Diagnosis of diabetes|0
5673882|NCT00423579|19578858|P2|Overall Study|Protocol Violation|3
5673883|NCT00423579|19578859|P1|Overall Study|Protocol Violation|1
5673884|NCT00423579|19578858|P2|Overall Study|Lost to Follow-up|0
5673885|NCT00423579|19578859|P1|Overall Study|Lost to Follow-up|3
5673886|NCT00423488|19578867|P2|Overall Study|No post baseline data|0
5673887|NCT00423488|19578868|P1|Overall Study|No post baseline data|3
5673888|NCT00423488|19578867|P2|Overall Study|No evidence of study drug intake|1
5673889|NCT00423488|19578868|P1|Overall Study|No evidence of study drug intake|2
5673890|NCT00423449|19578874|P5|Overall Study|Protocol Violation|0
5673891|NCT00423449|19578875|P4|Overall Study|Protocol Violation|1
5673892|NCT00423449|19578876|P3|Overall Study|Protocol Violation|2
5673893|NCT00423449|19578877|P2|Overall Study|Protocol Violation|0
5673894|NCT00423449|19578878|P1|Overall Study|Protocol Violation|0
5673895|NCT00423449|19578874|P5|Overall Study|Other|0
5673896|NCT00423449|19578875|P4|Overall Study|Other|1
5673897|NCT00423449|19578876|P3|Overall Study|Other|0
5673898|NCT00423449|19578877|P2|Overall Study|Other|0
5673899|NCT00423449|19578878|P1|Overall Study|Other|0
5673900|NCT00423449|19578874|P5|Overall Study|Laboratory Adverse Event|0
5673901|NCT00423449|19578875|P4|Overall Study|Laboratory Adverse Event|0
5673902|NCT00423449|19578876|P3|Overall Study|Laboratory Adverse Event|2
5673903|NCT00423449|19578877|P2|Overall Study|Laboratory Adverse Event|1
5673904|NCT00423449|19578878|P1|Overall Study|Laboratory Adverse Event|0
5673905|NCT00423449|19578874|P5|Overall Study|Progressive Disease|4
5673906|NCT00423449|19578875|P4|Overall Study|Progressive Disease|11
5673907|NCT00423449|19578876|P3|Overall Study|Progressive Disease|8
5673908|NCT00423449|19578877|P2|Overall Study|Progressive Disease|3
5673909|NCT00423449|19578878|P1|Overall Study|Progressive Disease|1
5673910|NCT00423449|19578874|P5|Overall Study|Death|1
5673911|NCT00423449|19578875|P4|Overall Study|Death|1
5673912|NCT00423449|19578876|P3|Overall Study|Death|2
5673913|NCT00423449|19578877|P2|Overall Study|Death|0
5673914|NCT00423449|19578878|P1|Overall Study|Death|1
5673915|NCT00423449|19578874|P5|Overall Study|Clinical Adverse Event|2
5673916|NCT00423449|19578875|P4|Overall Study|Clinical Adverse Event|8
5673917|NCT00423449|19578876|P3|Overall Study|Clinical Adverse Event|1
5673918|NCT00423449|19578877|P2|Overall Study|Clinical Adverse Event|0
5673919|NCT00423449|19578878|P1|Overall Study|Clinical Adverse Event|1
5673920|NCT00423332|19578925|P2|Overall Study|Unblinded before 12 weeks|3
5673921|NCT00423332|19578926|P1|Overall Study|Unblinded before 12 weeks|1
5673922|NCT00423332|19578925|P2|Overall Study|Progressive at Week 6|1
5673923|NCT00423332|19578926|P1|Overall Study|Progressive at Week 6|0
5673924|NCT00423332|19578925|P2|Overall Study|Condition under investigation worsened|1
5673925|NCT00423332|19578926|P1|Overall Study|Condition under investigation worsened|1
5673926|NCT00423332|19578925|P2|Overall Study|Withdrawal by Subject|0
5673927|NCT00423332|19578926|P1|Overall Study|Withdrawal by Subject|1
5673928|NCT00423332|19578925|P2|Overall Study|Adverse Event|2
5673929|NCT00423332|19578926|P1|Overall Study|Adverse Event|6
5673930|NCT00423319|19578945|P2|Overall Study|Other|22
5673931|NCT00423319|19578946|P1|Overall Study|Other|23
5673932|NCT00423319|19578945|P2|Overall Study|No longer meets study criteria|15
5673933|NCT00423319|19578946|P1|Overall Study|No longer meets study criteria|15
5673934|NCT00423319|19578945|P2|Overall Study|Poor compliance or noncompliance|1
5673935|NCT00423319|19578946|P1|Overall Study|Poor compliance or noncompliance|1
5673936|NCT00423319|19578945|P2|Overall Study|Lost to Follow-up|3
5673937|NCT00423319|19578946|P1|Overall Study|Lost to Follow-up|4
5673938|NCT00423319|19578945|P2|Overall Study|Withdrawal by Subject|99
5673939|NCT00423319|19578946|P1|Overall Study|Withdrawal by Subject|86
5673940|NCT00423319|19578945|P2|Overall Study|Adverse Event|112
5673941|NCT00423319|19578946|P1|Overall Study|Adverse Event|93
5673942|NCT00423319|19578945|P2|Overall Study|Death|0
5673943|NCT00423319|19578946|P1|Overall Study|Death|2
5673944|NCT00423293|19578978|P1|Overall Study|Ineligible / No protocol treatment|11
5673945|NCT00423267|19578995|P2|Period A|Administrative|0
5673946|NCT00423267|19578996|P1|Period A|Administrative|1
5673947|NCT00423267|19578995|P2|Period A|Non-compliance with protocol|0
5673948|NCT00423267|19578996|P1|Period A|Non-compliance with protocol|1
5673949|NCT00423267|19578995|P2|Period A|Withdrawal by Subject|1
5673950|NCT00423267|19578996|P1|Period A|Withdrawal by Subject|0
5673951|NCT00423189|19579016|P3|Overall Study|Death|0
5673952|NCT00423189|19579017|P2|Overall Study|Death|1
5673953|NCT00423189|19579018|P1|Overall Study|Death|0
5673954|NCT00423176|19579040|P2|Overall Study|Did not meet protocol eligibility|4
5673955|NCT00423176|19579041|P1|Overall Study|Did not meet protocol eligibility|2
5673956|NCT00423176|19579040|P2|Overall Study|Protocol Violation|3
5673957|NCT00423176|19579041|P1|Overall Study|Protocol Violation|1
5673958|NCT00423176|19579040|P2|Overall Study|Withdrawal by Subject|3
5673959|NCT00423176|19579041|P1|Overall Study|Withdrawal by Subject|4
5673960|NCT00423176|19579040|P2|Overall Study|Lost to Follow-up|7
5673961|NCT00423176|19579041|P1|Overall Study|Lost to Follow-up|4
5673962|NCT00423176|19579040|P2|Overall Study|Treatment Failure|6
5673963|NCT00423176|19579041|P1|Overall Study|Treatment Failure|1
5673964|NCT00423176|19579040|P2|Overall Study|Adverse Event|6
5673965|NCT00423176|19579041|P1|Overall Study|Adverse Event|4
5673966|NCT00423150|19579049|P1|Overall Study|Administrative|4
5673967|NCT00423150|19579049|P1|Overall Study|Non-compliance with protocol|1
5673968|NCT00423150|19579049|P1|Overall Study|Withdrawal by Subject|1
5673969|NCT00423150|19579049|P1|Overall Study|Progression of disease being studied|69
5673970|NCT00423150|19579049|P1|Overall Study|Adverse Event|11
5673971|NCT00423098|19579055|P2|Overall Study|Death|0
5673972|NCT00423098|19579056|P1|Overall Study|Death|2
5673973|NCT00423098|19579055|P2|Overall Study|Administrative problems|1
5673974|NCT00423098|19579056|P1|Overall Study|Administrative problems|0
5673975|NCT00423098|19579055|P2|Overall Study|Unsatisfactory therapeutic effect|1
5673976|NCT00423098|19579056|P1|Overall Study|Unsatisfactory therapeutic effect|0
5673977|NCT00423098|19579055|P2|Overall Study|Adverse Event|2
5673978|NCT00423098|19579056|P1|Overall Study|Adverse Event|1
5673979|NCT00423085|19579083|P4|52-Week Open-Label Extension Phase|Death|2
5673980|NCT00423085|19579084|P3|52-Week Open-Label Extension Phase|Death|0
5673981|NCT00423085|19579085|P2|52-Week Open-Label Extension Phase|Death|0
5673982|NCT00423085|19579086|P1|52-Week Open-Label Extension Phase|Death|0
5673983|NCT00423085|19579083|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
5673984|NCT00423085|19579084|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
5673985|NCT00423085|19579085|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
5673986|NCT00423085|19579086|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
5673987|NCT00423085|19579083|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
5673988|NCT00423085|19579084|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
5673989|NCT00423085|19579085|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
5673990|NCT00423085|19579086|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
5673991|NCT00423085|19579083|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
5673992|NCT00423085|19579084|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
5673993|NCT00423085|19579085|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
5673994|NCT00423085|19579086|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
5673995|NCT00423085|19579083|P4|52-Week Open-Label Extension Phase|Adverse Event|97
5673996|NCT00423085|19579084|P3|52-Week Open-Label Extension Phase|Adverse Event|0
5673997|NCT00423085|19579085|P2|52-Week Open-Label Extension Phase|Adverse Event|0
5673998|NCT00423085|19579086|P1|52-Week Open-Label Extension Phase|Adverse Event|0
5673999|NCT00423085|19579083|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
5674000|NCT00423085|19579084|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
5674001|NCT00423085|19579085|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
5674002|NCT00423085|19579086|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
5674003|NCT00423085|19579083|P4|24-Week Double-Blind Treatment Phase|Death|0
5674004|NCT00423085|19579084|P3|24-Week Double-Blind Treatment Phase|Death|0
5674005|NCT00423085|19579085|P2|24-Week Double-Blind Treatment Phase|Death|1
5674006|NCT00423085|19579086|P1|24-Week Double-Blind Treatment Phase|Death|1
5674007|NCT00423085|19579083|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
5674008|NCT00423085|19579084|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
5674009|NCT00423085|19579085|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
5674010|NCT00423085|19579086|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
5674011|NCT00423085|19579083|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
5674012|NCT00423085|19579084|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
5674013|NCT00423085|19579085|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
5674014|NCT00423085|19579086|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
5674015|NCT00423085|19579083|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
5674016|NCT00423085|19579084|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
5674017|NCT00423085|19579085|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
5674018|NCT00423085|19579086|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
5674019|NCT00423085|19579083|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
5674020|NCT00423085|19579084|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
5674021|NCT00423085|19579085|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
5674022|NCT00423085|19579086|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
5674023|NCT00423046|19579115|P2|Overall Study|Other|345
5674024|NCT00423046|19579116|P1|Overall Study|Other|340
5674025|NCT00422942|19579182|P1|Overall Study|Study terminated by Sponsor|3
5674026|NCT00422903|19579201|P2|Overall Study|Informed Consent Withdrawn|2
5674027|NCT00422903|19579202|P1|Overall Study|Informed Consent Withdrawn|1
5674028|NCT00422903|19579201|P2|Overall Study|Adverse Event|2
5674029|NCT00422903|19579202|P1|Overall Study|Adverse Event|0
5674030|NCT00422903|19579201|P2|Overall Study|Disease Progression|1
5674031|NCT00422903|19579202|P1|Overall Study|Disease Progression|3
5674032|NCT00422799|19579251|P1|Overall Study|Adverse Event|7
5674033|NCT00422799|19579251|P1|Overall Study|Withdrawal by Subject|6
5674034|NCT00422734|19579260|P2|Overall Study|Partner Decision|3
5674035|NCT00422734|19579261|P1|Overall Study|Partner Decision|0
5674036|NCT00422734|19579260|P2|Overall Study|Adverse Event|3
5674037|NCT00422734|19579261|P1|Overall Study|Adverse Event|0
5674038|NCT00422734|19579260|P2|Overall Study|Withdrawal by Subject|8
5674039|NCT00422734|19579261|P1|Overall Study|Withdrawal by Subject|12
5674040|NCT00422734|19579260|P2|Overall Study|Protocol Violation|6
5674041|NCT00422734|19579261|P1|Overall Study|Protocol Violation|1
5674042|NCT00422734|19579260|P2|Overall Study|Physician Decision|1
5674043|NCT00422734|19579261|P1|Overall Study|Physician Decision|1
5674044|NCT00422669|19579307|P3|Overall Study|The study was terminated early.|7
5674045|NCT00422669|19579308|P2|Overall Study|The study was terminated early.|100
5674046|NCT00422669|19579309|P1|Overall Study|The study was terminated early.|98
5674047|NCT00422591|19579337|P1|Overall Study|Withdrawal by Subject|2
5674048|NCT00422591|19579337|P1|Overall Study|Physician Decision|4
5674049|NCT00422513|19579345|P2|Overall Study|Death|7
5674050|NCT00422513|19579346|P1|Overall Study|Death|3
5674051|NCT00422513|19579345|P2|Overall Study|Adverse Event|4
5674052|NCT00422513|19579346|P1|Overall Study|Adverse Event|4
5674053|NCT00422513|19579345|P2|Overall Study|early termination of the study|80
5674054|NCT00422513|19579346|P1|Overall Study|early termination of the study|67
5674055|NCT00422513|19579345|P2|Overall Study|Withdrawal by Subject|1
5674056|NCT00422513|19579346|P1|Overall Study|Withdrawal by Subject|2
5674057|NCT00422513|19579345|P2|Overall Study|Refused Treatment|2
5674058|NCT00422513|19579346|P1|Overall Study|Refused Treatment|4
5674059|NCT00422513|19579345|P2|Overall Study|Protocol Violation|7
5674060|NCT00422513|19579346|P1|Overall Study|Protocol Violation|23
5674061|NCT00422513|19579345|P2|Overall Study|Lack of Efficacy|5
5674062|NCT00422513|19579346|P1|Overall Study|Lack of Efficacy|4
5674063|NCT00422422|19579363|P1|Overall Study|AE, non-serious non-fatal|5
5674064|NCT00422422|19579363|P1|Overall Study|SAE, non-fatal|1
5674065|NCT00422422|19579363|P1|Overall Study|Withdrawal by Subject|2
5674066|NCT00422422|19579363|P1|Overall Study|Protocol Violation|1
5674067|NCT00422422|19579363|P1|Overall Study|Lack of Efficacy|1
5674068|NCT00422383|19579380|P5|Overall Study|Withdrawal by Subject|1
5674069|NCT00422383|19579381|P4|Overall Study|Withdrawal by Subject|0
5674070|NCT00422383|19579382|P3|Overall Study|Withdrawal by Subject|0
5674071|NCT00422383|19579383|P2|Overall Study|Withdrawal by Subject|5
5674072|NCT00422383|19579384|P1|Overall Study|Withdrawal by Subject|5
5674073|NCT00422383|19579380|P5|Overall Study|Protocol Violation|0
5674074|NCT00422383|19579381|P4|Overall Study|Protocol Violation|0
5674075|NCT00422383|19579382|P3|Overall Study|Protocol Violation|1
5674076|NCT00422383|19579383|P2|Overall Study|Protocol Violation|1
5674077|NCT00422383|19579384|P1|Overall Study|Protocol Violation|1
5674078|NCT00422383|19579380|P5|Overall Study|Lost to Follow-up|1
5674079|NCT00422383|19579381|P4|Overall Study|Lost to Follow-up|0
5674080|NCT00422383|19579382|P3|Overall Study|Lost to Follow-up|0
5674081|NCT00422383|19579383|P2|Overall Study|Lost to Follow-up|1
5674082|NCT00422383|19579384|P1|Overall Study|Lost to Follow-up|0
5674083|NCT00422383|19579380|P5|Overall Study|Lack of Efficacy|1
5674084|NCT00422383|19579381|P4|Overall Study|Lack of Efficacy|1
5674085|NCT00422383|19579382|P3|Overall Study|Lack of Efficacy|2
5674086|NCT00422383|19579383|P2|Overall Study|Lack of Efficacy|4
5674087|NCT00422383|19579384|P1|Overall Study|Lack of Efficacy|4
5674088|NCT00422383|19579380|P5|Overall Study|Adverse Event|0
5674089|NCT00422383|19579381|P4|Overall Study|Adverse Event|1
5674090|NCT00422383|19579382|P3|Overall Study|Adverse Event|1
5674091|NCT00422383|19579383|P2|Overall Study|Adverse Event|3
5674092|NCT00422383|19579384|P1|Overall Study|Adverse Event|5
5674093|NCT00422292|19579527|P4|Overall Study|Withdrawal by Subject|13
5674094|NCT00422292|19579528|P3|Overall Study|Withdrawal by Subject|7
5674095|NCT00422292|19579529|P2|Overall Study|Withdrawal by Subject|25
5674096|NCT00422292|19579530|P1|Overall Study|Withdrawal by Subject|6
5674097|NCT00422292|19579527|P4|Overall Study|Lost to Follow-up|6
5674098|NCT00422292|19579528|P3|Overall Study|Lost to Follow-up|6
5674099|NCT00422292|19579529|P2|Overall Study|Lost to Follow-up|12
5674100|NCT00422292|19579530|P1|Overall Study|Lost to Follow-up|6
5674101|NCT00422292|19579527|P4|Overall Study|Protocol Violation|5
5674102|NCT00422292|19579528|P3|Overall Study|Protocol Violation|8
5674103|NCT00422292|19579529|P2|Overall Study|Protocol Violation|25
5674104|NCT00422292|19579530|P1|Overall Study|Protocol Violation|4
5674105|NCT00422292|19579527|P4|Overall Study|Adverse Event|0
5674106|NCT00422292|19579528|P3|Overall Study|Adverse Event|1
5674107|NCT00422292|19579529|P2|Overall Study|Adverse Event|0
5674108|NCT00422292|19579530|P1|Overall Study|Adverse Event|1
5674109|NCT00422292|19579527|P4|Overall Study|Serious adverse events|0
5674110|NCT00422292|19579528|P3|Overall Study|Serious adverse events|0
5674111|NCT00422292|19579529|P2|Overall Study|Serious adverse events|4
5674112|NCT00422292|19579530|P1|Overall Study|Serious adverse events|1
5674113|NCT00422227|19579569|P2|Overall Study|Withdrawal by Subject|4
5674114|NCT00422227|19579570|P1|Overall Study|Withdrawal by Subject|0
5674115|NCT00422227|19579569|P2|Overall Study|Lost to Follow-up|3
5674116|NCT00422227|19579570|P1|Overall Study|Lost to Follow-up|1
5674117|NCT00422227|19579569|P2|Overall Study|Adverse Event|8
5674118|NCT00422227|19579570|P1|Overall Study|Adverse Event|3
5674119|NCT00422162|19579601|P2|Overall Study|Didn't Receive Treatment|1
5674120|NCT00422162|19579602|P1|Overall Study|Didn't Receive Treatment|0
5674121|NCT00422162|19579601|P2|Overall Study|Other|1
5674122|NCT00422162|19579602|P1|Overall Study|Other|0
5674123|NCT00422162|19579601|P2|Overall Study|Non-Compliant with Protocol|1
5674124|NCT00422162|19579602|P1|Overall Study|Non-Compliant with Protocol|1
5674125|NCT00422162|19579601|P2|Overall Study|Lost to Follow-up|2
5674126|NCT00422162|19579602|P1|Overall Study|Lost to Follow-up|1
5674127|NCT00422162|19579601|P2|Overall Study|Withdrawal by Subject|6
5674128|NCT00422162|19579602|P1|Overall Study|Withdrawal by Subject|7
5674129|NCT00422162|19579601|P2|Overall Study|Lack of Efficacy|10
5674130|NCT00422162|19579602|P1|Overall Study|Lack of Efficacy|4
5674131|NCT00422162|19579601|P2|Overall Study|Adverse Event|9
5674132|NCT00422162|19579602|P1|Overall Study|Adverse Event|11
5674133|NCT00422097|19579662|P8|Dose Level 2|Still on treatment|0
5674134|NCT00422097|19579663|P7|Dose Level 2|Still on treatment|0
5674135|NCT00422097|19579664|P6|Dose Level 2|Still on treatment|0
5674136|NCT00422097|19579665|P5|Dose Level 2|Still on treatment|0
5674137|NCT00422097|19579666|P4|Dose Level 2|Still on treatment|0
5674138|NCT00422097|19579667|P3|Dose Level 2|Still on treatment|0
5674139|NCT00422097|19579668|P2|Dose Level 2|Still on treatment|1
5674140|NCT00422097|19579669|P1|Dose Level 2|Still on treatment|0
5674141|NCT00422058|19579734|P6|Open-Label Extension, Week 20-104|Other|18
5674142|NCT00422058|19579735|P5|Open-Label Extension, Week 20-104|Other|16
5674143|NCT00422058|19579736|P4|Open-Label Extension, Week 20-104|Other|13
5674144|NCT00422058|19579737|P3|Open-Label Extension, Week 20-104|Other|6
5674145|NCT00422058|19579738|P2|Open-Label Extension, Week 20-104|Other|14
5674146|NCT00422058|19579739|P1|Open-Label Extension, Week 20-104|Other|13
5674147|NCT00422058|19579734|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
5674148|NCT00422058|19579735|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
5674149|NCT00422058|19579736|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
5674150|NCT00422058|19579737|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
5674151|NCT00422058|19579738|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
5674152|NCT00422058|19579739|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
5674153|NCT00422058|19579734|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
5674154|NCT00422058|19579735|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
5674155|NCT00422058|19579736|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
5674156|NCT00422058|19579737|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
5674157|NCT00422058|19579738|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
5674158|NCT00422058|19579739|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
5674159|NCT00422058|19579734|P6|Open-Label Extension, Week 20-104|Adverse Event|0
5674160|NCT00422058|19579735|P5|Open-Label Extension, Week 20-104|Adverse Event|4
5674161|NCT00422058|19579736|P4|Open-Label Extension, Week 20-104|Adverse Event|4
5674162|NCT00422058|19579737|P3|Open-Label Extension, Week 20-104|Adverse Event|7
5674163|NCT00422058|19579738|P2|Open-Label Extension, Week 20-104|Adverse Event|4
5674164|NCT00422058|19579739|P1|Open-Label Extension, Week 20-104|Adverse Event|3
5674165|NCT00422058|19579734|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
5674166|NCT00422058|19579735|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
5674167|NCT00422058|19579736|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
5674168|NCT00422058|19579737|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
5674169|NCT00422058|19579738|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
5674170|NCT00422058|19579739|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
5674171|NCT00422058|19579734|P6|Double-Blind, Week 0-20|Other|10
5674172|NCT00422058|19579735|P5|Double-Blind, Week 0-20|Other|4
5674173|NCT00422058|19579736|P4|Double-Blind, Week 0-20|Other|8
5674174|NCT00422058|19579737|P3|Double-Blind, Week 0-20|Other|8
5674175|NCT00422058|19579738|P2|Double-Blind, Week 0-20|Other|3
5674176|NCT00422058|19579739|P1|Double-Blind, Week 0-20|Other|11
5674177|NCT00422058|19579734|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
5674178|NCT00422058|19579735|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
5674179|NCT00422058|19579736|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
5674180|NCT00422058|19579737|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
5674181|NCT00422058|19579738|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
5674182|NCT00422058|19579739|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
5674183|NCT00422058|19579734|P6|Double-Blind, Week 0-20|Protocol Violation|2
5674184|NCT00422058|19579735|P5|Double-Blind, Week 0-20|Protocol Violation|2
5674185|NCT00422058|19579736|P4|Double-Blind, Week 0-20|Protocol Violation|3
5674186|NCT00422058|19579737|P3|Double-Blind, Week 0-20|Protocol Violation|2
5674187|NCT00422058|19579738|P2|Double-Blind, Week 0-20|Protocol Violation|2
5674188|NCT00422058|19579739|P1|Double-Blind, Week 0-20|Protocol Violation|3
5674189|NCT00422058|19579734|P6|Double-Blind, Week 0-20|Adverse Event|3
5674190|NCT00422058|19579735|P5|Double-Blind, Week 0-20|Adverse Event|5
5674191|NCT00422058|19579736|P4|Double-Blind, Week 0-20|Adverse Event|9
5674192|NCT00422058|19579737|P3|Double-Blind, Week 0-20|Adverse Event|5
5674193|NCT00422058|19579738|P2|Double-Blind, Week 0-20|Adverse Event|4
5674194|NCT00422058|19579739|P1|Double-Blind, Week 0-20|Adverse Event|3
5674195|NCT00421993|19579880|P4|Overall Study|Subject transportation issues|1
5674196|NCT00421993|19579881|P3|Overall Study|Subject transportation issues|0
5674197|NCT00421993|19579882|P2|Overall Study|Subject transportation issues|0
5674198|NCT00421993|19579883|P1|Overall Study|Subject transportation issues|0
5674199|NCT00421993|19579880|P4|Overall Study|Pregnancy|2
5674200|NCT00421993|19579881|P3|Overall Study|Pregnancy|1
5674201|NCT00421993|19579882|P2|Overall Study|Pregnancy|1
5674202|NCT00421993|19579883|P1|Overall Study|Pregnancy|0
5674203|NCT00421993|19579880|P4|Overall Study|Lack of Efficacy|5
5674204|NCT00421993|19579881|P3|Overall Study|Lack of Efficacy|0
5674205|NCT00421993|19579882|P2|Overall Study|Lack of Efficacy|3
5674206|NCT00421993|19579883|P1|Overall Study|Lack of Efficacy|0
5674207|NCT00421993|19579880|P4|Overall Study|Protocol Violation|1
5674208|NCT00421993|19579881|P3|Overall Study|Protocol Violation|0
5674209|NCT00421993|19579882|P2|Overall Study|Protocol Violation|2
5674210|NCT00421993|19579883|P1|Overall Study|Protocol Violation|2
5674211|NCT00421993|19579880|P4|Overall Study|Adverse Event|4
5674212|NCT00421993|19579881|P3|Overall Study|Adverse Event|6
5674213|NCT00421993|19579882|P2|Overall Study|Adverse Event|1
5674214|NCT00421993|19579883|P1|Overall Study|Adverse Event|11
5674215|NCT00421993|19579880|P4|Overall Study|Lost to Follow-up|20
5674216|NCT00421993|19579881|P3|Overall Study|Lost to Follow-up|22
5674217|NCT00421993|19579882|P2|Overall Study|Lost to Follow-up|19
5674218|NCT00421993|19579883|P1|Overall Study|Lost to Follow-up|18
5674219|NCT00421993|19579880|P4|Overall Study|Withdrawal by Subject|24
5674220|NCT00421993|19579881|P3|Overall Study|Withdrawal by Subject|23
5674221|NCT00421993|19579882|P2|Overall Study|Withdrawal by Subject|23
5674222|NCT00421993|19579883|P1|Overall Study|Withdrawal by Subject|22
5674223|NCT00421928|19579920|P3|Overall Study|Death|0
5674224|NCT00421928|19579921|P2|Overall Study|Death|1
5674225|NCT00421928|19579922|P1|Overall Study|Death|0
5674226|NCT00421928|19579920|P3|Overall Study|All other|27
5674227|NCT00421928|19579921|P2|Overall Study|All other|21
5674228|NCT00421928|19579922|P1|Overall Study|All other|26
5674229|NCT00421928|19579920|P3|Overall Study|Study drug non-compliant|4
5674230|NCT00421928|19579921|P2|Overall Study|Study drug non-compliant|7
5674231|NCT00421928|19579922|P1|Overall Study|Study drug non-compliant|6
5674232|NCT00421928|19579920|P3|Overall Study|Lack of Efficacy|35
5674233|NCT00421928|19579921|P2|Overall Study|Lack of Efficacy|7
5674234|NCT00421928|19579922|P1|Overall Study|Lack of Efficacy|15
5674235|NCT00421928|19579920|P3|Overall Study|Withdrawal by Subject|43
5674236|NCT00421928|19579921|P2|Overall Study|Withdrawal by Subject|48
5674237|NCT00421928|19579922|P1|Overall Study|Withdrawal by Subject|50
5674238|NCT00421928|19579920|P3|Overall Study|Lost to Follow-up|3
5674239|NCT00421928|19579921|P2|Overall Study|Lost to Follow-up|0
5674240|NCT00421928|19579922|P1|Overall Study|Lost to Follow-up|5
5674241|NCT00421928|19579920|P3|Overall Study|Adverse Event|22
5674242|NCT00421928|19579921|P2|Overall Study|Adverse Event|140
5674243|NCT00421928|19579922|P1|Overall Study|Adverse Event|61
5674244|NCT00421889|19579957|P9|Overall Study|Lost to Follow-up|1
5674245|NCT00421889|19579958|P8|Overall Study|Lost to Follow-up|0
5674246|NCT00421889|19579959|P7|Overall Study|Lost to Follow-up|0
5674247|NCT00421889|19579960|P6|Overall Study|Lost to Follow-up|0
5674248|NCT00421889|19579961|P5|Overall Study|Lost to Follow-up|0
5674249|NCT00421889|19579962|P4|Overall Study|Lost to Follow-up|0
5674250|NCT00421889|19579963|P3|Overall Study|Lost to Follow-up|0
5674251|NCT00421889|19579964|P2|Overall Study|Lost to Follow-up|0
5674252|NCT00421889|19579965|P1|Overall Study|Lost to Follow-up|0
5674253|NCT00421889|19579957|P9|Overall Study|Patient/Investigator request|3
5674254|NCT00421889|19579958|P8|Overall Study|Patient/Investigator request|1
5674255|NCT00421889|19579959|P7|Overall Study|Patient/Investigator request|0
5674256|NCT00421889|19579960|P6|Overall Study|Patient/Investigator request|9
5674257|NCT00421889|19579961|P5|Overall Study|Patient/Investigator request|0
5674258|NCT00421889|19579962|P4|Overall Study|Patient/Investigator request|0
5674259|NCT00421889|19579963|P3|Overall Study|Patient/Investigator request|0
5674260|NCT00421889|19579964|P2|Overall Study|Patient/Investigator request|0
5674261|NCT00421889|19579965|P1|Overall Study|Patient/Investigator request|0
5674262|NCT00421889|19579957|P9|Overall Study|Progressive disease|5
5674263|NCT00421889|19579958|P8|Overall Study|Progressive disease|1
5674264|NCT00421889|19579959|P7|Overall Study|Progressive disease|3
5674265|NCT00421889|19579960|P6|Overall Study|Progressive disease|21
5674266|NCT00421889|19579961|P5|Overall Study|Progressive disease|2
5674267|NCT00421889|19579962|P4|Overall Study|Progressive disease|3
5674268|NCT00421889|19579963|P3|Overall Study|Progressive disease|2
5674269|NCT00421889|19579964|P2|Overall Study|Progressive disease|2
5674270|NCT00421889|19579965|P1|Overall Study|Progressive disease|3
5674271|NCT00421889|19579957|P9|Overall Study|Death|0
5674272|NCT00421889|19579958|P8|Overall Study|Death|0
5674273|NCT00421889|19579959|P7|Overall Study|Death|0
5674274|NCT00421889|19579960|P6|Overall Study|Death|1
5674275|NCT00421889|19579961|P5|Overall Study|Death|1
5674276|NCT00421889|19579962|P4|Overall Study|Death|0
5674277|NCT00421889|19579963|P3|Overall Study|Death|0
5674278|NCT00421889|19579964|P2|Overall Study|Death|0
5674279|NCT00421889|19579965|P1|Overall Study|Death|0
5674280|NCT00421889|19579957|P9|Overall Study|Withdrawal by Subject|0
5674281|NCT00421889|19579958|P8|Overall Study|Withdrawal by Subject|0
5674282|NCT00421889|19579959|P7|Overall Study|Withdrawal by Subject|0
5674283|NCT00421889|19579960|P6|Overall Study|Withdrawal by Subject|0
5674284|NCT00421889|19579961|P5|Overall Study|Withdrawal by Subject|2
5674285|NCT00421889|19579962|P4|Overall Study|Withdrawal by Subject|0
5674286|NCT00421889|19579963|P3|Overall Study|Withdrawal by Subject|0
5674287|NCT00421889|19579964|P2|Overall Study|Withdrawal by Subject|3
5674288|NCT00421889|19579965|P1|Overall Study|Withdrawal by Subject|1
5674289|NCT00421889|19579957|P9|Overall Study|Adverse Event|2
5674290|NCT00421889|19579958|P8|Overall Study|Adverse Event|0
5674291|NCT00421889|19579959|P7|Overall Study|Adverse Event|1
5674292|NCT00421889|19579960|P6|Overall Study|Adverse Event|4
5674293|NCT00421889|19579961|P5|Overall Study|Adverse Event|1
5674294|NCT00421889|19579962|P4|Overall Study|Adverse Event|1
5674295|NCT00421889|19579963|P3|Overall Study|Adverse Event|1
5674296|NCT00421889|19579964|P2|Overall Study|Adverse Event|0
5674297|NCT00421889|19579965|P1|Overall Study|Adverse Event|1
5674298|NCT00421733|19580010|P3|Overall Study|Protocol deviation|2
5674299|NCT00421733|19580011|P2|Overall Study|Protocol deviation|7
5674300|NCT00421733|19580012|P1|Overall Study|Protocol deviation|4
5674301|NCT00421733|19580010|P3|Overall Study|Sponsor request|3
5674302|NCT00421733|19580011|P2|Overall Study|Sponsor request|0
5674303|NCT00421733|19580012|P1|Overall Study|Sponsor request|1
5674304|NCT00421733|19580010|P3|Overall Study|Did not satisfy entry criteria|2
5674305|NCT00421733|19580011|P2|Overall Study|Did not satisfy entry criteria|3
5674306|NCT00421733|19580012|P1|Overall Study|Did not satisfy entry criteria|1
5674307|NCT00421733|19580010|P3|Overall Study|Administrative|0
5674308|NCT00421733|19580011|P2|Overall Study|Administrative|0
5674309|NCT00421733|19580012|P1|Overall Study|Administrative|2
5674310|NCT00421733|19580010|P3|Overall Study|Required dialysis|0
5674311|NCT00421733|19580011|P2|Overall Study|Required dialysis|0
5674312|NCT00421733|19580012|P1|Overall Study|Required dialysis|1
5674313|NCT00421733|19580010|P3|Overall Study|Death|0
5674314|NCT00421733|19580011|P2|Overall Study|Death|3
5674315|NCT00421733|19580012|P1|Overall Study|Death|0
5674316|NCT00421733|19580010|P3|Overall Study|Withdrawal by Subject|7
5674317|NCT00421733|19580011|P2|Overall Study|Withdrawal by Subject|2
5674318|NCT00421733|19580012|P1|Overall Study|Withdrawal by Subject|1
5674319|NCT00421733|19580010|P3|Overall Study|Lost to Follow-up|4
5674320|NCT00421733|19580011|P2|Overall Study|Lost to Follow-up|2
5674321|NCT00421733|19580012|P1|Overall Study|Lost to Follow-up|1
5674322|NCT00421733|19580010|P3|Overall Study|Adverse Event|2
5674323|NCT00421733|19580011|P2|Overall Study|Adverse Event|9
5674324|NCT00421733|19580012|P1|Overall Study|Adverse Event|4
5674325|NCT00421707|19580032|P2|Period 3:Treatment Period 2|Adverse Event|2
5674326|NCT00421707|19580033|P1|Period 3:Treatment Period 2|Adverse Event|0
5674327|NCT00421707|19580032|P2|Period 3:Treatment Period 2|Protocol Violation|0
5674328|NCT00421707|19580033|P1|Period 3:Treatment Period 2|Protocol Violation|1
5674329|NCT00421707|19580032|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
5674330|NCT00421707|19580033|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
5674331|NCT00421707|19580032|P2|Period 2: Washout|Other: Pregnancy|1
5674332|NCT00421707|19580033|P1|Period 2: Washout|Other: Pregnancy|0
5674333|NCT00421707|19580032|P2|Period 2: Washout|Lost to Follow-up|1
5674334|NCT00421707|19580033|P1|Period 2: Washout|Lost to Follow-up|0
5674335|NCT00421707|19580032|P2|Period 2: Washout|Withdrawal by Subject|1
5674336|NCT00421707|19580033|P1|Period 2: Washout|Withdrawal by Subject|0
5674337|NCT00421707|19580032|P2|Period 2: Washout|Adverse Event|1
5674338|NCT00421707|19580033|P1|Period 2: Washout|Adverse Event|1
5674339|NCT00421707|19580032|P2|Period 1: Treatment Period 1|Protocol Violation|0
5674340|NCT00421707|19580033|P1|Period 1: Treatment Period 1|Protocol Violation|1
5674341|NCT00421707|19580032|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
5674342|NCT00421707|19580033|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
5674343|NCT00421707|19580032|P2|Period 1: Treatment Period 1|Adverse Event|2
5674344|NCT00421707|19580033|P1|Period 1: Treatment Period 1|Adverse Event|7
5674345|NCT00421707|19580032|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
5674346|NCT00421707|19580033|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
5674347|NCT00421408|19580084|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
5674348|NCT00421408|19580085|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
5674349|NCT00421408|19580084|P2|Overall Study|Lost to Follow-up|20
5674350|NCT00421408|19580085|P1|Overall Study|Lost to Follow-up|30
5674351|NCT00421343|19580103|P1|Overall Study|Lost to Follow-up|3
5674352|NCT00421343|19580103|P1|Overall Study|Withdrawal by Subject|2
5674353|NCT00421343|19580103|P1|Overall Study|Death|1
5674354|NCT00421174|19580109|P2|Overall Study|Ineligible due to infection|0
5674355|NCT00421174|19580110|P1|Overall Study|Ineligible due to infection|2
5674356|NCT00421174|19580109|P2|Overall Study|Withdrawal by Subject|1
5674357|NCT00421174|19580110|P1|Overall Study|Withdrawal by Subject|0
5674358|NCT00421148|19580158|P20|Overall Study|Protocol Violation|0
5674359|NCT00421148|19580159|P19|Overall Study|Protocol Violation|1
5674360|NCT00421148|19580160|P18|Overall Study|Protocol Violation|0
5674361|NCT00421148|19580161|P17|Overall Study|Protocol Violation|0
5674362|NCT00421148|19580162|P16|Overall Study|Protocol Violation|0
5674363|NCT00421148|19580163|P15|Overall Study|Protocol Violation|0
5674364|NCT00421148|19580164|P14|Overall Study|Protocol Violation|0
5674365|NCT00421148|19580165|P13|Overall Study|Protocol Violation|0
5674366|NCT00421148|19580166|P12|Overall Study|Protocol Violation|0
5674367|NCT00421148|19580167|P11|Overall Study|Protocol Violation|0
5674368|NCT00421148|19580168|P10|Overall Study|Protocol Violation|0
5674369|NCT00421148|19580169|P9|Overall Study|Protocol Violation|0
5674370|NCT00421148|19580170|P8|Overall Study|Protocol Violation|0
5674371|NCT00421148|19580171|P7|Overall Study|Protocol Violation|0
5674372|NCT00421148|19580172|P6|Overall Study|Protocol Violation|1
5674373|NCT00421148|19580173|P5|Overall Study|Protocol Violation|0
5674374|NCT00421148|19580174|P4|Overall Study|Protocol Violation|0
5674375|NCT00421148|19580175|P3|Overall Study|Protocol Violation|0
5674376|NCT00421148|19580176|P2|Overall Study|Protocol Violation|0
5674377|NCT00421148|19580177|P1|Overall Study|Protocol Violation|0
5674378|NCT00421148|19580158|P20|Overall Study|Withdrawal by Subject|0
5674379|NCT00421148|19580159|P19|Overall Study|Withdrawal by Subject|0
5674380|NCT00421148|19580160|P18|Overall Study|Withdrawal by Subject|1
5674381|NCT00421148|19580161|P17|Overall Study|Withdrawal by Subject|0
5674382|NCT00421148|19580162|P16|Overall Study|Withdrawal by Subject|0
5674383|NCT00421148|19580163|P15|Overall Study|Withdrawal by Subject|0
5674384|NCT00421148|19580164|P14|Overall Study|Withdrawal by Subject|0
5674385|NCT00421148|19580165|P13|Overall Study|Withdrawal by Subject|0
5674386|NCT00421148|19580166|P12|Overall Study|Withdrawal by Subject|0
5674387|NCT00421148|19580167|P11|Overall Study|Withdrawal by Subject|0
5674388|NCT00421148|19580168|P10|Overall Study|Withdrawal by Subject|0
5674389|NCT00421148|19580169|P9|Overall Study|Withdrawal by Subject|0
5674390|NCT00421148|19580170|P8|Overall Study|Withdrawal by Subject|0
5674391|NCT00421148|19580171|P7|Overall Study|Withdrawal by Subject|0
5674392|NCT00421148|19580172|P6|Overall Study|Withdrawal by Subject|0
5674393|NCT00421148|19580173|P5|Overall Study|Withdrawal by Subject|0
5674394|NCT00421148|19580174|P4|Overall Study|Withdrawal by Subject|0
5674395|NCT00421148|19580175|P3|Overall Study|Withdrawal by Subject|0
5674396|NCT00421148|19580176|P2|Overall Study|Withdrawal by Subject|0
5674397|NCT00421148|19580177|P1|Overall Study|Withdrawal by Subject|0
5674398|NCT00421148|19580158|P20|Overall Study|Lost to Follow-up|0
5674399|NCT00421148|19580159|P19|Overall Study|Lost to Follow-up|0
5674400|NCT00421148|19580160|P18|Overall Study|Lost to Follow-up|1
5674401|NCT00421148|19580161|P17|Overall Study|Lost to Follow-up|0
5674402|NCT00421148|19580162|P16|Overall Study|Lost to Follow-up|0
5674403|NCT00421148|19580163|P15|Overall Study|Lost to Follow-up|0
5674404|NCT00421148|19580164|P14|Overall Study|Lost to Follow-up|0
5674405|NCT00421148|19580165|P13|Overall Study|Lost to Follow-up|0
5674406|NCT00421148|19580166|P12|Overall Study|Lost to Follow-up|0
5674407|NCT00421148|19580167|P11|Overall Study|Lost to Follow-up|0
5674408|NCT00421148|19580168|P10|Overall Study|Lost to Follow-up|0
5674409|NCT00421148|19580169|P9|Overall Study|Lost to Follow-up|0
5674410|NCT00421148|19580170|P8|Overall Study|Lost to Follow-up|0
5674411|NCT00421148|19580171|P7|Overall Study|Lost to Follow-up|0
5674412|NCT00421148|19580172|P6|Overall Study|Lost to Follow-up|0
5674413|NCT00421148|19580173|P5|Overall Study|Lost to Follow-up|0
5674414|NCT00421148|19580174|P4|Overall Study|Lost to Follow-up|0
5674415|NCT00421148|19580175|P3|Overall Study|Lost to Follow-up|0
5674416|NCT00421148|19580176|P2|Overall Study|Lost to Follow-up|0
5674417|NCT00421148|19580177|P1|Overall Study|Lost to Follow-up|0
5674418|NCT00420927|19580276|P7|Period 2|Took prohibited medication|0
5674419|NCT00420927|19580277|P6|Period 2|Took prohibited medication|0
5674420|NCT00420927|19580278|P5|Period 2|Took prohibited medication|1
5674421|NCT00420927|19580279|P4|Period 2|Took prohibited medication|0
5674422|NCT00420927|19580280|P3|Period 2|Took prohibited medication|0
5674423|NCT00420927|19580281|P2|Period 2|Took prohibited medication|0
5674424|NCT00420927|19580282|P1|Period 2|Took prohibited medication|0
5674425|NCT00420927|19580276|P7|Period 2|Methotrexate intolerance|1
5674426|NCT00420927|19580277|P6|Period 2|Methotrexate intolerance|0
5674427|NCT00420927|19580278|P5|Period 2|Methotrexate intolerance|0
5674428|NCT00420927|19580279|P4|Period 2|Methotrexate intolerance|0
5674429|NCT00420927|19580280|P3|Period 2|Methotrexate intolerance|0
5674430|NCT00420927|19580281|P2|Period 2|Methotrexate intolerance|0
5674431|NCT00420927|19580282|P1|Period 2|Methotrexate intolerance|0
5674432|NCT00420927|19580276|P7|Period 2|Noncompliant with study drug|2
5674433|NCT00420927|19580277|P6|Period 2|Noncompliant with study drug|0
5674434|NCT00420927|19580278|P5|Period 2|Noncompliant with study drug|0
5674435|NCT00420927|19580279|P4|Period 2|Noncompliant with study drug|1
5674436|NCT00420927|19580280|P3|Period 2|Noncompliant with study drug|0
5674437|NCT00420927|19580281|P2|Period 2|Noncompliant with study drug|0
5674438|NCT00420927|19580282|P1|Period 2|Noncompliant with study drug|0
5674439|NCT00420927|19580276|P7|Period 2|Randomization error|0
5674440|NCT00420927|19580277|P6|Period 2|Randomization error|1
5674441|NCT00420927|19580278|P5|Period 2|Randomization error|1
5674442|NCT00420927|19580279|P4|Period 2|Randomization error|0
5674443|NCT00420927|19580280|P3|Period 2|Randomization error|0
5674444|NCT00420927|19580281|P2|Period 2|Randomization error|0
5674445|NCT00420927|19580282|P1|Period 2|Randomization error|0
5674446|NCT00420927|19580276|P7|Period 2|Sponsor decision|1
5674447|NCT00420927|19580277|P6|Period 2|Sponsor decision|0
5674448|NCT00420927|19580278|P5|Period 2|Sponsor decision|0
5674449|NCT00420927|19580279|P4|Period 2|Sponsor decision|0
5674450|NCT00420927|19580280|P3|Period 2|Sponsor decision|1
5674451|NCT00420927|19580281|P2|Period 2|Sponsor decision|0
5674452|NCT00420927|19580282|P1|Period 2|Sponsor decision|0
5674453|NCT00420927|19580276|P7|Period 2|Physician Decision|0
5674454|NCT00420927|19580277|P6|Period 2|Physician Decision|1
5674455|NCT00420927|19580278|P5|Period 2|Physician Decision|1
5674456|NCT00420927|19580279|P4|Period 2|Physician Decision|0
5674457|NCT00420927|19580280|P3|Period 2|Physician Decision|0
5674458|NCT00420927|19580281|P2|Period 2|Physician Decision|0
5674459|NCT00420927|19580282|P1|Period 2|Physician Decision|0
5674460|NCT00420927|19580276|P7|Period 2|Subject unable to find transportation|1
5674461|NCT00420927|19580277|P6|Period 2|Subject unable to find transportation|0
5674462|NCT00420927|19580278|P5|Period 2|Subject unable to find transportation|0
5674463|NCT00420927|19580279|P4|Period 2|Subject unable to find transportation|0
5674464|NCT00420927|19580280|P3|Period 2|Subject unable to find transportation|0
5674465|NCT00420927|19580281|P2|Period 2|Subject unable to find transportation|0
5674466|NCT00420927|19580282|P1|Period 2|Subject unable to find transportation|0
5674467|NCT00420927|19580276|P7|Period 2|Received wrong treatment/incorrect dose|1
5674468|NCT00420927|19580277|P6|Period 2|Received wrong treatment/incorrect dose|0
5674469|NCT00420927|19580278|P5|Period 2|Received wrong treatment/incorrect dose|0
5674470|NCT00420927|19580279|P4|Period 2|Received wrong treatment/incorrect dose|0
5674471|NCT00420927|19580280|P3|Period 2|Received wrong treatment/incorrect dose|0
5674472|NCT00420927|19580281|P2|Period 2|Received wrong treatment/incorrect dose|0
5674473|NCT00420927|19580282|P1|Period 2|Received wrong treatment/incorrect dose|0
5674474|NCT00420927|19580276|P7|Period 2|Lack of efficacy/Loss of efficacy|6
5674475|NCT00420927|19580277|P6|Period 2|Lack of efficacy/Loss of efficacy|2
5674476|NCT00420927|19580278|P5|Period 2|Lack of efficacy/Loss of efficacy|6
5674477|NCT00420927|19580279|P4|Period 2|Lack of efficacy/Loss of efficacy|1
5674478|NCT00420927|19580280|P3|Period 2|Lack of efficacy/Loss of efficacy|2
5674479|NCT00420927|19580281|P2|Period 2|Lack of efficacy/Loss of efficacy|0
5674480|NCT00420927|19580282|P1|Period 2|Lack of efficacy/Loss of efficacy|0
5674481|NCT00420927|19580276|P7|Period 2|Lost to Follow-up|9
5674482|NCT00420927|19580277|P6|Period 2|Lost to Follow-up|3
5674483|NCT00420927|19580278|P5|Period 2|Lost to Follow-up|6
5674484|NCT00420927|19580279|P4|Period 2|Lost to Follow-up|2
5674485|NCT00420927|19580280|P3|Period 2|Lost to Follow-up|2
5674486|NCT00420927|19580281|P2|Period 2|Lost to Follow-up|0
5674487|NCT00420927|19580282|P1|Period 2|Lost to Follow-up|0
5674488|NCT00420927|19580276|P7|Period 2|Withdrawal by Subject|12
5674489|NCT00420927|19580277|P6|Period 2|Withdrawal by Subject|2
5674490|NCT00420927|19580278|P5|Period 2|Withdrawal by Subject|11
5674491|NCT00420927|19580279|P4|Period 2|Withdrawal by Subject|3
5674492|NCT00420927|19580280|P3|Period 2|Withdrawal by Subject|1
5674493|NCT00420927|19580281|P2|Period 2|Withdrawal by Subject|0
5674494|NCT00420927|19580282|P1|Period 2|Withdrawal by Subject|0
5674495|NCT00420927|19580276|P7|Period 2|Adverse Event|20
5674496|NCT00420927|19580277|P6|Period 2|Adverse Event|6
5674497|NCT00420927|19580278|P5|Period 2|Adverse Event|17
5674498|NCT00420927|19580279|P4|Period 2|Adverse Event|3
5674499|NCT00420927|19580280|P3|Period 2|Adverse Event|7
5674500|NCT00420927|19580281|P2|Period 2|Adverse Event|0
5674501|NCT00420927|19580282|P1|Period 2|Adverse Event|0
5674502|NCT00420927|19580276|P7|Period 1|Took prohibited medication|0
5674503|NCT00420927|19580277|P6|Period 1|Took prohibited medication|0
5674504|NCT00420927|19580278|P5|Period 1|Took prohibited medication|0
5674505|NCT00420927|19580279|P4|Period 1|Took prohibited medication|0
5674506|NCT00420927|19580280|P3|Period 1|Took prohibited medication|0
5674507|NCT00420927|19580281|P2|Period 1|Took prohibited medication|3
5674508|NCT00420927|19580282|P1|Period 1|Took prohibited medication|1
5674509|NCT00420927|19580276|P7|Period 1|Failed to meet entry criteria|0
5674510|NCT00420927|19580277|P6|Period 1|Failed to meet entry criteria|0
5674511|NCT00420927|19580278|P5|Period 1|Failed to meet entry criteria|0
5674512|NCT00420927|19580279|P4|Period 1|Failed to meet entry criteria|0
5674513|NCT00420927|19580280|P3|Period 1|Failed to meet entry criteria|0
5674514|NCT00420927|19580281|P2|Period 1|Failed to meet entry criteria|7
5674515|NCT00420927|19580282|P1|Period 1|Failed to meet entry criteria|8
5674516|NCT00420927|19580276|P7|Period 1|Received wrong treatment/incorrect dose|0
5674517|NCT00420927|19580277|P6|Period 1|Received wrong treatment/incorrect dose|0
5674518|NCT00420927|19580278|P5|Period 1|Received wrong treatment/incorrect dose|0
5674519|NCT00420927|19580279|P4|Period 1|Received wrong treatment/incorrect dose|0
5674520|NCT00420927|19580280|P3|Period 1|Received wrong treatment/incorrect dose|0
5674521|NCT00420927|19580281|P2|Period 1|Received wrong treatment/incorrect dose|1
5674522|NCT00420927|19580282|P1|Period 1|Received wrong treatment/incorrect dose|0
5674523|NCT00420927|19580276|P7|Period 1|Subject received new diagnosis|0
5674524|NCT00420927|19580277|P6|Period 1|Subject received new diagnosis|0
5674525|NCT00420927|19580278|P5|Period 1|Subject received new diagnosis|0
5674526|NCT00420927|19580279|P4|Period 1|Subject received new diagnosis|0
5674527|NCT00420927|19580280|P3|Period 1|Subject received new diagnosis|0
5674528|NCT00420927|19580281|P2|Period 1|Subject received new diagnosis|2
5674529|NCT00420927|19580282|P1|Period 1|Subject received new diagnosis|0
5674530|NCT00420927|19580276|P7|Period 1|Study site closure|0
5674531|NCT00420927|19580277|P6|Period 1|Study site closure|0
5674532|NCT00420927|19580278|P5|Period 1|Study site closure|0
5674533|NCT00420927|19580279|P4|Period 1|Study site closure|0
5674534|NCT00420927|19580280|P3|Period 1|Study site closure|0
5674535|NCT00420927|19580281|P2|Period 1|Study site closure|1
5674536|NCT00420927|19580282|P1|Period 1|Study site closure|0
5674537|NCT00420927|19580276|P7|Period 1|Suspected tuberculosis/positive test|0
5674538|NCT00420927|19580277|P6|Period 1|Suspected tuberculosis/positive test|0
5674539|NCT00420927|19580278|P5|Period 1|Suspected tuberculosis/positive test|0
5674540|NCT00420927|19580279|P4|Period 1|Suspected tuberculosis/positive test|0
5674541|NCT00420927|19580280|P3|Period 1|Suspected tuberculosis/positive test|0
5674542|NCT00420927|19580281|P2|Period 1|Suspected tuberculosis/positive test|1
5674543|NCT00420927|19580282|P1|Period 1|Suspected tuberculosis/positive test|1
5674544|NCT00420927|19580276|P7|Period 1|Randomization error|0
5674545|NCT00420927|19580277|P6|Period 1|Randomization error|0
5674546|NCT00420927|19580278|P5|Period 1|Randomization error|0
5674547|NCT00420927|19580279|P4|Period 1|Randomization error|0
5674548|NCT00420927|19580280|P3|Period 1|Randomization error|0
5674549|NCT00420927|19580281|P2|Period 1|Randomization error|0
5674550|NCT00420927|19580282|P1|Period 1|Randomization error|1
5674551|NCT00420927|19580276|P7|Period 1|Noncompliant with study drug|0
5674552|NCT00420927|19580277|P6|Period 1|Noncompliant with study drug|0
5674553|NCT00420927|19580278|P5|Period 1|Noncompliant with study drug|0
5674554|NCT00420927|19580279|P4|Period 1|Noncompliant with study drug|0
5674555|NCT00420927|19580280|P3|Period 1|Noncompliant with study drug|0
5674556|NCT00420927|19580281|P2|Period 1|Noncompliant with study drug|1
5674557|NCT00420927|19580282|P1|Period 1|Noncompliant with study drug|1
5674558|NCT00420927|19580276|P7|Period 1|Subject moved/relocated|0
5674559|NCT00420927|19580277|P6|Period 1|Subject moved/relocated|0
5674560|NCT00420927|19580278|P5|Period 1|Subject moved/relocated|0
5674561|NCT00420927|19580279|P4|Period 1|Subject moved/relocated|0
5674562|NCT00420927|19580280|P3|Period 1|Subject moved/relocated|0
5674563|NCT00420927|19580281|P2|Period 1|Subject moved/relocated|2
5674564|NCT00420927|19580282|P1|Period 1|Subject moved/relocated|0
5674565|NCT00420927|19580276|P7|Period 1|Death|0
5674566|NCT00420927|19580277|P6|Period 1|Death|0
5674567|NCT00420927|19580278|P5|Period 1|Death|0
5674568|NCT00420927|19580279|P4|Period 1|Death|0
5674569|NCT00420927|19580280|P3|Period 1|Death|0
5674570|NCT00420927|19580281|P2|Period 1|Death|0
5674571|NCT00420927|19580282|P1|Period 1|Death|2
5674572|NCT00420927|19580276|P7|Period 1|Lack of efficacy/Loss of efficacy|0
5674573|NCT00420927|19580277|P6|Period 1|Lack of efficacy/Loss of efficacy|0
5674574|NCT00420927|19580278|P5|Period 1|Lack of efficacy/Loss of efficacy|0
5674575|NCT00420927|19580279|P4|Period 1|Lack of efficacy/Loss of efficacy|0
5674576|NCT00420927|19580280|P3|Period 1|Lack of efficacy/Loss of efficacy|0
5674577|NCT00420927|19580281|P2|Period 1|Lack of efficacy/Loss of efficacy|6
5674578|NCT00420927|19580282|P1|Period 1|Lack of efficacy/Loss of efficacy|1
5674579|NCT00420927|19580276|P7|Period 1|Lost to Follow-up|0
5674580|NCT00420927|19580277|P6|Period 1|Lost to Follow-up|0
5674581|NCT00420927|19580278|P5|Period 1|Lost to Follow-up|0
5674582|NCT00420927|19580279|P4|Period 1|Lost to Follow-up|0
5674583|NCT00420927|19580280|P3|Period 1|Lost to Follow-up|0
5674584|NCT00420927|19580281|P2|Period 1|Lost to Follow-up|6
5674585|NCT00420927|19580282|P1|Period 1|Lost to Follow-up|8
5674586|NCT00420927|19580276|P7|Period 1|Withdrawal by Subject|0
5674587|NCT00420927|19580277|P6|Period 1|Withdrawal by Subject|0
5674588|NCT00420927|19580278|P5|Period 1|Withdrawal by Subject|0
5674589|NCT00420927|19580279|P4|Period 1|Withdrawal by Subject|0
5674590|NCT00420927|19580280|P3|Period 1|Withdrawal by Subject|0
5674591|NCT00420927|19580281|P2|Period 1|Withdrawal by Subject|12
5674592|NCT00420927|19580282|P1|Period 1|Withdrawal by Subject|7
5674593|NCT00420927|19580276|P7|Period 1|Adverse Event|0
5674594|NCT00420927|19580277|P6|Period 1|Adverse Event|0
5674595|NCT00420927|19580278|P5|Period 1|Adverse Event|0
5674596|NCT00420927|19580279|P4|Period 1|Adverse Event|0
5674597|NCT00420927|19580280|P3|Period 1|Adverse Event|0
5674598|NCT00420927|19580281|P2|Period 1|Adverse Event|15
5674599|NCT00420927|19580282|P1|Period 1|Adverse Event|19
5674600|NCT00420849|19580386|P1|Overall Study|Lost to Follow-up|1
5674601|NCT00420849|19580386|P1|Overall Study|Protocol Violation|1
5674602|NCT00420849|19580386|P1|Overall Study|Transplant|8
5674603|NCT00420849|19580386|P1|Overall Study|Other|14
5674604|NCT00420849|19580386|P1|Overall Study|Death|18
5674605|NCT00420849|19580386|P1|Overall Study|Withdrawal by Subject|28
5674606|NCT00420849|19580386|P1|Overall Study|Adverse Event|107
5674607|NCT00420849|19580386|P1|Overall Study|Lack of Efficacy|154
5674608|NCT00420784|19580455|P4|Overall Study|Other|5
5674609|NCT00420784|19580456|P3|Overall Study|Other|0
5674610|NCT00420784|19580457|P2|Overall Study|Other|2
5674611|NCT00420784|19580458|P1|Overall Study|Other|1
5674612|NCT00420784|19580455|P4|Overall Study|Virologic Stopping Rule|67
5674613|NCT00420784|19580456|P3|Overall Study|Virologic Stopping Rule|41
5674614|NCT00420784|19580457|P2|Overall Study|Virologic Stopping Rule|26
5674615|NCT00420784|19580458|P1|Overall Study|Virologic Stopping Rule|17
5674616|NCT00420784|19580455|P4|Overall Study|Lost to Follow-up|1
5674617|NCT00420784|19580456|P3|Overall Study|Lost to Follow-up|2
5674618|NCT00420784|19580457|P2|Overall Study|Lost to Follow-up|0
5674619|NCT00420784|19580458|P1|Overall Study|Lost to Follow-up|0
5674620|NCT00420784|19580455|P4|Overall Study|Withdrawal by Subject|0
5674621|NCT00420784|19580456|P3|Overall Study|Withdrawal by Subject|0
5674622|NCT00420784|19580457|P2|Overall Study|Withdrawal by Subject|1
5674623|NCT00420784|19580458|P1|Overall Study|Withdrawal by Subject|0
5674624|NCT00420784|19580455|P4|Overall Study|Adverse Event|5
5674625|NCT00420784|19580456|P3|Overall Study|Adverse Event|10
5674626|NCT00420784|19580457|P2|Overall Study|Adverse Event|29
5674627|NCT00420784|19580458|P1|Overall Study|Adverse Event|11
5674628|NCT00420745|19580496|P2|Overall Study|Age limit exceeded for Dose 2|0
5674629|NCT00420745|19580497|P1|Overall Study|Age limit exceeded for Dose 2|1
5674630|NCT00420745|19580496|P2|Overall Study|Recurrent pneumonia & bronchitis|1
5674631|NCT00420745|19580497|P1|Overall Study|Recurrent pneumonia & bronchitis|0
5674632|NCT00420745|19580496|P2|Overall Study|Physician Decision|1
5674633|NCT00420745|19580497|P1|Overall Study|Physician Decision|1
5674634|NCT00420745|19580496|P2|Overall Study|Protocol Violation|0
5674635|NCT00420745|19580497|P1|Overall Study|Protocol Violation|1
5674636|NCT00420745|19580496|P2|Overall Study|Lost to Follow-up|2
5674637|NCT00420745|19580497|P1|Overall Study|Lost to Follow-up|10
5674638|NCT00420745|19580496|P2|Overall Study|Adverse Event|2
5674639|NCT00420745|19580497|P1|Overall Study|Adverse Event|2
5674640|NCT00420641|19580516|P3|Overall Study|Other|3
5674641|NCT00420641|19580517|P2|Overall Study|Other|4
5674642|NCT00420641|19580518|P1|Overall Study|Other|4
5674643|NCT00420641|19580516|P3|Overall Study|Non-compliance|4
5674644|NCT00420641|19580517|P2|Overall Study|Non-compliance|5
5674645|NCT00420641|19580518|P1|Overall Study|Non-compliance|7
5674646|NCT00420641|19580516|P3|Overall Study|Lack of Efficacy|4
5674647|NCT00420641|19580517|P2|Overall Study|Lack of Efficacy|5
5674648|NCT00420641|19580518|P1|Overall Study|Lack of Efficacy|6
5674649|NCT00420641|19580516|P3|Overall Study|Withdrawal by Subject|14
5674650|NCT00420641|19580517|P2|Overall Study|Withdrawal by Subject|21
5674651|NCT00420641|19580518|P1|Overall Study|Withdrawal by Subject|15
5674652|NCT00420641|19580516|P3|Overall Study|Protocol Violation|7
5674653|NCT00420641|19580517|P2|Overall Study|Protocol Violation|8
5674654|NCT00420641|19580518|P1|Overall Study|Protocol Violation|8
5674655|NCT00420641|19580516|P3|Overall Study|Lost to Follow-up|2
5674656|NCT00420641|19580517|P2|Overall Study|Lost to Follow-up|4
5674657|NCT00420641|19580518|P1|Overall Study|Lost to Follow-up|2
5674658|NCT00420641|19580516|P3|Overall Study|Adverse Event|10
5674659|NCT00420641|19580517|P2|Overall Study|Adverse Event|25
5674660|NCT00420641|19580518|P1|Overall Study|Adverse Event|3
5674661|NCT00420628|19580594|P2|Overall Study|Adverse Event|0
5674662|NCT00420628|19580595|P1|Overall Study|Adverse Event|1
5674663|NCT00420628|19580594|P2|Overall Study|Lost to Follow-up|2
5674664|NCT00420628|19580595|P1|Overall Study|Lost to Follow-up|3
5674665|NCT00420628|19580594|P2|Overall Study|Withdrawn by parent or gaurdian|2
5674666|NCT00420628|19580595|P1|Overall Study|Withdrawn by parent or gaurdian|5
5674667|NCT00420511|19580611|P2|Overall Study|Lost to Follow-up|0
5674668|NCT00420511|19580612|P1|Overall Study|Lost to Follow-up|1
5674669|NCT00420511|19580611|P2|Overall Study|Adverse Event|1
5674670|NCT00420511|19580612|P1|Overall Study|Adverse Event|1
5674671|NCT00420420|19580633|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
5674672|NCT00420420|19580634|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
5674673|NCT00420420|19580633|P2|Overall Study|Withdrawal by Subject|0
5674674|NCT00420420|19580634|P1|Overall Study|Withdrawal by Subject|1
5674675|NCT00420420|19580633|P2|Overall Study|Protocol Violation|1
5674676|NCT00420420|19580634|P1|Overall Study|Protocol Violation|1
5674677|NCT00420420|19580633|P2|Overall Study|Adverse Event|3
5674678|NCT00420420|19580634|P1|Overall Study|Adverse Event|5
5674679|NCT00420407|19580652|P2|Overall Study|Withdrawal by Subject|2
5674680|NCT00420407|19580653|P1|Overall Study|Withdrawal by Subject|0
5674681|NCT00420407|19580652|P2|Overall Study|subject identified as Jehovah's witness|0
5674682|NCT00420407|19580653|P1|Overall Study|subject identified as Jehovah's witness|1
5674683|NCT00420407|19580652|P2|Overall Study|subject identified as detainee|0
5674684|NCT00420407|19580653|P1|Overall Study|subject identified as detainee|1
5674685|NCT00420407|19580652|P2|Overall Study|Physician Decision|1
5674686|NCT00420407|19580653|P1|Overall Study|Physician Decision|2
5674687|NCT00420407|19580652|P2|Overall Study|Lost to Follow-up|3
5674688|NCT00420407|19580653|P1|Overall Study|Lost to Follow-up|0
5674689|NCT00420381|19580660|P1|Overall Study|Protocol Violation|1
5674690|NCT00420342|19580672|P3|Overall Study|Withdrawal by Subject|0
5674691|NCT00420342|19580673|P2|Overall Study|Withdrawal by Subject|2
5674692|NCT00420342|19580674|P1|Overall Study|Withdrawal by Subject|0
5674693|NCT00420342|19580672|P3|Overall Study|Lost to Follow-up|1
5674694|NCT00420342|19580673|P2|Overall Study|Lost to Follow-up|0
5674695|NCT00420342|19580674|P1|Overall Study|Lost to Follow-up|1
5674696|NCT00420316|19580717|P2|Overall Study|Lost to Follow-up|8
5674697|NCT00420316|19580718|P1|Overall Study|Lost to Follow-up|12
5674698|NCT00420316|19580717|P2|Overall Study|Withdrawal by Subject|1
5674699|NCT00420316|19580718|P1|Overall Study|Withdrawal by Subject|0
5674700|NCT00420303|19580742|P2|Overall Study|Physician Decision|1
5674701|NCT00420303|19580743|P1|Overall Study|Physician Decision|0
5674702|NCT00420303|19580742|P2|Overall Study|Lack of Efficacy|3
5674703|NCT00420303|19580743|P1|Overall Study|Lack of Efficacy|0
5674704|NCT00420303|19580742|P2|Overall Study|Serious Adverse Event|0
5674705|NCT00420303|19580743|P1|Overall Study|Serious Adverse Event|1
5674706|NCT00420290|19580755|P2|Overall Study|did not meet inclusion/exclusion|1
5674707|NCT00420290|19580756|P1|Overall Study|did not meet inclusion/exclusion|1
5674708|NCT00420290|19580755|P2|Overall Study|Withdrawal by Subject|2
5674709|NCT00420290|19580756|P1|Overall Study|Withdrawal by Subject|0
5674710|NCT00420290|19580755|P2|Overall Study|Adverse Event|1
5674711|NCT00420290|19580756|P1|Overall Study|Adverse Event|3
5674712|NCT00420238|19580772|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
5674713|NCT00420238|19580773|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
5674714|NCT00420238|19580772|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
5674715|NCT00420238|19580773|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
5674716|NCT00420238|19580772|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
5674717|NCT00420238|19580773|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
5674718|NCT00420238|19580772|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
5674719|NCT00420238|19580773|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
5674720|NCT00420238|19580772|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
5674721|NCT00420238|19580773|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
5674722|NCT00420238|19580772|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
5674723|NCT00420238|19580773|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
5674724|NCT00420212|19580912|P3|Overall Study|Other-Unspecified|18
5674725|NCT00420212|19580913|P2|Overall Study|Other-Unspecified|14
5674726|NCT00420212|19580914|P1|Overall Study|Other-Unspecified|21
5674727|NCT00420212|19580912|P3|Overall Study|Death|1
5674728|NCT00420212|19580913|P2|Overall Study|Death|0
5674729|NCT00420212|19580914|P1|Overall Study|Death|0
5674730|NCT00420212|19580912|P3|Overall Study|Protocol Violation|8
5674731|NCT00420212|19580913|P2|Overall Study|Protocol Violation|4
5674732|NCT00420212|19580914|P1|Overall Study|Protocol Violation|4
5674733|NCT00420212|19580912|P3|Overall Study|Physician Decision|3
5674734|NCT00420212|19580913|P2|Overall Study|Physician Decision|4
5674735|NCT00420212|19580914|P1|Overall Study|Physician Decision|4
5674736|NCT00420212|19580912|P3|Overall Study|Withdrawal by Subject|19
5674737|NCT00420212|19580913|P2|Overall Study|Withdrawal by Subject|22
5674738|NCT00420212|19580914|P1|Overall Study|Withdrawal by Subject|31
5674739|NCT00420212|19580912|P3|Overall Study|Lost to Follow-up|11
5674740|NCT00420212|19580913|P2|Overall Study|Lost to Follow-up|11
5674741|NCT00420212|19580914|P1|Overall Study|Lost to Follow-up|9
5674742|NCT00420212|19580912|P3|Overall Study|Adverse Event|36
5674743|NCT00420212|19580913|P2|Overall Study|Adverse Event|40
5674744|NCT00420212|19580914|P1|Overall Study|Adverse Event|22
5674745|NCT00420199|19580940|P2|Overall Study|Participant no longer met study criteria|0
5674746|NCT00420199|19580941|P1|Overall Study|Participant no longer met study criteria|1
5674747|NCT00420095|19581007|P2|Overall Study|Lost to Follow-up|0
5674748|NCT00420095|19581008|P1|Overall Study|Lost to Follow-up|1
5674749|NCT00420095|19581007|P2|Overall Study|Protocol Violation|1
5674750|NCT00420095|19581008|P1|Overall Study|Protocol Violation|1
5674751|NCT00420095|19581007|P2|Overall Study|Adverse Event|0
5674752|NCT00420095|19581008|P1|Overall Study|Adverse Event|1
5674753|NCT00420056|19581026|P1|Overall Study|Objective progression or relapse|17
5674754|NCT00420004|19581066|P3|Overall Study|Sponsor Decision|1
5674755|NCT00420004|19581067|P2|Overall Study|Sponsor Decision|3
5674756|NCT00420004|19581068|P1|Overall Study|Sponsor Decision|3
5674757|NCT00420004|19581066|P3|Overall Study|Withdrawal by Subject|14
5674758|NCT00420004|19581067|P2|Overall Study|Withdrawal by Subject|42
5674759|NCT00420004|19581068|P1|Overall Study|Withdrawal by Subject|67
5674760|NCT00420004|19581066|P3|Overall Study|Protocol Violation|3
5674761|NCT00420004|19581067|P2|Overall Study|Protocol Violation|4
5674762|NCT00420004|19581068|P1|Overall Study|Protocol Violation|5
5674763|NCT00420004|19581066|P3|Overall Study|Physician Decision|2
5674764|NCT00420004|19581067|P2|Overall Study|Physician Decision|4
5674765|NCT00420004|19581068|P1|Overall Study|Physician Decision|14
5674766|NCT00420004|19581066|P3|Overall Study|Entry Criteria Not Met|0
5674767|NCT00420004|19581067|P2|Overall Study|Entry Criteria Not Met|1
5674768|NCT00420004|19581068|P1|Overall Study|Entry Criteria Not Met|0
5674769|NCT00420004|19581066|P3|Overall Study|Lost to Follow-up|10
5674770|NCT00420004|19581067|P2|Overall Study|Lost to Follow-up|12
5674771|NCT00420004|19581068|P1|Overall Study|Lost to Follow-up|31
5674772|NCT00420004|19581066|P3|Overall Study|Lack of Efficacy|1
5674773|NCT00420004|19581067|P2|Overall Study|Lack of Efficacy|4
5674774|NCT00420004|19581068|P1|Overall Study|Lack of Efficacy|5
5674775|NCT00420004|19581066|P3|Overall Study|Adverse Event|1
5674776|NCT00420004|19581067|P2|Overall Study|Adverse Event|1
5674777|NCT00420004|19581068|P1|Overall Study|Adverse Event|4
5674778|NCT00419952|19581133|P2|Overall Study|Abnormal ECG|0
5674779|NCT00419952|19581134|P1|Overall Study|Abnormal ECG|1
5674780|NCT00419952|19581133|P2|Overall Study|Diary or medication non-compliance|4
5674781|NCT00419952|19581134|P1|Overall Study|Diary or medication non-compliance|2
5674782|NCT00419952|19581133|P2|Overall Study|Occurence of 2 or more exacerbations|0
5674783|NCT00419952|19581134|P1|Overall Study|Occurence of 2 or more exacerbations|2
5674784|NCT00419952|19581133|P2|Overall Study|Intake of prohibited medication|2
5674785|NCT00419952|19581134|P1|Overall Study|Intake of prohibited medication|2
5674786|NCT00419952|19581133|P2|Overall Study|Incorrectly enrolled|3
5674787|NCT00419952|19581134|P1|Overall Study|Incorrectly enrolled|10
5674788|NCT00419952|19581133|P2|Overall Study|Physician Decision|3
5674789|NCT00419952|19581134|P1|Overall Study|Physician Decision|1
5674790|NCT00419952|19581133|P2|Overall Study|Pregnancy|2
5674791|NCT00419952|19581134|P1|Overall Study|Pregnancy|4
5674792|NCT00419952|19581133|P2|Overall Study|Protocol Violation|24
5674793|NCT00419952|19581134|P1|Overall Study|Protocol Violation|32
5674794|NCT00419952|19581133|P2|Overall Study|Lost to Follow-up|34
5674795|NCT00419952|19581134|P1|Overall Study|Lost to Follow-up|43
5674796|NCT00419952|19581133|P2|Overall Study|Withdrawal by Subject|43
5674797|NCT00419952|19581134|P1|Overall Study|Withdrawal by Subject|44
5674798|NCT00419952|19581133|P2|Overall Study|Adverse Event|10
5674799|NCT00419952|19581134|P1|Overall Study|Adverse Event|8
5674800|NCT00419926|19581168|P2|Overall Study|Death|1
5674801|NCT00419926|19581169|P1|Overall Study|Death|2
5674802|NCT00419926|19581168|P2|Overall Study|Lost to Follow-up|2
5674803|NCT00419926|19581169|P1|Overall Study|Lost to Follow-up|1
5674804|NCT00419926|19581168|P2|Overall Study|Administrative Problem|4
5674805|NCT00419926|19581169|P1|Overall Study|Administrative Problem|4
5674806|NCT00419926|19581168|P2|Overall Study|Withdrawal by Subject|3
5674807|NCT00419926|19581169|P1|Overall Study|Withdrawal by Subject|7
5674808|NCT00419770|19581185|P2|Overall Study|Withdrawal by Subject|1
5674809|NCT00419770|19581186|P1|Overall Study|Withdrawal by Subject|5
5674810|NCT00419757|19581194|P2|Overall Study|Multiple reasons|1
5674811|NCT00419757|19581195|P1|Overall Study|Multiple reasons|3
5674812|NCT00419757|19581194|P2|Overall Study|Study specific discontinuation criteria|8
5674813|NCT00419757|19581195|P1|Overall Study|Study specific discontinuation criteria|4
5674814|NCT00419757|19581194|P2|Overall Study|Protocol Violation|3
5674815|NCT00419757|19581195|P1|Overall Study|Protocol Violation|2
5674816|NCT00419757|19581194|P2|Overall Study|Withdrawal by Subject|1
5674817|NCT00419757|19581195|P1|Overall Study|Withdrawal by Subject|7
5674818|NCT00419757|19581194|P2|Overall Study|Lost to Follow-up|4
5674819|NCT00419757|19581195|P1|Overall Study|Lost to Follow-up|1
5674820|NCT00419757|19581194|P2|Overall Study|Adverse Event|4
5674821|NCT00419757|19581195|P1|Overall Study|Adverse Event|1
5674822|NCT00419744|19581234|P3|Overall Study|Incorrect medication kit dispensed|1
5674823|NCT00419744|19581235|P2|Overall Study|Incorrect medication kit dispensed|0
5674824|NCT00419744|19581236|P1|Overall Study|Incorrect medication kit dispensed|0
5674825|NCT00419744|19581234|P3|Overall Study|Spirometry mouthpiece issues|2
5674826|NCT00419744|19581235|P2|Overall Study|Spirometry mouthpiece issues|1
5674827|NCT00419744|19581236|P1|Overall Study|Spirometry mouthpiece issues|0
5674828|NCT00419744|19581234|P3|Overall Study|Physician Decision|6
5674829|NCT00419744|19581235|P2|Overall Study|Physician Decision|5
5674830|NCT00419744|19581236|P1|Overall Study|Physician Decision|10
5674831|NCT00419744|19581234|P3|Overall Study|Moving out of state|1
5674832|NCT00419744|19581235|P2|Overall Study|Moving out of state|0
5674833|NCT00419744|19581236|P1|Overall Study|Moving out of state|2
5674834|NCT00419744|19581234|P3|Overall Study|Randomized in error|7
5674835|NCT00419744|19581235|P2|Overall Study|Randomized in error|6
5674836|NCT00419744|19581236|P1|Overall Study|Randomized in error|9
5674837|NCT00419744|19581234|P3|Overall Study|Protocol Violation|8
5674838|NCT00419744|19581235|P2|Overall Study|Protocol Violation|7
5674839|NCT00419744|19581236|P1|Overall Study|Protocol Violation|4
5674840|NCT00419744|19581234|P3|Overall Study|Lost to Follow-up|6
5674841|NCT00419744|19581235|P2|Overall Study|Lost to Follow-up|10
5674842|NCT00419744|19581236|P1|Overall Study|Lost to Follow-up|8
5674843|NCT00419744|19581234|P3|Overall Study|Withdrawal by Subject|52
5674844|NCT00419744|19581235|P2|Overall Study|Withdrawal by Subject|49
5674845|NCT00419744|19581236|P1|Overall Study|Withdrawal by Subject|45
5674846|NCT00419744|19581234|P3|Overall Study|Adverse Event|50
5674847|NCT00419744|19581235|P2|Overall Study|Adverse Event|40
5674848|NCT00419744|19581236|P1|Overall Study|Adverse Event|39
5674849|NCT00419562|19581279|P2|Overall Study|Participant Institutionalized|0
5674850|NCT00419562|19581280|P1|Overall Study|Participant Institutionalized|1
5674851|NCT00419562|19581279|P2|Overall Study|Withdrawal by Subject|18
5674852|NCT00419562|19581280|P1|Overall Study|Withdrawal by Subject|20
5674853|NCT00419562|19581279|P2|Overall Study|Lost to Follow-up|13
5674854|NCT00419562|19581280|P1|Overall Study|Lost to Follow-up|12
5674855|NCT00419393|19581303|P1|Overall Study|Other: Investigator decision|1
5674856|NCT00419393|19581303|P1|Overall Study|Other: Other health problems|1
5674857|NCT00419393|19581303|P1|Overall Study|Other: Site closure|1
5674858|NCT00419393|19581303|P1|Overall Study|Other: Subject had temporal lobectomy|1
5674859|NCT00419393|19581303|P1|Overall Study|Other: Sponsor request|3
5674860|NCT00419393|19581303|P1|Overall Study|Withdrawal by Subject|7
5674861|NCT00419393|19581303|P1|Overall Study|Protocol Violation|5
5674862|NCT00419393|19581303|P1|Overall Study|Adverse Event|5
5674863|NCT00419380|19581313|P2|Overall Study|Withdrawal by Subject|1
5674864|NCT00419380|19581314|P1|Overall Study|Withdrawal by Subject|0
5674865|NCT00419380|19581313|P2|Overall Study|Lost to Follow-up|1
5674866|NCT00419380|19581314|P1|Overall Study|Lost to Follow-up|0
5674867|NCT00419380|19581313|P2|Overall Study|Physician Decision|1
5674868|NCT00419380|19581314|P1|Overall Study|Physician Decision|0
5674869|NCT00419380|19581313|P2|Overall Study|Lack of Efficacy|7
5674870|NCT00419380|19581314|P1|Overall Study|Lack of Efficacy|1
5674871|NCT00419341|19581322|P1|Efficacy Period|Termination of study site|1
5674872|NCT00419341|19581322|P1|Efficacy Period|Non-compliance|1
5674873|NCT00419341|19581322|P1|Efficacy Period|Lost to Follow-up|1
5674874|NCT00419341|19581322|P1|Efficacy Period|Protocol Violation|1
5674875|NCT00419341|19581322|P1|Efficacy Period|Withdrawal by Subject|6
5674876|NCT00419341|19581322|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
5674877|NCT00419341|19581322|P1|Wash in/Wash Out Period|Adverse Event|2
5674878|NCT00419341|19581322|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
5674879|NCT00419263|19581357|P3|Overall Study|Withdrawal by Subject|1
5674880|NCT00419263|19581358|P2|Overall Study|Withdrawal by Subject|0
5674881|NCT00419263|19581359|P1|Overall Study|Withdrawal by Subject|0
5674882|NCT00419263|19581357|P3|Overall Study|Adverse Event|1
5674883|NCT00419263|19581358|P2|Overall Study|Adverse Event|0
5674884|NCT00419263|19581359|P1|Overall Study|Adverse Event|0
5674885|NCT00419263|19581357|P3|Overall Study|Randomized in Error, Not Treated|0
5674886|NCT00419263|19581358|P2|Overall Study|Randomized in Error, Not Treated|1
5674887|NCT00419263|19581359|P1|Overall Study|Randomized in Error, Not Treated|1
5674888|NCT00419263|19581357|P3|Overall Study|Lost to Follow-up|1
5674889|NCT00419263|19581358|P2|Overall Study|Lost to Follow-up|1
5674890|NCT00419263|19581359|P1|Overall Study|Lost to Follow-up|2
5674891|NCT00419159|19581388|P2|Overall Study|Disease progression|76
5674892|NCT00419159|19581389|P1|Overall Study|Disease progression|79
5674893|NCT00419159|19581388|P2|Overall Study|Death|2
5674894|NCT00419159|19581389|P1|Overall Study|Death|2
5674895|NCT00419159|19581388|P2|Overall Study|Lost to Follow-up|1
5674896|NCT00419159|19581389|P1|Overall Study|Lost to Follow-up|0
5674897|NCT00419159|19581388|P2|Overall Study|Withdrawal by Subject|3
5674898|NCT00419159|19581389|P1|Overall Study|Withdrawal by Subject|10
5674899|NCT00419159|19581388|P2|Overall Study|Protocol Violation|0
5674900|NCT00419159|19581389|P1|Overall Study|Protocol Violation|1
5674901|NCT00419159|19581388|P2|Overall Study|Subject's no longer requires study drug|1
5674902|NCT00419159|19581389|P1|Overall Study|Subject's no longer requires study drug|0
5674903|NCT00419159|19581388|P2|Overall Study|Abnormal laboratory value(s)|2
5674904|NCT00419159|19581389|P1|Overall Study|Abnormal laboratory value(s)|0
5674905|NCT00419159|19581388|P2|Overall Study|Adverse Event|15
5674906|NCT00419159|19581389|P1|Overall Study|Adverse Event|7
5674907|NCT00419120|19581419|P1|Long Term Follow up Period|study ongoing|10
5674908|NCT00419094|19581426|P2|Overall Study|Other: No contact for extended period|1
5674909|NCT00419094|19581427|P1|Overall Study|Other: No contact for extended period|0
5674910|NCT00419094|19581426|P2|Overall Study|Other: Patient non-compliant|1
5674911|NCT00419094|19581427|P1|Overall Study|Other: Patient non-compliant|0
5674912|NCT00419094|19581426|P2|Overall Study|Other: Error determining exit criteria|0
5674913|NCT00419094|19581427|P1|Overall Study|Other: Error determining exit criteria|1
5674914|NCT00419094|19581426|P2|Overall Study|Withdrawal of consent|5
5674915|NCT00419094|19581427|P1|Overall Study|Withdrawal of consent|1
5674916|NCT00419094|19581426|P2|Overall Study|Protocol Violation|14
5674917|NCT00419094|19581427|P1|Overall Study|Protocol Violation|1
5674918|NCT00419094|19581426|P2|Overall Study|Lost to Follow-up|2
5674919|NCT00419094|19581427|P1|Overall Study|Lost to Follow-up|0
5674920|NCT00419094|19581426|P2|Overall Study|Lack of Efficacy|0
5674921|NCT00419094|19581427|P1|Overall Study|Lack of Efficacy|1
5674922|NCT00419094|19581426|P2|Overall Study|Adverse Event|7
5674923|NCT00419094|19581427|P1|Overall Study|Adverse Event|3
5674924|NCT00419003|19581441|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
5674925|NCT00419003|19581442|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
5674926|NCT00419003|19581441|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
5674927|NCT00419003|19581442|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
5674928|NCT00418938|19581496|P2|Overall Study|Ineligibility Determined|0
5674929|NCT00418938|19581497|P1|Overall Study|Ineligibility Determined|1
5674930|NCT00418938|19581496|P2|Overall Study|On-going|1
5674931|NCT00418938|19581497|P1|Overall Study|On-going|1
5674932|NCT00418938|19581496|P2|Overall Study|Adverse Event|1
5674933|NCT00418938|19581497|P1|Overall Study|Adverse Event|1
5674934|NCT00418938|19581496|P2|Overall Study|Lost to Follow-up|3
5674935|NCT00418938|19581497|P1|Overall Study|Lost to Follow-up|1
5674936|NCT00418938|19581496|P2|Overall Study|Withdrawal by Subject|15
5674937|NCT00418938|19581497|P1|Overall Study|Withdrawal by Subject|16
5674938|NCT00418938|19581496|P2|Overall Study|Administrative decision|3
5674939|NCT00418938|19581497|P1|Overall Study|Administrative decision|3
5674940|NCT00418938|19581496|P2|Overall Study|Reimbursement|0
5674941|NCT00418938|19581497|P1|Overall Study|Reimbursement|1
5674942|NCT00418886|19581517|P2|Overall Study|randomised but no treatment received|1
5674943|NCT00418886|19581518|P1|Overall Study|randomised but no treatment received|0
5674944|NCT00418886|19581517|P2|Overall Study|withdrawn due to other reason|0
5674945|NCT00418886|19581518|P1|Overall Study|withdrawn due to other reason|1
5674946|NCT00418886|19581517|P2|Overall Study|Lost to Follow-up|6
5674947|NCT00418886|19581518|P1|Overall Study|Lost to Follow-up|4
5674948|NCT00418886|19581517|P2|Overall Study|Withdrawal by Subject|10
5674949|NCT00418886|19581518|P1|Overall Study|Withdrawal by Subject|9
5674950|NCT00418886|19581517|P2|Overall Study|Death|147
5674951|NCT00418886|19581518|P1|Overall Study|Death|122
5674952|NCT00418886|19581517|P2|Overall Study|discontinue treatment survival follow up|91
5674953|NCT00418886|19581518|P1|Overall Study|discontinue treatment survival follow up|90
5674954|NCT00418834|19581544|P2|Overall Study|Withdrawal by Subject|7
5674955|NCT00418834|19581545|P1|Overall Study|Withdrawal by Subject|3
5674956|NCT00418834|19581544|P2|Overall Study|Protocol Violation|3
5674957|NCT00418834|19581545|P1|Overall Study|Protocol Violation|4
5674958|NCT00418834|19581544|P2|Overall Study|Lost to Follow-up|1
5674959|NCT00418834|19581545|P1|Overall Study|Lost to Follow-up|0
5674960|NCT00418834|19581544|P2|Overall Study|Adverse Event|9
5674961|NCT00418834|19581545|P1|Overall Study|Adverse Event|16
5674962|NCT00418717|19581605|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
5674963|NCT00418717|19581605|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
5674964|NCT00418691|19581613|P3|Overall Study|Progressive Disease|1
5674965|NCT00418691|19581614|P2|Overall Study|Progressive Disease|0
5674966|NCT00418691|19581615|P1|Overall Study|Progressive Disease|1
5674967|NCT00418691|19581613|P3|Overall Study|Started new medication voiding entry|1
5674968|NCT00418691|19581614|P2|Overall Study|Started new medication voiding entry|0
5674969|NCT00418691|19581615|P1|Overall Study|Started new medication voiding entry|0
5674970|NCT00418691|19581613|P3|Overall Study|Lost to Follow-up|3
5674971|NCT00418691|19581614|P2|Overall Study|Lost to Follow-up|2
5674972|NCT00418691|19581615|P1|Overall Study|Lost to Follow-up|1
5674973|NCT00418665|19581626|P3|Treatment Extension|Death|1
5674974|NCT00418665|19581627|P2|Treatment Extension|Death|0
5674975|NCT00418665|19581628|P1|Treatment Extension|Death|0
5674976|NCT00418665|19581626|P3|Treatment Extension|Physician Decision|1
5674977|NCT00418665|19581627|P2|Treatment Extension|Physician Decision|2
5674978|NCT00418665|19581628|P1|Treatment Extension|Physician Decision|2
5674979|NCT00418665|19581626|P3|Treatment Extension|Requirement for alternative therapy|0
5674980|NCT00418665|19581627|P2|Treatment Extension|Requirement for alternative therapy|2
5674981|NCT00418665|19581628|P1|Treatment Extension|Requirement for alternative therapy|2
5674982|NCT00418665|19581626|P3|Treatment Extension|Withdrawal by Subject|0
5674983|NCT00418665|19581627|P2|Treatment Extension|Withdrawal by Subject|0
5674984|NCT00418665|19581628|P1|Treatment Extension|Withdrawal by Subject|1
5674985|NCT00418665|19581626|P3|Treatment Extension|Adverse Event|0
5674986|NCT00418665|19581627|P2|Treatment Extension|Adverse Event|0
5674987|NCT00418665|19581628|P1|Treatment Extension|Adverse Event|1
5674988|NCT00418665|19581626|P3|Treatment Period|Physician Decision|3
5674989|NCT00418665|19581627|P2|Treatment Period|Physician Decision|0
5674990|NCT00418665|19581628|P1|Treatment Period|Physician Decision|1
5674991|NCT00418665|19581626|P3|Treatment Period|Requirement for alternative therapy|0
5674992|NCT00418665|19581627|P2|Treatment Period|Requirement for alternative therapy|0
5674993|NCT00418665|19581628|P1|Treatment Period|Requirement for alternative therapy|1
5674994|NCT00418665|19581626|P3|Treatment Period|Withdrawal by Subject|1
5674995|NCT00418665|19581627|P2|Treatment Period|Withdrawal by Subject|3
5674996|NCT00418665|19581628|P1|Treatment Period|Withdrawal by Subject|0
5674997|NCT00418665|19581626|P3|Treatment Period|Adverse Event|0
5674998|NCT00418665|19581627|P2|Treatment Period|Adverse Event|2
5674999|NCT00418665|19581628|P1|Treatment Period|Adverse Event|2
5675000|NCT00418665|19581626|P3|Treatment Period|Ineligibility determined|0
5675001|NCT00418665|19581627|P2|Treatment Period|Ineligibility determined|1
5675002|NCT00418665|19581628|P1|Treatment Period|Ineligibility determined|1
5675003|NCT00418561|19581662|P3|Overall Study|Participant's (guardian's) decision|0
5675004|NCT00418561|19581663|P2|Overall Study|Participant's (guardian's) decision|1
5675005|NCT00418561|19581664|P1|Overall Study|Participant's (guardian's) decision|0
5675006|NCT00418522|19581734|P2|Overall Study|Randomized but did not receive treatment|4
5675007|NCT00418522|19581735|P1|Overall Study|Randomized but did not receive treatment|7
5675008|NCT00418522|19581734|P2|Overall Study|Other|23
5675009|NCT00418522|19581735|P1|Overall Study|Other|27
5675010|NCT00418522|19581734|P2|Overall Study|Withdrawal by Subject|7
5675011|NCT00418522|19581735|P1|Overall Study|Withdrawal by Subject|31
5675012|NCT00418522|19581734|P2|Overall Study|Lost to Follow-up|4
5675013|NCT00418522|19581735|P1|Overall Study|Lost to Follow-up|10
5675014|NCT00418522|19581734|P2|Overall Study|Lack of Efficacy|3
5675015|NCT00418522|19581735|P1|Overall Study|Lack of Efficacy|1
5675016|NCT00418522|19581734|P2|Overall Study|Adverse Event|1
5675017|NCT00418522|19581735|P1|Overall Study|Adverse Event|7
5675018|NCT00418379|19581799|P3|Year 5|Any other reason not above-mentioned|3
5675019|NCT00418379|19581800|P2|Year 5|Any other reason not above-mentioned|4
5675020|NCT00418379|19581801|P1|Year 5|Any other reason not above-mentioned|2
5675021|NCT00418379|19581799|P3|Year 5|Adverse Event|0
5675022|NCT00418379|19581800|P2|Year 5|Adverse Event|1
5675023|NCT00418379|19581801|P1|Year 5|Adverse Event|0
5675024|NCT00418379|19581799|P3|Year 4|Any other reason not above-mentioned|0
5675025|NCT00418379|19581800|P2|Year 4|Any other reason not above-mentioned|1
5675026|NCT00418379|19581801|P1|Year 4|Any other reason not above-mentioned|1
5675027|NCT00418379|19581799|P3|Year 4|Withdrawal by Subject|2
5675028|NCT00418379|19581800|P2|Year 4|Withdrawal by Subject|3
5675029|NCT00418379|19581801|P1|Year 4|Withdrawal by Subject|2
5675030|NCT00418379|19581799|P3|Year 4|Adverse Event|0
5675031|NCT00418379|19581800|P2|Year 4|Adverse Event|1
5675032|NCT00418379|19581801|P1|Year 4|Adverse Event|0
5675033|NCT00418379|19581799|P3|Year 3|Any other reason not above-mentioned|1
5675034|NCT00418379|19581800|P2|Year 3|Any other reason not above-mentioned|1
5675035|NCT00418379|19581801|P1|Year 3|Any other reason not above-mentioned|2
5675036|NCT00418379|19581799|P3|Year 3|Withdrawal by Subject|2
5675037|NCT00418379|19581800|P2|Year 3|Withdrawal by Subject|1
5675038|NCT00418379|19581801|P1|Year 3|Withdrawal by Subject|1
5675039|NCT00418379|19581799|P3|Year 2|Any other reason not above-mentioned|6
5675040|NCT00418379|19581800|P2|Year 2|Any other reason not above-mentioned|1
5675041|NCT00418379|19581801|P1|Year 2|Any other reason not above-mentioned|2
5675042|NCT00418379|19581799|P3|Year 2|Withdrawal by Subject|3
5675043|NCT00418379|19581800|P2|Year 2|Withdrawal by Subject|1
5675044|NCT00418379|19581801|P1|Year 2|Withdrawal by Subject|1
5675045|NCT00418379|19581799|P3|Year 2|Adverse Event|1
5675046|NCT00418379|19581800|P2|Year 2|Adverse Event|2
5675047|NCT00418379|19581801|P1|Year 2|Adverse Event|5
5675048|NCT00418379|19581799|P3|Year 1|Any other reason not above-mentioned|7
5675049|NCT00418379|19581800|P2|Year 1|Any other reason not above-mentioned|5
5675050|NCT00418379|19581801|P1|Year 1|Any other reason not above-mentioned|2
5675051|NCT00418379|19581799|P3|Year 1|Withdrawal by Subject|5
5675052|NCT00418379|19581800|P2|Year 1|Withdrawal by Subject|8
5675053|NCT00418379|19581801|P1|Year 1|Withdrawal by Subject|7
5675054|NCT00418379|19581799|P3|Year 1|Adverse Event|3
5675055|NCT00418379|19581800|P2|Year 1|Adverse Event|15
5675056|NCT00418379|19581801|P1|Year 1|Adverse Event|9
5675057|NCT00418314|19581811|P2|Overall Study|Withdrawal by Subject|2
5675058|NCT00418314|19581812|P1|Overall Study|Withdrawal by Subject|1
5675059|NCT00418184|19581842|P2|Double-blind Phase|Poor compliance|1
5675060|NCT00418184|19581843|P1|Double-blind Phase|Poor compliance|3
5675061|NCT00418184|19581842|P2|Double-blind Phase|Adverse Event|1
5675062|NCT00418184|19581843|P1|Double-blind Phase|Adverse Event|2
5675063|NCT00418184|19581842|P2|Double-blind Phase|Withdrawal by Subject|9
5675064|NCT00418184|19581843|P1|Double-blind Phase|Withdrawal by Subject|22
5675065|NCT00418145|19581851|P1|Overall Study|study terminated|6
5675066|NCT00417989|19581926|P2|Overall Study|Physician Decision|2
5675067|NCT00417989|19581927|P1|Overall Study|Physician Decision|5
5675068|NCT00417989|19581926|P2|Overall Study|Death|1
5675069|NCT00417989|19581927|P1|Overall Study|Death|0
5675070|NCT00417989|19581926|P2|Overall Study|Protocol Violation|0
5675071|NCT00417989|19581927|P1|Overall Study|Protocol Violation|1
5675072|NCT00417989|19581926|P2|Overall Study|Lost to Follow-up|6
5675073|NCT00417989|19581927|P1|Overall Study|Lost to Follow-up|1
5675074|NCT00417989|19581926|P2|Overall Study|Withdrawal by Subject|13
5675075|NCT00417989|19581927|P1|Overall Study|Withdrawal by Subject|13
5675076|NCT00417976|19581949|P1|Overall Study|Treatment -related toxicity|2
5675077|NCT00417976|19581949|P1|Overall Study|Non compliance unrelated to toxicity|1
5675078|NCT00417963|19581954|P1|Overall Study|Study device could not be deployed|3
5675079|NCT00417963|19581954|P1|Overall Study|Death|17
5675080|NCT00417963|19581954|P1|Overall Study|Withdrawal by Subject|18
5675081|NCT00417963|19581954|P1|Overall Study|Lost to Follow-up|3
5675082|NCT00417885|19581971|P1|Overall Study|Transferred to Another Sunitinib Study|2
5675083|NCT00417885|19581971|P1|Overall Study|Objective Progression or Relapse|3
5675084|NCT00417885|19581971|P1|Overall Study|Adverse Event|1
5675085|NCT00417612|19581997|P2|Overall Study|Lost to Follow-up|0
5675086|NCT00417612|19581998|P1|Overall Study|Lost to Follow-up|1
5675087|NCT00417612|19581997|P2|Overall Study|Protocol Violation|2
5675088|NCT00417612|19581998|P1|Overall Study|Protocol Violation|0
5675089|NCT00417612|19581997|P2|Overall Study|Adverse Event|0
5675090|NCT00417612|19581998|P1|Overall Study|Adverse Event|2
5675091|NCT00417612|19581997|P2|Overall Study|Errant diagnosis|1
5675092|NCT00417612|19581998|P1|Overall Study|Errant diagnosis|0
5675093|NCT00417482|19582024|P3|Phase B 2nd 16 Weeks|Death|0
5675094|NCT00417482|19582025|P2|Phase B 2nd 16 Weeks|Death|1
5675095|NCT00417482|19582026|P1|Phase B 2nd 16 Weeks|Death|1
5675096|NCT00417482|19582024|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
5675097|NCT00417482|19582025|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
5675098|NCT00417482|19582026|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
5675099|NCT00417482|19582024|P3|Phase B 2nd 16 Weeks|Adverse Event|1
5675100|NCT00417482|19582025|P2|Phase B 2nd 16 Weeks|Adverse Event|0
5675101|NCT00417482|19582026|P1|Phase B 2nd 16 Weeks|Adverse Event|0
5675102|NCT00417482|19582024|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
5675103|NCT00417482|19582025|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
5675104|NCT00417482|19582026|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
5675105|NCT00417482|19582024|P3|Phase B 1st 16 Weeks|Death|0
5675106|NCT00417482|19582025|P2|Phase B 1st 16 Weeks|Death|0
5675107|NCT00417482|19582026|P1|Phase B 1st 16 Weeks|Death|1
5675108|NCT00417482|19582024|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
5675109|NCT00417482|19582025|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
5675110|NCT00417482|19582026|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
5675111|NCT00417482|19582024|P3|Phase B 1st 16 Weeks|Adverse Event|1
5675112|NCT00417482|19582025|P2|Phase B 1st 16 Weeks|Adverse Event|0
5675113|NCT00417482|19582026|P1|Phase B 1st 16 Weeks|Adverse Event|2
5675114|NCT00417482|19582024|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
5675115|NCT00417482|19582025|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
5675116|NCT00417482|19582026|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
5675117|NCT00417248|19582065|P1|Overall Study|Lack of Efficacy|1
5675118|NCT00417248|19582065|P1|Overall Study|Death|1
5675119|NCT00417248|19582065|P1|Overall Study|Study Terminated|6
5675120|NCT00417170|19582072|P2|Overall Study|Lost to Follow-up|1
5675121|NCT00417170|19582073|P1|Overall Study|Lost to Follow-up|0
5675122|NCT00417170|19582072|P2|Overall Study|Withdrawal by Subject|1
5675123|NCT00417170|19582073|P1|Overall Study|Withdrawal by Subject|1
5675124|NCT00417170|19582072|P2|Overall Study|Adverse Event|1
5675125|NCT00417170|19582073|P1|Overall Study|Adverse Event|1
5675126|NCT00417079|19582089|P2|Overall Study|abnormal liver function tests|1
5675127|NCT00417079|19582090|P1|Overall Study|abnormal liver function tests|0
5675128|NCT00417079|19582089|P2|Overall Study|Patient unable to come to the clinic|1
5675129|NCT00417079|19582090|P1|Overall Study|Patient unable to come to the clinic|0
5675130|NCT00417079|19582089|P2|Overall Study|Withdrawal by subject's family|1
5675131|NCT00417079|19582090|P1|Overall Study|Withdrawal by subject's family|0
5675132|NCT00417079|19582089|P2|Overall Study|Screening error|1
5675133|NCT00417079|19582090|P1|Overall Study|Screening error|2
5675134|NCT00417079|19582089|P2|Overall Study|Clinical deterioration|0
5675135|NCT00417079|19582090|P1|Overall Study|Clinical deterioration|1
5675136|NCT00417079|19582089|P2|Overall Study|Non-confirmed Disease progression|1
5675137|NCT00417079|19582090|P1|Overall Study|Non-confirmed Disease progression|1
5675138|NCT00417079|19582089|P2|Overall Study|Investigator's decision|4
5675139|NCT00417079|19582090|P1|Overall Study|Investigator's decision|1
5675140|NCT00417079|19582089|P2|Overall Study|Screened failure|1
5675141|NCT00417079|19582090|P1|Overall Study|Screened failure|2
5675142|NCT00417079|19582089|P2|Overall Study|Not treated|7
5675143|NCT00417079|19582090|P1|Overall Study|Not treated|6
5675144|NCT00417079|19582089|P2|Overall Study|Withdrawal by Subject|8
5675145|NCT00417079|19582090|P1|Overall Study|Withdrawal by Subject|17
5675146|NCT00417079|19582089|P2|Overall Study|Lost to Follow-up|0
5675147|NCT00417079|19582090|P1|Overall Study|Lost to Follow-up|2
5675148|NCT00417079|19582089|P2|Overall Study|Non-compliance to protocol|1
5675149|NCT00417079|19582090|P1|Overall Study|Non-compliance to protocol|0
5675150|NCT00417079|19582089|P2|Overall Study|Adverse Event|67
5675151|NCT00417079|19582090|P1|Overall Study|Adverse Event|32
5675152|NCT00417079|19582089|P2|Overall Study|Disease progression|180
5675153|NCT00417079|19582090|P1|Overall Study|Disease progression|267
5675154|NCT00417027|19582113|P3|Overall Study|Protocol Violation|5
5675155|NCT00417027|19582114|P2|Overall Study|Protocol Violation|5
5675156|NCT00417027|19582115|P1|Overall Study|Protocol Violation|0
5675157|NCT00416949|19582141|P1|Overall Study|Patients refused to participate|5
5675158|NCT00416884|19582145|P1|Overall Study|Study terminated due to low accrual|1
5675159|NCT00416715|19582154|P1|Overall Study|Vitamin D levels not evaluable|8
5675160|NCT00416715|19582154|P1|Overall Study|Not evaluable for joint aches|7
5675161|NCT00416624|19582165|P4|Overall Study|Cancel|0
5675162|NCT00416624|19582166|P3|Overall Study|Cancel|0
5675163|NCT00416624|19582167|P2|Overall Study|Cancel|0
5675164|NCT00416624|19582168|P1|Overall Study|Cancel|1
5675165|NCT00416624|19582165|P4|Overall Study|Other|5
5675166|NCT00416624|19582166|P3|Overall Study|Other|5
5675167|NCT00416624|19582167|P2|Overall Study|Other|11
5675168|NCT00416624|19582168|P1|Overall Study|Other|8
5675169|NCT00416624|19582165|P4|Overall Study|Adverse Event|2
5675170|NCT00416624|19582166|P3|Overall Study|Adverse Event|2
5675171|NCT00416624|19582167|P2|Overall Study|Adverse Event|3
5675172|NCT00416624|19582168|P1|Overall Study|Adverse Event|8
5675173|NCT00416624|19582165|P4|Overall Study|Death|1
5675174|NCT00416624|19582166|P3|Overall Study|Death|7
5675175|NCT00416624|19582167|P2|Overall Study|Death|7
5675176|NCT00416624|19582168|P1|Overall Study|Death|4
5675177|NCT00416624|19582165|P4|Overall Study|Withdrawal by Subject|9
5675178|NCT00416624|19582166|P3|Overall Study|Withdrawal by Subject|4
5675179|NCT00416624|19582167|P2|Overall Study|Withdrawal by Subject|6
5675180|NCT00416624|19582168|P1|Overall Study|Withdrawal by Subject|1
5675181|NCT00416598|19582222|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
5675182|NCT00416598|19582222|P1|Decitabine Maintenance|Alternative treatment|2
5675183|NCT00416598|19582222|P1|Decitabine Maintenance|Progression/relapse|38
5675184|NCT00416598|19582222|P1|Decitabine Maintenance|Withdrawal by Subject|18
5675185|NCT00416598|19582222|P1|Decitabine Maintenance|Adverse Event|5
5675186|NCT00416598|19582222|P1|Induction & Intensification|Failed induction|87
5675187|NCT00416598|19582222|P1|Induction & Intensification|Relapse/progression|29
5675188|NCT00416598|19582222|P1|Induction & Intensification|Physician discretion/other medical issue|45
5675189|NCT00416598|19582222|P1|Induction & Intensification|Alternative Treatment|135
5675190|NCT00416598|19582222|P1|Induction & Intensification|Withdrawal by Subject|46
5675191|NCT00416598|19582222|P1|Induction & Intensification|Death|32
5675192|NCT00416598|19582222|P1|Induction & Intensification|Adverse Event|38
5675193|NCT00416520|19582248|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
5675194|NCT00416520|19582249|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
5675195|NCT00416520|19582250|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
5675196|NCT00416520|19582251|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
5675197|NCT00416520|19582248|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
5675198|NCT00416520|19582249|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
5675199|NCT00416520|19582250|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
5675200|NCT00416520|19582251|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
5675201|NCT00416520|19582248|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
5675202|NCT00416520|19582249|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
5675203|NCT00416520|19582250|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
5675204|NCT00416520|19582251|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
5675205|NCT00416520|19582248|P4|Open-label Period|Other Reasons|0
5675206|NCT00416520|19582249|P3|Open-label Period|Other Reasons|0
5675207|NCT00416520|19582250|P2|Open-label Period|Other Reasons|12
5675208|NCT00416520|19582251|P1|Open-label Period|Other Reasons|3
5675209|NCT00416520|19582248|P4|Open-label Period|Withdrawal by Subject|0
5675210|NCT00416520|19582249|P3|Open-label Period|Withdrawal by Subject|0
5675211|NCT00416520|19582250|P2|Open-label Period|Withdrawal by Subject|5
5675212|NCT00416520|19582251|P1|Open-label Period|Withdrawal by Subject|16
5675213|NCT00416520|19582248|P4|Open-label Period|Protocol Violation|0
5675214|NCT00416520|19582249|P3|Open-label Period|Protocol Violation|0
5675215|NCT00416520|19582250|P2|Open-label Period|Protocol Violation|3
5675216|NCT00416520|19582251|P1|Open-label Period|Protocol Violation|3
5675217|NCT00416520|19582248|P4|Open-label Period|Lack of Efficacy|0
5675218|NCT00416520|19582249|P3|Open-label Period|Lack of Efficacy|0
5675219|NCT00416520|19582250|P2|Open-label Period|Lack of Efficacy|1
5675220|NCT00416520|19582251|P1|Open-label Period|Lack of Efficacy|8
5675221|NCT00416520|19582248|P4|Open-label Period|Death|0
5675222|NCT00416520|19582249|P3|Open-label Period|Death|0
5675223|NCT00416520|19582250|P2|Open-label Period|Death|1
5675224|NCT00416520|19582251|P1|Open-label Period|Death|2
5675225|NCT00416520|19582248|P4|Open-label Period|Adverse Event|0
5675226|NCT00416520|19582249|P3|Open-label Period|Adverse Event|0
5675227|NCT00416520|19582250|P2|Open-label Period|Adverse Event|10
5675228|NCT00416520|19582251|P1|Open-label Period|Adverse Event|28
5675229|NCT00416455|19582280|P2|Overall Study|Inadequate pathology|2
5675230|NCT00416455|19582281|P1|Overall Study|Inadequate pathology|11
5675231|NCT00416455|19582280|P2|Overall Study|PET / CT poor quality|1
5675232|NCT00416455|19582281|P1|Overall Study|PET / CT poor quality|2
5675233|NCT00416455|19582280|P2|Overall Study|PET / CT not done|5
5675234|NCT00416455|19582281|P1|Overall Study|PET / CT not done|3
5675235|NCT00416312|19582316|P1|Overall Study|tumors not visible on imaging|2
5675236|NCT00416195|19582322|P2|Overall Study|Other|1
5675237|NCT00416195|19582323|P1|Overall Study|Other|0
5675238|NCT00416195|19582322|P2|Overall Study|Protocol Violation|1
5675239|NCT00416195|19582323|P1|Overall Study|Protocol Violation|1
5675240|NCT00416195|19582322|P2|Overall Study|Adverse Event|2
5675241|NCT00416195|19582323|P1|Overall Study|Adverse Event|1
5675242|NCT00416078|19582348|P2|Overall Study|Lost to Follow-up|2
5675243|NCT00416078|19582349|P1|Overall Study|Lost to Follow-up|4
5675244|NCT00416078|19582348|P2|Overall Study|Physician Decision|0
5675245|NCT00416078|19582349|P1|Overall Study|Physician Decision|1
5675246|NCT00416078|19582348|P2|Overall Study|Withdrawal by Subject|2
5675247|NCT00416078|19582349|P1|Overall Study|Withdrawal by Subject|3
5675248|NCT00416078|19582348|P2|Overall Study|Death|4
5675249|NCT00416078|19582349|P1|Overall Study|Death|3
5675250|NCT00415909|19582365|P1|Overall Study|Death|1
5675251|NCT00415909|19582365|P1|Overall Study|Withdrawal by Subject|2
5675252|NCT00415636|19582399|P6|Overall Study|Disease progression|1
5675253|NCT00415636|19582400|P5|Overall Study|Disease progression|0
5675254|NCT00415636|19582401|P4|Overall Study|Disease progression|3
5675255|NCT00415636|19582402|P3|Overall Study|Disease progression|0
5675256|NCT00415636|19582403|P2|Overall Study|Disease progression|0
5675257|NCT00415636|19582404|P1|Overall Study|Disease progression|0
5675258|NCT00415636|19582399|P6|Overall Study|Withdrawal by Subject|0
5675259|NCT00415636|19582400|P5|Overall Study|Withdrawal by Subject|1
5675260|NCT00415636|19582401|P4|Overall Study|Withdrawal by Subject|0
5675261|NCT00415636|19582402|P3|Overall Study|Withdrawal by Subject|0
5675262|NCT00415636|19582403|P2|Overall Study|Withdrawal by Subject|0
5675263|NCT00415636|19582404|P1|Overall Study|Withdrawal by Subject|0
5675264|NCT00415636|19582399|P6|Overall Study|Adverse Event|0
5675265|NCT00415636|19582400|P5|Overall Study|Adverse Event|1
5675266|NCT00415636|19582401|P4|Overall Study|Adverse Event|1
5675267|NCT00415636|19582402|P3|Overall Study|Adverse Event|0
5675268|NCT00415636|19582403|P2|Overall Study|Adverse Event|0
5675269|NCT00415636|19582404|P1|Overall Study|Adverse Event|0
5675270|NCT00415636|19582399|P6|Overall Study|Symptomatic deterioration|1
5675271|NCT00415636|19582400|P5|Overall Study|Symptomatic deterioration|0
5675272|NCT00415636|19582401|P4|Overall Study|Symptomatic deterioration|2
5675273|NCT00415636|19582402|P3|Overall Study|Symptomatic deterioration|1
5675274|NCT00415636|19582403|P2|Overall Study|Symptomatic deterioration|0
5675275|NCT00415636|19582404|P1|Overall Study|Symptomatic deterioration|1
5675276|NCT00415623|19582438|P2|Overall Study|Withdrawal by Subject|1
5675277|NCT00415623|19582439|P1|Overall Study|Withdrawal by Subject|1
5675278|NCT00415623|19582438|P2|Overall Study|Death|0
5675279|NCT00415623|19582439|P1|Overall Study|Death|1
5675280|NCT00415623|19582438|P2|Overall Study|Adverse Event|4
5675281|NCT00415623|19582439|P1|Overall Study|Adverse Event|3
5675282|NCT00415610|19582466|P3|Overall Study|Death|5
5675283|NCT00415610|19582467|P2|Overall Study|Death|2
5675284|NCT00415610|19582468|P1|Overall Study|Death|3
5675285|NCT00415597|19582488|P1|Treatment|Multiple Reasons|1
5675286|NCT00415597|19582488|P1|Treatment|Sponsor Decision|1
5675287|NCT00415597|19582488|P1|Treatment|Administrative|3
5675288|NCT00415597|19582488|P1|Treatment|Drug Screen|2
5675289|NCT00415597|19582488|P1|Treatment|Lost to Follow-up|28
5675290|NCT00415597|19582488|P1|Treatment|Withdrawal by Subject|51
5675291|NCT00415597|19582488|P1|Treatment|Physician Decision|3
5675292|NCT00415597|19582488|P1|Treatment|Protocol Violation|67
5675293|NCT00415597|19582488|P1|Treatment|Lack of Efficacy|39
5675294|NCT00415597|19582488|P1|Treatment|Adverse Event|110
5675295|NCT00415597|19582488|P1|Enrollment|Protocol Violation|1
5675296|NCT00415597|19582488|P1|Enrollment|Withdrawal by Subject|1
5675297|NCT00415532|19582496|P2|Safety Follow Up Period|Requirement for alternative therapy|1
5675298|NCT00415532|19582497|P1|Safety Follow Up Period|Requirement for alternative therapy|0
5675299|NCT00415532|19582496|P2|Safety Follow Up Period|Noncompliance|0
5675300|NCT00415532|19582497|P1|Safety Follow Up Period|Noncompliance|1
5675301|NCT00415532|19582496|P2|Safety Follow Up Period|Ineligibility determined|1
5675302|NCT00415532|19582497|P1|Safety Follow Up Period|Ineligibility determined|1
5675303|NCT00415532|19582496|P2|Safety Follow Up Period|Other|4
5675304|NCT00415532|19582497|P1|Safety Follow Up Period|Other|1
5675305|NCT00415532|19582496|P2|Safety Follow Up Period|Withdrawal by Subject|3
5675306|NCT00415532|19582497|P1|Safety Follow Up Period|Withdrawal by Subject|2
5675307|NCT00415532|19582496|P2|Safety Follow Up Period|Death|0
5675308|NCT00415532|19582497|P1|Safety Follow Up Period|Death|3
5675309|NCT00415532|19582496|P2|Safety Follow Up Period|Adverse Event|3
5675310|NCT00415532|19582497|P1|Safety Follow Up Period|Adverse Event|1
5675311|NCT00415532|19582496|P2|Treatment Period|Requirement for alternative therapy|0
5675312|NCT00415532|19582497|P1|Treatment Period|Requirement for alternative therapy|1
5675313|NCT00415532|19582496|P2|Treatment Period|Noncompliance|1
5675314|NCT00415532|19582497|P1|Treatment Period|Noncompliance|1
5675315|NCT00415532|19582496|P2|Treatment Period|Ineligibility determined|1
5675316|NCT00415532|19582497|P1|Treatment Period|Ineligibility determined|1
5675317|NCT00415532|19582496|P2|Treatment Period|Other|2
5675318|NCT00415532|19582497|P1|Treatment Period|Other|2
5675319|NCT00415532|19582496|P2|Treatment Period|Withdrawal by Subject|6
5675320|NCT00415532|19582497|P1|Treatment Period|Withdrawal by Subject|6
5675321|NCT00415532|19582496|P2|Treatment Period|Protocol Violation|0
5675322|NCT00415532|19582497|P1|Treatment Period|Protocol Violation|1
5675323|NCT00415532|19582496|P2|Treatment Period|Lost to Follow-up|1
5675324|NCT00415532|19582497|P1|Treatment Period|Lost to Follow-up|1
5675325|NCT00415532|19582496|P2|Treatment Period|Death|1
5675326|NCT00415532|19582497|P1|Treatment Period|Death|2
5675327|NCT00415532|19582496|P2|Treatment Period|Adverse Event|3
5675328|NCT00415532|19582497|P1|Treatment Period|Adverse Event|2
5675329|NCT00415519|19582519|P2|Overall Study|Patient's convenience|0
5675330|NCT00415519|19582520|P1|Overall Study|Patient's convenience|1
5675331|NCT00415519|19582519|P2|Overall Study|Withdrawal by Subject|0
5675332|NCT00415519|19582520|P1|Overall Study|Withdrawal by Subject|2
5675333|NCT00415519|19582519|P2|Overall Study|Adverse Event|0
5675334|NCT00415519|19582520|P1|Overall Study|Adverse Event|1
5675335|NCT00415363|19582560|P2|Overall Study|Progressive disease|32
5675336|NCT00415363|19582561|P1|Overall Study|Progressive disease|26
5675337|NCT00415363|19582560|P2|Overall Study|Death|12
5675338|NCT00415363|19582561|P1|Overall Study|Death|16
5675339|NCT00415363|19582560|P2|Overall Study|Physician Decision|1
5675340|NCT00415363|19582561|P1|Overall Study|Physician Decision|3
5675341|NCT00415363|19582560|P2|Overall Study|Lost to Follow-up|1
5675342|NCT00415363|19582561|P1|Overall Study|Lost to Follow-up|2
5675343|NCT00415363|19582560|P2|Overall Study|Adverse Event|4
5675344|NCT00415363|19582561|P1|Overall Study|Adverse Event|4
5675345|NCT00415363|19582560|P2|Overall Study|Withdrawal by Subject|4
5675346|NCT00415363|19582561|P1|Overall Study|Withdrawal by Subject|4
5675347|NCT00415194|19582591|P2|Overall Study|Death Due to AE (Other Causes)|15
5675348|NCT00415194|19582592|P1|Overall Study|Death Due to AE (Other Causes)|27
5675349|NCT00415194|19582591|P2|Overall Study|Death Due to Procedural Related AE|1
5675350|NCT00415194|19582592|P1|Overall Study|Death Due to Procedural Related AE|0
5675351|NCT00415194|19582591|P2|Overall Study|Death Due to Study Drug Related AE|1
5675352|NCT00415194|19582592|P1|Overall Study|Death Due to Study Drug Related AE|11
5675353|NCT00415194|19582591|P2|Overall Study|Death Due to Study Disease|29
5675354|NCT00415194|19582592|P1|Overall Study|Death Due to Study Disease|26
5675355|NCT00415194|19582591|P2|Overall Study|Withdrawal by Subject|21
5675356|NCT00415194|19582592|P1|Overall Study|Withdrawal by Subject|28
5675357|NCT00415194|19582591|P2|Overall Study|Protocol Violation|2
5675358|NCT00415194|19582592|P1|Overall Study|Protocol Violation|4
5675359|NCT00415194|19582591|P2|Overall Study|Progressive Disease|217
5675360|NCT00415194|19582592|P1|Overall Study|Progressive Disease|180
5675361|NCT00415194|19582591|P2|Overall Study|Physician Decision|16
5675362|NCT00415194|19582592|P1|Overall Study|Physician Decision|10
5675363|NCT00415194|19582591|P2|Overall Study|Lost to Follow-up|0
5675364|NCT00415194|19582592|P1|Overall Study|Lost to Follow-up|1
5675365|NCT00415194|19582591|P2|Overall Study|Entry Criteria Not Met|8
5675366|NCT00415194|19582592|P1|Overall Study|Entry Criteria Not Met|4
5675367|NCT00415194|19582591|P2|Overall Study|Adverse Event|32
5675368|NCT00415194|19582592|P1|Overall Study|Adverse Event|37
5675369|NCT00415168|19582608|P1|Overall Study|Withdrawal by Subject|6
5675370|NCT00415168|19582608|P1|Overall Study|Sponsor Decision|4
5675371|NCT00415168|19582608|P1|Overall Study|Physician Decision|13
5675372|NCT00415168|19582608|P1|Overall Study|Lost to Follow-up|3
5675373|NCT00415168|19582608|P1|Overall Study|Death|26
5675374|NCT00415051|19582618|P1|Overall Study|Protocol Violation|1
5675375|NCT00414973|19582629|P4|Overall Study|Death|0
5675376|NCT00414973|19582630|P3|Overall Study|Death|1
5675377|NCT00414973|19582631|P2|Overall Study|Death|0
5675378|NCT00414973|19582632|P1|Overall Study|Death|0
5675379|NCT00414973|19582629|P4|Overall Study|Sponsor Decision|0
5675380|NCT00414973|19582630|P3|Overall Study|Sponsor Decision|0
5675381|NCT00414973|19582631|P2|Overall Study|Sponsor Decision|0
5675382|NCT00414973|19582632|P1|Overall Study|Sponsor Decision|1
5675383|NCT00414973|19582629|P4|Overall Study|Lost to Follow-up|0
5675384|NCT00414973|19582630|P3|Overall Study|Lost to Follow-up|0
5675385|NCT00414973|19582631|P2|Overall Study|Lost to Follow-up|2
5675386|NCT00414973|19582632|P1|Overall Study|Lost to Follow-up|0
5675387|NCT00414973|19582629|P4|Overall Study|Protocol Violation|0
5675388|NCT00414973|19582630|P3|Overall Study|Protocol Violation|0
5675389|NCT00414973|19582631|P2|Overall Study|Protocol Violation|4
5675390|NCT00414973|19582632|P1|Overall Study|Protocol Violation|3
5675391|NCT00414973|19582629|P4|Overall Study|Adverse Event|0
5675392|NCT00414973|19582630|P3|Overall Study|Adverse Event|1
5675393|NCT00414973|19582631|P2|Overall Study|Adverse Event|0
5675394|NCT00414973|19582632|P1|Overall Study|Adverse Event|10
5675395|NCT00414973|19582629|P4|Overall Study|Withdrawal by Subject|0
5675396|NCT00414973|19582630|P3|Overall Study|Withdrawal by Subject|1
5675397|NCT00414973|19582631|P2|Overall Study|Withdrawal by Subject|4
5675398|NCT00414973|19582632|P1|Overall Study|Withdrawal by Subject|14
5675399|NCT00414960|19582652|P2|Overall Study|Physician Decision|1
5675400|NCT00414960|19582653|P1|Overall Study|Physician Decision|0
5675401|NCT00414960|19582652|P2|Overall Study|Withdrawal by Subject|0
5675402|NCT00414960|19582653|P1|Overall Study|Withdrawal by Subject|3
5675403|NCT00414960|19582652|P2|Overall Study|Adverse Event|0
5675404|NCT00414960|19582653|P1|Overall Study|Adverse Event|4
5675405|NCT00414908|19582663|P2|Overall Study|Protocol Violation|1
5675406|NCT00414908|19582664|P1|Overall Study|Protocol Violation|1
5675407|NCT00414726|19582701|P2|Overall Study|Withdrawal by Subject|1
5675408|NCT00414726|19582702|P1|Overall Study|Withdrawal by Subject|0
5675409|NCT00414661|19582737|P4|Overall Study|Other|0
5675410|NCT00414661|19582738|P3|Overall Study|Other|0
5675411|NCT00414661|19582739|P2|Overall Study|Other|3
5675412|NCT00414661|19582740|P1|Overall Study|Other|6
5675413|NCT00414661|19582737|P4|Overall Study|Withdrawal by Subject|2
5675414|NCT00414661|19582738|P3|Overall Study|Withdrawal by Subject|2
5675415|NCT00414661|19582739|P2|Overall Study|Withdrawal by Subject|2
5675416|NCT00414661|19582740|P1|Overall Study|Withdrawal by Subject|5
5675417|NCT00414661|19582737|P4|Overall Study|Lost to Follow-up|1
5675418|NCT00414661|19582738|P3|Overall Study|Lost to Follow-up|0
5675419|NCT00414661|19582739|P2|Overall Study|Lost to Follow-up|4
5675420|NCT00414661|19582740|P1|Overall Study|Lost to Follow-up|1
5675421|NCT00414661|19582737|P4|Overall Study|Death|0
5675422|NCT00414661|19582738|P3|Overall Study|Death|0
5675423|NCT00414661|19582739|P2|Overall Study|Death|5
5675424|NCT00414661|19582740|P1|Overall Study|Death|2
5675425|NCT00414609|19582785|P3|Extension Study|Death|17
5675426|NCT00414609|19582786|P2|Extension Study|Death|0
5675427|NCT00414609|19582787|P1|Extension Study|Death|0
5675428|NCT00414609|19582785|P3|Extension Study|Administrative problems|1
5675429|NCT00414609|19582786|P2|Extension Study|Administrative problems|0
5675430|NCT00414609|19582787|P1|Extension Study|Administrative problems|0
5675431|NCT00414609|19582785|P3|Extension Study|Lost to Follow-up|10
5675432|NCT00414609|19582786|P2|Extension Study|Lost to Follow-up|0
5675433|NCT00414609|19582787|P1|Extension Study|Lost to Follow-up|0
5675434|NCT00414609|19582785|P3|Extension Study|Withdrawal by Subject|13
5675435|NCT00414609|19582786|P2|Extension Study|Withdrawal by Subject|0
5675436|NCT00414609|19582787|P1|Extension Study|Withdrawal by Subject|0
5675437|NCT00414609|19582785|P3|Extension Study|Unsatisfactory therapeutic effect|2
5675438|NCT00414609|19582786|P2|Extension Study|Unsatisfactory therapeutic effect|0
5675439|NCT00414609|19582787|P1|Extension Study|Unsatisfactory therapeutic effect|0
5675440|NCT00414609|19582785|P3|Extension Study|Adverse Event|14
5675441|NCT00414609|19582786|P2|Extension Study|Adverse Event|0
5675442|NCT00414609|19582787|P1|Extension Study|Adverse Event|0
5675443|NCT00414609|19582785|P3|Core Study|Death|0
5675444|NCT00414609|19582786|P2|Core Study|Death|14
5675445|NCT00414609|19582787|P1|Core Study|Death|7
5675446|NCT00414609|19582785|P3|Core Study|Administrative problems|0
5675447|NCT00414609|19582786|P2|Core Study|Administrative problems|2
5675448|NCT00414609|19582787|P1|Core Study|Administrative problems|0
5675449|NCT00414609|19582785|P3|Core Study|Lost to Follow-up|0
5675450|NCT00414609|19582786|P2|Core Study|Lost to Follow-up|4
5675451|NCT00414609|19582787|P1|Core Study|Lost to Follow-up|7
5675452|NCT00414609|19582785|P3|Core Study|Patient withdrew consent|0
5675453|NCT00414609|19582786|P2|Core Study|Patient withdrew consent|11
5675454|NCT00414609|19582787|P1|Core Study|Patient withdrew consent|10
5675455|NCT00414609|19582785|P3|Core Study|Protocol deviation|0
5675456|NCT00414609|19582786|P2|Core Study|Protocol deviation|1
5675457|NCT00414609|19582787|P1|Core Study|Protocol deviation|0
5675458|NCT00414609|19582785|P3|Core Study|Abnormal test procedure results|0
5675459|NCT00414609|19582786|P2|Core Study|Abnormal test procedure results|1
5675460|NCT00414609|19582787|P1|Core Study|Abnormal test procedure results|1
5675461|NCT00414609|19582785|P3|Core Study|Abnormal laboratory values|0
5675462|NCT00414609|19582786|P2|Core Study|Abnormal laboratory values|1
5675463|NCT00414609|19582787|P1|Core Study|Abnormal laboratory values|0
5675464|NCT00414609|19582785|P3|Core Study|Adverse Event|0
5675465|NCT00414609|19582786|P2|Core Study|Adverse Event|11
5675466|NCT00414609|19582787|P1|Core Study|Adverse Event|9
5675467|NCT00414596|19582810|P1|Overall Study|Protocol Violation|2
5675468|NCT00414544|19582819|P1|Overall Study|Lost to Follow-up|14
5675469|NCT00414466|19582842|P4|Overall Study|Withdrawn by Sponsor|0
5675470|NCT00414466|19582843|P3|Overall Study|Withdrawn by Sponsor|0
5675471|NCT00414466|19582844|P2|Overall Study|Withdrawn by Sponsor|0
5675472|NCT00414466|19582845|P1|Overall Study|Withdrawn by Sponsor|1
5675473|NCT00414466|19582842|P4|Overall Study|Lack of Efficacy|0
5675474|NCT00414466|19582843|P3|Overall Study|Lack of Efficacy|0
5675475|NCT00414466|19582844|P2|Overall Study|Lack of Efficacy|0
5675476|NCT00414466|19582845|P1|Overall Study|Lack of Efficacy|1
5675477|NCT00414466|19582842|P4|Overall Study|Adverse Event|1
5675478|NCT00414466|19582843|P3|Overall Study|Adverse Event|1
5675479|NCT00414466|19582844|P2|Overall Study|Adverse Event|0
5675480|NCT00414466|19582845|P1|Overall Study|Adverse Event|0
5675481|NCT00414453|19582863|P1|Overall Study|Abnormal lab work|16
5675482|NCT00414440|19582911|P2|Extension Period|Not included in follow up period|8
5675483|NCT00414440|19582912|P1|Extension Period|Not included in follow up period|18
5675484|NCT00414440|19582911|P2|Extension Period|Withdrawal by Subject|7
5675485|NCT00414440|19582912|P1|Extension Period|Withdrawal by Subject|9
5675486|NCT00414440|19582911|P2|Extension Period|Death|2
5675487|NCT00414440|19582912|P1|Extension Period|Death|1
5675488|NCT00414440|19582911|P2|Extension Period|Administrative|16
5675489|NCT00414440|19582912|P1|Extension Period|Administrative|16
5675490|NCT00414440|19582911|P2|Extension Period|Other|1
5675491|NCT00414440|19582912|P1|Extension Period|Other|1
5675492|NCT00414440|19582911|P2|Extension Period|Did not consent to continue follow up|54
5675493|NCT00414440|19582912|P1|Extension Period|Did not consent to continue follow up|61
5675494|NCT00414440|19582911|P2|Extension Period|Lost to Follow-up|52
5675495|NCT00414440|19582912|P1|Extension Period|Lost to Follow-up|44
5675496|NCT00414440|19582911|P2|Core Period|Withdrawal by Subject|32
5675497|NCT00414440|19582912|P1|Core Period|Withdrawal by Subject|70
5675498|NCT00414388|19582926|P1|Overall Study|Adverse Event|1
5675499|NCT00414310|19582934|P2|Overall Study|Not treated|0
5675500|NCT00414310|19582935|P1|Overall Study|Not treated|1
5675501|NCT00414076|19582979|P2|Overall Study|Adverse Event|0
5675502|NCT00414076|19582980|P1|Overall Study|Adverse Event|1
5675503|NCT00414076|19582979|P2|Overall Study|Withdrawal by Subject|3
5675504|NCT00414076|19582980|P1|Overall Study|Withdrawal by Subject|1
5675505|NCT00414076|19582979|P2|Overall Study|Progression|2
5675506|NCT00414076|19582980|P1|Overall Study|Progression|1
5675507|NCT00414050|19582990|P4|Overall Study|Subject Moved|1
5675508|NCT00414050|19582991|P3|Overall Study|Subject Moved|0
5675509|NCT00414050|19582992|P2|Overall Study|Subject Moved|0
5675510|NCT00414050|19582993|P1|Overall Study|Subject Moved|0
5675511|NCT00414050|19582990|P4|Overall Study|Subject discontinued for other reason|1
5675512|NCT00414050|19582991|P3|Overall Study|Subject discontinued for other reason|2
5675513|NCT00414050|19582992|P2|Overall Study|Subject discontinued for other reason|2
5675514|NCT00414050|19582993|P1|Overall Study|Subject discontinued for other reason|1
5675515|NCT00414050|19582990|P4|Overall Study|Withdrawal by Subject|4
5675516|NCT00414050|19582991|P3|Overall Study|Withdrawal by Subject|2
5675517|NCT00414050|19582992|P2|Overall Study|Withdrawal by Subject|3
5675518|NCT00414050|19582993|P1|Overall Study|Withdrawal by Subject|5
5675519|NCT00414050|19582990|P4|Overall Study|Lost to Follow-up|1
5675520|NCT00414050|19582991|P3|Overall Study|Lost to Follow-up|1
5675521|NCT00414050|19582992|P2|Overall Study|Lost to Follow-up|2
5675522|NCT00414050|19582993|P1|Overall Study|Lost to Follow-up|2
5675523|NCT00414050|19582990|P4|Overall Study|Adverse Event|1
5675524|NCT00414050|19582991|P3|Overall Study|Adverse Event|1
5675525|NCT00414050|19582992|P2|Overall Study|Adverse Event|1
5675526|NCT00414050|19582993|P1|Overall Study|Adverse Event|1
5675527|NCT00414011|19583007|P1|Overall Study|Withdrawal by Subject|2
5675528|NCT00414011|19583007|P1|Overall Study|Physician Decision|3
5675529|NCT00413972|19583016|P4|Overall Study|Other|1
5675530|NCT00413972|19583017|P3|Overall Study|Other|0
5675531|NCT00413972|19583018|P2|Overall Study|Other|0
5675532|NCT00413972|19583019|P1|Overall Study|Other|0
5675533|NCT00413972|19583016|P4|Overall Study|Protocol Violation|0
5675534|NCT00413972|19583017|P3|Overall Study|Protocol Violation|2
5675535|NCT00413972|19583018|P2|Overall Study|Protocol Violation|0
5675536|NCT00413972|19583019|P1|Overall Study|Protocol Violation|0
5675537|NCT00413972|19583016|P4|Overall Study|Withdrawal by Subject|2
5675538|NCT00413972|19583017|P3|Overall Study|Withdrawal by Subject|7
5675539|NCT00413972|19583018|P2|Overall Study|Withdrawal by Subject|5
5675540|NCT00413972|19583019|P1|Overall Study|Withdrawal by Subject|4
5675541|NCT00413972|19583016|P4|Overall Study|Lost to Follow-up|0
5675542|NCT00413972|19583017|P3|Overall Study|Lost to Follow-up|1
5675543|NCT00413972|19583018|P2|Overall Study|Lost to Follow-up|2
5675544|NCT00413972|19583019|P1|Overall Study|Lost to Follow-up|1
5675545|NCT00413972|19583016|P4|Overall Study|Adverse Event|0
5675546|NCT00413972|19583017|P3|Overall Study|Adverse Event|0
5675547|NCT00413972|19583018|P2|Overall Study|Adverse Event|1
5675548|NCT00413972|19583019|P1|Overall Study|Adverse Event|2
5675549|NCT00413959|19583029|P1|Overall Study|Pt had only one cycle.|1
5675550|NCT00413920|19583036|P2|Overall Study|Graft Loss|3
5675551|NCT00413920|19583037|P1|Overall Study|Graft Loss|5
5675552|NCT00413920|19583036|P2|Overall Study|Death|5
5675553|NCT00413920|19583037|P1|Overall Study|Death|3
5675554|NCT00413920|19583036|P2|Overall Study|Lack of Efficacy|9
5675555|NCT00413920|19583037|P1|Overall Study|Lack of Efficacy|11
5675556|NCT00413920|19583036|P2|Overall Study|Adverse Event|11
5675557|NCT00413920|19583037|P1|Overall Study|Adverse Event|9
5675558|NCT00413894|19583052|P1|Overall Study|Other|18
5675559|NCT00413894|19583052|P1|Overall Study|Protocol Violation|11
5675560|NCT00413894|19583052|P1|Overall Study|Adverse Event|28
5675561|NCT00413894|19583052|P1|Overall Study|Hb <10 grams/deciliter|12
5675562|NCT00413894|19583052|P1|Overall Study|Administrative Reasons|1
5675563|NCT00413894|19583052|P1|Overall Study|Withdrawal by Subject|10
5675564|NCT00413777|19583069|P2|Fixed-dose Period|Withdrew Consent|1
5675565|NCT00413777|19583070|P1|Fixed-dose Period|Withdrew Consent|0
5675566|NCT00413777|19583069|P2|Fixed-dose Period|Met Withdrawal Criteria|0
5675567|NCT00413777|19583070|P1|Fixed-dose Period|Met Withdrawal Criteria|1
5675568|NCT00413777|19583069|P2|Fixed-dose Period|Adverse Event|1
5675569|NCT00413777|19583070|P1|Fixed-dose Period|Adverse Event|2
5675570|NCT00413777|19583069|P2|Fixed-dose Period|Lost to Follow-up|1
5675571|NCT00413777|19583070|P1|Fixed-dose Period|Lost to Follow-up|1
5675572|NCT00413699|19583118|P3|Extension Period|Adverse Event|2
5675573|NCT00413699|19583119|P2|Extension Period|Adverse Event|0
5675574|NCT00413699|19583120|P1|Extension Period|Adverse Event|0
5675575|NCT00413699|19583118|P3|Extension Period|Protocol Violation|1
5675576|NCT00413699|19583119|P2|Extension Period|Protocol Violation|0
5675577|NCT00413699|19583120|P1|Extension Period|Protocol Violation|0
5675578|NCT00413699|19583118|P3|Extension Period|No Longer Willing to Participate|2
5675579|NCT00413699|19583119|P2|Extension Period|No Longer Willing to Participate|0
5675580|NCT00413699|19583120|P1|Extension Period|No Longer Willing to Participate|0
5675581|NCT00413699|19583118|P3|Initial Period|No longer willing to participate|0
5675582|NCT00413699|19583119|P2|Initial Period|No longer willing to participate|368
5675583|NCT00413699|19583120|P1|Initial Period|No longer willing to participate|116
5675584|NCT00413699|19583118|P3|Initial Period|Missing end of study page|0
5675585|NCT00413699|19583119|P2|Initial Period|Missing end of study page|4
5675586|NCT00413699|19583120|P1|Initial Period|Missing end of study page|0
5675587|NCT00413699|19583118|P3|Initial Period|Adverse event not related to study drug|0
5675588|NCT00413699|19583119|P2|Initial Period|Adverse event not related to study drug|248
5675589|NCT00413699|19583120|P1|Initial Period|Adverse event not related to study drug|113
5675590|NCT00413699|19583118|P3|Initial Period|Adverse event related to study drug|0
5675591|NCT00413699|19583119|P2|Initial Period|Adverse event related to study drug|527
5675592|NCT00413699|19583120|P1|Initial Period|Adverse event related to study drug|178
5675593|NCT00413699|19583118|P3|Initial Period|Other|0
5675594|NCT00413699|19583119|P2|Initial Period|Other|211
5675595|NCT00413699|19583120|P1|Initial Period|Other|67
5675596|NCT00413699|19583118|P3|Initial Period|Study terminated by Sponsor|0
5675597|NCT00413699|19583119|P2|Initial Period|Study terminated by Sponsor|1
5675598|NCT00413699|19583120|P1|Initial Period|Study terminated by Sponsor|0
5675599|NCT00413699|19583118|P3|Initial Period|Medication error without adverse event|0
5675600|NCT00413699|19583119|P2|Initial Period|Medication error without adverse event|1
5675601|NCT00413699|19583120|P1|Initial Period|Medication error without adverse event|0
5675602|NCT00413699|19583118|P3|Initial Period|Did not meet entrance criteria|0
5675603|NCT00413699|19583119|P2|Initial Period|Did not meet entrance criteria|2
5675604|NCT00413699|19583120|P1|Initial Period|Did not meet entrance criteria|2
5675605|NCT00413699|19583118|P3|Initial Period|Pregnancy|0
5675606|NCT00413699|19583119|P2|Initial Period|Pregnancy|8
5675607|NCT00413699|19583120|P1|Initial Period|Pregnancy|10
5675608|NCT00413699|19583118|P3|Initial Period|Protocol Violation|0
5675609|NCT00413699|19583119|P2|Initial Period|Protocol Violation|89
5675610|NCT00413699|19583120|P1|Initial Period|Protocol Violation|38
5675611|NCT00413699|19583118|P3|Initial Period|Lost to Follow-up|0
5675612|NCT00413699|19583119|P2|Initial Period|Lost to Follow-up|101
5675613|NCT00413699|19583120|P1|Initial Period|Lost to Follow-up|31
5675614|NCT00413699|19583118|P3|Initial Period|Lack of Efficacy|0
5675615|NCT00413699|19583119|P2|Initial Period|Lack of Efficacy|115
5675616|NCT00413699|19583120|P1|Initial Period|Lack of Efficacy|59
5675617|NCT00413699|19583118|P3|Initial Period|Death|0
5675618|NCT00413699|19583119|P2|Initial Period|Death|30
5675619|NCT00413699|19583120|P1|Initial Period|Death|25
5675620|NCT00413660|19583202|P11|Post Week 12|Other|0
5675621|NCT00413660|19583203|P10|Post Week 12|Other|0
5675622|NCT00413660|19583204|P9|Post Week 12|Other|0
5675623|NCT00413660|19583205|P8|Post Week 12|Other|0
5675624|NCT00413660|19583206|P7|Post Week 12|Other|1
5675625|NCT00413660|19583207|P6|Post Week 12|Other|1
5675626|NCT00413660|19583208|P5|Post Week 12|Other|1
5675627|NCT00413660|19583209|P4|Post Week 12|Other|0
5675628|NCT00413660|19583210|P3|Post Week 12|Other|3
5675629|NCT00413660|19583211|P2|Post Week 12|Other|2
5675630|NCT00413660|19583212|P1|Post Week 12|Other|1
5675631|NCT00413660|19583202|P11|Post Week 12|Withdrawal by Subject|1
5675632|NCT00413660|19583203|P10|Post Week 12|Withdrawal by Subject|0
5675633|NCT00413660|19583204|P9|Post Week 12|Withdrawal by Subject|0
5675634|NCT00413660|19583205|P8|Post Week 12|Withdrawal by Subject|0
5675635|NCT00413660|19583206|P7|Post Week 12|Withdrawal by Subject|0
5675636|NCT00413660|19583207|P6|Post Week 12|Withdrawal by Subject|0
5675637|NCT00413660|19583208|P5|Post Week 12|Withdrawal by Subject|1
5675638|NCT00413660|19583209|P4|Post Week 12|Withdrawal by Subject|0
5675639|NCT00413660|19583210|P3|Post Week 12|Withdrawal by Subject|1
5675640|NCT00413660|19583211|P2|Post Week 12|Withdrawal by Subject|1
5675641|NCT00413660|19583212|P1|Post Week 12|Withdrawal by Subject|0
5675642|NCT00413660|19583202|P11|Post Week 12|Lost to Follow-up|0
5675643|NCT00413660|19583203|P10|Post Week 12|Lost to Follow-up|0
5675644|NCT00413660|19583204|P9|Post Week 12|Lost to Follow-up|0
5675645|NCT00413660|19583205|P8|Post Week 12|Lost to Follow-up|0
5675646|NCT00413660|19583206|P7|Post Week 12|Lost to Follow-up|0
5675647|NCT00413660|19583207|P6|Post Week 12|Lost to Follow-up|0
5675648|NCT00413660|19583208|P5|Post Week 12|Lost to Follow-up|0
5675649|NCT00413660|19583209|P4|Post Week 12|Lost to Follow-up|0
5675650|NCT00413660|19583210|P3|Post Week 12|Lost to Follow-up|1
5675651|NCT00413660|19583211|P2|Post Week 12|Lost to Follow-up|1
5675652|NCT00413660|19583212|P1|Post Week 12|Lost to Follow-up|0
5675653|NCT00413660|19583202|P11|Post Week 12|Lack of Efficacy|0
5675654|NCT00413660|19583203|P10|Post Week 12|Lack of Efficacy|1
5675655|NCT00413660|19583204|P9|Post Week 12|Lack of Efficacy|0
5675656|NCT00413660|19583205|P8|Post Week 12|Lack of Efficacy|0
5675657|NCT00413660|19583206|P7|Post Week 12|Lack of Efficacy|0
5675658|NCT00413660|19583207|P6|Post Week 12|Lack of Efficacy|0
5675659|NCT00413660|19583208|P5|Post Week 12|Lack of Efficacy|0
5675660|NCT00413660|19583209|P4|Post Week 12|Lack of Efficacy|0
5675661|NCT00413660|19583210|P3|Post Week 12|Lack of Efficacy|1
5675662|NCT00413660|19583211|P2|Post Week 12|Lack of Efficacy|0
5675663|NCT00413660|19583212|P1|Post Week 12|Lack of Efficacy|0
5675664|NCT00413660|19583202|P11|Post Week 12|Adverse Event|0
5675665|NCT00413660|19583203|P10|Post Week 12|Adverse Event|0
5675666|NCT00413660|19583204|P9|Post Week 12|Adverse Event|0
5675667|NCT00413660|19583205|P8|Post Week 12|Adverse Event|0
5675668|NCT00413660|19583206|P7|Post Week 12|Adverse Event|2
5675669|NCT00413660|19583207|P6|Post Week 12|Adverse Event|2
5675670|NCT00413660|19583208|P5|Post Week 12|Adverse Event|4
5675671|NCT00413660|19583209|P4|Post Week 12|Adverse Event|1
5675672|NCT00413660|19583210|P3|Post Week 12|Adverse Event|2
5675673|NCT00413660|19583211|P2|Post Week 12|Adverse Event|0
5675674|NCT00413660|19583212|P1|Post Week 12|Adverse Event|2
5675675|NCT00413660|19583202|P11|Up To Week 12|Other|0
5675676|NCT00413660|19583203|P10|Up To Week 12|Other|0
5675677|NCT00413660|19583204|P9|Up To Week 12|Other|0
5675678|NCT00413660|19583205|P8|Up To Week 12|Other|0
5675679|NCT00413660|19583206|P7|Up To Week 12|Other|3
5675680|NCT00413660|19583207|P6|Up To Week 12|Other|4
5675681|NCT00413660|19583208|P5|Up To Week 12|Other|2
5675682|NCT00413660|19583209|P4|Up To Week 12|Other|1
5675683|NCT00413660|19583210|P3|Up To Week 12|Other|6
5675684|NCT00413660|19583211|P2|Up To Week 12|Other|1
5675685|NCT00413660|19583212|P1|Up To Week 12|Other|3
5675686|NCT00413660|19583202|P11|Up To Week 12|Randomized, Not Treated|0
5675687|NCT00413660|19583203|P10|Up To Week 12|Randomized, Not Treated|0
5675688|NCT00413660|19583204|P9|Up To Week 12|Randomized, Not Treated|0
5675689|NCT00413660|19583205|P8|Up To Week 12|Randomized, Not Treated|0
5675690|NCT00413660|19583206|P7|Up To Week 12|Randomized, Not Treated|0
5675691|NCT00413660|19583207|P6|Up To Week 12|Randomized, Not Treated|0
5675692|NCT00413660|19583208|P5|Up To Week 12|Randomized, Not Treated|0
5675693|NCT00413660|19583209|P4|Up To Week 12|Randomized, Not Treated|1
5675694|NCT00413660|19583210|P3|Up To Week 12|Randomized, Not Treated|0
5675695|NCT00413660|19583211|P2|Up To Week 12|Randomized, Not Treated|0
5675696|NCT00413660|19583212|P1|Up To Week 12|Randomized, Not Treated|1
5675697|NCT00413660|19583202|P11|Up To Week 12|Withdrawal by Subject|0
5675698|NCT00413660|19583203|P10|Up To Week 12|Withdrawal by Subject|0
5675699|NCT00413660|19583204|P9|Up To Week 12|Withdrawal by Subject|0
5675700|NCT00413660|19583205|P8|Up To Week 12|Withdrawal by Subject|0
5675701|NCT00413660|19583206|P7|Up To Week 12|Withdrawal by Subject|2
5675702|NCT00413660|19583207|P6|Up To Week 12|Withdrawal by Subject|2
5675703|NCT00413660|19583208|P5|Up To Week 12|Withdrawal by Subject|0
5675704|NCT00413660|19583209|P4|Up To Week 12|Withdrawal by Subject|2
5675705|NCT00413660|19583210|P3|Up To Week 12|Withdrawal by Subject|0
5675706|NCT00413660|19583211|P2|Up To Week 12|Withdrawal by Subject|2
5675707|NCT00413660|19583212|P1|Up To Week 12|Withdrawal by Subject|0
5675708|NCT00413660|19583202|P11|Up To Week 12|Lost to Follow-up|0
5675709|NCT00413660|19583203|P10|Up To Week 12|Lost to Follow-up|0
5675710|NCT00413660|19583204|P9|Up To Week 12|Lost to Follow-up|0
5675711|NCT00413660|19583205|P8|Up To Week 12|Lost to Follow-up|0
5675712|NCT00413660|19583206|P7|Up To Week 12|Lost to Follow-up|0
5675713|NCT00413660|19583207|P6|Up To Week 12|Lost to Follow-up|0
5675714|NCT00413660|19583208|P5|Up To Week 12|Lost to Follow-up|1
5675715|NCT00413660|19583209|P4|Up To Week 12|Lost to Follow-up|0
5675716|NCT00413660|19583210|P3|Up To Week 12|Lost to Follow-up|0
5675717|NCT00413660|19583211|P2|Up To Week 12|Lost to Follow-up|1
5675718|NCT00413660|19583212|P1|Up To Week 12|Lost to Follow-up|0
5675719|NCT00413660|19583202|P11|Up To Week 12|Lack of Efficacy|0
5675720|NCT00413660|19583203|P10|Up To Week 12|Lack of Efficacy|0
5675721|NCT00413660|19583204|P9|Up To Week 12|Lack of Efficacy|0
5675722|NCT00413660|19583205|P8|Up To Week 12|Lack of Efficacy|0
5675723|NCT00413660|19583206|P7|Up To Week 12|Lack of Efficacy|5
5675724|NCT00413660|19583207|P6|Up To Week 12|Lack of Efficacy|0
5675725|NCT00413660|19583208|P5|Up To Week 12|Lack of Efficacy|0
5675726|NCT00413660|19583209|P4|Up To Week 12|Lack of Efficacy|0
5675727|NCT00413660|19583210|P3|Up To Week 12|Lack of Efficacy|0
5675728|NCT00413660|19583211|P2|Up To Week 12|Lack of Efficacy|0
5675729|NCT00413660|19583212|P1|Up To Week 12|Lack of Efficacy|2
5675730|NCT00413660|19583202|P11|Up To Week 12|Adverse Event|0
5675731|NCT00413660|19583203|P10|Up To Week 12|Adverse Event|0
5675732|NCT00413660|19583204|P9|Up To Week 12|Adverse Event|0
5675733|NCT00413660|19583205|P8|Up To Week 12|Adverse Event|0
5675734|NCT00413660|19583206|P7|Up To Week 12|Adverse Event|1
5675735|NCT00413660|19583207|P6|Up To Week 12|Adverse Event|4
5675736|NCT00413660|19583208|P5|Up To Week 12|Adverse Event|6
5675737|NCT00413660|19583209|P4|Up To Week 12|Adverse Event|4
5675738|NCT00413660|19583210|P3|Up To Week 12|Adverse Event|1
5675739|NCT00413660|19583211|P2|Up To Week 12|Adverse Event|3
5675740|NCT00413660|19583212|P1|Up To Week 12|Adverse Event|1
5675741|NCT00413413|19583615|P3|Double-Blind|Lost to Follow-up|2
5675742|NCT00413413|19583616|P2|Double-Blind|Lost to Follow-up|4
5675743|NCT00413413|19583617|P1|Double-Blind|Lost to Follow-up|3
5675744|NCT00413413|19583615|P3|Double-Blind|Subject withdrew consent|9
5675745|NCT00413413|19583616|P2|Double-Blind|Subject withdrew consent|6
5675746|NCT00413413|19583617|P1|Double-Blind|Subject withdrew consent|4
5675747|NCT00413413|19583615|P3|Double-Blind|Protocol deviation|1
5675748|NCT00413413|19583616|P2|Double-Blind|Protocol deviation|2
5675749|NCT00413413|19583617|P1|Double-Blind|Protocol deviation|1
5675750|NCT00413413|19583615|P3|Double-Blind|Unsatisfactory therapeutic effect|1
5675751|NCT00413413|19583616|P2|Double-Blind|Unsatisfactory therapeutic effect|2
5675752|NCT00413413|19583617|P1|Double-Blind|Unsatisfactory therapeutic effect|1
5675753|NCT00413413|19583615|P3|Double-Blind|Adverse Event|5
5675754|NCT00413413|19583616|P2|Double-Blind|Adverse Event|0
5675755|NCT00413413|19583617|P1|Double-Blind|Adverse Event|6
5675756|NCT00413413|19583615|P3|Single-Blind|Lost to Follow-up|0
5675757|NCT00413413|19583616|P2|Single-Blind|Lost to Follow-up|8
5675758|NCT00413413|19583617|P1|Single-Blind|Lost to Follow-up|0
5675759|NCT00413413|19583615|P3|Single-Blind|Withdrawal by Subject|0
5675760|NCT00413413|19583616|P2|Single-Blind|Withdrawal by Subject|27
5675761|NCT00413413|19583617|P1|Single-Blind|Withdrawal by Subject|0
5675762|NCT00413413|19583615|P3|Single-Blind|Protocol Violation|0
5675763|NCT00413413|19583616|P2|Single-Blind|Protocol Violation|16
5675764|NCT00413413|19583617|P1|Single-Blind|Protocol Violation|0
5675765|NCT00413413|19583615|P3|Single-Blind|Subject no longer requires study drug|0
5675766|NCT00413413|19583616|P2|Single-Blind|Subject no longer requires study drug|151
5675767|NCT00413413|19583617|P1|Single-Blind|Subject no longer requires study drug|0
5675768|NCT00413413|19583615|P3|Single-Blind|Lack of Efficacy|0
5675769|NCT00413413|19583616|P2|Single-Blind|Lack of Efficacy|5
5675770|NCT00413413|19583617|P1|Single-Blind|Lack of Efficacy|0
5675771|NCT00413413|19583615|P3|Single-Blind|Adverse Event|0
5675772|NCT00413413|19583616|P2|Single-Blind|Adverse Event|9
5675773|NCT00413413|19583617|P1|Single-Blind|Adverse Event|0
5675774|NCT00413374|19583670|P2|Overall Study|Surgery|0
5675775|NCT00413374|19583671|P1|Overall Study|Surgery|1
5675776|NCT00413374|19583670|P2|Overall Study|Lost to Follow-up|0
5675777|NCT00413374|19583671|P1|Overall Study|Lost to Follow-up|1
5675778|NCT00413374|19583670|P2|Overall Study|Adverse Event|0
5675779|NCT00413374|19583671|P1|Overall Study|Adverse Event|1
5675780|NCT00413374|19583670|P2|Overall Study|Ineligible due to screening criteria.|0
5675781|NCT00413374|19583671|P1|Overall Study|Ineligible due to screening criteria.|3
5675782|NCT00413283|19583702|P4|Overall Study|Other|0
5675783|NCT00413283|19583703|P3|Overall Study|Other|1
5675784|NCT00413283|19583704|P2|Overall Study|Other|0
5675785|NCT00413283|19583705|P1|Overall Study|Other|0
5675786|NCT00413283|19583702|P4|Overall Study|Requirement for alternative therapy|0
5675787|NCT00413283|19583703|P3|Overall Study|Requirement for alternative therapy|0
5675788|NCT00413283|19583704|P2|Overall Study|Requirement for alternative therapy|2
5675789|NCT00413283|19583705|P1|Overall Study|Requirement for alternative therapy|0
5675790|NCT00413283|19583702|P4|Overall Study|Protocol deviation|0
5675791|NCT00413283|19583703|P3|Overall Study|Protocol deviation|0
5675792|NCT00413283|19583704|P2|Overall Study|Protocol deviation|1
5675793|NCT00413283|19583705|P1|Overall Study|Protocol deviation|0
5675794|NCT00413283|19583702|P4|Overall Study|Ineligibility determined|1
5675795|NCT00413283|19583703|P3|Overall Study|Ineligibility determined|0
5675796|NCT00413283|19583704|P2|Overall Study|Ineligibility determined|0
5675797|NCT00413283|19583705|P1|Overall Study|Ineligibility determined|0
5675798|NCT00413283|19583702|P4|Overall Study|Adverse Event|1
5675799|NCT00413283|19583703|P3|Overall Study|Adverse Event|0
5675800|NCT00413283|19583704|P2|Overall Study|Adverse Event|0
5675801|NCT00413283|19583705|P1|Overall Study|Adverse Event|0
5675802|NCT00413283|19583702|P4|Overall Study|Death|1
5675803|NCT00413283|19583703|P3|Overall Study|Death|1
5675804|NCT00413283|19583704|P2|Overall Study|Death|0
5675805|NCT00413283|19583705|P1|Overall Study|Death|0
5675806|NCT00413283|19583702|P4|Overall Study|Withdrawal by Subject|1
5675807|NCT00413283|19583703|P3|Overall Study|Withdrawal by Subject|0
5675808|NCT00413283|19583704|P2|Overall Study|Withdrawal by Subject|0
5675809|NCT00413283|19583705|P1|Overall Study|Withdrawal by Subject|1
5675810|NCT00413244|19583737|P2|Overall Study|Withdrawal by Subject|1
5675811|NCT00413244|19583738|P1|Overall Study|Withdrawal by Subject|10
5675812|NCT00413231|19583766|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
5675813|NCT00413231|19583766|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
5675814|NCT00413231|19583766|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
5675815|NCT00413231|19583766|P1|365-day to 60-month Post Treatment|Death|36
5675816|NCT00413231|19583766|P1|30-day to 365-day Post Treatment|Death|13
5675817|NCT00413231|19583766|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
5675818|NCT00413231|19583766|P1|0 to 30-day Post Treatment|Death|5
5675819|NCT00413218|19583798|P2|Overall Study|Withdrawal by Subject|1
5675820|NCT00413218|19583799|P1|Overall Study|Withdrawal by Subject|9
5675821|NCT00413218|19583798|P2|Overall Study|Missing|0
5675822|NCT00413218|19583799|P1|Overall Study|Missing|1
5675823|NCT00413218|19583798|P2|Overall Study|Admin|14
5675824|NCT00413218|19583799|P1|Overall Study|Admin|20
5675825|NCT00413218|19583798|P2|Overall Study|Lost to Follow-up|17
5675826|NCT00413218|19583799|P1|Overall Study|Lost to Follow-up|14
5675827|NCT00413218|19583798|P2|Overall Study|Death|56
5675828|NCT00413218|19583799|P1|Overall Study|Death|57
5675829|NCT00413218|19583798|P2|Overall Study|Randomized but didn't receive study drug|8
5675830|NCT00413218|19583799|P1|Overall Study|Randomized but didn't receive study drug|2
5675831|NCT00413192|19583825|P4|Overall Study|Not treated|1
5675832|NCT00413192|19583826|P3|Overall Study|Not treated|0
5675833|NCT00413192|19583827|P2|Overall Study|Not treated|0
5675834|NCT00413192|19583828|P1|Overall Study|Not treated|0
5675835|NCT00413192|19583825|P4|Overall Study|Other|2
5675836|NCT00413192|19583826|P3|Overall Study|Other|1
5675837|NCT00413192|19583827|P2|Overall Study|Other|1
5675838|NCT00413192|19583828|P1|Overall Study|Other|5
5675839|NCT00413192|19583825|P4|Overall Study|Intercurrent death|0
5675840|NCT00413192|19583826|P3|Overall Study|Intercurrent death|0
5675841|NCT00413192|19583827|P2|Overall Study|Intercurrent death|1
5675842|NCT00413192|19583828|P1|Overall Study|Intercurrent death|0
5675843|NCT00413192|19583825|P4|Overall Study|Intercurrent illness|1
5675844|NCT00413192|19583826|P3|Overall Study|Intercurrent illness|0
5675845|NCT00413192|19583827|P2|Overall Study|Intercurrent illness|0
5675846|NCT00413192|19583828|P1|Overall Study|Intercurrent illness|0
5675847|NCT00413192|19583825|P4|Overall Study|Withdrawal by Subject|1
5675848|NCT00413192|19583826|P3|Overall Study|Withdrawal by Subject|0
5675849|NCT00413192|19583827|P2|Overall Study|Withdrawal by Subject|5
5675850|NCT00413192|19583828|P1|Overall Study|Withdrawal by Subject|3
5675851|NCT00413192|19583825|P4|Overall Study|Toxicity|2
5675852|NCT00413192|19583826|P3|Overall Study|Toxicity|2
5675853|NCT00413192|19583827|P2|Overall Study|Toxicity|2
5675854|NCT00413192|19583828|P1|Overall Study|Toxicity|3
5675855|NCT00413192|19583825|P4|Overall Study|Disease progression|25
5675856|NCT00413192|19583826|P3|Overall Study|Disease progression|16
5675857|NCT00413192|19583827|P2|Overall Study|Disease progression|31
5675858|NCT00413192|19583828|P1|Overall Study|Disease progression|26
5675859|NCT00413153|19583881|P2|Overall Study|Adverse Event|0
5675860|NCT00413153|19583882|P1|Overall Study|Adverse Event|1
5675861|NCT00413153|19583881|P2|Overall Study|Withdrawal by Subject|1
5675862|NCT00413153|19583882|P1|Overall Study|Withdrawal by Subject|1
5675863|NCT00413062|19583906|P2|Overall Study|Other reason|34
5675864|NCT00413062|19583907|P1|Overall Study|Other reason|70
5675865|NCT00413062|19583906|P2|Overall Study|Lost to Follow-up|73
5675866|NCT00413062|19583907|P1|Overall Study|Lost to Follow-up|175
5675867|NCT00413062|19583906|P2|Overall Study|Pregnancy wish|6
5675868|NCT00413062|19583907|P1|Overall Study|Pregnancy wish|17
5675869|NCT00413062|19583906|P2|Overall Study|Pregnancy|5
5675870|NCT00413062|19583907|P1|Overall Study|Pregnancy|15
5675871|NCT00413062|19583906|P2|Overall Study|Withdrawal of informed consent|36
5675872|NCT00413062|19583907|P1|Overall Study|Withdrawal of informed consent|111
5675873|NCT00413062|19583906|P2|Overall Study|Pre-treatment (serious) adverse event|0
5675874|NCT00413062|19583907|P1|Overall Study|Pre-treatment (serious) adverse event|1
5675875|NCT00413062|19583906|P2|Overall Study|Adverse event/serious adverse event|56
5675876|NCT00413062|19583907|P1|Overall Study|Adverse event/serious adverse event|289
5675877|NCT00413049|19583933|P2|Overall Study|Lack of Efficacy|0
5675878|NCT00413049|19583934|P1|Overall Study|Lack of Efficacy|1
5675879|NCT00413049|19583933|P2|Overall Study|Abnormal laboratory value(s)|0
5675880|NCT00413049|19583934|P1|Overall Study|Abnormal laboratory value(s)|1
5675881|NCT00413049|19583933|P2|Overall Study|Subject no longer requires study drug|1
5675882|NCT00413049|19583934|P1|Overall Study|Subject no longer requires study drug|0
5675883|NCT00413049|19583933|P2|Overall Study|Protocol Violation|1
5675884|NCT00413049|19583934|P1|Overall Study|Protocol Violation|3
5675885|NCT00413049|19583933|P2|Overall Study|Lost to Follow-up|3
5675886|NCT00413049|19583934|P1|Overall Study|Lost to Follow-up|2
5675887|NCT00413049|19583933|P2|Overall Study|Withdrawal by Subject|5
5675888|NCT00413049|19583934|P1|Overall Study|Withdrawal by Subject|7
5675889|NCT00413049|19583933|P2|Overall Study|Adverse Event|8
5675890|NCT00413049|19583934|P1|Overall Study|Adverse Event|10
5675891|NCT00413036|19583950|P1|Overall Study|Missing|2
5675892|NCT00413036|19583950|P1|Overall Study|Other|26
5675893|NCT00413036|19583950|P1|Overall Study|Death|9
5675894|NCT00413036|19583950|P1|Overall Study|Withdrawal by Subject|7
5675895|NCT00413036|19583950|P1|Overall Study|Lack of Efficacy|129
5675896|NCT00413036|19583950|P1|Overall Study|Adverse Event|44
5675897|NCT00413010|19583960|P2|Overall Study|Due to termination of the study|52
5675898|NCT00413010|19583961|P1|Overall Study|Due to termination of the study|54
5675899|NCT00413010|19583960|P2|Overall Study|Withdrawal by Subject|2
5675900|NCT00413010|19583961|P1|Overall Study|Withdrawal by Subject|7
5675901|NCT00413010|19583960|P2|Overall Study|Lost to Follow-up|0
5675902|NCT00413010|19583961|P1|Overall Study|Lost to Follow-up|3
5675903|NCT00413010|19583960|P2|Overall Study|Lack of Efficacy|3
5675904|NCT00413010|19583961|P1|Overall Study|Lack of Efficacy|0
5675905|NCT00413010|19583960|P2|Overall Study|Laboratory abnormality|2
5675906|NCT00413010|19583961|P1|Overall Study|Laboratory abnormality|0
5675907|NCT00413010|19583960|P2|Overall Study|Adverse Event|4
5675908|NCT00413010|19583961|P1|Overall Study|Adverse Event|8
5675909|NCT00412984|19583983|P2|Overall Study|Not Reported|12
5675910|NCT00412984|19583984|P1|Overall Study|Not Reported|11
5675911|NCT00412984|19583983|P2|Overall Study|Other Reason|92
5675912|NCT00412984|19583984|P1|Overall Study|Other Reason|80
5675913|NCT00412984|19583983|P2|Overall Study|Physician Refused to Continue Treatment|89
5675914|NCT00412984|19583984|P1|Overall Study|Physician Refused to Continue Treatment|81
5675915|NCT00412984|19583983|P2|Overall Study|Administrative Reason by Sponsor|8
5675916|NCT00412984|19583984|P1|Overall Study|Administrative Reason by Sponsor|11
5675917|NCT00412984|19583983|P2|Overall Study|Subject No Longer Meets Study Criteria|100
5675918|NCT00412984|19583984|P1|Overall Study|Subject No Longer Meets Study Criteria|87
5675919|NCT00412984|19583983|P2|Overall Study|Pregnancy|0
5675920|NCT00412984|19583984|P1|Overall Study|Pregnancy|1
5675921|NCT00412984|19583983|P2|Overall Study|Poor/Noncompliance|77
5675922|NCT00412984|19583984|P1|Overall Study|Poor/Noncompliance|57
5675923|NCT00412984|19583983|P2|Overall Study|Lost to Follow-up|39
5675924|NCT00412984|19583984|P1|Overall Study|Lost to Follow-up|51
5675925|NCT00412984|19583983|P2|Overall Study|Withdrawal by Subject|989
5675926|NCT00412984|19583984|P1|Overall Study|Withdrawal by Subject|921
5675927|NCT00412984|19583983|P2|Overall Study|Adverse Event|738
5675928|NCT00412984|19583984|P1|Overall Study|Adverse Event|679
5675929|NCT00412984|19583983|P2|Overall Study|Death|349
5675930|NCT00412984|19583984|P1|Overall Study|Death|331
5675931|NCT00412971|19584028|P2|Overall Study|Protocol Violation|1
5675932|NCT00412971|19584029|P1|Overall Study|Protocol Violation|13
5675933|NCT00412971|19584028|P2|Overall Study|Lost to Follow-up|9
5675934|NCT00412971|19584029|P1|Overall Study|Lost to Follow-up|17
5675935|NCT00412958|19584042|P4|Overall Study|Transport issue|0
5675936|NCT00412958|19584043|P3|Overall Study|Transport issue|0
5675937|NCT00412958|19584044|P2|Overall Study|Transport issue|1
5675938|NCT00412958|19584045|P1|Overall Study|Transport issue|0
5675939|NCT00412958|19584042|P4|Overall Study|Death|0
5675940|NCT00412958|19584043|P3|Overall Study|Death|0
5675941|NCT00412958|19584044|P2|Overall Study|Death|1
5675942|NCT00412958|19584045|P1|Overall Study|Death|0
5675943|NCT00412958|19584042|P4|Overall Study|Lost to Follow-up|0
5675944|NCT00412958|19584043|P3|Overall Study|Lost to Follow-up|0
5675945|NCT00412958|19584044|P2|Overall Study|Lost to Follow-up|1
5675946|NCT00412958|19584045|P1|Overall Study|Lost to Follow-up|0
5675947|NCT00412958|19584042|P4|Overall Study|Adverse Event|0
5675948|NCT00412958|19584043|P3|Overall Study|Adverse Event|0
5675949|NCT00412958|19584044|P2|Overall Study|Adverse Event|1
5675950|NCT00412958|19584045|P1|Overall Study|Adverse Event|0
5675951|NCT00412958|19584042|P4|Overall Study|Withdrawal by Subject|1
5675952|NCT00412958|19584043|P3|Overall Study|Withdrawal by Subject|0
5675953|NCT00412958|19584044|P2|Overall Study|Withdrawal by Subject|0
5675954|NCT00412958|19584045|P1|Overall Study|Withdrawal by Subject|3
5675955|NCT00412932|19584055|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
5675956|NCT00412932|19584055|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
5675957|NCT00412932|19584055|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
5675958|NCT00412932|19584055|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
5675959|NCT00412932|19584055|P1|Olmesartan 40 mg|Withdrawal by Subject|1
5675960|NCT00412932|19584055|P1|Olmesartan 40 mg|Lack of Efficacy|3
5675961|NCT00412932|19584055|P1|Olmesartan 40 mg|Adverse Event|4
5675962|NCT00412932|19584055|P1|Olmesartan (Olm) 20 mg|Other|1
5675963|NCT00412932|19584055|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
5675964|NCT00412932|19584055|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
5675965|NCT00412932|19584055|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
5675966|NCT00412932|19584055|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
5675967|NCT00412893|19584066|P2|Overall Study|Randomized but Never Received Study Drug|6
5675968|NCT00412893|19584067|P1|Overall Study|Randomized but Never Received Study Drug|5
5675969|NCT00412893|19584066|P2|Overall Study|Administrative Reason|15
5675970|NCT00412893|19584067|P1|Overall Study|Administrative Reason|12
5675971|NCT00412893|19584066|P2|Overall Study|Did Not Cooperate|9
5675972|NCT00412893|19584067|P1|Overall Study|Did Not Cooperate|12
5675973|NCT00412893|19584066|P2|Overall Study|Other Protocol Violation|6
5675974|NCT00412893|19584067|P1|Overall Study|Other Protocol Violation|10
5675975|NCT00412893|19584066|P2|Overall Study|Violation of Selection at Entry|10
5675976|NCT00412893|19584067|P1|Overall Study|Violation of Selection at Entry|17
5675977|NCT00412893|19584066|P2|Overall Study|Lost to Follow-up|1
5675978|NCT00412893|19584067|P1|Overall Study|Lost to Follow-up|2
5675979|NCT00412893|19584066|P2|Overall Study|Insufficient Therapeutic Response|23
5675980|NCT00412893|19584067|P1|Overall Study|Insufficient Therapeutic Response|39
5675981|NCT00412893|19584066|P2|Overall Study|Death|21
5675982|NCT00412893|19584067|P1|Overall Study|Death|17
5675983|NCT00412893|19584066|P2|Overall Study|Adverse Event|53
5675984|NCT00412893|19584067|P1|Overall Study|Adverse Event|31
5675985|NCT00412854|19584105|P2|Overall Study|Withdrawn for other reasons|11
5675986|NCT00412854|19584106|P1|Overall Study|Withdrawn for other reasons|13
5675987|NCT00412854|19584105|P2|Overall Study|Withdrawn due to adverse events|5
5675988|NCT00412854|19584106|P1|Overall Study|Withdrawn due to adverse events|1
5675989|NCT00412750|19584150|P3|Overall Study|Lack of Efficacy|3
5675990|NCT00412750|19584151|P2|Overall Study|Lack of Efficacy|0
5675991|NCT00412750|19584152|P1|Overall Study|Lack of Efficacy|0
5675992|NCT00412750|19584150|P3|Overall Study|Withdrawal by Subject|2
5675993|NCT00412750|19584151|P2|Overall Study|Withdrawal by Subject|1
5675994|NCT00412750|19584152|P1|Overall Study|Withdrawal by Subject|0
5675995|NCT00412750|19584150|P3|Overall Study|Lost to Follow-up|1
5675996|NCT00412750|19584151|P2|Overall Study|Lost to Follow-up|0
5675997|NCT00412750|19584152|P1|Overall Study|Lost to Follow-up|1
5675998|NCT00412750|19584150|P3|Overall Study|Adverse Event|3
5675999|NCT00412750|19584151|P2|Overall Study|Adverse Event|3
5676000|NCT00412750|19584152|P1|Overall Study|Adverse Event|8
5676001|NCT00412750|19584150|P3|Overall Study|Administrative problems|14
5676002|NCT00412750|19584151|P2|Overall Study|Administrative problems|17
5676003|NCT00412750|19584152|P1|Overall Study|Administrative problems|21
5676004|NCT00412750|19584150|P3|Overall Study|Abnormal laboratory value(s)|0
5676005|NCT00412750|19584151|P2|Overall Study|Abnormal laboratory value(s)|0
5676006|NCT00412750|19584152|P1|Overall Study|Abnormal laboratory value(s)|1
5676007|NCT00412737|19584177|P2|Overall Study|Failure to Return|2
5676008|NCT00412737|19584178|P1|Overall Study|Failure to Return|6
5676009|NCT00412737|19584177|P2|Overall Study|Refused Treatment|2
5676010|NCT00412737|19584178|P1|Overall Study|Refused Treatment|6
5676011|NCT00412737|19584177|P2|Overall Study|Adverse Event|2
5676012|NCT00412737|19584178|P1|Overall Study|Adverse Event|3
5676013|NCT00412737|19584177|P2|Overall Study|Death|0
5676014|NCT00412737|19584178|P1|Overall Study|Death|1
5676015|NCT00412607|19584196|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
5676016|NCT00412607|19584196|P1|Overall Study|Death|61
5676017|NCT00412607|19584196|P1|Overall Study|Lost to Follow-up|19
5676018|NCT00412607|19584196|P1|Overall Study|Withdrawal by Subject|9
5676019|NCT00412542|19584209|P2|Overall Study|Not Eligible|1
5676020|NCT00412542|19584210|P1|Overall Study|Not Eligible|0
5676021|NCT00412542|19584209|P2|Overall Study|Withdrawal by Subject|2
5676022|NCT00412542|19584210|P1|Overall Study|Withdrawal by Subject|0
5676023|NCT00412373|19584295|P2|Overall Study|Other|2
5676024|NCT00412373|19584296|P1|Overall Study|Other|2
5676025|NCT00412373|19584295|P2|Overall Study|Withdrawal by Subject|27
5676026|NCT00412373|19584296|P1|Overall Study|Withdrawal by Subject|8
5676027|NCT00412373|19584295|P2|Overall Study|Lost to Follow-up|13
5676028|NCT00412373|19584296|P1|Overall Study|Lost to Follow-up|7
5676029|NCT00412373|19584295|P2|Overall Study|Lack of Efficacy|22
5676030|NCT00412373|19584296|P1|Overall Study|Lack of Efficacy|16
5676031|NCT00412373|19584295|P2|Overall Study|Adverse Event|13
5676032|NCT00412373|19584296|P1|Overall Study|Adverse Event|8
5676033|NCT00412360|19584338|P2|Overall Study|Not Transplanted|2
5676034|NCT00412360|19584339|P1|Overall Study|Not Transplanted|1
5676035|NCT00412360|19584338|P2|Overall Study|Lost to Follow-up|1
5676036|NCT00412360|19584339|P1|Overall Study|Lost to Follow-up|0
5676037|NCT00412217|19584369|P2|Overall Study|Other|1
5676038|NCT00412217|19584370|P1|Overall Study|Other|1
5676039|NCT00412217|19584369|P2|Overall Study|Study Terminated by Sponsor|33
5676040|NCT00412217|19584370|P1|Overall Study|Study Terminated by Sponsor|26
5676041|NCT00412217|19584369|P2|Overall Study|Lost to Follow-up|4
5676042|NCT00412217|19584370|P1|Overall Study|Lost to Follow-up|1
5676043|NCT00412217|19584369|P2|Overall Study|Withdrawal by Subject|0
5676044|NCT00412217|19584370|P1|Overall Study|Withdrawal by Subject|2
5676045|NCT00412217|19584369|P2|Overall Study|Investigator Decision|0
5676046|NCT00412217|19584370|P1|Overall Study|Investigator Decision|1
5676047|NCT00412217|19584369|P2|Overall Study|Disease Progression|3
5676048|NCT00412217|19584370|P1|Overall Study|Disease Progression|2
5676049|NCT00412217|19584369|P2|Overall Study|Death|4
5676050|NCT00412217|19584370|P1|Overall Study|Death|5
5676051|NCT00412217|19584369|P2|Overall Study|Insufficient Data Available|3
5676052|NCT00412217|19584370|P1|Overall Study|Insufficient Data Available|8
5676053|NCT00412113|19584384|P2|Overall Study|did not receive treatment|0
5676054|NCT00412113|19584385|P1|Overall Study|did not receive treatment|1
5676055|NCT00412113|19584384|P2|Overall Study|Adverse Event|15
5676056|NCT00412113|19584385|P1|Overall Study|Adverse Event|11
5676057|NCT00412061|19584469|P2|Open Label Phase|New Cancer Therapy|1
5676058|NCT00412061|19584470|P1|Open Label Phase|New Cancer Therapy|0
5676059|NCT00412061|19584469|P2|Open Label Phase|Lost to Follow-up|2
5676060|NCT00412061|19584470|P1|Open Label Phase|Lost to Follow-up|0
5676061|NCT00412061|19584469|P2|Open Label Phase|Death|7
5676062|NCT00412061|19584470|P1|Open Label Phase|Death|0
5676063|NCT00412061|19584469|P2|Open Label Phase|Administrative Problems|13
5676064|NCT00412061|19584470|P1|Open Label Phase|Administrative Problems|0
5676065|NCT00412061|19584469|P2|Open Label Phase|Withdrawal by Subject|15
5676066|NCT00412061|19584470|P1|Open Label Phase|Withdrawal by Subject|0
5676067|NCT00412061|19584469|P2|Open Label Phase|Adverse Event|46
5676068|NCT00412061|19584470|P1|Open Label Phase|Adverse Event|0
5676069|NCT00412061|19584469|P2|Open Label Phase|Disease Progression|86
5676070|NCT00412061|19584470|P1|Open Label Phase|Disease Progression|0
5676071|NCT00412061|19584469|P2|Double Blind Phase|Lost to Follow-up|1
5676072|NCT00412061|19584470|P1|Double Blind Phase|Lost to Follow-up|0
5676073|NCT00412061|19584469|P2|Double Blind Phase|New Cander Therapy|1
5676074|NCT00412061|19584470|P1|Double Blind Phase|New Cander Therapy|1
5676075|NCT00412061|19584469|P2|Double Blind Phase|Protocol Violation|4
5676076|NCT00412061|19584470|P1|Double Blind Phase|Protocol Violation|3
5676077|NCT00412061|19584469|P2|Double Blind Phase|Death|3
5676078|NCT00412061|19584470|P1|Double Blind Phase|Death|6
5676079|NCT00412061|19584469|P2|Double Blind Phase|Withdrawal by Subject|20
5676080|NCT00412061|19584470|P1|Double Blind Phase|Withdrawal by Subject|18
5676081|NCT00412061|19584469|P2|Double Blind Phase|Final Primary Analysis|14
5676082|NCT00412061|19584470|P1|Double Blind Phase|Final Primary Analysis|26
5676083|NCT00412061|19584469|P2|Double Blind Phase|Adverse Event|16
5676084|NCT00412061|19584470|P1|Double Blind Phase|Adverse Event|61
5676085|NCT00412061|19584469|P2|Double Blind Phase|Disease Progression|154
5676086|NCT00412061|19584470|P1|Double Blind Phase|Disease Progression|101
5676087|NCT00411788|19584488|P1|Overall Study|Adverse Event|1
5676088|NCT00411788|19584488|P1|Overall Study|Protocol Violation|1
5676089|NCT00411762|19584497|P1|Overall Study|Withdrawal by Subject|5
5676090|NCT00411671|19584521|P1|Overall Study|Lost to Follow-up|3
5676091|NCT00411671|19584521|P1|Overall Study|Death|2
5676092|NCT00411671|19584521|P1|Overall Study|Adverse Event|15
5676093|NCT00411645|19584529|P2|Overall Study|Lost to Follow-up|0
5676094|NCT00411645|19584530|P1|Overall Study|Lost to Follow-up|2
5676095|NCT00411645|19584529|P2|Overall Study|Investigator/Sponsor Decision|7
5676096|NCT00411645|19584530|P1|Overall Study|Investigator/Sponsor Decision|10
5676097|NCT00411645|19584529|P2|Overall Study|Death|135
5676098|NCT00411645|19584530|P1|Overall Study|Death|56
5676099|NCT00411645|19584529|P2|Overall Study|Consent Withdrawn|22
5676100|NCT00411645|19584530|P1|Overall Study|Consent Withdrawn|13
5676101|NCT00411632|19584554|P1|Overall Study|Death|1
5676102|NCT00411554|19584565|P2|Overall Study|Patient Moved|0
5676103|NCT00411554|19584566|P1|Overall Study|Patient Moved|1
5676104|NCT00411554|19584565|P2|Overall Study|Withdrawal by Subject|0
5676105|NCT00411554|19584566|P1|Overall Study|Withdrawal by Subject|3
5676106|NCT00411554|19584565|P2|Overall Study|Lack of Efficacy|5
5676107|NCT00411554|19584566|P1|Overall Study|Lack of Efficacy|2
5676108|NCT00411554|19584565|P2|Overall Study|Adverse Event|4
5676109|NCT00411554|19584566|P1|Overall Study|Adverse Event|2
5676110|NCT00411450|19584592|P1|Overall Study|Ongoing at time of data cut-off.|3
5676111|NCT00411216|19584635|P2|Overall Study|Ten participants were entered into the c|2
5676112|NCT00411216|19584636|P1|Overall Study|Ten participants were entered into the c|0
5676113|NCT00411151|19584642|P1|Overall Study|Trial prematurely closed|4
5676114|NCT00411151|19584642|P1|Overall Study|Protocol Violation|1
5676115|NCT00411151|19584642|P1|Overall Study|Lost to Follow-up|2
5676116|NCT00411151|19584642|P1|Overall Study|Withdrawal by Subject|2
5676117|NCT00411151|19584642|P1|Overall Study|Death|38
5676118|NCT00410813|19584686|P2|Overall Study|Death|2
5676119|NCT00410813|19584687|P1|Overall Study|Death|0
5676120|NCT00410813|19584686|P2|Overall Study|Ineligible|4
5676121|NCT00410813|19584687|P1|Overall Study|Ineligible|2
5676122|NCT00410813|19584686|P2|Overall Study|Not protocol specified|4
5676123|NCT00410813|19584687|P1|Overall Study|Not protocol specified|3
5676124|NCT00410813|19584686|P2|Overall Study|Progression|21
5676125|NCT00410813|19584687|P1|Overall Study|Progression|32
5676126|NCT00410813|19584686|P2|Overall Study|Adverse Event|11
5676127|NCT00410813|19584687|P1|Overall Study|Adverse Event|6
5676128|NCT00410761|19584724|P2|Overall Study|Never received randomised treatment|1
5676129|NCT00410761|19584725|P1|Overall Study|Never received randomised treatment|0
5676130|NCT00410761|19584724|P2|Overall Study|Other|9
5676131|NCT00410761|19584725|P1|Overall Study|Other|12
5676132|NCT00410761|19584724|P2|Overall Study|Withdrawal by Subject|4
5676133|NCT00410761|19584725|P1|Overall Study|Withdrawal by Subject|8
5676134|NCT00410761|19584724|P2|Overall Study|objective disease progression|55
5676135|NCT00410761|19584725|P1|Overall Study|objective disease progression|71
5676136|NCT00410761|19584724|P2|Overall Study|Adverse Event|3
5676137|NCT00410761|19584725|P1|Overall Study|Adverse Event|29
5676138|NCT00410605|19584745|P1|Overall Study|Transferred to another Institution|1
5676139|NCT00410605|19584745|P1|Overall Study|Stopped treatmen to collect stem cells|1
5676140|NCT00410605|19584745|P1|Overall Study|Started Non-Protocol Therapy|3
5676141|NCT00410605|19584745|P1|Overall Study|Withdrawal by Subject|5
5676142|NCT00410605|19584745|P1|Overall Study|Physician Decision|3
5676143|NCT00410605|19584745|P1|Overall Study|Adverse Event|12
5676144|NCT00410514|19584757|P3|Overall Study|Non-compliant with study procedures|2
5676145|NCT00410514|19584758|P2|Overall Study|Non-compliant with study procedures|0
5676146|NCT00410514|19584759|P1|Overall Study|Non-compliant with study procedures|0
5676147|NCT00410514|19584757|P3|Overall Study|Lost to Follow-up|2
5676148|NCT00410514|19584758|P2|Overall Study|Lost to Follow-up|0
5676149|NCT00410514|19584759|P1|Overall Study|Lost to Follow-up|0
5676150|NCT00410514|19584757|P3|Overall Study|Protocol Violation|1
5676151|NCT00410514|19584758|P2|Overall Study|Protocol Violation|1
5676152|NCT00410514|19584759|P1|Overall Study|Protocol Violation|0
5676153|NCT00410514|19584757|P3|Overall Study|Adverse Event|2
5676154|NCT00410514|19584758|P2|Overall Study|Adverse Event|2
5676155|NCT00410514|19584759|P1|Overall Study|Adverse Event|2
5676156|NCT00410410|19584842|P9|Open-Label Period (OL)|Other|7
5676157|NCT00410410|19584843|P8|Open-Label Period (OL)|Other|0
5676158|NCT00410410|19584844|P7|Open-Label Period (OL)|Other|0
5676159|NCT00410410|19584845|P6|Open-Label Period (OL)|Other|0
5676160|NCT00410410|19584846|P5|Open-Label Period (OL)|Other|0
5676161|NCT00410410|19584847|P4|Open-Label Period (OL)|Other|0
5676162|NCT00410410|19584848|P3|Open-Label Period (OL)|Other|0
5676163|NCT00410410|19584849|P2|Open-Label Period (OL)|Other|0
5676164|NCT00410410|19584850|P1|Open-Label Period (OL)|Other|0
5676165|NCT00410410|19584842|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
5676166|NCT00410410|19584843|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5676167|NCT00410410|19584844|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5676168|NCT00410410|19584845|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5676169|NCT00410410|19584846|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5676170|NCT00410410|19584847|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5676171|NCT00410410|19584848|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5676172|NCT00410410|19584849|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5676173|NCT00410410|19584850|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
5676174|NCT00410410|19584842|P9|Open-Label Period (OL)|Pregnancy|1
5676175|NCT00410410|19584843|P8|Open-Label Period (OL)|Pregnancy|0
5676176|NCT00410410|19584844|P7|Open-Label Period (OL)|Pregnancy|0
5676177|NCT00410410|19584845|P6|Open-Label Period (OL)|Pregnancy|0
5676178|NCT00410410|19584846|P5|Open-Label Period (OL)|Pregnancy|0
5676179|NCT00410410|19584847|P4|Open-Label Period (OL)|Pregnancy|0
5676180|NCT00410410|19584848|P3|Open-Label Period (OL)|Pregnancy|0
5676181|NCT00410410|19584849|P2|Open-Label Period (OL)|Pregnancy|0
5676182|NCT00410410|19584850|P1|Open-Label Period (OL)|Pregnancy|0
5676183|NCT00410410|19584842|P9|Open-Label Period (OL)|Withdrawal by Subject|20
5676184|NCT00410410|19584843|P8|Open-Label Period (OL)|Withdrawal by Subject|0
5676185|NCT00410410|19584844|P7|Open-Label Period (OL)|Withdrawal by Subject|0
5676186|NCT00410410|19584845|P6|Open-Label Period (OL)|Withdrawal by Subject|0
5676187|NCT00410410|19584846|P5|Open-Label Period (OL)|Withdrawal by Subject|0
5676188|NCT00410410|19584847|P4|Open-Label Period (OL)|Withdrawal by Subject|0
5676189|NCT00410410|19584848|P3|Open-Label Period (OL)|Withdrawal by Subject|0
5676190|NCT00410410|19584849|P2|Open-Label Period (OL)|Withdrawal by Subject|0
5676191|NCT00410410|19584850|P1|Open-Label Period (OL)|Withdrawal by Subject|0
5676192|NCT00410410|19584842|P9|Open-Label Period (OL)|Lost to Follow-up|4
5676193|NCT00410410|19584843|P8|Open-Label Period (OL)|Lost to Follow-up|0
5676194|NCT00410410|19584844|P7|Open-Label Period (OL)|Lost to Follow-up|0
5676195|NCT00410410|19584845|P6|Open-Label Period (OL)|Lost to Follow-up|0
5676196|NCT00410410|19584846|P5|Open-Label Period (OL)|Lost to Follow-up|0
5676197|NCT00410410|19584847|P4|Open-Label Period (OL)|Lost to Follow-up|0
5676198|NCT00410410|19584848|P3|Open-Label Period (OL)|Lost to Follow-up|0
5676199|NCT00410410|19584849|P2|Open-Label Period (OL)|Lost to Follow-up|0
5676200|NCT00410410|19584850|P1|Open-Label Period (OL)|Lost to Follow-up|0
5676201|NCT00410410|19584842|P9|Open-Label Period (OL)|Lack of Efficacy|161
5676202|NCT00410410|19584843|P8|Open-Label Period (OL)|Lack of Efficacy|0
5676203|NCT00410410|19584844|P7|Open-Label Period (OL)|Lack of Efficacy|0
5676204|NCT00410410|19584845|P6|Open-Label Period (OL)|Lack of Efficacy|0
5676205|NCT00410410|19584846|P5|Open-Label Period (OL)|Lack of Efficacy|0
5676206|NCT00410410|19584847|P4|Open-Label Period (OL)|Lack of Efficacy|0
5676207|NCT00410410|19584848|P3|Open-Label Period (OL)|Lack of Efficacy|0
5676208|NCT00410410|19584849|P2|Open-Label Period (OL)|Lack of Efficacy|0
5676209|NCT00410410|19584850|P1|Open-Label Period (OL)|Lack of Efficacy|0
5676210|NCT00410410|19584842|P9|Open-Label Period (OL)|Adverse Event|10
5676211|NCT00410410|19584843|P8|Open-Label Period (OL)|Adverse Event|0
5676212|NCT00410410|19584844|P7|Open-Label Period (OL)|Adverse Event|0
5676213|NCT00410410|19584845|P6|Open-Label Period (OL)|Adverse Event|0
5676214|NCT00410410|19584846|P5|Open-Label Period (OL)|Adverse Event|0
5676215|NCT00410410|19584847|P4|Open-Label Period (OL)|Adverse Event|0
5676216|NCT00410410|19584848|P3|Open-Label Period (OL)|Adverse Event|0
5676217|NCT00410410|19584849|P2|Open-Label Period (OL)|Adverse Event|0
5676218|NCT00410410|19584850|P1|Open-Label Period (OL)|Adverse Event|0
5676219|NCT00410410|19584842|P9|Open-Label Period (OL)|Death|1
5676220|NCT00410410|19584843|P8|Open-Label Period (OL)|Death|0
5676221|NCT00410410|19584844|P7|Open-Label Period (OL)|Death|0
5676222|NCT00410410|19584845|P6|Open-Label Period (OL)|Death|0
5676223|NCT00410410|19584846|P5|Open-Label Period (OL)|Death|0
5676224|NCT00410410|19584847|P4|Open-Label Period (OL)|Death|0
5676225|NCT00410410|19584848|P3|Open-Label Period (OL)|Death|0
5676226|NCT00410410|19584849|P2|Open-Label Period (OL)|Death|0
5676227|NCT00410410|19584850|P1|Open-Label Period (OL)|Death|0
5676228|NCT00410410|19584842|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5676229|NCT00410410|19584843|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
5676230|NCT00410410|19584844|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
5676231|NCT00410410|19584845|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5676232|NCT00410410|19584846|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5676233|NCT00410410|19584847|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5676234|NCT00410410|19584848|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5676235|NCT00410410|19584849|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5676236|NCT00410410|19584850|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
5676237|NCT00410410|19584842|P9|Maintenance Period (MP)|Withdrawal by Subject|0
5676238|NCT00410410|19584843|P8|Maintenance Period (MP)|Withdrawal by Subject|1
5676239|NCT00410410|19584844|P7|Maintenance Period (MP)|Withdrawal by Subject|1
5676240|NCT00410410|19584845|P6|Maintenance Period (MP)|Withdrawal by Subject|0
5676241|NCT00410410|19584846|P5|Maintenance Period (MP)|Withdrawal by Subject|0
5676242|NCT00410410|19584847|P4|Maintenance Period (MP)|Withdrawal by Subject|0
5676243|NCT00410410|19584848|P3|Maintenance Period (MP)|Withdrawal by Subject|0
5676244|NCT00410410|19584849|P2|Maintenance Period (MP)|Withdrawal by Subject|0
5676245|NCT00410410|19584850|P1|Maintenance Period (MP)|Withdrawal by Subject|0
5676246|NCT00410410|19584842|P9|Maintenance Period (MP)|Lost to Follow-up|0
5676247|NCT00410410|19584843|P8|Maintenance Period (MP)|Lost to Follow-up|2
5676248|NCT00410410|19584844|P7|Maintenance Period (MP)|Lost to Follow-up|1
5676249|NCT00410410|19584845|P6|Maintenance Period (MP)|Lost to Follow-up|0
5676250|NCT00410410|19584846|P5|Maintenance Period (MP)|Lost to Follow-up|0
5676251|NCT00410410|19584847|P4|Maintenance Period (MP)|Lost to Follow-up|0
5676252|NCT00410410|19584848|P3|Maintenance Period (MP)|Lost to Follow-up|0
5676253|NCT00410410|19584849|P2|Maintenance Period (MP)|Lost to Follow-up|0
5676254|NCT00410410|19584850|P1|Maintenance Period (MP)|Lost to Follow-up|0
5676255|NCT00410410|19584842|P9|Maintenance Period (MP)|Lack of Efficacy|0
5676256|NCT00410410|19584843|P8|Maintenance Period (MP)|Lack of Efficacy|24
5676257|NCT00410410|19584844|P7|Maintenance Period (MP)|Lack of Efficacy|25
5676258|NCT00410410|19584845|P6|Maintenance Period (MP)|Lack of Efficacy|0
5676259|NCT00410410|19584846|P5|Maintenance Period (MP)|Lack of Efficacy|0
5676260|NCT00410410|19584847|P4|Maintenance Period (MP)|Lack of Efficacy|0
5676261|NCT00410410|19584848|P3|Maintenance Period (MP)|Lack of Efficacy|0
5676262|NCT00410410|19584849|P2|Maintenance Period (MP)|Lack of Efficacy|0
5676263|NCT00410410|19584850|P1|Maintenance Period (MP)|Lack of Efficacy|0
5676264|NCT00410410|19584842|P9|Maintenance Period (MP)|Adverse Event|0
5676265|NCT00410410|19584843|P8|Maintenance Period (MP)|Adverse Event|3
5676266|NCT00410410|19584844|P7|Maintenance Period (MP)|Adverse Event|1
5676267|NCT00410410|19584845|P6|Maintenance Period (MP)|Adverse Event|0
5676268|NCT00410410|19584846|P5|Maintenance Period (MP)|Adverse Event|0
5676269|NCT00410410|19584847|P4|Maintenance Period (MP)|Adverse Event|0
5676270|NCT00410410|19584848|P3|Maintenance Period (MP)|Adverse Event|0
5676271|NCT00410410|19584849|P2|Maintenance Period (MP)|Adverse Event|0
5676272|NCT00410410|19584850|P1|Maintenance Period (MP)|Adverse Event|0
5676273|NCT00410410|19584842|P9|Maintenance Period (MP)|Death|0
5676274|NCT00410410|19584843|P8|Maintenance Period (MP)|Death|0
5676275|NCT00410410|19584844|P7|Maintenance Period (MP)|Death|1
5676276|NCT00410410|19584845|P6|Maintenance Period (MP)|Death|0
5676277|NCT00410410|19584846|P5|Maintenance Period (MP)|Death|0
5676278|NCT00410410|19584847|P4|Maintenance Period (MP)|Death|0
5676279|NCT00410410|19584848|P3|Maintenance Period (MP)|Death|0
5676280|NCT00410410|19584849|P2|Maintenance Period (MP)|Death|0
5676281|NCT00410410|19584850|P1|Maintenance Period (MP)|Death|0
5676282|NCT00410410|19584842|P9|Induction Period (IP)|Other|0
5676283|NCT00410410|19584843|P8|Induction Period (IP)|Other|0
5676284|NCT00410410|19584844|P7|Induction Period (IP)|Other|0
5676285|NCT00410410|19584845|P6|Induction Period (IP)|Other|0
5676286|NCT00410410|19584846|P5|Induction Period (IP)|Other|0
5676287|NCT00410410|19584847|P4|Induction Period (IP)|Other|0
5676288|NCT00410410|19584848|P3|Induction Period (IP)|Other|1
5676289|NCT00410410|19584849|P2|Induction Period (IP)|Other|0
5676290|NCT00410410|19584850|P1|Induction Period (IP)|Other|0
5676291|NCT00410410|19584842|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
5676292|NCT00410410|19584843|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
5676293|NCT00410410|19584844|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
5676294|NCT00410410|19584845|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
5676295|NCT00410410|19584846|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
5676296|NCT00410410|19584847|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
5676297|NCT00410410|19584848|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
5676298|NCT00410410|19584849|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
5676299|NCT00410410|19584850|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
5676300|NCT00410410|19584842|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5676301|NCT00410410|19584843|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5676302|NCT00410410|19584844|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5676303|NCT00410410|19584845|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5676304|NCT00410410|19584846|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5676305|NCT00410410|19584847|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5676306|NCT00410410|19584848|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
5676307|NCT00410410|19584849|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5676308|NCT00410410|19584850|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
5676309|NCT00410410|19584842|P9|Induction Period (IP)|Withdrawal by Subject|0
5676310|NCT00410410|19584843|P8|Induction Period (IP)|Withdrawal by Subject|0
5676311|NCT00410410|19584844|P7|Induction Period (IP)|Withdrawal by Subject|0
5676312|NCT00410410|19584845|P6|Induction Period (IP)|Withdrawal by Subject|0
5676313|NCT00410410|19584846|P5|Induction Period (IP)|Withdrawal by Subject|2
5676314|NCT00410410|19584847|P4|Induction Period (IP)|Withdrawal by Subject|5
5676315|NCT00410410|19584848|P3|Induction Period (IP)|Withdrawal by Subject|3
5676316|NCT00410410|19584849|P2|Induction Period (IP)|Withdrawal by Subject|5
5676317|NCT00410410|19584850|P1|Induction Period (IP)|Withdrawal by Subject|3
5676318|NCT00410410|19584842|P9|Induction Period (IP)|Lost to Follow-up|0
5676319|NCT00410410|19584843|P8|Induction Period (IP)|Lost to Follow-up|0
5676320|NCT00410410|19584844|P7|Induction Period (IP)|Lost to Follow-up|0
5676321|NCT00410410|19584845|P6|Induction Period (IP)|Lost to Follow-up|1
5676322|NCT00410410|19584846|P5|Induction Period (IP)|Lost to Follow-up|0
5676323|NCT00410410|19584847|P4|Induction Period (IP)|Lost to Follow-up|3
5676324|NCT00410410|19584848|P3|Induction Period (IP)|Lost to Follow-up|2
5676325|NCT00410410|19584849|P2|Induction Period (IP)|Lost to Follow-up|2
5676326|NCT00410410|19584850|P1|Induction Period (IP)|Lost to Follow-up|2
5676327|NCT00410410|19584842|P9|Induction Period (IP)|Lack of Efficacy|0
5676328|NCT00410410|19584843|P8|Induction Period (IP)|Lack of Efficacy|0
5676329|NCT00410410|19584844|P7|Induction Period (IP)|Lack of Efficacy|0
5676330|NCT00410410|19584845|P6|Induction Period (IP)|Lack of Efficacy|7
5676331|NCT00410410|19584846|P5|Induction Period (IP)|Lack of Efficacy|7
5676332|NCT00410410|19584847|P4|Induction Period (IP)|Lack of Efficacy|8
5676333|NCT00410410|19584848|P3|Induction Period (IP)|Lack of Efficacy|8
5676334|NCT00410410|19584849|P2|Induction Period (IP)|Lack of Efficacy|24
5676335|NCT00410410|19584850|P1|Induction Period (IP)|Lack of Efficacy|26
5676336|NCT00410410|19584842|P9|Induction Period (IP)|Adverse Event|0
5676337|NCT00410410|19584843|P8|Induction Period (IP)|Adverse Event|0
5676338|NCT00410410|19584844|P7|Induction Period (IP)|Adverse Event|0
5676339|NCT00410410|19584845|P6|Induction Period (IP)|Adverse Event|0
5676340|NCT00410410|19584846|P5|Induction Period (IP)|Adverse Event|1
5676341|NCT00410410|19584847|P4|Induction Period (IP)|Adverse Event|4
5676342|NCT00410410|19584848|P3|Induction Period (IP)|Adverse Event|2
5676343|NCT00410410|19584849|P2|Induction Period (IP)|Adverse Event|4
5676344|NCT00410410|19584850|P1|Induction Period (IP)|Adverse Event|3
5676345|NCT00410410|19584842|P9|Induction Period (IP)|Death|0
5676346|NCT00410410|19584843|P8|Induction Period (IP)|Death|0
5676347|NCT00410410|19584844|P7|Induction Period (IP)|Death|0
5676348|NCT00410410|19584845|P6|Induction Period (IP)|Death|0
5676349|NCT00410410|19584846|P5|Induction Period (IP)|Death|0
5676350|NCT00410410|19584847|P4|Induction Period (IP)|Death|0
5676351|NCT00410410|19584848|P3|Induction Period (IP)|Death|0
5676352|NCT00410410|19584849|P2|Induction Period (IP)|Death|0
5676353|NCT00410410|19584850|P1|Induction Period (IP)|Death|1
5676354|NCT00410384|19585011|P3|Overall Study|Other|4
5676355|NCT00410384|19585012|P2|Overall Study|Other|8
5676356|NCT00410384|19585013|P1|Overall Study|Other|3
5676357|NCT00410384|19585011|P3|Overall Study|Physician Decision|4
5676358|NCT00410384|19585012|P2|Overall Study|Physician Decision|3
5676359|NCT00410384|19585013|P1|Overall Study|Physician Decision|3
5676360|NCT00410384|19585011|P3|Overall Study|Protocol Violation|6
5676361|NCT00410384|19585012|P2|Overall Study|Protocol Violation|6
5676362|NCT00410384|19585013|P1|Overall Study|Protocol Violation|6
5676363|NCT00410384|19585011|P3|Overall Study|Lost to Follow-up|6
5676364|NCT00410384|19585012|P2|Overall Study|Lost to Follow-up|6
5676365|NCT00410384|19585013|P1|Overall Study|Lost to Follow-up|4
5676366|NCT00410384|19585011|P3|Overall Study|Lack of Compliance|2
5676367|NCT00410384|19585012|P2|Overall Study|Lack of Compliance|2
5676368|NCT00410384|19585013|P1|Overall Study|Lack of Compliance|2
5676369|NCT00410384|19585011|P3|Overall Study|Lack of Efficacy|17
5676370|NCT00410384|19585012|P2|Overall Study|Lack of Efficacy|12
5676371|NCT00410384|19585013|P1|Overall Study|Lack of Efficacy|20
5676372|NCT00410384|19585011|P3|Overall Study|Adverse Event|23
5676373|NCT00410384|19585012|P2|Overall Study|Adverse Event|18
5676374|NCT00410384|19585013|P1|Overall Study|Adverse Event|23
5676375|NCT00410384|19585011|P3|Overall Study|Withdrawal by Subject|20
5676376|NCT00410384|19585012|P2|Overall Study|Withdrawal by Subject|17
5676377|NCT00410384|19585013|P1|Overall Study|Withdrawal by Subject|28
5676378|NCT00410202|19585086|P3|Off-treatment Follow up|Lost to Follow-up|0
5676379|NCT00410202|19585087|P2|Off-treatment Follow up|Lost to Follow-up|0
5676380|NCT00410202|19585088|P1|Off-treatment Follow up|Lost to Follow-up|1
5676381|NCT00410202|19585086|P3|Off-treatment Follow up|Follow up not required per protocol|1
5676382|NCT00410202|19585087|P2|Off-treatment Follow up|Follow up not required per protocol|0
5676383|NCT00410202|19585088|P1|Off-treatment Follow up|Follow up not required per protocol|3
5676384|NCT00410202|19585086|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
5676385|NCT00410202|19585087|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
5676386|NCT00410202|19585088|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
5676387|NCT00410202|19585086|P3|On-Treatment|Other Reason|1
5676388|NCT00410202|19585087|P2|On-Treatment|Other Reason|0
5676389|NCT00410202|19585088|P1|On-Treatment|Other Reason|0
5676390|NCT00410202|19585086|P3|On-Treatment|Withdrawal by Subject|1
5676391|NCT00410202|19585087|P2|On-Treatment|Withdrawal by Subject|1
5676392|NCT00410202|19585088|P1|On-Treatment|Withdrawal by Subject|2
5676393|NCT00410202|19585086|P3|On-Treatment|Lack of Efficacy|0
5676394|NCT00410202|19585087|P2|On-Treatment|Lack of Efficacy|4
5676395|NCT00410202|19585088|P1|On-Treatment|Lack of Efficacy|1
5676396|NCT00410202|19585086|P3|On-Treatment|Lost to Follow-up|1
5676397|NCT00410202|19585087|P2|On-Treatment|Lost to Follow-up|0
5676398|NCT00410202|19585088|P1|On-Treatment|Lost to Follow-up|1
5676399|NCT00410202|19585086|P3|On-Treatment|Death|0
5676400|NCT00410202|19585087|P2|On-Treatment|Death|0
5676401|NCT00410202|19585088|P1|On-Treatment|Death|1
5676402|NCT00410202|19585086|P3|On-Treatment|Adverse Event|2
5676403|NCT00410202|19585087|P2|On-Treatment|Adverse Event|3
5676404|NCT00410202|19585088|P1|On-Treatment|Adverse Event|1
5676405|NCT00410202|19585086|P3|On-Treatment|Continuing treatment|66
5676406|NCT00410202|19585087|P2|On-Treatment|Continuing treatment|71
5676407|NCT00410202|19585088|P1|On-Treatment|Continuing treatment|69
5676408|NCT00410163|19585175|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
5676409|NCT00410163|19585176|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
5676410|NCT00410163|19585175|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
5676411|NCT00410163|19585176|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
5676412|NCT00410163|19585175|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
5676413|NCT00410163|19585176|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
5676414|NCT00410163|19585175|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
5676415|NCT00410163|19585176|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
5676416|NCT00410163|19585175|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
5676417|NCT00410163|19585176|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
5676418|NCT00410163|19585175|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
5676419|NCT00410163|19585176|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
5676420|NCT00410163|19585175|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
5676421|NCT00410163|19585176|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
5676422|NCT00410163|19585175|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
5676423|NCT00410163|19585176|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
5676424|NCT00410163|19585175|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
5676425|NCT00410163|19585176|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
5676426|NCT00410163|19585175|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
5676427|NCT00410163|19585176|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
5676428|NCT00410163|19585175|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
5676429|NCT00410163|19585176|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
5676430|NCT00410163|19585175|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
5676431|NCT00410163|19585176|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
5676432|NCT00410163|19585175|P2|Treatment and Follow-up Phase (2 Years)|Death|1
5676433|NCT00410163|19585176|P1|Treatment and Follow-up Phase (2 Years)|Death|1
5676434|NCT00410163|19585175|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
5676435|NCT00410163|19585176|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
5676436|NCT00410124|19585229|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
5676437|NCT00410124|19585230|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
5676438|NCT00410124|19585229|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
5676439|NCT00410124|19585230|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
5676440|NCT00410124|19585229|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
5676441|NCT00410124|19585230|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
5676442|NCT00410124|19585229|P2|Extension Phase - Open Label (45 Months)|Death|10
5676443|NCT00410124|19585230|P1|Extension Phase - Open Label (45 Months)|Death|2
5676444|NCT00410124|19585229|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
5676445|NCT00410124|19585230|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
5676446|NCT00410124|19585229|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
5676447|NCT00410124|19585230|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
5676448|NCT00410124|19585229|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
5676449|NCT00410124|19585230|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
5676450|NCT00410124|19585229|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
5676451|NCT00410124|19585230|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
5676452|NCT00410124|19585229|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
5676453|NCT00410124|19585230|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
5676454|NCT00410124|19585229|P2|Core Phase Double Blind (15 Months)|Death|4
5676455|NCT00410124|19585230|P1|Core Phase Double Blind (15 Months)|Death|7
5676456|NCT00410124|19585229|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
5676457|NCT00410124|19585230|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
5676458|NCT00410124|19585229|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
5676459|NCT00410124|19585230|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
5676460|NCT00410124|19585229|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
5676461|NCT00410124|19585230|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
5676462|NCT00410124|19585229|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
5676463|NCT00410124|19585230|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
5676464|NCT00410124|19585229|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
5676465|NCT00410124|19585230|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
5676466|NCT00410124|19585229|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
5676467|NCT00410124|19585230|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
5676468|NCT00410072|19585261|P2|After Week 48 to Week 96|Withdrawal by Subject|1
5676469|NCT00410072|19585262|P1|After Week 48 to Week 96|Withdrawal by Subject|0
5676470|NCT00410072|19585261|P2|After Week 48 to Week 96|Pregnancy|2
5676471|NCT00410072|19585262|P1|After Week 48 to Week 96|Pregnancy|0
5676472|NCT00410072|19585261|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
5676473|NCT00410072|19585262|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
5676474|NCT00410072|19585261|P2|After Week 48 to Week 96|Other|0
5676475|NCT00410072|19585262|P1|After Week 48 to Week 96|Other|2
5676476|NCT00410072|19585261|P2|After Week 48 to Week 96|Lost to Follow-up|4
5676477|NCT00410072|19585262|P1|After Week 48 to Week 96|Lost to Follow-up|2
5676478|NCT00410072|19585261|P2|After Week 48 to Week 96|Lack of Efficacy|0
5676479|NCT00410072|19585262|P1|After Week 48 to Week 96|Lack of Efficacy|1
5676480|NCT00410072|19585261|P2|After Week 48 to Week 96|Death|1
5676481|NCT00410072|19585262|P1|After Week 48 to Week 96|Death|0
5676482|NCT00410072|19585261|P2|After Week 48 to Week 96|Adverse Event|2
5676483|NCT00410072|19585262|P1|After Week 48 to Week 96|Adverse Event|1
5676484|NCT00410072|19585261|P2|Day 1 to Week 48|Withdrawal by Subject|2
5676485|NCT00410072|19585262|P1|Day 1 to Week 48|Withdrawal by Subject|0
5676486|NCT00410072|19585261|P2|Day 1 to Week 48|Pregnancy|2
5676487|NCT00410072|19585262|P1|Day 1 to Week 48|Pregnancy|0
5676488|NCT00410072|19585261|P2|Day 1 to Week 48|poor compliance/noncompliance|3
5676489|NCT00410072|19585262|P1|Day 1 to Week 48|poor compliance/noncompliance|0
5676490|NCT00410072|19585261|P2|Day 1 to Week 48|Other|1
5676491|NCT00410072|19585262|P1|Day 1 to Week 48|Other|0
5676492|NCT00410072|19585261|P2|Day 1 to Week 48|Lost to Follow-up|2
5676493|NCT00410072|19585262|P1|Day 1 to Week 48|Lost to Follow-up|5
5676494|NCT00410072|19585261|P2|Day 1 to Week 48|Adverse Event|2
5676495|NCT00410072|19585262|P1|Day 1 to Week 48|Adverse Event|1
5676496|NCT00410046|19585302|P1|Overall Study|Lost to Follow-up|1
5676497|NCT00410046|19585302|P1|Overall Study|Withdrawal by Subject|1
5676498|NCT00410046|19585302|P1|Overall Study|Adverse Event|3
5676499|NCT00409838|19585333|P2|Long-term Extension Period|Pregnancy|0
5676500|NCT00409838|19585334|P1|Long-term Extension Period|Pregnancy|1
5676501|NCT00409838|19585333|P2|Long-term Extension Period|Poor compliance/noncompliance|0
5676502|NCT00409838|19585334|P1|Long-term Extension Period|Poor compliance/noncompliance|1
5676503|NCT00409838|19585333|P2|Long-term Extension Period|Withdrawal by Subject|0
5676504|NCT00409838|19585334|P1|Long-term Extension Period|Withdrawal by Subject|3
5676505|NCT00409838|19585333|P2|Long-term Extension Period|Lack of Efficacy|0
5676506|NCT00409838|19585334|P1|Long-term Extension Period|Lack of Efficacy|2
5676507|NCT00409838|19585333|P2|Long-term Extension Period|Death|0
5676508|NCT00409838|19585334|P1|Long-term Extension Period|Death|1
5676509|NCT00409838|19585333|P2|Long-term Extension Period|Adverse Event|0
5676510|NCT00409838|19585334|P1|Long-term Extension Period|Adverse Event|10
5676511|NCT00409838|19585333|P2|Short-term Period|Never Treated|0
5676512|NCT00409838|19585334|P1|Short-term Period|Never Treated|1
5676513|NCT00409838|19585333|P2|Short-term Period|Withdrawal by Subject|3
5676514|NCT00409838|19585334|P1|Short-term Period|Withdrawal by Subject|2
5676515|NCT00409838|19585333|P2|Short-term Period|Lost to Follow-up|1
5676516|NCT00409838|19585334|P1|Short-term Period|Lost to Follow-up|0
5676517|NCT00409838|19585333|P2|Short-term Period|Adverse Event|1
5676518|NCT00409838|19585334|P1|Short-term Period|Adverse Event|0
5676519|NCT00409786|19585399|P1|Overall Study|Withdrawal by Subject|3
5676520|NCT00409773|19585408|P5|Overall Study|Lack of Eligibility|1
5676521|NCT00409773|19585409|P4|Overall Study|Lack of Eligibility|0
5676522|NCT00409773|19585410|P3|Overall Study|Lack of Eligibility|0
5676523|NCT00409773|19585411|P2|Overall Study|Lack of Eligibility|0
5676524|NCT00409773|19585412|P1|Overall Study|Lack of Eligibility|0
5676525|NCT00409773|19585408|P5|Overall Study|Withdrawal by Subject|1
5676526|NCT00409773|19585409|P4|Overall Study|Withdrawal by Subject|2
5676527|NCT00409773|19585410|P3|Overall Study|Withdrawal by Subject|0
5676528|NCT00409773|19585411|P2|Overall Study|Withdrawal by Subject|0
5676529|NCT00409773|19585412|P1|Overall Study|Withdrawal by Subject|0
5676530|NCT00409773|19585408|P5|Overall Study|Protocol Violation|1
5676531|NCT00409773|19585409|P4|Overall Study|Protocol Violation|3
5676532|NCT00409773|19585410|P3|Overall Study|Protocol Violation|3
5676533|NCT00409773|19585411|P2|Overall Study|Protocol Violation|2
5676534|NCT00409773|19585412|P1|Overall Study|Protocol Violation|0
5676535|NCT00409773|19585408|P5|Overall Study|Physician Decision|0
5676536|NCT00409773|19585409|P4|Overall Study|Physician Decision|2
5676537|NCT00409773|19585410|P3|Overall Study|Physician Decision|0
5676538|NCT00409773|19585411|P2|Overall Study|Physician Decision|0
5676539|NCT00409773|19585412|P1|Overall Study|Physician Decision|0
5676540|NCT00409773|19585408|P5|Overall Study|Lost to Follow-up|1
5676541|NCT00409773|19585409|P4|Overall Study|Lost to Follow-up|3
5676542|NCT00409773|19585410|P3|Overall Study|Lost to Follow-up|2
5676543|NCT00409773|19585411|P2|Overall Study|Lost to Follow-up|1
5676544|NCT00409773|19585412|P1|Overall Study|Lost to Follow-up|6
5676545|NCT00409773|19585408|P5|Overall Study|Adverse Event|6
5676546|NCT00409773|19585409|P4|Overall Study|Adverse Event|2
5676547|NCT00409773|19585410|P3|Overall Study|Adverse Event|4
5676548|NCT00409773|19585411|P2|Overall Study|Adverse Event|4
5676549|NCT00409773|19585412|P1|Overall Study|Adverse Event|3
5676550|NCT00409747|19585494|P1|Overall Study|Withdrawal by Subject|1
5676551|NCT00409708|19585501|P2|Washout|Lost to Follow-up|3
5676552|NCT00409708|19585502|P1|Washout|Lost to Follow-up|1
5676553|NCT00409708|19585501|P2|Washout|Withdrawal by Subject|5
5676554|NCT00409708|19585502|P1|Washout|Withdrawal by Subject|11
5676555|NCT00409708|19585501|P2|Washout|Protocol Violation|1
5676556|NCT00409708|19585502|P1|Washout|Protocol Violation|0
5676557|NCT00409708|19585501|P2|Washout|Lack of Efficacy|1
5676558|NCT00409708|19585502|P1|Washout|Lack of Efficacy|9
5676559|NCT00409708|19585501|P2|Treatment|Administrative problems|0
5676560|NCT00409708|19585502|P1|Treatment|Administrative problems|5
5676561|NCT00409708|19585501|P2|Treatment|Lost to Follow-up|6
5676562|NCT00409708|19585502|P1|Treatment|Lost to Follow-up|0
5676563|NCT00409708|19585501|P2|Treatment|Withdrawal by Subject|8
5676564|NCT00409708|19585502|P1|Treatment|Withdrawal by Subject|3
5676565|NCT00409708|19585501|P2|Treatment|Protocol Violation|2
5676566|NCT00409708|19585502|P1|Treatment|Protocol Violation|6
5676567|NCT00409708|19585501|P2|Treatment|Lack of Efficacy|1
5676568|NCT00409708|19585502|P1|Treatment|Lack of Efficacy|0
5676569|NCT00409708|19585501|P2|Treatment|Abnormal test procedure result(s)|0
5676570|NCT00409708|19585502|P1|Treatment|Abnormal test procedure result(s)|1
5676571|NCT00409682|19585523|P3|EOW Double-blind Maintenance Period|Non-compliance|1
5676572|NCT00409682|19585524|P2|EOW Double-blind Maintenance Period|Non-compliance|0
5676573|NCT00409682|19585525|P1|EOW Double-blind Maintenance Period|Non-compliance|0
5676574|NCT00409682|19585523|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
5676575|NCT00409682|19585524|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
5676576|NCT00409682|19585525|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
5676577|NCT00409682|19585523|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
5676578|NCT00409682|19585524|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
5676579|NCT00409682|19585525|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
5676580|NCT00409682|19585523|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
5676581|NCT00409682|19585524|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
5676582|NCT00409682|19585525|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
5676583|NCT00409682|19585523|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
5676584|NCT00409682|19585524|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
5676585|NCT00409682|19585525|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
5676586|NCT00409682|19585523|P3|EOW Double-blind Maintenance Period|Adverse Event|12
5676587|NCT00409682|19585524|P2|EOW Double-blind Maintenance Period|Adverse Event|10
5676588|NCT00409682|19585525|P1|EOW Double-blind Maintenance Period|Adverse Event|0
5676589|NCT00409682|19585523|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
5676590|NCT00409682|19585524|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
5676591|NCT00409682|19585525|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
5676592|NCT00409682|19585523|P3|Open-label Induction Period|Protocol Violation|0
5676593|NCT00409682|19585524|P2|Open-label Induction Period|Protocol Violation|0
5676594|NCT00409682|19585525|P1|Open-label Induction Period|Protocol Violation|1
5676595|NCT00409682|19585523|P3|Open-label Induction Period|Lack of Efficacy|0
5676596|NCT00409682|19585524|P2|Open-label Induction Period|Lack of Efficacy|0
5676597|NCT00409682|19585525|P1|Open-label Induction Period|Lack of Efficacy|1
5676598|NCT00409682|19585523|P3|Open-label Induction Period|Adverse Event|0
5676599|NCT00409682|19585524|P2|Open-label Induction Period|Adverse Event|0
5676600|NCT00409682|19585525|P1|Open-label Induction Period|Adverse Event|1
5676601|NCT00409617|19585542|P1|Overall Study|Not described|14
5676602|NCT00409617|19585542|P1|Overall Study|Administrative reasons|1
5676603|NCT00409617|19585542|P1|Overall Study|Withdrawal by Subject|8
5676604|NCT00409617|19585542|P1|Overall Study|Protocol Violation|24
5676605|NCT00409617|19585542|P1|Overall Study|Lost to Follow-up|2
5676606|NCT00409617|19585542|P1|Overall Study|Lack of Efficacy|54
5676607|NCT00409617|19585542|P1|Overall Study|Adverse Event|57
5676608|NCT00409578|19585558|P4|Overall Study|Missing|1
5676609|NCT00409578|19585559|P3|Overall Study|Missing|0
5676610|NCT00409578|19585560|P2|Overall Study|Missing|1
5676611|NCT00409578|19585561|P1|Overall Study|Missing|0
5676612|NCT00409578|19585558|P4|Overall Study|Protocol Violation|1
5676613|NCT00409578|19585559|P3|Overall Study|Protocol Violation|3
5676614|NCT00409578|19585560|P2|Overall Study|Protocol Violation|2
5676615|NCT00409578|19585561|P1|Overall Study|Protocol Violation|3
5676616|NCT00409578|19585558|P4|Overall Study|Death|2
5676617|NCT00409578|19585559|P3|Overall Study|Death|4
5676618|NCT00409578|19585560|P2|Overall Study|Death|4
5676619|NCT00409578|19585561|P1|Overall Study|Death|2
5676620|NCT00409578|19585558|P4|Overall Study|Administrative problems|4
5676621|NCT00409578|19585559|P3|Overall Study|Administrative problems|2
5676622|NCT00409578|19585560|P2|Overall Study|Administrative problems|9
5676623|NCT00409578|19585561|P1|Overall Study|Administrative problems|8
5676624|NCT00409578|19585558|P4|Overall Study|Lost to Follow-up|2
5676625|NCT00409578|19585559|P3|Overall Study|Lost to Follow-up|2
5676626|NCT00409578|19585560|P2|Overall Study|Lost to Follow-up|0
5676627|NCT00409578|19585561|P1|Overall Study|Lost to Follow-up|2
5676628|NCT00409578|19585558|P4|Overall Study|Withdrawal by Subject|17
5676629|NCT00409578|19585559|P3|Overall Study|Withdrawal by Subject|16
5676630|NCT00409578|19585560|P2|Overall Study|Withdrawal by Subject|15
5676631|NCT00409578|19585561|P1|Overall Study|Withdrawal by Subject|8
5676632|NCT00409578|19585558|P4|Overall Study|Subject no longer requires study drug|1
5676633|NCT00409578|19585559|P3|Overall Study|Subject no longer requires study drug|0
5676634|NCT00409578|19585560|P2|Overall Study|Subject no longer requires study drug|0
5676635|NCT00409578|19585561|P1|Overall Study|Subject no longer requires study drug|0
5676636|NCT00409578|19585558|P4|Overall Study|Lack of Efficacy|2
5676637|NCT00409578|19585559|P3|Overall Study|Lack of Efficacy|0
5676638|NCT00409578|19585560|P2|Overall Study|Lack of Efficacy|0
5676639|NCT00409578|19585561|P1|Overall Study|Lack of Efficacy|0
5676640|NCT00409578|19585558|P4|Overall Study|Abnormal laboratory value(s)|4
5676641|NCT00409578|19585559|P3|Overall Study|Abnormal laboratory value(s)|2
5676642|NCT00409578|19585560|P2|Overall Study|Abnormal laboratory value(s)|2
5676643|NCT00409578|19585561|P1|Overall Study|Abnormal laboratory value(s)|2
5676644|NCT00409578|19585558|P4|Overall Study|Adverse Event|33
5676645|NCT00409578|19585559|P3|Overall Study|Adverse Event|25
5676646|NCT00409578|19585560|P2|Overall Study|Adverse Event|37
5676647|NCT00409578|19585561|P1|Overall Study|Adverse Event|27
5676648|NCT00409409|19585619|P2|Overall Study|Any other reason not above-mentioned|1
5676649|NCT00409409|19585620|P1|Overall Study|Any other reason not above-mentioned|0
5676650|NCT00409409|19585619|P2|Overall Study|Withdrawal by Subject|1
5676651|NCT00409409|19585620|P1|Overall Study|Withdrawal by Subject|1
5676652|NCT00409409|19585619|P2|Overall Study|Adverse Event|2
5676653|NCT00409409|19585620|P1|Overall Study|Adverse Event|7
5676654|NCT00409344|19585628|P2|Overall Study|no enrollment|0
5676655|NCT00409344|19585629|P1|Overall Study|no enrollment|0
5676656|NCT00409331|19585647|P1|Overall Study|Physician Decision|1
5676657|NCT00409188|19585669|P2|Overall Study|Ongoing at data cut-off|175
5676658|NCT00409188|19585670|P1|Overall Study|Ongoing at data cut-off|383
5676659|NCT00409175|19585686|P2|Overall Study|Liver transplantation|13
5676660|NCT00409175|19585687|P1|Overall Study|Liver transplantation|13
5676661|NCT00409175|19585686|P2|Overall Study|Negative genotype|1
5676662|NCT00409175|19585687|P1|Overall Study|Negative genotype|0
5676663|NCT00409175|19585686|P2|Overall Study|Withdrawal by Subject|2
5676664|NCT00409175|19585687|P1|Overall Study|Withdrawal by Subject|1
5676665|NCT00409175|19585686|P2|Overall Study|Adverse Event|3
5676666|NCT00409175|19585687|P1|Overall Study|Adverse Event|4
5676667|NCT00409006|19585713|P2|Overall Study|Physician Decision|2
5676668|NCT00409006|19585714|P1|Overall Study|Physician Decision|1
5676669|NCT00409006|19585713|P2|Overall Study|Withdrawal by Subject|2
5676670|NCT00409006|19585714|P1|Overall Study|Withdrawal by Subject|3
5676671|NCT00409006|19585713|P2|Overall Study|Lost to Follow-up|2
5676672|NCT00409006|19585714|P1|Overall Study|Lost to Follow-up|1
5676673|NCT00409006|19585713|P2|Overall Study|Death|6
5676674|NCT00409006|19585714|P1|Overall Study|Death|15
5676675|NCT00408993|19585730|P2|Overall Study|Withdrawal by Subject|3
5676676|NCT00408993|19585731|P1|Overall Study|Withdrawal by Subject|2
5676677|NCT00408993|19585730|P2|Overall Study|Lack of Efficacy|4
5676678|NCT00408993|19585731|P1|Overall Study|Lack of Efficacy|1
5676679|NCT00408993|19585730|P2|Overall Study|Protocol Violation|6
5676680|NCT00408993|19585731|P1|Overall Study|Protocol Violation|1
5676681|NCT00408993|19585730|P2|Overall Study|Adverse Event|4
5676682|NCT00408993|19585731|P1|Overall Study|Adverse Event|15
5676683|NCT00408928|19585763|P1|Overall Study|Infection indistinguishable from GVHD|1
5676684|NCT00408928|19585763|P1|Overall Study|Death|1
5676685|NCT00408928|19585763|P1|Overall Study|Withdrawal by Subject|1
5676686|NCT00408902|19585768|P1|Overall Study|Adverse Event|3
5676687|NCT00408902|19585768|P1|Overall Study|Lack of Efficacy|7
5676688|NCT00408876|19585778|P4|Overall Study|Physician Decision|0
5676689|NCT00408876|19585779|P3|Overall Study|Physician Decision|3
5676690|NCT00408876|19585780|P2|Overall Study|Physician Decision|0
5676691|NCT00408876|19585781|P1|Overall Study|Physician Decision|1
5676692|NCT00408876|19585778|P4|Overall Study|Protocol Violation|3
5676693|NCT00408876|19585779|P3|Overall Study|Protocol Violation|4
5676694|NCT00408876|19585780|P2|Overall Study|Protocol Violation|3
5676695|NCT00408876|19585781|P1|Overall Study|Protocol Violation|0
5676696|NCT00408876|19585778|P4|Overall Study|Lost to Follow-up|2
5676697|NCT00408876|19585779|P3|Overall Study|Lost to Follow-up|5
5676698|NCT00408876|19585780|P2|Overall Study|Lost to Follow-up|6
5676699|NCT00408876|19585781|P1|Overall Study|Lost to Follow-up|1
5676700|NCT00408876|19585778|P4|Overall Study|Lack of Efficacy|6
5676701|NCT00408876|19585779|P3|Overall Study|Lack of Efficacy|5
5676702|NCT00408876|19585780|P2|Overall Study|Lack of Efficacy|4
5676703|NCT00408876|19585781|P1|Overall Study|Lack of Efficacy|2
5676704|NCT00408876|19585778|P4|Overall Study|Withdrawal by Subject|14
5676705|NCT00408876|19585779|P3|Overall Study|Withdrawal by Subject|6
5676706|NCT00408876|19585780|P2|Overall Study|Withdrawal by Subject|6
5676707|NCT00408876|19585781|P1|Overall Study|Withdrawal by Subject|3
5676708|NCT00408876|19585778|P4|Overall Study|Adverse Event|10
5676709|NCT00408876|19585779|P3|Overall Study|Adverse Event|27
5676710|NCT00408876|19585780|P2|Overall Study|Adverse Event|17
5676711|NCT00408876|19585781|P1|Overall Study|Adverse Event|9
5676712|NCT00408694|19586031|P1|Overall Study|No protocol treatment|1
5676713|NCT00408694|19586031|P1|Overall Study|Ineligible|1
5676714|NCT00408681|19586043|P1|Overall Study|Adverse Event|7
5676715|NCT00408681|19586043|P1|Overall Study|Lack of Efficacy|2
5676716|NCT00408629|19586062|P2|Overall Study|Miscellaneous|15
5676717|NCT00408629|19586063|P1|Overall Study|Miscellaneous|11
5676718|NCT00408629|19586062|P2|Overall Study|Protocol Violation|5
5676719|NCT00408629|19586063|P1|Overall Study|Protocol Violation|1
5676720|NCT00408629|19586062|P2|Overall Study|Lack of Efficacy|73
5676721|NCT00408629|19586063|P1|Overall Study|Lack of Efficacy|63
5676722|NCT00408629|19586062|P2|Overall Study|Lost to Follow-up|1
5676723|NCT00408629|19586063|P1|Overall Study|Lost to Follow-up|1
5676724|NCT00408629|19586062|P2|Overall Study|Withdrawal by Subject|4
5676725|NCT00408629|19586063|P1|Overall Study|Withdrawal by Subject|8
5676726|NCT00408629|19586062|P2|Overall Study|Adverse Event|27
5676727|NCT00408629|19586063|P1|Overall Study|Adverse Event|13
5676728|NCT00408499|19586159|P5|Phase II- MTD Expansion|treatment delay|3
5676729|NCT00408499|19586160|P4|Phase II- MTD Expansion|treatment delay|0
5676730|NCT00408499|19586161|P3|Phase II- MTD Expansion|treatment delay|0
5676731|NCT00408499|19586162|P2|Phase II- MTD Expansion|treatment delay|0
5676732|NCT00408499|19586163|P1|Phase II- MTD Expansion|treatment delay|0
5676733|NCT00408499|19586159|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
5676734|NCT00408499|19586160|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
5676735|NCT00408499|19586161|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
5676736|NCT00408499|19586162|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
5676737|NCT00408499|19586163|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
5676738|NCT00408499|19586159|P5|Phase II- MTD Expansion|Physician Decision|1
5676739|NCT00408499|19586160|P4|Phase II- MTD Expansion|Physician Decision|0
5676740|NCT00408499|19586161|P3|Phase II- MTD Expansion|Physician Decision|0
5676741|NCT00408499|19586162|P2|Phase II- MTD Expansion|Physician Decision|0
5676742|NCT00408499|19586163|P1|Phase II- MTD Expansion|Physician Decision|0
5676743|NCT00408499|19586159|P5|Phase II- MTD Expansion|Death|2
5676744|NCT00408499|19586160|P4|Phase II- MTD Expansion|Death|0
5676745|NCT00408499|19586161|P3|Phase II- MTD Expansion|Death|0
5676746|NCT00408499|19586162|P2|Phase II- MTD Expansion|Death|0
5676747|NCT00408499|19586163|P1|Phase II- MTD Expansion|Death|0
5676748|NCT00408499|19586159|P5|Phase II- MTD Expansion|Adverse Event|9
5676749|NCT00408499|19586160|P4|Phase II- MTD Expansion|Adverse Event|0
5676750|NCT00408499|19586161|P3|Phase II- MTD Expansion|Adverse Event|0
5676751|NCT00408499|19586162|P2|Phase II- MTD Expansion|Adverse Event|0
5676752|NCT00408499|19586163|P1|Phase II- MTD Expansion|Adverse Event|0
5676753|NCT00408499|19586159|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
5676754|NCT00408499|19586160|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
5676755|NCT00408499|19586161|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
5676756|NCT00408499|19586162|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
5676757|NCT00408499|19586163|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
5676758|NCT00408499|19586159|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
5676759|NCT00408499|19586160|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
5676760|NCT00408499|19586161|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
5676761|NCT00408499|19586162|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
5676762|NCT00408499|19586163|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
5676763|NCT00408499|19586159|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
5676764|NCT00408499|19586160|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
5676765|NCT00408499|19586161|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
5676766|NCT00408499|19586162|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
5676767|NCT00408499|19586163|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
5676768|NCT00408434|19586185|P7|Overall Study|Terminated by Investigator|0
5676769|NCT00408434|19586186|P6|Overall Study|Terminated by Investigator|1
5676770|NCT00408434|19586187|P5|Overall Study|Terminated by Investigator|1
5676771|NCT00408434|19586188|P4|Overall Study|Terminated by Investigator|0
5676772|NCT00408434|19586189|P3|Overall Study|Terminated by Investigator|0
5676773|NCT00408434|19586190|P2|Overall Study|Terminated by Investigator|0
5676774|NCT00408434|19586191|P1|Overall Study|Terminated by Investigator|0
5676775|NCT00408434|19586185|P7|Overall Study|Other|0
5676776|NCT00408434|19586186|P6|Overall Study|Other|1
5676777|NCT00408434|19586187|P5|Overall Study|Other|2
5676778|NCT00408434|19586188|P4|Overall Study|Other|0
5676779|NCT00408434|19586189|P3|Overall Study|Other|1
5676780|NCT00408434|19586190|P2|Overall Study|Other|0
5676781|NCT00408434|19586191|P1|Overall Study|Other|0
5676782|NCT00408434|19586185|P7|Overall Study|Progressive disease|4
5676783|NCT00408434|19586186|P6|Overall Study|Progressive disease|1
5676784|NCT00408434|19586187|P5|Overall Study|Progressive disease|3
5676785|NCT00408434|19586188|P4|Overall Study|Progressive disease|3
5676786|NCT00408434|19586189|P3|Overall Study|Progressive disease|4
5676787|NCT00408434|19586190|P2|Overall Study|Progressive disease|3
5676788|NCT00408434|19586191|P1|Overall Study|Progressive disease|6
5676789|NCT00408434|19586185|P7|Overall Study|Adverse Event|0
5676790|NCT00408434|19586186|P6|Overall Study|Adverse Event|0
5676791|NCT00408434|19586187|P5|Overall Study|Adverse Event|0
5676792|NCT00408434|19586188|P4|Overall Study|Adverse Event|0
5676793|NCT00408434|19586189|P3|Overall Study|Adverse Event|1
5676794|NCT00408434|19586190|P2|Overall Study|Adverse Event|0
5676795|NCT00408434|19586191|P1|Overall Study|Adverse Event|0
5676796|NCT00408421|19586238|P3|Treatment Re-Randomization|Withdrawal by Subject|0
5676797|NCT00408421|19586239|P2|Treatment Re-Randomization|Withdrawal by Subject|1
5676798|NCT00408421|19586240|P1|Treatment Re-Randomization|Withdrawal by Subject|2
5676799|NCT00408421|19586238|P3|Treatment Re-Randomization|Protocol Violation|0
5676800|NCT00408421|19586239|P2|Treatment Re-Randomization|Protocol Violation|1
5676801|NCT00408421|19586240|P1|Treatment Re-Randomization|Protocol Violation|1
5676802|NCT00408421|19586238|P3|Treatment Re-Randomization|Physician Decision|0
5676803|NCT00408421|19586239|P2|Treatment Re-Randomization|Physician Decision|3
5676804|NCT00408421|19586240|P1|Treatment Re-Randomization|Physician Decision|1
5676805|NCT00408421|19586238|P3|Treatment Re-Randomization|Lost to Follow-up|1
5676806|NCT00408421|19586239|P2|Treatment Re-Randomization|Lost to Follow-up|0
5676807|NCT00408421|19586240|P1|Treatment Re-Randomization|Lost to Follow-up|0
5676808|NCT00408421|19586238|P3|Treatment Re-Randomization|Lack of Efficacy|0
5676809|NCT00408421|19586239|P2|Treatment Re-Randomization|Lack of Efficacy|0
5676810|NCT00408421|19586240|P1|Treatment Re-Randomization|Lack of Efficacy|1
5676811|NCT00408421|19586238|P3|Treatment Re-Randomization|Adverse Event|4
5676812|NCT00408421|19586239|P2|Treatment Re-Randomization|Adverse Event|2
5676813|NCT00408421|19586240|P1|Treatment Re-Randomization|Adverse Event|2
5676814|NCT00408421|19586238|P3|Treatment Initial Randomization|Sponsor Decision|0
5676815|NCT00408421|19586239|P2|Treatment Initial Randomization|Sponsor Decision|0
5676816|NCT00408421|19586240|P1|Treatment Initial Randomization|Sponsor Decision|1
5676817|NCT00408421|19586238|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
5676818|NCT00408421|19586239|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
5676819|NCT00408421|19586240|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
5676820|NCT00408421|19586238|P3|Treatment Initial Randomization|Withdrawal by Subject|0
5676821|NCT00408421|19586239|P2|Treatment Initial Randomization|Withdrawal by Subject|7
5676822|NCT00408421|19586240|P1|Treatment Initial Randomization|Withdrawal by Subject|7
5676823|NCT00408421|19586238|P3|Treatment Initial Randomization|Protocol Violation|0
5676824|NCT00408421|19586239|P2|Treatment Initial Randomization|Protocol Violation|1
5676825|NCT00408421|19586240|P1|Treatment Initial Randomization|Protocol Violation|0
5676826|NCT00408421|19586238|P3|Treatment Initial Randomization|Physician Decision|0
5676827|NCT00408421|19586239|P2|Treatment Initial Randomization|Physician Decision|0
5676828|NCT00408421|19586240|P1|Treatment Initial Randomization|Physician Decision|1
5676829|NCT00408421|19586238|P3|Treatment Initial Randomization|Lost to Follow-up|0
5676830|NCT00408421|19586239|P2|Treatment Initial Randomization|Lost to Follow-up|3
5676831|NCT00408421|19586240|P1|Treatment Initial Randomization|Lost to Follow-up|0
5676832|NCT00408421|19586238|P3|Treatment Initial Randomization|Lack of Efficacy|0
5676833|NCT00408421|19586239|P2|Treatment Initial Randomization|Lack of Efficacy|2
5676834|NCT00408421|19586240|P1|Treatment Initial Randomization|Lack of Efficacy|2
5676835|NCT00408421|19586238|P3|Treatment Initial Randomization|Adverse Event|0
5676836|NCT00408421|19586239|P2|Treatment Initial Randomization|Adverse Event|9
5676837|NCT00408421|19586240|P1|Treatment Initial Randomization|Adverse Event|5
5676838|NCT00408408|19586320|P6|Overall Study|No follow up data|3
5676839|NCT00408408|19586321|P5|Overall Study|No follow up data|5
5676840|NCT00408408|19586322|P4|Overall Study|No follow up data|7
5676841|NCT00408408|19586323|P3|Overall Study|No follow up data|0
5676842|NCT00408408|19586324|P2|Overall Study|No follow up data|3
5676843|NCT00408408|19586325|P1|Overall Study|No follow up data|2
5676844|NCT00408317|19586387|P2|Second Intervention Period|Withdrawal of consent|1
5676845|NCT00408317|19586388|P1|Second Intervention Period|Withdrawal of consent|0
5676846|NCT00408317|19586387|P2|Second Intervention Period|Protocol Violation|1
5676847|NCT00408317|19586388|P1|Second Intervention Period|Protocol Violation|0
5676848|NCT00408317|19586387|P2|Second Intervention Period|Adverse Event|0
5676849|NCT00408317|19586388|P1|Second Intervention Period|Adverse Event|2
5676850|NCT00408317|19586387|P2|First Intervention Period|Adverse Event|1
5676851|NCT00408317|19586388|P1|First Intervention Period|Adverse Event|0
5676852|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Development of SMN|0
5676853|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Development of SMN|0
5676854|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Development of SMN|1
5676855|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Development of SMN|1
5676856|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Development of SMN|1
5676857|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Development of SMN|3
5676858|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Development of SMN|0
5676859|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Development of SMN|0
5676860|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
5676861|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
5676862|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
5676863|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
5676864|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
5676865|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
5676866|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
5676867|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
5676868|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5676869|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5676870|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
5676871|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
5676872|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5676873|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5676874|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5676875|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
5676876|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
5676877|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
5676878|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
5676879|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
5676880|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
5676881|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
5676882|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
5676883|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
5676884|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Inevaluable|0
5676885|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Inevaluable|0
5676886|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Inevaluable|1
5676887|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Inevaluable|0
5676888|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Inevaluable|0
5676889|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Inevaluable|0
5676890|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Inevaluable|0
5676891|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Inevaluable|0
5676892|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Progressive Disease|7
5676893|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Progressive Disease|7
5676894|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5676895|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Progressive Disease|1
5676896|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5676897|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5676898|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5676899|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Progressive Disease|0
5676900|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
5676901|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
5676902|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
5676903|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
5676904|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
5676905|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
5676906|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
5676907|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
5676908|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5676909|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5676910|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5676911|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
5676912|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5676913|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5676914|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5676915|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
5676916|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
5676917|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
5676918|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
5676919|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
5676920|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
5676921|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
5676922|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
5676923|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
5676924|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5676925|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5676926|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
5676927|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5676928|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
5676929|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
5676930|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5676931|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
5676932|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Physician Decision|4
5676933|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Physician Decision|10
5676934|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Physician Decision|45
5676935|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Physician Decision|27
5676936|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Physician Decision|19
5676937|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Physician Decision|24
5676938|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Physician Decision|0
5676939|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
5676940|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5676941|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5676942|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5676943|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
5676944|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5676945|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
5676946|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5676947|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
5676948|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Death|1
5676949|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Death|3
5676950|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Death|5
5676951|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Death|5
5676952|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Death|0
5676953|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Death|3
5676954|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Death|0
5676955|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Death|0
5676956|NCT00408005|19586421|P8|Post Induction Therapy by Tx Assignment|Adverse Event|0
5676957|NCT00408005|19586422|P7|Post Induction Therapy by Tx Assignment|Adverse Event|2
5676958|NCT00408005|19586423|P6|Post Induction Therapy by Tx Assignment|Adverse Event|12
5676959|NCT00408005|19586424|P5|Post Induction Therapy by Tx Assignment|Adverse Event|8
5676960|NCT00408005|19586425|P4|Post Induction Therapy by Tx Assignment|Adverse Event|4
5676961|NCT00408005|19586426|P3|Post Induction Therapy by Tx Assignment|Adverse Event|7
5676962|NCT00408005|19586427|P2|Post Induction Therapy by Tx Assignment|Adverse Event|0
5676963|NCT00408005|19586428|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
5676964|NCT00408005|19586421|P8|Induction|Recurrent leukemia|0
5676965|NCT00408005|19586422|P7|Induction|Recurrent leukemia|0
5676966|NCT00408005|19586423|P6|Induction|Recurrent leukemia|0
5676967|NCT00408005|19586424|P5|Induction|Recurrent leukemia|0
5676968|NCT00408005|19586425|P4|Induction|Recurrent leukemia|0
5676969|NCT00408005|19586426|P3|Induction|Recurrent leukemia|0
5676970|NCT00408005|19586427|P2|Induction|Recurrent leukemia|0
5676971|NCT00408005|19586428|P1|Induction|Recurrent leukemia|1
5676972|NCT00408005|19586421|P8|Induction|Hematopoietic Stem Cell Transplantation|0
5676973|NCT00408005|19586422|P7|Induction|Hematopoietic Stem Cell Transplantation|0
5676974|NCT00408005|19586423|P6|Induction|Hematopoietic Stem Cell Transplantation|0
5676975|NCT00408005|19586424|P5|Induction|Hematopoietic Stem Cell Transplantation|0
5676976|NCT00408005|19586425|P4|Induction|Hematopoietic Stem Cell Transplantation|0
5676977|NCT00408005|19586426|P3|Induction|Hematopoietic Stem Cell Transplantation|0
5676978|NCT00408005|19586427|P2|Induction|Hematopoietic Stem Cell Transplantation|0
5676979|NCT00408005|19586428|P1|Induction|Hematopoietic Stem Cell Transplantation|1
5676980|NCT00408005|19586421|P8|Induction|Protocol Deviation|0
5676981|NCT00408005|19586422|P7|Induction|Protocol Deviation|0
5676982|NCT00408005|19586423|P6|Induction|Protocol Deviation|0
5676983|NCT00408005|19586424|P5|Induction|Protocol Deviation|0
5676984|NCT00408005|19586425|P4|Induction|Protocol Deviation|0
5676985|NCT00408005|19586426|P3|Induction|Protocol Deviation|0
5676986|NCT00408005|19586427|P2|Induction|Protocol Deviation|1
5676987|NCT00408005|19586428|P1|Induction|Protocol Deviation|3
5676988|NCT00408005|19586421|P8|Induction|Failed to Complete Randomization|0
5676989|NCT00408005|19586422|P7|Induction|Failed to Complete Randomization|0
5676990|NCT00408005|19586423|P6|Induction|Failed to Complete Randomization|0
5676991|NCT00408005|19586424|P5|Induction|Failed to Complete Randomization|0
5676992|NCT00408005|19586425|P4|Induction|Failed to Complete Randomization|0
5676993|NCT00408005|19586426|P3|Induction|Failed to Complete Randomization|0
5676994|NCT00408005|19586427|P2|Induction|Failed to Complete Randomization|2
5676995|NCT00408005|19586428|P1|Induction|Failed to Complete Randomization|3
5676996|NCT00408005|19586421|P8|Induction|Inevaluable|0
5676997|NCT00408005|19586422|P7|Induction|Inevaluable|0
5676998|NCT00408005|19586423|P6|Induction|Inevaluable|0
5676999|NCT00408005|19586424|P5|Induction|Inevaluable|0
5677000|NCT00408005|19586425|P4|Induction|Inevaluable|0
5677001|NCT00408005|19586426|P3|Induction|Inevaluable|0
5677002|NCT00408005|19586427|P2|Induction|Inevaluable|14
5677003|NCT00408005|19586428|P1|Induction|Inevaluable|18
5677004|NCT00408005|19586421|P8|Induction|Progressive Disease|0
5677005|NCT00408005|19586422|P7|Induction|Progressive Disease|0
5677006|NCT00408005|19586423|P6|Induction|Progressive Disease|0
5677007|NCT00408005|19586424|P5|Induction|Progressive Disease|0
5677008|NCT00408005|19586425|P4|Induction|Progressive Disease|0
5677009|NCT00408005|19586426|P3|Induction|Progressive Disease|0
5677010|NCT00408005|19586427|P2|Induction|Progressive Disease|1
5677011|NCT00408005|19586428|P1|Induction|Progressive Disease|0
5677012|NCT00408005|19586421|P8|Induction|Identified as Philadelphia Chr. Positive|0
5677013|NCT00408005|19586422|P7|Induction|Identified as Philadelphia Chr. Positive|0
5677014|NCT00408005|19586423|P6|Induction|Identified as Philadelphia Chr. Positive|0
5677015|NCT00408005|19586424|P5|Induction|Identified as Philadelphia Chr. Positive|0
5677016|NCT00408005|19586425|P4|Induction|Identified as Philadelphia Chr. Positive|0
5677017|NCT00408005|19586426|P3|Induction|Identified as Philadelphia Chr. Positive|0
5677018|NCT00408005|19586427|P2|Induction|Identified as Philadelphia Chr. Positive|0
5677019|NCT00408005|19586428|P1|Induction|Identified as Philadelphia Chr. Positive|6
5677020|NCT00408005|19586421|P8|Induction|Patient transferred Tx to Non-COG Site|0
5677021|NCT00408005|19586422|P7|Induction|Patient transferred Tx to Non-COG Site|0
5677022|NCT00408005|19586423|P6|Induction|Patient transferred Tx to Non-COG Site|0
5677023|NCT00408005|19586424|P5|Induction|Patient transferred Tx to Non-COG Site|0
5677024|NCT00408005|19586425|P4|Induction|Patient transferred Tx to Non-COG Site|0
5677025|NCT00408005|19586426|P3|Induction|Patient transferred Tx to Non-COG Site|0
5677026|NCT00408005|19586427|P2|Induction|Patient transferred Tx to Non-COG Site|2
5677027|NCT00408005|19586428|P1|Induction|Patient transferred Tx to Non-COG Site|3
5677028|NCT00408005|19586421|P8|Induction|Entered another COG therapeutic protocol|0
5677029|NCT00408005|19586422|P7|Induction|Entered another COG therapeutic protocol|0
5677030|NCT00408005|19586423|P6|Induction|Entered another COG therapeutic protocol|0
5677031|NCT00408005|19586424|P5|Induction|Entered another COG therapeutic protocol|0
5677032|NCT00408005|19586425|P4|Induction|Entered another COG therapeutic protocol|0
5677033|NCT00408005|19586426|P3|Induction|Entered another COG therapeutic protocol|0
5677034|NCT00408005|19586427|P2|Induction|Entered another COG therapeutic protocol|0
5677035|NCT00408005|19586428|P1|Induction|Entered another COG therapeutic protocol|4
5677036|NCT00408005|19586421|P8|Induction|Refusal of Further Protocol Therapy|0
5677037|NCT00408005|19586422|P7|Induction|Refusal of Further Protocol Therapy|0
5677038|NCT00408005|19586423|P6|Induction|Refusal of Further Protocol Therapy|0
5677039|NCT00408005|19586424|P5|Induction|Refusal of Further Protocol Therapy|0
5677040|NCT00408005|19586425|P4|Induction|Refusal of Further Protocol Therapy|0
5677041|NCT00408005|19586426|P3|Induction|Refusal of Further Protocol Therapy|0
5677042|NCT00408005|19586427|P2|Induction|Refusal of Further Protocol Therapy|44
5677043|NCT00408005|19586428|P1|Induction|Refusal of Further Protocol Therapy|225
5677044|NCT00408005|19586421|P8|Induction|Ineligible|0
5677045|NCT00408005|19586422|P7|Induction|Ineligible|0
5677046|NCT00408005|19586423|P6|Induction|Ineligible|0
5677047|NCT00408005|19586424|P5|Induction|Ineligible|0
5677048|NCT00408005|19586425|P4|Induction|Ineligible|0
5677049|NCT00408005|19586426|P3|Induction|Ineligible|0
5677050|NCT00408005|19586427|P2|Induction|Ineligible|14
5677051|NCT00408005|19586428|P1|Induction|Ineligible|33
5677052|NCT00408005|19586421|P8|Induction|Withdrawal by Subject|0
5677053|NCT00408005|19586422|P7|Induction|Withdrawal by Subject|0
5677054|NCT00408005|19586423|P6|Induction|Withdrawal by Subject|0
5677055|NCT00408005|19586424|P5|Induction|Withdrawal by Subject|0
5677056|NCT00408005|19586425|P4|Induction|Withdrawal by Subject|0
5677057|NCT00408005|19586426|P3|Induction|Withdrawal by Subject|0
5677058|NCT00408005|19586427|P2|Induction|Withdrawal by Subject|4
5677059|NCT00408005|19586428|P1|Induction|Withdrawal by Subject|2
5677060|NCT00408005|19586421|P8|Induction|Physician Decision|0
5677061|NCT00408005|19586422|P7|Induction|Physician Decision|0
5677062|NCT00408005|19586423|P6|Induction|Physician Decision|0
5677063|NCT00408005|19586424|P5|Induction|Physician Decision|0
5677064|NCT00408005|19586425|P4|Induction|Physician Decision|0
5677065|NCT00408005|19586426|P3|Induction|Physician Decision|0
5677066|NCT00408005|19586427|P2|Induction|Physician Decision|9
5677067|NCT00408005|19586428|P1|Induction|Physician Decision|83
5677068|NCT00408005|19586421|P8|Induction|Death|0
5677069|NCT00408005|19586422|P7|Induction|Death|0
5677070|NCT00408005|19586423|P6|Induction|Death|0
5677071|NCT00408005|19586424|P5|Induction|Death|0
5677072|NCT00408005|19586425|P4|Induction|Death|0
5677073|NCT00408005|19586426|P3|Induction|Death|0
5677074|NCT00408005|19586427|P2|Induction|Death|0
5677075|NCT00408005|19586428|P1|Induction|Death|6
5677076|NCT00408005|19586421|P8|Induction|Adverse Event|0
5677077|NCT00408005|19586422|P7|Induction|Adverse Event|0
5677078|NCT00408005|19586423|P6|Induction|Adverse Event|0
5677079|NCT00408005|19586424|P5|Induction|Adverse Event|0
5677080|NCT00408005|19586425|P4|Induction|Adverse Event|0
5677081|NCT00408005|19586426|P3|Induction|Adverse Event|0
5677082|NCT00408005|19586427|P2|Induction|Adverse Event|3
5677083|NCT00408005|19586428|P1|Induction|Adverse Event|19
5677084|NCT00407797|19586470|P1|Overall Study|Withdrawal by Subject|3
5677085|NCT00407797|19586470|P1|Overall Study|Other|7
5677086|NCT00407797|19586470|P1|Overall Study|Adverse Event|6
5677087|NCT00407797|19586470|P1|Overall Study|Lost to Follow-up|2
5677088|NCT00407758|19586485|P1|Overall Study|ineligible -improper prior treatment|1
5677089|NCT00407745|19586498|P2|Overall Study|Randomized, unknown if treated|1
5677090|NCT00407745|19586499|P1|Overall Study|Randomized, unknown if treated|0
5677091|NCT00407745|19586498|P2|Overall Study|Other|0
5677092|NCT00407745|19586499|P1|Overall Study|Other|2
5677093|NCT00407745|19586498|P2|Overall Study|Adverse Event|8
5677094|NCT00407745|19586499|P1|Overall Study|Adverse Event|8
5677095|NCT00407745|19586498|P2|Overall Study|Protocol Violation|3
5677096|NCT00407745|19586499|P1|Overall Study|Protocol Violation|5
5677097|NCT00407745|19586498|P2|Overall Study|Withdrawal by Subject|3
5677098|NCT00407745|19586499|P1|Overall Study|Withdrawal by Subject|3
5677099|NCT00407745|19586498|P2|Overall Study|Lack of Efficacy|2
5677100|NCT00407745|19586499|P1|Overall Study|Lack of Efficacy|1
5677101|NCT00407563|19586585|P1|Overall Study|Patient continues on treatment|1
5677102|NCT00407550|19586595|P2|Overall Study|Insurance or Other medical condition|1
5677103|NCT00407550|19586596|P1|Overall Study|Insurance or Other medical condition|2
5677104|NCT00407550|19586595|P2|Overall Study|Death|0
5677105|NCT00407550|19586596|P1|Overall Study|Death|1
5677106|NCT00407550|19586595|P2|Overall Study|Withdrawal by Subject|2
5677107|NCT00407550|19586596|P1|Overall Study|Withdrawal by Subject|0
5677108|NCT00407550|19586595|P2|Overall Study|Adverse Event|1
5677109|NCT00407550|19586596|P1|Overall Study|Adverse Event|0
5677110|NCT00407537|19586610|P2|Overall Study|Withdrawal by Subject|16
5677111|NCT00407537|19586611|P1|Overall Study|Withdrawal by Subject|34
5677112|NCT00407537|19586610|P2|Overall Study|Other|7
5677113|NCT00407537|19586611|P1|Overall Study|Other|6
5677114|NCT00407537|19586610|P2|Overall Study|Lost to Follow-up|19
5677115|NCT00407537|19586611|P1|Overall Study|Lost to Follow-up|12
5677116|NCT00407537|19586610|P2|Overall Study|Adverse Event|0
5677117|NCT00407537|19586611|P1|Overall Study|Adverse Event|36
5677118|NCT00407537|19586610|P2|Overall Study|Death|2
5677119|NCT00407537|19586611|P1|Overall Study|Death|5
5677120|NCT00407511|19586659|P1|Overall Study|Withdrawal by Subject|4
5677121|NCT00407511|19586659|P1|Overall Study|Other|5
5677122|NCT00407511|19586659|P1|Overall Study|Lost to Follow-up|4
5677123|NCT00407511|19586659|P1|Overall Study|Adverse Event|9
5677124|NCT00407030|19586720|P3|Extension Period - up to 68 Weeks|Physician Decision|0
5677125|NCT00407030|19586721|P2|Extension Period - up to 68 Weeks|Physician Decision|2
5677126|NCT00407030|19586722|P1|Extension Period - up to 68 Weeks|Physician Decision|1
5677127|NCT00407030|19586720|P3|Extension Period - up to 68 Weeks|Patient Decision|0
5677128|NCT00407030|19586721|P2|Extension Period - up to 68 Weeks|Patient Decision|2
5677129|NCT00407030|19586722|P1|Extension Period - up to 68 Weeks|Patient Decision|1
5677130|NCT00407030|19586720|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
5677131|NCT00407030|19586721|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
5677132|NCT00407030|19586722|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
5677133|NCT00407030|19586720|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
5677134|NCT00407030|19586721|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
5677135|NCT00407030|19586722|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
5677136|NCT00407030|19586720|P3|Extension Period - up to 68 Weeks|Adverse Event|0
5677137|NCT00407030|19586721|P2|Extension Period - up to 68 Weeks|Adverse Event|0
5677138|NCT00407030|19586722|P1|Extension Period - up to 68 Weeks|Adverse Event|1
5677139|NCT00407030|19586720|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
5677140|NCT00407030|19586721|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
5677141|NCT00407030|19586722|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
5677142|NCT00407030|19586720|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
5677143|NCT00407030|19586721|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
5677144|NCT00407030|19586722|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
5677145|NCT00407030|19586720|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
5677146|NCT00407030|19586721|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
5677147|NCT00407030|19586722|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
5677148|NCT00407030|19586720|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
5677149|NCT00407030|19586721|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
5677150|NCT00407030|19586722|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
5677151|NCT00407030|19586720|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
5677152|NCT00407030|19586721|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
5677153|NCT00407030|19586722|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
5677154|NCT00407030|19586720|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
5677155|NCT00407030|19586721|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
5677156|NCT00407030|19586722|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
5677157|NCT00407030|19586720|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
5677158|NCT00407030|19586721|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
5677159|NCT00407030|19586722|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
5677160|NCT00407030|19586720|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
5677161|NCT00407030|19586721|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
5677162|NCT00407030|19586722|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
5677163|NCT00406848|19586750|P2|Overall Study|Sponsor Decision|1
5677164|NCT00406848|19586751|P1|Overall Study|Sponsor Decision|1
5677165|NCT00406848|19586750|P2|Overall Study|Physician Decision|2
5677166|NCT00406848|19586751|P1|Overall Study|Physician Decision|2
5677167|NCT00406848|19586750|P2|Overall Study|Lost to Follow-up|2
5677168|NCT00406848|19586751|P1|Overall Study|Lost to Follow-up|6
5677169|NCT00406848|19586750|P2|Overall Study|Protocol Violation|6
5677170|NCT00406848|19586751|P1|Overall Study|Protocol Violation|10
5677171|NCT00406848|19586750|P2|Overall Study|Lack of Efficacy|14
5677172|NCT00406848|19586751|P1|Overall Study|Lack of Efficacy|9
5677173|NCT00406848|19586750|P2|Overall Study|Adverse Event|7
5677174|NCT00406848|19586751|P1|Overall Study|Adverse Event|38
5677175|NCT00406848|19586750|P2|Overall Study|Withdrawal by Subject|22
5677176|NCT00406848|19586751|P1|Overall Study|Withdrawal by Subject|27
5677177|NCT00406783|19586815|P2|Overall Study|Protocol Violation|4
5677178|NCT00406783|19586816|P1|Overall Study|Protocol Violation|4
5677179|NCT00406783|19586815|P2|Overall Study|Withdrawal by Subject|4
5677180|NCT00406783|19586816|P1|Overall Study|Withdrawal by Subject|1
5677181|NCT00406783|19586815|P2|Overall Study|Lost to Follow-up|0
5677182|NCT00406783|19586816|P1|Overall Study|Lost to Follow-up|3
5677183|NCT00406783|19586815|P2|Overall Study|Treatment Failure|3
5677184|NCT00406783|19586816|P1|Overall Study|Treatment Failure|2
5677185|NCT00406783|19586815|P2|Overall Study|Adverse Event|4
5677186|NCT00406783|19586816|P1|Overall Study|Adverse Event|4
5677187|NCT00406718|19586831|P3|Overall Study|Lost to Follow-up|4
5677188|NCT00406718|19586832|P2|Overall Study|Lost to Follow-up|5
5677189|NCT00406718|19586833|P1|Overall Study|Lost to Follow-up|2
5677190|NCT00406718|19586831|P3|Overall Study|Withdrawal by Subject|4
5677191|NCT00406718|19586832|P2|Overall Study|Withdrawal by Subject|9
5677192|NCT00406718|19586833|P1|Overall Study|Withdrawal by Subject|2
5677193|NCT00406692|19586847|P1|Overall Study|Lack of Efficacy|1
5677194|NCT00406692|19586847|P1|Overall Study|Adverse Event|1
5677195|NCT00406692|19586847|P1|Overall Study|Physician Decision|1
5677196|NCT00406692|19586847|P1|Overall Study|Withdrawal by Subject|4
5677197|NCT00406653|19586857|P7|Open-Label Period|Refused followup|1
5677198|NCT00406653|19586858|P6|Open-Label Period|Refused followup|0
5677199|NCT00406653|19586859|P5|Open-Label Period|Refused followup|0
5677200|NCT00406653|19586860|P4|Open-Label Period|Refused followup|0
5677201|NCT00406653|19586861|P3|Open-Label Period|Refused followup|0
5677202|NCT00406653|19586862|P2|Open-Label Period|Refused followup|0
5677203|NCT00406653|19586863|P1|Open-Label Period|Refused followup|0
5677204|NCT00406653|19586857|P7|Open-Label Period|Discontinued by Sponsor|1
5677205|NCT00406653|19586858|P6|Open-Label Period|Discontinued by Sponsor|0
5677206|NCT00406653|19586859|P5|Open-Label Period|Discontinued by Sponsor|0
5677207|NCT00406653|19586860|P4|Open-Label Period|Discontinued by Sponsor|0
5677208|NCT00406653|19586861|P3|Open-Label Period|Discontinued by Sponsor|0
5677209|NCT00406653|19586862|P2|Open-Label Period|Discontinued by Sponsor|0
5677210|NCT00406653|19586863|P1|Open-Label Period|Discontinued by Sponsor|0
5677211|NCT00406653|19586857|P7|Open-Label Period|Declined participation but followup done|8
5677212|NCT00406653|19586858|P6|Open-Label Period|Declined participation but followup done|0
5677213|NCT00406653|19586859|P5|Open-Label Period|Declined participation but followup done|0
5677214|NCT00406653|19586860|P4|Open-Label Period|Declined participation but followup done|0
5677215|NCT00406653|19586861|P3|Open-Label Period|Declined participation but followup done|0
5677216|NCT00406653|19586862|P2|Open-Label Period|Declined participation but followup done|0
5677217|NCT00406653|19586863|P1|Open-Label Period|Declined participation but followup done|0
5677218|NCT00406653|19586857|P7|Open-Label Period|Administrative Reason By Sponsor|115
5677219|NCT00406653|19586858|P6|Open-Label Period|Administrative Reason By Sponsor|0
5677220|NCT00406653|19586859|P5|Open-Label Period|Administrative Reason By Sponsor|0
5677221|NCT00406653|19586860|P4|Open-Label Period|Administrative Reason By Sponsor|0
5677222|NCT00406653|19586861|P3|Open-Label Period|Administrative Reason By Sponsor|0
5677223|NCT00406653|19586862|P2|Open-Label Period|Administrative Reason By Sponsor|0
5677224|NCT00406653|19586863|P1|Open-Label Period|Administrative Reason By Sponsor|0
5677225|NCT00406653|19586857|P7|Open-Label Period|Pregnancy|2
5677226|NCT00406653|19586858|P6|Open-Label Period|Pregnancy|0
5677227|NCT00406653|19586859|P5|Open-Label Period|Pregnancy|0
5677228|NCT00406653|19586860|P4|Open-Label Period|Pregnancy|0
5677229|NCT00406653|19586861|P3|Open-Label Period|Pregnancy|0
5677230|NCT00406653|19586862|P2|Open-Label Period|Pregnancy|0
5677231|NCT00406653|19586863|P1|Open-Label Period|Pregnancy|0
5677232|NCT00406653|19586857|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
5677233|NCT00406653|19586858|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
5677234|NCT00406653|19586859|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
5677235|NCT00406653|19586860|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
5677236|NCT00406653|19586861|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
5677237|NCT00406653|19586862|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
5677238|NCT00406653|19586863|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
5677239|NCT00406653|19586857|P7|Open-Label Period|Withdrawal of Consent|11
5677240|NCT00406653|19586858|P6|Open-Label Period|Withdrawal of Consent|0
5677241|NCT00406653|19586859|P5|Open-Label Period|Withdrawal of Consent|0
5677242|NCT00406653|19586860|P4|Open-Label Period|Withdrawal of Consent|0
5677243|NCT00406653|19586861|P3|Open-Label Period|Withdrawal of Consent|0
5677244|NCT00406653|19586862|P2|Open-Label Period|Withdrawal of Consent|0
5677245|NCT00406653|19586863|P1|Open-Label Period|Withdrawal of Consent|0
5677246|NCT00406653|19586857|P7|Open-Label Period|Lost to Follow-up|6
5677247|NCT00406653|19586858|P6|Open-Label Period|Lost to Follow-up|0
5677248|NCT00406653|19586859|P5|Open-Label Period|Lost to Follow-up|0
5677249|NCT00406653|19586860|P4|Open-Label Period|Lost to Follow-up|0
5677250|NCT00406653|19586861|P3|Open-Label Period|Lost to Follow-up|0
5677251|NCT00406653|19586862|P2|Open-Label Period|Lost to Follow-up|0
5677252|NCT00406653|19586863|P1|Open-Label Period|Lost to Follow-up|0
5677253|NCT00406653|19586857|P7|Open-Label Period|Lack of Efficacy|160
5677254|NCT00406653|19586858|P6|Open-Label Period|Lack of Efficacy|0
5677255|NCT00406653|19586859|P5|Open-Label Period|Lack of Efficacy|0
5677256|NCT00406653|19586860|P4|Open-Label Period|Lack of Efficacy|0
5677257|NCT00406653|19586861|P3|Open-Label Period|Lack of Efficacy|0
5677258|NCT00406653|19586862|P2|Open-Label Period|Lack of Efficacy|0
5677259|NCT00406653|19586863|P1|Open-Label Period|Lack of Efficacy|0
5677260|NCT00406653|19586857|P7|Open-Label Period|Adverse Event|18
5677261|NCT00406653|19586858|P6|Open-Label Period|Adverse Event|0
5677262|NCT00406653|19586859|P5|Open-Label Period|Adverse Event|0
5677263|NCT00406653|19586860|P4|Open-Label Period|Adverse Event|0
5677264|NCT00406653|19586861|P3|Open-Label Period|Adverse Event|0
5677265|NCT00406653|19586862|P2|Open-Label Period|Adverse Event|0
5677266|NCT00406653|19586863|P1|Open-Label Period|Adverse Event|0
5677267|NCT00406653|19586857|P7|Open-Label Period|Death|1
5677268|NCT00406653|19586858|P6|Open-Label Period|Death|0
5677269|NCT00406653|19586859|P5|Open-Label Period|Death|0
5677270|NCT00406653|19586860|P4|Open-Label Period|Death|0
5677271|NCT00406653|19586861|P3|Open-Label Period|Death|0
5677272|NCT00406653|19586862|P2|Open-Label Period|Death|0
5677273|NCT00406653|19586863|P1|Open-Label Period|Death|0
5677274|NCT00406653|19586857|P7|Maintenance Period|Error in disease score evaluation|0
5677275|NCT00406653|19586858|P6|Maintenance Period|Error in disease score evaluation|0
5677276|NCT00406653|19586859|P5|Maintenance Period|Error in disease score evaluation|1
5677277|NCT00406653|19586860|P4|Maintenance Period|Error in disease score evaluation|0
5677278|NCT00406653|19586861|P3|Maintenance Period|Error in disease score evaluation|0
5677279|NCT00406653|19586862|P2|Maintenance Period|Error in disease score evaluation|0
5677280|NCT00406653|19586863|P1|Maintenance Period|Error in disease score evaluation|0
5677281|NCT00406653|19586857|P7|Maintenance Period|Administrative Reason By Sponsor|0
5677282|NCT00406653|19586858|P6|Maintenance Period|Administrative Reason By Sponsor|7
5677283|NCT00406653|19586859|P5|Maintenance Period|Administrative Reason By Sponsor|4
5677284|NCT00406653|19586860|P4|Maintenance Period|Administrative Reason By Sponsor|0
5677285|NCT00406653|19586861|P3|Maintenance Period|Administrative Reason By Sponsor|0
5677286|NCT00406653|19586862|P2|Maintenance Period|Administrative Reason By Sponsor|0
5677287|NCT00406653|19586863|P1|Maintenance Period|Administrative Reason By Sponsor|0
5677288|NCT00406653|19586857|P7|Maintenance Period|Pregnancy|0
5677289|NCT00406653|19586858|P6|Maintenance Period|Pregnancy|1
5677290|NCT00406653|19586859|P5|Maintenance Period|Pregnancy|0
5677291|NCT00406653|19586860|P4|Maintenance Period|Pregnancy|0
5677292|NCT00406653|19586861|P3|Maintenance Period|Pregnancy|0
5677293|NCT00406653|19586862|P2|Maintenance Period|Pregnancy|0
5677294|NCT00406653|19586863|P1|Maintenance Period|Pregnancy|0
5677295|NCT00406653|19586857|P7|Maintenance Period|Withdrawal of Consent|0
5677296|NCT00406653|19586858|P6|Maintenance Period|Withdrawal of Consent|0
5677297|NCT00406653|19586859|P5|Maintenance Period|Withdrawal of Consent|2
5677298|NCT00406653|19586860|P4|Maintenance Period|Withdrawal of Consent|0
5677299|NCT00406653|19586861|P3|Maintenance Period|Withdrawal of Consent|0
5677300|NCT00406653|19586862|P2|Maintenance Period|Withdrawal of Consent|0
5677301|NCT00406653|19586863|P1|Maintenance Period|Withdrawal of Consent|0
5677302|NCT00406653|19586857|P7|Maintenance Period|Lost to Follow-up|0
5677303|NCT00406653|19586858|P6|Maintenance Period|Lost to Follow-up|1
5677304|NCT00406653|19586859|P5|Maintenance Period|Lost to Follow-up|2
5677305|NCT00406653|19586860|P4|Maintenance Period|Lost to Follow-up|0
5677306|NCT00406653|19586861|P3|Maintenance Period|Lost to Follow-up|0
5677307|NCT00406653|19586862|P2|Maintenance Period|Lost to Follow-up|0
5677308|NCT00406653|19586863|P1|Maintenance Period|Lost to Follow-up|0
5677309|NCT00406653|19586857|P7|Maintenance Period|Lack of Efficacy|0
5677310|NCT00406653|19586858|P6|Maintenance Period|Lack of Efficacy|26
5677311|NCT00406653|19586859|P5|Maintenance Period|Lack of Efficacy|20
5677312|NCT00406653|19586860|P4|Maintenance Period|Lack of Efficacy|0
5677313|NCT00406653|19586861|P3|Maintenance Period|Lack of Efficacy|0
5677314|NCT00406653|19586862|P2|Maintenance Period|Lack of Efficacy|0
5677315|NCT00406653|19586863|P1|Maintenance Period|Lack of Efficacy|0
5677316|NCT00406653|19586857|P7|Maintenance Period|Adverse Event|0
5677317|NCT00406653|19586858|P6|Maintenance Period|Adverse Event|1
5677318|NCT00406653|19586859|P5|Maintenance Period|Adverse Event|1
5677319|NCT00406653|19586860|P4|Maintenance Period|Adverse Event|0
5677320|NCT00406653|19586861|P3|Maintenance Period|Adverse Event|0
5677321|NCT00406653|19586862|P2|Maintenance Period|Adverse Event|0
5677322|NCT00406653|19586863|P1|Maintenance Period|Adverse Event|0
5677323|NCT00406653|19586857|P7|Induction Period|Patient relocated|0
5677324|NCT00406653|19586858|P6|Induction Period|Patient relocated|0
5677325|NCT00406653|19586859|P5|Induction Period|Patient relocated|0
5677326|NCT00406653|19586860|P4|Induction Period|Patient relocated|0
5677327|NCT00406653|19586861|P3|Induction Period|Patient relocated|1
5677328|NCT00406653|19586862|P2|Induction Period|Patient relocated|0
5677329|NCT00406653|19586863|P1|Induction Period|Patient relocated|0
5677330|NCT00406653|19586857|P7|Induction Period|Incarcerated|0
5677331|NCT00406653|19586858|P6|Induction Period|Incarcerated|0
5677332|NCT00406653|19586859|P5|Induction Period|Incarcerated|0
5677333|NCT00406653|19586860|P4|Induction Period|Incarcerated|0
5677334|NCT00406653|19586861|P3|Induction Period|Incarcerated|1
5677335|NCT00406653|19586862|P2|Induction Period|Incarcerated|0
5677336|NCT00406653|19586863|P1|Induction Period|Incarcerated|0
5677337|NCT00406653|19586857|P7|Induction Period|Given prohibited drug|0
5677338|NCT00406653|19586858|P6|Induction Period|Given prohibited drug|0
5677339|NCT00406653|19586859|P5|Induction Period|Given prohibited drug|0
5677340|NCT00406653|19586860|P4|Induction Period|Given prohibited drug|0
5677341|NCT00406653|19586861|P3|Induction Period|Given prohibited drug|2
5677342|NCT00406653|19586862|P2|Induction Period|Given prohibited drug|1
5677343|NCT00406653|19586863|P1|Induction Period|Given prohibited drug|0
5677344|NCT00406653|19586857|P7|Induction Period|Declined participation but followup done|0
5677345|NCT00406653|19586858|P6|Induction Period|Declined participation but followup done|0
5677346|NCT00406653|19586859|P5|Induction Period|Declined participation but followup done|0
5677347|NCT00406653|19586860|P4|Induction Period|Declined participation but followup done|1
5677348|NCT00406653|19586861|P3|Induction Period|Declined participation but followup done|1
5677349|NCT00406653|19586862|P2|Induction Period|Declined participation but followup done|2
5677350|NCT00406653|19586863|P1|Induction Period|Declined participation but followup done|0
5677351|NCT00406653|19586857|P7|Induction Period|Pregnancy|0
5677352|NCT00406653|19586858|P6|Induction Period|Pregnancy|0
5677353|NCT00406653|19586859|P5|Induction Period|Pregnancy|0
5677354|NCT00406653|19586860|P4|Induction Period|Pregnancy|0
5677355|NCT00406653|19586861|P3|Induction Period|Pregnancy|0
5677356|NCT00406653|19586862|P2|Induction Period|Pregnancy|0
5677357|NCT00406653|19586863|P1|Induction Period|Pregnancy|1
5677358|NCT00406653|19586857|P7|Induction Period|Subject No Longer Meets Study Criteria|0
5677359|NCT00406653|19586858|P6|Induction Period|Subject No Longer Meets Study Criteria|0
5677360|NCT00406653|19586859|P5|Induction Period|Subject No Longer Meets Study Criteria|0
5677361|NCT00406653|19586860|P4|Induction Period|Subject No Longer Meets Study Criteria|2
5677362|NCT00406653|19586861|P3|Induction Period|Subject No Longer Meets Study Criteria|0
5677363|NCT00406653|19586862|P2|Induction Period|Subject No Longer Meets Study Criteria|0
5677364|NCT00406653|19586863|P1|Induction Period|Subject No Longer Meets Study Criteria|0
5677365|NCT00406653|19586857|P7|Induction Period|Withdrawal of Consent|0
5677366|NCT00406653|19586858|P6|Induction Period|Withdrawal of Consent|0
5677367|NCT00406653|19586859|P5|Induction Period|Withdrawal of Consent|0
5677368|NCT00406653|19586860|P4|Induction Period|Withdrawal of Consent|2
5677369|NCT00406653|19586861|P3|Induction Period|Withdrawal of Consent|1
5677370|NCT00406653|19586862|P2|Induction Period|Withdrawal of Consent|5
5677371|NCT00406653|19586863|P1|Induction Period|Withdrawal of Consent|2
5677372|NCT00406653|19586857|P7|Induction Period|Lost to Follow-up|0
5677373|NCT00406653|19586858|P6|Induction Period|Lost to Follow-up|0
5677374|NCT00406653|19586859|P5|Induction Period|Lost to Follow-up|0
5677375|NCT00406653|19586860|P4|Induction Period|Lost to Follow-up|0
5677376|NCT00406653|19586861|P3|Induction Period|Lost to Follow-up|0
5677377|NCT00406653|19586862|P2|Induction Period|Lost to Follow-up|2
5677378|NCT00406653|19586863|P1|Induction Period|Lost to Follow-up|0
5677379|NCT00406653|19586857|P7|Induction Period|Lack of Efficacy|0
5677380|NCT00406653|19586858|P6|Induction Period|Lack of Efficacy|0
5677381|NCT00406653|19586859|P5|Induction Period|Lack of Efficacy|0
5677382|NCT00406653|19586860|P4|Induction Period|Lack of Efficacy|10
5677383|NCT00406653|19586861|P3|Induction Period|Lack of Efficacy|8
5677384|NCT00406653|19586862|P2|Induction Period|Lack of Efficacy|14
5677385|NCT00406653|19586863|P1|Induction Period|Lack of Efficacy|11
5677386|NCT00406653|19586857|P7|Induction Period|Adverse Event|0
5677387|NCT00406653|19586858|P6|Induction Period|Adverse Event|0
5677388|NCT00406653|19586859|P5|Induction Period|Adverse Event|0
5677389|NCT00406653|19586860|P4|Induction Period|Adverse Event|11
5677390|NCT00406653|19586861|P3|Induction Period|Adverse Event|4
5677391|NCT00406653|19586862|P2|Induction Period|Adverse Event|10
5677392|NCT00406653|19586863|P1|Induction Period|Adverse Event|1
5677393|NCT00406640|19586944|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
5677394|NCT00406640|19586945|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
5677395|NCT00406640|19586944|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
5677396|NCT00406640|19586945|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
5677397|NCT00406640|19586944|P2|OL Extension Phase for Non-Responders|non-compliance|2
5677398|NCT00406640|19586945|P1|OL Extension Phase for Non-Responders|non-compliance|3
5677399|NCT00406640|19586944|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
5677400|NCT00406640|19586945|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
5677401|NCT00406640|19586944|P2|OL Extension Phase for Non-Responders|Physician Decision|0
5677402|NCT00406640|19586945|P1|OL Extension Phase for Non-Responders|Physician Decision|1
5677403|NCT00406640|19586944|P2|OL Extension Phase for Non-Responders|Failed to Return|0
5677404|NCT00406640|19586945|P1|OL Extension Phase for Non-Responders|Failed to Return|1
5677405|NCT00406640|19586944|P2|OL Extension Phase for Non-Responders|Adverse Event|6
5677406|NCT00406640|19586945|P1|OL Extension Phase for Non-Responders|Adverse Event|6
5677407|NCT00406640|19586944|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
5677408|NCT00406640|19586945|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
5677409|NCT00406640|19586944|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
5677410|NCT00406640|19586945|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
5677411|NCT00406640|19586944|P2|DB Continuation Phase for Responders|Protocol Violation|2
5677412|NCT00406640|19586945|P1|DB Continuation Phase for Responders|Protocol Violation|2
5677413|NCT00406640|19586944|P2|DB Continuation Phase for Responders|non-compliance|5
5677414|NCT00406640|19586945|P1|DB Continuation Phase for Responders|non-compliance|7
5677415|NCT00406640|19586944|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
5677416|NCT00406640|19586945|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
5677417|NCT00406640|19586944|P2|DB Continuation Phase for Responders|Physician Decision|3
5677418|NCT00406640|19586945|P1|DB Continuation Phase for Responders|Physician Decision|2
5677419|NCT00406640|19586944|P2|DB Continuation Phase for Responders|Failed to Return|2
5677420|NCT00406640|19586945|P1|DB Continuation Phase for Responders|Failed to Return|0
5677421|NCT00406640|19586944|P2|DB Continuation Phase for Responders|Death|0
5677422|NCT00406640|19586945|P1|DB Continuation Phase for Responders|Death|1
5677423|NCT00406640|19586944|P2|DB Continuation Phase for Responders|Adverse Event|11
5677424|NCT00406640|19586945|P1|DB Continuation Phase for Responders|Adverse Event|11
5677425|NCT00406640|19586944|P2|Acute Phase|Lack of Efficacy|3
5677426|NCT00406640|19586945|P1|Acute Phase|Lack of Efficacy|3
5677427|NCT00406640|19586944|P2|Acute Phase|Withdrawal by Subject|9
5677428|NCT00406640|19586945|P1|Acute Phase|Withdrawal by Subject|11
5677429|NCT00406640|19586944|P2|Acute Phase|Protocol Violation|2
5677430|NCT00406640|19586945|P1|Acute Phase|Protocol Violation|3
5677431|NCT00406640|19586944|P2|Acute Phase|Protocol deviation|10
5677432|NCT00406640|19586945|P1|Acute Phase|Protocol deviation|4
5677433|NCT00406640|19586944|P2|Acute Phase|Lost to Follow-up|4
5677434|NCT00406640|19586945|P1|Acute Phase|Lost to Follow-up|7
5677435|NCT00406640|19586944|P2|Acute Phase|Physician Decision|1
5677436|NCT00406640|19586945|P1|Acute Phase|Physician Decision|0
5677437|NCT00406640|19586944|P2|Acute Phase|Failed to Return|1
5677438|NCT00406640|19586945|P1|Acute Phase|Failed to Return|5
5677439|NCT00406640|19586944|P2|Acute Phase|Adverse Event|13
5677440|NCT00406640|19586945|P1|Acute Phase|Adverse Event|18
5677441|NCT00406419|19586978|P3|Overall Study|Lost to Follow-up|5
5677442|NCT00406419|19586979|P2|Overall Study|Lost to Follow-up|10
5677443|NCT00406419|19586980|P1|Overall Study|Lost to Follow-up|11
5677444|NCT00406419|19586978|P3|Overall Study|Adverse Event|16
5677445|NCT00406419|19586979|P2|Overall Study|Adverse Event|12
5677446|NCT00406419|19586980|P1|Overall Study|Adverse Event|10
5677447|NCT00406419|19586978|P3|Overall Study|Non-Compliance with Study Drug|3
5677448|NCT00406419|19586979|P2|Overall Study|Non-Compliance with Study Drug|6
5677449|NCT00406419|19586980|P1|Overall Study|Non-Compliance with Study Drug|5
5677450|NCT00406419|19586978|P3|Overall Study|Lack of Efficacy|6
5677451|NCT00406419|19586979|P2|Overall Study|Lack of Efficacy|1
5677452|NCT00406419|19586980|P1|Overall Study|Lack of Efficacy|12
5677453|NCT00406419|19586978|P3|Overall Study|Withdrawal by Subject|26
5677454|NCT00406419|19586979|P2|Overall Study|Withdrawal by Subject|24
5677455|NCT00406419|19586980|P1|Overall Study|Withdrawal by Subject|17
5677456|NCT00406419|19586978|P3|Overall Study|Study Terminated by Sponsor|282
5677457|NCT00406419|19586979|P2|Overall Study|Study Terminated by Sponsor|288
5677458|NCT00406419|19586980|P1|Overall Study|Study Terminated by Sponsor|260
5677459|NCT00406419|19586978|P3|Overall Study|Protocol Violation|5
5677460|NCT00406419|19586979|P2|Overall Study|Protocol Violation|2
5677461|NCT00406419|19586980|P1|Overall Study|Protocol Violation|6
5677462|NCT00406419|19586978|P3|Overall Study|Death|4
5677463|NCT00406419|19586979|P2|Overall Study|Death|1
5677464|NCT00406419|19586980|P1|Overall Study|Death|3
5677465|NCT00406393|19587065|P2|Overall Study|Did not undergo transplantation|1
5677466|NCT00406393|19587066|P1|Overall Study|Did not undergo transplantation|2
5677467|NCT00406367|19587096|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
5677468|NCT00406367|19587097|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
5677469|NCT00406367|19587096|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
5677470|NCT00406367|19587097|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
5677471|NCT00406367|19587096|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
5677472|NCT00406367|19587097|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
5677473|NCT00406367|19587096|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
5677474|NCT00406367|19587097|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
5677475|NCT00406367|19587096|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
5677476|NCT00406367|19587097|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
5677477|NCT00406367|19587096|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
5677478|NCT00406367|19587097|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
5677479|NCT00406367|19587096|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
5677480|NCT00406367|19587097|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
5677481|NCT00406367|19587096|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
5677482|NCT00406367|19587097|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
5677483|NCT00406367|19587096|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
5677484|NCT00406367|19587097|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
5677485|NCT00406367|19587096|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
5677486|NCT00406367|19587097|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
5677487|NCT00406367|19587096|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
5677488|NCT00406367|19587097|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
5677489|NCT00406367|19587096|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
5677490|NCT00406367|19587097|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
5677491|NCT00406354|19587112|P3|All Randomized and Treated Patients|Physician Decision|1
5677492|NCT00406354|19587113|P2|All Randomized and Treated Patients|Physician Decision|0
5677493|NCT00406354|19587114|P1|All Randomized and Treated Patients|Physician Decision|0
5677494|NCT00406354|19587112|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
5677495|NCT00406354|19587113|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
5677496|NCT00406354|19587114|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
5677497|NCT00406354|19587112|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
5677498|NCT00406354|19587113|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
5677499|NCT00406354|19587114|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
5677500|NCT00406354|19587112|P3|All Randomized and Treated Patients|Adverse Event|1
5677501|NCT00406354|19587113|P2|All Randomized and Treated Patients|Adverse Event|2
5677502|NCT00406354|19587114|P1|All Randomized and Treated Patients|Adverse Event|6
5677503|NCT00406354|19587112|P3|All Randomized and Treated Patients|Lack of Efficacy|17
5677504|NCT00406354|19587113|P2|All Randomized and Treated Patients|Lack of Efficacy|4
5677505|NCT00406354|19587114|P1|All Randomized and Treated Patients|Lack of Efficacy|7
5677506|NCT00406354|19587112|P3|All Randomized Patients|Protocol Violation|1
5677507|NCT00406354|19587113|P2|All Randomized Patients|Protocol Violation|0
5677508|NCT00406354|19587114|P1|All Randomized Patients|Protocol Violation|0
5677509|NCT00406315|19587185|P1|Overall Study|Withdrawal by Subject|30
5677510|NCT00406315|19587185|P1|Overall Study|Lost to Follow-up|21
5677511|NCT00406315|19587185|P1|Overall Study|Other|33
5677512|NCT00406315|19587185|P1|Overall Study|Lack of Efficacy|13
5677513|NCT00406315|19587185|P1|Overall Study|Laboratory Abnormality|4
5677514|NCT00406315|19587185|P1|Overall Study|Adverse Event|39
5677515|NCT00406315|19587185|P1|Overall Study|Death|1
5677516|NCT00406029|19587295|P5|Overall Study|Randomized in Error|1
5677517|NCT00406029|19587296|P4|Overall Study|Randomized in Error|3
5677518|NCT00406029|19587297|P3|Overall Study|Randomized in Error|2
5677519|NCT00406029|19587298|P2|Overall Study|Randomized in Error|0
5677520|NCT00406029|19587299|P1|Overall Study|Randomized in Error|0
5677521|NCT00406029|19587295|P5|Overall Study|Did Not Meet Eligibility Criteria|0
5677522|NCT00406029|19587296|P4|Overall Study|Did Not Meet Eligibility Criteria|0
5677523|NCT00406029|19587297|P3|Overall Study|Did Not Meet Eligibility Criteria|1
5677524|NCT00406029|19587298|P2|Overall Study|Did Not Meet Eligibility Criteria|0
5677613|NCT00405756|19587455|P3|Double-blind Treatment|Adverse Event|12
5677525|NCT00406029|19587299|P1|Overall Study|Did Not Meet Eligibility Criteria|0
5677526|NCT00406029|19587295|P5|Overall Study|Protocol Violation|0
5677527|NCT00406029|19587296|P4|Overall Study|Protocol Violation|2
5677528|NCT00406029|19587297|P3|Overall Study|Protocol Violation|0
5677529|NCT00406029|19587298|P2|Overall Study|Protocol Violation|2
5677530|NCT00406029|19587299|P1|Overall Study|Protocol Violation|1
5677531|NCT00406029|19587295|P5|Overall Study|Withdrawal by Subject|0
5677532|NCT00406029|19587296|P4|Overall Study|Withdrawal by Subject|2
5677533|NCT00406029|19587297|P3|Overall Study|Withdrawal by Subject|2
5677534|NCT00406029|19587298|P2|Overall Study|Withdrawal by Subject|4
5677535|NCT00406029|19587299|P1|Overall Study|Withdrawal by Subject|3
5677536|NCT00406029|19587295|P5|Overall Study|Adverse Event|7
5677537|NCT00406029|19587296|P4|Overall Study|Adverse Event|10
5677538|NCT00406029|19587297|P3|Overall Study|Adverse Event|5
5677539|NCT00406029|19587298|P2|Overall Study|Adverse Event|2
5677540|NCT00406029|19587299|P1|Overall Study|Adverse Event|12
5677541|NCT00405964|19587403|P2|Overall Study|Protocol Violation|6
5677542|NCT00405964|19587404|P1|Overall Study|Protocol Violation|11
5677543|NCT00405964|19587403|P2|Overall Study|Withdrawal by Subject|23
5677544|NCT00405964|19587404|P1|Overall Study|Withdrawal by Subject|19
5677545|NCT00405964|19587403|P2|Overall Study|Lost to Follow-up|5
5677546|NCT00405964|19587404|P1|Overall Study|Lost to Follow-up|5
5677547|NCT00405964|19587403|P2|Overall Study|Adverse Event|16
5677548|NCT00405964|19587404|P1|Overall Study|Adverse Event|7
5677549|NCT00405964|19587403|P2|Overall Study|Treatment Failure|45
5677550|NCT00405964|19587404|P1|Overall Study|Treatment Failure|17
5677551|NCT00405912|19587426|P3|Overall Study|Lost to Follow-up|4
5677552|NCT00405912|19587427|P2|Overall Study|Lost to Follow-up|8
5677553|NCT00405912|19587428|P1|Overall Study|Lost to Follow-up|4
5677554|NCT00405912|19587426|P3|Overall Study|Withdrawal by Subject|12
5677555|NCT00405912|19587427|P2|Overall Study|Withdrawal by Subject|11
5677556|NCT00405912|19587428|P1|Overall Study|Withdrawal by Subject|12
5677557|NCT00405821|19587441|P2|Overall Study|initiated ART|8
5677558|NCT00405821|19587442|P1|Overall Study|initiated ART|9
5677559|NCT00405821|19587441|P2|Overall Study|Protocol Violation|0
5677560|NCT00405821|19587442|P1|Overall Study|Protocol Violation|1
5677561|NCT00405821|19587441|P2|Overall Study|Lost to Follow-up|7
5677562|NCT00405821|19587442|P1|Overall Study|Lost to Follow-up|7
5677563|NCT00405821|19587441|P2|Overall Study|Death|7
5677564|NCT00405821|19587442|P1|Overall Study|Death|5
5677565|NCT00405756|19587455|P3|Follow-up|Lost to Follow-up|4
5677566|NCT00405756|19587456|P2|Follow-up|Lost to Follow-up|8
5677567|NCT00405756|19587457|P1|Follow-up|Lost to Follow-up|2
5677568|NCT00405756|19587455|P3|Follow-up|Death|24
5677569|NCT00405756|19587456|P2|Follow-up|Death|31
5677570|NCT00405756|19587457|P1|Follow-up|Death|21
5677571|NCT00405756|19587455|P3|Follow-up|Ongoing in Follow-up Period|60
5677572|NCT00405756|19587456|P2|Follow-up|Ongoing in Follow-up Period|51
5677573|NCT00405756|19587457|P1|Follow-up|Ongoing in Follow-up Period|52
5677574|NCT00405756|19587455|P3|Open-label Extension|Other|7
5677575|NCT00405756|19587456|P2|Open-label Extension|Other|1
5677576|NCT00405756|19587457|P1|Open-label Extension|Other|0
5677577|NCT00405756|19587455|P3|Open-label Extension|Death|4
5677578|NCT00405756|19587456|P2|Open-label Extension|Death|2
5677579|NCT00405756|19587457|P1|Open-label Extension|Death|1
5677580|NCT00405756|19587455|P3|Open-label Extension|Withdrawal by Subject|3
5677581|NCT00405756|19587456|P2|Open-label Extension|Withdrawal by Subject|3
5677582|NCT00405756|19587457|P1|Open-label Extension|Withdrawal by Subject|2
5677583|NCT00405756|19587455|P3|Open-label Extension|Disease Progression|26
5677584|NCT00405756|19587456|P2|Open-label Extension|Disease Progression|23
5677585|NCT00405756|19587457|P1|Open-label Extension|Disease Progression|8
5677586|NCT00405756|19587455|P3|Open-label Extension|Adverse Event|7
5677587|NCT00405756|19587456|P2|Open-label Extension|Adverse Event|3
5677588|NCT00405756|19587457|P1|Open-label Extension|Adverse Event|1
5677589|NCT00405756|19587455|P3|Open-label Extension|Ongoing in Open Label Period|25
5677590|NCT00405756|19587456|P2|Open-label Extension|Ongoing in Open Label Period|15
5677591|NCT00405756|19587457|P1|Open-label Extension|Ongoing in Open Label Period|7
5677592|NCT00405756|19587455|P3|Double-blind Treatment|Other|4
5677593|NCT00405756|19587456|P2|Double-blind Treatment|Other|4
5677594|NCT00405756|19587457|P1|Double-blind Treatment|Other|7
5677595|NCT00405756|19587455|P3|Double-blind Treatment|Protocol Violation|2
5677596|NCT00405756|19587456|P2|Double-blind Treatment|Protocol Violation|0
5677597|NCT00405756|19587457|P1|Double-blind Treatment|Protocol Violation|1
5677598|NCT00405756|19587455|P3|Double-blind Treatment|Death|4
5677599|NCT00405756|19587456|P2|Double-blind Treatment|Death|4
5677600|NCT00405756|19587457|P1|Double-blind Treatment|Death|4
5677601|NCT00405756|19587455|P3|Double-blind Treatment|Lost to Follow-up|0
5677602|NCT00405756|19587456|P2|Double-blind Treatment|Lost to Follow-up|0
5677603|NCT00405756|19587457|P1|Double-blind Treatment|Lost to Follow-up|1
5677604|NCT00405756|19587455|P3|Double-blind Treatment|Withdrawal by Subject|10
5677605|NCT00405756|19587456|P2|Double-blind Treatment|Withdrawal by Subject|9
5677606|NCT00405756|19587457|P1|Double-blind Treatment|Withdrawal by Subject|15
5677607|NCT00405756|19587455|P3|Double-blind Treatment|Lack of Efficacy|2
5677608|NCT00405756|19587456|P2|Double-blind Treatment|Lack of Efficacy|4
5677609|NCT00405756|19587457|P1|Double-blind Treatment|Lack of Efficacy|1
5677610|NCT00405756|19587455|P3|Double-blind Treatment|Disease Progression|102
5677611|NCT00405756|19587456|P2|Double-blind Treatment|Disease Progression|81
5677612|NCT00405756|19587457|P1|Double-blind Treatment|Disease Progression|47
5677614|NCT00405756|19587456|P2|Double-blind Treatment|Adverse Event|27
5677615|NCT00405756|19587457|P1|Double-blind Treatment|Adverse Event|31
5677616|NCT00405756|19587455|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
5677617|NCT00405756|19587456|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
5677618|NCT00405756|19587457|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
5677619|NCT00405652|19587568|P1|Overall Study|Adverse Event|4
5677620|NCT00405639|19587575|P2|Overall Study|Seizure prior to receiving BNP|0
5677621|NCT00405639|19587576|P1|Overall Study|Seizure prior to receiving BNP|1
5677622|NCT00405639|19587575|P2|Overall Study|Adverse Event|0
5677623|NCT00405639|19587576|P1|Overall Study|Adverse Event|1
5677624|NCT00405639|19587575|P2|Overall Study|Withdrawal by Subject|0
5677625|NCT00405639|19587576|P1|Overall Study|Withdrawal by Subject|1
5677626|NCT00405587|19587592|P4|Overall Study|Participant not dosed|0
5677627|NCT00405587|19587593|P3|Overall Study|Participant not dosed|0
5677628|NCT00405587|19587594|P2|Overall Study|Participant not dosed|1
5677629|NCT00405587|19587595|P1|Overall Study|Participant not dosed|0
5677630|NCT00405587|19587592|P4|Overall Study|Withdrawal by Subject|2
5677631|NCT00405587|19587593|P3|Overall Study|Withdrawal by Subject|0
5677632|NCT00405587|19587594|P2|Overall Study|Withdrawal by Subject|0
5677633|NCT00405587|19587595|P1|Overall Study|Withdrawal by Subject|0
5677634|NCT00405587|19587592|P4|Overall Study|Radiation induced necrosis|0
5677635|NCT00405587|19587593|P3|Overall Study|Radiation induced necrosis|0
5677636|NCT00405587|19587594|P2|Overall Study|Radiation induced necrosis|1
5677637|NCT00405587|19587595|P1|Overall Study|Radiation induced necrosis|0
5677638|NCT00405587|19587592|P4|Overall Study|Lost to Follow-up|0
5677639|NCT00405587|19587593|P3|Overall Study|Lost to Follow-up|1
5677640|NCT00405587|19587594|P2|Overall Study|Lost to Follow-up|1
5677641|NCT00405587|19587595|P1|Overall Study|Lost to Follow-up|0
5677642|NCT00405587|19587592|P4|Overall Study|Adverse Event|0
5677643|NCT00405587|19587593|P3|Overall Study|Adverse Event|0
5677644|NCT00405587|19587594|P2|Overall Study|Adverse Event|0
5677645|NCT00405587|19587595|P1|Overall Study|Adverse Event|1
5677646|NCT00405587|19587592|P4|Overall Study|Physician Decision|0
5677647|NCT00405587|19587593|P3|Overall Study|Physician Decision|0
5677648|NCT00405587|19587594|P2|Overall Study|Physician Decision|2
5677649|NCT00405587|19587595|P1|Overall Study|Physician Decision|3
5677650|NCT00405587|19587592|P4|Overall Study|Disease Progression|17
5677651|NCT00405587|19587593|P3|Overall Study|Disease Progression|21
5677652|NCT00405587|19587594|P2|Overall Study|Disease Progression|23
5677653|NCT00405587|19587595|P1|Overall Study|Disease Progression|22
5677654|NCT00405587|19587592|P4|Overall Study|Death|1
5677655|NCT00405587|19587593|P3|Overall Study|Death|0
5677656|NCT00405587|19587594|P2|Overall Study|Death|0
5677657|NCT00405587|19587595|P1|Overall Study|Death|0
5677658|NCT00405548|19587713|P2|Overall Study|Withdrawal by Subject|0
5677659|NCT00405548|19587714|P1|Overall Study|Withdrawal by Subject|1
5677660|NCT00405548|19587713|P2|Overall Study|Venous access failed during study day|0
5677661|NCT00405548|19587714|P1|Overall Study|Venous access failed during study day|1
5677662|NCT00405548|19587713|P2|Overall Study|Unable to self-administer shots|0
5677663|NCT00405548|19587714|P1|Overall Study|Unable to self-administer shots|1
5677664|NCT00405548|19587713|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
5677665|NCT00405548|19587714|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
5677666|NCT00405548|19587713|P2|Overall Study|Cognitive Memory problems on study day|0
5677667|NCT00405548|19587714|P1|Overall Study|Cognitive Memory problems on study day|1
5677668|NCT00405392|19587758|P2|Overall Study|Other|5
5677669|NCT00405392|19587759|P1|Overall Study|Other|1
5677670|NCT00405392|19587758|P2|Overall Study|Non-compliance|1
5677671|NCT00405392|19587759|P1|Overall Study|Non-compliance|0
5677672|NCT00405392|19587758|P2|Overall Study|Data missing|0
5677673|NCT00405392|19587759|P1|Overall Study|Data missing|2
5677674|NCT00405392|19587758|P2|Overall Study|Lost to Follow-up|2
5677675|NCT00405392|19587759|P1|Overall Study|Lost to Follow-up|1
5677676|NCT00405392|19587758|P2|Overall Study|Withdrawal by Subject|3
5677677|NCT00405392|19587759|P1|Overall Study|Withdrawal by Subject|4
5677678|NCT00405392|19587758|P2|Overall Study|Did not meet Eligibility criteria|2
5677679|NCT00405392|19587759|P1|Overall Study|Did not meet Eligibility criteria|7
5677680|NCT00405392|19587758|P2|Overall Study|Adverse Event|14
5677681|NCT00405392|19587759|P1|Overall Study|Adverse Event|15
5677682|NCT00405275|19587806|P2|Overall Study|Unwilling to continue|9
5677683|NCT00405275|19587807|P1|Overall Study|Unwilling to continue|10
5677684|NCT00405275|19587806|P2|Overall Study|Withdrawal by Subject|9
5677685|NCT00405275|19587807|P1|Overall Study|Withdrawal by Subject|7
5677686|NCT00405275|19587806|P2|Overall Study|Lost to Follow-up|1
5677687|NCT00405275|19587807|P1|Overall Study|Lost to Follow-up|5
5677688|NCT00405275|19587806|P2|Overall Study|Death|0
5677689|NCT00405275|19587807|P1|Overall Study|Death|1
5677690|NCT00405067|19587816|P3|Overall Study|Lost to Follow-up|1
5677691|NCT00405067|19587817|P2|Overall Study|Lost to Follow-up|0
5677692|NCT00405067|19587818|P1|Overall Study|Lost to Follow-up|0
5677693|NCT00405067|19587816|P3|Overall Study|Adverse Event|4
5677694|NCT00405067|19587817|P2|Overall Study|Adverse Event|9
5677695|NCT00405067|19587818|P1|Overall Study|Adverse Event|4
5677696|NCT00404924|19587855|P2|Overall Study|Randomised but not received treatment|1
5677697|NCT00404924|19587856|P1|Overall Study|Randomised but not received treatment|1
5677698|NCT00404924|19587855|P2|Overall Study|Other|11
5677699|NCT00404924|19587856|P1|Overall Study|Other|25
5677700|NCT00404924|19587855|P2|Overall Study|Withdrawal by Subject|13
5677701|NCT00404924|19587856|P1|Overall Study|Withdrawal by Subject|26
5677702|NCT00404924|19587855|P2|Overall Study|Lost to Follow-up|1
5677703|NCT00404924|19587856|P1|Overall Study|Lost to Follow-up|1
5677704|NCT00404924|19587855|P2|Overall Study|Condition under investigation worsened|264
5677705|NCT00404924|19587856|P1|Overall Study|Condition under investigation worsened|475
5677706|NCT00404924|19587855|P2|Overall Study|Adverse Event|16
5677707|NCT00404924|19587856|P1|Overall Study|Adverse Event|75
5677708|NCT00404820|19587874|P2|Overall Study|Other|2
5677709|NCT00404820|19587875|P1|Overall Study|Other|0
5677710|NCT00404820|19587874|P2|Overall Study|Death|0
5677711|NCT00404820|19587875|P1|Overall Study|Death|1
5677712|NCT00404820|19587874|P2|Overall Study|Administrative problems|0
5677713|NCT00404820|19587875|P1|Overall Study|Administrative problems|2
5677714|NCT00404820|19587874|P2|Overall Study|Lost to Follow-up|3
5677715|NCT00404820|19587875|P1|Overall Study|Lost to Follow-up|7
5677716|NCT00404820|19587874|P2|Overall Study|Withdrawal by Subject|3
5677717|NCT00404820|19587875|P1|Overall Study|Withdrawal by Subject|5
5677718|NCT00404820|19587874|P2|Overall Study|Adverse Event|16
5677719|NCT00404820|19587875|P1|Overall Study|Adverse Event|4
5677720|NCT00404768|19587897|P4|Part C|Researcher suspended study medication|1
5677721|NCT00404768|19587898|P3|Part C|Researcher suspended study medication|0
5677722|NCT00404768|19587899|P2|Part C|Researcher suspended study medication|0
5677723|NCT00404768|19587900|P1|Part C|Researcher suspended study medication|0
5677724|NCT00404768|19587897|P4|Part C|Investigator discretion|1
5677725|NCT00404768|19587898|P3|Part C|Investigator discretion|0
5677726|NCT00404768|19587899|P2|Part C|Investigator discretion|0
5677727|NCT00404768|19587900|P1|Part C|Investigator discretion|0
5677728|NCT00404768|19587897|P4|Part C|Treatment failure|1
5677729|NCT00404768|19587898|P3|Part C|Treatment failure|0
5677730|NCT00404768|19587899|P2|Part C|Treatment failure|0
5677731|NCT00404768|19587900|P1|Part C|Treatment failure|0
5677732|NCT00404768|19587897|P4|Part C|Lack of Efficacy|2
5677733|NCT00404768|19587898|P3|Part C|Lack of Efficacy|0
5677734|NCT00404768|19587899|P2|Part C|Lack of Efficacy|0
5677735|NCT00404768|19587900|P1|Part C|Lack of Efficacy|0
5677736|NCT00404768|19587897|P4|Part C|Active labor|1
5677737|NCT00404768|19587898|P3|Part C|Active labor|0
5677738|NCT00404768|19587899|P2|Part C|Active labor|0
5677739|NCT00404768|19587900|P1|Part C|Active labor|0
5677740|NCT00404768|19587897|P4|Part C|Unsatisfactory uterine response to IP|1
5677741|NCT00404768|19587898|P3|Part C|Unsatisfactory uterine response to IP|0
5677742|NCT00404768|19587899|P2|Part C|Unsatisfactory uterine response to IP|0
5677743|NCT00404768|19587900|P1|Part C|Unsatisfactory uterine response to IP|0
5677744|NCT00404768|19587897|P4|Part C|Participant delivered baby|1
5677745|NCT00404768|19587898|P3|Part C|Participant delivered baby|0
5677746|NCT00404768|19587899|P2|Part C|Participant delivered baby|0
5677747|NCT00404768|19587900|P1|Part C|Participant delivered baby|0
5677748|NCT00404768|19587897|P4|Part C|Physician withdrew the study medication|0
5677749|NCT00404768|19587898|P3|Part C|Physician withdrew the study medication|1
5677750|NCT00404768|19587899|P2|Part C|Physician withdrew the study medication|0
5677751|NCT00404768|19587900|P1|Part C|Physician withdrew the study medication|0
5677752|NCT00404768|19587897|P4|Part C|Participant did not respond to therapy|1
5677753|NCT00404768|19587898|P3|Part C|Participant did not respond to therapy|1
5677754|NCT00404768|19587899|P2|Part C|Participant did not respond to therapy|0
5677755|NCT00404768|19587900|P1|Part C|Participant did not respond to therapy|0
5677756|NCT00404768|19587897|P4|Part C|Early withdrawal from study medication|0
5677757|NCT00404768|19587898|P3|Part C|Early withdrawal from study medication|1
5677758|NCT00404768|19587899|P2|Part C|Early withdrawal from study medication|0
5677759|NCT00404768|19587900|P1|Part C|Early withdrawal from study medication|0
5677760|NCT00404768|19587897|P4|Part C|Withdrawal by Subject|1
5677761|NCT00404768|19587898|P3|Part C|Withdrawal by Subject|2
5677762|NCT00404768|19587899|P2|Part C|Withdrawal by Subject|0
5677763|NCT00404768|19587900|P1|Part C|Withdrawal by Subject|0
5677764|NCT00404768|19587897|P4|Part C|Lost to Follow-up|1
5677765|NCT00404768|19587898|P3|Part C|Lost to Follow-up|3
5677766|NCT00404768|19587899|P2|Part C|Lost to Follow-up|0
5677767|NCT00404768|19587900|P1|Part C|Lost to Follow-up|0
5677768|NCT00404768|19587897|P4|Part C|Adverse Event|3
5677769|NCT00404768|19587898|P3|Part C|Adverse Event|0
5677770|NCT00404768|19587899|P2|Part C|Adverse Event|0
5677771|NCT00404768|19587900|P1|Part C|Adverse Event|0
5677772|NCT00404768|19587897|P4|Part A and B|Withdrawn as delivery imminemnt|0
5677773|NCT00404768|19587898|P3|Part A and B|Withdrawn as delivery imminemnt|0
5677774|NCT00404768|19587899|P2|Part A and B|Withdrawn as delivery imminemnt|1
5677775|NCT00404768|19587900|P1|Part A and B|Withdrawn as delivery imminemnt|0
5677776|NCT00404768|19587897|P4|Part A and B|Withdrawn due to labor progression|0
5677777|NCT00404768|19587898|P3|Part A and B|Withdrawn due to labor progression|0
5677778|NCT00404768|19587899|P2|Part A and B|Withdrawn due to labor progression|0
5677779|NCT00404768|19587900|P1|Part A and B|Withdrawn due to labor progression|1
5677780|NCT00404755|19587961|P1|Phase II (Escitalopram)|Lost to Follow-up|2
5677781|NCT00404755|19587961|P1|Phase I (Bupropion)|Other|1
5677782|NCT00404755|19587961|P1|Phase I (Bupropion)|Adverse Event|3
5677783|NCT00404651|19587976|P4|Overall Study|Withdrawal by Subject|6
5677784|NCT00404651|19587977|P3|Overall Study|Withdrawal by Subject|16
5677785|NCT00404651|19587978|P2|Overall Study|Withdrawal by Subject|12
5677786|NCT00404651|19587979|P1|Overall Study|Withdrawal by Subject|14
5677787|NCT00404651|19587976|P4|Overall Study|Lost to Follow-up|10
5677788|NCT00404651|19587977|P3|Overall Study|Lost to Follow-up|13
5677789|NCT00404651|19587978|P2|Overall Study|Lost to Follow-up|11
5677790|NCT00404651|19587979|P1|Overall Study|Lost to Follow-up|15
5677791|NCT00404651|19587976|P4|Overall Study|Protocol Violation|5
5677792|NCT00404651|19587977|P3|Overall Study|Protocol Violation|14
5677793|NCT00404651|19587978|P2|Overall Study|Protocol Violation|5
5677794|NCT00404651|19587979|P1|Overall Study|Protocol Violation|10
5677795|NCT00404651|19587976|P4|Overall Study|Serious Adverse Event|0
5677796|NCT00404651|19587977|P3|Overall Study|Serious Adverse Event|2
5677797|NCT00404651|19587978|P2|Overall Study|Serious Adverse Event|0
5677798|NCT00404651|19587979|P1|Overall Study|Serious Adverse Event|0
5677799|NCT00404547|19588007|P2|Overall Study|Reason not stated|6
5677800|NCT00404547|19588008|P1|Overall Study|Reason not stated|3
5677801|NCT00404547|19588007|P2|Overall Study|Other|0
5677802|NCT00404547|19588008|P1|Overall Study|Other|4
5677803|NCT00404547|19588007|P2|Overall Study|Lack of compliance|1
5677804|NCT00404547|19588008|P1|Overall Study|Lack of compliance|5
5677805|NCT00404547|19588007|P2|Overall Study|Lost to Follow-up|9
5677806|NCT00404547|19588008|P1|Overall Study|Lost to Follow-up|20
5677807|NCT00404547|19588007|P2|Overall Study|Protocol Violation|1
5677808|NCT00404547|19588008|P1|Overall Study|Protocol Violation|0
5677809|NCT00404547|19588007|P2|Overall Study|Withdrawal by Subject|2
5677810|NCT00404547|19588008|P1|Overall Study|Withdrawal by Subject|19
5677811|NCT00404547|19588007|P2|Overall Study|Adverse Event|6
5677812|NCT00404547|19588008|P1|Overall Study|Adverse Event|39
5677813|NCT00404495|19588018|P2|Overall Study|Withdrawal by Subject|0
5677814|NCT00404495|19588019|P1|Overall Study|Withdrawal by Subject|1
5677815|NCT00404495|19588018|P2|Overall Study|Other|0
5677816|NCT00404495|19588019|P1|Overall Study|Other|1
5677817|NCT00404495|19588018|P2|Overall Study|Lost to Follow-up|0
5677818|NCT00404495|19588019|P1|Overall Study|Lost to Follow-up|5
5677819|NCT00404495|19588018|P2|Overall Study|Death|11
5677820|NCT00404495|19588019|P1|Overall Study|Death|37
5677821|NCT00404352|19588038|P9|Open Label Extension (up to 36 Months)|Other|2
5677822|NCT00404352|19588039|P8|Open Label Extension (up to 36 Months)|Other|0
5677823|NCT00404352|19588040|P7|Open Label Extension (up to 36 Months)|Other|0
5677824|NCT00404352|19588041|P6|Open Label Extension (up to 36 Months)|Other|0
5677825|NCT00404352|19588042|P5|Open Label Extension (up to 36 Months)|Other|0
5677826|NCT00404352|19588043|P4|Open Label Extension (up to 36 Months)|Other|0
5677827|NCT00404352|19588044|P3|Open Label Extension (up to 36 Months)|Other|0
5677828|NCT00404352|19588045|P2|Open Label Extension (up to 36 Months)|Other|0
5677829|NCT00404352|19588046|P1|Open Label Extension (up to 36 Months)|Other|0
5677830|NCT00404352|19588038|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
5677831|NCT00404352|19588039|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
5677832|NCT00404352|19588040|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
5677833|NCT00404352|19588041|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
5677834|NCT00404352|19588042|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
5677835|NCT00404352|19588043|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
5677836|NCT00404352|19588044|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
5677837|NCT00404352|19588045|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
5677838|NCT00404352|19588046|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
5677839|NCT00404352|19588038|P9|Open Label (up to 24 Month)|Disease progression|0
5677840|NCT00404352|19588039|P8|Open Label (up to 24 Month)|Disease progression|0
5677841|NCT00404352|19588040|P7|Open Label (up to 24 Month)|Disease progression|0
5677842|NCT00404352|19588041|P6|Open Label (up to 24 Month)|Disease progression|0
5677843|NCT00404352|19588042|P5|Open Label (up to 24 Month)|Disease progression|0
5677844|NCT00404352|19588043|P4|Open Label (up to 24 Month)|Disease progression|1
5677845|NCT00404352|19588044|P3|Open Label (up to 24 Month)|Disease progression|0
5677846|NCT00404352|19588045|P2|Open Label (up to 24 Month)|Disease progression|0
5677847|NCT00404352|19588046|P1|Open Label (up to 24 Month)|Disease progression|0
5677848|NCT00404352|19588038|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
5677849|NCT00404352|19588039|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
5677850|NCT00404352|19588040|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
5677851|NCT00404352|19588041|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
5677852|NCT00404352|19588042|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
5677853|NCT00404352|19588043|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
5677854|NCT00404352|19588044|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
5677855|NCT00404352|19588045|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
5677856|NCT00404352|19588046|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
5677857|NCT00404352|19588038|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
5677858|NCT00404352|19588039|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
5677859|NCT00404352|19588040|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
5677860|NCT00404352|19588041|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
5677861|NCT00404352|19588042|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
5677862|NCT00404352|19588043|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
5677863|NCT00404352|19588044|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
5677864|NCT00404352|19588045|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
5677865|NCT00404352|19588046|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
5677866|NCT00404352|19588038|P9|Open Label (up to 24 Month)|Pregnancy|0
5677867|NCT00404352|19588039|P8|Open Label (up to 24 Month)|Pregnancy|0
5677868|NCT00404352|19588040|P7|Open Label (up to 24 Month)|Pregnancy|0
5677869|NCT00404352|19588041|P6|Open Label (up to 24 Month)|Pregnancy|1
5677870|NCT00404352|19588042|P5|Open Label (up to 24 Month)|Pregnancy|0
5677871|NCT00404352|19588043|P4|Open Label (up to 24 Month)|Pregnancy|0
5677872|NCT00404352|19588044|P3|Open Label (up to 24 Month)|Pregnancy|0
5677873|NCT00404352|19588045|P2|Open Label (up to 24 Month)|Pregnancy|0
5677874|NCT00404352|19588046|P1|Open Label (up to 24 Month)|Pregnancy|0
5677875|NCT00404352|19588038|P9|Open Label (up to 24 Month)|Adverse Event|0
5677876|NCT00404352|19588039|P8|Open Label (up to 24 Month)|Adverse Event|0
5677877|NCT00404352|19588040|P7|Open Label (up to 24 Month)|Adverse Event|0
5677878|NCT00404352|19588041|P6|Open Label (up to 24 Month)|Adverse Event|1
5677879|NCT00404352|19588042|P5|Open Label (up to 24 Month)|Adverse Event|1
5677880|NCT00404352|19588043|P4|Open Label (up to 24 Month)|Adverse Event|2
5677881|NCT00404352|19588044|P3|Open Label (up to 24 Month)|Adverse Event|0
5677882|NCT00404352|19588045|P2|Open Label (up to 24 Month)|Adverse Event|0
5677883|NCT00404352|19588046|P1|Open Label (up to 24 Month)|Adverse Event|0
5677884|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Other|0
5677885|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Other|0
5677886|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Other|0
5677887|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Other|0
5677888|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Other|0
5677889|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Other|0
5677890|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Other|0
5677891|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Other|1
5677892|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Other|0
5677893|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Physician Decision|0
5677894|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Physician Decision|0
5677895|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Physician Decision|0
5677896|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Physician Decision|0
5677897|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Physician Decision|0
5677898|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Physician Decision|0
5677899|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Physician Decision|1
5677900|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Physician Decision|0
5677901|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Physician Decision|0
5677902|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
5677903|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
5677904|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
5677905|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
5677906|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
5677907|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
5677908|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
5677909|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
5677910|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
5677911|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
5677912|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
5677913|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
5677914|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
5677915|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
5677916|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
5677917|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
5677918|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
5677919|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
5677920|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Poor compliance|0
5677921|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Poor compliance|0
5677922|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Poor compliance|0
5677923|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Poor compliance|0
5677924|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Poor compliance|0
5677925|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Poor compliance|0
5677926|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Poor compliance|0
5677927|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Poor compliance|0
5677928|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Poor compliance|1
5677929|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Disease progression|0
5677930|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Disease progression|0
5677931|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Disease progression|0
5677932|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Disease progression|0
5677933|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Disease progression|0
5677934|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Disease progression|0
5677935|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Disease progression|2
5677936|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Disease progression|0
5677937|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Disease progression|3
5677938|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5677939|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5677940|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5677941|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5677942|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5677943|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
5677944|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
5677945|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
5677946|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
5677947|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
5677948|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
5677949|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
5677950|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
5677951|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
5677952|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
5677953|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
5677954|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
5677955|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
5677956|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Death|0
5677957|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Death|0
5677958|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Death|0
5677959|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Death|0
5677960|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Death|0
5677961|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Death|0
5677962|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Death|1
5677963|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Death|0
5677964|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Death|0
5677965|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Pregnancy|0
5677966|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Pregnancy|0
5677967|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Pregnancy|0
5677968|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Pregnancy|0
5677969|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Pregnancy|0
5677970|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Pregnancy|0
5677971|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Pregnancy|2
5677972|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Pregnancy|0
5677973|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Pregnancy|0
5677974|NCT00404352|19588038|P9|Double Blind (up to 24 Month)|Adverse Event|0
5677975|NCT00404352|19588039|P8|Double Blind (up to 24 Month)|Adverse Event|0
5677976|NCT00404352|19588040|P7|Double Blind (up to 24 Month)|Adverse Event|0
5677977|NCT00404352|19588041|P6|Double Blind (up to 24 Month)|Adverse Event|0
5677978|NCT00404352|19588042|P5|Double Blind (up to 24 Month)|Adverse Event|0
5677979|NCT00404352|19588043|P4|Double Blind (up to 24 Month)|Adverse Event|0
5677980|NCT00404352|19588044|P3|Double Blind (up to 24 Month)|Adverse Event|6
5677981|NCT00404352|19588045|P2|Double Blind (up to 24 Month)|Adverse Event|4
5677982|NCT00404352|19588046|P1|Double Blind (up to 24 Month)|Adverse Event|5
5677983|NCT00404248|19588081|P9|Overall Study|pts declining status|0
5677984|NCT00404248|19588082|P8|Overall Study|pts declining status|0
5677985|NCT00404248|19588083|P7|Overall Study|pts declining status|0
5677986|NCT00404248|19588084|P6|Overall Study|pts declining status|0
5677987|NCT00404248|19588085|P5|Overall Study|pts declining status|0
5677988|NCT00404248|19588086|P4|Overall Study|pts declining status|0
5677989|NCT00404248|19588087|P3|Overall Study|pts declining status|0
5677990|NCT00404248|19588088|P2|Overall Study|pts declining status|1
5677991|NCT00404248|19588089|P1|Overall Study|pts declining status|0
5677992|NCT00404235|19588122|P2|Overall Study|Withdrawal by Subject|2
5677993|NCT00404235|19588123|P1|Overall Study|Withdrawal by Subject|1
5677994|NCT00404092|19588141|P4|Overall Study|Adverse Event|0
5677995|NCT00404092|19588142|P3|Overall Study|Adverse Event|1
5677996|NCT00404092|19588143|P2|Overall Study|Adverse Event|0
5677997|NCT00404092|19588144|P1|Overall Study|Adverse Event|0
5677998|NCT00404092|19588141|P4|Overall Study|Death|0
5677999|NCT00404092|19588142|P3|Overall Study|Death|0
5678000|NCT00404092|19588143|P2|Overall Study|Death|0
5678001|NCT00404092|19588144|P1|Overall Study|Death|1
5678002|NCT00404079|19588160|P2|Overall Study|Lost to follow up, adverse event etc|20
5678003|NCT00404079|19588161|P1|Overall Study|Lost to follow up, adverse event etc|22
5678004|NCT00404066|19588167|P1|Overall Study|Withdrawal by Subject - Adverse event|2
5678005|NCT00404066|19588167|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
5678006|NCT00403845|19588172|P4|Treatment Period 3|Adverse Event|1
5678007|NCT00403845|19588173|P3|Treatment Period 3|Adverse Event|0
5678008|NCT00403845|19588174|P2|Treatment Period 3|Adverse Event|0
5678009|NCT00403845|19588175|P1|Treatment Period 3|Adverse Event|0
5678010|NCT00403845|19588172|P4|Treatment Period 3|Subject withdrew consent|1
5678011|NCT00403845|19588173|P3|Treatment Period 3|Subject withdrew consent|0
5678012|NCT00403845|19588174|P2|Treatment Period 3|Subject withdrew consent|0
5678013|NCT00403845|19588175|P1|Treatment Period 3|Subject withdrew consent|0
5678014|NCT00403845|19588172|P4|Treatment Period 2|Subject withdrew consent|0
5678015|NCT00403845|19588173|P3|Treatment Period 2|Subject withdrew consent|0
5678016|NCT00403845|19588174|P2|Treatment Period 2|Subject withdrew consent|0
5678017|NCT00403845|19588175|P1|Treatment Period 2|Subject withdrew consent|1
5678018|NCT00403845|19588172|P4|Treatment Period 1|Subject no longer needs study drug|1
5678019|NCT00403845|19588173|P3|Treatment Period 1|Subject no longer needs study drug|0
5678020|NCT00403845|19588174|P2|Treatment Period 1|Subject no longer needs study drug|0
5678021|NCT00403845|19588175|P1|Treatment Period 1|Subject no longer needs study drug|0
5678022|NCT00403845|19588172|P4|Treatment Period 1|Subject withdrew consent|0
5678023|NCT00403845|19588173|P3|Treatment Period 1|Subject withdrew consent|0
5678024|NCT00403845|19588174|P2|Treatment Period 1|Subject withdrew consent|0
5678025|NCT00403845|19588175|P1|Treatment Period 1|Subject withdrew consent|1
5678026|NCT00403767|19588199|P2|Overall Study|Missing/incomplete data|1
5678027|NCT00403767|19588200|P1|Overall Study|Missing/incomplete data|1
5678028|NCT00403767|19588199|P2|Overall Study|Study terminated by sponsor|69
5678029|NCT00403767|19588200|P1|Overall Study|Study terminated by sponsor|82
5678030|NCT00403767|19588199|P2|Overall Study|Clinical efficacy endpoint reached|332
5678031|NCT00403767|19588200|P1|Overall Study|Clinical efficacy endpoint reached|300
5678032|NCT00403767|19588199|P2|Overall Study|Protocol Violation|124
5678033|NCT00403767|19588200|P1|Overall Study|Protocol Violation|142
5678034|NCT00403767|19588199|P2|Overall Study|Lost to Follow-up|8
5678035|NCT00403767|19588200|P1|Overall Study|Lost to Follow-up|6
5678036|NCT00403767|19588199|P2|Overall Study|Investigator dec./not protocol-related|178
5678037|NCT00403767|19588200|P1|Overall Study|Investigator dec./not protocol-related|191
5678038|NCT00403767|19588199|P2|Overall Study|Consent withdrawn|673
5678039|NCT00403767|19588200|P1|Overall Study|Consent withdrawn|671
5678040|NCT00403767|19588199|P2|Overall Study|Non-compliant with study medication|164
5678041|NCT00403767|19588200|P1|Overall Study|Non-compliant with study medication|134
5678042|NCT00403767|19588199|P2|Overall Study|Adverse Event|919
5678043|NCT00403767|19588200|P1|Overall Study|Adverse Event|993
5678044|NCT00403754|19588224|P4|Core Treatment Period 2|Lack of Efficacy|0
5678045|NCT00403754|19588225|P3|Core Treatment Period 2|Lack of Efficacy|1
5678046|NCT00403754|19588226|P2|Core Treatment Period 2|Lack of Efficacy|0
5678047|NCT00403754|19588227|P1|Core Treatment Period 2|Lack of Efficacy|0
5678048|NCT00403754|19588224|P4|Core Treatment Period 1|Withdrawal by Subject|0
5678049|NCT00403754|19588225|P3|Core Treatment Period 1|Withdrawal by Subject|0
5678050|NCT00403754|19588226|P2|Core Treatment Period 1|Withdrawal by Subject|1
5678051|NCT00403754|19588227|P1|Core Treatment Period 1|Withdrawal by Subject|0
5678052|NCT00403585|19588254|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
5678053|NCT00403585|19588254|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
5678054|NCT00403585|19588254|P1|Initial Treatment Phase|Lost to Follow-up|2
5678055|NCT00403546|19588265|P3|Randomized Trial|Early Terminations|16
5678056|NCT00403546|19588266|P2|Randomized Trial|Early Terminations|17
5678057|NCT00403546|19588267|P1|Randomized Trial|Early Terminations|0
5678058|NCT00403546|19588265|P3|Screening Phase|Terminated Prior to Randomization|0
5678059|NCT00403546|19588266|P2|Screening Phase|Terminated Prior to Randomization|0
5678060|NCT00403546|19588267|P1|Screening Phase|Terminated Prior to Randomization|5
5678061|NCT00403546|19588265|P3|Screening Phase|Adverse Event|0
5678062|NCT00403546|19588266|P2|Screening Phase|Adverse Event|0
5678063|NCT00403546|19588267|P1|Screening Phase|Adverse Event|1
5678064|NCT00403546|19588265|P3|Screening Phase|Screening Failure|0
5678065|NCT00403546|19588266|P2|Screening Phase|Screening Failure|0
5678066|NCT00403546|19588267|P1|Screening Phase|Screening Failure|22
5678067|NCT00403546|19588265|P3|Signed Informed Consent/Open-Label|Adverse Event|0
5678068|NCT00403546|19588266|P2|Signed Informed Consent/Open-Label|Adverse Event|0
5678069|NCT00403546|19588267|P1|Signed Informed Consent/Open-Label|Adverse Event|5
5678070|NCT00403546|19588265|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
5678071|NCT00403546|19588266|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
5678072|NCT00403546|19588267|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
5678073|NCT00403546|19588265|P3|Signed Informed Consent/Open-Label|Early Termination|0
5678074|NCT00403546|19588266|P2|Signed Informed Consent/Open-Label|Early Termination|0
5678075|NCT00403546|19588267|P1|Signed Informed Consent/Open-Label|Early Termination|8
5678076|NCT00403546|19588265|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
5678077|NCT00403546|19588266|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
5678078|NCT00403546|19588267|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
5678079|NCT00403481|19588307|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
5678080|NCT00403481|19588307|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
5678081|NCT00403481|19588307|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
5678082|NCT00403481|19588307|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
5678083|NCT00403481|19588307|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
5678084|NCT00403481|19588307|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
5678085|NCT00403481|19588307|P1|Olm 40 mg|Other|1
5678086|NCT00403481|19588307|P1|Olm 40 mg|Withdrawal by Subject|1
5678087|NCT00403481|19588307|P1|Olm 40 mg|Protocol Violation|1
5678088|NCT00403481|19588307|P1|Olm 40 mg|Adverse Event|2
5678089|NCT00403481|19588307|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
5678090|NCT00403481|19588307|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
5678091|NCT00403481|19588307|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
5678092|NCT00403481|19588307|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
5678093|NCT00403455|19588322|P1|Overall Study|Withdrawal by Subject|1
5678094|NCT00403390|19588345|P2|Overall Study|non-compliant|0
5678095|NCT00403390|19588346|P1|Overall Study|non-compliant|1
5678096|NCT00403390|19588345|P2|Overall Study|samples lost|0
5678097|NCT00403390|19588346|P1|Overall Study|samples lost|1
5678098|NCT00403390|19588345|P2|Overall Study|Withdrawal by Subject|0
5678099|NCT00403390|19588346|P1|Overall Study|Withdrawal by Subject|1
5678100|NCT00403273|19588354|P2|Overall Study|pt. wanted to have a surgical procedure|1
5678101|NCT00403273|19588355|P1|Overall Study|pt. wanted to have a surgical procedure|0
5678102|NCT00403273|19588354|P2|Overall Study|Physician Decision|1
5678103|NCT00403273|19588355|P1|Overall Study|Physician Decision|0
5678104|NCT00403273|19588354|P2|Overall Study|Lost to Follow-up|2
5678105|NCT00403273|19588355|P1|Overall Study|Lost to Follow-up|3
5678106|NCT00403234|19588397|P4|Overall Study|Adverse Event|0
5678107|NCT00403234|19588398|P3|Overall Study|Adverse Event|1
5678108|NCT00403234|19588399|P2|Overall Study|Adverse Event|0
5678109|NCT00403234|19588400|P1|Overall Study|Adverse Event|1
5678110|NCT00403234|19588397|P4|Overall Study|Withdrawal by Subject|0
5678111|NCT00403234|19588398|P3|Overall Study|Withdrawal by Subject|0
5678112|NCT00403234|19588399|P2|Overall Study|Withdrawal by Subject|1
5678113|NCT00403234|19588400|P1|Overall Study|Withdrawal by Subject|0
5678114|NCT00403130|19588410|P1|Survival Follow-up up to 6 Years|Lost to Follow-up|10
5678115|NCT00403130|19588410|P1|2 Years From Start of Treatment|Withdrawal by Subject|1
5678116|NCT00403130|19588410|P1|2 Years From Start of Treatment|Lost to Follow up|1
5678117|NCT00403130|19588410|P1|2 Years From Start of Treatment|Not Eligible|3
5678118|NCT00402987|19588463|P4|Overall Study|Lack of Efficacy|0
5678119|NCT00402987|19588464|P3|Overall Study|Lack of Efficacy|1
5678120|NCT00402987|19588465|P2|Overall Study|Lack of Efficacy|0
5678121|NCT00402987|19588466|P1|Overall Study|Lack of Efficacy|0
5678122|NCT00402831|19588638|P2|Overall Study|Non-compliance with protocol|1
5678123|NCT00402831|19588639|P1|Overall Study|Non-compliance with protocol|0
5678124|NCT00402831|19588638|P2|Overall Study|Lost to Follow-up|2
5678125|NCT00402831|19588639|P1|Overall Study|Lost to Follow-up|1
5678126|NCT00402779|19588673|P2|Overall Study|Screen Failure|76
5678127|NCT00402779|19588674|P1|Overall Study|Screen Failure|77
5678128|NCT00402740|19588680|P1|Overall Study|Subject disposition unknown.|1
5678129|NCT00402740|19588680|P1|Overall Study|No stent. Completed FU at 30 days.|5
5678130|NCT00402740|19588680|P1|Overall Study|Lost to Follow-up|6
5678131|NCT00402740|19588680|P1|Overall Study|Death|50
5678132|NCT00402740|19588680|P1|Overall Study|Withdrawal by Subject|18
5678133|NCT00402727|19588692|P2|Overall Study|non-compliance|1
5678134|NCT00402727|19588693|P1|Overall Study|non-compliance|0
5678135|NCT00402727|19588692|P2|Overall Study|supply problems|1
5678136|NCT00402727|19588693|P1|Overall Study|supply problems|2
5678137|NCT00402727|19588692|P2|Overall Study|Withdrawal by Subject|7
5678138|NCT00402727|19588693|P1|Overall Study|Withdrawal by Subject|3
5678139|NCT00402727|19588692|P2|Overall Study|Protocol Violation|4
5678140|NCT00402727|19588693|P1|Overall Study|Protocol Violation|0
5678141|NCT00402727|19588692|P2|Overall Study|Physician Decision|1
5678142|NCT00402727|19588693|P1|Overall Study|Physician Decision|1
5678143|NCT00402727|19588692|P2|Overall Study|Lost to Follow-up|11
5678144|NCT00402727|19588693|P1|Overall Study|Lost to Follow-up|24
5678145|NCT00402727|19588692|P2|Overall Study|Lack of Efficacy|3
5678146|NCT00402727|19588693|P1|Overall Study|Lack of Efficacy|1
5678147|NCT00402727|19588692|P2|Overall Study|Death|0
5678148|NCT00402727|19588693|P1|Overall Study|Death|1
5678149|NCT00402727|19588692|P2|Overall Study|Adverse Event|6
5678150|NCT00402727|19588693|P1|Overall Study|Adverse Event|10
5678151|NCT00402688|19588735|P3|Overall Study|Patient Left Town and Forgot Medication|1
5678152|NCT00402688|19588736|P2|Overall Study|Patient Left Town and Forgot Medication|0
5678153|NCT00402688|19588737|P1|Overall Study|Patient Left Town and Forgot Medication|0
5678154|NCT00402688|19588735|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
5678155|NCT00402688|19588736|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
5678156|NCT00402688|19588737|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
5678157|NCT00402688|19588735|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
5678158|NCT00402688|19588736|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
5678159|NCT00402688|19588737|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
5678160|NCT00402688|19588735|P3|Overall Study|Lost to Follow-up|2
5678161|NCT00402688|19588736|P2|Overall Study|Lost to Follow-up|0
5678162|NCT00402688|19588737|P1|Overall Study|Lost to Follow-up|1
5678163|NCT00402688|19588735|P3|Overall Study|Protocol Violation|1
5678164|NCT00402688|19588736|P2|Overall Study|Protocol Violation|1
5678165|NCT00402688|19588737|P1|Overall Study|Protocol Violation|1
5678166|NCT00402688|19588735|P3|Overall Study|Lack of Efficacy|5
5678167|NCT00402688|19588736|P2|Overall Study|Lack of Efficacy|4
5678168|NCT00402688|19588737|P1|Overall Study|Lack of Efficacy|4
5678169|NCT00402688|19588735|P3|Overall Study|Physician Decision|1
5678170|NCT00402688|19588736|P2|Overall Study|Physician Decision|0
5678171|NCT00402688|19588737|P1|Overall Study|Physician Decision|0
5678172|NCT00402688|19588735|P3|Overall Study|Withdrawal by Subject|1
5678173|NCT00402688|19588736|P2|Overall Study|Withdrawal by Subject|1
5678174|NCT00402688|19588737|P1|Overall Study|Withdrawal by Subject|3
5678175|NCT00402688|19588735|P3|Overall Study|Adverse Event|3
5678176|NCT00402688|19588736|P2|Overall Study|Adverse Event|9
5678177|NCT00402688|19588737|P1|Overall Study|Adverse Event|12
5678178|NCT00402649|19588760|P1|Overall Study|Withdrawal by Subject|1
5678179|NCT00402649|19588760|P1|Overall Study|Lost to Follow-up|1
5678180|NCT00402597|19588775|P5|Overall Study|reason not specified|20
5678181|NCT00402597|19588776|P4|Overall Study|reason not specified|14
5678182|NCT00402597|19588777|P3|Overall Study|reason not specified|27
5678183|NCT00402597|19588778|P2|Overall Study|reason not specified|4
5678184|NCT00402597|19588779|P1|Overall Study|reason not specified|30
5678185|NCT00402597|19588775|P5|Overall Study|Withdrawal by Subject|24
5678186|NCT00402597|19588776|P4|Overall Study|Withdrawal by Subject|15
5678187|NCT00402597|19588777|P3|Overall Study|Withdrawal by Subject|65
5678188|NCT00402597|19588778|P2|Overall Study|Withdrawal by Subject|16
5678189|NCT00402597|19588779|P1|Overall Study|Withdrawal by Subject|57
5678190|NCT00402597|19588775|P5|Overall Study|Lost to Follow-up|3
5678191|NCT00402597|19588776|P4|Overall Study|Lost to Follow-up|2
5678192|NCT00402597|19588777|P3|Overall Study|Lost to Follow-up|8
5678193|NCT00402597|19588778|P2|Overall Study|Lost to Follow-up|1
5678194|NCT00402597|19588779|P1|Overall Study|Lost to Follow-up|8
5678195|NCT00402597|19588775|P5|Overall Study|Adverse Event|71
5678196|NCT00402597|19588776|P4|Overall Study|Adverse Event|39
5678197|NCT00402597|19588777|P3|Overall Study|Adverse Event|106
5678198|NCT00402597|19588778|P2|Overall Study|Adverse Event|18
5678199|NCT00402597|19588779|P1|Overall Study|Adverse Event|81
5678200|NCT00402597|19588775|P5|Overall Study|Death|6
5678201|NCT00402597|19588776|P4|Overall Study|Death|4
5678202|NCT00402597|19588777|P3|Overall Study|Death|6
5678203|NCT00402597|19588778|P2|Overall Study|Death|7
5678204|NCT00402597|19588779|P1|Overall Study|Death|15
5678205|NCT00402363|19588820|P4|Overall Study|"Captured as Other"|2
5678206|NCT00402363|19588821|P3|Overall Study|"Captured as Other"|2
5678207|NCT00402363|19588822|P2|Overall Study|"Captured as Other"|2
5678208|NCT00402363|19588823|P1|Overall Study|"Captured as Other"|6
5678209|NCT00402363|19588820|P4|Overall Study|Lost to Follow-up|2
5678210|NCT00402363|19588821|P3|Overall Study|Lost to Follow-up|0
5678211|NCT00402363|19588822|P2|Overall Study|Lost to Follow-up|4
5678212|NCT00402363|19588823|P1|Overall Study|Lost to Follow-up|5
5678213|NCT00402363|19588820|P4|Overall Study|Protocol Violation|3
5678214|NCT00402363|19588821|P3|Overall Study|Protocol Violation|0
5678215|NCT00402363|19588822|P2|Overall Study|Protocol Violation|5
5678216|NCT00402363|19588823|P1|Overall Study|Protocol Violation|3
5678217|NCT00402363|19588820|P4|Overall Study|Withdrew Consent|1
5678218|NCT00402363|19588821|P3|Overall Study|Withdrew Consent|2
5678219|NCT00402363|19588822|P2|Overall Study|Withdrew Consent|5
5678220|NCT00402363|19588823|P1|Overall Study|Withdrew Consent|10
5678221|NCT00402363|19588820|P4|Overall Study|Adverse Event|2
5678222|NCT00402363|19588821|P3|Overall Study|Adverse Event|2
5678223|NCT00402363|19588822|P2|Overall Study|Adverse Event|14
5678224|NCT00402363|19588823|P1|Overall Study|Adverse Event|9
5678225|NCT00402337|19588886|P5|Overall Study|Other Reason|0
5678226|NCT00402337|19588887|P4|Overall Study|Other Reason|0
5678227|NCT00402337|19588888|P3|Overall Study|Other Reason|0
5678228|NCT00402337|19588889|P2|Overall Study|Other Reason|1
5678229|NCT00402337|19588890|P1|Overall Study|Other Reason|0
5678230|NCT00402337|19588886|P5|Overall Study|Physician Decision|0
5678231|NCT00402337|19588887|P4|Overall Study|Physician Decision|1
5678232|NCT00402337|19588888|P3|Overall Study|Physician Decision|0
5678233|NCT00402337|19588889|P2|Overall Study|Physician Decision|0
5678234|NCT00402337|19588890|P1|Overall Study|Physician Decision|0
5678235|NCT00402337|19588886|P5|Overall Study|Lost to Follow-up|0
5678236|NCT00402337|19588887|P4|Overall Study|Lost to Follow-up|2
5678237|NCT00402337|19588888|P3|Overall Study|Lost to Follow-up|1
5678238|NCT00402337|19588889|P2|Overall Study|Lost to Follow-up|0
5678239|NCT00402337|19588890|P1|Overall Study|Lost to Follow-up|0
5678240|NCT00402337|19588886|P5|Overall Study|Withdrawal by Subject|4
5678241|NCT00402337|19588887|P4|Overall Study|Withdrawal by Subject|6
5678242|NCT00402337|19588888|P3|Overall Study|Withdrawal by Subject|1
5678243|NCT00402337|19588889|P2|Overall Study|Withdrawal by Subject|3
5678244|NCT00402337|19588890|P1|Overall Study|Withdrawal by Subject|5
5678245|NCT00402337|19588886|P5|Overall Study|Noncompliance|2
5678246|NCT00402337|19588887|P4|Overall Study|Noncompliance|0
5678247|NCT00402337|19588888|P3|Overall Study|Noncompliance|0
5678248|NCT00402337|19588889|P2|Overall Study|Noncompliance|0
5678249|NCT00402337|19588890|P1|Overall Study|Noncompliance|0
5678250|NCT00402337|19588886|P5|Overall Study|Adverse Event|2
5678251|NCT00402337|19588887|P4|Overall Study|Adverse Event|3
5678252|NCT00402337|19588888|P3|Overall Study|Adverse Event|2
5678253|NCT00402337|19588889|P2|Overall Study|Adverse Event|2
5678254|NCT00402337|19588890|P1|Overall Study|Adverse Event|0
5678255|NCT00402324|19588929|P2|Overall Study|Death|0
5678256|NCT00402324|19588930|P1|Overall Study|Death|1
5678257|NCT00402324|19588929|P2|Overall Study|Adverse Event|4
5678258|NCT00402324|19588930|P1|Overall Study|Adverse Event|6
5678259|NCT00402324|19588929|P2|Overall Study|Lack of Efficacy|4
5678260|NCT00402324|19588930|P1|Overall Study|Lack of Efficacy|1
5678261|NCT00402324|19588929|P2|Overall Study|Sponsor Decision|5
5678262|NCT00402324|19588930|P1|Overall Study|Sponsor Decision|4
5678263|NCT00402324|19588929|P2|Overall Study|Physician Decision|4
5678264|NCT00402324|19588930|P1|Overall Study|Physician Decision|2
5678265|NCT00402324|19588929|P2|Overall Study|Withdrawal by Subject|2
5678266|NCT00402324|19588930|P1|Overall Study|Withdrawal by Subject|5
5678267|NCT00402324|19588929|P2|Overall Study|Protocol Violation|7
5678268|NCT00402324|19588930|P1|Overall Study|Protocol Violation|8
5678269|NCT00402324|19588929|P2|Overall Study|Protocol Entry Criteria Not Met|4
5678270|NCT00402324|19588930|P1|Overall Study|Protocol Entry Criteria Not Met|5
5678271|NCT00402324|19588929|P2|Overall Study|Lost to Follow-up|11
5678272|NCT00402324|19588930|P1|Overall Study|Lost to Follow-up|11
5678273|NCT00402285|19588963|P3|Overall Study|insufficient RNA quality|2
5678274|NCT00402285|19588964|P2|Overall Study|insufficient RNA quality|6
5678275|NCT00402285|19588965|P1|Overall Study|insufficient RNA quality|7
5678276|NCT00402246|19588973|P2|Overall Study|Deterioriating Condition|2
5678277|NCT00402246|19588974|P1|Overall Study|Deterioriating Condition|3
5678278|NCT00402246|19588973|P2|Overall Study|Center Closure|3
5678279|NCT00402246|19588974|P1|Overall Study|Center Closure|5
5678280|NCT00402246|19588973|P2|Overall Study|Patient's device explanted|2
5678281|NCT00402246|19588974|P1|Overall Study|Patient's device explanted|6
5678282|NCT00402246|19588973|P2|Overall Study|Heart Transplant|1
5678283|NCT00402246|19588974|P1|Overall Study|Heart Transplant|0
5678284|NCT00402246|19588973|P2|Overall Study|Insurance Issues|1
5678285|NCT00402246|19588974|P1|Overall Study|Insurance Issues|2
5678286|NCT00402246|19588973|P2|Overall Study|Missed Final Visit|2
5678287|NCT00402246|19588974|P1|Overall Study|Missed Final Visit|1
5678288|NCT00402246|19588973|P2|Overall Study|Protocol Violation|24
5678289|NCT00402246|19588974|P1|Overall Study|Protocol Violation|25
5678290|NCT00402246|19588973|P2|Overall Study|Physician Decision|26
5678291|NCT00402246|19588974|P1|Overall Study|Physician Decision|24
5678292|NCT00402246|19588973|P2|Overall Study|Withdrawal by Subject|87
5678293|NCT00402246|19588974|P1|Overall Study|Withdrawal by Subject|72
5678294|NCT00402246|19588973|P2|Overall Study|Lost to Follow-up|28
5678295|NCT00402246|19588974|P1|Overall Study|Lost to Follow-up|20
5678296|NCT00402246|19588973|P2|Overall Study|Death|58
5678297|NCT00402246|19588974|P1|Overall Study|Death|62
5678298|NCT00402233|19589008|P4|Overall Study|Worsening of other pre-existing disease|0
5678299|NCT00402233|19589009|P3|Overall Study|Worsening of other pre-existing disease|0
5678300|NCT00402233|19589010|P2|Overall Study|Worsening of other pre-existing disease|1
5678301|NCT00402233|19589011|P1|Overall Study|Worsening of other pre-existing disease|0
5678302|NCT00402233|19589008|P4|Overall Study|Worsening of disease under study|0
5678303|NCT00402233|19589009|P3|Overall Study|Worsening of disease under study|0
5678304|NCT00402233|19589010|P2|Overall Study|Worsening of disease under study|0
5678305|NCT00402233|19589011|P1|Overall Study|Worsening of disease under study|2
5678306|NCT00402233|19589008|P4|Overall Study|Withdrawal by Subject|2
5678307|NCT00402233|19589009|P3|Overall Study|Withdrawal by Subject|2
5678308|NCT00402233|19589010|P2|Overall Study|Withdrawal by Subject|1
5678309|NCT00402233|19589011|P1|Overall Study|Withdrawal by Subject|2
5678310|NCT00402233|19589008|P4|Overall Study|Protocol Violation|0
5678311|NCT00402233|19589009|P3|Overall Study|Protocol Violation|0
5678312|NCT00402233|19589010|P2|Overall Study|Protocol Violation|1
5678313|NCT00402233|19589011|P1|Overall Study|Protocol Violation|0
5678314|NCT00402233|19589008|P4|Overall Study|Adverse Event|9
5678315|NCT00402233|19589009|P3|Overall Study|Adverse Event|9
5678316|NCT00402233|19589010|P2|Overall Study|Adverse Event|7
5678317|NCT00402233|19589011|P1|Overall Study|Adverse Event|1
5678318|NCT00402168|19589046|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
5678319|NCT00402168|19589047|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
5678320|NCT00402168|19589046|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
5678321|NCT00402168|19589047|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
5678322|NCT00402168|19589046|P2|Long Term (LT)|non-specified|2
5678323|NCT00402168|19589047|P1|Long Term (LT)|non-specified|1
5678324|NCT00402168|19589046|P2|Long Term (LT)|Lack of Efficacy|2
5678325|NCT00402168|19589047|P1|Long Term (LT)|Lack of Efficacy|0
5678326|NCT00402168|19589046|P2|Long Term (LT)|Death|0
5678327|NCT00402168|19589047|P1|Long Term (LT)|Death|4
5678328|NCT00402168|19589046|P2|Long Term (LT)|Lost to Follow-up|0
5678329|NCT00402168|19589047|P1|Long Term (LT)|Lost to Follow-up|1
5678330|NCT00402168|19589046|P2|Long Term (LT)|Pregnancy|1
5678331|NCT00402168|19589047|P1|Long Term (LT)|Pregnancy|0
5678332|NCT00402168|19589046|P2|Long Term (LT)|Withdrawal by Subject|7
5678333|NCT00402168|19589047|P1|Long Term (LT)|Withdrawal by Subject|4
5678334|NCT00402168|19589046|P2|Long Term (LT)|Adverse Event|5
5678335|NCT00402168|19589047|P1|Long Term (LT)|Adverse Event|1
5678336|NCT00402168|19589046|P2|Treatment (up to 12 Months)|non-specified|1
5678337|NCT00402168|19589047|P1|Treatment (up to 12 Months)|non-specified|0
5678338|NCT00402168|19589046|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
5678339|NCT00402168|19589047|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
5678340|NCT00402168|19589046|P2|Treatment (up to 12 Months)|Death|1
5678341|NCT00402168|19589047|P1|Treatment (up to 12 Months)|Death|0
5678342|NCT00402168|19589046|P2|Randomized|Withdrawal by Subject|1
5678343|NCT00402168|19589047|P1|Randomized|Withdrawal by Subject|0
5678344|NCT00402168|19589046|P2|Randomized|Lost to Follow-up|0
5678345|NCT00402168|19589047|P1|Randomized|Lost to Follow-up|1
5678346|NCT00402116|19589105|P3|Overall Study|Adverse Event|6
5678347|NCT00402116|19589106|P2|Overall Study|Adverse Event|1
5678348|NCT00402116|19589107|P1|Overall Study|Adverse Event|0
5678349|NCT00402116|19589105|P3|Overall Study|decline related hyponatremia/tumor|1
5678350|NCT00402116|19589106|P2|Overall Study|decline related hyponatremia/tumor|0
5678351|NCT00402116|19589107|P1|Overall Study|decline related hyponatremia/tumor|0
5678352|NCT00402116|19589105|P3|Overall Study|mistaken thrombocytopenia|1
5678353|NCT00402116|19589106|P2|Overall Study|mistaken thrombocytopenia|0
5678354|NCT00402116|19589107|P1|Overall Study|mistaken thrombocytopenia|0
5678355|NCT00402116|19589105|P3|Overall Study|Disease Progression|38
5678356|NCT00402116|19589106|P2|Overall Study|Disease Progression|4
5678357|NCT00402116|19589107|P1|Overall Study|Disease Progression|0
5678358|NCT00402116|19589105|P3|Overall Study|other complicating disease|2
5678359|NCT00402116|19589106|P2|Overall Study|other complicating disease|0
5678360|NCT00402116|19589107|P1|Overall Study|other complicating disease|0
5678361|NCT00402116|19589105|P3|Overall Study|Treatment completed per protocol|2
5678362|NCT00402116|19589106|P2|Overall Study|Treatment completed per protocol|1
5678363|NCT00402116|19589107|P1|Overall Study|Treatment completed per protocol|1
5678364|NCT00402116|19589105|P3|Overall Study|Withdrawal by Subject|5
5678365|NCT00402116|19589106|P2|Overall Study|Withdrawal by Subject|0
5678366|NCT00402116|19589107|P1|Overall Study|Withdrawal by Subject|1
5678367|NCT00402116|19589105|P3|Overall Study|Jaw infection after surgery-other|0
5678368|NCT00402116|19589106|P2|Overall Study|Jaw infection after surgery-other|0
5678369|NCT00402116|19589107|P1|Overall Study|Jaw infection after surgery-other|1
5678370|NCT00402103|19589137|P2|Overall Study|Administrative problems|0
5678371|NCT00402103|19589138|P1|Overall Study|Administrative problems|2
5678372|NCT00402103|19589137|P2|Overall Study|Lost to Follow-up|3
5678373|NCT00402103|19589138|P1|Overall Study|Lost to Follow-up|6
5678374|NCT00402103|19589137|P2|Overall Study|Patient withdrew consent|1
5678375|NCT00402103|19589138|P1|Overall Study|Patient withdrew consent|12
5678376|NCT00402103|19589137|P2|Overall Study|Protocol Deviation|0
5678377|NCT00402103|19589138|P1|Overall Study|Protocol Deviation|8
5678378|NCT00402103|19589137|P2|Overall Study|Condition no longer requires study drug|0
5678379|NCT00402103|19589138|P1|Overall Study|Condition no longer requires study drug|2
5678380|NCT00402103|19589137|P2|Overall Study|Unsatisfactory therapeutic effect|2
5678381|NCT00402103|19589138|P1|Overall Study|Unsatisfactory therapeutic effect|1
5678382|NCT00402103|19589137|P2|Overall Study|Adverse Event|7
5678383|NCT00402103|19589138|P1|Overall Study|Adverse Event|60
5678384|NCT00402051|19589154|P2|Overall Study|Lost to Follow-up|0
5678385|NCT00402051|19589155|P1|Overall Study|Lost to Follow-up|1
5678386|NCT00402051|19589154|P2|Overall Study|Death Due to Adverse Event|2
5678387|NCT00402051|19589155|P1|Overall Study|Death Due to Adverse Event|0
5678388|NCT00402051|19589154|P2|Overall Study|Death Due to Study Disease|1
5678389|NCT00402051|19589155|P1|Overall Study|Death Due to Study Disease|2
5678390|NCT00402051|19589154|P2|Overall Study|Death - Related to Study Drug|2
5678391|NCT00402051|19589155|P1|Overall Study|Death - Related to Study Drug|1
5678392|NCT00402051|19589154|P2|Overall Study|Withdrawal by Subject|3
5678393|NCT00402051|19589155|P1|Overall Study|Withdrawal by Subject|3
5678394|NCT00402051|19589154|P2|Overall Study|Physician Decision|3
5678395|NCT00402051|19589155|P1|Overall Study|Physician Decision|7
5678396|NCT00402051|19589154|P2|Overall Study|Adverse Event|4
5678397|NCT00402051|19589155|P1|Overall Study|Adverse Event|11
5678398|NCT00402051|19589154|P2|Overall Study|Progressive Disease|20
5678399|NCT00402051|19589155|P1|Overall Study|Progressive Disease|13
5678400|NCT00402025|19589172|P3|Overall Study|Participant Decision|1
5678401|NCT00402025|19589173|P2|Overall Study|Participant Decision|0
5678402|NCT00402025|19589174|P1|Overall Study|Participant Decision|0
5678403|NCT00402025|19589172|P3|Overall Study|Physician Decision|0
5678404|NCT00402025|19589173|P2|Overall Study|Physician Decision|1
5678405|NCT00402025|19589174|P1|Overall Study|Physician Decision|1
5678406|NCT00402025|19589172|P3|Overall Study|Disease Progression|2
5678407|NCT00402025|19589173|P2|Overall Study|Disease Progression|1
5678408|NCT00402025|19589174|P1|Overall Study|Disease Progression|1
5678409|NCT00402025|19589172|P3|Overall Study|Death|5
5678410|NCT00402025|19589173|P2|Overall Study|Death|1
5678411|NCT00402025|19589174|P1|Overall Study|Death|0
5678412|NCT00402025|19589172|P3|Overall Study|Adverse Event|2
5678413|NCT00402025|19589173|P2|Overall Study|Adverse Event|0
5678414|NCT00402025|19589174|P1|Overall Study|Adverse Event|0
5678415|NCT00401973|19589200|P3|Overall Study|Withdrawal by Subject|9
5678416|NCT00401973|19589201|P2|Overall Study|Withdrawal by Subject|12
5678417|NCT00401973|19589202|P1|Overall Study|Withdrawal by Subject|4
5678418|NCT00401973|19589200|P3|Overall Study|Sponsor Decision|0
5678419|NCT00401973|19589201|P2|Overall Study|Sponsor Decision|1
5678420|NCT00401973|19589202|P1|Overall Study|Sponsor Decision|0
5678421|NCT00401973|19589200|P3|Overall Study|Protocol Violation|3
5678422|NCT00401973|19589201|P2|Overall Study|Protocol Violation|2
5678423|NCT00401973|19589202|P1|Overall Study|Protocol Violation|1
5678424|NCT00401973|19589200|P3|Overall Study|Physician Decision|1
5678425|NCT00401973|19589201|P2|Overall Study|Physician Decision|0
5678426|NCT00401973|19589202|P1|Overall Study|Physician Decision|2
5678427|NCT00401973|19589200|P3|Overall Study|Lost to Follow-up|2
5678428|NCT00401973|19589201|P2|Overall Study|Lost to Follow-up|2
5678429|NCT00401973|19589202|P1|Overall Study|Lost to Follow-up|2
5678430|NCT00401973|19589200|P3|Overall Study|Lack of Efficacy|3
5678431|NCT00401973|19589201|P2|Overall Study|Lack of Efficacy|0
5678432|NCT00401973|19589202|P1|Overall Study|Lack of Efficacy|0
5678433|NCT00401973|19589200|P3|Overall Study|Clinical Relapse|1
5678434|NCT00401973|19589201|P2|Overall Study|Clinical Relapse|1
5678435|NCT00401973|19589202|P1|Overall Study|Clinical Relapse|0
5678436|NCT00401973|19589200|P3|Overall Study|Adverse Event|4
5678437|NCT00401973|19589201|P2|Overall Study|Adverse Event|8
5678438|NCT00401973|19589202|P1|Overall Study|Adverse Event|2
5678439|NCT00401960|19589241|P2|Overall Study|Death|0
5678440|NCT00401960|19589242|P1|Overall Study|Death|2
5678441|NCT00401960|19589241|P2|Overall Study|Lost to Follow-up|0
5678442|NCT00401960|19589242|P1|Overall Study|Lost to Follow-up|3
5678443|NCT00401843|19589272|P3|Overall Study|Received incorrect treatment|0
5678444|NCT00401843|19589273|P2|Overall Study|Received incorrect treatment|3
5678445|NCT00401843|19589274|P1|Overall Study|Received incorrect treatment|0
5678446|NCT00401843|19589272|P3|Overall Study|Randomized but not Treated|3
5678447|NCT00401843|19589273|P2|Overall Study|Randomized but not Treated|2
5678448|NCT00401843|19589274|P1|Overall Study|Randomized but not Treated|0
5678449|NCT00401843|19589272|P3|Overall Study|Withdrawal of consent to study agent|17
5678450|NCT00401843|19589273|P2|Overall Study|Withdrawal of consent to study agent|15
5678451|NCT00401843|19589274|P1|Overall Study|Withdrawal of consent to study agent|1
5678452|NCT00401843|19589272|P3|Overall Study|Withdrawal by Subject|5
5678453|NCT00401843|19589273|P2|Overall Study|Withdrawal by Subject|5
5678454|NCT00401843|19589274|P1|Overall Study|Withdrawal by Subject|1
5678455|NCT00401843|19589272|P3|Overall Study|Protocol Violation|1
5678456|NCT00401843|19589273|P2|Overall Study|Protocol Violation|0
5678457|NCT00401843|19589274|P1|Overall Study|Protocol Violation|0
5678458|NCT00401843|19589272|P3|Overall Study|Physician Decision|10
5678459|NCT00401843|19589273|P2|Overall Study|Physician Decision|16
5678460|NCT00401843|19589274|P1|Overall Study|Physician Decision|0
5678461|NCT00401843|19589272|P3|Overall Study|Other Unspecified|5
5678462|NCT00401843|19589273|P2|Overall Study|Other Unspecified|3
5678463|NCT00401843|19589274|P1|Overall Study|Other Unspecified|0
5678464|NCT00401843|19589272|P3|Overall Study|Lost to Follow-up|2
5678465|NCT00401843|19589273|P2|Overall Study|Lost to Follow-up|0
5678466|NCT00401843|19589274|P1|Overall Study|Lost to Follow-up|0
5678467|NCT00401843|19589272|P3|Overall Study|End of Study|2
5678468|NCT00401843|19589273|P2|Overall Study|End of Study|1
5678469|NCT00401843|19589274|P1|Overall Study|End of Study|1
5678470|NCT00401843|19589272|P3|Overall Study|Disease progression|49
5678471|NCT00401843|19589273|P2|Overall Study|Disease progression|60
5678472|NCT00401843|19589274|P1|Overall Study|Disease progression|10
5678473|NCT00401843|19589272|P3|Overall Study|Death|10
5678474|NCT00401843|19589273|P2|Overall Study|Death|8
5678475|NCT00401843|19589274|P1|Overall Study|Death|0
5678476|NCT00401843|19589272|P3|Overall Study|Adverse Event|27
5678477|NCT00401843|19589273|P2|Overall Study|Adverse Event|26
5678478|NCT00401843|19589274|P1|Overall Study|Adverse Event|7
5678479|NCT00401843|19589272|P3|Overall Study|Achieved Complete Response|11
5678480|NCT00401843|19589273|P2|Overall Study|Achieved Complete Response|5
5678481|NCT00401843|19589274|P1|Overall Study|Achieved Complete Response|1
5678482|NCT00401830|19589292|P2|Overall Study|Other: Personal / Family problems|0
5678483|NCT00401830|19589293|P1|Overall Study|Other: Personal / Family problems|1
5678484|NCT00401830|19589292|P2|Overall Study|Lost to Follow-up|3
5678485|NCT00401830|19589293|P1|Overall Study|Lost to Follow-up|1
5678486|NCT00401830|19589292|P2|Overall Study|Non-compliance with drug study|0
5678487|NCT00401830|19589293|P1|Overall Study|Non-compliance with drug study|1
5678488|NCT00401830|19589292|P2|Overall Study|Protocol Violation|3
5678489|NCT00401830|19589293|P1|Overall Study|Protocol Violation|3
5678490|NCT00401830|19589292|P2|Overall Study|Withdrawal by Subject|3
5678491|NCT00401830|19589293|P1|Overall Study|Withdrawal by Subject|4
5678492|NCT00401830|19589292|P2|Overall Study|Lack of Efficacy|5
5678493|NCT00401830|19589293|P1|Overall Study|Lack of Efficacy|11
5678494|NCT00401830|19589292|P2|Overall Study|Adverse Event|18
5678495|NCT00401830|19589293|P1|Overall Study|Adverse Event|10
5678496|NCT00401752|19589351|P2|Overall Study|Physician Decision|1
5678497|NCT00401752|19589352|P1|Overall Study|Physician Decision|1
5678498|NCT00401752|19589351|P2|Overall Study|Development of any exclusion criteria|2
5678499|NCT00401752|19589352|P1|Overall Study|Development of any exclusion criteria|4
5678500|NCT00401752|19589351|P2|Overall Study|Lost to Follow-up|4
5678501|NCT00401752|19589352|P1|Overall Study|Lost to Follow-up|1
5678502|NCT00401752|19589351|P2|Overall Study|Withdrawal by Subject|6
5678503|NCT00401752|19589352|P1|Overall Study|Withdrawal by Subject|2
5678504|NCT00401752|19589351|P2|Overall Study|Adverse Event|5
5678505|NCT00401752|19589352|P1|Overall Study|Adverse Event|2
5678506|NCT00401726|19589370|P2|Overall Study|Protocol Deviation|4
5678507|NCT00401726|19589371|P1|Overall Study|Protocol Deviation|9
5678508|NCT00401726|19589370|P2|Overall Study|Lack of Efficacy|6
5678509|NCT00401726|19589371|P1|Overall Study|Lack of Efficacy|4
5678510|NCT00401726|19589370|P2|Overall Study|Withdrawal by Subject|24
5678511|NCT00401726|19589371|P1|Overall Study|Withdrawal by Subject|18
5678512|NCT00401726|19589370|P2|Overall Study|Protocol Violation|3
5678513|NCT00401726|19589371|P1|Overall Study|Protocol Violation|6
5678514|NCT00401726|19589370|P2|Overall Study|Lost to Follow-up|20
5678515|NCT00401726|19589371|P1|Overall Study|Lost to Follow-up|23
5678516|NCT00401726|19589370|P2|Overall Study|Physician Decision|6
5678517|NCT00401726|19589371|P1|Overall Study|Physician Decision|3
5678518|NCT00401726|19589370|P2|Overall Study|Sponsor Request|1
5678519|NCT00401726|19589371|P1|Overall Study|Sponsor Request|0
5678520|NCT00401726|19589370|P2|Overall Study|Death|3
5678521|NCT00401726|19589371|P1|Overall Study|Death|0
5678522|NCT00401726|19589370|P2|Overall Study|Adverse Event|45
5678523|NCT00401726|19589371|P1|Overall Study|Adverse Event|34
5678524|NCT00401544|19589406|P4|Overall Study|Other|2
5678525|NCT00401544|19589407|P3|Overall Study|Other|2
5678526|NCT00401544|19589408|P2|Overall Study|Other|0
5678527|NCT00401544|19589409|P1|Overall Study|Other|0
5678528|NCT00401544|19589406|P4|Overall Study|Disease progression|0
5678529|NCT00401544|19589407|P3|Overall Study|Disease progression|0
5678530|NCT00401544|19589408|P2|Overall Study|Disease progression|1
5678531|NCT00401544|19589409|P1|Overall Study|Disease progression|0
5678532|NCT00401544|19589406|P4|Overall Study|Ineligibility determined|2
5678533|NCT00401544|19589407|P3|Overall Study|Ineligibility determined|0
5678534|NCT00401544|19589408|P2|Overall Study|Ineligibility determined|1
5678535|NCT00401544|19589409|P1|Overall Study|Ineligibility determined|0
5678536|NCT00401544|19589406|P4|Overall Study|Physician Decision|0
5678537|NCT00401544|19589407|P3|Overall Study|Physician Decision|0
5678538|NCT00401544|19589408|P2|Overall Study|Physician Decision|3
5678539|NCT00401544|19589409|P1|Overall Study|Physician Decision|1
5678540|NCT00401544|19589406|P4|Overall Study|Withdrawal by Subject|5
5678541|NCT00401544|19589407|P3|Overall Study|Withdrawal by Subject|6
5678542|NCT00401544|19589408|P2|Overall Study|Withdrawal by Subject|6
5678543|NCT00401544|19589409|P1|Overall Study|Withdrawal by Subject|7
5678544|NCT00401544|19589406|P4|Overall Study|Lost to Follow-up|1
5678545|NCT00401544|19589407|P3|Overall Study|Lost to Follow-up|1
5678546|NCT00401544|19589408|P2|Overall Study|Lost to Follow-up|0
5678547|NCT00401544|19589409|P1|Overall Study|Lost to Follow-up|2
5678548|NCT00401544|19589406|P4|Overall Study|Death|5
5678549|NCT00401544|19589407|P3|Overall Study|Death|2
5678550|NCT00401544|19589408|P2|Overall Study|Death|6
5678551|NCT00401544|19589409|P1|Overall Study|Death|3
5678552|NCT00401544|19589406|P4|Overall Study|Adverse Event|1
5678553|NCT00401544|19589407|P3|Overall Study|Adverse Event|1
5678554|NCT00401544|19589408|P2|Overall Study|Adverse Event|1
5678555|NCT00401544|19589409|P1|Overall Study|Adverse Event|5
5678556|NCT00401531|19589449|P2|Overall Study|Withdrawal by Subject|2
5678557|NCT00401531|19589450|P1|Overall Study|Withdrawal by Subject|3
5678558|NCT00401531|19589449|P2|Overall Study|Lost to Follow-up|1
5678559|NCT00401531|19589450|P1|Overall Study|Lost to Follow-up|1
5678560|NCT00401531|19589449|P2|Overall Study|Protocol Violation|7
5678561|NCT00401531|19589450|P1|Overall Study|Protocol Violation|3
5678562|NCT00401531|19589449|P2|Overall Study|Adverse Event|0
5678563|NCT00401531|19589450|P1|Overall Study|Adverse Event|2
5678564|NCT00401375|19589554|P3|Overall Study|Randomized but not treated|3
5678565|NCT00401375|19589555|P2|Overall Study|Randomized but not treated|3
5678566|NCT00401375|19589556|P1|Overall Study|Randomized but not treated|3
5678567|NCT00401375|19589554|P3|Overall Study|Other than specified|3
5678568|NCT00401375|19589555|P2|Overall Study|Other than specified|1
5678569|NCT00401375|19589556|P1|Overall Study|Other than specified|2
5678570|NCT00401375|19589554|P3|Overall Study|Lost to Follow-up|1
5678571|NCT00401375|19589555|P2|Overall Study|Lost to Follow-up|1
5678572|NCT00401375|19589556|P1|Overall Study|Lost to Follow-up|0
5678573|NCT00401375|19589554|P3|Overall Study|Withdrawal by Subject|7
5678574|NCT00401375|19589555|P2|Overall Study|Withdrawal by Subject|7
5678575|NCT00401375|19589556|P1|Overall Study|Withdrawal by Subject|9
5678576|NCT00401375|19589554|P3|Overall Study|Adverse Event|10
5678577|NCT00401375|19589555|P2|Overall Study|Adverse Event|11
5678578|NCT00401375|19589556|P1|Overall Study|Adverse Event|6
5678579|NCT00401375|19589554|P3|Overall Study|Protocol Violation|1
5678580|NCT00401375|19589555|P2|Overall Study|Protocol Violation|2
5678581|NCT00401375|19589556|P1|Overall Study|Protocol Violation|2
5678582|NCT00401258|19589573|P1|Overall Study|Adverse Event|7
5678583|NCT00401245|19589588|P8|Double Blind Tapering Phase|Lack of Efficacy|0
5678584|NCT00401245|19589589|P7|Double Blind Tapering Phase|Lack of Efficacy|0
5678585|NCT00401245|19589590|P6|Double Blind Tapering Phase|Lack of Efficacy|1
5678586|NCT00401245|19589591|P5|Double Blind Tapering Phase|Lack of Efficacy|0
5678587|NCT00401245|19589592|P4|Double Blind Tapering Phase|Lack of Efficacy|0
5678588|NCT00401245|19589593|P3|Double Blind Tapering Phase|Lack of Efficacy|0
5678589|NCT00401245|19589594|P2|Double Blind Tapering Phase|Lack of Efficacy|0
5678590|NCT00401245|19589595|P1|Double Blind Tapering Phase|Lack of Efficacy|0
5678591|NCT00401245|19589588|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
5678592|NCT00401245|19589589|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
5678593|NCT00401245|19589590|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
5678594|NCT00401245|19589591|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
5678595|NCT00401245|19589592|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
5678596|NCT00401245|19589593|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
5678597|NCT00401245|19589594|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
5678598|NCT00401245|19589595|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
5678599|NCT00401245|19589588|P8|Double Blind Tapering Phase|Other|2
5678600|NCT00401245|19589589|P7|Double Blind Tapering Phase|Other|2
5678601|NCT00401245|19589590|P6|Double Blind Tapering Phase|Other|0
5678602|NCT00401245|19589591|P5|Double Blind Tapering Phase|Other|1
5678603|NCT00401245|19589592|P4|Double Blind Tapering Phase|Other|0
5678604|NCT00401245|19589593|P3|Double Blind Tapering Phase|Other|0
5678605|NCT00401245|19589594|P2|Double Blind Tapering Phase|Other|0
5678606|NCT00401245|19589595|P1|Double Blind Tapering Phase|Other|0
5678607|NCT00401245|19589588|P8|Double Blind Tapering Phase|Investigator request|1
5678608|NCT00401245|19589589|P7|Double Blind Tapering Phase|Investigator request|0
5678609|NCT00401245|19589590|P6|Double Blind Tapering Phase|Investigator request|0
5678610|NCT00401245|19589591|P5|Double Blind Tapering Phase|Investigator request|0
5678611|NCT00401245|19589592|P4|Double Blind Tapering Phase|Investigator request|0
5678612|NCT00401245|19589593|P3|Double Blind Tapering Phase|Investigator request|0
5678613|NCT00401245|19589594|P2|Double Blind Tapering Phase|Investigator request|0
5678614|NCT00401245|19589595|P1|Double Blind Tapering Phase|Investigator request|0
5678615|NCT00401245|19589588|P8|Double Blind Tapering Phase|Adverse Event|4
5678616|NCT00401245|19589589|P7|Double Blind Tapering Phase|Adverse Event|2
5678617|NCT00401245|19589590|P6|Double Blind Tapering Phase|Adverse Event|1
5678618|NCT00401245|19589591|P5|Double Blind Tapering Phase|Adverse Event|1
5678619|NCT00401245|19589592|P4|Double Blind Tapering Phase|Adverse Event|0
5678620|NCT00401245|19589593|P3|Double Blind Tapering Phase|Adverse Event|0
5678621|NCT00401245|19589594|P2|Double Blind Tapering Phase|Adverse Event|0
5678622|NCT00401245|19589595|P1|Double Blind Tapering Phase|Adverse Event|0
5678623|NCT00401245|19589588|P8|Open Label Phase|Lack of Efficacy|0
5678624|NCT00401245|19589589|P7|Open Label Phase|Lack of Efficacy|0
5678625|NCT00401245|19589590|P6|Open Label Phase|Lack of Efficacy|0
5678626|NCT00401245|19589591|P5|Open Label Phase|Lack of Efficacy|0
5678627|NCT00401245|19589592|P4|Open Label Phase|Lack of Efficacy|0
5678628|NCT00401245|19589593|P3|Open Label Phase|Lack of Efficacy|3
5678629|NCT00401245|19589594|P2|Open Label Phase|Lack of Efficacy|2
5678630|NCT00401245|19589595|P1|Open Label Phase|Lack of Efficacy|4
5678631|NCT00401245|19589588|P8|Open Label Phase|Withdrawal by Subject|0
5678632|NCT00401245|19589589|P7|Open Label Phase|Withdrawal by Subject|0
5678633|NCT00401245|19589590|P6|Open Label Phase|Withdrawal by Subject|0
5678634|NCT00401245|19589591|P5|Open Label Phase|Withdrawal by Subject|0
5678635|NCT00401245|19589592|P4|Open Label Phase|Withdrawal by Subject|1
5678636|NCT00401245|19589593|P3|Open Label Phase|Withdrawal by Subject|2
5678637|NCT00401245|19589594|P2|Open Label Phase|Withdrawal by Subject|3
5678638|NCT00401245|19589595|P1|Open Label Phase|Withdrawal by Subject|3
5678639|NCT00401245|19589588|P8|Open Label Phase|Protocol Violation|0
5678640|NCT00401245|19589589|P7|Open Label Phase|Protocol Violation|0
5678641|NCT00401245|19589590|P6|Open Label Phase|Protocol Violation|0
5678642|NCT00401245|19589591|P5|Open Label Phase|Protocol Violation|0
5678643|NCT00401245|19589592|P4|Open Label Phase|Protocol Violation|1
5678644|NCT00401245|19589593|P3|Open Label Phase|Protocol Violation|0
5678645|NCT00401245|19589594|P2|Open Label Phase|Protocol Violation|1
5678646|NCT00401245|19589595|P1|Open Label Phase|Protocol Violation|0
5678647|NCT00401245|19589588|P8|Open Label Phase|Other|0
5678648|NCT00401245|19589589|P7|Open Label Phase|Other|0
5678649|NCT00401245|19589590|P6|Open Label Phase|Other|0
5678650|NCT00401245|19589591|P5|Open Label Phase|Other|0
5678651|NCT00401245|19589592|P4|Open Label Phase|Other|8
5678652|NCT00401245|19589593|P3|Open Label Phase|Other|7
5678653|NCT00401245|19589594|P2|Open Label Phase|Other|8
5678654|NCT00401245|19589595|P1|Open Label Phase|Other|4
5678655|NCT00401245|19589588|P8|Open Label Phase|Lost to Follow-up|0
5678656|NCT00401245|19589589|P7|Open Label Phase|Lost to Follow-up|0
5678657|NCT00401245|19589590|P6|Open Label Phase|Lost to Follow-up|0
5678658|NCT00401245|19589591|P5|Open Label Phase|Lost to Follow-up|0
5678659|NCT00401245|19589592|P4|Open Label Phase|Lost to Follow-up|4
5678660|NCT00401245|19589593|P3|Open Label Phase|Lost to Follow-up|5
5678661|NCT00401245|19589594|P2|Open Label Phase|Lost to Follow-up|7
5678662|NCT00401245|19589595|P1|Open Label Phase|Lost to Follow-up|5
5678663|NCT00401245|19589588|P8|Open Label Phase|Adverse Event|0
5678664|NCT00401245|19589589|P7|Open Label Phase|Adverse Event|0
5678665|NCT00401245|19589590|P6|Open Label Phase|Adverse Event|0
5678666|NCT00401245|19589591|P5|Open Label Phase|Adverse Event|0
5678667|NCT00401245|19589592|P4|Open Label Phase|Adverse Event|7
5678668|NCT00401245|19589593|P3|Open Label Phase|Adverse Event|6
5678669|NCT00401245|19589594|P2|Open Label Phase|Adverse Event|14
5678670|NCT00401245|19589595|P1|Open Label Phase|Adverse Event|5
5678671|NCT00401245|19589588|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
5678672|NCT00401245|19589589|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
5678673|NCT00401245|19589590|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
5678674|NCT00401245|19589591|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
5678675|NCT00401245|19589592|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
5678676|NCT00401245|19589593|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
5678677|NCT00401245|19589594|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
5678678|NCT00401245|19589595|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
5678679|NCT00401245|19589588|P8|Double Blind Titration Phase|Withdrawal by Subject|0
5678680|NCT00401245|19589589|P7|Double Blind Titration Phase|Withdrawal by Subject|0
5678681|NCT00401245|19589590|P6|Double Blind Titration Phase|Withdrawal by Subject|0
5678682|NCT00401245|19589591|P5|Double Blind Titration Phase|Withdrawal by Subject|0
5678683|NCT00401245|19589592|P4|Double Blind Titration Phase|Withdrawal by Subject|2
5678684|NCT00401245|19589593|P3|Double Blind Titration Phase|Withdrawal by Subject|0
5678685|NCT00401245|19589594|P2|Double Blind Titration Phase|Withdrawal by Subject|1
5678686|NCT00401245|19589595|P1|Double Blind Titration Phase|Withdrawal by Subject|1
5678687|NCT00401245|19589588|P8|Double Blind Titration Phase|Protocol Violation|0
5678688|NCT00401245|19589589|P7|Double Blind Titration Phase|Protocol Violation|0
5678689|NCT00401245|19589590|P6|Double Blind Titration Phase|Protocol Violation|0
5678690|NCT00401245|19589591|P5|Double Blind Titration Phase|Protocol Violation|0
5678691|NCT00401245|19589592|P4|Double Blind Titration Phase|Protocol Violation|1
5678692|NCT00401245|19589593|P3|Double Blind Titration Phase|Protocol Violation|0
5678693|NCT00401245|19589594|P2|Double Blind Titration Phase|Protocol Violation|0
5678694|NCT00401245|19589595|P1|Double Blind Titration Phase|Protocol Violation|0
5678695|NCT00401245|19589588|P8|Double Blind Titration Phase|Other|0
5678696|NCT00401245|19589589|P7|Double Blind Titration Phase|Other|0
5678697|NCT00401245|19589590|P6|Double Blind Titration Phase|Other|0
5678698|NCT00401245|19589591|P5|Double Blind Titration Phase|Other|0
5678699|NCT00401245|19589592|P4|Double Blind Titration Phase|Other|0
5678700|NCT00401245|19589593|P3|Double Blind Titration Phase|Other|1
5678701|NCT00401245|19589594|P2|Double Blind Titration Phase|Other|0
5678702|NCT00401245|19589595|P1|Double Blind Titration Phase|Other|0
5678703|NCT00401245|19589588|P8|Double Blind Titration Phase|Adverse Event|0
5678704|NCT00401245|19589589|P7|Double Blind Titration Phase|Adverse Event|0
5678705|NCT00401245|19589590|P6|Double Blind Titration Phase|Adverse Event|0
5678706|NCT00401245|19589591|P5|Double Blind Titration Phase|Adverse Event|0
5678707|NCT00401245|19589592|P4|Double Blind Titration Phase|Adverse Event|12
5678708|NCT00401245|19589593|P3|Double Blind Titration Phase|Adverse Event|5
5678709|NCT00401245|19589594|P2|Double Blind Titration Phase|Adverse Event|2
5678710|NCT00401245|19589595|P1|Double Blind Titration Phase|Adverse Event|3
5678711|NCT00401193|19589663|P3|Overall Study|Other Event|2
5678712|NCT00401193|19589664|P2|Overall Study|Other Event|2
5678713|NCT00401193|19589665|P1|Overall Study|Other Event|3
5678714|NCT00401193|19589663|P3|Overall Study|Withdrawal by Subject|1
5678715|NCT00401193|19589664|P2|Overall Study|Withdrawal by Subject|0
5678716|NCT00401193|19589665|P1|Overall Study|Withdrawal by Subject|2
5678717|NCT00401193|19589663|P3|Overall Study|Lost to Follow-up|1
5678718|NCT00401193|19589664|P2|Overall Study|Lost to Follow-up|5
5678719|NCT00401193|19589665|P1|Overall Study|Lost to Follow-up|6
5678720|NCT00401193|19589663|P3|Overall Study|Protocol Violation|1
5678721|NCT00401193|19589664|P2|Overall Study|Protocol Violation|1
5678722|NCT00401193|19589665|P1|Overall Study|Protocol Violation|3
5678723|NCT00401193|19589663|P3|Overall Study|Adverse Event|1
5678724|NCT00401193|19589664|P2|Overall Study|Adverse Event|3
5678725|NCT00401193|19589665|P1|Overall Study|Adverse Event|1
5678726|NCT00400985|19589683|P1|Overall Study|Lost to Follow-up|9
5678727|NCT00400985|19589683|P1|Overall Study|Death|30
5678728|NCT00400985|19589683|P1|Overall Study|system modification|8
5678729|NCT00400985|19589683|P1|Overall Study|Withdrawal by Subject|5
5678730|NCT00400946|19589692|P5|Overall Study|Other|1
5678731|NCT00400946|19589693|P4|Overall Study|Other|0
5678732|NCT00400946|19589694|P3|Overall Study|Other|0
5678733|NCT00400946|19589695|P2|Overall Study|Other|0
5678734|NCT00400946|19589696|P1|Overall Study|Other|0
5678735|NCT00400946|19589692|P5|Overall Study|Clinical|9
5678736|NCT00400946|19589693|P4|Overall Study|Clinical|2
5678737|NCT00400946|19589694|P3|Overall Study|Clinical|0
5678738|NCT00400946|19589695|P2|Overall Study|Clinical|2
5678739|NCT00400946|19589696|P1|Overall Study|Clinical|1
5678740|NCT00400946|19589692|P5|Overall Study|Withdrawal by Subject|8
5678741|NCT00400946|19589693|P4|Overall Study|Withdrawal by Subject|5
5678742|NCT00400946|19589694|P3|Overall Study|Withdrawal by Subject|1
5678743|NCT00400946|19589695|P2|Overall Study|Withdrawal by Subject|5
5678744|NCT00400946|19589696|P1|Overall Study|Withdrawal by Subject|2
5678745|NCT00400946|19589692|P5|Overall Study|Transplant in CR1|1
5678746|NCT00400946|19589693|P4|Overall Study|Transplant in CR1|10
5678747|NCT00400946|19589694|P3|Overall Study|Transplant in CR1|0
5678748|NCT00400946|19589695|P2|Overall Study|Transplant in CR1|0
5678749|NCT00400946|19589696|P1|Overall Study|Transplant in CR1|0
5678750|NCT00400946|19589692|P5|Overall Study|Relapse|5
5678751|NCT00400946|19589693|P4|Overall Study|Relapse|1
5678752|NCT00400946|19589694|P3|Overall Study|Relapse|1
5678753|NCT00400946|19589695|P2|Overall Study|Relapse|2
5678754|NCT00400946|19589696|P1|Overall Study|Relapse|9
5678755|NCT00400946|19589692|P5|Overall Study|Remission Death|1
5678756|NCT00400946|19589693|P4|Overall Study|Remission Death|0
5678757|NCT00400946|19589694|P3|Overall Study|Remission Death|0
5678758|NCT00400946|19589695|P2|Overall Study|Remission Death|1
5678759|NCT00400946|19589696|P1|Overall Study|Remission Death|1
5678760|NCT00400946|19589692|P5|Overall Study|Lost to Follow-up|1
5678761|NCT00400946|19589693|P4|Overall Study|Lost to Follow-up|0
5678762|NCT00400946|19589694|P3|Overall Study|Lost to Follow-up|0
5678763|NCT00400946|19589695|P2|Overall Study|Lost to Follow-up|1
5678764|NCT00400946|19589696|P1|Overall Study|Lost to Follow-up|1
5678765|NCT00400946|19589692|P5|Overall Study|Induction Death|3
5678766|NCT00400946|19589693|P4|Overall Study|Induction Death|13
5678767|NCT00400946|19589694|P3|Overall Study|Induction Death|0
5678768|NCT00400946|19589695|P2|Overall Study|Induction Death|0
5678769|NCT00400946|19589696|P1|Overall Study|Induction Death|0
5678770|NCT00400946|19589692|P5|Overall Study|Induction Failure|8
5678771|NCT00400946|19589693|P4|Overall Study|Induction Failure|11
5678772|NCT00400946|19589694|P3|Overall Study|Induction Failure|0
5678773|NCT00400946|19589695|P2|Overall Study|Induction Failure|0
5678774|NCT00400946|19589696|P1|Overall Study|Induction Failure|0
5678775|NCT00400946|19589692|P5|Overall Study|Ineligible|1
5678776|NCT00400946|19589693|P4|Overall Study|Ineligible|5
5678777|NCT00400946|19589694|P3|Overall Study|Ineligible|0
5678778|NCT00400946|19589695|P2|Overall Study|Ineligible|0
5678779|NCT00400946|19589696|P1|Overall Study|Ineligible|0
5678780|NCT00400764|19589755|P5|Phase II|Withdrawal by Subject|0
5678781|NCT00400764|19589756|P4|Phase II|Withdrawal by Subject|1
5678782|NCT00400764|19589757|P3|Phase II|Withdrawal by Subject|1
5678783|NCT00400764|19589758|P2|Phase II|Withdrawal by Subject|0
5678784|NCT00400764|19589759|P1|Phase II|Withdrawal by Subject|0
5678785|NCT00400764|19589755|P5|Phase II|Patient began new, non-protocol, therapy|0
5678786|NCT00400764|19589756|P4|Phase II|Patient began new, non-protocol, therapy|0
5678787|NCT00400764|19589757|P3|Phase II|Patient began new, non-protocol, therapy|1
5678788|NCT00400764|19589758|P2|Phase II|Patient began new, non-protocol, therapy|0
5678789|NCT00400764|19589759|P1|Phase II|Patient began new, non-protocol, therapy|0
5678790|NCT00400764|19589755|P5|Phase II|Sponsor's decision to terminate|11
5678791|NCT00400764|19589756|P4|Phase II|Sponsor's decision to terminate|22
5678792|NCT00400764|19589757|P3|Phase II|Sponsor's decision to terminate|18
5678793|NCT00400764|19589758|P2|Phase II|Sponsor's decision to terminate|0
5678794|NCT00400764|19589759|P1|Phase II|Sponsor's decision to terminate|0
5678795|NCT00400764|19589755|P5|Phase II|Physician Decision|0
5678796|NCT00400764|19589756|P4|Phase II|Physician Decision|1
5678797|NCT00400764|19589757|P3|Phase II|Physician Decision|1
5678798|NCT00400764|19589758|P2|Phase II|Physician Decision|0
5678799|NCT00400764|19589759|P1|Phase II|Physician Decision|0
5678800|NCT00400764|19589755|P5|Phase II|Lost to Follow-up|0
5678801|NCT00400764|19589756|P4|Phase II|Lost to Follow-up|0
5678802|NCT00400764|19589757|P3|Phase II|Lost to Follow-up|1
5678803|NCT00400764|19589758|P2|Phase II|Lost to Follow-up|0
5678804|NCT00400764|19589759|P1|Phase II|Lost to Follow-up|0
5678805|NCT00400764|19589755|P5|Phase II|Death|0
5678806|NCT00400764|19589756|P4|Phase II|Death|2
5678807|NCT00400764|19589757|P3|Phase II|Death|1
5678808|NCT00400764|19589758|P2|Phase II|Death|0
5678809|NCT00400764|19589759|P1|Phase II|Death|0
5678810|NCT00400764|19589755|P5|Phase Ib|Disease Progression|0
5678811|NCT00400764|19589756|P4|Phase Ib|Disease Progression|0
5678812|NCT00400764|19589757|P3|Phase Ib|Disease Progression|0
5678813|NCT00400764|19589758|P2|Phase Ib|Disease Progression|4
5678814|NCT00400764|19589759|P1|Phase Ib|Disease Progression|4
5678815|NCT00400764|19589755|P5|Phase Ib|Death|0
5678816|NCT00400764|19589756|P4|Phase Ib|Death|0
5678817|NCT00400764|19589757|P3|Phase Ib|Death|0
5678818|NCT00400764|19589758|P2|Phase Ib|Death|0
5678819|NCT00400764|19589759|P1|Phase Ib|Death|1
5678820|NCT00400764|19589755|P5|Phase Ib|Adverse Event|0
5678821|NCT00400764|19589756|P4|Phase Ib|Adverse Event|0
5678822|NCT00400764|19589757|P3|Phase Ib|Adverse Event|0
5678823|NCT00400764|19589758|P2|Phase Ib|Adverse Event|0
5678824|NCT00400764|19589759|P1|Phase Ib|Adverse Event|1
5678825|NCT00400712|19589812|P2|Overall Study|Physician Decision|4
5678826|NCT00400712|19589813|P1|Overall Study|Physician Decision|5
5678827|NCT00400712|19589812|P2|Overall Study|Withdrawal by Subject|12
5678828|NCT00400712|19589813|P1|Overall Study|Withdrawal by Subject|11
5678829|NCT00400712|19589812|P2|Overall Study|Death|0
5678830|NCT00400712|19589813|P1|Overall Study|Death|1
5678831|NCT00400569|19589848|P1|Overall Study|Death|1
5678832|NCT00400517|19589859|P1|Overall Study|Physician Decision|1
5678833|NCT00400517|19589859|P1|Overall Study|Withdrawal by Subject|1
5678834|NCT00400400|19589879|P2|Overall Study|Did not receive study drug|3
5678835|NCT00400400|19589880|P1|Overall Study|Did not receive study drug|1
5678836|NCT00400400|19589879|P2|Overall Study|Lost to Follow-up|1
5678837|NCT00400400|19589880|P1|Overall Study|Lost to Follow-up|0
5678838|NCT00400400|19589879|P2|Overall Study|Administrative Problem|0
5678839|NCT00400400|19589880|P1|Overall Study|Administrative Problem|1
5678840|NCT00400400|19589879|P2|Overall Study|Withdrawal by Subject|3
5678841|NCT00400400|19589880|P1|Overall Study|Withdrawal by Subject|1
5678842|NCT00400400|19589879|P2|Overall Study|Protocol Violation|0
5678843|NCT00400400|19589880|P1|Overall Study|Protocol Violation|2
5678844|NCT00400400|19589879|P2|Overall Study|Adverse Event|8
5678845|NCT00400400|19589880|P1|Overall Study|Adverse Event|9
5678846|NCT00400179|19589905|P2|Overall Study|Randomization error/patient ineligible|6
5678847|NCT00400179|19589906|P1|Overall Study|Randomization error/patient ineligible|1
5678848|NCT00400179|19589905|P2|Overall Study|Investigator judgment|1
5678849|NCT00400179|19589906|P1|Overall Study|Investigator judgment|0
5678850|NCT00400179|19589905|P2|Overall Study|Intercurrent illness|1
5678851|NCT00400179|19589906|P1|Overall Study|Intercurrent illness|0
5678852|NCT00400179|19589905|P2|Overall Study|Disease progression|1
5678853|NCT00400179|19589906|P1|Overall Study|Disease progression|1
5678854|NCT00400179|19589905|P2|Overall Study|Withdrew Consent|5
5678855|NCT00400179|19589906|P1|Overall Study|Withdrew Consent|1
5678856|NCT00400179|19589905|P2|Overall Study|Death|2
5678857|NCT00400179|19589906|P1|Overall Study|Death|1
5678858|NCT00400179|19589905|P2|Overall Study|Adverse Event|2
5678859|NCT00400179|19589906|P1|Overall Study|Adverse Event|2
5678860|NCT00400153|19589923|P3|Overall Study|Other reasons - not mentioned above|3
5678861|NCT00400153|19589924|P2|Overall Study|Other reasons - not mentioned above|5
5678862|NCT00400153|19589925|P1|Overall Study|Other reasons - not mentioned above|8
5678863|NCT00400153|19589923|P3|Overall Study|Withdrawal by Subject|10
5678864|NCT00400153|19589924|P2|Overall Study|Withdrawal by Subject|11
5678865|NCT00400153|19589925|P1|Overall Study|Withdrawal by Subject|12
5678866|NCT00400153|19589923|P3|Overall Study|Lost to Follow-up|4
5678867|NCT00400153|19589924|P2|Overall Study|Lost to Follow-up|1
5678868|NCT00400153|19589925|P1|Overall Study|Lost to Follow-up|2
5678869|NCT00400153|19589923|P3|Overall Study|Protocol Violation|9
5678870|NCT00400153|19589924|P2|Overall Study|Protocol Violation|4
5678871|NCT00400153|19589925|P1|Overall Study|Protocol Violation|7
5678872|NCT00400153|19589923|P3|Overall Study|AE due to other condition|15
5678873|NCT00400153|19589924|P2|Overall Study|AE due to other condition|14
5678874|NCT00400153|19589925|P1|Overall Study|AE due to other condition|3
5678875|NCT00400153|19589923|P3|Overall Study|AE due to other disease worsening|0
5678876|NCT00400153|19589924|P2|Overall Study|AE due to other disease worsening|1
5678877|NCT00400153|19589925|P1|Overall Study|AE due to other disease worsening|2
5678878|NCT00400153|19589923|P3|Overall Study|AE due to study disease worsening|20
5678879|NCT00400153|19589924|P2|Overall Study|AE due to study disease worsening|19
5678880|NCT00400153|19589925|P1|Overall Study|AE due to study disease worsening|14
5678881|NCT00399893|19590172|P2|Overall Study|Withdrawal by Subject|0
5678882|NCT00399893|19590173|P1|Overall Study|Withdrawal by Subject|1
5678883|NCT00399802|19590219|P2|Overall Study|Participant discontinued by mistake|1
5678884|NCT00399802|19590220|P1|Overall Study|Participant discontinued by mistake|0
5678885|NCT00399802|19590219|P2|Overall Study|Adverse Event|2
5678886|NCT00399802|19590220|P1|Overall Study|Adverse Event|0
5678887|NCT00399763|19590234|P2|Overall Study|Lost to Follow-up|3
5678888|NCT00399763|19590235|P1|Overall Study|Lost to Follow-up|2
5678889|NCT00399568|19590247|P2|Overall Study|Lost to Follow-up|2
5678890|NCT00399568|19590248|P1|Overall Study|Lost to Follow-up|2
5678891|NCT00399568|19590247|P2|Overall Study|Protocol non-compliance|2
5678892|NCT00399568|19590248|P1|Overall Study|Protocol non-compliance|2
5678893|NCT00399568|19590247|P2|Overall Study|Withdrawal by Subject|3
5678894|NCT00399568|19590248|P1|Overall Study|Withdrawal by Subject|7
5678895|NCT00399568|19590247|P2|Overall Study|Adverse Event|2
5678896|NCT00399568|19590248|P1|Overall Study|Adverse Event|1
5678897|NCT00399542|19590262|P2|Overall Study|Physician Decision|1
5678898|NCT00399542|19590263|P1|Overall Study|Physician Decision|0
5678899|NCT00399542|19590262|P2|Overall Study|Other|0
5678900|NCT00399542|19590263|P1|Overall Study|Other|1
5678901|NCT00399542|19590262|P2|Overall Study|Lost to Follow-up|6
5678902|NCT00399542|19590263|P1|Overall Study|Lost to Follow-up|6
5678903|NCT00399542|19590262|P2|Overall Study|Lack of Efficacy|8
5678904|NCT00399542|19590263|P1|Overall Study|Lack of Efficacy|18
5678905|NCT00399542|19590262|P2|Overall Study|Withdrawal by Subject|10
5678906|NCT00399542|19590263|P1|Overall Study|Withdrawal by Subject|28
5678907|NCT00399542|19590262|P2|Overall Study|Protocol Violation|3
5678908|NCT00399542|19590263|P1|Overall Study|Protocol Violation|13
5678909|NCT00399542|19590262|P2|Overall Study|Adverse Event|15
5678910|NCT00399542|19590263|P1|Overall Study|Adverse Event|18
5678911|NCT00399529|19590325|P1|Overall Study|Off Study Prior to Treatment|2
5678912|NCT00399516|19590331|P1|Overall Study|Lost to Follow-up|2
5678913|NCT00399360|19590339|P4|Overall Study|Withdrawal by Subject|2
5678914|NCT00399360|19590340|P3|Overall Study|Withdrawal by Subject|0
5678915|NCT00399360|19590341|P2|Overall Study|Withdrawal by Subject|2
5678916|NCT00399360|19590342|P1|Overall Study|Withdrawal by Subject|0
5678917|NCT00399360|19590339|P4|Overall Study|Adverse Event|0
5678918|NCT00399360|19590340|P3|Overall Study|Adverse Event|1
5678919|NCT00399360|19590341|P2|Overall Study|Adverse Event|0
5678920|NCT00399360|19590342|P1|Overall Study|Adverse Event|0
5678921|NCT00399360|19590339|P4|Overall Study|Lost to Follow-up|4
5678922|NCT00399360|19590340|P3|Overall Study|Lost to Follow-up|2
5678923|NCT00399360|19590341|P2|Overall Study|Lost to Follow-up|1
5678924|NCT00399360|19590342|P1|Overall Study|Lost to Follow-up|2
5678925|NCT00399035|19590413|P3|Overall Study|Severe non-compliance with protocol|0
5678926|NCT00399035|19590414|P2|Overall Study|Severe non-compliance with protocol|1
5678927|NCT00399035|19590415|P1|Overall Study|Severe non-compliance with protocol|2
5678928|NCT00399035|19590413|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
5678929|NCT00399035|19590414|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
5678930|NCT00399035|19590415|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
5678931|NCT00399035|19590413|P3|Overall Study|Withdrawal by Subject|12
5678932|NCT00399035|19590414|P2|Overall Study|Withdrawal by Subject|15
5678933|NCT00399035|19590415|P1|Overall Study|Withdrawal by Subject|19
5678934|NCT00399035|19590413|P3|Overall Study|Lost to Follow-up|5
5678935|NCT00399035|19590414|P2|Overall Study|Lost to Follow-up|1
5678936|NCT00399035|19590415|P1|Overall Study|Lost to Follow-up|2
5678937|NCT00399035|19590413|P3|Overall Study|Death|234
5678938|NCT00399035|19590414|P2|Overall Study|Death|141
5678939|NCT00399035|19590415|P1|Overall Study|Death|289
5678940|NCT00398866|19590451|P3|Overall Study|Unable to complete requirements of study|1
5678941|NCT00398866|19590452|P2|Overall Study|Unable to complete requirements of study|1
5678942|NCT00398866|19590453|P1|Overall Study|Unable to complete requirements of study|1
5678943|NCT00398866|19590451|P3|Overall Study|Withdrawal by Subject|2
5678944|NCT00398866|19590452|P2|Overall Study|Withdrawal by Subject|1
5678945|NCT00398866|19590453|P1|Overall Study|Withdrawal by Subject|5
5678946|NCT00398866|19590451|P3|Overall Study|Lost to Follow-up|4
5678947|NCT00398866|19590452|P2|Overall Study|Lost to Follow-up|6
5678948|NCT00398866|19590453|P1|Overall Study|Lost to Follow-up|7
5678949|NCT00398866|19590451|P3|Overall Study|Lack of Efficacy|1
5678950|NCT00398866|19590452|P2|Overall Study|Lack of Efficacy|0
5678951|NCT00398866|19590453|P1|Overall Study|Lack of Efficacy|0
5678952|NCT00398866|19590451|P3|Overall Study|Adverse Event|0
5678953|NCT00398866|19590452|P2|Overall Study|Adverse Event|0
5678954|NCT00398866|19590453|P1|Overall Study|Adverse Event|1
5678955|NCT00398632|19590464|P1|Overall Study|Lack of Efficacy|1
5678956|NCT00398632|19590464|P1|Overall Study|Withdrawal by Subject|1
5678957|NCT00398567|19590472|P3|Overall Study|Protocol Violation|1
5678958|NCT00398567|19590473|P2|Overall Study|Protocol Violation|0
5678959|NCT00398567|19590474|P1|Overall Study|Protocol Violation|0
5678960|NCT00398567|19590472|P3|Overall Study|Adverse Event|2
5678961|NCT00398567|19590473|P2|Overall Study|Adverse Event|0
5678962|NCT00398567|19590474|P1|Overall Study|Adverse Event|0
5678963|NCT00398567|19590472|P3|Overall Study|Withdrawal by Subject|4
5678964|NCT00398567|19590473|P2|Overall Study|Withdrawal by Subject|0
5678965|NCT00398567|19590474|P1|Overall Study|Withdrawal by Subject|1
5678966|NCT00398567|19590472|P3|Overall Study|Disease Progression|27
5678967|NCT00398567|19590473|P2|Overall Study|Disease Progression|4
5678968|NCT00398567|19590474|P1|Overall Study|Disease Progression|3
5678969|NCT00398411|19590528|P2|Overall Study|Death|1
5678970|NCT00398411|19590529|P1|Overall Study|Death|0
5678971|NCT00398320|19590552|P1|Overall Study|Physician Decision|1
5678972|NCT00398320|19590552|P1|Overall Study|Adverse Event|4
5678973|NCT00398320|19590552|P1|Overall Study|Death|1
5678974|NCT00398216|19590565|P5|Overall Study|entrance criteria|2
5678975|NCT00398216|19590566|P4|Overall Study|entrance criteria|0
5678976|NCT00398216|19590567|P3|Overall Study|entrance criteria|0
5678977|NCT00398216|19590568|P2|Overall Study|entrance criteria|0
5678978|NCT00398216|19590569|P1|Overall Study|entrance criteria|0
5678979|NCT00398216|19590565|P5|Overall Study|administrative reasons|3
5678980|NCT00398216|19590566|P4|Overall Study|administrative reasons|3
5678981|NCT00398216|19590567|P3|Overall Study|administrative reasons|4
5678982|NCT00398216|19590568|P2|Overall Study|administrative reasons|4
5678983|NCT00398216|19590569|P1|Overall Study|administrative reasons|3
5678984|NCT00398216|19590565|P5|Overall Study|Withdrawal by Subject|2
5678985|NCT00398216|19590566|P4|Overall Study|Withdrawal by Subject|1
5678986|NCT00398216|19590567|P3|Overall Study|Withdrawal by Subject|3
5678987|NCT00398216|19590568|P2|Overall Study|Withdrawal by Subject|0
5678988|NCT00398216|19590569|P1|Overall Study|Withdrawal by Subject|1
5678989|NCT00398216|19590565|P5|Overall Study|Death|0
5678990|NCT00398216|19590566|P4|Overall Study|Death|0
5678991|NCT00398216|19590567|P3|Overall Study|Death|0
5678992|NCT00398216|19590568|P2|Overall Study|Death|3
5678993|NCT00398216|19590569|P1|Overall Study|Death|0
5678994|NCT00398216|19590565|P5|Overall Study|Lost to Follow-up|1
5678995|NCT00398216|19590566|P4|Overall Study|Lost to Follow-up|4
5678996|NCT00398216|19590567|P3|Overall Study|Lost to Follow-up|4
5678997|NCT00398216|19590568|P2|Overall Study|Lost to Follow-up|6
5678998|NCT00398216|19590569|P1|Overall Study|Lost to Follow-up|1
5678999|NCT00398216|19590565|P5|Overall Study|Protocol Violation|5
5679000|NCT00398216|19590566|P4|Overall Study|Protocol Violation|7
5679001|NCT00398216|19590567|P3|Overall Study|Protocol Violation|5
5679002|NCT00398216|19590568|P2|Overall Study|Protocol Violation|4
5679003|NCT00398216|19590569|P1|Overall Study|Protocol Violation|2
5679004|NCT00398216|19590565|P5|Overall Study|Adverse Event|2
5679005|NCT00398216|19590566|P4|Overall Study|Adverse Event|7
5679006|NCT00398216|19590567|P3|Overall Study|Adverse Event|5
5679007|NCT00398216|19590568|P2|Overall Study|Adverse Event|2
5679008|NCT00398216|19590569|P1|Overall Study|Adverse Event|4
5679009|NCT00398138|19590596|P1|Overall Study|Adverse Event|2
5679010|NCT00398112|19590601|P1|Overall Study|Death|1
5679011|NCT00398112|19590601|P1|Overall Study|Withdrawal by Subject|3
5679012|NCT00398112|19590601|P1|Overall Study|Alternative treatment|1
5679013|NCT00398112|19590601|P1|Overall Study|Disease progression|9
5679014|NCT00398112|19590601|P1|Overall Study|Adverse Event|4
5679015|NCT00398086|19590612|P3|Overall Study|Withdrawal by Subject|0
5679016|NCT00398086|19590613|P2|Overall Study|Withdrawal by Subject|7
5679017|NCT00398086|19590614|P1|Overall Study|Withdrawal by Subject|5
5679018|NCT00398086|19590612|P3|Overall Study|Physician Decision|0
5679019|NCT00398086|19590613|P2|Overall Study|Physician Decision|4
5679020|NCT00398086|19590614|P1|Overall Study|Physician Decision|1
5679021|NCT00398086|19590612|P3|Overall Study|Adverse Event|0
5679022|NCT00398086|19590613|P2|Overall Study|Adverse Event|4
5679023|NCT00398086|19590614|P1|Overall Study|Adverse Event|1
5679024|NCT00398086|19590612|P3|Overall Study|Unacceptable Toxicity|2
5679025|NCT00398086|19590613|P2|Overall Study|Unacceptable Toxicity|8
5679026|NCT00398086|19590614|P1|Overall Study|Unacceptable Toxicity|2
5679027|NCT00398073|19590648|P2|Overall Study|Withdrawal by Subject|0
5679028|NCT00398073|19590649|P1|Overall Study|Withdrawal by Subject|1
5679029|NCT00398047|19590659|P1|Overall Study|all patient progressed before completion|3
5679030|NCT00397982|19590669|P1|Overall Study|Unrelated health issues|1
5679031|NCT00397982|19590669|P1|Overall Study|noncompliance|1
5679032|NCT00397982|19590669|P1|Overall Study|Adverse Event|1
5679033|NCT00397982|19590669|P1|Overall Study|Withdrawal by Subject|1
5679034|NCT00397943|19590683|P5|Overall Study|Unspecified reasons|0
5679035|NCT00397943|19590684|P4|Overall Study|Unspecified reasons|0
5679036|NCT00397943|19590685|P3|Overall Study|Unspecified reasons|0
5679037|NCT00397943|19590686|P2|Overall Study|Unspecified reasons|9
5679038|NCT00397943|19590687|P1|Overall Study|Unspecified reasons|12
5679039|NCT00397930|19590843|P2|Overall Study|Missing data|4
5679040|NCT00397930|19590844|P1|Overall Study|Missing data|0
5679041|NCT00397930|19590843|P2|Overall Study|Withdrawal by Subject|8
5679042|NCT00397930|19590844|P1|Overall Study|Withdrawal by Subject|0
5679043|NCT00397930|19590843|P2|Overall Study|Did not want to be in control group|1
5679044|NCT00397930|19590844|P1|Overall Study|Did not want to be in control group|0
5679045|NCT00397930|19590843|P2|Overall Study|Started own yoga program|1
5679046|NCT00397930|19590844|P1|Overall Study|Started own yoga program|1
5679047|NCT00397930|19590843|P2|Overall Study|Too time-consuming|9
5679048|NCT00397930|19590844|P1|Overall Study|Too time-consuming|2
5679049|NCT00397930|19590843|P2|Overall Study|Noncompliant|2
5679050|NCT00397930|19590844|P1|Overall Study|Noncompliant|3
5679051|NCT00397930|19590843|P2|Overall Study|Unknown reasons|14
5679052|NCT00397930|19590844|P1|Overall Study|Unknown reasons|9
5679053|NCT00397930|19590843|P2|Overall Study|Other medical|4
5679054|NCT00397930|19590844|P1|Overall Study|Other medical|9
5679055|NCT00397930|19590843|P2|Overall Study|Personal reasons|8
5679056|NCT00397930|19590844|P1|Overall Study|Personal reasons|14
5679057|NCT00397891|19590859|P5|Overall Study|Withdrawal by Subject|1
5679058|NCT00397891|19590860|P4|Overall Study|Withdrawal by Subject|0
5679059|NCT00397891|19590861|P3|Overall Study|Withdrawal by Subject|0
5679060|NCT00397891|19590862|P2|Overall Study|Withdrawal by Subject|0
5679061|NCT00397891|19590863|P1|Overall Study|Withdrawal by Subject|1
5679062|NCT00397631|19591036|P2|Overall Study|protocol discontinuation criteria|4
5679063|NCT00397631|19591037|P1|Overall Study|protocol discontinuation criteria|1
5679064|NCT00397631|19591036|P2|Overall Study|Withdrawal by Subject|14
5679065|NCT00397631|19591037|P1|Overall Study|Withdrawal by Subject|7
5679066|NCT00397631|19591036|P2|Overall Study|Protocol Violation|1
5679067|NCT00397631|19591037|P1|Overall Study|Protocol Violation|0
5679068|NCT00397631|19591036|P2|Overall Study|Physician Decision|0
5679069|NCT00397631|19591037|P1|Overall Study|Physician Decision|2
5679070|NCT00397631|19591036|P2|Overall Study|Lost to Follow-up|9
5679071|NCT00397631|19591037|P1|Overall Study|Lost to Follow-up|8
5679072|NCT00397631|19591036|P2|Overall Study|Lack of Efficacy|10
5679073|NCT00397631|19591037|P1|Overall Study|Lack of Efficacy|7
5679074|NCT00397631|19591036|P2|Overall Study|Adverse Event|6
5679075|NCT00397631|19591037|P1|Overall Study|Adverse Event|5
5679076|NCT00397540|19591053|P2|Overall Study|short follow-up duration < 12 months|0
5679077|NCT00397540|19591054|P1|Overall Study|short follow-up duration < 12 months|1
5679078|NCT00397514|19591062|P1|Overall Study|poor echocardiographic windows|1
5679079|NCT00397514|19591062|P1|Overall Study|early extubation|2
5679080|NCT00397514|19591062|P1|Overall Study|Not able to capture & pace LV intraoper.|4
5679081|NCT00397514|19591062|P1|Overall Study|Pacing wire malfunction|1
5679082|NCT00397514|19591062|P1|Overall Study|Withdrawal by Subject|1
5679083|NCT00397488|19591072|P1|Overall Study|Death|1
5679084|NCT00397488|19591072|P1|Overall Study|Adverse Event|3
5679085|NCT00397488|19591072|P1|Overall Study|Withdrawal by Subject|3
5679086|NCT00397254|19591092|P2|Overall Study|Lost to Follow-up|2
5679087|NCT00397254|19591093|P1|Overall Study|Lost to Follow-up|2
5679088|NCT00397215|19591115|P4|Month 6 (Day 180)|Other|0
5679089|NCT00397215|19591116|P3|Month 6 (Day 180)|Other|3
5679090|NCT00397215|19591117|P2|Month 6 (Day 180)|Other|0
5679091|NCT00397215|19591118|P1|Month 6 (Day 180)|Other|2
5679092|NCT00397215|19591115|P4|Month 6 (Day 180)|Adverse Event|0
5679093|NCT00397215|19591116|P3|Month 6 (Day 180)|Adverse Event|2
5679094|NCT00397215|19591117|P2|Month 6 (Day 180)|Adverse Event|3
5679095|NCT00397215|19591118|P1|Month 6 (Day 180)|Adverse Event|0
5679096|NCT00397215|19591115|P4|Month 0 (Day 0)|Other|3
5679097|NCT00397215|19591116|P3|Month 0 (Day 0)|Other|3
5679098|NCT00397215|19591117|P2|Month 0 (Day 0)|Other|1
5679099|NCT00397215|19591118|P1|Month 0 (Day 0)|Other|4
5679100|NCT00397215|19591115|P4|Month 0 (Day 0)|Withdrawal by Subject|1
5679101|NCT00397215|19591116|P3|Month 0 (Day 0)|Withdrawal by Subject|3
5679102|NCT00397215|19591117|P2|Month 0 (Day 0)|Withdrawal by Subject|3
5679103|NCT00397215|19591118|P1|Month 0 (Day 0)|Withdrawal by Subject|3
5679104|NCT00397215|19591115|P4|Month 0 (Day 0)|Adverse Event|0
5679105|NCT00397215|19591116|P3|Month 0 (Day 0)|Adverse Event|0
5679106|NCT00397215|19591117|P2|Month 0 (Day 0)|Adverse Event|1
5679107|NCT00397215|19591118|P1|Month 0 (Day 0)|Adverse Event|0
5679108|NCT00397189|19591254|P2|3 Weeks Period|Other|2
5679109|NCT00397189|19591255|P1|3 Weeks Period|Other|0
5679110|NCT00397189|19591254|P2|3 Weeks Period|Protocol Violation|3
5679111|NCT00397189|19591255|P1|3 Weeks Period|Protocol Violation|0
5679112|NCT00397189|19591254|P2|3 Weeks Period|Physician Decision|2
5679113|NCT00397189|19591255|P1|3 Weeks Period|Physician Decision|0
5679114|NCT00397189|19591254|P2|3 Weeks Period|Withdrawal by Subject|9
5679115|NCT00397189|19591255|P1|3 Weeks Period|Withdrawal by Subject|13
5679116|NCT00397189|19591254|P2|3 Weeks Period|Adverse Event|2
5679117|NCT00397189|19591255|P1|3 Weeks Period|Adverse Event|3
5679118|NCT00397189|19591254|P2|3 Weeks Period|Lost to Follow-up|4
5679119|NCT00397189|19591255|P1|3 Weeks Period|Lost to Follow-up|5
5679120|NCT00397046|19591282|P4|Overall Study|Disease Progression|5
5679121|NCT00397046|19591283|P3|Overall Study|Disease Progression|10
5679122|NCT00397046|19591284|P2|Overall Study|Disease Progression|3
5679123|NCT00397046|19591285|P1|Overall Study|Disease Progression|3
5679124|NCT00397033|19591307|P3|Overall Study|Other|2
5679125|NCT00397033|19591308|P2|Overall Study|Other|5
5679126|NCT00397033|19591309|P1|Overall Study|Other|0
5679127|NCT00397033|19591307|P3|Overall Study|Withdrawal by Subject|5
5679128|NCT00397033|19591308|P2|Overall Study|Withdrawal by Subject|7
5679129|NCT00397033|19591309|P1|Overall Study|Withdrawal by Subject|12
5679130|NCT00397033|19591307|P3|Overall Study|Lost to Follow-up|3
5679131|NCT00397033|19591308|P2|Overall Study|Lost to Follow-up|3
5679132|NCT00397033|19591309|P1|Overall Study|Lost to Follow-up|3
5679133|NCT00397033|19591307|P3|Overall Study|Lack of Efficacy|9
5679134|NCT00397033|19591308|P2|Overall Study|Lack of Efficacy|12
5679135|NCT00397033|19591309|P1|Overall Study|Lack of Efficacy|22
5679136|NCT00397033|19591307|P3|Overall Study|Adverse Event|4
5679137|NCT00397033|19591308|P2|Overall Study|Adverse Event|10
5679138|NCT00397033|19591309|P1|Overall Study|Adverse Event|7
5679139|NCT00396877|19591400|P2|Overall Study|Parent(s)/guardian(s)'s request|7
5679140|NCT00396877|19591401|P1|Overall Study|Parent(s)/guardian(s)'s request|4
5679141|NCT00396877|19591400|P2|Overall Study|Lost to Follow-up|1
5679142|NCT00396877|19591401|P1|Overall Study|Lost to Follow-up|2
5679143|NCT00396812|19591411|P1|Overall Study|Physician Decision|1
5679144|NCT00396656|19591423|P2|Second Treatment Period|Adverse Event|1
5679145|NCT00396656|19591424|P1|Second Treatment Period|Adverse Event|0
5679146|NCT00396656|19591423|P2|First Treatment Period|Withdrawal by Subject|2
5679147|NCT00396656|19591424|P1|First Treatment Period|Withdrawal by Subject|0
5679148|NCT00396630|19591442|P2|Overall Study|Not vaccinated at Visit 3|3
5679149|NCT00396630|19591443|P1|Overall Study|Not vaccinated at Visit 3|3
5679150|NCT00396630|19591442|P2|Overall Study|Withdrawal by Subject|1
5679151|NCT00396630|19591443|P1|Overall Study|Withdrawal by Subject|1
5679152|NCT00396630|19591442|P2|Overall Study|Lost to Follow-up|1
5679153|NCT00396630|19591443|P1|Overall Study|Lost to Follow-up|1
5679154|NCT00396591|19591463|P1|Overall Study|Participant request|1
5679155|NCT00396591|19591463|P1|Overall Study|Adverse Event|2
5679156|NCT00396591|19591463|P1|Overall Study|Disease Progression|13
5679157|NCT00396565|19591476|P3|Overall Study|Lack of Efficacy|11
5679158|NCT00396565|19591477|P2|Overall Study|Lack of Efficacy|64
5679159|NCT00396565|19591478|P1|Overall Study|Lack of Efficacy|32
5679160|NCT00396565|19591476|P3|Overall Study|Withdrawal by Subject|1
5679161|NCT00396565|19591477|P2|Overall Study|Withdrawal by Subject|13
5679162|NCT00396565|19591478|P1|Overall Study|Withdrawal by Subject|8
5679163|NCT00396565|19591476|P3|Overall Study|Adverse Event|3
5679164|NCT00396565|19591477|P2|Overall Study|Adverse Event|13
5679165|NCT00396565|19591478|P1|Overall Study|Adverse Event|5
5679166|NCT00396565|19591476|P3|Overall Study|Physician Decision|2
5679167|NCT00396565|19591477|P2|Overall Study|Physician Decision|1
5679168|NCT00396565|19591478|P1|Overall Study|Physician Decision|3
5679169|NCT00396409|19591503|P2|Period 2 - 2008|Lost to Follow-up|1
5679170|NCT00396409|19591504|P1|Period 2 - 2008|Lost to Follow-up|3
5679171|NCT00396409|19591503|P2|Period 2 - 2008|Withdrawal by Subject|1
5679172|NCT00396409|19591504|P1|Period 2 - 2008|Withdrawal by Subject|3
5679173|NCT00396409|19591503|P2|Period 2 - 2008|Protocol Violation|0
5679174|NCT00396409|19591504|P1|Period 2 - 2008|Protocol Violation|1
5679175|NCT00396409|19591503|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
5679176|NCT00396409|19591504|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
5679177|NCT00396409|19591503|P2|Period 1 - 2007|Lost to Follow-up|3
5679178|NCT00396409|19591504|P1|Period 1 - 2007|Lost to Follow-up|2
5679179|NCT00396409|19591503|P2|Period 1 - 2007|Withdrawal by Subject|1
5679180|NCT00396409|19591504|P1|Period 1 - 2007|Withdrawal by Subject|1
5679181|NCT00396409|19591503|P2|Period 1 - 2007|Lack of Efficacy|1
5679182|NCT00396409|19591504|P1|Period 1 - 2007|Lack of Efficacy|0
5679183|NCT00396409|19591503|P2|Period 1 - 2007|Adverse Event|1
5679184|NCT00396409|19591504|P1|Period 1 - 2007|Adverse Event|0
5679185|NCT00396383|19591534|P1|Overall Study|Lost to Follow-up|1
5679186|NCT00396383|19591534|P1|Overall Study|Death|2
5679187|NCT00396331|19591547|P1|Overall Study|Death|16
5679188|NCT00396331|19591547|P1|Overall Study|Lost to Follow-up|3
5679189|NCT00396331|19591547|P1|Overall Study|Did not go on to transplant|5
5679190|NCT00396331|19591547|P1|Overall Study|Failed to mobilize - no transplant|8
5679191|NCT00396318|19591600|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
5679192|NCT00396279|19591620|P1|Overall Study|Physician Decision|1
5679193|NCT00396279|19591620|P1|Overall Study|Withdrawal by Subject|1
5679194|NCT00396279|19591620|P1|Overall Study|Disease progression|2
5679195|NCT00396279|19591620|P1|Overall Study|Ongoing in study|26
5679196|NCT00396253|19591653|P1|Overall Study|Change in eligibility status|1
5679197|NCT00396253|19591653|P1|Overall Study|Physician Decision|1
5679198|NCT00396253|19591653|P1|Overall Study|Death|3
5679199|NCT00396253|19591653|P1|Overall Study|Withdrawal by Subject|7
5679200|NCT00396253|19591653|P1|Overall Study|Protocol Violation|1
5679201|NCT00396162|19591684|P2|Overall Study|Withdrawal by Subject|3
5679202|NCT00396162|19591685|P1|Overall Study|Withdrawal by Subject|2
5679203|NCT00396136|19591697|P1|Overall Study|Study device explanted|8
5679204|NCT00396136|19591697|P1|Overall Study|Lost to Follow-up|15
5679205|NCT00396136|19591697|P1|Overall Study|Withdrawal by Subject|59
5679206|NCT00396136|19591697|P1|Overall Study|Death|43
5679207|NCT00396097|19591704|P2|Overall Study|Insufficient Clinical Response|4
5679208|NCT00396097|19591705|P1|Overall Study|Insufficient Clinical Response|1
5679209|NCT00396097|19591704|P2|Overall Study|Adverse Event|5
5679210|NCT00396097|19591705|P1|Overall Study|Adverse Event|1
5679211|NCT00396097|19591704|P2|Overall Study|Protocol Violation|6
5679212|NCT00396097|19591705|P1|Overall Study|Protocol Violation|0
5679213|NCT00396097|19591704|P2|Overall Study|Other|5
5679214|NCT00396097|19591705|P1|Overall Study|Other|3
5679215|NCT00396097|19591704|P2|Overall Study|Lost to Follow-up|9
5679216|NCT00396097|19591705|P1|Overall Study|Lost to Follow-up|4
5679217|NCT00396097|19591704|P2|Overall Study|Withdrawal by Subject|17
5679218|NCT00396097|19591705|P1|Overall Study|Withdrawal by Subject|17
5679219|NCT00396084|19591733|P6|Overall Study|Withdrawal by Subject|0
5679220|NCT00396084|19591734|P5|Overall Study|Withdrawal by Subject|0
5679221|NCT00396084|19591735|P4|Overall Study|Withdrawal by Subject|1
5679222|NCT00396084|19591736|P3|Overall Study|Withdrawal by Subject|0
5679223|NCT00396084|19591737|P2|Overall Study|Withdrawal by Subject|0
5679224|NCT00396084|19591738|P1|Overall Study|Withdrawal by Subject|0
5679225|NCT00396084|19591733|P6|Overall Study|Adverse Event|2
5679226|NCT00396084|19591734|P5|Overall Study|Adverse Event|1
5679227|NCT00396084|19591735|P4|Overall Study|Adverse Event|0
5679228|NCT00396084|19591736|P3|Overall Study|Adverse Event|0
5679229|NCT00396084|19591737|P2|Overall Study|Adverse Event|0
5679230|NCT00396084|19591738|P1|Overall Study|Adverse Event|0
5679231|NCT00395967|19591867|P1|Follow-up Period|Lost to Follow-up|1
5679232|NCT00395967|19591867|P1|Follow-up Period|Death|1
5679233|NCT00395967|19591867|P1|Treatment Period|Failed Mobilization|1
5679234|NCT00395863|19591907|P2|Overall Study|Patients did not complete both exams|3
5679235|NCT00395863|19591908|P1|Overall Study|Patients did not complete both exams|2
5679236|NCT00395850|19591943|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
5679237|NCT00395850|19591944|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
5679238|NCT00395850|19591945|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
5679239|NCT00395850|19591946|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
5679240|NCT00395850|19591943|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
5679241|NCT00395850|19591944|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
5679242|NCT00395850|19591945|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
5679243|NCT00395850|19591946|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
5679244|NCT00395850|19591943|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
5679245|NCT00395850|19591944|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
5679246|NCT00395850|19591945|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
5679247|NCT00395850|19591946|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
5679248|NCT00395850|19591943|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
5679249|NCT00395850|19591944|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
5679250|NCT00395850|19591945|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
5679251|NCT00395850|19591946|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
5679252|NCT00395850|19591943|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
5679253|NCT00395850|19591944|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
5679254|NCT00395850|19591945|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
5679255|NCT00395850|19591946|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
5679256|NCT00395850|19591943|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
5679257|NCT00395850|19591944|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
5679258|NCT00395850|19591945|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
5679259|NCT00395850|19591946|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
5679260|NCT00395850|19591943|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
5679261|NCT00395850|19591944|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
5679262|NCT00395850|19591945|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
5679263|NCT00395850|19591946|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
5679264|NCT00395746|19591963|P3|Overall Study|Unable to visit site on schedule|0
5679265|NCT00395746|19591964|P2|Overall Study|Unable to visit site on schedule|0
5679266|NCT00395746|19591965|P1|Overall Study|Unable to visit site on schedule|1
5679267|NCT00395746|19591963|P3|Overall Study|Difficultulty in use of device|1
5679268|NCT00395746|19591964|P2|Overall Study|Difficultulty in use of device|0
5679269|NCT00395746|19591965|P1|Overall Study|Difficultulty in use of device|0
5679270|NCT00395746|19591963|P3|Overall Study|Withdrawal of consent|1
5679271|NCT00395746|19591964|P2|Overall Study|Withdrawal of consent|0
5679272|NCT00395746|19591965|P1|Overall Study|Withdrawal of consent|0
5679273|NCT00395746|19591963|P3|Overall Study|Subject decision|1
5679274|NCT00395746|19591964|P2|Overall Study|Subject decision|0
5679275|NCT00395746|19591965|P1|Overall Study|Subject decision|0
5679276|NCT00395746|19591963|P3|Overall Study|Hypoglycaemia|0
5679277|NCT00395746|19591964|P2|Overall Study|Hypoglycaemia|1
5679278|NCT00395746|19591965|P1|Overall Study|Hypoglycaemia|2
5679279|NCT00395746|19591963|P3|Overall Study|Lack of Efficacy|17
5679280|NCT00395746|19591964|P2|Overall Study|Lack of Efficacy|0
5679281|NCT00395746|19591965|P1|Overall Study|Lack of Efficacy|2
5679282|NCT00395746|19591963|P3|Overall Study|Protocol Violation|0
5679283|NCT00395746|19591964|P2|Overall Study|Protocol Violation|1
5679284|NCT00395746|19591965|P1|Overall Study|Protocol Violation|0
5679285|NCT00395746|19591963|P3|Overall Study|Adverse Event|2
5679286|NCT00395746|19591964|P2|Overall Study|Adverse Event|2
5679287|NCT00395746|19591965|P1|Overall Study|Adverse Event|5
5679288|NCT00395733|19592011|P2|Period 2|Technical problems|0
5679289|NCT00395733|19592012|P1|Period 2|Technical problems|1
5679290|NCT00395733|19592011|P2|Period 2|Adverse Event|2
5679291|NCT00395733|19592012|P1|Period 2|Adverse Event|0
5679292|NCT00395733|19592011|P2|Period 2|Protocol Violation|1
5679293|NCT00395733|19592012|P1|Period 2|Protocol Violation|0
5679294|NCT00395733|19592011|P2|Period 2|Withdrawal by Subject|2
5679295|NCT00395733|19592012|P1|Period 2|Withdrawal by Subject|1
5679296|NCT00395694|19592036|P2|Continuation Phase|Withdrawal by Subject|2
5679297|NCT00395694|19592037|P1|Continuation Phase|Withdrawal by Subject|0
5679298|NCT00395694|19592036|P2|Continuation Phase|Poor Compliance|0
5679299|NCT00395694|19592037|P1|Continuation Phase|Poor Compliance|1
5679300|NCT00395694|19592036|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
5679301|NCT00395694|19592037|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
5679302|NCT00395694|19592036|P2|Continuation Phase|Lack of Efficacy|11
5679303|NCT00395694|19592037|P1|Continuation Phase|Lack of Efficacy|12
5679304|NCT00395694|19592036|P2|Continuation Phase|Adverse Event|0
5679305|NCT00395694|19592037|P1|Continuation Phase|Adverse Event|1
5679306|NCT00395694|19592036|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
5679307|NCT00395694|19592037|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
5679308|NCT00395642|19592068|P1|Overall Study|Withdrawal by Subject|1
5679309|NCT00395642|19592068|P1|Overall Study|Physician Decision|7
5679310|NCT00395642|19592068|P1|Overall Study|Lost to Follow-up|1
5679311|NCT00395642|19592068|P1|Overall Study|Death|4
5679312|NCT00395629|19592075|P3|Extension Study|Administrative problems|1
5679313|NCT00395629|19592076|P2|Extension Study|Administrative problems|0
5679314|NCT00395629|19592077|P1|Extension Study|Administrative problems|0
5679315|NCT00395629|19592075|P3|Extension Study|Adverse Event|2
5679316|NCT00395629|19592076|P2|Extension Study|Adverse Event|0
5679317|NCT00395629|19592077|P1|Extension Study|Adverse Event|0
5679318|NCT00395629|19592075|P3|Core Study|Lost to Follow-up|1
5679319|NCT00395629|19592076|P2|Core Study|Lost to Follow-up|0
5679320|NCT00395629|19592077|P1|Core Study|Lost to Follow-up|0
5679321|NCT00395629|19592075|P3|Core Study|Withdrawal by Subject|1
5679322|NCT00395629|19592076|P2|Core Study|Withdrawal by Subject|1
5679323|NCT00395629|19592077|P1|Core Study|Withdrawal by Subject|0
5679324|NCT00395629|19592075|P3|Core Study|Protocol Violation|0
5679325|NCT00395629|19592076|P2|Core Study|Protocol Violation|0
5679326|NCT00395629|19592077|P1|Core Study|Protocol Violation|1
5679327|NCT00395629|19592075|P3|Core Study|Abnormal laboratory value(s)|1
5679328|NCT00395629|19592076|P2|Core Study|Abnormal laboratory value(s)|0
5679329|NCT00395629|19592077|P1|Core Study|Abnormal laboratory value(s)|0
5679330|NCT00395629|19592075|P3|Core Study|Adverse Event|4
5679331|NCT00395629|19592076|P2|Core Study|Adverse Event|3
5679332|NCT00395629|19592077|P1|Core Study|Adverse Event|0
5679333|NCT00395538|19592094|P3|Overall Study|Participant elected to discontinue|1
5679334|NCT00395538|19592095|P2|Overall Study|Participant elected to discontinue|0
5679335|NCT00395538|19592096|P1|Overall Study|Participant elected to discontinue|0
5679336|NCT00395538|19592094|P3|Overall Study|Partial recovery of parathyroid function|1
5679337|NCT00395538|19592095|P2|Overall Study|Partial recovery of parathyroid function|0
5679338|NCT00395538|19592096|P1|Overall Study|Partial recovery of parathyroid function|0
5679339|NCT00395538|19592094|P3|Overall Study|Pregnancy|0
5679340|NCT00395538|19592095|P2|Overall Study|Pregnancy|0
5679341|NCT00395538|19592096|P1|Overall Study|Pregnancy|1
5679342|NCT00395538|19592094|P3|Overall Study|PTH resistance|1
5679343|NCT00395538|19592095|P2|Overall Study|PTH resistance|0
5679344|NCT00395538|19592096|P1|Overall Study|PTH resistance|0
5679345|NCT00395538|19592094|P3|Overall Study|Non-compliance with study protocol|0
5679346|NCT00395538|19592095|P2|Overall Study|Non-compliance with study protocol|1
5679347|NCT00395538|19592096|P1|Overall Study|Non-compliance with study protocol|0
5679348|NCT00395538|19592094|P3|Overall Study|DXA or QCT z-score or t-score<-2|0
5679349|NCT00395538|19592095|P2|Overall Study|DXA or QCT z-score or t-score<-2|2
5679350|NCT00395538|19592096|P1|Overall Study|DXA or QCT z-score or t-score<-2|0
5679351|NCT00395538|19592094|P3|Overall Study|Adverse Event|2
5679352|NCT00395538|19592095|P2|Overall Study|Adverse Event|0
5679353|NCT00395538|19592096|P1|Overall Study|Adverse Event|1
5679354|NCT00395538|19592094|P3|Overall Study|Switch to Natpara|3
5679355|NCT00395538|19592095|P2|Overall Study|Switch to Natpara|0
5679356|NCT00395538|19592096|P1|Overall Study|Switch to Natpara|0
5679357|NCT00395538|19592094|P3|Overall Study|Failed screening|4
5679358|NCT00395538|19592095|P2|Overall Study|Failed screening|0
5679359|NCT00395538|19592096|P1|Overall Study|Failed screening|0
5679360|NCT00395538|19592094|P3|Overall Study|FDA partial hold on PTH|11
5679361|NCT00395538|19592095|P2|Overall Study|FDA partial hold on PTH|0
5679362|NCT00395538|19592096|P1|Overall Study|FDA partial hold on PTH|0
5679363|NCT00395538|19592094|P3|Overall Study|Did not re-consent to revised protocol|0
5679364|NCT00395538|19592095|P2|Overall Study|Did not re-consent to revised protocol|10
5679365|NCT00395538|19592096|P1|Overall Study|Did not re-consent to revised protocol|1
5679366|NCT00395512|19592169|P4|Overall Study|Hyperglycemic Rescue|6
5679367|NCT00395512|19592170|P3|Overall Study|Hyperglycemic Rescue|4
5679368|NCT00395512|19592171|P2|Overall Study|Hyperglycemic Rescue|10
5679369|NCT00395512|19592172|P1|Overall Study|Hyperglycemic Rescue|18
5679370|NCT00395512|19592169|P4|Overall Study|Other|0
5679371|NCT00395512|19592170|P3|Overall Study|Other|0
5679372|NCT00395512|19592171|P2|Overall Study|Other|1
5679373|NCT00395512|19592172|P1|Overall Study|Other|1
5679374|NCT00395512|19592169|P4|Overall Study|Physician Decision|2
5679375|NCT00395512|19592170|P3|Overall Study|Physician Decision|2
5679376|NCT00395512|19592171|P2|Overall Study|Physician Decision|4
5679377|NCT00395512|19592172|P1|Overall Study|Physician Decision|6
5679378|NCT00395512|19592169|P4|Overall Study|Withdrawal by Subject|12
5679379|NCT00395512|19592170|P3|Overall Study|Withdrawal by Subject|5
5679380|NCT00395512|19592171|P2|Overall Study|Withdrawal by Subject|5
5679381|NCT00395512|19592172|P1|Overall Study|Withdrawal by Subject|6
5679382|NCT00395512|19592169|P4|Overall Study|Lost to Follow-up|5
5679383|NCT00395512|19592170|P3|Overall Study|Lost to Follow-up|5
5679384|NCT00395512|19592171|P2|Overall Study|Lost to Follow-up|6
5679385|NCT00395512|19592172|P1|Overall Study|Lost to Follow-up|2
5679386|NCT00395512|19592169|P4|Overall Study|Protocol Violation|7
5679387|NCT00395512|19592170|P3|Overall Study|Protocol Violation|6
5679388|NCT00395512|19592171|P2|Overall Study|Protocol Violation|3
5679389|NCT00395512|19592172|P1|Overall Study|Protocol Violation|2
5679390|NCT00395512|19592169|P4|Overall Study|Adverse Event|6
5679391|NCT00395512|19592170|P3|Overall Study|Adverse Event|6
5679392|NCT00395512|19592171|P2|Overall Study|Adverse Event|8
5679393|NCT00395512|19592172|P1|Overall Study|Adverse Event|3
5679394|NCT00395486|19592344|P2|Overall Study|Lost to Follow-up|1
5679395|NCT00395486|19592345|P1|Overall Study|Lost to Follow-up|0
5679396|NCT00395486|19592344|P2|Overall Study|Withdrawal by Subject|2
5679397|NCT00395486|19592345|P1|Overall Study|Withdrawal by Subject|5
5679398|NCT00395486|19592344|P2|Overall Study|Adverse Event|2
5679399|NCT00395486|19592345|P1|Overall Study|Adverse Event|1
5679400|NCT00395460|19592375|P2|Overall Study|Withdrawal by Subject|0
5679401|NCT00395460|19592376|P1|Overall Study|Withdrawal by Subject|1
5679402|NCT00395447|19592400|P2|Overall Study|Withdrawl - Other (not subject)|17
5679403|NCT00395447|19592401|P1|Overall Study|Withdrawl - Other (not subject)|8
5679404|NCT00395447|19592400|P2|Overall Study|Withdrawal by Subject|19
5679405|NCT00395447|19592401|P1|Overall Study|Withdrawal by Subject|24
5679406|NCT00395447|19592400|P2|Overall Study|Lost to Follow-up|43
5679407|NCT00395447|19592401|P1|Overall Study|Lost to Follow-up|52
5679408|NCT00395447|19592400|P2|Overall Study|Death|32
5679409|NCT00395447|19592401|P1|Overall Study|Death|37
5679410|NCT00395343|19592409|P2|Overall Study|Other|2
5679411|NCT00395343|19592410|P1|Overall Study|Other|5
5679412|NCT00395343|19592409|P2|Overall Study|Withdrawal by Subject|12
5679413|NCT00395343|19592410|P1|Overall Study|Withdrawal by Subject|11
5679414|NCT00395343|19592409|P2|Overall Study|Protocol Violation|8
5679415|NCT00395343|19592410|P1|Overall Study|Protocol Violation|6
5679416|NCT00395343|19592409|P2|Overall Study|Physician Decision|4
5679417|NCT00395343|19592410|P1|Overall Study|Physician Decision|2
5679418|NCT00395343|19592409|P2|Overall Study|Lost to Follow-up|4
5679419|NCT00395343|19592410|P1|Overall Study|Lost to Follow-up|4
5679420|NCT00395343|19592409|P2|Overall Study|Lack of Efficacy|1
5679421|NCT00395343|19592410|P1|Overall Study|Lack of Efficacy|0
5679422|NCT00395343|19592409|P2|Overall Study|Adverse Event|5
5679423|NCT00395343|19592410|P1|Overall Study|Adverse Event|13
5679424|NCT00395304|19592428|P6|Treatment Period 3|Other|0
5679425|NCT00395304|19592429|P5|Treatment Period 3|Other|0
5679426|NCT00395304|19592430|P4|Treatment Period 3|Other|1
5679427|NCT00395304|19592431|P3|Treatment Period 3|Other|0
5679428|NCT00395304|19592432|P2|Treatment Period 3|Other|0
5679429|NCT00395304|19592433|P1|Treatment Period 3|Other|0
5679430|NCT00395304|19592428|P6|Treatment Period 3|Physician Decision|0
5679431|NCT00395304|19592429|P5|Treatment Period 3|Physician Decision|0
5679432|NCT00395304|19592430|P4|Treatment Period 3|Physician Decision|0
5679433|NCT00395304|19592431|P3|Treatment Period 3|Physician Decision|0
5679434|NCT00395304|19592432|P2|Treatment Period 3|Physician Decision|1
5679435|NCT00395304|19592433|P1|Treatment Period 3|Physician Decision|0
5679436|NCT00395304|19592428|P6|Treatment Period 3|Lost to Follow-up|0
5679437|NCT00395304|19592429|P5|Treatment Period 3|Lost to Follow-up|0
5679438|NCT00395304|19592430|P4|Treatment Period 3|Lost to Follow-up|0
5679439|NCT00395304|19592431|P3|Treatment Period 3|Lost to Follow-up|0
5679440|NCT00395304|19592432|P2|Treatment Period 3|Lost to Follow-up|1
5679441|NCT00395304|19592433|P1|Treatment Period 3|Lost to Follow-up|1
5679442|NCT00395304|19592428|P6|Treatment Period 3|Withdrawal by Subject|1
5679443|NCT00395304|19592429|P5|Treatment Period 3|Withdrawal by Subject|0
5679444|NCT00395304|19592430|P4|Treatment Period 3|Withdrawal by Subject|1
5679445|NCT00395304|19592431|P3|Treatment Period 3|Withdrawal by Subject|0
5679446|NCT00395304|19592432|P2|Treatment Period 3|Withdrawal by Subject|0
5679447|NCT00395304|19592433|P1|Treatment Period 3|Withdrawal by Subject|0
5679448|NCT00395304|19592428|P6|Treatment Period 2|Other|0
5679449|NCT00395304|19592429|P5|Treatment Period 2|Other|0
5679450|NCT00395304|19592430|P4|Treatment Period 2|Other|0
5679451|NCT00395304|19592431|P3|Treatment Period 2|Other|0
5679452|NCT00395304|19592432|P2|Treatment Period 2|Other|1
5679453|NCT00395304|19592433|P1|Treatment Period 2|Other|0
5679454|NCT00395304|19592428|P6|Treatment Period 2|Physician Decision|0
5679455|NCT00395304|19592429|P5|Treatment Period 2|Physician Decision|0
5679456|NCT00395304|19592430|P4|Treatment Period 2|Physician Decision|0
5679457|NCT00395304|19592431|P3|Treatment Period 2|Physician Decision|1
5679458|NCT00395304|19592432|P2|Treatment Period 2|Physician Decision|0
5679459|NCT00395304|19592433|P1|Treatment Period 2|Physician Decision|0
5679460|NCT00395304|19592428|P6|Treatment Period 2|Lost to Follow-up|0
5679461|NCT00395304|19592429|P5|Treatment Period 2|Lost to Follow-up|0
5679462|NCT00395304|19592430|P4|Treatment Period 2|Lost to Follow-up|0
5679463|NCT00395304|19592431|P3|Treatment Period 2|Lost to Follow-up|0
5679464|NCT00395304|19592432|P2|Treatment Period 2|Lost to Follow-up|3
5679465|NCT00395304|19592433|P1|Treatment Period 2|Lost to Follow-up|0
5679466|NCT00395304|19592428|P6|Treatment Period 2|Withdrawal by Subject|2
5679467|NCT00395304|19592429|P5|Treatment Period 2|Withdrawal by Subject|0
5679468|NCT00395304|19592430|P4|Treatment Period 2|Withdrawal by Subject|1
5679469|NCT00395304|19592431|P3|Treatment Period 2|Withdrawal by Subject|0
5679470|NCT00395304|19592432|P2|Treatment Period 2|Withdrawal by Subject|0
5679471|NCT00395304|19592433|P1|Treatment Period 2|Withdrawal by Subject|0
5679472|NCT00395304|19592428|P6|Treatment Period 1|Physician Decision|0
5679473|NCT00395304|19592429|P5|Treatment Period 1|Physician Decision|0
5679474|NCT00395304|19592430|P4|Treatment Period 1|Physician Decision|0
5679475|NCT00395304|19592431|P3|Treatment Period 1|Physician Decision|0
5679476|NCT00395304|19592432|P2|Treatment Period 1|Physician Decision|1
5679477|NCT00395304|19592433|P1|Treatment Period 1|Physician Decision|0
5679478|NCT00395304|19592428|P6|Treatment Period 1|Lost to Follow-up|1
5679479|NCT00395304|19592429|P5|Treatment Period 1|Lost to Follow-up|0
5679480|NCT00395304|19592430|P4|Treatment Period 1|Lost to Follow-up|1
5679481|NCT00395304|19592431|P3|Treatment Period 1|Lost to Follow-up|0
5679482|NCT00395304|19592432|P2|Treatment Period 1|Lost to Follow-up|0
5679483|NCT00395304|19592433|P1|Treatment Period 1|Lost to Follow-up|1
5679484|NCT00395304|19592428|P6|Treatment Period 1|Withdrawal by Subject|1
5679485|NCT00395304|19592429|P5|Treatment Period 1|Withdrawal by Subject|1
5679486|NCT00395304|19592430|P4|Treatment Period 1|Withdrawal by Subject|2
5679487|NCT00395304|19592431|P3|Treatment Period 1|Withdrawal by Subject|0
5679488|NCT00395304|19592432|P2|Treatment Period 1|Withdrawal by Subject|3
5679489|NCT00395304|19592433|P1|Treatment Period 1|Withdrawal by Subject|0
5679490|NCT00395226|19592509|P2|Overall Study|Lost to Follow-up|1
5679491|NCT00395226|19592510|P1|Overall Study|Lost to Follow-up|0
5679492|NCT00395226|19592509|P2|Overall Study|Withdrawal by Subject|1
5679493|NCT00395226|19592510|P1|Overall Study|Withdrawal by Subject|0
5679494|NCT00395226|19592509|P2|Overall Study|Adverse Event|3
5679495|NCT00395226|19592510|P1|Overall Study|Adverse Event|4
5679496|NCT00395083|19592557|P2|Overall Study|Developed another disease|3
5679497|NCT00395083|19592558|P1|Overall Study|Developed another disease|4
5679498|NCT00395083|19592557|P2|Overall Study|Withdrawal by Subject|5
5679499|NCT00395083|19592558|P1|Overall Study|Withdrawal by Subject|6
5679500|NCT00395018|19592624|P1|Off-Treatment Follow-up|Poor/non-compliance|1
5679501|NCT00395018|19592624|P1|Off-Treatment Follow-up|Lost to Follow-up|2
5679502|NCT00395018|19592624|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
5679503|NCT00395018|19592624|P1|On-Treatment|Subject no longer meets study criteria|2
5679504|NCT00395018|19592624|P1|On-Treatment|Poor/non-compliance|2
5679505|NCT00395018|19592624|P1|On-Treatment|Other Reason|2
5679506|NCT00395018|19592624|P1|On-Treatment|Death|4
5679507|NCT00394953|19592645|P2|Second Treatment Period|Not defined|8
5679508|NCT00394953|19592646|P1|Second Treatment Period|Not defined|3
5679509|NCT00394953|19592645|P2|Second Treatment Period|Renal transplant|6
5679510|NCT00394953|19592646|P1|Second Treatment Period|Renal transplant|4
5679511|NCT00394953|19592645|P2|Second Treatment Period|Lost to Follow-up|1
5679512|NCT00394953|19592646|P1|Second Treatment Period|Lost to Follow-up|0
5679513|NCT00394953|19592645|P2|Second Treatment Period|Withdrawal by Subject|3
5679514|NCT00394953|19592646|P1|Second Treatment Period|Withdrawal by Subject|3
5679515|NCT00394953|19592645|P2|Second Treatment Period|Lack of Efficacy|47
5679516|NCT00394953|19592646|P1|Second Treatment Period|Lack of Efficacy|9
5679517|NCT00394953|19592645|P2|Second Treatment Period|Death|4
5679518|NCT00394953|19592646|P1|Second Treatment Period|Death|8
5679519|NCT00394953|19592645|P2|Second Treatment Period|Adverse Event|5
5679520|NCT00394953|19592646|P1|Second Treatment Period|Adverse Event|2
5679521|NCT00394953|19592645|P2|First Treatment Period|Not defined|1
5679522|NCT00394953|19592646|P1|First Treatment Period|Not defined|4
5679523|NCT00394953|19592645|P2|First Treatment Period|Renal transplant|7
5679524|NCT00394953|19592646|P1|First Treatment Period|Renal transplant|11
5679525|NCT00394953|19592645|P2|First Treatment Period|Lost to Follow-up|1
5679526|NCT00394953|19592646|P1|First Treatment Period|Lost to Follow-up|0
5679527|NCT00394953|19592645|P2|First Treatment Period|Withdrawal by Subject|3
5679528|NCT00394953|19592646|P1|First Treatment Period|Withdrawal by Subject|6
5679529|NCT00394953|19592645|P2|First Treatment Period|Lack of Efficacy|1
5679530|NCT00394953|19592646|P1|First Treatment Period|Lack of Efficacy|1
5679531|NCT00394953|19592645|P2|First Treatment Period|Death|7
5679532|NCT00394953|19592646|P1|First Treatment Period|Death|6
5679533|NCT00394953|19592645|P2|First Treatment Period|Adverse Event|2
5679534|NCT00394953|19592646|P1|First Treatment Period|Adverse Event|1
5679535|NCT00394914|19592664|P3|Treatment Period|Did not meet protocol eligibility|1
5679536|NCT00394914|19592665|P2|Treatment Period|Did not meet protocol eligibility|1
5679537|NCT00394914|19592666|P1|Treatment Period|Did not meet protocol eligibility|0
5679538|NCT00394914|19592664|P3|Treatment Period|Noncompliance with protocol|2
5679539|NCT00394914|19592665|P2|Treatment Period|Noncompliance with protocol|3
5679540|NCT00394914|19592666|P1|Treatment Period|Noncompliance with protocol|0
5679541|NCT00394914|19592664|P3|Treatment Period|Withdrawal by Subject|2
5679542|NCT00394914|19592665|P2|Treatment Period|Withdrawal by Subject|2
5679543|NCT00394914|19592666|P1|Treatment Period|Withdrawal by Subject|0
5679544|NCT00394914|19592664|P3|Treatment Period|Lost to Follow-up|0
5679545|NCT00394914|19592665|P2|Treatment Period|Lost to Follow-up|1
5679546|NCT00394914|19592666|P1|Treatment Period|Lost to Follow-up|0
5679547|NCT00394914|19592664|P3|Treatment Period|Adverse Event|1
5679548|NCT00394914|19592665|P2|Treatment Period|Adverse Event|3
5679549|NCT00394914|19592666|P1|Treatment Period|Adverse Event|0
5679550|NCT00394901|19592694|P4|Double-blind Phase|Found not to meet entrance criteria|1
5679551|NCT00394901|19592695|P3|Double-blind Phase|Found not to meet entrance criteria|0
5679552|NCT00394901|19592696|P2|Double-blind Phase|Found not to meet entrance criteria|0
5679553|NCT00394901|19592697|P1|Double-blind Phase|Found not to meet entrance criteria|0
5679554|NCT00394901|19592694|P4|Double-blind Phase|Entry into another study was found|0
5679555|NCT00394901|19592695|P3|Double-blind Phase|Entry into another study was found|1
5679556|NCT00394901|19592696|P2|Double-blind Phase|Entry into another study was found|0
5679557|NCT00394901|19592697|P1|Double-blind Phase|Entry into another study was found|0
5679558|NCT00394901|19592694|P4|Double-blind Phase|Lack of Compliance|0
5679559|NCT00394901|19592695|P3|Double-blind Phase|Lack of Compliance|0
5679560|NCT00394901|19592696|P2|Double-blind Phase|Lack of Compliance|3
5679561|NCT00394901|19592697|P1|Double-blind Phase|Lack of Compliance|0
5679562|NCT00394901|19592694|P4|Double-blind Phase|Subject's Personal Reason|1
5679563|NCT00394901|19592695|P3|Double-blind Phase|Subject's Personal Reason|0
5679564|NCT00394901|19592696|P2|Double-blind Phase|Subject's Personal Reason|0
5679565|NCT00394901|19592697|P1|Double-blind Phase|Subject's Personal Reason|1
5679566|NCT00394901|19592694|P4|Double-blind Phase|Death|0
5679567|NCT00394901|19592695|P3|Double-blind Phase|Death|0
5679568|NCT00394901|19592696|P2|Double-blind Phase|Death|0
5679569|NCT00394901|19592697|P1|Double-blind Phase|Death|1
5679570|NCT00394901|19592694|P4|Double-blind Phase|Protocol Violation|1
5679571|NCT00394901|19592695|P3|Double-blind Phase|Protocol Violation|0
5679572|NCT00394901|19592696|P2|Double-blind Phase|Protocol Violation|0
5679573|NCT00394901|19592697|P1|Double-blind Phase|Protocol Violation|0
5679574|NCT00394901|19592694|P4|Double-blind Phase|Lost to Follow-up|1
5679575|NCT00394901|19592695|P3|Double-blind Phase|Lost to Follow-up|0
5679576|NCT00394901|19592696|P2|Double-blind Phase|Lost to Follow-up|0
5679577|NCT00394901|19592697|P1|Double-blind Phase|Lost to Follow-up|0
5679578|NCT00394901|19592694|P4|Double-blind Phase|Withdrawal by Subject|0
5679579|NCT00394901|19592695|P3|Double-blind Phase|Withdrawal by Subject|0
5679580|NCT00394901|19592696|P2|Double-blind Phase|Withdrawal by Subject|0
5679581|NCT00394901|19592697|P1|Double-blind Phase|Withdrawal by Subject|2
5679582|NCT00394901|19592694|P4|Double-blind Phase|Lack of Efficacy|3
5679583|NCT00394901|19592695|P3|Double-blind Phase|Lack of Efficacy|1
5679584|NCT00394901|19592696|P2|Double-blind Phase|Lack of Efficacy|4
5679585|NCT00394901|19592697|P1|Double-blind Phase|Lack of Efficacy|6
5679586|NCT00394901|19592694|P4|Double-blind Phase|Adverse Event|20
5679587|NCT00394901|19592695|P3|Double-blind Phase|Adverse Event|16
5679588|NCT00394901|19592696|P2|Double-blind Phase|Adverse Event|7
5679589|NCT00394901|19592697|P1|Double-blind Phase|Adverse Event|5
5679590|NCT00394901|19592694|P4|Baseline Phase|Protocol Violation|0
5679591|NCT00394901|19592695|P3|Baseline Phase|Protocol Violation|1
5679592|NCT00394901|19592696|P2|Baseline Phase|Protocol Violation|0
5679593|NCT00394901|19592697|P1|Baseline Phase|Protocol Violation|0
5679594|NCT00394836|19592940|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
5679595|NCT00394836|19592941|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
5679596|NCT00394836|19592940|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
5679597|NCT00394836|19592941|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
5679598|NCT00394836|19592940|P2|Extended Follow-up Phase (2-5 Years)|Death|1
5679599|NCT00394836|19592941|P1|Extended Follow-up Phase (2-5 Years)|Death|0
5679600|NCT00394836|19592940|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
5679601|NCT00394836|19592941|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
5679602|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Non compliance|1
5679603|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Non compliance|0
5679604|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
5679605|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
5679606|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Physician Decision|1
5679607|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Physician Decision|0
5679608|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
5679609|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
5679610|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Started alternative treatment|6
5679611|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Started alternative treatment|0
5679612|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
5679613|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
5679614|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Death|1
5679615|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Death|0
5679616|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Patient Refusal|2
5679617|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Patient Refusal|1
5679618|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Disease Progression|60
5679619|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Disease Progression|27
5679620|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Protocol Violation|2
5679621|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Protocol Violation|0
5679622|NCT00394836|19592940|P2|Teatment or Follow-up Phase|Adverse Event|2
5679623|NCT00394836|19592941|P1|Teatment or Follow-up Phase|Adverse Event|0
5679624|NCT00394771|19592987|P4|Overall Study|Other|0
5679625|NCT00394771|19592988|P3|Overall Study|Other|1
5679626|NCT00394771|19592989|P2|Overall Study|Other|3
5679627|NCT00394771|19592990|P1|Overall Study|Other|3
5679628|NCT00394771|19592987|P4|Overall Study|Lost to Follow-up|10
5679629|NCT00394771|19592988|P3|Overall Study|Lost to Follow-up|13
5679630|NCT00394771|19592989|P2|Overall Study|Lost to Follow-up|15
5679631|NCT00394771|19592990|P1|Overall Study|Lost to Follow-up|15
5679632|NCT00394771|19592987|P4|Overall Study|Participant pregnant|2
5679633|NCT00394771|19592988|P3|Overall Study|Participant pregnant|2
5679634|NCT00394771|19592989|P2|Overall Study|Participant pregnant|1
5679635|NCT00394771|19592990|P1|Overall Study|Participant pregnant|0
5679636|NCT00394771|19592987|P4|Overall Study|Adverse Event|8
5679637|NCT00394771|19592988|P3|Overall Study|Adverse Event|12
5679638|NCT00394771|19592989|P2|Overall Study|Adverse Event|5
5679639|NCT00394771|19592990|P1|Overall Study|Adverse Event|10
5679640|NCT00394771|19592987|P4|Overall Study|Withdrawal by Subject|12
5679641|NCT00394771|19592988|P3|Overall Study|Withdrawal by Subject|8
5679642|NCT00394771|19592989|P2|Overall Study|Withdrawal by Subject|6
5679643|NCT00394771|19592990|P1|Overall Study|Withdrawal by Subject|10
5679644|NCT00394771|19592987|P4|Overall Study|Protocol Violation|7
5679645|NCT00394771|19592988|P3|Overall Study|Protocol Violation|9
5679646|NCT00394771|19592989|P2|Overall Study|Protocol Violation|4
5679647|NCT00394771|19592990|P1|Overall Study|Protocol Violation|2
5679648|NCT00394771|19592987|P4|Overall Study|Did not meet protocol requirements|0
5679649|NCT00394771|19592988|P3|Overall Study|Did not meet protocol requirements|2
5679650|NCT00394771|19592989|P2|Overall Study|Did not meet protocol requirements|0
5679651|NCT00394771|19592990|P1|Overall Study|Did not meet protocol requirements|1
5679652|NCT00394706|19593060|P8|Overall Study|Lost to Follow-up|0
5679653|NCT00394706|19593061|P7|Overall Study|Lost to Follow-up|2
5679654|NCT00394706|19593062|P6|Overall Study|Lost to Follow-up|5
5679655|NCT00394706|19593063|P5|Overall Study|Lost to Follow-up|2
5679656|NCT00394706|19593064|P4|Overall Study|Lost to Follow-up|1
5679657|NCT00394706|19593065|P3|Overall Study|Lost to Follow-up|8
5679658|NCT00394706|19593066|P2|Overall Study|Lost to Follow-up|2
5679659|NCT00394706|19593067|P1|Overall Study|Lost to Follow-up|2
5679660|NCT00394706|19593060|P8|Overall Study|Withdrawal by Subject|0
5679661|NCT00394706|19593061|P7|Overall Study|Withdrawal by Subject|1
5679662|NCT00394706|19593062|P6|Overall Study|Withdrawal by Subject|2
5679663|NCT00394706|19593063|P5|Overall Study|Withdrawal by Subject|0
5679664|NCT00394706|19593064|P4|Overall Study|Withdrawal by Subject|0
5679665|NCT00394706|19593065|P3|Overall Study|Withdrawal by Subject|1
5679666|NCT00394706|19593066|P2|Overall Study|Withdrawal by Subject|0
5679667|NCT00394706|19593067|P1|Overall Study|Withdrawal by Subject|2
5679668|NCT00394654|19593099|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
5679669|NCT00394654|19593100|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
5679670|NCT00394654|19593099|P2|Overall Study|Lost to Follow-up|0
5679671|NCT00394654|19593100|P1|Overall Study|Lost to Follow-up|1
5679672|NCT00394589|19593165|P3|Overall Study|Protocol Violation|2
5679673|NCT00394589|19593166|P2|Overall Study|Protocol Violation|0
5679674|NCT00394589|19593167|P1|Overall Study|Protocol Violation|4
5679675|NCT00394589|19593165|P3|Overall Study|Lack of Efficacy|3
5679676|NCT00394589|19593166|P2|Overall Study|Lack of Efficacy|2
5679677|NCT00394589|19593167|P1|Overall Study|Lack of Efficacy|2
5679678|NCT00394589|19593165|P3|Overall Study|Adverse Event|2
5679679|NCT00394589|19593166|P2|Overall Study|Adverse Event|1
5679680|NCT00394589|19593167|P1|Overall Study|Adverse Event|2
5679681|NCT00394524|19593177|P2|Overall Study|Withdrawal by Subject|1
5679682|NCT00394524|19593178|P1|Overall Study|Withdrawal by Subject|0
5679683|NCT00394524|19593177|P2|Overall Study|Death|0
5679684|NCT00394524|19593178|P1|Overall Study|Death|1
5679685|NCT00394524|19593177|P2|Overall Study|Protocol Violation|3
5679686|NCT00394524|19593178|P1|Overall Study|Protocol Violation|2
5679687|NCT00394472|19593192|P2|Overall Study|Lost to Follow-up|1
5679688|NCT00394472|19593193|P1|Overall Study|Lost to Follow-up|0
5679689|NCT00394472|19593192|P2|Overall Study|Physician Decision|1
5679690|NCT00394472|19593193|P1|Overall Study|Physician Decision|0
5679691|NCT00394472|19593192|P2|Overall Study|Withdrawal by Subject|2
5679692|NCT00394472|19593193|P1|Overall Study|Withdrawal by Subject|0
5679693|NCT00394472|19593192|P2|Overall Study|Adverse Event|2
5679694|NCT00394472|19593193|P1|Overall Study|Adverse Event|4
5679695|NCT00394472|19593192|P2|Overall Study|incorrect enrolment|2
5679696|NCT00394472|19593193|P1|Overall Study|incorrect enrolment|4
5679697|NCT00394472|19593192|P2|Overall Study|Protocol Violation|3
5679698|NCT00394472|19593193|P1|Overall Study|Protocol Violation|1
5679699|NCT00394433|19593201|P1|Overall Study|Alternative Therapy|1
5679700|NCT00394433|19593201|P1|Overall Study|Adverse Event|2
5679701|NCT00394355|19593212|P4|Overall Study|Lack of Efficacy|3
5679702|NCT00394355|19593213|P3|Overall Study|Lack of Efficacy|2
5679703|NCT00394355|19593214|P2|Overall Study|Lack of Efficacy|0
5679704|NCT00394355|19593215|P1|Overall Study|Lack of Efficacy|0
5679705|NCT00394355|19593212|P4|Overall Study|Administrative|1
5679706|NCT00394355|19593213|P3|Overall Study|Administrative|1
5679707|NCT00394355|19593214|P2|Overall Study|Administrative|1
5679708|NCT00394355|19593215|P1|Overall Study|Administrative|0
5679709|NCT00394355|19593212|P4|Overall Study|Noncompliance with protocol|8
5679710|NCT00394355|19593213|P3|Overall Study|Noncompliance with protocol|10
5679711|NCT00394355|19593214|P2|Overall Study|Noncompliance with protocol|3
5679712|NCT00394355|19593215|P1|Overall Study|Noncompliance with protocol|4
5679713|NCT00394355|19593212|P4|Overall Study|Lost to Follow-up|3
5679714|NCT00394355|19593213|P3|Overall Study|Lost to Follow-up|4
5679715|NCT00394355|19593214|P2|Overall Study|Lost to Follow-up|5
5679716|NCT00394355|19593215|P1|Overall Study|Lost to Follow-up|7
5679717|NCT00394355|19593212|P4|Overall Study|Subject withdrawal - related to drug|0
5679718|NCT00394355|19593213|P3|Overall Study|Subject withdrawal - related to drug|0
5679719|NCT00394355|19593214|P2|Overall Study|Subject withdrawal - related to drug|0
5679720|NCT00394355|19593215|P1|Overall Study|Subject withdrawal - related to drug|1
5679721|NCT00394355|19593212|P4|Overall Study|Subject withdrawal - unrelated to drug|6
5679722|NCT00394355|19593213|P3|Overall Study|Subject withdrawal - unrelated to drug|10
5679723|NCT00394355|19593214|P2|Overall Study|Subject withdrawal - unrelated to drug|14
5679724|NCT00394355|19593215|P1|Overall Study|Subject withdrawal - unrelated to drug|12
5679725|NCT00394355|19593212|P4|Overall Study|Did not meet protocol eligibility|2
5679726|NCT00394355|19593213|P3|Overall Study|Did not meet protocol eligibility|4
5679727|NCT00394355|19593214|P2|Overall Study|Did not meet protocol eligibility|5
5679728|NCT00394355|19593215|P1|Overall Study|Did not meet protocol eligibility|1
5679729|NCT00394355|19593212|P4|Overall Study|Adverse Event|8
5679730|NCT00394355|19593213|P3|Overall Study|Adverse Event|7
5679731|NCT00394355|19593214|P2|Overall Study|Adverse Event|6
5679732|NCT00394355|19593215|P1|Overall Study|Adverse Event|10
5679733|NCT00394251|19593321|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
5679734|NCT00394251|19593322|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
5679735|NCT00394251|19593321|P2|Overall Study|Withdrawal by Subject|11
5679736|NCT00394251|19593322|P1|Overall Study|Withdrawal by Subject|7
5679737|NCT00394251|19593321|P2|Overall Study|Protocol Violation|1
5679738|NCT00394251|19593322|P1|Overall Study|Protocol Violation|0
5679739|NCT00394251|19593321|P2|Overall Study|Physician Decision|1
5679740|NCT00394251|19593322|P1|Overall Study|Physician Decision|1
5679741|NCT00394251|19593321|P2|Overall Study|Unacceptable Toxicity|18
5679742|NCT00394251|19593322|P1|Overall Study|Unacceptable Toxicity|20
5679743|NCT00394251|19593321|P2|Overall Study|Adverse Event|5
5679744|NCT00394251|19593322|P1|Overall Study|Adverse Event|7
5679745|NCT00394212|19593350|P2|Overall Study|Withdrawal by Subject|1
5679746|NCT00394212|19593351|P1|Overall Study|Withdrawal by Subject|4
5679747|NCT00394212|19593350|P2|Overall Study|Lost to Follow-up|0
5679748|NCT00394212|19593351|P1|Overall Study|Lost to Follow-up|3
5679749|NCT00394095|19593365|P2|Overall Study|Adverse Event|0
5679750|NCT00394095|19593366|P1|Overall Study|Adverse Event|1
5679751|NCT00394082|19593374|P1|Overall Study|Other|1
5679752|NCT00394082|19593374|P1|Overall Study|Withdrawal by Subject|2
5679753|NCT00394082|19593374|P1|Overall Study|Physician Decision|4
5679754|NCT00394082|19593374|P1|Overall Study|Adverse Event|4
5679755|NCT00394082|19593374|P1|Overall Study|Unacceptable toxicity|15
5679756|NCT00393939|19593396|P2|Overall Study|Other|45
5679757|NCT00393939|19593397|P1|Overall Study|Other|37
5679758|NCT00393939|19593396|P2|Overall Study|Withdrawal by Subject|7
5679759|NCT00393939|19593397|P1|Overall Study|Withdrawal by Subject|2
5679760|NCT00393939|19593396|P2|Overall Study|Objective progression or relapse|223
5679761|NCT00393939|19593397|P1|Overall Study|Objective progression or relapse|239
5679762|NCT00393939|19593396|P2|Overall Study|Sponsor|13
5679763|NCT00393939|19593397|P1|Overall Study|Sponsor|5
5679764|NCT00393939|19593396|P2|Overall Study|Death|4
5679765|NCT00393939|19593397|P1|Overall Study|Death|10
5679766|NCT00393939|19593396|P2|Overall Study|Lost to Follow-up|4
5679767|NCT00393939|19593397|P1|Overall Study|Lost to Follow-up|2
5679768|NCT00393939|19593396|P2|Overall Study|Protocol Violation|1
5679769|NCT00393939|19593397|P1|Overall Study|Protocol Violation|1
5679770|NCT00393913|19593415|P1|CPAP|TEchnical problem with CPAP|3
5679771|NCT00393913|19593415|P1|CPAP|Physician Decision|1
5679772|NCT00393913|19593415|P1|CPAP|Withdrawal by Subject|3
5679773|NCT00393913|19593415|P1|Initial Assessment|Withdrawal by Subject|16
5679774|NCT00393913|19593415|P1|Initial Assessment|diagnosed with other sleep disorder|21
5679775|NCT00393887|19593423|P2|Overall Study|Lost to Follow-up|9
5679776|NCT00393887|19593424|P1|Overall Study|Lost to Follow-up|11
5679777|NCT00393887|19593423|P2|Overall Study|Physician Decision|0
5679778|NCT00393887|19593424|P1|Overall Study|Physician Decision|5
5679779|NCT00393861|19593452|P1|Overall Study|Disease Progression|24
5679780|NCT00393861|19593452|P1|Overall Study|Adverse Event|2
5679781|NCT00393848|19593463|P4|Overall Study|Personal reasons|0
5679782|NCT00393848|19593464|P3|Overall Study|Personal reasons|2
5679783|NCT00393848|19593465|P2|Overall Study|Personal reasons|0
5679784|NCT00393848|19593466|P1|Overall Study|Personal reasons|0
5679785|NCT00393848|19593463|P4|Overall Study|Surgical schedule|1
5679786|NCT00393848|19593464|P3|Overall Study|Surgical schedule|0
5679787|NCT00393848|19593465|P2|Overall Study|Surgical schedule|0
5679788|NCT00393848|19593466|P1|Overall Study|Surgical schedule|0
5679789|NCT00393718|19593489|P2|Overall Study|Move|0
5679790|NCT00393718|19593490|P1|Overall Study|Move|1
5679791|NCT00393718|19593489|P2|Overall Study|Missed measurement|0
5679792|NCT00393718|19593490|P1|Overall Study|Missed measurement|1
5679793|NCT00393718|19593489|P2|Overall Study|Withdrawal of consent|1
5679794|NCT00393718|19593490|P1|Overall Study|Withdrawal of consent|2
5679795|NCT00393718|19593489|P2|Overall Study|Subject decision|0
5679796|NCT00393718|19593490|P1|Overall Study|Subject decision|5
5679797|NCT00393718|19593489|P2|Overall Study|Hypoglycaemia|2
5679798|NCT00393718|19593490|P1|Overall Study|Hypoglycaemia|3
5679799|NCT00393718|19593489|P2|Overall Study|Lack of Efficacy|9
5679800|NCT00393718|19593490|P1|Overall Study|Lack of Efficacy|10
5679801|NCT00393718|19593489|P2|Overall Study|Protocol Violation|2
5679802|NCT00393718|19593490|P1|Overall Study|Protocol Violation|1
5679803|NCT00393718|19593489|P2|Overall Study|Adverse Event|8
5679804|NCT00393718|19593490|P1|Overall Study|Adverse Event|20
5679805|NCT00393705|19593522|P2|Overall Study|Physician Decision|2
5679806|NCT00393705|19593523|P1|Overall Study|Physician Decision|2
5679807|NCT00393705|19593522|P2|Overall Study|Withdrawal by Subject|3
5679808|NCT00393705|19593523|P1|Overall Study|Withdrawal by Subject|5
5679809|NCT00393705|19593522|P2|Overall Study|Protocol Violation|3
5679810|NCT00393705|19593523|P1|Overall Study|Protocol Violation|4
5679811|NCT00393705|19593522|P2|Overall Study|Entry Criteria Not Met|10
5679812|NCT00393705|19593523|P1|Overall Study|Entry Criteria Not Met|10
5679813|NCT00393705|19593522|P2|Overall Study|Lost to Follow-up|2
5679814|NCT00393705|19593523|P1|Overall Study|Lost to Follow-up|2
5679815|NCT00393705|19593522|P2|Overall Study|Death|1
5679816|NCT00393705|19593523|P1|Overall Study|Death|0
5679817|NCT00393705|19593522|P2|Overall Study|Adverse Event|2
5679818|NCT00393705|19593523|P1|Overall Study|Adverse Event|0
5679819|NCT00393523|19593552|P5|Overall Study|Vaccine supply issue|0
5679820|NCT00393523|19593553|P4|Overall Study|Vaccine supply issue|0
5679821|NCT00393523|19593554|P3|Overall Study|Vaccine supply issue|1
5679822|NCT00393523|19593555|P2|Overall Study|Vaccine supply issue|0
5679823|NCT00393523|19593556|P1|Overall Study|Vaccine supply issue|0
5679824|NCT00393523|19593552|P5|Overall Study|Difficulties in specimen collection|0
5679825|NCT00393523|19593553|P4|Overall Study|Difficulties in specimen collection|0
5679826|NCT00393523|19593554|P3|Overall Study|Difficulties in specimen collection|1
5679827|NCT00393523|19593555|P2|Overall Study|Difficulties in specimen collection|0
5679828|NCT00393523|19593556|P1|Overall Study|Difficulties in specimen collection|0
5679829|NCT00393523|19593552|P5|Overall Study|Withdrawal by Subject|0
5679830|NCT00393523|19593553|P4|Overall Study|Withdrawal by Subject|3
5679831|NCT00393523|19593554|P3|Overall Study|Withdrawal by Subject|2
5679832|NCT00393523|19593555|P2|Overall Study|Withdrawal by Subject|7
5679833|NCT00393523|19593556|P1|Overall Study|Withdrawal by Subject|6
5679834|NCT00393523|19593552|P5|Overall Study|Protocol Violation|0
5679835|NCT00393523|19593553|P4|Overall Study|Protocol Violation|1
5679836|NCT00393523|19593554|P3|Overall Study|Protocol Violation|0
5679837|NCT00393523|19593555|P2|Overall Study|Protocol Violation|2
5679838|NCT00393523|19593556|P1|Overall Study|Protocol Violation|6
5679839|NCT00393523|19593552|P5|Overall Study|Lost to Follow-up|1
5679840|NCT00393523|19593553|P4|Overall Study|Lost to Follow-up|2
5679841|NCT00393523|19593554|P3|Overall Study|Lost to Follow-up|0
5679842|NCT00393523|19593555|P2|Overall Study|Lost to Follow-up|0
5679843|NCT00393523|19593556|P1|Overall Study|Lost to Follow-up|0
5679844|NCT00393510|19593573|P2|Overall Study|Physician Decision|9
5679845|NCT00393510|19593574|P1|Overall Study|Physician Decision|3
5679846|NCT00393484|19593586|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
5679847|NCT00393484|19593587|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
5679848|NCT00393484|19593586|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
5679849|NCT00393484|19593587|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
5679850|NCT00393484|19593586|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
5679851|NCT00393484|19593587|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
5679852|NCT00393484|19593586|P2|Open-label Period (Weeks 96 to 240)|Death|0
5679853|NCT00393484|19593587|P1|Open-label Period (Weeks 96 to 240)|Death|1
5679854|NCT00393484|19593586|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
5679855|NCT00393484|19593587|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
5679856|NCT00393484|19593586|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
5679857|NCT00393484|19593587|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
5679858|NCT00393484|19593586|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
5679859|NCT00393484|19593587|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
5679860|NCT00393484|19593586|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
5679861|NCT00393484|19593587|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
5679862|NCT00393484|19593586|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
5679863|NCT00393484|19593587|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
5679864|NCT00393484|19593586|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
5679865|NCT00393484|19593587|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
5679866|NCT00393458|19593623|P4|Overall Study|Subject no longer requires study drug|0
5679867|NCT00393458|19593624|P3|Overall Study|Subject no longer requires study drug|0
5679868|NCT00393458|19593625|P2|Overall Study|Subject no longer requires study drug|1
5679869|NCT00393458|19593626|P1|Overall Study|Subject no longer requires study drug|0
5679870|NCT00393458|19593623|P4|Overall Study|Abnormal test procedure result(s)|2
5679871|NCT00393458|19593624|P3|Overall Study|Abnormal test procedure result(s)|1
5679872|NCT00393458|19593625|P2|Overall Study|Abnormal test procedure result(s)|1
5679873|NCT00393458|19593626|P1|Overall Study|Abnormal test procedure result(s)|0
5679874|NCT00393458|19593623|P4|Overall Study|Death|5
5679875|NCT00393458|19593624|P3|Overall Study|Death|5
5679876|NCT00393458|19593625|P2|Overall Study|Death|1
5679877|NCT00393458|19593626|P1|Overall Study|Death|1
5679878|NCT00393458|19593623|P4|Overall Study|Abnormal laboratory value(s)|0
5679879|NCT00393458|19593624|P3|Overall Study|Abnormal laboratory value(s)|0
5679880|NCT00393458|19593625|P2|Overall Study|Abnormal laboratory value(s)|1
5679881|NCT00393458|19593626|P1|Overall Study|Abnormal laboratory value(s)|1
5679882|NCT00393458|19593623|P4|Overall Study|Lost to Follow-up|3
5679883|NCT00393458|19593624|P3|Overall Study|Lost to Follow-up|5
5679884|NCT00393458|19593625|P2|Overall Study|Lost to Follow-up|6
5679885|NCT00393458|19593626|P1|Overall Study|Lost to Follow-up|5
5679886|NCT00393458|19593623|P4|Overall Study|Administrative problems|2
5679887|NCT00393458|19593624|P3|Overall Study|Administrative problems|5
5679888|NCT00393458|19593625|P2|Overall Study|Administrative problems|8
5679889|NCT00393458|19593626|P1|Overall Study|Administrative problems|7
5679890|NCT00393458|19593623|P4|Overall Study|Protocol deviation|10
5679891|NCT00393458|19593624|P3|Overall Study|Protocol deviation|11
5679892|NCT00393458|19593625|P2|Overall Study|Protocol deviation|11
5679893|NCT00393458|19593626|P1|Overall Study|Protocol deviation|11
5679894|NCT00393458|19593623|P4|Overall Study|Unsatisfactory therapeutic effect|30
5679895|NCT00393458|19593624|P3|Overall Study|Unsatisfactory therapeutic effect|12
5679896|NCT00393458|19593625|P2|Overall Study|Unsatisfactory therapeutic effect|9
5679897|NCT00393458|19593626|P1|Overall Study|Unsatisfactory therapeutic effect|12
5679898|NCT00393458|19593623|P4|Overall Study|Subject withdrew consent|50
5679899|NCT00393458|19593624|P3|Overall Study|Subject withdrew consent|33
5679900|NCT00393458|19593625|P2|Overall Study|Subject withdrew consent|40
5679901|NCT00393458|19593626|P1|Overall Study|Subject withdrew consent|27
5679902|NCT00393458|19593623|P4|Overall Study|Adverse Event|35
5679903|NCT00393458|19593624|P3|Overall Study|Adverse Event|40
5679904|NCT00393458|19593625|P2|Overall Study|Adverse Event|24
5679905|NCT00393458|19593626|P1|Overall Study|Adverse Event|35
5679906|NCT00393367|19593653|P2|Overall Study|Withdrawal by Subject|2
5679907|NCT00393367|19593654|P1|Overall Study|Withdrawal by Subject|0
5679908|NCT00393367|19593653|P2|Overall Study|Protocol Violation|5
5679909|NCT00393367|19593654|P1|Overall Study|Protocol Violation|2
5679910|NCT00393094|19593682|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
5679911|NCT00393094|19593682|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
5679912|NCT00393042|19593693|P2|Second Intervetion|Protocol Violation|1
5679913|NCT00393042|19593694|P1|Second Intervetion|Protocol Violation|1
5679914|NCT00393042|19593693|P2|Second Intervetion|Lost to Follow-up|2
5679915|NCT00393042|19593694|P1|Second Intervetion|Lost to Follow-up|0
5679916|NCT00393042|19593693|P2|Second Intervetion|Lack of Efficacy|0
5679917|NCT00393042|19593694|P1|Second Intervetion|Lack of Efficacy|1
5679918|NCT00393042|19593693|P2|Second Intervetion|Withdrawal by Subject|2
5679919|NCT00393042|19593694|P1|Second Intervetion|Withdrawal by Subject|0
5679920|NCT00393042|19593693|P2|Second Intervetion|Adverse Event|3
5679921|NCT00393042|19593694|P1|Second Intervetion|Adverse Event|0
5679922|NCT00393042|19593693|P2|First Intervention|Adverse Event|1
5679923|NCT00393042|19593694|P1|First Intervention|Adverse Event|0
5679924|NCT00393042|19593693|P2|First Intervention|Protocol Violation|0
5679925|NCT00393042|19593694|P1|First Intervention|Protocol Violation|1
5679926|NCT00393042|19593693|P2|First Intervention|Lost to Follow-up|3
5679927|NCT00393042|19593694|P1|First Intervention|Lost to Follow-up|3
5679928|NCT00393042|19593693|P2|First Intervention|Withdrawal by Subject|2
5679929|NCT00393042|19593694|P1|First Intervention|Withdrawal by Subject|1
5679930|NCT00393029|19593766|P2|Overall Study|Not treated|1
5679931|NCT00393029|19593767|P1|Overall Study|Not treated|0
5679932|NCT00392990|19593778|P2|Follow up for 2 Years|Death|0
5679933|NCT00392990|19593779|P1|Follow up for 2 Years|Death|4
5679934|NCT00392990|19593778|P2|Treatment on Study|Adverse Event|1
5679935|NCT00392990|19593779|P1|Treatment on Study|Adverse Event|3
5679936|NCT00392925|19593803|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
5679937|NCT00392925|19593804|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
5679938|NCT00392925|19593805|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
5679939|NCT00392925|19593806|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
5679940|NCT00392925|19593803|P4|Randomization to Treatment Group Period|Protocol Violation|1
5679941|NCT00392925|19593804|P3|Randomization to Treatment Group Period|Protocol Violation|2
5679942|NCT00392925|19593805|P2|Randomization to Treatment Group Period|Protocol Violation|0
5679943|NCT00392925|19593806|P1|Randomization to Treatment Group Period|Protocol Violation|0
5679944|NCT00392925|19593803|P4|Randomization to Treatment Group Period|Adverse Event|5
5679945|NCT00392925|19593804|P3|Randomization to Treatment Group Period|Adverse Event|3
5679946|NCT00392925|19593805|P2|Randomization to Treatment Group Period|Adverse Event|3
5679947|NCT00392925|19593806|P1|Randomization to Treatment Group Period|Adverse Event|0
5679948|NCT00392925|19593803|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
5679949|NCT00392925|19593804|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
5679950|NCT00392925|19593805|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
5679951|NCT00392925|19593806|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
5679952|NCT00392925|19593803|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
5679953|NCT00392925|19593804|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
5679954|NCT00392925|19593805|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
5679955|NCT00392925|19593806|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
5679956|NCT00392925|19593803|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
5679957|NCT00392925|19593804|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
5679958|NCT00392925|19593805|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
5679959|NCT00392925|19593806|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
5679960|NCT00392925|19593803|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
5679961|NCT00392925|19593804|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
5679962|NCT00392925|19593805|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
5679963|NCT00392925|19593806|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
5679964|NCT00392925|19593803|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
5679965|NCT00392925|19593804|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
5679966|NCT00392925|19593805|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
5679967|NCT00392925|19593806|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
5679968|NCT00392925|19593803|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
5679969|NCT00392925|19593804|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
5679970|NCT00392925|19593805|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
5679971|NCT00392925|19593806|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
5679972|NCT00392808|19593920|P4|Overall Study|Unable to withdraw blood|2
5679973|NCT00392808|19593921|P3|Overall Study|Unable to withdraw blood|1
5679974|NCT00392808|19593922|P2|Overall Study|Unable to withdraw blood|1
5679975|NCT00392808|19593923|P1|Overall Study|Unable to withdraw blood|3
5679976|NCT00392808|19593920|P4|Overall Study|Lost to Follow-up|2
5679977|NCT00392808|19593921|P3|Overall Study|Lost to Follow-up|1
5679978|NCT00392808|19593922|P2|Overall Study|Lost to Follow-up|2
5679979|NCT00392808|19593923|P1|Overall Study|Lost to Follow-up|3
5679980|NCT00392769|19593947|P1|Overall Study|Adverse Event|1
5679981|NCT00392769|19593947|P1|Overall Study|Clinical Deterioration|9
5679982|NCT00392665|19593999|P2|Overall Study|Lost to Follow-up|1
5679983|NCT00392665|19594000|P1|Overall Study|Lost to Follow-up|1
5679984|NCT00392665|19593999|P2|Overall Study|Death|14
5679985|NCT00392665|19594000|P1|Overall Study|Death|16
5679986|NCT00392379|19594026|P2|Overall Study|Adverse Event|1
5679987|NCT00392379|19594027|P1|Overall Study|Adverse Event|1
5679988|NCT00392379|19594026|P2|Overall Study|Lost to Follow-up|9
5679989|NCT00392379|19594027|P1|Overall Study|Lost to Follow-up|4
5679990|NCT00392379|19594026|P2|Overall Study|Withdrawal by Subject|28
5679991|NCT00392379|19594027|P1|Overall Study|Withdrawal by Subject|17
5679992|NCT00392327|19594045|P8|Overall Study|Ineligible|0
5679993|NCT00392327|19594046|P7|Overall Study|Ineligible|0
5679994|NCT00392327|19594047|P6|Overall Study|Ineligible|0
5679995|NCT00392327|19594048|P5|Overall Study|Ineligible|0
5679996|NCT00392327|19594049|P4|Overall Study|Ineligible|2
5679997|NCT00392327|19594050|P3|Overall Study|Ineligible|3
5679998|NCT00392327|19594051|P2|Overall Study|Ineligible|4
5679999|NCT00392327|19594052|P1|Overall Study|Ineligible|0
5680000|NCT00392327|19594045|P8|Overall Study|Withdrawal by Subject|5
5680001|NCT00392327|19594046|P7|Overall Study|Withdrawal by Subject|1
5680002|NCT00392327|19594047|P6|Overall Study|Withdrawal by Subject|1
5680003|NCT00392327|19594048|P5|Overall Study|Withdrawal by Subject|0
5680004|NCT00392327|19594049|P4|Overall Study|Withdrawal by Subject|6
5680005|NCT00392327|19594050|P3|Overall Study|Withdrawal by Subject|4
5680006|NCT00392327|19594051|P2|Overall Study|Withdrawal by Subject|2
5680007|NCT00392327|19594052|P1|Overall Study|Withdrawal by Subject|3
5680008|NCT00392327|19594045|P8|Overall Study|Protocol Violation|0
5680009|NCT00392327|19594046|P7|Overall Study|Protocol Violation|0
5680010|NCT00392327|19594047|P6|Overall Study|Protocol Violation|0
5680011|NCT00392327|19594048|P5|Overall Study|Protocol Violation|0
5680012|NCT00392327|19594049|P4|Overall Study|Protocol Violation|0
5680013|NCT00392327|19594050|P3|Overall Study|Protocol Violation|1
5680014|NCT00392327|19594051|P2|Overall Study|Protocol Violation|0
5680015|NCT00392327|19594052|P1|Overall Study|Protocol Violation|0
5680016|NCT00392327|19594045|P8|Overall Study|Physician Decision|3
5680017|NCT00392327|19594046|P7|Overall Study|Physician Decision|5
5680018|NCT00392327|19594047|P6|Overall Study|Physician Decision|1
5680019|NCT00392327|19594048|P5|Overall Study|Physician Decision|0
5680020|NCT00392327|19594049|P4|Overall Study|Physician Decision|2
5680021|NCT00392327|19594050|P3|Overall Study|Physician Decision|2
5680022|NCT00392327|19594051|P2|Overall Study|Physician Decision|5
5680023|NCT00392327|19594052|P1|Overall Study|Physician Decision|3
5680024|NCT00392327|19594045|P8|Overall Study|Lack of Efficacy|3
5680025|NCT00392327|19594046|P7|Overall Study|Lack of Efficacy|3
5680026|NCT00392327|19594047|P6|Overall Study|Lack of Efficacy|3
5680027|NCT00392327|19594048|P5|Overall Study|Lack of Efficacy|3
5680028|NCT00392327|19594049|P4|Overall Study|Lack of Efficacy|6
5680029|NCT00392327|19594050|P3|Overall Study|Lack of Efficacy|9
5680030|NCT00392327|19594051|P2|Overall Study|Lack of Efficacy|8
5680031|NCT00392327|19594052|P1|Overall Study|Lack of Efficacy|8
5680032|NCT00392327|19594045|P8|Overall Study|Death|0
5680033|NCT00392327|19594046|P7|Overall Study|Death|0
5680034|NCT00392327|19594047|P6|Overall Study|Death|0
5680035|NCT00392327|19594048|P5|Overall Study|Death|0
5680036|NCT00392327|19594049|P4|Overall Study|Death|0
5680037|NCT00392327|19594050|P3|Overall Study|Death|1
5680038|NCT00392327|19594051|P2|Overall Study|Death|0
5680039|NCT00392327|19594052|P1|Overall Study|Death|1
5680040|NCT00392288|19594121|P3|Overall Study|Other|1
5680041|NCT00392288|19594122|P2|Overall Study|Other|4
5680042|NCT00392288|19594123|P1|Overall Study|Other|3
5680043|NCT00392288|19594121|P3|Overall Study|Parent/legal guardian withdrawal|1
5680044|NCT00392288|19594122|P2|Overall Study|Parent/legal guardian withdrawal|2
5680045|NCT00392288|19594123|P1|Overall Study|Parent/legal guardian withdrawal|1
5680046|NCT00392288|19594121|P3|Overall Study|Withdrawal by Subject|2
5680047|NCT00392288|19594122|P2|Overall Study|Withdrawal by Subject|0
5680048|NCT00392288|19594123|P1|Overall Study|Withdrawal by Subject|1
5680049|NCT00392288|19594121|P3|Overall Study|Lost to Follow-up|1
5680050|NCT00392288|19594122|P2|Overall Study|Lost to Follow-up|1
5680051|NCT00392288|19594123|P1|Overall Study|Lost to Follow-up|1
5680052|NCT00392288|19594121|P3|Overall Study|Protocol Violation|1
5680053|NCT00392288|19594122|P2|Overall Study|Protocol Violation|3
5680054|NCT00392288|19594123|P1|Overall Study|Protocol Violation|1
5680055|NCT00392288|19594121|P3|Overall Study|Lack of Efficacy|3
5680056|NCT00392288|19594122|P2|Overall Study|Lack of Efficacy|5
5680057|NCT00392288|19594123|P1|Overall Study|Lack of Efficacy|8
5680058|NCT00392288|19594121|P3|Overall Study|Adverse Event|8
5680059|NCT00392288|19594122|P2|Overall Study|Adverse Event|7
5680060|NCT00392288|19594123|P1|Overall Study|Adverse Event|17
5680061|NCT00392223|19594148|P2|Overall Study|Withdrawal by Subject|2
5680062|NCT00392223|19594149|P1|Overall Study|Withdrawal by Subject|3
5680063|NCT00392223|19594148|P2|Overall Study|Protocol Violation|3
5680064|NCT00392223|19594149|P1|Overall Study|Protocol Violation|0
5680065|NCT00392223|19594148|P2|Overall Study|Lost to Follow-up|4
5680066|NCT00392223|19594149|P1|Overall Study|Lost to Follow-up|1
5680067|NCT00392223|19594148|P2|Overall Study|Adverse Event|4
5680068|NCT00392223|19594149|P1|Overall Study|Adverse Event|5
5680069|NCT00392210|19594167|P2|First Voiding Trial|Physician Decision|2
5680070|NCT00392210|19594168|P1|First Voiding Trial|Physician Decision|2
5680071|NCT00392197|19594176|P2|Overall Study|Withdrawal by Subject|6
5680072|NCT00392197|19594177|P1|Overall Study|Withdrawal by Subject|4
5680073|NCT00392197|19594176|P2|Overall Study|Protocol Violation|5
5680074|NCT00392197|19594177|P1|Overall Study|Protocol Violation|7
5680075|NCT00392197|19594176|P2|Overall Study|Physician Decision|2
5680076|NCT00392197|19594177|P1|Overall Study|Physician Decision|3
5680077|NCT00392197|19594176|P2|Overall Study|Lost to Follow-up|1
5680078|NCT00392197|19594177|P1|Overall Study|Lost to Follow-up|0
5680079|NCT00392197|19594176|P2|Overall Study|Lack of Efficacy|4
5680080|NCT00392197|19594177|P1|Overall Study|Lack of Efficacy|3
5680081|NCT00392197|19594176|P2|Overall Study|Adverse Event|12
5680082|NCT00392197|19594177|P1|Overall Study|Adverse Event|4
5680083|NCT00392171|19594185|P1|Overall Study|Disease progression|101
5680084|NCT00392171|19594185|P1|Overall Study|Did not meet inclusion criteria|4
5680085|NCT00391976|19594219|P3|Overall Study|Positive P. aeruginosa antibody test|31
5680086|NCT00391976|19594220|P2|Overall Study|Positive P. aeruginosa antibody test|0
5680087|NCT00391976|19594221|P1|Overall Study|Positive P. aeruginosa antibody test|0
5680088|NCT00391976|19594219|P3|Overall Study|Unable to classify|1
5680089|NCT00391976|19594220|P2|Overall Study|Unable to classify|0
5680090|NCT00391976|19594221|P1|Overall Study|Unable to classify|0
5680091|NCT00391976|19594219|P3|Overall Study|Recurrence/no eradication of infection|0
5680092|NCT00391976|19594220|P2|Overall Study|Recurrence/no eradication of infection|19
5680093|NCT00391976|19594221|P1|Overall Study|Recurrence/no eradication of infection|21
5680094|NCT00391976|19594219|P3|Overall Study|Protocol deviation/violation|1
5680095|NCT00391976|19594220|P2|Overall Study|Protocol deviation/violation|2
5680096|NCT00391976|19594221|P1|Overall Study|Protocol deviation/violation|4
5680097|NCT00391976|19594219|P3|Overall Study|Inappropriate enrollment|0
5680098|NCT00391976|19594220|P2|Overall Study|Inappropriate enrollment|1
5680099|NCT00391976|19594221|P1|Overall Study|Inappropriate enrollment|1
5680100|NCT00391976|19594219|P3|Overall Study|Lost to Follow-up|0
5680101|NCT00391976|19594220|P2|Overall Study|Lost to Follow-up|2
5680102|NCT00391976|19594221|P1|Overall Study|Lost to Follow-up|1
5680103|NCT00391976|19594219|P3|Overall Study|Withdrawal of consent|1
5680104|NCT00391976|19594220|P2|Overall Study|Withdrawal of consent|1
5680105|NCT00391976|19594221|P1|Overall Study|Withdrawal of consent|0
5680106|NCT00391976|19594219|P3|Overall Study|Adverse Event|1
5680107|NCT00391976|19594220|P2|Overall Study|Adverse Event|0
5680108|NCT00391976|19594221|P1|Overall Study|Adverse Event|0
5680109|NCT00391898|19594245|P2|Overall Study|Other|10
5680110|NCT00391898|19594246|P1|Overall Study|Other|8
5680111|NCT00391898|19594245|P2|Overall Study|Adverse Event|0
5680112|NCT00391898|19594246|P1|Overall Study|Adverse Event|3
5680113|NCT00391872|19594266|P2|Overall Study|Lost to Follow-up|0
5680114|NCT00391872|19594267|P1|Overall Study|Lost to Follow-up|2
5680115|NCT00391872|19594266|P2|Overall Study|Reason unknown|4
5680116|NCT00391872|19594267|P1|Overall Study|Reason unknown|2
5680117|NCT00391872|19594266|P2|Overall Study|Withdrawal by Subject|249
5680118|NCT00391872|19594267|P1|Overall Study|Withdrawal by Subject|296
5680119|NCT00391872|19594266|P2|Overall Study|Protocol Violation|2
5680120|NCT00391872|19594267|P1|Overall Study|Protocol Violation|7
5680121|NCT00391846|19594305|P2|Overall Study|Developed study specific DC criteria|1
5680122|NCT00391846|19594306|P1|Overall Study|Developed study specific DC criteria|0
5680123|NCT00391846|19594305|P2|Overall Study|Withdrawal by Subject|3
5680124|NCT00391846|19594306|P1|Overall Study|Withdrawal by Subject|2
5680125|NCT00391846|19594305|P2|Overall Study|Did not meet the required elig. crit|2
5680126|NCT00391846|19594306|P1|Overall Study|Did not meet the required elig. crit|2
5680127|NCT00391846|19594305|P2|Overall Study|Adverse Event|1
5680128|NCT00391846|19594306|P1|Overall Study|Adverse Event|4
5680129|NCT00391807|19594326|P1|Overall Study|Various|96
5680130|NCT00391807|19594326|P1|Overall Study|Protocol Violation|20
5680131|NCT00391807|19594326|P1|Overall Study|Withdrawal by Subject|147
5680132|NCT00391807|19594326|P1|Overall Study|Lost to Follow-up|227
5680133|NCT00391807|19594326|P1|Overall Study|Pregnancy|25
5680134|NCT00391807|19594326|P1|Overall Study|Adverse Event|177
5680135|NCT00391807|19594326|P1|Overall Study|Did not receive study medication|23
5680136|NCT00391768|19594353|P7|Overall Study|Lost to Follow-up|3
5680137|NCT00391768|19594354|P6|Overall Study|Lost to Follow-up|2
5680138|NCT00391768|19594355|P5|Overall Study|Lost to Follow-up|2
5680139|NCT00391768|19594356|P4|Overall Study|Lost to Follow-up|1
5680140|NCT00391768|19594357|P3|Overall Study|Lost to Follow-up|0
5680141|NCT00391768|19594358|P2|Overall Study|Lost to Follow-up|0
5680142|NCT00391768|19594359|P1|Overall Study|Lost to Follow-up|0
5680143|NCT00391768|19594353|P7|Overall Study|Withdrawal by Subject|1
5680144|NCT00391768|19594354|P6|Overall Study|Withdrawal by Subject|1
5680145|NCT00391768|19594355|P5|Overall Study|Withdrawal by Subject|0
5680146|NCT00391768|19594356|P4|Overall Study|Withdrawal by Subject|0
5680147|NCT00391768|19594357|P3|Overall Study|Withdrawal by Subject|1
5680148|NCT00391768|19594358|P2|Overall Study|Withdrawal by Subject|0
5680149|NCT00391768|19594359|P1|Overall Study|Withdrawal by Subject|0
5680150|NCT00391625|19594446|P1|Month 50|Physician Decision|1
5680151|NCT00391625|19594446|P1|Month 14|Withdrawal by Subject|1
5680152|NCT00391586|19594499|P1|Overall Study|Death|4
5680153|NCT00391586|19594499|P1|Overall Study|Physician Decision|2
5680154|NCT00391586|19594499|P1|Overall Study|Adverse Event|5
5680155|NCT00391586|19594499|P1|Overall Study|Progressive disease|13
5680156|NCT00391391|19594536|P4|Overall Study|Withdrawal by Subject|7
5680157|NCT00391391|19594537|P3|Overall Study|Withdrawal by Subject|10
5680158|NCT00391391|19594538|P2|Overall Study|Withdrawal by Subject|4
5680159|NCT00391391|19594539|P1|Overall Study|Withdrawal by Subject|6
5680160|NCT00391391|19594536|P4|Overall Study|Protocol Violation|7
5680161|NCT00391391|19594537|P3|Overall Study|Protocol Violation|6
5680162|NCT00391391|19594538|P2|Overall Study|Protocol Violation|3
5680163|NCT00391391|19594539|P1|Overall Study|Protocol Violation|2
5680164|NCT00391391|19594536|P4|Overall Study|Lost to Follow-up|4
5680165|NCT00391391|19594537|P3|Overall Study|Lost to Follow-up|7
5680166|NCT00391391|19594538|P2|Overall Study|Lost to Follow-up|3
5680167|NCT00391391|19594539|P1|Overall Study|Lost to Follow-up|1
5680168|NCT00391391|19594536|P4|Overall Study|Adverse Event|1
5680169|NCT00391391|19594537|P3|Overall Study|Adverse Event|0
5680170|NCT00391391|19594538|P2|Overall Study|Adverse Event|0
5680171|NCT00391391|19594539|P1|Overall Study|Adverse Event|0
5680172|NCT00391274|19594584|P2|Overall Study|Death Not Study Related|1
5680173|NCT00391274|19594585|P1|Overall Study|Death Not Study Related|0
5680174|NCT00391274|19594584|P2|Overall Study|Death Due to Indeterminate Cause|0
5680175|NCT00391274|19594585|P1|Overall Study|Death Due to Indeterminate Cause|1
5680176|NCT00391274|19594584|P2|Overall Study|Death Due to Adverse Event|3
5680177|NCT00391274|19594585|P1|Overall Study|Death Due to Adverse Event|1
5680178|NCT00391274|19594584|P2|Overall Study|Withdrawal by Subject|3
5680179|NCT00391274|19594585|P1|Overall Study|Withdrawal by Subject|0
5680180|NCT00391274|19594584|P2|Overall Study|Physician Decision|2
5680181|NCT00391274|19594585|P1|Overall Study|Physician Decision|4
5680182|NCT00391274|19594584|P2|Overall Study|Lost to Follow-up|3
5680183|NCT00391274|19594585|P1|Overall Study|Lost to Follow-up|0
5680184|NCT00391274|19594584|P2|Overall Study|Death Due to Study Disease|45
5680185|NCT00391274|19594585|P1|Overall Study|Death Due to Study Disease|55
5680186|NCT00391222|19594604|P4|Period III (Double-Blind Treatment)|Other|0
5680187|NCT00391222|19594605|P3|Period III (Double-Blind Treatment)|Other|6
5680188|NCT00391222|19594606|P2|Period III (Double-Blind Treatment)|Other|1
5680189|NCT00391222|19594607|P1|Period III (Double-Blind Treatment)|Other|6
5680190|NCT00391222|19594604|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
5680191|NCT00391222|19594605|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
5680192|NCT00391222|19594606|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
5680193|NCT00391222|19594607|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
5680194|NCT00391222|19594604|P4|Period III (Double-Blind Treatment)|Pregnancy|0
5680195|NCT00391222|19594605|P3|Period III (Double-Blind Treatment)|Pregnancy|0
5680196|NCT00391222|19594606|P2|Period III (Double-Blind Treatment)|Pregnancy|2
5680197|NCT00391222|19594607|P1|Period III (Double-Blind Treatment)|Pregnancy|0
5680198|NCT00391222|19594604|P4|Period III (Double-Blind Treatment)|Adverse Event|0
5680199|NCT00391222|19594605|P3|Period III (Double-Blind Treatment)|Adverse Event|4
5680200|NCT00391222|19594606|P2|Period III (Double-Blind Treatment)|Adverse Event|2
5680201|NCT00391222|19594607|P1|Period III (Double-Blind Treatment)|Adverse Event|5
5680202|NCT00391222|19594604|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
5680203|NCT00391222|19594605|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
5680204|NCT00391222|19594606|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
5680205|NCT00391222|19594607|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
5680206|NCT00391222|19594604|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
5680207|NCT00391222|19594605|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
5680208|NCT00391222|19594606|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
5680209|NCT00391222|19594607|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
5680210|NCT00391222|19594604|P4|Period II (Open-label Risperidone LAI)|Other|24
5680211|NCT00391222|19594605|P3|Period II (Open-label Risperidone LAI)|Other|0
5680212|NCT00391222|19594606|P2|Period II (Open-label Risperidone LAI)|Other|0
5680213|NCT00391222|19594607|P1|Period II (Open-label Risperidone LAI)|Other|0
5680214|NCT00391222|19594604|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
5680215|NCT00391222|19594605|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
5680216|NCT00391222|19594606|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
5680217|NCT00391222|19594607|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
5680218|NCT00391222|19594604|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
5680219|NCT00391222|19594605|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
5680220|NCT00391222|19594606|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
5680221|NCT00391222|19594607|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
5680222|NCT00391222|19594604|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
5680223|NCT00391222|19594605|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
5680224|NCT00391222|19594606|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
5680225|NCT00391222|19594607|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
5680226|NCT00391222|19594604|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
5680227|NCT00391222|19594605|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
5680228|NCT00391222|19594606|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
5680229|NCT00391222|19594607|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
5680230|NCT00391118|19594634|P3|Overall Study|Protocol Violation|0
5680231|NCT00391118|19594635|P2|Overall Study|Protocol Violation|0
5680232|NCT00391118|19594636|P1|Overall Study|Protocol Violation|1
5680233|NCT00391118|19594634|P3|Overall Study|Sponsor Decision|3
5680234|NCT00391118|19594635|P2|Overall Study|Sponsor Decision|1
5680235|NCT00391118|19594636|P1|Overall Study|Sponsor Decision|0
5680236|NCT00391118|19594634|P3|Overall Study|Progressive Disease|43
5680237|NCT00391118|19594635|P2|Overall Study|Progressive Disease|26
5680238|NCT00391118|19594636|P1|Overall Study|Progressive Disease|7
5680239|NCT00391118|19594634|P3|Overall Study|Protocol Entry Criteria Not Met|1
5680240|NCT00391118|19594635|P2|Overall Study|Protocol Entry Criteria Not Met|3
5680241|NCT00391118|19594636|P1|Overall Study|Protocol Entry Criteria Not Met|0
5680242|NCT00391118|19594634|P3|Overall Study|Physician Decision|0
5680243|NCT00391118|19594635|P2|Overall Study|Physician Decision|3
5680244|NCT00391118|19594636|P1|Overall Study|Physician Decision|0
5680245|NCT00391118|19594634|P3|Overall Study|Death|0
5680246|NCT00391118|19594635|P2|Overall Study|Death|1
5680247|NCT00391118|19594636|P1|Overall Study|Death|0
5680248|NCT00391118|19594634|P3|Overall Study|Withdrawal by Subject|1
5680249|NCT00391118|19594635|P2|Overall Study|Withdrawal by Subject|9
5680250|NCT00391118|19594636|P1|Overall Study|Withdrawal by Subject|0
5680251|NCT00391118|19594634|P3|Overall Study|Lost to Follow-up|3
5680252|NCT00391118|19594635|P2|Overall Study|Lost to Follow-up|2
5680253|NCT00391118|19594636|P1|Overall Study|Lost to Follow-up|0
5680254|NCT00391118|19594634|P3|Overall Study|Adverse Event|7
5680255|NCT00391118|19594635|P2|Overall Study|Adverse Event|10
5680256|NCT00391118|19594636|P1|Overall Study|Adverse Event|3
5680257|NCT00391092|19594662|P2|Overall Study|Alive in follow-up|84
5680258|NCT00391092|19594663|P1|Overall Study|Alive in follow-up|88
5680259|NCT00391092|19594662|P2|Overall Study|Alive on treatment|33
5680260|NCT00391092|19594663|P1|Overall Study|Alive on treatment|29
5680261|NCT00391092|19594662|P2|Overall Study|Lost to Follow-up|18
5680262|NCT00391092|19594663|P1|Overall Study|Lost to Follow-up|13
5680263|NCT00391092|19594662|P2|Overall Study|Death|81
5680264|NCT00391092|19594663|P1|Overall Study|Death|78
5680265|NCT00391053|19594706|P4|Overall Study|Withdrawal by Subject|1
5680266|NCT00391053|19594707|P3|Overall Study|Withdrawal by Subject|1
5680267|NCT00391053|19594708|P2|Overall Study|Withdrawal by Subject|1
5680268|NCT00391053|19594709|P1|Overall Study|Withdrawal by Subject|5
5680269|NCT00391053|19594706|P4|Overall Study|Lost to Follow-up|5
5680270|NCT00391053|19594707|P3|Overall Study|Lost to Follow-up|0
5680271|NCT00391053|19594708|P2|Overall Study|Lost to Follow-up|0
5680272|NCT00391053|19594709|P1|Overall Study|Lost to Follow-up|1
5680273|NCT00391053|19594706|P4|Overall Study|Protocol Violation|0
5680274|NCT00391053|19594707|P3|Overall Study|Protocol Violation|0
5680275|NCT00391053|19594708|P2|Overall Study|Protocol Violation|0
5680276|NCT00391053|19594709|P1|Overall Study|Protocol Violation|2
5680277|NCT00391053|19594706|P4|Overall Study|Serious Adverse Events|4
5680278|NCT00391053|19594707|P3|Overall Study|Serious Adverse Events|1
5680279|NCT00391053|19594708|P2|Overall Study|Serious Adverse Events|0
5680280|NCT00391053|19594709|P1|Overall Study|Serious Adverse Events|1
5680281|NCT00391027|19594733|P2|Overall Study|Other|3
5680282|NCT00391027|19594734|P1|Overall Study|Other|4
5680283|NCT00391027|19594733|P2|Overall Study|Withdrawal by Subject|1
5680284|NCT00391027|19594734|P1|Overall Study|Withdrawal by Subject|10
5680285|NCT00391027|19594733|P2|Overall Study|Lack of Efficacy|0
5680286|NCT00391027|19594734|P1|Overall Study|Lack of Efficacy|3
5680287|NCT00391027|19594733|P2|Overall Study|Adverse Event|8
5680288|NCT00391027|19594734|P1|Overall Study|Adverse Event|8
5680289|NCT00390910|19594784|P3|Overall Study|Migrated/moved from study area|3
5680290|NCT00390910|19594785|P2|Overall Study|Migrated/moved from study area|0
5680291|NCT00390910|19594786|P1|Overall Study|Migrated/moved from study area|0
5680292|NCT00390910|19594784|P3|Overall Study|Withdrawal by Subject|2
5680293|NCT00390910|19594785|P2|Overall Study|Withdrawal by Subject|3
5680294|NCT00390910|19594786|P1|Overall Study|Withdrawal by Subject|1
5680295|NCT00390910|19594784|P3|Overall Study|Lost to Follow-up|5
5680296|NCT00390910|19594785|P2|Overall Study|Lost to Follow-up|1
5680297|NCT00390910|19594786|P1|Overall Study|Lost to Follow-up|0
5680298|NCT00390910|19594784|P3|Overall Study|Adverse Event|0
5680299|NCT00390910|19594785|P2|Overall Study|Adverse Event|0
5680300|NCT00390910|19594786|P1|Overall Study|Adverse Event|1
5680301|NCT00390884|19594874|P2|Overall Study|Withdrawal by Subject|2
5680302|NCT00390884|19594875|P1|Overall Study|Withdrawal by Subject|2
5680303|NCT00390858|19594887|P2|Overall Study|Withdrawal by Subject|4
5680304|NCT00390858|19594888|P1|Overall Study|Withdrawal by Subject|3
5680305|NCT00390858|19594887|P2|Overall Study|Lack of Efficacy|1
5680306|NCT00390858|19594888|P1|Overall Study|Lack of Efficacy|0
5680307|NCT00390858|19594887|P2|Overall Study|Adverse Event|2
5680308|NCT00390858|19594888|P1|Overall Study|Adverse Event|6
5680309|NCT00390806|19594902|P2|Overall Study|Ongoing|2
5680310|NCT00390806|19594903|P1|Overall Study|Ongoing|4
5680311|NCT00390806|19594902|P2|Overall Study|Physician Decision|1
5680312|NCT00390806|19594903|P1|Overall Study|Physician Decision|0
5680313|NCT00390806|19594902|P2|Overall Study|Death|0
5680314|NCT00390806|19594903|P1|Overall Study|Death|1
5680315|NCT00390806|19594902|P2|Overall Study|Investigator Decision|6
5680316|NCT00390806|19594903|P1|Overall Study|Investigator Decision|4
5680317|NCT00390806|19594902|P2|Overall Study|Withdrawal by Subject|15
5680318|NCT00390806|19594903|P1|Overall Study|Withdrawal by Subject|12
5680319|NCT00390806|19594902|P2|Overall Study|Protocol Violation|2
5680320|NCT00390806|19594903|P1|Overall Study|Protocol Violation|2
5680321|NCT00390806|19594902|P2|Overall Study|Lost to Follow-up|6
5680322|NCT00390806|19594903|P1|Overall Study|Lost to Follow-up|7
5680323|NCT00390780|19594971|P2|Overall Study|SAE, death|1
5680324|NCT00390780|19594972|P1|Overall Study|SAE, death|0
5680325|NCT00390780|19594971|P2|Overall Study|Investigator decision, SAE, other reason|1
5680326|NCT00390780|19594972|P1|Overall Study|Investigator decision, SAE, other reason|0
5680327|NCT00390780|19594971|P2|Overall Study|Lost to follow up and other reasons|1
5680328|NCT00390780|19594972|P1|Overall Study|Lost to follow up and other reasons|0
5680329|NCT00390780|19594971|P2|Overall Study|Inclusion criteria not satisfied|2
5680330|NCT00390780|19594972|P1|Overall Study|Inclusion criteria not satisfied|0
5680331|NCT00390780|19594971|P2|Overall Study|Withdrawal by Subject|2
5680332|NCT00390780|19594972|P1|Overall Study|Withdrawal by Subject|1
5680333|NCT00390780|19594971|P2|Overall Study|Death|3
5680334|NCT00390780|19594972|P1|Overall Study|Death|1
5680335|NCT00390780|19594971|P2|Overall Study|Adverse Event|3
5680336|NCT00390780|19594972|P1|Overall Study|Adverse Event|2
5680337|NCT00390780|19594971|P2|Overall Study|Lost to Follow-up|6
5680338|NCT00390780|19594972|P1|Overall Study|Lost to Follow-up|3
5680339|NCT00390780|19594971|P2|Overall Study|Protocol Violation|4
5680340|NCT00390780|19594972|P1|Overall Study|Protocol Violation|6
5680341|NCT00390780|19594971|P2|Overall Study|Not completed|4
5680342|NCT00390780|19594972|P1|Overall Study|Not completed|10
5680343|NCT00390689|19595005|P3|Overall Study|Investigator's judgement|0
5680344|NCT00390689|19595006|P2|Overall Study|Investigator's judgement|0
5680345|NCT00390689|19595007|P1|Overall Study|Investigator's judgement|2
5680346|NCT00390689|19595005|P3|Overall Study|Protocol Violation|0
5680347|NCT00390689|19595006|P2|Overall Study|Protocol Violation|0
5680348|NCT00390689|19595007|P1|Overall Study|Protocol Violation|1
5680349|NCT00390689|19595005|P3|Overall Study|Lack of Efficacy|1
5680350|NCT00390689|19595006|P2|Overall Study|Lack of Efficacy|0
5680351|NCT00390689|19595007|P1|Overall Study|Lack of Efficacy|0
5680352|NCT00390689|19595005|P3|Overall Study|Adverse Event|2
5680353|NCT00390689|19595006|P2|Overall Study|Adverse Event|5
5680354|NCT00390689|19595007|P1|Overall Study|Adverse Event|2
5680355|NCT00390572|19595082|P2|Overall Study|health condition|1
5680356|NCT00390572|19595083|P1|Overall Study|health condition|0
5680357|NCT00390572|19595082|P2|Overall Study|Lost to Follow-up|4
5680358|NCT00390572|19595083|P1|Overall Study|Lost to Follow-up|8
5680359|NCT00390546|19595109|P2|Overall Study|Physician Decision|5
5680360|NCT00390546|19595110|P1|Overall Study|Physician Decision|5
5680361|NCT00390546|19595109|P2|Overall Study|Renal impairment|0
5680362|NCT00390546|19595110|P1|Overall Study|Renal impairment|1
5680363|NCT00390468|19595120|P1|Overall Study|Lack of Efficacy|1
5680364|NCT00390468|19595120|P1|Overall Study|Protocol Violation|2
5680365|NCT00390455|19595126|P2|Overall Study|Other Medical Reasons|11
5680366|NCT00390455|19595127|P1|Overall Study|Other Medical Reasons|7
5680367|NCT00390455|19595126|P2|Overall Study|Alternate Treatment|1
5680368|NCT00390455|19595127|P1|Overall Study|Alternate Treatment|0
5680369|NCT00390455|19595126|P2|Overall Study|Withdrawal by Subject|8
5680370|NCT00390455|19595127|P1|Overall Study|Withdrawal by Subject|8
5680371|NCT00390455|19595126|P2|Overall Study|Adverse Event|3
5680372|NCT00390455|19595127|P1|Overall Study|Adverse Event|17
5680373|NCT00390416|19595172|P1|Overall Study|Not treated|3
5680374|NCT00390416|19595172|P1|Overall Study|Withdrawal by Subject|1
5680375|NCT00390299|19595210|P5|Overall Study|Cancellation|0
5680376|NCT00390299|19595211|P4|Overall Study|Cancellation|0
5680377|NCT00390299|19595212|P3|Overall Study|Cancellation|0
5680378|NCT00390299|19595213|P2|Overall Study|Cancellation|0
5680379|NCT00390299|19595214|P1|Overall Study|Cancellation|1
5680380|NCT00390221|19595245|P3|Overall Study|Other|2
5680381|NCT00390221|19595246|P2|Overall Study|Other|4
5680382|NCT00390221|19595247|P1|Overall Study|Other|3
5680383|NCT00390221|19595245|P3|Overall Study|Subject Non-compliance|2
5680384|NCT00390221|19595246|P2|Overall Study|Subject Non-compliance|0
5680385|NCT00390221|19595247|P1|Overall Study|Subject Non-compliance|1
5680386|NCT00390221|19595245|P3|Overall Study|Withdrawal by Subject|7
5680387|NCT00390221|19595246|P2|Overall Study|Withdrawal by Subject|9
5680388|NCT00390221|19595247|P1|Overall Study|Withdrawal by Subject|13
5680389|NCT00390221|19595245|P3|Overall Study|Investigator Decision|1
5680390|NCT00390221|19595246|P2|Overall Study|Investigator Decision|0
5680391|NCT00390221|19595247|P1|Overall Study|Investigator Decision|0
5680392|NCT00390221|19595245|P3|Overall Study|Adverse Event|3
5680393|NCT00390221|19595246|P2|Overall Study|Adverse Event|4
5680394|NCT00390221|19595247|P1|Overall Study|Adverse Event|1
5680395|NCT00390221|19595245|P3|Overall Study|Lost to Follow-up|0
5680396|NCT00390221|19595246|P2|Overall Study|Lost to Follow-up|3
5680397|NCT00390221|19595247|P1|Overall Study|Lost to Follow-up|0
5680398|NCT00390013|19595277|P4|Phase 2 First Treatment|Withdrawal by Subject|0
5680399|NCT00390013|19595278|P3|Phase 2 First Treatment|Withdrawal by Subject|0
5680400|NCT00390013|19595279|P2|Phase 2 First Treatment|Withdrawal by Subject|1
5680401|NCT00390013|19595280|P1|Phase 2 First Treatment|Withdrawal by Subject|0
5680402|NCT00390013|19595277|P4|Phase 2 First Treatment|tired|0
5680403|NCT00390013|19595278|P3|Phase 2 First Treatment|tired|0
5680404|NCT00390013|19595279|P2|Phase 2 First Treatment|tired|0
5680405|NCT00390013|19595280|P1|Phase 2 First Treatment|tired|1
5680406|NCT00390013|19595277|P4|Phase 1|tired|1
5680407|NCT00390013|19595278|P3|Phase 1|tired|0
5680408|NCT00390013|19595279|P2|Phase 1|tired|0
5680409|NCT00390013|19595280|P1|Phase 1|tired|0
5680410|NCT00389831|19595305|P2|Overall Study|Lost to Follow-up|1
5680411|NCT00389831|19595306|P1|Overall Study|Lost to Follow-up|0
5680412|NCT00389831|19595305|P2|Overall Study|Other reasons|2
5680413|NCT00389831|19595306|P1|Overall Study|Other reasons|0
5680414|NCT00389831|19595305|P2|Overall Study|Did not receive treatment.|2
5680415|NCT00389831|19595306|P1|Overall Study|Did not receive treatment.|0
5680416|NCT00389831|19595305|P2|Overall Study|Lack of Efficacy|2
5680417|NCT00389831|19595306|P1|Overall Study|Lack of Efficacy|0
5680418|NCT00389597|19595369|P4|Overall Study|Lost to Follow-up|6
5680419|NCT00389597|19595370|P3|Overall Study|Lost to Follow-up|4
5680420|NCT00389597|19595371|P2|Overall Study|Lost to Follow-up|6
5680421|NCT00389597|19595372|P1|Overall Study|Lost to Follow-up|8
5680422|NCT00389519|19595397|P4|Treated|Reason not specified|2
5680423|NCT00389519|19595398|P3|Treated|Reason not specified|0
5680424|NCT00389519|19595399|P2|Treated|Reason not specified|1
5680425|NCT00389519|19595400|P1|Treated|Reason not specified|1
5680426|NCT00389519|19595397|P4|Treated|Adverse Event|2
5680427|NCT00389519|19595398|P3|Treated|Adverse Event|0
5680428|NCT00389519|19595399|P2|Treated|Adverse Event|0
5680429|NCT00389519|19595400|P1|Treated|Adverse Event|1
5680430|NCT00389519|19595397|P4|Randomized|Did not receive study drug|0
5680431|NCT00389519|19595398|P3|Randomized|Did not receive study drug|0
5680432|NCT00389519|19595399|P2|Randomized|Did not receive study drug|0
5680433|NCT00389519|19595400|P1|Randomized|Did not receive study drug|2
5680434|NCT00389519|19595397|P4|Placebo Run-In|Reason not specified|0
5680435|NCT00389519|19595398|P3|Placebo Run-In|Reason not specified|0
5680436|NCT00389519|19595399|P2|Placebo Run-In|Reason not specified|0
5680437|NCT00389519|19595400|P1|Placebo Run-In|Reason not specified|40
5680438|NCT00389519|19595397|P4|Placebo Run-In|Withdrawal by Subject|0
5680439|NCT00389519|19595398|P3|Placebo Run-In|Withdrawal by Subject|0
5680440|NCT00389519|19595399|P2|Placebo Run-In|Withdrawal by Subject|0
5680441|NCT00389519|19595400|P1|Placebo Run-In|Withdrawal by Subject|19
5680442|NCT00389519|19595397|P4|Placebo Run-In|Did not meet blood pressure criteria|0
5680443|NCT00389519|19595398|P3|Placebo Run-In|Did not meet blood pressure criteria|0
5680444|NCT00389519|19595399|P2|Placebo Run-In|Did not meet blood pressure criteria|0
5680445|NCT00389519|19595400|P1|Placebo Run-In|Did not meet blood pressure criteria|119
5680446|NCT00389441|19595477|P1|Overall Study|Clinical progression|1
5680447|NCT00389441|19595477|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
5680448|NCT00389441|19595477|P1|Overall Study|Objective progression or relapse|26
5680449|NCT00389441|19595477|P1|Overall Study|Global deterioration of health status|4
5680450|NCT00389441|19595477|P1|Overall Study|Protocol Violation|1
5680451|NCT00389441|19595477|P1|Overall Study|Physician Decision|1
5680452|NCT00389441|19595477|P1|Overall Study|Withdrawal by Subject|4
5680453|NCT00389441|19595477|P1|Overall Study|Lost to Follow-up|2
5680454|NCT00389441|19595477|P1|Overall Study|Death|4
5680455|NCT00389441|19595477|P1|Overall Study|Adverse Event|7
5680456|NCT00389324|19595486|P1|Subcutaneous Phase|Lost to Follow-up|1
5680457|NCT00389324|19595486|P1|Subcutaneous Phase|Withdrawal by Subject|2
5680458|NCT00389324|19595486|P1|Subcutaneous Phase|Non-compliance with study medication|2
5680459|NCT00389324|19595486|P1|Subcutaneous Phase|Adverse Event|2
5680460|NCT00389324|19595486|P1|Run-In Phase|Withdrawal by Subject|1
5680461|NCT00389324|19595486|P1|Run-In Phase|Lost to Follow-up|1
5680462|NCT00389324|19595486|P1|Run-In Phase|Adverse Event|1
5680463|NCT00389207|19595496|P3|Overall Study|Other|9
5680464|NCT00389207|19595497|P2|Overall Study|Other|23
5680465|NCT00389207|19595498|P1|Overall Study|Other|17
5680466|NCT00389207|19595496|P3|Overall Study|Withdrawal by Subject|11
5680467|NCT00389207|19595497|P2|Overall Study|Withdrawal by Subject|7
5680468|NCT00389207|19595498|P1|Overall Study|Withdrawal by Subject|5
5680469|NCT00389207|19595496|P3|Overall Study|Lost to Follow-up|7
5680470|NCT00389207|19595497|P2|Overall Study|Lost to Follow-up|9
5680471|NCT00389207|19595498|P1|Overall Study|Lost to Follow-up|12
5680472|NCT00389207|19595496|P3|Overall Study|Protocol Violation|4
5680473|NCT00389207|19595497|P2|Overall Study|Protocol Violation|1
5680474|NCT00389207|19595498|P1|Overall Study|Protocol Violation|3
5680475|NCT00389207|19595496|P3|Overall Study|Adverse Event|10
5680476|NCT00389207|19595497|P2|Overall Study|Adverse Event|32
5680477|NCT00389207|19595498|P1|Overall Study|Adverse Event|26
5680478|NCT00389064|19595621|P2|Overall Study|Multiple Reasons|11
5680479|NCT00389064|19595622|P1|Overall Study|Multiple Reasons|9
5680480|NCT00389064|19595621|P2|Overall Study|Protocol Violation|0
5680481|NCT00389064|19595622|P1|Overall Study|Protocol Violation|2
5680482|NCT00389064|19595621|P2|Overall Study|Lost to Follow-up|2
5680483|NCT00389064|19595622|P1|Overall Study|Lost to Follow-up|1
5680484|NCT00389064|19595621|P2|Overall Study|Physician Decision|2
5680485|NCT00389064|19595622|P1|Overall Study|Physician Decision|2
5680486|NCT00389064|19595621|P2|Overall Study|Withdrawal by Subject|27
5680487|NCT00389064|19595622|P1|Overall Study|Withdrawal by Subject|17
5680488|NCT00389064|19595621|P2|Overall Study|Lack of Efficacy|14
5680489|NCT00389064|19595622|P1|Overall Study|Lack of Efficacy|3
5680490|NCT00389064|19595621|P2|Overall Study|Adverse Event|3
5680491|NCT00389064|19595622|P1|Overall Study|Adverse Event|11
5680492|NCT00388973|19595650|P2|Overall Study|Did not complete 2-week follow-up visit|17
5680493|NCT00388973|19595651|P1|Overall Study|Did not complete 2-week follow-up visit|17
5680494|NCT00388973|19595650|P2|Overall Study|Left region|1
5680495|NCT00388973|19595651|P1|Overall Study|Left region|0
5680496|NCT00388973|19595650|P2|Overall Study|Did not complete 61 days of treatment|4
5680497|NCT00388973|19595651|P1|Overall Study|Did not complete 61 days of treatment|5
5680498|NCT00388973|19595650|P2|Overall Study|Study specific Discontinuation Criteria|1
5680499|NCT00388973|19595651|P1|Overall Study|Study specific Discontinuation Criteria|0
5680500|NCT00388973|19595650|P2|Overall Study|Withdrawal by Subject|17
5680501|NCT00388973|19595651|P1|Overall Study|Withdrawal by Subject|14
5680502|NCT00388973|19595650|P2|Overall Study|Protocol Violation|0
5680503|NCT00388973|19595651|P1|Overall Study|Protocol Violation|3
5680504|NCT00388973|19595650|P2|Overall Study|Lack of Efficacy|12
5680505|NCT00388973|19595651|P1|Overall Study|Lack of Efficacy|1
5680506|NCT00388973|19595650|P2|Overall Study|Adverse Event|6
5680507|NCT00388973|19595651|P1|Overall Study|Adverse Event|16
5680508|NCT00388947|19595671|P1|Overall Study|Protocol Violation|47
5680509|NCT00388726|19595687|P2|Overall Study|Death|2
5680510|NCT00388726|19595688|P1|Overall Study|Death|3
5680511|NCT00388726|19595687|P2|Overall Study|Physician Decision|13
5680512|NCT00388726|19595688|P1|Overall Study|Physician Decision|18
5680513|NCT00388726|19595687|P2|Overall Study|Administrative|9
5680514|NCT00388726|19595688|P1|Overall Study|Administrative|6
5680515|NCT00388726|19595687|P2|Overall Study|Withdrawal by Subject|7
5680516|NCT00388726|19595688|P1|Overall Study|Withdrawal by Subject|10
5680517|NCT00388726|19595687|P2|Overall Study|Clinical Progression|36
5680518|NCT00388726|19595688|P1|Overall Study|Clinical Progression|61
5680519|NCT00388726|19595687|P2|Overall Study|Progressive Disease|153
5680520|NCT00388726|19595688|P1|Overall Study|Progressive Disease|336
5680521|NCT00388726|19595687|P2|Overall Study|Adverse Event|24
5680522|NCT00388726|19595688|P1|Overall Study|Adverse Event|50
5680523|NCT00388674|19595704|P2|End of Study|Not Reported|1
5680524|NCT00388674|19595705|P1|End of Study|Not Reported|0
5680525|NCT00388674|19595704|P2|End of Study|No Off-Treatment Status Data|30
5680526|NCT00388674|19595705|P1|End of Study|No Off-Treatment Status Data|22
5680527|NCT00388674|19595704|P2|End of Study|Participant Withdrew Consent|673
5680528|NCT00388674|19595705|P1|End of Study|Participant Withdrew Consent|437
5680529|NCT00388674|19595704|P2|End of Study|Not Defined|214
5680530|NCT00388674|19595705|P1|End of Study|Not Defined|135
5680531|NCT00388674|19595704|P2|End of Study|Non-Study Related Comorbidities|4
5680532|NCT00388674|19595705|P1|End of Study|Non-Study Related Comorbidities|3
5680533|NCT00388674|19595704|P2|End of Study|Malignancy (Non-HCC)|1
5680534|NCT00388674|19595705|P1|End of Study|Malignancy (Non-HCC)|1
5680535|NCT00388674|19595704|P2|End of Study|Lost to Follow-up|715
5680536|NCT00388674|19595705|P1|End of Study|Lost to Follow-up|587
5680537|NCT00388674|19595704|P2|End of Study|HCC|7
5680538|NCT00388674|19595705|P1|End of Study|HCC|8
5680539|NCT00388674|19595704|P2|End of Study|HBV Disease Progression (Non-HCC)|9
5680540|NCT00388674|19595705|P1|End of Study|HBV Disease Progression (Non-HCC)|3
5680541|NCT00388674|19595704|P2|End of Study|Death|262
5680542|NCT00388674|19595705|P1|End of Study|Death|239
5680543|NCT00388674|19595704|P2|End of Study|Administrative Reason By Sponsor|253
5680544|NCT00388674|19595705|P1|End of Study|Administrative Reason By Sponsor|299
5680545|NCT00388674|19595704|P2|Initial Treatment|Not Reported|12
5680546|NCT00388674|19595705|P1|Initial Treatment|Not Reported|10
5680547|NCT00388674|19595704|P2|Initial Treatment|No Off-Treatment Status Data|13
5680548|NCT00388674|19595705|P1|Initial Treatment|No Off-Treatment Status Data|11
5680549|NCT00388674|19595704|P2|Initial Treatment|Participant Request|673
5680550|NCT00388674|19595705|P1|Initial Treatment|Participant Request|501
5680551|NCT00388674|19595704|P2|Initial Treatment|Study Drug Toxicity|92
5680552|NCT00388674|19595705|P1|Initial Treatment|Study Drug Toxicity|5
5680553|NCT00388674|19595704|P2|Initial Treatment|Pregnancy|16
5680554|NCT00388674|19595705|P1|Initial Treatment|Pregnancy|26
5680555|NCT00388674|19595704|P2|Initial Treatment|Partial or inadequate Treatment|472
5680556|NCT00388674|19595705|P1|Initial Treatment|Partial or inadequate Treatment|112
5680557|NCT00388674|19595704|P2|Initial Treatment|Not Defined|172
5680558|NCT00388674|19595705|P1|Initial Treatment|Not Defined|125
5680559|NCT00388674|19595704|P2|Initial Treatment|Non-Study related Comorbidities|4
5680560|NCT00388674|19595705|P1|Initial Treatment|Non-Study related Comorbidities|3
5680561|NCT00388674|19595704|P2|Initial Treatment|Never Treated with Study Medication|7
5680562|NCT00388674|19595705|P1|Initial Treatment|Never Treated with Study Medication|1
5680563|NCT00388674|19595704|P2|Initial Treatment|Malignancy (Non-HCC)|3
5680564|NCT00388674|19595705|P1|Initial Treatment|Malignancy (Non-HCC)|7
5680565|NCT00388674|19595704|P2|Initial Treatment|Lost to Follow-up|624
5680566|NCT00388674|19595705|P1|Initial Treatment|Lost to Follow-up|526
5680567|NCT00388674|19595704|P2|Initial Treatment|HCC|20
5680568|NCT00388674|19595705|P1|Initial Treatment|HCC|12
5680569|NCT00388674|19595704|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
5680570|NCT00388674|19595705|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
5680571|NCT00388674|19595704|P2|Initial Treatment|Death|216
5680572|NCT00388674|19595705|P1|Initial Treatment|Death|215
5680573|NCT00388674|19595704|P2|Initial Treatment|Adverse Event|87
5680574|NCT00388674|19595705|P1|Initial Treatment|Adverse Event|22
5680575|NCT00388674|19595704|P2|Initial Treatment|Administrative Reason by Sponsor|158
5680576|NCT00388674|19595705|P1|Initial Treatment|Administrative Reason by Sponsor|241
5680577|NCT00388583|19595723|P2|Overall Study|Did not receive vaccine|1
5680578|NCT00388583|19595724|P1|Overall Study|Did not receive vaccine|0
5680579|NCT00388583|19595723|P2|Overall Study|Serious Adverse Event|0
5680580|NCT00388583|19595724|P1|Overall Study|Serious Adverse Event|2
5680581|NCT00388583|19595723|P2|Overall Study|Withdrawal by Subject|3
5680582|NCT00388583|19595724|P1|Overall Study|Withdrawal by Subject|3
5680583|NCT00388583|19595723|P2|Overall Study|Protocol Violation|0
5680584|NCT00388583|19595724|P1|Overall Study|Protocol Violation|1
5680585|NCT00388505|19595738|P2|Overall Study|Unable to classify|3
5680586|NCT00388505|19595739|P1|Overall Study|Unable to classify|4
5680587|NCT00388505|19595738|P2|Overall Study|Protocol Violation|5
5680588|NCT00388505|19595739|P1|Overall Study|Protocol Violation|6
5680589|NCT00388505|19595738|P2|Overall Study|Administrative Reason|0
5680590|NCT00388505|19595739|P1|Overall Study|Administrative Reason|1
5680591|NCT00388505|19595738|P2|Overall Study|Inappropriate Enrollment|1
5680592|NCT00388505|19595739|P1|Overall Study|Inappropriate Enrollment|0
5680593|NCT00388505|19595738|P2|Overall Study|Lost to Follow-up|3
5680594|NCT00388505|19595739|P1|Overall Study|Lost to Follow-up|5
5680595|NCT00388505|19595738|P2|Overall Study|Withdrawal by Subject|9
5680596|NCT00388505|19595739|P1|Overall Study|Withdrawal by Subject|24
5680597|NCT00388505|19595738|P2|Overall Study|Adverse Event or Death|17
5680598|NCT00388505|19595739|P1|Overall Study|Adverse Event or Death|43
5680599|NCT00388362|19595794|P1|Remained on Study Median of 514 Days|Death|2
5680600|NCT00388362|19595794|P1|Enrolled|Withdrawal by Subject|1
5680601|NCT00388362|19595794|P1|Enrolled|Loss insurance|1
5680602|NCT00388362|19595794|P1|Enrolled|Death|1
5680603|NCT00388362|19595794|P1|Enrolled|Adverse Event|9
5680604|NCT00388362|19595794|P1|Enrolled|Ineligible|1
5680605|NCT00388349|19595799|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
5680606|NCT00388349|19595800|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
5680607|NCT00388297|19595813|P4|Overall Study|Lost to Follow-up|8
5680608|NCT00388297|19595814|P3|Overall Study|Lost to Follow-up|11
5680609|NCT00388297|19595815|P2|Overall Study|Lost to Follow-up|12
5680610|NCT00388297|19595816|P1|Overall Study|Lost to Follow-up|16
5680611|NCT00388154|19595926|P1|Overall Study|Withdrawal by Subject|1
5680612|NCT00388037|19595931|P1|Overall Study|Protocol Violation|1
5680613|NCT00387894|19595939|P1|Overall Study|Withdrawal by Subject|1
5680614|NCT00387881|19595946|P2|Overall Study|Not otherwise specified|7
5680615|NCT00387881|19595947|P1|Overall Study|Not otherwise specified|11
5680616|NCT00387881|19595946|P2|Overall Study|No opportunity to treat headache|34
5680617|NCT00387881|19595947|P1|Overall Study|No opportunity to treat headache|32
5680618|NCT00387881|19595946|P2|Overall Study|Not eligible|7
5680619|NCT00387881|19595947|P1|Overall Study|Not eligible|6
5680620|NCT00387881|19595946|P2|Overall Study|Sponsor terminated Study|1
5680621|NCT00387881|19595947|P1|Overall Study|Sponsor terminated Study|0
5680622|NCT00387881|19595946|P2|Overall Study|Withdrawal by Subject|18
5680623|NCT00387881|19595947|P1|Overall Study|Withdrawal by Subject|15
5680624|NCT00387881|19595946|P2|Overall Study|Protocol Violation|12
5680625|NCT00387881|19595947|P1|Overall Study|Protocol Violation|2
5680626|NCT00387881|19595946|P2|Overall Study|Lost to Follow-up|23
5680627|NCT00387881|19595947|P1|Overall Study|Lost to Follow-up|23
5680628|NCT00387790|19595980|P1|Overall Study|Ineligible for study|2
5680629|NCT00387790|19595980|P1|Overall Study|Withdrawal by Subject|3
5680630|NCT00387790|19595980|P1|Overall Study|Physician Decision|2
5680631|NCT00387790|19595980|P1|Overall Study|Lack of Efficacy|2
5680632|NCT00387790|19595980|P1|Overall Study|Adverse Event|5
5680633|NCT00387764|19595986|P1|Overall Study|Death|7
5680634|NCT00387764|19595986|P1|Overall Study|Other|2
5680635|NCT00387764|19595986|P1|Overall Study|Physician Decision|1
5680636|NCT00387764|19595986|P1|Overall Study|Sponsor Terminated Study|1
5680637|NCT00387764|19595986|P1|Overall Study|Withdrawal by Subject|8
5680638|NCT00387764|19595986|P1|Overall Study|Adverse Event|12
5680639|NCT00387725|19596014|P4|Overall Study|Parent/legal guardian request|1
5680640|NCT00387725|19596015|P3|Overall Study|Parent/legal guardian request|1
5680641|NCT00387725|19596016|P2|Overall Study|Parent/legal guardian request|0
5680642|NCT00387725|19596017|P1|Overall Study|Parent/legal guardian request|0
5680643|NCT00387725|19596014|P4|Overall Study|Withdrawal by Subject|0
5680644|NCT00387725|19596015|P3|Overall Study|Withdrawal by Subject|1
5680645|NCT00387725|19596016|P2|Overall Study|Withdrawal by Subject|0
5680646|NCT00387725|19596017|P1|Overall Study|Withdrawal by Subject|1
5680647|NCT00387725|19596014|P4|Overall Study|Protocol Violation|0
5680648|NCT00387725|19596015|P3|Overall Study|Protocol Violation|0
5680649|NCT00387725|19596016|P2|Overall Study|Protocol Violation|1
5680650|NCT00387725|19596017|P1|Overall Study|Protocol Violation|0
5680651|NCT00387725|19596014|P4|Overall Study|Adverse Event|1
5680652|NCT00387725|19596015|P3|Overall Study|Adverse Event|0
5680653|NCT00387725|19596016|P2|Overall Study|Adverse Event|0
5680654|NCT00387725|19596017|P1|Overall Study|Adverse Event|0
5680655|NCT00387712|19596037|P2|Overall Study|Withdrawal by Subject|12
5680656|NCT00387712|19596038|P1|Overall Study|Withdrawal by Subject|6
5680657|NCT00387712|19596037|P2|Overall Study|Lost to Follow-up|20
5680658|NCT00387712|19596038|P1|Overall Study|Lost to Follow-up|17
5680659|NCT00387712|19596037|P2|Overall Study|Physician Decision|4
5680660|NCT00387712|19596038|P1|Overall Study|Physician Decision|6
5680661|NCT00387647|19596069|P1|Overall Study|Death|18
5680662|NCT00387465|19596112|P3|Overall Study|Withdrawal by Subject|0
5680663|NCT00387465|19596113|P2|Overall Study|Withdrawal by Subject|1
5680664|NCT00387465|19596114|P1|Overall Study|Withdrawal by Subject|0
5680665|NCT00387426|19596131|P1|Overall Study|Disease Progression|3
5680666|NCT00387426|19596131|P1|Overall Study|Toxicities|4
5680667|NCT00387426|19596131|P1|Overall Study|Lack of Response|7
5680668|NCT00387348|19596138|P3|Overall Study|Adverse Event|1
5680669|NCT00387348|19596139|P2|Overall Study|Adverse Event|0
5680670|NCT00387348|19596140|P1|Overall Study|Adverse Event|1
5680671|NCT00387348|19596138|P3|Overall Study|Withdrawal by Subject|2
5680672|NCT00387348|19596139|P2|Overall Study|Withdrawal by Subject|2
5680673|NCT00387348|19596140|P1|Overall Study|Withdrawal by Subject|0
5680674|NCT00387348|19596138|P3|Overall Study|Physician Decision|1
5680675|NCT00387348|19596139|P2|Overall Study|Physician Decision|0
5680676|NCT00387348|19596140|P1|Overall Study|Physician Decision|1
5680677|NCT00387348|19596138|P3|Overall Study|Death|0
5680678|NCT00387348|19596139|P2|Overall Study|Death|1
5680679|NCT00387348|19596140|P1|Overall Study|Death|1
5680680|NCT00387153|19596173|P1|Overall Study|Lack of Response|4
5680681|NCT00387153|19596173|P1|Overall Study|Disease Progression|3
5680682|NCT00387153|19596173|P1|Overall Study|Adverse Event|1
5680683|NCT00387127|19596179|P2|Overall Study|Sponsor Unblinded|0
5680684|NCT00387127|19596180|P1|Overall Study|Sponsor Unblinded|1
5680685|NCT00387127|19596179|P2|Overall Study|Serious Adverse Event|1
5680686|NCT00387127|19596180|P1|Overall Study|Serious Adverse Event|1
5680687|NCT00387127|19596179|P2|Overall Study|Required by Protocol Amendment #4|10
5680688|NCT00387127|19596180|P1|Overall Study|Required by Protocol Amendment #4|12
5680689|NCT00387127|19596179|P2|Overall Study|Withdrawal by Subject|2
5680690|NCT00387127|19596180|P1|Overall Study|Withdrawal by Subject|3
5680691|NCT00387127|19596179|P2|Overall Study|Physician Decision|1
5680692|NCT00387127|19596180|P1|Overall Study|Physician Decision|0
5680693|NCT00387127|19596179|P2|Overall Study|Death|16
5680694|NCT00387127|19596180|P1|Overall Study|Death|16
5680695|NCT00387127|19596179|P2|Overall Study|Lost to Follow-up|4
5680696|NCT00387127|19596180|P1|Overall Study|Lost to Follow-up|0
5680697|NCT00387088|19596222|P2|Overall Study|Other|52
5680698|NCT00387088|19596223|P1|Overall Study|Other|58
5680699|NCT00387088|19596222|P2|Overall Study|Lost to Follow-up|28
5680700|NCT00387088|19596223|P1|Overall Study|Lost to Follow-up|22
5680701|NCT00387088|19596222|P2|Overall Study|Lack of Efficacy|67
5680702|NCT00387088|19596223|P1|Overall Study|Lack of Efficacy|28
5680703|NCT00387088|19596222|P2|Overall Study|Withdrawal by Subject|35
5680704|NCT00387088|19596223|P1|Overall Study|Withdrawal by Subject|20
5680705|NCT00387088|19596222|P2|Overall Study|Protocol Violation|35
5680706|NCT00387088|19596223|P1|Overall Study|Protocol Violation|47
5680707|NCT00387088|19596222|P2|Overall Study|Adverse Event|156
5680708|NCT00387088|19596223|P1|Overall Study|Adverse Event|143
5680709|NCT00387010|19596280|P1|Treatment Period|Participant reported study drug stolen|1
5680710|NCT00387010|19596280|P1|Treatment Period|Noncompliance with study procedures|3
5680711|NCT00387010|19596280|P1|Treatment Period|Noncompliance with study medication|2
5680712|NCT00387010|19596280|P1|Treatment Period|Withdrawal by Subject|1
5680713|NCT00387010|19596280|P1|Treatment Period|Adverse Event|4
5680714|NCT00387010|19596280|P1|Dose Titration Period|Noncompliance with study procedures|7
5680715|NCT00387010|19596280|P1|Dose Titration Period|Noncompliance with study medication|8
5680716|NCT00387010|19596280|P1|Dose Titration Period|Lost to Follow-up|2
5680717|NCT00387010|19596280|P1|Dose Titration Period|Protocol Violation|1
5680718|NCT00387010|19596280|P1|Dose Titration Period|Withdrawal by Subject|3
5680719|NCT00387010|19596280|P1|Dose Titration Period|Lack of Efficacy|5
5680720|NCT00387010|19596280|P1|Dose Titration Period|Adverse Event|12
5680721|NCT00386776|19596307|P1|Overall Study|Withdrawal by Subject|8
5680722|NCT00386607|19596321|P2|Extension|Unsatisfactory therapeutic effect|1
5680723|NCT00386607|19596322|P1|Extension|Unsatisfactory therapeutic effect|0
5680724|NCT00386607|19596321|P2|Extension|Patient withdrew consent|5
5680725|NCT00386607|19596322|P1|Extension|Patient withdrew consent|0
5680726|NCT00386607|19596321|P2|Extension|Lost to Follow-up|3
5680727|NCT00386607|19596322|P1|Extension|Lost to Follow-up|0
5680728|NCT00386607|19596321|P2|Extension|Administrative problems|1
5680729|NCT00386607|19596322|P1|Extension|Administrative problems|0
5680730|NCT00386607|19596321|P2|Extension|Abnormal laboratory value(s)|1
5680731|NCT00386607|19596322|P1|Extension|Abnormal laboratory value(s)|0
5680732|NCT00386607|19596321|P2|Extension|Adverse Event|6
5680733|NCT00386607|19596322|P1|Extension|Adverse Event|0
5680734|NCT00386607|19596321|P2|Core|Protocol Deviation|0
5680735|NCT00386607|19596322|P1|Core|Protocol Deviation|6
5680736|NCT00386607|19596321|P2|Core|Administrative problems|0
5680737|NCT00386607|19596322|P1|Core|Administrative problems|1
5680738|NCT00386607|19596321|P2|Core|Lost to Follow-up|0
5680739|NCT00386607|19596322|P1|Core|Lost to Follow-up|23
5680740|NCT00386607|19596321|P2|Core|Patient withdrew consent|0
5680741|NCT00386607|19596322|P1|Core|Patient withdrew consent|15
5680742|NCT00386607|19596321|P2|Core|Condition no longer requires study drug|0
5680743|NCT00386607|19596322|P1|Core|Condition no longer requires study drug|4
5680744|NCT00386607|19596321|P2|Core|Unsatisfactory therapeutic effect|0
5680745|NCT00386607|19596322|P1|Core|Unsatisfactory therapeutic effect|23
5680746|NCT00386607|19596321|P2|Core|Abnormal laboratory value(s)|0
5680747|NCT00386607|19596322|P1|Core|Abnormal laboratory value(s)|3
5680748|NCT00386607|19596321|P2|Core|Adverse Event|0
5680749|NCT00386607|19596322|P1|Core|Adverse Event|40
5680750|NCT00386425|19596350|P3|Overall Study|Withdrawal by Subject|0
5680751|NCT00386425|19596351|P2|Overall Study|Withdrawal by Subject|1
5680752|NCT00386425|19596352|P1|Overall Study|Withdrawal by Subject|0
5680753|NCT00386425|19596350|P3|Overall Study|Physician Decision|0
5680754|NCT00386425|19596351|P2|Overall Study|Physician Decision|0
5680755|NCT00386425|19596352|P1|Overall Study|Physician Decision|3
5680756|NCT00386360|19596378|P2|Overall Study|Did not take any study medication|2
5680757|NCT00386360|19596379|P1|Overall Study|Did not take any study medication|0
5680758|NCT00386360|19596378|P2|Overall Study|Withdrawal by Subject|6
5680759|NCT00386360|19596379|P1|Overall Study|Withdrawal by Subject|3
5680760|NCT00386360|19596378|P2|Overall Study|Protocol Violation|3
5680761|NCT00386360|19596379|P1|Overall Study|Protocol Violation|0
5680762|NCT00386360|19596378|P2|Overall Study|Lost to Follow-up|2
5680763|NCT00386360|19596379|P1|Overall Study|Lost to Follow-up|0
5680764|NCT00386360|19596378|P2|Overall Study|Physician Decision|2
5680765|NCT00386360|19596379|P1|Overall Study|Physician Decision|2
5680766|NCT00386360|19596378|P2|Overall Study|Adverse Event|2
5680767|NCT00386360|19596379|P1|Overall Study|Adverse Event|4
5680768|NCT00386334|19596413|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
5680769|NCT00386334|19596414|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
5680770|NCT00386334|19596413|P2|Double Blind Period|Other|3
5680771|NCT00386334|19596414|P1|Double Blind Period|Other|3
5680772|NCT00386334|19596413|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
5680773|NCT00386334|19596414|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
5680774|NCT00386334|19596413|P2|Double Blind Period|Lack of Efficacy|11
5680775|NCT00386334|19596414|P1|Double Blind Period|Lack of Efficacy|20
5680776|NCT00386334|19596413|P2|Double Blind Period|Withdrawal by Subject|13
5680777|NCT00386334|19596414|P1|Double Blind Period|Withdrawal by Subject|9
5680778|NCT00386334|19596413|P2|Double Blind Period|Protocol Violation|1
5680779|NCT00386334|19596414|P1|Double Blind Period|Protocol Violation|1
5680780|NCT00386334|19596413|P2|Double Blind Period|Adverse Event|14
5680781|NCT00386334|19596414|P1|Double Blind Period|Adverse Event|9
5680782|NCT00386308|19596558|P2|Overall Study|Other Event|1
5680783|NCT00386308|19596559|P1|Overall Study|Other Event|8
5680784|NCT00386308|19596558|P2|Overall Study|Withdrawal by Subject|2
5680785|NCT00386308|19596559|P1|Overall Study|Withdrawal by Subject|6
5680786|NCT00386308|19596558|P2|Overall Study|Lost to Follow-up|6
5680787|NCT00386308|19596559|P1|Overall Study|Lost to Follow-up|10
5680788|NCT00386308|19596558|P2|Overall Study|Lack of Efficacy|2
5680789|NCT00386308|19596559|P1|Overall Study|Lack of Efficacy|0
5680790|NCT00386308|19596558|P2|Overall Study|Protocol Violation|5
5680791|NCT00386308|19596559|P1|Overall Study|Protocol Violation|2
5680792|NCT00386308|19596558|P2|Overall Study|Adverse Event|3
5680793|NCT00386308|19596559|P1|Overall Study|Adverse Event|3
5680794|NCT00386152|19596616|P3|Overall Study|Withdrawal by Subject|10
5680795|NCT00386152|19596617|P2|Overall Study|Withdrawal by Subject|6
5680796|NCT00386152|19596618|P1|Overall Study|Withdrawal by Subject|3
5680797|NCT00386152|19596616|P3|Overall Study|Protocol Violation|2
5680798|NCT00386152|19596617|P2|Overall Study|Protocol Violation|5
5680799|NCT00386152|19596618|P1|Overall Study|Protocol Violation|3
5680800|NCT00386152|19596616|P3|Overall Study|Completed chemotherapy|1
5680801|NCT00386152|19596617|P2|Overall Study|Completed chemotherapy|5
5680802|NCT00386152|19596618|P1|Overall Study|Completed chemotherapy|4
5680803|NCT00386152|19596616|P3|Overall Study|Lost to Follow-up|0
5680804|NCT00386152|19596617|P2|Overall Study|Lost to Follow-up|0
5680805|NCT00386152|19596618|P1|Overall Study|Lost to Follow-up|1
5680806|NCT00386152|19596616|P3|Overall Study|Physician Decision|4
5680807|NCT00386152|19596617|P2|Overall Study|Physician Decision|10
5680808|NCT00386152|19596618|P1|Overall Study|Physician Decision|13
5680809|NCT00386152|19596616|P3|Overall Study|Disease progression|5
5680810|NCT00386152|19596617|P2|Overall Study|Disease progression|4
5680811|NCT00386152|19596618|P1|Overall Study|Disease progression|7
5680812|NCT00386152|19596616|P3|Overall Study|Death|1
5680813|NCT00386152|19596617|P2|Overall Study|Death|0
5680814|NCT00386152|19596618|P1|Overall Study|Death|3
5680815|NCT00386152|19596616|P3|Overall Study|Chang from original chemo stratification|6
5680816|NCT00386152|19596617|P2|Overall Study|Chang from original chemo stratification|5
5680817|NCT00386152|19596618|P1|Overall Study|Chang from original chemo stratification|4
5680818|NCT00386152|19596616|P3|Overall Study|Adverse Event|4
5680819|NCT00386152|19596617|P2|Overall Study|Adverse Event|5
5680820|NCT00386152|19596618|P1|Overall Study|Adverse Event|6
5680821|NCT00386100|19596637|P2|Overall Study|Participant randomized in error|0
5680822|NCT00386100|19596638|P1|Overall Study|Participant randomized in error|1
5680823|NCT00386100|19596637|P2|Overall Study|Hb1Ac >8%|1
5680824|NCT00386100|19596638|P1|Overall Study|Hb1Ac >8%|0
5680825|NCT00386100|19596637|P2|Overall Study|Out of country for 5 months|0
5680826|NCT00386100|19596638|P1|Overall Study|Out of country for 5 months|1
5680827|NCT00386100|19596637|P2|Overall Study|Positive pregnancy test|3
5680828|NCT00386100|19596638|P1|Overall Study|Positive pregnancy test|1
5680829|NCT00386100|19596637|P2|Overall Study|Osteoporosis|1
5680830|NCT00386100|19596638|P1|Overall Study|Osteoporosis|0
5680831|NCT00386100|19596637|P2|Overall Study|7.6% bone loss|0
5680832|NCT00386100|19596638|P1|Overall Study|7.6% bone loss|1
5680833|NCT00386100|19596637|P2|Overall Study|DBP 93 mmHg at randomization|0
5680834|NCT00386100|19596638|P1|Overall Study|DBP 93 mmHg at randomization|1
5680835|NCT00386100|19596637|P2|Overall Study|Bone loss by DXA bone scan|0
5680836|NCT00386100|19596638|P1|Overall Study|Bone loss by DXA bone scan|1
5680837|NCT00386100|19596637|P2|Overall Study|Bad metabolic control & patient security|0
5680838|NCT00386100|19596638|P1|Overall Study|Bad metabolic control & patient security|1
5680839|NCT00386100|19596637|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
5680840|NCT00386100|19596638|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
5680841|NCT00386100|19596637|P2|Overall Study|Participant's PCP wanted to stop drug|0
5680842|NCT00386100|19596638|P1|Overall Study|Participant's PCP wanted to stop drug|1
5680843|NCT00386100|19596637|P2|Overall Study|Didn't meet entry criteria|1
5680844|NCT00386100|19596638|P1|Overall Study|Didn't meet entry criteria|1
5680845|NCT00386100|19596637|P2|Overall Study|Excessive bone loss vs. baseline value|1
5680846|NCT00386100|19596638|P1|Overall Study|Excessive bone loss vs. baseline value|0
5680847|NCT00386100|19596637|P2|Overall Study|Participant moving out of state|0
5680848|NCT00386100|19596638|P1|Overall Study|Participant moving out of state|2
5680849|NCT00386100|19596637|P2|Overall Study|Participant's concern due to CPK levels|0
5680850|NCT00386100|19596638|P1|Overall Study|Participant's concern due to CPK levels|1
5680851|NCT00386100|19596637|P2|Overall Study|Laboratory findings|0
5680852|NCT00386100|19596638|P1|Overall Study|Laboratory findings|1
5680853|NCT00386100|19596637|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
5680854|NCT00386100|19596638|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
5680855|NCT00386100|19596637|P2|Overall Study|Consecutive elevated Hba1C|0
5680856|NCT00386100|19596638|P1|Overall Study|Consecutive elevated Hba1C|1
5680857|NCT00386100|19596637|P2|Overall Study|BMD <2.5|0
5680858|NCT00386100|19596638|P1|Overall Study|BMD <2.5|1
5680859|NCT00386100|19596637|P2|Overall Study|Bone mass density (BMD) loss >6%|4
5680860|NCT00386100|19596638|P1|Overall Study|Bone mass density (BMD) loss >6%|4
5680861|NCT00386100|19596637|P2|Overall Study|Withdrawal by Subject|31
5680862|NCT00386100|19596638|P1|Overall Study|Withdrawal by Subject|32
5680863|NCT00386100|19596637|P2|Overall Study|Protocol Violation|3
5680864|NCT00386100|19596638|P1|Overall Study|Protocol Violation|5
5680865|NCT00386100|19596637|P2|Overall Study|Non-compliance|19
5680866|NCT00386100|19596638|P1|Overall Study|Non-compliance|18
5680867|NCT00386100|19596637|P2|Overall Study|Lost to Follow-up|29
5680868|NCT00386100|19596638|P1|Overall Study|Lost to Follow-up|29
5680869|NCT00386100|19596637|P2|Overall Study|Insufficient therapeutic effect|6
5680870|NCT00386100|19596638|P1|Overall Study|Insufficient therapeutic effect|30
5680871|NCT00386100|19596637|P2|Overall Study|Death|1
5680872|NCT00386100|19596638|P1|Overall Study|Death|0
5680873|NCT00386100|19596637|P2|Overall Study|Adverse Event|25
5680874|NCT00386100|19596638|P1|Overall Study|Adverse Event|15
5680875|NCT00386100|19596637|P2|Overall Study|Did not receive study medication|4
5680876|NCT00386100|19596638|P1|Overall Study|Did not receive study medication|6
5680877|NCT00386022|19596702|P2|Plus Estrogen|Adverse Event|1
5680878|NCT00386022|19596703|P1|Plus Estrogen|Adverse Event|0
5680879|NCT00386022|19596702|P2|Plus Estrogen|Lost to Follow-up|0
5680880|NCT00386022|19596703|P1|Plus Estrogen|Lost to Follow-up|2
5680881|NCT00386009|19596713|P2|Overall Study|Withdrawal by Subject|4
5680882|NCT00386009|19596714|P1|Overall Study|Withdrawal by Subject|5
5680883|NCT00386009|19596713|P2|Overall Study|Sponsor Decision|1
5680884|NCT00386009|19596714|P1|Overall Study|Sponsor Decision|1
5680885|NCT00386009|19596713|P2|Overall Study|Protocol Violation|0
5680886|NCT00386009|19596714|P1|Overall Study|Protocol Violation|1
5680887|NCT00386009|19596713|P2|Overall Study|Lost to Follow-up|1
5680888|NCT00386009|19596714|P1|Overall Study|Lost to Follow-up|1
5680889|NCT00386009|19596713|P2|Overall Study|Entry Criteria Not Met|2
5680890|NCT00386009|19596714|P1|Overall Study|Entry Criteria Not Met|0
5680891|NCT00386009|19596713|P2|Overall Study|Death|0
5680892|NCT00386009|19596714|P1|Overall Study|Death|1
5680893|NCT00386009|19596713|P2|Overall Study|Adverse Event|2
5680894|NCT00386009|19596714|P1|Overall Study|Adverse Event|0
5680895|NCT00385944|19596761|P3|2nd Maintenance Dose Period|Invalid PD Data|0
5680896|NCT00385944|19596762|P2|2nd Maintenance Dose Period|Invalid PD Data|3
5680897|NCT00385944|19596763|P1|2nd Maintenance Dose Period|Invalid PD Data|2
5680898|NCT00385944|19596761|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
5680899|NCT00385944|19596762|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
5680900|NCT00385944|19596763|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
5680901|NCT00385944|19596761|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
5680902|NCT00385944|19596762|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
5680903|NCT00385944|19596763|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
5680904|NCT00385944|19596761|P3|1st Maintenance Dose Period|Physician Decision|0
5680905|NCT00385944|19596762|P2|1st Maintenance Dose Period|Physician Decision|0
5680906|NCT00385944|19596763|P1|1st Maintenance Dose Period|Physician Decision|1
5680907|NCT00385918|19596806|P3|Intervention Phase After Randomization|Lost to Follow-up|0
5680908|NCT00385918|19596807|P2|Intervention Phase After Randomization|Lost to Follow-up|0
5680909|NCT00385918|19596808|P1|Intervention Phase After Randomization|Lost to Follow-up|1
5680910|NCT00385918|19596806|P3|Intervention Phase After Randomization|Physician Decision|0
5680911|NCT00385918|19596807|P2|Intervention Phase After Randomization|Physician Decision|0
5680912|NCT00385918|19596808|P1|Intervention Phase After Randomization|Physician Decision|1
5680913|NCT00385918|19596806|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
5680914|NCT00385918|19596807|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
5680915|NCT00385918|19596808|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
5680916|NCT00385918|19596806|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
5680917|NCT00385918|19596807|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
5680918|NCT00385918|19596808|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
5680919|NCT00385918|19596806|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
5680920|NCT00385918|19596807|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
5680921|NCT00385918|19596808|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
5680922|NCT00385918|19596806|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
5680923|NCT00385918|19596807|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
5680924|NCT00385918|19596808|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
5680925|NCT00385840|19596832|P2|Overall Study|Lost to Follow-up|13
5680926|NCT00385840|19596833|P1|Overall Study|Lost to Follow-up|3
5680927|NCT00385840|19596832|P2|Overall Study|Adverse Event|1
5680928|NCT00385840|19596833|P1|Overall Study|Adverse Event|1
5680929|NCT00385827|19596856|P3|Part 2|Other|21
5680930|NCT00385827|19596857|P2|Part 2|Other|11
5680931|NCT00385827|19596858|P1|Part 2|Other|0
5680932|NCT00385827|19596856|P3|Part 2|Randomized but not treated|2
5680933|NCT00385827|19596857|P2|Part 2|Randomized but not treated|2
5680934|NCT00385827|19596858|P1|Part 2|Randomized but not treated|0
5680935|NCT00385827|19596856|P3|Part 2|Lack of Efficacy|13
5680936|NCT00385827|19596857|P2|Part 2|Lack of Efficacy|14
5680937|NCT00385827|19596858|P1|Part 2|Lack of Efficacy|0
5680938|NCT00385827|19596856|P3|Part 2|Death|2
5680939|NCT00385827|19596857|P2|Part 2|Death|0
5680940|NCT00385827|19596858|P1|Part 2|Death|0
5680941|NCT00385827|19596856|P3|Part 2|Adverse Event|10
5680942|NCT00385827|19596857|P2|Part 2|Adverse Event|6
5680943|NCT00385827|19596858|P1|Part 2|Adverse Event|0
5680944|NCT00385827|19596856|P3|Part 1|Other|0
5680945|NCT00385827|19596857|P2|Part 1|Other|0
5680946|NCT00385827|19596858|P1|Part 1|Other|1
5680947|NCT00385827|19596856|P3|Part 1|Lack of Efficacy|0
5680948|NCT00385827|19596857|P2|Part 1|Lack of Efficacy|0
5680949|NCT00385827|19596858|P1|Part 1|Lack of Efficacy|5
5680950|NCT00385827|19596856|P3|Part 1|Death|0
5680951|NCT00385827|19596857|P2|Part 1|Death|0
5680952|NCT00385827|19596858|P1|Part 1|Death|2
5680953|NCT00385827|19596856|P3|Part 1|Adverse Event|0
5680954|NCT00385827|19596857|P2|Part 1|Adverse Event|0
5680955|NCT00385827|19596858|P1|Part 1|Adverse Event|1
5680956|NCT00385762|19596902|P1|Overall Study|Lost to Follow-up|1
5680957|NCT00385762|19596902|P1|Overall Study|Adverse Event|1
5680958|NCT00385736|19596912|P3|Safety Analysis Set|Other|4
5680959|NCT00385736|19596913|P2|Safety Analysis Set|Other|4
5680960|NCT00385736|19596914|P1|Safety Analysis Set|Other|1
5680961|NCT00385736|19596912|P3|Safety Analysis Set|Protocol Violation|6
5680962|NCT00385736|19596913|P2|Safety Analysis Set|Protocol Violation|1
5680963|NCT00385736|19596914|P1|Safety Analysis Set|Protocol Violation|2
5680964|NCT00385736|19596912|P3|Safety Analysis Set|Lack of Efficacy|31
5680965|NCT00385736|19596913|P2|Safety Analysis Set|Lack of Efficacy|16
5680966|NCT00385736|19596914|P1|Safety Analysis Set|Lack of Efficacy|38
5680967|NCT00385736|19596912|P3|Safety Analysis Set|Lost to Follow-up|2
5680968|NCT00385736|19596913|P2|Safety Analysis Set|Lost to Follow-up|2
5680969|NCT00385736|19596914|P1|Safety Analysis Set|Lost to Follow-up|0
5680970|NCT00385736|19596912|P3|Safety Analysis Set|Withdrawal by Subject|14
5680971|NCT00385736|19596913|P2|Safety Analysis Set|Withdrawal by Subject|6
5680972|NCT00385736|19596914|P1|Safety Analysis Set|Withdrawal by Subject|6
5680973|NCT00385736|19596912|P3|Safety Analysis Set|Adverse Event|23
5680974|NCT00385736|19596913|P2|Safety Analysis Set|Adverse Event|15
5680975|NCT00385736|19596914|P1|Safety Analysis Set|Adverse Event|23
5680976|NCT00385736|19596912|P3|Efficacy Analysis Set - Maintenance|Other|4
5680977|NCT00385736|19596913|P2|Efficacy Analysis Set - Maintenance|Other|4
5680978|NCT00385736|19596914|P1|Efficacy Analysis Set - Maintenance|Other|0
5680979|NCT00385736|19596912|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
5680980|NCT00385736|19596913|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
5680981|NCT00385736|19596914|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
5680982|NCT00385736|19596912|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
5680983|NCT00385736|19596913|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
5680984|NCT00385736|19596914|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
5680985|NCT00385736|19596912|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
5680986|NCT00385736|19596913|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
5680987|NCT00385736|19596914|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
5680988|NCT00385736|19596912|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
5680989|NCT00385736|19596913|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
5680990|NCT00385736|19596914|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
5680991|NCT00385736|19596912|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
5680992|NCT00385736|19596913|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
5680993|NCT00385736|19596914|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
5680994|NCT00385736|19596912|P3|Efficacy Analysis Set - Induction|Other|1
5680995|NCT00385736|19596913|P2|Efficacy Analysis Set - Induction|Other|0
5680996|NCT00385736|19596914|P1|Efficacy Analysis Set - Induction|Other|0
5680997|NCT00385736|19596912|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
5680998|NCT00385736|19596913|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
5680999|NCT00385736|19596914|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
5681000|NCT00385736|19596912|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
5681001|NCT00385736|19596913|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
5681002|NCT00385736|19596914|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
5681003|NCT00385736|19596912|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
5681004|NCT00385736|19596913|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
5681005|NCT00385736|19596914|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
5681006|NCT00385736|19596912|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
5681007|NCT00385736|19596913|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
5681008|NCT00385736|19596914|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
5681009|NCT00385736|19596912|P3|Efficacy Analysis Set - Induction|Adverse Event|4
5681010|NCT00385736|19596913|P2|Efficacy Analysis Set - Induction|Adverse Event|6
5681011|NCT00385736|19596914|P1|Efficacy Analysis Set - Induction|Adverse Event|5
5681012|NCT00385723|19596959|P3|Overall Study|Withdrawal by Subject|2
5681013|NCT00385723|19596960|P2|Overall Study|Withdrawal by Subject|0
5681014|NCT00385723|19596961|P1|Overall Study|Withdrawal by Subject|1
5681015|NCT00385723|19596959|P3|Overall Study|Lost to Follow-up|0
5681016|NCT00385723|19596960|P2|Overall Study|Lost to Follow-up|1
5681017|NCT00385723|19596961|P1|Overall Study|Lost to Follow-up|1
5681018|NCT00385684|19596975|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
5681019|NCT00385684|19596976|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
5681020|NCT00385684|19596975|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
5681021|NCT00385684|19596976|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
5681022|NCT00385684|19596975|P2|FIRST INTERVENTION OF PHASE A|Death|0
5681023|NCT00385684|19596976|P1|FIRST INTERVENTION OF PHASE A|Death|1
5681024|NCT00385671|19596985|P3|Overall Study|Withdrawal by Subject|4
5681025|NCT00385671|19596986|P2|Overall Study|Withdrawal by Subject|4
5681026|NCT00385671|19596987|P1|Overall Study|Withdrawal by Subject|4
5681027|NCT00385671|19596985|P3|Overall Study|Sponsor Decision|1
5681028|NCT00385671|19596986|P2|Overall Study|Sponsor Decision|2
5681029|NCT00385671|19596987|P1|Overall Study|Sponsor Decision|2
5681030|NCT00385671|19596985|P3|Overall Study|Protocol Violation|1
5681031|NCT00385671|19596986|P2|Overall Study|Protocol Violation|2
5681032|NCT00385671|19596987|P1|Overall Study|Protocol Violation|5
5681033|NCT00385671|19596985|P3|Overall Study|Physician Decision|2
5681034|NCT00385671|19596986|P2|Overall Study|Physician Decision|1
5681035|NCT00385671|19596987|P1|Overall Study|Physician Decision|2
5681036|NCT00385671|19596985|P3|Overall Study|Lost to Follow-up|5
5681037|NCT00385671|19596986|P2|Overall Study|Lost to Follow-up|6
5681038|NCT00385671|19596987|P1|Overall Study|Lost to Follow-up|6
5681039|NCT00385671|19596985|P3|Overall Study|Lack of Efficacy|5
5681040|NCT00385671|19596986|P2|Overall Study|Lack of Efficacy|9
5681041|NCT00385671|19596987|P1|Overall Study|Lack of Efficacy|5
5681042|NCT00385671|19596985|P3|Overall Study|Adverse Event|18
5681043|NCT00385671|19596986|P2|Overall Study|Adverse Event|27
5681044|NCT00385671|19596987|P1|Overall Study|Adverse Event|14
5681045|NCT00385593|19597143|P2|Overall Study|Incorrect randomization|1
5681046|NCT00385593|19597144|P1|Overall Study|Incorrect randomization|0
5681047|NCT00385593|19597143|P2|Overall Study|Incorrect inclusion|0
5681048|NCT00385593|19597144|P1|Overall Study|Incorrect inclusion|2
5681049|NCT00385593|19597143|P2|Overall Study|Several reasons|15
5681050|NCT00385593|19597144|P1|Overall Study|Several reasons|17
5681051|NCT00385593|19597143|P2|Overall Study|Protocol Violation|4
5681052|NCT00385593|19597144|P1|Overall Study|Protocol Violation|7
5681053|NCT00385593|19597143|P2|Overall Study|Lost to Follow-up|8
5681054|NCT00385593|19597144|P1|Overall Study|Lost to Follow-up|12
5681055|NCT00385593|19597143|P2|Overall Study|Withdrawal by Subject|7
5681056|NCT00385593|19597144|P1|Overall Study|Withdrawal by Subject|17
5681057|NCT00385593|19597143|P2|Overall Study|Adverse Event|2
5681058|NCT00385593|19597144|P1|Overall Study|Adverse Event|3
5681059|NCT00385541|19597254|P2|Overall Study|severe pain, clinician requested unblind|1
5681060|NCT00385541|19597255|P1|Overall Study|severe pain, clinician requested unblind|0
5681061|NCT00385255|19597289|P2|Overall Study|Lost to Follow-up|58
5681062|NCT00385255|19597290|P1|Overall Study|Lost to Follow-up|20
5681063|NCT00385255|19597289|P2|Overall Study|Migrated/moved from study area|1
5681064|NCT00385255|19597290|P1|Overall Study|Migrated/moved from study area|0
5681065|NCT00385255|19597289|P2|Overall Study|Withdrawal by Subject|8
5681066|NCT00385255|19597290|P1|Overall Study|Withdrawal by Subject|0
5681067|NCT00385255|19597289|P2|Overall Study|Protocol Violation|4
5681068|NCT00385255|19597290|P1|Overall Study|Protocol Violation|0
5681069|NCT00385255|19597289|P2|Overall Study|Serious Adverse Event|2
5681070|NCT00385255|19597290|P1|Overall Study|Serious Adverse Event|1
5681071|NCT00385203|19597369|P2|Overall Study|Incorrect enrollment|0
5681072|NCT00385203|19597370|P1|Overall Study|Incorrect enrollment|2
5681073|NCT00385203|19597369|P2|Overall Study|Condition under investigation worsened|3
5681074|NCT00385203|19597370|P1|Overall Study|Condition under investigation worsened|18
5681075|NCT00385203|19597369|P2|Overall Study|Death|0
5681076|NCT00385203|19597370|P1|Overall Study|Death|1
5681077|NCT00385203|19597369|P2|Overall Study|Adverse Event|4
5681078|NCT00385203|19597370|P1|Overall Study|Adverse Event|5
5681079|NCT00384956|19597458|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
5681080|NCT00384930|19597475|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
5681081|NCT00384930|19597476|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
5681082|NCT00384930|19597477|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
5681083|NCT00384930|19597478|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
5681084|NCT00384930|19597479|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
5681085|NCT00384930|19597475|P5|Overall Study|Withdrawal by Subject|16
5681086|NCT00384930|19597476|P4|Overall Study|Withdrawal by Subject|6
5681087|NCT00384930|19597477|P3|Overall Study|Withdrawal by Subject|7
5681088|NCT00384930|19597478|P2|Overall Study|Withdrawal by Subject|7
5681089|NCT00384930|19597479|P1|Overall Study|Withdrawal by Subject|9
5681090|NCT00384930|19597475|P5|Overall Study|Sponsor Decision|0
5681091|NCT00384930|19597476|P4|Overall Study|Sponsor Decision|5
5681092|NCT00384930|19597477|P3|Overall Study|Sponsor Decision|0
5681093|NCT00384930|19597478|P2|Overall Study|Sponsor Decision|4
5681094|NCT00384930|19597479|P1|Overall Study|Sponsor Decision|3
5681095|NCT00384930|19597475|P5|Overall Study|Protocol Violation|4
5681096|NCT00384930|19597476|P4|Overall Study|Protocol Violation|6
5681097|NCT00384930|19597477|P3|Overall Study|Protocol Violation|1
5681098|NCT00384930|19597478|P2|Overall Study|Protocol Violation|0
5681099|NCT00384930|19597479|P1|Overall Study|Protocol Violation|1
5681100|NCT00384930|19597475|P5|Overall Study|Physician Decision|1
5681101|NCT00384930|19597476|P4|Overall Study|Physician Decision|0
5681102|NCT00384930|19597477|P3|Overall Study|Physician Decision|1
5681103|NCT00384930|19597478|P2|Overall Study|Physician Decision|1
5681104|NCT00384930|19597479|P1|Overall Study|Physician Decision|0
5681105|NCT00384930|19597475|P5|Overall Study|Lost to Follow-up|6
5681106|NCT00384930|19597476|P4|Overall Study|Lost to Follow-up|4
5681107|NCT00384930|19597477|P3|Overall Study|Lost to Follow-up|0
5681108|NCT00384930|19597478|P2|Overall Study|Lost to Follow-up|3
5681109|NCT00384930|19597479|P1|Overall Study|Lost to Follow-up|5
5681110|NCT00384930|19597475|P5|Overall Study|Lack of Efficacy|2
5681111|NCT00384930|19597476|P4|Overall Study|Lack of Efficacy|1
5681112|NCT00384930|19597477|P3|Overall Study|Lack of Efficacy|2
5681113|NCT00384930|19597478|P2|Overall Study|Lack of Efficacy|1
5681114|NCT00384930|19597479|P1|Overall Study|Lack of Efficacy|1
5681115|NCT00384930|19597475|P5|Overall Study|Entry Criteria Not Met|4
5681116|NCT00384930|19597476|P4|Overall Study|Entry Criteria Not Met|8
5681117|NCT00384930|19597477|P3|Overall Study|Entry Criteria Not Met|7
5681118|NCT00384930|19597478|P2|Overall Study|Entry Criteria Not Met|6
5681119|NCT00384930|19597479|P1|Overall Study|Entry Criteria Not Met|2
5681120|NCT00384930|19597475|P5|Overall Study|Adverse Event|14
5681121|NCT00384930|19597476|P4|Overall Study|Adverse Event|11
5681122|NCT00384930|19597477|P3|Overall Study|Adverse Event|12
5681123|NCT00384930|19597478|P2|Overall Study|Adverse Event|4
5681124|NCT00384930|19597479|P1|Overall Study|Adverse Event|5
5681125|NCT00384839|19597558|P1|Overall Study|Ineligible|2
5681126|NCT00384839|19597558|P1|Overall Study|Patient Request|1
5681127|NCT00384839|19597558|P1|Overall Study|Investigator Request|1
5681128|NCT00384839|19597558|P1|Overall Study|Adverse Event|4
5681129|NCT00384397|19597691|P3|Overall Study|Withdrawal by Subject|15
5681130|NCT00384397|19597692|P2|Overall Study|Withdrawal by Subject|17
5681131|NCT00384397|19597693|P1|Overall Study|Withdrawal by Subject|14
5681132|NCT00384397|19597691|P3|Overall Study|Lost to Follow-up|3
5681133|NCT00384397|19597692|P2|Overall Study|Lost to Follow-up|13
5681134|NCT00384397|19597693|P1|Overall Study|Lost to Follow-up|11
5681135|NCT00384397|19597691|P3|Overall Study|Protocol Violation|13
5681136|NCT00384397|19597692|P2|Overall Study|Protocol Violation|15
5681137|NCT00384397|19597693|P1|Overall Study|Protocol Violation|7
5681138|NCT00384397|19597691|P3|Overall Study|Adverse Event|2
5681139|NCT00384397|19597692|P2|Overall Study|Adverse Event|1
5681140|NCT00384397|19597693|P1|Overall Study|Adverse Event|0
5681141|NCT00384332|19597712|P2|Overall Study|Lost to Follow-up|0
5681142|NCT00384332|19597713|P1|Overall Study|Lost to Follow-up|4
5681143|NCT00384293|19597723|P3|Post-randomization Period|Patient Randomized in Error|1
5681144|NCT00384293|19597724|P2|Post-randomization Period|Patient Randomized in Error|0
5681145|NCT00384293|19597725|P1|Post-randomization Period|Patient Randomized in Error|0
5681146|NCT00384293|19597723|P3|Post-randomization Period|Trial Termination|204
5681147|NCT00384293|19597724|P2|Post-randomization Period|Trial Termination|180
5681148|NCT00384293|19597725|P1|Post-randomization Period|Trial Termination|0
5681149|NCT00384293|19597723|P3|Post-randomization Period|Withdrawal by Subject|6
5681150|NCT00384293|19597724|P2|Post-randomization Period|Withdrawal by Subject|8
5681151|NCT00384293|19597725|P1|Post-randomization Period|Withdrawal by Subject|0
5681152|NCT00384293|19597723|P3|Post-randomization Period|Protocol Violation|0
5681153|NCT00384293|19597724|P2|Post-randomization Period|Protocol Violation|1
5681154|NCT00384293|19597725|P1|Post-randomization Period|Protocol Violation|0
5681155|NCT00384293|19597723|P3|Post-randomization Period|Lost to Follow-up|1
5681156|NCT00384293|19597724|P2|Post-randomization Period|Lost to Follow-up|2
5681157|NCT00384293|19597725|P1|Post-randomization Period|Lost to Follow-up|0
5681158|NCT00384293|19597723|P3|Post-randomization Period|Adverse Event|7
5681159|NCT00384293|19597724|P2|Post-randomization Period|Adverse Event|23
5681160|NCT00384293|19597725|P1|Post-randomization Period|Adverse Event|0
5681161|NCT00384293|19597723|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
5681162|NCT00384293|19597724|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
5681163|NCT00384293|19597725|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
5681164|NCT00384293|19597723|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
5681165|NCT00384293|19597724|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
5681166|NCT00384293|19597725|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
5681167|NCT00384293|19597723|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
5681168|NCT00384293|19597724|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
5681169|NCT00384293|19597725|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
5681170|NCT00384293|19597723|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
5681171|NCT00384293|19597724|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
5681172|NCT00384293|19597725|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
5681173|NCT00384293|19597723|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
5681174|NCT00384293|19597724|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
5681175|NCT00384293|19597725|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
5681176|NCT00384293|19597723|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
5681177|NCT00384293|19597724|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
5681178|NCT00384293|19597725|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
5681179|NCT00384293|19597723|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
5681180|NCT00384293|19597724|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
5681181|NCT00384293|19597725|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
5681182|NCT00384189|19597749|P4|Overall Study|Reason Not Specified|40
5681183|NCT00384189|19597750|P3|Overall Study|Reason Not Specified|58
5681184|NCT00384189|19597751|P2|Overall Study|Reason Not Specified|57
5681185|NCT00384189|19597752|P1|Overall Study|Reason Not Specified|50
5681186|NCT00384176|19597813|P3|Overall Study|Liver metastases, colon resec. planned|0
5681187|NCT00384176|19597814|P2|Overall Study|Liver metastases, colon resec. planned|0
5681188|NCT00384176|19597815|P1|Overall Study|Liver metastases, colon resec. planned|1
5681189|NCT00384176|19597813|P3|Overall Study|Physician Decision|0
5681190|NCT00384176|19597814|P2|Overall Study|Physician Decision|2
5681191|NCT00384176|19597815|P1|Overall Study|Physician Decision|0
5681192|NCT00384176|19597813|P3|Overall Study|Did not receive study treatment|1
5681193|NCT00384176|19597814|P2|Overall Study|Did not receive study treatment|1
5681194|NCT00384176|19597815|P1|Overall Study|Did not receive study treatment|0
5681195|NCT00384176|19597813|P3|Overall Study|Toxicity of treatment|0
5681196|NCT00384176|19597814|P2|Overall Study|Toxicity of treatment|0
5681197|NCT00384176|19597815|P1|Overall Study|Toxicity of treatment|1
5681198|NCT00384176|19597813|P3|Overall Study|Longer QTC as Visit 1|0
5681199|NCT00384176|19597814|P2|Overall Study|Longer QTC as Visit 1|0
5681200|NCT00384176|19597815|P1|Overall Study|Longer QTC as Visit 1|1
5681201|NCT00384176|19597813|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
5681202|NCT00384176|19597814|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
5681203|NCT00384176|19597815|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
5681204|NCT00384176|19597813|P3|Overall Study|Lost to Follow-up|4
5681205|NCT00384176|19597814|P2|Overall Study|Lost to Follow-up|18
5681206|NCT00384176|19597815|P1|Overall Study|Lost to Follow-up|16
5681207|NCT00384176|19597813|P3|Overall Study|Withdrawal by Subject|22
5681208|NCT00384176|19597814|P2|Overall Study|Withdrawal by Subject|48
5681209|NCT00384176|19597815|P1|Overall Study|Withdrawal by Subject|52
5681210|NCT00384176|19597813|P3|Overall Study|Death|105
5681211|NCT00384176|19597814|P2|Overall Study|Death|247
5681212|NCT00384176|19597815|P1|Overall Study|Death|239
5681213|NCT00384085|19597841|P3|Overall Study|Patient required surgery|0
5681214|NCT00384085|19597842|P2|Overall Study|Patient required surgery|1
5681215|NCT00384085|19597843|P1|Overall Study|Patient required surgery|0
5681216|NCT00384085|19597841|P3|Overall Study|Patient moved|1
5681217|NCT00384085|19597842|P2|Overall Study|Patient moved|0
5681218|NCT00384085|19597843|P1|Overall Study|Patient moved|1
5681219|NCT00384085|19597841|P3|Overall Study|Sponsor decision|1
5681220|NCT00384085|19597842|P2|Overall Study|Sponsor decision|2
5681221|NCT00384085|19597843|P1|Overall Study|Sponsor decision|1
5681222|NCT00384085|19597841|P3|Overall Study|Loss of site personnel|1
5681223|NCT00384085|19597842|P2|Overall Study|Loss of site personnel|0
5681224|NCT00384085|19597843|P1|Overall Study|Loss of site personnel|1
5681225|NCT00384085|19597841|P3|Overall Study|Physician Decision|0
5681226|NCT00384085|19597842|P2|Overall Study|Physician Decision|0
5681227|NCT00384085|19597843|P1|Overall Study|Physician Decision|1
5681228|NCT00384085|19597841|P3|Overall Study|Patient non-compliant|5
5681229|NCT00384085|19597842|P2|Overall Study|Patient non-compliant|4
5681230|NCT00384085|19597843|P1|Overall Study|Patient non-compliant|4
5681231|NCT00384085|19597841|P3|Overall Study|Withdrawal by Subject|29
5681232|NCT00384085|19597842|P2|Overall Study|Withdrawal by Subject|19
5681233|NCT00384085|19597843|P1|Overall Study|Withdrawal by Subject|14
5681234|NCT00384085|19597841|P3|Overall Study|Progressive Disease|0
5681235|NCT00384085|19597842|P2|Overall Study|Progressive Disease|1
5681236|NCT00384085|19597843|P1|Overall Study|Progressive Disease|0
5681237|NCT00384085|19597841|P3|Overall Study|Lost to Follow-up|10
5681238|NCT00384085|19597842|P2|Overall Study|Lost to Follow-up|9
5681239|NCT00384085|19597843|P1|Overall Study|Lost to Follow-up|9
5681240|NCT00384085|19597841|P3|Overall Study|Protocol Violation|2
5681241|NCT00384085|19597842|P2|Overall Study|Protocol Violation|2
5681242|NCT00384085|19597843|P1|Overall Study|Protocol Violation|2
5681243|NCT00384085|19597841|P3|Overall Study|No longer Requires Study Treatment|1
5681244|NCT00384085|19597842|P2|Overall Study|No longer Requires Study Treatment|0
5681245|NCT00384085|19597843|P1|Overall Study|No longer Requires Study Treatment|1
5681246|NCT00384085|19597841|P3|Overall Study|Lack of Efficacy|2
5681247|NCT00384085|19597842|P2|Overall Study|Lack of Efficacy|3
5681248|NCT00384085|19597843|P1|Overall Study|Lack of Efficacy|0
5681249|NCT00384085|19597841|P3|Overall Study|Adverse Event|4
5681250|NCT00384085|19597842|P2|Overall Study|Adverse Event|5
5681251|NCT00384085|19597843|P1|Overall Study|Adverse Event|5
5681252|NCT00384059|19597869|P2|Toddler Dose|Failed to return|1
5681253|NCT00384059|19597870|P1|Toddler Dose|Failed to return|0
5681254|NCT00384059|19597869|P2|Toddler Dose|Lost to Follow-up|1
5681255|NCT00384059|19597870|P1|Toddler Dose|Lost to Follow-up|1
5681256|NCT00384059|19597869|P2|After Infant Series|Lost to Follow-up|1
5681257|NCT00384059|19597870|P1|After Infant Series|Lost to Follow-up|0
5681258|NCT00384059|19597869|P2|After Infant Series|Physician Decision|1
5681259|NCT00384059|19597870|P1|After Infant Series|Physician Decision|0
5681260|NCT00384059|19597869|P2|After Infant Series|Adverse Event|1
5681261|NCT00384059|19597870|P1|After Infant Series|Adverse Event|0
5681262|NCT00384059|19597869|P2|After Infant Series|Failed to Return|2
5681263|NCT00384059|19597870|P1|After Infant Series|Failed to Return|0
5681264|NCT00384059|19597869|P2|After Infant Series|Withdrawal by Subject|2
5681265|NCT00384059|19597870|P1|After Infant Series|Withdrawal by Subject|2
5681266|NCT00384059|19597869|P2|After Infant Series|Protocol Violation|3
5681267|NCT00384059|19597870|P1|After Infant Series|Protocol Violation|2
5681268|NCT00384059|19597869|P2|Infant Series|Lost to Follow-up|1
5681269|NCT00384059|19597870|P1|Infant Series|Lost to Follow-up|0
5681270|NCT00384059|19597869|P2|Infant Series|Protocol Violation|2
5681271|NCT00384059|19597870|P1|Infant Series|Protocol Violation|1
5681272|NCT00384059|19597869|P2|Infant Series|Adverse Event|2
5681273|NCT00384059|19597870|P1|Infant Series|Adverse Event|1
5681274|NCT00384059|19597869|P2|Infant Series|Withdrawal by Subject|2
5681275|NCT00384059|19597870|P1|Infant Series|Withdrawal by Subject|2
5681276|NCT00384059|19597869|P2|Infant Series|Not consented|6
5681277|NCT00384059|19597870|P1|Infant Series|Not consented|2
5681278|NCT00384033|19597920|P4|Overall Study|Randomized but not treated|2
5681279|NCT00384033|19597921|P3|Overall Study|Randomized but not treated|10
5681280|NCT00384033|19597922|P2|Overall Study|Randomized but not treated|7
5681281|NCT00384033|19597923|P1|Overall Study|Randomized but not treated|3
5681282|NCT00384033|19597920|P4|Overall Study|Lack of Efficacy|1
5681283|NCT00384033|19597921|P3|Overall Study|Lack of Efficacy|3
5681284|NCT00384033|19597922|P2|Overall Study|Lack of Efficacy|3
5681285|NCT00384033|19597923|P1|Overall Study|Lack of Efficacy|7
5681286|NCT00384033|19597920|P4|Overall Study|Withdrawal by Subject|2
5681287|NCT00384033|19597921|P3|Overall Study|Withdrawal by Subject|5
5681288|NCT00384033|19597922|P2|Overall Study|Withdrawal by Subject|2
5681289|NCT00384033|19597923|P1|Overall Study|Withdrawal by Subject|6
5681290|NCT00384033|19597920|P4|Overall Study|Protocol Violation|6
5681291|NCT00384033|19597921|P3|Overall Study|Protocol Violation|5
5681292|NCT00384033|19597922|P2|Overall Study|Protocol Violation|0
5681293|NCT00384033|19597923|P1|Overall Study|Protocol Violation|5
5681294|NCT00384033|19597920|P4|Overall Study|Other|0
5681295|NCT00384033|19597921|P3|Overall Study|Other|0
5681296|NCT00384033|19597922|P2|Overall Study|Other|0
5681297|NCT00384033|19597923|P1|Overall Study|Other|2
5681298|NCT00384033|19597920|P4|Overall Study|Lost to Follow-up|7
5681299|NCT00384033|19597921|P3|Overall Study|Lost to Follow-up|7
5681300|NCT00384033|19597922|P2|Overall Study|Lost to Follow-up|12
5681301|NCT00384033|19597923|P1|Overall Study|Lost to Follow-up|6
5681302|NCT00384033|19597920|P4|Overall Study|Physician Decision|0
5681303|NCT00384033|19597921|P3|Overall Study|Physician Decision|0
5681304|NCT00384033|19597922|P2|Overall Study|Physician Decision|0
5681305|NCT00384033|19597923|P1|Overall Study|Physician Decision|1
5681306|NCT00384033|19597920|P4|Overall Study|Failed to return|2
5681307|NCT00384033|19597921|P3|Overall Study|Failed to return|2
5681308|NCT00384033|19597922|P2|Overall Study|Failed to return|3
5681309|NCT00384033|19597923|P1|Overall Study|Failed to return|1
5681310|NCT00384033|19597920|P4|Overall Study|Adverse Event|20
5681311|NCT00384033|19597921|P3|Overall Study|Adverse Event|11
5681312|NCT00384033|19597922|P2|Overall Study|Adverse Event|8
5681313|NCT00384033|19597923|P1|Overall Study|Adverse Event|10
5681314|NCT00383786|19597976|P2|Overall Study|Physician Decision|1
5681315|NCT00383786|19597977|P1|Overall Study|Physician Decision|0
5681316|NCT00383786|19597976|P2|Overall Study|Withdrawal by Subject|5
5681317|NCT00383786|19597977|P1|Overall Study|Withdrawal by Subject|2
5681318|NCT00383786|19597976|P2|Overall Study|Protocol Violation|6
5681319|NCT00383786|19597977|P1|Overall Study|Protocol Violation|2
5681320|NCT00383721|19598027|P5|26-Week Treatment Safety Extension|Administrative|0
5681321|NCT00383721|19598028|P4|26-Week Treatment Safety Extension|Administrative|1
5681322|NCT00383721|19598029|P3|26-Week Treatment Safety Extension|Administrative|3
5681323|NCT00383721|19598030|P2|26-Week Treatment Safety Extension|Administrative|2
5681324|NCT00383721|19598031|P1|26-Week Treatment Safety Extension|Administrative|1
5681325|NCT00383721|19598027|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5681326|NCT00383721|19598028|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5681327|NCT00383721|19598029|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5681328|NCT00383721|19598030|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5681329|NCT00383721|19598031|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5681330|NCT00383721|19598027|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
5681331|NCT00383721|19598028|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
5681332|NCT00383721|19598029|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5681333|NCT00383721|19598030|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5681334|NCT00383721|19598031|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
5681335|NCT00383721|19598027|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
5681336|NCT00383721|19598028|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
5681337|NCT00383721|19598029|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
5681338|NCT00383721|19598030|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
5681339|NCT00383721|19598031|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
5681340|NCT00383721|19598027|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
5681341|NCT00383721|19598028|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
5681342|NCT00383721|19598029|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
5681343|NCT00383721|19598030|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
5681344|NCT00383721|19598031|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
5681345|NCT00383721|19598027|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
5681346|NCT00383721|19598028|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
5681347|NCT00383721|19598029|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
5681348|NCT00383721|19598030|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
5681349|NCT00383721|19598031|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
5681350|NCT00383721|19598027|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
5681351|NCT00383721|19598028|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
5681352|NCT00383721|19598029|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
5681353|NCT00383721|19598030|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
5681354|NCT00383721|19598031|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
5681355|NCT00383721|19598027|P5|26-Week Treatment Safety Extension|Adverse Event|0
5681356|NCT00383721|19598028|P4|26-Week Treatment Safety Extension|Adverse Event|1
5681357|NCT00383721|19598029|P3|26-Week Treatment Safety Extension|Adverse Event|10
5681358|NCT00383721|19598030|P2|26-Week Treatment Safety Extension|Adverse Event|7
5681359|NCT00383721|19598031|P1|26-Week Treatment Safety Extension|Adverse Event|6
5681360|NCT00383721|19598027|P5|26-Week Double-Blind Treatment Period|Ongoing|0
5681361|NCT00383721|19598028|P4|26-Week Double-Blind Treatment Period|Ongoing|0
5681362|NCT00383721|19598029|P3|26-Week Double-Blind Treatment Period|Ongoing|0
5681363|NCT00383721|19598030|P2|26-Week Double-Blind Treatment Period|Ongoing|0
5681364|NCT00383721|19598031|P1|26-Week Double-Blind Treatment Period|Ongoing|1
5681365|NCT00383721|19598027|P5|26-Week Double-Blind Treatment Period|Administrative|3
5681366|NCT00383721|19598028|P4|26-Week Double-Blind Treatment Period|Administrative|3
5681367|NCT00383721|19598029|P3|26-Week Double-Blind Treatment Period|Administrative|3
5681368|NCT00383721|19598030|P2|26-Week Double-Blind Treatment Period|Administrative|3
5681369|NCT00383721|19598031|P1|26-Week Double-Blind Treatment Period|Administrative|1
5681370|NCT00383721|19598027|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
5681371|NCT00383721|19598028|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
5681372|NCT00383721|19598029|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
5681373|NCT00383721|19598030|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
5681374|NCT00383721|19598031|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
5681375|NCT00383721|19598027|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
5681376|NCT00383721|19598028|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
5681377|NCT00383721|19598029|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
5681378|NCT00383721|19598030|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
5681379|NCT00383721|19598031|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
5681380|NCT00383721|19598027|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
5681381|NCT00383721|19598028|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
5681382|NCT00383721|19598029|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
5681383|NCT00383721|19598030|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
5681384|NCT00383721|19598031|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
5681385|NCT00383721|19598027|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
5681386|NCT00383721|19598028|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
5681387|NCT00383721|19598029|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
5681388|NCT00383721|19598030|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
5681389|NCT00383721|19598031|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
5681390|NCT00383721|19598027|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
5681391|NCT00383721|19598028|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
5681392|NCT00383721|19598029|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
5681393|NCT00383721|19598030|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
5681394|NCT00383721|19598031|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
5681395|NCT00383721|19598027|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
5681396|NCT00383721|19598028|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
5681397|NCT00383721|19598029|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
5681398|NCT00383721|19598030|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
5681399|NCT00383721|19598031|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
5681400|NCT00383721|19598027|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
5681401|NCT00383721|19598028|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
5681402|NCT00383721|19598029|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
5681403|NCT00383721|19598030|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
5681404|NCT00383721|19598031|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
5681405|NCT00383708|19598068|P1|Co-administration Period|Adverse Event|5
5681406|NCT00383708|19598068|P1|Run-in Period|Claustrophobia|1
5681407|NCT00383708|19598068|P1|Run-in Period|Adverse Event|2
5681408|NCT00383708|19598068|P1|Run-in Period|Protocol Violation|4
5681409|NCT00383708|19598068|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
5681410|NCT00383708|19598068|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
5681411|NCT00383552|19598143|P4|Overall Study|Administrative|1
5681412|NCT00383552|19598144|P3|Overall Study|Administrative|1
5681413|NCT00383552|19598145|P2|Overall Study|Administrative|0
5681414|NCT00383552|19598146|P1|Overall Study|Administrative|1
5681415|NCT00383552|19598143|P4|Overall Study|Did not meet protocol eligibility|3
5681416|NCT00383552|19598144|P3|Overall Study|Did not meet protocol eligibility|2
5681417|NCT00383552|19598145|P2|Overall Study|Did not meet protocol eligibility|6
5681418|NCT00383552|19598146|P1|Overall Study|Did not meet protocol eligibility|8
5681419|NCT00383552|19598143|P4|Overall Study|Noncompliance with the protocol|10
5681420|NCT00383552|19598144|P3|Overall Study|Noncompliance with the protocol|8
5681421|NCT00383552|19598145|P2|Overall Study|Noncompliance with the protocol|6
5681422|NCT00383552|19598146|P1|Overall Study|Noncompliance with the protocol|11
5681423|NCT00383552|19598143|P4|Overall Study|Did not wish to continue (related)|3
5681424|NCT00383552|19598144|P3|Overall Study|Did not wish to continue (related)|2
5681425|NCT00383552|19598145|P2|Overall Study|Did not wish to continue (related)|0
5681426|NCT00383552|19598146|P1|Overall Study|Did not wish to continue (related)|1
5681427|NCT00383552|19598143|P4|Overall Study|Did not wish to continue (unrelated)|6
5681428|NCT00383552|19598144|P3|Overall Study|Did not wish to continue (unrelated)|5
5681429|NCT00383552|19598145|P2|Overall Study|Did not wish to continue (unrelated)|9
5681430|NCT00383552|19598146|P1|Overall Study|Did not wish to continue (unrelated)|4
5681431|NCT00383552|19598143|P4|Overall Study|Lost to Follow-up|1
5681432|NCT00383552|19598144|P3|Overall Study|Lost to Follow-up|5
5681433|NCT00383552|19598145|P2|Overall Study|Lost to Follow-up|1
5681434|NCT00383552|19598146|P1|Overall Study|Lost to Follow-up|0
5681435|NCT00383552|19598143|P4|Overall Study|Lack of Efficacy|42
5681436|NCT00383552|19598144|P3|Overall Study|Lack of Efficacy|29
5681437|NCT00383552|19598145|P2|Overall Study|Lack of Efficacy|13
5681438|NCT00383552|19598146|P1|Overall Study|Lack of Efficacy|4
5681439|NCT00383552|19598143|P4|Overall Study|Adverse Event|6
5681440|NCT00383552|19598144|P3|Overall Study|Adverse Event|9
5681441|NCT00383552|19598145|P2|Overall Study|Adverse Event|6
5681442|NCT00383552|19598146|P1|Overall Study|Adverse Event|7
5681443|NCT00383500|19598188|P3|Overall Study|Lost to Follow-up|2
5681444|NCT00383500|19598189|P2|Overall Study|Lost to Follow-up|0
5681445|NCT00383500|19598190|P1|Overall Study|Lost to Follow-up|0
5681446|NCT00383500|19598188|P3|Overall Study|Withdrawal by Subject|0
5681447|NCT00383500|19598189|P2|Overall Study|Withdrawal by Subject|3
5681448|NCT00383500|19598190|P1|Overall Study|Withdrawal by Subject|8
5681449|NCT00383435|19598214|P5|26-Week Treatment Safety Extension|Administrative|0
5681450|NCT00383435|19598215|P4|26-Week Treatment Safety Extension|Administrative|1
5681451|NCT00383435|19598216|P3|26-Week Treatment Safety Extension|Administrative|0
5681452|NCT00383435|19598217|P2|26-Week Treatment Safety Extension|Administrative|1
5681453|NCT00383435|19598218|P1|26-Week Treatment Safety Extension|Administrative|1
5681454|NCT00383435|19598214|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5681455|NCT00383435|19598215|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5681456|NCT00383435|19598216|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5681457|NCT00383435|19598217|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
5681458|NCT00383435|19598218|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
5681459|NCT00383435|19598214|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
5681460|NCT00383435|19598215|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5681461|NCT00383435|19598216|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5681462|NCT00383435|19598217|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
5681463|NCT00383435|19598218|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
5681464|NCT00383435|19598214|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
5681465|NCT00383435|19598215|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
5681466|NCT00383435|19598216|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
5681467|NCT00383435|19598217|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
5681468|NCT00383435|19598218|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
5681469|NCT00383435|19598214|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
5681470|NCT00383435|19598215|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
5681471|NCT00383435|19598216|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
5681472|NCT00383435|19598217|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
5681473|NCT00383435|19598218|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
5681474|NCT00383435|19598214|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
5681475|NCT00383435|19598215|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
5681476|NCT00383435|19598216|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
5681477|NCT00383435|19598217|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
5681478|NCT00383435|19598218|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
5681479|NCT00383435|19598214|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
5681480|NCT00383435|19598215|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
5681481|NCT00383435|19598216|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
5681482|NCT00383435|19598217|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
5681483|NCT00383435|19598218|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
5681484|NCT00383435|19598214|P5|26-Week Treatment Safety Extension|Adverse Event|1
5681485|NCT00383435|19598215|P4|26-Week Treatment Safety Extension|Adverse Event|5
5681486|NCT00383435|19598216|P3|26-Week Treatment Safety Extension|Adverse Event|5
5681487|NCT00383435|19598217|P2|26-Week Treatment Safety Extension|Adverse Event|2
5681488|NCT00383435|19598218|P1|26-Week Treatment Safety Extension|Adverse Event|4
5681489|NCT00383435|19598214|P5|26-Week Double-Blind Treatment Period|Administrative|1
5681490|NCT00383435|19598215|P4|26-Week Double-Blind Treatment Period|Administrative|1
5681491|NCT00383435|19598216|P3|26-Week Double-Blind Treatment Period|Administrative|1
5681492|NCT00383435|19598217|P2|26-Week Double-Blind Treatment Period|Administrative|3
5681493|NCT00383435|19598218|P1|26-Week Double-Blind Treatment Period|Administrative|5
5681494|NCT00383435|19598214|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
5681495|NCT00383435|19598215|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
5681496|NCT00383435|19598216|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
5681497|NCT00383435|19598217|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
5681498|NCT00383435|19598218|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
5681499|NCT00383435|19598214|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
5681500|NCT00383435|19598215|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
5681501|NCT00383435|19598216|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
5681502|NCT00383435|19598217|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
5681503|NCT00383435|19598218|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
5681504|NCT00383435|19598214|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
5681505|NCT00383435|19598215|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
5681506|NCT00383435|19598216|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
5681507|NCT00383435|19598217|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
5681508|NCT00383435|19598218|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
5681509|NCT00383435|19598214|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
5681510|NCT00383435|19598215|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
5681511|NCT00383435|19598216|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
5681512|NCT00383435|19598217|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
5681513|NCT00383435|19598218|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
5681514|NCT00383435|19598214|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
5681515|NCT00383435|19598215|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
5681516|NCT00383435|19598216|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
5681517|NCT00383435|19598217|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
5681518|NCT00383435|19598218|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
5681519|NCT00383435|19598214|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
5681520|NCT00383435|19598215|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
5681521|NCT00383435|19598216|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
5681522|NCT00383435|19598217|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
5681523|NCT00383435|19598218|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
5681524|NCT00383435|19598214|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
5681525|NCT00383435|19598215|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
5681526|NCT00383435|19598216|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
5681527|NCT00383435|19598217|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
5681528|NCT00383435|19598218|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
5681529|NCT00383331|19598257|P2|Overall Study|Protocol Violation|1
5681530|NCT00383331|19598258|P1|Overall Study|Protocol Violation|0
5681531|NCT00383292|19598277|P3|Overall Study|Other|0
5681532|NCT00383292|19598278|P2|Overall Study|Other|0
5681533|NCT00383292|19598279|P1|Overall Study|Other|1
5681534|NCT00383292|19598277|P3|Overall Study|Withdrawal by Subject|2
5681535|NCT00383292|19598278|P2|Overall Study|Withdrawal by Subject|2
5681536|NCT00383292|19598279|P1|Overall Study|Withdrawal by Subject|3
5681537|NCT00383292|19598277|P3|Overall Study|Physician Decision|1
5681538|NCT00383292|19598278|P2|Overall Study|Physician Decision|0
5681539|NCT00383292|19598279|P1|Overall Study|Physician Decision|4
5681540|NCT00383292|19598277|P3|Overall Study|Death|3
5681541|NCT00383292|19598278|P2|Overall Study|Death|3
5681542|NCT00383292|19598279|P1|Overall Study|Death|3
5681543|NCT00383292|19598277|P3|Overall Study|Adverse Event|2
5681544|NCT00383292|19598278|P2|Overall Study|Adverse Event|1
5681545|NCT00383292|19598279|P1|Overall Study|Adverse Event|4
5681546|NCT00383240|19598320|P4|Overall Study|Administrative|0
5681547|NCT00383240|19598321|P3|Overall Study|Administrative|0
5681548|NCT00383240|19598322|P2|Overall Study|Administrative|1
5681549|NCT00383240|19598323|P1|Overall Study|Administrative|1
5681550|NCT00383240|19598320|P4|Overall Study|Did not meet protocol eligibility|3
5681551|NCT00383240|19598321|P3|Overall Study|Did not meet protocol eligibility|9
5681552|NCT00383240|19598322|P2|Overall Study|Did not meet protocol eligibility|4
5681553|NCT00383240|19598323|P1|Overall Study|Did not meet protocol eligibility|9
5681554|NCT00383240|19598320|P4|Overall Study|Protocol Violation|6
5681555|NCT00383240|19598321|P3|Overall Study|Protocol Violation|9
5681556|NCT00383240|19598322|P2|Overall Study|Protocol Violation|5
5681557|NCT00383240|19598323|P1|Overall Study|Protocol Violation|4
5681558|NCT00383240|19598320|P4|Overall Study|Withdrawal by subjects, reasons related|5
5681559|NCT00383240|19598321|P3|Overall Study|Withdrawal by subjects, reasons related|3
5681560|NCT00383240|19598322|P2|Overall Study|Withdrawal by subjects, reasons related|1
5681561|NCT00383240|19598323|P1|Overall Study|Withdrawal by subjects, reasons related|0
5681562|NCT00383240|19598320|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
5681563|NCT00383240|19598321|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
5681564|NCT00383240|19598322|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
5681565|NCT00383240|19598323|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
5681566|NCT00383240|19598320|P4|Overall Study|Lost to Follow-up|2
5681567|NCT00383240|19598321|P3|Overall Study|Lost to Follow-up|0
5681568|NCT00383240|19598322|P2|Overall Study|Lost to Follow-up|0
5681569|NCT00383240|19598323|P1|Overall Study|Lost to Follow-up|3
5681570|NCT00383240|19598320|P4|Overall Study|Treatment Failure|46
5681571|NCT00383240|19598321|P3|Overall Study|Treatment Failure|47
5681572|NCT00383240|19598322|P2|Overall Study|Treatment Failure|13
5681573|NCT00383240|19598323|P1|Overall Study|Treatment Failure|8
5681574|NCT00383240|19598320|P4|Overall Study|Adverse Event|7
5681575|NCT00383240|19598321|P3|Overall Study|Adverse Event|9
5681576|NCT00383240|19598322|P2|Overall Study|Adverse Event|6
5681577|NCT00383240|19598323|P1|Overall Study|Adverse Event|4
5681578|NCT00383162|19598354|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
5681579|NCT00383162|19598355|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
5681580|NCT00383162|19598354|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
5681581|NCT00383162|19598355|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
5681582|NCT00383162|19598354|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
5681583|NCT00383162|19598355|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
5681584|NCT00383162|19598354|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
5681585|NCT00383162|19598355|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
5681586|NCT00383162|19598354|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
5681587|NCT00383162|19598355|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
5681588|NCT00383162|19598354|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
5681589|NCT00383162|19598355|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
5681590|NCT00383162|19598354|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
5681591|NCT00383162|19598355|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
5681592|NCT00383162|19598354|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
5681593|NCT00383162|19598355|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
5681594|NCT00383162|19598354|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
5681595|NCT00383162|19598355|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
5681596|NCT00383149|19598397|P1|Overall Study|Participant Withdrew Consent|1
5681597|NCT00383149|19598397|P1|Overall Study|Request to Discontinue Treatment|4
5681598|NCT00383149|19598397|P1|Overall Study|Study Drug Toxicity|4
5681599|NCT00383149|19598397|P1|Overall Study|Other|1
5681600|NCT00383149|19598397|P1|Overall Study|Lost to Follow-up|1
5681601|NCT00383149|19598397|P1|Overall Study|Disease Progression|38
5681602|NCT00383149|19598397|P1|Overall Study|Death|2
5681603|NCT00383149|19598397|P1|Overall Study|Adverse Event not Related to Study Drug|3
5681604|NCT00383123|19598416|P2|Overall Study|Other reason|6
5681605|NCT00383123|19598417|P1|Overall Study|Other reason|10
5681606|NCT00383123|19598416|P2|Overall Study|Withdrawal by Subject|18
5681607|NCT00383123|19598417|P1|Overall Study|Withdrawal by Subject|27
5681608|NCT00383123|19598416|P2|Overall Study|Protocol Violation|1
5681609|NCT00383123|19598417|P1|Overall Study|Protocol Violation|5
5681610|NCT00383123|19598416|P2|Overall Study|Lost to Follow-up|61
5681611|NCT00383123|19598417|P1|Overall Study|Lost to Follow-up|68
5681612|NCT00383123|19598416|P2|Overall Study|Adverse Event|0
5681613|NCT00383123|19598417|P1|Overall Study|Adverse Event|1
5681614|NCT00383084|19598458|P2|Overall Study|Withdrawal by Subject|10
5681615|NCT00383084|19598459|P1|Overall Study|Withdrawal by Subject|12
5681616|NCT00383019|19598490|P2|Overall Study|Withdrawal by Subject|1
5681617|NCT00383019|19598491|P1|Overall Study|Withdrawal by Subject|0
5681618|NCT00383019|19598490|P2|Overall Study|Adverse Event|1
5681619|NCT00383019|19598491|P1|Overall Study|Adverse Event|5
5681620|NCT00382993|19598513|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
5681621|NCT00382993|19598514|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
5681622|NCT00382993|19598513|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
5681623|NCT00382993|19598514|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
5681624|NCT00382993|19598513|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
5681625|NCT00382993|19598514|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
5681626|NCT00382993|19598513|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
5681627|NCT00382993|19598514|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
5681628|NCT00382993|19598513|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
5681629|NCT00382993|19598514|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
5681630|NCT00382993|19598513|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
5681631|NCT00382993|19598514|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
5681632|NCT00382993|19598513|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
5681633|NCT00382993|19598514|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
5681634|NCT00382993|19598513|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
5681635|NCT00382993|19598514|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
5681636|NCT00382993|19598513|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
5681637|NCT00382993|19598514|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
5681638|NCT00382993|19598513|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
5681639|NCT00382993|19598514|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
5681640|NCT00382967|19598558|P2|Overall Study|Protocol Violation|1
5681641|NCT00382967|19598559|P1|Overall Study|Protocol Violation|1
5681642|NCT00382863|19598584|P2|Overall Study|Withdrawal by Subject|25
5681643|NCT00382863|19598585|P1|Overall Study|Withdrawal by Subject|5
5681644|NCT00382863|19598584|P2|Overall Study|Lost to Follow-up|2
5681645|NCT00382863|19598585|P1|Overall Study|Lost to Follow-up|1
5681646|NCT00382863|19598584|P2|Overall Study|Death|9
5681647|NCT00382863|19598585|P1|Overall Study|Death|9
5681648|NCT00382733|19598669|P5|Overall Study|Withdrawal by Subject|0
5681649|NCT00382733|19598670|P4|Overall Study|Withdrawal by Subject|0
5681650|NCT00382733|19598671|P3|Overall Study|Withdrawal by Subject|0
5681651|NCT00382733|19598672|P2|Overall Study|Withdrawal by Subject|1
5681652|NCT00382733|19598673|P1|Overall Study|Withdrawal by Subject|0
5681653|NCT00382720|19598694|P3|Overall Study|Discontinued at end of study|2
5681654|NCT00382720|19598695|P2|Overall Study|Discontinued at end of study|1
5681655|NCT00382720|19598696|P1|Overall Study|Discontinued at end of study|0
5681656|NCT00382720|19598694|P3|Overall Study|Investigator/Clinical decision|6
5681657|NCT00382720|19598695|P2|Overall Study|Investigator/Clinical decision|6
5681658|NCT00382720|19598696|P1|Overall Study|Investigator/Clinical decision|5
5681659|NCT00382720|19598694|P3|Overall Study|Good prognosis|0
5681660|NCT00382720|19598695|P2|Overall Study|Good prognosis|1
5681661|NCT00382720|19598696|P1|Overall Study|Good prognosis|0
5681662|NCT00382720|19598694|P3|Overall Study|Clinically progressive disease|0
5681663|NCT00382720|19598695|P2|Overall Study|Clinically progressive disease|1
5681664|NCT00382720|19598696|P1|Overall Study|Clinically progressive disease|0
5681665|NCT00382720|19598694|P3|Overall Study|Patient did not receive study medication|4
5681666|NCT00382720|19598695|P2|Overall Study|Patient did not receive study medication|1
5681667|NCT00382720|19598696|P1|Overall Study|Patient did not receive study medication|1
5681668|NCT00382720|19598694|P3|Overall Study|Surgery|4
5681669|NCT00382720|19598695|P2|Overall Study|Surgery|1
5681670|NCT00382720|19598696|P1|Overall Study|Surgery|1
5681671|NCT00382720|19598694|P3|Overall Study|Withdrawal by Subject|12
5681672|NCT00382720|19598695|P2|Overall Study|Withdrawal by Subject|20
5681673|NCT00382720|19598696|P1|Overall Study|Withdrawal by Subject|11
5681674|NCT00382720|19598694|P3|Overall Study|Withdrew consent|2
5681675|NCT00382720|19598695|P2|Overall Study|Withdrew consent|1
5681676|NCT00382720|19598696|P1|Overall Study|Withdrew consent|1
5681677|NCT00382720|19598694|P3|Overall Study|Progressive disease|38
5681678|NCT00382720|19598695|P2|Overall Study|Progressive disease|28
5681679|NCT00382720|19598696|P1|Overall Study|Progressive disease|37
5681680|NCT00382720|19598694|P3|Overall Study|Death|2
5681681|NCT00382720|19598695|P2|Overall Study|Death|1
5681682|NCT00382720|19598696|P1|Overall Study|Death|0
5681683|NCT00382720|19598694|P3|Overall Study|Protocol Violation|1
5681684|NCT00382720|19598695|P2|Overall Study|Protocol Violation|5
5681685|NCT00382720|19598696|P1|Overall Study|Protocol Violation|2
5681686|NCT00382720|19598694|P3|Overall Study|Adverse Event|15
5681687|NCT00382720|19598695|P2|Overall Study|Adverse Event|23
5681688|NCT00382720|19598696|P1|Overall Study|Adverse Event|21
5681689|NCT00382408|19598721|P2|Overall Study|Other|35
5681690|NCT00382408|19598722|P1|Overall Study|Other|100
5681691|NCT00382408|19598721|P2|Overall Study|Lost to Follow-up|8
5681692|NCT00382408|19598722|P1|Overall Study|Lost to Follow-up|19
5681693|NCT00382408|19598721|P2|Overall Study|Pregnancy|0
5681694|NCT00382408|19598722|P1|Overall Study|Pregnancy|2
5681695|NCT00382408|19598721|P2|Overall Study|Withdrawal by Subject|6
5681696|NCT00382408|19598722|P1|Overall Study|Withdrawal by Subject|17
5681697|NCT00382408|19598721|P2|Overall Study|Physician Decision|0
5681698|NCT00382408|19598722|P1|Overall Study|Physician Decision|1
5681699|NCT00382408|19598721|P2|Overall Study|Protocol Violation|2
5681700|NCT00382408|19598722|P1|Overall Study|Protocol Violation|2
5681701|NCT00382408|19598721|P2|Overall Study|Did not meet protocol requirement|3
5681702|NCT00382408|19598722|P1|Overall Study|Did not meet protocol requirement|3
5681703|NCT00382291|19598749|P3|Overall Study|Lack of Efficacy|1
5681704|NCT00382291|19598750|P2|Overall Study|Lack of Efficacy|0
5681705|NCT00382291|19598751|P1|Overall Study|Lack of Efficacy|0
5681706|NCT00382291|19598749|P3|Overall Study|Physician Decision|0
5681707|NCT00382291|19598750|P2|Overall Study|Physician Decision|1
5681708|NCT00382291|19598751|P1|Overall Study|Physician Decision|0
5681709|NCT00382291|19598749|P3|Overall Study|Withdrawal by Subject|0
5681710|NCT00382291|19598750|P2|Overall Study|Withdrawal by Subject|2
5681711|NCT00382291|19598751|P1|Overall Study|Withdrawal by Subject|0
5681712|NCT00382291|19598749|P3|Overall Study|Temporary study suspension|5
5681713|NCT00382291|19598750|P2|Overall Study|Temporary study suspension|2
5681714|NCT00382291|19598751|P1|Overall Study|Temporary study suspension|2
5681715|NCT00382291|19598749|P3|Overall Study|Protocol Violation|0
5681716|NCT00382291|19598750|P2|Overall Study|Protocol Violation|0
5681717|NCT00382291|19598751|P1|Overall Study|Protocol Violation|1
5681718|NCT00382291|19598749|P3|Overall Study|Adverse Event|2
5681719|NCT00382291|19598750|P2|Overall Study|Adverse Event|2
5681720|NCT00382291|19598751|P1|Overall Study|Adverse Event|1
5681721|NCT00382174|19598783|P3|Overall Study|Wounds merged|2
5681722|NCT00382174|19598784|P2|Overall Study|Wounds merged|2
5681723|NCT00382174|19598785|P1|Overall Study|Wounds merged|0
5681724|NCT00382174|19598783|P3|Overall Study|Failed to meet criteria|1
5681725|NCT00382174|19598784|P2|Overall Study|Failed to meet criteria|1
5681726|NCT00382174|19598785|P1|Overall Study|Failed to meet criteria|0
5681727|NCT00382174|19598783|P3|Overall Study|Physician Decision|2
5681728|NCT00382174|19598784|P2|Overall Study|Physician Decision|2
5681729|NCT00382174|19598785|P1|Overall Study|Physician Decision|0
5681730|NCT00382174|19598783|P3|Overall Study|Non compliance|1
5681731|NCT00382174|19598784|P2|Overall Study|Non compliance|0
5681732|NCT00382174|19598785|P1|Overall Study|Non compliance|1
5681733|NCT00382174|19598783|P3|Overall Study|Withdrawal by Subject|5
5681734|NCT00382174|19598784|P2|Overall Study|Withdrawal by Subject|4
5681735|NCT00382174|19598785|P1|Overall Study|Withdrawal by Subject|1
5681736|NCT00382174|19598783|P3|Overall Study|Adverse Event|5
5681737|NCT00382174|19598784|P2|Overall Study|Adverse Event|4
5681738|NCT00382174|19598785|P1|Overall Study|Adverse Event|1
5681739|NCT00382174|19598783|P3|Overall Study|Lost to Follow-up|5
5681740|NCT00382174|19598784|P2|Overall Study|Lost to Follow-up|4
5681741|NCT00382174|19598785|P1|Overall Study|Lost to Follow-up|1
5681742|NCT00382109|19598813|P2|Overall Study|consent withdrawal|1
5681743|NCT00382109|19598814|P1|Overall Study|consent withdrawal|0
5681744|NCT00382109|19598813|P2|Overall Study|Other|2
5681745|NCT00382109|19598814|P1|Overall Study|Other|0
5681746|NCT00382109|19598813|P2|Overall Study|ineligible|0
5681747|NCT00382109|19598814|P1|Overall Study|ineligible|2
5681748|NCT00382109|19598813|P2|Overall Study|Withdrawal by Subject|0
5681749|NCT00382109|19598814|P1|Overall Study|Withdrawal by Subject|1
5681750|NCT00382109|19598813|P2|Overall Study|Physician Decision|1
5681751|NCT00382109|19598814|P1|Overall Study|Physician Decision|6
5681752|NCT00382109|19598813|P2|Overall Study|Adverse Event|0
5681753|NCT00382109|19598814|P1|Overall Study|Adverse Event|3
5681754|NCT00382018|19598853|P4|Overall Study|Other, not protocol specified|1
5681755|NCT00382018|19598854|P3|Overall Study|Other, not protocol specified|3
5681756|NCT00382018|19598855|P2|Overall Study|Other, not protocol specified|16
5681757|NCT00382018|19598856|P1|Overall Study|Other, not protocol specified|0
5681758|NCT00382018|19598853|P4|Overall Study|Withdrawal by Subject|4
5681759|NCT00382018|19598854|P3|Overall Study|Withdrawal by Subject|3
5681760|NCT00382018|19598855|P2|Overall Study|Withdrawal by Subject|4
5681761|NCT00382018|19598856|P1|Overall Study|Withdrawal by Subject|0
5681762|NCT00382018|19598853|P4|Overall Study|Death|11
5681763|NCT00382018|19598854|P3|Overall Study|Death|7
5681764|NCT00382018|19598855|P2|Overall Study|Death|9
5681765|NCT00382018|19598856|P1|Overall Study|Death|0
5681766|NCT00382018|19598853|P4|Overall Study|Progression|43
5681767|NCT00382018|19598854|P3|Overall Study|Progression|51
5681768|NCT00382018|19598855|P2|Overall Study|Progression|136
5681769|NCT00382018|19598856|P1|Overall Study|Progression|0
5681770|NCT00381940|19598879|P1|Overall Study|Ineligible|1
5681771|NCT00381940|19598879|P1|Overall Study|Protocol Violation|1
5681772|NCT00381940|19598879|P1|Overall Study|Lack of Efficacy|3
5681773|NCT00381888|19598883|P1|Overall Study|Adverse Event|1
5681774|NCT00381888|19598883|P1|Overall Study|Surgery was cancelled|2
5681775|NCT00381888|19598883|P1|Overall Study|Had laparoscopic surgery|2
5681776|NCT00381888|19598883|P1|Overall Study|Protocol Violation|9
5681777|NCT00381888|19598883|P1|Overall Study|Physician Decision|1
5681778|NCT00381888|19598883|P1|Overall Study|Withdrawal by Subject|1
5681779|NCT00381888|19598883|P1|Overall Study|Death|1
5681780|NCT00381849|19598894|P2|Wash Out|Withdrawal by Subject|1
5681781|NCT00381849|19598895|P1|Wash Out|Withdrawal by Subject|0
5681782|NCT00381797|19598922|P5|Overall Study|Ineligible|0
5681783|NCT00381797|19598923|P4|Overall Study|Ineligible|1
5681784|NCT00381797|19598924|P3|Overall Study|Ineligible|0
5681785|NCT00381797|19598925|P2|Overall Study|Ineligible|0
5681786|NCT00381797|19598926|P1|Overall Study|Ineligible|0
5681787|NCT00381797|19598922|P5|Overall Study|Withdrawal by Subject|2
5681788|NCT00381797|19598923|P4|Overall Study|Withdrawal by Subject|0
5681789|NCT00381797|19598924|P3|Overall Study|Withdrawal by Subject|0
5681790|NCT00381797|19598925|P2|Overall Study|Withdrawal by Subject|1
5681791|NCT00381797|19598926|P1|Overall Study|Withdrawal by Subject|1
5681792|NCT00381706|19599001|P3|Overall Study|Never treated|1
5681793|NCT00381706|19599002|P2|Overall Study|Never treated|2
5681794|NCT00381706|19599003|P1|Overall Study|Never treated|7
5681795|NCT00381693|19599026|P1|Overall Study|Progression|2
5681796|NCT00381693|19599026|P1|Overall Study|Patient Choice|1
5681797|NCT00381693|19599026|P1|Overall Study|Adverse Event|4
5681798|NCT00381693|19599026|P1|Overall Study|Death|1
5681799|NCT00381680|19599035|P2|Overall Study|Ineligible|1
5681800|NCT00381680|19599036|P1|Overall Study|Ineligible|3
5681801|NCT00381680|19599035|P2|Overall Study|Other not otherwise specified|2
5681802|NCT00381680|19599036|P1|Overall Study|Other not otherwise specified|7
5681803|NCT00381680|19599035|P2|Overall Study|Progression|1
5681804|NCT00381680|19599036|P1|Overall Study|Progression|1
5681805|NCT00381680|19599035|P2|Overall Study|Induction Failure|1
5681806|NCT00381680|19599036|P1|Overall Study|Induction Failure|4
5681807|NCT00381680|19599035|P2|Overall Study|Relapse|9
5681808|NCT00381680|19599036|P1|Overall Study|Relapse|18
5681809|NCT00381680|19599035|P2|Overall Study|Stem Cell Transplant|10
5681810|NCT00381680|19599036|P1|Overall Study|Stem Cell Transplant|26
5681811|NCT00381680|19599035|P2|Overall Study|Delay initiation|0
5681812|NCT00381680|19599036|P1|Overall Study|Delay initiation|1
5681813|NCT00381680|19599035|P2|Overall Study|Secondary Malignancy|0
5681814|NCT00381680|19599036|P1|Overall Study|Secondary Malignancy|3
5681815|NCT00381680|19599035|P2|Overall Study|Alternative Therapy|5
5681816|NCT00381680|19599036|P1|Overall Study|Alternative Therapy|11
5681817|NCT00381680|19599035|P2|Overall Study|Entry onto another COG Trial|2
5681818|NCT00381680|19599036|P1|Overall Study|Entry onto another COG Trial|1
5681819|NCT00381680|19599035|P2|Overall Study|Withdrawal by Subject|1
5681820|NCT00381680|19599036|P1|Overall Study|Withdrawal by Subject|3
5681821|NCT00381680|19599035|P2|Overall Study|Physician Decision|6
5681822|NCT00381680|19599036|P1|Overall Study|Physician Decision|25
5681823|NCT00381680|19599035|P2|Overall Study|Lost to Follow-up|2
5681824|NCT00381680|19599036|P1|Overall Study|Lost to Follow-up|3
5681825|NCT00381680|19599035|P2|Overall Study|Death|7
5681826|NCT00381680|19599036|P1|Overall Study|Death|10
5681827|NCT00381680|19599035|P2|Overall Study|Adverse Event|3
5681828|NCT00381680|19599036|P1|Overall Study|Adverse Event|9
5681829|NCT00381641|19599053|P2|Overall Study|Withdrawal by Subject|2
5681830|NCT00381641|19599054|P1|Overall Study|Withdrawal by Subject|0
5681831|NCT00381615|19599087|P4|Overall Study|Protocol Violation|0
5681832|NCT00381615|19599088|P3|Overall Study|Protocol Violation|1
5681833|NCT00381615|19599089|P2|Overall Study|Protocol Violation|0
5681834|NCT00381615|19599090|P1|Overall Study|Protocol Violation|0
5681835|NCT00381615|19599087|P4|Overall Study|Lost to Follow-up|1
5681836|NCT00381615|19599088|P3|Overall Study|Lost to Follow-up|0
5681837|NCT00381615|19599089|P2|Overall Study|Lost to Follow-up|2
5681838|NCT00381615|19599090|P1|Overall Study|Lost to Follow-up|3
5681839|NCT00381615|19599087|P4|Overall Study|Withdrawal by Subject|1
5681840|NCT00381615|19599088|P3|Overall Study|Withdrawal by Subject|0
5681841|NCT00381615|19599089|P2|Overall Study|Withdrawal by Subject|3
5681842|NCT00381615|19599090|P1|Overall Study|Withdrawal by Subject|1
5681843|NCT00381563|19599142|P2|Overall Study|Protocol Violation|1
5681844|NCT00381563|19599143|P1|Overall Study|Protocol Violation|0
5681845|NCT00381563|19599142|P2|Overall Study|Lost to Follow-up|0
5681846|NCT00381563|19599143|P1|Overall Study|Lost to Follow-up|2
5681847|NCT00381563|19599142|P2|Overall Study|Withdrawal by Subject|5
5681848|NCT00381563|19599143|P1|Overall Study|Withdrawal by Subject|5
5681849|NCT00381485|19599158|P4|Double-Blind Treatment Period|Administrative|1
5681850|NCT00381485|19599159|P3|Double-Blind Treatment Period|Administrative|0
5681851|NCT00381485|19599160|P2|Double-Blind Treatment Period|Administrative|1
5681852|NCT00381485|19599161|P1|Double-Blind Treatment Period|Administrative|0
5681853|NCT00381485|19599158|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
5681854|NCT00381485|19599159|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
5681855|NCT00381485|19599160|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
5681856|NCT00381485|19599161|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
5681932|NCT00381303|19599188|P2|Overall Study|Non-Adherence|6
5681857|NCT00381485|19599158|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
5681858|NCT00381485|19599159|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
5681859|NCT00381485|19599160|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
5681860|NCT00381485|19599161|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
5681861|NCT00381485|19599158|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
5681862|NCT00381485|19599159|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
5681863|NCT00381485|19599160|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
5681864|NCT00381485|19599161|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
5681865|NCT00381485|19599158|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
5681866|NCT00381485|19599159|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
5681867|NCT00381485|19599160|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
5681868|NCT00381485|19599161|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
5681869|NCT00381485|19599158|P4|Double-Blind Treatment Period|Lost to Follow-up|1
5681870|NCT00381485|19599159|P3|Double-Blind Treatment Period|Lost to Follow-up|1
5681871|NCT00381485|19599160|P2|Double-Blind Treatment Period|Lost to Follow-up|0
5681872|NCT00381485|19599161|P1|Double-Blind Treatment Period|Lost to Follow-up|0
5681873|NCT00381485|19599158|P4|Double-Blind Treatment Period|Lack of Efficacy|13
5681874|NCT00381485|19599159|P3|Double-Blind Treatment Period|Lack of Efficacy|11
5681875|NCT00381485|19599160|P2|Double-Blind Treatment Period|Lack of Efficacy|8
5681876|NCT00381485|19599161|P1|Double-Blind Treatment Period|Lack of Efficacy|0
5681877|NCT00381485|19599158|P4|Double-Blind Treatment Period|Adverse Event|5
5681878|NCT00381485|19599159|P3|Double-Blind Treatment Period|Adverse Event|2
5681879|NCT00381485|19599160|P2|Double-Blind Treatment Period|Adverse Event|2
5681880|NCT00381485|19599161|P1|Double-Blind Treatment Period|Adverse Event|0
5681881|NCT00381485|19599158|P4|Open-Label Run-In Period|Treatment failure|0
5681882|NCT00381485|19599159|P3|Open-Label Run-In Period|Treatment failure|0
5681883|NCT00381485|19599160|P2|Open-Label Run-In Period|Treatment failure|0
5681884|NCT00381485|19599161|P1|Open-Label Run-In Period|Treatment failure|1
5681885|NCT00381485|19599158|P4|Open-Label Run-In Period|Lost to Follow-up|0
5681886|NCT00381485|19599159|P3|Open-Label Run-In Period|Lost to Follow-up|0
5681887|NCT00381485|19599160|P2|Open-Label Run-In Period|Lost to Follow-up|0
5681888|NCT00381485|19599161|P1|Open-Label Run-In Period|Lost to Follow-up|3
5681889|NCT00381485|19599158|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
5681890|NCT00381485|19599159|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
5681891|NCT00381485|19599160|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
5681892|NCT00381485|19599161|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
5681893|NCT00381485|19599158|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
5681894|NCT00381485|19599159|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
5681895|NCT00381485|19599160|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
5681896|NCT00381485|19599161|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
5681897|NCT00381485|19599158|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
5681898|NCT00381485|19599159|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
5681899|NCT00381485|19599160|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
5681900|NCT00381485|19599161|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
5681901|NCT00381485|19599158|P4|Open-Label Run-In Period|Adverse Event|0
5681902|NCT00381485|19599159|P3|Open-Label Run-In Period|Adverse Event|0
5681903|NCT00381485|19599160|P2|Open-Label Run-In Period|Adverse Event|0
5681904|NCT00381485|19599161|P1|Open-Label Run-In Period|Adverse Event|9
5681905|NCT00381381|19599179|P1|Overall Study|Withdrawal by Subject|9
5681906|NCT00381381|19599179|P1|Overall Study|Lost to Follow-up|52
5681907|NCT00381381|19599179|P1|Overall Study|Adverse Event|3
5681908|NCT00381303|19599188|P2|Overall Study|Subject primary physician's decision|0
5681909|NCT00381303|19599189|P1|Overall Study|Subject primary physician's decision|1
5681910|NCT00381303|19599188|P2|Overall Study|Subject did not continue visits|0
5681911|NCT00381303|19599189|P1|Overall Study|Subject did not continue visits|1
5681912|NCT00381303|19599188|P2|Overall Study|Subject was too busy for appointments|0
5681913|NCT00381303|19599189|P1|Overall Study|Subject was too busy for appointments|1
5681914|NCT00381303|19599188|P2|Overall Study|No virologic response by week 12|0
5681915|NCT00381303|19599189|P1|Overall Study|No virologic response by week 12|1
5681916|NCT00381303|19599188|P2|Overall Study|Subject taking too many different meds|0
5681917|NCT00381303|19599189|P1|Overall Study|Subject taking too many different meds|1
5681918|NCT00381303|19599188|P2|Overall Study|Subject moved out of state|0
5681919|NCT00381303|19599189|P1|Overall Study|Subject moved out of state|2
5681920|NCT00381303|19599188|P2|Overall Study|Physician's decision to close the site|1
5681921|NCT00381303|19599189|P1|Overall Study|Physician's decision to close the site|3
5681922|NCT00381303|19599188|P2|Overall Study|Physician Decision|0
5681923|NCT00381303|19599189|P1|Overall Study|Physician Decision|1
5681924|NCT00381303|19599188|P2|Overall Study|Pregnancy|0
5681925|NCT00381303|19599189|P1|Overall Study|Pregnancy|2
5681926|NCT00381303|19599188|P2|Overall Study|Ineligible to continue the trial|1
5681927|NCT00381303|19599189|P1|Overall Study|Ineligible to continue the trial|2
5681928|NCT00381303|19599188|P2|Overall Study|Virologic failure|4
5681929|NCT00381303|19599189|P1|Overall Study|Virologic failure|6
5681930|NCT00381303|19599188|P2|Overall Study|Withdrawal by Subject|6
5681931|NCT00381303|19599189|P1|Overall Study|Withdrawal by Subject|13
5681933|NCT00381303|19599189|P1|Overall Study|Non-Adherence|13
5681934|NCT00381303|19599188|P2|Overall Study|AE/HIV-related event|6
5681935|NCT00381303|19599189|P1|Overall Study|AE/HIV-related event|22
5681936|NCT00381303|19599188|P2|Overall Study|Lost to Follow-up|9
5681937|NCT00381303|19599189|P1|Overall Study|Lost to Follow-up|25
5681938|NCT00381238|19599249|P1|Overall Study|Disease progression|1
5681939|NCT00381238|19599249|P1|Overall Study|Withdrew by physician|1
5681940|NCT00381238|19599249|P1|Overall Study|Lack of Efficacy|2
5681941|NCT00381238|19599249|P1|Overall Study|Withdrawal by Subject|4
5681942|NCT00381238|19599249|P1|Overall Study|Protocol Violation|1
5681943|NCT00381238|19599249|P1|Overall Study|Adverse Event|3
5681944|NCT00381095|19599265|P2|Overall Study|Adverse Event|7
5681945|NCT00381095|19599266|P1|Overall Study|Adverse Event|2
5681946|NCT00381095|19599265|P2|Overall Study|Withdrawal by Subject|3
5681947|NCT00381095|19599266|P1|Overall Study|Withdrawal by Subject|3
5681948|NCT00381095|19599265|P2|Overall Study|Protocol Violation|1
5681949|NCT00381095|19599266|P1|Overall Study|Protocol Violation|1
5681950|NCT00381095|19599265|P2|Overall Study|Other|2
5681951|NCT00381095|19599266|P1|Overall Study|Other|2
5681952|NCT00381095|19599265|P2|Overall Study|Lack of Efficacy|4
5681953|NCT00381095|19599266|P1|Overall Study|Lack of Efficacy|2
5681954|NCT00381095|19599265|P2|Overall Study|Death|4
5681955|NCT00381095|19599266|P1|Overall Study|Death|3
5681956|NCT00381043|19599298|P2|Overall Study|incarcerated|0
5681957|NCT00381043|19599299|P1|Overall Study|incarcerated|1
5681958|NCT00381043|19599298|P2|Overall Study|wanted more care|1
5681959|NCT00381043|19599299|P1|Overall Study|wanted more care|0
5681960|NCT00381043|19599298|P2|Overall Study|Withdrawal by Subject|1
5681961|NCT00381043|19599299|P1|Overall Study|Withdrawal by Subject|3
5681962|NCT00381043|19599298|P2|Overall Study|Lost to Follow-up|6
5681963|NCT00381043|19599299|P1|Overall Study|Lost to Follow-up|8
5681964|NCT00380978|19599325|P2|Overall Study|Parous patient|0
5681965|NCT00380978|19599326|P1|Overall Study|Parous patient|1
5681966|NCT00380978|19599325|P2|Overall Study|Allocation prior to analgesia request|2
5681967|NCT00380978|19599326|P1|Overall Study|Allocation prior to analgesia request|1
5681968|NCT00380978|19599325|P2|Overall Study|Wrong study envelope|2
5681969|NCT00380978|19599326|P1|Overall Study|Wrong study envelope|0
5681970|NCT00380978|19599325|P2|Overall Study|Refused allocated intervention|6
5681971|NCT00380978|19599326|P1|Overall Study|Refused allocated intervention|0
5681972|NCT00380874|19599348|P2|Overall Study|Not related to study drug|2
5681973|NCT00380874|19599349|P1|Overall Study|Not related to study drug|3
5681974|NCT00380874|19599348|P2|Overall Study|Withdrawal by Subject|1
5681975|NCT00380874|19599349|P1|Overall Study|Withdrawal by Subject|2
5681976|NCT00380874|19599348|P2|Overall Study|Death|0
5681977|NCT00380874|19599349|P1|Overall Study|Death|1
5681978|NCT00380874|19599348|P2|Overall Study|Adverse Event|7
5681979|NCT00380874|19599349|P1|Overall Study|Adverse Event|7
5681980|NCT00380744|19599381|P7|Overall Study|Withdrawal by Subject|0
5681981|NCT00380744|19599382|P6|Overall Study|Withdrawal by Subject|0
5681982|NCT00380744|19599383|P5|Overall Study|Withdrawal by Subject|0
5681983|NCT00380744|19599384|P4|Overall Study|Withdrawal by Subject|0
5681984|NCT00380744|19599385|P3|Overall Study|Withdrawal by Subject|0
5681985|NCT00380744|19599386|P2|Overall Study|Withdrawal by Subject|0
5681986|NCT00380744|19599387|P1|Overall Study|Withdrawal by Subject|1
5681987|NCT00380744|19599381|P7|Overall Study|Death|1
5681988|NCT00380744|19599382|P6|Overall Study|Death|0
5681989|NCT00380744|19599383|P5|Overall Study|Death|0
5681990|NCT00380744|19599384|P4|Overall Study|Death|0
5681991|NCT00380744|19599385|P3|Overall Study|Death|0
5681992|NCT00380744|19599386|P2|Overall Study|Death|0
5681993|NCT00380744|19599387|P1|Overall Study|Death|0
5681994|NCT00380718|19599437|P1|Overall Study|Death after 30-day post-therapy followup|17
5681995|NCT00380718|19599437|P1|Overall Study|Adverse Event|1
5681996|NCT00380692|19599449|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
5681997|NCT00380692|19599450|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
5681998|NCT00380692|19599449|P2|Study Period III - Open Label|Lack of Efficacy|4
5681999|NCT00380692|19599450|P1|Study Period III - Open Label|Lack of Efficacy|0
5682000|NCT00380692|19599449|P2|Study Period III - Open Label|Physician Decision|3
5682001|NCT00380692|19599450|P1|Study Period III - Open Label|Physician Decision|0
5682002|NCT00380692|19599449|P2|Study Period III - Open Label|Withdrawal by Subject|1
5682003|NCT00380692|19599450|P1|Study Period III - Open Label|Withdrawal by Subject|0
5682004|NCT00380692|19599449|P2|Study Period III - Open Label|Protocol Violation|0
5682005|NCT00380692|19599450|P1|Study Period III - Open Label|Protocol Violation|0
5682006|NCT00380692|19599449|P2|Study Period III - Open Label|Adverse Event|3
5682007|NCT00380692|19599450|P1|Study Period III - Open Label|Adverse Event|5
5682008|NCT00380692|19599449|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
5682009|NCT00380692|19599450|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
5682010|NCT00380692|19599449|P2|Study Period II - Double Blind|Lack of Efficacy|0
5682011|NCT00380692|19599450|P1|Study Period II - Double Blind|Lack of Efficacy|1
5682012|NCT00380692|19599449|P2|Study Period II - Double Blind|Physician Decision|1
5682013|NCT00380692|19599450|P1|Study Period II - Double Blind|Physician Decision|0
5682014|NCT00380692|19599449|P2|Study Period II - Double Blind|Withdrawal by Subject|0
5682015|NCT00380692|19599450|P1|Study Period II - Double Blind|Withdrawal by Subject|0
5682016|NCT00380692|19599449|P2|Study Period II - Double Blind|Protocol Violation|2
5682017|NCT00380692|19599450|P1|Study Period II - Double Blind|Protocol Violation|2
5682018|NCT00380692|19599449|P2|Study Period II - Double Blind|Adverse Event|0
5682019|NCT00380692|19599450|P1|Study Period II - Double Blind|Adverse Event|1
5682020|NCT00380588|19599498|P2|Overall Study|Physician Decision|0
5682021|NCT00380588|19599499|P1|Overall Study|Physician Decision|2
5682022|NCT00380588|19599498|P2|Overall Study|Withdrawal by Subject|3
5682023|NCT00380588|19599499|P1|Overall Study|Withdrawal by Subject|1
5682024|NCT00380588|19599498|P2|Overall Study|Adverse Event|3
5682025|NCT00380588|19599499|P1|Overall Study|Adverse Event|7
5682026|NCT00380588|19599498|P2|Overall Study|Next Cycle Not Started|0
5682027|NCT00380588|19599499|P1|Overall Study|Next Cycle Not Started|4
5682028|NCT00380588|19599498|P2|Overall Study|Unequivocal Disease Progression|34
5682029|NCT00380588|19599499|P1|Overall Study|Unequivocal Disease Progression|25
5682030|NCT00380393|19599513|P2|Month 14|Others|6
5682031|NCT00380393|19599514|P1|Month 14|Others|6
5682032|NCT00380393|19599513|P2|Month 14|Protocol Violation|0
5682033|NCT00380393|19599514|P1|Month 14|Protocol Violation|2
5682034|NCT00380393|19599513|P2|Month 14|Migrated/moved from study area|42
5682035|NCT00380393|19599514|P1|Month 14|Migrated/moved from study area|39
5682036|NCT00380393|19599513|P2|Month 14|Lost to Follow-up|1
5682037|NCT00380393|19599514|P1|Month 14|Lost to Follow-up|0
5682038|NCT00380393|19599513|P2|Month 14|Death|0
5682039|NCT00380393|19599514|P1|Month 14|Death|1
5682040|NCT00380393|19599513|P2|Month 14|Withdrawal by Subject|7
5682041|NCT00380393|19599514|P1|Month 14|Withdrawal by Subject|9
5682042|NCT00380393|19599513|P2|Month 8 (Cross-sectional Visit)|Others|4
5682043|NCT00380393|19599514|P1|Month 8 (Cross-sectional Visit)|Others|5
5682044|NCT00380393|19599513|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
5682045|NCT00380393|19599514|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
5682046|NCT00380393|19599513|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
5682047|NCT00380393|19599514|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
5682048|NCT00380393|19599513|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
5682049|NCT00380393|19599514|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
5682050|NCT00380393|19599513|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
5682051|NCT00380393|19599514|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
5682052|NCT00380367|19599562|P1|Overall Study|Withdrawal by Subject|1
5682053|NCT00380367|19599562|P1|Overall Study|Lost to Follow-up|1
5682054|NCT00380250|19599569|P2|Overall Study|Physician Decision|0
5682055|NCT00380250|19599570|P1|Overall Study|Physician Decision|1
5682056|NCT00380250|19599569|P2|Overall Study|Lost to Follow-up|5
5682057|NCT00380250|19599570|P1|Overall Study|Lost to Follow-up|14
5682058|NCT00380250|19599569|P2|Overall Study|Protocol Violation|5
5682059|NCT00380250|19599570|P1|Overall Study|Protocol Violation|15
5682060|NCT00380250|19599569|P2|Overall Study|Lack of Efficacy|8
5682061|NCT00380250|19599570|P1|Overall Study|Lack of Efficacy|10
5682062|NCT00380250|19599569|P2|Overall Study|Adverse Event|9
5682063|NCT00380250|19599570|P1|Overall Study|Adverse Event|20
5682064|NCT00380250|19599569|P2|Overall Study|Withdrawal by Subject|28
5682065|NCT00380250|19599570|P1|Overall Study|Withdrawal by Subject|39
5682066|NCT00380081|19599638|P6|Overall Study|Family Emergency|1
5682067|NCT00380081|19599639|P5|Overall Study|Family Emergency|0
5682068|NCT00380081|19599640|P4|Overall Study|Family Emergency|0
5682069|NCT00380081|19599641|P3|Overall Study|Family Emergency|0
5682070|NCT00380081|19599642|P2|Overall Study|Family Emergency|0
5682071|NCT00380081|19599643|P1|Overall Study|Family Emergency|0
5682072|NCT00380081|19599638|P6|Overall Study|Withdrawal by Subject|0
5682073|NCT00380081|19599639|P5|Overall Study|Withdrawal by Subject|1
5682074|NCT00380081|19599640|P4|Overall Study|Withdrawal by Subject|0
5682075|NCT00380081|19599641|P3|Overall Study|Withdrawal by Subject|0
5682076|NCT00380081|19599642|P2|Overall Study|Withdrawal by Subject|0
5682077|NCT00380081|19599643|P1|Overall Study|Withdrawal by Subject|0
5682078|NCT00380068|19599693|P1|Overall Study|Lack of Efficacy|5
5682079|NCT00380068|19599693|P1|Overall Study|Partipant moved away|1
5682080|NCT00380068|19599693|P1|Overall Study|Physician Decision|2
5682081|NCT00380068|19599693|P1|Overall Study|Lung transplant|3
5682082|NCT00380068|19599693|P1|Overall Study|Addition of other PAH therapeutic agent|1
5682083|NCT00380068|19599693|P1|Overall Study|Lost to Follow-up|1
5682084|NCT00380068|19599693|P1|Overall Study|Not compliant|6
5682085|NCT00380068|19599693|P1|Overall Study|Withdrawal by Subject|10
5682086|NCT00380068|19599693|P1|Overall Study|Adverse Event|40
5682087|NCT00379912|19599725|P2|Overall Study|Lack of Efficacy|0
5682088|NCT00379912|19599726|P1|Overall Study|Lack of Efficacy|1
5682089|NCT00379899|19599748|P2|Overall Study|Other|1
5682090|NCT00379899|19599749|P1|Overall Study|Other|3
5682091|NCT00379899|19599748|P2|Overall Study|Other protocol-specified criteria|4
5682092|NCT00379899|19599749|P1|Overall Study|Other protocol-specified criteria|3
5682093|NCT00379899|19599748|P2|Overall Study|Coronary artery bypass graft|1
5682094|NCT00379899|19599749|P1|Overall Study|Coronary artery bypass graft|1
5682095|NCT00379899|19599748|P2|Overall Study|Renal transplantation|4
5682096|NCT00379899|19599749|P1|Overall Study|Renal transplantation|5
5682097|NCT00379899|19599748|P2|Overall Study|Parathyroidectomy|2
5682098|NCT00379899|19599749|P1|Overall Study|Parathyroidectomy|0
5682099|NCT00379899|19599748|P2|Overall Study|Noncompliance|1
5682100|NCT00379899|19599749|P1|Overall Study|Noncompliance|1
5682101|NCT00379899|19599748|P2|Overall Study|Ineligibility determined|1
5682102|NCT00379899|19599749|P1|Overall Study|Ineligibility determined|0
5682103|NCT00379899|19599748|P2|Overall Study|Withdrawal by Subject|5
5682104|NCT00379899|19599749|P1|Overall Study|Withdrawal by Subject|5
5682105|NCT00379899|19599748|P2|Overall Study|Physician Decision|4
5682106|NCT00379899|19599749|P1|Overall Study|Physician Decision|3
5682107|NCT00379899|19599748|P2|Overall Study|Lost to Follow-up|4
5682108|NCT00379899|19599749|P1|Overall Study|Lost to Follow-up|2
5682109|NCT00379899|19599748|P2|Overall Study|Death|10
5682110|NCT00379899|19599749|P1|Overall Study|Death|10
5682111|NCT00379899|19599748|P2|Overall Study|Adverse Event|3
5682112|NCT00379899|19599749|P1|Overall Study|Adverse Event|7
5682113|NCT00379834|19599777|P1|Overall Study|Time constraints|2
5682114|NCT00379808|19599929|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
5682115|NCT00379808|19599930|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
5682116|NCT00379795|19599951|P5|Overall Study|Sponsor's decision|10
5682117|NCT00379795|19599952|P4|Overall Study|Sponsor's decision|47
5682118|NCT00379795|19599953|P3|Overall Study|Sponsor's decision|54
5682119|NCT00379795|19599954|P2|Overall Study|Sponsor's decision|17
5682120|NCT00379795|19599955|P1|Overall Study|Sponsor's decision|257
5682121|NCT00379795|19599951|P5|Overall Study|Subjects condition mandated intervention|7
5682122|NCT00379795|19599952|P4|Overall Study|Subjects condition mandated intervention|5
5682123|NCT00379795|19599953|P3|Overall Study|Subjects condition mandated intervention|7
5682124|NCT00379795|19599954|P2|Overall Study|Subjects condition mandated intervention|9
5682125|NCT00379795|19599955|P1|Overall Study|Subjects condition mandated intervention|34
5682126|NCT00379795|19599951|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
5682127|NCT00379795|19599952|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
5682128|NCT00379795|19599953|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
5682129|NCT00379795|19599954|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
5682130|NCT00379795|19599955|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
5682131|NCT00379795|19599951|P5|Overall Study|Subject non-compliance|1
5682132|NCT00379795|19599952|P4|Overall Study|Subject non-compliance|0
5682133|NCT00379795|19599953|P3|Overall Study|Subject non-compliance|0
5682134|NCT00379795|19599954|P2|Overall Study|Subject non-compliance|2
5682135|NCT00379795|19599955|P1|Overall Study|Subject non-compliance|7
5682136|NCT00379795|19599951|P5|Overall Study|Withdrawal by Subject|14
5682137|NCT00379795|19599952|P4|Overall Study|Withdrawal by Subject|7
5682138|NCT00379795|19599953|P3|Overall Study|Withdrawal by Subject|19
5682139|NCT00379795|19599954|P2|Overall Study|Withdrawal by Subject|11
5682140|NCT00379795|19599955|P1|Overall Study|Withdrawal by Subject|94
5682141|NCT00379795|19599951|P5|Overall Study|Physician Decision|2
5682142|NCT00379795|19599952|P4|Overall Study|Physician Decision|2
5682143|NCT00379795|19599953|P3|Overall Study|Physician Decision|2
5682144|NCT00379795|19599954|P2|Overall Study|Physician Decision|0
5682145|NCT00379795|19599955|P1|Overall Study|Physician Decision|25
5682146|NCT00379795|19599951|P5|Overall Study|Lost to Follow-up|4
5682147|NCT00379795|19599952|P4|Overall Study|Lost to Follow-up|1
5682148|NCT00379795|19599953|P3|Overall Study|Lost to Follow-up|2
5682149|NCT00379795|19599954|P2|Overall Study|Lost to Follow-up|1
5682150|NCT00379795|19599955|P1|Overall Study|Lost to Follow-up|8
5682151|NCT00379795|19599951|P5|Overall Study|Adverse Event|4
5682152|NCT00379795|19599952|P4|Overall Study|Adverse Event|1
5682153|NCT00379795|19599953|P3|Overall Study|Adverse Event|3
5682154|NCT00379795|19599954|P2|Overall Study|Adverse Event|3
5682155|NCT00379795|19599955|P1|Overall Study|Adverse Event|17
5682156|NCT00379795|19599951|P5|Overall Study|Death|7
5682157|NCT00379795|19599952|P4|Overall Study|Death|4
5682158|NCT00379795|19599953|P3|Overall Study|Death|6
5682159|NCT00379795|19599954|P2|Overall Study|Death|8
5682160|NCT00379795|19599955|P1|Overall Study|Death|31
5682161|NCT00379769|19599985|P6|Observational Follow-up|Unknown; Reason Not Provided|1
5682162|NCT00379769|19599986|P5|Observational Follow-up|Unknown; Reason Not Provided|1
5682163|NCT00379769|19599987|P4|Observational Follow-up|Unknown; Reason Not Provided|0
5682164|NCT00379769|19599988|P3|Observational Follow-up|Unknown; Reason Not Provided|0
5682165|NCT00379769|19599989|P2|Observational Follow-up|Unknown; Reason Not Provided|0
5682166|NCT00379769|19599990|P1|Observational Follow-up|Unknown; Reason Not Provided|0
5682167|NCT00379769|19599985|P6|Observational Follow-up|Participant Moved|1
5682168|NCT00379769|19599986|P5|Observational Follow-up|Participant Moved|0
5682169|NCT00379769|19599987|P4|Observational Follow-up|Participant Moved|0
5682170|NCT00379769|19599988|P3|Observational Follow-up|Participant Moved|0
5682171|NCT00379769|19599989|P2|Observational Follow-up|Participant Moved|0
5682172|NCT00379769|19599990|P1|Observational Follow-up|Participant Moved|0
5682173|NCT00379769|19599985|P6|Observational Follow-up|Site Closed Early|7
5682174|NCT00379769|19599986|P5|Observational Follow-up|Site Closed Early|6
5682175|NCT00379769|19599987|P4|Observational Follow-up|Site Closed Early|0
5682176|NCT00379769|19599988|P3|Observational Follow-up|Site Closed Early|0
5682177|NCT00379769|19599989|P2|Observational Follow-up|Site Closed Early|0
5682178|NCT00379769|19599990|P1|Observational Follow-up|Site Closed Early|0
5682179|NCT00379769|19599985|P6|Observational Follow-up|Physician Decision|8
5682180|NCT00379769|19599986|P5|Observational Follow-up|Physician Decision|8
5682181|NCT00379769|19599987|P4|Observational Follow-up|Physician Decision|0
5682182|NCT00379769|19599988|P3|Observational Follow-up|Physician Decision|0
5682183|NCT00379769|19599989|P2|Observational Follow-up|Physician Decision|0
5682184|NCT00379769|19599990|P1|Observational Follow-up|Physician Decision|0
5682185|NCT00379769|19599985|P6|Observational Follow-up|Entered into Another Clinical Trial|22
5682186|NCT00379769|19599986|P5|Observational Follow-up|Entered into Another Clinical Trial|18
5682187|NCT00379769|19599987|P4|Observational Follow-up|Entered into Another Clinical Trial|0
5682188|NCT00379769|19599988|P3|Observational Follow-up|Entered into Another Clinical Trial|0
5682189|NCT00379769|19599989|P2|Observational Follow-up|Entered into Another Clinical Trial|0
5682190|NCT00379769|19599990|P1|Observational Follow-up|Entered into Another Clinical Trial|0
5682191|NCT00379769|19599985|P6|Observational Follow-up|Withdrawal by Subject|12
5682192|NCT00379769|19599986|P5|Observational Follow-up|Withdrawal by Subject|12
5682193|NCT00379769|19599987|P4|Observational Follow-up|Withdrawal by Subject|0
5682194|NCT00379769|19599988|P3|Observational Follow-up|Withdrawal by Subject|0
5682195|NCT00379769|19599989|P2|Observational Follow-up|Withdrawal by Subject|0
5682196|NCT00379769|19599990|P1|Observational Follow-up|Withdrawal by Subject|0
5682197|NCT00379769|19599985|P6|Observational Follow-up|Lost to Follow-up|27
5682198|NCT00379769|19599986|P5|Observational Follow-up|Lost to Follow-up|25
5682199|NCT00379769|19599987|P4|Observational Follow-up|Lost to Follow-up|0
5682200|NCT00379769|19599988|P3|Observational Follow-up|Lost to Follow-up|0
5682201|NCT00379769|19599989|P2|Observational Follow-up|Lost to Follow-up|0
5682202|NCT00379769|19599990|P1|Observational Follow-up|Lost to Follow-up|0
5682203|NCT00379769|19599985|P6|Observational Follow-up|Adverse Event|0
5682204|NCT00379769|19599986|P5|Observational Follow-up|Adverse Event|1
5682205|NCT00379769|19599987|P4|Observational Follow-up|Adverse Event|0
5682206|NCT00379769|19599988|P3|Observational Follow-up|Adverse Event|0
5682207|NCT00379769|19599989|P2|Observational Follow-up|Adverse Event|0
5682208|NCT00379769|19599990|P1|Observational Follow-up|Adverse Event|0
5682209|NCT00379769|19599985|P6|Observational Follow-up|Death|70
5682210|NCT00379769|19599986|P5|Observational Follow-up|Death|78
5682211|NCT00379769|19599987|P4|Observational Follow-up|Death|0
5682212|NCT00379769|19599988|P3|Observational Follow-up|Death|0
5682213|NCT00379769|19599989|P2|Observational Follow-up|Death|0
5682214|NCT00379769|19599990|P1|Observational Follow-up|Death|0
5682215|NCT00379769|19599985|P6|Main Study|Reason unspecified|0
5682216|NCT00379769|19599986|P5|Main Study|Reason unspecified|0
5682217|NCT00379769|19599987|P4|Main Study|Reason unspecified|0
5682218|NCT00379769|19599988|P3|Main Study|Reason unspecified|1
5682219|NCT00379769|19599989|P2|Main Study|Reason unspecified|0
5682220|NCT00379769|19599990|P1|Main Study|Reason unspecified|0
5682221|NCT00379769|19599985|P6|Main Study|Investigator refused to log temperature|0
5682222|NCT00379769|19599986|P5|Main Study|Investigator refused to log temperature|0
5682223|NCT00379769|19599987|P4|Main Study|Investigator refused to log temperature|0
5682224|NCT00379769|19599988|P3|Main Study|Investigator refused to log temperature|1
5682225|NCT00379769|19599989|P2|Main Study|Investigator refused to log temperature|0
5682226|NCT00379769|19599990|P1|Main Study|Investigator refused to log temperature|0
5682227|NCT00379769|19599985|P6|Main Study|Risk of heart failure|0
5682228|NCT00379769|19599986|P5|Main Study|Risk of heart failure|0
5682229|NCT00379769|19599987|P4|Main Study|Risk of heart failure|0
5682230|NCT00379769|19599988|P3|Main Study|Risk of heart failure|0
5682231|NCT00379769|19599989|P2|Main Study|Risk of heart failure|1
5682232|NCT00379769|19599990|P1|Main Study|Risk of heart failure|0
5682233|NCT00379769|19599985|P6|Main Study|Personal reasons|0
5682234|NCT00379769|19599986|P5|Main Study|Personal reasons|0
5682235|NCT00379769|19599987|P4|Main Study|Personal reasons|0
5682236|NCT00379769|19599988|P3|Main Study|Personal reasons|0
5682237|NCT00379769|19599989|P2|Main Study|Personal reasons|0
5682238|NCT00379769|19599990|P1|Main Study|Personal reasons|1
5682239|NCT00379769|19599985|P6|Main Study|Participant completed study at visit 27|0
5682240|NCT00379769|19599986|P5|Main Study|Participant completed study at visit 27|0
5682241|NCT00379769|19599987|P4|Main Study|Participant completed study at visit 27|0
5682242|NCT00379769|19599988|P3|Main Study|Participant completed study at visit 27|0
5682243|NCT00379769|19599989|P2|Main Study|Participant completed study at visit 27|0
5682244|NCT00379769|19599990|P1|Main Study|Participant completed study at visit 27|1
5682245|NCT00379769|19599985|P6|Main Study|Physician Decision|0
5682246|NCT00379769|19599986|P5|Main Study|Physician Decision|0
5682247|NCT00379769|19599987|P4|Main Study|Physician Decision|1
5682248|NCT00379769|19599988|P3|Main Study|Physician Decision|1
5682249|NCT00379769|19599989|P2|Main Study|Physician Decision|2
5682250|NCT00379769|19599990|P1|Main Study|Physician Decision|2
5682251|NCT00379769|19599985|P6|Main Study|Participant did not take study drug|0
5682252|NCT00379769|19599986|P5|Main Study|Participant did not take study drug|0
5682253|NCT00379769|19599987|P4|Main Study|Participant did not take study drug|0
5682254|NCT00379769|19599988|P3|Main Study|Participant did not take study drug|1
5682255|NCT00379769|19599989|P2|Main Study|Participant did not take study drug|0
5682256|NCT00379769|19599990|P1|Main Study|Participant did not take study drug|0
5682257|NCT00379769|19599985|P6|Main Study|Entry criteria violation|0
5682258|NCT00379769|19599986|P5|Main Study|Entry criteria violation|0
5682259|NCT00379769|19599987|P4|Main Study|Entry criteria violation|1
5682260|NCT00379769|19599988|P3|Main Study|Entry criteria violation|1
5682261|NCT00379769|19599989|P2|Main Study|Entry criteria violation|0
5682262|NCT00379769|19599990|P1|Main Study|Entry criteria violation|0
5682263|NCT00379769|19599985|P6|Main Study|Site closed|0
5682264|NCT00379769|19599986|P5|Main Study|Site closed|0
5682265|NCT00379769|19599987|P4|Main Study|Site closed|8
5682266|NCT00379769|19599988|P3|Main Study|Site closed|4
5682267|NCT00379769|19599989|P2|Main Study|Site closed|4
5682268|NCT00379769|19599990|P1|Main Study|Site closed|4
5682269|NCT00379769|19599985|P6|Main Study|Prohibited glucose lowering medication|0
5682270|NCT00379769|19599986|P5|Main Study|Prohibited glucose lowering medication|0
5682271|NCT00379769|19599987|P4|Main Study|Prohibited glucose lowering medication|1
5682272|NCT00379769|19599988|P3|Main Study|Prohibited glucose lowering medication|0
5682273|NCT00379769|19599989|P2|Main Study|Prohibited glucose lowering medication|3
5682274|NCT00379769|19599990|P1|Main Study|Prohibited glucose lowering medication|0
5682275|NCT00379769|19599985|P6|Main Study|Poor compliance|0
5682276|NCT00379769|19599986|P5|Main Study|Poor compliance|0
5682277|NCT00379769|19599987|P4|Main Study|Poor compliance|1
5682278|NCT00379769|19599988|P3|Main Study|Poor compliance|2
5682279|NCT00379769|19599989|P2|Main Study|Poor compliance|2
5682280|NCT00379769|19599990|P1|Main Study|Poor compliance|3
5682281|NCT00379769|19599985|P6|Main Study|Participant moved|0
5682282|NCT00379769|19599986|P5|Main Study|Participant moved|0
5682283|NCT00379769|19599987|P4|Main Study|Participant moved|3
5682284|NCT00379769|19599988|P3|Main Study|Participant moved|3
5682285|NCT00379769|19599989|P2|Main Study|Participant moved|2
5682286|NCT00379769|19599990|P1|Main Study|Participant moved|3
5682287|NCT00379769|19599985|P6|Main Study|Moved to survival status follow-up only|0
5682288|NCT00379769|19599986|P5|Main Study|Moved to survival status follow-up only|0
5682289|NCT00379769|19599987|P4|Main Study|Moved to survival status follow-up only|36
5682290|NCT00379769|19599988|P3|Main Study|Moved to survival status follow-up only|32
5682291|NCT00379769|19599989|P2|Main Study|Moved to survival status follow-up only|25
5682292|NCT00379769|19599990|P1|Main Study|Moved to survival status follow-up only|27
5682293|NCT00379769|19599985|P6|Main Study|Withdrawal by Subject|0
5682294|NCT00379769|19599986|P5|Main Study|Withdrawal by Subject|0
5682295|NCT00379769|19599987|P4|Main Study|Withdrawal by Subject|70
5682296|NCT00379769|19599988|P3|Main Study|Withdrawal by Subject|72
5682297|NCT00379769|19599989|P2|Main Study|Withdrawal by Subject|56
5682298|NCT00379769|19599990|P1|Main Study|Withdrawal by Subject|46
5682299|NCT00379769|19599985|P6|Main Study|Lost to Follow-up|0
5682300|NCT00379769|19599986|P5|Main Study|Lost to Follow-up|0
5682301|NCT00379769|19599987|P4|Main Study|Lost to Follow-up|26
5682302|NCT00379769|19599988|P3|Main Study|Lost to Follow-up|25
5682303|NCT00379769|19599989|P2|Main Study|Lost to Follow-up|29
5682304|NCT00379769|19599990|P1|Main Study|Lost to Follow-up|29
5682305|NCT00379769|19599985|P6|Main Study|Adverse Event|0
5682306|NCT00379769|19599986|P5|Main Study|Adverse Event|0
5682307|NCT00379769|19599987|P4|Main Study|Adverse Event|11
5682308|NCT00379769|19599988|P3|Main Study|Adverse Event|10
5682309|NCT00379769|19599989|P2|Main Study|Adverse Event|8
5682310|NCT00379769|19599990|P1|Main Study|Adverse Event|5
5682311|NCT00379769|19599985|P6|Main Study|Death|0
5682312|NCT00379769|19599986|P5|Main Study|Death|0
5682313|NCT00379769|19599987|P4|Main Study|Death|72
5682314|NCT00379769|19599988|P3|Main Study|Death|54
5682315|NCT00379769|19599989|P2|Main Study|Death|67
5682316|NCT00379769|19599990|P1|Main Study|Death|57
5682317|NCT00379639|19600149|P5|Overall Study|Other|0
5682318|NCT00379639|19600150|P4|Overall Study|Other|0
5682319|NCT00379639|19600151|P3|Overall Study|Other|3
5682320|NCT00379639|19600152|P2|Overall Study|Other|0
5682321|NCT00379639|19600153|P1|Overall Study|Other|0
5682322|NCT00379639|19600149|P5|Overall Study|Lost to Follow-up|0
5682323|NCT00379639|19600150|P4|Overall Study|Lost to Follow-up|1
5682324|NCT00379639|19600151|P3|Overall Study|Lost to Follow-up|0
5682325|NCT00379639|19600152|P2|Overall Study|Lost to Follow-up|0
5682326|NCT00379639|19600153|P1|Overall Study|Lost to Follow-up|0
5682327|NCT00379639|19600149|P5|Overall Study|Adverse Event|1
5682328|NCT00379639|19600150|P4|Overall Study|Adverse Event|0
5682329|NCT00379639|19600151|P3|Overall Study|Adverse Event|1
5682330|NCT00379639|19600152|P2|Overall Study|Adverse Event|0
5682331|NCT00379639|19600153|P1|Overall Study|Adverse Event|0
5682332|NCT00379639|19600149|P5|Overall Study|Symptomatic Deterioration|1
5682333|NCT00379639|19600150|P4|Overall Study|Symptomatic Deterioration|0
5682334|NCT00379639|19600151|P3|Overall Study|Symptomatic Deterioration|1
5682335|NCT00379639|19600152|P2|Overall Study|Symptomatic Deterioration|0
5682336|NCT00379639|19600153|P1|Overall Study|Symptomatic Deterioration|0
5682337|NCT00379639|19600149|P5|Overall Study|Physician Decision|0
5682338|NCT00379639|19600150|P4|Overall Study|Physician Decision|1
5682339|NCT00379639|19600151|P3|Overall Study|Physician Decision|1
5682340|NCT00379639|19600152|P2|Overall Study|Physician Decision|2
5682341|NCT00379639|19600153|P1|Overall Study|Physician Decision|0
5682342|NCT00379639|19600149|P5|Overall Study|Disease Progression|4
5682343|NCT00379639|19600150|P4|Overall Study|Disease Progression|4
5682344|NCT00379639|19600151|P3|Overall Study|Disease Progression|3
5682345|NCT00379639|19600152|P2|Overall Study|Disease Progression|3
5682346|NCT00379639|19600153|P1|Overall Study|Disease Progression|3
5682347|NCT00379587|19600175|P1|Overall Study|Lost to Follow-up|2
5682348|NCT00379353|19600189|P2|Overall Study|Conflicting drug treatment|1
5682349|NCT00379353|19600190|P1|Overall Study|Conflicting drug treatment|0
5682350|NCT00379353|19600189|P2|Overall Study|Non-compliance|0
5682351|NCT00379353|19600190|P1|Overall Study|Non-compliance|1
5682352|NCT00379353|19600189|P2|Overall Study|Cardiac Tamponade|0
5682353|NCT00379353|19600190|P1|Overall Study|Cardiac Tamponade|1
5682354|NCT00379353|19600189|P2|Overall Study|Death|0
5682355|NCT00379353|19600190|P1|Overall Study|Death|1
5682356|NCT00379353|19600189|P2|Overall Study|Withdrawal by Subject|2
5682357|NCT00379353|19600190|P1|Overall Study|Withdrawal by Subject|5
5682358|NCT00379353|19600189|P2|Overall Study|Hospitalization|3
5682359|NCT00379353|19600190|P1|Overall Study|Hospitalization|3
5682360|NCT00379340|19600225|P5|Overall Study|Delayed nephrectomy and anaplasia|1
5682361|NCT00379340|19600226|P4|Overall Study|Delayed nephrectomy and anaplasia|1
5682362|NCT00379340|19600227|P3|Overall Study|Delayed nephrectomy and anaplasia|0
5682363|NCT00379340|19600228|P2|Overall Study|Delayed nephrectomy and anaplasia|0
5682364|NCT00379340|19600229|P1|Overall Study|Delayed nephrectomy and anaplasia|0
5682365|NCT00379340|19600225|P5|Overall Study|On more than 1 tumor therapeutic study|0
5682366|NCT00379340|19600226|P4|Overall Study|On more than 1 tumor therapeutic study|2
5682367|NCT00379340|19600227|P3|Overall Study|On more than 1 tumor therapeutic study|0
5682368|NCT00379340|19600228|P2|Overall Study|On more than 1 tumor therapeutic study|0
5682369|NCT00379340|19600229|P1|Overall Study|On more than 1 tumor therapeutic study|0
5682370|NCT00379340|19600225|P5|Overall Study|Refusal of further protocol therapy|7
5682371|NCT00379340|19600226|P4|Overall Study|Refusal of further protocol therapy|1
5682372|NCT00379340|19600227|P3|Overall Study|Refusal of further protocol therapy|1
5682373|NCT00379340|19600228|P2|Overall Study|Refusal of further protocol therapy|0
5682374|NCT00379340|19600229|P1|Overall Study|Refusal of further protocol therapy|1
5682375|NCT00379340|19600225|P5|Overall Study|Withdrawal by Subject|0
5682376|NCT00379340|19600226|P4|Overall Study|Withdrawal by Subject|1
5682377|NCT00379340|19600227|P3|Overall Study|Withdrawal by Subject|0
5682378|NCT00379340|19600228|P2|Overall Study|Withdrawal by Subject|0
5682379|NCT00379340|19600229|P1|Overall Study|Withdrawal by Subject|0
5682380|NCT00379340|19600225|P5|Overall Study|Physician Decision|3
5682381|NCT00379340|19600226|P4|Overall Study|Physician Decision|2
5682382|NCT00379340|19600227|P3|Overall Study|Physician Decision|1
5682383|NCT00379340|19600228|P2|Overall Study|Physician Decision|2
5682384|NCT00379340|19600229|P1|Overall Study|Physician Decision|6
5682385|NCT00379340|19600225|P5|Overall Study|Lack of Efficacy|3
5682386|NCT00379340|19600226|P4|Overall Study|Lack of Efficacy|4
5682387|NCT00379340|19600227|P3|Overall Study|Lack of Efficacy|0
5682388|NCT00379340|19600228|P2|Overall Study|Lack of Efficacy|1
5682389|NCT00379340|19600229|P1|Overall Study|Lack of Efficacy|6
5682390|NCT00379340|19600225|P5|Overall Study|Death|0
5682391|NCT00379340|19600226|P4|Overall Study|Death|2
5682392|NCT00379340|19600227|P3|Overall Study|Death|0
5682393|NCT00379340|19600228|P2|Overall Study|Death|0
5682394|NCT00379340|19600229|P1|Overall Study|Death|0
5682395|NCT00379288|19600246|P4|Overall Study|Administrative|1
5682396|NCT00379288|19600247|P3|Overall Study|Administrative|0
5682397|NCT00379288|19600248|P2|Overall Study|Administrative|2
5682398|NCT00379288|19600249|P1|Overall Study|Administrative|2
5682399|NCT00379288|19600246|P4|Overall Study|Did not meet protocol eligibility|2
5682400|NCT00379288|19600247|P3|Overall Study|Did not meet protocol eligibility|0
5682401|NCT00379288|19600248|P2|Overall Study|Did not meet protocol eligibility|1
5682402|NCT00379288|19600249|P1|Overall Study|Did not meet protocol eligibility|0
5682403|NCT00379288|19600246|P4|Overall Study|Noncompliance with protocol|1
5682404|NCT00379288|19600247|P3|Overall Study|Noncompliance with protocol|2
5682405|NCT00379288|19600248|P2|Overall Study|Noncompliance with protocol|6
5682406|NCT00379288|19600249|P1|Overall Study|Noncompliance with protocol|8
5682407|NCT00379288|19600246|P4|Overall Study|Subject withdrew-related to study drug|1
5682408|NCT00379288|19600247|P3|Overall Study|Subject withdrew-related to study drug|0
5682409|NCT00379288|19600248|P2|Overall Study|Subject withdrew-related to study drug|0
5682410|NCT00379288|19600249|P1|Overall Study|Subject withdrew-related to study drug|1
5682411|NCT00379288|19600246|P4|Overall Study|Subject withdrew-unrelated to study drug|2
5682412|NCT00379288|19600247|P3|Overall Study|Subject withdrew-unrelated to study drug|4
5682413|NCT00379288|19600248|P2|Overall Study|Subject withdrew-unrelated to study drug|3
5682414|NCT00379288|19600249|P1|Overall Study|Subject withdrew-unrelated to study drug|0
5682415|NCT00379288|19600246|P4|Overall Study|Lost to Follow-up|0
5682416|NCT00379288|19600247|P3|Overall Study|Lost to Follow-up|2
5682417|NCT00379288|19600248|P2|Overall Study|Lost to Follow-up|3
5682418|NCT00379288|19600249|P1|Overall Study|Lost to Follow-up|3
5682419|NCT00379288|19600246|P4|Overall Study|Treatment Failure|1
5682420|NCT00379288|19600247|P3|Overall Study|Treatment Failure|0
5682421|NCT00379288|19600248|P2|Overall Study|Treatment Failure|1
5682422|NCT00379288|19600249|P1|Overall Study|Treatment Failure|0
5682423|NCT00379288|19600246|P4|Overall Study|Adverse Event|0
5682424|NCT00379288|19600247|P3|Overall Study|Adverse Event|2
5682425|NCT00379288|19600248|P2|Overall Study|Adverse Event|6
5682426|NCT00379288|19600249|P1|Overall Study|Adverse Event|5
5682427|NCT00379236|19600261|P3|Open-label Extension|Other|7
5682428|NCT00379236|19600262|P2|Open-label Extension|Other|0
5682429|NCT00379236|19600263|P1|Open-label Extension|Other|0
5682430|NCT00379236|19600261|P3|Open-label Extension|Use of exclusionary medication|3
5682431|NCT00379236|19600262|P2|Open-label Extension|Use of exclusionary medication|0
5682432|NCT00379236|19600263|P1|Open-label Extension|Use of exclusionary medication|0
5682433|NCT00379236|19600261|P3|Open-label Extension|Lost to Follow-up|12
5682434|NCT00379236|19600262|P2|Open-label Extension|Lost to Follow-up|0
5682435|NCT00379236|19600263|P1|Open-label Extension|Lost to Follow-up|0
5682436|NCT00379236|19600261|P3|Open-label Extension|Withdrawal by Subject|13
5682437|NCT00379236|19600262|P2|Open-label Extension|Withdrawal by Subject|0
5682438|NCT00379236|19600263|P1|Open-label Extension|Withdrawal by Subject|0
5682439|NCT00379236|19600261|P3|Open-label Extension|Protocol Violation|7
5682440|NCT00379236|19600262|P2|Open-label Extension|Protocol Violation|0
5682441|NCT00379236|19600263|P1|Open-label Extension|Protocol Violation|0
5682442|NCT00379236|19600261|P3|Open-label Extension|Adverse Event|13
5682443|NCT00379236|19600262|P2|Open-label Extension|Adverse Event|0
5682444|NCT00379236|19600263|P1|Open-label Extension|Adverse Event|0
5682445|NCT00379236|19600261|P3|Double-blind|Data could not be retrieved|0
5682446|NCT00379236|19600262|P2|Double-blind|Data could not be retrieved|2
5682447|NCT00379236|19600263|P1|Double-blind|Data could not be retrieved|2
5682448|NCT00379236|19600261|P3|Double-blind|Other|0
5682449|NCT00379236|19600262|P2|Double-blind|Other|7
5682450|NCT00379236|19600263|P1|Double-blind|Other|3
5682451|NCT00379236|19600261|P3|Double-blind|Use of exclusionary medication|0
5682452|NCT00379236|19600262|P2|Double-blind|Use of exclusionary medication|2
5682453|NCT00379236|19600263|P1|Double-blind|Use of exclusionary medication|1
5682454|NCT00379236|19600261|P3|Double-blind|Lost to Follow-up|0
5682455|NCT00379236|19600262|P2|Double-blind|Lost to Follow-up|3
5682456|NCT00379236|19600263|P1|Double-blind|Lost to Follow-up|4
5682457|NCT00379236|19600261|P3|Double-blind|Withdrawal by Subject|0
5682458|NCT00379236|19600262|P2|Double-blind|Withdrawal by Subject|13
5682459|NCT00379236|19600263|P1|Double-blind|Withdrawal by Subject|12
5682460|NCT00379236|19600261|P3|Double-blind|Protocol Violation|0
5682461|NCT00379236|19600262|P2|Double-blind|Protocol Violation|3
5682462|NCT00379236|19600263|P1|Double-blind|Protocol Violation|3
5682463|NCT00379236|19600261|P3|Double-blind|Adverse Event|0
5682464|NCT00379236|19600262|P2|Double-blind|Adverse Event|6
5682465|NCT00379236|19600263|P1|Double-blind|Adverse Event|11
5682466|NCT00379210|19600308|P2|Overall Study|Withdrawal by Subject|7
5682467|NCT00379210|19600309|P1|Overall Study|Withdrawal by Subject|10
5682468|NCT00379080|19600332|P3|Overall Study|Withdrawal by Subject|0
5682469|NCT00379080|19600333|P2|Overall Study|Withdrawal by Subject|4
5682470|NCT00379080|19600334|P1|Overall Study|Withdrawal by Subject|0
5682471|NCT00378898|19600379|P2|Overall Study|Protocol Violation|1
5682472|NCT00378898|19600380|P1|Overall Study|Protocol Violation|1
5682473|NCT00378898|19600379|P2|Overall Study|Withdrawal by Subject|5
5682474|NCT00378898|19600380|P1|Overall Study|Withdrawal by Subject|10
5682475|NCT00378703|19600392|P4|Overall Study|Other|3
5682476|NCT00378703|19600393|P3|Overall Study|Other|2
5682477|NCT00378703|19600394|P2|Overall Study|Other|1
5682478|NCT00378703|19600395|P1|Overall Study|Other|1
5682479|NCT00378703|19600392|P4|Overall Study|Never started treatment|0
5682480|NCT00378703|19600393|P3|Overall Study|Never started treatment|0
5682481|NCT00378703|19600394|P2|Overall Study|Never started treatment|4
5682482|NCT00378703|19600395|P1|Overall Study|Never started treatment|1
5682483|NCT00378703|19600392|P4|Overall Study|Ineligible|7
5682484|NCT00378703|19600393|P3|Overall Study|Ineligible|7
5682485|NCT00378703|19600394|P2|Overall Study|Ineligible|7
5682486|NCT00378703|19600395|P1|Overall Study|Ineligible|4
5682487|NCT00378703|19600392|P4|Overall Study|Relocation|0
5682488|NCT00378703|19600393|P3|Overall Study|Relocation|1
5682489|NCT00378703|19600394|P2|Overall Study|Relocation|0
5682490|NCT00378703|19600395|P1|Overall Study|Relocation|0
5682491|NCT00378703|19600392|P4|Overall Study|Adverse events and progressive disease|1
5682492|NCT00378703|19600393|P3|Overall Study|Adverse events and progressive disease|0
5682493|NCT00378703|19600394|P2|Overall Study|Adverse events and progressive disease|0
5682494|NCT00378703|19600395|P1|Overall Study|Adverse events and progressive disease|0
5682495|NCT00378703|19600392|P4|Overall Study|Joint decision of physician and patient|0
5682496|NCT00378703|19600393|P3|Overall Study|Joint decision of physician and patient|0
5682497|NCT00378703|19600394|P2|Overall Study|Joint decision of physician and patient|0
5682498|NCT00378703|19600395|P1|Overall Study|Joint decision of physician and patient|1
5682499|NCT00378703|19600392|P4|Overall Study|Surgery|1
5682500|NCT00378703|19600393|P3|Overall Study|Surgery|0
5682501|NCT00378703|19600394|P2|Overall Study|Surgery|0
5682502|NCT00378703|19600395|P1|Overall Study|Surgery|1
5682503|NCT00378703|19600392|P4|Overall Study|Symptomatic deterioration|2
5682504|NCT00378703|19600393|P3|Overall Study|Symptomatic deterioration|0
5682505|NCT00378703|19600394|P2|Overall Study|Symptomatic deterioration|1
5682506|NCT00378703|19600395|P1|Overall Study|Symptomatic deterioration|0
5682507|NCT00378703|19600392|P4|Overall Study|Other complicated disease|0
5682508|NCT00378703|19600393|P3|Overall Study|Other complicated disease|2
5682509|NCT00378703|19600394|P2|Overall Study|Other complicated disease|2
5682510|NCT00378703|19600395|P1|Overall Study|Other complicated disease|0
5682511|NCT00378703|19600392|P4|Overall Study|Alternative therapy|0
5682512|NCT00378703|19600393|P3|Overall Study|Alternative therapy|0
5682513|NCT00378703|19600394|P2|Overall Study|Alternative therapy|2
5682514|NCT00378703|19600395|P1|Overall Study|Alternative therapy|4
5682515|NCT00378703|19600392|P4|Overall Study|Physician Decision|0
5682516|NCT00378703|19600393|P3|Overall Study|Physician Decision|1
5682517|NCT00378703|19600394|P2|Overall Study|Physician Decision|4
5682518|NCT00378703|19600395|P1|Overall Study|Physician Decision|1
5682519|NCT00378703|19600392|P4|Overall Study|Withdrawal by Subject|7
5682520|NCT00378703|19600393|P3|Overall Study|Withdrawal by Subject|5
5682521|NCT00378703|19600394|P2|Overall Study|Withdrawal by Subject|8
5682522|NCT00378703|19600395|P1|Overall Study|Withdrawal by Subject|4
5682523|NCT00378703|19600392|P4|Overall Study|Death|3
5682524|NCT00378703|19600393|P3|Overall Study|Death|4
5682525|NCT00378703|19600394|P2|Overall Study|Death|2
5682526|NCT00378703|19600395|P1|Overall Study|Death|2
5682527|NCT00378703|19600392|P4|Overall Study|Adverse Event|18
5682528|NCT00378703|19600393|P3|Overall Study|Adverse Event|20
5682529|NCT00378703|19600394|P2|Overall Study|Adverse Event|17
5682530|NCT00378703|19600395|P1|Overall Study|Adverse Event|11
5682531|NCT00378703|19600392|P4|Overall Study|Disease progression|49
5682532|NCT00378703|19600393|P3|Overall Study|Disease progression|48
5682533|NCT00378703|19600394|P2|Overall Study|Disease progression|43
5682534|NCT00378703|19600395|P1|Overall Study|Disease progression|59
5682535|NCT00378599|19600417|P1|Overall Study|Withdrawal by Subject|5
5682536|NCT00378599|19600417|P1|Overall Study|Treatment failure|7
5682537|NCT00378599|19600417|P1|Overall Study|Protocol Violation|2
5682538|NCT00378599|19600417|P1|Overall Study|Adverse Event|38
5682539|NCT00378573|19600421|P1|Follow-up|Withdrawal by Subject|1
5682540|NCT00378573|19600421|P1|Follow-up|Lost to Follow-up|1
5682541|NCT00378573|19600421|P1|Follow-up|Death|12
5682542|NCT00378573|19600421|P1|Treatment Period|Sponsor decision to close study|1
5682543|NCT00378573|19600421|P1|Treatment Period|Disease Progression|4
5682544|NCT00378573|19600421|P1|Treatment Period|Withdrawal by Subject|2
5682545|NCT00378573|19600421|P1|Treatment Period|Physician Decision|1
5682546|NCT00378573|19600421|P1|Treatment Period|Adverse Event|9
5682547|NCT00378560|19600429|P2|Overall Study|Laboratory test values abnormal|0
5682548|NCT00378560|19600430|P1|Overall Study|Laboratory test values abnormal|1
5682549|NCT00378560|19600429|P2|Overall Study|Pregnancy|5
5682550|NCT00378560|19600430|P1|Overall Study|Pregnancy|7
5682551|NCT00378560|19600429|P2|Overall Study|Moved|3
5682552|NCT00378560|19600430|P1|Overall Study|Moved|4
5682553|NCT00378560|19600429|P2|Overall Study|Withdrawal by Subject|21
5682554|NCT00378560|19600430|P1|Overall Study|Withdrawal by Subject|17
5682555|NCT00378560|19600429|P2|Overall Study|Protocol Violation|0
5682556|NCT00378560|19600430|P1|Overall Study|Protocol Violation|2
5682557|NCT00378560|19600429|P2|Overall Study|Lost to Follow-up|29
5682558|NCT00378560|19600430|P1|Overall Study|Lost to Follow-up|24
5682559|NCT00378560|19600429|P2|Overall Study|Adverse Event|0
5682560|NCT00378560|19600430|P1|Overall Study|Adverse Event|1
5682561|NCT00378534|19600444|P1|Overall Study|Subjects did not receive a transplant|3
5682562|NCT00378534|19600444|P1|Overall Study|Donors|57
5682563|NCT00378508|19600450|P2|Overall Study|Lost to Follow-up|0
5682564|NCT00378508|19600451|P1|Overall Study|Lost to Follow-up|1
5682565|NCT00378508|19600450|P2|Overall Study|Withdrawal by Subject|3
5682566|NCT00378508|19600451|P1|Overall Study|Withdrawal by Subject|1
5682567|NCT00378378|19600470|P3|Overall Study|Non-compliance with protocol|1
5682568|NCT00378378|19600471|P2|Overall Study|Non-compliance with protocol|0
5682569|NCT00378378|19600472|P1|Overall Study|Non-compliance with protocol|0
5682570|NCT00378378|19600470|P3|Overall Study|Treatment Failure|1
5682571|NCT00378378|19600471|P2|Overall Study|Treatment Failure|0
5682572|NCT00378378|19600472|P1|Overall Study|Treatment Failure|0
5682573|NCT00378378|19600470|P3|Overall Study|Withdrawal by Subject|0
5682574|NCT00378378|19600471|P2|Overall Study|Withdrawal by Subject|1
5682575|NCT00378378|19600472|P1|Overall Study|Withdrawal by Subject|0
5682576|NCT00378209|19600518|P1|Overall Study|Treatment delay|1
5682577|NCT00378209|19600518|P1|Overall Study|Death|1
5682578|NCT00378209|19600518|P1|Overall Study|Physician Decision|3
5682579|NCT00378209|19600518|P1|Overall Study|Initiation of non-protocol therapy|3
5682580|NCT00378209|19600518|P1|Overall Study|Adverse Event|3
5682581|NCT00378209|19600518|P1|Overall Study|Progressive disease|11
5682582|NCT00378105|19600528|P2|Overall Study|necessity to increase lenalidomide dose|1
5682583|NCT00378105|19600529|P1|Overall Study|necessity to increase lenalidomide dose|0
5682584|NCT00378105|19600528|P2|Overall Study|Going non-protocol therapy|1
5682585|NCT00378105|19600529|P1|Overall Study|Going non-protocol therapy|0
5682586|NCT00378105|19600528|P2|Overall Study|Physician Decision|2
5682587|NCT00378105|19600529|P1|Overall Study|Physician Decision|0
5682588|NCT00378105|19600528|P2|Overall Study|remain on study|11
5682589|NCT00378105|19600529|P1|Overall Study|remain on study|3
5682590|NCT00378105|19600528|P2|Overall Study|Progressive disease|3
5682591|NCT00378105|19600529|P1|Overall Study|Progressive disease|3
5682592|NCT00378105|19600528|P2|Overall Study|Going to transplant|8
5682593|NCT00378105|19600529|P1|Overall Study|Going to transplant|7
5682594|NCT00378105|19600528|P2|Overall Study|Death|0
5682595|NCT00378105|19600529|P1|Overall Study|Death|1
5682596|NCT00378105|19600528|P2|Overall Study|Withdrawal by Subject|3
5682597|NCT00378105|19600529|P1|Overall Study|Withdrawal by Subject|3
5682598|NCT00378105|19600528|P2|Overall Study|Adverse Event|1
5682599|NCT00378105|19600529|P1|Overall Study|Adverse Event|3
5682600|NCT00378079|19600541|P3|Overall Study|Lost to Follow-up|0
5682601|NCT00378079|19600542|P2|Overall Study|Lost to Follow-up|1
5682602|NCT00378079|19600543|P1|Overall Study|Lost to Follow-up|6
5682603|NCT00378014|19600565|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
5682604|NCT00378014|19600566|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
5682605|NCT00378014|19600565|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
5682606|NCT00378014|19600566|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
5682607|NCT00378014|19600565|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
5682608|NCT00378014|19600566|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
5682609|NCT00378014|19600565|P2|Extension (Month 12 to Month 59)|Administrative problems|0
5682610|NCT00378014|19600566|P1|Extension (Month 12 to Month 59)|Administrative problems|1
5682611|NCT00378014|19600565|P2|Extension (Month 12 to Month 59)|Death|2
5682612|NCT00378014|19600566|P1|Extension (Month 12 to Month 59)|Death|1
5682613|NCT00378014|19600565|P2|Extension (Month 12 to Month 59)|Adverse Event|7
5682614|NCT00378014|19600566|P1|Extension (Month 12 to Month 59)|Adverse Event|8
5682615|NCT00378014|19600565|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
5682616|NCT00378014|19600566|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
5682617|NCT00378014|19600565|P2|Core (Randomization to Month 11)|Protocol deviation|1
5682618|NCT00378014|19600566|P1|Core (Randomization to Month 11)|Protocol deviation|0
5682619|NCT00378014|19600565|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
5682620|NCT00378014|19600566|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
5682621|NCT00378014|19600565|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
5682622|NCT00378014|19600566|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
5682623|NCT00378014|19600565|P2|Core (Randomization to Month 11)|Administrative Problems|2
5682624|NCT00378014|19600566|P1|Core (Randomization to Month 11)|Administrative Problems|2
5682625|NCT00378014|19600565|P2|Core (Randomization to Month 11)|Death|3
5682626|NCT00378014|19600566|P1|Core (Randomization to Month 11)|Death|5
5682627|NCT00378014|19600565|P2|Core (Randomization to Month 11)|Graft loss|2
5682628|NCT00378014|19600566|P1|Core (Randomization to Month 11)|Graft loss|1
5682629|NCT00378014|19600565|P2|Core (Randomization to Month 11)|Adverse Event|0
5682630|NCT00378014|19600566|P1|Core (Randomization to Month 11)|Adverse Event|1
5682631|NCT00377962|19600592|P2|Extension Study: 12-24 Months|Unspecified reason|3
5682632|NCT00377962|19600593|P1|Extension Study: 12-24 Months|Unspecified reason|0
5682633|NCT00377962|19600592|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
5682634|NCT00377962|19600593|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
5682635|NCT00377962|19600592|P2|Extension Study: 12-24 Months|Adverse Event|0
5682636|NCT00377962|19600593|P1|Extension Study: 12-24 Months|Adverse Event|8
5682637|NCT00377962|19600592|P2|Extension Study: 12-24 Months|Death|1
5682638|NCT00377962|19600593|P1|Extension Study: 12-24 Months|Death|1
5682639|NCT00377962|19600592|P2|Core Study: 0-12 Months|Unspecified reasons|4
5682640|NCT00377962|19600593|P1|Core Study: 0-12 Months|Unspecified reasons|1
5682641|NCT00377962|19600592|P2|Core Study: 0-12 Months|Administrative Reason|1
5682642|NCT00377962|19600593|P1|Core Study: 0-12 Months|Administrative Reason|1
5682643|NCT00377962|19600592|P2|Core Study: 0-12 Months|Withdrew Consent|2
5682644|NCT00377962|19600593|P1|Core Study: 0-12 Months|Withdrew Consent|5
5682645|NCT00377962|19600592|P2|Core Study: 0-12 Months|Death|0
5682646|NCT00377962|19600593|P1|Core Study: 0-12 Months|Death|3
5682647|NCT00377962|19600592|P2|Core Study: 0-12 Months|Adverse Event|2
5682648|NCT00377962|19600593|P1|Core Study: 0-12 Months|Adverse Event|18
5682649|NCT00377858|19600629|P2|Overall Study|Death|3
5682650|NCT00377858|19600630|P1|Overall Study|Death|0
5682651|NCT00377858|19600629|P2|Overall Study|Sponsor Decision|2
5682652|NCT00377858|19600630|P1|Overall Study|Sponsor Decision|1
5682653|NCT00377858|19600629|P2|Overall Study|Entry Criteria Not Met|0
5682654|NCT00377858|19600630|P1|Overall Study|Entry Criteria Not Met|2
5682655|NCT00377858|19600629|P2|Overall Study|Adverse Event|1
5682656|NCT00377858|19600630|P1|Overall Study|Adverse Event|2
5682657|NCT00377858|19600629|P2|Overall Study|Protocol Violation|4
5682658|NCT00377858|19600630|P1|Overall Study|Protocol Violation|3
5682659|NCT00377858|19600629|P2|Overall Study|Physician Decision|5
5682660|NCT00377858|19600630|P1|Overall Study|Physician Decision|5
5682661|NCT00377858|19600629|P2|Overall Study|Lost to Follow-up|1
5682662|NCT00377858|19600630|P1|Overall Study|Lost to Follow-up|6
5682663|NCT00377858|19600629|P2|Overall Study|Withdrawal by Subject|11
5682664|NCT00377858|19600630|P1|Overall Study|Withdrawal by Subject|12
5682665|NCT00377819|19600683|P2|Overall Study|Protocol Violation|1
5682666|NCT00377819|19600684|P1|Overall Study|Protocol Violation|1
5682667|NCT00377819|19600683|P2|Overall Study|Lost to Follow-up|1
5682668|NCT00377819|19600684|P1|Overall Study|Lost to Follow-up|0
5682669|NCT00377819|19600683|P2|Overall Study|Death|1
5682670|NCT00377819|19600684|P1|Overall Study|Death|0
5682671|NCT00377819|19600683|P2|Overall Study|Withdrawal by Subject|4
5682672|NCT00377819|19600684|P1|Overall Study|Withdrawal by Subject|10
5682673|NCT00377819|19600683|P2|Overall Study|Adverse Event|3
5682674|NCT00377819|19600684|P1|Overall Study|Adverse Event|2
5682675|NCT00377676|19600713|P2|Overall Study|Other|58
5682676|NCT00377676|19600714|P1|Overall Study|Other|118
5682677|NCT00377676|19600713|P2|Overall Study|Lost to Follow-up|56
5682678|NCT00377676|19600714|P1|Overall Study|Lost to Follow-up|120
5682679|NCT00377676|19600713|P2|Overall Study|Withdrawal by Subject|72
5682680|NCT00377676|19600714|P1|Overall Study|Withdrawal by Subject|187
5682681|NCT00377676|19600713|P2|Overall Study|Death|2
5682682|NCT00377676|19600714|P1|Overall Study|Death|5
5682683|NCT00377676|19600713|P2|Overall Study|Protocol Violation|27
5682684|NCT00377676|19600714|P1|Overall Study|Protocol Violation|33
5682685|NCT00377676|19600713|P2|Overall Study|Adverse Event|107
5682686|NCT00377676|19600714|P1|Overall Study|Adverse Event|498
5682687|NCT00377637|19600730|P4|Maintenance Phase|Death|1
5682688|NCT00377637|19600731|P3|Maintenance Phase|Death|0
5682689|NCT00377637|19600732|P2|Maintenance Phase|Death|0
5682690|NCT00377637|19600733|P1|Maintenance Phase|Death|0
5682691|NCT00377637|19600730|P4|Maintenance Phase|Study medication stopped > 14 days|1
5682692|NCT00377637|19600731|P3|Maintenance Phase|Study medication stopped > 14 days|0
5682693|NCT00377637|19600732|P2|Maintenance Phase|Study medication stopped > 14 days|0
5682694|NCT00377637|19600733|P1|Maintenance Phase|Study medication stopped > 14 days|0
5682695|NCT00377637|19600730|P4|Maintenance Phase|Non-compliance|1
5682696|NCT00377637|19600731|P3|Maintenance Phase|Non-compliance|1
5682697|NCT00377637|19600732|P2|Maintenance Phase|Non-compliance|0
5682698|NCT00377637|19600733|P1|Maintenance Phase|Non-compliance|0
5682699|NCT00377637|19600730|P4|Maintenance Phase|Sponsor decision|3
5682700|NCT00377637|19600731|P3|Maintenance Phase|Sponsor decision|2
5682701|NCT00377637|19600732|P2|Maintenance Phase|Sponsor decision|0
5682702|NCT00377637|19600733|P1|Maintenance Phase|Sponsor decision|0
5682703|NCT00377637|19600730|P4|Maintenance Phase|Withdrawal by Subject|3
5682704|NCT00377637|19600731|P3|Maintenance Phase|Withdrawal by Subject|3
5682705|NCT00377637|19600732|P2|Maintenance Phase|Withdrawal by Subject|0
5682706|NCT00377637|19600733|P1|Maintenance Phase|Withdrawal by Subject|0
5682707|NCT00377637|19600730|P4|Maintenance Phase|Lost to Follow-up|1
5682708|NCT00377637|19600731|P3|Maintenance Phase|Lost to Follow-up|3
5682709|NCT00377637|19600732|P2|Maintenance Phase|Lost to Follow-up|0
5682710|NCT00377637|19600733|P1|Maintenance Phase|Lost to Follow-up|0
5682711|NCT00377637|19600730|P4|Maintenance Phase|Physician Decision|4
5682712|NCT00377637|19600731|P3|Maintenance Phase|Physician Decision|5
5682713|NCT00377637|19600732|P2|Maintenance Phase|Physician Decision|0
5682714|NCT00377637|19600733|P1|Maintenance Phase|Physician Decision|0
5682715|NCT00377637|19600730|P4|Maintenance Phase|Adverse Event|43
5682716|NCT00377637|19600731|P3|Maintenance Phase|Adverse Event|29
5682717|NCT00377637|19600732|P2|Maintenance Phase|Adverse Event|0
5682718|NCT00377637|19600733|P1|Maintenance Phase|Adverse Event|0
5682719|NCT00377637|19600730|P4|Induction Phase|Reason for withdrawal is not noted|0
5682720|NCT00377637|19600731|P3|Induction Phase|Reason for withdrawal is not noted|0
5682721|NCT00377637|19600732|P2|Induction Phase|Reason for withdrawal is not noted|0
5682722|NCT00377637|19600733|P1|Induction Phase|Reason for withdrawal is not noted|2
5682723|NCT00377637|19600730|P4|Induction Phase|Non-Compliance|0
5682724|NCT00377637|19600731|P3|Induction Phase|Non-Compliance|0
5682725|NCT00377637|19600732|P2|Induction Phase|Non-Compliance|0
5682726|NCT00377637|19600733|P1|Induction Phase|Non-Compliance|1
5682727|NCT00377637|19600730|P4|Induction Phase|Sponsor decision|0
5682728|NCT00377637|19600731|P3|Induction Phase|Sponsor decision|0
5682729|NCT00377637|19600732|P2|Induction Phase|Sponsor decision|2
5682730|NCT00377637|19600733|P1|Induction Phase|Sponsor decision|1
5682731|NCT00377637|19600730|P4|Induction Phase|Physician Decision|0
5682732|NCT00377637|19600731|P3|Induction Phase|Physician Decision|0
5682733|NCT00377637|19600732|P2|Induction Phase|Physician Decision|1
5682734|NCT00377637|19600733|P1|Induction Phase|Physician Decision|3
5682735|NCT00377637|19600730|P4|Induction Phase|Withdrawal by Subject|0
5682736|NCT00377637|19600731|P3|Induction Phase|Withdrawal by Subject|0
5682737|NCT00377637|19600732|P2|Induction Phase|Withdrawal by Subject|6
5682738|NCT00377637|19600733|P1|Induction Phase|Withdrawal by Subject|5
5682739|NCT00377637|19600730|P4|Induction Phase|Death|0
5682740|NCT00377637|19600731|P3|Induction Phase|Death|0
5682741|NCT00377637|19600732|P2|Induction Phase|Death|3
5682742|NCT00377637|19600733|P1|Induction Phase|Death|1
5682743|NCT00377637|19600730|P4|Induction Phase|Lost to Follow-up|0
5682744|NCT00377637|19600731|P3|Induction Phase|Lost to Follow-up|0
5682745|NCT00377637|19600732|P2|Induction Phase|Lost to Follow-up|1
5682746|NCT00377637|19600733|P1|Induction Phase|Lost to Follow-up|2
5682747|NCT00377637|19600730|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
5682748|NCT00377637|19600731|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
5682749|NCT00377637|19600732|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
5682750|NCT00377637|19600733|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
5682751|NCT00377637|19600730|P4|Induction Phase|Deterioration/serum creatinine|0
5682752|NCT00377637|19600731|P3|Induction Phase|Deterioration/serum creatinine|0
5682753|NCT00377637|19600732|P2|Induction Phase|Deterioration/serum creatinine|0
5682754|NCT00377637|19600733|P1|Induction Phase|Deterioration/serum creatinine|2
5682755|NCT00377637|19600730|P4|Induction Phase|Adverse Event|0
5682756|NCT00377637|19600731|P3|Induction Phase|Adverse Event|0
5682757|NCT00377637|19600732|P2|Induction Phase|Adverse Event|21
5682758|NCT00377637|19600733|P1|Induction Phase|Adverse Event|12
5682759|NCT00377611|19600769|P2|Overall Study|Other|3
5682760|NCT00377611|19600770|P1|Overall Study|Other|0
5682761|NCT00377611|19600769|P2|Overall Study|Lost to Follow-up|16
5682762|NCT00377611|19600770|P1|Overall Study|Lost to Follow-up|18
5682763|NCT00377611|19600769|P2|Overall Study|Withdrawal by Subject|5
5682764|NCT00377611|19600770|P1|Overall Study|Withdrawal by Subject|0
5682765|NCT00377611|19600769|P2|Overall Study|Protocol Violation|0
5682766|NCT00377611|19600770|P1|Overall Study|Protocol Violation|2
5682767|NCT00377611|19600769|P2|Overall Study|Adverse Event|9
5682768|NCT00377611|19600770|P1|Overall Study|Adverse Event|2
5682769|NCT00377520|19600872|P1|Overall Study|Ineligible (Prior radiation)|1
5682770|NCT00377455|19600877|P1|Overall Study|Withdrawal by Subject|1
5682771|NCT00377429|19600885|P1|Overall Study|Patient non-compliance|1
5682772|NCT00377429|19600885|P1|Overall Study|Physician Decision|1
5682773|NCT00377429|19600885|P1|Overall Study|Adverse Event|8
5682774|NCT00377429|19600885|P1|Overall Study|Withdrawal by Subject|5
5682775|NCT00377403|19600896|P2|Overall Study|Unable to contact for telephone intervie|7
5682776|NCT00377403|19600897|P1|Overall Study|Unable to contact for telephone intervie|4
5682777|NCT00377364|19600905|P2|Overall Study|Withdrawal by Subject|0
5682778|NCT00377364|19600906|P1|Overall Study|Withdrawal by Subject|1
5682779|NCT00377364|19600905|P2|Overall Study|Lost to Follow-up|0
5682780|NCT00377364|19600906|P1|Overall Study|Lost to Follow-up|1
5682781|NCT00377312|19600932|P2|Overall Study|Adverse Event|1
5682782|NCT00377312|19600933|P1|Overall Study|Adverse Event|1
5682783|NCT00377299|19600965|P2|Overall Study|Withdrawal by Subject|4
5682784|NCT00377299|19600966|P1|Overall Study|Withdrawal by Subject|5
5682785|NCT00377299|19600965|P2|Overall Study|Adverse Event|1
5682786|NCT00377299|19600966|P1|Overall Study|Adverse Event|0
5682787|NCT00377299|19600965|P2|Overall Study|Lost to Follow-up|19
5682788|NCT00377299|19600966|P1|Overall Study|Lost to Follow-up|14
5682789|NCT00377260|19600982|P2|Overall Study|Withdrawal by Subject|4
5682790|NCT00377260|19600983|P1|Overall Study|Withdrawal by Subject|2
5682791|NCT00377260|19600982|P2|Overall Study|Lost to Follow-up|1
5682792|NCT00377260|19600983|P1|Overall Study|Lost to Follow-up|0
5682793|NCT00377234|19601037|P2|Overall Study|Not assigned|2
5682794|NCT00377234|19601038|P1|Overall Study|Not assigned|3
5682795|NCT00377234|19601037|P2|Overall Study|Administrative|1
5682796|NCT00377234|19601038|P1|Overall Study|Administrative|2
5682797|NCT00377234|19601037|P2|Overall Study|Lost to Follow-up|2
5682798|NCT00377234|19601038|P1|Overall Study|Lost to Follow-up|4
5682799|NCT00377234|19601037|P2|Overall Study|Withdrawal by Subject|9
5682800|NCT00377234|19601038|P1|Overall Study|Withdrawal by Subject|11
5682801|NCT00377234|19601037|P2|Overall Study|Adverse Event|17
5682802|NCT00377234|19601038|P1|Overall Study|Adverse Event|14
5682803|NCT00377156|19601056|P2|Overall Study|Other|2
5682804|NCT00377156|19601057|P1|Overall Study|Other|5
5682805|NCT00377156|19601056|P2|Overall Study|Disability or language problem|1
5682806|NCT00377156|19601057|P1|Overall Study|Disability or language problem|0
5682807|NCT00377156|19601056|P2|Overall Study|Ineligible|1
5682808|NCT00377156|19601057|P1|Overall Study|Ineligible|0
5682809|NCT00377156|19601056|P2|Overall Study|Refused testing|1
5682810|NCT00377156|19601057|P1|Overall Study|Refused testing|0
5682811|NCT00377156|19601056|P2|Overall Study|Cancellation|0
5682812|NCT00377156|19601057|P1|Overall Study|Cancellation|1
5682813|NCT00377156|19601056|P2|Overall Study|Had follow-up <90 d|6
5682814|NCT00377156|19601057|P1|Overall Study|Had follow-up <90 d|3
5682815|NCT00377156|19601056|P2|Overall Study|Withdrawal by Subject|24
5682816|NCT00377156|19601057|P1|Overall Study|Withdrawal by Subject|16
5682817|NCT00377156|19601056|P2|Overall Study|Death|19
5682818|NCT00377156|19601057|P1|Overall Study|Death|23
5682819|NCT00376961|19601071|P2|Maintenance|Ineligible|3
5682820|NCT00376961|19601072|P1|Maintenance|Ineligible|0
5682821|NCT00376961|19601071|P2|Maintenance|Progression/relapse|18
5682822|NCT00376961|19601072|P1|Maintenance|Progression/relapse|0
5682823|NCT00376961|19601071|P2|Maintenance|Refusal Unrelated to Adverse Event|1
5682824|NCT00376961|19601072|P1|Maintenance|Refusal Unrelated to Adverse Event|0
5682825|NCT00376961|19601071|P2|Maintenance|Adverse Event|1
5682826|NCT00376961|19601072|P1|Maintenance|Adverse Event|0
5682827|NCT00376961|19601071|P2|Initial Registration|Ineligible|0
5682828|NCT00376961|19601072|P1|Initial Registration|Ineligible|3
5682829|NCT00376961|19601071|P2|Initial Registration|Progression/relapse|0
5682830|NCT00376961|19601072|P1|Initial Registration|Progression/relapse|1
5682831|NCT00376961|19601071|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
5682832|NCT00376961|19601072|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
5682833|NCT00376961|19601071|P2|Initial Registration|Adverse Event|0
5682834|NCT00376961|19601072|P1|Initial Registration|Adverse Event|1
5682835|NCT00376688|19601138|P1|Overall Study|Death|1
5682836|NCT00376688|19601138|P1|Overall Study|Adverse Event|3
5682837|NCT00376675|19601144|P2|Overall Study|Other Reason|7
5682838|NCT00376675|19601145|P1|Overall Study|Other Reason|1
5682839|NCT00376675|19601144|P2|Overall Study|Adverse Event|5
5682840|NCT00376675|19601145|P1|Overall Study|Adverse Event|10
5682841|NCT00376675|19601144|P2|Overall Study|Withdrawal by Subject|2
5682842|NCT00376675|19601145|P1|Overall Study|Withdrawal by Subject|9
5682843|NCT00376532|19601194|P2|Overall Study|Lack sufficient blood sample|6
5682844|NCT00376532|19601195|P1|Overall Study|Lack sufficient blood sample|6
5682845|NCT00376506|19601205|P2|Overall Study|Death|2
5682846|NCT00376506|19601206|P1|Overall Study|Death|0
5682847|NCT00376259|19601237|P2|Overall Study|Patient request|0
5682848|NCT00376259|19601238|P1|Overall Study|Patient request|1
5682849|NCT00376259|19601237|P2|Overall Study|Sponsor request - study termination|21
5682850|NCT00376259|19601238|P1|Overall Study|Sponsor request - study termination|21
5682851|NCT00376246|19601250|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
5682852|NCT00376246|19601251|P1|First Intervention (2 Weeks)|Lost to Follow-up|1
5682853|NCT00376246|19601250|P2|First Intervention (2 Weeks)|Withdrawal by Subject|2
5682854|NCT00376246|19601251|P1|First Intervention (2 Weeks)|Withdrawal by Subject|1
5682855|NCT00376246|19601250|P2|First Intervention (2 Weeks)|Adverse Event|0
5682856|NCT00376246|19601251|P1|First Intervention (2 Weeks)|Adverse Event|2
5682857|NCT00376220|19601261|P2|Overall Study|Withdrawal by Subject|2
5682858|NCT00376220|19601262|P1|Overall Study|Withdrawal by Subject|3
5682859|NCT00376220|19601261|P2|Overall Study|Lost to Follow-up|10
5682860|NCT00376220|19601262|P1|Overall Study|Lost to Follow-up|7
5682861|NCT00376168|19601270|P2|Overall Study|Pregnancy|0
5682862|NCT00376168|19601271|P1|Overall Study|Pregnancy|1
5682863|NCT00376168|19601270|P2|Overall Study|Adverse Event|1
5682864|NCT00376168|19601271|P1|Overall Study|Adverse Event|1
5682865|NCT00375934|19601312|P2|Overall Study|Physician Decision|1
5682866|NCT00375934|19601313|P1|Overall Study|Physician Decision|0
5682867|NCT00375934|19601312|P2|Overall Study|Lack of Efficacy|2
5682868|NCT00375934|19601313|P1|Overall Study|Lack of Efficacy|0
5682869|NCT00375934|19601312|P2|Overall Study|Withdrawal by Subject|2
5682870|NCT00375934|19601313|P1|Overall Study|Withdrawal by Subject|2
5682871|NCT00375934|19601312|P2|Overall Study|Adverse Event|1
5682872|NCT00375934|19601313|P1|Overall Study|Adverse Event|1
5682873|NCT00375752|19601371|P2|Overall Study|Administrative Problems|1
5682874|NCT00375752|19601372|P1|Overall Study|Administrative Problems|0
5682875|NCT00375752|19601371|P2|Overall Study|Protocol Violation|2
5682876|NCT00375752|19601372|P1|Overall Study|Protocol Violation|0
5682877|NCT00375752|19601371|P2|Overall Study|Abnormal Laboratory Value(s)|1
5682878|NCT00375752|19601372|P1|Overall Study|Abnormal Laboratory Value(s)|1
5682879|NCT00375752|19601371|P2|Overall Study|Withdrawal by Subject|1
5682880|NCT00375752|19601372|P1|Overall Study|Withdrawal by Subject|6
5682881|NCT00375752|19601371|P2|Overall Study|Adverse Event|6
5682882|NCT00375752|19601372|P1|Overall Study|Adverse Event|1
5682883|NCT00375752|19601371|P2|Overall Study|Lack of Efficacy|4
5682884|NCT00375752|19601372|P1|Overall Study|Lack of Efficacy|4
5682885|NCT00375674|19601403|P2|Overall Study|Enrolled but not treated|2
5682886|NCT00375674|19601404|P1|Overall Study|Enrolled but not treated|3
5682887|NCT00375674|19601403|P2|Overall Study|Lost to Follow-up|15
5682888|NCT00375674|19601404|P1|Overall Study|Lost to Follow-up|17
5682889|NCT00375674|19601403|P2|Overall Study|Participants refused further follow-up|30
5682890|NCT00375674|19601404|P1|Overall Study|Participants refused further follow-up|31
5682891|NCT00375674|19601403|P2|Overall Study|Death|76
5682892|NCT00375674|19601404|P1|Overall Study|Death|67
5682893|NCT00375674|19601403|P2|Overall Study|Other|18
5682894|NCT00375674|19601404|P1|Overall Study|Other|26
5682895|NCT00375609|19601433|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
5682896|NCT00375609|19601434|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
5682897|NCT00375609|19601435|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
5682898|NCT00375609|19601433|P3|Overall Study|Withdrawal by Subject|0
5682899|NCT00375609|19601434|P2|Overall Study|Withdrawal by Subject|4
5682900|NCT00375609|19601435|P1|Overall Study|Withdrawal by Subject|1
5682901|NCT00375609|19601433|P3|Overall Study|Physician Decision|1
5682902|NCT00375609|19601434|P2|Overall Study|Physician Decision|0
5682903|NCT00375609|19601435|P1|Overall Study|Physician Decision|0
5682904|NCT00375609|19601433|P3|Overall Study|Lost to Follow-up|0
5682905|NCT00375609|19601434|P2|Overall Study|Lost to Follow-up|0
5682906|NCT00375609|19601435|P1|Overall Study|Lost to Follow-up|1
5682907|NCT00375609|19601433|P3|Overall Study|Adverse Event|0
5682908|NCT00375609|19601434|P2|Overall Study|Adverse Event|3
5682909|NCT00375609|19601435|P1|Overall Study|Adverse Event|0
5682910|NCT00375609|19601433|P3|Overall Study|Did not receive treatment|0
5682911|NCT00375609|19601434|P2|Overall Study|Did not receive treatment|0
5682912|NCT00375609|19601435|P1|Overall Study|Did not receive treatment|1
5682913|NCT00375518|19601451|P2|Overall Study|Death|1
5682914|NCT00375518|19601452|P1|Overall Study|Death|0
5682915|NCT00375518|19601451|P2|Overall Study|Patient Not Treated|6
5682916|NCT00375518|19601452|P1|Overall Study|Patient Not Treated|6
5682917|NCT00375518|19601451|P2|Overall Study|Withdrawal by Subject|10
5682918|NCT00375518|19601452|P1|Overall Study|Withdrawal by Subject|2
5682919|NCT00375505|19601460|P2|Overall Study|Adverse Event|2
5682920|NCT00375505|19601461|P1|Overall Study|Adverse Event|1
5682921|NCT00375492|19601505|P2|Overall Study|Withdrawal by Subject|6
5682922|NCT00375492|19601506|P1|Overall Study|Withdrawal by Subject|6
5682923|NCT00375492|19601505|P2|Overall Study|Sponsor Decision|1
5682924|NCT00375492|19601506|P1|Overall Study|Sponsor Decision|0
5682925|NCT00375492|19601505|P2|Overall Study|Protocol Violation|3
5682926|NCT00375492|19601506|P1|Overall Study|Protocol Violation|6
5682927|NCT00375492|19601505|P2|Overall Study|Physician Decision|4
5682928|NCT00375492|19601506|P1|Overall Study|Physician Decision|0
5682929|NCT00375492|19601505|P2|Overall Study|Lost to Follow-up|5
5682930|NCT00375492|19601506|P1|Overall Study|Lost to Follow-up|10
5682931|NCT00375492|19601505|P2|Overall Study|Loss of Glucose Control|1
5682932|NCT00375492|19601506|P1|Overall Study|Loss of Glucose Control|0
5682933|NCT00375492|19601505|P2|Overall Study|Entry Criteria Not Met|1
5682934|NCT00375492|19601506|P1|Overall Study|Entry Criteria Not Met|0
5682935|NCT00375492|19601505|P2|Overall Study|Adverse Event|5
5682936|NCT00375492|19601506|P1|Overall Study|Adverse Event|4
5682937|NCT00375427|19601536|P2|Overall Study|Death|10
5682938|NCT00375427|19601537|P1|Overall Study|Death|11
5682939|NCT00375427|19601536|P2|Overall Study|Administrative reasons|1
5682940|NCT00375427|19601537|P1|Overall Study|Administrative reasons|0
5682941|NCT00375427|19601536|P2|Overall Study|Lost to Follow-up|1
5682942|NCT00375427|19601537|P1|Overall Study|Lost to Follow-up|1
5682943|NCT00375427|19601536|P2|Overall Study|Withdrawal by Subject|13
5682944|NCT00375427|19601537|P1|Overall Study|Withdrawal by Subject|9
5682945|NCT00375427|19601536|P2|Overall Study|Protocol Violation|8
5682946|NCT00375427|19601537|P1|Overall Study|Protocol Violation|10
5682947|NCT00375427|19601536|P2|Overall Study|Patient no longer requires study drug|7
5682948|NCT00375427|19601537|P1|Overall Study|Patient no longer requires study drug|3
5682949|NCT00375427|19601536|P2|Overall Study|Unsatisfactory therapeutic effect|4
5682950|NCT00375427|19601537|P1|Overall Study|Unsatisfactory therapeutic effect|4
5682951|NCT00375427|19601536|P2|Overall Study|Abnormal laboratory value(s)|2
5682952|NCT00375427|19601537|P1|Overall Study|Abnormal laboratory value(s)|1
5682953|NCT00375427|19601536|P2|Overall Study|Abnormal test procedure result(s)|1
5682954|NCT00375427|19601537|P1|Overall Study|Abnormal test procedure result(s)|0
5682955|NCT00375427|19601536|P2|Overall Study|Adverse Event|27
5682956|NCT00375427|19601537|P1|Overall Study|Adverse Event|21
5682957|NCT00375219|19601562|P3|Overall Study|Withdrawal by Subject|0
5682958|NCT00375219|19601563|P2|Overall Study|Withdrawal by Subject|0
5682959|NCT00375219|19601564|P1|Overall Study|Withdrawal by Subject|1
5682960|NCT00375219|19601562|P3|Overall Study|Cord blood transplantation|0
5682961|NCT00375219|19601563|P2|Overall Study|Cord blood transplantation|0
5682962|NCT00375219|19601564|P1|Overall Study|Cord blood transplantation|1
5682963|NCT00375219|19601562|P3|Overall Study|Allograft|0
5682964|NCT00375219|19601563|P2|Overall Study|Allograft|0
5682965|NCT00375219|19601564|P1|Overall Study|Allograft|2
5682966|NCT00375219|19601562|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
5682967|NCT00375219|19601563|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
5682968|NCT00375219|19601564|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
5682969|NCT00375219|19601562|P3|Overall Study|Hematologic resistance|0
5682970|NCT00375219|19601563|P2|Overall Study|Hematologic resistance|0
5682971|NCT00375219|19601564|P1|Overall Study|Hematologic resistance|1
5682972|NCT00375219|19601562|P3|Overall Study|Death|7
5682973|NCT00375219|19601563|P2|Overall Study|Death|3
5682974|NCT00375219|19601564|P1|Overall Study|Death|4
5682975|NCT00375219|19601562|P3|Overall Study|Disease progression|12
5682976|NCT00375219|19601563|P2|Overall Study|Disease progression|9
5682977|NCT00375219|19601564|P1|Overall Study|Disease progression|18
5682978|NCT00375219|19601562|P3|Overall Study|Lost to Follow-up|0
5682979|NCT00375219|19601563|P2|Overall Study|Lost to Follow-up|1
5682980|NCT00375219|19601564|P1|Overall Study|Lost to Follow-up|1
5682981|NCT00375219|19601562|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
5682982|NCT00375219|19601563|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
5682983|NCT00375219|19601564|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
5682984|NCT00375219|19601562|P3|Overall Study|Protocol Violation|1
5682985|NCT00375219|19601563|P2|Overall Study|Protocol Violation|0
5682986|NCT00375219|19601564|P1|Overall Study|Protocol Violation|1
5682987|NCT00375219|19601562|P3|Overall Study|Adverse Event|1
5682988|NCT00375219|19601563|P2|Overall Study|Adverse Event|2
5682989|NCT00375219|19601564|P1|Overall Study|Adverse Event|8
5682990|NCT00375219|19601562|P3|Overall Study|Failure to achieve a response|0
5682991|NCT00375219|19601563|P2|Overall Study|Failure to achieve a response|2
5682992|NCT00375219|19601564|P1|Overall Study|Failure to achieve a response|16
5682993|NCT00374907|19601647|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
5682994|NCT00374907|19601648|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
5682995|NCT00374907|19601647|P2|116-Week Short-term + Long-term Period|Adverse Event|2
5682996|NCT00374907|19601648|P1|116-Week Short-term + Long-term Period|Adverse Event|0
5682997|NCT00374907|19601647|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
5682998|NCT00374907|19601648|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
5682999|NCT00374907|19601647|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
5683000|NCT00374907|19601648|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
5683001|NCT00374907|19601647|P2|12-Week Short-term Period|Subject Withdrew Consent|1
5683002|NCT00374907|19601648|P1|12-Week Short-term Period|Subject Withdrew Consent|3
5683003|NCT00374868|19601660|P1|Overall Study|Other - Not Specified|1
5683004|NCT00374868|19601660|P1|Overall Study|Death|2
5683005|NCT00374868|19601660|P1|Overall Study|Lost to Follow-up|1
5683006|NCT00374868|19601660|P1|Overall Study|Physician Decision|13
5683007|NCT00374868|19601660|P1|Overall Study|Progressive Disease|7
5683008|NCT00374868|19601660|P1|Overall Study|Adverse Event|12
5683009|NCT00374556|19601724|P2|Overall Study|Removed at baseline due to medical cond|1
5683010|NCT00374556|19601725|P1|Overall Study|Removed at baseline due to medical cond|0
5683011|NCT00374556|19601724|P2|Overall Study|Lost to Follow-up|0
5683012|NCT00374556|19601725|P1|Overall Study|Lost to Follow-up|1
5683013|NCT00374452|19601786|P2|Overall Study|Withdrawal by Subject|2
5683014|NCT00374452|19601787|P1|Overall Study|Withdrawal by Subject|0
5683015|NCT00374452|19601786|P2|Overall Study|Left clinic after intervention started|1
5683016|NCT00374452|19601787|P1|Overall Study|Left clinic after intervention started|1
5683017|NCT00374452|19601786|P2|Overall Study|Change in job role before intervention|1
5683018|NCT00374452|19601787|P1|Overall Study|Change in job role before intervention|0
5683019|NCT00374452|19601786|P2|Overall Study|Left clinic before intervention started|1
5683020|NCT00374452|19601787|P1|Overall Study|Left clinic before intervention started|4
5683021|NCT00374322|19601800|P2|Overall Study|Did Not Receive Study Medication|6
5683022|NCT00374322|19601801|P1|Overall Study|Did Not Receive Study Medication|8
5683023|NCT00374322|19601800|P2|Overall Study|Withdrew Consent During Follow-up|5
5683024|NCT00374322|19601801|P1|Overall Study|Withdrew Consent During Follow-up|0
5683025|NCT00374322|19601800|P2|Overall Study|Noncompliance with Study Requirements|1
5683026|NCT00374322|19601801|P1|Overall Study|Noncompliance with Study Requirements|0
5683027|NCT00374322|19601800|P2|Overall Study|Started Another Chemotherapy Regimen|1
5683028|NCT00374322|19601801|P1|Overall Study|Started Another Chemotherapy Regimen|0
5683029|NCT00374322|19601800|P2|Overall Study|Participant Changed Physician|0
5683030|NCT00374322|19601801|P1|Overall Study|Participant Changed Physician|1
5683031|NCT00374322|19601800|P2|Overall Study|Site Closed|2
5683032|NCT00374322|19601801|P1|Overall Study|Site Closed|2
5683033|NCT00374322|19601800|P2|Overall Study|Severe Toxicity|0
5683034|NCT00374322|19601801|P1|Overall Study|Severe Toxicity|1
5683035|NCT00374322|19601800|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
5683036|NCT00374322|19601801|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
5683037|NCT00374322|19601800|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
5683038|NCT00374322|19601801|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
5683039|NCT00374322|19601800|P2|Overall Study|Sponsor Decision|3
5683040|NCT00374322|19601801|P1|Overall Study|Sponsor Decision|2
5683041|NCT00374322|19601800|P2|Overall Study|Par. Consented to Survival FU Only|1
5683042|NCT00374322|19601801|P1|Overall Study|Par. Consented to Survival FU Only|3
5683043|NCT00374322|19601800|P2|Overall Study|Physician Decision|32
5683044|NCT00374322|19601801|P1|Overall Study|Physician Decision|36
5683045|NCT00374322|19601800|P2|Overall Study|Sponsor Terminated Study|990
5683046|NCT00374322|19601801|P1|Overall Study|Sponsor Terminated Study|866
5683047|NCT00374322|19601800|P2|Overall Study|Withdrawal by Subject|167
5683048|NCT00374322|19601801|P1|Overall Study|Withdrawal by Subject|235
5683049|NCT00374322|19601800|P2|Overall Study|Protocol Violation|3
5683050|NCT00374322|19601801|P1|Overall Study|Protocol Violation|8
5683051|NCT00374322|19601800|P2|Overall Study|Lost to Follow-up|90
5683052|NCT00374322|19601801|P1|Overall Study|Lost to Follow-up|92
5683053|NCT00374140|19601892|P1|Overall Study|Protocol Violation|1
5683054|NCT00374140|19601892|P1|Overall Study|Lost to Follow-up|1
5683055|NCT00374127|19601899|P1|Overall Study|Pregnancy|1
5683056|NCT00374127|19601899|P1|Overall Study|Protocol Violation|5
5683057|NCT00374127|19601899|P1|Overall Study|Blood could not be drawn.|2
5683058|NCT00374127|19601899|P1|Overall Study|Did not inhale during smoking procedure.|3
5683059|NCT00373958|19601948|P2|Toddler Dose|Withdrawn after infant series|25
5683060|NCT00373958|19601949|P1|Toddler Dose|Withdrawn after infant series|22
5683061|NCT00373958|19601948|P2|Toddler Dose|Protocol Violation|1
5683062|NCT00373958|19601949|P1|Toddler Dose|Protocol Violation|0
5683063|NCT00373958|19601948|P2|Toddler Dose|Failed to return|2
5683064|NCT00373958|19601949|P1|Toddler Dose|Failed to return|1
5683065|NCT00373958|19601948|P2|Toddler Dose|Withdrawal by Subject|2
5683066|NCT00373958|19601949|P1|Toddler Dose|Withdrawal by Subject|2
5683067|NCT00373958|19601948|P2|Toddler Dose|Lost to Follow-up|8
5683068|NCT00373958|19601949|P1|Toddler Dose|Lost to Follow-up|5
5683069|NCT00373958|19601948|P2|Infant Series|Physician Decision|1
5683070|NCT00373958|19601949|P1|Infant Series|Physician Decision|1
5683071|NCT00373958|19601948|P2|Infant Series|Adverse Event|1
5683072|NCT00373958|19601949|P1|Infant Series|Adverse Event|3
5683073|NCT00373958|19601948|P2|Infant Series|Consent was not received|0
5683074|NCT00373958|19601949|P1|Infant Series|Consent was not received|1
5683075|NCT00373958|19601948|P2|Infant Series|Child relocated|0
5683076|NCT00373958|19601949|P1|Infant Series|Child relocated|1
5683077|NCT00373958|19601948|P2|Infant Series|Lost Kaiser coverage|0
5683078|NCT00373958|19601949|P1|Infant Series|Lost Kaiser coverage|4
5683079|NCT00373958|19601948|P2|Infant Series|Protocol Violation|7
5683080|NCT00373958|19601949|P1|Infant Series|Protocol Violation|3
5683081|NCT00373958|19601948|P2|Infant Series|Lost to Follow-up|5
5683082|NCT00373958|19601949|P1|Infant Series|Lost to Follow-up|6
5683083|NCT00373958|19601948|P2|Infant Series|Failed to return|13
5683084|NCT00373958|19601949|P1|Infant Series|Failed to return|8
5683085|NCT00373958|19601948|P2|Infant Series|Withdrawal by Subject|15
5683086|NCT00373958|19601949|P1|Infant Series|Withdrawal by Subject|13
5683087|NCT00373880|19601997|P1|Overall Study|Protocol Violation|14
5683088|NCT00373880|19601997|P1|Overall Study|Arrested|1
5683089|NCT00373880|19601997|P1|Overall Study|Physician Decision|3
5683090|NCT00373685|19602042|P2|Overall Study|Randomized, not treated|77
5683091|NCT00373685|19602043|P1|Overall Study|Randomized, not treated|51
5683092|NCT00373685|19602042|P2|Overall Study|Final Status Unknown|4
5683093|NCT00373685|19602043|P1|Overall Study|Final Status Unknown|12
5683094|NCT00373685|19602042|P2|Overall Study|Protocol Violation|182
5683095|NCT00373685|19602043|P1|Overall Study|Protocol Violation|191
5683096|NCT00373685|19602042|P2|Overall Study|Other|146
5683097|NCT00373685|19602043|P1|Overall Study|Other|149
5683098|NCT00373685|19602042|P2|Overall Study|No longer willing to participate|352
5683099|NCT00373685|19602043|P1|Overall Study|No longer willing to participate|337
5683100|NCT00373685|19602042|P2|Overall Study|Lost to follow up|103
5683101|NCT00373685|19602043|P1|Overall Study|Lost to follow up|83
5683102|NCT00373685|19602042|P2|Overall Study|Did not meet entrance criteria|184
5683103|NCT00373685|19602043|P1|Overall Study|Did not meet entrance criteria|167
5683104|NCT00373685|19602042|P2|Overall Study|Insufficient clinical response|119
5683105|NCT00373685|19602043|P1|Overall Study|Insufficient clinical response|169
5683106|NCT00373685|19602042|P2|Overall Study|Adverse Event|253
5683107|NCT00373685|19602043|P1|Overall Study|Adverse Event|278
5683108|NCT00373685|19602042|P2|Overall Study|Death|1
5683109|NCT00373685|19602043|P1|Overall Study|Death|2
5683110|NCT00373529|19602077|P1|Overall Study|Consent violation|1
5683111|NCT00373529|19602077|P1|Overall Study|Failed independent confirmation of AML|3
5683112|NCT00373529|19602077|P1|Overall Study|Other|8
5683113|NCT00373529|19602077|P1|Overall Study|Need for treatment prohibited by study|1
5683114|NCT00373529|19602077|P1|Overall Study|Death|16
5683115|NCT00373529|19602077|P1|Overall Study|Disease recurrence|10
5683116|NCT00373529|19602077|P1|Overall Study|Treatment failure|36
5683117|NCT00373529|19602077|P1|Overall Study|Adverse Event|7
5683118|NCT00373529|19602077|P1|Overall Study|Withdrawal by Subject|7
5683119|NCT00373529|19602077|P1|Overall Study|Physician Decision|19
5683120|NCT00373490|19602089|P2|Overall Study|Withdrawal by Subject|1
5683121|NCT00373490|19602090|P1|Overall Study|Withdrawal by Subject|0
5683122|NCT00373490|19602089|P2|Overall Study|Lack of Efficacy|4
5683123|NCT00373490|19602090|P1|Overall Study|Lack of Efficacy|9
5683124|NCT00373490|19602089|P2|Overall Study|Adverse Event|1
5683125|NCT00373490|19602090|P1|Overall Study|Adverse Event|0
5683126|NCT00373425|19602113|P5|Overall Study|Death|0
5683127|NCT00373425|19602114|P4|Overall Study|Death|1
5683128|NCT00373425|19602115|P3|Overall Study|Death|3
5683129|NCT00373425|19602116|P2|Overall Study|Death|0
5683130|NCT00373425|19602117|P1|Overall Study|Death|7
5683131|NCT00373425|19602113|P5|Overall Study|Medical/ethical/noncompliance reason|5
5683132|NCT00373425|19602114|P4|Overall Study|Medical/ethical/noncompliance reason|2
5683133|NCT00373425|19602115|P3|Overall Study|Medical/ethical/noncompliance reason|10
5683134|NCT00373425|19602116|P2|Overall Study|Medical/ethical/noncompliance reason|9
5683135|NCT00373425|19602117|P1|Overall Study|Medical/ethical/noncompliance reason|21
5683136|NCT00373425|19602113|P5|Overall Study|Patient request|7
5683137|NCT00373425|19602114|P4|Overall Study|Patient request|6
5683138|NCT00373425|19602115|P3|Overall Study|Patient request|43
5683139|NCT00373425|19602116|P2|Overall Study|Patient request|18
5683140|NCT00373425|19602117|P1|Overall Study|Patient request|35
5683141|NCT00373425|19602113|P5|Overall Study|Adverse Event|34
5683142|NCT00373425|19602114|P4|Overall Study|Adverse Event|0
5683143|NCT00373425|19602115|P3|Overall Study|Adverse Event|59
5683144|NCT00373425|19602116|P2|Overall Study|Adverse Event|22
5683145|NCT00373425|19602117|P1|Overall Study|Adverse Event|191
5683146|NCT00373425|19602113|P5|Overall Study|Relapse of NSCLC|26
5683147|NCT00373425|19602114|P4|Overall Study|Relapse of NSCLC|2
5683148|NCT00373425|19602115|P3|Overall Study|Relapse of NSCLC|19
5683149|NCT00373425|19602116|P2|Overall Study|Relapse of NSCLC|104
5683150|NCT00373425|19602117|P1|Overall Study|Relapse of NSCLC|116
5683151|NCT00373295|19602212|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
5683152|NCT00373295|19602213|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
5683153|NCT00373295|19602214|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
5683154|NCT00373295|19602215|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
5683155|NCT00373295|19602216|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
5683156|NCT00373295|19602217|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
5683157|NCT00373256|19602238|P2|Overall Study|Study Terminated by Sponsor|13
5683158|NCT00373256|19602239|P1|Overall Study|Study Terminated by Sponsor|41
5683159|NCT00373256|19602238|P2|Overall Study|Protocol Violation|2
5683160|NCT00373256|19602239|P1|Overall Study|Protocol Violation|0
5683161|NCT00373256|19602238|P2|Overall Study|Other|107
5683162|NCT00373256|19602239|P1|Overall Study|Other|73
5683163|NCT00373256|19602238|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
5683164|NCT00373256|19602239|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
5683165|NCT00373256|19602238|P2|Overall Study|Objective Progression or Relapse|104
5683166|NCT00373256|19602239|P1|Overall Study|Objective Progression or Relapse|111
5683167|NCT00373256|19602238|P2|Overall Study|Death|8
5683168|NCT00373256|19602239|P1|Overall Study|Death|9
5683169|NCT00373256|19602238|P2|Overall Study|Lost to Follow-up|1
5683170|NCT00373256|19602239|P1|Overall Study|Lost to Follow-up|2
5683171|NCT00373256|19602238|P2|Overall Study|Adverse Event (AE)|5
5683172|NCT00373256|19602239|P1|Overall Study|Adverse Event (AE)|1
5683173|NCT00373113|19602265|P2|Overall Study|Withdrawal by Subject|15
5683174|NCT00373113|19602266|P1|Overall Study|Withdrawal by Subject|10
5683175|NCT00373113|19602265|P2|Overall Study|Protocol Violation|1
5683176|NCT00373113|19602266|P1|Overall Study|Protocol Violation|5
5683177|NCT00373113|19602265|P2|Overall Study|Other|17
5683178|NCT00373113|19602266|P1|Overall Study|Other|14
5683179|NCT00373113|19602265|P2|Overall Study|Objective progression or relapse|169
5683180|NCT00373113|19602266|P1|Overall Study|Objective progression or relapse|150
5683181|NCT00373113|19602265|P2|Overall Study|Lost to Follow-up|3
5683182|NCT00373113|19602266|P1|Overall Study|Lost to Follow-up|1
5683183|NCT00373113|19602265|P2|Overall Study|Global deterioration of health status|7
5683184|NCT00373113|19602266|P1|Overall Study|Global deterioration of health status|10
5683185|NCT00373113|19602265|P2|Overall Study|Study terminated by sponsor|1
5683186|NCT00373113|19602266|P1|Overall Study|Study terminated by sponsor|9
5683187|NCT00373113|19602265|P2|Overall Study|Adverse Event|24
5683188|NCT00373113|19602266|P1|Overall Study|Adverse Event|38
5683189|NCT00373113|19602265|P2|Overall Study|Death|7
5683190|NCT00373113|19602266|P1|Overall Study|Death|1
5683191|NCT00372996|19602288|P4|Overall Study|Other|7
5683192|NCT00372996|19602289|P3|Overall Study|Other|7
5683193|NCT00372996|19602290|P2|Overall Study|Other|2
5683194|NCT00372996|19602291|P1|Overall Study|Other|10
5683195|NCT00372996|19602288|P4|Overall Study|Study Terminated by Sponsor|0
5683196|NCT00372996|19602289|P3|Overall Study|Study Terminated by Sponsor|4
5683197|NCT00372996|19602290|P2|Overall Study|Study Terminated by Sponsor|0
5683198|NCT00372996|19602291|P1|Overall Study|Study Terminated by Sponsor|4
5683199|NCT00372996|19602288|P4|Overall Study|Withdrawal by Subject|5
5683200|NCT00372996|19602289|P3|Overall Study|Withdrawal by Subject|9
5683201|NCT00372996|19602290|P2|Overall Study|Withdrawal by Subject|6
5683202|NCT00372996|19602291|P1|Overall Study|Withdrawal by Subject|12
5683203|NCT00372996|19602288|P4|Overall Study|Lost to Follow-up|1
5683204|NCT00372996|19602289|P3|Overall Study|Lost to Follow-up|0
5683205|NCT00372996|19602290|P2|Overall Study|Lost to Follow-up|2
5683206|NCT00372996|19602291|P1|Overall Study|Lost to Follow-up|0
5683207|NCT00372996|19602288|P4|Overall Study|Death|7
5683208|NCT00372996|19602289|P3|Overall Study|Death|8
5683209|NCT00372996|19602290|P2|Overall Study|Death|4
5683210|NCT00372996|19602291|P1|Overall Study|Death|11
5683211|NCT00372905|19602376|P4|Follow up Until Relapse or Progression|Other|0
5683212|NCT00372905|19602377|P3|Follow up Until Relapse or Progression|Other|0
5683213|NCT00372905|19602378|P2|Follow up Until Relapse or Progression|Other|1
5683214|NCT00372905|19602379|P1|Follow up Until Relapse or Progression|Other|0
5683215|NCT00372905|19602376|P4|Follow up Until Relapse or Progression|Study closed|3
5683216|NCT00372905|19602377|P3|Follow up Until Relapse or Progression|Study closed|0
5683217|NCT00372905|19602378|P2|Follow up Until Relapse or Progression|Study closed|0
5683218|NCT00372905|19602379|P1|Follow up Until Relapse or Progression|Study closed|0
5683219|NCT00372905|19602376|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
5683220|NCT00372905|19602377|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
5683221|NCT00372905|19602378|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
5683222|NCT00372905|19602379|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
5683223|NCT00372905|19602376|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
5683313|NCT00372424|19602548|P1|Overall Study|Withdrawal by Subject|1
5683224|NCT00372905|19602377|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
5683225|NCT00372905|19602378|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
5683226|NCT00372905|19602379|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
5683227|NCT00372905|19602376|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
5683228|NCT00372905|19602377|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
5683229|NCT00372905|19602378|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
5683230|NCT00372905|19602379|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
5683231|NCT00372905|19602376|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
5683232|NCT00372905|19602377|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
5683233|NCT00372905|19602378|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
5683234|NCT00372905|19602379|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
5683235|NCT00372775|19602391|P1|Overall Study|Not Treated|2
5683236|NCT00372775|19602391|P1|Overall Study|Other|1
5683237|NCT00372775|19602391|P1|Overall Study|Withdrawal by Subject|1
5683238|NCT00372775|19602391|P1|Overall Study|Global deterioration of health status|6
5683239|NCT00372775|19602391|P1|Overall Study|Objective progression or relapse|30
5683240|NCT00372775|19602391|P1|Overall Study|Death|15
5683241|NCT00372775|19602391|P1|Overall Study|Adverse Event|8
5683242|NCT00372697|19602413|P2|Overall Study|Protocol Violation|1
5683243|NCT00372697|19602414|P1|Overall Study|Protocol Violation|1
5683244|NCT00372619|19602439|P7|Overall Study|Inevaluable|0
5683245|NCT00372619|19602440|P6|Overall Study|Inevaluable|1
5683246|NCT00372619|19602441|P5|Overall Study|Inevaluable|0
5683247|NCT00372619|19602442|P4|Overall Study|Inevaluable|0
5683248|NCT00372619|19602443|P3|Overall Study|Inevaluable|0
5683249|NCT00372619|19602444|P2|Overall Study|Inevaluable|0
5683250|NCT00372619|19602445|P1|Overall Study|Inevaluable|0
5683251|NCT00372619|19602439|P7|Overall Study|Ineligible|0
5683252|NCT00372619|19602440|P6|Overall Study|Ineligible|2
5683253|NCT00372619|19602441|P5|Overall Study|Ineligible|0
5683254|NCT00372619|19602442|P4|Overall Study|Ineligible|0
5683255|NCT00372619|19602443|P3|Overall Study|Ineligible|0
5683256|NCT00372619|19602444|P2|Overall Study|Ineligible|0
5683257|NCT00372619|19602445|P1|Overall Study|Ineligible|0
5683258|NCT00372593|19602478|P3|Overall Study|Ineligible|1
5683259|NCT00372593|19602479|P2|Overall Study|Ineligible|21
5683260|NCT00372593|19602480|P1|Overall Study|Ineligible|20
5683261|NCT00372593|19602478|P3|Overall Study|Physician Decision|0
5683262|NCT00372593|19602479|P2|Overall Study|Physician Decision|41
5683263|NCT00372593|19602480|P1|Overall Study|Physician Decision|42
5683264|NCT00372593|19602478|P3|Overall Study|Lost to Follow-up|0
5683265|NCT00372593|19602479|P2|Overall Study|Lost to Follow-up|0
5683266|NCT00372593|19602480|P1|Overall Study|Lost to Follow-up|1
5683267|NCT00372593|19602478|P3|Overall Study|Lack of Efficacy|2
5683268|NCT00372593|19602479|P2|Overall Study|Lack of Efficacy|71
5683269|NCT00372593|19602480|P1|Overall Study|Lack of Efficacy|82
5683270|NCT00372593|19602478|P3|Overall Study|Death|1
5683271|NCT00372593|19602479|P2|Overall Study|Death|20
5683272|NCT00372593|19602480|P1|Overall Study|Death|16
5683273|NCT00372593|19602478|P3|Overall Study|Adverse Event|0
5683274|NCT00372593|19602479|P2|Overall Study|Adverse Event|45
5683275|NCT00372593|19602480|P1|Overall Study|Adverse Event|43
5683276|NCT00372567|19602509|P3|Phase 3 Study|study terminated by sponsor|5
5683277|NCT00372567|19602510|P2|Phase 3 Study|study terminated by sponsor|8
5683278|NCT00372567|19602511|P1|Phase 3 Study|study terminated by sponsor|13
5683279|NCT00372567|19602509|P3|Phase 3 Study|Other|1
5683280|NCT00372567|19602510|P2|Phase 3 Study|Other|2
5683281|NCT00372567|19602511|P1|Phase 3 Study|Other|2
5683282|NCT00372567|19602509|P3|Phase 3 Study|Global deterioration of health status|0
5683283|NCT00372567|19602510|P2|Phase 3 Study|Global deterioration of health status|1
5683284|NCT00372567|19602511|P1|Phase 3 Study|Global deterioration of health status|0
5683285|NCT00372567|19602509|P3|Phase 3 Study|Objective progression or relapse|4
5683286|NCT00372567|19602510|P2|Phase 3 Study|Objective progression or relapse|13
5683287|NCT00372567|19602511|P1|Phase 3 Study|Objective progression or relapse|10
5683288|NCT00372567|19602509|P3|Phase 3 Study|Protocol Violation|1
5683289|NCT00372567|19602510|P2|Phase 3 Study|Protocol Violation|0
5683290|NCT00372567|19602511|P1|Phase 3 Study|Protocol Violation|0
5683291|NCT00372567|19602509|P3|Phase 3 Study|Death|0
5683292|NCT00372567|19602510|P2|Phase 3 Study|Death|1
5683293|NCT00372567|19602511|P1|Phase 3 Study|Death|1
5683294|NCT00372567|19602509|P3|Phase 3 Study|Adverse Event|1
5683295|NCT00372567|19602510|P2|Phase 3 Study|Adverse Event|1
5683296|NCT00372567|19602511|P1|Phase 3 Study|Adverse Event|5
5683297|NCT00372528|19602539|P1|Overall Study|Other|1
5683298|NCT00372528|19602539|P1|Overall Study|Study Terminated by Sponsor|18
5683299|NCT00372528|19602539|P1|Overall Study|Adverse Event|1
5683300|NCT00372528|19602539|P1|Overall Study|Lack of Efficacy|1
5683301|NCT00372489|19602544|P1|Overall Study|Sponsor Decision to Terminate Study|41
5683302|NCT00372489|19602544|P1|Overall Study|Renal transplant|6
5683303|NCT00372489|19602544|P1|Overall Study|Patient Relocation|2
5683304|NCT00372489|19602544|P1|Overall Study|Withdrawal by Subject|5
5683305|NCT00372489|19602544|P1|Overall Study|Physician Decision|3
5683306|NCT00372489|19602544|P1|Overall Study|Lost to Follow-up|3
5683307|NCT00372489|19602544|P1|Overall Study|Lack of Efficacy|1
5683308|NCT00372489|19602544|P1|Overall Study|Adverse Event|18
5683309|NCT00372424|19602548|P1|Overall Study|Enrolled, Not Treated|1
5683310|NCT00372424|19602548|P1|Overall Study|Other|7
5683311|NCT00372424|19602548|P1|Overall Study|Objective Progression or Relapse|14
5683312|NCT00372424|19602548|P1|Overall Study|Death|1
5683314|NCT00372424|19602548|P1|Overall Study|Adverse Event|2
5683315|NCT00372411|19602562|P3|Overall Study|Adverse Event|0
5683316|NCT00372411|19602563|P2|Overall Study|Adverse Event|1
5683317|NCT00372411|19602564|P1|Overall Study|Adverse Event|1
5683318|NCT00372411|19602562|P3|Overall Study|Lost to Follow-up|1
5683319|NCT00372411|19602563|P2|Overall Study|Lost to Follow-up|1
5683320|NCT00372411|19602564|P1|Overall Study|Lost to Follow-up|1
5683321|NCT00372411|19602562|P3|Overall Study|Death|1
5683322|NCT00372411|19602563|P2|Overall Study|Death|2
5683323|NCT00372411|19602564|P1|Overall Study|Death|0
5683324|NCT00372411|19602562|P3|Overall Study|Withdrawal by Subject|1
5683325|NCT00372411|19602563|P2|Overall Study|Withdrawal by Subject|4
5683326|NCT00372411|19602564|P1|Overall Study|Withdrawal by Subject|3
5683327|NCT00372385|19602588|P4|Overall Study|Virologic Stopping Rule|0
5683328|NCT00372385|19602589|P3|Overall Study|Virologic Stopping Rule|0
5683329|NCT00372385|19602590|P2|Overall Study|Virologic Stopping Rule|0
5683330|NCT00372385|19602591|P1|Overall Study|Virologic Stopping Rule|17
5683331|NCT00372385|19602588|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
5683332|NCT00372385|19602589|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
5683333|NCT00372385|19602590|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
5683334|NCT00372385|19602591|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
5683335|NCT00372385|19602588|P4|Overall Study|No Response|0
5683336|NCT00372385|19602589|P3|Overall Study|No Response|0
5683337|NCT00372385|19602590|P2|Overall Study|No Response|1
5683338|NCT00372385|19602591|P1|Overall Study|No Response|1
5683339|NCT00372385|19602588|P4|Overall Study|Refusal of Treatment|0
5683340|NCT00372385|19602589|P3|Overall Study|Refusal of Treatment|0
5683341|NCT00372385|19602590|P2|Overall Study|Refusal of Treatment|6
5683342|NCT00372385|19602591|P1|Overall Study|Refusal of Treatment|3
5683343|NCT00372385|19602588|P4|Overall Study|Withdrawal by Subject|0
5683344|NCT00372385|19602589|P3|Overall Study|Withdrawal by Subject|0
5683345|NCT00372385|19602590|P2|Overall Study|Withdrawal by Subject|1
5683346|NCT00372385|19602591|P1|Overall Study|Withdrawal by Subject|2
5683347|NCT00372385|19602588|P4|Overall Study|Lost to Follow-up|0
5683348|NCT00372385|19602589|P3|Overall Study|Lost to Follow-up|0
5683349|NCT00372385|19602590|P2|Overall Study|Lost to Follow-up|0
5683350|NCT00372385|19602591|P1|Overall Study|Lost to Follow-up|2
5683351|NCT00372385|19602588|P4|Overall Study|Physician Decision|0
5683352|NCT00372385|19602589|P3|Overall Study|Physician Decision|0
5683353|NCT00372385|19602590|P2|Overall Study|Physician Decision|0
5683354|NCT00372385|19602591|P1|Overall Study|Physician Decision|1
5683355|NCT00372385|19602588|P4|Overall Study|Noncompliance|1
5683356|NCT00372385|19602589|P3|Overall Study|Noncompliance|1
5683357|NCT00372385|19602590|P2|Overall Study|Noncompliance|1
5683358|NCT00372385|19602591|P1|Overall Study|Noncompliance|0
5683359|NCT00372385|19602588|P4|Overall Study|Adverse Event|7
5683360|NCT00372385|19602589|P3|Overall Study|Adverse Event|9
5683361|NCT00372385|19602590|P2|Overall Study|Adverse Event|11
5683362|NCT00372385|19602591|P1|Overall Study|Adverse Event|6
5683363|NCT00372255|19602620|P2|Overall Study|Withdrawn for other reasons|1
5683364|NCT00372255|19602621|P1|Overall Study|Withdrawn for other reasons|2
5683365|NCT00372229|19602643|P2|Follow-Up Phase|Lost to Follow-up|10
5683366|NCT00372229|19602644|P1|Follow-Up Phase|Lost to Follow-up|12
5683367|NCT00372229|19602643|P2|Follow-Up Phase|Reason not specified|3
5683368|NCT00372229|19602644|P1|Follow-Up Phase|Reason not specified|2
5683369|NCT00372229|19602643|P2|Follow-Up Phase|Administrative|0
5683370|NCT00372229|19602644|P1|Follow-Up Phase|Administrative|1
5683371|NCT00372229|19602643|P2|Follow-Up Phase|Death|12
5683372|NCT00372229|19602644|P1|Follow-Up Phase|Death|9
5683373|NCT00372229|19602643|P2|Follow-Up Phase|Adverse event/intercurrent illness|0
5683374|NCT00372229|19602644|P1|Follow-Up Phase|Adverse event/intercurrent illness|1
5683375|NCT00372229|19602643|P2|Follow-Up Phase|Refused treatment/did not cooperate|1
5683376|NCT00372229|19602644|P1|Follow-Up Phase|Refused treatment/did not cooperate|0
5683377|NCT00372229|19602643|P2|Follow-Up Phase|Consent withdrawn|19
5683378|NCT00372229|19602644|P1|Follow-Up Phase|Consent withdrawn|13
5683379|NCT00372229|19602643|P2|Follow-Up Phase|Graft loss|7
5683380|NCT00372229|19602644|P1|Follow-Up Phase|Graft loss|8
5683381|NCT00372229|19602643|P2|Study Phase|Lost to Follow-up|3
5683382|NCT00372229|19602644|P1|Study Phase|Lost to Follow-up|3
5683383|NCT00372229|19602643|P2|Study Phase|Reason not specified|2
5683384|NCT00372229|19602644|P1|Study Phase|Reason not specified|3
5683385|NCT00372229|19602643|P2|Study Phase|Death|2
5683386|NCT00372229|19602644|P1|Study Phase|Death|3
5683387|NCT00372229|19602643|P2|Study Phase|Refused treatment/did not cooperate|1
5683388|NCT00372229|19602644|P1|Study Phase|Refused treatment/did not cooperate|3
5683389|NCT00372229|19602643|P2|Study Phase|Consent withdrawn|14
5683390|NCT00372229|19602644|P1|Study Phase|Consent withdrawn|16
5683391|NCT00372229|19602643|P2|Study Phase|Protocol Violation|4
5683392|NCT00372229|19602644|P1|Study Phase|Protocol Violation|3
5683393|NCT00372229|19602643|P2|Study Phase|Graft loss|3
5683394|NCT00372229|19602644|P1|Study Phase|Graft loss|0
5683395|NCT00372190|19602734|P2|Overall Study|Lost to Follow-up|1
5683396|NCT00372190|19602735|P1|Overall Study|Lost to Follow-up|3
5683397|NCT00372112|19602751|P4|Overall Study|Other-protocol violation|0
5683398|NCT00372112|19602752|P3|Overall Study|Other-protocol violation|1
5683399|NCT00372112|19602753|P2|Overall Study|Other-protocol violation|0
5683400|NCT00372112|19602754|P1|Overall Study|Other-protocol violation|0
5683401|NCT00372112|19602751|P4|Overall Study|Hepatitis B|0
5683402|NCT00372112|19602752|P3|Overall Study|Hepatitis B|0
5683403|NCT00372112|19602753|P2|Overall Study|Hepatitis B|0
5683404|NCT00372112|19602754|P1|Overall Study|Hepatitis B|1
5683405|NCT00372112|19602751|P4|Overall Study|PR >240 at Visit 3|1
5683406|NCT00372112|19602752|P3|Overall Study|PR >240 at Visit 3|0
5683407|NCT00372112|19602753|P2|Overall Study|PR >240 at Visit 3|0
5683408|NCT00372112|19602754|P1|Overall Study|PR >240 at Visit 3|0
5683409|NCT00372112|19602751|P4|Overall Study|Exacerbation|1
5683410|NCT00372112|19602752|P3|Overall Study|Exacerbation|0
5683411|NCT00372112|19602753|P2|Overall Study|Exacerbation|0
5683412|NCT00372112|19602754|P1|Overall Study|Exacerbation|0
5683413|NCT00372112|19602751|P4|Overall Study|Withdrawal by Subject|1
5683414|NCT00372112|19602752|P3|Overall Study|Withdrawal by Subject|2
5683415|NCT00372112|19602753|P2|Overall Study|Withdrawal by Subject|0
5683416|NCT00372112|19602754|P1|Overall Study|Withdrawal by Subject|0
5683417|NCT00372112|19602751|P4|Overall Study|Adverse Event|1
5683418|NCT00372112|19602752|P3|Overall Study|Adverse Event|1
5683419|NCT00372112|19602753|P2|Overall Study|Adverse Event|1
5683420|NCT00372112|19602754|P1|Overall Study|Adverse Event|0
5683421|NCT00372060|19602885|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
5683422|NCT00372060|19602886|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
5683423|NCT00372060|19602885|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
5683424|NCT00372060|19602886|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
5683425|NCT00372060|19602885|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
5683426|NCT00372060|19602886|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
5683427|NCT00372060|19602885|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
5683428|NCT00372060|19602886|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
5683429|NCT00372060|19602885|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
5683430|NCT00372060|19602886|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
5683431|NCT00372060|19602885|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
5683432|NCT00372060|19602886|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
5683433|NCT00371865|19602901|P2|Overall Study|Withdrawal by Subject|10
5683434|NCT00371865|19602902|P1|Overall Study|Withdrawal by Subject|12
5683435|NCT00371865|19602901|P2|Overall Study|Protocol Violation|2
5683436|NCT00371865|19602902|P1|Overall Study|Protocol Violation|3
5683437|NCT00371865|19602901|P2|Overall Study|Lack of Efficacy|2
5683438|NCT00371865|19602902|P1|Overall Study|Lack of Efficacy|0
5683439|NCT00371839|19602919|P3|Overall Study|Lost to Follow-up|2
5683440|NCT00371839|19602920|P2|Overall Study|Lost to Follow-up|3
5683441|NCT00371839|19602921|P1|Overall Study|Lost to Follow-up|6
5683442|NCT00371839|19602919|P3|Overall Study|Withdrawal by Subject|0
5683443|NCT00371839|19602920|P2|Overall Study|Withdrawal by Subject|4
5683444|NCT00371839|19602921|P1|Overall Study|Withdrawal by Subject|7
5683445|NCT00371839|19602919|P3|Overall Study|Death|0
5683446|NCT00371839|19602920|P2|Overall Study|Death|0
5683447|NCT00371839|19602921|P1|Overall Study|Death|4
5683448|NCT00371826|19602930|P3|Extension Phase (24 Months)|Administrative problems|2
5683449|NCT00371826|19602931|P2|Extension Phase (24 Months)|Administrative problems|0
5683450|NCT00371826|19602932|P1|Extension Phase (24 Months)|Administrative problems|0
5683451|NCT00371826|19602930|P3|Extension Phase (24 Months)|Subject withdrew consent|0
5683452|NCT00371826|19602931|P2|Extension Phase (24 Months)|Subject withdrew consent|2
5683453|NCT00371826|19602932|P1|Extension Phase (24 Months)|Subject withdrew consent|1
5683454|NCT00371826|19602930|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
5683455|NCT00371826|19602931|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
5683456|NCT00371826|19602932|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
5683457|NCT00371826|19602930|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
5683458|NCT00371826|19602931|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
5683459|NCT00371826|19602932|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
5683460|NCT00371826|19602930|P3|Extension Phase (24 Months)|Adverse Event|0
5683461|NCT00371826|19602931|P2|Extension Phase (24 Months)|Adverse Event|5
5683462|NCT00371826|19602932|P1|Extension Phase (24 Months)|Adverse Event|4
5683463|NCT00371826|19602930|P3|Core Phase (12 Months)|Graft Loss|0
5683464|NCT00371826|19602931|P2|Core Phase (12 Months)|Graft Loss|1
5683465|NCT00371826|19602932|P1|Core Phase (12 Months)|Graft Loss|0
5683466|NCT00371826|19602930|P3|Core Phase (12 Months)|Administrative problems|8
5683467|NCT00371826|19602931|P2|Core Phase (12 Months)|Administrative problems|0
5683468|NCT00371826|19602932|P1|Core Phase (12 Months)|Administrative problems|1
5683469|NCT00371826|19602930|P3|Core Phase (12 Months)|Subject withdrew consent|3
5683470|NCT00371826|19602931|P2|Core Phase (12 Months)|Subject withdrew consent|0
5683471|NCT00371826|19602932|P1|Core Phase (12 Months)|Subject withdrew consent|0
5683472|NCT00371826|19602930|P3|Core Phase (12 Months)|Protocol Violation|1
5683473|NCT00371826|19602931|P2|Core Phase (12 Months)|Protocol Violation|0
5683474|NCT00371826|19602932|P1|Core Phase (12 Months)|Protocol Violation|1
5683475|NCT00371826|19602930|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
5683476|NCT00371826|19602931|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
5683477|NCT00371826|19602932|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
5683478|NCT00371826|19602930|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
5683479|NCT00371826|19602931|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
5683480|NCT00371826|19602932|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
5683481|NCT00371826|19602930|P3|Core Phase (12 Months)|Adverse Event|9
5683482|NCT00371826|19602931|P2|Core Phase (12 Months)|Adverse Event|4
5683483|NCT00371826|19602932|P1|Core Phase (12 Months)|Adverse Event|15
5683484|NCT00371787|19603056|P2|Overall Study|Withdrawal by Subject|1
5683485|NCT00371787|19603057|P1|Overall Study|Withdrawal by Subject|3
5683486|NCT00371761|19603071|P2|Overall Study|Study termination|3
5683487|NCT00371761|19603072|P1|Overall Study|Study termination|4
5683488|NCT00371761|19603071|P2|Overall Study|Investigator Judgment|3
5683489|NCT00371761|19603072|P1|Overall Study|Investigator Judgment|2
5683490|NCT00371761|19603071|P2|Overall Study|Withdrawal by Subject|3
5683491|NCT00371761|19603072|P1|Overall Study|Withdrawal by Subject|1
5683492|NCT00371761|19603071|P2|Overall Study|Adverse Event|1
5683493|NCT00371761|19603072|P1|Overall Study|Adverse Event|1
5683494|NCT00371683|19603080|P2|Follow-Up Period - Randomized Patients|non-specified|12
5683495|NCT00371683|19603081|P1|Follow-Up Period - Randomized Patients|non-specified|6
5683496|NCT00371683|19603080|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
5683497|NCT00371683|19603081|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
5683498|NCT00371683|19603080|P2|Follow-Up Period - Randomized Patients|Death|2
5683499|NCT00371683|19603081|P1|Follow-Up Period - Randomized Patients|Death|0
5683500|NCT00371683|19603080|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
5683501|NCT00371683|19603081|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
5683502|NCT00371683|19603080|P2|DB Treatment Period-Randomized Patients|non-specified|8
5683503|NCT00371683|19603081|P1|DB Treatment Period-Randomized Patients|non-specified|9
5683504|NCT00371683|19603080|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
5683505|NCT00371683|19603081|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
5683506|NCT00371683|19603080|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
5683507|NCT00371683|19603081|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
5683508|NCT00371683|19603080|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
5683509|NCT00371683|19603081|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
5683510|NCT00371683|19603080|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
5683511|NCT00371683|19603081|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
5683512|NCT00371683|19603080|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
5683513|NCT00371683|19603081|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
5683514|NCT00371683|19603080|P2|DB Treatment Period-Randomized Patients|Death|1
5683515|NCT00371683|19603081|P1|DB Treatment Period-Randomized Patients|Death|1
5683516|NCT00371566|19603149|P2|Follow Up Phase|Lost to Follow-up|0
5683517|NCT00371566|19603150|P1|Follow Up Phase|Lost to Follow-up|1
5683518|NCT00371566|19603149|P2|Follow Up Phase|Physician Decision|1
5683519|NCT00371566|19603150|P1|Follow Up Phase|Physician Decision|1
5683520|NCT00371566|19603149|P2|Follow Up Phase|Withdrawal by Subject|1
5683521|NCT00371566|19603150|P1|Follow Up Phase|Withdrawal by Subject|0
5683522|NCT00371566|19603149|P2|Follow Up Phase|Disease progression|0
5683523|NCT00371566|19603150|P1|Follow Up Phase|Disease progression|1
5683524|NCT00371566|19603149|P2|Follow Up Phase|Death|5
5683525|NCT00371566|19603150|P1|Follow Up Phase|Death|0
5683526|NCT00371566|19603149|P2|Chemoradiation Phase|Death|0
5683527|NCT00371566|19603150|P1|Chemoradiation Phase|Death|2
5683528|NCT00371566|19603149|P2|Chemoradiation Phase|Progressive Disease|1
5683529|NCT00371566|19603150|P1|Chemoradiation Phase|Progressive Disease|1
5683530|NCT00371566|19603149|P2|Chemoradiation Phase|Non compliant|1
5683531|NCT00371566|19603150|P1|Chemoradiation Phase|Non compliant|0
5683532|NCT00371566|19603149|P2|Chemoradiation Phase|Withdrawal by Subject|1
5683533|NCT00371566|19603150|P1|Chemoradiation Phase|Withdrawal by Subject|0
5683534|NCT00371566|19603149|P2|Chemoradiation Phase|Physician Decision|0
5683535|NCT00371566|19603150|P1|Chemoradiation Phase|Physician Decision|2
5683536|NCT00371566|19603149|P2|Treatment Phase|Protocol Violation|1
5683537|NCT00371566|19603150|P1|Treatment Phase|Protocol Violation|0
5683538|NCT00371566|19603149|P2|Treatment Phase|Adverse Event|1
5683539|NCT00371566|19603150|P1|Treatment Phase|Adverse Event|0
5683540|NCT00371566|19603149|P2|Treatment Phase|Withdrawal by Subject|1
5683541|NCT00371566|19603150|P1|Treatment Phase|Withdrawal by Subject|0
5683542|NCT00371462|19603235|P2|Overall Study|Other|8
5683543|NCT00371462|19603236|P1|Overall Study|Other|7
5683544|NCT00371462|19603235|P2|Overall Study|Withdrawal by Subject|0
5683545|NCT00371462|19603236|P1|Overall Study|Withdrawal by Subject|1
5683546|NCT00371397|19603260|P12|Session 1|Withdrawal by Subject|0
5683547|NCT00371397|19603261|P11|Session 1|Withdrawal by Subject|0
5683548|NCT00371397|19603262|P10|Session 1|Withdrawal by Subject|0
5683549|NCT00371397|19603263|P9|Session 1|Withdrawal by Subject|0
5683550|NCT00371397|19603264|P8|Session 1|Withdrawal by Subject|1
5683551|NCT00371397|19603265|P7|Session 1|Withdrawal by Subject|0
5683552|NCT00371397|19603266|P6|Session 1|Withdrawal by Subject|0
5683553|NCT00371397|19603267|P5|Session 1|Withdrawal by Subject|0
5683554|NCT00371397|19603268|P4|Session 1|Withdrawal by Subject|0
5683555|NCT00371397|19603269|P3|Session 1|Withdrawal by Subject|0
5683556|NCT00371397|19603270|P2|Session 1|Withdrawal by Subject|0
5683557|NCT00371397|19603271|P1|Session 1|Withdrawal by Subject|1
5683558|NCT00371345|19603279|P2|Overall Study|Participant Withdrew Consent|1
5683559|NCT00371345|19603280|P1|Overall Study|Participant Withdrew Consent|0
5683560|NCT00371345|19603279|P2|Overall Study|Participant Request|1
5683561|NCT00371345|19603280|P1|Overall Study|Participant Request|1
5683562|NCT00371345|19603279|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
5683563|NCT00371345|19603280|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
5683564|NCT00371345|19603279|P2|Overall Study|Study Drug Toxicity|7
5683565|NCT00371345|19603280|P1|Overall Study|Study Drug Toxicity|1
5683566|NCT00371345|19603279|P2|Overall Study|Disease Progression|35
5683567|NCT00371345|19603280|P1|Overall Study|Disease Progression|21
5683568|NCT00371254|19603381|P2|Overall Study|Withdrawal by Subject|1
5683569|NCT00371254|19603382|P1|Overall Study|Withdrawal by Subject|0
5683570|NCT00371254|19603381|P2|Overall Study|Lost to Follow-up|1
5683571|NCT00371254|19603382|P1|Overall Study|Lost to Follow-up|0
5683572|NCT00371254|19603381|P2|Overall Study|Adverse event unrelated to study drug|1
5683573|NCT00371254|19603382|P1|Overall Study|Adverse event unrelated to study drug|0
5683574|NCT00371254|19603381|P2|Overall Study|Investigator Decision|0
5683575|NCT00371254|19603382|P1|Overall Study|Investigator Decision|2
5683576|NCT00371254|19603381|P2|Overall Study|Subject request|0
5683577|NCT00371254|19603382|P1|Overall Study|Subject request|5
5683578|NCT00371254|19603381|P2|Overall Study|Study drug toxicity|5
5683579|NCT00371254|19603382|P1|Overall Study|Study drug toxicity|3
5683580|NCT00371254|19603381|P2|Overall Study|Disease progression|13
5683581|NCT00371254|19603382|P1|Overall Study|Disease progression|13
5683582|NCT00371150|19603465|P2|Overall Study|Lost to Follow-up|2
5683583|NCT00371150|19603466|P1|Overall Study|Lost to Follow-up|3
5683584|NCT00371137|19603501|P3|Overall Study|Protocol Violation|1
5683585|NCT00371137|19603502|P2|Overall Study|Protocol Violation|1
5683586|NCT00371137|19603503|P1|Overall Study|Protocol Violation|2
5683587|NCT00371137|19603501|P3|Overall Study|Physician Decision|1
5683588|NCT00371137|19603502|P2|Overall Study|Physician Decision|1
5683589|NCT00371137|19603503|P1|Overall Study|Physician Decision|1
5683590|NCT00371137|19603501|P3|Overall Study|Sponsor Decision|2
5683591|NCT00371137|19603502|P2|Overall Study|Sponsor Decision|1
5683592|NCT00371137|19603503|P1|Overall Study|Sponsor Decision|2
5683593|NCT00371137|19603501|P3|Overall Study|Lack of Efficacy|13
5683594|NCT00371137|19603502|P2|Overall Study|Lack of Efficacy|12
5683595|NCT00371137|19603503|P1|Overall Study|Lack of Efficacy|30
5683596|NCT00371137|19603501|P3|Overall Study|Lost to Follow-up|5
5683597|NCT00371137|19603502|P2|Overall Study|Lost to Follow-up|3
5683598|NCT00371137|19603503|P1|Overall Study|Lost to Follow-up|6
5683599|NCT00371137|19603501|P3|Overall Study|Withdrawal by Subject|15
5683600|NCT00371137|19603502|P2|Overall Study|Withdrawal by Subject|10
5683601|NCT00371137|19603503|P1|Overall Study|Withdrawal by Subject|11
5683602|NCT00371137|19603501|P3|Overall Study|Adverse Event|42
5683603|NCT00371137|19603502|P2|Overall Study|Adverse Event|35
5683604|NCT00371137|19603503|P1|Overall Study|Adverse Event|20
5683605|NCT00370682|19603550|P3|Overall Study|Lost to Follow-up|1
5683606|NCT00370682|19603551|P2|Overall Study|Lost to Follow-up|1
5683607|NCT00370682|19603552|P1|Overall Study|Lost to Follow-up|0
5683608|NCT00370682|19603550|P3|Overall Study|Moved from area|0
5683609|NCT00370682|19603551|P2|Overall Study|Moved from area|2
5683610|NCT00370682|19603552|P1|Overall Study|Moved from area|0
5683611|NCT00370552|19603594|P3|Overall Study|Planned radiation for palliation|0
5683612|NCT00370552|19603595|P2|Overall Study|Planned radiation for palliation|1
5683613|NCT00370552|19603596|P1|Overall Study|Planned radiation for palliation|0
5683614|NCT00370552|19603594|P3|Overall Study|High risk of allergic reaction|0
5683615|NCT00370552|19603595|P2|Overall Study|High risk of allergic reaction|1
5683616|NCT00370552|19603596|P1|Overall Study|High risk of allergic reaction|0
5683617|NCT00370552|19603594|P3|Overall Study|Investigator decision|0
5683618|NCT00370552|19603595|P2|Overall Study|Investigator decision|1
5683619|NCT00370552|19603596|P1|Overall Study|Investigator decision|2
5683620|NCT00370552|19603594|P3|Overall Study|Physician Decision|0
5683621|NCT00370552|19603595|P2|Overall Study|Physician Decision|1
5683622|NCT00370552|19603596|P1|Overall Study|Physician Decision|1
5683623|NCT00370552|19603594|P3|Overall Study|Never treated|0
5683624|NCT00370552|19603595|P2|Overall Study|Never treated|0
5683625|NCT00370552|19603596|P1|Overall Study|Never treated|1
5683626|NCT00370552|19603594|P3|Overall Study|Still on treatment|2
5683627|NCT00370552|19603595|P2|Overall Study|Still on treatment|3
5683628|NCT00370552|19603596|P1|Overall Study|Still on treatment|1
5683629|NCT00370552|19603594|P3|Overall Study|Withdrawal by Subject|1
5683630|NCT00370552|19603595|P2|Overall Study|Withdrawal by Subject|0
5683631|NCT00370552|19603596|P1|Overall Study|Withdrawal by Subject|2
5683632|NCT00370552|19603594|P3|Overall Study|Study drug toxicity|6
5683633|NCT00370552|19603595|P2|Overall Study|Study drug toxicity|8
5683634|NCT00370552|19603596|P1|Overall Study|Study drug toxicity|11
5683635|NCT00370552|19603594|P3|Overall Study|Poor or noncompliance|1
5683636|NCT00370552|19603595|P2|Overall Study|Poor or noncompliance|0
5683637|NCT00370552|19603596|P1|Overall Study|Poor or noncompliance|0
5683638|NCT00370552|19603594|P3|Overall Study|Maximum clinical benefit|5
5683639|NCT00370552|19603595|P2|Overall Study|Maximum clinical benefit|5
5683640|NCT00370552|19603596|P1|Overall Study|Maximum clinical benefit|3
5683641|NCT00370552|19603594|P3|Overall Study|Disease progression|15
5683642|NCT00370552|19603595|P2|Overall Study|Disease progression|23
5683643|NCT00370552|19603596|P1|Overall Study|Disease progression|23
5683644|NCT00370552|19603594|P3|Overall Study|Adverse Event|2
5683645|NCT00370552|19603595|P2|Overall Study|Adverse Event|2
5683646|NCT00370552|19603596|P1|Overall Study|Adverse Event|2
5683647|NCT00370396|19603637|P3|Overall Study|Lost to Follow-up|0
5683648|NCT00370396|19603638|P2|Overall Study|Lost to Follow-up|1
5683649|NCT00370396|19603639|P1|Overall Study|Lost to Follow-up|11
5683650|NCT00370396|19603637|P3|Overall Study|Withdrawal by Subject|1
5683651|NCT00370396|19603638|P2|Overall Study|Withdrawal by Subject|0
5683652|NCT00370396|19603639|P1|Overall Study|Withdrawal by Subject|0
5683653|NCT00370331|19603693|P2|Overall Study|Protocol Violation|1
5683654|NCT00370331|19603694|P1|Overall Study|Protocol Violation|1
5683655|NCT00370331|19603693|P2|Overall Study|Non-compliance|1
5683656|NCT00370331|19603694|P1|Overall Study|Non-compliance|0
5683657|NCT00370331|19603693|P2|Overall Study|Lack of Efficacy|1
5683658|NCT00370331|19603694|P1|Overall Study|Lack of Efficacy|0
5683659|NCT00370331|19603693|P2|Overall Study|Lost to Follow-up|3
5683660|NCT00370331|19603694|P1|Overall Study|Lost to Follow-up|0
5683661|NCT00370331|19603693|P2|Overall Study|Withdrawal by Subject|4
5683662|NCT00370331|19603694|P1|Overall Study|Withdrawal by Subject|2
5683663|NCT00370331|19603693|P2|Overall Study|Adverse Event|13
5683664|NCT00370331|19603694|P1|Overall Study|Adverse Event|4
5683665|NCT00370292|19603720|P1|Overall Study|Physician Decision|2
5683666|NCT00370292|19603720|P1|Overall Study|Adverse Event|7
5683667|NCT00370292|19603720|P1|Overall Study|Disease Progression|4
5683668|NCT00370149|19603733|P2|Overall Study|Antibiotic coated dressing placed|1
5683669|NCT00370149|19603734|P1|Overall Study|Antibiotic coated dressing placed|0
5683670|NCT00370149|19603733|P2|Overall Study|Pre-existing infection|1
5683671|NCT00370149|19603734|P1|Overall Study|Pre-existing infection|0
5683672|NCT00370149|19603733|P2|Overall Study|Catheter inserted in wrong vessel-|1
5683673|NCT00370149|19603734|P1|Overall Study|Catheter inserted in wrong vessel-|2
5683674|NCT00370149|19603733|P2|Overall Study|Protocol Violation|0
5683675|NCT00370149|19603734|P1|Overall Study|Protocol Violation|1
5683676|NCT00370149|19603733|P2|Overall Study|Physician Decision|16
5683677|NCT00370149|19603734|P1|Overall Study|Physician Decision|16
5683678|NCT00370071|19603744|P1|Overall Study|Withdrawal by Subject|2
5683679|NCT00370032|19603761|P2|Follow-up Period|Withdrawal by Subject|0
5683680|NCT00370032|19603762|P1|Follow-up Period|Withdrawal by Subject|1
5683681|NCT00370032|19603761|P2|Washout Period|Adverse Event|0
5683682|NCT00370032|19603762|P1|Washout Period|Adverse Event|1
5683683|NCT00370032|19603761|P2|Washout Period|Lost to Follow-up|1
5683684|NCT00370032|19603762|P1|Washout Period|Lost to Follow-up|0
5683685|NCT00370032|19603761|P2|Washout Period|Withdrawal by Subject|1
5683686|NCT00370032|19603762|P1|Washout Period|Withdrawal by Subject|0
5683687|NCT00370032|19603761|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
5683688|NCT00370032|19603762|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
5683689|NCT00369967|19603782|P2|Overall Study|Lost to Follow-up|12
5683690|NCT00369967|19603783|P1|Overall Study|Lost to Follow-up|23
5683691|NCT00369941|19603801|P2|Overall Study|Miscellaneous|3
5683692|NCT00369941|19603802|P1|Overall Study|Miscellaneous|3
5683693|NCT00369941|19603801|P2|Overall Study|Study Site Terminated|0
5683694|NCT00369941|19603802|P1|Overall Study|Study Site Terminated|2
5683695|NCT00369941|19603801|P2|Overall Study|Employment Interfered with Study Visits|0
5683696|NCT00369941|19603802|P1|Overall Study|Employment Interfered with Study Visits|1
5683697|NCT00369941|19603801|P2|Overall Study|Treatment with Prohibited Medication|1
5683698|NCT00369941|19603802|P1|Overall Study|Treatment with Prohibited Medication|3
5683699|NCT00369941|19603801|P2|Overall Study|Moved|5
5683700|NCT00369941|19603802|P1|Overall Study|Moved|11
5683701|NCT00369941|19603801|P2|Overall Study|Completed, Did Not Enter Extension|6
5683702|NCT00369941|19603802|P1|Overall Study|Completed, Did Not Enter Extension|5
5683703|NCT00369941|19603801|P2|Overall Study|Pregnancy|2
5683704|NCT00369941|19603802|P1|Overall Study|Pregnancy|4
5683705|NCT00369941|19603801|P2|Overall Study|Withdrawal by Subject|18
5683706|NCT00369941|19603802|P1|Overall Study|Withdrawal by Subject|5
5683707|NCT00369941|19603801|P2|Overall Study|Protocol Violation|3
5683708|NCT00369941|19603802|P1|Overall Study|Protocol Violation|5
5683709|NCT00369941|19603801|P2|Overall Study|Lost to Follow-up|22
5683710|NCT00369941|19603802|P1|Overall Study|Lost to Follow-up|12
5683711|NCT00369941|19603801|P2|Overall Study|Lack of Efficacy|10
5683712|NCT00369941|19603802|P1|Overall Study|Lack of Efficacy|6
5683713|NCT00369941|19603801|P2|Overall Study|Adverse Event|28
5683714|NCT00369941|19603802|P1|Overall Study|Adverse Event|14
5683715|NCT00369941|19603801|P2|Overall Study|Never Treated|2
5683716|NCT00369941|19603802|P1|Overall Study|Never Treated|1
5683717|NCT00369915|19603967|P2|Overall Study|W/drawl by investigators|1
5683718|NCT00369915|19603968|P1|Overall Study|W/drawl by investigators|0
5683719|NCT00369915|19603967|P2|Overall Study|Withdrawal by Subject|1
5683720|NCT00369915|19603968|P1|Overall Study|Withdrawal by Subject|4
5683721|NCT00369915|19603967|P2|Overall Study|expected side effects|1
5683722|NCT00369915|19603968|P1|Overall Study|expected side effects|2
5683723|NCT00369824|19603982|P6|Overall Study|Other|3
5683724|NCT00369824|19603983|P5|Overall Study|Other|1
5683725|NCT00369824|19603984|P4|Overall Study|Other|2
5683726|NCT00369824|19603985|P3|Overall Study|Other|0
5683727|NCT00369824|19603986|P2|Overall Study|Other|0
5683728|NCT00369824|19603987|P1|Overall Study|Other|0
5683729|NCT00369824|19603982|P6|Overall Study|Lost to Follow-up|6
5683730|NCT00369824|19603983|P5|Overall Study|Lost to Follow-up|9
5683731|NCT00369824|19603984|P4|Overall Study|Lost to Follow-up|8
5683732|NCT00369824|19603985|P3|Overall Study|Lost to Follow-up|7
5683733|NCT00369824|19603986|P2|Overall Study|Lost to Follow-up|11
5683734|NCT00369824|19603987|P1|Overall Study|Lost to Follow-up|6
5683735|NCT00369824|19603982|P6|Overall Study|Withdrawal by Subject|2
5683736|NCT00369824|19603983|P5|Overall Study|Withdrawal by Subject|6
5683737|NCT00369824|19603984|P4|Overall Study|Withdrawal by Subject|4
5683738|NCT00369824|19603985|P3|Overall Study|Withdrawal by Subject|5
5683739|NCT00369824|19603986|P2|Overall Study|Withdrawal by Subject|5
5683740|NCT00369824|19603987|P1|Overall Study|Withdrawal by Subject|9
5683741|NCT00369824|19603982|P6|Overall Study|Protocol Violation|0
5683742|NCT00369824|19603983|P5|Overall Study|Protocol Violation|1
5683743|NCT00369824|19603984|P4|Overall Study|Protocol Violation|1
5683744|NCT00369824|19603985|P3|Overall Study|Protocol Violation|0
5683745|NCT00369824|19603986|P2|Overall Study|Protocol Violation|1
5683746|NCT00369824|19603987|P1|Overall Study|Protocol Violation|0
5683747|NCT00369824|19603982|P6|Overall Study|Adverse Event|0
5683748|NCT00369824|19603983|P5|Overall Study|Adverse Event|1
5683749|NCT00369824|19603984|P4|Overall Study|Adverse Event|0
5683750|NCT00369824|19603985|P3|Overall Study|Adverse Event|0
5683751|NCT00369824|19603986|P2|Overall Study|Adverse Event|2
5683752|NCT00369824|19603987|P1|Overall Study|Adverse Event|0
5683753|NCT00369785|19604087|P2|Overall Study|Multiple reasons|5
5683754|NCT00369785|19604088|P1|Overall Study|Multiple reasons|6
5683755|NCT00369785|19604087|P2|Overall Study|Progression|4
5683756|NCT00369785|19604088|P1|Overall Study|Progression|4
5683757|NCT00369785|19604087|P2|Overall Study|Never started|2
5683758|NCT00369785|19604088|P1|Overall Study|Never started|0
5683759|NCT00369785|19604087|P2|Overall Study|Toxicity|4
5683760|NCT00369785|19604088|P1|Overall Study|Toxicity|6
5683761|NCT00369785|19604087|P2|Overall Study|Withdrawal by Subject|6
5683762|NCT00369785|19604088|P1|Overall Study|Withdrawal by Subject|7
5683763|NCT00369785|19604087|P2|Overall Study|Death|2
5683764|NCT00369785|19604088|P1|Overall Study|Death|1
5683765|NCT00369785|19604087|P2|Overall Study|Physician Decision|2
5683766|NCT00369785|19604088|P1|Overall Study|Physician Decision|3
5683767|NCT00369707|19604109|P1|Follow up for 2 Years After Treatment|Other|2
5683768|NCT00369707|19604109|P1|Follow up for 2 Years After Treatment|Death|1
5683769|NCT00369707|19604109|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
5683770|NCT00369707|19604109|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
5683771|NCT00369707|19604109|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
5683772|NCT00369707|19604109|P1|Induction Part B (2 Cycles)|Progressive disease|1
5683773|NCT00369707|19604109|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
5683774|NCT00369707|19604109|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
5683775|NCT00369707|19604109|P1|Induction Part B (2 Cycles)|Adverse Event|3
5683776|NCT00369681|19604122|P1|Overall Study|Death|1
5683777|NCT00369668|19604132|P3|Overall Study|Lack of Efficacy|7
5683778|NCT00369668|19604133|P2|Overall Study|Lack of Efficacy|5
5683779|NCT00369668|19604134|P1|Overall Study|Lack of Efficacy|4
5683780|NCT00369655|19604148|P1|Overall Study|Refusal of further treatment|2
5683781|NCT00369629|19604157|P4|Follow up for 1 Year|stopped being followed as study closed|0
5683782|NCT00369629|19604158|P3|Follow up for 1 Year|stopped being followed as study closed|2
5683783|NCT00369629|19604159|P2|Follow up for 1 Year|stopped being followed as study closed|0
5683784|NCT00369629|19604160|P1|Follow up for 1 Year|stopped being followed as study closed|0
5683785|NCT00369629|19604157|P4|Follow up for 1 Year|Lost to Follow-up|0
5683786|NCT00369629|19604158|P3|Follow up for 1 Year|Lost to Follow-up|0
5683787|NCT00369629|19604159|P2|Follow up for 1 Year|Lost to Follow-up|1
5683788|NCT00369629|19604160|P1|Follow up for 1 Year|Lost to Follow-up|0
5683789|NCT00369629|19604157|P4|Follow up for 1 Year|Death|0
5683790|NCT00369629|19604158|P3|Follow up for 1 Year|Death|1
5683791|NCT00369629|19604159|P2|Follow up for 1 Year|Death|1
5683792|NCT00369629|19604160|P1|Follow up for 1 Year|Death|2
5683793|NCT00369629|19604157|P4|Completed 4 More Cycles|Progressive disease|0
5683794|NCT00369629|19604158|P3|Completed 4 More Cycles|Progressive disease|2
5683795|NCT00369629|19604159|P2|Completed 4 More Cycles|Progressive disease|1
5683796|NCT00369629|19604160|P1|Completed 4 More Cycles|Progressive disease|2
5683797|NCT00369629|19604157|P4|Completed 4 More Cycles|Withdrawal by Subject|0
5683798|NCT00369629|19604158|P3|Completed 4 More Cycles|Withdrawal by Subject|0
5683799|NCT00369629|19604159|P2|Completed 4 More Cycles|Withdrawal by Subject|1
5683800|NCT00369629|19604160|P1|Completed 4 More Cycles|Withdrawal by Subject|2
5683801|NCT00369629|19604157|P4|Moved on to 4 More Cycles|Progressive Disease|0
5683802|NCT00369629|19604158|P3|Moved on to 4 More Cycles|Progressive Disease|1
5683803|NCT00369629|19604159|P2|Moved on to 4 More Cycles|Progressive Disease|0
5683804|NCT00369629|19604160|P1|Moved on to 4 More Cycles|Progressive Disease|0
5683805|NCT00369629|19604157|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
5683806|NCT00369629|19604158|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
5683807|NCT00369629|19604159|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
5683808|NCT00369629|19604160|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
5683809|NCT00369629|19604157|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
5683810|NCT00369629|19604158|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
5683811|NCT00369629|19604159|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
5683812|NCT00369629|19604160|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
5683813|NCT00369629|19604157|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
5683814|NCT00369629|19604158|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
5683815|NCT00369629|19604159|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
5683816|NCT00369629|19604160|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
5683817|NCT00369577|19604191|P3|Overall Study|Withdrawal by Subject|1
5683818|NCT00369577|19604192|P2|Overall Study|Withdrawal by Subject|0
5683819|NCT00369577|19604193|P1|Overall Study|Withdrawal by Subject|0
5683820|NCT00369486|19604230|P5|34-Week Visit|Dropped|3
5683821|NCT00369486|19604231|P4|34-Week Visit|Dropped|3
5683822|NCT00369486|19604232|P3|34-Week Visit|Dropped|1
5683823|NCT00369486|19604233|P2|34-Week Visit|Dropped|1
5683824|NCT00369486|19604234|P1|34-Week Visit|Dropped|0
5683825|NCT00369486|19604230|P5|17-Week Visit|Missed visit|1
5683826|NCT00369486|19604231|P4|17-Week Visit|Missed visit|1
5683827|NCT00369486|19604232|P3|17-Week Visit|Missed visit|1
5683828|NCT00369486|19604233|P2|17-Week Visit|Missed visit|0
5683829|NCT00369486|19604234|P1|17-Week Visit|Missed visit|0
5683830|NCT00369486|19604230|P5|8-Week Visit|Dropped|0
5683831|NCT00369486|19604231|P4|8-Week Visit|Dropped|1
5683832|NCT00369486|19604232|P3|8-Week Visit|Dropped|0
5683833|NCT00369486|19604233|P2|8-Week Visit|Dropped|0
5683834|NCT00369486|19604234|P1|8-Week Visit|Dropped|0
5683835|NCT00369486|19604230|P5|8-Week Visit|Missed visit|1
5683836|NCT00369486|19604231|P4|8-Week Visit|Missed visit|0
5683837|NCT00369486|19604232|P3|8-Week Visit|Missed visit|0
5683838|NCT00369486|19604233|P2|8-Week Visit|Missed visit|1
5683839|NCT00369486|19604234|P1|8-Week Visit|Missed visit|0
5683840|NCT00369486|19604230|P5|4-Week Visit|Dropped|0
5683841|NCT00369486|19604231|P4|4-Week Visit|Dropped|0
5683842|NCT00369486|19604232|P3|4-Week Visit|Dropped|1
5683843|NCT00369486|19604233|P2|4-Week Visit|Dropped|0
5683844|NCT00369486|19604234|P1|4-Week Visit|Dropped|0
5683845|NCT00369486|19604230|P5|4-Week Visit|Missed visit|1
5683846|NCT00369486|19604231|P4|4-Week Visit|Missed visit|2
5683847|NCT00369486|19604232|P3|4-Week Visit|Missed visit|0
5683848|NCT00369486|19604233|P2|4-Week Visit|Missed visit|2
5683849|NCT00369486|19604234|P1|4-Week Visit|Missed visit|2
5683850|NCT00369382|19604273|P2|Overall Study|Other|0
5683851|NCT00369382|19604274|P1|Overall Study|Other|1
5683852|NCT00369382|19604273|P2|Overall Study|Randomized, not treated|0
5683853|NCT00369382|19604274|P1|Overall Study|Randomized, not treated|2
5683854|NCT00369382|19604273|P2|Overall Study|Withdrawal by Subject|0
5683855|NCT00369382|19604274|P1|Overall Study|Withdrawal by Subject|5
5683856|NCT00369382|19604273|P2|Overall Study|Physician Decision|1
5683857|NCT00369382|19604274|P1|Overall Study|Physician Decision|2
5683858|NCT00369382|19604273|P2|Overall Study|Death|2
5683859|NCT00369382|19604274|P1|Overall Study|Death|0
5683860|NCT00369343|19604307|P2|Open-label Phase|did not take study drug|2
5683861|NCT00369343|19604308|P1|Open-label Phase|did not take study drug|1
5683862|NCT00369343|19604307|P2|Open-label Phase|Lack of continuance tolerability|4
5683863|NCT00369343|19604308|P1|Open-label Phase|Lack of continuance tolerability|3
5683864|NCT00369343|19604307|P2|Open-label Phase|Lack of Efficacy|3
5683865|NCT00369343|19604308|P1|Open-label Phase|Lack of Efficacy|4
5683866|NCT00369343|19604307|P2|Open-label Phase|Withdrawal by Subject|6
5683867|NCT00369343|19604308|P1|Open-label Phase|Withdrawal by Subject|15
5683868|NCT00369343|19604307|P2|Open-label Phase|Protocol Violation|3
5683869|NCT00369343|19604308|P1|Open-label Phase|Protocol Violation|1
5683870|NCT00369343|19604307|P2|Open-label Phase|inadvertently reported study completers|2
5683871|NCT00369343|19604308|P1|Open-label Phase|inadvertently reported study completers|3
5683872|NCT00369343|19604307|P2|Open-label Phase|Lost to Follow-up|3
5683873|NCT00369343|19604308|P1|Open-label Phase|Lost to Follow-up|5
5683874|NCT00369343|19604307|P2|Open-label Phase|Physician Decision|0
5683875|NCT00369343|19604308|P1|Open-label Phase|Physician Decision|2
5683876|NCT00369343|19604307|P2|Open-label Phase|Failed to return|0
5683877|NCT00369343|19604308|P1|Open-label Phase|Failed to return|4
5683878|NCT00369343|19604307|P2|Open-label Phase|Adverse Event|7
5683879|NCT00369343|19604308|P1|Open-label Phase|Adverse Event|19
5683880|NCT00369343|19604307|P2|Double-blind Phase|Protocol deviation|0
5683881|NCT00369343|19604308|P1|Double-blind Phase|Protocol deviation|4
5683882|NCT00369343|19604307|P2|Double-blind Phase|Lack of Efficacy|4
5683883|NCT00369343|19604308|P1|Double-blind Phase|Lack of Efficacy|0
5683884|NCT00369343|19604307|P2|Double-blind Phase|Withdrawal by Subject|6
5683885|NCT00369343|19604308|P1|Double-blind Phase|Withdrawal by Subject|8
5683886|NCT00369343|19604307|P2|Double-blind Phase|Protocol Violation|0
5683887|NCT00369343|19604308|P1|Double-blind Phase|Protocol Violation|2
5683888|NCT00369343|19604307|P2|Double-blind Phase|Lost to Follow-up|2
5683889|NCT00369343|19604308|P1|Double-blind Phase|Lost to Follow-up|9
5683890|NCT00369343|19604307|P2|Double-blind Phase|Failed to return|0
5683891|NCT00369343|19604308|P1|Double-blind Phase|Failed to return|2
5683892|NCT00369343|19604307|P2|Double-blind Phase|Adverse Event|4
5683893|NCT00369343|19604308|P1|Double-blind Phase|Adverse Event|19
5683894|NCT00369317|19604341|P1|Overall Study|Ineligible|1
5683895|NCT00369317|19604341|P1|Overall Study|Withdrawal by Subject|8
5683896|NCT00369317|19604341|P1|Overall Study|Physician Decision|2
5683897|NCT00369317|19604341|P1|Overall Study|Lack of Efficacy|5
5683898|NCT00369317|19604341|P1|Overall Study|Death|1
5683899|NCT00369317|19604341|P1|Overall Study|Adverse Event|3
5683900|NCT00369278|19604357|P2|Overall Study|Graft loss|2
5683901|NCT00369278|19604358|P1|Overall Study|Graft loss|1
5683902|NCT00369278|19604357|P2|Overall Study|Lost to Follow-up|0
5683903|NCT00369278|19604358|P1|Overall Study|Lost to Follow-up|1
5683904|NCT00369278|19604357|P2|Overall Study|Withdrawal by Subject|2
5683905|NCT00369278|19604358|P1|Overall Study|Withdrawal by Subject|2
5683906|NCT00369278|19604357|P2|Overall Study|Protocol Violation|1
5683907|NCT00369278|19604358|P1|Overall Study|Protocol Violation|2
5683908|NCT00369278|19604357|P2|Overall Study|Unsatisfactory therapeutic effect|5
5683909|NCT00369278|19604358|P1|Overall Study|Unsatisfactory therapeutic effect|4
5683910|NCT00369278|19604357|P2|Overall Study|Adverse Event|11
5683911|NCT00369278|19604358|P1|Overall Study|Adverse Event|14
5683912|NCT00369265|19604374|P2|Overall Study|Study terminated|7
5683913|NCT00369265|19604375|P1|Overall Study|Study terminated|4
5683914|NCT00369161|19604396|P2|Overall Study|Administrative Problem|2
5683915|NCT00369161|19604397|P1|Overall Study|Administrative Problem|2
5683916|NCT00369161|19604396|P2|Overall Study|Graft loss|0
5683917|NCT00369161|19604397|P1|Overall Study|Graft loss|4
5683918|NCT00369161|19604396|P2|Overall Study|Death|2
5683919|NCT00369161|19604397|P1|Overall Study|Death|1
5683920|NCT00369161|19604396|P2|Overall Study|Withdrawal by Subject|3
5683921|NCT00369161|19604397|P1|Overall Study|Withdrawal by Subject|2
5683922|NCT00369161|19604396|P2|Overall Study|Protocol Violation|2
5683923|NCT00369161|19604397|P1|Overall Study|Protocol Violation|0
5683924|NCT00369161|19604396|P2|Overall Study|Lack of Efficacy|1
5683925|NCT00369161|19604397|P1|Overall Study|Lack of Efficacy|3
5683926|NCT00369161|19604396|P2|Overall Study|Abnormal laboratory value|1
5683927|NCT00369161|19604397|P1|Overall Study|Abnormal laboratory value|0
5683928|NCT00369161|19604396|P2|Overall Study|Adverse Event|13
5683929|NCT00369161|19604397|P1|Overall Study|Adverse Event|15
5683930|NCT00369122|19604407|P1|Overall Study|No protocol treatment|1
5683931|NCT00369122|19604407|P1|Overall Study|Ineligible|10
5683932|NCT00368992|19604414|P1|Overall Study|Other|9
5683933|NCT00368992|19604414|P1|Overall Study|Death|4
5683934|NCT00368992|19604414|P1|Overall Study|Adverse Event|26
5683935|NCT00368992|19604414|P1|Overall Study|Lack of Efficacy|63
5683936|NCT00368992|19604414|P1|Overall Study|Refused treatment|3
5683937|NCT00368992|19604414|P1|Overall Study|Ineligible|5
5683938|NCT00368979|19604423|P2|Overall Study|Withdrawal by Subject|9
5683939|NCT00368979|19604424|P1|Overall Study|Withdrawal by Subject|5
5683940|NCT00368979|19604423|P2|Overall Study|Protocol Violation|1
5683941|NCT00368979|19604424|P1|Overall Study|Protocol Violation|2
5683942|NCT00368979|19604423|P2|Overall Study|Lost to Follow-up|0
5683943|NCT00368979|19604424|P1|Overall Study|Lost to Follow-up|1
5683944|NCT00368979|19604423|P2|Overall Study|Other|1
5683945|NCT00368979|19604424|P1|Overall Study|Other|3
5683946|NCT00368979|19604423|P2|Overall Study|Lack of Efficacy|3
5683947|NCT00368979|19604424|P1|Overall Study|Lack of Efficacy|5
5683948|NCT00368979|19604423|P2|Overall Study|Adverse Event|16
5683949|NCT00368979|19604424|P1|Overall Study|Adverse Event|9
5683950|NCT00368966|19604440|P2|Toddler Dose|Lost to Follow-up|2
5683951|NCT00368966|19604441|P1|Toddler Dose|Lost to Follow-up|0
5683952|NCT00368966|19604440|P2|Toddler Dose|Withdrawal by Subject|1
5683953|NCT00368966|19604441|P1|Toddler Dose|Withdrawal by Subject|1
5683954|NCT00368966|19604440|P2|After Infant|Lost to Follow-up|1
5683955|NCT00368966|19604441|P1|After Infant|Lost to Follow-up|0
5683956|NCT00368966|19604440|P2|After Infant|Death|0
5683957|NCT00368966|19604441|P1|After Infant|Death|1
5683958|NCT00368966|19604440|P2|After Infant|Withdrawal by Subject|1
5683959|NCT00368966|19604441|P1|After Infant|Withdrawal by Subject|1
5683960|NCT00368966|19604440|P2|After Infant|Adverse Event|2
5683961|NCT00368966|19604441|P1|After Infant|Adverse Event|1
5683962|NCT00368966|19604440|P2|After Infant|Failed to return|1
5683963|NCT00368966|19604441|P1|After Infant|Failed to return|3
5683964|NCT00368966|19604440|P2|Infant Series|Failed to return|0
5683965|NCT00368966|19604441|P1|Infant Series|Failed to return|1
5683966|NCT00368966|19604440|P2|Infant Series|Adverse Event|1
5683967|NCT00368966|19604441|P1|Infant Series|Adverse Event|0
5683968|NCT00368966|19604440|P2|Infant Series|Failed to meet eligibility criteria|1
5683969|NCT00368966|19604441|P1|Infant Series|Failed to meet eligibility criteria|0
5683970|NCT00368966|19604440|P2|Infant Series|Randomization error|1
5683971|NCT00368966|19604441|P1|Infant Series|Randomization error|0
5683972|NCT00368966|19604440|P2|Infant Series|Lost to Follow-up|0
5683973|NCT00368966|19604441|P1|Infant Series|Lost to Follow-up|2
5683974|NCT00368966|19604440|P2|Infant Series|Protocol Violation|1
5683975|NCT00368966|19604441|P1|Infant Series|Protocol Violation|2
5683976|NCT00368966|19604440|P2|Infant Series|Withdrawal by Subject|6
5683977|NCT00368966|19604441|P1|Infant Series|Withdrawal by Subject|11
5683978|NCT00368927|19604512|P2|Overall Study|Physician Decision|0
5683979|NCT00368927|19604513|P1|Overall Study|Physician Decision|1
5683980|NCT00368927|19604512|P2|Overall Study|Withdrawal by Subject|2
5683981|NCT00368927|19604513|P1|Overall Study|Withdrawal by Subject|1
5683982|NCT00368927|19604512|P2|Overall Study|Adverse Event|1
5683983|NCT00368927|19604513|P1|Overall Study|Adverse Event|1
5683984|NCT00368927|19604512|P2|Overall Study|Lost to Follow-up|0
5683985|NCT00368927|19604513|P1|Overall Study|Lost to Follow-up|2
5683986|NCT00368875|19604521|P2|Overall Study|Alternative Therapy|1
5683987|NCT00368875|19604522|P1|Overall Study|Alternative Therapy|1
5683988|NCT00368875|19604521|P2|Overall Study|Other Reason|2
5683989|NCT00368875|19604522|P1|Overall Study|Other Reason|0
5683990|NCT00368875|19604521|P2|Overall Study|Withdrawal by Subject|6
5683991|NCT00368875|19604522|P1|Overall Study|Withdrawal by Subject|2
5683992|NCT00368875|19604521|P2|Overall Study|Progressive disease|27
5683993|NCT00368875|19604522|P1|Overall Study|Progressive disease|3
5683994|NCT00368875|19604521|P2|Overall Study|Adverse Event|12
5683995|NCT00368875|19604522|P1|Overall Study|Adverse Event|0
5683996|NCT00368849|19604530|P2|Overall Study|Physician Decision|1
5683997|NCT00368849|19604531|P1|Overall Study|Physician Decision|0
5683998|NCT00368849|19604530|P2|Overall Study|Withdrawal by Subject|1
5683999|NCT00368849|19604531|P1|Overall Study|Withdrawal by Subject|0
5684000|NCT00368745|19604547|P2|Double-blind Treatment Period|Other|6
5684001|NCT00368745|19604548|P1|Double-blind Treatment Period|Other|7
5684002|NCT00368745|19604547|P2|Double-blind Treatment Period|Withdrawal by Subject|3
5684003|NCT00368745|19604548|P1|Double-blind Treatment Period|Withdrawal by Subject|5
5684004|NCT00368745|19604547|P2|Double-blind Treatment Period|Lost to Follow-up|0
5684005|NCT00368745|19604548|P1|Double-blind Treatment Period|Lost to Follow-up|1
5684006|NCT00368745|19604547|P2|Double-blind Treatment Period|Lack of Efficacy|16
5684007|NCT00368745|19604548|P1|Double-blind Treatment Period|Lack of Efficacy|7
5684008|NCT00368745|19604547|P2|Double-blind Treatment Period|Adverse Event|6
5684009|NCT00368745|19604548|P1|Double-blind Treatment Period|Adverse Event|6
5684010|NCT00368641|19604601|P2|Overall Study|Sponsor decision to terminate study|5
5684011|NCT00368641|19604602|P1|Overall Study|Sponsor decision to terminate study|2
5684012|NCT00368641|19604601|P2|Overall Study|Withdrawal by Subject|0
5684013|NCT00368641|19604602|P1|Overall Study|Withdrawal by Subject|1
5684014|NCT00368641|19604601|P2|Overall Study|Death|0
5684015|NCT00368641|19604602|P1|Overall Study|Death|1
5684016|NCT00368641|19604601|P2|Overall Study|Adverse Event|1
5684017|NCT00368641|19604602|P1|Overall Study|Adverse Event|2
5684018|NCT00368550|19604610|P2|Overall Study|Withdrawal by Subject|10
5684019|NCT00368550|19604611|P1|Overall Study|Withdrawal by Subject|17
5684020|NCT00368550|19604610|P2|Overall Study|Lack of Efficacy|9
5684021|NCT00368550|19604611|P1|Overall Study|Lack of Efficacy|4
5684022|NCT00368550|19604610|P2|Overall Study|Adverse Event|4
5684023|NCT00368550|19604611|P1|Overall Study|Adverse Event|7
5684024|NCT00368537|19604623|P2|Baseline Participants|Patient uncompliant|1
5684025|NCT00368537|19604624|P1|Baseline Participants|Patient uncompliant|0
5684026|NCT00368537|19604623|P2|Baseline Participants|No susceptibility|0
5684027|NCT00368537|19604624|P1|Baseline Participants|No susceptibility|1
5684028|NCT00368537|19604623|P2|Baseline Participants|Death|2
5684029|NCT00368537|19604624|P1|Baseline Participants|Death|1
5684030|NCT00368537|19604623|P2|Baseline Participants|Withdrawal by Subject|4
5684031|NCT00368537|19604624|P1|Baseline Participants|Withdrawal by Subject|6
5684032|NCT00368537|19604623|P2|Baseline Participants|Lost to Follow-up|17
5684033|NCT00368537|19604624|P1|Baseline Participants|Lost to Follow-up|16
5684034|NCT00368537|19604623|P2|Randomization|No study drug dosed|6
5684035|NCT00368537|19604624|P1|Randomization|No study drug dosed|13
5684036|NCT00368472|19604638|P1|Overall Study|Missing Final Disposition Date|1
5684037|NCT00368472|19604638|P1|Overall Study|Other|32
5684038|NCT00368472|19604638|P1|Overall Study|Diary non-compliance|1
5684039|NCT00368472|19604638|P1|Overall Study|Withdrawal by Subject|40
5684040|NCT00368472|19604638|P1|Overall Study|Request of Investigator or Sponsor|3
5684041|NCT00368472|19604638|P1|Overall Study|Protocol Violation|2
5684042|NCT00368472|19604638|P1|Overall Study|Medication non-compliance|4
5684043|NCT00368472|19604638|P1|Overall Study|Adverse Event|22
5684044|NCT00368355|19604673|P2|Overall Study|Treatment - hematopoietic cell product|0
5684045|NCT00368355|19604674|P1|Overall Study|Treatment - hematopoietic cell product|2
5684046|NCT00368355|19604673|P2|Overall Study|Subsequent transplant|3
5684047|NCT00368355|19604674|P1|Overall Study|Subsequent transplant|0
5684048|NCT00368355|19604673|P2|Overall Study|Relapse|10
5684049|NCT00368355|19604674|P1|Overall Study|Relapse|6
5684050|NCT00368355|19604673|P2|Overall Study|Death|4
5684051|NCT00368355|19604674|P1|Overall Study|Death|2
5684052|NCT00368355|19604673|P2|Overall Study|Adverse Event|0
5684053|NCT00368355|19604674|P1|Overall Study|Adverse Event|1
5684054|NCT00368277|19604714|P2|Overall Study|Lost to Follow-up|6
5684055|NCT00368277|19604715|P1|Overall Study|Lost to Follow-up|8
5684056|NCT00368277|19604714|P2|Overall Study|Patient withdrew consent|28
5684057|NCT00368277|19604715|P1|Overall Study|Patient withdrew consent|32
5684058|NCT00368277|19604714|P2|Overall Study|Protocol deviation|0
5684059|NCT00368277|19604715|P1|Overall Study|Protocol deviation|7
5684060|NCT00368277|19604714|P2|Overall Study|Unsatisfactory therapeutic effect|24
5684061|NCT00368277|19604715|P1|Overall Study|Unsatisfactory therapeutic effect|31
5684062|NCT00368277|19604714|P2|Overall Study|Death|1
5684063|NCT00368277|19604715|P1|Overall Study|Death|2
5684064|NCT00368277|19604714|P2|Overall Study|Adverse Event|49
5684065|NCT00368277|19604715|P1|Overall Study|Adverse Event|33
5684066|NCT00368251|19604730|P3|Overall Study|AE, non-serious non-fatal|1
5684067|NCT00368251|19604731|P2|Overall Study|AE, non-serious non-fatal|0
5684068|NCT00368251|19604732|P1|Overall Study|AE, non-serious non-fatal|0
5684069|NCT00368251|19604730|P3|Overall Study|SAE, non-fatal|0
5684070|NCT00368251|19604731|P2|Overall Study|SAE, non-fatal|0
5684071|NCT00368251|19604732|P1|Overall Study|SAE, non-fatal|1
5684072|NCT00368108|19604755|P3|Overall Study|Other|1
5684073|NCT00368108|19604756|P2|Overall Study|Other|7
5684074|NCT00368108|19604757|P1|Overall Study|Other|3
5684075|NCT00368108|19604755|P3|Overall Study|Physician Decision|1
5684076|NCT00368108|19604756|P2|Overall Study|Physician Decision|0
5684077|NCT00368108|19604757|P1|Overall Study|Physician Decision|2
5684078|NCT00368108|19604755|P3|Overall Study|Lack of Efficacy|5
5684079|NCT00368108|19604756|P2|Overall Study|Lack of Efficacy|8
5684080|NCT00368108|19604757|P1|Overall Study|Lack of Efficacy|7
5684081|NCT00368108|19604755|P3|Overall Study|Withdrawal by Subject|5
5684082|NCT00368108|19604756|P2|Overall Study|Withdrawal by Subject|3
5684083|NCT00368108|19604757|P1|Overall Study|Withdrawal by Subject|9
5684084|NCT00368108|19604755|P3|Overall Study|Protocol Violation|9
5684085|NCT00368108|19604756|P2|Overall Study|Protocol Violation|9
5684086|NCT00368108|19604757|P1|Overall Study|Protocol Violation|5
5684087|NCT00368108|19604755|P3|Overall Study|Abnormal Laboratory Value|3
5684088|NCT00368108|19604756|P2|Overall Study|Abnormal Laboratory Value|0
5684089|NCT00368108|19604757|P1|Overall Study|Abnormal Laboratory Value|0
5684090|NCT00368108|19604755|P3|Overall Study|Adverse Event|44
5684091|NCT00368108|19604756|P2|Overall Study|Adverse Event|26
5684092|NCT00368108|19604757|P1|Overall Study|Adverse Event|38
5684093|NCT00368069|19604776|P2|Overall Study|no blood sampling possible|1
5684094|NCT00368069|19604777|P1|Overall Study|no blood sampling possible|0
5684095|NCT00368069|19604776|P2|Overall Study|Withdrawal of Consent|1
5684096|NCT00368069|19604777|P1|Overall Study|Withdrawal of Consent|2
5684097|NCT00368069|19604776|P2|Overall Study|Protocol Violation|2
5684098|NCT00368069|19604777|P1|Overall Study|Protocol Violation|0
5684099|NCT00368069|19604776|P2|Overall Study|Lost to Follow-up|0
5684100|NCT00368069|19604777|P1|Overall Study|Lost to Follow-up|1
5684101|NCT00368069|19604776|P2|Overall Study|Lack of Efficacy|1
5684102|NCT00368069|19604777|P1|Overall Study|Lack of Efficacy|0
5684103|NCT00368069|19604776|P2|Overall Study|Adverse Event|2
5684104|NCT00368069|19604777|P1|Overall Study|Adverse Event|5
5684105|NCT00367991|19604795|P2|Overall Study|Adverse Event|1
5684106|NCT00367991|19604796|P1|Overall Study|Adverse Event|1
5684107|NCT00367991|19604795|P2|Overall Study|Withdrawal by Subject|1
5684108|NCT00367991|19604796|P1|Overall Study|Withdrawal by Subject|1
5684109|NCT00367835|19604814|P2|Overall Study|History of lead poisoning|1
5684110|NCT00367835|19604815|P1|Overall Study|History of lead poisoning|0
5684111|NCT00367835|19604814|P2|Overall Study|Did not respond to calls|0
5684112|NCT00367835|19604815|P1|Overall Study|Did not respond to calls|1
5684113|NCT00367835|19604814|P2|Overall Study|refused blood collection|0
5684114|NCT00367835|19604815|P1|Overall Study|refused blood collection|1
5684115|NCT00367835|19604814|P2|Overall Study|Subject in juvenile detention center|0
5684116|NCT00367835|19604815|P1|Overall Study|Subject in juvenile detention center|1
5684117|NCT00367835|19604814|P2|Overall Study|Lack of Efficacy|12
5684118|NCT00367835|19604815|P1|Overall Study|Lack of Efficacy|3
5684119|NCT00367835|19604814|P2|Overall Study|Lost to Follow-up|4
5684120|NCT00367835|19604815|P1|Overall Study|Lost to Follow-up|1
5684121|NCT00367835|19604814|P2|Overall Study|Withdrawal by Subject|6
5684122|NCT00367835|19604815|P1|Overall Study|Withdrawal by Subject|7
5684123|NCT00367835|19604814|P2|Overall Study|Protocol Violation|7
5684124|NCT00367835|19604815|P1|Overall Study|Protocol Violation|1
5684125|NCT00367835|19604814|P2|Overall Study|Adverse Event|1
5684126|NCT00367835|19604815|P1|Overall Study|Adverse Event|14
5684127|NCT00367770|19604841|P1|Overall Study|Withdrawal by Subject|1
5684128|NCT00367770|19604841|P1|Overall Study|Adverse Event|1
5684129|NCT00367744|19604849|P2|Overall Study|Lost to Follow-up|5
5684130|NCT00367744|19604850|P1|Overall Study|Lost to Follow-up|4
5684131|NCT00367640|19604879|P4|Overall Study|Any other reason not above-mentioned|4
5684132|NCT00367640|19604880|P3|Overall Study|Any other reason not above-mentioned|3
5684133|NCT00367640|19604881|P2|Overall Study|Any other reason not above-mentioned|5
5684134|NCT00367640|19604882|P1|Overall Study|Any other reason not above-mentioned|7
5684135|NCT00367640|19604879|P4|Overall Study|Withdrawal by Subject|6
5684136|NCT00367640|19604880|P3|Overall Study|Withdrawal by Subject|8
5684137|NCT00367640|19604881|P2|Overall Study|Withdrawal by Subject|11
5684138|NCT00367640|19604882|P1|Overall Study|Withdrawal by Subject|8
5684139|NCT00367640|19604879|P4|Overall Study|Adverse Event|0
5684140|NCT00367640|19604880|P3|Overall Study|Adverse Event|8
5684141|NCT00367640|19604881|P2|Overall Study|Adverse Event|6
5684142|NCT00367640|19604882|P1|Overall Study|Adverse Event|3
5684143|NCT00367484|19604898|P1|Overall Study|Lack of Efficacy|1
5684144|NCT00367484|19604898|P1|Overall Study|The choice of the patient|1
5684145|NCT00367484|19604898|P1|Overall Study|Protocol Violation|1
5684146|NCT00367484|19604898|P1|Overall Study|Lost to Follow-up|1
5684147|NCT00367484|19604898|P1|Overall Study|Travel to USA|1
5684148|NCT00367484|19604898|P1|Overall Study|Withdrew informed consent|5
5684149|NCT00367484|19604898|P1|Overall Study|Adverse Event|7
5684150|NCT00367458|19604904|P2|First Intervention - 8 Weeks|Adverse Event|0
5684151|NCT00367458|19604905|P1|First Intervention - 8 Weeks|Adverse Event|2
5684152|NCT00367432|19604919|P2|Second Period (up to 54 Months)|Other Reason|2
5684153|NCT00367432|19604920|P1|Second Period (up to 54 Months)|Other Reason|6
5684154|NCT00367432|19604919|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
5684155|NCT00367432|19604920|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
5684156|NCT00367432|19604919|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
5684157|NCT00367432|19604920|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
5684158|NCT00367432|19604919|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
5684159|NCT00367432|19604920|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
5684160|NCT00367432|19604919|P2|Second Period (up to 54 Months)|Adverse Event|3
5684161|NCT00367432|19604920|P1|Second Period (up to 54 Months)|Adverse Event|14
5684162|NCT00367432|19604919|P2|First Period (16 Weeks)|Other Reason|0
5684163|NCT00367432|19604920|P1|First Period (16 Weeks)|Other Reason|2
5684164|NCT00367432|19604919|P2|First Period (16 Weeks)|Withdrawal by Subject|0
5684165|NCT00367432|19604920|P1|First Period (16 Weeks)|Withdrawal by Subject|6
5684166|NCT00367432|19604919|P2|First Period (16 Weeks)|Lack of Efficacy|0
5684167|NCT00367432|19604920|P1|First Period (16 Weeks)|Lack of Efficacy|24
5684168|NCT00367432|19604919|P2|First Period (16 Weeks)|Adverse Event|0
5684169|NCT00367432|19604920|P1|First Period (16 Weeks)|Adverse Event|6
5684170|NCT00367341|19604947|P2|Overall Study|Protocol Violation|0
5684171|NCT00367341|19604948|P1|Overall Study|Protocol Violation|1
5684172|NCT00367341|19604947|P2|Overall Study|Physician Decision|0
5684173|NCT00367341|19604948|P1|Overall Study|Physician Decision|1
5684174|NCT00367237|19604958|P2|Overall Study|Protocol Violation|5
5684175|NCT00367237|19604959|P1|Overall Study|Protocol Violation|2
5684176|NCT00367237|19604958|P2|Overall Study|Withdrawal by Subject|4
5684177|NCT00367237|19604959|P1|Overall Study|Withdrawal by Subject|0
5684178|NCT00367237|19604958|P2|Overall Study|Lost to Follow-up|0
5684179|NCT00367237|19604959|P1|Overall Study|Lost to Follow-up|1
5684180|NCT00367237|19604958|P2|Overall Study|Adverse Event|2
5684181|NCT00367237|19604959|P1|Overall Study|Adverse Event|7
5684182|NCT00367133|19604968|P3|2 Years|Missed visit|4
5684183|NCT00367133|19604969|P2|2 Years|Missed visit|5
5684184|NCT00367133|19604970|P1|2 Years|Missed visit|4
5684185|NCT00367133|19604968|P3|2 Years|Dropped|33
5684186|NCT00367133|19604969|P2|2 Years|Dropped|19
5684187|NCT00367133|19604970|P1|2 Years|Dropped|34
5684188|NCT00367133|19604968|P3|2 Years|Death|12
5684189|NCT00367133|19604969|P2|2 Years|Death|12
5684190|NCT00367133|19604970|P1|2 Years|Death|20
5684191|NCT00367055|19605022|P2|Overall Study|Participant Living too Far from Hospital|1
5684192|NCT00367055|19605023|P1|Overall Study|Participant Living too Far from Hospital|0
5684193|NCT00367055|19605022|P2|Overall Study|Stopping Criterion Met|1
5684194|NCT00367055|19605023|P1|Overall Study|Stopping Criterion Met|0
5684195|NCT00367055|19605022|P2|Overall Study|Protocol Violation|1
5684196|NCT00367055|19605023|P1|Overall Study|Protocol Violation|0
5684197|NCT00367055|19605022|P2|Overall Study|Lost to Follow-up|1
5684198|NCT00367055|19605023|P1|Overall Study|Lost to Follow-up|1
5684199|NCT00367055|19605022|P2|Overall Study|Lack of Efficacy|2
5684200|NCT00367055|19605023|P1|Overall Study|Lack of Efficacy|1
5684201|NCT00367055|19605022|P2|Overall Study|Patient's Willing|2
5684202|NCT00367055|19605023|P1|Overall Study|Patient's Willing|3
5684203|NCT00367055|19605022|P2|Overall Study|Adverse Event|3
5684204|NCT00367055|19605023|P1|Overall Study|Adverse Event|6
5684205|NCT00366899|19605043|P2|Toddler Dose|Protocol Violation|0
5684206|NCT00366899|19605044|P1|Toddler Dose|Protocol Violation|1
5684207|NCT00366899|19605043|P2|Toddler Dose|Withdrawal by Subject|1
5684208|NCT00366899|19605044|P1|Toddler Dose|Withdrawal by Subject|1
5684209|NCT00366899|19605043|P2|After Infant Series|Protocol Violation|0
5684210|NCT00366899|19605044|P1|After Infant Series|Protocol Violation|1
5684211|NCT00366899|19605043|P2|After Infant Series|Adverse Event|2
5684212|NCT00366899|19605044|P1|After Infant Series|Adverse Event|1
5684213|NCT00366899|19605043|P2|After Infant Series|Withdrawal by Subject|4
5684214|NCT00366899|19605044|P1|After Infant Series|Withdrawal by Subject|1
5684215|NCT00366899|19605043|P2|After Infant Series|Lost to Follow-up|3
5684216|NCT00366899|19605044|P1|After Infant Series|Lost to Follow-up|4
5684217|NCT00366899|19605043|P2|Infant Series|Randomized but not consented|0
5684218|NCT00366899|19605044|P1|Infant Series|Randomized but not consented|1
5684219|NCT00366899|19605043|P2|Infant Series|Physician Decision|0
5684220|NCT00366899|19605044|P1|Infant Series|Physician Decision|1
5684221|NCT00366899|19605043|P2|Infant Series|Adverse Event|1
5684222|NCT00366899|19605044|P1|Infant Series|Adverse Event|0
5684223|NCT00366899|19605043|P2|Infant Series|Lost to Follow-up|2
5684224|NCT00366899|19605044|P1|Infant Series|Lost to Follow-up|0
5684225|NCT00366899|19605043|P2|Infant Series|Failed to return|1
5684226|NCT00366899|19605044|P1|Infant Series|Failed to return|1
5684227|NCT00366899|19605043|P2|Infant Series|Protocol Violation|1
5684228|NCT00366899|19605044|P1|Infant Series|Protocol Violation|2
5684229|NCT00366899|19605043|P2|Infant Series|Withdrawal by Subject|7
5684230|NCT00366899|19605044|P1|Infant Series|Withdrawal by Subject|4
5684231|NCT00366678|19605104|P3|Toddler Dose|protocol deviation|0
5684232|NCT00366678|19605105|P2|Toddler Dose|protocol deviation|0
5684233|NCT00366678|19605106|P1|Toddler Dose|protocol deviation|1
5684234|NCT00366678|19605104|P3|Toddler Dose|Withdrawal by Subject|0
5684235|NCT00366678|19605105|P2|Toddler Dose|Withdrawal by Subject|0
5684236|NCT00366678|19605106|P1|Toddler Dose|Withdrawal by Subject|1
5684237|NCT00366678|19605104|P3|Toddler Dose|Failed to return|0
5684238|NCT00366678|19605105|P2|Toddler Dose|Failed to return|0
5684239|NCT00366678|19605106|P1|Toddler Dose|Failed to return|1
5684240|NCT00366678|19605104|P3|Toddler Dose|Protocol Violation|0
5684241|NCT00366678|19605105|P2|Toddler Dose|Protocol Violation|1
5684242|NCT00366678|19605106|P1|Toddler Dose|Protocol Violation|2
5684243|NCT00366678|19605104|P3|After Infant|Protocol Violation|0
5684244|NCT00366678|19605105|P2|After Infant|Protocol Violation|0
5684245|NCT00366678|19605106|P1|After Infant|Protocol Violation|1
5684246|NCT00366678|19605104|P3|After Infant|Adverse Event|0
5684247|NCT00366678|19605105|P2|After Infant|Adverse Event|0
5684248|NCT00366678|19605106|P1|After Infant|Adverse Event|1
5684249|NCT00366678|19605104|P3|After Infant|Failed to return|0
5684250|NCT00366678|19605105|P2|After Infant|Failed to return|5
5684251|NCT00366678|19605106|P1|After Infant|Failed to return|5
5684252|NCT00366678|19605104|P3|After Infant|Lost to Follow-up|0
5684253|NCT00366678|19605105|P2|After Infant|Lost to Follow-up|1
5684254|NCT00366678|19605106|P1|After Infant|Lost to Follow-up|2
5684255|NCT00366678|19605104|P3|After Infant|Withdrawal by Subject|0
5684256|NCT00366678|19605105|P2|After Infant|Withdrawal by Subject|4
5684257|NCT00366678|19605106|P1|After Infant|Withdrawal by Subject|8
5684258|NCT00366678|19605104|P3|Infant Series|Adverse Event|0
5684259|NCT00366678|19605105|P2|Infant Series|Adverse Event|0
5684260|NCT00366678|19605106|P1|Infant Series|Adverse Event|1
5684261|NCT00366678|19605104|P3|Infant Series|Failed to return|0
5684262|NCT00366678|19605105|P2|Infant Series|Failed to return|1
5684263|NCT00366678|19605106|P1|Infant Series|Failed to return|1
5684264|NCT00366678|19605104|P3|Infant Series|Protocol Violation|0
5684265|NCT00366678|19605105|P2|Infant Series|Protocol Violation|3
5684266|NCT00366678|19605106|P1|Infant Series|Protocol Violation|4
5684267|NCT00366678|19605104|P3|Infant Series|Withdrawal by Subject|0
5684268|NCT00366678|19605105|P2|Infant Series|Withdrawal by Subject|6
5684269|NCT00366678|19605106|P1|Infant Series|Withdrawal by Subject|8
5684270|NCT00366548|19605188|P2|After Infant Series|Lost to Follow-up|0
5684271|NCT00366548|19605189|P1|After Infant Series|Lost to Follow-up|1
5684272|NCT00366548|19605188|P2|After Infant Series|Adverse Event|0
5684273|NCT00366548|19605189|P1|After Infant Series|Adverse Event|2
5684274|NCT00366548|19605188|P2|After Infant Series|Withdrawal by Subject|1
5684275|NCT00366548|19605189|P1|After Infant Series|Withdrawal by Subject|3
5684276|NCT00366548|19605188|P2|Infant Series|Withdrawal by Subject|1
5684277|NCT00366548|19605189|P1|Infant Series|Withdrawal by Subject|3
5684278|NCT00366548|19605188|P2|Infant Series|Protocol Violation|1
5684279|NCT00366548|19605189|P1|Infant Series|Protocol Violation|0
5684280|NCT00366548|19605188|P2|Infant Series|Adverse Event|3
5684281|NCT00366548|19605189|P1|Infant Series|Adverse Event|1
5684282|NCT00366535|19605225|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
5684283|NCT00366535|19605226|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
5684284|NCT00366535|19605225|P2|Second Phase: 12 Weeks|Adverse Event|1
5684285|NCT00366535|19605226|P1|Second Phase: 12 Weeks|Adverse Event|1
5684286|NCT00366535|19605225|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
5684287|NCT00366535|19605226|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
5684288|NCT00366535|19605225|P2|First Phase: 12 Weeks|Adverse Event|3
5684289|NCT00366535|19605226|P1|First Phase: 12 Weeks|Adverse Event|1
5684290|NCT00366457|19605240|P1|Overall Study|never began study therapy|2
5684291|NCT00366444|19605249|P2|Overall Study|Lack of Efficacy|1
5684292|NCT00366444|19605250|P1|Overall Study|Lack of Efficacy|0
5684293|NCT00366444|19605249|P2|Overall Study|Withdrawal by Subject|1
5684294|NCT00366444|19605250|P1|Overall Study|Withdrawal by Subject|1
5684295|NCT00366340|19605278|P2|Toddler Dose|Parent/legal guardian request|1
5684296|NCT00366340|19605279|P1|Toddler Dose|Parent/legal guardian request|0
5684297|NCT00366340|19605278|P2|Toddler Dose|Failed to return|0
5684298|NCT00366340|19605279|P1|Toddler Dose|Failed to return|1
5684299|NCT00366340|19605278|P2|After the Infant Series|Lost to Follow-up|1
5684300|NCT00366340|19605279|P1|After the Infant Series|Lost to Follow-up|0
5684301|NCT00366340|19605278|P2|After the Infant Series|Adverse Event|1
5684302|NCT00366340|19605279|P1|After the Infant Series|Adverse Event|0
5684303|NCT00366340|19605278|P2|After the Infant Series|Protocol Violation|2
5684304|NCT00366340|19605279|P1|After the Infant Series|Protocol Violation|2
5684305|NCT00366340|19605278|P2|After the Infant Series|Failed to return|1
5684306|NCT00366340|19605279|P1|After the Infant Series|Failed to return|0
5684307|NCT00366340|19605278|P2|After the Infant Series|Parent/legal guardian request|1
5684308|NCT00366340|19605279|P1|After the Infant Series|Parent/legal guardian request|1
5684309|NCT00366340|19605278|P2|Infant Series|Failure to return|0
5684310|NCT00366340|19605279|P1|Infant Series|Failure to return|1
5684311|NCT00366340|19605278|P2|Infant Series|Lost to Follow-up|1
5684312|NCT00366340|19605279|P1|Infant Series|Lost to Follow-up|1
5684313|NCT00366340|19605278|P2|Infant Series|Adverse Event|2
5684314|NCT00366340|19605279|P1|Infant Series|Adverse Event|0
5684315|NCT00366340|19605278|P2|Infant Series|Withdrawal by Subject|3
5684316|NCT00366340|19605279|P1|Infant Series|Withdrawal by Subject|3
5684317|NCT00366340|19605278|P2|Infant Series|Protocol Violation|4
5684318|NCT00366340|19605279|P1|Infant Series|Protocol Violation|3
5684319|NCT00366301|19605337|P4|Overall Study|Withdrawal by Subject|1
5684320|NCT00366301|19605338|P3|Overall Study|Withdrawal by Subject|1
5684321|NCT00366301|19605339|P2|Overall Study|Withdrawal by Subject|2
5684322|NCT00366301|19605340|P1|Overall Study|Withdrawal by Subject|4
5684323|NCT00366301|19605337|P4|Overall Study|Lost to Follow-up|7
5684324|NCT00366301|19605338|P3|Overall Study|Lost to Follow-up|3
5684325|NCT00366301|19605339|P2|Overall Study|Lost to Follow-up|4
5684326|NCT00366301|19605340|P1|Overall Study|Lost to Follow-up|4
5684327|NCT00366249|19605356|P2|Overall Study|Most due to osteomylitis status|20
5684328|NCT00366249|19605357|P1|Overall Study|Most due to osteomylitis status|31
5684329|NCT00366249|19605356|P2|Overall Study|Lack of Efficacy|21
5684330|NCT00366249|19605357|P1|Overall Study|Lack of Efficacy|21
5684331|NCT00366249|19605356|P2|Overall Study|Withdrawal by Subject|4
5684332|NCT00366249|19605357|P1|Overall Study|Withdrawal by Subject|18
5684333|NCT00366249|19605356|P2|Overall Study|Protocol Violation|2
5684334|NCT00366249|19605357|P1|Overall Study|Protocol Violation|1
5684335|NCT00366249|19605356|P2|Overall Study|Lost to Follow-up|0
5684336|NCT00366249|19605357|P1|Overall Study|Lost to Follow-up|2
5684337|NCT00366249|19605356|P2|Overall Study|Physician Decision|2
5684338|NCT00366249|19605357|P1|Overall Study|Physician Decision|5
5684339|NCT00366249|19605356|P2|Overall Study|Death|1
5684340|NCT00366249|19605357|P1|Overall Study|Death|0
5684341|NCT00366249|19605356|P2|Overall Study|Adverse Event|28
5684342|NCT00366249|19605357|P1|Overall Study|Adverse Event|53
5684343|NCT00365989|19605389|P1|Overall Study|Non-compliance|1
5684344|NCT00365989|19605389|P1|Overall Study|Withdrawal by Subject|1
5684345|NCT00365976|19605397|P2|Overall Study|Withdrawal by Subject|5
5684346|NCT00365976|19605398|P1|Overall Study|Withdrawal by Subject|1
5684347|NCT00365846|19605536|P1|Overall Study|Lost to Follow-up|1
5684348|NCT00365794|19605545|P1|Overall Study|Withdrawal by Subject|2
5684349|NCT00365716|19605574|P7|Extension 2|Withdrawal by Subject|5
5684350|NCT00365716|19605575|P6|Extension 2|Withdrawal by Subject|0
5684351|NCT00365716|19605576|P5|Extension 2|Withdrawal by Subject|0
5684352|NCT00365716|19605577|P4|Extension 2|Withdrawal by Subject|0
5684353|NCT00365716|19605578|P3|Extension 2|Withdrawal by Subject|0
5684354|NCT00365716|19605579|P2|Extension 2|Withdrawal by Subject|0
5684355|NCT00365716|19605580|P1|Extension 2|Withdrawal by Subject|0
5684356|NCT00365716|19605574|P7|Extension 2|Other|3
5684357|NCT00365716|19605575|P6|Extension 2|Other|0
5684358|NCT00365716|19605576|P5|Extension 2|Other|0
5684359|NCT00365716|19605577|P4|Extension 2|Other|0
5684360|NCT00365716|19605578|P3|Extension 2|Other|0
5684361|NCT00365716|19605579|P2|Extension 2|Other|0
5684362|NCT00365716|19605580|P1|Extension 2|Other|0
5684363|NCT00365716|19605574|P7|Extension 2|Lost to Follow-up|2
5684364|NCT00365716|19605575|P6|Extension 2|Lost to Follow-up|0
5684365|NCT00365716|19605576|P5|Extension 2|Lost to Follow-up|0
5684366|NCT00365716|19605577|P4|Extension 2|Lost to Follow-up|0
5684367|NCT00365716|19605578|P3|Extension 2|Lost to Follow-up|0
5684368|NCT00365716|19605579|P2|Extension 2|Lost to Follow-up|0
5684369|NCT00365716|19605580|P1|Extension 2|Lost to Follow-up|0
5684370|NCT00365716|19605574|P7|Extension 1|Protocol Violation|0
5684371|NCT00365716|19605575|P6|Extension 1|Protocol Violation|1
5684372|NCT00365716|19605576|P5|Extension 1|Protocol Violation|0
5684373|NCT00365716|19605577|P4|Extension 1|Protocol Violation|0
5684374|NCT00365716|19605578|P3|Extension 1|Protocol Violation|0
5684375|NCT00365716|19605579|P2|Extension 1|Protocol Violation|0
5684376|NCT00365716|19605580|P1|Extension 1|Protocol Violation|0
5684377|NCT00365716|19605574|P7|Extension 1|Pregnancy|0
5684378|NCT00365716|19605575|P6|Extension 1|Pregnancy|4
5684379|NCT00365716|19605576|P5|Extension 1|Pregnancy|0
5684380|NCT00365716|19605577|P4|Extension 1|Pregnancy|0
5684381|NCT00365716|19605578|P3|Extension 1|Pregnancy|0
5684382|NCT00365716|19605579|P2|Extension 1|Pregnancy|0
5684383|NCT00365716|19605580|P1|Extension 1|Pregnancy|0
5684384|NCT00365716|19605574|P7|Extension 1|Withdrawal by Subject|0
5684385|NCT00365716|19605575|P6|Extension 1|Withdrawal by Subject|3
5684386|NCT00365716|19605576|P5|Extension 1|Withdrawal by Subject|0
5684387|NCT00365716|19605577|P4|Extension 1|Withdrawal by Subject|0
5684388|NCT00365716|19605578|P3|Extension 1|Withdrawal by Subject|0
5684389|NCT00365716|19605579|P2|Extension 1|Withdrawal by Subject|0
5684390|NCT00365716|19605580|P1|Extension 1|Withdrawal by Subject|0
5684391|NCT00365716|19605574|P7|Extension 1|Moved|0
5684392|NCT00365716|19605575|P6|Extension 1|Moved|4
5684393|NCT00365716|19605576|P5|Extension 1|Moved|0
5684394|NCT00365716|19605577|P4|Extension 1|Moved|0
5684395|NCT00365716|19605578|P3|Extension 1|Moved|0
5684396|NCT00365716|19605579|P2|Extension 1|Moved|0
5684397|NCT00365716|19605580|P1|Extension 1|Moved|0
5684398|NCT00365716|19605574|P7|Extension 1|Other|0
5684399|NCT00365716|19605575|P6|Extension 1|Other|9
5684400|NCT00365716|19605576|P5|Extension 1|Other|0
5684401|NCT00365716|19605577|P4|Extension 1|Other|0
5684402|NCT00365716|19605578|P3|Extension 1|Other|0
5684403|NCT00365716|19605579|P2|Extension 1|Other|0
5684404|NCT00365716|19605580|P1|Extension 1|Other|0
5684405|NCT00365716|19605574|P7|Extension 1|Lost to Follow-up|0
5684406|NCT00365716|19605575|P6|Extension 1|Lost to Follow-up|1
5684407|NCT00365716|19605576|P5|Extension 1|Lost to Follow-up|0
5684408|NCT00365716|19605577|P4|Extension 1|Lost to Follow-up|0
5684409|NCT00365716|19605578|P3|Extension 1|Lost to Follow-up|0
5684410|NCT00365716|19605579|P2|Extension 1|Lost to Follow-up|0
5684411|NCT00365716|19605580|P1|Extension 1|Lost to Follow-up|0
5684412|NCT00365716|19605574|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
5684413|NCT00365716|19605575|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
5684414|NCT00365716|19605576|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
5684415|NCT00365716|19605577|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
5684416|NCT00365716|19605578|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
5684417|NCT00365716|19605579|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
5684418|NCT00365716|19605580|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
5684419|NCT00365716|19605574|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5684420|NCT00365716|19605575|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5684421|NCT00365716|19605576|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5684422|NCT00365716|19605577|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5684423|NCT00365716|19605578|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
5684424|NCT00365716|19605579|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
5684425|NCT00365716|19605580|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
5684426|NCT00365716|19605574|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5684427|NCT00365716|19605575|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5684428|NCT00365716|19605576|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
5684429|NCT00365716|19605577|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5684430|NCT00365716|19605578|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5684431|NCT00365716|19605579|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
5684432|NCT00365716|19605580|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
5684433|NCT00365716|19605574|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
5684434|NCT00365716|19605575|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
5684435|NCT00365716|19605576|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
5684436|NCT00365716|19605577|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
5684437|NCT00365716|19605578|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
5684438|NCT00365716|19605579|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
5684439|NCT00365716|19605580|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
5684440|NCT00365716|19605574|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
5684441|NCT00365716|19605575|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
5684442|NCT00365716|19605576|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
5684443|NCT00365716|19605577|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
5684444|NCT00365716|19605578|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
5684445|NCT00365716|19605579|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
5684446|NCT00365716|19605580|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
5684447|NCT00365716|19605574|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
5684448|NCT00365716|19605575|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
5684449|NCT00365716|19605576|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
5684450|NCT00365716|19605577|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
5684451|NCT00365716|19605578|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
5684452|NCT00365716|19605579|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
5684453|NCT00365716|19605580|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
5684454|NCT00365716|19605574|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
5684455|NCT00365716|19605575|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
5684456|NCT00365716|19605576|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
5684457|NCT00365716|19605577|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
5684458|NCT00365716|19605578|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
5684459|NCT00365716|19605579|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
5684460|NCT00365716|19605580|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
5684461|NCT00365716|19605574|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
5684462|NCT00365716|19605575|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
5684463|NCT00365716|19605576|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
5684464|NCT00365716|19605577|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
5684465|NCT00365716|19605578|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
5684466|NCT00365716|19605579|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
5684467|NCT00365716|19605580|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
5684468|NCT00365716|19605574|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
5684469|NCT00365716|19605575|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
5684470|NCT00365716|19605576|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
5684471|NCT00365716|19605577|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
5684472|NCT00365716|19605578|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
5684473|NCT00365716|19605579|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
5684474|NCT00365716|19605580|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
5684475|NCT00365716|19605574|P7|Base Study (Day 1 to Month 7)|Other|0
5684476|NCT00365716|19605575|P6|Base Study (Day 1 to Month 7)|Other|0
5684477|NCT00365716|19605576|P5|Base Study (Day 1 to Month 7)|Other|0
5684478|NCT00365716|19605577|P4|Base Study (Day 1 to Month 7)|Other|0
5684479|NCT00365716|19605578|P3|Base Study (Day 1 to Month 7)|Other|0
5684480|NCT00365716|19605579|P2|Base Study (Day 1 to Month 7)|Other|1
5684481|NCT00365716|19605580|P1|Base Study (Day 1 to Month 7)|Other|0
5684482|NCT00365716|19605574|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
5684483|NCT00365716|19605575|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
5684484|NCT00365716|19605576|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
5684485|NCT00365716|19605577|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
5684486|NCT00365716|19605578|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
5684487|NCT00365716|19605579|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
5684488|NCT00365716|19605580|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
5684489|NCT00365716|19605574|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
5684490|NCT00365716|19605575|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
5684491|NCT00365716|19605576|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
5684492|NCT00365716|19605577|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
5684493|NCT00365716|19605578|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
5684494|NCT00365716|19605579|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
5684495|NCT00365716|19605580|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
5684496|NCT00365716|19605574|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5684497|NCT00365716|19605575|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5684498|NCT00365716|19605576|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5684499|NCT00365716|19605577|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5684500|NCT00365716|19605578|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
5684501|NCT00365716|19605579|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
5684502|NCT00365716|19605580|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
5684503|NCT00365547|19605601|P1|Overall Study|Withdrawal by Subject|1
5684504|NCT00365547|19605601|P1|Overall Study|Screen failure|1
5684505|NCT00365547|19605601|P1|Overall Study|Insurance did not cover Avastin|1
5684506|NCT00365508|19605611|P2|Overall Study|Lost to Follow-up|154
5684507|NCT00365508|19605612|P1|Overall Study|Lost to Follow-up|139
5684508|NCT00365456|19605620|P2|Trial Period III (12 Months)|Other|1
5684509|NCT00365456|19605621|P1|Trial Period III (12 Months)|Other|1
5684510|NCT00365456|19605620|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
5684511|NCT00365456|19605621|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
5684512|NCT00365456|19605620|P2|Trial Period III (12 Months)|Adverse Event|3
5684513|NCT00365456|19605621|P1|Trial Period III (12 Months)|Adverse Event|13
5684514|NCT00365456|19605620|P2|Trial Period II (12 Months)|Other|1
5684515|NCT00365456|19605621|P1|Trial Period II (12 Months)|Other|0
5684516|NCT00365456|19605620|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
5684517|NCT00365456|19605621|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
5684518|NCT00365456|19605620|P2|Trial Period II (12 Months)|Non-compliance|2
5684519|NCT00365456|19605621|P1|Trial Period II (12 Months)|Non-compliance|0
5684520|NCT00365456|19605620|P2|Trial Period II (12 Months)|Adverse Event|6
5684521|NCT00365456|19605621|P1|Trial Period II (12 Months)|Adverse Event|0
5684522|NCT00365456|19605620|P2|Trial Period I (12 Months)|Other|0
5684523|NCT00365456|19605621|P1|Trial Period I (12 Months)|Other|11
5684524|NCT00365456|19605620|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
5684525|NCT00365456|19605621|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
5684526|NCT00365456|19605620|P2|Trial Period I (12 Months)|Non-compliance|0
5684527|NCT00365456|19605621|P1|Trial Period I (12 Months)|Non-compliance|3
5684528|NCT00365456|19605620|P2|Trial Period I (12 Months)|Adverse Event|0
5684529|NCT00365456|19605621|P1|Trial Period I (12 Months)|Adverse Event|84
5684530|NCT00365378|19605648|P3|Extension|Other|31
5684531|NCT00365378|19605649|P2|Extension|Other|0
5684532|NCT00365378|19605650|P1|Extension|Other|0
5684533|NCT00365378|19605648|P3|Extension|Withdrawal by Subject|98
5684534|NCT00365378|19605649|P2|Extension|Withdrawal by Subject|0
5684535|NCT00365378|19605650|P1|Extension|Withdrawal by Subject|0
5684536|NCT00365378|19605648|P3|Extension|Protocol Violation|2
5684537|NCT00365378|19605649|P2|Extension|Protocol Violation|0
5684538|NCT00365378|19605650|P1|Extension|Protocol Violation|0
5684539|NCT00365378|19605648|P3|Extension|Lost to Follow-up|57
5684540|NCT00365378|19605649|P2|Extension|Lost to Follow-up|0
5684541|NCT00365378|19605650|P1|Extension|Lost to Follow-up|0
5684542|NCT00365378|19605648|P3|Extension|Moved|8
5684543|NCT00365378|19605649|P2|Extension|Moved|0
5684544|NCT00365378|19605650|P1|Extension|Moved|0
5684545|NCT00365378|19605648|P3|Extension|Adverse Event|1
5684546|NCT00365378|19605649|P2|Extension|Adverse Event|0
5684547|NCT00365378|19605650|P1|Extension|Adverse Event|0
5684548|NCT00365378|19605648|P3|Follow-up (Month 7 Though Month 48)|Other|0
5684549|NCT00365378|19605649|P2|Follow-up (Month 7 Though Month 48)|Other|21
5684550|NCT00365378|19605650|P1|Follow-up (Month 7 Though Month 48)|Other|11
5684551|NCT00365378|19605648|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
5684552|NCT00365378|19605649|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
5684553|NCT00365378|19605650|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
5684554|NCT00365378|19605648|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
5684555|NCT00365378|19605649|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
5684556|NCT00365378|19605650|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
5684557|NCT00365378|19605648|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
5684558|NCT00365378|19605649|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
5684559|NCT00365378|19605650|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
5684560|NCT00365378|19605648|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
5684561|NCT00365378|19605649|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
5684562|NCT00365378|19605650|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
5684563|NCT00365378|19605648|P3|Follow-up (Month 7 Though Month 48)|Moved|0
5684564|NCT00365378|19605649|P2|Follow-up (Month 7 Though Month 48)|Moved|5
5684565|NCT00365378|19605650|P1|Follow-up (Month 7 Though Month 48)|Moved|6
5684566|NCT00365378|19605648|P3|Vaccination (Day 1 to Month 7)|Other|0
5684567|NCT00365378|19605649|P2|Vaccination (Day 1 to Month 7)|Other|9
5684568|NCT00365378|19605650|P1|Vaccination (Day 1 to Month 7)|Other|17
5684569|NCT00365378|19605648|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
5684570|NCT00365378|19605649|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
5684571|NCT00365378|19605650|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
5684572|NCT00365378|19605648|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
5684573|NCT00365378|19605649|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
5684574|NCT00365378|19605650|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
5684575|NCT00365378|19605648|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
5684576|NCT00365378|19605649|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
5684577|NCT00365378|19605650|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
5684578|NCT00365378|19605648|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
5684579|NCT00365378|19605649|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
5684580|NCT00365378|19605650|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
5684581|NCT00365378|19605648|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
5684582|NCT00365378|19605649|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
5684583|NCT00365378|19605650|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
5684584|NCT00365378|19605648|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
5684585|NCT00365378|19605649|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
5684586|NCT00365378|19605650|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
5684587|NCT00365365|19605664|P3|Overall Study|Patient/physician decision|1
5684588|NCT00365365|19605665|P2|Overall Study|Patient/physician decision|0
5684589|NCT00365365|19605666|P1|Overall Study|Patient/physician decision|0
5684590|NCT00365365|19605664|P3|Overall Study|Second malignancy|0
5684591|NCT00365365|19605665|P2|Overall Study|Second malignancy|1
5684592|NCT00365365|19605666|P1|Overall Study|Second malignancy|0
5684593|NCT00365365|19605664|P3|Overall Study|Withdrew consent|0
5684594|NCT00365365|19605665|P2|Overall Study|Withdrew consent|1
5684595|NCT00365365|19605666|P1|Overall Study|Withdrew consent|1
5684596|NCT00365365|19605664|P3|Overall Study|New cancer|0
5684597|NCT00365365|19605665|P2|Overall Study|New cancer|0
5684598|NCT00365365|19605666|P1|Overall Study|New cancer|1
5684599|NCT00365365|19605664|P3|Overall Study|Moved|0
5684600|NCT00365365|19605665|P2|Overall Study|Moved|0
5684601|NCT00365365|19605666|P1|Overall Study|Moved|2
5684602|NCT00365365|19605664|P3|Overall Study|Adverse Event|3
5684603|NCT00365365|19605665|P2|Overall Study|Adverse Event|6
5684604|NCT00365365|19605666|P1|Overall Study|Adverse Event|6
5684605|NCT00365365|19605664|P3|Overall Study|Disease progression/relapse|7
5684606|NCT00365365|19605665|P2|Overall Study|Disease progression/relapse|6
5684607|NCT00365365|19605666|P1|Overall Study|Disease progression/relapse|9
5684608|NCT00365365|19605664|P3|Overall Study|Subject's request|1
5684609|NCT00365365|19605665|P2|Overall Study|Subject's request|13
5684610|NCT00365365|19605666|P1|Overall Study|Subject's request|11
5684611|NCT00365365|19605664|P3|Overall Study|Death|0
5684612|NCT00365365|19605665|P2|Overall Study|Death|3
5684613|NCT00365365|19605666|P1|Overall Study|Death|1
5684614|NCT00365365|19605664|P3|Overall Study|Lost to Follow-up|3
5684615|NCT00365365|19605665|P2|Overall Study|Lost to Follow-up|3
5684616|NCT00365365|19605666|P1|Overall Study|Lost to Follow-up|3
5684617|NCT00365365|19605664|P3|Overall Study|Poor compliance to protocol|0
5684618|NCT00365365|19605665|P2|Overall Study|Poor compliance to protocol|1
5684619|NCT00365365|19605666|P1|Overall Study|Poor compliance to protocol|0
5684620|NCT00365365|19605664|P3|Overall Study|Randomized but not treated|0
5684621|NCT00365365|19605665|P2|Overall Study|Randomized but not treated|2
5684622|NCT00365365|19605666|P1|Overall Study|Randomized but not treated|0
5684623|NCT00365352|19605683|P3|Overall Study|Withdrawal of Participant by Sponsor|0
5684624|NCT00365352|19605684|P2|Overall Study|Withdrawal of Participant by Sponsor|0
5684625|NCT00365352|19605685|P1|Overall Study|Withdrawal of Participant by Sponsor|1
5684626|NCT00365352|19605683|P3|Overall Study|Lost to Follow-up|0
5684627|NCT00365352|19605684|P2|Overall Study|Lost to Follow-up|1
5684628|NCT00365352|19605685|P1|Overall Study|Lost to Follow-up|1
5684629|NCT00365352|19605683|P3|Overall Study|Non-Compliance (after Randomization)|1
5684630|NCT00365352|19605684|P2|Overall Study|Non-Compliance (after Randomization)|0
5684631|NCT00365352|19605685|P1|Overall Study|Non-Compliance (after Randomization)|1
5684632|NCT00365352|19605683|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
5684633|NCT00365352|19605684|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
5684634|NCT00365352|19605685|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
5684635|NCT00365352|19605683|P3|Overall Study|Lack of Efficacy|0
5684636|NCT00365352|19605684|P2|Overall Study|Lack of Efficacy|0
5684637|NCT00365352|19605685|P1|Overall Study|Lack of Efficacy|3
5684638|NCT00365352|19605683|P3|Overall Study|Participant Withdrew Consent|4
5684639|NCT00365352|19605684|P2|Overall Study|Participant Withdrew Consent|3
5684640|NCT00365352|19605685|P1|Overall Study|Participant Withdrew Consent|8
5684641|NCT00365352|19605683|P3|Overall Study|Adverse Event|8
5684642|NCT00365352|19605684|P2|Overall Study|Adverse Event|7
5684643|NCT00365352|19605685|P1|Overall Study|Adverse Event|6
5684644|NCT00365300|19605769|P2|Double-blind Phase|Lack of Efficacy|6
5684645|NCT00365300|19605770|P1|Double-blind Phase|Lack of Efficacy|6
5684646|NCT00365300|19605769|P2|Double-blind Phase|Protocol Violation|1
5684647|NCT00365300|19605770|P1|Double-blind Phase|Protocol Violation|3
5684648|NCT00365300|19605769|P2|Double-blind Phase|Withdrawal by Subject|1
5684649|NCT00365300|19605770|P1|Double-blind Phase|Withdrawal by Subject|0
5684650|NCT00365300|19605769|P2|Double-blind Phase|Noncompliance|1
5684651|NCT00365300|19605770|P1|Double-blind Phase|Noncompliance|1
5684652|NCT00365300|19605769|P2|Double-blind Phase|Failed to return|0
5684653|NCT00365300|19605770|P1|Double-blind Phase|Failed to return|1
5684654|NCT00365300|19605769|P2|Open-label Phase|Patient skipped open label phase|0
5684655|NCT00365300|19605770|P1|Open-label Phase|Patient skipped open label phase|1
5684656|NCT00365300|19605769|P2|Open-label Phase|Lack of Efficacy|0
5684657|NCT00365300|19605770|P1|Open-label Phase|Lack of Efficacy|1
5684658|NCT00365300|19605769|P2|Open-label Phase|Protocol Violation|0
5684659|NCT00365300|19605770|P1|Open-label Phase|Protocol Violation|1
5684660|NCT00365300|19605769|P2|Open-label Phase|Parent/Legal Guardian Request|0
5684661|NCT00365300|19605770|P1|Open-label Phase|Parent/Legal Guardian Request|4
5684662|NCT00365300|19605769|P2|Open-label Phase|Noncompliance|0
5684663|NCT00365300|19605770|P1|Open-label Phase|Noncompliance|9
5684664|NCT00365300|19605769|P2|Open-label Phase|Physician Decision|0
5684665|NCT00365300|19605770|P1|Open-label Phase|Physician Decision|1
5684666|NCT00365300|19605769|P2|Open-label Phase|Failed to Return|0
5684667|NCT00365300|19605770|P1|Open-label Phase|Failed to Return|1
5684668|NCT00365300|19605769|P2|Open-label Phase|Adverse Event|0
5684669|NCT00365300|19605770|P1|Open-label Phase|Adverse Event|4
5684670|NCT00365105|19605835|P2|Overall Study|Protocol Violation|8
5684671|NCT00365105|19605836|P1|Overall Study|Protocol Violation|5
5684672|NCT00364923|19605882|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
5684673|NCT00364923|19605882|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
5684674|NCT00364858|19605891|P2|Overall Study|Clinical baseline issue|1
5684675|NCT00364858|19605892|P1|Overall Study|Clinical baseline issue|0
5684676|NCT00364858|19605891|P2|Overall Study|Return to Q2 regimen|1
5684677|NCT00364858|19605892|P1|Overall Study|Return to Q2 regimen|0
5684678|NCT00364858|19605891|P2|Overall Study|Non-compliant|0
5684679|NCT00364858|19605892|P1|Overall Study|Non-compliant|1
5684680|NCT00364858|19605891|P2|Overall Study|Discontinuation at baseline|0
5684681|NCT00364858|19605892|P1|Overall Study|Discontinuation at baseline|1
5684682|NCT00364858|19605891|P2|Overall Study|Clinical failure|13
5684683|NCT00364858|19605892|P1|Overall Study|Clinical failure|2
5684684|NCT00364858|19605891|P2|Overall Study|Pregnancy|1
5684685|NCT00364858|19605892|P1|Overall Study|Pregnancy|1
5684686|NCT00364858|19605891|P2|Overall Study|Withdrawal by Subject|1
5684687|NCT00364858|19605892|P1|Overall Study|Withdrawal by Subject|1
5684688|NCT00364858|19605891|P2|Overall Study|Adverse Event|5
5684689|NCT00364858|19605892|P1|Overall Study|Adverse Event|1
5684690|NCT00364845|19605907|P2|Overall Study|Death|1
5684691|NCT00364845|19605908|P1|Overall Study|Death|0
5684692|NCT00364845|19605907|P2|Overall Study|Lost to Follow-up|1
5684693|NCT00364845|19605908|P1|Overall Study|Lost to Follow-up|0
5684694|NCT00364845|19605907|P2|Overall Study|Physician Decision|8
5684695|NCT00364845|19605908|P1|Overall Study|Physician Decision|8
5684696|NCT00364845|19605907|P2|Overall Study|Withdrawal by Subject|1
5684697|NCT00364845|19605908|P1|Overall Study|Withdrawal by Subject|2
5684698|NCT00364845|19605907|P2|Overall Study|Adverse Event|0
5684699|NCT00364845|19605908|P1|Overall Study|Adverse Event|1
5684700|NCT00364832|19605929|P12|Extension Year 2|Early Withdrawals|3
5684701|NCT00364832|19605930|P11|Extension Year 2|Early Withdrawals|5
5684702|NCT00364832|19605931|P10|Extension Year 2|Early Withdrawals|5
5684703|NCT00364832|19605932|P9|Extension Year 2|Early Withdrawals|0
5684704|NCT00364832|19605933|P8|Extension Year 2|Early Withdrawals|0
5684705|NCT00364832|19605934|P7|Extension Year 2|Early Withdrawals|0
5684706|NCT00364832|19605935|P6|Extension Year 2|Early Withdrawals|0
5684707|NCT00364832|19605936|P5|Extension Year 2|Early Withdrawals|0
5684708|NCT00364832|19605937|P4|Extension Year 2|Early Withdrawals|0
5684709|NCT00364832|19605938|P3|Extension Year 2|Early Withdrawals|0
5684710|NCT00364832|19605939|P2|Extension Year 2|Early Withdrawals|0
5684711|NCT00364832|19605940|P1|Extension Year 2|Early Withdrawals|0
5684712|NCT00364832|19605929|P12|Extension Year 1|Early Withdrawals|10
5684713|NCT00364832|19605930|P11|Extension Year 1|Early Withdrawals|2
5684714|NCT00364832|19605931|P10|Extension Year 1|Early Withdrawals|4
5684715|NCT00364832|19605932|P9|Extension Year 1|Early Withdrawals|0
5684716|NCT00364832|19605933|P8|Extension Year 1|Early Withdrawals|0
5684717|NCT00364832|19605934|P7|Extension Year 1|Early Withdrawals|0
5684718|NCT00364832|19605935|P6|Extension Year 1|Early Withdrawals|0
5684719|NCT00364832|19605936|P5|Extension Year 1|Early Withdrawals|0
5684720|NCT00364832|19605937|P4|Extension Year 1|Early Withdrawals|0
5684721|NCT00364832|19605938|P3|Extension Year 1|Early Withdrawals|0
5684722|NCT00364832|19605939|P2|Extension Year 1|Early Withdrawals|0
5684723|NCT00364832|19605940|P1|Extension Year 1|Early Withdrawals|0
5684724|NCT00364832|19605929|P12|Core Period|Early Withdrawals|0
5684725|NCT00364832|19605930|P11|Core Period|Early Withdrawals|0
5684726|NCT00364832|19605931|P10|Core Period|Early Withdrawals|0
5684727|NCT00364832|19605932|P9|Core Period|Early Withdrawals|0
5684728|NCT00364832|19605933|P8|Core Period|Early Withdrawals|1
5684729|NCT00364832|19605934|P7|Core Period|Early Withdrawals|4
5684730|NCT00364832|19605935|P6|Core Period|Early Withdrawals|0
5684731|NCT00364832|19605936|P5|Core Period|Early Withdrawals|0
5684732|NCT00364832|19605937|P4|Core Period|Early Withdrawals|1
5684733|NCT00364832|19605938|P3|Core Period|Early Withdrawals|1
5684734|NCT00364832|19605939|P2|Core Period|Early Withdrawals|2
5684735|NCT00364832|19605940|P1|Core Period|Early Withdrawals|2
5684736|NCT00364793|19606005|P4|Overall Study|Withdrawal by Subject|0
5684737|NCT00364793|19606006|P3|Overall Study|Withdrawal by Subject|0
5684738|NCT00364793|19606007|P2|Overall Study|Withdrawal by Subject|1
5684739|NCT00364793|19606008|P1|Overall Study|Withdrawal by Subject|0
5684740|NCT00364793|19606005|P4|Overall Study|No longer meets criteria|1
5684741|NCT00364793|19606006|P3|Overall Study|No longer meets criteria|0
5684742|NCT00364793|19606007|P2|Overall Study|No longer meets criteria|0
5684743|NCT00364793|19606008|P1|Overall Study|No longer meets criteria|0
5684744|NCT00364793|19606005|P4|Overall Study|Poor or non-compliance|1
5684745|NCT00364793|19606006|P3|Overall Study|Poor or non-compliance|0
5684746|NCT00364793|19606007|P2|Overall Study|Poor or non-compliance|1
5684747|NCT00364793|19606008|P1|Overall Study|Poor or non-compliance|1
5684748|NCT00364793|19606005|P4|Overall Study|Lost to Follow-up|0
5684749|NCT00364793|19606006|P3|Overall Study|Lost to Follow-up|2
5684750|NCT00364793|19606007|P2|Overall Study|Lost to Follow-up|0
5684751|NCT00364793|19606008|P1|Overall Study|Lost to Follow-up|1
5684752|NCT00364793|19606005|P4|Overall Study|Lack of Efficacy|1
5684753|NCT00364793|19606006|P3|Overall Study|Lack of Efficacy|1
5684754|NCT00364793|19606007|P2|Overall Study|Lack of Efficacy|3
5684755|NCT00364793|19606008|P1|Overall Study|Lack of Efficacy|3
5684756|NCT00364793|19606005|P4|Overall Study|Death|0
5684757|NCT00364793|19606006|P3|Overall Study|Death|1
5684758|NCT00364793|19606007|P2|Overall Study|Death|0
5684759|NCT00364793|19606008|P1|Overall Study|Death|1
5684760|NCT00364793|19606005|P4|Overall Study|Adverse Event|0
5684761|NCT00364793|19606006|P3|Overall Study|Adverse Event|0
5684762|NCT00364793|19606007|P2|Overall Study|Adverse Event|0
5684763|NCT00364793|19606008|P1|Overall Study|Adverse Event|2
5684764|NCT00364689|19606145|P1|Overall Study|Lost to Follow-up|1
5684765|NCT00364611|19606165|P2|Overall Study|Receiving Liver Ablation|1
5684766|NCT00364611|19606166|P1|Overall Study|Receiving Liver Ablation|0
5684767|NCT00364611|19606165|P2|Overall Study|Presumed CR on Study|1
5684768|NCT00364611|19606166|P1|Overall Study|Presumed CR on Study|0
5684769|NCT00364611|19606165|P2|Overall Study|Found Ineligible|0
5684770|NCT00364611|19606166|P1|Overall Study|Found Ineligible|1
5684771|NCT00364611|19606165|P2|Overall Study|Investigator decision|2
5684772|NCT00364611|19606166|P1|Overall Study|Investigator decision|2
5684773|NCT00364611|19606165|P2|Overall Study|Disease Progression|8
5684774|NCT00364611|19606166|P1|Overall Study|Disease Progression|38
5684775|NCT00364611|19606165|P2|Overall Study|Participant's Request|4
5684776|NCT00364611|19606166|P1|Overall Study|Participant's Request|3
5684777|NCT00364611|19606165|P2|Overall Study|Adverse Event|4
5684778|NCT00364611|19606166|P1|Overall Study|Adverse Event|7
5684779|NCT00364611|19606165|P2|Overall Study|Did not receive study medication|1
5684780|NCT00364611|19606166|P1|Overall Study|Did not receive study medication|0
5684781|NCT00364533|19606189|P5|Overall Study|Protocol Violation|0
5684782|NCT00364533|19606190|P4|Overall Study|Protocol Violation|0
5684783|NCT00364533|19606191|P3|Overall Study|Protocol Violation|0
5684784|NCT00364533|19606192|P2|Overall Study|Protocol Violation|1
5684785|NCT00364533|19606193|P1|Overall Study|Protocol Violation|1
5684786|NCT00364533|19606189|P5|Overall Study|Non-compliance|0
5684787|NCT00364533|19606190|P4|Overall Study|Non-compliance|0
5684788|NCT00364533|19606191|P3|Overall Study|Non-compliance|0
5684789|NCT00364533|19606192|P2|Overall Study|Non-compliance|0
5684790|NCT00364533|19606193|P1|Overall Study|Non-compliance|1
5684791|NCT00364533|19606189|P5|Overall Study|Variations in drug compliance|0
5684792|NCT00364533|19606190|P4|Overall Study|Variations in drug compliance|0
5684793|NCT00364533|19606191|P3|Overall Study|Variations in drug compliance|1
5684794|NCT00364533|19606192|P2|Overall Study|Variations in drug compliance|1
5684795|NCT00364533|19606193|P1|Overall Study|Variations in drug compliance|2
5684796|NCT00364533|19606189|P5|Overall Study|Subject discharged from hospital|1
5684797|NCT00364533|19606190|P4|Overall Study|Subject discharged from hospital|3
5684798|NCT00364533|19606191|P3|Overall Study|Subject discharged from hospital|2
5684799|NCT00364533|19606192|P2|Overall Study|Subject discharged from hospital|1
5684800|NCT00364533|19606193|P1|Overall Study|Subject discharged from hospital|4
5684801|NCT00364533|19606189|P5|Overall Study|Lack of Efficacy|42
5684802|NCT00364533|19606190|P4|Overall Study|Lack of Efficacy|17
5684803|NCT00364533|19606191|P3|Overall Study|Lack of Efficacy|21
5684804|NCT00364533|19606192|P2|Overall Study|Lack of Efficacy|22
5684805|NCT00364533|19606193|P1|Overall Study|Lack of Efficacy|22
5684806|NCT00364533|19606189|P5|Overall Study|Withdrawal by Subject|6
5684807|NCT00364533|19606190|P4|Overall Study|Withdrawal by Subject|6
5684808|NCT00364533|19606191|P3|Overall Study|Withdrawal by Subject|6
5684809|NCT00364533|19606192|P2|Overall Study|Withdrawal by Subject|8
5684810|NCT00364533|19606193|P1|Overall Study|Withdrawal by Subject|4
5684811|NCT00364533|19606189|P5|Overall Study|Adverse Event|2
5684812|NCT00364533|19606190|P4|Overall Study|Adverse Event|5
5684813|NCT00364533|19606191|P3|Overall Study|Adverse Event|15
5684814|NCT00364533|19606192|P2|Overall Study|Adverse Event|7
5684815|NCT00364533|19606193|P1|Overall Study|Adverse Event|8
5684816|NCT00364351|19606226|P2|Overall Study|Randomised treatment not started|3
5684817|NCT00364351|19606227|P1|Overall Study|Randomised treatment not started|0
5684818|NCT00364351|19606226|P2|Overall Study|Patient could not travel to site|1
5684819|NCT00364351|19606227|P1|Overall Study|Patient could not travel to site|0
5684820|NCT00364351|19606226|P2|Overall Study|Investigator error|2
5684821|NCT00364351|19606227|P1|Overall Study|Investigator error|0
5684822|NCT00364351|19606226|P2|Overall Study|Poor treatment compliance|3
5684823|NCT00364351|19606227|P1|Overall Study|Poor treatment compliance|0
5684824|NCT00364351|19606226|P2|Overall Study|Sponsor decision|0
5684825|NCT00364351|19606227|P1|Overall Study|Sponsor decision|1
5684826|NCT00364351|19606226|P2|Overall Study|Incorrect enrollment|1
5684827|NCT00364351|19606227|P1|Overall Study|Incorrect enrollment|1
5684828|NCT00364351|19606226|P2|Overall Study|Withdrawal by Subject|29
5684829|NCT00364351|19606227|P1|Overall Study|Withdrawal by Subject|30
5684830|NCT00364351|19606226|P2|Overall Study|Lost to Follow-up|1
5684831|NCT00364351|19606227|P1|Overall Study|Lost to Follow-up|1
5684832|NCT00364351|19606226|P2|Overall Study|Prohibited concomitant medication|2
5684833|NCT00364351|19606227|P1|Overall Study|Prohibited concomitant medication|0
5684834|NCT00364351|19606226|P2|Overall Study|Condition under investigation worsened|497
5684835|NCT00364351|19606227|P1|Overall Study|Condition under investigation worsened|469
5684836|NCT00364351|19606226|P2|Overall Study|Adverse Event|44
5684837|NCT00364351|19606227|P1|Overall Study|Adverse Event|90
5684838|NCT00364286|19606245|P1|Overall Study|Adverse Event|2
5684839|NCT00364286|19606245|P1|Overall Study|Withdrawal by Subject|1
5684840|NCT00364182|19606252|P3|Third Intervention|Lost to Follow-up|1
5684841|NCT00364182|19606253|P2|Third Intervention|Lost to Follow-up|0
5684842|NCT00364182|19606254|P1|Third Intervention|Lost to Follow-up|0
5684843|NCT00364182|19606252|P3|Third Intervention|non-compliance|0
5684844|NCT00364182|19606253|P2|Third Intervention|non-compliance|1
5684845|NCT00364182|19606254|P1|Third Intervention|non-compliance|0
5684846|NCT00364182|19606252|P3|Second Intervention|Adverse Event|1
5684847|NCT00364182|19606253|P2|Second Intervention|Adverse Event|0
5684848|NCT00364182|19606254|P1|Second Intervention|Adverse Event|0
5684849|NCT00364182|19606252|P3|Second Intervention|Protocol Violation|0
5684850|NCT00364182|19606253|P2|Second Intervention|Protocol Violation|1
5684851|NCT00364182|19606254|P1|Second Intervention|Protocol Violation|0
5684852|NCT00364182|19606252|P3|Second Intervention|non-compliance|1
5684853|NCT00364182|19606253|P2|Second Intervention|non-compliance|1
5684854|NCT00364182|19606254|P1|Second Intervention|non-compliance|0
5684855|NCT00364182|19606252|P3|First Intervention|Withdrawal by Subject|0
5684856|NCT00364182|19606253|P2|First Intervention|Withdrawal by Subject|0
5684857|NCT00364182|19606254|P1|First Intervention|Withdrawal by Subject|2
5684858|NCT00364182|19606252|P3|First Intervention|Secondary prophylaxis|0
5684859|NCT00364182|19606253|P2|First Intervention|Secondary prophylaxis|0
5684860|NCT00364182|19606254|P1|First Intervention|Secondary prophylaxis|1
5684861|NCT00364156|19606288|P2|Overall Study|Protocol Violation|1
5684862|NCT00364156|19606289|P1|Overall Study|Protocol Violation|6
5684863|NCT00364156|19606288|P2|Overall Study|Withdrawal by Subject|80
5684864|NCT00364156|19606289|P1|Overall Study|Withdrawal by Subject|73
5684865|NCT00364130|19606297|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
5684866|NCT00364130|19606298|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
5684867|NCT00364130|19606297|P2|Intervention Period|Withdrawal by Subject|5
5684868|NCT00364130|19606298|P1|Intervention Period|Withdrawal by Subject|4
5684869|NCT00364130|19606297|P2|Intervention Period|Pregnancy|0
5684870|NCT00364130|19606298|P1|Intervention Period|Pregnancy|1
5684871|NCT00364130|19606297|P2|Intervention Period|Lost to Follow-up|3
5684872|NCT00364130|19606298|P1|Intervention Period|Lost to Follow-up|4
5684873|NCT00364013|19606320|P2|Overall Study|Ongoing|13
5684874|NCT00364013|19606321|P1|Overall Study|Ongoing|20
5684875|NCT00364013|19606320|P2|Overall Study|Other|47
5684876|NCT00364013|19606321|P1|Overall Study|Other|41
5684877|NCT00364013|19606320|P2|Overall Study|Protocol-specified criteria|6
5684878|NCT00364013|19606321|P1|Overall Study|Protocol-specified criteria|6
5684879|NCT00364013|19606320|P2|Overall Study|Lost to Follow-up|3
5684880|NCT00364013|19606321|P1|Overall Study|Lost to Follow-up|10
5684881|NCT00364013|19606320|P2|Overall Study|Physician Decision|3
5684882|NCT00364013|19606321|P1|Overall Study|Physician Decision|3
5684883|NCT00364013|19606320|P2|Overall Study|Withdrawal by Subject|18
5684884|NCT00364013|19606321|P1|Overall Study|Withdrawal by Subject|13
5684885|NCT00364013|19606320|P2|Overall Study|Adverse Event|3
5684886|NCT00364013|19606321|P1|Overall Study|Adverse Event|4
5684887|NCT00364013|19606320|P2|Overall Study|Ineligibility determined|2
5684888|NCT00364013|19606321|P1|Overall Study|Ineligibility determined|4
5684889|NCT00363896|19606349|P2|Overall Study|Other|2
5684890|NCT00363896|19606350|P1|Overall Study|Other|1
5684891|NCT00363896|19606349|P2|Overall Study|Non-fulfilment of entry criteria|0
5684892|NCT00363896|19606350|P1|Overall Study|Non-fulfilment of entry criteria|1
5684893|NCT00363896|19606349|P2|Overall Study|Lost to Follow-up|0
5684894|NCT00363896|19606350|P1|Overall Study|Lost to Follow-up|3
5684895|NCT00363896|19606349|P2|Overall Study|Protocol Violation|1
5684896|NCT00363896|19606350|P1|Overall Study|Protocol Violation|6
5684897|NCT00363896|19606349|P2|Overall Study|Lack of Efficacy|8
5684898|NCT00363896|19606350|P1|Overall Study|Lack of Efficacy|12
5684899|NCT00363896|19606349|P2|Overall Study|COPD exacerbation|7
5684900|NCT00363896|19606350|P1|Overall Study|COPD exacerbation|13
5684901|NCT00363896|19606349|P2|Overall Study|Adverse Event|13
5684902|NCT00363896|19606350|P1|Overall Study|Adverse Event|24
5684903|NCT00363896|19606349|P2|Overall Study|Withdrawal by Subject|16
5684904|NCT00363896|19606350|P1|Overall Study|Withdrawal by Subject|29
5684905|NCT00363766|19606391|P2|Overall Study|Physician Decision|2
5684906|NCT00363766|19606392|P1|Overall Study|Physician Decision|1
5684907|NCT00363766|19606391|P2|Overall Study|Withdrawal by Subject|0
5684908|NCT00363766|19606392|P1|Overall Study|Withdrawal by Subject|2
5684909|NCT00363766|19606391|P2|Overall Study|Not Disease Related Death|4
5684910|NCT00363766|19606392|P1|Overall Study|Not Disease Related Death|3
5684911|NCT00363766|19606391|P2|Overall Study|Disease Related Death|3
5684912|NCT00363766|19606392|P1|Overall Study|Disease Related Death|1
5684913|NCT00363766|19606391|P2|Overall Study|Adverse Event|2
5684914|NCT00363766|19606392|P1|Overall Study|Adverse Event|10
5684915|NCT00363766|19606391|P2|Overall Study|Progressive Disease|9
5684916|NCT00363766|19606392|P1|Overall Study|Progressive Disease|15
5684917|NCT00363649|19606421|P2|Overall Study|Adverse Event|0
5684918|NCT00363649|19606422|P1|Overall Study|Adverse Event|6
5684919|NCT00363649|19606421|P2|Overall Study|Withdrawal by Subject|1
5684920|NCT00363649|19606422|P1|Overall Study|Withdrawal by Subject|1
5684921|NCT00363545|19606438|P2|Overall Study|Others|0
5684922|NCT00363545|19606439|P1|Overall Study|Others|1
5684923|NCT00363545|19606438|P2|Overall Study|Lost to follow-up (complete vaccination)|17
5684924|NCT00363545|19606439|P1|Overall Study|Lost to follow-up (complete vaccination)|14
5684925|NCT00363545|19606438|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
5684926|NCT00363545|19606439|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
5684927|NCT00363545|19606438|P2|Overall Study|Migrated/moved from study area|6
5684928|NCT00363545|19606439|P1|Overall Study|Migrated/moved from study area|3
5684929|NCT00363545|19606438|P2|Overall Study|Withdrawal by Subject|15
5684930|NCT00363545|19606439|P1|Overall Study|Withdrawal by Subject|12
5684931|NCT00363545|19606438|P2|Overall Study|Serious Adverse Event|1
5684932|NCT00363545|19606439|P1|Overall Study|Serious Adverse Event|0
5684933|NCT00363480|19606457|P1|Overall Study|Participant discontinued on its own|1
5684934|NCT00363480|19606457|P1|Overall Study|Non-compliance of subject|1
5684935|NCT00363480|19606457|P1|Overall Study|Withdrawal by Subject|5
5684936|NCT00363480|19606457|P1|Overall Study|Lost to Follow-up|5
5684937|NCT00363480|19606457|P1|Overall Study|Adverse Event|4
5684938|NCT00363480|19606457|P1|Overall Study|Criteria for treatment period not fulfil|1
5684939|NCT00363467|19606477|P1|Overall Study|Physician Decision|1
5684940|NCT00363415|19606487|P2|Overall Study|Protocol Violation|4
5684941|NCT00363415|19606488|P1|Overall Study|Protocol Violation|1
5684942|NCT00363415|19606487|P2|Overall Study|Lost to Follow-up|3
5684943|NCT00363415|19606488|P1|Overall Study|Lost to Follow-up|3
5684944|NCT00363415|19606487|P2|Overall Study|Withdrawal by Subject|15
5684945|NCT00363415|19606488|P1|Overall Study|Withdrawal by Subject|9
5684946|NCT00363415|19606487|P2|Overall Study|Entry Criteria Not Met|10
5684947|NCT00363415|19606488|P1|Overall Study|Entry Criteria Not Met|11
5684948|NCT00363415|19606487|P2|Overall Study|Physician Decision|35
5684949|NCT00363415|19606488|P1|Overall Study|Physician Decision|18
5684950|NCT00363415|19606487|P2|Overall Study|Adverse Event|15
5684951|NCT00363415|19606488|P1|Overall Study|Adverse Event|24
5684952|NCT00363415|19606487|P2|Overall Study|Death|29
5684953|NCT00363415|19606488|P1|Overall Study|Death|32
5684954|NCT00363415|19606487|P2|Overall Study|Sponsor Decision|31
5684955|NCT00363415|19606488|P1|Overall Study|Sponsor Decision|67
5684956|NCT00363415|19606487|P2|Overall Study|Progressive Disease|107
5684957|NCT00363415|19606488|P1|Overall Study|Progressive Disease|196
5684958|NCT00363311|19606506|P2|Overall Study|Participant Moved to Louisiana|1
5684959|NCT00363311|19606507|P1|Overall Study|Participant Moved to Louisiana|0
5684960|NCT00363311|19606506|P2|Overall Study|Withdrawn per Instructions of Monitor|1
5684961|NCT00363311|19606507|P1|Overall Study|Withdrawn per Instructions of Monitor|0
5684962|NCT00363311|19606506|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
5684963|NCT00363311|19606507|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
5684964|NCT00363311|19606506|P2|Overall Study|Participant Moved to Another Country|0
5684965|NCT00363311|19606507|P1|Overall Study|Participant Moved to Another Country|1
5684966|NCT00363311|19606506|P2|Overall Study|Participant Opted for Treatment|0
5684967|NCT00363311|19606507|P1|Overall Study|Participant Opted for Treatment|1
5684968|NCT00363311|19606506|P2|Overall Study|Prostate Volume/PSA Doubled|0
5684969|NCT00363311|19606507|P1|Overall Study|Prostate Volume/PSA Doubled|1
5684970|NCT00363311|19606506|P2|Overall Study|Participant Refused Biopsy|0
5684971|NCT00363311|19606507|P1|Overall Study|Participant Refused Biopsy|1
5684972|NCT00363311|19606506|P2|Overall Study|Non-Compliance|1
5684973|NCT00363311|19606507|P1|Overall Study|Non-Compliance|1
5684974|NCT00363311|19606506|P2|Overall Study|Disease Progression|26
5684975|NCT00363311|19606507|P1|Overall Study|Disease Progression|46
5684976|NCT00363311|19606506|P2|Overall Study|Sponsor Terminated Study|2
5684977|NCT00363311|19606507|P1|Overall Study|Sponsor Terminated Study|2
5684978|NCT00363311|19606506|P2|Overall Study|Physician Decision|1
5684979|NCT00363311|19606507|P1|Overall Study|Physician Decision|1
5684980|NCT00363311|19606506|P2|Overall Study|Withdrawal by Subject|6
5684981|NCT00363311|19606507|P1|Overall Study|Withdrawal by Subject|12
5684982|NCT00363311|19606506|P2|Overall Study|Protocol Violation|2
5684983|NCT00363311|19606507|P1|Overall Study|Protocol Violation|1
5684984|NCT00363311|19606506|P2|Overall Study|Lost to Follow-up|0
5684985|NCT00363311|19606507|P1|Overall Study|Lost to Follow-up|3
5684986|NCT00363311|19606506|P2|Overall Study|Adverse Event|4
5684987|NCT00363311|19606507|P1|Overall Study|Adverse Event|6
5684988|NCT00363298|19606573|P2|4-week Study Continuation Phase|Lack of Efficacy|0
5684989|NCT00363298|19606574|P1|4-week Study Continuation Phase|Lack of Efficacy|1
5684990|NCT00363298|19606573|P2|First Study Week|Lack of Efficacy|5
5684991|NCT00363298|19606574|P1|First Study Week|Lack of Efficacy|6
5684992|NCT00363246|19606582|P1|Overall Study|Eligibility changed due to Hospice move|5
5684993|NCT00363246|19606582|P1|Overall Study|Subject expressed security concerns|2
5684994|NCT00363246|19606582|P1|Overall Study|Stopped using wheelchair|11
5684995|NCT00363246|19606582|P1|Overall Study|Bad health|6
5684996|NCT00363246|19606582|P1|Overall Study|Lost to Follow-up|14
5684997|NCT00363246|19606582|P1|Overall Study|Withdrawal by Subject|19
5684998|NCT00363246|19606582|P1|Overall Study|Death|40
5684999|NCT00363142|19606600|P2|Overall Study|Withdrawal by Subject|1
5685000|NCT00363142|19606601|P1|Overall Study|Withdrawal by Subject|3
5685001|NCT00363142|19606600|P2|Overall Study|Non-compliance|1
5685002|NCT00363142|19606601|P1|Overall Study|Non-compliance|1
5685003|NCT00363142|19606600|P2|Overall Study|Lost to Follow-up|0
5685004|NCT00363142|19606601|P1|Overall Study|Lost to Follow-up|1
5685005|NCT00363142|19606600|P2|Overall Study|Lack of Efficacy|1
5685006|NCT00363142|19606601|P1|Overall Study|Lack of Efficacy|0
5685007|NCT00363142|19606600|P2|Overall Study|Adverse Event|0
5685008|NCT00363142|19606601|P1|Overall Study|Adverse Event|2
5685009|NCT00363129|19606630|P2|Overall Study|Other Reasons|3
5685010|NCT00363129|19606631|P1|Overall Study|Other Reasons|6
5685011|NCT00363129|19606630|P2|Overall Study|Death|1
5685012|NCT00363129|19606631|P1|Overall Study|Death|0
5685013|NCT00363129|19606630|P2|Overall Study|Other Medical Problems|4
5685014|NCT00363129|19606631|P1|Overall Study|Other Medical Problems|2
5685015|NCT00363129|19606630|P2|Overall Study|Alternate Treatment|4
5685016|NCT00363129|19606631|P1|Overall Study|Alternate Treatment|2
5685017|NCT00363129|19606630|P2|Overall Study|Adverse Event|3
5685018|NCT00363129|19606631|P1|Overall Study|Adverse Event|8
5685019|NCT00363129|19606630|P2|Overall Study|Withdrawal by Subject|18
5685020|NCT00363129|19606631|P1|Overall Study|Withdrawal by Subject|11
5685021|NCT00363051|19606674|P2|Overall Study|Death|2
5685022|NCT00363051|19606675|P1|Overall Study|Death|3
5685023|NCT00363051|19606674|P2|Overall Study|Protocol Violation|2
5685024|NCT00363051|19606675|P1|Overall Study|Protocol Violation|0
5685025|NCT00363051|19606674|P2|Overall Study|Lost to Follow-up|1
5685026|NCT00363051|19606675|P1|Overall Study|Lost to Follow-up|0
5685027|NCT00363051|19606674|P2|Overall Study|Withdrawal by Subject|3
5685028|NCT00363051|19606675|P1|Overall Study|Withdrawal by Subject|11
5685029|NCT00363051|19606674|P2|Overall Study|New Cancer Therapy|1
5685030|NCT00363051|19606675|P1|Overall Study|New Cancer Therapy|2
5685031|NCT00363051|19606674|P2|Overall Study|Adverse Event|12
5685032|NCT00363051|19606675|P1|Overall Study|Adverse Event|21
5685033|NCT00363051|19606674|P2|Overall Study|Adminstrative problems|1
5685034|NCT00363051|19606675|P1|Overall Study|Adminstrative problems|1
5685035|NCT00362648|19606724|P4|Overall Study|Withdrawal by Subject|6
5685036|NCT00362648|19606725|P3|Overall Study|Withdrawal by Subject|2
5685037|NCT00362648|19606726|P2|Overall Study|Withdrawal by Subject|42
5685038|NCT00362648|19606727|P1|Overall Study|Withdrawal by Subject|48
5685039|NCT00362648|19606724|P4|Overall Study|Protocol Violation|2
5685040|NCT00362648|19606725|P3|Overall Study|Protocol Violation|2
5685041|NCT00362648|19606726|P2|Overall Study|Protocol Violation|2
5685042|NCT00362648|19606727|P1|Overall Study|Protocol Violation|4
5685043|NCT00362648|19606724|P4|Overall Study|Lost to Follow-up|3
5685044|NCT00362648|19606725|P3|Overall Study|Lost to Follow-up|4
5685045|NCT00362648|19606726|P2|Overall Study|Lost to Follow-up|69
5685046|NCT00362648|19606727|P1|Overall Study|Lost to Follow-up|62
5685047|NCT00362648|19606724|P4|Overall Study|Adverse Event|0
5685048|NCT00362648|19606725|P3|Overall Study|Adverse Event|1
5685049|NCT00362648|19606726|P2|Overall Study|Adverse Event|21
5685050|NCT00362648|19606727|P1|Overall Study|Adverse Event|12
5685051|NCT00362609|19606745|P2|Overall Study|Protocol Violation|1
5685052|NCT00362609|19606746|P1|Overall Study|Protocol Violation|0
5685053|NCT00362609|19606745|P2|Overall Study|Withdrawal by Subject|1
5685054|NCT00362609|19606746|P1|Overall Study|Withdrawal by Subject|0
5685055|NCT00362414|19606827|P1|Overall Study|Adverse Event|1
5685056|NCT00362414|19606827|P1|Overall Study|Death|2
5685057|NCT00362375|19606856|P2|Overall Study|Lost to Follow-up|35
5685058|NCT00362375|19606857|P1|Overall Study|Lost to Follow-up|40
5685059|NCT00362336|19606874|P3|Overall Study|Withdrawal by Subject|1
5685060|NCT00362336|19606875|P2|Overall Study|Withdrawal by Subject|3
5685061|NCT00362336|19606876|P1|Overall Study|Withdrawal by Subject|3
5685062|NCT00362336|19606874|P3|Overall Study|Lost to Follow-up|0
5685063|NCT00362336|19606875|P2|Overall Study|Lost to Follow-up|4
5685064|NCT00362336|19606876|P1|Overall Study|Lost to Follow-up|6
5685065|NCT00362336|19606874|P3|Overall Study|Protocol Violation|1
5685066|NCT00362336|19606875|P2|Overall Study|Protocol Violation|0
5685067|NCT00362336|19606876|P1|Overall Study|Protocol Violation|0
5685068|NCT00362336|19606874|P3|Overall Study|Serious Adverse Event|1
5685069|NCT00362336|19606875|P2|Overall Study|Serious Adverse Event|0
5685070|NCT00362336|19606876|P1|Overall Study|Serious Adverse Event|1
5685071|NCT00362297|19606904|P2|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
5685072|NCT00362297|19606905|P1|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
5685073|NCT00362232|19606913|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
5685074|NCT00362232|19606914|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
5685075|NCT00362232|19606913|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
5685076|NCT00362232|19606914|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
5685077|NCT00362232|19606913|P2|Follow-up (30 (+ 5) Days)|Death|1
5685078|NCT00362232|19606914|P1|Follow-up (30 (+ 5) Days)|Death|1
5685079|NCT00362232|19606913|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
5685080|NCT00362232|19606914|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
5685081|NCT00362232|19606913|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
5685082|NCT00362232|19606914|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
5685083|NCT00362232|19606913|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
5685084|NCT00362232|19606914|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
5685085|NCT00362232|19606913|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
5685086|NCT00362232|19606914|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
5685087|NCT00362232|19606913|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
5685088|NCT00362232|19606914|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
5685089|NCT00362232|19606913|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
5685090|NCT00362232|19606914|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
5685091|NCT00362232|19606913|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
5685092|NCT00362232|19606914|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
5685093|NCT00362232|19606913|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
5685094|NCT00362232|19606914|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
5685095|NCT00362232|19606913|P2|Treatment (12 +/- 2 Days)|Death|3
5685096|NCT00362232|19606914|P1|Treatment (12 +/- 2 Days)|Death|1
5685097|NCT00362232|19606913|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
5685098|NCT00362232|19606914|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
5685099|NCT00362180|19606959|P9|Treated Period|Adverse Event|0
5685100|NCT00362180|19606960|P8|Treated Period|Adverse Event|1
5685101|NCT00362180|19606961|P7|Treated Period|Adverse Event|0
5685102|NCT00362180|19606962|P6|Treated Period|Adverse Event|1
5685103|NCT00362180|19606963|P5|Treated Period|Adverse Event|0
5685104|NCT00362180|19606964|P4|Treated Period|Adverse Event|0
5685105|NCT00362180|19606965|P3|Treated Period|Adverse Event|0
5685106|NCT00362180|19606966|P2|Treated Period|Adverse Event|0
5685107|NCT00362180|19606967|P1|Treated Period|Adverse Event|0
5685108|NCT00362180|19606959|P9|Treated Period|Withdrawal by Subject|0
5685109|NCT00362180|19606960|P8|Treated Period|Withdrawal by Subject|0
5685110|NCT00362180|19606961|P7|Treated Period|Withdrawal by Subject|0
5685111|NCT00362180|19606962|P6|Treated Period|Withdrawal by Subject|0
5685112|NCT00362180|19606963|P5|Treated Period|Withdrawal by Subject|0
5685113|NCT00362180|19606964|P4|Treated Period|Withdrawal by Subject|0
5685114|NCT00362180|19606965|P3|Treated Period|Withdrawal by Subject|0
5685115|NCT00362180|19606966|P2|Treated Period|Withdrawal by Subject|0
5685116|NCT00362180|19606967|P1|Treated Period|Withdrawal by Subject|1
5685117|NCT00362115|19607039|P7|Overall Study|Other|0
5685118|NCT00362115|19607040|P6|Overall Study|Other|1
5685119|NCT00362115|19607041|P5|Overall Study|Other|0
5685120|NCT00362115|19607042|P4|Overall Study|Other|1
5685121|NCT00362115|19607043|P3|Overall Study|Other|0
5685122|NCT00362115|19607044|P2|Overall Study|Other|1
5685123|NCT00362115|19607045|P1|Overall Study|Other|0
5685124|NCT00362115|19607039|P7|Overall Study|Physician Decision|3
5685125|NCT00362115|19607040|P6|Overall Study|Physician Decision|0
5685126|NCT00362115|19607041|P5|Overall Study|Physician Decision|0
5685127|NCT00362115|19607042|P4|Overall Study|Physician Decision|0
5685128|NCT00362115|19607043|P3|Overall Study|Physician Decision|0
5685129|NCT00362115|19607044|P2|Overall Study|Physician Decision|0
5685130|NCT00362115|19607045|P1|Overall Study|Physician Decision|0
5685131|NCT00362115|19607039|P7|Overall Study|Lack of Efficacy|3
5685132|NCT00362115|19607040|P6|Overall Study|Lack of Efficacy|0
5685133|NCT00362115|19607041|P5|Overall Study|Lack of Efficacy|2
5685134|NCT00362115|19607042|P4|Overall Study|Lack of Efficacy|2
5685135|NCT00362115|19607043|P3|Overall Study|Lack of Efficacy|5
5685136|NCT00362115|19607044|P2|Overall Study|Lack of Efficacy|0
5685137|NCT00362115|19607045|P1|Overall Study|Lack of Efficacy|1
5685138|NCT00362115|19607039|P7|Overall Study|Withdrawal by Subject|4
5685139|NCT00362115|19607040|P6|Overall Study|Withdrawal by Subject|3
5685140|NCT00362115|19607041|P5|Overall Study|Withdrawal by Subject|1
5685141|NCT00362115|19607042|P4|Overall Study|Withdrawal by Subject|0
5685142|NCT00362115|19607043|P3|Overall Study|Withdrawal by Subject|1
5685143|NCT00362115|19607044|P2|Overall Study|Withdrawal by Subject|3
5685144|NCT00362115|19607045|P1|Overall Study|Withdrawal by Subject|1
5685145|NCT00362115|19607039|P7|Overall Study|Lost to Follow-up|1
5685146|NCT00362115|19607040|P6|Overall Study|Lost to Follow-up|0
5685147|NCT00362115|19607041|P5|Overall Study|Lost to Follow-up|2
5685148|NCT00362115|19607042|P4|Overall Study|Lost to Follow-up|0
5685149|NCT00362115|19607043|P3|Overall Study|Lost to Follow-up|0
5685150|NCT00362115|19607044|P2|Overall Study|Lost to Follow-up|1
5685151|NCT00362115|19607045|P1|Overall Study|Lost to Follow-up|0
5685152|NCT00362115|19607039|P7|Overall Study|Protocol Violation|0
5685153|NCT00362115|19607040|P6|Overall Study|Protocol Violation|1
5685154|NCT00362115|19607041|P5|Overall Study|Protocol Violation|0
5685155|NCT00362115|19607042|P4|Overall Study|Protocol Violation|0
5685156|NCT00362115|19607043|P3|Overall Study|Protocol Violation|0
5685157|NCT00362115|19607044|P2|Overall Study|Protocol Violation|0
5685158|NCT00362115|19607045|P1|Overall Study|Protocol Violation|0
5685159|NCT00362115|19607039|P7|Overall Study|Adverse Event|1
5685160|NCT00362115|19607040|P6|Overall Study|Adverse Event|2
5685161|NCT00362115|19607041|P5|Overall Study|Adverse Event|2
5685162|NCT00362115|19607042|P4|Overall Study|Adverse Event|1
5685163|NCT00362115|19607043|P3|Overall Study|Adverse Event|1
5685164|NCT00362115|19607044|P2|Overall Study|Adverse Event|1
5685165|NCT00362115|19607045|P1|Overall Study|Adverse Event|0
5685166|NCT00361634|19607218|P1|Overall Study|Withdrawal by Subject|1
5685167|NCT00361634|19607218|P1|Overall Study|Lost to Follow-up|1
5685168|NCT00361569|19607247|P4|Overall Study|Not specified by investigator|1
5685169|NCT00361569|19607248|P3|Overall Study|Not specified by investigator|0
5685170|NCT00361569|19607249|P2|Overall Study|Not specified by investigator|0
5685171|NCT00361569|19607250|P1|Overall Study|Not specified by investigator|2
5685172|NCT00361569|19607247|P4|Overall Study|Lost to Follow-up|2
5685173|NCT00361569|19607248|P3|Overall Study|Lost to Follow-up|3
5685174|NCT00361569|19607249|P2|Overall Study|Lost to Follow-up|3
5685175|NCT00361569|19607250|P1|Overall Study|Lost to Follow-up|2
5685176|NCT00361569|19607247|P4|Overall Study|Adverse Event|2
5685177|NCT00361569|19607248|P3|Overall Study|Adverse Event|2
5685178|NCT00361569|19607249|P2|Overall Study|Adverse Event|5
5685179|NCT00361569|19607250|P1|Overall Study|Adverse Event|3
5685180|NCT00361569|19607247|P4|Overall Study|Withdrawal by Subject|14
5685181|NCT00361569|19607248|P3|Overall Study|Withdrawal by Subject|9
5685182|NCT00361569|19607249|P2|Overall Study|Withdrawal by Subject|1
5685183|NCT00361569|19607250|P1|Overall Study|Withdrawal by Subject|2
5685184|NCT00361569|19607247|P4|Overall Study|Protocol Violation|2
5685185|NCT00361569|19607248|P3|Overall Study|Protocol Violation|4
5685186|NCT00361569|19607249|P2|Overall Study|Protocol Violation|2
5685187|NCT00361569|19607250|P1|Overall Study|Protocol Violation|3
5685188|NCT00361504|19607274|P2|Overall Study|All other|3
5685189|NCT00361504|19607275|P1|Overall Study|All other|28
5685190|NCT00361504|19607274|P2|Overall Study|Study medication non compliant|15
5685191|NCT00361504|19607275|P1|Overall Study|Study medication non compliant|42
5685192|NCT00361504|19607274|P2|Overall Study|Resolution of Pain|0
5685193|NCT00361504|19607275|P1|Overall Study|Resolution of Pain|2
5685194|NCT00361504|19607274|P2|Overall Study|Lack of Efficacy|7
5685195|NCT00361504|19607275|P1|Overall Study|Lack of Efficacy|72
5685196|NCT00361504|19607274|P2|Overall Study|Adverse Event|82
5685197|NCT00361504|19607275|P1|Overall Study|Adverse Event|203
5685198|NCT00361504|19607274|P2|Overall Study|Lost to Follow-up|7
5685199|NCT00361504|19607275|P1|Overall Study|Lost to Follow-up|40
5685200|NCT00361504|19607274|P2|Overall Study|Withdrawal by Subject|31
5685201|NCT00361504|19607275|P1|Overall Study|Withdrawal by Subject|94
5685202|NCT00361335|19607316|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
5685203|NCT00361335|19607317|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5685204|NCT00361335|19607318|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5685205|NCT00361335|19607319|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5685206|NCT00361335|19607320|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
5685207|NCT00361335|19607321|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5685208|NCT00361335|19607322|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
5685209|NCT00361335|19607316|P7|SC Period: Week E0 to Week E24|Other|2
5685210|NCT00361335|19607317|P6|SC Period: Week E0 to Week E24|Other|1
5685211|NCT00361335|19607318|P5|SC Period: Week E0 to Week E24|Other|0
5685212|NCT00361335|19607319|P4|SC Period: Week E0 to Week E24|Other|1
5685213|NCT00361335|19607320|P3|SC Period: Week E0 to Week E24|Other|0
5685214|NCT00361335|19607321|P2|SC Period: Week E0 to Week E24|Other|0
5685215|NCT00361335|19607322|P1|SC Period: Week E0 to Week E24|Other|1
5685216|NCT00361335|19607316|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
5685217|NCT00361335|19607317|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
5685218|NCT00361335|19607318|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
5685219|NCT00361335|19607319|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
5685220|NCT00361335|19607320|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
5685221|NCT00361335|19607321|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
5685222|NCT00361335|19607322|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
5685223|NCT00361335|19607316|P7|SC Period: Week E0 to Week E24|Death|1
5685224|NCT00361335|19607317|P6|SC Period: Week E0 to Week E24|Death|0
5685225|NCT00361335|19607318|P5|SC Period: Week E0 to Week E24|Death|0
5685226|NCT00361335|19607319|P4|SC Period: Week E0 to Week E24|Death|0
5685227|NCT00361335|19607320|P3|SC Period: Week E0 to Week E24|Death|0
5685228|NCT00361335|19607321|P2|SC Period: Week E0 to Week E24|Death|0
5685229|NCT00361335|19607322|P1|SC Period: Week E0 to Week E24|Death|0
5685230|NCT00361335|19607316|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
5685231|NCT00361335|19607317|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
5685232|NCT00361335|19607318|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
5685233|NCT00361335|19607319|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
5685234|NCT00361335|19607320|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
5685235|NCT00361335|19607321|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
5685236|NCT00361335|19607322|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
5685237|NCT00361335|19607316|P7|SC Period: Week E0 to Week E24|Adverse Event|2
5685238|NCT00361335|19607317|P6|SC Period: Week E0 to Week E24|Adverse Event|0
5685239|NCT00361335|19607318|P5|SC Period: Week E0 to Week E24|Adverse Event|0
5685240|NCT00361335|19607319|P4|SC Period: Week E0 to Week E24|Adverse Event|2
5685241|NCT00361335|19607320|P3|SC Period: Week E0 to Week E24|Adverse Event|1
5685242|NCT00361335|19607321|P2|SC Period: Week E0 to Week E24|Adverse Event|2
5685243|NCT00361335|19607322|P1|SC Period: Week E0 to Week E24|Adverse Event|0
5685244|NCT00361335|19607316|P7|IV Period: Baseline to E0|Lack of Efficacy|0
5685245|NCT00361335|19607317|P6|IV Period: Baseline to E0|Lack of Efficacy|0
5685246|NCT00361335|19607318|P5|IV Period: Baseline to E0|Lack of Efficacy|8
5685247|NCT00361335|19607319|P4|IV Period: Baseline to E0|Lack of Efficacy|7
5685248|NCT00361335|19607320|P3|IV Period: Baseline to E0|Lack of Efficacy|3
5685249|NCT00361335|19607321|P2|IV Period: Baseline to E0|Lack of Efficacy|9
5685250|NCT00361335|19607322|P1|IV Period: Baseline to E0|Lack of Efficacy|5
5685251|NCT00361335|19607316|P7|IV Period: Baseline to E0|Other|0
5685252|NCT00361335|19607317|P6|IV Period: Baseline to E0|Other|0
5685253|NCT00361335|19607318|P5|IV Period: Baseline to E0|Other|2
5685254|NCT00361335|19607319|P4|IV Period: Baseline to E0|Other|3
5685255|NCT00361335|19607320|P3|IV Period: Baseline to E0|Other|9
5685256|NCT00361335|19607321|P2|IV Period: Baseline to E0|Other|9
5685257|NCT00361335|19607322|P1|IV Period: Baseline to E0|Other|2
5685258|NCT00361335|19607316|P7|IV Period: Baseline to E0|Worsening of RA|0
5685259|NCT00361335|19607317|P6|IV Period: Baseline to E0|Worsening of RA|0
5685260|NCT00361335|19607318|P5|IV Period: Baseline to E0|Worsening of RA|2
5685261|NCT00361335|19607319|P4|IV Period: Baseline to E0|Worsening of RA|4
5685262|NCT00361335|19607320|P3|IV Period: Baseline to E0|Worsening of RA|1
5685263|NCT00361335|19607321|P2|IV Period: Baseline to E0|Worsening of RA|5
5685264|NCT00361335|19607322|P1|IV Period: Baseline to E0|Worsening of RA|0
5685265|NCT00361335|19607316|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
5685266|NCT00361335|19607317|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
5685267|NCT00361335|19607318|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
5685268|NCT00361335|19607319|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
5685269|NCT00361335|19607320|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
5685270|NCT00361335|19607321|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
5685271|NCT00361335|19607322|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
5685272|NCT00361335|19607316|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
5685273|NCT00361335|19607317|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
5685274|NCT00361335|19607318|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
5685275|NCT00361335|19607319|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
5685276|NCT00361335|19607320|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
5685277|NCT00361335|19607321|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
5685278|NCT00361335|19607322|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
5685279|NCT00361335|19607316|P7|IV Period: Baseline to E0|Death|0
5685280|NCT00361335|19607317|P6|IV Period: Baseline to E0|Death|0
5685281|NCT00361335|19607318|P5|IV Period: Baseline to E0|Death|0
5685282|NCT00361335|19607319|P4|IV Period: Baseline to E0|Death|1
5685283|NCT00361335|19607320|P3|IV Period: Baseline to E0|Death|1
5685284|NCT00361335|19607321|P2|IV Period: Baseline to E0|Death|1
5685285|NCT00361335|19607322|P1|IV Period: Baseline to E0|Death|1
5685286|NCT00361335|19607316|P7|IV Period: Baseline to E0|Lost to Follow-up|0
5685287|NCT00361335|19607317|P6|IV Period: Baseline to E0|Lost to Follow-up|0
5685288|NCT00361335|19607318|P5|IV Period: Baseline to E0|Lost to Follow-up|2
5685289|NCT00361335|19607319|P4|IV Period: Baseline to E0|Lost to Follow-up|2
5685290|NCT00361335|19607320|P3|IV Period: Baseline to E0|Lost to Follow-up|0
5685291|NCT00361335|19607321|P2|IV Period: Baseline to E0|Lost to Follow-up|0
5685292|NCT00361335|19607322|P1|IV Period: Baseline to E0|Lost to Follow-up|1
5685293|NCT00361335|19607316|P7|IV Period: Baseline to E0|Adverse Event|0
5685294|NCT00361335|19607317|P6|IV Period: Baseline to E0|Adverse Event|0
5685295|NCT00361335|19607318|P5|IV Period: Baseline to E0|Adverse Event|8
5685296|NCT00361335|19607319|P4|IV Period: Baseline to E0|Adverse Event|9
5685297|NCT00361335|19607320|P3|IV Period: Baseline to E0|Adverse Event|5
5685298|NCT00361335|19607321|P2|IV Period: Baseline to E0|Adverse Event|4
5685299|NCT00361335|19607322|P1|IV Period: Baseline to E0|Adverse Event|9
5685300|NCT00361296|19607366|P1|Overall Study|Lack of Efficacy|2
5685301|NCT00361296|19607366|P1|Overall Study|Physician Decision|1
5685302|NCT00361283|19607373|P1|Overall Study|Lost to Follow-up|27
5685303|NCT00361270|19607381|P4|Overall Study|Adverse Event|0
5685304|NCT00361270|19607382|P3|Overall Study|Adverse Event|1
5685305|NCT00361270|19607383|P2|Overall Study|Adverse Event|1
5685306|NCT00361270|19607384|P1|Overall Study|Adverse Event|0
5685307|NCT00361270|19607381|P4|Overall Study|Problems with Transportation|0
5685308|NCT00361270|19607382|P3|Overall Study|Problems with Transportation|0
5685309|NCT00361270|19607383|P2|Overall Study|Problems with Transportation|0
5685310|NCT00361270|19607384|P1|Overall Study|Problems with Transportation|4
5685311|NCT00361270|19607381|P4|Overall Study|Afraid of Hypnosis|0
5685312|NCT00361270|19607382|P3|Overall Study|Afraid of Hypnosis|0
5685313|NCT00361270|19607383|P2|Overall Study|Afraid of Hypnosis|2
5685314|NCT00361270|19607384|P1|Overall Study|Afraid of Hypnosis|1
5685315|NCT00361270|19607381|P4|Overall Study|Withdrawal by Subject|7
5685316|NCT00361270|19607382|P3|Overall Study|Withdrawal by Subject|3
5685317|NCT00361270|19607383|P2|Overall Study|Withdrawal by Subject|6
5685318|NCT00361270|19607384|P1|Overall Study|Withdrawal by Subject|6
5685319|NCT00361270|19607381|P4|Overall Study|Protocol Violation|4
5685320|NCT00361270|19607382|P3|Overall Study|Protocol Violation|5
5685321|NCT00361270|19607383|P2|Overall Study|Protocol Violation|4
5685322|NCT00361270|19607384|P1|Overall Study|Protocol Violation|9
5685323|NCT00361270|19607381|P4|Overall Study|Physician Decision|0
5685324|NCT00361270|19607382|P3|Overall Study|Physician Decision|1
5685325|NCT00361270|19607383|P2|Overall Study|Physician Decision|0
5685326|NCT00361270|19607384|P1|Overall Study|Physician Decision|0
5685327|NCT00361270|19607381|P4|Overall Study|Lost to Follow-up|0
5685328|NCT00361270|19607382|P3|Overall Study|Lost to Follow-up|0
5685329|NCT00361270|19607383|P2|Overall Study|Lost to Follow-up|1
5685330|NCT00361270|19607384|P1|Overall Study|Lost to Follow-up|4
5685331|NCT00361270|19607381|P4|Overall Study|Death|2
5685332|NCT00361270|19607382|P3|Overall Study|Death|0
5685333|NCT00361270|19607383|P2|Overall Study|Death|0
5685334|NCT00361270|19607384|P1|Overall Study|Death|0
5685335|NCT00361231|19607457|P1|Overall Study|Adverse Event|6
5685336|NCT00361231|19607457|P1|Overall Study|Withdrawal by Subject|4
5685337|NCT00361231|19607457|P1|Overall Study|Radiographic disease progression|16
5685338|NCT00361231|19607457|P1|Overall Study|Symptomatic deterioration|5
5685339|NCT00361231|19607457|P1|Overall Study|Physician Decision|3
5685340|NCT00361218|19607462|P1|Overall Study|terminated / withdrawn due to toxicity /|5
5685341|NCT00361218|19607462|P1|Overall Study|Personal Reasons|7
5685342|NCT00361218|19607462|P1|Overall Study|Lost to Follow-up|11
5685343|NCT00360698|19607541|P2|Treatment Period|Early termination by error|1
5685344|NCT00360698|19607542|P1|Treatment Period|Early termination by error|0
5685345|NCT00360698|19607541|P2|Treatment Period|Non compliance with treatment procedure|0
5685346|NCT00360698|19607542|P1|Treatment Period|Non compliance with treatment procedure|1
5685347|NCT00360698|19607541|P2|Run-In|Need of insulin with meals|1
5685348|NCT00360698|19607542|P1|Run-In|Need of insulin with meals|0
5685349|NCT00360698|19607541|P2|Run-In|Patient personal reasons|2
5685350|NCT00360698|19607542|P1|Run-In|Patient personal reasons|0
5685351|NCT00360698|19607541|P2|Run-In|Patient did not meet inclusion criteria|1
5685352|NCT00360698|19607542|P1|Run-In|Patient did not meet inclusion criteria|0
5685353|NCT00360698|19607541|P2|Run-In|Sponsor request|2
5685354|NCT00360698|19607542|P1|Run-In|Sponsor request|0
5685355|NCT00360698|19607541|P2|Run-In|Non compliance with treatment procedure|1
5685356|NCT00360698|19607542|P1|Run-In|Non compliance with treatment procedure|0
5685357|NCT00360698|19607541|P2|Run-In|Withdrawal by Subject|2
5685358|NCT00360698|19607542|P1|Run-In|Withdrawal by Subject|0
5685359|NCT00360698|19607541|P2|Run-In|Physician Decision|1
5685360|NCT00360698|19607542|P1|Run-In|Physician Decision|0
5685361|NCT00360568|19607587|P2|Overall Study|Withdrawal by Subject|3
5685362|NCT00360568|19607588|P1|Overall Study|Withdrawal by Subject|0
5685363|NCT00360568|19607587|P2|Overall Study|Lack of Efficacy|0
5685364|NCT00360568|19607588|P1|Overall Study|Lack of Efficacy|1
5685365|NCT00360568|19607587|P2|Overall Study|Adverse Event|2
5685366|NCT00360568|19607588|P1|Overall Study|Adverse Event|1
5685367|NCT00360529|19607719|P3|Overall Study|Reason discontinued not explained above|11
5685368|NCT00360529|19607720|P2|Overall Study|Reason discontinued not explained above|9
5685369|NCT00360529|19607721|P1|Overall Study|Reason discontinued not explained above|4
5685370|NCT00360529|19607719|P3|Overall Study|Lack of Efficacy|5
5685371|NCT00360529|19607720|P2|Overall Study|Lack of Efficacy|6
5685372|NCT00360529|19607721|P1|Overall Study|Lack of Efficacy|8
5685373|NCT00360529|19607719|P3|Overall Study|Withdrawal by Subject|18
5685374|NCT00360529|19607720|P2|Overall Study|Withdrawal by Subject|14
5685375|NCT00360529|19607721|P1|Overall Study|Withdrawal by Subject|22
5685376|NCT00360529|19607719|P3|Overall Study|Lost to Follow-up|13
5685377|NCT00360529|19607720|P2|Overall Study|Lost to Follow-up|10
5685378|NCT00360529|19607721|P1|Overall Study|Lost to Follow-up|14
5685379|NCT00360529|19607719|P3|Overall Study|Protocol Violation|11
5685380|NCT00360529|19607720|P2|Overall Study|Protocol Violation|3
5685381|NCT00360529|19607721|P1|Overall Study|Protocol Violation|3
5685382|NCT00360529|19607719|P3|Overall Study|Adverse Event|33
5685383|NCT00360529|19607720|P2|Overall Study|Adverse Event|23
5685384|NCT00360529|19607721|P1|Overall Study|Adverse Event|10
5685385|NCT00360490|19607749|P2|Overall Study|Withdrawal by Subject|3
5685386|NCT00360490|19607750|P1|Overall Study|Withdrawal by Subject|1
5685387|NCT00360490|19607749|P2|Overall Study|Protocol Violation|4
5685388|NCT00360490|19607750|P1|Overall Study|Protocol Violation|0
5685389|NCT00360490|19607749|P2|Overall Study|Physician Decision|1
5685390|NCT00360490|19607750|P1|Overall Study|Physician Decision|2
5685391|NCT00360490|19607749|P2|Overall Study|Lost to Follow-up|1
5685392|NCT00360490|19607750|P1|Overall Study|Lost to Follow-up|2
5685393|NCT00360490|19607749|P2|Overall Study|Adverse Event|2
5685394|NCT00360490|19607750|P1|Overall Study|Adverse Event|4
5685395|NCT00360412|19607785|P2|Overall Study|Study termination by Sponsor|469
5685396|NCT00360412|19607786|P1|Overall Study|Study termination by Sponsor|214
5685397|NCT00360412|19607785|P2|Overall Study|Other|6
5685398|NCT00360412|19607786|P1|Overall Study|Other|5
5685399|NCT00360412|19607785|P2|Overall Study|Physician Decision|4
5685400|NCT00360412|19607786|P1|Overall Study|Physician Decision|2
5685401|NCT00360412|19607785|P2|Overall Study|Lack of therapeutic efficacy|61
5685402|NCT00360412|19607786|P1|Overall Study|Lack of therapeutic efficacy|46
5685403|NCT00360412|19607785|P2|Overall Study|Patient withdrew consent|52
5685404|NCT00360412|19607786|P1|Overall Study|Patient withdrew consent|27
5685405|NCT00360412|19607785|P2|Overall Study|Protocol Violation|5
5685406|NCT00360412|19607786|P1|Overall Study|Protocol Violation|2
5685407|NCT00360412|19607785|P2|Overall Study|Adverse Event|65
5685408|NCT00360412|19607786|P1|Overall Study|Adverse Event|37
5685409|NCT00360334|19607833|P2|Overall Study|Subject decision|2
5685410|NCT00360334|19607834|P1|Overall Study|Subject decision|8
5685411|NCT00360334|19607833|P2|Overall Study|Entry criterion not met|2
5685412|NCT00360334|19607834|P1|Overall Study|Entry criterion not met|1
5685413|NCT00360334|19607833|P2|Overall Study|Lack of Efficacy|1
5685414|NCT00360334|19607834|P1|Overall Study|Lack of Efficacy|0
5685415|NCT00360334|19607833|P2|Overall Study|Physician Decision|3
5685416|NCT00360334|19607834|P1|Overall Study|Physician Decision|2
5685417|NCT00360334|19607833|P2|Overall Study|Protocol Violation|1
5685418|NCT00360334|19607834|P1|Overall Study|Protocol Violation|1
5685419|NCT00360334|19607833|P2|Overall Study|Adverse Event|4
5685420|NCT00360334|19607834|P1|Overall Study|Adverse Event|7
5685421|NCT00360308|19607897|P3|Overall Study|Study termination by sponsor|44
5685422|NCT00360308|19607898|P2|Overall Study|Study termination by sponsor|55
5685423|NCT00360308|19607899|P1|Overall Study|Study termination by sponsor|43
5685424|NCT00360308|19607897|P3|Overall Study|Other|1
5685425|NCT00360308|19607898|P2|Overall Study|Other|1
5685426|NCT00360308|19607899|P1|Overall Study|Other|2
5685427|NCT00360308|19607897|P3|Overall Study|Lack of Efficacy|2
5685428|NCT00360308|19607898|P2|Overall Study|Lack of Efficacy|0
5685429|NCT00360308|19607899|P1|Overall Study|Lack of Efficacy|3
5685430|NCT00360308|19607897|P3|Overall Study|Withdrawal by Subject|14
5685431|NCT00360308|19607898|P2|Overall Study|Withdrawal by Subject|7
5685432|NCT00360308|19607899|P1|Overall Study|Withdrawal by Subject|11
5685433|NCT00360308|19607897|P3|Overall Study|Protocol Violation|2
5685434|NCT00360308|19607898|P2|Overall Study|Protocol Violation|1
5685435|NCT00360308|19607899|P1|Overall Study|Protocol Violation|2
5685436|NCT00360308|19607897|P3|Overall Study|Abnormal Laboratory Value(s)|0
5685437|NCT00360308|19607898|P2|Overall Study|Abnormal Laboratory Value(s)|1
5685438|NCT00360308|19607899|P1|Overall Study|Abnormal Laboratory Value(s)|0
5685439|NCT00360308|19607897|P3|Overall Study|Adverse Event|25
5685440|NCT00360308|19607898|P2|Overall Study|Adverse Event|14
5685441|NCT00360308|19607899|P1|Overall Study|Adverse Event|15
5685442|NCT00360282|19607916|P4|Second Intervention|Adverse Event|0
5685443|NCT00360282|19607917|P3|Second Intervention|Adverse Event|0
5685444|NCT00360282|19607918|P2|Second Intervention|Adverse Event|1
5685445|NCT00360282|19607919|P1|Second Intervention|Adverse Event|0
5685446|NCT00360282|19607916|P4|Washout 1-3 Weeks|Lost to Follow-up|0
5685447|NCT00360282|19607917|P3|Washout 1-3 Weeks|Lost to Follow-up|1
5685448|NCT00360282|19607918|P2|Washout 1-3 Weeks|Lost to Follow-up|0
5685449|NCT00360282|19607919|P1|Washout 1-3 Weeks|Lost to Follow-up|0
5685450|NCT00360269|19607931|P2|Overall Study|Withdrawal by Subject|1
5685451|NCT00360269|19607932|P1|Overall Study|Withdrawal by Subject|1
5685452|NCT00360269|19607931|P2|Overall Study|Adverse Event|0
5685453|NCT00360269|19607932|P1|Overall Study|Adverse Event|1
5685454|NCT00360269|19607931|P2|Overall Study|Physician Decision|2
5685455|NCT00360269|19607932|P1|Overall Study|Physician Decision|1
5685456|NCT00360269|19607931|P2|Overall Study|Lost to Follow-up|9
5685457|NCT00360269|19607932|P1|Overall Study|Lost to Follow-up|7
5685458|NCT00360230|19607974|P7|Overall Study|Death|1
5685459|NCT00360230|19607975|P6|Overall Study|Death|1
5685460|NCT00360230|19607976|P5|Overall Study|Death|0
5685461|NCT00360230|19607977|P4|Overall Study|Death|0
5685462|NCT00360230|19607978|P3|Overall Study|Death|0
5685463|NCT00360230|19607979|P2|Overall Study|Death|1
5685464|NCT00360230|19607980|P1|Overall Study|Death|0
5685465|NCT00360230|19607974|P7|Overall Study|Protocol Violation|0
5685466|NCT00360230|19607975|P6|Overall Study|Protocol Violation|1
5685467|NCT00360230|19607976|P5|Overall Study|Protocol Violation|0
5685468|NCT00360230|19607977|P4|Overall Study|Protocol Violation|0
5685469|NCT00360230|19607978|P3|Overall Study|Protocol Violation|0
5685470|NCT00360230|19607979|P2|Overall Study|Protocol Violation|0
5685471|NCT00360230|19607980|P1|Overall Study|Protocol Violation|0
5685472|NCT00360230|19607974|P7|Overall Study|Other|0
5685473|NCT00360230|19607975|P6|Overall Study|Other|0
5685474|NCT00360230|19607976|P5|Overall Study|Other|0
5685475|NCT00360230|19607977|P4|Overall Study|Other|0
5685476|NCT00360230|19607978|P3|Overall Study|Other|0
5685477|NCT00360230|19607979|P2|Overall Study|Other|0
5685478|NCT00360230|19607980|P1|Overall Study|Other|1
5685479|NCT00360230|19607974|P7|Overall Study|Migrated|1
5685480|NCT00360230|19607975|P6|Overall Study|Migrated|1
5685481|NCT00360230|19607976|P5|Overall Study|Migrated|4
5685482|NCT00360230|19607977|P4|Overall Study|Migrated|1
5685483|NCT00360230|19607978|P3|Overall Study|Migrated|3
5685484|NCT00360230|19607979|P2|Overall Study|Migrated|1
5685485|NCT00360230|19607980|P1|Overall Study|Migrated|4
5685486|NCT00360230|19607974|P7|Overall Study|Withdrawal by Subject|0
5685487|NCT00360230|19607975|P6|Overall Study|Withdrawal by Subject|1
5685488|NCT00360230|19607976|P5|Overall Study|Withdrawal by Subject|1
5685489|NCT00360230|19607977|P4|Overall Study|Withdrawal by Subject|1
5685490|NCT00360230|19607978|P3|Overall Study|Withdrawal by Subject|0
5685491|NCT00360230|19607979|P2|Overall Study|Withdrawal by Subject|1
5685492|NCT00360230|19607980|P1|Overall Study|Withdrawal by Subject|1
5685493|NCT00359801|19608136|P2|Overall Study|Sponsor Decision|16
5685494|NCT00359801|19608137|P1|Overall Study|Sponsor Decision|17
5685495|NCT00359801|19608136|P2|Overall Study|Final Status Unknown: missing data|4
5685496|NCT00359801|19608137|P1|Overall Study|Final Status Unknown: missing data|7
5685497|NCT00359801|19608136|P2|Overall Study|Other|46
5685498|NCT00359801|19608137|P1|Overall Study|Other|66
5685499|NCT00359801|19608136|P2|Overall Study|Withdrawal by Subject|96
5685500|NCT00359801|19608137|P1|Overall Study|Withdrawal by Subject|143
5685501|NCT00359801|19608136|P2|Overall Study|Lost to Follow-up|58
5685502|NCT00359801|19608137|P1|Overall Study|Lost to Follow-up|72
5685503|NCT00359788|19608171|P2|Overall Study|Protocol Violation|2
5685504|NCT00359788|19608172|P1|Overall Study|Protocol Violation|4
5685505|NCT00359788|19608171|P2|Overall Study|Withdrawal by Subject|1
5685506|NCT00359788|19608172|P1|Overall Study|Withdrawal by Subject|4
5685507|NCT00359788|19608171|P2|Overall Study|Lost to Follow-up|2
5685508|NCT00359788|19608172|P1|Overall Study|Lost to Follow-up|3
5685509|NCT00359788|19608171|P2|Overall Study|Lack of Efficacy|2
5685510|NCT00359788|19608172|P1|Overall Study|Lack of Efficacy|1
5685511|NCT00359788|19608171|P2|Overall Study|Adverse Event|10
5685512|NCT00359788|19608172|P1|Overall Study|Adverse Event|11
5685513|NCT00359762|19608406|P5|Period III|Subject Decision|0
5685514|NCT00359762|19608407|P4|Period III|Subject Decision|20
5685515|NCT00359762|19608408|P3|Period III|Subject Decision|8
5685516|NCT00359762|19608409|P2|Period III|Subject Decision|7
5685517|NCT00359762|19608410|P1|Period III|Subject Decision|0
5685518|NCT00359762|19608406|P5|Period III|Entry Criteria Not Met|0
5685519|NCT00359762|19608407|P4|Period III|Entry Criteria Not Met|1
5685520|NCT00359762|19608408|P3|Period III|Entry Criteria Not Met|0
5685521|NCT00359762|19608409|P2|Period III|Entry Criteria Not Met|1
5685522|NCT00359762|19608410|P1|Period III|Entry Criteria Not Met|0
5685523|NCT00359762|19608406|P5|Period III|Lost to follow up|0
5685524|NCT00359762|19608407|P4|Period III|Lost to follow up|2
5685525|NCT00359762|19608408|P3|Period III|Lost to follow up|1
5685526|NCT00359762|19608409|P2|Period III|Lost to follow up|1
5685527|NCT00359762|19608410|P1|Period III|Lost to follow up|0
5685528|NCT00359762|19608406|P5|Period III|Lack of Efficacy|0
5685529|NCT00359762|19608407|P4|Period III|Lack of Efficacy|9
5685530|NCT00359762|19608408|P3|Period III|Lack of Efficacy|5
5685531|NCT00359762|19608409|P2|Period III|Lack of Efficacy|7
5685532|NCT00359762|19608410|P1|Period III|Lack of Efficacy|0
5685533|NCT00359762|19608406|P5|Period III|Physician Decision|0
5685534|NCT00359762|19608407|P4|Period III|Physician Decision|15
5685535|NCT00359762|19608408|P3|Period III|Physician Decision|9
5685536|NCT00359762|19608409|P2|Period III|Physician Decision|5
5685537|NCT00359762|19608410|P1|Period III|Physician Decision|0
5685538|NCT00359762|19608406|P5|Period III|Adverse Event|0
5685539|NCT00359762|19608407|P4|Period III|Adverse Event|10
5685540|NCT00359762|19608408|P3|Period III|Adverse Event|4
5685541|NCT00359762|19608409|P2|Period III|Adverse Event|3
5685542|NCT00359762|19608410|P1|Period III|Adverse Event|0
5685543|NCT00359762|19608406|P5|Period III|Protocol Violation|0
5685544|NCT00359762|19608407|P4|Period III|Protocol Violation|8
5685545|NCT00359762|19608408|P3|Period III|Protocol Violation|3
5685546|NCT00359762|19608409|P2|Period III|Protocol Violation|5
5685547|NCT00359762|19608410|P1|Period III|Protocol Violation|0
5685548|NCT00359762|19608406|P5|Period II|Subject Decision|70
5685549|NCT00359762|19608407|P4|Period II|Subject Decision|0
5685550|NCT00359762|19608408|P3|Period II|Subject Decision|0
5685551|NCT00359762|19608409|P2|Period II|Subject Decision|0
5685552|NCT00359762|19608410|P1|Period II|Subject Decision|50
5685553|NCT00359762|19608406|P5|Period II|Entry Criteria Not Met|4
5685554|NCT00359762|19608407|P4|Period II|Entry Criteria Not Met|0
5685555|NCT00359762|19608408|P3|Period II|Entry Criteria Not Met|0
5685556|NCT00359762|19608409|P2|Period II|Entry Criteria Not Met|0
5685557|NCT00359762|19608410|P1|Period II|Entry Criteria Not Met|8
5685558|NCT00359762|19608406|P5|Period II|Lost to follow up|5
5685559|NCT00359762|19608407|P4|Period II|Lost to follow up|0
5685560|NCT00359762|19608408|P3|Period II|Lost to follow up|0
5685561|NCT00359762|19608409|P2|Period II|Lost to follow up|0
5685562|NCT00359762|19608410|P1|Period II|Lost to follow up|5
5685563|NCT00359762|19608406|P5|Period II|Lack of Efficacy|8
5685564|NCT00359762|19608407|P4|Period II|Lack of Efficacy|0
5685565|NCT00359762|19608408|P3|Period II|Lack of Efficacy|0
5685566|NCT00359762|19608409|P2|Period II|Lack of Efficacy|0
5685567|NCT00359762|19608410|P1|Period II|Lack of Efficacy|11
5685568|NCT00359762|19608406|P5|Period II|Death|4
5685569|NCT00359762|19608407|P4|Period II|Death|0
5685570|NCT00359762|19608408|P3|Period II|Death|0
5685571|NCT00359762|19608409|P2|Period II|Death|0
5685572|NCT00359762|19608410|P1|Period II|Death|2
5685573|NCT00359762|19608406|P5|Period II|Physician Decision|23
5685574|NCT00359762|19608407|P4|Period II|Physician Decision|0
5685575|NCT00359762|19608408|P3|Period II|Physician Decision|0
5685576|NCT00359762|19608409|P2|Period II|Physician Decision|0
5685577|NCT00359762|19608410|P1|Period II|Physician Decision|17
5685578|NCT00359762|19608406|P5|Period II|Protocol Violation|11
5685579|NCT00359762|19608407|P4|Period II|Protocol Violation|0
5685580|NCT00359762|19608408|P3|Period II|Protocol Violation|0
5685581|NCT00359762|19608409|P2|Period II|Protocol Violation|0
5685582|NCT00359762|19608410|P1|Period II|Protocol Violation|18
5685583|NCT00359762|19608406|P5|Period II|Adverse Event|49
5685584|NCT00359762|19608407|P4|Period II|Adverse Event|0
5685585|NCT00359762|19608408|P3|Period II|Adverse Event|0
5685586|NCT00359762|19608409|P2|Period II|Adverse Event|0
5685587|NCT00359762|19608410|P1|Period II|Adverse Event|17
5685588|NCT00359632|19608484|P2|Overall Study|Non-compliance with visit schedule|0
5685589|NCT00359632|19608485|P1|Overall Study|Non-compliance with visit schedule|1
5685590|NCT00359632|19608484|P2|Overall Study|Adverse Event|0
5685591|NCT00359632|19608485|P1|Overall Study|Adverse Event|1
5685592|NCT00359632|19608484|P2|Overall Study|Death|0
5685593|NCT00359632|19608485|P1|Overall Study|Death|2
5685594|NCT00359619|19608499|P7|Overall Study|Lost to Follow-up|0
5685595|NCT00359619|19608500|P6|Overall Study|Lost to Follow-up|5
5685596|NCT00359619|19608501|P5|Overall Study|Lost to Follow-up|1
5685597|NCT00359619|19608502|P4|Overall Study|Lost to Follow-up|1
5685598|NCT00359619|19608503|P3|Overall Study|Lost to Follow-up|2
5685599|NCT00359619|19608504|P2|Overall Study|Lost to Follow-up|4
5685600|NCT00359619|19608505|P1|Overall Study|Lost to Follow-up|4
5685601|NCT00359619|19608499|P7|Overall Study|Other|0
5685602|NCT00359619|19608500|P6|Overall Study|Other|0
5685603|NCT00359619|19608501|P5|Overall Study|Other|0
5685604|NCT00359619|19608502|P4|Overall Study|Other|0
5685605|NCT00359619|19608503|P3|Overall Study|Other|0
5685606|NCT00359619|19608504|P2|Overall Study|Other|0
5685607|NCT00359619|19608505|P1|Overall Study|Other|1
5685608|NCT00359619|19608499|P7|Overall Study|Withdrawal by Subject|3
5685609|NCT00359619|19608500|P6|Overall Study|Withdrawal by Subject|0
5685610|NCT00359619|19608501|P5|Overall Study|Withdrawal by Subject|2
5685611|NCT00359619|19608502|P4|Overall Study|Withdrawal by Subject|2
5685612|NCT00359619|19608503|P3|Overall Study|Withdrawal by Subject|4
5685613|NCT00359619|19608504|P2|Overall Study|Withdrawal by Subject|1
5685614|NCT00359619|19608505|P1|Overall Study|Withdrawal by Subject|3
5685615|NCT00359619|19608499|P7|Overall Study|Adverse Event|1
5685616|NCT00359619|19608500|P6|Overall Study|Adverse Event|0
5685617|NCT00359619|19608501|P5|Overall Study|Adverse Event|0
5685618|NCT00359619|19608502|P4|Overall Study|Adverse Event|0
5685619|NCT00359619|19608503|P3|Overall Study|Adverse Event|1
5685620|NCT00359619|19608504|P2|Overall Study|Adverse Event|0
5685621|NCT00359619|19608505|P1|Overall Study|Adverse Event|0
5685622|NCT00359424|19608635|P2|Overall Study|follow up not conducted|0
5685623|NCT00359424|19608636|P1|Overall Study|follow up not conducted|2
5685624|NCT00359424|19608635|P2|Overall Study|Withdrawal by Subject|2
5685625|NCT00359424|19608636|P1|Overall Study|Withdrawal by Subject|10
5685626|NCT00359424|19608635|P2|Overall Study|Lost to Follow-up|7
5685627|NCT00359424|19608636|P1|Overall Study|Lost to Follow-up|19
5685628|NCT00359424|19608635|P2|Overall Study|Death|58
5685629|NCT00359424|19608636|P1|Overall Study|Death|99
5685630|NCT00359281|19608675|P9|Overall Study|Withdrawal by Subject|0
5685631|NCT00359281|19608676|P8|Overall Study|Withdrawal by Subject|0
5685632|NCT00359281|19608677|P7|Overall Study|Withdrawal by Subject|1
5685633|NCT00359281|19608678|P6|Overall Study|Withdrawal by Subject|0
5685634|NCT00359281|19608679|P5|Overall Study|Withdrawal by Subject|0
5685635|NCT00359281|19608680|P4|Overall Study|Withdrawal by Subject|0
5685636|NCT00359281|19608681|P3|Overall Study|Withdrawal by Subject|0
5685637|NCT00359281|19608682|P2|Overall Study|Withdrawal by Subject|0
5685638|NCT00359281|19608683|P1|Overall Study|Withdrawal by Subject|0
5685639|NCT00359281|19608675|P9|Overall Study|Adverse Event|0
5685640|NCT00359281|19608676|P8|Overall Study|Adverse Event|0
5685641|NCT00359281|19608677|P7|Overall Study|Adverse Event|1
5685642|NCT00359281|19608678|P6|Overall Study|Adverse Event|0
5685643|NCT00359281|19608679|P5|Overall Study|Adverse Event|0
5685644|NCT00359281|19608680|P4|Overall Study|Adverse Event|0
5685645|NCT00359281|19608681|P3|Overall Study|Adverse Event|0
5685646|NCT00359281|19608682|P2|Overall Study|Adverse Event|0
5685647|NCT00359281|19608683|P1|Overall Study|Adverse Event|1
5685648|NCT00359073|19608746|P2|Overall Study|developed RV16 antibody|1
5685649|NCT00359073|19608747|P1|Overall Study|developed RV16 antibody|0
5685650|NCT00359073|19608746|P2|Overall Study|Eligibility criteria no longer met|0
5685651|NCT00359073|19608747|P1|Overall Study|Eligibility criteria no longer met|3
5685652|NCT00359073|19608746|P2|Overall Study|Withdrawal by Subject|1
5685653|NCT00359073|19608747|P1|Overall Study|Withdrawal by Subject|1
5685654|NCT00359021|19608759|P2|Overall Study|Pregnancy|0
5685655|NCT00359021|19608760|P1|Overall Study|Pregnancy|1
5685656|NCT00359021|19608759|P2|Overall Study|Other|1
5685657|NCT00359021|19608760|P1|Overall Study|Other|4
5685658|NCT00359021|19608759|P2|Overall Study|Lost to Follow-up|0
5685659|NCT00359021|19608760|P1|Overall Study|Lost to Follow-up|1
5685660|NCT00359021|19608759|P2|Overall Study|Withdrawal by Subject|9
5685661|NCT00359021|19608760|P1|Overall Study|Withdrawal by Subject|2
5685662|NCT00359021|19608759|P2|Overall Study|Subject Reached A Virologic Endpoint|32
5685663|NCT00359021|19608760|P1|Overall Study|Subject Reached A Virologic Endpoint|45
5685664|NCT00359021|19608759|P2|Overall Study|Subject Ineligible To Continue The Trial|0
5685665|NCT00359021|19608760|P1|Overall Study|Subject Ineligible To Continue The Trial|1
5685666|NCT00359021|19608759|P2|Overall Study|Subject Non-Compliant|2
5685667|NCT00359021|19608760|P1|Overall Study|Subject Non-Compliant|1
5685668|NCT00359021|19608759|P2|Overall Study|Adverse Event|8
5685669|NCT00359021|19608760|P1|Overall Study|Adverse Event|26
5685670|NCT00358956|19608772|P1|Overall Study|Withdrawal by Subject|1
5685671|NCT00358956|19608772|P1|Overall Study|condition under investigation worsened|4
5685672|NCT00358956|19608772|P1|Overall Study|Adverse Event|3
5685673|NCT00358917|19608784|P2|Overall Study|Unable to Continue Participation|2
5685674|NCT00358917|19608785|P1|Overall Study|Unable to Continue Participation|2
5685675|NCT00358917|19608784|P2|Overall Study|Virologic failure|8
5685676|NCT00358917|19608785|P1|Overall Study|Virologic failure|11
5685677|NCT00358917|19608784|P2|Overall Study|Death|3
5685678|NCT00358917|19608785|P1|Overall Study|Death|2
5685679|NCT00358917|19608784|P2|Overall Study|Noncompliance|11
5685680|NCT00358917|19608785|P1|Overall Study|Noncompliance|12
5685681|NCT00358917|19608784|P2|Overall Study|Lost to Follow-up|17
5685682|NCT00358917|19608785|P1|Overall Study|Lost to Follow-up|20
5685683|NCT00358917|19608784|P2|Overall Study|Withdrawal by Subject|7
5685684|NCT00358917|19608785|P1|Overall Study|Withdrawal by Subject|5
5685685|NCT00358917|19608784|P2|Overall Study|Adverse Event|21
5685686|NCT00358917|19608785|P1|Overall Study|Adverse Event|14
5685687|NCT00358826|19608803|P8|MDCT Substudy|Withdrawal by Subject|0
5685688|NCT00358826|19608804|P7|MDCT Substudy|Withdrawal by Subject|0
5685689|NCT00358826|19608805|P6|MDCT Substudy|Withdrawal by Subject|1
5685690|NCT00358826|19608806|P5|MDCT Substudy|Withdrawal by Subject|0
5685691|NCT00358826|19608807|P4|MDCT Substudy|Withdrawal by Subject|0
5685692|NCT00358826|19608808|P3|MDCT Substudy|Withdrawal by Subject|0
5685693|NCT00358826|19608809|P2|MDCT Substudy|Withdrawal by Subject|0
5685694|NCT00358826|19608810|P1|MDCT Substudy|Withdrawal by Subject|0
5685695|NCT00358826|19608803|P8|MDCT Substudy|Lost to Follow-up|0
5685696|NCT00358826|19608804|P7|MDCT Substudy|Lost to Follow-up|0
5685697|NCT00358826|19608805|P6|MDCT Substudy|Lost to Follow-up|1
5685698|NCT00358826|19608806|P5|MDCT Substudy|Lost to Follow-up|0
5685699|NCT00358826|19608807|P4|MDCT Substudy|Lost to Follow-up|0
5685700|NCT00358826|19608808|P3|MDCT Substudy|Lost to Follow-up|0
5685701|NCT00358826|19608809|P2|MDCT Substudy|Lost to Follow-up|0
5685702|NCT00358826|19608810|P1|MDCT Substudy|Lost to Follow-up|0
5685703|NCT00358826|19608803|P8|MDCT Substudy|Adverse Event|0
5685704|NCT00358826|19608804|P7|MDCT Substudy|Adverse Event|0
5685705|NCT00358826|19608805|P6|MDCT Substudy|Adverse Event|0
5685706|NCT00358826|19608806|P5|MDCT Substudy|Adverse Event|1
5685707|NCT00358826|19608807|P4|MDCT Substudy|Adverse Event|0
5685708|NCT00358826|19608808|P3|MDCT Substudy|Adverse Event|0
5685709|NCT00358826|19608809|P2|MDCT Substudy|Adverse Event|0
5685710|NCT00358826|19608810|P1|MDCT Substudy|Adverse Event|0
5685711|NCT00358826|19608803|P8|Core Study|Physician Decision|0
5685712|NCT00358826|19608804|P7|Core Study|Physician Decision|0
5685713|NCT00358826|19608805|P6|Core Study|Physician Decision|0
5685714|NCT00358826|19608806|P5|Core Study|Physician Decision|0
5685715|NCT00358826|19608807|P4|Core Study|Physician Decision|0
5685716|NCT00358826|19608808|P3|Core Study|Physician Decision|1
5685717|NCT00358826|19608809|P2|Core Study|Physician Decision|0
5685718|NCT00358826|19608810|P1|Core Study|Physician Decision|0
5685719|NCT00358826|19608803|P8|Core Study|Lost to Follow-up|0
5685720|NCT00358826|19608804|P7|Core Study|Lost to Follow-up|0
5685721|NCT00358826|19608805|P6|Core Study|Lost to Follow-up|0
5685722|NCT00358826|19608806|P5|Core Study|Lost to Follow-up|0
5685723|NCT00358826|19608807|P4|Core Study|Lost to Follow-up|1
5685724|NCT00358826|19608808|P3|Core Study|Lost to Follow-up|0
5685725|NCT00358826|19608809|P2|Core Study|Lost to Follow-up|0
5685726|NCT00358826|19608810|P1|Core Study|Lost to Follow-up|0
5685727|NCT00358826|19608803|P8|Core Study|Withdrawal by Subject|0
5685728|NCT00358826|19608804|P7|Core Study|Withdrawal by Subject|0
5685729|NCT00358826|19608805|P6|Core Study|Withdrawal by Subject|0
5685730|NCT00358826|19608806|P5|Core Study|Withdrawal by Subject|0
5685731|NCT00358826|19608807|P4|Core Study|Withdrawal by Subject|0
5685732|NCT00358826|19608808|P3|Core Study|Withdrawal by Subject|0
5685733|NCT00358826|19608809|P2|Core Study|Withdrawal by Subject|2
5685734|NCT00358826|19608810|P1|Core Study|Withdrawal by Subject|2
5685735|NCT00358826|19608803|P8|Core Study|Adverse Event|0
5685736|NCT00358826|19608804|P7|Core Study|Adverse Event|0
5685737|NCT00358826|19608805|P6|Core Study|Adverse Event|0
5685738|NCT00358826|19608806|P5|Core Study|Adverse Event|0
5685739|NCT00358826|19608807|P4|Core Study|Adverse Event|1
5685740|NCT00358826|19608808|P3|Core Study|Adverse Event|1
5685741|NCT00358826|19608809|P2|Core Study|Adverse Event|3
5685742|NCT00358826|19608810|P1|Core Study|Adverse Event|1
5685743|NCT00358670|19608877|P2|Overall Study|Administrative|125
5685744|NCT00358670|19608878|P1|Overall Study|Administrative|153
5685745|NCT00358670|19608877|P2|Overall Study|Did Not Meet Protocol Eligibility|3
5685746|NCT00358670|19608878|P1|Overall Study|Did Not Meet Protocol Eligibility|0
5685747|NCT00358670|19608877|P2|Overall Study|Protocol Defined Clinical Event|1
5685748|NCT00358670|19608878|P1|Overall Study|Protocol Defined Clinical Event|0
5685749|NCT00358670|19608877|P2|Overall Study|Withdrawal by Subject|24
5685750|NCT00358670|19608878|P1|Overall Study|Withdrawal by Subject|13
5685751|NCT00358670|19608877|P2|Overall Study|Lost to Follow-up|5
5685752|NCT00358670|19608878|P1|Overall Study|Lost to Follow-up|4
5685753|NCT00358670|19608877|P2|Overall Study|Protocol Violation|9
5685754|NCT00358670|19608878|P1|Overall Study|Protocol Violation|6
5685755|NCT00358670|19608877|P2|Overall Study|Lack of Efficacy|23
5685756|NCT00358670|19608878|P1|Overall Study|Lack of Efficacy|20
5685757|NCT00358670|19608877|P2|Overall Study|Adverse Event|29
5685758|NCT00358670|19608878|P1|Overall Study|Adverse Event|26
5685759|NCT00358644|19608892|P1|Overall Study|Patient not eligible for study|1
5685760|NCT00358644|19608892|P1|Overall Study|Physician Decision|6
5685761|NCT00358644|19608892|P1|Overall Study|Withdrawal by Subject|4
5685762|NCT00358644|19608892|P1|Overall Study|Death|11
5685763|NCT00358644|19608892|P1|Overall Study|Adverse Event|7
5685764|NCT00358644|19608892|P1|Overall Study|Progressive Disease|21
5685765|NCT00358527|19608915|P2|Overall Study|Administrative|1
5685766|NCT00358527|19608916|P1|Overall Study|Administrative|2
5685767|NCT00358527|19608915|P2|Overall Study|Non-compliance with protocol|1
5685768|NCT00358527|19608916|P1|Overall Study|Non-compliance with protocol|6
5685769|NCT00358527|19608915|P2|Overall Study|Withdrawal by Subject|1
5685770|NCT00358527|19608916|P1|Overall Study|Withdrawal by Subject|1
5685771|NCT00358527|19608915|P2|Overall Study|Adverse Event|0
5685772|NCT00358527|19608916|P1|Overall Study|Adverse Event|4
5685773|NCT00358449|19608966|P3|Overall Study|Steriod Inhaler was Increased|1
5685774|NCT00358449|19608967|P2|Overall Study|Steriod Inhaler was Increased|0
5685775|NCT00358449|19608968|P1|Overall Study|Steriod Inhaler was Increased|0
5685776|NCT00358449|19608966|P3|Overall Study|Lack of Efficacy|0
5685777|NCT00358449|19608967|P2|Overall Study|Lack of Efficacy|1
5685778|NCT00358449|19608968|P1|Overall Study|Lack of Efficacy|0
5685779|NCT00358449|19608966|P3|Overall Study|Withdrawal by Subject|0
5685780|NCT00358449|19608967|P2|Overall Study|Withdrawal by Subject|0
5685781|NCT00358449|19608968|P1|Overall Study|Withdrawal by Subject|2
5685782|NCT00358449|19608966|P3|Overall Study|Lost to Follow-up|0
5685783|NCT00358449|19608967|P2|Overall Study|Lost to Follow-up|0
5685784|NCT00358449|19608968|P1|Overall Study|Lost to Follow-up|1
5685785|NCT00358449|19608966|P3|Overall Study|Adverse Event|1
5685786|NCT00358449|19608967|P2|Overall Study|Adverse Event|0
5685787|NCT00358449|19608968|P1|Overall Study|Adverse Event|1
5685788|NCT00358436|19609071|P2|Overall Study|Other|1
5685789|NCT00358436|19609072|P1|Overall Study|Other|6
5685790|NCT00358436|19609071|P2|Overall Study|COPD exacerbation|10
5685791|NCT00358436|19609072|P1|Overall Study|COPD exacerbation|22
5685792|NCT00358436|19609071|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
5685793|NCT00358436|19609072|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
5685794|NCT00358436|19609071|P2|Overall Study|Withdrawal by Subject|17
5685795|NCT00358436|19609072|P1|Overall Study|Withdrawal by Subject|40
5685796|NCT00358436|19609071|P2|Overall Study|Protocol Violation|3
5685797|NCT00358436|19609072|P1|Overall Study|Protocol Violation|8
5685798|NCT00358436|19609071|P2|Overall Study|Lost to Follow-up|6
5685799|NCT00358436|19609072|P1|Overall Study|Lost to Follow-up|11
5685800|NCT00358436|19609071|P2|Overall Study|Lack of Efficacy|36
5685801|NCT00358436|19609072|P1|Overall Study|Lack of Efficacy|34
5685802|NCT00358436|19609071|P2|Overall Study|Adverse Event|13
5685803|NCT00358436|19609072|P1|Overall Study|Adverse Event|29
5685804|NCT00358215|19609143|P2|Overall Study|Did not receive investigational product|3
5685805|NCT00358215|19609144|P1|Overall Study|Did not receive investigational product|2
5685806|NCT00358215|19609143|P2|Overall Study|Other|14
5685807|NCT00358215|19609144|P1|Overall Study|Other|21
5685808|NCT00358215|19609143|P2|Overall Study|Pregnancy|0
5685809|NCT00358215|19609144|P1|Overall Study|Pregnancy|1
5685810|NCT00358215|19609143|P2|Overall Study|Protocol Violation|59
5685811|NCT00358215|19609144|P1|Overall Study|Protocol Violation|64
5685812|NCT00358215|19609143|P2|Overall Study|Death|281
5685813|NCT00358215|19609144|P1|Overall Study|Death|265
5685814|NCT00358215|19609143|P2|Overall Study|Lost to Follow-up|22
5685815|NCT00358215|19609144|P1|Overall Study|Lost to Follow-up|16
5685816|NCT00358215|19609143|P2|Overall Study|Physician Decision|39
5685817|NCT00358215|19609144|P1|Overall Study|Physician Decision|47
5685818|NCT00358215|19609143|P2|Overall Study|Participant request|64
5685819|NCT00358215|19609144|P1|Overall Study|Participant request|65
5685820|NCT00358215|19609143|P2|Overall Study|Withdrawal by Subject|102
5685821|NCT00358215|19609144|P1|Overall Study|Withdrawal by Subject|111
5685822|NCT00358215|19609143|P2|Overall Study|Adverse Event|65
5685823|NCT00358215|19609144|P1|Overall Study|Adverse Event|83
5685824|NCT00358215|19609143|P2|Overall Study|Ineligibility determined|3
5685825|NCT00358215|19609144|P1|Overall Study|Ineligibility determined|4
5685826|NCT00358150|19609158|P1|Overall Study|Undefined|3
5685827|NCT00358150|19609158|P1|Overall Study|Withdrawal by Subject|1
5685828|NCT00358150|19609158|P1|Overall Study|Adverse Event|3
5685829|NCT00357994|19609187|P2|Overall Study|Protocol Violation|0
5685830|NCT00357994|19609188|P1|Overall Study|Protocol Violation|1
5685831|NCT00357994|19609187|P2|Overall Study|Lack of Efficacy|1
5685832|NCT00357994|19609188|P1|Overall Study|Lack of Efficacy|0
5685833|NCT00357994|19609187|P2|Overall Study|Adverse Event|2
5685834|NCT00357994|19609188|P1|Overall Study|Adverse Event|1
5685835|NCT00357968|19609242|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
5685836|NCT00357968|19609243|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
5685837|NCT00357968|19609242|P2|First Maintenance Dose Phase|Not a PCI patient|42
5685838|NCT00357968|19609243|P1|First Maintenance Dose Phase|Not a PCI patient|47
5685839|NCT00357903|19609296|P2|Overall Study|Other|10
5685840|NCT00357903|19609297|P1|Overall Study|Other|49
5685841|NCT00357903|19609296|P2|Overall Study|Response status|9
5685842|NCT00357903|19609297|P1|Overall Study|Response status|61
5685843|NCT00357903|19609296|P2|Overall Study|Protocol issues|3
5685844|NCT00357903|19609297|P1|Overall Study|Protocol issues|14
5685845|NCT00357903|19609296|P2|Overall Study|Completed month 12 only|1
5685846|NCT00357903|19609297|P1|Overall Study|Completed month 12 only|0
5685847|NCT00357903|19609296|P2|Overall Study|Withdrawal by Subject|7
5685848|NCT00357903|19609297|P1|Overall Study|Withdrawal by Subject|57
5685849|NCT00357903|19609296|P2|Overall Study|Physician Decision|5
5685850|NCT00357903|19609297|P1|Overall Study|Physician Decision|39
5685851|NCT00357903|19609296|P2|Overall Study|Lost to Follow-up|4
5685852|NCT00357903|19609297|P1|Overall Study|Lost to Follow-up|23
5685853|NCT00357903|19609296|P2|Overall Study|Death|0
5685854|NCT00357903|19609297|P1|Overall Study|Death|33
5685855|NCT00357903|19609296|P2|Overall Study|Adverse Event|4
5685856|NCT00357903|19609297|P1|Overall Study|Adverse Event|87
5685857|NCT00357877|19609337|P2|Overall Study|Other|2
5685858|NCT00357877|19609338|P1|Overall Study|Other|0
5685859|NCT00357877|19609337|P2|Overall Study|Administrative withdrawal|1
5685860|NCT00357877|19609338|P1|Overall Study|Administrative withdrawal|1
5685861|NCT00357877|19609337|P2|Overall Study|Withdrawal by Subject|3
5685862|NCT00357877|19609338|P1|Overall Study|Withdrawal by Subject|3
5685863|NCT00357877|19609337|P2|Overall Study|Lost to Follow-up|23
5685864|NCT00357877|19609338|P1|Overall Study|Lost to Follow-up|20
5685865|NCT00357877|19609337|P2|Overall Study|Death|1
5685866|NCT00357877|19609338|P1|Overall Study|Death|2
5685867|NCT00357760|19609352|P2|Overall Study|To receive hospice care|1
5685868|NCT00357760|19609353|P1|Overall Study|To receive hospice care|0
5685869|NCT00357760|19609352|P2|Overall Study|Protocol Violation|1
5685870|NCT00357760|19609353|P1|Overall Study|Protocol Violation|0
5685871|NCT00357760|19609352|P2|Overall Study|Physician Decision|1
5685872|NCT00357760|19609353|P1|Overall Study|Physician Decision|2
5685873|NCT00357760|19609352|P2|Overall Study|Ineligible|2
5685874|NCT00357760|19609353|P1|Overall Study|Ineligible|0
5685875|NCT00357760|19609352|P2|Overall Study|Never started treatment|1
5685876|NCT00357760|19609353|P1|Overall Study|Never started treatment|2
5685877|NCT00357760|19609352|P2|Overall Study|Withdrawal by Subject|2
5685878|NCT00357760|19609353|P1|Overall Study|Withdrawal by Subject|0
5685879|NCT00357760|19609352|P2|Overall Study|Alternative therapy|0
5685880|NCT00357760|19609353|P1|Overall Study|Alternative therapy|1
5685881|NCT00357760|19609352|P2|Overall Study|Death|3
5685882|NCT00357760|19609353|P1|Overall Study|Death|0
5685883|NCT00357760|19609352|P2|Overall Study|Adverse Event|7
5685884|NCT00357760|19609353|P1|Overall Study|Adverse Event|10
5685885|NCT00357760|19609352|P2|Overall Study|Disease progression|17
5685886|NCT00357760|19609353|P1|Overall Study|Disease progression|44
5685887|NCT00357656|19609374|P2|Overall Study|Other, No surgery performed|3
5685888|NCT00357656|19609375|P1|Overall Study|Other, No surgery performed|0
5685889|NCT00357552|19609426|P1|Weeks 24 to 104|Not able to get to clinic|2
5685890|NCT00357552|19609426|P1|Weeks 24 to 104|Death|3
5685891|NCT00357552|19609426|P1|Weeks 0 to 24|Death|1
5685892|NCT00357552|19609426|P1|Screening|Did not meet eligibility criteria|84
5685893|NCT00357500|19609441|P1|Overall Study|Not Started Protocol Therapy|4
5685894|NCT00357500|19609441|P1|Overall Study|Progressive Disease|65
5685895|NCT00357500|19609441|P1|Overall Study|Withdrawal by Subject|5
5685896|NCT00357500|19609441|P1|Overall Study|Adverse Event|3
5685897|NCT00357396|19609450|P2|Overall Study|Adverse Event|0
5685898|NCT00357396|19609451|P1|Overall Study|Adverse Event|1
5685899|NCT00357370|19609459|P3|Cohort 2|Withdrawal by Subject|0
5685900|NCT00357370|19609460|P2|Cohort 2|Withdrawal by Subject|2
5685901|NCT00357370|19609461|P1|Cohort 2|Withdrawal by Subject|0
5685902|NCT00357370|19609459|P3|Cohort 2|non-compliance, not met criteria, etc|0
5685903|NCT00357370|19609460|P2|Cohort 2|non-compliance, not met criteria, etc|1
5685904|NCT00357370|19609461|P1|Cohort 2|non-compliance, not met criteria, etc|1
5685905|NCT00357370|19609459|P3|Cohort 2|Lost to Follow-up|0
5685906|NCT00357370|19609460|P2|Cohort 2|Lost to Follow-up|1
5685907|NCT00357370|19609461|P1|Cohort 2|Lost to Follow-up|0
5685908|NCT00357370|19609459|P3|Cohort 2|Adverse Event|1
5685909|NCT00357370|19609460|P2|Cohort 2|Adverse Event|1
5685910|NCT00357370|19609461|P1|Cohort 2|Adverse Event|1
5685911|NCT00357370|19609459|P3|Cohort 2|Lack of Efficacy|1
5685912|NCT00357370|19609460|P2|Cohort 2|Lack of Efficacy|2
5685913|NCT00357370|19609461|P1|Cohort 2|Lack of Efficacy|0
5685914|NCT00357110|19609524|P2|Overall Study|Early study termination|5
5685915|NCT00357110|19609525|P1|Overall Study|Early study termination|5
5685916|NCT00357097|19609533|P2|Overall Study|Increase of RLS Symptoms|1
5685917|NCT00357097|19609534|P1|Overall Study|Increase of RLS Symptoms|0
5685918|NCT00357097|19609533|P2|Overall Study|Other|1
5685919|NCT00357097|19609534|P1|Overall Study|Other|1
5685920|NCT00357097|19609533|P2|Overall Study|Met Exclusion Criteria|1
5685921|NCT00357097|19609534|P1|Overall Study|Met Exclusion Criteria|3
5685922|NCT00357097|19609533|P2|Overall Study|Lack of Efficacy|8
5685923|NCT00357097|19609534|P1|Overall Study|Lack of Efficacy|2
5685924|NCT00357097|19609533|P2|Overall Study|Non-compliance|2
5685925|NCT00357097|19609534|P1|Overall Study|Non-compliance|1
5685926|NCT00357097|19609533|P2|Overall Study|Withdrawal by Subject|7
5685927|NCT00357097|19609534|P1|Overall Study|Withdrawal by Subject|8
5685928|NCT00357097|19609533|P2|Overall Study|Adverse Event|6
5685929|NCT00357097|19609534|P1|Overall Study|Adverse Event|34
5685930|NCT00357097|19609533|P2|Overall Study|Did not meet inclusion criteria|3
5685931|NCT00357097|19609534|P1|Overall Study|Did not meet inclusion criteria|5
5685932|NCT00357006|19609588|P3|Overall Study|Withdrawal by Subject|2
5685933|NCT00357006|19609589|P2|Overall Study|Withdrawal by Subject|3
5685934|NCT00357006|19609590|P1|Overall Study|Withdrawal by Subject|1
5685935|NCT00357006|19609588|P3|Overall Study|Lost to Follow-up|1
5685936|NCT00357006|19609589|P2|Overall Study|Lost to Follow-up|2
5685937|NCT00357006|19609590|P1|Overall Study|Lost to Follow-up|1
5685938|NCT00356915|19609605|P3|Overall Study|Miscellaneous reasons|3
5685939|NCT00356915|19609606|P2|Overall Study|Miscellaneous reasons|8
5685940|NCT00356915|19609607|P1|Overall Study|Miscellaneous reasons|11
5685941|NCT00356915|19609605|P3|Overall Study|Adverse Event|8
5685942|NCT00356915|19609606|P2|Overall Study|Adverse Event|31
5685943|NCT00356915|19609607|P1|Overall Study|Adverse Event|21
5685944|NCT00356915|19609605|P3|Overall Study|Physician Decision|0
5685945|NCT00356915|19609606|P2|Overall Study|Physician Decision|2
5685946|NCT00356915|19609607|P1|Overall Study|Physician Decision|0
5685947|NCT00356915|19609605|P3|Overall Study|Administrative Decision|1
5685948|NCT00356915|19609606|P2|Overall Study|Administrative Decision|0
5685949|NCT00356915|19609607|P1|Overall Study|Administrative Decision|0
5685950|NCT00356915|19609605|P3|Overall Study|Lost to Follow-up|14
5685951|NCT00356915|19609606|P2|Overall Study|Lost to Follow-up|34
5685952|NCT00356915|19609607|P1|Overall Study|Lost to Follow-up|27
5685953|NCT00356915|19609605|P3|Overall Study|Lack of Efficacy|3
5685954|NCT00356915|19609606|P2|Overall Study|Lack of Efficacy|0
5685955|NCT00356915|19609607|P1|Overall Study|Lack of Efficacy|0
5685956|NCT00356915|19609605|P3|Overall Study|Withdrawal by Subject|10
5685957|NCT00356915|19609606|P2|Overall Study|Withdrawal by Subject|14
5685958|NCT00356915|19609607|P1|Overall Study|Withdrawal by Subject|14
5685959|NCT00356915|19609605|P3|Overall Study|Protocol Violation|2
5685960|NCT00356915|19609606|P2|Overall Study|Protocol Violation|3
5685961|NCT00356915|19609607|P1|Overall Study|Protocol Violation|2
5685962|NCT00356915|19609605|P3|Overall Study|Non compliance|1
5685963|NCT00356915|19609606|P2|Overall Study|Non compliance|2
5685964|NCT00356915|19609607|P1|Overall Study|Non compliance|1
5685965|NCT00356889|19609624|P1|Overall Study|Adverse Event|1
5685966|NCT00356889|19609624|P1|Overall Study|Protocol Violation|2
5685967|NCT00356863|19609633|P2|Overall Study|Lost to Follow-up|43
5685968|NCT00356863|19609634|P1|Overall Study|Lost to Follow-up|76
5685969|NCT00356863|19609633|P2|Overall Study|Death|32
5685970|NCT00356863|19609634|P1|Overall Study|Death|16
5685971|NCT00356811|19609660|P1|Overall Study|Site Closed during Follow-up|2
5685972|NCT00356811|19609660|P1|Overall Study|Study Is Terminating|3
5685973|NCT00356811|19609660|P1|Overall Study|Participant Could Not Make a Checkup|1
5685974|NCT00356811|19609660|P1|Overall Study|Withdrawal by Subject|6
5685975|NCT00356811|19609660|P1|Overall Study|Lost to Follow-up|2
5685976|NCT00356811|19609660|P1|Overall Study|Death|35
5685977|NCT00356759|19609675|P2|Overall Study|Intercurrent disease or persistent extre|2
5685978|NCT00356759|19609676|P1|Overall Study|Intercurrent disease or persistent extre|5
5685979|NCT00356759|19609675|P2|Overall Study|Lost to Follow-up|1
5685980|NCT00356759|19609676|P1|Overall Study|Lost to Follow-up|1
5685981|NCT00356759|19609675|P2|Overall Study|Adverse Event|3
5685982|NCT00356759|19609676|P1|Overall Study|Adverse Event|1
5685983|NCT00356759|19609675|P2|Overall Study|Withdrawal by Subject|2
5685984|NCT00356759|19609676|P1|Overall Study|Withdrawal by Subject|2
5685985|NCT00356759|19609675|P2|Overall Study|Death|2
5685986|NCT00356759|19609676|P1|Overall Study|Death|5
5685987|NCT00356603|19609694|P2|Overall Study|Other|3
5685988|NCT00356603|19609695|P1|Overall Study|Other|6
5685989|NCT00356590|19609709|P1|Overall Study|Other|52
5685990|NCT00356590|19609709|P1|Overall Study|Response status|28
5685991|NCT00356590|19609709|P1|Overall Study|Protocol issues|6
5685992|NCT00356590|19609709|P1|Overall Study|Completed month 12 only|2
5685993|NCT00356590|19609709|P1|Overall Study|Withdrawal by Subject|41
5685994|NCT00356590|19609709|P1|Overall Study|Physician Decision|46
5685995|NCT00356590|19609709|P1|Overall Study|Lost to Follow-up|35
5685996|NCT00356590|19609709|P1|Overall Study|Death|10
5685997|NCT00356590|19609709|P1|Overall Study|Adverse Event|54
5685998|NCT00356525|19609745|P4|Overall Study|Sponsor Decision|1
5685999|NCT00356525|19609746|P3|Overall Study|Sponsor Decision|0
5686000|NCT00356525|19609747|P2|Overall Study|Sponsor Decision|0
5686001|NCT00356525|19609748|P1|Overall Study|Sponsor Decision|0
5686002|NCT00356525|19609745|P4|Overall Study|Death|1
5686003|NCT00356525|19609746|P3|Overall Study|Death|0
5686004|NCT00356525|19609747|P2|Overall Study|Death|0
5686005|NCT00356525|19609748|P1|Overall Study|Death|0
5686006|NCT00356525|19609745|P4|Overall Study|Withdrawal by Subject|3
5686007|NCT00356525|19609746|P3|Overall Study|Withdrawal by Subject|0
5686008|NCT00356525|19609747|P2|Overall Study|Withdrawal by Subject|1
5686009|NCT00356525|19609748|P1|Overall Study|Withdrawal by Subject|1
5686010|NCT00356525|19609745|P4|Overall Study|Protocol Entry Criteria Not Met|0
5686011|NCT00356525|19609746|P3|Overall Study|Protocol Entry Criteria Not Met|0
5686012|NCT00356525|19609747|P2|Overall Study|Protocol Entry Criteria Not Met|0
5686013|NCT00356525|19609748|P1|Overall Study|Protocol Entry Criteria Not Met|1
5686014|NCT00356525|19609745|P4|Overall Study|Physician Decision|1
5686015|NCT00356525|19609746|P3|Overall Study|Physician Decision|2
5686016|NCT00356525|19609747|P2|Overall Study|Physician Decision|2
5686017|NCT00356525|19609748|P1|Overall Study|Physician Decision|2
5686018|NCT00356525|19609745|P4|Overall Study|Lost to Follow-up|0
5686019|NCT00356525|19609746|P3|Overall Study|Lost to Follow-up|0
5686020|NCT00356525|19609747|P2|Overall Study|Lost to Follow-up|0
5686021|NCT00356525|19609748|P1|Overall Study|Lost to Follow-up|1
5686022|NCT00356525|19609745|P4|Overall Study|Adverse Event|1
5686023|NCT00356525|19609746|P3|Overall Study|Adverse Event|1
5686024|NCT00356525|19609747|P2|Overall Study|Adverse Event|3
5686025|NCT00356525|19609748|P1|Overall Study|Adverse Event|1
5686026|NCT00356525|19609745|P4|Overall Study|Progressive Disease|2
5686027|NCT00356525|19609746|P3|Overall Study|Progressive Disease|4
5686028|NCT00356525|19609747|P2|Overall Study|Progressive Disease|5
5686029|NCT00356525|19609748|P1|Overall Study|Progressive Disease|8
5686030|NCT00356421|19609789|P2|Overall Study|Not related to study drug|3
5686031|NCT00356421|19609790|P1|Overall Study|Not related to study drug|5
5686032|NCT00356421|19609789|P2|Overall Study|Related to study drug|12
5686033|NCT00356421|19609790|P1|Overall Study|Related to study drug|15
5686034|NCT00356421|19609789|P2|Overall Study|Withdrawal by Subject|2
5686035|NCT00356421|19609790|P1|Overall Study|Withdrawal by Subject|9
5686036|NCT00356421|19609789|P2|Overall Study|Lack of Efficacy|0
5686037|NCT00356421|19609790|P1|Overall Study|Lack of Efficacy|3
5686038|NCT00356408|19609830|P1|Overall Study|Other: Subject chose commerical dosing|1
5686039|NCT00356408|19609830|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
5686040|NCT00356408|19609830|P1|Overall Study|Other: Azathioprine stopped|1
5686041|NCT00356408|19609830|P1|Overall Study|Other: Sponsor request|1
5686042|NCT00356408|19609830|P1|Overall Study|Other: Principal investigator discretion|3
5686043|NCT00356408|19609830|P1|Overall Study|Withdrawal by Subject|6
5686044|NCT00356408|19609830|P1|Overall Study|Lost to Follow-up|2
5686045|NCT00356408|19609830|P1|Overall Study|Lack of Efficacy|36
5686046|NCT00356408|19609830|P1|Overall Study|Adverse Event|9
5686047|NCT00356369|19609847|P2|Active Phase|Withdrawal by Subject|1
5686048|NCT00356369|19609848|P1|Active Phase|Withdrawal by Subject|2
5686049|NCT00356278|19609930|P3|Overall Study|Withdrawal by Subject|19
5686050|NCT00356278|19609931|P2|Overall Study|Withdrawal by Subject|15
5686051|NCT00356278|19609932|P1|Overall Study|Withdrawal by Subject|25
5686052|NCT00356265|19609970|P3|Overall Study|Withdrawal by Subject|1
5686053|NCT00356265|19609971|P2|Overall Study|Withdrawal by Subject|0
5686054|NCT00356265|19609972|P1|Overall Study|Withdrawal by Subject|0
5686055|NCT00356200|19609984|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
5686056|NCT00356200|19609985|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
5686057|NCT00356200|19609984|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
5686058|NCT00356200|19609985|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
5686059|NCT00356148|19610014|P2|Overall Study|Reoperation within 30 days|1
5686060|NCT00356148|19610015|P1|Overall Study|Reoperation within 30 days|2
5686061|NCT00356135|19610026|P3|Overall Study|Subject non-compliance|3
5686062|NCT00356135|19610027|P2|Overall Study|Subject non-compliance|1
5686063|NCT00356135|19610028|P1|Overall Study|Subject non-compliance|1
5686064|NCT00356135|19610026|P3|Overall Study|Physician Decision|1
5686065|NCT00356135|19610027|P2|Overall Study|Physician Decision|1
5686066|NCT00356135|19610028|P1|Overall Study|Physician Decision|1
5686067|NCT00356135|19610026|P3|Overall Study|Lost to Follow-up|1
5686068|NCT00356135|19610027|P2|Overall Study|Lost to Follow-up|0
5686069|NCT00356135|19610028|P1|Overall Study|Lost to Follow-up|0
5686070|NCT00356135|19610026|P3|Overall Study|Adverse Event|0
5686071|NCT00356135|19610027|P2|Overall Study|Adverse Event|0
5686072|NCT00356135|19610028|P1|Overall Study|Adverse Event|1
5686073|NCT00356135|19610026|P3|Overall Study|Protocol Violation|0
5686074|NCT00356135|19610027|P2|Overall Study|Protocol Violation|0
5686075|NCT00356135|19610028|P1|Overall Study|Protocol Violation|1
5686076|NCT00356122|19610050|P1|FOLLOW-UP|Other|2
5686077|NCT00356122|19610050|P1|FOLLOW-UP|Lost to Follow-up|2
5686078|NCT00356122|19610050|P1|FOLLOW-UP|Death|37
5686079|NCT00356122|19610050|P1|TREATMENT|Did not receive study medication|1
5686080|NCT00356122|19610050|P1|TREATMENT|Other|4
5686081|NCT00356122|19610050|P1|TREATMENT|Subject's request|4
5686082|NCT00356122|19610050|P1|TREATMENT|Adverse Event|10
5686083|NCT00356122|19610050|P1|TREATMENT|Lack of Efficacy|26
5686084|NCT00355784|19610158|P3|Overall Study|Withdrawal by Subject|2
5686085|NCT00355784|19610159|P2|Overall Study|Withdrawal by Subject|0
5686086|NCT00355784|19610160|P1|Overall Study|Withdrawal by Subject|0
5686087|NCT00355615|19610209|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
5686088|NCT00355615|19610210|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
5686089|NCT00355615|19610211|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
5686090|NCT00355615|19610212|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
5686091|NCT00355615|19610213|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
5686092|NCT00355615|19610209|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
5686093|NCT00355615|19610210|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
5686094|NCT00355615|19610211|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
5686095|NCT00355615|19610212|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
5686096|NCT00355615|19610213|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
5686097|NCT00355615|19610209|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
5686098|NCT00355615|19610210|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
5686099|NCT00355615|19610211|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
5686100|NCT00355615|19610212|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
5686101|NCT00355615|19610213|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
5686102|NCT00355615|19610209|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
5686103|NCT00355615|19610210|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
5686104|NCT00355615|19610211|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
5686105|NCT00355615|19610212|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
5686106|NCT00355615|19610213|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
5686107|NCT00355615|19610209|P5|Randomized Double Blind Period|Protocol Violation|0
5686108|NCT00355615|19610210|P4|Randomized Double Blind Period|Protocol Violation|1
5686109|NCT00355615|19610211|P3|Randomized Double Blind Period|Protocol Violation|1
5686110|NCT00355615|19610212|P2|Randomized Double Blind Period|Protocol Violation|0
5686111|NCT00355615|19610213|P1|Randomized Double Blind Period|Protocol Violation|0
5686112|NCT00355615|19610209|P5|Randomized Double Blind Period|Adverse Event|0
5686113|NCT00355615|19610210|P4|Randomized Double Blind Period|Adverse Event|0
5686114|NCT00355615|19610211|P3|Randomized Double Blind Period|Adverse Event|0
5686115|NCT00355615|19610212|P2|Randomized Double Blind Period|Adverse Event|0
5686116|NCT00355615|19610213|P1|Randomized Double Blind Period|Adverse Event|1
5686117|NCT00355472|19610272|P1|Overall Study|Physician Decision|1
5686118|NCT00355368|19610318|P2|Overall Study|cardiac arrest prior to intubation|2
5686119|NCT00355368|19610319|P1|Overall Study|cardiac arrest prior to intubation|2
5686120|NCT00355368|19610318|P2|Overall Study|Protocol Violation|7
5686121|NCT00355368|19610319|P1|Overall Study|Protocol Violation|8
5686122|NCT00355342|19610333|P2|Overall Study|Use of protocol excluded medication|1
5686123|NCT00355342|19610334|P1|Overall Study|Use of protocol excluded medication|0
5686124|NCT00355342|19610333|P2|Overall Study|Protocol Violation|1
5686125|NCT00355342|19610334|P1|Overall Study|Protocol Violation|0
5686126|NCT00355342|19610333|P2|Overall Study|Study management|1
5686127|NCT00355342|19610334|P1|Overall Study|Study management|0
5686128|NCT00355342|19610333|P2|Overall Study|Participant discontinued study drug|1
5686129|NCT00355342|19610334|P1|Overall Study|Participant discontinued study drug|0
5686130|NCT00355342|19610333|P2|Overall Study|Participant relocated|1
5686131|NCT00355342|19610334|P1|Overall Study|Participant relocated|0
5686132|NCT00355342|19610333|P2|Overall Study|Withdrawal by participant and physician|0
5686133|NCT00355342|19610334|P1|Overall Study|Withdrawal by participant and physician|1
5686134|NCT00355342|19610333|P2|Overall Study|Non-compliance with Dexa scans|0
5686135|NCT00355342|19610334|P1|Overall Study|Non-compliance with Dexa scans|1
5686136|NCT00355342|19610333|P2|Overall Study|Dispensed wrong study drug kit|0
5686137|NCT00355342|19610334|P1|Overall Study|Dispensed wrong study drug kit|1
5686138|NCT00355342|19610333|P2|Overall Study|COPD exacerbation|1
5686139|NCT00355342|19610334|P1|Overall Study|COPD exacerbation|1
5686140|NCT00355342|19610333|P2|Overall Study|Use of prohibited medication|0
5686141|NCT00355342|19610334|P1|Overall Study|Use of prohibited medication|1
5686142|NCT00355342|19610333|P2|Overall Study|Overcompliant-PI discretion|0
5686143|NCT00355342|19610334|P1|Overall Study|Overcompliant-PI discretion|1
5686144|NCT00355342|19610333|P2|Overall Study|Sponsor terminated study|2
5686145|NCT00355342|19610334|P1|Overall Study|Sponsor terminated study|2
5686146|NCT00355342|19610333|P2|Overall Study|Withdrawal by Subject|11
5686147|NCT00355342|19610334|P1|Overall Study|Withdrawal by Subject|14
5686148|NCT00355342|19610333|P2|Overall Study|Lost to Follow-up|2
5686149|NCT00355342|19610334|P1|Overall Study|Lost to Follow-up|4
5686150|NCT00355342|19610333|P2|Overall Study|Adverse Event|15
5686151|NCT00355342|19610334|P1|Overall Study|Adverse Event|13
5686152|NCT00355264|19610342|P1|Extension (Variable Duration)|Withdrew Consent|1
5686153|NCT00355264|19610342|P1|Extension (Variable Duration)|Adverse Event|1
5686154|NCT00355147|19610370|P2|Overall Study|Withdrawal by Subject|12
5686155|NCT00355147|19610371|P1|Overall Study|Withdrawal by Subject|8
5686156|NCT00355147|19610370|P2|Overall Study|Lost to Follow-up|8
5686157|NCT00355147|19610371|P1|Overall Study|Lost to Follow-up|10
5686158|NCT00355134|19610390|P5|Extension Phase|Protocol Violation|0
5686159|NCT00355134|19610391|P4|Extension Phase|Protocol Violation|1
5686160|NCT00355134|19610392|P3|Extension Phase|Protocol Violation|0
5686161|NCT00355134|19610393|P2|Extension Phase|Protocol Violation|0
5686162|NCT00355134|19610394|P1|Extension Phase|Protocol Violation|0
5686163|NCT00355134|19610390|P5|Extension Phase|Abnormal test procedure result(s)|1
5686164|NCT00355134|19610391|P4|Extension Phase|Abnormal test procedure result(s)|0
5686165|NCT00355134|19610392|P3|Extension Phase|Abnormal test procedure result(s)|0
5686166|NCT00355134|19610393|P2|Extension Phase|Abnormal test procedure result(s)|1
5686167|NCT00355134|19610394|P1|Extension Phase|Abnormal test procedure result(s)|0
5686168|NCT00355134|19610390|P5|Extension Phase|Unsatisfactory therapeutic effect|1
5686169|NCT00355134|19610391|P4|Extension Phase|Unsatisfactory therapeutic effect|0
5686170|NCT00355134|19610392|P3|Extension Phase|Unsatisfactory therapeutic effect|0
5686171|NCT00355134|19610393|P2|Extension Phase|Unsatisfactory therapeutic effect|4
5686172|NCT00355134|19610394|P1|Extension Phase|Unsatisfactory therapeutic effect|3
5686173|NCT00355134|19610390|P5|Extension Phase|Administrative problems|1
5686174|NCT00355134|19610391|P4|Extension Phase|Administrative problems|1
5686175|NCT00355134|19610392|P3|Extension Phase|Administrative problems|0
5686176|NCT00355134|19610393|P2|Extension Phase|Administrative problems|4
5686177|NCT00355134|19610394|P1|Extension Phase|Administrative problems|2
5686178|NCT00355134|19610390|P5|Extension Phase|Abnormal laboratory value(s)|2
5686179|NCT00355134|19610391|P4|Extension Phase|Abnormal laboratory value(s)|2
5686180|NCT00355134|19610392|P3|Extension Phase|Abnormal laboratory value(s)|0
5686181|NCT00355134|19610393|P2|Extension Phase|Abnormal laboratory value(s)|2
5686182|NCT00355134|19610394|P1|Extension Phase|Abnormal laboratory value(s)|4
5686183|NCT00355134|19610390|P5|Extension Phase|Lost to Follow-up|4
5686184|NCT00355134|19610391|P4|Extension Phase|Lost to Follow-up|2
5686185|NCT00355134|19610392|P3|Extension Phase|Lost to Follow-up|0
5686186|NCT00355134|19610393|P2|Extension Phase|Lost to Follow-up|6
5686187|NCT00355134|19610394|P1|Extension Phase|Lost to Follow-up|2
5686188|NCT00355134|19610390|P5|Extension Phase|Adverse Event|5
5686189|NCT00355134|19610391|P4|Extension Phase|Adverse Event|3
5686190|NCT00355134|19610392|P3|Extension Phase|Adverse Event|0
5686191|NCT00355134|19610393|P2|Extension Phase|Adverse Event|9
5686192|NCT00355134|19610394|P1|Extension Phase|Adverse Event|13
5686193|NCT00355134|19610390|P5|Extension Phase|Withdrawal by Subject|5
5686194|NCT00355134|19610391|P4|Extension Phase|Withdrawal by Subject|7
5686195|NCT00355134|19610392|P3|Extension Phase|Withdrawal by Subject|0
5686196|NCT00355134|19610393|P2|Extension Phase|Withdrawal by Subject|11
5686197|NCT00355134|19610394|P1|Extension Phase|Withdrawal by Subject|7
5686198|NCT00355134|19610390|P5|Core Phase|Condition no longer requires study drug|0
5686199|NCT00355134|19610391|P4|Core Phase|Condition no longer requires study drug|0
5686200|NCT00355134|19610392|P3|Core Phase|Condition no longer requires study drug|1
5686201|NCT00355134|19610393|P2|Core Phase|Condition no longer requires study drug|0
5686202|NCT00355134|19610394|P1|Core Phase|Condition no longer requires study drug|1
5686203|NCT00355134|19610390|P5|Core Phase|Abnormal test procedure result(s)|0
5686204|NCT00355134|19610391|P4|Core Phase|Abnormal test procedure result(s)|0
5686205|NCT00355134|19610392|P3|Core Phase|Abnormal test procedure result(s)|1
5686206|NCT00355134|19610393|P2|Core Phase|Abnormal test procedure result(s)|2
5686207|NCT00355134|19610394|P1|Core Phase|Abnormal test procedure result(s)|1
5686208|NCT00355134|19610390|P5|Core Phase|Protocol Violation|0
5686209|NCT00355134|19610391|P4|Core Phase|Protocol Violation|0
5686210|NCT00355134|19610392|P3|Core Phase|Protocol Violation|2
5686211|NCT00355134|19610393|P2|Core Phase|Protocol Violation|2
5686212|NCT00355134|19610394|P1|Core Phase|Protocol Violation|3
5686213|NCT00355134|19610390|P5|Core Phase|Administrative problems|0
5686214|NCT00355134|19610391|P4|Core Phase|Administrative problems|0
5686215|NCT00355134|19610392|P3|Core Phase|Administrative problems|5
5686216|NCT00355134|19610393|P2|Core Phase|Administrative problems|3
5686217|NCT00355134|19610394|P1|Core Phase|Administrative problems|5
5686218|NCT00355134|19610390|P5|Core Phase|Unsatisfactory therapeutic effect|0
5686219|NCT00355134|19610391|P4|Core Phase|Unsatisfactory therapeutic effect|0
5686220|NCT00355134|19610392|P3|Core Phase|Unsatisfactory therapeutic effect|17
5686221|NCT00355134|19610393|P2|Core Phase|Unsatisfactory therapeutic effect|6
5686222|NCT00355134|19610394|P1|Core Phase|Unsatisfactory therapeutic effect|10
5686223|NCT00355134|19610390|P5|Core Phase|Abnormal laboratory value(s)|0
5686224|NCT00355134|19610391|P4|Core Phase|Abnormal laboratory value(s)|0
5686225|NCT00355134|19610392|P3|Core Phase|Abnormal laboratory value(s)|2
5686226|NCT00355134|19610393|P2|Core Phase|Abnormal laboratory value(s)|14
5686227|NCT00355134|19610394|P1|Core Phase|Abnormal laboratory value(s)|19
5686228|NCT00355134|19610390|P5|Core Phase|Lost to Follow-up|0
5686229|NCT00355134|19610391|P4|Core Phase|Lost to Follow-up|0
5686230|NCT00355134|19610392|P3|Core Phase|Lost to Follow-up|21
5686231|NCT00355134|19610393|P2|Core Phase|Lost to Follow-up|13
5686232|NCT00355134|19610394|P1|Core Phase|Lost to Follow-up|17
5686233|NCT00355134|19610390|P5|Core Phase|Adverse Event|0
5686234|NCT00355134|19610391|P4|Core Phase|Adverse Event|0
5686235|NCT00355134|19610392|P3|Core Phase|Adverse Event|16
5686236|NCT00355134|19610393|P2|Core Phase|Adverse Event|22
5686237|NCT00355134|19610394|P1|Core Phase|Adverse Event|28
5686238|NCT00355134|19610390|P5|Core Phase|Withdrawal by Subject|0
5686239|NCT00355134|19610391|P4|Core Phase|Withdrawal by Subject|0
5686240|NCT00355134|19610392|P3|Core Phase|Withdrawal by Subject|35
5686241|NCT00355134|19610393|P2|Core Phase|Withdrawal by Subject|24
5686242|NCT00355134|19610394|P1|Core Phase|Withdrawal by Subject|35
5686243|NCT00355121|19610437|P3|Overall Study|Serious adverse events|0
5686244|NCT00355121|19610438|P2|Overall Study|Serious adverse events|2
5686245|NCT00355121|19610439|P1|Overall Study|Serious adverse events|0
5686246|NCT00355121|19610437|P3|Overall Study|Withdrawal by Subject|2
5686247|NCT00355121|19610438|P2|Overall Study|Withdrawal by Subject|10
5686248|NCT00355121|19610439|P1|Overall Study|Withdrawal by Subject|9
5686249|NCT00355121|19610437|P3|Overall Study|Lost to Follow-up|1
5686250|NCT00355121|19610438|P2|Overall Study|Lost to Follow-up|7
5686251|NCT00355121|19610439|P1|Overall Study|Lost to Follow-up|4
5686252|NCT00355121|19610437|P3|Overall Study|Protocol Violation|1
5686253|NCT00355121|19610438|P2|Overall Study|Protocol Violation|9
5686254|NCT00355121|19610439|P1|Overall Study|Protocol Violation|7
5686255|NCT00355121|19610437|P3|Overall Study|Adverse Event|0
5686256|NCT00355121|19610438|P2|Overall Study|Adverse Event|1
5686257|NCT00355121|19610439|P1|Overall Study|Adverse Event|0
5686258|NCT00355121|19610437|P3|Overall Study|Did not receive study vaccine|1
5686259|NCT00355121|19610438|P2|Overall Study|Did not receive study vaccine|0
5686260|NCT00355121|19610439|P1|Overall Study|Did not receive study vaccine|1
5686261|NCT00355082|19610470|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
5686262|NCT00355082|19610471|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
5686263|NCT00355082|19610472|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
5686264|NCT00355082|19610470|P3|Continuation Phase|Scheduling Error|0
5686265|NCT00355082|19610471|P2|Continuation Phase|Scheduling Error|0
5686266|NCT00355082|19610472|P1|Continuation Phase|Scheduling Error|1
5686267|NCT00355082|19610470|P3|Continuation Phase|Site Closed by Sponsor|0
5686268|NCT00355082|19610471|P2|Continuation Phase|Site Closed by Sponsor|0
5686269|NCT00355082|19610472|P1|Continuation Phase|Site Closed by Sponsor|8
5686270|NCT00355082|19610470|P3|Continuation Phase|Lack of Efficacy|0
5686271|NCT00355082|19610471|P2|Continuation Phase|Lack of Efficacy|0
5686272|NCT00355082|19610472|P1|Continuation Phase|Lack of Efficacy|5
5686273|NCT00355082|19610470|P3|Continuation Phase|Withdrawal by Subject|0
5686274|NCT00355082|19610471|P2|Continuation Phase|Withdrawal by Subject|0
5686275|NCT00355082|19610472|P1|Continuation Phase|Withdrawal by Subject|4
5686276|NCT00355082|19610470|P3|Continuation Phase|Protocol Violation|1
5686277|NCT00355082|19610471|P2|Continuation Phase|Protocol Violation|0
5686278|NCT00355082|19610472|P1|Continuation Phase|Protocol Violation|1
5686279|NCT00355082|19610470|P3|Continuation Phase|Lost to Follow-up|1
5686280|NCT00355082|19610471|P2|Continuation Phase|Lost to Follow-up|0
5686281|NCT00355082|19610472|P1|Continuation Phase|Lost to Follow-up|2
5686282|NCT00355082|19610470|P3|Continuation Phase|Adverse Event|1
5686283|NCT00355082|19610471|P2|Continuation Phase|Adverse Event|0
5686284|NCT00355082|19610472|P1|Continuation Phase|Adverse Event|2
5686285|NCT00355082|19610470|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
5686286|NCT00355082|19610471|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
5686287|NCT00355082|19610472|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
5686288|NCT00355082|19610470|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
5686289|NCT00355082|19610471|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
5686290|NCT00355082|19610472|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
5686291|NCT00355082|19610470|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
5686292|NCT00355082|19610471|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
5686293|NCT00355082|19610472|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
5686294|NCT00355082|19610470|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
5686295|NCT00355082|19610471|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
5686296|NCT00355082|19610472|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
5686297|NCT00355082|19610470|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
5686298|NCT00355082|19610471|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
5686299|NCT00355082|19610472|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
5686300|NCT00355082|19610470|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
5686301|NCT00355082|19610471|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
5686302|NCT00355082|19610472|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
5686303|NCT00355056|19610494|P2|Randomization Period|Early Termination|6
5686304|NCT00355056|19610495|P1|Randomization Period|Early Termination|4
5686305|NCT00355030|19610525|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
5686306|NCT00355030|19610526|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
5686307|NCT00355030|19610525|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
5686308|NCT00355030|19610526|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
5686309|NCT00355030|19610525|P2|Study Period 1 Treatment|Other|6
5686310|NCT00355030|19610526|P1|Study Period 1 Treatment|Other|2
5686311|NCT00355030|19610525|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
5686312|NCT00355030|19610526|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
5686313|NCT00355030|19610525|P2|Study Period 1 Treatment|Sponsor Decision|32
5686314|NCT00355030|19610526|P1|Study Period 1 Treatment|Sponsor Decision|34
5686315|NCT00355030|19610525|P2|Study Period 1 Treatment|Physician Decision|1
5686316|NCT00355030|19610526|P1|Study Period 1 Treatment|Physician Decision|0
5686317|NCT00355030|19610525|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
5686318|NCT00355030|19610526|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
5686319|NCT00355030|19610525|P2|Study Period 1 Treatment|Withdrawal by Subject|1
5686320|NCT00355030|19610526|P1|Study Period 1 Treatment|Withdrawal by Subject|4
5686321|NCT00355030|19610525|P2|Study Period 1 Treatment|Lost to Follow-up|0
5686322|NCT00355030|19610526|P1|Study Period 1 Treatment|Lost to Follow-up|3
5686323|NCT00355030|19610525|P2|Study Period 1 Treatment|Adverse Event|1
5686324|NCT00355030|19610526|P1|Study Period 1 Treatment|Adverse Event|1
5686325|NCT00354835|19610565|P2|Overall Study|Refusal of further therapy|8
5686326|NCT00354835|19610566|P1|Overall Study|Refusal of further therapy|3
5686327|NCT00354835|19610565|P2|Overall Study|Adverse Event|0
5686328|NCT00354835|19610566|P1|Overall Study|Adverse Event|6
5686329|NCT00354835|19610565|P2|Overall Study|Disease progression or relapse|22
5686330|NCT00354835|19610566|P1|Overall Study|Disease progression or relapse|15
5686331|NCT00354835|19610565|P2|Overall Study|Ineligible|16
5686332|NCT00354835|19610566|P1|Overall Study|Ineligible|17
5686333|NCT00354835|19610565|P2|Overall Study|Withdrawal by Subject|1
5686334|NCT00354835|19610566|P1|Overall Study|Withdrawal by Subject|2
5686335|NCT00354835|19610565|P2|Overall Study|Physician Decision|13
5686336|NCT00354835|19610566|P1|Overall Study|Physician Decision|8
5686337|NCT00354835|19610565|P2|Overall Study|Death|1
5686338|NCT00354835|19610566|P1|Overall Study|Death|1
5686339|NCT00354744|19610605|P1|Overall Study|Withdrawal by Subject|14
5686340|NCT00354744|19610605|P1|Overall Study|Physician Decision|11
5686341|NCT00354744|19610605|P1|Overall Study|Lost to Follow-up|2
5686342|NCT00354744|19610605|P1|Overall Study|Lack of Efficacy|11
5686343|NCT00354744|19610605|P1|Overall Study|Death|2
5686344|NCT00354744|19610605|P1|Overall Study|Adverse Event|2
5686345|NCT00354679|19610611|P1|Overall Study|Patient Not Treated|1
5686346|NCT00354614|19610620|P1|Overall Study|Lack of Efficacy|28
5686347|NCT00354601|19610624|P1|Overall Study|progression|1
5686348|NCT00354601|19610624|P1|Overall Study|Protocol Violation|1
5686349|NCT00354432|19610644|P4|Overall Study|Off/Toxicity|5
5686350|NCT00354432|19610645|P3|Overall Study|Off/Toxicity|5
5686351|NCT00354432|19610646|P2|Overall Study|Off/Toxicity|7
5686352|NCT00354432|19610647|P1|Overall Study|Off/Toxicity|3
5686353|NCT00354432|19610644|P4|Overall Study|Adverse Event|5
5686354|NCT00354432|19610645|P3|Overall Study|Adverse Event|5
5686355|NCT00354432|19610646|P2|Overall Study|Adverse Event|1
5686356|NCT00354432|19610647|P1|Overall Study|Adverse Event|3
5686357|NCT00354341|19610663|P2|Overall Study|Other|2
5686358|NCT00354341|19610664|P1|Overall Study|Other|1
5686359|NCT00354341|19610663|P2|Overall Study|Failure to return|1
5686360|NCT00354341|19610664|P1|Overall Study|Failure to return|0
5686361|NCT00354341|19610663|P2|Overall Study|Refused treatment|2
5686362|NCT00354341|19610664|P1|Overall Study|Refused treatment|1
5686363|NCT00354341|19610663|P2|Overall Study|Death|2
5686364|NCT00354341|19610664|P1|Overall Study|Death|0
5686365|NCT00354341|19610663|P2|Overall Study|Adverse Event|0
5686366|NCT00354341|19610664|P1|Overall Study|Adverse Event|1
5686367|NCT00354172|19610686|P1|Overall Study|Did not receive transplant|1
5686368|NCT00354159|19610706|P2|Long-term Follow-up|Study Closed|34
5686369|NCT00354159|19610707|P1|Long-term Follow-up|Study Closed|29
5686370|NCT00354159|19610706|P2|Long-term Follow-up|Death|11
5686371|NCT00354159|19610707|P1|Long-term Follow-up|Death|14
5686372|NCT00354159|19610706|P2|Long-term Follow-up|Lost to Follow-up|0
5686373|NCT00354159|19610707|P1|Long-term Follow-up|Lost to Follow-up|1
5686374|NCT00354159|19610706|P2|Long-term Follow-up|Physician Decision|122
5686375|NCT00354159|19610707|P1|Long-term Follow-up|Physician Decision|127
5686376|NCT00354159|19610706|P2|Long-term Follow-up|Withdrawal by Subject|9
5686377|NCT00354159|19610707|P1|Long-term Follow-up|Withdrawal by Subject|9
5686378|NCT00354159|19610706|P2|Randomized Study Period|Death|9
5686379|NCT00354159|19610707|P1|Randomized Study Period|Death|7
5686380|NCT00354159|19610706|P2|Randomized Study Period|Lost to Follow-up|0
5686381|NCT00354159|19610707|P1|Randomized Study Period|Lost to Follow-up|4
5686382|NCT00354159|19610706|P2|Randomized Study Period|Physician Decision|10
5686383|NCT00354159|19610707|P1|Randomized Study Period|Physician Decision|6
5686384|NCT00354159|19610706|P2|Randomized Study Period|Withdrawal by Subject|3
5686385|NCT00354159|19610707|P1|Randomized Study Period|Withdrawal by Subject|5
5686386|NCT00354107|19610750|P1|Overall Study|Withdrawal by Subject|1
5686387|NCT00354107|19610750|P1|Overall Study|Physician Decision|2
5686388|NCT00354107|19610750|P1|Overall Study|Adverse Event|2
5686389|NCT00354029|19610760|P2|Overall Study|Protocol Violation|2
5686390|NCT00354029|19610761|P1|Overall Study|Protocol Violation|4
5686391|NCT00353873|19610773|P2|Overall Study|Withdrawal by Subject|1
5686392|NCT00353873|19610774|P1|Overall Study|Withdrawal by Subject|1
5686393|NCT00353873|19610773|P2|Overall Study|Physician Decision|0
5686394|NCT00353873|19610774|P1|Overall Study|Physician Decision|2
5686395|NCT00353873|19610773|P2|Overall Study|Adverse Event|0
5686396|NCT00353873|19610774|P1|Overall Study|Adverse Event|1
5686397|NCT00353873|19610773|P2|Overall Study|Exacerbation|0
5686398|NCT00353873|19610774|P1|Overall Study|Exacerbation|1
5686399|NCT00353873|19610773|P2|Overall Study|Protocol Violation|2
5686400|NCT00353873|19610774|P1|Overall Study|Protocol Violation|1
5686401|NCT00353704|19610803|P2|Overall Study|Protocol Violation|1
5686402|NCT00353704|19610804|P1|Overall Study|Protocol Violation|3
5686403|NCT00353496|19610874|P2|Overall Study|Not otherwise specified|2
5686404|NCT00353496|19610875|P1|Overall Study|Not otherwise specified|4
5686405|NCT00353496|19610874|P2|Overall Study|Physician Decision|9
5686406|NCT00353496|19610875|P1|Overall Study|Physician Decision|6
5686407|NCT00353496|19610874|P2|Overall Study|Withdrawal by Subject|4
5686408|NCT00353496|19610875|P1|Overall Study|Withdrawal by Subject|3
5686409|NCT00353496|19610874|P2|Overall Study|Protocol Violation|2
5686410|NCT00353496|19610875|P1|Overall Study|Protocol Violation|2
5686411|NCT00353496|19610874|P2|Overall Study|Adverse Event|0
5686412|NCT00353496|19610875|P1|Overall Study|Adverse Event|1
5686413|NCT00353366|19610928|P1|Overall Study|Other|135
5686414|NCT00353366|19610928|P1|Overall Study|Adverse Event|8
5686415|NCT00353262|19610955|P1|Overall Study|Break from Chemotherapy|1
5686416|NCT00353262|19610955|P1|Overall Study|Surgery|4
5686417|NCT00353262|19610955|P1|Overall Study|Progression|1
5686418|NCT00353262|19610955|P1|Overall Study|Insufficient Therapeutic Response|13
5686419|NCT00353262|19610955|P1|Overall Study|Withdrawal by Subject|2
5686420|NCT00353262|19610955|P1|Overall Study|Adverse Event|8
5686421|NCT00352885|19610996|P2|Overall Study|Side effects of IL-2 administration|0
5686422|NCT00352885|19610997|P1|Overall Study|Side effects of IL-2 administration|1
5686423|NCT00352885|19610996|P2|Overall Study|Progression of metastatic melanoma|3
5686424|NCT00352885|19610997|P1|Overall Study|Progression of metastatic melanoma|5
5686425|NCT00352885|19610996|P2|Overall Study|Development of major depression|1
5686426|NCT00352885|19610997|P1|Overall Study|Development of major depression|0
5686427|NCT00352885|19610996|P2|Overall Study|Withdrawal by Subject|3
5686428|NCT00352885|19610997|P1|Overall Study|Withdrawal by Subject|0
5686429|NCT00352846|19611015|P2|Overall Study|Death|1
5686430|NCT00352846|19611016|P1|Overall Study|Death|0
5686431|NCT00352846|19611015|P2|Overall Study|Non-compliance|0
5686432|NCT00352846|19611016|P1|Overall Study|Non-compliance|2
5686433|NCT00352846|19611015|P2|Overall Study|Ineligible|2
5686434|NCT00352846|19611016|P1|Overall Study|Ineligible|3
5686435|NCT00352846|19611015|P2|Overall Study|Withdrawal by Subject|8
5686436|NCT00352846|19611016|P1|Overall Study|Withdrawal by Subject|3
5686437|NCT00352846|19611015|P2|Overall Study|Disease progression|2
5686438|NCT00352846|19611016|P1|Overall Study|Disease progression|0
5686439|NCT00352755|19611031|P1|Overall Study|Adverse Event|1
5686440|NCT00352755|19611031|P1|Overall Study|Physician Decision|1
5686441|NCT00352690|19611041|P2|Overall Study|Determined to be ineligible|0
5686442|NCT00352690|19611042|P1|Overall Study|Determined to be ineligible|2
5686443|NCT00352664|19611062|P2|Overall Study|Withdrawal by Subject|0
5686444|NCT00352664|19611063|P1|Overall Study|Withdrawal by Subject|7
5686445|NCT00352534|19611080|P7|Final Risk Group Assignment|Death|0
5686446|NCT00352534|19611081|P6|Final Risk Group Assignment|Death|2
5686447|NCT00352534|19611082|P5|Final Risk Group Assignment|Death|0
5686448|NCT00352534|19611083|P4|Final Risk Group Assignment|Death|0
5686449|NCT00352534|19611084|P3|Final Risk Group Assignment|Death|0
5686450|NCT00352534|19611085|P2|Final Risk Group Assignment|Death|0
5686451|NCT00352534|19611086|P1|Final Risk Group Assignment|Death|0
5686452|NCT00352534|19611080|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
5686453|NCT00352534|19611081|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5686454|NCT00352534|19611082|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5686455|NCT00352534|19611083|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5686456|NCT00352534|19611084|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5686457|NCT00352534|19611085|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5686458|NCT00352534|19611086|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
5686459|NCT00352534|19611080|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
5686460|NCT00352534|19611081|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
5686461|NCT00352534|19611082|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
5686462|NCT00352534|19611083|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
5686463|NCT00352534|19611084|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
5686464|NCT00352534|19611085|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
5686465|NCT00352534|19611086|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
5686466|NCT00352534|19611080|P7|Final Risk Group Assignment|Ineligible|0
5686467|NCT00352534|19611081|P6|Final Risk Group Assignment|Ineligible|13
5686468|NCT00352534|19611082|P5|Final Risk Group Assignment|Ineligible|0
5686469|NCT00352534|19611083|P4|Final Risk Group Assignment|Ineligible|1
5686470|NCT00352534|19611084|P3|Final Risk Group Assignment|Ineligible|3
5686471|NCT00352534|19611085|P2|Final Risk Group Assignment|Ineligible|0
5686472|NCT00352534|19611086|P1|Final Risk Group Assignment|Ineligible|0
5686473|NCT00352534|19611080|P7|Final Risk Group Assignment|Withdrawal by Subject|0
5686474|NCT00352534|19611081|P6|Final Risk Group Assignment|Withdrawal by Subject|3
5686475|NCT00352534|19611082|P5|Final Risk Group Assignment|Withdrawal by Subject|0
5686476|NCT00352534|19611083|P4|Final Risk Group Assignment|Withdrawal by Subject|0
5686477|NCT00352534|19611084|P3|Final Risk Group Assignment|Withdrawal by Subject|0
5686478|NCT00352534|19611085|P2|Final Risk Group Assignment|Withdrawal by Subject|0
5686479|NCT00352534|19611086|P1|Final Risk Group Assignment|Withdrawal by Subject|0
5686480|NCT00352534|19611080|P7|Final Risk Group Assignment|Physician Decision|0
5686481|NCT00352534|19611081|P6|Final Risk Group Assignment|Physician Decision|8
5686482|NCT00352534|19611082|P5|Final Risk Group Assignment|Physician Decision|0
5686483|NCT00352534|19611083|P4|Final Risk Group Assignment|Physician Decision|0
5686484|NCT00352534|19611084|P3|Final Risk Group Assignment|Physician Decision|0
5686485|NCT00352534|19611085|P2|Final Risk Group Assignment|Physician Decision|0
5686486|NCT00352534|19611086|P1|Final Risk Group Assignment|Physician Decision|0
5686487|NCT00352534|19611080|P7|Final Risk Group Assignment|Lack of Efficacy|0
5686488|NCT00352534|19611081|P6|Final Risk Group Assignment|Lack of Efficacy|19
5686489|NCT00352534|19611082|P5|Final Risk Group Assignment|Lack of Efficacy|1
5686490|NCT00352534|19611083|P4|Final Risk Group Assignment|Lack of Efficacy|2
5686491|NCT00352534|19611084|P3|Final Risk Group Assignment|Lack of Efficacy|0
5686492|NCT00352534|19611085|P2|Final Risk Group Assignment|Lack of Efficacy|0
5686493|NCT00352534|19611086|P1|Final Risk Group Assignment|Lack of Efficacy|0
5686494|NCT00352534|19611080|P7|Initial Staging|Ineligible|0
5686495|NCT00352534|19611081|P6|Initial Staging|Ineligible|0
5686496|NCT00352534|19611082|P5|Initial Staging|Ineligible|0
5686497|NCT00352534|19611083|P4|Initial Staging|Ineligible|0
5686498|NCT00352534|19611084|P3|Initial Staging|Ineligible|0
5686499|NCT00352534|19611085|P2|Initial Staging|Ineligible|9
5686500|NCT00352534|19611086|P1|Initial Staging|Ineligible|8
5686501|NCT00352417|19611103|P2|Overall Study|Schedule Change|1
5686502|NCT00352417|19611104|P1|Overall Study|Schedule Change|2
5686503|NCT00352417|19611103|P2|Overall Study|Lost to Follow-up|0
5686504|NCT00352417|19611104|P1|Overall Study|Lost to Follow-up|1
5686505|NCT00352417|19611103|P2|Overall Study|Withdrawal by Subject|2
5686506|NCT00352417|19611104|P1|Overall Study|Withdrawal by Subject|1
5686507|NCT00352417|19611103|P2|Overall Study|Protocol Violation|2
5686508|NCT00352417|19611104|P1|Overall Study|Protocol Violation|0
5686509|NCT00352417|19611103|P2|Overall Study|Adverse Event|0
5686510|NCT00352417|19611104|P1|Overall Study|Adverse Event|1
5686511|NCT00352365|19611118|P1|Maintenance Therapy|Not eligible|4
5686512|NCT00352365|19611118|P1|Maintenance Therapy|Not protocol specified|3
5686513|NCT00352365|19611118|P1|Maintenance Therapy|Death|2
5686514|NCT00352365|19611118|P1|Maintenance Therapy|Progression/Relapse|3
5686515|NCT00352365|19611118|P1|Induction Therapy|Death before starting protocol therapy|1
5686516|NCT00352365|19611118|P1|Induction Therapy|Not eligible|3
5686517|NCT00352365|19611118|P1|Induction Therapy|Not protocol specified|1
5686518|NCT00352365|19611118|P1|Induction Therapy|Death|7
5686519|NCT00352365|19611118|P1|Induction Therapy|Progression/Relapse|8
5686520|NCT00352365|19611118|P1|Induction Therapy|Adverse Event|7
5686521|NCT00352118|19611128|P1|Overall Study|Physician Decision|4
5686522|NCT00352105|19611138|P1|Overall Study|Protocol Violation|2
5686523|NCT00352105|19611138|P1|Overall Study|Adverse Event|19
5686524|NCT00352105|19611138|P1|Overall Study|Lack of Efficacy|9
5686525|NCT00352105|19611138|P1|Overall Study|Withdrawal by Subject|5
5686526|NCT00352105|19611138|P1|Overall Study|Death|5
5686527|NCT00352053|19611149|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
5686528|NCT00352053|19611150|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
5686529|NCT00352053|19611149|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
5686530|NCT00352053|19611150|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
5686531|NCT00352053|19611149|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
5686532|NCT00352053|19611150|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
5686533|NCT00352053|19611149|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
5686534|NCT00352053|19611150|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
5686535|NCT00352053|19611149|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
5686536|NCT00352053|19611150|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
5686537|NCT00352053|19611149|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
5686538|NCT00352053|19611150|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
5686539|NCT00352053|19611149|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
5686540|NCT00352053|19611150|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
5686541|NCT00352053|19611149|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
5686542|NCT00352053|19611150|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
5686543|NCT00352053|19611149|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
5686544|NCT00352053|19611150|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
5686545|NCT00352053|19611149|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
5686546|NCT00352053|19611150|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
5686547|NCT00352053|19611149|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
5686548|NCT00352053|19611150|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
5686549|NCT00352053|19611149|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
5686550|NCT00352053|19611150|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
5686551|NCT00352053|19611149|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
5686552|NCT00352053|19611150|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
5686553|NCT00352027|19611317|P1|Overall Study|Progressive disease|3
5686554|NCT00351819|19611616|P2|Overall Study|Enrolled in another trial|1
5686555|NCT00351819|19611617|P1|Overall Study|Enrolled in another trial|0
5686556|NCT00351819|19611616|P2|Overall Study|Incarcerated|1
5686557|NCT00351819|19611617|P1|Overall Study|Incarcerated|0
5686558|NCT00351819|19611616|P2|Overall Study|Non-compliance|1
5686559|NCT00351819|19611617|P1|Overall Study|Non-compliance|0
5686560|NCT00351819|19611616|P2|Overall Study|Unprofessional behavior|0
5686561|NCT00351819|19611617|P1|Overall Study|Unprofessional behavior|1
5686562|NCT00351819|19611616|P2|Overall Study|Traumatic ankle fracture|0
5686563|NCT00351819|19611617|P1|Overall Study|Traumatic ankle fracture|1
5686564|NCT00351819|19611616|P2|Overall Study|Elevated PSA|1
5686565|NCT00351819|19611617|P1|Overall Study|Elevated PSA|1
5686566|NCT00351819|19611616|P2|Overall Study|Withdrawal by Subject|4
5686567|NCT00351819|19611617|P1|Overall Study|Withdrawal by Subject|0
5686568|NCT00351819|19611616|P2|Overall Study|Lost to Follow-up|4
5686569|NCT00351819|19611617|P1|Overall Study|Lost to Follow-up|4
5686570|NCT00351533|19611688|P2|Overall Study|Withdrawal by Subject|1
5686571|NCT00351533|19611689|P1|Overall Study|Withdrawal by Subject|0
5686572|NCT00351533|19611688|P2|Overall Study|Physician Decision|1
5686573|NCT00351533|19611689|P1|Overall Study|Physician Decision|0
5686574|NCT00351533|19611688|P2|Overall Study|Lost to Follow-up|3
5686575|NCT00351533|19611689|P1|Overall Study|Lost to Follow-up|1
5686576|NCT00351533|19611688|P2|Overall Study|Extubated before first BAL|0
5686577|NCT00351533|19611689|P1|Overall Study|Extubated before first BAL|1
5686578|NCT00351468|19611749|P1|Overall Study|Protocol Violation|3
5686579|NCT00351468|19611749|P1|Overall Study|Lost to Follow-up|4
5686580|NCT00351468|19611749|P1|Overall Study|Non-compliance|8
5686581|NCT00351468|19611749|P1|Overall Study|Lack of Efficacy|32
5686582|NCT00351468|19611749|P1|Overall Study|Various -follow up w clinical team|39
5686583|NCT00351468|19611749|P1|Overall Study|Withdrawal by Subject|39
5686584|NCT00351468|19611749|P1|Overall Study|Adverse Event|42
5686585|NCT00351377|19611773|P1|Overall Study|Unsatisfactory therapeutic effect|1
5686586|NCT00351377|19611773|P1|Overall Study|Death|1
5686587|NCT00351377|19611773|P1|Overall Study|Adverse Event|5
5686588|NCT00351351|19611787|P2|Overall Study|surgical access pbs; device issues|4
5686589|NCT00351351|19611788|P1|Overall Study|surgical access pbs; device issues|9
5686590|NCT00351273|19611814|P3|Overall Study|Lost to Follow-up|5
5686591|NCT00351273|19611815|P2|Overall Study|Lost to Follow-up|2
5686592|NCT00351273|19611816|P1|Overall Study|Lost to Follow-up|1
5686593|NCT00350870|19611859|P4|Overall Study|Physician Decision|1
5686594|NCT00350870|19611860|P3|Overall Study|Physician Decision|1
5686595|NCT00350870|19611861|P2|Overall Study|Physician Decision|0
5686596|NCT00350870|19611862|P1|Overall Study|Physician Decision|1
5686597|NCT00350870|19611859|P4|Overall Study|Withdrawal by Subject|14
5686598|NCT00350870|19611860|P3|Overall Study|Withdrawal by Subject|15
5686599|NCT00350870|19611861|P2|Overall Study|Withdrawal by Subject|17
5686600|NCT00350870|19611862|P1|Overall Study|Withdrawal by Subject|21
5686601|NCT00350844|19611876|P1|Overall Study|Lost to Follow-up|1
5686602|NCT00350792|19611880|P1|Overall Study|Lack of Efficacy|11
5686603|NCT00350792|19611880|P1|Overall Study|Physician Decision|2
5686604|NCT00350792|19611880|P1|Overall Study|Withdrawal by Subject|4
5686605|NCT00350792|19611880|P1|Overall Study|Protocol Violation|1
5686606|NCT00350792|19611880|P1|Overall Study|Death Not Study Drug Related|2
5686607|NCT00350792|19611880|P1|Overall Study|Death from Study Drug Toxicity|1
5686608|NCT00350792|19611880|P1|Overall Study|Death from Study Disease|1
5686609|NCT00350792|19611880|P1|Overall Study|Adverse Event|11
5686610|NCT00350779|19611890|P2|Overall Study|Non-compliance with study procedures|1
5686611|NCT00350779|19611891|P1|Overall Study|Non-compliance with study procedures|0
5686612|NCT00350779|19611890|P2|Overall Study|Patient Moved|1
5686613|NCT00350779|19611891|P1|Overall Study|Patient Moved|2
5686614|NCT00350779|19611890|P2|Overall Study|Withdrawal by Subject|8
5686615|NCT00350779|19611891|P1|Overall Study|Withdrawal by Subject|9
5686616|NCT00350779|19611890|P2|Overall Study|Protocol Violation|1
5686617|NCT00350779|19611891|P1|Overall Study|Protocol Violation|3
5686618|NCT00350779|19611890|P2|Overall Study|Physician Decision|4
5686619|NCT00350779|19611891|P1|Overall Study|Physician Decision|2
5686620|NCT00350779|19611890|P2|Overall Study|Lost to Follow-up|0
5686621|NCT00350779|19611891|P1|Overall Study|Lost to Follow-up|2
5686622|NCT00350779|19611890|P2|Overall Study|Lack of Efficacy|4
5686623|NCT00350779|19611891|P1|Overall Study|Lack of Efficacy|0
5686624|NCT00350779|19611890|P2|Overall Study|Adverse Event|2
5686625|NCT00350779|19611891|P1|Overall Study|Adverse Event|4
5686626|NCT00350727|19611912|P3|Phase II|Enrolled in Rollover Study|1
5686627|NCT00350727|19611913|P2|Phase II|Enrolled in Rollover Study|0
5686628|NCT00350727|19611914|P1|Phase II|Enrolled in Rollover Study|0
5686629|NCT00350727|19611912|P3|Phase II|Sponsor Terminated Study|1
5686630|NCT00350727|19611913|P2|Phase II|Sponsor Terminated Study|0
5686631|NCT00350727|19611914|P1|Phase II|Sponsor Terminated Study|0
5686632|NCT00350727|19611912|P3|Phase II|Death|2
5686633|NCT00350727|19611913|P2|Phase II|Death|0
5686634|NCT00350727|19611914|P1|Phase II|Death|0
5686635|NCT00350727|19611912|P3|Phase II|Adverse Event|1
5686636|NCT00350727|19611913|P2|Phase II|Adverse Event|1
5686637|NCT00350727|19611914|P1|Phase II|Adverse Event|0
5686638|NCT00350727|19611912|P3|Phase II|Withdrawal by Subject|1
5686639|NCT00350727|19611913|P2|Phase II|Withdrawal by Subject|2
5686640|NCT00350727|19611914|P1|Phase II|Withdrawal by Subject|0
5686641|NCT00350727|19611912|P3|Phase II|Clinical Deterioration|0
5686642|NCT00350727|19611913|P2|Phase II|Clinical Deterioration|1
5686643|NCT00350727|19611914|P1|Phase II|Clinical Deterioration|0
5686644|NCT00350727|19611912|P3|Phase II|Disease Progression|16
5686645|NCT00350727|19611913|P2|Phase II|Disease Progression|15
5686646|NCT00350727|19611914|P1|Phase II|Disease Progression|0
5686647|NCT00350727|19611912|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
5686648|NCT00350727|19611913|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
5686649|NCT00350727|19611914|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
5686650|NCT00350727|19611912|P3|Phase I: Dose Escalation|Physician Decision|0
5686651|NCT00350727|19611913|P2|Phase I: Dose Escalation|Physician Decision|0
5686652|NCT00350727|19611914|P1|Phase I: Dose Escalation|Physician Decision|1
5686653|NCT00350727|19611912|P3|Phase I: Dose Escalation|Death|0
5686654|NCT00350727|19611913|P2|Phase I: Dose Escalation|Death|0
5686655|NCT00350727|19611914|P1|Phase I: Dose Escalation|Death|1
5686656|NCT00350727|19611912|P3|Phase I: Dose Escalation|Lack of Efficacy|0
5686657|NCT00350727|19611913|P2|Phase I: Dose Escalation|Lack of Efficacy|0
5686658|NCT00350727|19611914|P1|Phase I: Dose Escalation|Lack of Efficacy|25
5686659|NCT00350727|19611912|P3|Phase I: Dose Escalation|Adverse Event|0
5686660|NCT00350727|19611913|P2|Phase I: Dose Escalation|Adverse Event|0
5686661|NCT00350727|19611914|P1|Phase I: Dose Escalation|Adverse Event|4
5686662|NCT00350636|19612058|P2|Overall Study|Other|2
5686663|NCT00350636|19612059|P1|Overall Study|Other|1
5686664|NCT00350636|19612058|P2|Overall Study|Physician Decision|2
5686665|NCT00350636|19612059|P1|Overall Study|Physician Decision|0
5686666|NCT00350636|19612058|P2|Overall Study|Lost to Follow-up|8
5686667|NCT00350636|19612059|P1|Overall Study|Lost to Follow-up|9
5686668|NCT00350636|19612058|P2|Overall Study|Withdrawal by Subject|17
5686669|NCT00350636|19612059|P1|Overall Study|Withdrawal by Subject|13
5686670|NCT00350636|19612058|P2|Overall Study|Protocol Violation|3
5686671|NCT00350636|19612059|P1|Overall Study|Protocol Violation|1
5686672|NCT00350636|19612058|P2|Overall Study|Adverse Event|13
5686673|NCT00350636|19612059|P1|Overall Study|Adverse Event|19
5686674|NCT00350623|19612078|P3|Overall Study|patient traveling outside the country|1
5686675|NCT00350623|19612079|P2|Overall Study|patient traveling outside the country|0
5686676|NCT00350623|19612080|P1|Overall Study|patient traveling outside the country|0
5686677|NCT00350623|19612078|P3|Overall Study|Withdrawal by Subject|1
5686678|NCT00350623|19612079|P2|Overall Study|Withdrawal by Subject|1
5686679|NCT00350623|19612080|P1|Overall Study|Withdrawal by Subject|0
5686680|NCT00350623|19612078|P3|Overall Study|Lost to Follow-up|4
5686681|NCT00350623|19612079|P2|Overall Study|Lost to Follow-up|3
5686682|NCT00350623|19612080|P1|Overall Study|Lost to Follow-up|8
5686683|NCT00350545|19612088|P1|Overall Study|Withdrawal by Subject|2
5686684|NCT00350519|19612107|P2|Overall Study|Withdrawal by Subject|2
5686685|NCT00350519|19612108|P1|Overall Study|Withdrawal by Subject|3
5686686|NCT00350519|19612107|P2|Overall Study|Protocol Violation|2
5686687|NCT00350519|19612108|P1|Overall Study|Protocol Violation|1
5686688|NCT00350519|19612107|P2|Overall Study|Physician Decision|1
5686689|NCT00350519|19612108|P1|Overall Study|Physician Decision|0
5686690|NCT00350519|19612107|P2|Overall Study|Death|1
5686691|NCT00350519|19612108|P1|Overall Study|Death|0
5686692|NCT00350402|19612122|P2|Overall Study|Lost to Follow-up|1
5686693|NCT00350402|19612123|P1|Overall Study|Lost to Follow-up|1
5686694|NCT00350272|19612196|P2|Open-Label 84 Week Treatment|Sponsor decision|1
5686695|NCT00350272|19612197|P1|Open-Label 84 Week Treatment|Sponsor decision|2
5686696|NCT00350272|19612196|P2|Open-Label 84 Week Treatment|Physician Decision|2
5686697|NCT00350272|19612197|P1|Open-Label 84 Week Treatment|Physician Decision|1
5686698|NCT00350272|19612196|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
5686699|NCT00350272|19612197|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
5686700|NCT00350272|19612196|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
5686701|NCT00350272|19612197|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
5686702|NCT00350272|19612196|P2|Open-Label 84 Week Treatment|Adverse Event|1
5686703|NCT00350272|19612197|P1|Open-Label 84 Week Treatment|Adverse Event|2
5686704|NCT00350272|19612196|P2|Blinded 12 Week Treatment|Sponsor decision|1
5686705|NCT00350272|19612197|P1|Blinded 12 Week Treatment|Sponsor decision|0
5686706|NCT00350272|19612196|P2|Blinded 12 Week Treatment|Physician Decision|1
5686707|NCT00350272|19612197|P1|Blinded 12 Week Treatment|Physician Decision|2
5686708|NCT00350272|19612196|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
5686709|NCT00350272|19612197|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
5686710|NCT00350272|19612196|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
5686711|NCT00350272|19612197|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
5686712|NCT00350272|19612196|P2|Blinded 12 Week Treatment|Death|0
5686713|NCT00350272|19612197|P1|Blinded 12 Week Treatment|Death|1
5686714|NCT00350272|19612196|P2|Blinded 12 Week Treatment|Adverse Event|0
5686715|NCT00350272|19612197|P1|Blinded 12 Week Treatment|Adverse Event|1
5686716|NCT00350207|19612219|P3|Overall Study|Other|1
5686717|NCT00350207|19612220|P2|Overall Study|Other|3
5686718|NCT00350207|19612221|P1|Overall Study|Other|1
5686719|NCT00350207|19612219|P3|Overall Study|Withdrawal by Subject|1
5686720|NCT00350207|19612220|P2|Overall Study|Withdrawal by Subject|1
5686721|NCT00350207|19612221|P1|Overall Study|Withdrawal by Subject|0
5686722|NCT00350207|19612219|P3|Overall Study|Lost to Follow-up|1
5686723|NCT00350207|19612220|P2|Overall Study|Lost to Follow-up|0
5686724|NCT00350207|19612221|P1|Overall Study|Lost to Follow-up|1
5686725|NCT00350207|19612219|P3|Overall Study|Lack of Efficacy|2
5686726|NCT00350207|19612220|P2|Overall Study|Lack of Efficacy|0
5686727|NCT00350207|19612221|P1|Overall Study|Lack of Efficacy|1
5686728|NCT00350207|19612219|P3|Overall Study|Adverse Event|2
5686729|NCT00350207|19612220|P2|Overall Study|Adverse Event|2
5686730|NCT00350207|19612221|P1|Overall Study|Adverse Event|5
5686731|NCT00349973|19612433|P2|Overall Study|Withdrawal by Subject|0
5686732|NCT00349973|19612434|P1|Overall Study|Withdrawal by Subject|1
5686733|NCT00349973|19612433|P2|Overall Study|Adverse Event|3
5686734|NCT00349973|19612434|P1|Overall Study|Adverse Event|3
5686735|NCT00349921|19612448|P4|First Spinal Injection|Adverse Event|0
5686736|NCT00349921|19612449|P3|First Spinal Injection|Adverse Event|1
5686737|NCT00349921|19612450|P2|First Spinal Injection|Adverse Event|0
5686738|NCT00349921|19612451|P1|First Spinal Injection|Adverse Event|0
5686739|NCT00349921|19612448|P4|First Spinal Injection|Physician Decision|0
5686740|NCT00349921|19612449|P3|First Spinal Injection|Physician Decision|0
5686741|NCT00349921|19612450|P2|First Spinal Injection|Physician Decision|0
5686742|NCT00349921|19612451|P1|First Spinal Injection|Physician Decision|1
5686743|NCT00349908|19612462|P2|Overall Study|Withdrawal by Subject|4
5686744|NCT00349908|19612463|P1|Overall Study|Withdrawal by Subject|0
5686745|NCT00349752|19612489|P2|Overall Study|Other:History of squamous cell carcinoma|0
5686746|NCT00349752|19612490|P1|Overall Study|Other:History of squamous cell carcinoma|1
5686747|NCT00349752|19612489|P2|Overall Study|Other: Inadvertently unblinded|0
5686748|NCT00349752|19612490|P1|Overall Study|Other: Inadvertently unblinded|1
5686749|NCT00349752|19612489|P2|Overall Study|Other: Ineligible|0
5686750|NCT00349752|19612490|P1|Overall Study|Other: Ineligible|1
5686751|NCT00349752|19612489|P2|Overall Study|Other: Patient's steroid use|0
5686752|NCT00349752|19612490|P1|Overall Study|Other: Patient's steroid use|1
5686753|NCT00349752|19612489|P2|Overall Study|Other: Patient stopped steroids|1
5686754|NCT00349752|19612490|P1|Overall Study|Other: Patient stopped steroids|0
5686755|NCT00349752|19612489|P2|Overall Study|Other: Non compliance|1
5686756|NCT00349752|19612490|P1|Overall Study|Other: Non compliance|0
5686757|NCT00349752|19612489|P2|Overall Study|Other: Required exclusionary medication|1
5686758|NCT00349752|19612490|P1|Overall Study|Other: Required exclusionary medication|0
5686759|NCT00349752|19612489|P2|Overall Study|Personal reasons|5
5686760|NCT00349752|19612490|P1|Overall Study|Personal reasons|6
5686761|NCT00349752|19612489|P2|Overall Study|Lost to Follow-up|2
5686762|NCT00349752|19612490|P1|Overall Study|Lost to Follow-up|4
5686763|NCT00349752|19612489|P2|Overall Study|Lack of Efficacy|42
5686764|NCT00349752|19612490|P1|Overall Study|Lack of Efficacy|37
5686765|NCT00349752|19612489|P2|Overall Study|Adverse Event|12
5686766|NCT00349752|19612490|P1|Overall Study|Adverse Event|8
5686767|NCT00349622|19612543|P2|Overall Study|Withdrawal by Subject|9
5686768|NCT00349622|19612544|P1|Overall Study|Withdrawal by Subject|5
5686769|NCT00349622|19612543|P2|Overall Study|Lost to Follow-up|1
5686770|NCT00349622|19612544|P1|Overall Study|Lost to Follow-up|5
5686771|NCT00349622|19612543|P2|Overall Study|Death|86
5686772|NCT00349622|19612544|P1|Overall Study|Death|168
5686773|NCT00349349|19612583|P3|Overall Study|New Malignancy (Bladder Cancer)|0
5686774|NCT00349349|19612584|P2|Overall Study|New Malignancy (Bladder Cancer)|1
5686775|NCT00349349|19612585|P1|Overall Study|New Malignancy (Bladder Cancer)|0
5686776|NCT00349349|19612583|P3|Overall Study|No Response|0
5686777|NCT00349349|19612584|P2|Overall Study|No Response|3
5686778|NCT00349349|19612585|P1|Overall Study|No Response|0
5686779|NCT00349349|19612583|P3|Overall Study|Physician Decision|1
5686780|NCT00349349|19612584|P2|Overall Study|Physician Decision|2
5686781|NCT00349349|19612585|P1|Overall Study|Physician Decision|1
5686782|NCT00349349|19612583|P3|Overall Study|Participant Reduced General Condition|0
5686783|NCT00349349|19612584|P2|Overall Study|Participant Reduced General Condition|1
5686784|NCT00349349|19612585|P1|Overall Study|Participant Reduced General Condition|0
5686785|NCT00349349|19612583|P3|Overall Study|Other Treatment Selected|0
5686786|NCT00349349|19612584|P2|Overall Study|Other Treatment Selected|0
5686787|NCT00349349|19612585|P1|Overall Study|Other Treatment Selected|2
5686788|NCT00349349|19612583|P3|Overall Study|Death|1
5686789|NCT00349349|19612584|P2|Overall Study|Death|10
5686790|NCT00349349|19612585|P1|Overall Study|Death|13
5686791|NCT00349349|19612583|P3|Overall Study|Withdrawn due to Disease Progression|1
5686792|NCT00349349|19612584|P2|Overall Study|Withdrawn due to Disease Progression|37
5686793|NCT00349349|19612585|P1|Overall Study|Withdrawn due to Disease Progression|27
5686794|NCT00349349|19612583|P3|Overall Study|Withdrawal by Subject|1
5686795|NCT00349349|19612584|P2|Overall Study|Withdrawal by Subject|2
5686796|NCT00349349|19612585|P1|Overall Study|Withdrawal by Subject|5
5686797|NCT00349349|19612583|P3|Overall Study|Adverse Event|2
5686798|NCT00349349|19612584|P2|Overall Study|Adverse Event|6
5686799|NCT00349349|19612585|P1|Overall Study|Adverse Event|5
5686800|NCT00348933|19612674|P1|Overall Study|Adverse Event|7
5686801|NCT00348933|19612674|P1|Overall Study|Protocol Violation|2
5686802|NCT00348933|19612674|P1|Overall Study|Lost to Follow-up|6
5686803|NCT00348933|19612674|P1|Overall Study|Withdrawal by Subject|10
5686804|NCT00348881|19612682|P2|Overall Study|Serious Adverse Event|2
5686805|NCT00348881|19612683|P1|Overall Study|Serious Adverse Event|0
5686806|NCT00348881|19612682|P2|Overall Study|Adverse Event|0
5686807|NCT00348881|19612683|P1|Overall Study|Adverse Event|2
5686808|NCT00348881|19612682|P2|Overall Study|Withdrawal by Subject|4
5686809|NCT00348881|19612683|P1|Overall Study|Withdrawal by Subject|3
5686810|NCT00348881|19612682|P2|Overall Study|Lost to Follow-up|6
5686811|NCT00348881|19612683|P1|Overall Study|Lost to Follow-up|12
5686812|NCT00348816|19612695|P1|Overall Study|Noncompliance with radiation treatment|1
5686813|NCT00348790|19612702|P1|Completed Treatment|Unable to travel to study site|1
5686814|NCT00348790|19612702|P1|Completed Treatment|Required surgery|2
5686815|NCT00348790|19612702|P1|Completed Treatment|Adverse Event|4
5686816|NCT00348790|19612702|P1|Completed Treatment|Disease progression|14
5686817|NCT00348790|19612702|P1|Completed Treatment|Withdrawal by Subject|4
5686818|NCT00348686|19612714|P1|Overall Study|Multiple Reasons|8
5686819|NCT00348686|19612714|P1|Overall Study|Lost to Follow-up|2
5686820|NCT00348686|19612714|P1|Overall Study|Protocol Violation|6
5686821|NCT00348686|19612714|P1|Overall Study|Adverse Event|5
5686822|NCT00348686|19612714|P1|Overall Study|Withdrawal by Subject|45
5686823|NCT00348673|19612731|P9|Stage 1|Randomized but not Treated|0
5686824|NCT00348673|19612732|P8|Stage 1|Randomized but not Treated|0
5686825|NCT00348673|19612733|P7|Stage 1|Randomized but not Treated|0
5686826|NCT00348673|19612734|P6|Stage 1|Randomized but not Treated|0
5686827|NCT00348673|19612735|P5|Stage 1|Randomized but not Treated|0
5686828|NCT00348673|19612736|P4|Stage 1|Randomized but not Treated|0
5686829|NCT00348673|19612737|P3|Stage 1|Randomized but not Treated|1
5686830|NCT00348673|19612738|P2|Stage 1|Randomized but not Treated|0
5686831|NCT00348673|19612739|P1|Stage 1|Randomized but not Treated|0
5686832|NCT00348595|19612788|P2|Overall Study|Adverse Event|8
5686833|NCT00348595|19612789|P1|Overall Study|Adverse Event|5
5686834|NCT00348556|19612801|P1|Overall Study|Adverse Event|1
5686835|NCT00348374|19612808|P2|Overall Study|randomized but did not receive treatment|7
5686836|NCT00348374|19612809|P1|Overall Study|randomized but did not receive treatment|0
5686837|NCT00348374|19612808|P2|Overall Study|ongoing at date of cutoff|1
5686838|NCT00348374|19612809|P1|Overall Study|ongoing at date of cutoff|1
5686839|NCT00348374|19612808|P2|Overall Study|Other|12
5686840|NCT00348374|19612809|P1|Overall Study|Other|11
5686841|NCT00348374|19612808|P2|Overall Study|Withdrawal by Subject|5
5686842|NCT00348374|19612809|P1|Overall Study|Withdrawal by Subject|5
5686843|NCT00348374|19612808|P2|Overall Study|Lost to Follow-up|3
5686844|NCT00348374|19612809|P1|Overall Study|Lost to Follow-up|1
5686845|NCT00348374|19612808|P2|Overall Study|Adverse Event|4
5686846|NCT00348374|19612809|P1|Overall Study|Adverse Event|1
5686847|NCT00348348|19612856|P2|Overall Study|Adverse event probably related to study|0
5686848|NCT00348348|19612857|P1|Overall Study|Adverse event probably related to study|1
5686849|NCT00348348|19612856|P2|Overall Study|Worsening of BC - Unlikely related|2
5686850|NCT00348348|19612857|P1|Overall Study|Worsening of BC - Unlikely related|1
5686851|NCT00348348|19612856|P2|Overall Study|Worsening of BC - Unrelated to study|3
5686852|NCT00348348|19612857|P1|Overall Study|Worsening of BC - Unrelated to study|0
5686853|NCT00348348|19612856|P2|Overall Study|Dissallowed Meds - possibly releated|1
5686854|NCT00348348|19612857|P1|Overall Study|Dissallowed Meds - possibly releated|1
5686855|NCT00348348|19612856|P2|Overall Study|Dissallowed Meds - unlikley related|1
5686856|NCT00348348|19612857|P1|Overall Study|Dissallowed Meds - unlikley related|1
5686857|NCT00348348|19612856|P2|Overall Study|Dissallowed Meds - unrelated to study|3
5686858|NCT00348348|19612857|P1|Overall Study|Dissallowed Meds - unrelated to study|1
5686859|NCT00348348|19612856|P2|Overall Study|Other|4
5686860|NCT00348348|19612857|P1|Overall Study|Other|7
5686861|NCT00348348|19612856|P2|Overall Study|Withdrawal by Subject|1
5686862|NCT00348348|19612857|P1|Overall Study|Withdrawal by Subject|4
5686863|NCT00348348|19612856|P2|Overall Study|Lost to Follow-up|10
5686864|NCT00348348|19612857|P1|Overall Study|Lost to Follow-up|8
5686865|NCT00348348|19612856|P2|Overall Study|Lack of Efficacy|1
5686866|NCT00348348|19612857|P1|Overall Study|Lack of Efficacy|1
5686867|NCT00348348|19612856|P2|Overall Study|Adverse event - unrelated to study drug|1
5686868|NCT00348348|19612857|P1|Overall Study|Adverse event - unrelated to study drug|0
5686869|NCT00348309|19612872|P3|Overall Study|HCV career|1
5686870|NCT00348309|19612873|P2|Overall Study|HCV career|0
5686871|NCT00348309|19612874|P1|Overall Study|HCV career|0
5686872|NCT00348309|19612872|P3|Overall Study|Cardiologist recommendations|1
5686873|NCT00348309|19612873|P2|Overall Study|Cardiologist recommendations|0
5686874|NCT00348309|19612874|P1|Overall Study|Cardiologist recommendations|0
5686875|NCT00348309|19612872|P3|Overall Study|ECG abnormal|2
5686876|NCT00348309|19612873|P2|Overall Study|ECG abnormal|0
5686877|NCT00348309|19612874|P1|Overall Study|ECG abnormal|0
5686878|NCT00348309|19612872|P3|Overall Study|Adverse event not attended|1
5686879|NCT00348309|19612873|P2|Overall Study|Adverse event not attended|0
5686880|NCT00348309|19612874|P1|Overall Study|Adverse event not attended|0
5686881|NCT00348309|19612872|P3|Overall Study|Site closure|1
5686882|NCT00348309|19612873|P2|Overall Study|Site closure|0
5686883|NCT00348309|19612874|P1|Overall Study|Site closure|0
5686884|NCT00348309|19612872|P3|Overall Study|Increased dose of Aricept|1
5686885|NCT00348309|19612873|P2|Overall Study|Increased dose of Aricept|0
5686886|NCT00348309|19612874|P1|Overall Study|Increased dose of Aricept|0
5686887|NCT00348309|19612872|P3|Overall Study|Medical Monitor decision|1
5686888|NCT00348309|19612873|P2|Overall Study|Medical Monitor decision|0
5686889|NCT00348309|19612874|P1|Overall Study|Medical Monitor decision|0
5686890|NCT00348309|19612872|P3|Overall Study|Forgot often medication|0
5686891|NCT00348309|19612873|P2|Overall Study|Forgot often medication|1
5686892|NCT00348309|19612874|P1|Overall Study|Forgot often medication|0
5686893|NCT00348309|19612872|P3|Overall Study|Sponsor refuseal|1
5686894|NCT00348309|19612873|P2|Overall Study|Sponsor refuseal|1
5686895|NCT00348309|19612874|P1|Overall Study|Sponsor refuseal|0
5686896|NCT00348309|19612872|P3|Overall Study|Participant was hospitalized|0
5686897|NCT00348309|19612873|P2|Overall Study|Participant was hospitalized|1
5686898|NCT00348309|19612874|P1|Overall Study|Participant was hospitalized|0
5686899|NCT00348309|19612872|P3|Overall Study|A foul of exclusion criteria|0
5686900|NCT00348309|19612873|P2|Overall Study|A foul of exclusion criteria|1
5686901|NCT00348309|19612874|P1|Overall Study|A foul of exclusion criteria|0
5686902|NCT00348309|19612872|P3|Overall Study|Ineffectiveness of treatment|0
5686903|NCT00348309|19612873|P2|Overall Study|Ineffectiveness of treatment|1
5686904|NCT00348309|19612874|P1|Overall Study|Ineffectiveness of treatment|0
5686905|NCT00348309|19612872|P3|Overall Study|Decision of sponsor|0
5686906|NCT00348309|19612873|P2|Overall Study|Decision of sponsor|0
5686907|NCT00348309|19612874|P1|Overall Study|Decision of sponsor|1
5686908|NCT00348309|19612872|P3|Overall Study|Participant died|1
5686909|NCT00348309|19612873|P2|Overall Study|Participant died|1
5686910|NCT00348309|19612874|P1|Overall Study|Participant died|2
5686911|NCT00348309|19612872|P3|Overall Study|Did not appear in time for Visit 3|0
5686912|NCT00348309|19612873|P2|Overall Study|Did not appear in time for Visit 3|0
5686913|NCT00348309|19612874|P1|Overall Study|Did not appear in time for Visit 3|1
5686914|NCT00348309|19612872|P3|Overall Study|Worsening of alzheimer|1
5686915|NCT00348309|19612873|P2|Overall Study|Worsening of alzheimer|0
5686916|NCT00348309|19612874|P1|Overall Study|Worsening of alzheimer|1
5686917|NCT00348309|19612872|P3|Overall Study|Cognitive and behaviour worsening|0
5686918|NCT00348309|19612873|P2|Overall Study|Cognitive and behaviour worsening|0
5686919|NCT00348309|19612874|P1|Overall Study|Cognitive and behaviour worsening|2
5686920|NCT00348309|19612872|P3|Overall Study|Worsened neurodegenerative disease|0
5686921|NCT00348309|19612873|P2|Overall Study|Worsened neurodegenerative disease|0
5686922|NCT00348309|19612874|P1|Overall Study|Worsened neurodegenerative disease|1
5686923|NCT00348309|19612872|P3|Overall Study|No disponibility of medication|0
5686924|NCT00348309|19612873|P2|Overall Study|No disponibility of medication|0
5686925|NCT00348309|19612874|P1|Overall Study|No disponibility of medication|1
5686926|NCT00348309|19612872|P3|Overall Study|Principal investigator's decision|0
5686927|NCT00348309|19612873|P2|Overall Study|Principal investigator's decision|0
5686928|NCT00348309|19612874|P1|Overall Study|Principal investigator's decision|1
5686929|NCT00348309|19612872|P3|Overall Study|PI closing medical practice|0
5686930|NCT00348309|19612873|P2|Overall Study|PI closing medical practice|0
5686931|NCT00348309|19612874|P1|Overall Study|PI closing medical practice|1
5686932|NCT00348309|19612872|P3|Overall Study|Unable to complete ET visit|0
5686933|NCT00348309|19612873|P2|Overall Study|Unable to complete ET visit|0
5686934|NCT00348309|19612874|P1|Overall Study|Unable to complete ET visit|1
5686935|NCT00348309|19612872|P3|Overall Study|Caregiver withdrawal|7
5686936|NCT00348309|19612873|P2|Overall Study|Caregiver withdrawal|0
5686937|NCT00348309|19612874|P1|Overall Study|Caregiver withdrawal|3
5686938|NCT00348309|19612872|P3|Overall Study|Use of prohibited medication|2
5686939|NCT00348309|19612873|P2|Overall Study|Use of prohibited medication|2
5686940|NCT00348309|19612874|P1|Overall Study|Use of prohibited medication|5
5686941|NCT00348309|19612872|P3|Overall Study|Caregiver sick|0
5686942|NCT00348309|19612873|P2|Overall Study|Caregiver sick|0
5686943|NCT00348309|19612874|P1|Overall Study|Caregiver sick|1
5686944|NCT00348309|19612872|P3|Overall Study|Wrong bottle allocated|0
5686945|NCT00348309|19612873|P2|Overall Study|Wrong bottle allocated|0
5686946|NCT00348309|19612874|P1|Overall Study|Wrong bottle allocated|1
5686947|NCT00348309|19612872|P3|Overall Study|Lack of insight, dementia|0
5686948|NCT00348309|19612873|P2|Overall Study|Lack of insight, dementia|0
5686949|NCT00348309|19612874|P1|Overall Study|Lack of insight, dementia|1
5686950|NCT00348309|19612872|P3|Overall Study|Death of caregiver|1
5686951|NCT00348309|19612873|P2|Overall Study|Death of caregiver|0
5686952|NCT00348309|19612874|P1|Overall Study|Death of caregiver|1
5686953|NCT00348309|19612872|P3|Overall Study|Non-compliance|8
5686954|NCT00348309|19612873|P2|Overall Study|Non-compliance|6
5686955|NCT00348309|19612874|P1|Overall Study|Non-compliance|8
5686956|NCT00348309|19612872|P3|Overall Study|Withdrawal by Subject|40
5686957|NCT00348309|19612873|P2|Overall Study|Withdrawal by Subject|37
5686958|NCT00348309|19612874|P1|Overall Study|Withdrawal by Subject|33
5686959|NCT00348309|19612872|P3|Overall Study|Protocol Violation|7
5686960|NCT00348309|19612873|P2|Overall Study|Protocol Violation|12
5686961|NCT00348309|19612874|P1|Overall Study|Protocol Violation|7
5686962|NCT00348309|19612872|P3|Overall Study|Lost to Follow-up|4
5686963|NCT00348309|19612873|P2|Overall Study|Lost to Follow-up|7
5686964|NCT00348309|19612874|P1|Overall Study|Lost to Follow-up|6
5686965|NCT00348309|19612872|P3|Overall Study|Adverse Event|63
5686966|NCT00348309|19612873|P2|Overall Study|Adverse Event|28
5686967|NCT00348309|19612874|P1|Overall Study|Adverse Event|56
5686968|NCT00348283|19612947|P2|Open Label|Sponsor decision|1
5686969|NCT00348283|19612948|P1|Open Label|Sponsor decision|0
5686970|NCT00348283|19612947|P2|Open Label|Pregnancy|1
5686971|NCT00348283|19612948|P1|Open Label|Pregnancy|0
5686972|NCT00348283|19612947|P2|Open Label|Subject moved to the United States|1
5686973|NCT00348283|19612948|P1|Open Label|Subject moved to the United States|0
5686974|NCT00348283|19612947|P2|Open Label|Administrative reasons|5
5686975|NCT00348283|19612948|P1|Open Label|Administrative reasons|0
5686976|NCT00348283|19612947|P2|Open Label|Lack of Efficacy|13
5686977|NCT00348283|19612948|P1|Open Label|Lack of Efficacy|0
5686978|NCT00348283|19612947|P2|Open Label|Lost to Follow-up|1
5686979|NCT00348283|19612948|P1|Open Label|Lost to Follow-up|0
5686980|NCT00348283|19612947|P2|Open Label|Withdrawal by Subject|4
5686981|NCT00348283|19612948|P1|Open Label|Withdrawal by Subject|0
5686982|NCT00348283|19612947|P2|Open Label|Adverse Event|8
5686983|NCT00348283|19612948|P1|Open Label|Adverse Event|0
5686984|NCT00348283|19612947|P2|Double Blind|Pregnancy|1
5686985|NCT00348283|19612948|P1|Double Blind|Pregnancy|0
5686986|NCT00348283|19612947|P2|Double Blind|Lack of Efficacy|2
5686987|NCT00348283|19612948|P1|Double Blind|Lack of Efficacy|2
5686988|NCT00348283|19612947|P2|Double Blind|Protocol Violation|1
5686989|NCT00348283|19612948|P1|Double Blind|Protocol Violation|0
5686990|NCT00348283|19612947|P2|Double Blind|Withdrawal by Subject|1
5686991|NCT00348283|19612948|P1|Double Blind|Withdrawal by Subject|1
5686992|NCT00348283|19612947|P2|Double Blind|Adverse Event|5
5686993|NCT00348283|19612948|P1|Double Blind|Adverse Event|2
5686994|NCT00348283|19612947|P2|Induction|Protocol Violation|4
5686995|NCT00348283|19612948|P1|Induction|Protocol Violation|0
5686996|NCT00348283|19612947|P2|Induction|Adverse Event|2
5686997|NCT00348283|19612948|P1|Induction|Adverse Event|0
5686998|NCT00348140|19612977|P3|Overall Study|Memory declined|1
5686999|NCT00348140|19612978|P2|Overall Study|Memory declined|0
5687000|NCT00348140|19612979|P1|Overall Study|Memory declined|0
5687001|NCT00348140|19612977|P3|Overall Study|Exclusion criteria met|1
5687002|NCT00348140|19612978|P2|Overall Study|Exclusion criteria met|0
5687003|NCT00348140|19612979|P1|Overall Study|Exclusion criteria met|0
5687004|NCT00348140|19612977|P3|Overall Study|Participant died|0
5687005|NCT00348140|19612978|P2|Overall Study|Participant died|1
5687006|NCT00348140|19612979|P1|Overall Study|Participant died|0
5687007|NCT00348140|19612977|P3|Overall Study|Abnormal ECG|3
5687008|NCT00348140|19612978|P2|Overall Study|Abnormal ECG|1
5687009|NCT00348140|19612979|P1|Overall Study|Abnormal ECG|0
5687010|NCT00348140|19612977|P3|Overall Study|Serious adverse event|0
5687011|NCT00348140|19612978|P2|Overall Study|Serious adverse event|1
5687012|NCT00348140|19612979|P1|Overall Study|Serious adverse event|0
5687013|NCT00348140|19612977|P3|Overall Study|Increased risk of cardiac infarction|0
5687014|NCT00348140|19612978|P2|Overall Study|Increased risk of cardiac infarction|1
5687015|NCT00348140|19612979|P1|Overall Study|Increased risk of cardiac infarction|0
5687016|NCT00348140|19612977|P3|Overall Study|Disease progression|5
5687017|NCT00348140|19612978|P2|Overall Study|Disease progression|2
5687018|NCT00348140|19612979|P1|Overall Study|Disease progression|1
5687019|NCT00348140|19612977|P3|Overall Study|Use of prohibited drug|2
5687020|NCT00348140|19612978|P2|Overall Study|Use of prohibited drug|0
5687021|NCT00348140|19612979|P1|Overall Study|Use of prohibited drug|1
5687022|NCT00348140|19612977|P3|Overall Study|Decided to discontinue on their own|1
5687023|NCT00348140|19612978|P2|Overall Study|Decided to discontinue on their own|4
5687024|NCT00348140|19612979|P1|Overall Study|Decided to discontinue on their own|1
5687025|NCT00348140|19612977|P3|Overall Study|Investigator decided to discontinue|4
5687026|NCT00348140|19612978|P2|Overall Study|Investigator decided to discontinue|1
5687027|NCT00348140|19612979|P1|Overall Study|Investigator decided to discontinue|4
5687028|NCT00348140|19612977|P3|Overall Study|Screen failure|0
5687029|NCT00348140|19612978|P2|Overall Study|Screen failure|0
5687030|NCT00348140|19612979|P1|Overall Study|Screen failure|1
5687031|NCT00348140|19612977|P3|Overall Study|Participant unwell|0
5687032|NCT00348140|19612978|P2|Overall Study|Participant unwell|0
5687033|NCT00348140|19612979|P1|Overall Study|Participant unwell|1
5687034|NCT00348140|19612977|P3|Overall Study|Unmet inclusion-exclusion criteria|1
5687035|NCT00348140|19612978|P2|Overall Study|Unmet inclusion-exclusion criteria|0
5687036|NCT00348140|19612979|P1|Overall Study|Unmet inclusion-exclusion criteria|1
5687037|NCT00348140|19612977|P3|Overall Study|Administration related|1
5687038|NCT00348140|19612978|P2|Overall Study|Administration related|1
5687039|NCT00348140|19612979|P1|Overall Study|Administration related|3
5687040|NCT00348140|19612977|P3|Overall Study|Efficacy related|0
5687041|NCT00348140|19612978|P2|Overall Study|Efficacy related|1
5687042|NCT00348140|19612979|P1|Overall Study|Efficacy related|1
5687043|NCT00348140|19612977|P3|Overall Study|Participant hospitalised|0
5687044|NCT00348140|19612978|P2|Overall Study|Participant hospitalised|0
5687045|NCT00348140|19612979|P1|Overall Study|Participant hospitalised|3
5687046|NCT00348140|19612977|P3|Overall Study|Caregiver related|3
5687047|NCT00348140|19612978|P2|Overall Study|Caregiver related|7
5687048|NCT00348140|19612979|P1|Overall Study|Caregiver related|4
5687049|NCT00348140|19612977|P3|Overall Study|Conditional medication increased dose|0
5687050|NCT00348140|19612978|P2|Overall Study|Conditional medication increased dose|0
5687051|NCT00348140|19612979|P1|Overall Study|Conditional medication increased dose|1
5687052|NCT00348140|19612977|P3|Overall Study|Participant at risk due to study drug|0
5687053|NCT00348140|19612978|P2|Overall Study|Participant at risk due to study drug|0
5687054|NCT00348140|19612979|P1|Overall Study|Participant at risk due to study drug|2
5687055|NCT00348140|19612977|P3|Overall Study|Non-compliance|5
5687056|NCT00348140|19612978|P2|Overall Study|Non-compliance|13
5687057|NCT00348140|19612979|P1|Overall Study|Non-compliance|8
5687058|NCT00348140|19612977|P3|Overall Study|Withdrawal by Subject|40
5687059|NCT00348140|19612978|P2|Overall Study|Withdrawal by Subject|40
5687060|NCT00348140|19612979|P1|Overall Study|Withdrawal by Subject|32
5687061|NCT00348140|19612977|P3|Overall Study|Protocol Violation|14
5687062|NCT00348140|19612978|P2|Overall Study|Protocol Violation|13
5687063|NCT00348140|19612979|P1|Overall Study|Protocol Violation|12
5687064|NCT00348140|19612977|P3|Overall Study|Lost to Follow-up|4
5687065|NCT00348140|19612978|P2|Overall Study|Lost to Follow-up|4
5687066|NCT00348140|19612979|P1|Overall Study|Lost to Follow-up|4
5687067|NCT00348140|19612977|P3|Overall Study|Adverse Event|78
5687068|NCT00348140|19612978|P2|Overall Study|Adverse Event|49
5687069|NCT00348140|19612979|P1|Overall Study|Adverse Event|46
5687070|NCT00347958|19613077|P1|Overall Study|Withdrawal by Subject|1
5687071|NCT00347958|19613077|P1|Overall Study|Protocol Violation|2
5687072|NCT00347958|19613077|P1|Overall Study|Adverse Event|1
5687073|NCT00347932|19613086|P2|Overall Study|Did not meet inclusion criteria|8
5687074|NCT00347932|19613087|P1|Overall Study|Did not meet inclusion criteria|4
5687075|NCT00347932|19613086|P2|Overall Study|Withdrawal by Subject|16
5687076|NCT00347932|19613087|P1|Overall Study|Withdrawal by Subject|10
5687077|NCT00347932|19613086|P2|Overall Study|Lost to Follow-up|9
5687078|NCT00347932|19613087|P1|Overall Study|Lost to Follow-up|10
5687079|NCT00347932|19613086|P2|Overall Study|Lack of Efficacy|14
5687080|NCT00347932|19613087|P1|Overall Study|Lack of Efficacy|3
5687081|NCT00347932|19613086|P2|Overall Study|Adverse Event|5
5687082|NCT00347932|19613087|P1|Overall Study|Adverse Event|4
5687083|NCT00347919|19613102|P3|Overall Study|Missing|2
5687084|NCT00347919|19613103|P2|Overall Study|Missing|1
5687085|NCT00347919|19613104|P1|Overall Study|Missing|2
5687086|NCT00347919|19613102|P3|Overall Study|Par. Started Other Treatment|1
5687087|NCT00347919|19613103|P2|Overall Study|Par. Started Other Treatment|1
5687088|NCT00347919|19613104|P1|Overall Study|Par. Started Other Treatment|1
5687089|NCT00347919|19613102|P3|Overall Study|Death|19
5687090|NCT00347919|19613103|P2|Overall Study|Death|42
5687091|NCT00347919|19613104|P1|Overall Study|Death|35
5687092|NCT00347919|19613102|P3|Overall Study|Sponsor terminated study|16
5687093|NCT00347919|19613103|P2|Overall Study|Sponsor terminated study|10
5687094|NCT00347919|19613104|P1|Overall Study|Sponsor terminated study|15
5687095|NCT00347919|19613102|P3|Overall Study|Physician Decision|0
5687096|NCT00347919|19613103|P2|Overall Study|Physician Decision|1
5687097|NCT00347919|19613104|P1|Overall Study|Physician Decision|1
5687098|NCT00347919|19613102|P3|Overall Study|Withdrawal by Subject|0
5687099|NCT00347919|19613103|P2|Overall Study|Withdrawal by Subject|8
5687100|NCT00347919|19613104|P1|Overall Study|Withdrawal by Subject|6
5687101|NCT00347919|19613102|P3|Overall Study|Lost to Follow-up|0
5687102|NCT00347919|19613103|P2|Overall Study|Lost to Follow-up|13
5687103|NCT00347919|19613104|P1|Overall Study|Lost to Follow-up|11
5687104|NCT00347776|19613127|P3|12 Month Follow-up|Reached endpoint|9
5687105|NCT00347776|19613128|P2|12 Month Follow-up|Reached endpoint|6
5687106|NCT00347776|19613129|P1|12 Month Follow-up|Reached endpoint|13
5687107|NCT00347776|19613127|P3|12 Month Follow-up|Death|4
5687108|NCT00347776|19613128|P2|12 Month Follow-up|Death|4
5687109|NCT00347776|19613129|P1|12 Month Follow-up|Death|3
5687110|NCT00347776|19613127|P3|12 Month Follow-up|Lost to Follow-up|6
5687111|NCT00347776|19613128|P2|12 Month Follow-up|Lost to Follow-up|6
5687112|NCT00347776|19613129|P1|12 Month Follow-up|Lost to Follow-up|7
5687113|NCT00347776|19613127|P3|6 Month Follow-up|reached endpont|15
5687114|NCT00347776|19613128|P2|6 Month Follow-up|reached endpont|12
5687115|NCT00347776|19613129|P1|6 Month Follow-up|reached endpont|20
5687116|NCT00347776|19613127|P3|6 Month Follow-up|Death|3
5687117|NCT00347776|19613128|P2|6 Month Follow-up|Death|1
5687118|NCT00347776|19613129|P1|6 Month Follow-up|Death|2
5687119|NCT00347776|19613127|P3|1.5 Month Follow-up|reached the endpoint|12
5687120|NCT00347776|19613128|P2|1.5 Month Follow-up|reached the endpoint|8
5687121|NCT00347776|19613129|P1|1.5 Month Follow-up|reached the endpoint|12
5687122|NCT00347776|19613127|P3|1.5 Month Follow-up|Death|0
5687123|NCT00347776|19613128|P2|1.5 Month Follow-up|Death|0
5687124|NCT00347776|19613129|P1|1.5 Month Follow-up|Death|2
5687125|NCT00347438|19613141|P1|Overall Study|Physician Decision|1
5687126|NCT00347438|19613141|P1|Overall Study|Withdrawal by Subject|1
5687127|NCT00347360|19613163|P15|Overall Study|Visits conflicted with new job|0
5687128|NCT00347360|19613164|P14|Overall Study|Visits conflicted with new job|0
5687129|NCT00347360|19613165|P13|Overall Study|Visits conflicted with new job|0
5687130|NCT00347360|19613166|P12|Overall Study|Visits conflicted with new job|0
5687131|NCT00347360|19613167|P11|Overall Study|Visits conflicted with new job|0
5687132|NCT00347360|19613168|P10|Overall Study|Visits conflicted with new job|0
5687133|NCT00347360|19613169|P9|Overall Study|Visits conflicted with new job|0
5687134|NCT00347360|19613170|P8|Overall Study|Visits conflicted with new job|0
5687135|NCT00347360|19613171|P7|Overall Study|Visits conflicted with new job|1
5687136|NCT00347360|19613172|P6|Overall Study|Visits conflicted with new job|0
5687137|NCT00347360|19613173|P5|Overall Study|Visits conflicted with new job|0
5687138|NCT00347360|19613174|P4|Overall Study|Visits conflicted with new job|0
5687139|NCT00347360|19613175|P3|Overall Study|Visits conflicted with new job|0
5687140|NCT00347360|19613176|P2|Overall Study|Visits conflicted with new job|0
5687141|NCT00347360|19613177|P1|Overall Study|Visits conflicted with new job|0
5687142|NCT00347360|19613163|P15|Overall Study|Subject refuse to sign updated consent|1
5687143|NCT00347360|19613164|P14|Overall Study|Subject refuse to sign updated consent|0
5687144|NCT00347360|19613165|P13|Overall Study|Subject refuse to sign updated consent|0
5687145|NCT00347360|19613166|P12|Overall Study|Subject refuse to sign updated consent|0
5687146|NCT00347360|19613167|P11|Overall Study|Subject refuse to sign updated consent|0
5687147|NCT00347360|19613168|P10|Overall Study|Subject refuse to sign updated consent|0
5687148|NCT00347360|19613169|P9|Overall Study|Subject refuse to sign updated consent|0
5687149|NCT00347360|19613170|P8|Overall Study|Subject refuse to sign updated consent|0
5687150|NCT00347360|19613171|P7|Overall Study|Subject refuse to sign updated consent|0
5687151|NCT00347360|19613172|P6|Overall Study|Subject refuse to sign updated consent|0
5687152|NCT00347360|19613173|P5|Overall Study|Subject refuse to sign updated consent|0
5687153|NCT00347360|19613174|P4|Overall Study|Subject refuse to sign updated consent|0
5687154|NCT00347360|19613175|P3|Overall Study|Subject refuse to sign updated consent|0
5687155|NCT00347360|19613176|P2|Overall Study|Subject refuse to sign updated consent|0
5687156|NCT00347360|19613177|P1|Overall Study|Subject refuse to sign updated consent|0
5687157|NCT00347360|19613163|P15|Overall Study|Subject left town, ran out of study drug|0
5687158|NCT00347360|19613164|P14|Overall Study|Subject left town, ran out of study drug|1
5687159|NCT00347360|19613165|P13|Overall Study|Subject left town, ran out of study drug|0
5687160|NCT00347360|19613166|P12|Overall Study|Subject left town, ran out of study drug|0
5687161|NCT00347360|19613167|P11|Overall Study|Subject left town, ran out of study drug|0
5687162|NCT00347360|19613168|P10|Overall Study|Subject left town, ran out of study drug|0
5687163|NCT00347360|19613169|P9|Overall Study|Subject left town, ran out of study drug|0
5687164|NCT00347360|19613170|P8|Overall Study|Subject left town, ran out of study drug|0
5687165|NCT00347360|19613171|P7|Overall Study|Subject left town, ran out of study drug|0
5687166|NCT00347360|19613172|P6|Overall Study|Subject left town, ran out of study drug|0
5687167|NCT00347360|19613173|P5|Overall Study|Subject left town, ran out of study drug|0
5687168|NCT00347360|19613174|P4|Overall Study|Subject left town, ran out of study drug|0
5687169|NCT00347360|19613175|P3|Overall Study|Subject left town, ran out of study drug|0
5687170|NCT00347360|19613176|P2|Overall Study|Subject left town, ran out of study drug|0
5687171|NCT00347360|19613177|P1|Overall Study|Subject left town, ran out of study drug|0
5687172|NCT00347360|19613163|P15|Overall Study|Prolonged duration between visits|0
5687173|NCT00347360|19613164|P14|Overall Study|Prolonged duration between visits|0
5687174|NCT00347360|19613165|P13|Overall Study|Prolonged duration between visits|1
5687175|NCT00347360|19613166|P12|Overall Study|Prolonged duration between visits|0
5687176|NCT00347360|19613167|P11|Overall Study|Prolonged duration between visits|0
5687177|NCT00347360|19613168|P10|Overall Study|Prolonged duration between visits|0
5687178|NCT00347360|19613169|P9|Overall Study|Prolonged duration between visits|0
5687179|NCT00347360|19613170|P8|Overall Study|Prolonged duration between visits|0
5687180|NCT00347360|19613171|P7|Overall Study|Prolonged duration between visits|0
5687181|NCT00347360|19613172|P6|Overall Study|Prolonged duration between visits|0
5687182|NCT00347360|19613173|P5|Overall Study|Prolonged duration between visits|0
5687183|NCT00347360|19613174|P4|Overall Study|Prolonged duration between visits|0
5687184|NCT00347360|19613175|P3|Overall Study|Prolonged duration between visits|0
5687185|NCT00347360|19613176|P2|Overall Study|Prolonged duration between visits|0
5687186|NCT00347360|19613177|P1|Overall Study|Prolonged duration between visits|0
5687187|NCT00347360|19613163|P15|Overall Study|Failed inclusion criteria #4|0
5687188|NCT00347360|19613164|P14|Overall Study|Failed inclusion criteria #4|0
5687189|NCT00347360|19613165|P13|Overall Study|Failed inclusion criteria #4|0
5687190|NCT00347360|19613166|P12|Overall Study|Failed inclusion criteria #4|1
5687191|NCT00347360|19613167|P11|Overall Study|Failed inclusion criteria #4|0
5687192|NCT00347360|19613168|P10|Overall Study|Failed inclusion criteria #4|0
5687193|NCT00347360|19613169|P9|Overall Study|Failed inclusion criteria #4|0
5687194|NCT00347360|19613170|P8|Overall Study|Failed inclusion criteria #4|0
5687195|NCT00347360|19613171|P7|Overall Study|Failed inclusion criteria #4|0
5687196|NCT00347360|19613172|P6|Overall Study|Failed inclusion criteria #4|0
5687197|NCT00347360|19613173|P5|Overall Study|Failed inclusion criteria #4|0
5687198|NCT00347360|19613174|P4|Overall Study|Failed inclusion criteria #4|0
5687199|NCT00347360|19613175|P3|Overall Study|Failed inclusion criteria #4|0
5687200|NCT00347360|19613176|P2|Overall Study|Failed inclusion criteria #4|0
5687201|NCT00347360|19613177|P1|Overall Study|Failed inclusion criteria #4|0
5687202|NCT00347360|19613163|P15|Overall Study|Randomized in error|0
5687203|NCT00347360|19613164|P14|Overall Study|Randomized in error|0
5687204|NCT00347360|19613165|P13|Overall Study|Randomized in error|0
5687205|NCT00347360|19613166|P12|Overall Study|Randomized in error|1
5687206|NCT00347360|19613167|P11|Overall Study|Randomized in error|0
5687207|NCT00347360|19613168|P10|Overall Study|Randomized in error|0
5687208|NCT00347360|19613169|P9|Overall Study|Randomized in error|0
5687209|NCT00347360|19613170|P8|Overall Study|Randomized in error|0
5687210|NCT00347360|19613171|P7|Overall Study|Randomized in error|0
5687211|NCT00347360|19613172|P6|Overall Study|Randomized in error|0
5687212|NCT00347360|19613173|P5|Overall Study|Randomized in error|0
5687213|NCT00347360|19613174|P4|Overall Study|Randomized in error|0
5687214|NCT00347360|19613175|P3|Overall Study|Randomized in error|0
5687215|NCT00347360|19613176|P2|Overall Study|Randomized in error|0
5687216|NCT00347360|19613177|P1|Overall Study|Randomized in error|0
5687217|NCT00347360|19613163|P15|Overall Study|Did not meet criteria before ABPM|0
5687218|NCT00347360|19613164|P14|Overall Study|Did not meet criteria before ABPM|0
5687219|NCT00347360|19613165|P13|Overall Study|Did not meet criteria before ABPM|0
5687220|NCT00347360|19613166|P12|Overall Study|Did not meet criteria before ABPM|0
5687221|NCT00347360|19613167|P11|Overall Study|Did not meet criteria before ABPM|1
5687222|NCT00347360|19613168|P10|Overall Study|Did not meet criteria before ABPM|0
5687223|NCT00347360|19613169|P9|Overall Study|Did not meet criteria before ABPM|0
5687224|NCT00347360|19613170|P8|Overall Study|Did not meet criteria before ABPM|0
5687225|NCT00347360|19613171|P7|Overall Study|Did not meet criteria before ABPM|0
5687226|NCT00347360|19613172|P6|Overall Study|Did not meet criteria before ABPM|0
5687227|NCT00347360|19613173|P5|Overall Study|Did not meet criteria before ABPM|0
5687228|NCT00347360|19613174|P4|Overall Study|Did not meet criteria before ABPM|0
5687229|NCT00347360|19613175|P3|Overall Study|Did not meet criteria before ABPM|0
5687230|NCT00347360|19613176|P2|Overall Study|Did not meet criteria before ABPM|0
5687231|NCT00347360|19613177|P1|Overall Study|Did not meet criteria before ABPM|0
5687232|NCT00347360|19613163|P15|Overall Study|PI recommended early withdrawal|0
5687233|NCT00347360|19613164|P14|Overall Study|PI recommended early withdrawal|0
5687234|NCT00347360|19613165|P13|Overall Study|PI recommended early withdrawal|0
5687235|NCT00347360|19613166|P12|Overall Study|PI recommended early withdrawal|0
5687236|NCT00347360|19613167|P11|Overall Study|PI recommended early withdrawal|0
5687237|NCT00347360|19613168|P10|Overall Study|PI recommended early withdrawal|1
5687238|NCT00347360|19613169|P9|Overall Study|PI recommended early withdrawal|0
5687239|NCT00347360|19613170|P8|Overall Study|PI recommended early withdrawal|0
5687240|NCT00347360|19613171|P7|Overall Study|PI recommended early withdrawal|0
5687241|NCT00347360|19613172|P6|Overall Study|PI recommended early withdrawal|0
5687242|NCT00347360|19613173|P5|Overall Study|PI recommended early withdrawal|0
5687243|NCT00347360|19613174|P4|Overall Study|PI recommended early withdrawal|0
5687244|NCT00347360|19613175|P3|Overall Study|PI recommended early withdrawal|0
5687245|NCT00347360|19613176|P2|Overall Study|PI recommended early withdrawal|0
5687246|NCT00347360|19613177|P1|Overall Study|PI recommended early withdrawal|0
5687247|NCT00347360|19613163|P15|Overall Study|Abnormal lab values|0
5687248|NCT00347360|19613164|P14|Overall Study|Abnormal lab values|0
5687249|NCT00347360|19613165|P13|Overall Study|Abnormal lab values|0
5687250|NCT00347360|19613166|P12|Overall Study|Abnormal lab values|0
5687251|NCT00347360|19613167|P11|Overall Study|Abnormal lab values|0
5687252|NCT00347360|19613168|P10|Overall Study|Abnormal lab values|0
5687253|NCT00347360|19613169|P9|Overall Study|Abnormal lab values|0
5687254|NCT00347360|19613170|P8|Overall Study|Abnormal lab values|0
5687255|NCT00347360|19613171|P7|Overall Study|Abnormal lab values|1
5687256|NCT00347360|19613172|P6|Overall Study|Abnormal lab values|0
5687257|NCT00347360|19613173|P5|Overall Study|Abnormal lab values|0
5687258|NCT00347360|19613174|P4|Overall Study|Abnormal lab values|0
5687259|NCT00347360|19613175|P3|Overall Study|Abnormal lab values|0
5687260|NCT00347360|19613176|P2|Overall Study|Abnormal lab values|0
5687261|NCT00347360|19613177|P1|Overall Study|Abnormal lab values|0
5687262|NCT00347360|19613163|P15|Overall Study|Subject did not meet end of study ABPM|0
5687263|NCT00347360|19613164|P14|Overall Study|Subject did not meet end of study ABPM|1
5687264|NCT00347360|19613165|P13|Overall Study|Subject did not meet end of study ABPM|1
5687265|NCT00347360|19613166|P12|Overall Study|Subject did not meet end of study ABPM|0
5687266|NCT00347360|19613167|P11|Overall Study|Subject did not meet end of study ABPM|1
5687267|NCT00347360|19613168|P10|Overall Study|Subject did not meet end of study ABPM|0
5687268|NCT00347360|19613169|P9|Overall Study|Subject did not meet end of study ABPM|0
5687269|NCT00347360|19613170|P8|Overall Study|Subject did not meet end of study ABPM|0
5687270|NCT00347360|19613171|P7|Overall Study|Subject did not meet end of study ABPM|1
5687271|NCT00347360|19613172|P6|Overall Study|Subject did not meet end of study ABPM|0
5687272|NCT00347360|19613173|P5|Overall Study|Subject did not meet end of study ABPM|0
5687273|NCT00347360|19613174|P4|Overall Study|Subject did not meet end of study ABPM|0
5687274|NCT00347360|19613175|P3|Overall Study|Subject did not meet end of study ABPM|0
5687275|NCT00347360|19613176|P2|Overall Study|Subject did not meet end of study ABPM|0
5687276|NCT00347360|19613177|P1|Overall Study|Subject did not meet end of study ABPM|0
5687277|NCT00347360|19613163|P15|Overall Study|P.I. recommended due to blood pressure|0
5687278|NCT00347360|19613164|P14|Overall Study|P.I. recommended due to blood pressure|0
5687279|NCT00347360|19613165|P13|Overall Study|P.I. recommended due to blood pressure|0
5687280|NCT00347360|19613166|P12|Overall Study|P.I. recommended due to blood pressure|0
5687281|NCT00347360|19613167|P11|Overall Study|P.I. recommended due to blood pressure|0
5687282|NCT00347360|19613168|P10|Overall Study|P.I. recommended due to blood pressure|0
5687283|NCT00347360|19613169|P9|Overall Study|P.I. recommended due to blood pressure|0
5687284|NCT00347360|19613170|P8|Overall Study|P.I. recommended due to blood pressure|0
5687285|NCT00347360|19613171|P7|Overall Study|P.I. recommended due to blood pressure|0
5687286|NCT00347360|19613172|P6|Overall Study|P.I. recommended due to blood pressure|0
5687287|NCT00347360|19613173|P5|Overall Study|P.I. recommended due to blood pressure|1
5687288|NCT00347360|19613174|P4|Overall Study|P.I. recommended due to blood pressure|0
5687289|NCT00347360|19613175|P3|Overall Study|P.I. recommended due to blood pressure|0
5687290|NCT00347360|19613176|P2|Overall Study|P.I. recommended due to blood pressure|0
5687291|NCT00347360|19613177|P1|Overall Study|P.I. recommended due to blood pressure|0
5687292|NCT00347360|19613163|P15|Overall Study|Per sponsors instruction|0
5687293|NCT00347360|19613164|P14|Overall Study|Per sponsors instruction|0
5687294|NCT00347360|19613165|P13|Overall Study|Per sponsors instruction|0
5687295|NCT00347360|19613166|P12|Overall Study|Per sponsors instruction|0
5687296|NCT00347360|19613167|P11|Overall Study|Per sponsors instruction|0
5687297|NCT00347360|19613168|P10|Overall Study|Per sponsors instruction|0
5687298|NCT00347360|19613169|P9|Overall Study|Per sponsors instruction|0
5687299|NCT00347360|19613170|P8|Overall Study|Per sponsors instruction|0
5687300|NCT00347360|19613171|P7|Overall Study|Per sponsors instruction|0
5687301|NCT00347360|19613172|P6|Overall Study|Per sponsors instruction|0
5687302|NCT00347360|19613173|P5|Overall Study|Per sponsors instruction|0
5687303|NCT00347360|19613174|P4|Overall Study|Per sponsors instruction|0
5687304|NCT00347360|19613175|P3|Overall Study|Per sponsors instruction|0
5687305|NCT00347360|19613176|P2|Overall Study|Per sponsors instruction|1
5687306|NCT00347360|19613177|P1|Overall Study|Per sponsors instruction|0
5687307|NCT00347360|19613163|P15|Overall Study|Reason not listed/blank|0
5687308|NCT00347360|19613164|P14|Overall Study|Reason not listed/blank|1
5687309|NCT00347360|19613165|P13|Overall Study|Reason not listed/blank|0
5687310|NCT00347360|19613166|P12|Overall Study|Reason not listed/blank|0
5687311|NCT00347360|19613167|P11|Overall Study|Reason not listed/blank|0
5687312|NCT00347360|19613168|P10|Overall Study|Reason not listed/blank|0
5687313|NCT00347360|19613169|P9|Overall Study|Reason not listed/blank|0
5687314|NCT00347360|19613170|P8|Overall Study|Reason not listed/blank|0
5687315|NCT00347360|19613171|P7|Overall Study|Reason not listed/blank|1
5687316|NCT00347360|19613172|P6|Overall Study|Reason not listed/blank|0
5687317|NCT00347360|19613173|P5|Overall Study|Reason not listed/blank|0
5687318|NCT00347360|19613174|P4|Overall Study|Reason not listed/blank|0
5687319|NCT00347360|19613175|P3|Overall Study|Reason not listed/blank|0
5687320|NCT00347360|19613176|P2|Overall Study|Reason not listed/blank|0
5687321|NCT00347360|19613177|P1|Overall Study|Reason not listed/blank|1
5687322|NCT00347360|19613163|P15|Overall Study|Lack of Efficacy|0
5687323|NCT00347360|19613164|P14|Overall Study|Lack of Efficacy|0
5687324|NCT00347360|19613165|P13|Overall Study|Lack of Efficacy|0
5687325|NCT00347360|19613166|P12|Overall Study|Lack of Efficacy|0
5687326|NCT00347360|19613167|P11|Overall Study|Lack of Efficacy|0
5687327|NCT00347360|19613168|P10|Overall Study|Lack of Efficacy|0
5687328|NCT00347360|19613169|P9|Overall Study|Lack of Efficacy|1
5687329|NCT00347360|19613170|P8|Overall Study|Lack of Efficacy|1
5687330|NCT00347360|19613171|P7|Overall Study|Lack of Efficacy|0
5687331|NCT00347360|19613172|P6|Overall Study|Lack of Efficacy|1
5687332|NCT00347360|19613173|P5|Overall Study|Lack of Efficacy|0
5687333|NCT00347360|19613174|P4|Overall Study|Lack of Efficacy|1
5687334|NCT00347360|19613175|P3|Overall Study|Lack of Efficacy|3
5687335|NCT00347360|19613176|P2|Overall Study|Lack of Efficacy|1
5687336|NCT00347360|19613177|P1|Overall Study|Lack of Efficacy|1
5687337|NCT00347360|19613163|P15|Overall Study|Withdrawal by Subject|1
5687338|NCT00347360|19613164|P14|Overall Study|Withdrawal by Subject|2
5687339|NCT00347360|19613165|P13|Overall Study|Withdrawal by Subject|4
5687340|NCT00347360|19613166|P12|Overall Study|Withdrawal by Subject|3
5687341|NCT00347360|19613167|P11|Overall Study|Withdrawal by Subject|0
5687342|NCT00347360|19613168|P10|Overall Study|Withdrawal by Subject|1
5687343|NCT00347360|19613169|P9|Overall Study|Withdrawal by Subject|1
5687344|NCT00347360|19613170|P8|Overall Study|Withdrawal by Subject|1
5687345|NCT00347360|19613171|P7|Overall Study|Withdrawal by Subject|1
5687346|NCT00347360|19613172|P6|Overall Study|Withdrawal by Subject|2
5687347|NCT00347360|19613173|P5|Overall Study|Withdrawal by Subject|1
5687348|NCT00347360|19613174|P4|Overall Study|Withdrawal by Subject|4
5687349|NCT00347360|19613175|P3|Overall Study|Withdrawal by Subject|2
5687350|NCT00347360|19613176|P2|Overall Study|Withdrawal by Subject|1
5687351|NCT00347360|19613177|P1|Overall Study|Withdrawal by Subject|0
5687352|NCT00347360|19613163|P15|Overall Study|Protocol Violation|0
5687353|NCT00347360|19613164|P14|Overall Study|Protocol Violation|1
5687354|NCT00347360|19613165|P13|Overall Study|Protocol Violation|0
5687355|NCT00347360|19613166|P12|Overall Study|Protocol Violation|0
5687356|NCT00347360|19613167|P11|Overall Study|Protocol Violation|0
5687357|NCT00347360|19613168|P10|Overall Study|Protocol Violation|2
5687358|NCT00347360|19613169|P9|Overall Study|Protocol Violation|1
5687359|NCT00347360|19613170|P8|Overall Study|Protocol Violation|0
5687360|NCT00347360|19613171|P7|Overall Study|Protocol Violation|0
5687361|NCT00347360|19613172|P6|Overall Study|Protocol Violation|2
5687362|NCT00347360|19613173|P5|Overall Study|Protocol Violation|1
5687363|NCT00347360|19613174|P4|Overall Study|Protocol Violation|2
5687364|NCT00347360|19613175|P3|Overall Study|Protocol Violation|1
5687365|NCT00347360|19613176|P2|Overall Study|Protocol Violation|3
5687366|NCT00347360|19613177|P1|Overall Study|Protocol Violation|2
5687367|NCT00347360|19613163|P15|Overall Study|Lost to Follow-up|0
5687368|NCT00347360|19613164|P14|Overall Study|Lost to Follow-up|0
5687369|NCT00347360|19613165|P13|Overall Study|Lost to Follow-up|1
5687370|NCT00347360|19613166|P12|Overall Study|Lost to Follow-up|0
5687371|NCT00347360|19613167|P11|Overall Study|Lost to Follow-up|0
5687372|NCT00347360|19613168|P10|Overall Study|Lost to Follow-up|2
5687373|NCT00347360|19613169|P9|Overall Study|Lost to Follow-up|1
5687374|NCT00347360|19613170|P8|Overall Study|Lost to Follow-up|1
5687375|NCT00347360|19613171|P7|Overall Study|Lost to Follow-up|0
5687376|NCT00347360|19613172|P6|Overall Study|Lost to Follow-up|1
5687377|NCT00347360|19613173|P5|Overall Study|Lost to Follow-up|1
5687378|NCT00347360|19613174|P4|Overall Study|Lost to Follow-up|2
5687379|NCT00347360|19613175|P3|Overall Study|Lost to Follow-up|0
5687380|NCT00347360|19613176|P2|Overall Study|Lost to Follow-up|0
5687381|NCT00347360|19613177|P1|Overall Study|Lost to Follow-up|0
5687382|NCT00347360|19613163|P15|Overall Study|Adverse Event|2
5687383|NCT00347360|19613164|P14|Overall Study|Adverse Event|2
5687384|NCT00347360|19613165|P13|Overall Study|Adverse Event|3
5687385|NCT00347360|19613166|P12|Overall Study|Adverse Event|1
5687386|NCT00347360|19613167|P11|Overall Study|Adverse Event|3
5687387|NCT00347360|19613168|P10|Overall Study|Adverse Event|3
5687388|NCT00347360|19613169|P9|Overall Study|Adverse Event|2
5687389|NCT00347360|19613170|P8|Overall Study|Adverse Event|0
5687390|NCT00347360|19613171|P7|Overall Study|Adverse Event|2
5687391|NCT00347360|19613172|P6|Overall Study|Adverse Event|2
5687392|NCT00347360|19613173|P5|Overall Study|Adverse Event|1
5687393|NCT00347360|19613174|P4|Overall Study|Adverse Event|4
5687394|NCT00347360|19613175|P3|Overall Study|Adverse Event|0
5687395|NCT00347360|19613176|P2|Overall Study|Adverse Event|2
5687396|NCT00347360|19613177|P1|Overall Study|Adverse Event|1
5687397|NCT00347269|19613365|P2|Overall Study|Death|3
5687398|NCT00347269|19613366|P1|Overall Study|Death|2
5687399|NCT00347269|19613365|P2|Overall Study|Withdrawal by Subject|38
5687400|NCT00347269|19613366|P1|Overall Study|Withdrawal by Subject|18
5687401|NCT00347269|19613365|P2|Overall Study|Lost to Follow-up|65
5687402|NCT00347269|19613366|P1|Overall Study|Lost to Follow-up|74
5687403|NCT00347009|19613381|P1|Overall Study|Serious Adverse Event|1
5687404|NCT00347009|19613381|P1|Overall Study|Increased ALT/HBV DNA|1
5687405|NCT00347009|19613381|P1|Overall Study|Insufficient Viral Suppression|3
5687406|NCT00347009|19613381|P1|Overall Study|Adverse Laboratory Experience|1
5687407|NCT00347009|19613381|P1|Overall Study|Protocol Violation|2
5687408|NCT00347009|19613381|P1|Overall Study|Lost to Follow-up|4
5687409|NCT00347009|19613381|P1|Overall Study|Physician Decision|5
5687410|NCT00347009|19613381|P1|Overall Study|Withdrawal by Subject|3
5687411|NCT00347009|19613381|P1|Overall Study|Adverse Event|6
5687412|NCT00347009|19613381|P1|Overall Study|Death|1
5687413|NCT00346775|19613402|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
5687414|NCT00346775|19613403|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
5687415|NCT00346775|19613402|P2|Period 1: Intervention Period 1|Protocol Violation|2
5687416|NCT00346775|19613403|P1|Period 1: Intervention Period 1|Protocol Violation|3
5687417|NCT00346775|19613402|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
5687418|NCT00346775|19613403|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
5687419|NCT00346697|19613415|P2|Overall Study|Lost to Follow-up|1
5687420|NCT00346697|19613416|P1|Overall Study|Lost to Follow-up|0
5687421|NCT00346632|19613452|P10|Overall Study|Not Stated|1
5687422|NCT00346632|19613453|P9|Overall Study|Not Stated|2
5687423|NCT00346632|19613454|P8|Overall Study|Not Stated|2
5687424|NCT00346632|19613455|P7|Overall Study|Not Stated|0
5687425|NCT00346632|19613456|P6|Overall Study|Not Stated|0
5687426|NCT00346632|19613457|P5|Overall Study|Not Stated|0
5687427|NCT00346632|19613458|P4|Overall Study|Not Stated|0
5687428|NCT00346632|19613459|P3|Overall Study|Not Stated|0
5687429|NCT00346632|19613460|P2|Overall Study|Not Stated|1
5687430|NCT00346632|19613461|P1|Overall Study|Not Stated|1
5687431|NCT00346632|19613452|P10|Overall Study|Switched to alternative treatment|0
5687432|NCT00346632|19613453|P9|Overall Study|Switched to alternative treatment|0
5687433|NCT00346632|19613454|P8|Overall Study|Switched to alternative treatment|0
5687434|NCT00346632|19613455|P7|Overall Study|Switched to alternative treatment|0
5687435|NCT00346632|19613456|P6|Overall Study|Switched to alternative treatment|0
5687436|NCT00346632|19613457|P5|Overall Study|Switched to alternative treatment|0
5687437|NCT00346632|19613458|P4|Overall Study|Switched to alternative treatment|0
5687438|NCT00346632|19613459|P3|Overall Study|Switched to alternative treatment|1
5687439|NCT00346632|19613460|P2|Overall Study|Switched to alternative treatment|0
5687440|NCT00346632|19613461|P1|Overall Study|Switched to alternative treatment|0
5687441|NCT00346632|19613452|P10|Overall Study|Withdrawal by Subject|0
5687442|NCT00346632|19613453|P9|Overall Study|Withdrawal by Subject|0
5687443|NCT00346632|19613454|P8|Overall Study|Withdrawal by Subject|0
5687444|NCT00346632|19613455|P7|Overall Study|Withdrawal by Subject|1
5687445|NCT00346632|19613456|P6|Overall Study|Withdrawal by Subject|0
5687446|NCT00346632|19613457|P5|Overall Study|Withdrawal by Subject|0
5687447|NCT00346632|19613458|P4|Overall Study|Withdrawal by Subject|0
5687448|NCT00346632|19613459|P3|Overall Study|Withdrawal by Subject|0
5687449|NCT00346632|19613460|P2|Overall Study|Withdrawal by Subject|0
5687450|NCT00346632|19613461|P1|Overall Study|Withdrawal by Subject|0
5687451|NCT00346632|19613452|P10|Overall Study|Protocol Violation|0
5687452|NCT00346632|19613453|P9|Overall Study|Protocol Violation|0
5687453|NCT00346632|19613454|P8|Overall Study|Protocol Violation|0
5687454|NCT00346632|19613455|P7|Overall Study|Protocol Violation|1
5687455|NCT00346632|19613456|P6|Overall Study|Protocol Violation|0
5687456|NCT00346632|19613457|P5|Overall Study|Protocol Violation|0
5687457|NCT00346632|19613458|P4|Overall Study|Protocol Violation|0
5687458|NCT00346632|19613459|P3|Overall Study|Protocol Violation|0
5687459|NCT00346632|19613460|P2|Overall Study|Protocol Violation|0
5687460|NCT00346632|19613461|P1|Overall Study|Protocol Violation|0
5687461|NCT00346632|19613452|P10|Overall Study|Death|0
5687462|NCT00346632|19613453|P9|Overall Study|Death|0
5687463|NCT00346632|19613454|P8|Overall Study|Death|0
5687464|NCT00346632|19613455|P7|Overall Study|Death|0
5687465|NCT00346632|19613456|P6|Overall Study|Death|0
5687466|NCT00346632|19613457|P5|Overall Study|Death|0
5687467|NCT00346632|19613458|P4|Overall Study|Death|0
5687468|NCT00346632|19613459|P3|Overall Study|Death|1
5687469|NCT00346632|19613460|P2|Overall Study|Death|0
5687470|NCT00346632|19613461|P1|Overall Study|Death|0
5687471|NCT00346632|19613452|P10|Overall Study|Adverse Event|0
5687472|NCT00346632|19613453|P9|Overall Study|Adverse Event|0
5687473|NCT00346632|19613454|P8|Overall Study|Adverse Event|0
5687474|NCT00346632|19613455|P7|Overall Study|Adverse Event|1
5687475|NCT00346632|19613456|P6|Overall Study|Adverse Event|1
5687476|NCT00346632|19613457|P5|Overall Study|Adverse Event|1
5687477|NCT00346632|19613458|P4|Overall Study|Adverse Event|0
5687478|NCT00346632|19613459|P3|Overall Study|Adverse Event|0
5687479|NCT00346632|19613460|P2|Overall Study|Adverse Event|0
5687480|NCT00346632|19613461|P1|Overall Study|Adverse Event|0
5687481|NCT00346632|19613452|P10|Overall Study|Progressive Disease|2
5687482|NCT00346632|19613453|P9|Overall Study|Progressive Disease|2
5687483|NCT00346632|19613454|P8|Overall Study|Progressive Disease|2
5687484|NCT00346632|19613455|P7|Overall Study|Progressive Disease|2
5687485|NCT00346632|19613456|P6|Overall Study|Progressive Disease|1
5687486|NCT00346632|19613457|P5|Overall Study|Progressive Disease|3
5687487|NCT00346632|19613458|P4|Overall Study|Progressive Disease|3
5687488|NCT00346632|19613459|P3|Overall Study|Progressive Disease|4
5687489|NCT00346632|19613460|P2|Overall Study|Progressive Disease|2
5687490|NCT00346632|19613461|P1|Overall Study|Progressive Disease|2
5687491|NCT00346398|19613611|P2|Overall Study|Withdrawal by Subject|2
5687492|NCT00346398|19613612|P1|Overall Study|Withdrawal by Subject|0
5687493|NCT00346398|19613611|P2|Overall Study|Lost to Follow-up|0
5687494|NCT00346398|19613612|P1|Overall Study|Lost to Follow-up|3
5687495|NCT00346333|19613624|P2|Overall Study|unwilling or unable to continue|8
5687496|NCT00346333|19613625|P1|Overall Study|unwilling or unable to continue|4
5687497|NCT00346333|19613624|P2|Overall Study|Death|0
5687498|NCT00346333|19613625|P1|Overall Study|Death|1
5687499|NCT00346268|19613641|P2|Overall Study|Participant refused|3
5687500|NCT00346268|19613642|P1|Overall Study|Participant refused|0
5687501|NCT00346268|19613641|P2|Overall Study|Protocol Violation|0
5687502|NCT00346268|19613642|P1|Overall Study|Protocol Violation|1
5687503|NCT00346268|19613641|P2|Overall Study|Adverse Event|0
5687504|NCT00346268|19613642|P1|Overall Study|Adverse Event|1
5687505|NCT00346216|19613677|P3|Overall Study|Missing Subject Summary Status|62
5687506|NCT00346216|19613678|P2|Overall Study|Missing Subject Summary Status|61
5687507|NCT00346216|19613679|P1|Overall Study|Missing Subject Summary Status|62
5687508|NCT00346216|19613677|P3|Overall Study|Study terminated by sponsor|8
5687509|NCT00346216|19613678|P2|Overall Study|Study terminated by sponsor|4
5687510|NCT00346216|19613679|P1|Overall Study|Study terminated by sponsor|11
5687511|NCT00346216|19613677|P3|Overall Study|Death|228
5687512|NCT00346216|19613678|P2|Overall Study|Death|192
5687513|NCT00346216|19613679|P1|Overall Study|Death|189
5687514|NCT00346216|19613677|P3|Overall Study|Does not meet entrance criteria|8
5687515|NCT00346216|19613678|P2|Overall Study|Does not meet entrance criteria|10
5687516|NCT00346216|19613679|P1|Overall Study|Does not meet entrance criteria|13
5687517|NCT00346216|19613677|P3|Overall Study|Physician Decision|59
5687518|NCT00346216|19613678|P2|Overall Study|Physician Decision|76
5687519|NCT00346216|19613679|P1|Overall Study|Physician Decision|80
5687520|NCT00346216|19613677|P3|Overall Study|Lost to Follow-up|542
5687521|NCT00346216|19613678|P2|Overall Study|Lost to Follow-up|588
5687522|NCT00346216|19613679|P1|Overall Study|Lost to Follow-up|611
5687523|NCT00346216|19613677|P3|Overall Study|Withdrawal by Subject|651
5687524|NCT00346216|19613678|P2|Overall Study|Withdrawal by Subject|692
5687525|NCT00346216|19613679|P1|Overall Study|Withdrawal by Subject|661
5687526|NCT00346216|19613677|P3|Overall Study|No longer willing to participate|585
5687527|NCT00346216|19613678|P2|Overall Study|No longer willing to participate|606
5687528|NCT00346216|19613679|P1|Overall Study|No longer willing to participate|600
5687529|NCT00346216|19613677|P3|Overall Study|Other|205
5687530|NCT00346216|19613678|P2|Overall Study|Other|231
5687531|NCT00346216|19613679|P1|Overall Study|Other|181
5687532|NCT00346164|19613700|P4|Overall Study|Inability to start week 16 tx on time|11
5687533|NCT00346164|19613701|P3|Overall Study|Inability to start week 16 tx on time|0
5687534|NCT00346164|19613702|P2|Overall Study|Inability to start week 16 tx on time|0
5687535|NCT00346164|19613703|P1|Overall Study|Inability to start week 16 tx on time|0
5687536|NCT00346164|19613700|P4|Overall Study|Refusal of further protocol therapy|15
5687537|NCT00346164|19613701|P3|Overall Study|Refusal of further protocol therapy|3
5687538|NCT00346164|19613702|P2|Overall Study|Refusal of further protocol therapy|1
5687539|NCT00346164|19613703|P1|Overall Study|Refusal of further protocol therapy|0
5687540|NCT00346164|19613700|P4|Overall Study|Ineligible|23
5687541|NCT00346164|19613701|P3|Overall Study|Ineligible|2
5687542|NCT00346164|19613702|P2|Overall Study|Ineligible|2
5687543|NCT00346164|19613703|P1|Overall Study|Ineligible|11
5687544|NCT00346164|19613700|P4|Overall Study|Withdrawal by Subject|0
5687545|NCT00346164|19613701|P3|Overall Study|Withdrawal by Subject|2
5687546|NCT00346164|19613702|P2|Overall Study|Withdrawal by Subject|0
5687547|NCT00346164|19613703|P1|Overall Study|Withdrawal by Subject|0
5687548|NCT00346164|19613700|P4|Overall Study|Protocol Violation|4
5687549|NCT00346164|19613701|P3|Overall Study|Protocol Violation|10
5687550|NCT00346164|19613702|P2|Overall Study|Protocol Violation|2
5687551|NCT00346164|19613703|P1|Overall Study|Protocol Violation|6
5687552|NCT00346164|19613700|P4|Overall Study|Physician Decision|27
5687553|NCT00346164|19613701|P3|Overall Study|Physician Decision|2
5687554|NCT00346164|19613702|P2|Overall Study|Physician Decision|1
5687555|NCT00346164|19613703|P1|Overall Study|Physician Decision|0
5687556|NCT00346164|19613700|P4|Overall Study|Lack of Efficacy|25
5687557|NCT00346164|19613701|P3|Overall Study|Lack of Efficacy|7
5687558|NCT00346164|19613702|P2|Overall Study|Lack of Efficacy|1
5687559|NCT00346164|19613703|P1|Overall Study|Lack of Efficacy|0
5687560|NCT00346164|19613700|P4|Overall Study|Adverse Event|1
5687561|NCT00346164|19613701|P3|Overall Study|Adverse Event|0
5687562|NCT00346164|19613702|P2|Overall Study|Adverse Event|0
5687563|NCT00346164|19613703|P1|Overall Study|Adverse Event|0
5687564|NCT00346151|19613738|P1|Overall Study|Withdrawal by Subject|3
5687565|NCT00346073|19613758|P2|Overall Study|Lost to Follow-up|24
5687566|NCT00346073|19613759|P1|Overall Study|Lost to Follow-up|39
5687567|NCT00346073|19613758|P2|Overall Study|Serious Adverse Event|0
5687568|NCT00346073|19613759|P1|Overall Study|Serious Adverse Event|2
5687569|NCT00346034|19613793|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
5687570|NCT00346034|19613793|P1|Overall Study|Patient Stopped Taking Study Drug|1
5687571|NCT00346034|19613793|P1|Overall Study|Withdrawal by Subject|13
5687572|NCT00346034|19613793|P1|Overall Study|Lack of Efficacy|8
5687573|NCT00346034|19613793|P1|Overall Study|Adverse Event|34
5687574|NCT00345878|19613833|P2|Overall Study|Other|0
5687575|NCT00345878|19613834|P1|Overall Study|Other|1
5687576|NCT00345878|19613833|P2|Overall Study|Lost to Follow-up|1
5687577|NCT00345878|19613834|P1|Overall Study|Lost to Follow-up|2
5687578|NCT00345878|19613833|P2|Overall Study|Adverse Event|0
5687579|NCT00345878|19613834|P1|Overall Study|Adverse Event|1
5687580|NCT00345839|19613893|P2|Overall Study|Lost to Follow-up|61
5687581|NCT00345839|19613894|P1|Overall Study|Lost to Follow-up|58
5687582|NCT00345839|19613893|P2|Overall Study|Withdrawal by Subject|98
5687583|NCT00345839|19613894|P1|Overall Study|Withdrawal by Subject|91
5687584|NCT00345683|19613920|P2|Overall Study|Other|2
5687585|NCT00345683|19613921|P1|Overall Study|Other|6
5687586|NCT00345683|19613920|P2|Overall Study|Lost to Follow-up|7
5687587|NCT00345683|19613921|P1|Overall Study|Lost to Follow-up|19
5687588|NCT00345631|19613944|P3|Overall Study|Other reasons|1
5687589|NCT00345631|19613945|P2|Overall Study|Other reasons|0
5687590|NCT00345631|19613946|P1|Overall Study|Other reasons|0
5687591|NCT00345631|19613944|P3|Overall Study|Lost to Follow-up|4
5687592|NCT00345631|19613945|P2|Overall Study|Lost to Follow-up|7
5687593|NCT00345631|19613946|P1|Overall Study|Lost to Follow-up|3
5687594|NCT00345631|19613944|P3|Overall Study|Adverse Event|0
5687595|NCT00345631|19613945|P2|Overall Study|Adverse Event|1
5687596|NCT00345631|19613946|P1|Overall Study|Adverse Event|0
5687597|NCT00345631|19613944|P3|Overall Study|Withdrawal by Subject|1
5687598|NCT00345631|19613945|P2|Overall Study|Withdrawal by Subject|0
5687599|NCT00345631|19613946|P1|Overall Study|Withdrawal by Subject|1
5687600|NCT00345605|19613978|P2|Arm 2, Opposite Treatment|Adverse Event|0
5687601|NCT00345605|19613979|P1|Arm 2, Opposite Treatment|Adverse Event|1
5687602|NCT00345605|19613978|P2|Arm 1|Adverse Event|1
5687603|NCT00345605|19613979|P1|Arm 1|Adverse Event|0
5687604|NCT00345592|19613999|P2|Overall Study|Withdrawal by Subject|8
5687605|NCT00345592|19614000|P1|Overall Study|Withdrawal by Subject|11
5687606|NCT00345592|19613999|P2|Overall Study|Death|16
5687607|NCT00345592|19614000|P1|Overall Study|Death|14
5687608|NCT00345579|19614008|P2|Overall Study|Other|1
5687609|NCT00345579|19614009|P1|Overall Study|Other|9
5687610|NCT00345579|19614008|P2|Overall Study|Lost to Follow-up|36
5687611|NCT00345579|19614009|P1|Overall Study|Lost to Follow-up|82
5687612|NCT00345579|19614008|P2|Overall Study|Withdrawal by Subject|17
5687613|NCT00345579|19614009|P1|Overall Study|Withdrawal by Subject|50
5687614|NCT00345579|19614008|P2|Overall Study|Protocol Violation|5
5687615|NCT00345579|19614009|P1|Overall Study|Protocol Violation|14
5687616|NCT00345579|19614008|P2|Overall Study|Adverse Event|6
5687617|NCT00345579|19614009|P1|Overall Study|Adverse Event|9
5687618|NCT00345540|19614029|P1|Overall Study|Withdrawal by Subject|1
5687619|NCT00345397|19614035|P1|Overall Study|Death|1
5687620|NCT00345358|19614066|P4|Booster Vaccination Phase|Lost to Follow-up|0
5687621|NCT00345358|19614067|P3|Booster Vaccination Phase|Lost to Follow-up|0
5687622|NCT00345358|19614068|P2|Booster Vaccination Phase|Lost to Follow-up|0
5687623|NCT00345358|19614069|P1|Booster Vaccination Phase|Lost to Follow-up|3
5687624|NCT00345358|19614066|P4|Booster Vaccination Phase|Withdrawal by Subject|0
5687625|NCT00345358|19614067|P3|Booster Vaccination Phase|Withdrawal by Subject|0
5687626|NCT00345358|19614068|P2|Booster Vaccination Phase|Withdrawal by Subject|0
5687627|NCT00345358|19614069|P1|Booster Vaccination Phase|Withdrawal by Subject|1
5687628|NCT00345358|19614066|P4|Primary Vaccination Phase|Lost to Follow-up|2
5687629|NCT00345358|19614067|P3|Primary Vaccination Phase|Lost to Follow-up|2
5687630|NCT00345358|19614068|P2|Primary Vaccination Phase|Lost to Follow-up|0
5687631|NCT00345358|19614069|P1|Primary Vaccination Phase|Lost to Follow-up|1
5687632|NCT00345358|19614066|P4|Primary Vaccination Phase|Withdrawal by Subject|0
5687633|NCT00345358|19614067|P3|Primary Vaccination Phase|Withdrawal by Subject|4
5687634|NCT00345358|19614068|P2|Primary Vaccination Phase|Withdrawal by Subject|2
5687635|NCT00345358|19614069|P1|Primary Vaccination Phase|Withdrawal by Subject|1
5687636|NCT00345358|19614066|P4|Primary Vaccination Phase|Adverse event, non-fatal|0
5687637|NCT00345358|19614067|P3|Primary Vaccination Phase|Adverse event, non-fatal|1
5687638|NCT00345358|19614068|P2|Primary Vaccination Phase|Adverse event, non-fatal|1
5687639|NCT00345358|19614069|P1|Primary Vaccination Phase|Adverse event, non-fatal|3
5687640|NCT00345358|19614066|P4|Primary Vaccination Phase|Other|0
5687641|NCT00345358|19614067|P3|Primary Vaccination Phase|Other|1
5687642|NCT00345358|19614068|P2|Primary Vaccination Phase|Other|1
5687643|NCT00345358|19614069|P1|Primary Vaccination Phase|Other|0
5687644|NCT00345293|19614159|P2|Overall Study|Withdrawal by Subject|0
5687645|NCT00345293|19614160|P1|Overall Study|Withdrawal by Subject|1
5687646|NCT00345293|19614159|P2|Overall Study|Unable to access line for sample|0
5687647|NCT00345293|19614160|P1|Overall Study|Unable to access line for sample|1
5687648|NCT00345046|19614206|P3|Overall Study|Protocol Violation|2
5687649|NCT00345046|19614207|P2|Overall Study|Protocol Violation|1
5687650|NCT00345046|19614208|P1|Overall Study|Protocol Violation|1
5687651|NCT00344968|19614238|P3|Overall Study|Other|0
5687652|NCT00344968|19614239|P2|Overall Study|Other|1
5687653|NCT00344968|19614240|P1|Overall Study|Other|0
5687654|NCT00344968|19614238|P3|Overall Study|Death|31
5687655|NCT00344968|19614239|P2|Overall Study|Death|27
5687656|NCT00344968|19614240|P1|Overall Study|Death|11
5687657|NCT00344968|19614238|P3|Overall Study|Lost to Follow-up|37
5687658|NCT00344968|19614239|P2|Overall Study|Lost to Follow-up|37
5687659|NCT00344968|19614240|P1|Overall Study|Lost to Follow-up|24
5687660|NCT00344968|19614238|P3|Overall Study|Withdrawal by Subject|27
5687661|NCT00344968|19614239|P2|Overall Study|Withdrawal by Subject|31
5687662|NCT00344968|19614240|P1|Overall Study|Withdrawal by Subject|14
5687663|NCT00344968|19614238|P3|Overall Study|Protocol Violation|5
5687664|NCT00344968|19614239|P2|Overall Study|Protocol Violation|2
5687665|NCT00344968|19614240|P1|Overall Study|Protocol Violation|2
5687666|NCT00344968|19614238|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
5687667|NCT00344968|19614239|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
5687668|NCT00344968|19614240|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
5687669|NCT00344968|19614238|P3|Overall Study|Adverse Event|15
5687670|NCT00344968|19614239|P2|Overall Study|Adverse Event|4
5687671|NCT00344968|19614240|P1|Overall Study|Adverse Event|5
5687672|NCT00344773|19614251|P1|Overall Study|Not Eligible for the study|2
5687673|NCT00344773|19614251|P1|Overall Study|Withdrawal by Subject|1
5687674|NCT00344773|19614251|P1|Overall Study|Objective Disease Progression|16
5687675|NCT00344773|19614251|P1|Overall Study|Adverse Event|2
5687676|NCT00344500|19614274|P3|Overall Study|Not Noted|0
5687677|NCT00344500|19614275|P2|Overall Study|Not Noted|3
5687678|NCT00344500|19614276|P1|Overall Study|Not Noted|1
5687679|NCT00344500|19614274|P3|Overall Study|Protocol Violation|1
5687680|NCT00344500|19614275|P2|Overall Study|Protocol Violation|7
5687681|NCT00344500|19614276|P1|Overall Study|Protocol Violation|4
5687682|NCT00344500|19614274|P3|Overall Study|Withdrawal by Subject|0
5687683|NCT00344500|19614275|P2|Overall Study|Withdrawal by Subject|10
5687684|NCT00344500|19614276|P1|Overall Study|Withdrawal by Subject|7
5687685|NCT00344500|19614274|P3|Overall Study|Lost to Follow-up|1
5687686|NCT00344500|19614275|P2|Overall Study|Lost to Follow-up|13
5687687|NCT00344500|19614276|P1|Overall Study|Lost to Follow-up|5
5687688|NCT00344500|19614274|P3|Overall Study|Adverse Event|0
5687689|NCT00344500|19614275|P2|Overall Study|Adverse Event|2
5687690|NCT00344500|19614276|P1|Overall Study|Adverse Event|6
5687691|NCT00344487|19614287|P1|Overall Study|immunologic failure|1
5687692|NCT00344461|19614291|P1|Overall Study|Withdrawal by Subject|2
5687693|NCT00344461|19614291|P1|Overall Study|Protocol Violation|6
5687694|NCT00344461|19614291|P1|Overall Study|Physician Decision|2
5687695|NCT00344461|19614291|P1|Overall Study|Lost to Follow-up|2
5687696|NCT00344461|19614291|P1|Overall Study|Lack of Efficacy|2
5687697|NCT00344461|19614291|P1|Overall Study|Death|1
5687698|NCT00344461|19614291|P1|Overall Study|Adverse Event|6
5687699|NCT00344448|19614302|P2|Open Label|Study terminated|0
5687700|NCT00344448|19614303|P1|Open Label|Study terminated|1
5687701|NCT00344448|19614302|P2|Open Label|Withdrawal by Subject|1
5687702|NCT00344448|19614303|P1|Open Label|Withdrawal by Subject|1
5687703|NCT00344448|19614302|P2|Double Blind, Placebo Controlled|Study terminated|0
5687704|NCT00344448|19614303|P1|Double Blind, Placebo Controlled|Study terminated|1
5687705|NCT00344448|19614302|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
5687706|NCT00344448|19614303|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
5687707|NCT00344448|19614302|P2|Screening|Withdrawal by Subject|1
5687708|NCT00344448|19614303|P1|Screening|Withdrawal by Subject|0
5687709|NCT00344318|19614324|P4|Overall Study|Lost to Follow-up|0
5687710|NCT00344318|19614325|P3|Overall Study|Lost to Follow-up|1
5687711|NCT00344318|19614326|P2|Overall Study|Lost to Follow-up|0
5687712|NCT00344318|19614327|P1|Overall Study|Lost to Follow-up|2
5687713|NCT00344318|19614324|P4|Overall Study|Withdrawal by Subject|2
5687714|NCT00344318|19614325|P3|Overall Study|Withdrawal by Subject|0
5687715|NCT00344318|19614326|P2|Overall Study|Withdrawal by Subject|2
5687716|NCT00344318|19614327|P1|Overall Study|Withdrawal by Subject|2
5687717|NCT00344318|19614324|P4|Overall Study|Adverse Event|1
5687718|NCT00344318|19614325|P3|Overall Study|Adverse Event|0
5687719|NCT00344318|19614326|P2|Overall Study|Adverse Event|3
5687720|NCT00344318|19614327|P1|Overall Study|Adverse Event|0
5687721|NCT00344305|19614449|P2|Overall Study|Participant was not contacted in window|1
5687722|NCT00344305|19614450|P1|Overall Study|Participant was not contacted in window|0
5687723|NCT00344305|19614449|P2|Overall Study|Lost to Follow-up|0
5687724|NCT00344305|19614450|P1|Overall Study|Lost to Follow-up|2
5687725|NCT00344032|19614500|P2|Overall Study|Physician Decision|1
5687726|NCT00344032|19614501|P1|Overall Study|Physician Decision|4
5687727|NCT00344032|19614500|P2|Overall Study|Lost to Follow-up|6
5687728|NCT00344032|19614501|P1|Overall Study|Lost to Follow-up|4
5687729|NCT00344032|19614500|P2|Overall Study|Withdrawal by Subject|2
5687730|NCT00344032|19614501|P1|Overall Study|Withdrawal by Subject|6
5687731|NCT00344032|19614500|P2|Overall Study|Adverse Event|1
5687732|NCT00344032|19614501|P1|Overall Study|Adverse Event|0
5687733|NCT00344019|19614520|P3|Overall Study|did not meet final inclusion criteria|74
5687734|NCT00344019|19614521|P2|Overall Study|did not meet final inclusion criteria|0
5687735|NCT00344019|19614522|P1|Overall Study|did not meet final inclusion criteria|0
5687736|NCT00343915|19614540|P2|Primary Study|Other|0
5687737|NCT00343915|19614541|P1|Primary Study|Other|1
5687738|NCT00343915|19614540|P2|Primary Study|Lost to Follow-up|3
5687739|NCT00343915|19614541|P1|Primary Study|Lost to Follow-up|2
5687740|NCT00343915|19614540|P2|Primary Study|Withdrawal by Subject|0
5687741|NCT00343915|19614541|P1|Primary Study|Withdrawal by Subject|1
5687742|NCT00343889|19614567|P2|Overall Study|Protocol Violation|0
5687743|NCT00343889|19614568|P1|Overall Study|Protocol Violation|1
5687744|NCT00343889|19614567|P2|Overall Study|Withdrawal by Subject|1
5687745|NCT00343889|19614568|P1|Overall Study|Withdrawal by Subject|0
5687746|NCT00343889|19614567|P2|Overall Study|Lost to Follow-up|0
5687747|NCT00343889|19614568|P1|Overall Study|Lost to Follow-up|2
5687748|NCT00343512|19614732|P1|Overall Study|Withdrawal by Subject|2
5687749|NCT00343382|19614820|P3|Overall Study|Other Reason Not Specified|4
5687750|NCT00343382|19614821|P2|Overall Study|Other Reason Not Specified|2
5687751|NCT00343382|19614822|P1|Overall Study|Other Reason Not Specified|1
5687752|NCT00343382|19614820|P3|Overall Study|Withdrawal by Subject|6
5687753|NCT00343382|19614821|P2|Overall Study|Withdrawal by Subject|2
5687754|NCT00343382|19614822|P1|Overall Study|Withdrawal by Subject|1
5687755|NCT00343382|19614820|P3|Overall Study|Adverse Event|7
5687756|NCT00343382|19614821|P2|Overall Study|Adverse Event|10
5687757|NCT00343382|19614822|P1|Overall Study|Adverse Event|2
5687758|NCT00343291|19614841|P2|Overall Study|Other|5
5687759|NCT00343291|19614842|P1|Overall Study|Other|8
5687760|NCT00343291|19614841|P2|Overall Study|Withdrawal by Subject|2
5687761|NCT00343291|19614842|P1|Overall Study|Withdrawal by Subject|0
5687762|NCT00343291|19614841|P2|Overall Study|Progressive disease|34
5687763|NCT00343291|19614842|P1|Overall Study|Progressive disease|33
5687764|NCT00343291|19614841|P2|Overall Study|Death|2
5687765|NCT00343291|19614842|P1|Overall Study|Death|3
5687766|NCT00343291|19614841|P2|Overall Study|Adverse Event|13
5687767|NCT00343291|19614842|P1|Overall Study|Adverse Event|13
5687768|NCT00343252|19614858|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
5687769|NCT00343252|19614859|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
5687770|NCT00343252|19614858|P2|18 Months (All Treated Participants)|Sponsor Decision|5
5687771|NCT00343252|19614859|P1|18 Months (All Treated Participants)|Sponsor Decision|8
5687772|NCT00343252|19614858|P2|18 Months (All Treated Participants)|Protocol Violation|3
5687773|NCT00343252|19614859|P1|18 Months (All Treated Participants)|Protocol Violation|3
5687774|NCT00343252|19614858|P2|18 Months (All Treated Participants)|Physician Decision|7
5687775|NCT00343252|19614859|P1|18 Months (All Treated Participants)|Physician Decision|4
5687776|NCT00343252|19614858|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
5687777|NCT00343252|19614859|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
5687778|NCT00343252|19614858|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
5687779|NCT00343252|19614859|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
5687780|NCT00343252|19614858|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
5687781|NCT00343252|19614859|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
5687782|NCT00343252|19614858|P2|18 Months (All Treated Participants)|Death|5
5687783|NCT00343252|19614859|P1|18 Months (All Treated Participants)|Death|4
5687784|NCT00343252|19614858|P2|18 Months (All Treated Participants)|Adverse Event|23
5687785|NCT00343252|19614859|P1|18 Months (All Treated Participants)|Adverse Event|31
5687786|NCT00343252|19614858|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
5687787|NCT00343252|19614859|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
5687788|NCT00343252|19614858|P2|12 Months (All Treated Participants)|Sponsor Decision|6
5687789|NCT00343252|19614859|P1|12 Months (All Treated Participants)|Sponsor Decision|9
5687790|NCT00343252|19614858|P2|12 Months (All Treated Participants)|Protocol Violation|2
5687791|NCT00343252|19614859|P1|12 Months (All Treated Participants)|Protocol Violation|3
5687792|NCT00343252|19614858|P2|12 Months (All Treated Participants)|Physician Decision|5
5687793|NCT00343252|19614859|P1|12 Months (All Treated Participants)|Physician Decision|4
5687794|NCT00343252|19614858|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
5687795|NCT00343252|19614859|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
5687796|NCT00343252|19614858|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
5687797|NCT00343252|19614859|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
5687798|NCT00343252|19614858|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
5687799|NCT00343252|19614859|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
5687800|NCT00343252|19614858|P2|12 Months (All Treated Participants)|Death|3
5687801|NCT00343252|19614859|P1|12 Months (All Treated Participants)|Death|3
5687802|NCT00343252|19614858|P2|12 Months (All Treated Participants)|Adverse Event|20
5687803|NCT00343252|19614859|P1|12 Months (All Treated Participants)|Adverse Event|22
5687804|NCT00343252|19614858|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
5687805|NCT00343252|19614859|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
5687806|NCT00343252|19614858|P2|6 Months (All Treated Participants)|Sponsor Decision|4
5687807|NCT00343252|19614859|P1|6 Months (All Treated Participants)|Sponsor Decision|7
5687808|NCT00343252|19614858|P2|6 Months (All Treated Participants)|Protocol Violation|2
5687809|NCT00343252|19614859|P1|6 Months (All Treated Participants)|Protocol Violation|2
5687810|NCT00343252|19614858|P2|6 Months (All Treated Participants)|Physician Decision|3
5687811|NCT00343252|19614859|P1|6 Months (All Treated Participants)|Physician Decision|1
5687812|NCT00343252|19614858|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
5687813|NCT00343252|19614859|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
5687814|NCT00343252|19614858|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
5687815|NCT00343252|19614859|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
5687816|NCT00343252|19614858|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
5687817|NCT00343252|19614859|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
5687818|NCT00343252|19614858|P2|6 Months (All Treated Participants)|Death|2
5687819|NCT00343252|19614859|P1|6 Months (All Treated Participants)|Death|0
5687820|NCT00343252|19614858|P2|6 Months (All Treated Participants)|Adverse Event|11
5687821|NCT00343252|19614859|P1|6 Months (All Treated Participants)|Adverse Event|17
5687822|NCT00342628|19614924|P3|Overall Study|moved residence|1
5687823|NCT00342628|19614925|P2|Overall Study|moved residence|1
5687824|NCT00342628|19614926|P1|Overall Study|moved residence|0
5687825|NCT00342628|19614924|P3|Overall Study|Death|0
5687826|NCT00342628|19614925|P2|Overall Study|Death|1
5687827|NCT00342628|19614926|P1|Overall Study|Death|1
5687828|NCT00342628|19614924|P3|Overall Study|Withdrawal by Subject|18
5687829|NCT00342628|19614925|P2|Overall Study|Withdrawal by Subject|19
5687830|NCT00342628|19614926|P1|Overall Study|Withdrawal by Subject|19
5687831|NCT00340834|19614992|P5|Extension Phase of Study|Death|1
5687832|NCT00340834|19614993|P4|Extension Phase of Study|Death|0
5687833|NCT00340834|19614994|P3|Extension Phase of Study|Death|0
5687834|NCT00340834|19614995|P2|Extension Phase of Study|Death|0
5687835|NCT00340834|19614996|P1|Extension Phase of Study|Death|0
5687836|NCT00340834|19614992|P5|Extension Phase of Study|Protocol Violation|0
5687837|NCT00340834|19614993|P4|Extension Phase of Study|Protocol Violation|0
5687838|NCT00340834|19614994|P3|Extension Phase of Study|Protocol Violation|0
5687839|NCT00340834|19614995|P2|Extension Phase of Study|Protocol Violation|0
5687840|NCT00340834|19614996|P1|Extension Phase of Study|Protocol Violation|3
5687841|NCT00340834|19614992|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
5687842|NCT00340834|19614993|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
5687843|NCT00340834|19614994|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
5687844|NCT00340834|19614995|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
5687845|NCT00340834|19614996|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
5687846|NCT00340834|19614992|P5|Extension Phase of Study|Administrative problems|1
5687847|NCT00340834|19614993|P4|Extension Phase of Study|Administrative problems|1
5687848|NCT00340834|19614994|P3|Extension Phase of Study|Administrative problems|0
5687849|NCT00340834|19614995|P2|Extension Phase of Study|Administrative problems|0
5687850|NCT00340834|19614996|P1|Extension Phase of Study|Administrative problems|3
5687851|NCT00340834|19614992|P5|Extension Phase of Study|Subject no longer requires study drug|2
5687852|NCT00340834|19614993|P4|Extension Phase of Study|Subject no longer requires study drug|0
5687853|NCT00340834|19614994|P3|Extension Phase of Study|Subject no longer requires study drug|0
5687854|NCT00340834|19614995|P2|Extension Phase of Study|Subject no longer requires study drug|0
5687855|NCT00340834|19614996|P1|Extension Phase of Study|Subject no longer requires study drug|4
5687856|NCT00340834|19614992|P5|Extension Phase of Study|Lost to Follow-up|3
5687857|NCT00340834|19614993|P4|Extension Phase of Study|Lost to Follow-up|2
5687858|NCT00340834|19614994|P3|Extension Phase of Study|Lost to Follow-up|0
5687859|NCT00340834|19614995|P2|Extension Phase of Study|Lost to Follow-up|1
5687860|NCT00340834|19614996|P1|Extension Phase of Study|Lost to Follow-up|1
5687861|NCT00340834|19614992|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
5687862|NCT00340834|19614993|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
5687863|NCT00340834|19614994|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
5687864|NCT00340834|19614995|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
5687865|NCT00340834|19614996|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
5687866|NCT00340834|19614992|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
5687867|NCT00340834|19614993|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
5687868|NCT00340834|19614994|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
5687869|NCT00340834|19614995|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
5687870|NCT00340834|19614996|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
5687871|NCT00340834|19614992|P5|Extension Phase of Study|Adverse Event|7
5687872|NCT00340834|19614993|P4|Extension Phase of Study|Adverse Event|19
5687873|NCT00340834|19614994|P3|Extension Phase of Study|Adverse Event|0
5687874|NCT00340834|19614995|P2|Extension Phase of Study|Adverse Event|22
5687875|NCT00340834|19614996|P1|Extension Phase of Study|Adverse Event|21
5687876|NCT00340834|19614992|P5|Extension Phase of Study|Subject withdrew consent|15
5687877|NCT00340834|19614993|P4|Extension Phase of Study|Subject withdrew consent|12
5687878|NCT00340834|19614994|P3|Extension Phase of Study|Subject withdrew consent|0
5687879|NCT00340834|19614995|P2|Extension Phase of Study|Subject withdrew consent|31
5687880|NCT00340834|19614996|P1|Extension Phase of Study|Subject withdrew consent|26
5687881|NCT00340834|19614992|P5|Extension Phase of Study|Subject did not receive study drug|0
5687882|NCT00340834|19614993|P4|Extension Phase of Study|Subject did not receive study drug|2
5687883|NCT00340834|19614994|P3|Extension Phase of Study|Subject did not receive study drug|0
5687884|NCT00340834|19614995|P2|Extension Phase of Study|Subject did not receive study drug|1
5687885|NCT00340834|19614996|P1|Extension Phase of Study|Subject did not receive study drug|0
5687886|NCT00340834|19614992|P5|Core Phase of Study|Protocol Violation|0
5687887|NCT00340834|19614993|P4|Core Phase of Study|Protocol Violation|0
5687888|NCT00340834|19614994|P3|Core Phase of Study|Protocol Violation|2
5687889|NCT00340834|19614995|P2|Core Phase of Study|Protocol Violation|0
5687890|NCT00340834|19614996|P1|Core Phase of Study|Protocol Violation|0
5687891|NCT00340834|19614992|P5|Core Phase of Study|Death|0
5687892|NCT00340834|19614993|P4|Core Phase of Study|Death|0
5687893|NCT00340834|19614994|P3|Core Phase of Study|Death|0
5687894|NCT00340834|19614995|P2|Core Phase of Study|Death|0
5687895|NCT00340834|19614996|P1|Core Phase of Study|Death|2
5687896|NCT00340834|19614992|P5|Core Phase of Study|Lost to Follow-up|0
5687897|NCT00340834|19614993|P4|Core Phase of Study|Lost to Follow-up|0
5687898|NCT00340834|19614994|P3|Core Phase of Study|Lost to Follow-up|4
5687899|NCT00340834|19614995|P2|Core Phase of Study|Lost to Follow-up|1
5687900|NCT00340834|19614996|P1|Core Phase of Study|Lost to Follow-up|1
5687901|NCT00340834|19614992|P5|Core Phase of Study|Abnormal test procedure result(s)|0
5687902|NCT00340834|19614993|P4|Core Phase of Study|Abnormal test procedure result(s)|0
5687903|NCT00340834|19614994|P3|Core Phase of Study|Abnormal test procedure result(s)|3
5687904|NCT00340834|19614995|P2|Core Phase of Study|Abnormal test procedure result(s)|3
5687905|NCT00340834|19614996|P1|Core Phase of Study|Abnormal test procedure result(s)|4
5687906|NCT00340834|19614992|P5|Core Phase of Study|Abnormal laboratory value(s)|0
5687907|NCT00340834|19614993|P4|Core Phase of Study|Abnormal laboratory value(s)|0
5687908|NCT00340834|19614994|P3|Core Phase of Study|Abnormal laboratory value(s)|1
5687909|NCT00340834|19614995|P2|Core Phase of Study|Abnormal laboratory value(s)|6
5687910|NCT00340834|19614996|P1|Core Phase of Study|Abnormal laboratory value(s)|4
5687911|NCT00340834|19614992|P5|Core Phase of Study|Lack of Efficacy|0
5687912|NCT00340834|19614993|P4|Core Phase of Study|Lack of Efficacy|0
5687913|NCT00340834|19614994|P3|Core Phase of Study|Lack of Efficacy|7
5687914|NCT00340834|19614995|P2|Core Phase of Study|Lack of Efficacy|3
5687915|NCT00340834|19614996|P1|Core Phase of Study|Lack of Efficacy|3
5687916|NCT00340834|19614992|P5|Core Phase of Study|Administrative Problems|0
5687917|NCT00340834|19614993|P4|Core Phase of Study|Administrative Problems|0
5687918|NCT00340834|19614994|P3|Core Phase of Study|Administrative Problems|7
5687919|NCT00340834|19614995|P2|Core Phase of Study|Administrative Problems|2
5687920|NCT00340834|19614996|P1|Core Phase of Study|Administrative Problems|6
5687921|NCT00340834|19614992|P5|Core Phase of Study|Withdrawal by Subject|0
5687922|NCT00340834|19614993|P4|Core Phase of Study|Withdrawal by Subject|0
5687923|NCT00340834|19614994|P3|Core Phase of Study|Withdrawal by Subject|16
5687924|NCT00340834|19614995|P2|Core Phase of Study|Withdrawal by Subject|9
5687925|NCT00340834|19614996|P1|Core Phase of Study|Withdrawal by Subject|11
5687926|NCT00340834|19614992|P5|Core Phase of Study|Adverse Event|0
5687927|NCT00340834|19614993|P4|Core Phase of Study|Adverse Event|0
5687928|NCT00340834|19614994|P3|Core Phase of Study|Adverse Event|9
5687929|NCT00340834|19614995|P2|Core Phase of Study|Adverse Event|9
5687930|NCT00340834|19614996|P1|Core Phase of Study|Adverse Event|26
5687931|NCT00340704|19615030|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
5687932|NCT00340704|19615031|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
5687933|NCT00340704|19615032|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
5687934|NCT00340704|19615033|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
5687935|NCT00340704|19615034|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5687936|NCT00340704|19615035|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5687937|NCT00340704|19615036|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5687938|NCT00340704|19615037|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5687939|NCT00340704|19615038|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
5687940|NCT00340704|19615030|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5687941|NCT00340704|19615031|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5687942|NCT00340704|19615032|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5687943|NCT00340704|19615033|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
5687944|NCT00340704|19615034|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
5687945|NCT00340704|19615035|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5687946|NCT00340704|19615036|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5687947|NCT00340704|19615037|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5687948|NCT00340704|19615038|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
5687949|NCT00340704|19615030|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5687950|NCT00340704|19615031|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5687951|NCT00340704|19615032|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5687952|NCT00340704|19615033|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
5687953|NCT00340704|19615034|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5687954|NCT00340704|19615035|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5687955|NCT00340704|19615036|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5687956|NCT00340704|19615037|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5687957|NCT00340704|19615038|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
5687958|NCT00340704|19615030|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
5687959|NCT00340704|19615031|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
5687960|NCT00340704|19615032|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5687961|NCT00340704|19615033|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5687962|NCT00340704|19615034|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
5687963|NCT00340704|19615035|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
5687964|NCT00340704|19615036|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5687965|NCT00340704|19615037|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5687966|NCT00340704|19615038|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
5687967|NCT00340704|19615030|P9|PK Study|Not treated|0
5687968|NCT00340704|19615031|P8|PK Study|Not treated|0
5687969|NCT00340704|19615032|P7|PK Study|Not treated|0
5687970|NCT00340704|19615033|P6|PK Study|Not treated|0
5687971|NCT00340704|19615034|P5|PK Study|Not treated|0
5687972|NCT00340704|19615035|P4|PK Study|Not treated|0
5687973|NCT00340704|19615036|P3|PK Study|Not treated|1
5687974|NCT00340704|19615037|P2|PK Study|Not treated|0
5687975|NCT00340704|19615038|P1|PK Study|Not treated|0
5687976|NCT00340704|19615030|P9|PK Study|Adverse Event|0
5687977|NCT00340704|19615031|P8|PK Study|Adverse Event|0
5687978|NCT00340704|19615032|P7|PK Study|Adverse Event|0
5687979|NCT00340704|19615033|P6|PK Study|Adverse Event|0
5687980|NCT00340704|19615034|P5|PK Study|Adverse Event|0
5687981|NCT00340704|19615035|P4|PK Study|Adverse Event|0
5687982|NCT00340704|19615036|P3|PK Study|Adverse Event|0
5687983|NCT00340704|19615037|P2|PK Study|Adverse Event|1
5687984|NCT00340704|19615038|P1|PK Study|Adverse Event|0
5687985|NCT00340678|19615144|P4|Overall Study|Lost to Follow-up|0
5687986|NCT00340678|19615145|P3|Overall Study|Lost to Follow-up|0
5687987|NCT00340678|19615146|P2|Overall Study|Lost to Follow-up|0
5687988|NCT00340678|19615147|P1|Overall Study|Lost to Follow-up|1
5687989|NCT00339833|19615174|P2|Overall Study|Error in data records|0
5687990|NCT00339833|19615175|P1|Overall Study|Error in data records|1
5687991|NCT00339833|19615174|P2|Overall Study|anaemia or excess drop in glycaemia|0
5687992|NCT00339833|19615175|P1|Overall Study|anaemia or excess drop in glycaemia|2
5687993|NCT00339833|19615174|P2|Overall Study|Poor venous access|2
5687994|NCT00339833|19615175|P1|Overall Study|Poor venous access|2
5687995|NCT00339833|19615174|P2|Overall Study|minor infection|1
5687996|NCT00339833|19615175|P1|Overall Study|minor infection|0
5687997|NCT00339833|19615174|P2|Overall Study|Chest pain|1
5687998|NCT00339833|19615175|P1|Overall Study|Chest pain|0
5687999|NCT00339833|19615174|P2|Overall Study|indigestion|1
5688000|NCT00339833|19615175|P1|Overall Study|indigestion|0
5688001|NCT00339833|19615174|P2|Overall Study|toothache|1
5688002|NCT00339833|19615175|P1|Overall Study|toothache|0
5688003|NCT00339833|19615174|P2|Overall Study|Withdrawal by Subject|2
5688004|NCT00339833|19615175|P1|Overall Study|Withdrawal by Subject|1
5688005|NCT00339183|19615185|P2|Overall Study|Ongoing|13
5688006|NCT00339183|19615186|P1|Overall Study|Ongoing|20
5688007|NCT00339183|19615185|P2|Overall Study|Other|40
5688008|NCT00339183|19615186|P1|Overall Study|Other|46
5688009|NCT00339183|19615185|P2|Overall Study|Missing reason|1
5688010|NCT00339183|19615186|P1|Overall Study|Missing reason|3
5688011|NCT00339183|19615185|P2|Overall Study|Protocol-specified criteria|8
5688012|NCT00339183|19615186|P1|Overall Study|Protocol-specified criteria|12
5688013|NCT00339183|19615185|P2|Overall Study|Lost to Follow-up|17
5688014|NCT00339183|19615186|P1|Overall Study|Lost to Follow-up|17
5688015|NCT00339183|19615185|P2|Overall Study|Physician Decision|4
5688016|NCT00339183|19615186|P1|Overall Study|Physician Decision|2
5688017|NCT00339183|19615185|P2|Overall Study|Withdrawal by Subject|19
5688018|NCT00339183|19615186|P1|Overall Study|Withdrawal by Subject|16
5688019|NCT00339183|19615185|P2|Overall Study|Adverse Event|3
5688020|NCT00339183|19615186|P1|Overall Study|Adverse Event|5
5688021|NCT00339144|19615215|P3|Overall Study|Participant's request to discontinuation|1
5688022|NCT00339144|19615216|P2|Overall Study|Participant's request to discontinuation|0
5688023|NCT00339144|19615217|P1|Overall Study|Participant's request to discontinuation|1
5688024|NCT00339144|19615215|P3|Overall Study|Study drug toxicity|1
5688025|NCT00339144|19615216|P2|Overall Study|Study drug toxicity|1
5688026|NCT00339144|19615217|P1|Overall Study|Study drug toxicity|3
5688027|NCT00339144|19615215|P3|Overall Study|Disease progression|2
5688028|NCT00339144|19615216|P2|Overall Study|Disease progression|2
5688029|NCT00339144|19615217|P1|Overall Study|Disease progression|5
5688030|NCT00339040|19615322|P2|Stage II|Site closing|0
5688031|NCT00339040|19615323|P1|Stage II|Site closing|2
5688032|NCT00339040|19615322|P2|Stage II|Not able to attend clinic|0
5688033|NCT00339040|19615323|P1|Stage II|Not able to attend clinic|1
5688034|NCT00339040|19615322|P2|Stage II|Protocol Violation|0
5688035|NCT00339040|19615323|P1|Stage II|Protocol Violation|3
5688036|NCT00339040|19615322|P2|Stage II|Withdrawal by Subject|2
5688037|NCT00339040|19615323|P1|Stage II|Withdrawal by Subject|1
5688038|NCT00339040|19615322|P2|Stage II|Lost to Follow-up|0
5688039|NCT00339040|19615323|P1|Stage II|Lost to Follow-up|3
5688040|NCT00339040|19615322|P2|Stage I|Protocol Violation|1
5688041|NCT00339040|19615323|P1|Stage I|Protocol Violation|1
5688042|NCT00339040|19615322|P2|Stage I|Not able to attend clinic|0
5688043|NCT00339040|19615323|P1|Stage I|Not able to attend clinic|1
5688044|NCT00338962|19615350|P4|Overall Study|Poor Compliance|0
5688045|NCT00338962|19615351|P3|Overall Study|Poor Compliance|2
5688046|NCT00338962|19615352|P2|Overall Study|Poor Compliance|0
5688047|NCT00338962|19615353|P1|Overall Study|Poor Compliance|0
5688048|NCT00338962|19615350|P4|Overall Study|Adverse Event|0
5688049|NCT00338962|19615351|P3|Overall Study|Adverse Event|2
5688050|NCT00338962|19615352|P2|Overall Study|Adverse Event|0
5688051|NCT00338962|19615353|P1|Overall Study|Adverse Event|0
5688052|NCT00338962|19615350|P4|Overall Study|Moved|0
5688053|NCT00338962|19615351|P3|Overall Study|Moved|0
5688054|NCT00338962|19615352|P2|Overall Study|Moved|1
5688055|NCT00338962|19615353|P1|Overall Study|Moved|0
5688056|NCT00338962|19615350|P4|Overall Study|Time Constraint|0
5688057|NCT00338962|19615351|P3|Overall Study|Time Constraint|0
5688058|NCT00338962|19615352|P2|Overall Study|Time Constraint|0
5688059|NCT00338962|19615353|P1|Overall Study|Time Constraint|2
5688060|NCT00338962|19615350|P4|Overall Study|No Transportation|0
5688061|NCT00338962|19615351|P3|Overall Study|No Transportation|0
5688062|NCT00338962|19615352|P2|Overall Study|No Transportation|0
5688063|NCT00338962|19615353|P1|Overall Study|No Transportation|2
5688064|NCT00338962|19615350|P4|Overall Study|Withdrawal by Subject|0
5688065|NCT00338962|19615351|P3|Overall Study|Withdrawal by Subject|0
5688066|NCT00338962|19615352|P2|Overall Study|Withdrawal by Subject|0
5688067|NCT00338962|19615353|P1|Overall Study|Withdrawal by Subject|1
5688068|NCT00338962|19615350|P4|Overall Study|Lost to Follow-up|3
5688069|NCT00338962|19615351|P3|Overall Study|Lost to Follow-up|2
5688070|NCT00338962|19615352|P2|Overall Study|Lost to Follow-up|3
5688071|NCT00338962|19615353|P1|Overall Study|Lost to Follow-up|3
5688072|NCT00338949|19615377|P2|Randomization|Adverse Event|5
5688073|NCT00338949|19615378|P1|Randomization|Adverse Event|0
5688074|NCT00338949|19615377|P2|Randomization|Withdrawal by Subject|0
5688075|NCT00338949|19615378|P1|Randomization|Withdrawal by Subject|1
5688076|NCT00338949|19615377|P2|Subject Screening|Screen failures|11
5688077|NCT00338949|19615378|P1|Subject Screening|Screen failures|11
5688078|NCT00338884|19615386|P1|Overall Study|Randomized But Did Not Receive Treatment|1
5688079|NCT00338884|19615386|P1|Overall Study|Lost to Follow-up|1
5688080|NCT00338884|19615386|P1|Overall Study|Withdrawal by Subject|3
5688081|NCT00338884|19615386|P1|Overall Study|Global Deterioration of Health Status|3
5688082|NCT00338884|19615386|P1|Overall Study|Other|4
5688083|NCT00338884|19615386|P1|Overall Study|Death|8
5688084|NCT00338884|19615386|P1|Overall Study|Adverse Event|14
5688085|NCT00338884|19615386|P1|Overall Study|Objective Disease Progression or Relapse|44
5688086|NCT00338806|19615420|P2|Follow-up|Lost to Follow-up|3
5688087|NCT00338806|19615421|P1|Follow-up|Lost to Follow-up|1
5688088|NCT00338806|19615420|P2|Acute Phase|Withdrawal by Subject|1
5688089|NCT00338806|19615421|P1|Acute Phase|Withdrawal by Subject|0
5688090|NCT00338741|19615483|P2|Overall Study|Lost to Follow-up|0
5688091|NCT00338741|19615484|P1|Overall Study|Lost to Follow-up|2
5688092|NCT00338728|19615492|P1|Overall Study|Screen Failure|14
5688093|NCT00338455|19615520|P2|Overall Study|Physician Decision|0
5688094|NCT00338455|19615521|P1|Overall Study|Physician Decision|1
5688095|NCT00338455|19615520|P2|Overall Study|Death|1
5688096|NCT00338455|19615521|P1|Overall Study|Death|2
5688097|NCT00338286|19615535|P2|Overall Study|Other|93
5688098|NCT00338286|19615536|P1|Overall Study|Other|103
5688099|NCT00338286|19615535|P2|Overall Study|Lost to Follow-up|66
5688100|NCT00338286|19615536|P1|Overall Study|Lost to Follow-up|80
5688101|NCT00338286|19615535|P2|Overall Study|Withdrawal by Subject|54
5688102|NCT00338286|19615536|P1|Overall Study|Withdrawal by Subject|50
5688103|NCT00338104|19615553|P3|Overall Study|Protocol Violation|3
5688104|NCT00338104|19615554|P2|Overall Study|Protocol Violation|1
5688105|NCT00338104|19615555|P1|Overall Study|Protocol Violation|2
5688106|NCT00337935|19615578|P2|Overall Study|Lack of Efficacy|1
5688107|NCT00337935|19615579|P1|Overall Study|Lack of Efficacy|0
5688108|NCT00337935|19615578|P2|Overall Study|Other|1
5688109|NCT00337935|19615579|P1|Overall Study|Other|0
5688110|NCT00337935|19615578|P2|Overall Study|Withdrawal by Subject|7
5688111|NCT00337935|19615579|P1|Overall Study|Withdrawal by Subject|1
5688112|NCT00337935|19615578|P2|Overall Study|Protocol Violation|3
5688113|NCT00337935|19615579|P1|Overall Study|Protocol Violation|4
5688114|NCT00337935|19615578|P2|Overall Study|Lost to Follow-up|1
5688115|NCT00337935|19615579|P1|Overall Study|Lost to Follow-up|0
5688116|NCT00337935|19615578|P2|Overall Study|Physician Decision|1
5688117|NCT00337935|19615579|P1|Overall Study|Physician Decision|1
5688118|NCT00337935|19615578|P2|Overall Study|Death|8
5688119|NCT00337935|19615579|P1|Overall Study|Death|2
5688120|NCT00337935|19615578|P2|Overall Study|Adverse Event|5
5688121|NCT00337935|19615579|P1|Overall Study|Adverse Event|2
5688122|NCT00337818|19615592|P3|Overall Study|Lost to Follow-up|107
5688123|NCT00337818|19615593|P2|Overall Study|Lost to Follow-up|91
5688124|NCT00337818|19615594|P1|Overall Study|Lost to Follow-up|289
5688125|NCT00337779|19615616|P2|Overall Study|Death|1
5688126|NCT00337779|19615617|P1|Overall Study|Death|0
5688127|NCT00337779|19615616|P2|Overall Study|Pregnancy|2
5688128|NCT00337779|19615617|P1|Overall Study|Pregnancy|3
5688129|NCT00337779|19615616|P2|Overall Study|Adverse Event|51
5688130|NCT00337779|19615617|P1|Overall Study|Adverse Event|28
5688131|NCT00337779|19615616|P2|Overall Study|Lost to Follow-up|5
5688132|NCT00337779|19615617|P1|Overall Study|Lost to Follow-up|6
5688133|NCT00337779|19615616|P2|Overall Study|Protocol Violation|1
5688134|NCT00337779|19615617|P1|Overall Study|Protocol Violation|1
5688135|NCT00337779|19615616|P2|Overall Study|Physician Decision|6
5688136|NCT00337779|19615617|P1|Overall Study|Physician Decision|3
5688137|NCT00337779|19615616|P2|Overall Study|Sponsor decision|1
5688138|NCT00337779|19615617|P1|Overall Study|Sponsor decision|1
5688139|NCT00337779|19615616|P2|Overall Study|Withdrawal by Subject|12
5688140|NCT00337779|19615617|P1|Overall Study|Withdrawal by Subject|10
5688141|NCT00337727|19615629|P2|Overall Study|Withdrawal by Subject|5
5688142|NCT00337727|19615630|P1|Overall Study|Withdrawal by Subject|3
5688143|NCT00337727|19615629|P2|Overall Study|Protocol Violation|0
5688144|NCT00337727|19615630|P1|Overall Study|Protocol Violation|4
5688145|NCT00337727|19615629|P2|Overall Study|Physician Decision|0
5688146|NCT00337727|19615630|P1|Overall Study|Physician Decision|1
5688147|NCT00337727|19615629|P2|Overall Study|Lost to Follow-up|4
5688148|NCT00337727|19615630|P1|Overall Study|Lost to Follow-up|5
5688149|NCT00337727|19615629|P2|Overall Study|Adverse Event|3
5688150|NCT00337727|19615630|P1|Overall Study|Adverse Event|5
5688151|NCT00337675|19615641|P3|Overall Study|Trial Terminated|2
5688152|NCT00337675|19615642|P2|Overall Study|Trial Terminated|0
5688153|NCT00337675|19615643|P1|Overall Study|Trial Terminated|0
5688154|NCT00337675|19615641|P3|Overall Study|Progressive Disease|0
5688155|NCT00337675|19615642|P2|Overall Study|Progressive Disease|2
5688156|NCT00337675|19615643|P1|Overall Study|Progressive Disease|0
5688157|NCT00337675|19615641|P3|Overall Study|Withdrawal by Subject|19
5688158|NCT00337675|19615642|P2|Overall Study|Withdrawal by Subject|25
5688159|NCT00337675|19615643|P1|Overall Study|Withdrawal by Subject|25
5688160|NCT00337675|19615641|P3|Overall Study|Protocol Violation|19
5688161|NCT00337675|19615642|P2|Overall Study|Protocol Violation|24
5688162|NCT00337675|19615643|P1|Overall Study|Protocol Violation|21
5688163|NCT00337675|19615641|P3|Overall Study|Physician Decision|14
5688164|NCT00337675|19615642|P2|Overall Study|Physician Decision|17
5688165|NCT00337675|19615643|P1|Overall Study|Physician Decision|9
5688166|NCT00337675|19615641|P3|Overall Study|Lost to Follow-up|17
5688167|NCT00337675|19615642|P2|Overall Study|Lost to Follow-up|19
5688168|NCT00337675|19615643|P1|Overall Study|Lost to Follow-up|22
5688169|NCT00337675|19615641|P3|Overall Study|Lack of Efficacy|9
5688170|NCT00337675|19615642|P2|Overall Study|Lack of Efficacy|7
5688171|NCT00337675|19615643|P1|Overall Study|Lack of Efficacy|10
5688172|NCT00337675|19615641|P3|Overall Study|Adverse Event|19
5688173|NCT00337675|19615642|P2|Overall Study|Adverse Event|9
5688174|NCT00337675|19615643|P1|Overall Study|Adverse Event|10
5688175|NCT00337662|19615660|P4|Study Period III|Clinical Relapse|0
5688176|NCT00337662|19615661|P3|Study Period III|Clinical Relapse|0
5688177|NCT00337662|19615662|P2|Study Period III|Clinical Relapse|0
5688178|NCT00337662|19615663|P1|Study Period III|Clinical Relapse|1
5688179|NCT00337662|19615660|P4|Study Period III|Sponsor Decision|0
5688180|NCT00337662|19615661|P3|Study Period III|Sponsor Decision|1
5688181|NCT00337662|19615662|P2|Study Period III|Sponsor Decision|0
5688182|NCT00337662|19615663|P1|Study Period III|Sponsor Decision|1
5688183|NCT00337662|19615660|P4|Study Period III|Parent/Caregiver Decision|0
5688184|NCT00337662|19615661|P3|Study Period III|Parent/Caregiver Decision|2
5688185|NCT00337662|19615662|P2|Study Period III|Parent/Caregiver Decision|0
5688186|NCT00337662|19615663|P1|Study Period III|Parent/Caregiver Decision|0
5688187|NCT00337662|19615660|P4|Study Period III|Lack of Efficacy|0
5688188|NCT00337662|19615661|P3|Study Period III|Lack of Efficacy|2
5688189|NCT00337662|19615662|P2|Study Period III|Lack of Efficacy|4
5688190|NCT00337662|19615663|P1|Study Period III|Lack of Efficacy|4
5688191|NCT00337662|19615660|P4|Study Period III|Entry Criteria Not Met|0
5688192|NCT00337662|19615661|P3|Study Period III|Entry Criteria Not Met|3
5688193|NCT00337662|19615662|P2|Study Period III|Entry Criteria Not Met|1
5688194|NCT00337662|19615663|P1|Study Period III|Entry Criteria Not Met|4
5688195|NCT00337662|19615660|P4|Study Period III|Physician Decision|0
5688196|NCT00337662|19615661|P3|Study Period III|Physician Decision|0
5688197|NCT00337662|19615662|P2|Study Period III|Physician Decision|5
5688198|NCT00337662|19615663|P1|Study Period III|Physician Decision|6
5688199|NCT00337662|19615660|P4|Study Period III|Protocol Violation|0
5688200|NCT00337662|19615661|P3|Study Period III|Protocol Violation|2
5688201|NCT00337662|19615662|P2|Study Period III|Protocol Violation|8
5688202|NCT00337662|19615663|P1|Study Period III|Protocol Violation|3
5688203|NCT00337662|19615660|P4|Study Period III|Adverse Event|0
5688204|NCT00337662|19615661|P3|Study Period III|Adverse Event|8
5688205|NCT00337662|19615662|P2|Study Period III|Adverse Event|10
5688206|NCT00337662|19615663|P1|Study Period III|Adverse Event|9
5688207|NCT00337662|19615660|P4|Study Period III|Withdrawal by Subject|0
5688208|NCT00337662|19615661|P3|Study Period III|Withdrawal by Subject|12
5688209|NCT00337662|19615662|P2|Study Period III|Withdrawal by Subject|14
5688210|NCT00337662|19615663|P1|Study Period III|Withdrawal by Subject|18
5688211|NCT00337662|19615660|P4|Study Period III|Lost to Follow-up|0
5688212|NCT00337662|19615661|P3|Study Period III|Lost to Follow-up|14
5688213|NCT00337662|19615662|P2|Study Period III|Lost to Follow-up|16
5688214|NCT00337662|19615663|P1|Study Period III|Lost to Follow-up|14
5688215|NCT00337662|19615660|P4|Study Period II|Parent/Caregiver Decision|1
5688216|NCT00337662|19615661|P3|Study Period II|Parent/Caregiver Decision|0
5688217|NCT00337662|19615662|P2|Study Period II|Parent/Caregiver Decision|0
5688218|NCT00337662|19615663|P1|Study Period II|Parent/Caregiver Decision|0
5688219|NCT00337662|19615660|P4|Study Period II|Sponsor Decision|2
5688220|NCT00337662|19615661|P3|Study Period II|Sponsor Decision|0
5688221|NCT00337662|19615662|P2|Study Period II|Sponsor Decision|0
5688222|NCT00337662|19615663|P1|Study Period II|Sponsor Decision|0
5688223|NCT00337662|19615660|P4|Study Period II|Lack of Efficacy|7
5688224|NCT00337662|19615661|P3|Study Period II|Lack of Efficacy|0
5688225|NCT00337662|19615662|P2|Study Period II|Lack of Efficacy|0
5688226|NCT00337662|19615663|P1|Study Period II|Lack of Efficacy|0
5688227|NCT00337662|19615660|P4|Study Period II|Protocol Violation|6
5688228|NCT00337662|19615661|P3|Study Period II|Protocol Violation|0
5688229|NCT00337662|19615662|P2|Study Period II|Protocol Violation|0
5688230|NCT00337662|19615663|P1|Study Period II|Protocol Violation|0
5688231|NCT00337662|19615660|P4|Study Period II|Entry Criteria Not Met|6
5688232|NCT00337662|19615661|P3|Study Period II|Entry Criteria Not Met|0
5688233|NCT00337662|19615662|P2|Study Period II|Entry Criteria Not Met|0
5688234|NCT00337662|19615663|P1|Study Period II|Entry Criteria Not Met|0
5688235|NCT00337662|19615660|P4|Study Period II|Physician Decision|13
5688236|NCT00337662|19615661|P3|Study Period II|Physician Decision|0
5688237|NCT00337662|19615662|P2|Study Period II|Physician Decision|0
5688238|NCT00337662|19615663|P1|Study Period II|Physician Decision|0
5688239|NCT00337662|19615660|P4|Study Period II|Adverse Event|16
5688240|NCT00337662|19615661|P3|Study Period II|Adverse Event|0
5688241|NCT00337662|19615662|P2|Study Period II|Adverse Event|0
5688242|NCT00337662|19615663|P1|Study Period II|Adverse Event|0
5688243|NCT00337662|19615660|P4|Study Period II|Withdrawal by Subject|20
5688244|NCT00337662|19615661|P3|Study Period II|Withdrawal by Subject|0
5688245|NCT00337662|19615662|P2|Study Period II|Withdrawal by Subject|0
5688246|NCT00337662|19615663|P1|Study Period II|Withdrawal by Subject|0
5688247|NCT00337662|19615660|P4|Study Period II|Lost to Follow-up|35
5688248|NCT00337662|19615661|P3|Study Period II|Lost to Follow-up|0
5688249|NCT00337662|19615662|P2|Study Period II|Lost to Follow-up|0
5688250|NCT00337662|19615663|P1|Study Period II|Lost to Follow-up|0
5688251|NCT00337610|19615717|P2|Overall Study|Withdrawal by Subject|5
5688252|NCT00337610|19615718|P1|Overall Study|Withdrawal by Subject|6
5688253|NCT00337610|19615717|P2|Overall Study|Lost to Follow-up|3
5688254|NCT00337610|19615718|P1|Overall Study|Lost to Follow-up|3
5688255|NCT00337610|19615717|P2|Overall Study|Lack of Efficacy|3
5688256|NCT00337610|19615718|P1|Overall Study|Lack of Efficacy|6
5688257|NCT00337610|19615717|P2|Overall Study|Death|1
5688258|NCT00337610|19615718|P1|Overall Study|Death|0
5688259|NCT00337610|19615717|P2|Overall Study|Adverse Event|2
5688260|NCT00337610|19615718|P1|Overall Study|Adverse Event|2
5688261|NCT00337571|19615734|P4|Overall Study|High Potassium level|1
5688262|NCT00337571|19615735|P3|Overall Study|High Potassium level|0
5688263|NCT00337571|19615736|P2|Overall Study|High Potassium level|0
5688264|NCT00337571|19615737|P1|Overall Study|High Potassium level|0
5688265|NCT00337571|19615734|P4|Overall Study|No longer met study criteria|0
5688266|NCT00337571|19615735|P3|Overall Study|No longer met study criteria|0
5688267|NCT00337571|19615736|P2|Overall Study|No longer met study criteria|0
5688268|NCT00337571|19615737|P1|Overall Study|No longer met study criteria|1
5688269|NCT00337571|19615734|P4|Overall Study|Poor/noncompliance|1
5688270|NCT00337571|19615735|P3|Overall Study|Poor/noncompliance|1
5688271|NCT00337571|19615736|P2|Overall Study|Poor/noncompliance|1
5688272|NCT00337571|19615737|P1|Overall Study|Poor/noncompliance|1
5688273|NCT00337571|19615734|P4|Overall Study|Lost to Follow-up|1
5688274|NCT00337571|19615735|P3|Overall Study|Lost to Follow-up|0
5688275|NCT00337571|19615736|P2|Overall Study|Lost to Follow-up|1
5688276|NCT00337571|19615737|P1|Overall Study|Lost to Follow-up|3
5688277|NCT00337571|19615734|P4|Overall Study|Withdrawal by Subject|0
5688278|NCT00337571|19615735|P3|Overall Study|Withdrawal by Subject|1
5688279|NCT00337571|19615736|P2|Overall Study|Withdrawal by Subject|2
5688280|NCT00337571|19615737|P1|Overall Study|Withdrawal by Subject|2
5688281|NCT00337571|19615734|P4|Overall Study|Adverse Event|4
5688282|NCT00337571|19615735|P3|Overall Study|Adverse Event|8
5688283|NCT00337571|19615736|P2|Overall Study|Adverse Event|5
5688284|NCT00337571|19615737|P1|Overall Study|Adverse Event|4
5688285|NCT00337571|19615734|P4|Overall Study|Lack of Efficacy|0
5688286|NCT00337571|19615735|P3|Overall Study|Lack of Efficacy|0
5688287|NCT00337571|19615736|P2|Overall Study|Lack of Efficacy|0
5688288|NCT00337571|19615737|P1|Overall Study|Lack of Efficacy|3
5688289|NCT00337467|19615775|P1|Overall Study|Subject No Longer Met Study Criteria|2
5688290|NCT00337467|19615775|P1|Overall Study|Lost to Follow-up|2
5688291|NCT00337467|19615775|P1|Overall Study|Pregnancy|1
5688292|NCT00337467|19615775|P1|Overall Study|Subject Withdrew Consent|2
5688293|NCT00337467|19615775|P1|Overall Study|Adverse Event|3
5688294|NCT00337428|19615794|P2|Overall Study|Anorexia|0
5688295|NCT00337428|19615795|P1|Overall Study|Anorexia|1
5688296|NCT00337428|19615794|P2|Overall Study|Unwilling to Continue|0
5688297|NCT00337428|19615795|P1|Overall Study|Unwilling to Continue|1
5688298|NCT00337428|19615794|P2|Overall Study|Lack of Time|1
5688299|NCT00337428|19615795|P1|Overall Study|Lack of Time|1
5688300|NCT00337428|19615794|P2|Overall Study|Withdrawal by Subject|2
5688301|NCT00337428|19615795|P1|Overall Study|Withdrawal by Subject|1
5688302|NCT00337285|19615846|P1|Overall Study|Lack of protocol compliance|7
5688303|NCT00337285|19615846|P1|Overall Study|Physician Decision|1
5688304|NCT00337285|19615846|P1|Overall Study|Death|1
5688305|NCT00337285|19615846|P1|Overall Study|Lack of Efficacy|11
5688306|NCT00337285|19615846|P1|Overall Study|Protocol Violation|27
5688307|NCT00337285|19615846|P1|Overall Study|Adverse Event|28
5688308|NCT00337285|19615846|P1|Overall Study|Lost to Follow-up|41
5688309|NCT00337285|19615846|P1|Overall Study|Withdrawal by Subject|42
5688310|NCT00337272|19615854|P2|Withdrawal Period|Non-compliance|1
5688311|NCT00337272|19615855|P1|Withdrawal Period|Non-compliance|0
5688312|NCT00337272|19615854|P2|Treatment Period|Withdrawal by Subject|1
5688313|NCT00337272|19615855|P1|Treatment Period|Withdrawal by Subject|0
5688314|NCT00337272|19615854|P2|Treatment Period|Non-compliance|1
5688315|NCT00337272|19615855|P1|Treatment Period|Non-compliance|1
5688316|NCT00337272|19615854|P2|Screening Period (Pre-randomization)|Screen failure|0
5688317|NCT00337272|19615855|P1|Screening Period (Pre-randomization)|Screen failure|3
5688318|NCT00337272|19615854|P2|Screening Period (Pre-randomization)|Non-compliance|0
5688319|NCT00337272|19615855|P1|Screening Period (Pre-randomization)|Non-compliance|1
5688320|NCT00337272|19615854|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
5688321|NCT00337272|19615855|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
5688322|NCT00337207|19615875|P1|Overall Study|Withdrawal by Subject|3
5688323|NCT00337194|19615883|P2|Overall Study|Subsequent non-protocol therapy|1
5688324|NCT00337194|19615884|P1|Overall Study|Subsequent non-protocol therapy|3
5688325|NCT00337194|19615883|P2|Overall Study|Disease progression|2
5688326|NCT00337194|19615884|P1|Overall Study|Disease progression|1
5688327|NCT00337194|19615883|P2|Overall Study|Withdrawal by Subject|0
5688328|NCT00337194|19615884|P1|Overall Study|Withdrawal by Subject|1
5688329|NCT00337194|19615883|P2|Overall Study|Death|0
5688330|NCT00337194|19615884|P1|Overall Study|Death|2
5688331|NCT00337194|19615883|P2|Overall Study|Adverse Event|1
5688332|NCT00337194|19615884|P1|Overall Study|Adverse Event|5
5688333|NCT00337168|19615908|P1|Overall Study|Did not start therapy|1
5688334|NCT00337168|19615908|P1|Overall Study|Not protocol specified|2
5688335|NCT00337168|19615908|P1|Overall Study|Death|5
5688336|NCT00337129|19615915|P1|Overall Study|not protocol specified|1
5688337|NCT00337129|19615915|P1|Overall Study|Death|2
5688338|NCT00337129|19615915|P1|Overall Study|Lack of Efficacy|32
5688339|NCT00337129|19615915|P1|Overall Study|Withdrawal by Subject|1
5688340|NCT00337129|19615915|P1|Overall Study|Adverse Event|4
5688341|NCT00337103|19615924|P2|Overall Study|Death|0
5688342|NCT00337103|19615925|P1|Overall Study|Death|1
5688343|NCT00337103|19615924|P2|Overall Study|Lost to Follow-up|2
5688344|NCT00337103|19615925|P1|Overall Study|Lost to Follow-up|1
5688345|NCT00337103|19615924|P2|Overall Study|Entry Criteria Not Met|1
5688346|NCT00337103|19615925|P1|Overall Study|Entry Criteria Not Met|4
5688347|NCT00337103|19615924|P2|Overall Study|Other|6
5688348|NCT00337103|19615925|P1|Overall Study|Other|5
5688349|NCT00337103|19615924|P2|Overall Study|Withdrawal by Subject|5
5688350|NCT00337103|19615925|P1|Overall Study|Withdrawal by Subject|8
5688351|NCT00337103|19615924|P2|Overall Study|Physician Decision|14
5688352|NCT00337103|19615925|P1|Overall Study|Physician Decision|15
5688353|NCT00337103|19615924|P2|Overall Study|Clinical Progression|24
5688354|NCT00337103|19615925|P1|Overall Study|Clinical Progression|27
5688355|NCT00337103|19615924|P2|Overall Study|Subject Choice|27
5688356|NCT00337103|19615925|P1|Overall Study|Subject Choice|34
5688357|NCT00337103|19615924|P2|Overall Study|Adverse Event|59
5688358|NCT00337103|19615925|P1|Overall Study|Adverse Event|45
5688359|NCT00337103|19615924|P2|Overall Study|Progressive Disease|410
5688360|NCT00337103|19615925|P1|Overall Study|Progressive Disease|414
5688361|NCT00337077|19615959|P3|Overall Study|Ineligible|1
5688362|NCT00337077|19615960|P2|Overall Study|Ineligible|1
5688363|NCT00337077|19615961|P1|Overall Study|Ineligible|1
5688364|NCT00337077|19615959|P3|Overall Study|Never started treatment|0
5688365|NCT00337077|19615960|P2|Overall Study|Never started treatment|1
5688366|NCT00337077|19615961|P1|Overall Study|Never started treatment|1
5688367|NCT00337077|19615959|P3|Overall Study|Physician Decision|2
5688368|NCT00337077|19615960|P2|Overall Study|Physician Decision|4
5688369|NCT00337077|19615961|P1|Overall Study|Physician Decision|1
5688370|NCT00337077|19615959|P3|Overall Study|Alternative therapy|0
5688371|NCT00337077|19615960|P2|Overall Study|Alternative therapy|0
5688372|NCT00337077|19615961|P1|Overall Study|Alternative therapy|1
5688373|NCT00337077|19615959|P3|Overall Study|Withdrawal by Subject|2
5688374|NCT00337077|19615960|P2|Overall Study|Withdrawal by Subject|2
5688375|NCT00337077|19615961|P1|Overall Study|Withdrawal by Subject|7
5688376|NCT00337077|19615959|P3|Overall Study|Death|0
5688377|NCT00337077|19615960|P2|Overall Study|Death|1
5688378|NCT00337077|19615961|P1|Overall Study|Death|0
5688379|NCT00337077|19615959|P3|Overall Study|Adverse Event|1
5688380|NCT00337077|19615960|P2|Overall Study|Adverse Event|7
5688381|NCT00337077|19615961|P1|Overall Study|Adverse Event|7
5688382|NCT00337077|19615959|P3|Overall Study|Progressive disease|19
5688383|NCT00337077|19615960|P2|Overall Study|Progressive disease|37
5688384|NCT00337077|19615961|P1|Overall Study|Progressive disease|25
5688385|NCT00336895|19615976|P1|Overall Study|screen failed|1
5688386|NCT00336895|19615976|P1|Overall Study|Physician Decision|1
5688387|NCT00336895|19615976|P1|Overall Study|nausea and upset stomach|1
5688388|NCT00336895|19615976|P1|Overall Study|diarrhea|1
5688389|NCT00336856|19615982|P1|Overall Study|Found ineligible at time of analysis|1
5688390|NCT00336856|19615982|P1|Overall Study|Withdrawal by Subject|3
5688391|NCT00336583|19616030|P1|Overall Study|Death|1
5688392|NCT00336583|19616030|P1|Overall Study|Lost to Follow-up|1
5688393|NCT00336544|19616037|P2|Overall Study|Other|5
5688394|NCT00336544|19616038|P1|Overall Study|Other|3
5688395|NCT00336544|19616037|P2|Overall Study|Withdrawal by Subject|3
5688396|NCT00336544|19616038|P1|Overall Study|Withdrawal by Subject|4
5688397|NCT00336544|19616037|P2|Overall Study|Adverse Event|9
5688398|NCT00336544|19616038|P1|Overall Study|Adverse Event|4
5688399|NCT00336544|19616037|P2|Overall Study|Lack of Efficacy|5
5688400|NCT00336544|19616038|P1|Overall Study|Lack of Efficacy|8
5688401|NCT00336505|19616052|P2|Overall Study|Other|7
5688402|NCT00336505|19616053|P1|Overall Study|Other|7
5688403|NCT00336505|19616052|P2|Overall Study|Withdrawal by Subject|3
5688404|NCT00336505|19616053|P1|Overall Study|Withdrawal by Subject|5
5688405|NCT00336505|19616052|P2|Overall Study|Lost to Follow-up|4
5688406|NCT00336505|19616053|P1|Overall Study|Lost to Follow-up|7
5688407|NCT00336505|19616052|P2|Overall Study|Lack of Efficacy|4
5688408|NCT00336505|19616053|P1|Overall Study|Lack of Efficacy|8
5688409|NCT00336505|19616052|P2|Overall Study|Adverse Event|9
5688410|NCT00336505|19616053|P1|Overall Study|Adverse Event|10
5688411|NCT00336492|19616068|P3|Overall Study|Other|1
5688412|NCT00336492|19616069|P2|Overall Study|Other|0
5688413|NCT00336492|19616070|P1|Overall Study|Other|5
5688414|NCT00336492|19616068|P3|Overall Study|Lack of Efficacy|4
5688415|NCT00336492|19616069|P2|Overall Study|Lack of Efficacy|1
5688416|NCT00336492|19616070|P1|Overall Study|Lack of Efficacy|6
5688417|NCT00336492|19616068|P3|Overall Study|Adverse Event|6
5688418|NCT00336492|19616069|P2|Overall Study|Adverse Event|3
5688419|NCT00336492|19616070|P1|Overall Study|Adverse Event|4
5688420|NCT00336479|19616082|P4|Overall Study|Virologic Stopping Rule|0
5688421|NCT00336479|19616083|P3|Overall Study|Virologic Stopping Rule|0
5688422|NCT00336479|19616084|P2|Overall Study|Virologic Stopping Rule|0
5688423|NCT00336479|19616085|P1|Overall Study|Virologic Stopping Rule|20
5688424|NCT00336479|19616082|P4|Overall Study|Other|0
5688425|NCT00336479|19616083|P3|Overall Study|Other|1
5688426|NCT00336479|19616084|P2|Overall Study|Other|0
5688427|NCT00336479|19616085|P1|Overall Study|Other|0
5688428|NCT00336479|19616082|P4|Overall Study|Withdrawal by Subject|0
5688429|NCT00336479|19616083|P3|Overall Study|Withdrawal by Subject|3
5688430|NCT00336479|19616084|P2|Overall Study|Withdrawal by Subject|2
5688431|NCT00336479|19616085|P1|Overall Study|Withdrawal by Subject|3
5688432|NCT00336479|19616082|P4|Overall Study|Lost to Follow-up|0
5688433|NCT00336479|19616083|P3|Overall Study|Lost to Follow-up|0
5688434|NCT00336479|19616084|P2|Overall Study|Lost to Follow-up|2
5688435|NCT00336479|19616085|P1|Overall Study|Lost to Follow-up|3
5688436|NCT00336479|19616082|P4|Overall Study|Physician Decision|0
5688437|NCT00336479|19616083|P3|Overall Study|Physician Decision|1
5688438|NCT00336479|19616084|P2|Overall Study|Physician Decision|3
5688439|NCT00336479|19616085|P1|Overall Study|Physician Decision|2
5688440|NCT00336479|19616082|P4|Overall Study|Noncompliant|0
5688441|NCT00336479|19616083|P3|Overall Study|Noncompliant|3
5688442|NCT00336479|19616084|P2|Overall Study|Noncompliant|7
5688443|NCT00336479|19616085|P1|Overall Study|Noncompliant|1
5688444|NCT00336479|19616082|P4|Overall Study|Adverse Event|4
5688445|NCT00336479|19616083|P3|Overall Study|Adverse Event|18
5688446|NCT00336479|19616084|P2|Overall Study|Adverse Event|11
5688447|NCT00336479|19616085|P1|Overall Study|Adverse Event|8
5688448|NCT00336284|19616174|P2|Overall Study|Withdrawal by Physician or Subject|64
5688449|NCT00336284|19616175|P1|Overall Study|Withdrawal by Physician or Subject|102
5688450|NCT00336284|19616174|P2|Overall Study|Lost to Follow-up|61
5688451|NCT00336284|19616175|P1|Overall Study|Lost to Follow-up|82
5688452|NCT00336284|19616174|P2|Overall Study|Death|26
5688453|NCT00336284|19616175|P1|Overall Study|Death|52
5688454|NCT00336024|19616193|P2|Overall Study|Ineligible|7
5688455|NCT00336024|19616194|P1|Overall Study|Ineligible|7
5688456|NCT00336024|19616193|P2|Overall Study|Progressive Disease|7
5688457|NCT00336024|19616194|P1|Overall Study|Progressive Disease|4
5688458|NCT00336024|19616193|P2|Overall Study|Failure to fulfill consolidation|1
5688459|NCT00336024|19616194|P1|Overall Study|Failure to fulfill consolidation|1
5688460|NCT00336024|19616193|P2|Overall Study|Withdrawal by Subject|2
5688461|NCT00336024|19616194|P1|Overall Study|Withdrawal by Subject|1
5688462|NCT00336024|19616193|P2|Overall Study|Protocol Violation|0
5688463|NCT00336024|19616194|P1|Overall Study|Protocol Violation|1
5688464|NCT00336024|19616193|P2|Overall Study|Physician Decision|1
5688465|NCT00336024|19616194|P1|Overall Study|Physician Decision|4
5688466|NCT00336024|19616193|P2|Overall Study|Death|1
5688467|NCT00336024|19616194|P1|Overall Study|Death|2
5688468|NCT00335972|19616230|P2|Overall Study|not given treatments|3
5688469|NCT00335972|19616231|P1|Overall Study|not given treatments|0
5688470|NCT00335959|19616241|P1|Overall Study|Ineligible|1
5688471|NCT00335959|19616241|P1|Overall Study|Adverse Event|2
5688472|NCT00335829|19616246|P1|Overall Study|Adverse Event|1
5688473|NCT00335829|19616246|P1|Overall Study|Lost to Follow-up|1
5688474|NCT00335829|19616246|P1|Overall Study|Withdrawal by Subject|1
5688475|NCT00335777|19616260|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
5688476|NCT00335777|19616260|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
5688563|NCT00334815|19616570|P2|Overall Study|Progression|0
5688477|NCT00335777|19616260|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
5688478|NCT00335777|19616260|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
5688479|NCT00335777|19616260|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
5688480|NCT00335764|19616270|P5|Overall Study|wrong histology|1
5688481|NCT00335764|19616271|P4|Overall Study|wrong histology|0
5688482|NCT00335764|19616272|P3|Overall Study|wrong histology|0
5688483|NCT00335764|19616273|P2|Overall Study|wrong histology|0
5688484|NCT00335764|19616274|P1|Overall Study|wrong histology|1
5688485|NCT00335738|19616323|P2|Overall Study|Ineligible|4
5688486|NCT00335738|19616324|P1|Overall Study|Ineligible|3
5688487|NCT00335738|19616323|P2|Overall Study|Withdrawal by Subject|0
5688488|NCT00335738|19616324|P1|Overall Study|Withdrawal by Subject|2
5688489|NCT00335738|19616323|P2|Overall Study|Physician Decision|0
5688490|NCT00335738|19616324|P1|Overall Study|Physician Decision|6
5688491|NCT00335556|19616356|P6|Overall Study|Refusal of further protocol therapy|0
5688492|NCT00335556|19616357|P5|Overall Study|Refusal of further protocol therapy|0
5688493|NCT00335556|19616358|P4|Overall Study|Refusal of further protocol therapy|1
5688494|NCT00335556|19616359|P3|Overall Study|Refusal of further protocol therapy|0
5688495|NCT00335556|19616360|P2|Overall Study|Refusal of further protocol therapy|4
5688496|NCT00335556|19616361|P1|Overall Study|Refusal of further protocol therapy|0
5688497|NCT00335556|19616356|P6|Overall Study|Ineligible|0
5688498|NCT00335556|19616357|P5|Overall Study|Ineligible|0
5688499|NCT00335556|19616358|P4|Overall Study|Ineligible|0
5688500|NCT00335556|19616359|P3|Overall Study|Ineligible|0
5688501|NCT00335556|19616360|P2|Overall Study|Ineligible|0
5688502|NCT00335556|19616361|P1|Overall Study|Ineligible|2
5688503|NCT00335556|19616356|P6|Overall Study|Physician Decision|0
5688504|NCT00335556|19616357|P5|Overall Study|Physician Decision|0
5688505|NCT00335556|19616358|P4|Overall Study|Physician Decision|1
5688506|NCT00335556|19616359|P3|Overall Study|Physician Decision|2
5688507|NCT00335556|19616360|P2|Overall Study|Physician Decision|6
5688508|NCT00335556|19616361|P1|Overall Study|Physician Decision|0
5688509|NCT00335556|19616356|P6|Overall Study|Lack of Efficacy|1
5688510|NCT00335556|19616357|P5|Overall Study|Lack of Efficacy|0
5688511|NCT00335556|19616358|P4|Overall Study|Lack of Efficacy|3
5688512|NCT00335556|19616359|P3|Overall Study|Lack of Efficacy|3
5688513|NCT00335556|19616360|P2|Overall Study|Lack of Efficacy|19
5688514|NCT00335556|19616361|P1|Overall Study|Lack of Efficacy|0
5688515|NCT00335556|19616356|P6|Overall Study|Death|0
5688516|NCT00335556|19616357|P5|Overall Study|Death|1
5688517|NCT00335556|19616358|P4|Overall Study|Death|0
5688518|NCT00335556|19616359|P3|Overall Study|Death|0
5688519|NCT00335556|19616360|P2|Overall Study|Death|5
5688520|NCT00335556|19616361|P1|Overall Study|Death|0
5688521|NCT00335452|19616423|P4|Overall Study|Lost to Follow-up|2
5688522|NCT00335452|19616424|P3|Overall Study|Lost to Follow-up|1
5688523|NCT00335452|19616425|P2|Overall Study|Lost to Follow-up|3
5688524|NCT00335452|19616426|P1|Overall Study|Lost to Follow-up|2
5688525|NCT00335452|19616423|P4|Overall Study|Death|129
5688526|NCT00335452|19616424|P3|Overall Study|Death|158
5688527|NCT00335452|19616425|P2|Overall Study|Death|144
5688528|NCT00335452|19616426|P1|Overall Study|Death|156
5688529|NCT00335322|19616451|P3|Overall Study|Randomised but withdrew prior to ART sta|2
5688530|NCT00335322|19616452|P2|Overall Study|Randomised but withdrew prior to ART sta|2
5688531|NCT00335322|19616453|P1|Overall Study|Randomised but withdrew prior to ART sta|1
5688532|NCT00335153|19616501|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
5688533|NCT00335153|19616501|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
5688534|NCT00335153|19616501|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
5688535|NCT00335153|19616501|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
5688536|NCT00335153|19616501|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
5688537|NCT00335153|19616501|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
5688538|NCT00335153|19616501|P1|Nasojejunal (NJ) Test Period|Administrative|1
5688539|NCT00335153|19616501|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
5688540|NCT00335153|19616501|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
5688541|NCT00335153|19616501|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
5688542|NCT00335140|19616538|P1|Overall Study|Ineligible|1
5688543|NCT00334958|19616544|P2|Overall Study|Other|2
5688544|NCT00334958|19616545|P1|Overall Study|Other|1
5688545|NCT00334958|19616544|P2|Overall Study|Adverse Event|12
5688546|NCT00334958|19616545|P1|Overall Study|Adverse Event|27
5688547|NCT00334958|19616544|P2|Overall Study|Withdrawal by Subject|4
5688548|NCT00334958|19616545|P1|Overall Study|Withdrawal by Subject|7
5688549|NCT00334958|19616544|P2|Overall Study|Request of the investigator or sponsor|1
5688550|NCT00334958|19616545|P1|Overall Study|Request of the investigator or sponsor|0
5688551|NCT00334958|19616544|P2|Overall Study|Protocol Violation|2
5688552|NCT00334958|19616545|P1|Overall Study|Protocol Violation|2
5688553|NCT00334958|19616544|P2|Overall Study|Medication Noncompliance|3
5688554|NCT00334958|19616545|P1|Overall Study|Medication Noncompliance|0
5688555|NCT00334893|19616559|P2|Overall Study|Not Treated|0
5688556|NCT00334893|19616560|P1|Overall Study|Not Treated|1
5688557|NCT00334815|19616570|P2|Overall Study|Physician Decision|4
5688558|NCT00334815|19616571|P1|Overall Study|Physician Decision|2
5688559|NCT00334815|19616570|P2|Overall Study|patient refused treatment|1
5688560|NCT00334815|19616571|P1|Overall Study|patient refused treatment|0
5688561|NCT00334815|19616570|P2|Overall Study|ineligible|1
5688562|NCT00334815|19616571|P1|Overall Study|ineligible|1
5688564|NCT00334815|19616571|P1|Overall Study|Progression|1
5688565|NCT00334815|19616570|P2|Overall Study|Death|2
5688566|NCT00334815|19616571|P1|Overall Study|Death|0
5688567|NCT00334815|19616570|P2|Overall Study|Adverse Event|2
5688568|NCT00334815|19616571|P1|Overall Study|Adverse Event|3
5688569|NCT00334802|19616585|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
5688570|NCT00334802|19616586|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
5688571|NCT00334802|19616585|P2|Overall Study|Adverse Event|3
5688572|NCT00334802|19616586|P1|Overall Study|Adverse Event|0
5688573|NCT00334802|19616585|P2|Overall Study|Withdrawal by Subject|4
5688574|NCT00334802|19616586|P1|Overall Study|Withdrawal by Subject|0
5688575|NCT00334802|19616585|P2|Overall Study|Physician Decision|0
5688576|NCT00334802|19616586|P1|Overall Study|Physician Decision|1
5688577|NCT00334802|19616585|P2|Overall Study|Patient Condition Aggrevated|0
5688578|NCT00334802|19616586|P1|Overall Study|Patient Condition Aggrevated|1
5688579|NCT00334802|19616585|P2|Overall Study|Lack of Efficacy|3
5688580|NCT00334802|19616586|P1|Overall Study|Lack of Efficacy|1
5688581|NCT00334802|19616585|P2|Overall Study|Toxicity|5
5688582|NCT00334802|19616586|P1|Overall Study|Toxicity|1
5688583|NCT00334802|19616585|P2|Overall Study|Progressive Disease|24
5688584|NCT00334802|19616586|P1|Overall Study|Progressive Disease|2
5688585|NCT00334737|19616606|P3|Follow up Phase|Lost to Follow-up|6
5688586|NCT00334737|19616607|P2|Follow up Phase|Lost to Follow-up|3
5688587|NCT00334737|19616608|P1|Follow up Phase|Lost to Follow-up|5
5688588|NCT00334737|19616606|P3|Hospital Phase|Did not receive study drug|0
5688589|NCT00334737|19616607|P2|Hospital Phase|Did not receive study drug|0
5688590|NCT00334737|19616608|P1|Hospital Phase|Did not receive study drug|1
5688591|NCT00334737|19616606|P3|Hospital Phase|Withdrawal by Subject|1
5688592|NCT00334737|19616607|P2|Hospital Phase|Withdrawal by Subject|0
5688593|NCT00334737|19616608|P1|Hospital Phase|Withdrawal by Subject|0
5688594|NCT00334737|19616606|P3|Hospital Phase|Death|3
5688595|NCT00334737|19616607|P2|Hospital Phase|Death|2
5688596|NCT00334737|19616608|P1|Hospital Phase|Death|1
5688597|NCT00334542|19616656|P1|Overall Study|New cancer diagnosis|1
5688598|NCT00334542|19616656|P1|Overall Study|Withdrawal by Subject|1
5688599|NCT00334542|19616656|P1|Overall Study|Adverse Event|3
5688600|NCT00334295|19616663|P1|Overall Study|Patients received fewer than 3 injection|5
5688601|NCT00334282|19616673|P2|Overall Study|Death|100
5688602|NCT00334282|19616674|P1|Overall Study|Death|194
5688603|NCT00334282|19616673|P2|Overall Study|Withdrawal by Subject|3
5688604|NCT00334282|19616674|P1|Overall Study|Withdrawal by Subject|17
5688605|NCT00334282|19616673|P2|Overall Study|Lost to Follow-up|5
5688606|NCT00334282|19616674|P1|Overall Study|Lost to Follow-up|11
5688607|NCT00334113|19616705|P2|Overall Study|Withdrawal by Subject|1
5688608|NCT00334113|19616706|P1|Overall Study|Withdrawal by Subject|0
5688609|NCT00334113|19616705|P2|Overall Study|Lost to Follow-up|2
5688610|NCT00334113|19616706|P1|Overall Study|Lost to Follow-up|2
5688611|NCT00333983|19616729|P3|Overall Study|Withdrawal by Subject|1
5688612|NCT00333983|19616730|P2|Overall Study|Withdrawal by Subject|3
5688613|NCT00333983|19616731|P1|Overall Study|Withdrawal by Subject|0
5688614|NCT00333983|19616729|P3|Overall Study|Adverse Event|1
5688615|NCT00333983|19616730|P2|Overall Study|Adverse Event|1
5688616|NCT00333983|19616731|P1|Overall Study|Adverse Event|1
5688617|NCT00333983|19616729|P3|Overall Study|Lost to Follow-up|0
5688618|NCT00333983|19616730|P2|Overall Study|Lost to Follow-up|1
5688619|NCT00333983|19616731|P1|Overall Study|Lost to Follow-up|2
5688620|NCT00333970|19616741|P2|Overall Study|Withdrawal by Subject|7
5688621|NCT00333970|19616742|P1|Overall Study|Withdrawal by Subject|13
5688622|NCT00333866|19616757|P4|Overall Study|Randomized but not Treated|1
5688623|NCT00333866|19616758|P3|Overall Study|Randomized but not Treated|2
5688624|NCT00333866|19616759|P2|Overall Study|Randomized but not Treated|3
5688625|NCT00333866|19616760|P1|Overall Study|Randomized but not Treated|5
5688626|NCT00333866|19616757|P4|Overall Study|Withdrawal by Subject|9
5688627|NCT00333866|19616758|P3|Overall Study|Withdrawal by Subject|4
5688628|NCT00333866|19616759|P2|Overall Study|Withdrawal by Subject|14
5688629|NCT00333866|19616760|P1|Overall Study|Withdrawal by Subject|8
5688630|NCT00333866|19616757|P4|Overall Study|Lost to Follow-up|2
5688631|NCT00333866|19616758|P3|Overall Study|Lost to Follow-up|2
5688632|NCT00333866|19616759|P2|Overall Study|Lost to Follow-up|2
5688633|NCT00333866|19616760|P1|Overall Study|Lost to Follow-up|1
5688634|NCT00333866|19616757|P4|Overall Study|Lack of Efficacy|5
5688635|NCT00333866|19616758|P3|Overall Study|Lack of Efficacy|3
5688636|NCT00333866|19616759|P2|Overall Study|Lack of Efficacy|6
5688637|NCT00333866|19616760|P1|Overall Study|Lack of Efficacy|8
5688638|NCT00333866|19616757|P4|Overall Study|Other|2
5688639|NCT00333866|19616758|P3|Overall Study|Other|2
5688640|NCT00333866|19616759|P2|Overall Study|Other|2
5688641|NCT00333866|19616760|P1|Overall Study|Other|3
5688642|NCT00333866|19616757|P4|Overall Study|Adverse Event|47
5688643|NCT00333866|19616758|P3|Overall Study|Adverse Event|38
5688644|NCT00333866|19616759|P2|Overall Study|Adverse Event|37
5688645|NCT00333866|19616760|P1|Overall Study|Adverse Event|23
5688646|NCT00333840|19616820|P4|Second-line Treatment Period|Death|9
5688647|NCT00333840|19616821|P3|Second-line Treatment Period|Death|0
5688648|NCT00333840|19616822|P2|Second-line Treatment Period|Death|0
5688649|NCT00333840|19616823|P1|Second-line Treatment Period|Death|0
5688650|NCT00333840|19616820|P4|Second-line Treatment Period|Administrative problems|7
5688651|NCT00333840|19616821|P3|Second-line Treatment Period|Administrative problems|0
5688652|NCT00333840|19616822|P2|Second-line Treatment Period|Administrative problems|0
5688653|NCT00333840|19616823|P1|Second-line Treatment Period|Administrative problems|0
5688654|NCT00333840|19616820|P4|Second-line Treatment Period|Lost to Follow-up|6
5688655|NCT00333840|19616821|P3|Second-line Treatment Period|Lost to Follow-up|0
5688656|NCT00333840|19616822|P2|Second-line Treatment Period|Lost to Follow-up|0
5688657|NCT00333840|19616823|P1|Second-line Treatment Period|Lost to Follow-up|0
5688658|NCT00333840|19616820|P4|Second-line Treatment Period|Subject withdrew consent|34
5688659|NCT00333840|19616821|P3|Second-line Treatment Period|Subject withdrew consent|0
5688660|NCT00333840|19616822|P2|Second-line Treatment Period|Subject withdrew consent|0
5688661|NCT00333840|19616823|P1|Second-line Treatment Period|Subject withdrew consent|0
5688662|NCT00333840|19616820|P4|Second-line Treatment Period|Protocol Violation|10
5688663|NCT00333840|19616821|P3|Second-line Treatment Period|Protocol Violation|1
5688664|NCT00333840|19616822|P2|Second-line Treatment Period|Protocol Violation|0
5688665|NCT00333840|19616823|P1|Second-line Treatment Period|Protocol Violation|0
5688666|NCT00333840|19616820|P4|Second-line Treatment Period|No longer required study drug|14
5688667|NCT00333840|19616821|P3|Second-line Treatment Period|No longer required study drug|1
5688668|NCT00333840|19616822|P2|Second-line Treatment Period|No longer required study drug|0
5688669|NCT00333840|19616823|P1|Second-line Treatment Period|No longer required study drug|0
5688670|NCT00333840|19616820|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
5688671|NCT00333840|19616821|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
5688672|NCT00333840|19616822|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
5688673|NCT00333840|19616823|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
5688674|NCT00333840|19616820|P4|Second-line Treatment Period|Abnormal procedure|1
5688675|NCT00333840|19616821|P3|Second-line Treatment Period|Abnormal procedure|0
5688676|NCT00333840|19616822|P2|Second-line Treatment Period|Abnormal procedure|0
5688677|NCT00333840|19616823|P1|Second-line Treatment Period|Abnormal procedure|0
5688678|NCT00333840|19616820|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
5688679|NCT00333840|19616821|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
5688680|NCT00333840|19616822|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
5688681|NCT00333840|19616823|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
5688682|NCT00333840|19616820|P4|Second-line Treatment Period|Adverse Event|34
5688683|NCT00333840|19616821|P3|Second-line Treatment Period|Adverse Event|3
5688684|NCT00333840|19616822|P2|Second-line Treatment Period|Adverse Event|0
5688685|NCT00333840|19616823|P1|Second-line Treatment Period|Adverse Event|0
5688686|NCT00333840|19616820|P4|First-line Treatment Period|Crossed over to other treatment arm|0
5688687|NCT00333840|19616821|P3|First-line Treatment Period|Crossed over to other treatment arm|0
5688688|NCT00333840|19616822|P2|First-line Treatment Period|Crossed over to other treatment arm|363
5688689|NCT00333840|19616823|P1|First-line Treatment Period|Crossed over to other treatment arm|14
5688690|NCT00333840|19616820|P4|First-line Treatment Period|Death|0
5688691|NCT00333840|19616821|P3|First-line Treatment Period|Death|0
5688692|NCT00333840|19616822|P2|First-line Treatment Period|Death|2
5688693|NCT00333840|19616823|P1|First-line Treatment Period|Death|19
5688694|NCT00333840|19616820|P4|First-line Treatment Period|Administrative problems|0
5688695|NCT00333840|19616821|P3|First-line Treatment Period|Administrative problems|0
5688696|NCT00333840|19616822|P2|First-line Treatment Period|Administrative problems|6
5688697|NCT00333840|19616823|P1|First-line Treatment Period|Administrative problems|12
5688698|NCT00333840|19616820|P4|First-line Treatment Period|Lost to Follow-up|0
5688699|NCT00333840|19616821|P3|First-line Treatment Period|Lost to Follow-up|0
5688700|NCT00333840|19616822|P2|First-line Treatment Period|Lost to Follow-up|6
5688701|NCT00333840|19616823|P1|First-line Treatment Period|Lost to Follow-up|15
5688702|NCT00333840|19616820|P4|First-line Treatment Period|Subject withdrew consent|0
5688703|NCT00333840|19616821|P3|First-line Treatment Period|Subject withdrew consent|0
5688704|NCT00333840|19616822|P2|First-line Treatment Period|Subject withdrew consent|77
5688705|NCT00333840|19616823|P1|First-line Treatment Period|Subject withdrew consent|57
5688706|NCT00333840|19616820|P4|First-line Treatment Period|Protocol Violation|0
5688707|NCT00333840|19616821|P3|First-line Treatment Period|Protocol Violation|0
5688708|NCT00333840|19616822|P2|First-line Treatment Period|Protocol Violation|17
5688709|NCT00333840|19616823|P1|First-line Treatment Period|Protocol Violation|17
5688710|NCT00333840|19616820|P4|First-line Treatment Period|No longer required study drug|0
5688711|NCT00333840|19616821|P3|First-line Treatment Period|No longer required study drug|0
5688712|NCT00333840|19616822|P2|First-line Treatment Period|No longer required study drug|8
5688713|NCT00333840|19616823|P1|First-line Treatment Period|No longer required study drug|21
5688714|NCT00333840|19616820|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
5688715|NCT00333840|19616821|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
5688716|NCT00333840|19616822|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
5688717|NCT00333840|19616823|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
5688718|NCT00333840|19616820|P4|First-line Treatment Period|Abnormal procedure|0
5688719|NCT00333840|19616821|P3|First-line Treatment Period|Abnormal procedure|0
5688720|NCT00333840|19616822|P2|First-line Treatment Period|Abnormal procedure|0
5688721|NCT00333840|19616823|P1|First-line Treatment Period|Abnormal procedure|2
5688722|NCT00333840|19616820|P4|First-line Treatment Period|Abnormal laboratory values|0
5688723|NCT00333840|19616821|P3|First-line Treatment Period|Abnormal laboratory values|0
5688724|NCT00333840|19616822|P2|First-line Treatment Period|Abnormal laboratory values|1
5688725|NCT00333840|19616823|P1|First-line Treatment Period|Abnormal laboratory values|3
5688726|NCT00333840|19616820|P4|First-line Treatment Period|Adverse Event|0
5688727|NCT00333840|19616821|P3|First-line Treatment Period|Adverse Event|0
5688728|NCT00333840|19616822|P2|First-line Treatment Period|Adverse Event|37
5688729|NCT00333840|19616823|P1|First-line Treatment Period|Adverse Event|38
5688730|NCT00333801|19616869|P2|Overall Study|Withdrawal by Subject|1
5688731|NCT00333801|19616870|P1|Overall Study|Withdrawal by Subject|0
5688732|NCT00333801|19616869|P2|Overall Study|Incarcerated|2
5688733|NCT00333801|19616870|P1|Overall Study|Incarcerated|1
5688734|NCT00333801|19616869|P2|Overall Study|Lost to Follow-up|0
5688735|NCT00333801|19616870|P1|Overall Study|Lost to Follow-up|2
5688736|NCT00333801|19616869|P2|Overall Study|Moved to another state|3
5688737|NCT00333801|19616870|P1|Overall Study|Moved to another state|5
5688738|NCT00333788|19616888|P1|Overall Study|Other: Signed consent for another study|1
5688739|NCT00333788|19616888|P1|Overall Study|Other: Physician decision|1
5688740|NCT00333788|19616888|P1|Overall Study|Other: Medical monitor decision|1
5688741|NCT00333788|19616888|P1|Overall Study|Other: Subject in need of an Entocort|1
5688742|NCT00333788|19616888|P1|Overall Study|Other: Sponsor decision|1
5688743|NCT00333788|19616888|P1|Overall Study|Other: Quality of life concern|1
5688744|NCT00333788|19616888|P1|Overall Study|Other: Investigator decision|1
5688745|NCT00333788|19616888|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
5688746|NCT00333788|19616888|P1|Overall Study|Other: Moved|2
5688747|NCT00333788|19616888|P1|Overall Study|Other: Non-compliance|2
5688748|NCT00333788|19616888|P1|Overall Study|Withdrawal by Subject|24
5688749|NCT00333788|19616888|P1|Overall Study|Lost to Follow-up|2
5688750|NCT00333788|19616888|P1|Overall Study|Lack of Efficacy|80
5688751|NCT00333788|19616888|P1|Overall Study|Adverse Event|44
5688752|NCT00333775|19616918|P3|Overall Study|Lost to Follow-up|8
5688753|NCT00333775|19616919|P2|Overall Study|Lost to Follow-up|7
5688754|NCT00333775|19616920|P1|Overall Study|Lost to Follow-up|10
5688755|NCT00333775|19616918|P3|Overall Study|In Follow-up When Study Stopped|96
5688756|NCT00333775|19616919|P2|Overall Study|In Follow-up When Study Stopped|92
5688757|NCT00333775|19616920|P1|Overall Study|In Follow-up When Study Stopped|87
5688758|NCT00333775|19616918|P3|Overall Study|Death|143
5688759|NCT00333775|19616919|P2|Overall Study|Death|149
5688760|NCT00333775|19616920|P1|Overall Study|Death|144
5688761|NCT00333619|19616959|P2|Overall Study|Lost to Follow-up|3
5688762|NCT00333619|19616960|P1|Overall Study|Lost to Follow-up|3
5688763|NCT00333619|19616959|P2|Overall Study|Withdrawal by Subject|1
5688764|NCT00333619|19616960|P1|Overall Study|Withdrawal by Subject|6
5688765|NCT00333619|19616959|P2|Overall Study|Death|6
5688766|NCT00333619|19616960|P1|Overall Study|Death|12
5688767|NCT00333359|19616989|P2|Overall Study|Withdrew before Receiving One Dose|6
5688768|NCT00333359|19616990|P1|Overall Study|Withdrew before Receiving One Dose|2
5688769|NCT00333359|19616989|P2|Overall Study|Treatment Failure|8
5688770|NCT00333359|19616990|P1|Overall Study|Treatment Failure|3
5688771|NCT00333359|19616989|P2|Overall Study|Termination or Withdrawal by Sponsor|1
5688772|NCT00333359|19616990|P1|Overall Study|Termination or Withdrawal by Sponsor|1
5688773|NCT00333359|19616989|P2|Overall Study|Lost to Follow-up|25
5688774|NCT00333359|19616990|P1|Overall Study|Lost to Follow-up|15
5688775|NCT00333359|19616989|P2|Overall Study|Protocol Non-compliance|8
5688776|NCT00333359|19616990|P1|Overall Study|Protocol Non-compliance|2
5688777|NCT00333359|19616989|P2|Overall Study|Physician Decision|2
5688778|NCT00333359|19616990|P1|Overall Study|Physician Decision|2
5688779|NCT00333359|19616989|P2|Overall Study|Withdrawal by Subject|37
5688780|NCT00333359|19616990|P1|Overall Study|Withdrawal by Subject|19
5688781|NCT00333359|19616989|P2|Overall Study|Adverse Event|35
5688782|NCT00333359|19616990|P1|Overall Study|Adverse Event|29
5688783|NCT00333229|19617033|P2|Overall Study|Lack of Efficacy|1
5688784|NCT00333229|19617034|P1|Overall Study|Lack of Efficacy|0
5688785|NCT00333138|19617104|P3|Extension Study (Month6 to End of Study)|Death|0
5688786|NCT00333138|19617105|P2|Extension Study (Month6 to End of Study)|Death|1
5688787|NCT00333138|19617106|P1|Extension Study (Month6 to End of Study)|Death|0
5688788|NCT00333138|19617104|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
5688789|NCT00333138|19617105|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
5688790|NCT00333138|19617106|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
5688791|NCT00333138|19617104|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
5688792|NCT00333138|19617105|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
5688793|NCT00333138|19617106|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
5688794|NCT00333138|19617104|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
5688795|NCT00333138|19617105|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
5688796|NCT00333138|19617106|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
5688797|NCT00333138|19617104|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
5688798|NCT00333138|19617105|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
5688799|NCT00333138|19617106|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
5688800|NCT00333138|19617104|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
5688801|NCT00333138|19617105|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
5688802|NCT00333138|19617106|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
5688803|NCT00333138|19617104|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
5688804|NCT00333138|19617105|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
5688805|NCT00333138|19617106|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
5688806|NCT00333138|19617104|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
5688807|NCT00333138|19617105|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
5688808|NCT00333138|19617106|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
5688809|NCT00333138|19617104|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
5688810|NCT00333138|19617105|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
5688811|NCT00333138|19617106|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
5688812|NCT00333138|19617104|P3|Core Study (6 Months)|Laboratory abnormality|1
5688813|NCT00333138|19617105|P2|Core Study (6 Months)|Laboratory abnormality|0
5688814|NCT00333138|19617106|P1|Core Study (6 Months)|Laboratory abnormality|0
5688815|NCT00333138|19617104|P3|Core Study (6 Months)|Protocol Violation|1
5688816|NCT00333138|19617105|P2|Core Study (6 Months)|Protocol Violation|0
5688817|NCT00333138|19617106|P1|Core Study (6 Months)|Protocol Violation|1
5688818|NCT00333138|19617104|P3|Core Study (6 Months)|Lack of Efficacy|0
5688819|NCT00333138|19617105|P2|Core Study (6 Months)|Lack of Efficacy|0
5688820|NCT00333138|19617106|P1|Core Study (6 Months)|Lack of Efficacy|1
5688821|NCT00333138|19617104|P3|Core Study (6 Months)|Withdrawal by Subject|2
5688822|NCT00333138|19617105|P2|Core Study (6 Months)|Withdrawal by Subject|1
5688823|NCT00333138|19617106|P1|Core Study (6 Months)|Withdrawal by Subject|1
5688824|NCT00333138|19617104|P3|Core Study (6 Months)|Adverse Event|8
5688825|NCT00333138|19617105|P2|Core Study (6 Months)|Adverse Event|5
5688826|NCT00333138|19617106|P1|Core Study (6 Months)|Adverse Event|4
5688827|NCT00332839|19617145|P2|Follow-up (Months 12 - 60)|Death|1
5688828|NCT00332839|19617146|P1|Follow-up (Months 12 - 60)|Death|1
5688829|NCT00332839|19617145|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
5688830|NCT00332839|19617146|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
5688831|NCT00332839|19617145|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
5688832|NCT00332839|19617146|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
5688833|NCT00332839|19617145|P2|Core (Months 0 - 12)|Adverse Event|15
5688834|NCT00332839|19617146|P1|Core (Months 0 - 12)|Adverse Event|5
5688835|NCT00332839|19617145|P2|Core (Months 0 - 12)|Protocol deviation|1
5688836|NCT00332839|19617146|P1|Core (Months 0 - 12)|Protocol deviation|1
5688837|NCT00332839|19617145|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
5688838|NCT00332839|19617146|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
5688839|NCT00332839|19617145|P2|Core (Months 0 - 12)|Administrative problems|1
5688840|NCT00332839|19617146|P1|Core (Months 0 - 12)|Administrative problems|1
5688841|NCT00332709|19617177|P2|Overall Study|Abnormal test procedure result|0
5688842|NCT00332709|19617178|P1|Overall Study|Abnormal test procedure result|1
5688843|NCT00332709|19617177|P2|Overall Study|Administrative Problems|3
5688844|NCT00332709|19617178|P1|Overall Study|Administrative Problems|0
5688845|NCT00332709|19617177|P2|Overall Study|Lost to Follow-up|0
5688846|NCT00332709|19617178|P1|Overall Study|Lost to Follow-up|2
5688847|NCT00332709|19617177|P2|Overall Study|Withdrawal by Subject|3
5688848|NCT00332709|19617178|P1|Overall Study|Withdrawal by Subject|2
5688849|NCT00332709|19617177|P2|Overall Study|Adverse Event|14
5688850|NCT00332709|19617178|P1|Overall Study|Adverse Event|11
5688851|NCT00332696|19617202|P2|Overall Study|Withdrawal by Subject|0
5688852|NCT00332696|19617203|P1|Overall Study|Withdrawal by Subject|1
5688853|NCT00332696|19617202|P2|Overall Study|Lost to Follow-up|1
5688854|NCT00332696|19617203|P1|Overall Study|Lost to Follow-up|0
5688855|NCT00332696|19617202|P2|Overall Study|Condition does not justify treatment|2
5688856|NCT00332696|19617203|P1|Overall Study|Condition does not justify treatment|0
5688857|NCT00332696|19617202|P2|Overall Study|Adverse Event|2
5688858|NCT00332696|19617203|P1|Overall Study|Adverse Event|1
5688859|NCT00332696|19617202|P2|Overall Study|Insufficient therapeutic effect|11
5688860|NCT00332696|19617203|P1|Overall Study|Insufficient therapeutic effect|4
5688861|NCT00332696|19617202|P2|Overall Study|Death|14
5688862|NCT00332696|19617203|P1|Overall Study|Death|24
5688863|NCT00332488|19617279|P3|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
5688864|NCT00332488|19617280|P2|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
5688865|NCT00332488|19617281|P1|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
5688866|NCT00332488|19617279|P3|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
5688867|NCT00332488|19617280|P2|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
5688868|NCT00332488|19617281|P1|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
5688869|NCT00332488|19617279|P3|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
5688870|NCT00332488|19617280|P2|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
5688871|NCT00332488|19617281|P1|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
5688872|NCT00332488|19617279|P3|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
5688873|NCT00332488|19617280|P2|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
5688874|NCT00332488|19617281|P1|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
5688875|NCT00332488|19617279|P3|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
5688876|NCT00332488|19617280|P2|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
5688877|NCT00332488|19617281|P1|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
5688878|NCT00332488|19617279|P3|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
5688879|NCT00332488|19617280|P2|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
5688880|NCT00332488|19617281|P1|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
5688881|NCT00332488|19617279|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
5688882|NCT00332488|19617280|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
5688883|NCT00332488|19617281|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
5688884|NCT00332488|19617279|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
5688885|NCT00332488|19617280|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
5688886|NCT00332488|19617281|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
5688887|NCT00332488|19617279|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
5688888|NCT00332488|19617280|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
5688889|NCT00332488|19617281|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
5688890|NCT00332488|19617279|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
5688891|NCT00332488|19617280|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
5688892|NCT00332488|19617281|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
5688893|NCT00332488|19617279|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
5688894|NCT00332488|19617280|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
5688895|NCT00332488|19617281|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
5688896|NCT00332488|19617279|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
5688897|NCT00332488|19617280|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
5688898|NCT00332488|19617281|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
5688899|NCT00332462|19617293|P1|Overall Study|Graft Loss|2
5688900|NCT00332462|19617293|P1|Overall Study|Death|3
5688901|NCT00332462|19617293|P1|Overall Study|no longer requires study drug|1
5688902|NCT00332462|19617293|P1|Overall Study|Unsatisfactory therapeutic effect|4
5688903|NCT00332462|19617293|P1|Overall Study|Abnormal Lab Value|1
5688904|NCT00332462|19617293|P1|Overall Study|Adverse Event|5
5688905|NCT00332332|19617300|P1|Overall Study|Did not receive study treatment|16
5688906|NCT00332332|19617300|P1|Overall Study|Other|18
5688907|NCT00332332|19617300|P1|Overall Study|Disease progression|2
5688908|NCT00332332|19617300|P1|Overall Study|Noncompliance|2
5688909|NCT00332332|19617300|P1|Overall Study|Protocol deviation|4
5688910|NCT00332332|19617300|P1|Overall Study|Lost to Follow-up|3
5688911|NCT00332332|19617300|P1|Overall Study|Physician Decision|1
5688912|NCT00332332|19617300|P1|Overall Study|Withdrawal by Subject|8
5688913|NCT00332332|19617300|P1|Overall Study|Death|1
5688914|NCT00332332|19617300|P1|Overall Study|Adverse Event|13
5688915|NCT00332241|19617309|P2|Overall Study|Lost to Follow-up|1
5688916|NCT00332241|19617310|P1|Overall Study|Lost to Follow-up|4
5688917|NCT00332241|19617309|P2|Overall Study|Withdrawal by Subject|1
5688918|NCT00332241|19617310|P1|Overall Study|Withdrawal by Subject|2
5688919|NCT00332241|19617309|P2|Overall Study|Adverse Event|5
5688920|NCT00332241|19617310|P1|Overall Study|Adverse Event|3
5688921|NCT00332241|19617309|P2|Overall Study|Lack of Efficacy|1
5688922|NCT00332241|19617310|P1|Overall Study|Lack of Efficacy|6
5688923|NCT00332202|19617332|P2|Overall Study|Death|2
5688924|NCT00332202|19617333|P1|Overall Study|Death|5
5688925|NCT00332202|19617332|P2|Overall Study|Progressive Disease|60
5688926|NCT00332202|19617333|P1|Overall Study|Progressive Disease|106
5688927|NCT00332202|19617332|P2|Overall Study|Withdrawal by Subject|17
5688928|NCT00332202|19617333|P1|Overall Study|Withdrawal by Subject|36
5688929|NCT00332202|19617332|P2|Overall Study|Sponsor Decision|2
5688930|NCT00332202|19617333|P1|Overall Study|Sponsor Decision|1
5688931|NCT00332202|19617332|P2|Overall Study|Protocol Violation|2
5688932|NCT00332202|19617333|P1|Overall Study|Protocol Violation|7
5688933|NCT00332202|19617332|P2|Overall Study|Protocol Entry Criteria Not Met|5
5688934|NCT00332202|19617333|P1|Overall Study|Protocol Entry Criteria Not Met|6
5688935|NCT00332202|19617332|P2|Overall Study|Physician Decision|8
5688936|NCT00332202|19617333|P1|Overall Study|Physician Decision|6
5688937|NCT00332202|19617332|P2|Overall Study|Lost to Follow-up|1
5688938|NCT00332202|19617333|P1|Overall Study|Lost to Follow-up|2
5688939|NCT00332202|19617332|P2|Overall Study|Adverse Event|28
5688940|NCT00332202|19617333|P1|Overall Study|Adverse Event|72
5688941|NCT00332189|19617362|P1|Overall Study|Moved out of country|2
5688942|NCT00332189|19617362|P1|Overall Study|Lack of Efficacy|4
5688943|NCT00332189|19617362|P1|Overall Study|Withdrawal by Subject|9
5688944|NCT00332189|19617362|P1|Overall Study|Uncooperative/Noncompliant|3
5688945|NCT00332189|19617362|P1|Overall Study|Adverse Event|3
5688946|NCT00331864|19617404|P2|Overall Study|Death|0
5688947|NCT00331864|19617405|P1|Overall Study|Death|6
5688948|NCT00331864|19617404|P2|Overall Study|Administrative Problems|0
5688949|NCT00331864|19617405|P1|Overall Study|Administrative Problems|1
5688950|NCT00331864|19617404|P2|Overall Study|Lost to Follow-up|3
5688951|NCT00331864|19617405|P1|Overall Study|Lost to Follow-up|4
5688952|NCT00331864|19617404|P2|Overall Study|Withdrawal by Subject|0
5688953|NCT00331864|19617405|P1|Overall Study|Withdrawal by Subject|10
5688954|NCT00331864|19617404|P2|Overall Study|Protocol Violation|0
5688955|NCT00331864|19617405|P1|Overall Study|Protocol Violation|3
5688956|NCT00331864|19617404|P2|Overall Study|Lack of Efficacy|0
5688957|NCT00331864|19617405|P1|Overall Study|Lack of Efficacy|4
5688958|NCT00331864|19617404|P2|Overall Study|Adverse Event|1
5688959|NCT00331864|19617405|P1|Overall Study|Adverse Event|30
5688960|NCT00331799|19617424|P1|Overall Study|Sedation|1
5688961|NCT00331799|19617424|P1|Overall Study|Withdrawal by Subject|2
5688962|NCT00331773|19617430|P2|Overall Study|Protocol Violation|3
5688963|NCT00331773|19617431|P1|Overall Study|Protocol Violation|10
5688964|NCT00331773|19617430|P2|Overall Study|Withdrawal by Subject|4
5688965|NCT00331773|19617431|P1|Overall Study|Withdrawal by Subject|6
5688966|NCT00331760|19617461|P2|Overall Study|Ineligible / no protocol treatment|8
5688967|NCT00331760|19617462|P1|Overall Study|Ineligible / no protocol treatment|15
5688968|NCT00331682|19617483|P1|Overall Study|Adverse Event|1
5688969|NCT00331630|19617489|P1|Follow up for 5 Years|Data collection was stopped|24
5688970|NCT00331630|19617489|P1|Follow up for 5 Years|Death|5
5688971|NCT00331630|19617489|P1|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
5688972|NCT00331630|19617489|P1|Evaluated for and Completed SOC Surgery|Progressive Disease|1
5688973|NCT00331552|19617501|P2|Period 3: Phase II|Severe Nausea|0
5688974|NCT00331552|19617502|P1|Period 3: Phase II|Severe Nausea|1
5688975|NCT00331552|19617501|P2|Period 3: Phase II|Neurological Symptoms|0
5688976|NCT00331552|19617502|P1|Period 3: Phase II|Neurological Symptoms|1
5688977|NCT00331422|19617516|P1|Overall Study|Did not receive entire study regimen|5
5688978|NCT00331409|19617525|P1|Overall Study|Lack of Efficacy|4
5688979|NCT00331344|19617533|P9|Phase II|Death|4
5688980|NCT00331344|19617534|P8|Phase II|Death|0
5688981|NCT00331344|19617535|P7|Phase II|Death|0
5688982|NCT00331344|19617536|P6|Phase II|Death|0
5688983|NCT00331344|19617537|P5|Phase II|Death|0
5688984|NCT00331344|19617538|P4|Phase II|Death|0
5688985|NCT00331344|19617539|P3|Phase II|Death|0
5688986|NCT00331344|19617540|P2|Phase II|Death|0
5688987|NCT00331344|19617541|P1|Phase II|Death|0
5688988|NCT00331344|19617533|P9|Phase I|Adverse Event|0
5688989|NCT00331344|19617534|P8|Phase I|Adverse Event|1
5688990|NCT00331344|19617535|P7|Phase I|Adverse Event|0
5688991|NCT00331344|19617536|P6|Phase I|Adverse Event|2
5688992|NCT00331344|19617537|P5|Phase I|Adverse Event|2
5688993|NCT00331344|19617538|P4|Phase I|Adverse Event|1
5688994|NCT00331344|19617539|P3|Phase I|Adverse Event|0
5688995|NCT00331344|19617540|P2|Phase I|Adverse Event|0
5688996|NCT00331344|19617541|P1|Phase I|Adverse Event|0
5688997|NCT00331006|19617578|P1|Follow-Up Phase II|Lost to Follow-up|3
5688998|NCT00331006|19617578|P1|Follow-Up Phase I|Lost to Follow-up|1
5688999|NCT00331006|19617578|P1|Treatment Phase|Withdrawal by Subject|1
5689000|NCT00331006|19617578|P1|Screening Phase|Ineligible for treatment phase|4
5689001|NCT00331006|19617578|P1|Screening Phase|Lost to Follow-up|1
5689002|NCT00331006|19617578|P1|Screening Phase|enrollment halted|1
5689003|NCT00331006|19617578|P1|Screening Phase|Withdrawal by Subject|1
5689004|NCT00330967|19617591|P2|Overall Study|Physician Decision|9
5689005|NCT00330967|19617592|P1|Overall Study|Physician Decision|0
5689006|NCT00330967|19617591|P2|Overall Study|Withdrawal by Subject|5
5689007|NCT00330967|19617592|P1|Overall Study|Withdrawal by Subject|0
5689008|NCT00330928|19617603|P1|Overall Study|IVUS could not be performed.|1
5689009|NCT00330928|19617603|P1|Overall Study|Death|1
5689010|NCT00330928|19617603|P1|Overall Study|Physician Decision|9
5689011|NCT00330928|19617603|P1|Overall Study|Lost to Follow-up|6
5689012|NCT00330759|19617645|P2|Overall Study|Other|44
5689013|NCT00330759|19617646|P1|Overall Study|Other|36
5689014|NCT00330759|19617645|P2|Overall Study|Ineligibility determined|1
5689015|NCT00330759|19617646|P1|Overall Study|Ineligibility determined|2
5689016|NCT00330759|19617645|P2|Overall Study|Protocol deviation|2
5689017|NCT00330759|19617646|P1|Overall Study|Protocol deviation|0
5689018|NCT00330759|19617645|P2|Overall Study|Physician Decision|2
5689019|NCT00330759|19617646|P1|Overall Study|Physician Decision|1
5689020|NCT00330759|19617645|P2|Overall Study|Noncompliance|17
5689021|NCT00330759|19617646|P1|Overall Study|Noncompliance|15
5689022|NCT00330759|19617645|P2|Overall Study|Lost to Follow-up|22
5689023|NCT00330759|19617646|P1|Overall Study|Lost to Follow-up|16
5689024|NCT00330759|19617645|P2|Overall Study|Participant request|22
5689025|NCT00330759|19617646|P1|Overall Study|Participant request|31
5689026|NCT00330759|19617645|P2|Overall Study|Adverse Event|36
5689027|NCT00330759|19617646|P1|Overall Study|Adverse Event|48
5689028|NCT00330759|19617645|P2|Overall Study|Withdrawal by Subject|124
5689029|NCT00330759|19617646|P1|Overall Study|Withdrawal by Subject|143
5689030|NCT00330759|19617645|P2|Overall Study|Disease progression|126
5689031|NCT00330759|19617646|P1|Overall Study|Disease progression|104
5689032|NCT00330759|19617645|P2|Overall Study|Death|310
5689033|NCT00330759|19617646|P1|Overall Study|Death|316
5689034|NCT00330681|19617679|P2|Overall Study|Tracheotomy due to worsening of ALS|2
5689035|NCT00330681|19617680|P1|Overall Study|Tracheotomy due to worsening of ALS|1
5689036|NCT00330681|19617679|P2|Overall Study|Withdrawal by Subject|5
5689037|NCT00330681|19617680|P1|Overall Study|Withdrawal by Subject|5
5689038|NCT00330681|19617679|P2|Overall Study|Protocol Violation|1
5689039|NCT00330681|19617680|P1|Overall Study|Protocol Violation|0
5689040|NCT00330681|19617679|P2|Overall Study|Adverse Event|6
5689041|NCT00330681|19617680|P1|Overall Study|Adverse Event|3
5689042|NCT00330668|19617702|P1|QD Dosing Period|Lost to Follow-up|2
5689043|NCT00330668|19617702|P1|QD Dosing Period|Withdrawal by Subject|1
5689044|NCT00330668|19617702|P1|QD Dosing Period|Other|1
5689045|NCT00330668|19617702|P1|QD Dosing Period|Sponsor decision to terminate study|74
5689046|NCT00330668|19617702|P1|BID Dosing Period|Other|3
5689047|NCT00330668|19617702|P1|BID Dosing Period|Sponsor's decision|1
5689048|NCT00330668|19617702|P1|BID Dosing Period|Withdrawal by Subject|19
5689049|NCT00330668|19617702|P1|BID Dosing Period|Non-Compliance|5
5689050|NCT00330668|19617702|P1|BID Dosing Period|Lost to Follow-up|7
5689051|NCT00330668|19617702|P1|BID Dosing Period|Adverse Event|1
5689052|NCT00330616|19617710|P1|Overall Study|Other|1
5689053|NCT00330616|19617710|P1|Overall Study|Withdrawal by Subject|4
5689054|NCT00330616|19617710|P1|Overall Study|Lost to Follow-up|2
5689055|NCT00330616|19617710|P1|Overall Study|Lack of Efficacy|1
5689056|NCT00330616|19617710|P1|Overall Study|Adverse Event|13
5689057|NCT00330460|19617761|P2|Overall Study|Other|0
5689058|NCT00330460|19617762|P1|Overall Study|Other|1
5689059|NCT00330460|19617761|P2|Overall Study|Noncompliance|1
5689060|NCT00330460|19617762|P1|Overall Study|Noncompliance|2
5689061|NCT00330460|19617761|P2|Overall Study|Lost to Follow-up|3
5689062|NCT00330460|19617762|P1|Overall Study|Lost to Follow-up|8
5689063|NCT00330460|19617761|P2|Overall Study|Ineligibility determined|3
5689064|NCT00330460|19617762|P1|Overall Study|Ineligibility determined|1
5689065|NCT00330460|19617761|P2|Overall Study|Death|1
5689066|NCT00330460|19617762|P1|Overall Study|Death|1
5689067|NCT00330460|19617761|P2|Overall Study|Withdrawal by Subject|17
5689068|NCT00330460|19617762|P1|Overall Study|Withdrawal by Subject|18
5689069|NCT00330460|19617761|P2|Overall Study|Adverse Event|8
5689070|NCT00330460|19617762|P1|Overall Study|Adverse Event|10
5689071|NCT00330460|19617761|P2|Overall Study|Physician Decision|0
5689072|NCT00330460|19617762|P1|Overall Study|Physician Decision|1
5689073|NCT00330343|19617805|P1|Overall Study|Lost to Follow-up|5
5689074|NCT00330187|19617813|P4|Overall Study|Withdrawal by Subject|4
5689075|NCT00330187|19617814|P3|Overall Study|Withdrawal by Subject|4
5689076|NCT00330187|19617815|P2|Overall Study|Withdrawal by Subject|5
5689077|NCT00330187|19617816|P1|Overall Study|Withdrawal by Subject|8
5689078|NCT00330187|19617813|P4|Overall Study|Lost to Follow-up|10
5689079|NCT00330187|19617814|P3|Overall Study|Lost to Follow-up|14
5689080|NCT00330187|19617815|P2|Overall Study|Lost to Follow-up|13
5689081|NCT00330187|19617816|P1|Overall Study|Lost to Follow-up|12
5689082|NCT00330174|19617828|P2|Overall Study|Miscellaneous reasons|1
5689083|NCT00330174|19617829|P1|Overall Study|Miscellaneous reasons|7
5689084|NCT00330174|19617828|P2|Overall Study|Excessive missed visits|8
5689085|NCT00330174|19617829|P1|Overall Study|Excessive missed visits|3
5689086|NCT00330174|19617828|P2|Overall Study|Clinical deterioration|2
5689087|NCT00330174|19617829|P1|Overall Study|Clinical deterioration|1
5689088|NCT00330174|19617828|P2|Overall Study|Lost to Follow-up|1
5689089|NCT00330174|19617829|P1|Overall Study|Lost to Follow-up|4
5689090|NCT00330174|19617828|P2|Overall Study|Withdrawal by Subject|7
5689091|NCT00330174|19617829|P1|Overall Study|Withdrawal by Subject|7
5689092|NCT00329901|19617853|P3|Overall Study|Unable to classify|0
5689093|NCT00329901|19617854|P2|Overall Study|Unable to classify|2
5689094|NCT00329901|19617855|P1|Overall Study|Unable to classify|2
5689095|NCT00329901|19617853|P3|Overall Study|Protocol Violation|1
5689096|NCT00329901|19617854|P2|Overall Study|Protocol Violation|0
5689097|NCT00329901|19617855|P1|Overall Study|Protocol Violation|1
5689098|NCT00329901|19617853|P3|Overall Study|Lost to Follow-up|1
5689099|NCT00329901|19617854|P2|Overall Study|Lost to Follow-up|0
5689100|NCT00329901|19617855|P1|Overall Study|Lost to Follow-up|2
5689101|NCT00329901|19617853|P3|Overall Study|Withdrawal by Subject|2
5689102|NCT00329901|19617854|P2|Overall Study|Withdrawal by Subject|3
5689103|NCT00329901|19617855|P1|Overall Study|Withdrawal by Subject|4
5689104|NCT00329849|19617885|P2|Overall Study|Withdrawal by Subject|4
5689105|NCT00329849|19617886|P1|Overall Study|Withdrawal by Subject|6
5689106|NCT00329797|19617912|P2|Overall Study|Withdrawal by Subject|6
5689107|NCT00329797|19617913|P1|Overall Study|Withdrawal by Subject|6
5689108|NCT00329797|19617912|P2|Overall Study|Protocol Violation|0
5689109|NCT00329797|19617913|P1|Overall Study|Protocol Violation|1
5689110|NCT00329784|19617929|P4|Overall Study|Other|0
5689111|NCT00329784|19617930|P3|Overall Study|Other|0
5689112|NCT00329784|19617931|P2|Overall Study|Other|2
5689113|NCT00329784|19617932|P1|Overall Study|Other|1
5689114|NCT00329784|19617929|P4|Overall Study|Withdrawal by Subject|0
5689115|NCT00329784|19617930|P3|Overall Study|Withdrawal by Subject|0
5689116|NCT00329784|19617931|P2|Overall Study|Withdrawal by Subject|2
5689117|NCT00329784|19617932|P1|Overall Study|Withdrawal by Subject|4
5689118|NCT00329784|19617929|P4|Overall Study|Lost to Follow-up|0
5689119|NCT00329784|19617930|P3|Overall Study|Lost to Follow-up|0
5689120|NCT00329784|19617931|P2|Overall Study|Lost to Follow-up|1
5689121|NCT00329784|19617932|P1|Overall Study|Lost to Follow-up|0
5689122|NCT00329745|19617960|P2|Overall Study|Lost to Follow-up|101
5689123|NCT00329745|19617961|P1|Overall Study|Lost to Follow-up|86
5689124|NCT00329745|19617960|P2|Overall Study|Withdrawal by Subject|1
5689125|NCT00329745|19617961|P1|Overall Study|Withdrawal by Subject|0
5689126|NCT00329745|19617960|P2|Overall Study|Protocol Violation|0
5689127|NCT00329745|19617961|P1|Overall Study|Protocol Violation|1
5689128|NCT00329719|19617981|P4|Overall Study|Lost to Follow-up|1
5689129|NCT00329719|19617982|P3|Overall Study|Lost to Follow-up|0
5689130|NCT00329719|19617983|P2|Overall Study|Lost to Follow-up|0
5689131|NCT00329719|19617984|P1|Overall Study|Lost to Follow-up|0
5689132|NCT00329641|19618006|P1|Overall Study|Other reason, not protocol specified|1
5689133|NCT00329641|19618006|P1|Overall Study|Adverse Event|3
5689134|NCT00329641|19618006|P1|Overall Study|Not eligible|1
5689135|NCT00329641|19618006|P1|Overall Study|Did not start treatment|1
5689136|NCT00329602|19618015|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
5689137|NCT00329602|19618016|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
5689138|NCT00329602|19618017|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
5689139|NCT00329602|19618015|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
5689140|NCT00329602|19618016|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
5689141|NCT00329602|19618017|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
5689142|NCT00329602|19618015|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
5689143|NCT00329602|19618016|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
5689144|NCT00329602|19618017|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
5689145|NCT00329602|19618015|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
5689146|NCT00329602|19618016|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
5689147|NCT00329602|19618017|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
5689148|NCT00329602|19618015|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
5689149|NCT00329602|19618016|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
5689150|NCT00329602|19618017|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
5689151|NCT00329602|19618015|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
5689152|NCT00329602|19618016|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
5689153|NCT00329602|19618017|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
5689154|NCT00329550|19618055|P3|Overall Study|Due to Relocation|1
5689155|NCT00329550|19618056|P2|Overall Study|Due to Relocation|0
5689156|NCT00329550|19618057|P1|Overall Study|Due to Relocation|0
5689157|NCT00329550|19618055|P3|Overall Study|Withdrawal of Consent|1
5689158|NCT00329550|19618056|P2|Overall Study|Withdrawal of Consent|0
5689159|NCT00329550|19618057|P1|Overall Study|Withdrawal of Consent|1
5689160|NCT00329550|19618055|P3|Overall Study|Adverse Event|2
5689161|NCT00329550|19618056|P2|Overall Study|Adverse Event|4
5689162|NCT00329550|19618057|P1|Overall Study|Adverse Event|3
5689163|NCT00329420|19618326|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
5689164|NCT00329420|19618327|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
5689165|NCT00329420|19618328|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
5689166|NCT00329420|19618326|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
5689167|NCT00329420|19618327|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
5689168|NCT00329420|19618328|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
5689169|NCT00329420|19618326|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
5689170|NCT00329420|19618327|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
5689171|NCT00329420|19618328|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
5689172|NCT00329420|19618326|P3|Re-induction Phase|Did not respond to re-induction|7
5689173|NCT00329420|19618327|P2|Re-induction Phase|Did not respond to re-induction|5
5689174|NCT00329420|19618328|P1|Re-induction Phase|Did not respond to re-induction|6
5689175|NCT00329420|19618326|P3|Re-induction Phase|Withdrawal of Consent|1
5689176|NCT00329420|19618327|P2|Re-induction Phase|Withdrawal of Consent|0
5689177|NCT00329420|19618328|P1|Re-induction Phase|Withdrawal of Consent|0
5689178|NCT00329420|19618326|P3|Re-induction Phase|Lack of Efficacy|0
5689179|NCT00329420|19618327|P2|Re-induction Phase|Lack of Efficacy|1
5689180|NCT00329420|19618328|P1|Re-induction Phase|Lack of Efficacy|0
5689181|NCT00329407|19618707|P1|Overall Study|Withdrawal by Subject|1
5689182|NCT00329303|19618714|P2|Overall Study|Patient relocated|1
5689183|NCT00329303|19618715|P1|Overall Study|Patient relocated|0
5689184|NCT00329303|19618714|P2|Overall Study|Patient no longer available|0
5689185|NCT00329303|19618715|P1|Overall Study|Patient no longer available|1
5689186|NCT00329303|19618714|P2|Overall Study|Decision of the sponsor|1
5689187|NCT00329303|19618715|P1|Overall Study|Decision of the sponsor|0
5689188|NCT00329303|19618714|P2|Overall Study|Lack of Efficacy|0
5689189|NCT00329303|19618715|P1|Overall Study|Lack of Efficacy|1
5689190|NCT00329238|19618877|P2|Overall Study|Other reason (not specified)|54
5689191|NCT00329238|19618878|P1|Overall Study|Other reason (not specified)|40
5689192|NCT00329238|19618877|P2|Overall Study|Withdrawal by Subject|58
5689193|NCT00329238|19618878|P1|Overall Study|Withdrawal by Subject|64
5689194|NCT00329238|19618877|P2|Overall Study|Lost to Follow-up|6
5689195|NCT00329238|19618878|P1|Overall Study|Lost to Follow-up|2
5689196|NCT00329238|19618877|P2|Overall Study|Protocol Violation|34
5689197|NCT00329238|19618878|P1|Overall Study|Protocol Violation|23
5689198|NCT00329238|19618877|P2|Overall Study|Adverse Event|129
5689199|NCT00329238|19618878|P1|Overall Study|Adverse Event|147
5689200|NCT00329160|19618914|P1|Overall Study|Incomplete IVUS|45
5689201|NCT00329160|19618914|P1|Overall Study|Did not Receive Study Drug|1
5689202|NCT00329160|19618914|P1|Overall Study|Protocol Violation|2
5689203|NCT00329160|19618914|P1|Overall Study|Withdrawal by Subject|13
5689204|NCT00329160|19618914|P1|Overall Study|Adverse Event|27
5689205|NCT00329108|19618923|P2|Overall Study|Protocol Violation|2
5689206|NCT00329108|19618924|P1|Overall Study|Protocol Violation|0
5689207|NCT00329108|19618923|P2|Overall Study|withdrew patient after SAE resolved|0
5689208|NCT00329108|19618924|P1|Overall Study|withdrew patient after SAE resolved|1
5689209|NCT00329108|19618923|P2|Overall Study|study terminated by sponsor|0
5689210|NCT00329108|19618924|P1|Overall Study|study terminated by sponsor|1
5689211|NCT00329108|19618923|P2|Overall Study|Subject no longer willing to participate|2
5689212|NCT00329108|19618924|P1|Overall Study|Subject no longer willing to participate|2
5689213|NCT00329108|19618923|P2|Overall Study|symptomatic deterioration|1
5689214|NCT00329108|19618924|P1|Overall Study|symptomatic deterioration|1
5689215|NCT00329108|19618923|P2|Overall Study|Withdrawal by Subject|2
5689216|NCT00329108|19618924|P1|Overall Study|Withdrawal by Subject|0
5689217|NCT00329108|19618923|P2|Overall Study|Lack of Efficacy|3
5689218|NCT00329108|19618924|P1|Overall Study|Lack of Efficacy|3
5689219|NCT00329108|19618923|P2|Overall Study|Adverse Event|2
5689220|NCT00329108|19618924|P1|Overall Study|Adverse Event|2
5689221|NCT00329030|19618932|P2|Overall Study|Ineligible Pathology|1
5689222|NCT00329030|19618933|P1|Overall Study|Ineligible Pathology|1
5689223|NCT00329030|19618932|P2|Overall Study|Progressive Disease|2
5689224|NCT00329030|19618933|P1|Overall Study|Progressive Disease|6
5689225|NCT00329030|19618932|P2|Overall Study|Withdrawal by Subject|3
5689226|NCT00329030|19618933|P1|Overall Study|Withdrawal by Subject|1
5689227|NCT00328926|19618964|P3|Overall Study|Lack of ovarian response|0
5689228|NCT00328926|19618965|P2|Overall Study|Lack of ovarian response|1
5689229|NCT00328926|19618966|P1|Overall Study|Lack of ovarian response|0
5689230|NCT00328926|19618964|P3|Overall Study|In vitro fertilization treatment|1
5689231|NCT00328926|19618965|P2|Overall Study|In vitro fertilization treatment|0
5689232|NCT00328926|19618966|P1|Overall Study|In vitro fertilization treatment|0
5689233|NCT00328926|19618964|P3|Overall Study|Death|1
5689234|NCT00328926|19618965|P2|Overall Study|Death|0
5689235|NCT00328926|19618966|P1|Overall Study|Death|0
5689236|NCT00328926|19618964|P3|Overall Study|Lost to Follow-up|0
5689237|NCT00328926|19618965|P2|Overall Study|Lost to Follow-up|1
5689238|NCT00328926|19618966|P1|Overall Study|Lost to Follow-up|0
5689239|NCT00328926|19618964|P3|Overall Study|Pregnancy|0
5689240|NCT00328926|19618965|P2|Overall Study|Pregnancy|1
5689241|NCT00328926|19618966|P1|Overall Study|Pregnancy|2
5689242|NCT00328783|19618991|P1|Overall Study|Withdrawal by Subject|1
5689243|NCT00328783|19618991|P1|Overall Study|No heart in RT field|4
5689244|NCT00328783|19618991|P1|Overall Study|Could not tolerate ABC|21
5689245|NCT00328627|19619017|P12|Overall Study|Other|0
5689246|NCT00328627|19619018|P11|Overall Study|Other|1
5689247|NCT00328627|19619019|P10|Overall Study|Other|1
5689248|NCT00328627|19619020|P9|Overall Study|Other|0
5689249|NCT00328627|19619021|P8|Overall Study|Other|0
5689250|NCT00328627|19619022|P7|Overall Study|Other|1
5689251|NCT00328627|19619023|P6|Overall Study|Other|0
5689252|NCT00328627|19619024|P5|Overall Study|Other|0
5689253|NCT00328627|19619025|P4|Overall Study|Other|1
5689254|NCT00328627|19619026|P3|Overall Study|Other|0
5689255|NCT00328627|19619027|P2|Overall Study|Other|0
5689256|NCT00328627|19619028|P1|Overall Study|Other|0
5689257|NCT00328627|19619017|P12|Overall Study|Physician Decision|0
5689258|NCT00328627|19619018|P11|Overall Study|Physician Decision|1
5689259|NCT00328627|19619019|P10|Overall Study|Physician Decision|2
5689260|NCT00328627|19619020|P9|Overall Study|Physician Decision|3
5689261|NCT00328627|19619021|P8|Overall Study|Physician Decision|0
5689262|NCT00328627|19619022|P7|Overall Study|Physician Decision|1
5689263|NCT00328627|19619023|P6|Overall Study|Physician Decision|1
5689264|NCT00328627|19619024|P5|Overall Study|Physician Decision|1
5689265|NCT00328627|19619025|P4|Overall Study|Physician Decision|2
5689266|NCT00328627|19619026|P3|Overall Study|Physician Decision|1
5689267|NCT00328627|19619027|P2|Overall Study|Physician Decision|3
5689268|NCT00328627|19619028|P1|Overall Study|Physician Decision|4
5689269|NCT00328627|19619017|P12|Overall Study|Pregnancy|0
5689270|NCT00328627|19619018|P11|Overall Study|Pregnancy|0
5689271|NCT00328627|19619019|P10|Overall Study|Pregnancy|0
5689272|NCT00328627|19619020|P9|Overall Study|Pregnancy|0
5689273|NCT00328627|19619021|P8|Overall Study|Pregnancy|0
5689274|NCT00328627|19619022|P7|Overall Study|Pregnancy|0
5689275|NCT00328627|19619023|P6|Overall Study|Pregnancy|0
5689276|NCT00328627|19619024|P5|Overall Study|Pregnancy|0
5689277|NCT00328627|19619025|P4|Overall Study|Pregnancy|0
5689278|NCT00328627|19619026|P3|Overall Study|Pregnancy|0
5689279|NCT00328627|19619027|P2|Overall Study|Pregnancy|1
5689280|NCT00328627|19619028|P1|Overall Study|Pregnancy|0
5689281|NCT00328627|19619017|P12|Overall Study|Withdrawal by Subject|7
5689282|NCT00328627|19619018|P11|Overall Study|Withdrawal by Subject|2
5689283|NCT00328627|19619019|P10|Overall Study|Withdrawal by Subject|5
5689284|NCT00328627|19619020|P9|Overall Study|Withdrawal by Subject|4
5689285|NCT00328627|19619021|P8|Overall Study|Withdrawal by Subject|4
5689286|NCT00328627|19619022|P7|Overall Study|Withdrawal by Subject|4
5689287|NCT00328627|19619023|P6|Overall Study|Withdrawal by Subject|5
5689288|NCT00328627|19619024|P5|Overall Study|Withdrawal by Subject|2
5689289|NCT00328627|19619025|P4|Overall Study|Withdrawal by Subject|6
5689290|NCT00328627|19619026|P3|Overall Study|Withdrawal by Subject|5
5689291|NCT00328627|19619027|P2|Overall Study|Withdrawal by Subject|4
5689292|NCT00328627|19619028|P1|Overall Study|Withdrawal by Subject|5
5689293|NCT00328627|19619017|P12|Overall Study|Lost to Follow-up|1
5689294|NCT00328627|19619018|P11|Overall Study|Lost to Follow-up|0
5689295|NCT00328627|19619019|P10|Overall Study|Lost to Follow-up|2
5689296|NCT00328627|19619020|P9|Overall Study|Lost to Follow-up|3
5689297|NCT00328627|19619021|P8|Overall Study|Lost to Follow-up|0
5689298|NCT00328627|19619022|P7|Overall Study|Lost to Follow-up|3
5689299|NCT00328627|19619023|P6|Overall Study|Lost to Follow-up|2
5689300|NCT00328627|19619024|P5|Overall Study|Lost to Follow-up|0
5689301|NCT00328627|19619025|P4|Overall Study|Lost to Follow-up|4
5689302|NCT00328627|19619026|P3|Overall Study|Lost to Follow-up|2
5689303|NCT00328627|19619027|P2|Overall Study|Lost to Follow-up|2
5689304|NCT00328627|19619028|P1|Overall Study|Lost to Follow-up|4
5689305|NCT00328627|19619017|P12|Overall Study|Protocol Violation|2
5689306|NCT00328627|19619018|P11|Overall Study|Protocol Violation|6
5689307|NCT00328627|19619019|P10|Overall Study|Protocol Violation|4
5689308|NCT00328627|19619020|P9|Overall Study|Protocol Violation|1
5689309|NCT00328627|19619021|P8|Overall Study|Protocol Violation|2
5689310|NCT00328627|19619022|P7|Overall Study|Protocol Violation|6
5689311|NCT00328627|19619023|P6|Overall Study|Protocol Violation|5
5689312|NCT00328627|19619024|P5|Overall Study|Protocol Violation|5
5689313|NCT00328627|19619025|P4|Overall Study|Protocol Violation|8
5689314|NCT00328627|19619026|P3|Overall Study|Protocol Violation|2
5689315|NCT00328627|19619027|P2|Overall Study|Protocol Violation|2
5689316|NCT00328627|19619028|P1|Overall Study|Protocol Violation|2
5689317|NCT00328627|19619017|P12|Overall Study|Adverse Event|4
5689318|NCT00328627|19619018|P11|Overall Study|Adverse Event|5
5689319|NCT00328627|19619019|P10|Overall Study|Adverse Event|7
5689320|NCT00328627|19619020|P9|Overall Study|Adverse Event|0
5689321|NCT00328627|19619021|P8|Overall Study|Adverse Event|2
5689322|NCT00328627|19619022|P7|Overall Study|Adverse Event|1
5689323|NCT00328627|19619023|P6|Overall Study|Adverse Event|2
5689324|NCT00328627|19619024|P5|Overall Study|Adverse Event|1
5689325|NCT00328627|19619025|P4|Overall Study|Adverse Event|3
5689326|NCT00328627|19619026|P3|Overall Study|Adverse Event|2
5689327|NCT00328627|19619027|P2|Overall Study|Adverse Event|1
5689328|NCT00328627|19619028|P1|Overall Study|Adverse Event|3
5689329|NCT00328627|19619017|P12|Overall Study|Hyperglycemic Rescue|2
5689330|NCT00328627|19619018|P11|Overall Study|Hyperglycemic Rescue|3
5689331|NCT00328627|19619019|P10|Overall Study|Hyperglycemic Rescue|11
5689332|NCT00328627|19619020|P9|Overall Study|Hyperglycemic Rescue|6
5689333|NCT00328627|19619021|P8|Overall Study|Hyperglycemic Rescue|6
5689334|NCT00328627|19619022|P7|Overall Study|Hyperglycemic Rescue|19
5689335|NCT00328627|19619023|P6|Overall Study|Hyperglycemic Rescue|5
5689336|NCT00328627|19619024|P5|Overall Study|Hyperglycemic Rescue|6
5689337|NCT00328627|19619025|P4|Overall Study|Hyperglycemic Rescue|13
5689338|NCT00328627|19619026|P3|Overall Study|Hyperglycemic Rescue|16
5689339|NCT00328627|19619027|P2|Overall Study|Hyperglycemic Rescue|18
5689340|NCT00328627|19619028|P1|Overall Study|Hyperglycemic Rescue|41
5689341|NCT00328562|19620565|P1|Overall Study|Disease progression|1
5689342|NCT00328510|19620574|P2|Overall Study|Treatment changed to a single fraction|1
5689343|NCT00328510|19620575|P1|Overall Study|Treatment changed to a single fraction|1
5689344|NCT00328510|19620574|P2|Overall Study|Severe kyphosis, could not use mask|1
5689345|NCT00328510|19620575|P1|Overall Study|Severe kyphosis, could not use mask|0
5689346|NCT00328510|19620574|P2|Overall Study|Withdrawal by Subject|2
5689347|NCT00328510|19620575|P1|Overall Study|Withdrawal by Subject|4
5689348|NCT00328510|19620574|P2|Overall Study|Dentition problems, could not use frame|0
5689349|NCT00328510|19620575|P1|Overall Study|Dentition problems, could not use frame|1
5689350|NCT00328510|19620574|P2|Overall Study|Gag disorder, could not use frame|0
5689351|NCT00328510|19620575|P1|Overall Study|Gag disorder, could not use frame|4
5689352|NCT00328198|19620590|P1|Follow-up|Death|31
5689353|NCT00328198|19620590|P1|Follow-up|Lost to Follow-up|4
5689354|NCT00328198|19620590|P1|Treatment|Confirmed complete response, MRD -|3
5689355|NCT00328198|19620590|P1|Treatment|Non-compliance|1
5689356|NCT00328198|19620590|P1|Treatment|Evidence of disease progression|2
5689357|NCT00328198|19620590|P1|Treatment|Withdrawal by Subject|5
5689358|NCT00328198|19620590|P1|Treatment|Physician Decision|5
5689359|NCT00328198|19620590|P1|Treatment|Death|1
5689360|NCT00328198|19620590|P1|Treatment|Adverse Event|21
5689361|NCT00328172|19620605|P5|Overall Study|Other reason (not specified)|0
5689362|NCT00328172|19620606|P4|Overall Study|Other reason (not specified)|0
5689363|NCT00328172|19620607|P3|Overall Study|Other reason (not specified)|1
5689364|NCT00328172|19620608|P2|Overall Study|Other reason (not specified)|0
5689365|NCT00328172|19620609|P1|Overall Study|Other reason (not specified)|3
5689366|NCT00328172|19620605|P5|Overall Study|Lack of Efficacy|3
5689367|NCT00328172|19620606|P4|Overall Study|Lack of Efficacy|4
5689368|NCT00328172|19620607|P3|Overall Study|Lack of Efficacy|4
5689369|NCT00328172|19620608|P2|Overall Study|Lack of Efficacy|9
5689370|NCT00328172|19620609|P1|Overall Study|Lack of Efficacy|14
5689371|NCT00328172|19620605|P5|Overall Study|Withdrawal by Subject|0
5689372|NCT00328172|19620606|P4|Overall Study|Withdrawal by Subject|6
5689373|NCT00328172|19620607|P3|Overall Study|Withdrawal by Subject|1
5689374|NCT00328172|19620608|P2|Overall Study|Withdrawal by Subject|1
5689375|NCT00328172|19620609|P1|Overall Study|Withdrawal by Subject|1
5689376|NCT00328172|19620605|P5|Overall Study|Lost to Follow-up|1
5689377|NCT00328172|19620606|P4|Overall Study|Lost to Follow-up|1
5689378|NCT00328172|19620607|P3|Overall Study|Lost to Follow-up|2
5689379|NCT00328172|19620608|P2|Overall Study|Lost to Follow-up|1
5689380|NCT00328172|19620609|P1|Overall Study|Lost to Follow-up|1
5689381|NCT00328172|19620605|P5|Overall Study|Protocol Violation|0
5689382|NCT00328172|19620606|P4|Overall Study|Protocol Violation|0
5689383|NCT00328172|19620607|P3|Overall Study|Protocol Violation|1
5689384|NCT00328172|19620608|P2|Overall Study|Protocol Violation|1
5689385|NCT00328172|19620609|P1|Overall Study|Protocol Violation|0
5689386|NCT00328172|19620605|P5|Overall Study|Adverse Event|1
5689387|NCT00328172|19620606|P4|Overall Study|Adverse Event|2
5689388|NCT00328172|19620607|P3|Overall Study|Adverse Event|1
5689389|NCT00328172|19620608|P2|Overall Study|Adverse Event|2
5689390|NCT00328172|19620609|P1|Overall Study|Adverse Event|3
5689391|NCT00328094|19620633|P2|Overall Study|Physician Decision|3
5689392|NCT00328094|19620634|P1|Overall Study|Physician Decision|3
5689393|NCT00327717|19620668|P2|Overall Study|Withdrawal by Subject|7
5689394|NCT00327717|19620669|P1|Overall Study|Withdrawal by Subject|3
5689395|NCT00327717|19620668|P2|Overall Study|Lack of Efficacy|1
5689396|NCT00327717|19620669|P1|Overall Study|Lack of Efficacy|0
5689397|NCT00327717|19620668|P2|Overall Study|Adverse Event|6
5689398|NCT00327717|19620669|P1|Overall Study|Adverse Event|6
5689399|NCT00327470|19620695|P2|Overall Study|Death|4
5689400|NCT00327470|19620696|P1|Overall Study|Death|1
5689401|NCT00327470|19620695|P2|Overall Study|Withdrawal by Subject|12
5689402|NCT00327470|19620696|P1|Overall Study|Withdrawal by Subject|6
5689403|NCT00327470|19620695|P2|Overall Study|Lost to Follow-up|3
5689404|NCT00327470|19620696|P1|Overall Study|Lost to Follow-up|1
5689405|NCT00327470|19620695|P2|Overall Study|Other|9
5689406|NCT00327470|19620696|P1|Overall Study|Other|5
5689407|NCT00327470|19620695|P2|Overall Study|Lack of Efficacy|19
5689408|NCT00327470|19620696|P1|Overall Study|Lack of Efficacy|7
5689409|NCT00327470|19620695|P2|Overall Study|Adverse Event|14
5689410|NCT00327470|19620696|P1|Overall Study|Adverse Event|9
5689411|NCT00327470|19620695|P2|Overall Study|Randomized, but not treated|2
5689412|NCT00327470|19620696|P1|Overall Study|Randomized, but not treated|0
5689413|NCT00327444|19620716|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
5689414|NCT00327444|19620717|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
5689415|NCT00327444|19620716|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
5689416|NCT00327444|19620717|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
5689417|NCT00327444|19620716|P2|Open Label Treatment (OL) Period|Adverse Event|2
5689418|NCT00327444|19620717|P1|Open Label Treatment (OL) Period|Adverse Event|2
5689419|NCT00327444|19620716|P2|Open Label Treatment (OL) Period|Disease progression|7
5689420|NCT00327444|19620717|P1|Open Label Treatment (OL) Period|Disease progression|8
5689421|NCT00327444|19620716|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
5689422|NCT00327444|19620717|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
5689423|NCT00327444|19620716|P2|Double Blind Treatment (DB) Period|Subject request|1
5689424|NCT00327444|19620717|P1|Double Blind Treatment (DB) Period|Subject request|0
5689425|NCT00327444|19620716|P2|Double Blind Treatment (DB) Period|Adverse Event|5
5689426|NCT00327444|19620717|P1|Double Blind Treatment (DB) Period|Adverse Event|5
5689427|NCT00327444|19620716|P2|Double Blind Treatment (DB) Period|Disease progression|13
5689428|NCT00327444|19620717|P1|Double Blind Treatment (DB) Period|Disease progression|10
5689429|NCT00327340|19620735|P2|Overall Study|Adverse Event|3
5689430|NCT00327340|19620736|P1|Overall Study|Adverse Event|3
5689431|NCT00327340|19620735|P2|Overall Study|Symptomatic Disease|2
5689432|NCT00327340|19620736|P1|Overall Study|Symptomatic Disease|0
5689433|NCT00327340|19620735|P2|Overall Study|Disease Progression|19
5689434|NCT00327340|19620736|P1|Overall Study|Disease Progression|10
5689435|NCT00327340|19620735|P2|Overall Study|Physician Decision|1
5689436|NCT00327340|19620736|P1|Overall Study|Physician Decision|1
5689437|NCT00327340|19620735|P2|Overall Study|Withdrawal by Subject|5
5689438|NCT00327340|19620736|P1|Overall Study|Withdrawal by Subject|1
5689439|NCT00327171|19620750|P2|Overall Study|Other|0
5689440|NCT00327171|19620751|P1|Overall Study|Other|1
5689441|NCT00327171|19620750|P2|Overall Study|Undisclosed history of ischemia|1
5689442|NCT00327171|19620751|P1|Overall Study|Undisclosed history of ischemia|0
5689443|NCT00327171|19620750|P2|Overall Study|Clinical progression|8
5689444|NCT00327171|19620751|P1|Overall Study|Clinical progression|12
5689445|NCT00327171|19620750|P2|Overall Study|Investigator/participant request|8
5689446|NCT00327171|19620751|P1|Overall Study|Investigator/participant request|1
5689447|NCT00327171|19620750|P2|Overall Study|Disease progression/lack of efficacy|69
5689448|NCT00327171|19620751|P1|Overall Study|Disease progression/lack of efficacy|68
5689449|NCT00327171|19620750|P2|Overall Study|Adverse Event|23
5689450|NCT00327171|19620751|P1|Overall Study|Adverse Event|23
5689451|NCT00327171|19620750|P2|Overall Study|Did not receive study medication|0
5689452|NCT00327171|19620751|P1|Overall Study|Did not receive study medication|3
5689453|NCT00327015|19620783|P4|Overall Study|Administrative Reason by Sponsor|1
5689454|NCT00327015|19620784|P3|Overall Study|Administrative Reason by Sponsor|2
5689455|NCT00327015|19620785|P2|Overall Study|Administrative Reason by Sponsor|2
5689456|NCT00327015|19620786|P1|Overall Study|Administrative Reason by Sponsor|1
5689457|NCT00327015|19620783|P4|Overall Study|Pregnancy|1
5689458|NCT00327015|19620784|P3|Overall Study|Pregnancy|1
5689459|NCT00327015|19620785|P2|Overall Study|Pregnancy|2
5689460|NCT00327015|19620786|P1|Overall Study|Pregnancy|0
5689461|NCT00327015|19620783|P4|Overall Study|Death|3
5689462|NCT00327015|19620784|P3|Overall Study|Death|2
5689463|NCT00327015|19620785|P2|Overall Study|Death|2
5689464|NCT00327015|19620786|P1|Overall Study|Death|1
5689465|NCT00327015|19620783|P4|Overall Study|Physician Decision|2
5689466|NCT00327015|19620784|P3|Overall Study|Physician Decision|3
5689467|NCT00327015|19620785|P2|Overall Study|Physician Decision|1
5689468|NCT00327015|19620786|P1|Overall Study|Physician Decision|0
5689469|NCT00327015|19620783|P4|Overall Study|Poor/Noncompliance|5
5689470|NCT00327015|19620784|P3|Overall Study|Poor/Noncompliance|4
5689471|NCT00327015|19620785|P2|Overall Study|Poor/Noncompliance|8
5689472|NCT00327015|19620786|P1|Overall Study|Poor/Noncompliance|11
5689473|NCT00327015|19620783|P4|Overall Study|Subject no longer meets study criteria|7
5689474|NCT00327015|19620784|P3|Overall Study|Subject no longer meets study criteria|8
5689475|NCT00327015|19620785|P2|Overall Study|Subject no longer meets study criteria|2
5689476|NCT00327015|19620786|P1|Overall Study|Subject no longer meets study criteria|4
5689477|NCT00327015|19620783|P4|Overall Study|Adverse Event|14
5689478|NCT00327015|19620784|P3|Overall Study|Adverse Event|14
5689479|NCT00327015|19620785|P2|Overall Study|Adverse Event|10
5689480|NCT00327015|19620786|P1|Overall Study|Adverse Event|14
5689481|NCT00327015|19620783|P4|Overall Study|Lost to Follow-up|22
5689482|NCT00327015|19620784|P3|Overall Study|Lost to Follow-up|29
5689483|NCT00327015|19620785|P2|Overall Study|Lost to Follow-up|23
5689484|NCT00327015|19620786|P1|Overall Study|Lost to Follow-up|22
5689485|NCT00327015|19620783|P4|Overall Study|Withdrawal of Consent by Subject|25
5689486|NCT00327015|19620784|P3|Overall Study|Withdrawal of Consent by Subject|28
5689487|NCT00327015|19620785|P2|Overall Study|Withdrawal of Consent by Subject|24
5689488|NCT00327015|19620786|P1|Overall Study|Withdrawal of Consent by Subject|20
5689489|NCT00327015|19620783|P4|Overall Study|Lack of Efficacy|29
5689490|NCT00327015|19620784|P3|Overall Study|Lack of Efficacy|35
5689491|NCT00327015|19620785|P2|Overall Study|Lack of Efficacy|18
5689492|NCT00327015|19620786|P1|Overall Study|Lack of Efficacy|18
5689493|NCT00326963|19620828|P1|Overall Study|Administrative / other|1
5689494|NCT00326963|19620828|P1|Overall Study|Other protocol violation|1
5689495|NCT00326963|19620828|P1|Overall Study|Violation of selection criteria at entry|2
5689496|NCT00326963|19620828|P1|Overall Study|Refused treatment / did not cooperate|5
5689497|NCT00326963|19620828|P1|Overall Study|Withdrawal by Subject|10
5689498|NCT00326963|19620828|P1|Overall Study|Failure to return|10
5689499|NCT00326963|19620828|P1|Overall Study|Death|1
5689500|NCT00326963|19620828|P1|Overall Study|Injection site reaction|1
5689501|NCT00326963|19620828|P1|Overall Study|Adverse Event|2
5689502|NCT00326950|19620848|P1|Overall Study|Progressive Disease|1
5689503|NCT00326911|19620870|P2|Overall Study|Withdrawal by subject prior to treatment|1
5689504|NCT00326911|19620871|P1|Overall Study|Withdrawal by subject prior to treatment|0
5689505|NCT00326911|19620870|P2|Overall Study|Physician decision prior to treatment|0
5689506|NCT00326911|19620871|P1|Overall Study|Physician decision prior to treatment|1
5689507|NCT00326911|19620870|P2|Overall Study|Hospitalization prior to treatment|1
5689508|NCT00326911|19620871|P1|Overall Study|Hospitalization prior to treatment|0
5689509|NCT00326898|19620924|P3|Overall Study|Other/Missing/Unknown|32
5689510|NCT00326898|19620925|P2|Overall Study|Other/Missing/Unknown|28
5689511|NCT00326898|19620926|P1|Overall Study|Other/Missing/Unknown|33
5689512|NCT00326898|19620924|P3|Overall Study|Other complicating disease|4
5689513|NCT00326898|19620925|P2|Overall Study|Other complicating disease|5
5689514|NCT00326898|19620926|P1|Overall Study|Other complicating disease|5
5689515|NCT00326898|19620924|P3|Overall Study|Alternative therapy|0
5689516|NCT00326898|19620925|P2|Overall Study|Alternative therapy|0
5689517|NCT00326898|19620926|P1|Overall Study|Alternative therapy|1
5689518|NCT00326898|19620924|P3|Overall Study|Withdrawal by Subject|32
5689519|NCT00326898|19620925|P2|Overall Study|Withdrawal by Subject|128
5689520|NCT00326898|19620926|P1|Overall Study|Withdrawal by Subject|134
5689521|NCT00326898|19620924|P3|Overall Study|Death|0
5689522|NCT00326898|19620925|P2|Overall Study|Death|0
5689523|NCT00326898|19620926|P1|Overall Study|Death|2
5689524|NCT00326898|19620924|P3|Overall Study|Adverse Event|33
5689525|NCT00326898|19620925|P2|Overall Study|Adverse Event|128
5689526|NCT00326898|19620926|P1|Overall Study|Adverse Event|124
5689527|NCT00326898|19620924|P3|Overall Study|Disease progression|102
5689528|NCT00326898|19620925|P2|Overall Study|Disease progression|54
5689529|NCT00326898|19620926|P1|Overall Study|Disease progression|52
5689530|NCT00326885|19620943|P1|Overall Study|Hospice withdrew consent|2
5689531|NCT00326885|19620943|P1|Overall Study|Physician Decision|1
5689532|NCT00326885|19620943|P1|Overall Study|Withdrawal by Subject|3
5689533|NCT00326885|19620943|P1|Overall Study|Adverse Event|1
5689534|NCT00326716|19620974|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
5689535|NCT00326716|19620975|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
5689536|NCT00326716|19620976|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
5689537|NCT00326716|19620977|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
5689538|NCT00326612|19621049|P2|Overall Study|They did not have a seizure requiring tx|137
5689539|NCT00326612|19621050|P1|Overall Study|They did not have a seizure requiring tx|129
5689540|NCT00326599|19621072|P4|Overall Study|Other Unspecified Reason|1
5689541|NCT00326599|19621073|P3|Overall Study|Other Unspecified Reason|2
5689542|NCT00326599|19621074|P2|Overall Study|Other Unspecified Reason|0
5689543|NCT00326599|19621075|P1|Overall Study|Other Unspecified Reason|0
5689544|NCT00326599|19621072|P4|Overall Study|Death|2
5689545|NCT00326599|19621073|P3|Overall Study|Death|1
5689546|NCT00326599|19621074|P2|Overall Study|Death|0
5689547|NCT00326599|19621075|P1|Overall Study|Death|0
5689548|NCT00326599|19621072|P4|Overall Study|Alternate Treatment|0
5689549|NCT00326599|19621073|P3|Overall Study|Alternate Treatment|0
5689550|NCT00326599|19621074|P2|Overall Study|Alternate Treatment|0
5689551|NCT00326599|19621075|P1|Overall Study|Alternate Treatment|1
5689552|NCT00326599|19621072|P4|Overall Study|Disease Progression|11
5689553|NCT00326599|19621073|P3|Overall Study|Disease Progression|13
5689554|NCT00326599|19621074|P2|Overall Study|Disease Progression|1
5689555|NCT00326599|19621075|P1|Overall Study|Disease Progression|3
5689556|NCT00326599|19621072|P4|Overall Study|Adverse Event|3
5689557|NCT00326599|19621073|P3|Overall Study|Adverse Event|32
5689558|NCT00326599|19621074|P2|Overall Study|Adverse Event|0
5689559|NCT00326599|19621075|P1|Overall Study|Adverse Event|1
5689560|NCT00326599|19621072|P4|Overall Study|Withdrawal by Subject|2
5689561|NCT00326599|19621073|P3|Overall Study|Withdrawal by Subject|5
5689562|NCT00326599|19621074|P2|Overall Study|Withdrawal by Subject|0
5689563|NCT00326599|19621075|P1|Overall Study|Withdrawal by Subject|1
5689564|NCT00326495|19621094|P1|Overall Study|Subject off study before assessment|1
5689565|NCT00326495|19621094|P1|Overall Study|Refused further treatment|2
5689566|NCT00326495|19621094|P1|Overall Study|Disease progression before treatment|1
5689567|NCT00326495|19621094|P1|Overall Study|Switched to alternative treatment|1
5689568|NCT00326417|19621101|P4|Overall Study|Death|0
5689569|NCT00326417|19621102|P3|Overall Study|Death|0
5689570|NCT00326417|19621103|P2|Overall Study|Death|0
5689571|NCT00326417|19621104|P1|Overall Study|Death|7
5689572|NCT00326417|19621101|P4|Overall Study|Arm Closed|3
5689573|NCT00326417|19621102|P3|Overall Study|Arm Closed|0
5689574|NCT00326417|19621103|P2|Overall Study|Arm Closed|0
5689575|NCT00326417|19621104|P1|Overall Study|Arm Closed|7
5689576|NCT00326417|19621101|P4|Overall Study|Withdrawal by Subject|0
5689577|NCT00326417|19621102|P3|Overall Study|Withdrawal by Subject|1
5689578|NCT00326417|19621103|P2|Overall Study|Withdrawal by Subject|0
5689579|NCT00326417|19621104|P1|Overall Study|Withdrawal by Subject|0
5689580|NCT00326209|19621120|P1|Overall Study|Pregnancy|1
5689581|NCT00326209|19621120|P1|Overall Study|Withdrawn in error|1
5689582|NCT00326209|19621120|P1|Overall Study|Violation of entry criteria|1
5689583|NCT00326209|19621120|P1|Overall Study|Prohibited medication use|1
5689584|NCT00326209|19621120|P1|Overall Study|Sponsor closed study|173
5689585|NCT00326209|19621120|P1|Overall Study|Participant non-compliant|6
5689586|NCT00326209|19621120|P1|Overall Study|Lost to Follow-up|18
5689587|NCT00326209|19621120|P1|Overall Study|Lack of Efficacy|31
5689588|NCT00326209|19621120|P1|Overall Study|Withdrawal by Subject|22
5689589|NCT00326209|19621120|P1|Overall Study|Adverse Event|28
5689590|NCT00326183|19621138|P2|Overall Study|Adverse Event|0
5689591|NCT00326183|19621139|P1|Overall Study|Adverse Event|1
5689592|NCT00326183|19621138|P2|Overall Study|Other|13
5689593|NCT00326183|19621139|P1|Overall Study|Other|47
5689594|NCT00326183|19621138|P2|Overall Study|Subject Moved|4
5689595|NCT00326183|19621139|P1|Overall Study|Subject Moved|7
5689596|NCT00326183|19621138|P2|Overall Study|Withdrawal by Subject|7
5689597|NCT00326183|19621139|P1|Overall Study|Withdrawal by Subject|35
5689598|NCT00326183|19621138|P2|Overall Study|Protocol Violation|3
5689599|NCT00326183|19621139|P1|Overall Study|Protocol Violation|6
5689600|NCT00326183|19621138|P2|Overall Study|Lost to Follow-up|56
5689601|NCT00326183|19621139|P1|Overall Study|Lost to Follow-up|104
5689602|NCT00326118|19621171|P2|Active Phase|Withdrawal by Subject|1
5689603|NCT00326118|19621172|P1|Active Phase|Withdrawal by Subject|4
5689604|NCT00326001|19621208|P2|Overall Study|Physician Decision|3
5689605|NCT00326001|19621209|P1|Overall Study|Physician Decision|3
5689606|NCT00326001|19621208|P2|Overall Study|Adverse Event|5
5689607|NCT00326001|19621209|P1|Overall Study|Adverse Event|4
5689608|NCT00325897|19621223|P2|Overall Study|Lost to Follow-up|13
5689609|NCT00325897|19621224|P1|Overall Study|Lost to Follow-up|12
5689610|NCT00325819|19621244|P2|Overall Study|Lost to Follow-up|3
5689611|NCT00325819|19621245|P1|Overall Study|Lost to Follow-up|3
5689612|NCT00325819|19621244|P2|Overall Study|Did not take a dose of study product|9
5689613|NCT00325819|19621245|P1|Overall Study|Did not take a dose of study product|4
5689614|NCT00325819|19621244|P2|Overall Study|Study product lost in mail|1
5689615|NCT00325819|19621245|P1|Overall Study|Study product lost in mail|2
5689616|NCT00325754|19621272|P2|Overall Study|Adverse Event|1
5689617|NCT00325754|19621273|P1|Overall Study|Adverse Event|4
5689618|NCT00325468|19621328|P5|Overall Study|site closure etc|1
5689619|NCT00325468|19621329|P4|Overall Study|site closure etc|8
5689620|NCT00325468|19621330|P3|Overall Study|site closure etc|1
5689621|NCT00325468|19621331|P2|Overall Study|site closure etc|2
5689622|NCT00325468|19621332|P1|Overall Study|site closure etc|4
5689623|NCT00325468|19621328|P5|Overall Study|Withdrawal by Subject|4
5689624|NCT00325468|19621329|P4|Overall Study|Withdrawal by Subject|14
5689625|NCT00325468|19621330|P3|Overall Study|Withdrawal by Subject|0
5689626|NCT00325468|19621331|P2|Overall Study|Withdrawal by Subject|1
5689627|NCT00325468|19621332|P1|Overall Study|Withdrawal by Subject|3
5689628|NCT00325468|19621328|P5|Overall Study|Physician Decision|0
5689629|NCT00325468|19621329|P4|Overall Study|Physician Decision|1
5689630|NCT00325468|19621330|P3|Overall Study|Physician Decision|0
5689631|NCT00325468|19621331|P2|Overall Study|Physician Decision|1
5689632|NCT00325468|19621332|P1|Overall Study|Physician Decision|1
5689633|NCT00325468|19621328|P5|Overall Study|Lost to Follow-up|2
5689634|NCT00325468|19621329|P4|Overall Study|Lost to Follow-up|2
5689635|NCT00325468|19621330|P3|Overall Study|Lost to Follow-up|1
5689636|NCT00325468|19621331|P2|Overall Study|Lost to Follow-up|0
5689637|NCT00325468|19621332|P1|Overall Study|Lost to Follow-up|0
5689638|NCT00325468|19621328|P5|Overall Study|Death|0
5689639|NCT00325468|19621329|P4|Overall Study|Death|4
5689640|NCT00325468|19621330|P3|Overall Study|Death|2
5689641|NCT00325468|19621331|P2|Overall Study|Death|0
5689642|NCT00325468|19621332|P1|Overall Study|Death|2
5689643|NCT00325468|19621328|P5|Overall Study|Adverse Event|1
5689644|NCT00325468|19621329|P4|Overall Study|Adverse Event|5
5689645|NCT00325468|19621330|P3|Overall Study|Adverse Event|0
5689646|NCT00325468|19621331|P2|Overall Study|Adverse Event|1
5689647|NCT00325468|19621332|P1|Overall Study|Adverse Event|1
5689648|NCT00325416|19621415|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
5689649|NCT00325416|19621416|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
5689650|NCT00325416|19621415|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
5689651|NCT00325416|19621416|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
5689652|NCT00325416|19621415|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
5689653|NCT00325416|19621416|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
5689654|NCT00325416|19621415|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
5689655|NCT00325416|19621416|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
5689656|NCT00325416|19621415|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
5689657|NCT00325416|19621416|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
5689658|NCT00325416|19621415|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
5689659|NCT00325416|19621416|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
5689660|NCT00325234|19621469|P2|Overall Study|Progressive Disease|37
5689661|NCT00325234|19621470|P1|Overall Study|Progressive Disease|34
5689662|NCT00325234|19621469|P2|Overall Study|Physician Decision|12
5689663|NCT00325234|19621470|P1|Overall Study|Physician Decision|17
5689664|NCT00325234|19621469|P2|Overall Study|Subject Decision|8
5689665|NCT00325234|19621470|P1|Overall Study|Subject Decision|6
5689666|NCT00325234|19621469|P2|Overall Study|Entry Criteria Not Met|2
5689667|NCT00325234|19621470|P1|Overall Study|Entry Criteria Not Met|1
5689668|NCT00325234|19621469|P2|Overall Study|Death due to Study Disease|0
5689669|NCT00325234|19621470|P1|Overall Study|Death due to Study Disease|1
5689670|NCT00325234|19621469|P2|Overall Study|Adverse Event|7
5689671|NCT00325234|19621470|P1|Overall Study|Adverse Event|10
5689672|NCT00325195|19621489|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
5689673|NCT00325195|19621490|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
5689674|NCT00325195|19621491|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
5689675|NCT00325195|19621489|P3|Received Intervention: ITT Population|Lost to Follow-up|2
5689676|NCT00325195|19621490|P2|Received Intervention: ITT Population|Lost to Follow-up|0
5689677|NCT00325195|19621491|P1|Received Intervention: ITT Population|Lost to Follow-up|0
5689678|NCT00325195|19621489|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
5689679|NCT00325195|19621490|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
5689680|NCT00325195|19621491|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
5689681|NCT00325195|19621489|P3|Received Intervention: ITT Population|Death|0
5689682|NCT00325195|19621490|P2|Received Intervention: ITT Population|Death|1
5689683|NCT00325195|19621491|P1|Received Intervention: ITT Population|Death|3
5689684|NCT00325195|19621489|P3|Received Intervention: ITT Population|Adverse Event|1
5689685|NCT00325195|19621490|P2|Received Intervention: ITT Population|Adverse Event|17
5689686|NCT00325195|19621491|P1|Received Intervention: ITT Population|Adverse Event|15
5689687|NCT00325195|19621489|P3|Randomized|Not dosed|3
5689688|NCT00325195|19621490|P2|Randomized|Not dosed|5
5689689|NCT00325195|19621491|P1|Randomized|Not dosed|5
5689690|NCT00325156|19621514|P1|Overall Study|Withdrawal by Subject|31
5689691|NCT00325156|19621514|P1|Overall Study|Other|1
5689692|NCT00325156|19621514|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
5689693|NCT00325156|19621514|P1|Overall Study|Adverse event, non-fatal|3
5689694|NCT00325156|19621514|P1|Overall Study|Migrated/moved from study area|12
5689695|NCT00325156|19621514|P1|Overall Study|Lost to follow-up (complete vaccination)|41
5689696|NCT00325156|19621514|P1|Overall Study|Protocol Violation|8
5689697|NCT00325143|19621521|P1|Overall Study|Withdrawal by Subject|8
5689698|NCT00325143|19621521|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
5689699|NCT00325143|19621521|P1|Overall Study|Migrated/moved from study area|1
5689700|NCT00325143|19621521|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
5689701|NCT00325130|19621531|P2|Overall Study|Patient Discontinued for Other|0
5689702|NCT00325130|19621532|P1|Overall Study|Patient Discontinued for Other|1
5689703|NCT00325130|19621531|P2|Overall Study|Moved|1
5689704|NCT00325130|19621532|P1|Overall Study|Moved|0
5689705|NCT00325130|19621531|P2|Overall Study|Protocol Deviation|1
5689706|NCT00325130|19621532|P1|Overall Study|Protocol Deviation|0
5689707|NCT00325130|19621531|P2|Overall Study|Withdrawal by Subject|14
5689708|NCT00325130|19621532|P1|Overall Study|Withdrawal by Subject|12
5689709|NCT00325130|19621531|P2|Overall Study|Lost to Follow-up|14
5689710|NCT00325130|19621532|P1|Overall Study|Lost to Follow-up|6
5689711|NCT00325039|19621589|P2|Overall Study|Lost to Follow-up|14
5689712|NCT00325039|19621590|P1|Overall Study|Lost to Follow-up|18
5689713|NCT00324987|19621606|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
5689714|NCT00324987|19621607|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
5689715|NCT00324987|19621606|P2|Overall Study|Progression|1
5689716|NCT00324987|19621607|P1|Overall Study|Progression|1
5689717|NCT00324987|19621606|P2|Overall Study|Withdrawal by Subject|1
5689718|NCT00324987|19621607|P1|Overall Study|Withdrawal by Subject|1
5689719|NCT00324987|19621606|P2|Overall Study|Adverse Event|1
5689720|NCT00324987|19621607|P1|Overall Study|Adverse Event|2
5689721|NCT00324961|19621621|P1|Overall Study|Other|2
5689722|NCT00324961|19621621|P1|Overall Study|Protocol Violation|3
5689723|NCT00324961|19621621|P1|Overall Study|Lost to Follow-up|22
5689724|NCT00324961|19621621|P1|Overall Study|Consent Withdrawn|11
5689725|NCT00324961|19621621|P1|Overall Study|Adverse Event|5
5689726|NCT00324805|19621672|P2|Overall Study|Did not start therapy|17
5689727|NCT00324805|19621673|P1|Overall Study|Did not start therapy|12
5689728|NCT00324805|19621672|P2|Overall Study|Other|2
5689729|NCT00324805|19621673|P1|Overall Study|Other|0
5689730|NCT00324805|19621672|P2|Overall Study|Other reasons|26
5689731|NCT00324805|19621673|P1|Overall Study|Other reasons|7
5689732|NCT00324805|19621672|P2|Overall Study|Other complicating disease|9
5689733|NCT00324805|19621673|P1|Overall Study|Other complicating disease|1
5689734|NCT00324805|19621672|P2|Overall Study|Alternative therapy|8
5689735|NCT00324805|19621673|P1|Overall Study|Alternative therapy|4
5689736|NCT00324805|19621672|P2|Overall Study|Death|9
5689737|NCT00324805|19621673|P1|Overall Study|Death|6
5689738|NCT00324805|19621672|P2|Overall Study|Withdrawal by Subject|174
5689739|NCT00324805|19621673|P1|Overall Study|Withdrawal by Subject|51
5689740|NCT00324805|19621672|P2|Overall Study|Progression|35
5689741|NCT00324805|19621673|P1|Overall Study|Progression|7
5689742|NCT00324805|19621672|P2|Overall Study|Adverse Event|203
5689743|NCT00324805|19621673|P1|Overall Study|Adverse Event|62
5689744|NCT00324740|19621698|P3|Overall Study|Withdrawal by Subject|1
5689745|NCT00324740|19621699|P2|Overall Study|Withdrawal by Subject|0
5689746|NCT00324740|19621700|P1|Overall Study|Withdrawal by Subject|1
5689747|NCT00324675|19621720|P2|Overall Study|Adverse Event|0
5689748|NCT00324675|19621721|P1|Overall Study|Adverse Event|1
5689749|NCT00324649|19621729|P2|Overall Study|Noncompliance|0
5689750|NCT00324649|19621730|P1|Overall Study|Noncompliance|1
5689751|NCT00324649|19621729|P2|Overall Study|Withdrawal by Subject|1
5689752|NCT00324649|19621730|P1|Overall Study|Withdrawal by Subject|0
5689753|NCT00324649|19621729|P2|Overall Study|Adverse Event|4
5689754|NCT00324649|19621730|P1|Overall Study|Adverse Event|1
5689755|NCT00324233|19621861|P2|Second Period|Protocol Violation|6
5689756|NCT00324233|19621862|P1|Second Period|Protocol Violation|4
5689757|NCT00324233|19621861|P2|Second Period|unable to insert catheter|1
5689758|NCT00324233|19621862|P1|Second Period|unable to insert catheter|1
5689759|NCT00324233|19621861|P2|First Period|unable to insert catheter|0
5689760|NCT00324233|19621862|P1|First Period|unable to insert catheter|1
5689761|NCT00324168|19621870|P2|Overall Study|Patient did not visit in f/u window|9
5689762|NCT00324168|19621871|P1|Overall Study|Patient did not visit in f/u window|6
5689763|NCT00324168|19621870|P2|Overall Study|Death|3
5689764|NCT00324168|19621871|P1|Overall Study|Death|3
5689765|NCT00324168|19621870|P2|Overall Study|Lost to Follow-up|18
5689766|NCT00324168|19621871|P1|Overall Study|Lost to Follow-up|19
5689767|NCT00324155|19621899|P2|Follow-up Phase|On-going participants still on drug|6
5689768|NCT00324155|19621900|P1|Follow-up Phase|On-going participants still on drug|11
5689769|NCT00324155|19621899|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
5689770|NCT00324155|19621900|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
5689771|NCT00324155|19621899|P2|Received Treatment in Maintenance Phase|Adverse Event|3
5689772|NCT00324155|19621900|P1|Received Treatment in Maintenance Phase|Adverse Event|0
5689773|NCT00324155|19621899|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
5689774|NCT00324155|19621900|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
5689775|NCT00324155|19621899|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
5689776|NCT00324155|19621900|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
5689777|NCT00324155|19621899|P2|Received Treatment in Maintenance Phase|Disease Progression|41
5689778|NCT00324155|19621900|P1|Received Treatment in Maintenance Phase|Disease Progression|26
5689779|NCT00324155|19621899|P2|Received Treatment in Induction Phase|Physician Decision|0
5689780|NCT00324155|19621900|P1|Received Treatment in Induction Phase|Physician Decision|2
5689781|NCT00324155|19621899|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
5689782|NCT00324155|19621900|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
5689783|NCT00324155|19621899|P2|Received Treatment in Induction Phase|Adverse Event|7
5689784|NCT00324155|19621900|P1|Received Treatment in Induction Phase|Adverse Event|6
5689785|NCT00324155|19621899|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
5689786|NCT00324155|19621900|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
5689787|NCT00324155|19621899|P2|Received Treatment in Induction Phase|Death|15
5689788|NCT00324155|19621900|P1|Received Treatment in Induction Phase|Death|8
5689789|NCT00324155|19621899|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
5689790|NCT00324155|19621900|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
5689791|NCT00324155|19621899|P2|Received Treatment in Induction Phase|Disease Progression|152
5689792|NCT00324155|19621900|P1|Received Treatment in Induction Phase|Disease Progression|88
5689793|NCT00324155|19621899|P2|Enrolled and Randomized|Lost to Follow-up|1
5689794|NCT00324155|19621900|P1|Enrolled and Randomized|Lost to Follow-up|0
5689795|NCT00324155|19621899|P2|Enrolled and Randomized|No longer met study criteria|0
5689796|NCT00324155|19621900|P1|Enrolled and Randomized|No longer met study criteria|3
5689797|NCT00324116|19621930|P1|Overall Study|Other|5
5689798|NCT00324116|19621930|P1|Overall Study|Withdrawal by Subject|5
5689799|NCT00324116|19621930|P1|Overall Study|Lack of Efficacy|17
5689800|NCT00324116|19621930|P1|Overall Study|Adverse Event|5
5689801|NCT00324038|19621942|P2|Overall Study|Other|13
5689802|NCT00324038|19621943|P1|Overall Study|Other|6
5689803|NCT00324038|19621942|P2|Overall Study|Lost to Follow-up|2
5689804|NCT00324038|19621943|P1|Overall Study|Lost to Follow-up|0
5689805|NCT00324038|19621942|P2|Overall Study|Lack of Efficacy|13
5689806|NCT00324038|19621943|P1|Overall Study|Lack of Efficacy|5
5689807|NCT00324038|19621942|P2|Overall Study|Adverse Event|23
5689808|NCT00324038|19621943|P1|Overall Study|Adverse Event|38
5689809|NCT00323882|19621954|P5|Overall Study|Other|1
5689810|NCT00323882|19621955|P4|Overall Study|Other|1
5689811|NCT00323882|19621956|P3|Overall Study|Other|0
5689812|NCT00323882|19621957|P2|Overall Study|Other|0
5689813|NCT00323882|19621958|P1|Overall Study|Other|0
5689814|NCT00323882|19621954|P5|Overall Study|Lost to Follow-up|1
5689815|NCT00323882|19621955|P4|Overall Study|Lost to Follow-up|0
5689816|NCT00323882|19621956|P3|Overall Study|Lost to Follow-up|1
5689817|NCT00323882|19621957|P2|Overall Study|Lost to Follow-up|0
5689818|NCT00323882|19621958|P1|Overall Study|Lost to Follow-up|0
5689819|NCT00323882|19621954|P5|Overall Study|Death|5
5689820|NCT00323882|19621955|P4|Overall Study|Death|0
5689821|NCT00323882|19621956|P3|Overall Study|Death|1
5689822|NCT00323882|19621957|P2|Overall Study|Death|1
5689823|NCT00323882|19621958|P1|Overall Study|Death|0
5689824|NCT00323882|19621954|P5|Overall Study|Disease Progression|22
5689825|NCT00323882|19621955|P4|Overall Study|Disease Progression|5
5689826|NCT00323882|19621956|P3|Overall Study|Disease Progression|10
5689827|NCT00323882|19621957|P2|Overall Study|Disease Progression|4
5689828|NCT00323882|19621958|P1|Overall Study|Disease Progression|6
5689829|NCT00323882|19621954|P5|Overall Study|Adverse Event|3
5689830|NCT00323882|19621955|P4|Overall Study|Adverse Event|1
5689831|NCT00323882|19621956|P3|Overall Study|Adverse Event|1
5689832|NCT00323882|19621957|P2|Overall Study|Adverse Event|1
5689833|NCT00323882|19621958|P1|Overall Study|Adverse Event|2
5689834|NCT00323869|19622029|P1|Overall Study|Death|1
5689835|NCT00323622|19622085|P8|Overall Study|Death|2
5689836|NCT00323622|19622086|P7|Overall Study|Death|0
5689837|NCT00323622|19622087|P6|Overall Study|Death|0
5689838|NCT00323622|19622088|P5|Overall Study|Death|7
5689839|NCT00323622|19622089|P4|Overall Study|Death|0
5689840|NCT00323622|19622090|P3|Overall Study|Death|0
5689841|NCT00323622|19622091|P2|Overall Study|Death|1
5689842|NCT00323622|19622092|P1|Overall Study|Death|1
5689843|NCT00323622|19622085|P8|Overall Study|Other|13
5689844|NCT00323622|19622086|P7|Overall Study|Other|5
5689845|NCT00323622|19622087|P6|Overall Study|Other|74
5689846|NCT00323622|19622088|P5|Overall Study|Other|32
5689847|NCT00323622|19622089|P4|Overall Study|Other|12
5689848|NCT00323622|19622090|P3|Overall Study|Other|4
5689849|NCT00323622|19622091|P2|Overall Study|Other|91
5689850|NCT00323622|19622092|P1|Overall Study|Other|30
5689851|NCT00323609|19622134|P4|Overall Study|Other reason|9
5689852|NCT00323609|19622135|P3|Overall Study|Other reason|4
5689853|NCT00323609|19622136|P2|Overall Study|Other reason|8
5689854|NCT00323609|19622137|P1|Overall Study|Other reason|11
5689855|NCT00323609|19622134|P4|Overall Study|Logistical withdrawal|1
5689856|NCT00323609|19622135|P3|Overall Study|Logistical withdrawal|0
5689857|NCT00323609|19622136|P2|Overall Study|Logistical withdrawal|5
5689858|NCT00323609|19622137|P1|Overall Study|Logistical withdrawal|9
5689859|NCT00323609|19622134|P4|Overall Study|Unrelenting or severe back pain|0
5689860|NCT00323609|19622135|P3|Overall Study|Unrelenting or severe back pain|0
5689861|NCT00323609|19622136|P2|Overall Study|Unrelenting or severe back pain|1
5689862|NCT00323609|19622137|P1|Overall Study|Unrelenting or severe back pain|1
5689863|NCT00323609|19622134|P4|Overall Study|Sponsor discontinued trial|0
5689864|NCT00323609|19622135|P3|Overall Study|Sponsor discontinued trial|0
5689865|NCT00323609|19622136|P2|Overall Study|Sponsor discontinued trial|29
5689866|NCT00323609|19622137|P1|Overall Study|Sponsor discontinued trial|29
5689867|NCT00323609|19622134|P4|Overall Study|Other non-VCF-related medical condition|0
5689868|NCT00323609|19622135|P3|Overall Study|Other non-VCF-related medical condition|0
5689869|NCT00323609|19622136|P2|Overall Study|Other non-VCF-related medical condition|2
5689870|NCT00323609|19622137|P1|Overall Study|Other non-VCF-related medical condition|3
5689871|NCT00323609|19622134|P4|Overall Study|Withdrawal by Subject|4
5689872|NCT00323609|19622135|P3|Overall Study|Withdrawal by Subject|4
5689873|NCT00323609|19622136|P2|Overall Study|Withdrawal by Subject|23
5689874|NCT00323609|19622137|P1|Overall Study|Withdrawal by Subject|11
5689875|NCT00323609|19622134|P4|Overall Study|Physician Decision|1
5689876|NCT00323609|19622135|P3|Overall Study|Physician Decision|0
5689877|NCT00323609|19622136|P2|Overall Study|Physician Decision|0
5689878|NCT00323609|19622137|P1|Overall Study|Physician Decision|2
5689879|NCT00323609|19622134|P4|Overall Study|Lost to Follow-up|0
5689880|NCT00323609|19622135|P3|Overall Study|Lost to Follow-up|0
5689881|NCT00323609|19622136|P2|Overall Study|Lost to Follow-up|10
5689882|NCT00323609|19622137|P1|Overall Study|Lost to Follow-up|9
5689883|NCT00323609|19622134|P4|Overall Study|Death|0
5689884|NCT00323609|19622135|P3|Overall Study|Death|0
5689885|NCT00323609|19622136|P2|Overall Study|Death|21
5689886|NCT00323609|19622137|P1|Overall Study|Death|16
5689887|NCT00323557|19622173|P2|Overall Study|Physician Decision|0
5689888|NCT00323557|19622174|P1|Overall Study|Physician Decision|1
5689889|NCT00323492|19622183|P3|Study Phase 2|Protocol Violation|0
5689890|NCT00323492|19622184|P2|Study Phase 2|Protocol Violation|0
5689891|NCT00323492|19622185|P1|Study Phase 2|Protocol Violation|1
5689892|NCT00323492|19622183|P3|Study Phase 2|Noncompliance with study schedule|1
5689893|NCT00323492|19622184|P2|Study Phase 2|Noncompliance with study schedule|0
5689894|NCT00323492|19622185|P1|Study Phase 2|Noncompliance with study schedule|0
5689895|NCT00323492|19622183|P3|Study Phase 2|Withdrawal by Subject|0
5689896|NCT00323492|19622184|P2|Study Phase 2|Withdrawal by Subject|1
5689897|NCT00323492|19622185|P1|Study Phase 2|Withdrawal by Subject|0
5689898|NCT00323492|19622183|P3|Study Phase 2|Lost to Follow-up|0
5689899|NCT00323492|19622184|P2|Study Phase 2|Lost to Follow-up|0
5689900|NCT00323492|19622185|P1|Study Phase 2|Lost to Follow-up|1
5689901|NCT00323492|19622183|P3|Study Phase 2|Physician Decision|0
5689902|NCT00323492|19622184|P2|Study Phase 2|Physician Decision|0
5689903|NCT00323492|19622185|P1|Study Phase 2|Physician Decision|1
5689904|NCT00323492|19622183|P3|Study Phase 2|Adverse Event|0
5689905|NCT00323492|19622184|P2|Study Phase 2|Adverse Event|0
5689906|NCT00323492|19622185|P1|Study Phase 2|Adverse Event|1
5689907|NCT00323492|19622183|P3|Study Phase 1|Adverse Event|0
5689908|NCT00323492|19622184|P2|Study Phase 1|Adverse Event|0
5689909|NCT00323492|19622185|P1|Study Phase 1|Adverse Event|2
5689910|NCT00323479|19622216|P1|Overall Study|house moving|1
5689911|NCT00323479|19622216|P1|Overall Study|Protocol Violation|3
5689912|NCT00323479|19622216|P1|Overall Study|Withdrawal by Subject|2
5689913|NCT00323479|19622216|P1|Overall Study|Adverse Event|2
5689914|NCT00323414|19622249|P2|Overall Study|Withdrawal by Subject|1
5689915|NCT00323414|19622250|P1|Overall Study|Withdrawal by Subject|0
5689916|NCT00323310|19622272|P1|Overall Study|did not complete the 24-hr f-up visit|1
5689917|NCT00323310|19622272|P1|Overall Study|a parent refused blood draw|1
5689918|NCT00323310|19622272|P1|Overall Study|Withdrawal by Subject|1
5689919|NCT00323297|19622287|P2|Part B (Open-label)|Protocol Violation|1
5689920|NCT00323297|19622288|P1|Part B (Open-label)|Protocol Violation|0
5689921|NCT00323297|19622287|P2|Part B (Open-label)|Adverse Event|5
5689922|NCT00323297|19622288|P1|Part B (Open-label)|Adverse Event|5
5689923|NCT00323297|19622287|P2|Part B (Open-label)|Lack of Efficacy|1
5689924|NCT00323297|19622288|P1|Part B (Open-label)|Lack of Efficacy|3
5689925|NCT00323297|19622287|P2|Part B (Open-label)|Withdrawal by Subject|3
5689926|NCT00323297|19622288|P1|Part B (Open-label)|Withdrawal by Subject|1
5689927|NCT00323297|19622287|P2|Part B (Open-label)|Reason unspecified|1
5689928|NCT00323297|19622288|P1|Part B (Open-label)|Reason unspecified|0
5689929|NCT00323297|19622287|P2|Part B (Open-label)|Death|1
5689930|NCT00323297|19622288|P1|Part B (Open-label)|Death|0
5689931|NCT00323297|19622287|P2|Part A (Double Blind Randomized)|Related adverse event|2
5689932|NCT00323297|19622288|P1|Part A (Double Blind Randomized)|Related adverse event|2
5689933|NCT00323297|19622287|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
5689934|NCT00323297|19622288|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
5689935|NCT00323297|19622287|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
5689936|NCT00323297|19622288|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
5689937|NCT00323297|19622287|P2|Part A (Double Blind Randomized)|Protocol Violation|3
5689938|NCT00323297|19622288|P1|Part A (Double Blind Randomized)|Protocol Violation|1
5689939|NCT00323297|19622287|P2|Part A (Double Blind Randomized)|Death|1
5689940|NCT00323297|19622288|P1|Part A (Double Blind Randomized)|Death|0
5689941|NCT00323297|19622287|P2|Part A (Double Blind Randomized)|Reason unspecified|1
5689942|NCT00323297|19622288|P1|Part A (Double Blind Randomized)|Reason unspecified|0
5689943|NCT00323258|19622328|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
5689944|NCT00323258|19622329|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
5689945|NCT00323258|19622328|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
5689946|NCT00323258|19622329|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
5689947|NCT00323258|19622328|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
5689948|NCT00323258|19622329|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
5689949|NCT00323258|19622328|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
5689950|NCT00323258|19622329|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
5689951|NCT00323258|19622328|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
5689952|NCT00323258|19622329|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
5689953|NCT00323258|19622328|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
5689954|NCT00323258|19622329|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
5689955|NCT00323258|19622328|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
5689956|NCT00323258|19622329|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
5689957|NCT00323115|19622354|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
5689958|NCT00323115|19622354|P1|Vaccine Administration|Adverse Event|1
5689959|NCT00323063|19622381|P2|Overall Study|brain mets discovered prior to treatment|0
5689960|NCT00323063|19622382|P1|Overall Study|brain mets discovered prior to treatment|1
5689961|NCT00323063|19622381|P2|Overall Study|Adverse Event|0
5689962|NCT00323063|19622382|P1|Overall Study|Adverse Event|1
5689963|NCT00322881|19622399|P1|Overall Study|Disease Progression|2
5689964|NCT00322881|19622399|P1|Overall Study|Adverse Event|1
5689965|NCT00322881|19622399|P1|Overall Study|Death|2
5689966|NCT00322868|19622403|P1|Overall Study|disease progression|1
5689967|NCT00322842|19622428|P2|Overall Study|Death|0
5689968|NCT00322842|19622429|P1|Overall Study|Death|1
5689969|NCT00322842|19622428|P2|Overall Study|Refused transplant|0
5689970|NCT00322842|19622429|P1|Overall Study|Refused transplant|1
5689971|NCT00322842|19622428|P2|Overall Study|Lost to Follow-up|1
5689972|NCT00322842|19622429|P1|Overall Study|Lost to Follow-up|0
5689973|NCT00322842|19622428|P2|Overall Study|Withdrawal by Subject|1
5689974|NCT00322842|19622429|P1|Overall Study|Withdrawal by Subject|0
5689975|NCT00322712|19622467|P1|Overall Study|treated with bevacizumab not cetuximab|1
5689976|NCT00322621|19622471|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
5689977|NCT00322621|19622472|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
5689978|NCT00322621|19622473|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
5689979|NCT00322621|19622471|P3|Period III - Maintenance / Rescue Phase|Death|0
5689980|NCT00322621|19622472|P2|Period III - Maintenance / Rescue Phase|Death|1
5689981|NCT00322621|19622473|P1|Period III - Maintenance / Rescue Phase|Death|0
5689982|NCT00322621|19622471|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
5689983|NCT00322621|19622472|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
5689984|NCT00322621|19622473|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
5689985|NCT00322621|19622471|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
5689986|NCT00322621|19622472|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
5689987|NCT00322621|19622473|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
5689988|NCT00322621|19622471|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
5689989|NCT00322621|19622472|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
5689990|NCT00322621|19622473|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
5689991|NCT00322621|19622471|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
5689992|NCT00322621|19622472|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
5689993|NCT00322621|19622473|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
5689994|NCT00322621|19622471|P3|Period II - Acute Therapy Phase|Physician Decision|0
5689995|NCT00322621|19622472|P2|Period II - Acute Therapy Phase|Physician Decision|0
5689996|NCT00322621|19622473|P1|Period II - Acute Therapy Phase|Physician Decision|1
5689997|NCT00322621|19622471|P3|Period II - Acute Therapy Phase|Protocol Violation|0
5689998|NCT00322621|19622472|P2|Period II - Acute Therapy Phase|Protocol Violation|0
5689999|NCT00322621|19622473|P1|Period II - Acute Therapy Phase|Protocol Violation|2
5690000|NCT00322621|19622471|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
5690001|NCT00322621|19622472|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
5690002|NCT00322621|19622473|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
5690003|NCT00322621|19622471|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
5690004|NCT00322621|19622472|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
5690005|NCT00322621|19622473|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
5690006|NCT00322621|19622471|P3|Period II - Acute Therapy Phase|Adverse Event|0
5690007|NCT00322621|19622472|P2|Period II - Acute Therapy Phase|Adverse Event|0
5690008|NCT00322621|19622473|P1|Period II - Acute Therapy Phase|Adverse Event|20
5690009|NCT00322556|19622525|P1|Overall Study|Other Reason|7
5690010|NCT00322556|19622525|P1|Overall Study|Lost to Follow-up|3
5690011|NCT00322556|19622525|P1|Overall Study|Withdrawal by Subject|1
5690012|NCT00322556|19622525|P1|Overall Study|Adverse Event|1
5690013|NCT00322491|19622541|P2|Overall Study|Death|2
5690014|NCT00322491|19622542|P1|Overall Study|Death|1
5690015|NCT00322491|19622541|P2|Overall Study|Adverse Event|0
5690016|NCT00322491|19622542|P1|Overall Study|Adverse Event|1
5690017|NCT00322452|19622632|P2|Overall Study|Death|227
5690018|NCT00322452|19622633|P1|Overall Study|Death|223
5690019|NCT00322452|19622632|P2|Overall Study|Withdrawal by Subject|46
5690020|NCT00322452|19622633|P1|Overall Study|Withdrawal by Subject|19
5690021|NCT00322452|19622632|P2|Overall Study|Lost to Follow-up|2
5690022|NCT00322452|19622633|P1|Overall Study|Lost to Follow-up|5
5690023|NCT00322452|19622632|P2|Overall Study|Eligibility criteria not fulfilled|1
5690024|NCT00322452|19622633|P1|Overall Study|Eligibility criteria not fulfilled|0
5690025|NCT00322387|19622684|P2|Follow-up Period|Death|0
5690026|NCT00322387|19622685|P1|Follow-up Period|Death|1
5690027|NCT00322387|19622684|P2|Follow-up Period|Final assessment not done|3
5690028|NCT00322387|19622685|P1|Follow-up Period|Final assessment not done|1
5690029|NCT00322387|19622684|P2|Treatment Period|Adverse Event|1
5690030|NCT00322387|19622685|P1|Treatment Period|Adverse Event|0
5690031|NCT00322374|19622719|P4|Second Escalation|Study Drug Toxicity|0
5690032|NCT00322374|19622720|P3|Second Escalation|Study Drug Toxicity|1
5690033|NCT00322374|19622721|P2|Second Escalation|Study Drug Toxicity|0
5690034|NCT00322374|19622722|P1|Second Escalation|Study Drug Toxicity|0
5690035|NCT00322374|19622719|P4|Second Escalation|Physician Decision|0
5690036|NCT00322374|19622720|P3|Second Escalation|Physician Decision|5
5690037|NCT00322374|19622721|P2|Second Escalation|Physician Decision|0
5690038|NCT00322374|19622722|P1|Second Escalation|Physician Decision|0
5690039|NCT00322374|19622719|P4|First Escalation|Participant Request|0
5690040|NCT00322374|19622720|P3|First Escalation|Participant Request|0
5690041|NCT00322374|19622721|P2|First Escalation|Participant Request|1
5690042|NCT00322374|19622722|P1|First Escalation|Participant Request|0
5690043|NCT00322374|19622719|P4|First Escalation|Study Drug Toxicity|0
5690044|NCT00322374|19622720|P3|First Escalation|Study Drug Toxicity|0
5690045|NCT00322374|19622721|P2|First Escalation|Study Drug Toxicity|11
5690046|NCT00322374|19622722|P1|First Escalation|Study Drug Toxicity|0
5690047|NCT00322374|19622719|P4|First Escalation|Physician Decision|0
5690048|NCT00322374|19622720|P3|First Escalation|Physician Decision|0
5690049|NCT00322374|19622721|P2|First Escalation|Physician Decision|12
5690050|NCT00322374|19622722|P1|First Escalation|Physician Decision|0
5690051|NCT00322374|19622719|P4|First Escalation|Documented Disease Progression|0
5690052|NCT00322374|19622720|P3|First Escalation|Documented Disease Progression|0
5690053|NCT00322374|19622721|P2|First Escalation|Documented Disease Progression|6
5690054|NCT00322374|19622722|P1|First Escalation|Documented Disease Progression|0
5690055|NCT00322374|19622719|P4|Starting Dose|Study Drug Toxicity|0
5690056|NCT00322374|19622720|P3|Starting Dose|Study Drug Toxicity|0
5690057|NCT00322374|19622721|P2|Starting Dose|Study Drug Toxicity|0
5690058|NCT00322374|19622722|P1|Starting Dose|Study Drug Toxicity|4
5690059|NCT00322374|19622719|P4|Starting Dose|Physician Decision|0
5690060|NCT00322374|19622720|P3|Starting Dose|Physician Decision|0
5690061|NCT00322374|19622721|P2|Starting Dose|Physician Decision|0
5690062|NCT00322374|19622722|P1|Starting Dose|Physician Decision|2
5690063|NCT00322348|19622772|P2|Overall Study|Reasons not specified|1
5690064|NCT00322348|19622773|P1|Overall Study|Reasons not specified|5
5690065|NCT00322348|19622772|P2|Overall Study|Disease Progression|25
5690066|NCT00322348|19622773|P1|Overall Study|Disease Progression|30
5690067|NCT00322348|19622772|P2|Overall Study|Death|2
5690068|NCT00322348|19622773|P1|Overall Study|Death|0
5690069|NCT00322348|19622772|P2|Overall Study|Lost to Follow-up|0
5690070|NCT00322348|19622773|P1|Overall Study|Lost to Follow-up|1
5690071|NCT00322348|19622772|P2|Overall Study|Withdrawal by Subject|4
5690072|NCT00322348|19622773|P1|Overall Study|Withdrawal by Subject|1
5690073|NCT00322348|19622772|P2|Overall Study|Adverse Event|1
5690074|NCT00322348|19622773|P1|Overall Study|Adverse Event|0
5690075|NCT00322153|19622864|P2|Overall Study|Withdrawn for other reasons|4
5690076|NCT00322153|19622865|P1|Overall Study|Withdrawn for other reasons|5
5690077|NCT00322153|19622864|P2|Overall Study|Lost to Follow-up|4
5690078|NCT00322153|19622865|P1|Overall Study|Lost to Follow-up|5
5690079|NCT00322153|19622864|P2|Overall Study|Lack of Efficacy|3
5690080|NCT00322153|19622865|P1|Overall Study|Lack of Efficacy|8
5690081|NCT00322153|19622864|P2|Overall Study|Withdrawal by Subject|10
5690082|NCT00322153|19622865|P1|Overall Study|Withdrawal by Subject|18
5690083|NCT00322153|19622864|P2|Overall Study|Protocol Violation|14
5690084|NCT00322153|19622865|P1|Overall Study|Protocol Violation|6
5690085|NCT00322153|19622864|P2|Overall Study|Adverse Event|34
5690086|NCT00322153|19622865|P1|Overall Study|Adverse Event|21
5690087|NCT00322049|19622898|P4|Overall Study|Infected with Dengue during study|0
5690088|NCT00322049|19622899|P3|Overall Study|Infected with Dengue during study|0
5690089|NCT00322049|19622900|P2|Overall Study|Infected with Dengue during study|1
5690090|NCT00322049|19622901|P1|Overall Study|Infected with Dengue during study|0
5690091|NCT00322049|19622898|P4|Overall Study|Moved out of area|1
5690092|NCT00322049|19622899|P3|Overall Study|Moved out of area|0
5690093|NCT00322049|19622900|P2|Overall Study|Moved out of area|0
5690094|NCT00322049|19622901|P1|Overall Study|Moved out of area|0
5690095|NCT00322023|19622934|P3|Overall Study|various|6
5690096|NCT00322023|19622935|P2|Overall Study|various|2
5690097|NCT00322023|19622936|P1|Overall Study|various|0
5690098|NCT00321984|19622953|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
5690099|NCT00321984|19622954|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
5690100|NCT00321984|19622955|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
5690101|NCT00321984|19622953|P3|Overall Study|Per Investigator Request|0
5690102|NCT00321984|19622954|P2|Overall Study|Per Investigator Request|0
5690103|NCT00321984|19622955|P1|Overall Study|Per Investigator Request|1
5690104|NCT00321984|19622953|P3|Overall Study|Per Subject Request|0
5690105|NCT00321984|19622954|P2|Overall Study|Per Subject Request|0
5690106|NCT00321984|19622955|P1|Overall Study|Per Subject Request|1
5690107|NCT00321984|19622953|P3|Overall Study|Pregnancy|0
5690108|NCT00321984|19622954|P2|Overall Study|Pregnancy|1
5690109|NCT00321984|19622955|P1|Overall Study|Pregnancy|0
5690110|NCT00321984|19622953|P3|Overall Study|Noncompliant|2
5690111|NCT00321984|19622954|P2|Overall Study|Noncompliant|0
5690112|NCT00321984|19622955|P1|Overall Study|Noncompliant|0
5690113|NCT00321984|19622953|P3|Overall Study|Lack of Efficacy|3
5690114|NCT00321984|19622954|P2|Overall Study|Lack of Efficacy|1
5690115|NCT00321984|19622955|P1|Overall Study|Lack of Efficacy|3
5690116|NCT00321984|19622953|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
5690117|NCT00321984|19622954|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
5690118|NCT00321984|19622955|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
5690119|NCT00321984|19622953|P3|Overall Study|Withdrawal by Subject|5
5690120|NCT00321984|19622954|P2|Overall Study|Withdrawal by Subject|6
5690121|NCT00321984|19622955|P1|Overall Study|Withdrawal by Subject|8
5690122|NCT00321984|19622953|P3|Overall Study|Lost to Follow-up|2
5690123|NCT00321984|19622954|P2|Overall Study|Lost to Follow-up|4
5690124|NCT00321984|19622955|P1|Overall Study|Lost to Follow-up|2
5690125|NCT00321984|19622953|P3|Overall Study|Protocol Violation|1
5690126|NCT00321984|19622954|P2|Overall Study|Protocol Violation|1
5690127|NCT00321984|19622955|P1|Overall Study|Protocol Violation|0
5690128|NCT00321984|19622953|P3|Overall Study|Adverse Event|8
5690129|NCT00321984|19622954|P2|Overall Study|Adverse Event|6
5690130|NCT00321984|19622955|P1|Overall Study|Adverse Event|9
5690131|NCT00321932|19622983|P2|Overall Study|Missing data|1
5690132|NCT00321932|19622984|P1|Overall Study|Missing data|2
5690133|NCT00321932|19622983|P2|Overall Study|Early relapse|8
5690134|NCT00321932|19622984|P1|Overall Study|Early relapse|2
5690135|NCT00321932|19622983|P2|Overall Study|Withdrawal by Subject|6
5690136|NCT00321932|19622984|P1|Overall Study|Withdrawal by Subject|3
5690137|NCT00321932|19622983|P2|Overall Study|Death|6
5690138|NCT00321932|19622984|P1|Overall Study|Death|3
5690139|NCT00321919|19623008|P2|Overall Study|Other withdrawal reason|6
5690140|NCT00321919|19623009|P1|Overall Study|Other withdrawal reason|7
5690141|NCT00321919|19623008|P2|Overall Study|Failure to Return|1
5690142|NCT00321919|19623009|P1|Overall Study|Failure to Return|3
5690143|NCT00321919|19623008|P2|Overall Study|Other Protocol Violation|3
5690144|NCT00321919|19623009|P1|Overall Study|Other Protocol Violation|2
5690145|NCT00321919|19623008|P2|Overall Study|Refused Treatment|14
5690146|NCT00321919|19623009|P1|Overall Study|Refused Treatment|23
5690147|NCT00321919|19623008|P2|Overall Study|Violation of Selection Criteria at Entry|1
5690148|NCT00321919|19623009|P1|Overall Study|Violation of Selection Criteria at Entry|1
5690149|NCT00321919|19623008|P2|Overall Study|Insufficient Therapeutic Response|0
5690150|NCT00321919|19623009|P1|Overall Study|Insufficient Therapeutic Response|1
5690151|NCT00321919|19623008|P2|Overall Study|Death|17
5690152|NCT00321919|19623009|P1|Overall Study|Death|21
5690153|NCT00321919|19623008|P2|Overall Study|Adverse Event|10
5690154|NCT00321919|19623009|P1|Overall Study|Adverse Event|17
5690155|NCT00321906|19623051|P2|Overall Study|Withdrawal by Subject|4
5690156|NCT00321906|19623052|P1|Overall Study|Withdrawal by Subject|0
5690157|NCT00321906|19623051|P2|Overall Study|Lost to Follow-up|2
5690158|NCT00321906|19623052|P1|Overall Study|Lost to Follow-up|1
5690159|NCT00321906|19623051|P2|Overall Study|Death|6
5690160|NCT00321906|19623052|P1|Overall Study|Death|9
5690161|NCT00321906|19623051|P2|Overall Study|Adverse Event|44
5690162|NCT00321906|19623052|P1|Overall Study|Adverse Event|36
5690163|NCT00321893|19623074|P2|Overall Study|Adverse Event|3
5690164|NCT00321893|19623075|P1|Overall Study|Adverse Event|6
5690165|NCT00321893|19623074|P2|Overall Study|Lost to Follow-up|1
5690166|NCT00321893|19623075|P1|Overall Study|Lost to Follow-up|2
5690167|NCT00321893|19623074|P2|Overall Study|Non-Compliance/Refusal|10
5690168|NCT00321893|19623075|P1|Overall Study|Non-Compliance/Refusal|16
5690169|NCT00321854|19623089|P2|Overall Study|Other|1
5690170|NCT00321854|19623090|P1|Overall Study|Other|1
5690171|NCT00321854|19623089|P2|Overall Study|Withdrawal by Subject|17
5690172|NCT00321854|19623090|P1|Overall Study|Withdrawal by Subject|6
5690173|NCT00321854|19623089|P2|Overall Study|Lost to Follow-up|2
5690174|NCT00321854|19623090|P1|Overall Study|Lost to Follow-up|0
5690175|NCT00321854|19623089|P2|Overall Study|Protocol Violation|5
5690176|NCT00321854|19623090|P1|Overall Study|Protocol Violation|6
5690177|NCT00321854|19623089|P2|Overall Study|Lack of Efficacy|14
5690178|NCT00321854|19623090|P1|Overall Study|Lack of Efficacy|9
5690179|NCT00321854|19623089|P2|Overall Study|Adverse Event|43
5690180|NCT00321854|19623090|P1|Overall Study|Adverse Event|41
5690181|NCT00321828|19623208|P1|Overall Study|No follow up data|1
5690182|NCT00321828|19623208|P1|Overall Study|Ineligible|3
5690183|NCT00321789|19623214|P2|Overall Study|Protocol Violation|3
5690184|NCT00321789|19623215|P1|Overall Study|Protocol Violation|5
5690185|NCT00321789|19623214|P2|Overall Study|Withdrawal by Subject|6
5690186|NCT00321789|19623215|P1|Overall Study|Withdrawal by Subject|6
5690187|NCT00321789|19623214|P2|Overall Study|Lost to Follow-up|7
5690188|NCT00321789|19623215|P1|Overall Study|Lost to Follow-up|4
5690189|NCT00321763|19623247|P4|Overall Study|Lost to Follow-up|4
5690190|NCT00321763|19623248|P3|Overall Study|Lost to Follow-up|5
5690191|NCT00321763|19623249|P2|Overall Study|Lost to Follow-up|1
5690192|NCT00321763|19623250|P1|Overall Study|Lost to Follow-up|3
5690193|NCT00321763|19623247|P4|Overall Study|Withdrawal by Subject|0
5690194|NCT00321763|19623248|P3|Overall Study|Withdrawal by Subject|1
5690195|NCT00321763|19623249|P2|Overall Study|Withdrawal by Subject|0
5690196|NCT00321763|19623250|P1|Overall Study|Withdrawal by Subject|2
5690197|NCT00321763|19623247|P4|Overall Study|Adverse Event|1
5690198|NCT00321763|19623248|P3|Overall Study|Adverse Event|0
5690199|NCT00321763|19623249|P2|Overall Study|Adverse Event|1
5690200|NCT00321763|19623250|P1|Overall Study|Adverse Event|1
5690201|NCT00321737|19623310|P3|Overall Study|Subject Request/ Subject Unavailable|2
5690202|NCT00321737|19623311|P2|Overall Study|Subject Request/ Subject Unavailable|0
5690203|NCT00321737|19623312|P1|Overall Study|Subject Request/ Subject Unavailable|0
5690204|NCT00321737|19623310|P3|Overall Study|Noncompliance|0
5690205|NCT00321737|19623311|P2|Overall Study|Noncompliance|0
5690206|NCT00321737|19623312|P1|Overall Study|Noncompliance|2
5690207|NCT00321737|19623310|P3|Overall Study|Pregnancy|0
5690208|NCT00321737|19623311|P2|Overall Study|Pregnancy|2
5690209|NCT00321737|19623312|P1|Overall Study|Pregnancy|0
5690210|NCT00321737|19623310|P3|Overall Study|Therapeutic Failure|2
5690211|NCT00321737|19623311|P2|Overall Study|Therapeutic Failure|0
5690212|NCT00321737|19623312|P1|Overall Study|Therapeutic Failure|6
5690213|NCT00321737|19623310|P3|Overall Study|Possible Barrett's Esophagus|1
5690214|NCT00321737|19623311|P2|Overall Study|Possible Barrett's Esophagus|1
5690215|NCT00321737|19623312|P1|Overall Study|Possible Barrett's Esophagus|2
5690216|NCT00321737|19623310|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
5690217|NCT00321737|19623311|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
5690218|NCT00321737|19623312|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
5690219|NCT00321737|19623310|P3|Overall Study|Protocol Violation|1
5690220|NCT00321737|19623311|P2|Overall Study|Protocol Violation|0
5690221|NCT00321737|19623312|P1|Overall Study|Protocol Violation|0
5690222|NCT00321737|19623310|P3|Overall Study|Withdrawal by Subject|17
5690223|NCT00321737|19623311|P2|Overall Study|Withdrawal by Subject|12
5690224|NCT00321737|19623312|P1|Overall Study|Withdrawal by Subject|19
5690225|NCT00321737|19623310|P3|Overall Study|Lost to Follow-up|6
5690226|NCT00321737|19623311|P2|Overall Study|Lost to Follow-up|5
5690227|NCT00321737|19623312|P1|Overall Study|Lost to Follow-up|5
5690228|NCT00321737|19623310|P3|Overall Study|Adverse Event|6
5690229|NCT00321737|19623311|P2|Overall Study|Adverse Event|3
5690230|NCT00321737|19623312|P1|Overall Study|Adverse Event|11
5690231|NCT00321737|19623310|P3|Overall Study|Relapse of Erosive Esophagitis|19
5690232|NCT00321737|19623311|P2|Overall Study|Relapse of Erosive Esophagitis|25
5690233|NCT00321737|19623312|P1|Overall Study|Relapse of Erosive Esophagitis|76
5690234|NCT00321711|19623340|P5|Part B|Death|1
5690235|NCT00321711|19623341|P4|Part B|Death|2
5690236|NCT00321711|19623342|P3|Part B|Death|0
5690237|NCT00321711|19623343|P2|Part B|Death|0
5690238|NCT00321711|19623344|P1|Part B|Death|0
5690239|NCT00321711|19623340|P5|Part B|Physician Decision|2
5690240|NCT00321711|19623341|P4|Part B|Physician Decision|1
5690241|NCT00321711|19623342|P3|Part B|Physician Decision|0
5690242|NCT00321711|19623343|P2|Part B|Physician Decision|0
5690243|NCT00321711|19623344|P1|Part B|Physician Decision|0
5690244|NCT00321711|19623340|P5|Part B|Disease progression|0
5690245|NCT00321711|19623341|P4|Part B|Disease progression|1
5690246|NCT00321711|19623342|P3|Part B|Disease progression|0
5690247|NCT00321711|19623343|P2|Part B|Disease progression|0
5690248|NCT00321711|19623344|P1|Part B|Disease progression|0
5690249|NCT00321711|19623340|P5|Part B|Adverse Event|1
5690250|NCT00321711|19623341|P4|Part B|Adverse Event|2
5690251|NCT00321711|19623342|P3|Part B|Adverse Event|0
5690252|NCT00321711|19623343|P2|Part B|Adverse Event|0
5690253|NCT00321711|19623344|P1|Part B|Adverse Event|0
5690254|NCT00321711|19623340|P5|Part B|Noncompliance|1
5690255|NCT00321711|19623341|P4|Part B|Noncompliance|0
5690256|NCT00321711|19623342|P3|Part B|Noncompliance|0
5690257|NCT00321711|19623343|P2|Part B|Noncompliance|0
5690258|NCT00321711|19623344|P1|Part B|Noncompliance|0
5690259|NCT00321711|19623340|P5|Part A|Protocol deviation|0
5690260|NCT00321711|19623341|P4|Part A|Protocol deviation|0
5690261|NCT00321711|19623342|P3|Part A|Protocol deviation|1
5690262|NCT00321711|19623343|P2|Part A|Protocol deviation|0
5690263|NCT00321711|19623344|P1|Part A|Protocol deviation|0
5690264|NCT00321711|19623340|P5|Part A|Other|0
5690265|NCT00321711|19623341|P4|Part A|Other|0
5690266|NCT00321711|19623342|P3|Part A|Other|3
5690267|NCT00321711|19623343|P2|Part A|Other|2
5690268|NCT00321711|19623344|P1|Part A|Other|1
5690269|NCT00321711|19623340|P5|Part A|Physician Decision|0
5690270|NCT00321711|19623341|P4|Part A|Physician Decision|0
5690271|NCT00321711|19623342|P3|Part A|Physician Decision|3
5690272|NCT00321711|19623343|P2|Part A|Physician Decision|1
5690273|NCT00321711|19623344|P1|Part A|Physician Decision|0
5690274|NCT00321711|19623340|P5|Part A|Requirement for alternative therapy|0
5690275|NCT00321711|19623341|P4|Part A|Requirement for alternative therapy|0
5690276|NCT00321711|19623342|P3|Part A|Requirement for alternative therapy|1
5690277|NCT00321711|19623343|P2|Part A|Requirement for alternative therapy|2
5690278|NCT00321711|19623344|P1|Part A|Requirement for alternative therapy|0
5690279|NCT00321711|19623340|P5|Part A|Disease progression|0
5690280|NCT00321711|19623341|P4|Part A|Disease progression|0
5690281|NCT00321711|19623342|P3|Part A|Disease progression|0
5690282|NCT00321711|19623343|P2|Part A|Disease progression|1
5690283|NCT00321711|19623344|P1|Part A|Disease progression|0
5690284|NCT00321711|19623340|P5|Part A|Withdrawal by Subject|0
5690285|NCT00321711|19623341|P4|Part A|Withdrawal by Subject|0
5690286|NCT00321711|19623342|P3|Part A|Withdrawal by Subject|1
5690287|NCT00321711|19623343|P2|Part A|Withdrawal by Subject|1
5690288|NCT00321711|19623344|P1|Part A|Withdrawal by Subject|1
5690289|NCT00321711|19623340|P5|Part A|Adverse Event|0
5690290|NCT00321711|19623341|P4|Part A|Adverse Event|0
5690291|NCT00321711|19623342|P3|Part A|Adverse Event|2
5690292|NCT00321711|19623343|P2|Part A|Adverse Event|3
5690293|NCT00321711|19623344|P1|Part A|Adverse Event|3
5690294|NCT00321685|19623394|P1|Overall Study|Ineligible|2
5690295|NCT00321685|19623394|P1|Overall Study|Not start protocol therapy|2
5690296|NCT00321685|19623394|P1|Overall Study|Other|5
5690297|NCT00321685|19623394|P1|Overall Study|Complicating disese|1
5690298|NCT00321685|19623394|P1|Overall Study|Alternative therapy|1
5690299|NCT00321685|19623394|P1|Overall Study|Withdrawal by Subject|8
5690300|NCT00321685|19623394|P1|Overall Study|Death|2
5690301|NCT00321685|19623394|P1|Overall Study|Adverse Event|18
5690302|NCT00321672|19623406|P4|Overall Study|Extensive travel required for new job|0
5690303|NCT00321672|19623407|P3|Overall Study|Extensive travel required for new job|0
5690304|NCT00321672|19623408|P2|Overall Study|Extensive travel required for new job|1
5690305|NCT00321672|19623409|P1|Overall Study|Extensive travel required for new job|0
5690306|NCT00321672|19623406|P4|Overall Study|Diagnosis of testicular cancer|0
5690307|NCT00321672|19623407|P3|Overall Study|Diagnosis of testicular cancer|0
5690308|NCT00321672|19623408|P2|Overall Study|Diagnosis of testicular cancer|1
5690309|NCT00321672|19623409|P1|Overall Study|Diagnosis of testicular cancer|0
5690310|NCT00321672|19623406|P4|Overall Study|Protocol Violation|0
5690311|NCT00321672|19623407|P3|Overall Study|Protocol Violation|1
5690312|NCT00321672|19623408|P2|Overall Study|Protocol Violation|0
5690313|NCT00321672|19623409|P1|Overall Study|Protocol Violation|0
5690314|NCT00321672|19623406|P4|Overall Study|Moved out of state|0
5690315|NCT00321672|19623407|P3|Overall Study|Moved out of state|1
5690316|NCT00321672|19623408|P2|Overall Study|Moved out of state|1
5690317|NCT00321672|19623409|P1|Overall Study|Moved out of state|0
5690318|NCT00321672|19623406|P4|Overall Study|Incarcerated|0
5690319|NCT00321672|19623407|P3|Overall Study|Incarcerated|2
5690320|NCT00321672|19623408|P2|Overall Study|Incarcerated|0
5690321|NCT00321672|19623409|P1|Overall Study|Incarcerated|0
5690322|NCT00321672|19623406|P4|Overall Study|Too far to travel for visits|0
5690323|NCT00321672|19623407|P3|Overall Study|Too far to travel for visits|0
5690324|NCT00321672|19623408|P2|Overall Study|Too far to travel for visits|0
5690325|NCT00321672|19623409|P1|Overall Study|Too far to travel for visits|1
5690326|NCT00321672|19623406|P4|Overall Study|Death|0
5690327|NCT00321672|19623407|P3|Overall Study|Death|0
5690328|NCT00321672|19623408|P2|Overall Study|Death|0
5690329|NCT00321672|19623409|P1|Overall Study|Death|1
5690330|NCT00321672|19623406|P4|Overall Study|Lost to Follow-up|2
5690331|NCT00321672|19623407|P3|Overall Study|Lost to Follow-up|4
5690332|NCT00321672|19623408|P2|Overall Study|Lost to Follow-up|0
5690333|NCT00321672|19623409|P1|Overall Study|Lost to Follow-up|2
5690334|NCT00321672|19623406|P4|Overall Study|Lack of Efficacy|0
5690335|NCT00321672|19623407|P3|Overall Study|Lack of Efficacy|0
5690336|NCT00321672|19623408|P2|Overall Study|Lack of Efficacy|1
5690337|NCT00321672|19623409|P1|Overall Study|Lack of Efficacy|1
5690338|NCT00321672|19623406|P4|Overall Study|Adverse Event|0
5690339|NCT00321672|19623407|P3|Overall Study|Adverse Event|0
5690340|NCT00321672|19623408|P2|Overall Study|Adverse Event|1
5690341|NCT00321672|19623409|P1|Overall Study|Adverse Event|1
5690342|NCT00321672|19623406|P4|Overall Study|Noncompliance|0
5690343|NCT00321672|19623407|P3|Overall Study|Noncompliance|1
5690344|NCT00321672|19623408|P2|Overall Study|Noncompliance|2
5690345|NCT00321672|19623409|P1|Overall Study|Noncompliance|1
5690346|NCT00321672|19623406|P4|Overall Study|Withdrawal by Subject|0
5690347|NCT00321672|19623407|P3|Overall Study|Withdrawal by Subject|2
5690348|NCT00321672|19623408|P2|Overall Study|Withdrawal by Subject|1
5690349|NCT00321672|19623409|P1|Overall Study|Withdrawal by Subject|5
5690350|NCT00321646|19623435|P1|Neoadjuvant Chemotherapy|Disease progression|1
5690351|NCT00321646|19623435|P1|Neoadjuvant Chemotherapy|Adverse Event|2
5690352|NCT00321646|19623435|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
5690353|NCT00321620|19623442|P2|Overall Study|Other|33
5690354|NCT00321620|19623443|P1|Overall Study|Other|42
5690355|NCT00321620|19623442|P2|Overall Study|Participant request|52
5690356|NCT00321620|19623443|P1|Overall Study|Participant request|75
5690357|NCT00321620|19623442|P2|Overall Study|Ineligibility determined|3
5690358|NCT00321620|19623443|P1|Overall Study|Ineligibility determined|2
5690359|NCT00321620|19623442|P2|Overall Study|Protocol deviation|3
5690360|NCT00321620|19623443|P1|Overall Study|Protocol deviation|4
5690361|NCT00321620|19623442|P2|Overall Study|Noncompliance|7
5690362|NCT00321620|19623443|P1|Overall Study|Noncompliance|14
5690363|NCT00321620|19623442|P2|Overall Study|Physician Decision|1
5690364|NCT00321620|19623443|P1|Overall Study|Physician Decision|4
5690365|NCT00321620|19623442|P2|Overall Study|Lost to Follow-up|9
5690366|NCT00321620|19623443|P1|Overall Study|Lost to Follow-up|13
5690367|NCT00321620|19623442|P2|Overall Study|Adverse Event|56
5690368|NCT00321620|19623443|P1|Overall Study|Adverse Event|43
5690369|NCT00321620|19623442|P2|Overall Study|Disease progression|117
5690370|NCT00321620|19623443|P1|Overall Study|Disease progression|113
5690371|NCT00321620|19623442|P2|Overall Study|Withdrawal by Subject|147
5690372|NCT00321620|19623443|P1|Overall Study|Withdrawal by Subject|164
5690373|NCT00321620|19623442|P2|Overall Study|Death|294
5690374|NCT00321620|19623443|P1|Overall Study|Death|269
5690375|NCT00321555|19623471|P1|Overall Study|Disease progression on study|1
5690376|NCT00321555|19623471|P1|Overall Study|Physician Decision|1
5690377|NCT00321555|19623471|P1|Overall Study|Switched to alternative treatment|3
5690378|NCT00321555|19623471|P1|Overall Study|Developed antibodies|1
5690379|NCT00321464|19623479|P2|Overall Study|Other|18
5690380|NCT00321464|19623480|P1|Overall Study|Other|21
5690381|NCT00321464|19623479|P2|Overall Study|Ineligibility determined|1
5690382|NCT00321464|19623480|P1|Overall Study|Ineligibility determined|2
5690383|NCT00321464|19623479|P2|Overall Study|Protocol deviation|2
5690384|NCT00321464|19623480|P1|Overall Study|Protocol deviation|0
5690385|NCT00321464|19623479|P2|Overall Study|Lost to Follow-up|8
5690386|NCT00321464|19623480|P1|Overall Study|Lost to Follow-up|7
5690387|NCT00321464|19623479|P2|Overall Study|Noncompliance|10
5690388|NCT00321464|19623480|P1|Overall Study|Noncompliance|4
5690389|NCT00321464|19623479|P2|Overall Study|Physician Decision|14
5690390|NCT00321464|19623480|P1|Overall Study|Physician Decision|15
5690391|NCT00321464|19623479|P2|Overall Study|Adverse Event|28
5690392|NCT00321464|19623480|P1|Overall Study|Adverse Event|43
5690393|NCT00321464|19623479|P2|Overall Study|Participant request|61
5690394|NCT00321464|19623480|P1|Overall Study|Participant request|57
5690395|NCT00321464|19623479|P2|Overall Study|Withdrawal by Subject|118
5690396|NCT00321464|19623480|P1|Overall Study|Withdrawal by Subject|117
5690397|NCT00321464|19623479|P2|Overall Study|Disease progression|124
5690398|NCT00321464|19623480|P1|Overall Study|Disease progression|124
5690399|NCT00321464|19623479|P2|Overall Study|Death|174
5690400|NCT00321464|19623480|P1|Overall Study|Death|169
5690401|NCT00321373|19623493|P3|Overall Study|Other|1
5690402|NCT00321373|19623494|P2|Overall Study|Other|0
5690403|NCT00321373|19623495|P1|Overall Study|Other|0
5690404|NCT00321373|19623493|P3|Overall Study|Withdrawal by Subject|0
5690405|NCT00321373|19623494|P2|Overall Study|Withdrawal by Subject|0
5690406|NCT00321373|19623495|P1|Overall Study|Withdrawal by Subject|1
5690407|NCT00321373|19623493|P3|Overall Study|Lost to Follow-up|1
5690408|NCT00321373|19623494|P2|Overall Study|Lost to Follow-up|0
5690409|NCT00321373|19623495|P1|Overall Study|Lost to Follow-up|1
5690410|NCT00321373|19623493|P3|Overall Study|Adverse Event|1
5690411|NCT00321373|19623494|P2|Overall Study|Adverse Event|0
5690412|NCT00321373|19623495|P1|Overall Study|Adverse Event|0
5690413|NCT00321048|19623535|P2|Overall Study|Withdrawal by Subject|8
5690414|NCT00321048|19623536|P1|Overall Study|Withdrawal by Subject|6
5690415|NCT00320801|19623544|P4|Extension Phase|Lost to Follow-up|3
5690416|NCT00320801|19623545|P3|Extension Phase|Lost to Follow-up|0
5690417|NCT00320801|19623546|P2|Extension Phase|Lost to Follow-up|0
5690418|NCT00320801|19623547|P1|Extension Phase|Lost to Follow-up|0
5690419|NCT00320801|19623544|P4|Extension Phase|Lack of Efficacy|2
5690420|NCT00320801|19623545|P3|Extension Phase|Lack of Efficacy|0
5690421|NCT00320801|19623546|P2|Extension Phase|Lack of Efficacy|0
5690422|NCT00320801|19623547|P1|Extension Phase|Lack of Efficacy|0
5690423|NCT00320801|19623544|P4|Extension Phase|Administrative|29
5690424|NCT00320801|19623545|P3|Extension Phase|Administrative|0
5690425|NCT00320801|19623546|P2|Extension Phase|Administrative|0
5690426|NCT00320801|19623547|P1|Extension Phase|Administrative|0
5690427|NCT00320801|19623544|P4|Extension Phase|Adverse Event|8
5690428|NCT00320801|19623545|P3|Extension Phase|Adverse Event|0
5690429|NCT00320801|19623546|P2|Extension Phase|Adverse Event|0
5690430|NCT00320801|19623547|P1|Extension Phase|Adverse Event|0
5690431|NCT00320801|19623544|P4|Extension Phase|Withdrawal by Subject|6
5690432|NCT00320801|19623545|P3|Extension Phase|Withdrawal by Subject|0
5690433|NCT00320801|19623546|P2|Extension Phase|Withdrawal by Subject|0
5690434|NCT00320801|19623547|P1|Extension Phase|Withdrawal by Subject|0
5690435|NCT00320801|19623544|P4|Double-blind Phase|Lack of Efficacy|0
5690436|NCT00320801|19623545|P3|Double-blind Phase|Lack of Efficacy|1
5690437|NCT00320801|19623546|P2|Double-blind Phase|Lack of Efficacy|9
5690438|NCT00320801|19623547|P1|Double-blind Phase|Lack of Efficacy|0
5690439|NCT00320801|19623544|P4|Double-blind Phase|Administrative|0
5690440|NCT00320801|19623545|P3|Double-blind Phase|Administrative|4
5690441|NCT00320801|19623546|P2|Double-blind Phase|Administrative|0
5690442|NCT00320801|19623547|P1|Double-blind Phase|Administrative|0
5690443|NCT00320801|19623544|P4|Double-blind Phase|Adverse Event|0
5690444|NCT00320801|19623545|P3|Double-blind Phase|Adverse Event|8
5690445|NCT00320801|19623546|P2|Double-blind Phase|Adverse Event|2
5690446|NCT00320801|19623547|P1|Double-blind Phase|Adverse Event|0
5690447|NCT00320801|19623544|P4|Double-blind Phase|Withdrawal by Subject|0
5690448|NCT00320801|19623545|P3|Double-blind Phase|Withdrawal by Subject|1
5690449|NCT00320801|19623546|P2|Double-blind Phase|Withdrawal by Subject|0
5690450|NCT00320801|19623547|P1|Double-blind Phase|Withdrawal by Subject|0
5690451|NCT00320801|19623544|P4|Open-label Run-in Period|Did not qualify|0
5690452|NCT00320801|19623545|P3|Open-label Run-in Period|Did not qualify|0
5690453|NCT00320801|19623546|P2|Open-label Run-in Period|Did not qualify|0
5690454|NCT00320801|19623547|P1|Open-label Run-in Period|Did not qualify|1
5690455|NCT00320801|19623544|P4|Open-label Run-in Period|Lost to Follow-up|0
5690456|NCT00320801|19623545|P3|Open-label Run-in Period|Lost to Follow-up|0
5690457|NCT00320801|19623546|P2|Open-label Run-in Period|Lost to Follow-up|0
5690458|NCT00320801|19623547|P1|Open-label Run-in Period|Lost to Follow-up|2
5690459|NCT00320801|19623544|P4|Open-label Run-in Period|Lack of Efficacy|0
5690460|NCT00320801|19623545|P3|Open-label Run-in Period|Lack of Efficacy|0
5690461|NCT00320801|19623546|P2|Open-label Run-in Period|Lack of Efficacy|0
5690462|NCT00320801|19623547|P1|Open-label Run-in Period|Lack of Efficacy|44
5690463|NCT00320801|19623544|P4|Open-label Run-in Period|Administrative|0
5690464|NCT00320801|19623545|P3|Open-label Run-in Period|Administrative|0
5690465|NCT00320801|19623546|P2|Open-label Run-in Period|Administrative|0
5690466|NCT00320801|19623547|P1|Open-label Run-in Period|Administrative|10
5690467|NCT00320801|19623544|P4|Open-label Run-in Period|Adverse Event|0
5690468|NCT00320801|19623545|P3|Open-label Run-in Period|Adverse Event|0
5690469|NCT00320801|19623546|P2|Open-label Run-in Period|Adverse Event|0
5690470|NCT00320801|19623547|P1|Open-label Run-in Period|Adverse Event|33
5690471|NCT00320801|19623544|P4|Open-label Run-in Period|Withdrawal by Subject|0
5690472|NCT00320801|19623545|P3|Open-label Run-in Period|Withdrawal by Subject|0
5690473|NCT00320801|19623546|P2|Open-label Run-in Period|Withdrawal by Subject|0
5690474|NCT00320801|19623547|P1|Open-label Run-in Period|Withdrawal by Subject|2
5690475|NCT00320788|19623562|P5|Overall Study|Withdrawal by Subject|1
5690476|NCT00320788|19623563|P4|Overall Study|Withdrawal by Subject|3
5690477|NCT00320788|19623564|P3|Overall Study|Withdrawal by Subject|0
5690478|NCT00320788|19623565|P2|Overall Study|Withdrawal by Subject|0
5690479|NCT00320788|19623566|P1|Overall Study|Withdrawal by Subject|3
5690480|NCT00320788|19623562|P5|Overall Study|Protocol Violation|1
5690481|NCT00320788|19623563|P4|Overall Study|Protocol Violation|0
5690482|NCT00320788|19623564|P3|Overall Study|Protocol Violation|0
5690483|NCT00320788|19623565|P2|Overall Study|Protocol Violation|0
5690484|NCT00320788|19623566|P1|Overall Study|Protocol Violation|0
5690485|NCT00320788|19623562|P5|Overall Study|Physician Decision|0
5690486|NCT00320788|19623563|P4|Overall Study|Physician Decision|0
5690487|NCT00320788|19623564|P3|Overall Study|Physician Decision|0
5690488|NCT00320788|19623565|P2|Overall Study|Physician Decision|1
5690489|NCT00320788|19623566|P1|Overall Study|Physician Decision|1
5690490|NCT00320788|19623562|P5|Overall Study|Other|1
5690491|NCT00320788|19623563|P4|Overall Study|Other|1
5690492|NCT00320788|19623564|P3|Overall Study|Other|1
5690493|NCT00320788|19623565|P2|Overall Study|Other|2
5690494|NCT00320788|19623566|P1|Overall Study|Other|1
5690495|NCT00320788|19623562|P5|Overall Study|Decision by the Sponsor|1
5690496|NCT00320788|19623563|P4|Overall Study|Decision by the Sponsor|0
5690497|NCT00320788|19623564|P3|Overall Study|Decision by the Sponsor|0
5690498|NCT00320788|19623565|P2|Overall Study|Decision by the Sponsor|1
5690499|NCT00320788|19623566|P1|Overall Study|Decision by the Sponsor|1
5690500|NCT00320788|19623562|P5|Overall Study|Lost to Follow-up|0
5690501|NCT00320788|19623563|P4|Overall Study|Lost to Follow-up|0
5690502|NCT00320788|19623564|P3|Overall Study|Lost to Follow-up|1
5690503|NCT00320788|19623565|P2|Overall Study|Lost to Follow-up|2
5690504|NCT00320788|19623566|P1|Overall Study|Lost to Follow-up|0
5690505|NCT00320788|19623562|P5|Overall Study|Death|1
5690506|NCT00320788|19623563|P4|Overall Study|Death|0
5690507|NCT00320788|19623564|P3|Overall Study|Death|1
5690508|NCT00320788|19623565|P2|Overall Study|Death|0
5690509|NCT00320788|19623566|P1|Overall Study|Death|0
5690510|NCT00320788|19623562|P5|Overall Study|Adverse Event|0
5690511|NCT00320788|19623563|P4|Overall Study|Adverse Event|1
5690512|NCT00320788|19623564|P3|Overall Study|Adverse Event|0
5690513|NCT00320788|19623565|P2|Overall Study|Adverse Event|0
5690514|NCT00320788|19623566|P1|Overall Study|Adverse Event|0
5690515|NCT00320710|19623620|P3|Overall Study|Lost to Follow-up|0
5690516|NCT00320710|19623621|P2|Overall Study|Lost to Follow-up|0
5690517|NCT00320710|19623622|P1|Overall Study|Lost to Follow-up|1
5690518|NCT00320710|19623620|P3|Overall Study|Adverse Event|1
5690519|NCT00320710|19623621|P2|Overall Study|Adverse Event|14
5690520|NCT00320710|19623622|P1|Overall Study|Adverse Event|18
5690521|NCT00320710|19623620|P3|Overall Study|Abnormal laboratory value(s)|0
5690522|NCT00320710|19623621|P2|Overall Study|Abnormal laboratory value(s)|3
5690523|NCT00320710|19623622|P1|Overall Study|Abnormal laboratory value(s)|12
5690524|NCT00320710|19623620|P3|Overall Study|Abnormal test procedure result(s)|0
5690525|NCT00320710|19623621|P2|Overall Study|Abnormal test procedure result(s)|0
5690526|NCT00320710|19623622|P1|Overall Study|Abnormal test procedure result(s)|2
5690527|NCT00320710|19623620|P3|Overall Study|Protocol Violation|0
5690528|NCT00320710|19623621|P2|Overall Study|Protocol Violation|5
5690529|NCT00320710|19623622|P1|Overall Study|Protocol Violation|6
5690530|NCT00320710|19623620|P3|Overall Study|Withdrawal by Subject|1
5690531|NCT00320710|19623621|P2|Overall Study|Withdrawal by Subject|26
5690532|NCT00320710|19623622|P1|Overall Study|Withdrawal by Subject|20
5690533|NCT00320710|19623620|P3|Overall Study|Administrative problems|0
5690534|NCT00320710|19623621|P2|Overall Study|Administrative problems|2
5690535|NCT00320710|19623622|P1|Overall Study|Administrative problems|1
5690536|NCT00320710|19623620|P3|Overall Study|Death|1
5690537|NCT00320710|19623621|P2|Overall Study|Death|7
5690538|NCT00320710|19623622|P1|Overall Study|Death|10
5690539|NCT00320710|19623620|P3|Overall Study|Disease progression|2
5690540|NCT00320710|19623621|P2|Overall Study|Disease progression|19
5690541|NCT00320710|19623622|P1|Overall Study|Disease progression|24
5690542|NCT00320606|19623652|P1|Overall Study|Withdrawal by Subject|1
5690543|NCT00320606|19623652|P1|Overall Study|Protocol Violation|1
5690544|NCT00320606|19623652|P1|Overall Study|Adverse Event|1
5690545|NCT00320593|19623668|P2|Overall Study|Withdrawal by clinical center|0
5690546|NCT00320593|19623669|P1|Overall Study|Withdrawal by clinical center|1
5690547|NCT00320593|19623668|P2|Overall Study|Withdrawal by Subject|1
5690548|NCT00320593|19623669|P1|Overall Study|Withdrawal by Subject|2
5690549|NCT00320593|19623668|P2|Overall Study|Moved to another state|0
5690550|NCT00320593|19623669|P1|Overall Study|Moved to another state|1
5690551|NCT00320593|19623668|P2|Overall Study|Lost to Follow-up|0
5690552|NCT00320593|19623669|P1|Overall Study|Lost to Follow-up|3
5690553|NCT00320541|19623693|P2|Overall Study|Protocol Entry Criterion Not Met|0
5690554|NCT00320541|19623694|P1|Overall Study|Protocol Entry Criterion Not Met|1
5690555|NCT00320541|19623693|P2|Overall Study|Death due to Adverse Event(s)|0
5690556|NCT00320541|19623694|P1|Overall Study|Death due to Adverse Event(s)|1
5690557|NCT00320541|19623693|P2|Overall Study|Death due to Study Disease|3
5690558|NCT00320541|19623694|P1|Overall Study|Death due to Study Disease|1
5690559|NCT00320541|19623693|P2|Overall Study|Sponsor Decision|1
5690560|NCT00320541|19623694|P1|Overall Study|Sponsor Decision|2
5690561|NCT00320541|19623693|P2|Overall Study|Other|4
5690562|NCT00320541|19623694|P1|Overall Study|Other|3
5690563|NCT00320541|19623693|P2|Overall Study|Physician Decision|13
5690564|NCT00320541|19623694|P1|Overall Study|Physician Decision|9
5690565|NCT00320541|19623693|P2|Overall Study|Withdrawal by Subject|16
5690566|NCT00320541|19623694|P1|Overall Study|Withdrawal by Subject|12
5690567|NCT00320541|19623693|P2|Overall Study|Protocol Violation|1
5690568|NCT00320541|19623694|P1|Overall Study|Protocol Violation|0
5690569|NCT00320541|19623693|P2|Overall Study|Adverse Event|19
5690570|NCT00320541|19623694|P1|Overall Study|Adverse Event|21
5690571|NCT00320528|19623721|P3|Study Period III|Atomoxetine Commercially Available|90
5690572|NCT00320528|19623722|P2|Study Period III|Atomoxetine Commercially Available|25
5690573|NCT00320528|19623723|P1|Study Period III|Atomoxetine Commercially Available|68
5690574|NCT00320528|19623721|P3|Study Period III|Sponsor Decision|1
5690575|NCT00320528|19623722|P2|Study Period III|Sponsor Decision|0
5690576|NCT00320528|19623723|P1|Study Period III|Sponsor Decision|0
5690577|NCT00320528|19623721|P3|Study Period III|Physician Decision|2
5690578|NCT00320528|19623722|P2|Study Period III|Physician Decision|1
5690579|NCT00320528|19623723|P1|Study Period III|Physician Decision|0
5690580|NCT00320528|19623721|P3|Study Period III|Protocol Violation|0
5690581|NCT00320528|19623722|P2|Study Period III|Protocol Violation|1
5690582|NCT00320528|19623723|P1|Study Period III|Protocol Violation|0
5690583|NCT00320528|19623721|P3|Study Period III|Parent/Caregiver Decision|11
5690584|NCT00320528|19623722|P2|Study Period III|Parent/Caregiver Decision|3
5690585|NCT00320528|19623723|P1|Study Period III|Parent/Caregiver Decision|14
5690586|NCT00320528|19623721|P3|Study Period III|Lack of Efficacy|0
5690587|NCT00320528|19623722|P2|Study Period III|Lack of Efficacy|0
5690588|NCT00320528|19623723|P1|Study Period III|Lack of Efficacy|2
5690589|NCT00320528|19623721|P3|Study Period III|Withdrawal by Subject|2
5690590|NCT00320528|19623722|P2|Study Period III|Withdrawal by Subject|1
5690591|NCT00320528|19623723|P1|Study Period III|Withdrawal by Subject|1
5690592|NCT00320528|19623721|P3|Study Period III|Lost to Follow-up|0
5690593|NCT00320528|19623722|P2|Study Period III|Lost to Follow-up|0
5690594|NCT00320528|19623723|P1|Study Period III|Lost to Follow-up|1
5690595|NCT00320528|19623721|P3|Study Period III|Adverse Event|0
5690596|NCT00320528|19623722|P2|Study Period III|Adverse Event|0
5690597|NCT00320528|19623723|P1|Study Period III|Adverse Event|1
5690598|NCT00320528|19623721|P3|Study Period II|Entry Criteria Exclusion|2
5690599|NCT00320528|19623722|P2|Study Period II|Entry Criteria Exclusion|2
5690600|NCT00320528|19623723|P1|Study Period II|Entry Criteria Exclusion|0
5690601|NCT00320528|19623721|P3|Study Period II|Withdrawal by Subject|1
5690602|NCT00320528|19623722|P2|Study Period II|Withdrawal by Subject|1
5690603|NCT00320528|19623723|P1|Study Period II|Withdrawal by Subject|0
5690604|NCT00320528|19623721|P3|Study Period II|Parent/Caregiver Decision|11
5690605|NCT00320528|19623722|P2|Study Period II|Parent/Caregiver Decision|3
5690606|NCT00320528|19623723|P1|Study Period II|Parent/Caregiver Decision|8
5690607|NCT00320528|19623721|P3|Study Period II|Adverse Event|8
5690608|NCT00320528|19623722|P2|Study Period II|Adverse Event|4
5690609|NCT00320528|19623723|P1|Study Period II|Adverse Event|3
5690610|NCT00320515|19623758|P1|Overall Study|Withdrawal by Subject|8
5690611|NCT00320515|19623758|P1|Overall Study|Physician Decision|2
5690612|NCT00320515|19623758|P1|Overall Study|Lost to Follow-up|6
5690613|NCT00320515|19623758|P1|Overall Study|Death|33
5690614|NCT00320489|19623767|P2|Overall Study|Withdrawal by Subject|41
5690615|NCT00320489|19623768|P1|Overall Study|Withdrawal by Subject|39
5690616|NCT00320489|19623767|P2|Overall Study|Sponsor Decision|3
5690617|NCT00320489|19623768|P1|Overall Study|Sponsor Decision|3
5690618|NCT00320489|19623767|P2|Overall Study|Protocol Violation|4
5690619|NCT00320489|19623768|P1|Overall Study|Protocol Violation|4
5690620|NCT00320489|19623767|P2|Overall Study|Physician Decision|8
5690621|NCT00320489|19623768|P1|Overall Study|Physician Decision|8
5690622|NCT00320489|19623767|P2|Overall Study|Lost to Follow-up|22
5690623|NCT00320489|19623768|P1|Overall Study|Lost to Follow-up|21
5690624|NCT00320489|19623767|P2|Overall Study|Lack of Efficacy|7
5690625|NCT00320489|19623768|P1|Overall Study|Lack of Efficacy|16
5690626|NCT00320489|19623767|P2|Overall Study|Entry Criteria Exclusion|4
5690627|NCT00320489|19623768|P1|Overall Study|Entry Criteria Exclusion|2
5690628|NCT00320489|19623767|P2|Overall Study|Death|2
5690629|NCT00320489|19623768|P1|Overall Study|Death|0
5690630|NCT00320489|19623767|P2|Overall Study|Clinical Relapse|20
5690631|NCT00320489|19623768|P1|Overall Study|Clinical Relapse|26
5690632|NCT00320489|19623767|P2|Overall Study|Adverse Event|25
5690633|NCT00320489|19623768|P1|Overall Study|Adverse Event|26
5690634|NCT00320424|19623824|P1|Overall Study|Other|3
5690635|NCT00320424|19623824|P1|Overall Study|Adverse Event|3
5690636|NCT00320411|19623838|P1|Overall Study|No investigational product admin.|4
5690637|NCT00320398|19623861|P2|Overall Study|Other|0
5690638|NCT00320398|19623862|P1|Overall Study|Other|1
5690639|NCT00320398|19623861|P2|Overall Study|Adverse Event|4
5690640|NCT00320398|19623862|P1|Overall Study|Adverse Event|1
5690641|NCT00320385|19623890|P2|Overall Study|Adverse Event|1
5690642|NCT00320385|19623891|P1|Overall Study|Adverse Event|0
5690643|NCT00320385|19623890|P2|Overall Study|Withdrew Consent|0
5690644|NCT00320385|19623891|P1|Overall Study|Withdrew Consent|1
5690645|NCT00320385|19623890|P2|Overall Study|Serious Adverse Event|0
5690646|NCT00320385|19623891|P1|Overall Study|Serious Adverse Event|1
5690647|NCT00320385|19623890|P2|Overall Study|Death|2
5690648|NCT00320385|19623891|P1|Overall Study|Death|1
5690649|NCT00320385|19623890|P2|Overall Study|Investigator Decision|1
5690650|NCT00320385|19623891|P1|Overall Study|Investigator Decision|0
5690651|NCT00320385|19623890|P2|Overall Study|Sponsor Terminated Study|1
5690652|NCT00320385|19623891|P1|Overall Study|Sponsor Terminated Study|2
5690653|NCT00320385|19623890|P2|Overall Study|Withdrawal by Subject|7
5690654|NCT00320385|19623891|P1|Overall Study|Withdrawal by Subject|6
5690655|NCT00320385|19623890|P2|Overall Study|Lost to Follow-up|10
5690656|NCT00320385|19623891|P1|Overall Study|Lost to Follow-up|7
5690657|NCT00320372|19623914|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
5690658|NCT00320372|19623915|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
5690659|NCT00320372|19623914|P2|Overall Study|Did not Meet (I/E)|1
5690660|NCT00320372|19623915|P1|Overall Study|Did not Meet (I/E)|3
5690661|NCT00320372|19623914|P2|Overall Study|Non-Compliance|39
5690662|NCT00320372|19623915|P1|Overall Study|Non-Compliance|40
5690663|NCT00320372|19623914|P2|Overall Study|Withdrawal by Subject|37
5690664|NCT00320372|19623915|P1|Overall Study|Withdrawal by Subject|55
5690665|NCT00320372|19623914|P2|Overall Study|Death|8
5690666|NCT00320372|19623915|P1|Overall Study|Death|7
5690667|NCT00320372|19623914|P2|Overall Study|Physician Decision|7
5690668|NCT00320372|19623915|P1|Overall Study|Physician Decision|4
5690669|NCT00320255|19623957|P6|Overall Study|Other|0
5690670|NCT00320255|19623958|P5|Overall Study|Other|0
5690671|NCT00320255|19623959|P4|Overall Study|Other|0
5690672|NCT00320255|19623960|P3|Overall Study|Other|1
5690673|NCT00320255|19623961|P2|Overall Study|Other|2
5690674|NCT00320255|19623962|P1|Overall Study|Other|3
5690675|NCT00320255|19623957|P6|Overall Study|No longer meets study criteria|0
5690676|NCT00320255|19623958|P5|Overall Study|No longer meets study criteria|0
5690677|NCT00320255|19623959|P4|Overall Study|No longer meets study criteria|1
5690678|NCT00320255|19623960|P3|Overall Study|No longer meets study criteria|0
5690679|NCT00320255|19623961|P2|Overall Study|No longer meets study criteria|0
5690680|NCT00320255|19623962|P1|Overall Study|No longer meets study criteria|0
5690681|NCT00320255|19623957|P6|Overall Study|Poor compliance/noncompliance|0
5690682|NCT00320255|19623958|P5|Overall Study|Poor compliance/noncompliance|0
5690683|NCT00320255|19623959|P4|Overall Study|Poor compliance/noncompliance|1
5690684|NCT00320255|19623960|P3|Overall Study|Poor compliance/noncompliance|0
5690685|NCT00320255|19623961|P2|Overall Study|Poor compliance/noncompliance|1
5690686|NCT00320255|19623962|P1|Overall Study|Poor compliance/noncompliance|1
5690687|NCT00320255|19623957|P6|Overall Study|Withdrawal by Subject|0
5690688|NCT00320255|19623958|P5|Overall Study|Withdrawal by Subject|0
5690689|NCT00320255|19623959|P4|Overall Study|Withdrawal by Subject|4
5690690|NCT00320255|19623960|P3|Overall Study|Withdrawal by Subject|2
5690691|NCT00320255|19623961|P2|Overall Study|Withdrawal by Subject|2
5690692|NCT00320255|19623962|P1|Overall Study|Withdrawal by Subject|1
5690693|NCT00320255|19623957|P6|Overall Study|Adverse Event|0
5690694|NCT00320255|19623958|P5|Overall Study|Adverse Event|0
5690695|NCT00320255|19623959|P4|Overall Study|Adverse Event|2
5690696|NCT00320255|19623960|P3|Overall Study|Adverse Event|3
5690697|NCT00320255|19623961|P2|Overall Study|Adverse Event|2
5690698|NCT00320255|19623962|P1|Overall Study|Adverse Event|5
5690699|NCT00320255|19623957|P6|Overall Study|Lack of Efficacy|0
5690700|NCT00320255|19623958|P5|Overall Study|Lack of Efficacy|0
5690701|NCT00320255|19623959|P4|Overall Study|Lack of Efficacy|0
5690702|NCT00320255|19623960|P3|Overall Study|Lack of Efficacy|0
5690703|NCT00320255|19623961|P2|Overall Study|Lack of Efficacy|0
5690704|NCT00320255|19623962|P1|Overall Study|Lack of Efficacy|1
5690705|NCT00320216|19624055|P5|Overall Study|Other|3
5690706|NCT00320216|19624056|P4|Overall Study|Other|1
5690707|NCT00320216|19624057|P3|Overall Study|Other|5
5690708|NCT00320216|19624058|P2|Overall Study|Other|2
5690709|NCT00320216|19624059|P1|Overall Study|Other|7
5690710|NCT00320216|19624055|P5|Overall Study|Lost to Follow-up|0
5690711|NCT00320216|19624056|P4|Overall Study|Lost to Follow-up|0
5690712|NCT00320216|19624057|P3|Overall Study|Lost to Follow-up|0
5690713|NCT00320216|19624058|P2|Overall Study|Lost to Follow-up|0
5690714|NCT00320216|19624059|P1|Overall Study|Lost to Follow-up|3
5690715|NCT00320216|19624055|P5|Overall Study|Lack of Efficacy|1
5690716|NCT00320216|19624056|P4|Overall Study|Lack of Efficacy|0
5690717|NCT00320216|19624057|P3|Overall Study|Lack of Efficacy|1
5690718|NCT00320216|19624058|P2|Overall Study|Lack of Efficacy|2
5690719|NCT00320216|19624059|P1|Overall Study|Lack of Efficacy|6
5690720|NCT00320216|19624055|P5|Overall Study|Adverse Event|2
5690721|NCT00320216|19624056|P4|Overall Study|Adverse Event|2
5690722|NCT00320216|19624057|P3|Overall Study|Adverse Event|0
5690723|NCT00320216|19624058|P2|Overall Study|Adverse Event|6
5690724|NCT00320216|19624059|P1|Overall Study|Adverse Event|0
5690725|NCT00320190|19624093|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
5690726|NCT00320190|19624094|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
5690727|NCT00320190|19624093|P2|Long-term (12-month) Extension|Lack of major molecular response|2
5690728|NCT00320190|19624094|P1|Long-term (12-month) Extension|Lack of major molecular response|1
5690729|NCT00320190|19624093|P2|Long-term (12-month) Extension|Sponsor terminated study|0
5690730|NCT00320190|19624094|P1|Long-term (12-month) Extension|Sponsor terminated study|7
5690731|NCT00320190|19624093|P2|First 12 Months|Withdrawal by Subject|1
5690732|NCT00320190|19624094|P1|First 12 Months|Withdrawal by Subject|0
5690733|NCT00320190|19624093|P2|First 12 Months|Study drug toxicity|1
5690734|NCT00320190|19624094|P1|First 12 Months|Study drug toxicity|0
5690735|NCT00320190|19624093|P2|First 12 Months|Investigator request|1
5690736|NCT00320190|19624094|P1|First 12 Months|Investigator request|0
5690737|NCT00320190|19624093|P2|First 12 Months|Adverse event unrelated to study drug|0
5690738|NCT00320190|19624094|P1|First 12 Months|Adverse event unrelated to study drug|1
5690739|NCT00320190|19624093|P2|First 12 Months|Enrollment failure|1
5690740|NCT00320190|19624094|P1|First 12 Months|Enrollment failure|0
5690741|NCT00320190|19624093|P2|First 12 Months|Lost to Follow-up|1
5690742|NCT00320190|19624094|P1|First 12 Months|Lost to Follow-up|0
5690743|NCT00320190|19624093|P2|First 12 Months|Sponsor terminated study|2
5690744|NCT00320190|19624094|P1|First 12 Months|Sponsor terminated study|2
5690745|NCT00320190|19624093|P2|First 12 Months|Completed but did not enter extension|3
5690746|NCT00320190|19624094|P1|First 12 Months|Completed but did not enter extension|5
5690747|NCT00320112|19624114|P2|Overall Study|Death|1
5690748|NCT00320112|19624115|P1|Overall Study|Death|2
5690749|NCT00320112|19624114|P2|Overall Study|Withdrawal by Subject|0
5690750|NCT00320112|19624115|P1|Overall Study|Withdrawal by Subject|3
5690751|NCT00320112|19624114|P2|Overall Study|Lost to Follow-up|4
5690752|NCT00320112|19624115|P1|Overall Study|Lost to Follow-up|3
5690753|NCT00319982|19624129|P2|Overall Study|Withdrawal by Subject|0
5690754|NCT00319982|19624130|P1|Overall Study|Withdrawal by Subject|1
5690755|NCT00319956|19624150|P2|Overall Study|Death|24
5690756|NCT00319956|19624151|P1|Overall Study|Death|20
5690757|NCT00319839|19624163|P1|Overall Study|Withdrawal by Subject|1
5690758|NCT00319839|19624163|P1|Overall Study|Adverse Event|5
5690759|NCT00319735|19624179|P1|Overall Study|Death|2
5690760|NCT00319696|19624192|P1|Overall Study|Lost to Follow-up|3
5690761|NCT00319696|19624192|P1|Overall Study|administrative|7
5690762|NCT00319696|19624192|P1|Overall Study|withdrawal of consent|14
5690763|NCT00319696|19624192|P1|Overall Study|Adverse Event|36
5690764|NCT00319592|19624229|P2|Overall Study|Physician Decision|1
5690765|NCT00319592|19624230|P1|Overall Study|Physician Decision|0
5690766|NCT00319592|19624229|P2|Overall Study|Protocol Violation|0
5690767|NCT00319592|19624230|P1|Overall Study|Protocol Violation|1
5690768|NCT00319553|19624246|P2|Overall Study|Withdrawal by Subject|1
5690769|NCT00319553|19624247|P1|Overall Study|Withdrawal by Subject|1
5690770|NCT00319553|19624246|P2|Overall Study|Lost to Follow-up|1
5690771|NCT00319553|19624247|P1|Overall Study|Lost to Follow-up|2
5690772|NCT00319553|19624246|P2|Overall Study|Protocol Violation|2
5690773|NCT00319553|19624247|P1|Overall Study|Protocol Violation|1
5690774|NCT00319501|19624261|P2|Open-label Extension Period|Withdrawal by Subject|0
5690775|NCT00319501|19624262|P1|Open-label Extension Period|Withdrawal by Subject|2
5690776|NCT00319501|19624261|P2|Open-label Extension Period|Sponsor request|0
5690777|NCT00319501|19624262|P1|Open-label Extension Period|Sponsor request|26
5690778|NCT00319501|19624261|P2|Open-label Extension Period|Principal investigator decision|0
5690779|NCT00319501|19624262|P1|Open-label Extension Period|Principal investigator decision|2
5690780|NCT00319501|19624261|P2|Open-label Extension Period|Other|0
5690781|NCT00319501|19624262|P1|Open-label Extension Period|Other|1
5690782|NCT00319501|19624261|P2|Open-label Extension Period|Did not receive treatment|0
5690783|NCT00319501|19624262|P1|Open-label Extension Period|Did not receive treatment|18
5690784|NCT00319501|19624261|P2|Open-label Extension Period|Adverse Event|0
5690785|NCT00319501|19624262|P1|Open-label Extension Period|Adverse Event|2
5690786|NCT00319501|19624261|P2|Open-label Period|Other|0
5690787|NCT00319501|19624262|P1|Open-label Period|Other|11
5690788|NCT00319501|19624261|P2|Open-label Period|Did not receive treatment|0
5690789|NCT00319501|19624262|P1|Open-label Period|Did not receive treatment|33
5690790|NCT00319501|19624261|P2|Open-label Period|Lost to Follow-up|0
5690791|NCT00319501|19624262|P1|Open-label Period|Lost to Follow-up|5
5690792|NCT00319501|19624261|P2|Open-label Period|Sponsor request|0
5690793|NCT00319501|19624262|P1|Open-label Period|Sponsor request|12
5690794|NCT00319501|19624261|P2|Open-label Period|Principal Investigator decision|0
5690795|NCT00319501|19624262|P1|Open-label Period|Principal Investigator decision|6
5690796|NCT00319501|19624261|P2|Open-label Period|Withdrawal by Subject|0
5690797|NCT00319501|19624262|P1|Open-label Period|Withdrawal by Subject|38
5690798|NCT00319501|19624261|P2|Open-label Period|Protocol Violation|0
5690799|NCT00319501|19624262|P1|Open-label Period|Protocol Violation|6
5690800|NCT00319501|19624261|P2|Open-label Period|Adverse Event|0
5690801|NCT00319501|19624262|P1|Open-label Period|Adverse Event|5
5690802|NCT00319501|19624261|P2|Double-blind Period|Did not receive treatment|29
5690803|NCT00319501|19624262|P1|Double-blind Period|Did not receive treatment|42
5690804|NCT00319501|19624261|P2|Double-blind Period|Sponsor Request|0
5690805|NCT00319501|19624262|P1|Double-blind Period|Sponsor Request|1
5690806|NCT00319501|19624261|P2|Double-blind Period|Withdrawal by Subject|3
5690807|NCT00319501|19624262|P1|Double-blind Period|Withdrawal by Subject|0
5690808|NCT00319449|19624288|P2|Overall Study|Noncompliance with the protocol|0
5690809|NCT00319449|19624289|P1|Overall Study|Noncompliance with the protocol|1
5690810|NCT00319449|19624288|P2|Overall Study|Subject did not wish to continue|0
5690811|NCT00319449|19624289|P1|Overall Study|Subject did not wish to continue|1
5690812|NCT00319436|19624301|P2|Overall Study|Withdrawal by Subject|7
5690813|NCT00319436|19624302|P1|Overall Study|Withdrawal by Subject|6
5690814|NCT00319254|19624320|P1|Overall Study|Enrolled, Not Treated|2
5690815|NCT00319254|19624320|P1|Overall Study|Lost to Follow-up|2
5690816|NCT00319254|19624320|P1|Overall Study|Death|46
5690817|NCT00319254|19624320|P1|Overall Study|Withdrawal by Subject|4
5690818|NCT00319111|19624333|P1|Overall Study|Treatment failure|1
5690819|NCT00319111|19624333|P1|Overall Study|Administrative|2
5690820|NCT00319111|19624333|P1|Overall Study|Lack of clinical improvement|4
5690821|NCT00319111|19624333|P1|Overall Study|Death|9
5690822|NCT00319111|19624333|P1|Overall Study|Withdrawal of consent|11
5690823|NCT00319111|19624333|P1|Overall Study|Adverse Event|20
5690824|NCT00319098|19624347|P2|Overall Study|Protocol Violation|1
5690825|NCT00319098|19624348|P1|Overall Study|Protocol Violation|3
5690826|NCT00319098|19624347|P2|Overall Study|Others|8
5690827|NCT00319098|19624348|P1|Overall Study|Others|33
5690828|NCT00319098|19624347|P2|Overall Study|Lost to Follow-up|13
5690829|NCT00319098|19624348|P1|Overall Study|Lost to Follow-up|37
5690830|NCT00319098|19624347|P2|Overall Study|Migrated/moved from study area|1
5690831|NCT00319098|19624348|P1|Overall Study|Migrated/moved from study area|2
5690832|NCT00319098|19624347|P2|Overall Study|Withdrawal by Subject|8
5690833|NCT00319098|19624348|P1|Overall Study|Withdrawal by Subject|37
5690834|NCT00319098|19624347|P2|Overall Study|Adverse Event|1
5690835|NCT00319098|19624348|P1|Overall Study|Adverse Event|20
5690836|NCT00319098|19624347|P2|Overall Study|Serious adverse event|0
5690837|NCT00319098|19624348|P1|Overall Study|Serious adverse event|3
5690838|NCT00319046|19624406|P1|Overall Study|administrative reason|1
5690839|NCT00319046|19624406|P1|Overall Study|withdrawal of subject's consent|7
5690840|NCT00319020|19624415|P2|Overall Study|Adverse Event|1
5690841|NCT00319020|19624416|P1|Overall Study|Adverse Event|0
5690842|NCT00319020|19624415|P2|Overall Study|Treatment failure|1
5690843|NCT00319020|19624416|P1|Overall Study|Treatment failure|0
5690844|NCT00319020|19624415|P2|Overall Study|Transplant|1
5690845|NCT00319020|19624416|P1|Overall Study|Transplant|0
5690846|NCT00319020|19624415|P2|Overall Study|Disease progression|2
5690847|NCT00319020|19624416|P1|Overall Study|Disease progression|0
5690848|NCT00319020|19624415|P2|Overall Study|Administrative reason|5
5690849|NCT00319020|19624416|P1|Overall Study|Administrative reason|0
5690850|NCT00319020|19624415|P2|Overall Study|F-1 completed but not enrolled in F-2|0
5690851|NCT00319020|19624416|P1|Overall Study|F-1 completed but not enrolled in F-2|1
5690852|NCT00319020|19624415|P2|Overall Study|Withdrawal by Subject|1
5690853|NCT00319020|19624416|P1|Overall Study|Withdrawal by Subject|4
5690854|NCT00319020|19624415|P2|Overall Study|Death|2
5690855|NCT00319020|19624416|P1|Overall Study|Death|2
5690856|NCT00318656|19624488|P2|Overall Study|Did not receive any treatment|1
5690857|NCT00318656|19624489|P1|Overall Study|Did not receive any treatment|0
5690858|NCT00318656|19624488|P2|Overall Study|Took Avandamet instead of Glim/Met|1
5690859|NCT00318656|19624489|P1|Overall Study|Took Avandamet instead of Glim/Met|0
5690860|NCT00318565|19624546|P1|Overall Study|Excluded per protocol|24
5690861|NCT00318474|19624553|P2|Overall Study|Trial terminated|7
5690862|NCT00318474|19624554|P1|Overall Study|Trial terminated|10
5690863|NCT00318474|19624553|P2|Overall Study|Post-therapy hyperflycemia|1
5690864|NCT00318474|19624554|P1|Overall Study|Post-therapy hyperflycemia|0
5690865|NCT00318474|19624553|P2|Overall Study|Fall in GFR|3
5690866|NCT00318474|19624554|P1|Overall Study|Fall in GFR|3
5690867|NCT00318474|19624553|P2|Overall Study|Withdrawal by Subject|2
5690868|NCT00318474|19624554|P1|Overall Study|Withdrawal by Subject|3
5690869|NCT00318474|19624553|P2|Overall Study|Protocol Violation|0
5690870|NCT00318474|19624554|P1|Overall Study|Protocol Violation|1
5690871|NCT00318474|19624553|P2|Overall Study|Pregnancy|2
5690872|NCT00318474|19624554|P1|Overall Study|Pregnancy|0
5690873|NCT00318474|19624553|P2|Overall Study|Lost to Follow-up|1
5690874|NCT00318474|19624554|P1|Overall Study|Lost to Follow-up|0
5690875|NCT00318474|19624553|P2|Overall Study|Adverse Event|1
5690876|NCT00318474|19624554|P1|Overall Study|Adverse Event|1
5690877|NCT00318461|19624565|P5|Open-Label Extension, 18 Months|Protocol Violation|6
5690878|NCT00318461|19624566|P4|Open-Label Extension, 18 Months|Protocol Violation|4
5690879|NCT00318461|19624567|P3|Open-Label Extension, 18 Months|Protocol Violation|3
5690880|NCT00318461|19624568|P2|Open-Label Extension, 18 Months|Protocol Violation|5
5690881|NCT00318461|19624569|P1|Open-Label Extension, 18 Months|Protocol Violation|7
5690882|NCT00318461|19624565|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
5690883|NCT00318461|19624566|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
5690884|NCT00318461|19624567|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
5690885|NCT00318461|19624568|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
5690886|NCT00318461|19624569|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
5690887|NCT00318461|19624565|P5|Open-Label Extension, 18 Months|Adverse Event|6
5690888|NCT00318461|19624566|P4|Open-Label Extension, 18 Months|Adverse Event|1
5690889|NCT00318461|19624567|P3|Open-Label Extension, 18 Months|Adverse Event|6
5690890|NCT00318461|19624568|P2|Open-Label Extension, 18 Months|Adverse Event|8
5690891|NCT00318461|19624569|P1|Open-Label Extension, 18 Months|Adverse Event|11
5690892|NCT00318461|19624565|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
5690893|NCT00318461|19624566|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
5690894|NCT00318461|19624567|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
5690895|NCT00318461|19624568|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
5690896|NCT00318461|19624569|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
5690897|NCT00318461|19624565|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
5690898|NCT00318461|19624566|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
5690899|NCT00318461|19624567|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
5690900|NCT00318461|19624568|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
5690901|NCT00318461|19624569|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
5690902|NCT00318461|19624565|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
5690903|NCT00318461|19624566|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
5690904|NCT00318461|19624567|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
5690905|NCT00318461|19624568|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
5690906|NCT00318461|19624569|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
5690907|NCT00318461|19624565|P5|Double-Blind, 6 Months|Hyperglicaemia|0
5690908|NCT00318461|19624566|P4|Double-Blind, 6 Months|Hyperglicaemia|1
5690909|NCT00318461|19624567|P3|Double-Blind, 6 Months|Hyperglicaemia|0
5690910|NCT00318461|19624568|P2|Double-Blind, 6 Months|Hyperglicaemia|0
5690911|NCT00318461|19624569|P1|Double-Blind, 6 Months|Hyperglicaemia|0
5690912|NCT00318461|19624565|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
5690913|NCT00318461|19624566|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
5690914|NCT00318461|19624567|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
5690915|NCT00318461|19624568|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
5690916|NCT00318461|19624569|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
5690917|NCT00318461|19624565|P5|Double-Blind, 6 Months|Lack of time|0
5690918|NCT00318461|19624566|P4|Double-Blind, 6 Months|Lack of time|0
5690919|NCT00318461|19624567|P3|Double-Blind, 6 Months|Lack of time|0
5690920|NCT00318461|19624568|P2|Double-Blind, 6 Months|Lack of time|0
5690921|NCT00318461|19624569|P1|Double-Blind, 6 Months|Lack of time|1
5690922|NCT00318461|19624565|P5|Double-Blind, 6 Months|Investigator decision|1
5690923|NCT00318461|19624566|P4|Double-Blind, 6 Months|Investigator decision|0
5690924|NCT00318461|19624567|P3|Double-Blind, 6 Months|Investigator decision|0
5690925|NCT00318461|19624568|P2|Double-Blind, 6 Months|Investigator decision|0
5690926|NCT00318461|19624569|P1|Double-Blind, 6 Months|Investigator decision|0
5690927|NCT00318461|19624565|P5|Double-Blind, 6 Months|Work commitment|1
5690928|NCT00318461|19624566|P4|Double-Blind, 6 Months|Work commitment|0
5690929|NCT00318461|19624567|P3|Double-Blind, 6 Months|Work commitment|0
5690930|NCT00318461|19624568|P2|Double-Blind, 6 Months|Work commitment|0
5690931|NCT00318461|19624569|P1|Double-Blind, 6 Months|Work commitment|0
5690932|NCT00318461|19624565|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
5690933|NCT00318461|19624566|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
5690934|NCT00318461|19624567|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
5690935|NCT00318461|19624568|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
5690936|NCT00318461|19624569|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
5690937|NCT00318461|19624565|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
5690938|NCT00318461|19624566|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
5690939|NCT00318461|19624567|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
5690940|NCT00318461|19624568|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
5690941|NCT00318461|19624569|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
5690942|NCT00318461|19624565|P5|Double-Blind, 6 Months|Move|0
5690943|NCT00318461|19624566|P4|Double-Blind, 6 Months|Move|0
5690944|NCT00318461|19624567|P3|Double-Blind, 6 Months|Move|0
5690945|NCT00318461|19624568|P2|Double-Blind, 6 Months|Move|1
5690946|NCT00318461|19624569|P1|Double-Blind, 6 Months|Move|0
5690947|NCT00318461|19624565|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
5690948|NCT00318461|19624566|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
5690949|NCT00318461|19624567|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
5690950|NCT00318461|19624568|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
5690951|NCT00318461|19624569|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
5690952|NCT00318461|19624565|P5|Double-Blind, 6 Months|Consent withdrawn|4
5690953|NCT00318461|19624566|P4|Double-Blind, 6 Months|Consent withdrawn|10
5690954|NCT00318461|19624567|P3|Double-Blind, 6 Months|Consent withdrawn|4
5690955|NCT00318461|19624568|P2|Double-Blind, 6 Months|Consent withdrawn|3
5690956|NCT00318461|19624569|P1|Double-Blind, 6 Months|Consent withdrawn|0
5690957|NCT00318461|19624565|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
5690958|NCT00318461|19624566|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
5690959|NCT00318461|19624567|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
5690960|NCT00318461|19624568|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
5690961|NCT00318461|19624569|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
5690962|NCT00318461|19624565|P5|Double-Blind, 6 Months|Lost to follow up|0
5690963|NCT00318461|19624566|P4|Double-Blind, 6 Months|Lost to follow up|0
5690964|NCT00318461|19624567|P3|Double-Blind, 6 Months|Lost to follow up|0
5690965|NCT00318461|19624568|P2|Double-Blind, 6 Months|Lost to follow up|1
5690966|NCT00318461|19624569|P1|Double-Blind, 6 Months|Lost to follow up|0
5690967|NCT00318461|19624565|P5|Double-Blind, 6 Months|Protocol Violation|5
5690968|NCT00318461|19624566|P4|Double-Blind, 6 Months|Protocol Violation|4
5690969|NCT00318461|19624567|P3|Double-Blind, 6 Months|Protocol Violation|4
5690970|NCT00318461|19624568|P2|Double-Blind, 6 Months|Protocol Violation|4
5690971|NCT00318461|19624569|P1|Double-Blind, 6 Months|Protocol Violation|2
5690972|NCT00318461|19624565|P5|Double-Blind, 6 Months|Lack of Efficacy|9
5690973|NCT00318461|19624566|P4|Double-Blind, 6 Months|Lack of Efficacy|29
5690974|NCT00318461|19624567|P3|Double-Blind, 6 Months|Lack of Efficacy|13
5690975|NCT00318461|19624568|P2|Double-Blind, 6 Months|Lack of Efficacy|8
5690976|NCT00318461|19624569|P1|Double-Blind, 6 Months|Lack of Efficacy|19
5690977|NCT00318461|19624565|P5|Double-Blind, 6 Months|Adverse Event|8
5690978|NCT00318461|19624566|P4|Double-Blind, 6 Months|Adverse Event|2
5690979|NCT00318461|19624567|P3|Double-Blind, 6 Months|Adverse Event|29
5690980|NCT00318461|19624568|P2|Double-Blind, 6 Months|Adverse Event|23
5690981|NCT00318461|19624569|P1|Double-Blind, 6 Months|Adverse Event|11
5690982|NCT00318370|19624668|P3|Period 3|Other|3
5690983|NCT00318370|19624669|P2|Period 3|Other|0
5690984|NCT00318370|19624670|P1|Period 3|Other|0
5690985|NCT00318370|19624668|P3|Period 3|Withdrawal by Subject|3
5690986|NCT00318370|19624669|P2|Period 3|Withdrawal by Subject|0
5690987|NCT00318370|19624670|P1|Period 3|Withdrawal by Subject|0
5690988|NCT00318370|19624668|P3|Period 3|Physician Decision|1
5690989|NCT00318370|19624669|P2|Period 3|Physician Decision|0
5690990|NCT00318370|19624670|P1|Period 3|Physician Decision|0
5690991|NCT00318370|19624668|P3|Period 3|Death|1
5690992|NCT00318370|19624669|P2|Period 3|Death|0
5690993|NCT00318370|19624670|P1|Period 3|Death|0
5690994|NCT00318370|19624668|P3|Period 3|Lack of Efficacy|24
5690995|NCT00318370|19624669|P2|Period 3|Lack of Efficacy|0
5690996|NCT00318370|19624670|P1|Period 3|Lack of Efficacy|0
5690997|NCT00318370|19624668|P3|Period 3|Adverse Event|1
5690998|NCT00318370|19624669|P2|Period 3|Adverse Event|0
5690999|NCT00318370|19624670|P1|Period 3|Adverse Event|0
5691000|NCT00318370|19624668|P3|Period 2|Other|0
5691001|NCT00318370|19624669|P2|Period 2|Other|1
5691002|NCT00318370|19624670|P1|Period 2|Other|0
5691003|NCT00318370|19624668|P3|Period 2|Withdrawal by Subject|0
5691004|NCT00318370|19624669|P2|Period 2|Withdrawal by Subject|1
5691005|NCT00318370|19624670|P1|Period 2|Withdrawal by Subject|0
5691006|NCT00318370|19624668|P3|Period 2|Physician Decision|0
5691007|NCT00318370|19624669|P2|Period 2|Physician Decision|1
5691008|NCT00318370|19624670|P1|Period 2|Physician Decision|0
5691009|NCT00318370|19624668|P3|Period 2|Lack of Efficacy|0
5691010|NCT00318370|19624669|P2|Period 2|Lack of Efficacy|5
5691011|NCT00318370|19624670|P1|Period 2|Lack of Efficacy|0
5691012|NCT00318370|19624668|P3|Period 2|Adverse Event|0
5691013|NCT00318370|19624669|P2|Period 2|Adverse Event|3
5691014|NCT00318370|19624670|P1|Period 2|Adverse Event|0
5691015|NCT00318370|19624668|P3|Period 1|Withdrawal by Subject|0
5691016|NCT00318370|19624669|P2|Period 1|Withdrawal by Subject|0
5691017|NCT00318370|19624670|P1|Period 1|Withdrawal by Subject|1
5691018|NCT00318370|19624668|P3|Period 1|Physician Decision|0
5691019|NCT00318370|19624669|P2|Period 1|Physician Decision|0
5691020|NCT00318370|19624670|P1|Period 1|Physician Decision|1
5691021|NCT00318370|19624668|P3|Period 1|Lack of Efficacy|0
5691022|NCT00318370|19624669|P2|Period 1|Lack of Efficacy|0
5691023|NCT00318370|19624670|P1|Period 1|Lack of Efficacy|5
5691024|NCT00318149|19624704|P6|Overall Study|Adverse Event|2
5691025|NCT00318149|19624705|P5|Overall Study|Adverse Event|0
5691026|NCT00318149|19624706|P4|Overall Study|Adverse Event|0
5691027|NCT00318149|19624707|P3|Overall Study|Adverse Event|0
5691028|NCT00318149|19624708|P2|Overall Study|Adverse Event|0
5691029|NCT00318149|19624709|P1|Overall Study|Adverse Event|0
5691030|NCT00317642|19624855|P2|Overall Study|AML Not Centrally Confirmed|5
5691031|NCT00317642|19624856|P1|Overall Study|AML Not Centrally Confirmed|1
5691032|NCT00317642|19624855|P2|Overall Study|Referred For Transplantation|0
5691033|NCT00317642|19624856|P1|Overall Study|Referred For Transplantation|1
5691034|NCT00317642|19624855|P2|Overall Study|Withdrawal by Subject|1
5691035|NCT00317642|19624856|P1|Overall Study|Withdrawal by Subject|0
5691036|NCT00317642|19624855|P2|Overall Study|Not Continue to Consolidation|0
5691037|NCT00317642|19624856|P1|Overall Study|Not Continue to Consolidation|2
5691038|NCT00317642|19624855|P2|Overall Study|Death|7
5691039|NCT00317642|19624856|P1|Overall Study|Death|14
5691040|NCT00317642|19624855|P2|Overall Study|Disease Recurrence|2
5691041|NCT00317642|19624856|P1|Overall Study|Disease Recurrence|1
5691042|NCT00317642|19624855|P2|Overall Study|Treatment Failure|102
5691043|NCT00317642|19624856|P1|Overall Study|Treatment Failure|56
5691044|NCT00317642|19624855|P2|Overall Study|Adverse Event|5
5691045|NCT00317642|19624856|P1|Overall Study|Adverse Event|17
5691046|NCT00317642|19624855|P2|Overall Study|Participant declined treatment|3
5691047|NCT00317642|19624856|P1|Overall Study|Participant declined treatment|14
5691048|NCT00317642|19624855|P2|Overall Study|Physician Decision|7
5691049|NCT00317642|19624856|P1|Overall Study|Physician Decision|15
5691050|NCT00317642|19624855|P2|Overall Study|Not Received Either Study Drug|3
5691051|NCT00317642|19624856|P1|Overall Study|Not Received Either Study Drug|1
5691052|NCT00317473|19624935|P6|Overall Study|Other|0
5691053|NCT00317473|19624936|P5|Overall Study|Other|0
5691054|NCT00317473|19624937|P4|Overall Study|Other|0
5691055|NCT00317473|19624938|P3|Overall Study|Other|0
5691056|NCT00317473|19624939|P2|Overall Study|Other|2
5691057|NCT00317473|19624940|P1|Overall Study|Other|0
5691058|NCT00317473|19624935|P6|Overall Study|Death|0
5691059|NCT00317473|19624936|P5|Overall Study|Death|0
5691060|NCT00317473|19624937|P4|Overall Study|Death|0
5691061|NCT00317473|19624938|P3|Overall Study|Death|0
5691062|NCT00317473|19624939|P2|Overall Study|Death|0
5691063|NCT00317473|19624940|P1|Overall Study|Death|1
5691064|NCT00317473|19624935|P6|Overall Study|Relocation|2
5691065|NCT00317473|19624936|P5|Overall Study|Relocation|5
5691066|NCT00317473|19624937|P4|Overall Study|Relocation|1
5691067|NCT00317473|19624938|P3|Overall Study|Relocation|1
5691068|NCT00317473|19624939|P2|Overall Study|Relocation|0
5691069|NCT00317473|19624940|P1|Overall Study|Relocation|1
5691070|NCT00317473|19624935|P6|Overall Study|Withdrawal by Subject|1
5691071|NCT00317473|19624936|P5|Overall Study|Withdrawal by Subject|3
5691072|NCT00317473|19624937|P4|Overall Study|Withdrawal by Subject|1
5691073|NCT00317473|19624938|P3|Overall Study|Withdrawal by Subject|2
5691074|NCT00317473|19624939|P2|Overall Study|Withdrawal by Subject|1
5691075|NCT00317473|19624940|P1|Overall Study|Withdrawal by Subject|2
5691076|NCT00317109|19624979|P2|Overall Study|Migated/moved from study area|0
5691077|NCT00317109|19624980|P1|Overall Study|Migated/moved from study area|1
5691078|NCT00317109|19624979|P2|Overall Study|Withdrawal by Subject|0
5691079|NCT00317109|19624980|P1|Overall Study|Withdrawal by Subject|2
5691080|NCT00317044|19625017|P3|Overall Study|Multiple Reasons|6
5691081|NCT00317044|19625018|P2|Overall Study|Multiple Reasons|2
5691082|NCT00317044|19625019|P1|Overall Study|Multiple Reasons|6
5691083|NCT00317044|19625017|P3|Overall Study|Lost to Follow-up|3
5691084|NCT00317044|19625018|P2|Overall Study|Lost to Follow-up|2
5691085|NCT00317044|19625019|P1|Overall Study|Lost to Follow-up|0
5691086|NCT00317044|19625017|P3|Overall Study|Withdrawal by Subject|12
5691087|NCT00317044|19625018|P2|Overall Study|Withdrawal by Subject|7
5691088|NCT00317044|19625019|P1|Overall Study|Withdrawal by Subject|10
5691089|NCT00317044|19625017|P3|Overall Study|Adverse Event|4
5691090|NCT00317044|19625018|P2|Overall Study|Adverse Event|7
5691091|NCT00317044|19625019|P1|Overall Study|Adverse Event|4
5691092|NCT00317044|19625017|P3|Overall Study|Protocol Violation|20
5691093|NCT00317044|19625018|P2|Overall Study|Protocol Violation|22
5691094|NCT00317044|19625019|P1|Overall Study|Protocol Violation|28
5691095|NCT00316914|19625065|P2|Overall Study|Missing end of treatment documentation|15
5691096|NCT00316914|19625066|P1|Overall Study|Missing end of treatment documentation|14
5691097|NCT00316914|19625065|P2|Overall Study|Other Problems|11
5691098|NCT00316914|19625066|P1|Overall Study|Other Problems|6
5691099|NCT00316914|19625065|P2|Overall Study|Adverse Event|7
5691100|NCT00316914|19625066|P1|Overall Study|Adverse Event|8
5691101|NCT00316914|19625065|P2|Overall Study|Withdrawal by Subject|3
5691102|NCT00316914|19625066|P1|Overall Study|Withdrawal by Subject|5
5691103|NCT00316888|19625096|P2|Overall Study|Not start protocol therapy|1
5691104|NCT00316888|19625097|P1|Overall Study|Not start protocol therapy|0
5691105|NCT00316888|19625096|P2|Overall Study|Withdrawal by Subject|2
5691106|NCT00316888|19625097|P1|Overall Study|Withdrawal by Subject|2
5691107|NCT00316888|19625096|P2|Overall Study|Adverse Event|5
5691108|NCT00316888|19625097|P1|Overall Study|Adverse Event|4
5691109|NCT00316719|19625119|P2|Overall Study|Consent withdrawn|0
5691110|NCT00316719|19625120|P1|Overall Study|Consent withdrawn|2
5691111|NCT00316719|19625119|P2|Overall Study|Adverse Event|6
5691112|NCT00316719|19625120|P1|Overall Study|Adverse Event|0
5691113|NCT00316706|19625146|P2|Overall Study|Lost to Follow-up|48
5691114|NCT00316706|19625147|P1|Overall Study|Lost to Follow-up|38
5691115|NCT00316693|19625163|P2|Overall Study|Other|44
5691116|NCT00316693|19625164|P1|Overall Study|Other|38
5691117|NCT00316693|19625163|P2|Overall Study|Lost to Follow-up|34
5691118|NCT00316693|19625164|P1|Overall Study|Lost to Follow-up|26
5691119|NCT00316693|19625163|P2|Overall Study|Withdrawal by Subject|6
5691120|NCT00316693|19625164|P1|Overall Study|Withdrawal by Subject|6
5691121|NCT00316693|19625163|P2|Overall Study|Protocol Violation|0
5691122|NCT00316693|19625164|P1|Overall Study|Protocol Violation|1
5691123|NCT00316693|19625163|P2|Overall Study|Adverse Event|1
5691124|NCT00316693|19625164|P1|Overall Study|Adverse Event|6
5691125|NCT00316602|19625206|P2|Overall Study|Other|6
5691126|NCT00316602|19625207|P1|Overall Study|Other|3
5691127|NCT00316602|19625206|P2|Overall Study|Adverse Event|0
5691128|NCT00316602|19625207|P1|Overall Study|Adverse Event|1
5691129|NCT00316602|19625206|P2|Overall Study|Subject unwilling/unable to comply with|17
5691130|NCT00316602|19625207|P1|Overall Study|Subject unwilling/unable to comply with|3
5691131|NCT00316602|19625206|P2|Overall Study|Withdrawal by Subject|2
5691132|NCT00316602|19625207|P1|Overall Study|Withdrawal by Subject|3
5691133|NCT00316589|19625239|P4|Overall Study|Other reason|1
5691134|NCT00316589|19625240|P3|Overall Study|Other reason|1
5691135|NCT00316589|19625241|P2|Overall Study|Other reason|12
5691136|NCT00316589|19625242|P1|Overall Study|Other reason|0
5691137|NCT00316589|19625239|P4|Overall Study|Physician Decision|0
5691138|NCT00316589|19625240|P3|Overall Study|Physician Decision|0
5691139|NCT00316589|19625241|P2|Overall Study|Physician Decision|1
5691140|NCT00316589|19625242|P1|Overall Study|Physician Decision|0
5691141|NCT00316589|19625239|P4|Overall Study|Adverse Event|1
5691142|NCT00316589|19625240|P3|Overall Study|Adverse Event|0
5691143|NCT00316589|19625241|P2|Overall Study|Adverse Event|0
5691144|NCT00316589|19625242|P1|Overall Study|Adverse Event|1
5691145|NCT00316589|19625239|P4|Overall Study|Subject unwilling/unable to comply|2
5691146|NCT00316589|19625240|P3|Overall Study|Subject unwilling/unable to comply|0
5691147|NCT00316589|19625241|P2|Overall Study|Subject unwilling/unable to comply|6
5691148|NCT00316589|19625242|P1|Overall Study|Subject unwilling/unable to comply|0
5691149|NCT00316589|19625239|P4|Overall Study|Withdrawal by Subject|1
5691150|NCT00316589|19625240|P3|Overall Study|Withdrawal by Subject|0
5691151|NCT00316589|19625241|P2|Overall Study|Withdrawal by Subject|5
5691152|NCT00316589|19625242|P1|Overall Study|Withdrawal by Subject|0
5691153|NCT00316303|19625376|P2|Overall Study|Lost to Follow-up|16
5691154|NCT00316303|19625377|P1|Overall Study|Lost to Follow-up|11
5691155|NCT00316277|19625393|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
5691156|NCT00316277|19625394|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
5691157|NCT00316277|19625393|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
5691158|NCT00316277|19625394|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
5691159|NCT00316277|19625393|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
5691160|NCT00316277|19625394|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
5691161|NCT00316277|19625393|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
5691162|NCT00316277|19625394|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
5691163|NCT00316277|19625393|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
5691164|NCT00316277|19625394|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
5691165|NCT00316264|19625415|P3|Overall Study|Other|0
5691166|NCT00316264|19625416|P2|Overall Study|Other|1
5691167|NCT00316264|19625417|P1|Overall Study|Other|1
5691168|NCT00316264|19625415|P3|Overall Study|Death|0
5691169|NCT00316264|19625416|P2|Overall Study|Death|0
5691170|NCT00316264|19625417|P1|Overall Study|Death|2
5691171|NCT00316264|19625415|P3|Overall Study|Withdrawal of Consent|6
5691172|NCT00316264|19625416|P2|Overall Study|Withdrawal of Consent|5
5691173|NCT00316264|19625417|P1|Overall Study|Withdrawal of Consent|3
5691174|NCT00316264|19625415|P3|Overall Study|Lost to Follow-up|0
5691175|NCT00316264|19625416|P2|Overall Study|Lost to Follow-up|1
5691176|NCT00316264|19625417|P1|Overall Study|Lost to Follow-up|0
5691177|NCT00316225|19625485|P1|Overall Study|Death|2
5691178|NCT00316225|19625485|P1|Overall Study|Withdrawal by Subject|3
5691179|NCT00316225|19625485|P1|Overall Study|Progressive Disease|15
5691180|NCT00316225|19625485|P1|Overall Study|Physician Decision|3
5691181|NCT00316225|19625485|P1|Overall Study|Adverse Event|2
5691182|NCT00316199|19625494|P1|Overall Study|Lost to Follow-up|2
5691183|NCT00316199|19625494|P1|Overall Study|Death|8
5691184|NCT00316199|19625494|P1|Overall Study|Adverse Event|2
5691185|NCT00316186|19625502|P1|Overall Study|Other|1
5691186|NCT00316186|19625502|P1|Overall Study|Lost to Follow-up|1
5691187|NCT00316186|19625502|P1|Overall Study|Disease Progression|4
5691188|NCT00316186|19625502|P1|Overall Study|Adverse Event|6
5691189|NCT00316173|19625516|P2|Treatment Phase|Study Follow-up Stopped|34
5691190|NCT00316173|19625517|P1|Treatment Phase|Study Follow-up Stopped|0
5691191|NCT00316173|19625516|P2|Treatment Phase|Withdrawal by Subject|1
5691192|NCT00316173|19625517|P1|Treatment Phase|Withdrawal by Subject|0
5691193|NCT00316173|19625516|P2|Treatment Phase|Lost to Follow-up|3
5691194|NCT00316173|19625517|P1|Treatment Phase|Lost to Follow-up|0
5691195|NCT00316173|19625516|P2|Treatment Phase|Lack of Efficacy|3
5691196|NCT00316173|19625517|P1|Treatment Phase|Lack of Efficacy|0
5691197|NCT00316173|19625516|P2|Treatment Phase|Adverse Event|1
5691198|NCT00316173|19625517|P1|Treatment Phase|Adverse Event|0
5691199|NCT00316173|19625516|P2|Run-in Phase|Study Follow-up Stopped|0
5691200|NCT00316173|19625517|P1|Run-in Phase|Study Follow-up Stopped|5
5691201|NCT00316173|19625516|P2|Run-in Phase|Protocol Violation|0
5691202|NCT00316173|19625517|P1|Run-in Phase|Protocol Violation|1
5691203|NCT00316173|19625516|P2|Run-in Phase|Adverse Event|0
5691204|NCT00316173|19625517|P1|Run-in Phase|Adverse Event|1
5691205|NCT00316121|19625530|P2|Overall Study|Subject did not have 24 month visit|0
5691206|NCT00316121|19625531|P1|Overall Study|Subject did not have 24 month visit|1
5691207|NCT00316121|19625530|P2|Overall Study|Subject no show for visit x 3|0
5691208|NCT00316121|19625531|P1|Overall Study|Subject no show for visit x 3|1
5691209|NCT00316121|19625530|P2|Overall Study|Subject refused to return|0
5691210|NCT00316121|19625531|P1|Overall Study|Subject refused to return|1
5691211|NCT00316121|19625530|P2|Overall Study|Subject relocated|1
5691212|NCT00316121|19625531|P1|Overall Study|Subject relocated|1
5691213|NCT00316121|19625530|P2|Overall Study|Reason is missing|0
5691214|NCT00316121|19625531|P1|Overall Study|Reason is missing|1
5691215|NCT00316121|19625530|P2|Overall Study|Withdrawal by Subject|0
5691216|NCT00316121|19625531|P1|Overall Study|Withdrawal by Subject|2
5691217|NCT00316121|19625530|P2|Overall Study|Lost to Follow-up|8
5691218|NCT00316121|19625531|P1|Overall Study|Lost to Follow-up|14
5691219|NCT00316121|19625530|P2|Overall Study|Death|0
5691220|NCT00316121|19625531|P1|Overall Study|Death|1
5691221|NCT00316082|19625542|P5|Overall Study|Administrative reason by sponsor|0
5691222|NCT00316082|19625543|P4|Overall Study|Administrative reason by sponsor|0
5691223|NCT00316082|19625544|P3|Overall Study|Administrative reason by sponsor|1
5691224|NCT00316082|19625545|P2|Overall Study|Administrative reason by sponsor|0
5691225|NCT00316082|19625546|P1|Overall Study|Administrative reason by sponsor|0
5691226|NCT00316082|19625542|P5|Overall Study|Death|0
5691227|NCT00316082|19625543|P4|Overall Study|Death|0
5691228|NCT00316082|19625544|P3|Overall Study|Death|1
5691229|NCT00316082|19625545|P2|Overall Study|Death|0
5691230|NCT00316082|19625546|P1|Overall Study|Death|0
5691231|NCT00316082|19625542|P5|Overall Study|Physician Decision|1
5691232|NCT00316082|19625543|P4|Overall Study|Physician Decision|1
5691233|NCT00316082|19625544|P3|Overall Study|Physician Decision|2
5691234|NCT00316082|19625545|P2|Overall Study|Physician Decision|1
5691235|NCT00316082|19625546|P1|Overall Study|Physician Decision|1
5691236|NCT00316082|19625542|P5|Overall Study|Subject no longer meets study criteria|1
5691237|NCT00316082|19625543|P4|Overall Study|Subject no longer meets study criteria|2
5691238|NCT00316082|19625544|P3|Overall Study|Subject no longer meets study criteria|2
5691239|NCT00316082|19625545|P2|Overall Study|Subject no longer meets study criteria|1
5691240|NCT00316082|19625546|P1|Overall Study|Subject no longer meets study criteria|3
5691241|NCT00316082|19625542|P5|Overall Study|Adverse Event|3
5691242|NCT00316082|19625543|P4|Overall Study|Adverse Event|1
5691243|NCT00316082|19625544|P3|Overall Study|Adverse Event|5
5691244|NCT00316082|19625545|P2|Overall Study|Adverse Event|2
5691245|NCT00316082|19625546|P1|Overall Study|Adverse Event|4
5691246|NCT00316082|19625542|P5|Overall Study|Poor/noncompliance|4
5691247|NCT00316082|19625543|P4|Overall Study|Poor/noncompliance|1
5691248|NCT00316082|19625544|P3|Overall Study|Poor/noncompliance|4
5691249|NCT00316082|19625545|P2|Overall Study|Poor/noncompliance|1
5691250|NCT00316082|19625546|P1|Overall Study|Poor/noncompliance|6
5691251|NCT00316082|19625542|P5|Overall Study|Lost to Follow-up|6
5691252|NCT00316082|19625543|P4|Overall Study|Lost to Follow-up|8
5691253|NCT00316082|19625544|P3|Overall Study|Lost to Follow-up|7
5691254|NCT00316082|19625545|P2|Overall Study|Lost to Follow-up|6
5691255|NCT00316082|19625546|P1|Overall Study|Lost to Follow-up|7
5691256|NCT00316082|19625542|P5|Overall Study|Withdrawal of Consent by Subject|5
5691257|NCT00316082|19625543|P4|Overall Study|Withdrawal of Consent by Subject|9
5691258|NCT00316082|19625544|P3|Overall Study|Withdrawal of Consent by Subject|2
5691259|NCT00316082|19625545|P2|Overall Study|Withdrawal of Consent by Subject|8
5691260|NCT00316082|19625546|P1|Overall Study|Withdrawal of Consent by Subject|10
5691261|NCT00316082|19625542|P5|Overall Study|Lack of Efficacy|6
5691262|NCT00316082|19625543|P4|Overall Study|Lack of Efficacy|4
5691263|NCT00316082|19625544|P3|Overall Study|Lack of Efficacy|3
5691264|NCT00316082|19625545|P2|Overall Study|Lack of Efficacy|3
5691265|NCT00316082|19625546|P1|Overall Study|Lack of Efficacy|2
5691266|NCT00316017|19625577|P3|Overall Study|Protocol Violation|19
5691267|NCT00316017|19625578|P2|Overall Study|Protocol Violation|13
5691268|NCT00316017|19625579|P1|Overall Study|Protocol Violation|11
5691269|NCT00316004|19625653|P3|Overall Study|Subject was not given study fluid.|21
5691270|NCT00316004|19625654|P2|Overall Study|Subject was not given study fluid.|14
5691271|NCT00316004|19625655|P1|Overall Study|Subject was not given study fluid.|14
5691272|NCT00315731|19625726|P1|Overall Study|Death|5
5691273|NCT00315731|19625726|P1|Overall Study|Lost to Follow-up|1
5691274|NCT00315705|19625754|P1|Phase 2|Death|7
5691275|NCT00315705|19625754|P1|Phase 2|Other|1
5691276|NCT00315705|19625754|P1|Phase 2|Scheduled for transplant|8
5691277|NCT00315705|19625754|P1|Phase 2|Disease relapse|1
5691278|NCT00315705|19625754|P1|Phase 2|Failure to achieve response|3
5691279|NCT00315705|19625754|P1|Phase 2|Adverse Event|1
5691280|NCT00315705|19625754|P1|Phase 2|Physician Decision|4
5691281|NCT00315705|19625754|P1|Phase 1|Death|3
5691282|NCT00315705|19625754|P1|Phase 1|Scheduled for transplant|9
5691283|NCT00315705|19625754|P1|Phase 1|Disease relapse|4
5691284|NCT00315705|19625754|P1|Phase 1|Failure to achieve response|8
5691285|NCT00315705|19625754|P1|Phase 1|Refused further treatment|1
5691286|NCT00315458|19625815|P4|Overall Study|Did not qualify|0
5691287|NCT00315458|19625816|P3|Overall Study|Did not qualify|1
5691288|NCT00315458|19625817|P2|Overall Study|Did not qualify|0
5691289|NCT00315458|19625818|P1|Overall Study|Did not qualify|0
5691290|NCT00315458|19625815|P4|Overall Study|Lack of Efficacy|1
5691291|NCT00315458|19625816|P3|Overall Study|Lack of Efficacy|20
5691292|NCT00315458|19625817|P2|Overall Study|Lack of Efficacy|0
5691293|NCT00315458|19625818|P1|Overall Study|Lack of Efficacy|0
5691294|NCT00315458|19625815|P4|Overall Study|Withdrawal by Subject|2
5691295|NCT00315458|19625816|P3|Overall Study|Withdrawal by Subject|0
5691296|NCT00315458|19625817|P2|Overall Study|Withdrawal by Subject|3
5691297|NCT00315458|19625818|P1|Overall Study|Withdrawal by Subject|0
5691298|NCT00315458|19625815|P4|Overall Study|Lost to Follow-up|2
5691299|NCT00315458|19625816|P3|Overall Study|Lost to Follow-up|0
5691300|NCT00315458|19625817|P2|Overall Study|Lost to Follow-up|2
5691301|NCT00315458|19625818|P1|Overall Study|Lost to Follow-up|1
5691302|NCT00315458|19625815|P4|Overall Study|Adverse Event|3
5691303|NCT00315458|19625816|P3|Overall Study|Adverse Event|23
5691304|NCT00315458|19625817|P2|Overall Study|Adverse Event|4
5691305|NCT00315458|19625818|P1|Overall Study|Adverse Event|2
5691306|NCT00315458|19625815|P4|Overall Study|Administrative|21
5691307|NCT00315458|19625816|P3|Overall Study|Administrative|8
5691308|NCT00315458|19625817|P2|Overall Study|Administrative|3
5691309|NCT00315458|19625818|P1|Overall Study|Administrative|0
5691310|NCT00315445|19625831|P3|Overall Study|Other|0
5691311|NCT00315445|19625832|P2|Overall Study|Other|3
5691312|NCT00315445|19625833|P1|Overall Study|Other|1
5691313|NCT00315445|19625831|P3|Overall Study|Protocol Violation|1
5691314|NCT00315445|19625832|P2|Overall Study|Protocol Violation|0
5691315|NCT00315445|19625833|P1|Overall Study|Protocol Violation|2
5691316|NCT00315445|19625831|P3|Overall Study|Lost to Follow-up|1
5691317|NCT00315445|19625832|P2|Overall Study|Lost to Follow-up|0
5691318|NCT00315445|19625833|P1|Overall Study|Lost to Follow-up|1
5691319|NCT00315445|19625831|P3|Overall Study|Lack of Efficacy|7
5691320|NCT00315445|19625832|P2|Overall Study|Lack of Efficacy|1
5691321|NCT00315445|19625833|P1|Overall Study|Lack of Efficacy|16
5691322|NCT00315445|19625831|P3|Overall Study|Adverse Event|15
5691323|NCT00315445|19625832|P2|Overall Study|Adverse Event|12
5691324|NCT00315445|19625833|P1|Overall Study|Adverse Event|7
5691325|NCT00315055|19626123|P2|Overall Study|Lost to Follow-up|1
5691326|NCT00315055|19626124|P1|Overall Study|Lost to Follow-up|1
5691327|NCT00315055|19626123|P2|Overall Study|Protocol Violation|4
5691328|NCT00315055|19626124|P1|Overall Study|Protocol Violation|2
5691329|NCT00314951|19626142|P2|Follow-up|mITT failure|34
5691330|NCT00314951|19626143|P1|Follow-up|mITT failure|44
5691331|NCT00314951|19626142|P2|Treatment|Didn't meet criteria for mITT population|11
5691332|NCT00314951|19626143|P1|Treatment|Didn't meet criteria for mITT population|16
5691333|NCT00314808|19626153|P1|Overall Study|Withdrawal by Subject/PI without AE|4
5691334|NCT00314808|19626153|P1|Overall Study|Disease Progression without AE|4
5691335|NCT00314795|19626161|P1|Overall Study|Participants Withdrew Consent|2
5691336|NCT00314795|19626161|P1|Overall Study|Renal Transplant|3
5691337|NCT00314795|19626161|P1|Overall Study|Reason not Specified|3
5691338|NCT00314795|19626161|P1|Overall Study|Death|4
5691339|NCT00314795|19626161|P1|Overall Study|Adverse Event|8
5691340|NCT00314574|19626171|P2|Overall Study|Data unknown at database lock|1
5691341|NCT00314574|19626172|P1|Overall Study|Data unknown at database lock|0
5691342|NCT00314574|19626171|P2|Overall Study|Pregnancy|4
5691343|NCT00314574|19626172|P1|Overall Study|Pregnancy|6
5691344|NCT00314574|19626171|P2|Overall Study|Physician Decision|15
5691345|NCT00314574|19626172|P1|Overall Study|Physician Decision|22
5691346|NCT00314574|19626171|P2|Overall Study|Withdrawal by Subject|22
5691347|NCT00314574|19626172|P1|Overall Study|Withdrawal by Subject|33
5691348|NCT00314574|19626171|P2|Overall Study|Lost to Follow-up|25
5691349|NCT00314574|19626172|P1|Overall Study|Lost to Follow-up|19
5691350|NCT00314574|19626171|P2|Overall Study|Adverse Event|16
5691351|NCT00314574|19626172|P1|Overall Study|Adverse Event|11
5691352|NCT00314574|19626171|P2|Overall Study|Death|0
5691353|NCT00314574|19626172|P1|Overall Study|Death|3
5691354|NCT00314366|19626188|P2|Overall Study|not treated due to patient medical condi|0
5691355|NCT00314366|19626189|P1|Overall Study|not treated due to patient medical condi|1
5691356|NCT00314340|19626234|P1|Overall Study|lost interest|1
5691357|NCT00314327|19626240|P1|Overall Study|Withdrawal by Subject|1
5691358|NCT00314262|19626245|P1|Overall Study|Physician Decision|1
5691359|NCT00314262|19626245|P1|Overall Study|Withdrawal by Subject|2
5691360|NCT00314262|19626245|P1|Overall Study|Adverse Event|2
5691361|NCT00314249|19626253|P2|Overall Study|Non-Compliant|6
5691362|NCT00314249|19626254|P1|Overall Study|Non-Compliant|5
5691363|NCT00314249|19626253|P2|Overall Study|Withdrawn for other reasons|1
5691364|NCT00314249|19626254|P1|Overall Study|Withdrawn for other reasons|4
5691365|NCT00314249|19626253|P2|Overall Study|Physician Decision|1
5691366|NCT00314249|19626254|P1|Overall Study|Physician Decision|1
5691367|NCT00314249|19626253|P2|Overall Study|Lost to Follow-up|9
5691368|NCT00314249|19626254|P1|Overall Study|Lost to Follow-up|15
5691369|NCT00314249|19626253|P2|Overall Study|Withdrawal by Subject|28
5691370|NCT00314249|19626254|P1|Overall Study|Withdrawal by Subject|21
5691371|NCT00314249|19626253|P2|Overall Study|Lack of Efficacy|24
5691372|NCT00314249|19626254|P1|Overall Study|Lack of Efficacy|33
5691373|NCT00314249|19626253|P2|Overall Study|Adverse Event|94
5691374|NCT00314249|19626254|P1|Overall Study|Adverse Event|73
5691375|NCT00314145|19626287|P2|Overall Study|Sponsor Decision|0
5691376|NCT00314145|19626288|P1|Overall Study|Sponsor Decision|2
5691377|NCT00314145|19626287|P2|Overall Study|Protocol Violation|0
5691378|NCT00314145|19626288|P1|Overall Study|Protocol Violation|3
5691379|NCT00314145|19626287|P2|Overall Study|Adverse Event|3
5691380|NCT00314145|19626288|P1|Overall Study|Adverse Event|0
5691381|NCT00314145|19626287|P2|Overall Study|Physician Decision|4
5691382|NCT00314145|19626288|P1|Overall Study|Physician Decision|3
5691383|NCT00314145|19626287|P2|Overall Study|Lost to Follow-up|12
5691384|NCT00314145|19626288|P1|Overall Study|Lost to Follow-up|5
5691385|NCT00314145|19626287|P2|Overall Study|Withdrawal by Subject|10
5691386|NCT00314145|19626288|P1|Overall Study|Withdrawal by Subject|8
5691387|NCT00314132|19626302|P2|Overall Study|Physician Decision|0
5691388|NCT00314132|19626303|P1|Overall Study|Physician Decision|1
5691389|NCT00314132|19626302|P2|Overall Study|Adverse Event|0
5691390|NCT00314132|19626303|P1|Overall Study|Adverse Event|1
5691391|NCT00314132|19626302|P2|Overall Study|Withdrawal by Subject|5
5691392|NCT00314132|19626303|P1|Overall Study|Withdrawal by Subject|3
5691393|NCT00314132|19626302|P2|Overall Study|Lost to Follow-up|13
5691394|NCT00314132|19626303|P1|Overall Study|Lost to Follow-up|3
5691395|NCT00313911|19626330|P2|Overall Study|Did not meet age criteria|1
5691396|NCT00313911|19626331|P1|Overall Study|Did not meet age criteria|1
5691397|NCT00313911|19626330|P2|Overall Study|Withdrawal by Subject|12
5691398|NCT00313911|19626331|P1|Overall Study|Withdrawal by Subject|39
5691399|NCT00313911|19626330|P2|Overall Study|Lost to Follow-up|14
5691400|NCT00313911|19626331|P1|Overall Study|Lost to Follow-up|27
5691401|NCT00313911|19626330|P2|Overall Study|Protocol Violation|10
5691402|NCT00313911|19626331|P1|Overall Study|Protocol Violation|19
5691403|NCT00313911|19626330|P2|Overall Study|Adverse Event|3
5691404|NCT00313911|19626331|P1|Overall Study|Adverse Event|2
5691405|NCT00313911|19626330|P2|Overall Study|Serious adverse event|1
5691406|NCT00313911|19626331|P1|Overall Study|Serious adverse event|6
5691407|NCT00313846|19626345|P2|Overall Study|Administrative|3
5691408|NCT00313846|19626346|P1|Overall Study|Administrative|2
5691409|NCT00313846|19626345|P2|Overall Study|Adverse Event|8
5691410|NCT00313846|19626346|P1|Overall Study|Adverse Event|1
5691411|NCT00313846|19626345|P2|Overall Study|Withdrawal by Subject|0
5691412|NCT00313846|19626346|P1|Overall Study|Withdrawal by Subject|2
5691413|NCT00313820|19626357|P2|Pregabalin or Placebo Treatment Period|Other|3
5691414|NCT00313820|19626358|P1|Pregabalin or Placebo Treatment Period|Other|2
5691415|NCT00313820|19626357|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
5691416|NCT00313820|19626358|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
5691417|NCT00313820|19626357|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
5691418|NCT00313820|19626358|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
5691419|NCT00313820|19626357|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
5691420|NCT00313820|19626358|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
5691421|NCT00313820|19626357|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
5691422|NCT00313820|19626358|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
5691423|NCT00313820|19626357|P2|Assigned to Treatment|Other|0
5691424|NCT00313820|19626358|P1|Assigned to Treatment|Other|1
5691425|NCT00313781|19626396|P3|After Crossover|Other|18
5691426|NCT00313781|19626397|P2|After Crossover|Other|0
5691427|NCT00313781|19626398|P1|After Crossover|Other|0
5691428|NCT00313781|19626396|P3|After Crossover|Withdrawal by Subject|3
5691429|NCT00313781|19626397|P2|After Crossover|Withdrawal by Subject|0
5691430|NCT00313781|19626398|P1|After Crossover|Withdrawal by Subject|0
5691431|NCT00313781|19626396|P3|After Crossover|Death|6
5691432|NCT00313781|19626397|P2|After Crossover|Death|0
5691433|NCT00313781|19626398|P1|After Crossover|Death|0
5691434|NCT00313781|19626396|P3|Before Crossover|Randomized, not treated|0
5691435|NCT00313781|19626397|P2|Before Crossover|Randomized, not treated|0
5691436|NCT00313781|19626398|P1|Before Crossover|Randomized, not treated|5
5691437|NCT00313781|19626396|P3|Before Crossover|Crossover|0
5691438|NCT00313781|19626397|P2|Before Crossover|Crossover|37
5691439|NCT00313781|19626398|P1|Before Crossover|Crossover|0
5691440|NCT00313781|19626396|P3|Before Crossover|Other|0
5691441|NCT00313781|19626397|P2|Before Crossover|Other|30
5691442|NCT00313781|19626398|P1|Before Crossover|Other|45
5691443|NCT00313781|19626396|P3|Before Crossover|Withdrawal by Subject|0
5691444|NCT00313781|19626397|P2|Before Crossover|Withdrawal by Subject|1
5691445|NCT00313781|19626398|P1|Before Crossover|Withdrawal by Subject|3
5691446|NCT00313781|19626396|P3|Before Crossover|Lost to Follow-up|0
5691447|NCT00313781|19626397|P2|Before Crossover|Lost to Follow-up|3
5691448|NCT00313781|19626398|P1|Before Crossover|Lost to Follow-up|0
5691449|NCT00313781|19626396|P3|Before Crossover|Death|0
5691450|NCT00313781|19626397|P2|Before Crossover|Death|8
5691451|NCT00313781|19626398|P1|Before Crossover|Death|22
5691452|NCT00313716|19626444|P6|Overall Study|Withdrawal by Subject|0
5691453|NCT00313716|19626445|P5|Overall Study|Withdrawal by Subject|1
5691454|NCT00313716|19626446|P4|Overall Study|Withdrawal by Subject|0
5691455|NCT00313716|19626447|P3|Overall Study|Withdrawal by Subject|1
5691456|NCT00313716|19626448|P2|Overall Study|Withdrawal by Subject|1
5691457|NCT00313716|19626449|P1|Overall Study|Withdrawal by Subject|0
5691458|NCT00313716|19626444|P6|Overall Study|Lost to Follow-up|4
5691459|NCT00313716|19626445|P5|Overall Study|Lost to Follow-up|0
5691460|NCT00313716|19626446|P4|Overall Study|Lost to Follow-up|1
5691461|NCT00313716|19626447|P3|Overall Study|Lost to Follow-up|2
5691462|NCT00313716|19626448|P2|Overall Study|Lost to Follow-up|5
5691463|NCT00313716|19626449|P1|Overall Study|Lost to Follow-up|2
5691464|NCT00313716|19626444|P6|Overall Study|Death|9
5691465|NCT00313716|19626445|P5|Overall Study|Death|5
5691466|NCT00313716|19626446|P4|Overall Study|Death|3
5691467|NCT00313716|19626447|P3|Overall Study|Death|9
5691468|NCT00313716|19626448|P2|Overall Study|Death|2
5691469|NCT00313716|19626449|P1|Overall Study|Death|3
5691470|NCT00313703|19626476|P4|Overall Study|Lost to Follow-up|12
5691471|NCT00313703|19626477|P3|Overall Study|Lost to Follow-up|5
5691472|NCT00313703|19626478|P2|Overall Study|Lost to Follow-up|2
5691473|NCT00313703|19626479|P1|Overall Study|Lost to Follow-up|11
5691474|NCT00313612|19626495|P2|Overall Study|Patient never received treatment|1
5691475|NCT00313612|19626496|P1|Overall Study|Patient never received treatment|0
5691476|NCT00313586|19626508|P4|Overall Study|Death before starting treatment|0
5691477|NCT00313586|19626509|P3|Overall Study|Death before starting treatment|0
5691478|NCT00313586|19626510|P2|Overall Study|Death before starting treatment|0
5691479|NCT00313586|19626511|P1|Overall Study|Death before starting treatment|1
5691480|NCT00313586|19626508|P4|Overall Study|Moved|0
5691481|NCT00313586|19626509|P3|Overall Study|Moved|0
5691482|NCT00313586|19626510|P2|Overall Study|Moved|1
5691483|NCT00313586|19626511|P1|Overall Study|Moved|0
5691484|NCT00313586|19626508|P4|Overall Study|Lost insurance|0
5691485|NCT00313586|19626509|P3|Overall Study|Lost insurance|0
5691486|NCT00313586|19626510|P2|Overall Study|Lost insurance|1
5691487|NCT00313586|19626511|P1|Overall Study|Lost insurance|0
5691488|NCT00313586|19626508|P4|Overall Study|Absolute neutrophil count not recovered|0
5691489|NCT00313586|19626509|P3|Overall Study|Absolute neutrophil count not recovered|0
5691490|NCT00313586|19626510|P2|Overall Study|Absolute neutrophil count not recovered|1
5691491|NCT00313586|19626511|P1|Overall Study|Absolute neutrophil count not recovered|2
5691492|NCT00313586|19626508|P4|Overall Study|Physician Decision|0
5691493|NCT00313586|19626509|P3|Overall Study|Physician Decision|0
5691494|NCT00313586|19626510|P2|Overall Study|Physician Decision|1
5691495|NCT00313586|19626511|P1|Overall Study|Physician Decision|2
5691496|NCT00313586|19626508|P4|Overall Study|Did not achieve HI-major/better response|1
5691497|NCT00313586|19626509|P3|Overall Study|Did not achieve HI-major/better response|2
5691498|NCT00313586|19626510|P2|Overall Study|Did not achieve HI-major/better response|7
5691499|NCT00313586|19626511|P1|Overall Study|Did not achieve HI-major/better response|10
5691500|NCT00313586|19626508|P4|Overall Study|Other complicating disease|0
5691501|NCT00313586|19626509|P3|Overall Study|Other complicating disease|0
5691502|NCT00313586|19626510|P2|Overall Study|Other complicating disease|2
5691503|NCT00313586|19626511|P1|Overall Study|Other complicating disease|2
5691504|NCT00313586|19626508|P4|Overall Study|Alternative therapy|0
5691505|NCT00313586|19626509|P3|Overall Study|Alternative therapy|2
5691506|NCT00313586|19626510|P2|Overall Study|Alternative therapy|6
5691507|NCT00313586|19626511|P1|Overall Study|Alternative therapy|3
5691508|NCT00313586|19626508|P4|Overall Study|Withdrawal by Subject|2
5691509|NCT00313586|19626509|P3|Overall Study|Withdrawal by Subject|6
5691510|NCT00313586|19626510|P2|Overall Study|Withdrawal by Subject|6
5691511|NCT00313586|19626511|P1|Overall Study|Withdrawal by Subject|13
5691512|NCT00313586|19626508|P4|Overall Study|Death|7
5691513|NCT00313586|19626509|P3|Overall Study|Death|1
5691514|NCT00313586|19626510|P2|Overall Study|Death|8
5691515|NCT00313586|19626511|P1|Overall Study|Death|11
5691516|NCT00313586|19626508|P4|Overall Study|Adverse Event|10
5691517|NCT00313586|19626509|P3|Overall Study|Adverse Event|3
5691518|NCT00313586|19626510|P2|Overall Study|Adverse Event|18
5691519|NCT00313586|19626511|P1|Overall Study|Adverse Event|12
5691520|NCT00313586|19626508|P4|Overall Study|Disease progression|3
5691521|NCT00313586|19626509|P3|Overall Study|Disease progression|10
5691522|NCT00313586|19626510|P2|Overall Study|Disease progression|19
5691523|NCT00313586|19626511|P1|Overall Study|Disease progression|14
5691524|NCT00313313|19626539|P3|Overall Study|Subject No Longer Meets Study Criteria|2
5691525|NCT00313313|19626540|P2|Overall Study|Subject No Longer Meets Study Criteria|3
5691526|NCT00313313|19626541|P1|Overall Study|Subject No Longer Meets Study Criteria|0
5691527|NCT00313313|19626539|P3|Overall Study|Death|2
5691528|NCT00313313|19626540|P2|Overall Study|Death|0
5691529|NCT00313313|19626541|P1|Overall Study|Death|0
5691530|NCT00313313|19626539|P3|Overall Study|Pregnancy|0
5691531|NCT00313313|19626540|P2|Overall Study|Pregnancy|2
5691532|NCT00313313|19626541|P1|Overall Study|Pregnancy|1
5691533|NCT00313313|19626539|P3|Overall Study|Poor/Noncompliance|2
5691534|NCT00313313|19626540|P2|Overall Study|Poor/Noncompliance|6
5691535|NCT00313313|19626541|P1|Overall Study|Poor/Noncompliance|3
5691536|NCT00313313|19626539|P3|Overall Study|Physician Decision|4
5691537|NCT00313313|19626540|P2|Overall Study|Physician Decision|6
5691538|NCT00313313|19626541|P1|Overall Study|Physician Decision|2
5691539|NCT00313313|19626539|P3|Overall Study|Adverse Event|12
5691540|NCT00313313|19626540|P2|Overall Study|Adverse Event|16
5691541|NCT00313313|19626541|P1|Overall Study|Adverse Event|15
5691542|NCT00313313|19626539|P3|Overall Study|Lost to Follow-up|9
5691543|NCT00313313|19626540|P2|Overall Study|Lost to Follow-up|7
5691544|NCT00313313|19626541|P1|Overall Study|Lost to Follow-up|10
5691545|NCT00313313|19626539|P3|Overall Study|Withdrawal of consent by subject|31
5691546|NCT00313313|19626540|P2|Overall Study|Withdrawal of consent by subject|17
5691547|NCT00313313|19626541|P1|Overall Study|Withdrawal of consent by subject|18
5691548|NCT00313313|19626539|P3|Overall Study|Lack of Efficacy|20
5691549|NCT00313313|19626540|P2|Overall Study|Lack of Efficacy|9
5691550|NCT00313313|19626541|P1|Overall Study|Lack of Efficacy|14
5691551|NCT00313300|19626563|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
5691552|NCT00313300|19626564|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
5691553|NCT00313300|19626565|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
5691554|NCT00313300|19626566|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
5691555|NCT00313300|19626567|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
5691556|NCT00313300|19626563|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
5691557|NCT00313300|19626564|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
5691558|NCT00313300|19626565|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
5691559|NCT00313300|19626566|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
5691560|NCT00313300|19626567|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
5691561|NCT00313300|19626563|P5|Follow-Up(30days)-Randomized Phase B|Death|0
5691562|NCT00313300|19626564|P4|Follow-Up(30days)-Randomized Phase B|Death|0
5691563|NCT00313300|19626565|P3|Follow-Up(30days)-Randomized Phase B|Death|0
5691564|NCT00313300|19626566|P2|Follow-Up(30days)-Randomized Phase B|Death|0
5691565|NCT00313300|19626567|P1|Follow-Up(30days)-Randomized Phase B|Death|1
5691566|NCT00313300|19626563|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
5691567|NCT00313300|19626564|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
5691568|NCT00313300|19626565|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
5691569|NCT00313300|19626566|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
5691570|NCT00313300|19626567|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
5691571|NCT00313300|19626563|P5|Follow-Up(30days)-Randomized Phase A|Death|0
5691572|NCT00313300|19626564|P4|Follow-Up(30days)-Randomized Phase A|Death|0
5691573|NCT00313300|19626565|P3|Follow-Up(30days)-Randomized Phase A|Death|0
5691574|NCT00313300|19626566|P2|Follow-Up(30days)-Randomized Phase A|Death|1
5691575|NCT00313300|19626567|P1|Follow-Up(30days)-Randomized Phase A|Death|0
5691576|NCT00313300|19626563|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
5691577|NCT00313300|19626564|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
5691578|NCT00313300|19626565|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
5691579|NCT00313300|19626566|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
5691580|NCT00313300|19626567|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
5691581|NCT00313300|19626563|P5|Randomized in Phase B (26 Weeks)|non-specified|0
5691582|NCT00313300|19626564|P4|Randomized in Phase B (26 Weeks)|non-specified|0
5691583|NCT00313300|19626565|P3|Randomized in Phase B (26 Weeks)|non-specified|0
5691584|NCT00313300|19626566|P2|Randomized in Phase B (26 Weeks)|non-specified|0
5691585|NCT00313300|19626567|P1|Randomized in Phase B (26 Weeks)|non-specified|1
5691586|NCT00313300|19626563|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
5691587|NCT00313300|19626564|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
5691588|NCT00313300|19626565|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
5691589|NCT00313300|19626566|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
5691590|NCT00313300|19626567|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
5691591|NCT00313300|19626563|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
5691592|NCT00313300|19626564|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
5691593|NCT00313300|19626565|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
5691594|NCT00313300|19626566|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
5691595|NCT00313300|19626567|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
5691596|NCT00313300|19626563|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
5691597|NCT00313300|19626564|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
5691598|NCT00313300|19626565|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
5691599|NCT00313300|19626566|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
5691600|NCT00313300|19626567|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
5691601|NCT00313300|19626563|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
5691602|NCT00313300|19626564|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
5691603|NCT00313300|19626565|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
5691604|NCT00313300|19626566|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
5691605|NCT00313300|19626567|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
5691606|NCT00313300|19626563|P5|Randomized in Phase B (26 Weeks)|Death|1
5691607|NCT00313300|19626564|P4|Randomized in Phase B (26 Weeks)|Death|0
5691608|NCT00313300|19626565|P3|Randomized in Phase B (26 Weeks)|Death|1
5691609|NCT00313300|19626566|P2|Randomized in Phase B (26 Weeks)|Death|3
5691610|NCT00313300|19626567|P1|Randomized in Phase B (26 Weeks)|Death|5
5691611|NCT00313300|19626563|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
5691612|NCT00313300|19626564|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
5691613|NCT00313300|19626565|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
5691614|NCT00313300|19626566|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
5691615|NCT00313300|19626567|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
5691616|NCT00313300|19626563|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
5691617|NCT00313300|19626564|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
5691618|NCT00313300|19626565|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
5691619|NCT00313300|19626566|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
5691620|NCT00313300|19626567|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
5691621|NCT00313300|19626563|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
5691622|NCT00313300|19626564|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
5691623|NCT00313300|19626565|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
5691624|NCT00313300|19626566|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
5691625|NCT00313300|19626567|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
5691626|NCT00313300|19626563|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
5691627|NCT00313300|19626564|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
5691628|NCT00313300|19626565|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
5691629|NCT00313300|19626566|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
5691630|NCT00313300|19626567|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
5691631|NCT00313300|19626563|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
5691632|NCT00313300|19626564|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
5691633|NCT00313300|19626565|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
5691634|NCT00313300|19626566|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
5691635|NCT00313300|19626567|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
5691636|NCT00313300|19626563|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
5691637|NCT00313300|19626564|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
5691638|NCT00313300|19626565|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
5691639|NCT00313300|19626566|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
5691640|NCT00313300|19626567|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
5691641|NCT00313300|19626563|P5|Randomized in Phase A (26 Weeks)|Death|0
5691642|NCT00313300|19626564|P4|Randomized in Phase A (26 Weeks)|Death|0
5691643|NCT00313300|19626565|P3|Randomized in Phase A (26 Weeks)|Death|0
5691644|NCT00313300|19626566|P2|Randomized in Phase A (26 Weeks)|Death|4
5691645|NCT00313300|19626567|P1|Randomized in Phase A (26 Weeks)|Death|3
5691646|NCT00313300|19626563|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
5691647|NCT00313300|19626564|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
5691648|NCT00313300|19626565|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
5691649|NCT00313300|19626566|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
5691650|NCT00313300|19626567|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
5691651|NCT00313300|19626563|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
5691741|NCT00312728|19626868|P1|Overall Study|Protocol Violation|2
5691652|NCT00313300|19626564|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
5691653|NCT00313300|19626565|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
5691654|NCT00313300|19626566|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
5691655|NCT00313300|19626567|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
5691656|NCT00313170|19626637|P3|Overall Study|Progression (investigators opinion)|0
5691657|NCT00313170|19626638|P2|Overall Study|Progression (investigators opinion)|0
5691658|NCT00313170|19626639|P1|Overall Study|Progression (investigators opinion)|1
5691659|NCT00313170|19626637|P3|Overall Study|Lost to Follow-up|1
5691660|NCT00313170|19626638|P2|Overall Study|Lost to Follow-up|0
5691661|NCT00313170|19626639|P1|Overall Study|Lost to Follow-up|0
5691662|NCT00313170|19626637|P3|Overall Study|Incorrect enrollment|1
5691663|NCT00313170|19626638|P2|Overall Study|Incorrect enrollment|2
5691664|NCT00313170|19626639|P1|Overall Study|Incorrect enrollment|0
5691665|NCT00313170|19626637|P3|Overall Study|Withdrawal by Subject|1
5691666|NCT00313170|19626638|P2|Overall Study|Withdrawal by Subject|0
5691667|NCT00313170|19626639|P1|Overall Study|Withdrawal by Subject|1
5691668|NCT00313170|19626637|P3|Overall Study|Disease progression|27
5691669|NCT00313170|19626638|P2|Overall Study|Disease progression|26
5691670|NCT00313170|19626639|P1|Overall Study|Disease progression|31
5691671|NCT00313170|19626637|P3|Overall Study|Adverse Event|0
5691672|NCT00313170|19626638|P2|Overall Study|Adverse Event|2
5691673|NCT00313170|19626639|P1|Overall Study|Adverse Event|1
5691674|NCT00313170|19626637|P3|Overall Study|Death|2
5691675|NCT00313170|19626638|P2|Overall Study|Death|4
5691676|NCT00313170|19626639|P1|Overall Study|Death|2
5691677|NCT00313144|19626658|P1|Overall Study|Due to termination of the study|66
5691678|NCT00313144|19626658|P1|Overall Study|Change to different product|1
5691679|NCT00313144|19626658|P1|Overall Study|Insurance (homecare provider) change|1
5691680|NCT00313144|19626658|P1|Overall Study|Liver transplant|1
5691681|NCT00313144|19626658|P1|Overall Study|Adverse event - transient|5
5691682|NCT00313144|19626658|P1|Overall Study|Physician Decision|4
5691683|NCT00313144|19626658|P1|Overall Study|Terminated by sponsor/ homecare provider|4
5691684|NCT00313144|19626658|P1|Overall Study|Withdrawal by Subject|4
5691685|NCT00313144|19626658|P1|Overall Study|Lost to Follow-up|5
5691686|NCT00313144|19626658|P1|Overall Study|Death|7
5691687|NCT00313144|19626658|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
5691688|NCT00313014|19626745|P3|Overall Study|Lack of Efficacy|16
5691689|NCT00313014|19626746|P2|Overall Study|Lack of Efficacy|25
5691690|NCT00313014|19626747|P1|Overall Study|Lack of Efficacy|52
5691691|NCT00313014|19626745|P3|Overall Study|Administrative|14
5691692|NCT00313014|19626746|P2|Overall Study|Administrative|6
5691693|NCT00313014|19626747|P1|Overall Study|Administrative|9
5691694|NCT00313014|19626745|P3|Overall Study|Lost to Follow-up|10
5691695|NCT00313014|19626746|P2|Overall Study|Lost to Follow-up|6
5691696|NCT00313014|19626747|P1|Overall Study|Lost to Follow-up|7
5691697|NCT00313014|19626745|P3|Overall Study|Adverse Event|16
5691698|NCT00313014|19626746|P2|Overall Study|Adverse Event|29
5691699|NCT00313014|19626747|P1|Overall Study|Adverse Event|14
5691700|NCT00313014|19626745|P3|Overall Study|Withdrawal by Subject|5
5691701|NCT00313014|19626746|P2|Overall Study|Withdrawal by Subject|7
5691702|NCT00313014|19626747|P1|Overall Study|Withdrawal by Subject|11
5691703|NCT00312897|19626778|P2|Overall Study|discontinued prior to getting treatment|3
5691704|NCT00312897|19626779|P1|Overall Study|discontinued prior to getting treatment|0
5691705|NCT00312897|19626778|P2|Overall Study|Pregnancy|0
5691706|NCT00312897|19626779|P1|Overall Study|Pregnancy|1
5691707|NCT00312897|19626778|P2|Overall Study|Withdrawal by Subject|3
5691708|NCT00312897|19626779|P1|Overall Study|Withdrawal by Subject|1
5691709|NCT00312897|19626778|P2|Overall Study|Physician Decision|0
5691710|NCT00312897|19626779|P1|Overall Study|Physician Decision|1
5691711|NCT00312897|19626778|P2|Overall Study|Lost to Follow-up|0
5691712|NCT00312897|19626779|P1|Overall Study|Lost to Follow-up|2
5691713|NCT00312897|19626778|P2|Overall Study|Adverse Event|0
5691714|NCT00312897|19626779|P1|Overall Study|Adverse Event|1
5691715|NCT00312858|19626804|P2|Overall Study|Other|12
5691716|NCT00312858|19626805|P1|Overall Study|Other|9
5691717|NCT00312858|19626804|P2|Overall Study|Participant Moved|10
5691718|NCT00312858|19626805|P1|Overall Study|Participant Moved|11
5691719|NCT00312858|19626804|P2|Overall Study|Withdraw by Participant|20
5691720|NCT00312858|19626805|P1|Overall Study|Withdraw by Participant|20
5691721|NCT00312858|19626804|P2|Overall Study|Protocol Violation|8
5691722|NCT00312858|19626805|P1|Overall Study|Protocol Violation|3
5691723|NCT00312858|19626804|P2|Overall Study|Lost to Follow-up|42
5691724|NCT00312858|19626805|P1|Overall Study|Lost to Follow-up|25
5691725|NCT00312858|19626804|P2|Overall Study|Adverse Event|1
5691726|NCT00312858|19626805|P1|Overall Study|Adverse Event|0
5691727|NCT00312845|19626859|P2|Overall Study|Other|5
5691728|NCT00312845|19626860|P1|Overall Study|Other|6
5691729|NCT00312845|19626859|P2|Overall Study|Lost to Follow-up|0
5691730|NCT00312845|19626860|P1|Overall Study|Lost to Follow-up|2
5691731|NCT00312845|19626859|P2|Overall Study|Disease Progression|77
5691732|NCT00312845|19626860|P1|Overall Study|Disease Progression|56
5691733|NCT00312845|19626859|P2|Overall Study|Withdrawal by Subject|6
5691734|NCT00312845|19626860|P1|Overall Study|Withdrawal by Subject|14
5691735|NCT00312845|19626859|P2|Overall Study|Death|2
5691736|NCT00312845|19626860|P1|Overall Study|Death|2
5691737|NCT00312845|19626859|P2|Overall Study|Adverse Event|5
5691738|NCT00312845|19626860|P1|Overall Study|Adverse Event|19
5691739|NCT00312728|19626868|P1|Overall Study|Other|1
5691740|NCT00312728|19626868|P1|Overall Study|Other|10
5691742|NCT00312728|19626868|P1|Overall Study|Required non-protocol cancer treatment|2
5691743|NCT00312728|19626868|P1|Overall Study|Withdrawal by Subject|10
5691744|NCT00312728|19626868|P1|Overall Study|Adverse Event|32
5691745|NCT00312728|19626868|P1|Overall Study|Progressive disease|53
5691746|NCT00312702|19626880|P3|Immunization Phase|Lost to Follow-up|0
5691747|NCT00312702|19626881|P2|Immunization Phase|Lost to Follow-up|1
5691748|NCT00312702|19626882|P1|Immunization Phase|Lost to Follow-up|0
5691749|NCT00312663|19626895|P3|Immunization Phase|Adverse Event|0
5691750|NCT00312663|19626896|P2|Immunization Phase|Adverse Event|1
5691751|NCT00312663|19626897|P1|Immunization Phase|Adverse Event|0
5691752|NCT00312572|19626910|P2|Overall Study|Lack of Efficacy|2
5691753|NCT00312572|19626911|P1|Overall Study|Lack of Efficacy|1
5691754|NCT00312572|19626910|P2|Overall Study|Administrative|2
5691755|NCT00312572|19626911|P1|Overall Study|Administrative|4
5691756|NCT00312572|19626910|P2|Overall Study|Lost to Follow-up|1
5691757|NCT00312572|19626911|P1|Overall Study|Lost to Follow-up|1
5691758|NCT00312572|19626910|P2|Overall Study|Adverse Event|16
5691759|NCT00312572|19626911|P1|Overall Study|Adverse Event|10
5691760|NCT00312494|19626922|P3|Overall Study|Other|1
5691761|NCT00312494|19626923|P2|Overall Study|Other|10
5691762|NCT00312494|19626924|P1|Overall Study|Other|10
5691763|NCT00312494|19626922|P3|Overall Study|Withdrawal by Subject|10
5691764|NCT00312494|19626923|P2|Overall Study|Withdrawal by Subject|9
5691765|NCT00312494|19626924|P1|Overall Study|Withdrawal by Subject|6
5691766|NCT00312494|19626922|P3|Overall Study|Lost to Follow-up|8
5691767|NCT00312494|19626923|P2|Overall Study|Lost to Follow-up|8
5691768|NCT00312494|19626924|P1|Overall Study|Lost to Follow-up|8
5691769|NCT00312494|19626922|P3|Overall Study|Laboratory abnormality|0
5691770|NCT00312494|19626923|P2|Overall Study|Laboratory abnormality|0
5691771|NCT00312494|19626924|P1|Overall Study|Laboratory abnormality|1
5691772|NCT00312494|19626922|P3|Overall Study|Lack of Efficacy|8
5691773|NCT00312494|19626923|P2|Overall Study|Lack of Efficacy|6
5691774|NCT00312494|19626924|P1|Overall Study|Lack of Efficacy|4
5691775|NCT00312494|19626922|P3|Overall Study|Adverse Event|11
5691776|NCT00312494|19626923|P2|Overall Study|Adverse Event|15
5691777|NCT00312494|19626924|P1|Overall Study|Adverse Event|33
5691778|NCT00312494|19626922|P3|Overall Study|Randomized; not treated with study drug|5
5691779|NCT00312494|19626923|P2|Overall Study|Randomized; not treated with study drug|10
5691780|NCT00312494|19626924|P1|Overall Study|Randomized; not treated with study drug|9
5691781|NCT00312377|19626958|P2|Overall Study|Site ended participation in study|0
5691782|NCT00312377|19626959|P1|Overall Study|Site ended participation in study|1
5691783|NCT00312377|19626958|P2|Overall Study|Discontinue treatment survival follow up|200
5691784|NCT00312377|19626959|P1|Overall Study|Discontinue treatment survival follow up|202
5691785|NCT00312377|19626958|P2|Overall Study|Randomised but never received treatment|6
5691786|NCT00312377|19626959|P1|Overall Study|Randomised but never received treatment|6
5691787|NCT00312377|19626958|P2|Overall Study|Non-compliance|2
5691788|NCT00312377|19626959|P1|Overall Study|Non-compliance|0
5691789|NCT00312377|19626958|P2|Overall Study|Lost to Follow-up|12
5691790|NCT00312377|19626959|P1|Overall Study|Lost to Follow-up|9
5691791|NCT00312377|19626958|P2|Overall Study|Withdrawal by Subject|30
5691792|NCT00312377|19626959|P1|Overall Study|Withdrawal by Subject|23
5691793|NCT00312377|19626958|P2|Overall Study|Death|418
5691794|NCT00312377|19626959|P1|Overall Study|Death|403
5691795|NCT00312338|19626983|P2|Overall Study|Subsequent infection|0
5691796|NCT00312338|19626984|P1|Overall Study|Subsequent infection|2
5691797|NCT00312338|19626983|P2|Overall Study|Withdrawal by Subject|0
5691798|NCT00312338|19626984|P1|Overall Study|Withdrawal by Subject|4
5691799|NCT00312338|19626983|P2|Overall Study|Lost to Follow-up|1
5691800|NCT00312338|19626984|P1|Overall Study|Lost to Follow-up|9
5691801|NCT00312338|19626983|P2|Overall Study|Adverse Event|2
5691802|NCT00312338|19626984|P1|Overall Study|Adverse Event|7
5691803|NCT00312221|19626997|P4|Double-blind Phase|Lack of Efficacy|10
5691804|NCT00312221|19626998|P3|Double-blind Phase|Lack of Efficacy|6
5691805|NCT00312221|19626999|P2|Double-blind Phase|Lack of Efficacy|17
5691806|NCT00312221|19627000|P1|Double-blind Phase|Lack of Efficacy|0
5691807|NCT00312221|19626997|P4|Double-blind Phase|Administrative|33
5691808|NCT00312221|19626998|P3|Double-blind Phase|Administrative|37
5691809|NCT00312221|19626999|P2|Double-blind Phase|Administrative|26
5691810|NCT00312221|19627000|P1|Double-blind Phase|Administrative|0
5691811|NCT00312221|19626997|P4|Double-blind Phase|Lost to Follow-up|2
5691812|NCT00312221|19626998|P3|Double-blind Phase|Lost to Follow-up|2
5691813|NCT00312221|19626999|P2|Double-blind Phase|Lost to Follow-up|0
5691814|NCT00312221|19627000|P1|Double-blind Phase|Lost to Follow-up|0
5691815|NCT00312221|19626997|P4|Double-blind Phase|Adverse Event|18
5691816|NCT00312221|19626998|P3|Double-blind Phase|Adverse Event|19
5691817|NCT00312221|19626999|P2|Double-blind Phase|Adverse Event|10
5691818|NCT00312221|19627000|P1|Double-blind Phase|Adverse Event|0
5691819|NCT00312221|19626997|P4|Double-blind Phase|Withdrawal by Subject|7
5691820|NCT00312221|19626998|P3|Double-blind Phase|Withdrawal by Subject|8
5691821|NCT00312221|19626999|P2|Double-blind Phase|Withdrawal by Subject|6
5691822|NCT00312221|19627000|P1|Double-blind Phase|Withdrawal by Subject|0
5691823|NCT00312221|19626997|P4|Open-label Run-in Period|Did not qualify|0
5691824|NCT00312221|19626998|P3|Open-label Run-in Period|Did not qualify|0
5691825|NCT00312221|19626999|P2|Open-label Run-in Period|Did not qualify|0
5691826|NCT00312221|19627000|P1|Open-label Run-in Period|Did not qualify|5
5691827|NCT00312221|19626997|P4|Open-label Run-in Period|Lack of Efficacy|0
5691828|NCT00312221|19626998|P3|Open-label Run-in Period|Lack of Efficacy|0
5691829|NCT00312221|19626999|P2|Open-label Run-in Period|Lack of Efficacy|0
5691830|NCT00312221|19627000|P1|Open-label Run-in Period|Lack of Efficacy|102
5691831|NCT00312221|19626997|P4|Open-label Run-in Period|Administrative|0
5691832|NCT00312221|19626998|P3|Open-label Run-in Period|Administrative|0
5691833|NCT00312221|19626999|P2|Open-label Run-in Period|Administrative|0
5691834|NCT00312221|19627000|P1|Open-label Run-in Period|Administrative|42
5691835|NCT00312221|19626997|P4|Open-label Run-in Period|Lost to Follow-up|0
5691836|NCT00312221|19626998|P3|Open-label Run-in Period|Lost to Follow-up|0
5691837|NCT00312221|19626999|P2|Open-label Run-in Period|Lost to Follow-up|0
5691838|NCT00312221|19627000|P1|Open-label Run-in Period|Lost to Follow-up|5
5691839|NCT00312221|19626997|P4|Open-label Run-in Period|Adverse Event|0
5691840|NCT00312221|19626998|P3|Open-label Run-in Period|Adverse Event|0
5691841|NCT00312221|19626999|P2|Open-label Run-in Period|Adverse Event|0
5691842|NCT00312221|19627000|P1|Open-label Run-in Period|Adverse Event|74
5691843|NCT00312221|19626997|P4|Open-label Run-in Period|Withdrawal by Subject|0
5691844|NCT00312221|19626998|P3|Open-label Run-in Period|Withdrawal by Subject|0
5691845|NCT00312221|19626999|P2|Open-label Run-in Period|Withdrawal by Subject|0
5691846|NCT00312221|19627000|P1|Open-label Run-in Period|Withdrawal by Subject|6
5691847|NCT00312208|19627020|P2|Overall Study|Other|7
5691848|NCT00312208|19627021|P1|Overall Study|Other|5
5691849|NCT00312208|19627020|P2|Overall Study|Withdrawal by Subject|42
5691850|NCT00312208|19627021|P1|Overall Study|Withdrawal by Subject|53
5691851|NCT00312208|19627020|P2|Overall Study|Lost to Follow-up|5
5691852|NCT00312208|19627021|P1|Overall Study|Lost to Follow-up|3
5691853|NCT00312208|19627020|P2|Overall Study|Lack of Efficacy|4
5691854|NCT00312208|19627021|P1|Overall Study|Lack of Efficacy|7
5691855|NCT00312208|19627020|P2|Overall Study|Death|1
5691856|NCT00312208|19627021|P1|Overall Study|Death|2
5691857|NCT00312208|19627020|P2|Overall Study|Protocol Violation|3
5691858|NCT00312208|19627021|P1|Overall Study|Protocol Violation|5
5691859|NCT00312208|19627020|P2|Overall Study|Adverse Event|61
5691860|NCT00312208|19627021|P1|Overall Study|Adverse Event|97
5691861|NCT00312195|19627031|P2|Overall Study|Protocol Violation|0
5691862|NCT00312195|19627032|P1|Overall Study|Protocol Violation|1
5691863|NCT00312195|19627031|P2|Overall Study|Lost to Follow-up|0
5691864|NCT00312195|19627032|P1|Overall Study|Lost to Follow-up|1
5691865|NCT00312195|19627031|P2|Overall Study|Adverse Event|6
5691866|NCT00312195|19627032|P1|Overall Study|Adverse Event|4
5691867|NCT00311623|19627060|P3|Overall Study|Physician Decision|2
5691868|NCT00311623|19627061|P2|Overall Study|Physician Decision|0
5691869|NCT00311623|19627062|P1|Overall Study|Physician Decision|0
5691870|NCT00311584|19627104|P2|Overall Study|ineligible|2
5691871|NCT00311584|19627105|P1|Overall Study|ineligible|2
5691872|NCT00311584|19627104|P2|Overall Study|Withdrawal by Subject|1
5691873|NCT00311584|19627105|P1|Overall Study|Withdrawal by Subject|1
5691874|NCT00311584|19627104|P2|Overall Study|Physician Decision|5
5691875|NCT00311584|19627105|P1|Overall Study|Physician Decision|4
5691876|NCT00311584|19627104|P2|Overall Study|Lack of Efficacy|15
5691877|NCT00311584|19627105|P1|Overall Study|Lack of Efficacy|12
5691878|NCT00311584|19627104|P2|Overall Study|Death|0
5691879|NCT00311584|19627105|P1|Overall Study|Death|1
5691880|NCT00311402|19627113|P2|Overall Study|IRB's rejection etc.|3
5691881|NCT00311402|19627114|P1|Overall Study|IRB's rejection etc.|10
5691882|NCT00311402|19627113|P2|Overall Study|Protocol Violation|6
5691883|NCT00311402|19627114|P1|Overall Study|Protocol Violation|7
5691884|NCT00311402|19627113|P2|Overall Study|Lack of Efficacy|42
5691885|NCT00311402|19627114|P1|Overall Study|Lack of Efficacy|58
5691886|NCT00311402|19627113|P2|Overall Study|Withdrawal by Subject|18
5691887|NCT00311402|19627114|P1|Overall Study|Withdrawal by Subject|17
5691888|NCT00311402|19627113|P2|Overall Study|Lost to Follow-up|3
5691889|NCT00311402|19627114|P1|Overall Study|Lost to Follow-up|0
5691890|NCT00311402|19627113|P2|Overall Study|Adverse Event|105
5691891|NCT00311402|19627114|P1|Overall Study|Adverse Event|118
5691892|NCT00311363|19627163|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
5691893|NCT00311363|19627164|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
5691894|NCT00311363|19627165|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
5691895|NCT00311363|19627163|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
5691896|NCT00311363|19627164|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
5691897|NCT00311363|19627165|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
5691898|NCT00311363|19627163|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
5691899|NCT00311363|19627164|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
5691900|NCT00311363|19627165|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
5691901|NCT00311363|19627163|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
5691902|NCT00311363|19627164|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
5691903|NCT00311363|19627165|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
5691904|NCT00311363|19627163|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
5691905|NCT00311363|19627164|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
5691906|NCT00311363|19627165|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
5691907|NCT00311363|19627163|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
5691908|NCT00311363|19627164|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
5691909|NCT00311363|19627165|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
5691910|NCT00311363|19627163|P3|24-Week Single-Blind Treatment Period|Death|0
5691911|NCT00311363|19627164|P2|24-Week Single-Blind Treatment Period|Death|0
5691912|NCT00311363|19627165|P1|24-Week Single-Blind Treatment Period|Death|1
5691913|NCT00311363|19627163|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
5691914|NCT00311363|19627164|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
5691915|NCT00311363|19627165|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
5691916|NCT00311363|19627163|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
5691917|NCT00311363|19627164|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
5691918|NCT00311363|19627165|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
5691919|NCT00311363|19627163|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
5691920|NCT00311363|19627164|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
5691921|NCT00311363|19627165|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
5691922|NCT00311363|19627163|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
5691923|NCT00311363|19627164|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
5691924|NCT00311363|19627165|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
5691925|NCT00311363|19627163|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
5691926|NCT00311363|19627164|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
5691927|NCT00311363|19627165|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
5691928|NCT00311363|19627163|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
5691929|NCT00311363|19627164|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
5691930|NCT00311363|19627165|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
5691931|NCT00311363|19627163|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
5691932|NCT00311363|19627164|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
5691933|NCT00311363|19627165|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
5691934|NCT00311363|19627163|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
5691935|NCT00311363|19627164|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
5691936|NCT00311363|19627165|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
5691937|NCT00311311|19627225|P2|Overall Study|Lack of ancillary assistance|1
5691938|NCT00311311|19627226|P1|Overall Study|Lack of ancillary assistance|0
5691939|NCT00311311|19627225|P2|Overall Study|Death|0
5691940|NCT00311311|19627226|P1|Overall Study|Death|1
5691941|NCT00311311|19627225|P2|Overall Study|Study Termination by Sponsor|4
5691942|NCT00311311|19627226|P1|Overall Study|Study Termination by Sponsor|3
5691943|NCT00311311|19627225|P2|Overall Study|Noncompliance|1
5691944|NCT00311311|19627226|P1|Overall Study|Noncompliance|0
5691945|NCT00311311|19627225|P2|Overall Study|Withdrawal by Subject|1
5691946|NCT00311311|19627226|P1|Overall Study|Withdrawal by Subject|1
5691947|NCT00311311|19627225|P2|Overall Study|Adverse Event|2
5691948|NCT00311311|19627226|P1|Overall Study|Adverse Event|3
5691949|NCT00311181|19627284|P1|Overall Study|Final DFTs were not obtained|96
5691950|NCT00311155|19627290|P1|Overall Study|Did not meet entry criteria|55
5691951|NCT00311155|19627290|P1|Overall Study|Withdrawal by Subject|17
5691952|NCT00311155|19627290|P1|Overall Study|Adverse Event|21
5691953|NCT00310856|19627302|P3|Overall Study|Unable to classify|0
5691954|NCT00310856|19627303|P2|Overall Study|Unable to classify|0
5691955|NCT00310856|19627304|P1|Overall Study|Unable to classify|1
5691956|NCT00310856|19627302|P3|Overall Study|Inappropriate enrollment|0
5691957|NCT00310856|19627303|P2|Overall Study|Inappropriate enrollment|1
5691958|NCT00310856|19627304|P1|Overall Study|Inappropriate enrollment|1
5691959|NCT00310856|19627302|P3|Overall Study|Lost to Follow-up|6
5691960|NCT00310856|19627303|P2|Overall Study|Lost to Follow-up|2
5691961|NCT00310856|19627304|P1|Overall Study|Lost to Follow-up|1
5691962|NCT00310856|19627302|P3|Overall Study|Withdrawal by Subject|2
5691963|NCT00310856|19627303|P2|Overall Study|Withdrawal by Subject|2
5691964|NCT00310856|19627304|P1|Overall Study|Withdrawal by Subject|2
5691965|NCT00310817|19627328|P4|Overall Study|Unable to classify|0
5691966|NCT00310817|19627329|P3|Overall Study|Unable to classify|0
5691967|NCT00310817|19627330|P2|Overall Study|Unable to classify|1
5691968|NCT00310817|19627331|P1|Overall Study|Unable to classify|3
5691969|NCT00310817|19627328|P4|Overall Study|Protocol Violation|1
5691970|NCT00310817|19627329|P3|Overall Study|Protocol Violation|1
5691971|NCT00310817|19627330|P2|Overall Study|Protocol Violation|1
5691972|NCT00310817|19627331|P1|Overall Study|Protocol Violation|1
5691973|NCT00310817|19627328|P4|Overall Study|Inappropriate Enrollment|0
5691974|NCT00310817|19627329|P3|Overall Study|Inappropriate Enrollment|1
5691975|NCT00310817|19627330|P2|Overall Study|Inappropriate Enrollment|0
5691976|NCT00310817|19627331|P1|Overall Study|Inappropriate Enrollment|1
5691977|NCT00310817|19627328|P4|Overall Study|Lost to Follow-up|0
5691978|NCT00310817|19627329|P3|Overall Study|Lost to Follow-up|0
5691979|NCT00310817|19627330|P2|Overall Study|Lost to Follow-up|1
5691980|NCT00310817|19627331|P1|Overall Study|Lost to Follow-up|2
5691981|NCT00310817|19627328|P4|Overall Study|Withdrawal by Subject|7
5691982|NCT00310817|19627329|P3|Overall Study|Withdrawal by Subject|6
5691983|NCT00310817|19627330|P2|Overall Study|Withdrawal by Subject|4
5691984|NCT00310817|19627331|P1|Overall Study|Withdrawal by Subject|1
5691985|NCT00310817|19627328|P4|Overall Study|AE or Death|0
5691986|NCT00310817|19627329|P3|Overall Study|AE or Death|0
5691987|NCT00310817|19627330|P2|Overall Study|AE or Death|1
5691988|NCT00310817|19627331|P1|Overall Study|AE or Death|3
5691989|NCT00310804|19627419|P2|Overall Study|Withdrawal by Subject|0
5691990|NCT00310804|19627420|P1|Overall Study|Withdrawal by Subject|3
5691991|NCT00310804|19627419|P2|Overall Study|Lost to Follow-up|0
5691992|NCT00310804|19627420|P1|Overall Study|Lost to Follow-up|2
5691993|NCT00310440|19627479|P2|Overall Study|Missed 12 Month Visit|4
5691994|NCT00310440|19627480|P1|Overall Study|Missed 12 Month Visit|7
5691995|NCT00310440|19627479|P2|Overall Study|Withdrawal by Subject|1
5691996|NCT00310440|19627480|P1|Overall Study|Withdrawal by Subject|2
5691997|NCT00310440|19627479|P2|Overall Study|Lost to Follow-up|8
5691998|NCT00310440|19627480|P1|Overall Study|Lost to Follow-up|17
5691999|NCT00310388|19627544|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
5692000|NCT00310388|19627545|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
5692001|NCT00310388|19627544|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
5692002|NCT00310388|19627545|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
5692003|NCT00310388|19627544|P2|Safety Follow-up Continuation Phase|Adverse Event|1
5692004|NCT00310388|19627545|P1|Safety Follow-up Continuation Phase|Adverse Event|0
5692005|NCT00310388|19627544|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
5692006|NCT00310388|19627545|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
5692007|NCT00310388|19627544|P2|Primary Reporting Phase|Other|0
5692008|NCT00310388|19627545|P1|Primary Reporting Phase|Other|1
5692009|NCT00310388|19627544|P2|Primary Reporting Phase|Missing|0
5692010|NCT00310388|19627545|P1|Primary Reporting Phase|Missing|1
5692011|NCT00310388|19627544|P2|Primary Reporting Phase|Participant retired the informed consent|0
5692012|NCT00310388|19627545|P1|Primary Reporting Phase|Participant retired the informed consent|1
5692013|NCT00310388|19627544|P2|Primary Reporting Phase|Participant passed away|0
5692014|NCT00310388|19627545|P1|Primary Reporting Phase|Participant passed away|1
5692015|NCT00310388|19627544|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
5692016|NCT00310388|19627545|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
5692017|NCT00310388|19627544|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
5692018|NCT00310388|19627545|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
5692019|NCT00310388|19627544|P2|Primary Reporting Phase|Termination of study at sponsor request|0
5692020|NCT00310388|19627545|P1|Primary Reporting Phase|Termination of study at sponsor request|3
5692021|NCT00310388|19627544|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
5692022|NCT00310388|19627545|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
5692023|NCT00310388|19627544|P2|Primary Reporting Phase|Discontinuation of study|0
5692024|NCT00310388|19627545|P1|Primary Reporting Phase|Discontinuation of study|1
5692025|NCT00310388|19627544|P2|Primary Reporting Phase|Ministry of Health decision|0
5692026|NCT00310388|19627545|P1|Primary Reporting Phase|Ministry of Health decision|25
5692027|NCT00310388|19627544|P2|Primary Reporting Phase|Participant request|0
5692028|NCT00310388|19627545|P1|Primary Reporting Phase|Participant request|2
5692029|NCT00310388|19627544|P2|Primary Reporting Phase|Participant request unrelated to study|0
5692030|NCT00310388|19627545|P1|Primary Reporting Phase|Participant request unrelated to study|2
5692031|NCT00310388|19627544|P2|Primary Reporting Phase|Failed to return|0
5692032|NCT00310388|19627545|P1|Primary Reporting Phase|Failed to return|8
5692033|NCT00310388|19627544|P2|Primary Reporting Phase|Request of the sponsor|0
5692034|NCT00310388|19627545|P1|Primary Reporting Phase|Request of the sponsor|19
5692035|NCT00310388|19627544|P2|Primary Reporting Phase|Physician Decision|0
5692036|NCT00310388|19627545|P1|Primary Reporting Phase|Physician Decision|2
5692037|NCT00310388|19627544|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
5692038|NCT00310388|19627545|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
5692039|NCT00310388|19627544|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
5692040|NCT00310388|19627545|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
5692041|NCT00310388|19627544|P2|Primary Reporting Phase|Change in participant medical condition|0
5692042|NCT00310388|19627545|P1|Primary Reporting Phase|Change in participant medical condition|3
5692043|NCT00310388|19627544|P2|Primary Reporting Phase|Pregnancy|0
5692044|NCT00310388|19627545|P1|Primary Reporting Phase|Pregnancy|3
5692045|NCT00310388|19627544|P2|Primary Reporting Phase|Protocol Violation|0
5692046|NCT00310388|19627545|P1|Primary Reporting Phase|Protocol Violation|10
5692047|NCT00310388|19627544|P2|Primary Reporting Phase|Withdrawal by Subject|0
5692048|NCT00310388|19627545|P1|Primary Reporting Phase|Withdrawal by Subject|97
5692049|NCT00310388|19627544|P2|Primary Reporting Phase|Lack of Efficacy|0
5692050|NCT00310388|19627545|P1|Primary Reporting Phase|Lack of Efficacy|56
5692051|NCT00310388|19627544|P2|Primary Reporting Phase|Adverse Event|0
5692052|NCT00310388|19627545|P1|Primary Reporting Phase|Adverse Event|101
5692053|NCT00310375|19627587|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
5692054|NCT00310375|19627588|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
5692055|NCT00310375|19627589|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
5692056|NCT00310375|19627587|P3|Primary Reporting Phase|Request of Ethics Committee|0
5692057|NCT00310375|19627588|P2|Primary Reporting Phase|Request of Ethics Committee|1
5692058|NCT00310375|19627589|P1|Primary Reporting Phase|Request of Ethics Committee|0
5692059|NCT00310375|19627587|P3|Primary Reporting Phase|Par. switched to commercial product|0
5692060|NCT00310375|19627588|P2|Primary Reporting Phase|Par. switched to commercial product|1
5692061|NCT00310375|19627589|P1|Primary Reporting Phase|Par. switched to commercial product|0
5692062|NCT00310375|19627587|P3|Primary Reporting Phase|Missed study drug for 2 months|0
5692063|NCT00310375|19627588|P2|Primary Reporting Phase|Missed study drug for 2 months|0
5692064|NCT00310375|19627589|P1|Primary Reporting Phase|Missed study drug for 2 months|1
5692065|NCT00310375|19627587|P3|Primary Reporting Phase|Site closure|0
5692066|NCT00310375|19627588|P2|Primary Reporting Phase|Site closure|0
5692067|NCT00310375|19627589|P1|Primary Reporting Phase|Site closure|3
5692152|NCT00309777|19627808|P4|Overall Study|Protocol Violation|1
5692068|NCT00310375|19627587|P3|Primary Reporting Phase|Missed study drug >5 days|0
5692069|NCT00310375|19627588|P2|Primary Reporting Phase|Missed study drug >5 days|0
5692070|NCT00310375|19627589|P1|Primary Reporting Phase|Missed study drug >5 days|1
5692071|NCT00310375|19627587|P3|Primary Reporting Phase|Going for temporal lobectomy|0
5692072|NCT00310375|19627588|P2|Primary Reporting Phase|Going for temporal lobectomy|0
5692073|NCT00310375|19627589|P1|Primary Reporting Phase|Going for temporal lobectomy|1
5692074|NCT00310375|19627587|P3|Primary Reporting Phase|Participant request unrelated to study|0
5692075|NCT00310375|19627588|P2|Primary Reporting Phase|Participant request unrelated to study|2
5692076|NCT00310375|19627589|P1|Primary Reporting Phase|Participant request unrelated to study|1
5692077|NCT00310375|19627587|P3|Primary Reporting Phase|Failed to return|0
5692078|NCT00310375|19627588|P2|Primary Reporting Phase|Failed to return|3
5692079|NCT00310375|19627589|P1|Primary Reporting Phase|Failed to return|1
5692080|NCT00310375|19627587|P3|Primary Reporting Phase|Request of the sponsor|0
5692081|NCT00310375|19627588|P2|Primary Reporting Phase|Request of the sponsor|2
5692082|NCT00310375|19627589|P1|Primary Reporting Phase|Request of the sponsor|2
5692083|NCT00310375|19627587|P3|Primary Reporting Phase|Physician Decision|0
5692084|NCT00310375|19627588|P2|Primary Reporting Phase|Physician Decision|3
5692085|NCT00310375|19627589|P1|Primary Reporting Phase|Physician Decision|5
5692086|NCT00310375|19627587|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
5692087|NCT00310375|19627588|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
5692088|NCT00310375|19627589|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
5692089|NCT00310375|19627587|P3|Primary Reporting Phase|Change in Par medical condition|0
5692090|NCT00310375|19627588|P2|Primary Reporting Phase|Change in Par medical condition|0
5692091|NCT00310375|19627589|P1|Primary Reporting Phase|Change in Par medical condition|2
5692092|NCT00310375|19627587|P3|Primary Reporting Phase|Protocol Violation|0
5692093|NCT00310375|19627588|P2|Primary Reporting Phase|Protocol Violation|5
5692094|NCT00310375|19627589|P1|Primary Reporting Phase|Protocol Violation|8
5692095|NCT00310375|19627587|P3|Primary Reporting Phase|Withdrawal by Subject|0
5692096|NCT00310375|19627588|P2|Primary Reporting Phase|Withdrawal by Subject|7
5692097|NCT00310375|19627589|P1|Primary Reporting Phase|Withdrawal by Subject|10
5692098|NCT00310375|19627587|P3|Primary Reporting Phase|Pregnancy|0
5692099|NCT00310375|19627588|P2|Primary Reporting Phase|Pregnancy|2
5692100|NCT00310375|19627589|P1|Primary Reporting Phase|Pregnancy|2
5692101|NCT00310375|19627587|P3|Primary Reporting Phase|Lack of Efficacy|0
5692102|NCT00310375|19627588|P2|Primary Reporting Phase|Lack of Efficacy|19
5692103|NCT00310375|19627589|P1|Primary Reporting Phase|Lack of Efficacy|24
5692104|NCT00310375|19627587|P3|Primary Reporting Phase|Adverse Event|0
5692105|NCT00310375|19627588|P2|Primary Reporting Phase|Adverse Event|22
5692106|NCT00310375|19627589|P1|Primary Reporting Phase|Adverse Event|28
5692107|NCT00310037|19627734|P2|Overall Study|Non-protocol treatment|0
5692108|NCT00310037|19627735|P1|Overall Study|Non-protocol treatment|1
5692109|NCT00310037|19627734|P2|Overall Study|Progression|0
5692110|NCT00310037|19627735|P1|Overall Study|Progression|6
5692111|NCT00310037|19627734|P2|Overall Study|Withdrawal by Subject|3
5692112|NCT00310037|19627735|P1|Overall Study|Withdrawal by Subject|4
5692113|NCT00310037|19627734|P2|Overall Study|Adverse Event|14
5692114|NCT00310037|19627735|P1|Overall Study|Adverse Event|7
5692115|NCT00309985|19627749|P2|Overall Study|Chemotherapy discontinued only|0
5692116|NCT00309985|19627750|P1|Overall Study|Chemotherapy discontinued only|1
5692117|NCT00309985|19627749|P2|Overall Study|Non-compliance|0
5692118|NCT00309985|19627750|P1|Overall Study|Non-compliance|1
5692119|NCT00309985|19627749|P2|Overall Study|Complicating disease|0
5692120|NCT00309985|19627750|P1|Overall Study|Complicating disease|1
5692121|NCT00309985|19627749|P2|Overall Study|Never started treatment|0
5692122|NCT00309985|19627750|P1|Overall Study|Never started treatment|7
5692123|NCT00309985|19627749|P2|Overall Study|Physician Decision|0
5692124|NCT00309985|19627750|P1|Overall Study|Physician Decision|3
5692125|NCT00309985|19627749|P2|Overall Study|Withdrawal by Subject|1
5692126|NCT00309985|19627750|P1|Overall Study|Withdrawal by Subject|5
5692127|NCT00309985|19627749|P2|Overall Study|Death|0
5692128|NCT00309985|19627750|P1|Overall Study|Death|2
5692129|NCT00309985|19627749|P2|Overall Study|Adverse Event|0
5692130|NCT00309985|19627750|P1|Overall Study|Adverse Event|30
5692131|NCT00309985|19627749|P2|Overall Study|Disease progression|0
5692132|NCT00309985|19627750|P1|Overall Study|Disease progression|12
5692133|NCT00309959|19627766|P1|Overall Study|Ineligible - no prior chemotherapy|2
5692134|NCT00309946|19627775|P1|Overall Study|Withdrawal by Subject|1
5692135|NCT00309907|19627781|P1|Overall Study|Major infectious event|4
5692136|NCT00309907|19627781|P1|Overall Study|Ineligible|11
5692137|NCT00309907|19627781|P1|Overall Study|Physician Decision|1
5692138|NCT00309907|19627781|P1|Overall Study|Death|4
5692139|NCT00309842|19627790|P1|Overall Study|Lost to Follow-up|1
5692140|NCT00309777|19627808|P4|Overall Study|Death|0
5692141|NCT00309777|19627809|P3|Overall Study|Death|0
5692142|NCT00309777|19627810|P2|Overall Study|Death|1
5692143|NCT00309777|19627811|P1|Overall Study|Death|0
5692144|NCT00309777|19627808|P4|Overall Study|Lost to Follow-up|0
5692145|NCT00309777|19627809|P3|Overall Study|Lost to Follow-up|1
5692146|NCT00309777|19627810|P2|Overall Study|Lost to Follow-up|0
5692147|NCT00309777|19627811|P1|Overall Study|Lost to Follow-up|0
5692148|NCT00309777|19627808|P4|Overall Study|Withdrawal by Subject|2
5692149|NCT00309777|19627809|P3|Overall Study|Withdrawal by Subject|7
5692150|NCT00309777|19627810|P2|Overall Study|Withdrawal by Subject|5
5692151|NCT00309777|19627811|P1|Overall Study|Withdrawal by Subject|6
5692153|NCT00309777|19627809|P3|Overall Study|Protocol Violation|3
5692154|NCT00309777|19627810|P2|Overall Study|Protocol Violation|1
5692155|NCT00309777|19627811|P1|Overall Study|Protocol Violation|4
5692156|NCT00309777|19627808|P4|Overall Study|Adverse Event|1
5692157|NCT00309777|19627809|P3|Overall Study|Adverse Event|8
5692158|NCT00309777|19627810|P2|Overall Study|Adverse Event|2
5692159|NCT00309777|19627811|P1|Overall Study|Adverse Event|13
5692160|NCT00309608|19627852|P5|Overall Study|Other incl. Lack of efficacy|0
5692161|NCT00309608|19627853|P4|Overall Study|Other incl. Lack of efficacy|4
5692162|NCT00309608|19627854|P3|Overall Study|Other incl. Lack of efficacy|3
5692163|NCT00309608|19627855|P2|Overall Study|Other incl. Lack of efficacy|4
5692164|NCT00309608|19627856|P1|Overall Study|Other incl. Lack of efficacy|10
5692165|NCT00309608|19627852|P5|Overall Study|Withdrawal by Subject|0
5692166|NCT00309608|19627853|P4|Overall Study|Withdrawal by Subject|0
5692167|NCT00309608|19627854|P3|Overall Study|Withdrawal by Subject|2
5692168|NCT00309608|19627855|P2|Overall Study|Withdrawal by Subject|4
5692169|NCT00309608|19627856|P1|Overall Study|Withdrawal by Subject|1
5692170|NCT00309608|19627852|P5|Overall Study|Lost to Follow-up|1
5692171|NCT00309608|19627853|P4|Overall Study|Lost to Follow-up|0
5692172|NCT00309608|19627854|P3|Overall Study|Lost to Follow-up|2
5692173|NCT00309608|19627855|P2|Overall Study|Lost to Follow-up|0
5692174|NCT00309608|19627856|P1|Overall Study|Lost to Follow-up|0
5692175|NCT00309608|19627852|P5|Overall Study|Protocol Violation|0
5692176|NCT00309608|19627853|P4|Overall Study|Protocol Violation|0
5692177|NCT00309608|19627854|P3|Overall Study|Protocol Violation|0
5692178|NCT00309608|19627855|P2|Overall Study|Protocol Violation|0
5692179|NCT00309608|19627856|P1|Overall Study|Protocol Violation|2
5692180|NCT00309608|19627852|P5|Overall Study|Adverse Event|3
5692181|NCT00309608|19627853|P4|Overall Study|Adverse Event|2
5692182|NCT00309608|19627854|P3|Overall Study|Adverse Event|3
5692183|NCT00309608|19627855|P2|Overall Study|Adverse Event|5
5692184|NCT00309608|19627856|P1|Overall Study|Adverse Event|1
5692185|NCT00309452|19627904|P2|Overall Study|Withdrawal by Subject|0
5692186|NCT00309452|19627905|P1|Overall Study|Withdrawal by Subject|3
5692187|NCT00309387|19627933|P2|Overall Study|Lost to Follow-up|86
5692188|NCT00309387|19627934|P1|Overall Study|Lost to Follow-up|70
5692189|NCT00309387|19627933|P2|Overall Study|Death|73
5692190|NCT00309387|19627934|P1|Overall Study|Death|72
5692191|NCT00309244|19627952|P2|Overall Study|Death|1
5692192|NCT00309244|19627953|P1|Overall Study|Death|4
5692193|NCT00309244|19627952|P2|Overall Study|Randomized but not dosed|12
5692194|NCT00309244|19627953|P1|Overall Study|Randomized but not dosed|11
5692195|NCT00309244|19627952|P2|Overall Study|Various|7
5692196|NCT00309244|19627953|P1|Overall Study|Various|7
5692197|NCT00309244|19627952|P2|Overall Study|Withdrawal by Subject|32
5692198|NCT00309244|19627953|P1|Overall Study|Withdrawal by Subject|50
5692199|NCT00309244|19627952|P2|Overall Study|Protocol Violation|3
5692200|NCT00309244|19627953|P1|Overall Study|Protocol Violation|6
5692201|NCT00309244|19627952|P2|Overall Study|Physician Decision|8
5692202|NCT00309244|19627953|P1|Overall Study|Physician Decision|5
5692203|NCT00309244|19627952|P2|Overall Study|Lost to Follow-up|22
5692204|NCT00309244|19627953|P1|Overall Study|Lost to Follow-up|6
5692205|NCT00309244|19627952|P2|Overall Study|Adverse Event|12
5692206|NCT00309244|19627953|P1|Overall Study|Adverse Event|29
5692207|NCT00309166|19627975|P2|Overall Study|Withdrawal by Subject|3
5692208|NCT00309166|19627976|P1|Overall Study|Withdrawal by Subject|4
5692209|NCT00309166|19627975|P2|Overall Study|Adverse event, non-fatal|0
5692210|NCT00309166|19627976|P1|Overall Study|Adverse event, non-fatal|1
5692211|NCT00308997|19628010|P2|Overall Study|Unable to tolerate intervention|0
5692212|NCT00308997|19628011|P1|Overall Study|Unable to tolerate intervention|1
5692213|NCT00308997|19628010|P2|Overall Study|Subject feigned clinical data|1
5692214|NCT00308997|19628011|P1|Overall Study|Subject feigned clinical data|0
5692215|NCT00308737|19628030|P3|Overall Study|Various|8
5692216|NCT00308737|19628031|P2|Overall Study|Various|20
5692217|NCT00308737|19628032|P1|Overall Study|Various|32
5692218|NCT00308737|19628030|P3|Overall Study|Withdrawal by Subject|18
5692219|NCT00308737|19628031|P2|Overall Study|Withdrawal by Subject|166
5692220|NCT00308737|19628032|P1|Overall Study|Withdrawal by Subject|218
5692221|NCT00308737|19628030|P3|Overall Study|Protocol Violation|5
5692222|NCT00308737|19628031|P2|Overall Study|Protocol Violation|9
5692223|NCT00308737|19628032|P1|Overall Study|Protocol Violation|34
5692224|NCT00308737|19628030|P3|Overall Study|Physician Decision|1
5692225|NCT00308737|19628031|P2|Overall Study|Physician Decision|2
5692226|NCT00308737|19628032|P1|Overall Study|Physician Decision|15
5692227|NCT00308737|19628030|P3|Overall Study|Lost to Follow-up|5
5692228|NCT00308737|19628031|P2|Overall Study|Lost to Follow-up|80
5692229|NCT00308737|19628032|P1|Overall Study|Lost to Follow-up|56
5692230|NCT00308737|19628030|P3|Overall Study|Death|0
5692231|NCT00308737|19628031|P2|Overall Study|Death|3
5692232|NCT00308737|19628032|P1|Overall Study|Death|4
5692233|NCT00308737|19628030|P3|Overall Study|Adverse Event|0
5692234|NCT00308737|19628031|P2|Overall Study|Adverse Event|9
5692235|NCT00308737|19628032|P1|Overall Study|Adverse Event|104
5692236|NCT00308711|19628072|P3|Overall Study|Subject incarcerated, data not allowed|1
5692237|NCT00308711|19628073|P2|Overall Study|Subject incarcerated, data not allowed|0
5692238|NCT00308711|19628074|P1|Overall Study|Subject incarcerated, data not allowed|0
5692239|NCT00308711|19628072|P3|Overall Study|Baby not born within 7 days of treatment|2
5692240|NCT00308711|19628073|P2|Overall Study|Baby not born within 7 days of treatment|2
5692241|NCT00308711|19628074|P1|Overall Study|Baby not born within 7 days of treatment|1
5692242|NCT00308711|19628072|P3|Overall Study|Lost to Follow-up|0
5692243|NCT00308711|19628073|P2|Overall Study|Lost to Follow-up|1
5692244|NCT00308711|19628074|P1|Overall Study|Lost to Follow-up|0
5692245|NCT00308711|19628072|P3|Overall Study|Protocol Violation|1
5692246|NCT00308711|19628073|P2|Overall Study|Protocol Violation|1
5692247|NCT00308711|19628074|P1|Overall Study|Protocol Violation|0
5692248|NCT00308711|19628072|P3|Overall Study|Withdrawal by Subject|1
5692249|NCT00308711|19628073|P2|Overall Study|Withdrawal by Subject|0
5692250|NCT00308711|19628074|P1|Overall Study|Withdrawal by Subject|1
5692251|NCT00308620|19628109|P3|Overall Study|Lost to Follow-up|1
5692252|NCT00308620|19628110|P2|Overall Study|Lost to Follow-up|0
5692253|NCT00308620|19628111|P1|Overall Study|Lost to Follow-up|0
5692254|NCT00308620|19628109|P3|Overall Study|Death|0
5692255|NCT00308620|19628110|P2|Overall Study|Death|1
5692256|NCT00308620|19628111|P1|Overall Study|Death|1
5692257|NCT00308581|19628120|P3|Randomized Maintenance Phase|Unknown reason|0
5692258|NCT00308581|19628121|P2|Randomized Maintenance Phase|Unknown reason|0
5692259|NCT00308581|19628122|P1|Randomized Maintenance Phase|Unknown reason|3
5692260|NCT00308581|19628120|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
5692261|NCT00308581|19628121|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
5692262|NCT00308581|19628122|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
5692263|NCT00308581|19628120|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
5692264|NCT00308581|19628121|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
5692265|NCT00308581|19628122|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
5692266|NCT00308581|19628120|P3|Randomized Maintenance Phase|Lost to Follow-up|0
5692267|NCT00308581|19628121|P2|Randomized Maintenance Phase|Lost to Follow-up|2
5692268|NCT00308581|19628122|P1|Randomized Maintenance Phase|Lost to Follow-up|0
5692269|NCT00308581|19628120|P3|Randomized Maintenance Phase|Lack of Efficacy|0
5692270|NCT00308581|19628121|P2|Randomized Maintenance Phase|Lack of Efficacy|21
5692271|NCT00308581|19628122|P1|Randomized Maintenance Phase|Lack of Efficacy|9
5692272|NCT00308581|19628120|P3|Randomized Maintenance Phase|Adverse Event|0
5692273|NCT00308581|19628121|P2|Randomized Maintenance Phase|Adverse Event|17
5692274|NCT00308581|19628122|P1|Randomized Maintenance Phase|Adverse Event|10
5692275|NCT00308581|19628120|P3|Induction Phase|Unknown reason|3
5692276|NCT00308581|19628121|P2|Induction Phase|Unknown reason|0
5692277|NCT00308581|19628122|P1|Induction Phase|Unknown reason|0
5692278|NCT00308581|19628120|P3|Induction Phase|Withdrawal by Subject|5
5692279|NCT00308581|19628121|P2|Induction Phase|Withdrawal by Subject|0
5692280|NCT00308581|19628122|P1|Induction Phase|Withdrawal by Subject|0
5692281|NCT00308581|19628120|P3|Induction Phase|Lack of Efficacy|121
5692282|NCT00308581|19628121|P2|Induction Phase|Lack of Efficacy|0
5692283|NCT00308581|19628122|P1|Induction Phase|Lack of Efficacy|0
5692284|NCT00308581|19628120|P3|Induction Phase|Adverse Event|37
5692285|NCT00308581|19628121|P2|Induction Phase|Adverse Event|0
5692286|NCT00308581|19628122|P1|Induction Phase|Adverse Event|0
5692287|NCT00308555|19628248|P2|Overall Study|Physician Decision|0
5692288|NCT00308555|19628249|P1|Overall Study|Physician Decision|2
5692289|NCT00308555|19628248|P2|Overall Study|Withdrawal by Subject|0
5692290|NCT00308555|19628249|P1|Overall Study|Withdrawal by Subject|1
5692291|NCT00308308|19628266|P2|Overall Study|Other|0
5692292|NCT00308308|19628267|P1|Overall Study|Other|1
5692293|NCT00308308|19628266|P2|Overall Study|Randomized but not dosed|16
5692294|NCT00308308|19628267|P1|Overall Study|Randomized but not dosed|8
5692295|NCT00308308|19628266|P2|Overall Study|Various|5
5692296|NCT00308308|19628267|P1|Overall Study|Various|7
5692297|NCT00308308|19628266|P2|Overall Study|Withdrawal by Subject|19
5692298|NCT00308308|19628267|P1|Overall Study|Withdrawal by Subject|47
5692299|NCT00308308|19628266|P2|Overall Study|Protocol Violation|14
5692300|NCT00308308|19628267|P1|Overall Study|Protocol Violation|3
5692301|NCT00308308|19628266|P2|Overall Study|Physician Decision|7
5692302|NCT00308308|19628267|P1|Overall Study|Physician Decision|15
5692303|NCT00308308|19628266|P2|Overall Study|Lost to Follow-up|5
5692304|NCT00308308|19628267|P1|Overall Study|Lost to Follow-up|5
5692305|NCT00308308|19628266|P2|Overall Study|Adverse Event|2
5692306|NCT00308308|19628267|P1|Overall Study|Adverse Event|17
5692307|NCT00308139|19628346|P2|Overall Study|Other|0
5692308|NCT00308139|19628347|P1|Overall Study|Other|1
5692309|NCT00308139|19628346|P2|Overall Study|Administrative|4
5692310|NCT00308139|19628347|P1|Overall Study|Administrative|1
5692311|NCT00308139|19628346|P2|Overall Study|Loss of Glucose Control|7
5692312|NCT00308139|19628347|P1|Overall Study|Loss of Glucose Control|5
5692313|NCT00308139|19628346|P2|Overall Study|Investigator Decision|10
5692314|NCT00308139|19628347|P1|Overall Study|Investigator Decision|11
5692315|NCT00308139|19628346|P2|Overall Study|Withdrawal of Consent|42
5692316|NCT00308139|19628347|P1|Overall Study|Withdrawal of Consent|40
5692317|NCT00308139|19628346|P2|Overall Study|Protocol Violation|2
5692318|NCT00308139|19628347|P1|Overall Study|Protocol Violation|3
5692319|NCT00308139|19628346|P2|Overall Study|Lost to Follow-up|8
5692320|NCT00308139|19628347|P1|Overall Study|Lost to Follow-up|13
5692321|NCT00308139|19628346|P2|Overall Study|Adverse Event|14
5692322|NCT00308139|19628347|P1|Overall Study|Adverse Event|20
5692323|NCT00308113|19628421|P4|Overall Study|Protocol closure|1
5692324|NCT00308113|19628422|P3|Overall Study|Protocol closure|0
5692325|NCT00308113|19628423|P2|Overall Study|Protocol closure|0
5692326|NCT00308113|19628424|P1|Overall Study|Protocol closure|0
5692327|NCT00308087|19628444|P2|Overall Study|Other|3
5692328|NCT00308087|19628445|P1|Overall Study|Other|4
5692329|NCT00308087|19628444|P2|Overall Study|Withdrawal by Subject|1
5692330|NCT00308087|19628445|P1|Overall Study|Withdrawal by Subject|2
5692331|NCT00308087|19628444|P2|Overall Study|Study Closure|12
5692332|NCT00308087|19628445|P1|Overall Study|Study Closure|11
5692333|NCT00308087|19628444|P2|Overall Study|Progressive Disease|21
5692334|NCT00308087|19628445|P1|Overall Study|Progressive Disease|19
5692335|NCT00308074|19628461|P1|Overall Study|Withdrawal by Subject|1
5692336|NCT00307931|19628478|P1|Overall Study|Adverse Event|1
5692337|NCT00307801|19628495|P2|Overall Study|Pregnancy|1
5692338|NCT00307801|19628496|P1|Overall Study|Pregnancy|0
5692339|NCT00307801|19628495|P2|Overall Study|No reason specified|0
5692340|NCT00307801|19628496|P1|Overall Study|No reason specified|2
5692341|NCT00307801|19628495|P2|Overall Study|Protocol Violation|2
5692342|NCT00307801|19628496|P1|Overall Study|Protocol Violation|3
5692343|NCT00307801|19628495|P2|Overall Study|Frustration with e-diary|0
5692344|NCT00307801|19628496|P1|Overall Study|Frustration with e-diary|1
5692345|NCT00307801|19628495|P2|Overall Study|Lost to Follow-up, moved abroad|1
5692346|NCT00307801|19628496|P1|Overall Study|Lost to Follow-up, moved abroad|1
5692347|NCT00307801|19628495|P2|Overall Study|Lack of Efficacy|2
5692348|NCT00307801|19628496|P1|Overall Study|Lack of Efficacy|0
5692349|NCT00307801|19628495|P2|Overall Study|Wrong Randomization|0
5692350|NCT00307801|19628496|P1|Overall Study|Wrong Randomization|1
5692351|NCT00307801|19628495|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
5692352|NCT00307801|19628496|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
5692353|NCT00307801|19628495|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
5692354|NCT00307801|19628496|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
5692355|NCT00307801|19628495|P2|Overall Study|Non-compliance, not taken all tablets|2
5692356|NCT00307801|19628496|P1|Overall Study|Non-compliance, not taken all tablets|1
5692357|NCT00307801|19628495|P2|Overall Study|Withdrawal by Subject|4
5692358|NCT00307801|19628496|P1|Overall Study|Withdrawal by Subject|9
5692359|NCT00307801|19628495|P2|Overall Study|Adverse Event|4
5692360|NCT00307801|19628496|P1|Overall Study|Adverse Event|12
5692361|NCT00307736|19628608|P4|Overall Study|Withdrawal by Subject|0
5692362|NCT00307736|19628609|P3|Overall Study|Withdrawal by Subject|2
5692363|NCT00307736|19628610|P2|Overall Study|Withdrawal by Subject|0
5692364|NCT00307736|19628611|P1|Overall Study|Withdrawal by Subject|0
5692365|NCT00307736|19628608|P4|Overall Study|Adverse Event|3
5692366|NCT00307736|19628609|P3|Overall Study|Adverse Event|1
5692367|NCT00307736|19628610|P2|Overall Study|Adverse Event|0
5692368|NCT00307736|19628611|P1|Overall Study|Adverse Event|0
5692369|NCT00307684|19628622|P3|Double Blind Phase|Lack of Efficacy|0
5692370|NCT00307684|19628623|P2|Double Blind Phase|Lack of Efficacy|5
5692371|NCT00307684|19628624|P1|Double Blind Phase|Lack of Efficacy|2
5692372|NCT00307684|19628622|P3|Open Label Phase|other|6
5692373|NCT00307684|19628623|P2|Open Label Phase|other|0
5692374|NCT00307684|19628624|P1|Open Label Phase|other|0
5692375|NCT00307684|19628622|P3|Open Label Phase|non compliance|5
5692376|NCT00307684|19628623|P2|Open Label Phase|non compliance|0
5692377|NCT00307684|19628624|P1|Open Label Phase|non compliance|0
5692378|NCT00307684|19628622|P3|Open Label Phase|Lost to Follow-up|11
5692379|NCT00307684|19628623|P2|Open Label Phase|Lost to Follow-up|0
5692380|NCT00307684|19628624|P1|Open Label Phase|Lost to Follow-up|0
5692381|NCT00307684|19628622|P3|Open Label Phase|Withdrawal by Subject|15
5692382|NCT00307684|19628623|P2|Open Label Phase|Withdrawal by Subject|0
5692383|NCT00307684|19628624|P1|Open Label Phase|Withdrawal by Subject|0
5692384|NCT00307684|19628622|P3|Open Label Phase|Adverse Event|16
5692385|NCT00307684|19628623|P2|Open Label Phase|Adverse Event|0
5692386|NCT00307684|19628624|P1|Open Label Phase|Adverse Event|0
5692387|NCT00307684|19628622|P3|Open Label Phase|Lack of Efficacy|3
5692388|NCT00307684|19628623|P2|Open Label Phase|Lack of Efficacy|0
5692389|NCT00307684|19628624|P1|Open Label Phase|Lack of Efficacy|0
5692390|NCT00307489|19628652|P2|Week 48 Through Week 168|Seroconversion|0
5692391|NCT00307489|19628653|P1|Week 48 Through Week 168|Seroconversion|1
5692392|NCT00307489|19628652|P2|Week 48 Through Week 168|Lost to Follow-up|1
5692393|NCT00307489|19628653|P1|Week 48 Through Week 168|Lost to Follow-up|0
5692394|NCT00307489|19628652|P2|Week 48 Through Week 168|Death|1
5692395|NCT00307489|19628653|P1|Week 48 Through Week 168|Death|0
5692396|NCT00307489|19628652|P2|Week 48 Through Week 168|Lack of Efficacy|2
5692397|NCT00307489|19628653|P1|Week 48 Through Week 168|Lack of Efficacy|2
5692398|NCT00307489|19628652|P2|Week 48 Through Week 168|Withdrawal by Subject|2
5692399|NCT00307489|19628653|P1|Week 48 Through Week 168|Withdrawal by Subject|1
5692400|NCT00307489|19628652|P2|Week 48 Through Week 168|Physician Decision|0
5692401|NCT00307489|19628653|P1|Week 48 Through Week 168|Physician Decision|1
5692402|NCT00307489|19628652|P2|Week 48 Through Week 168|Adverse Event|0
5692403|NCT00307489|19628653|P1|Week 48 Through Week 168|Adverse Event|1
5692404|NCT00307489|19628652|P2|Baseline Through Week 48|Withdrawal by Subject|1
5692405|NCT00307489|19628653|P1|Baseline Through Week 48|Withdrawal by Subject|0
5692406|NCT00307489|19628652|P2|Baseline Through Week 48|Physician Decision|0
5692407|NCT00307489|19628653|P1|Baseline Through Week 48|Physician Decision|1
5692408|NCT00307489|19628652|P2|Baseline Through Week 48|Lost to Follow-up|1
5692409|NCT00307489|19628653|P1|Baseline Through Week 48|Lost to Follow-up|0
5692410|NCT00307437|19628698|P7|After Controlled Period|Other|28
5692411|NCT00307437|19628699|P6|After Controlled Period|Other|40
5692412|NCT00307437|19628700|P5|After Controlled Period|Other|9
5692413|NCT00307437|19628701|P4|After Controlled Period|Other|15
5692414|NCT00307437|19628702|P3|After Controlled Period|Other|0
5692415|NCT00307437|19628703|P2|After Controlled Period|Other|0
5692416|NCT00307437|19628704|P1|After Controlled Period|Other|0
5692417|NCT00307437|19628698|P7|After Controlled Period|Lost to Follow-up|18
5692418|NCT00307437|19628699|P6|After Controlled Period|Lost to Follow-up|13
5692419|NCT00307437|19628700|P5|After Controlled Period|Lost to Follow-up|12
5692420|NCT00307437|19628701|P4|After Controlled Period|Lost to Follow-up|7
5692421|NCT00307437|19628702|P3|After Controlled Period|Lost to Follow-up|0
5692422|NCT00307437|19628703|P2|After Controlled Period|Lost to Follow-up|0
5692423|NCT00307437|19628704|P1|After Controlled Period|Lost to Follow-up|0
5692424|NCT00307437|19628698|P7|After Controlled Period|Lack of Efficacy|24
5692425|NCT00307437|19628699|P6|After Controlled Period|Lack of Efficacy|37
5692426|NCT00307437|19628700|P5|After Controlled Period|Lack of Efficacy|17
5692427|NCT00307437|19628701|P4|After Controlled Period|Lack of Efficacy|15
5692428|NCT00307437|19628702|P3|After Controlled Period|Lack of Efficacy|0
5692429|NCT00307437|19628703|P2|After Controlled Period|Lack of Efficacy|0
5692430|NCT00307437|19628704|P1|After Controlled Period|Lack of Efficacy|0
5692431|NCT00307437|19628698|P7|After Controlled Period|Death|3
5692432|NCT00307437|19628699|P6|After Controlled Period|Death|1
5692433|NCT00307437|19628700|P5|After Controlled Period|Death|1
5692434|NCT00307437|19628701|P4|After Controlled Period|Death|3
5692435|NCT00307437|19628702|P3|After Controlled Period|Death|0
5692436|NCT00307437|19628703|P2|After Controlled Period|Death|0
5692437|NCT00307437|19628704|P1|After Controlled Period|Death|0
5692438|NCT00307437|19628698|P7|After Controlled Period|Adverse Event|40
5692439|NCT00307437|19628699|P6|After Controlled Period|Adverse Event|31
5692440|NCT00307437|19628700|P5|After Controlled Period|Adverse Event|16
5692441|NCT00307437|19628701|P4|After Controlled Period|Adverse Event|18
5692442|NCT00307437|19628702|P3|After Controlled Period|Adverse Event|0
5692443|NCT00307437|19628703|P2|After Controlled Period|Adverse Event|0
5692444|NCT00307437|19628704|P1|After Controlled Period|Adverse Event|0
5692445|NCT00307437|19628698|P7|Controlled Period|Other|0
5692446|NCT00307437|19628699|P6|Controlled Period|Other|0
5692447|NCT00307437|19628700|P5|Controlled Period|Other|0
5692448|NCT00307437|19628701|P4|Controlled Period|Other|0
5692449|NCT00307437|19628702|P3|Controlled Period|Other|3
5692450|NCT00307437|19628703|P2|Controlled Period|Other|1
5692451|NCT00307437|19628704|P1|Controlled Period|Other|5
5692452|NCT00307437|19628698|P7|Controlled Period|Lost to Follow-up|0
5692453|NCT00307437|19628699|P6|Controlled Period|Lost to Follow-up|0
5692454|NCT00307437|19628700|P5|Controlled Period|Lost to Follow-up|0
5692455|NCT00307437|19628701|P4|Controlled Period|Lost to Follow-up|0
5692456|NCT00307437|19628702|P3|Controlled Period|Lost to Follow-up|0
5692457|NCT00307437|19628703|P2|Controlled Period|Lost to Follow-up|3
5692458|NCT00307437|19628704|P1|Controlled Period|Lost to Follow-up|2
5692459|NCT00307437|19628698|P7|Controlled Period|Lack of Efficacy|0
5692460|NCT00307437|19628699|P6|Controlled Period|Lack of Efficacy|0
5692461|NCT00307437|19628700|P5|Controlled Period|Lack of Efficacy|0
5692462|NCT00307437|19628701|P4|Controlled Period|Lack of Efficacy|0
5692463|NCT00307437|19628702|P3|Controlled Period|Lack of Efficacy|0
5692464|NCT00307437|19628703|P2|Controlled Period|Lack of Efficacy|0
5692465|NCT00307437|19628704|P1|Controlled Period|Lack of Efficacy|2
5692466|NCT00307437|19628698|P7|Controlled Period|Death|0
5692467|NCT00307437|19628699|P6|Controlled Period|Death|0
5692468|NCT00307437|19628700|P5|Controlled Period|Death|0
5692469|NCT00307437|19628701|P4|Controlled Period|Death|0
5692470|NCT00307437|19628702|P3|Controlled Period|Death|1
5692471|NCT00307437|19628703|P2|Controlled Period|Death|0
5692472|NCT00307437|19628704|P1|Controlled Period|Death|0
5692473|NCT00307437|19628698|P7|Controlled Period|Adverse Event|0
5692474|NCT00307437|19628699|P6|Controlled Period|Adverse Event|0
5692475|NCT00307437|19628700|P5|Controlled Period|Adverse Event|0
5692476|NCT00307437|19628701|P4|Controlled Period|Adverse Event|0
5692477|NCT00307437|19628702|P3|Controlled Period|Adverse Event|5
5692478|NCT00307437|19628703|P2|Controlled Period|Adverse Event|2
5692479|NCT00307437|19628704|P1|Controlled Period|Adverse Event|7
5692480|NCT00307333|19628730|P2|Overall Study|Lost to Follow-up|3
5692481|NCT00307333|19628731|P1|Overall Study|Lost to Follow-up|11
5692482|NCT00307294|19628743|P1|Overall Study|Withdrawal by Subject|1
5692483|NCT00307164|19628752|P2|Overall Study|Lost to Follow-up|1
5692484|NCT00307164|19628753|P1|Overall Study|Lost to Follow-up|6
5692485|NCT00307164|19628752|P2|Overall Study|Not compliant with requirements|4
5692486|NCT00307164|19628753|P1|Overall Study|Not compliant with requirements|4
5692487|NCT00307164|19628752|P2|Overall Study|Withdrawal by Subject|8
5692488|NCT00307164|19628753|P1|Overall Study|Withdrawal by Subject|1
5692489|NCT00307164|19628752|P2|Overall Study|Subject/parent not able to get to clinic|1
5692490|NCT00307164|19628753|P1|Overall Study|Subject/parent not able to get to clinic|2
5692491|NCT00307164|19628752|P2|Overall Study|Severe debilitation, unable to continue|0
5692492|NCT00307164|19628753|P1|Overall Study|Severe debilitation, unable to continue|1
5692493|NCT00307164|19628752|P2|Overall Study|Death|0
5692494|NCT00307164|19628753|P1|Overall Study|Death|1
5692495|NCT00307151|19628793|P4|Overall Study|Clinic unable to contact subject|1
5692496|NCT00307151|19628794|P3|Overall Study|Clinic unable to contact subject|1
5692497|NCT00307151|19628795|P2|Overall Study|Clinic unable to contact subject|3
5692498|NCT00307151|19628796|P1|Overall Study|Clinic unable to contact subject|3
5692499|NCT00307151|19628793|P4|Overall Study|Not willing to adhere to study reqs|2
5692500|NCT00307151|19628794|P3|Overall Study|Not willing to adhere to study reqs|2
5692501|NCT00307151|19628795|P2|Overall Study|Not willing to adhere to study reqs|0
5692502|NCT00307151|19628796|P1|Overall Study|Not willing to adhere to study reqs|2
5692503|NCT00307151|19628793|P4|Overall Study|Withdrew consent|3
5692504|NCT00307151|19628794|P3|Overall Study|Withdrew consent|1
5692505|NCT00307151|19628795|P2|Overall Study|Withdrew consent|1
5692506|NCT00307151|19628796|P1|Overall Study|Withdrew consent|0
5692507|NCT00307151|19628793|P4|Overall Study|Subject unable to get to clinic|2
5692508|NCT00307151|19628794|P3|Overall Study|Subject unable to get to clinic|6
5692509|NCT00307151|19628795|P2|Overall Study|Subject unable to get to clinic|0
5692510|NCT00307151|19628796|P1|Overall Study|Subject unable to get to clinic|1
5692511|NCT00307151|19628793|P4|Overall Study|Severe debilitation, unable to continue|0
5692512|NCT00307151|19628794|P3|Overall Study|Severe debilitation, unable to continue|0
5692513|NCT00307151|19628795|P2|Overall Study|Severe debilitation, unable to continue|0
5692514|NCT00307151|19628796|P1|Overall Study|Severe debilitation, unable to continue|1
5692515|NCT00307151|19628793|P4|Overall Study|Death|3
5692516|NCT00307151|19628794|P3|Overall Study|Death|10
5692517|NCT00307151|19628795|P2|Overall Study|Death|3
5692518|NCT00307151|19628796|P1|Overall Study|Death|4
5692519|NCT00307125|19628840|P3|Pilot Phase|Withdrawal by Subject|1
5692520|NCT00307125|19628841|P2|Pilot Phase|Withdrawal by Subject|1
5692521|NCT00307125|19628842|P1|Pilot Phase|Withdrawal by Subject|0
5692522|NCT00307125|19628840|P3|Pilot Phase|Lost to Follow-up|0
5692523|NCT00307125|19628841|P2|Pilot Phase|Lost to Follow-up|1
5692524|NCT00307125|19628842|P1|Pilot Phase|Lost to Follow-up|0
5692525|NCT00307125|19628840|P3|Screening Phase|Coronary artery bypass|0
5692526|NCT00307125|19628841|P2|Screening Phase|Coronary artery bypass|0
5692527|NCT00307125|19628842|P1|Screening Phase|Coronary artery bypass|1
5692528|NCT00307125|19628840|P3|Screening Phase|AMR and treated with rituximab|0
5692529|NCT00307125|19628841|P2|Screening Phase|AMR and treated with rituximab|0
5692530|NCT00307125|19628842|P1|Screening Phase|AMR and treated with rituximab|1
5692531|NCT00307125|19628840|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
5692532|NCT00307125|19628841|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
5692533|NCT00307125|19628842|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
5692534|NCT00307125|19628840|P3|Screening Phase|Screen Error|0
5692535|NCT00307125|19628841|P2|Screening Phase|Screen Error|0
5692536|NCT00307125|19628842|P1|Screening Phase|Screen Error|1
5692537|NCT00307125|19628840|P3|Screening Phase|Ineligible|0
5692538|NCT00307125|19628841|P2|Screening Phase|Ineligible|0
5692539|NCT00307125|19628842|P1|Screening Phase|Ineligible|1
5692540|NCT00307125|19628840|P3|Screening Phase|PAK|0
5692541|NCT00307125|19628841|P2|Screening Phase|PAK|0
5692542|NCT00307125|19628842|P1|Screening Phase|PAK|1
5692543|NCT00307125|19628840|P3|Screening Phase|Malignancy|0
5692544|NCT00307125|19628841|P2|Screening Phase|Malignancy|0
5692545|NCT00307125|19628842|P1|Screening Phase|Malignancy|1
5692546|NCT00307125|19628840|P3|Screening Phase|Metastatic colon cancer|0
5692547|NCT00307125|19628841|P2|Screening Phase|Metastatic colon cancer|0
5692548|NCT00307125|19628842|P1|Screening Phase|Metastatic colon cancer|1
5692549|NCT00307125|19628840|P3|Screening Phase|Developed acute leukemia|0
5692550|NCT00307125|19628841|P2|Screening Phase|Developed acute leukemia|0
5692551|NCT00307125|19628842|P1|Screening Phase|Developed acute leukemia|1
5692552|NCT00307125|19628840|P3|Screening Phase|Try to get pregnant|0
5692553|NCT00307125|19628841|P2|Screening Phase|Try to get pregnant|0
5692554|NCT00307125|19628842|P1|Screening Phase|Try to get pregnant|1
5692555|NCT00307125|19628840|P3|Screening Phase|Ineligible for pilot|0
5692556|NCT00307125|19628841|P2|Screening Phase|Ineligible for pilot|0
5692557|NCT00307125|19628842|P1|Screening Phase|Ineligible for pilot|4
5692558|NCT00307125|19628840|P3|Screening Phase|Received Pancreas Transplant|0
5692559|NCT00307125|19628841|P2|Screening Phase|Received Pancreas Transplant|0
5692560|NCT00307125|19628842|P1|Screening Phase|Received Pancreas Transplant|8
5692561|NCT00307125|19628840|P3|Screening Phase|Moved or transferred facilities|0
5692562|NCT00307125|19628841|P2|Screening Phase|Moved or transferred facilities|0
5692563|NCT00307125|19628842|P1|Screening Phase|Moved or transferred facilities|34
5692564|NCT00307125|19628840|P3|Screening Phase|Scheduling issues/Non-compliance|0
5692565|NCT00307125|19628841|P2|Screening Phase|Scheduling issues/Non-compliance|0
5692566|NCT00307125|19628842|P1|Screening Phase|Scheduling issues/Non-compliance|55
5692567|NCT00307125|19628840|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
5692568|NCT00307125|19628841|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
5692569|NCT00307125|19628842|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
5692570|NCT00307125|19628840|P3|Screening Phase|Graft Failure|0
5692571|NCT00307125|19628841|P2|Screening Phase|Graft Failure|0
5692572|NCT00307125|19628842|P1|Screening Phase|Graft Failure|8
5692573|NCT00307125|19628840|P3|Screening Phase|Graft Loss|0
5692574|NCT00307125|19628841|P2|Screening Phase|Graft Loss|0
5692575|NCT00307125|19628842|P1|Screening Phase|Graft Loss|3
5692576|NCT00307125|19628840|P3|Screening Phase|Study Terminated|0
5692577|NCT00307125|19628841|P2|Screening Phase|Study Terminated|0
5692578|NCT00307125|19628842|P1|Screening Phase|Study Terminated|17
5692579|NCT00307125|19628840|P3|Screening Phase|Sponsor Decision|0
5692580|NCT00307125|19628841|P2|Screening Phase|Sponsor Decision|0
5692581|NCT00307125|19628842|P1|Screening Phase|Sponsor Decision|4
5692582|NCT00307125|19628840|P3|Screening Phase|Physician Decision|0
5692583|NCT00307125|19628841|P2|Screening Phase|Physician Decision|0
5692584|NCT00307125|19628842|P1|Screening Phase|Physician Decision|26
5692585|NCT00307125|19628840|P3|Screening Phase|Withdrawal by Subject|0
5692586|NCT00307125|19628841|P2|Screening Phase|Withdrawal by Subject|0
5692587|NCT00307125|19628842|P1|Screening Phase|Withdrawal by Subject|77
5692588|NCT00307125|19628840|P3|Screening Phase|Death|0
5692589|NCT00307125|19628841|P2|Screening Phase|Death|0
5692590|NCT00307125|19628842|P1|Screening Phase|Death|10
5692591|NCT00307125|19628840|P3|Screening Phase|Lost to Follow-up|0
5692592|NCT00307125|19628841|P2|Screening Phase|Lost to Follow-up|0
5692593|NCT00307125|19628842|P1|Screening Phase|Lost to Follow-up|87
5692594|NCT00307125|19628840|P3|Screening Phase|Protocol Violation|0
5692595|NCT00307125|19628841|P2|Screening Phase|Protocol Violation|0
5692596|NCT00307125|19628842|P1|Screening Phase|Protocol Violation|27
5692597|NCT00307125|19628840|P3|Screening Phase|Adverse Event|0
5692598|NCT00307125|19628841|P2|Screening Phase|Adverse Event|0
5692599|NCT00307125|19628842|P1|Screening Phase|Adverse Event|1
5692600|NCT00307086|19628864|P1|Overall Study|ineligible|5
5692601|NCT00307047|19628870|P2|Overall Study|All death, all MI, all Revascularization|16
5692602|NCT00307047|19628871|P1|Overall Study|All death, all MI, all Revascularization|27
5692603|NCT00307047|19628870|P2|Overall Study|Lost to follow-up for other reasons|1
5692604|NCT00307047|19628871|P1|Overall Study|Lost to follow-up for other reasons|0
5692605|NCT00307047|19628870|P2|Overall Study|Physician Decision|2
5692606|NCT00307047|19628871|P1|Overall Study|Physician Decision|1
5692607|NCT00307047|19628870|P2|Overall Study|Withdrawal by Subject|6
5692608|NCT00307047|19628871|P1|Overall Study|Withdrawal by Subject|6
5692609|NCT00307047|19628870|P2|Overall Study|Lost to Follow-up|24
5692610|NCT00307047|19628871|P1|Overall Study|Lost to Follow-up|35
5692611|NCT00307034|19629009|P2|Overall Study|Lost to Follow-up|3
5692612|NCT00307034|19629010|P1|Overall Study|Lost to Follow-up|0
5692613|NCT00307034|19629009|P2|Overall Study|Withdrawal by Subject|2
5692614|NCT00307034|19629010|P1|Overall Study|Withdrawal by Subject|1
5692615|NCT00307034|19629009|P2|Overall Study|Adverse Event|2
5692616|NCT00307034|19629010|P1|Overall Study|Adverse Event|1
5692617|NCT00306995|19629055|P7|Study Part II for Subset 2|Serious Adverse Event|0
5692618|NCT00306995|19629056|P6|Study Part II for Subset 2|Serious Adverse Event|0
5692619|NCT00306995|19629057|P5|Study Part II for Subset 2|Serious Adverse Event|0
5692620|NCT00306995|19629058|P4|Study Part II for Subset 2|Serious Adverse Event|0
5692621|NCT00306995|19629059|P3|Study Part II for Subset 2|Serious Adverse Event|0
5692622|NCT00306995|19629060|P2|Study Part II for Subset 2|Serious Adverse Event|1
5692623|NCT00306995|19629061|P1|Study Part II for Subset 2|Serious Adverse Event|0
5692624|NCT00306995|19629055|P7|Study Part I|Withdrawal by Subject|1
5692625|NCT00306995|19629056|P6|Study Part I|Withdrawal by Subject|0
5692626|NCT00306995|19629057|P5|Study Part I|Withdrawal by Subject|0
5692627|NCT00306995|19629058|P4|Study Part I|Withdrawal by Subject|0
5692628|NCT00306995|19629059|P3|Study Part I|Withdrawal by Subject|0
5692629|NCT00306995|19629060|P2|Study Part I|Withdrawal by Subject|0
5692630|NCT00306995|19629061|P1|Study Part I|Withdrawal by Subject|0
5692631|NCT00306891|19629454|P4|Part B|Development of study specific disc crit.|1
5692632|NCT00306891|19629455|P3|Part B|Development of study specific disc crit.|0
5692633|NCT00306891|19629456|P2|Part B|Development of study specific disc crit.|0
5692634|NCT00306891|19629457|P1|Part B|Development of study specific disc crit.|0
5692635|NCT00306891|19629454|P4|Part B|Condition under investigation worsened|8
5692636|NCT00306891|19629455|P3|Part B|Condition under investigation worsened|2
5692637|NCT00306891|19629456|P2|Part B|Condition under investigation worsened|0
5692638|NCT00306891|19629457|P1|Part B|Condition under investigation worsened|0
5692639|NCT00306891|19629454|P4|Part B|Withdrawal by Subject|1
5692640|NCT00306891|19629455|P3|Part B|Withdrawal by Subject|3
5692641|NCT00306891|19629456|P2|Part B|Withdrawal by Subject|0
5692642|NCT00306891|19629457|P1|Part B|Withdrawal by Subject|0
5692643|NCT00306891|19629454|P4|Part B|Adverse Event|5
5692644|NCT00306891|19629455|P3|Part B|Adverse Event|5
5692645|NCT00306891|19629456|P2|Part B|Adverse Event|0
5692646|NCT00306891|19629457|P1|Part B|Adverse Event|0
5692647|NCT00306891|19629454|P4|Part B|Death|2
5692648|NCT00306891|19629455|P3|Part B|Death|1
5692649|NCT00306891|19629456|P2|Part B|Death|0
5692650|NCT00306891|19629457|P1|Part B|Death|0
5692651|NCT00306891|19629454|P4|Part A|QTC interval outwith elig. criteria|0
5692652|NCT00306891|19629455|P3|Part A|QTC interval outwith elig. criteria|0
5692653|NCT00306891|19629456|P2|Part A|QTC interval outwith elig. criteria|0
5692654|NCT00306891|19629457|P1|Part A|QTC interval outwith elig. criteria|1
5692655|NCT00306891|19629454|P4|Part A|Suspicion of second malignancy|0
5692656|NCT00306891|19629455|P3|Part A|Suspicion of second malignancy|0
5692657|NCT00306891|19629456|P2|Part A|Suspicion of second malignancy|1
5692658|NCT00306891|19629457|P1|Part A|Suspicion of second malignancy|0
5692659|NCT00306891|19629454|P4|Part A|Reaccumul. of ascites following drainage|0
5692660|NCT00306891|19629455|P3|Part A|Reaccumul. of ascites following drainage|0
5692661|NCT00306891|19629456|P2|Part A|Reaccumul. of ascites following drainage|1
5692662|NCT00306891|19629457|P1|Part A|Reaccumul. of ascites following drainage|0
5692663|NCT00306891|19629454|P4|Part A|Partial bowel obstruction|0
5692664|NCT00306891|19629455|P3|Part A|Partial bowel obstruction|0
5692665|NCT00306891|19629456|P2|Part A|Partial bowel obstruction|0
5692666|NCT00306891|19629457|P1|Part A|Partial bowel obstruction|1
5692667|NCT00306891|19629454|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
5692668|NCT00306891|19629455|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
5692669|NCT00306891|19629456|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
5692670|NCT00306891|19629457|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
5692671|NCT00306891|19629454|P4|Part A|Condition under investigation worsened|0
5692672|NCT00306891|19629455|P3|Part A|Condition under investigation worsened|0
5692673|NCT00306891|19629456|P2|Part A|Condition under investigation worsened|2
5692674|NCT00306891|19629457|P1|Part A|Condition under investigation worsened|2
5692675|NCT00306891|19629454|P4|Part A|Withdrawal by Subject|0
5692676|NCT00306891|19629455|P3|Part A|Withdrawal by Subject|0
5692677|NCT00306891|19629456|P2|Part A|Withdrawal by Subject|1
5692678|NCT00306891|19629457|P1|Part A|Withdrawal by Subject|1
5692679|NCT00306852|19629480|P2|Overall Study|Lost to Follow-up|24
5692680|NCT00306852|19629481|P1|Overall Study|Lost to Follow-up|15
5692681|NCT00306852|19629480|P2|Overall Study|Death|14
5692682|NCT00306852|19629481|P1|Overall Study|Death|14
5692683|NCT00306787|19629499|P2|Overall Study|Abnormal laboratory value(s)|0
5692684|NCT00306787|19629500|P1|Overall Study|Abnormal laboratory value(s)|1
5692685|NCT00306787|19629499|P2|Overall Study|Administrative problems|0
5692686|NCT00306787|19629500|P1|Overall Study|Administrative problems|4
5692687|NCT00306787|19629499|P2|Overall Study|Lost to Follow-up|6
5692688|NCT00306787|19629500|P1|Overall Study|Lost to Follow-up|9
5692689|NCT00306787|19629499|P2|Overall Study|Withdrawal by Subject|9
5692690|NCT00306787|19629500|P1|Overall Study|Withdrawal by Subject|2
5692691|NCT00306787|19629499|P2|Overall Study|Protocol Violation|10
5692692|NCT00306787|19629500|P1|Overall Study|Protocol Violation|8
5692693|NCT00306787|19629499|P2|Overall Study|Lack of Efficacy|0
5692694|NCT00306787|19629500|P1|Overall Study|Lack of Efficacy|1
5692695|NCT00306787|19629499|P2|Overall Study|Adverse Event|1
5692696|NCT00306787|19629500|P1|Overall Study|Adverse Event|1
5692697|NCT00306787|19629499|P2|Overall Study|Discontinued without taking study drug|215
5692698|NCT00306787|19629500|P1|Overall Study|Discontinued without taking study drug|208
5692699|NCT00306670|19629518|P2|Overall Study|patients recruited; Genentech, the st|2
5692700|NCT00306670|19629519|P1|Overall Study|patients recruited; Genentech, the st|0
5692701|NCT00306592|19629525|P2|Overall Study|48-week Treatment Period Ongoing|20
5692702|NCT00306592|19629526|P1|Overall Study|48-week Treatment Period Ongoing|0
5692703|NCT00306592|19629525|P2|Overall Study|Other|2
5692704|NCT00306592|19629526|P1|Overall Study|Other|1
5692705|NCT00306592|19629525|P2|Overall Study|Other|10
5692706|NCT00306592|19629526|P1|Overall Study|Other|5
5692707|NCT00306592|19629525|P2|Overall Study|Voluntary|6
5692708|NCT00306592|19629526|P1|Overall Study|Voluntary|10
5692709|NCT00306592|19629525|P2|Overall Study|Persistent Antibodies|3
5692710|NCT00306592|19629526|P1|Overall Study|Persistent Antibodies|6
5692711|NCT00306592|19629525|P2|Overall Study|Noncompliance|2
5692712|NCT00306592|19629526|P1|Overall Study|Noncompliance|0
5692713|NCT00306592|19629525|P2|Overall Study|Lost to Follow-up|0
5692714|NCT00306592|19629526|P1|Overall Study|Lost to Follow-up|1
5692715|NCT00306592|19629525|P2|Overall Study|Adverse Event|15
5692716|NCT00306592|19629526|P1|Overall Study|Adverse Event|8
5692717|NCT00306527|19629536|P4|Overall Study|Death|2
5692718|NCT00306527|19629537|P3|Overall Study|Death|1
5692719|NCT00306527|19629538|P2|Overall Study|Death|0
5692720|NCT00306527|19629539|P1|Overall Study|Death|1
5692721|NCT00306527|19629536|P4|Overall Study|Adverse Event|1
5692722|NCT00306527|19629537|P3|Overall Study|Adverse Event|1
5692723|NCT00306527|19629538|P2|Overall Study|Adverse Event|0
5692724|NCT00306527|19629539|P1|Overall Study|Adverse Event|0
5692725|NCT00306527|19629536|P4|Overall Study|Withdrawal by Subject|3
5692726|NCT00306527|19629537|P3|Overall Study|Withdrawal by Subject|0
5692727|NCT00306527|19629538|P2|Overall Study|Withdrawal by Subject|3
5692728|NCT00306527|19629539|P1|Overall Study|Withdrawal by Subject|2
5692729|NCT00306527|19629536|P4|Overall Study|Lost to Follow-up|0
5692730|NCT00306527|19629537|P3|Overall Study|Lost to Follow-up|3
5692731|NCT00306527|19629538|P2|Overall Study|Lost to Follow-up|4
5692732|NCT00306527|19629539|P1|Overall Study|Lost to Follow-up|3
5692733|NCT00306384|19629611|P3|Overall Study|Site closure|0
5692734|NCT00306384|19629612|P2|Overall Study|Site closure|0
5692735|NCT00306384|19629613|P1|Overall Study|Site closure|2
5692736|NCT00306384|19629611|P3|Overall Study|Other|32
5692737|NCT00306384|19629612|P2|Overall Study|Other|70
5692738|NCT00306384|19629613|P1|Overall Study|Other|80
5692739|NCT00306384|19629611|P3|Overall Study|Investigator discretion|21
5692740|NCT00306384|19629612|P2|Overall Study|Investigator discretion|31
5692741|NCT00306384|19629613|P1|Overall Study|Investigator discretion|28
5692742|NCT00306384|19629611|P3|Overall Study|Lack of Efficacy|38
5692743|NCT00306384|19629612|P2|Overall Study|Lack of Efficacy|40
5692744|NCT00306384|19629613|P1|Overall Study|Lack of Efficacy|26
5692745|NCT00306384|19629611|P3|Overall Study|Pregnancy|1
5692746|NCT00306384|19629612|P2|Overall Study|Pregnancy|1
5692747|NCT00306384|19629613|P1|Overall Study|Pregnancy|3
5692748|NCT00306384|19629611|P3|Overall Study|Study termination|1
5692749|NCT00306384|19629612|P2|Overall Study|Study termination|0
5692750|NCT00306384|19629613|P1|Overall Study|Study termination|1
5692751|NCT00306384|19629611|P3|Overall Study|Voluntary withdrawal|91
5692752|NCT00306384|19629612|P2|Overall Study|Voluntary withdrawal|187
5692753|NCT00306384|19629613|P1|Overall Study|Voluntary withdrawal|199
5692754|NCT00306384|19629611|P3|Overall Study|Lost to Follow-up|35
5692755|NCT00306384|19629612|P2|Overall Study|Lost to Follow-up|41
5692756|NCT00306384|19629613|P1|Overall Study|Lost to Follow-up|57
5692757|NCT00306384|19629611|P3|Overall Study|Major protocol deviation|18
5692758|NCT00306384|19629612|P2|Overall Study|Major protocol deviation|51
5692759|NCT00306384|19629613|P1|Overall Study|Major protocol deviation|43
5692760|NCT00306384|19629611|P3|Overall Study|Adverse Event|40
5692761|NCT00306384|19629612|P2|Overall Study|Adverse Event|87
5692762|NCT00306384|19629613|P1|Overall Study|Adverse Event|103
5692763|NCT00306293|19629645|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
5692764|NCT00306293|19629646|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
5692765|NCT00306293|19629645|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
5692766|NCT00306293|19629646|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
5692767|NCT00306293|19629645|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
5692768|NCT00306293|19629646|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
5692769|NCT00306293|19629645|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
5692770|NCT00306293|19629646|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
5692771|NCT00306293|19629645|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
5692772|NCT00306293|19629646|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
5692773|NCT00306293|19629645|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
5692774|NCT00306293|19629646|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
5692775|NCT00306293|19629645|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
5692776|NCT00306293|19629646|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
5692777|NCT00306293|19629645|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
5692778|NCT00306293|19629646|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
5692779|NCT00306189|19629829|P4|Overall Study|Other|0
5692780|NCT00306189|19629830|P3|Overall Study|Other|0
5692781|NCT00306189|19629831|P2|Overall Study|Other|0
5692782|NCT00306189|19629832|P1|Overall Study|Other|1
5692783|NCT00306189|19629829|P4|Overall Study|Ineligibility determined|1
5692784|NCT00306189|19629830|P3|Overall Study|Ineligibility determined|1
5692785|NCT00306189|19629831|P2|Overall Study|Ineligibility determined|1
5692786|NCT00306189|19629832|P1|Overall Study|Ineligibility determined|1
5692787|NCT00306189|19629829|P4|Overall Study|Withdrawal by Subject|1
5692788|NCT00306189|19629830|P3|Overall Study|Withdrawal by Subject|8
5692789|NCT00306189|19629831|P2|Overall Study|Withdrawal by Subject|2
5692790|NCT00306189|19629832|P1|Overall Study|Withdrawal by Subject|4
5692791|NCT00306189|19629829|P4|Overall Study|Adverse Event|2
5692792|NCT00306189|19629830|P3|Overall Study|Adverse Event|2
5692793|NCT00306189|19629831|P2|Overall Study|Adverse Event|3
5692794|NCT00306189|19629832|P1|Overall Study|Adverse Event|3
5692795|NCT00306189|19629829|P4|Overall Study|Physician Decision|1
5692796|NCT00306189|19629830|P3|Overall Study|Physician Decision|0
5692797|NCT00306189|19629831|P2|Overall Study|Physician Decision|0
5692798|NCT00306189|19629832|P1|Overall Study|Physician Decision|0
5692799|NCT00305877|19629859|P2|Overall Study|Transportation issue with daily RT|1
5692800|NCT00305877|19629860|P1|Overall Study|Transportation issue with daily RT|0
5692801|NCT00305877|19629859|P2|Overall Study|Ineligible|1
5692802|NCT00305877|19629860|P1|Overall Study|Ineligible|2
5692803|NCT00305877|19629859|P2|Overall Study|Never start treatment|5
5692804|NCT00305877|19629860|P1|Overall Study|Never start treatment|2
5692805|NCT00305877|19629859|P2|Overall Study|Physician Decision|1
5692806|NCT00305877|19629860|P1|Overall Study|Physician Decision|1
5692807|NCT00305877|19629859|P2|Overall Study|Withdrawal by Subject|2
5692808|NCT00305877|19629860|P1|Overall Study|Withdrawal by Subject|4
5692809|NCT00305877|19629859|P2|Overall Study|Death|1
5692810|NCT00305877|19629860|P1|Overall Study|Death|0
5692811|NCT00305877|19629859|P2|Overall Study|Adverse Event|14
5692812|NCT00305877|19629860|P1|Overall Study|Adverse Event|9
5692813|NCT00305877|19629859|P2|Overall Study|Lack of Efficacy|9
5692814|NCT00305877|19629860|P1|Overall Study|Lack of Efficacy|6
5692815|NCT00305864|19629874|P4|Overall Study|Ineligible / No protocol treatment|13
5692816|NCT00305864|19629875|P3|Overall Study|Ineligible / No protocol treatment|1
5692817|NCT00305864|19629876|P2|Overall Study|Ineligible / No protocol treatment|1
5692818|NCT00305864|19629877|P1|Overall Study|Ineligible / No protocol treatment|0
5692819|NCT00305773|19629890|P2|Overall Study|All other reasons|2
5692820|NCT00305773|19629891|P1|Overall Study|All other reasons|3
5692821|NCT00305773|19629890|P2|Overall Study|Disease Progression|3
5692822|NCT00305773|19629891|P1|Overall Study|Disease Progression|1
5692823|NCT00305773|19629890|P2|Overall Study|Withdrawal by Subject|4
5692824|NCT00305773|19629891|P1|Overall Study|Withdrawal by Subject|1
5692825|NCT00305773|19629890|P2|Overall Study|Physician Decision|1
5692826|NCT00305773|19629891|P1|Overall Study|Physician Decision|1
5692827|NCT00305773|19629890|P2|Overall Study|Alternative Treatment|4
5692828|NCT00305773|19629891|P1|Overall Study|Alternative Treatment|4
5692829|NCT00305773|19629890|P2|Overall Study|Adverse Event|2
5692830|NCT00305773|19629891|P1|Overall Study|Adverse Event|1
5692831|NCT00305773|19629890|P2|Overall Study|Death|2
5692832|NCT00305773|19629891|P1|Overall Study|Death|3
5692833|NCT00305695|19629911|P2|Overall Study|Did not have baseline scan|1
5692834|NCT00305695|19629912|P1|Overall Study|Did not have baseline scan|1
5692835|NCT00305695|19629911|P2|Overall Study|Withdrawal by subject prior to 18 month|26
5692836|NCT00305695|19629912|P1|Overall Study|Withdrawal by subject prior to 18 month|40
5692837|NCT00305604|19630046|P2|Overall Study|Patient moved|0
5692838|NCT00305604|19630047|P1|Overall Study|Patient moved|1
5692839|NCT00305604|19630046|P2|Overall Study|Withdrawal by Subject|21
5692840|NCT00305604|19630047|P1|Overall Study|Withdrawal by Subject|12
5692841|NCT00305604|19630046|P2|Overall Study|Protocol Violation|1
5692842|NCT00305604|19630047|P1|Overall Study|Protocol Violation|2
5692843|NCT00305604|19630046|P2|Overall Study|Lost to Follow-up|4
5692844|NCT00305604|19630047|P1|Overall Study|Lost to Follow-up|0
5692845|NCT00305604|19630046|P2|Overall Study|Lack of Efficacy|18
5692846|NCT00305604|19630047|P1|Overall Study|Lack of Efficacy|11
5692847|NCT00305604|19630046|P2|Overall Study|Adverse Event|3
5692848|NCT00305604|19630047|P1|Overall Study|Adverse Event|6
5692849|NCT00305448|19630191|P3|Overall Study|Tumor Marker Elevation|1
5692850|NCT00305448|19630192|P2|Overall Study|Tumor Marker Elevation|0
5692851|NCT00305448|19630193|P1|Overall Study|Tumor Marker Elevation|0
5692852|NCT00305448|19630191|P3|Overall Study|Subjective Disease Progression|2
5692853|NCT00305448|19630192|P2|Overall Study|Subjective Disease Progression|2
5692854|NCT00305448|19630193|P1|Overall Study|Subjective Disease Progression|1
5692855|NCT00305448|19630191|P3|Overall Study|Disease Progression|28
5692856|NCT00305448|19630192|P2|Overall Study|Disease Progression|31
5692857|NCT00305448|19630193|P1|Overall Study|Disease Progression|27
5692858|NCT00305448|19630191|P3|Overall Study|Adverse Event|1
5692859|NCT00305448|19630192|P2|Overall Study|Adverse Event|0
5692860|NCT00305448|19630193|P1|Overall Study|Adverse Event|1
5692861|NCT00305448|19630191|P3|Overall Study|Withdrawal by Subject|1
5692862|NCT00305448|19630192|P2|Overall Study|Withdrawal by Subject|0
5692863|NCT00305448|19630193|P1|Overall Study|Withdrawal by Subject|2
5692864|NCT00305448|19630191|P3|Overall Study|Protocol Violation|0
5692865|NCT00305448|19630192|P2|Overall Study|Protocol Violation|1
5692866|NCT00305448|19630193|P1|Overall Study|Protocol Violation|0
5692867|NCT00305253|19630215|P2|Overall Study|Withdrawal by Subject|1
5692868|NCT00305253|19630216|P1|Overall Study|Withdrawal by Subject|0
5692869|NCT00305227|19630228|P2|Overall Study|Lost to Follow-up|6
5692870|NCT00305227|19630229|P1|Overall Study|Lost to Follow-up|7
5692871|NCT00305110|19630276|P1|Overall Study|Missing data|29
5692872|NCT00305058|19630349|P2|Overall Study|Missing outcome data|2
5692873|NCT00305058|19630350|P1|Overall Study|Missing outcome data|3
5692874|NCT00305058|19630349|P2|Overall Study|Missing data collection instrument|2
5692875|NCT00305058|19630350|P1|Overall Study|Missing data collection instrument|3
5692876|NCT00305058|19630349|P2|Overall Study|Participant too young|0
5692877|NCT00305058|19630350|P1|Overall Study|Participant too young|1
5692878|NCT00304954|19630366|P4|Overall Study|Adverse Event|0
5692879|NCT00304954|19630367|P3|Overall Study|Adverse Event|0
5692880|NCT00304954|19630368|P2|Overall Study|Adverse Event|0
5692881|NCT00304954|19630369|P1|Overall Study|Adverse Event|1
5692882|NCT00304954|19630366|P4|Overall Study|Withdrawal by Subject|0
5692883|NCT00304954|19630367|P3|Overall Study|Withdrawal by Subject|1
5692884|NCT00304954|19630368|P2|Overall Study|Withdrawal by Subject|0
5692885|NCT00304954|19630369|P1|Overall Study|Withdrawal by Subject|0
5692886|NCT00304915|19630389|P2|Overall Study|Withdrawal by Subject|0
5692887|NCT00304915|19630390|P1|Overall Study|Withdrawal by Subject|3
5692888|NCT00304915|19630389|P2|Overall Study|Death|5
5692889|NCT00304915|19630390|P1|Overall Study|Death|4
5692890|NCT00304915|19630389|P2|Overall Study|Lost to Follow-up|11
5692891|NCT00304915|19630390|P1|Overall Study|Lost to Follow-up|11
5692892|NCT00304356|19630435|P1|Nitazoxanide|Physician Decision|1
5692893|NCT00304356|19630435|P1|Nitazoxanide|Physician Decision|1
5692894|NCT00304356|19630435|P1|Nitazoxanide|Physician Decision|1
5692895|NCT00304356|19630435|P1|Nitazoxanide|number is 0|1
5692896|NCT00304356|19630435|P1|Nitazoxanide|Physician Decision|1
5692897|NCT00304356|19630435|P1|Nitazoxanide|Physician Decision|5
5692898|NCT00304278|19630439|P1|Overall Study|PT had medical condition preventing TX|1
5692899|NCT00304278|19630439|P1|Overall Study|lack of insurance coverage for chemoRT|1
5692900|NCT00304083|19630488|P2|Overall Study|Other|2
5692901|NCT00304083|19630489|P1|Overall Study|Other|5
5692902|NCT00304083|19630488|P2|Overall Study|Disease Progression|1
5692903|NCT00304083|19630489|P1|Overall Study|Disease Progression|5
5692904|NCT00304083|19630488|P2|Overall Study|Physician Decision|3
5692905|NCT00304083|19630489|P1|Overall Study|Physician Decision|8
5692906|NCT00304083|19630488|P2|Overall Study|Withdrawal by Subject|2
5692907|NCT00304083|19630489|P1|Overall Study|Withdrawal by Subject|4
5692908|NCT00304070|19630508|P3|Overall Study|Progressive Disease|4
5692909|NCT00304070|19630509|P2|Overall Study|Progressive Disease|7
5692910|NCT00304070|19630510|P1|Overall Study|Progressive Disease|3
5692911|NCT00304070|19630508|P3|Overall Study|Withdrawal by Subject|1
5692912|NCT00304070|19630509|P2|Overall Study|Withdrawal by Subject|0
5692913|NCT00304070|19630510|P1|Overall Study|Withdrawal by Subject|0
5692914|NCT00304070|19630508|P3|Overall Study|Physician Decision|3
5692915|NCT00304070|19630509|P2|Overall Study|Physician Decision|0
5692916|NCT00304070|19630510|P1|Overall Study|Physician Decision|0
5692917|NCT00304070|19630508|P3|Overall Study|Lost to Follow-up|1
5692918|NCT00304070|19630509|P2|Overall Study|Lost to Follow-up|0
5692919|NCT00304070|19630510|P1|Overall Study|Lost to Follow-up|0
5692920|NCT00304070|19630508|P3|Overall Study|Death|3
5692921|NCT00304070|19630509|P2|Overall Study|Death|0
5692922|NCT00304070|19630510|P1|Overall Study|Death|0
5692923|NCT00304031|19630525|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
5692924|NCT00304031|19630526|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
5692925|NCT00304031|19630527|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
5692926|NCT00304031|19630525|P3|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
5692927|NCT00304031|19630526|P2|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
5692928|NCT00304031|19630527|P1|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
5692929|NCT00304031|19630525|P3|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
5692930|NCT00304031|19630526|P2|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
5693097|NCT00303446|19630878|P2|Overall Study|Withdrawal by Subject|2
5692931|NCT00304031|19630527|P1|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
5692932|NCT00304031|19630525|P3|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
5692933|NCT00304031|19630526|P2|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
5692934|NCT00304031|19630527|P1|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
5692935|NCT00304031|19630525|P3|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
5692936|NCT00304031|19630526|P2|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
5692937|NCT00304031|19630527|P1|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
5692938|NCT00304031|19630525|P3|Concomitant RT+TMZ (Pre-randomization)|Death|0
5692939|NCT00304031|19630526|P2|Concomitant RT+TMZ (Pre-randomization)|Death|0
5692940|NCT00304031|19630527|P1|Concomitant RT+TMZ (Pre-randomization)|Death|18
5692941|NCT00304031|19630525|P3|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
5692942|NCT00304031|19630526|P2|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
5692943|NCT00304031|19630527|P1|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
5692944|NCT00304031|19630525|P3|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
5692945|NCT00304031|19630526|P2|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
5692946|NCT00304031|19630527|P1|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
5692947|NCT00304031|19630525|P3|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
5692948|NCT00304031|19630526|P2|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
5692949|NCT00304031|19630527|P1|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
5692950|NCT00303953|19630609|P1|Overall Study|Physician Decision|1
5692951|NCT00303953|19630609|P1|Overall Study|Lack of Efficacy|12
5692952|NCT00303953|19630609|P1|Overall Study|Adverse Event|4
5692953|NCT00303953|19630609|P1|Overall Study|Death|1
5692954|NCT00303953|19630609|P1|Overall Study|Ineligible|1
5692955|NCT00303719|19630645|P2|Overall Study|Lost to Follow-up|7
5692956|NCT00303719|19630646|P1|Overall Study|Lost to Follow-up|0
5692957|NCT00303719|19630645|P2|Overall Study|Not evaluable, prior therapies|30
5692958|NCT00303719|19630646|P1|Overall Study|Not evaluable, prior therapies|0
5692959|NCT00303667|19630662|P2|Overall Study|Death|4
5692960|NCT00303667|19630663|P1|Overall Study|Death|0
5692961|NCT00303628|19630687|P2|Overall Study|Other|9
5692962|NCT00303628|19630688|P1|Overall Study|Other|8
5692963|NCT00303628|19630687|P2|Overall Study|Not start protocol therapy|5
5692964|NCT00303628|19630688|P1|Overall Study|Not start protocol therapy|3
5692965|NCT00303628|19630687|P2|Overall Study|Other complicating disease|1
5692966|NCT00303628|19630688|P1|Overall Study|Other complicating disease|0
5692967|NCT00303628|19630687|P2|Overall Study|Alternative therapy|0
5692968|NCT00303628|19630688|P1|Overall Study|Alternative therapy|2
5692969|NCT00303628|19630687|P2|Overall Study|Withdrawal by Subject|20
5692970|NCT00303628|19630688|P1|Overall Study|Withdrawal by Subject|11
5692971|NCT00303628|19630687|P2|Overall Study|Death|1
5692972|NCT00303628|19630688|P1|Overall Study|Death|0
5692973|NCT00303628|19630687|P2|Overall Study|Adverse Event|36
5692974|NCT00303628|19630688|P1|Overall Study|Adverse Event|26
5692975|NCT00303628|19630687|P2|Overall Study|Disease progression|1
5692976|NCT00303628|19630688|P1|Overall Study|Disease progression|0
5692977|NCT00303602|19630706|P2|Overall Study|Protocol Violation|0
5692978|NCT00303602|19630707|P1|Overall Study|Protocol Violation|1
5692979|NCT00303602|19630706|P2|Overall Study|Noncompliance|2
5692980|NCT00303602|19630707|P1|Overall Study|Noncompliance|2
5692981|NCT00303602|19630706|P2|Overall Study|Physician Decision|1
5692982|NCT00303602|19630707|P1|Overall Study|Physician Decision|2
5692983|NCT00303602|19630706|P2|Overall Study|Protocol entry criteria not met|2
5692984|NCT00303602|19630707|P1|Overall Study|Protocol entry criteria not met|2
5692985|NCT00303602|19630706|P2|Overall Study|Lost to Follow-up|2
5692986|NCT00303602|19630707|P1|Overall Study|Lost to Follow-up|5
5692987|NCT00303602|19630706|P2|Overall Study|Withdrawal by Subject|6
5692988|NCT00303602|19630707|P1|Overall Study|Withdrawal by Subject|5
5692989|NCT00303602|19630706|P2|Overall Study|Adverse Event|2
5692990|NCT00303602|19630707|P1|Overall Study|Adverse Event|2
5692991|NCT00303485|19630753|P2|Overall Study|Withdrawal by Subject|0
5692992|NCT00303485|19630754|P1|Overall Study|Withdrawal by Subject|1
5692993|NCT00303485|19630753|P2|Overall Study|Failure to return|1
5692994|NCT00303485|19630754|P1|Overall Study|Failure to return|0
5692995|NCT00303485|19630753|P2|Overall Study|Adverse Event/Intercurrent Illness|1
5692996|NCT00303485|19630754|P1|Overall Study|Adverse Event/Intercurrent Illness|0
5692997|NCT00303472|19630785|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
5692998|NCT00303472|19630786|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
5692999|NCT00303472|19630787|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
5693000|NCT00303472|19630788|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
5693001|NCT00303472|19630789|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
5693002|NCT00303472|19630790|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
5693003|NCT00303472|19630791|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
5693004|NCT00303472|19630785|P7|Treatment Extension (Optional)|Other|0
5693005|NCT00303472|19630786|P6|Treatment Extension (Optional)|Other|0
5693006|NCT00303472|19630787|P5|Treatment Extension (Optional)|Other|1
5693007|NCT00303472|19630788|P4|Treatment Extension (Optional)|Other|2
5693008|NCT00303472|19630789|P3|Treatment Extension (Optional)|Other|4
5693009|NCT00303472|19630790|P2|Treatment Extension (Optional)|Other|2
5693010|NCT00303472|19630791|P1|Treatment Extension (Optional)|Other|0
5693011|NCT00303472|19630785|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
5693012|NCT00303472|19630786|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
5693013|NCT00303472|19630787|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
5693014|NCT00303472|19630788|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
5693015|NCT00303472|19630789|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
5693016|NCT00303472|19630790|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
5693017|NCT00303472|19630791|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
5693018|NCT00303472|19630785|P7|Treatment Extension (Optional)|Physician Decision|0
5693019|NCT00303472|19630786|P6|Treatment Extension (Optional)|Physician Decision|0
5693020|NCT00303472|19630787|P5|Treatment Extension (Optional)|Physician Decision|2
5693021|NCT00303472|19630788|P4|Treatment Extension (Optional)|Physician Decision|3
5693022|NCT00303472|19630789|P3|Treatment Extension (Optional)|Physician Decision|2
5693023|NCT00303472|19630790|P2|Treatment Extension (Optional)|Physician Decision|4
5693024|NCT00303472|19630791|P1|Treatment Extension (Optional)|Physician Decision|0
5693025|NCT00303472|19630785|P7|Treatment Extension (Optional)|Lost to Follow-up|0
5693026|NCT00303472|19630786|P6|Treatment Extension (Optional)|Lost to Follow-up|0
5693027|NCT00303472|19630787|P5|Treatment Extension (Optional)|Lost to Follow-up|0
5693028|NCT00303472|19630788|P4|Treatment Extension (Optional)|Lost to Follow-up|1
5693029|NCT00303472|19630789|P3|Treatment Extension (Optional)|Lost to Follow-up|0
5693030|NCT00303472|19630790|P2|Treatment Extension (Optional)|Lost to Follow-up|0
5693031|NCT00303472|19630791|P1|Treatment Extension (Optional)|Lost to Follow-up|0
5693032|NCT00303472|19630785|P7|Treatment Extension (Optional)|Death|0
5693033|NCT00303472|19630786|P6|Treatment Extension (Optional)|Death|0
5693034|NCT00303472|19630787|P5|Treatment Extension (Optional)|Death|0
5693035|NCT00303472|19630788|P4|Treatment Extension (Optional)|Death|0
5693036|NCT00303472|19630789|P3|Treatment Extension (Optional)|Death|1
5693037|NCT00303472|19630790|P2|Treatment Extension (Optional)|Death|0
5693038|NCT00303472|19630791|P1|Treatment Extension (Optional)|Death|2
5693039|NCT00303472|19630785|P7|Treatment Extension (Optional)|Adverse Event|0
5693040|NCT00303472|19630786|P6|Treatment Extension (Optional)|Adverse Event|0
5693041|NCT00303472|19630787|P5|Treatment Extension (Optional)|Adverse Event|0
5693042|NCT00303472|19630788|P4|Treatment Extension (Optional)|Adverse Event|0
5693043|NCT00303472|19630789|P3|Treatment Extension (Optional)|Adverse Event|1
5693044|NCT00303472|19630790|P2|Treatment Extension (Optional)|Adverse Event|0
5693045|NCT00303472|19630791|P1|Treatment Extension (Optional)|Adverse Event|1
5693046|NCT00303472|19630785|P7|Treatment Period|Disease Progression (to AML)|0
5693047|NCT00303472|19630786|P6|Treatment Period|Disease Progression (to AML)|0
5693048|NCT00303472|19630787|P5|Treatment Period|Disease Progression (to AML)|1
5693049|NCT00303472|19630788|P4|Treatment Period|Disease Progression (to AML)|0
5693050|NCT00303472|19630789|P3|Treatment Period|Disease Progression (to AML)|0
5693051|NCT00303472|19630790|P2|Treatment Period|Disease Progression (to AML)|0
5693052|NCT00303472|19630791|P1|Treatment Period|Disease Progression (to AML)|0
5693053|NCT00303472|19630785|P7|Treatment Period|Other|1
5693054|NCT00303472|19630786|P6|Treatment Period|Other|0
5693055|NCT00303472|19630787|P5|Treatment Period|Other|1
5693056|NCT00303472|19630788|P4|Treatment Period|Other|0
5693057|NCT00303472|19630789|P3|Treatment Period|Other|0
5693058|NCT00303472|19630790|P2|Treatment Period|Other|0
5693059|NCT00303472|19630791|P1|Treatment Period|Other|0
5693060|NCT00303472|19630785|P7|Treatment Period|Withdrawal by Subject|0
5693061|NCT00303472|19630786|P6|Treatment Period|Withdrawal by Subject|1
5693062|NCT00303472|19630787|P5|Treatment Period|Withdrawal by Subject|0
5693063|NCT00303472|19630788|P4|Treatment Period|Withdrawal by Subject|1
5693064|NCT00303472|19630789|P3|Treatment Period|Withdrawal by Subject|0
5693065|NCT00303472|19630790|P2|Treatment Period|Withdrawal by Subject|0
5693066|NCT00303472|19630791|P1|Treatment Period|Withdrawal by Subject|0
5693067|NCT00303472|19630785|P7|Treatment Period|Death|1
5693068|NCT00303472|19630786|P6|Treatment Period|Death|0
5693069|NCT00303472|19630787|P5|Treatment Period|Death|0
5693070|NCT00303472|19630788|P4|Treatment Period|Death|1
5693071|NCT00303472|19630789|P3|Treatment Period|Death|0
5693072|NCT00303472|19630790|P2|Treatment Period|Death|0
5693073|NCT00303472|19630791|P1|Treatment Period|Death|0
5693074|NCT00303472|19630785|P7|Treatment Period|Adverse Event|0
5693075|NCT00303472|19630786|P6|Treatment Period|Adverse Event|0
5693076|NCT00303472|19630787|P5|Treatment Period|Adverse Event|1
5693077|NCT00303472|19630788|P4|Treatment Period|Adverse Event|0
5693078|NCT00303472|19630789|P3|Treatment Period|Adverse Event|0
5693079|NCT00303472|19630790|P2|Treatment Period|Adverse Event|0
5693080|NCT00303472|19630791|P1|Treatment Period|Adverse Event|0
5693081|NCT00303459|19630851|P2|Overall Study|Lung transplantation|1
5693082|NCT00303459|19630852|P1|Overall Study|Lung transplantation|1
5693083|NCT00303459|19630851|P2|Overall Study|Decision by the investigator|7
5693084|NCT00303459|19630852|P1|Overall Study|Decision by the investigator|5
5693085|NCT00303459|19630851|P2|Overall Study|Administrative reason|7
5693086|NCT00303459|19630852|P1|Overall Study|Administrative reason|7
5693087|NCT00303459|19630851|P2|Overall Study|Lost to Follow-up|4
5693088|NCT00303459|19630852|P1|Overall Study|Lost to Follow-up|5
5693089|NCT00303459|19630851|P2|Overall Study|Withdrawal of consent|26
5693090|NCT00303459|19630852|P1|Overall Study|Withdrawal of consent|32
5693091|NCT00303459|19630851|P2|Overall Study|Death|44
5693092|NCT00303459|19630852|P1|Overall Study|Death|33
5693093|NCT00303446|19630878|P2|Overall Study|Physician Decision|1
5693094|NCT00303446|19630879|P1|Overall Study|Physician Decision|0
5693095|NCT00303446|19630878|P2|Overall Study|Death|1
5693096|NCT00303446|19630879|P1|Overall Study|Death|0
5693098|NCT00303446|19630879|P1|Overall Study|Withdrawal by Subject|2
5693099|NCT00303329|19630915|P2|Overall Study|Stopped at end of extension 1|0
5693100|NCT00303329|19630916|P1|Overall Study|Stopped at end of extension 1|1
5693101|NCT00303329|19630915|P2|Overall Study|Stopped at end of core|9
5693102|NCT00303329|19630916|P1|Overall Study|Stopped at end of core|3
5693103|NCT00303329|19630915|P2|Overall Study|Death|12
5693104|NCT00303329|19630916|P1|Overall Study|Death|2
5693105|NCT00303329|19630915|P2|Overall Study|Administrative problems|0
5693106|NCT00303329|19630916|P1|Overall Study|Administrative problems|1
5693107|NCT00303329|19630915|P2|Overall Study|Lost to Follow-up|1
5693108|NCT00303329|19630916|P1|Overall Study|Lost to Follow-up|0
5693109|NCT00303329|19630915|P2|Overall Study|Withdrawal by Subject|15
5693110|NCT00303329|19630916|P1|Overall Study|Withdrawal by Subject|9
5693111|NCT00303329|19630915|P2|Overall Study|Protocol Violation|0
5693112|NCT00303329|19630916|P1|Overall Study|Protocol Violation|3
5693113|NCT00303329|19630915|P2|Overall Study|Condition no longer requires study drug|8
5693114|NCT00303329|19630916|P1|Overall Study|Condition no longer requires study drug|0
5693115|NCT00303329|19630915|P2|Overall Study|Unsatisfactory therapeutic effect|2
5693116|NCT00303329|19630916|P1|Overall Study|Unsatisfactory therapeutic effect|9
5693117|NCT00303329|19630915|P2|Overall Study|Abnormal Laboratory Values|1
5693118|NCT00303329|19630916|P1|Overall Study|Abnormal Laboratory Values|0
5693119|NCT00303329|19630915|P2|Overall Study|Adverse Event|14
5693120|NCT00303329|19630916|P1|Overall Study|Adverse Event|7
5693121|NCT00303316|19630930|P2|Overall Study|Withdrawal by Subject|2
5693122|NCT00303316|19630931|P1|Overall Study|Withdrawal by Subject|1
5693123|NCT00303316|19630930|P2|Overall Study|Lost to Follow-up|1
5693124|NCT00303316|19630931|P1|Overall Study|Lost to Follow-up|0
5693125|NCT00303316|19630930|P2|Overall Study|Protocol Violation|0
5693126|NCT00303316|19630931|P1|Overall Study|Protocol Violation|1
5693127|NCT00303186|19630943|P1|Overall Study|Other|52
5693128|NCT00303108|19630977|P3|Overall Study|ineligible|0
5693129|NCT00303108|19630978|P2|Overall Study|ineligible|1
5693130|NCT00303108|19630979|P1|Overall Study|ineligible|2
5693131|NCT00303108|19630977|P3|Overall Study|Failed Entry|1
5693132|NCT00303108|19630978|P2|Overall Study|Failed Entry|0
5693133|NCT00303108|19630979|P1|Overall Study|Failed Entry|1
5693134|NCT00303108|19630977|P3|Overall Study|Patient Request|8
5693135|NCT00303108|19630978|P2|Overall Study|Patient Request|2
5693136|NCT00303108|19630979|P1|Overall Study|Patient Request|4
5693137|NCT00303108|19630977|P3|Overall Study|Adverse Event|7
5693138|NCT00303108|19630978|P2|Overall Study|Adverse Event|6
5693139|NCT00303108|19630979|P1|Overall Study|Adverse Event|5
5693140|NCT00303069|19630999|P4|Overall Study|Recruitment into Army Reserves|0
5693141|NCT00303069|19631000|P3|Overall Study|Recruitment into Army Reserves|1
5693142|NCT00303069|19631001|P2|Overall Study|Recruitment into Army Reserves|0
5693143|NCT00303069|19631002|P1|Overall Study|Recruitment into Army Reserves|0
5693144|NCT00303069|19630999|P4|Overall Study|subject moved|0
5693145|NCT00303069|19631000|P3|Overall Study|subject moved|0
5693146|NCT00303069|19631001|P2|Overall Study|subject moved|0
5693147|NCT00303069|19631002|P1|Overall Study|subject moved|1
5693148|NCT00303069|19630999|P4|Overall Study|Lost to Follow-up|2
5693149|NCT00303069|19631000|P3|Overall Study|Lost to Follow-up|0
5693150|NCT00303069|19631001|P2|Overall Study|Lost to Follow-up|0
5693151|NCT00303069|19631002|P1|Overall Study|Lost to Follow-up|1
5693152|NCT00302952|19631022|P2|Overall Study|Elevated SGOT (AST) lab value|1
5693153|NCT00302952|19631023|P1|Overall Study|Elevated SGOT (AST) lab value|0
5693154|NCT00302952|19631022|P2|Overall Study|Withdrawal by Subject|3
5693155|NCT00302952|19631023|P1|Overall Study|Withdrawal by Subject|2
5693156|NCT00302952|19631022|P2|Overall Study|Physician Decision|1
5693157|NCT00302952|19631023|P1|Overall Study|Physician Decision|1
5693158|NCT00302731|19631073|P4|Overall Study|cancer unrelated to study discovered|0
5693159|NCT00302731|19631074|P3|Overall Study|cancer unrelated to study discovered|1
5693160|NCT00302731|19631075|P2|Overall Study|cancer unrelated to study discovered|0
5693161|NCT00302731|19631076|P1|Overall Study|cancer unrelated to study discovered|1
5693162|NCT00302731|19631073|P4|Overall Study|Protocol Violation|0
5693163|NCT00302731|19631074|P3|Overall Study|Protocol Violation|0
5693164|NCT00302731|19631075|P2|Overall Study|Protocol Violation|0
5693165|NCT00302731|19631076|P1|Overall Study|Protocol Violation|1
5693166|NCT00302731|19631073|P4|Overall Study|Withdrawal by Subject|0
5693167|NCT00302731|19631074|P3|Overall Study|Withdrawal by Subject|0
5693168|NCT00302731|19631075|P2|Overall Study|Withdrawal by Subject|1
5693169|NCT00302731|19631076|P1|Overall Study|Withdrawal by Subject|1
5693170|NCT00302731|19631073|P4|Overall Study|Adverse Event|0
5693171|NCT00302731|19631074|P3|Overall Study|Adverse Event|2
5693172|NCT00302731|19631075|P2|Overall Study|Adverse Event|2
5693173|NCT00302731|19631076|P1|Overall Study|Adverse Event|0
5693174|NCT00302731|19631073|P4|Overall Study|Lost to Follow-up|0
5693175|NCT00302731|19631074|P3|Overall Study|Lost to Follow-up|0
5693176|NCT00302731|19631075|P2|Overall Study|Lost to Follow-up|2
5693177|NCT00302731|19631076|P1|Overall Study|Lost to Follow-up|1
5693178|NCT00302718|19631102|P4|Overall Study|Participant left primary care setting|1
5693179|NCT00302718|19631103|P3|Overall Study|Participant left primary care setting|2
5693180|NCT00302718|19631104|P2|Overall Study|Participant left primary care setting|0
5693181|NCT00302718|19631105|P1|Overall Study|Participant left primary care setting|0
5693182|NCT00302718|19631102|P4|Overall Study|Withdrawal by Subject|0
5693183|NCT00302718|19631103|P3|Overall Study|Withdrawal by Subject|0
5693184|NCT00302718|19631104|P2|Overall Study|Withdrawal by Subject|1
5693185|NCT00302718|19631105|P1|Overall Study|Withdrawal by Subject|0
5693186|NCT00302718|19631102|P4|Overall Study|Participant left the hospital|1
5693187|NCT00302718|19631103|P3|Overall Study|Participant left the hospital|0
5693188|NCT00302718|19631104|P2|Overall Study|Participant left the hospital|0
5693189|NCT00302718|19631105|P1|Overall Study|Participant left the hospital|1
5693190|NCT00302458|19631171|P1|Overall Study|Withdrawal by Subject|1
5693191|NCT00302458|19631171|P1|Overall Study|Ineligible after screening|1
5693192|NCT00302458|19631171|P1|Overall Study|Lost to Follow-up|1
5693193|NCT00302328|19631182|P3|Overall Study|Physician Decision|0
5693194|NCT00302328|19631183|P2|Overall Study|Physician Decision|1
5693195|NCT00302328|19631184|P1|Overall Study|Physician Decision|0
5693196|NCT00302211|19631201|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
5693197|NCT00302211|19631202|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
5693198|NCT00302211|19631203|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
5693199|NCT00302211|19631204|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
5693200|NCT00302211|19631205|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
5693201|NCT00302211|19631201|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
5693202|NCT00302211|19631202|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
5693203|NCT00302211|19631203|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
5693204|NCT00302211|19631204|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
5693205|NCT00302211|19631205|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
5693206|NCT00302211|19631201|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
5693207|NCT00302211|19631202|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
5693208|NCT00302211|19631203|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
5693209|NCT00302211|19631204|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
5693210|NCT00302211|19631205|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
5693211|NCT00302211|19631201|P5|Open Label-Patients From Double-Blind|Death|1
5693212|NCT00302211|19631202|P4|Open Label-Patients From Double-Blind|Death|1
5693213|NCT00302211|19631203|P3|Open Label-Patients From Double-Blind|Death|0
5693214|NCT00302211|19631204|P2|Open Label-Patients From Double-Blind|Death|0
5693215|NCT00302211|19631205|P1|Open Label-Patients From Double-Blind|Death|0
5693216|NCT00302211|19631201|P5|Open Label-Patients From Double-Blind|Disease progression|2
5693217|NCT00302211|19631202|P4|Open Label-Patients From Double-Blind|Disease progression|1
5693218|NCT00302211|19631203|P3|Open Label-Patients From Double-Blind|Disease progression|0
5693219|NCT00302211|19631204|P2|Open Label-Patients From Double-Blind|Disease progression|0
5693220|NCT00302211|19631205|P1|Open Label-Patients From Double-Blind|Disease progression|0
5693221|NCT00302211|19631201|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
5693222|NCT00302211|19631202|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
5693223|NCT00302211|19631203|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
5693224|NCT00302211|19631204|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
5693225|NCT00302211|19631205|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
5693226|NCT00302211|19631201|P5|Open Label-Patients From Double-Blind|Adverse Event|0
5693227|NCT00302211|19631202|P4|Open Label-Patients From Double-Blind|Adverse Event|1
5693228|NCT00302211|19631203|P3|Open Label-Patients From Double-Blind|Adverse Event|0
5693229|NCT00302211|19631204|P2|Open Label-Patients From Double-Blind|Adverse Event|0
5693230|NCT00302211|19631205|P1|Open Label-Patients From Double-Blind|Adverse Event|0
5693231|NCT00302211|19631201|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
5693232|NCT00302211|19631202|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
5693233|NCT00302211|19631203|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
5693234|NCT00302211|19631204|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
5693235|NCT00302211|19631205|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
5693236|NCT00302211|19631201|P5|Double Blind Period (New Patients)|Disease progression|0
5693237|NCT00302211|19631202|P4|Double Blind Period (New Patients)|Disease progression|0
5693238|NCT00302211|19631203|P3|Double Blind Period (New Patients)|Disease progression|1
5693239|NCT00302211|19631204|P2|Double Blind Period (New Patients)|Disease progression|1
5693240|NCT00302211|19631205|P1|Double Blind Period (New Patients)|Disease progression|0
5693241|NCT00302211|19631201|P5|Double Blind Period (New Patients)|Investigator's judgement|0
5693242|NCT00302211|19631202|P4|Double Blind Period (New Patients)|Investigator's judgement|0
5693243|NCT00302211|19631203|P3|Double Blind Period (New Patients)|Investigator's judgement|0
5693244|NCT00302211|19631204|P2|Double Blind Period (New Patients)|Investigator's judgement|0
5693245|NCT00302211|19631205|P1|Double Blind Period (New Patients)|Investigator's judgement|1
5693246|NCT00302211|19631201|P5|Double Blind Period (New Patients)|Adverse Event|0
5693247|NCT00302211|19631202|P4|Double Blind Period (New Patients)|Adverse Event|0
5693248|NCT00302211|19631203|P3|Double Blind Period (New Patients)|Adverse Event|3
5693249|NCT00302211|19631204|P2|Double Blind Period (New Patients)|Adverse Event|0
5693250|NCT00302211|19631205|P1|Double Blind Period (New Patients)|Adverse Event|0
5693251|NCT00302211|19631201|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
5693252|NCT00302211|19631202|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
5693253|NCT00302211|19631203|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
5693254|NCT00302211|19631204|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
5693255|NCT00302211|19631205|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
5693256|NCT00302159|19631231|P1|Overall Study|pt started Avastin|1
5693257|NCT00302159|19631231|P1|Overall Study|pt declined before treatment started|1
5693258|NCT00302107|19631253|P2|Overall Study|Adverse Event|0
5693259|NCT00302107|19631254|P1|Overall Study|Adverse Event|1
5693260|NCT00302107|19631253|P2|Overall Study|Withdrawal by Subject|3
5693261|NCT00302107|19631254|P1|Overall Study|Withdrawal by Subject|0
5693262|NCT00302107|19631253|P2|Overall Study|Relocation|1
5693263|NCT00302107|19631254|P1|Overall Study|Relocation|0
5693264|NCT00302107|19631253|P2|Overall Study|Protocol Violation|0
5693265|NCT00302107|19631254|P1|Overall Study|Protocol Violation|1
5693266|NCT00302107|19631253|P2|Overall Study|Lost to Follow-up|5
5693267|NCT00302107|19631254|P1|Overall Study|Lost to Follow-up|6
5693268|NCT00302081|19631263|P3|Overall Study|Other|5
5693269|NCT00302081|19631264|P2|Overall Study|Other|6
5693270|NCT00302081|19631265|P1|Overall Study|Other|13
5693271|NCT00302081|19631263|P3|Overall Study|Death|0
5693272|NCT00302081|19631264|P2|Overall Study|Death|1
5693273|NCT00302081|19631265|P1|Overall Study|Death|2
5693274|NCT00302081|19631263|P3|Overall Study|Lack of Efficacy|5
5693275|NCT00302081|19631264|P2|Overall Study|Lack of Efficacy|0
5693276|NCT00302081|19631265|P1|Overall Study|Lack of Efficacy|1
5693277|NCT00302081|19631263|P3|Overall Study|Protocol Violation|2
5693278|NCT00302081|19631264|P2|Overall Study|Protocol Violation|1
5693279|NCT00302081|19631265|P1|Overall Study|Protocol Violation|5
5693280|NCT00302081|19631263|P3|Overall Study|Withdrawal by Subject|8
5693281|NCT00302081|19631264|P2|Overall Study|Withdrawal by Subject|12
5693282|NCT00302081|19631265|P1|Overall Study|Withdrawal by Subject|8
5693283|NCT00302081|19631263|P3|Overall Study|Lost to Follow-up|28
5693284|NCT00302081|19631264|P2|Overall Study|Lost to Follow-up|18
5693285|NCT00302081|19631265|P1|Overall Study|Lost to Follow-up|21
5693286|NCT00302081|19631263|P3|Overall Study|Adverse Event|4
5693287|NCT00302081|19631264|P2|Overall Study|Adverse Event|5
5693288|NCT00302081|19631265|P1|Overall Study|Adverse Event|6
5693289|NCT00302003|19631322|P1|Overall Study|Protocol Violation|1
5693290|NCT00302003|19631322|P1|Overall Study|Ineligible|9
5693291|NCT00302003|19631322|P1|Overall Study|Withdrawal by Subject|5
5693292|NCT00302003|19631322|P1|Overall Study|Physician Decision|2
5693293|NCT00302003|19631322|P1|Overall Study|Lost to Follow-up|1
5693294|NCT00302003|19631322|P1|Overall Study|Lack of Efficacy|62
5693295|NCT00301964|19631329|P1|Overall Study|Inadequate pathology|1
5693296|NCT00301964|19631329|P1|Overall Study|Wrong primary|1
5693297|NCT00301964|19631329|P1|Overall Study|Second primary|2
5693298|NCT00301834|19631350|P1|Overall Study|Death|1
5693299|NCT00301821|19631359|P1|Overall Study|Cancel|1
5693300|NCT00301821|19631359|P1|Overall Study|Ineligible|25
5693301|NCT00301808|19631366|P1|Overall Study|Lack of Efficacy|4
5693302|NCT00301808|19631366|P1|Overall Study|Death|3
5693303|NCT00301808|19631366|P1|Overall Study|Adverse Event|5
5693304|NCT00301366|19631391|P1|Overall Study|Adverse Event|1
5693305|NCT00301262|19631397|P2|Open Label Phase (OL)|Other|0
5693306|NCT00301262|19631398|P1|Open Label Phase (OL)|Other|2
5693307|NCT00301262|19631397|P2|Open Label Phase (OL)|Lost to Follow-up|2
5693308|NCT00301262|19631398|P1|Open Label Phase (OL)|Lost to Follow-up|1
5693309|NCT00301262|19631397|P2|Open Label Phase (OL)|Adverse Event|0
5693310|NCT00301262|19631398|P1|Open Label Phase (OL)|Adverse Event|1
5693311|NCT00301262|19631397|P2|Double Blind Phase (DB)|Other|4
5693312|NCT00301262|19631398|P1|Double Blind Phase (DB)|Other|1
5693313|NCT00301262|19631397|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
5693314|NCT00301262|19631398|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
5693315|NCT00301262|19631397|P2|Double Blind Phase (DB)|Lost to Follow-up|3
5693316|NCT00301262|19631398|P1|Double Blind Phase (DB)|Lost to Follow-up|3
5693317|NCT00301262|19631397|P2|Double Blind Phase (DB)|Lack of Efficacy|1
5693318|NCT00301262|19631398|P1|Double Blind Phase (DB)|Lack of Efficacy|0
5693319|NCT00301262|19631397|P2|Double Blind Phase (DB)|Adverse Event|0
5693320|NCT00301262|19631398|P1|Double Blind Phase (DB)|Adverse Event|1
5693321|NCT00301080|19631556|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
5693322|NCT00301080|19631557|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
5693323|NCT00301080|19631558|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
5693324|NCT00301080|19631559|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
5693325|NCT00301080|19631560|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
5693326|NCT00301067|19631589|P4|Follow up Until Death|Alive at last data cut point|1
5693327|NCT00301067|19631590|P3|Follow up Until Death|Alive at last data cut point|0
5693328|NCT00301067|19631591|P2|Follow up Until Death|Alive at last data cut point|0
5693329|NCT00301067|19631592|P1|Follow up Until Death|Alive at last data cut point|1
5693330|NCT00301067|19631589|P4|Completed 12 Cycles of Treatment|Adverse Event|1
5693331|NCT00301067|19631590|P3|Completed 12 Cycles of Treatment|Adverse Event|0
5693332|NCT00301067|19631591|P2|Completed 12 Cycles of Treatment|Adverse Event|0
5693333|NCT00301067|19631592|P1|Completed 12 Cycles of Treatment|Adverse Event|0
5693334|NCT00301067|19631589|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
5693335|NCT00301067|19631590|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
5693336|NCT00301067|19631591|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
5693337|NCT00301067|19631592|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
5693338|NCT00301067|19631589|P4|Completed 4 Cycles of Treatment|Progressive disease|5
5693339|NCT00301067|19631590|P3|Completed 4 Cycles of Treatment|Progressive disease|2
5693340|NCT00301067|19631591|P2|Completed 4 Cycles of Treatment|Progressive disease|1
5693341|NCT00301067|19631592|P1|Completed 4 Cycles of Treatment|Progressive disease|1
5693342|NCT00301067|19631589|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
5693343|NCT00301067|19631590|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
5693344|NCT00301067|19631591|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
5693345|NCT00301067|19631592|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
5693346|NCT00301067|19631589|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
5693347|NCT00301067|19631590|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
5693348|NCT00301067|19631591|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
5693349|NCT00301067|19631592|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
5693350|NCT00300885|19631617|P2|Follow-up|Withdrawal by Subject|25
5693351|NCT00300885|19631618|P1|Follow-up|Withdrawal by Subject|26
5693352|NCT00300885|19631617|P2|Follow-up|Lost to Follow-up|7
5693353|NCT00300885|19631618|P1|Follow-up|Lost to Follow-up|11
5693354|NCT00300885|19631617|P2|Follow-up|Death|163
5693355|NCT00300885|19631618|P1|Follow-up|Death|141
5693356|NCT00300885|19631617|P2|Treatment|Non-compliant with study medication|4
5693357|NCT00300885|19631618|P1|Treatment|Non-compliant with study medication|3
5693358|NCT00300885|19631617|P2|Treatment|Random code broken (subject died)|1
5693359|NCT00300885|19631618|P1|Treatment|Random code broken (subject died)|0
5693360|NCT00300885|19631617|P2|Treatment|Disease progression|238
5693361|NCT00300885|19631618|P1|Treatment|Disease progression|171
5693362|NCT00300885|19631617|P2|Treatment|Withdrawal by Subject|23
5693363|NCT00300885|19631618|P1|Treatment|Withdrawal by Subject|26
5693364|NCT00300885|19631617|P2|Treatment|Protocol Violation|11
5693365|NCT00300885|19631618|P1|Treatment|Protocol Violation|11
5693366|NCT00300885|19631617|P2|Treatment|Physician Decision|5
5693367|NCT00300885|19631618|P1|Treatment|Physician Decision|4
5693368|NCT00300885|19631617|P2|Treatment|Lost to Follow-up|2
5693369|NCT00300885|19631618|P1|Treatment|Lost to Follow-up|3
5693370|NCT00300885|19631617|P2|Treatment|Lack of Efficacy|1
5693371|NCT00300885|19631618|P1|Treatment|Lack of Efficacy|1
5693372|NCT00300885|19631617|P2|Treatment|Death|7
5693373|NCT00300885|19631618|P1|Treatment|Death|20
5693374|NCT00300885|19631617|P2|Treatment|Adverse Event|82
5693375|NCT00300885|19631618|P1|Treatment|Adverse Event|134
5693376|NCT00300781|19631636|P2|Overall Study|Lost to Follow-up|1
5693377|NCT00300781|19631637|P1|Overall Study|Lost to Follow-up|0
5693378|NCT00300781|19631636|P2|Overall Study|Symptomatic Deterioration|0
5693379|NCT00300781|19631637|P1|Overall Study|Symptomatic Deterioration|1
5693380|NCT00300781|19631636|P2|Overall Study|Not Recorded|1
5693381|NCT00300781|19631637|P1|Overall Study|Not Recorded|0
5693382|NCT00300781|19631636|P2|Overall Study|Physician Decision|0
5693383|NCT00300781|19631637|P1|Overall Study|Physician Decision|1
5693384|NCT00300781|19631636|P2|Overall Study|Withdrawal by Subject|2
5693385|NCT00300781|19631637|P1|Overall Study|Withdrawal by Subject|1
5693386|NCT00300781|19631636|P2|Overall Study|Adverse Event|6
5693387|NCT00300781|19631637|P1|Overall Study|Adverse Event|5
5693388|NCT00300781|19631636|P2|Overall Study|Disease Progression|52
5693389|NCT00300781|19631637|P1|Overall Study|Disease Progression|55
5693390|NCT00300755|19631652|P3|Overall Study|Protocol Violation|1
5693391|NCT00300755|19631653|P2|Overall Study|Protocol Violation|0
5693392|NCT00300755|19631654|P1|Overall Study|Protocol Violation|0
5693393|NCT00300755|19631652|P3|Overall Study|Withdrawal by Subject|0
5693394|NCT00300755|19631653|P2|Overall Study|Withdrawal by Subject|2
5693395|NCT00300755|19631654|P1|Overall Study|Withdrawal by Subject|0
5693396|NCT00300755|19631652|P3|Overall Study|Adverse Event|1
5693397|NCT00300755|19631653|P2|Overall Study|Adverse Event|2
5693398|NCT00300755|19631654|P1|Overall Study|Adverse Event|1
5693399|NCT00300495|19631688|P2|Overall Study|Protocol Violation|1
5693400|NCT00300495|19631689|P1|Overall Study|Protocol Violation|4
5693401|NCT00300365|19631956|P2|Overall Study|Adverse Event|2
5693402|NCT00300365|19631957|P1|Overall Study|Adverse Event|0
5693403|NCT00300365|19631956|P2|Overall Study|Withdrawal by Subject|0
5693404|NCT00300365|19631957|P1|Overall Study|Withdrawal by Subject|1
5693405|NCT00300365|19631956|P2|Overall Study|Physician Decision|0
5693406|NCT00300365|19631957|P1|Overall Study|Physician Decision|2
5693407|NCT00300365|19631956|P2|Overall Study|Lost to Follow-up|0
5693408|NCT00300365|19631957|P1|Overall Study|Lost to Follow-up|1
5693409|NCT00300274|19631966|P3|Overall Study|Re-transplant|1
5693410|NCT00300274|19631967|P2|Overall Study|Re-transplant|0
5693411|NCT00300274|19631968|P1|Overall Study|Re-transplant|0
5693412|NCT00300274|19631966|P3|Overall Study|Death|25
5693413|NCT00300274|19631967|P2|Overall Study|Death|20
5693414|NCT00300274|19631968|P1|Overall Study|Death|31
5693415|NCT00300274|19631966|P3|Overall Study|Lost to Follow-up|5
5693416|NCT00300274|19631967|P2|Overall Study|Lost to Follow-up|4
5693417|NCT00300274|19631968|P1|Overall Study|Lost to Follow-up|3
5693418|NCT00300274|19631966|P3|Overall Study|Withdrawal by Subject|14
5693419|NCT00300274|19631967|P2|Overall Study|Withdrawal by Subject|3
5693420|NCT00300274|19631968|P1|Overall Study|Withdrawal by Subject|12
5693421|NCT00299975|19632038|P3|Overall Study|Physician Decision|1
5693422|NCT00299975|19632039|P2|Overall Study|Physician Decision|0
5693423|NCT00299975|19632040|P1|Overall Study|Physician Decision|0
5693424|NCT00299975|19632038|P3|Overall Study|Withdrawal by Subject|3
5693425|NCT00299975|19632039|P2|Overall Study|Withdrawal by Subject|1
5693426|NCT00299975|19632040|P1|Overall Study|Withdrawal by Subject|0
5693427|NCT00299975|19632038|P3|Overall Study|Lost to Follow-up|0
5693428|NCT00299975|19632039|P2|Overall Study|Lost to Follow-up|0
5693429|NCT00299975|19632040|P1|Overall Study|Lost to Follow-up|1
5693430|NCT00299975|19632038|P3|Overall Study|Lack of Efficacy|1
5693431|NCT00299975|19632039|P2|Overall Study|Lack of Efficacy|0
5693432|NCT00299975|19632040|P1|Overall Study|Lack of Efficacy|1
5693433|NCT00299975|19632038|P3|Overall Study|Pregnancy|1
5693434|NCT00299975|19632039|P2|Overall Study|Pregnancy|0
5693435|NCT00299975|19632040|P1|Overall Study|Pregnancy|0
5693436|NCT00299975|19632038|P3|Overall Study|Adverse Event|2
5693437|NCT00299975|19632039|P2|Overall Study|Adverse Event|0
5693438|NCT00299975|19632040|P1|Overall Study|Adverse Event|1
5693439|NCT00299702|19632097|P2|Overall Study|Admin issues, sponsor decision, etc.|9
5693440|NCT00299702|19632098|P1|Overall Study|Admin issues, sponsor decision, etc.|5
5693441|NCT00299702|19632097|P2|Overall Study|Insufficient Response|3
5693442|NCT00299702|19632098|P1|Overall Study|Insufficient Response|4
5693443|NCT00299702|19632097|P2|Overall Study|Pregnancy|1
5693444|NCT00299702|19632098|P1|Overall Study|Pregnancy|0
5693445|NCT00299702|19632097|P2|Overall Study|Withdrawal by Subject|23
5693446|NCT00299702|19632098|P1|Overall Study|Withdrawal by Subject|25
5693447|NCT00299702|19632097|P2|Overall Study|Lost to Follow-up|10
5693448|NCT00299702|19632098|P1|Overall Study|Lost to Follow-up|18
5693449|NCT00299702|19632097|P2|Overall Study|Adverse Event|4
5693450|NCT00299702|19632098|P1|Overall Study|Adverse Event|0
5693451|NCT00299702|19632097|P2|Overall Study|Death|0
5693452|NCT00299702|19632098|P1|Overall Study|Death|1
5693453|NCT00299546|19632113|P3|Overall Study|Not treated|1
5693454|NCT00299546|19632114|P2|Overall Study|Not treated|1
5693455|NCT00299546|19632115|P1|Overall Study|Not treated|0
5693456|NCT00299546|19632113|P3|Overall Study|Other|19
5693457|NCT00299546|19632114|P2|Overall Study|Other|26
5693458|NCT00299546|19632115|P1|Overall Study|Other|24
5693459|NCT00299546|19632113|P3|Overall Study|Unsatisfactory therapeutic effect|34
5693460|NCT00299546|19632114|P2|Overall Study|Unsatisfactory therapeutic effect|39
5693461|NCT00299546|19632115|P1|Overall Study|Unsatisfactory therapeutic effect|34
5693462|NCT00299546|19632113|P3|Overall Study|Adverse Event|27
5693463|NCT00299546|19632114|P2|Overall Study|Adverse Event|22
5693464|NCT00299546|19632115|P1|Overall Study|Adverse Event|37
5693465|NCT00299546|19632113|P3|Overall Study|Lost to Follow-up|5
5693466|NCT00299546|19632114|P2|Overall Study|Lost to Follow-up|2
5693467|NCT00299546|19632115|P1|Overall Study|Lost to Follow-up|2
5693468|NCT00299546|19632113|P3|Overall Study|Death|0
5693469|NCT00299546|19632114|P2|Overall Study|Death|2
5693470|NCT00299546|19632115|P1|Overall Study|Death|3
5693471|NCT00299494|19632146|P6|Overall Study|Other - site closure|1
5693472|NCT00299494|19632147|P5|Overall Study|Other - site closure|1
5693473|NCT00299494|19632148|P4|Overall Study|Other - site closure|1
5693474|NCT00299494|19632149|P3|Overall Study|Other - site closure|0
5693475|NCT00299494|19632150|P2|Overall Study|Other - site closure|0
5693476|NCT00299494|19632151|P1|Overall Study|Other - site closure|0
5693477|NCT00299494|19632146|P6|Overall Study|Other - Unspecified|1
5693478|NCT00299494|19632147|P5|Overall Study|Other - Unspecified|3
5693479|NCT00299494|19632148|P4|Overall Study|Other - Unspecified|0
5693480|NCT00299494|19632149|P3|Overall Study|Other - Unspecified|0
5693481|NCT00299494|19632150|P2|Overall Study|Other - Unspecified|0
5693482|NCT00299494|19632151|P1|Overall Study|Other - Unspecified|0
5693483|NCT00299494|19632146|P6|Overall Study|Lost to Follow-up|1
5693484|NCT00299494|19632147|P5|Overall Study|Lost to Follow-up|3
5693485|NCT00299494|19632148|P4|Overall Study|Lost to Follow-up|0
5693486|NCT00299494|19632149|P3|Overall Study|Lost to Follow-up|0
5693487|NCT00299494|19632150|P2|Overall Study|Lost to Follow-up|0
5693488|NCT00299494|19632151|P1|Overall Study|Lost to Follow-up|0
5693489|NCT00299494|19632146|P6|Overall Study|Death|19
5693490|NCT00299494|19632147|P5|Overall Study|Death|18
5693491|NCT00299494|19632148|P4|Overall Study|Death|6
5693492|NCT00299494|19632149|P3|Overall Study|Death|4
5693493|NCT00299494|19632150|P2|Overall Study|Death|1
5693494|NCT00299494|19632151|P1|Overall Study|Death|3
5693495|NCT00299494|19632146|P6|Overall Study|Physician Decision|0
5693496|NCT00299494|19632147|P5|Overall Study|Physician Decision|1
5693497|NCT00299494|19632148|P4|Overall Study|Physician Decision|0
5693498|NCT00299494|19632149|P3|Overall Study|Physician Decision|0
5693499|NCT00299494|19632150|P2|Overall Study|Physician Decision|0
5693500|NCT00299494|19632151|P1|Overall Study|Physician Decision|0
5693501|NCT00299494|19632146|P6|Overall Study|Withdrawal by Subject|4
5693502|NCT00299494|19632147|P5|Overall Study|Withdrawal by Subject|1
5693503|NCT00299494|19632148|P4|Overall Study|Withdrawal by Subject|3
5693504|NCT00299494|19632149|P3|Overall Study|Withdrawal by Subject|0
5693505|NCT00299494|19632150|P2|Overall Study|Withdrawal by Subject|0
5693506|NCT00299494|19632151|P1|Overall Study|Withdrawal by Subject|0
5693507|NCT00299156|19632297|P3|Period 2 (Randomized)|Screen Failure|0
5693508|NCT00299156|19632298|P2|Period 2 (Randomized)|Screen Failure|1
5693509|NCT00299156|19632299|P1|Period 2 (Randomized)|Screen Failure|0
5693510|NCT00299130|19632310|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
5693511|NCT00299130|19632311|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
5693512|NCT00299130|19632312|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
5693513|NCT00299130|19632310|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
5693514|NCT00299130|19632311|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
5693515|NCT00299130|19632312|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
5693516|NCT00299130|19632310|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
5693517|NCT00299130|19632311|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
5693518|NCT00299130|19632312|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
5693519|NCT00299130|19632310|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
5693520|NCT00299130|19632311|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
5693521|NCT00299130|19632312|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
5693522|NCT00299130|19632310|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
5693523|NCT00299130|19632311|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
5693524|NCT00299130|19632312|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
5693525|NCT00299130|19632310|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
5693526|NCT00299130|19632311|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
5693527|NCT00299130|19632312|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
5693528|NCT00299130|19632310|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
5693529|NCT00299130|19632311|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
5693530|NCT00299130|19632312|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
5693531|NCT00299130|19632310|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
5693532|NCT00299130|19632311|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
5693533|NCT00299130|19632312|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
5693534|NCT00299130|19632310|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
5693535|NCT00299130|19632311|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
5693536|NCT00299130|19632312|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
5693537|NCT00299130|19632310|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
5693538|NCT00299130|19632311|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
5693539|NCT00299130|19632312|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
5693540|NCT00299130|19632310|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
5693541|NCT00299130|19632311|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
5693542|NCT00299130|19632312|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
5693543|NCT00299130|19632310|P3|Treatment Period (up to 5 Years)|Failure to Return|6
5693544|NCT00299130|19632311|P2|Treatment Period (up to 5 Years)|Failure to Return|6
5693545|NCT00299130|19632312|P1|Treatment Period (up to 5 Years)|Failure to Return|4
5693546|NCT00299130|19632310|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
5693547|NCT00299130|19632311|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
5693548|NCT00299130|19632312|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
5693549|NCT00299130|19632310|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
5693550|NCT00299130|19632311|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
5693551|NCT00299130|19632312|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
5693552|NCT00299130|19632310|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
5693553|NCT00299130|19632311|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
5693554|NCT00299130|19632312|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
5693555|NCT00299130|19632310|P3|Treatment Period (up to 5 Years)|Death|1
5693556|NCT00299130|19632311|P2|Treatment Period (up to 5 Years)|Death|3
5693557|NCT00299130|19632312|P1|Treatment Period (up to 5 Years)|Death|1
5693558|NCT00299130|19632310|P3|Treatment Period (up to 5 Years)|Adverse Event|13
5693559|NCT00299130|19632311|P2|Treatment Period (up to 5 Years)|Adverse Event|8
5693560|NCT00299130|19632312|P1|Treatment Period (up to 5 Years)|Adverse Event|13
5693561|NCT00299104|19632417|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
5693562|NCT00299104|19632418|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
5693563|NCT00299104|19632419|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
5693564|NCT00299104|19632417|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
5693565|NCT00299104|19632418|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
5693566|NCT00299104|19632419|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
5693567|NCT00299104|19632417|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
5693568|NCT00299104|19632418|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
5693569|NCT00299104|19632419|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
5693570|NCT00299104|19632417|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
5693571|NCT00299104|19632418|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
5693572|NCT00299104|19632419|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
5693573|NCT00299104|19632417|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
5693574|NCT00299104|19632418|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
5693575|NCT00299104|19632419|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
5693576|NCT00299104|19632417|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
5693577|NCT00299104|19632418|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
5693578|NCT00299104|19632419|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
5693579|NCT00299104|19632417|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
5693580|NCT00299104|19632418|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
5693581|NCT00299104|19632419|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
5693582|NCT00299104|19632417|P3|Safety Follow-Up (SFU) Period|Death|1
5693583|NCT00299104|19632418|P2|Safety Follow-Up (SFU) Period|Death|2
5693584|NCT00299104|19632419|P1|Safety Follow-Up (SFU) Period|Death|3
5693585|NCT00299104|19632417|P3|Treatment Period|Administrative reasons|137
5693586|NCT00299104|19632418|P2|Treatment Period|Administrative reasons|120
5693587|NCT00299104|19632419|P1|Treatment Period|Administrative reasons|106
5693588|NCT00299104|19632417|P3|Treatment Period|Withdrew consent|9
5693589|NCT00299104|19632418|P2|Treatment Period|Withdrew consent|19
5693590|NCT00299104|19632419|P1|Treatment Period|Withdrew consent|14
5693591|NCT00299104|19632417|P3|Treatment Period|Refused treatment|2
5693592|NCT00299104|19632418|P2|Treatment Period|Refused treatment|2
5693593|NCT00299104|19632419|P1|Treatment Period|Refused treatment|9
5693594|NCT00299104|19632417|P3|Treatment Period|Protocol Violation|0
5693595|NCT00299104|19632418|P2|Treatment Period|Protocol Violation|1
5693596|NCT00299104|19632419|P1|Treatment Period|Protocol Violation|1
5693597|NCT00299104|19632417|P3|Treatment Period|Violation of selection criteria|0
5693598|NCT00299104|19632418|P2|Treatment Period|Violation of selection criteria|2
5693599|NCT00299104|19632419|P1|Treatment Period|Violation of selection criteria|1
5693600|NCT00299104|19632417|P3|Treatment Period|Failure to return|8
5693601|NCT00299104|19632418|P2|Treatment Period|Failure to return|8
5693602|NCT00299104|19632419|P1|Treatment Period|Failure to return|9
5693603|NCT00299104|19632417|P3|Treatment Period|Insufficient therapeutic response|8
5693604|NCT00299104|19632418|P2|Treatment Period|Insufficient therapeutic response|13
5693605|NCT00299104|19632419|P1|Treatment Period|Insufficient therapeutic response|34
5693606|NCT00299104|19632417|P3|Treatment Period|Death|1
5693607|NCT00299104|19632418|P2|Treatment Period|Death|1
5693608|NCT00299104|19632419|P1|Treatment Period|Death|1
5693609|NCT00299104|19632417|P3|Treatment Period|Adverse Event|7
5693610|NCT00299104|19632418|P2|Treatment Period|Adverse Event|9
5693611|NCT00299104|19632419|P1|Treatment Period|Adverse Event|14
5693612|NCT00298896|19632529|P1|Overall Study|Assigned to treatment in error|1
5693613|NCT00298896|19632529|P1|Overall Study|Withdrawal by Subject|2
5693614|NCT00298896|19632529|P1|Overall Study|Disease Progression|41
5693615|NCT00298896|19632529|P1|Overall Study|Intercurrent Illness|1
5693616|NCT00298896|19632529|P1|Overall Study|Physician Decision|2
5693617|NCT00298896|19632529|P1|Overall Study|Death|3
5693618|NCT00298831|19632534|P1|Overall Study|Participants did not receive treatment|27
5693619|NCT00298831|19632534|P1|Overall Study|Withdrawal by Subject|1
5693620|NCT00298831|19632534|P1|Overall Study|Lost to Follow-up|3
5693621|NCT00298831|19632534|P1|Overall Study|Adverse Event|1
5693622|NCT00298766|19632543|P1|Overall Study|Other|4
5693623|NCT00298766|19632543|P1|Overall Study|Subjects overall condition deterioration|4
5693624|NCT00298766|19632543|P1|Overall Study|Deterioration in KPS and organ function|1
5693625|NCT00298766|19632543|P1|Overall Study|Progression of amyloid markers|4
5693626|NCT00298766|19632543|P1|Overall Study|Treatment ongoing|4
5693627|NCT00298766|19632543|P1|Overall Study|Withdrawal by Subject|9
5693628|NCT00298766|19632543|P1|Overall Study|Death|2
5693629|NCT00298766|19632543|P1|Overall Study|Adverse Event|18
5693630|NCT00298740|19632552|P1|Overall Study|Withdrawal by Subject|3
5693631|NCT00298740|19632552|P1|Overall Study|Lack of Efficacy|6
5693632|NCT00298363|19632622|P3|Overall Study|Lack of Efficacy|0
5693633|NCT00298363|19632623|P2|Overall Study|Lack of Efficacy|3
5693634|NCT00298363|19632624|P1|Overall Study|Lack of Efficacy|2
5693635|NCT00298363|19632622|P3|Overall Study|Adverse Event|2
5693636|NCT00298363|19632623|P2|Overall Study|Adverse Event|2
5693637|NCT00298363|19632624|P1|Overall Study|Adverse Event|5
5693638|NCT00298363|19632622|P3|Overall Study|Withdrawal by Subject|3
5693639|NCT00298363|19632623|P2|Overall Study|Withdrawal by Subject|1
5693640|NCT00298363|19632624|P1|Overall Study|Withdrawal by Subject|5
5693641|NCT00298363|19632622|P3|Overall Study|Protocol Violation|0
5693642|NCT00298363|19632623|P2|Overall Study|Protocol Violation|1
5693643|NCT00298363|19632624|P1|Overall Study|Protocol Violation|1
5693644|NCT00298363|19632622|P3|Overall Study|Physician Decision|0
5693645|NCT00298363|19632623|P2|Overall Study|Physician Decision|1
5693646|NCT00298363|19632624|P1|Overall Study|Physician Decision|4
5693647|NCT00298363|19632622|P3|Overall Study|Lost to Follow-up|1
5693648|NCT00298363|19632623|P2|Overall Study|Lost to Follow-up|0
5693649|NCT00298363|19632624|P1|Overall Study|Lost to Follow-up|0
5693650|NCT00298272|19632782|P2|Safety Follow-up Phase|Administrative/Other Reason|1
5693651|NCT00298272|19632783|P1|Safety Follow-up Phase|Administrative/Other Reason|1
5693652|NCT00298272|19632782|P2|Safety Follow-up Phase|Withdrawal by Subject|2
5693653|NCT00298272|19632783|P1|Safety Follow-up Phase|Withdrawal by Subject|2
5693654|NCT00298272|19632782|P2|Safety Follow-up Phase|Failure to Return|1
5693655|NCT00298272|19632783|P1|Safety Follow-up Phase|Failure to Return|1
5693656|NCT00298272|19632782|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
5693657|NCT00298272|19632783|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
5693658|NCT00298272|19632782|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
5693659|NCT00298272|19632783|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
5693660|NCT00298272|19632782|P2|Open Label Retreatment Phase|Protocol Violation|1
5693661|NCT00298272|19632783|P1|Open Label Retreatment Phase|Protocol Violation|2
5693662|NCT00298272|19632782|P2|Open Label Retreatment Phase|Failure to Return|0
5693663|NCT00298272|19632783|P1|Open Label Retreatment Phase|Failure to Return|1
5693664|NCT00298272|19632782|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
5693665|NCT00298272|19632783|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
5693666|NCT00298272|19632782|P2|Open Label Retreatment Phase|Adverse Event|2
5693667|NCT00298272|19632783|P1|Open Label Retreatment Phase|Adverse Event|1
5693668|NCT00298272|19632782|P2|Double-blind Phase|Withdrawal by Subject|0
5693669|NCT00298272|19632783|P1|Double-blind Phase|Withdrawal by Subject|2
5693670|NCT00298272|19632782|P2|Double-blind Phase|Protocol Violation|0
5693671|NCT00298272|19632783|P1|Double-blind Phase|Protocol Violation|2
5693672|NCT00298272|19632782|P2|Double-blind Phase|Failure to Return|0
5693673|NCT00298272|19632783|P1|Double-blind Phase|Failure to Return|2
5693674|NCT00298272|19632782|P2|Double-blind Phase|Adverse Event|0
5693675|NCT00298272|19632783|P1|Double-blind Phase|Adverse Event|2
5693676|NCT00298038|19632847|P2|Overall Study|Severe Gastrointestinal Bleed|0
5693677|NCT00298038|19632848|P1|Overall Study|Severe Gastrointestinal Bleed|1
5693678|NCT00298038|19632847|P2|Overall Study|Cocaine Abuse|0
5693679|NCT00298038|19632848|P1|Overall Study|Cocaine Abuse|1
5693680|NCT00298038|19632847|P2|Overall Study|Noncompliance|0
5693681|NCT00298038|19632848|P1|Overall Study|Noncompliance|1
5693682|NCT00298038|19632847|P2|Overall Study|Breakthrough overt HE episode|69
5693683|NCT00298038|19632848|P1|Overall Study|Breakthrough overt HE episode|28
5693684|NCT00298038|19632847|P2|Overall Study|Adverse Event|7
5693685|NCT00298038|19632848|P1|Overall Study|Adverse Event|8
5693686|NCT00298038|19632847|P2|Overall Study|Withdrawal by Subject|9
5693687|NCT00298038|19632848|P1|Overall Study|Withdrawal by Subject|6
5693688|NCT00298038|19632847|P2|Overall Study|Death|3
5693689|NCT00298038|19632848|P1|Overall Study|Death|6
5693690|NCT00298038|19632847|P2|Overall Study|Protocol Violation|3
5693691|NCT00298038|19632848|P1|Overall Study|Protocol Violation|1
5693692|NCT00298038|19632847|P2|Overall Study|Liver Transplant|1
5693693|NCT00298038|19632848|P1|Overall Study|Liver Transplant|0
5693694|NCT00298038|19632847|P2|Overall Study|Lost to Follow-up|1
5693695|NCT00298038|19632848|P1|Overall Study|Lost to Follow-up|0
5693696|NCT00297830|19632867|P3|12 Month Visit|Withdrawal by Subject|0
5693697|NCT00297830|19632868|P2|12 Month Visit|Withdrawal by Subject|3
5693698|NCT00297830|19632869|P1|12 Month Visit|Withdrawal by Subject|0
5693699|NCT00297830|19632867|P3|12 Month Visit|Adverse Event|0
5693700|NCT00297830|19632868|P2|12 Month Visit|Adverse Event|3
5693701|NCT00297830|19632869|P1|12 Month Visit|Adverse Event|0
5693702|NCT00297830|19632867|P3|12 Month Visit|Lost to Follow-up|0
5693703|NCT00297830|19632868|P2|12 Month Visit|Lost to Follow-up|0
5693704|NCT00297830|19632869|P1|12 Month Visit|Lost to Follow-up|1
5693705|NCT00297830|19632867|P3|6 Month Visit|Adverse Event|0
5693706|NCT00297830|19632868|P2|6 Month Visit|Adverse Event|1
5693707|NCT00297830|19632869|P1|6 Month Visit|Adverse Event|0
5693708|NCT00297830|19632867|P3|6 Month Visit|Withdrawal by Subject|1
5693709|NCT00297830|19632868|P2|6 Month Visit|Withdrawal by Subject|1
5693710|NCT00297830|19632869|P1|6 Month Visit|Withdrawal by Subject|2
5693711|NCT00297830|19632867|P3|6 Month Visit|Death|2
5693712|NCT00297830|19632868|P2|6 Month Visit|Death|0
5693713|NCT00297830|19632869|P1|6 Month Visit|Death|1
5693714|NCT00297778|19632888|P2|Overall Study|Other|1
5693715|NCT00297778|19632889|P1|Overall Study|Other|0
5693716|NCT00297778|19632888|P2|Overall Study|Non-compliant with trial protocol|3
5693717|NCT00297778|19632889|P1|Overall Study|Non-compliant with trial protocol|0
5693718|NCT00297778|19632888|P2|Overall Study|Lack of Efficacy|1
5693719|NCT00297778|19632889|P1|Overall Study|Lack of Efficacy|2
5693720|NCT00297778|19632888|P2|Overall Study|Withdrawal by Subject|5
5693721|NCT00297778|19632889|P1|Overall Study|Withdrawal by Subject|1
5693722|NCT00297778|19632888|P2|Overall Study|Adverse Event|10
5693723|NCT00297778|19632889|P1|Overall Study|Adverse Event|16
5693724|NCT00297648|19632923|P1|Overall Study|Other: Incompliance|1
5693725|NCT00297648|19632923|P1|Overall Study|Withdrawal by Subject|3
5693726|NCT00297648|19632923|P1|Overall Study|Lost to Follow-up|1
5693727|NCT00297648|19632923|P1|Overall Study|Lack of Efficacy|18
5693728|NCT00297648|19632923|P1|Overall Study|Adverse Event|13
5693729|NCT00297492|19632969|P3|6 Month Follow-up|Lost to Follow-up|27
5693730|NCT00297492|19632970|P2|6 Month Follow-up|Lost to Follow-up|49
5693731|NCT00297492|19632971|P1|6 Month Follow-up|Lost to Follow-up|63
5693732|NCT00297492|19632969|P3|Set Quit Date|Lost to Follow-up|5
5693733|NCT00297492|19632970|P2|Set Quit Date|Lost to Follow-up|13
5693734|NCT00297492|19632971|P1|Set Quit Date|Lost to Follow-up|7
5693735|NCT00297479|19632982|P3|Overall Study|Lost to Follow-up|51
5693736|NCT00297479|19632983|P2|Overall Study|Lost to Follow-up|54
5693737|NCT00297479|19632984|P1|Overall Study|Lost to Follow-up|37
5693738|NCT00297427|19633003|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
5693739|NCT00297427|19633004|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
5693740|NCT00297427|19633003|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
5693741|NCT00297427|19633004|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
5693742|NCT00297427|19633003|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
5693743|NCT00297427|19633004|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
5693744|NCT00297427|19633003|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
5693745|NCT00297427|19633004|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
5693746|NCT00297427|19633003|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
5693747|NCT00297427|19633004|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
5693748|NCT00297427|19633003|P2|Phase 1: Initial Intervention|Death|1
5693749|NCT00297427|19633004|P1|Phase 1: Initial Intervention|Death|0
5693750|NCT00297427|19633003|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
5693751|NCT00297427|19633004|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
5693752|NCT00297427|19633003|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
5693753|NCT00297427|19633004|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
5693754|NCT00297258|19633045|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
5693755|NCT00297258|19633045|P1|Overall Study|Switch to Commercial Treatment|1
5693756|NCT00297258|19633045|P1|Overall Study|Surgery Performed on Target Lesion|1
5693757|NCT00297258|19633045|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
5693758|NCT00297258|19633045|P1|Overall Study|Deteriorization of General Condition|1
5693759|NCT00297258|19633045|P1|Overall Study|Intercurrent Death|2
5693760|NCT00297258|19633045|P1|Overall Study|Intercurrent Illness|3
5693761|NCT00297258|19633045|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
5693762|NCT00297258|19633045|P1|Overall Study|Toxicity (or Toxic Death)|10
5693763|NCT00297258|19633045|P1|Overall Study|Disease Progression, Relapse, Death|120
5693764|NCT00297232|19633064|P1|Overall Study|Other|1
5693765|NCT00297232|19633064|P1|Overall Study|No data available after Week 264|161
5693766|NCT00297232|19633064|P1|Overall Study|Did Not Enroll to Week 480|17
5693767|NCT00297232|19633064|P1|Overall Study|Did Not Enroll to Week 264|34
5693768|NCT00297232|19633064|P1|Overall Study|Investigator Withdrew From Program|19
5693769|NCT00297232|19633064|P1|Overall Study|Persistently Positive Antibodies|11
5693770|NCT00297232|19633064|P1|Overall Study|Subject Withdrew Consent|37
5693771|NCT00297232|19633064|P1|Overall Study|Subject Relocated|7
5693772|NCT00297232|19633064|P1|Overall Study|Sponsor Decision|34
5693773|NCT00297232|19633064|P1|Overall Study|Miscellaneous|5
5693774|NCT00297232|19633064|P1|Overall Study|Anti-JCV Antibody Positive|13
5693775|NCT00297232|19633064|P1|Overall Study|Fear of PML|10
5693776|NCT00297232|19633064|P1|Overall Study|Disease Progression|8
5693777|NCT00297232|19633064|P1|Overall Study|Switched to Commercial Tysabri|22
5693778|NCT00297232|19633064|P1|Overall Study|Anti-natalizumab Positive|8
5693779|NCT00297232|19633064|P1|Overall Study|Death|9
5693780|NCT00297232|19633064|P1|Overall Study|Subject was Noncompliant|9
5693781|NCT00297232|19633064|P1|Overall Study|Voluntary Withdrawal|120
5693782|NCT00297232|19633064|P1|Overall Study|Adverse Event|63
5693783|NCT00297232|19633064|P1|Overall Study|Lost to Follow-up|10
5693784|NCT00297232|19633064|P1|Overall Study|Lack of Efficacy|7
5693785|NCT00297167|19633070|P3|Second Double-blind Intervention Period|Protocol Violation|0
5693786|NCT00297167|19633071|P2|Second Double-blind Intervention Period|Protocol Violation|0
5693787|NCT00297167|19633072|P1|Second Double-blind Intervention Period|Protocol Violation|1
5693788|NCT00297167|19633070|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
5693789|NCT00297167|19633071|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
5693790|NCT00297167|19633072|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
5693791|NCT00297037|19633136|P2|Overall Study|Withdrawal by Subject|0
5693792|NCT00297037|19633137|P1|Overall Study|Withdrawal by Subject|2
5693793|NCT00296816|19633149|P1|Overall Study|ineligibility due to radiation treatment|1
5693794|NCT00296816|19633149|P1|Overall Study|Proteinuria|1
5693795|NCT00296816|19633149|P1|Overall Study|Neuropathy/patient preference|1
5693796|NCT00296816|19633149|P1|Overall Study|Urine protein/creatinine ratio delay|1
5693797|NCT00296816|19633149|P1|Overall Study|Noncompliance/decision to discontinue|1
5693798|NCT00296816|19633149|P1|Overall Study|Relocation to Florida|1
5693799|NCT00296816|19633149|P1|Overall Study|Poor performance status|1
5693800|NCT00296816|19633149|P1|Overall Study|Progression based on CA-125 (biomarker)|2
5693801|NCT00296816|19633149|P1|Overall Study|Missing for end of treatment|4
5693802|NCT00296816|19633149|P1|Overall Study|Non-compliance|1
5693803|NCT00296816|19633149|P1|Overall Study|Investigator/Participant request|5
5693804|NCT00296816|19633149|P1|Overall Study|Adverse Event|18
5693805|NCT00296816|19633149|P1|Overall Study|Disease Progression|37
5693806|NCT00296725|19633161|P1|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
5693807|NCT00296725|19633161|P1|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
5693808|NCT00296725|19633161|P1|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
5693809|NCT00296647|19633174|P5|Overall Study|Withdrawal by Subject|19
5693810|NCT00296647|19633175|P4|Overall Study|Withdrawal by Subject|16
5693811|NCT00296647|19633176|P3|Overall Study|Withdrawal by Subject|32
5693812|NCT00296647|19633177|P2|Overall Study|Withdrawal by Subject|27
5693813|NCT00296647|19633178|P1|Overall Study|Withdrawal by Subject|28
5693814|NCT00296647|19633174|P5|Overall Study|Death|1
5693815|NCT00296647|19633175|P4|Overall Study|Death|1
5693816|NCT00296647|19633176|P3|Overall Study|Death|2
5693817|NCT00296647|19633177|P2|Overall Study|Death|1
5693818|NCT00296647|19633178|P1|Overall Study|Death|4
5693819|NCT00296517|19633192|P2|Dose Level 3 - Weeks 3-12|Other|2
5693820|NCT00296517|19633193|P1|Dose Level 3 - Weeks 3-12|Other|0
5693821|NCT00296517|19633192|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
5693822|NCT00296517|19633193|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
5693823|NCT00296517|19633192|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
5693824|NCT00296517|19633193|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
5693825|NCT00296517|19633192|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
5693826|NCT00296517|19633193|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
5693827|NCT00296517|19633192|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
5693828|NCT00296517|19633193|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
5693829|NCT00296517|19633192|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
5693830|NCT00296517|19633193|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
5693831|NCT00296517|19633192|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
5693832|NCT00296517|19633193|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
5693833|NCT00296517|19633192|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
5693834|NCT00296517|19633193|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
5693835|NCT00296517|19633192|P2|Dose Level 2 - Week 2|Adverse Event|5
5693836|NCT00296517|19633193|P1|Dose Level 2 - Week 2|Adverse Event|1
5693837|NCT00296504|19633229|P9|Final Analysis|Poor Adherence|1
5693838|NCT00296504|19633230|P8|Final Analysis|Poor Adherence|0
5693839|NCT00296504|19633231|P7|Final Analysis|Poor Adherence|0
5693840|NCT00296504|19633232|P6|Final Analysis|Poor Adherence|0
5693841|NCT00296504|19633233|P5|Final Analysis|Poor Adherence|0
5693842|NCT00296504|19633234|P4|Final Analysis|Poor Adherence|0
5693843|NCT00296504|19633235|P3|Final Analysis|Poor Adherence|0
5693844|NCT00296504|19633236|P2|Final Analysis|Poor Adherence|0
5693845|NCT00296504|19633237|P1|Final Analysis|Poor Adherence|0
5693846|NCT00296504|19633229|P9|Final Analysis|Participant Moved to Another Country|1
5693847|NCT00296504|19633230|P8|Final Analysis|Participant Moved to Another Country|0
5694095|NCT00296504|19633235|P3|Interim Analysis|Participant Non-compliant|2
5693848|NCT00296504|19633231|P7|Final Analysis|Participant Moved to Another Country|0
5693849|NCT00296504|19633232|P6|Final Analysis|Participant Moved to Another Country|0
5693850|NCT00296504|19633233|P5|Final Analysis|Participant Moved to Another Country|0
5693851|NCT00296504|19633234|P4|Final Analysis|Participant Moved to Another Country|0
5693852|NCT00296504|19633235|P3|Final Analysis|Participant Moved to Another Country|0
5693853|NCT00296504|19633236|P2|Final Analysis|Participant Moved to Another Country|0
5693854|NCT00296504|19633237|P1|Final Analysis|Participant Moved to Another Country|0
5693855|NCT00296504|19633229|P9|Final Analysis|Tuberculosis|1
5693856|NCT00296504|19633230|P8|Final Analysis|Tuberculosis|0
5693857|NCT00296504|19633231|P7|Final Analysis|Tuberculosis|0
5693858|NCT00296504|19633232|P6|Final Analysis|Tuberculosis|0
5693859|NCT00296504|19633233|P5|Final Analysis|Tuberculosis|0
5693860|NCT00296504|19633234|P4|Final Analysis|Tuberculosis|0
5693861|NCT00296504|19633235|P3|Final Analysis|Tuberculosis|0
5693862|NCT00296504|19633236|P2|Final Analysis|Tuberculosis|0
5693863|NCT00296504|19633237|P1|Final Analysis|Tuberculosis|0
5693864|NCT00296504|19633229|P9|Final Analysis|Pregnancy|4
5693865|NCT00296504|19633230|P8|Final Analysis|Pregnancy|0
5693866|NCT00296504|19633231|P7|Final Analysis|Pregnancy|0
5693867|NCT00296504|19633232|P6|Final Analysis|Pregnancy|0
5693868|NCT00296504|19633233|P5|Final Analysis|Pregnancy|0
5693869|NCT00296504|19633234|P4|Final Analysis|Pregnancy|0
5693870|NCT00296504|19633235|P3|Final Analysis|Pregnancy|0
5693871|NCT00296504|19633236|P2|Final Analysis|Pregnancy|0
5693872|NCT00296504|19633237|P1|Final Analysis|Pregnancy|0
5693873|NCT00296504|19633229|P9|Final Analysis|Adverse Event|2
5693874|NCT00296504|19633230|P8|Final Analysis|Adverse Event|0
5693875|NCT00296504|19633231|P7|Final Analysis|Adverse Event|0
5693876|NCT00296504|19633232|P6|Final Analysis|Adverse Event|0
5693877|NCT00296504|19633233|P5|Final Analysis|Adverse Event|0
5693878|NCT00296504|19633234|P4|Final Analysis|Adverse Event|0
5693879|NCT00296504|19633235|P3|Final Analysis|Adverse Event|0
5693880|NCT00296504|19633236|P2|Final Analysis|Adverse Event|0
5693881|NCT00296504|19633237|P1|Final Analysis|Adverse Event|0
5693882|NCT00296504|19633229|P9|Final Analysis|Insufficient Viral Load Response|6
5693883|NCT00296504|19633230|P8|Final Analysis|Insufficient Viral Load Response|0
5693884|NCT00296504|19633231|P7|Final Analysis|Insufficient Viral Load Response|0
5693885|NCT00296504|19633232|P6|Final Analysis|Insufficient Viral Load Response|0
5693886|NCT00296504|19633233|P5|Final Analysis|Insufficient Viral Load Response|0
5693887|NCT00296504|19633234|P4|Final Analysis|Insufficient Viral Load Response|0
5693888|NCT00296504|19633235|P3|Final Analysis|Insufficient Viral Load Response|0
5693889|NCT00296504|19633236|P2|Final Analysis|Insufficient Viral Load Response|0
5693890|NCT00296504|19633237|P1|Final Analysis|Insufficient Viral Load Response|0
5693891|NCT00296504|19633229|P9|Final Analysis|Lost to Follow-up|5
5693892|NCT00296504|19633230|P8|Final Analysis|Lost to Follow-up|0
5693893|NCT00296504|19633231|P7|Final Analysis|Lost to Follow-up|0
5693894|NCT00296504|19633232|P6|Final Analysis|Lost to Follow-up|0
5693895|NCT00296504|19633233|P5|Final Analysis|Lost to Follow-up|0
5693896|NCT00296504|19633234|P4|Final Analysis|Lost to Follow-up|0
5693897|NCT00296504|19633235|P3|Final Analysis|Lost to Follow-up|0
5693898|NCT00296504|19633236|P2|Final Analysis|Lost to Follow-up|0
5693899|NCT00296504|19633237|P1|Final Analysis|Lost to Follow-up|0
5693900|NCT00296504|19633229|P9|Final Analysis|Withdrawal by Subject|1
5693901|NCT00296504|19633230|P8|Final Analysis|Withdrawal by Subject|0
5693902|NCT00296504|19633231|P7|Final Analysis|Withdrawal by Subject|0
5693903|NCT00296504|19633232|P6|Final Analysis|Withdrawal by Subject|0
5693904|NCT00296504|19633233|P5|Final Analysis|Withdrawal by Subject|0
5693905|NCT00296504|19633234|P4|Final Analysis|Withdrawal by Subject|0
5693906|NCT00296504|19633235|P3|Final Analysis|Withdrawal by Subject|0
5693907|NCT00296504|19633236|P2|Final Analysis|Withdrawal by Subject|0
5693908|NCT00296504|19633237|P1|Final Analysis|Withdrawal by Subject|0
5693909|NCT00296504|19633229|P9|Interim Analysis|Ongoing|0
5693910|NCT00296504|19633230|P8|Interim Analysis|Ongoing|1
5693911|NCT00296504|19633231|P7|Interim Analysis|Ongoing|30
5693912|NCT00296504|19633232|P6|Interim Analysis|Ongoing|0
5693913|NCT00296504|19633233|P5|Interim Analysis|Ongoing|0
5693914|NCT00296504|19633234|P4|Interim Analysis|Ongoing|22
5693915|NCT00296504|19633235|P3|Interim Analysis|Ongoing|16
5693916|NCT00296504|19633236|P2|Interim Analysis|Ongoing|12
5693917|NCT00296504|19633237|P1|Interim Analysis|Ongoing|32
5693918|NCT00296504|19633229|P9|Interim Analysis|Participant Needed Interferon|0
5693919|NCT00296504|19633230|P8|Interim Analysis|Participant Needed Interferon|1
5693920|NCT00296504|19633231|P7|Interim Analysis|Participant Needed Interferon|0
5693921|NCT00296504|19633232|P6|Interim Analysis|Participant Needed Interferon|0
5693922|NCT00296504|19633233|P5|Interim Analysis|Participant Needed Interferon|0
5693923|NCT00296504|19633234|P4|Interim Analysis|Participant Needed Interferon|0
5693924|NCT00296504|19633235|P3|Interim Analysis|Participant Needed Interferon|0
5693925|NCT00296504|19633236|P2|Interim Analysis|Participant Needed Interferon|0
5693926|NCT00296504|19633237|P1|Interim Analysis|Participant Needed Interferon|0
5693927|NCT00296504|19633229|P9|Interim Analysis|Study Ended|0
5693928|NCT00296504|19633230|P8|Interim Analysis|Study Ended|0
5693929|NCT00296504|19633231|P7|Interim Analysis|Study Ended|1
5693930|NCT00296504|19633232|P6|Interim Analysis|Study Ended|0
5693931|NCT00296504|19633233|P5|Interim Analysis|Study Ended|0
5693932|NCT00296504|19633234|P4|Interim Analysis|Study Ended|0
5693933|NCT00296504|19633235|P3|Interim Analysis|Study Ended|0
5693934|NCT00296504|19633236|P2|Interim Analysis|Study Ended|0
5693935|NCT00296504|19633237|P1|Interim Analysis|Study Ended|0
5693936|NCT00296504|19633229|P9|Interim Analysis|Participant Stopped HIV Medications|0
5693937|NCT00296504|19633230|P8|Interim Analysis|Participant Stopped HIV Medications|0
5693938|NCT00296504|19633231|P7|Interim Analysis|Participant Stopped HIV Medications|1
5693939|NCT00296504|19633232|P6|Interim Analysis|Participant Stopped HIV Medications|0
5693940|NCT00296504|19633233|P5|Interim Analysis|Participant Stopped HIV Medications|0
5693941|NCT00296504|19633234|P4|Interim Analysis|Participant Stopped HIV Medications|0
5693942|NCT00296504|19633235|P3|Interim Analysis|Participant Stopped HIV Medications|0
5693943|NCT00296504|19633236|P2|Interim Analysis|Participant Stopped HIV Medications|0
5693944|NCT00296504|19633237|P1|Interim Analysis|Participant Stopped HIV Medications|0
5693945|NCT00296504|19633229|P9|Interim Analysis|Physician and Participant Decision|0
5693946|NCT00296504|19633230|P8|Interim Analysis|Physician and Participant Decision|0
5693947|NCT00296504|19633231|P7|Interim Analysis|Physician and Participant Decision|0
5693948|NCT00296504|19633232|P6|Interim Analysis|Physician and Participant Decision|1
5693949|NCT00296504|19633233|P5|Interim Analysis|Physician and Participant Decision|0
5693950|NCT00296504|19633234|P4|Interim Analysis|Physician and Participant Decision|0
5693951|NCT00296504|19633235|P3|Interim Analysis|Physician and Participant Decision|0
5693952|NCT00296504|19633236|P2|Interim Analysis|Physician and Participant Decision|0
5693953|NCT00296504|19633237|P1|Interim Analysis|Physician and Participant Decision|0
5693954|NCT00296504|19633229|P9|Interim Analysis|Participant Stopped|0
5693955|NCT00296504|19633230|P8|Interim Analysis|Participant Stopped|0
5693956|NCT00296504|19633231|P7|Interim Analysis|Participant Stopped|0
5693957|NCT00296504|19633232|P6|Interim Analysis|Participant Stopped|0
5693958|NCT00296504|19633233|P5|Interim Analysis|Participant Stopped|1
5693959|NCT00296504|19633234|P4|Interim Analysis|Participant Stopped|0
5693960|NCT00296504|19633235|P3|Interim Analysis|Participant Stopped|0
5693961|NCT00296504|19633236|P2|Interim Analysis|Participant Stopped|0
5693962|NCT00296504|19633237|P1|Interim Analysis|Participant Stopped|0
5693963|NCT00296504|19633229|P9|Interim Analysis|Inclusion in Other Protocol|0
5693964|NCT00296504|19633230|P8|Interim Analysis|Inclusion in Other Protocol|0
5693965|NCT00296504|19633231|P7|Interim Analysis|Inclusion in Other Protocol|0
5693966|NCT00296504|19633232|P6|Interim Analysis|Inclusion in Other Protocol|0
5693967|NCT00296504|19633233|P5|Interim Analysis|Inclusion in Other Protocol|0
5693968|NCT00296504|19633234|P4|Interim Analysis|Inclusion in Other Protocol|1
5693969|NCT00296504|19633235|P3|Interim Analysis|Inclusion in Other Protocol|0
5693970|NCT00296504|19633236|P2|Interim Analysis|Inclusion in Other Protocol|0
5693971|NCT00296504|19633237|P1|Interim Analysis|Inclusion in Other Protocol|0
5693972|NCT00296504|19633229|P9|Interim Analysis|Missed Schedule Date|0
5693973|NCT00296504|19633230|P8|Interim Analysis|Missed Schedule Date|0
5693974|NCT00296504|19633231|P7|Interim Analysis|Missed Schedule Date|0
5693975|NCT00296504|19633232|P6|Interim Analysis|Missed Schedule Date|0
5693976|NCT00296504|19633233|P5|Interim Analysis|Missed Schedule Date|0
5693977|NCT00296504|19633234|P4|Interim Analysis|Missed Schedule Date|0
5693978|NCT00296504|19633235|P3|Interim Analysis|Missed Schedule Date|0
5693979|NCT00296504|19633236|P2|Interim Analysis|Missed Schedule Date|0
5693980|NCT00296504|19633237|P1|Interim Analysis|Missed Schedule Date|1
5693981|NCT00296504|19633229|P9|Interim Analysis|Lack of Personnel at Site|0
5693982|NCT00296504|19633230|P8|Interim Analysis|Lack of Personnel at Site|0
5693983|NCT00296504|19633231|P7|Interim Analysis|Lack of Personnel at Site|0
5693984|NCT00296504|19633232|P6|Interim Analysis|Lack of Personnel at Site|0
5693985|NCT00296504|19633233|P5|Interim Analysis|Lack of Personnel at Site|0
5693986|NCT00296504|19633234|P4|Interim Analysis|Lack of Personnel at Site|0
5693987|NCT00296504|19633235|P3|Interim Analysis|Lack of Personnel at Site|0
5693988|NCT00296504|19633236|P2|Interim Analysis|Lack of Personnel at Site|0
5693989|NCT00296504|19633237|P1|Interim Analysis|Lack of Personnel at Site|1
5693990|NCT00296504|19633229|P9|Interim Analysis|Site Closing|0
5693991|NCT00296504|19633230|P8|Interim Analysis|Site Closing|0
5693992|NCT00296504|19633231|P7|Interim Analysis|Site Closing|2
5693993|NCT00296504|19633232|P6|Interim Analysis|Site Closing|1
5693994|NCT00296504|19633233|P5|Interim Analysis|Site Closing|0
5693995|NCT00296504|19633234|P4|Interim Analysis|Site Closing|0
5693996|NCT00296504|19633235|P3|Interim Analysis|Site Closing|0
5693997|NCT00296504|19633236|P2|Interim Analysis|Site Closing|0
5693998|NCT00296504|19633237|P1|Interim Analysis|Site Closing|1
5693999|NCT00296504|19633229|P9|Interim Analysis|Non-adherence|0
5694000|NCT00296504|19633230|P8|Interim Analysis|Non-adherence|1
5694001|NCT00296504|19633231|P7|Interim Analysis|Non-adherence|0
5694002|NCT00296504|19633232|P6|Interim Analysis|Non-adherence|0
5694003|NCT00296504|19633233|P5|Interim Analysis|Non-adherence|1
5694004|NCT00296504|19633234|P4|Interim Analysis|Non-adherence|0
5694005|NCT00296504|19633235|P3|Interim Analysis|Non-adherence|0
5694006|NCT00296504|19633236|P2|Interim Analysis|Non-adherence|0
5694007|NCT00296504|19633237|P1|Interim Analysis|Non-adherence|2
5694008|NCT00296504|19633229|P9|Interim Analysis|Principle Investigator Terminated Study|0
5694009|NCT00296504|19633230|P8|Interim Analysis|Principle Investigator Terminated Study|0
5694010|NCT00296504|19633231|P7|Interim Analysis|Principle Investigator Terminated Study|0
5694011|NCT00296504|19633232|P6|Interim Analysis|Principle Investigator Terminated Study|0
5694012|NCT00296504|19633233|P5|Interim Analysis|Principle Investigator Terminated Study|0
5694013|NCT00296504|19633234|P4|Interim Analysis|Principle Investigator Terminated Study|0
5694014|NCT00296504|19633235|P3|Interim Analysis|Principle Investigator Terminated Study|1
5694015|NCT00296504|19633236|P2|Interim Analysis|Principle Investigator Terminated Study|0
5694096|NCT00296504|19633236|P2|Interim Analysis|Participant Non-compliant|1
5694016|NCT00296504|19633237|P1|Interim Analysis|Principle Investigator Terminated Study|0
5694017|NCT00296504|19633229|P9|Interim Analysis|Principle Investigator Discretion|0
5694018|NCT00296504|19633230|P8|Interim Analysis|Principle Investigator Discretion|0
5694019|NCT00296504|19633231|P7|Interim Analysis|Principle Investigator Discretion|0
5694020|NCT00296504|19633232|P6|Interim Analysis|Principle Investigator Discretion|0
5694021|NCT00296504|19633233|P5|Interim Analysis|Principle Investigator Discretion|0
5694022|NCT00296504|19633234|P4|Interim Analysis|Principle Investigator Discretion|1
5694023|NCT00296504|19633235|P3|Interim Analysis|Principle Investigator Discretion|1
5694024|NCT00296504|19633236|P2|Interim Analysis|Principle Investigator Discretion|0
5694025|NCT00296504|19633237|P1|Interim Analysis|Principle Investigator Discretion|2
5694026|NCT00296504|19633229|P9|Interim Analysis|Physician Decision|0
5694027|NCT00296504|19633230|P8|Interim Analysis|Physician Decision|0
5694028|NCT00296504|19633231|P7|Interim Analysis|Physician Decision|0
5694029|NCT00296504|19633232|P6|Interim Analysis|Physician Decision|0
5694030|NCT00296504|19633233|P5|Interim Analysis|Physician Decision|0
5694031|NCT00296504|19633234|P4|Interim Analysis|Physician Decision|0
5694032|NCT00296504|19633235|P3|Interim Analysis|Physician Decision|1
5694033|NCT00296504|19633236|P2|Interim Analysis|Physician Decision|0
5694034|NCT00296504|19633237|P1|Interim Analysis|Physician Decision|0
5694035|NCT00296504|19633229|P9|Interim Analysis|Resistance to FPV|0
5694036|NCT00296504|19633230|P8|Interim Analysis|Resistance to FPV|0
5694037|NCT00296504|19633231|P7|Interim Analysis|Resistance to FPV|0
5694038|NCT00296504|19633232|P6|Interim Analysis|Resistance to FPV|0
5694039|NCT00296504|19633233|P5|Interim Analysis|Resistance to FPV|0
5694040|NCT00296504|19633234|P4|Interim Analysis|Resistance to FPV|0
5694041|NCT00296504|19633235|P3|Interim Analysis|Resistance to FPV|1
5694042|NCT00296504|19633236|P2|Interim Analysis|Resistance to FPV|0
5694043|NCT00296504|19633237|P1|Interim Analysis|Resistance to FPV|0
5694044|NCT00296504|19633229|P9|Interim Analysis|Participant Was Incarcerated|0
5694045|NCT00296504|19633230|P8|Interim Analysis|Participant Was Incarcerated|0
5694046|NCT00296504|19633231|P7|Interim Analysis|Participant Was Incarcerated|0
5694047|NCT00296504|19633232|P6|Interim Analysis|Participant Was Incarcerated|0
5694048|NCT00296504|19633233|P5|Interim Analysis|Participant Was Incarcerated|0
5694049|NCT00296504|19633234|P4|Interim Analysis|Participant Was Incarcerated|0
5694050|NCT00296504|19633235|P3|Interim Analysis|Participant Was Incarcerated|1
5694051|NCT00296504|19633236|P2|Interim Analysis|Participant Was Incarcerated|0
5694052|NCT00296504|19633237|P1|Interim Analysis|Participant Was Incarcerated|2
5694053|NCT00296504|19633229|P9|Interim Analysis|Participant Moved|0
5694054|NCT00296504|19633230|P8|Interim Analysis|Participant Moved|0
5694055|NCT00296504|19633231|P7|Interim Analysis|Participant Moved|1
5694056|NCT00296504|19633232|P6|Interim Analysis|Participant Moved|1
5694057|NCT00296504|19633233|P5|Interim Analysis|Participant Moved|0
5694058|NCT00296504|19633234|P4|Interim Analysis|Participant Moved|0
5694059|NCT00296504|19633235|P3|Interim Analysis|Participant Moved|1
5694060|NCT00296504|19633236|P2|Interim Analysis|Participant Moved|0
5694061|NCT00296504|19633237|P1|Interim Analysis|Participant Moved|1
5694062|NCT00296504|19633229|P9|Interim Analysis|Participant Had Problems with Alcohol|0
5694063|NCT00296504|19633230|P8|Interim Analysis|Participant Had Problems with Alcohol|0
5694064|NCT00296504|19633231|P7|Interim Analysis|Participant Had Problems with Alcohol|0
5694065|NCT00296504|19633232|P6|Interim Analysis|Participant Had Problems with Alcohol|0
5694066|NCT00296504|19633233|P5|Interim Analysis|Participant Had Problems with Alcohol|0
5694067|NCT00296504|19633234|P4|Interim Analysis|Participant Had Problems with Alcohol|0
5694068|NCT00296504|19633235|P3|Interim Analysis|Participant Had Problems with Alcohol|1
5694069|NCT00296504|19633236|P2|Interim Analysis|Participant Had Problems with Alcohol|0
5694070|NCT00296504|19633237|P1|Interim Analysis|Participant Had Problems with Alcohol|0
5694071|NCT00296504|19633229|P9|Interim Analysis|To Simplify Treatment|0
5694072|NCT00296504|19633230|P8|Interim Analysis|To Simplify Treatment|0
5694073|NCT00296504|19633231|P7|Interim Analysis|To Simplify Treatment|2
5694074|NCT00296504|19633232|P6|Interim Analysis|To Simplify Treatment|0
5694075|NCT00296504|19633233|P5|Interim Analysis|To Simplify Treatment|0
5694076|NCT00296504|19633234|P4|Interim Analysis|To Simplify Treatment|0
5694077|NCT00296504|19633235|P3|Interim Analysis|To Simplify Treatment|1
5694078|NCT00296504|19633236|P2|Interim Analysis|To Simplify Treatment|0
5694079|NCT00296504|19633237|P1|Interim Analysis|To Simplify Treatment|0
5694080|NCT00296504|19633229|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
5694081|NCT00296504|19633230|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
5694082|NCT00296504|19633231|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
5694083|NCT00296504|19633232|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
5694084|NCT00296504|19633233|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
5694085|NCT00296504|19633234|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
5694086|NCT00296504|19633235|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
5694087|NCT00296504|19633236|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
5694088|NCT00296504|19633237|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
5694089|NCT00296504|19633229|P9|Interim Analysis|Participant Non-compliant|0
5694090|NCT00296504|19633230|P8|Interim Analysis|Participant Non-compliant|2
5694091|NCT00296504|19633231|P7|Interim Analysis|Participant Non-compliant|6
5694092|NCT00296504|19633232|P6|Interim Analysis|Participant Non-compliant|3
5694093|NCT00296504|19633233|P5|Interim Analysis|Participant Non-compliant|1
5694094|NCT00296504|19633234|P4|Interim Analysis|Participant Non-compliant|1
5694097|NCT00296504|19633237|P1|Interim Analysis|Participant Non-compliant|0
5694098|NCT00296504|19633229|P9|Interim Analysis|Death|0
5694099|NCT00296504|19633230|P8|Interim Analysis|Death|0
5694100|NCT00296504|19633231|P7|Interim Analysis|Death|0
5694101|NCT00296504|19633232|P6|Interim Analysis|Death|0
5694102|NCT00296504|19633233|P5|Interim Analysis|Death|0
5694103|NCT00296504|19633234|P4|Interim Analysis|Death|0
5694104|NCT00296504|19633235|P3|Interim Analysis|Death|3
5694105|NCT00296504|19633236|P2|Interim Analysis|Death|0
5694106|NCT00296504|19633237|P1|Interim Analysis|Death|1
5694107|NCT00296504|19633229|P9|Interim Analysis|Pregnancy|0
5694108|NCT00296504|19633230|P8|Interim Analysis|Pregnancy|1
5694109|NCT00296504|19633231|P7|Interim Analysis|Pregnancy|1
5694110|NCT00296504|19633232|P6|Interim Analysis|Pregnancy|1
5694111|NCT00296504|19633233|P5|Interim Analysis|Pregnancy|0
5694112|NCT00296504|19633234|P4|Interim Analysis|Pregnancy|2
5694113|NCT00296504|19633235|P3|Interim Analysis|Pregnancy|4
5694114|NCT00296504|19633236|P2|Interim Analysis|Pregnancy|1
5694115|NCT00296504|19633237|P1|Interim Analysis|Pregnancy|4
5694116|NCT00296504|19633229|P9|Interim Analysis|Switched to Commercially Available Drug|0
5694117|NCT00296504|19633230|P8|Interim Analysis|Switched to Commercially Available Drug|4
5694118|NCT00296504|19633231|P7|Interim Analysis|Switched to Commercially Available Drug|3
5694119|NCT00296504|19633232|P6|Interim Analysis|Switched to Commercially Available Drug|5
5694120|NCT00296504|19633233|P5|Interim Analysis|Switched to Commercially Available Drug|0
5694121|NCT00296504|19633234|P4|Interim Analysis|Switched to Commercially Available Drug|1
5694122|NCT00296504|19633235|P3|Interim Analysis|Switched to Commercially Available Drug|4
5694123|NCT00296504|19633236|P2|Interim Analysis|Switched to Commercially Available Drug|0
5694124|NCT00296504|19633237|P1|Interim Analysis|Switched to Commercially Available Drug|2
5694125|NCT00296504|19633229|P9|Interim Analysis|Insufficient CD4 Response|0
5694126|NCT00296504|19633230|P8|Interim Analysis|Insufficient CD4 Response|0
5694127|NCT00296504|19633231|P7|Interim Analysis|Insufficient CD4 Response|0
5694128|NCT00296504|19633232|P6|Interim Analysis|Insufficient CD4 Response|1
5694129|NCT00296504|19633233|P5|Interim Analysis|Insufficient CD4 Response|1
5694130|NCT00296504|19633234|P4|Interim Analysis|Insufficient CD4 Response|0
5694131|NCT00296504|19633235|P3|Interim Analysis|Insufficient CD4 Response|0
5694132|NCT00296504|19633236|P2|Interim Analysis|Insufficient CD4 Response|0
5694133|NCT00296504|19633237|P1|Interim Analysis|Insufficient CD4 Response|0
5694134|NCT00296504|19633229|P9|Interim Analysis|Protocol Violation|0
5694135|NCT00296504|19633230|P8|Interim Analysis|Protocol Violation|1
5694136|NCT00296504|19633231|P7|Interim Analysis|Protocol Violation|0
5694137|NCT00296504|19633232|P6|Interim Analysis|Protocol Violation|0
5694138|NCT00296504|19633233|P5|Interim Analysis|Protocol Violation|1
5694139|NCT00296504|19633234|P4|Interim Analysis|Protocol Violation|0
5694140|NCT00296504|19633235|P3|Interim Analysis|Protocol Violation|2
5694141|NCT00296504|19633236|P2|Interim Analysis|Protocol Violation|0
5694142|NCT00296504|19633237|P1|Interim Analysis|Protocol Violation|0
5694143|NCT00296504|19633229|P9|Interim Analysis|Adverse Event|0
5694144|NCT00296504|19633230|P8|Interim Analysis|Adverse Event|5
5694145|NCT00296504|19633231|P7|Interim Analysis|Adverse Event|4
5694146|NCT00296504|19633232|P6|Interim Analysis|Adverse Event|3
5694147|NCT00296504|19633233|P5|Interim Analysis|Adverse Event|6
5694148|NCT00296504|19633234|P4|Interim Analysis|Adverse Event|4
5694149|NCT00296504|19633235|P3|Interim Analysis|Adverse Event|13
5694150|NCT00296504|19633236|P2|Interim Analysis|Adverse Event|0
5694151|NCT00296504|19633237|P1|Interim Analysis|Adverse Event|0
5694152|NCT00296504|19633229|P9|Interim Analysis|Insufficient Viral Load Response|0
5694153|NCT00296504|19633230|P8|Interim Analysis|Insufficient Viral Load Response|24
5694154|NCT00296504|19633231|P7|Interim Analysis|Insufficient Viral Load Response|2
5694155|NCT00296504|19633232|P6|Interim Analysis|Insufficient Viral Load Response|9
5694156|NCT00296504|19633233|P5|Interim Analysis|Insufficient Viral Load Response|7
5694157|NCT00296504|19633234|P4|Interim Analysis|Insufficient Viral Load Response|2
5694158|NCT00296504|19633235|P3|Interim Analysis|Insufficient Viral Load Response|12
5694159|NCT00296504|19633236|P2|Interim Analysis|Insufficient Viral Load Response|1
5694160|NCT00296504|19633237|P1|Interim Analysis|Insufficient Viral Load Response|5
5694161|NCT00296504|19633229|P9|Interim Analysis|Clinical Progression|0
5694162|NCT00296504|19633230|P8|Interim Analysis|Clinical Progression|2
5694163|NCT00296504|19633231|P7|Interim Analysis|Clinical Progression|1
5694164|NCT00296504|19633232|P6|Interim Analysis|Clinical Progression|2
5694165|NCT00296504|19633233|P5|Interim Analysis|Clinical Progression|0
5694166|NCT00296504|19633234|P4|Interim Analysis|Clinical Progression|1
5694167|NCT00296504|19633235|P3|Interim Analysis|Clinical Progression|1
5694168|NCT00296504|19633236|P2|Interim Analysis|Clinical Progression|0
5694169|NCT00296504|19633237|P1|Interim Analysis|Clinical Progression|1
5694170|NCT00296504|19633229|P9|Interim Analysis|Lost to Follow-up|0
5694171|NCT00296504|19633230|P8|Interim Analysis|Lost to Follow-up|4
5694172|NCT00296504|19633231|P7|Interim Analysis|Lost to Follow-up|11
5694173|NCT00296504|19633232|P6|Interim Analysis|Lost to Follow-up|4
5694174|NCT00296504|19633233|P5|Interim Analysis|Lost to Follow-up|14
5694175|NCT00296504|19633234|P4|Interim Analysis|Lost to Follow-up|8
5694176|NCT00296504|19633235|P3|Interim Analysis|Lost to Follow-up|26
5694177|NCT00296504|19633236|P2|Interim Analysis|Lost to Follow-up|3
5694178|NCT00296504|19633237|P1|Interim Analysis|Lost to Follow-up|13
5694179|NCT00296504|19633229|P9|Interim Analysis|Withdrawal by Subject|0
5694180|NCT00296504|19633230|P8|Interim Analysis|Withdrawal by Subject|3
5694181|NCT00296504|19633231|P7|Interim Analysis|Withdrawal by Subject|9
5694182|NCT00296504|19633232|P6|Interim Analysis|Withdrawal by Subject|5
5694183|NCT00296504|19633233|P5|Interim Analysis|Withdrawal by Subject|5
5694184|NCT00296504|19633234|P4|Interim Analysis|Withdrawal by Subject|0
5694185|NCT00296504|19633235|P3|Interim Analysis|Withdrawal by Subject|12
5694186|NCT00296504|19633236|P2|Interim Analysis|Withdrawal by Subject|0
5694187|NCT00296504|19633237|P1|Interim Analysis|Withdrawal by Subject|8
5694188|NCT00296491|19633330|P4|Overall Study|Lost to Follow-up|0
5694189|NCT00296491|19633331|P3|Overall Study|Lost to Follow-up|2
5694190|NCT00296491|19633332|P2|Overall Study|Lost to Follow-up|2
5694191|NCT00296491|19633333|P1|Overall Study|Lost to Follow-up|0
5694192|NCT00296491|19633330|P4|Overall Study|Non-Compliance|14
5694193|NCT00296491|19633331|P3|Overall Study|Non-Compliance|10
5694194|NCT00296491|19633332|P2|Overall Study|Non-Compliance|13
5694195|NCT00296491|19633333|P1|Overall Study|Non-Compliance|12
5694196|NCT00296491|19633330|P4|Overall Study|Withdrawal by Subject|2
5694197|NCT00296491|19633331|P3|Overall Study|Withdrawal by Subject|3
5694198|NCT00296491|19633332|P2|Overall Study|Withdrawal by Subject|3
5694199|NCT00296491|19633333|P1|Overall Study|Withdrawal by Subject|7
5694200|NCT00296491|19633330|P4|Overall Study|Withdrawn due to Asthma|4
5694201|NCT00296491|19633331|P3|Overall Study|Withdrawn due to Asthma|0
5694202|NCT00296491|19633332|P2|Overall Study|Withdrawn due to Asthma|0
5694203|NCT00296491|19633333|P1|Overall Study|Withdrawn due to Asthma|0
5694204|NCT00296491|19633330|P4|Overall Study|Adverse Event|4
5694205|NCT00296491|19633331|P3|Overall Study|Adverse Event|1
5694206|NCT00296491|19633332|P2|Overall Study|Adverse Event|3
5694207|NCT00296491|19633333|P1|Overall Study|Adverse Event|1
5694208|NCT00296491|19633330|P4|Overall Study|Protocol Violation|3
5694209|NCT00296491|19633331|P3|Overall Study|Protocol Violation|2
5694210|NCT00296491|19633332|P2|Overall Study|Protocol Violation|6
5694211|NCT00296491|19633333|P1|Overall Study|Protocol Violation|4
5694212|NCT00296491|19633330|P4|Overall Study|Low Pollen Counts|16
5694213|NCT00296491|19633331|P3|Overall Study|Low Pollen Counts|25
5694214|NCT00296491|19633332|P2|Overall Study|Low Pollen Counts|26
5694215|NCT00296491|19633333|P1|Overall Study|Low Pollen Counts|18
5694216|NCT00296400|19633362|P3|Overall Study|Pregnancy|0
5694217|NCT00296400|19633363|P2|Overall Study|Pregnancy|2
5694218|NCT00296400|19633364|P1|Overall Study|Pregnancy|1
5694219|NCT00296400|19633362|P3|Overall Study|Visit 10 was performed earlier|0
5694220|NCT00296400|19633363|P2|Overall Study|Visit 10 was performed earlier|1
5694221|NCT00296400|19633364|P1|Overall Study|Visit 10 was performed earlier|0
5694222|NCT00296400|19633362|P3|Overall Study|Study specific discontinuation criteria|1
5694223|NCT00296400|19633363|P2|Overall Study|Study specific discontinuation criteria|0
5694224|NCT00296400|19633364|P1|Overall Study|Study specific discontinuation criteria|0
5694225|NCT00296400|19633362|P3|Overall Study|Lost to Follow-up|2
5694226|NCT00296400|19633363|P2|Overall Study|Lost to Follow-up|1
5694227|NCT00296400|19633364|P1|Overall Study|Lost to Follow-up|1
5694228|NCT00296400|19633362|P3|Overall Study|Protocol Violation|1
5694229|NCT00296400|19633363|P2|Overall Study|Protocol Violation|1
5694230|NCT00296400|19633364|P1|Overall Study|Protocol Violation|1
5694231|NCT00296400|19633362|P3|Overall Study|Incorrect enrollment|0
5694232|NCT00296400|19633363|P2|Overall Study|Incorrect enrollment|0
5694233|NCT00296400|19633364|P1|Overall Study|Incorrect enrollment|2
5694234|NCT00296400|19633362|P3|Overall Study|Withdrawal by Subject|2
5694235|NCT00296400|19633363|P2|Overall Study|Withdrawal by Subject|6
5694236|NCT00296400|19633364|P1|Overall Study|Withdrawal by Subject|5
5694237|NCT00296400|19633362|P3|Overall Study|Adverse Event|7
5694238|NCT00296400|19633363|P2|Overall Study|Adverse Event|7
5694239|NCT00296400|19633364|P1|Overall Study|Adverse Event|7
5694240|NCT00296374|19633588|P3|Overall Study|Other|1
5694241|NCT00296374|19633589|P2|Overall Study|Other|0
5694242|NCT00296374|19633590|P1|Overall Study|Other|0
5694243|NCT00296374|19633588|P3|Overall Study|Pregnancy|2
5694244|NCT00296374|19633589|P2|Overall Study|Pregnancy|0
5694245|NCT00296374|19633590|P1|Overall Study|Pregnancy|0
5694246|NCT00296374|19633588|P3|Overall Study|Nephrologist introduced ACE|0
5694247|NCT00296374|19633589|P2|Overall Study|Nephrologist introduced ACE|1
5694248|NCT00296374|19633590|P1|Overall Study|Nephrologist introduced ACE|0
5694249|NCT00296374|19633588|P3|Overall Study|Stopped drug before end of study visit|0
5694250|NCT00296374|19633589|P2|Overall Study|Stopped drug before end of study visit|1
5694251|NCT00296374|19633590|P1|Overall Study|Stopped drug before end of study visit|0
5694252|NCT00296374|19633588|P3|Overall Study|Relocated to another state|0
5694253|NCT00296374|19633589|P2|Overall Study|Relocated to another state|0
5694254|NCT00296374|19633590|P1|Overall Study|Relocated to another state|1
5694255|NCT00296374|19633588|P3|Overall Study|Lost to Follow-up|1
5694256|NCT00296374|19633589|P2|Overall Study|Lost to Follow-up|1
5694257|NCT00296374|19633590|P1|Overall Study|Lost to Follow-up|3
5694258|NCT00296374|19633588|P3|Overall Study|Protocol Violation|3
5694259|NCT00296374|19633589|P2|Overall Study|Protocol Violation|2
5694260|NCT00296374|19633590|P1|Overall Study|Protocol Violation|1
5694261|NCT00296374|19633588|P3|Overall Study|Incorrect enrollment|4
5694262|NCT00296374|19633589|P2|Overall Study|Incorrect enrollment|3
5694263|NCT00296374|19633590|P1|Overall Study|Incorrect enrollment|3
5694264|NCT00296374|19633588|P3|Overall Study|Withdrawal by Subject|11
5694265|NCT00296374|19633589|P2|Overall Study|Withdrawal by Subject|5
5694266|NCT00296374|19633590|P1|Overall Study|Withdrawal by Subject|3
5694267|NCT00296374|19633588|P3|Overall Study|Adverse Event|7
5694268|NCT00296374|19633589|P2|Overall Study|Adverse Event|10
5694269|NCT00296374|19633590|P1|Overall Study|Adverse Event|14
5694270|NCT00296335|19633813|P2|Overall Study|Physician Decision|11
5694271|NCT00296335|19633814|P1|Overall Study|Physician Decision|3
5694272|NCT00296335|19633813|P2|Overall Study|Lost to Follow-up|33
5694273|NCT00296335|19633814|P1|Overall Study|Lost to Follow-up|7
5694274|NCT00296335|19633813|P2|Overall Study|Adverse Event|27
5694275|NCT00296335|19633814|P1|Overall Study|Adverse Event|17
5694276|NCT00296335|19633813|P2|Overall Study|Recurrence|51
5694277|NCT00296335|19633814|P1|Overall Study|Recurrence|3
5694278|NCT00296244|19633854|P2|Overall Study|Underwent retransplant|1
5694279|NCT00296244|19633855|P1|Overall Study|Underwent retransplant|0
5694280|NCT00296140|19633919|P2|Overall Study|Discharge to Nursing Home|0
5694281|NCT00296140|19633920|P1|Overall Study|Discharge to Nursing Home|1
5694282|NCT00296140|19633919|P2|Overall Study|Withdrawal by Subject|0
5694283|NCT00296140|19633920|P1|Overall Study|Withdrawal by Subject|1
5694284|NCT00296140|19633919|P2|Overall Study|Lost to Follow-up|0
5694285|NCT00296140|19633920|P1|Overall Study|Lost to Follow-up|1
5694286|NCT00296036|19633932|P6|Overall Study|Protocol Violation|3
5694287|NCT00296036|19633933|P5|Overall Study|Protocol Violation|0
5694288|NCT00296036|19633934|P4|Overall Study|Protocol Violation|0
5694289|NCT00296036|19633935|P3|Overall Study|Protocol Violation|0
5694290|NCT00296036|19633936|P2|Overall Study|Protocol Violation|0
5694291|NCT00296036|19633937|P1|Overall Study|Protocol Violation|0
5694292|NCT00296036|19633932|P6|Overall Study|Withdrawal by Subject|1
5694293|NCT00296036|19633933|P5|Overall Study|Withdrawal by Subject|2
5694294|NCT00296036|19633934|P4|Overall Study|Withdrawal by Subject|1
5694295|NCT00296036|19633935|P3|Overall Study|Withdrawal by Subject|2
5694296|NCT00296036|19633936|P2|Overall Study|Withdrawal by Subject|0
5694297|NCT00296036|19633937|P1|Overall Study|Withdrawal by Subject|1
5694298|NCT00295932|19633974|P11|Overall Study|Not Treated|1
5694299|NCT00295932|19633975|P10|Overall Study|Not Treated|0
5694300|NCT00295932|19633976|P9|Overall Study|Not Treated|0
5694301|NCT00295932|19633977|P8|Overall Study|Not Treated|0
5694302|NCT00295932|19633978|P7|Overall Study|Not Treated|0
5694303|NCT00295932|19633979|P6|Overall Study|Not Treated|0
5694304|NCT00295932|19633980|P5|Overall Study|Not Treated|0
5694305|NCT00295932|19633981|P4|Overall Study|Not Treated|0
5694306|NCT00295932|19633982|P3|Overall Study|Not Treated|0
5694307|NCT00295932|19633983|P2|Overall Study|Not Treated|0
5694308|NCT00295932|19633984|P1|Overall Study|Not Treated|0
5694309|NCT00295880|19634018|P1|Overall Study|Unit randomization did not occur|1
5694310|NCT00295880|19634018|P1|Overall Study|IBMI unit could not be volume reduced|1
5694311|NCT00295854|19634038|P3|Overall Study|Other|1
5694312|NCT00295854|19634039|P2|Overall Study|Other|5
5694313|NCT00295854|19634040|P1|Overall Study|Other|3
5694314|NCT00295854|19634038|P3|Overall Study|required a prohibited medication|0
5694315|NCT00295854|19634039|P2|Overall Study|required a prohibited medication|0
5694316|NCT00295854|19634040|P1|Overall Study|required a prohibited medication|1
5694317|NCT00295854|19634038|P3|Overall Study|did not continue to meet criteria|2
5694318|NCT00295854|19634039|P2|Overall Study|did not continue to meet criteria|1
5694319|NCT00295854|19634040|P1|Overall Study|did not continue to meet criteria|1
5694320|NCT00295854|19634038|P3|Overall Study|Withdrawal by Subject|4
5694321|NCT00295854|19634039|P2|Overall Study|Withdrawal by Subject|7
5694322|NCT00295854|19634040|P1|Overall Study|Withdrawal by Subject|3
5694323|NCT00295854|19634038|P3|Overall Study|Lost to Follow-up|1
5694324|NCT00295854|19634039|P2|Overall Study|Lost to Follow-up|0
5694325|NCT00295854|19634040|P1|Overall Study|Lost to Follow-up|2
5694326|NCT00295854|19634038|P3|Overall Study|Protocol Violation|1
5694327|NCT00295854|19634039|P2|Overall Study|Protocol Violation|1
5694328|NCT00295854|19634040|P1|Overall Study|Protocol Violation|1
5694329|NCT00295854|19634038|P3|Overall Study|Adverse Event|6
5694330|NCT00295854|19634039|P2|Overall Study|Adverse Event|7
5694331|NCT00295854|19634040|P1|Overall Study|Adverse Event|7
5694332|NCT00295750|19634054|P3|Overall Study|Protocol Violation|2
5694333|NCT00295750|19634055|P2|Overall Study|Protocol Violation|4
5694334|NCT00295750|19634056|P1|Overall Study|Protocol Violation|2
5694335|NCT00295750|19634054|P3|Overall Study|Withdrawal by Subject|7
5694336|NCT00295750|19634055|P2|Overall Study|Withdrawal by Subject|4
5694337|NCT00295750|19634056|P1|Overall Study|Withdrawal by Subject|9
5694338|NCT00295750|19634054|P3|Overall Study|Randomized but never received trial drug|3
5694339|NCT00295750|19634055|P2|Overall Study|Randomized but never received trial drug|3
5694340|NCT00295750|19634056|P1|Overall Study|Randomized but never received trial drug|4
5694341|NCT00295750|19634054|P3|Overall Study|Personal reasons|0
5694342|NCT00295750|19634055|P2|Overall Study|Personal reasons|1
5694343|NCT00295750|19634056|P1|Overall Study|Personal reasons|0
5694344|NCT00295750|19634054|P3|Overall Study|Disease progression|0
5694345|NCT00295750|19634055|P2|Overall Study|Disease progression|1
5694346|NCT00295750|19634056|P1|Overall Study|Disease progression|2
5694347|NCT00295750|19634054|P3|Overall Study|Trial drug errors|0
5694348|NCT00295750|19634055|P2|Overall Study|Trial drug errors|1
5694349|NCT00295750|19634056|P1|Overall Study|Trial drug errors|1
5694350|NCT00295750|19634054|P3|Overall Study|Administrative errors|5
5694351|NCT00295750|19634055|P2|Overall Study|Administrative errors|4
5694352|NCT00295750|19634056|P1|Overall Study|Administrative errors|2
5694353|NCT00295750|19634054|P3|Overall Study|Taking prohibited therapy|2
5694354|NCT00295750|19634055|P2|Overall Study|Taking prohibited therapy|3
5694355|NCT00295750|19634056|P1|Overall Study|Taking prohibited therapy|2
5694356|NCT00295750|19634054|P3|Overall Study|Lost to Follow-up|1
5694357|NCT00295750|19634055|P2|Overall Study|Lost to Follow-up|4
5694358|NCT00295750|19634056|P1|Overall Study|Lost to Follow-up|1
5694359|NCT00295750|19634054|P3|Overall Study|Lack of Efficacy|0
5694360|NCT00295750|19634055|P2|Overall Study|Lack of Efficacy|1
5694361|NCT00295750|19634056|P1|Overall Study|Lack of Efficacy|1
5694362|NCT00295750|19634054|P3|Overall Study|Adverse Event|12
5694363|NCT00295750|19634055|P2|Overall Study|Adverse Event|15
5694364|NCT00295750|19634056|P1|Overall Study|Adverse Event|19
5694365|NCT00295633|19634091|P3|Overall Study|Administrative reason by sponsor|1
5694366|NCT00295633|19634092|P2|Overall Study|Administrative reason by sponsor|0
5694367|NCT00295633|19634093|P1|Overall Study|Administrative reason by sponsor|0
5694368|NCT00295633|19634091|P3|Overall Study|Death|0
5694369|NCT00295633|19634092|P2|Overall Study|Death|1
5694370|NCT00295633|19634093|P1|Overall Study|Death|1
5694371|NCT00295633|19634091|P3|Overall Study|Subject No Longer Meets Study Criteria|3
5694372|NCT00295633|19634092|P2|Overall Study|Subject No Longer Meets Study Criteria|3
5694373|NCT00295633|19634093|P1|Overall Study|Subject No Longer Meets Study Criteria|0
5694374|NCT00295633|19634091|P3|Overall Study|Poor/Noncompliance|6
5694375|NCT00295633|19634092|P2|Overall Study|Poor/Noncompliance|2
5694376|NCT00295633|19634093|P1|Overall Study|Poor/Noncompliance|2
5694377|NCT00295633|19634091|P3|Overall Study|Physician Decision|8
5694378|NCT00295633|19634092|P2|Overall Study|Physician Decision|10
5694379|NCT00295633|19634093|P1|Overall Study|Physician Decision|9
5694380|NCT00295633|19634091|P3|Overall Study|Lost to Follow-up|7
5694381|NCT00295633|19634092|P2|Overall Study|Lost to Follow-up|11
5694382|NCT00295633|19634093|P1|Overall Study|Lost to Follow-up|6
5694383|NCT00295633|19634091|P3|Overall Study|Adverse Event|9
5694384|NCT00295633|19634092|P2|Overall Study|Adverse Event|17
5694385|NCT00295633|19634093|P1|Overall Study|Adverse Event|9
5694386|NCT00295633|19634091|P3|Overall Study|Withdrawal of consent by subject|26
5694387|NCT00295633|19634092|P2|Overall Study|Withdrawal of consent by subject|16
5694388|NCT00295633|19634093|P1|Overall Study|Withdrawal of consent by subject|16
5694389|NCT00295633|19634091|P3|Overall Study|Lack of Efficacy|16
5694390|NCT00295633|19634092|P2|Overall Study|Lack of Efficacy|7
5694391|NCT00295633|19634093|P1|Overall Study|Lack of Efficacy|19
5694392|NCT00295620|19634112|P2|Overall Study|Protocol Violation|32
5694393|NCT00295620|19634113|P1|Overall Study|Protocol Violation|30
5694394|NCT00295620|19634112|P2|Overall Study|Discontinuation by sponsor|593
5694395|NCT00295620|19634113|P1|Overall Study|Discontinuation by sponsor|580
5694396|NCT00295620|19634112|P2|Overall Study|Other reasons|9
5694397|NCT00295620|19634113|P1|Overall Study|Other reasons|10
5694398|NCT00295620|19634112|P2|Overall Study|Death|207
5694399|NCT00295620|19634113|P1|Overall Study|Death|206
5694400|NCT00295620|19634112|P2|Overall Study|Withdrawal by Subject|50
5694401|NCT00295620|19634113|P1|Overall Study|Withdrawal by Subject|37
5694402|NCT00295620|19634112|P2|Overall Study|Lost to Follow-up|5
5694403|NCT00295620|19634113|P1|Overall Study|Lost to Follow-up|9
5694404|NCT00295490|19634137|P4|Overall Study|Other|1
5694405|NCT00295490|19634138|P3|Overall Study|Other|0
5694406|NCT00295490|19634139|P2|Overall Study|Other|2
5694407|NCT00295490|19634140|P1|Overall Study|Other|0
5694408|NCT00295490|19634137|P4|Overall Study|Adverse Event|0
5694409|NCT00295490|19634138|P3|Overall Study|Adverse Event|0
5694410|NCT00295490|19634139|P2|Overall Study|Adverse Event|0
5694411|NCT00295490|19634140|P1|Overall Study|Adverse Event|1
5694412|NCT00295490|19634137|P4|Overall Study|Lost to Follow-up|0
5694413|NCT00295490|19634138|P3|Overall Study|Lost to Follow-up|1
5694414|NCT00295490|19634139|P2|Overall Study|Lost to Follow-up|0
5694415|NCT00295490|19634140|P1|Overall Study|Lost to Follow-up|0
5694416|NCT00295490|19634137|P4|Overall Study|Withdrawal by Subject|1
5694417|NCT00295490|19634138|P3|Overall Study|Withdrawal by Subject|0
5694418|NCT00295490|19634139|P2|Overall Study|Withdrawal by Subject|2
5694419|NCT00295490|19634140|P1|Overall Study|Withdrawal by Subject|0
5694420|NCT00295490|19634137|P4|Overall Study|Protocol Violation|3
5694421|NCT00295490|19634138|P3|Overall Study|Protocol Violation|3
5694422|NCT00295490|19634139|P2|Overall Study|Protocol Violation|0
5694423|NCT00295490|19634140|P1|Overall Study|Protocol Violation|0
5694424|NCT00295022|19634190|P3|Overall Study|Withdrawal by Subject|2
5694425|NCT00295022|19634191|P2|Overall Study|Withdrawal by Subject|0
5694426|NCT00295022|19634192|P1|Overall Study|Withdrawal by Subject|0
5694427|NCT00295022|19634190|P3|Overall Study|Lost to Follow-up|1
5694428|NCT00295022|19634191|P2|Overall Study|Lost to Follow-up|0
5694429|NCT00295022|19634192|P1|Overall Study|Lost to Follow-up|0
5694430|NCT00295022|19634190|P3|Overall Study|Adverse Event|2
5694431|NCT00295022|19634191|P2|Overall Study|Adverse Event|1
5694432|NCT00295022|19634192|P1|Overall Study|Adverse Event|1
5694433|NCT00294762|19634308|P2|Overall Study|Did not receive study treatment|3
5694434|NCT00294762|19634309|P1|Overall Study|Did not receive study treatment|3
5694435|NCT00294723|19634328|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
5694436|NCT00294723|19634329|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
5694437|NCT00294723|19634330|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
5694438|NCT00294723|19634328|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
5694439|NCT00294723|19634329|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
5694440|NCT00294723|19634330|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
5694441|NCT00294723|19634328|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
5694526|NCT00294047|19634604|P2|Month 84|Visit missed|1
5694442|NCT00294723|19634329|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
5694443|NCT00294723|19634330|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
5694444|NCT00294723|19634328|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
5694445|NCT00294723|19634329|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
5694446|NCT00294723|19634330|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
5694447|NCT00294723|19634328|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
5694448|NCT00294723|19634329|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
5694449|NCT00294723|19634330|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
5694450|NCT00294723|19634328|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
5694451|NCT00294723|19634329|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
5694452|NCT00294723|19634330|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
5694453|NCT00294723|19634328|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
5694454|NCT00294723|19634329|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
5694455|NCT00294723|19634330|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
5694456|NCT00294723|19634328|P3|Open-Label Extension 52 Weeks|Adverse Event|2
5694457|NCT00294723|19634329|P2|Open-Label Extension 52 Weeks|Adverse Event|5
5694458|NCT00294723|19634330|P1|Open-Label Extension 52 Weeks|Adverse Event|5
5694459|NCT00294723|19634328|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
5694460|NCT00294723|19634329|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
5694461|NCT00294723|19634330|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
5694462|NCT00294723|19634328|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
5694463|NCT00294723|19634329|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
5694464|NCT00294723|19634330|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
5694465|NCT00294723|19634328|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
5694466|NCT00294723|19634329|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
5694467|NCT00294723|19634330|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
5694468|NCT00294723|19634328|P3|Double-Blind Period 52 Weeks|Adverse Event|15
5694469|NCT00294723|19634329|P2|Double-Blind Period 52 Weeks|Adverse Event|25
5694470|NCT00294723|19634330|P1|Double-Blind Period 52 Weeks|Adverse Event|18
5694471|NCT00294684|19634391|P2|Overall Study|Lost to Follow-up|8
5694472|NCT00294684|19634392|P1|Overall Study|Lost to Follow-up|5
5694473|NCT00294671|19634432|P2|Overall Study|Death|1
5694474|NCT00294671|19634433|P1|Overall Study|Death|0
5694475|NCT00294671|19634432|P2|Overall Study|Non-compliance|0
5694476|NCT00294671|19634433|P1|Overall Study|Non-compliance|1
5694477|NCT00294671|19634432|P2|Overall Study|Lost to Follow-up|3
5694478|NCT00294671|19634433|P1|Overall Study|Lost to Follow-up|1
5694479|NCT00294671|19634432|P2|Overall Study|Non-drug related AE|2
5694480|NCT00294671|19634433|P1|Overall Study|Non-drug related AE|3
5694481|NCT00294671|19634432|P2|Overall Study|Drug related adverse event (AE)|2
5694482|NCT00294671|19634433|P1|Overall Study|Drug related adverse event (AE)|4
5694483|NCT00294671|19634432|P2|Overall Study|Liver transplant|9
5694484|NCT00294671|19634433|P1|Overall Study|Liver transplant|7
5694485|NCT00294671|19634432|P2|Overall Study|Lack of Efficacy|23
5694486|NCT00294671|19634433|P1|Overall Study|Lack of Efficacy|11
5694487|NCT00294658|19634449|P2|Overall Study|Patient and family were not satisfied|1
5694488|NCT00294658|19634450|P1|Overall Study|Patient and family were not satisfied|0
5694489|NCT00294658|19634449|P2|Overall Study|Found to have invasive thymoma|0
5694490|NCT00294658|19634450|P1|Overall Study|Found to have invasive thymoma|1
5694491|NCT00294658|19634449|P2|Overall Study|Withdrawal by Subject|4
5694492|NCT00294658|19634450|P1|Overall Study|Withdrawal by Subject|0
5694493|NCT00294658|19634449|P2|Overall Study|Pregnancy|1
5694494|NCT00294658|19634450|P1|Overall Study|Pregnancy|0
5694495|NCT00294658|19634449|P2|Overall Study|Physician Decision|2
5694496|NCT00294658|19634450|P1|Overall Study|Physician Decision|1
5694497|NCT00294658|19634449|P2|Overall Study|Lost to Follow-up|0
5694498|NCT00294658|19634450|P1|Overall Study|Lost to Follow-up|4
5694499|NCT00294658|19634449|P2|Overall Study|Death|1
5694500|NCT00294658|19634450|P1|Overall Study|Death|0
5694501|NCT00294645|19634514|P2|Overall Study|Other|10
5694502|NCT00294645|19634515|P1|Overall Study|Other|4
5694503|NCT00294645|19634514|P2|Overall Study|Physician Decision|20
5694504|NCT00294645|19634515|P1|Overall Study|Physician Decision|15
5694505|NCT00294645|19634514|P2|Overall Study|Withdrawal by Subject|34
5694506|NCT00294645|19634515|P1|Overall Study|Withdrawal by Subject|18
5694507|NCT00294645|19634514|P2|Overall Study|Lost to Follow-up|10
5694508|NCT00294645|19634515|P1|Overall Study|Lost to Follow-up|1
5694509|NCT00294645|19634514|P2|Overall Study|Death|18
5694510|NCT00294645|19634515|P1|Overall Study|Death|10
5694511|NCT00294554|19634559|P2|Overall Study|Physician Decision|1
5694512|NCT00294554|19634560|P1|Overall Study|Physician Decision|0
5694513|NCT00294554|19634559|P2|Overall Study|Lack of Efficacy|1
5694514|NCT00294554|19634560|P1|Overall Study|Lack of Efficacy|0
5694515|NCT00294398|19634587|P2|Overall Study|Lost to Follow-up|26
5694516|NCT00294398|19634588|P1|Overall Study|Lost to Follow-up|21
5694517|NCT00294060|19634596|P1|Overall Study|Device explanted/not replaced|23
5694518|NCT00294060|19634596|P1|Overall Study|Medical condition|3
5694519|NCT00294060|19634596|P1|Overall Study|Physician Decision|797
5694520|NCT00294060|19634596|P1|Overall Study|Withdrawal by Subject|11
5694521|NCT00294060|19634596|P1|Overall Study|Lost to Follow-up|55
5694522|NCT00294060|19634596|P1|Overall Study|Other|59
5694523|NCT00294060|19634596|P1|Overall Study|Death|225
5694524|NCT00294047|19634604|P2|Month 84|No consent for Month 84 Follow-up|754
5694525|NCT00294047|19634605|P1|Month 84|No consent for Month 84 Follow-up|731
5694527|NCT00294047|19634605|P1|Month 84|Visit missed|0
5694528|NCT00294047|19634604|P2|Month 84|Under investigation locally|0
5694529|NCT00294047|19634605|P1|Month 84|Under investigation locally|1
5694530|NCT00294047|19634604|P2|Month 84|Unable to reach study site|0
5694531|NCT00294047|19634605|P1|Month 84|Unable to reach study site|1
5694532|NCT00294047|19634604|P2|Month 84|Transport reimbursement delayed|1
5694533|NCT00294047|19634605|P1|Month 84|Transport reimbursement delayed|0
5694534|NCT00294047|19634604|P2|Month 84|Subject does not want male physician|0
5694535|NCT00294047|19634605|P1|Month 84|Subject does not want male physician|1
5694536|NCT00294047|19634604|P2|Month 84|Personal reason|4
5694537|NCT00294047|19634605|P1|Month 84|Personal reason|2
5694538|NCT00294047|19634604|P2|Month 84|Lack of time|1
5694539|NCT00294047|19634605|P1|Month 84|Lack of time|3
5694540|NCT00294047|19634604|P2|Month 84|Family problems|2
5694541|NCT00294047|19634605|P1|Month 84|Family problems|2
5694542|NCT00294047|19634604|P2|Month 84|Center closed, subject did not transfer|0
5694543|NCT00294047|19634605|P1|Month 84|Center closed, subject did not transfer|1
5694544|NCT00294047|19634604|P2|Month 84|Work related reasons|2
5694545|NCT00294047|19634605|P1|Month 84|Work related reasons|4
5694546|NCT00294047|19634604|P2|Month 84|Absent Cervix|0
5694547|NCT00294047|19634605|P1|Month 84|Absent Cervix|2
5694548|NCT00294047|19634604|P2|Month 84|Lost to Follow-up|190
5694549|NCT00294047|19634605|P1|Month 84|Lost to Follow-up|187
5694550|NCT00294047|19634604|P2|Month 84|Withdrawal by Subject|31
5694551|NCT00294047|19634605|P1|Month 84|Withdrawal by Subject|33
5694552|NCT00294047|19634604|P2|Month 84|Protocol Violation|1
5694553|NCT00294047|19634605|P1|Month 84|Protocol Violation|1
5694554|NCT00294047|19634604|P2|Month 84|Adverse Event|2
5694555|NCT00294047|19634605|P1|Month 84|Adverse Event|4
5694556|NCT00294047|19634604|P2|Month 48|Other|14
5694557|NCT00294047|19634605|P1|Month 48|Other|10
5694558|NCT00294047|19634604|P2|Month 48|Lost to Follow-up|287
5694559|NCT00294047|19634605|P1|Month 48|Lost to Follow-up|272
5694560|NCT00294047|19634604|P2|Month 48|Withdrawal by Subject|115
5694561|NCT00294047|19634605|P1|Month 48|Withdrawal by Subject|111
5694562|NCT00294047|19634604|P2|Month 48|Protocol Violation|4
5694563|NCT00294047|19634605|P1|Month 48|Protocol Violation|4
5694564|NCT00294047|19634604|P2|Month 48|Adverse Event|13
5694565|NCT00294047|19634605|P1|Month 48|Adverse Event|28
5694566|NCT00293813|19634710|P3|Overall Study|Noncompliance|0
5694567|NCT00293813|19634711|P2|Overall Study|Noncompliance|1
5694568|NCT00293813|19634712|P1|Overall Study|Noncompliance|0
5694569|NCT00293813|19634710|P3|Overall Study|Lost to Follow-up|3
5694570|NCT00293813|19634711|P2|Overall Study|Lost to Follow-up|2
5694571|NCT00293813|19634712|P1|Overall Study|Lost to Follow-up|3
5694572|NCT00293813|19634710|P3|Overall Study|Withdrawal by Subject|4
5694573|NCT00293813|19634711|P2|Overall Study|Withdrawal by Subject|4
5694574|NCT00293813|19634712|P1|Overall Study|Withdrawal by Subject|7
5694575|NCT00293813|19634710|P3|Overall Study|Adverse Event|1
5694576|NCT00293813|19634711|P2|Overall Study|Adverse Event|1
5694577|NCT00293813|19634712|P1|Overall Study|Adverse Event|3
5694578|NCT00293813|19634710|P3|Overall Study|Physician Decision|0
5694579|NCT00293813|19634711|P2|Overall Study|Physician Decision|1
5694580|NCT00293813|19634712|P1|Overall Study|Physician Decision|0
5694581|NCT00293722|19634723|P1|Overall Study|Other|427
5694582|NCT00293709|19634737|P1|Overall Study|Other|47
5694583|NCT00293579|19634751|P1|Overall Study|Withdrawal by Subject|1
5694584|NCT00293462|19634770|P3|Overall Study|Physician Decision|0
5694585|NCT00293462|19634771|P2|Overall Study|Physician Decision|1
5694586|NCT00293462|19634772|P1|Overall Study|Physician Decision|0
5694587|NCT00293462|19634770|P3|Overall Study|Low radiation dose in oral cavity|0
5694588|NCT00293462|19634771|P2|Overall Study|Low radiation dose in oral cavity|1
5694589|NCT00293462|19634772|P1|Overall Study|Low radiation dose in oral cavity|0
5694590|NCT00293462|19634770|P3|Overall Study|Possible Tracheostomy leakage|0
5694591|NCT00293462|19634771|P2|Overall Study|Possible Tracheostomy leakage|1
5694592|NCT00293462|19634772|P1|Overall Study|Possible Tracheostomy leakage|0
5694593|NCT00293462|19634770|P3|Overall Study|Ischemic stroke after chemotherapy|1
5694594|NCT00293462|19634771|P2|Overall Study|Ischemic stroke after chemotherapy|0
5694595|NCT00293462|19634772|P1|Overall Study|Ischemic stroke after chemotherapy|0
5694596|NCT00293462|19634770|P3|Overall Study|Blood clot after chemotherapy|1
5694597|NCT00293462|19634771|P2|Overall Study|Blood clot after chemotherapy|0
5694598|NCT00293462|19634772|P1|Overall Study|Blood clot after chemotherapy|0
5694599|NCT00293462|19634770|P3|Overall Study|Went back to his home country|1
5694600|NCT00293462|19634771|P2|Overall Study|Went back to his home country|0
5694601|NCT00293462|19634772|P1|Overall Study|Went back to his home country|0
5694602|NCT00293462|19634770|P3|Overall Study|No Show|1
5694603|NCT00293462|19634771|P2|Overall Study|No Show|0
5694604|NCT00293462|19634772|P1|Overall Study|No Show|0
5694605|NCT00293462|19634770|P3|Overall Study|Refuse Radiation Treatment|0
5694606|NCT00293462|19634771|P2|Overall Study|Refuse Radiation Treatment|0
5694607|NCT00293462|19634772|P1|Overall Study|Refuse Radiation Treatment|1
5694608|NCT00293462|19634770|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
5694609|NCT00293462|19634771|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
5694610|NCT00293462|19634772|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
5694611|NCT00293462|19634770|P3|Overall Study|Change Treatment Regimen (ineligible)|0
5694612|NCT00293462|19634771|P2|Overall Study|Change Treatment Regimen (ineligible)|0
5694613|NCT00293462|19634772|P1|Overall Study|Change Treatment Regimen (ineligible)|1
5694614|NCT00293462|19634770|P3|Overall Study|Lost to Follow-up|0
5694615|NCT00293462|19634771|P2|Overall Study|Lost to Follow-up|1
5694616|NCT00293462|19634772|P1|Overall Study|Lost to Follow-up|0
5694617|NCT00293462|19634770|P3|Overall Study|Death|0
5694618|NCT00293462|19634771|P2|Overall Study|Death|0
5694619|NCT00293462|19634772|P1|Overall Study|Death|1
5694620|NCT00293462|19634770|P3|Overall Study|Withdrawal by Subject|6
5694621|NCT00293462|19634771|P2|Overall Study|Withdrawal by Subject|3
5694622|NCT00293462|19634772|P1|Overall Study|Withdrawal by Subject|4
5694623|NCT00293397|19634791|P1|Overall Study|Death|2
5694624|NCT00293384|19634801|P1|Overall Study|Ineligible|2
5694625|NCT00293384|19634801|P1|Overall Study|Missed dosage/study drug|1
5694626|NCT00293384|19634801|P1|Overall Study|Non-compliance|2
5694627|NCT00293293|19634810|P2|Overall Study|Patient discontinued chemotherapy|1
5694628|NCT00293293|19634811|P1|Overall Study|Patient discontinued chemotherapy|0
5694629|NCT00293293|19634810|P2|Overall Study|"Patient too anxious to complete trial"|0
5694630|NCT00293293|19634811|P1|Overall Study|"Patient too anxious to complete trial"|1
5694631|NCT00293293|19634810|P2|Overall Study|Withdrawal by Subject|1
5694632|NCT00293293|19634811|P1|Overall Study|Withdrawal by Subject|1
5694633|NCT00293267|19634839|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
5694634|NCT00293267|19634840|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
5694635|NCT00293267|19634839|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
5694636|NCT00293267|19634840|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
5694637|NCT00293267|19634839|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
5694638|NCT00293267|19634840|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
5694639|NCT00293267|19634839|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
5694640|NCT00293267|19634840|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
5694641|NCT00293267|19634839|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
5694642|NCT00293267|19634840|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
5694643|NCT00293267|19634839|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
5694644|NCT00293267|19634840|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
5694645|NCT00293267|19634839|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
5694646|NCT00293267|19634840|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
5694647|NCT00293267|19634839|P2|Extension - Open-Label Week 157-240|Other Reason|1
5694648|NCT00293267|19634840|P1|Extension - Open-Label Week 157-240|Other Reason|3
5694649|NCT00293267|19634839|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
5694650|NCT00293267|19634840|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
5694651|NCT00293267|19634839|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
5694652|NCT00293267|19634840|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
5694653|NCT00293267|19634839|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
5694654|NCT00293267|19634840|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
5694655|NCT00293267|19634839|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
5694656|NCT00293267|19634840|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
5694657|NCT00293267|19634839|P2|Extension - Open-Label Week 157-240|Adverse Event|0
5694658|NCT00293267|19634840|P1|Extension - Open-Label Week 157-240|Adverse Event|5
5694659|NCT00293267|19634839|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
5694660|NCT00293267|19634840|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
5694661|NCT00293267|19634839|P2|Extension - Double-Blind Week 49-156|Other Reason|0
5694662|NCT00293267|19634840|P1|Extension - Double-Blind Week 49-156|Other Reason|7
5694663|NCT00293267|19634839|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
5694664|NCT00293267|19634840|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
5694665|NCT00293267|19634839|P2|Extension - Double-Blind Week 49-156|Death|0
5694666|NCT00293267|19634840|P1|Extension - Double-Blind Week 49-156|Death|3
5694667|NCT00293267|19634839|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
5694668|NCT00293267|19634840|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
5694669|NCT00293267|19634839|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
5694670|NCT00293267|19634840|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
5694671|NCT00293267|19634839|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
5694672|NCT00293267|19634840|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
5694673|NCT00293267|19634839|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
5694674|NCT00293267|19634840|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
5694675|NCT00293267|19634839|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
5694676|NCT00293267|19634840|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
5694677|NCT00293267|19634839|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
5694678|NCT00293267|19634840|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
5694679|NCT00293267|19634839|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
5694680|NCT00293267|19634840|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
5694681|NCT00293267|19634839|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
5694682|NCT00293267|19634840|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
5694683|NCT00293267|19634839|P2|Primary Study - Double-Blind Week 0-48|Death|3
5694684|NCT00293267|19634840|P1|Primary Study - Double-Blind Week 0-48|Death|3
5694685|NCT00293267|19634839|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
5694686|NCT00293267|19634840|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
5694687|NCT00293267|19634839|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
5694688|NCT00293267|19634840|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
5694689|NCT00293254|19634880|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
5694690|NCT00293254|19634881|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
5694691|NCT00293254|19634880|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
5694692|NCT00293254|19634881|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
5694693|NCT00293254|19634880|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
5694694|NCT00293254|19634881|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
5694695|NCT00293254|19634880|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
5694696|NCT00293254|19634881|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
5694697|NCT00293254|19634880|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
5694698|NCT00293254|19634881|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
5694699|NCT00293254|19634880|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
5694700|NCT00293254|19634881|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
5694701|NCT00293254|19634880|P2|Extension - Open-Label Week 157-240|Other Reason|0
5694702|NCT00293254|19634881|P1|Extension - Open-Label Week 157-240|Other Reason|4
5694703|NCT00293254|19634880|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
5694704|NCT00293254|19634881|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
5694705|NCT00293254|19634880|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
5694706|NCT00293254|19634881|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
5694707|NCT00293254|19634880|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
5694708|NCT00293254|19634881|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
5694709|NCT00293254|19634880|P2|Extension - Open-Label Week 157-240|Adverse Event|1
5694710|NCT00293254|19634881|P1|Extension - Open-Label Week 157-240|Adverse Event|2
5694711|NCT00293254|19634880|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
5694712|NCT00293254|19634881|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
5694713|NCT00293254|19634880|P2|Extension - Double-Blind Week 49-156|Other Reason|2
5694714|NCT00293254|19634881|P1|Extension - Double-Blind Week 49-156|Other Reason|10
5694715|NCT00293254|19634880|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
5694716|NCT00293254|19634881|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
5694717|NCT00293254|19634880|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
5694718|NCT00293254|19634881|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
5694719|NCT00293254|19634880|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
5694720|NCT00293254|19634881|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
5694721|NCT00293254|19634880|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
5694722|NCT00293254|19634881|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
5694723|NCT00293254|19634880|P2|Extension - Double-Blind Week 49-156|Death|1
5694724|NCT00293254|19634881|P1|Extension - Double-Blind Week 49-156|Death|4
5694725|NCT00293254|19634880|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
5694726|NCT00293254|19634881|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
5694727|NCT00293254|19634880|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
5694728|NCT00293254|19634881|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
5694729|NCT00293254|19634880|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
5694730|NCT00293254|19634881|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
5694731|NCT00293254|19634880|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
5694732|NCT00293254|19634881|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
5694733|NCT00293254|19634880|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
5694734|NCT00293254|19634881|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
5694735|NCT00293254|19634880|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
5694736|NCT00293254|19634881|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
5694737|NCT00293254|19634880|P2|Primary Study - Double-Blind Week 0-48|Death|2
5694738|NCT00293254|19634881|P1|Primary Study - Double-Blind Week 0-48|Death|5
5694739|NCT00293254|19634880|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
5694740|NCT00293254|19634881|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
5694741|NCT00293254|19634880|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
5694742|NCT00293254|19634881|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
5694743|NCT00293241|19634921|P2|Overall Study|Withdrawal by Subject|8
5694744|NCT00293241|19634922|P1|Overall Study|Withdrawal by Subject|4
5694745|NCT00293241|19634921|P2|Overall Study|Physician Decision|17
5694746|NCT00293241|19634922|P1|Overall Study|Physician Decision|23
5694747|NCT00293241|19634921|P2|Overall Study|Lost to Follow-up|16
5694748|NCT00293241|19634922|P1|Overall Study|Lost to Follow-up|9
5694749|NCT00293215|19634966|P2|Overall Study|Adverse Event|2
5694750|NCT00293215|19634967|P1|Overall Study|Adverse Event|2
5694751|NCT00293215|19634966|P2|Overall Study|Progressive disease|1
5694752|NCT00293215|19634967|P1|Overall Study|Progressive disease|3
5694753|NCT00293059|19634989|P2|Overall Study|missing|5
5694754|NCT00293059|19634990|P1|Overall Study|missing|3
5694755|NCT00293059|19634989|P2|Overall Study|Noncompliant - sanitary pads collection|1
5694756|NCT00293059|19634990|P1|Overall Study|Noncompliant - sanitary pads collection|0
5694757|NCT00293059|19634989|P2|Overall Study|Participant stopped study drug|0
5694758|NCT00293059|19634990|P1|Overall Study|Participant stopped study drug|1
5694759|NCT00293059|19634989|P2|Overall Study|Participant moved out of state|0
5694760|NCT00293059|19634990|P1|Overall Study|Participant moved out of state|1
5694761|NCT00293059|19634989|P2|Overall Study|Withdrawal by Subject|5
5694762|NCT00293059|19634990|P1|Overall Study|Withdrawal by Subject|11
5694763|NCT00293059|19634989|P2|Overall Study|Protocol Violation|0
5694764|NCT00293059|19634990|P1|Overall Study|Protocol Violation|2
5694765|NCT00293059|19634989|P2|Overall Study|Pregnancy|1
5694766|NCT00293059|19634990|P1|Overall Study|Pregnancy|1
5694767|NCT00293059|19634989|P2|Overall Study|Lost to Follow-up|3
5694768|NCT00293059|19634990|P1|Overall Study|Lost to Follow-up|2
5694769|NCT00293059|19634989|P2|Overall Study|Lack of Efficacy|0
5694770|NCT00293059|19634990|P1|Overall Study|Lack of Efficacy|2
5694771|NCT00293059|19634989|P2|Overall Study|Adverse Event|4
5694772|NCT00293059|19634990|P1|Overall Study|Adverse Event|12
5694773|NCT00293033|19635102|P1|Double-blind Treatment Period|Noncompliance|4
5694774|NCT00293033|19635102|P1|Double-blind Treatment Period|Withdrawal by Subject|4
5694775|NCT00293033|19635102|P1|Double-blind Treatment Period|Lack of Efficacy|1
5694776|NCT00293033|19635102|P1|Double-blind Treatment Period|Adverse Event|3
5694777|NCT00293033|19635102|P1|Open-label Titration Period|Noncompliance and other|27
5694778|NCT00293033|19635102|P1|Open-label Titration Period|Withdrawal by Subject|22
5694779|NCT00293033|19635102|P1|Open-label Titration Period|Protocol Violation|2
5694780|NCT00293033|19635102|P1|Open-label Titration Period|Lack of Efficacy|5
5694781|NCT00293033|19635102|P1|Open-label Titration Period|Death|3
5694782|NCT00293033|19635102|P1|Open-label Titration Period|Adverse Event|10
5694783|NCT00293020|19635205|P1|Overall Study|No dose taken|1
5694784|NCT00293020|19635205|P1|Overall Study|Other Reason|22
5694785|NCT00293020|19635205|P1|Overall Study|Physician Decision|21
5694786|NCT00293020|19635205|P1|Overall Study|Protocol Violation|6
5694787|NCT00293020|19635205|P1|Overall Study|Lost to Follow-up|4
5694788|NCT00293020|19635205|P1|Overall Study|Lack of Efficacy|12
5694789|NCT00293020|19635205|P1|Overall Study|Death|32
5694790|NCT00293020|19635205|P1|Overall Study|Adverse Event|30
5694791|NCT00293020|19635205|P1|Overall Study|Withdrawal by Subject|34
5694792|NCT00292981|19635209|P1|Overall Study|Other|3
5694793|NCT00292981|19635209|P1|Overall Study|Withdrawal by Subject|22
5694794|NCT00292981|19635209|P1|Overall Study|Lost to Follow-up|13
5694795|NCT00292981|19635209|P1|Overall Study|Adverse Event|1
5694796|NCT00292942|19635220|P4|Overall Study|Adverse Event|1
5694797|NCT00292942|19635221|P3|Overall Study|Adverse Event|0
5694798|NCT00292942|19635222|P2|Overall Study|Adverse Event|0
5694799|NCT00292942|19635223|P1|Overall Study|Adverse Event|0
5694800|NCT00292942|19635220|P4|Overall Study|Withdrawal by Subject|0
5694801|NCT00292942|19635221|P3|Overall Study|Withdrawal by Subject|1
5694802|NCT00292942|19635222|P2|Overall Study|Withdrawal by Subject|0
5694803|NCT00292942|19635223|P1|Overall Study|Withdrawal by Subject|0
5694804|NCT00292461|19635269|P2|Overall Study|Lost to Follow-up|0
5694805|NCT00292461|19635270|P1|Overall Study|Lost to Follow-up|1
5694806|NCT00292461|19635269|P2|Overall Study|Protocol Violation|3
5694807|NCT00292461|19635270|P1|Overall Study|Protocol Violation|4
5694808|NCT00292461|19635269|P2|Overall Study|Withdrawal by Subject|1
5694809|NCT00292461|19635270|P1|Overall Study|Withdrawal by Subject|0
5694810|NCT00292461|19635269|P2|Overall Study|Lack of Efficacy|0
5694811|NCT00292461|19635270|P1|Overall Study|Lack of Efficacy|1
5694812|NCT00292461|19635269|P2|Overall Study|Adverse Event|2
5694813|NCT00292461|19635270|P1|Overall Study|Adverse Event|4
5694814|NCT00292370|19635285|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
5694815|NCT00292370|19635286|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
5694816|NCT00292370|19635287|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
5694817|NCT00292370|19635285|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
5694818|NCT00292370|19635286|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
5694819|NCT00292370|19635287|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
5694820|NCT00292370|19635285|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
5694821|NCT00292370|19635286|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
5694822|NCT00292370|19635287|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
5694823|NCT00292370|19635285|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
5694824|NCT00292370|19635286|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
5694825|NCT00292370|19635287|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
5694826|NCT00292370|19635285|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
5694827|NCT00292370|19635286|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
5694828|NCT00292370|19635287|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
5694829|NCT00292370|19635285|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
5694830|NCT00292370|19635286|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
5694831|NCT00292370|19635287|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
5694832|NCT00292318|19635312|P2|Overall Study|Study terminated by officials|1
5694833|NCT00292318|19635313|P1|Overall Study|Study terminated by officials|2
5694834|NCT00292227|19635323|P3|Patch Period|Withdrawal by Subject|1
5694835|NCT00292227|19635324|P2|Patch Period|Withdrawal by Subject|0
5694836|NCT00292227|19635325|P1|Patch Period|Withdrawal by Subject|0
5694837|NCT00292227|19635323|P3|Patch Period|Adverse Event|2
5694838|NCT00292227|19635324|P2|Patch Period|Adverse Event|0
5694839|NCT00292227|19635325|P1|Patch Period|Adverse Event|1
5694840|NCT00292188|19635407|P3|Double-Blind|Laboratory Abnormality|1
5694841|NCT00292188|19635408|P2|Double-Blind|Laboratory Abnormality|0
5694842|NCT00292188|19635409|P1|Double-Blind|Laboratory Abnormality|0
5694843|NCT00292188|19635407|P3|Double-Blind|Withdrawal by Subject|3
5694844|NCT00292188|19635408|P2|Double-Blind|Withdrawal by Subject|0
5694845|NCT00292188|19635409|P1|Double-Blind|Withdrawal by Subject|0
5694846|NCT00292188|19635407|P3|Double-Blind|Other|4
5694847|NCT00292188|19635408|P2|Double-Blind|Other|3
5694848|NCT00292188|19635409|P1|Double-Blind|Other|0
5694849|NCT00292188|19635407|P3|Double-Blind|Lost to Follow-up|0
5694850|NCT00292188|19635408|P2|Double-Blind|Lost to Follow-up|1
5694851|NCT00292188|19635409|P1|Double-Blind|Lost to Follow-up|0
5694852|NCT00292188|19635407|P3|Double-Blind|Lack of Efficacy|12
5694853|NCT00292188|19635408|P2|Double-Blind|Lack of Efficacy|2
5694854|NCT00292188|19635409|P1|Double-Blind|Lack of Efficacy|0
5694855|NCT00292188|19635407|P3|Double-Blind|Adverse Event|9
5694856|NCT00292188|19635408|P2|Double-Blind|Adverse Event|25
5694857|NCT00292188|19635409|P1|Double-Blind|Adverse Event|0
5694858|NCT00292188|19635407|P3|Single-Blind|Did not receive treatment|0
5694859|NCT00292188|19635408|P2|Single-Blind|Did not receive treatment|0
5694860|NCT00292188|19635409|P1|Single-Blind|Did not receive treatment|1
5694861|NCT00292188|19635407|P3|Single-Blind|Withdrawal by Subject|0
5694862|NCT00292188|19635408|P2|Single-Blind|Withdrawal by Subject|0
5694863|NCT00292188|19635409|P1|Single-Blind|Withdrawal by Subject|12
5694864|NCT00292188|19635407|P3|Single-Blind|Other|0
5694865|NCT00292188|19635408|P2|Single-Blind|Other|0
5694866|NCT00292188|19635409|P1|Single-Blind|Other|77
5694867|NCT00292188|19635407|P3|Single-Blind|Lost to Follow-up|0
5694868|NCT00292188|19635408|P2|Single-Blind|Lost to Follow-up|0
5694869|NCT00292188|19635409|P1|Single-Blind|Lost to Follow-up|3
5694870|NCT00292188|19635407|P3|Single-Blind|Laboratory Abnormality|0
5694871|NCT00292188|19635408|P2|Single-Blind|Laboratory Abnormality|0
5694872|NCT00292188|19635409|P1|Single-Blind|Laboratory Abnormality|5
5694873|NCT00292188|19635407|P3|Single-Blind|Lack of Efficacy|0
5694874|NCT00292188|19635408|P2|Single-Blind|Lack of Efficacy|0
5694875|NCT00292188|19635409|P1|Single-Blind|Lack of Efficacy|2
5694876|NCT00292188|19635407|P3|Single-Blind|Adverse Event|0
5694877|NCT00292188|19635408|P2|Single-Blind|Adverse Event|0
5694878|NCT00292188|19635409|P1|Single-Blind|Adverse Event|14
5694879|NCT00291668|19635519|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5694880|NCT00291668|19635520|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
5694881|NCT00291668|19635521|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
5694882|NCT00291668|19635519|P3|Overall Study|AE, non-serious non-fatal|0
5694883|NCT00291668|19635520|P2|Overall Study|AE, non-serious non-fatal|0
5694884|NCT00291668|19635521|P1|Overall Study|AE, non-serious non-fatal|1
5694885|NCT00291668|19635519|P3|Overall Study|SAE, non-fatal|1
5694886|NCT00291668|19635520|P2|Overall Study|SAE, non-fatal|1
5694887|NCT00291668|19635521|P1|Overall Study|SAE, non-fatal|1
5694888|NCT00291668|19635519|P3|Overall Study|Lack of Efficacy|0
5694889|NCT00291668|19635520|P2|Overall Study|Lack of Efficacy|0
5694890|NCT00291668|19635521|P1|Overall Study|Lack of Efficacy|1
5694891|NCT00291642|19635617|P5|Overall Study|Intake of prohibited medication|0
5694892|NCT00291642|19635618|P4|Overall Study|Intake of prohibited medication|0
5694893|NCT00291642|19635619|P3|Overall Study|Intake of prohibited medication|0
5694894|NCT00291642|19635620|P2|Overall Study|Intake of prohibited medication|0
5694895|NCT00291642|19635621|P1|Overall Study|Intake of prohibited medication|1
5694896|NCT00291642|19635617|P5|Overall Study|Patient missed visit|0
5694897|NCT00291642|19635618|P4|Overall Study|Patient missed visit|0
5694898|NCT00291642|19635619|P3|Overall Study|Patient missed visit|1
5694899|NCT00291642|19635620|P2|Overall Study|Patient missed visit|0
5694900|NCT00291642|19635621|P1|Overall Study|Patient missed visit|0
5694901|NCT00291642|19635617|P5|Overall Study|Adverse Event|1
5694902|NCT00291642|19635618|P4|Overall Study|Adverse Event|0
5694903|NCT00291642|19635619|P3|Overall Study|Adverse Event|1
5694904|NCT00291642|19635620|P2|Overall Study|Adverse Event|0
5694905|NCT00291642|19635621|P1|Overall Study|Adverse Event|1
5694906|NCT00291577|19635673|P1|Overall Study|Lack of Efficacy|14
5694907|NCT00291577|19635673|P1|Overall Study|Withdrawal by Subject|2
5694908|NCT00291577|19635673|P1|Overall Study|Other|4
5694909|NCT00291577|19635673|P1|Overall Study|Adverse Event|1
5694910|NCT00291551|19635692|P1|Overall Study|Withdrawal by Subject|6
5694911|NCT00291551|19635692|P1|Overall Study|Death|7
5694912|NCT00291330|19635740|P2|Overall Study|Other|1
5694913|NCT00291330|19635741|P1|Overall Study|Other|3
5694914|NCT00291330|19635740|P2|Overall Study|Withdrawal by Subject|25
5694915|NCT00291330|19635741|P1|Overall Study|Withdrawal by Subject|22
5694916|NCT00291330|19635740|P2|Overall Study|Lost to Follow-up|11
5694917|NCT00291330|19635741|P1|Overall Study|Lost to Follow-up|16
5694918|NCT00291330|19635740|P2|Overall Study|Protocol Violation|20
5694919|NCT00291330|19635741|P1|Overall Study|Protocol Violation|13
5694920|NCT00291330|19635740|P2|Overall Study|Adverse Event|40
5694921|NCT00291330|19635741|P1|Overall Study|Adverse Event|47
5694922|NCT00291187|19635783|P4|Overall Study|Protocol Violation- No Drug Administered|0
5694923|NCT00291187|19635784|P3|Overall Study|Protocol Violation- No Drug Administered|1
5694924|NCT00291187|19635785|P2|Overall Study|Protocol Violation- No Drug Administered|0
5694925|NCT00291187|19635786|P1|Overall Study|Protocol Violation- No Drug Administered|0
5694926|NCT00291018|19635830|P3|Overall Study|Lost to Follow-up|18
5694927|NCT00291018|19635831|P2|Overall Study|Lost to Follow-up|4
5694928|NCT00291018|19635832|P1|Overall Study|Lost to Follow-up|3
5694929|NCT00291018|19635830|P3|Overall Study|Failures|5
5694930|NCT00291018|19635831|P2|Overall Study|Failures|12
5694931|NCT00291018|19635832|P1|Overall Study|Failures|5
5694932|NCT00291018|19635830|P3|Overall Study|Withdrawal by Subject|1
5694933|NCT00291018|19635831|P2|Overall Study|Withdrawal by Subject|8
5694934|NCT00291018|19635832|P1|Overall Study|Withdrawal by Subject|2
5694935|NCT00291018|19635830|P3|Overall Study|Death|4
5694936|NCT00291018|19635831|P2|Overall Study|Death|3
5694937|NCT00291018|19635832|P1|Overall Study|Death|3
5694938|NCT00291018|19635830|P3|Overall Study|Not Consented or Declined PAS|15
5694939|NCT00291018|19635831|P2|Overall Study|Not Consented or Declined PAS|15
5694940|NCT00291018|19635832|P1|Overall Study|Not Consented or Declined PAS|12
5694941|NCT00290888|19635872|P2|Overall Study|Physician Decision|1
5694942|NCT00290888|19635873|P1|Overall Study|Physician Decision|3
5694943|NCT00290771|19635890|P2|Overall Study|Lost to Follow-up|1
5694944|NCT00290771|19635891|P1|Overall Study|Lost to Follow-up|0
5694945|NCT00290771|19635890|P2|Overall Study|Protocol Violation|0
5694946|NCT00290771|19635891|P1|Overall Study|Protocol Violation|2
5694947|NCT00290771|19635890|P2|Overall Study|Administrative problems|1
5694948|NCT00290771|19635891|P1|Overall Study|Administrative problems|2
5694949|NCT00290771|19635890|P2|Overall Study|Withdrawal by Subject|6
5694950|NCT00290771|19635891|P1|Overall Study|Withdrawal by Subject|5
5694951|NCT00290771|19635890|P2|Overall Study|Adverse Event|6
5694952|NCT00290771|19635891|P1|Overall Study|Adverse Event|12
5694953|NCT00290771|19635890|P2|Overall Study|Death|10
5694954|NCT00290771|19635891|P1|Overall Study|Death|11
5694955|NCT00290771|19635890|P2|Overall Study|Disease progression|73
5694956|NCT00290771|19635891|P1|Overall Study|Disease progression|95
5694957|NCT00290758|19635915|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
5694958|NCT00290758|19635916|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
5694959|NCT00290758|19635915|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
5694960|NCT00290758|19635916|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
5694961|NCT00290758|19635915|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
5694962|NCT00290758|19635916|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
5694963|NCT00290758|19635915|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
5694964|NCT00290758|19635916|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
5694965|NCT00290758|19635915|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
5694966|NCT00290758|19635916|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
5694967|NCT00290758|19635915|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
5694968|NCT00290758|19635916|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
5694969|NCT00290758|19635915|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
5694970|NCT00290758|19635916|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
5694971|NCT00290758|19635915|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
5694972|NCT00290758|19635916|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
5694973|NCT00290745|19635936|P1|Overall Study|Baseline MRI not available|3
5694974|NCT00290745|19635936|P1|Overall Study|Surgery after 3 months for progression|3
5694975|NCT00290745|19635936|P1|Overall Study|Physician Decision|2
5694976|NCT00290745|19635936|P1|Overall Study|Withdrawal by Subject|4
5694977|NCT00290732|19635950|P5|Overall Study|Inability to instill drug intraductally.|0
5694978|NCT00290732|19635951|P4|Overall Study|Inability to instill drug intraductally.|0
5694979|NCT00290732|19635952|P3|Overall Study|Inability to instill drug intraductally.|1
5694980|NCT00290732|19635953|P2|Overall Study|Inability to instill drug intraductally.|1
5694981|NCT00290732|19635954|P1|Overall Study|Inability to instill drug intraductally.|0
5694982|NCT00290706|19635976|P4|Overall Study|Physician Decision|1
5694983|NCT00290706|19635977|P3|Overall Study|Physician Decision|0
5694984|NCT00290706|19635978|P2|Overall Study|Physician Decision|0
5694985|NCT00290706|19635979|P1|Overall Study|Physician Decision|0
5694986|NCT00290706|19635976|P4|Overall Study|Receive auto transplant or radiation|1
5694987|NCT00290706|19635977|P3|Overall Study|Receive auto transplant or radiation|0
5694988|NCT00290706|19635978|P2|Overall Study|Receive auto transplant or radiation|0
5694989|NCT00290706|19635979|P1|Overall Study|Receive auto transplant or radiation|0
5694990|NCT00290706|19635976|P4|Overall Study|Adverse Event|0
5694991|NCT00290706|19635977|P3|Overall Study|Adverse Event|2
5694992|NCT00290706|19635978|P2|Overall Study|Adverse Event|1
5694993|NCT00290706|19635979|P1|Overall Study|Adverse Event|0
5694994|NCT00290706|19635976|P4|Overall Study|Progressive Disease|10
5694995|NCT00290706|19635977|P3|Overall Study|Progressive Disease|4
5694996|NCT00290706|19635978|P2|Overall Study|Progressive Disease|5
5694997|NCT00290706|19635979|P1|Overall Study|Progressive Disease|3
5694998|NCT00290706|19635976|P4|Overall Study|Withdrawal by Subject|0
5694999|NCT00290706|19635977|P3|Overall Study|Withdrawal by Subject|0
5695000|NCT00290706|19635978|P2|Overall Study|Withdrawal by Subject|0
5695001|NCT00290706|19635979|P1|Overall Study|Withdrawal by Subject|2
5695002|NCT00290693|19635998|P1|Overall Study|Withdrawal by Subject|2
5695003|NCT00290589|19636026|P2|Overall Study|Lost to Follow-up|2
5695004|NCT00290589|19636027|P1|Overall Study|Lost to Follow-up|2
5695005|NCT00290498|19636045|P2|Overall Study|Non-Compliance|0
5695006|NCT00290498|19636046|P1|Overall Study|Non-Compliance|1
5695007|NCT00290498|19636045|P2|Overall Study|Ineligible|0
5695008|NCT00290498|19636046|P1|Overall Study|Ineligible|3
5695009|NCT00290498|19636045|P2|Overall Study|Withdrawal by Subject|0
5695010|NCT00290498|19636046|P1|Overall Study|Withdrawal by Subject|1
5695011|NCT00290498|19636045|P2|Overall Study|Physician Decision|0
5695012|NCT00290498|19636046|P1|Overall Study|Physician Decision|1
5695013|NCT00290498|19636045|P2|Overall Study|Death|0
5695014|NCT00290498|19636046|P1|Overall Study|Death|2
5695015|NCT00290433|19636071|P1|Overall Study|Unrelated Infection/Death|1
5695016|NCT00290433|19636071|P1|Overall Study|Transplant in CR|5
5695017|NCT00290433|19636071|P1|Overall Study|Congestive Heart Failure|1
5695018|NCT00290433|19636071|P1|Overall Study|Non-Compliance|1
5695019|NCT00290433|19636071|P1|Overall Study|Withdrawal by Subject|1
5695020|NCT00290433|19636071|P1|Overall Study|Adverse Event|14
5695021|NCT00290433|19636071|P1|Overall Study|Disease Progression|13
5695022|NCT00290407|19636075|P1|Overall Study|Physician Decision|2
5695023|NCT00290355|19636082|P2|Overall Study|Other|0
5695024|NCT00290355|19636083|P1|Overall Study|Other|2
5695025|NCT00290355|19636082|P2|Overall Study|Lost to Follow-up|1
5695026|NCT00290355|19636083|P1|Overall Study|Lost to Follow-up|3
5695027|NCT00290355|19636082|P2|Overall Study|Migrated / moved from the study area|0
5695028|NCT00290355|19636083|P1|Overall Study|Migrated / moved from the study area|1
5695029|NCT00290355|19636082|P2|Overall Study|Withdrawal by Subject|0
5695030|NCT00290355|19636083|P1|Overall Study|Withdrawal by Subject|2
5695031|NCT00290355|19636082|P2|Overall Study|Protocol Violation|0
5695032|NCT00290355|19636083|P1|Overall Study|Protocol Violation|1
5695033|NCT00290355|19636082|P2|Overall Study|Study product reactogenicity|0
5695034|NCT00290355|19636083|P1|Overall Study|Study product reactogenicity|1
5695035|NCT00290355|19636082|P2|Overall Study|Serious adverse event|4
5695036|NCT00290355|19636083|P1|Overall Study|Serious adverse event|7
5695037|NCT00290342|19636127|P2|Overall Study|Lost to Follow-up|0
5695038|NCT00290342|19636128|P1|Overall Study|Lost to Follow-up|1
5695039|NCT00290342|19636127|P2|Overall Study|Withdrawal by Subject|4
5695040|NCT00290342|19636128|P1|Overall Study|Withdrawal by Subject|6
5695041|NCT00290342|19636127|P2|Overall Study|Other|1
5695042|NCT00290342|19636128|P1|Overall Study|Other|0
5695043|NCT00290290|19636183|P2|Overall Study|Underwent clean surgical procedure|12
5695044|NCT00290290|19636184|P1|Overall Study|Underwent clean surgical procedure|13
5695045|NCT00290290|19636183|P2|Overall Study|Withdrawal by Subject|2
5695046|NCT00290290|19636184|P1|Overall Study|Withdrawal by Subject|2
5695047|NCT00290290|19636183|P2|Overall Study|Death|4
5695048|NCT00290290|19636184|P1|Overall Study|Death|3
5695049|NCT00290251|19636190|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
5695050|NCT00290251|19636191|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
5695051|NCT00290251|19636192|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
5695052|NCT00290251|19636190|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
5695053|NCT00290251|19636191|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
5695054|NCT00290251|19636192|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
5695055|NCT00290251|19636190|P3|Treatment 1 (Months 1 - 3)|headache|0
5695056|NCT00290251|19636191|P2|Treatment 1 (Months 1 - 3)|headache|1
5695057|NCT00290251|19636192|P1|Treatment 1 (Months 1 - 3)|headache|0
5695058|NCT00290251|19636190|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
5695059|NCT00290251|19636191|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
5695060|NCT00290251|19636192|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
5695061|NCT00290238|19636204|P2|Overall Study|Withdrawal by Subject|13
5695062|NCT00290238|19636205|P1|Overall Study|Withdrawal by Subject|15
5695063|NCT00290238|19636204|P2|Overall Study|Lost to Follow-up|1
5695064|NCT00290238|19636205|P1|Overall Study|Lost to Follow-up|0
5695065|NCT00290238|19636204|P2|Overall Study|Study terminated|27
5695066|NCT00290238|19636205|P1|Overall Study|Study terminated|27
5695067|NCT00290186|19636230|P2|Overall Study|Withdrawal by Subject|1
5695068|NCT00290186|19636231|P1|Overall Study|Withdrawal by Subject|0
5695069|NCT00290186|19636230|P2|Overall Study|Study was terminated prior to 3-month te|1
5695070|NCT00290186|19636231|P1|Overall Study|Study was terminated prior to 3-month te|1
5695071|NCT00290186|19636230|P2|Overall Study|Lost to Follow-up|2
5695072|NCT00290186|19636231|P1|Overall Study|Lost to Follow-up|3
5695073|NCT00290186|19636230|P2|Overall Study|Adverse Event|1
5695074|NCT00290186|19636231|P1|Overall Study|Adverse Event|1
5695075|NCT00289991|19636282|P2|Overall Study|Other|14
5695076|NCT00289991|19636283|P1|Overall Study|Other|5
5695077|NCT00289991|19636282|P2|Overall Study|Withdrawal by Subject|12
5695078|NCT00289991|19636283|P1|Overall Study|Withdrawal by Subject|2
5695079|NCT00289991|19636282|P2|Overall Study|Lost to Follow-up|1
5695080|NCT00289991|19636283|P1|Overall Study|Lost to Follow-up|0
5695081|NCT00289991|19636282|P2|Overall Study|Fungal breakthrough infection|1
5695082|NCT00289991|19636283|P1|Overall Study|Fungal breakthrough infection|0
5695083|NCT00289991|19636282|P2|Overall Study|Failure of prophylaxis|1
5695084|NCT00289991|19636283|P1|Overall Study|Failure of prophylaxis|1
5695085|NCT00289991|19636282|P2|Overall Study|Adverse Event|13
5695086|NCT00289991|19636283|P1|Overall Study|Adverse Event|15
5695087|NCT00289991|19636282|P2|Overall Study|Death|38
5695088|NCT00289991|19636283|P1|Overall Study|Death|35
5695089|NCT00289978|19636308|P3|Overall Study|Death|2
5695090|NCT00289978|19636309|P2|Overall Study|Death|0
5695091|NCT00289978|19636310|P1|Overall Study|Death|1
5695092|NCT00289978|19636308|P3|Overall Study|Abnormal test procedure result(s)|1
5695093|NCT00289978|19636309|P2|Overall Study|Abnormal test procedure result(s)|1
5695094|NCT00289978|19636310|P1|Overall Study|Abnormal test procedure result(s)|2
5695095|NCT00289978|19636308|P3|Overall Study|Protocol Violation|4
5695096|NCT00289978|19636309|P2|Overall Study|Protocol Violation|5
5695097|NCT00289978|19636310|P1|Overall Study|Protocol Violation|5
5695098|NCT00289978|19636308|P3|Overall Study|Lost to Follow-up|7
5695099|NCT00289978|19636309|P2|Overall Study|Lost to Follow-up|5
5695100|NCT00289978|19636310|P1|Overall Study|Lost to Follow-up|3
5695101|NCT00289978|19636308|P3|Overall Study|Abnormal laboratory value(s)|1
5695102|NCT00289978|19636309|P2|Overall Study|Abnormal laboratory value(s)|9
5695103|NCT00289978|19636310|P1|Overall Study|Abnormal laboratory value(s)|20
5695104|NCT00289978|19636308|P3|Overall Study|Lack of Efficacy|25
5695105|NCT00289978|19636309|P2|Overall Study|Lack of Efficacy|6
5695106|NCT00289978|19636310|P1|Overall Study|Lack of Efficacy|13
5695107|NCT00289978|19636308|P3|Overall Study|Adverse Event|18
5695108|NCT00289978|19636309|P2|Overall Study|Adverse Event|13
5695109|NCT00289978|19636310|P1|Overall Study|Adverse Event|22
5695110|NCT00289978|19636308|P3|Overall Study|Withdrawal by Subject|28
5695111|NCT00289978|19636309|P2|Overall Study|Withdrawal by Subject|17
5695112|NCT00289978|19636310|P1|Overall Study|Withdrawal by Subject|31
5695113|NCT00289913|19636329|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
5695114|NCT00289913|19636330|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
5695115|NCT00289913|19636331|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
5695116|NCT00289913|19636332|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
5695117|NCT00289913|19636333|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
5695118|NCT00289913|19636329|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
5695119|NCT00289913|19636330|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
5695120|NCT00289913|19636331|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
5695121|NCT00289913|19636332|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
5695122|NCT00289913|19636333|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
5695123|NCT00289913|19636329|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5695124|NCT00289913|19636330|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5695125|NCT00289913|19636331|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
5695126|NCT00289913|19636332|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
5695127|NCT00289913|19636333|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5695128|NCT00289913|19636329|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
5695129|NCT00289913|19636330|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
5695130|NCT00289913|19636331|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
5695131|NCT00289913|19636332|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
5695132|NCT00289913|19636333|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
5695133|NCT00289913|19636329|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
5695134|NCT00289913|19636330|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
5695135|NCT00289913|19636331|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
5695136|NCT00289913|19636332|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
5695137|NCT00289913|19636333|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
5695138|NCT00289913|19636329|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5695139|NCT00289913|19636330|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
5695140|NCT00289913|19636331|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5695141|NCT00289913|19636332|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5695142|NCT00289913|19636333|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5695143|NCT00289913|19636329|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
5695144|NCT00289913|19636330|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
5695145|NCT00289913|19636331|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
5695146|NCT00289913|19636332|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
5695147|NCT00289913|19636333|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
5695148|NCT00289913|19636329|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695149|NCT00289913|19636330|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695150|NCT00289913|19636331|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695151|NCT00289913|19636332|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
5695152|NCT00289913|19636333|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695153|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
5695154|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
5695155|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
5695156|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
5695157|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
5695158|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
5695159|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
5695160|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
5695161|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
5695162|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
5695163|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
5695164|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
5695165|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
5695166|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
5695167|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
5695168|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
5695169|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
5695170|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
5695171|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
5695172|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
5695173|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
5695174|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
5695175|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
5695176|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
5695177|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
5695178|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
5695179|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
5695180|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
5695181|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
5695182|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
5695183|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
5695184|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
5695185|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
5695186|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
5695187|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
5695188|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
5695189|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
5695190|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
5695191|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
5695192|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
5695193|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5695194|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
5695195|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
5695196|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
5695197|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5695198|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
5695199|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
5695200|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
5695201|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
5695202|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
5695203|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5695204|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5695205|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
5695206|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5695207|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
5695208|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
5695209|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
5695210|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
5695211|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
5695212|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
5695213|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
5695214|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
5695215|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
5695216|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
5695217|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
5695218|NCT00289913|19636329|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695219|NCT00289913|19636330|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695220|NCT00289913|19636331|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
5695221|NCT00289913|19636332|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695222|NCT00289913|19636333|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695223|NCT00289913|19636329|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
5695224|NCT00289913|19636330|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
5695225|NCT00289913|19636331|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
5695226|NCT00289913|19636332|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
5695227|NCT00289913|19636333|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
5695228|NCT00289913|19636329|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5695229|NCT00289913|19636330|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
5695230|NCT00289913|19636331|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
5695231|NCT00289913|19636332|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
5695232|NCT00289913|19636333|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
5695233|NCT00289913|19636329|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
5695234|NCT00289913|19636330|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
5695235|NCT00289913|19636331|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
5695236|NCT00289913|19636332|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
5695237|NCT00289913|19636333|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
5695238|NCT00289913|19636329|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5695239|NCT00289913|19636330|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5695240|NCT00289913|19636331|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
5695241|NCT00289913|19636332|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
5695242|NCT00289913|19636333|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
5695243|NCT00289913|19636329|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
5695244|NCT00289913|19636330|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
5695245|NCT00289913|19636331|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
5695246|NCT00289913|19636332|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
5695247|NCT00289913|19636333|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
5695248|NCT00289913|19636329|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
5695249|NCT00289913|19636330|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
5695250|NCT00289913|19636331|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
5695251|NCT00289913|19636332|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
5695252|NCT00289913|19636333|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
5695253|NCT00289913|19636329|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5695254|NCT00289913|19636330|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5695255|NCT00289913|19636331|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
5695256|NCT00289913|19636332|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5695257|NCT00289913|19636333|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
5695258|NCT00289913|19636329|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
5695259|NCT00289913|19636330|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
5695260|NCT00289913|19636331|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
5695261|NCT00289913|19636332|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
5695262|NCT00289913|19636333|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
5695263|NCT00289913|19636329|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695264|NCT00289913|19636330|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695265|NCT00289913|19636331|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695266|NCT00289913|19636332|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
5695267|NCT00289913|19636333|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
5695268|NCT00289900|19636364|P6|Overall Study|Not treated|0
5695269|NCT00289900|19636365|P5|Overall Study|Not treated|0
5695270|NCT00289900|19636366|P4|Overall Study|Not treated|0
5695271|NCT00289900|19636367|P3|Overall Study|Not treated|0
5695272|NCT00289900|19636368|P2|Overall Study|Not treated|1
5695273|NCT00289900|19636369|P1|Overall Study|Not treated|0
5695274|NCT00289900|19636364|P6|Overall Study|site terminated|0
5695275|NCT00289900|19636365|P5|Overall Study|site terminated|0
5695276|NCT00289900|19636366|P4|Overall Study|site terminated|0
5695277|NCT00289900|19636367|P3|Overall Study|site terminated|1
5695278|NCT00289900|19636368|P2|Overall Study|site terminated|0
5695279|NCT00289900|19636369|P1|Overall Study|site terminated|1
5695280|NCT00289900|19636364|P6|Overall Study|Protocol Violation|4
5695281|NCT00289900|19636365|P5|Overall Study|Protocol Violation|7
5695282|NCT00289900|19636366|P4|Overall Study|Protocol Violation|6
5695283|NCT00289900|19636367|P3|Overall Study|Protocol Violation|2
5695284|NCT00289900|19636368|P2|Overall Study|Protocol Violation|9
5695285|NCT00289900|19636369|P1|Overall Study|Protocol Violation|3
5695286|NCT00289900|19636364|P6|Overall Study|Withdrawal by Subject|11
5695287|NCT00289900|19636365|P5|Overall Study|Withdrawal by Subject|12
5695288|NCT00289900|19636366|P4|Overall Study|Withdrawal by Subject|18
5695289|NCT00289900|19636367|P3|Overall Study|Withdrawal by Subject|8
5695290|NCT00289900|19636368|P2|Overall Study|Withdrawal by Subject|21
5695291|NCT00289900|19636369|P1|Overall Study|Withdrawal by Subject|10
5695292|NCT00289900|19636364|P6|Overall Study|Participant moved|1
5695293|NCT00289900|19636365|P5|Overall Study|Participant moved|1
5695294|NCT00289900|19636366|P4|Overall Study|Participant moved|1
5695295|NCT00289900|19636367|P3|Overall Study|Participant moved|0
5695296|NCT00289900|19636368|P2|Overall Study|Participant moved|0
5695297|NCT00289900|19636369|P1|Overall Study|Participant moved|1
5695298|NCT00289900|19636364|P6|Overall Study|Other|0
5695299|NCT00289900|19636365|P5|Overall Study|Other|1
5695300|NCT00289900|19636366|P4|Overall Study|Other|5
5695301|NCT00289900|19636367|P3|Overall Study|Other|0
5695302|NCT00289900|19636368|P2|Overall Study|Other|0
5695303|NCT00289900|19636369|P1|Overall Study|Other|0
5695304|NCT00289900|19636364|P6|Overall Study|Participant had flushing|4
5695305|NCT00289900|19636365|P5|Overall Study|Participant had flushing|0
5695306|NCT00289900|19636366|P4|Overall Study|Participant had flushing|2
5695307|NCT00289900|19636367|P3|Overall Study|Participant had flushing|1
5695308|NCT00289900|19636368|P2|Overall Study|Participant had flushing|42
5695309|NCT00289900|19636369|P1|Overall Study|Participant had flushing|18
5695310|NCT00289900|19636364|P6|Overall Study|Lost to Follow-up|8
5695311|NCT00289900|19636365|P5|Overall Study|Lost to Follow-up|4
5695312|NCT00289900|19636366|P4|Overall Study|Lost to Follow-up|8
5695313|NCT00289900|19636367|P3|Overall Study|Lost to Follow-up|8
5695314|NCT00289900|19636368|P2|Overall Study|Lost to Follow-up|7
5695315|NCT00289900|19636369|P1|Overall Study|Lost to Follow-up|7
5695316|NCT00289900|19636364|P6|Overall Study|Adverse Event|33
5695317|NCT00289900|19636365|P5|Overall Study|Adverse Event|20
5695318|NCT00289900|19636366|P4|Overall Study|Adverse Event|19
5695319|NCT00289900|19636367|P3|Overall Study|Adverse Event|13
5695320|NCT00289900|19636368|P2|Overall Study|Adverse Event|40
5695321|NCT00289900|19636369|P1|Overall Study|Adverse Event|28
5695322|NCT00289887|19636473|P2|Overall Study|Other|3
5695323|NCT00289887|19636474|P1|Overall Study|Other|7
5695324|NCT00289887|19636473|P2|Overall Study|Withdrawal by Subject|8
5695325|NCT00289887|19636474|P1|Overall Study|Withdrawal by Subject|3
5695326|NCT00289887|19636473|P2|Overall Study|Protocol Violation|1
5695327|NCT00289887|19636474|P1|Overall Study|Protocol Violation|3
5695328|NCT00289887|19636473|P2|Overall Study|Lost to Follow-up|3
5695329|NCT00289887|19636474|P1|Overall Study|Lost to Follow-up|3
5695330|NCT00289887|19636473|P2|Overall Study|Lack of Efficacy|11
5695331|NCT00289887|19636474|P1|Overall Study|Lack of Efficacy|3
5695332|NCT00289887|19636473|P2|Overall Study|Adverse Event|3
5695333|NCT00289887|19636474|P1|Overall Study|Adverse Event|3
5695334|NCT00289874|19636492|P2|Overall Study|Did not meet eligibility|0
5695335|NCT00289874|19636493|P1|Overall Study|Did not meet eligibility|1
5695336|NCT00289874|19636492|P2|Overall Study|Protocol Violation|2
5695337|NCT00289874|19636493|P1|Overall Study|Protocol Violation|3
5695338|NCT00289874|19636492|P2|Overall Study|Lost to Follow-up|1
5695339|NCT00289874|19636493|P1|Overall Study|Lost to Follow-up|1
5695340|NCT00289874|19636492|P2|Overall Study|Adverse Event|5
5695341|NCT00289874|19636493|P1|Overall Study|Adverse Event|1
5695342|NCT00289848|19636503|P2|Overall Study|Open-Label AHA Treatment Requested|1
5695343|NCT00289848|19636504|P1|Overall Study|Open-Label AHA Treatment Requested|0
5695344|NCT00289848|19636503|P2|Overall Study|Patient Moved|2
5695345|NCT00289848|19636504|P1|Overall Study|Patient Moved|6
5695346|NCT00289848|19636503|P2|Overall Study|Withdrawal by Subject|11
5695347|NCT00289848|19636504|P1|Overall Study|Withdrawal by Subject|5
5695348|NCT00289848|19636503|P2|Overall Study|Protocol Violation|2
5695349|NCT00289848|19636504|P1|Overall Study|Protocol Violation|5
5695350|NCT00289848|19636503|P2|Overall Study|Lost to Follow-up|1
5695351|NCT00289848|19636504|P1|Overall Study|Lost to Follow-up|3
5695352|NCT00289848|19636503|P2|Overall Study|Lack of Efficacy|24
5695353|NCT00289848|19636504|P1|Overall Study|Lack of Efficacy|20
5695354|NCT00289848|19636503|P2|Overall Study|Death|0
5695355|NCT00289848|19636504|P1|Overall Study|Death|1
5695356|NCT00289848|19636503|P2|Overall Study|Adverse Event|4
5695357|NCT00289848|19636504|P1|Overall Study|Adverse Event|6
5695358|NCT00289783|19636516|P2|Fourth Dose Phase|Other|10
5695359|NCT00289783|19636517|P1|Fourth Dose Phase|Other|22
5695360|NCT00289783|19636516|P2|Fourth Dose Phase|Migration from the study area|1
5695361|NCT00289783|19636517|P1|Fourth Dose Phase|Migration from the study area|1
5695362|NCT00289783|19636516|P2|Fourth Dose Phase|Lost to Follow-up|12
5695363|NCT00289783|19636517|P1|Fourth Dose Phase|Lost to Follow-up|53
5695364|NCT00289783|19636516|P2|Fourth Dose Phase|Withdrawal by Subject|1
5695365|NCT00289783|19636517|P1|Fourth Dose Phase|Withdrawal by Subject|10
5695366|NCT00289783|19636516|P2|Fourth Dose Phase|Adverse Event|0
5695367|NCT00289783|19636517|P1|Fourth Dose Phase|Adverse Event|1
5695368|NCT00289783|19636516|P2|Primary Phase|Other|12
5695369|NCT00289783|19636517|P1|Primary Phase|Other|32
5695370|NCT00289783|19636516|P2|Primary Phase|Migration from the study area|10
5695371|NCT00289783|19636517|P1|Primary Phase|Migration from the study area|26
5695372|NCT00289783|19636516|P2|Primary Phase|Lost to Follow-up|14
5695373|NCT00289783|19636517|P1|Primary Phase|Lost to Follow-up|60
5695374|NCT00289783|19636516|P2|Primary Phase|Withdrawal by Subject|40
5695375|NCT00289783|19636517|P1|Primary Phase|Withdrawal by Subject|93
5695376|NCT00289783|19636516|P2|Primary Phase|Protocol Violation|6
5695377|NCT00289783|19636517|P1|Primary Phase|Protocol Violation|27
5695378|NCT00289783|19636516|P2|Primary Phase|Adverse Event|1
5695379|NCT00289783|19636517|P1|Primary Phase|Adverse Event|10
5695380|NCT00289770|19636695|P1|Year 15|Withdrawal by Subject|1
5695381|NCT00289731|19636741|P3|Overall Study|Other|0
5695382|NCT00289731|19636742|P2|Overall Study|Other|0
5695383|NCT00289731|19636743|P1|Overall Study|Other|1
5695384|NCT00289731|19636741|P3|Overall Study|Adverse Event|2
5695385|NCT00289731|19636742|P2|Overall Study|Adverse Event|2
5695386|NCT00289731|19636743|P1|Overall Study|Adverse Event|1
5695387|NCT00289536|19636855|P3|Period 3|Lost to Follow-up|1
5695388|NCT00289536|19636856|P2|Period 3|Lost to Follow-up|0
5695389|NCT00289536|19636857|P1|Period 3|Lost to Follow-up|0
5695390|NCT00289458|19636903|P3|Overall Study|Withdrawal by Subject|4
5695391|NCT00289458|19636904|P2|Overall Study|Withdrawal by Subject|2
5695392|NCT00289458|19636905|P1|Overall Study|Withdrawal by Subject|2
5695393|NCT00289458|19636903|P3|Overall Study|Physician Decision|2
5695394|NCT00289458|19636904|P2|Overall Study|Physician Decision|4
5695395|NCT00289458|19636905|P1|Overall Study|Physician Decision|3
5695396|NCT00289458|19636903|P3|Overall Study|Death|0
5695397|NCT00289458|19636904|P2|Overall Study|Death|0
5695398|NCT00289458|19636905|P1|Overall Study|Death|1
5695399|NCT00289289|19636966|P3|Overall Study|Other Exit Reason|12
5695400|NCT00289289|19636967|P2|Overall Study|Other Exit Reason|4
5695401|NCT00289289|19636968|P1|Overall Study|Other Exit Reason|6
5695402|NCT00289289|19636966|P3|Overall Study|Did not meet inclusion/exclusion|6
5695403|NCT00289289|19636967|P2|Overall Study|Did not meet inclusion/exclusion|0
5695404|NCT00289289|19636968|P1|Overall Study|Did not meet inclusion/exclusion|0
5695405|NCT00289289|19636966|P3|Overall Study|Non-study device implanted|3
5695406|NCT00289289|19636967|P2|Overall Study|Non-study device implanted|1
5695407|NCT00289289|19636968|P1|Overall Study|Non-study device implanted|2
5695408|NCT00289289|19636966|P3|Overall Study|Physician Decision|6
5695409|NCT00289289|19636967|P2|Overall Study|Physician Decision|0
5695410|NCT00289289|19636968|P1|Overall Study|Physician Decision|1
5695411|NCT00289289|19636966|P3|Overall Study|No implant attempted|1
5695412|NCT00289289|19636967|P2|Overall Study|No implant attempted|0
5695413|NCT00289289|19636968|P1|Overall Study|No implant attempted|0
5695414|NCT00289289|19636966|P3|Overall Study|Death|5
5695415|NCT00289289|19636967|P2|Overall Study|Death|2
5695416|NCT00289289|19636968|P1|Overall Study|Death|4
5695417|NCT00289289|19636966|P3|Overall Study|Lost to Follow-up|1
5695418|NCT00289289|19636967|P2|Overall Study|Lost to Follow-up|0
5695419|NCT00289289|19636968|P1|Overall Study|Lost to Follow-up|1
5695420|NCT00289289|19636966|P3|Overall Study|Withdrawal by Subject|15
5695421|NCT00289289|19636967|P2|Overall Study|Withdrawal by Subject|3
5695422|NCT00289289|19636968|P1|Overall Study|Withdrawal by Subject|5
5695423|NCT00289276|19636983|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
5695424|NCT00289276|19636984|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
5695425|NCT00289276|19636983|P2|Second Part of FAST Study (Expansion)|Death|2
5695426|NCT00289276|19636984|P1|Second Part of FAST Study (Expansion)|Death|0
5695427|NCT00289198|19637019|P2|Overall Study|Other: Impossible to come on visit|1
5695428|NCT00289198|19637020|P1|Overall Study|Other: Impossible to come on visit|0
5695429|NCT00289198|19637019|P2|Overall Study|Other: Miscalculation of the visit date|22
5695430|NCT00289198|19637020|P1|Overall Study|Other: Miscalculation of the visit date|21
5695431|NCT00289198|19637019|P2|Overall Study|Other: Unable to attend on schedule|1
5695432|NCT00289198|19637020|P1|Overall Study|Other: Unable to attend on schedule|2
5695433|NCT00289198|19637019|P2|Overall Study|Other: Physician's decision|1
5695434|NCT00289198|19637020|P1|Overall Study|Other: Physician's decision|0
5695435|NCT00289198|19637019|P2|Overall Study|Other: Low compliance|1
5695436|NCT00289198|19637020|P1|Overall Study|Other: Low compliance|0
5695437|NCT00289198|19637019|P2|Overall Study|Lack of Efficacy|0
5695438|NCT00289198|19637020|P1|Overall Study|Lack of Efficacy|2
5695439|NCT00289198|19637019|P2|Overall Study|Withdrawal by Subject|1
5695440|NCT00289198|19637020|P1|Overall Study|Withdrawal by Subject|4
5695441|NCT00289198|19637019|P2|Overall Study|Protocol Violation|1
5695442|NCT00289198|19637020|P1|Overall Study|Protocol Violation|2
5695443|NCT00289198|19637019|P2|Overall Study|Adverse Event|2
5695444|NCT00289198|19637020|P1|Overall Study|Adverse Event|0
5695445|NCT00289185|19637070|P2|Overall Study|Death|1
5695446|NCT00289185|19637071|P1|Overall Study|Death|1
5695447|NCT00289185|19637070|P2|Overall Study|Lost to Follow-up|17
5695448|NCT00289185|19637071|P1|Overall Study|Lost to Follow-up|23
5695449|NCT00289185|19637070|P2|Overall Study|Withdrawal by Subject|8
5695450|NCT00289185|19637071|P1|Overall Study|Withdrawal by Subject|4
5695451|NCT00289133|19637118|P2|Overall Study|Lost to Follow-up|115
5695452|NCT00289133|19637119|P1|Overall Study|Lost to Follow-up|92
5695453|NCT00289133|19637118|P2|Overall Study|Revision|6
5695454|NCT00289133|19637119|P1|Overall Study|Revision|8
5695455|NCT00289133|19637118|P2|Overall Study|Physician Decision|45
5695456|NCT00289133|19637119|P1|Overall Study|Physician Decision|41
5695457|NCT00289133|19637118|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
5695458|NCT00289133|19637119|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
5695459|NCT00289133|19637118|P2|Overall Study|Death|10
5695460|NCT00289133|19637119|P1|Overall Study|Death|5
5695461|NCT00289133|19637118|P2|Overall Study|Withdrawal by Subject|10
5695462|NCT00289133|19637119|P1|Overall Study|Withdrawal by Subject|9
5695463|NCT00289133|19637118|P2|Overall Study|Protocol Violation|38
5695464|NCT00289133|19637119|P1|Overall Study|Protocol Violation|32
5695465|NCT00289133|19637118|P2|Overall Study|Non-study device implanted|0
5695466|NCT00289133|19637119|P1|Overall Study|Non-study device implanted|12
5695467|NCT00289016|19637175|P1|Overall Study|Other|1
5695468|NCT00289016|19637175|P1|Overall Study|Adverse Event|1
5695469|NCT00289016|19637175|P1|Overall Study|Withdrawal by Subject|2
5695470|NCT00289016|19637175|P1|Overall Study|Unrelated Medical Condition or Accident|2
5695471|NCT00289016|19637175|P1|Overall Study|Death|2
5695472|NCT00289016|19637175|P1|Overall Study|Disease Progression|29
5695473|NCT00288912|19637187|P3|Overall Study|Withdrawal by Subject|12
5695474|NCT00288912|19637188|P2|Overall Study|Withdrawal by Subject|5
5695475|NCT00288912|19637189|P1|Overall Study|Withdrawal by Subject|4
5695476|NCT00288912|19637187|P3|Overall Study|Lost to Follow-up|9
5695477|NCT00288912|19637188|P2|Overall Study|Lost to Follow-up|6
5695478|NCT00288912|19637189|P1|Overall Study|Lost to Follow-up|9
5695479|NCT00288912|19637187|P3|Overall Study|Developed exclusion criterion|7
5695480|NCT00288912|19637188|P2|Overall Study|Developed exclusion criterion|6
5695481|NCT00288912|19637189|P1|Overall Study|Developed exclusion criterion|4
5695482|NCT00288860|19637229|P2|Overall Study|Lost to Follow-up|71
5695483|NCT00288860|19637230|P1|Overall Study|Lost to Follow-up|74
5695484|NCT00288860|19637229|P2|Overall Study|Withdrawal by Subject|15
5695485|NCT00288860|19637230|P1|Overall Study|Withdrawal by Subject|20
5695486|NCT00288860|19637229|P2|Overall Study|Death|3
5695487|NCT00288860|19637230|P1|Overall Study|Death|4
5695488|NCT00288860|19637229|P2|Overall Study|Did not complete intake|8
5695489|NCT00288860|19637230|P1|Overall Study|Did not complete intake|4
5695490|NCT00288704|19637243|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
5695491|NCT00288704|19637244|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
5695492|NCT00288704|19637245|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
5695493|NCT00288704|19637243|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
5695494|NCT00288704|19637244|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
5695495|NCT00288704|19637245|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
5695496|NCT00288704|19637243|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
5695497|NCT00288704|19637244|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
5695498|NCT00288704|19637245|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
5695499|NCT00288704|19637243|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
5695500|NCT00288704|19637244|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
5695501|NCT00288704|19637245|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
5695502|NCT00288704|19637243|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
5695503|NCT00288704|19637244|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
5695504|NCT00288704|19637245|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
5695505|NCT00288704|19637243|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
5695506|NCT00288704|19637244|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
5695507|NCT00288704|19637245|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
5695508|NCT00288704|19637243|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
5695509|NCT00288704|19637244|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
5695510|NCT00288704|19637245|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
5695511|NCT00288639|19637272|P1|Overall Study|Other|1
5695512|NCT00288639|19637272|P1|Overall Study|Withdrawal by Subject|2
5695513|NCT00288639|19637272|P1|Overall Study|Lack of Efficacy|4
5695514|NCT00288639|19637272|P1|Overall Study|Adverse Event|5
5695515|NCT00288626|19637289|P1|Overall Study|Withdrawal by Subject|4
5695516|NCT00288626|19637289|P1|Overall Study|Death|3
5695517|NCT00288587|19637323|P2|Overall Study|Severe Aortic Stenosis|0
5695518|NCT00288587|19637324|P1|Overall Study|Severe Aortic Stenosis|1
5695519|NCT00288587|19637323|P2|Overall Study|Physician Decision|2
5695520|NCT00288587|19637324|P1|Overall Study|Physician Decision|0
5695521|NCT00288587|19637323|P2|Overall Study|Adverse Event|1
5695522|NCT00288587|19637324|P1|Overall Study|Adverse Event|0
5695523|NCT00288587|19637323|P2|Overall Study|Transplant|3
5695524|NCT00288587|19637324|P1|Overall Study|Transplant|0
5695525|NCT00288587|19637323|P2|Overall Study|Death|4
5695526|NCT00288587|19637324|P1|Overall Study|Death|4
5695527|NCT00288509|19637367|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
5695528|NCT00288509|19637367|P1|Treatment Cycle 4|Physician Decision|4
5695529|NCT00288509|19637367|P1|Treatment Cycle 4|Withdrawal by Subject|3
5695530|NCT00288509|19637367|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
5695531|NCT00288509|19637367|P1|Treatment Cycle 3|Lost to Follow-up|2
5695532|NCT00288509|19637367|P1|Treatment Cycle 3|Withdrawal by Subject|1
5695533|NCT00288509|19637367|P1|Treatment Cycle 3|Lack of Efficacy|1
5695534|NCT00288509|19637367|P1|Treatment Cycle 2|Withdrawal by Subject|2
5695535|NCT00288509|19637367|P1|Treatment Cycle 2|Lack of Efficacy|1
5695536|NCT00288509|19637367|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
5695537|NCT00288509|19637367|P1|Treatment Cycle 1|Lost to Follow-up|2
5695538|NCT00288509|19637367|P1|Treatment Cycle 1|Withdrawal by Subject|1
5695539|NCT00288509|19637367|P1|Treatment Cycle 1|Lack of Efficacy|1
5695540|NCT00288509|19637367|P1|Treatment Cycle 1|Adverse Event|1
5695541|NCT00288080|19637385|P2|Overall Study|Protocol Violation|20
5695542|NCT00288080|19637386|P1|Overall Study|Protocol Violation|25
5695543|NCT00288080|19637385|P2|Overall Study|Withdrawal by Subject|3
5695544|NCT00288080|19637386|P1|Overall Study|Withdrawal by Subject|1
5695545|NCT00288054|19637408|P1|Overall Study|Not protocol specified|2
5695546|NCT00288054|19637408|P1|Overall Study|Withdrawal by Subject|1
5695547|NCT00288054|19637408|P1|Overall Study|Adverse Event|3
5695548|NCT00288054|19637408|P1|Overall Study|Lack of Efficacy|16
5695549|NCT00288054|19637408|P1|Overall Study|Protocol Violation|2
5695550|NCT00288015|19637416|P1|Follow up for Survival x 2 Years|Other|9
5695551|NCT00288015|19637416|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
5695552|NCT00288015|19637416|P1|Follow up for Survival x 2 Years|Death|13
5695553|NCT00288015|19637416|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
5695554|NCT00288015|19637416|P1|First Response Assessment|Physician Decision|2
5695555|NCT00288015|19637416|P1|First Response Assessment|Death|1
5695556|NCT00288015|19637416|P1|First Response Assessment|Withdrawal by Subject|1
5695557|NCT00288015|19637416|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
5695558|NCT00288015|19637416|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
5695559|NCT00287690|19637508|P2|Overall Study|Protocol Violation|26
5695560|NCT00287690|19637509|P1|Overall Study|Protocol Violation|20
5695561|NCT00287586|19637521|P2|Overall Study|Recurrent Melanoma|1
5695562|NCT00287586|19637522|P1|Overall Study|Recurrent Melanoma|0
5695563|NCT00287586|19637521|P2|Overall Study|Itchy Swollen Eyes|1
5695564|NCT00287586|19637522|P1|Overall Study|Itchy Swollen Eyes|0
5695565|NCT00287586|19637521|P2|Overall Study|Bradycardia|1
5695566|NCT00287586|19637522|P1|Overall Study|Bradycardia|0
5695567|NCT00287586|19637521|P2|Overall Study|Mood Swings and Irritability|1
5695568|NCT00287586|19637522|P1|Overall Study|Mood Swings and Irritability|0
5695569|NCT00287586|19637521|P2|Overall Study|Mastodynia and Gynecomastia|1
5695570|NCT00287586|19637522|P1|Overall Study|Mastodynia and Gynecomastia|0
5695571|NCT00287586|19637521|P2|Overall Study|Retroperitoneal Cancer|1
5695572|NCT00287586|19637522|P1|Overall Study|Retroperitoneal Cancer|0
5695573|NCT00287586|19637521|P2|Overall Study|Elevated IPSS Score|1
5695574|NCT00287586|19637522|P1|Overall Study|Elevated IPSS Score|0
5695575|NCT00287586|19637521|P2|Overall Study|Lung Cancer|2
5695576|NCT00287586|19637522|P1|Overall Study|Lung Cancer|0
5695577|NCT00287586|19637521|P2|Overall Study|Major Depression|2
5695578|NCT00287586|19637522|P1|Overall Study|Major Depression|0
5695579|NCT00287586|19637521|P2|Overall Study|Enrolled in Another Study|0
5695580|NCT00287586|19637522|P1|Overall Study|Enrolled in Another Study|1
5695581|NCT00287586|19637521|P2|Overall Study|Nonadherence|1
5695582|NCT00287586|19637522|P1|Overall Study|Nonadherence|1
5695583|NCT00287586|19637521|P2|Overall Study|Inappropriate Behaviour with Staff|0
5695584|NCT00287586|19637522|P1|Overall Study|Inappropriate Behaviour with Staff|1
5695585|NCT00287586|19637521|P2|Overall Study|Shoulder Pain|0
5695586|NCT00287586|19637522|P1|Overall Study|Shoulder Pain|1
5695587|NCT00287586|19637521|P2|Overall Study|Sleep Apnea|0
5695588|NCT00287586|19637522|P1|Overall Study|Sleep Apnea|1
5695589|NCT00287586|19637521|P2|Overall Study|Pancreatic Cancer|3
5695590|NCT00287586|19637522|P1|Overall Study|Pancreatic Cancer|1
5695591|NCT00287586|19637521|P2|Overall Study|Cognitive Impairment|0
5695592|NCT00287586|19637522|P1|Overall Study|Cognitive Impairment|1
5695593|NCT00287586|19637521|P2|Overall Study|Lower Urinary Tract Symptoms|0
5695594|NCT00287586|19637522|P1|Overall Study|Lower Urinary Tract Symptoms|1
5695595|NCT00287586|19637521|P2|Overall Study|Myocardial Infarction|0
5695596|NCT00287586|19637522|P1|Overall Study|Myocardial Infarction|1
5695597|NCT00287586|19637521|P2|Overall Study|Stroke|0
5695598|NCT00287586|19637522|P1|Overall Study|Stroke|2
5695599|NCT00287586|19637521|P2|Overall Study|Elevated Prostate Specific Antigen|0
5695600|NCT00287586|19637522|P1|Overall Study|Elevated Prostate Specific Antigen|2
5695601|NCT00287586|19637521|P2|Overall Study|Rash|0
5695602|NCT00287586|19637522|P1|Overall Study|Rash|3
5695603|NCT00287586|19637521|P2|Overall Study|Elevated Hematocrit|0
5695604|NCT00287586|19637522|P1|Overall Study|Elevated Hematocrit|3
5695605|NCT00287586|19637521|P2|Overall Study|Death|3
5695606|NCT00287586|19637522|P1|Overall Study|Death|2
5695607|NCT00287586|19637521|P2|Overall Study|Lost to Follow-up|4
5695608|NCT00287586|19637522|P1|Overall Study|Lost to Follow-up|5
5695609|NCT00287586|19637521|P2|Overall Study|Withdrew Consent|30
5695610|NCT00287586|19637522|P1|Overall Study|Withdrew Consent|19
5695611|NCT00287469|19637560|P2|Overall Study|Lost to Follow-up|69
5695612|NCT00287469|19637561|P1|Overall Study|Lost to Follow-up|74
5695613|NCT00287469|19637560|P2|Overall Study|moved from area|138
5695614|NCT00287469|19637561|P1|Overall Study|moved from area|144
5695615|NCT00287469|19637560|P2|Overall Study|Adverse Event|1
5695616|NCT00287469|19637561|P1|Overall Study|Adverse Event|1
5695617|NCT00287469|19637560|P2|Overall Study|serious adverse event|6
5695618|NCT00287469|19637561|P1|Overall Study|serious adverse event|1
5695619|NCT00287365|19637571|P1|Overall Study|sample not acquired|13
5695620|NCT00287118|19637597|P1|Overall Study|Other|7
5695621|NCT00287118|19637597|P1|Overall Study|Protocol Violation|2
5695622|NCT00287118|19637597|P1|Overall Study|Lost to Follow-up|1
5695623|NCT00287118|19637597|P1|Overall Study|Lack of Efficacy|11
5695624|NCT00287118|19637597|P1|Overall Study|Death|1
5695625|NCT00287118|19637597|P1|Overall Study|Adverse Event|30
5695626|NCT00287079|19637603|P2|Overall Study|Other|0
5695627|NCT00287079|19637604|P1|Overall Study|Other|3
5695628|NCT00287079|19637603|P2|Overall Study|Protocol Violation|0
5695629|NCT00287079|19637604|P1|Overall Study|Protocol Violation|1
5695630|NCT00287079|19637603|P2|Overall Study|Adverse Event|0
5695631|NCT00287079|19637604|P1|Overall Study|Adverse Event|5
5695632|NCT00287079|19637603|P2|Overall Study|Non-qualifying relapse|0
5695633|NCT00287079|19637604|P1|Overall Study|Non-qualifying relapse|1
5695634|NCT00287079|19637603|P2|Overall Study|Qualifying relapse|1
5695635|NCT00287079|19637604|P1|Overall Study|Qualifying relapse|12
5695636|NCT00286754|19637632|P3|Overall Study|Moved out of state|1
5695637|NCT00286754|19637633|P2|Overall Study|Moved out of state|0
5695638|NCT00286754|19637634|P1|Overall Study|Moved out of state|0
5695639|NCT00286754|19637632|P3|Overall Study|Lost to Follow-up|6
5695640|NCT00286754|19637633|P2|Overall Study|Lost to Follow-up|14
5695641|NCT00286754|19637634|P1|Overall Study|Lost to Follow-up|12
5695642|NCT00286754|19637632|P3|Overall Study|Withdrawal by Subject|0
5695643|NCT00286754|19637633|P2|Overall Study|Withdrawal by Subject|2
5695644|NCT00286754|19637634|P1|Overall Study|Withdrawal by Subject|6
5695645|NCT00286754|19637632|P3|Overall Study|Adverse Event|3
5695646|NCT00286754|19637633|P2|Overall Study|Adverse Event|2
5695647|NCT00286754|19637634|P1|Overall Study|Adverse Event|2
5695648|NCT00286494|19637693|P3|Overall Study|Protocol Violation|2
5695649|NCT00286494|19637694|P2|Overall Study|Protocol Violation|1
5695650|NCT00286494|19637695|P1|Overall Study|Protocol Violation|1
5695651|NCT00286494|19637693|P3|Overall Study|Lost to Follow-up|3
5695652|NCT00286494|19637694|P2|Overall Study|Lost to Follow-up|1
5695653|NCT00286494|19637695|P1|Overall Study|Lost to Follow-up|3
5695654|NCT00286494|19637693|P3|Overall Study|Physician Decision|1
5695655|NCT00286494|19637694|P2|Overall Study|Physician Decision|5
5695656|NCT00286494|19637695|P1|Overall Study|Physician Decision|5
5695657|NCT00286494|19637693|P3|Overall Study|Adverse Event|6
5695658|NCT00286494|19637694|P2|Overall Study|Adverse Event|8
5695659|NCT00286494|19637695|P1|Overall Study|Adverse Event|3
5695660|NCT00286494|19637693|P3|Overall Study|Withdrawal by Subject|9
5695661|NCT00286494|19637694|P2|Overall Study|Withdrawal by Subject|10
5695662|NCT00286494|19637695|P1|Overall Study|Withdrawal by Subject|2
5695663|NCT00286494|19637693|P3|Overall Study|Hyperglycemic rescue|18
5695664|NCT00286494|19637694|P2|Overall Study|Hyperglycemic rescue|19
5695665|NCT00286494|19637695|P1|Overall Study|Hyperglycemic rescue|12
5695666|NCT00286468|19637856|P3|Overall Study|Physician Decision|1
5695667|NCT00286468|19637857|P2|Overall Study|Physician Decision|2
5695668|NCT00286468|19637858|P1|Overall Study|Physician Decision|3
5695669|NCT00286468|19637856|P3|Overall Study|Withdrawal by Subject|11
5695670|NCT00286468|19637857|P2|Overall Study|Withdrawal by Subject|8
5695671|NCT00286468|19637858|P1|Overall Study|Withdrawal by Subject|3
5695672|NCT00286468|19637856|P3|Overall Study|Lost to Follow-up|2
5695673|NCT00286468|19637857|P2|Overall Study|Lost to Follow-up|1
5695674|NCT00286468|19637858|P1|Overall Study|Lost to Follow-up|1
5695675|NCT00286468|19637856|P3|Overall Study|Protocol Violation|1
5695676|NCT00286468|19637857|P2|Overall Study|Protocol Violation|3
5695677|NCT00286468|19637858|P1|Overall Study|Protocol Violation|0
5695678|NCT00286468|19637856|P3|Overall Study|Adverse Event|4
5695679|NCT00286468|19637857|P2|Overall Study|Adverse Event|6
5695680|NCT00286468|19637858|P1|Overall Study|Adverse Event|2
5695681|NCT00286468|19637856|P3|Overall Study|Hyperglycemic Rescue|31
5695682|NCT00286468|19637857|P2|Overall Study|Hyperglycemic Rescue|30
5695683|NCT00286468|19637858|P1|Overall Study|Hyperglycemic Rescue|28
5695684|NCT00286455|19638019|P3|Overall Study|Withdrawal by Subject|7
5695685|NCT00286455|19638020|P2|Overall Study|Withdrawal by Subject|8
5695686|NCT00286455|19638021|P1|Overall Study|Withdrawal by Subject|0
5695687|NCT00286455|19638019|P3|Overall Study|Participant Non-compliance|0
5695688|NCT00286455|19638020|P2|Overall Study|Participant Non-compliance|0
5695689|NCT00286455|19638021|P1|Overall Study|Participant Non-compliance|1
5695690|NCT00286455|19638019|P3|Overall Study|Protocol Violation|0
5695691|NCT00286455|19638020|P2|Overall Study|Protocol Violation|1
5695692|NCT00286455|19638021|P1|Overall Study|Protocol Violation|1
5695693|NCT00286455|19638019|P3|Overall Study|Physician Decision|2
5695694|NCT00286455|19638020|P2|Overall Study|Physician Decision|0
5695695|NCT00286455|19638021|P1|Overall Study|Physician Decision|3
5695696|NCT00286455|19638019|P3|Overall Study|Lost to Follow-up|3
5695697|NCT00286455|19638020|P2|Overall Study|Lost to Follow-up|3
5695698|NCT00286455|19638021|P1|Overall Study|Lost to Follow-up|0
5695699|NCT00286455|19638019|P3|Overall Study|Adverse Event|2
5695700|NCT00286455|19638020|P2|Overall Study|Adverse Event|3
5695701|NCT00286455|19638021|P1|Overall Study|Adverse Event|1
5695702|NCT00286455|19638019|P3|Overall Study|Hyperglycemia rescue|10
5695703|NCT00286455|19638020|P2|Overall Study|Hyperglycemia rescue|13
5695704|NCT00286455|19638021|P1|Overall Study|Hyperglycemia rescue|19
5695705|NCT00286442|19638200|P3|Overall Study|Withdrawal by Subject|2
5695706|NCT00286442|19638201|P2|Overall Study|Withdrawal by Subject|14
5695707|NCT00286442|19638202|P1|Overall Study|Withdrawal by Subject|2
5695708|NCT00286442|19638200|P3|Overall Study|Administrative Error|0
5695709|NCT00286442|19638201|P2|Overall Study|Administrative Error|1
5695710|NCT00286442|19638202|P1|Overall Study|Administrative Error|1
5695711|NCT00286442|19638200|P3|Overall Study|Physician Decision|1
5695712|NCT00286442|19638201|P2|Overall Study|Physician Decision|1
5695713|NCT00286442|19638202|P1|Overall Study|Physician Decision|1
5695714|NCT00286442|19638200|P3|Overall Study|Lost to Follow-up|1
5695715|NCT00286442|19638201|P2|Overall Study|Lost to Follow-up|2
5695716|NCT00286442|19638202|P1|Overall Study|Lost to Follow-up|5
5695717|NCT00286442|19638200|P3|Overall Study|Protocol Violation|2
5695718|NCT00286442|19638201|P2|Overall Study|Protocol Violation|4
5695719|NCT00286442|19638202|P1|Overall Study|Protocol Violation|2
5695720|NCT00286442|19638200|P3|Overall Study|Adverse Event|1
5695721|NCT00286442|19638201|P2|Overall Study|Adverse Event|6
5695722|NCT00286442|19638202|P1|Overall Study|Adverse Event|7
5695723|NCT00286442|19638200|P3|Overall Study|Hyperglycemic Rescue|25
5695724|NCT00286442|19638201|P2|Overall Study|Hyperglycemic Rescue|17
5695725|NCT00286442|19638202|P1|Overall Study|Hyperglycemic Rescue|19
5695726|NCT00286429|19638363|P3|Overall Study|Administrative Decision|0
5695727|NCT00286429|19638364|P2|Overall Study|Administrative Decision|1
5695728|NCT00286429|19638365|P1|Overall Study|Administrative Decision|0
5695729|NCT00286429|19638363|P3|Overall Study|Administrative Error|1
5695730|NCT00286429|19638364|P2|Overall Study|Administrative Error|1
5695731|NCT00286429|19638365|P1|Overall Study|Administrative Error|1
5695732|NCT00286429|19638363|P3|Overall Study|Withdrawal by Subject|6
5695733|NCT00286429|19638364|P2|Overall Study|Withdrawal by Subject|2
5695734|NCT00286429|19638365|P1|Overall Study|Withdrawal by Subject|3
5695735|NCT00286429|19638363|P3|Overall Study|Protocol Violation|4
5695736|NCT00286429|19638364|P2|Overall Study|Protocol Violation|5
5695737|NCT00286429|19638365|P1|Overall Study|Protocol Violation|3
5695738|NCT00286429|19638363|P3|Overall Study|Physician Decision|7
5695739|NCT00286429|19638364|P2|Overall Study|Physician Decision|7
5695740|NCT00286429|19638365|P1|Overall Study|Physician Decision|10
5695741|NCT00286429|19638363|P3|Overall Study|Lost to Follow-up|3
5695742|NCT00286429|19638364|P2|Overall Study|Lost to Follow-up|4
5695743|NCT00286429|19638365|P1|Overall Study|Lost to Follow-up|2
5695744|NCT00286429|19638363|P3|Overall Study|Lack of Efficacy|25
5695745|NCT00286429|19638364|P2|Overall Study|Lack of Efficacy|27
5695746|NCT00286429|19638365|P1|Overall Study|Lack of Efficacy|52
5695747|NCT00286429|19638363|P3|Overall Study|Adverse Event|6
5695748|NCT00286429|19638364|P2|Overall Study|Adverse Event|1
5695749|NCT00286429|19638365|P1|Overall Study|Adverse Event|4
5695750|NCT00286221|19638481|P4|Overall Study|Unrecognized exclusion criteria met|0
5695751|NCT00286221|19638482|P3|Overall Study|Unrecognized exclusion criteria met|0
5695752|NCT00286221|19638483|P2|Overall Study|Unrecognized exclusion criteria met|1
5695753|NCT00286221|19638484|P1|Overall Study|Unrecognized exclusion criteria met|0
5695754|NCT00286221|19638481|P4|Overall Study|Inability to trigger PCA|0
5695755|NCT00286221|19638482|P3|Overall Study|Inability to trigger PCA|0
5695756|NCT00286221|19638483|P2|Overall Study|Inability to trigger PCA|0
5695757|NCT00286221|19638484|P1|Overall Study|Inability to trigger PCA|2
5695758|NCT00286221|19638481|P4|Overall Study|Unanticipated Neurosurgical Complication|2
5695759|NCT00286221|19638482|P3|Overall Study|Unanticipated Neurosurgical Complication|3
5695760|NCT00286221|19638483|P2|Overall Study|Unanticipated Neurosurgical Complication|3
5695761|NCT00286221|19638484|P1|Overall Study|Unanticipated Neurosurgical Complication|6
5695762|NCT00286221|19638481|P4|Overall Study|Protocol Violation|4
5695763|NCT00286221|19638482|P3|Overall Study|Protocol Violation|6
5695764|NCT00286221|19638483|P2|Overall Study|Protocol Violation|1
5695765|NCT00286221|19638484|P1|Overall Study|Protocol Violation|2
5695766|NCT00286156|19638510|P3|Overall Study|AE: pneumonia|0
5695767|NCT00286156|19638511|P2|Overall Study|AE: pneumonia|0
5695768|NCT00286156|19638512|P1|Overall Study|AE: pneumonia|1
5695769|NCT00286156|19638510|P3|Overall Study|AE: nephrotic-range proteinuruia|0
5695770|NCT00286156|19638511|P2|Overall Study|AE: nephrotic-range proteinuruia|0
5695771|NCT00286156|19638512|P1|Overall Study|AE: nephrotic-range proteinuruia|1
5695772|NCT00286156|19638510|P3|Overall Study|AE: pulmonary embolus|0
5695773|NCT00286156|19638511|P2|Overall Study|AE: pulmonary embolus|1
5695774|NCT00286156|19638512|P1|Overall Study|AE: pulmonary embolus|0
5695775|NCT00286156|19638510|P3|Overall Study|Missed 12 month visit|1
5695776|NCT00286156|19638511|P2|Overall Study|Missed 12 month visit|0
5695777|NCT00286156|19638512|P1|Overall Study|Missed 12 month visit|0
5695778|NCT00286091|19638525|P2|Open-label Treatment Phase|Missing End of Study Information|1
5695779|NCT00286091|19638526|P1|Open-label Treatment Phase|Missing End of Study Information|0
5695780|NCT00286091|19638525|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
5695781|NCT00286091|19638526|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
5695782|NCT00286091|19638525|P2|Open-label Treatment Phase|Lost to Follow-up|1
5695783|NCT00286091|19638526|P1|Open-label Treatment Phase|Lost to Follow-up|0
5695784|NCT00286091|19638525|P2|Open-label Treatment Phase|Noncompliance|1
5695785|NCT00286091|19638526|P1|Open-label Treatment Phase|Noncompliance|3
5695786|NCT00286091|19638525|P2|Open-label Treatment Phase|Disease Progression|3
5695787|NCT00286091|19638526|P1|Open-label Treatment Phase|Disease Progression|9
5695788|NCT00286091|19638525|P2|Open-label Treatment Phase|Death|7
5695789|NCT00286091|19638526|P1|Open-label Treatment Phase|Death|10
5695790|NCT00286091|19638525|P2|Open-label Treatment Phase|Withdrawal by Subject|10
5695791|NCT00286091|19638526|P1|Open-label Treatment Phase|Withdrawal by Subject|14
5695792|NCT00286091|19638525|P2|Open-label Treatment Phase|Other|11
5695793|NCT00286091|19638526|P1|Open-label Treatment Phase|Other|11
5695794|NCT00286091|19638525|P2|Open-label Treatment Phase|Adverse Event|16
5695795|NCT00286091|19638526|P1|Open-label Treatment Phase|Adverse Event|5
5695796|NCT00286091|19638525|P2|Open-label Treatment Phase|Physician Decision|21
5695797|NCT00286091|19638526|P1|Open-label Treatment Phase|Physician Decision|24
5695798|NCT00286091|19638525|P2|Double-blind Treatment Phase|Ineligibility Determined|2
5695799|NCT00286091|19638526|P1|Double-blind Treatment Phase|Ineligibility Determined|1
5695800|NCT00286091|19638525|P2|Double-blind Treatment Phase|Protocol Deviation|3
5695801|NCT00286091|19638526|P1|Double-blind Treatment Phase|Protocol Deviation|1
5695802|NCT00286091|19638525|P2|Double-blind Treatment Phase|Lost to Follow-up|4
5695803|NCT00286091|19638526|P1|Double-blind Treatment Phase|Lost to Follow-up|11
5695804|NCT00286091|19638525|P2|Double-blind Treatment Phase|Noncompliance|8
5695805|NCT00286091|19638526|P1|Double-blind Treatment Phase|Noncompliance|8
5695806|NCT00286091|19638525|P2|Double-blind Treatment Phase|Administrative Decision|21
5695807|NCT00286091|19638526|P1|Double-blind Treatment Phase|Administrative Decision|20
5695808|NCT00286091|19638525|P2|Double-blind Treatment Phase|Other|33
5695809|NCT00286091|19638526|P1|Double-blind Treatment Phase|Other|25
5695810|NCT00286091|19638525|P2|Double-blind Treatment Phase|Disease Progression|35
5695811|NCT00286091|19638526|P1|Double-blind Treatment Phase|Disease Progression|22
5695812|NCT00286091|19638525|P2|Double-blind Treatment Phase|Adverse Event|40
5695813|NCT00286091|19638526|P1|Double-blind Treatment Phase|Adverse Event|28
5695814|NCT00286091|19638525|P2|Double-blind Treatment Phase|Death|65
5695815|NCT00286091|19638526|P1|Double-blind Treatment Phase|Death|58
5695816|NCT00286091|19638525|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
5695817|NCT00286091|19638526|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
5695818|NCT00286091|19638525|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
5695819|NCT00286091|19638526|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
5695820|NCT00285857|19638549|P1|Overall Study|Adverse Event|1
5695821|NCT00285857|19638549|P1|Overall Study|Inadequate initial breast cytology|1
5695822|NCT00285857|19638549|P1|Overall Study|Withdrawal by Subject|2
5695823|NCT00285818|19638562|P2|Overall Study|Lost to Follow-up|0
5695824|NCT00285818|19638563|P1|Overall Study|Lost to Follow-up|1
5695825|NCT00285818|19638562|P2|Overall Study|Withdrawal by Subject|2
5695826|NCT00285818|19638563|P1|Overall Study|Withdrawal by Subject|3
5695827|NCT00285649|19638608|P3|Overall Study|Withdrawal by Subject|2
5695828|NCT00285649|19638609|P2|Overall Study|Withdrawal by Subject|2
5695829|NCT00285649|19638610|P1|Overall Study|Withdrawal by Subject|3
5695830|NCT00285649|19638608|P3|Overall Study|Lost to Follow-up|4
5695831|NCT00285649|19638609|P2|Overall Study|Lost to Follow-up|4
5695832|NCT00285649|19638610|P1|Overall Study|Lost to Follow-up|6
5695833|NCT00285584|19638620|P2|Month 6|Lost to Follow-up|1
5695834|NCT00285584|19638621|P1|Month 6|Lost to Follow-up|0
5695835|NCT00285584|19638620|P2|Month 3|Withdrawal by Subject|0
5695836|NCT00285584|19638621|P1|Month 3|Withdrawal by Subject|1
5695837|NCT00285584|19638620|P2|Month 3|Lost to Follow-up|3
5695838|NCT00285584|19638621|P1|Month 3|Lost to Follow-up|3
5695839|NCT00285207|19638653|P2|Overall Study|non-compliance|1
5695840|NCT00285207|19638654|P1|Overall Study|non-compliance|0
5695841|NCT00285207|19638653|P2|Overall Study|Pregnancy|1
5695842|NCT00285207|19638654|P1|Overall Study|Pregnancy|1
5695843|NCT00285207|19638653|P2|Overall Study|Withdrawal by Subject|2
5695844|NCT00285207|19638654|P1|Overall Study|Withdrawal by Subject|5
5695845|NCT00285207|19638653|P2|Overall Study|Lost to Follow-up|2
5695846|NCT00285207|19638654|P1|Overall Study|Lost to Follow-up|3
5695847|NCT00285012|19638662|P2|Received Study Tx|Other|5
5695848|NCT00285012|19638663|P1|Received Study Tx|Other|5
5695849|NCT00285012|19638662|P2|Received Study Tx|Withdrawal by Subject|43
5695850|NCT00285012|19638663|P1|Received Study Tx|Withdrawal by Subject|31
5695851|NCT00285012|19638662|P2|Received Study Tx|Lost to Follow-up|31
5695852|NCT00285012|19638663|P1|Received Study Tx|Lost to Follow-up|29
5695853|NCT00285012|19638662|P2|Received Study Tx|Lack of Efficacy|3
5695854|NCT00285012|19638663|P1|Received Study Tx|Lack of Efficacy|0
5695855|NCT00285012|19638662|P2|Received Study Tx|Adverse Event|11
5695856|NCT00285012|19638663|P1|Received Study Tx|Adverse Event|5
5695857|NCT00285012|19638662|P2|Received Study Tx|Death|1
5695858|NCT00285012|19638663|P1|Received Study Tx|Death|2
5695859|NCT00285012|19638662|P2|Assigned to Study Treatment (Tx)|Other|3
5695860|NCT00285012|19638663|P1|Assigned to Study Treatment (Tx)|Other|2
5695861|NCT00284934|19638689|P2|Overall Study|Other reasons|1
5695862|NCT00284934|19638690|P1|Overall Study|Other reasons|3
5695863|NCT00284934|19638689|P2|Overall Study|Adverse Event|2
5695864|NCT00284934|19638690|P1|Overall Study|Adverse Event|1
5695865|NCT00284856|19638705|P3|Overall Study|Other|4
5695866|NCT00284856|19638706|P2|Overall Study|Other|5
5695867|NCT00284856|19638707|P1|Overall Study|Other|4
5695868|NCT00284856|19638705|P3|Overall Study|Withdrawal by Subject|18
5695869|NCT00284856|19638706|P2|Overall Study|Withdrawal by Subject|16
5695870|NCT00284856|19638707|P1|Overall Study|Withdrawal by Subject|12
5695871|NCT00284856|19638705|P3|Overall Study|Protocol Violation|5
5695872|NCT00284856|19638706|P2|Overall Study|Protocol Violation|4
5695873|NCT00284856|19638707|P1|Overall Study|Protocol Violation|5
5695874|NCT00284856|19638705|P3|Overall Study|Lost to Follow-up|22
5695875|NCT00284856|19638706|P2|Overall Study|Lost to Follow-up|21
5695876|NCT00284856|19638707|P1|Overall Study|Lost to Follow-up|25
5695877|NCT00284856|19638705|P3|Overall Study|Lack of Efficacy|8
5695878|NCT00284856|19638706|P2|Overall Study|Lack of Efficacy|1
5695879|NCT00284856|19638707|P1|Overall Study|Lack of Efficacy|2
5695880|NCT00284856|19638705|P3|Overall Study|Adverse Event|3
5695881|NCT00284856|19638706|P2|Overall Study|Adverse Event|3
5695882|NCT00284856|19638707|P1|Overall Study|Adverse Event|3
5695883|NCT00284141|19638806|P1|Overall Study|Ongoing treatment|2
5695884|NCT00284141|19638806|P1|Overall Study|Did not take study medication|2
5695885|NCT00284141|19638806|P1|Overall Study|Pneumonia|1
5695886|NCT00284141|19638806|P1|Overall Study|General decline|1
5695887|NCT00284141|19638806|P1|Overall Study|Clinical deterioration / death|2
5695888|NCT00284141|19638806|P1|Overall Study|Symptomatic / Clinical Progression|11
5695889|NCT00284141|19638806|P1|Overall Study|Participant's request|9
5695890|NCT00284141|19638806|P1|Overall Study|Adverse Event|19
5695891|NCT00284141|19638806|P1|Overall Study|Disease Progression / Lack of efficacy|51
5695892|NCT00284089|19638829|P4|Extension Phase|Withdrawal by Subject|3
5695893|NCT00284089|19638830|P3|Extension Phase|Withdrawal by Subject|1
5695894|NCT00284089|19638831|P2|Extension Phase|Withdrawal by Subject|0
5695895|NCT00284089|19638832|P1|Extension Phase|Withdrawal by Subject|0
5695896|NCT00284089|19638829|P4|Extension Phase|Protocol Violation|0
5695897|NCT00284089|19638830|P3|Extension Phase|Protocol Violation|1
5695898|NCT00284089|19638831|P2|Extension Phase|Protocol Violation|0
5695899|NCT00284089|19638832|P1|Extension Phase|Protocol Violation|0
5695900|NCT00284089|19638829|P4|Extension Phase|condition no longer requires study drug|7
5695901|NCT00284089|19638830|P3|Extension Phase|condition no longer requires study drug|2
5695902|NCT00284089|19638831|P2|Extension Phase|condition no longer requires study drug|0
5695903|NCT00284089|19638832|P1|Extension Phase|condition no longer requires study drug|2
5695904|NCT00284089|19638829|P4|Extension Phase|Adverse Event|2
5695905|NCT00284089|19638830|P3|Extension Phase|Adverse Event|2
5695906|NCT00284089|19638831|P2|Extension Phase|Adverse Event|0
5695907|NCT00284089|19638832|P1|Extension Phase|Adverse Event|0
5695908|NCT00284089|19638829|P4|Multiple Dose Phase|Death|1
5695909|NCT00284089|19638830|P3|Multiple Dose Phase|Death|1
5695910|NCT00284089|19638831|P2|Multiple Dose Phase|Death|0
5695911|NCT00284089|19638832|P1|Multiple Dose Phase|Death|0
5695912|NCT00284089|19638829|P4|Multiple Dose Phase|Withdrawal by Subject|2
5695913|NCT00284089|19638830|P3|Multiple Dose Phase|Withdrawal by Subject|1
5695914|NCT00284089|19638831|P2|Multiple Dose Phase|Withdrawal by Subject|0
5695915|NCT00284089|19638832|P1|Multiple Dose Phase|Withdrawal by Subject|0
5695916|NCT00284089|19638829|P4|Multiple Dose Phase|Protocol Violation|0
5695917|NCT00284089|19638830|P3|Multiple Dose Phase|Protocol Violation|1
5695918|NCT00284089|19638831|P2|Multiple Dose Phase|Protocol Violation|0
5695919|NCT00284089|19638832|P1|Multiple Dose Phase|Protocol Violation|0
5695920|NCT00284089|19638829|P4|Multiple Dose Phase|Adverse Event|1
5695921|NCT00284089|19638830|P3|Multiple Dose Phase|Adverse Event|1
5695922|NCT00284089|19638831|P2|Multiple Dose Phase|Adverse Event|0
5695923|NCT00284089|19638832|P1|Multiple Dose Phase|Adverse Event|1
5695924|NCT00284050|19638861|P3|Overall Study|Death|0
5695925|NCT00284050|19638862|P2|Overall Study|Death|0
5695926|NCT00284050|19638863|P1|Overall Study|Death|1
5695927|NCT00284050|19638861|P3|Overall Study|Lost to Follow-up|1
5695928|NCT00284050|19638862|P2|Overall Study|Lost to Follow-up|0
5695929|NCT00284050|19638863|P1|Overall Study|Lost to Follow-up|1
5695930|NCT00284050|19638861|P3|Overall Study|Withdrawal by Subject|2
5695931|NCT00284050|19638862|P2|Overall Study|Withdrawal by Subject|2
5695932|NCT00284050|19638863|P1|Overall Study|Withdrawal by Subject|2
5695933|NCT00284050|19638861|P3|Overall Study|Protocol Violation|2
5695934|NCT00284050|19638862|P2|Overall Study|Protocol Violation|1
5695935|NCT00284050|19638863|P1|Overall Study|Protocol Violation|0
5695936|NCT00284050|19638861|P3|Overall Study|Lack of Efficacy|3
5695937|NCT00284050|19638862|P2|Overall Study|Lack of Efficacy|1
5695938|NCT00284050|19638863|P1|Overall Study|Lack of Efficacy|0
5695939|NCT00284050|19638861|P3|Overall Study|Adverse Event|1
5695940|NCT00284050|19638862|P2|Overall Study|Adverse Event|1
5695941|NCT00284050|19638863|P1|Overall Study|Adverse Event|1
5695942|NCT00283959|19638877|P1|Extension Period|Low Compliance|1
5695943|NCT00283868|19638889|P2|Overall Study|Lost to Follow-up|8
5695944|NCT00283868|19638890|P1|Overall Study|Lost to Follow-up|7
5695945|NCT00283842|19638907|P5|Overall Study|Lost to Follow-up|1
5695946|NCT00283842|19638908|P4|Overall Study|Lost to Follow-up|1
5695947|NCT00283842|19638909|P3|Overall Study|Lost to Follow-up|4
5695948|NCT00283842|19638910|P2|Overall Study|Lost to Follow-up|2
5695949|NCT00283842|19638911|P1|Overall Study|Lost to Follow-up|0
5695950|NCT00283842|19638907|P5|Overall Study|Lack of Efficacy|3
5695951|NCT00283842|19638908|P4|Overall Study|Lack of Efficacy|0
5695952|NCT00283842|19638909|P3|Overall Study|Lack of Efficacy|1
5695953|NCT00283842|19638910|P2|Overall Study|Lack of Efficacy|3
5695954|NCT00283842|19638911|P1|Overall Study|Lack of Efficacy|1
5695955|NCT00283842|19638907|P5|Overall Study|Withdrawal by Subject|4
5695956|NCT00283842|19638908|P4|Overall Study|Withdrawal by Subject|5
5695957|NCT00283842|19638909|P3|Overall Study|Withdrawal by Subject|1
5695958|NCT00283842|19638910|P2|Overall Study|Withdrawal by Subject|1
5695959|NCT00283842|19638911|P1|Overall Study|Withdrawal by Subject|2
5695960|NCT00283842|19638907|P5|Overall Study|Protocol deviation|2
5695961|NCT00283842|19638908|P4|Overall Study|Protocol deviation|0
5695962|NCT00283842|19638909|P3|Overall Study|Protocol deviation|0
5695963|NCT00283842|19638910|P2|Overall Study|Protocol deviation|0
5695964|NCT00283842|19638911|P1|Overall Study|Protocol deviation|0
5695965|NCT00283842|19638907|P5|Overall Study|Protocol Violation|0
5695966|NCT00283842|19638908|P4|Overall Study|Protocol Violation|0
5695967|NCT00283842|19638909|P3|Overall Study|Protocol Violation|4
5695968|NCT00283842|19638910|P2|Overall Study|Protocol Violation|5
5695969|NCT00283842|19638911|P1|Overall Study|Protocol Violation|1
5695970|NCT00283842|19638907|P5|Overall Study|Adverse Event|5
5695971|NCT00283842|19638908|P4|Overall Study|Adverse Event|21
5695972|NCT00283842|19638909|P3|Overall Study|Adverse Event|21
5695973|NCT00283842|19638910|P2|Overall Study|Adverse Event|7
5695974|NCT00283842|19638911|P1|Overall Study|Adverse Event|8
5695975|NCT00283803|19638943|P1|Overall Study|Withdrawal by Subject|4
5695976|NCT00283803|19638943|P1|Overall Study|Physician Decision|9
5695977|NCT00283712|19638951|P2|Overall Study|Death|1
5695978|NCT00283712|19638952|P1|Overall Study|Death|0
5695979|NCT00283686|19638990|P4|Overall Study|Less than full participation|12
5695980|NCT00283686|19638991|P3|Overall Study|Less than full participation|6
5695981|NCT00283686|19638992|P2|Overall Study|Less than full participation|9
5695982|NCT00283686|19638993|P1|Overall Study|Less than full participation|7
5695983|NCT00283686|19638990|P4|Overall Study|Lost to Follow-up|20
5695984|NCT00283686|19638991|P3|Overall Study|Lost to Follow-up|26
5695985|NCT00283686|19638992|P2|Overall Study|Lost to Follow-up|31
5695986|NCT00283686|19638993|P1|Overall Study|Lost to Follow-up|21
5695987|NCT00283686|19638990|P4|Overall Study|Death|0
5695988|NCT00283686|19638991|P3|Overall Study|Death|1
5695989|NCT00283686|19638992|P2|Overall Study|Death|1
5695990|NCT00283686|19638993|P1|Overall Study|Death|1
5695991|NCT00283595|19639037|P2|Overall Study|Withdrawal by Subject|2
5695992|NCT00283595|19639038|P1|Overall Study|Withdrawal by Subject|1
5695993|NCT00283439|19639063|P4|Overall Study|Other|0
5695994|NCT00283439|19639064|P3|Overall Study|Other|0
5695995|NCT00283439|19639065|P2|Overall Study|Other|0
5695996|NCT00283439|19639066|P1|Overall Study|Other|1
5695997|NCT00283439|19639063|P4|Overall Study|Treatment discontinued|3
5695998|NCT00283439|19639064|P3|Overall Study|Treatment discontinued|1
5695999|NCT00283439|19639065|P2|Overall Study|Treatment discontinued|2
5696000|NCT00283439|19639066|P1|Overall Study|Treatment discontinued|0
5696001|NCT00283439|19639063|P4|Overall Study|Stem cell transplant|3
5696002|NCT00283439|19639064|P3|Overall Study|Stem cell transplant|4
5696003|NCT00283439|19639065|P2|Overall Study|Stem cell transplant|6
5696004|NCT00283439|19639066|P1|Overall Study|Stem cell transplant|6
5696005|NCT00283439|19639063|P4|Overall Study|Requirement for alternative therapy|2
5696006|NCT00283439|19639064|P3|Overall Study|Requirement for alternative therapy|5
5696007|NCT00283439|19639065|P2|Overall Study|Requirement for alternative therapy|2
5696008|NCT00283439|19639066|P1|Overall Study|Requirement for alternative therapy|1
5696009|NCT00283439|19639063|P4|Overall Study|Disease progression|0
5696010|NCT00283439|19639064|P3|Overall Study|Disease progression|0
5696011|NCT00283439|19639065|P2|Overall Study|Disease progression|1
5696012|NCT00283439|19639066|P1|Overall Study|Disease progression|0
5696013|NCT00283439|19639063|P4|Overall Study|Death|0
5696014|NCT00283439|19639064|P3|Overall Study|Death|1
5696015|NCT00283439|19639065|P2|Overall Study|Death|0
5696016|NCT00283439|19639066|P1|Overall Study|Death|0
5696017|NCT00283439|19639063|P4|Overall Study|Adverse Event|1
5696018|NCT00283439|19639064|P3|Overall Study|Adverse Event|0
5696019|NCT00283439|19639065|P2|Overall Study|Adverse Event|0
5696020|NCT00283439|19639066|P1|Overall Study|Adverse Event|0
5696021|NCT00283400|19639092|P4|Overall Study|Death|0
5696022|NCT00283400|19639093|P3|Overall Study|Death|1
5696023|NCT00283400|19639094|P2|Overall Study|Death|0
5696024|NCT00283400|19639095|P1|Overall Study|Death|1
5696025|NCT00283400|19639092|P4|Overall Study|Withdrawal by Subject|0
5696026|NCT00283400|19639093|P3|Overall Study|Withdrawal by Subject|0
5696027|NCT00283400|19639094|P2|Overall Study|Withdrawal by Subject|1
5696028|NCT00283400|19639095|P1|Overall Study|Withdrawal by Subject|1
5696029|NCT00283387|19639113|P2|First Intervention|Withdrawal by Subject|1
5696030|NCT00283387|19639114|P1|First Intervention|Withdrawal by Subject|0
5696031|NCT00283387|19639113|P2|First Intervention|Subject non-compliant|1
5696032|NCT00283387|19639114|P1|First Intervention|Subject non-compliant|1
5696033|NCT00283296|19639120|P1|Overall Study|in-home trial not completed|5
5696034|NCT00283244|19639151|P3|Overall Study|Clinical deterioration|3
5696035|NCT00283244|19639152|P2|Overall Study|Clinical deterioration|3
5696036|NCT00283244|19639153|P1|Overall Study|Clinical deterioration|1
5696037|NCT00283244|19639151|P3|Overall Study|Medical illness (other complicating dz)|6
5696038|NCT00283244|19639152|P2|Overall Study|Medical illness (other complicating dz)|3
5696039|NCT00283244|19639153|P1|Overall Study|Medical illness (other complicating dz)|4
5696040|NCT00283244|19639151|P3|Overall Study|Physician Decision|1
5696041|NCT00283244|19639152|P2|Overall Study|Physician Decision|0
5696042|NCT00283244|19639153|P1|Overall Study|Physician Decision|0
5696043|NCT00283244|19639151|P3|Overall Study|Withdrawal by Subject|2
5696044|NCT00283244|19639152|P2|Overall Study|Withdrawal by Subject|2
5696045|NCT00283244|19639153|P1|Overall Study|Withdrawal by Subject|1
5696046|NCT00283244|19639151|P3|Overall Study|Lack of Efficacy|26
5696047|NCT00283244|19639152|P2|Overall Study|Lack of Efficacy|32
5696048|NCT00283244|19639153|P1|Overall Study|Lack of Efficacy|8
5696049|NCT00283244|19639151|P3|Overall Study|Death|2
5696050|NCT00283244|19639152|P2|Overall Study|Death|3
5696051|NCT00283244|19639153|P1|Overall Study|Death|4
5696052|NCT00283244|19639151|P3|Overall Study|Adverse Event|11
5696053|NCT00283244|19639152|P2|Overall Study|Adverse Event|8
5696054|NCT00283244|19639153|P1|Overall Study|Adverse Event|0
5696055|NCT00283062|19639189|P4|Overall Study|chemotherapy not completed (cycle 6)|0
5696056|NCT00283062|19639190|P3|Overall Study|chemotherapy not completed (cycle 6)|0
5696057|NCT00283062|19639191|P2|Overall Study|chemotherapy not completed (cycle 6)|0
5696058|NCT00283062|19639192|P1|Overall Study|chemotherapy not completed (cycle 6)|1
5696059|NCT00283062|19639189|P4|Overall Study|Undefined|4
5696060|NCT00283062|19639190|P3|Overall Study|Undefined|1
5696061|NCT00283062|19639191|P2|Overall Study|Undefined|1
5696062|NCT00283062|19639192|P1|Overall Study|Undefined|0
5696063|NCT00283062|19639189|P4|Overall Study|Participant did not wish to continue|0
5696064|NCT00283062|19639190|P3|Overall Study|Participant did not wish to continue|1
5696065|NCT00283062|19639191|P2|Overall Study|Participant did not wish to continue|2
5696066|NCT00283062|19639192|P1|Overall Study|Participant did not wish to continue|3
5696067|NCT00283062|19639189|P4|Overall Study|Progressive disease|0
5696068|NCT00283062|19639190|P3|Overall Study|Progressive disease|1
5696069|NCT00283062|19639191|P2|Overall Study|Progressive disease|0
5696070|NCT00283062|19639192|P1|Overall Study|Progressive disease|0
5696071|NCT00283062|19639189|P4|Overall Study|Lost to Follow-up|0
5696072|NCT00283062|19639190|P3|Overall Study|Lost to Follow-up|1
5696073|NCT00283062|19639191|P2|Overall Study|Lost to Follow-up|0
5696074|NCT00283062|19639192|P1|Overall Study|Lost to Follow-up|1
5696075|NCT00283062|19639189|P4|Overall Study|Adverse Event|0
5696076|NCT00283062|19639190|P3|Overall Study|Adverse Event|1
5696077|NCT00283062|19639191|P2|Overall Study|Adverse Event|0
5696078|NCT00283062|19639192|P1|Overall Study|Adverse Event|2
5696079|NCT00283062|19639189|P4|Overall Study|Did not receive any study medication|45
5696080|NCT00283062|19639190|P3|Overall Study|Did not receive any study medication|36
5696081|NCT00283062|19639191|P2|Overall Study|Did not receive any study medication|4
5696082|NCT00283062|19639192|P1|Overall Study|Did not receive any study medication|5
5696083|NCT00283049|19639225|P3|Overall Study|No longer requires study treatment|1
5696084|NCT00283049|19639226|P2|Overall Study|No longer requires study treatment|0
5696085|NCT00283049|19639227|P1|Overall Study|No longer requires study treatment|0
5696086|NCT00283049|19639225|P3|Overall Study|Discontinuation of Study|20
5696087|NCT00283049|19639226|P2|Overall Study|Discontinuation of Study|16
5696088|NCT00283049|19639227|P1|Overall Study|Discontinuation of Study|18
5696089|NCT00283049|19639225|P3|Overall Study|Withdrawal by Subject|19
5696090|NCT00283049|19639226|P2|Overall Study|Withdrawal by Subject|24
5696091|NCT00283049|19639227|P1|Overall Study|Withdrawal by Subject|26
5696092|NCT00283049|19639225|P3|Overall Study|Lost to Follow-up|5
5696093|NCT00283049|19639226|P2|Overall Study|Lost to Follow-up|2
5696094|NCT00283049|19639227|P1|Overall Study|Lost to Follow-up|4
5696095|NCT00283049|19639225|P3|Overall Study|Lack of Efficacy|1
5696096|NCT00283049|19639226|P2|Overall Study|Lack of Efficacy|1
5696097|NCT00283049|19639227|P1|Overall Study|Lack of Efficacy|0
5696098|NCT00283049|19639225|P3|Overall Study|Death|1
5696099|NCT00283049|19639226|P2|Overall Study|Death|1
5696100|NCT00283049|19639227|P1|Overall Study|Death|1
5696101|NCT00283049|19639225|P3|Overall Study|Protocol Violation|3
5696102|NCT00283049|19639226|P2|Overall Study|Protocol Violation|0
5696103|NCT00283049|19639227|P1|Overall Study|Protocol Violation|3
5696104|NCT00283049|19639225|P3|Overall Study|Adverse Event|4
5696105|NCT00283049|19639226|P2|Overall Study|Adverse Event|1
5696106|NCT00283049|19639227|P1|Overall Study|Adverse Event|6
5696107|NCT00282984|19639255|P2|Overall Study|Protocol Violation|0
5696108|NCT00282984|19639256|P1|Overall Study|Protocol Violation|2
5696109|NCT00282984|19639255|P2|Overall Study|in prison|1
5696110|NCT00282984|19639256|P1|Overall Study|in prison|0
5696111|NCT00282984|19639255|P2|Overall Study|lack of motivation|0
5696112|NCT00282984|19639256|P1|Overall Study|lack of motivation|1
5696113|NCT00282984|19639255|P2|Overall Study|Participant used antipsychosis meds|1
5696114|NCT00282984|19639256|P1|Overall Study|Participant used antipsychosis meds|0
5696115|NCT00282984|19639255|P2|Overall Study|Participant only allowed phone follow-up|1
5696116|NCT00282984|19639256|P1|Overall Study|Participant only allowed phone follow-up|0
5696117|NCT00282984|19639255|P2|Overall Study|Participant stopped study medication|2
5696118|NCT00282984|19639256|P1|Overall Study|Participant stopped study medication|2
5696119|NCT00282984|19639255|P2|Overall Study|Withdrawal by Participant|34
5696120|NCT00282984|19639256|P1|Overall Study|Withdrawal by Participant|22
5696121|NCT00282984|19639255|P2|Overall Study|Lost to Follow-up|10
5696122|NCT00282984|19639256|P1|Overall Study|Lost to Follow-up|14
5696123|NCT00282984|19639255|P2|Overall Study|Lack of Efficacy|2
5696124|NCT00282984|19639256|P1|Overall Study|Lack of Efficacy|0
5696125|NCT00282984|19639255|P2|Overall Study|Adverse Event|5
5696126|NCT00282984|19639256|P1|Overall Study|Adverse Event|8
5696127|NCT00282984|19639255|P2|Overall Study|Death|5
5696128|NCT00282984|19639256|P1|Overall Study|Death|2
5696129|NCT00282919|19639293|P1|Overall Study|Asymptomatic Parasitemia|2
5696130|NCT00282919|19639293|P1|Overall Study|Withdrawal by Subject|1
5696131|NCT00282919|19639293|P1|Overall Study|Lack of Efficacy|4
5696132|NCT00282867|19639308|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
5696133|NCT00282867|19639309|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
5696134|NCT00282867|19639310|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
5696135|NCT00282568|19639412|P1|Extended Treatment Period|Lost to Follow-up|2
5696136|NCT00282568|19639412|P1|Extended Treatment Period|Physician Decision|1
5696137|NCT00282568|19639412|P1|Extended Treatment Period|Non-compliance|4
5696138|NCT00282568|19639412|P1|Extended Treatment Period|Adverse Event|17
5696139|NCT00282568|19639412|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
5696140|NCT00282568|19639412|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
5696141|NCT00282464|19639438|P2|Overall Study|dropped due to missed visits|1
5696142|NCT00282464|19639439|P1|Overall Study|dropped due to missed visits|0
5696143|NCT00282464|19639438|P2|Overall Study|dispensed wrong kit|1
5696144|NCT00282464|19639439|P1|Overall Study|dispensed wrong kit|0
5696145|NCT00282464|19639438|P2|Overall Study|family crisis|1
5696146|NCT00282464|19639439|P1|Overall Study|family crisis|0
5696147|NCT00282464|19639438|P2|Overall Study|patient incarcerated|1
5696148|NCT00282464|19639439|P1|Overall Study|patient incarcerated|0
5696149|NCT00282464|19639438|P2|Overall Study|patient no show|1
5696150|NCT00282464|19639439|P1|Overall Study|patient no show|0
5696151|NCT00282464|19639438|P2|Overall Study|patient non-compliant|0
5696152|NCT00282464|19639439|P1|Overall Study|patient non-compliant|3
5696153|NCT00282464|19639438|P2|Overall Study|Patient moved|0
5696154|NCT00282464|19639439|P1|Overall Study|Patient moved|1
5696155|NCT00282464|19639438|P2|Overall Study|Protocol Violation|7
5696156|NCT00282464|19639439|P1|Overall Study|Protocol Violation|0
5696157|NCT00282464|19639438|P2|Overall Study|laboratory abnormality|2
5696158|NCT00282464|19639439|P1|Overall Study|laboratory abnormality|1
5696159|NCT00282464|19639438|P2|Overall Study|Withdrawal by Subject|10
5696160|NCT00282464|19639439|P1|Overall Study|Withdrawal by Subject|24
5696161|NCT00282464|19639438|P2|Overall Study|Lost to Follow-up|10
5696162|NCT00282464|19639439|P1|Overall Study|Lost to Follow-up|10
5696163|NCT00282464|19639438|P2|Overall Study|Lack of Efficacy|8
5696164|NCT00282464|19639439|P1|Overall Study|Lack of Efficacy|8
5696165|NCT00282464|19639438|P2|Overall Study|Adverse Event|20
5696166|NCT00282464|19639439|P1|Overall Study|Adverse Event|26
5696167|NCT00282438|19639489|P2|Overall Study|Death|1
5696168|NCT00282438|19639490|P1|Overall Study|Death|0
5696169|NCT00282438|19639489|P2|Overall Study|Lack of Efficacy|0
5696170|NCT00282438|19639490|P1|Overall Study|Lack of Efficacy|1
5696171|NCT00282412|19639500|P1|Overall Study|Death|2
5696172|NCT00282347|19639506|P2|B Cell Follow-up Period|Reason Not Specified|0
5696173|NCT00282347|19639507|P1|B Cell Follow-up Period|Reason Not Specified|2
5696174|NCT00282347|19639506|P2|B Cell Follow-up Period|Physician Decision|0
5696175|NCT00282347|19639507|P1|B Cell Follow-up Period|Physician Decision|1
5696176|NCT00282347|19639506|P2|B Cell Follow-up Period|Withdrawal by Subject|0
5696177|NCT00282347|19639507|P1|B Cell Follow-up Period|Withdrawal by Subject|2
5696178|NCT00282347|19639506|P2|Safety Follow-up Period|Protocol Deviation|2
5696179|NCT00282347|19639507|P1|Safety Follow-up Period|Protocol Deviation|0
5696180|NCT00282347|19639506|P2|Safety Follow-up Period|Physician Decision|1
5696181|NCT00282347|19639507|P1|Safety Follow-up Period|Physician Decision|1
5696182|NCT00282347|19639506|P2|Safety Follow-up Period|Withdrawal by Subject|1
5696183|NCT00282347|19639507|P1|Safety Follow-up Period|Withdrawal by Subject|2
5696184|NCT00282347|19639506|P2|Safety Follow-up Period|Lost to Follow-up|2
5696185|NCT00282347|19639507|P1|Safety Follow-up Period|Lost to Follow-up|0
5696186|NCT00282347|19639506|P2|Treatment Period|Physician Decision|1
5696187|NCT00282347|19639507|P1|Treatment Period|Physician Decision|0
5696188|NCT00282347|19639506|P2|Treatment Period|Withdrawal by Subject|3
5696189|NCT00282347|19639507|P1|Treatment Period|Withdrawal by Subject|1
5696190|NCT00282347|19639506|P2|Treatment Period|Lost to Follow-up|5
5696191|NCT00282347|19639507|P1|Treatment Period|Lost to Follow-up|2
5696192|NCT00282347|19639506|P2|Treatment Period|Death|0
5696193|NCT00282347|19639507|P1|Treatment Period|Death|2
5696194|NCT00282334|19639533|P2|Overall Study|Withdrawal by Subject|5
5696195|NCT00282334|19639534|P1|Overall Study|Withdrawal by Subject|8
5696196|NCT00282308|19639542|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
5696197|NCT00282308|19639543|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
5696198|NCT00282308|19639544|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
5696199|NCT00282308|19639542|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
5696200|NCT00282308|19639543|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
5696201|NCT00282308|19639544|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
5696202|NCT00282308|19639542|P3|Safety Follow-up Period|Lost to Follow-up|5
5696203|NCT00282308|19639543|P2|Safety Follow-up Period|Lost to Follow-up|0
5696204|NCT00282308|19639544|P1|Safety Follow-up Period|Lost to Follow-up|0
5696205|NCT00282308|19639542|P3|Safety Follow-up Period|Adverse Event|1
5696206|NCT00282308|19639543|P2|Safety Follow-up Period|Adverse Event|0
5696207|NCT00282308|19639544|P1|Safety Follow-up Period|Adverse Event|0
5696208|NCT00282308|19639542|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
5696209|NCT00282308|19639543|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
5696210|NCT00282308|19639544|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
5696211|NCT00282308|19639542|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
5696212|NCT00282308|19639543|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
5696213|NCT00282308|19639544|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
5696214|NCT00282308|19639542|P3|Optional Extension Re-treatment Period|Adverse Event|4
5696215|NCT00282308|19639543|P2|Optional Extension Re-treatment Period|Adverse Event|0
5696216|NCT00282308|19639544|P1|Optional Extension Re-treatment Period|Adverse Event|0
5696217|NCT00282308|19639542|P3|Treatment Period|Not Treated with Study Drug|0
5696218|NCT00282308|19639543|P2|Treatment Period|Not Treated with Study Drug|0
5696219|NCT00282308|19639544|P1|Treatment Period|Not Treated with Study Drug|1
5696220|NCT00282308|19639542|P3|Treatment Period|Adverse Event|0
5696221|NCT00282308|19639543|P2|Treatment Period|Adverse Event|2
5696222|NCT00282308|19639544|P1|Treatment Period|Adverse Event|0
5696223|NCT00282308|19639542|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
5696224|NCT00282308|19639543|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
5696225|NCT00282308|19639544|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
5696226|NCT00282308|19639542|P3|Treatment Period|Lost to Follow-up|0
5696227|NCT00282308|19639543|P2|Treatment Period|Lost to Follow-up|0
5696228|NCT00282308|19639544|P1|Treatment Period|Lost to Follow-up|1
5696229|NCT00282295|19639574|P3|Overall Study|Other|0
5696230|NCT00282295|19639575|P2|Overall Study|Other|1
5696231|NCT00282295|19639576|P1|Overall Study|Other|0
5696232|NCT00282295|19639574|P3|Overall Study|Lost to Follow-up|2
5696233|NCT00282295|19639575|P2|Overall Study|Lost to Follow-up|7
5696234|NCT00282295|19639576|P1|Overall Study|Lost to Follow-up|1
5696235|NCT00282295|19639574|P3|Overall Study|Withdrawal by Subject|4
5696236|NCT00282295|19639575|P2|Overall Study|Withdrawal by Subject|6
5696237|NCT00282295|19639576|P1|Overall Study|Withdrawal by Subject|2
5696238|NCT00282295|19639574|P3|Overall Study|Protocol Violation|1
5696239|NCT00282295|19639575|P2|Overall Study|Protocol Violation|2
5696240|NCT00282295|19639576|P1|Overall Study|Protocol Violation|0
5696241|NCT00282295|19639574|P3|Overall Study|Serious Adverse Events|1
5696242|NCT00282295|19639575|P2|Overall Study|Serious Adverse Events|0
5696243|NCT00282295|19639576|P1|Overall Study|Serious Adverse Events|0
5696244|NCT00282295|19639574|P3|Overall Study|Adverse Event|0
5696245|NCT00282295|19639575|P2|Overall Study|Adverse Event|1
5696246|NCT00282295|19639576|P1|Overall Study|Adverse Event|0
5696247|NCT00282256|19639631|P1|Extension Treatment Period|Adverse Event|2
5696248|NCT00282256|19639631|P1|Pharmacokinetic Treatment Period|Poor venous access|1
5696249|NCT00282243|19639652|P1|Extension Treatment Period|Physician Decision|1
5696250|NCT00282243|19639652|P1|Extension Treatment Period|Non-compliance|2
5696251|NCT00282243|19639652|P1|Extension Treatment Period|Withdrawal by Subject|4
5696252|NCT00282243|19639652|P1|Extension Treatment Period|Adverse Event|15
5696253|NCT00282243|19639652|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
5696254|NCT00282243|19639652|P1|Pharmacokinetic Treatment Period|Adverse Event|3
5696255|NCT00282152|19639678|P2|Overall Study|Withdrawal by Subject|0
5696256|NCT00282152|19639679|P1|Overall Study|Withdrawal by Subject|1
5696257|NCT00282113|19639700|P3|Overall Study|Removed at parents request|0
5696258|NCT00282113|19639701|P2|Overall Study|Removed at parents request|0
5696259|NCT00282113|19639702|P1|Overall Study|Removed at parents request|1
5696260|NCT00282087|19639716|P1|Overall Study|Death|1
5696261|NCT00282048|19639729|P1|Overall Study|Ongoing|1
5696262|NCT00282048|19639729|P1|Overall Study|Other|8
5696263|NCT00282048|19639729|P1|Overall Study|Withdrawal by Subject|1
5696264|NCT00282048|19639729|P1|Overall Study|Adverse Event|22
5696265|NCT00282048|19639729|P1|Overall Study|Lack of Efficacy|30
5696266|NCT00281957|19639743|P2|Overall Study|Refusal unrelated to adverse events|1
5696267|NCT00281957|19639744|P1|Overall Study|Refusal unrelated to adverse events|0
5696268|NCT00281957|19639743|P2|Overall Study|Did not start treatment|1
5696269|NCT00281957|19639744|P1|Overall Study|Did not start treatment|3
5696270|NCT00281957|19639743|P2|Overall Study|Not eligible|2
5696271|NCT00281957|19639744|P1|Overall Study|Not eligible|1
5696272|NCT00281957|19639743|P2|Overall Study|Not protocol specified|1
5696273|NCT00281957|19639744|P1|Overall Study|Not protocol specified|8
5696274|NCT00281957|19639743|P2|Overall Study|Progression/relapse|35
5696275|NCT00281957|19639744|P1|Overall Study|Progression/relapse|47
5696276|NCT00281957|19639743|P2|Overall Study|Death|0
5696277|NCT00281957|19639744|P1|Overall Study|Death|1
5696278|NCT00281957|19639743|P2|Overall Study|Adverse Event|2
5696279|NCT00281957|19639744|P1|Overall Study|Adverse Event|7
5696280|NCT00281840|19639818|P1|Overall Study|Complicating Disease|1
5696281|NCT00281840|19639818|P1|Overall Study|exceed maximum delay in treatment|1
5696282|NCT00281840|19639818|P1|Overall Study|Disease Progression|2
5696283|NCT00281840|19639818|P1|Overall Study|Withdrawal by Subject|3
5696284|NCT00281840|19639818|P1|Overall Study|Physician Decision|6
5696285|NCT00281840|19639818|P1|Overall Study|Adverse Event|12
5696286|NCT00281697|19639834|P2|Overall Study|Did not receive study drug|2
5696287|NCT00281697|19639835|P1|Overall Study|Did not receive study drug|3
5696288|NCT00281697|19639834|P2|Overall Study|Subject/guardian's decision to withdraw|6
5696289|NCT00281697|19639835|P1|Overall Study|Subject/guardian's decision to withdraw|33
5696290|NCT00281697|19639834|P2|Overall Study|Physician's decision to withdraw|12
5696291|NCT00281697|19639835|P1|Overall Study|Physician's decision to withdraw|15
5696292|NCT00281697|19639834|P2|Overall Study|Other|6
5696293|NCT00281697|19639835|P1|Overall Study|Other|5
5696294|NCT00281697|19639834|P2|Overall Study|Disease progression|149
5696295|NCT00281697|19639835|P1|Overall Study|Disease progression|279
5696296|NCT00281697|19639834|P2|Overall Study|Death|3
5696297|NCT00281697|19639835|P1|Overall Study|Death|8
5696298|NCT00281697|19639834|P2|Overall Study|Adverse Event|15
5696299|NCT00281697|19639835|P1|Overall Study|Adverse Event|54
5696300|NCT00281697|19639834|P2|Overall Study|> 60 days since last dose of study drug|4
5696301|NCT00281697|19639835|P1|Overall Study|> 60 days since last dose of study drug|4
5696302|NCT00281684|19639855|P4|Overall Study|Withdrawal by Subject|0
5696303|NCT00281684|19639856|P3|Overall Study|Withdrawal by Subject|0
5696304|NCT00281684|19639857|P2|Overall Study|Withdrawal by Subject|0
5696305|NCT00281684|19639858|P1|Overall Study|Withdrawal by Subject|1
5696306|NCT00281684|19639855|P4|Overall Study|Lost to Follow-up|0
5696307|NCT00281684|19639856|P3|Overall Study|Lost to Follow-up|1
5696308|NCT00281684|19639857|P2|Overall Study|Lost to Follow-up|0
5696309|NCT00281684|19639858|P1|Overall Study|Lost to Follow-up|0
5696310|NCT00281658|19639945|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
5696311|NCT00281658|19639946|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
5696312|NCT00281658|19639947|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
5696313|NCT00281658|19639945|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
5696314|NCT00281658|19639946|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
5696315|NCT00281658|19639947|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
5696316|NCT00281658|19639945|P3|Open-label Monotherapy Extension Phase|Death|97
5696317|NCT00281658|19639946|P2|Open-label Monotherapy Extension Phase|Death|0
5696318|NCT00281658|19639947|P1|Open-label Monotherapy Extension Phase|Death|0
5696319|NCT00281658|19639945|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
5696320|NCT00281658|19639946|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
5696321|NCT00281658|19639947|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
5696322|NCT00281658|19639945|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
5696323|NCT00281658|19639946|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
5696324|NCT00281658|19639947|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
5696325|NCT00281658|19639945|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
5696326|NCT00281658|19639946|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
5696327|NCT00281658|19639947|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
5696328|NCT00281658|19639945|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
5696329|NCT00281658|19639946|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
5696330|NCT00281658|19639947|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
5696331|NCT00281658|19639945|P3|Double-blind, Randomized Phase|Death|0
5696332|NCT00281658|19639946|P2|Double-blind, Randomized Phase|Death|46
5696333|NCT00281658|19639947|P1|Double-blind, Randomized Phase|Death|120
5696334|NCT00281632|19639964|P1|Overall Study|Ongoing|3
5696335|NCT00281632|19639964|P1|Overall Study|Physician Decision|1
5696336|NCT00281632|19639964|P1|Overall Study|Death|1
5696337|NCT00281632|19639964|P1|Overall Study|Disease Progression|22
5696338|NCT00281632|19639964|P1|Overall Study|Withdrawal by Subject|2
5696339|NCT00281632|19639964|P1|Overall Study|Adverse Event|7
5696340|NCT00281580|19640006|P16|Overall Study|Randomised in error; pregnancy; moving|2
5696341|NCT00281580|19640007|P15|Overall Study|Randomised in error; pregnancy; moving|1
5696342|NCT00281580|19640008|P14|Overall Study|Randomised in error; pregnancy; moving|0
5696343|NCT00281580|19640009|P13|Overall Study|Randomised in error; pregnancy; moving|2
5696344|NCT00281580|19640010|P12|Overall Study|Randomised in error; pregnancy; moving|1
5696345|NCT00281580|19640011|P11|Overall Study|Randomised in error; pregnancy; moving|1
5696346|NCT00281580|19640012|P10|Overall Study|Randomised in error; pregnancy; moving|1
5696347|NCT00281580|19640013|P9|Overall Study|Randomised in error; pregnancy; moving|2
5696348|NCT00281580|19640014|P8|Overall Study|Randomised in error; pregnancy; moving|0
5696349|NCT00281580|19640015|P7|Overall Study|Randomised in error; pregnancy; moving|1
5696350|NCT00281580|19640016|P6|Overall Study|Randomised in error; pregnancy; moving|0
5696351|NCT00281580|19640017|P5|Overall Study|Randomised in error; pregnancy; moving|0
5696352|NCT00281580|19640018|P4|Overall Study|Randomised in error; pregnancy; moving|2
5696353|NCT00281580|19640019|P3|Overall Study|Randomised in error; pregnancy; moving|0
5696354|NCT00281580|19640020|P2|Overall Study|Randomised in error; pregnancy; moving|0
5696355|NCT00281580|19640021|P1|Overall Study|Randomised in error; pregnancy; moving|0
5696356|NCT00281580|19640006|P16|Overall Study|Lost to Follow-up|0
5696357|NCT00281580|19640007|P15|Overall Study|Lost to Follow-up|0
5696358|NCT00281580|19640008|P14|Overall Study|Lost to Follow-up|0
5696359|NCT00281580|19640009|P13|Overall Study|Lost to Follow-up|1
5696360|NCT00281580|19640010|P12|Overall Study|Lost to Follow-up|0
5696361|NCT00281580|19640011|P11|Overall Study|Lost to Follow-up|1
5696362|NCT00281580|19640012|P10|Overall Study|Lost to Follow-up|1
5696363|NCT00281580|19640013|P9|Overall Study|Lost to Follow-up|2
5696364|NCT00281580|19640014|P8|Overall Study|Lost to Follow-up|1
5696365|NCT00281580|19640015|P7|Overall Study|Lost to Follow-up|0
5696366|NCT00281580|19640016|P6|Overall Study|Lost to Follow-up|1
5696367|NCT00281580|19640017|P5|Overall Study|Lost to Follow-up|0
5696368|NCT00281580|19640018|P4|Overall Study|Lost to Follow-up|3
5696369|NCT00281580|19640019|P3|Overall Study|Lost to Follow-up|0
5696370|NCT00281580|19640020|P2|Overall Study|Lost to Follow-up|0
5696371|NCT00281580|19640021|P1|Overall Study|Lost to Follow-up|0
5696372|NCT00281580|19640006|P16|Overall Study|Lack of Efficacy|0
5696373|NCT00281580|19640007|P15|Overall Study|Lack of Efficacy|1
5696374|NCT00281580|19640008|P14|Overall Study|Lack of Efficacy|2
5696375|NCT00281580|19640009|P13|Overall Study|Lack of Efficacy|0
5696376|NCT00281580|19640010|P12|Overall Study|Lack of Efficacy|1
5696377|NCT00281580|19640011|P11|Overall Study|Lack of Efficacy|0
5696378|NCT00281580|19640012|P10|Overall Study|Lack of Efficacy|0
5696379|NCT00281580|19640013|P9|Overall Study|Lack of Efficacy|0
5696380|NCT00281580|19640014|P8|Overall Study|Lack of Efficacy|0
5696381|NCT00281580|19640015|P7|Overall Study|Lack of Efficacy|0
5696382|NCT00281580|19640016|P6|Overall Study|Lack of Efficacy|0
5696383|NCT00281580|19640017|P5|Overall Study|Lack of Efficacy|2
5696384|NCT00281580|19640018|P4|Overall Study|Lack of Efficacy|6
5696385|NCT00281580|19640019|P3|Overall Study|Lack of Efficacy|1
5696386|NCT00281580|19640020|P2|Overall Study|Lack of Efficacy|1
5696387|NCT00281580|19640021|P1|Overall Study|Lack of Efficacy|2
5696388|NCT00281580|19640006|P16|Overall Study|Withdrawal by Subject|5
5696389|NCT00281580|19640007|P15|Overall Study|Withdrawal by Subject|1
5696390|NCT00281580|19640008|P14|Overall Study|Withdrawal by Subject|2
5696391|NCT00281580|19640009|P13|Overall Study|Withdrawal by Subject|2
5696392|NCT00281580|19640010|P12|Overall Study|Withdrawal by Subject|1
5696393|NCT00281580|19640011|P11|Overall Study|Withdrawal by Subject|1
5696394|NCT00281580|19640012|P10|Overall Study|Withdrawal by Subject|4
5696395|NCT00281580|19640013|P9|Overall Study|Withdrawal by Subject|1
5696396|NCT00281580|19640014|P8|Overall Study|Withdrawal by Subject|0
5696397|NCT00281580|19640015|P7|Overall Study|Withdrawal by Subject|2
5696398|NCT00281580|19640016|P6|Overall Study|Withdrawal by Subject|2
5696399|NCT00281580|19640017|P5|Overall Study|Withdrawal by Subject|1
5696400|NCT00281580|19640018|P4|Overall Study|Withdrawal by Subject|1
5696401|NCT00281580|19640019|P3|Overall Study|Withdrawal by Subject|1
5696402|NCT00281580|19640020|P2|Overall Study|Withdrawal by Subject|0
5696403|NCT00281580|19640021|P1|Overall Study|Withdrawal by Subject|3
5696404|NCT00281580|19640006|P16|Overall Study|Protocol Violation|3
5696405|NCT00281580|19640007|P15|Overall Study|Protocol Violation|1
5696406|NCT00281580|19640008|P14|Overall Study|Protocol Violation|1
5696407|NCT00281580|19640009|P13|Overall Study|Protocol Violation|0
5696408|NCT00281580|19640010|P12|Overall Study|Protocol Violation|2
5696409|NCT00281580|19640011|P11|Overall Study|Protocol Violation|1
5696410|NCT00281580|19640012|P10|Overall Study|Protocol Violation|0
5696411|NCT00281580|19640013|P9|Overall Study|Protocol Violation|2
5696412|NCT00281580|19640014|P8|Overall Study|Protocol Violation|0
5696413|NCT00281580|19640015|P7|Overall Study|Protocol Violation|1
5696414|NCT00281580|19640016|P6|Overall Study|Protocol Violation|0
5696415|NCT00281580|19640017|P5|Overall Study|Protocol Violation|0
5696416|NCT00281580|19640018|P4|Overall Study|Protocol Violation|1
5696417|NCT00281580|19640019|P3|Overall Study|Protocol Violation|1
5696418|NCT00281580|19640020|P2|Overall Study|Protocol Violation|0
5696419|NCT00281580|19640021|P1|Overall Study|Protocol Violation|0
5696420|NCT00281580|19640006|P16|Overall Study|Adverse Event|3
5696421|NCT00281580|19640007|P15|Overall Study|Adverse Event|3
5696422|NCT00281580|19640008|P14|Overall Study|Adverse Event|2
5696423|NCT00281580|19640009|P13|Overall Study|Adverse Event|8
5696424|NCT00281580|19640010|P12|Overall Study|Adverse Event|5
5696425|NCT00281580|19640011|P11|Overall Study|Adverse Event|0
5696426|NCT00281580|19640012|P10|Overall Study|Adverse Event|6
5696427|NCT00281580|19640013|P9|Overall Study|Adverse Event|1
5696428|NCT00281580|19640014|P8|Overall Study|Adverse Event|0
5696429|NCT00281580|19640015|P7|Overall Study|Adverse Event|1
5696430|NCT00281580|19640016|P6|Overall Study|Adverse Event|0
5696431|NCT00281580|19640017|P5|Overall Study|Adverse Event|1
5696432|NCT00281580|19640018|P4|Overall Study|Adverse Event|4
5696433|NCT00281580|19640019|P3|Overall Study|Adverse Event|2
5696434|NCT00281580|19640020|P2|Overall Study|Adverse Event|0
5696435|NCT00281580|19640021|P1|Overall Study|Adverse Event|2
5696436|NCT00281528|19640368|P3|Overall Study|Other|5
5696437|NCT00281528|19640369|P2|Overall Study|Other|3
5696438|NCT00281528|19640370|P1|Overall Study|Other|6
5696439|NCT00281528|19640368|P3|Overall Study|Withdrawal by Subject|7
5696440|NCT00281528|19640369|P2|Overall Study|Withdrawal by Subject|5
5696441|NCT00281528|19640370|P1|Overall Study|Withdrawal by Subject|5
5696442|NCT00281528|19640368|P3|Overall Study|Protocol Violation|1
5696443|NCT00281528|19640369|P2|Overall Study|Protocol Violation|0
5696444|NCT00281528|19640370|P1|Overall Study|Protocol Violation|1
5696445|NCT00281528|19640368|P3|Overall Study|Physician Decision|5
5696446|NCT00281528|19640369|P2|Overall Study|Physician Decision|4
5696447|NCT00281528|19640370|P1|Overall Study|Physician Decision|11
5696448|NCT00281528|19640368|P3|Overall Study|Adverse Event-unrelated to treatment|2
5696449|NCT00281528|19640369|P2|Overall Study|Adverse Event-unrelated to treatment|0
5696450|NCT00281528|19640370|P1|Overall Study|Adverse Event-unrelated to treatment|3
5696451|NCT00281528|19640368|P3|Overall Study|Unacceptable Toxicity-related to trt|32
5696452|NCT00281528|19640369|P2|Overall Study|Unacceptable Toxicity-related to trt|24
5696453|NCT00281528|19640370|P1|Overall Study|Unacceptable Toxicity-related to trt|21
5696454|NCT00281528|19640368|P3|Overall Study|Progressive Disease|27
5696455|NCT00281528|19640369|P2|Overall Study|Progressive Disease|18
5696456|NCT00281528|19640370|P1|Overall Study|Progressive Disease|28
5696457|NCT00281320|19640421|P2|Overall Study|Other|1
5696458|NCT00281320|19640422|P1|Overall Study|Other|3
5696459|NCT00281320|19640421|P2|Overall Study|Lost to Follow-up|2
5696460|NCT00281320|19640422|P1|Overall Study|Lost to Follow-up|1
5696461|NCT00281320|19640421|P2|Overall Study|Withdrawal by Subject|6
5696462|NCT00281320|19640422|P1|Overall Study|Withdrawal by Subject|5
5696463|NCT00281320|19640421|P2|Overall Study|Lack of Efficacy|3
5696464|NCT00281320|19640422|P1|Overall Study|Lack of Efficacy|4
5696465|NCT00281320|19640421|P2|Overall Study|Adverse Event|9
5696466|NCT00281320|19640422|P1|Overall Study|Adverse Event|12
5696467|NCT00281099|19640444|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
5696468|NCT00281099|19640445|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
5696469|NCT00281099|19640444|P2|Overall Study|Physician Decision|72
5696470|NCT00281099|19640445|P1|Overall Study|Physician Decision|79
5696471|NCT00281099|19640444|P2|Overall Study|Withdrawal by Subject|70
5696472|NCT00281099|19640445|P1|Overall Study|Withdrawal by Subject|65
5696473|NCT00281099|19640444|P2|Overall Study|Lost to Follow-up|19
5696474|NCT00281099|19640445|P1|Overall Study|Lost to Follow-up|10
5696475|NCT00281099|19640444|P2|Overall Study|Death|57
5696476|NCT00281099|19640445|P1|Overall Study|Death|46
5696477|NCT00280917|19640494|P4|Overall Study|Noncompliance|0
5696478|NCT00280917|19640495|P3|Overall Study|Noncompliance|2
5696479|NCT00280917|19640496|P2|Overall Study|Noncompliance|1
5696480|NCT00280917|19640497|P1|Overall Study|Noncompliance|0
5696481|NCT00280917|19640494|P4|Overall Study|Withdrawal by Subject|1
5696482|NCT00280917|19640495|P3|Overall Study|Withdrawal by Subject|0
5696483|NCT00280917|19640496|P2|Overall Study|Withdrawal by Subject|2
5696484|NCT00280917|19640497|P1|Overall Study|Withdrawal by Subject|0
5696485|NCT00280917|19640494|P4|Overall Study|Change Therapy|0
5696486|NCT00280917|19640495|P3|Overall Study|Change Therapy|0
5696487|NCT00280917|19640496|P2|Overall Study|Change Therapy|2
5696488|NCT00280917|19640497|P1|Overall Study|Change Therapy|1
5696489|NCT00280917|19640494|P4|Overall Study|Adverse Event|1
5696490|NCT00280917|19640495|P3|Overall Study|Adverse Event|4
5696491|NCT00280917|19640496|P2|Overall Study|Adverse Event|1
5696492|NCT00280917|19640497|P1|Overall Study|Adverse Event|1
5696493|NCT00280748|19640520|P1|Overall Study|Extra-cranial disease progression|1
5696494|NCT00280748|19640520|P1|Overall Study|Decline in performance|3
5696495|NCT00280735|19640530|P1|Overall Study|Intercurrent Illness|2
5696496|NCT00280735|19640530|P1|Overall Study|Withdrawal by Subject|8
5696497|NCT00280735|19640530|P1|Overall Study|Lack of Efficacy|3
5696498|NCT00280735|19640530|P1|Overall Study|Adverse Event|5
5696499|NCT00280683|19640542|P2|Overall Study|Adverse Event|1
5696500|NCT00280683|19640543|P1|Overall Study|Adverse Event|1
5696501|NCT00280683|19640542|P2|Overall Study|Withdrawal by Subject|2
5696502|NCT00280683|19640543|P1|Overall Study|Withdrawal by Subject|1
5696503|NCT00280566|19640553|P3|Period 2 Double Blind|miscellaneous|5
5696504|NCT00280566|19640554|P2|Period 2 Double Blind|miscellaneous|10
5696505|NCT00280566|19640555|P1|Period 2 Double Blind|miscellaneous|0
5696506|NCT00280566|19640553|P3|Period 2 Double Blind|Withdrawal by Subject|9
5696507|NCT00280566|19640554|P2|Period 2 Double Blind|Withdrawal by Subject|9
5696508|NCT00280566|19640555|P1|Period 2 Double Blind|Withdrawal by Subject|0
5696509|NCT00280566|19640553|P3|Period 2 Double Blind|Lost to Follow-up|6
5696510|NCT00280566|19640554|P2|Period 2 Double Blind|Lost to Follow-up|3
5696511|NCT00280566|19640555|P1|Period 2 Double Blind|Lost to Follow-up|0
5696512|NCT00280566|19640553|P3|Period 2 Double Blind|Adverse Event|15
5696513|NCT00280566|19640554|P2|Period 2 Double Blind|Adverse Event|11
5696514|NCT00280566|19640555|P1|Period 2 Double Blind|Adverse Event|0
5696515|NCT00280566|19640553|P3|Period 2 Double Blind|Laboratory Abnormality|0
5696516|NCT00280566|19640554|P2|Period 2 Double Blind|Laboratory Abnormality|1
5696517|NCT00280566|19640555|P1|Period 2 Double Blind|Laboratory Abnormality|0
5696518|NCT00280566|19640553|P3|Period 2 Double Blind|Lack of Efficacy|22
5696519|NCT00280566|19640554|P2|Period 2 Double Blind|Lack of Efficacy|9
5696520|NCT00280566|19640555|P1|Period 2 Double Blind|Lack of Efficacy|0
5696521|NCT00280566|19640553|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
5696522|NCT00280566|19640554|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
5696523|NCT00280566|19640555|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
5696524|NCT00280566|19640553|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
5696525|NCT00280566|19640554|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
5696526|NCT00280566|19640555|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
5696527|NCT00280566|19640553|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
5696528|NCT00280566|19640554|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
5696529|NCT00280566|19640555|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
5696530|NCT00280566|19640553|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
5696531|NCT00280566|19640554|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
5696532|NCT00280566|19640555|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
5696533|NCT00280566|19640553|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
5696534|NCT00280566|19640554|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
5696535|NCT00280566|19640555|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
5696536|NCT00280566|19640553|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
5696537|NCT00280566|19640554|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
5696538|NCT00280566|19640555|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
5696539|NCT00280397|19640580|P1|Overall Study|Adverse Event|1
5696540|NCT00280293|19640646|P2|Overall Study|Adverse Event|1
5696541|NCT00280293|19640647|P1|Overall Study|Adverse Event|0
5696542|NCT00280293|19640646|P2|Overall Study|Incarceration/Legal Reasons|1
5696543|NCT00280293|19640647|P1|Overall Study|Incarceration/Legal Reasons|1
5696544|NCT00280293|19640646|P2|Overall Study|Withdrawal by Subject|5
5696545|NCT00280293|19640647|P1|Overall Study|Withdrawal by Subject|3
5696546|NCT00280293|19640646|P2|Overall Study|Lost to Follow-up|12
5696547|NCT00280293|19640647|P1|Overall Study|Lost to Follow-up|14
5696548|NCT00280293|19640646|P2|Overall Study|Physician Decision|4
5696549|NCT00280293|19640647|P1|Overall Study|Physician Decision|5
5696550|NCT00280293|19640646|P2|Overall Study|Protocol Violation|0
5696551|NCT00280293|19640647|P1|Overall Study|Protocol Violation|3
5696552|NCT00280150|19640670|P4|Overall Study|Declining Performance Status|1
5696553|NCT00280150|19640671|P3|Overall Study|Declining Performance Status|0
5696554|NCT00280150|19640672|P2|Overall Study|Declining Performance Status|0
5696555|NCT00280150|19640673|P1|Overall Study|Declining Performance Status|0
5696556|NCT00280150|19640670|P4|Overall Study|Did not get consolidation therapy|0
5696557|NCT00280150|19640671|P3|Overall Study|Did not get consolidation therapy|3
5696558|NCT00280150|19640672|P2|Overall Study|Did not get consolidation therapy|0
5696559|NCT00280150|19640673|P1|Overall Study|Did not get consolidation therapy|3
5696560|NCT00280150|19640670|P4|Overall Study|Withdrawal by Subject|1
5696561|NCT00280150|19640671|P3|Overall Study|Withdrawal by Subject|0
5696562|NCT00280150|19640672|P2|Overall Study|Withdrawal by Subject|0
5696563|NCT00280150|19640673|P1|Overall Study|Withdrawal by Subject|0
5696564|NCT00280150|19640670|P4|Overall Study|Protocol Violation|1
5696565|NCT00280150|19640671|P3|Overall Study|Protocol Violation|0
5696566|NCT00280150|19640672|P2|Overall Study|Protocol Violation|0
5696567|NCT00280150|19640673|P1|Overall Study|Protocol Violation|0
5696568|NCT00280150|19640670|P4|Overall Study|Physician Decision|1
5696569|NCT00280150|19640671|P3|Overall Study|Physician Decision|0
5696570|NCT00280150|19640672|P2|Overall Study|Physician Decision|0
5696571|NCT00280150|19640673|P1|Overall Study|Physician Decision|0
5696572|NCT00280150|19640670|P4|Overall Study|Lack of Efficacy|3
5696573|NCT00280150|19640671|P3|Overall Study|Lack of Efficacy|0
5696574|NCT00280150|19640672|P2|Overall Study|Lack of Efficacy|0
5696575|NCT00280150|19640673|P1|Overall Study|Lack of Efficacy|0
5696576|NCT00280150|19640670|P4|Overall Study|Adverse Event|3
5696577|NCT00280150|19640671|P3|Overall Study|Adverse Event|2
5696578|NCT00280150|19640672|P2|Overall Study|Adverse Event|1
5696579|NCT00280150|19640673|P1|Overall Study|Adverse Event|0
5696580|NCT00280059|19640688|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
5696581|NCT00280059|19640689|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
5696582|NCT00280059|19640688|P2|Efficacy Assessment Phase|Other|8
5696583|NCT00280059|19640689|P1|Efficacy Assessment Phase|Other|7
5696584|NCT00280059|19640688|P2|Efficacy Assessment Phase|Lost to Follow-up|13
5696585|NCT00280059|19640689|P1|Efficacy Assessment Phase|Lost to Follow-up|6
5696586|NCT00280059|19640688|P2|Efficacy Assessment Phase|Lack of Efficacy|3
5696587|NCT00280059|19640689|P1|Efficacy Assessment Phase|Lack of Efficacy|19
5696588|NCT00280059|19640688|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
5696589|NCT00280059|19640689|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
5696590|NCT00280059|19640688|P2|Efficacy Assessment Phase|Adverse Event|31
5696591|NCT00280059|19640689|P1|Efficacy Assessment Phase|Adverse Event|33
5696592|NCT00280059|19640688|P2|Efficacy Assessment Phase|Death|0
5696593|NCT00280059|19640689|P1|Efficacy Assessment Phase|Death|2
5696594|NCT00279916|19640753|P2|Overall Study|Lost to Follow-up|2
5696595|NCT00279916|19640754|P1|Overall Study|Lost to Follow-up|3
5696596|NCT00279916|19640753|P2|Overall Study|Withdrawal by Subject|3
5696597|NCT00279916|19640754|P1|Overall Study|Withdrawal by Subject|4
5696598|NCT00279812|19640780|P6|Overall Study|Adverse Event|1
5696599|NCT00279812|19640781|P5|Overall Study|Adverse Event|2
5696600|NCT00279812|19640782|P4|Overall Study|Adverse Event|0
5696601|NCT00279812|19640783|P3|Overall Study|Adverse Event|1
5696602|NCT00279812|19640784|P2|Overall Study|Adverse Event|1
5696603|NCT00279812|19640785|P1|Overall Study|Adverse Event|0
5696604|NCT00279812|19640780|P6|Overall Study|Withdrawal by Subject|0
5696605|NCT00279812|19640781|P5|Overall Study|Withdrawal by Subject|0
5696606|NCT00279812|19640782|P4|Overall Study|Withdrawal by Subject|0
5696607|NCT00279812|19640783|P3|Overall Study|Withdrawal by Subject|2
5696608|NCT00279812|19640784|P2|Overall Study|Withdrawal by Subject|4
5696609|NCT00279812|19640785|P1|Overall Study|Withdrawal by Subject|0
5696610|NCT00279812|19640780|P6|Overall Study|Protocol Violation|0
5696611|NCT00279812|19640781|P5|Overall Study|Protocol Violation|1
5696612|NCT00279812|19640782|P4|Overall Study|Protocol Violation|0
5696613|NCT00279812|19640783|P3|Overall Study|Protocol Violation|0
5696614|NCT00279812|19640784|P2|Overall Study|Protocol Violation|1
5696615|NCT00279812|19640785|P1|Overall Study|Protocol Violation|1
5696616|NCT00279708|19640813|P2|Overall Study|Adverse Event|1
5696617|NCT00279708|19640814|P1|Overall Study|Adverse Event|1
5696618|NCT00279708|19640813|P2|Overall Study|Withdrawal by Subject|3
5696619|NCT00279708|19640814|P1|Overall Study|Withdrawal by Subject|2
5696620|NCT00279305|19640852|P2|Overall Study|FDA Safety Alert|1
5696621|NCT00279305|19640853|P1|Overall Study|FDA Safety Alert|4
5696622|NCT00279305|19640852|P2|Overall Study|Dificulting establishing IV|0
5696623|NCT00279305|19640853|P1|Overall Study|Dificulting establishing IV|1
5696624|NCT00279305|19640852|P2|Overall Study|Withdrawal by Subject|0
5696625|NCT00279305|19640853|P1|Overall Study|Withdrawal by Subject|2
5696626|NCT00279305|19640852|P2|Overall Study|Pregnancy|0
5696627|NCT00279305|19640853|P1|Overall Study|Pregnancy|1
5696628|NCT00279214|19640861|P2|Overall Study|Physician Decision|2
5696629|NCT00279214|19640862|P1|Overall Study|Physician Decision|3
5696630|NCT00279201|19640892|P6|Intensification Addendum|Death|0
5696631|NCT00279201|19640893|P5|Intensification Addendum|Death|1
5696632|NCT00279201|19640894|P4|Intensification Addendum|Death|0
5696633|NCT00279201|19640895|P3|Intensification Addendum|Death|0
5696634|NCT00279201|19640896|P2|Intensification Addendum|Death|0
5696635|NCT00279201|19640897|P1|Intensification Addendum|Death|0
5696636|NCT00279201|19640892|P6|Intensification Addendum|Lack of Efficacy|0
5696637|NCT00279201|19640893|P5|Intensification Addendum|Lack of Efficacy|1
5696638|NCT00279201|19640894|P4|Intensification Addendum|Lack of Efficacy|1
5696639|NCT00279201|19640895|P3|Intensification Addendum|Lack of Efficacy|0
5696640|NCT00279201|19640896|P2|Intensification Addendum|Lack of Efficacy|0
5696641|NCT00279201|19640897|P1|Intensification Addendum|Lack of Efficacy|0
5696642|NCT00279201|19640892|P6|Intensification Addendum|Entry Criteria Exclusion|0
5696643|NCT00279201|19640893|P5|Intensification Addendum|Entry Criteria Exclusion|0
5696644|NCT00279201|19640894|P4|Intensification Addendum|Entry Criteria Exclusion|0
5696645|NCT00279201|19640895|P3|Intensification Addendum|Entry Criteria Exclusion|1
5696646|NCT00279201|19640896|P2|Intensification Addendum|Entry Criteria Exclusion|0
5696647|NCT00279201|19640897|P1|Intensification Addendum|Entry Criteria Exclusion|0
5696648|NCT00279201|19640892|P6|Intensification Addendum|Sponsor Decision|1
5696649|NCT00279201|19640893|P5|Intensification Addendum|Sponsor Decision|1
5696650|NCT00279201|19640894|P4|Intensification Addendum|Sponsor Decision|0
5696651|NCT00279201|19640895|P3|Intensification Addendum|Sponsor Decision|0
5696652|NCT00279201|19640896|P2|Intensification Addendum|Sponsor Decision|0
5696653|NCT00279201|19640897|P1|Intensification Addendum|Sponsor Decision|0
5696654|NCT00279201|19640892|P6|Intensification Addendum|Physician Decision|2
5696655|NCT00279201|19640893|P5|Intensification Addendum|Physician Decision|3
5696656|NCT00279201|19640894|P4|Intensification Addendum|Physician Decision|1
5696657|NCT00279201|19640895|P3|Intensification Addendum|Physician Decision|4
5696658|NCT00279201|19640896|P2|Intensification Addendum|Physician Decision|0
5696659|NCT00279201|19640897|P1|Intensification Addendum|Physician Decision|0
5696660|NCT00279201|19640892|P6|Intensification Addendum|Adverse Event|3
5696661|NCT00279201|19640893|P5|Intensification Addendum|Adverse Event|1
5696662|NCT00279201|19640894|P4|Intensification Addendum|Adverse Event|4
5696663|NCT00279201|19640895|P3|Intensification Addendum|Adverse Event|0
5696664|NCT00279201|19640896|P2|Intensification Addendum|Adverse Event|0
5696665|NCT00279201|19640897|P1|Intensification Addendum|Adverse Event|0
5696666|NCT00279201|19640892|P6|Intensification Addendum|Protocol Violation|6
5696667|NCT00279201|19640893|P5|Intensification Addendum|Protocol Violation|6
5696668|NCT00279201|19640894|P4|Intensification Addendum|Protocol Violation|2
5696669|NCT00279201|19640895|P3|Intensification Addendum|Protocol Violation|2
5696670|NCT00279201|19640896|P2|Intensification Addendum|Protocol Violation|0
5696671|NCT00279201|19640897|P1|Intensification Addendum|Protocol Violation|0
5696672|NCT00279201|19640892|P6|Intensification Addendum|Lost to Follow-up|7
5696673|NCT00279201|19640893|P5|Intensification Addendum|Lost to Follow-up|7
5696674|NCT00279201|19640894|P4|Intensification Addendum|Lost to Follow-up|6
5696675|NCT00279201|19640895|P3|Intensification Addendum|Lost to Follow-up|4
5696676|NCT00279201|19640896|P2|Intensification Addendum|Lost to Follow-up|0
5696677|NCT00279201|19640897|P1|Intensification Addendum|Lost to Follow-up|0
5696678|NCT00279201|19640892|P6|Intensification Addendum|Withdrawal by Subject|18
5696679|NCT00279201|19640893|P5|Intensification Addendum|Withdrawal by Subject|9
5696680|NCT00279201|19640894|P4|Intensification Addendum|Withdrawal by Subject|14
5696681|NCT00279201|19640895|P3|Intensification Addendum|Withdrawal by Subject|12
5696682|NCT00279201|19640896|P2|Intensification Addendum|Withdrawal by Subject|0
5696683|NCT00279201|19640897|P1|Intensification Addendum|Withdrawal by Subject|0
5696684|NCT00279201|19640892|P6|Maintenance|HbA1c>7.5%|0
5696685|NCT00279201|19640893|P5|Maintenance|HbA1c>7.5%|0
5696686|NCT00279201|19640894|P4|Maintenance|HbA1c>7.5%|0
5696687|NCT00279201|19640895|P3|Maintenance|HbA1c>7.5%|0
5696688|NCT00279201|19640896|P2|Maintenance|HbA1c>7.5%|126
5696689|NCT00279201|19640897|P1|Maintenance|HbA1c>7.5%|123
5696690|NCT00279201|19640892|P6|Maintenance|Sponsor Decision|0
5696691|NCT00279201|19640893|P5|Maintenance|Sponsor Decision|0
5696692|NCT00279201|19640894|P4|Maintenance|Sponsor Decision|0
5696693|NCT00279201|19640895|P3|Maintenance|Sponsor Decision|0
5696694|NCT00279201|19640896|P2|Maintenance|Sponsor Decision|0
5696695|NCT00279201|19640897|P1|Maintenance|Sponsor Decision|4
5696696|NCT00279201|19640892|P6|Maintenance|Physician Decision|0
5696697|NCT00279201|19640893|P5|Maintenance|Physician Decision|0
5696698|NCT00279201|19640894|P4|Maintenance|Physician Decision|0
5696699|NCT00279201|19640895|P3|Maintenance|Physician Decision|0
5696700|NCT00279201|19640896|P2|Maintenance|Physician Decision|9
5696701|NCT00279201|19640897|P1|Maintenance|Physician Decision|9
5696702|NCT00279201|19640892|P6|Maintenance|Withdrawal by Subject|0
5696703|NCT00279201|19640893|P5|Maintenance|Withdrawal by Subject|0
5696704|NCT00279201|19640894|P4|Maintenance|Withdrawal by Subject|0
5696705|NCT00279201|19640895|P3|Maintenance|Withdrawal by Subject|0
5696706|NCT00279201|19640896|P2|Maintenance|Withdrawal by Subject|18
5696707|NCT00279201|19640897|P1|Maintenance|Withdrawal by Subject|18
5696708|NCT00279201|19640892|P6|Maintenance|Protocol Violation|0
5696709|NCT00279201|19640893|P5|Maintenance|Protocol Violation|0
5696710|NCT00279201|19640894|P4|Maintenance|Protocol Violation|0
5696711|NCT00279201|19640895|P3|Maintenance|Protocol Violation|0
5696712|NCT00279201|19640896|P2|Maintenance|Protocol Violation|24
5696713|NCT00279201|19640897|P1|Maintenance|Protocol Violation|16
5696714|NCT00279201|19640892|P6|Maintenance|Entry Criteria Exclusion|0
5696715|NCT00279201|19640893|P5|Maintenance|Entry Criteria Exclusion|0
5696716|NCT00279201|19640894|P4|Maintenance|Entry Criteria Exclusion|0
5696717|NCT00279201|19640895|P3|Maintenance|Entry Criteria Exclusion|0
5696718|NCT00279201|19640896|P2|Maintenance|Entry Criteria Exclusion|4
5696719|NCT00279201|19640897|P1|Maintenance|Entry Criteria Exclusion|1
5696720|NCT00279201|19640892|P6|Maintenance|Lost to Follow-up|0
5696721|NCT00279201|19640893|P5|Maintenance|Lost to Follow-up|0
5696722|NCT00279201|19640894|P4|Maintenance|Lost to Follow-up|0
5696723|NCT00279201|19640895|P3|Maintenance|Lost to Follow-up|0
5696724|NCT00279201|19640896|P2|Maintenance|Lost to Follow-up|13
5696725|NCT00279201|19640897|P1|Maintenance|Lost to Follow-up|17
5696726|NCT00279201|19640892|P6|Maintenance|Death|0
5696727|NCT00279201|19640893|P5|Maintenance|Death|0
5696728|NCT00279201|19640894|P4|Maintenance|Death|0
5696729|NCT00279201|19640895|P3|Maintenance|Death|0
5696730|NCT00279201|19640896|P2|Maintenance|Death|4
5696731|NCT00279201|19640897|P1|Maintenance|Death|4
5696732|NCT00279201|19640892|P6|Maintenance|Adverse Event|0
5696733|NCT00279201|19640893|P5|Maintenance|Adverse Event|0
5696734|NCT00279201|19640894|P4|Maintenance|Adverse Event|0
5696735|NCT00279201|19640895|P3|Maintenance|Adverse Event|0
5696736|NCT00279201|19640896|P2|Maintenance|Adverse Event|4
5696737|NCT00279201|19640897|P1|Maintenance|Adverse Event|4
5696738|NCT00279201|19640892|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
5696739|NCT00279201|19640893|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
5696740|NCT00279201|19640894|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
5696741|NCT00279201|19640895|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
5696742|NCT00279201|19640896|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
5696743|NCT00279201|19640897|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
5696744|NCT00279201|19640892|P6|Maintenance|Lack of Efficacy|0
5696745|NCT00279201|19640893|P5|Maintenance|Lack of Efficacy|0
5696746|NCT00279201|19640894|P4|Maintenance|Lack of Efficacy|0
5696747|NCT00279201|19640895|P3|Maintenance|Lack of Efficacy|0
5696748|NCT00279201|19640896|P2|Maintenance|Lack of Efficacy|30
5696749|NCT00279201|19640897|P1|Maintenance|Lack of Efficacy|32
5696750|NCT00279201|19640892|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
5696751|NCT00279201|19640893|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
5696752|NCT00279201|19640894|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
5696753|NCT00279201|19640895|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
5696754|NCT00279201|19640896|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
5696755|NCT00279201|19640897|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
5696756|NCT00279201|19640892|P6|Initiation|Sponsor Decision|0
5696757|NCT00279201|19640893|P5|Initiation|Sponsor Decision|0
5696758|NCT00279201|19640894|P4|Initiation|Sponsor Decision|0
5696759|NCT00279201|19640895|P3|Initiation|Sponsor Decision|0
5696760|NCT00279201|19640896|P2|Initiation|Sponsor Decision|5
5696761|NCT00279201|19640897|P1|Initiation|Sponsor Decision|13
5696762|NCT00279201|19640892|P6|Initiation|Physician Decision|0
5696763|NCT00279201|19640893|P5|Initiation|Physician Decision|0
5696764|NCT00279201|19640894|P4|Initiation|Physician Decision|0
5696765|NCT00279201|19640895|P3|Initiation|Physician Decision|0
5696766|NCT00279201|19640896|P2|Initiation|Physician Decision|18
5696767|NCT00279201|19640897|P1|Initiation|Physician Decision|15
5696768|NCT00279201|19640892|P6|Initiation|Withdrawal by Subject|0
5696769|NCT00279201|19640893|P5|Initiation|Withdrawal by Subject|0
5696770|NCT00279201|19640894|P4|Initiation|Withdrawal by Subject|0
5696771|NCT00279201|19640895|P3|Initiation|Withdrawal by Subject|0
5696772|NCT00279201|19640896|P2|Initiation|Withdrawal by Subject|41
5696773|NCT00279201|19640897|P1|Initiation|Withdrawal by Subject|35
5696774|NCT00279201|19640892|P6|Initiation|Protocol Violation|0
5696775|NCT00279201|19640893|P5|Initiation|Protocol Violation|0
5696776|NCT00279201|19640894|P4|Initiation|Protocol Violation|0
5696777|NCT00279201|19640895|P3|Initiation|Protocol Violation|0
5696778|NCT00279201|19640896|P2|Initiation|Protocol Violation|10
5696779|NCT00279201|19640897|P1|Initiation|Protocol Violation|9
5696780|NCT00279201|19640892|P6|Initiation|Entry Criteria Exclusion|0
5696781|NCT00279201|19640893|P5|Initiation|Entry Criteria Exclusion|0
5696782|NCT00279201|19640894|P4|Initiation|Entry Criteria Exclusion|0
5696783|NCT00279201|19640895|P3|Initiation|Entry Criteria Exclusion|0
5696784|NCT00279201|19640896|P2|Initiation|Entry Criteria Exclusion|9
5696785|NCT00279201|19640897|P1|Initiation|Entry Criteria Exclusion|7
5696786|NCT00279201|19640892|P6|Initiation|Lost to Follow-up|0
5696787|NCT00279201|19640893|P5|Initiation|Lost to Follow-up|0
5696788|NCT00279201|19640894|P4|Initiation|Lost to Follow-up|0
5696789|NCT00279201|19640895|P3|Initiation|Lost to Follow-up|0
5696790|NCT00279201|19640896|P2|Initiation|Lost to Follow-up|41
5696791|NCT00279201|19640897|P1|Initiation|Lost to Follow-up|42
5696792|NCT00279201|19640892|P6|Initiation|Adverse Event|0
5696793|NCT00279201|19640893|P5|Initiation|Adverse Event|0
5696794|NCT00279201|19640894|P4|Initiation|Adverse Event|0
5696795|NCT00279201|19640895|P3|Initiation|Adverse Event|0
5696796|NCT00279201|19640896|P2|Initiation|Adverse Event|15
5696797|NCT00279201|19640897|P1|Initiation|Adverse Event|6
5696798|NCT00279201|19640892|P6|Initiation|Death|0
5696799|NCT00279201|19640893|P5|Initiation|Death|0
5696800|NCT00279201|19640894|P4|Initiation|Death|0
5696801|NCT00279201|19640895|P3|Initiation|Death|0
5696802|NCT00279201|19640896|P2|Initiation|Death|5
5696803|NCT00279201|19640897|P1|Initiation|Death|1
5696804|NCT00278993|19641041|P1|Overall Study|Not Otherwise Specified|4
5696805|NCT00278993|19641041|P1|Overall Study|Physician Decision|9
5696806|NCT00278993|19641041|P1|Overall Study|Progressive Disease|65
5696807|NCT00278993|19641041|P1|Overall Study|Withdrawal by Subject|5
5696808|NCT00278993|19641041|P1|Overall Study|Adverse Event|24
5696809|NCT00278954|19641049|P1|Overall Study|Withdrawal by Subject|1
5696810|NCT00278954|19641049|P1|Overall Study|Lost to Follow-up|1
5696811|NCT00278954|19641049|P1|Overall Study|Adverse Event|3
5696812|NCT00278915|19641057|P1|Overall Study|Lack of Efficacy|1
5696813|NCT00278889|19641093|P3|Overall Study|Death|17
5696814|NCT00278889|19641094|P2|Overall Study|Death|21
5696815|NCT00278889|19641095|P1|Overall Study|Death|24
5696816|NCT00278889|19641093|P3|Overall Study|Lost to Follow-up|0
5696817|NCT00278889|19641094|P2|Overall Study|Lost to Follow-up|1
5696818|NCT00278889|19641095|P1|Overall Study|Lost to Follow-up|1
5696819|NCT00278889|19641093|P3|Overall Study|Withdrawal by Subject|3
5696820|NCT00278889|19641094|P2|Overall Study|Withdrawal by Subject|5
5696821|NCT00278889|19641095|P1|Overall Study|Withdrawal by Subject|0
5696822|NCT00278629|19641143|P1|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
5696823|NCT00278564|19641150|P1|Overall Study|Lack of Efficacy|4
5696824|NCT00278512|19641171|P2|Overall Study|Death|0
5696825|NCT00278512|19641172|P1|Overall Study|Death|1
5696826|NCT00278473|19641180|P2|Overall Study|drop out|3
5696827|NCT00278473|19641181|P1|Overall Study|drop out|4
5696828|NCT00278395|19641197|P1|Overall Study|Nonevaluable|1
5696829|NCT00278395|19641197|P1|Overall Study|Adverse Event|2
5696830|NCT00278200|19641215|P2|Overall Study|Physician Decision|1
5696831|NCT00278200|19641216|P1|Overall Study|Physician Decision|0
5696832|NCT00278200|19641215|P2|Overall Study|Death|3
5696833|NCT00278200|19641216|P1|Overall Study|Death|1
5696834|NCT00278161|19641225|P1|Overall Study|Death|11
5696835|NCT00278148|19641231|P3|Phase II - Expansion Phase|Adverse Event|2
5696836|NCT00278148|19641232|P2|Phase II - Expansion Phase|Adverse Event|0
5696837|NCT00278148|19641233|P1|Phase II - Expansion Phase|Adverse Event|0
5696838|NCT00278148|19641231|P3|Phase II - Expansion Phase|Disease progression|4
5696839|NCT00278148|19641232|P2|Phase II - Expansion Phase|Disease progression|0
5696840|NCT00278148|19641233|P1|Phase II - Expansion Phase|Disease progression|0
5696841|NCT00278109|19641245|P1|Overall Study|social circumstances|1
5696842|NCT00278109|19641245|P1|Overall Study|Adverse Event|3
5696843|NCT00277355|19641291|P2|Overall Study|Physician Decision|0
5696844|NCT00277355|19641292|P1|Overall Study|Physician Decision|1
5696845|NCT00277355|19641291|P2|Overall Study|Death|0
5696846|NCT00277355|19641292|P1|Overall Study|Death|3
5696847|NCT00277355|19641291|P2|Overall Study|Adverse Event|0
5696848|NCT00277355|19641292|P1|Overall Study|Adverse Event|5
5696849|NCT00277355|19641291|P2|Overall Study|Lost to Follow-up|2
5696850|NCT00277355|19641292|P1|Overall Study|Lost to Follow-up|2
5696851|NCT00277355|19641291|P2|Overall Study|Withdrawal by Subject|3
5696852|NCT00277355|19641292|P1|Overall Study|Withdrawal by Subject|3
5696853|NCT00277212|19641300|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
5696854|NCT00277212|19641301|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
5696855|NCT00277212|19641302|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
5696856|NCT00277212|19641300|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
5696857|NCT00277212|19641301|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
5696858|NCT00277212|19641302|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
5696859|NCT00277212|19641300|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
5696860|NCT00277212|19641301|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
5696861|NCT00277212|19641302|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
5696862|NCT00277212|19641300|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
5696863|NCT00277212|19641301|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
5696864|NCT00277212|19641302|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
5696865|NCT00277212|19641300|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
5696866|NCT00277212|19641301|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
5696867|NCT00277212|19641302|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
5696868|NCT00277212|19641300|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
5696869|NCT00277212|19641301|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
5696870|NCT00277212|19641302|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
5696871|NCT00277212|19641300|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
5696872|NCT00277212|19641301|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
5696873|NCT00277212|19641302|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
5696874|NCT00277212|19641300|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
5696875|NCT00277212|19641301|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
5696876|NCT00277212|19641302|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
5696877|NCT00277212|19641300|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
5696878|NCT00277212|19641301|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
5696879|NCT00277212|19641302|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
5696880|NCT00277212|19641300|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
5696881|NCT00277212|19641301|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
5696882|NCT00277212|19641302|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
5696883|NCT00277212|19641300|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
5696884|NCT00277212|19641301|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
5696885|NCT00277212|19641302|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
5696886|NCT00277212|19641300|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
5696887|NCT00277212|19641301|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
5696888|NCT00277212|19641302|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
5696889|NCT00277212|19641300|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
5696890|NCT00277212|19641301|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
5696891|NCT00277212|19641302|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
5696892|NCT00277212|19641300|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
5696893|NCT00277212|19641301|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
5696894|NCT00277212|19641302|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
5696895|NCT00277212|19641300|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
5696896|NCT00277212|19641301|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
5696897|NCT00277212|19641302|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
5696898|NCT00277212|19641300|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
5696899|NCT00277212|19641301|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
5696900|NCT00277212|19641302|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
5696901|NCT00277212|19641300|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
5696902|NCT00277212|19641301|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
5696903|NCT00277212|19641302|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
5696904|NCT00277212|19641300|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
5696905|NCT00277212|19641301|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
5696906|NCT00277212|19641302|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
5696907|NCT00277095|19641340|P1|Overall Study|Physician Decision|1
5696908|NCT00277095|19641340|P1|Overall Study|Missed Follow-up|9
5696909|NCT00277095|19641340|P1|Overall Study|Lost to Follow-up|2
5696910|NCT00277095|19641340|P1|Overall Study|Explanted|7
5696911|NCT00277095|19641340|P1|Overall Study|Death|2
5696912|NCT00276744|19641349|P1|PART A|Reason unknown|98
5696913|NCT00276614|19641353|P1|Overall Study|Progression of disease under study|3
5696914|NCT00276484|19641364|P2|Overall Study|Could not take time off work|1
5696915|NCT00276484|19641365|P1|Overall Study|Could not take time off work|0
5696916|NCT00276484|19641364|P2|Overall Study|Withdrawal by Subject|3
5696917|NCT00276484|19641365|P1|Overall Study|Withdrawal by Subject|4
5696918|NCT00276484|19641364|P2|Overall Study|Protocol Violation|1
5696919|NCT00276484|19641365|P1|Overall Study|Protocol Violation|0
5696920|NCT00276484|19641364|P2|Overall Study|Lost to Follow-up|1
5696921|NCT00276484|19641365|P1|Overall Study|Lost to Follow-up|1
5696922|NCT00276484|19641364|P2|Overall Study|Adverse Event|7
5696923|NCT00276484|19641365|P1|Overall Study|Adverse Event|4
5696924|NCT00276458|19641397|P2|Overall Study|Protocol Violation|3
5696925|NCT00276458|19641398|P1|Overall Study|Protocol Violation|4
5696926|NCT00276458|19641397|P2|Overall Study|Lost to Follow-up|2
5696927|NCT00276458|19641398|P1|Overall Study|Lost to Follow-up|2
5696928|NCT00276458|19641397|P2|Overall Study|Adverse Event|2
5696929|NCT00276458|19641398|P1|Overall Study|Adverse Event|0
5696930|NCT00276419|19641432|P2|First Intervention|Withdrawal by Subject|2
5696931|NCT00276419|19641433|P1|First Intervention|Withdrawal by Subject|0
5696932|NCT00276419|19641432|P2|First Intervention|Adverse Event|0
5696933|NCT00276419|19641433|P1|First Intervention|Adverse Event|1
5696934|NCT00276380|19641476|P2|Overall Study|Abnormal aPPT Levels|1
5696935|NCT00276380|19641477|P1|Overall Study|Abnormal aPPT Levels|0
5696936|NCT00276380|19641476|P2|Overall Study|Death|3
5696937|NCT00276380|19641477|P1|Overall Study|Death|5
5696938|NCT00276380|19641476|P2|Overall Study|Withdrawal by Subject|6
5696939|NCT00276380|19641477|P1|Overall Study|Withdrawal by Subject|3
5696940|NCT00276380|19641476|P2|Overall Study|Lost to Follow-up|1
5696941|NCT00276380|19641477|P1|Overall Study|Lost to Follow-up|1
5696942|NCT00276380|19641476|P2|Overall Study|Adverse Event|3
5696943|NCT00276380|19641477|P1|Overall Study|Adverse Event|5
5696944|NCT00276159|19641532|P1|Overall Study|Did not receive all 24 doses of 852A|6
5696945|NCT00276094|19641542|P3|Overall Study|Other-Study medication lost|1
5696946|NCT00276094|19641543|P2|Overall Study|Other-Study medication lost|0
5696947|NCT00276094|19641544|P1|Overall Study|Other-Study medication lost|0
5696948|NCT00276094|19641542|P3|Overall Study|Other-Relocation|0
5696949|NCT00276094|19641543|P2|Overall Study|Other-Relocation|1
5696950|NCT00276094|19641544|P1|Overall Study|Other-Relocation|0
5696951|NCT00276094|19641542|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
5696952|NCT00276094|19641543|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
5696953|NCT00276094|19641544|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
5696954|NCT00276094|19641542|P3|Overall Study|Other-Refused follow-up visit|0
5696955|NCT00276094|19641543|P2|Overall Study|Other-Refused follow-up visit|0
5696956|NCT00276094|19641544|P1|Overall Study|Other-Refused follow-up visit|1
5696957|NCT00276094|19641542|P3|Overall Study|Other-Lack of efficacy|0
5696958|NCT00276094|19641543|P2|Overall Study|Other-Lack of efficacy|0
5696959|NCT00276094|19641544|P1|Overall Study|Other-Lack of efficacy|1
5696960|NCT00276094|19641542|P3|Overall Study|Other-Scheduled gastroplasty|0
5696961|NCT00276094|19641543|P2|Overall Study|Other-Scheduled gastroplasty|0
5696962|NCT00276094|19641544|P1|Overall Study|Other-Scheduled gastroplasty|1
5696963|NCT00276094|19641542|P3|Overall Study|Other-Subject moved out of country|0
5696964|NCT00276094|19641543|P2|Overall Study|Other-Subject moved out of country|0
5696965|NCT00276094|19641544|P1|Overall Study|Other-Subject moved out of country|1
5696966|NCT00276094|19641542|P3|Overall Study|Lost to Follow-up|4
5696967|NCT00276094|19641543|P2|Overall Study|Lost to Follow-up|6
5696968|NCT00276094|19641544|P1|Overall Study|Lost to Follow-up|8
5696969|NCT00276094|19641542|P3|Overall Study|Protocol Violation|10
5696970|NCT00276094|19641543|P2|Overall Study|Protocol Violation|7
5696971|NCT00276094|19641544|P1|Overall Study|Protocol Violation|16
5696972|NCT00276094|19641542|P3|Overall Study|Withdrawal by Subject|12
5696973|NCT00276094|19641543|P2|Overall Study|Withdrawal by Subject|14
5696974|NCT00276094|19641544|P1|Overall Study|Withdrawal by Subject|14
5696975|NCT00276094|19641542|P3|Overall Study|Adverse Event|11
5696976|NCT00276094|19641543|P2|Overall Study|Adverse Event|13
5696977|NCT00276094|19641544|P1|Overall Study|Adverse Event|15
5696978|NCT00276016|19641597|P6|Intervention 1|Withdrawal by Subject|0
5696979|NCT00276016|19641598|P5|Intervention 1|Withdrawal by Subject|0
5696980|NCT00276016|19641599|P4|Intervention 1|Withdrawal by Subject|0
5696981|NCT00276016|19641600|P3|Intervention 1|Withdrawal by Subject|0
5696982|NCT00276016|19641601|P2|Intervention 1|Withdrawal by Subject|1
5696983|NCT00276016|19641602|P1|Intervention 1|Withdrawal by Subject|0
5696984|NCT00275821|19641648|P3|Overall Study|Protocol Violation|0
5696985|NCT00275821|19641649|P2|Overall Study|Protocol Violation|1
5696986|NCT00275821|19641650|P1|Overall Study|Protocol Violation|5
5696987|NCT00275821|19641648|P3|Overall Study|Lack of Efficacy|0
5696988|NCT00275821|19641649|P2|Overall Study|Lack of Efficacy|1
5696989|NCT00275821|19641650|P1|Overall Study|Lack of Efficacy|2
5696990|NCT00275821|19641648|P3|Overall Study|Death|1
5696991|NCT00275821|19641649|P2|Overall Study|Death|2
5696992|NCT00275821|19641650|P1|Overall Study|Death|0
5696993|NCT00275821|19641648|P3|Overall Study|Lost to Follow-up|1
5696994|NCT00275821|19641649|P2|Overall Study|Lost to Follow-up|1
5696995|NCT00275821|19641650|P1|Overall Study|Lost to Follow-up|0
5696996|NCT00275821|19641648|P3|Overall Study|Withdrawal by Subject|1
5696997|NCT00275821|19641649|P2|Overall Study|Withdrawal by Subject|2
5696998|NCT00275821|19641650|P1|Overall Study|Withdrawal by Subject|0
5696999|NCT00275821|19641648|P3|Overall Study|Administrative problems|4
5697000|NCT00275821|19641649|P2|Overall Study|Administrative problems|4
5697001|NCT00275821|19641650|P1|Overall Study|Administrative problems|3
5697002|NCT00275821|19641648|P3|Overall Study|Adverse Event|5
5697003|NCT00275821|19641649|P2|Overall Study|Adverse Event|12
5697004|NCT00275821|19641650|P1|Overall Study|Adverse Event|4
5697005|NCT00275561|19641669|P2|Overall Study|Family Issues|2
5697006|NCT00275561|19641670|P1|Overall Study|Family Issues|0
5697007|NCT00275561|19641669|P2|Overall Study|Scheduling|2
5697008|NCT00275561|19641670|P1|Overall Study|Scheduling|1
5697009|NCT00275561|19641669|P2|Overall Study|Travel|1
5697010|NCT00275561|19641670|P1|Overall Study|Travel|1
5697011|NCT00275561|19641669|P2|Overall Study|Withdrawal by Subject|1
5697012|NCT00275561|19641670|P1|Overall Study|Withdrawal by Subject|0
5697013|NCT00275509|19641682|P2|Overall Study|graft thrombosis, post-operative day #8|1
5697014|NCT00275509|19641683|P1|Overall Study|graft thrombosis, post-operative day #8|0
5697015|NCT00275340|19641706|P2|Overall Study|Lost to Follow-up|4
5697016|NCT00275340|19641707|P1|Overall Study|Lost to Follow-up|2
5697017|NCT00275301|19641711|P1|Overall Study|Adverse Event|5
5697018|NCT00275262|19641730|P2|Overall Study|Started Chemotherapy|0
5697019|NCT00275262|19641731|P1|Overall Study|Started Chemotherapy|1
5697020|NCT00275262|19641730|P2|Overall Study|Death|0
5697021|NCT00275262|19641731|P1|Overall Study|Death|1
5697022|NCT00275262|19641730|P2|Overall Study|Protocol Violation|2
5697023|NCT00275262|19641731|P1|Overall Study|Protocol Violation|0
5697024|NCT00275262|19641730|P2|Overall Study|Lost to Follow-up|2
5697025|NCT00275262|19641731|P1|Overall Study|Lost to Follow-up|0
5697026|NCT00275262|19641730|P2|Overall Study|Disease progression|5
5697027|NCT00275262|19641731|P1|Overall Study|Disease progression|2
5697028|NCT00275262|19641730|P2|Overall Study|Adverse Event|0
5697029|NCT00275262|19641731|P1|Overall Study|Adverse Event|2
5697030|NCT00275028|19641745|P1|Overall Study|Physician Decision|2
5697031|NCT00275028|19641745|P1|Overall Study|Progressive Disease|30
5697032|NCT00275028|19641745|P1|Overall Study|Adverse Event|9
5697033|NCT00275028|19641745|P1|Overall Study|Withdrawal by Subject|5
5697034|NCT00275028|19641745|P1|Overall Study|Withdrew consent before treatment began|1
5697035|NCT00275002|19641752|P2|Overall Study|Adverse Event|1
5697036|NCT00275002|19641753|P1|Overall Study|Adverse Event|0
5697037|NCT00275002|19641752|P2|Overall Study|Disease progression|15
5697038|NCT00275002|19641753|P1|Overall Study|Disease progression|21
5697039|NCT00275002|19641752|P2|Overall Study|Death|0
5697040|NCT00275002|19641753|P1|Overall Study|Death|1
5697041|NCT00274937|19641761|P1|Overall Study|Progressive Disease|4
5697042|NCT00274937|19641761|P1|Overall Study|Withdrawal by Subject|6
5697043|NCT00274937|19641761|P1|Overall Study|Physician Decision|10
5697044|NCT00274924|19641773|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
5697045|NCT00274924|19641774|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
5697046|NCT00274924|19641775|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
5697131|NCT00274716|19641861|P1|Phase B|Participant moved|1
5697047|NCT00274924|19641773|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
5697048|NCT00274924|19641774|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
5697049|NCT00274924|19641775|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
5697050|NCT00274924|19641773|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
5697051|NCT00274924|19641774|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
5697052|NCT00274924|19641775|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
5697053|NCT00274924|19641773|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
5697054|NCT00274924|19641774|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
5697055|NCT00274924|19641775|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
5697056|NCT00274924|19641773|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
5697057|NCT00274924|19641774|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
5697058|NCT00274924|19641775|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
5697059|NCT00274924|19641773|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
5697060|NCT00274924|19641774|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
5697061|NCT00274924|19641775|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
5697062|NCT00274924|19641773|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
5697063|NCT00274924|19641774|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
5697064|NCT00274924|19641775|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
5697065|NCT00274924|19641773|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
5697066|NCT00274924|19641774|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
5697067|NCT00274924|19641775|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
5697068|NCT00274924|19641773|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
5697069|NCT00274924|19641774|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
5697070|NCT00274924|19641775|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
5697071|NCT00274924|19641773|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
5697072|NCT00274924|19641774|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
5697073|NCT00274924|19641775|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
5697074|NCT00274924|19641773|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
5697075|NCT00274924|19641774|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
5697076|NCT00274924|19641775|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
5697077|NCT00274924|19641773|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
5697078|NCT00274924|19641774|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
5697079|NCT00274924|19641775|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
5697080|NCT00274924|19641773|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
5697081|NCT00274924|19641774|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
5697082|NCT00274924|19641775|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
5697083|NCT00274846|19641784|P1|Overall Study|Did not receive adequate NK cells|1
5697084|NCT00274742|19641813|P6|Overall Study|Other|0
5697085|NCT00274742|19641814|P5|Overall Study|Other|2
5697086|NCT00274742|19641815|P4|Overall Study|Other|0
5697087|NCT00274742|19641816|P3|Overall Study|Other|0
5697088|NCT00274742|19641817|P2|Overall Study|Other|3
5697089|NCT00274742|19641818|P1|Overall Study|Other|0
5697090|NCT00274742|19641813|P6|Overall Study|Disease Progression|0
5697091|NCT00274742|19641814|P5|Overall Study|Disease Progression|1
5697092|NCT00274742|19641815|P4|Overall Study|Disease Progression|0
5697093|NCT00274742|19641816|P3|Overall Study|Disease Progression|1
5697094|NCT00274742|19641817|P2|Overall Study|Disease Progression|1
5697095|NCT00274742|19641818|P1|Overall Study|Disease Progression|0
5697096|NCT00274742|19641813|P6|Overall Study|End of Study|0
5697097|NCT00274742|19641814|P5|Overall Study|End of Study|0
5697098|NCT00274742|19641815|P4|Overall Study|End of Study|1
5697099|NCT00274742|19641816|P3|Overall Study|End of Study|0
5697100|NCT00274742|19641817|P2|Overall Study|End of Study|0
5697101|NCT00274742|19641818|P1|Overall Study|End of Study|0
5697102|NCT00274742|19641813|P6|Overall Study|Lost to Follow-up|0
5697103|NCT00274742|19641814|P5|Overall Study|Lost to Follow-up|1
5697104|NCT00274742|19641815|P4|Overall Study|Lost to Follow-up|0
5697105|NCT00274742|19641816|P3|Overall Study|Lost to Follow-up|0
5697106|NCT00274742|19641817|P2|Overall Study|Lost to Follow-up|0
5697107|NCT00274742|19641818|P1|Overall Study|Lost to Follow-up|0
5697108|NCT00274742|19641813|P6|Overall Study|Adverse Event|3
5697109|NCT00274742|19641814|P5|Overall Study|Adverse Event|12
5697110|NCT00274742|19641815|P4|Overall Study|Adverse Event|4
5697111|NCT00274742|19641816|P3|Overall Study|Adverse Event|1
5697112|NCT00274742|19641817|P2|Overall Study|Adverse Event|4
5697113|NCT00274742|19641818|P1|Overall Study|Adverse Event|0
5697114|NCT00274716|19641856|P6|Phase B|Lost to Follow-up|0
5697115|NCT00274716|19641857|P5|Phase B|Lost to Follow-up|0
5697116|NCT00274716|19641858|P4|Phase B|Lost to Follow-up|0
5697117|NCT00274716|19641859|P3|Phase B|Lost to Follow-up|0
5697118|NCT00274716|19641860|P2|Phase B|Lost to Follow-up|1
5697119|NCT00274716|19641861|P1|Phase B|Lost to Follow-up|0
5697120|NCT00274716|19641856|P6|Phase B|Other non-reported reason|0
5697121|NCT00274716|19641857|P5|Phase B|Other non-reported reason|0
5697122|NCT00274716|19641858|P4|Phase B|Other non-reported reason|1
5697123|NCT00274716|19641859|P3|Phase B|Other non-reported reason|1
5697124|NCT00274716|19641860|P2|Phase B|Other non-reported reason|0
5697125|NCT00274716|19641861|P1|Phase B|Other non-reported reason|0
5697126|NCT00274716|19641856|P6|Phase B|Participant moved|0
5697127|NCT00274716|19641857|P5|Phase B|Participant moved|0
5697128|NCT00274716|19641858|P4|Phase B|Participant moved|0
5697129|NCT00274716|19641859|P3|Phase B|Participant moved|0
5697130|NCT00274716|19641860|P2|Phase B|Participant moved|0
5697132|NCT00274716|19641856|P6|Phase B|Withdrawal by Subject|0
5697133|NCT00274716|19641857|P5|Phase B|Withdrawal by Subject|0
5697134|NCT00274716|19641858|P4|Phase B|Withdrawal by Subject|0
5697135|NCT00274716|19641859|P3|Phase B|Withdrawal by Subject|0
5697136|NCT00274716|19641860|P2|Phase B|Withdrawal by Subject|1
5697137|NCT00274716|19641861|P1|Phase B|Withdrawal by Subject|0
5697138|NCT00274716|19641856|P6|Phase B|Protocol Violation|0
5697139|NCT00274716|19641857|P5|Phase B|Protocol Violation|0
5697140|NCT00274716|19641858|P4|Phase B|Protocol Violation|0
5697141|NCT00274716|19641859|P3|Phase B|Protocol Violation|0
5697142|NCT00274716|19641860|P2|Phase B|Protocol Violation|2
5697143|NCT00274716|19641861|P1|Phase B|Protocol Violation|0
5697144|NCT00274716|19641856|P6|Phase B|Adverse Event|1
5697145|NCT00274716|19641857|P5|Phase B|Adverse Event|0
5697146|NCT00274716|19641858|P4|Phase B|Adverse Event|0
5697147|NCT00274716|19641859|P3|Phase B|Adverse Event|2
5697148|NCT00274716|19641860|P2|Phase B|Adverse Event|0
5697149|NCT00274716|19641861|P1|Phase B|Adverse Event|0
5697150|NCT00274716|19641856|P6|Phase A|Completed but did not enter Phase B|1
5697151|NCT00274716|19641857|P5|Phase A|Completed but did not enter Phase B|1
5697152|NCT00274716|19641858|P4|Phase A|Completed but did not enter Phase B|2
5697153|NCT00274716|19641859|P3|Phase A|Completed but did not enter Phase B|2
5697154|NCT00274716|19641860|P2|Phase A|Completed but did not enter Phase B|2
5697155|NCT00274716|19641861|P1|Phase A|Completed but did not enter Phase B|1
5697156|NCT00274716|19641856|P6|Phase A|Adverse Event|0
5697157|NCT00274716|19641857|P5|Phase A|Adverse Event|2
5697158|NCT00274716|19641858|P4|Phase A|Adverse Event|0
5697159|NCT00274716|19641859|P3|Phase A|Adverse Event|3
5697160|NCT00274716|19641860|P2|Phase A|Adverse Event|3
5697161|NCT00274716|19641861|P1|Phase A|Adverse Event|2
5697162|NCT00274716|19641856|P6|Phase A|Withdrawal by Subject|1
5697163|NCT00274716|19641857|P5|Phase A|Withdrawal by Subject|0
5697164|NCT00274716|19641858|P4|Phase A|Withdrawal by Subject|3
5697165|NCT00274716|19641859|P3|Phase A|Withdrawal by Subject|1
5697166|NCT00274716|19641860|P2|Phase A|Withdrawal by Subject|2
5697167|NCT00274716|19641861|P1|Phase A|Withdrawal by Subject|2
5697168|NCT00274716|19641856|P6|Phase A|Met criteria for discontinuation|0
5697169|NCT00274716|19641857|P5|Phase A|Met criteria for discontinuation|0
5697170|NCT00274716|19641858|P4|Phase A|Met criteria for discontinuation|0
5697171|NCT00274716|19641859|P3|Phase A|Met criteria for discontinuation|0
5697172|NCT00274716|19641860|P2|Phase A|Met criteria for discontinuation|1
5697173|NCT00274716|19641861|P1|Phase A|Met criteria for discontinuation|1
5697174|NCT00274716|19641856|P6|Phase A|Protocol Violation|0
5697175|NCT00274716|19641857|P5|Phase A|Protocol Violation|0
5697176|NCT00274716|19641858|P4|Phase A|Protocol Violation|1
5697177|NCT00274716|19641859|P3|Phase A|Protocol Violation|0
5697178|NCT00274716|19641860|P2|Phase A|Protocol Violation|0
5697179|NCT00274716|19641861|P1|Phase A|Protocol Violation|1
5697180|NCT00274716|19641856|P6|Phase A|Site Terminated|0
5697181|NCT00274716|19641857|P5|Phase A|Site Terminated|0
5697182|NCT00274716|19641858|P4|Phase A|Site Terminated|1
5697183|NCT00274716|19641859|P3|Phase A|Site Terminated|0
5697184|NCT00274716|19641860|P2|Phase A|Site Terminated|0
5697185|NCT00274716|19641861|P1|Phase A|Site Terminated|0
5697186|NCT00274716|19641856|P6|Phase A|Participant moved|1
5697187|NCT00274716|19641857|P5|Phase A|Participant moved|0
5697188|NCT00274716|19641858|P4|Phase A|Participant moved|0
5697189|NCT00274716|19641859|P3|Phase A|Participant moved|1
5697190|NCT00274716|19641860|P2|Phase A|Participant moved|0
5697191|NCT00274716|19641861|P1|Phase A|Participant moved|0
5697192|NCT00274716|19641856|P6|Phase A|Other non-reported reason|1
5697193|NCT00274716|19641857|P5|Phase A|Other non-reported reason|0
5697194|NCT00274716|19641858|P4|Phase A|Other non-reported reason|2
5697195|NCT00274716|19641859|P3|Phase A|Other non-reported reason|1
5697196|NCT00274716|19641860|P2|Phase A|Other non-reported reason|2
5697197|NCT00274716|19641861|P1|Phase A|Other non-reported reason|4
5697198|NCT00274651|19641923|P2|Overall Study|Physician Decision|7
5697199|NCT00274651|19641924|P1|Overall Study|Physician Decision|8
5697200|NCT00274651|19641923|P2|Overall Study|Withdrawal by Subject|1
5697201|NCT00274651|19641924|P1|Overall Study|Withdrawal by Subject|0
5697202|NCT00274651|19641923|P2|Overall Study|Death|3
5697203|NCT00274651|19641924|P1|Overall Study|Death|1
5697204|NCT00274651|19641923|P2|Overall Study|Lack of Efficacy|6
5697205|NCT00274651|19641924|P1|Overall Study|Lack of Efficacy|13
5697206|NCT00274651|19641923|P2|Overall Study|Adverse Event|3
5697207|NCT00274651|19641924|P1|Overall Study|Adverse Event|6
5697208|NCT00274625|19641939|P2|Overall Study|Excluded from analysis|8
5697209|NCT00274625|19641940|P1|Overall Study|Excluded from analysis|14
5697210|NCT00274625|19641939|P2|Overall Study|Lost to Follow-up|54
5697211|NCT00274625|19641940|P1|Overall Study|Lost to Follow-up|46
5697212|NCT00274469|19641948|P2|Overall Study|Did not consent to OS follow-up|19
5697213|NCT00274469|19641949|P1|Overall Study|Did not consent to OS follow-up|16
5697214|NCT00274469|19641948|P2|Overall Study|Death|74
5697215|NCT00274469|19641949|P1|Overall Study|Death|63
5697216|NCT00274456|19641969|P4|Overall Study|Withdrawal by Subject|13
5697217|NCT00274456|19641970|P3|Overall Study|Withdrawal by Subject|9
5697218|NCT00274456|19641971|P2|Overall Study|Withdrawal by Subject|13
5697219|NCT00274456|19641972|P1|Overall Study|Withdrawal by Subject|18
5697220|NCT00274456|19641969|P4|Overall Study|Lost to Follow-up|0
5697221|NCT00274456|19641970|P3|Overall Study|Lost to Follow-up|1
5697222|NCT00274456|19641971|P2|Overall Study|Lost to Follow-up|0
5697223|NCT00274456|19641972|P1|Overall Study|Lost to Follow-up|0
5697224|NCT00274456|19641969|P4|Overall Study|Physician Decision|13
5697225|NCT00274456|19641970|P3|Overall Study|Physician Decision|6
5697226|NCT00274456|19641971|P2|Overall Study|Physician Decision|5
5697227|NCT00274456|19641972|P1|Overall Study|Physician Decision|7
5697228|NCT00274456|19641969|P4|Overall Study|Adverse Event|2
5697229|NCT00274456|19641970|P3|Overall Study|Adverse Event|2
5697230|NCT00274456|19641971|P2|Overall Study|Adverse Event|1
5697231|NCT00274456|19641972|P1|Overall Study|Adverse Event|0
5697232|NCT00274456|19641969|P4|Overall Study|Unacceptable toxicity|16
5697233|NCT00274456|19641970|P3|Overall Study|Unacceptable toxicity|12
5697234|NCT00274456|19641971|P2|Overall Study|Unacceptable toxicity|5
5697235|NCT00274456|19641972|P1|Overall Study|Unacceptable toxicity|10
5697236|NCT00274456|19641969|P4|Overall Study|Still on treatment|1
5697237|NCT00274456|19641970|P3|Overall Study|Still on treatment|5
5697238|NCT00274456|19641971|P2|Overall Study|Still on treatment|3
5697239|NCT00274456|19641972|P1|Overall Study|Still on treatment|2
5697240|NCT00274287|19642014|P1|Overall Study|subject non-compliance|1
5697241|NCT00274287|19642014|P1|Overall Study|Withdrawal by Subject|1
5697242|NCT00274261|19642024|P2|Overall Study|Lost to Follow-up|75
5697243|NCT00274261|19642025|P1|Overall Study|Lost to Follow-up|106
5697244|NCT00274261|19642024|P2|Overall Study|Protocol Violation|42
5697245|NCT00274261|19642025|P1|Overall Study|Protocol Violation|71
5697246|NCT00274261|19642024|P2|Overall Study|Withdrawal by Subject|126
5697247|NCT00274261|19642025|P1|Overall Study|Withdrawal by Subject|179
5697248|NCT00274261|19642024|P2|Overall Study|Pregnancy|83
5697249|NCT00274261|19642025|P1|Overall Study|Pregnancy|114
5697250|NCT00274261|19642024|P2|Overall Study|Adverse Event|11
5697251|NCT00274261|19642025|P1|Overall Study|Adverse Event|19
5697252|NCT00273858|19642064|P1|Overall Study|Adverse Event|81
5697253|NCT00273858|19642064|P1|Overall Study|Withdrawal by Subject|21
5697254|NCT00273858|19642064|P1|Overall Study|Lost to Follow-up|101
5697255|NCT00273858|19642064|P1|Overall Study|Not completed 24 month observation time|334
5697256|NCT00273182|19642132|P1|Overall Study|Site exit, system change, 36 m FU missed|36
5697257|NCT00273182|19642132|P1|Overall Study|Device/System Explant|154
5697258|NCT00273182|19642132|P1|Overall Study|Withdrawal by Subject|257
5697259|NCT00273182|19642132|P1|Overall Study|Lost to Follow-up|88
5697260|NCT00273182|19642132|P1|Overall Study|Death|450
5697261|NCT00273052|19642142|P2|Overall Study|Worsening serum lipid levels|2
5697262|NCT00273052|19642143|P1|Overall Study|Worsening serum lipid levels|0
5697263|NCT00273052|19642142|P2|Overall Study|Other|0
5697264|NCT00273052|19642143|P1|Overall Study|Other|2
5697265|NCT00273052|19642142|P2|Overall Study|Non-Compliance|1
5697266|NCT00273052|19642143|P1|Overall Study|Non-Compliance|3
5697267|NCT00273052|19642142|P2|Overall Study|Lack of Efficacy|4
5697268|NCT00273052|19642143|P1|Overall Study|Lack of Efficacy|6
5697269|NCT00273052|19642142|P2|Overall Study|Lost to Follow-up|25
5697270|NCT00273052|19642143|P1|Overall Study|Lost to Follow-up|7
5697271|NCT00273052|19642142|P2|Overall Study|Protocol Violation|18
5697272|NCT00273052|19642143|P1|Overall Study|Protocol Violation|14
5697273|NCT00273052|19642142|P2|Overall Study|Adverse Event|19
5697274|NCT00273052|19642143|P1|Overall Study|Adverse Event|21
5697275|NCT00273052|19642142|P2|Overall Study|Withdrawal by Subject|19
5697276|NCT00273052|19642143|P1|Overall Study|Withdrawal by Subject|16
5697277|NCT00272987|19642178|P3|Overall Study|Death|0
5697278|NCT00272987|19642179|P2|Overall Study|Death|0
5697279|NCT00272987|19642180|P1|Overall Study|Death|1
5697280|NCT00272987|19642178|P3|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4
5697281|NCT00272987|19642179|P2|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1
5697282|NCT00272987|19642180|P1|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2
5697283|NCT00272987|19642178|P3|Overall Study|Disease progression|2
5697284|NCT00272987|19642179|P2|Overall Study|Disease progression|1
5697285|NCT00272987|19642180|P1|Overall Study|Disease progression|1
5697286|NCT00272987|19642178|P3|Overall Study|Sponsor Terminated study|1
5697287|NCT00272987|19642179|P2|Overall Study|Sponsor Terminated study|1
5697288|NCT00272987|19642180|P1|Overall Study|Sponsor Terminated study|0
5697289|NCT00272987|19642178|P3|Overall Study|Withdrawal by Subject|3
5697290|NCT00272987|19642179|P2|Overall Study|Withdrawal by Subject|0
5697291|NCT00272987|19642180|P1|Overall Study|Withdrawal by Subject|1
5697292|NCT00272987|19642178|P3|Overall Study|Lost to Follow-up|1
5697293|NCT00272987|19642179|P2|Overall Study|Lost to Follow-up|1
5697294|NCT00272987|19642180|P1|Overall Study|Lost to Follow-up|3
5697295|NCT00272987|19642178|P3|Overall Study|Adverse Event|0
5697296|NCT00272987|19642179|P2|Overall Study|Adverse Event|0
5697297|NCT00272987|19642180|P1|Overall Study|Adverse Event|1
5697298|NCT00272961|19642250|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
5697299|NCT00272961|19642251|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
5697300|NCT00272961|19642252|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
5697301|NCT00272961|19642253|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
5697302|NCT00272961|19642254|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
5697303|NCT00272961|19642250|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
5697304|NCT00272961|19642251|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
5697305|NCT00272961|19642252|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
5697306|NCT00272961|19642253|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
5697307|NCT00272961|19642254|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
5697308|NCT00272961|19642250|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
5697309|NCT00272961|19642251|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
5697310|NCT00272961|19642252|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
5697311|NCT00272961|19642253|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
5697312|NCT00272961|19642254|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
5697313|NCT00272961|19642250|P5|Placebo Run-in Phase: Up to Week 2|Other|0
5697314|NCT00272961|19642251|P4|Placebo Run-in Phase: Up to Week 2|Other|0
5697315|NCT00272961|19642252|P3|Placebo Run-in Phase: Up to Week 2|Other|0
5697316|NCT00272961|19642253|P2|Placebo Run-in Phase: Up to Week 2|Other|0
5697317|NCT00272961|19642254|P1|Placebo Run-in Phase: Up to Week 2|Other|2
5697318|NCT00272961|19642250|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
5697319|NCT00272961|19642251|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
5697320|NCT00272961|19642252|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
5697321|NCT00272961|19642253|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
5697322|NCT00272961|19642254|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
5697323|NCT00272961|19642250|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
5697324|NCT00272961|19642251|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
5697325|NCT00272961|19642252|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
5697326|NCT00272961|19642253|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
5697327|NCT00272961|19642254|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
5697328|NCT00272961|19642250|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
5697329|NCT00272961|19642251|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
5697330|NCT00272961|19642252|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
5697331|NCT00272961|19642253|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
5697332|NCT00272961|19642254|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
5697333|NCT00272961|19642250|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
5697334|NCT00272961|19642251|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
5697335|NCT00272961|19642252|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
5697336|NCT00272961|19642253|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
5697337|NCT00272961|19642254|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
5697338|NCT00272844|19642311|P1|Overall Study|Withdrawal by Subject|5
5697339|NCT00272792|19642319|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
5697340|NCT00272792|19642320|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
5697341|NCT00272792|19642319|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
5697342|NCT00272792|19642320|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
5697343|NCT00272792|19642319|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
5697344|NCT00272792|19642320|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
5697345|NCT00272792|19642319|P2|Part 1: Responsiveness|Lost to Follow-up|0
5697346|NCT00272792|19642320|P1|Part 1: Responsiveness|Lost to Follow-up|1
5697347|NCT00272779|19642330|P2|Baseline Through Week 96|Continuing on treatment|38
5697348|NCT00272779|19642331|P1|Baseline Through Week 96|Continuing on treatment|61
5697349|NCT00272779|19642330|P2|Baseline Through Week 96|Never treated|3
5697350|NCT00272779|19642331|P1|Baseline Through Week 96|Never treated|2
5697351|NCT00272779|19642330|P2|Baseline Through Week 96|Pregnancy at Week 96|0
5697352|NCT00272779|19642331|P1|Baseline Through Week 96|Pregnancy at Week 96|1
5697353|NCT00272779|19642330|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
5697354|NCT00272779|19642331|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
5697355|NCT00272779|19642330|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
5697356|NCT00272779|19642331|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
5697357|NCT00272779|19642330|P2|Baseline Through Week 96|Changed address before Week 96|1
5697358|NCT00272779|19642331|P1|Baseline Through Week 96|Changed address before Week 96|0
5697359|NCT00272779|19642330|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
5697360|NCT00272779|19642331|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
5697361|NCT00272779|19642330|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
5697362|NCT00272779|19642331|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
5697363|NCT00272779|19642330|P2|Baseline Through Week 96|Pregnancy before Week 96|7
5697364|NCT00272779|19642331|P1|Baseline Through Week 96|Pregnancy before Week 96|5
5697365|NCT00272779|19642330|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
5697366|NCT00272779|19642331|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
5697367|NCT00272779|19642330|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
5697368|NCT00272779|19642331|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
5697369|NCT00272779|19642330|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
5697370|NCT00272779|19642331|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
5697371|NCT00272779|19642330|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
5697372|NCT00272779|19642331|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
5697373|NCT00272779|19642330|P2|Baseline Through Week 96|Death before Week 96|5
5697374|NCT00272779|19642331|P1|Baseline Through Week 96|Death before Week 96|6
5697375|NCT00272779|19642330|P2|Baseline Through Week 96|Adverse event before Week 96|22
5697376|NCT00272779|19642331|P1|Baseline Through Week 96|Adverse event before Week 96|13
5697377|NCT00272779|19642330|P2|Baseline Through Week 48|Never treated|3
5697378|NCT00272779|19642331|P1|Baseline Through Week 48|Never treated|2
5697379|NCT00272779|19642330|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
5697380|NCT00272779|19642331|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
5697381|NCT00272779|19642330|P2|Baseline Through Week 48|Continuing treatment|368
5697382|NCT00272779|19642331|P1|Baseline Through Week 48|Continuing treatment|385
5697383|NCT00272779|19642330|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
5697384|NCT00272779|19642331|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
5697385|NCT00272779|19642330|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
5697386|NCT00272779|19642331|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
5697387|NCT00272779|19642330|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
5697388|NCT00272779|19642331|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
5697389|NCT00272779|19642330|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
5697390|NCT00272779|19642331|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
5697391|NCT00272779|19642330|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
5697392|NCT00272779|19642331|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
5697393|NCT00272779|19642330|P2|Baseline Through Week 48|Death on/after Week 48|1
5697394|NCT00272779|19642331|P1|Baseline Through Week 48|Death on/after Week 48|1
5697395|NCT00272779|19642330|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
5697396|NCT00272779|19642331|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
5697397|NCT00272779|19642330|P2|Baseline Through Week 48|Chose different site before wk 48|1
5697398|NCT00272779|19642331|P1|Baseline Through Week 48|Chose different site before wk 48|0
5697399|NCT00272779|19642330|P2|Baseline Through Week 48|Participant's decision before wk 48|1
5697400|NCT00272779|19642331|P1|Baseline Through Week 48|Participant's decision before wk 48|0
5697401|NCT00272779|19642330|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
5697402|NCT00272779|19642331|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
5697403|NCT00272779|19642330|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
5697404|NCT00272779|19642331|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
5697405|NCT00272779|19642330|P2|Baseline Through Week 48|Pregnancy before Week 48|2
5697406|NCT00272779|19642331|P1|Baseline Through Week 48|Pregnancy before Week 48|2
5697407|NCT00272779|19642330|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
5697408|NCT00272779|19642331|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
5697409|NCT00272779|19642330|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
5697410|NCT00272779|19642331|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
5697411|NCT00272779|19642330|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
5697412|NCT00272779|19642331|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
5697413|NCT00272779|19642330|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
5697414|NCT00272779|19642331|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
5697415|NCT00272779|19642330|P2|Baseline Through Week 48|Death before Week 48|4
5697416|NCT00272779|19642331|P1|Baseline Through Week 48|Death before Week 48|4
5697417|NCT00272779|19642330|P2|Baseline Through Week 48|Adverse event before Week 48|14
5697418|NCT00272779|19642331|P1|Baseline Through Week 48|Adverse event before Week 48|10
5697419|NCT00272038|19642591|P1|Overall Study|withdrew before they received 2 cycles|7
5697420|NCT00271947|19642597|P1|Overall Study|Lost to Follow-up|1
5697421|NCT00271856|19642603|P2|Overall Study|Lost to Follow-up|11
5697422|NCT00271856|19642604|P1|Overall Study|Lost to Follow-up|10
5697423|NCT00271856|19642603|P2|Overall Study|Withdrawal by Subject|7
5697424|NCT00271856|19642604|P1|Overall Study|Withdrawal by Subject|1
5697425|NCT00271817|19642623|P3|Part 2|LDL < 50 mg/dL|4
5697426|NCT00271817|19642624|P2|Part 2|LDL < 50 mg/dL|3
5697427|NCT00271817|19642625|P1|Part 2|LDL < 50 mg/dL|0
5697428|NCT00271817|19642623|P3|Part 2|Withdrawal by Subject|13
5697429|NCT00271817|19642624|P2|Part 2|Withdrawal by Subject|2
5697430|NCT00271817|19642625|P1|Part 2|Withdrawal by Subject|0
5697431|NCT00271817|19642623|P3|Part 2|Patient Moved|5
5697432|NCT00271817|19642624|P2|Part 2|Patient Moved|0
5697433|NCT00271817|19642625|P1|Part 2|Patient Moved|0
5697434|NCT00271817|19642623|P3|Part 2|Protocol Violation|5
5697435|NCT00271817|19642624|P2|Part 2|Protocol Violation|3
5697436|NCT00271817|19642625|P1|Part 2|Protocol Violation|0
5697437|NCT00271817|19642623|P3|Part 2|Lost to Follow-up|18
5697438|NCT00271817|19642624|P2|Part 2|Lost to Follow-up|6
5697439|NCT00271817|19642625|P1|Part 2|Lost to Follow-up|0
5697440|NCT00271817|19642623|P3|Part 2|Lack of Efficacy|6
5697441|NCT00271817|19642624|P2|Part 2|Lack of Efficacy|1
5697442|NCT00271817|19642625|P1|Part 2|Lack of Efficacy|0
5697443|NCT00271817|19642623|P3|Part 2|Adverse Event|33
5697444|NCT00271817|19642624|P2|Part 2|Adverse Event|17
5697445|NCT00271817|19642625|P1|Part 2|Adverse Event|0
5697446|NCT00271817|19642623|P3|Part 1|LDL < 50 mg/dL|48
5697447|NCT00271817|19642624|P2|Part 1|LDL < 50 mg/dL|4
5697448|NCT00271817|19642625|P1|Part 1|LDL < 50 mg/dL|1
5697449|NCT00271817|19642623|P3|Part 1|Withdrawal by Subject|45
5697450|NCT00271817|19642624|P2|Part 1|Withdrawal by Subject|17
5697451|NCT00271817|19642625|P1|Part 1|Withdrawal by Subject|23
5697452|NCT00271817|19642623|P3|Part 1|Patient Moved|5
5697453|NCT00271817|19642624|P2|Part 1|Patient Moved|1
5697454|NCT00271817|19642625|P1|Part 1|Patient Moved|3
5697455|NCT00271817|19642623|P3|Part 1|Protocol Violation|7
5697456|NCT00271817|19642624|P2|Part 1|Protocol Violation|4
5697457|NCT00271817|19642625|P1|Part 1|Protocol Violation|5
5697458|NCT00271817|19642623|P3|Part 1|Lost to Follow-up|24
5697459|NCT00271817|19642624|P2|Part 1|Lost to Follow-up|8
5697460|NCT00271817|19642625|P1|Part 1|Lost to Follow-up|6
5697461|NCT00271817|19642623|P3|Part 1|Adverse Event|156
5697462|NCT00271817|19642624|P2|Part 1|Adverse Event|25
5697463|NCT00271817|19642625|P1|Part 1|Adverse Event|68
5697464|NCT00271609|19642667|P2|Overall Study|Withdrawal by Subject|0
5697465|NCT00271609|19642668|P1|Overall Study|Withdrawal by Subject|2
5697466|NCT00271609|19642667|P2|Overall Study|Adverse Event|3
5697467|NCT00271609|19642668|P1|Overall Study|Adverse Event|11
5697468|NCT00271596|19642678|P2|Overall Study|Withdrawal by Subject|1
5697469|NCT00271596|19642679|P1|Overall Study|Withdrawal by Subject|0
5697470|NCT00271596|19642678|P2|Overall Study|Protocol Violation|0
5697471|NCT00271596|19642679|P1|Overall Study|Protocol Violation|1
5697472|NCT00271544|19642714|P1|Overall Study|Implant not attempted|4
5697473|NCT00271544|19642714|P1|Overall Study|Model 4196 lead not attempted|9
5697474|NCT00271544|19642714|P1|Overall Study|Subjects did not receive a 4196 lead|7
5697475|NCT00271505|19642735|P1|Overall Study|Death|1
5697476|NCT00271505|19642735|P1|Overall Study|Adverse Event|1
5697477|NCT00271505|19642735|P1|Overall Study|Screen Failure|3
5697478|NCT00271024|19642834|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
5697479|NCT00271024|19642835|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
5697480|NCT00271024|19642836|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
5697481|NCT00271024|19642837|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
5697482|NCT00271024|19642834|P4|Overall Study|Unpleasant Reaction To Tablet|2
5697483|NCT00271024|19642835|P3|Overall Study|Unpleasant Reaction To Tablet|4
5697484|NCT00271024|19642836|P2|Overall Study|Unpleasant Reaction To Tablet|3
5697485|NCT00271024|19642837|P1|Overall Study|Unpleasant Reaction To Tablet|1
5697486|NCT00271024|19642834|P4|Overall Study|Protocol Violation|11
5697487|NCT00271024|19642835|P3|Overall Study|Protocol Violation|5
5697488|NCT00271024|19642836|P2|Overall Study|Protocol Violation|6
5697489|NCT00271024|19642837|P1|Overall Study|Protocol Violation|1
5697490|NCT00271024|19642834|P4|Overall Study|Unknown/Unspecified|4
5697491|NCT00271024|19642835|P3|Overall Study|Unknown/Unspecified|8
5697492|NCT00271024|19642836|P2|Overall Study|Unknown/Unspecified|11
5697493|NCT00271024|19642837|P1|Overall Study|Unknown/Unspecified|11
5697494|NCT00271024|19642834|P4|Overall Study|Lost Interest|3
5697495|NCT00271024|19642835|P3|Overall Study|Lost Interest|2
5697496|NCT00271024|19642836|P2|Overall Study|Lost Interest|4
5697497|NCT00271024|19642837|P1|Overall Study|Lost Interest|3
5697498|NCT00270998|19642887|P3|12 Month Follow-up|Received/desired alternate treatment|1
5697499|NCT00270998|19642888|P2|12 Month Follow-up|Received/desired alternate treatment|4
5697500|NCT00270998|19642889|P1|12 Month Follow-up|Received/desired alternate treatment|1
5697501|NCT00270998|19642887|P3|12 Month Follow-up|Personal/family health|1
5697502|NCT00270998|19642888|P2|12 Month Follow-up|Personal/family health|5
5697503|NCT00270998|19642889|P1|12 Month Follow-up|Personal/family health|0
5697504|NCT00270998|19642887|P3|12 Month Follow-up|Pessary did not fit|0
5697505|NCT00270998|19642888|P2|12 Month Follow-up|Pessary did not fit|0
5697506|NCT00270998|19642889|P1|12 Month Follow-up|Pessary did not fit|1
5697507|NCT00270998|19642887|P3|12 Month Follow-up|Withdrawal by Subject|16
5697508|NCT00270998|19642888|P2|12 Month Follow-up|Withdrawal by Subject|12
5697509|NCT00270998|19642889|P1|12 Month Follow-up|Withdrawal by Subject|7
5697510|NCT00270998|19642887|P3|12 Month Follow-up|Lack of Efficacy|3
5697511|NCT00270998|19642888|P2|12 Month Follow-up|Lack of Efficacy|4
5697512|NCT00270998|19642889|P1|12 Month Follow-up|Lack of Efficacy|5
5697513|NCT00270998|19642887|P3|3 Month Follow-up|Received/desired alternate treatment|2
5697514|NCT00270998|19642888|P2|3 Month Follow-up|Received/desired alternate treatment|5
5697515|NCT00270998|19642889|P1|3 Month Follow-up|Received/desired alternate treatment|13
5697516|NCT00270998|19642887|P3|3 Month Follow-up|Personal/family health|0
5697517|NCT00270998|19642888|P2|3 Month Follow-up|Personal/family health|1
5697518|NCT00270998|19642889|P1|3 Month Follow-up|Personal/family health|1
5697519|NCT00270998|19642887|P3|3 Month Follow-up|Pessary did not fit|0
5697520|NCT00270998|19642888|P2|3 Month Follow-up|Pessary did not fit|0
5697521|NCT00270998|19642889|P1|3 Month Follow-up|Pessary did not fit|12
5697522|NCT00270998|19642887|P3|3 Month Follow-up|Withdrawal by Subject|15
5697523|NCT00270998|19642888|P2|3 Month Follow-up|Withdrawal by Subject|14
5697524|NCT00270998|19642889|P1|3 Month Follow-up|Withdrawal by Subject|11
5697525|NCT00270998|19642887|P3|3 Month Follow-up|Lack of Efficacy|1
5697526|NCT00270998|19642888|P2|3 Month Follow-up|Lack of Efficacy|2
5697527|NCT00270998|19642889|P1|3 Month Follow-up|Lack of Efficacy|1
5697528|NCT00270998|19642887|P3|3 Month Follow-up|Adverse Event|0
5697529|NCT00270998|19642888|P2|3 Month Follow-up|Adverse Event|0
5697530|NCT00270998|19642889|P1|3 Month Follow-up|Adverse Event|1
5697531|NCT00270894|19642918|P1|Overall Study|Withdrawal by Subject|1
5697532|NCT00270894|19642918|P1|Overall Study|Adverse Event|1
5697533|NCT00270855|19642930|P2|Overall Study|Withdrawal by Subject|8
5697534|NCT00270855|19642931|P1|Overall Study|Withdrawal by Subject|8
5697535|NCT00270257|19643067|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
5697536|NCT00270257|19643068|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
5697537|NCT00270231|19643086|P2|Second Intervention|Lost to Follow-up|1
5697538|NCT00270231|19643087|P1|Second Intervention|Lost to Follow-up|0
5697539|NCT00270231|19643086|P2|Washout Period|Lost to Follow-up|0
5697540|NCT00270231|19643087|P1|Washout Period|Lost to Follow-up|1
5697541|NCT00270231|19643086|P2|First Intervention|Lost to Follow-up|1
5697542|NCT00270231|19643087|P1|First Intervention|Lost to Follow-up|1
5697543|NCT00270205|19643097|P4|Overall Study|Lost to Follow-up|1
5697544|NCT00270205|19643098|P3|Overall Study|Lost to Follow-up|0
5697545|NCT00270205|19643099|P2|Overall Study|Lost to Follow-up|0
5697546|NCT00270205|19643100|P1|Overall Study|Lost to Follow-up|1
5697547|NCT00269919|19643218|P1|Overall Study|Started but not treated|1
5697548|NCT00269919|19643218|P1|Overall Study|Other|26
5697549|NCT00269633|19643237|P2|Overall Study|Withdrawal by Subject|0
5697550|NCT00269633|19643238|P1|Overall Study|Withdrawal by Subject|1
5697551|NCT00269477|19643248|P4|Overall Study|Missed post-vaccination blood draw|0
5697552|NCT00269477|19643249|P3|Overall Study|Missed post-vaccination blood draw|0
5697553|NCT00269477|19643250|P2|Overall Study|Missed post-vaccination blood draw|1
5697554|NCT00269477|19643251|P1|Overall Study|Missed post-vaccination blood draw|0
5697555|NCT00269477|19643248|P4|Overall Study|Protocol Violation|0
5697556|NCT00269477|19643249|P3|Overall Study|Protocol Violation|1
5697557|NCT00269477|19643250|P2|Overall Study|Protocol Violation|5
5697558|NCT00269477|19643251|P1|Overall Study|Protocol Violation|5
5697559|NCT00269399|19643267|P2|Overall Study|Development of exclusion criteria|1
5697560|NCT00269399|19643268|P1|Overall Study|Development of exclusion criteria|0
5697561|NCT00269399|19643267|P2|Overall Study|Other|4
5697562|NCT00269399|19643268|P1|Overall Study|Other|0
5697563|NCT00269399|19643267|P2|Overall Study|Negative Lab Result for C. difficile|3
5697564|NCT00269399|19643268|P1|Overall Study|Negative Lab Result for C. difficile|2
5697565|NCT00269399|19643267|P2|Overall Study|Withdrawal by Subject|5
5697566|NCT00269399|19643268|P1|Overall Study|Withdrawal by Subject|2
5697567|NCT00269399|19643267|P2|Overall Study|Adverse Event|4
5697568|NCT00269399|19643268|P1|Overall Study|Adverse Event|10
5697569|NCT00269399|19643267|P2|Overall Study|Lack of Efficacy|10
5697570|NCT00269399|19643268|P1|Overall Study|Lack of Efficacy|27
5697571|NCT00269152|19643278|P2|Overall Study|Protocol Violation|1
5697572|NCT00269152|19643279|P1|Overall Study|Protocol Violation|0
5697573|NCT00269152|19643278|P2|Overall Study|Physician Decision|3
5697574|NCT00269152|19643279|P1|Overall Study|Physician Decision|2
5697575|NCT00269152|19643278|P2|Overall Study|Withdrawal by Subject|3
5697576|NCT00269152|19643279|P1|Overall Study|Withdrawal by Subject|7
5697577|NCT00269152|19643278|P2|Overall Study|Adverse Event|3
5697578|NCT00269152|19643279|P1|Overall Study|Adverse Event|9
5697579|NCT00269113|19643295|P2|Overall Study|Other|2
5697580|NCT00269113|19643296|P1|Overall Study|Other|0
5697581|NCT00269113|19643295|P2|Overall Study|Protocol Violation|5
5697582|NCT00269113|19643296|P1|Overall Study|Protocol Violation|15
5697583|NCT00269113|19643295|P2|Overall Study|Lost to Follow-up|1
5697584|NCT00269113|19643296|P1|Overall Study|Lost to Follow-up|2
5697585|NCT00269113|19643295|P2|Overall Study|Death|2
5697586|NCT00269113|19643296|P1|Overall Study|Death|6
5697587|NCT00269113|19643295|P2|Overall Study|Withdrawal by Subject|2
5697588|NCT00269113|19643296|P1|Overall Study|Withdrawal by Subject|0
5697589|NCT00269113|19643295|P2|Overall Study|Early Improvement|0
5697590|NCT00269113|19643296|P1|Overall Study|Early Improvement|2
5697591|NCT00269113|19643295|P2|Overall Study|Lack of Efficacy|18
5697592|NCT00269113|19643296|P1|Overall Study|Lack of Efficacy|35
5697593|NCT00269113|19643295|P2|Overall Study|Adverse Event|7
5697594|NCT00269113|19643296|P1|Overall Study|Adverse Event|14
5697595|NCT00269087|19643314|P1|Overall Study|Exacerbation of COPD|13
5697596|NCT00269087|19643314|P1|Overall Study|Withdrawal by Subject|1
5697597|NCT00269087|19643314|P1|Overall Study|Adverse Event|20
5697598|NCT00268996|19643344|P2|Overall Study|Other|1
5697599|NCT00268996|19643345|P1|Overall Study|Other|1
5697600|NCT00268996|19643344|P2|Overall Study|Non-compliance|0
5697601|NCT00268996|19643345|P1|Overall Study|Non-compliance|1
5697602|NCT00268996|19643344|P2|Overall Study|Withdrawal by Subject|11
5697603|NCT00268996|19643345|P1|Overall Study|Withdrawal by Subject|5
5697604|NCT00268996|19643344|P2|Overall Study|Lost to Follow-up|1
5697605|NCT00268996|19643345|P1|Overall Study|Lost to Follow-up|3
5697606|NCT00268996|19643344|P2|Overall Study|Adverse Event|7
5697607|NCT00268996|19643345|P1|Overall Study|Adverse Event|11
5697608|NCT00268983|19643389|P2|Overall Study|Death|0
5697609|NCT00268983|19643390|P1|Overall Study|Death|3
5697610|NCT00268905|19643433|P3|Overall Study|Clinical Progression|1
5697611|NCT00268905|19643434|P2|Overall Study|Clinical Progression|4
5697612|NCT00268905|19643435|P1|Overall Study|Clinical Progression|9
5697613|NCT00268905|19643433|P3|Overall Study|Physician Decision|1
5697614|NCT00268905|19643434|P2|Overall Study|Physician Decision|0
5697615|NCT00268905|19643435|P1|Overall Study|Physician Decision|3
5697616|NCT00268905|19643433|P3|Overall Study|Progressive Disease|3
5697617|NCT00268905|19643434|P2|Overall Study|Progressive Disease|4
5697618|NCT00268905|19643435|P1|Overall Study|Progressive Disease|28
5697619|NCT00268905|19643433|P3|Overall Study|Withdrawal by Subject|3
5697620|NCT00268905|19643434|P2|Overall Study|Withdrawal by Subject|0
5697621|NCT00268905|19643435|P1|Overall Study|Withdrawal by Subject|0
5697622|NCT00268905|19643433|P3|Overall Study|Lost to Follow-up|0
5697623|NCT00268905|19643434|P2|Overall Study|Lost to Follow-up|1
5697624|NCT00268905|19643435|P1|Overall Study|Lost to Follow-up|0
5697625|NCT00268905|19643433|P3|Overall Study|Adverse Event|4
5697626|NCT00268905|19643434|P2|Overall Study|Adverse Event|0
5697627|NCT00268905|19643435|P1|Overall Study|Adverse Event|3
5697628|NCT00268892|19643452|P3|Overall Study|Trial Site Closed|2
5697629|NCT00268892|19643453|P2|Overall Study|Trial Site Closed|2
5697630|NCT00268892|19643454|P1|Overall Study|Trial Site Closed|4
5697631|NCT00268892|19643452|P3|Overall Study|Disease Progression|0
5697632|NCT00268892|19643453|P2|Overall Study|Disease Progression|1
5697633|NCT00268892|19643454|P1|Overall Study|Disease Progression|1
5697634|NCT00268892|19643452|P3|Overall Study|Protocol Violation|0
5697635|NCT00268892|19643453|P2|Overall Study|Protocol Violation|1
5697636|NCT00268892|19643454|P1|Overall Study|Protocol Violation|0
5697637|NCT00268892|19643452|P3|Overall Study|Lost to Follow-up|4
5697638|NCT00268892|19643453|P2|Overall Study|Lost to Follow-up|2
5697639|NCT00268892|19643454|P1|Overall Study|Lost to Follow-up|5
5697640|NCT00268892|19643452|P3|Overall Study|Physician Decision|0
5697641|NCT00268892|19643453|P2|Overall Study|Physician Decision|1
5697642|NCT00268892|19643454|P1|Overall Study|Physician Decision|0
5697643|NCT00268892|19643452|P3|Overall Study|Withdrawal by Subject|13
5697644|NCT00268892|19643453|P2|Overall Study|Withdrawal by Subject|15
5697645|NCT00268892|19643454|P1|Overall Study|Withdrawal by Subject|14
5697646|NCT00268892|19643452|P3|Overall Study|Lack of Efficacy|0
5697647|NCT00268892|19643453|P2|Overall Study|Lack of Efficacy|3
5697648|NCT00268892|19643454|P1|Overall Study|Lack of Efficacy|1
5697649|NCT00268892|19643452|P3|Overall Study|Adverse Event|20
5697650|NCT00268892|19643453|P2|Overall Study|Adverse Event|17
5697651|NCT00268892|19643454|P1|Overall Study|Adverse Event|14
5697652|NCT00268463|19643473|P2|Overall Study|study terminated due to low accrual|12
5697653|NCT00268463|19643474|P1|Overall Study|study terminated due to low accrual|10
5697654|NCT00268437|19643490|P1|Overall Study|Ineligible|1
5697655|NCT00268346|19643497|P2|Overall Study|Withdrawal by Subject|1
5697656|NCT00268346|19643498|P1|Overall Study|Withdrawal by Subject|0
5697657|NCT00268346|19643497|P2|Overall Study|Death|1
5697658|NCT00268346|19643498|P1|Overall Study|Death|0
5697659|NCT00268346|19643497|P2|Overall Study|Adverse Event|1
5697660|NCT00268346|19643498|P1|Overall Study|Adverse Event|0
5697661|NCT00268242|19643504|P1|Overall Study|Death|1
5697662|NCT00268203|19643513|P1|Overall Study|Completed 2 Years of Follow-up|62
5697663|NCT00268203|19643513|P1|Overall Study|Reason Not Specified|34
5697664|NCT00268203|19643513|P1|Overall Study|Death|84
5697665|NCT00268203|19643513|P1|Overall Study|Progressive Disease|359
5697666|NCT00268203|19643513|P1|Overall Study|Received Other NHL Therapy|7
5697667|NCT00268203|19643513|P1|Overall Study|Withdrawal by Subject|9
5697668|NCT00268203|19643513|P1|Overall Study|Lost to Follow-up|92
5697669|NCT00267969|19643527|P7|After Controlled Period|Other|25
5697670|NCT00267969|19643528|P6|After Controlled Period|Other|22
5697671|NCT00267969|19643529|P5|After Controlled Period|Other|11
5697672|NCT00267969|19643530|P4|After Controlled Period|Other|13
5697673|NCT00267969|19643531|P3|After Controlled Period|Other|0
5697674|NCT00267969|19643532|P2|After Controlled Period|Other|0
5697675|NCT00267969|19643533|P1|After Controlled Period|Other|0
5697676|NCT00267969|19643527|P7|After Controlled Period|Lost to Follow-up|10
5697677|NCT00267969|19643528|P6|After Controlled Period|Lost to Follow-up|9
5697678|NCT00267969|19643529|P5|After Controlled Period|Lost to Follow-up|8
5697679|NCT00267969|19643530|P4|After Controlled Period|Lost to Follow-up|5
5697680|NCT00267969|19643531|P3|After Controlled Period|Lost to Follow-up|0
5697681|NCT00267969|19643532|P2|After Controlled Period|Lost to Follow-up|0
5697682|NCT00267969|19643533|P1|After Controlled Period|Lost to Follow-up|0
5697683|NCT00267969|19643527|P7|After Controlled Period|Lack of Efficacy|15
5697684|NCT00267969|19643528|P6|After Controlled Period|Lack of Efficacy|28
5697685|NCT00267969|19643529|P5|After Controlled Period|Lack of Efficacy|6
5697686|NCT00267969|19643530|P4|After Controlled Period|Lack of Efficacy|10
5697687|NCT00267969|19643531|P3|After Controlled Period|Lack of Efficacy|0
5697688|NCT00267969|19643532|P2|After Controlled Period|Lack of Efficacy|0
5697689|NCT00267969|19643533|P1|After Controlled Period|Lack of Efficacy|0
5697690|NCT00267969|19643527|P7|After Controlled Period|Death|1
5697691|NCT00267969|19643528|P6|After Controlled Period|Death|0
5697692|NCT00267969|19643529|P5|After Controlled Period|Death|2
5697693|NCT00267969|19643530|P4|After Controlled Period|Death|1
5697694|NCT00267969|19643531|P3|After Controlled Period|Death|0
5697695|NCT00267969|19643532|P2|After Controlled Period|Death|0
5697696|NCT00267969|19643533|P1|After Controlled Period|Death|0
5697697|NCT00267969|19643527|P7|After Controlled Period|Adverse Event|21
5697698|NCT00267969|19643528|P6|After Controlled Period|Adverse Event|23
5697699|NCT00267969|19643529|P5|After Controlled Period|Adverse Event|8
5697700|NCT00267969|19643530|P4|After Controlled Period|Adverse Event|7
5697701|NCT00267969|19643531|P3|After Controlled Period|Adverse Event|0
5697702|NCT00267969|19643532|P2|After Controlled Period|Adverse Event|0
5697703|NCT00267969|19643533|P1|After Controlled Period|Adverse Event|0
5697704|NCT00267969|19643527|P7|Controlled Period|Other|0
5697705|NCT00267969|19643528|P6|Controlled Period|Other|0
5697706|NCT00267969|19643529|P5|Controlled Period|Other|0
5697707|NCT00267969|19643530|P4|Controlled Period|Other|0
5697708|NCT00267969|19643531|P3|Controlled Period|Other|6
5697709|NCT00267969|19643532|P2|Controlled Period|Other|1
5697710|NCT00267969|19643533|P1|Controlled Period|Other|2
5697711|NCT00267969|19643527|P7|Controlled Period|Randomized but not treated|0
5697712|NCT00267969|19643528|P6|Controlled Period|Randomized but not treated|0
5697713|NCT00267969|19643529|P5|Controlled Period|Randomized but not treated|0
5697714|NCT00267969|19643530|P4|Controlled Period|Randomized but not treated|0
5697715|NCT00267969|19643531|P3|Controlled Period|Randomized but not treated|1
5697716|NCT00267969|19643532|P2|Controlled Period|Randomized but not treated|0
5697717|NCT00267969|19643533|P1|Controlled Period|Randomized but not treated|0
5697718|NCT00267969|19643527|P7|Controlled Period|Lost to Follow-up|0
5697719|NCT00267969|19643528|P6|Controlled Period|Lost to Follow-up|0
5697720|NCT00267969|19643529|P5|Controlled Period|Lost to Follow-up|0
5697721|NCT00267969|19643530|P4|Controlled Period|Lost to Follow-up|0
5697722|NCT00267969|19643531|P3|Controlled Period|Lost to Follow-up|1
5697723|NCT00267969|19643532|P2|Controlled Period|Lost to Follow-up|0
5697724|NCT00267969|19643533|P1|Controlled Period|Lost to Follow-up|1
5697725|NCT00267969|19643527|P7|Controlled Period|Lack of Efficacy|0
5697726|NCT00267969|19643528|P6|Controlled Period|Lack of Efficacy|0
5697727|NCT00267969|19643529|P5|Controlled Period|Lack of Efficacy|0
5697728|NCT00267969|19643530|P4|Controlled Period|Lack of Efficacy|0
5697729|NCT00267969|19643531|P3|Controlled Period|Lack of Efficacy|1
5697730|NCT00267969|19643532|P2|Controlled Period|Lack of Efficacy|0
5697731|NCT00267969|19643533|P1|Controlled Period|Lack of Efficacy|3
5697732|NCT00267969|19643527|P7|Controlled Period|Adverse Event|0
5697733|NCT00267969|19643528|P6|Controlled Period|Adverse Event|0
5697734|NCT00267969|19643529|P5|Controlled Period|Adverse Event|0
5697735|NCT00267969|19643530|P4|Controlled Period|Adverse Event|0
5697736|NCT00267969|19643531|P3|Controlled Period|Adverse Event|2
5697737|NCT00267969|19643532|P2|Controlled Period|Adverse Event|0
5697738|NCT00267969|19643533|P1|Controlled Period|Adverse Event|6
5697739|NCT00267956|19643559|P4|After Controlled Period|Withdrew consent|0
5697740|NCT00267956|19643560|P3|After Controlled Period|Withdrew consent|1
5697741|NCT00267956|19643561|P2|After Controlled Period|Withdrew consent|0
5697742|NCT00267956|19643562|P1|After Controlled Period|Withdrew consent|0
5697743|NCT00267956|19643559|P4|After Controlled Period|Lost to Follow-up|0
5697744|NCT00267956|19643560|P3|After Controlled Period|Lost to Follow-up|1
5697745|NCT00267956|19643561|P2|After Controlled Period|Lost to Follow-up|0
5697746|NCT00267956|19643562|P1|After Controlled Period|Lost to Follow-up|0
5697747|NCT00267956|19643559|P4|After Controlled Period|Lack of Efficacy|1
5697748|NCT00267956|19643560|P3|After Controlled Period|Lack of Efficacy|1
5697749|NCT00267956|19643561|P2|After Controlled Period|Lack of Efficacy|0
5697750|NCT00267956|19643562|P1|After Controlled Period|Lack of Efficacy|0
5697751|NCT00267956|19643559|P4|After Controlled Period|Adverse Event|1
5697752|NCT00267956|19643560|P3|After Controlled Period|Adverse Event|2
5697753|NCT00267956|19643561|P2|After Controlled Period|Adverse Event|0
5697754|NCT00267956|19643562|P1|After Controlled Period|Adverse Event|0
5697755|NCT00267956|19643559|P4|Controlled Period|Withdrew consent|0
5697756|NCT00267956|19643560|P3|Controlled Period|Withdrew consent|0
5697757|NCT00267956|19643561|P2|Controlled Period|Withdrew consent|1
5697758|NCT00267956|19643562|P1|Controlled Period|Withdrew consent|3
5697759|NCT00267956|19643559|P4|Controlled Period|Lost to Follow-up|0
5697760|NCT00267956|19643560|P3|Controlled Period|Lost to Follow-up|0
5697761|NCT00267956|19643561|P2|Controlled Period|Lost to Follow-up|0
5697762|NCT00267956|19643562|P1|Controlled Period|Lost to Follow-up|2
5697763|NCT00267956|19643559|P4|Controlled Period|Lack of Efficacy|0
5697764|NCT00267956|19643560|P3|Controlled Period|Lack of Efficacy|0
5697765|NCT00267956|19643561|P2|Controlled Period|Lack of Efficacy|2
5697766|NCT00267956|19643562|P1|Controlled Period|Lack of Efficacy|4
5697767|NCT00267956|19643559|P4|Controlled Period|Adverse Event|0
5697768|NCT00267956|19643560|P3|Controlled Period|Adverse Event|0
5697769|NCT00267956|19643561|P2|Controlled Period|Adverse Event|1
5697770|NCT00267956|19643562|P1|Controlled Period|Adverse Event|4
5697771|NCT00267865|19643580|P1|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
5697772|NCT00267865|19643580|P1|Induction Treatment|Died before completing.|2
5697773|NCT00267748|19643603|P3|Randomized Period|randomized but not treated|3
5697774|NCT00267748|19643604|P2|Randomized Period|randomized but not treated|0
5697775|NCT00267748|19643605|P1|Randomized Period|randomized but not treated|0
5697776|NCT00267748|19643603|P3|Randomized Period|Other|6
5697777|NCT00267748|19643604|P2|Randomized Period|Other|9
5697778|NCT00267748|19643605|P1|Randomized Period|Other|0
5697779|NCT00267748|19643603|P3|Randomized Period|Withdrawal by Subject|2
5697780|NCT00267748|19643604|P2|Randomized Period|Withdrawal by Subject|9
5697781|NCT00267748|19643605|P1|Randomized Period|Withdrawal by Subject|0
5697782|NCT00267748|19643603|P3|Randomized Period|Objective progression or relapse|86
5697783|NCT00267748|19643604|P2|Randomized Period|Objective progression or relapse|77
5697784|NCT00267748|19643605|P1|Randomized Period|Objective progression or relapse|0
5697785|NCT00267748|19643603|P3|Randomized Period|Lost to Follow-up|0
5697786|NCT00267748|19643604|P2|Randomized Period|Lost to Follow-up|1
5697787|NCT00267748|19643605|P1|Randomized Period|Lost to Follow-up|0
5697788|NCT00267748|19643603|P3|Randomized Period|Global deterioration of health status|7
5697789|NCT00267748|19643604|P2|Randomized Period|Global deterioration of health status|6
5697790|NCT00267748|19643605|P1|Randomized Period|Global deterioration of health status|0
5697791|NCT00267748|19643603|P3|Randomized Period|Adverse Event|25
5697792|NCT00267748|19643604|P2|Randomized Period|Adverse Event|23
5697793|NCT00267748|19643605|P1|Randomized Period|Adverse Event|0
5697794|NCT00267748|19643603|P3|Randomized Period|Death|3
5697795|NCT00267748|19643604|P2|Randomized Period|Death|2
5697796|NCT00267748|19643605|P1|Randomized Period|Death|0
5697797|NCT00267748|19643603|P3|Non-randomized Period|Other|0
5697798|NCT00267748|19643604|P2|Non-randomized Period|Other|0
5697799|NCT00267748|19643605|P1|Non-randomized Period|Other|3
5697800|NCT00267748|19643603|P3|Non-randomized Period|Participant not willing to participate|0
5697801|NCT00267748|19643604|P2|Non-randomized Period|Participant not willing to participate|0
5697802|NCT00267748|19643605|P1|Non-randomized Period|Participant not willing to participate|1
5697803|NCT00267748|19643603|P3|Non-randomized Period|Death|0
5697804|NCT00267748|19643604|P2|Non-randomized Period|Death|0
5697805|NCT00267748|19643605|P1|Non-randomized Period|Death|1
5697806|NCT00267748|19643603|P3|Non-randomized Period|Adverse Event|0
5697807|NCT00267748|19643604|P2|Non-randomized Period|Adverse Event|0
5697808|NCT00267748|19643605|P1|Non-randomized Period|Adverse Event|8
5697809|NCT00267748|19643603|P3|Non-randomized Period|Progressive disease|0
5697810|NCT00267748|19643604|P2|Non-randomized Period|Progressive disease|0
5697811|NCT00267748|19643605|P1|Non-randomized Period|Progressive disease|10
5697812|NCT00267488|19643662|P1|Overall Study|Other (Disease Progression)|1
5697813|NCT00267488|19643662|P1|Overall Study|Protocol Violation|1
5697814|NCT00267488|19643662|P1|Overall Study|Sponsor Terminated Study|9
5697815|NCT00267202|19643686|P2|Overall Study|Lost to Follow-up|0
5697816|NCT00267202|19643687|P1|Overall Study|Lost to Follow-up|3
5697817|NCT00267202|19643686|P2|Overall Study|Administrative problems|1
5697818|NCT00267202|19643687|P1|Overall Study|Administrative problems|2
5697819|NCT00267202|19643686|P2|Overall Study|Protocol Violation|3
5697820|NCT00267202|19643687|P1|Overall Study|Protocol Violation|2
5697821|NCT00267202|19643686|P2|Overall Study|Adverse Event|7
5697822|NCT00267202|19643687|P1|Overall Study|Adverse Event|13
5697823|NCT00267202|19643686|P2|Overall Study|Withdrawal by Subject|15
5697824|NCT00267202|19643687|P1|Overall Study|Withdrawal by Subject|12
5697825|NCT00267202|19643686|P2|Overall Study|Unsatisfactory therapeutic effect|8
5697826|NCT00267202|19643687|P1|Overall Study|Unsatisfactory therapeutic effect|21
5697827|NCT00267189|19643708|P2|Overall Study|Missing|0
5697828|NCT00267189|19643709|P1|Overall Study|Missing|3
5697829|NCT00267189|19643708|P2|Overall Study|Death|0
5697830|NCT00267189|19643709|P1|Overall Study|Death|1
5697831|NCT00267189|19643708|P2|Overall Study|Patient withdrew consent|1
5697832|NCT00267189|19643709|P1|Overall Study|Patient withdrew consent|1
5697833|NCT00267150|19643719|P1|Overall Study|Adverse Event|1
5697834|NCT00267098|19643743|P8|Overall Study|Sponsor withdrew subject|0
5697835|NCT00267098|19643744|P7|Overall Study|Sponsor withdrew subject|0
5697836|NCT00267098|19643745|P6|Overall Study|Sponsor withdrew subject|0
5697837|NCT00267098|19643746|P5|Overall Study|Sponsor withdrew subject|0
5697838|NCT00267098|19643747|P4|Overall Study|Sponsor withdrew subject|1
5697839|NCT00267098|19643748|P3|Overall Study|Sponsor withdrew subject|0
5697840|NCT00267098|19643749|P2|Overall Study|Sponsor withdrew subject|0
5697841|NCT00267098|19643750|P1|Overall Study|Sponsor withdrew subject|0
5697842|NCT00267098|19643743|P8|Overall Study|Subject listed for heart transplant|0
5697843|NCT00267098|19643744|P7|Overall Study|Subject listed for heart transplant|1
5697844|NCT00267098|19643745|P6|Overall Study|Subject listed for heart transplant|0
5697845|NCT00267098|19643746|P5|Overall Study|Subject listed for heart transplant|0
5697846|NCT00267098|19643747|P4|Overall Study|Subject listed for heart transplant|0
5697847|NCT00267098|19643748|P3|Overall Study|Subject listed for heart transplant|0
5697848|NCT00267098|19643749|P2|Overall Study|Subject listed for heart transplant|0
5697849|NCT00267098|19643750|P1|Overall Study|Subject listed for heart transplant|0
5697850|NCT00267098|19643743|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
5697851|NCT00267098|19643744|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
5697852|NCT00267098|19643745|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
5697853|NCT00267098|19643746|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
5697854|NCT00267098|19643747|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
5697855|NCT00267098|19643748|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
5697856|NCT00267098|19643749|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
5697857|NCT00267098|19643750|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
5697858|NCT00267098|19643743|P8|Overall Study|Explanted Medtronic device|0
5697859|NCT00267098|19643744|P7|Overall Study|Explanted Medtronic device|0
5697860|NCT00267098|19643745|P6|Overall Study|Explanted Medtronic device|0
5697861|NCT00267098|19643746|P5|Overall Study|Explanted Medtronic device|0
5697862|NCT00267098|19643747|P4|Overall Study|Explanted Medtronic device|1
5697863|NCT00267098|19643748|P3|Overall Study|Explanted Medtronic device|0
5697864|NCT00267098|19643749|P2|Overall Study|Explanted Medtronic device|0
5697865|NCT00267098|19643750|P1|Overall Study|Explanted Medtronic device|0
5697866|NCT00267098|19643743|P8|Overall Study|Site closure|0
5697867|NCT00267098|19643744|P7|Overall Study|Site closure|1
5697868|NCT00267098|19643745|P6|Overall Study|Site closure|1
5697869|NCT00267098|19643746|P5|Overall Study|Site closure|0
5697870|NCT00267098|19643747|P4|Overall Study|Site closure|1
5697871|NCT00267098|19643748|P3|Overall Study|Site closure|0
5697872|NCT00267098|19643749|P2|Overall Study|Site closure|0
5697873|NCT00267098|19643750|P1|Overall Study|Site closure|0
5697874|NCT00267098|19643743|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5697875|NCT00267098|19643744|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5697876|NCT00267098|19643745|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5697877|NCT00267098|19643746|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5697878|NCT00267098|19643747|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5697879|NCT00267098|19643748|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5697880|NCT00267098|19643749|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
5697881|NCT00267098|19643750|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
5697882|NCT00267098|19643743|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5697883|NCT00267098|19643744|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5697884|NCT00267098|19643745|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5697885|NCT00267098|19643746|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
5697886|NCT00267098|19643747|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5697887|NCT00267098|19643748|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5697888|NCT00267098|19643749|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
5697889|NCT00267098|19643750|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
5697890|NCT00267098|19643743|P8|Overall Study|Physician Decision|0
5697891|NCT00267098|19643744|P7|Overall Study|Physician Decision|3
5697892|NCT00267098|19643745|P6|Overall Study|Physician Decision|4
5697893|NCT00267098|19643746|P5|Overall Study|Physician Decision|5
5697894|NCT00267098|19643747|P4|Overall Study|Physician Decision|11
5697895|NCT00267098|19643748|P3|Overall Study|Physician Decision|7
5697896|NCT00267098|19643749|P2|Overall Study|Physician Decision|0
5697897|NCT00267098|19643750|P1|Overall Study|Physician Decision|5
5697898|NCT00267098|19643743|P8|Overall Study|Withdrawal by Subject|5
5697899|NCT00267098|19643744|P7|Overall Study|Withdrawal by Subject|12
5697900|NCT00267098|19643745|P6|Overall Study|Withdrawal by Subject|9
5697901|NCT00267098|19643746|P5|Overall Study|Withdrawal by Subject|12
5697902|NCT00267098|19643747|P4|Overall Study|Withdrawal by Subject|21
5697903|NCT00267098|19643748|P3|Overall Study|Withdrawal by Subject|24
5697904|NCT00267098|19643749|P2|Overall Study|Withdrawal by Subject|0
5697905|NCT00267098|19643750|P1|Overall Study|Withdrawal by Subject|8
5697906|NCT00267098|19643743|P8|Overall Study|Lost to Follow-up|1
5697907|NCT00267098|19643744|P7|Overall Study|Lost to Follow-up|1
5697908|NCT00267098|19643745|P6|Overall Study|Lost to Follow-up|3
5697909|NCT00267098|19643746|P5|Overall Study|Lost to Follow-up|2
5697910|NCT00267098|19643747|P4|Overall Study|Lost to Follow-up|5
5697911|NCT00267098|19643748|P3|Overall Study|Lost to Follow-up|6
5697912|NCT00267098|19643749|P2|Overall Study|Lost to Follow-up|0
5697913|NCT00267098|19643750|P1|Overall Study|Lost to Follow-up|0
5697914|NCT00267098|19643743|P8|Overall Study|Death|9
5697915|NCT00267098|19643744|P7|Overall Study|Death|28
5697916|NCT00267098|19643745|P6|Overall Study|Death|23
5697917|NCT00267098|19643746|P5|Overall Study|Death|14
5697918|NCT00267098|19643747|P4|Overall Study|Death|66
5697919|NCT00267098|19643748|P3|Overall Study|Death|57
5697920|NCT00267098|19643749|P2|Overall Study|Death|0
5697921|NCT00267098|19643750|P1|Overall Study|Death|0
5697922|NCT00267046|19643893|P2|Overall Study|Radiation|1
5697923|NCT00267046|19643894|P1|Overall Study|Radiation|0
5697924|NCT00267046|19643893|P2|Overall Study|Withdrawal by Subject|0
5697925|NCT00267046|19643894|P1|Overall Study|Withdrawal by Subject|1
5697926|NCT00267046|19643893|P2|Overall Study|Surgery|1
5697927|NCT00267046|19643894|P1|Overall Study|Surgery|3
5697928|NCT00267046|19643893|P2|Overall Study|Open-label palifermin|7
5697929|NCT00267046|19643894|P1|Overall Study|Open-label palifermin|2
5697930|NCT00267046|19643893|P2|Overall Study|Chemotoxicity|0
5697931|NCT00267046|19643894|P1|Overall Study|Chemotoxicity|2
5697932|NCT00267046|19643893|P2|Overall Study|Disease progression|2
5697933|NCT00267046|19643894|P1|Overall Study|Disease progression|4
5697934|NCT00267020|19643904|P2|Overall Study|Other|2
5697935|NCT00267020|19643905|P1|Overall Study|Other|1
5697936|NCT00267020|19643904|P2|Overall Study|Sponsor Request|0
5697937|NCT00267020|19643905|P1|Overall Study|Sponsor Request|1
5697938|NCT00267020|19643904|P2|Overall Study|Unrelated Complication|1
5697939|NCT00267020|19643905|P1|Overall Study|Unrelated Complication|1
5697940|NCT00267020|19643904|P2|Overall Study|Disease Progression|25
5697941|NCT00267020|19643905|P1|Overall Study|Disease Progression|39
5697942|NCT00267020|19643904|P2|Overall Study|Physician Decision|2
5697943|NCT00267020|19643905|P1|Overall Study|Physician Decision|3
5697944|NCT00267020|19643904|P2|Overall Study|Withdrawal by Subject|7
5697945|NCT00267020|19643905|P1|Overall Study|Withdrawal by Subject|17
5697946|NCT00267020|19643904|P2|Overall Study|Death|1
5697947|NCT00267020|19643905|P1|Overall Study|Death|2
5697948|NCT00267020|19643904|P2|Overall Study|Adverse Event|5
5697949|NCT00267020|19643905|P1|Overall Study|Adverse Event|22
5697950|NCT00267007|19643927|P2|Overall Study|Adverse Event|0
5697951|NCT00267007|19643928|P1|Overall Study|Adverse Event|1
5697952|NCT00267007|19643927|P2|Overall Study|Non-compliance|1
5697953|NCT00267007|19643928|P1|Overall Study|Non-compliance|0
5697954|NCT00267007|19643927|P2|Overall Study|Lost to Follow-up|0
5697955|NCT00267007|19643928|P1|Overall Study|Lost to Follow-up|1
5697956|NCT00267007|19643927|P2|Overall Study|Withdrawal by Subject|0
5697957|NCT00267007|19643928|P1|Overall Study|Withdrawal by Subject|6
5697958|NCT00266877|19643939|P3|Overall Study|Concomitant Radiotherapy|0
5697959|NCT00266877|19643940|P2|Overall Study|Concomitant Radiotherapy|1
5697960|NCT00266877|19643941|P1|Overall Study|Concomitant Radiotherapy|0
5697961|NCT00266877|19643939|P3|Overall Study|Hospitalization|0
5697962|NCT00266877|19643940|P2|Overall Study|Hospitalization|0
5697963|NCT00266877|19643941|P1|Overall Study|Hospitalization|1
5697964|NCT00266877|19643939|P3|Overall Study|Symptomatic Deterioration|1
5697965|NCT00266877|19643940|P2|Overall Study|Symptomatic Deterioration|3
5697966|NCT00266877|19643941|P1|Overall Study|Symptomatic Deterioration|6
5697967|NCT00266877|19643939|P3|Overall Study|Disease Progression|23
5697968|NCT00266877|19643940|P2|Overall Study|Disease Progression|37
5697969|NCT00266877|19643941|P1|Overall Study|Disease Progression|72
5697970|NCT00266877|19643939|P3|Overall Study|Withdrawal by Subject|1
5697971|NCT00266877|19643940|P2|Overall Study|Withdrawal by Subject|1
5697972|NCT00266877|19643941|P1|Overall Study|Withdrawal by Subject|3
5697973|NCT00266877|19643939|P3|Overall Study|Physician Decision|1
5697974|NCT00266877|19643940|P2|Overall Study|Physician Decision|1
5697975|NCT00266877|19643941|P1|Overall Study|Physician Decision|2
5697976|NCT00266877|19643939|P3|Overall Study|Adverse Event|1
5697977|NCT00266877|19643940|P2|Overall Study|Adverse Event|4
5697978|NCT00266877|19643941|P1|Overall Study|Adverse Event|6
5697979|NCT00266877|19643939|P3|Overall Study|Death|1
5697980|NCT00266877|19643940|P2|Overall Study|Death|1
5697981|NCT00266877|19643941|P1|Overall Study|Death|1
5697982|NCT00266864|19643960|P2|Overall Study|Withdrawal by Subject|1
5697983|NCT00266864|19643961|P1|Overall Study|Withdrawal by Subject|1
5697984|NCT00266864|19643960|P2|Overall Study|Lost to Follow-up|1
5697985|NCT00266864|19643961|P1|Overall Study|Lost to Follow-up|4
5697986|NCT00266825|19643992|P2|Completed Follow-Up|Withdrawal by Subject|5
5697987|NCT00266825|19643993|P1|Completed Follow-Up|Withdrawal by Subject|11
5697988|NCT00266825|19643992|P2|Completed Follow-Up|Lost to Follow-up|19
5697989|NCT00266825|19643993|P1|Completed Follow-Up|Lost to Follow-up|14
5697990|NCT00266812|19644019|P2|Overall Study|Discontinued before starting study drug|0
5697991|NCT00266812|19644020|P1|Overall Study|Discontinued before starting study drug|4
5697992|NCT00266812|19644019|P2|Overall Study|Withdrawal by Subject|2
5697993|NCT00266812|19644020|P1|Overall Study|Withdrawal by Subject|0
5697994|NCT00266812|19644019|P2|Overall Study|Protocol Violation|1
5697995|NCT00266812|19644020|P1|Overall Study|Protocol Violation|0
5697996|NCT00266812|19644019|P2|Overall Study|Adverse Event|1
5697997|NCT00266812|19644020|P1|Overall Study|Adverse Event|3
5697998|NCT00266812|19644019|P2|Overall Study|Death|4
5697999|NCT00266812|19644020|P1|Overall Study|Death|5
5698000|NCT00266812|19644019|P2|Overall Study|Disease Progression|3
5698001|NCT00266812|19644020|P1|Overall Study|Disease Progression|9
5698002|NCT00266708|19644045|P2|Overall Study|Asthma|2
5698003|NCT00266708|19644046|P1|Overall Study|Asthma|0
5698004|NCT00266708|19644045|P2|Overall Study|Refused biopsy|6
5698005|NCT00266708|19644046|P1|Overall Study|Refused biopsy|3
5698006|NCT00266708|19644045|P2|Overall Study|No renal function|1
5698007|NCT00266708|19644046|P1|Overall Study|No renal function|1
5698008|NCT00266695|19644086|P1|Overall Study|Withdrawal by Subject|15
5698009|NCT00266695|19644086|P1|Overall Study|Lost to Follow-up|3
5698010|NCT00266695|19644086|P1|Overall Study|Physician Decision|1
5698011|NCT00266695|19644086|P1|Overall Study|Death|9
5698012|NCT00266695|19644086|P1|Overall Study|Adverse Event|1
5698013|NCT00266656|19644098|P2|Overall Study|Parent/Caregiver Decision|2
5698014|NCT00266656|19644099|P1|Overall Study|Parent/Caregiver Decision|1
5698015|NCT00266656|19644098|P2|Overall Study|Did Not Reach Final Height|8
5698016|NCT00266656|19644099|P1|Overall Study|Did Not Reach Final Height|4
5698017|NCT00266656|19644098|P2|Overall Study|Withdrawal by Subject|2
5698018|NCT00266656|19644099|P1|Overall Study|Withdrawal by Subject|4
5698019|NCT00266656|19644098|P2|Overall Study|Lost to Follow-up|1
5698020|NCT00266656|19644099|P1|Overall Study|Lost to Follow-up|4
5698021|NCT00266656|19644098|P2|Overall Study|Death|0
5698022|NCT00266656|19644099|P1|Overall Study|Death|1
5698023|NCT00266630|19644123|P2|Overall Study|Other|11
5698024|NCT00266630|19644124|P1|Overall Study|Other|19
5698025|NCT00266630|19644123|P2|Overall Study|Lost to Follow-up|0
5698026|NCT00266630|19644124|P1|Overall Study|Lost to Follow-up|1
5698027|NCT00266630|19644123|P2|Overall Study|Withdrawal by Subject|2
5698028|NCT00266630|19644124|P1|Overall Study|Withdrawal by Subject|10
5698029|NCT00266630|19644123|P2|Overall Study|Physician Decision|2
5698030|NCT00266630|19644124|P1|Overall Study|Physician Decision|1
5698031|NCT00266630|19644123|P2|Overall Study|Protocol Violation|3
5698032|NCT00266630|19644124|P1|Overall Study|Protocol Violation|1
5698033|NCT00266630|19644123|P2|Overall Study|Entry Criteria not met|0
5698034|NCT00266630|19644124|P1|Overall Study|Entry Criteria not met|1
5698035|NCT00266630|19644123|P2|Overall Study|Lack of Efficacy|4
5698036|NCT00266630|19644124|P1|Overall Study|Lack of Efficacy|1
5698037|NCT00266630|19644123|P2|Overall Study|Adverse Event|6
5698038|NCT00266630|19644124|P1|Overall Study|Adverse Event|8
5698039|NCT00266409|19644166|P4|Overall Study|Other|0
5698040|NCT00266409|19644167|P3|Overall Study|Other|2
5698041|NCT00266409|19644168|P2|Overall Study|Other|4
5698042|NCT00266409|19644169|P1|Overall Study|Other|7
5698043|NCT00266409|19644166|P4|Overall Study|Protocol Violation|2
5698044|NCT00266409|19644167|P3|Overall Study|Protocol Violation|4
5698045|NCT00266409|19644168|P2|Overall Study|Protocol Violation|3
5698046|NCT00266409|19644169|P1|Overall Study|Protocol Violation|5
5698047|NCT00266409|19644166|P4|Overall Study|Withdrawal by Subject|9
5698048|NCT00266409|19644167|P3|Overall Study|Withdrawal by Subject|3
5698049|NCT00266409|19644168|P2|Overall Study|Withdrawal by Subject|10
5698050|NCT00266409|19644169|P1|Overall Study|Withdrawal by Subject|6
5698051|NCT00266409|19644166|P4|Overall Study|Lost to Follow-up|8
5698052|NCT00266409|19644167|P3|Overall Study|Lost to Follow-up|6
5698053|NCT00266409|19644168|P2|Overall Study|Lost to Follow-up|21
5698054|NCT00266409|19644169|P1|Overall Study|Lost to Follow-up|18
5698055|NCT00266409|19644166|P4|Overall Study|Adverse Event|1
5698056|NCT00266409|19644167|P3|Overall Study|Adverse Event|1
5698057|NCT00266409|19644168|P2|Overall Study|Adverse Event|2
5698058|NCT00266409|19644169|P1|Overall Study|Adverse Event|7
5698059|NCT00266409|19644166|P4|Overall Study|Lack of Efficacy|2
5698060|NCT00266409|19644167|P3|Overall Study|Lack of Efficacy|1
5698061|NCT00266409|19644168|P2|Overall Study|Lack of Efficacy|6
5698062|NCT00266409|19644169|P1|Overall Study|Lack of Efficacy|2
5698063|NCT00266227|19644458|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
5698064|NCT00266227|19644459|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
5698065|NCT00266227|19644460|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
5698066|NCT00266227|19644458|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
5698067|NCT00266227|19644459|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
5698068|NCT00266227|19644460|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
5698069|NCT00266227|19644458|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
5698070|NCT00266227|19644459|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
5698071|NCT00266227|19644460|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
5698072|NCT00266227|19644458|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
5698073|NCT00266227|19644459|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
5698074|NCT00266227|19644460|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
5698075|NCT00266227|19644458|P3|Retreatment: Week 48 to Week 72|Death|0
5698076|NCT00266227|19644459|P2|Retreatment: Week 48 to Week 72|Death|1
5698077|NCT00266227|19644460|P1|Retreatment: Week 48 to Week 72|Death|1
5698078|NCT00266227|19644458|P3|Retreatment: Up to Week 48|Pregnancy|0
5698079|NCT00266227|19644459|P2|Retreatment: Up to Week 48|Pregnancy|0
5698080|NCT00266227|19644460|P1|Retreatment: Up to Week 48|Pregnancy|1
5698081|NCT00266227|19644458|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
5698082|NCT00266227|19644459|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
5698083|NCT00266227|19644460|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
5698084|NCT00266227|19644458|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
5698085|NCT00266227|19644459|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
5698086|NCT00266227|19644460|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
5698087|NCT00266227|19644458|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
5698088|NCT00266227|19644459|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
5698089|NCT00266227|19644460|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
5698090|NCT00266227|19644458|P3|Retreatment: Up to Week 48|Adverse Event|0
5698091|NCT00266227|19644459|P2|Retreatment: Up to Week 48|Adverse Event|7
5698092|NCT00266227|19644460|P1|Retreatment: Up to Week 48|Adverse Event|7
5698093|NCT00266227|19644458|P3|Retreatment: Up to Week 48|Death|0
5698094|NCT00266227|19644459|P2|Retreatment: Up to Week 48|Death|0
5698095|NCT00266227|19644460|P1|Retreatment: Up to Week 48|Death|1
5698096|NCT00266227|19644458|P3|Initial Treatment|Pregnancy|1
5698097|NCT00266227|19644459|P2|Initial Treatment|Pregnancy|0
5698098|NCT00266227|19644460|P1|Initial Treatment|Pregnancy|0
5698099|NCT00266227|19644458|P3|Initial Treatment|Physician decision to withdraw|12
5698100|NCT00266227|19644459|P2|Initial Treatment|Physician decision to withdraw|0
5698101|NCT00266227|19644460|P1|Initial Treatment|Physician decision to withdraw|0
5698102|NCT00266227|19644458|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
5698103|NCT00266227|19644459|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
5698104|NCT00266227|19644460|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
5698105|NCT00266227|19644458|P3|Initial Treatment|Lost to Follow-up|6
5698106|NCT00266227|19644459|P2|Initial Treatment|Lost to Follow-up|0
5698107|NCT00266227|19644460|P1|Initial Treatment|Lost to Follow-up|0
5698108|NCT00266227|19644458|P3|Initial Treatment|Adverse Event|13
5698109|NCT00266227|19644459|P2|Initial Treatment|Adverse Event|0
5698110|NCT00266227|19644460|P1|Initial Treatment|Adverse Event|0
5698111|NCT00266032|19644514|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
5698112|NCT00266032|19644515|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
5698113|NCT00266032|19644516|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
5698114|NCT00266032|19644514|P3|Open-label Safety Extension|Withdrawal by Subject|12
5698115|NCT00266032|19644515|P2|Open-label Safety Extension|Withdrawal by Subject|3
5698116|NCT00266032|19644516|P1|Open-label Safety Extension|Withdrawal by Subject|19
5698117|NCT00266032|19644514|P3|Open-label Safety Extension|Protocol Violation|2
5698118|NCT00266032|19644515|P2|Open-label Safety Extension|Protocol Violation|3
5698119|NCT00266032|19644516|P1|Open-label Safety Extension|Protocol Violation|1
5698120|NCT00266032|19644514|P3|Open-label Safety Extension|Pregnancy|2
5698121|NCT00266032|19644515|P2|Open-label Safety Extension|Pregnancy|1
5698122|NCT00266032|19644516|P1|Open-label Safety Extension|Pregnancy|4
5698123|NCT00266032|19644514|P3|Open-label Safety Extension|Lost to Follow-up|4
5698124|NCT00266032|19644515|P2|Open-label Safety Extension|Lost to Follow-up|5
5698125|NCT00266032|19644516|P1|Open-label Safety Extension|Lost to Follow-up|2
5698126|NCT00266032|19644514|P3|Open-label Safety Extension|Adverse Event|4
5698127|NCT00266032|19644515|P2|Open-label Safety Extension|Adverse Event|0
5698128|NCT00266032|19644516|P1|Open-label Safety Extension|Adverse Event|5
5698129|NCT00266032|19644514|P3|Treatment|patient moved/wish for pregnancy/no need|8
5698130|NCT00266032|19644515|P2|Treatment|patient moved/wish for pregnancy/no need|5
5698131|NCT00266032|19644516|P1|Treatment|patient moved/wish for pregnancy/no need|13
5698132|NCT00266032|19644514|P3|Treatment|Withdrawal by Subject|12
5698133|NCT00266032|19644515|P2|Treatment|Withdrawal by Subject|13
5698134|NCT00266032|19644516|P1|Treatment|Withdrawal by Subject|28
5698135|NCT00266032|19644514|P3|Treatment|Protocol Violation|13
5698136|NCT00266032|19644515|P2|Treatment|Protocol Violation|14
5698137|NCT00266032|19644516|P1|Treatment|Protocol Violation|6
5698138|NCT00266032|19644514|P3|Treatment|Pregnancy|2
5698139|NCT00266032|19644515|P2|Treatment|Pregnancy|2
5698140|NCT00266032|19644516|P1|Treatment|Pregnancy|3
5698141|NCT00266032|19644514|P3|Treatment|Lost to Follow-up|2
5698142|NCT00266032|19644515|P2|Treatment|Lost to Follow-up|4
5698143|NCT00266032|19644516|P1|Treatment|Lost to Follow-up|19
5698144|NCT00266032|19644514|P3|Treatment|Adverse Event|10
5698145|NCT00266032|19644515|P2|Treatment|Adverse Event|26
5698146|NCT00266032|19644516|P1|Treatment|Adverse Event|42
5698147|NCT00265941|19644551|P2|Overall Study|Lost to Follow-up|1
5698148|NCT00265941|19644552|P1|Overall Study|Lost to Follow-up|1
5698149|NCT00265941|19644551|P2|Overall Study|Protocol Violation|25
5698150|NCT00265941|19644552|P1|Overall Study|Protocol Violation|22
5698151|NCT00265889|19644584|P1|Overall Study|Insurance denied the request|3
5698152|NCT00265889|19644584|P1|Overall Study|Protocol Violation|1
5698153|NCT00265889|19644584|P1|Overall Study|Physician Decision|1
5698154|NCT00265785|19644611|P1|Overall Study|Did not receive protocol treatment|2
5698155|NCT00265785|19644611|P1|Overall Study|Ineligible|1
5698156|NCT00265785|19644611|P1|Overall Study|Not protocol specified|2
5698157|NCT00265785|19644611|P1|Overall Study|Progression/Relapse|15
5698158|NCT00265785|19644611|P1|Overall Study|Withdrawal by Subject|3
5698159|NCT00265785|19644611|P1|Overall Study|Adverse Event|4
5698160|NCT00265759|19644624|P4|Overall Study|Discontinued due to intolerability|1
5698161|NCT00265759|19644625|P3|Overall Study|Discontinued due to intolerability|0
5698162|NCT00265759|19644626|P2|Overall Study|Discontinued due to intolerability|0
5698163|NCT00265759|19644627|P1|Overall Study|Discontinued due to intolerability|0
5698164|NCT00265759|19644624|P4|Overall Study|Bilateral disease|2
5698165|NCT00265759|19644625|P3|Overall Study|Bilateral disease|0
5698166|NCT00265759|19644626|P2|Overall Study|Bilateral disease|0
5698167|NCT00265759|19644627|P1|Overall Study|Bilateral disease|0
5698168|NCT00265759|19644624|P4|Overall Study|Ineligible|1
5698169|NCT00265759|19644625|P3|Overall Study|Ineligible|0
5698170|NCT00265759|19644626|P2|Overall Study|Ineligible|0
5698171|NCT00265759|19644627|P1|Overall Study|Ineligible|0
5698172|NCT00265759|19644624|P4|Overall Study|Cancel|3
5698173|NCT00265759|19644625|P3|Overall Study|Cancel|0
5698174|NCT00265759|19644626|P2|Overall Study|Cancel|0
5698175|NCT00265759|19644627|P1|Overall Study|Cancel|0
5698176|NCT00265759|19644624|P4|Overall Study|Withdrawal by Subject|2
5698177|NCT00265759|19644625|P3|Overall Study|Withdrawal by Subject|2
5698178|NCT00265759|19644626|P2|Overall Study|Withdrawal by Subject|1
5698179|NCT00265759|19644627|P1|Overall Study|Withdrawal by Subject|0
5698180|NCT00265564|19644677|P2|Overall Study|met exclusion criteria|2
5698181|NCT00265564|19644678|P1|Overall Study|met exclusion criteria|5
5698182|NCT00265564|19644677|P2|Overall Study|Lost to Follow-up|7
5698183|NCT00265564|19644678|P1|Overall Study|Lost to Follow-up|5
5698184|NCT00265395|19644728|P2|Overall Study|Administrative|1
5698185|NCT00265395|19644729|P1|Overall Study|Administrative|0
5698186|NCT00265395|19644728|P2|Overall Study|Lack of Efficacy|1
5698187|NCT00265395|19644729|P1|Overall Study|Lack of Efficacy|0
5698188|NCT00265395|19644728|P2|Overall Study|Protocol Violation|2
5698189|NCT00265395|19644729|P1|Overall Study|Protocol Violation|2
5698190|NCT00265395|19644728|P2|Overall Study|Withdrawal by Subject|6
5698191|NCT00265395|19644729|P1|Overall Study|Withdrawal by Subject|1
5698192|NCT00265395|19644728|P2|Overall Study|Lost to Follow-up|1
5698193|NCT00265395|19644729|P1|Overall Study|Lost to Follow-up|2
5698194|NCT00265395|19644728|P2|Overall Study|Adverse Event|6
5698195|NCT00265395|19644729|P1|Overall Study|Adverse Event|3
5698196|NCT00265382|19644734|P1|Overall Study|Death|1
5698197|NCT00265382|19644734|P1|Overall Study|Study terminated by sponsor|94
5698198|NCT00265382|19644734|P1|Overall Study|Withdrawal by Subject|13
5698199|NCT00265382|19644734|P1|Overall Study|Miscellaneous|6
5698200|NCT00265382|19644734|P1|Overall Study|Lack of Efficacy|6
5698201|NCT00265382|19644734|P1|Overall Study|Lost to Follow-up|3
5698202|NCT00265382|19644734|P1|Overall Study|Laboratory Abnormality|1
5698203|NCT00265382|19644734|P1|Overall Study|Adverse Event|21
5698204|NCT00265343|19644754|P2|Overall Study|Other|3
5698205|NCT00265343|19644755|P1|Overall Study|Other|8
5698206|NCT00265343|19644754|P2|Overall Study|Withdrawal by Subject|9
5698207|NCT00265343|19644755|P1|Overall Study|Withdrawal by Subject|3
5698208|NCT00265343|19644754|P2|Overall Study|Adverse Event|7
5698209|NCT00265343|19644755|P1|Overall Study|Adverse Event|10
5698210|NCT00265330|19644763|P1|Overall Study|Protocol Violation|1
5698211|NCT00265330|19644763|P1|Overall Study|Withdrew Consent|1
5698212|NCT00265330|19644763|P1|Overall Study|Principal Investigators Request|1
5698213|NCT00265330|19644763|P1|Overall Study|Site Closed by Sponsor|1
5698214|NCT00265330|19644763|P1|Overall Study|Discharged from Unit for Long Term Care|1
5698215|NCT00265330|19644763|P1|Overall Study|Began Taking Formulary Geodon|1
5698216|NCT00265330|19644763|P1|Overall Study|Family Scheduling Conflicts|1
5698217|NCT00265330|19644763|P1|Overall Study|Lack of Efficacy|4
5698218|NCT00265330|19644763|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
5698219|NCT00265330|19644763|P1|Overall Study|Withdrawal by Subject|34
5698220|NCT00265330|19644763|P1|Overall Study|Lost to Follow-up|8
5698221|NCT00265330|19644763|P1|Overall Study|Adverse Event|41
5698222|NCT00265317|19644789|P4|Phase 2|Other|1
5698223|NCT00265317|19644790|P3|Phase 2|Other|1
5698224|NCT00265317|19644791|P2|Phase 2|Other|0
5698225|NCT00265317|19644792|P1|Phase 2|Other|0
5698226|NCT00265317|19644789|P4|Phase 2|Study terminated by sponsor|0
5698227|NCT00265317|19644790|P3|Phase 2|Study terminated by sponsor|1
5698228|NCT00265317|19644791|P2|Phase 2|Study terminated by sponsor|0
5698229|NCT00265317|19644792|P1|Phase 2|Study terminated by sponsor|0
5698230|NCT00265317|19644789|P4|Phase 2|Withdrawal/other than adverse event|1
5698231|NCT00265317|19644790|P3|Phase 2|Withdrawal/other than adverse event|2
5698232|NCT00265317|19644791|P2|Phase 2|Withdrawal/other than adverse event|0
5698233|NCT00265317|19644792|P1|Phase 2|Withdrawal/other than adverse event|0
5698234|NCT00265317|19644789|P4|Phase 2|Lost to Follow-up|1
5698235|NCT00265317|19644790|P3|Phase 2|Lost to Follow-up|0
5698236|NCT00265317|19644791|P2|Phase 2|Lost to Follow-up|0
5698237|NCT00265317|19644792|P1|Phase 2|Lost to Follow-up|0
5698238|NCT00265317|19644789|P4|Phase 2|Protocol Violation|4
5698239|NCT00265317|19644790|P3|Phase 2|Protocol Violation|1
5698240|NCT00265317|19644791|P2|Phase 2|Protocol Violation|0
5698241|NCT00265317|19644792|P1|Phase 2|Protocol Violation|0
5698242|NCT00265317|19644789|P4|Phase 2|Death|15
5698243|NCT00265317|19644790|P3|Phase 2|Death|12
5698244|NCT00265317|19644791|P2|Phase 2|Death|0
5698245|NCT00265317|19644792|P1|Phase 2|Death|0
5698246|NCT00265317|19644789|P4|Phase 2|Adverse Event|5
5698247|NCT00265317|19644790|P3|Phase 2|Adverse Event|7
5698248|NCT00265317|19644791|P2|Phase 2|Adverse Event|0
5698249|NCT00265317|19644792|P1|Phase 2|Adverse Event|0
5698250|NCT00265317|19644789|P4|Phase 2|Global deterioration of health status|0
5698251|NCT00265317|19644790|P3|Phase 2|Global deterioration of health status|3
5698252|NCT00265317|19644791|P2|Phase 2|Global deterioration of health status|0
5698253|NCT00265317|19644792|P1|Phase 2|Global deterioration of health status|0
5698254|NCT00265317|19644789|P4|Phase 2|Objective progression or relapse|38
5698255|NCT00265317|19644790|P3|Phase 2|Objective progression or relapse|37
5698256|NCT00265317|19644791|P2|Phase 2|Objective progression or relapse|0
5698257|NCT00265317|19644792|P1|Phase 2|Objective progression or relapse|0
5698258|NCT00265317|19644789|P4|Lead-In|Withdrawal/other than adverse event|0
5698259|NCT00265317|19644790|P3|Lead-In|Withdrawal/other than adverse event|0
5698260|NCT00265317|19644791|P2|Lead-In|Withdrawal/other than adverse event|0
5698261|NCT00265317|19644792|P1|Lead-In|Withdrawal/other than adverse event|1
5698262|NCT00265317|19644789|P4|Lead-In|Death|0
5698263|NCT00265317|19644790|P3|Lead-In|Death|0
5698264|NCT00265317|19644791|P2|Lead-In|Death|5
5698265|NCT00265317|19644792|P1|Lead-In|Death|3
5698266|NCT00265317|19644789|P4|Lead-In|Adverse Event|0
5698267|NCT00265317|19644790|P3|Lead-In|Adverse Event|0
5698268|NCT00265317|19644791|P2|Lead-In|Adverse Event|1
5698269|NCT00265317|19644792|P1|Lead-In|Adverse Event|2
5698270|NCT00265317|19644789|P4|Lead-In|Objective progression or relapse|0
5698271|NCT00265317|19644790|P3|Lead-In|Objective progression or relapse|0
5698272|NCT00265317|19644791|P2|Lead-In|Objective progression or relapse|11
5698273|NCT00265317|19644792|P1|Lead-In|Objective progression or relapse|6
5698274|NCT00265239|19644907|P2|Overall Study|Adverse Event|1
5698275|NCT00265239|19644908|P1|Overall Study|Adverse Event|2
5698276|NCT00265148|19644926|P2|Overall Study|Subject chose to change of the dose|0
5698277|NCT00265148|19644927|P1|Overall Study|Subject chose to change of the dose|1
5698278|NCT00265148|19644926|P2|Overall Study|Increasing frailty|1
5698279|NCT00265148|19644927|P1|Overall Study|Increasing frailty|0
5698280|NCT00265148|19644926|P2|Overall Study|Physician Decision|0
5698281|NCT00265148|19644927|P1|Overall Study|Physician Decision|1
5698282|NCT00265148|19644926|P2|Overall Study|Withdrawal by Subject|1
5698283|NCT00265148|19644927|P1|Overall Study|Withdrawal by Subject|2
5698284|NCT00265148|19644926|P2|Overall Study|Lost to Follow-up|1
5698285|NCT00265148|19644927|P1|Overall Study|Lost to Follow-up|0
5698286|NCT00265148|19644926|P2|Overall Study|Protocol Violation|2
5698287|NCT00265148|19644927|P1|Overall Study|Protocol Violation|3
5698288|NCT00265148|19644926|P2|Overall Study|Lack of Efficacy|2
5698289|NCT00265148|19644927|P1|Overall Study|Lack of Efficacy|0
5698290|NCT00265148|19644926|P2|Overall Study|Adverse Event|2
5698291|NCT00265148|19644927|P1|Overall Study|Adverse Event|2
5698292|NCT00265122|19644991|P6|Intervention Period 2 (Weeks 8 to 28):|Other|0
5698293|NCT00265122|19644992|P5|Intervention Period 2 (Weeks 8 to 28):|Other|0
5698294|NCT00265122|19644993|P4|Intervention Period 2 (Weeks 8 to 28):|Other|1
5698295|NCT00265122|19644994|P3|Intervention Period 2 (Weeks 8 to 28):|Other|1
5698296|NCT00265122|19644995|P2|Intervention Period 2 (Weeks 8 to 28):|Other|0
5698297|NCT00265122|19644996|P1|Intervention Period 2 (Weeks 8 to 28):|Other|4
5698298|NCT00265122|19644991|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
5698299|NCT00265122|19644992|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
5698300|NCT00265122|19644993|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
5698301|NCT00265122|19644994|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
5698302|NCT00265122|19644995|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
5698303|NCT00265122|19644996|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
5698304|NCT00265122|19644991|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
5698305|NCT00265122|19644992|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
5698306|NCT00265122|19644993|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
5698307|NCT00265122|19644994|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
5698308|NCT00265122|19644995|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
5698309|NCT00265122|19644996|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
5698310|NCT00265122|19644991|P6|Intervention Period 1 (Weeks 0 to 8):|Other|0
5698311|NCT00265122|19644992|P5|Intervention Period 1 (Weeks 0 to 8):|Other|0
5698312|NCT00265122|19644993|P4|Intervention Period 1 (Weeks 0 to 8):|Other|1
5698313|NCT00265122|19644994|P3|Intervention Period 1 (Weeks 0 to 8):|Other|2
5698314|NCT00265122|19644995|P2|Intervention Period 1 (Weeks 0 to 8):|Other|1
5698315|NCT00265122|19644996|P1|Intervention Period 1 (Weeks 0 to 8):|Other|0
5698316|NCT00265122|19644991|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
5698317|NCT00265122|19644992|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
5698318|NCT00265122|19644993|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
5698319|NCT00265122|19644994|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
5698320|NCT00265122|19644995|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
5698321|NCT00265122|19644996|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
5698322|NCT00265122|19644991|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
5698323|NCT00265122|19644992|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
5698324|NCT00265122|19644993|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
5698325|NCT00265122|19644994|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
5698326|NCT00265122|19644995|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
5698327|NCT00265122|19644996|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
5698328|NCT00265109|19645018|P1|Overall Study|Adverse Event|1
5698329|NCT00265109|19645018|P1|Overall Study|Withdrawal by Subject|5
5698330|NCT00265096|19645037|P3|Overall Study|Other|10
5698331|NCT00265096|19645038|P2|Overall Study|Other|19
5698332|NCT00265096|19645039|P1|Overall Study|Other|11
5698333|NCT00265096|19645037|P3|Overall Study|Unsatisfactory therapeutic effect|6
5698334|NCT00265096|19645038|P2|Overall Study|Unsatisfactory therapeutic effect|8
5698335|NCT00265096|19645039|P1|Overall Study|Unsatisfactory therapeutic effect|9
5698336|NCT00265096|19645037|P3|Overall Study|Death|2
5698337|NCT00265096|19645038|P2|Overall Study|Death|1
5698338|NCT00265096|19645039|P1|Overall Study|Death|0
5698339|NCT00265096|19645037|P3|Overall Study|Lost to Follow-up|3
5698340|NCT00265096|19645038|P2|Overall Study|Lost to Follow-up|5
5698341|NCT00265096|19645039|P1|Overall Study|Lost to Follow-up|2
5698342|NCT00265096|19645037|P3|Overall Study|Adverse Event|18
5698343|NCT00265096|19645038|P2|Overall Study|Adverse Event|18
5698344|NCT00265096|19645039|P1|Overall Study|Adverse Event|14
5698345|NCT00265083|19645071|P3|Overall Study|Other|9
5698346|NCT00265083|19645072|P2|Overall Study|Other|12
5698347|NCT00265083|19645073|P1|Overall Study|Other|1
5698348|NCT00265083|19645071|P3|Overall Study|Unsatisfactory therapeutic effect|14
5698349|NCT00265083|19645072|P2|Overall Study|Unsatisfactory therapeutic effect|13
5698350|NCT00265083|19645073|P1|Overall Study|Unsatisfactory therapeutic effect|8
5698351|NCT00265083|19645071|P3|Overall Study|Lost to Follow-up|4
5698352|NCT00265083|19645072|P2|Overall Study|Lost to Follow-up|4
5698353|NCT00265083|19645073|P1|Overall Study|Lost to Follow-up|3
5698354|NCT00265083|19645071|P3|Overall Study|Adverse Event|15
5698355|NCT00265083|19645072|P2|Overall Study|Adverse Event|13
5698356|NCT00265083|19645073|P1|Overall Study|Adverse Event|5
5698357|NCT00264875|19645094|P1|Overall Study|Withdrawal by Subject|7
5698358|NCT00264875|19645094|P1|Overall Study|Protocol Violation|11
5698359|NCT00264875|19645094|P1|Overall Study|Lost to Follow-up|6
5698360|NCT00264875|19645094|P1|Overall Study|Adverse Event|6
5698361|NCT00264849|19645100|P2|Overall Study|Administrative Problems|0
5698362|NCT00264849|19645101|P1|Overall Study|Administrative Problems|2
5698363|NCT00264849|19645100|P2|Overall Study|Death|1
5698364|NCT00264849|19645101|P1|Overall Study|Death|0
5698365|NCT00264849|19645100|P2|Overall Study|Lost to Follow-up|2
5698366|NCT00264849|19645101|P1|Overall Study|Lost to Follow-up|0
5698367|NCT00264849|19645100|P2|Overall Study|Lack of Efficacy|6
5698368|NCT00264849|19645101|P1|Overall Study|Lack of Efficacy|1
5698369|NCT00264849|19645100|P2|Overall Study|Protocol Violation|3
5698370|NCT00264849|19645101|P1|Overall Study|Protocol Violation|5
5698371|NCT00264849|19645100|P2|Overall Study|Withdrawal by Subject|11
5698372|NCT00264849|19645101|P1|Overall Study|Withdrawal by Subject|7
5698373|NCT00264849|19645100|P2|Overall Study|Adverse Event|2
5698374|NCT00264849|19645101|P1|Overall Study|Adverse Event|7
5698375|NCT00264810|19645135|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
5698376|NCT00264810|19645136|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
5698377|NCT00264810|19645135|P2|Open Label Evaluation Period|Death|2
5698378|NCT00264810|19645136|P1|Open Label Evaluation Period|Death|3
5698379|NCT00264810|19645135|P2|Open Label Evaluation Period|Explant due to infection|1
5698380|NCT00264810|19645136|P1|Open Label Evaluation Period|Explant due to infection|1
5698381|NCT00264810|19645135|P2|Blinded Evaluation Period|Explant due to infection|1
5698382|NCT00264810|19645136|P1|Blinded Evaluation Period|Explant due to infection|1
5698383|NCT00264810|19645135|P2|Stimulation Optimization Period|Death|1
5698384|NCT00264810|19645136|P1|Stimulation Optimization Period|Death|0
5698385|NCT00264810|19645135|P2|Stimulation Optimization Period|Withdrawal by Subject|0
5698386|NCT00264810|19645136|P1|Stimulation Optimization Period|Withdrawal by Subject|1
5698387|NCT00264810|19645135|P2|Baseline|Other|1
5698388|NCT00264810|19645136|P1|Baseline|Other|0
5698389|NCT00264810|19645135|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
5698390|NCT00264810|19645136|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
5698391|NCT00264810|19645135|P2|Baseline|Insufficient Seizure Frequency|2
5698392|NCT00264810|19645136|P1|Baseline|Insufficient Seizure Frequency|2
5698393|NCT00264810|19645135|P2|Baseline|Subject Compliance Failure|3
5698394|NCT00264810|19645136|P1|Baseline|Subject Compliance Failure|3
5698395|NCT00264810|19645135|P2|Baseline|Physician Decision|8
5698396|NCT00264810|19645136|P1|Baseline|Physician Decision|7
5698397|NCT00264810|19645135|P2|Baseline|Withdrawal by Subject|10
5698398|NCT00264810|19645136|P1|Baseline|Withdrawal by Subject|10
5698399|NCT00264797|19645146|P2|Overall Study|Other|4
5698400|NCT00264797|19645147|P1|Overall Study|Other|3
5698401|NCT00264797|19645146|P2|Overall Study|Feels treatment not necessary, not worki|1
5698402|NCT00264797|19645147|P1|Overall Study|Feels treatment not necessary, not worki|0
5698403|NCT00264797|19645146|P2|Overall Study|Pressure/advice from Outsiders|1
5698404|NCT00264797|19645147|P1|Overall Study|Pressure/advice from Outsiders|1
5698405|NCT00264797|19645146|P2|Overall Study|Incarceration|5
5698406|NCT00264797|19645147|P1|Overall Study|Incarceration|4
5698407|NCT00264797|19645146|P2|Overall Study|Practical Problems|3
5698408|NCT00264797|19645147|P1|Overall Study|Practical Problems|2
5698409|NCT00264797|19645146|P2|Overall Study|Moved from area|1
5698410|NCT00264797|19645147|P1|Overall Study|Moved from area|3
5698411|NCT00264797|19645146|P2|Overall Study|Lost to Follow-up|17
5698412|NCT00264797|19645147|P1|Overall Study|Lost to Follow-up|9
5698413|NCT00264797|19645146|P2|Overall Study|Withdrawal by Subject|11
5698414|NCT00264797|19645147|P1|Overall Study|Withdrawal by Subject|11
5698415|NCT00264576|19645169|P2|Overall Study|Lost to Follow-up|1
5698416|NCT00264576|19645170|P1|Overall Study|Lost to Follow-up|1
5698417|NCT00264550|19645194|P4|Overall Study|Other|9
5698418|NCT00264550|19645195|P3|Overall Study|Other|3
5698419|NCT00264550|19645196|P2|Overall Study|Other|7
5698420|NCT00264550|19645197|P1|Overall Study|Other|13
5698421|NCT00264550|19645194|P4|Overall Study|Discontinued oral study agent|0
5698422|NCT00264550|19645195|P3|Overall Study|Discontinued oral study agent|0
5698423|NCT00264550|19645196|P2|Overall Study|Discontinued oral study agent|1
5698424|NCT00264550|19645197|P1|Overall Study|Discontinued oral study agent|0
5698425|NCT00264550|19645194|P4|Overall Study|Unsatisfactory therapeutic effect|6
5698426|NCT00264550|19645195|P3|Overall Study|Unsatisfactory therapeutic effect|4
5698427|NCT00264550|19645196|P2|Overall Study|Unsatisfactory therapeutic effect|11
5698428|NCT00264550|19645197|P1|Overall Study|Unsatisfactory therapeutic effect|4
5698429|NCT00264550|19645194|P4|Overall Study|Adverse Event|14
5698430|NCT00264550|19645195|P3|Overall Study|Adverse Event|9
5698431|NCT00264550|19645196|P2|Overall Study|Adverse Event|18
5698432|NCT00264550|19645197|P1|Overall Study|Adverse Event|23
5698433|NCT00264550|19645194|P4|Overall Study|Lost to Follow-up|1
5698434|NCT00264550|19645195|P3|Overall Study|Lost to Follow-up|1
5698435|NCT00264550|19645196|P2|Overall Study|Lost to Follow-up|1
5698436|NCT00264550|19645197|P1|Overall Study|Lost to Follow-up|3
5698437|NCT00264550|19645194|P4|Overall Study|Death|0
5698438|NCT00264550|19645195|P3|Overall Study|Death|0
5698439|NCT00264550|19645196|P2|Overall Study|Death|3
5698440|NCT00264550|19645197|P1|Overall Study|Death|0
5698441|NCT00264537|19645236|P4|Overall Study|Not treated|0
5698442|NCT00264537|19645237|P3|Overall Study|Not treated|1
5698443|NCT00264537|19645238|P2|Overall Study|Not treated|2
5698444|NCT00264537|19645239|P1|Overall Study|Not treated|0
5698445|NCT00264537|19645236|P4|Overall Study|Other|11
5698446|NCT00264537|19645237|P3|Overall Study|Other|10
5698447|NCT00264537|19645238|P2|Overall Study|Other|11
5698448|NCT00264537|19645239|P1|Overall Study|Other|21
5698449|NCT00264537|19645236|P4|Overall Study|Unsatisfactory therapeutic effect|7
5698450|NCT00264537|19645237|P3|Overall Study|Unsatisfactory therapeutic effect|5
5698451|NCT00264537|19645238|P2|Overall Study|Unsatisfactory therapeutic effect|6
5698452|NCT00264537|19645239|P1|Overall Study|Unsatisfactory therapeutic effect|5
5698453|NCT00264537|19645236|P4|Overall Study|Adverse Event|34
5698454|NCT00264537|19645237|P3|Overall Study|Adverse Event|24
5698455|NCT00264537|19645238|P2|Overall Study|Adverse Event|32
5698456|NCT00264537|19645239|P1|Overall Study|Adverse Event|21
5698457|NCT00264537|19645236|P4|Overall Study|Lost to Follow-up|6
5698458|NCT00264537|19645237|P3|Overall Study|Lost to Follow-up|7
5698459|NCT00264537|19645238|P2|Overall Study|Lost to Follow-up|4
5698460|NCT00264537|19645239|P1|Overall Study|Lost to Follow-up|3
5698461|NCT00264537|19645236|P4|Overall Study|Death|2
5698462|NCT00264537|19645237|P3|Overall Study|Death|3
5698463|NCT00264537|19645238|P2|Overall Study|Death|3
5698464|NCT00264537|19645239|P1|Overall Study|Death|0
5698465|NCT00264498|19645271|P2|Crossover Treatment|Withdrawal by Subject|0
5698466|NCT00264498|19645272|P1|Crossover Treatment|Withdrawal by Subject|1
5698467|NCT00264498|19645271|P2|Crossover Treatment|Study closure|1
5698468|NCT00264498|19645272|P1|Crossover Treatment|Study closure|0
5698469|NCT00264498|19645271|P2|Crossover Treatment|Objective disease progression|5
5698470|NCT00264498|19645272|P1|Crossover Treatment|Objective disease progression|4
5698471|NCT00264498|19645271|P2|Crossover Treatment|Death|3
5698472|NCT00264498|19645272|P1|Crossover Treatment|Death|1
5698473|NCT00264498|19645271|P2|Randomized Treatment|Protocol Violation|0
5698474|NCT00264498|19645272|P1|Randomized Treatment|Protocol Violation|1
5698475|NCT00264498|19645271|P2|Randomized Treatment|Study Closure|0
5698476|NCT00264498|19645272|P1|Randomized Treatment|Study Closure|1
5698477|NCT00264498|19645271|P2|Randomized Treatment|Incorrectly randomized|0
5698478|NCT00264498|19645272|P1|Randomized Treatment|Incorrectly randomized|1
5698479|NCT00264498|19645271|P2|Randomized Treatment|Physician Decision|0
5698480|NCT00264498|19645272|P1|Randomized Treatment|Physician Decision|1
5698481|NCT00264498|19645271|P2|Randomized Treatment|Objective disease Progression|14
5698482|NCT00264498|19645272|P1|Randomized Treatment|Objective disease Progression|13
5698483|NCT00264498|19645271|P2|Randomized Treatment|Withdrawal by Subject|1
5698484|NCT00264498|19645272|P1|Randomized Treatment|Withdrawal by Subject|0
5698485|NCT00264498|19645271|P2|Randomized Treatment|Death|3
5698486|NCT00264498|19645272|P1|Randomized Treatment|Death|0
5698487|NCT00264303|19645295|P2|Overall Study|Various reasons listed in study report|7
5698488|NCT00264303|19645296|P1|Overall Study|Various reasons listed in study report|6
5698489|NCT00264303|19645295|P2|Overall Study|Withdrawal by Subject|3
5698490|NCT00264303|19645296|P1|Overall Study|Withdrawal by Subject|2
5698491|NCT00264303|19645295|P2|Overall Study|Lost to Follow-up|3
5698492|NCT00264303|19645296|P1|Overall Study|Lost to Follow-up|3
5698493|NCT00264303|19645295|P2|Overall Study|Lack of Efficacy|13
5698494|NCT00264303|19645296|P1|Overall Study|Lack of Efficacy|10
5698495|NCT00264303|19645295|P2|Overall Study|Adverse Event|3
5698496|NCT00264303|19645296|P1|Overall Study|Adverse Event|4
5698497|NCT00264290|19645314|P2|Intervention (8 Weeks)|Adverse Event|0
5698498|NCT00264290|19645315|P1|Intervention (8 Weeks)|Adverse Event|1
5698499|NCT00264238|19645331|P1|Overall Study|Protocol Violation|1
5698500|NCT00264147|19645343|P6|Treatment II Period|Pre-scheduled total hip replacement|1
5698581|NCT00264147|19645346|P3|Treatment I Period|Laboratory Adverse Event|0
5698501|NCT00264147|19645344|P5|Treatment II Period|Pre-scheduled total hip replacement|0
5698502|NCT00264147|19645345|P4|Treatment II Period|Pre-scheduled total hip replacement|0
5698503|NCT00264147|19645346|P3|Treatment II Period|Pre-scheduled total hip replacement|0
5698504|NCT00264147|19645347|P2|Treatment II Period|Pre-scheduled total hip replacement|0
5698505|NCT00264147|19645348|P1|Treatment II Period|Pre-scheduled total hip replacement|0
5698506|NCT00264147|19645343|P6|Treatment II Period|Withdrawal by Subject|2
5698507|NCT00264147|19645344|P5|Treatment II Period|Withdrawal by Subject|3
5698508|NCT00264147|19645345|P4|Treatment II Period|Withdrawal by Subject|0
5698509|NCT00264147|19645346|P3|Treatment II Period|Withdrawal by Subject|0
5698510|NCT00264147|19645347|P2|Treatment II Period|Withdrawal by Subject|0
5698511|NCT00264147|19645348|P1|Treatment II Period|Withdrawal by Subject|0
5698512|NCT00264147|19645343|P6|Treatment II Period|Lost to Follow-up|1
5698513|NCT00264147|19645344|P5|Treatment II Period|Lost to Follow-up|1
5698514|NCT00264147|19645345|P4|Treatment II Period|Lost to Follow-up|0
5698515|NCT00264147|19645346|P3|Treatment II Period|Lost to Follow-up|0
5698516|NCT00264147|19645347|P2|Treatment II Period|Lost to Follow-up|0
5698517|NCT00264147|19645348|P1|Treatment II Period|Lost to Follow-up|0
5698518|NCT00264147|19645343|P6|Treatment II Period|Lack of Efficacy|19
5698519|NCT00264147|19645344|P5|Treatment II Period|Lack of Efficacy|20
5698520|NCT00264147|19645345|P4|Treatment II Period|Lack of Efficacy|0
5698521|NCT00264147|19645346|P3|Treatment II Period|Lack of Efficacy|0
5698522|NCT00264147|19645347|P2|Treatment II Period|Lack of Efficacy|0
5698523|NCT00264147|19645348|P1|Treatment II Period|Lack of Efficacy|0
5698524|NCT00264147|19645343|P6|Treatment II Period|Laboratory Adverse Event|1
5698525|NCT00264147|19645344|P5|Treatment II Period|Laboratory Adverse Event|0
5698526|NCT00264147|19645345|P4|Treatment II Period|Laboratory Adverse Event|0
5698527|NCT00264147|19645346|P3|Treatment II Period|Laboratory Adverse Event|0
5698528|NCT00264147|19645347|P2|Treatment II Period|Laboratory Adverse Event|0
5698529|NCT00264147|19645348|P1|Treatment II Period|Laboratory Adverse Event|0
5698530|NCT00264147|19645343|P6|Treatment II Period|Adverse Event|9
5698531|NCT00264147|19645344|P5|Treatment II Period|Adverse Event|9
5698532|NCT00264147|19645345|P4|Treatment II Period|Adverse Event|0
5698533|NCT00264147|19645346|P3|Treatment II Period|Adverse Event|0
5698534|NCT00264147|19645347|P2|Treatment II Period|Adverse Event|0
5698535|NCT00264147|19645348|P1|Treatment II Period|Adverse Event|0
5698536|NCT00264147|19645343|P6|Treatment I Period|Reassigned to Treatment II Period|0
5698537|NCT00264147|19645344|P5|Treatment I Period|Reassigned to Treatment II Period|45
5698538|NCT00264147|19645345|P4|Treatment I Period|Reassigned to Treatment II Period|63
5698539|NCT00264147|19645346|P3|Treatment I Period|Reassigned to Treatment II Period|65
5698540|NCT00264147|19645347|P2|Treatment I Period|Reassigned to Treatment II Period|72
5698541|NCT00264147|19645348|P1|Treatment I Period|Reassigned to Treatment II Period|84
5698542|NCT00264147|19645343|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
5698543|NCT00264147|19645344|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
5698544|NCT00264147|19645345|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
5698545|NCT00264147|19645346|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
5698546|NCT00264147|19645347|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
5698547|NCT00264147|19645348|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
5698548|NCT00264147|19645343|P6|Treatment I Period|Patient out of town for an extended time|0
5698549|NCT00264147|19645344|P5|Treatment I Period|Patient out of town for an extended time|0
5698550|NCT00264147|19645345|P4|Treatment I Period|Patient out of town for an extended time|0
5698551|NCT00264147|19645346|P3|Treatment I Period|Patient out of town for an extended time|0
5698552|NCT00264147|19645347|P2|Treatment I Period|Patient out of town for an extended time|1
5698553|NCT00264147|19645348|P1|Treatment I Period|Patient out of town for an extended time|0
5698554|NCT00264147|19645343|P6|Treatment I Period|Withdrawal by Subject|0
5698555|NCT00264147|19645344|P5|Treatment I Period|Withdrawal by Subject|2
5698556|NCT00264147|19645345|P4|Treatment I Period|Withdrawal by Subject|2
5698557|NCT00264147|19645346|P3|Treatment I Period|Withdrawal by Subject|0
5698558|NCT00264147|19645347|P2|Treatment I Period|Withdrawal by Subject|0
5698559|NCT00264147|19645348|P1|Treatment I Period|Withdrawal by Subject|2
5698560|NCT00264147|19645343|P6|Treatment I Period|Protocol Violation|0
5698561|NCT00264147|19645344|P5|Treatment I Period|Protocol Violation|0
5698562|NCT00264147|19645345|P4|Treatment I Period|Protocol Violation|0
5698563|NCT00264147|19645346|P3|Treatment I Period|Protocol Violation|0
5698564|NCT00264147|19645347|P2|Treatment I Period|Protocol Violation|2
5698565|NCT00264147|19645348|P1|Treatment I Period|Protocol Violation|2
5698566|NCT00264147|19645343|P6|Treatment I Period|Lost to Follow-up|0
5698567|NCT00264147|19645344|P5|Treatment I Period|Lost to Follow-up|1
5698568|NCT00264147|19645345|P4|Treatment I Period|Lost to Follow-up|1
5698569|NCT00264147|19645346|P3|Treatment I Period|Lost to Follow-up|0
5698570|NCT00264147|19645347|P2|Treatment I Period|Lost to Follow-up|0
5698571|NCT00264147|19645348|P1|Treatment I Period|Lost to Follow-up|1
5698572|NCT00264147|19645343|P6|Treatment I Period|Lack of Efficacy|0
5698573|NCT00264147|19645344|P5|Treatment I Period|Lack of Efficacy|1
5698574|NCT00264147|19645345|P4|Treatment I Period|Lack of Efficacy|0
5698575|NCT00264147|19645346|P3|Treatment I Period|Lack of Efficacy|8
5698576|NCT00264147|19645347|P2|Treatment I Period|Lack of Efficacy|2
5698577|NCT00264147|19645348|P1|Treatment I Period|Lack of Efficacy|6
5698578|NCT00264147|19645343|P6|Treatment I Period|Laboratory Adverse Event|0
5698579|NCT00264147|19645344|P5|Treatment I Period|Laboratory Adverse Event|0
5698580|NCT00264147|19645345|P4|Treatment I Period|Laboratory Adverse Event|1
5698582|NCT00264147|19645347|P2|Treatment I Period|Laboratory Adverse Event|0
5698583|NCT00264147|19645348|P1|Treatment I Period|Laboratory Adverse Event|0
5698584|NCT00264147|19645343|P6|Treatment I Period|Adverse Event|0
5698585|NCT00264147|19645344|P5|Treatment I Period|Adverse Event|7
5698586|NCT00264147|19645345|P4|Treatment I Period|Adverse Event|5
5698587|NCT00264147|19645346|P3|Treatment I Period|Adverse Event|3
5698588|NCT00264147|19645347|P2|Treatment I Period|Adverse Event|6
5698589|NCT00264147|19645348|P1|Treatment I Period|Adverse Event|3
5698590|NCT00264004|19645391|P4|Overall Study|Not treated|2
5698591|NCT00264004|19645392|P3|Overall Study|Not treated|2
5698592|NCT00264004|19645393|P2|Overall Study|Not treated|0
5698593|NCT00264004|19645394|P1|Overall Study|Not treated|3
5698594|NCT00264004|19645391|P4|Overall Study|Cond. under inv. worsened|4
5698595|NCT00264004|19645392|P3|Overall Study|Cond. under inv. worsened|3
5698596|NCT00264004|19645393|P2|Overall Study|Cond. under inv. worsened|5
5698597|NCT00264004|19645394|P1|Overall Study|Cond. under inv. worsened|9
5698598|NCT00264004|19645391|P4|Overall Study|Development study specific disc. crit.|0
5698599|NCT00264004|19645392|P3|Overall Study|Development study specific disc. crit.|1
5698600|NCT00264004|19645393|P2|Overall Study|Development study specific disc. crit.|0
5698601|NCT00264004|19645394|P1|Overall Study|Development study specific disc. crit.|1
5698602|NCT00264004|19645391|P4|Overall Study|Other|3
5698603|NCT00264004|19645392|P3|Overall Study|Other|0
5698604|NCT00264004|19645393|P2|Overall Study|Other|2
5698605|NCT00264004|19645394|P1|Overall Study|Other|2
5698606|NCT00264004|19645391|P4|Overall Study|Withdrawal by Subject|2
5698607|NCT00264004|19645392|P3|Overall Study|Withdrawal by Subject|2
5698608|NCT00264004|19645393|P2|Overall Study|Withdrawal by Subject|1
5698609|NCT00264004|19645394|P1|Overall Study|Withdrawal by Subject|0
5698610|NCT00264004|19645391|P4|Overall Study|Adverse Event|4
5698611|NCT00264004|19645392|P3|Overall Study|Adverse Event|6
5698612|NCT00264004|19645393|P2|Overall Study|Adverse Event|3
5698613|NCT00264004|19645394|P1|Overall Study|Adverse Event|2
5698614|NCT00263887|19645422|P2|Overall Study|Lack of Efficacy|1
5698615|NCT00263887|19645423|P1|Overall Study|Lack of Efficacy|0
5698616|NCT00263887|19645422|P2|Overall Study|Disease progression|1
5698617|NCT00263887|19645423|P1|Overall Study|Disease progression|0
5698618|NCT00263887|19645422|P2|Overall Study|Adverse Event|2
5698619|NCT00263887|19645423|P1|Overall Study|Adverse Event|0
5698620|NCT00263887|19645422|P2|Overall Study|Too ill to attend visit|0
5698621|NCT00263887|19645423|P1|Overall Study|Too ill to attend visit|1
5698622|NCT00263887|19645422|P2|Overall Study|Lung transplantation|2
5698623|NCT00263887|19645423|P1|Overall Study|Lung transplantation|1
5698624|NCT00263887|19645422|P2|Overall Study|Withdrawal by Subject|1
5698625|NCT00263887|19645423|P1|Overall Study|Withdrawal by Subject|1
5698626|NCT00263757|19645431|P2|Overall Study|Adverse Event|3
5698627|NCT00263757|19645432|P1|Overall Study|Adverse Event|3
5698628|NCT00263757|19645431|P2|Overall Study|Screen failure|1
5698629|NCT00263757|19645432|P1|Overall Study|Screen failure|0
5698630|NCT00263757|19645431|P2|Overall Study|Withdrawal by Subject|4
5698631|NCT00263757|19645432|P1|Overall Study|Withdrawal by Subject|5
5698632|NCT00263666|19645444|P2|Overall Study|Withdrawal by Subject|1
5698633|NCT00263666|19645445|P1|Overall Study|Withdrawal by Subject|0
5698634|NCT00263666|19645444|P2|Overall Study|Lost to Follow-up|2
5698635|NCT00263666|19645445|P1|Overall Study|Lost to Follow-up|1
5698636|NCT00263666|19645444|P2|Overall Study|Adverse Event|8
5698637|NCT00263666|19645445|P1|Overall Study|Adverse Event|6
5698638|NCT00263588|19645498|P2|Overall Study|Sponsor terminated study|1
5698639|NCT00263588|19645499|P1|Overall Study|Sponsor terminated study|0
5698640|NCT00263588|19645498|P2|Overall Study|Investigator decision|15
5698641|NCT00263588|19645499|P1|Overall Study|Investigator decision|7
5698642|NCT00263588|19645498|P2|Overall Study|Protocol Violation|1
5698643|NCT00263588|19645499|P1|Overall Study|Protocol Violation|0
5698644|NCT00263588|19645498|P2|Overall Study|Withdrawal by Subject|4
5698645|NCT00263588|19645499|P1|Overall Study|Withdrawal by Subject|3
5698646|NCT00263588|19645498|P2|Overall Study|Lost to Follow-up|10
5698647|NCT00263588|19645499|P1|Overall Study|Lost to Follow-up|7
5698648|NCT00263588|19645498|P2|Overall Study|disease progression, coma, 1 unknown|11
5698649|NCT00263588|19645499|P1|Overall Study|disease progression, coma, 1 unknown|10
5698650|NCT00263588|19645498|P2|Overall Study|Death|90
5698651|NCT00263588|19645499|P1|Overall Study|Death|54
5698652|NCT00263575|19645522|P1|Maintence Period|Other|7
5698653|NCT00263575|19645522|P1|Maintence Period|Sponsor Decision|24
5698654|NCT00263575|19645522|P1|Maintence Period|Lost to Follow-up|1
5698655|NCT00263575|19645522|P1|Maintence Period|Physician Decision|6
5698656|NCT00263575|19645522|P1|Maintence Period|Lack of Efficacy|4
5698657|NCT00263575|19645522|P1|Maintence Period|Protocol Violation|4
5698658|NCT00263575|19645522|P1|Maintence Period|Withdrawal by Subject|8
5698659|NCT00263575|19645522|P1|Maintence Period|Adverse Event|23
5698660|NCT00263575|19645522|P1|Titration Period|Lack of Efficacy|6
5698661|NCT00263575|19645522|P1|Titration Period|Other|2
5698662|NCT00263575|19645522|P1|Titration Period|Sponsor Decision|2
5698663|NCT00263575|19645522|P1|Titration Period|Protocol Violation|9
5698664|NCT00263575|19645522|P1|Titration Period|Withdrawal by Subject|10
5698665|NCT00263575|19645522|P1|Titration Period|Adverse Event|14
5698666|NCT00263562|19645530|P2|Overall Study|Protocol Violation|0
5698667|NCT00263562|19645531|P1|Overall Study|Protocol Violation|3
5698668|NCT00263328|19645548|P3|Overall Study|Adverse Event|4
5698669|NCT00263328|19645549|P2|Overall Study|Adverse Event|1
5698670|NCT00263328|19645550|P1|Overall Study|Adverse Event|1
5698671|NCT00263328|19645548|P3|Overall Study|Other|1
5698672|NCT00263328|19645549|P2|Overall Study|Other|0
5698673|NCT00263328|19645550|P1|Overall Study|Other|3
5698674|NCT00263328|19645548|P3|Overall Study|Withdrawal by Subject|1
5698675|NCT00263328|19645549|P2|Overall Study|Withdrawal by Subject|0
5698676|NCT00263328|19645550|P1|Overall Study|Withdrawal by Subject|3
5698677|NCT00263328|19645548|P3|Overall Study|Lost to Follow-up|0
5698678|NCT00263328|19645549|P2|Overall Study|Lost to Follow-up|1
5698679|NCT00263328|19645550|P1|Overall Study|Lost to Follow-up|1
5698680|NCT00263328|19645548|P3|Overall Study|Death|1
5698681|NCT00263328|19645549|P2|Overall Study|Death|0
5698682|NCT00263328|19645550|P1|Overall Study|Death|0
5698683|NCT00263211|19645708|P2|Overall Study|Disease Progression|1
5698684|NCT00263211|19645709|P1|Overall Study|Disease Progression|0
5698685|NCT00263211|19645708|P2|Overall Study|Protocol Violation|0
5698686|NCT00263211|19645709|P1|Overall Study|Protocol Violation|1
5698687|NCT00263211|19645708|P2|Overall Study|Withdrawal by Subject|0
5698688|NCT00263211|19645709|P1|Overall Study|Withdrawal by Subject|3
5698689|NCT00263211|19645708|P2|Overall Study|Death|0
5698690|NCT00263211|19645709|P1|Overall Study|Death|1
5698691|NCT00262951|19645760|P1|Overall Study|Off treatment for other disease|1
5698692|NCT00262951|19645760|P1|Overall Study|Alternative treatment|3
5698693|NCT00262951|19645760|P1|Overall Study|Withdrawal by Subject|1
5698694|NCT00262951|19645760|P1|Overall Study|Death|1
5698695|NCT00262951|19645760|P1|Overall Study|Adverse Event|7
5698696|NCT00262951|19645760|P1|Overall Study|Progressive disease/relapse|3
5698697|NCT00262925|19645765|P1|Overall Study|Other|1
5698698|NCT00262925|19645765|P1|Overall Study|alternative therapy|1
5698699|NCT00262925|19645765|P1|Overall Study|Death|2
5698700|NCT00262925|19645765|P1|Overall Study|Adverse Event|4
5698701|NCT00262925|19645765|P1|Overall Study|Lack of Efficacy|3
5698702|NCT00262873|19645771|P1|Overall Study|Withdrawal by Subject|5
5698703|NCT00262873|19645771|P1|Overall Study|Adverse Event|3
5698704|NCT00262860|19645782|P1|Overall Study|Adverse Event|2
5698705|NCT00262847|19645791|P3|Overall Study|Did not receive study treatment|4
5698706|NCT00262847|19645792|P2|Overall Study|Did not receive study treatment|1
5698707|NCT00262847|19645793|P1|Overall Study|Did not receive study treatment|4
5698708|NCT00262847|19645791|P3|Overall Study|Other Reasons|27
5698709|NCT00262847|19645792|P2|Overall Study|Other Reasons|88
5698710|NCT00262847|19645793|P1|Overall Study|Other Reasons|79
5698711|NCT00262847|19645791|P3|Overall Study|Concomitant disease|4
5698712|NCT00262847|19645792|P2|Overall Study|Concomitant disease|2
5698713|NCT00262847|19645793|P1|Overall Study|Concomitant disease|3
5698714|NCT00262847|19645791|P3|Overall Study|Death|11
5698715|NCT00262847|19645792|P2|Overall Study|Death|8
5698716|NCT00262847|19645793|P1|Overall Study|Death|8
5698717|NCT00262847|19645791|P3|Overall Study|Adverse Event|108
5698718|NCT00262847|19645792|P2|Overall Study|Adverse Event|88
5698719|NCT00262847|19645793|P1|Overall Study|Adverse Event|74
5698720|NCT00262847|19645791|P3|Overall Study|Patient Refusal|47
5698721|NCT00262847|19645792|P2|Overall Study|Patient Refusal|52
5698722|NCT00262847|19645793|P1|Overall Study|Patient Refusal|41
5698723|NCT00262847|19645791|P3|Overall Study|Disease Progression|195
5698724|NCT00262847|19645792|P2|Overall Study|Disease Progression|274
5698725|NCT00262847|19645793|P1|Overall Study|Disease Progression|309
5698726|NCT00262834|19645812|P2|Overall Study|Surgery delayed/tissue not collected|4
5698727|NCT00262834|19645813|P1|Overall Study|Surgery delayed/tissue not collected|1
5698728|NCT00262821|19645826|P2|Overall Study|Inevaluable - inadequate data|4
5698729|NCT00262821|19645827|P1|Overall Study|Inevaluable - inadequate data|0
5698730|NCT00262821|19645826|P2|Overall Study|Ineligible - required test not done|4
5698731|NCT00262821|19645827|P1|Overall Study|Ineligible - required test not done|1
5698732|NCT00262821|19645826|P2|Overall Study|Ineligible - elevated creatinine|2
5698733|NCT00262821|19645827|P1|Overall Study|Ineligible - elevated creatinine|0
5698734|NCT00262821|19645826|P2|Overall Study|Ineligible - inadequate pathology|3
5698735|NCT00262821|19645827|P1|Overall Study|Ineligible - inadequate pathology|1
5698736|NCT00262821|19645826|P2|Overall Study|Ineligible - wrong primary|1
5698737|NCT00262821|19645827|P1|Overall Study|Ineligible - wrong primary|0
5698738|NCT00262821|19645826|P2|Overall Study|Ineligible - wrong cell type|2
5698739|NCT00262821|19645827|P1|Overall Study|Ineligible - wrong cell type|2
5698740|NCT00262821|19645826|P2|Overall Study|Ineligible - wrong stage|3
5698741|NCT00262821|19645827|P1|Overall Study|Ineligible - wrong stage|0
5698742|NCT00262743|19645839|P2|Overall Study|Disease progression|3
5698743|NCT00262743|19645840|P1|Overall Study|Disease progression|0
5698744|NCT00262743|19645839|P2|Overall Study|Adverse Event|9
5698745|NCT00262743|19645840|P1|Overall Study|Adverse Event|0
5698746|NCT00262600|19645875|P3|Overall Study|Other|62
5698747|NCT00262600|19645876|P2|Overall Study|Other|59
5698748|NCT00262600|19645877|P1|Overall Study|Other|58
5698749|NCT00262600|19645875|P3|Overall Study|Not Treated|24
5698750|NCT00262600|19645876|P2|Overall Study|Not Treated|17
5698751|NCT00262600|19645877|P1|Overall Study|Not Treated|32
5698752|NCT00262600|19645875|P3|Overall Study|Withdrawal by Subject|139
5698753|NCT00262600|19645876|P2|Overall Study|Withdrawal by Subject|145
5698754|NCT00262600|19645877|P1|Overall Study|Withdrawal by Subject|128
5698755|NCT00262600|19645875|P3|Overall Study|Lost to Follow-up|41
5698756|NCT00262600|19645876|P2|Overall Study|Lost to Follow-up|31
5698757|NCT00262600|19645877|P1|Overall Study|Lost to Follow-up|17
5698758|NCT00262522|19645904|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
5698759|NCT00262522|19645905|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
5698760|NCT00262522|19645906|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
5698761|NCT00262522|19645907|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
5698762|NCT00262522|19645904|P4|Study Start Through 96 Weeks|Virologic failure|0
5698763|NCT00262522|19645905|P3|Study Start Through 96 Weeks|Virologic failure|8
5698764|NCT00262522|19645906|P2|Study Start Through 96 Weeks|Virologic failure|0
5698765|NCT00262522|19645907|P1|Study Start Through 96 Weeks|Virologic failure|5
5698766|NCT00262522|19645904|P4|Study Start Through 96 Weeks|Death|0
5698767|NCT00262522|19645905|P3|Study Start Through 96 Weeks|Death|2
5698768|NCT00262522|19645906|P2|Study Start Through 96 Weeks|Death|0
5698769|NCT00262522|19645907|P1|Study Start Through 96 Weeks|Death|2
5698770|NCT00262522|19645904|P4|Study Start Through 96 Weeks|Noncompliance|0
5698771|NCT00262522|19645905|P3|Study Start Through 96 Weeks|Noncompliance|11
5698772|NCT00262522|19645906|P2|Study Start Through 96 Weeks|Noncompliance|0
5698773|NCT00262522|19645907|P1|Study Start Through 96 Weeks|Noncompliance|6
5698774|NCT00262522|19645904|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
5698775|NCT00262522|19645905|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
5698776|NCT00262522|19645906|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
5698777|NCT00262522|19645907|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
5698778|NCT00262522|19645904|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
5698779|NCT00262522|19645905|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
5698780|NCT00262522|19645906|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
5698781|NCT00262522|19645907|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
5698782|NCT00262522|19645904|P4|Study Start Through 96 Weeks|Adverse Event|0
5698783|NCT00262522|19645905|P3|Study Start Through 96 Weeks|Adverse Event|16
5698784|NCT00262522|19645906|P2|Study Start Through 96 Weeks|Adverse Event|0
5698785|NCT00262522|19645907|P1|Study Start Through 96 Weeks|Adverse Event|20
5698786|NCT00262522|19645904|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
5698787|NCT00262522|19645905|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
5698788|NCT00262522|19645906|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
5698789|NCT00262522|19645907|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
5698790|NCT00262522|19645904|P4|Study Start Through 48 Weeks|Virologic failure|0
5698791|NCT00262522|19645905|P3|Study Start Through 48 Weeks|Virologic failure|4
5698792|NCT00262522|19645906|P2|Study Start Through 48 Weeks|Virologic failure|0
5698793|NCT00262522|19645907|P1|Study Start Through 48 Weeks|Virologic failure|2
5698794|NCT00262522|19645904|P4|Study Start Through 48 Weeks|Death|0
5698795|NCT00262522|19645905|P3|Study Start Through 48 Weeks|Death|1
5698796|NCT00262522|19645906|P2|Study Start Through 48 Weeks|Death|0
5698797|NCT00262522|19645907|P1|Study Start Through 48 Weeks|Death|2
5698798|NCT00262522|19645904|P4|Study Start Through 48 Weeks|Noncompliance|0
5698799|NCT00262522|19645905|P3|Study Start Through 48 Weeks|Noncompliance|8
5698800|NCT00262522|19645906|P2|Study Start Through 48 Weeks|Noncompliance|0
5698801|NCT00262522|19645907|P1|Study Start Through 48 Weeks|Noncompliance|3
5698802|NCT00262522|19645904|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
5698803|NCT00262522|19645905|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
5698804|NCT00262522|19645906|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
5698805|NCT00262522|19645907|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
5698806|NCT00262522|19645904|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
5698807|NCT00262522|19645905|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
5698808|NCT00262522|19645906|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
5698809|NCT00262522|19645907|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
5698810|NCT00262522|19645904|P4|Study Start Through 48 Weeks|Adverse Event|0
5698811|NCT00262522|19645905|P3|Study Start Through 48 Weeks|Adverse Event|10
5698812|NCT00262522|19645906|P2|Study Start Through 48 Weeks|Adverse Event|0
5698813|NCT00262522|19645907|P1|Study Start Through 48 Weeks|Adverse Event|16
5698814|NCT00262522|19645904|P4|Study Start Through 8 Weeks|Death|0
5698815|NCT00262522|19645905|P3|Study Start Through 8 Weeks|Death|0
5698816|NCT00262522|19645906|P2|Study Start Through 8 Weeks|Death|0
5698817|NCT00262522|19645907|P1|Study Start Through 8 Weeks|Death|1
5698818|NCT00262522|19645904|P4|Study Start Through 8 Weeks|Noncompliance|2
5698819|NCT00262522|19645905|P3|Study Start Through 8 Weeks|Noncompliance|2
5698820|NCT00262522|19645906|P2|Study Start Through 8 Weeks|Noncompliance|0
5698821|NCT00262522|19645907|P1|Study Start Through 8 Weeks|Noncompliance|0
5698822|NCT00262522|19645904|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
5698823|NCT00262522|19645905|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
5698824|NCT00262522|19645906|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
5698825|NCT00262522|19645907|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
5698826|NCT00262522|19645904|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
5698827|NCT00262522|19645905|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
5698828|NCT00262522|19645906|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
5698829|NCT00262522|19645907|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
5698830|NCT00262522|19645904|P4|Study Start Through 8 Weeks|Adverse Event|1
5698831|NCT00262522|19645905|P3|Study Start Through 8 Weeks|Adverse Event|3
5698832|NCT00262522|19645906|P2|Study Start Through 8 Weeks|Adverse Event|2
5698833|NCT00262522|19645907|P1|Study Start Through 8 Weeks|Adverse Event|1
5698834|NCT00262314|19645936|P1|Overall Study|Administrative withdrawal|30
5698835|NCT00262314|19645936|P1|Overall Study|Lost to Follow-up|70
5698836|NCT00262314|19645936|P1|Overall Study|Other|95
5698837|NCT00262314|19645936|P1|Overall Study|Patient's decision|92
5698838|NCT00262314|19645936|P1|Overall Study|Death|12
5698839|NCT00262314|19645936|P1|Overall Study|Changing physicians|38
5698840|NCT00262301|19645954|P3|Double-blind Phase|"worsening of HAE symptoms"|0
5698841|NCT00262301|19645955|P2|Double-blind Phase|"worsening of HAE symptoms"|1
5698842|NCT00262301|19645956|P1|Double-blind Phase|"worsening of HAE symptoms"|0
5698843|NCT00262301|19645954|P3|Double-blind Phase|Lost to Follow-up|0
5698844|NCT00262301|19645955|P2|Double-blind Phase|Lost to Follow-up|0
5698845|NCT00262301|19645956|P1|Double-blind Phase|Lost to Follow-up|1
5698846|NCT00262223|19645969|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
5698847|NCT00262223|19645970|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
5698848|NCT00262223|19645969|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
5698849|NCT00262223|19645970|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
5698850|NCT00262223|19645969|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
5698851|NCT00262223|19645970|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
5698852|NCT00262223|19645969|P2|Treatment Phase|Adverse Event|2
5698853|NCT00262223|19645970|P1|Treatment Phase|Adverse Event|1
5698854|NCT00262223|19645969|P2|Treatment Phase|Withdrawal by Subject|6
5698855|NCT00262223|19645970|P1|Treatment Phase|Withdrawal by Subject|3
5698856|NCT00262119|19645981|P3|Overall Study|Death|16
5698857|NCT00262119|19645982|P2|Overall Study|Death|19
5698858|NCT00262119|19645983|P1|Overall Study|Death|20
5698859|NCT00262119|19645981|P3|Overall Study|Lost to Follow-up|42
5698860|NCT00262119|19645982|P2|Overall Study|Lost to Follow-up|51
5698861|NCT00262119|19645983|P1|Overall Study|Lost to Follow-up|38
5698862|NCT00262080|19646003|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
5698863|NCT00262080|19646004|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
5698864|NCT00262080|19646005|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
5698865|NCT00262080|19646003|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
5698866|NCT00262080|19646004|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
5698867|NCT00262080|19646005|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
5698868|NCT00262080|19646003|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
5698869|NCT00262080|19646004|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
5698870|NCT00262080|19646005|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
5698871|NCT00262080|19646003|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
5698872|NCT00262080|19646004|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
5698873|NCT00262080|19646005|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
5698874|NCT00262080|19646003|P3|Repeat Dose Treatment Period|Adverse Event|0
5698875|NCT00262080|19646004|P2|Repeat Dose Treatment Period|Adverse Event|0
5698876|NCT00262080|19646005|P1|Repeat Dose Treatment Period|Adverse Event|1
5698877|NCT00262080|19646003|P3|Double Blind Treatment Period|Lost to Follow-up|0
5698878|NCT00262080|19646004|P2|Double Blind Treatment Period|Lost to Follow-up|0
5698879|NCT00262080|19646005|P1|Double Blind Treatment Period|Lost to Follow-up|1
5698880|NCT00262067|19646025|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
5698881|NCT00262067|19646026|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
5698882|NCT00262067|19646027|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
5698883|NCT00262067|19646028|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
5698884|NCT00262067|19646025|P4|Overall Study|Sponsor's Decision to Terminate Study|0
5698885|NCT00262067|19646026|P3|Overall Study|Sponsor's Decision to Terminate Study|0
5698886|NCT00262067|19646027|P2|Overall Study|Sponsor's Decision to Terminate Study|0
5698887|NCT00262067|19646028|P1|Overall Study|Sponsor's Decision to Terminate Study|1
5698888|NCT00262067|19646025|P4|Overall Study|Lost to Follow-up|5
5698889|NCT00262067|19646026|P3|Overall Study|Lost to Follow-up|7
5698890|NCT00262067|19646027|P2|Overall Study|Lost to Follow-up|4
5698891|NCT00262067|19646028|P1|Overall Study|Lost to Follow-up|5
5698892|NCT00262067|19646025|P4|Overall Study|Death|99
5698893|NCT00262067|19646026|P3|Overall Study|Death|186
5698894|NCT00262067|19646027|P2|Overall Study|Death|89
5698895|NCT00262067|19646028|P1|Overall Study|Death|190
5698896|NCT00262041|19646062|P3|Overall Study|Unable to classify|0
5698897|NCT00262041|19646063|P2|Overall Study|Unable to classify|0
5698898|NCT00262041|19646064|P1|Overall Study|Unable to classify|1
5698899|NCT00262041|19646062|P3|Overall Study|Lost to Follow-up|5
5698900|NCT00262041|19646063|P2|Overall Study|Lost to Follow-up|1
5698901|NCT00262041|19646064|P1|Overall Study|Lost to Follow-up|1
5698902|NCT00262041|19646062|P3|Overall Study|Withdrawal by Subject|1
5698903|NCT00262041|19646063|P2|Overall Study|Withdrawal by Subject|3
5698904|NCT00262041|19646064|P1|Overall Study|Withdrawal by Subject|0
5698905|NCT00262028|19646093|P9|Overall Study|Unable to classify|1
5698906|NCT00262028|19646094|P8|Overall Study|Unable to classify|0
5698907|NCT00262028|19646095|P7|Overall Study|Unable to classify|0
5698908|NCT00262028|19646096|P6|Overall Study|Unable to classify|0
5698909|NCT00262028|19646097|P5|Overall Study|Unable to classify|0
5698910|NCT00262028|19646098|P4|Overall Study|Unable to classify|0
5698911|NCT00262028|19646099|P3|Overall Study|Unable to classify|0
5698912|NCT00262028|19646100|P2|Overall Study|Unable to classify|3
5698913|NCT00262028|19646101|P1|Overall Study|Unable to classify|0
5698914|NCT00262028|19646093|P9|Overall Study|Protocol Violation|0
5698915|NCT00262028|19646094|P8|Overall Study|Protocol Violation|0
5698916|NCT00262028|19646095|P7|Overall Study|Protocol Violation|0
5698917|NCT00262028|19646096|P6|Overall Study|Protocol Violation|0
5698918|NCT00262028|19646097|P5|Overall Study|Protocol Violation|0
5698919|NCT00262028|19646098|P4|Overall Study|Protocol Violation|1
5698920|NCT00262028|19646099|P3|Overall Study|Protocol Violation|0
5698921|NCT00262028|19646100|P2|Overall Study|Protocol Violation|0
5698922|NCT00262028|19646101|P1|Overall Study|Protocol Violation|0
5698923|NCT00262028|19646093|P9|Overall Study|Administrative Reason|10
5698924|NCT00262028|19646094|P8|Overall Study|Administrative Reason|6
5698925|NCT00262028|19646095|P7|Overall Study|Administrative Reason|4
5698926|NCT00262028|19646096|P6|Overall Study|Administrative Reason|7
5698927|NCT00262028|19646097|P5|Overall Study|Administrative Reason|6
5698928|NCT00262028|19646098|P4|Overall Study|Administrative Reason|12
5698929|NCT00262028|19646099|P3|Overall Study|Administrative Reason|9
5698930|NCT00262028|19646100|P2|Overall Study|Administrative Reason|14
5698931|NCT00262028|19646101|P1|Overall Study|Administrative Reason|11
5698932|NCT00262028|19646093|P9|Overall Study|Lost to Follow-up|6
5698933|NCT00262028|19646094|P8|Overall Study|Lost to Follow-up|5
5698934|NCT00262028|19646095|P7|Overall Study|Lost to Follow-up|3
5698935|NCT00262028|19646096|P6|Overall Study|Lost to Follow-up|3
5698936|NCT00262028|19646097|P5|Overall Study|Lost to Follow-up|4
5698937|NCT00262028|19646098|P4|Overall Study|Lost to Follow-up|5
5698938|NCT00262028|19646099|P3|Overall Study|Lost to Follow-up|5
5698939|NCT00262028|19646100|P2|Overall Study|Lost to Follow-up|7
5698940|NCT00262028|19646101|P1|Overall Study|Lost to Follow-up|7
5698941|NCT00262028|19646093|P9|Overall Study|Withdrawal by Subject|2
5698942|NCT00262028|19646094|P8|Overall Study|Withdrawal by Subject|7
5698943|NCT00262028|19646095|P7|Overall Study|Withdrawal by Subject|5
5698944|NCT00262028|19646096|P6|Overall Study|Withdrawal by Subject|3
5698945|NCT00262028|19646097|P5|Overall Study|Withdrawal by Subject|2
5698946|NCT00262028|19646098|P4|Overall Study|Withdrawal by Subject|5
5698947|NCT00262028|19646099|P3|Overall Study|Withdrawal by Subject|6
5698948|NCT00262028|19646100|P2|Overall Study|Withdrawal by Subject|3
5698949|NCT00262028|19646101|P1|Overall Study|Withdrawal by Subject|6
5698950|NCT00262002|19646163|P7|Overall Study|Unable to classify|2
5698951|NCT00262002|19646164|P6|Overall Study|Unable to classify|0
5698952|NCT00262002|19646165|P5|Overall Study|Unable to classify|0
5698953|NCT00262002|19646166|P4|Overall Study|Unable to classify|0
5698954|NCT00262002|19646167|P3|Overall Study|Unable to classify|0
5698955|NCT00262002|19646168|P2|Overall Study|Unable to classify|0
5698956|NCT00262002|19646169|P1|Overall Study|Unable to classify|0
5698957|NCT00262002|19646163|P7|Overall Study|Protocol Violation|2
5698958|NCT00262002|19646164|P6|Overall Study|Protocol Violation|3
5698959|NCT00262002|19646165|P5|Overall Study|Protocol Violation|5
5698960|NCT00262002|19646166|P4|Overall Study|Protocol Violation|2
5698961|NCT00262002|19646167|P3|Overall Study|Protocol Violation|0
5698962|NCT00262002|19646168|P2|Overall Study|Protocol Violation|2
5698963|NCT00262002|19646169|P1|Overall Study|Protocol Violation|3
5698964|NCT00262002|19646163|P7|Overall Study|Inapropriate enrollment|0
5698965|NCT00262002|19646164|P6|Overall Study|Inapropriate enrollment|0
5698966|NCT00262002|19646165|P5|Overall Study|Inapropriate enrollment|0
5698967|NCT00262002|19646166|P4|Overall Study|Inapropriate enrollment|0
5698968|NCT00262002|19646167|P3|Overall Study|Inapropriate enrollment|0
5698969|NCT00262002|19646168|P2|Overall Study|Inapropriate enrollment|1
5698970|NCT00262002|19646169|P1|Overall Study|Inapropriate enrollment|0
5698971|NCT00262002|19646163|P7|Overall Study|Lost to Follow-up|0
5698972|NCT00262002|19646164|P6|Overall Study|Lost to Follow-up|1
5698973|NCT00262002|19646165|P5|Overall Study|Lost to Follow-up|0
5698974|NCT00262002|19646166|P4|Overall Study|Lost to Follow-up|2
5698975|NCT00262002|19646167|P3|Overall Study|Lost to Follow-up|0
5698976|NCT00262002|19646168|P2|Overall Study|Lost to Follow-up|0
5698977|NCT00262002|19646169|P1|Overall Study|Lost to Follow-up|2
5698978|NCT00262002|19646163|P7|Overall Study|Withdrawal by Subject|2
5698979|NCT00262002|19646164|P6|Overall Study|Withdrawal by Subject|2
5698980|NCT00262002|19646165|P5|Overall Study|Withdrawal by Subject|2
5698981|NCT00262002|19646166|P4|Overall Study|Withdrawal by Subject|1
5698982|NCT00262002|19646167|P3|Overall Study|Withdrawal by Subject|0
5698983|NCT00262002|19646168|P2|Overall Study|Withdrawal by Subject|2
5698984|NCT00262002|19646169|P1|Overall Study|Withdrawal by Subject|4
5698985|NCT00262002|19646163|P7|Overall Study|Adverse Event|0
5698986|NCT00262002|19646164|P6|Overall Study|Adverse Event|1
5698987|NCT00262002|19646165|P5|Overall Study|Adverse Event|0
5698988|NCT00262002|19646166|P4|Overall Study|Adverse Event|0
5698989|NCT00262002|19646167|P3|Overall Study|Adverse Event|0
5698990|NCT00262002|19646168|P2|Overall Study|Adverse Event|1
5698991|NCT00262002|19646169|P1|Overall Study|Adverse Event|2
5698992|NCT00261950|19646262|P1|Overall Study|Protocol specified Criteria|11
5698993|NCT00261950|19646262|P1|Overall Study|Physician Decision|1
5698994|NCT00261950|19646262|P1|Overall Study|Other|1
5698995|NCT00261950|19646262|P1|Overall Study|Withdrawal by Subject|5
5698996|NCT00261950|19646262|P1|Overall Study|Death|6
5698997|NCT00261950|19646262|P1|Overall Study|Lost to Follow-up|2
5698998|NCT00261846|19646287|P12|Period 2: Part 2 (Efficacy)|Extension study|1
5698999|NCT00261846|19646288|P11|Period 2: Part 2 (Efficacy)|Extension study|1
5699000|NCT00261846|19646289|P10|Period 2: Part 2 (Efficacy)|Extension study|9
5699001|NCT00261846|19646290|P9|Period 2: Part 2 (Efficacy)|Extension study|5
5699002|NCT00261846|19646291|P8|Period 2: Part 2 (Efficacy)|Extension study|9
5699003|NCT00261846|19646292|P7|Period 2: Part 2 (Efficacy)|Extension study|4
5699004|NCT00261846|19646293|P6|Period 2: Part 2 (Efficacy)|Extension study|0
5699005|NCT00261846|19646294|P5|Period 2: Part 2 (Efficacy)|Extension study|27
5699006|NCT00261846|19646295|P4|Period 2: Part 2 (Efficacy)|Extension study|61
5699007|NCT00261846|19646296|P3|Period 2: Part 2 (Efficacy)|Extension study|0
5699008|NCT00261846|19646297|P2|Period 2: Part 2 (Efficacy)|Extension study|0
5699009|NCT00261846|19646298|P1|Period 2: Part 2 (Efficacy)|Extension study|0
5699010|NCT00261846|19646287|P12|Period 2: Part 2 (Efficacy)|Death|22
5699011|NCT00261846|19646288|P11|Period 2: Part 2 (Efficacy)|Death|44
5699012|NCT00261846|19646289|P10|Period 2: Part 2 (Efficacy)|Death|30
5699013|NCT00261846|19646290|P9|Period 2: Part 2 (Efficacy)|Death|3
5699014|NCT00261846|19646291|P8|Period 2: Part 2 (Efficacy)|Death|12
5699015|NCT00261846|19646292|P7|Period 2: Part 2 (Efficacy)|Death|10
5699016|NCT00261846|19646293|P6|Period 2: Part 2 (Efficacy)|Death|1
5699017|NCT00261846|19646294|P5|Period 2: Part 2 (Efficacy)|Death|7
5699018|NCT00261846|19646295|P4|Period 2: Part 2 (Efficacy)|Death|37
5699019|NCT00261846|19646296|P3|Period 2: Part 2 (Efficacy)|Death|0
5699020|NCT00261846|19646297|P2|Period 2: Part 2 (Efficacy)|Death|0
5699021|NCT00261846|19646298|P1|Period 2: Part 2 (Efficacy)|Death|0
5699022|NCT00261846|19646287|P12|Period 2: Part 2 (Efficacy)|Other|0
5699023|NCT00261846|19646288|P11|Period 2: Part 2 (Efficacy)|Other|0
5699024|NCT00261846|19646289|P10|Period 2: Part 2 (Efficacy)|Other|4
5699025|NCT00261846|19646290|P9|Period 2: Part 2 (Efficacy)|Other|4
5699026|NCT00261846|19646291|P8|Period 2: Part 2 (Efficacy)|Other|5
5699027|NCT00261846|19646292|P7|Period 2: Part 2 (Efficacy)|Other|1
5699028|NCT00261846|19646293|P6|Period 2: Part 2 (Efficacy)|Other|0
5699029|NCT00261846|19646294|P5|Period 2: Part 2 (Efficacy)|Other|4
5699030|NCT00261846|19646295|P4|Period 2: Part 2 (Efficacy)|Other|15
5699031|NCT00261846|19646296|P3|Period 2: Part 2 (Efficacy)|Other|0
5699032|NCT00261846|19646297|P2|Period 2: Part 2 (Efficacy)|Other|0
5699033|NCT00261846|19646298|P1|Period 2: Part 2 (Efficacy)|Other|0
5699034|NCT00261846|19646287|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5699035|NCT00261846|19646288|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
5699036|NCT00261846|19646289|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
5699037|NCT00261846|19646290|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
5699038|NCT00261846|19646291|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5699039|NCT00261846|19646292|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
5699040|NCT00261846|19646293|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5699041|NCT00261846|19646294|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
5699042|NCT00261846|19646295|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
5699043|NCT00261846|19646296|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5699044|NCT00261846|19646297|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5699045|NCT00261846|19646298|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
5699046|NCT00261846|19646287|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5699047|NCT00261846|19646288|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5699048|NCT00261846|19646289|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
5699049|NCT00261846|19646290|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5699050|NCT00261846|19646291|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
5699051|NCT00261846|19646292|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
5699052|NCT00261846|19646293|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
5699053|NCT00261846|19646294|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
5699054|NCT00261846|19646295|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
5699055|NCT00261846|19646296|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5699056|NCT00261846|19646297|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5699057|NCT00261846|19646298|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
5699058|NCT00261846|19646287|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699059|NCT00261846|19646288|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699060|NCT00261846|19646289|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699061|NCT00261846|19646290|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
5699062|NCT00261846|19646291|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699063|NCT00261846|19646292|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699064|NCT00261846|19646293|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699065|NCT00261846|19646294|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699066|NCT00261846|19646295|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
5699067|NCT00261846|19646296|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699068|NCT00261846|19646297|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699069|NCT00261846|19646298|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
5699070|NCT00261846|19646287|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5699071|NCT00261846|19646288|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5699072|NCT00261846|19646289|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5699073|NCT00261846|19646290|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5699074|NCT00261846|19646291|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5699075|NCT00261846|19646292|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5699076|NCT00261846|19646293|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5699077|NCT00261846|19646294|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5699078|NCT00261846|19646295|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
5699079|NCT00261846|19646296|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
5699080|NCT00261846|19646297|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
5699081|NCT00261846|19646298|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
5699082|NCT00261833|19646557|P2|Overall Study|Not interested in being participant|1
5699083|NCT00261833|19646558|P1|Overall Study|Not interested in being participant|0
5699084|NCT00261833|19646557|P2|Overall Study|Missing reason|0
5699085|NCT00261833|19646558|P1|Overall Study|Missing reason|1
5699086|NCT00261833|19646557|P2|Overall Study|Lung transplantation|1
5699087|NCT00261833|19646558|P1|Overall Study|Lung transplantation|1
5699088|NCT00261833|19646557|P2|Overall Study|Suspicion of pulmonary cancer|1
5699089|NCT00261833|19646558|P1|Overall Study|Suspicion of pulmonary cancer|0
5699090|NCT00261833|19646557|P2|Overall Study|Protocol Violation|1
5699091|NCT00261833|19646558|P1|Overall Study|Protocol Violation|0
5699092|NCT00261833|19646557|P2|Overall Study|Withdrawal by Subject|7
5699093|NCT00261833|19646558|P1|Overall Study|Withdrawal by Subject|5
5699094|NCT00261833|19646557|P2|Overall Study|Adverse Event|4
5699095|NCT00261833|19646558|P1|Overall Study|Adverse Event|1
5699096|NCT00261833|19646557|P2|Overall Study|Death|3
5699097|NCT00261833|19646558|P1|Overall Study|Death|1
5699098|NCT00261716|19646592|P2|Overall Study|Lost to Follow-up|2
5699099|NCT00261716|19646593|P1|Overall Study|Lost to Follow-up|0
5699100|NCT00261716|19646592|P2|Overall Study|Withdrawal by Subject|8
5699101|NCT00261716|19646593|P1|Overall Study|Withdrawal by Subject|6
5699102|NCT00261495|19646613|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
5699103|NCT00261495|19646614|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
5699104|NCT00261495|19646613|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
5699105|NCT00261495|19646614|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
5699106|NCT00261495|19646613|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
5699107|NCT00261495|19646614|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
5699108|NCT00261495|19646613|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
5699109|NCT00261495|19646614|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
5699110|NCT00261495|19646613|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
5699111|NCT00261495|19646614|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
5699112|NCT00261495|19646613|P2|Extension Phase (Weeks 24 to 52)|Other|2
5699113|NCT00261495|19646614|P1|Extension Phase (Weeks 24 to 52)|Other|4
5699114|NCT00261495|19646613|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
5699115|NCT00261495|19646614|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
5699116|NCT00261495|19646613|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
5699117|NCT00261495|19646614|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
5699118|NCT00261495|19646613|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
5699119|NCT00261495|19646614|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
5699120|NCT00261495|19646613|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
5699121|NCT00261495|19646614|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
5699122|NCT00261495|19646613|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
5699123|NCT00261495|19646614|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
5699124|NCT00261495|19646613|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
5699125|NCT00261495|19646614|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
5699126|NCT00261495|19646613|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
5699127|NCT00261495|19646614|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
5699128|NCT00261495|19646613|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
5699129|NCT00261495|19646614|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
5699130|NCT00261495|19646613|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
5699131|NCT00261495|19646614|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
5699132|NCT00261495|19646613|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
5699133|NCT00261495|19646614|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
5699134|NCT00261495|19646613|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
5699135|NCT00261495|19646614|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
5699136|NCT00261495|19646613|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
5699137|NCT00261495|19646614|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
5699138|NCT00261495|19646613|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
5699139|NCT00261495|19646614|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
5699140|NCT00261495|19646613|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
5699141|NCT00261495|19646614|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
5699142|NCT00261495|19646613|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
5699143|NCT00261495|19646614|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
5699144|NCT00261443|19646778|P3|4: Extension Phase|Lost to Follow-up|0
5699145|NCT00261443|19646779|P2|4: Extension Phase|Lost to Follow-up|1
5699146|NCT00261443|19646780|P1|4: Extension Phase|Lost to Follow-up|0
5699147|NCT00261443|19646778|P3|4: Extension Phase|Withdrawal by Subject|2
5699148|NCT00261443|19646779|P2|4: Extension Phase|Withdrawal by Subject|1
5699149|NCT00261443|19646780|P1|4: Extension Phase|Withdrawal by Subject|0
5699150|NCT00261443|19646778|P3|4: Extension Phase|Adverse Event|0
5699151|NCT00261443|19646779|P2|4: Extension Phase|Adverse Event|1
5699152|NCT00261443|19646780|P1|4: Extension Phase|Adverse Event|0
5699153|NCT00261443|19646778|P3|3: Assessment of Relapse|Other Reasons|3
5699154|NCT00261443|19646779|P2|3: Assessment of Relapse|Other Reasons|4
5699155|NCT00261443|19646780|P1|3: Assessment of Relapse|Other Reasons|0
5699156|NCT00261443|19646778|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
5699157|NCT00261443|19646779|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
5699158|NCT00261443|19646780|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
5699159|NCT00261443|19646778|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
5699160|NCT00261443|19646779|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
5699161|NCT00261443|19646780|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
5699162|NCT00261443|19646778|P3|3: Assessment of Relapse|Pregnancy|1
5699163|NCT00261443|19646779|P2|3: Assessment of Relapse|Pregnancy|2
5699164|NCT00261443|19646780|P1|3: Assessment of Relapse|Pregnancy|0
5699165|NCT00261443|19646778|P3|3: Assessment of Relapse|Poor/Noncompliance|3
5699166|NCT00261443|19646779|P2|3: Assessment of Relapse|Poor/Noncompliance|5
5699167|NCT00261443|19646780|P1|3: Assessment of Relapse|Poor/Noncompliance|0
5699168|NCT00261443|19646778|P3|3: Assessment of Relapse|Lost to Follow-up|6
5699169|NCT00261443|19646779|P2|3: Assessment of Relapse|Lost to Follow-up|7
5699170|NCT00261443|19646780|P1|3: Assessment of Relapse|Lost to Follow-up|0
5699171|NCT00261443|19646778|P3|3: Assessment of Relapse|Death|1
5699172|NCT00261443|19646779|P2|3: Assessment of Relapse|Death|0
5699173|NCT00261443|19646780|P1|3: Assessment of Relapse|Death|0
5699174|NCT00261443|19646778|P3|3: Assessment of Relapse|Withdrawal by Subject|15
5699175|NCT00261443|19646779|P2|3: Assessment of Relapse|Withdrawal by Subject|14
5699176|NCT00261443|19646780|P1|3: Assessment of Relapse|Withdrawal by Subject|0
5699177|NCT00261443|19646778|P3|3: Assessment of Relapse|Adverse Event|19
5699178|NCT00261443|19646779|P2|3: Assessment of Relapse|Adverse Event|15
5699179|NCT00261443|19646780|P1|3: Assessment of Relapse|Adverse Event|0
5699180|NCT00261443|19646778|P3|3: Assessment of Relapse|Lack of Efficacy|14
5699181|NCT00261443|19646779|P2|3: Assessment of Relapse|Lack of Efficacy|31
5699182|NCT00261443|19646780|P1|3: Assessment of Relapse|Lack of Efficacy|0
5699183|NCT00261443|19646778|P3|2: Stability & Maintenance of Stability|Other Reasons|0
5699184|NCT00261443|19646779|P2|2: Stability & Maintenance of Stability|Other Reasons|0
5699185|NCT00261443|19646780|P1|2: Stability & Maintenance of Stability|Other Reasons|13
5699186|NCT00261443|19646778|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
5699187|NCT00261443|19646779|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
5699188|NCT00261443|19646780|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
5699189|NCT00261443|19646778|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
5699190|NCT00261443|19646779|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
5699191|NCT00261443|19646780|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
5699192|NCT00261443|19646778|P3|2: Stability & Maintenance of Stability|Pregnancy|0
5699193|NCT00261443|19646779|P2|2: Stability & Maintenance of Stability|Pregnancy|0
5699194|NCT00261443|19646780|P1|2: Stability & Maintenance of Stability|Pregnancy|1
5699195|NCT00261443|19646778|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
5699196|NCT00261443|19646779|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
5699197|NCT00261443|19646780|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
5699198|NCT00261443|19646778|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
5699199|NCT00261443|19646779|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
5699200|NCT00261443|19646780|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
5699201|NCT00261443|19646778|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
5699202|NCT00261443|19646779|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
5699203|NCT00261443|19646780|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
5699204|NCT00261443|19646778|P3|2: Stability & Maintenance of Stability|Adverse Event|0
5699205|NCT00261443|19646779|P2|2: Stability & Maintenance of Stability|Adverse Event|0
5699206|NCT00261443|19646780|P1|2: Stability & Maintenance of Stability|Adverse Event|93
5699207|NCT00261443|19646778|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
5699208|NCT00261443|19646779|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
5699209|NCT00261443|19646780|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
5699210|NCT00261443|19646778|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
5699211|NCT00261443|19646779|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
5699212|NCT00261443|19646780|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
5699213|NCT00261443|19646778|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
5699214|NCT00261443|19646779|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
5699215|NCT00261443|19646780|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
5699216|NCT00261443|19646778|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
5699217|NCT00261443|19646779|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
5699218|NCT00261443|19646780|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
5699219|NCT00261443|19646778|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
5699220|NCT00261443|19646779|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
5699221|NCT00261443|19646780|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
5699222|NCT00261443|19646778|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
5699223|NCT00261443|19646779|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
5699224|NCT00261443|19646780|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
5699225|NCT00261443|19646778|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
5699226|NCT00261443|19646779|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
5699227|NCT00261443|19646780|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
5699228|NCT00261443|19646778|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
5699229|NCT00261443|19646779|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
5699230|NCT00261443|19646780|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
5699231|NCT00260832|19647065|P2|Overall Study|Protocol Violation|1
5699232|NCT00260832|19647066|P1|Overall Study|Protocol Violation|3
5699233|NCT00260832|19647065|P2|Overall Study|Other|7
5699234|NCT00260832|19647066|P1|Overall Study|Other|10
5699235|NCT00260832|19647065|P2|Overall Study|Death|62
5699236|NCT00260832|19647066|P1|Overall Study|Death|43
5699237|NCT00260832|19647065|P2|Overall Study|Physician Decision|9
5699238|NCT00260832|19647066|P1|Overall Study|Physician Decision|15
5699239|NCT00260832|19647065|P2|Overall Study|Withdrawal by Subject|17
5699240|NCT00260832|19647066|P1|Overall Study|Withdrawal by Subject|15
5699241|NCT00260832|19647065|P2|Overall Study|Progression|96
5699242|NCT00260832|19647066|P1|Overall Study|Progression|116
5699243|NCT00260832|19647065|P2|Overall Study|Adverse Event|19
5699244|NCT00260832|19647066|P1|Overall Study|Adverse Event|26
5699245|NCT00260533|19647095|P2|Overall Study|Other|3
5699246|NCT00260533|19647096|P1|Overall Study|Other|3
5699247|NCT00260429|19647104|P2|Overall Study|scheduled hand surgery|0
5699248|NCT00260429|19647105|P1|Overall Study|scheduled hand surgery|1
5699249|NCT00260429|19647104|P2|Overall Study|failure to follow appointments|0
5699250|NCT00260429|19647105|P1|Overall Study|failure to follow appointments|1
5699251|NCT00260208|19647113|P2|Overall Study|Missing|16
5699252|NCT00260208|19647114|P1|Overall Study|Missing|18
5699253|NCT00260208|19647113|P2|Overall Study|Death|10
5699254|NCT00260208|19647114|P1|Overall Study|Death|12
5699255|NCT00260208|19647113|P2|Overall Study|Lost to Follow-up|1
5699256|NCT00260208|19647114|P1|Overall Study|Lost to Follow-up|6
5699257|NCT00260208|19647113|P2|Overall Study|Subject withdrew consent|7
5699258|NCT00260208|19647114|P1|Overall Study|Subject withdrew consent|11
5699259|NCT00260065|19647157|P1|Overall Study|Medication Noncompliance|1
5699260|NCT00260065|19647157|P1|Overall Study|Not otherwise specified|8
5699261|NCT00260065|19647157|P1|Overall Study|Physician Decision|19
5699262|NCT00260065|19647157|P1|Overall Study|Withdrawal by Subject|13
5699263|NCT00260065|19647157|P1|Overall Study|Death|13
5699264|NCT00260065|19647157|P1|Overall Study|Adverse Event|17
5699265|NCT00260065|19647157|P1|Overall Study|Progressive Disease|22
5699266|NCT00259857|19647164|P2|24 Months Treatment|Lost to Follow-up|3
5699267|NCT00259857|19647165|P1|24 Months Treatment|Lost to Follow-up|0
5699268|NCT00259857|19647164|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
5699269|NCT00259857|19647165|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
5699270|NCT00259740|19647183|P2|Overall Study|Requirement for alternative therapy|4
5699271|NCT00259740|19647184|P1|Overall Study|Requirement for alternative therapy|0
5699272|NCT00259740|19647183|P2|Overall Study|Other|0
5699273|NCT00259740|19647184|P1|Overall Study|Other|3
5699274|NCT00259740|19647183|P2|Overall Study|Ongoing|3
5699275|NCT00259740|19647184|P1|Overall Study|Ongoing|17
5699276|NCT00259740|19647183|P2|Overall Study|Disease progression|36
5699277|NCT00259740|19647184|P1|Overall Study|Disease progression|19
5699278|NCT00259740|19647183|P2|Overall Study|Death|1
5699279|NCT00259740|19647184|P1|Overall Study|Death|1
5699280|NCT00259740|19647183|P2|Overall Study|Withdrawal by Subject|6
5699281|NCT00259740|19647184|P1|Overall Study|Withdrawal by Subject|2
5699282|NCT00259740|19647183|P2|Overall Study|Adverse Event|2
5699283|NCT00259740|19647184|P1|Overall Study|Adverse Event|0
5699284|NCT00259740|19647183|P2|Overall Study|Physician Decision|1
5699285|NCT00259740|19647184|P1|Overall Study|Physician Decision|1
5699286|NCT00259649|19647194|P1|Overall Study|irregular menses|3
5699287|NCT00259649|19647194|P1|Overall Study|Lost to Follow-up|7
5699288|NCT00259610|19647202|P4|Overall Study|Serious Adverse Event|2
5699289|NCT00259610|19647203|P3|Overall Study|Serious Adverse Event|2
5699290|NCT00259610|19647204|P2|Overall Study|Serious Adverse Event|2
5699291|NCT00259610|19647205|P1|Overall Study|Serious Adverse Event|8
5699292|NCT00259610|19647202|P4|Overall Study|Adverse Event|2
5699293|NCT00259610|19647203|P3|Overall Study|Adverse Event|5
5699294|NCT00259610|19647204|P2|Overall Study|Adverse Event|4
5699295|NCT00259610|19647205|P1|Overall Study|Adverse Event|3
5699296|NCT00259610|19647202|P4|Overall Study|non medical reason|3
5699297|NCT00259610|19647203|P3|Overall Study|non medical reason|10
5699298|NCT00259610|19647204|P2|Overall Study|non medical reason|2
5699299|NCT00259610|19647205|P1|Overall Study|non medical reason|6
5699300|NCT00259610|19647202|P4|Overall Study|Death|0
5699301|NCT00259610|19647203|P3|Overall Study|Death|2
5699302|NCT00259610|19647204|P2|Overall Study|Death|1
5699303|NCT00259610|19647205|P1|Overall Study|Death|1
5699304|NCT00259610|19647202|P4|Overall Study|Physician Decision|2
5699305|NCT00259610|19647203|P3|Overall Study|Physician Decision|7
5699306|NCT00259610|19647204|P2|Overall Study|Physician Decision|4
5699307|NCT00259610|19647205|P1|Overall Study|Physician Decision|6
5699308|NCT00259610|19647202|P4|Overall Study|Lost to Follow-up|15
5699309|NCT00259610|19647203|P3|Overall Study|Lost to Follow-up|18
5699310|NCT00259610|19647204|P2|Overall Study|Lost to Follow-up|8
5699311|NCT00259610|19647205|P1|Overall Study|Lost to Follow-up|19
5699312|NCT00259610|19647202|P4|Overall Study|Withdrawal by Subject|19
5699313|NCT00259610|19647203|P3|Overall Study|Withdrawal by Subject|29
5699314|NCT00259610|19647204|P2|Overall Study|Withdrawal by Subject|25
5699315|NCT00259610|19647205|P1|Overall Study|Withdrawal by Subject|33
5699316|NCT00259298|19647219|P1|Overall Study|Physician Decision|2
5699317|NCT00259298|19647219|P1|Overall Study|Withdrawal by Subject|1
5699318|NCT00259272|19647237|P4|Overall Study|Lost to Follow-up|1
5699319|NCT00259272|19647238|P3|Overall Study|Lost to Follow-up|0
5699320|NCT00259272|19647239|P2|Overall Study|Lost to Follow-up|0
5699321|NCT00259272|19647240|P1|Overall Study|Lost to Follow-up|1
5699322|NCT00259272|19647237|P4|Overall Study|Withdrawal by Subject|7
5699323|NCT00259272|19647238|P3|Overall Study|Withdrawal by Subject|2
5699324|NCT00259272|19647239|P2|Overall Study|Withdrawal by Subject|2
5699325|NCT00259272|19647240|P1|Overall Study|Withdrawal by Subject|4
5699326|NCT00259272|19647237|P4|Overall Study|Sponsor Decision|0
5699327|NCT00259272|19647238|P3|Overall Study|Sponsor Decision|0
5699328|NCT00259272|19647239|P2|Overall Study|Sponsor Decision|1
5699329|NCT00259272|19647240|P1|Overall Study|Sponsor Decision|0
5699330|NCT00259272|19647237|P4|Overall Study|Protocol Violation|1
5699331|NCT00259272|19647238|P3|Overall Study|Protocol Violation|0
5699332|NCT00259272|19647239|P2|Overall Study|Protocol Violation|0
5699333|NCT00259272|19647240|P1|Overall Study|Protocol Violation|2
5699334|NCT00259272|19647237|P4|Overall Study|Physician Decision|3
5699335|NCT00259272|19647238|P3|Overall Study|Physician Decision|1
5699336|NCT00259272|19647239|P2|Overall Study|Physician Decision|2
5699337|NCT00259272|19647240|P1|Overall Study|Physician Decision|1
5699338|NCT00259272|19647237|P4|Overall Study|Lack of Efficacy|6
5699339|NCT00259272|19647238|P3|Overall Study|Lack of Efficacy|2
5699340|NCT00259272|19647239|P2|Overall Study|Lack of Efficacy|1
5699341|NCT00259272|19647240|P1|Overall Study|Lack of Efficacy|5
5699342|NCT00259272|19647237|P4|Overall Study|Adverse Event|3
5699343|NCT00259272|19647238|P3|Overall Study|Adverse Event|0
5699344|NCT00259272|19647239|P2|Overall Study|Adverse Event|1
5699345|NCT00259272|19647240|P1|Overall Study|Adverse Event|2
5699346|NCT00259012|19647336|P2|Overall Study|Protocol Violation|1
5699347|NCT00259012|19647337|P1|Overall Study|Protocol Violation|1
5699348|NCT00259012|19647336|P2|Overall Study|Lost to Follow-up|1
5699349|NCT00259012|19647337|P1|Overall Study|Lost to Follow-up|0
5699350|NCT00259012|19647336|P2|Overall Study|Physician Decision|1
5699351|NCT00259012|19647337|P1|Overall Study|Physician Decision|0
5699352|NCT00259012|19647336|P2|Overall Study|Withdrawal by Subject|0
5699353|NCT00259012|19647337|P1|Overall Study|Withdrawal by Subject|1
5699354|NCT00259012|19647336|P2|Overall Study|Adverse Event|1
5699355|NCT00259012|19647337|P1|Overall Study|Adverse Event|0
5699356|NCT00258960|19647369|P1|Overall Study|Mistake|2
5699357|NCT00258960|19647369|P1|Overall Study|Withdrawal by Subject|1
5699358|NCT00258960|19647369|P1|Overall Study|Physician Decision|1
5699359|NCT00258960|19647369|P1|Overall Study|Adverse Event|4
5699360|NCT00258960|19647369|P1|Overall Study|Disease Progression|7
5699361|NCT00258960|19647369|P1|Overall Study|Death|2
5699362|NCT00258895|19647385|P2|Overall Study|Withdrawal by Subject|0
5699363|NCT00258895|19647386|P1|Overall Study|Withdrawal by Subject|1
5699364|NCT00258895|19647385|P2|Overall Study|Protocol Violation|2
5699365|NCT00258895|19647386|P1|Overall Study|Protocol Violation|6
5699366|NCT00258895|19647385|P2|Overall Study|Lost to Follow-up|1
5699367|NCT00258895|19647386|P1|Overall Study|Lost to Follow-up|3
5699368|NCT00258856|19647422|P4|Overall Study|Non-compliance|1
5699369|NCT00258856|19647423|P3|Overall Study|Non-compliance|0
5699370|NCT00258856|19647424|P2|Overall Study|Non-compliance|0
5699371|NCT00258856|19647425|P1|Overall Study|Non-compliance|2
5699372|NCT00258856|19647422|P4|Overall Study|Lost to Follow-up|0
5699373|NCT00258856|19647423|P3|Overall Study|Lost to Follow-up|2
5699374|NCT00258856|19647424|P2|Overall Study|Lost to Follow-up|0
5699375|NCT00258856|19647425|P1|Overall Study|Lost to Follow-up|1
5699376|NCT00258674|19647466|P3|Overall Study|Death|34
5699377|NCT00258674|19647467|P2|Overall Study|Death|53
5699378|NCT00258674|19647468|P1|Overall Study|Death|32
5699379|NCT00258440|19647527|P3|Overall Study|Withdrawal by Subject|1
5699380|NCT00258440|19647528|P2|Overall Study|Withdrawal by Subject|0
5699381|NCT00258440|19647529|P1|Overall Study|Withdrawal by Subject|0
5699382|NCT00258154|19647567|P2|Overall Study|Patient Moved|1
5699383|NCT00258154|19647568|P1|Overall Study|Patient Moved|3
5699384|NCT00258154|19647567|P2|Overall Study|Withdrawal by Subject|4
5699385|NCT00258154|19647568|P1|Overall Study|Withdrawal by Subject|3
5699386|NCT00258154|19647567|P2|Overall Study|Protocol Violation|1
5699387|NCT00258154|19647568|P1|Overall Study|Protocol Violation|2
5699388|NCT00258154|19647567|P2|Overall Study|Lost to Follow-up|1
5699389|NCT00258154|19647568|P1|Overall Study|Lost to Follow-up|0
5699390|NCT00258154|19647567|P2|Overall Study|Adverse Event|0
5699391|NCT00258154|19647568|P1|Overall Study|Adverse Event|1
5699392|NCT00257920|19647663|P2|Period: Second Intervention|Other|1
5699393|NCT00257920|19647664|P1|Period: Second Intervention|Other|2
5699394|NCT00257920|19647663|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
5699395|NCT00257920|19647664|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
5699396|NCT00257725|19647687|P1|Overall Study|Adverse Event|3
5699397|NCT00257660|19647726|P2|Overall Study|No longer wanted to do blood draws|0
5699398|NCT00257660|19647727|P1|Overall Study|No longer wanted to do blood draws|1
5699399|NCT00257660|19647726|P2|Overall Study|PI & Subject Schedule Conflicts|0
5699400|NCT00257660|19647727|P1|Overall Study|PI & Subject Schedule Conflicts|1
5699401|NCT00257660|19647726|P2|Overall Study|Lost to Follow-up|0
5699402|NCT00257660|19647727|P1|Overall Study|Lost to Follow-up|1
5699403|NCT00257660|19647726|P2|Overall Study|Withdrawal by Subject|0
5699404|NCT00257660|19647727|P1|Overall Study|Withdrawal by Subject|2
5699405|NCT00257660|19647726|P2|Overall Study|Lack of Efficacy|23
5699406|NCT00257660|19647727|P1|Overall Study|Lack of Efficacy|5
5699407|NCT00257608|19647757|P3|Post Chemotherapy Phase|Not treated|7
5699408|NCT00257608|19647758|P2|Post Chemotherapy Phase|Not treated|4
5699409|NCT00257608|19647759|P1|Post Chemotherapy Phase|Not treated|0
5699410|NCT00257608|19647757|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
5699411|NCT00257608|19647758|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
5699412|NCT00257608|19647759|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
5699413|NCT00257608|19647757|P3|Post Chemotherapy Phase|Physician Decision|11
5699414|NCT00257608|19647758|P2|Post Chemotherapy Phase|Physician Decision|8
5699415|NCT00257608|19647759|P1|Post Chemotherapy Phase|Physician Decision|0
5699416|NCT00257608|19647757|P3|Post Chemotherapy Phase|Lost to Follow-up|1
5699417|NCT00257608|19647758|P2|Post Chemotherapy Phase|Lost to Follow-up|0
5699418|NCT00257608|19647759|P1|Post Chemotherapy Phase|Lost to Follow-up|0
5699419|NCT00257608|19647757|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
5699420|NCT00257608|19647758|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
5699421|NCT00257608|19647759|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
5699422|NCT00257608|19647757|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
5699423|NCT00257608|19647758|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
5699424|NCT00257608|19647759|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
5699425|NCT00257608|19647757|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
5699426|NCT00257608|19647758|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
5699427|NCT00257608|19647759|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
5699428|NCT00257608|19647757|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
5699429|NCT00257608|19647758|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
5699430|NCT00257608|19647759|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
5699431|NCT00257608|19647757|P3|Post Chemotherapy Phase|Disease progression|168
5699432|NCT00257608|19647758|P2|Post Chemotherapy Phase|Disease progression|204
5699433|NCT00257608|19647759|P1|Post Chemotherapy Phase|Disease progression|0
5699434|NCT00257608|19647757|P3|Post Chemotherapy Phase|Adverse Event|38
5699435|NCT00257608|19647758|P2|Post Chemotherapy Phase|Adverse Event|34
5699436|NCT00257608|19647759|P1|Post Chemotherapy Phase|Adverse Event|0
5699437|NCT00257608|19647757|P3|Chemotherapy Phase|Physician Decision|0
5699438|NCT00257608|19647758|P2|Chemotherapy Phase|Physician Decision|0
5699439|NCT00257608|19647759|P1|Chemotherapy Phase|Physician Decision|28
5699440|NCT00257608|19647757|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
5699441|NCT00257608|19647758|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
5699442|NCT00257608|19647759|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
5699443|NCT00257608|19647757|P3|Chemotherapy Phase|Patient's decision to discontinue|0
5699444|NCT00257608|19647758|P2|Chemotherapy Phase|Patient's decision to discontinue|0
5699445|NCT00257608|19647759|P1|Chemotherapy Phase|Patient's decision to discontinue|35
5699446|NCT00257608|19647757|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
5699447|NCT00257608|19647758|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
5699448|NCT00257608|19647759|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
5699449|NCT00257608|19647757|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
5699450|NCT00257608|19647758|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
5699451|NCT00257608|19647759|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
5699452|NCT00257608|19647757|P3|Chemotherapy Phase|Disease progression|0
5699453|NCT00257608|19647758|P2|Chemotherapy Phase|Disease progression|0
5699454|NCT00257608|19647759|P1|Chemotherapy Phase|Disease progression|139
5699455|NCT00257608|19647757|P3|Chemotherapy Phase|Adverse Event|0
5699456|NCT00257608|19647758|P2|Chemotherapy Phase|Adverse Event|0
5699457|NCT00257608|19647759|P1|Chemotherapy Phase|Adverse Event|138
5699458|NCT00257556|19647785|P2|Overall Study|other reason|6
5699459|NCT00257556|19647786|P1|Overall Study|other reason|4
5699460|NCT00257556|19647785|P2|Overall Study|Did not meet hCG criterion|0
5699461|NCT00257556|19647786|P1|Overall Study|Did not meet hCG criterion|3
5699462|NCT00257556|19647785|P2|Overall Study|Physician Decision|0
5699463|NCT00257556|19647786|P1|Overall Study|Physician Decision|6
5699464|NCT00257556|19647785|P2|Overall Study|Adverse Event|4
5699465|NCT00257556|19647786|P1|Overall Study|Adverse Event|1
5699466|NCT00257192|19647830|P2|Overall Study|Miscellaneous|4
5699467|NCT00257192|19647831|P1|Overall Study|Miscellaneous|0
5699468|NCT00257192|19647830|P2|Overall Study|Study terminated by sponsor|0
5699469|NCT00257192|19647831|P1|Overall Study|Study terminated by sponsor|1
5699470|NCT00257192|19647830|P2|Overall Study|Randomized but not treated|1
5699471|NCT00257192|19647831|P1|Overall Study|Randomized but not treated|0
5699472|NCT00257192|19647830|P2|Overall Study|Withdrawal by Subject|2
5699473|NCT00257192|19647831|P1|Overall Study|Withdrawal by Subject|14
5699474|NCT00257192|19647830|P2|Overall Study|Insufficient clinical response|18
5699475|NCT00257192|19647831|P1|Overall Study|Insufficient clinical response|18
5699476|NCT00257192|19647830|P2|Overall Study|Lost to Follow-up|3
5699477|NCT00257192|19647831|P1|Overall Study|Lost to Follow-up|3
5699478|NCT00257192|19647830|P2|Overall Study|Laboratory abnormality|1
5699479|NCT00257192|19647831|P1|Overall Study|Laboratory abnormality|1
5699480|NCT00257192|19647830|P2|Overall Study|Adverse Event|10
5699481|NCT00257192|19647831|P1|Overall Study|Adverse Event|21
5699482|NCT00257166|19647875|P2|Overall Study|Randomized, but not treated|0
5699483|NCT00257166|19647876|P1|Overall Study|Randomized, but not treated|1
5699484|NCT00257166|19647875|P2|Overall Study|Other|21
5699485|NCT00257166|19647876|P1|Overall Study|Other|16
5699486|NCT00257166|19647875|P2|Overall Study|Withdrawal by Subject|2
5699487|NCT00257166|19647876|P1|Overall Study|Withdrawal by Subject|9
5699488|NCT00257166|19647875|P2|Overall Study|Lost to Follow-up|1
5699489|NCT00257166|19647876|P1|Overall Study|Lost to Follow-up|8
5699490|NCT00257166|19647875|P2|Overall Study|Laboratory abnormality|0
5699491|NCT00257166|19647876|P1|Overall Study|Laboratory abnormality|1
5699492|NCT00257166|19647875|P2|Overall Study|Adverse Event|13
5699493|NCT00257166|19647876|P1|Overall Study|Adverse Event|18
5699494|NCT00257010|19647888|P1|Overall Study|no headache reported|9
5699495|NCT00257010|19647888|P1|Overall Study|various|11
5699496|NCT00257010|19647888|P1|Overall Study|Adverse Event|10
5699497|NCT00257010|19647888|P1|Overall Study|Withdrawal by Subject|34
5699498|NCT00257010|19647888|P1|Overall Study|Lost to Follow-up|53
5699499|NCT00257010|19647888|P1|Overall Study|Lack of Efficacy|11
5699500|NCT00256997|19647899|P2|Overall Study|Investigator Withdrew Participant|1
5699501|NCT00256997|19647900|P1|Overall Study|Investigator Withdrew Participant|2
5699502|NCT00256997|19647899|P2|Overall Study|Participant Non-compliant|6
5699503|NCT00256997|19647900|P1|Overall Study|Participant Non-compliant|3
5699504|NCT00256997|19647899|P2|Overall Study|End of Study (As Per Sponsor)|24
5699505|NCT00256997|19647900|P1|Overall Study|End of Study (As Per Sponsor)|12
5699506|NCT00256997|19647899|P2|Overall Study|Other|8
5699507|NCT00256997|19647900|P1|Overall Study|Other|5
5699508|NCT00256997|19647899|P2|Overall Study|Started but not treated|0
5699509|NCT00256997|19647900|P1|Overall Study|Started but not treated|2
5699510|NCT00256997|19647899|P2|Overall Study|Withdrawal by Subject|3
5699511|NCT00256997|19647900|P1|Overall Study|Withdrawal by Subject|13
5699512|NCT00256997|19647899|P2|Overall Study|Lost to Follow-up|5
5699513|NCT00256997|19647900|P1|Overall Study|Lost to Follow-up|3
5699514|NCT00256997|19647899|P2|Overall Study|Adverse Event|0
5699515|NCT00256997|19647900|P1|Overall Study|Adverse Event|4
5699516|NCT00256997|19647899|P2|Overall Study|Death|0
5699517|NCT00256997|19647900|P1|Overall Study|Death|2
5699518|NCT00256997|19647899|P2|Overall Study|Lack of Efficacy|4
5699519|NCT00256997|19647900|P1|Overall Study|Lack of Efficacy|1
5699520|NCT00256997|19647899|P2|Overall Study|Protocol Violation|4
5699521|NCT00256997|19647900|P1|Overall Study|Protocol Violation|1
5699522|NCT00256867|19647942|P8|Overall Study|Withdrawal by participant|0
5699523|NCT00256867|19647943|P7|Overall Study|Withdrawal by participant|0
5699524|NCT00256867|19647944|P6|Overall Study|Withdrawal by participant|1
5699525|NCT00256867|19647945|P5|Overall Study|Withdrawal by participant|0
5699526|NCT00256867|19647946|P4|Overall Study|Withdrawal by participant|0
5699527|NCT00256867|19647947|P3|Overall Study|Withdrawal by participant|0
5699528|NCT00256867|19647948|P2|Overall Study|Withdrawal by participant|0
5699529|NCT00256867|19647949|P1|Overall Study|Withdrawal by participant|0
5699530|NCT00256867|19647942|P8|Overall Study|Participant out of assessment window|0
5699531|NCT00256867|19647943|P7|Overall Study|Participant out of assessment window|0
5699532|NCT00256867|19647944|P6|Overall Study|Participant out of assessment window|0
5699533|NCT00256867|19647945|P5|Overall Study|Participant out of assessment window|0
5699534|NCT00256867|19647946|P4|Overall Study|Participant out of assessment window|0
5699535|NCT00256867|19647947|P3|Overall Study|Participant out of assessment window|1
5699536|NCT00256867|19647948|P2|Overall Study|Participant out of assessment window|0
5699537|NCT00256867|19647949|P1|Overall Study|Participant out of assessment window|0
5699538|NCT00256867|19647942|P8|Overall Study|Participant travelled Overseas|0
5699539|NCT00256867|19647943|P7|Overall Study|Participant travelled Overseas|0
5699540|NCT00256867|19647944|P6|Overall Study|Participant travelled Overseas|0
5699541|NCT00256867|19647945|P5|Overall Study|Participant travelled Overseas|0
5699542|NCT00256867|19647946|P4|Overall Study|Participant travelled Overseas|0
5699543|NCT00256867|19647947|P3|Overall Study|Participant travelled Overseas|0
5699544|NCT00256867|19647948|P2|Overall Study|Participant travelled Overseas|1
5699545|NCT00256867|19647949|P1|Overall Study|Participant travelled Overseas|0
5699546|NCT00256867|19647942|P8|Overall Study|Non-compliance with study medication|1
5699547|NCT00256867|19647943|P7|Overall Study|Non-compliance with study medication|0
5699548|NCT00256867|19647944|P6|Overall Study|Non-compliance with study medication|0
5699549|NCT00256867|19647945|P5|Overall Study|Non-compliance with study medication|0
5699550|NCT00256867|19647946|P4|Overall Study|Non-compliance with study medication|0
5699551|NCT00256867|19647947|P3|Overall Study|Non-compliance with study medication|0
5699552|NCT00256867|19647948|P2|Overall Study|Non-compliance with study medication|0
5699553|NCT00256867|19647949|P1|Overall Study|Non-compliance with study medication|0
5699554|NCT00256867|19647942|P8|Overall Study|Investigator's Decision|0
5699555|NCT00256867|19647943|P7|Overall Study|Investigator's Decision|0
5699556|NCT00256867|19647944|P6|Overall Study|Investigator's Decision|0
5699557|NCT00256867|19647945|P5|Overall Study|Investigator's Decision|1
5699558|NCT00256867|19647946|P4|Overall Study|Investigator's Decision|0
5699559|NCT00256867|19647947|P3|Overall Study|Investigator's Decision|0
5699560|NCT00256867|19647948|P2|Overall Study|Investigator's Decision|0
5699561|NCT00256867|19647949|P1|Overall Study|Investigator's Decision|0
5699562|NCT00256867|19647942|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
5699563|NCT00256867|19647943|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
5699564|NCT00256867|19647944|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
5699565|NCT00256867|19647945|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
5699566|NCT00256867|19647946|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
5699567|NCT00256867|19647947|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
5699568|NCT00256867|19647948|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
5699569|NCT00256867|19647949|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
5699570|NCT00256867|19647942|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
5699571|NCT00256867|19647943|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
5699572|NCT00256867|19647944|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
5699573|NCT00256867|19647945|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
5699574|NCT00256867|19647946|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
5699575|NCT00256867|19647947|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
5699576|NCT00256867|19647948|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
5699577|NCT00256867|19647949|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
5699578|NCT00256867|19647942|P8|Overall Study|Withdrawal by Subject|2
5699579|NCT00256867|19647943|P7|Overall Study|Withdrawal by Subject|3
5699580|NCT00256867|19647944|P6|Overall Study|Withdrawal by Subject|2
5699581|NCT00256867|19647945|P5|Overall Study|Withdrawal by Subject|2
5699582|NCT00256867|19647946|P4|Overall Study|Withdrawal by Subject|1
5699583|NCT00256867|19647947|P3|Overall Study|Withdrawal by Subject|1
5699584|NCT00256867|19647948|P2|Overall Study|Withdrawal by Subject|0
5699585|NCT00256867|19647949|P1|Overall Study|Withdrawal by Subject|0
5699586|NCT00256867|19647942|P8|Overall Study|Protocol Violation|1
5699587|NCT00256867|19647943|P7|Overall Study|Protocol Violation|0
5699588|NCT00256867|19647944|P6|Overall Study|Protocol Violation|1
5699589|NCT00256867|19647945|P5|Overall Study|Protocol Violation|0
5699590|NCT00256867|19647946|P4|Overall Study|Protocol Violation|1
5699591|NCT00256867|19647947|P3|Overall Study|Protocol Violation|0
5699592|NCT00256867|19647948|P2|Overall Study|Protocol Violation|0
5699593|NCT00256867|19647949|P1|Overall Study|Protocol Violation|0
5699594|NCT00256867|19647942|P8|Overall Study|Lost to Follow-up|2
5699595|NCT00256867|19647943|P7|Overall Study|Lost to Follow-up|1
5699596|NCT00256867|19647944|P6|Overall Study|Lost to Follow-up|0
5699597|NCT00256867|19647945|P5|Overall Study|Lost to Follow-up|2
5699598|NCT00256867|19647946|P4|Overall Study|Lost to Follow-up|3
5699599|NCT00256867|19647947|P3|Overall Study|Lost to Follow-up|2
5699600|NCT00256867|19647948|P2|Overall Study|Lost to Follow-up|2
5699601|NCT00256867|19647949|P1|Overall Study|Lost to Follow-up|2
5699602|NCT00256867|19647942|P8|Overall Study|Adverse Event|4
5699603|NCT00256867|19647943|P7|Overall Study|Adverse Event|1
5699604|NCT00256867|19647944|P6|Overall Study|Adverse Event|2
5699605|NCT00256867|19647945|P5|Overall Study|Adverse Event|2
5699606|NCT00256867|19647946|P4|Overall Study|Adverse Event|1
5699607|NCT00256867|19647947|P3|Overall Study|Adverse Event|1
5699608|NCT00256867|19647948|P2|Overall Study|Adverse Event|1
5699609|NCT00256867|19647949|P1|Overall Study|Adverse Event|0
5699610|NCT00256854|19648039|P6|Overall Study|Not compliant with the study drug|0
5699611|NCT00256854|19648040|P5|Overall Study|Not compliant with the study drug|1
5699612|NCT00256854|19648041|P4|Overall Study|Not compliant with the study drug|0
5699613|NCT00256854|19648042|P3|Overall Study|Not compliant with the study drug|0
5699614|NCT00256854|19648043|P2|Overall Study|Not compliant with the study drug|0
5699615|NCT00256854|19648044|P1|Overall Study|Not compliant with the study drug|0
5699616|NCT00256854|19648039|P6|Overall Study|Adverse Event|1
5699617|NCT00256854|19648040|P5|Overall Study|Adverse Event|0
5699618|NCT00256854|19648041|P4|Overall Study|Adverse Event|2
5699619|NCT00256854|19648042|P3|Overall Study|Adverse Event|2
5699620|NCT00256854|19648043|P2|Overall Study|Adverse Event|0
5699621|NCT00256854|19648044|P1|Overall Study|Adverse Event|0
5699622|NCT00256854|19648039|P6|Overall Study|Protocol Violation|0
5699623|NCT00256854|19648040|P5|Overall Study|Protocol Violation|0
5699624|NCT00256854|19648041|P4|Overall Study|Protocol Violation|1
5699625|NCT00256854|19648042|P3|Overall Study|Protocol Violation|1
5699626|NCT00256854|19648043|P2|Overall Study|Protocol Violation|1
5699627|NCT00256854|19648044|P1|Overall Study|Protocol Violation|0
5699628|NCT00256854|19648039|P6|Overall Study|Lack of Efficacy|0
5699629|NCT00256854|19648040|P5|Overall Study|Lack of Efficacy|0
5699630|NCT00256854|19648041|P4|Overall Study|Lack of Efficacy|0
5699631|NCT00256854|19648042|P3|Overall Study|Lack of Efficacy|0
5699632|NCT00256854|19648043|P2|Overall Study|Lack of Efficacy|0
5699633|NCT00256854|19648044|P1|Overall Study|Lack of Efficacy|1
5699634|NCT00256854|19648039|P6|Overall Study|Withdrawal by Subject|0
5699635|NCT00256854|19648040|P5|Overall Study|Withdrawal by Subject|0
5699636|NCT00256854|19648041|P4|Overall Study|Withdrawal by Subject|0
5699637|NCT00256854|19648042|P3|Overall Study|Withdrawal by Subject|0
5699638|NCT00256854|19648043|P2|Overall Study|Withdrawal by Subject|3
5699639|NCT00256854|19648044|P1|Overall Study|Withdrawal by Subject|2
5699640|NCT00256750|19648103|P3|Long Term Extension (LTE; 84 Months)|Other|5
5699641|NCT00256750|19648104|P2|Long Term Extension (LTE; 84 Months)|Other|4
5699642|NCT00256750|19648105|P1|Long Term Extension (LTE; 84 Months)|Other|5
5699643|NCT00256750|19648103|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
5699644|NCT00256750|19648104|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
5699645|NCT00256750|19648105|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
5699646|NCT00256750|19648103|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
5699647|NCT00256750|19648104|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
5699648|NCT00256750|19648105|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
5699649|NCT00256750|19648103|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
5699650|NCT00256750|19648104|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
5699651|NCT00256750|19648105|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
5699652|NCT00256750|19648103|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
5699653|NCT00256750|19648104|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
5699654|NCT00256750|19648105|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
5699655|NCT00256750|19648103|P3|Long Term Extension (LTE; 84 Months)|Death|4
5699656|NCT00256750|19648104|P2|Long Term Extension (LTE; 84 Months)|Death|4
5699657|NCT00256750|19648105|P1|Long Term Extension (LTE; 84 Months)|Death|9
5699658|NCT00256750|19648103|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
5699659|NCT00256750|19648104|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
5699660|NCT00256750|19648105|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
5699661|NCT00256750|19648103|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
5699662|NCT00256750|19648104|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
5699663|NCT00256750|19648105|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
5699664|NCT00256750|19648103|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
5699665|NCT00256750|19648104|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
5699666|NCT00256750|19648105|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
5699667|NCT00256750|19648103|P3|Post-Transplant Treated (36 Months)|Other|1
5699668|NCT00256750|19648104|P2|Post-Transplant Treated (36 Months)|Other|1
5699669|NCT00256750|19648105|P1|Post-Transplant Treated (36 Months)|Other|0
5699670|NCT00256750|19648103|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
5699671|NCT00256750|19648104|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
5699672|NCT00256750|19648105|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
5699673|NCT00256750|19648103|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
5699674|NCT00256750|19648104|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
5699675|NCT00256750|19648105|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
5699676|NCT00256750|19648103|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
5699677|NCT00256750|19648104|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
5699678|NCT00256750|19648105|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
5699679|NCT00256750|19648103|P3|Post-Transplant Treated (36 Months)|Death|1
5699680|NCT00256750|19648104|P2|Post-Transplant Treated (36 Months)|Death|2
5699681|NCT00256750|19648105|P1|Post-Transplant Treated (36 Months)|Death|0
5699682|NCT00256750|19648103|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
5699683|NCT00256750|19648104|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
5699684|NCT00256750|19648105|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
5699685|NCT00256750|19648103|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
5699686|NCT00256750|19648104|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
5699687|NCT00256750|19648105|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
5699688|NCT00256750|19648103|P3|Post-Transplant Treated (24 Months)|Other|1
5699689|NCT00256750|19648104|P2|Post-Transplant Treated (24 Months)|Other|0
5699690|NCT00256750|19648105|P1|Post-Transplant Treated (24 Months)|Other|2
5699691|NCT00256750|19648103|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
5699692|NCT00256750|19648104|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
5699693|NCT00256750|19648105|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
5699694|NCT00256750|19648103|P3|Post-Transplant Treated (24 Months)|Death|0
5699695|NCT00256750|19648104|P2|Post-Transplant Treated (24 Months)|Death|0
5699696|NCT00256750|19648105|P1|Post-Transplant Treated (24 Months)|Death|3
5699697|NCT00256750|19648103|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
5699698|NCT00256750|19648104|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
5699699|NCT00256750|19648105|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
5699700|NCT00256750|19648103|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
5699701|NCT00256750|19648104|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
5699702|NCT00256750|19648105|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
5699703|NCT00256750|19648103|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
5699704|NCT00256750|19648104|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
5699705|NCT00256750|19648105|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
5699706|NCT00256750|19648103|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
5699707|NCT00256750|19648104|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
5699708|NCT00256750|19648105|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
5699709|NCT00256750|19648103|P3|Post-Transplant Treated (12 Months)|Other|2
5699710|NCT00256750|19648104|P2|Post-Transplant Treated (12 Months)|Other|4
5699711|NCT00256750|19648105|P1|Post-Transplant Treated (12 Months)|Other|5
5699712|NCT00256750|19648103|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
5699713|NCT00256750|19648104|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
5699714|NCT00256750|19648105|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
5699715|NCT00256750|19648103|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
5699716|NCT00256750|19648104|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
5699717|NCT00256750|19648105|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
5699718|NCT00256750|19648103|P3|Post-Transplant Treated (12 Months)|Death|4
5699719|NCT00256750|19648104|P2|Post-Transplant Treated (12 Months)|Death|2
5699720|NCT00256750|19648105|P1|Post-Transplant Treated (12 Months)|Death|3
5699721|NCT00256750|19648103|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
5699722|NCT00256750|19648104|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
5699723|NCT00256750|19648105|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
5699724|NCT00256750|19648103|P3|Transplanted Pre-Treatment|Death|0
5699725|NCT00256750|19648104|P2|Transplanted Pre-Treatment|Death|0
5699726|NCT00256750|19648105|P1|Transplanted Pre-Treatment|Death|1
5699727|NCT00256750|19648103|P3|Transplanted Pre-Treatment|Other|0
5699728|NCT00256750|19648104|P2|Transplanted Pre-Treatment|Other|0
5699729|NCT00256750|19648105|P1|Transplanted Pre-Treatment|Other|2
5699730|NCT00256750|19648103|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
5699731|NCT00256750|19648104|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
5699732|NCT00256750|19648105|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
5699733|NCT00256724|19648241|P2|Overall Study|Protocol Violation|3
5699734|NCT00256724|19648242|P1|Overall Study|Protocol Violation|3
5699735|NCT00256724|19648241|P2|Overall Study|Physician Decision|5
5699736|NCT00256724|19648242|P1|Overall Study|Physician Decision|2
5699737|NCT00256698|19648252|P2|Overall Study|Prematurely Discontinued|0
5699738|NCT00256698|19648253|P1|Overall Study|Prematurely Discontinued|1
5699739|NCT00256698|19648252|P2|Overall Study|withdrawn due to osteoporosis|0
5699740|NCT00256698|19648253|P1|Overall Study|withdrawn due to osteoporosis|1
5699741|NCT00256698|19648252|P2|Overall Study|still ongoing at data cut-off|46
5699742|NCT00256698|19648253|P1|Overall Study|still ongoing at data cut-off|41
5699743|NCT00256698|19648252|P2|Overall Study|disease progression|105
5699744|NCT00256698|19648253|P1|Overall Study|disease progression|97
5699745|NCT00256698|19648252|P2|Overall Study|Lost to Follow-up|3
5699746|NCT00256698|19648253|P1|Overall Study|Lost to Follow-up|1
5699747|NCT00256698|19648252|P2|Overall Study|Protocol Violation|5
5699748|NCT00256698|19648253|P1|Overall Study|Protocol Violation|6
5699749|NCT00256698|19648252|P2|Overall Study|Adverse Event|6
5699750|NCT00256698|19648253|P1|Overall Study|Adverse Event|13
5699751|NCT00256698|19648252|P2|Overall Study|Withdrawal by Subject|7
5699752|NCT00256698|19648253|P1|Overall Study|Withdrawal by Subject|7
5699753|NCT00256308|19648300|P1|Overall Study|Death|2
5699754|NCT00256295|19648308|P1|Overall Study|Death|1
5699755|NCT00256295|19648308|P1|Overall Study|Withdrawal by Subject|3
5699756|NCT00256282|19648314|P1|Overall Study|Physician Decision|1
5699757|NCT00256282|19648314|P1|Overall Study|Adverse Event|3
5699758|NCT00256282|19648314|P1|Overall Study|Disease progression, relapse during acti|12
5699759|NCT00256243|19648319|P1|Overall Study|Not treated|1
5699760|NCT00256243|19648319|P1|Overall Study|Death|7
5699761|NCT00256243|19648319|P1|Overall Study|Lost to Follow-up|2
5699762|NCT00256204|19648328|P4|Overall Study|Need for additional prohibited treatment|25
5699763|NCT00256204|19648329|P3|Overall Study|Need for additional prohibited treatment|27
5699764|NCT00256204|19648330|P2|Overall Study|Need for additional prohibited treatment|28
5699765|NCT00256204|19648331|P1|Overall Study|Need for additional prohibited treatment|38
5699766|NCT00256204|19648328|P4|Overall Study|Withdrawal by Subject|5
5699767|NCT00256204|19648329|P3|Overall Study|Withdrawal by Subject|7
5699768|NCT00256204|19648330|P2|Overall Study|Withdrawal by Subject|6
5699769|NCT00256204|19648331|P1|Overall Study|Withdrawal by Subject|17
5699770|NCT00256204|19648328|P4|Overall Study|Physician Decision|2
5699771|NCT00256204|19648329|P3|Overall Study|Physician Decision|1
5699772|NCT00256204|19648330|P2|Overall Study|Physician Decision|0
5699773|NCT00256204|19648331|P1|Overall Study|Physician Decision|0
5699774|NCT00256204|19648328|P4|Overall Study|Protocol Violation|1
5699775|NCT00256204|19648329|P3|Overall Study|Protocol Violation|2
5699776|NCT00256204|19648330|P2|Overall Study|Protocol Violation|0
5699777|NCT00256204|19648331|P1|Overall Study|Protocol Violation|1
5699778|NCT00256204|19648328|P4|Overall Study|Lost to Follow-up|2
5699779|NCT00256204|19648329|P3|Overall Study|Lost to Follow-up|1
5699780|NCT00256204|19648330|P2|Overall Study|Lost to Follow-up|1
5699781|NCT00256204|19648331|P1|Overall Study|Lost to Follow-up|1
5699782|NCT00256204|19648328|P4|Overall Study|Death|0
5699783|NCT00256204|19648329|P3|Overall Study|Death|0
5699784|NCT00256204|19648330|P2|Overall Study|Death|1
5699785|NCT00256204|19648331|P1|Overall Study|Death|0
5699786|NCT00256204|19648328|P4|Overall Study|Adverse Event|14
5699787|NCT00256204|19648329|P3|Overall Study|Adverse Event|16
5699788|NCT00256204|19648330|P2|Overall Study|Adverse Event|14
5699789|NCT00256204|19648331|P1|Overall Study|Adverse Event|10
5699790|NCT00256126|19648346|P2|Overall Study|Other|2
5699791|NCT00256126|19648347|P1|Overall Study|Other|1
5699792|NCT00256126|19648346|P2|Overall Study|Adverse Event|0
5699793|NCT00256126|19648347|P1|Overall Study|Adverse Event|1
5699794|NCT00255944|19648386|P2|Overall Study|Lost to Follow-up|834
5699795|NCT00255944|19648387|P1|Overall Study|Lost to Follow-up|797
5699796|NCT00255840|19648395|P2|Overall Study|Discontinued intervention|56
5699797|NCT00255840|19648396|P1|Overall Study|Discontinued intervention|53
5699798|NCT00255840|19648395|P2|Overall Study|Lost to Follow-up|14
5699799|NCT00255840|19648396|P1|Overall Study|Lost to Follow-up|10
5699800|NCT00255723|19648409|P2|Overall Study|Response Data Not Available|0
5699801|NCT00255723|19648410|P1|Overall Study|Response Data Not Available|1
5699802|NCT00255723|19648409|P2|Overall Study|Death|1
5699803|NCT00255723|19648410|P1|Overall Study|Death|0
5699804|NCT00255723|19648409|P2|Overall Study|Adverse Event|1
5699805|NCT00255723|19648410|P1|Overall Study|Adverse Event|1
5699806|NCT00255346|19648426|P5|Overall Study|Adverse Event|0
5699807|NCT00255346|19648427|P4|Overall Study|Adverse Event|0
5699808|NCT00255346|19648428|P3|Overall Study|Adverse Event|0
5699809|NCT00255346|19648429|P2|Overall Study|Adverse Event|0
5699810|NCT00255346|19648430|P1|Overall Study|Adverse Event|1
5699811|NCT00255190|19648445|P2|Overall Study|Various|23
5699812|NCT00255190|19648446|P1|Overall Study|Various|4
5699813|NCT00255190|19648445|P2|Overall Study|Erosive esophagitis not healed|20
5699814|NCT00255190|19648446|P1|Overall Study|Erosive esophagitis not healed|0
5699815|NCT00255190|19648445|P2|Overall Study|Inclusion/Exclusion criteria not met|1
5699816|NCT00255190|19648446|P1|Overall Study|Inclusion/Exclusion criteria not met|0
5699817|NCT00255190|19648445|P2|Overall Study|Withdrew Consent|48
5699818|NCT00255190|19648446|P1|Overall Study|Withdrew Consent|17
5699819|NCT00255190|19648445|P2|Overall Study|Lost to Follow-up|27
5699820|NCT00255190|19648446|P1|Overall Study|Lost to Follow-up|10
5699821|NCT00255190|19648445|P2|Overall Study|Protocol Violation|2
5699822|NCT00255190|19648446|P1|Overall Study|Protocol Violation|2
5699823|NCT00255190|19648445|P2|Overall Study|Adverse Event|36
5699824|NCT00255190|19648446|P1|Overall Study|Adverse Event|17
5699825|NCT00255164|19648530|P3|Overall Study|Therapeutic Failure|3
5699826|NCT00255164|19648531|P2|Overall Study|Therapeutic Failure|2
5699827|NCT00255164|19648532|P1|Overall Study|Therapeutic Failure|11
5699828|NCT00255164|19648530|P3|Overall Study|Esophageal Stricture|1
5699829|NCT00255164|19648531|P2|Overall Study|Esophageal Stricture|0
5699830|NCT00255164|19648532|P1|Overall Study|Esophageal Stricture|0
5699831|NCT00255164|19648530|P3|Overall Study|Possible Barrett's Esophagus|8
5699832|NCT00255164|19648531|P2|Overall Study|Possible Barrett's Esophagus|3
5699833|NCT00255164|19648532|P1|Overall Study|Possible Barrett's Esophagus|1
5699834|NCT00255164|19648530|P3|Overall Study|Relapse of Erosive Esophagitis|12
5699835|NCT00255164|19648531|P2|Overall Study|Relapse of Erosive Esophagitis|16
5699836|NCT00255164|19648532|P1|Overall Study|Relapse of Erosive Esophagitis|78
5699837|NCT00255164|19648530|P3|Overall Study|Subject Request/Subject Unavailable|2
5699838|NCT00255164|19648531|P2|Overall Study|Subject Request/Subject Unavailable|1
5699839|NCT00255164|19648532|P1|Overall Study|Subject Request/Subject Unavailable|1
5699840|NCT00255164|19648530|P3|Overall Study|Noncompliance|2
5699841|NCT00255164|19648531|P2|Overall Study|Noncompliance|1
5699842|NCT00255164|19648532|P1|Overall Study|Noncompliance|0
5699843|NCT00255164|19648530|P3|Overall Study|Withdrawal by Subject|8
5699844|NCT00255164|19648531|P2|Overall Study|Withdrawal by Subject|17
5699845|NCT00255164|19648532|P1|Overall Study|Withdrawal by Subject|18
5699846|NCT00255164|19648530|P3|Overall Study|Lost to Follow-up|4
5699847|NCT00255164|19648531|P2|Overall Study|Lost to Follow-up|3
5699848|NCT00255164|19648532|P1|Overall Study|Lost to Follow-up|4
5699849|NCT00255164|19648530|P3|Overall Study|Adverse Event|9
5699850|NCT00255164|19648531|P2|Overall Study|Adverse Event|6
5699851|NCT00255164|19648532|P1|Overall Study|Adverse Event|10
5699852|NCT00255151|19648558|P3|Overall Study|Therapeutic Failure|3
5699853|NCT00255151|19648559|P2|Overall Study|Therapeutic Failure|2
5699854|NCT00255151|19648560|P1|Overall Study|Therapeutic Failure|11
5699855|NCT00255151|19648558|P3|Overall Study|Esophageal Stricture|1
5699856|NCT00255151|19648559|P2|Overall Study|Esophageal Stricture|0
5699857|NCT00255151|19648560|P1|Overall Study|Esophageal Stricture|0
5699858|NCT00255151|19648558|P3|Overall Study|Possible Barrett's Esophagus|8
5699859|NCT00255151|19648559|P2|Overall Study|Possible Barrett's Esophagus|3
5699860|NCT00255151|19648560|P1|Overall Study|Possible Barrett's Esophagus|1
5699861|NCT00255151|19648558|P3|Overall Study|Relapse of Erosive Esophagitis|12
5699862|NCT00255151|19648559|P2|Overall Study|Relapse of Erosive Esophagitis|16
5699863|NCT00255151|19648560|P1|Overall Study|Relapse of Erosive Esophagitis|78
5699864|NCT00255151|19648558|P3|Overall Study|Subject Request/Subject Unavailable|2
5699865|NCT00255151|19648559|P2|Overall Study|Subject Request/Subject Unavailable|1
5699866|NCT00255151|19648560|P1|Overall Study|Subject Request/Subject Unavailable|1
5699867|NCT00255151|19648558|P3|Overall Study|Noncompliance|2
5699868|NCT00255151|19648559|P2|Overall Study|Noncompliance|1
5699869|NCT00255151|19648560|P1|Overall Study|Noncompliance|0
5699870|NCT00255151|19648558|P3|Overall Study|Withdrawal by Subject|8
5699871|NCT00255151|19648559|P2|Overall Study|Withdrawal by Subject|17
5699872|NCT00255151|19648560|P1|Overall Study|Withdrawal by Subject|18
5699873|NCT00255151|19648558|P3|Overall Study|Lost to Follow-up|4
5699874|NCT00255151|19648559|P2|Overall Study|Lost to Follow-up|3
5699875|NCT00255151|19648560|P1|Overall Study|Lost to Follow-up|4
5699876|NCT00255151|19648558|P3|Overall Study|Adverse Event|9
5699877|NCT00255151|19648559|P2|Overall Study|Adverse Event|6
5699878|NCT00255151|19648560|P1|Overall Study|Adverse Event|10
5699879|NCT00255086|19648598|P2|Overall Study|Protocol Violation|1
5699880|NCT00255086|19648599|P1|Overall Study|Protocol Violation|1
5699881|NCT00255086|19648598|P2|Overall Study|Adverse Event|1
5699882|NCT00255086|19648599|P1|Overall Study|Adverse Event|1
5699883|NCT00255047|19648611|P4|Overall Study|Withdrawal by Subject|18
5699884|NCT00255047|19648612|P3|Overall Study|Withdrawal by Subject|25
5699885|NCT00255047|19648613|P2|Overall Study|Withdrawal by Subject|23
5699886|NCT00255047|19648614|P1|Overall Study|Withdrawal by Subject|24
5699887|NCT00255047|19648611|P4|Overall Study|Lost to Follow-up|6
5699888|NCT00255047|19648612|P3|Overall Study|Lost to Follow-up|5
5699889|NCT00255047|19648613|P2|Overall Study|Lost to Follow-up|8
5699890|NCT00255047|19648614|P1|Overall Study|Lost to Follow-up|9
5699891|NCT00255047|19648611|P4|Overall Study|Protocol Violation|20
5699892|NCT00255047|19648612|P3|Overall Study|Protocol Violation|16
5699893|NCT00255047|19648613|P2|Overall Study|Protocol Violation|13
5699894|NCT00255047|19648614|P1|Overall Study|Protocol Violation|13
5699895|NCT00255047|19648611|P4|Overall Study|Adverse Event|1
5699896|NCT00255047|19648612|P3|Overall Study|Adverse Event|2
5699897|NCT00255047|19648613|P2|Overall Study|Adverse Event|3
5699898|NCT00255047|19648614|P1|Overall Study|Adverse Event|0
5699899|NCT00255047|19648611|P4|Overall Study|Serious Adverse Events|1
5699900|NCT00255047|19648612|P3|Overall Study|Serious Adverse Events|2
5699901|NCT00255047|19648613|P2|Overall Study|Serious Adverse Events|1
5699902|NCT00255047|19648614|P1|Overall Study|Serious Adverse Events|2
5699903|NCT00255034|19648638|P2|Overall Study|Withdrawal by Subject|38
5699904|NCT00255034|19648639|P1|Overall Study|Withdrawal by Subject|15
5699905|NCT00255008|19648649|P4|Overall Study|Other|2
5699906|NCT00255008|19648650|P3|Overall Study|Other|3
5699907|NCT00255008|19648651|P2|Overall Study|Other|0
5699908|NCT00255008|19648652|P1|Overall Study|Other|7
5699909|NCT00255008|19648649|P4|Overall Study|Adverse lab experience|0
5699910|NCT00255008|19648650|P3|Overall Study|Adverse lab experience|0
5699911|NCT00255008|19648651|P2|Overall Study|Adverse lab experience|0
5699912|NCT00255008|19648652|P1|Overall Study|Adverse lab experience|1
5699913|NCT00255008|19648649|P4|Overall Study|Sponsor request|17
5699914|NCT00255008|19648650|P3|Overall Study|Sponsor request|8
5699915|NCT00255008|19648651|P2|Overall Study|Sponsor request|3
5699916|NCT00255008|19648652|P1|Overall Study|Sponsor request|18
5699917|NCT00255008|19648649|P4|Overall Study|Withdrew consent|0
5699918|NCT00255008|19648650|P3|Overall Study|Withdrew consent|2
5699919|NCT00255008|19648651|P2|Overall Study|Withdrew consent|0
5699920|NCT00255008|19648652|P1|Overall Study|Withdrew consent|0
5699921|NCT00255008|19648649|P4|Overall Study|Did not meet viral reduction criteria|1
5699922|NCT00255008|19648650|P3|Overall Study|Did not meet viral reduction criteria|0
5699923|NCT00255008|19648651|P2|Overall Study|Did not meet viral reduction criteria|5
5699924|NCT00255008|19648652|P1|Overall Study|Did not meet viral reduction criteria|4
5699925|NCT00255008|19648649|P4|Overall Study|Lost to Follow-up|2
5699926|NCT00255008|19648650|P3|Overall Study|Lost to Follow-up|1
5699927|NCT00255008|19648651|P2|Overall Study|Lost to Follow-up|0
5699928|NCT00255008|19648652|P1|Overall Study|Lost to Follow-up|1
5699929|NCT00255008|19648649|P4|Overall Study|Adverse Event|0
5699930|NCT00255008|19648650|P3|Overall Study|Adverse Event|2
5699931|NCT00255008|19648651|P2|Overall Study|Adverse Event|1
5699932|NCT00255008|19648652|P1|Overall Study|Adverse Event|1
5699933|NCT00254982|19648688|P2|Overall Study|Abnormal liver function tests|1
5699934|NCT00254982|19648689|P1|Overall Study|Abnormal liver function tests|2
5699935|NCT00254982|19648688|P2|Overall Study|Opportunistic infection|0
5699936|NCT00254982|19648689|P1|Overall Study|Opportunistic infection|1
5699937|NCT00254982|19648688|P2|Overall Study|Malignancy|2
5699938|NCT00254982|19648689|P1|Overall Study|Malignancy|0
5699939|NCT00254982|19648688|P2|Overall Study|Diagnosis of Tuberculosis|1
5699940|NCT00254982|19648689|P1|Overall Study|Diagnosis of Tuberculosis|1
5699941|NCT00254982|19648688|P2|Overall Study|Protocol deviation|1
5699942|NCT00254982|19648689|P1|Overall Study|Protocol deviation|1
5699943|NCT00254982|19648688|P2|Overall Study|Inclusion/exclusion criteria violation|2
5699944|NCT00254982|19648689|P1|Overall Study|Inclusion/exclusion criteria violation|0
5699945|NCT00254982|19648688|P2|Overall Study|Withdrawal by Subject|1
5699946|NCT00254982|19648689|P1|Overall Study|Withdrawal by Subject|1
5699947|NCT00254982|19648688|P2|Overall Study|Adverse Event|16
5699948|NCT00254982|19648689|P1|Overall Study|Adverse Event|18
5699949|NCT00254982|19648688|P2|Overall Study|Lost to Follow-up|3
5699950|NCT00254982|19648689|P1|Overall Study|Lost to Follow-up|5
5699951|NCT00254982|19648688|P2|Overall Study|Lack of Efficacy|3
5699952|NCT00254982|19648689|P1|Overall Study|Lack of Efficacy|5
5699953|NCT00254982|19648688|P2|Overall Study|Other|1
5699954|NCT00254982|19648689|P1|Overall Study|Other|2
5699955|NCT00254566|19648701|P2|Overall Study|Lost to Follow-up|2
5699956|NCT00254566|19648702|P1|Overall Study|Lost to Follow-up|7
5699957|NCT00254566|19648701|P2|Overall Study|Withdrawal by Subject|6
5699958|NCT00254566|19648702|P1|Overall Study|Withdrawal by Subject|5
5699959|NCT00254566|19648701|P2|Overall Study|Other|5
5699960|NCT00254566|19648702|P1|Overall Study|Other|1
5699961|NCT00254566|19648701|P2|Overall Study|Lack of Efficacy|9
5699962|NCT00254566|19648702|P1|Overall Study|Lack of Efficacy|12
5699963|NCT00254566|19648701|P2|Overall Study|Adverse Event|4
5699964|NCT00254566|19648702|P1|Overall Study|Adverse Event|5
5699965|NCT00254566|19648701|P2|Overall Study|Death|0
5699966|NCT00254566|19648702|P1|Overall Study|Death|1
5699967|NCT00254540|19648726|P2|Overall Study|Laboratory Test Abnormality|1
5699968|NCT00254540|19648727|P1|Overall Study|Laboratory Test Abnormality|0
5699969|NCT00254540|19648726|P2|Overall Study|Death|1
5699970|NCT00254540|19648727|P1|Overall Study|Death|0
5699971|NCT00254540|19648726|P2|Overall Study|Lack of Efficacy|13
5699972|NCT00254540|19648727|P1|Overall Study|Lack of Efficacy|13
5699973|NCT00254540|19648726|P2|Overall Study|Adverse Event|7
5699974|NCT00254540|19648727|P1|Overall Study|Adverse Event|6
5699975|NCT00254501|19648756|P2|Overall Study|Lost to Follow-up|1
5699976|NCT00254501|19648757|P1|Overall Study|Lost to Follow-up|1
5699977|NCT00254397|19648802|P4|Overall Study|Adverse Event|1
5699978|NCT00254397|19648803|P3|Overall Study|Adverse Event|3
5699979|NCT00254397|19648804|P2|Overall Study|Adverse Event|0
5699980|NCT00254397|19648805|P1|Overall Study|Adverse Event|2
5699981|NCT00254397|19648802|P4|Overall Study|Non-Compliant|1
5699982|NCT00254397|19648803|P3|Overall Study|Non-Compliant|0
5699983|NCT00254397|19648804|P2|Overall Study|Non-Compliant|0
5699984|NCT00254397|19648805|P1|Overall Study|Non-Compliant|0
5699985|NCT00254397|19648802|P4|Overall Study|Disease Progression|23
5699986|NCT00254397|19648803|P3|Overall Study|Disease Progression|16
5699987|NCT00254397|19648804|P2|Overall Study|Disease Progression|1
5699988|NCT00254397|19648805|P1|Overall Study|Disease Progression|4
5699989|NCT00254293|19648829|P7|LTE Open Label Fixed Dosing|Other|1
5699990|NCT00254293|19648830|P6|LTE Open Label Fixed Dosing|Other|0
5699991|NCT00254293|19648831|P5|LTE Open Label Fixed Dosing|Other|0
5699992|NCT00254293|19648832|P4|LTE Open Label Fixed Dosing|Other|0
5699993|NCT00254293|19648833|P3|LTE Open Label Fixed Dosing|Other|0
5699994|NCT00254293|19648834|P2|LTE Open Label Fixed Dosing|Other|0
5699995|NCT00254293|19648835|P1|LTE Open Label Fixed Dosing|Other|0
5699996|NCT00254293|19648829|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
5699997|NCT00254293|19648830|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5699998|NCT00254293|19648831|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5699999|NCT00254293|19648832|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5700000|NCT00254293|19648833|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5700001|NCT00254293|19648834|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5700002|NCT00254293|19648835|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
5700003|NCT00254293|19648829|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
5700004|NCT00254293|19648830|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5700005|NCT00254293|19648831|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5700006|NCT00254293|19648832|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5700007|NCT00254293|19648833|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5700008|NCT00254293|19648834|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5700009|NCT00254293|19648835|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
5700010|NCT00254293|19648829|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
5700011|NCT00254293|19648830|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5700012|NCT00254293|19648831|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5700013|NCT00254293|19648832|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5700014|NCT00254293|19648833|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5700015|NCT00254293|19648834|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5700016|NCT00254293|19648835|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
5700017|NCT00254293|19648829|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
5700018|NCT00254293|19648830|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5700019|NCT00254293|19648831|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5700020|NCT00254293|19648832|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5700021|NCT00254293|19648833|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5700022|NCT00254293|19648834|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5700023|NCT00254293|19648835|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
5700024|NCT00254293|19648829|P7|LTE Open Label Fixed Dosing|Adverse Event|1
5700025|NCT00254293|19648830|P6|LTE Open Label Fixed Dosing|Adverse Event|0
5700026|NCT00254293|19648831|P5|LTE Open Label Fixed Dosing|Adverse Event|0
5700027|NCT00254293|19648832|P4|LTE Open Label Fixed Dosing|Adverse Event|0
5700028|NCT00254293|19648833|P3|LTE Open Label Fixed Dosing|Adverse Event|0
5700029|NCT00254293|19648834|P2|LTE Open Label Fixed Dosing|Adverse Event|0
5700030|NCT00254293|19648835|P1|LTE Open Label Fixed Dosing|Adverse Event|0
5700031|NCT00254293|19648829|P7|LTE Open Label Fixed Dosing|Death|3
5700032|NCT00254293|19648830|P6|LTE Open Label Fixed Dosing|Death|0
5700033|NCT00254293|19648831|P5|LTE Open Label Fixed Dosing|Death|0
5700034|NCT00254293|19648832|P4|LTE Open Label Fixed Dosing|Death|0
5700035|NCT00254293|19648833|P3|LTE Open Label Fixed Dosing|Death|0
5700036|NCT00254293|19648834|P2|LTE Open Label Fixed Dosing|Death|0
5700037|NCT00254293|19648835|P1|LTE Open Label Fixed Dosing|Death|0
5700038|NCT00254293|19648829|P7|LTE Open Label Variable SC Dosing|Other|0
5700039|NCT00254293|19648830|P6|LTE Open Label Variable SC Dosing|Other|0
5700040|NCT00254293|19648831|P5|LTE Open Label Variable SC Dosing|Other|0
5700041|NCT00254293|19648832|P4|LTE Open Label Variable SC Dosing|Other|0
5700042|NCT00254293|19648833|P3|LTE Open Label Variable SC Dosing|Other|2
5700043|NCT00254293|19648834|P2|LTE Open Label Variable SC Dosing|Other|0
5700044|NCT00254293|19648835|P1|LTE Open Label Variable SC Dosing|Other|0
5700045|NCT00254293|19648829|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5700046|NCT00254293|19648830|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5700047|NCT00254293|19648831|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5700048|NCT00254293|19648832|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5700049|NCT00254293|19648833|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
5700050|NCT00254293|19648834|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5700051|NCT00254293|19648835|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
5700052|NCT00254293|19648829|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5700053|NCT00254293|19648830|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5700054|NCT00254293|19648831|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5700055|NCT00254293|19648832|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5700056|NCT00254293|19648833|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
5700057|NCT00254293|19648834|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5700058|NCT00254293|19648835|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
5700059|NCT00254293|19648829|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5700060|NCT00254293|19648830|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5700061|NCT00254293|19648831|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5700062|NCT00254293|19648832|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5700063|NCT00254293|19648833|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
5700064|NCT00254293|19648834|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5700065|NCT00254293|19648835|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
5700066|NCT00254293|19648829|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
5700067|NCT00254293|19648830|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
5700068|NCT00254293|19648831|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
5700069|NCT00254293|19648832|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
5700070|NCT00254293|19648833|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
5700071|NCT00254293|19648834|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
5700072|NCT00254293|19648835|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
5700073|NCT00254293|19648829|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
5700074|NCT00254293|19648830|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
5700075|NCT00254293|19648831|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
5700076|NCT00254293|19648832|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
5700077|NCT00254293|19648833|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
5700078|NCT00254293|19648834|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
5700079|NCT00254293|19648835|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
5700080|NCT00254293|19648829|P7|LTE Open Label Variable SC Dosing|Death|0
5700081|NCT00254293|19648830|P6|LTE Open Label Variable SC Dosing|Death|0
5700082|NCT00254293|19648831|P5|LTE Open Label Variable SC Dosing|Death|0
5700083|NCT00254293|19648832|P4|LTE Open Label Variable SC Dosing|Death|0
5700084|NCT00254293|19648833|P3|LTE Open Label Variable SC Dosing|Death|1
5700085|NCT00254293|19648834|P2|LTE Open Label Variable SC Dosing|Death|0
5700086|NCT00254293|19648835|P1|LTE Open Label Variable SC Dosing|Death|0
5700087|NCT00254293|19648829|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5700088|NCT00254293|19648830|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5700089|NCT00254293|19648831|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5700090|NCT00254293|19648832|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5700091|NCT00254293|19648833|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
5700092|NCT00254293|19648834|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5700093|NCT00254293|19648835|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
5700094|NCT00254293|19648829|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5700095|NCT00254293|19648830|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5700096|NCT00254293|19648831|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5700097|NCT00254293|19648832|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5700098|NCT00254293|19648833|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
5700099|NCT00254293|19648834|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5700100|NCT00254293|19648835|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
5700101|NCT00254293|19648829|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5700102|NCT00254293|19648830|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5700103|NCT00254293|19648831|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5700104|NCT00254293|19648832|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
5700105|NCT00254293|19648833|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5700106|NCT00254293|19648834|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
5700107|NCT00254293|19648835|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
5700108|NCT00254163|19648918|P2|Overall Study|Other|8
5700109|NCT00254163|19648919|P1|Overall Study|Other|8
5700110|NCT00254163|19648918|P2|Overall Study|Death|1
5700111|NCT00254163|19648919|P1|Overall Study|Death|0
5700112|NCT00254163|19648918|P2|Overall Study|Progressive disease|1
5700113|NCT00254163|19648919|P1|Overall Study|Progressive disease|0
5700114|NCT00254163|19648918|P2|Overall Study|Failed entry|3
5700115|NCT00254163|19648919|P1|Overall Study|Failed entry|1
5700116|NCT00254163|19648918|P2|Overall Study|Investigator request|3
5700117|NCT00254163|19648919|P1|Overall Study|Investigator request|1
5700118|NCT00254163|19648918|P2|Overall Study|Patient request/withdrew consent|4
5700119|NCT00254163|19648919|P1|Overall Study|Patient request/withdrew consent|6
5700120|NCT00254163|19648918|P2|Overall Study|Adverse Event|26
5700121|NCT00254163|19648919|P1|Overall Study|Adverse Event|29
5700122|NCT00253747|19648970|P2|Overall Study|Administrative Discharge (1), Other (2)|2
5700123|NCT00253747|19648971|P1|Overall Study|Administrative Discharge (1), Other (2)|1
5700124|NCT00253747|19648970|P2|Overall Study|Withdrawal by Subject|11
5700125|NCT00253747|19648971|P1|Overall Study|Withdrawal by Subject|10
5700126|NCT00253747|19648970|P2|Overall Study|Lost to Follow-up|14
5700127|NCT00253747|19648971|P1|Overall Study|Lost to Follow-up|13
5700128|NCT00253643|19649024|P4|Overall Study|Non-Compliance|2
5700129|NCT00253643|19649025|P3|Overall Study|Non-Compliance|0
5700130|NCT00253643|19649026|P2|Overall Study|Non-Compliance|0
5700131|NCT00253643|19649027|P1|Overall Study|Non-Compliance|0
5700132|NCT00253643|19649024|P4|Overall Study|Withdrawal by Subject|1
5700133|NCT00253643|19649025|P3|Overall Study|Withdrawal by Subject|1
5700134|NCT00253643|19649026|P2|Overall Study|Withdrawal by Subject|0
5700135|NCT00253643|19649027|P1|Overall Study|Withdrawal by Subject|0
5700136|NCT00253630|19649041|P1|Overall Study|ineligible|2
5700137|NCT00253448|19649057|P1|Overall Study|Withdrawal by Subject|1
5700138|NCT00253370|19649076|P1|Overall Study|Abdominal pain due to disease|1
5700139|NCT00253370|19649076|P1|Overall Study|Protocol Violation|1
5700140|NCT00253370|19649076|P1|Overall Study|Physician Decision|1
5700141|NCT00253370|19649076|P1|Overall Study|Non-protocol therapy|1
5700142|NCT00253370|19649076|P1|Overall Study|Withdrawal by Subject|6
5700143|NCT00253370|19649076|P1|Overall Study|Death|2
5700144|NCT00253370|19649076|P1|Overall Study|Disease progression|13
5700145|NCT00253370|19649076|P1|Overall Study|Adverse Event|18
5700146|NCT00252733|19649122|P2|Overall Study|Multiple Reasons|14
5700147|NCT00252733|19649123|P1|Overall Study|Multiple Reasons|14
5700148|NCT00252733|19649122|P2|Overall Study|Lost to Follow-up|6
5700149|NCT00252733|19649123|P1|Overall Study|Lost to Follow-up|12
5700150|NCT00252733|19649122|P2|Overall Study|Death|5
5700151|NCT00252733|19649123|P1|Overall Study|Death|7
5700152|NCT00252733|19649122|P2|Overall Study|Withdrawal by Subject|67
5700153|NCT00252733|19649123|P1|Overall Study|Withdrawal by Subject|73
5700154|NCT00252720|19649133|P2|Overall Study|Mainly patients lost to follow-up|18
5700155|NCT00252720|19649134|P1|Overall Study|Mainly patients lost to follow-up|7
5700156|NCT00252720|19649133|P2|Overall Study|Moving|42
5700157|NCT00252720|19649134|P1|Overall Study|Moving|23
5700158|NCT00252720|19649133|P2|Overall Study|Death|8
5700159|NCT00252720|19649134|P1|Overall Study|Death|7
5700160|NCT00252720|19649133|P2|Overall Study|Withdrawal by Subject|97
5700161|NCT00252720|19649134|P1|Overall Study|Withdrawal by Subject|95
5700162|NCT00252694|19649148|P2|Overall Study|Patient Moving|16
5700163|NCT00252694|19649149|P1|Overall Study|Patient Moving|17
5700164|NCT00252694|19649148|P2|Overall Study|Mostly Lost to Follow Up|13
5700165|NCT00252694|19649149|P1|Overall Study|Mostly Lost to Follow Up|8
5700166|NCT00252694|19649148|P2|Overall Study|Death|34
5700167|NCT00252694|19649149|P1|Overall Study|Death|36
5700168|NCT00252694|19649148|P2|Overall Study|Withdrawal by Subject|91
5700169|NCT00252694|19649149|P1|Overall Study|Withdrawal by Subject|83
5700170|NCT00252577|19649195|P1|Overall Study|Lost to Follow-up|20
5700171|NCT00252564|19649201|P2|Overall Study|Withdrawal by Subject|2
5700172|NCT00252564|19649202|P1|Overall Study|Withdrawal by Subject|0
5700173|NCT00252564|19649201|P2|Overall Study|Patient Request|5
5700174|NCT00252564|19649202|P1|Overall Study|Patient Request|4
5700175|NCT00252564|19649201|P2|Overall Study|Lost to Follow-up|0
5700176|NCT00252564|19649202|P1|Overall Study|Lost to Follow-up|1
5700177|NCT00252564|19649201|P2|Overall Study|Physician Decision|0
5700178|NCT00252564|19649202|P1|Overall Study|Physician Decision|1
5700179|NCT00252564|19649201|P2|Overall Study|Death|3
5700180|NCT00252564|19649202|P1|Overall Study|Death|0
5700181|NCT00252564|19649201|P2|Overall Study|Disease Progression|20
5700182|NCT00252564|19649202|P1|Overall Study|Disease Progression|14
5700183|NCT00252564|19649201|P2|Overall Study|Unrelated Complication|1
5700184|NCT00252564|19649202|P1|Overall Study|Unrelated Complication|2
5700185|NCT00252564|19649201|P2|Overall Study|Adverse Event|13
5700186|NCT00252564|19649202|P1|Overall Study|Adverse Event|17
5700187|NCT00252499|19649242|P3|Overall Study|Lost to Follow-up|0
5700188|NCT00252499|19649243|P2|Overall Study|Lost to Follow-up|0
5700189|NCT00252499|19649244|P1|Overall Study|Lost to Follow-up|1
5700190|NCT00252239|19649276|P4|Overall Study|Lost to Follow-up|0
5700191|NCT00252239|19649277|P3|Overall Study|Lost to Follow-up|2
5700192|NCT00252239|19649278|P2|Overall Study|Lost to Follow-up|0
5700193|NCT00252239|19649279|P1|Overall Study|Lost to Follow-up|0
5700194|NCT00252239|19649276|P4|Overall Study|Withdrawal by Subject|1
5700195|NCT00252239|19649277|P3|Overall Study|Withdrawal by Subject|0
5700196|NCT00252239|19649278|P2|Overall Study|Withdrawal by Subject|0
5700197|NCT00252239|19649279|P1|Overall Study|Withdrawal by Subject|1
5700198|NCT00252187|19649291|P2|Overall Study|Withdrawal by Subject|0
5700199|NCT00252187|19649292|P1|Overall Study|Withdrawal by Subject|1
5700200|NCT00252187|19649291|P2|Overall Study|Adverse Event|1
5700201|NCT00252187|19649292|P1|Overall Study|Adverse Event|3
5700202|NCT00252174|19649315|P3|Overall Study|Withdrawal by Subject|0
5700203|NCT00252174|19649316|P2|Overall Study|Withdrawal by Subject|1
5700204|NCT00252174|19649317|P1|Overall Study|Withdrawal by Subject|0
5700205|NCT00252057|19649357|P2|Overall Study|Participant previously enrolled|1
5700206|NCT00252057|19649358|P1|Overall Study|Participant previously enrolled|0
5700207|NCT00252057|19649357|P2|Overall Study|Death|2
5700208|NCT00252057|19649358|P1|Overall Study|Death|1
5700209|NCT00252057|19649357|P2|Overall Study|Withdrawal by Subject|5
5700210|NCT00252057|19649358|P1|Overall Study|Withdrawal by Subject|2
5700211|NCT00251979|19649366|P2|Overall Study|Death|5
5700212|NCT00251979|19649367|P1|Overall Study|Death|3
5700213|NCT00251979|19649366|P2|Overall Study|Lost to Follow-up|6
5700214|NCT00251979|19649367|P1|Overall Study|Lost to Follow-up|8
5700215|NCT00251979|19649366|P2|Overall Study|Withdrawal by Subject|7
5700216|NCT00251979|19649367|P1|Overall Study|Withdrawal by Subject|13
5700217|NCT00251979|19649366|P2|Overall Study|Adverse Event|17
5700218|NCT00251979|19649367|P1|Overall Study|Adverse Event|11
5700219|NCT00251979|19649366|P2|Overall Study|Protocol Violation|5
5700220|NCT00251979|19649367|P1|Overall Study|Protocol Violation|3
5700221|NCT00251927|19649399|P2|Overall Study|Study procedure non-compliance|6
5700222|NCT00251927|19649400|P1|Overall Study|Study procedure non-compliance|5
5700223|NCT00251927|19649399|P2|Overall Study|Study-specific discont. achieved|2
5700224|NCT00251927|19649400|P1|Overall Study|Study-specific discont. achieved|13
5700225|NCT00251927|19649399|P2|Overall Study|Withdrawal by Subject|25
5700226|NCT00251927|19649400|P1|Overall Study|Withdrawal by Subject|40
5700227|NCT00251927|19649399|P2|Overall Study|Pregnancy|0
5700228|NCT00251927|19649400|P1|Overall Study|Pregnancy|2
5700229|NCT00251927|19649399|P2|Overall Study|Protocol Violation|2
5700230|NCT00251927|19649400|P1|Overall Study|Protocol Violation|1
5700231|NCT00251927|19649399|P2|Overall Study|Lost to Follow-up|8
5700232|NCT00251927|19649400|P1|Overall Study|Lost to Follow-up|22
5700233|NCT00251927|19649399|P2|Overall Study|Lack of Efficacy|16
5700234|NCT00251927|19649400|P1|Overall Study|Lack of Efficacy|22
5700235|NCT00251927|19649399|P2|Overall Study|Adverse Event|15
5700236|NCT00251927|19649400|P1|Overall Study|Adverse Event|3
5700237|NCT00251758|19649452|P3|Overall Study|Per Investigator Request|0
5700238|NCT00251758|19649453|P2|Overall Study|Per Investigator Request|0
5700239|NCT00251758|19649454|P1|Overall Study|Per Investigator Request|1
5700240|NCT00251758|19649452|P3|Overall Study|Per Subject Request|1
5700241|NCT00251758|19649453|P2|Overall Study|Per Subject Request|0
5700242|NCT00251758|19649454|P1|Overall Study|Per Subject Request|0
5700243|NCT00251758|19649452|P3|Overall Study|Pregnancy|0
5700244|NCT00251758|19649453|P2|Overall Study|Pregnancy|1
5700245|NCT00251758|19649454|P1|Overall Study|Pregnancy|0
5700246|NCT00251758|19649452|P3|Overall Study|Noncompliant|2
5700247|NCT00251758|19649453|P2|Overall Study|Noncompliant|2
5700248|NCT00251758|19649454|P1|Overall Study|Noncompliant|0
5700249|NCT00251758|19649452|P3|Overall Study|Lack of Efficacy|0
5700250|NCT00251758|19649453|P2|Overall Study|Lack of Efficacy|0
5700251|NCT00251758|19649454|P1|Overall Study|Lack of Efficacy|3
5700252|NCT00251758|19649452|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
5700253|NCT00251758|19649453|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
5700254|NCT00251758|19649454|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
5700255|NCT00251758|19649452|P3|Overall Study|Withdrawal by Subject|3
5700256|NCT00251758|19649453|P2|Overall Study|Withdrawal by Subject|7
5700257|NCT00251758|19649454|P1|Overall Study|Withdrawal by Subject|13
5700258|NCT00251758|19649452|P3|Overall Study|Lost to Follow-up|5
5700259|NCT00251758|19649453|P2|Overall Study|Lost to Follow-up|2
5700260|NCT00251758|19649454|P1|Overall Study|Lost to Follow-up|4
5700261|NCT00251758|19649452|P3|Overall Study|Adverse Event|11
5700262|NCT00251758|19649453|P2|Overall Study|Adverse Event|9
5700263|NCT00251758|19649454|P1|Overall Study|Adverse Event|7
5700264|NCT00251745|19649474|P3|Overall Study|Per Investigator Request|0
5700265|NCT00251745|19649475|P2|Overall Study|Per Investigator Request|0
5700266|NCT00251745|19649476|P1|Overall Study|Per Investigator Request|1
5700267|NCT00251745|19649474|P3|Overall Study|Per Subject Request|1
5700268|NCT00251745|19649475|P2|Overall Study|Per Subject Request|0
5700269|NCT00251745|19649476|P1|Overall Study|Per Subject Request|0
5700270|NCT00251745|19649474|P3|Overall Study|Pregnancy|0
5700271|NCT00251745|19649475|P2|Overall Study|Pregnancy|1
5700272|NCT00251745|19649476|P1|Overall Study|Pregnancy|0
5700273|NCT00251745|19649474|P3|Overall Study|Noncompliant|2
5700274|NCT00251745|19649475|P2|Overall Study|Noncompliant|2
5700275|NCT00251745|19649476|P1|Overall Study|Noncompliant|0
5700276|NCT00251745|19649474|P3|Overall Study|Lack of Efficacy|0
5700277|NCT00251745|19649475|P2|Overall Study|Lack of Efficacy|0
5700278|NCT00251745|19649476|P1|Overall Study|Lack of Efficacy|3
5700279|NCT00251745|19649474|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
5700280|NCT00251745|19649475|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
5700281|NCT00251745|19649476|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
5700282|NCT00251745|19649474|P3|Overall Study|Withdrawal by Subject|3
5700283|NCT00251745|19649475|P2|Overall Study|Withdrawal by Subject|7
5700284|NCT00251745|19649476|P1|Overall Study|Withdrawal by Subject|13
5700285|NCT00251745|19649474|P3|Overall Study|Lost to Follow-up|5
5700286|NCT00251745|19649475|P2|Overall Study|Lost to Follow-up|2
5700287|NCT00251745|19649476|P1|Overall Study|Lost to Follow-up|4
5700288|NCT00251745|19649474|P3|Overall Study|Adverse Event|11
5700289|NCT00251745|19649475|P2|Overall Study|Adverse Event|9
5700290|NCT00251745|19649476|P1|Overall Study|Adverse Event|7
5700291|NCT00251719|19649496|P3|Overall Study|Barrett's esophagus|0
5700292|NCT00251719|19649497|P2|Overall Study|Barrett's esophagus|2
5700293|NCT00251719|19649498|P1|Overall Study|Barrett's esophagus|2
5700294|NCT00251719|19649496|P3|Overall Study|Noncompliance|1
5700295|NCT00251719|19649497|P2|Overall Study|Noncompliance|3
5700296|NCT00251719|19649498|P1|Overall Study|Noncompliance|2
5700297|NCT00251719|19649496|P3|Overall Study|Investigator decision|0
5700298|NCT00251719|19649497|P2|Overall Study|Investigator decision|1
5700299|NCT00251719|19649498|P1|Overall Study|Investigator decision|1
5700300|NCT00251719|19649496|P3|Overall Study|Inclusion/exclusion criteria not met|2
5700301|NCT00251719|19649497|P2|Overall Study|Inclusion/exclusion criteria not met|6
5700302|NCT00251719|19649498|P1|Overall Study|Inclusion/exclusion criteria not met|12
5700303|NCT00251719|19649496|P3|Overall Study|Lack of Efficacy|0
5700304|NCT00251719|19649497|P2|Overall Study|Lack of Efficacy|1
5700305|NCT00251719|19649498|P1|Overall Study|Lack of Efficacy|2
5700306|NCT00251719|19649496|P3|Overall Study|Withdrawal by Subject|11
5700307|NCT00251719|19649497|P2|Overall Study|Withdrawal by Subject|12
5700308|NCT00251719|19649498|P1|Overall Study|Withdrawal by Subject|14
5700309|NCT00251719|19649496|P3|Overall Study|Lost to Follow-up|8
5700310|NCT00251719|19649497|P2|Overall Study|Lost to Follow-up|11
5700311|NCT00251719|19649498|P1|Overall Study|Lost to Follow-up|5
5700312|NCT00251719|19649496|P3|Overall Study|Protocol Violation|1
5700313|NCT00251719|19649497|P2|Overall Study|Protocol Violation|1
5700314|NCT00251719|19649498|P1|Overall Study|Protocol Violation|1
5700315|NCT00251719|19649496|P3|Overall Study|Adverse Event|7
5700316|NCT00251719|19649497|P2|Overall Study|Adverse Event|8
5700317|NCT00251719|19649498|P1|Overall Study|Adverse Event|14
5700318|NCT00251693|19649524|P3|Overall Study|Abnormal laboratory findings|1
5700319|NCT00251693|19649525|P2|Overall Study|Abnormal laboratory findings|0
5700320|NCT00251693|19649526|P1|Overall Study|Abnormal laboratory findings|0
5700321|NCT00251693|19649524|P3|Overall Study|Subject request/subject unavailable|0
5700322|NCT00251693|19649525|P2|Overall Study|Subject request/subject unavailable|2
5700323|NCT00251693|19649526|P1|Overall Study|Subject request/subject unavailable|1
5700324|NCT00251693|19649524|P3|Overall Study|Possible Barrett's esophagus|2
5700325|NCT00251693|19649525|P2|Overall Study|Possible Barrett's esophagus|5
5700326|NCT00251693|19649526|P1|Overall Study|Possible Barrett's esophagus|3
5700327|NCT00251693|19649524|P3|Overall Study|Noncompliant|2
5700328|NCT00251693|19649525|P2|Overall Study|Noncompliant|0
5700329|NCT00251693|19649526|P1|Overall Study|Noncompliant|0
5700330|NCT00251693|19649524|P3|Overall Study|Inclusion/exclusion criteria not met|8
5700331|NCT00251693|19649525|P2|Overall Study|Inclusion/exclusion criteria not met|3
5700332|NCT00251693|19649526|P1|Overall Study|Inclusion/exclusion criteria not met|5
5700333|NCT00251693|19649524|P3|Overall Study|Lack of Efficacy|0
5700334|NCT00251693|19649525|P2|Overall Study|Lack of Efficacy|1
5700335|NCT00251693|19649526|P1|Overall Study|Lack of Efficacy|0
5700336|NCT00251693|19649524|P3|Overall Study|Withdrawal by Subject|14
5700337|NCT00251693|19649525|P2|Overall Study|Withdrawal by Subject|17
5700338|NCT00251693|19649526|P1|Overall Study|Withdrawal by Subject|11
5700339|NCT00251693|19649524|P3|Overall Study|Lost to Follow-up|8
5700340|NCT00251693|19649525|P2|Overall Study|Lost to Follow-up|7
5700341|NCT00251693|19649526|P1|Overall Study|Lost to Follow-up|12
5700342|NCT00251693|19649524|P3|Overall Study|Protocol Violation|2
5700343|NCT00251693|19649525|P2|Overall Study|Protocol Violation|0
5700344|NCT00251693|19649526|P1|Overall Study|Protocol Violation|2
5700345|NCT00251693|19649524|P3|Overall Study|Adverse Event|9
5700346|NCT00251693|19649525|P2|Overall Study|Adverse Event|9
5700347|NCT00251693|19649526|P1|Overall Study|Adverse Event|17
5700348|NCT00251641|19649551|P2|Overall Study|Switched Treatment|63
5700349|NCT00251641|19649552|P1|Overall Study|Switched Treatment|9
5700350|NCT00251641|19649551|P2|Overall Study|Did not Meet protocol Eligibility|1
5700351|NCT00251641|19649552|P1|Overall Study|Did not Meet protocol Eligibility|2
5700352|NCT00251641|19649551|P2|Overall Study|Protocol Violation|2
5700353|NCT00251641|19649552|P1|Overall Study|Protocol Violation|10
5700354|NCT00251641|19649551|P2|Overall Study|Withdrawal by Subject|8
5700355|NCT00251641|19649552|P1|Overall Study|Withdrawal by Subject|6
5700356|NCT00251641|19649551|P2|Overall Study|Lost to Follow-up|3
5700357|NCT00251641|19649552|P1|Overall Study|Lost to Follow-up|3
5700358|NCT00251641|19649551|P2|Overall Study|Progression of Disease|2
5700359|NCT00251641|19649552|P1|Overall Study|Progression of Disease|0
5700360|NCT00251641|19649551|P2|Overall Study|Lack of Efficacy|1
5700361|NCT00251641|19649552|P1|Overall Study|Lack of Efficacy|2
5700362|NCT00251641|19649551|P2|Overall Study|Adverse Event|8
5700363|NCT00251641|19649552|P1|Overall Study|Adverse Event|80
5700364|NCT00251589|19649570|P4|Overall Study|Discontinued due to progressive disease|1
5700365|NCT00251589|19649571|P3|Overall Study|Discontinued due to progressive disease|0
5700366|NCT00251589|19649572|P2|Overall Study|Discontinued due to progressive disease|1
5700367|NCT00251589|19649573|P1|Overall Study|Discontinued due to progressive disease|9
5700368|NCT00251589|19649570|P4|Overall Study|Withdrawal by Subject|0
5700369|NCT00251589|19649571|P3|Overall Study|Withdrawal by Subject|0
5700370|NCT00251589|19649572|P2|Overall Study|Withdrawal by Subject|1
5700371|NCT00251589|19649573|P1|Overall Study|Withdrawal by Subject|1
5700372|NCT00251589|19649570|P4|Overall Study|Adverse Event|1
5700373|NCT00251589|19649571|P3|Overall Study|Adverse Event|2
5700374|NCT00251589|19649572|P2|Overall Study|Adverse Event|1
5700375|NCT00251589|19649573|P1|Overall Study|Adverse Event|5
5700376|NCT00251316|19649610|P2|Overall Study|Physician Decision|3
5700377|NCT00251316|19649611|P1|Overall Study|Physician Decision|2
5700378|NCT00251004|19649650|P3|Overall Study|Graft Loss|8
5700379|NCT00251004|19649651|P2|Overall Study|Graft Loss|13
5700380|NCT00251004|19649652|P1|Overall Study|Graft Loss|12
5700381|NCT00251004|19649650|P3|Overall Study|Lost to Follow-up|1
5700382|NCT00251004|19649651|P2|Overall Study|Lost to Follow-up|2
5700383|NCT00251004|19649652|P1|Overall Study|Lost to Follow-up|1
5700384|NCT00251004|19649650|P3|Overall Study|Death|8
5700385|NCT00251004|19649651|P2|Overall Study|Death|10
5700386|NCT00251004|19649652|P1|Overall Study|Death|9
5700387|NCT00251004|19649650|P3|Overall Study|Withdrawal by Subject|14
5700388|NCT00251004|19649651|P2|Overall Study|Withdrawal by Subject|16
5700389|NCT00251004|19649652|P1|Overall Study|Withdrawal by Subject|23
5700390|NCT00250835|19649676|P1|Overall Study|Withdrawal by Subject|1
5700391|NCT00250718|19649685|P1|Overall Study|Withdrawal by Subject|1
5700392|NCT00250718|19649685|P1|Overall Study|Adverse Event|1
5700393|NCT00250718|19649685|P1|Overall Study|Death|1
5700394|NCT00250705|19649690|P1|Overall Study|Lack of Efficacy|2
5700395|NCT00250679|19649701|P3|Overall Study|various single events: hip surgery,diary|1
5700396|NCT00250679|19649702|P2|Overall Study|various single events: hip surgery,diary|1
5700397|NCT00250679|19649703|P1|Overall Study|various single events: hip surgery,diary|3
5700398|NCT00250679|19649701|P3|Overall Study|Non-compliance|0
5700399|NCT00250679|19649702|P2|Overall Study|Non-compliance|1
5700400|NCT00250679|19649703|P1|Overall Study|Non-compliance|1
5700401|NCT00250679|19649701|P3|Overall Study|Moved|0
5700402|NCT00250679|19649702|P2|Overall Study|Moved|1
5700403|NCT00250679|19649703|P1|Overall Study|Moved|1
5700404|NCT00250679|19649701|P3|Overall Study|Technical Holter issues|2
5700405|NCT00250679|19649702|P2|Overall Study|Technical Holter issues|0
5700406|NCT00250679|19649703|P1|Overall Study|Technical Holter issues|1
5700407|NCT00250679|19649701|P3|Overall Study|Lack of Efficacy|3
5700408|NCT00250679|19649702|P2|Overall Study|Lack of Efficacy|1
5700409|NCT00250679|19649703|P1|Overall Study|Lack of Efficacy|0
5700410|NCT00250679|19649701|P3|Overall Study|Does Not Meet Entry Criteria|2
5700411|NCT00250679|19649702|P2|Overall Study|Does Not Meet Entry Criteria|4
5700412|NCT00250679|19649703|P1|Overall Study|Does Not Meet Entry Criteria|1
5700413|NCT00250679|19649701|P3|Overall Study|Lost to Follow-up|2
5700414|NCT00250679|19649702|P2|Overall Study|Lost to Follow-up|4
5700415|NCT00250679|19649703|P1|Overall Study|Lost to Follow-up|3
5700416|NCT00250679|19649701|P3|Overall Study|Withdrawal by Subject|15
5700417|NCT00250679|19649702|P2|Overall Study|Withdrawal by Subject|18
5700418|NCT00250679|19649703|P1|Overall Study|Withdrawal by Subject|15
5700419|NCT00250679|19649701|P3|Overall Study|Protocol Violation|3
5700420|NCT00250679|19649702|P2|Overall Study|Protocol Violation|4
5700421|NCT00250679|19649703|P1|Overall Study|Protocol Violation|2
5700422|NCT00250679|19649701|P3|Overall Study|Adverse Event|16
5700423|NCT00250679|19649702|P2|Overall Study|Adverse Event|15
5700424|NCT00250679|19649703|P1|Overall Study|Adverse Event|12
5700425|NCT00250588|19649804|P3|Overall Study|Lost to Follow-up|13
5700426|NCT00250588|19649805|P2|Overall Study|Lost to Follow-up|13
5700427|NCT00250588|19649806|P1|Overall Study|Lost to Follow-up|6
5700428|NCT00250588|19649804|P3|Overall Study|Withdrawal by Subject|0
5700429|NCT00250588|19649805|P2|Overall Study|Withdrawal by Subject|6
5700430|NCT00250588|19649806|P1|Overall Study|Withdrawal by Subject|3
5700431|NCT00250458|19649854|P2|Overall Study|Other|0
5700432|NCT00250458|19649855|P1|Overall Study|Other|1
5700433|NCT00250458|19649854|P2|Overall Study|Qualifying migraine but did not treat|3
5700434|NCT00250458|19649855|P1|Overall Study|Qualifying migraine but did not treat|3
5700435|NCT00250458|19649854|P2|Overall Study|Lack of Migraine Attack|9
5700436|NCT00250458|19649855|P1|Overall Study|Lack of Migraine Attack|20
5700437|NCT00250458|19649854|P2|Overall Study|Withdrawal by Subject|2
5700438|NCT00250458|19649855|P1|Overall Study|Withdrawal by Subject|4
5700439|NCT00250458|19649854|P2|Overall Study|Protocol Violation|1
5700440|NCT00250458|19649855|P1|Overall Study|Protocol Violation|0
5700441|NCT00250458|19649854|P2|Overall Study|Lost to Follow-up|2
5700442|NCT00250458|19649855|P1|Overall Study|Lost to Follow-up|4
5700443|NCT00250432|19649865|P2|Overall Study|Pt was considered untreatable|1
5700444|NCT00250432|19649866|P1|Overall Study|Pt was considered untreatable|0
5700445|NCT00250432|19649865|P2|Overall Study|Pt died out of posttherapy report period|5
5700446|NCT00250432|19649866|P1|Overall Study|Pt died out of posttherapy report period|6
5700447|NCT00250432|19649865|P2|Overall Study|Withdrawal by Subject|2
5700448|NCT00250432|19649866|P1|Overall Study|Withdrawal by Subject|6
5700449|NCT00250432|19649865|P2|Overall Study|Protocol Violation|3
5700450|NCT00250432|19649866|P1|Overall Study|Protocol Violation|0
5700451|NCT00250432|19649865|P2|Overall Study|Patient Moved|1
5700452|NCT00250432|19649866|P1|Overall Study|Patient Moved|0
5700453|NCT00250432|19649865|P2|Overall Study|Lost to Follow-up|5
5700454|NCT00250432|19649866|P1|Overall Study|Lost to Follow-up|6
5700455|NCT00250432|19649865|P2|Overall Study|Lack of Efficacy|1
5700456|NCT00250432|19649866|P1|Overall Study|Lack of Efficacy|2
5700457|NCT00250432|19649865|P2|Overall Study|Adverse Event|29
5700458|NCT00250432|19649866|P1|Overall Study|Adverse Event|25
5700459|NCT00250276|19649878|P4|Overall Study|Lost to Follow-up|8
5700460|NCT00250276|19649879|P3|Overall Study|Lost to Follow-up|13
5700461|NCT00250276|19649880|P2|Overall Study|Lost to Follow-up|18
5700462|NCT00250276|19649881|P1|Overall Study|Lost to Follow-up|11
5700463|NCT00250276|19649878|P4|Overall Study|Migrated/moved from study area|7
5700464|NCT00250276|19649879|P3|Overall Study|Migrated/moved from study area|2
5700465|NCT00250276|19649880|P2|Overall Study|Migrated/moved from study area|0
5700466|NCT00250276|19649881|P1|Overall Study|Migrated/moved from study area|3
5700467|NCT00250276|19649878|P4|Overall Study|Withdrawal by Subject|2
5700468|NCT00250276|19649879|P3|Overall Study|Withdrawal by Subject|3
5700469|NCT00250276|19649880|P2|Overall Study|Withdrawal by Subject|2
5700470|NCT00250276|19649881|P1|Overall Study|Withdrawal by Subject|1
5700471|NCT00250276|19649878|P4|Overall Study|Protocol Violation|0
5700472|NCT00250276|19649879|P3|Overall Study|Protocol Violation|0
5700473|NCT00250276|19649880|P2|Overall Study|Protocol Violation|1
5700474|NCT00250276|19649881|P1|Overall Study|Protocol Violation|0
5700475|NCT00250276|19649878|P4|Overall Study|Non-serious Adverse Event|2
5700476|NCT00250276|19649879|P3|Overall Study|Non-serious Adverse Event|0
5700477|NCT00250276|19649880|P2|Overall Study|Non-serious Adverse Event|0
5700478|NCT00250276|19649881|P1|Overall Study|Non-serious Adverse Event|2
5700479|NCT00250276|19649878|P4|Overall Study|Serious Adverse Event|0
5700480|NCT00250276|19649879|P3|Overall Study|Serious Adverse Event|1
5700481|NCT00250276|19649880|P2|Overall Study|Serious Adverse Event|0
5700482|NCT00250276|19649881|P1|Overall Study|Serious Adverse Event|0
5700483|NCT00249873|19649961|P2|Overall Study|Thromboembolic/outcome event|122
5700484|NCT00249873|19649962|P1|Overall Study|Thromboembolic/outcome event|82
5700485|NCT00249873|19649961|P2|Overall Study|Event related to cardiac condition|21
5700486|NCT00249873|19649962|P1|Overall Study|Event related to cardiac condition|12
5700487|NCT00249873|19649961|P2|Overall Study|Surgery/ procedure|9
5700488|NCT00249873|19649962|P1|Overall Study|Surgery/ procedure|9
5700489|NCT00249873|19649961|P2|Overall Study|Study drug intolerance|0
5700490|NCT00249873|19649962|P1|Overall Study|Study drug intolerance|5
5700491|NCT00249873|19649961|P2|Overall Study|Oral anticoagulant required|157
5700492|NCT00249873|19649962|P1|Overall Study|Oral anticoagulant required|159
5700493|NCT00249873|19649961|P2|Overall Study|Angiotensin II receptor blocker required|0
5700494|NCT00249873|19649962|P1|Overall Study|Angiotensin II receptor blocker required|1
5700495|NCT00249873|19649961|P2|Overall Study|Open label clopidogrel required|42
5700496|NCT00249873|19649962|P1|Overall Study|Open label clopidogrel required|31
5700497|NCT00249873|19649961|P2|Overall Study|Physician withdrew consent|60
5700498|NCT00249873|19649962|P1|Overall Study|Physician withdrew consent|59
5700499|NCT00249873|19649961|P2|Overall Study|Patient not wish to continue after May08|4
5700500|NCT00249873|19649962|P1|Overall Study|Patient not wish to continue after May08|3
5700501|NCT00249873|19649961|P2|Overall Study|Other contraindicated medication|0
5700502|NCT00249873|19649962|P1|Overall Study|Other contraindicated medication|1
5700503|NCT00249873|19649961|P2|Overall Study|Other non serious Adverse Event|108
5700504|NCT00249873|19649962|P1|Overall Study|Other non serious Adverse Event|112
5700505|NCT00249873|19649961|P2|Overall Study|Non-compliance|46
5700506|NCT00249873|19649962|P1|Overall Study|Non-compliance|41
5700507|NCT00249873|19649961|P2|Overall Study|Minor bleeding|37
5700508|NCT00249873|19649962|P1|Overall Study|Minor bleeding|99
5700509|NCT00249873|19649961|P2|Overall Study|Lost to Follow-up|7
5700510|NCT00249873|19649962|P1|Overall Study|Lost to Follow-up|4
5700511|NCT00249873|19649961|P2|Overall Study|Withdrawal by Subject|466
5700512|NCT00249873|19649962|P1|Overall Study|Withdrawal by Subject|504
5700513|NCT00249873|19649961|P2|Overall Study|Contraindication to oral anticoagulant|8
5700514|NCT00249873|19649962|P1|Overall Study|Contraindication to oral anticoagulant|4
5700515|NCT00249873|19649961|P2|Overall Study|Qualifying condition not present|23
5700516|NCT00249873|19649962|P1|Overall Study|Qualifying condition not present|20
5700517|NCT00249873|19649961|P2|Overall Study|Other Serious Adverse Event|97
5700518|NCT00249873|19649962|P1|Overall Study|Other Serious Adverse Event|86
5700519|NCT00249873|19649961|P2|Overall Study|Serious haemorrhagic Adverse Event|30
5700520|NCT00249873|19649962|P1|Overall Study|Serious haemorrhagic Adverse Event|74
5700521|NCT00249873|19649961|P2|Overall Study|Severe allergic reaction|1
5700522|NCT00249873|19649962|P1|Overall Study|Severe allergic reaction|8
5700523|NCT00249873|19649961|P2|Overall Study|Significant thrombocytopenia|8
5700524|NCT00249873|19649962|P1|Overall Study|Significant thrombocytopenia|9
5700525|NCT00249873|19649961|P2|Overall Study|Not treated|8
5700526|NCT00249873|19649962|P1|Overall Study|Not treated|7
5700527|NCT00249834|19649982|P8|Overall Study|Protocol Violation|0
5700528|NCT00249834|19649983|P7|Overall Study|Protocol Violation|0
5700529|NCT00249834|19649984|P6|Overall Study|Protocol Violation|2
5700530|NCT00249834|19649985|P5|Overall Study|Protocol Violation|5
5700531|NCT00249834|19649986|P4|Overall Study|Protocol Violation|8
5700532|NCT00249834|19649987|P3|Overall Study|Protocol Violation|14
5700533|NCT00249834|19649988|P2|Overall Study|Protocol Violation|19
5700534|NCT00249834|19649989|P1|Overall Study|Protocol Violation|0
5700535|NCT00249834|19649982|P8|Overall Study|Failure of down-regulation|0
5700536|NCT00249834|19649983|P7|Overall Study|Failure of down-regulation|1
5700537|NCT00249834|19649984|P6|Overall Study|Failure of down-regulation|0
5700538|NCT00249834|19649985|P5|Overall Study|Failure of down-regulation|0
5700539|NCT00249834|19649986|P4|Overall Study|Failure of down-regulation|0
5700540|NCT00249834|19649987|P3|Overall Study|Failure of down-regulation|0
5700541|NCT00249834|19649988|P2|Overall Study|Failure of down-regulation|0
5700542|NCT00249834|19649989|P1|Overall Study|Failure of down-regulation|0
5700543|NCT00249834|19649982|P8|Overall Study|Ovarian stimulation failed|0
5700544|NCT00249834|19649983|P7|Overall Study|Ovarian stimulation failed|0
5700545|NCT00249834|19649984|P6|Overall Study|Ovarian stimulation failed|0
5700546|NCT00249834|19649985|P5|Overall Study|Ovarian stimulation failed|0
5700547|NCT00249834|19649986|P4|Overall Study|Ovarian stimulation failed|0
5700548|NCT00249834|19649987|P3|Overall Study|Ovarian stimulation failed|0
5700549|NCT00249834|19649988|P2|Overall Study|Ovarian stimulation failed|0
5700550|NCT00249834|19649989|P1|Overall Study|Ovarian stimulation failed|1
5700551|NCT00249821|19650038|P2|Overall Study|Technical problem|1
5700552|NCT00249821|19650039|P1|Overall Study|Technical problem|0
5700553|NCT00249808|19650059|P1|Overall Study|Did Not Provide Post-Baseline Data|11
5700554|NCT00249808|19650059|P1|Overall Study|Lack of Efficacy|52
5700555|NCT00249808|19650059|P1|Overall Study|Adverse Event|81
5700556|NCT00249808|19650059|P1|Overall Study|Lost to Follow-up|8
5700557|NCT00249808|19650059|P1|Overall Study|Protocol Violation|3
5700558|NCT00249808|19650059|P1|Overall Study|Other|27
5700559|NCT00249795|19650067|P2|Overall Study|Missing|1
5700560|NCT00249795|19650068|P1|Overall Study|Missing|0
5700561|NCT00249795|19650067|P2|Overall Study|Lost to Follow-up|2
5700562|NCT00249795|19650068|P1|Overall Study|Lost to Follow-up|0
5700563|NCT00249795|19650067|P2|Overall Study|Site not agree to continue after May08|1
5700564|NCT00249795|19650068|P1|Overall Study|Site not agree to continue after May08|1
5700565|NCT00249795|19650067|P2|Overall Study|Patient not wish to continue after May08|6
5700566|NCT00249795|19650068|P1|Overall Study|Patient not wish to continue after May08|4
5700567|NCT00249795|19650067|P2|Overall Study|Event related to cardiac condition|16
5700568|NCT00249795|19650068|P1|Overall Study|Event related to cardiac condition|17
5700569|NCT00249795|19650067|P2|Overall Study|Other contraindicated medication|1
5700570|NCT00249795|19650068|P1|Overall Study|Other contraindicated medication|1
5700571|NCT00249795|19650067|P2|Overall Study|Hypotension (non-symptomatic)|5
5700572|NCT00249795|19650068|P1|Overall Study|Hypotension (non-symptomatic)|5
5700573|NCT00249795|19650067|P2|Overall Study|Lightheadedness / dizziness|11
5700574|NCT00249795|19650068|P1|Overall Study|Lightheadedness / dizziness|15
5700575|NCT00249795|19650067|P2|Overall Study|Angiotensin II receptor blocker required|58
5700576|NCT00249795|19650068|P1|Overall Study|Angiotensin II receptor blocker required|35
5700577|NCT00249795|19650067|P2|Overall Study|Surgery / procedure|5
5700578|NCT00249795|19650068|P1|Overall Study|Surgery / procedure|4
5700579|NCT00249795|19650067|P2|Overall Study|Physician withdrew consent|63
5700580|NCT00249795|19650068|P1|Overall Study|Physician withdrew consent|71
5700581|NCT00249795|19650067|P2|Overall Study|Other adverse events (non-serious)|159
5700582|NCT00249795|19650068|P1|Overall Study|Other adverse events (non-serious)|188
5700583|NCT00249795|19650067|P2|Overall Study|Study drug intolerance|3
5700584|NCT00249795|19650068|P1|Overall Study|Study drug intolerance|3
5700585|NCT00249795|19650067|P2|Overall Study|Non-compliance|69
5700586|NCT00249795|19650068|P1|Overall Study|Non-compliance|71
5700587|NCT00249795|19650067|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
5700588|NCT00249795|19650068|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
5700589|NCT00249795|19650067|P2|Overall Study|Oral anticoagulant required|0
5700590|NCT00249795|19650068|P1|Overall Study|Oral anticoagulant required|2
5700591|NCT00249795|19650067|P2|Overall Study|Thromboembolic / outcome event|45
5700592|NCT00249795|19650068|P1|Overall Study|Thromboembolic / outcome event|39
5700593|NCT00249795|19650067|P2|Overall Study|Withdrawal by Subject|742
5700594|NCT00249795|19650068|P1|Overall Study|Withdrawal by Subject|678
5700595|NCT00249795|19650067|P2|Overall Study|Qualifying condition not present|29
5700596|NCT00249795|19650068|P1|Overall Study|Qualifying condition not present|26
5700597|NCT00249795|19650067|P2|Overall Study|Other Serious Adverse Event|93
5700598|NCT00249795|19650068|P1|Overall Study|Other Serious Adverse Event|84
5700599|NCT00249795|19650067|P2|Overall Study|Symptomatic hypotension|64
5700600|NCT00249795|19650068|P1|Overall Study|Symptomatic hypotension|127
5700601|NCT00249795|19650067|P2|Overall Study|Not treated|14
5700602|NCT00249795|19650068|P1|Overall Study|Not treated|16
5700603|NCT00249769|19650089|P3|Overall Study|Lost to Follow-up|3
5700604|NCT00249769|19650090|P2|Overall Study|Lost to Follow-up|0
5700605|NCT00249769|19650091|P1|Overall Study|Lost to Follow-up|0
5700606|NCT00249769|19650089|P3|Overall Study|Physician Decision|2
5700607|NCT00249769|19650090|P2|Overall Study|Physician Decision|0
5700608|NCT00249769|19650091|P1|Overall Study|Physician Decision|0
5700609|NCT00249769|19650089|P3|Overall Study|Adverse Event|1
5700610|NCT00249769|19650090|P2|Overall Study|Adverse Event|0
5700611|NCT00249769|19650091|P1|Overall Study|Adverse Event|0
5700612|NCT00249769|19650089|P3|Overall Study|Miscellaneous|2
5700613|NCT00249769|19650090|P2|Overall Study|Miscellaneous|2
5700614|NCT00249769|19650091|P1|Overall Study|Miscellaneous|0
5700615|NCT00249769|19650089|P3|Overall Study|Migration from Study Area|14
5700616|NCT00249769|19650090|P2|Overall Study|Migration from Study Area|3
5700617|NCT00249769|19650091|P1|Overall Study|Migration from Study Area|1
5700618|NCT00249769|19650089|P3|Overall Study|Withdrawal by Subject|6
5700619|NCT00249769|19650090|P2|Overall Study|Withdrawal by Subject|10
5700620|NCT00249769|19650091|P1|Overall Study|Withdrawal by Subject|1
5700621|NCT00249613|19650119|P2|12 Month Follow-up|Lost to Follow-up|8
5700622|NCT00249613|19650120|P1|12 Month Follow-up|Lost to Follow-up|10
5700623|NCT00249613|19650119|P2|12 Month Follow-up|Withdrawal by Subject|6
5700624|NCT00249613|19650120|P1|12 Month Follow-up|Withdrawal by Subject|6
5700625|NCT00249613|19650119|P2|12 Month Follow-up|Death|1
5700626|NCT00249613|19650120|P1|12 Month Follow-up|Death|1
5700627|NCT00249444|19650161|P2|Overall Study|life event|1
5700628|NCT00249444|19650162|P1|Overall Study|life event|0
5700629|NCT00249444|19650161|P2|Overall Study|Adverse Event|1
5700630|NCT00249444|19650162|P1|Overall Study|Adverse Event|1
5700631|NCT00249444|19650161|P2|Overall Study|non-compliant|11
5700632|NCT00249444|19650162|P1|Overall Study|non-compliant|9
5700633|NCT00249444|19650161|P2|Overall Study|Lost to Follow-up|2
5700634|NCT00249444|19650162|P1|Overall Study|Lost to Follow-up|2
5700635|NCT00249288|19650187|P2|Overall Study|Withdrawal by Subject|2
5700636|NCT00249288|19650188|P1|Overall Study|Withdrawal by Subject|2
5700637|NCT00249288|19650187|P2|Overall Study|Lost to Follow-up|3
5700638|NCT00249288|19650188|P1|Overall Study|Lost to Follow-up|3
5700639|NCT00249002|19650280|P1|Overall Study|Other|2
5700640|NCT00249002|19650280|P1|Overall Study|Study cancellation|3
5700641|NCT00249002|19650280|P1|Overall Study|Adverse Event|2
5700642|NCT00248833|19650299|P3|Overall Study|Other|0
5700643|NCT00248833|19650300|P2|Overall Study|Other|1
5700644|NCT00248833|19650301|P1|Overall Study|Other|0
5700645|NCT00248833|19650299|P3|Overall Study|Lost to Follow-up|1
5700646|NCT00248833|19650300|P2|Overall Study|Lost to Follow-up|1
5700647|NCT00248833|19650301|P1|Overall Study|Lost to Follow-up|1
5700648|NCT00248833|19650299|P3|Overall Study|Withdrawal by Subject|1
5700649|NCT00248833|19650300|P2|Overall Study|Withdrawal by Subject|1
5700650|NCT00248833|19650301|P1|Overall Study|Withdrawal by Subject|0
5700651|NCT00248833|19650299|P3|Overall Study|Adverse Event|0
5700652|NCT00248833|19650300|P2|Overall Study|Adverse Event|0
5700653|NCT00248833|19650301|P1|Overall Study|Adverse Event|2
5700654|NCT00248794|19650337|P3|Overall Study|Lost to Follow-up|3
5700655|NCT00248794|19650338|P2|Overall Study|Lost to Follow-up|8
5700656|NCT00248794|19650339|P1|Overall Study|Lost to Follow-up|6
5700657|NCT00248651|19650389|P3|Overall Study|Withdrawal by Subject|32
5700658|NCT00248651|19650390|P2|Overall Study|Withdrawal by Subject|40
5700659|NCT00248651|19650391|P1|Overall Study|Withdrawal by Subject|28
5700660|NCT00248625|19650427|P2|Overall Study|Withdrawal by Subject|2
5700661|NCT00248625|19650428|P1|Overall Study|Withdrawal by Subject|0
5700662|NCT00248495|19650520|P1|Overall Study|Withdrawal by Subject|1
5700663|NCT00248287|19650531|P2|Overall Study|Other|2
5700664|NCT00248287|19650532|P1|Overall Study|Other|3
5700665|NCT00248287|19650531|P2|Overall Study|Patient Request|3
5700666|NCT00248287|19650532|P1|Overall Study|Patient Request|5
5700667|NCT00248287|19650531|P2|Overall Study|Investigator Request|3
5700668|NCT00248287|19650532|P1|Overall Study|Investigator Request|4
5700669|NCT00248287|19650531|P2|Overall Study|Lost to Follow-up|1
5700670|NCT00248287|19650532|P1|Overall Study|Lost to Follow-up|0
5700671|NCT00248287|19650531|P2|Overall Study|Death|0
5700672|NCT00248287|19650532|P1|Overall Study|Death|1
5700673|NCT00248287|19650531|P2|Overall Study|Adverse Event|10
5700674|NCT00248287|19650532|P1|Overall Study|Adverse Event|11
5700675|NCT00248170|19650546|P2|Overall Study|Protocol deviation|19
5700676|NCT00248170|19650547|P1|Overall Study|Protocol deviation|17
5700677|NCT00248170|19650546|P2|Overall Study|Abnormal laboratory values|0
5700678|NCT00248170|19650547|P1|Overall Study|Abnormal laboratory values|4
5700679|NCT00248170|19650546|P2|Overall Study|Abnormal test procedure(s) result|61
5700680|NCT00248170|19650547|P1|Overall Study|Abnormal test procedure(s) result|49
5700681|NCT00248170|19650546|P2|Overall Study|Administrative problems|25
5700682|NCT00248170|19650547|P1|Overall Study|Administrative problems|22
5700683|NCT00248170|19650546|P2|Overall Study|Adverse Event|296
5700684|NCT00248170|19650547|P1|Overall Study|Adverse Event|311
5700685|NCT00248170|19650546|P2|Overall Study|Death|47
5700686|NCT00248170|19650547|P1|Overall Study|Death|28
5700687|NCT00248170|19650546|P2|Overall Study|Disease progression|216
5700688|NCT00248170|19650547|P1|Overall Study|Disease progression|196
5700689|NCT00248170|19650546|P2|Overall Study|Lost to Follow-up|35
5700690|NCT00248170|19650547|P1|Overall Study|Lost to Follow-up|28
5700691|NCT00248170|19650546|P2|Overall Study|Protocol Violation|30
5700692|NCT00248170|19650547|P1|Overall Study|Protocol Violation|35
5700693|NCT00248170|19650546|P2|Overall Study|Withdrawal by Subject|79
5700694|NCT00248170|19650547|P1|Overall Study|Withdrawal by Subject|71
5700695|NCT00248040|19650570|P3|Overall Study|Death|1
5700696|NCT00248040|19650571|P2|Overall Study|Death|0
5700697|NCT00248040|19650572|P1|Overall Study|Death|0
5700698|NCT00248040|19650570|P3|Overall Study|transplant cancelled post treat start|0
5700699|NCT00248040|19650571|P2|Overall Study|transplant cancelled post treat start|0
5700700|NCT00248040|19650572|P1|Overall Study|transplant cancelled post treat start|1
5700701|NCT00248040|19650570|P3|Overall Study|transplantectomy|3
5700702|NCT00248040|19650571|P2|Overall Study|transplantectomy|1
5700703|NCT00248040|19650572|P1|Overall Study|transplantectomy|2
5700704|NCT00247962|19650621|P2|Overall Study|Lack of Efficacy|2
5700705|NCT00247962|19650622|P1|Overall Study|Lack of Efficacy|4
5700706|NCT00247962|19650621|P2|Overall Study|Withdrawal by Subject|2
5700707|NCT00247962|19650622|P1|Overall Study|Withdrawal by Subject|3
5700708|NCT00247962|19650621|P2|Overall Study|Protocol Violation|1
5700709|NCT00247962|19650622|P1|Overall Study|Protocol Violation|1
5700710|NCT00247962|19650621|P2|Overall Study|Physician Decision|1
5700711|NCT00247962|19650622|P1|Overall Study|Physician Decision|0
5700712|NCT00247962|19650621|P2|Overall Study|Lost to Follow-up|1
5700713|NCT00247962|19650622|P1|Overall Study|Lost to Follow-up|3
5700714|NCT00247962|19650621|P2|Overall Study|Adverse Event|12
5700715|NCT00247962|19650622|P1|Overall Study|Adverse Event|15
5700716|NCT00247676|19650649|P1|Overall Study|Withdrawal by Subject|2
5700717|NCT00247676|19650649|P1|Overall Study|Other|3
5700718|NCT00247676|19650649|P1|Overall Study|Lack of Efficacy|15
5700719|NCT00247676|19650649|P1|Overall Study|Adverse Event|11
5700720|NCT00247676|19650649|P1|Overall Study|Death|5
5700721|NCT00247611|19650694|P2|Baselined|Completed baseline only|8
5700722|NCT00247611|19650695|P1|Baselined|Completed baseline only|9
5700723|NCT00247611|19650694|P2|Baselined|Completed baseline, never placed on ARVs|5
5700724|NCT00247611|19650695|P1|Baselined|Completed baseline, never placed on ARVs|8
5700725|NCT00247416|19650713|P2|Overall Study|3 patients were found to be ineligible|2
5700726|NCT00247416|19650714|P1|Overall Study|3 patients were found to be ineligible|1
5700727|NCT00247273|19650755|P2|Overall Study|Did not take any study drug|0
5700728|NCT00247273|19650756|P1|Overall Study|Did not take any study drug|2
5700729|NCT00247273|19650755|P2|Overall Study|Withdrawal by Subject|47
5700730|NCT00247273|19650756|P1|Overall Study|Withdrawal by Subject|46
5700731|NCT00247273|19650755|P2|Overall Study|Lost to Follow-up|7
5700732|NCT00247273|19650756|P1|Overall Study|Lost to Follow-up|7
5700733|NCT00247273|19650755|P2|Overall Study|Physician Decision|3
5700734|NCT00247273|19650756|P1|Overall Study|Physician Decision|6
5700735|NCT00247273|19650755|P2|Overall Study|Adverse Event|80
5700736|NCT00247273|19650756|P1|Overall Study|Adverse Event|85
5700737|NCT00246805|19650802|P2|Phase 1|Lost to Follow-up|0
5700738|NCT00246805|19650803|P1|Phase 1|Lost to Follow-up|1
5700739|NCT00246753|19650809|P1|Overall Study|Unacceptable toxicity|2
5700740|NCT00246753|19650809|P1|Overall Study|Adverse Event|2
5700741|NCT00246753|19650809|P1|Overall Study|Physician Decision|2
5700742|NCT00246753|19650809|P1|Overall Study|Withdrawal by Subject|2
5700743|NCT00246740|19650817|P2|Initial Enrollment|Other|2
5700744|NCT00246740|19650818|P1|Initial Enrollment|Other|1
5700745|NCT00246740|19650817|P2|Initial Enrollment|Surgery schedule change|4
5700746|NCT00246740|19650818|P1|Initial Enrollment|Surgery schedule change|4
5700747|NCT00246740|19650817|P2|Initial Enrollment|Additional surgery scheduled|2
5700748|NCT00246740|19650818|P1|Initial Enrollment|Additional surgery scheduled|0
5700749|NCT00246740|19650817|P2|Initial Enrollment|Death|0
5700750|NCT00246740|19650818|P1|Initial Enrollment|Death|1
5700751|NCT00246571|19650842|P2|Overall Study|Crossover participants|74
5700752|NCT00246571|19650843|P1|Overall Study|Crossover participants|0
5700753|NCT00246571|19650842|P2|Overall Study|Laboratory abnormalities|0
5700754|NCT00246571|19650843|P1|Overall Study|Laboratory abnormalities|1
5700755|NCT00246571|19650842|P2|Overall Study|Did not meet entrance criteria|1
5700756|NCT00246571|19650843|P1|Overall Study|Did not meet entrance criteria|2
5700757|NCT00246571|19650842|P2|Overall Study|Sponsor|1
5700758|NCT00246571|19650843|P1|Overall Study|Sponsor|0
5700759|NCT00246571|19650842|P2|Overall Study|Death|3
5700760|NCT00246571|19650843|P1|Overall Study|Death|17
5700761|NCT00246571|19650842|P2|Overall Study|Lack of Efficacy|21
5700762|NCT00246571|19650843|P1|Overall Study|Lack of Efficacy|84
5700763|NCT00246571|19650842|P2|Overall Study|Withdrawal by Subject|3
5700764|NCT00246571|19650843|P1|Overall Study|Withdrawal by Subject|2
5700765|NCT00246571|19650842|P2|Overall Study|Protocol Violation|1
5700766|NCT00246571|19650843|P1|Overall Study|Protocol Violation|0
5700767|NCT00246571|19650842|P2|Overall Study|Adverse Event|0
5700768|NCT00246571|19650843|P1|Overall Study|Adverse Event|7
5700769|NCT00246376|19650908|P5|Overall Study|Lost to Follow-up|13
5700770|NCT00246376|19650909|P4|Overall Study|Lost to Follow-up|16
5700771|NCT00246376|19650910|P3|Overall Study|Lost to Follow-up|11
5700772|NCT00246376|19650911|P2|Overall Study|Lost to Follow-up|11
5700773|NCT00246376|19650912|P1|Overall Study|Lost to Follow-up|2
5700774|NCT00246376|19650908|P5|Overall Study|Adverse Event|1
5700775|NCT00246376|19650909|P4|Overall Study|Adverse Event|3
5700776|NCT00246376|19650910|P3|Overall Study|Adverse Event|1
5700777|NCT00246376|19650911|P2|Overall Study|Adverse Event|3
5700778|NCT00246376|19650912|P1|Overall Study|Adverse Event|2
5700779|NCT00246376|19650908|P5|Overall Study|Dropped/withdrew during dietary run-in|3
5700780|NCT00246376|19650909|P4|Overall Study|Dropped/withdrew during dietary run-in|7
5700781|NCT00246376|19650910|P3|Overall Study|Dropped/withdrew during dietary run-in|4
5700782|NCT00246376|19650911|P2|Overall Study|Dropped/withdrew during dietary run-in|5
5700783|NCT00246376|19650912|P1|Overall Study|Dropped/withdrew during dietary run-in|11
5700784|NCT00246337|19650963|P9|Overall Study|Reported as completing trial in error|0
5700785|NCT00246337|19650964|P8|Overall Study|Reported as completing trial in error|1
5700786|NCT00246337|19650965|P7|Overall Study|Reported as completing trial in error|0
5700787|NCT00246337|19650966|P6|Overall Study|Reported as completing trial in error|0
5700788|NCT00246337|19650967|P5|Overall Study|Reported as completing trial in error|0
5700789|NCT00246337|19650968|P4|Overall Study|Reported as completing trial in error|0
5700790|NCT00246337|19650969|P3|Overall Study|Reported as completing trial in error|0
5700791|NCT00246337|19650970|P2|Overall Study|Reported as completing trial in error|0
5700792|NCT00246337|19650971|P1|Overall Study|Reported as completing trial in error|0
5700793|NCT00246337|19650963|P9|Overall Study|Protocol Violator|0
5700794|NCT00246337|19650964|P8|Overall Study|Protocol Violator|0
5700795|NCT00246337|19650965|P7|Overall Study|Protocol Violator|0
5700796|NCT00246337|19650966|P6|Overall Study|Protocol Violator|0
5700797|NCT00246337|19650967|P5|Overall Study|Protocol Violator|0
5700798|NCT00246337|19650968|P4|Overall Study|Protocol Violator|0
5700799|NCT00246337|19650969|P3|Overall Study|Protocol Violator|0
5700800|NCT00246337|19650970|P2|Overall Study|Protocol Violator|0
5700801|NCT00246337|19650971|P1|Overall Study|Protocol Violator|1
5700802|NCT00246337|19650963|P9|Overall Study|Overwhelmed|0
5700803|NCT00246337|19650964|P8|Overall Study|Overwhelmed|0
5700804|NCT00246337|19650965|P7|Overall Study|Overwhelmed|0
5700805|NCT00246337|19650966|P6|Overall Study|Overwhelmed|1
5700806|NCT00246337|19650967|P5|Overall Study|Overwhelmed|0
5700807|NCT00246337|19650968|P4|Overall Study|Overwhelmed|0
5700808|NCT00246337|19650969|P3|Overall Study|Overwhelmed|0
5700809|NCT00246337|19650970|P2|Overall Study|Overwhelmed|0
5700810|NCT00246337|19650971|P1|Overall Study|Overwhelmed|0
5700811|NCT00246337|19650963|P9|Overall Study|Abnormal baseline lab values|4
5700812|NCT00246337|19650964|P8|Overall Study|Abnormal baseline lab values|0
5700813|NCT00246337|19650965|P7|Overall Study|Abnormal baseline lab values|2
5700814|NCT00246337|19650966|P6|Overall Study|Abnormal baseline lab values|2
5700815|NCT00246337|19650967|P5|Overall Study|Abnormal baseline lab values|0
5700816|NCT00246337|19650968|P4|Overall Study|Abnormal baseline lab values|0
5700817|NCT00246337|19650969|P3|Overall Study|Abnormal baseline lab values|2
5700818|NCT00246337|19650970|P2|Overall Study|Abnormal baseline lab values|0
5700819|NCT00246337|19650971|P1|Overall Study|Abnormal baseline lab values|7
5700820|NCT00246337|19650963|P9|Overall Study|Site Terminated|2
5700821|NCT00246337|19650964|P8|Overall Study|Site Terminated|6
5700822|NCT00246337|19650965|P7|Overall Study|Site Terminated|1
5700823|NCT00246337|19650966|P6|Overall Study|Site Terminated|7
5700824|NCT00246337|19650967|P5|Overall Study|Site Terminated|0
5700825|NCT00246337|19650968|P4|Overall Study|Site Terminated|0
5700826|NCT00246337|19650969|P3|Overall Study|Site Terminated|0
5700827|NCT00246337|19650970|P2|Overall Study|Site Terminated|0
5700828|NCT00246337|19650971|P1|Overall Study|Site Terminated|10
5700829|NCT00246337|19650963|P9|Overall Study|Lack of Qualifying Event|5
5700830|NCT00246337|19650964|P8|Overall Study|Lack of Qualifying Event|2
5700831|NCT00246337|19650965|P7|Overall Study|Lack of Qualifying Event|3
5700832|NCT00246337|19650966|P6|Overall Study|Lack of Qualifying Event|3
5700833|NCT00246337|19650967|P5|Overall Study|Lack of Qualifying Event|1
5700834|NCT00246337|19650968|P4|Overall Study|Lack of Qualifying Event|1
5700835|NCT00246337|19650969|P3|Overall Study|Lack of Qualifying Event|1
5700836|NCT00246337|19650970|P2|Overall Study|Lack of Qualifying Event|2
5700837|NCT00246337|19650971|P1|Overall Study|Lack of Qualifying Event|8
5700838|NCT00246337|19650963|P9|Overall Study|Withdrawal by Subject|0
5700839|NCT00246337|19650964|P8|Overall Study|Withdrawal by Subject|1
5700840|NCT00246337|19650965|P7|Overall Study|Withdrawal by Subject|1
5700841|NCT00246337|19650966|P6|Overall Study|Withdrawal by Subject|0
5700842|NCT00246337|19650967|P5|Overall Study|Withdrawal by Subject|0
5700843|NCT00246337|19650968|P4|Overall Study|Withdrawal by Subject|0
5700844|NCT00246337|19650969|P3|Overall Study|Withdrawal by Subject|0
5700845|NCT00246337|19650970|P2|Overall Study|Withdrawal by Subject|0
5700846|NCT00246337|19650971|P1|Overall Study|Withdrawal by Subject|2
5700847|NCT00246337|19650963|P9|Overall Study|Protocol Violation|0
5700848|NCT00246337|19650964|P8|Overall Study|Protocol Violation|1
5700849|NCT00246337|19650965|P7|Overall Study|Protocol Violation|1
5700850|NCT00246337|19650966|P6|Overall Study|Protocol Violation|0
5700851|NCT00246337|19650967|P5|Overall Study|Protocol Violation|1
5700852|NCT00246337|19650968|P4|Overall Study|Protocol Violation|0
5700853|NCT00246337|19650969|P3|Overall Study|Protocol Violation|0
5700854|NCT00246337|19650970|P2|Overall Study|Protocol Violation|0
5700855|NCT00246337|19650971|P1|Overall Study|Protocol Violation|1
5700856|NCT00246337|19650963|P9|Overall Study|Lost to Follow-up|0
5700857|NCT00246337|19650964|P8|Overall Study|Lost to Follow-up|2
5700858|NCT00246337|19650965|P7|Overall Study|Lost to Follow-up|1
5700859|NCT00246337|19650966|P6|Overall Study|Lost to Follow-up|2
5700860|NCT00246337|19650967|P5|Overall Study|Lost to Follow-up|2
5700861|NCT00246337|19650968|P4|Overall Study|Lost to Follow-up|0
5700862|NCT00246337|19650969|P3|Overall Study|Lost to Follow-up|0
5700863|NCT00246337|19650970|P2|Overall Study|Lost to Follow-up|0
5700864|NCT00246337|19650971|P1|Overall Study|Lost to Follow-up|3
5700865|NCT00246324|19651018|P1|Overall Study|Withdrawal by Subject|1
5700866|NCT00246259|19651025|P2|Overall Study|randomly assigned, not eligible for ITT|6
5700867|NCT00246259|19651026|P1|Overall Study|randomly assigned, not eligible for ITT|2
5700868|NCT00246259|19651025|P2|Overall Study|Withdrawal by Subject|1
5700869|NCT00246259|19651026|P1|Overall Study|Withdrawal by Subject|5
5700870|NCT00246259|19651025|P2|Overall Study|Lost to Follow-up|4
5700871|NCT00246259|19651026|P1|Overall Study|Lost to Follow-up|3
5700872|NCT00246259|19651025|P2|Overall Study|Adverse Event|0
5700873|NCT00246259|19651026|P1|Overall Study|Adverse Event|5
5700874|NCT00246259|19651025|P2|Overall Study|Investigator withdrew participant|0
5700875|NCT00246259|19651026|P1|Overall Study|Investigator withdrew participant|2
5700876|NCT00246259|19651025|P2|Overall Study|Lack of Efficacy|2
5700877|NCT00246259|19651026|P1|Overall Study|Lack of Efficacy|2
5700878|NCT00246259|19651025|P2|Overall Study|Participant non-compliant|9
5700879|NCT00246259|19651026|P1|Overall Study|Participant non-compliant|4
5700880|NCT00246259|19651025|P2|Overall Study|Not stable by Week 18|1
5700881|NCT00246259|19651026|P1|Overall Study|Not stable by Week 18|2
5700882|NCT00246259|19651025|P2|Overall Study|Other|3
5700883|NCT00246259|19651026|P1|Overall Study|Other|3
5700884|NCT00246090|19651060|P1|Overall Study|Not Otherwise Specified|10
5700885|NCT00246090|19651060|P1|Overall Study|Physician Decision|11
5700886|NCT00246090|19651060|P1|Overall Study|Clinical Progression|30
5700887|NCT00246090|19651060|P1|Overall Study|Progressive Disease|212
5700888|NCT00246090|19651060|P1|Overall Study|Withdrawal by Subject|7
5700889|NCT00246090|19651060|P1|Overall Study|Adverse Event|25
5700890|NCT00246025|19651069|P4|Overall Study|unsuitable medical history was found|1
5700891|NCT00246025|19651070|P3|Overall Study|unsuitable medical history was found|0
5700892|NCT00246025|19651071|P2|Overall Study|unsuitable medical history was found|0
5700893|NCT00246025|19651072|P1|Overall Study|unsuitable medical history was found|0
5700894|NCT00246025|19651069|P4|Overall Study|Withdrawal by Subject|2
5700895|NCT00246025|19651070|P3|Overall Study|Withdrawal by Subject|1
5700896|NCT00246025|19651071|P2|Overall Study|Withdrawal by Subject|0
5700897|NCT00246025|19651072|P1|Overall Study|Withdrawal by Subject|3
5700898|NCT00246025|19651069|P4|Overall Study|Adverse Event|10
5700899|NCT00246025|19651070|P3|Overall Study|Adverse Event|9
5700900|NCT00246025|19651071|P2|Overall Study|Adverse Event|9
5700901|NCT00246025|19651072|P1|Overall Study|Adverse Event|7
5700902|NCT00246012|19651131|P9|Overall Study|Randomly assigned but not treated|0
5700903|NCT00246012|19651132|P8|Overall Study|Randomly assigned but not treated|0
5700904|NCT00246012|19651133|P7|Overall Study|Randomly assigned but not treated|1
5700905|NCT00246012|19651134|P6|Overall Study|Randomly assigned but not treated|1
5700906|NCT00246012|19651135|P5|Overall Study|Randomly assigned but not treated|0
5700907|NCT00246012|19651136|P4|Overall Study|Randomly assigned but not treated|0
5700908|NCT00246012|19651137|P3|Overall Study|Randomly assigned but not treated|0
5700909|NCT00246012|19651138|P2|Overall Study|Randomly assigned but not treated|0
5700910|NCT00246012|19651139|P1|Overall Study|Randomly assigned but not treated|0
5700911|NCT00246012|19651131|P9|Overall Study|Other|0
5700912|NCT00246012|19651132|P8|Overall Study|Other|1
5700913|NCT00246012|19651133|P7|Overall Study|Other|0
5700914|NCT00246012|19651134|P6|Overall Study|Other|0
5700915|NCT00246012|19651135|P5|Overall Study|Other|0
5700916|NCT00246012|19651136|P4|Overall Study|Other|0
5700917|NCT00246012|19651137|P3|Overall Study|Other|0
5700918|NCT00246012|19651138|P2|Overall Study|Other|0
5700919|NCT00246012|19651139|P1|Overall Study|Other|0
5700920|NCT00246012|19651131|P9|Overall Study|Disease progression|26
5700921|NCT00246012|19651132|P8|Overall Study|Disease progression|27
5700922|NCT00246012|19651133|P7|Overall Study|Disease progression|30
5700923|NCT00246012|19651134|P6|Overall Study|Disease progression|25
5700924|NCT00246012|19651135|P5|Overall Study|Disease progression|3
5700925|NCT00246012|19651136|P4|Overall Study|Disease progression|3
5700926|NCT00246012|19651137|P3|Overall Study|Disease progression|2
5700927|NCT00246012|19651138|P2|Overall Study|Disease progression|1
5700928|NCT00246012|19651139|P1|Overall Study|Disease progression|3
5700929|NCT00246012|19651131|P9|Overall Study|Withdrawal by Subject|0
5700930|NCT00246012|19651132|P8|Overall Study|Withdrawal by Subject|0
5700931|NCT00246012|19651133|P7|Overall Study|Withdrawal by Subject|0
5700932|NCT00246012|19651134|P6|Overall Study|Withdrawal by Subject|1
5700933|NCT00246012|19651135|P5|Overall Study|Withdrawal by Subject|0
5700934|NCT00246012|19651136|P4|Overall Study|Withdrawal by Subject|0
5700935|NCT00246012|19651137|P3|Overall Study|Withdrawal by Subject|0
5700936|NCT00246012|19651138|P2|Overall Study|Withdrawal by Subject|0
5700937|NCT00246012|19651139|P1|Overall Study|Withdrawal by Subject|0
5700938|NCT00246012|19651131|P9|Overall Study|Adverse Event|2
5700939|NCT00246012|19651132|P8|Overall Study|Adverse Event|0
5700940|NCT00246012|19651133|P7|Overall Study|Adverse Event|0
5700941|NCT00246012|19651134|P6|Overall Study|Adverse Event|1
5700942|NCT00246012|19651135|P5|Overall Study|Adverse Event|0
5700943|NCT00246012|19651136|P4|Overall Study|Adverse Event|0
5700944|NCT00246012|19651137|P3|Overall Study|Adverse Event|0
5700945|NCT00246012|19651138|P2|Overall Study|Adverse Event|0
5700946|NCT00246012|19651139|P1|Overall Study|Adverse Event|0
5700947|NCT00245960|19651234|P2|Overall Study|Lack of Efficacy|6
5700948|NCT00245960|19651235|P1|Overall Study|Lack of Efficacy|4
5700949|NCT00245960|19651234|P2|Overall Study|Withdrawal by Subject|7
5700950|NCT00245960|19651235|P1|Overall Study|Withdrawal by Subject|5
5700951|NCT00245960|19651234|P2|Overall Study|Protocol Violation|3
5700952|NCT00245960|19651235|P1|Overall Study|Protocol Violation|4
5700953|NCT00245960|19651234|P2|Overall Study|Lost to Follow-up|2
5700954|NCT00245960|19651235|P1|Overall Study|Lost to Follow-up|2
5700955|NCT00245960|19651234|P2|Overall Study|Adverse Event|10
5700956|NCT00245960|19651235|P1|Overall Study|Adverse Event|14
5700957|NCT00245856|19651243|P2|Period Two|Withdrawal by Subject|1
5700958|NCT00245856|19651244|P1|Period Two|Withdrawal by Subject|0
5700959|NCT00245765|19651254|P3|Overall Study|Other|4
5700960|NCT00245765|19651255|P2|Overall Study|Other|4
5700961|NCT00245765|19651256|P1|Overall Study|Other|13
5700962|NCT00245765|19651254|P3|Overall Study|Other reason|1
5700963|NCT00245765|19651255|P2|Overall Study|Other reason|0
5700964|NCT00245765|19651256|P1|Overall Study|Other reason|2
5700965|NCT00245765|19651254|P3|Overall Study|Withdrawal by Subject|3
5700966|NCT00245765|19651255|P2|Overall Study|Withdrawal by Subject|0
5700967|NCT00245765|19651256|P1|Overall Study|Withdrawal by Subject|1
5700968|NCT00245765|19651254|P3|Overall Study|Lost to Follow-up|0
5700969|NCT00245765|19651255|P2|Overall Study|Lost to Follow-up|2
5700970|NCT00245765|19651256|P1|Overall Study|Lost to Follow-up|1
5700971|NCT00245765|19651254|P3|Overall Study|Lack of Efficacy|0
5700972|NCT00245765|19651255|P2|Overall Study|Lack of Efficacy|7
5700973|NCT00245765|19651256|P1|Overall Study|Lack of Efficacy|14
5700974|NCT00245765|19651254|P3|Overall Study|Adverse Event|0
5700975|NCT00245765|19651255|P2|Overall Study|Adverse Event|1
5700976|NCT00245765|19651256|P1|Overall Study|Adverse Event|1
5700977|NCT00245583|19651305|P2|Overall Study|Withdrawal by Subject|3
5700978|NCT00245583|19651306|P1|Overall Study|Withdrawal by Subject|2
5700979|NCT00245583|19651305|P2|Overall Study|Lack of Efficacy|0
5700980|NCT00245583|19651306|P1|Overall Study|Lack of Efficacy|1
5700981|NCT00245583|19651305|P2|Overall Study|Adverse Event|1
5700982|NCT00245583|19651306|P1|Overall Study|Adverse Event|2
5700983|NCT00245583|19651305|P2|Overall Study|Lost to Follow-up|5
5700984|NCT00245583|19651306|P1|Overall Study|Lost to Follow-up|1
5700985|NCT00245570|19651326|P6|Washout Between Periods III and IV|Adverse Event|0
5700986|NCT00245570|19651327|P5|Washout Between Periods III and IV|Adverse Event|0
5700987|NCT00245570|19651328|P4|Washout Between Periods III and IV|Adverse Event|0
5700988|NCT00245570|19651329|P3|Washout Between Periods III and IV|Adverse Event|0
5700989|NCT00245570|19651330|P2|Washout Between Periods III and IV|Adverse Event|1
5700990|NCT00245570|19651331|P1|Washout Between Periods III and IV|Adverse Event|0
5700991|NCT00245466|19651465|P3|Overall Study|Administrative reasons|0
5700992|NCT00245466|19651466|P2|Overall Study|Administrative reasons|1
5700993|NCT00245466|19651467|P1|Overall Study|Administrative reasons|0
5700994|NCT00245466|19651465|P3|Overall Study|Death|0
5700995|NCT00245466|19651466|P2|Overall Study|Death|2
5700996|NCT00245466|19651467|P1|Overall Study|Death|0
5700997|NCT00245466|19651465|P3|Overall Study|Protocol Violation|2
5700998|NCT00245466|19651466|P2|Overall Study|Protocol Violation|2
5700999|NCT00245466|19651467|P1|Overall Study|Protocol Violation|1
5701000|NCT00245466|19651465|P3|Overall Study|Disease progression|1
5701001|NCT00245466|19651466|P2|Overall Study|Disease progression|3
5701002|NCT00245466|19651467|P1|Overall Study|Disease progression|0
5701003|NCT00245466|19651465|P3|Overall Study|Lost to Follow-up|0
5701004|NCT00245466|19651466|P2|Overall Study|Lost to Follow-up|0
5701005|NCT00245466|19651467|P1|Overall Study|Lost to Follow-up|3
5701006|NCT00245466|19651465|P3|Overall Study|Withdrawal by Subject|1
5701007|NCT00245466|19651466|P2|Overall Study|Withdrawal by Subject|2
5701008|NCT00245466|19651467|P1|Overall Study|Withdrawal by Subject|2
5701009|NCT00245466|19651465|P3|Overall Study|Insufficient PSA and testosterone suppr|3
5701010|NCT00245466|19651466|P2|Overall Study|Insufficient PSA and testosterone suppr|0
5701011|NCT00245466|19651467|P1|Overall Study|Insufficient PSA and testosterone suppr|0
5701012|NCT00245466|19651465|P3|Overall Study|Insufficient testosterone suppr|21
5701013|NCT00245466|19651466|P2|Overall Study|Insufficient testosterone suppr|12
5701014|NCT00245466|19651467|P1|Overall Study|Insufficient testosterone suppr|12
5701015|NCT00245466|19651465|P3|Overall Study|Low prostate specific antigen suppr|5
5701016|NCT00245466|19651466|P2|Overall Study|Low prostate specific antigen suppr|14
5701017|NCT00245466|19651467|P1|Overall Study|Low prostate specific antigen suppr|16
5701018|NCT00245466|19651465|P3|Overall Study|Adverse Event|4
5701019|NCT00245466|19651466|P2|Overall Study|Adverse Event|8
5701020|NCT00245466|19651467|P1|Overall Study|Adverse Event|2
5701021|NCT00245102|19651510|P6|Overall Study|Clinical progression|0
5701022|NCT00245102|19651511|P5|Overall Study|Clinical progression|0
5701023|NCT00245102|19651512|P4|Overall Study|Clinical progression|0
5701024|NCT00245102|19651513|P3|Overall Study|Clinical progression|0
5701025|NCT00245102|19651514|P2|Overall Study|Clinical progression|0
5701026|NCT00245102|19651515|P1|Overall Study|Clinical progression|1
5701027|NCT00245102|19651510|P6|Overall Study|Participant needed surgery|0
5701028|NCT00245102|19651511|P5|Overall Study|Participant needed surgery|0
5701029|NCT00245102|19651512|P4|Overall Study|Participant needed surgery|0
5701030|NCT00245102|19651513|P3|Overall Study|Participant needed surgery|1
5701031|NCT00245102|19651514|P2|Overall Study|Participant needed surgery|0
5701032|NCT00245102|19651515|P1|Overall Study|Participant needed surgery|0
5701033|NCT00245102|19651510|P6|Overall Study|Decline in performance|2
5701034|NCT00245102|19651511|P5|Overall Study|Decline in performance|0
5701035|NCT00245102|19651512|P4|Overall Study|Decline in performance|1
5701036|NCT00245102|19651513|P3|Overall Study|Decline in performance|0
5701037|NCT00245102|19651514|P2|Overall Study|Decline in performance|2
5701038|NCT00245102|19651515|P1|Overall Study|Decline in performance|0
5701039|NCT00245102|19651510|P6|Overall Study|Adverse Event|2
5701040|NCT00245102|19651511|P5|Overall Study|Adverse Event|0
5701041|NCT00245102|19651512|P4|Overall Study|Adverse Event|1
5701042|NCT00245102|19651513|P3|Overall Study|Adverse Event|5
5701043|NCT00245102|19651514|P2|Overall Study|Adverse Event|2
5701044|NCT00245102|19651515|P1|Overall Study|Adverse Event|4
5701045|NCT00245102|19651510|P6|Overall Study|Death|0
5701046|NCT00245102|19651511|P5|Overall Study|Death|0
5701047|NCT00245102|19651512|P4|Overall Study|Death|1
5701048|NCT00245102|19651513|P3|Overall Study|Death|0
5701049|NCT00245102|19651514|P2|Overall Study|Death|0
5701050|NCT00245102|19651515|P1|Overall Study|Death|0
5701051|NCT00245102|19651510|P6|Overall Study|Protocol Violation|0
5701052|NCT00245102|19651511|P5|Overall Study|Protocol Violation|0
5701053|NCT00245102|19651512|P4|Overall Study|Protocol Violation|0
5701054|NCT00245102|19651513|P3|Overall Study|Protocol Violation|0
5701055|NCT00245102|19651514|P2|Overall Study|Protocol Violation|0
5701056|NCT00245102|19651515|P1|Overall Study|Protocol Violation|1
5701057|NCT00245102|19651510|P6|Overall Study|Not Treated|0
5701058|NCT00245102|19651511|P5|Overall Study|Not Treated|0
5701059|NCT00245102|19651512|P4|Overall Study|Not Treated|0
5701060|NCT00245102|19651513|P3|Overall Study|Not Treated|1
5701061|NCT00245102|19651514|P2|Overall Study|Not Treated|0
5701062|NCT00245102|19651515|P1|Overall Study|Not Treated|1
5701063|NCT00245063|19651531|P2|Overall Study|Death|0
5701064|NCT00245063|19651532|P1|Overall Study|Death|1
5701065|NCT00245063|19651531|P2|Overall Study|Adverse Event|5
5701066|NCT00245063|19651532|P1|Overall Study|Adverse Event|6
5701067|NCT00245050|19651540|P2|Overall Study|Adverse Event|2
5701068|NCT00245050|19651541|P1|Overall Study|Adverse Event|3
5701069|NCT00245037|19651549|P1|Overall Study|Death|17
5701070|NCT00245011|19651559|P1|Overall Study|Lack of Efficacy|1
5701071|NCT00244933|19651576|P1|Overall Study|Not response evaluable|2
5701072|NCT00244881|19651580|P1|Overall Study|Withdrawal by Subject|3
5701073|NCT00244855|19651588|P2|Overall Study|Withdrawal by Subject|1
5701074|NCT00244855|19651589|P1|Overall Study|Withdrawal by Subject|0
5701075|NCT00244764|19651597|P1|Overall Study|Developed Secondary Malignancy|1
5701076|NCT00244764|19651597|P1|Overall Study|Sponsor Terminated Study|2
5701077|NCT00244764|19651597|P1|Overall Study|Primary Investigator Discretion|2
5701078|NCT00244764|19651597|P1|Overall Study|Participant was Hospitalized until Death|1
5701079|NCT00244764|19651597|P1|Overall Study|Declining Performance Status|1
5701080|NCT00244764|19651597|P1|Overall Study|Off Study Medication for >21 Days|1
5701081|NCT00244764|19651597|P1|Overall Study|Death|1
5701082|NCT00244764|19651597|P1|Overall Study|Protocol Violation|2
5701083|NCT00244764|19651597|P1|Overall Study|Disease Progression|13
5701084|NCT00244764|19651597|P1|Overall Study|Withdrawal by Subject|12
5701085|NCT00244764|19651597|P1|Overall Study|Lost to Follow-up|23
5701086|NCT00244764|19651597|P1|Overall Study|Adverse Event|37
5701087|NCT00244751|19651607|P3|Overall Study|Participant randomized by mistake|1
5701088|NCT00244751|19651608|P2|Overall Study|Participant randomized by mistake|0
5701089|NCT00244751|19651609|P1|Overall Study|Participant randomized by mistake|0
5701090|NCT00244751|19651607|P3|Overall Study|Safety reasons|0
5701091|NCT00244751|19651608|P2|Overall Study|Safety reasons|1
5701092|NCT00244751|19651609|P1|Overall Study|Safety reasons|0
5701093|NCT00244751|19651607|P3|Overall Study|Lack of compliance with protocol|0
5701094|NCT00244751|19651608|P2|Overall Study|Lack of compliance with protocol|1
5701095|NCT00244751|19651609|P1|Overall Study|Lack of compliance with protocol|0
5701096|NCT00244751|19651607|P3|Overall Study|Elevated liver enzymes|0
5701097|NCT00244751|19651608|P2|Overall Study|Elevated liver enzymes|0
5701098|NCT00244751|19651609|P1|Overall Study|Elevated liver enzymes|1
5701099|NCT00244751|19651607|P3|Overall Study|Withdrawal by Subject|3
5701100|NCT00244751|19651608|P2|Overall Study|Withdrawal by Subject|5
5701101|NCT00244751|19651609|P1|Overall Study|Withdrawal by Subject|7
5701102|NCT00244751|19651607|P3|Overall Study|Protocol Violation|1
5701103|NCT00244751|19651608|P2|Overall Study|Protocol Violation|0
5701104|NCT00244751|19651609|P1|Overall Study|Protocol Violation|1
5701105|NCT00244751|19651607|P3|Overall Study|Lost to Follow-up|0
5701106|NCT00244751|19651608|P2|Overall Study|Lost to Follow-up|1
5701107|NCT00244751|19651609|P1|Overall Study|Lost to Follow-up|0
5701108|NCT00244751|19651607|P3|Overall Study|Adverse Event|5
5701109|NCT00244751|19651608|P2|Overall Study|Adverse Event|7
5701110|NCT00244751|19651609|P1|Overall Study|Adverse Event|7
5701111|NCT00244725|19651710|P4|Overall Study|Failed to follow-up|1
5701112|NCT00244725|19651711|P3|Overall Study|Failed to follow-up|1
5701113|NCT00244725|19651712|P2|Overall Study|Failed to follow-up|0
5701114|NCT00244725|19651713|P1|Overall Study|Failed to follow-up|0
5701115|NCT00244725|19651710|P4|Overall Study|Vomit|0
5701116|NCT00244725|19651711|P3|Overall Study|Vomit|1
5701117|NCT00244725|19651712|P2|Overall Study|Vomit|0
5701118|NCT00244725|19651713|P1|Overall Study|Vomit|0
5701119|NCT00244725|19651710|P4|Overall Study|Administrative reason|0
5701120|NCT00244725|19651711|P3|Overall Study|Administrative reason|1
5701121|NCT00244725|19651712|P2|Overall Study|Administrative reason|0
5701122|NCT00244725|19651713|P1|Overall Study|Administrative reason|0
5701123|NCT00244725|19651710|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
5701124|NCT00244725|19651711|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
5701125|NCT00244725|19651712|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
5701126|NCT00244725|19651713|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
5701127|NCT00244725|19651710|P4|Overall Study|Received prohibited medication|1
5701128|NCT00244725|19651711|P3|Overall Study|Received prohibited medication|0
5701129|NCT00244725|19651712|P2|Overall Study|Received prohibited medication|1
5701130|NCT00244725|19651713|P1|Overall Study|Received prohibited medication|0
5701131|NCT00244725|19651710|P4|Overall Study|Headache|0
5701132|NCT00244725|19651711|P3|Overall Study|Headache|0
5701133|NCT00244725|19651712|P2|Overall Study|Headache|1
5701134|NCT00244725|19651713|P1|Overall Study|Headache|0
5701135|NCT00244725|19651710|P4|Overall Study|Rehab Refused to allow participantion|0
5701136|NCT00244725|19651711|P3|Overall Study|Rehab Refused to allow participantion|0
5701137|NCT00244725|19651712|P2|Overall Study|Rehab Refused to allow participantion|1
5701138|NCT00244725|19651713|P1|Overall Study|Rehab Refused to allow participantion|0
5701139|NCT00244725|19651710|P4|Overall Study|Mediciation Error|0
5701140|NCT00244725|19651711|P3|Overall Study|Mediciation Error|0
5701141|NCT00244725|19651712|P2|Overall Study|Mediciation Error|1
5701142|NCT00244725|19651713|P1|Overall Study|Mediciation Error|0
5701143|NCT00244725|19651710|P4|Overall Study|Sponsor withdrew the participant|1
5701144|NCT00244725|19651711|P3|Overall Study|Sponsor withdrew the participant|0
5701145|NCT00244725|19651712|P2|Overall Study|Sponsor withdrew the participant|0
5701146|NCT00244725|19651713|P1|Overall Study|Sponsor withdrew the participant|1
5701147|NCT00244725|19651710|P4|Overall Study|Liver function test abnormality|1
5701148|NCT00244725|19651711|P3|Overall Study|Liver function test abnormality|0
5701149|NCT00244725|19651712|P2|Overall Study|Liver function test abnormality|0
5701150|NCT00244725|19651713|P1|Overall Study|Liver function test abnormality|2
5701151|NCT00244725|19651710|P4|Overall Study|Withdrwal by participant|1
5701152|NCT00244725|19651711|P3|Overall Study|Withdrwal by participant|0
5701153|NCT00244725|19651712|P2|Overall Study|Withdrwal by participant|0
5701154|NCT00244725|19651713|P1|Overall Study|Withdrwal by participant|1
5701155|NCT00244725|19651710|P4|Overall Study|Adverse Events|4
5701156|NCT00244725|19651711|P3|Overall Study|Adverse Events|4
5701157|NCT00244725|19651712|P2|Overall Study|Adverse Events|1
5701158|NCT00244725|19651713|P1|Overall Study|Adverse Events|3
5701159|NCT00244725|19651710|P4|Overall Study|Physician Decision|2
5701160|NCT00244725|19651711|P3|Overall Study|Physician Decision|1
5701161|NCT00244725|19651712|P2|Overall Study|Physician Decision|0
5701162|NCT00244725|19651713|P1|Overall Study|Physician Decision|3
5701163|NCT00244725|19651710|P4|Overall Study|Not meet treatment eligibility criteria|0
5701164|NCT00244725|19651711|P3|Overall Study|Not meet treatment eligibility criteria|0
5701165|NCT00244725|19651712|P2|Overall Study|Not meet treatment eligibility criteria|2
5701166|NCT00244725|19651713|P1|Overall Study|Not meet treatment eligibility criteria|1
5701167|NCT00244725|19651710|P4|Overall Study|Withdrawal by Subject|8
5701168|NCT00244725|19651711|P3|Overall Study|Withdrawal by Subject|7
5701169|NCT00244725|19651712|P2|Overall Study|Withdrawal by Subject|7
5701170|NCT00244725|19651713|P1|Overall Study|Withdrawal by Subject|9
5701171|NCT00244725|19651710|P4|Overall Study|Lost to Follow-up|2
5701172|NCT00244725|19651711|P3|Overall Study|Lost to Follow-up|9
5701173|NCT00244725|19651712|P2|Overall Study|Lost to Follow-up|4
5701174|NCT00244725|19651713|P1|Overall Study|Lost to Follow-up|3
5701175|NCT00244712|19651769|P2|Overall Study|Protocol Violation, disease progression|11
5701176|NCT00244712|19651770|P1|Overall Study|Protocol Violation, disease progression|13
5701177|NCT00244712|19651769|P2|Overall Study|Withdrawal by Subject|23
5701178|NCT00244712|19651770|P1|Overall Study|Withdrawal by Subject|13
5701179|NCT00244712|19651769|P2|Overall Study|Lost to Follow-up|52
5701180|NCT00244712|19651770|P1|Overall Study|Lost to Follow-up|45
5701181|NCT00244712|19651769|P2|Overall Study|Lack of Compliance|11
5701182|NCT00244712|19651770|P1|Overall Study|Lack of Compliance|10
5701183|NCT00244712|19651769|P2|Overall Study|Protocol-Defined Virologic Failure|6
5701184|NCT00244712|19651770|P1|Overall Study|Protocol-Defined Virologic Failure|8
5701185|NCT00244712|19651769|P2|Overall Study|Adverse Event|21
5701186|NCT00244712|19651770|P1|Overall Study|Adverse Event|20
5701187|NCT00244621|19651805|P3|Open-label Treatment Period|Moved abroad|1
5701188|NCT00244621|19651806|P2|Open-label Treatment Period|Moved abroad|0
5701189|NCT00244621|19651807|P1|Open-label Treatment Period|Moved abroad|0
5701190|NCT00244621|19651805|P3|Open-label Treatment Period|Adverse Event|1
5701191|NCT00244621|19651806|P2|Open-label Treatment Period|Adverse Event|0
5701192|NCT00244621|19651807|P1|Open-label Treatment Period|Adverse Event|0
5701193|NCT00244621|19651805|P3|Open-label Treatment Period|Withdrawal by Subject|0
5701194|NCT00244621|19651806|P2|Open-label Treatment Period|Withdrawal by Subject|0
5701195|NCT00244621|19651807|P1|Open-label Treatment Period|Withdrawal by Subject|1
5701196|NCT00244621|19651805|P3|Open-label Treatment Period|Lost to Follow-up|0
5701197|NCT00244621|19651806|P2|Open-label Treatment Period|Lost to Follow-up|1
5701198|NCT00244621|19651807|P1|Open-label Treatment Period|Lost to Follow-up|0
5701199|NCT00244621|19651805|P3|Double-blind Treatment Period|Multiple Reasons|1
5701200|NCT00244621|19651806|P2|Double-blind Treatment Period|Multiple Reasons|1
5701201|NCT00244621|19651807|P1|Double-blind Treatment Period|Multiple Reasons|2
5701202|NCT00244621|19651805|P3|Double-blind Treatment Period|Lack of Efficacy|0
5701203|NCT00244621|19651806|P2|Double-blind Treatment Period|Lack of Efficacy|1
5701204|NCT00244621|19651807|P1|Double-blind Treatment Period|Lack of Efficacy|0
5701205|NCT00244621|19651805|P3|Double-blind Treatment Period|Withdrawal by Subject|0
5701206|NCT00244621|19651806|P2|Double-blind Treatment Period|Withdrawal by Subject|1
5701207|NCT00244621|19651807|P1|Double-blind Treatment Period|Withdrawal by Subject|0
5701208|NCT00244621|19651805|P3|Double-blind Treatment Period|Lost to Follow-up|1
5701209|NCT00244621|19651806|P2|Double-blind Treatment Period|Lost to Follow-up|0
5701210|NCT00244621|19651807|P1|Double-blind Treatment Period|Lost to Follow-up|0
5701211|NCT00244374|19651824|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
5701212|NCT00244374|19651825|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
5701213|NCT00244374|19651826|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
5701214|NCT00244374|19651827|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
5701215|NCT00244374|19651828|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
5701216|NCT00244374|19651824|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
5701217|NCT00244374|19651825|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
5701218|NCT00244374|19651826|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
5701219|NCT00244374|19651827|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
5701220|NCT00244374|19651828|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
5701221|NCT00244374|19651824|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
5701222|NCT00244374|19651825|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
5701223|NCT00244374|19651826|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
5701224|NCT00244374|19651827|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
5701225|NCT00244374|19651828|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
5701226|NCT00244374|19651824|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
5701227|NCT00244374|19651825|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
5701228|NCT00244374|19651826|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
5701229|NCT00244374|19651827|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
5701230|NCT00244374|19651828|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
5701231|NCT00244374|19651824|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
5701232|NCT00244374|19651825|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
5701233|NCT00244374|19651826|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
5701234|NCT00244374|19651827|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
5701235|NCT00244374|19651828|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
5701236|NCT00244374|19651824|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
5701237|NCT00244374|19651825|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
5701238|NCT00244374|19651826|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
5701239|NCT00244374|19651827|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
5701240|NCT00244374|19651828|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
5701241|NCT00244374|19651824|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
5701242|NCT00244374|19651825|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
5701243|NCT00244374|19651826|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
5701244|NCT00244374|19651827|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
5701245|NCT00244374|19651828|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
5701246|NCT00244374|19651824|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
5701247|NCT00244374|19651825|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
5701248|NCT00244374|19651826|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
5701249|NCT00244374|19651827|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
5701250|NCT00244374|19651828|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
5701251|NCT00244374|19651824|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
5701252|NCT00244374|19651825|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
5701253|NCT00244374|19651826|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
5701254|NCT00244374|19651827|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
5701255|NCT00244374|19651828|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
5701256|NCT00243932|19651884|P3|Stage 1: Dose Selection|Lost to Follow-up|0
5701257|NCT00243932|19651885|P2|Stage 1: Dose Selection|Lost to Follow-up|0
5701258|NCT00243932|19651886|P1|Stage 1: Dose Selection|Lost to Follow-up|2
5701259|NCT00243919|19651897|P3|Overall Study|Physician Decision|0
5701260|NCT00243919|19651898|P2|Overall Study|Physician Decision|1
5701261|NCT00243919|19651899|P1|Overall Study|Physician Decision|1
5701262|NCT00243919|19651897|P3|Overall Study|Administrative Error|0
5701263|NCT00243919|19651898|P2|Overall Study|Administrative Error|0
5701264|NCT00243919|19651899|P1|Overall Study|Administrative Error|1
5701265|NCT00243919|19651897|P3|Overall Study|Lost to Follow-up|3
5701266|NCT00243919|19651898|P2|Overall Study|Lost to Follow-up|7
5701267|NCT00243919|19651899|P1|Overall Study|Lost to Follow-up|6
5701268|NCT00243919|19651897|P3|Overall Study|Withdrawal by Subject|2
5701269|NCT00243919|19651898|P2|Overall Study|Withdrawal by Subject|6
5701270|NCT00243919|19651899|P1|Overall Study|Withdrawal by Subject|6
5701271|NCT00243919|19651897|P3|Overall Study|Death|6
5701272|NCT00243919|19651898|P2|Overall Study|Death|4
5701273|NCT00243919|19651899|P1|Overall Study|Death|3
5701274|NCT00243841|19651943|P6|Overall Study|Physician Decision|2
5701275|NCT00243841|19651944|P5|Overall Study|Physician Decision|0
5701276|NCT00243841|19651945|P4|Overall Study|Physician Decision|0
5701277|NCT00243841|19651946|P3|Overall Study|Physician Decision|1
5701278|NCT00243841|19651947|P2|Overall Study|Physician Decision|0
5701279|NCT00243841|19651948|P1|Overall Study|Physician Decision|0
5701280|NCT00243659|19651970|P2|Overall Study|Protocol Violation|2
5701281|NCT00243659|19651971|P1|Overall Study|Protocol Violation|1
5701282|NCT00243659|19651970|P2|Overall Study|Withdrawal by Subject|1
5701283|NCT00243659|19651971|P1|Overall Study|Withdrawal by Subject|1
5701284|NCT00243503|19651979|P1|Overall Study|Other|1
5701285|NCT00243503|19651979|P1|Overall Study|Death|1
5701286|NCT00243503|19651979|P1|Overall Study|Lack of Efficacy|44
5701287|NCT00243503|19651979|P1|Overall Study|Withdrawal by Subject|1
5701288|NCT00243503|19651979|P1|Overall Study|Adverse Event|11
5701289|NCT00243412|19651996|P2|Overall Study|Other|1
5701290|NCT00243412|19651997|P1|Overall Study|Other|1
5701291|NCT00243412|19651996|P2|Overall Study|Withdrawal by Subject|5
5701292|NCT00243412|19651997|P1|Overall Study|Withdrawal by Subject|4
5701293|NCT00243412|19651996|P2|Overall Study|Physician Decision|1
5701294|NCT00243412|19651997|P1|Overall Study|Physician Decision|1
5701295|NCT00243412|19651996|P2|Overall Study|Lost to Follow-up|1
5701296|NCT00243412|19651997|P1|Overall Study|Lost to Follow-up|0
5701297|NCT00243412|19651996|P2|Overall Study|Adverse Event|2
5701298|NCT00243412|19651997|P1|Overall Study|Adverse Event|4
5701299|NCT00243412|19651996|P2|Overall Study|Death|1
5701300|NCT00243412|19651997|P1|Overall Study|Death|0
5701301|NCT00243386|19652023|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
5701302|NCT00243386|19652024|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
5701303|NCT00243386|19652025|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
5701304|NCT00243386|19652023|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
5701305|NCT00243386|19652024|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
5701306|NCT00243386|19652025|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
5701307|NCT00243386|19652023|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
5701308|NCT00243386|19652024|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
5701309|NCT00243386|19652025|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
5701310|NCT00243386|19652023|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
5701311|NCT00243386|19652024|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
5701312|NCT00243386|19652025|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
5701313|NCT00243386|19652023|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
5701314|NCT00243386|19652024|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
5701315|NCT00243386|19652025|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
5701316|NCT00243386|19652023|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
5701317|NCT00243386|19652024|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
5701318|NCT00243386|19652025|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
5701319|NCT00243386|19652023|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
5701320|NCT00243386|19652024|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
5701321|NCT00243386|19652025|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
5701322|NCT00243386|19652023|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
5701323|NCT00243386|19652024|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
5701324|NCT00243386|19652025|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
5701325|NCT00243347|19652090|P1|Overall Study|Condition worsened|7
5701326|NCT00243347|19652090|P1|Overall Study|Withdrawal by Subject|5
5701327|NCT00243347|19652090|P1|Overall Study|Death|1
5701328|NCT00243347|19652090|P1|Overall Study|Adverse Event|2
5701329|NCT00243347|19652090|P1|Overall Study|Lack of Efficacy|4
5701330|NCT00243269|19652099|P4|Overall Study|Lost to Follow-up|3
5701331|NCT00243269|19652100|P3|Overall Study|Lost to Follow-up|1
5701332|NCT00243269|19652101|P2|Overall Study|Lost to Follow-up|0
5701333|NCT00243269|19652102|P1|Overall Study|Lost to Follow-up|1
5701334|NCT00243269|19652099|P4|Overall Study|Protocol Violation|1
5701335|NCT00243269|19652100|P3|Overall Study|Protocol Violation|0
5701336|NCT00243269|19652101|P2|Overall Study|Protocol Violation|1
5701337|NCT00243269|19652102|P1|Overall Study|Protocol Violation|2
5701338|NCT00243074|19652137|P1|Overall Study|Did not receive any treatment|1
5701339|NCT00243074|19652137|P1|Overall Study|not protocol specified|1
5701340|NCT00243074|19652137|P1|Overall Study|Death|2
5701341|NCT00243074|19652137|P1|Overall Study|Lack of Efficacy|36
5701342|NCT00243074|19652137|P1|Overall Study|Withdrawal by Subject|2
5701343|NCT00243074|19652137|P1|Overall Study|Adverse Event|6
5701344|NCT00243074|19652137|P1|Overall Study|Ineligible|6
5701345|NCT00243022|19652163|P2|Overall Study|Difficult Travel Distance|1
5701346|NCT00243022|19652164|P1|Overall Study|Difficult Travel Distance|0
5701347|NCT00243022|19652163|P2|Overall Study|Death|0
5701348|NCT00243022|19652164|P1|Overall Study|Death|1
5701349|NCT00243022|19652163|P2|Overall Study|Withdrawal by Subject|0
5701350|NCT00243022|19652164|P1|Overall Study|Withdrawal by Subject|1
5701351|NCT00242710|19652188|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
5701352|NCT00242710|19652189|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
5701353|NCT00242710|19652190|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
5701354|NCT00242710|19652191|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
5701355|NCT00242710|19652188|P4|Study Extension (up to Year 2)|Protocol Violation|1
5701356|NCT00242710|19652189|P3|Study Extension (up to Year 2)|Protocol Violation|0
5701357|NCT00242710|19652190|P2|Study Extension (up to Year 2)|Protocol Violation|2
5701358|NCT00242710|19652191|P1|Study Extension (up to Year 2)|Protocol Violation|0
5701359|NCT00242710|19652188|P4|Study Extension (up to Year 2)|Other|3
5701360|NCT00242710|19652189|P3|Study Extension (up to Year 2)|Other|4
5701361|NCT00242710|19652190|P2|Study Extension (up to Year 2)|Other|5
5701362|NCT00242710|19652191|P1|Study Extension (up to Year 2)|Other|3
5701363|NCT00242710|19652188|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
5701364|NCT00242710|19652189|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
5701365|NCT00242710|19652190|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
5701366|NCT00242710|19652191|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
5701367|NCT00242710|19652188|P4|Study Extension (up to Year 2)|Death|1
5701368|NCT00242710|19652189|P3|Study Extension (up to Year 2)|Death|0
5701369|NCT00242710|19652190|P2|Study Extension (up to Year 2)|Death|0
5701370|NCT00242710|19652191|P1|Study Extension (up to Year 2)|Death|0
5701371|NCT00242710|19652188|P4|Study Extension (up to Year 2)|Adverse Event|4
5701372|NCT00242710|19652189|P3|Study Extension (up to Year 2)|Adverse Event|2
5701373|NCT00242710|19652190|P2|Study Extension (up to Year 2)|Adverse Event|9
5701374|NCT00242710|19652191|P1|Study Extension (up to Year 2)|Adverse Event|7
5701375|NCT00242710|19652188|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
5701376|NCT00242710|19652189|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
5701377|NCT00242710|19652190|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
5701378|NCT00242710|19652191|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
5701379|NCT00242710|19652188|P4|Period Between Core Study and Extension|Protocol Violation|1
5701380|NCT00242710|19652189|P3|Period Between Core Study and Extension|Protocol Violation|2
5701381|NCT00242710|19652190|P2|Period Between Core Study and Extension|Protocol Violation|0
5701382|NCT00242710|19652191|P1|Period Between Core Study and Extension|Protocol Violation|0
5701383|NCT00242710|19652188|P4|Period Between Core Study and Extension|Extension not Available|7
5701384|NCT00242710|19652189|P3|Period Between Core Study and Extension|Extension not Available|8
5701385|NCT00242710|19652190|P2|Period Between Core Study and Extension|Extension not Available|21
5701386|NCT00242710|19652191|P1|Period Between Core Study and Extension|Extension not Available|17
5701387|NCT00242710|19652188|P4|Period Between Core Study and Extension|Other|11
5701388|NCT00242710|19652189|P3|Period Between Core Study and Extension|Other|9
5701389|NCT00242710|19652190|P2|Period Between Core Study and Extension|Other|24
5701390|NCT00242710|19652191|P1|Period Between Core Study and Extension|Other|24
5701391|NCT00242710|19652188|P4|Period Between Core Study and Extension|Physician Decision|0
5701392|NCT00242710|19652189|P3|Period Between Core Study and Extension|Physician Decision|0
5701393|NCT00242710|19652190|P2|Period Between Core Study and Extension|Physician Decision|1
5701394|NCT00242710|19652191|P1|Period Between Core Study and Extension|Physician Decision|1
5701395|NCT00242710|19652188|P4|Period Between Core Study and Extension|Adverse Event|2
5701396|NCT00242710|19652189|P3|Period Between Core Study and Extension|Adverse Event|5
5701397|NCT00242710|19652190|P2|Period Between Core Study and Extension|Adverse Event|3
5701398|NCT00242710|19652191|P1|Period Between Core Study and Extension|Adverse Event|2
5701399|NCT00242710|19652188|P4|Core Study (up to Year 1)|Randomized but not Treated|2
5701400|NCT00242710|19652189|P3|Core Study (up to Year 1)|Randomized but not Treated|4
5701401|NCT00242710|19652190|P2|Core Study (up to Year 1)|Randomized but not Treated|4
5701402|NCT00242710|19652191|P1|Core Study (up to Year 1)|Randomized but not Treated|12
5701403|NCT00242710|19652188|P4|Core Study (up to Year 1)|Lack of Efficacy|0
5701404|NCT00242710|19652189|P3|Core Study (up to Year 1)|Lack of Efficacy|0
5701405|NCT00242710|19652190|P2|Core Study (up to Year 1)|Lack of Efficacy|0
5701406|NCT00242710|19652191|P1|Core Study (up to Year 1)|Lack of Efficacy|1
5701407|NCT00242710|19652188|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
5701408|NCT00242710|19652189|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
5701409|NCT00242710|19652190|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
5701410|NCT00242710|19652191|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
5701411|NCT00242710|19652188|P4|Core Study (up to Year 1)|Protocol Violation|3
5701412|NCT00242710|19652189|P3|Core Study (up to Year 1)|Protocol Violation|1
5701413|NCT00242710|19652190|P2|Core Study (up to Year 1)|Protocol Violation|9
5701414|NCT00242710|19652191|P1|Core Study (up to Year 1)|Protocol Violation|2
5701415|NCT00242710|19652188|P4|Core Study (up to Year 1)|Other|2
5701416|NCT00242710|19652189|P3|Core Study (up to Year 1)|Other|0
5701417|NCT00242710|19652190|P2|Core Study (up to Year 1)|Other|1
5701418|NCT00242710|19652191|P1|Core Study (up to Year 1)|Other|6
5701419|NCT00242710|19652188|P4|Core Study (up to Year 1)|Lost to Follow-up|3
5701420|NCT00242710|19652189|P3|Core Study (up to Year 1)|Lost to Follow-up|7
5701421|NCT00242710|19652190|P2|Core Study (up to Year 1)|Lost to Follow-up|8
5701422|NCT00242710|19652191|P1|Core Study (up to Year 1)|Lost to Follow-up|8
5701423|NCT00242710|19652188|P4|Core Study (up to Year 1)|Physician Decision|1
5701424|NCT00242710|19652189|P3|Core Study (up to Year 1)|Physician Decision|0
5701425|NCT00242710|19652190|P2|Core Study (up to Year 1)|Physician Decision|1
5701426|NCT00242710|19652191|P1|Core Study (up to Year 1)|Physician Decision|0
5701427|NCT00242710|19652188|P4|Core Study (up to Year 1)|Death|0
5701428|NCT00242710|19652189|P3|Core Study (up to Year 1)|Death|1
5701429|NCT00242710|19652190|P2|Core Study (up to Year 1)|Death|0
5701430|NCT00242710|19652191|P1|Core Study (up to Year 1)|Death|0
5701431|NCT00242710|19652188|P4|Core Study (up to Year 1)|Adverse Event|14
5701432|NCT00242710|19652189|P3|Core Study (up to Year 1)|Adverse Event|23
5701433|NCT00242710|19652190|P2|Core Study (up to Year 1)|Adverse Event|25
5701434|NCT00242710|19652191|P1|Core Study (up to Year 1)|Adverse Event|30
5701435|NCT00242658|19652248|P2|Overall Study|Lost to Follow-up|19
5701436|NCT00242658|19652249|P1|Overall Study|Lost to Follow-up|22
5701437|NCT00242580|19652280|P3|Overall Study|Death|1
5701438|NCT00242580|19652281|P2|Overall Study|Death|2
5701439|NCT00242580|19652282|P1|Overall Study|Death|1
5701440|NCT00242580|19652280|P3|Overall Study|Lost to Follow-up|0
5701441|NCT00242580|19652281|P2|Overall Study|Lost to Follow-up|3
5701442|NCT00242580|19652282|P1|Overall Study|Lost to Follow-up|0
5701443|NCT00242580|19652280|P3|Overall Study|Subject withdrew consent|5
5701444|NCT00242580|19652281|P2|Overall Study|Subject withdrew consent|2
5701445|NCT00242580|19652282|P1|Overall Study|Subject withdrew consent|2
5701446|NCT00242580|19652280|P3|Overall Study|Protocol Violation|1
5701447|NCT00242580|19652281|P2|Overall Study|Protocol Violation|0
5701448|NCT00242580|19652282|P1|Overall Study|Protocol Violation|0
5701449|NCT00242580|19652280|P3|Overall Study|Unsatisfactory therapeutic effect|5
5701450|NCT00242580|19652281|P2|Overall Study|Unsatisfactory therapeutic effect|5
5701451|NCT00242580|19652282|P1|Overall Study|Unsatisfactory therapeutic effect|4
5701452|NCT00242580|19652280|P3|Overall Study|Adverse Event|2
5701453|NCT00242580|19652281|P2|Overall Study|Adverse Event|0
5701454|NCT00242580|19652282|P1|Overall Study|Adverse Event|3
5701455|NCT00242567|19652307|P2|Overall Study|Other|9
5701456|NCT00242567|19652308|P1|Overall Study|Other|14
5701457|NCT00242567|19652307|P2|Overall Study|Use of an inhibitor of bone resorption|2
5701458|NCT00242567|19652308|P1|Overall Study|Use of an inhibitor of bone resorption|0
5701459|NCT00242567|19652307|P2|Overall Study|Protocol Violation|12
5701460|NCT00242567|19652308|P1|Overall Study|Protocol Violation|12
5701461|NCT00242567|19652307|P2|Overall Study|Withdrawal by Subject|28
5701462|NCT00242567|19652308|P1|Overall Study|Withdrawal by Subject|33
5701463|NCT00242567|19652307|P2|Overall Study|Lost to Follow-up|19
5701464|NCT00242567|19652308|P1|Overall Study|Lost to Follow-up|9
5701465|NCT00242567|19652307|P2|Overall Study|Lack of Efficacy|2
5701466|NCT00242567|19652308|P1|Overall Study|Lack of Efficacy|2
5701467|NCT00242567|19652307|P2|Overall Study|Symptomatic deterioration|3
5701468|NCT00242567|19652308|P1|Overall Study|Symptomatic deterioration|9
5701469|NCT00242567|19652307|P2|Overall Study|Disease Progression|22
5701470|NCT00242567|19652308|P1|Overall Study|Disease Progression|17
5701471|NCT00242567|19652307|P2|Overall Study|Adverse Event|43
5701472|NCT00242567|19652308|P1|Overall Study|Adverse Event|70
5701473|NCT00242216|19652355|P2|Overall Study|no medicaiton dispensed|1
5701474|NCT00242216|19652356|P1|Overall Study|no medicaiton dispensed|1
5701475|NCT00242216|19652355|P2|Overall Study|Lack of Efficacy|2
5701476|NCT00242216|19652356|P1|Overall Study|Lack of Efficacy|1
5701477|NCT00242216|19652355|P2|Overall Study|Death|2
5701478|NCT00242216|19652356|P1|Overall Study|Death|4
5701479|NCT00242216|19652355|P2|Overall Study|Lost to Follow-up|17
5701480|NCT00242216|19652356|P1|Overall Study|Lost to Follow-up|12
5701481|NCT00241839|19652394|P2|Overall Study|Adverse Event|1
5701482|NCT00241839|19652395|P1|Overall Study|Adverse Event|1
5701483|NCT00241839|19652394|P2|Overall Study|Withdrawal by Subject|17
5701484|NCT00241839|19652395|P1|Overall Study|Withdrawal by Subject|18
5701485|NCT00241644|19652411|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
5701486|NCT00241644|19652412|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
5701487|NCT00241644|19652413|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
5701488|NCT00241644|19652414|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
5701489|NCT00241644|19652411|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
5701490|NCT00241644|19652412|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
5701491|NCT00241644|19652413|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
5701492|NCT00241644|19652414|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
5701493|NCT00241644|19652411|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
5701494|NCT00241644|19652412|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
5701495|NCT00241644|19652413|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
5701496|NCT00241644|19652414|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
5701497|NCT00241644|19652411|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
5701498|NCT00241644|19652412|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
5701499|NCT00241644|19652413|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
5701500|NCT00241644|19652414|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
5701501|NCT00241644|19652411|P4|Second Efficacy Period (Year 2)|Adverse Event|20
5701502|NCT00241644|19652412|P3|Second Efficacy Period (Year 2)|Adverse Event|12
5701503|NCT00241644|19652413|P2|Second Efficacy Period (Year 2)|Adverse Event|9
5701504|NCT00241644|19652414|P1|Second Efficacy Period (Year 2)|Adverse Event|11
5701505|NCT00241644|19652411|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
5701506|NCT00241644|19652412|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
5701507|NCT00241644|19652413|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
5701508|NCT00241644|19652414|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
5701509|NCT00241644|19652411|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
5701510|NCT00241644|19652412|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
5701511|NCT00241644|19652413|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
5701512|NCT00241644|19652414|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
5701513|NCT00241644|19652411|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
5701514|NCT00241644|19652412|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
5701515|NCT00241644|19652413|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
5701516|NCT00241644|19652414|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
5701517|NCT00241644|19652411|P4|First Efficacy Period (Year 1)|Non-compliance|3
5701518|NCT00241644|19652412|P3|First Efficacy Period (Year 1)|Non-compliance|2
5701519|NCT00241644|19652413|P2|First Efficacy Period (Year 1)|Non-compliance|1
5701520|NCT00241644|19652414|P1|First Efficacy Period (Year 1)|Non-compliance|2
5701521|NCT00241644|19652411|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
5701522|NCT00241644|19652412|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
5701523|NCT00241644|19652413|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
5701524|NCT00241644|19652414|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
5701525|NCT00241644|19652411|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
5701526|NCT00241644|19652412|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
5701527|NCT00241644|19652413|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
5701528|NCT00241644|19652414|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
5701529|NCT00241644|19652411|P4|First Efficacy Period (Year 1)|Protocol Violation|8
5701530|NCT00241644|19652412|P3|First Efficacy Period (Year 1)|Protocol Violation|4
5701531|NCT00241644|19652413|P2|First Efficacy Period (Year 1)|Protocol Violation|5
5701532|NCT00241644|19652414|P1|First Efficacy Period (Year 1)|Protocol Violation|3
5701533|NCT00241644|19652411|P4|First Efficacy Period (Year 1)|Adverse Event|91
5701534|NCT00241644|19652412|P3|First Efficacy Period (Year 1)|Adverse Event|45
5701535|NCT00241644|19652413|P2|First Efficacy Period (Year 1)|Adverse Event|45
5701536|NCT00241644|19652414|P1|First Efficacy Period (Year 1)|Adverse Event|46
5701537|NCT00241631|19652498|P2|Phase 1 (4 Weeks)|Lack of Efficacy|1
5701538|NCT00241631|19652499|P1|Phase 1 (4 Weeks)|Lack of Efficacy|0
5701539|NCT00241631|19652498|P2|Phase 1 (4 Weeks)|Lost to Follow-up|0
5701540|NCT00241631|19652499|P1|Phase 1 (4 Weeks)|Lost to Follow-up|3
5701541|NCT00241631|19652498|P2|Phase 1 (4 Weeks)|Withdrawal by Subject|4
5701542|NCT00241631|19652499|P1|Phase 1 (4 Weeks)|Withdrawal by Subject|4
5701543|NCT00241631|19652498|P2|Phase 1 (4 Weeks)|sore throat|0
5701544|NCT00241631|19652499|P1|Phase 1 (4 Weeks)|sore throat|1
5701545|NCT00241631|19652498|P2|Run in (2 Weeks)|Physician Decision|3
5701546|NCT00241631|19652499|P1|Run in (2 Weeks)|Physician Decision|3
5701547|NCT00241358|19652512|P3|Overall Study|Determined to be not ineligible|1
5701548|NCT00241358|19652513|P2|Overall Study|Determined to be not ineligible|1
5701549|NCT00241358|19652514|P1|Overall Study|Determined to be not ineligible|0
5701550|NCT00241280|19652547|P2|Overall Study|Excessive Dryness|1
5701551|NCT00241280|19652548|P1|Overall Study|Excessive Dryness|0
5701552|NCT00241280|19652547|P2|Overall Study|Coating on Lens|0
5701553|NCT00241280|19652548|P1|Overall Study|Coating on Lens|1
5701554|NCT00241280|19652547|P2|Overall Study|History of Ocular Surgery|1
5701555|NCT00241280|19652548|P1|Overall Study|History of Ocular Surgery|0
5701556|NCT00241280|19652547|P2|Overall Study|Scheduling Conflict|2
5701557|NCT00241280|19652548|P1|Overall Study|Scheduling Conflict|0
5701558|NCT00241280|19652547|P2|Overall Study|Unacceptable Fit|1
5701559|NCT00241280|19652548|P1|Overall Study|Unacceptable Fit|0
5701560|NCT00241280|19652547|P2|Overall Study|Dispensed incorrect test article|2
5701561|NCT00241280|19652548|P1|Overall Study|Dispensed incorrect test article|1
5701562|NCT00241280|19652547|P2|Overall Study|Subject Ineligible/Dispensed|6
5701563|NCT00241280|19652548|P1|Overall Study|Subject Ineligible/Dispensed|9
5701564|NCT00241280|19652547|P2|Overall Study|Diabetic|0
5701565|NCT00241280|19652548|P1|Overall Study|Diabetic|1
5701566|NCT00241280|19652547|P2|Overall Study|Unsatisfactory Visual Response|1
5701567|NCT00241280|19652548|P1|Overall Study|Unsatisfactory Visual Response|1
5701568|NCT00241280|19652547|P2|Overall Study|Unsatisfactory Physiological Response|1
5701569|NCT00241280|19652548|P1|Overall Study|Unsatisfactory Physiological Response|1
5701570|NCT00241280|19652547|P2|Overall Study|Relocation|4
5701571|NCT00241280|19652548|P1|Overall Study|Relocation|4
5701572|NCT00241280|19652547|P2|Overall Study|Protocol Violation|10
5701573|NCT00241280|19652548|P1|Overall Study|Protocol Violation|4
5701574|NCT00241280|19652547|P2|Overall Study|Withdrawal by Subject|4
5701575|NCT00241280|19652548|P1|Overall Study|Withdrawal by Subject|7
5701576|NCT00241280|19652547|P2|Overall Study|Lost to Follow-up|8
5701577|NCT00241280|19652548|P1|Overall Study|Lost to Follow-up|5
5701578|NCT00241280|19652547|P2|Overall Study|Pregnancy|5
5701579|NCT00241280|19652548|P1|Overall Study|Pregnancy|1
5701580|NCT00241280|19652547|P2|Overall Study|Discomfort|16
5701581|NCT00241280|19652548|P1|Overall Study|Discomfort|11
5701582|NCT00241280|19652547|P2|Overall Study|Adverse Event|6
5701583|NCT00241280|19652548|P1|Overall Study|Adverse Event|2
5701584|NCT00240994|19652563|P1|Overall Study|Graft failure|1
5701585|NCT00240994|19652563|P1|Overall Study|Protocol Violation|1
5701586|NCT00240994|19652563|P1|Overall Study|Lost to Follow-up|1
5701587|NCT00240331|19652698|P2|Overall Study|Option selected by investigator|2
5701588|NCT00240331|19652699|P1|Overall Study|Option selected by investigator|1
5701589|NCT00240331|19652698|P2|Overall Study|Withdrawal by Subject|132
5701590|NCT00240331|19652699|P1|Overall Study|Withdrawal by Subject|125
5701591|NCT00240110|19652742|P2|Overall Study|Lost to Follow-up|7
5701592|NCT00240110|19652743|P1|Overall Study|Lost to Follow-up|6
5701593|NCT00240097|19652751|P1|Part II|did not continue from Part I|23
5701594|NCT00240097|19652751|P1|Part I|unevaluable|1
5701595|NCT00240097|19652751|P1|Part I|histology|1
5701596|NCT00240097|19652751|P1|Part I|Death|1
5701597|NCT00240097|19652751|P1|Part I|Adverse Event|1
5701598|NCT00240071|19652761|P1|Overall Study|Withdrawal by Subject|3
5701599|NCT00239928|19652766|P1|Overall Study|Withdrawal by Subject|2
5701600|NCT00239928|19652766|P1|Overall Study|Not need to continue study|3
5701601|NCT00239928|19652766|P1|Overall Study|Adverse Event|4
5701602|NCT00239928|19652766|P1|Overall Study|Lack of Efficacy|1
5701603|NCT00239837|19652778|P2|Overall Study|Lost to Follow-up|7
5701604|NCT00239837|19652779|P1|Overall Study|Lost to Follow-up|3
5701605|NCT00239720|19652806|P2|Overall Study|Lost to Follow-up|1
5701606|NCT00239720|19652807|P1|Overall Study|Lost to Follow-up|0
5701607|NCT00239720|19652806|P2|Overall Study|Adverse Event|0
5701608|NCT00239720|19652807|P1|Overall Study|Adverse Event|1
5701609|NCT00239681|19652815|P2|Overall Study|No information chacked on CaseReportForm|84
5701610|NCT00239681|19652816|P1|Overall Study|No information chacked on CaseReportForm|90
5701611|NCT00239681|19652815|P2|Overall Study|Physician Decision|17
5701612|NCT00239681|19652816|P1|Overall Study|Physician Decision|13
5701613|NCT00239681|19652815|P2|Overall Study|Protocol Violation|4
5701614|NCT00239681|19652816|P1|Overall Study|Protocol Violation|4
5701615|NCT00239681|19652815|P2|Overall Study|Lost to Follow-up|22
5701616|NCT00239681|19652816|P1|Overall Study|Lost to Follow-up|28
5701617|NCT00239681|19652815|P2|Overall Study|Withdrawal by Subject|489
5701618|NCT00239681|19652816|P1|Overall Study|Withdrawal by Subject|458
5701619|NCT00239681|19652815|P2|Overall Study|Adverse Event|99
5701620|NCT00239681|19652816|P1|Overall Study|Adverse Event|100
5701621|NCT00239590|19652869|P2|Completed Study Protocol|Withdrawal by Subject|1
5701622|NCT00239590|19652870|P1|Completed Study Protocol|Withdrawal by Subject|0
5701623|NCT00239590|19652869|P2|Completed Study Protocol|Adverse Event|1
5701624|NCT00239590|19652870|P1|Completed Study Protocol|Adverse Event|1
5701625|NCT00239590|19652869|P2|Randomized|Withdrawal by Subject|1
5701626|NCT00239590|19652870|P1|Randomized|Withdrawal by Subject|0
5701627|NCT00239590|19652869|P2|Randomized|Lost to Follow-up|1
5701628|NCT00239590|19652870|P1|Randomized|Lost to Follow-up|0
5701629|NCT00239577|19652882|P4|Primary Phase|Other|0
5701630|NCT00239577|19652883|P3|Primary Phase|Other|2
5701631|NCT00239577|19652884|P2|Primary Phase|Other|3
5701632|NCT00239577|19652885|P1|Primary Phase|Other|5
5701633|NCT00239577|19652882|P4|Primary Phase|Adverse Event|0
5701634|NCT00239577|19652883|P3|Primary Phase|Adverse Event|1
5701635|NCT00239577|19652884|P2|Primary Phase|Adverse Event|0
5701636|NCT00239577|19652885|P1|Primary Phase|Adverse Event|0
5701637|NCT00239356|19652989|P2|Overall Study|Drug available on market|2
5701638|NCT00239356|19652990|P1|Overall Study|Drug available on market|11
5701639|NCT00239356|19652989|P2|Overall Study|Administrative reason|1
5701640|NCT00239356|19652990|P1|Overall Study|Administrative reason|0
5701641|NCT00239356|19652989|P2|Overall Study|Pregnancy|0
5701642|NCT00239356|19652990|P1|Overall Study|Pregnancy|1
5701643|NCT00239356|19652989|P2|Overall Study|poor/non-compliance|0
5701644|NCT00239356|19652990|P1|Overall Study|poor/non-compliance|2
5701645|NCT00239356|19652989|P2|Overall Study|Lost to Follow-up|0
5701646|NCT00239356|19652990|P1|Overall Study|Lost to Follow-up|3
5701647|NCT00239356|19652989|P2|Overall Study|Withdrawal by Subject|6
5701648|NCT00239356|19652990|P1|Overall Study|Withdrawal by Subject|15
5701649|NCT00239356|19652989|P2|Overall Study|Adverse Event|0
5701650|NCT00239356|19652990|P1|Overall Study|Adverse Event|6
5701651|NCT00239356|19652989|P2|Overall Study|Lack of Efficacy|0
5701652|NCT00239356|19652990|P1|Overall Study|Lack of Efficacy|1
5701653|NCT00239226|19653012|P4|Overall Study|Lost to Follow-up|0
5701654|NCT00239226|19653013|P3|Overall Study|Lost to Follow-up|1
5701655|NCT00239226|19653014|P2|Overall Study|Lost to Follow-up|0
5701656|NCT00239226|19653015|P1|Overall Study|Lost to Follow-up|1
5701657|NCT00239226|19653012|P4|Overall Study|permAF during stabilization period|3
5701658|NCT00239226|19653013|P3|Overall Study|permAF during stabilization period|0
5701659|NCT00239226|19653014|P2|Overall Study|permAF during stabilization period|0
5701660|NCT00239226|19653015|P1|Overall Study|permAF during stabilization period|0
5701661|NCT00239005|19653027|P2|Overall Study|Lost to Follow-up|1
5701662|NCT00239005|19653028|P1|Overall Study|Lost to Follow-up|0
5701663|NCT00239005|19653027|P2|Overall Study|Subj. cond. no longer needs study drug|1
5701664|NCT00239005|19653028|P1|Overall Study|Subj. cond. no longer needs study drug|0
5701665|NCT00239005|19653027|P2|Overall Study|Protocol Violation|0
5701666|NCT00239005|19653028|P1|Overall Study|Protocol Violation|1
5701667|NCT00239005|19653027|P2|Overall Study|Unsatisfactory Therapeutic effect|0
5701668|NCT00239005|19653028|P1|Overall Study|Unsatisfactory Therapeutic effect|2
5701669|NCT00239005|19653027|P2|Overall Study|Withdrawal by Subject|4
5701670|NCT00239005|19653028|P1|Overall Study|Withdrawal by Subject|3
5701671|NCT00239005|19653027|P2|Overall Study|Adverse Event|6
5701672|NCT00239005|19653028|P1|Overall Study|Adverse Event|6
5701673|NCT00238433|19653044|P1|Overall Study|Death|1
5701674|NCT00238433|19653044|P1|Overall Study|Lost to Follow-up|1
5701675|NCT00238433|19653044|P1|Overall Study|Screen failure|1
5701676|NCT00238420|19653051|P2|Overall Study|Protocol Violation|1
5701677|NCT00238420|19653052|P1|Overall Study|Protocol Violation|1
5701678|NCT00238303|19653069|P3|Overall Study|Adverse Event|3
5701679|NCT00238303|19653070|P2|Overall Study|Adverse Event|1
5701680|NCT00238303|19653071|P1|Overall Study|Adverse Event|0
5701681|NCT00238303|19653069|P3|Overall Study|Poor tolerance of study treatment|1
5701682|NCT00238303|19653070|P2|Overall Study|Poor tolerance of study treatment|0
5701683|NCT00238303|19653071|P1|Overall Study|Poor tolerance of study treatment|1
5701684|NCT00238303|19653069|P3|Overall Study|Other Medical Problems|2
5701685|NCT00238303|19653070|P2|Overall Study|Other Medical Problems|0
5701686|NCT00238303|19653071|P1|Overall Study|Other Medical Problems|2
5701687|NCT00238303|19653069|P3|Overall Study|Death|1
5701688|NCT00238303|19653070|P2|Overall Study|Death|0
5701689|NCT00238303|19653071|P1|Overall Study|Death|1
5701690|NCT00238303|19653069|P3|Overall Study|Withdrawal by Subject|2
5701691|NCT00238303|19653070|P2|Overall Study|Withdrawal by Subject|1
5701692|NCT00238303|19653071|P1|Overall Study|Withdrawal by Subject|11
5701693|NCT00238264|19653088|P1|Overall Study|Ineligible|7
5701694|NCT00238264|19653088|P1|Overall Study|Withdrawal by Subject|4
5701695|NCT00238264|19653088|P1|Overall Study|Lost to Follow-up|18
5701696|NCT00238264|19653088|P1|Overall Study|Death|7
5701697|NCT00238238|19653101|P3|Overall Study|Withdrawal by Subject|0
5701698|NCT00238238|19653102|P2|Overall Study|Withdrawal by Subject|3
5701699|NCT00238238|19653103|P1|Overall Study|Withdrawal by Subject|0
5701700|NCT00238121|19653116|P2|Overall Study|Adverse Event|1
5701701|NCT00238121|19653117|P1|Overall Study|Adverse Event|2
5701702|NCT00238121|19653116|P2|Overall Study|Withdrawal by Subject|1
5701703|NCT00238121|19653117|P1|Overall Study|Withdrawal by Subject|1
5701704|NCT00237809|19653143|P4|Overall Study|Lost to Follow-up|9
5701705|NCT00237809|19653144|P3|Overall Study|Lost to Follow-up|9
5701706|NCT00237809|19653145|P2|Overall Study|Lost to Follow-up|10
5701707|NCT00237809|19653146|P1|Overall Study|Lost to Follow-up|11
5701708|NCT00237796|19653182|P2|Overall Study|Baseline and one other ILSS required|5
5701709|NCT00237796|19653183|P1|Overall Study|Baseline and one other ILSS required|10
5701710|NCT00237744|19653217|P3|Overall Study|Withdrawal by Subject|0
5701711|NCT00237744|19653218|P2|Overall Study|Withdrawal by Subject|1
5701712|NCT00237744|19653219|P1|Overall Study|Withdrawal by Subject|3
5701713|NCT00237692|19653245|P4|Overall Study|Withdrawal by Subject|4
5701714|NCT00237692|19653246|P3|Overall Study|Withdrawal by Subject|10
5701715|NCT00237692|19653247|P2|Overall Study|Withdrawal by Subject|6
5701716|NCT00237692|19653248|P1|Overall Study|Withdrawal by Subject|4
5701717|NCT00237692|19653245|P4|Overall Study|Excluded - did not meet criteria|9
5701718|NCT00237692|19653246|P3|Overall Study|Excluded - did not meet criteria|5
5701719|NCT00237692|19653247|P2|Overall Study|Excluded - did not meet criteria|3
5701720|NCT00237692|19653248|P1|Overall Study|Excluded - did not meet criteria|4
5701721|NCT00237692|19653245|P4|Overall Study|Death|3
5701722|NCT00237692|19653246|P3|Overall Study|Death|2
5701723|NCT00237692|19653247|P2|Overall Study|Death|2
5701724|NCT00237692|19653248|P1|Overall Study|Death|1
5701725|NCT00237692|19653245|P4|Overall Study|Lost to Follow-up|3
5701726|NCT00237692|19653246|P3|Overall Study|Lost to Follow-up|5
5701727|NCT00237692|19653247|P2|Overall Study|Lost to Follow-up|3
5701728|NCT00237692|19653248|P1|Overall Study|Lost to Follow-up|9
5701729|NCT00237458|19653288|P1|Overall Study|Withdrawal by Subject|1
5701730|NCT00237458|19653288|P1|Overall Study|Adverse Event|1
5701731|NCT00237458|19653288|P1|Overall Study|Lack of Efficacy|1
5701732|NCT00237185|19653306|P2|Extension|Death|1
5701733|NCT00237185|19653307|P1|Extension|Death|1
5701734|NCT00237185|19653306|P2|Extension|Administrative problems|0
5701735|NCT00237185|19653307|P1|Extension|Administrative problems|1
5701736|NCT00237185|19653306|P2|Extension|Lost to Follow-up|0
5701737|NCT00237185|19653307|P1|Extension|Lost to Follow-up|1
5701738|NCT00237185|19653306|P2|Extension|Withdrawal by Subject|2
5701739|NCT00237185|19653307|P1|Extension|Withdrawal by Subject|3
5701740|NCT00237185|19653306|P2|Extension|Condition no longer required study drug|1
5701741|NCT00237185|19653307|P1|Extension|Condition no longer required study drug|0
5701742|NCT00237185|19653306|P2|Extension|Lack of Efficacy|14
5701743|NCT00237185|19653307|P1|Extension|Lack of Efficacy|9
5701744|NCT00237185|19653306|P2|Extension|Abnormal laboratory value|1
5701745|NCT00237185|19653307|P1|Extension|Abnormal laboratory value|0
5701746|NCT00237185|19653306|P2|Extension|Adverse Event|0
5701747|NCT00237185|19653307|P1|Extension|Adverse Event|1
5701748|NCT00237185|19653306|P2|Core|Determined ineligible post randomization|0
5701749|NCT00237185|19653307|P1|Core|Determined ineligible post randomization|1
5701750|NCT00237185|19653306|P2|Core|Death|0
5701751|NCT00237185|19653307|P1|Core|Death|4
5701752|NCT00237185|19653306|P2|Core|Administrative problems|1
5701753|NCT00237185|19653307|P1|Core|Administrative problems|0
5701754|NCT00237185|19653306|P2|Core|Withdrawal by Subject|4
5701755|NCT00237185|19653307|P1|Core|Withdrawal by Subject|4
5701756|NCT00237185|19653306|P2|Core|Protocol Violation|1
5701757|NCT00237185|19653307|P1|Core|Protocol Violation|1
5701758|NCT00237185|19653306|P2|Core|Lack of Efficacy|23
5701759|NCT00237185|19653307|P1|Core|Lack of Efficacy|30
5701760|NCT00237185|19653306|P2|Core|Abnormal test procedure results|0
5701761|NCT00237185|19653307|P1|Core|Abnormal test procedure results|1
5701762|NCT00237185|19653306|P2|Core|Abnormal laboratory value|4
5701763|NCT00237185|19653307|P1|Core|Abnormal laboratory value|0
5701764|NCT00237185|19653306|P2|Core|Adverse Event|4
5701765|NCT00237185|19653307|P1|Core|Adverse Event|3
5701766|NCT00237042|19653338|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
5701767|NCT00237042|19653339|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
5701768|NCT00237042|19653340|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
5701769|NCT00237042|19653338|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
5701770|NCT00237042|19653339|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
5701771|NCT00237042|19653340|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
5701772|NCT00237042|19653338|P3|Treatment|Completed no treatment|21
5701773|NCT00237042|19653339|P2|Treatment|Completed no treatment|5
5701774|NCT00237042|19653340|P1|Treatment|Completed no treatment|5
5701775|NCT00237042|19653338|P3|Treatment|Moved out of state|1
5701776|NCT00237042|19653339|P2|Treatment|Moved out of state|1
5701777|NCT00237042|19653340|P1|Treatment|Moved out of state|1
5701778|NCT00237042|19653338|P3|Treatment|Became ineligible post-randomization|16
5701779|NCT00237042|19653339|P2|Treatment|Became ineligible post-randomization|1
5701780|NCT00237042|19653340|P1|Treatment|Became ineligible post-randomization|0
5701781|NCT00236899|19653414|P4|Overall Study|Lack of Efficacy|23
5701782|NCT00236899|19653415|P3|Overall Study|Lack of Efficacy|25
5701783|NCT00236899|19653416|P2|Overall Study|Lack of Efficacy|18
5701784|NCT00236899|19653417|P1|Overall Study|Lack of Efficacy|18
5701785|NCT00236899|19653414|P4|Overall Study|Satisfactory Response|1
5701786|NCT00236899|19653415|P3|Overall Study|Satisfactory Response|0
5701787|NCT00236899|19653416|P2|Overall Study|Satisfactory Response|0
5701788|NCT00236899|19653417|P1|Overall Study|Satisfactory Response|2
5701789|NCT00236899|19653414|P4|Overall Study|Physician Decision|6
5701790|NCT00236899|19653415|P3|Overall Study|Physician Decision|7
5701791|NCT00236899|19653416|P2|Overall Study|Physician Decision|8
5701792|NCT00236899|19653417|P1|Overall Study|Physician Decision|7
5701793|NCT00236899|19653414|P4|Overall Study|Withdrawal by Subject|2
5701794|NCT00236899|19653415|P3|Overall Study|Withdrawal by Subject|5
5701795|NCT00236899|19653416|P2|Overall Study|Withdrawal by Subject|4
5701796|NCT00236899|19653417|P1|Overall Study|Withdrawal by Subject|6
5701797|NCT00236899|19653414|P4|Overall Study|Protocol Violation|0
5701798|NCT00236899|19653415|P3|Overall Study|Protocol Violation|0
5701799|NCT00236899|19653416|P2|Overall Study|Protocol Violation|0
5701800|NCT00236899|19653417|P1|Overall Study|Protocol Violation|1
5701801|NCT00236899|19653414|P4|Overall Study|Entry Criteria Exclusion|0
5701802|NCT00236899|19653415|P3|Overall Study|Entry Criteria Exclusion|1
5701803|NCT00236899|19653416|P2|Overall Study|Entry Criteria Exclusion|1
5701804|NCT00236899|19653417|P1|Overall Study|Entry Criteria Exclusion|0
5701805|NCT00236899|19653414|P4|Overall Study|Lost to Follow-up|0
5701806|NCT00236899|19653415|P3|Overall Study|Lost to Follow-up|0
5701807|NCT00236899|19653416|P2|Overall Study|Lost to Follow-up|1
5701808|NCT00236899|19653417|P1|Overall Study|Lost to Follow-up|0
5701809|NCT00236899|19653414|P4|Overall Study|Death (Study Drug Toxicity)|0
5701810|NCT00236899|19653415|P3|Overall Study|Death (Study Drug Toxicity)|0
5701811|NCT00236899|19653416|P2|Overall Study|Death (Study Drug Toxicity)|0
5701812|NCT00236899|19653417|P1|Overall Study|Death (Study Drug Toxicity)|1
5701813|NCT00236899|19653414|P4|Overall Study|Death (Not Study Related)|0
5701814|NCT00236899|19653415|P3|Overall Study|Death (Not Study Related)|0
5701815|NCT00236899|19653416|P2|Overall Study|Death (Not Study Related)|0
5701816|NCT00236899|19653417|P1|Overall Study|Death (Not Study Related)|2
5701817|NCT00236899|19653414|P4|Overall Study|Death (Study Disease)|0
5701818|NCT00236899|19653415|P3|Overall Study|Death (Study Disease)|0
5701819|NCT00236899|19653416|P2|Overall Study|Death (Study Disease)|4
5701820|NCT00236899|19653417|P1|Overall Study|Death (Study Disease)|1
5701821|NCT00236899|19653414|P4|Overall Study|Adverse Event (Not Study Related)|7
5701822|NCT00236899|19653415|P3|Overall Study|Adverse Event (Not Study Related)|4
5701823|NCT00236899|19653416|P2|Overall Study|Adverse Event (Not Study Related)|3
5701824|NCT00236899|19653417|P1|Overall Study|Adverse Event (Not Study Related)|3
5701825|NCT00236899|19653414|P4|Overall Study|Adverse Event (Study Related)|1
5701826|NCT00236899|19653415|P3|Overall Study|Adverse Event (Study Related)|2
5701827|NCT00236899|19653416|P2|Overall Study|Adverse Event (Study Related)|1
5701828|NCT00236899|19653417|P1|Overall Study|Adverse Event (Study Related)|1
5701829|NCT00236197|19653449|P2|Overall Study|Other|2
5701830|NCT00236197|19653450|P1|Overall Study|Other|0
5701831|NCT00236197|19653449|P2|Overall Study|Medication non-compliance|2
5701832|NCT00236197|19653450|P1|Overall Study|Medication non-compliance|1
5701833|NCT00236197|19653449|P2|Overall Study|Protocol Violation|3
5701834|NCT00236197|19653450|P1|Overall Study|Protocol Violation|0
5701835|NCT00236197|19653449|P2|Overall Study|Lost to Follow-up|5
5701836|NCT00236197|19653450|P1|Overall Study|Lost to Follow-up|1
5701837|NCT00236197|19653449|P2|Overall Study|Withdrawal by Subject|2
5701838|NCT00236197|19653450|P1|Overall Study|Withdrawal by Subject|3
5701839|NCT00236184|19653458|P2|Overall Study|other|2
5701840|NCT00236184|19653459|P1|Overall Study|other|1
5701841|NCT00236184|19653458|P2|Overall Study|non-compliance with study drug|1
5701842|NCT00236184|19653459|P1|Overall Study|non-compliance with study drug|2
5701843|NCT00236184|19653458|P2|Overall Study|Protocol Violation|0
5701844|NCT00236184|19653459|P1|Overall Study|Protocol Violation|3
5701845|NCT00236184|19653458|P2|Overall Study|Withdrawal by Subject|0
5701846|NCT00236184|19653459|P1|Overall Study|Withdrawal by Subject|3
5701847|NCT00236184|19653458|P2|Overall Study|Physician Decision|1
5701848|NCT00236184|19653459|P1|Overall Study|Physician Decision|1
5701849|NCT00236184|19653458|P2|Overall Study|Lost to Follow-up|4
5701850|NCT00236184|19653459|P1|Overall Study|Lost to Follow-up|3
5701851|NCT00236184|19653458|P2|Overall Study|Lack of Efficacy|1
5701852|NCT00236184|19653459|P1|Overall Study|Lack of Efficacy|0
5701853|NCT00236184|19653458|P2|Overall Study|Adverse Event|2
5701854|NCT00236184|19653459|P1|Overall Study|Adverse Event|5
5701855|NCT00236080|19653470|P5|Overall Study|Miscellaneous|0
5701856|NCT00236080|19653471|P4|Overall Study|Miscellaneous|0
5701857|NCT00236080|19653472|P3|Overall Study|Miscellaneous|1
5701858|NCT00236080|19653473|P2|Overall Study|Miscellaneous|0
5701859|NCT00236080|19653474|P1|Overall Study|Miscellaneous|0
5701860|NCT00236080|19653470|P5|Overall Study|Withdrawal by Subject|0
5701861|NCT00236080|19653471|P4|Overall Study|Withdrawal by Subject|0
5701862|NCT00236080|19653472|P3|Overall Study|Withdrawal by Subject|0
5701863|NCT00236080|19653473|P2|Overall Study|Withdrawal by Subject|0
5701864|NCT00236080|19653474|P1|Overall Study|Withdrawal by Subject|1
5701865|NCT00236080|19653470|P5|Overall Study|Physician Decision|1
5701866|NCT00236080|19653471|P4|Overall Study|Physician Decision|1
5701867|NCT00236080|19653472|P3|Overall Study|Physician Decision|1
5701868|NCT00236080|19653473|P2|Overall Study|Physician Decision|0
5701869|NCT00236080|19653474|P1|Overall Study|Physician Decision|1
5701870|NCT00236080|19653470|P5|Overall Study|Lost to Follow-up|0
5701871|NCT00236080|19653471|P4|Overall Study|Lost to Follow-up|0
5701872|NCT00236080|19653472|P3|Overall Study|Lost to Follow-up|0
5701873|NCT00236080|19653473|P2|Overall Study|Lost to Follow-up|1
5701874|NCT00236080|19653474|P1|Overall Study|Lost to Follow-up|0
5701875|NCT00236080|19653470|P5|Overall Study|Adverse Event|0
5701876|NCT00236080|19653471|P4|Overall Study|Adverse Event|1
5701877|NCT00236080|19653472|P3|Overall Study|Adverse Event|3
5701878|NCT00236080|19653473|P2|Overall Study|Adverse Event|0
5701879|NCT00236080|19653474|P1|Overall Study|Adverse Event|0
5701880|NCT00235989|19653495|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
5701881|NCT00235989|19653496|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
5701882|NCT00235989|19653497|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
5701883|NCT00235989|19653498|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
5701884|NCT00235989|19653499|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
5701885|NCT00235989|19653500|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
5701886|NCT00235989|19653495|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
5701887|NCT00235989|19653496|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
5701888|NCT00235989|19653497|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
5701889|NCT00235989|19653498|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
5701890|NCT00235989|19653499|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
5701891|NCT00235989|19653500|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
5701892|NCT00235989|19653495|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
5701893|NCT00235989|19653496|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
5701894|NCT00235989|19653497|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
5701895|NCT00235989|19653498|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
5701896|NCT00235989|19653499|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
5701897|NCT00235989|19653500|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
5701898|NCT00235989|19653495|P6|Extension Treatment Period (ET)|Adverse Event|0
5701899|NCT00235989|19653496|P5|Extension Treatment Period (ET)|Adverse Event|0
5701900|NCT00235989|19653497|P4|Extension Treatment Period (ET)|Adverse Event|0
5701901|NCT00235989|19653498|P3|Extension Treatment Period (ET)|Adverse Event|2
5701902|NCT00235989|19653499|P2|Extension Treatment Period (ET)|Adverse Event|0
5701903|NCT00235989|19653500|P1|Extension Treatment Period (ET)|Adverse Event|3
5701904|NCT00235989|19653495|P6|Core Treatment Period (CT)|Lost to Follow-up|2
5701905|NCT00235989|19653496|P5|Core Treatment Period (CT)|Lost to Follow-up|0
5701906|NCT00235989|19653497|P4|Core Treatment Period (CT)|Lost to Follow-up|0
5701907|NCT00235989|19653498|P3|Core Treatment Period (CT)|Lost to Follow-up|0
5701908|NCT00235989|19653499|P2|Core Treatment Period (CT)|Lost to Follow-up|0
5701909|NCT00235989|19653500|P1|Core Treatment Period (CT)|Lost to Follow-up|0
5701910|NCT00235872|19653514|P1|Overall Study|Administrative reason|61
5701911|NCT00235872|19653514|P1|Overall Study|Withdrawal by Subject|50
5701912|NCT00235872|19653514|P1|Overall Study|Lost to Follow-up|1
5701913|NCT00235872|19653514|P1|Overall Study|Death|1
5701914|NCT00235872|19653514|P1|Overall Study|Adverse Event|34
5701915|NCT00235755|19653545|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
5701916|NCT00235755|19653546|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
5701917|NCT00235755|19653547|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
5701918|NCT00235755|19653545|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
5701919|NCT00235755|19653546|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
5701920|NCT00235755|19653547|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
5701921|NCT00235755|19653545|P3|12-Week Maintenance Phase|Protocol Violation|2
5701922|NCT00235755|19653546|P2|12-Week Maintenance Phase|Protocol Violation|4
5701923|NCT00235755|19653547|P1|12-Week Maintenance Phase|Protocol Violation|0
5701924|NCT00235755|19653545|P3|12-Week Maintenance Phase|Lack of Efficacy|0
5701925|NCT00235755|19653546|P2|12-Week Maintenance Phase|Lack of Efficacy|0
5701926|NCT00235755|19653547|P1|12-Week Maintenance Phase|Lack of Efficacy|5
5701927|NCT00235755|19653545|P3|12-Week Maintenance Phase|Lost to Follow-up|0
5701928|NCT00235755|19653546|P2|12-Week Maintenance Phase|Lost to Follow-up|3
5701929|NCT00235755|19653547|P1|12-Week Maintenance Phase|Lost to Follow-up|2
5701930|NCT00235755|19653545|P3|12-Week Maintenance Phase|Adverse Event|26
5701931|NCT00235755|19653546|P2|12-Week Maintenance Phase|Adverse Event|12
5701932|NCT00235755|19653547|P1|12-Week Maintenance Phase|Adverse Event|8
5701933|NCT00235755|19653545|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
5701934|NCT00235755|19653546|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
5701935|NCT00235755|19653547|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
5701936|NCT00235755|19653545|P3|4-Week Titration Phase|Randomization Occurred in Error|0
5701937|NCT00235755|19653546|P2|4-Week Titration Phase|Randomization Occurred in Error|0
5701938|NCT00235755|19653547|P1|4-Week Titration Phase|Randomization Occurred in Error|1
5701939|NCT00235755|19653545|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
5701940|NCT00235755|19653546|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
5701941|NCT00235755|19653547|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
5701942|NCT00235755|19653545|P3|4-Week Titration Phase|Withdrawal by Subject|3
5701943|NCT00235755|19653546|P2|4-Week Titration Phase|Withdrawal by Subject|2
5701944|NCT00235755|19653547|P1|4-Week Titration Phase|Withdrawal by Subject|1
5701945|NCT00235755|19653545|P3|4-Week Titration Phase|Protocol Violation|1
5701946|NCT00235755|19653546|P2|4-Week Titration Phase|Protocol Violation|2
5701947|NCT00235755|19653547|P1|4-Week Titration Phase|Protocol Violation|2
5701948|NCT00235755|19653545|P3|4-Week Titration Phase|Lost to Follow-up|1
5701949|NCT00235755|19653546|P2|4-Week Titration Phase|Lost to Follow-up|1
5701950|NCT00235755|19653547|P1|4-Week Titration Phase|Lost to Follow-up|0
5701951|NCT00235755|19653545|P3|4-Week Titration Phase|Adverse Event|20
5701952|NCT00235755|19653546|P2|4-Week Titration Phase|Adverse Event|14
5701953|NCT00235755|19653547|P1|4-Week Titration Phase|Adverse Event|6
5701954|NCT00235716|19653625|P4|Overall Study|Physician Decision|3
5701955|NCT00235716|19653626|P3|Overall Study|Physician Decision|1
5701956|NCT00235716|19653627|P2|Overall Study|Physician Decision|1
5701957|NCT00235716|19653628|P1|Overall Study|Physician Decision|0
5701958|NCT00235716|19653625|P4|Overall Study|Adverse Event|0
5701959|NCT00235716|19653626|P3|Overall Study|Adverse Event|1
5701960|NCT00235716|19653627|P2|Overall Study|Adverse Event|1
5701961|NCT00235716|19653628|P1|Overall Study|Adverse Event|1
5701962|NCT00235716|19653625|P4|Overall Study|Lost to Follow-up|10
5701963|NCT00235716|19653626|P3|Overall Study|Lost to Follow-up|14
5701964|NCT00235716|19653627|P2|Overall Study|Lost to Follow-up|7
5701965|NCT00235716|19653628|P1|Overall Study|Lost to Follow-up|12
5701966|NCT00235716|19653625|P4|Overall Study|Withdrawal by Subject|18
5701967|NCT00235716|19653626|P3|Overall Study|Withdrawal by Subject|17
5701968|NCT00235716|19653627|P2|Overall Study|Withdrawal by Subject|19
5701969|NCT00235716|19653628|P1|Overall Study|Withdrawal by Subject|23
5701970|NCT00235716|19653625|P4|Overall Study|Death|31
5701971|NCT00235716|19653626|P3|Overall Study|Death|32
5701972|NCT00235716|19653627|P2|Overall Study|Death|39
5701973|NCT00235716|19653628|P1|Overall Study|Death|26
5701974|NCT00235495|19653679|P2|Overall Study|Visit/assessmen outside window/missing|10
5701975|NCT00235495|19653680|P1|Overall Study|Visit/assessmen outside window/missing|0
5701976|NCT00235495|19653679|P2|Overall Study|Lost to Follow-up|13
5701977|NCT00235495|19653680|P1|Overall Study|Lost to Follow-up|11
5701978|NCT00235495|19653679|P2|Overall Study|Withdrawal by Subject|3
5701979|NCT00235495|19653680|P1|Overall Study|Withdrawal by Subject|5
5701980|NCT00235495|19653679|P2|Overall Study|Death|42
5701981|NCT00235495|19653680|P1|Overall Study|Death|52
5701982|NCT00235443|19653753|P6|Overall Study|Other reasons for premature termination|6
5701983|NCT00235443|19653754|P5|Overall Study|Other reasons for premature termination|3
5701984|NCT00235443|19653755|P4|Overall Study|Other reasons for premature termination|7
5701985|NCT00235443|19653756|P3|Overall Study|Other reasons for premature termination|6
5701986|NCT00235443|19653757|P2|Overall Study|Other reasons for premature termination|6
5701987|NCT00235443|19653758|P1|Overall Study|Other reasons for premature termination|1
5701988|NCT00235443|19653753|P6|Overall Study|Unsatisfactory compliance|0
5701989|NCT00235443|19653754|P5|Overall Study|Unsatisfactory compliance|1
5701990|NCT00235443|19653755|P4|Overall Study|Unsatisfactory compliance|4
5701991|NCT00235443|19653756|P3|Overall Study|Unsatisfactory compliance|3
5701992|NCT00235443|19653757|P2|Overall Study|Unsatisfactory compliance|2
5701993|NCT00235443|19653758|P1|Overall Study|Unsatisfactory compliance|0
5701994|NCT00235443|19653753|P6|Overall Study|Lost to Follow-up|3
5701995|NCT00235443|19653754|P5|Overall Study|Lost to Follow-up|4
5701996|NCT00235443|19653755|P4|Overall Study|Lost to Follow-up|6
5701997|NCT00235443|19653756|P3|Overall Study|Lost to Follow-up|6
5701998|NCT00235443|19653757|P2|Overall Study|Lost to Follow-up|8
5701999|NCT00235443|19653758|P1|Overall Study|Lost to Follow-up|0
5702000|NCT00235443|19653753|P6|Overall Study|Withdrawal by Subject|12
5702001|NCT00235443|19653754|P5|Overall Study|Withdrawal by Subject|10
5702002|NCT00235443|19653755|P4|Overall Study|Withdrawal by Subject|24
5702003|NCT00235443|19653756|P3|Overall Study|Withdrawal by Subject|25
5702004|NCT00235443|19653757|P2|Overall Study|Withdrawal by Subject|9
5702005|NCT00235443|19653758|P1|Overall Study|Withdrawal by Subject|3
5702006|NCT00235443|19653753|P6|Overall Study|Lack of Efficacy|9
5702007|NCT00235443|19653754|P5|Overall Study|Lack of Efficacy|2
5702008|NCT00235443|19653755|P4|Overall Study|Lack of Efficacy|12
5702009|NCT00235443|19653756|P3|Overall Study|Lack of Efficacy|5
5702010|NCT00235443|19653757|P2|Overall Study|Lack of Efficacy|1
5702011|NCT00235443|19653758|P1|Overall Study|Lack of Efficacy|0
5702012|NCT00235443|19653753|P6|Overall Study|Adverse Event|15
5702013|NCT00235443|19653754|P5|Overall Study|Adverse Event|10
5702014|NCT00235443|19653755|P4|Overall Study|Adverse Event|44
5702015|NCT00235443|19653756|P3|Overall Study|Adverse Event|17
5702016|NCT00235443|19653757|P2|Overall Study|Adverse Event|12
5702017|NCT00235443|19653758|P1|Overall Study|Adverse Event|4
5702018|NCT00235391|19653899|P6|Overall Study|Death|0
5702019|NCT00235391|19653900|P5|Overall Study|Death|0
5702020|NCT00235391|19653901|P4|Overall Study|Death|4
5702021|NCT00235391|19653902|P3|Overall Study|Death|1
5702022|NCT00235391|19653903|P2|Overall Study|Death|0
5702023|NCT00235391|19653904|P1|Overall Study|Death|0
5702024|NCT00235391|19653899|P6|Overall Study|Administrative problems|0
5702025|NCT00235391|19653900|P5|Overall Study|Administrative problems|0
5702026|NCT00235391|19653901|P4|Overall Study|Administrative problems|1
5702027|NCT00235391|19653902|P3|Overall Study|Administrative problems|0
5702028|NCT00235391|19653903|P2|Overall Study|Administrative problems|0
5702029|NCT00235391|19653904|P1|Overall Study|Administrative problems|0
5702030|NCT00235391|19653899|P6|Overall Study|Lost to Follow-up|0
5702031|NCT00235391|19653900|P5|Overall Study|Lost to Follow-up|0
5702032|NCT00235391|19653901|P4|Overall Study|Lost to Follow-up|16
5702033|NCT00235391|19653902|P3|Overall Study|Lost to Follow-up|3
5702034|NCT00235391|19653903|P2|Overall Study|Lost to Follow-up|3
5702035|NCT00235391|19653904|P1|Overall Study|Lost to Follow-up|0
5702036|NCT00235391|19653899|P6|Overall Study|Withdrawal by Subject|0
5702037|NCT00235391|19653900|P5|Overall Study|Withdrawal by Subject|5
5702038|NCT00235391|19653901|P4|Overall Study|Withdrawal by Subject|61
5702039|NCT00235391|19653902|P3|Overall Study|Withdrawal by Subject|3
5702040|NCT00235391|19653903|P2|Overall Study|Withdrawal by Subject|3
5702041|NCT00235391|19653904|P1|Overall Study|Withdrawal by Subject|2
5702042|NCT00235391|19653899|P6|Overall Study|Protocol deviation|0
5702043|NCT00235391|19653900|P5|Overall Study|Protocol deviation|0
5702044|NCT00235391|19653901|P4|Overall Study|Protocol deviation|11
5702045|NCT00235391|19653902|P3|Overall Study|Protocol deviation|1
5702046|NCT00235391|19653903|P2|Overall Study|Protocol deviation|0
5702047|NCT00235391|19653904|P1|Overall Study|Protocol deviation|0
5702048|NCT00235391|19653899|P6|Overall Study|Condition no longer requires treatment|0
5702049|NCT00235391|19653900|P5|Overall Study|Condition no longer requires treatment|1
5702050|NCT00235391|19653901|P4|Overall Study|Condition no longer requires treatment|11
5702051|NCT00235391|19653902|P3|Overall Study|Condition no longer requires treatment|0
5702052|NCT00235391|19653903|P2|Overall Study|Condition no longer requires treatment|0
5702053|NCT00235391|19653904|P1|Overall Study|Condition no longer requires treatment|3
5702054|NCT00235391|19653899|P6|Overall Study|Unsatisfactory therapeutic effect|0
5702055|NCT00235391|19653900|P5|Overall Study|Unsatisfactory therapeutic effect|0
5702056|NCT00235391|19653901|P4|Overall Study|Unsatisfactory therapeutic effect|17
5702057|NCT00235391|19653902|P3|Overall Study|Unsatisfactory therapeutic effect|2
5702058|NCT00235391|19653903|P2|Overall Study|Unsatisfactory therapeutic effect|2
5702059|NCT00235391|19653904|P1|Overall Study|Unsatisfactory therapeutic effect|0
5702060|NCT00235391|19653899|P6|Overall Study|Abnormal laboratory value(s)|2
5702061|NCT00235391|19653900|P5|Overall Study|Abnormal laboratory value(s)|1
5702062|NCT00235391|19653901|P4|Overall Study|Abnormal laboratory value(s)|27
5702063|NCT00235391|19653902|P3|Overall Study|Abnormal laboratory value(s)|4
5702064|NCT00235391|19653903|P2|Overall Study|Abnormal laboratory value(s)|5
5702065|NCT00235391|19653904|P1|Overall Study|Abnormal laboratory value(s)|3
5702066|NCT00235391|19653899|P6|Overall Study|Adverse Event|2
5702067|NCT00235391|19653900|P5|Overall Study|Adverse Event|5
5702068|NCT00235391|19653901|P4|Overall Study|Adverse Event|72
5702069|NCT00235391|19653902|P3|Overall Study|Adverse Event|10
5702070|NCT00235391|19653903|P2|Overall Study|Adverse Event|5
5702071|NCT00235391|19653904|P1|Overall Study|Adverse Event|4
5702072|NCT00235326|19653921|P2|Overall Study|Lost to Follow-up|1400
5702073|NCT00235326|19653922|P1|Overall Study|Lost to Follow-up|746
5702074|NCT00234533|19653962|P1|Overall Study|Enrolled but not treated|3
5702075|NCT00234533|19653962|P1|Overall Study|Adverse Event|2
5702076|NCT00234533|19653962|P1|Overall Study|Withdrawal by Subject|6
5702077|NCT00234494|19653981|P1|Overall Study|Protocol Violation|2
5702078|NCT00234104|19654027|P4|Overall Study|Physician Decision|2
5702079|NCT00234104|19654028|P3|Overall Study|Physician Decision|2
5702080|NCT00234104|19654029|P2|Overall Study|Physician Decision|1
5702081|NCT00234104|19654030|P1|Overall Study|Physician Decision|0
5702082|NCT00234104|19654027|P4|Overall Study|Protocol Violation|1
5702083|NCT00234104|19654028|P3|Overall Study|Protocol Violation|0
5702084|NCT00234104|19654029|P2|Overall Study|Protocol Violation|0
5702085|NCT00234104|19654030|P1|Overall Study|Protocol Violation|0
5702086|NCT00234104|19654027|P4|Overall Study|Adverse Event|5
5702087|NCT00234104|19654028|P3|Overall Study|Adverse Event|3
5702088|NCT00234104|19654029|P2|Overall Study|Adverse Event|0
5702089|NCT00234104|19654030|P1|Overall Study|Adverse Event|4
5702090|NCT00234065|19654071|P2|Overall Study|Not Classified|112
5702091|NCT00234065|19654072|P1|Overall Study|Not Classified|111
5702092|NCT00234065|19654071|P2|Overall Study|Physician Decision|22
5702093|NCT00234065|19654072|P1|Overall Study|Physician Decision|23
5702094|NCT00234065|19654071|P2|Overall Study|Withdrawal by Subject|56
5702095|NCT00234065|19654072|P1|Overall Study|Withdrawal by Subject|73
5702096|NCT00234065|19654071|P2|Overall Study|Adverse Event|166
5702097|NCT00234065|19654072|P1|Overall Study|Adverse Event|268
5702098|NCT00234052|19654088|P1|Follow-up for 5 Years|Other|7
5702099|NCT00234052|19654088|P1|Follow-up for 5 Years|Lost to Follow-up|1
5702100|NCT00234052|19654088|P1|Follow-up for 5 Years|Death|41
5702101|NCT00234052|19654088|P1|Treatment|Progressive Disease|11
5702102|NCT00234052|19654088|P1|Treatment|Death|2
5702103|NCT00234052|19654088|P1|Treatment|Adverse Event|5
5702104|NCT00234052|19654088|P1|Treatment|Withdrawal by Subject|3
5702105|NCT00234039|19654098|P1|Overall Study|No Protocol Treatment Received|2
5702106|NCT00234039|19654098|P1|Overall Study|Ineligible|9
5702107|NCT00234039|19654098|P1|Overall Study|Other - Not Protocol Specified|3
5702108|NCT00234039|19654098|P1|Overall Study|Progression/relapse|34
5702109|NCT00234039|19654098|P1|Overall Study|Adverse Event|2
5702110|NCT00233987|19654105|P1|Overall Study|Ineligible|4
5702111|NCT00233987|19654105|P1|Overall Study|Eligible but No Treatment Received|2
5702112|NCT00233987|19654105|P1|Overall Study|Other - Not Protocol Specified|5
5702113|NCT00233987|19654105|P1|Overall Study|Reason Under Review|1
5702114|NCT00233987|19654105|P1|Overall Study|Lack of Efficacy|2
5702115|NCT00233987|19654105|P1|Overall Study|Withdrawal by Subject|1
5702116|NCT00233948|19654114|P6|Overall Study|Adverse Event|0
5702117|NCT00233948|19654115|P5|Overall Study|Adverse Event|0
5702118|NCT00233948|19654116|P4|Overall Study|Adverse Event|0
5702119|NCT00233948|19654117|P3|Overall Study|Adverse Event|0
5702120|NCT00233948|19654118|P2|Overall Study|Adverse Event|0
5702121|NCT00233948|19654119|P1|Overall Study|Adverse Event|1
5702122|NCT00233480|19654145|P2|Overall Study|Underwent status II heart transplant|1
5702123|NCT00233480|19654146|P1|Overall Study|Underwent status II heart transplant|0
5702124|NCT00233454|19654162|P1|Overall Study|Death|6
5702125|NCT00233402|19654170|P2|Overall Study|Lost to follow up etc|21
5702126|NCT00233402|19654171|P1|Overall Study|Lost to follow up etc|3
5702127|NCT00233402|19654170|P2|Overall Study|No Ta/T1|94
5702128|NCT00233402|19654171|P1|Overall Study|No Ta/T1|89
5702129|NCT00233402|19654170|P2|Overall Study|No pathology data|9
5702130|NCT00233402|19654171|P1|Overall Study|No pathology data|12
5702131|NCT00233324|19654186|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
5702132|NCT00233324|19654187|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
5702133|NCT00233324|19654188|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
5702134|NCT00233324|19654189|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
5702135|NCT00233324|19654186|P4|Follow up at 18-22 Months Corrected Age|Death|4
5702136|NCT00233324|19654187|P3|Follow up at 18-22 Months Corrected Age|Death|5
5702137|NCT00233324|19654188|P2|Follow up at 18-22 Months Corrected Age|Death|7
5702138|NCT00233324|19654189|P1|Follow up at 18-22 Months Corrected Age|Death|5
5702139|NCT00233324|19654186|P4|Main Study|Death|47
5702140|NCT00233324|19654187|P3|Main Study|Death|62
5702141|NCT00233324|19654188|P2|Main Study|Death|60
5702142|NCT00233324|19654189|P1|Main Study|Death|68
5702143|NCT00233064|19654311|P2|Overall Study|Moved to Dom. Republic|0
5702144|NCT00233064|19654312|P1|Overall Study|Moved to Dom. Republic|1
5702145|NCT00233064|19654311|P2|Overall Study|Protocol Violation|0
5702146|NCT00233064|19654312|P1|Overall Study|Protocol Violation|1
5702147|NCT00233064|19654311|P2|Overall Study|Relocation|1
5702148|NCT00233064|19654312|P1|Overall Study|Relocation|0
5702149|NCT00233064|19654311|P2|Overall Study|Death|1
5702150|NCT00233064|19654312|P1|Overall Study|Death|0
5702151|NCT00233064|19654311|P2|Overall Study|Withdrawal by Subject|3
5702152|NCT00233064|19654312|P1|Overall Study|Withdrawal by Subject|5
5702153|NCT00233064|19654311|P2|Overall Study|Lost to Follow-up|7
5702154|NCT00233064|19654312|P1|Overall Study|Lost to Follow-up|7
5702155|NCT00232596|19654338|P2|12-Week Maintenance Phase|Other|3
5702156|NCT00232596|19654339|P1|12-Week Maintenance Phase|Other|1
5702157|NCT00232596|19654338|P2|12-Week Maintenance Phase|Protocol Violation|1
5702158|NCT00232596|19654339|P1|12-Week Maintenance Phase|Protocol Violation|3
5702159|NCT00232596|19654338|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
5702160|NCT00232596|19654339|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
5702161|NCT00232596|19654338|P2|12-Week Maintenance Phase|Adverse Event|22
5702162|NCT00232596|19654339|P1|12-Week Maintenance Phase|Adverse Event|7
5702163|NCT00232596|19654338|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
5702164|NCT00232596|19654339|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
5702165|NCT00232596|19654338|P2|6-Week Titration Phase|Other|3
5702166|NCT00232596|19654339|P1|6-Week Titration Phase|Other|3
5702167|NCT00232596|19654338|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
5702168|NCT00232596|19654339|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
5702169|NCT00232596|19654338|P2|6-Week Titration Phase|Protocol Violation|3
5702170|NCT00232596|19654339|P1|6-Week Titration Phase|Protocol Violation|1
5702171|NCT00232596|19654338|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
5702172|NCT00232596|19654339|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
5702173|NCT00232596|19654338|P2|6-Week Titration Phase|Failed to Return|1
5702174|NCT00232596|19654339|P1|6-Week Titration Phase|Failed to Return|2
5702175|NCT00232596|19654338|P2|6-Week Titration Phase|Adverse Event|19
5702176|NCT00232596|19654339|P1|6-Week Titration Phase|Adverse Event|6
5702177|NCT00232557|19654430|P2|Overall Study|Lost to Follow-up|5
5702178|NCT00232557|19654431|P1|Overall Study|Lost to Follow-up|3
5702179|NCT00232544|19654441|P2|Overall Study|Lost to Follow-up|15
5702180|NCT00232544|19654442|P1|Overall Study|Lost to Follow-up|20
5702181|NCT00232180|19654473|P3|Open Label Phase|Randomized but not treated|1
5702182|NCT00232180|19654474|P2|Open Label Phase|Randomized but not treated|0
5702183|NCT00232180|19654475|P1|Open Label Phase|Randomized but not treated|0
5702184|NCT00232180|19654473|P3|Open Label Phase|Laboratory abnormality|10
5702185|NCT00232180|19654474|P2|Open Label Phase|Laboratory abnormality|0
5702186|NCT00232180|19654475|P1|Open Label Phase|Laboratory abnormality|0
5702187|NCT00232180|19654473|P3|Open Label Phase|Adverse Event|25
5702188|NCT00232180|19654474|P2|Open Label Phase|Adverse Event|0
5702189|NCT00232180|19654475|P1|Open Label Phase|Adverse Event|0
5702190|NCT00232180|19654473|P3|Open Label Phase|Other|16
5702191|NCT00232180|19654474|P2|Open Label Phase|Other|0
5702192|NCT00232180|19654475|P1|Open Label Phase|Other|0
5702193|NCT00232180|19654473|P3|Open Label Phase|Withdrawal by Subject|37
5702194|NCT00232180|19654474|P2|Open Label Phase|Withdrawal by Subject|0
5702195|NCT00232180|19654475|P1|Open Label Phase|Withdrawal by Subject|0
5702196|NCT00232180|19654473|P3|Open Label Phase|Study terminated by sponsor|3
5702197|NCT00232180|19654474|P2|Open Label Phase|Study terminated by sponsor|0
5702198|NCT00232180|19654475|P1|Open Label Phase|Study terminated by sponsor|0
5702199|NCT00232180|19654473|P3|Open Label Phase|Protocol Violation|3
5702200|NCT00232180|19654474|P2|Open Label Phase|Protocol Violation|0
5702201|NCT00232180|19654475|P1|Open Label Phase|Protocol Violation|0
5702202|NCT00232180|19654473|P3|Open Label Phase|Lost to Follow-up|5
5702203|NCT00232180|19654474|P2|Open Label Phase|Lost to Follow-up|0
5702204|NCT00232180|19654475|P1|Open Label Phase|Lost to Follow-up|0
5702205|NCT00232180|19654473|P3|Open Label Phase|Death|48
5702206|NCT00232180|19654474|P2|Open Label Phase|Death|0
5702207|NCT00232180|19654475|P1|Open Label Phase|Death|0
5702208|NCT00232180|19654473|P3|Double-blind (DB) Phase|Laboratory abnormality|0
5702209|NCT00232180|19654474|P2|Double-blind (DB) Phase|Laboratory abnormality|7
5702210|NCT00232180|19654475|P1|Double-blind (DB) Phase|Laboratory abnormality|6
5702211|NCT00232180|19654473|P3|Double-blind (DB) Phase|Randomized but not treated|0
5702212|NCT00232180|19654474|P2|Double-blind (DB) Phase|Randomized but not treated|4
5702213|NCT00232180|19654475|P1|Double-blind (DB) Phase|Randomized but not treated|3
5702214|NCT00232180|19654473|P3|Double-blind (DB) Phase|Other|0
5702215|NCT00232180|19654474|P2|Double-blind (DB) Phase|Other|75
5702216|NCT00232180|19654475|P1|Double-blind (DB) Phase|Other|70
5702217|NCT00232180|19654473|P3|Double-blind (DB) Phase|Adverse Event|0
5702218|NCT00232180|19654474|P2|Double-blind (DB) Phase|Adverse Event|100
5702219|NCT00232180|19654475|P1|Double-blind (DB) Phase|Adverse Event|83
5702220|NCT00232180|19654473|P3|Double-blind (DB) Phase|Protocol Violation|0
5702221|NCT00232180|19654474|P2|Double-blind (DB) Phase|Protocol Violation|21
5702222|NCT00232180|19654475|P1|Double-blind (DB) Phase|Protocol Violation|28
5702223|NCT00232180|19654473|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
5702224|NCT00232180|19654474|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
5702225|NCT00232180|19654475|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
5702226|NCT00232180|19654473|P3|Double-blind (DB) Phase|Lost to Follow-up|0
5702227|NCT00232180|19654474|P2|Double-blind (DB) Phase|Lost to Follow-up|28
5702228|NCT00232180|19654475|P1|Double-blind (DB) Phase|Lost to Follow-up|34
5702229|NCT00232180|19654473|P3|Double-blind (DB) Phase|Death|0
5702230|NCT00232180|19654474|P2|Double-blind (DB) Phase|Death|222
5702231|NCT00232180|19654475|P1|Double-blind (DB) Phase|Death|186
5702232|NCT00232141|19654520|P2|Overall Study|Withdrawal by Subject|3
5702233|NCT00232141|19654521|P1|Overall Study|Withdrawal by Subject|5
5702234|NCT00232141|19654520|P2|Overall Study|Other|10
5702235|NCT00232141|19654521|P1|Overall Study|Other|8
5702236|NCT00232141|19654520|P2|Overall Study|Lost to Follow-up|6
5702237|NCT00232141|19654521|P1|Overall Study|Lost to Follow-up|9
5702238|NCT00232141|19654520|P2|Overall Study|Lack of Efficacy|3
5702239|NCT00232141|19654521|P1|Overall Study|Lack of Efficacy|0
5702240|NCT00232141|19654520|P2|Overall Study|Adverse Event|4
5702241|NCT00232141|19654521|P1|Overall Study|Adverse Event|9
5702242|NCT00231894|19654591|P2|Overall Study|Withdrawal by Subject|1
5702243|NCT00231894|19654592|P1|Overall Study|Withdrawal by Subject|1
5702244|NCT00231842|19654618|P1|Overall Study|Did not complete the last 3 cycle|8
5702245|NCT00231842|19654618|P1|Overall Study|Withdrawal by Subject|3
5702246|NCT00231816|19654625|P2|Overall Study|Other|1
5702247|NCT00231816|19654626|P1|Overall Study|Other|2
5702248|NCT00231816|19654625|P2|Overall Study|Withdrawal by Subject|3
5702249|NCT00231816|19654626|P1|Overall Study|Withdrawal by Subject|3
5702250|NCT00231816|19654625|P2|Overall Study|Protocol Violation|3
5702251|NCT00231816|19654626|P1|Overall Study|Protocol Violation|2
5702252|NCT00231816|19654625|P2|Overall Study|Lost to Follow-up|5
5702253|NCT00231816|19654626|P1|Overall Study|Lost to Follow-up|8
5702254|NCT00231816|19654625|P2|Overall Study|Adverse Event|0
5702255|NCT00231816|19654626|P1|Overall Study|Adverse Event|1
5702256|NCT00231777|19654641|P2|Overall Study|Other|2
5702257|NCT00231777|19654642|P1|Overall Study|Other|3
5702258|NCT00231777|19654641|P2|Overall Study|Lost to Follow-up|0
5702259|NCT00231777|19654642|P1|Overall Study|Lost to Follow-up|3
5702260|NCT00231478|19654656|P2|Overall Study|Administrative|2
5702261|NCT00231478|19654657|P1|Overall Study|Administrative|3
5702262|NCT00231478|19654656|P2|Overall Study|Adverse Event|1
5702263|NCT00231478|19654657|P1|Overall Study|Adverse Event|0
5702264|NCT00231478|19654656|P2|Overall Study|Withdrawal by Subject|0
5702265|NCT00231478|19654657|P1|Overall Study|Withdrawal by Subject|1
5702266|NCT00231478|19654656|P2|Overall Study|Refused Treatment|1
5702267|NCT00231478|19654657|P1|Overall Study|Refused Treatment|1
5702268|NCT00231478|19654656|P2|Overall Study|Protocol Violation|2
5702269|NCT00231478|19654657|P1|Overall Study|Protocol Violation|3
5702270|NCT00231465|19654669|P1|Overall Study|Did not have follow up CT scans|1
5702271|NCT00231465|19654669|P1|Overall Study|Completed only one cycle|1
5702272|NCT00231413|19654682|P7|Overall Study|Pregnancy|0
5702273|NCT00231413|19654683|P6|Overall Study|Pregnancy|0
5702274|NCT00231413|19654684|P5|Overall Study|Pregnancy|0
5702275|NCT00231413|19654685|P4|Overall Study|Pregnancy|0
5702276|NCT00231413|19654686|P3|Overall Study|Pregnancy|0
5702277|NCT00231413|19654687|P2|Overall Study|Pregnancy|0
5702278|NCT00231413|19654688|P1|Overall Study|Pregnancy|1
5702279|NCT00231413|19654682|P7|Overall Study|Lost to Follow-up|0
5702280|NCT00231413|19654683|P6|Overall Study|Lost to Follow-up|4
5702281|NCT00231413|19654684|P5|Overall Study|Lost to Follow-up|1
5702282|NCT00231413|19654685|P4|Overall Study|Lost to Follow-up|1
5702283|NCT00231413|19654686|P3|Overall Study|Lost to Follow-up|1
5702284|NCT00231413|19654687|P2|Overall Study|Lost to Follow-up|4
5702285|NCT00231413|19654688|P1|Overall Study|Lost to Follow-up|4
5702286|NCT00231413|19654682|P7|Overall Study|Migrated/moved from study area|0
5702287|NCT00231413|19654683|P6|Overall Study|Migrated/moved from study area|1
5702288|NCT00231413|19654684|P5|Overall Study|Migrated/moved from study area|0
5702289|NCT00231413|19654685|P4|Overall Study|Migrated/moved from study area|0
5702290|NCT00231413|19654686|P3|Overall Study|Migrated/moved from study area|1
5702291|NCT00231413|19654687|P2|Overall Study|Migrated/moved from study area|0
5702292|NCT00231413|19654688|P1|Overall Study|Migrated/moved from study area|0
5702293|NCT00231413|19654682|P7|Overall Study|Withdrawal by Subject|3
5702294|NCT00231413|19654683|P6|Overall Study|Withdrawal by Subject|0
5702295|NCT00231413|19654684|P5|Overall Study|Withdrawal by Subject|2
5702296|NCT00231413|19654685|P4|Overall Study|Withdrawal by Subject|2
5702297|NCT00231413|19654686|P3|Overall Study|Withdrawal by Subject|4
5702298|NCT00231413|19654687|P2|Overall Study|Withdrawal by Subject|1
5702299|NCT00231413|19654688|P1|Overall Study|Withdrawal by Subject|3
5702300|NCT00231413|19654682|P7|Overall Study|Non-serious AE|1
5702301|NCT00231413|19654683|P6|Overall Study|Non-serious AE|0
5702302|NCT00231413|19654684|P5|Overall Study|Non-serious AE|0
5702303|NCT00231413|19654685|P4|Overall Study|Non-serious AE|0
5702304|NCT00231413|19654686|P3|Overall Study|Non-serious AE|1
5702305|NCT00231413|19654687|P2|Overall Study|Non-serious AE|0
5702306|NCT00231413|19654688|P1|Overall Study|Non-serious AE|0
5702307|NCT00231179|19654858|P2|Overall Study|Withdrawal by Subject|3
5702308|NCT00231179|19654859|P1|Overall Study|Withdrawal by Subject|3
5702309|NCT00231179|19654858|P2|Overall Study|Lost to Follow-up|21
5702310|NCT00231179|19654859|P1|Overall Study|Lost to Follow-up|21
5702311|NCT00231114|19654886|P2|Post-Treatment Period|Withdrawal by Subject|0
5702312|NCT00231114|19654887|P1|Post-Treatment Period|Withdrawal by Subject|1
5702313|NCT00231114|19654886|P2|Post-Treatment Period|Physician Decision|0
5702314|NCT00231114|19654887|P1|Post-Treatment Period|Physician Decision|1
5702315|NCT00231114|19654886|P2|Post-Treatment Period|Lost to Follow-up|1
5702316|NCT00231114|19654887|P1|Post-Treatment Period|Lost to Follow-up|6
5702317|NCT00231114|19654886|P2|Treatment Period|Death: Motor Vehicle Accident|0
5702318|NCT00231114|19654887|P1|Treatment Period|Death: Motor Vehicle Accident|1
5702319|NCT00231114|19654886|P2|Randomized|Withdrawal by Subject|3
5702320|NCT00231114|19654887|P1|Randomized|Withdrawal by Subject|6
5702321|NCT00231062|19654923|P1|Overall Study|Physician Decision|6
5702322|NCT00230971|19654931|P2|Baseline Participants|Reintervention|0
5702323|NCT00230971|19654932|P1|Baseline Participants|Reintervention|1
5702324|NCT00230971|19654931|P2|Baseline Participants|Failure to return|1
5702325|NCT00230971|19654932|P1|Baseline Participants|Failure to return|1
5702326|NCT00230971|19654931|P2|Baseline Participants|No bacteria observed|0
5702327|NCT00230971|19654932|P1|Baseline Participants|No bacteria observed|1
5702328|NCT00230971|19654931|P2|Baseline Participants|Adverse Event|0
5702329|NCT00230971|19654932|P1|Baseline Participants|Adverse Event|1
5702330|NCT00230971|19654931|P2|Baseline Participants|Withdrawal by Subject|1
5702331|NCT00230971|19654932|P1|Baseline Participants|Withdrawal by Subject|7
5702332|NCT00230971|19654931|P2|Baseline Participants|Death|5
5702333|NCT00230971|19654932|P1|Baseline Participants|Death|6
5702334|NCT00230971|19654931|P2|Baseline Participants|Lost to Follow-up|12
5702335|NCT00230971|19654932|P1|Baseline Participants|Lost to Follow-up|5
5702336|NCT00230971|19654931|P2|Randomization|No study drug administered|3
5702337|NCT00230971|19654932|P1|Randomization|No study drug administered|3
5702338|NCT00230282|19654970|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
5702339|NCT00230282|19654970|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
5702340|NCT00230282|19654970|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
5702341|NCT00230282|19654970|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
5702342|NCT00230178|19654978|P3|Overall Study|Various other reasons|4
5702343|NCT00230178|19654979|P2|Overall Study|Various other reasons|2
5702344|NCT00230178|19654980|P1|Overall Study|Various other reasons|3
5702345|NCT00230178|19654978|P3|Overall Study|Withdrawal by Subject|1
5702346|NCT00230178|19654979|P2|Overall Study|Withdrawal by Subject|0
5702347|NCT00230178|19654980|P1|Overall Study|Withdrawal by Subject|0
5702348|NCT00230178|19654978|P3|Overall Study|Adverse Event|2
5702349|NCT00230178|19654979|P2|Overall Study|Adverse Event|5
5702350|NCT00230178|19654980|P1|Overall Study|Adverse Event|1
5702351|NCT00230048|19655032|P2|Overall Study|Lost to Follow-up|18
5702352|NCT00230048|19655033|P1|Overall Study|Lost to Follow-up|13
5702353|NCT00229931|19655091|P2|Overall Study|Lost to Follow-up|2
5702354|NCT00229931|19655092|P1|Overall Study|Lost to Follow-up|3
5702355|NCT00229931|19655091|P2|Overall Study|Death|0
5702356|NCT00229931|19655092|P1|Overall Study|Death|1
5702357|NCT00229723|19655107|P7|Maintenance Phase|Other|1
5702358|NCT00229723|19655108|P6|Maintenance Phase|Other|3
5702359|NCT00229723|19655109|P5|Maintenance Phase|Other|3
5702360|NCT00229723|19655110|P4|Maintenance Phase|Other|2
5702361|NCT00229723|19655111|P3|Maintenance Phase|Other|1
5702362|NCT00229723|19655112|P2|Maintenance Phase|Other|4
5702363|NCT00229723|19655113|P1|Maintenance Phase|Other|5
5702364|NCT00229723|19655107|P7|Maintenance Phase|Severe non-compliance|0
5702365|NCT00229723|19655108|P6|Maintenance Phase|Severe non-compliance|0
5702366|NCT00229723|19655109|P5|Maintenance Phase|Severe non-compliance|1
5702367|NCT00229723|19655110|P4|Maintenance Phase|Severe non-compliance|0
5702368|NCT00229723|19655111|P3|Maintenance Phase|Severe non-compliance|0
5702369|NCT00229723|19655112|P2|Maintenance Phase|Severe non-compliance|1
5702370|NCT00229723|19655113|P1|Maintenance Phase|Severe non-compliance|3
5702371|NCT00229723|19655107|P7|Maintenance Phase|Informed consent withdrawn|0
5702372|NCT00229723|19655108|P6|Maintenance Phase|Informed consent withdrawn|1
5702373|NCT00229723|19655109|P5|Maintenance Phase|Informed consent withdrawn|1
5702374|NCT00229723|19655110|P4|Maintenance Phase|Informed consent withdrawn|1
5702375|NCT00229723|19655111|P3|Maintenance Phase|Informed consent withdrawn|0
5702376|NCT00229723|19655112|P2|Maintenance Phase|Informed consent withdrawn|0
5702377|NCT00229723|19655113|P1|Maintenance Phase|Informed consent withdrawn|1
5702378|NCT00229723|19655107|P7|Maintenance Phase|Lost to Follow-up|1
5702379|NCT00229723|19655108|P6|Maintenance Phase|Lost to Follow-up|0
5702380|NCT00229723|19655109|P5|Maintenance Phase|Lost to Follow-up|0
5702381|NCT00229723|19655110|P4|Maintenance Phase|Lost to Follow-up|2
5702382|NCT00229723|19655111|P3|Maintenance Phase|Lost to Follow-up|2
5702383|NCT00229723|19655112|P2|Maintenance Phase|Lost to Follow-up|1
5702384|NCT00229723|19655113|P1|Maintenance Phase|Lost to Follow-up|0
5702385|NCT00229723|19655107|P7|Maintenance Phase|Clinical progression|1
5702386|NCT00229723|19655108|P6|Maintenance Phase|Clinical progression|1
5702387|NCT00229723|19655109|P5|Maintenance Phase|Clinical progression|1
5702388|NCT00229723|19655110|P4|Maintenance Phase|Clinical progression|2
5702389|NCT00229723|19655111|P3|Maintenance Phase|Clinical progression|2
5702390|NCT00229723|19655112|P2|Maintenance Phase|Clinical progression|1
5702391|NCT00229723|19655113|P1|Maintenance Phase|Clinical progression|4
5702392|NCT00229723|19655107|P7|Maintenance Phase|Objective disease progression|5
5702393|NCT00229723|19655108|P6|Maintenance Phase|Objective disease progression|9
5702394|NCT00229723|19655109|P5|Maintenance Phase|Objective disease progression|2
5702395|NCT00229723|19655110|P4|Maintenance Phase|Objective disease progression|6
5702396|NCT00229723|19655111|P3|Maintenance Phase|Objective disease progression|3
5702397|NCT00229723|19655112|P2|Maintenance Phase|Objective disease progression|5
5702398|NCT00229723|19655113|P1|Maintenance Phase|Objective disease progression|5
5702399|NCT00229723|19655107|P7|Maintenance Phase|Adverse Event|2
5702400|NCT00229723|19655108|P6|Maintenance Phase|Adverse Event|5
5702401|NCT00229723|19655109|P5|Maintenance Phase|Adverse Event|7
5702402|NCT00229723|19655110|P4|Maintenance Phase|Adverse Event|4
5702403|NCT00229723|19655111|P3|Maintenance Phase|Adverse Event|1
5702404|NCT00229723|19655112|P2|Maintenance Phase|Adverse Event|2
5702405|NCT00229723|19655113|P1|Maintenance Phase|Adverse Event|7
5702406|NCT00229723|19655107|P7|Concomitant Phase|Other|0
5702407|NCT00229723|19655108|P6|Concomitant Phase|Other|2
5702408|NCT00229723|19655109|P5|Concomitant Phase|Other|0
5702409|NCT00229723|19655110|P4|Concomitant Phase|Other|1
5702410|NCT00229723|19655111|P3|Concomitant Phase|Other|1
5702411|NCT00229723|19655112|P2|Concomitant Phase|Other|0
5702412|NCT00229723|19655113|P1|Concomitant Phase|Other|3
5702413|NCT00229723|19655107|P7|Concomitant Phase|Severe non-compliance|0
5702414|NCT00229723|19655108|P6|Concomitant Phase|Severe non-compliance|0
5702415|NCT00229723|19655109|P5|Concomitant Phase|Severe non-compliance|1
5702416|NCT00229723|19655110|P4|Concomitant Phase|Severe non-compliance|0
5702417|NCT00229723|19655111|P3|Concomitant Phase|Severe non-compliance|0
5702418|NCT00229723|19655112|P2|Concomitant Phase|Severe non-compliance|1
5702419|NCT00229723|19655113|P1|Concomitant Phase|Severe non-compliance|0
5702420|NCT00229723|19655107|P7|Concomitant Phase|Informed consent withdrawn|0
5702421|NCT00229723|19655108|P6|Concomitant Phase|Informed consent withdrawn|0
5702422|NCT00229723|19655109|P5|Concomitant Phase|Informed consent withdrawn|0
5702423|NCT00229723|19655110|P4|Concomitant Phase|Informed consent withdrawn|2
5702424|NCT00229723|19655111|P3|Concomitant Phase|Informed consent withdrawn|0
5702425|NCT00229723|19655112|P2|Concomitant Phase|Informed consent withdrawn|2
5702426|NCT00229723|19655113|P1|Concomitant Phase|Informed consent withdrawn|3
5702427|NCT00229723|19655107|P7|Concomitant Phase|Lost to Follow-up|0
5702428|NCT00229723|19655108|P6|Concomitant Phase|Lost to Follow-up|0
5702429|NCT00229723|19655109|P5|Concomitant Phase|Lost to Follow-up|1
5702430|NCT00229723|19655110|P4|Concomitant Phase|Lost to Follow-up|0
5702431|NCT00229723|19655111|P3|Concomitant Phase|Lost to Follow-up|0
5702432|NCT00229723|19655112|P2|Concomitant Phase|Lost to Follow-up|0
5702433|NCT00229723|19655113|P1|Concomitant Phase|Lost to Follow-up|0
5702434|NCT00229723|19655107|P7|Concomitant Phase|Clinical progression|1
5702435|NCT00229723|19655108|P6|Concomitant Phase|Clinical progression|0
5702436|NCT00229723|19655109|P5|Concomitant Phase|Clinical progression|0
5702437|NCT00229723|19655110|P4|Concomitant Phase|Clinical progression|0
5702438|NCT00229723|19655111|P3|Concomitant Phase|Clinical progression|0
5702439|NCT00229723|19655112|P2|Concomitant Phase|Clinical progression|0
5702440|NCT00229723|19655113|P1|Concomitant Phase|Clinical progression|0
5702441|NCT00229723|19655107|P7|Concomitant Phase|Objective disease progression|0
5702442|NCT00229723|19655108|P6|Concomitant Phase|Objective disease progression|0
5702443|NCT00229723|19655109|P5|Concomitant Phase|Objective disease progression|0
5702444|NCT00229723|19655110|P4|Concomitant Phase|Objective disease progression|0
5702445|NCT00229723|19655111|P3|Concomitant Phase|Objective disease progression|0
5702446|NCT00229723|19655112|P2|Concomitant Phase|Objective disease progression|0
5702447|NCT00229723|19655113|P1|Concomitant Phase|Objective disease progression|0
5702448|NCT00229723|19655107|P7|Concomitant Phase|Adverse Event|2
5702449|NCT00229723|19655108|P6|Concomitant Phase|Adverse Event|1
5702450|NCT00229723|19655109|P5|Concomitant Phase|Adverse Event|0
5702451|NCT00229723|19655110|P4|Concomitant Phase|Adverse Event|2
5702452|NCT00229723|19655111|P3|Concomitant Phase|Adverse Event|5
5702453|NCT00229723|19655112|P2|Concomitant Phase|Adverse Event|2
5702454|NCT00229723|19655113|P1|Concomitant Phase|Adverse Event|4
5702455|NCT00229658|19655166|P2|Overall Study|Withdrawal of consent|39
5702456|NCT00229658|19655167|P1|Overall Study|Withdrawal of consent|46
5702457|NCT00229658|19655166|P2|Overall Study|Serious Adverse Event|2
5702458|NCT00229658|19655167|P1|Overall Study|Serious Adverse Event|2
5702459|NCT00229658|19655166|P2|Overall Study|Lost to Follow-up|55
5702460|NCT00229658|19655167|P1|Overall Study|Lost to Follow-up|82
5702461|NCT00229658|19655166|P2|Overall Study|Other|60
5702462|NCT00229658|19655167|P1|Overall Study|Other|80
5702463|NCT00229658|19655166|P2|Overall Study|Investigator decision|10
5702464|NCT00229658|19655167|P1|Overall Study|Investigator decision|13
5702465|NCT00229658|19655166|P2|Overall Study|Administrative|1
5702466|NCT00229658|19655167|P1|Overall Study|Administrative|2
5702467|NCT00229203|19655203|P2|Overall Study|Withdrawal by Subject|4
5702468|NCT00229203|19655204|P1|Overall Study|Withdrawal by Subject|1
5702469|NCT00229203|19655203|P2|Overall Study|Other|3
5702470|NCT00229203|19655204|P1|Overall Study|Other|3
5702471|NCT00229203|19655203|P2|Overall Study|Death|2
5702472|NCT00229203|19655204|P1|Overall Study|Death|4
5702473|NCT00229203|19655203|P2|Overall Study|Toxicity|1
5702474|NCT00229203|19655204|P1|Overall Study|Toxicity|6
5702475|NCT00229203|19655203|P2|Overall Study|Progressive disease|9
5702476|NCT00229203|19655204|P1|Overall Study|Progressive disease|18
5702477|NCT00228917|19655232|P8|Overall Study|Migrated/moved from study area|0
5702478|NCT00228917|19655233|P7|Overall Study|Migrated/moved from study area|0
5702479|NCT00228917|19655234|P6|Overall Study|Migrated/moved from study area|2
5702480|NCT00228917|19655235|P5|Overall Study|Migrated/moved from study area|0
5702481|NCT00228917|19655236|P4|Overall Study|Migrated/moved from study area|0
5702482|NCT00228917|19655237|P3|Overall Study|Migrated/moved from study area|0
5702483|NCT00228917|19655238|P2|Overall Study|Migrated/moved from study area|0
5702484|NCT00228917|19655239|P1|Overall Study|Migrated/moved from study area|0
5702485|NCT00228813|19655285|P1|Overall Study|Death|4
5702486|NCT00228566|19655291|P1|Overall Study|Miscellaneous|1
5702487|NCT00228566|19655291|P1|Overall Study|Withdrawal by Subject|4
5702488|NCT00228566|19655291|P1|Overall Study|Physician Decision|5
5702489|NCT00228566|19655291|P1|Overall Study|Lost to Follow-up|16
5702490|NCT00228566|19655291|P1|Overall Study|Lack of Efficacy|14
5702491|NCT00228566|19655291|P1|Overall Study|Adverse Event|31
5702492|NCT00228553|19655295|P1|Overall Study|Miscellaneous|46
5702493|NCT00228553|19655295|P1|Overall Study|Pregnancy|2
5702494|NCT00228553|19655295|P1|Overall Study|Withdrawal by Subject|115
5702495|NCT00228553|19655295|P1|Overall Study|Protocol Violation|6
5702496|NCT00228553|19655295|P1|Overall Study|Physician Decision|48
5702497|NCT00228553|19655295|P1|Overall Study|Lost to Follow-up|67
5702498|NCT00228553|19655295|P1|Overall Study|Lack of Efficacy|34
5702499|NCT00228553|19655295|P1|Overall Study|Adverse Event|112
5702500|NCT00228384|19655301|P2|Overall Study|Physician Decision|1
5702501|NCT00228384|19655302|P1|Overall Study|Physician Decision|0
5702502|NCT00228384|19655301|P2|Overall Study|Withdrawal by Subject|10
5702503|NCT00228384|19655302|P1|Overall Study|Withdrawal by Subject|9
5702504|NCT00228384|19655301|P2|Overall Study|Surgical Intervention (bypass)|5
5702505|NCT00228384|19655302|P1|Overall Study|Surgical Intervention (bypass)|5
5702506|NCT00228384|19655301|P2|Overall Study|Lost to Follow-up|10
5702507|NCT00228384|19655302|P1|Overall Study|Lost to Follow-up|6
5702508|NCT00228384|19655301|P2|Overall Study|Death|3
5702509|NCT00228384|19655302|P1|Overall Study|Death|9
5702510|NCT00227903|19655353|P2|Overall Study|Miscarriage|0
5702511|NCT00227903|19655354|P1|Overall Study|Miscarriage|1
5702512|NCT00227903|19655353|P2|Overall Study|Lost to Follow-up|3
5702513|NCT00227903|19655354|P1|Overall Study|Lost to Follow-up|1
5702514|NCT00227903|19655353|P2|Overall Study|Subject moved out of area|2
5702515|NCT00227903|19655354|P1|Overall Study|Subject moved out of area|1
5702516|NCT00227903|19655353|P2|Overall Study|Withdrawal by Subject|5
5702517|NCT00227903|19655354|P1|Overall Study|Withdrawal by Subject|2
5702518|NCT00227877|19655418|P4|12-months Follow-up|Lost to Follow-up|26
5702519|NCT00227877|19655419|P3|12-months Follow-up|Lost to Follow-up|30
5702520|NCT00227877|19655420|P2|12-months Follow-up|Lost to Follow-up|189
5702521|NCT00227877|19655421|P1|12-months Follow-up|Lost to Follow-up|232
5702522|NCT00227877|19655418|P4|12-months Follow-up|Completed late|0
5702523|NCT00227877|19655419|P3|12-months Follow-up|Completed late|1
5702524|NCT00227877|19655420|P2|12-months Follow-up|Completed late|74
5702525|NCT00227877|19655421|P1|12-months Follow-up|Completed late|78
5702526|NCT00227877|19655418|P4|3-months Follow-up|Lost to Follow-up|13
5702527|NCT00227877|19655419|P3|3-months Follow-up|Lost to Follow-up|18
5702528|NCT00227877|19655420|P2|3-months Follow-up|Lost to Follow-up|139
5702529|NCT00227877|19655421|P1|3-months Follow-up|Lost to Follow-up|178
5702530|NCT00227877|19655418|P4|3-months Follow-up|Completed late|8
5702531|NCT00227877|19655419|P3|3-months Follow-up|Completed late|34
5702532|NCT00227877|19655420|P2|3-months Follow-up|Completed late|128
5702533|NCT00227877|19655421|P1|3-months Follow-up|Completed late|135
5702534|NCT00227877|19655418|P4|Post-visit Checklist|Lost to Follow-up|0
5702535|NCT00227877|19655419|P3|Post-visit Checklist|Lost to Follow-up|1
5702536|NCT00227877|19655420|P2|Post-visit Checklist|Lost to Follow-up|13
5702537|NCT00227877|19655421|P1|Post-visit Checklist|Lost to Follow-up|24
5702538|NCT00227877|19655418|P4|Pre-visit Assessment|Technical difficulties|0
5702539|NCT00227877|19655419|P3|Pre-visit Assessment|Technical difficulties|0
5702540|NCT00227877|19655420|P2|Pre-visit Assessment|Technical difficulties|3
5702541|NCT00227877|19655421|P1|Pre-visit Assessment|Technical difficulties|7
5702542|NCT00227721|19655457|P1|Overall Study|On study, but never treated.|1
5702543|NCT00227591|19655480|P1|Overall Study|Withdrawal by Subject|1
5702544|NCT00227539|19655484|P1|Overall Study|Protocol Violation|1
5702545|NCT00227370|19655492|P2|Overall Study|Other reasons|1
5702546|NCT00227370|19655493|P1|Overall Study|Other reasons|2
5702547|NCT00227370|19655492|P2|Overall Study|Physician Decision|6
5702548|NCT00227370|19655493|P1|Overall Study|Physician Decision|9
5702549|NCT00227370|19655492|P2|Overall Study|Adverse Event|11
5702550|NCT00227370|19655493|P1|Overall Study|Adverse Event|6
5702551|NCT00227370|19655492|P2|Overall Study|Death|4
5702552|NCT00227370|19655493|P1|Overall Study|Death|3
5702553|NCT00227370|19655492|P2|Overall Study|Withdrawal by Subject|2
5702554|NCT00227370|19655493|P1|Overall Study|Withdrawal by Subject|1
5702555|NCT00227344|19655513|P2|Overall Study|study terminated early|5
5702556|NCT00227344|19655514|P1|Overall Study|study terminated early|12
5702557|NCT00227305|19655534|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
5702558|NCT00227305|19655534|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
5702559|NCT00227305|19655534|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
5702560|NCT00227305|19655534|P1|Overall Study|Physician Decision|3
5702561|NCT00227305|19655534|P1|Overall Study|Lack of Efficacy|7
5702562|NCT00227305|19655534|P1|Overall Study|MOVED OUT OF AREA|3
5702563|NCT00227305|19655534|P1|Overall Study|Study specific discontinuation|13
5702564|NCT00227305|19655534|P1|Overall Study|Lost to Follow-up|33
5702565|NCT00227305|19655534|P1|Overall Study|Withdrawal by Subject|42
5702566|NCT00227305|19655534|P1|Overall Study|Adverse Event|40
5702567|NCT00227266|19655551|P3|Overall Study|Excessive weight gain|2
5702568|NCT00227266|19655552|P2|Overall Study|Excessive weight gain|0
5702569|NCT00227266|19655553|P1|Overall Study|Excessive weight gain|0
5702570|NCT00227266|19655551|P3|Overall Study|Protocol Violation|1
5702571|NCT00227266|19655552|P2|Overall Study|Protocol Violation|0
5702572|NCT00227266|19655553|P1|Overall Study|Protocol Violation|1
5702573|NCT00227266|19655551|P3|Overall Study|Withdrawal by Subject|1
5702574|NCT00227266|19655552|P2|Overall Study|Withdrawal by Subject|0
5702575|NCT00227266|19655553|P1|Overall Study|Withdrawal by Subject|0
5702576|NCT00226941|19655583|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
5702577|NCT00226941|19655584|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
5702578|NCT00226941|19655585|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
5702579|NCT00226941|19655586|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
5702580|NCT00226941|19655583|P4|Overall Study|Withdrawal by subject - toxicity|1
5702581|NCT00226941|19655584|P3|Overall Study|Withdrawal by subject - toxicity|0
5702582|NCT00226941|19655585|P2|Overall Study|Withdrawal by subject - toxicity|0
5702583|NCT00226941|19655586|P1|Overall Study|Withdrawal by subject - toxicity|0
5702584|NCT00226811|19655620|P1|Overall Study|Withdrawal by Subject|2
5702585|NCT00226811|19655620|P1|Overall Study|Lack of Efficacy|55
5702586|NCT00226811|19655620|P1|Overall Study|Adverse Event|11
5702587|NCT00226811|19655620|P1|Overall Study|Death|8
5702588|NCT00226655|19655630|P1|Overall Study|Clinical deterioration|10
5702589|NCT00226655|19655630|P1|Overall Study|Physician Decision|6
5702590|NCT00226655|19655630|P1|Overall Study|Adverse Event|35
5702591|NCT00226655|19655630|P1|Overall Study|Withdrawal by Subject|15
5702592|NCT00226655|19655630|P1|Overall Study|Death|13
5702593|NCT00226499|19655652|P3|Overall Study|Others|356
5702594|NCT00226499|19655653|P2|Overall Study|Others|1066
5702595|NCT00226499|19655654|P1|Overall Study|Others|1064
5702596|NCT00226499|19655652|P3|Overall Study|Adverse Event|3
5702597|NCT00226499|19655653|P2|Overall Study|Adverse Event|6
5702598|NCT00226499|19655654|P1|Overall Study|Adverse Event|10
5702599|NCT00225758|19655789|P1|Overall Study|Adverse Event|4
5702600|NCT00225277|19655821|P2|Overall Study|Other|9
5702601|NCT00225277|19655822|P1|Overall Study|Other|7
5702602|NCT00225277|19655821|P2|Overall Study|Withdrawal by Subject|34
5702603|NCT00225277|19655822|P1|Overall Study|Withdrawal by Subject|40
5702604|NCT00225277|19655821|P2|Overall Study|Protocol Violation|3
5702605|NCT00225277|19655822|P1|Overall Study|Protocol Violation|6
5702606|NCT00225277|19655821|P2|Overall Study|Physician Decision|8
5702607|NCT00225277|19655822|P1|Overall Study|Physician Decision|6
5702608|NCT00225277|19655821|P2|Overall Study|Lost to Follow-up|6
5702609|NCT00225277|19655822|P1|Overall Study|Lost to Follow-up|4
5702610|NCT00225277|19655821|P2|Overall Study|Lack of Efficacy|1
5702611|NCT00225277|19655822|P1|Overall Study|Lack of Efficacy|4
5702612|NCT00225277|19655821|P2|Overall Study|Adverse Event|34
5702613|NCT00225277|19655822|P1|Overall Study|Adverse Event|30
5702614|NCT00225251|19655840|P2|Overall Study|Withdrawal by Subject|1
5702615|NCT00225251|19655841|P1|Overall Study|Withdrawal by Subject|1
5702616|NCT00225212|19655855|P1|Overall Study|Intercurrent illness|1
5702617|NCT00225212|19655855|P1|Overall Study|Adverse Event|2
5702618|NCT00225212|19655855|P1|Overall Study|Death|1
5702619|NCT00225212|19655855|P1|Overall Study|Disease progression|2
5702620|NCT00225147|19655864|P4|Open-label Phase|Withdrawal by Subject|6
5702621|NCT00225147|19655865|P3|Open-label Phase|Withdrawal by Subject|0
5702622|NCT00225147|19655866|P2|Open-label Phase|Withdrawal by Subject|0
5702623|NCT00225147|19655867|P1|Open-label Phase|Withdrawal by Subject|0
5702624|NCT00225147|19655864|P4|Open-label Phase|Lost to Follow-up|4
5702625|NCT00225147|19655865|P3|Open-label Phase|Lost to Follow-up|0
5702626|NCT00225147|19655866|P2|Open-label Phase|Lost to Follow-up|0
5702627|NCT00225147|19655867|P1|Open-label Phase|Lost to Follow-up|0
5702628|NCT00224874|19655914|P4|Overall Study|Withdrawal by Subject|0
5702629|NCT00224874|19655915|P3|Overall Study|Withdrawal by Subject|1
5702630|NCT00224874|19655916|P2|Overall Study|Withdrawal by Subject|0
5702631|NCT00224874|19655917|P1|Overall Study|Withdrawal by Subject|0
5702632|NCT00224770|19655962|P3|Overall Study|Lost to Follow-up|0
5702633|NCT00224770|19655963|P2|Overall Study|Lost to Follow-up|2
5702634|NCT00224770|19655964|P1|Overall Study|Lost to Follow-up|4
5702635|NCT00224484|19655999|P3|Overall Study|Reason not specified|2
5702636|NCT00224484|19656000|P2|Overall Study|Reason not specified|4
5702637|NCT00224484|19656001|P1|Overall Study|Reason not specified|5
5702638|NCT00224484|19655999|P3|Overall Study|Lost to Follow-up|36
5702639|NCT00224484|19656000|P2|Overall Study|Lost to Follow-up|28
5702640|NCT00224484|19656001|P1|Overall Study|Lost to Follow-up|66
5702641|NCT00224484|19655999|P3|Overall Study|Migrated/moved from study area|5
5702642|NCT00224484|19656000|P2|Overall Study|Migrated/moved from study area|5
5702643|NCT00224484|19656001|P1|Overall Study|Migrated/moved from study area|18
5702644|NCT00224484|19655999|P3|Overall Study|Withdrawal by Subject|16
5702645|NCT00224484|19656000|P2|Overall Study|Withdrawal by Subject|18
5702646|NCT00224484|19656001|P1|Overall Study|Withdrawal by Subject|49
5702647|NCT00224484|19655999|P3|Overall Study|Protocol Violation|0
5702648|NCT00224484|19656000|P2|Overall Study|Protocol Violation|2
5702649|NCT00224484|19656001|P1|Overall Study|Protocol Violation|2
5702650|NCT00224484|19655999|P3|Overall Study|Non-Serious Adverse Event|3
5702651|NCT00224484|19656000|P2|Overall Study|Non-Serious Adverse Event|7
5702652|NCT00224484|19656001|P1|Overall Study|Non-Serious Adverse Event|5
5702653|NCT00224484|19655999|P3|Overall Study|Serious Adverse Event|0
5702654|NCT00224484|19656000|P2|Overall Study|Serious Adverse Event|1
5702655|NCT00224484|19656001|P1|Overall Study|Serious Adverse Event|1
5702656|NCT00224133|19656065|P1|Overall Study|Other|14
5702657|NCT00224133|19656065|P1|Overall Study|Physician Decision|1
5702658|NCT00224133|19656065|P1|Overall Study|Lost to Follow-up|21
5702659|NCT00224133|19656065|P1|Overall Study|Lack of Efficacy|58
5702660|NCT00224133|19656065|P1|Overall Study|Withdrawal by Subject|33
5702661|NCT00224133|19656065|P1|Overall Study|Protocol Violation|6
5702662|NCT00224133|19656065|P1|Overall Study|Adverse Event|93
5702663|NCT00224120|19656071|P2|Overall Study|Other|5
5702664|NCT00224120|19656072|P1|Overall Study|Other|4
5702665|NCT00224120|19656071|P2|Overall Study|Lost to Follow-up|3
5702666|NCT00224120|19656072|P1|Overall Study|Lost to Follow-up|2
5702667|NCT00224120|19656071|P2|Overall Study|Lack of Efficacy|2
5702668|NCT00224120|19656072|P1|Overall Study|Lack of Efficacy|0
5702669|NCT00224120|19656071|P2|Overall Study|Withdrawal by Subject|10
5702670|NCT00224120|19656072|P1|Overall Study|Withdrawal by Subject|5
5702671|NCT00224120|19656071|P2|Overall Study|Protocol Violation|0
5702672|NCT00224120|19656072|P1|Overall Study|Protocol Violation|1
5702673|NCT00224120|19656071|P2|Overall Study|Adverse Event|4
5702674|NCT00224120|19656072|P1|Overall Study|Adverse Event|10
5702675|NCT00224107|19656082|P2|Overall Study|Other|1
5702676|NCT00224107|19656083|P1|Overall Study|Other|1
5702677|NCT00224107|19656082|P2|Overall Study|Physician Decision|0
5702678|NCT00224107|19656083|P1|Overall Study|Physician Decision|1
5702679|NCT00224107|19656082|P2|Overall Study|Lost to Follow-up|0
5702680|NCT00224107|19656083|P1|Overall Study|Lost to Follow-up|4
5702681|NCT00224107|19656082|P2|Overall Study|Lack of Efficacy|0
5702682|NCT00224107|19656083|P1|Overall Study|Lack of Efficacy|2
5702683|NCT00224107|19656082|P2|Overall Study|Withdrawal by Subject|4
5702684|NCT00224107|19656083|P1|Overall Study|Withdrawal by Subject|1
5702685|NCT00224107|19656082|P2|Overall Study|Protocol Violation|3
5702686|NCT00224107|19656083|P1|Overall Study|Protocol Violation|2
5702687|NCT00224107|19656082|P2|Overall Study|Adverse Event|6
5702688|NCT00224107|19656083|P1|Overall Study|Adverse Event|20
5702689|NCT00224055|19656093|P2|Overall Study|Other|0
5702690|NCT00224055|19656094|P1|Overall Study|Other|1
5702691|NCT00224055|19656093|P2|Overall Study|Withdrawal by Subject|2
5702692|NCT00224055|19656094|P1|Overall Study|Withdrawal by Subject|0
5702693|NCT00224055|19656093|P2|Overall Study|Inclusion Violation|6
5702694|NCT00224055|19656094|P1|Overall Study|Inclusion Violation|3
5702695|NCT00224055|19656093|P2|Overall Study|Protocol Violation|1
5702696|NCT00224055|19656094|P1|Overall Study|Protocol Violation|1
5702697|NCT00224055|19656093|P2|Overall Study|Lost to Follow-up|2
5702698|NCT00224055|19656094|P1|Overall Study|Lost to Follow-up|1
5702699|NCT00224055|19656093|P2|Overall Study|Adverse Event|3
5702700|NCT00224055|19656094|P1|Overall Study|Adverse Event|9
5702701|NCT00224042|19656104|P2|Overall Study|Other|0
5702702|NCT00224042|19656105|P1|Overall Study|Other|2
5702703|NCT00224042|19656104|P2|Overall Study|Did not meet lab incusion criteria|3
5702704|NCT00224042|19656105|P1|Overall Study|Did not meet lab incusion criteria|2
5702705|NCT00224042|19656104|P2|Overall Study|Physician Decision|1
5702706|NCT00224042|19656105|P1|Overall Study|Physician Decision|0
5702707|NCT00224042|19656104|P2|Overall Study|Protocol Violation|1
5702708|NCT00224042|19656105|P1|Overall Study|Protocol Violation|0
5702709|NCT00224042|19656104|P2|Overall Study|Adverse Event|1
5702710|NCT00224042|19656105|P1|Overall Study|Adverse Event|2
5702711|NCT00224029|19656117|P1|Overall Study|Other|1
5702712|NCT00224029|19656117|P1|Overall Study|Withdrawal by Subject|4
5702713|NCT00224029|19656117|P1|Overall Study|Lost to Follow-up|1
5702714|NCT00224016|19656123|P2|Maintenance Period|Lost to Follow-up|1
5702715|NCT00224016|19656124|P1|Maintenance Period|Lost to Follow-up|0
5702716|NCT00224016|19656123|P2|Maintenance Period|Withdrawal by Subject|0
5702717|NCT00224016|19656124|P1|Maintenance Period|Withdrawal by Subject|2
5702718|NCT00224016|19656123|P2|Titration Period|Lost to Follow-up|0
5702719|NCT00224016|19656124|P1|Titration Period|Lost to Follow-up|1
5702720|NCT00224016|19656123|P2|Titration Period|Withdrawal by Subject|1
5702721|NCT00224016|19656124|P1|Titration Period|Withdrawal by Subject|0
5702722|NCT00224003|19656132|P1|Overall Study|unk|3
5702723|NCT00224003|19656132|P1|Overall Study|Withdrawal by Subject|1
5702724|NCT00224003|19656132|P1|Overall Study|Protocol Violation|2
5702725|NCT00224003|19656132|P1|Overall Study|Adverse Event|1
5702726|NCT00223990|19656138|P2|Overall Study|Lost to Follow-up|0
5702727|NCT00223990|19656139|P1|Overall Study|Lost to Follow-up|1
5702728|NCT00223990|19656138|P2|Overall Study|Withdrawal by Subject|8
5702729|NCT00223990|19656139|P1|Overall Study|Withdrawal by Subject|4
5702730|NCT00223990|19656138|P2|Overall Study|Moved from area|1
5702731|NCT00223990|19656139|P1|Overall Study|Moved from area|2
5702732|NCT00223977|19656164|P3|Overall Study|Other|0
5702733|NCT00223977|19656165|P2|Overall Study|Other|0
5702734|NCT00223977|19656166|P1|Overall Study|Other|1
5702735|NCT00223977|19656164|P3|Overall Study|Withdrawal by Subject|2
5702736|NCT00223977|19656165|P2|Overall Study|Withdrawal by Subject|1
5702737|NCT00223977|19656166|P1|Overall Study|Withdrawal by Subject|1
5702738|NCT00223977|19656164|P3|Overall Study|Protocol Violation|1
5702739|NCT00223977|19656165|P2|Overall Study|Protocol Violation|0
5702740|NCT00223977|19656166|P1|Overall Study|Protocol Violation|0
5702741|NCT00223977|19656164|P3|Overall Study|Adverse Event|0
5702742|NCT00223977|19656165|P2|Overall Study|Adverse Event|10
5702743|NCT00223977|19656166|P1|Overall Study|Adverse Event|7
5702744|NCT00223808|19656200|P3|Overall Study|<5 hrs therapy before discharge|5
5702745|NCT00223808|19656201|P2|Overall Study|<5 hrs therapy before discharge|5
5702746|NCT00223808|19656202|P1|Overall Study|<5 hrs therapy before discharge|3
5702747|NCT00223795|19656219|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
5702748|NCT00223795|19656220|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
5702749|NCT00223795|19656219|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
5702750|NCT00223795|19656220|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
5702751|NCT00223496|19656298|P1|Overall Study|Physician Decision|2
5702752|NCT00223496|19656298|P1|Overall Study|Withdrawal by Subject|1
5702753|NCT00223496|19656298|P1|Overall Study|Lack of Efficacy|6
5702754|NCT00223496|19656298|P1|Overall Study|Lost to Follow-up|4
5702755|NCT00223496|19656298|P1|Overall Study|screen failure|9
5702756|NCT00223080|19656328|P2|Overall Study|Adverse Event|1
5702757|NCT00223080|19656329|P1|Overall Study|Adverse Event|0
5702758|NCT00223080|19656328|P2|Overall Study|Reason not provided|140
5702759|NCT00223080|19656329|P1|Overall Study|Reason not provided|141
5702760|NCT00223080|19656328|P2|Overall Study|Other|11
5702761|NCT00223080|19656329|P1|Overall Study|Other|14
5702762|NCT00223080|19656328|P2|Overall Study|Death|74
5702763|NCT00223080|19656329|P1|Overall Study|Death|85
5702764|NCT00223080|19656328|P2|Overall Study|Lost to Follow-up|284
5702765|NCT00223080|19656329|P1|Overall Study|Lost to Follow-up|259
5702766|NCT00223080|19656328|P2|Overall Study|Moved from study area|47
5702767|NCT00223080|19656329|P1|Overall Study|Moved from study area|37
5702768|NCT00223080|19656328|P2|Overall Study|Non-compliant|7
5702769|NCT00223080|19656329|P1|Overall Study|Non-compliant|7
5702770|NCT00223080|19656328|P2|Overall Study|Required contraindicated med|1
5702771|NCT00223080|19656329|P1|Overall Study|Required contraindicated med|0
5702772|NCT00223080|19656328|P2|Overall Study|Withdrawal by Subject|232
5702773|NCT00223080|19656329|P1|Overall Study|Withdrawal by Subject|253
5702774|NCT00222729|19656347|P1|Overall Study|Adverse Event|3
5702775|NCT00222105|19656365|P1|Overall Study|Death|2
5702776|NCT00222105|19656365|P1|Overall Study|Treatment delays|2
5702777|NCT00222105|19656365|P1|Overall Study|Adverse Event|8
5702778|NCT00222105|19656365|P1|Overall Study|Withdrawal by Subject|1
5702779|NCT00222105|19656365|P1|Overall Study|Removed due to wrong diagnosis|1
5702780|NCT00221403|19656373|P3|Overall Study|Adverse Event|0
5702781|NCT00221403|19656374|P2|Overall Study|Adverse Event|1
5702782|NCT00221403|19656375|P1|Overall Study|Adverse Event|0
5702783|NCT00221403|19656373|P3|Overall Study|Lack of Efficacy|0
5702784|NCT00221403|19656374|P2|Overall Study|Lack of Efficacy|1
5702785|NCT00221403|19656375|P1|Overall Study|Lack of Efficacy|0
5702786|NCT00221403|19656373|P3|Overall Study|Withdrawal by Subject|0
5702787|NCT00221403|19656374|P2|Overall Study|Withdrawal by Subject|3
5702788|NCT00221403|19656375|P1|Overall Study|Withdrawal by Subject|0
5702789|NCT00221403|19656373|P3|Overall Study|Physician Decision|0
5702790|NCT00221403|19656374|P2|Overall Study|Physician Decision|0
5702791|NCT00221403|19656375|P1|Overall Study|Physician Decision|1
5702792|NCT00221403|19656373|P3|Overall Study|Protocol Violation|0
5702793|NCT00221403|19656374|P2|Overall Study|Protocol Violation|0
5702794|NCT00221403|19656375|P1|Overall Study|Protocol Violation|1
5702795|NCT00221195|19656418|P2|Therapy 2 (Months 10-15)|Adverse Event|0
5702796|NCT00221195|19656419|P1|Therapy 2 (Months 10-15)|Adverse Event|1
5702797|NCT00221195|19656418|P2|Therapy 2 (Months 10-15)|Death|0
5702798|NCT00221195|19656419|P1|Therapy 2 (Months 10-15)|Death|1
5702799|NCT00221195|19656418|P2|Washout Period (Months 7-9)|Death|1
5702800|NCT00221195|19656419|P1|Washout Period (Months 7-9)|Death|0
5702801|NCT00221195|19656418|P2|Therapy 1 (Months 1-6)|Lost to Follow-up|1
5702802|NCT00221195|19656419|P1|Therapy 1 (Months 1-6)|Lost to Follow-up|0
5702803|NCT00221195|19656418|P2|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
5702804|NCT00221195|19656419|P1|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
5702805|NCT00221104|19656441|P2|Overall Study|Others|47
5702806|NCT00221104|19656442|P1|Overall Study|Others|37
5702807|NCT00221104|19656441|P2|Overall Study|Withdrawal by Subject|29
5702808|NCT00221104|19656442|P1|Overall Study|Withdrawal by Subject|42
5702809|NCT00221104|19656441|P2|Overall Study|Protocol Violation|0
5702810|NCT00221104|19656442|P1|Overall Study|Protocol Violation|2
5702811|NCT00221104|19656441|P2|Overall Study|Physician Decision|0
5702812|NCT00221104|19656442|P1|Overall Study|Physician Decision|1
5702813|NCT00221104|19656441|P2|Overall Study|Adverse Event|0
5702814|NCT00221104|19656442|P1|Overall Study|Adverse Event|1
5702815|NCT00220805|19656475|P2|Overall Study|Develop. of choroidal neovascularization|8
5702816|NCT00220805|19656476|P1|Overall Study|Develop. of choroidal neovascularization|3
5702817|NCT00220805|19656475|P2|Overall Study|Lack of Efficacy|0
5702818|NCT00220805|19656476|P1|Overall Study|Lack of Efficacy|1
5702819|NCT00220805|19656475|P2|Overall Study|Withdrawal by Subject|0
5702820|NCT00220805|19656476|P1|Overall Study|Withdrawal by Subject|3
5702821|NCT00220805|19656475|P2|Overall Study|Adverse Event|3
5702822|NCT00220805|19656476|P1|Overall Study|Adverse Event|1
5702823|NCT00220779|19656497|P3|Overall Study|Lack of Efficacy|1
5702824|NCT00220779|19656498|P2|Overall Study|Lack of Efficacy|0
5702825|NCT00220779|19656499|P1|Overall Study|Lack of Efficacy|3
5702826|NCT00220779|19656497|P3|Overall Study|Pregnancy|2
5702827|NCT00220779|19656498|P2|Overall Study|Pregnancy|0
5702828|NCT00220779|19656499|P1|Overall Study|Pregnancy|0
5702829|NCT00220779|19656497|P3|Overall Study|Too time consuming|0
5702830|NCT00220779|19656498|P2|Overall Study|Too time consuming|0
5702831|NCT00220779|19656499|P1|Overall Study|Too time consuming|1
5702832|NCT00220779|19656497|P3|Overall Study|Non-compliance|0
5702833|NCT00220779|19656498|P2|Overall Study|Non-compliance|0
5702834|NCT00220779|19656499|P1|Overall Study|Non-compliance|1
5702835|NCT00220779|19656497|P3|Overall Study|Withdrawal by Subject|1
5702836|NCT00220779|19656498|P2|Overall Study|Withdrawal by Subject|4
5702837|NCT00220779|19656499|P1|Overall Study|Withdrawal by Subject|1
5702838|NCT00220779|19656497|P3|Overall Study|Adverse Event|0
5702839|NCT00220779|19656498|P2|Overall Study|Adverse Event|0
5702840|NCT00220779|19656499|P1|Overall Study|Adverse Event|1
5702841|NCT00220740|19656509|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
5702842|NCT00220740|19656510|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
5702843|NCT00220740|19656509|P2|Efficacy Period|Protocol Violation|0
5702844|NCT00220740|19656510|P1|Efficacy Period|Protocol Violation|1
5702845|NCT00220740|19656509|P2|Efficacy Period|Withdrawal by Subject|0
5702846|NCT00220740|19656510|P1|Efficacy Period|Withdrawal by Subject|1
5702847|NCT00220740|19656509|P2|Efficacy Period|Adverse Event|1
5702848|NCT00220740|19656510|P1|Efficacy Period|Adverse Event|1
5702849|NCT00220740|19656509|P2|Efficacy Period|Entered rescue treatment with placebo|0
5702850|NCT00220740|19656510|P1|Efficacy Period|Entered rescue treatment with placebo|23
5702851|NCT00220727|19656524|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
5702852|NCT00220727|19656525|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
5702853|NCT00220701|19656541|P2|Overall Study|Lost to Follow-up|4
5702854|NCT00220701|19656542|P1|Overall Study|Lost to Follow-up|5
5702855|NCT00220636|19656558|P1|Overall Study|Withdrawal by Subject|4
5702856|NCT00219557|19656568|P3|Phase 2|Treatment not received|3
5702857|NCT00219557|19656569|P2|Phase 2|Treatment not received|1
5702858|NCT00219557|19656570|P1|Phase 2|Treatment not received|0
5702859|NCT00219557|19656568|P3|Phase 2|Withdrawal by Subject|5
5702860|NCT00219557|19656569|P2|Phase 2|Withdrawal by Subject|9
5702861|NCT00219557|19656570|P1|Phase 2|Withdrawal by Subject|0
5702862|NCT00219557|19656568|P3|Phase 2|Other|6
5702863|NCT00219557|19656569|P2|Phase 2|Other|8
5702864|NCT00219557|19656570|P1|Phase 2|Other|0
5702865|NCT00219557|19656568|P3|Phase 2|Death|2
5702866|NCT00219557|19656569|P2|Phase 2|Death|8
5702867|NCT00219557|19656570|P1|Phase 2|Death|0
5702868|NCT00219557|19656568|P3|Phase 2|Adverse Event|2
5702869|NCT00219557|19656569|P2|Phase 2|Adverse Event|22
5702870|NCT00219557|19656570|P1|Phase 2|Adverse Event|0
5702871|NCT00219557|19656568|P3|Phase 2|Lack of Efficacy|15
5702872|NCT00219557|19656569|P2|Phase 2|Lack of Efficacy|21
5702873|NCT00219557|19656570|P1|Phase 2|Lack of Efficacy|0
5702874|NCT00219557|19656568|P3|Phase 1|Started chemotherapy at other institute|0
5702875|NCT00219557|19656569|P2|Phase 1|Started chemotherapy at other institute|0
5702876|NCT00219557|19656570|P1|Phase 1|Started chemotherapy at other institute|1
5702877|NCT00219557|19656568|P3|Phase 1|Withdrawal by Subject|0
5702878|NCT00219557|19656569|P2|Phase 1|Withdrawal by Subject|0
5702879|NCT00219557|19656570|P1|Phase 1|Withdrawal by Subject|1
5702880|NCT00219557|19656568|P3|Phase 1|Adverse Event|0
5702881|NCT00219557|19656569|P2|Phase 1|Adverse Event|0
5702882|NCT00219557|19656570|P1|Phase 1|Adverse Event|2
5702883|NCT00219557|19656568|P3|Phase 1|Lack of Efficacy|0
5702884|NCT00219557|19656569|P2|Phase 1|Lack of Efficacy|0
5702885|NCT00219557|19656570|P1|Phase 1|Lack of Efficacy|3
5702886|NCT00219544|19656598|P2|Single Blind Treatment Period|Withdrawal by Subject|0
5702887|NCT00219544|19656599|P1|Single Blind Treatment Period|Withdrawal by Subject|1
5702888|NCT00219544|19656598|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
5702889|NCT00219544|19656599|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
5702890|NCT00219544|19656598|P2|Single Blind Treatment Period|Lost to Follow-up|0
5702891|NCT00219544|19656599|P1|Single Blind Treatment Period|Lost to Follow-up|2
5702892|NCT00219544|19656598|P2|Single Blind Treatment Period|Protocol Violation|0
5702893|NCT00219544|19656599|P1|Single Blind Treatment Period|Protocol Violation|4
5702894|NCT00219544|19656598|P2|Single Blind Treatment Period|Adverse Event|0
5702895|NCT00219544|19656599|P1|Single Blind Treatment Period|Adverse Event|9
5702896|NCT00219544|19656598|P2|Single Blind Treatment Period|Lack of Efficacy|0
5702897|NCT00219544|19656599|P1|Single Blind Treatment Period|Lack of Efficacy|5
5702898|NCT00219349|19656637|P1|Escitalopram Phase|Withdrawal by Subject|3
5702899|NCT00219349|19656637|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
5702900|NCT00219349|19656637|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
5702901|NCT00219349|19656637|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
5702902|NCT00219284|19656650|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
5702903|NCT00219284|19656651|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
5702904|NCT00219284|19656650|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
5702905|NCT00219284|19656651|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
5702906|NCT00219284|19656650|P2|Extension Phase - 8 Weeks|Adverse Event|3
5702907|NCT00219284|19656651|P1|Extension Phase - 8 Weeks|Adverse Event|2
5702908|NCT00219284|19656650|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
5702909|NCT00219284|19656651|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
5702910|NCT00219284|19656650|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
5702911|NCT00219284|19656651|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
5702912|NCT00219284|19656650|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
5702913|NCT00219284|19656651|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
5702914|NCT00219284|19656650|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
5702915|NCT00219284|19656651|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
5702916|NCT00219284|19656650|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
5702917|NCT00219284|19656651|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
5702918|NCT00219284|19656650|P2|Treatment Phase - 16 Weeks|Adverse Event|24
5702919|NCT00219284|19656651|P1|Treatment Phase - 16 Weeks|Adverse Event|26
5702920|NCT00219141|19656676|P3|Overall Study|Condition no longer requires study drug|0
5702921|NCT00219141|19656677|P2|Overall Study|Condition no longer requires study drug|0
5702922|NCT00219141|19656678|P1|Overall Study|Condition no longer requires study drug|1
5702923|NCT00219141|19656676|P3|Overall Study|Withdrawal by Subject|5
5702924|NCT00219141|19656677|P2|Overall Study|Withdrawal by Subject|3
5702925|NCT00219141|19656678|P1|Overall Study|Withdrawal by Subject|1
5702926|NCT00219141|19656676|P3|Overall Study|Protocol Violation|1
5702927|NCT00219141|19656677|P2|Overall Study|Protocol Violation|1
5702928|NCT00219141|19656678|P1|Overall Study|Protocol Violation|3
5702929|NCT00219141|19656676|P3|Overall Study|Lost to Follow-up|1
5702930|NCT00219141|19656677|P2|Overall Study|Lost to Follow-up|4
5702931|NCT00219141|19656678|P1|Overall Study|Lost to Follow-up|2
5702932|NCT00219141|19656676|P3|Overall Study|Administrative problems|0
5702933|NCT00219141|19656677|P2|Overall Study|Administrative problems|1
5702934|NCT00219141|19656678|P1|Overall Study|Administrative problems|0
5702935|NCT00219141|19656676|P3|Overall Study|Lack of Efficacy|0
5702936|NCT00219141|19656677|P2|Overall Study|Lack of Efficacy|2
5702937|NCT00219141|19656678|P1|Overall Study|Lack of Efficacy|3
5702938|NCT00219141|19656676|P3|Overall Study|Adverse Event|5
5702939|NCT00219141|19656677|P2|Overall Study|Adverse Event|10
5702940|NCT00219141|19656678|P1|Overall Study|Adverse Event|4
5702941|NCT00218634|19656724|P2|Overall Study|Lost to Follow-up|15
5702942|NCT00218634|19656725|P1|Overall Study|Lost to Follow-up|8
5702943|NCT00218543|19656745|P1|Overall Study|Adverse Event|2
5702944|NCT00218543|19656745|P1|Overall Study|Physician Decision|3
5702945|NCT00218543|19656745|P1|Overall Study|Withdrawal by Subject|1
5702946|NCT00218543|19656745|P1|Overall Study|relocated|1
5702947|NCT00218543|19656745|P1|Overall Study|Lost to Follow-up|8
5702948|NCT00218296|19656923|P2|Overall Study|Randomized but did not enter treatment|67
5702949|NCT00218296|19656924|P1|Overall Study|Randomized but did not enter treatment|66
5702950|NCT00218296|19656923|P2|Overall Study|Withdrawal by Subject|47
5702951|NCT00218296|19656924|P1|Overall Study|Withdrawal by Subject|36
5702952|NCT00218296|19656923|P2|Overall Study|Lost to Follow-up|7
5702953|NCT00218296|19656924|P1|Overall Study|Lost to Follow-up|9
5702954|NCT00218257|19656940|P2|Period Between Visit 1 and 2|Lost to Follow-up|3
5702955|NCT00218257|19656941|P1|Period Between Visit 1 and 2|Lost to Follow-up|4
5702956|NCT00217971|19657042|P2|Overall Study|non compliant|0
5702957|NCT00217971|19657043|P1|Overall Study|non compliant|1
5702958|NCT00217971|19657042|P2|Overall Study|Withdrawal by Subject|12
5702959|NCT00217971|19657043|P1|Overall Study|Withdrawal by Subject|7
5702960|NCT00217971|19657042|P2|Overall Study|Physician Decision|1
5702961|NCT00217971|19657043|P1|Overall Study|Physician Decision|0
5702962|NCT00217971|19657042|P2|Overall Study|Lost to Follow-up|19
5702963|NCT00217971|19657043|P1|Overall Study|Lost to Follow-up|15
5702964|NCT00217971|19657042|P2|Overall Study|Adverse Event|1
5702965|NCT00217971|19657043|P1|Overall Study|Adverse Event|1
5702966|NCT00217672|19657058|P2|Follow-up|Lost to Follow-up|0
5702967|NCT00217672|19657059|P1|Follow-up|Lost to Follow-up|1
5702968|NCT00217672|19657058|P2|Follow-up|Withdrawal by Subject|0
5702969|NCT00217672|19657059|P1|Follow-up|Withdrawal by Subject|4
5702970|NCT00217672|19657058|P2|Treatment|secondary malignancy|0
5702971|NCT00217672|19657059|P1|Treatment|secondary malignancy|1
5702972|NCT00217672|19657058|P2|Treatment|Death|0
5702973|NCT00217672|19657059|P1|Treatment|Death|2
5702974|NCT00217672|19657058|P2|Treatment|insurance issues|1
5702975|NCT00217672|19657059|P1|Treatment|insurance issues|1
5702976|NCT00217672|19657058|P2|Treatment|Physician Decision|0
5702977|NCT00217672|19657059|P1|Treatment|Physician Decision|6
5702978|NCT00217672|19657058|P2|Treatment|reqd treatment not permitted by protocol|0
5702979|NCT00217672|19657059|P1|Treatment|reqd treatment not permitted by protocol|6
5702980|NCT00217672|19657058|P2|Treatment|Adverse Event|2
5702981|NCT00217672|19657059|P1|Treatment|Adverse Event|18
5702982|NCT00217672|19657058|P2|Treatment|disease progression|4
5702983|NCT00217672|19657059|P1|Treatment|disease progression|33
5702984|NCT00217672|19657058|P2|Allocation|Ineligible|0
5702985|NCT00217672|19657059|P1|Allocation|Ineligible|2
5702986|NCT00217620|19657065|P1|Overall Study|Never received treatment|1
5702987|NCT00217620|19657065|P1|Overall Study|Ineligible|13
5702988|NCT00217620|19657065|P1|Overall Study|Not Protocol Specified|4
5702989|NCT00217620|19657065|P1|Overall Study|Progression|31
5702990|NCT00217620|19657065|P1|Overall Study|Adverse Event|2
5702991|NCT00217581|19657080|P1|Overall Study|Withdrawal by Subject|1
5702992|NCT00217464|19657109|P1|Overall Study|Other|2
5702993|NCT00217464|19657109|P1|Overall Study|Progression|15
5702994|NCT00217425|19657125|P1|Overall Study|Other|4
5702995|NCT00217425|19657125|P1|Overall Study|Other complicating disease|1
5702996|NCT00217425|19657125|P1|Overall Study|Withdrawal by Subject|4
5702997|NCT00217425|19657125|P1|Overall Study|Adverse Event|8
5702998|NCT00217425|19657125|P1|Overall Study|Lack of Efficacy|13
5702999|NCT00217425|19657125|P1|Overall Study|Patient ineligible|5
5703000|NCT00217425|19657125|P1|Overall Study|Never started treatment|2
5703001|NCT00217087|19657139|P2|Overall Study|completed less than 12 months return|18
5703002|NCT00217087|19657140|P1|Overall Study|completed less than 12 months return|10
5703003|NCT00217087|19657139|P2|Overall Study|decided to have esophagectomy|2
5703004|NCT00217087|19657140|P1|Overall Study|decided to have esophagectomy|1
5703005|NCT00217022|19657154|P2|Overall Study|Withdrawal by Subject|1
5703006|NCT00217022|19657155|P1|Overall Study|Withdrawal by Subject|1
5703007|NCT00216736|19657165|P2|Overall Study|Lost to Follow-up|1
5703008|NCT00216736|19657166|P1|Overall Study|Lost to Follow-up|1
5703009|NCT00216671|19657180|P2|Overall Study|Insufficient Response Adverse Event|1
5703010|NCT00216671|19657181|P1|Overall Study|Insufficient Response Adverse Event|2
5703011|NCT00216671|19657180|P2|Overall Study|Ineligible, no efficacy data|2
5703012|NCT00216671|19657181|P1|Overall Study|Ineligible, no efficacy data|2
5703013|NCT00216671|19657180|P2|Overall Study|Patient Moved|1
5703014|NCT00216671|19657181|P1|Overall Study|Patient Moved|0
5703015|NCT00216671|19657180|P2|Overall Study|Investigator Illness|1
5703016|NCT00216671|19657181|P1|Overall Study|Investigator Illness|0
5703017|NCT00216671|19657180|P2|Overall Study|Relapse|0
5703018|NCT00216671|19657181|P1|Overall Study|Relapse|1
5703019|NCT00216671|19657180|P2|Overall Study|Protocol Violation|5
5703020|NCT00216671|19657181|P1|Overall Study|Protocol Violation|3
5703021|NCT00216671|19657180|P2|Overall Study|Physician Decision|1
5703022|NCT00216671|19657181|P1|Overall Study|Physician Decision|1
5703023|NCT00216671|19657180|P2|Overall Study|Ineligible|2
5703024|NCT00216671|19657181|P1|Overall Study|Ineligible|0
5703025|NCT00216671|19657180|P2|Overall Study|Non compliant|2
5703026|NCT00216671|19657181|P1|Overall Study|Non compliant|2
5703027|NCT00216671|19657180|P2|Overall Study|Lost to Follow-up|5
5703028|NCT00216671|19657181|P1|Overall Study|Lost to Follow-up|3
5703029|NCT00216671|19657180|P2|Overall Study|Insufficient Response|4
5703030|NCT00216671|19657181|P1|Overall Study|Insufficient Response|9
5703031|NCT00216671|19657180|P2|Overall Study|No Need to Continue Medication|1
5703032|NCT00216671|19657181|P1|Overall Study|No Need to Continue Medication|1
5703033|NCT00216671|19657180|P2|Overall Study|Refused Injections|13
5703034|NCT00216671|19657181|P1|Overall Study|Refused Injections|3
5703035|NCT00216671|19657180|P2|Overall Study|Withdrawal by Subject|2
5703036|NCT00216671|19657181|P1|Overall Study|Withdrawal by Subject|4
5703037|NCT00216671|19657180|P2|Overall Study|Pregnancy|1
5703038|NCT00216671|19657181|P1|Overall Study|Pregnancy|0
5703039|NCT00216671|19657180|P2|Overall Study|Adverse Event|9
5703040|NCT00216671|19657181|P1|Overall Study|Adverse Event|4
5703041|NCT00216476|19657199|P3|Overall Study|Patient Moved|0
5703042|NCT00216476|19657200|P2|Overall Study|Patient Moved|2
5703043|NCT00216476|19657201|P1|Overall Study|Patient Moved|2
5703044|NCT00216476|19657199|P3|Overall Study|Protocol Deviation|0
5703045|NCT00216476|19657200|P2|Overall Study|Protocol Deviation|1
5703046|NCT00216476|19657201|P1|Overall Study|Protocol Deviation|5
5703047|NCT00216476|19657199|P3|Overall Study|Administrative Reasons|0
5703048|NCT00216476|19657200|P2|Overall Study|Administrative Reasons|1
5703049|NCT00216476|19657201|P1|Overall Study|Administrative Reasons|1
5703050|NCT00216476|19657199|P3|Overall Study|Higher dose/Extra Medication Required|2
5703051|NCT00216476|19657200|P2|Overall Study|Higher dose/Extra Medication Required|0
5703052|NCT00216476|19657201|P1|Overall Study|Higher dose/Extra Medication Required|2
5703053|NCT00216476|19657199|P3|Overall Study|Non-compliance|1
5703054|NCT00216476|19657200|P2|Overall Study|Non-compliance|4
5703055|NCT00216476|19657201|P1|Overall Study|Non-compliance|0
5703056|NCT00216476|19657199|P3|Overall Study|No Further Need for Treatment|1
5703057|NCT00216476|19657200|P2|Overall Study|No Further Need for Treatment|4
5703058|NCT00216476|19657201|P1|Overall Study|No Further Need for Treatment|3
5703059|NCT00216476|19657199|P3|Overall Study|Refuses Injection|0
5703060|NCT00216476|19657200|P2|Overall Study|Refuses Injection|0
5703061|NCT00216476|19657201|P1|Overall Study|Refuses Injection|11
5703062|NCT00216476|19657199|P3|Overall Study|Other|1
5703063|NCT00216476|19657200|P2|Overall Study|Other|0
5703064|NCT00216476|19657201|P1|Overall Study|Other|0
5703065|NCT00216476|19657199|P3|Overall Study|Pregnancy|1
5703066|NCT00216476|19657200|P2|Overall Study|Pregnancy|1
5703067|NCT00216476|19657201|P1|Overall Study|Pregnancy|0
5703068|NCT00216476|19657199|P3|Overall Study|Death|0
5703069|NCT00216476|19657200|P2|Overall Study|Death|0
5703070|NCT00216476|19657201|P1|Overall Study|Death|2
5703071|NCT00216476|19657199|P3|Overall Study|Lack of Efficacy|0
5703072|NCT00216476|19657200|P2|Overall Study|Lack of Efficacy|3
5703073|NCT00216476|19657201|P1|Overall Study|Lack of Efficacy|4
5703074|NCT00216476|19657199|P3|Overall Study|Adverse Event|1
5703075|NCT00216476|19657200|P2|Overall Study|Adverse Event|10
5703076|NCT00216476|19657201|P1|Overall Study|Adverse Event|6
5703077|NCT00216476|19657199|P3|Overall Study|Lost to Follow-up|1
5703078|NCT00216476|19657200|P2|Overall Study|Lost to Follow-up|9
5703079|NCT00216476|19657201|P1|Overall Study|Lost to Follow-up|10
5703080|NCT00216476|19657199|P3|Overall Study|Withdrawal by Subject|9
5703081|NCT00216476|19657200|P2|Overall Study|Withdrawal by Subject|72
5703082|NCT00216476|19657201|P1|Overall Study|Withdrawal by Subject|59
5703083|NCT00216203|19657238|P1|Overall Study|Withdrawal by Subject|2
5703084|NCT00216086|19657268|P1|Overall Study|Social Reasons|2
5703085|NCT00216086|19657268|P1|Overall Study|Diagnosis of Metastatic Disease|1
5703086|NCT00216086|19657268|P1|Overall Study|Protocol Violation|1
5703087|NCT00215943|19657300|P2|Overall Study|Other complications|1
5703088|NCT00215943|19657301|P1|Overall Study|Other complications|3
5703089|NCT00215943|19657300|P2|Overall Study|Other disease|1
5703090|NCT00215943|19657301|P1|Overall Study|Other disease|0
5703091|NCT00215943|19657300|P2|Overall Study|Adverse Event|6
5703092|NCT00215943|19657301|P1|Overall Study|Adverse Event|3
5703093|NCT00215943|19657300|P2|Overall Study|Alternate therapy|1
5703094|NCT00215943|19657301|P1|Overall Study|Alternate therapy|0
5703095|NCT00215943|19657300|P2|Overall Study|Disease Progression|5
5703096|NCT00215943|19657301|P1|Overall Study|Disease Progression|3
5703097|NCT00215683|19657326|P3|Overall Study|Intermittent therapy required|0
5703098|NCT00215683|19657327|P2|Overall Study|Intermittent therapy required|1
5703099|NCT00215683|19657328|P1|Overall Study|Intermittent therapy required|0
5703100|NCT00215683|19657326|P3|Overall Study|No study drug available|0
5703101|NCT00215683|19657327|P2|Overall Study|No study drug available|1
5703102|NCT00215683|19657328|P1|Overall Study|No study drug available|0
5703103|NCT00215683|19657326|P3|Overall Study|Difficult to attend visits|0
5703104|NCT00215683|19657327|P2|Overall Study|Difficult to attend visits|1
5703105|NCT00215683|19657328|P1|Overall Study|Difficult to attend visits|0
5703106|NCT00215683|19657326|P3|Overall Study|Physician Decision|1
5703107|NCT00215683|19657327|P2|Overall Study|Physician Decision|0
5703108|NCT00215683|19657328|P1|Overall Study|Physician Decision|0
5703109|NCT00215683|19657326|P3|Overall Study|Withdrawal by Subject|13
5703110|NCT00215683|19657327|P2|Overall Study|Withdrawal by Subject|4
5703111|NCT00215683|19657328|P1|Overall Study|Withdrawal by Subject|9
5703112|NCT00215683|19657326|P3|Overall Study|Lost to Follow-up|1
5703113|NCT00215683|19657327|P2|Overall Study|Lost to Follow-up|2
5703114|NCT00215683|19657328|P1|Overall Study|Lost to Follow-up|0
5703115|NCT00215683|19657326|P3|Overall Study|Lack of Efficacy|2
5703116|NCT00215683|19657327|P2|Overall Study|Lack of Efficacy|1
5703117|NCT00215683|19657328|P1|Overall Study|Lack of Efficacy|5
5703118|NCT00215683|19657326|P3|Overall Study|Adverse Event|15
5703119|NCT00215683|19657327|P2|Overall Study|Adverse Event|16
5703120|NCT00215683|19657328|P1|Overall Study|Adverse Event|15
5703121|NCT00215657|19657347|P8|Overall Study|Other|1
5703122|NCT00215657|19657348|P7|Overall Study|Other|6
5703123|NCT00215657|19657349|P6|Overall Study|Other|4
5703124|NCT00215657|19657350|P5|Overall Study|Other|5
5703125|NCT00215657|19657351|P4|Overall Study|Other|3
5703126|NCT00215657|19657352|P3|Overall Study|Other|2
5703127|NCT00215657|19657353|P2|Overall Study|Other|1
5703128|NCT00215657|19657354|P1|Overall Study|Other|3
5703129|NCT00215657|19657347|P8|Overall Study|Insufficient testosterone response|7
5703130|NCT00215657|19657348|P7|Overall Study|Insufficient testosterone response|4
5703131|NCT00215657|19657349|P6|Overall Study|Insufficient testosterone response|12
5703132|NCT00215657|19657350|P5|Overall Study|Insufficient testosterone response|8
5703133|NCT00215657|19657351|P4|Overall Study|Insufficient testosterone response|12
5703134|NCT00215657|19657352|P3|Overall Study|Insufficient testosterone response|1
5703135|NCT00215657|19657353|P2|Overall Study|Insufficient testosterone response|4
5703136|NCT00215657|19657354|P1|Overall Study|Insufficient testosterone response|5
5703137|NCT00215657|19657347|P8|Overall Study|Insuff prostate specific antigen resp|2
5703138|NCT00215657|19657348|P7|Overall Study|Insuff prostate specific antigen resp|3
5703139|NCT00215657|19657349|P6|Overall Study|Insuff prostate specific antigen resp|2
5703140|NCT00215657|19657350|P5|Overall Study|Insuff prostate specific antigen resp|1
5703141|NCT00215657|19657351|P4|Overall Study|Insuff prostate specific antigen resp|2
5703142|NCT00215657|19657352|P3|Overall Study|Insuff prostate specific antigen resp|2
5703143|NCT00215657|19657353|P2|Overall Study|Insuff prostate specific antigen resp|2
5703144|NCT00215657|19657354|P1|Overall Study|Insuff prostate specific antigen resp|3
5703145|NCT00215657|19657347|P8|Overall Study|Withdrawal by Subject|3
5703146|NCT00215657|19657348|P7|Overall Study|Withdrawal by Subject|10
5703147|NCT00215657|19657349|P6|Overall Study|Withdrawal by Subject|1
5703148|NCT00215657|19657350|P5|Overall Study|Withdrawal by Subject|6
5703149|NCT00215657|19657351|P4|Overall Study|Withdrawal by Subject|1
5703150|NCT00215657|19657352|P3|Overall Study|Withdrawal by Subject|3
5703151|NCT00215657|19657353|P2|Overall Study|Withdrawal by Subject|3
5703152|NCT00215657|19657354|P1|Overall Study|Withdrawal by Subject|6
5703153|NCT00215657|19657347|P8|Overall Study|Adverse Event|3
5703154|NCT00215657|19657348|P7|Overall Study|Adverse Event|0
5703155|NCT00215657|19657349|P6|Overall Study|Adverse Event|1
5703156|NCT00215657|19657350|P5|Overall Study|Adverse Event|3
5703157|NCT00215657|19657351|P4|Overall Study|Adverse Event|0
5703158|NCT00215657|19657352|P3|Overall Study|Adverse Event|3
5703159|NCT00215657|19657353|P2|Overall Study|Adverse Event|1
5703160|NCT00215657|19657354|P1|Overall Study|Adverse Event|5
5703161|NCT00215644|19657382|P2|Overall Study|Randomized but Not Treated|0
5703162|NCT00215644|19657383|P1|Overall Study|Randomized but Not Treated|1
5703163|NCT00215644|19657382|P2|Overall Study|Other|15
5703164|NCT00215644|19657383|P1|Overall Study|Other|3
5703165|NCT00215644|19657382|P2|Overall Study|Withdrawal by Subject|0
5703166|NCT00215644|19657383|P1|Overall Study|Withdrawal by Subject|1
5703167|NCT00215644|19657382|P2|Overall Study|Death|2
5703168|NCT00215644|19657383|P1|Overall Study|Death|1
5703169|NCT00215644|19657382|P2|Overall Study|Adverse Event|9
5703170|NCT00215644|19657383|P1|Overall Study|Adverse Event|2
5703171|NCT00215644|19657382|P2|Overall Study|Disease Progression|10
5703172|NCT00215644|19657383|P1|Overall Study|Disease Progression|28
5703173|NCT00215553|19657410|P7|Overall Study|Adverse Event|0
5703174|NCT00215553|19657411|P6|Overall Study|Adverse Event|6
5703175|NCT00215553|19657412|P5|Overall Study|Adverse Event|2
5703176|NCT00215553|19657413|P4|Overall Study|Adverse Event|1
5703177|NCT00215553|19657414|P3|Overall Study|Adverse Event|2
5703178|NCT00215553|19657415|P2|Overall Study|Adverse Event|1
5703179|NCT00215553|19657416|P1|Overall Study|Adverse Event|0
5703180|NCT00215540|19657449|P3|Overall Study|Withdrew from study medication|0
5703181|NCT00215540|19657450|P2|Overall Study|Withdrew from study medication|0
5703182|NCT00215540|19657451|P1|Overall Study|Withdrew from study medication|1
5703183|NCT00215150|19657486|P1|Randomization Phase Placebo|Withdrawal by Subject|1
5703184|NCT00215150|19657486|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
5703185|NCT00215150|19657486|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
5703186|NCT00215150|19657486|P1|Open Label Phase|Did not meet randomization criteria|9
5703187|NCT00215150|19657486|P1|Open Label Phase|Did not complete a post base visit|13
5703188|NCT00215150|19657486|P1|Open Label Phase|Withdrawal by Subject|1
5703189|NCT00215150|19657486|P1|Open Label Phase|Lost to Follow-up|7
5703190|NCT00215137|19657494|P3|Randomization Period|Withdrawal by Subject|0
5703191|NCT00215137|19657495|P2|Randomization Period|Withdrawal by Subject|1
5703192|NCT00215137|19657496|P1|Randomization Period|Withdrawal by Subject|0
5703193|NCT00215137|19657494|P3|Randomization Period|Lost to Follow-up|0
5703194|NCT00215137|19657495|P2|Randomization Period|Lost to Follow-up|1
5703195|NCT00215137|19657496|P1|Randomization Period|Lost to Follow-up|0
5703196|NCT00215137|19657494|P3|Open Label Escitalopram|Lack of Efficacy|0
5703197|NCT00215137|19657495|P2|Open Label Escitalopram|Lack of Efficacy|0
5703198|NCT00215137|19657496|P1|Open Label Escitalopram|Lack of Efficacy|1
5703199|NCT00214500|19657594|P1|Extension Period|Withdrawal by Subject|2
5703200|NCT00214500|19657594|P1|Treatment Period|Adverse Event|1
5703201|NCT00214461|19657615|P4|Overall Study|Withdrawal by Subject|0
5703202|NCT00214461|19657616|P3|Overall Study|Withdrawal by Subject|1
5703203|NCT00214461|19657617|P2|Overall Study|Withdrawal by Subject|0
5703204|NCT00214461|19657618|P1|Overall Study|Withdrawal by Subject|0
5703205|NCT00214461|19657615|P4|Overall Study|Adverse Event|1
5703206|NCT00214461|19657616|P3|Overall Study|Adverse Event|1
5703207|NCT00214461|19657617|P2|Overall Study|Adverse Event|0
5703208|NCT00214461|19657618|P1|Overall Study|Adverse Event|0
5703209|NCT00214422|19657635|P3|Overall Study|Unable to make a radiation treatment|1
5703210|NCT00214422|19657636|P2|Overall Study|Unable to make a radiation treatment|0
5703211|NCT00214422|19657637|P1|Overall Study|Unable to make a radiation treatment|0
5703212|NCT00214422|19657635|P3|Overall Study|Disease progression on study|0
5703213|NCT00214422|19657636|P2|Overall Study|Disease progression on study|0
5703214|NCT00214422|19657637|P1|Overall Study|Disease progression on study|1
5703215|NCT00214422|19657635|P3|Overall Study|Pt taken off study|0
5703216|NCT00214422|19657636|P2|Overall Study|Pt taken off study|1
5703217|NCT00214422|19657637|P1|Overall Study|Pt taken off study|1
5703218|NCT00214422|19657635|P3|Overall Study|Developed esophageal ca|0
5703219|NCT00214422|19657636|P2|Overall Study|Developed esophageal ca|0
5703220|NCT00214422|19657637|P1|Overall Study|Developed esophageal ca|1
5703221|NCT00214422|19657635|P3|Overall Study|Physician Decision|0
5703222|NCT00214422|19657636|P2|Overall Study|Physician Decision|0
5703223|NCT00214422|19657637|P1|Overall Study|Physician Decision|2
5703224|NCT00214383|19657660|P2|Overall Study|Lost to Follow-up|26
5703225|NCT00214383|19657661|P1|Overall Study|Lost to Follow-up|16
5703226|NCT00214201|19657673|P2|Overall Study|Death|2
5703227|NCT00214201|19657674|P1|Overall Study|Death|0
5703228|NCT00214201|19657673|P2|Overall Study|Withdrawal by Subject|0
5703229|NCT00214201|19657674|P1|Overall Study|Withdrawal by Subject|2
5703230|NCT00214136|19657689|P1|Overall Study|Death|5
5703231|NCT00214019|19657734|P1|Overall Study|Screen Failed prior to randomization|17
5703232|NCT00214019|19657734|P1|Overall Study|Withdrawal by Subject|2
5703233|NCT00214019|19657734|P1|Overall Study|Lost to Follow-up|11
5703234|NCT00213980|19657743|P2|Overall Study|Failed to obtain all 3 DXAs|3
5703235|NCT00213980|19657744|P1|Overall Study|Failed to obtain all 3 DXAs|1
5703236|NCT00213980|19657743|P2|Overall Study|Developed ovarian cancer|0
5703237|NCT00213980|19657744|P1|Overall Study|Developed ovarian cancer|1
5703238|NCT00213980|19657743|P2|Overall Study|Disease progression|2
5703239|NCT00213980|19657744|P1|Overall Study|Disease progression|0
5703240|NCT00213980|19657743|P2|Overall Study|Adverse Event|1
5703241|NCT00213980|19657744|P1|Overall Study|Adverse Event|1
5703242|NCT00213980|19657743|P2|Overall Study|Withdrawal by Subject|1
5703243|NCT00213980|19657744|P1|Overall Study|Withdrawal by Subject|3
5703244|NCT00213148|19657771|P5|Cycle 3 (1 Month)|Other|0
5703245|NCT00213148|19657772|P4|Cycle 3 (1 Month)|Other|1
5703246|NCT00213148|19657773|P3|Cycle 3 (1 Month)|Other|1
5703247|NCT00213148|19657774|P2|Cycle 3 (1 Month)|Other|0
5703248|NCT00213148|19657775|P1|Cycle 3 (1 Month)|Other|0
5703249|NCT00213148|19657771|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
5703250|NCT00213148|19657772|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
5703251|NCT00213148|19657773|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
5703252|NCT00213148|19657774|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
5703253|NCT00213148|19657775|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
5703254|NCT00213148|19657771|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
5703255|NCT00213148|19657772|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
5703256|NCT00213148|19657773|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
5703257|NCT00213148|19657774|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
5703258|NCT00213148|19657775|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
5703259|NCT00213148|19657771|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
5703260|NCT00213148|19657772|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
5703261|NCT00213148|19657773|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
5703262|NCT00213148|19657774|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
5703263|NCT00213148|19657775|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
5703264|NCT00213148|19657771|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
5703265|NCT00213148|19657772|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
5703266|NCT00213148|19657773|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
5703267|NCT00213148|19657774|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
5703268|NCT00213148|19657775|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
5703269|NCT00213148|19657771|P5|Cycle 2 (1 Month)|Other|7
5703270|NCT00213148|19657772|P4|Cycle 2 (1 Month)|Other|8
5703271|NCT00213148|19657773|P3|Cycle 2 (1 Month)|Other|2
5703272|NCT00213148|19657774|P2|Cycle 2 (1 Month)|Other|1
5703273|NCT00213148|19657775|P1|Cycle 2 (1 Month)|Other|2
5703274|NCT00213148|19657771|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
5703275|NCT00213148|19657772|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
5703276|NCT00213148|19657773|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
5703277|NCT00213148|19657774|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
5703278|NCT00213148|19657775|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
5703279|NCT00213148|19657771|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
5703280|NCT00213148|19657772|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
5703281|NCT00213148|19657773|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
5703282|NCT00213148|19657774|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
5703283|NCT00213148|19657775|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
5703284|NCT00213148|19657771|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
5703285|NCT00213148|19657772|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
5703286|NCT00213148|19657773|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
5703287|NCT00213148|19657774|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
5703288|NCT00213148|19657775|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
5703289|NCT00213148|19657771|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
5703290|NCT00213148|19657772|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
5703291|NCT00213148|19657773|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
5703292|NCT00213148|19657774|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
5703293|NCT00213148|19657775|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
5703294|NCT00213148|19657771|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
5703295|NCT00213148|19657772|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
5703296|NCT00213148|19657773|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
5703297|NCT00213148|19657774|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
5703298|NCT00213148|19657775|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
5703299|NCT00213148|19657771|P5|Cycle 1 (1 Month)|Other|7
5703300|NCT00213148|19657772|P4|Cycle 1 (1 Month)|Other|2
5703301|NCT00213148|19657773|P3|Cycle 1 (1 Month)|Other|2
5703302|NCT00213148|19657774|P2|Cycle 1 (1 Month)|Other|0
5703303|NCT00213148|19657775|P1|Cycle 1 (1 Month)|Other|3
5703304|NCT00213148|19657771|P5|Cycle 1 (1 Month)|Protocol Violation|0
5703305|NCT00213148|19657772|P4|Cycle 1 (1 Month)|Protocol Violation|0
5703306|NCT00213148|19657773|P3|Cycle 1 (1 Month)|Protocol Violation|1
5703307|NCT00213148|19657774|P2|Cycle 1 (1 Month)|Protocol Violation|0
5703308|NCT00213148|19657775|P1|Cycle 1 (1 Month)|Protocol Violation|1
5703309|NCT00213148|19657771|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
5703310|NCT00213148|19657772|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
5703311|NCT00213148|19657773|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
5703312|NCT00213148|19657774|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
5703313|NCT00213148|19657775|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
5703314|NCT00213148|19657771|P5|Cycle 1 (1 Month)|Adverse Event|0
5703315|NCT00213148|19657772|P4|Cycle 1 (1 Month)|Adverse Event|0
5703316|NCT00213148|19657773|P3|Cycle 1 (1 Month)|Adverse Event|1
5703317|NCT00213148|19657774|P2|Cycle 1 (1 Month)|Adverse Event|0
5703318|NCT00213148|19657775|P1|Cycle 1 (1 Month)|Adverse Event|0
5703319|NCT00213148|19657771|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
5703320|NCT00213148|19657772|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
5703321|NCT00213148|19657773|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
5703322|NCT00213148|19657774|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
5703323|NCT00213148|19657775|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
5703324|NCT00213135|19657802|P3|Overall Study|Other|15
5703325|NCT00213135|19657803|P2|Overall Study|Other|12
5703326|NCT00213135|19657804|P1|Overall Study|Other|21
5703327|NCT00213135|19657802|P3|Overall Study|Disease progression|21
5703328|NCT00213135|19657803|P2|Overall Study|Disease progression|5
5703329|NCT00213135|19657804|P1|Overall Study|Disease progression|4
5703330|NCT00213135|19657802|P3|Overall Study|Death|2
5703331|NCT00213135|19657803|P2|Overall Study|Death|1
5703332|NCT00213135|19657804|P1|Overall Study|Death|1
5703333|NCT00213135|19657802|P3|Overall Study|Protocol Violation|10
5703334|NCT00213135|19657803|P2|Overall Study|Protocol Violation|4
5703335|NCT00213135|19657804|P1|Overall Study|Protocol Violation|4
5703336|NCT00213135|19657802|P3|Overall Study|Lost to Follow-up|4
5703337|NCT00213135|19657803|P2|Overall Study|Lost to Follow-up|8
5703338|NCT00213135|19657804|P1|Overall Study|Lost to Follow-up|11
5703339|NCT00213135|19657802|P3|Overall Study|Adverse Event|5
5703340|NCT00213135|19657803|P2|Overall Study|Adverse Event|5
5703341|NCT00213135|19657804|P1|Overall Study|Adverse Event|9
5703342|NCT00212758|19657847|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
5703343|NCT00212758|19657848|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
5703344|NCT00212758|19657847|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
5703345|NCT00212758|19657848|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
5703346|NCT00212355|19657864|P1|Overall Study|A change of address|1
5703347|NCT00212355|19657864|P1|Overall Study|Withdrawal by Subject|1
5703348|NCT00212355|19657864|P1|Overall Study|Adverse Event|1
5703349|NCT00212134|19657885|P2|Phase 3 (Age 10 Years)|On Going|21
5703350|NCT00212134|19657886|P1|Phase 3 (Age 10 Years)|On Going|21
5703351|NCT00211887|19657907|P3|Overall Study|Side effects|5
5703352|NCT00211887|19657908|P2|Overall Study|Side effects|13
5703353|NCT00211887|19657909|P1|Overall Study|Side effects|19
5703354|NCT00211887|19657907|P3|Overall Study|Other medical reason|7
5703355|NCT00211887|19657908|P2|Overall Study|Other medical reason|11
5703356|NCT00211887|19657909|P1|Overall Study|Other medical reason|15
5703357|NCT00211887|19657907|P3|Overall Study|Non-medical reason|8
5703358|NCT00211887|19657908|P2|Overall Study|Non-medical reason|14
5703359|NCT00211887|19657909|P1|Overall Study|Non-medical reason|31
5703360|NCT00211887|19657907|P3|Overall Study|Lost to Follow-up|9
5703361|NCT00211887|19657908|P2|Overall Study|Lost to Follow-up|13
5703362|NCT00211887|19657909|P1|Overall Study|Lost to Follow-up|28
5703363|NCT00211887|19657907|P3|Overall Study|Death|1
5703364|NCT00211887|19657908|P2|Overall Study|Death|1
5703365|NCT00211887|19657909|P1|Overall Study|Death|1
5703366|NCT00211887|19657907|P3|Overall Study|Adverse Event|6
5703367|NCT00211887|19657908|P2|Overall Study|Adverse Event|4
5703368|NCT00211887|19657909|P1|Overall Study|Adverse Event|8
5703369|NCT00211809|19657926|P1|Overall Study|side effects|2
5703370|NCT00211809|19657926|P1|Overall Study|Pregnancy|1
5703371|NCT00211809|19657926|P1|Overall Study|Lost to Follow-up|2
5703372|NCT00211809|19657926|P1|Overall Study|Lack of Efficacy|1
5703373|NCT00211757|19657942|P2|Overall Study|Lack of Efficacy|1
5703374|NCT00211757|19657943|P1|Overall Study|Lack of Efficacy|0
5703375|NCT00211757|19657942|P2|Overall Study|Withdrawal by Subject|1
5703376|NCT00211757|19657943|P1|Overall Study|Withdrawal by Subject|1
5703377|NCT00211536|19657964|P2|Overall Study|Adverse Event|0
5703378|NCT00211536|19657965|P1|Overall Study|Adverse Event|2
5703379|NCT00211536|19657964|P2|Overall Study|Physician Decision|5
5703380|NCT00211536|19657965|P1|Overall Study|Physician Decision|0
5703381|NCT00211536|19657964|P2|Overall Study|Withdrawal by Subject|2
5703382|NCT00211536|19657965|P1|Overall Study|Withdrawal by Subject|2
5703383|NCT00211510|19657981|P2|Overall Study|Withdrawal by Subject|1
5703384|NCT00211510|19657982|P1|Overall Study|Withdrawal by Subject|3
5703385|NCT00211510|19657981|P2|Overall Study|Physician Decision|1
5703386|NCT00211510|19657982|P1|Overall Study|Physician Decision|3
5703387|NCT00211237|19658000|P3|12 Months|unrelated medical problem|1
5703388|NCT00211237|19658001|P2|12 Months|unrelated medical problem|0
5703389|NCT00211237|19658002|P1|12 Months|unrelated medical problem|0
5703390|NCT00211237|19658000|P3|12 Months|Withdrew|1
5703391|NCT00211237|19658001|P2|12 Months|Withdrew|0
5703392|NCT00211237|19658002|P1|12 Months|Withdrew|0
5703393|NCT00211237|19658000|P3|12 Months|Lost to Follow-up|1
5703394|NCT00211237|19658001|P2|12 Months|Lost to Follow-up|0
5703395|NCT00211237|19658002|P1|12 Months|Lost to Follow-up|1
5703396|NCT00211237|19658000|P3|12 Months|Death|3
5703397|NCT00211237|19658001|P2|12 Months|Death|2
5703398|NCT00211237|19658002|P1|12 Months|Death|8
5703399|NCT00211237|19658000|P3|6 Months|Could not comply with protocol|0
5703400|NCT00211237|19658001|P2|6 Months|Could not comply with protocol|2
5703401|NCT00211237|19658002|P1|6 Months|Could not comply with protocol|0
5703402|NCT00211237|19658000|P3|6 Months|Lost to Follow-up|0
5703403|NCT00211237|19658001|P2|6 Months|Lost to Follow-up|0
5703404|NCT00211237|19658002|P1|6 Months|Lost to Follow-up|2
5703405|NCT00211237|19658000|P3|6 Months|Death|3
5703406|NCT00211237|19658001|P2|6 Months|Death|0
5703407|NCT00211237|19658002|P1|6 Months|Death|6
5703408|NCT00211237|19658000|P3|3 Months|Non-medical problem|1
5703409|NCT00211237|19658001|P2|3 Months|Non-medical problem|0
5703410|NCT00211237|19658002|P1|3 Months|Non-medical problem|0
5703411|NCT00211237|19658000|P3|3 Months|Withdrew|0
5703412|NCT00211237|19658001|P2|3 Months|Withdrew|1
5703413|NCT00211237|19658002|P1|3 Months|Withdrew|0
5703414|NCT00211237|19658000|P3|3 Months|Could not comply with protocol|0
5703415|NCT00211237|19658001|P2|3 Months|Could not comply with protocol|0
5703416|NCT00211237|19658002|P1|3 Months|Could not comply with protocol|1
5703417|NCT00211237|19658000|P3|3 Months|Death|0
5703418|NCT00211237|19658001|P2|3 Months|Death|3
5703419|NCT00211237|19658002|P1|3 Months|Death|7
5703420|NCT00211237|19658000|P3|1 Month|Non-medical problem|0
5703421|NCT00211237|19658001|P2|1 Month|Non-medical problem|2
5703422|NCT00211237|19658002|P1|1 Month|Non-medical problem|0
5703423|NCT00211237|19658000|P3|1 Month|Additional surgery needed|0
5703424|NCT00211237|19658001|P2|1 Month|Additional surgery needed|0
5703425|NCT00211237|19658002|P1|1 Month|Additional surgery needed|1
5703426|NCT00211237|19658000|P3|1 Month|Withdrew|0
5703427|NCT00211237|19658001|P2|1 Month|Withdrew|4
5703428|NCT00211237|19658002|P1|1 Month|Withdrew|0
5703429|NCT00211237|19658000|P3|1 Month|Lost to Follow-up|0
5703430|NCT00211237|19658001|P2|1 Month|Lost to Follow-up|2
5703431|NCT00211237|19658002|P1|1 Month|Lost to Follow-up|0
5703432|NCT00211237|19658000|P3|1 Month|Death|0
5703433|NCT00211237|19658001|P2|1 Month|Death|1
5703434|NCT00211237|19658002|P1|1 Month|Death|2
5703435|NCT00211237|19658000|P3|Baseline|Refused random assignment|0
5703436|NCT00211237|19658001|P2|Baseline|Refused random assignment|0
5703437|NCT00211237|19658002|P1|Baseline|Refused random assignment|1
5703438|NCT00211237|19658000|P3|Baseline|Withdrew|0
5703439|NCT00211237|19658001|P2|Baseline|Withdrew|3
5703440|NCT00211237|19658002|P1|Baseline|Withdrew|1
5703441|NCT00211185|19658092|P1|Overall Study|Physician Decision|5
5703442|NCT00211185|19658092|P1|Overall Study|Withdrawal by Subject|6
5703443|NCT00211185|19658092|P1|Overall Study|Disease progression|7
5703444|NCT00211185|19658092|P1|Overall Study|Death|2
5703445|NCT00211172|19658106|P2|Overall Study|Died or lost health plan eligibility|32
5703446|NCT00211172|19658107|P1|Overall Study|Died or lost health plan eligibility|39
5703447|NCT00211081|19658113|P1|Overall Study|Withdrawal by Subject|2
5703448|NCT00210639|19658125|P2|Overall Study|Other|12
5703449|NCT00210639|19658126|P1|Overall Study|Other|18
5703450|NCT00210639|19658125|P2|Overall Study|Withdrawal by Subject|1
5703451|NCT00210639|19658126|P1|Overall Study|Withdrawal by Subject|8
5703452|NCT00210639|19658125|P2|Overall Study|Lost to Follow-up|29
5703453|NCT00210639|19658126|P1|Overall Study|Lost to Follow-up|37
5703454|NCT00210626|19658134|P2|Overall Study|Other|5
5703455|NCT00210626|19658135|P1|Overall Study|Other|4
5703456|NCT00210626|19658134|P2|Overall Study|Sponser Request|0
5703457|NCT00210626|19658135|P1|Overall Study|Sponser Request|1
5703458|NCT00210626|19658134|P2|Overall Study|Physician Decision|2
5703459|NCT00210626|19658135|P1|Overall Study|Physician Decision|0
5703460|NCT00210626|19658134|P2|Overall Study|Withdrawal by Subject|20
5703461|NCT00210626|19658135|P1|Overall Study|Withdrawal by Subject|29
5703462|NCT00210626|19658134|P2|Overall Study|Death|0
5703463|NCT00210626|19658135|P1|Overall Study|Death|1
5703464|NCT00210626|19658134|P2|Overall Study|Lost to Follow-up|11
5703465|NCT00210626|19658135|P1|Overall Study|Lost to Follow-up|11
5703466|NCT00210626|19658134|P2|Overall Study|Protocol Violation|5
5703467|NCT00210626|19658135|P1|Overall Study|Protocol Violation|1
5703468|NCT00210626|19658134|P2|Overall Study|Adverse Event|2
5703469|NCT00210626|19658135|P1|Overall Study|Adverse Event|1
5703470|NCT00209560|19658182|P2|Overall Study|Lack of Efficacy|0
5703471|NCT00209560|19658183|P1|Overall Study|Lack of Efficacy|1
5703472|NCT00209339|19658202|P1|At 5 Years Follow-up|Death|1
5703473|NCT00209339|19658202|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
5703474|NCT00209339|19658202|P1|At 5 Years Follow-up|Withdrawal by Subject|2
5703475|NCT00209339|19658202|P1|At 4 Years Follow-up|Death|1
5703476|NCT00209339|19658202|P1|At 4 Years Follow-up|Withdrawal by Subject|4
5703477|NCT00209339|19658202|P1|At 3 Years Follow-up|Withdrawal by Subject|1
5703478|NCT00209339|19658202|P1|At 24 Months Follow-up|Death|1
5703479|NCT00209339|19658202|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
5703480|NCT00209339|19658202|P1|At 24 Months Follow-up|Withdrawal by Subject|4
5703481|NCT00209339|19658202|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
5703482|NCT00209339|19658202|P1|At 12 Months Follow-up|Death|1
5703483|NCT00209339|19658202|P1|At 12 Months Follow-up|Withdrawal by Subject|8
5703484|NCT00209274|19658286|P2|Overall Study|Randomized not treated (RNT)|15
5703485|NCT00209274|19658287|P1|Overall Study|Randomized not treated (RNT)|6
5703486|NCT00209274|19658286|P2|Overall Study|Withdrawal by Subject|15
5703487|NCT00209274|19658287|P1|Overall Study|Withdrawal by Subject|30
5703488|NCT00209274|19658286|P2|Overall Study|Death|15
5703489|NCT00209274|19658287|P1|Overall Study|Death|32
5703490|NCT00209274|19658286|P2|Overall Study|Missed visit|2
5703491|NCT00209274|19658287|P1|Overall Study|Missed visit|3
5703492|NCT00209170|19658607|P2|Overall Study|Lack of Efficacy|1
5703493|NCT00209170|19658608|P1|Overall Study|Lack of Efficacy|0
5703494|NCT00209170|19658607|P2|Overall Study|Withdrawal by Subject|1
5703495|NCT00209170|19658608|P1|Overall Study|Withdrawal by Subject|2
5703496|NCT00209170|19658607|P2|Overall Study|Adverse Event|1
5703497|NCT00209170|19658608|P1|Overall Study|Adverse Event|0
5703498|NCT00209131|19658616|P2|Overall Study|Lack of personnel due to turnovers.|11
5703499|NCT00209131|19658617|P1|Overall Study|Lack of personnel due to turnovers.|15
5703500|NCT00209092|19658627|P2|Overall Study|Withdrawal by Subject|0
5703501|NCT00209092|19658628|P1|Overall Study|Withdrawal by Subject|1
5703502|NCT00209092|19658627|P2|Overall Study|Adverse Event|1
5703503|NCT00209092|19658628|P1|Overall Study|Adverse Event|0
5703504|NCT00209092|19658627|P2|Overall Study|Progression of disease|1
5703505|NCT00209092|19658628|P1|Overall Study|Progression of disease|7
5703506|NCT00209027|19658638|P2|Overall Study|study terminated|0
5703507|NCT00209027|19658639|P1|Overall Study|study terminated|10
5703508|NCT00208767|19658663|P2|Overall Study|Lost to Follow-up|3
5703509|NCT00208767|19658664|P1|Overall Study|Lost to Follow-up|3
5703510|NCT00208767|19658663|P2|Overall Study|Death|0
5703511|NCT00208767|19658664|P1|Overall Study|Death|1
5703512|NCT00208767|19658663|P2|Overall Study|Withdrawal by Subject|3
5703513|NCT00208767|19658664|P1|Overall Study|Withdrawal by Subject|14
5703514|NCT00208767|19658663|P2|Overall Study|Adverse Event|1
5703515|NCT00208767|19658664|P1|Overall Study|Adverse Event|9
5703516|NCT00208325|19658692|P4|Overall Study|Mis-Randomized|0
5703517|NCT00208325|19658693|P3|Overall Study|Mis-Randomized|0
5703518|NCT00208325|19658694|P2|Overall Study|Mis-Randomized|20
5703519|NCT00208325|19658695|P1|Overall Study|Mis-Randomized|17
5703520|NCT00208325|19658692|P4|Overall Study|Other|0
5703521|NCT00208325|19658693|P3|Overall Study|Other|1
5703522|NCT00208325|19658694|P2|Overall Study|Other|1
5703523|NCT00208325|19658695|P1|Overall Study|Other|2
5703524|NCT00208325|19658692|P4|Overall Study|Does not wish to Continue in Study|2
5703525|NCT00208325|19658693|P3|Overall Study|Does not wish to Continue in Study|3
5703526|NCT00208325|19658694|P2|Overall Study|Does not wish to Continue in Study|8
5703527|NCT00208325|19658695|P1|Overall Study|Does not wish to Continue in Study|5
5703528|NCT00208325|19658692|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
5703529|NCT00208325|19658693|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
5703530|NCT00208325|19658694|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
5703531|NCT00208325|19658695|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
5703532|NCT00208325|19658692|P4|Overall Study|Lost to Follow-up|0
5703533|NCT00208325|19658693|P3|Overall Study|Lost to Follow-up|2
5703534|NCT00208325|19658694|P2|Overall Study|Lost to Follow-up|0
5703535|NCT00208325|19658695|P1|Overall Study|Lost to Follow-up|1
5703536|NCT00208325|19658692|P4|Overall Study|Revision|4
5703537|NCT00208325|19658693|P3|Overall Study|Revision|0
5703538|NCT00208325|19658694|P2|Overall Study|Revision|1
5703539|NCT00208325|19658695|P1|Overall Study|Revision|4
5703540|NCT00208325|19658692|P4|Overall Study|Withdrawal by Subject|0
5703541|NCT00208325|19658693|P3|Overall Study|Withdrawal by Subject|0
5703542|NCT00208325|19658694|P2|Overall Study|Withdrawal by Subject|1
5703543|NCT00208325|19658695|P1|Overall Study|Withdrawal by Subject|0
5703544|NCT00208325|19658692|P4|Overall Study|Death|5
5703545|NCT00208325|19658693|P3|Overall Study|Death|7
5703546|NCT00208325|19658694|P2|Overall Study|Death|19
5703547|NCT00208325|19658695|P1|Overall Study|Death|18
5703548|NCT00207740|19658832|P4|Overall Study|Other|5
5703549|NCT00207740|19658833|P3|Overall Study|Other|7
5703550|NCT00207740|19658834|P2|Overall Study|Other|10
5703551|NCT00207740|19658835|P1|Overall Study|Other|2
5703552|NCT00207740|19658832|P4|Overall Study|Sponsor Directive|21
5703553|NCT00207740|19658833|P3|Overall Study|Sponsor Directive|16
5703554|NCT00207740|19658834|P2|Overall Study|Sponsor Directive|15
5703555|NCT00207740|19658835|P1|Overall Study|Sponsor Directive|22
5703556|NCT00207740|19658832|P4|Overall Study|Death|1
5703557|NCT00207740|19658833|P3|Overall Study|Death|0
5703558|NCT00207740|19658834|P2|Overall Study|Death|0
5703559|NCT00207740|19658835|P1|Overall Study|Death|0
5703560|NCT00207740|19658832|P4|Overall Study|Lost to Follow-up|1
5703561|NCT00207740|19658833|P3|Overall Study|Lost to Follow-up|1
5703562|NCT00207740|19658834|P2|Overall Study|Lost to Follow-up|2
5703563|NCT00207740|19658835|P1|Overall Study|Lost to Follow-up|0
5703564|NCT00207740|19658832|P4|Overall Study|Unsatisfactory therapeutic effect|4
5703565|NCT00207740|19658833|P3|Overall Study|Unsatisfactory therapeutic effect|2
5703566|NCT00207740|19658834|P2|Overall Study|Unsatisfactory therapeutic effect|0
5703567|NCT00207740|19658835|P1|Overall Study|Unsatisfactory therapeutic effect|1
5703568|NCT00207740|19658832|P4|Overall Study|Adverse Event|11
5703569|NCT00207740|19658833|P3|Overall Study|Adverse Event|14
5703570|NCT00207740|19658834|P2|Overall Study|Adverse Event|14
5703571|NCT00207740|19658835|P1|Overall Study|Adverse Event|4
5703572|NCT00207727|19658881|P5|Overall Study|Other|33
5703573|NCT00207727|19658882|P4|Overall Study|Other|37
5703574|NCT00207727|19658883|P3|Overall Study|Other|41
5703575|NCT00207727|19658884|P2|Overall Study|Other|41
5703576|NCT00207727|19658885|P1|Overall Study|Other|38
5703577|NCT00207727|19658881|P5|Overall Study|Lost to Follow-up|0
5703578|NCT00207727|19658882|P4|Overall Study|Lost to Follow-up|0
5703579|NCT00207727|19658883|P3|Overall Study|Lost to Follow-up|0
5703580|NCT00207727|19658884|P2|Overall Study|Lost to Follow-up|1
5703581|NCT00207727|19658885|P1|Overall Study|Lost to Follow-up|0
5703582|NCT00207727|19658881|P5|Overall Study|Withdrawal by Subject|1
5703583|NCT00207727|19658882|P4|Overall Study|Withdrawal by Subject|0
5703584|NCT00207727|19658883|P3|Overall Study|Withdrawal by Subject|0
5703585|NCT00207727|19658884|P2|Overall Study|Withdrawal by Subject|0
5703586|NCT00207727|19658885|P1|Overall Study|Withdrawal by Subject|0
5703587|NCT00207714|19658912|P5|Overall Study|Other|0
5703588|NCT00207714|19658913|P4|Overall Study|Other|1
5703589|NCT00207714|19658914|P3|Overall Study|Other|5
5703590|NCT00207714|19658915|P2|Overall Study|Other|2
5703591|NCT00207714|19658916|P1|Overall Study|Other|3
5703592|NCT00207714|19658912|P5|Overall Study|Unsatisfactory therapeutic effect|4
5703593|NCT00207714|19658913|P4|Overall Study|Unsatisfactory therapeutic effect|4
5703594|NCT00207714|19658914|P3|Overall Study|Unsatisfactory therapeutic effect|1
5703595|NCT00207714|19658915|P2|Overall Study|Unsatisfactory therapeutic effect|3
5703596|NCT00207714|19658916|P1|Overall Study|Unsatisfactory therapeutic effect|5
5703597|NCT00207714|19658912|P5|Overall Study|Adverse Event|1
5703598|NCT00207714|19658913|P4|Overall Study|Adverse Event|3
5703599|NCT00207714|19658914|P3|Overall Study|Adverse Event|4
5703600|NCT00207714|19658915|P2|Overall Study|Adverse Event|2
5703601|NCT00207714|19658916|P1|Overall Study|Adverse Event|6
5703602|NCT00207142|19658938|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
5703603|NCT00207142|19658939|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
5703604|NCT00207142|19658940|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
5703605|NCT00207142|19658941|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
5703606|NCT00207142|19658938|P4|Maintenance Phase/Rescue Phase|Death|1
5703607|NCT00207142|19658939|P3|Maintenance Phase/Rescue Phase|Death|0
5703608|NCT00207142|19658940|P2|Maintenance Phase/Rescue Phase|Death|0
5703609|NCT00207142|19658941|P1|Maintenance Phase/Rescue Phase|Death|0
5703610|NCT00207142|19658938|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
5703611|NCT00207142|19658939|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
5703612|NCT00207142|19658940|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
5703613|NCT00207142|19658941|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
5703614|NCT00207142|19658938|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
5703615|NCT00207142|19658939|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
5703616|NCT00207142|19658940|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
5703617|NCT00207142|19658941|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
5703618|NCT00207142|19658938|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
5703619|NCT00207142|19658939|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
5703620|NCT00207142|19658940|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
5703621|NCT00207142|19658941|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
5703622|NCT00207142|19658938|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
5703623|NCT00207142|19658939|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
5703624|NCT00207142|19658940|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
5703625|NCT00207142|19658941|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
5703626|NCT00207142|19658938|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
5703627|NCT00207142|19658939|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
5703628|NCT00207142|19658940|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
5703629|NCT00207142|19658941|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
5703630|NCT00207142|19658938|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
5703631|NCT00207142|19658939|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
5703632|NCT00207142|19658940|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
5703633|NCT00207142|19658941|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
5703634|NCT00207142|19658938|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
5703635|NCT00207142|19658939|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
5703636|NCT00207142|19658940|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
5703637|NCT00207142|19658941|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
5703638|NCT00207142|19658938|P4|Induction Phase|Missing lab data|0
5703639|NCT00207142|19658939|P3|Induction Phase|Missing lab data|0
5703640|NCT00207142|19658940|P2|Induction Phase|Missing lab data|0
5703641|NCT00207142|19658941|P1|Induction Phase|Missing lab data|1
5703642|NCT00207142|19658938|P4|Induction Phase|Incarceration|0
5703643|NCT00207142|19658939|P3|Induction Phase|Incarceration|0
5703644|NCT00207142|19658940|P2|Induction Phase|Incarceration|0
5703645|NCT00207142|19658941|P1|Induction Phase|Incarceration|1
5703646|NCT00207142|19658938|P4|Induction Phase|Withdrawal by Subject|0
5703647|NCT00207142|19658939|P3|Induction Phase|Withdrawal by Subject|0
5703648|NCT00207142|19658940|P2|Induction Phase|Withdrawal by Subject|0
5703649|NCT00207142|19658941|P1|Induction Phase|Withdrawal by Subject|4
5703650|NCT00207142|19658938|P4|Induction Phase|Subject no longer meets study criteria|0
5703651|NCT00207142|19658939|P3|Induction Phase|Subject no longer meets study criteria|0
5703652|NCT00207142|19658940|P2|Induction Phase|Subject no longer meets study criteria|0
5703653|NCT00207142|19658941|P1|Induction Phase|Subject no longer meets study criteria|3
5703654|NCT00207142|19658938|P4|Induction Phase|Pregnancy|0
5703655|NCT00207142|19658939|P3|Induction Phase|Pregnancy|0
5703656|NCT00207142|19658940|P2|Induction Phase|Pregnancy|0
5703657|NCT00207142|19658941|P1|Induction Phase|Pregnancy|1
5703658|NCT00207142|19658938|P4|Induction Phase|Poor/noncompliance|0
5703659|NCT00207142|19658939|P3|Induction Phase|Poor/noncompliance|0
5703660|NCT00207142|19658940|P2|Induction Phase|Poor/noncompliance|0
5703661|NCT00207142|19658941|P1|Induction Phase|Poor/noncompliance|2
5703662|NCT00207142|19658938|P4|Induction Phase|Physician Decision|0
5703663|NCT00207142|19658939|P3|Induction Phase|Physician Decision|0
5703664|NCT00207142|19658940|P2|Induction Phase|Physician Decision|0
5703665|NCT00207142|19658941|P1|Induction Phase|Physician Decision|2
5703666|NCT00207142|19658938|P4|Induction Phase|Lost to Follow-up|0
5703667|NCT00207142|19658939|P3|Induction Phase|Lost to Follow-up|0
5703668|NCT00207142|19658940|P2|Induction Phase|Lost to Follow-up|0
5703669|NCT00207142|19658941|P1|Induction Phase|Lost to Follow-up|5
5703670|NCT00207142|19658938|P4|Induction Phase|Lack of Efficacy|0
5703671|NCT00207142|19658939|P3|Induction Phase|Lack of Efficacy|0
5703672|NCT00207142|19658940|P2|Induction Phase|Lack of Efficacy|0
5703673|NCT00207142|19658941|P1|Induction Phase|Lack of Efficacy|1
5703674|NCT00207142|19658938|P4|Induction Phase|Death|0
5703675|NCT00207142|19658939|P3|Induction Phase|Death|0
5703676|NCT00207142|19658940|P2|Induction Phase|Death|0
5703677|NCT00207142|19658941|P1|Induction Phase|Death|1
5703678|NCT00207142|19658938|P4|Induction Phase|Adverse Event|0
5703679|NCT00207142|19658939|P3|Induction Phase|Adverse Event|0
5703680|NCT00207142|19658940|P2|Induction Phase|Adverse Event|0
5703681|NCT00207142|19658941|P1|Induction Phase|Adverse Event|9
5703682|NCT00207090|19658978|P1|Overall Study|Physician Decision|1
5703683|NCT00207090|19658978|P1|Overall Study|Disease progression/relapse|2
5703684|NCT00207090|19658978|P1|Overall Study|Chest wall mass larger|1
5703685|NCT00207090|19658978|P1|Overall Study|Study drug toxicity|3
5703686|NCT00206726|19659007|P1|Overall Study|Withdrawal by Subject|8
5703687|NCT00206726|19659007|P1|Overall Study|Protocol Violation|1
5703688|NCT00206726|19659007|P1|Overall Study|Death|4
5703689|NCT00206726|19659007|P1|Overall Study|Adverse Event|17
5703690|NCT00206726|19659007|P1|Overall Study|Bone marrow transplant|1
5703691|NCT00206726|19659007|P1|Overall Study|Placed on new protocol|1
5703692|NCT00206726|19659007|P1|Overall Study|Progressive disease or relapsed disease|18
5703693|NCT00206726|19659007|P1|Overall Study|Delayed recovery of blood counts|1
5703694|NCT00206518|19659018|P2|Overall Study|Protocol Violation|1
5703695|NCT00206518|19659019|P1|Overall Study|Protocol Violation|1
5703696|NCT00206518|19659018|P2|Overall Study|Physician Decision|0
5703697|NCT00206518|19659019|P1|Overall Study|Physician Decision|1
5703698|NCT00206518|19659018|P2|Overall Study|Adverse Event|1
5703699|NCT00206518|19659019|P1|Overall Study|Adverse Event|2
5703700|NCT00206518|19659018|P2|Overall Study|Lack of Efficacy|4
5703701|NCT00206518|19659019|P1|Overall Study|Lack of Efficacy|6
5703702|NCT00206440|19659031|P2|Overall Study|Adverse Event|2
5703703|NCT00206440|19659032|P1|Overall Study|Adverse Event|4
5703704|NCT00206440|19659031|P2|Overall Study|Protocol Violation|2
5703705|NCT00206440|19659032|P1|Overall Study|Protocol Violation|1
5703706|NCT00206427|19659038|P1|Overall Study|Adverse Event|2
5703707|NCT00206375|19659045|P3|Overall Study|Study terminated due to lack of funds|1
5703708|NCT00206375|19659046|P2|Overall Study|Study terminated due to lack of funds|1
5703709|NCT00206375|19659047|P1|Overall Study|Study terminated due to lack of funds|0
5703710|NCT00206375|19659045|P3|Overall Study|Withdrawal by Subject|3
5703711|NCT00206375|19659046|P2|Overall Study|Withdrawal by Subject|1
5703712|NCT00206375|19659047|P1|Overall Study|Withdrawal by Subject|2
5703713|NCT00206375|19659045|P3|Overall Study|Lost to Follow-up|0
5703714|NCT00206375|19659046|P2|Overall Study|Lost to Follow-up|0
5703715|NCT00206375|19659047|P1|Overall Study|Lost to Follow-up|1
5703716|NCT00206323|19659067|P2|Overall Study|Lost to Follow-up|1
5703717|NCT00206323|19659068|P1|Overall Study|Lost to Follow-up|1
5703718|NCT00206323|19659067|P2|Overall Study|Adverse Event|1
5703719|NCT00206323|19659068|P1|Overall Study|Adverse Event|1
5703720|NCT00206323|19659067|P2|Overall Study|Lack of Efficacy|1
5703721|NCT00206323|19659068|P1|Overall Study|Lack of Efficacy|4
5703722|NCT00206102|19659076|P2|Overall Study|None of those categories|36
5703723|NCT00206102|19659077|P1|Overall Study|None of those categories|42
5703724|NCT00206102|19659076|P2|Overall Study|Study-specific discontinuation criteria|17
5703725|NCT00206102|19659077|P1|Overall Study|Study-specific discontinuation criteria|18
5703726|NCT00206102|19659076|P2|Overall Study|Withdrawal by Subject|101
5703727|NCT00206102|19659077|P1|Overall Study|Withdrawal by Subject|118
5703728|NCT00206102|19659076|P2|Overall Study|Lost to Follow-up|66
5703729|NCT00206102|19659077|P1|Overall Study|Lost to Follow-up|95
5703730|NCT00206102|19659076|P2|Overall Study|Lack of therapeutic response|11
5703731|NCT00206102|19659077|P1|Overall Study|Lack of therapeutic response|16
5703732|NCT00206102|19659076|P2|Overall Study|Protocol Violation|2
5703733|NCT00206102|19659077|P1|Overall Study|Protocol Violation|0
5703734|NCT00206102|19659076|P2|Overall Study|Adverse Event|82
5703735|NCT00206102|19659077|P1|Overall Study|Adverse Event|119
5703736|NCT00206076|19659113|P2|Overall Study|Withdrawal by Subject|1
5703737|NCT00206076|19659114|P1|Overall Study|Withdrawal by Subject|1
5703738|NCT00206076|19659113|P2|Overall Study|Physician Decision|0
5703739|NCT00206076|19659114|P1|Overall Study|Physician Decision|2
5703740|NCT00205881|19659124|P1|Overall Study|Withdrawal by Subject|16
5703741|NCT00205855|19659129|P1|Overall Study|Withdrawal by Subject|5
5703742|NCT00205855|19659129|P1|Overall Study|Only received temporary implants|16
5703743|NCT00205803|19659135|P2|Toddler Dose|Lost to Follow-up|3
5703744|NCT00205803|19659136|P1|Toddler Dose|Lost to Follow-up|2
5703745|NCT00205803|19659135|P2|After Infant Series|Other|4
5703746|NCT00205803|19659136|P1|After Infant Series|Other|10
5703747|NCT00205803|19659135|P2|After Infant Series|Withdrawal by Subject|4
5703748|NCT00205803|19659136|P1|After Infant Series|Withdrawal by Subject|1
5703749|NCT00205803|19659135|P2|After Infant Series|Physician Decision|2
5703750|NCT00205803|19659136|P1|After Infant Series|Physician Decision|3
5703751|NCT00205803|19659135|P2|After Infant Series|Lost to Follow-up|1
5703752|NCT00205803|19659136|P1|After Infant Series|Lost to Follow-up|2
5703753|NCT00205803|19659135|P2|After Infant Series|Protocol Violation|1
5703754|NCT00205803|19659136|P1|After Infant Series|Protocol Violation|1
5703755|NCT00205803|19659135|P2|After Infant Series|Adverse Event|1
5703756|NCT00205803|19659136|P1|After Infant Series|Adverse Event|1
5703757|NCT00205803|19659135|P2|Infant Series|Sponsor request|0
5703758|NCT00205803|19659136|P1|Infant Series|Sponsor request|1
5703759|NCT00205803|19659135|P2|Infant Series|Non-compliant|0
5703760|NCT00205803|19659136|P1|Infant Series|Non-compliant|1
5703761|NCT00205803|19659135|P2|Infant Series|Lost Kaiser coverage|1
5703762|NCT00205803|19659136|P1|Infant Series|Lost Kaiser coverage|0
5703763|NCT00205803|19659135|P2|Infant Series|Protocol Violation|0
5703764|NCT00205803|19659136|P1|Infant Series|Protocol Violation|1
5703765|NCT00205803|19659135|P2|Infant Series|Physician Decision|1
5703766|NCT00205803|19659136|P1|Infant Series|Physician Decision|3
5703767|NCT00205803|19659135|P2|Infant Series|Withdrawal by Subject|5
5703768|NCT00205803|19659136|P1|Infant Series|Withdrawal by Subject|2
5703769|NCT00205803|19659135|P2|Infant Series|Lost to Follow-up|4
5703770|NCT00205803|19659136|P1|Infant Series|Lost to Follow-up|10
5703771|NCT00205777|19659192|P6|Study Extension II|Enrolled but not treated|131
5703772|NCT00205777|19659193|P5|Study Extension II|Enrolled but not treated|0
5703773|NCT00205777|19659194|P4|Study Extension II|Enrolled but not treated|71
5703774|NCT00205777|19659195|P3|Study Extension II|Enrolled but not treated|0
5703775|NCT00205777|19659196|P2|Study Extension II|Enrolled but not treated|0
5703776|NCT00205777|19659197|P1|Study Extension II|Enrolled but not treated|0
5703777|NCT00205777|19659192|P6|Study Extension II|Other Event|20
5703778|NCT00205777|19659193|P5|Study Extension II|Other Event|0
5703779|NCT00205777|19659194|P4|Study Extension II|Other Event|12
5703780|NCT00205777|19659195|P3|Study Extension II|Other Event|0
5703781|NCT00205777|19659196|P2|Study Extension II|Other Event|0
5703782|NCT00205777|19659197|P1|Study Extension II|Other Event|0
5703783|NCT00205777|19659192|P6|Study Extension II|Failed to return|26
5703784|NCT00205777|19659193|P5|Study Extension II|Failed to return|0
5703785|NCT00205777|19659194|P4|Study Extension II|Failed to return|14
5703786|NCT00205777|19659195|P3|Study Extension II|Failed to return|0
5703787|NCT00205777|19659196|P2|Study Extension II|Failed to return|0
5703788|NCT00205777|19659197|P1|Study Extension II|Failed to return|0
5703789|NCT00205777|19659192|P6|Study Extension II|Lack of Efficacy|1
5703790|NCT00205777|19659193|P5|Study Extension II|Lack of Efficacy|0
5703791|NCT00205777|19659194|P4|Study Extension II|Lack of Efficacy|0
5703792|NCT00205777|19659195|P3|Study Extension II|Lack of Efficacy|0
5703793|NCT00205777|19659196|P2|Study Extension II|Lack of Efficacy|0
5703794|NCT00205777|19659197|P1|Study Extension II|Lack of Efficacy|0
5703795|NCT00205777|19659192|P6|Study Extension II|Protocol Violation|10
5703796|NCT00205777|19659193|P5|Study Extension II|Protocol Violation|0
5703797|NCT00205777|19659194|P4|Study Extension II|Protocol Violation|1
5703798|NCT00205777|19659195|P3|Study Extension II|Protocol Violation|0
5703799|NCT00205777|19659196|P2|Study Extension II|Protocol Violation|0
5703800|NCT00205777|19659197|P1|Study Extension II|Protocol Violation|0
5703801|NCT00205777|19659192|P6|Study Extension II|Withdrawal by Subject|59
5703802|NCT00205777|19659193|P5|Study Extension II|Withdrawal by Subject|0
5703803|NCT00205777|19659194|P4|Study Extension II|Withdrawal by Subject|35
5703804|NCT00205777|19659195|P3|Study Extension II|Withdrawal by Subject|0
5703805|NCT00205777|19659196|P2|Study Extension II|Withdrawal by Subject|0
5703806|NCT00205777|19659197|P1|Study Extension II|Withdrawal by Subject|0
5703807|NCT00205777|19659192|P6|Study Extension II|Death|5
5703808|NCT00205777|19659193|P5|Study Extension II|Death|0
5703809|NCT00205777|19659194|P4|Study Extension II|Death|2
5703810|NCT00205777|19659195|P3|Study Extension II|Death|0
5703811|NCT00205777|19659196|P2|Study Extension II|Death|0
5703812|NCT00205777|19659197|P1|Study Extension II|Death|0
5703813|NCT00205777|19659192|P6|Study Extension II|Adverse Event|30
5703814|NCT00205777|19659193|P5|Study Extension II|Adverse Event|0
5703815|NCT00205777|19659194|P4|Study Extension II|Adverse Event|14
5703816|NCT00205777|19659195|P3|Study Extension II|Adverse Event|0
5703817|NCT00205777|19659196|P2|Study Extension II|Adverse Event|0
5703818|NCT00205777|19659197|P1|Study Extension II|Adverse Event|0
5703819|NCT00205777|19659192|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
5703820|NCT00205777|19659193|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
5703821|NCT00205777|19659194|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
5703822|NCT00205777|19659195|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
5703823|NCT00205777|19659196|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
5703824|NCT00205777|19659197|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
5703825|NCT00205777|19659192|P6|Study Extension I|Withdrawn as per protocol|0
5703826|NCT00205777|19659193|P5|Study Extension I|Withdrawn as per protocol|0
5703827|NCT00205777|19659194|P4|Study Extension I|Withdrawn as per protocol|0
5703828|NCT00205777|19659195|P3|Study Extension I|Withdrawn as per protocol|1070
5703829|NCT00205777|19659196|P2|Study Extension I|Withdrawn as per protocol|0
5703830|NCT00205777|19659197|P1|Study Extension I|Withdrawn as per protocol|0
5703831|NCT00205777|19659192|P6|Study Extension I|Other Event|0
5703832|NCT00205777|19659193|P5|Study Extension I|Other Event|29
5703833|NCT00205777|19659194|P4|Study Extension I|Other Event|34
5703834|NCT00205777|19659195|P3|Study Extension I|Other Event|0
5703835|NCT00205777|19659196|P2|Study Extension I|Other Event|0
5703836|NCT00205777|19659197|P1|Study Extension I|Other Event|34
5703837|NCT00205777|19659192|P6|Study Extension I|Failed to return|0
5703838|NCT00205777|19659193|P5|Study Extension I|Failed to return|13
5703839|NCT00205777|19659194|P4|Study Extension I|Failed to return|17
5703840|NCT00205777|19659195|P3|Study Extension I|Failed to return|0
5703841|NCT00205777|19659196|P2|Study Extension I|Failed to return|0
5703842|NCT00205777|19659197|P1|Study Extension I|Failed to return|15
5703843|NCT00205777|19659192|P6|Study Extension I|Lack of Efficacy|0
5703844|NCT00205777|19659193|P5|Study Extension I|Lack of Efficacy|2
5703845|NCT00205777|19659194|P4|Study Extension I|Lack of Efficacy|1
5703846|NCT00205777|19659195|P3|Study Extension I|Lack of Efficacy|0
5703847|NCT00205777|19659196|P2|Study Extension I|Lack of Efficacy|0
5703848|NCT00205777|19659197|P1|Study Extension I|Lack of Efficacy|0
5703849|NCT00205777|19659192|P6|Study Extension I|Protocol Violation|0
5703850|NCT00205777|19659193|P5|Study Extension I|Protocol Violation|8
5703851|NCT00205777|19659194|P4|Study Extension I|Protocol Violation|8
5703852|NCT00205777|19659195|P3|Study Extension I|Protocol Violation|0
5703853|NCT00205777|19659196|P2|Study Extension I|Protocol Violation|0
5703854|NCT00205777|19659197|P1|Study Extension I|Protocol Violation|4
5703855|NCT00205777|19659192|P6|Study Extension I|Withdrawal by Subject|0
5703856|NCT00205777|19659193|P5|Study Extension I|Withdrawal by Subject|89
5703857|NCT00205777|19659194|P4|Study Extension I|Withdrawal by Subject|106
5703858|NCT00205777|19659195|P3|Study Extension I|Withdrawal by Subject|0
5703859|NCT00205777|19659196|P2|Study Extension I|Withdrawal by Subject|0
5703860|NCT00205777|19659197|P1|Study Extension I|Withdrawal by Subject|99
5703861|NCT00205777|19659192|P6|Study Extension I|Death|0
5703862|NCT00205777|19659193|P5|Study Extension I|Death|2
5703863|NCT00205777|19659194|P4|Study Extension I|Death|1
5703864|NCT00205777|19659195|P3|Study Extension I|Death|0
5703865|NCT00205777|19659196|P2|Study Extension I|Death|0
5703866|NCT00205777|19659197|P1|Study Extension I|Death|5
5703867|NCT00205777|19659192|P6|Study Extension I|Adverse Event|0
5703868|NCT00205777|19659193|P5|Study Extension I|Adverse Event|58
5703869|NCT00205777|19659194|P4|Study Extension I|Adverse Event|61
5703870|NCT00205777|19659195|P3|Study Extension I|Adverse Event|0
5703871|NCT00205777|19659196|P2|Study Extension I|Adverse Event|0
5703872|NCT00205777|19659197|P1|Study Extension I|Adverse Event|57
5703873|NCT00205777|19659192|P6|Completed Core Study, Entered SE I|Other Event|0
5703874|NCT00205777|19659193|P5|Completed Core Study, Entered SE I|Other Event|0
5703875|NCT00205777|19659194|P4|Completed Core Study, Entered SE I|Other Event|50
5703876|NCT00205777|19659195|P3|Completed Core Study, Entered SE I|Other Event|47
5703877|NCT00205777|19659196|P2|Completed Core Study, Entered SE I|Other Event|46
5703878|NCT00205777|19659197|P1|Completed Core Study, Entered SE I|Other Event|52
5703879|NCT00205777|19659192|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
5703880|NCT00205777|19659193|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
5703881|NCT00205777|19659194|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
5703882|NCT00205777|19659195|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
5703883|NCT00205777|19659196|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
5703884|NCT00205777|19659197|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
5703885|NCT00205777|19659192|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
5703886|NCT00205777|19659193|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
5703887|NCT00205777|19659194|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
5703888|NCT00205777|19659195|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
5703889|NCT00205777|19659196|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
5703890|NCT00205777|19659197|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
5703891|NCT00205777|19659192|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
5703892|NCT00205777|19659193|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
5703893|NCT00205777|19659194|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
5703894|NCT00205777|19659195|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
5703895|NCT00205777|19659196|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
5703896|NCT00205777|19659197|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
5703897|NCT00205777|19659192|P6|Core Study (Up to 3 Years)|Protocol Violation|0
5703898|NCT00205777|19659193|P5|Core Study (Up to 3 Years)|Protocol Violation|0
5703899|NCT00205777|19659194|P4|Core Study (Up to 3 Years)|Protocol Violation|42
5703900|NCT00205777|19659195|P3|Core Study (Up to 3 Years)|Protocol Violation|50
5703901|NCT00205777|19659196|P2|Core Study (Up to 3 Years)|Protocol Violation|55
5703902|NCT00205777|19659197|P1|Core Study (Up to 3 Years)|Protocol Violation|53
5703903|NCT00205777|19659192|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
5703904|NCT00205777|19659193|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
5703905|NCT00205777|19659194|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
5703906|NCT00205777|19659195|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
5703907|NCT00205777|19659196|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
5703908|NCT00205777|19659197|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
5703909|NCT00205777|19659192|P6|Core Study (Up to 3 Years)|Other Event|0
5703910|NCT00205777|19659193|P5|Core Study (Up to 3 Years)|Other Event|0
5703911|NCT00205777|19659194|P4|Core Study (Up to 3 Years)|Other Event|58
5703912|NCT00205777|19659195|P3|Core Study (Up to 3 Years)|Other Event|41
5703913|NCT00205777|19659196|P2|Core Study (Up to 3 Years)|Other Event|52
5703914|NCT00205777|19659197|P1|Core Study (Up to 3 Years)|Other Event|49
5703915|NCT00205777|19659192|P6|Core Study (Up to 3 Years)|Failed to return|0
5703916|NCT00205777|19659193|P5|Core Study (Up to 3 Years)|Failed to return|0
5703917|NCT00205777|19659194|P4|Core Study (Up to 3 Years)|Failed to return|27
5703918|NCT00205777|19659195|P3|Core Study (Up to 3 Years)|Failed to return|27
5703919|NCT00205777|19659196|P2|Core Study (Up to 3 Years)|Failed to return|25
5703920|NCT00205777|19659197|P1|Core Study (Up to 3 Years)|Failed to return|40
5703921|NCT00205777|19659192|P6|Core Study (Up to 3 Years)|Death|0
5703922|NCT00205777|19659193|P5|Core Study (Up to 3 Years)|Death|0
5703923|NCT00205777|19659194|P4|Core Study (Up to 3 Years)|Death|7
5703924|NCT00205777|19659195|P3|Core Study (Up to 3 Years)|Death|14
5703925|NCT00205777|19659196|P2|Core Study (Up to 3 Years)|Death|7
5703926|NCT00205777|19659197|P1|Core Study (Up to 3 Years)|Death|9
5703927|NCT00205777|19659192|P6|Core Study (Up to 3 Years)|Adverse Event|0
5703928|NCT00205777|19659193|P5|Core Study (Up to 3 Years)|Adverse Event|0
5703929|NCT00205777|19659194|P4|Core Study (Up to 3 Years)|Adverse Event|232
5703930|NCT00205777|19659195|P3|Core Study (Up to 3 Years)|Adverse Event|252
5703931|NCT00205777|19659196|P2|Core Study (Up to 3 Years)|Adverse Event|267
5703932|NCT00205777|19659197|P1|Core Study (Up to 3 Years)|Adverse Event|260
5703933|NCT00205712|19659406|P2|Overall Study|Lost to Follow-up|1
5703934|NCT00205712|19659407|P1|Overall Study|Lost to Follow-up|0
5703935|NCT00205699|19659420|P3|Overall Study|Lack of Efficacy|0
5703936|NCT00205699|19659421|P2|Overall Study|Lack of Efficacy|1
5703937|NCT00205699|19659422|P1|Overall Study|Lack of Efficacy|0
5703938|NCT00205699|19659420|P3|Overall Study|Withdrawal by Subject|1
5703939|NCT00205699|19659421|P2|Overall Study|Withdrawal by Subject|2
5703940|NCT00205699|19659422|P1|Overall Study|Withdrawal by Subject|1
5703941|NCT00205699|19659420|P3|Overall Study|Adverse Event|0
5703942|NCT00205699|19659421|P2|Overall Study|Adverse Event|0
5703943|NCT00205699|19659422|P1|Overall Study|Adverse Event|1
5703944|NCT00205699|19659420|P3|Overall Study|Lost to Follow-up|5
5703945|NCT00205699|19659421|P2|Overall Study|Lost to Follow-up|3
5703946|NCT00205699|19659422|P1|Overall Study|Lost to Follow-up|1
5703947|NCT00205179|19659502|P2|Overall Study|Adverse Event|1
5703948|NCT00205179|19659503|P1|Overall Study|Adverse Event|1
5703949|NCT00205179|19659502|P2|Overall Study|Physician Decision|1
5703950|NCT00205179|19659503|P1|Overall Study|Physician Decision|1
5703951|NCT00205179|19659502|P2|Overall Study|Death|2
5703952|NCT00205179|19659503|P1|Overall Study|Death|0
5703953|NCT00203996|19659621|P10|Overall Study|Scheduling issue|0
5703954|NCT00203996|19659622|P9|Overall Study|Scheduling issue|0
5703955|NCT00203996|19659623|P8|Overall Study|Scheduling issue|2
5703956|NCT00203996|19659624|P7|Overall Study|Scheduling issue|0
5703957|NCT00203996|19659625|P6|Overall Study|Scheduling issue|0
5703958|NCT00203996|19659626|P5|Overall Study|Scheduling issue|0
5703959|NCT00203996|19659627|P4|Overall Study|Scheduling issue|0
5703960|NCT00203996|19659628|P3|Overall Study|Scheduling issue|0
5703961|NCT00203996|19659629|P2|Overall Study|Scheduling issue|0
5703962|NCT00203996|19659630|P1|Overall Study|Scheduling issue|0
5703963|NCT00203996|19659621|P10|Overall Study|CPAP machine malfunction|0
5703964|NCT00203996|19659622|P9|Overall Study|CPAP machine malfunction|0
5703965|NCT00203996|19659623|P8|Overall Study|CPAP machine malfunction|0
5703966|NCT00203996|19659624|P7|Overall Study|CPAP machine malfunction|0
5703967|NCT00203996|19659625|P6|Overall Study|CPAP machine malfunction|0
5703968|NCT00203996|19659626|P5|Overall Study|CPAP machine malfunction|0
5703969|NCT00203996|19659627|P4|Overall Study|CPAP machine malfunction|1
5703970|NCT00203996|19659628|P3|Overall Study|CPAP machine malfunction|0
5703971|NCT00203996|19659629|P2|Overall Study|CPAP machine malfunction|0
5703972|NCT00203996|19659630|P1|Overall Study|CPAP machine malfunction|0
5703973|NCT00203996|19659621|P10|Overall Study|Physician Decision|1
5703974|NCT00203996|19659622|P9|Overall Study|Physician Decision|0
5703975|NCT00203996|19659623|P8|Overall Study|Physician Decision|0
5703976|NCT00203996|19659624|P7|Overall Study|Physician Decision|0
5703977|NCT00203996|19659625|P6|Overall Study|Physician Decision|0
5703978|NCT00203996|19659626|P5|Overall Study|Physician Decision|0
5703979|NCT00203996|19659627|P4|Overall Study|Physician Decision|2
5703980|NCT00203996|19659628|P3|Overall Study|Physician Decision|0
5703981|NCT00203996|19659629|P2|Overall Study|Physician Decision|0
5703982|NCT00203996|19659630|P1|Overall Study|Physician Decision|0
5703983|NCT00203996|19659621|P10|Overall Study|Protocol Violation|0
5703984|NCT00203996|19659622|P9|Overall Study|Protocol Violation|0
5703985|NCT00203996|19659623|P8|Overall Study|Protocol Violation|0
5703986|NCT00203996|19659624|P7|Overall Study|Protocol Violation|0
5703987|NCT00203996|19659625|P6|Overall Study|Protocol Violation|0
5703988|NCT00203996|19659626|P5|Overall Study|Protocol Violation|1
5703989|NCT00203996|19659627|P4|Overall Study|Protocol Violation|6
5703990|NCT00203996|19659628|P3|Overall Study|Protocol Violation|0
5703991|NCT00203996|19659629|P2|Overall Study|Protocol Violation|0
5703992|NCT00203996|19659630|P1|Overall Study|Protocol Violation|0
5703993|NCT00203996|19659621|P10|Overall Study|Lost to Follow-up|0
5703994|NCT00203996|19659622|P9|Overall Study|Lost to Follow-up|0
5703995|NCT00203996|19659623|P8|Overall Study|Lost to Follow-up|0
5703996|NCT00203996|19659624|P7|Overall Study|Lost to Follow-up|0
5703997|NCT00203996|19659625|P6|Overall Study|Lost to Follow-up|0
5703998|NCT00203996|19659626|P5|Overall Study|Lost to Follow-up|0
5703999|NCT00203996|19659627|P4|Overall Study|Lost to Follow-up|1
5704000|NCT00203996|19659628|P3|Overall Study|Lost to Follow-up|0
5704001|NCT00203996|19659629|P2|Overall Study|Lost to Follow-up|0
5704002|NCT00203996|19659630|P1|Overall Study|Lost to Follow-up|0
5704003|NCT00203892|19659697|P3|Overall Study|Death|0
5704004|NCT00203892|19659698|P2|Overall Study|Death|0
5704005|NCT00203892|19659699|P1|Overall Study|Death|1
5704006|NCT00203892|19659697|P3|Overall Study|Physician Decision|0
5704007|NCT00203892|19659698|P2|Overall Study|Physician Decision|2
5704008|NCT00203892|19659699|P1|Overall Study|Physician Decision|1
5704009|NCT00203502|19659710|P1|Overall Study|Death|1
5704010|NCT00203476|19659721|P3|Overall Study|Withdrawal by Subject|0
5704011|NCT00203476|19659722|P2|Overall Study|Withdrawal by Subject|1
5704012|NCT00203476|19659723|P1|Overall Study|Withdrawal by Subject|0
5704013|NCT00203476|19659721|P3|Overall Study|Lost to Follow-up|0
5704014|NCT00203476|19659722|P2|Overall Study|Lost to Follow-up|0
5704015|NCT00203476|19659723|P1|Overall Study|Lost to Follow-up|1
5704016|NCT00203424|19659740|P1|Follow-up Period|Lost to Follow-up|1
5704017|NCT00203424|19659740|P1|Follow-up Period|progressive disease|4
5704018|NCT00203424|19659740|P1|Follow-up Period|Withdrawal by Subject|1
5704019|NCT00203424|19659740|P1|Treatment Period|progressive disease|2
5704020|NCT00203424|19659740|P1|Treatment Period|Adverse Event|5
5704021|NCT00203424|19659740|P1|Treatment Period|Withdrawal by Subject|4
5704022|NCT00203411|19659747|P1|Follow-up|Progressive Disease|4
5704023|NCT00203307|19659756|P2|First Intervention|Adverse Event|0
5704024|NCT00203307|19659757|P1|First Intervention|Adverse Event|2
5704025|NCT00203294|19659765|P2|Overall Study|Withdrawal by Subject|13
5704026|NCT00203294|19659766|P1|Overall Study|Withdrawal by Subject|8
5704027|NCT00203268|19659772|P1|Early Treatment|Withdrawal by Subject|1
5704028|NCT00203268|19659772|P1|Early Treatment|Lost to Follow-up|1
5704029|NCT00203268|19659772|P1|Early Treatment|only treated one headache|2
5704030|NCT00203242|19659778|P1|Overall Study|Lost to Follow-up|1
5704031|NCT00203047|19659830|P2|Overall Study|Other|5
5704032|NCT00203047|19659831|P1|Overall Study|Other|5
5704033|NCT00203047|19659830|P2|Overall Study|Pregnancy|0
5704034|NCT00203047|19659831|P1|Overall Study|Pregnancy|3
5704035|NCT00203047|19659830|P2|Overall Study|Death|2
5704036|NCT00203047|19659831|P1|Overall Study|Death|1
5704037|NCT00203047|19659830|P2|Overall Study|Adverse Event|18
5704038|NCT00203047|19659831|P1|Overall Study|Adverse Event|8
5704039|NCT00203047|19659830|P2|Overall Study|Lost to Follow-up|5
5704040|NCT00203047|19659831|P1|Overall Study|Lost to Follow-up|11
5704041|NCT00203047|19659830|P2|Overall Study|Protocol Violation|0
5704042|NCT00203047|19659831|P1|Overall Study|Protocol Violation|1
5704043|NCT00203047|19659830|P2|Overall Study|Non-compliance|8
5704044|NCT00203047|19659831|P1|Overall Study|Non-compliance|4
5704045|NCT00203047|19659830|P2|Overall Study|Physician Decision|7
5704046|NCT00203047|19659831|P1|Overall Study|Physician Decision|8
5704047|NCT00203047|19659830|P2|Overall Study|Teva requested participant withdrawal|1
5704048|NCT00203047|19659831|P1|Overall Study|Teva requested participant withdrawal|1
5704049|NCT00203047|19659830|P2|Overall Study|Withdrawal by Subject|47
5704050|NCT00203047|19659831|P1|Overall Study|Withdrawal by Subject|13
5704051|NCT00203047|19659830|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
5704052|NCT00203047|19659831|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
5704053|NCT00203047|19659830|P2|Overall Study|Ongoing: in database - January 29, 2009|109
5704054|NCT00203047|19659831|P1|Overall Study|Ongoing: in database - January 29, 2009|131
5704055|NCT00203021|19659845|P2|Overall Study|Other than specified|16
5704056|NCT00203021|19659846|P1|Overall Study|Other than specified|11
5704057|NCT00203021|19659845|P2|Overall Study|Lost to Follow-up|7
5704058|NCT00203021|19659846|P1|Overall Study|Lost to Follow-up|9
5704059|NCT00203021|19659845|P2|Overall Study|Withdrawal by Subject|48
5704060|NCT00203021|19659846|P1|Overall Study|Withdrawal by Subject|45
5704061|NCT00203021|19659845|P2|Overall Study|Adverse Event|5
5704062|NCT00203021|19659846|P1|Overall Study|Adverse Event|10
5704063|NCT00203021|19659845|P2|Overall Study|Death|1
5704064|NCT00203021|19659846|P1|Overall Study|Death|4
5704065|NCT00202878|19659856|P2|Overall Study|Withdrawal by Subject|808
5704066|NCT00202878|19659857|P1|Overall Study|Withdrawal by Subject|795
5704067|NCT00202878|19659856|P2|Overall Study|Site Closure|36
5704068|NCT00202878|19659857|P1|Overall Study|Site Closure|39
5704069|NCT00202878|19659856|P2|Overall Study|Lost to Follow-up|49
5704070|NCT00202878|19659857|P1|Overall Study|Lost to Follow-up|44
5704071|NCT00202878|19659856|P2|Overall Study|Only Vital Status Known|356
5704072|NCT00202878|19659857|P1|Overall Study|Only Vital Status Known|357
5704073|NCT00202878|19659856|P2|Overall Study|Death|968
5704074|NCT00202878|19659857|P1|Overall Study|Death|964
5704075|NCT00202839|19659871|P2|Overall Study|Lost to Follow-up|2
5704076|NCT00202839|19659872|P1|Overall Study|Lost to Follow-up|3
5704077|NCT00202839|19659871|P2|Overall Study|Protocol Violation|1
5704078|NCT00202839|19659872|P1|Overall Study|Protocol Violation|2
5704079|NCT00202839|19659871|P2|Overall Study|Withdrawal by Subject|2
5704080|NCT00202839|19659872|P1|Overall Study|Withdrawal by Subject|6
5704081|NCT00202839|19659871|P2|Overall Study|Physician Decision|0
5704082|NCT00202839|19659872|P1|Overall Study|Physician Decision|12
5704083|NCT00202839|19659871|P2|Overall Study|Adverse Event|5
5704084|NCT00202839|19659872|P1|Overall Study|Adverse Event|1
5704085|NCT00202644|19659887|P2|Overall Study|Other|1
5704086|NCT00202644|19659888|P1|Overall Study|Other|9
5704087|NCT00202644|19659887|P2|Overall Study|Lost to Follow-up|1
5704088|NCT00202644|19659888|P1|Overall Study|Lost to Follow-up|0
5704089|NCT00202644|19659887|P2|Overall Study|Lack of Efficacy|6
5704090|NCT00202644|19659888|P1|Overall Study|Lack of Efficacy|6
5704091|NCT00202644|19659887|P2|Overall Study|Withdrawal by Subject|6
5704092|NCT00202644|19659888|P1|Overall Study|Withdrawal by Subject|8
5704093|NCT00202644|19659887|P2|Overall Study|Adverse Event|13
5704094|NCT00202644|19659888|P1|Overall Study|Adverse Event|12
5704095|NCT00201851|19659949|P3|Overall Study|Ineligible post enrollment|1
5704096|NCT00201851|19659950|P2|Overall Study|Ineligible post enrollment|1
5704097|NCT00201851|19659951|P1|Overall Study|Ineligible post enrollment|6
5704098|NCT00201851|19659949|P3|Overall Study|Lost to Follow-up|0
5704099|NCT00201851|19659950|P2|Overall Study|Lost to Follow-up|1
5704100|NCT00201851|19659951|P1|Overall Study|Lost to Follow-up|2
5704101|NCT00201643|19660023|P2|Overall Study|Withdrawal by Subject|4
5704102|NCT00201643|19660024|P1|Overall Study|Withdrawal by Subject|5
5704103|NCT00201201|19660088|P2|Overall Study|Withdrawal by Subject|5
5704104|NCT00201201|19660089|P1|Overall Study|Withdrawal by Subject|5
5704105|NCT00201201|19660088|P2|Overall Study|Death|2
5704106|NCT00201201|19660089|P1|Overall Study|Death|0
5704107|NCT00201006|19660127|P3|Overall Study|Adverse Event|1
5704108|NCT00201006|19660128|P2|Overall Study|Adverse Event|0
5704109|NCT00201006|19660129|P1|Overall Study|Adverse Event|1
5704110|NCT00201006|19660127|P3|Overall Study|Withdrawal by Subject|3
5704111|NCT00201006|19660128|P2|Overall Study|Withdrawal by Subject|2
5704112|NCT00201006|19660129|P1|Overall Study|Withdrawal by Subject|7
5704113|NCT00200967|19660139|P2|Run-out Period|Lost to Follow-up|0
5704114|NCT00200967|19660140|P1|Run-out Period|Lost to Follow-up|1
5704115|NCT00200967|19660139|P2|Second Treatment Period|Withdrawal by Subject|2
5704116|NCT00200967|19660140|P1|Second Treatment Period|Withdrawal by Subject|1
5704117|NCT00200967|19660139|P2|Wash-out Period|Lost to Follow-up|1
5704118|NCT00200967|19660140|P1|Wash-out Period|Lost to Follow-up|0
5704119|NCT00200967|19660139|P2|First Treatment Period|Pregnancy|0
5704120|NCT00200967|19660140|P1|First Treatment Period|Pregnancy|1
5704121|NCT00200967|19660139|P2|First Treatment Period|Withdrawal by Subject|1
5704122|NCT00200967|19660140|P1|First Treatment Period|Withdrawal by Subject|5
5704123|NCT00200850|19660190|P3|Overall Study|Adverse Event|2
5704124|NCT00200850|19660191|P2|Overall Study|Adverse Event|1
5704125|NCT00200850|19660192|P1|Overall Study|Adverse Event|1
5704126|NCT00200850|19660190|P3|Overall Study|optic neuritis|1
5704127|NCT00200850|19660191|P2|Overall Study|optic neuritis|0
5704128|NCT00200850|19660192|P1|Overall Study|optic neuritis|0
5704129|NCT00200850|19660190|P3|Overall Study|Poor adherence|1
5704130|NCT00200850|19660191|P2|Overall Study|Poor adherence|0
5704131|NCT00200850|19660192|P1|Overall Study|Poor adherence|0
5704132|NCT00200850|19660190|P3|Overall Study|Pregnancy|1
5704133|NCT00200850|19660191|P2|Overall Study|Pregnancy|0
5704134|NCT00200850|19660192|P1|Overall Study|Pregnancy|0
5704135|NCT00200850|19660190|P3|Overall Study|too busy|0
5704136|NCT00200850|19660191|P2|Overall Study|too busy|0
5704137|NCT00200850|19660192|P1|Overall Study|too busy|1
5704138|NCT00200850|19660190|P3|Overall Study|relocation|1
5704139|NCT00200850|19660191|P2|Overall Study|relocation|0
5704140|NCT00200850|19660192|P1|Overall Study|relocation|1
5704141|NCT00200356|19660213|P2|Overall Study|Nontreatment|0
5704142|NCT00200356|19660214|P1|Overall Study|Nontreatment|1
5704143|NCT00200356|19660213|P2|Overall Study|Protocol Violation|4
5704144|NCT00200356|19660214|P1|Overall Study|Protocol Violation|4
5704145|NCT00200356|19660213|P2|Overall Study|Lack of Efficacy|3
5704146|NCT00200356|19660214|P1|Overall Study|Lack of Efficacy|3
5704147|NCT00200057|19660281|P1|Overall Study|Death|1
5704148|NCT00200057|19660281|P1|Overall Study|Infection|1
5704149|NCT00200057|19660281|P1|Overall Study|Change in medical condition|1
5704150|NCT00200057|19660281|P1|Overall Study|Withdrawal by Subject|1
5704151|NCT00200057|19660281|P1|Overall Study|Exited due to terminal illness of PI|2
5704152|NCT00200057|19660281|P1|Overall Study|Lack of Efficacy|3
5704153|NCT00199875|19660305|P5|Overall Study|Withdrawal by Subject|1
5704154|NCT00199875|19660306|P4|Overall Study|Withdrawal by Subject|0
5704155|NCT00199875|19660307|P3|Overall Study|Withdrawal by Subject|0
5704156|NCT00199875|19660308|P2|Overall Study|Withdrawal by Subject|0
5704157|NCT00199875|19660309|P1|Overall Study|Withdrawal by Subject|0
5704158|NCT00199381|19660331|P1|Overall Study|Study termination by Sponsor|323
5704159|NCT00199381|19660331|P1|Overall Study|Not including due to early termination|37
5704160|NCT00199381|19660331|P1|Overall Study|Lack of Efficacy|27
5704161|NCT00199381|19660331|P1|Overall Study|Protocol Violation|6
5704162|NCT00199381|19660331|P1|Overall Study|Adverse Event|73
5704163|NCT00199381|19660331|P1|Overall Study|Withdrawal by Subject|38
5704164|NCT00198822|19660338|P3|Overall Study|Lost to Follow-up|21
5704165|NCT00198822|19660339|P2|Overall Study|Lost to Follow-up|20
5704166|NCT00198822|19660340|P1|Overall Study|Lost to Follow-up|14
5704167|NCT00198133|19660359|P2|Overall Study|Physician Decision|0
5704168|NCT00198133|19660360|P1|Overall Study|Physician Decision|1
5704169|NCT00198133|19660359|P2|Overall Study|Withdrawal by Subject|0
5704170|NCT00198133|19660360|P1|Overall Study|Withdrawal by Subject|1
5704171|NCT00198133|19660359|P2|Overall Study|Adverse Event|3
5704172|NCT00198133|19660360|P1|Overall Study|Adverse Event|1
5704173|NCT00198133|19660359|P2|Overall Study|Disease progression|5
5704174|NCT00198133|19660360|P1|Overall Study|Disease progression|2
5704175|NCT00198107|19660372|P3|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
5704176|NCT00198107|19660373|P2|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
5704177|NCT00198107|19660374|P1|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
5704178|NCT00198107|19660372|P3|Double-Blind Period|Withdrawal by Subject|0
5704179|NCT00198107|19660373|P2|Double-Blind Period|Withdrawal by Subject|1
5704180|NCT00198107|19660374|P1|Double-Blind Period|Withdrawal by Subject|0
5704181|NCT00198107|19660372|P3|Double-Blind Period|Physician Decision|0
5704182|NCT00198107|19660373|P2|Double-Blind Period|Physician Decision|0
5704183|NCT00198107|19660374|P1|Double-Blind Period|Physician Decision|1
5704184|NCT00198107|19660372|P3|Double-Blind Period|Lost to Follow-up|0
5704185|NCT00198107|19660373|P2|Double-Blind Period|Lost to Follow-up|1
5704186|NCT00198107|19660374|P1|Double-Blind Period|Lost to Follow-up|2
5704187|NCT00198107|19660372|P3|Double-Blind Period|Lack of Efficacy|0
5704188|NCT00198107|19660373|P2|Double-Blind Period|Lack of Efficacy|0
5704189|NCT00198107|19660374|P1|Double-Blind Period|Lack of Efficacy|2
5704190|NCT00198107|19660372|P3|Double-Blind Period|Adverse Event|0
5704191|NCT00198107|19660373|P2|Double-Blind Period|Adverse Event|1
5704192|NCT00198107|19660374|P1|Double-Blind Period|Adverse Event|1
5704193|NCT00198029|19660442|P1|Overall Study|Withdrawal by Subject|4
5704194|NCT00197496|19660449|P2|Follow-up|Lost to Follow-up|1
5704195|NCT00197496|19660450|P1|Follow-up|Lost to Follow-up|2
5704196|NCT00197496|19660449|P2|Baseline to Discharge|Protocol Violation|1
5704197|NCT00197496|19660450|P1|Baseline to Discharge|Protocol Violation|0
5704198|NCT00197496|19660449|P2|Baseline to Discharge|Physician Decision|1
5704199|NCT00197496|19660450|P1|Baseline to Discharge|Physician Decision|0
5704200|NCT00197496|19660449|P2|Baseline to Discharge|MRSA|0
5704201|NCT00197496|19660450|P1|Baseline to Discharge|MRSA|1
5704202|NCT00197496|19660449|P2|Baseline to Discharge|not interested|0
5704203|NCT00197496|19660450|P1|Baseline to Discharge|not interested|1
5704204|NCT00197236|19660498|P3|Overall Study|Returned out of specified time window|1
5704205|NCT00197236|19660499|P2|Overall Study|Returned out of specified time window|0
5704206|NCT00197236|19660500|P1|Overall Study|Returned out of specified time window|0
5704207|NCT00197236|19660498|P3|Overall Study|Study drug/medication expiration|3
5704208|NCT00197236|19660499|P2|Overall Study|Study drug/medication expiration|0
5704209|NCT00197236|19660500|P1|Overall Study|Study drug/medication expiration|1
5704210|NCT00197236|19660498|P3|Overall Study|Withdrawal by Subject|11
5704211|NCT00197236|19660499|P2|Overall Study|Withdrawal by Subject|3
5704212|NCT00197236|19660500|P1|Overall Study|Withdrawal by Subject|7
5704213|NCT00197236|19660498|P3|Overall Study|Protocol Violation|1
5704214|NCT00197236|19660499|P2|Overall Study|Protocol Violation|0
5704215|NCT00197236|19660500|P1|Overall Study|Protocol Violation|0
5704216|NCT00197236|19660498|P3|Overall Study|Lost to Follow-up|6
5704217|NCT00197236|19660499|P2|Overall Study|Lost to Follow-up|14
5704218|NCT00197236|19660500|P1|Overall Study|Lost to Follow-up|5
5704219|NCT00197236|19660498|P3|Overall Study|Adverse Event|1
5704220|NCT00197236|19660499|P2|Overall Study|Adverse Event|0
5704221|NCT00197236|19660500|P1|Overall Study|Adverse Event|1
5704222|NCT00197145|19660574|P2|Period 2 : Open Label Phase|Other|0
5704223|NCT00197145|19660575|P1|Period 2 : Open Label Phase|Other|1
5704224|NCT00197145|19660574|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
5704225|NCT00197145|19660575|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
5704226|NCT00197145|19660574|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
5704227|NCT00197145|19660575|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
5704228|NCT00197145|19660574|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
5704229|NCT00197145|19660575|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
5704230|NCT00197145|19660574|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
5704231|NCT00197145|19660575|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
5704232|NCT00197145|19660574|P2|Period 1: Randomized Treatment Phase|Other|2
5704233|NCT00197145|19660575|P1|Period 1: Randomized Treatment Phase|Other|2
5704234|NCT00197145|19660574|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
5704235|NCT00197145|19660575|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
5704236|NCT00197145|19660574|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
5704237|NCT00197145|19660575|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
5704238|NCT00197106|19660646|P3|Overall Treatment Period|Withdrawal by Subject|2
5704239|NCT00197106|19660647|P2|Overall Treatment Period|Withdrawal by Subject|0
5704240|NCT00197106|19660648|P1|Overall Treatment Period|Withdrawal by Subject|0
5704241|NCT00197106|19660646|P3|Overall Treatment Period|Protocol Violation|2
5704242|NCT00197106|19660647|P2|Overall Treatment Period|Protocol Violation|0
5704243|NCT00197106|19660648|P1|Overall Treatment Period|Protocol Violation|0
5704244|NCT00197106|19660646|P3|Overall Treatment Period|Lost to Follow-up|2
5704245|NCT00197106|19660647|P2|Overall Treatment Period|Lost to Follow-up|0
5704246|NCT00197106|19660648|P1|Overall Treatment Period|Lost to Follow-up|0
5704247|NCT00197106|19660646|P3|Overall Treatment Period|Lack of Efficacy|0
5704248|NCT00197106|19660647|P2|Overall Treatment Period|Lack of Efficacy|1
5704249|NCT00197106|19660648|P1|Overall Treatment Period|Lack of Efficacy|0
5704250|NCT00197106|19660646|P3|4-Week Run-In Period|Did not meet entry criteria|0
5704251|NCT00197106|19660647|P2|4-Week Run-In Period|Did not meet entry criteria|0
5704252|NCT00197106|19660648|P1|4-Week Run-In Period|Did not meet entry criteria|99
5704253|NCT00197054|19660685|P3|Overall Study|Lost to Follow-up|0
5704254|NCT00197054|19660686|P2|Overall Study|Lost to Follow-up|4
5704255|NCT00197054|19660687|P1|Overall Study|Lost to Follow-up|1
5704256|NCT00197054|19660685|P3|Overall Study|Moved from area|9
5704257|NCT00197054|19660686|P2|Overall Study|Moved from area|14
5704258|NCT00197054|19660687|P1|Overall Study|Moved from area|7
5704259|NCT00197054|19660685|P3|Overall Study|Withdrawal by Subject|3
5704260|NCT00197054|19660686|P2|Overall Study|Withdrawal by Subject|3
5704261|NCT00197054|19660687|P1|Overall Study|Withdrawal by Subject|9
5704262|NCT00197028|19660797|P2|Overall Study|Other|6
5704263|NCT00197028|19660798|P1|Overall Study|Other|3
5704264|NCT00197028|19660797|P2|Overall Study|Lost to Follow-up|0
5704265|NCT00197028|19660798|P1|Overall Study|Lost to Follow-up|1
5704266|NCT00197028|19660797|P2|Overall Study|Withdrawal by Subject|12
5704267|NCT00197028|19660798|P1|Overall Study|Withdrawal by Subject|8
5704268|NCT00197028|19660797|P2|Overall Study|Protocol Violation|1
5704269|NCT00197028|19660798|P1|Overall Study|Protocol Violation|2
5704270|NCT00197028|19660797|P2|Overall Study|Adverse Event|2
5704271|NCT00197028|19660798|P1|Overall Study|Adverse Event|2
5704272|NCT00197015|19660841|P3|Overall Study|Other|2
5704273|NCT00197015|19660842|P2|Overall Study|Other|3
5704274|NCT00197015|19660843|P1|Overall Study|Other|2
5704275|NCT00197015|19660841|P3|Overall Study|Lost to Follow-up|37
5704276|NCT00197015|19660842|P2|Overall Study|Lost to Follow-up|46
5704277|NCT00197015|19660843|P1|Overall Study|Lost to Follow-up|28
5704278|NCT00197015|19660841|P3|Overall Study|Withdrawal by Subject|34
5704279|NCT00197015|19660842|P2|Overall Study|Withdrawal by Subject|37
5704280|NCT00197015|19660843|P1|Overall Study|Withdrawal by Subject|17
5704281|NCT00197015|19660841|P3|Overall Study|Protocol Violation|3
5704282|NCT00197015|19660842|P2|Overall Study|Protocol Violation|3
5704283|NCT00197015|19660843|P1|Overall Study|Protocol Violation|0
5704284|NCT00197015|19660841|P3|Overall Study|Adverse Event|1
5704285|NCT00197015|19660842|P2|Overall Study|Adverse Event|0
5704286|NCT00197015|19660843|P1|Overall Study|Adverse Event|3
5704287|NCT00197002|19660902|P3|Overall Study|Others|1
5704288|NCT00197002|19660903|P2|Overall Study|Others|1
5704289|NCT00197002|19660904|P1|Overall Study|Others|3
5704290|NCT00197002|19660902|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
5704291|NCT00197002|19660903|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
5704292|NCT00197002|19660904|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
5704293|NCT00197002|19660902|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
5704294|NCT00197002|19660903|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
5704295|NCT00197002|19660904|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
5704296|NCT00197002|19660902|P3|Overall Study|Migrated/moved from study area|1
5704297|NCT00197002|19660903|P2|Overall Study|Migrated/moved from study area|5
5704298|NCT00197002|19660904|P1|Overall Study|Migrated/moved from study area|3
5704299|NCT00197002|19660902|P3|Overall Study|Withdrawal by Subject|7
5704300|NCT00197002|19660903|P2|Overall Study|Withdrawal by Subject|5
5704301|NCT00197002|19660904|P1|Overall Study|Withdrawal by Subject|9
5704302|NCT00197002|19660902|P3|Overall Study|Protocol Violation|2
5704303|NCT00197002|19660903|P2|Overall Study|Protocol Violation|0
5704304|NCT00197002|19660904|P1|Overall Study|Protocol Violation|1
5704305|NCT00197002|19660902|P3|Overall Study|Adverse Event|0
5704306|NCT00197002|19660903|P2|Overall Study|Adverse Event|1
5704307|NCT00197002|19660904|P1|Overall Study|Adverse Event|0
5704308|NCT00196976|19660955|P14|Booster Study|Lost to Follow-up|0
5704309|NCT00196976|19660956|P13|Booster Study|Lost to Follow-up|0
5704310|NCT00196976|19660957|P12|Booster Study|Lost to Follow-up|2
5704311|NCT00196976|19660958|P11|Booster Study|Lost to Follow-up|1
5704312|NCT00196976|19660959|P10|Booster Study|Lost to Follow-up|0
5704313|NCT00196976|19660960|P9|Booster Study|Lost to Follow-up|0
5704314|NCT00196976|19660961|P8|Booster Study|Lost to Follow-up|0
5704315|NCT00196976|19660962|P7|Booster Study|Lost to Follow-up|0
5704316|NCT00196976|19660963|P6|Booster Study|Lost to Follow-up|0
5704317|NCT00196976|19660964|P5|Booster Study|Lost to Follow-up|0
5704318|NCT00196976|19660965|P4|Booster Study|Lost to Follow-up|0
5704319|NCT00196976|19660966|P3|Booster Study|Lost to Follow-up|0
5704320|NCT00196976|19660967|P2|Booster Study|Lost to Follow-up|0
5704321|NCT00196976|19660968|P1|Booster Study|Lost to Follow-up|0
5704322|NCT00196976|19660955|P14|Booster Study|Withdrawal by Subject|0
5704323|NCT00196976|19660956|P13|Booster Study|Withdrawal by Subject|0
5704324|NCT00196976|19660957|P12|Booster Study|Withdrawal by Subject|0
5704325|NCT00196976|19660958|P11|Booster Study|Withdrawal by Subject|1
5704326|NCT00196976|19660959|P10|Booster Study|Withdrawal by Subject|0
5704327|NCT00196976|19660960|P9|Booster Study|Withdrawal by Subject|0
5704328|NCT00196976|19660961|P8|Booster Study|Withdrawal by Subject|0
5704329|NCT00196976|19660962|P7|Booster Study|Withdrawal by Subject|0
5704330|NCT00196976|19660963|P6|Booster Study|Withdrawal by Subject|0
5704331|NCT00196976|19660964|P5|Booster Study|Withdrawal by Subject|0
5704332|NCT00196976|19660965|P4|Booster Study|Withdrawal by Subject|0
5704333|NCT00196976|19660966|P3|Booster Study|Withdrawal by Subject|0
5704334|NCT00196976|19660967|P2|Booster Study|Withdrawal by Subject|0
5704335|NCT00196976|19660968|P1|Booster Study|Withdrawal by Subject|0
5704336|NCT00196976|19660955|P14|Primary Study|Other|0
5704337|NCT00196976|19660956|P13|Primary Study|Other|0
5704338|NCT00196976|19660957|P12|Primary Study|Other|0
5704339|NCT00196976|19660958|P11|Primary Study|Other|0
5704340|NCT00196976|19660959|P10|Primary Study|Other|0
5704341|NCT00196976|19660960|P9|Primary Study|Other|0
5704342|NCT00196976|19660961|P8|Primary Study|Other|0
5704343|NCT00196976|19660962|P7|Primary Study|Other|0
5704344|NCT00196976|19660963|P6|Primary Study|Other|0
5704345|NCT00196976|19660964|P5|Primary Study|Other|0
5704346|NCT00196976|19660965|P4|Primary Study|Other|0
5704347|NCT00196976|19660966|P3|Primary Study|Other|2
5704348|NCT00196976|19660967|P2|Primary Study|Other|0
5704349|NCT00196976|19660968|P1|Primary Study|Other|0
5704350|NCT00196976|19660955|P14|Primary Study|Lost to Follow-up|0
5704351|NCT00196976|19660956|P13|Primary Study|Lost to Follow-up|0
5704352|NCT00196976|19660957|P12|Primary Study|Lost to Follow-up|0
5704353|NCT00196976|19660958|P11|Primary Study|Lost to Follow-up|0
5704354|NCT00196976|19660959|P10|Primary Study|Lost to Follow-up|0
5704355|NCT00196976|19660960|P9|Primary Study|Lost to Follow-up|0
5704356|NCT00196976|19660961|P8|Primary Study|Lost to Follow-up|2
5704357|NCT00196976|19660962|P7|Primary Study|Lost to Follow-up|0
5704358|NCT00196976|19660963|P6|Primary Study|Lost to Follow-up|1
5704359|NCT00196976|19660964|P5|Primary Study|Lost to Follow-up|1
5704360|NCT00196976|19660965|P4|Primary Study|Lost to Follow-up|0
5704361|NCT00196976|19660966|P3|Primary Study|Lost to Follow-up|0
5704362|NCT00196976|19660967|P2|Primary Study|Lost to Follow-up|0
5704363|NCT00196976|19660968|P1|Primary Study|Lost to Follow-up|0
5704364|NCT00196976|19660955|P14|Primary Study|Withdrawal by Subject|0
5704365|NCT00196976|19660956|P13|Primary Study|Withdrawal by Subject|0
5704366|NCT00196976|19660957|P12|Primary Study|Withdrawal by Subject|0
5704367|NCT00196976|19660958|P11|Primary Study|Withdrawal by Subject|0
5704368|NCT00196976|19660959|P10|Primary Study|Withdrawal by Subject|1
5704369|NCT00196976|19660960|P9|Primary Study|Withdrawal by Subject|0
5704370|NCT00196976|19660961|P8|Primary Study|Withdrawal by Subject|0
5704371|NCT00196976|19660962|P7|Primary Study|Withdrawal by Subject|0
5704372|NCT00196976|19660963|P6|Primary Study|Withdrawal by Subject|1
5704373|NCT00196976|19660964|P5|Primary Study|Withdrawal by Subject|2
5704374|NCT00196976|19660965|P4|Primary Study|Withdrawal by Subject|1
5704375|NCT00196976|19660966|P3|Primary Study|Withdrawal by Subject|1
5704376|NCT00196976|19660967|P2|Primary Study|Withdrawal by Subject|0
5704377|NCT00196976|19660968|P1|Primary Study|Withdrawal by Subject|1
5704378|NCT00196976|19660955|P14|Primary Study|Protocol Violation|0
5704379|NCT00196976|19660956|P13|Primary Study|Protocol Violation|0
5704380|NCT00196976|19660957|P12|Primary Study|Protocol Violation|0
5704381|NCT00196976|19660958|P11|Primary Study|Protocol Violation|0
5704382|NCT00196976|19660959|P10|Primary Study|Protocol Violation|0
5704383|NCT00196976|19660960|P9|Primary Study|Protocol Violation|0
5704384|NCT00196976|19660961|P8|Primary Study|Protocol Violation|0
5704385|NCT00196976|19660962|P7|Primary Study|Protocol Violation|0
5704386|NCT00196976|19660963|P6|Primary Study|Protocol Violation|0
5704387|NCT00196976|19660964|P5|Primary Study|Protocol Violation|0
5704388|NCT00196976|19660965|P4|Primary Study|Protocol Violation|0
5704389|NCT00196976|19660966|P3|Primary Study|Protocol Violation|1
5704390|NCT00196976|19660967|P2|Primary Study|Protocol Violation|1
5704391|NCT00196976|19660968|P1|Primary Study|Protocol Violation|0
5704392|NCT00196976|19660955|P14|Primary Study|Migrated from study area|0
5704393|NCT00196976|19660956|P13|Primary Study|Migrated from study area|0
5704394|NCT00196976|19660957|P12|Primary Study|Migrated from study area|0
5704395|NCT00196976|19660958|P11|Primary Study|Migrated from study area|0
5704396|NCT00196976|19660959|P10|Primary Study|Migrated from study area|0
5704397|NCT00196976|19660960|P9|Primary Study|Migrated from study area|0
5704398|NCT00196976|19660961|P8|Primary Study|Migrated from study area|1
5704399|NCT00196976|19660962|P7|Primary Study|Migrated from study area|0
5704400|NCT00196976|19660963|P6|Primary Study|Migrated from study area|0
5704401|NCT00196976|19660964|P5|Primary Study|Migrated from study area|0
5704402|NCT00196976|19660965|P4|Primary Study|Migrated from study area|0
5704403|NCT00196976|19660966|P3|Primary Study|Migrated from study area|0
5704404|NCT00196976|19660967|P2|Primary Study|Migrated from study area|0
5704405|NCT00196976|19660968|P1|Primary Study|Migrated from study area|0
5704406|NCT00196937|19661164|P3|Overall Study|Other|1
5704407|NCT00196937|19661165|P2|Overall Study|Other|1
5704408|NCT00196937|19661166|P1|Overall Study|Other|3
5704409|NCT00196937|19661164|P3|Overall Study|Lost to Follow-up|3
5704410|NCT00196937|19661165|P2|Overall Study|Lost to Follow-up|3
5704411|NCT00196937|19661166|P1|Overall Study|Lost to Follow-up|4
5704412|NCT00196937|19661164|P3|Overall Study|Withdrawal by Subject|2
5704413|NCT00196937|19661165|P2|Overall Study|Withdrawal by Subject|0
5704414|NCT00196937|19661166|P1|Overall Study|Withdrawal by Subject|0
5704415|NCT00196937|19661164|P3|Overall Study|Non-serious adverse event|1
5704416|NCT00196937|19661165|P2|Overall Study|Non-serious adverse event|1
5704417|NCT00196937|19661166|P1|Overall Study|Non-serious adverse event|1
5704418|NCT00196937|19661164|P3|Overall Study|Serious Adverse Event|0
5704419|NCT00196937|19661165|P2|Overall Study|Serious Adverse Event|0
5704420|NCT00196937|19661166|P1|Overall Study|Serious Adverse Event|1
5704421|NCT00196326|19661220|P1|Overall Study|Other|22
5704422|NCT00196326|19661220|P1|Overall Study|Lost to Follow-up|304
5704423|NCT00196326|19661220|P1|Overall Study|Pregnancy|34
5704424|NCT00196326|19661220|P1|Overall Study|Adverse Event|253
5704425|NCT00196326|19661220|P1|Overall Study|Withdrawal by Subject|225
5704426|NCT00196326|19661220|P1|Overall Study|Physician Decision|3
5704427|NCT00196326|19661220|P1|Overall Study|Non-compliance with the protocol|81
5704428|NCT00196326|19661220|P1|Overall Study|Did not meet protocol requirements|64
5704429|NCT00196313|19661228|P2|Overall Study|Lost to Follow-up|2
5704430|NCT00196313|19661229|P1|Overall Study|Lost to Follow-up|2
5704431|NCT00196313|19661228|P2|Overall Study|Subject Pregnant|1
5704432|NCT00196313|19661229|P1|Overall Study|Subject Pregnant|1
5704433|NCT00196313|19661228|P2|Overall Study|Adverse Event|1
5704434|NCT00196313|19661229|P1|Overall Study|Adverse Event|3
5704435|NCT00196313|19661228|P2|Overall Study|Withdrawal by Subject|1
5704436|NCT00196313|19661229|P1|Overall Study|Withdrawal by Subject|3
5704437|NCT00196313|19661228|P2|Overall Study|Protocol Violation|3
5704438|NCT00196313|19661229|P1|Overall Study|Protocol Violation|2
5704439|NCT00196196|19661243|P1|Overall Study|Did not have required condition (hydroce|5
5704440|NCT00196196|19661243|P1|Overall Study|Withdrawal by Subject|2
5704441|NCT00196105|19661251|P3|Overall Study|Lost to Follow-up|7
5704442|NCT00196105|19661252|P2|Overall Study|Lost to Follow-up|5
5704443|NCT00196105|19661253|P1|Overall Study|Lost to Follow-up|4
5704444|NCT00195819|19661273|P2|Open-label|Withdrawal by Subject|5
5704445|NCT00195819|19661274|P1|Open-label|Withdrawal by Subject|0
5704446|NCT00195819|19661273|P2|Open-label|Moved|1
5704447|NCT00195819|19661274|P1|Open-label|Moved|0
5704448|NCT00195819|19661273|P2|Open-label|Protocol Violation|2
5704449|NCT00195819|19661274|P1|Open-label|Protocol Violation|0
5704450|NCT00195819|19661273|P2|Open-label|Pregnancy|1
5704451|NCT00195819|19661274|P1|Open-label|Pregnancy|0
5704452|NCT00195819|19661273|P2|Open-label|Lack of Efficacy|2
5704453|NCT00195819|19661274|P1|Open-label|Lack of Efficacy|0
5704454|NCT00195819|19661273|P2|Open-label|Adverse Event|9
5704455|NCT00195819|19661274|P1|Open-label|Adverse Event|0
5704456|NCT00195819|19661273|P2|Double-Blind|Moved|0
5704457|NCT00195819|19661274|P1|Double-Blind|Moved|1
5704458|NCT00195819|19661273|P2|Double-Blind|Withdrawal by Subject|0
5704459|NCT00195819|19661274|P1|Double-Blind|Withdrawal by Subject|1
5704460|NCT00195715|19661324|P1|Overall Study|Sponsor discretion - trial ended early|1
5704461|NCT00195715|19661324|P1|Overall Study|Sponsor discontinued trial|1
5704462|NCT00195715|19661324|P1|Overall Study|Colonic stricture|1
5704463|NCT00195715|19661324|P1|Overall Study|Ineligible|1
5704464|NCT00195715|19661324|P1|Overall Study|Increased infection rate|1
5704465|NCT00195715|19661324|P1|Overall Study|Planned surgery|2
5704466|NCT00195715|19661324|P1|Overall Study|Use of prohibited medication|2
5704467|NCT00195715|19661324|P1|Overall Study|Subject wants to get pregnant|4
5704468|NCT00195715|19661324|P1|Overall Study|Investigator's decision|2
5704469|NCT00195715|19661324|P1|Overall Study|Administrative reasons|2
5704470|NCT00195715|19661324|P1|Overall Study|Sponsor stopped study|1
5704471|NCT00195715|19661324|P1|Overall Study|Loss of response/no improvement|3
5704472|NCT00195715|19661324|P1|Overall Study|Subject choice|3
5704473|NCT00195715|19661324|P1|Overall Study|Subject started commercial Humira|5
5704474|NCT00195715|19661324|P1|Overall Study|Subject non-compliance|6
5704475|NCT00195715|19661324|P1|Overall Study|Subject moved/relocated|7
5704476|NCT00195715|19661324|P1|Overall Study|Investigative site closure|8
5704477|NCT00195715|19661324|P1|Overall Study|Pregnancy|14
5704478|NCT00195715|19661324|P1|Overall Study|Lack of Efficacy|93
5704479|NCT00195715|19661324|P1|Overall Study|Protocol Violation|13
5704480|NCT00195715|19661324|P1|Overall Study|Lost to Follow-up|27
5704481|NCT00195715|19661324|P1|Overall Study|Withdrawal by Subject|58
5704482|NCT00195715|19661324|P1|Overall Study|Adverse Event|122
5704483|NCT00195676|19661424|P1|Period R - Retreatment 16 Weeks|Other reasons|6
5704484|NCT00195676|19661424|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
5704485|NCT00195676|19661424|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
5704486|NCT00195676|19661424|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
5704487|NCT00195676|19661424|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
5704488|NCT00195676|19661424|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
5704489|NCT00195676|19661424|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
5704490|NCT00195676|19661424|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
5704491|NCT00195676|19661424|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
5704492|NCT00195676|19661424|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
5704493|NCT00195676|19661424|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
5704494|NCT00195676|19661424|P1|Period W (Withdrawal) - No Treatment|Death|2
5704495|NCT00195676|19661424|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
5704496|NCT00195676|19661424|P1|Period O - Open-label Treatment|Other reasons|68
5704497|NCT00195676|19661424|P1|Period O - Open-label Treatment|Administrative reasons|2
5704498|NCT00195676|19661424|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
5704499|NCT00195676|19661424|P1|Period O - Open-label Treatment|Protocol Violation|12
5704500|NCT00195676|19661424|P1|Period O - Open-label Treatment|Lost to Follow-up|91
5704501|NCT00195676|19661424|P1|Period O - Open-label Treatment|Lack of Efficacy|198
5704502|NCT00195676|19661424|P1|Period O - Open-label Treatment|Death|6
5704503|NCT00195676|19661424|P1|Period O - Open-label Treatment|Adverse Event|82
5704504|NCT00195663|19661438|P3|Open-Label Extension Period|Administrative reasons|13
5704505|NCT00195663|19661439|P2|Open-Label Extension Period|Administrative reasons|11
5704506|NCT00195663|19661440|P1|Open-Label Extension Period|Administrative reasons|11
5704507|NCT00195663|19661438|P3|Open-Label Extension Period|Lack of Efficacy|12
5704508|NCT00195663|19661439|P2|Open-Label Extension Period|Lack of Efficacy|6
5704509|NCT00195663|19661440|P1|Open-Label Extension Period|Lack of Efficacy|14
5704510|NCT00195663|19661438|P3|Open-Label Extension Period|Withdrawal by Subject|22
5704511|NCT00195663|19661439|P2|Open-Label Extension Period|Withdrawal by Subject|15
5704512|NCT00195663|19661440|P1|Open-Label Extension Period|Withdrawal by Subject|16
5704513|NCT00195663|19661438|P3|Open-Label Extension Period|Death|2
5704514|NCT00195663|19661439|P2|Open-Label Extension Period|Death|2
5704515|NCT00195663|19661440|P1|Open-Label Extension Period|Death|2
5704516|NCT00195663|19661438|P3|Open-Label Extension Period|Protocol Violation|4
5704517|NCT00195663|19661439|P2|Open-Label Extension Period|Protocol Violation|4
5704518|NCT00195663|19661440|P1|Open-Label Extension Period|Protocol Violation|3
5704519|NCT00195663|19661438|P3|Open-Label Extension Period|Recovery|2
5704520|NCT00195663|19661439|P2|Open-Label Extension Period|Recovery|2
5704521|NCT00195663|19661440|P1|Open-Label Extension Period|Recovery|0
5704522|NCT00195663|19661438|P3|Open-Label Extension Period|Lost to Follow-up|6
5704523|NCT00195663|19661439|P2|Open-Label Extension Period|Lost to Follow-up|2
5704524|NCT00195663|19661440|P1|Open-Label Extension Period|Lost to Follow-up|9
5704525|NCT00195663|19661438|P3|Open-Label Extension Period|Adverse Event|36
5704526|NCT00195663|19661439|P2|Open-Label Extension Period|Adverse Event|32
5704527|NCT00195663|19661440|P1|Open-Label Extension Period|Adverse Event|21
5704528|NCT00195663|19661438|P3|2-year Double-blind Treatment Period|Administrative reasons|9
5704529|NCT00195663|19661439|P2|2-year Double-blind Treatment Period|Administrative reasons|2
5704530|NCT00195663|19661440|P1|2-year Double-blind Treatment Period|Administrative reasons|3
5704531|NCT00195663|19661438|P3|2-year Double-blind Treatment Period|Recovery|1
5704532|NCT00195663|19661439|P2|2-year Double-blind Treatment Period|Recovery|0
5704533|NCT00195663|19661440|P1|2-year Double-blind Treatment Period|Recovery|1
5704534|NCT00195663|19661438|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
5704535|NCT00195663|19661439|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
5704536|NCT00195663|19661440|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
5704537|NCT00195663|19661438|P3|2-year Double-blind Treatment Period|Protocol Violation|4
5704538|NCT00195663|19661439|P2|2-year Double-blind Treatment Period|Protocol Violation|6
5704539|NCT00195663|19661440|P1|2-year Double-blind Treatment Period|Protocol Violation|6
5704540|NCT00195663|19661438|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
5704541|NCT00195663|19661439|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
5704542|NCT00195663|19661440|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
5704543|NCT00195663|19661438|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
5704544|NCT00195663|19661439|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
5704545|NCT00195663|19661440|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
5704546|NCT00195663|19661438|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
5704547|NCT00195663|19661439|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
5704548|NCT00195663|19661440|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
5704549|NCT00195663|19661438|P3|2-year Double-blind Treatment Period|Death|0
5704550|NCT00195663|19661439|P2|2-year Double-blind Treatment Period|Death|2
5704551|NCT00195663|19661440|P1|2-year Double-blind Treatment Period|Death|0
5704552|NCT00195663|19661438|P3|2-year Double-blind Treatment Period|Adverse Event|32
5704553|NCT00195663|19661439|P2|2-year Double-blind Treatment Period|Adverse Event|27
5704554|NCT00195663|19661440|P1|2-year Double-blind Treatment Period|Adverse Event|21
5704555|NCT00195650|19661534|P1|Overall Study|Administrative reasons|83
5704556|NCT00195650|19661534|P1|Overall Study|Protocol Violation|15
5704557|NCT00195650|19661534|P1|Overall Study|Death|23
5704558|NCT00195650|19661534|P1|Overall Study|Lost to Follow-up|44
5704559|NCT00195650|19661534|P1|Overall Study|Withdrawal by Subject|67
5704560|NCT00195650|19661534|P1|Overall Study|Lack of Efficacy|99
5704561|NCT00195650|19661534|P1|Overall Study|Adverse Event|194
5704562|NCT00195507|19661559|P2|Overall Study|Protocol Deviation|3
5704563|NCT00195507|19661560|P1|Overall Study|Protocol Deviation|6
5704564|NCT00195507|19661559|P2|Overall Study|Withdrawal by Subject|23
5704565|NCT00195507|19661560|P1|Overall Study|Withdrawal by Subject|16
5704566|NCT00195507|19661559|P2|Overall Study|Lack of Efficacy|67
5704567|NCT00195507|19661560|P1|Overall Study|Lack of Efficacy|40
5704568|NCT00195507|19661559|P2|Overall Study|Protocol Violation|4
5704569|NCT00195507|19661560|P1|Overall Study|Protocol Violation|5
5704570|NCT00195507|19661559|P2|Overall Study|Lost to Follow-up|2
5704571|NCT00195507|19661560|P1|Overall Study|Lost to Follow-up|3
5704572|NCT00195507|19661559|P2|Overall Study|Physician Decision|2
5704573|NCT00195507|19661560|P1|Overall Study|Physician Decision|1
5704574|NCT00195507|19661559|P2|Overall Study|Failed to Return|3
5704575|NCT00195507|19661560|P1|Overall Study|Failed to Return|4
5704576|NCT00195507|19661559|P2|Overall Study|Death|1
5704577|NCT00195507|19661560|P1|Overall Study|Death|0
5704578|NCT00195507|19661559|P2|Overall Study|Adverse Event|13
5704579|NCT00195507|19661560|P1|Overall Study|Adverse Event|24
5704580|NCT00195494|19661574|P6|Year 2|System toxicity|0
5704581|NCT00195494|19661575|P5|Year 2|System toxicity|0
5704582|NCT00195494|19661576|P4|Year 2|System toxicity|1
5704583|NCT00195494|19661577|P3|Year 2|System toxicity|0
5704584|NCT00195494|19661578|P2|Year 2|System toxicity|0
5704585|NCT00195494|19661579|P1|Year 2|System toxicity|0
5704586|NCT00195494|19661574|P6|Year 2|Withdrawal by Subject|0
5704587|NCT00195494|19661575|P5|Year 2|Withdrawal by Subject|0
5704588|NCT00195494|19661576|P4|Year 2|Withdrawal by Subject|3
5704589|NCT00195494|19661577|P3|Year 2|Withdrawal by Subject|4
5704590|NCT00195494|19661578|P2|Year 2|Withdrawal by Subject|5
5704591|NCT00195494|19661579|P1|Year 2|Withdrawal by Subject|1
5704592|NCT00195494|19661574|P6|Year 2|Physician Decision|0
5704593|NCT00195494|19661575|P5|Year 2|Physician Decision|0
5704594|NCT00195494|19661576|P4|Year 2|Physician Decision|0
5704595|NCT00195494|19661577|P3|Year 2|Physician Decision|0
5704596|NCT00195494|19661578|P2|Year 2|Physician Decision|1
5704597|NCT00195494|19661579|P1|Year 2|Physician Decision|1
5704598|NCT00195494|19661574|P6|Year 2|Protocol deviation|0
5704599|NCT00195494|19661575|P5|Year 2|Protocol deviation|0
5704600|NCT00195494|19661576|P4|Year 2|Protocol deviation|0
5704601|NCT00195494|19661577|P3|Year 2|Protocol deviation|0
5704602|NCT00195494|19661578|P2|Year 2|Protocol deviation|1
5704603|NCT00195494|19661579|P1|Year 2|Protocol deviation|0
5704604|NCT00195494|19661574|P6|Year 2|Missed >4 consecutive doses|0
5704605|NCT00195494|19661575|P5|Year 2|Missed >4 consecutive doses|0
5704606|NCT00195494|19661576|P4|Year 2|Missed >4 consecutive doses|0
5704607|NCT00195494|19661577|P3|Year 2|Missed >4 consecutive doses|1
5704608|NCT00195494|19661578|P2|Year 2|Missed >4 consecutive doses|1
5704609|NCT00195494|19661579|P1|Year 2|Missed >4 consecutive doses|1
5704610|NCT00195494|19661574|P6|Year 2|Lost to Follow-up|0
5704611|NCT00195494|19661575|P5|Year 2|Lost to Follow-up|0
5704612|NCT00195494|19661576|P4|Year 2|Lost to Follow-up|1
5704613|NCT00195494|19661577|P3|Year 2|Lost to Follow-up|1
5704614|NCT00195494|19661578|P2|Year 2|Lost to Follow-up|0
5704615|NCT00195494|19661579|P1|Year 2|Lost to Follow-up|0
5704616|NCT00195494|19661574|P6|Year 2|Compliance|0
5704617|NCT00195494|19661575|P5|Year 2|Compliance|0
5704618|NCT00195494|19661576|P4|Year 2|Compliance|2
5704619|NCT00195494|19661577|P3|Year 2|Compliance|0
5704620|NCT00195494|19661578|P2|Year 2|Compliance|0
5704621|NCT00195494|19661579|P1|Year 2|Compliance|1
5704622|NCT00195494|19661574|P6|Year 2|Lack of Efficacy|0
5704623|NCT00195494|19661575|P5|Year 2|Lack of Efficacy|0
5704624|NCT00195494|19661576|P4|Year 2|Lack of Efficacy|7
5704625|NCT00195494|19661577|P3|Year 2|Lack of Efficacy|7
5704626|NCT00195494|19661578|P2|Year 2|Lack of Efficacy|1
5704627|NCT00195494|19661579|P1|Year 2|Lack of Efficacy|0
5704628|NCT00195494|19661574|P6|Year 2|Adverse Event|0
5704629|NCT00195494|19661575|P5|Year 2|Adverse Event|0
5704630|NCT00195494|19661576|P4|Year 2|Adverse Event|9
5704631|NCT00195494|19661577|P3|Year 2|Adverse Event|5
5704632|NCT00195494|19661578|P2|Year 2|Adverse Event|7
5704633|NCT00195494|19661579|P1|Year 2|Adverse Event|3
5704634|NCT00195494|19661574|P6|Year 1|Protocol Violation|1
5704635|NCT00195494|19661575|P5|Year 1|Protocol Violation|1
5704636|NCT00195494|19661576|P4|Year 1|Protocol Violation|0
5704637|NCT00195494|19661577|P3|Year 1|Protocol Violation|0
5704638|NCT00195494|19661578|P2|Year 1|Protocol Violation|0
5704639|NCT00195494|19661579|P1|Year 1|Protocol Violation|0
5704640|NCT00195494|19661574|P6|Year 1|Withdrawal by Subject|9
5704641|NCT00195494|19661575|P5|Year 1|Withdrawal by Subject|8
5704642|NCT00195494|19661576|P4|Year 1|Withdrawal by Subject|0
5704643|NCT00195494|19661577|P3|Year 1|Withdrawal by Subject|0
5704644|NCT00195494|19661578|P2|Year 1|Withdrawal by Subject|0
5704645|NCT00195494|19661579|P1|Year 1|Withdrawal by Subject|0
5704646|NCT00195494|19661574|P6|Year 1|Physician Decision|0
5704647|NCT00195494|19661575|P5|Year 1|Physician Decision|1
5704648|NCT00195494|19661576|P4|Year 1|Physician Decision|0
5704649|NCT00195494|19661577|P3|Year 1|Physician Decision|0
5704650|NCT00195494|19661578|P2|Year 1|Physician Decision|0
5704651|NCT00195494|19661579|P1|Year 1|Physician Decision|0
5704652|NCT00195494|19661574|P6|Year 1|Protocol deviation|3
5704653|NCT00195494|19661575|P5|Year 1|Protocol deviation|2
5704654|NCT00195494|19661576|P4|Year 1|Protocol deviation|0
5704655|NCT00195494|19661577|P3|Year 1|Protocol deviation|0
5704656|NCT00195494|19661578|P2|Year 1|Protocol deviation|0
5704657|NCT00195494|19661579|P1|Year 1|Protocol deviation|0
5704658|NCT00195494|19661574|P6|Year 1|Missed >4 consecutive doses|2
5704659|NCT00195494|19661575|P5|Year 1|Missed >4 consecutive doses|3
5704660|NCT00195494|19661576|P4|Year 1|Missed >4 consecutive doses|0
5704661|NCT00195494|19661577|P3|Year 1|Missed >4 consecutive doses|0
5704662|NCT00195494|19661578|P2|Year 1|Missed >4 consecutive doses|0
5704663|NCT00195494|19661579|P1|Year 1|Missed >4 consecutive doses|0
5704664|NCT00195494|19661574|P6|Year 1|Lost to Follow-up|0
5704665|NCT00195494|19661575|P5|Year 1|Lost to Follow-up|1
5704666|NCT00195494|19661576|P4|Year 1|Lost to Follow-up|0
5704667|NCT00195494|19661577|P3|Year 1|Lost to Follow-up|0
5704668|NCT00195494|19661578|P2|Year 1|Lost to Follow-up|0
5704669|NCT00195494|19661579|P1|Year 1|Lost to Follow-up|0
5704670|NCT00195494|19661574|P6|Year 1|Compliance|1
5704671|NCT00195494|19661575|P5|Year 1|Compliance|5
5704672|NCT00195494|19661576|P4|Year 1|Compliance|0
5704673|NCT00195494|19661577|P3|Year 1|Compliance|0
5704674|NCT00195494|19661578|P2|Year 1|Compliance|0
5704675|NCT00195494|19661579|P1|Year 1|Compliance|0
5704676|NCT00195494|19661574|P6|Year 1|Lack of Efficacy|9
5704677|NCT00195494|19661575|P5|Year 1|Lack of Efficacy|24
5704678|NCT00195494|19661576|P4|Year 1|Lack of Efficacy|0
5704679|NCT00195494|19661577|P3|Year 1|Lack of Efficacy|0
5704680|NCT00195494|19661578|P2|Year 1|Lack of Efficacy|0
5704681|NCT00195494|19661579|P1|Year 1|Lack of Efficacy|0
5704682|NCT00195494|19661574|P6|Year 1|System Toxicity|1
5704683|NCT00195494|19661575|P5|Year 1|System Toxicity|0
5704684|NCT00195494|19661576|P4|Year 1|System Toxicity|0
5704685|NCT00195494|19661577|P3|Year 1|System Toxicity|0
5704686|NCT00195494|19661578|P2|Year 1|System Toxicity|0
5704687|NCT00195494|19661579|P1|Year 1|System Toxicity|0
5704688|NCT00195494|19661574|P6|Year 1|Adverse Event|27
5704689|NCT00195494|19661575|P5|Year 1|Adverse Event|34
5704690|NCT00195494|19661576|P4|Year 1|Adverse Event|0
5704691|NCT00195494|19661577|P3|Year 1|Adverse Event|0
5704692|NCT00195494|19661578|P2|Year 1|Adverse Event|0
5704693|NCT00195494|19661579|P1|Year 1|Adverse Event|0
5704694|NCT00195442|19661597|P1|Overall Study|Other|14
5704695|NCT00195442|19661597|P1|Overall Study|Poor cooperation|2
5704696|NCT00195442|19661597|P1|Overall Study|No reason specified|4
5704697|NCT00195442|19661597|P1|Overall Study|Death|7
5704698|NCT00195442|19661597|P1|Overall Study|Intermittent product shortage|21
5704699|NCT00195442|19661597|P1|Overall Study|Switch to other Factor VIII preparation|23
5704700|NCT00195442|19661597|P1|Overall Study|Lost to Follow-up|27
5704701|NCT00195442|19661597|P1|Overall Study|Less than expected therapeutic effect|38
5704702|NCT00195429|19661616|P2|Overall Study|Lost to Follow-up|0
5704703|NCT00195429|19661617|P1|Overall Study|Lost to Follow-up|1
5704704|NCT00195429|19661616|P2|Overall Study|Lack of Efficacy|1
5704705|NCT00195429|19661617|P1|Overall Study|Lack of Efficacy|2
5704706|NCT00195429|19661616|P2|Overall Study|Adverse Event|4
5704707|NCT00195429|19661617|P1|Overall Study|Adverse Event|2
5704708|NCT00195351|19661633|P2|Overall Study|Lack of Efficacy|1
5704709|NCT00195351|19661634|P1|Overall Study|Lack of Efficacy|0
5704710|NCT00195351|19661633|P2|Overall Study|Death|1
5704711|NCT00195351|19661634|P1|Overall Study|Death|3
5704712|NCT00195351|19661633|P2|Overall Study|Protocol Deviation|2
5704713|NCT00195351|19661634|P1|Overall Study|Protocol Deviation|3
5704714|NCT00195351|19661633|P2|Overall Study|Withdrawal by Subject|3
5704715|NCT00195351|19661634|P1|Overall Study|Withdrawal by Subject|6
5704716|NCT00195351|19661633|P2|Overall Study|Lost to Follow-up|9
5704717|NCT00195351|19661634|P1|Overall Study|Lost to Follow-up|9
5704718|NCT00195338|19661644|P1|Overall Study|Early closure of the site|4
5704719|NCT00195338|19661644|P1|Overall Study|Lack of Efficacy|1
5704720|NCT00195338|19661644|P1|Overall Study|Adverse Event|5
5704721|NCT00195338|19661644|P1|Overall Study|Lost to Follow-up|2
5704722|NCT00195273|19661654|P2|Overall Study|Procedural complications|3
5704723|NCT00195273|19661655|P1|Overall Study|Procedural complications|9
5704724|NCT00195273|19661654|P2|Overall Study|Lack of Efficacy|1
5704725|NCT00195273|19661655|P1|Overall Study|Lack of Efficacy|3
5704726|NCT00195273|19661654|P2|Overall Study|Protocol deviation|1
5704727|NCT00195273|19661655|P1|Overall Study|Protocol deviation|0
5704728|NCT00195273|19661654|P2|Overall Study|Adverse Event|9
5704729|NCT00195273|19661655|P1|Overall Study|Adverse Event|9
5704730|NCT00195260|19661669|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
5704731|NCT00195260|19661670|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
5704732|NCT00195260|19661671|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
5704733|NCT00195260|19661672|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5704734|NCT00195260|19661673|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5704735|NCT00195260|19661674|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5704736|NCT00195260|19661675|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5704737|NCT00195260|19661676|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5704738|NCT00195260|19661677|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5704739|NCT00195260|19661678|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5704740|NCT00195260|19661679|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
5704741|NCT00195260|19661669|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
5704742|NCT00195260|19661670|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
5704743|NCT00195260|19661671|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
5704744|NCT00195260|19661672|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5704745|NCT00195260|19661673|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5704746|NCT00195260|19661674|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5704747|NCT00195260|19661675|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5704748|NCT00195260|19661676|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5704749|NCT00195260|19661677|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5704750|NCT00195260|19661678|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5704751|NCT00195260|19661679|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
5704752|NCT00195260|19661669|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
5704753|NCT00195260|19661670|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
5704754|NCT00195260|19661671|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
5704755|NCT00195260|19661672|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5704756|NCT00195260|19661673|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5704757|NCT00195260|19661674|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5704758|NCT00195260|19661675|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5704759|NCT00195260|19661676|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5704760|NCT00195260|19661677|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5704761|NCT00195260|19661678|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5704762|NCT00195260|19661679|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
5704763|NCT00195260|19661669|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
5704764|NCT00195260|19661670|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
5704765|NCT00195260|19661671|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
5704766|NCT00195260|19661672|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5704767|NCT00195260|19661673|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5704768|NCT00195260|19661674|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5704769|NCT00195260|19661675|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5704770|NCT00195260|19661676|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5704771|NCT00195260|19661677|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5704772|NCT00195260|19661678|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5704773|NCT00195260|19661679|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
5704774|NCT00195260|19661669|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
5704775|NCT00195260|19661670|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
5704776|NCT00195260|19661671|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
5704777|NCT00195260|19661672|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
5704778|NCT00195260|19661673|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
5704779|NCT00195260|19661674|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
5704780|NCT00195260|19661675|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
5704781|NCT00195260|19661676|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
5704782|NCT00195260|19661677|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
5704783|NCT00195260|19661678|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
5704784|NCT00195260|19661679|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
5704785|NCT00195260|19661669|P11|Part 1: Dose Escalation|Disease Progression|0
5704786|NCT00195260|19661670|P10|Part 1: Dose Escalation|Disease Progression|0
5704787|NCT00195260|19661671|P9|Part 1: Dose Escalation|Disease Progression|0
5704788|NCT00195260|19661672|P8|Part 1: Dose Escalation|Disease Progression|4
5704789|NCT00195260|19661673|P7|Part 1: Dose Escalation|Disease Progression|7
5704790|NCT00195260|19661674|P6|Part 1: Dose Escalation|Disease Progression|6
5704791|NCT00195260|19661675|P5|Part 1: Dose Escalation|Disease Progression|4
5704792|NCT00195260|19661676|P4|Part 1: Dose Escalation|Disease Progression|6
5704793|NCT00195260|19661677|P3|Part 1: Dose Escalation|Disease Progression|5
5704794|NCT00195260|19661678|P2|Part 1: Dose Escalation|Disease Progression|2
5704795|NCT00195260|19661679|P1|Part 1: Dose Escalation|Disease Progression|3
5704796|NCT00195260|19661669|P11|Part 1: Dose Escalation|Death|0
5704797|NCT00195260|19661670|P10|Part 1: Dose Escalation|Death|0
5704798|NCT00195260|19661671|P9|Part 1: Dose Escalation|Death|0
5704799|NCT00195260|19661672|P8|Part 1: Dose Escalation|Death|1
5704800|NCT00195260|19661673|P7|Part 1: Dose Escalation|Death|0
5704801|NCT00195260|19661674|P6|Part 1: Dose Escalation|Death|0
5704802|NCT00195260|19661675|P5|Part 1: Dose Escalation|Death|0
5704803|NCT00195260|19661676|P4|Part 1: Dose Escalation|Death|0
5704804|NCT00195260|19661677|P3|Part 1: Dose Escalation|Death|0
5704805|NCT00195260|19661678|P2|Part 1: Dose Escalation|Death|0
5704806|NCT00195260|19661679|P1|Part 1: Dose Escalation|Death|0
5704807|NCT00195260|19661669|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
5704808|NCT00195260|19661670|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
5704809|NCT00195260|19661671|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
5704810|NCT00195260|19661672|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
5704811|NCT00195260|19661673|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
5704812|NCT00195260|19661674|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
5704813|NCT00195260|19661675|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
5704814|NCT00195260|19661676|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
5704815|NCT00195260|19661677|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
5704816|NCT00195260|19661678|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
5704817|NCT00195260|19661679|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
5704818|NCT00195260|19661669|P11|Part 1: Dose Escalation|Adverse Event|0
5704819|NCT00195260|19661670|P10|Part 1: Dose Escalation|Adverse Event|0
5704820|NCT00195260|19661671|P9|Part 1: Dose Escalation|Adverse Event|0
5704821|NCT00195260|19661672|P8|Part 1: Dose Escalation|Adverse Event|0
5704822|NCT00195260|19661673|P7|Part 1: Dose Escalation|Adverse Event|3
5704823|NCT00195260|19661674|P6|Part 1: Dose Escalation|Adverse Event|0
5704824|NCT00195260|19661675|P5|Part 1: Dose Escalation|Adverse Event|1
5704825|NCT00195260|19661676|P4|Part 1: Dose Escalation|Adverse Event|1
5704826|NCT00195260|19661677|P3|Part 1: Dose Escalation|Adverse Event|0
5704827|NCT00195260|19661678|P2|Part 1: Dose Escalation|Adverse Event|1
5704828|NCT00195260|19661679|P1|Part 1: Dose Escalation|Adverse Event|0
5704829|NCT00194987|19661847|P2|Overall Study|Withdrawal by Subject|3
5704830|NCT00194987|19661848|P1|Overall Study|Withdrawal by Subject|0
5704831|NCT00194792|19661881|P1|Overall Study|Withdrawal by Subject|1
5704832|NCT00194675|19661905|P2|Overall Study|Death|0
5704833|NCT00194675|19661906|P1|Overall Study|Death|1
5704834|NCT00194675|19661905|P2|Overall Study|Protocol Violation|0
5704835|NCT00194675|19661906|P1|Overall Study|Protocol Violation|1
5704836|NCT00194675|19661905|P2|Overall Study|"withdrew due to edgy feeling"|0
5704837|NCT00194675|19661906|P1|Overall Study|"withdrew due to edgy feeling"|1
5704838|NCT00194675|19661905|P2|Overall Study|lack of interest|1
5704839|NCT00194675|19661906|P1|Overall Study|lack of interest|1
5704840|NCT00194675|19661905|P2|Overall Study|Lost to Follow-up|1
5704841|NCT00194675|19661906|P1|Overall Study|Lost to Follow-up|1
5704842|NCT00194077|19661981|P2|Overall Study|Withdrawal by Subject|1
5704843|NCT00194077|19661982|P1|Overall Study|Withdrawal by Subject|1
5704844|NCT00194077|19661981|P2|Overall Study|Study nonadherence|0
5704845|NCT00194077|19661982|P1|Overall Study|Study nonadherence|1
5704846|NCT00194077|19661981|P2|Overall Study|Lack of Efficacy|29
5704847|NCT00194077|19661982|P1|Overall Study|Lack of Efficacy|22
5704848|NCT00194025|19661988|P1|Overall Study|non-adherence with study medication|4
5704849|NCT00194025|19661988|P1|Overall Study|Adverse Event|1
5704850|NCT00194012|19662003|P2|Open Label Extension (OLE)|Lack of Efficacy|0
5704851|NCT00194012|19662004|P1|Open Label Extension (OLE)|Lack of Efficacy|1
5704852|NCT00194012|19662003|P2|Open Label Extension (OLE)|Lost to Follow-up|5
5704853|NCT00194012|19662004|P1|Open Label Extension (OLE)|Lost to Follow-up|3
5704854|NCT00194012|19662003|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
5704855|NCT00194012|19662004|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
5704856|NCT00194012|19662003|P2|Open Label Extension (OLE)|Weight Gain|0
5704857|NCT00194012|19662004|P1|Open Label Extension (OLE)|Weight Gain|1
5704858|NCT00194012|19662003|P2|Randomized Phase|Oral/nasal twitching|1
5704859|NCT00194012|19662004|P1|Randomized Phase|Oral/nasal twitching|0
5704860|NCT00194012|19662003|P2|Randomized Phase|Emesis and enuresis|1
5704861|NCT00194012|19662004|P1|Randomized Phase|Emesis and enuresis|0
5704862|NCT00194012|19662003|P2|Randomized Phase|Participant reported having a rash|0
5704863|NCT00194012|19662004|P1|Randomized Phase|Participant reported having a rash|1
5704864|NCT00194012|19662003|P2|Randomized Phase|Adverse Event|1
5704865|NCT00194012|19662004|P1|Randomized Phase|Adverse Event|2
5704866|NCT00194012|19662003|P2|Randomized Phase|Withdrawal by Subject|3
5704867|NCT00194012|19662004|P1|Randomized Phase|Withdrawal by Subject|3
5704868|NCT00194012|19662003|P2|Randomized Phase|Study nonadherence|1
5704869|NCT00194012|19662004|P1|Randomized Phase|Study nonadherence|2
5704870|NCT00194012|19662003|P2|Randomized Phase|Lack of Efficacy|18
5704871|NCT00194012|19662004|P1|Randomized Phase|Lack of Efficacy|8
5704872|NCT00193609|19662040|P1|Overall Study|Adverse Event|2
5704873|NCT00193609|19662040|P1|Overall Study|Lack of Efficacy|2
5704874|NCT00193479|19662067|P1|Induction Chemotherapy|Disease Progression|1
5704875|NCT00193479|19662067|P1|Induction Chemotherapy|Adverse Event|2
5704876|NCT00193206|19662108|P1|Postoperative Therapy|Protocol Violation|1
5704877|NCT00193206|19662108|P1|Postoperative Therapy|Lack of Efficacy|1
5704878|NCT00193206|19662108|P1|Postoperative Therapy|Intercurrent Illness|2
5704879|NCT00193206|19662108|P1|Postoperative Therapy|Physician Decision|3
5704880|NCT00193206|19662108|P1|Postoperative Therapy|Withdrawal by Subject|7
5704881|NCT00193206|19662108|P1|Preoperative Therapy|False Positive Pregnancy Test|1
5704882|NCT00193206|19662108|P1|Preoperative Therapy|Withdrawal by Subject|2
5704883|NCT00193206|19662108|P1|Preoperative Therapy|Adverse Event|2
5704884|NCT00193206|19662108|P1|Preoperative Therapy|Lack of Efficacy|2
5704885|NCT00193180|19662112|P1|Overall Study|Protocol Violation|1
5704886|NCT00193180|19662112|P1|Overall Study|Adverse Event|8
5704887|NCT00193180|19662112|P1|Overall Study|Lack of Efficacy|1
5704888|NCT00193063|19662127|P1|Overall Study|Adverse Event|1
5704889|NCT00193063|19662127|P1|Overall Study|Lack of Efficacy|3
5704890|NCT00193050|19662133|P1|Adjuvant|Lack of Efficacy|2
5704891|NCT00193050|19662133|P1|Adjuvant|Intercurrent Hospitalization|3
5704892|NCT00193050|19662133|P1|Adjuvant|Physician Decision|5
5704893|NCT00193050|19662133|P1|Neoadjuvant Treatment|Adverse Event|2
5704894|NCT00193050|19662133|P1|Neoadjuvant Treatment|Physician Decision|2
5704895|NCT00193050|19662133|P1|Neoadjuvant Treatment|Intercurrent Illness|3
5704896|NCT00193050|19662133|P1|Neoadjuvant Treatment|Lack of Efficacy|2
5704897|NCT00192647|19662150|P2|Overall Study|Other/Administrative|3
5704898|NCT00192647|19662151|P1|Overall Study|Other/Administrative|5
5704899|NCT00192647|19662150|P2|Overall Study|Failure to Return|13
5704900|NCT00192647|19662151|P1|Overall Study|Failure to Return|11
5704901|NCT00192647|19662150|P2|Overall Study|Refused Treatment/Did not Cooperate|8
5704902|NCT00192647|19662151|P1|Overall Study|Refused Treatment/Did not Cooperate|10
5704903|NCT00192647|19662150|P2|Overall Study|Protocol Violation|1
5704904|NCT00192647|19662151|P1|Overall Study|Protocol Violation|3
5704905|NCT00192647|19662150|P2|Overall Study|Entry Criteria Violation|6
5704906|NCT00192647|19662151|P1|Overall Study|Entry Criteria Violation|6
5704907|NCT00192647|19662150|P2|Overall Study|Insufficient Therapeutic Response|83
5704908|NCT00192647|19662151|P1|Overall Study|Insufficient Therapeutic Response|53
5704909|NCT00192647|19662150|P2|Overall Study|Laboratory Test Abnormality|2
5704910|NCT00192647|19662151|P1|Overall Study|Laboratory Test Abnormality|4
5704911|NCT00192647|19662150|P2|Overall Study|Adverse Event|29
5704912|NCT00192647|19662151|P1|Overall Study|Adverse Event|35
5704913|NCT00192647|19662150|P2|Overall Study|Death|1
5704914|NCT00192647|19662151|P1|Overall Study|Death|1
5704915|NCT00192296|19662171|P4|Overall Study|Withdrawal by Subject|0
5704916|NCT00192296|19662172|P3|Overall Study|Withdrawal by Subject|0
5704917|NCT00192296|19662173|P2|Overall Study|Withdrawal by Subject|1
5704918|NCT00192296|19662174|P1|Overall Study|Withdrawal by Subject|0
5704919|NCT00192114|19662228|P1|Overall Study|Death|1
5704920|NCT00192114|19662228|P1|Overall Study|Clinical Progression|2
5704921|NCT00192114|19662228|P1|Overall Study|Adverse Event|2
5704922|NCT00192114|19662228|P1|Overall Study|Objective Tumor Progression|19
5704923|NCT00192075|19662245|P2|Overall Study|Other|2
5704924|NCT00192075|19662246|P1|Overall Study|Other|5
5704925|NCT00192075|19662245|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
5704926|NCT00192075|19662246|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
5704927|NCT00192075|19662245|P2|Overall Study|Patient Non-Compliance|1
5704928|NCT00192075|19662246|P1|Overall Study|Patient Non-Compliance|0
5704929|NCT00192075|19662245|P2|Overall Study|Withdrawal by Subject|5
5704930|NCT00192075|19662246|P1|Overall Study|Withdrawal by Subject|5
5704931|NCT00192075|19662245|P2|Overall Study|Physician Decision|0
5704932|NCT00192075|19662246|P1|Overall Study|Physician Decision|3
5704933|NCT00192075|19662245|P2|Overall Study|Lack of Efficacy|0
5704934|NCT00192075|19662246|P1|Overall Study|Lack of Efficacy|0
5704935|NCT00192075|19662245|P2|Overall Study|Death|1
5704936|NCT00192075|19662246|P1|Overall Study|Death|0
5704937|NCT00192075|19662245|P2|Overall Study|Adverse Event|3
5704938|NCT00192075|19662246|P1|Overall Study|Adverse Event|1
5704939|NCT00192075|19662245|P2|Overall Study|Disease Progression|6
5704940|NCT00192075|19662246|P1|Overall Study|Disease Progression|23
5704941|NCT00192036|19662271|P1|Overall Study|Unknown or Not Specified|5
5704942|NCT00192036|19662271|P1|Overall Study|Death|1
5704943|NCT00192036|19662271|P1|Overall Study|Clinical Disease Progression|1
5704944|NCT00192036|19662271|P1|Overall Study|Objective Tumor Progression|4
5704945|NCT00192036|19662271|P1|Overall Study|Patient/Physician Perception|1
5704946|NCT00192036|19662271|P1|Overall Study|Adverse Event|6
5704947|NCT00192036|19662271|P1|Overall Study|Protocol Violation|3
5704948|NCT00192023|19662281|P2|Period IV - Optional Open-Label|Physician Decision|0
5704949|NCT00192023|19662282|P1|Period IV - Optional Open-Label|Physician Decision|9
5704950|NCT00192023|19662281|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
5704951|NCT00192023|19662282|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
5704952|NCT00192023|19662281|P2|Period IV - Optional Open-Label|Protocol Violation|0
5704953|NCT00192023|19662282|P1|Period IV - Optional Open-Label|Protocol Violation|1
5704954|NCT00192023|19662281|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
5704955|NCT00192023|19662282|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
5704956|NCT00192023|19662281|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
5704957|NCT00192023|19662282|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
5704958|NCT00192023|19662281|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
5704959|NCT00192023|19662282|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
5704960|NCT00192023|19662281|P2|Period IV - Optional Open-Label|Adverse Event|0
5704961|NCT00192023|19662282|P1|Period IV - Optional Open-Label|Adverse Event|6
5704962|NCT00192023|19662281|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
5704963|NCT00192023|19662282|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
5704964|NCT00192023|19662281|P2|Period III - Double-Blind|Physician Decision|0
5704965|NCT00192023|19662282|P1|Period III - Double-Blind|Physician Decision|2
5704966|NCT00192023|19662281|P2|Period III - Double-Blind|Adverse Event|0
5704967|NCT00192023|19662282|P1|Period III - Double-Blind|Adverse Event|3
5704968|NCT00191984|19662304|P1|Overall Study|Physician Decision|4
5704969|NCT00191984|19662304|P1|Overall Study|Withdrawal by Subject|7
5704970|NCT00191984|19662304|P1|Overall Study|Entry Criteria Exclusion|1
5704971|NCT00191984|19662304|P1|Overall Study|Death|2
5704972|NCT00191984|19662304|P1|Overall Study|Adverse Event|4
5704973|NCT00191984|19662304|P1|Overall Study|Disease Progression|21
5704974|NCT00191945|19662314|P2|Double-Blind Acute Treatment|Physician Decision|2
5704975|NCT00191945|19662315|P1|Double-Blind Acute Treatment|Physician Decision|0
5704976|NCT00191945|19662314|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
5704977|NCT00191945|19662315|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
5704978|NCT00191945|19662314|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
5704979|NCT00191945|19662315|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
5704980|NCT00191945|19662314|P2|Double-Blind Acute Treatment|Parent's Decision|0
5704981|NCT00191945|19662315|P1|Double-Blind Acute Treatment|Parent's Decision|3
5704982|NCT00191906|19662351|P4|Study Period III|Lack of Efficacy|0
5704983|NCT00191906|19662352|P3|Study Period III|Lack of Efficacy|0
5704984|NCT00191906|19662353|P2|Study Period III|Lack of Efficacy|3
5704985|NCT00191906|19662354|P1|Study Period III|Lack of Efficacy|3
5704986|NCT00191906|19662351|P4|Study Period III|Parent/Caregiver Decision|0
5704987|NCT00191906|19662352|P3|Study Period III|Parent/Caregiver Decision|0
5704988|NCT00191906|19662353|P2|Study Period III|Parent/Caregiver Decision|0
5704989|NCT00191906|19662354|P1|Study Period III|Parent/Caregiver Decision|1
5704990|NCT00191906|19662351|P4|Study Period III|Lost to Follow-up|0
5704991|NCT00191906|19662352|P3|Study Period III|Lost to Follow-up|0
5704992|NCT00191906|19662353|P2|Study Period III|Lost to Follow-up|1
5704993|NCT00191906|19662354|P1|Study Period III|Lost to Follow-up|0
5704994|NCT00191906|19662351|P4|Study Period III|Adverse Event|0
5704995|NCT00191906|19662352|P3|Study Period III|Adverse Event|0
5704996|NCT00191906|19662353|P2|Study Period III|Adverse Event|0
5704997|NCT00191906|19662354|P1|Study Period III|Adverse Event|1
5704998|NCT00191906|19662351|P4|Study Period II|Entry Criteria Exclusion|0
5704999|NCT00191906|19662352|P3|Study Period II|Entry Criteria Exclusion|1
5705000|NCT00191906|19662353|P2|Study Period II|Entry Criteria Exclusion|0
5705001|NCT00191906|19662354|P1|Study Period II|Entry Criteria Exclusion|0
5705002|NCT00191906|19662351|P4|Study Period II|Parent/Caregiver Decision|0
5705003|NCT00191906|19662352|P3|Study Period II|Parent/Caregiver Decision|0
5705004|NCT00191906|19662353|P2|Study Period II|Parent/Caregiver Decision|1
5705005|NCT00191906|19662354|P1|Study Period II|Parent/Caregiver Decision|0
5705006|NCT00191906|19662351|P4|Study Period II|Withdrawal by Subject|0
5705007|NCT00191906|19662352|P3|Study Period II|Withdrawal by Subject|0
5705008|NCT00191906|19662353|P2|Study Period II|Withdrawal by Subject|3
5705009|NCT00191906|19662354|P1|Study Period II|Withdrawal by Subject|0
5705010|NCT00191906|19662351|P4|Study Period II|Adverse Event|0
5705011|NCT00191906|19662352|P3|Study Period II|Adverse Event|0
5705012|NCT00191906|19662353|P2|Study Period II|Adverse Event|1
5705013|NCT00191906|19662354|P1|Study Period II|Adverse Event|0
5705014|NCT00191854|19662397|P3|Overall Study|Screen Failure|1
5705015|NCT00191854|19662398|P2|Overall Study|Screen Failure|0
5705016|NCT00191854|19662399|P1|Overall Study|Screen Failure|0
5705017|NCT00191854|19662397|P3|Overall Study|Sponsor Decision|1
5705018|NCT00191854|19662398|P2|Overall Study|Sponsor Decision|0
5705019|NCT00191854|19662399|P1|Overall Study|Sponsor Decision|0
5705020|NCT00191854|19662397|P3|Overall Study|Withdrawal by Subject|3
5705021|NCT00191854|19662398|P2|Overall Study|Withdrawal by Subject|2
5705022|NCT00191854|19662399|P1|Overall Study|Withdrawal by Subject|4
5705023|NCT00191854|19662397|P3|Overall Study|Lost to Follow-up|5
5705024|NCT00191854|19662398|P2|Overall Study|Lost to Follow-up|5
5705025|NCT00191854|19662399|P1|Overall Study|Lost to Follow-up|7
5705026|NCT00191854|19662397|P3|Overall Study|Death|29
5705027|NCT00191854|19662398|P2|Overall Study|Death|23
5705028|NCT00191854|19662399|P1|Overall Study|Death|26
5705029|NCT00191815|19662419|P1|Overall Study|Withdrawal by Subject|7
5705030|NCT00191815|19662419|P1|Overall Study|Physician Decision|2
5705031|NCT00191815|19662419|P1|Overall Study|Protocol Violation|3
5705032|NCT00191815|19662419|P1|Overall Study|Death|2
5705033|NCT00191815|19662419|P1|Overall Study|Disease progression or relapse|24
5705034|NCT00191815|19662419|P1|Overall Study|Adverse Event|2
5705035|NCT00191789|19662431|P1|Overall Study|Death - Not Study-Drug Related|1
5705036|NCT00191789|19662431|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
5705037|NCT00191789|19662431|P1|Overall Study|Death - Possibly Study Drug Related|4
5705038|NCT00191789|19662431|P1|Overall Study|Withdrawal by Subject|4
5705039|NCT00191789|19662431|P1|Overall Study|Patient/Physician: Satisfactory Response|4
5705040|NCT00191789|19662431|P1|Overall Study|Patient: Satisfactory Response|5
5705041|NCT00191789|19662431|P1|Overall Study|Adverse Event|5
5705042|NCT00191724|19662448|P5|Overall Study|Withdrawal by Subject|0
5705043|NCT00191724|19662449|P4|Overall Study|Withdrawal by Subject|1
5705044|NCT00191724|19662450|P3|Overall Study|Withdrawal by Subject|0
5705045|NCT00191724|19662451|P2|Overall Study|Withdrawal by Subject|0
5705046|NCT00191724|19662452|P1|Overall Study|Withdrawal by Subject|0
5705047|NCT00191724|19662448|P5|Overall Study|Lost to Follow-up|3
5705048|NCT00191724|19662449|P4|Overall Study|Lost to Follow-up|2
5705049|NCT00191724|19662450|P3|Overall Study|Lost to Follow-up|0
5705050|NCT00191724|19662451|P2|Overall Study|Lost to Follow-up|1
5705051|NCT00191724|19662452|P1|Overall Study|Lost to Follow-up|1
5705052|NCT00191724|19662448|P5|Overall Study|Adverse Event|0
5705053|NCT00191724|19662449|P4|Overall Study|Adverse Event|0
5705054|NCT00191724|19662450|P3|Overall Study|Adverse Event|1
5705055|NCT00191724|19662451|P2|Overall Study|Adverse Event|0
5705056|NCT00191724|19662452|P1|Overall Study|Adverse Event|0
5705057|NCT00191646|19662481|P2|Overall Study|Missing Data|11
5705058|NCT00191646|19662482|P1|Overall Study|Missing Data|18
5705059|NCT00191646|19662481|P2|Overall Study|Other|34
5705060|NCT00191646|19662482|P1|Overall Study|Other|33
5705061|NCT00191646|19662481|P2|Overall Study|Death|8
5705062|NCT00191646|19662482|P1|Overall Study|Death|6
5705063|NCT00191646|19662481|P2|Overall Study|Protocol Violation|7
5705064|NCT00191646|19662482|P1|Overall Study|Protocol Violation|5
5705065|NCT00191646|19662481|P2|Overall Study|Withdrawal by Subject|39
5705066|NCT00191646|19662482|P1|Overall Study|Withdrawal by Subject|58
5705067|NCT00191646|19662481|P2|Overall Study|Physician Decision|11
5705068|NCT00191646|19662482|P1|Overall Study|Physician Decision|20
5705069|NCT00191646|19662481|P2|Overall Study|Disease Progression|6
5705070|NCT00191646|19662482|P1|Overall Study|Disease Progression|5
5705071|NCT00191646|19662481|P2|Overall Study|Toxicity|37
5705072|NCT00191646|19662482|P1|Overall Study|Toxicity|26
5705073|NCT00191477|19662502|P2|Overall Study|Discontinued Prior to Instillation|14
5705074|NCT00191477|19662503|P1|Overall Study|Discontinued Prior to Instillation|13
5705075|NCT00191477|19662502|P2|Overall Study|Pathological Specimen Lost|0
5705076|NCT00191477|19662503|P1|Overall Study|Pathological Specimen Lost|1
5705077|NCT00191477|19662502|P2|Overall Study|Not Eligible|38
5705078|NCT00191477|19662503|P1|Overall Study|Not Eligible|41
5705079|NCT00191477|19662502|P2|Overall Study|Other|0
5705080|NCT00191477|19662503|P1|Overall Study|Other|2
5705081|NCT00191477|19662502|P2|Overall Study|Withdrawal by Subject|0
5705082|NCT00191477|19662503|P1|Overall Study|Withdrawal by Subject|2
5705083|NCT00191477|19662502|P2|Overall Study|Treatment Change|0
5705084|NCT00191477|19662503|P1|Overall Study|Treatment Change|2
5705085|NCT00191477|19662502|P2|Overall Study|Protocol Violation|1
5705086|NCT00191477|19662503|P1|Overall Study|Protocol Violation|1
5705087|NCT00191477|19662502|P2|Overall Study|Lost to Follow-up|21
5705088|NCT00191477|19662503|P1|Overall Study|Lost to Follow-up|23
5705089|NCT00191477|19662502|P2|Overall Study|Death, Other Cause|6
5705090|NCT00191477|19662503|P1|Overall Study|Death, Other Cause|3
5705091|NCT00191477|19662502|P2|Overall Study|Death, Study Disease|1
5705092|NCT00191477|19662503|P1|Overall Study|Death, Study Disease|1
5705093|NCT00191477|19662502|P2|Overall Study|Tumor Recurrence|48
5705094|NCT00191477|19662503|P1|Overall Study|Tumor Recurrence|49
5705095|NCT00191451|19662522|P3|Overall Study|Reason Not Specified|3
5705096|NCT00191451|19662523|P2|Overall Study|Reason Not Specified|1
5705097|NCT00191451|19662524|P1|Overall Study|Reason Not Specified|2
5705098|NCT00191451|19662522|P3|Overall Study|Ineligible|0
5705099|NCT00191451|19662523|P2|Overall Study|Ineligible|1
5705100|NCT00191451|19662524|P1|Overall Study|Ineligible|0
5705101|NCT00191451|19662522|P3|Overall Study|Sponsor Decision|0
5705102|NCT00191451|19662523|P2|Overall Study|Sponsor Decision|0
5705103|NCT00191451|19662524|P1|Overall Study|Sponsor Decision|1
5705104|NCT00191451|19662522|P3|Overall Study|Physician Decision|6
5705105|NCT00191451|19662523|P2|Overall Study|Physician Decision|9
5705106|NCT00191451|19662524|P1|Overall Study|Physician Decision|2
5705107|NCT00191451|19662522|P3|Overall Study|Withdrawal by Subject|5
5705108|NCT00191451|19662523|P2|Overall Study|Withdrawal by Subject|3
5705109|NCT00191451|19662524|P1|Overall Study|Withdrawal by Subject|2
5705110|NCT00191386|19662544|P1|Overall Study|Lack of Efficacy|15
5705111|NCT00191386|19662544|P1|Overall Study|Physician Decision|11
5705112|NCT00191386|19662544|P1|Overall Study|Withdrawal by Subject|96
5705113|NCT00191386|19662544|P1|Overall Study|Protocol Violation|18
5705114|NCT00191386|19662544|P1|Overall Study|Entry Criteria Exclusion|3
5705115|NCT00191386|19662544|P1|Overall Study|Lost to Follow-up|1
5705116|NCT00191386|19662544|P1|Overall Study|Adverse Event|16
5705117|NCT00191334|19662551|P1|Overall Study|Withdrawal by Subject|4
5705118|NCT00191334|19662551|P1|Overall Study|Physician Decision|1
5705119|NCT00191334|19662551|P1|Overall Study|Disease Progression or Relapse|8
5705120|NCT00191334|19662551|P1|Overall Study|Adverse Event|4
5705121|NCT00191308|19662559|P1|Overall Study|Adverse Event|1
5705122|NCT00191282|19662569|P2|Overall Study|Lost to Follow-up|31
5705123|NCT00191282|19662570|P1|Overall Study|Lost to Follow-up|24
5705124|NCT00191282|19662569|P2|Overall Study|Sponsor's decision|2
5705125|NCT00191282|19662570|P1|Overall Study|Sponsor's decision|2
5705126|NCT00191282|19662569|P2|Overall Study|Severity of outcome|5
5705127|NCT00191282|19662570|P1|Overall Study|Severity of outcome|2
5705128|NCT00191282|19662569|P2|Overall Study|Protocol Violation|12
5705129|NCT00191282|19662570|P1|Overall Study|Protocol Violation|9
5705130|NCT00191282|19662569|P2|Overall Study|Protocol entry criteria not met|9
5705131|NCT00191282|19662570|P1|Overall Study|Protocol entry criteria not met|14
5705132|NCT00191282|19662569|P2|Overall Study|Physician Decision|15
5705133|NCT00191282|19662570|P1|Overall Study|Physician Decision|18
5705134|NCT00191282|19662569|P2|Overall Study|Withdrawal by Subject|44
5705135|NCT00191282|19662570|P1|Overall Study|Withdrawal by Subject|59
5705136|NCT00191282|19662569|P2|Overall Study|Patient moved|14
5705137|NCT00191282|19662570|P1|Overall Study|Patient moved|11
5705138|NCT00191282|19662569|P2|Overall Study|Noncompliance|17
5705139|NCT00191282|19662570|P1|Overall Study|Noncompliance|14
5705140|NCT00191282|19662569|P2|Overall Study|Lack of Efficacy|6
5705141|NCT00191282|19662570|P1|Overall Study|Lack of Efficacy|11
5705142|NCT00191282|19662569|P2|Overall Study|Death|51
5705143|NCT00191282|19662570|P1|Overall Study|Death|51
5705144|NCT00191282|19662569|P2|Overall Study|Adverse Event|6
5705145|NCT00191282|19662570|P1|Overall Study|Adverse Event|5
5705146|NCT00191269|19662630|P2|Overall Study|Physician Decision|3
5705147|NCT00191269|19662631|P1|Overall Study|Physician Decision|0
5705148|NCT00191269|19662630|P2|Overall Study|Pathologic Aggrevation|1
5705149|NCT00191269|19662631|P1|Overall Study|Pathologic Aggrevation|0
5705150|NCT00191269|19662630|P2|Overall Study|Withdrawal by Subject|1
5705151|NCT00191269|19662631|P1|Overall Study|Withdrawal by Subject|0
5705152|NCT00191269|19662630|P2|Overall Study|Lack of Efficacy|5
5705153|NCT00191269|19662631|P1|Overall Study|Lack of Efficacy|1
5705154|NCT00191269|19662630|P2|Overall Study|Progression of Disease|42
5705155|NCT00191269|19662631|P1|Overall Study|Progression of Disease|4
5705156|NCT00191269|19662630|P2|Overall Study|Adverse Event|4
5705157|NCT00191269|19662631|P1|Overall Study|Adverse Event|1
5705158|NCT00191269|19662630|P2|Overall Study|Protocol Violation|2
5705159|NCT00191269|19662631|P1|Overall Study|Protocol Violation|0
5705160|NCT00191191|19662647|P2|Overall Study|Good Clinical Practice Violation|1
5705161|NCT00191191|19662648|P1|Overall Study|Good Clinical Practice Violation|0
5705162|NCT00191191|19662647|P2|Overall Study|Physician Decision|2
5705163|NCT00191191|19662648|P1|Overall Study|Physician Decision|3
5705164|NCT00191191|19662647|P2|Overall Study|Lost to Follow-up|0
5705165|NCT00191191|19662648|P1|Overall Study|Lost to Follow-up|1
5705166|NCT00191191|19662647|P2|Overall Study|Family/Caregiver Decision|7
5705167|NCT00191191|19662648|P1|Overall Study|Family/Caregiver Decision|5
5705168|NCT00191191|19662647|P2|Overall Study|Toxicity After Dose Reduction|8
5705169|NCT00191191|19662648|P1|Overall Study|Toxicity After Dose Reduction|7
5705170|NCT00191191|19662647|P2|Overall Study|Progressive Disease|72
5705171|NCT00191191|19662648|P1|Overall Study|Progressive Disease|84
5705172|NCT00191191|19662647|P2|Overall Study|Adverse Event|21
5705173|NCT00191191|19662648|P1|Overall Study|Adverse Event|11
5705174|NCT00191191|19662647|P2|Overall Study|Treated with Another Systemic Agent|1
5705175|NCT00191191|19662648|P1|Overall Study|Treated with Another Systemic Agent|1
5705176|NCT00191191|19662647|P2|Overall Study|Entry Criteria Exclusion|0
5705177|NCT00191191|19662648|P1|Overall Study|Entry Criteria Exclusion|2
5705178|NCT00191165|19662664|P2|Overall Study|Participant Moved Away|1
5705179|NCT00191165|19662665|P1|Overall Study|Participant Moved Away|0
5705180|NCT00191165|19662664|P2|Overall Study|Protocol Violation|1
5705181|NCT00191165|19662665|P1|Overall Study|Protocol Violation|0
5705182|NCT00191165|19662664|P2|Overall Study|Adverse Event|0
5705183|NCT00191165|19662665|P1|Overall Study|Adverse Event|2
5705184|NCT00191152|19662677|P2|Crossover Treatment|Other|3
5705185|NCT00191152|19662678|P1|Crossover Treatment|Other|4
5705186|NCT00191152|19662677|P2|Crossover Treatment|Lost to Follow-up|1
5705187|NCT00191152|19662678|P1|Crossover Treatment|Lost to Follow-up|2
5705188|NCT00191152|19662677|P2|Crossover Treatment|Withdrawal by Subject|9
5705189|NCT00191152|19662678|P1|Crossover Treatment|Withdrawal by Subject|6
5705190|NCT00191152|19662677|P2|Crossover Treatment|Physician Decision|7
5705191|NCT00191152|19662678|P1|Crossover Treatment|Physician Decision|7
5705192|NCT00191152|19662677|P2|Crossover Treatment|Adverse Event|8
5705193|NCT00191152|19662678|P1|Crossover Treatment|Adverse Event|8
5705194|NCT00191152|19662677|P2|Initial Treatment|Other|21
5705195|NCT00191152|19662678|P1|Initial Treatment|Other|18
5705196|NCT00191152|19662677|P2|Initial Treatment|Lost to Follow-up|6
5705197|NCT00191152|19662678|P1|Initial Treatment|Lost to Follow-up|0
5705198|NCT00191152|19662677|P2|Initial Treatment|Withdrawal by Subject|28
5705199|NCT00191152|19662678|P1|Initial Treatment|Withdrawal by Subject|40
5705200|NCT00191152|19662677|P2|Initial Treatment|Physician Decision|31
5705201|NCT00191152|19662678|P1|Initial Treatment|Physician Decision|40
5705202|NCT00191152|19662677|P2|Initial Treatment|Adverse Event|67
5705203|NCT00191152|19662678|P1|Initial Treatment|Adverse Event|43
5705204|NCT00191139|19662710|P2|Overall Study|Other|2
5705205|NCT00191139|19662711|P1|Overall Study|Other|1
5705206|NCT00191139|19662710|P2|Overall Study|Disease Progression|1
5705207|NCT00191139|19662711|P1|Overall Study|Disease Progression|0
5705208|NCT00191139|19662710|P2|Overall Study|Withdrawal by Subject|3
5705209|NCT00191139|19662711|P1|Overall Study|Withdrawal by Subject|0
5705210|NCT00191139|19662710|P2|Overall Study|Death|0
5705211|NCT00191139|19662711|P1|Overall Study|Death|2
5705212|NCT00191139|19662710|P2|Overall Study|Adverse Event|6
5705213|NCT00191139|19662711|P1|Overall Study|Adverse Event|2
5705214|NCT00191113|19662727|P2|Core Study|Death|0
5705215|NCT00191113|19662728|P1|Core Study|Death|1
5705216|NCT00191113|19662727|P2|Core Study|Lack of Efficacy|2
5705217|NCT00191113|19662728|P1|Core Study|Lack of Efficacy|0
5705218|NCT00191113|19662727|P2|Core Study|Adverse Event|2
5705219|NCT00191113|19662728|P1|Core Study|Adverse Event|0
5705220|NCT00191113|19662727|P2|Core Study|Lost to Follow-up|0
5705221|NCT00191113|19662728|P1|Core Study|Lost to Follow-up|3
5705222|NCT00191113|19662727|P2|Core Study|Protocol Violation|2
5705223|NCT00191113|19662728|P1|Core Study|Protocol Violation|6
5705224|NCT00191113|19662727|P2|Core Study|Withdrawal by Subject|9
5705225|NCT00191113|19662728|P1|Core Study|Withdrawal by Subject|25
5705226|NCT00191100|19662770|P2|Overall Study|Reason Not Specified|1
5705227|NCT00191100|19662771|P1|Overall Study|Reason Not Specified|0
5705228|NCT00191100|19662770|P2|Overall Study|Death from Other Cause|0
5705229|NCT00191100|19662771|P1|Overall Study|Death from Other Cause|1
5705230|NCT00191100|19662770|P2|Overall Study|Protocol Violation|1
5705231|NCT00191100|19662771|P1|Overall Study|Protocol Violation|1
5705232|NCT00191100|19662770|P2|Overall Study|Death from Study Drug Toxicity|0
5705233|NCT00191100|19662771|P1|Overall Study|Death from Study Drug Toxicity|2
5705234|NCT00191100|19662770|P2|Overall Study|Physician Decision|1
5705235|NCT00191100|19662771|P1|Overall Study|Physician Decision|3
5705236|NCT00191100|19662770|P2|Overall Study|Lack of Efficacy, Stable Disease|0
5705237|NCT00191100|19662771|P1|Overall Study|Lack of Efficacy, Stable Disease|1
5705238|NCT00191100|19662770|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
5705239|NCT00191100|19662771|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
5705240|NCT00191100|19662770|P2|Overall Study|Clinical Relapse|1
5705241|NCT00191100|19662771|P1|Overall Study|Clinical Relapse|2
5705242|NCT00191100|19662770|P2|Overall Study|Protocol Entry Criteria Not Met|1
5705243|NCT00191100|19662771|P1|Overall Study|Protocol Entry Criteria Not Met|2
5705244|NCT00191100|19662770|P2|Overall Study|Withdrawal by Subject|3
5705245|NCT00191100|19662771|P1|Overall Study|Withdrawal by Subject|9
5705246|NCT00191100|19662770|P2|Overall Study|Patient Moved|1
5705247|NCT00191100|19662771|P1|Overall Study|Patient Moved|0
5705248|NCT00191100|19662770|P2|Overall Study|Lost to Follow-up|0
5705249|NCT00191100|19662771|P1|Overall Study|Lost to Follow-up|2
5705250|NCT00191100|19662770|P2|Overall Study|Adverse Event|1
5705251|NCT00191100|19662771|P1|Overall Study|Adverse Event|18
5705252|NCT00190983|19662787|P1|Overall Study|Inevaluable (never treated)|2
5705253|NCT00190775|19662796|P2|Overall Study|Exclusion Criteria Met|3
5705254|NCT00190775|19662797|P1|Overall Study|Exclusion Criteria Met|1
5705255|NCT00190775|19662796|P2|Overall Study|Protocol Violation|1
5705256|NCT00190775|19662797|P1|Overall Study|Protocol Violation|0
5705257|NCT00190775|19662796|P2|Overall Study|Noncompliance|5
5705258|NCT00190775|19662797|P1|Overall Study|Noncompliance|3
5705259|NCT00190775|19662796|P2|Overall Study|Physician Decision|0
5705260|NCT00190775|19662797|P1|Overall Study|Physician Decision|3
5705261|NCT00190775|19662796|P2|Overall Study|Sponsor Decision|0
5705262|NCT00190775|19662797|P1|Overall Study|Sponsor Decision|1
5705263|NCT00190775|19662796|P2|Overall Study|Withdrawal by Subject|13
5705264|NCT00190775|19662797|P1|Overall Study|Withdrawal by Subject|24
5705265|NCT00190775|19662796|P2|Overall Study|Participant Moved|1
5705266|NCT00190775|19662797|P1|Overall Study|Participant Moved|0
5705267|NCT00190775|19662796|P2|Overall Study|Lost to Follow-up|23
5705268|NCT00190775|19662797|P1|Overall Study|Lost to Follow-up|31
5705269|NCT00190775|19662796|P2|Overall Study|Lack of Efficacy|32
5705270|NCT00190775|19662797|P1|Overall Study|Lack of Efficacy|28
5705271|NCT00190775|19662796|P2|Overall Study|Satisfactory Response|0
5705272|NCT00190775|19662797|P1|Overall Study|Satisfactory Response|1
5705273|NCT00190775|19662796|P2|Overall Study|Adverse Event|22
5705274|NCT00190775|19662797|P1|Overall Study|Adverse Event|57
5705275|NCT00190749|19662868|P2|Overall Study|Sponsor Decision|0
5705276|NCT00190749|19662869|P1|Overall Study|Sponsor Decision|1
5705277|NCT00190749|19662868|P2|Overall Study|Reason Not Specified|2
5705278|NCT00190749|19662869|P1|Overall Study|Reason Not Specified|0
5705279|NCT00190749|19662868|P2|Overall Study|Lack of Efficacy|3
5705280|NCT00190749|19662869|P1|Overall Study|Lack of Efficacy|2
5705281|NCT00190749|19662868|P2|Overall Study|Adverse Event|5
5705282|NCT00190749|19662869|P1|Overall Study|Adverse Event|0
5705283|NCT00190749|19662868|P2|Overall Study|Protocol Violation|4
5705284|NCT00190749|19662869|P1|Overall Study|Protocol Violation|5
5705285|NCT00190749|19662868|P2|Overall Study|Withdrawal by Subject|6
5705286|NCT00190749|19662869|P1|Overall Study|Withdrawal by Subject|10
5705287|NCT00190749|19662868|P2|Overall Study|Lost to Follow-up|11
5705288|NCT00190749|19662869|P1|Overall Study|Lost to Follow-up|8
5705289|NCT00190684|19662933|P1|Overall Study|Study Period V Completed|1
5705290|NCT00190684|19662933|P1|Overall Study|Study Period III Completed|103
5705291|NCT00190684|19662933|P1|Overall Study|Protocol Violation|123
5705292|NCT00190684|19662933|P1|Overall Study|Physician Decision|84
5705293|NCT00190684|19662933|P1|Overall Study|Sponsor's decision|17
5705294|NCT00190684|19662933|P1|Overall Study|Clinical relapse|67
5705295|NCT00190684|19662933|P1|Overall Study|Patient Decision|432
5705296|NCT00190684|19662933|P1|Overall Study|Patient moved|60
5705297|NCT00190684|19662933|P1|Overall Study|Lost to Follow-up|232
5705298|NCT00190684|19662933|P1|Overall Study|Lack of efficacy|204
5705299|NCT00190684|19662933|P1|Overall Study|Satisfactory response|80
5705300|NCT00190684|19662933|P1|Overall Study|Adverse Event|86
5705301|NCT00190671|19662954|P2|Overall Study|Withdrawal by Subject|2
5705302|NCT00190671|19662955|P1|Overall Study|Withdrawal by Subject|0
5705303|NCT00190671|19662954|P2|Overall Study|Protocol Violation|1
5705304|NCT00190671|19662955|P1|Overall Study|Protocol Violation|0
5705305|NCT00190671|19662954|P2|Overall Study|Death from Other Causes|2
5705306|NCT00190671|19662955|P1|Overall Study|Death from Other Causes|0
5705307|NCT00190671|19662954|P2|Overall Study|Death from Study-Drug Toxicity|2
5705308|NCT00190671|19662955|P1|Overall Study|Death from Study-Drug Toxicity|0
5705309|NCT00190671|19662954|P2|Overall Study|Clinical Relapse|1
5705310|NCT00190671|19662955|P1|Overall Study|Clinical Relapse|0
5705311|NCT00190671|19662954|P2|Overall Study|Adverse Event|2
5705312|NCT00190671|19662955|P1|Overall Study|Adverse Event|3
5705313|NCT00190671|19662954|P2|Overall Study|Death from Study Disease|1
5705314|NCT00190671|19662955|P1|Overall Study|Death from Study Disease|1
5705315|NCT00190671|19662954|P2|Overall Study|Lack of Efficacy|24
5705316|NCT00190671|19662955|P1|Overall Study|Lack of Efficacy|19
5705317|NCT00190671|19662954|P2|Overall Study|Satisfactory Response|7
5705318|NCT00190671|19662955|P1|Overall Study|Satisfactory Response|4
5705319|NCT00189540|19662975|P2|Overall Study|Death|1
5705320|NCT00189540|19662976|P1|Overall Study|Death|4
5705321|NCT00189540|19662975|P2|Overall Study|Withdrawal by Subject|0
5705322|NCT00189540|19662976|P1|Overall Study|Withdrawal by Subject|3
5705323|NCT00189488|19662994|P2|Overall Study|Other|0
5705324|NCT00189488|19662995|P1|Overall Study|Other|1
5705325|NCT00189488|19662994|P2|Overall Study|Death|8
5705326|NCT00189488|19662995|P1|Overall Study|Death|5
5705327|NCT00189488|19662994|P2|Overall Study|Administrative Decision|2
5705328|NCT00189488|19662995|P1|Overall Study|Administrative Decision|0
5705329|NCT00189488|19662994|P2|Overall Study|Disease progression|4
5705330|NCT00189488|19662995|P1|Overall Study|Disease progression|2
5705331|NCT00189488|19662994|P2|Overall Study|Withdrawal by Subject|6
5705332|NCT00189488|19662995|P1|Overall Study|Withdrawal by Subject|2
5705333|NCT00189488|19662994|P2|Overall Study|Adverse Event|1
5705334|NCT00189488|19662995|P1|Overall Study|Adverse Event|2
5705335|NCT00189488|19662994|P2|Overall Study|Protocol deviation|1
5705336|NCT00189488|19662995|P1|Overall Study|Protocol deviation|2
5705337|NCT00189488|19662994|P2|Overall Study|Ineligibility determined|0
5705338|NCT00189488|19662995|P1|Overall Study|Ineligibility determined|1
5705339|NCT00189462|19663026|P2|Overall Study|Lost to Follow-up|20
5705340|NCT00189462|19663027|P1|Overall Study|Lost to Follow-up|18
5705341|NCT00189462|19663026|P2|Overall Study|Lack of Efficacy|1
5705342|NCT00189462|19663027|P1|Overall Study|Lack of Efficacy|5
5705343|NCT00189423|19663044|P2|Overall Study|Lost to Follow-up|10
5705344|NCT00189423|19663045|P1|Overall Study|Lost to Follow-up|10
5705345|NCT00189423|19663044|P2|Overall Study|Withdrawal by Subject|9
5705346|NCT00189423|19663045|P1|Overall Study|Withdrawal by Subject|9
5705347|NCT00189423|19663044|P2|Overall Study|Death|747
5705348|NCT00189423|19663045|P1|Overall Study|Death|746
5705349|NCT00189306|19663067|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
5705350|NCT00189306|19663067|P1|Long-Term Follow-up|Lost to Follow-up|9
5705351|NCT00189306|19663067|P1|Long-Term Follow-up|Intercurrent disease|2
5705352|NCT00189306|19663067|P1|Long-Term Follow-up|Withdrawal by Subject|1
5705353|NCT00189306|19663067|P1|Long-Term Follow-up|Death|4
5705354|NCT00189306|19663067|P1|Long-Term Follow-up|Adverse Event|2
5705355|NCT00189306|19663067|P1|Posttreatment Period|Local skin reaction/sign|1
5705356|NCT00189306|19663067|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
5705357|NCT00189306|19663067|P1|Posttreatment Period|Protocol Violation|1
5705358|NCT00189306|19663067|P1|Posttreatment Period|Target lesion excised|1
5705359|NCT00189306|19663067|P1|Posttreatment Period|Noncompliance|1
5705360|NCT00189306|19663067|P1|Posttreatment Period|Withdrawal by Subject|2
5705361|NCT00189306|19663067|P1|Posttreatment Period|Death|1
5705362|NCT00189306|19663067|P1|Treatment Period|Protocol Violation|1
5705363|NCT00189306|19663067|P1|Treatment Period|Adverse Event|2
5705364|NCT00189306|19663067|P1|Treatment Period|Withdrawal by Subject|2
5705365|NCT00189202|19663076|P1|Overall Study|Physician Decision|5
5705366|NCT00187889|19663117|P2|Overall Study|Withdrawal by Subject|4
5705367|NCT00187889|19663118|P1|Overall Study|Withdrawal by Subject|6
5705368|NCT00187486|19663160|P1|Overall Study|Protocol Violation|1
5705369|NCT00187135|19663240|P6|Visit Three|Study Discontinued|6
5705370|NCT00187135|19663241|P5|Visit Three|Study Discontinued|7
5705371|NCT00187135|19663242|P4|Visit Three|Study Discontinued|7
5705372|NCT00187135|19663243|P3|Visit Three|Study Discontinued|7
5705373|NCT00187135|19663244|P2|Visit Three|Study Discontinued|6
5705374|NCT00187135|19663245|P1|Visit Three|Study Discontinued|7
5705375|NCT00187135|19663240|P6|Visit Three|Withdrawal by Subject|0
5705376|NCT00187135|19663241|P5|Visit Three|Withdrawal by Subject|0
5705377|NCT00187135|19663242|P4|Visit Three|Withdrawal by Subject|2
5705378|NCT00187135|19663243|P3|Visit Three|Withdrawal by Subject|1
5705379|NCT00187135|19663244|P2|Visit Three|Withdrawal by Subject|1
5705380|NCT00187135|19663245|P1|Visit Three|Withdrawal by Subject|0
5705381|NCT00187135|19663240|P6|Visit Three|Death|0
5705382|NCT00187135|19663241|P5|Visit Three|Death|1
5705383|NCT00187135|19663242|P4|Visit Three|Death|0
5705384|NCT00187135|19663243|P3|Visit Three|Death|1
5705385|NCT00187135|19663244|P2|Visit Three|Death|0
5705386|NCT00187135|19663245|P1|Visit Three|Death|0
5705387|NCT00187135|19663240|P6|Visit Two|Study Discontinued|6
5705388|NCT00187135|19663241|P5|Visit Two|Study Discontinued|5
5705389|NCT00187135|19663242|P4|Visit Two|Study Discontinued|7
5705390|NCT00187135|19663243|P3|Visit Two|Study Discontinued|1
5705391|NCT00187135|19663244|P2|Visit Two|Study Discontinued|2
5705392|NCT00187135|19663245|P1|Visit Two|Study Discontinued|3
5705393|NCT00187135|19663240|P6|Visit Two|Withdrawal by Subject|1
5705394|NCT00187135|19663241|P5|Visit Two|Withdrawal by Subject|1
5705395|NCT00187135|19663242|P4|Visit Two|Withdrawal by Subject|0
5705396|NCT00187135|19663243|P3|Visit Two|Withdrawal by Subject|1
5705397|NCT00187135|19663244|P2|Visit Two|Withdrawal by Subject|1
5705398|NCT00187135|19663245|P1|Visit Two|Withdrawal by Subject|1
5705399|NCT00187135|19663240|P6|Visit Two|Physician Decision|0
5705400|NCT00187135|19663241|P5|Visit Two|Physician Decision|0
5705401|NCT00187135|19663242|P4|Visit Two|Physician Decision|0
5705402|NCT00187135|19663243|P3|Visit Two|Physician Decision|0
5705403|NCT00187135|19663244|P2|Visit Two|Physician Decision|0
5705404|NCT00187135|19663245|P1|Visit Two|Physician Decision|1
5705405|NCT00187135|19663240|P6|Visit Two|Death|1
5705406|NCT00187135|19663241|P5|Visit Two|Death|0
5705407|NCT00187135|19663242|P4|Visit Two|Death|1
5705408|NCT00187135|19663243|P3|Visit Two|Death|0
5705409|NCT00187135|19663244|P2|Visit Two|Death|0
5705410|NCT00187135|19663245|P1|Visit Two|Death|0
5705411|NCT00187135|19663240|P6|Visit One|Physician Decision|1
5705412|NCT00187135|19663241|P5|Visit One|Physician Decision|0
5705413|NCT00187135|19663242|P4|Visit One|Physician Decision|0
5705414|NCT00187135|19663243|P3|Visit One|Physician Decision|0
5705415|NCT00187135|19663244|P2|Visit One|Physician Decision|1
5705416|NCT00187135|19663245|P1|Visit One|Physician Decision|3
5705417|NCT00187135|19663240|P6|Visit One|Withdrawal by Subject|1
5705418|NCT00187135|19663241|P5|Visit One|Withdrawal by Subject|0
5705419|NCT00187135|19663242|P4|Visit One|Withdrawal by Subject|0
5705420|NCT00187135|19663243|P3|Visit One|Withdrawal by Subject|0
5705421|NCT00187135|19663244|P2|Visit One|Withdrawal by Subject|0
5705422|NCT00187135|19663245|P1|Visit One|Withdrawal by Subject|1
5705423|NCT00187096|19663268|P3|Overall Study|unacceptable toxicity|1
5705424|NCT00187096|19663269|P2|Overall Study|unacceptable toxicity|0
5705425|NCT00187096|19663270|P1|Overall Study|unacceptable toxicity|0
5705426|NCT00186901|19663308|P3|Overall Study|Bone Mineral Density > 0|149
5705427|NCT00186901|19663309|P2|Overall Study|Bone Mineral Density > 0|0
5705428|NCT00186901|19663310|P1|Overall Study|Bone Mineral Density > 0|0
5705429|NCT00186901|19663308|P3|Overall Study|Limited adherence to study requirements|0
5705430|NCT00186901|19663309|P2|Overall Study|Limited adherence to study requirements|23
5705431|NCT00186901|19663310|P1|Overall Study|Limited adherence to study requirements|20
5705432|NCT00186901|19663308|P3|Overall Study|Open label|0
5705433|NCT00186901|19663309|P2|Overall Study|Open label|2
5705434|NCT00186901|19663310|P1|Overall Study|Open label|3
5705435|NCT00186901|19663308|P3|Overall Study|Withdrawal by Subject|0
5705436|NCT00186901|19663309|P2|Overall Study|Withdrawal by Subject|5
5705437|NCT00186901|19663310|P1|Overall Study|Withdrawal by Subject|4
5705438|NCT00186901|19663308|P3|Overall Study|ALL relapse or second malignancy|0
5705439|NCT00186901|19663309|P2|Overall Study|ALL relapse or second malignancy|2
5705440|NCT00186901|19663310|P1|Overall Study|ALL relapse or second malignancy|1
5705441|NCT00186901|19663308|P3|Overall Study|Bone Mineral Density dropped > 5%|0
5705442|NCT00186901|19663309|P2|Overall Study|Bone Mineral Density dropped > 5%|7
5705443|NCT00186901|19663310|P1|Overall Study|Bone Mineral Density dropped > 5%|9
5705444|NCT00186901|19663308|P3|Overall Study|Lost to Follow-up|0
5705445|NCT00186901|19663309|P2|Overall Study|Lost to Follow-up|3
5705446|NCT00186901|19663310|P1|Overall Study|Lost to Follow-up|6
5705447|NCT00186901|19663308|P3|Overall Study|Pregnancy|0
5705448|NCT00186901|19663309|P2|Overall Study|Pregnancy|3
5705449|NCT00186901|19663310|P1|Overall Study|Pregnancy|6
5705450|NCT00186888|19663350|P3|Overall Study|Relapse or progression of disease|0
5705451|NCT00186888|19663351|P2|Overall Study|Relapse or progression of disease|2
5705452|NCT00186888|19663352|P1|Overall Study|Relapse or progression of disease|4
5705453|NCT00186888|19663350|P3|Overall Study|Toxicity|0
5705454|NCT00186888|19663351|P2|Overall Study|Toxicity|1
5705455|NCT00186888|19663352|P1|Overall Study|Toxicity|0
5705456|NCT00186628|19663444|P1|Overall Study|Withdrawal by subject (before treatment)|1
5705457|NCT00186628|19663444|P1|Overall Study|Death|2
5705458|NCT00186537|19663455|P3|Overall Study|ALT > 1.5 x ULN|0
5705459|NCT00186537|19663456|P2|Overall Study|ALT > 1.5 x ULN|0
5705460|NCT00186537|19663457|P1|Overall Study|ALT > 1.5 x ULN|3
5705461|NCT00186537|19663455|P3|Overall Study|Withdrawal by Subject|3
5705462|NCT00186537|19663456|P2|Overall Study|Withdrawal by Subject|0
5705463|NCT00186537|19663457|P1|Overall Study|Withdrawal by Subject|4
5705464|NCT00186485|19663480|P1|Overall Study|Lost to Follow-up|3
5705465|NCT00186186|19663492|P1|Overall Study|Not reported as to reason|2
5705466|NCT00186186|19663492|P1|Overall Study|Withdrawal by Subject|3
5705467|NCT00186186|19663492|P1|Overall Study|Lack of Efficacy|3
5705468|NCT00186121|19663497|P1|Overall Study|Not eligible (no treatment)|1
5705469|NCT00186121|19663497|P1|Overall Study|Underwent oophorectomy (no treatment)|1
5705470|NCT00186121|19663497|P1|Overall Study|Subject withdrawal (no treatment)|1
5705471|NCT00186043|19663531|P2|Overall Study|Protocol Violation|1
5705472|NCT00186043|19663532|P1|Overall Study|Protocol Violation|2
5705473|NCT00186043|19663531|P2|Overall Study|Adverse Event|3
5705474|NCT00186043|19663532|P1|Overall Study|Adverse Event|7
5705475|NCT00186043|19663531|P2|Overall Study|Withdrawal by Subject|0
5705476|NCT00186043|19663532|P1|Overall Study|Withdrawal by Subject|1
5705477|NCT00186043|19663531|P2|Overall Study|Lost to Follow-up|6
5705478|NCT00186043|19663532|P1|Overall Study|Lost to Follow-up|4
5705479|NCT00186043|19663531|P2|Overall Study|Lack of Efficacy|3
5705480|NCT00186043|19663532|P1|Overall Study|Lack of Efficacy|1
5705481|NCT00185965|19663559|P2|Overall Study|Adverse Event|1
5705482|NCT00185965|19663560|P1|Overall Study|Adverse Event|0
5705483|NCT00185731|19663585|P1|Overall Study|Not Eligible|1
5705484|NCT00185731|19663585|P1|Overall Study|Withdrawal by Subject|1
5705485|NCT00185640|19663602|P1|Overall Study|Death|138
5705486|NCT00185640|19663602|P1|Overall Study|Withdrawal by Subject|3
5705487|NCT00185640|19663602|P1|Overall Study|Not Eligible|4
5705488|NCT00185614|19663611|P1|Inter-treatment Period|Lack of allogenic donor|1
5705489|NCT00185614|19663611|P1|Inter-treatment Period|Relapse|2
5705490|NCT00185614|19663611|P1|Inter-treatment Period|Physician Decision|1
5705491|NCT00185588|19663623|P4|Overall Study|Physician Decision|0
5705492|NCT00185588|19663624|P3|Overall Study|Physician Decision|1
5705493|NCT00185588|19663625|P2|Overall Study|Physician Decision|0
5705494|NCT00185588|19663626|P1|Overall Study|Physician Decision|0
5705495|NCT00185588|19663623|P4|Overall Study|Withdrawal by Subject|0
5705496|NCT00185588|19663624|P3|Overall Study|Withdrawal by Subject|0
5705497|NCT00185588|19663625|P2|Overall Study|Withdrawal by Subject|1
5705498|NCT00185588|19663626|P1|Overall Study|Withdrawal by Subject|0
5705499|NCT00185588|19663623|P4|Overall Study|Lost to Follow-up|2
5705500|NCT00185588|19663624|P3|Overall Study|Lost to Follow-up|1
5705501|NCT00185588|19663625|P2|Overall Study|Lost to Follow-up|0
5705502|NCT00185588|19663626|P1|Overall Study|Lost to Follow-up|0
5705503|NCT00185588|19663623|P4|Overall Study|Adverse Event|2
5705504|NCT00185588|19663624|P3|Overall Study|Adverse Event|4
5705505|NCT00185588|19663625|P2|Overall Study|Adverse Event|1
5705506|NCT00185588|19663626|P1|Overall Study|Adverse Event|3
5705507|NCT00185458|19663640|P1|HRT Phase|Withdrawal by Subject|3
5705508|NCT00185458|19663640|P1|HRT Phase|Protocol Violation|2
5705509|NCT00185458|19663640|P1|HRT Phase|Lost to Follow-up|4
5705510|NCT00185458|19663640|P1|HRT Phase|Adverse Event|18
5705511|NCT00185458|19663640|P1|Contraception Phase|Withdrawal by Subject|7
5705512|NCT00185458|19663640|P1|Contraception Phase|Physician Decision|2
5705513|NCT00185458|19663640|P1|Contraception Phase|Protocol Violation|2
5705514|NCT00185458|19663640|P1|Contraception Phase|Lost to Follow-up|10
5705515|NCT00185458|19663640|P1|Contraception Phase|Adverse Event|37
5705516|NCT00185380|19663703|P3|Overall Study|personal reason|1
5705517|NCT00185380|19663704|P2|Overall Study|personal reason|1
5705518|NCT00185380|19663705|P1|Overall Study|personal reason|6
5705519|NCT00185380|19663703|P3|Overall Study|Could not attend visits|4
5705520|NCT00185380|19663704|P2|Overall Study|Could not attend visits|0
5705521|NCT00185380|19663705|P1|Overall Study|Could not attend visits|2
5705522|NCT00185380|19663703|P3|Overall Study|No need for contraception|3
5705523|NCT00185380|19663704|P2|Overall Study|No need for contraception|3
5705524|NCT00185380|19663705|P1|Overall Study|No need for contraception|3
5705525|NCT00185380|19663703|P3|Overall Study|Planned pregnancy|12
5705526|NCT00185380|19663704|P2|Overall Study|Planned pregnancy|12
5705527|NCT00185380|19663705|P1|Overall Study|Planned pregnancy|9
5705528|NCT00185380|19663703|P3|Overall Study|Failed insertion|2
5705529|NCT00185380|19663704|P2|Overall Study|Failed insertion|1
5705530|NCT00185380|19663705|P1|Overall Study|Failed insertion|1
5705531|NCT00185380|19663703|P3|Overall Study|Withdrawal by Subject|0
5705532|NCT00185380|19663704|P2|Overall Study|Withdrawal by Subject|2
5705533|NCT00185380|19663705|P1|Overall Study|Withdrawal by Subject|1
5705534|NCT00185380|19663703|P3|Overall Study|Protocol Violation|1
5705535|NCT00185380|19663704|P2|Overall Study|Protocol Violation|2
5705536|NCT00185380|19663705|P1|Overall Study|Protocol Violation|2
5705537|NCT00185380|19663703|P3|Overall Study|Pregnancy|0
5705538|NCT00185380|19663704|P2|Overall Study|Pregnancy|4
5705539|NCT00185380|19663705|P1|Overall Study|Pregnancy|1
5705540|NCT00185380|19663703|P3|Overall Study|Lost to Follow-up|3
5705541|NCT00185380|19663704|P2|Overall Study|Lost to Follow-up|4
5705542|NCT00185380|19663705|P1|Overall Study|Lost to Follow-up|0
5705543|NCT00185380|19663703|P3|Overall Study|Adverse Event|48
5705544|NCT00185380|19663704|P2|Overall Study|Adverse Event|43
5705545|NCT00185380|19663705|P1|Overall Study|Adverse Event|41
5705546|NCT00185211|19663733|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
5705547|NCT00185211|19663734|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
5705548|NCT00185211|19663733|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
5705549|NCT00185211|19663734|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
5705550|NCT00185211|19663733|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
5705551|NCT00185211|19663734|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
5705552|NCT00185211|19663733|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
5705553|NCT00185211|19663734|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
5705554|NCT00185211|19663733|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
5705555|NCT00185211|19663734|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
5705556|NCT00185211|19663733|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
5705557|NCT00185211|19663734|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
5705558|NCT00185211|19663733|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
5705559|NCT00185211|19663734|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
5705560|NCT00185211|19663733|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
5705561|NCT00185211|19663734|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
5705562|NCT00185211|19663733|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
5705563|NCT00185211|19663734|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
5705564|NCT00185211|19663733|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
5705565|NCT00185211|19663734|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
5705566|NCT00185211|19663733|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
5705567|NCT00185211|19663734|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
5705568|NCT00185211|19663733|P2|Placebo-controlled Study (92012)|Adverse Event|0
5705569|NCT00185211|19663734|P1|Placebo-controlled Study (92012)|Adverse Event|8
5705570|NCT00184600|19663807|P3|Overall Study|Unclassified|3
5705571|NCT00184600|19663808|P2|Overall Study|Unclassified|5
5705572|NCT00184600|19663809|P1|Overall Study|Unclassified|4
5705573|NCT00184600|19663807|P3|Overall Study|Withdrawal by Subject|12
5705574|NCT00184600|19663808|P2|Overall Study|Withdrawal by Subject|28
5705575|NCT00184600|19663809|P1|Overall Study|Withdrawal by Subject|20
5705576|NCT00184600|19663807|P3|Overall Study|Protocol Violation|3
5705577|NCT00184600|19663808|P2|Overall Study|Protocol Violation|2
5705578|NCT00184600|19663809|P1|Overall Study|Protocol Violation|2
5705579|NCT00184600|19663807|P3|Overall Study|Lost to Follow-up|1
5705580|NCT00184600|19663808|P2|Overall Study|Lost to Follow-up|6
5705581|NCT00184600|19663809|P1|Overall Study|Lost to Follow-up|4
5705582|NCT00184600|19663807|P3|Overall Study|Lack of Efficacy|3
5705583|NCT00184600|19663808|P2|Overall Study|Lack of Efficacy|1
5705584|NCT00184600|19663809|P1|Overall Study|Lack of Efficacy|3
5705585|NCT00184600|19663807|P3|Overall Study|Death|7
5705586|NCT00184600|19663808|P2|Overall Study|Death|9
5705587|NCT00184600|19663809|P1|Overall Study|Death|3
5705588|NCT00184600|19663807|P3|Overall Study|Adverse Event|5
5705589|NCT00184600|19663808|P2|Overall Study|Adverse Event|0
5705590|NCT00184600|19663809|P1|Overall Study|Adverse Event|9
5705591|NCT00184093|19663900|P1|Overall Study|Withdrawal by Subject|2
5705592|NCT00184093|19663900|P1|Overall Study|Physician Decision|1
5705593|NCT00184093|19663900|P1|Overall Study|Lost to Follow-up|3
5705594|NCT00184093|19663900|P1|Overall Study|Adverse Event|3
5705595|NCT00184054|19663905|P1|Overall Study|Adverse Event|1
5705596|NCT00184028|19663910|P1|Overall Study|Non-compliance|2
5705597|NCT00184028|19663910|P1|Overall Study|Withdrawal by Subject|1
5705598|NCT00184028|19663910|P1|Overall Study|Adverse Event|2
5705599|NCT00184028|19663910|P1|Overall Study|Lack of Efficacy|4
5705600|NCT00184028|19663910|P1|Overall Study|Death|1
5705601|NCT00184002|19663915|P1|Overall Study|Withdrawal by Subject|4
5705602|NCT00184002|19663915|P1|Overall Study|Physician Decision|1
5705603|NCT00184002|19663915|P1|Overall Study|Death|3
5705604|NCT00184002|19663915|P1|Overall Study|Adverse Event|9
5705605|NCT00183872|19663941|P1|Overall Study|Drug delayed more than 28 days|2
5705606|NCT00183872|19663941|P1|Overall Study|Withdrawal by Subject|2
5705607|NCT00183872|19663941|P1|Overall Study|Adverse Event|9
5705608|NCT00183872|19663941|P1|Overall Study|Death|3
5705609|NCT00183625|19663970|P4|Overall Study|Withdrawal by Subject|14
5705610|NCT00183625|19663971|P3|Overall Study|Withdrawal by Subject|19
5705611|NCT00183625|19663972|P2|Overall Study|Withdrawal by Subject|18
5705612|NCT00183625|19663973|P1|Overall Study|Withdrawal by Subject|18
5705613|NCT00183430|19664070|P2|Overall Study|Withdrawal by Subject|0
5705614|NCT00183430|19664071|P1|Overall Study|Withdrawal by Subject|1
5705615|NCT00183430|19664070|P2|Overall Study|did not meet inclusion criteria|0
5705616|NCT00183430|19664071|P1|Overall Study|did not meet inclusion criteria|1
5705617|NCT00183430|19664070|P2|Overall Study|Lost to Follow-up|0
5705618|NCT00183430|19664071|P1|Overall Study|Lost to Follow-up|3
5705619|NCT00183430|19664070|P2|Overall Study|Adverse Event|0
5705620|NCT00183430|19664071|P1|Overall Study|Adverse Event|1
5705621|NCT00183391|19664083|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
5705622|NCT00183391|19664084|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
5705623|NCT00183391|19664083|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
5705624|NCT00183391|19664084|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
5705625|NCT00183274|19664157|P6|Phase 3: Double-Blind|Relapsed|2
5705626|NCT00183274|19664158|P5|Phase 3: Double-Blind|Relapsed|11
5705627|NCT00183274|19664159|P4|Phase 3: Double-Blind|Relapsed|1
5705628|NCT00183274|19664160|P3|Phase 3: Double-Blind|Relapsed|0
5705629|NCT00183274|19664161|P2|Phase 3: Double-Blind|Relapsed|0
5705630|NCT00183274|19664162|P1|Phase 3: Double-Blind|Relapsed|0
5705631|NCT00183274|19664157|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
5705632|NCT00183274|19664158|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
5705633|NCT00183274|19664159|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
5705634|NCT00183274|19664160|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
5705635|NCT00183274|19664161|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
5705636|NCT00183274|19664162|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
5705637|NCT00183274|19664157|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
5705638|NCT00183274|19664158|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
5705639|NCT00183274|19664159|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
5705640|NCT00183274|19664160|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
5705641|NCT00183274|19664161|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
5705642|NCT00183274|19664162|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
5705643|NCT00183274|19664157|P6|Phase 2: Double-Blind|Relapsed|0
5705644|NCT00183274|19664158|P5|Phase 2: Double-Blind|Relapsed|0
5705645|NCT00183274|19664159|P4|Phase 2: Double-Blind|Relapsed|0
5705646|NCT00183274|19664160|P3|Phase 2: Double-Blind|Relapsed|29
5705647|NCT00183274|19664161|P2|Phase 2: Double-Blind|Relapsed|8
5705648|NCT00183274|19664162|P1|Phase 2: Double-Blind|Relapsed|0
5705649|NCT00183274|19664157|P6|Phase 1: Open-Label|Other|0
5705650|NCT00183274|19664158|P5|Phase 1: Open-Label|Other|0
5705651|NCT00183274|19664159|P4|Phase 1: Open-Label|Other|0
5705652|NCT00183274|19664160|P3|Phase 1: Open-Label|Other|0
5705653|NCT00183274|19664161|P2|Phase 1: Open-Label|Other|0
5705654|NCT00183274|19664162|P1|Phase 1: Open-Label|Other|9
5705655|NCT00183274|19664157|P6|Phase 1: Open-Label|Lost to Follow-up|0
5705656|NCT00183274|19664158|P5|Phase 1: Open-Label|Lost to Follow-up|0
5705657|NCT00183274|19664159|P4|Phase 1: Open-Label|Lost to Follow-up|0
5705658|NCT00183274|19664160|P3|Phase 1: Open-Label|Lost to Follow-up|0
5705659|NCT00183274|19664161|P2|Phase 1: Open-Label|Lost to Follow-up|0
5705660|NCT00183274|19664162|P1|Phase 1: Open-Label|Lost to Follow-up|33
5705661|NCT00183274|19664157|P6|Phase 1: Open-Label|Withdrawal by Subject|0
5705662|NCT00183274|19664158|P5|Phase 1: Open-Label|Withdrawal by Subject|0
5705663|NCT00183274|19664159|P4|Phase 1: Open-Label|Withdrawal by Subject|0
5705664|NCT00183274|19664160|P3|Phase 1: Open-Label|Withdrawal by Subject|0
5705665|NCT00183274|19664161|P2|Phase 1: Open-Label|Withdrawal by Subject|0
5705666|NCT00183274|19664162|P1|Phase 1: Open-Label|Withdrawal by Subject|13
5705667|NCT00183274|19664157|P6|Phase 1: Open-Label|Protocol Violation|0
5705668|NCT00183274|19664158|P5|Phase 1: Open-Label|Protocol Violation|0
5705669|NCT00183274|19664159|P4|Phase 1: Open-Label|Protocol Violation|0
5705670|NCT00183274|19664160|P3|Phase 1: Open-Label|Protocol Violation|0
5705671|NCT00183274|19664161|P2|Phase 1: Open-Label|Protocol Violation|0
5705672|NCT00183274|19664162|P1|Phase 1: Open-Label|Protocol Violation|11
5705673|NCT00183274|19664157|P6|Phase 1: Open-Label|Lack of Efficacy|0
5705674|NCT00183274|19664158|P5|Phase 1: Open-Label|Lack of Efficacy|0
5705675|NCT00183274|19664159|P4|Phase 1: Open-Label|Lack of Efficacy|0
5705676|NCT00183274|19664160|P3|Phase 1: Open-Label|Lack of Efficacy|0
5705677|NCT00183274|19664161|P2|Phase 1: Open-Label|Lack of Efficacy|0
5705678|NCT00183274|19664162|P1|Phase 1: Open-Label|Lack of Efficacy|13
5705679|NCT00183274|19664157|P6|Phase 1: Open-Label|Adverse Event|0
5705680|NCT00183274|19664158|P5|Phase 1: Open-Label|Adverse Event|0
5705681|NCT00183274|19664159|P4|Phase 1: Open-Label|Adverse Event|0
5705682|NCT00183274|19664160|P3|Phase 1: Open-Label|Adverse Event|0
5705683|NCT00183274|19664161|P2|Phase 1: Open-Label|Adverse Event|0
5705684|NCT00183274|19664162|P1|Phase 1: Open-Label|Adverse Event|31
5705685|NCT00183248|19664179|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
5705686|NCT00183248|19664180|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
5705687|NCT00183248|19664179|P2|Overall Study|Lost to Follow-up|1
5705688|NCT00183248|19664180|P1|Overall Study|Lost to Follow-up|0
5705689|NCT00183196|19664201|P3|Overall Study|Required more intensive care|2
5705690|NCT00183196|19664202|P2|Overall Study|Required more intensive care|1
5705691|NCT00183196|19664203|P1|Overall Study|Required more intensive care|0
5705692|NCT00183196|19664201|P3|Overall Study|Legal event|1
5705693|NCT00183196|19664202|P2|Overall Study|Legal event|1
5705694|NCT00183196|19664203|P1|Overall Study|Legal event|1
5705695|NCT00183196|19664201|P3|Overall Study|Adverse Event|2
5705696|NCT00183196|19664202|P2|Overall Study|Adverse Event|2
5705697|NCT00183196|19664203|P1|Overall Study|Adverse Event|1
5705698|NCT00183196|19664201|P3|Overall Study|Withdrawal by Subject|13
5705699|NCT00183196|19664202|P2|Overall Study|Withdrawal by Subject|11
5705700|NCT00183196|19664203|P1|Overall Study|Withdrawal by Subject|18
5705701|NCT00183170|19664213|P2|Second Intervention|Did not meet targeted BrAC|2
5705702|NCT00183170|19664214|P1|Second Intervention|Did not meet targeted BrAC|0
5705703|NCT00183170|19664213|P2|Second Intervention|Did not complete study|0
5705704|NCT00183170|19664214|P1|Second Intervention|Did not complete study|1
5705705|NCT00183170|19664213|P2|Washout 1 Week|Did not complete study|8
5705706|NCT00183170|19664214|P1|Washout 1 Week|Did not complete study|6
5705707|NCT00183170|19664213|P2|First Intervention|Did not meet targeted BrAC|0
5705708|NCT00183170|19664214|P1|First Intervention|Did not meet targeted BrAC|1
5705709|NCT00183170|19664213|P2|First Intervention|Did not complete study|0
5705710|NCT00183170|19664214|P1|First Intervention|Did not complete study|1
5705711|NCT00182689|19664303|P2|Overall Study|Never received treatment|0
5705712|NCT00182689|19664304|P1|Overall Study|Never received treatment|1
5705713|NCT00182689|19664303|P2|Overall Study|Ineligible|4
5705714|NCT00182689|19664304|P1|Overall Study|Ineligible|1
5705715|NCT00182689|19664303|P2|Overall Study|not protocol specified|3
5705716|NCT00182689|19664304|P1|Overall Study|not protocol specified|0
5705717|NCT00182689|19664303|P2|Overall Study|Death|0
5705718|NCT00182689|19664304|P1|Overall Study|Death|1
5705719|NCT00182689|19664303|P2|Overall Study|Progression|29
5705720|NCT00182689|19664304|P1|Overall Study|Progression|27
5705721|NCT00182689|19664303|P2|Overall Study|Withdrawal by Subject|2
5705722|NCT00182689|19664304|P1|Overall Study|Withdrawal by Subject|2
5705723|NCT00182689|19664303|P2|Overall Study|Adverse Event|11
5705724|NCT00182689|19664304|P1|Overall Study|Adverse Event|8
5705725|NCT00182637|19664314|P1|Overall Study|Disease Progression|1
5705726|NCT00182637|19664314|P1|Overall Study|Adverse Event|2
5705727|NCT00182325|19664322|P2|Overall Study|Did not complete survey|43
5705728|NCT00182325|19664323|P1|Overall Study|Did not complete survey|22
5705729|NCT00182325|19664322|P2|Overall Study|Miscarriage|3
5705730|NCT00182325|19664323|P1|Overall Study|Miscarriage|5
5705731|NCT00182325|19664322|P2|Overall Study|Lost to Follow-up|7
5705732|NCT00182325|19664323|P1|Overall Study|Lost to Follow-up|7
5705733|NCT00182091|19664351|P4|Overall Study|Withdrawal by Subject|0
5705734|NCT00182091|19664352|P3|Overall Study|Withdrawal by Subject|0
5705735|NCT00182091|19664353|P2|Overall Study|Withdrawal by Subject|0
5705736|NCT00182091|19664354|P1|Overall Study|Withdrawal by Subject|1
5705737|NCT00182078|19664370|P2|Overall Study|Withdrawal by Subject|0
5705738|NCT00182078|19664371|P1|Overall Study|Withdrawal by Subject|1
5705739|NCT00181883|19664399|P1|Overall Study|Lost to Follow-up|1
5705740|NCT00181883|19664399|P1|Overall Study|Withdrawal by Subject|4
5705741|NCT00181883|19664399|P1|Overall Study|Treatment Limiting AEs|3
5705742|NCT00181883|19664399|P1|Overall Study|Lack of Efficacy|2
5705743|NCT00181844|19664403|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
5705744|NCT00181844|19664403|P1|Exposed to Study Medication|Withdrawal by Subject|1
5705745|NCT00181844|19664403|P1|Exposed to Study Medication|Non-compliance|2
5705746|NCT00181844|19664403|P1|Exposed to Study Medication|Lack of Efficacy|2
5705747|NCT00181844|19664403|P1|Exposed to Study Medication|Adverse Event|10
5705748|NCT00181844|19664403|P1|Signed Consent|Did not meet entrance criteria|7
5705749|NCT00181844|19664403|P1|Signed Consent|Withdrawal by Subject|5
5705750|NCT00181766|19664407|P1|Overall Study|non-compliance|2
5705751|NCT00181766|19664407|P1|Overall Study|Adverse Event|4
5705752|NCT00181766|19664407|P1|Overall Study|Lost to Follow-up|6
5705753|NCT00181155|19664481|P2|Overall Study|Withdrawal by Subject|0
5705754|NCT00181155|19664482|P1|Overall Study|Withdrawal by Subject|1
5705755|NCT00181155|19664481|P2|Overall Study|Physician Decision|0
5705756|NCT00181155|19664482|P1|Overall Study|Physician Decision|1
5705757|NCT00180713|19664492|P2|Overall Study|Adverse Event|3
5705758|NCT00180713|19664493|P1|Overall Study|Adverse Event|3
5705759|NCT00180713|19664492|P2|Overall Study|Withdrawal by Subject|0
5705760|NCT00180713|19664493|P1|Overall Study|Withdrawal by Subject|2
5705761|NCT00180674|19664536|P1|Phase 2, Warfarin Treatment Period|Adverse Event|1
5705762|NCT00180674|19664536|P1|Phase 1, Observation Period|Withdrawal by Subject|4
5705763|NCT00180479|19664565|P2|Overall Study|Informed consent not signed|1
5705764|NCT00180479|19664566|P1|Overall Study|Informed consent not signed|0
5705765|NCT00180479|19664565|P2|Overall Study|Withdrawal by Subject|3
5705766|NCT00180479|19664566|P1|Overall Study|Withdrawal by Subject|3
5705767|NCT00180479|19664565|P2|Overall Study|Lost to Follow-up|7
5705768|NCT00180479|19664566|P1|Overall Study|Lost to Follow-up|9
5705769|NCT00180479|19664565|P2|Overall Study|Death|2
5705770|NCT00180479|19664566|P1|Overall Study|Death|4
5705771|NCT00179959|19664691|P2|Overall Study|Withdrawal by Subject|2
5705772|NCT00179959|19664692|P1|Overall Study|Withdrawal by Subject|3
5705773|NCT00179959|19664691|P2|Overall Study|Lost to Follow-up|1
5705774|NCT00179959|19664692|P1|Overall Study|Lost to Follow-up|3
5705775|NCT00179673|19664698|P1|Overall Study|Other Observations and options|14
5705776|NCT00179673|19664698|P1|Overall Study|Death|4
5705777|NCT00179673|19664698|P1|Overall Study|Withdrawal by Subject|3
5705778|NCT00179673|19664698|P1|Overall Study|Lack of Efficacy|15
5705779|NCT00179673|19664698|P1|Overall Study|Adverse Event|7
5705780|NCT00179660|19664706|P1|Overall Study|Other - Unspecified|9
5705781|NCT00179660|19664706|P1|Overall Study|Death|3
5705782|NCT00179660|19664706|P1|Overall Study|Lost to Follow-up|1
5705783|NCT00179660|19664706|P1|Overall Study|Withdrawal by Subject|2
5705784|NCT00179660|19664706|P1|Overall Study|Lack of therapeutic effect|28
5705785|NCT00179660|19664706|P1|Overall Study|Adverse Event|7
5705786|NCT00179647|19664715|P1|Overall Study|Other|960
5705787|NCT00179647|19664715|P1|Overall Study|Death|94
5705788|NCT00179647|19664715|P1|Overall Study|Lost to Follow-up|4
5705789|NCT00179647|19664715|P1|Overall Study|Withdrawal by Subject|83
5705790|NCT00179647|19664715|P1|Overall Study|Lack of Efficacy|478
5705791|NCT00179647|19664715|P1|Overall Study|Adverse Event|294
5705792|NCT00179621|19664722|P4|Open-Label Period|Other|2
5705793|NCT00179621|19664723|P3|Open-Label Period|Other|1
5705794|NCT00179621|19664724|P2|Open-Label Period|Other|1
5705795|NCT00179621|19664725|P1|Open-Label Period|Other|0
5705796|NCT00179621|19664722|P4|Open-Label Period|Death|2
5705797|NCT00179621|19664723|P3|Open-Label Period|Death|1
5705798|NCT00179621|19664724|P2|Open-Label Period|Death|0
5705799|NCT00179621|19664725|P1|Open-Label Period|Death|0
5705800|NCT00179621|19664722|P4|Open-Label Period|Withdrawal by Subject|2
5705801|NCT00179621|19664723|P3|Open-Label Period|Withdrawal by Subject|2
5705802|NCT00179621|19664724|P2|Open-Label Period|Withdrawal by Subject|2
5705803|NCT00179621|19664725|P1|Open-Label Period|Withdrawal by Subject|0
5705804|NCT00179621|19664722|P4|Open-Label Period|Adverse Event|6
5705805|NCT00179621|19664723|P3|Open-Label Period|Adverse Event|5
5705806|NCT00179621|19664724|P2|Open-Label Period|Adverse Event|6
5705807|NCT00179621|19664725|P1|Open-Label Period|Adverse Event|0
5705808|NCT00179621|19664722|P4|Open-Label Period|Lack of Therapeutic Effect|31
5705809|NCT00179621|19664723|P3|Open-Label Period|Lack of Therapeutic Effect|19
5705810|NCT00179621|19664724|P2|Open-Label Period|Lack of Therapeutic Effect|19
5705811|NCT00179621|19664725|P1|Open-Label Period|Lack of Therapeutic Effect|0
5705812|NCT00179621|19664722|P4|Double-Blind Period|Other|0
5705813|NCT00179621|19664723|P3|Double-Blind Period|Other|2
5705814|NCT00179621|19664724|P2|Double-Blind Period|Other|2
5705815|NCT00179621|19664725|P1|Double-Blind Period|Other|0
5705816|NCT00179621|19664722|P4|Double-Blind Period|Protocol Violation|0
5705817|NCT00179621|19664723|P3|Double-Blind Period|Protocol Violation|0
5705818|NCT00179621|19664724|P2|Double-Blind Period|Protocol Violation|0
5705819|NCT00179621|19664725|P1|Double-Blind Period|Protocol Violation|1
5705820|NCT00179621|19664722|P4|Double-Blind Period|Death|0
5705821|NCT00179621|19664723|P3|Double-Blind Period|Death|2
5705822|NCT00179621|19664724|P2|Double-Blind Period|Death|1
5705823|NCT00179621|19664725|P1|Double-Blind Period|Death|0
5705824|NCT00179621|19664722|P4|Double-Blind Period|Withdrawal by Subject|0
5705825|NCT00179621|19664723|P3|Double-Blind Period|Withdrawal by Subject|3
5705826|NCT00179621|19664724|P2|Double-Blind Period|Withdrawal by Subject|1
5705827|NCT00179621|19664725|P1|Double-Blind Period|Withdrawal by Subject|2
5705828|NCT00179621|19664722|P4|Double-Blind Period|Adverse Event|0
5705829|NCT00179621|19664723|P3|Double-Blind Period|Adverse Event|4
5705830|NCT00179621|19664724|P2|Double-Blind Period|Adverse Event|7
5705831|NCT00179621|19664725|P1|Double-Blind Period|Adverse Event|2
5705832|NCT00179621|19664722|P4|Double-Blind Period|Lack of Therapeutic Effect|0
5705833|NCT00179621|19664723|P3|Double-Blind Period|Lack of Therapeutic Effect|19
5705834|NCT00179621|19664724|P2|Double-Blind Period|Lack of Therapeutic Effect|35
5705835|NCT00179621|19664725|P1|Double-Blind Period|Lack of Therapeutic Effect|59
5705836|NCT00179517|19664778|P2|Overall Study|Withdrawal by Subject|1
5705837|NCT00179517|19664779|P1|Overall Study|Withdrawal by Subject|2
5705838|NCT00179413|19664817|P2|Overall Study|Withdrawal by Subject|95
5705839|NCT00179413|19664818|P1|Overall Study|Withdrawal by Subject|87
5705840|NCT00179413|19664817|P2|Overall Study|Adverse Event|20
5705841|NCT00179413|19664818|P1|Overall Study|Adverse Event|38
5705842|NCT00179309|19664830|P2|Treatment|Allergy|0
5705843|NCT00179309|19664831|P1|Treatment|Allergy|1
5705844|NCT00179309|19664830|P2|Treatment|Withdrawal by Subject|2
5705845|NCT00179309|19664831|P1|Treatment|Withdrawal by Subject|1
5705846|NCT00179309|19664830|P2|Treatment|Toxicity|3
5705847|NCT00179309|19664831|P1|Treatment|Toxicity|2
5705848|NCT00179010|19664854|P2|Overall Study|Failure to place arterial line|1
5705849|NCT00179010|19664855|P1|Overall Study|Failure to place arterial line|0
5705850|NCT00179010|19664854|P2|Overall Study|Muscle probe defective|1
5705851|NCT00179010|19664855|P1|Overall Study|Muscle probe defective|1
5705852|NCT00178685|19664894|P3|Overall Study|Withdrawal by Subject|7
5705853|NCT00178685|19664895|P2|Overall Study|Withdrawal by Subject|14
5705854|NCT00178685|19664896|P1|Overall Study|Withdrawal by Subject|8
5705855|NCT00178685|19664894|P3|Overall Study|Lost to Follow-up|183
5705856|NCT00178685|19664895|P2|Overall Study|Lost to Follow-up|187
5705857|NCT00178685|19664896|P1|Overall Study|Lost to Follow-up|100
5705858|NCT00178685|19664894|P3|Overall Study|Death|6
5705859|NCT00178685|19664895|P2|Overall Study|Death|3
5705860|NCT00178685|19664896|P1|Overall Study|Death|3
5705861|NCT00178633|19664907|P1|Overall Study|Lost to Follow-up|6
5705862|NCT00178464|19664937|P1|Overall Study|Physician Decision|1
5705863|NCT00178464|19664937|P1|Overall Study|Withdrawal by Subject|1
5705864|NCT00178399|19664942|P1|Overall Study|Lost to Follow-up|1
5705865|NCT00178399|19664942|P1|Overall Study|Withdrawal by Subject|8
5705866|NCT00178399|19664942|P1|Overall Study|Physician Decision|4
5705867|NCT00178256|19664949|P4|Overall Study|Cancer progression|1
5705868|NCT00178256|19664950|P3|Overall Study|Cancer progression|0
5705869|NCT00178256|19664951|P2|Overall Study|Cancer progression|0
5705870|NCT00178256|19664952|P1|Overall Study|Cancer progression|2
5705871|NCT00178256|19664949|P4|Overall Study|Death|1
5705872|NCT00178256|19664950|P3|Overall Study|Death|0
5705873|NCT00178256|19664951|P2|Overall Study|Death|1
5705874|NCT00178256|19664952|P1|Overall Study|Death|0
5705875|NCT00178256|19664949|P4|Overall Study|Adverse Event|0
5705876|NCT00178256|19664950|P3|Overall Study|Adverse Event|0
5705877|NCT00178256|19664951|P2|Overall Study|Adverse Event|0
5705878|NCT00178256|19664952|P1|Overall Study|Adverse Event|2
5705879|NCT00178126|19664991|P2|Overall Study|did not receive intervention|6
5705880|NCT00178126|19664992|P1|Overall Study|did not receive intervention|4
5705881|NCT00178126|19664991|P2|Overall Study|Lost to Follow-up|21
5705882|NCT00178126|19664992|P1|Overall Study|Lost to Follow-up|21
5705883|NCT00177671|19665034|P2|Overall Study|Physician Decision|8
5705884|NCT00177671|19665035|P1|Overall Study|Physician Decision|12
5705885|NCT00177671|19665034|P2|Overall Study|Adverse Event|0
5705886|NCT00177671|19665035|P1|Overall Study|Adverse Event|6
5705887|NCT00177671|19665034|P2|Overall Study|medical complications|0
5705888|NCT00177671|19665035|P1|Overall Study|medical complications|2
5705889|NCT00177671|19665034|P2|Overall Study|Withdrawal by Subject|6
5705890|NCT00177671|19665035|P1|Overall Study|Withdrawal by Subject|5
5705891|NCT00177307|19665047|P1|Overall Study|Withdrawal by Subject|1
5705892|NCT00177294|19665056|P2|Overall Study|Withdrawal by Subject|5
5705893|NCT00177294|19665057|P1|Overall Study|Withdrawal by Subject|7
5705894|NCT00177216|19665071|P3|Overall Study|Withdrawal by Subject|1
5705895|NCT00177216|19665072|P2|Overall Study|Withdrawal by Subject|3
5705896|NCT00177216|19665073|P1|Overall Study|Withdrawal by Subject|6
5705897|NCT00177164|19665089|P2|Overall Study|Pregnancy|1
5705898|NCT00177164|19665090|P1|Overall Study|Pregnancy|0
5705899|NCT00177164|19665089|P2|Overall Study|Lack of Efficacy|1
5705900|NCT00177164|19665090|P1|Overall Study|Lack of Efficacy|2
5705901|NCT00177164|19665089|P2|Overall Study|discharge from hospital|0
5705902|NCT00177164|19665090|P1|Overall Study|discharge from hospital|1
5705903|NCT00177164|19665089|P2|Overall Study|Adverse Event|0
5705904|NCT00177164|19665090|P1|Overall Study|Adverse Event|1
5705905|NCT00177164|19665089|P2|Overall Study|increase in alcohol and drug use|2
5705906|NCT00177164|19665090|P1|Overall Study|increase in alcohol and drug use|1
5705907|NCT00177164|19665089|P2|Overall Study|Lost to Follow-up|5
5705908|NCT00177164|19665090|P1|Overall Study|Lost to Follow-up|4
5705909|NCT00177164|19665089|P2|Overall Study|Protocol Violation|7
5705910|NCT00177164|19665090|P1|Overall Study|Protocol Violation|0
5705911|NCT00176644|19665263|P1|Overall Study|Withdrawal by Subject|1
5705912|NCT00176605|19665276|P1|Overall Study|Withdrawal by Subject|2
5705913|NCT00176488|19665287|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
5705914|NCT00176462|19665295|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
5705915|NCT00176462|19665296|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
5705916|NCT00176462|19665295|P2|Intensive Continuation (8X8-week Cycles)|Death|0
5705917|NCT00176462|19665296|P1|Intensive Continuation (8X8-week Cycles)|Death|1
5705918|NCT00176462|19665295|P2|Consolidation (12 Weeks)|Not documented|1
5705919|NCT00176462|19665296|P1|Consolidation (12 Weeks)|Not documented|0
5705920|NCT00176462|19665295|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
5705921|NCT00176462|19665296|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
5705922|NCT00176462|19665295|P2|Consolidation (12 Weeks)|Adverse Event|1
5705923|NCT00176462|19665296|P1|Consolidation (12 Weeks)|Adverse Event|0
5705924|NCT00176462|19665295|P2|Consolidation (12 Weeks)|Patient moved to another state|1
5705925|NCT00176462|19665296|P1|Consolidation (12 Weeks)|Patient moved to another state|0
5705926|NCT00176462|19665295|P2|Induction (4 Weeks)|Lack of Efficacy|1
5705927|NCT00176462|19665296|P1|Induction (4 Weeks)|Lack of Efficacy|0
5705928|NCT00176462|19665295|P2|Induction (4 Weeks)|Death|2
5705929|NCT00176462|19665296|P1|Induction (4 Weeks)|Death|1
5705930|NCT00176462|19665295|P2|Induction (4 Weeks)|Withdrawal by Subject|2
5705931|NCT00176462|19665296|P1|Induction (4 Weeks)|Withdrawal by Subject|0
5705932|NCT00176254|19665331|P1|Overall Study|Lost to Follow-up|1
5705933|NCT00175916|19665359|P1|Overall Study|Patient went to prison|1
5705934|NCT00175916|19665359|P1|Overall Study|Site was closed|9
5705935|NCT00175916|19665359|P1|Overall Study|Loss of job and economic burden|1
5705936|NCT00175916|19665359|P1|Overall Study|Moved overseas|1
5705937|NCT00175916|19665359|P1|Overall Study|Treating physiciant's choice|1
5705938|NCT00175916|19665359|P1|Overall Study|Patient's request|2
5705939|NCT00175916|19665359|P1|Overall Study|Pregnancy|1
5705940|NCT00175916|19665359|P1|Overall Study|Administrative reason|1
5705941|NCT00175916|19665359|P1|Overall Study|Seizure - free|4
5705942|NCT00175916|19665359|P1|Overall Study|Withdrawal by Subject|1
5705943|NCT00175916|19665359|P1|Overall Study|Suicidal behaviour|1
5705944|NCT00175916|19665359|P1|Overall Study|Vigabatrin intake|1
5705945|NCT00175916|19665359|P1|Overall Study|Sponsor decision|17
5705946|NCT00175916|19665359|P1|Overall Study|Patient cannot record seizures|1
5705947|NCT00175916|19665359|P1|Overall Study|Lack of compliance|8
5705948|NCT00175916|19665359|P1|Overall Study|Subject Choice|98
5705949|NCT00175916|19665359|P1|Overall Study|Lost to Follow-up|17
5705950|NCT00175916|19665359|P1|Overall Study|Lack of Efficacy|354
5705951|NCT00175916|19665359|P1|Overall Study|Adverse Event|81
5705952|NCT00175916|19665359|P1|Overall Study|Death|19
5705953|NCT00175877|19665368|P1|Overall Study|Withdrawal by subject & Other|1
5705954|NCT00175877|19665368|P1|Overall Study|AE & Other|1
5705955|NCT00175877|19665368|P1|Overall Study|Other Reason|20
5705956|NCT00175877|19665368|P1|Overall Study|Protocol Violation|15
5705957|NCT00175877|19665368|P1|Overall Study|Lack of Efficacy|26
5705958|NCT00175877|19665368|P1|Overall Study|Lost to Follow-up|9
5705959|NCT00175877|19665368|P1|Overall Study|Withdrawal by Subject|141
5705960|NCT00175877|19665368|P1|Overall Study|Adverse Event|136
5705961|NCT00175825|19665403|P4|Overall Study|Withdrawal by Subject|0
5705962|NCT00175825|19665404|P3|Overall Study|Withdrawal by Subject|0
5705963|NCT00175825|19665405|P2|Overall Study|Withdrawal by Subject|0
5705964|NCT00175825|19665406|P1|Overall Study|Withdrawal by Subject|1
5705965|NCT00175825|19665403|P4|Overall Study|Lost to Follow-up|0
5705966|NCT00175825|19665404|P3|Overall Study|Lost to Follow-up|0
5705967|NCT00175825|19665405|P2|Overall Study|Lost to Follow-up|2
5705968|NCT00175825|19665406|P1|Overall Study|Lost to Follow-up|1
5705969|NCT00175825|19665403|P4|Overall Study|Adverse Event|1
5705970|NCT00175825|19665404|P3|Overall Study|Adverse Event|1
5705971|NCT00175825|19665405|P2|Overall Study|Adverse Event|2
5705972|NCT00175825|19665406|P1|Overall Study|Adverse Event|3
5705973|NCT00175019|19665459|P3|Overall Study|Reason Not Specified|11
5705974|NCT00175019|19665460|P2|Overall Study|Reason Not Specified|34
5705975|NCT00175019|19665461|P1|Overall Study|Reason Not Specified|40
5705976|NCT00175019|19665459|P3|Overall Study|Gout Flare|0
5705977|NCT00175019|19665460|P2|Overall Study|Gout Flare|3
5705978|NCT00175019|19665461|P1|Overall Study|Gout Flare|2
5705979|NCT00175019|19665459|P3|Overall Study|Therapeutic Failure|22
5705980|NCT00175019|19665460|P2|Overall Study|Therapeutic Failure|38
5705981|NCT00175019|19665461|P1|Overall Study|Therapeutic Failure|10
5705982|NCT00175019|19665459|P3|Overall Study|Personal Reason(s)|8
5705983|NCT00175019|19665460|P2|Overall Study|Personal Reason(s)|31
5705984|NCT00175019|19665461|P1|Overall Study|Personal Reason(s)|39
5705985|NCT00175019|19665459|P3|Overall Study|Did not continue under Amendment 4|2
5705986|NCT00175019|19665460|P2|Overall Study|Did not continue under Amendment 4|1
5705987|NCT00175019|19665461|P1|Overall Study|Did not continue under Amendment 4|1
5705988|NCT00175019|19665459|P3|Overall Study|Lost to Follow-up|9
5705989|NCT00175019|19665460|P2|Overall Study|Lost to Follow-up|39
5705990|NCT00175019|19665461|P1|Overall Study|Lost to Follow-up|42
5705991|NCT00175019|19665459|P3|Overall Study|Protocol Violation|3
5705992|NCT00175019|19665460|P2|Overall Study|Protocol Violation|3
5705993|NCT00175019|19665461|P1|Overall Study|Protocol Violation|6
5705994|NCT00175019|19665459|P3|Overall Study|Adverse Event|2
5705995|NCT00175019|19665460|P2|Overall Study|Adverse Event|22
5705996|NCT00175019|19665461|P1|Overall Study|Adverse Event|54
5705997|NCT00174967|19665514|P4|Overall Study|Other|0
5705998|NCT00174967|19665515|P3|Overall Study|Other|0
5705999|NCT00174967|19665516|P2|Overall Study|Other|1
5706000|NCT00174967|19665517|P1|Overall Study|Other|0
5706001|NCT00174967|19665514|P4|Overall Study|Gout Flare|1
5706002|NCT00174967|19665515|P3|Overall Study|Gout Flare|0
5706003|NCT00174967|19665516|P2|Overall Study|Gout Flare|0
5706004|NCT00174967|19665517|P1|Overall Study|Gout Flare|0
5706005|NCT00174967|19665514|P4|Overall Study|Adverse Event|1
5706006|NCT00174967|19665515|P3|Overall Study|Adverse Event|2
5706007|NCT00174967|19665516|P2|Overall Study|Adverse Event|2
5706008|NCT00174967|19665517|P1|Overall Study|Adverse Event|1
5706009|NCT00174954|19665563|P1|Overall Study|Physician Decision|1
5706010|NCT00174954|19665563|P1|Overall Study|No tophi found in MRI|1
5706011|NCT00174954|19665563|P1|Overall Study|Adverse Event|2
5706012|NCT00174941|19665571|P4|Overall Study|Reason Not Specified|9
5706013|NCT00174941|19665572|P3|Overall Study|Reason Not Specified|2
5706014|NCT00174941|19665573|P2|Overall Study|Reason Not Specified|6
5706015|NCT00174941|19665574|P1|Overall Study|Reason Not Specified|1
5706016|NCT00174941|19665571|P4|Overall Study|Gout Flare|8
5706017|NCT00174941|19665572|P3|Overall Study|Gout Flare|4
5706018|NCT00174941|19665573|P2|Overall Study|Gout Flare|4
5706019|NCT00174941|19665574|P1|Overall Study|Gout Flare|0
5706020|NCT00174941|19665571|P4|Overall Study|Personal Reason(s)|22
5706021|NCT00174941|19665572|P3|Overall Study|Personal Reason(s)|8
5706022|NCT00174941|19665573|P2|Overall Study|Personal Reason(s)|14
5706023|NCT00174941|19665574|P1|Overall Study|Personal Reason(s)|0
5706024|NCT00174941|19665571|P4|Overall Study|Lost to Follow-up|5
5706025|NCT00174941|19665572|P3|Overall Study|Lost to Follow-up|2
5706026|NCT00174941|19665573|P2|Overall Study|Lost to Follow-up|3
5706027|NCT00174941|19665574|P1|Overall Study|Lost to Follow-up|0
5706028|NCT00174941|19665571|P4|Overall Study|Protocol Violation|1
5706029|NCT00174941|19665572|P3|Overall Study|Protocol Violation|0
5706030|NCT00174941|19665573|P2|Overall Study|Protocol Violation|1
5706031|NCT00174941|19665574|P1|Overall Study|Protocol Violation|0
5706032|NCT00174941|19665571|P4|Overall Study|Adverse Event|13
5706033|NCT00174941|19665572|P3|Overall Study|Adverse Event|2
5706034|NCT00174941|19665573|P2|Overall Study|Adverse Event|10
5706035|NCT00174941|19665574|P1|Overall Study|Adverse Event|1
5706036|NCT00174915|19665649|P5|Overall Study|Therapeutic Failure|3
5706037|NCT00174915|19665650|P4|Overall Study|Therapeutic Failure|1
5706038|NCT00174915|19665651|P3|Overall Study|Therapeutic Failure|2
5706039|NCT00174915|19665652|P2|Overall Study|Therapeutic Failure|3
5706040|NCT00174915|19665653|P1|Overall Study|Therapeutic Failure|6
5706041|NCT00174915|19665649|P5|Overall Study|Protocol Violation|3
5706042|NCT00174915|19665650|P4|Overall Study|Protocol Violation|6
5706043|NCT00174915|19665651|P3|Overall Study|Protocol Violation|3
5706044|NCT00174915|19665652|P2|Overall Study|Protocol Violation|3
5706045|NCT00174915|19665653|P1|Overall Study|Protocol Violation|6
5706046|NCT00174915|19665649|P5|Overall Study|Gout Flare|0
5706047|NCT00174915|19665650|P4|Overall Study|Gout Flare|1
5706048|NCT00174915|19665651|P3|Overall Study|Gout Flare|8
5706049|NCT00174915|19665652|P2|Overall Study|Gout Flare|6
5706050|NCT00174915|19665653|P1|Overall Study|Gout Flare|13
5706051|NCT00174915|19665649|P5|Overall Study|Other|3
5706052|NCT00174915|19665650|P4|Overall Study|Other|5
5706053|NCT00174915|19665651|P3|Overall Study|Other|6
5706054|NCT00174915|19665652|P2|Overall Study|Other|8
5706055|NCT00174915|19665653|P1|Overall Study|Other|15
5706056|NCT00174915|19665649|P5|Overall Study|Personal Reason(s)|9
5706057|NCT00174915|19665650|P4|Overall Study|Personal Reason(s)|9
5706058|NCT00174915|19665651|P3|Overall Study|Personal Reason(s)|9
5706059|NCT00174915|19665652|P2|Overall Study|Personal Reason(s)|16
5706060|NCT00174915|19665653|P1|Overall Study|Personal Reason(s)|16
5706061|NCT00174915|19665649|P5|Overall Study|Adverse Event|5
5706062|NCT00174915|19665650|P4|Overall Study|Adverse Event|18
5706063|NCT00174915|19665651|P3|Overall Study|Adverse Event|11
5706064|NCT00174915|19665652|P2|Overall Study|Adverse Event|16
5706065|NCT00174915|19665653|P1|Overall Study|Adverse Event|18
5706066|NCT00174915|19665649|P5|Overall Study|Lost to Follow-up|10
5706067|NCT00174915|19665650|P4|Overall Study|Lost to Follow-up|17
5706068|NCT00174915|19665651|P3|Overall Study|Lost to Follow-up|9
5706069|NCT00174915|19665652|P2|Overall Study|Lost to Follow-up|17
5706070|NCT00174915|19665653|P1|Overall Study|Lost to Follow-up|19
5706071|NCT00174785|19665712|P2|Overall Study|Not pre-specified/Not coded|70
5706072|NCT00174785|19665713|P1|Overall Study|Not pre-specified/Not coded|56
5706073|NCT00174785|19665712|P2|Overall Study|Family request|8
5706074|NCT00174785|19665713|P1|Overall Study|Family request|6
5706075|NCT00174785|19665712|P2|Overall Study|Other prohibited medication|3
5706076|NCT00174785|19665713|P1|Overall Study|Other prohibited medication|5
5706077|NCT00174785|19665712|P2|Overall Study|Prohibited antiarrhythmic medication|88
5706078|NCT00174785|19665713|P1|Overall Study|Prohibited antiarrhythmic medication|39
5706079|NCT00174785|19665712|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
5706080|NCT00174785|19665713|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
5706081|NCT00174785|19665712|P2|Overall Study|Withdrawal by Subject|175
5706082|NCT00174785|19665713|P1|Overall Study|Withdrawal by Subject|173
5706083|NCT00174785|19665712|P2|Overall Study|Protocol Violation|14
5706084|NCT00174785|19665713|P1|Overall Study|Protocol Violation|14
5706085|NCT00174785|19665712|P2|Overall Study|Adverse Event|191
5706086|NCT00174785|19665713|P1|Overall Study|Adverse Event|293
5706087|NCT00174460|19665729|P2|Overall Study|Withdrawal by Subject|1
5706088|NCT00174460|19665730|P1|Overall Study|Withdrawal by Subject|0
5706089|NCT00174447|19665776|P1|Overall Study|Administrative reason/Other|2
5706090|NCT00174447|19665776|P1|Overall Study|Lack of Efficacy|1
5706091|NCT00174447|19665776|P1|Overall Study|Protocol Violation|1
5706092|NCT00174447|19665776|P1|Overall Study|Withdrawal by Subject|15
5706093|NCT00174447|19665776|P1|Overall Study|Adverse Event|19
5706094|NCT00174382|19665785|P1|Overall Study|Lost to Follow-up|1
5706095|NCT00174382|19665785|P1|Overall Study|Subject felt pill not effective enough|1
5706096|NCT00174382|19665785|P1|Overall Study|Arrived early for last visit in error|1
5706097|NCT00174382|19665785|P1|Overall Study|Protocol Violation|3
5706098|NCT00174382|19665785|P1|Overall Study|Withdrawal by Subject|6
5706099|NCT00174382|19665785|P1|Overall Study|Adverse Event|19
5706100|NCT00174382|19665785|P1|Overall Study|Death|2
5706101|NCT00174291|19665804|P2|Overall Study|Withdrawal by Subject|3
5706102|NCT00174291|19665805|P1|Overall Study|Withdrawal by Subject|3
5706103|NCT00174291|19665804|P2|Overall Study|Study terminated by sponsor|0
5706104|NCT00174291|19665805|P1|Overall Study|Study terminated by sponsor|1
5706105|NCT00174291|19665804|P2|Overall Study|Protocol Violation|2
5706106|NCT00174291|19665805|P1|Overall Study|Protocol Violation|0
5706107|NCT00174291|19665804|P2|Overall Study|Lost to Follow-up|1
5706108|NCT00174291|19665805|P1|Overall Study|Lost to Follow-up|1
5706109|NCT00174265|19665835|P2|Overall Study|Other (Not specified)|10
5706110|NCT00174265|19665836|P1|Overall Study|Other (Not specified)|16
5706111|NCT00174265|19665835|P2|Overall Study|Lost to Follow-up|0
5706112|NCT00174265|19665836|P1|Overall Study|Lost to Follow-up|1
5706113|NCT00174265|19665835|P2|Overall Study|Withdrawal by Subject|5
5706114|NCT00174265|19665836|P1|Overall Study|Withdrawal by Subject|3
5706115|NCT00174265|19665835|P2|Overall Study|Lack of Efficacy|2
5706116|NCT00174265|19665836|P1|Overall Study|Lack of Efficacy|2
5706117|NCT00174265|19665835|P2|Overall Study|Adverse Event|4
5706118|NCT00174265|19665836|P1|Overall Study|Adverse Event|7
5706119|NCT00174252|19665844|P1|Overall Study|Protocol Violation|2
5706120|NCT00174187|19665879|P3|Period 2 (After 3 Years)|Other|5
5706121|NCT00174187|19665880|P2|Period 2 (After 3 Years)|Other|0
5706122|NCT00174187|19665881|P1|Period 2 (After 3 Years)|Other|0
5706123|NCT00174187|19665879|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
5706124|NCT00174187|19665880|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
5706125|NCT00174187|19665881|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
5706126|NCT00174187|19665879|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
5706127|NCT00174187|19665880|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
5706128|NCT00174187|19665881|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
5706129|NCT00174187|19665879|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
5706130|NCT00174187|19665880|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
5706131|NCT00174187|19665881|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
5706132|NCT00174187|19665879|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
5706133|NCT00174187|19665880|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
5706134|NCT00174187|19665881|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
5706135|NCT00174187|19665879|P3|Period 1 (up to 3 Years)|Other|0
5706136|NCT00174187|19665880|P2|Period 1 (up to 3 Years)|Other|1
5706137|NCT00174187|19665881|P1|Period 1 (up to 3 Years)|Other|0
5706138|NCT00174187|19665879|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
5706139|NCT00174187|19665880|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
5706140|NCT00174187|19665881|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
5706141|NCT00174187|19665879|P3|Period 1 (up to 3 Years)|Non compliance|0
5706142|NCT00174187|19665880|P2|Period 1 (up to 3 Years)|Non compliance|1
5706143|NCT00174187|19665881|P1|Period 1 (up to 3 Years)|Non compliance|0
5706144|NCT00174187|19665879|P3|Period 1 (up to 3 Years)|Serious adverse event|0
5706145|NCT00174187|19665880|P2|Period 1 (up to 3 Years)|Serious adverse event|1
5706146|NCT00174187|19665881|P1|Period 1 (up to 3 Years)|Serious adverse event|0
5706147|NCT00172185|19665946|P4|Overall Study|Withdrawal by Subject|0
5706148|NCT00172185|19665947|P3|Overall Study|Withdrawal by Subject|1
5706149|NCT00172185|19665948|P2|Overall Study|Withdrawal by Subject|0
5706150|NCT00172185|19665949|P1|Overall Study|Withdrawal by Subject|0
5706151|NCT00172185|19665946|P4|Overall Study|SPONSOR Decision|0
5706152|NCT00172185|19665947|P3|Overall Study|SPONSOR Decision|0
5706153|NCT00172185|19665948|P2|Overall Study|SPONSOR Decision|1
5706154|NCT00172185|19665949|P1|Overall Study|SPONSOR Decision|0
5706155|NCT00172185|19665946|P4|Overall Study|Physician Decision|0
5706156|NCT00172185|19665947|P3|Overall Study|Physician Decision|1
5706157|NCT00172185|19665948|P2|Overall Study|Physician Decision|0
5706158|NCT00172185|19665949|P1|Overall Study|Physician Decision|0
5706159|NCT00172185|19665946|P4|Overall Study|Adverse Event|4
5706160|NCT00172185|19665947|P3|Overall Study|Adverse Event|3
5706161|NCT00172185|19665948|P2|Overall Study|Adverse Event|1
5706162|NCT00172185|19665949|P1|Overall Study|Adverse Event|0
5706163|NCT00172042|19665965|P2|Overall Study|Death|42
5706164|NCT00172042|19665966|P1|Overall Study|Death|42
5706165|NCT00172042|19665965|P2|Overall Study|Administrative problems|10
5706166|NCT00172042|19665966|P1|Overall Study|Administrative problems|13
5706167|NCT00172042|19665965|P2|Overall Study|Lost to Follow-up|5
5706168|NCT00172042|19665966|P1|Overall Study|Lost to Follow-up|3
5706169|NCT00172042|19665965|P2|Overall Study|Withdrawal by Subject|25
5706170|NCT00172042|19665966|P1|Overall Study|Withdrawal by Subject|37
5706171|NCT00172042|19665965|P2|Overall Study|Protocol Violation|7
5706172|NCT00172042|19665966|P1|Overall Study|Protocol Violation|8
5706173|NCT00172042|19665965|P2|Overall Study|Patient no longer requires study drug|8
5706174|NCT00172042|19665966|P1|Overall Study|Patient no longer requires study drug|10
5706175|NCT00172042|19665965|P2|Overall Study|Unsatisfactory therapeutic effect|11
5706176|NCT00172042|19665966|P1|Overall Study|Unsatisfactory therapeutic effect|13
5706177|NCT00172042|19665965|P2|Overall Study|Abnormal test procedure(s)|3
5706178|NCT00172042|19665966|P1|Overall Study|Abnormal test procedure(s)|0
5706179|NCT00172042|19665965|P2|Overall Study|Abnormal laboratory value(s)|1
5706180|NCT00172042|19665966|P1|Overall Study|Abnormal laboratory value(s)|5
5706181|NCT00172042|19665965|P2|Overall Study|Adverse Event|13
5706182|NCT00172042|19665966|P1|Overall Study|Adverse Event|27
5706183|NCT00171925|19665988|P2|Overall Study|Death|2
5706184|NCT00171925|19665989|P1|Overall Study|Death|1
5706185|NCT00171925|19665988|P2|Overall Study|Administrative problems|11
5706186|NCT00171925|19665989|P1|Overall Study|Administrative problems|10
5706187|NCT00171925|19665988|P2|Overall Study|Lost to Follow-up|2
5706188|NCT00171925|19665989|P1|Overall Study|Lost to Follow-up|2
5706189|NCT00171925|19665988|P2|Overall Study|Withdrawal by Subject|9
5706190|NCT00171925|19665989|P1|Overall Study|Withdrawal by Subject|6
5706191|NCT00171925|19665988|P2|Overall Study|Protocol Violation|1
5706192|NCT00171925|19665989|P1|Overall Study|Protocol Violation|1
5706193|NCT00171925|19665988|P2|Overall Study|Adverse Event|6
5706194|NCT00171925|19665989|P1|Overall Study|Adverse Event|10
5706195|NCT00171873|19666001|P2|Overall Study|Switched to Octreotide|1
5706196|NCT00171873|19666002|P1|Overall Study|Switched to Octreotide|0
5706197|NCT00171873|19666001|P2|Overall Study|Adverse Event|0
5706198|NCT00171873|19666002|P1|Overall Study|Adverse Event|5
5706199|NCT00171873|19666001|P2|Overall Study|Withdrawal by Subject|2
5706200|NCT00171873|19666002|P1|Overall Study|Withdrawal by Subject|4
5706201|NCT00171834|19666015|P7|Overall Study|Treatment Duration Completed|0
5706202|NCT00171834|19666016|P6|Overall Study|Treatment Duration Completed|1
5706203|NCT00171834|19666017|P5|Overall Study|Treatment Duration Completed|2
5706204|NCT00171834|19666018|P4|Overall Study|Treatment Duration Completed|0
5706205|NCT00171834|19666019|P3|Overall Study|Treatment Duration Completed|1
5706206|NCT00171834|19666020|P2|Overall Study|Treatment Duration Completed|0
5706207|NCT00171834|19666021|P1|Overall Study|Treatment Duration Completed|0
5706208|NCT00171834|19666015|P7|Overall Study|Disease Progression|3
5706209|NCT00171834|19666016|P6|Overall Study|Disease Progression|18
5706210|NCT00171834|19666017|P5|Overall Study|Disease Progression|2
5706211|NCT00171834|19666018|P4|Overall Study|Disease Progression|9
5706212|NCT00171834|19666019|P3|Overall Study|Disease Progression|8
5706213|NCT00171834|19666020|P2|Overall Study|Disease Progression|8
5706214|NCT00171834|19666021|P1|Overall Study|Disease Progression|4
5706215|NCT00171834|19666015|P7|Overall Study|Death from study indication|0
5706216|NCT00171834|19666016|P6|Overall Study|Death from study indication|0
5706217|NCT00171834|19666017|P5|Overall Study|Death from study indication|1
5706218|NCT00171834|19666018|P4|Overall Study|Death from study indication|0
5706219|NCT00171834|19666019|P3|Overall Study|Death from study indication|0
5706220|NCT00171834|19666020|P2|Overall Study|Death from study indication|1
5706221|NCT00171834|19666021|P1|Overall Study|Death from study indication|0
5706222|NCT00171834|19666015|P7|Overall Study|Withdrawal by Subject|0
5706223|NCT00171834|19666016|P6|Overall Study|Withdrawal by Subject|1
5706224|NCT00171834|19666017|P5|Overall Study|Withdrawal by Subject|1
5706225|NCT00171834|19666018|P4|Overall Study|Withdrawal by Subject|1
5706226|NCT00171834|19666019|P3|Overall Study|Withdrawal by Subject|0
5706227|NCT00171834|19666020|P2|Overall Study|Withdrawal by Subject|2
5706228|NCT00171834|19666021|P1|Overall Study|Withdrawal by Subject|0
5706229|NCT00171834|19666015|P7|Overall Study|Adverse Event|1
5706230|NCT00171834|19666016|P6|Overall Study|Adverse Event|15
5706231|NCT00171834|19666017|P5|Overall Study|Adverse Event|2
5706232|NCT00171834|19666018|P4|Overall Study|Adverse Event|2
5706233|NCT00171834|19666019|P3|Overall Study|Adverse Event|3
5706234|NCT00171834|19666020|P2|Overall Study|Adverse Event|1
5706235|NCT00171834|19666021|P1|Overall Study|Adverse Event|2
5706236|NCT00171704|19666061|P2|Overall Study|Protocol Violation|1
5706237|NCT00171704|19666062|P1|Overall Study|Protocol Violation|0
5706238|NCT00171704|19666061|P2|Overall Study|Withdrawal by Subject|3
5706239|NCT00171704|19666062|P1|Overall Study|Withdrawal by Subject|1
5706240|NCT00171704|19666061|P2|Overall Study|Death|2
5706241|NCT00171704|19666062|P1|Overall Study|Death|2
5706242|NCT00171704|19666061|P2|Overall Study|Administrative Problems|1
5706243|NCT00171704|19666062|P1|Overall Study|Administrative Problems|2
5706244|NCT00171704|19666061|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
5706245|NCT00171704|19666062|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
5706246|NCT00171704|19666061|P2|Overall Study|Disease Progression|9
5706247|NCT00171704|19666062|P1|Overall Study|Disease Progression|14
5706248|NCT00171704|19666061|P2|Overall Study|Adverse Event|33
5706249|NCT00171704|19666062|P1|Overall Study|Adverse Event|24
5706250|NCT00171340|19666084|P2|Overall Study|Death|6
5706251|NCT00171340|19666085|P1|Overall Study|Death|6
5706252|NCT00171340|19666084|P2|Overall Study|Administrative Problems|2
5706253|NCT00171340|19666085|P1|Overall Study|Administrative Problems|5
5706254|NCT00171340|19666084|P2|Overall Study|No Longer Required Study Drug|1
5706255|NCT00171340|19666085|P1|Overall Study|No Longer Required Study Drug|1
5706256|NCT00171340|19666084|P2|Overall Study|Abnormal Test Procedure Results|11
5706257|NCT00171340|19666085|P1|Overall Study|Abnormal Test Procedure Results|6
5706258|NCT00171340|19666084|P2|Overall Study|Abnormal Laboratory Results|0
5706259|NCT00171340|19666085|P1|Overall Study|Abnormal Laboratory Results|2
5706260|NCT00171340|19666084|P2|Overall Study|Lost to Follow-up|5
5706261|NCT00171340|19666085|P1|Overall Study|Lost to Follow-up|0
5706262|NCT00171340|19666084|P2|Overall Study|Withdrawal by Subject|19
5706263|NCT00171340|19666085|P1|Overall Study|Withdrawal by Subject|22
5706264|NCT00171340|19666084|P2|Overall Study|Protocol Violation|8
5706265|NCT00171340|19666085|P1|Overall Study|Protocol Violation|7
5706266|NCT00171340|19666084|P2|Overall Study|Lack of Efficacy|41
5706267|NCT00171340|19666085|P1|Overall Study|Lack of Efficacy|29
5706268|NCT00171340|19666084|P2|Overall Study|Adverse Event|42
5706269|NCT00171340|19666085|P1|Overall Study|Adverse Event|46
5706270|NCT00171314|19666101|P2|Overall Study|Death|1
5706271|NCT00171314|19666102|P1|Overall Study|Death|2
5706272|NCT00171314|19666101|P2|Overall Study|Lost to Follow-up|3
5706273|NCT00171314|19666102|P1|Overall Study|Lost to Follow-up|1
5706274|NCT00171314|19666101|P2|Overall Study|Administrative Problems|3
5706275|NCT00171314|19666102|P1|Overall Study|Administrative Problems|4
5706276|NCT00171314|19666101|P2|Overall Study|Protocol Violation|7
5706277|NCT00171314|19666102|P1|Overall Study|Protocol Violation|3
5706278|NCT00171314|19666101|P2|Overall Study|Abnormal Test Procedure Results|3
5706279|NCT00171314|19666102|P1|Overall Study|Abnormal Test Procedure Results|9
5706280|NCT00171314|19666101|P2|Overall Study|Withdrawal by Subject|6
5706281|NCT00171314|19666102|P1|Overall Study|Withdrawal by Subject|9
5706282|NCT00171314|19666101|P2|Overall Study|Lack of Efficacy|14
5706283|NCT00171314|19666102|P1|Overall Study|Lack of Efficacy|19
5706284|NCT00171314|19666101|P2|Overall Study|Adverse Event|41
5706285|NCT00171314|19666102|P1|Overall Study|Adverse Event|44
5706286|NCT00171301|19666118|P2|Overall Study|Withdrawal by Subject|1
5706287|NCT00171301|19666119|P1|Overall Study|Withdrawal by Subject|0
5706288|NCT00171301|19666118|P2|Overall Study|Protocol Violation|2
5706289|NCT00171301|19666119|P1|Overall Study|Protocol Violation|0
5706290|NCT00171301|19666118|P2|Overall Study|Lost to Follow-up|2
5706291|NCT00171301|19666119|P1|Overall Study|Lost to Follow-up|6
5706292|NCT00171301|19666118|P2|Overall Study|Adverse Event|2
5706293|NCT00171301|19666119|P1|Overall Study|Adverse Event|1
5706294|NCT00171301|19666118|P2|Overall Study|Death|2
5706295|NCT00171301|19666119|P1|Overall Study|Death|1
5706296|NCT00171210|19666132|P2|Overall Study|Stopped at end of extension 1|1
5706297|NCT00171210|19666133|P1|Overall Study|Stopped at end of extension 1|0
5706298|NCT00171210|19666132|P2|Overall Study|Stopped at end of core|32
5706299|NCT00171210|19666133|P1|Overall Study|Stopped at end of core|0
5706300|NCT00171210|19666132|P2|Overall Study|Death|3
5706301|NCT00171210|19666133|P1|Overall Study|Death|2
5706302|NCT00171210|19666132|P2|Overall Study|Administrative problems|1
5706303|NCT00171210|19666133|P1|Overall Study|Administrative problems|1
5706304|NCT00171210|19666132|P2|Overall Study|Lost to Follow-up|0
5706305|NCT00171210|19666133|P1|Overall Study|Lost to Follow-up|1
5706306|NCT00171210|19666132|P2|Overall Study|Withdrawal by Subject|30
5706307|NCT00171210|19666133|P1|Overall Study|Withdrawal by Subject|32
5706308|NCT00171210|19666132|P2|Overall Study|Protocol Violation|2
5706309|NCT00171210|19666133|P1|Overall Study|Protocol Violation|0
5706310|NCT00171210|19666132|P2|Overall Study|Unsatisfactory therapeutic effect|15
5706311|NCT00171210|19666133|P1|Overall Study|Unsatisfactory therapeutic effect|11
5706312|NCT00171210|19666132|P2|Overall Study|Abnormal test procedure result(s)|1
5706313|NCT00171210|19666133|P1|Overall Study|Abnormal test procedure result(s)|0
5706314|NCT00171210|19666132|P2|Overall Study|Abnormal laboratory value(s)|3
5706315|NCT00171210|19666133|P1|Overall Study|Abnormal laboratory value(s)|6
5706316|NCT00171210|19666132|P2|Overall Study|Adverse Event|27
5706317|NCT00171210|19666133|P1|Overall Study|Adverse Event|16
5706318|NCT00171054|19666163|P2|Overall Study|Condition no longer required study drug|1
5706319|NCT00171054|19666164|P1|Overall Study|Condition no longer required study drug|0
5706320|NCT00171054|19666163|P2|Overall Study|Adverse Event|8
5706321|NCT00171054|19666164|P1|Overall Study|Adverse Event|8
5706322|NCT00171054|19666163|P2|Overall Study|Lost to Follow-up|1
5706323|NCT00171054|19666164|P1|Overall Study|Lost to Follow-up|0
5706324|NCT00171054|19666163|P2|Overall Study|Patient withdrew consent|0
5706325|NCT00171054|19666164|P1|Overall Study|Patient withdrew consent|1
5706326|NCT00171054|19666163|P2|Overall Study|Protocol Violation|2
5706327|NCT00171054|19666164|P1|Overall Study|Protocol Violation|1
5706328|NCT00170950|19666196|P2|Overall Study|Termination Data Not Recorded|22
5706329|NCT00170950|19666197|P1|Overall Study|Termination Data Not Recorded|17
5706330|NCT00170950|19666196|P2|Overall Study|Missing|1
5706331|NCT00170950|19666197|P1|Overall Study|Missing|2
5706332|NCT00170950|19666196|P2|Overall Study|Lost to Follow-up|115
5706333|NCT00170950|19666197|P1|Overall Study|Lost to Follow-up|134
5706334|NCT00170950|19666196|P2|Overall Study|Withdrawal by Subject|498
5706335|NCT00170950|19666197|P1|Overall Study|Withdrawal by Subject|496
5706336|NCT00170950|19666196|P2|Overall Study|Death|274
5706337|NCT00170950|19666197|P1|Overall Study|Death|236
5706338|NCT00170846|19666210|P3|Overall Study|Reason Missing|0
5706339|NCT00170846|19666211|P2|Overall Study|Reason Missing|1
5706340|NCT00170846|19666212|P1|Overall Study|Reason Missing|0
5706341|NCT00170846|19666210|P3|Overall Study|Death|3
5706342|NCT00170846|19666211|P2|Overall Study|Death|3
5706343|NCT00170846|19666212|P1|Overall Study|Death|0
5706344|NCT00170846|19666210|P3|Overall Study|Lost to Follow-up|2
5706345|NCT00170846|19666211|P2|Overall Study|Lost to Follow-up|3
5706346|NCT00170846|19666212|P1|Overall Study|Lost to Follow-up|6
5706347|NCT00170846|19666210|P3|Overall Study|Subject withdrew Informed Consent|8
5706348|NCT00170846|19666211|P2|Overall Study|Subject withdrew Informed Consent|12
5706349|NCT00170846|19666212|P1|Overall Study|Subject withdrew Informed Consent|5
5706350|NCT00169442|19666244|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
5706351|NCT00169442|19666245|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
5706352|NCT00169442|19666246|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
5706353|NCT00169442|19666247|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
5706354|NCT00169442|19666248|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
5706355|NCT00169442|19666249|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
5706356|NCT00169442|19666244|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
5706357|NCT00169442|19666245|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
5706358|NCT00169442|19666246|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
5706359|NCT00169442|19666247|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
5706360|NCT00169442|19666248|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
5706361|NCT00169442|19666249|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
5706362|NCT00169442|19666244|P6|Overall Study|Migrated/moved from study area|2
5706363|NCT00169442|19666245|P5|Overall Study|Migrated/moved from study area|0
5706364|NCT00169442|19666246|P4|Overall Study|Migrated/moved from study area|0
5706365|NCT00169442|19666247|P3|Overall Study|Migrated/moved from study area|0
5706366|NCT00169442|19666248|P2|Overall Study|Migrated/moved from study area|0
5706367|NCT00169442|19666249|P1|Overall Study|Migrated/moved from study area|0
5706368|NCT00169442|19666244|P6|Overall Study|Withdrawal by Subject|0
5706369|NCT00169442|19666245|P5|Overall Study|Withdrawal by Subject|0
5706370|NCT00169442|19666246|P4|Overall Study|Withdrawal by Subject|0
5706371|NCT00169442|19666247|P3|Overall Study|Withdrawal by Subject|1
5706372|NCT00169442|19666248|P2|Overall Study|Withdrawal by Subject|0
5706373|NCT00169442|19666249|P1|Overall Study|Withdrawal by Subject|0
5706374|NCT00169104|19666358|P2|Overall Study|Physician Decision|1
5706375|NCT00169104|19666359|P1|Overall Study|Physician Decision|0
5706376|NCT00169104|19666358|P2|Overall Study|Protocol Violation|1
5706377|NCT00169104|19666359|P1|Overall Study|Protocol Violation|0
5706378|NCT00169104|19666358|P2|Overall Study|Withdrawal by Subject|0
5706379|NCT00169104|19666359|P1|Overall Study|Withdrawal by Subject|2
5706380|NCT00168844|19666373|P3|Overall Study|Other|9
5706381|NCT00168844|19666374|P2|Overall Study|Other|7
5706382|NCT00168844|19666375|P1|Overall Study|Other|6
5706383|NCT00168844|19666373|P3|Overall Study|Protocol Violation|4
5706384|NCT00168844|19666374|P2|Overall Study|Protocol Violation|2
5706385|NCT00168844|19666375|P1|Overall Study|Protocol Violation|2
5706386|NCT00168844|19666373|P3|Overall Study|Withdrawal by Subject|19
5706387|NCT00168844|19666374|P2|Overall Study|Withdrawal by Subject|9
5706388|NCT00168844|19666375|P1|Overall Study|Withdrawal by Subject|12
5706389|NCT00168844|19666373|P3|Overall Study|Lost to Follow-up|11
5706390|NCT00168844|19666374|P2|Overall Study|Lost to Follow-up|5
5706391|NCT00168844|19666375|P1|Overall Study|Lost to Follow-up|4
5706392|NCT00168844|19666373|P3|Overall Study|Adverse Event|48
5706393|NCT00168844|19666374|P2|Overall Study|Adverse Event|32
5706394|NCT00168844|19666375|P1|Overall Study|Adverse Event|31
5706395|NCT00168831|19666557|P3|Overall Study|Other|6
5706396|NCT00168831|19666558|P2|Overall Study|Other|3
5706397|NCT00168831|19666559|P1|Overall Study|Other|6
5706398|NCT00168831|19666557|P3|Overall Study|Protocol Violation|11
5706399|NCT00168831|19666558|P2|Overall Study|Protocol Violation|11
5706400|NCT00168831|19666559|P1|Overall Study|Protocol Violation|6
5706401|NCT00168831|19666557|P3|Overall Study|Withdrawal by Subject|19
5706402|NCT00168831|19666558|P2|Overall Study|Withdrawal by Subject|14
5706403|NCT00168831|19666559|P1|Overall Study|Withdrawal by Subject|7
5706404|NCT00168831|19666557|P3|Overall Study|Lost to Follow-up|4
5706405|NCT00168831|19666558|P2|Overall Study|Lost to Follow-up|6
5706406|NCT00168831|19666559|P1|Overall Study|Lost to Follow-up|5
5706407|NCT00168831|19666557|P3|Overall Study|Adverse Event|74
5706408|NCT00168831|19666558|P2|Overall Study|Adverse Event|47
5706409|NCT00168831|19666559|P1|Overall Study|Adverse Event|36
5706410|NCT00168818|19666741|P3|Treatment|Other|31
5706411|NCT00168818|19666742|P2|Treatment|Other|29
5706412|NCT00168818|19666743|P1|Treatment|Other|23
5706413|NCT00168818|19666741|P3|Treatment|Withdrawal by Subject|22
5706414|NCT00168818|19666742|P2|Treatment|Withdrawal by Subject|20
5706415|NCT00168818|19666743|P1|Treatment|Withdrawal by Subject|25
5706416|NCT00168818|19666741|P3|Treatment|Lost to Follow-up|1
5706417|NCT00168818|19666742|P2|Treatment|Lost to Follow-up|2
5706418|NCT00168818|19666743|P1|Treatment|Lost to Follow-up|0
5706419|NCT00168818|19666741|P3|Treatment|Protocol Violation|11
5706420|NCT00168818|19666742|P2|Treatment|Protocol Violation|11
5706421|NCT00168818|19666743|P1|Treatment|Protocol Violation|8
5706422|NCT00168818|19666741|P3|Treatment|Adverse Event|68
5706423|NCT00168818|19666742|P2|Treatment|Adverse Event|89
5706424|NCT00168818|19666743|P1|Treatment|Adverse Event|77
5706425|NCT00168818|19666741|P3|Overall Study|Other|30
5706426|NCT00168818|19666742|P2|Overall Study|Other|24
5706427|NCT00168818|19666743|P1|Overall Study|Other|22
5706428|NCT00168818|19666741|P3|Overall Study|Withdrawal by Subject|37
5706429|NCT00168818|19666742|P2|Overall Study|Withdrawal by Subject|41
5706430|NCT00168818|19666743|P1|Overall Study|Withdrawal by Subject|43
5706431|NCT00168818|19666741|P3|Overall Study|Lost to Follow-up|15
5706432|NCT00168818|19666742|P2|Overall Study|Lost to Follow-up|4
5706433|NCT00168818|19666743|P1|Overall Study|Lost to Follow-up|13
5706434|NCT00168818|19666741|P3|Overall Study|Protocol Violation|11
5706435|NCT00168818|19666742|P2|Overall Study|Protocol Violation|11
5706436|NCT00168818|19666743|P1|Overall Study|Protocol Violation|16
5706437|NCT00168818|19666741|P3|Overall Study|Adverse Event|31
5706438|NCT00168818|19666742|P2|Overall Study|Adverse Event|29
5706439|NCT00168818|19666743|P1|Overall Study|Adverse Event|23
5706440|NCT00168805|19666787|P3|Treatment|Other|17
5706441|NCT00168805|19666788|P2|Treatment|Other|18
5706442|NCT00168805|19666789|P1|Treatment|Other|18
5706443|NCT00168805|19666787|P3|Treatment|Withdrawal by Subject|8
5706444|NCT00168805|19666788|P2|Treatment|Withdrawal by Subject|7
5706445|NCT00168805|19666789|P1|Treatment|Withdrawal by Subject|3
5706446|NCT00168805|19666787|P3|Treatment|Protocol Violation|5
5706447|NCT00168805|19666788|P2|Treatment|Protocol Violation|5
5706448|NCT00168805|19666789|P1|Treatment|Protocol Violation|3
5706449|NCT00168805|19666787|P3|Treatment|Adverse Event|32
5706450|NCT00168805|19666788|P2|Treatment|Adverse Event|26
5706451|NCT00168805|19666789|P1|Treatment|Adverse Event|25
5706452|NCT00168805|19666787|P3|Overall Study|Other|22
5706453|NCT00168805|19666788|P2|Overall Study|Other|21
5706454|NCT00168805|19666789|P1|Overall Study|Other|24
5706455|NCT00168805|19666787|P3|Overall Study|Withdrawal by Subject|21
5706456|NCT00168805|19666788|P2|Overall Study|Withdrawal by Subject|18
5706457|NCT00168805|19666789|P1|Overall Study|Withdrawal by Subject|16
5706458|NCT00168805|19666787|P3|Overall Study|Lost to Follow-up|11
5706459|NCT00168805|19666788|P2|Overall Study|Lost to Follow-up|17
5706460|NCT00168805|19666789|P1|Overall Study|Lost to Follow-up|12
5706461|NCT00168805|19666787|P3|Overall Study|Protocol Violation|8
5706462|NCT00168805|19666788|P2|Overall Study|Protocol Violation|11
5706463|NCT00168805|19666789|P1|Overall Study|Protocol Violation|12
5706464|NCT00168805|19666787|P3|Overall Study|Adverse Event|16
5706465|NCT00168805|19666788|P2|Overall Study|Adverse Event|11
5706466|NCT00168805|19666789|P1|Overall Study|Adverse Event|7
5706467|NCT00168103|19667025|P4|Overall Study|Lost to Follow-up|0
5706468|NCT00168103|19667026|P3|Overall Study|Lost to Follow-up|0
5706469|NCT00168103|19667027|P2|Overall Study|Lost to Follow-up|3
5706470|NCT00168103|19667028|P1|Overall Study|Lost to Follow-up|1
5706471|NCT00168103|19667025|P4|Overall Study|Withdrawal by Subject|0
5706472|NCT00168103|19667026|P3|Overall Study|Withdrawal by Subject|1
5706473|NCT00168103|19667027|P2|Overall Study|Withdrawal by Subject|2
5706474|NCT00168103|19667028|P1|Overall Study|Withdrawal by Subject|1
5706475|NCT00168064|19667050|P2|Overall Study|Various|3
5706476|NCT00168064|19667051|P1|Overall Study|Various|4
5706477|NCT00168064|19667050|P2|Overall Study|Subject's Best interest|2
5706478|NCT00168064|19667051|P1|Overall Study|Subject's Best interest|2
5706479|NCT00168064|19667050|P2|Overall Study|Concurrent Illness|3
5706480|NCT00168064|19667051|P1|Overall Study|Concurrent Illness|4
5706481|NCT00168064|19667050|P2|Overall Study|Non-compliance|3
5706482|NCT00168064|19667051|P1|Overall Study|Non-compliance|2
5706483|NCT00168064|19667050|P2|Overall Study|Lost to Follow-up|3
5706484|NCT00168064|19667051|P1|Overall Study|Lost to Follow-up|4
5706485|NCT00168064|19667050|P2|Overall Study|Lack of Efficacy|4
5706486|NCT00168064|19667051|P1|Overall Study|Lack of Efficacy|4
5706487|NCT00168064|19667050|P2|Overall Study|Withdrawal by Subject|4
5706488|NCT00168064|19667051|P1|Overall Study|Withdrawal by Subject|3
5706489|NCT00168064|19667050|P2|Overall Study|Adverse Event|22
5706490|NCT00168064|19667051|P1|Overall Study|Adverse Event|26
5706491|NCT00168038|19667059|P1|Overall Study|Therapy failure|1
5706492|NCT00168038|19667059|P1|Overall Study|Adverse Event|1
5706493|NCT00167778|19667082|P1|Overall Study|Withdrawal by Subject|1
5706494|NCT00167414|19667161|P1|Overall Study|Death|10
5706495|NCT00167310|19667186|P2|Overall Study|Withdrawal by Subject|7
5706496|NCT00167310|19667187|P1|Overall Study|Withdrawal by Subject|3
5706497|NCT00167310|19667186|P2|Overall Study|Protocol Violation|3
5706498|NCT00167310|19667187|P1|Overall Study|Protocol Violation|5
5706499|NCT00167245|19667197|P2|Overall Study|Drowsy|0
5706500|NCT00167245|19667198|P1|Overall Study|Drowsy|1
5706501|NCT00167245|19667197|P2|Overall Study|Incarcerated|2
5706502|NCT00167245|19667198|P1|Overall Study|Incarcerated|3
5706503|NCT00167245|19667197|P2|Overall Study|Withdrawal by Subject|8
5706504|NCT00167245|19667198|P1|Overall Study|Withdrawal by Subject|5
5706505|NCT00167245|19667197|P2|Overall Study|Lost to Follow-up|31
5706506|NCT00167245|19667198|P1|Overall Study|Lost to Follow-up|20
5706507|NCT00166712|19667252|P2|Overall Study|Physician Decision|2
5706508|NCT00166712|19667253|P1|Overall Study|Physician Decision|0
5706509|NCT00166712|19667252|P2|Overall Study|Withdrawal by Subject|2
5706510|NCT00166712|19667253|P1|Overall Study|Withdrawal by Subject|1
5706511|NCT00166712|19667252|P2|Overall Study|Adverse Event|0
5706512|NCT00166712|19667253|P1|Overall Study|Adverse Event|1
5706513|NCT00166712|19667252|P2|Overall Study|Death|1
5706514|NCT00166712|19667253|P1|Overall Study|Death|0
5706515|NCT00166517|19667270|P2|Overall Study|Withdrawal by Subject|1
5706516|NCT00166517|19667271|P1|Overall Study|Withdrawal by Subject|0
5706517|NCT00166517|19667270|P2|Overall Study|Protocol Violation|1
5706518|NCT00166517|19667271|P1|Overall Study|Protocol Violation|4
5706519|NCT00166517|19667270|P2|Overall Study|Lost to Follow-up|0
5706520|NCT00166517|19667271|P1|Overall Study|Lost to Follow-up|1
5706521|NCT00166504|19667281|P2|Overall Study|Withdrawal by Subject|0
5706522|NCT00166504|19667282|P1|Overall Study|Withdrawal by Subject|1
5706523|NCT00166504|19667281|P2|Overall Study|Lost to Follow-up|1
5706524|NCT00166504|19667282|P1|Overall Study|Lost to Follow-up|1
5706525|NCT00166504|19667281|P2|Overall Study|Adverse Event|3
5706526|NCT00166504|19667282|P1|Overall Study|Adverse Event|3
5706527|NCT00166439|19667288|P1|Overall Study|Ineligible|5
5706528|NCT00166296|19667305|P2|Overall Study|Lost to Follow-up|2
5706529|NCT00166296|19667306|P1|Overall Study|Lost to Follow-up|4
5706530|NCT00166296|19667305|P2|Overall Study|Adverse Event|4
5706531|NCT00166296|19667306|P1|Overall Study|Adverse Event|2
5706532|NCT00166296|19667305|P2|Overall Study|Withdrawal by Subject|3
5706533|NCT00166296|19667306|P1|Overall Study|Withdrawal by Subject|1
5706534|NCT00166114|19667358|P2|Overall Study|Adverse Event|1
5706535|NCT00166114|19667359|P1|Overall Study|Adverse Event|2
5706536|NCT00166114|19667358|P2|Overall Study|Withdrawal by Subject|4
5706537|NCT00166114|19667359|P1|Overall Study|Withdrawal by Subject|10
5706538|NCT00166114|19667358|P2|Overall Study|Protocol Violation|1
5706539|NCT00166114|19667359|P1|Overall Study|Protocol Violation|2
5706540|NCT00165984|19667376|P1|Overall Study|Death|15
5706541|NCT00165841|19667394|P2|Overall Study|Medication Noncompliance|1
5706542|NCT00165841|19667395|P1|Overall Study|Medication Noncompliance|1
5706543|NCT00165841|19667394|P2|Overall Study|Other|5
5706544|NCT00165841|19667395|P1|Overall Study|Other|3
5706545|NCT00165841|19667394|P2|Overall Study|Protocol Violation|8
5706546|NCT00165841|19667395|P1|Overall Study|Protocol Violation|6
5706547|NCT00165841|19667394|P2|Overall Study|Physician Decision|0
5706548|NCT00165841|19667395|P1|Overall Study|Physician Decision|1
5706549|NCT00165841|19667394|P2|Overall Study|Withdrawal by Subject|8
5706550|NCT00165841|19667395|P1|Overall Study|Withdrawal by Subject|7
5706551|NCT00165841|19667394|P2|Overall Study|Lost to Follow-up|4
5706552|NCT00165841|19667395|P1|Overall Study|Lost to Follow-up|4
5706553|NCT00165841|19667394|P2|Overall Study|Lack of Efficacy|33
5706554|NCT00165841|19667395|P1|Overall Study|Lack of Efficacy|6
5706555|NCT00165841|19667394|P2|Overall Study|Adverse Event|3
5706556|NCT00165841|19667395|P1|Overall Study|Adverse Event|2
5706557|NCT00165789|19667405|P4|Overall Study|Withdrawal by Subject|2
5706558|NCT00165789|19667406|P3|Overall Study|Withdrawal by Subject|1
5706559|NCT00165789|19667407|P2|Overall Study|Withdrawal by Subject|1
5706560|NCT00165789|19667408|P1|Overall Study|Withdrawal by Subject|0
5706561|NCT00165789|19667405|P4|Overall Study|Adverse Event|12
5706562|NCT00165789|19667406|P3|Overall Study|Adverse Event|0
5706563|NCT00165789|19667407|P2|Overall Study|Adverse Event|3
5706564|NCT00165789|19667408|P1|Overall Study|Adverse Event|0
5706565|NCT00165776|19667462|P4|Overall Study|Worsening of Cervical Dystonia|1
5706566|NCT00165776|19667463|P3|Overall Study|Worsening of Cervical Dystonia|0
5706567|NCT00165776|19667464|P2|Overall Study|Worsening of Cervical Dystonia|0
5706568|NCT00165776|19667465|P1|Overall Study|Worsening of Cervical Dystonia|0
5706569|NCT00165776|19667462|P4|Overall Study|Withdrawal by Subject|0
5706570|NCT00165776|19667463|P3|Overall Study|Withdrawal by Subject|2
5706571|NCT00165776|19667464|P2|Overall Study|Withdrawal by Subject|1
5706572|NCT00165776|19667465|P1|Overall Study|Withdrawal by Subject|4
5706573|NCT00165776|19667462|P4|Overall Study|Lack of Efficacy|1
5706574|NCT00165776|19667463|P3|Overall Study|Lack of Efficacy|0
5706575|NCT00165776|19667464|P2|Overall Study|Lack of Efficacy|0
5706576|NCT00165776|19667465|P1|Overall Study|Lack of Efficacy|0
5706577|NCT00165698|19667501|P2|Overall Study|Not Taken/Lost the medicine|2
5706578|NCT00165698|19667502|P1|Overall Study|Not Taken/Lost the medicine|1
5706579|NCT00165698|19667501|P2|Overall Study|Protocol Violation|0
5706580|NCT00165698|19667502|P1|Overall Study|Protocol Violation|1
5706581|NCT00165698|19667501|P2|Overall Study|Withdrawal by Subject|1
5706582|NCT00165698|19667502|P1|Overall Study|Withdrawal by Subject|2
5706583|NCT00165698|19667501|P2|Overall Study|Lost to Follow-up|2
5706584|NCT00165698|19667502|P1|Overall Study|Lost to Follow-up|2
5706585|NCT00165698|19667501|P2|Overall Study|Adverse Event|10
5706586|NCT00165698|19667502|P1|Overall Study|Adverse Event|2
5706587|NCT00165672|19667528|P2|Overall Study|Adverse Event|1
5706588|NCT00165672|19667529|P1|Overall Study|Adverse Event|0
5706589|NCT00165646|19667538|P3|Overall Study|Protocol Violation|0
5706590|NCT00165646|19667539|P2|Overall Study|Protocol Violation|0
5706591|NCT00165646|19667540|P1|Overall Study|Protocol Violation|1
5706592|NCT00165646|19667538|P3|Overall Study|Physician Decision|2
5706593|NCT00165646|19667539|P2|Overall Study|Physician Decision|0
5706594|NCT00165646|19667540|P1|Overall Study|Physician Decision|2
5706595|NCT00165646|19667538|P3|Overall Study|Withdrawal by Subject|1
5706596|NCT00165646|19667539|P2|Overall Study|Withdrawal by Subject|2
5706597|NCT00165646|19667540|P1|Overall Study|Withdrawal by Subject|0
5706598|NCT00165646|19667538|P3|Overall Study|Lack of Efficacy|0
5706599|NCT00165646|19667539|P2|Overall Study|Lack of Efficacy|2
5706600|NCT00165646|19667540|P1|Overall Study|Lack of Efficacy|1
5706601|NCT00165646|19667538|P3|Overall Study|Adverse Event|1
5706602|NCT00165646|19667539|P2|Overall Study|Adverse Event|1
5706603|NCT00165646|19667540|P1|Overall Study|Adverse Event|1
5706604|NCT00165503|19667548|P1|Overall Study|Unresectable|3
5706605|NCT00165503|19667548|P1|Overall Study|Lost to Follow-up|12
5706606|NCT00165503|19667548|P1|Overall Study|Death|1
5706607|NCT00163657|19667555|P3|Overall Study|Other reason|3
5706608|NCT00163657|19667556|P2|Overall Study|Other reason|1
5706609|NCT00163657|19667557|P1|Overall Study|Other reason|0
5706610|NCT00163657|19667555|P3|Overall Study|Lost to Follow-up|10
5706611|NCT00163657|19667556|P2|Overall Study|Lost to Follow-up|3
5706612|NCT00163657|19667557|P1|Overall Study|Lost to Follow-up|1
5706613|NCT00163657|19667555|P3|Overall Study|Non Compliance|0
5706614|NCT00163657|19667556|P2|Overall Study|Non Compliance|0
5706615|NCT00163657|19667557|P1|Overall Study|Non Compliance|1
5706616|NCT00163657|19667555|P3|Overall Study|Physician Decision|1
5706617|NCT00163657|19667556|P2|Overall Study|Physician Decision|1
5706618|NCT00163657|19667557|P1|Overall Study|Physician Decision|0
5706619|NCT00163657|19667555|P3|Overall Study|Withdrawal by Subject|2
5706620|NCT00163657|19667556|P2|Overall Study|Withdrawal by Subject|3
5706621|NCT00163657|19667557|P1|Overall Study|Withdrawal by Subject|2
5706622|NCT00163657|19667555|P3|Overall Study|graft loss|2
5706623|NCT00163657|19667556|P2|Overall Study|graft loss|1
5706624|NCT00163657|19667557|P1|Overall Study|graft loss|4
5706625|NCT00163657|19667555|P3|Overall Study|Death|19
5706626|NCT00163657|19667556|P2|Overall Study|Death|14
5706627|NCT00163657|19667557|P1|Overall Study|Death|12
5706628|NCT00163215|19667647|P1|Overall Study|Other|7
5706629|NCT00163215|19667647|P1|Overall Study|Withdrawal by Subject|5
5706630|NCT00163215|19667647|P1|Overall Study|Lack of Efficacy|3
5706631|NCT00163189|19667667|P1|Overall Study|Did not meet continuation criterion|16
5706632|NCT00163189|19667667|P1|Overall Study|Withdrawal by Subject|11
5706633|NCT00163189|19667667|P1|Overall Study|Study terminated by sponsor|11
5706634|NCT00163189|19667667|P1|Overall Study|Lack of Efficacy|7
5706635|NCT00163189|19667667|P1|Overall Study|Adverse Event|6
5706636|NCT00163189|19667667|P1|Overall Study|Death|3
5706637|NCT00163189|19667667|P1|Overall Study|Protocol Violation|2
5706638|NCT00163189|19667667|P1|Overall Study|Lost to Follow-up|1
5706639|NCT00163189|19667667|P1|Overall Study|Other|6
5706640|NCT00163020|19667691|P2|Overall Study|Lost to Follow-up|2
5706641|NCT00163020|19667692|P1|Overall Study|Lost to Follow-up|0
5706642|NCT00162981|19667732|P2|Overall Study|Physician Decision|0
5706643|NCT00162981|19667733|P1|Overall Study|Physician Decision|1
5706644|NCT00162981|19667732|P2|Overall Study|Withdrawal by Subject|1
5706645|NCT00162981|19667733|P1|Overall Study|Withdrawal by Subject|1
5706646|NCT00162981|19667732|P2|Overall Study|Adverse Event|5
5706647|NCT00162981|19667733|P1|Overall Study|Adverse Event|2
5706648|NCT00162942|19667749|P2|Overall Study|2 or more consecutive treatments missed|0
5706649|NCT00162942|19667750|P1|Overall Study|2 or more consecutive treatments missed|1
5706650|NCT00162942|19667749|P2|Overall Study|Flare During Active Treatment|3
5706651|NCT00162942|19667750|P1|Overall Study|Flare During Active Treatment|7
5706652|NCT00162942|19667749|P2|Overall Study|Lack of Efficacy|0
5706653|NCT00162942|19667750|P1|Overall Study|Lack of Efficacy|1
5706654|NCT00162942|19667749|P2|Overall Study|Alternate Therapy|2
5706655|NCT00162942|19667750|P1|Overall Study|Alternate Therapy|6
5706656|NCT00162942|19667749|P2|Overall Study|Enter Open-Label Study|35
5706657|NCT00162942|19667750|P1|Overall Study|Enter Open-Label Study|76
5706658|NCT00162942|19667749|P2|Overall Study|Physician Decision|0
5706659|NCT00162942|19667750|P1|Overall Study|Physician Decision|1
5706660|NCT00162942|19667749|P2|Overall Study|Withdrawal by Subject|6
5706661|NCT00162942|19667750|P1|Overall Study|Withdrawal by Subject|3
5706662|NCT00162942|19667749|P2|Overall Study|Death|0
5706663|NCT00162942|19667750|P1|Overall Study|Death|1
5706664|NCT00162942|19667749|P2|Overall Study|Adverse Event|6
5706665|NCT00162942|19667750|P1|Overall Study|Adverse Event|10
5706666|NCT00162773|19667798|P1|Overall Study|P.I, Left institution. Study terminated|22
5706667|NCT00162370|19667802|P1|Efficacy Population|Lost to Follow-up|51
5706668|NCT00162266|19667810|P4|Open-Label Period|Other Reasons|15
5706669|NCT00162266|19667811|P3|Open-Label Period|Other Reasons|0
5706670|NCT00162266|19667812|P2|Open-Label Period|Other Reasons|0
5706671|NCT00162266|19667813|P1|Open-Label Period|Other Reasons|0
5706672|NCT00162266|19667810|P4|Open-Label Period|Administrative Reason By Sponsor|9
5706673|NCT00162266|19667811|P3|Open-Label Period|Administrative Reason By Sponsor|0
5706674|NCT00162266|19667812|P2|Open-Label Period|Administrative Reason By Sponsor|0
5706675|NCT00162266|19667813|P1|Open-Label Period|Administrative Reason By Sponsor|0
5706676|NCT00162266|19667810|P4|Open-Label Period|Withdrawal by Subject|31
5706677|NCT00162266|19667811|P3|Open-Label Period|Withdrawal by Subject|0
5706678|NCT00162266|19667812|P2|Open-Label Period|Withdrawal by Subject|0
5706679|NCT00162266|19667813|P1|Open-Label Period|Withdrawal by Subject|0
5706680|NCT00162266|19667810|P4|Open-Label Period|Lost to Follow-up|3
5706681|NCT00162266|19667811|P3|Open-Label Period|Lost to Follow-up|0
5706682|NCT00162266|19667812|P2|Open-Label Period|Lost to Follow-up|0
5706683|NCT00162266|19667813|P1|Open-Label Period|Lost to Follow-up|0
5706684|NCT00162266|19667810|P4|Open-Label Period|Lack of Efficacy|26
5706685|NCT00162266|19667811|P3|Open-Label Period|Lack of Efficacy|0
5706686|NCT00162266|19667812|P2|Open-Label Period|Lack of Efficacy|0
5706687|NCT00162266|19667813|P1|Open-Label Period|Lack of Efficacy|0
5706688|NCT00162266|19667810|P4|Open-Label Period|Adverse Event|46
5706689|NCT00162266|19667811|P3|Open-Label Period|Adverse Event|0
5706690|NCT00162266|19667812|P2|Open-Label Period|Adverse Event|0
5706691|NCT00162266|19667813|P1|Open-Label Period|Adverse Event|0
5706692|NCT00162266|19667810|P4|Open-Label Period|Death|7
5706693|NCT00162266|19667811|P3|Open-Label Period|Death|0
5706694|NCT00162266|19667812|P2|Open-Label Period|Death|0
5706695|NCT00162266|19667813|P1|Open-Label Period|Death|0
5706696|NCT00162266|19667810|P4|Double-Blind Period|Withdrawal by Subject|0
5706697|NCT00162266|19667811|P3|Double-Blind Period|Withdrawal by Subject|6
5706698|NCT00162266|19667812|P2|Double-Blind Period|Withdrawal by Subject|2
5706699|NCT00162266|19667813|P1|Double-Blind Period|Withdrawal by Subject|5
5706700|NCT00162266|19667810|P4|Double-Blind Period|Lack of Efficacy|0
5706701|NCT00162266|19667811|P3|Double-Blind Period|Lack of Efficacy|30
5706702|NCT00162266|19667812|P2|Double-Blind Period|Lack of Efficacy|17
5706703|NCT00162266|19667813|P1|Double-Blind Period|Lack of Efficacy|13
5706704|NCT00162266|19667810|P4|Double-Blind Period|Other Reason|0
5706705|NCT00162266|19667811|P3|Double-Blind Period|Other Reason|1
5706706|NCT00162266|19667812|P2|Double-Blind Period|Other Reason|0
5706707|NCT00162266|19667813|P1|Double-Blind Period|Other Reason|1
5706708|NCT00162266|19667810|P4|Double-Blind Period|Lost to Follow-up|0
5706709|NCT00162266|19667811|P3|Double-Blind Period|Lost to Follow-up|0
5706710|NCT00162266|19667812|P2|Double-Blind Period|Lost to Follow-up|2
5706711|NCT00162266|19667813|P1|Double-Blind Period|Lost to Follow-up|1
5706712|NCT00162266|19667810|P4|Double-Blind Period|Death|0
5706713|NCT00162266|19667811|P3|Double-Blind Period|Death|0
5706714|NCT00162266|19667812|P2|Double-Blind Period|Death|1
5706715|NCT00162266|19667813|P1|Double-Blind Period|Death|0
5706716|NCT00162266|19667810|P4|Double-Blind Period|Adverse Event|0
5706717|NCT00162266|19667811|P3|Double-Blind Period|Adverse Event|11
5706718|NCT00162266|19667812|P2|Double-Blind Period|Adverse Event|9
5706719|NCT00162266|19667813|P1|Double-Blind Period|Adverse Event|5
5706720|NCT00162136|19668014|P1|Overall Study|Withdrawal by Subject|1
5706721|NCT00162136|19668014|P1|Overall Study|Study Drug Toxicity|4
5706722|NCT00162136|19668014|P1|Overall Study|Investigator Request|5
5706723|NCT00162136|19668014|P1|Overall Study|Disease Progression/Relapse|23
5706724|NCT00162136|19668014|P1|Overall Study|Death|1
5706725|NCT00162136|19668014|P1|Overall Study|Adverse Event|1
5706726|NCT00162123|19668046|P8|Overall Study|Follow-up only (not treated or assessed)|57
5706727|NCT00162123|19668047|P7|Overall Study|Follow-up only (not treated or assessed)|0
5706728|NCT00162123|19668048|P6|Overall Study|Follow-up only (not treated or assessed)|0
5706729|NCT00162123|19668049|P5|Overall Study|Follow-up only (not treated or assessed)|0
5706730|NCT00162123|19668050|P4|Overall Study|Follow-up only (not treated or assessed)|0
5706731|NCT00162123|19668051|P3|Overall Study|Follow-up only (not treated or assessed)|0
5706732|NCT00162123|19668052|P2|Overall Study|Follow-up only (not treated or assessed)|0
5706733|NCT00162123|19668053|P1|Overall Study|Follow-up only (not treated or assessed)|0
5706734|NCT00162123|19668046|P8|Overall Study|Tumor assessment only (not treated)|1
5706735|NCT00162123|19668047|P7|Overall Study|Tumor assessment only (not treated)|0
5706736|NCT00162123|19668048|P6|Overall Study|Tumor assessment only (not treated)|0
5706737|NCT00162123|19668049|P5|Overall Study|Tumor assessment only (not treated)|0
5706738|NCT00162123|19668050|P4|Overall Study|Tumor assessment only (not treated)|0
5706823|NCT00161616|19668174|P1|Overall Study|Protocol deviation|1
5706739|NCT00162123|19668051|P3|Overall Study|Tumor assessment only (not treated)|0
5706740|NCT00162123|19668052|P2|Overall Study|Tumor assessment only (not treated)|0
5706741|NCT00162123|19668053|P1|Overall Study|Tumor assessment only (not treated)|0
5706742|NCT00162123|19668046|P8|Overall Study|Physician Decision|0
5706743|NCT00162123|19668047|P7|Overall Study|Physician Decision|1
5706744|NCT00162123|19668048|P6|Overall Study|Physician Decision|1
5706745|NCT00162123|19668049|P5|Overall Study|Physician Decision|0
5706746|NCT00162123|19668050|P4|Overall Study|Physician Decision|0
5706747|NCT00162123|19668051|P3|Overall Study|Physician Decision|0
5706748|NCT00162123|19668052|P2|Overall Study|Physician Decision|2
5706749|NCT00162123|19668053|P1|Overall Study|Physician Decision|1
5706750|NCT00162123|19668046|P8|Overall Study|Not specified (after start of treatment)|0
5706751|NCT00162123|19668047|P7|Overall Study|Not specified (after start of treatment)|0
5706752|NCT00162123|19668048|P6|Overall Study|Not specified (after start of treatment)|0
5706753|NCT00162123|19668049|P5|Overall Study|Not specified (after start of treatment)|3
5706754|NCT00162123|19668050|P4|Overall Study|Not specified (after start of treatment)|0
5706755|NCT00162123|19668051|P3|Overall Study|Not specified (after start of treatment)|0
5706756|NCT00162123|19668052|P2|Overall Study|Not specified (after start of treatment)|0
5706757|NCT00162123|19668053|P1|Overall Study|Not specified (after start of treatment)|0
5706758|NCT00162123|19668046|P8|Overall Study|Not specified (before treatment)|0
5706759|NCT00162123|19668047|P7|Overall Study|Not specified (before treatment)|0
5706760|NCT00162123|19668048|P6|Overall Study|Not specified (before treatment)|1
5706761|NCT00162123|19668049|P5|Overall Study|Not specified (before treatment)|12
5706762|NCT00162123|19668050|P4|Overall Study|Not specified (before treatment)|0
5706763|NCT00162123|19668051|P3|Overall Study|Not specified (before treatment)|0
5706764|NCT00162123|19668052|P2|Overall Study|Not specified (before treatment)|0
5706765|NCT00162123|19668053|P1|Overall Study|Not specified (before treatment)|2
5706766|NCT00162123|19668046|P8|Overall Study|Adverse Event|0
5706767|NCT00162123|19668047|P7|Overall Study|Adverse Event|0
5706768|NCT00162123|19668048|P6|Overall Study|Adverse Event|0
5706769|NCT00162123|19668049|P5|Overall Study|Adverse Event|1
5706770|NCT00162123|19668050|P4|Overall Study|Adverse Event|2
5706771|NCT00162123|19668051|P3|Overall Study|Adverse Event|0
5706772|NCT00162123|19668052|P2|Overall Study|Adverse Event|2
5706773|NCT00162123|19668053|P1|Overall Study|Adverse Event|1
5706774|NCT00162123|19668046|P8|Overall Study|Deterioration without progression|0
5706775|NCT00162123|19668047|P7|Overall Study|Deterioration without progression|0
5706776|NCT00162123|19668048|P6|Overall Study|Deterioration without progression|0
5706777|NCT00162123|19668049|P5|Overall Study|Deterioration without progression|1
5706778|NCT00162123|19668050|P4|Overall Study|Deterioration without progression|0
5706779|NCT00162123|19668051|P3|Overall Study|Deterioration without progression|3
5706780|NCT00162123|19668052|P2|Overall Study|Deterioration without progression|2
5706781|NCT00162123|19668053|P1|Overall Study|Deterioration without progression|2
5706782|NCT00162123|19668046|P8|Overall Study|Withdrawal by Subject|0
5706783|NCT00162123|19668047|P7|Overall Study|Withdrawal by Subject|1
5706784|NCT00162123|19668048|P6|Overall Study|Withdrawal by Subject|2
5706785|NCT00162123|19668049|P5|Overall Study|Withdrawal by Subject|1
5706786|NCT00162123|19668050|P4|Overall Study|Withdrawal by Subject|1
5706787|NCT00162123|19668051|P3|Overall Study|Withdrawal by Subject|2
5706788|NCT00162123|19668052|P2|Overall Study|Withdrawal by Subject|0
5706789|NCT00162123|19668053|P1|Overall Study|Withdrawal by Subject|2
5706790|NCT00162123|19668046|P8|Overall Study|Death|0
5706791|NCT00162123|19668047|P7|Overall Study|Death|0
5706792|NCT00162123|19668048|P6|Overall Study|Death|1
5706793|NCT00162123|19668049|P5|Overall Study|Death|1
5706794|NCT00162123|19668050|P4|Overall Study|Death|1
5706795|NCT00162123|19668051|P3|Overall Study|Death|1
5706796|NCT00162123|19668052|P2|Overall Study|Death|3
5706797|NCT00162123|19668053|P1|Overall Study|Death|3
5706798|NCT00162123|19668046|P8|Overall Study|Study drug toxicity|0
5706799|NCT00162123|19668047|P7|Overall Study|Study drug toxicity|1
5706800|NCT00162123|19668048|P6|Overall Study|Study drug toxicity|1
5706801|NCT00162123|19668049|P5|Overall Study|Study drug toxicity|4
5706802|NCT00162123|19668050|P4|Overall Study|Study drug toxicity|0
5706803|NCT00162123|19668051|P3|Overall Study|Study drug toxicity|5
5706804|NCT00162123|19668052|P2|Overall Study|Study drug toxicity|1
5706805|NCT00162123|19668053|P1|Overall Study|Study drug toxicity|6
5706806|NCT00162123|19668046|P8|Overall Study|Disease progression|0
5706807|NCT00162123|19668047|P7|Overall Study|Disease progression|1
5706808|NCT00162123|19668048|P6|Overall Study|Disease progression|3
5706809|NCT00162123|19668049|P5|Overall Study|Disease progression|8
5706810|NCT00162123|19668050|P4|Overall Study|Disease progression|4
5706811|NCT00162123|19668051|P3|Overall Study|Disease progression|10
5706812|NCT00162123|19668052|P2|Overall Study|Disease progression|19
5706813|NCT00162123|19668053|P1|Overall Study|Disease progression|27
5706814|NCT00162097|19668086|P4|Overall Study|Participant no longer met study criteria|1
5706815|NCT00162097|19668087|P3|Overall Study|Participant no longer met study criteria|0
5706816|NCT00162097|19668088|P2|Overall Study|Participant no longer met study criteria|0
5706817|NCT00162097|19668089|P1|Overall Study|Participant no longer met study criteria|0
5706818|NCT00162032|19668151|P2|Overall Study|Reason not specified|0
5706819|NCT00162032|19668152|P1|Overall Study|Reason not specified|1
5706820|NCT00162032|19668151|P2|Overall Study|Lost to Follow-up|2
5706821|NCT00162032|19668152|P1|Overall Study|Lost to Follow-up|4
5706822|NCT00161616|19668173|P2|Overall Study|Protocol deviation|0
5706824|NCT00161616|19668173|P2|Overall Study|Lost to Follow-up|13
5706825|NCT00161616|19668174|P1|Overall Study|Lost to Follow-up|17
5706826|NCT00161616|19668173|P2|Overall Study|Death|1
5706827|NCT00161616|19668174|P1|Overall Study|Death|1
5706828|NCT00161616|19668173|P2|Overall Study|Physician Decision|0
5706829|NCT00161616|19668174|P1|Overall Study|Physician Decision|1
5706830|NCT00161616|19668173|P2|Overall Study|Withdrawal by Subject|5
5706831|NCT00161616|19668174|P1|Overall Study|Withdrawal by Subject|6
5706832|NCT00161213|19668206|P1|Overall Study|Evaluable for toxicity but not response|1
5706833|NCT00161213|19668206|P1|Overall Study|Withdrawal by Subject|1
5706834|NCT00160706|19668213|P1|Overall Study|Other Reason|11
5706835|NCT00160706|19668213|P1|Overall Study|Lack of Efficacy and Other|1
5706836|NCT00160706|19668213|P1|Overall Study|Lack of Efficacy|42
5706837|NCT00160706|19668213|P1|Overall Study|Lost to Follow-up and Other|1
5706838|NCT00160706|19668213|P1|Overall Study|Lost to Follow-up|4
5706839|NCT00160706|19668213|P1|Overall Study|Physician Decision and Other|3
5706840|NCT00160706|19668213|P1|Overall Study|Physician Decision|10
5706841|NCT00160706|19668213|P1|Overall Study|Withdrawal by Subject and Other|12
5706842|NCT00160706|19668213|P1|Overall Study|Withdrawal by Subject|41
5706843|NCT00160706|19668213|P1|Overall Study|Protocol Violation|3
5706844|NCT00160706|19668213|P1|Overall Study|Adverse Event and Other Reason|105
5706845|NCT00160706|19668213|P1|Overall Study|Adverse Event|53
5706846|NCT00160693|19668225|P1|Overall Study|Study terminated by sponsor|15
5706847|NCT00160693|19668225|P1|Overall Study|Withdrawal by Subject|54
5706848|NCT00160693|19668225|P1|Overall Study|Lost to Follow-up|15
5706849|NCT00160693|19668225|P1|Overall Study|Protocol Violation|24
5706850|NCT00160693|19668225|P1|Overall Study|Lack of Efficacy|30
5706851|NCT00160693|19668225|P1|Overall Study|Adverse Event|97
5706852|NCT00160680|19668244|P2|Overall Study|Withdrawal by Subject|9
5706853|NCT00160680|19668245|P1|Overall Study|Withdrawal by Subject|4
5706854|NCT00160680|19668244|P2|Overall Study|Lost to Follow-up|2
5706855|NCT00160680|19668245|P1|Overall Study|Lost to Follow-up|3
5706856|NCT00160680|19668244|P2|Overall Study|Lack of Efficacy|1
5706857|NCT00160680|19668245|P1|Overall Study|Lack of Efficacy|2
5706858|NCT00160680|19668244|P2|Overall Study|Adverse Event|1
5706859|NCT00160680|19668245|P1|Overall Study|Adverse Event|0
5706860|NCT00160667|19668280|P3|Overall Study|Patient decision|1
5706861|NCT00160667|19668281|P2|Overall Study|Patient decision|0
5706862|NCT00160667|19668282|P1|Overall Study|Patient decision|0
5706863|NCT00160667|19668280|P3|Overall Study|Protocol Violation|0
5706864|NCT00160667|19668281|P2|Overall Study|Protocol Violation|1
5706865|NCT00160667|19668282|P1|Overall Study|Protocol Violation|0
5706866|NCT00160667|19668280|P3|Overall Study|Lack of Efficacy|0
5706867|NCT00160667|19668281|P2|Overall Study|Lack of Efficacy|1
5706868|NCT00160667|19668282|P1|Overall Study|Lack of Efficacy|0
5706869|NCT00160667|19668280|P3|Overall Study|Withdrawal by Subject|1
5706870|NCT00160667|19668281|P2|Overall Study|Withdrawal by Subject|0
5706871|NCT00160667|19668282|P1|Overall Study|Withdrawal by Subject|2
5706872|NCT00160667|19668280|P3|Overall Study|Adverse Event|4
5706873|NCT00160667|19668281|P2|Overall Study|Adverse Event|1
5706874|NCT00160667|19668282|P1|Overall Study|Adverse Event|3
5706875|NCT00160654|19668329|P1|Overall Study|Met exclusion criteria|1
5706876|NCT00160654|19668329|P1|Overall Study|Poor compliance, dilantin toxicity|1
5706877|NCT00160654|19668329|P1|Overall Study|Patient decision|1
5706878|NCT00160654|19668329|P1|Overall Study|Patient met exclusion criteria|1
5706879|NCT00160654|19668329|P1|Overall Study|Sponsor decision|1
5706880|NCT00160654|19668329|P1|Overall Study|Psychological trauma|1
5706881|NCT00160654|19668329|P1|Overall Study|Intake of expired drug|7
5706882|NCT00160654|19668329|P1|Overall Study|Lost to Follow-up|2
5706883|NCT00160654|19668329|P1|Overall Study|Lack of Efficacy|4
5706884|NCT00160654|19668329|P1|Overall Study|Adverse Event|14
5706885|NCT00160641|19668339|P1|Overall Study|Other|9
5706886|NCT00160641|19668339|P1|Overall Study|Protocol Violation|3
5706887|NCT00160641|19668339|P1|Overall Study|Lack of Efficacy|12
5706888|NCT00160641|19668339|P1|Overall Study|Lost to Follow-up|8
5706889|NCT00160641|19668339|P1|Overall Study|Withdrawal by Subject|87
5706890|NCT00160641|19668339|P1|Overall Study|Adverse Event|102
5706891|NCT00160615|19668372|P2|Overall Study|Poor compliance|1
5706892|NCT00160615|19668373|P1|Overall Study|Poor compliance|0
5706893|NCT00160615|19668372|P2|Overall Study|Non-compliance was suspected|1
5706894|NCT00160615|19668373|P1|Overall Study|Non-compliance was suspected|0
5706895|NCT00160615|19668372|P2|Overall Study|Switch to surgical treatment|2
5706896|NCT00160615|19668373|P1|Overall Study|Switch to surgical treatment|0
5706897|NCT00160615|19668372|P2|Overall Study|AE agents had to be discontinued (exam.)|1
5706898|NCT00160615|19668373|P1|Overall Study|AE agents had to be discontinued (exam.)|0
5706899|NCT00160615|19668372|P2|Overall Study|Investigator decision|1
5706900|NCT00160615|19668373|P1|Overall Study|Investigator decision|1
5706901|NCT00160615|19668372|P2|Overall Study|Patient decision|2
5706902|NCT00160615|19668373|P1|Overall Study|Patient decision|1
5706903|NCT00160615|19668372|P2|Overall Study|Lack of Efficacy|23
5706904|NCT00160615|19668373|P1|Overall Study|Lack of Efficacy|11
5706905|NCT00160615|19668372|P2|Overall Study|Withdrawal by Subject|2
5706906|NCT00160615|19668373|P1|Overall Study|Withdrawal by Subject|0
5706907|NCT00160615|19668372|P2|Overall Study|Adverse Event|12
5706908|NCT00160615|19668373|P1|Overall Study|Adverse Event|5
5706909|NCT00160563|19668396|P3|Overall Study|Missing reason|0
5706910|NCT00160563|19668397|P2|Overall Study|Missing reason|1
5706911|NCT00160563|19668398|P1|Overall Study|Missing reason|0
5706912|NCT00160563|19668396|P3|Overall Study|Other (listed in the study report)|81
5706913|NCT00160563|19668397|P2|Overall Study|Other (listed in the study report)|40
5706914|NCT00160563|19668398|P1|Overall Study|Other (listed in the study report)|48
5706915|NCT00160563|19668396|P3|Overall Study|Withdrawal by Subject|3
5706916|NCT00160563|19668397|P2|Overall Study|Withdrawal by Subject|2
5706917|NCT00160563|19668398|P1|Overall Study|Withdrawal by Subject|1
5706918|NCT00160563|19668396|P3|Overall Study|Protocol Violation|3
5706919|NCT00160563|19668397|P2|Overall Study|Protocol Violation|0
5706920|NCT00160563|19668398|P1|Overall Study|Protocol Violation|0
5706921|NCT00160563|19668396|P3|Overall Study|Lost to Follow-up|2
5706922|NCT00160563|19668397|P2|Overall Study|Lost to Follow-up|1
5706923|NCT00160563|19668398|P1|Overall Study|Lost to Follow-up|1
5706924|NCT00160563|19668396|P3|Overall Study|Adverse Event|1
5706925|NCT00160563|19668397|P2|Overall Study|Adverse Event|1
5706926|NCT00160563|19668398|P1|Overall Study|Adverse Event|1
5706927|NCT00160524|19668410|P1|Overall Study|Other|20
5706928|NCT00160524|19668410|P1|Overall Study|Lack of Efficacy and Other|1
5706929|NCT00160524|19668410|P1|Overall Study|Lack of Efficacy|21
5706930|NCT00160524|19668410|P1|Overall Study|Lost to Follow-up and Other|1
5706931|NCT00160524|19668410|P1|Overall Study|Lost to Follow-up|13
5706932|NCT00160524|19668410|P1|Overall Study|Physician Decision and Other|6
5706933|NCT00160524|19668410|P1|Overall Study|Physician Decision|27
5706934|NCT00160524|19668410|P1|Overall Study|Withdrawal by Subject and Other|17
5706935|NCT00160524|19668410|P1|Overall Study|Withdrawal by Subject|141
5706936|NCT00160524|19668410|P1|Overall Study|Protocol Violation and Other|2
5706937|NCT00160524|19668410|P1|Overall Study|Protocol Violation|16
5706938|NCT00160524|19668410|P1|Overall Study|Adverse Event and Other|94
5706939|NCT00160524|19668410|P1|Overall Study|Adverse Event|119
5706940|NCT00160251|19668427|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
5706941|NCT00160251|19668428|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5706942|NCT00160251|19668429|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5706943|NCT00160251|19668430|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5706944|NCT00160251|19668431|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5706945|NCT00160251|19668432|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5706946|NCT00160251|19668433|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5706947|NCT00160251|19668434|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
5706948|NCT00160251|19668427|P8|Post-amendment 2|Lack of Efficacy|24
5706949|NCT00160251|19668428|P7|Post-amendment 2|Lack of Efficacy|0
5706950|NCT00160251|19668429|P6|Post-amendment 2|Lack of Efficacy|0
5706951|NCT00160251|19668430|P5|Post-amendment 2|Lack of Efficacy|0
5706952|NCT00160251|19668431|P4|Post-amendment 2|Lack of Efficacy|0
5706953|NCT00160251|19668432|P3|Post-amendment 2|Lack of Efficacy|0
5706954|NCT00160251|19668433|P2|Post-amendment 2|Lack of Efficacy|0
5706955|NCT00160251|19668434|P1|Post-amendment 2|Lack of Efficacy|0
5706956|NCT00160251|19668427|P8|Post-amendment 2|Adverse Event|20
5706957|NCT00160251|19668428|P7|Post-amendment 2|Adverse Event|0
5706958|NCT00160251|19668429|P6|Post-amendment 2|Adverse Event|0
5706959|NCT00160251|19668430|P5|Post-amendment 2|Adverse Event|0
5706960|NCT00160251|19668431|P4|Post-amendment 2|Adverse Event|0
5706961|NCT00160251|19668432|P3|Post-amendment 2|Adverse Event|0
5706962|NCT00160251|19668433|P2|Post-amendment 2|Adverse Event|0
5706963|NCT00160251|19668434|P1|Post-amendment 2|Adverse Event|0
5706964|NCT00160251|19668427|P8|Prior to Amendment 2|Completed Treatment Phase|0
5706965|NCT00160251|19668428|P7|Prior to Amendment 2|Completed Treatment Phase|0
5706966|NCT00160251|19668429|P6|Prior to Amendment 2|Completed Treatment Phase|23
5706967|NCT00160251|19668430|P5|Prior to Amendment 2|Completed Treatment Phase|0
5706968|NCT00160251|19668431|P4|Prior to Amendment 2|Completed Treatment Phase|0
5706969|NCT00160251|19668432|P3|Prior to Amendment 2|Completed Treatment Phase|0
5706970|NCT00160251|19668433|P2|Prior to Amendment 2|Completed Treatment Phase|0
5706971|NCT00160251|19668434|P1|Prior to Amendment 2|Completed Treatment Phase|3
5706972|NCT00160251|19668427|P8|Prior to Amendment 2|Noncompliance with protocol|0
5706973|NCT00160251|19668428|P7|Prior to Amendment 2|Noncompliance with protocol|0
5706974|NCT00160251|19668429|P6|Prior to Amendment 2|Noncompliance with protocol|0
5706975|NCT00160251|19668430|P5|Prior to Amendment 2|Noncompliance with protocol|0
5706976|NCT00160251|19668431|P4|Prior to Amendment 2|Noncompliance with protocol|0
5706977|NCT00160251|19668432|P3|Prior to Amendment 2|Noncompliance with protocol|0
5706978|NCT00160251|19668433|P2|Prior to Amendment 2|Noncompliance with protocol|0
5706979|NCT00160251|19668434|P1|Prior to Amendment 2|Noncompliance with protocol|1
5706980|NCT00160251|19668427|P8|Prior to Amendment 2|Withdrawal by Subject|0
5706981|NCT00160251|19668428|P7|Prior to Amendment 2|Withdrawal by Subject|3
5706982|NCT00160251|19668429|P6|Prior to Amendment 2|Withdrawal by Subject|3
5706983|NCT00160251|19668430|P5|Prior to Amendment 2|Withdrawal by Subject|2
5706984|NCT00160251|19668431|P4|Prior to Amendment 2|Withdrawal by Subject|4
5706985|NCT00160251|19668432|P3|Prior to Amendment 2|Withdrawal by Subject|3
5706986|NCT00160251|19668433|P2|Prior to Amendment 2|Withdrawal by Subject|1
5706987|NCT00160251|19668434|P1|Prior to Amendment 2|Withdrawal by Subject|3
5706988|NCT00160251|19668427|P8|Prior to Amendment 2|Lost to Follow-up|0
5706989|NCT00160251|19668428|P7|Prior to Amendment 2|Lost to Follow-up|0
5706990|NCT00160251|19668429|P6|Prior to Amendment 2|Lost to Follow-up|1
5706991|NCT00160251|19668430|P5|Prior to Amendment 2|Lost to Follow-up|1
5706992|NCT00160251|19668431|P4|Prior to Amendment 2|Lost to Follow-up|0
5706993|NCT00160251|19668432|P3|Prior to Amendment 2|Lost to Follow-up|1
5706994|NCT00160251|19668433|P2|Prior to Amendment 2|Lost to Follow-up|0
5706995|NCT00160251|19668434|P1|Prior to Amendment 2|Lost to Follow-up|0
5706996|NCT00160251|19668427|P8|Prior to Amendment 2|Lack of Efficacy|0
5706997|NCT00160251|19668428|P7|Prior to Amendment 2|Lack of Efficacy|0
5706998|NCT00160251|19668429|P6|Prior to Amendment 2|Lack of Efficacy|55
5706999|NCT00160251|19668430|P5|Prior to Amendment 2|Lack of Efficacy|24
5707000|NCT00160251|19668431|P4|Prior to Amendment 2|Lack of Efficacy|35
5707001|NCT00160251|19668432|P3|Prior to Amendment 2|Lack of Efficacy|37
5707002|NCT00160251|19668433|P2|Prior to Amendment 2|Lack of Efficacy|4
5707003|NCT00160251|19668434|P1|Prior to Amendment 2|Lack of Efficacy|0
5707004|NCT00160251|19668427|P8|Prior to Amendment 2|Adverse Event|0
5707005|NCT00160251|19668428|P7|Prior to Amendment 2|Adverse Event|1
5707006|NCT00160251|19668429|P6|Prior to Amendment 2|Adverse Event|1
5707007|NCT00160251|19668430|P5|Prior to Amendment 2|Adverse Event|1
5707008|NCT00160251|19668431|P4|Prior to Amendment 2|Adverse Event|1
5707009|NCT00160251|19668432|P3|Prior to Amendment 2|Adverse Event|3
5707010|NCT00160251|19668433|P2|Prior to Amendment 2|Adverse Event|1
5707011|NCT00160251|19668434|P1|Prior to Amendment 2|Adverse Event|2
5707012|NCT00160199|19668510|P2|Overall Study|Protocol Violation|8
5707013|NCT00160199|19668511|P1|Overall Study|Protocol Violation|8
5707014|NCT00160199|19668510|P2|Overall Study|Administrative|1
5707015|NCT00160199|19668511|P1|Overall Study|Administrative|0
5707016|NCT00160199|19668510|P2|Overall Study|Withdrawal by Subject|6
5707017|NCT00160199|19668511|P1|Overall Study|Withdrawal by Subject|4
5707018|NCT00160199|19668510|P2|Overall Study|Lost to Follow-up|7
5707019|NCT00160199|19668511|P1|Overall Study|Lost to Follow-up|7
5707020|NCT00160199|19668510|P2|Overall Study|Lack of Efficacy|1
5707021|NCT00160199|19668511|P1|Overall Study|Lack of Efficacy|0
5707022|NCT00160199|19668510|P2|Overall Study|Adverse Event|14
5707023|NCT00160199|19668511|P1|Overall Study|Adverse Event|5
5707024|NCT00159913|19668568|P4|Overall Study|Protocol Violation|0
5707025|NCT00159913|19668569|P3|Overall Study|Protocol Violation|1
5707026|NCT00159913|19668570|P2|Overall Study|Protocol Violation|0
5707027|NCT00159913|19668571|P1|Overall Study|Protocol Violation|1
5707028|NCT00159913|19668568|P4|Overall Study|Lost to Follow-up|1
5707029|NCT00159913|19668569|P3|Overall Study|Lost to Follow-up|0
5707030|NCT00159913|19668570|P2|Overall Study|Lost to Follow-up|0
5707031|NCT00159913|19668571|P1|Overall Study|Lost to Follow-up|0
5707032|NCT00159913|19668568|P4|Overall Study|Withdrawal by Subject|1
5707033|NCT00159913|19668569|P3|Overall Study|Withdrawal by Subject|0
5707034|NCT00159913|19668570|P2|Overall Study|Withdrawal by Subject|0
5707035|NCT00159913|19668571|P1|Overall Study|Withdrawal by Subject|0
5707036|NCT00159913|19668568|P4|Overall Study|Adverse Event|0
5707037|NCT00159913|19668569|P3|Overall Study|Adverse Event|1
5707038|NCT00159913|19668570|P2|Overall Study|Adverse Event|0
5707039|NCT00159913|19668571|P1|Overall Study|Adverse Event|1
5707040|NCT00159874|19668645|P7|Overall Study|Pregnancy|0
5707041|NCT00159874|19668646|P6|Overall Study|Pregnancy|0
5707042|NCT00159874|19668647|P5|Overall Study|Pregnancy|0
5707043|NCT00159874|19668648|P4|Overall Study|Pregnancy|0
5707044|NCT00159874|19668649|P3|Overall Study|Pregnancy|0
5707045|NCT00159874|19668650|P2|Overall Study|Pregnancy|1
5707046|NCT00159874|19668651|P1|Overall Study|Pregnancy|1
5707047|NCT00159874|19668645|P7|Overall Study|Withdrawal by Subject|1
5707048|NCT00159874|19668646|P6|Overall Study|Withdrawal by Subject|2
5707049|NCT00159874|19668647|P5|Overall Study|Withdrawal by Subject|3
5707050|NCT00159874|19668648|P4|Overall Study|Withdrawal by Subject|4
5707051|NCT00159874|19668649|P3|Overall Study|Withdrawal by Subject|8
5707052|NCT00159874|19668650|P2|Overall Study|Withdrawal by Subject|6
5707053|NCT00159874|19668651|P1|Overall Study|Withdrawal by Subject|2
5707054|NCT00159874|19668645|P7|Overall Study|Death|0
5707055|NCT00159874|19668646|P6|Overall Study|Death|2
5707056|NCT00159874|19668647|P5|Overall Study|Death|1
5707057|NCT00159874|19668648|P4|Overall Study|Death|0
5707058|NCT00159874|19668649|P3|Overall Study|Death|15
5707059|NCT00159874|19668650|P2|Overall Study|Death|8
5707060|NCT00159874|19668651|P1|Overall Study|Death|3
5707061|NCT00159874|19668645|P7|Overall Study|Protocol Violation|0
5707062|NCT00159874|19668646|P6|Overall Study|Protocol Violation|0
5707063|NCT00159874|19668647|P5|Overall Study|Protocol Violation|0
5707064|NCT00159874|19668648|P4|Overall Study|Protocol Violation|0
5707065|NCT00159874|19668649|P3|Overall Study|Protocol Violation|2
5707066|NCT00159874|19668650|P2|Overall Study|Protocol Violation|5
5707067|NCT00159874|19668651|P1|Overall Study|Protocol Violation|0
5707068|NCT00159874|19668645|P7|Overall Study|Other|3
5707069|NCT00159874|19668646|P6|Overall Study|Other|1
5707070|NCT00159874|19668647|P5|Overall Study|Other|2
5707071|NCT00159874|19668648|P4|Overall Study|Other|0
5707072|NCT00159874|19668649|P3|Overall Study|Other|8
5707073|NCT00159874|19668650|P2|Overall Study|Other|8
5707074|NCT00159874|19668651|P1|Overall Study|Other|8
5707075|NCT00159874|19668645|P7|Overall Study|Lost to Follow-up|1
5707076|NCT00159874|19668646|P6|Overall Study|Lost to Follow-up|2
5707077|NCT00159874|19668647|P5|Overall Study|Lost to Follow-up|1
5707078|NCT00159874|19668648|P4|Overall Study|Lost to Follow-up|0
5707079|NCT00159874|19668649|P3|Overall Study|Lost to Follow-up|3
5707080|NCT00159874|19668650|P2|Overall Study|Lost to Follow-up|0
5707081|NCT00159874|19668651|P1|Overall Study|Lost to Follow-up|1
5707082|NCT00159874|19668645|P7|Overall Study|Lack of Efficacy|0
5707083|NCT00159874|19668646|P6|Overall Study|Lack of Efficacy|3
5707084|NCT00159874|19668647|P5|Overall Study|Lack of Efficacy|0
5707085|NCT00159874|19668648|P4|Overall Study|Lack of Efficacy|1
5707086|NCT00159874|19668649|P3|Overall Study|Lack of Efficacy|1
5707087|NCT00159874|19668650|P2|Overall Study|Lack of Efficacy|0
5707088|NCT00159874|19668651|P1|Overall Study|Lack of Efficacy|2
5707089|NCT00159874|19668645|P7|Overall Study|Does Not Meet Entrance Criteria|0
5707090|NCT00159874|19668646|P6|Overall Study|Does Not Meet Entrance Criteria|0
5707091|NCT00159874|19668647|P5|Overall Study|Does Not Meet Entrance Criteria|0
5707092|NCT00159874|19668648|P4|Overall Study|Does Not Meet Entrance Criteria|0
5707093|NCT00159874|19668649|P3|Overall Study|Does Not Meet Entrance Criteria|1
5707094|NCT00159874|19668650|P2|Overall Study|Does Not Meet Entrance Criteria|0
5707095|NCT00159874|19668651|P1|Overall Study|Does Not Meet Entrance Criteria|1
5707096|NCT00159874|19668645|P7|Overall Study|Adverse Event|0
5707097|NCT00159874|19668646|P6|Overall Study|Adverse Event|2
5707098|NCT00159874|19668647|P5|Overall Study|Adverse Event|1
5707099|NCT00159874|19668648|P4|Overall Study|Adverse Event|1
5707100|NCT00159874|19668649|P3|Overall Study|Adverse Event|5
5707101|NCT00159874|19668650|P2|Overall Study|Adverse Event|2
5707102|NCT00159874|19668651|P1|Overall Study|Adverse Event|2
5707103|NCT00159861|19668821|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
5707104|NCT00159861|19668822|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
5707105|NCT00159861|19668821|P2|Extension Study - up to 3 Years|Reason Unspecified|19
5707106|NCT00159861|19668822|P1|Extension Study - up to 3 Years|Reason Unspecified|12
5707107|NCT00159861|19668821|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
5707108|NCT00159861|19668822|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
5707109|NCT00159861|19668821|P2|Extension Study - up to 3 Years|Adverse Event|14
5707110|NCT00159861|19668822|P1|Extension Study - up to 3 Years|Adverse Event|14
5707111|NCT00159861|19668821|P2|Extension Study - up to 3 Years|Death|28
5707112|NCT00159861|19668822|P1|Extension Study - up to 3 Years|Death|24
5707113|NCT00159861|19668821|P2|Core Study - 16 Weeks|Randomized but not Treated|0
5707114|NCT00159861|19668822|P1|Core Study - 16 Weeks|Randomized but not Treated|2
5707115|NCT00159861|19668821|P2|Core Study - 16 Weeks|Subject Defaulted|0
5707116|NCT00159861|19668822|P1|Core Study - 16 Weeks|Subject Defaulted|1
5707117|NCT00159861|19668821|P2|Core Study - 16 Weeks|Reason Unspecified|3
5707118|NCT00159861|19668822|P1|Core Study - 16 Weeks|Reason Unspecified|5
5707119|NCT00159861|19668821|P2|Core Study - 16 Weeks|Lack of Efficacy|3
5707120|NCT00159861|19668822|P1|Core Study - 16 Weeks|Lack of Efficacy|2
5707121|NCT00159861|19668821|P2|Core Study - 16 Weeks|Adverse Event|6
5707122|NCT00159861|19668822|P1|Core Study - 16 Weeks|Adverse Event|12
5707123|NCT00159861|19668821|P2|Core Study - 16 Weeks|Death|0
5707124|NCT00159861|19668822|P1|Core Study - 16 Weeks|Death|3
5707125|NCT00159822|19668843|P1|Post-treatment Follow-up Period|Reason unspecified|1
5707126|NCT00159822|19668843|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
5707127|NCT00159822|19668843|P1|Post-treatment Follow-up Period|Death|1
5707128|NCT00159822|19668843|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
5707129|NCT00159822|19668843|P1|Voriconazole Treatment Period|Lost to Follow-up|2
5707130|NCT00159822|19668843|P1|Voriconazole Treatment Period|Protocol Violation|2
5707131|NCT00159822|19668843|P1|Voriconazole Treatment Period|Death|4
5707132|NCT00159822|19668843|P1|Voriconazole Treatment Period|Adverse Event|9
5707133|NCT00159822|19668843|P1|Voriconazole Treatment Period|Lack of Efficacy|3
5707134|NCT00159783|19668861|P3|Overall Study|Other|4
5707135|NCT00159783|19668862|P2|Overall Study|Other|2
5707136|NCT00159783|19668863|P1|Overall Study|Other|0
5707137|NCT00159783|19668861|P3|Overall Study|Lost to Follow-up|11
5707138|NCT00159783|19668862|P2|Overall Study|Lost to Follow-up|5
5707139|NCT00159783|19668863|P1|Overall Study|Lost to Follow-up|6
5707140|NCT00159783|19668861|P3|Overall Study|Withdrawal by Subject|12
5707141|NCT00159783|19668862|P2|Overall Study|Withdrawal by Subject|11
5707142|NCT00159783|19668863|P1|Overall Study|Withdrawal by Subject|7
5707143|NCT00159783|19668861|P3|Overall Study|Lack of Efficacy|3
5707144|NCT00159783|19668862|P2|Overall Study|Lack of Efficacy|2
5707145|NCT00159783|19668863|P1|Overall Study|Lack of Efficacy|1
5707146|NCT00159783|19668861|P3|Overall Study|Adverse Event|9
5707147|NCT00159783|19668862|P2|Overall Study|Adverse Event|7
5707148|NCT00159783|19668863|P1|Overall Study|Adverse Event|5
5707149|NCT00159432|19668893|P1|Overall Study|Lack of Efficacy|8
5707150|NCT00159432|19668893|P1|Overall Study|Death|1
5707151|NCT00159432|19668893|P1|Overall Study|Adverse Event|1
5707152|NCT00158860|19668967|P2|Overall Study|Closed per sponsor|1
5707153|NCT00158860|19668968|P1|Overall Study|Closed per sponsor|0
5707154|NCT00158860|19668967|P2|Overall Study|Lost to Follow up but returned per GSK|1
5707155|NCT00158860|19668968|P1|Overall Study|Lost to Follow up but returned per GSK|0
5707156|NCT00158860|19668967|P2|Overall Study|SPONSOR REQUEST|1
5707157|NCT00158860|19668968|P1|Overall Study|SPONSOR REQUEST|0
5707158|NCT00158860|19668967|P2|Overall Study|SPONSOR STOPPED STUDY|2
5707159|NCT00158860|19668968|P1|Overall Study|SPONSOR STOPPED STUDY|2
5707160|NCT00158860|19668967|P2|Overall Study|Pregnancy|3
5707161|NCT00158860|19668968|P1|Overall Study|Pregnancy|3
5707162|NCT00158860|19668967|P2|Overall Study|MOVING OUT OF STATE|0
5707163|NCT00158860|19668968|P1|Overall Study|MOVING OUT OF STATE|1
5707164|NCT00158860|19668967|P2|Overall Study|Withdrawal by Subject|17
5707165|NCT00158860|19668968|P1|Overall Study|Withdrawal by Subject|7
5707166|NCT00158860|19668967|P2|Overall Study|Protocol Violation|23
5707167|NCT00158860|19668968|P1|Overall Study|Protocol Violation|8
5707168|NCT00158860|19668967|P2|Overall Study|Lost to Follow-up|17
5707169|NCT00158860|19668968|P1|Overall Study|Lost to Follow-up|11
5707170|NCT00158860|19668967|P2|Overall Study|Adverse Event|6
5707171|NCT00158860|19668968|P1|Overall Study|Adverse Event|3
5707172|NCT00158756|19668987|P5|Overall Study|Serious adverse event|0
5707173|NCT00158756|19668988|P4|Overall Study|Serious adverse event|0
5707174|NCT00158756|19668989|P3|Overall Study|Serious adverse event|1
5707175|NCT00158756|19668990|P2|Overall Study|Serious adverse event|0
5707176|NCT00158756|19668991|P1|Overall Study|Serious adverse event|0
5707177|NCT00158756|19668987|P5|Overall Study|Adverse Event|0
5707178|NCT00158756|19668988|P4|Overall Study|Adverse Event|0
5707179|NCT00158756|19668989|P3|Overall Study|Adverse Event|1
5707180|NCT00158756|19668990|P2|Overall Study|Adverse Event|0
5707181|NCT00158756|19668991|P1|Overall Study|Adverse Event|0
5707182|NCT00158756|19668987|P5|Overall Study|Withdrawal by Subject|3
5707183|NCT00158756|19668988|P4|Overall Study|Withdrawal by Subject|1
5707184|NCT00158756|19668989|P3|Overall Study|Withdrawal by Subject|6
5707185|NCT00158756|19668990|P2|Overall Study|Withdrawal by Subject|0
5707186|NCT00158756|19668991|P1|Overall Study|Withdrawal by Subject|5
5707187|NCT00158600|19669097|P2|Overall Study|Withdrawal by Subject|2
5707188|NCT00158600|19669098|P1|Overall Study|Withdrawal by Subject|2
5707189|NCT00158600|19669097|P2|Overall Study|Death|0
5707190|NCT00158600|19669098|P1|Overall Study|Death|1
5707191|NCT00158600|19669097|P2|Overall Study|Adverse Event|1
5707192|NCT00158600|19669098|P1|Overall Study|Adverse Event|2
5707193|NCT00158600|19669097|P2|Overall Study|unable to commit time to study|1
5707194|NCT00158600|19669098|P1|Overall Study|unable to commit time to study|0
5707195|NCT00158262|19669123|P2|Overall Study|Lost to Follow-up|1
5707196|NCT00158262|19669124|P1|Overall Study|Lost to Follow-up|1
5707197|NCT00158184|19669185|P2|Overall Study|Adverse Event|1
5707198|NCT00158184|19669186|P1|Overall Study|Adverse Event|1
5707199|NCT00158184|19669185|P2|Overall Study|failed for follow unit/study rules|0
5707200|NCT00158184|19669186|P1|Overall Study|failed for follow unit/study rules|2
5707201|NCT00158184|19669185|P2|Overall Study|personal issues|1
5707202|NCT00158184|19669186|P1|Overall Study|personal issues|3
5707203|NCT00158054|19669196|P2|Overall Study|Unavailable for follow up|3
5707204|NCT00158054|19669197|P1|Overall Study|Unavailable for follow up|7
5707205|NCT00158054|19669196|P2|Overall Study|Refused to continue|0
5707206|NCT00158054|19669197|P1|Overall Study|Refused to continue|3
5707207|NCT00157950|19669211|P2|Overall Study|Death|0
5707208|NCT00157950|19669212|P1|Overall Study|Death|1
5707209|NCT00157820|19669229|P3|2nd 8 Months|Premature cross-over|9
5707210|NCT00157820|19669230|P2|2nd 8 Months|Premature cross-over|7
5707211|NCT00157820|19669231|P1|2nd 8 Months|Premature cross-over|1
5707212|NCT00157820|19669229|P3|2nd 8 Months|Lost to Follow-up|2
5707213|NCT00157820|19669230|P2|2nd 8 Months|Lost to Follow-up|5
5707214|NCT00157820|19669231|P1|2nd 8 Months|Lost to Follow-up|1
5707215|NCT00157820|19669229|P3|2nd 8 Months|Death|3
5707216|NCT00157820|19669230|P2|2nd 8 Months|Death|1
5707217|NCT00157820|19669231|P1|2nd 8 Months|Death|3
5707218|NCT00157820|19669229|P3|1st 8 Month|Premature cross-over|2
5707219|NCT00157820|19669230|P2|1st 8 Month|Premature cross-over|2
5707220|NCT00157820|19669231|P1|1st 8 Month|Premature cross-over|0
5707221|NCT00157820|19669229|P3|1st 8 Month|Lost to Follow-up|1
5707222|NCT00157820|19669230|P2|1st 8 Month|Lost to Follow-up|2
5707223|NCT00157820|19669231|P1|1st 8 Month|Lost to Follow-up|1
5707224|NCT00157820|19669229|P3|1st 8 Month|Death|3
5707225|NCT00157820|19669230|P2|1st 8 Month|Death|8
5707226|NCT00157820|19669231|P1|1st 8 Month|Death|7
5707227|NCT00157820|19669229|P3|Randomized|Protocol Violation|2
5707228|NCT00157820|19669230|P2|Randomized|Protocol Violation|1
5707229|NCT00157820|19669231|P1|Randomized|Protocol Violation|2
5707230|NCT00157820|19669229|P3|Randomized|Withdrawal by Subject|3
5707231|NCT00157820|19669230|P2|Randomized|Withdrawal by Subject|2
5707232|NCT00157820|19669231|P1|Randomized|Withdrawal by Subject|1
5707233|NCT00157820|19669229|P3|Randomized|Physician Decision|3
5707234|NCT00157820|19669230|P2|Randomized|Physician Decision|2
5707235|NCT00157820|19669231|P1|Randomized|Physician Decision|4
5707236|NCT00157755|19669244|P6|Overall Study|Study completion|2
5707237|NCT00157755|19669245|P5|Overall Study|Study completion|1
5707238|NCT00157755|19669246|P4|Overall Study|Study completion|0
5707239|NCT00157755|19669247|P3|Overall Study|Study completion|0
5707240|NCT00157755|19669248|P2|Overall Study|Study completion|0
5707241|NCT00157755|19669249|P1|Overall Study|Study completion|0
5707242|NCT00157755|19669244|P6|Overall Study|Subject non-compliance|1
5707243|NCT00157755|19669245|P5|Overall Study|Subject non-compliance|0
5707244|NCT00157755|19669246|P4|Overall Study|Subject non-compliance|0
5707245|NCT00157755|19669247|P3|Overall Study|Subject non-compliance|0
5707246|NCT00157755|19669248|P2|Overall Study|Subject non-compliance|0
5707247|NCT00157755|19669249|P1|Overall Study|Subject non-compliance|0
5707248|NCT00157755|19669244|P6|Overall Study|Study site closure|0
5707249|NCT00157755|19669245|P5|Overall Study|Study site closure|0
5707250|NCT00157755|19669246|P4|Overall Study|Study site closure|0
5707251|NCT00157755|19669247|P3|Overall Study|Study site closure|0
5707252|NCT00157755|19669248|P2|Overall Study|Study site closure|1
5707253|NCT00157755|19669249|P1|Overall Study|Study site closure|0
5707254|NCT00157755|19669244|P6|Overall Study|Medical reason|0
5707255|NCT00157755|19669245|P5|Overall Study|Medical reason|0
5707256|NCT00157755|19669246|P4|Overall Study|Medical reason|1
5707257|NCT00157755|19669247|P3|Overall Study|Medical reason|1
5707258|NCT00157755|19669248|P2|Overall Study|Medical reason|0
5707259|NCT00157755|19669249|P1|Overall Study|Medical reason|0
5707260|NCT00157755|19669244|P6|Overall Study|Explant due to infection|0
5707261|NCT00157755|19669245|P5|Overall Study|Explant due to infection|0
5707262|NCT00157755|19669246|P4|Overall Study|Explant due to infection|0
5707263|NCT00157755|19669247|P3|Overall Study|Explant due to infection|1
5707264|NCT00157755|19669248|P2|Overall Study|Explant due to infection|0
5707265|NCT00157755|19669249|P1|Overall Study|Explant due to infection|0
5707266|NCT00157755|19669244|P6|Overall Study|Withdrawal by Subject|2
5707267|NCT00157755|19669245|P5|Overall Study|Withdrawal by Subject|1
5707268|NCT00157755|19669246|P4|Overall Study|Withdrawal by Subject|1
5707269|NCT00157755|19669247|P3|Overall Study|Withdrawal by Subject|1
5707270|NCT00157755|19669248|P2|Overall Study|Withdrawal by Subject|0
5707271|NCT00157755|19669249|P1|Overall Study|Withdrawal by Subject|0
5707272|NCT00157755|19669244|P6|Overall Study|Lost to Follow-up|0
5707273|NCT00157755|19669245|P5|Overall Study|Lost to Follow-up|0
5707274|NCT00157755|19669246|P4|Overall Study|Lost to Follow-up|0
5707275|NCT00157755|19669247|P3|Overall Study|Lost to Follow-up|1
5707276|NCT00157755|19669248|P2|Overall Study|Lost to Follow-up|0
5707277|NCT00157755|19669249|P1|Overall Study|Lost to Follow-up|0
5707278|NCT00157755|19669244|P6|Overall Study|Death|0
5707279|NCT00157755|19669245|P5|Overall Study|Death|0
5707280|NCT00157755|19669246|P4|Overall Study|Death|2
5707281|NCT00157755|19669247|P3|Overall Study|Death|3
5707282|NCT00157755|19669248|P2|Overall Study|Death|3
5707283|NCT00157755|19669249|P1|Overall Study|Death|2
5707284|NCT00157248|19669285|P4|Overall Study|site closures, subject moving|9
5707285|NCT00157248|19669286|P3|Overall Study|site closures, subject moving|3
5707286|NCT00157248|19669287|P2|Overall Study|site closures, subject moving|7
5707287|NCT00157248|19669288|P1|Overall Study|site closures, subject moving|7
5707288|NCT00157248|19669285|P4|Overall Study|Withdrawal by Subject|3
5707289|NCT00157248|19669286|P3|Overall Study|Withdrawal by Subject|3
5707290|NCT00157248|19669287|P2|Overall Study|Withdrawal by Subject|4
5707291|NCT00157248|19669288|P1|Overall Study|Withdrawal by Subject|1
5707292|NCT00157248|19669285|P4|Overall Study|Lost to Follow-up|0
5707293|NCT00157248|19669286|P3|Overall Study|Lost to Follow-up|0
5707294|NCT00157248|19669287|P2|Overall Study|Lost to Follow-up|1
5707295|NCT00157248|19669288|P1|Overall Study|Lost to Follow-up|0
5707296|NCT00157248|19669285|P4|Overall Study|Protocol Violation|2
5707297|NCT00157248|19669286|P3|Overall Study|Protocol Violation|2
5707298|NCT00157248|19669287|P2|Overall Study|Protocol Violation|0
5707299|NCT00157248|19669288|P1|Overall Study|Protocol Violation|4
5707300|NCT00157248|19669285|P4|Overall Study|Adverse Event|33
5707301|NCT00157248|19669286|P3|Overall Study|Adverse Event|13
5707302|NCT00157248|19669287|P2|Overall Study|Adverse Event|25
5707303|NCT00157248|19669288|P1|Overall Study|Adverse Event|36
5707304|NCT00157209|19669394|P2|Overall Study|Ongoing at data cut-off|0
5707305|NCT00157209|19669395|P1|Overall Study|Ongoing at data cut-off|10
5707306|NCT00157196|19669409|P1|Overall Study|Ongoing at data cut-off|9
5707307|NCT00157157|19669415|P1|Overall Study|Inclusion not met- baseline FVIII value|1
5707308|NCT00157157|19669415|P1|Overall Study|Met exclusion criteria|1
5707309|NCT00157157|19669415|P1|Overall Study|Enrolled in another study|1
5707310|NCT00157157|19669415|P1|Overall Study|Lost to Follow-up|1
5707311|NCT00157157|19669415|P1|Overall Study|Physician Decision|1
5707312|NCT00157157|19669415|P1|Overall Study|Withdrawal by Subject|6
5707313|NCT00157014|19669442|P4|Overall Study|Withdrawal by Subject|0
5707314|NCT00157014|19669443|P3|Overall Study|Withdrawal by Subject|0
5707315|NCT00157014|19669444|P2|Overall Study|Withdrawal by Subject|0
5707316|NCT00157014|19669445|P1|Overall Study|Withdrawal by Subject|1
5707317|NCT00157014|19669442|P4|Overall Study|Patient would not receive transplant|0
5707318|NCT00157014|19669443|P3|Overall Study|Patient would not receive transplant|0
5707319|NCT00157014|19669444|P2|Overall Study|Patient would not receive transplant|1
5707320|NCT00157014|19669445|P1|Overall Study|Patient would not receive transplant|0
5707321|NCT00157014|19669442|P4|Overall Study|Patient unable to return in nursing home|0
5707322|NCT00157014|19669443|P3|Overall Study|Patient unable to return in nursing home|0
5707323|NCT00157014|19669444|P2|Overall Study|Patient unable to return in nursing home|0
5707324|NCT00157014|19669445|P1|Overall Study|Patient unable to return in nursing home|1
5707325|NCT00157014|19669442|P4|Overall Study|Patient withdrawn by investigator|0
5707326|NCT00157014|19669443|P3|Overall Study|Patient withdrawn by investigator|0
5707327|NCT00157014|19669444|P2|Overall Study|Patient withdrawn by investigator|0
5707328|NCT00157014|19669445|P1|Overall Study|Patient withdrawn by investigator|1
5707329|NCT00157014|19669442|P4|Overall Study|Medications withdrawn on family request|0
5707330|NCT00157014|19669443|P3|Overall Study|Medications withdrawn on family request|0
5707331|NCT00157014|19669444|P2|Overall Study|Medications withdrawn on family request|1
5707332|NCT00157014|19669445|P1|Overall Study|Medications withdrawn on family request|0
5707333|NCT00157014|19669442|P4|Overall Study|Physician Decision|0
5707334|NCT00157014|19669443|P3|Overall Study|Physician Decision|0
5707335|NCT00157014|19669444|P2|Overall Study|Physician Decision|1
5707336|NCT00157014|19669445|P1|Overall Study|Physician Decision|0
5707337|NCT00157014|19669442|P4|Overall Study|Death|1
5707338|NCT00157014|19669443|P3|Overall Study|Death|1
5707339|NCT00157014|19669444|P2|Overall Study|Death|2
5707340|NCT00157014|19669445|P1|Overall Study|Death|4
5707341|NCT00156819|19669561|P3|Overall Study|Lost to Follow-up|3
5707342|NCT00156819|19669562|P2|Overall Study|Lost to Follow-up|1
5707343|NCT00156819|19669563|P1|Overall Study|Lost to Follow-up|1
5707344|NCT00156533|19669580|P4|Overall Study|Failed Screening|1
5707345|NCT00156533|19669581|P3|Overall Study|Failed Screening|1
5707346|NCT00156533|19669582|P2|Overall Study|Failed Screening|0
5707347|NCT00156533|19669583|P1|Overall Study|Failed Screening|1
5707348|NCT00156533|19669580|P4|Overall Study|Withdrawal by Subject|1
5707349|NCT00156533|19669581|P3|Overall Study|Withdrawal by Subject|0
5707350|NCT00156533|19669582|P2|Overall Study|Withdrawal by Subject|0
5707351|NCT00156533|19669583|P1|Overall Study|Withdrawal by Subject|1
5707352|NCT00156533|19669580|P4|Overall Study|Withdrawn - Medication Expiration|0
5707353|NCT00156533|19669581|P3|Overall Study|Withdrawn - Medication Expiration|1
5707354|NCT00156533|19669582|P2|Overall Study|Withdrawn - Medication Expiration|2
5707355|NCT00156533|19669583|P1|Overall Study|Withdrawn - Medication Expiration|0
5707356|NCT00156065|19669617|P3|Overall Study|Other|3
5707357|NCT00156065|19669618|P2|Overall Study|Other|9
5707358|NCT00156065|19669619|P1|Overall Study|Other|2
5707359|NCT00156065|19669617|P3|Overall Study|Lost to Follow-up|1
5707360|NCT00156065|19669618|P2|Overall Study|Lost to Follow-up|7
5707361|NCT00156065|19669619|P1|Overall Study|Lost to Follow-up|5
5707362|NCT00156065|19669617|P3|Overall Study|Withdrawal by Subject|16
5707363|NCT00156065|19669618|P2|Overall Study|Withdrawal by Subject|26
5707364|NCT00156065|19669619|P1|Overall Study|Withdrawal by Subject|13
5707365|NCT00156065|19669617|P3|Overall Study|Lack of Efficacy|3
5707366|NCT00156065|19669618|P2|Overall Study|Lack of Efficacy|9
5707367|NCT00156065|19669619|P1|Overall Study|Lack of Efficacy|2
5707368|NCT00156065|19669617|P3|Overall Study|Adverse Event|4
5707369|NCT00156065|19669618|P2|Overall Study|Adverse Event|11
5707370|NCT00156065|19669619|P1|Overall Study|Adverse Event|8
5707371|NCT00156065|19669617|P3|Overall Study|Enrolled But Never Received Treatment|0
5707372|NCT00156065|19669618|P2|Overall Study|Enrolled But Never Received Treatment|1
5707373|NCT00156065|19669619|P1|Overall Study|Enrolled But Never Received Treatment|1
5707374|NCT00154375|19669653|P2|Overall Study|Suspected progression of disease|30
5707375|NCT00154375|19669654|P1|Overall Study|Suspected progression of disease|44
5707376|NCT00154375|19669653|P2|Overall Study|Protocol Violation|1
5707377|NCT00154375|19669654|P1|Overall Study|Protocol Violation|0
5707378|NCT00154375|19669653|P2|Overall Study|Abnormal laboratory value(s)|2
5707379|NCT00154375|19669654|P1|Overall Study|Abnormal laboratory value(s)|0
5707380|NCT00154375|19669653|P2|Overall Study|Lost to Follow-up|1
5707381|NCT00154375|19669654|P1|Overall Study|Lost to Follow-up|2
5707382|NCT00154375|19669653|P2|Overall Study|Study drug no longer required|3
5707383|NCT00154375|19669654|P1|Overall Study|Study drug no longer required|5
5707384|NCT00154375|19669653|P2|Overall Study|Death|13
5707385|NCT00154375|19669654|P1|Overall Study|Death|5
5707386|NCT00154375|19669653|P2|Overall Study|Withdrawal by Subject|10
5707387|NCT00154375|19669654|P1|Overall Study|Withdrawal by Subject|14
5707388|NCT00154375|19669653|P2|Overall Study|Adverse Event|20
5707389|NCT00154375|19669654|P1|Overall Study|Adverse Event|18
5707390|NCT00154375|19669653|P2|Overall Study|Unsatisfactory therapeutic effect|26
5707391|NCT00154375|19669654|P1|Overall Study|Unsatisfactory therapeutic effect|25
5707392|NCT00154310|19669665|P2|Overall Study|Death|1
5707393|NCT00154310|19669666|P1|Overall Study|Death|0
5707394|NCT00154310|19669665|P2|Overall Study|Administrative problems|1
5707395|NCT00154310|19669666|P1|Overall Study|Administrative problems|0
5707396|NCT00154310|19669665|P2|Overall Study|Lost to Follow-up|8
5707397|NCT00154310|19669666|P1|Overall Study|Lost to Follow-up|0
5707398|NCT00154310|19669665|P2|Overall Study|Withdrawal by Subject|3
5707399|NCT00154310|19669666|P1|Overall Study|Withdrawal by Subject|9
5707400|NCT00154310|19669665|P2|Overall Study|Protocol Violation|2
5707401|NCT00154310|19669666|P1|Overall Study|Protocol Violation|4
5707402|NCT00154310|19669665|P2|Overall Study|Lack of Efficacy|4
5707403|NCT00154310|19669666|P1|Overall Study|Lack of Efficacy|5
5707404|NCT00154310|19669665|P2|Overall Study|Adverse Event|9
5707405|NCT00154310|19669666|P1|Overall Study|Adverse Event|19
5707406|NCT00154297|19669682|P2|Overall Study|Lost to Follow-up|0
5707407|NCT00154297|19669683|P1|Overall Study|Lost to Follow-up|3
5707408|NCT00154297|19669682|P2|Overall Study|Withdrawal by Subject|5
5707409|NCT00154297|19669683|P1|Overall Study|Withdrawal by Subject|0
5707410|NCT00154297|19669682|P2|Overall Study|Death|2
5707411|NCT00154297|19669683|P1|Overall Study|Death|5
5707412|NCT00154284|19669701|P2|Overall Study|Protocol Violation|1
5707413|NCT00154284|19669702|P1|Overall Study|Protocol Violation|0
5707414|NCT00154284|19669701|P2|Overall Study|Lack of Efficacy|2
5707415|NCT00154284|19669702|P1|Overall Study|Lack of Efficacy|1
5707416|NCT00154284|19669701|P2|Overall Study|Abnormal laboratory value(s)|1
5707417|NCT00154284|19669702|P1|Overall Study|Abnormal laboratory value(s)|0
5707418|NCT00154284|19669701|P2|Overall Study|Adverse Event|9
5707419|NCT00154284|19669702|P1|Overall Study|Adverse Event|6
5707420|NCT00154102|19669716|P2|Overall Study|investigational study phase ongoing|2
5707421|NCT00154102|19669717|P1|Overall Study|investigational study phase ongoing|7
5707422|NCT00154063|19669753|P2|Overall Study|Other|3
5707423|NCT00154063|19669754|P1|Overall Study|Other|3
5707424|NCT00154063|19669753|P2|Overall Study|Withdrawal by Subject|9
5707425|NCT00154063|19669754|P1|Overall Study|Withdrawal by Subject|4
5707426|NCT00154063|19669753|P2|Overall Study|Investigator or Sponsor Request|1
5707427|NCT00154063|19669754|P1|Overall Study|Investigator or Sponsor Request|0
5707428|NCT00154063|19669753|P2|Overall Study|Protocol Violation|1
5707429|NCT00154063|19669754|P1|Overall Study|Protocol Violation|1
5707430|NCT00154063|19669753|P2|Overall Study|Adverse Event|8
5707431|NCT00154063|19669754|P1|Overall Study|Adverse Event|4
5707432|NCT00153920|19669816|P1|Overall Study|Progressive Disease before Trt|1
5707433|NCT00153920|19669816|P1|Overall Study|Withdrawal of Consent before Trt|1
5707434|NCT00153920|19669816|P1|Overall Study|Non-Protocol Therapy|1
5707435|NCT00153920|19669816|P1|Overall Study|Withdrawal by Subject|1
5707436|NCT00153920|19669816|P1|Overall Study|Death|2
5707437|NCT00153920|19669816|P1|Overall Study|Lack of Response|3
5707438|NCT00153920|19669816|P1|Overall Study|Physician Decision|3
5707439|NCT00153920|19669816|P1|Overall Study|Progressive Disease|9
5707440|NCT00153920|19669816|P1|Overall Study|Adverse Event|9
5707441|NCT00153816|19669842|P6|Overall Study|Follow-up exam done, histology missing|2
5707442|NCT00153816|19669843|P5|Overall Study|Follow-up exam done, histology missing|1
5707443|NCT00153816|19669844|P4|Overall Study|Follow-up exam done, histology missing|3
5707444|NCT00153816|19669845|P3|Overall Study|Follow-up exam done, histology missing|3
5707445|NCT00153816|19669846|P2|Overall Study|Follow-up exam done, histology missing|3
5707446|NCT00153816|19669847|P1|Overall Study|Follow-up exam done, histology missing|2
5707447|NCT00153816|19669842|P6|Overall Study|Follow-up exam not done|9
5707448|NCT00153816|19669843|P5|Overall Study|Follow-up exam not done|8
5707449|NCT00153816|19669844|P4|Overall Study|Follow-up exam not done|10
5707450|NCT00153816|19669845|P3|Overall Study|Follow-up exam not done|11
5707451|NCT00153816|19669846|P2|Overall Study|Follow-up exam not done|7
5707452|NCT00153816|19669847|P1|Overall Study|Follow-up exam not done|8
5707453|NCT00153816|19669842|P6|Overall Study|Withdrawal by Subject|5
5707454|NCT00153816|19669843|P5|Overall Study|Withdrawal by Subject|1
5707455|NCT00153816|19669844|P4|Overall Study|Withdrawal by Subject|4
5707456|NCT00153816|19669845|P3|Overall Study|Withdrawal by Subject|9
5707457|NCT00153816|19669846|P2|Overall Study|Withdrawal by Subject|9
5707458|NCT00153816|19669847|P1|Overall Study|Withdrawal by Subject|9
5707459|NCT00153816|19669842|P6|Overall Study|Lost to Follow-up|9
5707460|NCT00153816|19669843|P5|Overall Study|Lost to Follow-up|7
5707461|NCT00153816|19669844|P4|Overall Study|Lost to Follow-up|8
5707462|NCT00153816|19669845|P3|Overall Study|Lost to Follow-up|5
5707463|NCT00153816|19669846|P2|Overall Study|Lost to Follow-up|8
5707464|NCT00153816|19669847|P1|Overall Study|Lost to Follow-up|7
5707465|NCT00153816|19669842|P6|Overall Study|Death|2
5707466|NCT00153816|19669843|P5|Overall Study|Death|0
5707467|NCT00153816|19669844|P4|Overall Study|Death|6
5707468|NCT00153816|19669845|P3|Overall Study|Death|4
5707469|NCT00153816|19669846|P2|Overall Study|Death|5
5707470|NCT00153816|19669847|P1|Overall Study|Death|6
5707471|NCT00153179|19669888|P4|Study Visit Day 2|Withdrawal by Subject|2
5707472|NCT00153179|19669889|P3|Study Visit Day 2|Withdrawal by Subject|2
5707473|NCT00153179|19669890|P2|Study Visit Day 2|Withdrawal by Subject|0
5707474|NCT00153179|19669891|P1|Study Visit Day 2|Withdrawal by Subject|1
5707475|NCT00153101|19669923|P5|Overall Study|Withdrawal by Subject|5
5707476|NCT00153101|19669924|P4|Overall Study|Withdrawal by Subject|3
5707477|NCT00153101|19669925|P3|Overall Study|Withdrawal by Subject|3
5707478|NCT00153101|19669926|P2|Overall Study|Withdrawal by Subject|4
5707479|NCT00153101|19669927|P1|Overall Study|Withdrawal by Subject|3
5707480|NCT00153101|19669923|P5|Overall Study|Lost to Follow-up|5
5707481|NCT00153101|19669924|P4|Overall Study|Lost to Follow-up|5
5707482|NCT00153101|19669925|P3|Overall Study|Lost to Follow-up|12
5707483|NCT00153101|19669926|P2|Overall Study|Lost to Follow-up|14
5707484|NCT00153101|19669927|P1|Overall Study|Lost to Follow-up|14
5707485|NCT00153062|19670035|P4|Overall Study|Other|0
5707486|NCT00153062|19670036|P3|Overall Study|Other|1
5707487|NCT00153062|19670037|P2|Overall Study|Other|0
5707488|NCT00153062|19670038|P1|Overall Study|Other|0
5707489|NCT00153062|19670035|P4|Overall Study|No disposition data available|1
5707490|NCT00153062|19670036|P3|Overall Study|No disposition data available|1
5707491|NCT00153062|19670037|P2|Overall Study|No disposition data available|1
5707492|NCT00153062|19670038|P1|Overall Study|No disposition data available|1
5707493|NCT00153062|19670035|P4|Overall Study|Protocol Violation|1
5707494|NCT00153062|19670036|P3|Overall Study|Protocol Violation|1
5707495|NCT00153062|19670037|P2|Overall Study|Protocol Violation|2
5707496|NCT00153062|19670038|P1|Overall Study|Protocol Violation|0
5707497|NCT00153062|19670035|P4|Overall Study|Adverse Event|0
5707498|NCT00153062|19670036|P3|Overall Study|Adverse Event|1
5707499|NCT00153062|19670037|P2|Overall Study|Adverse Event|1
5707500|NCT00153062|19670038|P1|Overall Study|Adverse Event|0
5707501|NCT00153062|19670035|P4|Overall Study|Lost to Follow-up|16
5707502|NCT00153062|19670036|P3|Overall Study|Lost to Follow-up|15
5707503|NCT00153062|19670037|P2|Overall Study|Lost to Follow-up|20
5707504|NCT00153062|19670038|P1|Overall Study|Lost to Follow-up|12
5707505|NCT00153062|19670035|P4|Overall Study|Withdrawal by Subject|28
5707506|NCT00153062|19670036|P3|Overall Study|Withdrawal by Subject|27
5707507|NCT00153062|19670037|P2|Overall Study|Withdrawal by Subject|30
5707508|NCT00153062|19670038|P1|Overall Study|Withdrawal by Subject|14
5707509|NCT00153062|19670035|P4|Overall Study|Death|365
5707510|NCT00153062|19670036|P3|Overall Study|Death|369
5707511|NCT00153062|19670037|P2|Overall Study|Death|352
5707512|NCT00153062|19670038|P1|Overall Study|Death|360
5707513|NCT00152971|19670057|P3|Treatment|Other|10
5707514|NCT00152971|19670058|P2|Treatment|Other|11
5707515|NCT00152971|19670059|P1|Treatment|Other|9
5707516|NCT00152971|19670057|P3|Treatment|Withdrawal by Subject|5
5707517|NCT00152971|19670058|P2|Treatment|Withdrawal by Subject|4
5707518|NCT00152971|19670059|P1|Treatment|Withdrawal by Subject|4
5707519|NCT00152971|19670057|P3|Treatment|Lost to Follow-up|1
5707520|NCT00152971|19670058|P2|Treatment|Lost to Follow-up|2
5707521|NCT00152971|19670059|P1|Treatment|Lost to Follow-up|1
5707522|NCT00152971|19670057|P3|Treatment|Protocol Violation|10
5707523|NCT00152971|19670058|P2|Treatment|Protocol Violation|6
5707524|NCT00152971|19670059|P1|Treatment|Protocol Violation|8
5707525|NCT00152971|19670057|P3|Treatment|Adverse Event|54
5707526|NCT00152971|19670058|P2|Treatment|Adverse Event|40
5707527|NCT00152971|19670059|P1|Treatment|Adverse Event|49
5707528|NCT00152971|19670057|P3|Overall Study|Other|5
5707529|NCT00152971|19670058|P2|Overall Study|Other|5
5707530|NCT00152971|19670059|P1|Overall Study|Other|3
5707531|NCT00152971|19670057|P3|Overall Study|Withdrawal by Subject|14
5707532|NCT00152971|19670058|P2|Overall Study|Withdrawal by Subject|8
5707533|NCT00152971|19670059|P1|Overall Study|Withdrawal by Subject|9
5707534|NCT00152971|19670057|P3|Overall Study|Lost to Follow-up|13
5707535|NCT00152971|19670058|P2|Overall Study|Lost to Follow-up|14
5707536|NCT00152971|19670059|P1|Overall Study|Lost to Follow-up|17
5707537|NCT00152971|19670057|P3|Overall Study|Protocol Violation|8
5707538|NCT00152971|19670058|P2|Overall Study|Protocol Violation|11
5707539|NCT00152971|19670059|P1|Overall Study|Protocol Violation|10
5707540|NCT00152971|19670057|P3|Overall Study|Adverse Event|9
5707541|NCT00152971|19670058|P2|Overall Study|Adverse Event|10
5707542|NCT00152971|19670059|P1|Overall Study|Adverse Event|12
5707543|NCT00152763|19670095|P4|Overall Study|Lost to Follow-up|13
5707544|NCT00152763|19670096|P3|Overall Study|Lost to Follow-up|2
5707545|NCT00152763|19670097|P2|Overall Study|Lost to Follow-up|4
5707546|NCT00152763|19670098|P1|Overall Study|Lost to Follow-up|6
5707547|NCT00152763|19670095|P4|Overall Study|Death|1
5707548|NCT00152763|19670096|P3|Overall Study|Death|2
5707549|NCT00152763|19670097|P2|Overall Study|Death|1
5707550|NCT00152763|19670098|P1|Overall Study|Death|4
5707551|NCT00152516|19670214|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
5707552|NCT00152516|19670214|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
5707553|NCT00152516|19670214|P1|Overall Study|Other: Moved Out Of State|1
5707554|NCT00152516|19670214|P1|Overall Study|Other: Primary Care Physician's Decision|1
5707555|NCT00152516|19670214|P1|Overall Study|Other: Non-Compliance|2
5707556|NCT00152516|19670214|P1|Overall Study|Other: Parents Withdrew Consent|2
5707557|NCT00152516|19670214|P1|Overall Study|Other: Given Commercial Drug in Error|2
5707558|NCT00152516|19670214|P1|Overall Study|Other: Mother Refused To Cooperate|1
5707559|NCT00152516|19670214|P1|Overall Study|Protocol Violation|3
5707560|NCT00152516|19670214|P1|Overall Study|Withdrawal by Subject|8
5707561|NCT00152516|19670214|P1|Overall Study|Lost to Follow-up|5
5707562|NCT00152516|19670214|P1|Overall Study|Lack and Loss of Efficacy|30
5707563|NCT00152516|19670214|P1|Overall Study|Adverse Event|18
5707564|NCT00152464|19670240|P2|Overall Study|Patient relocated|0
5707565|NCT00152464|19670241|P1|Overall Study|Patient relocated|1
5707566|NCT00152464|19670240|P2|Overall Study|Eczema poorly controlled|0
5707567|NCT00152464|19670241|P1|Overall Study|Eczema poorly controlled|1
5707568|NCT00152464|19670240|P2|Overall Study|Lack of Efficacy|0
5707569|NCT00152464|19670241|P1|Overall Study|Lack of Efficacy|1
5707570|NCT00152464|19670240|P2|Overall Study|Investigator decision|0
5707571|NCT00152464|19670241|P1|Overall Study|Investigator decision|1
5707572|NCT00152464|19670240|P2|Overall Study|Parent decision|1
5707573|NCT00152464|19670241|P1|Overall Study|Parent decision|1
5707574|NCT00152464|19670240|P2|Overall Study|Eczema deterioration|1
5707575|NCT00152464|19670241|P1|Overall Study|Eczema deterioration|0
5707576|NCT00152464|19670240|P2|Overall Study|Atopic dermatitis poorly controlled|1
5707577|NCT00152464|19670241|P1|Overall Study|Atopic dermatitis poorly controlled|0
5707578|NCT00152464|19670240|P2|Overall Study|Withdrawal by Subject|22
5707579|NCT00152464|19670241|P1|Overall Study|Withdrawal by Subject|21
5707580|NCT00152464|19670240|P2|Overall Study|Protocol Violation|1
5707581|NCT00152464|19670241|P1|Overall Study|Protocol Violation|3
5707582|NCT00152464|19670240|P2|Overall Study|Lost to Follow-up|4
5707583|NCT00152464|19670241|P1|Overall Study|Lost to Follow-up|8
5707584|NCT00152464|19670240|P2|Overall Study|Adverse Event|6
5707585|NCT00152464|19670241|P1|Overall Study|Adverse Event|3
5707586|NCT00152009|19670269|P4|Overall Study|Sponsor's decision|3
5707587|NCT00152009|19670270|P3|Overall Study|Sponsor's decision|1
5707588|NCT00152009|19670271|P2|Overall Study|Sponsor's decision|3
5707589|NCT00152009|19670272|P1|Overall Study|Sponsor's decision|3
5707590|NCT00152009|19670269|P4|Overall Study|ECG abnormalities|1
5707591|NCT00152009|19670270|P3|Overall Study|ECG abnormalities|2
5707592|NCT00152009|19670271|P2|Overall Study|ECG abnormalities|2
5707593|NCT00152009|19670272|P1|Overall Study|ECG abnormalities|2
5707594|NCT00152009|19670269|P4|Overall Study|Lack of Efficacy|15
5707595|NCT00152009|19670270|P3|Overall Study|Lack of Efficacy|7
5707596|NCT00152009|19670271|P2|Overall Study|Lack of Efficacy|6
5707597|NCT00152009|19670272|P1|Overall Study|Lack of Efficacy|8
5707598|NCT00152009|19670269|P4|Overall Study|Lost to Follow-up|3
5707599|NCT00152009|19670270|P3|Overall Study|Lost to Follow-up|3
5707600|NCT00152009|19670271|P2|Overall Study|Lost to Follow-up|4
5707601|NCT00152009|19670272|P1|Overall Study|Lost to Follow-up|2
5707602|NCT00152009|19670269|P4|Overall Study|Withdrawal by Subject|9
5707603|NCT00152009|19670270|P3|Overall Study|Withdrawal by Subject|4
5707604|NCT00152009|19670271|P2|Overall Study|Withdrawal by Subject|3
5707605|NCT00152009|19670272|P1|Overall Study|Withdrawal by Subject|2
5707606|NCT00152009|19670269|P4|Overall Study|Protocol Violation|1
5707607|NCT00152009|19670270|P3|Overall Study|Protocol Violation|0
5707608|NCT00152009|19670271|P2|Overall Study|Protocol Violation|0
5707609|NCT00152009|19670272|P1|Overall Study|Protocol Violation|3
5707610|NCT00152009|19670269|P4|Overall Study|Adverse Event|1
5707611|NCT00152009|19670270|P3|Overall Study|Adverse Event|20
5707612|NCT00152009|19670271|P2|Overall Study|Adverse Event|13
5707613|NCT00152009|19670272|P1|Overall Study|Adverse Event|9
5707614|NCT00151996|19670304|P2|Overall Study|Sponsor's decision|2
5707615|NCT00151996|19670305|P1|Overall Study|Sponsor's decision|0
5707616|NCT00151996|19670304|P2|Overall Study|Protocol Violation|2
5707617|NCT00151996|19670305|P1|Overall Study|Protocol Violation|1
5707618|NCT00151996|19670304|P2|Overall Study|Withdrawal by Subject|1
5707619|NCT00151996|19670305|P1|Overall Study|Withdrawal by Subject|1
5707620|NCT00151996|19670304|P2|Overall Study|Adverse Event|2
5707621|NCT00151996|19670305|P1|Overall Study|Adverse Event|3
5707622|NCT00151892|19670321|P2|Overall Study|Lack of study medication at center|1
5707623|NCT00151892|19670322|P1|Overall Study|Lack of study medication at center|0
5707624|NCT00151892|19670321|P2|Overall Study|Used prohibited corticosteroids|0
5707625|NCT00151892|19670322|P1|Overall Study|Used prohibited corticosteroids|1
5707626|NCT00151892|19670321|P2|Overall Study|Did not return for a visit|0
5707627|NCT00151892|19670322|P1|Overall Study|Did not return for a visit|1
5707628|NCT00151892|19670321|P2|Overall Study|Pregnancy|1
5707629|NCT00151892|19670322|P1|Overall Study|Pregnancy|0
5707630|NCT00151892|19670321|P2|Overall Study|Non-compliance|1
5707631|NCT00151892|19670322|P1|Overall Study|Non-compliance|0
5707632|NCT00151892|19670321|P2|Overall Study|Protocol Violation|3
5707633|NCT00151892|19670322|P1|Overall Study|Protocol Violation|3
5707634|NCT00151892|19670321|P2|Overall Study|Adverse Event|3
5707635|NCT00151892|19670322|P1|Overall Study|Adverse Event|6
5707636|NCT00151892|19670321|P2|Overall Study|Lost to Follow-up|10
5707637|NCT00151892|19670322|P1|Overall Study|Lost to Follow-up|5
5707638|NCT00151892|19670321|P2|Overall Study|Patient request|7
5707639|NCT00151892|19670322|P1|Overall Study|Patient request|10
5707640|NCT00151892|19670321|P2|Overall Study|Lack of Efficacy|57
5707641|NCT00151892|19670322|P1|Overall Study|Lack of Efficacy|50
5707642|NCT00151775|19670367|P12|Period 4: Open Label|Protocol Violation|0
5707643|NCT00151775|19670368|P11|Period 4: Open Label|Protocol Violation|0
5707644|NCT00151775|19670369|P10|Period 4: Open Label|Protocol Violation|0
5707645|NCT00151775|19670370|P9|Period 4: Open Label|Protocol Violation|0
5707646|NCT00151775|19670371|P8|Period 4: Open Label|Protocol Violation|0
5707647|NCT00151775|19670372|P7|Period 4: Open Label|Protocol Violation|0
5707648|NCT00151775|19670373|P6|Period 4: Open Label|Protocol Violation|0
5707649|NCT00151775|19670374|P5|Period 4: Open Label|Protocol Violation|1
5707650|NCT00151775|19670375|P4|Period 4: Open Label|Protocol Violation|0
5707651|NCT00151775|19670376|P3|Period 4: Open Label|Protocol Violation|0
5707652|NCT00151775|19670377|P2|Period 4: Open Label|Protocol Violation|0
5707653|NCT00151775|19670378|P1|Period 4: Open Label|Protocol Violation|0
5707654|NCT00151775|19670367|P12|Period 4: Open Label|Physician Decision|0
5707655|NCT00151775|19670368|P11|Period 4: Open Label|Physician Decision|0
5707656|NCT00151775|19670369|P10|Period 4: Open Label|Physician Decision|2
5707657|NCT00151775|19670370|P9|Period 4: Open Label|Physician Decision|0
5707658|NCT00151775|19670371|P8|Period 4: Open Label|Physician Decision|0
5707659|NCT00151775|19670372|P7|Period 4: Open Label|Physician Decision|0
5707660|NCT00151775|19670373|P6|Period 4: Open Label|Physician Decision|0
5707661|NCT00151775|19670374|P5|Period 4: Open Label|Physician Decision|0
5707662|NCT00151775|19670375|P4|Period 4: Open Label|Physician Decision|0
5707663|NCT00151775|19670376|P3|Period 4: Open Label|Physician Decision|0
5707664|NCT00151775|19670377|P2|Period 4: Open Label|Physician Decision|0
5707665|NCT00151775|19670378|P1|Period 4: Open Label|Physician Decision|0
5707666|NCT00151775|19670367|P12|Period 4: Open Label|Other|0
5707667|NCT00151775|19670368|P11|Period 4: Open Label|Other|0
5707668|NCT00151775|19670369|P10|Period 4: Open Label|Other|3
5707669|NCT00151775|19670370|P9|Period 4: Open Label|Other|0
5707670|NCT00151775|19670371|P8|Period 4: Open Label|Other|0
5707671|NCT00151775|19670372|P7|Period 4: Open Label|Other|0
5707672|NCT00151775|19670373|P6|Period 4: Open Label|Other|0
5707673|NCT00151775|19670374|P5|Period 4: Open Label|Other|1
5707674|NCT00151775|19670375|P4|Period 4: Open Label|Other|0
5707675|NCT00151775|19670376|P3|Period 4: Open Label|Other|0
5707676|NCT00151775|19670377|P2|Period 4: Open Label|Other|0
5707677|NCT00151775|19670378|P1|Period 4: Open Label|Other|0
5707678|NCT00151775|19670367|P12|Period 4: Open Label|Non-compliance with protocol|0
5707679|NCT00151775|19670368|P11|Period 4: Open Label|Non-compliance with protocol|0
5707680|NCT00151775|19670369|P10|Period 4: Open Label|Non-compliance with protocol|4
5707681|NCT00151775|19670370|P9|Period 4: Open Label|Non-compliance with protocol|0
5707682|NCT00151775|19670371|P8|Period 4: Open Label|Non-compliance with protocol|0
5707683|NCT00151775|19670372|P7|Period 4: Open Label|Non-compliance with protocol|0
5707684|NCT00151775|19670373|P6|Period 4: Open Label|Non-compliance with protocol|0
5707685|NCT00151775|19670374|P5|Period 4: Open Label|Non-compliance with protocol|4
5707686|NCT00151775|19670375|P4|Period 4: Open Label|Non-compliance with protocol|0
5707687|NCT00151775|19670376|P3|Period 4: Open Label|Non-compliance with protocol|0
5707688|NCT00151775|19670377|P2|Period 4: Open Label|Non-compliance with protocol|0
5707689|NCT00151775|19670378|P1|Period 4: Open Label|Non-compliance with protocol|0
5707690|NCT00151775|19670367|P12|Period 4: Open Label|Lost to Follow-up|0
5707691|NCT00151775|19670368|P11|Period 4: Open Label|Lost to Follow-up|0
5707692|NCT00151775|19670369|P10|Period 4: Open Label|Lost to Follow-up|7
5707693|NCT00151775|19670370|P9|Period 4: Open Label|Lost to Follow-up|0
5707694|NCT00151775|19670371|P8|Period 4: Open Label|Lost to Follow-up|0
5707695|NCT00151775|19670372|P7|Period 4: Open Label|Lost to Follow-up|0
5707696|NCT00151775|19670373|P6|Period 4: Open Label|Lost to Follow-up|0
5707697|NCT00151775|19670374|P5|Period 4: Open Label|Lost to Follow-up|17
5707698|NCT00151775|19670375|P4|Period 4: Open Label|Lost to Follow-up|0
5707699|NCT00151775|19670376|P3|Period 4: Open Label|Lost to Follow-up|0
5707700|NCT00151775|19670377|P2|Period 4: Open Label|Lost to Follow-up|0
5707701|NCT00151775|19670378|P1|Period 4: Open Label|Lost to Follow-up|0
5707702|NCT00151775|19670367|P12|Period 4: Open Label|Adverse Event|0
5707703|NCT00151775|19670368|P11|Period 4: Open Label|Adverse Event|0
5707704|NCT00151775|19670369|P10|Period 4: Open Label|Adverse Event|2
5707705|NCT00151775|19670370|P9|Period 4: Open Label|Adverse Event|0
5707706|NCT00151775|19670371|P8|Period 4: Open Label|Adverse Event|0
5707707|NCT00151775|19670372|P7|Period 4: Open Label|Adverse Event|0
5707708|NCT00151775|19670373|P6|Period 4: Open Label|Adverse Event|0
5707709|NCT00151775|19670374|P5|Period 4: Open Label|Adverse Event|1
5707710|NCT00151775|19670375|P4|Period 4: Open Label|Adverse Event|0
5707711|NCT00151775|19670376|P3|Period 4: Open Label|Adverse Event|0
5707712|NCT00151775|19670377|P2|Period 4: Open Label|Adverse Event|0
5707713|NCT00151775|19670378|P1|Period 4: Open Label|Adverse Event|0
5707714|NCT00151775|19670367|P12|Period 4: Open Label|Withdrawal by Subject|0
5707715|NCT00151775|19670368|P11|Period 4: Open Label|Withdrawal by Subject|0
5707716|NCT00151775|19670369|P10|Period 4: Open Label|Withdrawal by Subject|2
5707717|NCT00151775|19670370|P9|Period 4: Open Label|Withdrawal by Subject|0
5707718|NCT00151775|19670371|P8|Period 4: Open Label|Withdrawal by Subject|0
5707719|NCT00151775|19670372|P7|Period 4: Open Label|Withdrawal by Subject|0
5707720|NCT00151775|19670373|P6|Period 4: Open Label|Withdrawal by Subject|0
5707721|NCT00151775|19670374|P5|Period 4: Open Label|Withdrawal by Subject|5
5707722|NCT00151775|19670375|P4|Period 4: Open Label|Withdrawal by Subject|0
5707723|NCT00151775|19670376|P3|Period 4: Open Label|Withdrawal by Subject|0
5707724|NCT00151775|19670377|P2|Period 4: Open Label|Withdrawal by Subject|0
5707725|NCT00151775|19670378|P1|Period 4: Open Label|Withdrawal by Subject|0
5707726|NCT00151775|19670367|P12|Period 4: Open Label|Increased blood pressure|0
5707727|NCT00151775|19670368|P11|Period 4: Open Label|Increased blood pressure|0
5707728|NCT00151775|19670369|P10|Period 4: Open Label|Increased blood pressure|1
5707729|NCT00151775|19670370|P9|Period 4: Open Label|Increased blood pressure|0
5707730|NCT00151775|19670371|P8|Period 4: Open Label|Increased blood pressure|0
5707731|NCT00151775|19670372|P7|Period 4: Open Label|Increased blood pressure|0
5707732|NCT00151775|19670373|P6|Period 4: Open Label|Increased blood pressure|0
5707733|NCT00151775|19670374|P5|Period 4: Open Label|Increased blood pressure|1
5707734|NCT00151775|19670375|P4|Period 4: Open Label|Increased blood pressure|0
5707735|NCT00151775|19670376|P3|Period 4: Open Label|Increased blood pressure|0
5707736|NCT00151775|19670377|P2|Period 4: Open Label|Increased blood pressure|0
5707737|NCT00151775|19670378|P1|Period 4: Open Label|Increased blood pressure|0
5707738|NCT00151775|19670367|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
5707739|NCT00151775|19670368|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707740|NCT00151775|19670369|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707741|NCT00151775|19670370|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707742|NCT00151775|19670371|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707743|NCT00151775|19670372|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707744|NCT00151775|19670373|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707745|NCT00151775|19670374|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707746|NCT00151775|19670375|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707747|NCT00151775|19670376|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707748|NCT00151775|19670377|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707749|NCT00151775|19670378|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
5707750|NCT00151775|19670367|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707751|NCT00151775|19670368|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707752|NCT00151775|19670369|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707753|NCT00151775|19670370|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707754|NCT00151775|19670371|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707755|NCT00151775|19670372|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707756|NCT00151775|19670373|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707757|NCT00151775|19670374|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707758|NCT00151775|19670375|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707759|NCT00151775|19670376|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
5707760|NCT00151775|19670377|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707761|NCT00151775|19670378|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
5707762|NCT00151775|19670367|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707763|NCT00151775|19670368|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707764|NCT00151775|19670369|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707765|NCT00151775|19670370|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707766|NCT00151775|19670371|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707767|NCT00151775|19670372|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707768|NCT00151775|19670373|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707769|NCT00151775|19670374|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707770|NCT00151775|19670375|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707771|NCT00151775|19670376|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
5707772|NCT00151775|19670377|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707773|NCT00151775|19670378|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
5707774|NCT00151775|19670367|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707775|NCT00151775|19670368|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707776|NCT00151775|19670369|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707777|NCT00151775|19670370|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707778|NCT00151775|19670371|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707779|NCT00151775|19670372|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
5707780|NCT00151775|19670373|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707781|NCT00151775|19670374|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707782|NCT00151775|19670375|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707783|NCT00151775|19670376|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707784|NCT00151775|19670377|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707785|NCT00151775|19670378|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
5707786|NCT00151775|19670367|P12|Period 3: Double-blind, Withdrawal|Other|0
5707787|NCT00151775|19670368|P11|Period 3: Double-blind, Withdrawal|Other|0
5707788|NCT00151775|19670369|P10|Period 3: Double-blind, Withdrawal|Other|0
5707789|NCT00151775|19670370|P9|Period 3: Double-blind, Withdrawal|Other|0
5707790|NCT00151775|19670371|P8|Period 3: Double-blind, Withdrawal|Other|1
5707791|NCT00151775|19670372|P7|Period 3: Double-blind, Withdrawal|Other|0
5707792|NCT00151775|19670373|P6|Period 3: Double-blind, Withdrawal|Other|0
5707793|NCT00151775|19670374|P5|Period 3: Double-blind, Withdrawal|Other|0
5707794|NCT00151775|19670375|P4|Period 3: Double-blind, Withdrawal|Other|0
5707795|NCT00151775|19670376|P3|Period 3: Double-blind, Withdrawal|Other|1
5707796|NCT00151775|19670377|P2|Period 3: Double-blind, Withdrawal|Other|0
5707797|NCT00151775|19670378|P1|Period 3: Double-blind, Withdrawal|Other|0
5707798|NCT00151775|19670367|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707799|NCT00151775|19670368|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707800|NCT00151775|19670369|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707801|NCT00151775|19670370|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707802|NCT00151775|19670371|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707803|NCT00151775|19670372|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707804|NCT00151775|19670373|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
5707805|NCT00151775|19670374|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707806|NCT00151775|19670375|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707807|NCT00151775|19670376|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707808|NCT00151775|19670377|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707809|NCT00151775|19670378|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
5707810|NCT00151775|19670367|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707811|NCT00151775|19670368|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707812|NCT00151775|19670369|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707813|NCT00151775|19670370|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707814|NCT00151775|19670371|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707815|NCT00151775|19670372|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
5707816|NCT00151775|19670373|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707817|NCT00151775|19670374|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707818|NCT00151775|19670375|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707819|NCT00151775|19670376|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707820|NCT00151775|19670377|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707821|NCT00151775|19670378|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
5707822|NCT00151775|19670367|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707823|NCT00151775|19670368|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707824|NCT00151775|19670369|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707825|NCT00151775|19670370|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707826|NCT00151775|19670371|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707827|NCT00151775|19670372|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707828|NCT00151775|19670373|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
5707829|NCT00151775|19670374|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707830|NCT00151775|19670375|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707831|NCT00151775|19670376|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707832|NCT00151775|19670377|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707833|NCT00151775|19670378|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
5707834|NCT00151775|19670367|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
5707835|NCT00151775|19670368|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
5707836|NCT00151775|19670369|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
5707837|NCT00151775|19670370|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
5707838|NCT00151775|19670371|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
5707839|NCT00151775|19670372|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
5707840|NCT00151775|19670373|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
5707841|NCT00151775|19670374|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
5707842|NCT00151775|19670375|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
5707843|NCT00151775|19670376|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
5707844|NCT00151775|19670377|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
5707845|NCT00151775|19670378|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
5707846|NCT00151775|19670367|P12|Period 2 - Double-Blind Dose Response|Other|0
5707847|NCT00151775|19670368|P11|Period 2 - Double-Blind Dose Response|Other|0
5707848|NCT00151775|19670369|P10|Period 2 - Double-Blind Dose Response|Other|0
5707849|NCT00151775|19670370|P9|Period 2 - Double-Blind Dose Response|Other|0
5707850|NCT00151775|19670371|P8|Period 2 - Double-Blind Dose Response|Other|0
5707851|NCT00151775|19670372|P7|Period 2 - Double-Blind Dose Response|Other|1
5707852|NCT00151775|19670373|P6|Period 2 - Double-Blind Dose Response|Other|0
5707853|NCT00151775|19670374|P5|Period 2 - Double-Blind Dose Response|Other|0
5707854|NCT00151775|19670375|P4|Period 2 - Double-Blind Dose Response|Other|0
5707855|NCT00151775|19670376|P3|Period 2 - Double-Blind Dose Response|Other|0
5707856|NCT00151775|19670377|P2|Period 2 - Double-Blind Dose Response|Other|0
5707857|NCT00151775|19670378|P1|Period 2 - Double-Blind Dose Response|Other|0
5707858|NCT00151775|19670367|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707859|NCT00151775|19670368|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707860|NCT00151775|19670369|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707861|NCT00151775|19670370|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707862|NCT00151775|19670371|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707863|NCT00151775|19670372|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707864|NCT00151775|19670373|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707865|NCT00151775|19670374|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707866|NCT00151775|19670375|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707867|NCT00151775|19670376|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707868|NCT00151775|19670377|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
5707869|NCT00151775|19670378|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
5707870|NCT00151775|19670367|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5707871|NCT00151775|19670368|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
5707872|NCT00151775|19670369|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5707873|NCT00151775|19670370|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5707874|NCT00151775|19670371|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5707875|NCT00151775|19670372|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
5707876|NCT00151775|19670373|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5707877|NCT00151775|19670374|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5707878|NCT00151775|19670375|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5707879|NCT00151775|19670376|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5707880|NCT00151775|19670377|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
5707881|NCT00151775|19670378|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
5707882|NCT00151775|19670367|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707883|NCT00151775|19670368|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707884|NCT00151775|19670369|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707885|NCT00151775|19670370|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707886|NCT00151775|19670371|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707887|NCT00151775|19670372|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707888|NCT00151775|19670373|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707889|NCT00151775|19670374|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707890|NCT00151775|19670375|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707891|NCT00151775|19670376|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
5707892|NCT00151775|19670377|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
5707893|NCT00151775|19670378|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
5707894|NCT00151476|19670422|P2|FAP Analyzed Subjects|Other study participation|1
5707895|NCT00151476|19670423|P1|FAP Analyzed Subjects|Other study participation|0
5707896|NCT00151476|19670422|P2|FAP Analyzed Subjects|Lost to Follow-up|2
5707897|NCT00151476|19670423|P1|FAP Analyzed Subjects|Lost to Follow-up|0
5707898|NCT00151476|19670422|P2|FAP Identified Subjects|Protocol Violation|1
5707899|NCT00151476|19670423|P1|FAP Identified Subjects|Protocol Violation|0
5707900|NCT00151411|19670480|P2|Overall Study|Pregnancy|4
5707901|NCT00151411|19670481|P1|Overall Study|Pregnancy|0
5707902|NCT00151411|19670480|P2|Overall Study|Adverse Event|0
5707903|NCT00151411|19670481|P1|Overall Study|Adverse Event|6
5707904|NCT00151411|19670480|P2|Overall Study|Withdrawal by Subject|20
5707905|NCT00151411|19670481|P1|Overall Study|Withdrawal by Subject|12
5707906|NCT00151411|19670480|P2|Overall Study|Lost to Follow-up|19
5707907|NCT00151411|19670481|P1|Overall Study|Lost to Follow-up|15
5707908|NCT00151372|19670493|P2|Overall Study|Withdrawal by Subject|7
5707909|NCT00151372|19670494|P1|Overall Study|Withdrawal by Subject|7
5707910|NCT00151372|19670493|P2|Overall Study|Too sick medically to continue|6
5707911|NCT00151372|19670494|P1|Overall Study|Too sick medically to continue|5
5707912|NCT00151372|19670493|P2|Overall Study|Lost to Follow-up|5
5707913|NCT00151372|19670494|P1|Overall Study|Lost to Follow-up|5
5707914|NCT00151372|19670493|P2|Overall Study|Death|11
5707915|NCT00151372|19670494|P1|Overall Study|Death|12
5707916|NCT00151281|19670509|P1|Overall Study|Not evaluable|3
5707917|NCT00150969|19670518|P2|24-48 Month Extension|Other Reason|91
5707918|NCT00150969|19670519|P1|24-48 Month Extension|Other Reason|81
5707919|NCT00150969|19670518|P2|24-48 Month Extension|Adverse Event|3
5707920|NCT00150969|19670519|P1|24-48 Month Extension|Adverse Event|1
5707921|NCT00150969|19670518|P2|24-48 Month Extension|Lack of Efficacy|1
5707922|NCT00150969|19670519|P1|24-48 Month Extension|Lack of Efficacy|0
5707923|NCT00150969|19670518|P2|24-48 Month Extension|Withdrawal by Subject|5
5707924|NCT00150969|19670519|P1|24-48 Month Extension|Withdrawal by Subject|6
5707925|NCT00150969|19670518|P2|24 Month Main Study|Withdrawal by Subject|4
5707926|NCT00150969|19670519|P1|24 Month Main Study|Withdrawal by Subject|7
5707927|NCT00150969|19670518|P2|24 Month Main Study|Protocol Violation|2
5707928|NCT00150969|19670519|P1|24 Month Main Study|Protocol Violation|4
5707929|NCT00150969|19670518|P2|24 Month Main Study|Lost to Follow-up|2
5707930|NCT00150969|19670519|P1|24 Month Main Study|Lost to Follow-up|3
5707931|NCT00150969|19670518|P2|24 Month Main Study|Lack of Efficacy|8
5707932|NCT00150969|19670519|P1|24 Month Main Study|Lack of Efficacy|1
5707933|NCT00150969|19670518|P2|24 Month Main Study|Death|1
5707934|NCT00150969|19670519|P1|24 Month Main Study|Death|1
5707935|NCT00150969|19670518|P2|24 Month Main Study|Adverse Event|4
5707936|NCT00150969|19670519|P1|24 Month Main Study|Adverse Event|3
5707937|NCT00150813|19670551|P1|Overall Study|Switch to commercially available LEV|2
5707938|NCT00150813|19670551|P1|Overall Study|Planned pregancy|1
5707939|NCT00150813|19670551|P1|Overall Study|Remission|3
5707940|NCT00150813|19670551|P1|Overall Study|Withdrawal by Subject|5
5707941|NCT00150813|19670551|P1|Overall Study|Lost to Follow-up|5
5707942|NCT00150813|19670551|P1|Overall Study|Lack of Efficacy|1
5707943|NCT00150813|19670551|P1|Overall Study|Adverse Event|1
5707944|NCT00150800|19670555|P1|Overall Study|PI discontinuation request|1
5707945|NCT00150800|19670555|P1|Overall Study|Pregnancy planned|1
5707946|NCT00150800|19670555|P1|Overall Study|Surgical intervention|4
5707947|NCT00150800|19670555|P1|Overall Study|Patient insurance|1
5707948|NCT00150800|19670555|P1|Overall Study|PI leaving site|2
5707949|NCT00150800|19670555|P1|Overall Study|PI retiring|2
5707950|NCT00150800|19670555|P1|Overall Study|Moved from area/country|8
5707951|NCT00150800|19670555|P1|Overall Study|Generalized Epilepsy|1
5707952|NCT00150800|19670555|P1|Overall Study|Sponsor's request|2
5707953|NCT00150800|19670555|P1|Overall Study|Visit refusal|3
5707954|NCT00150800|19670555|P1|Overall Study|BRV monotherapy|1
5707955|NCT00150800|19670555|P1|Overall Study|Neurosurgery|2
5707956|NCT00150800|19670555|P1|Overall Study|Distance too long for patient|1
5707957|NCT00150800|19670555|P1|Overall Study|Nobody to accompany patient|1
5707958|NCT00150800|19670555|P1|Overall Study|Protocol non-adherence|2
5707959|NCT00150800|19670555|P1|Overall Study|Site closure|24
5707960|NCT00150800|19670555|P1|Overall Study|IP misshandling|1
5707961|NCT00150800|19670555|P1|Overall Study|No compliance|18
5707962|NCT00150800|19670555|P1|Overall Study|Subject's choice|90
5707963|NCT00150800|19670555|P1|Overall Study|Lost to Follow-up|58
5707964|NCT00150800|19670555|P1|Overall Study|Lack of Efficacy|166
5707965|NCT00150800|19670555|P1|Overall Study|Death|18
5707966|NCT00150800|19670555|P1|Overall Study|Adverse Event|89
5707967|NCT00150618|19670569|P5|Overall Study|Sponsor's decision|0
5707968|NCT00150618|19670570|P4|Overall Study|Sponsor's decision|1
5707969|NCT00150618|19670571|P3|Overall Study|Sponsor's decision|0
5707970|NCT00150618|19670572|P2|Overall Study|Sponsor's decision|0
5707971|NCT00150618|19670573|P1|Overall Study|Sponsor's decision|0
5707972|NCT00150618|19670569|P5|Overall Study|Abnormal ECG|0
5707973|NCT00150618|19670570|P4|Overall Study|Abnormal ECG|0
5707974|NCT00150618|19670571|P3|Overall Study|Abnormal ECG|0
5707975|NCT00150618|19670572|P2|Overall Study|Abnormal ECG|0
5707976|NCT00150618|19670573|P1|Overall Study|Abnormal ECG|1
5707977|NCT00150618|19670569|P5|Overall Study|Lack of compliance|1
5707978|NCT00150618|19670570|P4|Overall Study|Lack of compliance|0
5707979|NCT00150618|19670571|P3|Overall Study|Lack of compliance|1
5707980|NCT00150618|19670572|P2|Overall Study|Lack of compliance|1
5707981|NCT00150618|19670573|P1|Overall Study|Lack of compliance|2
5707982|NCT00150618|19670569|P5|Overall Study|Physician Decision|1
5707983|NCT00150618|19670570|P4|Overall Study|Physician Decision|0
5707984|NCT00150618|19670571|P3|Overall Study|Physician Decision|0
5707985|NCT00150618|19670572|P2|Overall Study|Physician Decision|2
5707986|NCT00150618|19670573|P1|Overall Study|Physician Decision|0
5707987|NCT00150618|19670569|P5|Overall Study|No study meds|2
5707988|NCT00150618|19670570|P4|Overall Study|No study meds|0
5707989|NCT00150618|19670571|P3|Overall Study|No study meds|0
5707990|NCT00150618|19670572|P2|Overall Study|No study meds|0
5707991|NCT00150618|19670573|P1|Overall Study|No study meds|0
5707992|NCT00150618|19670569|P5|Overall Study|Lack of Efficacy|6
5707993|NCT00150618|19670570|P4|Overall Study|Lack of Efficacy|4
5707994|NCT00150618|19670571|P3|Overall Study|Lack of Efficacy|7
5707995|NCT00150618|19670572|P2|Overall Study|Lack of Efficacy|4
5707996|NCT00150618|19670573|P1|Overall Study|Lack of Efficacy|1
5707997|NCT00150618|19670569|P5|Overall Study|Protocol Violation|1
5707998|NCT00150618|19670570|P4|Overall Study|Protocol Violation|0
5707999|NCT00150618|19670571|P3|Overall Study|Protocol Violation|0
5708000|NCT00150618|19670572|P2|Overall Study|Protocol Violation|0
5708001|NCT00150618|19670573|P1|Overall Study|Protocol Violation|1
5708002|NCT00150618|19670569|P5|Overall Study|Lost to Follow-up|4
5708003|NCT00150618|19670570|P4|Overall Study|Lost to Follow-up|8
5708004|NCT00150618|19670571|P3|Overall Study|Lost to Follow-up|5
5708005|NCT00150618|19670572|P2|Overall Study|Lost to Follow-up|1
5708006|NCT00150618|19670573|P1|Overall Study|Lost to Follow-up|4
5708007|NCT00150618|19670569|P5|Overall Study|Withdrawal by Subject|5
5708008|NCT00150618|19670570|P4|Overall Study|Withdrawal by Subject|4
5708009|NCT00150618|19670571|P3|Overall Study|Withdrawal by Subject|8
5708010|NCT00150618|19670572|P2|Overall Study|Withdrawal by Subject|8
5708011|NCT00150618|19670573|P1|Overall Study|Withdrawal by Subject|6
5708012|NCT00150618|19670569|P5|Overall Study|Adverse Event|5
5708013|NCT00150618|19670570|P4|Overall Study|Adverse Event|9
5708014|NCT00150618|19670571|P3|Overall Study|Adverse Event|6
5708015|NCT00150618|19670572|P2|Overall Study|Adverse Event|2
5708016|NCT00150618|19670573|P1|Overall Study|Adverse Event|2
5708017|NCT00150592|19670607|P2|Overall Study|Non-compliance|0
5708018|NCT00150592|19670608|P1|Overall Study|Non-compliance|1
5708019|NCT00150592|19670607|P2|Overall Study|Withdrawal by Subject|2
5708020|NCT00150592|19670608|P1|Overall Study|Withdrawal by Subject|1
5708021|NCT00150592|19670607|P2|Overall Study|Protocol Violation|0
5708022|NCT00150592|19670608|P1|Overall Study|Protocol Violation|1
5708023|NCT00150592|19670607|P2|Overall Study|Adverse Event|1
5708024|NCT00150592|19670608|P1|Overall Study|Adverse Event|4
5708025|NCT00150462|19670639|P11|Overall Study|Other|1
5708026|NCT00150462|19670640|P10|Overall Study|Other|1
5708027|NCT00150462|19670641|P9|Overall Study|Other|0
5708028|NCT00150462|19670642|P8|Overall Study|Other|0
5708029|NCT00150462|19670643|P7|Overall Study|Other|0
5708030|NCT00150462|19670644|P6|Overall Study|Other|0
5708031|NCT00150462|19670645|P5|Overall Study|Other|0
5708032|NCT00150462|19670646|P4|Overall Study|Other|0
5708033|NCT00150462|19670647|P3|Overall Study|Other|0
5708034|NCT00150462|19670648|P2|Overall Study|Other|0
5708035|NCT00150462|19670649|P1|Overall Study|Other|0
5708036|NCT00150462|19670639|P11|Overall Study|Physician Decision|0
5708037|NCT00150462|19670640|P10|Overall Study|Physician Decision|0
5708038|NCT00150462|19670641|P9|Overall Study|Physician Decision|0
5708039|NCT00150462|19670642|P8|Overall Study|Physician Decision|0
5708040|NCT00150462|19670643|P7|Overall Study|Physician Decision|0
5708041|NCT00150462|19670644|P6|Overall Study|Physician Decision|0
5708042|NCT00150462|19670645|P5|Overall Study|Physician Decision|0
5708043|NCT00150462|19670646|P4|Overall Study|Physician Decision|1
5708044|NCT00150462|19670647|P3|Overall Study|Physician Decision|1
5708045|NCT00150462|19670648|P2|Overall Study|Physician Decision|0
5708046|NCT00150462|19670649|P1|Overall Study|Physician Decision|0
5708047|NCT00150462|19670639|P11|Overall Study|Adverse Event|0
5708048|NCT00150462|19670640|P10|Overall Study|Adverse Event|1
5708049|NCT00150462|19670641|P9|Overall Study|Adverse Event|0
5708050|NCT00150462|19670642|P8|Overall Study|Adverse Event|2
5708051|NCT00150462|19670643|P7|Overall Study|Adverse Event|0
5708052|NCT00150462|19670644|P6|Overall Study|Adverse Event|0
5708053|NCT00150462|19670645|P5|Overall Study|Adverse Event|0
5708054|NCT00150462|19670646|P4|Overall Study|Adverse Event|1
5708055|NCT00150462|19670647|P3|Overall Study|Adverse Event|0
5708056|NCT00150462|19670648|P2|Overall Study|Adverse Event|0
5708057|NCT00150462|19670649|P1|Overall Study|Adverse Event|0
5708058|NCT00150462|19670639|P11|Overall Study|Death|0
5708059|NCT00150462|19670640|P10|Overall Study|Death|0
5708060|NCT00150462|19670641|P9|Overall Study|Death|1
5708061|NCT00150462|19670642|P8|Overall Study|Death|0
5708062|NCT00150462|19670643|P7|Overall Study|Death|0
5708063|NCT00150462|19670644|P6|Overall Study|Death|0
5708064|NCT00150462|19670645|P5|Overall Study|Death|0
5708065|NCT00150462|19670646|P4|Overall Study|Death|0
5708066|NCT00150462|19670647|P3|Overall Study|Death|0
5708067|NCT00150462|19670648|P2|Overall Study|Death|1
5708068|NCT00150462|19670649|P1|Overall Study|Death|0
5708069|NCT00150462|19670639|P11|Overall Study|Withdrawal by Subject|0
5708070|NCT00150462|19670640|P10|Overall Study|Withdrawal by Subject|1
5708071|NCT00150462|19670641|P9|Overall Study|Withdrawal by Subject|0
5708072|NCT00150462|19670642|P8|Overall Study|Withdrawal by Subject|1
5708073|NCT00150462|19670643|P7|Overall Study|Withdrawal by Subject|0
5708074|NCT00150462|19670644|P6|Overall Study|Withdrawal by Subject|2
5708075|NCT00150462|19670645|P5|Overall Study|Withdrawal by Subject|1
5708076|NCT00150462|19670646|P4|Overall Study|Withdrawal by Subject|0
5708077|NCT00150462|19670647|P3|Overall Study|Withdrawal by Subject|1
5708078|NCT00150462|19670648|P2|Overall Study|Withdrawal by Subject|1
5708079|NCT00150462|19670649|P1|Overall Study|Withdrawal by Subject|0
5708080|NCT00150462|19670639|P11|Overall Study|Disease Progression or Relapse|2
5708081|NCT00150462|19670640|P10|Overall Study|Disease Progression or Relapse|3
5708082|NCT00150462|19670641|P9|Overall Study|Disease Progression or Relapse|5
5708083|NCT00150462|19670642|P8|Overall Study|Disease Progression or Relapse|5
5708084|NCT00150462|19670643|P7|Overall Study|Disease Progression or Relapse|3
5708085|NCT00150462|19670644|P6|Overall Study|Disease Progression or Relapse|2
5708086|NCT00150462|19670645|P5|Overall Study|Disease Progression or Relapse|2
5708087|NCT00150462|19670646|P4|Overall Study|Disease Progression or Relapse|1
5708088|NCT00150462|19670647|P3|Overall Study|Disease Progression or Relapse|2
5708089|NCT00150462|19670648|P2|Overall Study|Disease Progression or Relapse|1
5708090|NCT00150462|19670649|P1|Overall Study|Disease Progression or Relapse|3
5708091|NCT00150345|19670759|P2|Overall Study|Other|14
5708092|NCT00150345|19670760|P1|Overall Study|Other|12
5708093|NCT00150345|19670759|P2|Overall Study|Laboratory abnormality|2
5708094|NCT00150345|19670760|P1|Overall Study|Laboratory abnormality|1
5708095|NCT00150345|19670759|P2|Overall Study|Withdrawal by Subject|4
5708096|NCT00150345|19670760|P1|Overall Study|Withdrawal by Subject|3
5708097|NCT00150345|19670759|P2|Overall Study|Lack of Efficacy|4
5708098|NCT00150345|19670760|P1|Overall Study|Lack of Efficacy|5
5708099|NCT00150345|19670759|P2|Overall Study|Adverse Event|6
5708100|NCT00150345|19670760|P1|Overall Study|Adverse Event|8
5708101|NCT00150345|19670759|P2|Overall Study|Death|2
5708102|NCT00150345|19670760|P1|Overall Study|Death|5
5708103|NCT00150176|19670824|P2|Overall Study|OTHER|13
5708104|NCT00150176|19670825|P1|Overall Study|OTHER|11
5708105|NCT00150176|19670824|P2|Overall Study|Lost to Follow-up|3
5708106|NCT00150176|19670825|P1|Overall Study|Lost to Follow-up|3
5708107|NCT00150176|19670824|P2|Overall Study|Withdrawal by Subject|12
5708108|NCT00150176|19670825|P1|Overall Study|Withdrawal by Subject|19
5708109|NCT00150176|19670824|P2|Overall Study|Relapse/Impending relapse, non-AE|39
5708110|NCT00150176|19670825|P1|Overall Study|Relapse/Impending relapse, non-AE|10
5708111|NCT00150176|19670824|P2|Overall Study|Adverse Event|53
5708112|NCT00150176|19670825|P1|Overall Study|Adverse Event|16
5708113|NCT00149994|19670836|P2|Overall Study|Protocol Violation|1
5708114|NCT00149994|19670837|P1|Overall Study|Protocol Violation|0
5708115|NCT00149994|19670836|P2|Overall Study|Administrative problems:|0
5708116|NCT00149994|19670837|P1|Overall Study|Administrative problems:|1
5708117|NCT00149890|19670845|P2|Overall Study|Graft Loss|1
5708118|NCT00149890|19670846|P1|Overall Study|Graft Loss|2
5708119|NCT00149890|19670845|P2|Overall Study|Lost to Follow-up|0
5708120|NCT00149890|19670846|P1|Overall Study|Lost to Follow-up|1
5708121|NCT00149890|19670845|P2|Overall Study|Protocol Violation|0
5708122|NCT00149890|19670846|P1|Overall Study|Protocol Violation|1
5708123|NCT00149890|19670845|P2|Overall Study|Lack of Efficacy|9
5708124|NCT00149890|19670846|P1|Overall Study|Lack of Efficacy|8
5708125|NCT00149890|19670845|P2|Overall Study|Adverse Event|8
5708126|NCT00149890|19670846|P1|Overall Study|Adverse Event|1
5708127|NCT00149825|19670881|P2|Overall Study|Other|0
5708128|NCT00149825|19670882|P1|Overall Study|Other|1
5708129|NCT00149825|19670881|P2|Overall Study|Not liking insomnia therapy|0
5708130|NCT00149825|19670882|P1|Overall Study|Not liking insomnia therapy|1
5708131|NCT00149825|19670881|P2|Overall Study|Time commitments|1
5708132|NCT00149825|19670882|P1|Overall Study|Time commitments|2
5708133|NCT00149825|19670881|P2|Overall Study|Intolerance to medication side effects|2
5708134|NCT00149825|19670882|P1|Overall Study|Intolerance to medication side effects|1
5708135|NCT00149747|19670910|P2|Overall Study|Withdrawal by Subject|3
5708136|NCT00149747|19670911|P1|Overall Study|Withdrawal by Subject|3
5708137|NCT00149747|19670910|P2|Overall Study|Death|0
5708138|NCT00149747|19670911|P1|Overall Study|Death|1
5708139|NCT00149630|19670957|P2|Overall Study|Adverse Event|0
5708140|NCT00149630|19670958|P1|Overall Study|Adverse Event|2
5708141|NCT00149630|19670957|P2|Overall Study|Treatment Programs|5
5708142|NCT00149630|19670958|P1|Overall Study|Treatment Programs|4
5708143|NCT00149630|19670957|P2|Overall Study|Incarceration|0
5708144|NCT00149630|19670958|P1|Overall Study|Incarceration|2
5708145|NCT00149396|19670968|P1|Overall Study|other treatment|5
5708146|NCT00149396|19670968|P1|Overall Study|Subject noncompliance|2
5708147|NCT00149396|19670968|P1|Overall Study|Withdrawal by Subject|1
5708148|NCT00149396|19670968|P1|Overall Study|Death|15
5708149|NCT00149214|19671038|P2|Overall Study|Progressive Disease|3
5708150|NCT00149214|19671039|P1|Overall Study|Progressive Disease|7
5708151|NCT00149214|19671038|P2|Overall Study|Sponsor Decision|1
5708152|NCT00149214|19671039|P1|Overall Study|Sponsor Decision|0
5708153|NCT00149214|19671038|P2|Overall Study|Physician Decision|3
5708154|NCT00149214|19671039|P1|Overall Study|Physician Decision|3
5708155|NCT00149214|19671038|P2|Overall Study|Withdrawal by Subject|1
5708156|NCT00149214|19671039|P1|Overall Study|Withdrawal by Subject|4
5708157|NCT00149214|19671038|P2|Overall Study|Adverse Event|9
5708158|NCT00149214|19671039|P1|Overall Study|Adverse Event|12
5708159|NCT00148941|19671066|P4|Overall Study|Other|2
5708160|NCT00148941|19671067|P3|Overall Study|Other|1
5708161|NCT00148941|19671068|P2|Overall Study|Other|0
5708162|NCT00148941|19671069|P1|Overall Study|Other|0
5708163|NCT00148941|19671066|P4|Overall Study|Withdrawal by Subject|0
5708164|NCT00148941|19671067|P3|Overall Study|Withdrawal by Subject|1
5708165|NCT00148941|19671068|P2|Overall Study|Withdrawal by Subject|0
5708166|NCT00148941|19671069|P1|Overall Study|Withdrawal by Subject|1
5708167|NCT00148941|19671066|P4|Overall Study|Lost to Follow-up|22
5708168|NCT00148941|19671067|P3|Overall Study|Lost to Follow-up|18
5708169|NCT00148941|19671068|P2|Overall Study|Lost to Follow-up|24
5708170|NCT00148941|19671069|P1|Overall Study|Lost to Follow-up|17
5708171|NCT00148759|19671184|P2|Overall Study|Lost to Follow-up|0
5708172|NCT00148759|19671185|P1|Overall Study|Lost to Follow-up|1
5708173|NCT00148759|19671184|P2|Overall Study|Withdrawal by Subject|1
5708174|NCT00148759|19671185|P1|Overall Study|Withdrawal by Subject|1
5708175|NCT00148343|19671213|P2|Overall Study|Physician Decision|4
5708176|NCT00148343|19671214|P1|Overall Study|Physician Decision|3
5708177|NCT00148343|19671213|P2|Overall Study|Withdrawal by Subject|7
5708178|NCT00148343|19671214|P1|Overall Study|Withdrawal by Subject|12
5708179|NCT00148317|19671228|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
5708180|NCT00148317|19671228|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
5708181|NCT00148317|19671228|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
5708182|NCT00148122|19671235|P1|Overall Study|Withdrawal by Subject|2
5708183|NCT00148109|19671243|P2|Overall Study|Withdrawal by Subject|0
5708184|NCT00148109|19671244|P1|Overall Study|Withdrawal by Subject|2
5708185|NCT00148109|19671243|P2|Overall Study|Adverse Event|2
5708186|NCT00148109|19671244|P1|Overall Study|Adverse Event|0
5708187|NCT00148109|19671243|P2|Overall Study|Lack of Efficacy|18
5708188|NCT00148109|19671244|P1|Overall Study|Lack of Efficacy|10
5708189|NCT00147823|19671260|P2|Overall Study|Did not receive vitoss due to infection|2
5708190|NCT00147823|19671261|P1|Overall Study|Did not receive vitoss due to infection|6
5708191|NCT00147823|19671260|P2|Overall Study|Withdrawal by Subject|1
5708192|NCT00147823|19671261|P1|Overall Study|Withdrawal by Subject|0
5708193|NCT00147823|19671260|P2|Overall Study|Physician Decision|0
5708194|NCT00147823|19671261|P1|Overall Study|Physician Decision|1
5708195|NCT00147823|19671260|P2|Overall Study|Lost to Follow-up|12
5708196|NCT00147823|19671261|P1|Overall Study|Lost to Follow-up|6
5708197|NCT00147745|19671292|P3|Overall Study|Withdrawal by Subject|0
5708198|NCT00147745|19671293|P2|Overall Study|Withdrawal by Subject|0
5708199|NCT00147745|19671294|P1|Overall Study|Withdrawal by Subject|1
5708200|NCT00147537|19671316|P11|Phase 2|Randomized but not treated|1
5708201|NCT00147537|19671317|P10|Phase 2|Randomized but not treated|1
5708202|NCT00147537|19671318|P9|Phase 2|Randomized but not treated|0
5708203|NCT00147537|19671319|P8|Phase 2|Randomized but not treated|0
5708204|NCT00147537|19671320|P7|Phase 2|Randomized but not treated|0
5708205|NCT00147537|19671321|P6|Phase 2|Randomized but not treated|0
5708206|NCT00147537|19671322|P5|Phase 2|Randomized but not treated|0
5708207|NCT00147537|19671323|P4|Phase 2|Randomized but not treated|0
5708208|NCT00147537|19671324|P3|Phase 2|Randomized but not treated|0
5708209|NCT00147537|19671325|P2|Phase 2|Randomized but not treated|0
5708210|NCT00147537|19671326|P1|Phase 2|Randomized but not treated|0
5708211|NCT00147537|19671316|P11|Phase 2|Withdrawal by Subject|4
5708212|NCT00147537|19671317|P10|Phase 2|Withdrawal by Subject|16
5708213|NCT00147537|19671318|P9|Phase 2|Withdrawal by Subject|0
5708214|NCT00147537|19671319|P8|Phase 2|Withdrawal by Subject|0
5708215|NCT00147537|19671320|P7|Phase 2|Withdrawal by Subject|0
5708216|NCT00147537|19671321|P6|Phase 2|Withdrawal by Subject|0
5708217|NCT00147537|19671322|P5|Phase 2|Withdrawal by Subject|0
5708218|NCT00147537|19671323|P4|Phase 2|Withdrawal by Subject|0
5708219|NCT00147537|19671324|P3|Phase 2|Withdrawal by Subject|0
5708220|NCT00147537|19671325|P2|Phase 2|Withdrawal by Subject|0
5708221|NCT00147537|19671326|P1|Phase 2|Withdrawal by Subject|0
5708222|NCT00147537|19671316|P11|Phase 2|Other|12
5708223|NCT00147537|19671317|P10|Phase 2|Other|47
5708224|NCT00147537|19671318|P9|Phase 2|Other|0
5708225|NCT00147537|19671319|P8|Phase 2|Other|0
5708226|NCT00147537|19671320|P7|Phase 2|Other|0
5708227|NCT00147537|19671321|P6|Phase 2|Other|0
5708228|NCT00147537|19671322|P5|Phase 2|Other|0
5708229|NCT00147537|19671323|P4|Phase 2|Other|0
5708230|NCT00147537|19671324|P3|Phase 2|Other|0
5708231|NCT00147537|19671325|P2|Phase 2|Other|0
5708232|NCT00147537|19671326|P1|Phase 2|Other|0
5708233|NCT00147537|19671316|P11|Phase 2|Lost to Follow-up|4
5708234|NCT00147537|19671317|P10|Phase 2|Lost to Follow-up|12
5708235|NCT00147537|19671318|P9|Phase 2|Lost to Follow-up|0
5708236|NCT00147537|19671319|P8|Phase 2|Lost to Follow-up|0
5708237|NCT00147537|19671320|P7|Phase 2|Lost to Follow-up|0
5708238|NCT00147537|19671321|P6|Phase 2|Lost to Follow-up|0
5708239|NCT00147537|19671322|P5|Phase 2|Lost to Follow-up|0
5708240|NCT00147537|19671323|P4|Phase 2|Lost to Follow-up|0
5708241|NCT00147537|19671324|P3|Phase 2|Lost to Follow-up|0
5708242|NCT00147537|19671325|P2|Phase 2|Lost to Follow-up|0
5708243|NCT00147537|19671326|P1|Phase 2|Lost to Follow-up|0
5708244|NCT00147537|19671316|P11|Phase 2|Death|31
5708245|NCT00147537|19671317|P10|Phase 2|Death|85
5708246|NCT00147537|19671318|P9|Phase 2|Death|0
5708247|NCT00147537|19671319|P8|Phase 2|Death|0
5708248|NCT00147537|19671320|P7|Phase 2|Death|0
5708249|NCT00147537|19671321|P6|Phase 2|Death|0
5708250|NCT00147537|19671322|P5|Phase 2|Death|0
5708251|NCT00147537|19671323|P4|Phase 2|Death|0
5708252|NCT00147537|19671324|P3|Phase 2|Death|0
5708253|NCT00147537|19671325|P2|Phase 2|Death|0
5708254|NCT00147537|19671326|P1|Phase 2|Death|0
5708255|NCT00147537|19671316|P11|Phase 1b|Randomized but not treated|0
5708256|NCT00147537|19671317|P10|Phase 1b|Randomized but not treated|0
5708257|NCT00147537|19671318|P9|Phase 1b|Randomized but not treated|1
5708258|NCT00147537|19671319|P8|Phase 1b|Randomized but not treated|0
5708259|NCT00147537|19671320|P7|Phase 1b|Randomized but not treated|1
5708260|NCT00147537|19671321|P6|Phase 1b|Randomized but not treated|0
5708261|NCT00147537|19671322|P5|Phase 1b|Randomized but not treated|0
5708262|NCT00147537|19671323|P4|Phase 1b|Randomized but not treated|0
5708263|NCT00147537|19671324|P3|Phase 1b|Randomized but not treated|0
5708264|NCT00147537|19671325|P2|Phase 1b|Randomized but not treated|0
5708265|NCT00147537|19671326|P1|Phase 1b|Randomized but not treated|0
5708266|NCT00147537|19671316|P11|Phase 1b|Withdrawal by Subject|0
5708267|NCT00147537|19671317|P10|Phase 1b|Withdrawal by Subject|0
5708268|NCT00147537|19671318|P9|Phase 1b|Withdrawal by Subject|2
5708269|NCT00147537|19671319|P8|Phase 1b|Withdrawal by Subject|0
5708270|NCT00147537|19671320|P7|Phase 1b|Withdrawal by Subject|0
5708271|NCT00147537|19671321|P6|Phase 1b|Withdrawal by Subject|0
5708272|NCT00147537|19671322|P5|Phase 1b|Withdrawal by Subject|0
5708273|NCT00147537|19671323|P4|Phase 1b|Withdrawal by Subject|0
5708274|NCT00147537|19671324|P3|Phase 1b|Withdrawal by Subject|0
5708275|NCT00147537|19671325|P2|Phase 1b|Withdrawal by Subject|0
5708276|NCT00147537|19671326|P1|Phase 1b|Withdrawal by Subject|0
5708277|NCT00147537|19671316|P11|Phase 1b|Other|0
5708278|NCT00147537|19671317|P10|Phase 1b|Other|0
5708279|NCT00147537|19671318|P9|Phase 1b|Other|4
5708280|NCT00147537|19671319|P8|Phase 1b|Other|4
5708281|NCT00147537|19671320|P7|Phase 1b|Other|14
5708282|NCT00147537|19671321|P6|Phase 1b|Other|1
5708283|NCT00147537|19671322|P5|Phase 1b|Other|1
5708284|NCT00147537|19671323|P4|Phase 1b|Other|1
5708285|NCT00147537|19671324|P3|Phase 1b|Other|2
5708286|NCT00147537|19671325|P2|Phase 1b|Other|0
5708287|NCT00147537|19671326|P1|Phase 1b|Other|0
5708288|NCT00147537|19671316|P11|Phase 1b|Lost to Follow-up|0
5708289|NCT00147537|19671317|P10|Phase 1b|Lost to Follow-up|0
5708290|NCT00147537|19671318|P9|Phase 1b|Lost to Follow-up|1
5708291|NCT00147537|19671319|P8|Phase 1b|Lost to Follow-up|0
5708292|NCT00147537|19671320|P7|Phase 1b|Lost to Follow-up|2
5708293|NCT00147537|19671321|P6|Phase 1b|Lost to Follow-up|0
5708294|NCT00147537|19671322|P5|Phase 1b|Lost to Follow-up|0
5708295|NCT00147537|19671323|P4|Phase 1b|Lost to Follow-up|0
5708296|NCT00147537|19671324|P3|Phase 1b|Lost to Follow-up|0
5708297|NCT00147537|19671325|P2|Phase 1b|Lost to Follow-up|1
5708298|NCT00147537|19671326|P1|Phase 1b|Lost to Follow-up|2
5708299|NCT00147537|19671316|P11|Phase 1b|Death|0
5708300|NCT00147537|19671317|P10|Phase 1b|Death|0
5708301|NCT00147537|19671318|P9|Phase 1b|Death|9
5708302|NCT00147537|19671319|P8|Phase 1b|Death|3
5708303|NCT00147537|19671320|P7|Phase 1b|Death|1
5708304|NCT00147537|19671321|P6|Phase 1b|Death|2
5708305|NCT00147537|19671322|P5|Phase 1b|Death|2
5708306|NCT00147537|19671323|P4|Phase 1b|Death|1
5708307|NCT00147537|19671324|P3|Phase 1b|Death|2
5708308|NCT00147537|19671325|P2|Phase 1b|Death|1
5708309|NCT00147537|19671326|P1|Phase 1b|Death|0
5708310|NCT00147498|19671509|P4|Overall Study|Other|3
5708311|NCT00147498|19671510|P3|Overall Study|Other|3
5708312|NCT00147498|19671511|P2|Overall Study|Other|1
5708313|NCT00147498|19671512|P1|Overall Study|Other|1
5708314|NCT00147498|19671509|P4|Overall Study|Participant defaulted|3
5708315|NCT00147498|19671510|P3|Overall Study|Participant defaulted|4
5708316|NCT00147498|19671511|P2|Overall Study|Participant defaulted|1
5708317|NCT00147498|19671512|P1|Overall Study|Participant defaulted|0
5708318|NCT00147498|19671509|P4|Overall Study|Laboratory abnormality|0
5708319|NCT00147498|19671510|P3|Overall Study|Laboratory abnormality|2
5708320|NCT00147498|19671511|P2|Overall Study|Laboratory abnormality|0
5708321|NCT00147498|19671512|P1|Overall Study|Laboratory abnormality|0
5708322|NCT00147498|19671509|P4|Overall Study|Lack of Efficacy|8
5708323|NCT00147498|19671510|P3|Overall Study|Lack of Efficacy|1
5708324|NCT00147498|19671511|P2|Overall Study|Lack of Efficacy|1
5708325|NCT00147498|19671512|P1|Overall Study|Lack of Efficacy|1
5708326|NCT00147498|19671509|P4|Overall Study|Adverse Event|3
5708327|NCT00147498|19671510|P3|Overall Study|Adverse Event|7
5708328|NCT00147498|19671511|P2|Overall Study|Adverse Event|6
5708329|NCT00147498|19671512|P1|Overall Study|Adverse Event|1
5708330|NCT00147238|19671636|P1|Overall Study|Inevaluable|8
5708331|NCT00147225|19671646|P6|Overall Study|Chemotherapy Changed|1
5708332|NCT00147225|19671647|P5|Overall Study|Chemotherapy Changed|0
5708333|NCT00147225|19671648|P4|Overall Study|Chemotherapy Changed|0
5708334|NCT00147225|19671649|P3|Overall Study|Chemotherapy Changed|0
5708335|NCT00147225|19671650|P2|Overall Study|Chemotherapy Changed|0
5708336|NCT00147225|19671651|P1|Overall Study|Chemotherapy Changed|0
5708337|NCT00147225|19671646|P6|Overall Study|Screen Failure|0
5708338|NCT00147225|19671647|P5|Overall Study|Screen Failure|1
5708339|NCT00147225|19671648|P4|Overall Study|Screen Failure|0
5708340|NCT00147225|19671649|P3|Overall Study|Screen Failure|0
5708341|NCT00147225|19671650|P2|Overall Study|Screen Failure|0
5708342|NCT00147225|19671651|P1|Overall Study|Screen Failure|0
5708343|NCT00147225|19671646|P6|Overall Study|Adverse Event|0
5708344|NCT00147225|19671647|P5|Overall Study|Adverse Event|0
5708345|NCT00147225|19671648|P4|Overall Study|Adverse Event|1
5708346|NCT00147225|19671649|P3|Overall Study|Adverse Event|1
5708347|NCT00147225|19671650|P2|Overall Study|Adverse Event|0
5708348|NCT00147225|19671651|P1|Overall Study|Adverse Event|0
5708349|NCT00147225|19671646|P6|Overall Study|Withdrawal by Subject|1
5708350|NCT00147225|19671647|P5|Overall Study|Withdrawal by Subject|0
5708351|NCT00147225|19671648|P4|Overall Study|Withdrawal by Subject|0
5708352|NCT00147225|19671649|P3|Overall Study|Withdrawal by Subject|1
5708353|NCT00147225|19671650|P2|Overall Study|Withdrawal by Subject|0
5708354|NCT00147225|19671651|P1|Overall Study|Withdrawal by Subject|1
5708355|NCT00146848|19671826|P3|Post-randomization|Withdrawn|27
5708356|NCT00146848|19671827|P2|Post-randomization|Withdrawn|32
5708357|NCT00146848|19671828|P1|Post-randomization|Withdrawn|26
5708358|NCT00146848|19671826|P3|Post-randomization|Lost to Follow-up|12
5708359|NCT00146848|19671827|P2|Post-randomization|Lost to Follow-up|15
5708360|NCT00146848|19671828|P1|Post-randomization|Lost to Follow-up|12
5708361|NCT00146848|19671826|P3|Pre-randomization|Withdrawal by Subject|0
5708362|NCT00146848|19671827|P2|Pre-randomization|Withdrawal by Subject|0
5708363|NCT00146848|19671828|P1|Pre-randomization|Withdrawal by Subject|40
5708364|NCT00146848|19671826|P3|Pre-randomization|Protocol Violation|0
5708365|NCT00146848|19671827|P2|Pre-randomization|Protocol Violation|0
5708366|NCT00146848|19671828|P1|Pre-randomization|Protocol Violation|172
5708367|NCT00146848|19671826|P3|Pre-randomization|Physician Decision|0
5708368|NCT00146848|19671827|P2|Pre-randomization|Physician Decision|0
5708369|NCT00146848|19671828|P1|Pre-randomization|Physician Decision|8
5708370|NCT00146848|19671826|P3|Pre-randomization|Lost to Follow-up|0
5708371|NCT00146848|19671827|P2|Pre-randomization|Lost to Follow-up|0
5708372|NCT00146848|19671828|P1|Pre-randomization|Lost to Follow-up|70
5708373|NCT00146848|19671826|P3|Pre-randomization|Death|0
5708374|NCT00146848|19671827|P2|Pre-randomization|Death|0
5708375|NCT00146848|19671828|P1|Pre-randomization|Death|19
5708376|NCT00146770|19671844|P2|Overall Study|Withdrawal by Subject|0
5708377|NCT00146770|19671845|P1|Overall Study|Withdrawal by Subject|2
5708378|NCT00146770|19671844|P2|Overall Study|Pregnancy|0
5708379|NCT00146770|19671845|P1|Overall Study|Pregnancy|1
5708380|NCT00146770|19671844|P2|Overall Study|Adverse Event|0
5708381|NCT00146770|19671845|P1|Overall Study|Adverse Event|2
5708382|NCT00146757|19671863|P2|Overall Study|Adverse Event|0
5708383|NCT00146757|19671864|P1|Overall Study|Adverse Event|1
5708384|NCT00146757|19671863|P2|Overall Study|Death|0
5708385|NCT00146757|19671864|P1|Overall Study|Death|1
5708386|NCT00146640|19671883|P2|Overall Study|Non-Medical Reasons|4
5708387|NCT00146640|19671884|P1|Overall Study|Non-Medical Reasons|8
5708388|NCT00146640|19671883|P2|Overall Study|Medical Reasons|0
5708389|NCT00146640|19671884|P1|Overall Study|Medical Reasons|3
5708390|NCT00146640|19671883|P2|Overall Study|Adverse Event|10
5708391|NCT00146640|19671884|P1|Overall Study|Adverse Event|12
5708392|NCT00146328|19671907|P3|Overall Study|Interaction with other medication|1
5708393|NCT00146328|19671908|P2|Overall Study|Interaction with other medication|0
5708394|NCT00146328|19671909|P1|Overall Study|Interaction with other medication|2
5708395|NCT00146328|19671907|P3|Overall Study|Moved|0
5708396|NCT00146328|19671908|P2|Overall Study|Moved|0
5708397|NCT00146328|19671909|P1|Overall Study|Moved|2
5708398|NCT00146328|19671907|P3|Overall Study|Death|1
5708399|NCT00146328|19671908|P2|Overall Study|Death|1
5708400|NCT00146328|19671909|P1|Overall Study|Death|0
5708401|NCT00146328|19671907|P3|Overall Study|Enroll into other trial|2
5708402|NCT00146328|19671908|P2|Overall Study|Enroll into other trial|4
5708403|NCT00146328|19671909|P1|Overall Study|Enroll into other trial|2
5708404|NCT00146328|19671907|P3|Overall Study|Patient decision to end|6
5708405|NCT00146328|19671908|P2|Overall Study|Patient decision to end|1
5708406|NCT00146328|19671909|P1|Overall Study|Patient decision to end|0
5708407|NCT00146328|19671907|P3|Overall Study|Trial ended/site closed|19
5708408|NCT00146328|19671908|P2|Overall Study|Trial ended/site closed|2
5708409|NCT00146328|19671909|P1|Overall Study|Trial ended/site closed|8
5708410|NCT00146328|19671907|P3|Overall Study|Virologic Failure/lack of efficacy|142
5708411|NCT00146328|19671908|P2|Overall Study|Virologic Failure/lack of efficacy|72
5708412|NCT00146328|19671909|P1|Overall Study|Virologic Failure/lack of efficacy|54
5708413|NCT00146328|19671907|P3|Overall Study|Withdrawal by Subject|22
5708414|NCT00146328|19671908|P2|Overall Study|Withdrawal by Subject|16
5708415|NCT00146328|19671909|P1|Overall Study|Withdrawal by Subject|16
5708416|NCT00146328|19671907|P3|Overall Study|Lost to Follow-up|7
5708417|NCT00146328|19671908|P2|Overall Study|Lost to Follow-up|4
5708418|NCT00146328|19671909|P1|Overall Study|Lost to Follow-up|7
5708419|NCT00146328|19671907|P3|Overall Study|Protocol Violation|12
5708420|NCT00146328|19671908|P2|Overall Study|Protocol Violation|6
5708421|NCT00146328|19671909|P1|Overall Study|Protocol Violation|11
5708422|NCT00146328|19671907|P3|Overall Study|Adverse Event|79
5708423|NCT00146328|19671908|P2|Overall Study|Adverse Event|48
5708424|NCT00146328|19671909|P1|Overall Study|Adverse Event|39
5708425|NCT00146172|19672000|P8|Overall Study|Symptomatic Deterioration|2
5708426|NCT00146172|19672001|P7|Overall Study|Symptomatic Deterioration|0
5708427|NCT00146172|19672002|P6|Overall Study|Symptomatic Deterioration|2
5708428|NCT00146172|19672003|P5|Overall Study|Symptomatic Deterioration|1
5708429|NCT00146172|19672004|P4|Overall Study|Symptomatic Deterioration|0
5708430|NCT00146172|19672005|P3|Overall Study|Symptomatic Deterioration|1
5708431|NCT00146172|19672006|P2|Overall Study|Symptomatic Deterioration|0
5708432|NCT00146172|19672007|P1|Overall Study|Symptomatic Deterioration|1
5708433|NCT00146172|19672000|P8|Overall Study|Withdrawal by Subject|4
5708434|NCT00146172|19672001|P7|Overall Study|Withdrawal by Subject|1
5708435|NCT00146172|19672002|P6|Overall Study|Withdrawal by Subject|1
5708436|NCT00146172|19672003|P5|Overall Study|Withdrawal by Subject|0
5708437|NCT00146172|19672004|P4|Overall Study|Withdrawal by Subject|0
5708438|NCT00146172|19672005|P3|Overall Study|Withdrawal by Subject|0
5708439|NCT00146172|19672006|P2|Overall Study|Withdrawal by Subject|0
5708440|NCT00146172|19672007|P1|Overall Study|Withdrawal by Subject|0
5708441|NCT00146172|19672000|P8|Overall Study|Physician Decision|1
5708442|NCT00146172|19672001|P7|Overall Study|Physician Decision|0
5708443|NCT00146172|19672002|P6|Overall Study|Physician Decision|0
5708444|NCT00146172|19672003|P5|Overall Study|Physician Decision|0
5708445|NCT00146172|19672004|P4|Overall Study|Physician Decision|0
5708446|NCT00146172|19672005|P3|Overall Study|Physician Decision|0
5708447|NCT00146172|19672006|P2|Overall Study|Physician Decision|0
5708448|NCT00146172|19672007|P1|Overall Study|Physician Decision|0
5708449|NCT00146172|19672000|P8|Overall Study|Death|0
5708450|NCT00146172|19672001|P7|Overall Study|Death|1
5708451|NCT00146172|19672002|P6|Overall Study|Death|0
5708452|NCT00146172|19672003|P5|Overall Study|Death|0
5708453|NCT00146172|19672004|P4|Overall Study|Death|0
5708454|NCT00146172|19672005|P3|Overall Study|Death|0
5708455|NCT00146172|19672006|P2|Overall Study|Death|0
5708456|NCT00146172|19672007|P1|Overall Study|Death|0
5708457|NCT00146172|19672000|P8|Overall Study|Disease Progression|22
5708458|NCT00146172|19672001|P7|Overall Study|Disease Progression|1
5708459|NCT00146172|19672002|P6|Overall Study|Disease Progression|2
5708460|NCT00146172|19672003|P5|Overall Study|Disease Progression|2
5708461|NCT00146172|19672004|P4|Overall Study|Disease Progression|5
5708462|NCT00146172|19672005|P3|Overall Study|Disease Progression|2
5708463|NCT00146172|19672006|P2|Overall Study|Disease Progression|4
5708464|NCT00146172|19672007|P1|Overall Study|Disease Progression|2
5708465|NCT00146172|19672000|P8|Overall Study|Lost to Follow-up|1
5708466|NCT00146172|19672001|P7|Overall Study|Lost to Follow-up|0
5708467|NCT00146172|19672002|P6|Overall Study|Lost to Follow-up|0
5708468|NCT00146172|19672003|P5|Overall Study|Lost to Follow-up|0
5708469|NCT00146172|19672004|P4|Overall Study|Lost to Follow-up|0
5708470|NCT00146172|19672005|P3|Overall Study|Lost to Follow-up|0
5708471|NCT00146172|19672006|P2|Overall Study|Lost to Follow-up|0
5708472|NCT00146172|19672007|P1|Overall Study|Lost to Follow-up|0
5708473|NCT00146172|19672000|P8|Overall Study|Adverse Event|10
5708474|NCT00146172|19672001|P7|Overall Study|Adverse Event|3
5708475|NCT00146172|19672002|P6|Overall Study|Adverse Event|2
5708476|NCT00146172|19672003|P5|Overall Study|Adverse Event|0
5708477|NCT00146172|19672004|P4|Overall Study|Adverse Event|1
5708478|NCT00146172|19672005|P3|Overall Study|Adverse Event|1
5708479|NCT00146172|19672006|P2|Overall Study|Adverse Event|0
5708480|NCT00146172|19672007|P1|Overall Study|Adverse Event|0
5708481|NCT00145977|19672042|P2|Overall Study|Withdrawal by Subject|0
5708482|NCT00145977|19672043|P1|Overall Study|Withdrawal by Subject|1
5708483|NCT00145977|19672042|P2|Overall Study|Lost to Follow-up|0
5708484|NCT00145977|19672043|P1|Overall Study|Lost to Follow-up|1
5708485|NCT00145977|19672042|P2|Overall Study|Lack of Efficacy|4
5708486|NCT00145977|19672043|P1|Overall Study|Lack of Efficacy|0
5708487|NCT00145795|19672069|P2|Overall Study|Adverse Event|0
5708488|NCT00145795|19672070|P1|Overall Study|Adverse Event|1
5708489|NCT00145626|19672105|P1|Overall Study|Withdrawal by Subject|1
5708490|NCT00145626|19672105|P1|Overall Study|Death|1
5708491|NCT00145626|19672105|P1|Overall Study|Turned 2 years old before treatment|1
5708492|NCT00145626|19672105|P1|Overall Study|Did not have NK infusions|2
5708493|NCT00145600|19672151|P4|Overall Study|Withdrawal by Subject|1
5708494|NCT00145600|19672152|P3|Overall Study|Withdrawal by Subject|0
5708495|NCT00145600|19672153|P2|Overall Study|Withdrawal by Subject|2
5708496|NCT00145600|19672154|P1|Overall Study|Withdrawal by Subject|1
5708497|NCT00145600|19672151|P4|Overall Study|Noncompliance|0
5708498|NCT00145600|19672152|P3|Overall Study|Noncompliance|0
5708499|NCT00145600|19672153|P2|Overall Study|Noncompliance|0
5708500|NCT00145600|19672154|P1|Overall Study|Noncompliance|1
5708501|NCT00145600|19672151|P4|Overall Study|Lost to Follow-up|4
5708502|NCT00145600|19672152|P3|Overall Study|Lost to Follow-up|2
5708503|NCT00145600|19672153|P2|Overall Study|Lost to Follow-up|6
5708504|NCT00145600|19672154|P1|Overall Study|Lost to Follow-up|2
5708505|NCT00145600|19672151|P4|Overall Study|Ineligible|5
5708506|NCT00145600|19672152|P3|Overall Study|Ineligible|1
5708507|NCT00145600|19672153|P2|Overall Study|Ineligible|0
5708508|NCT00145600|19672154|P1|Overall Study|Ineligible|3
5708509|NCT00145600|19672151|P4|Overall Study|Death|6
5708510|NCT00145600|19672152|P3|Overall Study|Death|2
5708511|NCT00145600|19672153|P2|Overall Study|Death|2
5708512|NCT00145600|19672154|P1|Overall Study|Death|1
5708513|NCT00145574|19672278|P3|Open Label Long-term Extension|required restricted medicine|1
5708514|NCT00145574|19672279|P2|Open Label Long-term Extension|required restricted medicine|0
5708515|NCT00145574|19672280|P1|Open Label Long-term Extension|required restricted medicine|0
5708516|NCT00145574|19672278|P3|Open Label Long-term Extension|Withdrawal by Subject|4
5708517|NCT00145574|19672279|P2|Open Label Long-term Extension|Withdrawal by Subject|0
5708518|NCT00145574|19672280|P1|Open Label Long-term Extension|Withdrawal by Subject|0
5708519|NCT00145574|19672278|P3|Open Label Long-term Extension|Lost to Follow-up|1
5708520|NCT00145574|19672279|P2|Open Label Long-term Extension|Lost to Follow-up|0
5708521|NCT00145574|19672280|P1|Open Label Long-term Extension|Lost to Follow-up|0
5708522|NCT00145574|19672278|P3|Open Label Long-term Extension|Adverse Event|5
5708523|NCT00145574|19672279|P2|Open Label Long-term Extension|Adverse Event|0
5708524|NCT00145574|19672280|P1|Open Label Long-term Extension|Adverse Event|0
5708525|NCT00145574|19672278|P3|Double Blind|required restricted medicine|0
5708526|NCT00145574|19672279|P2|Double Blind|required restricted medicine|1
5708527|NCT00145574|19672280|P1|Double Blind|required restricted medicine|0
5708528|NCT00145574|19672278|P3|Double Blind|Withdrawal by Subject|1
5708529|NCT00145574|19672279|P2|Double Blind|Withdrawal by Subject|1
5708530|NCT00145574|19672280|P1|Double Blind|Withdrawal by Subject|1
5708531|NCT00145574|19672278|P3|Double Blind|Adverse Event|1
5708532|NCT00145574|19672279|P2|Double Blind|Adverse Event|3
5708533|NCT00145574|19672280|P1|Double Blind|Adverse Event|0
5708534|NCT00145509|19672337|P2|Overall Study|Reason not provided|1
5708535|NCT00145509|19672338|P1|Overall Study|Reason not provided|2
5708536|NCT00145509|19672337|P2|Overall Study|Withdrew Consent|7
5708537|NCT00145509|19672338|P1|Overall Study|Withdrew Consent|2
5708538|NCT00145509|19672337|P2|Overall Study|Lost to Follow-up|9
5708539|NCT00145509|19672338|P1|Overall Study|Lost to Follow-up|5
5708540|NCT00145509|19672337|P2|Overall Study|Lack of Efficacy|1
5708541|NCT00145509|19672338|P1|Overall Study|Lack of Efficacy|3
5708542|NCT00145509|19672337|P2|Overall Study|Adverse Event|3
5708543|NCT00145509|19672338|P1|Overall Study|Adverse Event|10
5708544|NCT00145496|19672352|P2|Overall Study|Other|13
5708545|NCT00145496|19672353|P1|Overall Study|Other|25
5708546|NCT00145496|19672352|P2|Overall Study|Lost to Follow-up|5
5708547|NCT00145496|19672353|P1|Overall Study|Lost to Follow-up|12
5708548|NCT00145496|19672352|P2|Overall Study|Withdrawal by Subject|26
5708549|NCT00145496|19672353|P1|Overall Study|Withdrawal by Subject|32
5708550|NCT00145496|19672352|P2|Overall Study|Lack of Efficacy|7
5708551|NCT00145496|19672353|P1|Overall Study|Lack of Efficacy|12
5708552|NCT00145496|19672352|P2|Overall Study|Adverse Event|30
5708553|NCT00145496|19672353|P1|Overall Study|Adverse Event|42
5708554|NCT00145470|19672365|P2|Overall Study|Reason Not Reported|9
5708555|NCT00145470|19672366|P1|Overall Study|Reason Not Reported|9
5708556|NCT00145470|19672365|P2|Overall Study|Lost to Follow-up|17
5708557|NCT00145470|19672366|P1|Overall Study|Lost to Follow-up|21
5708558|NCT00145470|19672365|P2|Overall Study|Withdrawal by Subject|34
5708559|NCT00145470|19672366|P1|Overall Study|Withdrawal by Subject|36
5708560|NCT00145470|19672365|P2|Overall Study|Lack of Efficacy|13
5708561|NCT00145470|19672366|P1|Overall Study|Lack of Efficacy|27
5708562|NCT00145470|19672365|P2|Overall Study|Adverse Event|25
5708563|NCT00145470|19672366|P1|Overall Study|Adverse Event|19
5708564|NCT00145327|19672436|P3|Overall Study|Missing - not stated|1
5708565|NCT00145327|19672437|P2|Overall Study|Missing - not stated|0
5708566|NCT00145327|19672438|P1|Overall Study|Missing - not stated|1
5708567|NCT00145327|19672436|P3|Overall Study|Abnormal laboratory value(s)|2
5708568|NCT00145327|19672437|P2|Overall Study|Abnormal laboratory value(s)|0
5708569|NCT00145327|19672438|P1|Overall Study|Abnormal laboratory value(s)|1
5708570|NCT00145327|19672436|P3|Overall Study|Protocol Violation|2
5708571|NCT00145327|19672437|P2|Overall Study|Protocol Violation|0
5708572|NCT00145327|19672438|P1|Overall Study|Protocol Violation|2
5708573|NCT00145327|19672436|P3|Overall Study|Administrative problems|13
5708574|NCT00145327|19672437|P2|Overall Study|Administrative problems|9
5708575|NCT00145327|19672438|P1|Overall Study|Administrative problems|12
5708576|NCT00145327|19672436|P3|Overall Study|Lost to Follow-up|14
5708577|NCT00145327|19672437|P2|Overall Study|Lost to Follow-up|14
5708578|NCT00145327|19672438|P1|Overall Study|Lost to Follow-up|9
5708579|NCT00145327|19672436|P3|Overall Study|Adverse Event|22
5708580|NCT00145327|19672437|P2|Overall Study|Adverse Event|11
5708581|NCT00145327|19672438|P1|Overall Study|Adverse Event|14
5708582|NCT00145327|19672436|P3|Overall Study|Death|30
5708583|NCT00145327|19672437|P2|Overall Study|Death|18
5708584|NCT00145327|19672438|P1|Overall Study|Death|26
5708585|NCT00145327|19672436|P3|Overall Study|Withdrawal by Subject|164
5708586|NCT00145327|19672437|P2|Overall Study|Withdrawal by Subject|72
5708587|NCT00145327|19672438|P1|Overall Study|Withdrawal by Subject|77
5708588|NCT00145119|19672537|P1|Overall Study|Death|45
5708589|NCT00144781|19672555|P4|Overall Study|Non-compliant|0
5708590|NCT00144781|19672556|P3|Overall Study|Non-compliant|0
5708591|NCT00144781|19672557|P2|Overall Study|Non-compliant|1
5708592|NCT00144781|19672558|P1|Overall Study|Non-compliant|0
5708593|NCT00144781|19672555|P4|Overall Study|Adverse Event|0
5708594|NCT00144781|19672556|P3|Overall Study|Adverse Event|0
5708595|NCT00144781|19672557|P2|Overall Study|Adverse Event|1
5708596|NCT00144781|19672558|P1|Overall Study|Adverse Event|0
5708597|NCT00144339|19672587|P2|Overall Study|Other|60
5708598|NCT00144339|19672588|P1|Overall Study|Other|58
5708599|NCT00144339|19672587|P2|Overall Study|Lost to Follow-up|64
5708600|NCT00144339|19672588|P1|Overall Study|Lost to Follow-up|76
5708601|NCT00144339|19672587|P2|Overall Study|Withdrawal by Subject|300
5708602|NCT00144339|19672588|P1|Overall Study|Withdrawal by Subject|403
5708603|NCT00144339|19672587|P2|Overall Study|Protocol Violation|48
5708604|NCT00144339|19672588|P1|Overall Study|Protocol Violation|75
5708605|NCT00144339|19672587|P2|Overall Study|Adverse Event|627
5708606|NCT00144339|19672588|P1|Overall Study|Adverse Event|746
5708607|NCT00144300|19672796|P2|Overall Study|Other reason (not specified)|3
5708608|NCT00144300|19672797|P1|Overall Study|Other reason (not specified)|1
5708609|NCT00144300|19672796|P2|Overall Study|Withdrawal by Subject|6
5708610|NCT00144300|19672797|P1|Overall Study|Withdrawal by Subject|6
5708611|NCT00144300|19672796|P2|Overall Study|Lost to Follow-up|0
5708612|NCT00144300|19672797|P1|Overall Study|Lost to Follow-up|3
5708613|NCT00144300|19672796|P2|Overall Study|Protocol Violation|3
5708614|NCT00144300|19672797|P1|Overall Study|Protocol Violation|1
5708615|NCT00144300|19672796|P2|Overall Study|Adverse Event|16
5708616|NCT00144300|19672797|P1|Overall Study|Adverse Event|18
5708617|NCT00144170|19672845|P2|Overall Study|Other reason not defined above|316
5708618|NCT00144170|19672846|P1|Overall Study|Other reason not defined above|211
5708619|NCT00144170|19672845|P2|Overall Study|Withdrawal by Subject|13
5708620|NCT00144170|19672846|P1|Overall Study|Withdrawal by Subject|29
5708621|NCT00144170|19672845|P2|Overall Study|Lost to Follow-up|10
5708622|NCT00144170|19672846|P1|Overall Study|Lost to Follow-up|5
5708623|NCT00144170|19672845|P2|Overall Study|Protocol Violation|16
5708624|NCT00144170|19672846|P1|Overall Study|Protocol Violation|23
5708625|NCT00144170|19672845|P2|Overall Study|Adverse Event|41
5708626|NCT00144170|19672846|P1|Overall Study|Adverse Event|84
5708627|NCT00144027|19673036|P2|Overall Study|did not complete baseline assessment|6
5708628|NCT00144027|19673037|P1|Overall Study|did not complete baseline assessment|0
5708629|NCT00144027|19673036|P2|Overall Study|Withdrawal by Subject|2
5708630|NCT00144027|19673037|P1|Overall Study|Withdrawal by Subject|2
5708631|NCT00144027|19673036|P2|Overall Study|Lost to Follow-up|3
5708632|NCT00144027|19673037|P1|Overall Study|Lost to Follow-up|1
5708633|NCT00143598|19673067|P2|Overall Study|Death|36
5708634|NCT00143598|19673068|P1|Overall Study|Death|36
5708635|NCT00143598|19673067|P2|Overall Study|Withdrawal by Subject|37
5708636|NCT00143598|19673068|P1|Overall Study|Withdrawal by Subject|33
5708637|NCT00143598|19673067|P2|Overall Study|Lost to Follow-up|21
5708638|NCT00143598|19673068|P1|Overall Study|Lost to Follow-up|23
5708639|NCT00143507|19673082|P2|Overall Study|Withdrawn by sponsor's decision|3
5708640|NCT00143507|19673083|P1|Overall Study|Withdrawn by sponsor's decision|0
5708641|NCT00143507|19673082|P2|Overall Study|Lost to Follow-up|0
5708642|NCT00143507|19673083|P1|Overall Study|Lost to Follow-up|1
5708643|NCT00143507|19673082|P2|Overall Study|Withdrawal by Subject|102
5708644|NCT00143507|19673083|P1|Overall Study|Withdrawal by Subject|114
5708645|NCT00143507|19673082|P2|Overall Study|Death|547
5708646|NCT00143507|19673083|P1|Overall Study|Death|572
5708647|NCT00143455|19673117|P4|Cohort 2|Randomized But Not Treated|1
5708648|NCT00143455|19673118|P3|Cohort 2|Randomized But Not Treated|1
5708649|NCT00143455|19673119|P2|Cohort 2|Randomized But Not Treated|0
5708650|NCT00143455|19673120|P1|Cohort 2|Randomized But Not Treated|0
5708651|NCT00143455|19673117|P4|Cohort 2|Other|6
5708652|NCT00143455|19673118|P3|Cohort 2|Other|7
5708653|NCT00143455|19673119|P2|Cohort 2|Other|0
5708654|NCT00143455|19673120|P1|Cohort 2|Other|0
5708655|NCT00143455|19673117|P4|Cohort 2|Withdrawal by Subject|12
5708656|NCT00143455|19673118|P3|Cohort 2|Withdrawal by Subject|13
5708657|NCT00143455|19673119|P2|Cohort 2|Withdrawal by Subject|0
5708658|NCT00143455|19673120|P1|Cohort 2|Withdrawal by Subject|0
5708659|NCT00143455|19673117|P4|Cohort 2|Progressive Disease|27
5708660|NCT00143455|19673118|P3|Cohort 2|Progressive Disease|20
5708661|NCT00143455|19673119|P2|Cohort 2|Progressive Disease|0
5708662|NCT00143455|19673120|P1|Cohort 2|Progressive Disease|0
5708663|NCT00143455|19673117|P4|Cohort 2|Death|12
5708664|NCT00143455|19673118|P3|Cohort 2|Death|20
5708665|NCT00143455|19673119|P2|Cohort 2|Death|0
5708666|NCT00143455|19673120|P1|Cohort 2|Death|0
5708667|NCT00143455|19673117|P4|Cohort 2|Lost to Follow-up|4
5708668|NCT00143455|19673118|P3|Cohort 2|Lost to Follow-up|1
5708669|NCT00143455|19673119|P2|Cohort 2|Lost to Follow-up|0
5708670|NCT00143455|19673120|P1|Cohort 2|Lost to Follow-up|0
5708671|NCT00143455|19673117|P4|Cohort 2|Protocol Violation|1
5708672|NCT00143455|19673118|P3|Cohort 2|Protocol Violation|1
5708673|NCT00143455|19673119|P2|Cohort 2|Protocol Violation|0
5708674|NCT00143455|19673120|P1|Cohort 2|Protocol Violation|0
5708675|NCT00143455|19673117|P4|Cohort 2|No Longer Required Study Treatment|0
5708676|NCT00143455|19673118|P3|Cohort 2|No Longer Required Study Treatment|1
5708677|NCT00143455|19673119|P2|Cohort 2|No Longer Required Study Treatment|0
5708678|NCT00143455|19673120|P1|Cohort 2|No Longer Required Study Treatment|0
5708679|NCT00143455|19673117|P4|Cohort 2|Adverse Event|30
5708680|NCT00143455|19673118|P3|Cohort 2|Adverse Event|42
5708681|NCT00143455|19673119|P2|Cohort 2|Adverse Event|0
5708682|NCT00143455|19673120|P1|Cohort 2|Adverse Event|0
5708683|NCT00143455|19673117|P4|Cohort 1|Randomized But Not Treated|0
5708684|NCT00143455|19673118|P3|Cohort 1|Randomized But Not Treated|0
5708685|NCT00143455|19673119|P2|Cohort 1|Randomized But Not Treated|1
5708686|NCT00143455|19673120|P1|Cohort 1|Randomized But Not Treated|0
5708687|NCT00143455|19673117|P4|Cohort 1|Withdrawal by Subject|0
5708688|NCT00143455|19673118|P3|Cohort 1|Withdrawal by Subject|0
5708689|NCT00143455|19673119|P2|Cohort 1|Withdrawal by Subject|4
5708690|NCT00143455|19673120|P1|Cohort 1|Withdrawal by Subject|1
5708691|NCT00143455|19673117|P4|Cohort 1|Progressive Disease|0
5708692|NCT00143455|19673118|P3|Cohort 1|Progressive Disease|0
5708693|NCT00143455|19673119|P2|Cohort 1|Progressive Disease|6
5708694|NCT00143455|19673120|P1|Cohort 1|Progressive Disease|0
5708695|NCT00143455|19673117|P4|Cohort 1|Death|0
5708696|NCT00143455|19673118|P3|Cohort 1|Death|0
5708697|NCT00143455|19673119|P2|Cohort 1|Death|2
5708698|NCT00143455|19673120|P1|Cohort 1|Death|5
5708699|NCT00143455|19673117|P4|Cohort 1|Adverse Event|0
5708700|NCT00143455|19673118|P3|Cohort 1|Adverse Event|0
5708701|NCT00143455|19673119|P2|Cohort 1|Adverse Event|4
5708702|NCT00143455|19673120|P1|Cohort 1|Adverse Event|8
5708703|NCT00143403|19673154|P2|Overall Study|Randomized Not Treated|8
5708704|NCT00143403|19673155|P1|Overall Study|Randomized Not Treated|7
5708705|NCT00143403|19673154|P2|Overall Study|specified by site|9
5708706|NCT00143403|19673155|P1|Overall Study|specified by site|4
5708707|NCT00143403|19673154|P2|Overall Study|Protocol Violation|2
5708708|NCT00143403|19673155|P1|Overall Study|Protocol Violation|2
5708709|NCT00143403|19673154|P2|Overall Study|Relapse|7
5708710|NCT00143403|19673155|P1|Overall Study|Relapse|15
5708711|NCT00143403|19673154|P2|Overall Study|Withdrawal by Subject|12
5708712|NCT00143403|19673155|P1|Overall Study|Withdrawal by Subject|3
5708713|NCT00143403|19673154|P2|Overall Study|Death|0
5708714|NCT00143403|19673155|P1|Overall Study|Death|1
5708715|NCT00143403|19673154|P2|Overall Study|Adverse Event|8
5708716|NCT00143403|19673155|P1|Overall Study|Adverse Event|3
5708717|NCT00143390|19673165|P2|Overall Study|Other|2
5708718|NCT00143390|19673166|P1|Overall Study|Other|1
5708719|NCT00143390|19673165|P2|Overall Study|Adverse Event|8
5708720|NCT00143390|19673166|P1|Overall Study|Adverse Event|9
5708721|NCT00143390|19673165|P2|Overall Study|Study termination|15
5708722|NCT00143390|19673166|P1|Overall Study|Study termination|10
5708723|NCT00143390|19673165|P2|Overall Study|Protocol Violation|0
5708724|NCT00143390|19673166|P1|Overall Study|Protocol Violation|2
5708725|NCT00143390|19673165|P2|Overall Study|Progressive disease|115
5708726|NCT00143390|19673166|P1|Overall Study|Progressive disease|119
5708727|NCT00143390|19673165|P2|Overall Study|Withdrawal by Subject|4
5708728|NCT00143390|19673166|P1|Overall Study|Withdrawal by Subject|4
5708729|NCT00143390|19673165|P2|Overall Study|Not meeting entry criteria|5
5708730|NCT00143390|19673166|P1|Overall Study|Not meeting entry criteria|2
5708731|NCT00143390|19673165|P2|Overall Study|Death|0
5708732|NCT00143390|19673166|P1|Overall Study|Death|2
5708733|NCT00143312|19673182|P1|Overall Study|Withdrawal by Subject|1
5708734|NCT00143312|19673182|P1|Overall Study|Other|1
5708735|NCT00143312|19673182|P1|Overall Study|Lost to Follow-up|1
5708736|NCT00143312|19673182|P1|Overall Study|Adverse Event|2
5708737|NCT00143312|19673182|P1|Overall Study|Death|11
5708738|NCT00143247|19673192|P1|Overall Study|Other|12
5708739|NCT00143247|19673192|P1|Overall Study|following inaccurate lab adverse event|1
5708740|NCT00143247|19673192|P1|Overall Study|Lost to Follow-up|12
5708741|NCT00143247|19673192|P1|Overall Study|Protocol Violation|15
5708742|NCT00143247|19673192|P1|Overall Study|Study terminated by sponsor|31
5708743|NCT00143247|19673192|P1|Overall Study|Withdrawal by Subject|55
5708744|NCT00143247|19673192|P1|Overall Study|Lack of Efficacy|3
5708745|NCT00143247|19673192|P1|Overall Study|Adverse Event|19
5708746|NCT00143247|19673192|P1|Overall Study|Death|8
5708747|NCT00142935|19673209|P3|Overall Study|Death|1
5708748|NCT00142935|19673210|P2|Overall Study|Death|2
5708749|NCT00142935|19673211|P1|Overall Study|Death|0
5708750|NCT00142935|19673209|P3|Overall Study|Lost to Follow-up|5
5708751|NCT00142935|19673210|P2|Overall Study|Lost to Follow-up|5
5708752|NCT00142935|19673211|P1|Overall Study|Lost to Follow-up|2
5708753|NCT00142935|19673209|P3|Overall Study|Other reason|1
5708754|NCT00142935|19673210|P2|Overall Study|Other reason|1
5708755|NCT00142935|19673211|P1|Overall Study|Other reason|1
5708756|NCT00142909|19673236|P2|Medications Begin|Withdrawal by Subject|0
5708757|NCT00142909|19673237|P1|Medications Begin|Withdrawal by Subject|2
5708758|NCT00142909|19673236|P2|Medications Begin|Withdrawal by Subject|3
5708759|NCT00142909|19673237|P1|Medications Begin|Withdrawal by Subject|5
5708760|NCT00142909|19673236|P2|Medications Begin|Protocol Violation|0
5708761|NCT00142909|19673237|P1|Medications Begin|Protocol Violation|2
5708762|NCT00142909|19673236|P2|Randomization|Various Reasons|10
5708763|NCT00142909|19673237|P1|Randomization|Various Reasons|7
5708764|NCT00142792|19673277|P3|Overall Study|No category|1
5708765|NCT00142792|19673278|P2|Overall Study|No category|2
5708766|NCT00142792|19673279|P1|Overall Study|No category|1
5708767|NCT00142792|19673277|P3|Overall Study|Lost to Follow-up|7
5708768|NCT00142792|19673278|P2|Overall Study|Lost to Follow-up|11
5708769|NCT00142792|19673279|P1|Overall Study|Lost to Follow-up|8
5708770|NCT00142792|19673277|P3|Overall Study|Withdrawal by Subject|3
5708771|NCT00142792|19673278|P2|Overall Study|Withdrawal by Subject|2
5708772|NCT00142792|19673279|P1|Overall Study|Withdrawal by Subject|3
5708773|NCT00142792|19673277|P3|Overall Study|Death|1
5708774|NCT00142792|19673278|P2|Overall Study|Death|0
5708775|NCT00142792|19673279|P1|Overall Study|Death|0
5708776|NCT00142519|19673301|P2|Overall Study|Withdrawal by Subject|7
5708777|NCT00142519|19673302|P1|Overall Study|Withdrawal by Subject|10
5708778|NCT00142519|19673301|P2|Overall Study|Protocol Violation|0
5708779|NCT00142519|19673302|P1|Overall Study|Protocol Violation|1
5708780|NCT00142519|19673301|P2|Overall Study|Not Treated|9
5708781|NCT00142519|19673302|P1|Overall Study|Not Treated|7
5708782|NCT00142415|19673331|P6|Overall Study|Physician Decision|2
5708783|NCT00142415|19673332|P5|Overall Study|Physician Decision|1
5708784|NCT00142415|19673333|P4|Overall Study|Physician Decision|0
5708785|NCT00142415|19673334|P3|Overall Study|Physician Decision|0
5708786|NCT00142415|19673335|P2|Overall Study|Physician Decision|0
5708787|NCT00142415|19673336|P1|Overall Study|Physician Decision|0
5708788|NCT00142298|19673374|P10|Overall Study|Treatment Failure|0
5708789|NCT00142298|19673375|P9|Overall Study|Treatment Failure|0
5708790|NCT00142298|19673376|P8|Overall Study|Treatment Failure|0
5708791|NCT00142298|19673377|P7|Overall Study|Treatment Failure|2
5708792|NCT00142298|19673378|P6|Overall Study|Treatment Failure|2
5708793|NCT00142298|19673379|P5|Overall Study|Treatment Failure|0
5708794|NCT00142298|19673380|P4|Overall Study|Treatment Failure|0
5708795|NCT00142298|19673381|P3|Overall Study|Treatment Failure|0
5708796|NCT00142298|19673382|P2|Overall Study|Treatment Failure|0
5708797|NCT00142298|19673383|P1|Overall Study|Treatment Failure|0
5708798|NCT00142298|19673374|P10|Overall Study|Lost to Follow-up|0
5708799|NCT00142298|19673375|P9|Overall Study|Lost to Follow-up|0
5708800|NCT00142298|19673376|P8|Overall Study|Lost to Follow-up|0
5708801|NCT00142298|19673377|P7|Overall Study|Lost to Follow-up|2
5708802|NCT00142298|19673378|P6|Overall Study|Lost to Follow-up|0
5708803|NCT00142298|19673379|P5|Overall Study|Lost to Follow-up|0
5708804|NCT00142298|19673380|P4|Overall Study|Lost to Follow-up|0
5708805|NCT00142298|19673381|P3|Overall Study|Lost to Follow-up|0
5708806|NCT00142298|19673382|P2|Overall Study|Lost to Follow-up|0
5708807|NCT00142298|19673383|P1|Overall Study|Lost to Follow-up|0
5708808|NCT00142298|19673374|P10|Overall Study|Other- not specified|0
5708809|NCT00142298|19673375|P9|Overall Study|Other- not specified|0
5708810|NCT00142298|19673376|P8|Overall Study|Other- not specified|0
5708811|NCT00142298|19673377|P7|Overall Study|Other- not specified|0
5708812|NCT00142298|19673378|P6|Overall Study|Other- not specified|0
5708813|NCT00142298|19673379|P5|Overall Study|Other- not specified|0
5708814|NCT00142298|19673380|P4|Overall Study|Other- not specified|1
5708815|NCT00142298|19673381|P3|Overall Study|Other- not specified|0
5708816|NCT00142298|19673382|P2|Overall Study|Other- not specified|3
5708817|NCT00142298|19673383|P1|Overall Study|Other- not specified|0
5708818|NCT00142298|19673374|P10|Overall Study|Virologic breakthrough|0
5708819|NCT00142298|19673375|P9|Overall Study|Virologic breakthrough|0
5708820|NCT00142298|19673376|P8|Overall Study|Virologic breakthrough|0
5708821|NCT00142298|19673377|P7|Overall Study|Virologic breakthrough|3
5708822|NCT00142298|19673378|P6|Overall Study|Virologic breakthrough|3
5708823|NCT00142298|19673379|P5|Overall Study|Virologic breakthrough|2
5708824|NCT00142298|19673380|P4|Overall Study|Virologic breakthrough|7
5708825|NCT00142298|19673381|P3|Overall Study|Virologic breakthrough|9
5708826|NCT00142298|19673382|P2|Overall Study|Virologic breakthrough|23
5708827|NCT00142298|19673383|P1|Overall Study|Virologic breakthrough|19
5708828|NCT00142298|19673374|P10|Overall Study|Pregnancy|0
5708829|NCT00142298|19673375|P9|Overall Study|Pregnancy|1
5708830|NCT00142298|19673376|P8|Overall Study|Pregnancy|0
5708831|NCT00142298|19673377|P7|Overall Study|Pregnancy|0
5708832|NCT00142298|19673378|P6|Overall Study|Pregnancy|0
5708833|NCT00142298|19673379|P5|Overall Study|Pregnancy|0
5708834|NCT00142298|19673380|P4|Overall Study|Pregnancy|3
5708835|NCT00142298|19673381|P3|Overall Study|Pregnancy|2
5708836|NCT00142298|19673382|P2|Overall Study|Pregnancy|4
5708837|NCT00142298|19673383|P1|Overall Study|Pregnancy|4
5708838|NCT00142298|19673374|P10|Overall Study|Patient, Investigator,or Sponsor request|0
5708839|NCT00142298|19673375|P9|Overall Study|Patient, Investigator,or Sponsor request|1
5708840|NCT00142298|19673376|P8|Overall Study|Patient, Investigator,or Sponsor request|4
5708841|NCT00142298|19673377|P7|Overall Study|Patient, Investigator,or Sponsor request|1
5708842|NCT00142298|19673378|P6|Overall Study|Patient, Investigator,or Sponsor request|3
5708843|NCT00142298|19673379|P5|Overall Study|Patient, Investigator,or Sponsor request|4
5708844|NCT00142298|19673380|P4|Overall Study|Patient, Investigator,or Sponsor request|51
5708845|NCT00142298|19673381|P3|Overall Study|Patient, Investigator,or Sponsor request|11
5708846|NCT00142298|19673382|P2|Overall Study|Patient, Investigator,or Sponsor request|60
5708847|NCT00142298|19673383|P1|Overall Study|Patient, Investigator,or Sponsor request|66
5708848|NCT00142298|19673374|P10|Overall Study|Non-compliance|0
5708849|NCT00142298|19673375|P9|Overall Study|Non-compliance|3
5708850|NCT00142298|19673376|P8|Overall Study|Non-compliance|3
5708851|NCT00142298|19673377|P7|Overall Study|Non-compliance|0
5708852|NCT00142298|19673378|P6|Overall Study|Non-compliance|0
5708853|NCT00142298|19673379|P5|Overall Study|Non-compliance|1
5708854|NCT00142298|19673380|P4|Overall Study|Non-compliance|6
5708855|NCT00142298|19673381|P3|Overall Study|Non-compliance|0
5708856|NCT00142298|19673382|P2|Overall Study|Non-compliance|13
5708857|NCT00142298|19673383|P1|Overall Study|Non-compliance|15
5708858|NCT00142298|19673374|P10|Overall Study|Lack of Efficacy|0
5708859|NCT00142298|19673375|P9|Overall Study|Lack of Efficacy|0
5708860|NCT00142298|19673376|P8|Overall Study|Lack of Efficacy|1
5708861|NCT00142298|19673377|P7|Overall Study|Lack of Efficacy|0
5708862|NCT00142298|19673378|P6|Overall Study|Lack of Efficacy|0
5708863|NCT00142298|19673379|P5|Overall Study|Lack of Efficacy|1
5708864|NCT00142298|19673380|P4|Overall Study|Lack of Efficacy|12
5708865|NCT00142298|19673381|P3|Overall Study|Lack of Efficacy|9
5708866|NCT00142298|19673382|P2|Overall Study|Lack of Efficacy|62
5708867|NCT00142298|19673383|P1|Overall Study|Lack of Efficacy|44
5708868|NCT00142298|19673374|P10|Overall Study|Death|0
5708869|NCT00142298|19673375|P9|Overall Study|Death|0
5708870|NCT00142298|19673376|P8|Overall Study|Death|0
5708871|NCT00142298|19673377|P7|Overall Study|Death|0
5708872|NCT00142298|19673378|P6|Overall Study|Death|6
5708873|NCT00142298|19673379|P5|Overall Study|Death|0
5708874|NCT00142298|19673380|P4|Overall Study|Death|0
5708875|NCT00142298|19673381|P3|Overall Study|Death|1
5708876|NCT00142298|19673382|P2|Overall Study|Death|1
5708877|NCT00142298|19673383|P1|Overall Study|Death|1
5708878|NCT00142298|19673374|P10|Overall Study|Clinical disease progression|0
5708879|NCT00142298|19673375|P9|Overall Study|Clinical disease progression|0
5708880|NCT00142298|19673376|P8|Overall Study|Clinical disease progression|0
5708881|NCT00142298|19673377|P7|Overall Study|Clinical disease progression|0
5708882|NCT00142298|19673378|P6|Overall Study|Clinical disease progression|0
5708883|NCT00142298|19673379|P5|Overall Study|Clinical disease progression|0
5708884|NCT00142298|19673380|P4|Overall Study|Clinical disease progression|0
5708885|NCT00142298|19673381|P3|Overall Study|Clinical disease progression|0
5708886|NCT00142298|19673382|P2|Overall Study|Clinical disease progression|0
5708887|NCT00142298|19673383|P1|Overall Study|Clinical disease progression|1
5708888|NCT00142298|19673374|P10|Overall Study|Adverse Event|0
5708889|NCT00142298|19673375|P9|Overall Study|Adverse Event|0
5708890|NCT00142298|19673376|P8|Overall Study|Adverse Event|0
5708891|NCT00142298|19673377|P7|Overall Study|Adverse Event|0
5708892|NCT00142298|19673378|P6|Overall Study|Adverse Event|2
5708893|NCT00142298|19673379|P5|Overall Study|Adverse Event|2
5708894|NCT00142298|19673380|P4|Overall Study|Adverse Event|5
5708895|NCT00142298|19673381|P3|Overall Study|Adverse Event|1
5708896|NCT00142298|19673382|P2|Overall Study|Adverse Event|10
5708897|NCT00142298|19673383|P1|Overall Study|Adverse Event|10
5708898|NCT00141921|19673417|P1|Overall Study|Other|8
5708899|NCT00141921|19673417|P1|Overall Study|Ineligibility Determined|2
5708900|NCT00141921|19673417|P1|Overall Study|Pregnancy|4
5708901|NCT00141921|19673417|P1|Overall Study|Administrative Decision|2
5708902|NCT00141921|19673417|P1|Overall Study|Adverse Event|5
5708903|NCT00141921|19673417|P1|Overall Study|Protocol Deviation|7
5708904|NCT00141921|19673417|P1|Overall Study|Disease Progression|7
5708905|NCT00141921|19673417|P1|Overall Study|Noncompliance|17
5708906|NCT00141921|19673417|P1|Overall Study|Lost to Follow-up|19
5708907|NCT00141921|19673417|P1|Overall Study|Withdrawal by Subject|42
5708908|NCT00141921|19673417|P1|Overall Study|Remain on Study|28
5708909|NCT00141817|19673443|P4|Overall Study|Parent request|0
5708910|NCT00141817|19673444|P3|Overall Study|Parent request|0
5708911|NCT00141817|19673445|P2|Overall Study|Parent request|0
5708912|NCT00141817|19673446|P1|Overall Study|Parent request|1
5708913|NCT00141817|19673443|P4|Overall Study|Protocol Violation|0
5708914|NCT00141817|19673444|P3|Overall Study|Protocol Violation|1
5708915|NCT00141817|19673445|P2|Overall Study|Protocol Violation|0
5708916|NCT00141817|19673446|P1|Overall Study|Protocol Violation|0
5708917|NCT00141778|19673487|P3|Started Study Medication|Chest Discomfort|1
5708918|NCT00141778|19673488|P2|Started Study Medication|Chest Discomfort|0
5708919|NCT00141778|19673489|P1|Started Study Medication|Chest Discomfort|0
5708920|NCT00141778|19673487|P3|Started Study Medication|Difficulty Swallowing|0
5708921|NCT00141778|19673488|P2|Started Study Medication|Difficulty Swallowing|1
5708922|NCT00141778|19673489|P1|Started Study Medication|Difficulty Swallowing|0
5708923|NCT00141778|19673487|P3|Started Study Medication|Withdrawal by Subject|0
5708924|NCT00141778|19673488|P2|Started Study Medication|Withdrawal by Subject|2
5708925|NCT00141778|19673489|P1|Started Study Medication|Withdrawal by Subject|0
5708926|NCT00141778|19673487|P3|Started Study Medication|Met safety criteria for discontinuation|3
5708927|NCT00141778|19673488|P2|Started Study Medication|Met safety criteria for discontinuation|4
5708928|NCT00141778|19673489|P1|Started Study Medication|Met safety criteria for discontinuation|2
5708929|NCT00141778|19673487|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
5708930|NCT00141778|19673488|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
5708931|NCT00141778|19673489|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
5708932|NCT00141726|19673542|P1|Overall Study|Completed <50% Scheduled Dosing|3
5708933|NCT00141518|19673550|P3|Overall Study|Lack of Efficacy|0
5708934|NCT00141518|19673551|P2|Overall Study|Lack of Efficacy|0
5708935|NCT00141518|19673552|P1|Overall Study|Lack of Efficacy|5
5708936|NCT00141518|19673550|P3|Overall Study|Protocol Violation|2
5708937|NCT00141518|19673551|P2|Overall Study|Protocol Violation|1
5708938|NCT00141518|19673552|P1|Overall Study|Protocol Violation|1
5708939|NCT00141518|19673550|P3|Overall Study|Withdrawal by Subject|2
5708940|NCT00141518|19673551|P2|Overall Study|Withdrawal by Subject|0
5708941|NCT00141518|19673552|P1|Overall Study|Withdrawal by Subject|2
5708942|NCT00141518|19673550|P3|Overall Study|Adverse Event|2
5708943|NCT00141518|19673551|P2|Overall Study|Adverse Event|5
5708944|NCT00141518|19673552|P1|Overall Study|Adverse Event|7
5708945|NCT00141518|19673550|P3|Overall Study|Withdrew Consent Prior to Treatment|0
5708946|NCT00141518|19673551|P2|Overall Study|Withdrew Consent Prior to Treatment|0
5708947|NCT00141518|19673552|P1|Overall Study|Withdrew Consent Prior to Treatment|1
5708948|NCT00141453|19673741|P2|Overall Study|Protocol Violation|5
5708949|NCT00141453|19673742|P1|Overall Study|Protocol Violation|6
5708950|NCT00141297|19673756|P10|Overall Study|Transitioned|0
5708951|NCT00141297|19673757|P9|Overall Study|Transitioned|0
5708952|NCT00141297|19673758|P8|Overall Study|Transitioned|0
5708953|NCT00141297|19673759|P7|Overall Study|Transitioned|0
5708954|NCT00141297|19673760|P6|Overall Study|Transitioned|0
5708955|NCT00141297|19673761|P5|Overall Study|Transitioned|1
5708956|NCT00141297|19673762|P4|Overall Study|Transitioned|0
5708957|NCT00141297|19673763|P3|Overall Study|Transitioned|0
5708958|NCT00141297|19673764|P2|Overall Study|Transitioned|0
5708959|NCT00141297|19673765|P1|Overall Study|Transitioned|0
5708960|NCT00141297|19673756|P10|Overall Study|Progressive Disease|6
5708961|NCT00141297|19673757|P9|Overall Study|Progressive Disease|15
5708962|NCT00141297|19673758|P8|Overall Study|Progressive Disease|3
5708963|NCT00141297|19673759|P7|Overall Study|Progressive Disease|3
5708964|NCT00141297|19673760|P6|Overall Study|Progressive Disease|2
5708965|NCT00141297|19673761|P5|Overall Study|Progressive Disease|15
5708966|NCT00141297|19673762|P4|Overall Study|Progressive Disease|2
5708967|NCT00141297|19673763|P3|Overall Study|Progressive Disease|6
5708968|NCT00141297|19673764|P2|Overall Study|Progressive Disease|3
5708969|NCT00141297|19673765|P1|Overall Study|Progressive Disease|2
5708970|NCT00141297|19673756|P10|Overall Study|Other|0
5708971|NCT00141297|19673757|P9|Overall Study|Other|2
5708972|NCT00141297|19673758|P8|Overall Study|Other|0
5708973|NCT00141297|19673759|P7|Overall Study|Other|0
5708974|NCT00141297|19673760|P6|Overall Study|Other|0
5708975|NCT00141297|19673761|P5|Overall Study|Other|5
5708976|NCT00141297|19673762|P4|Overall Study|Other|1
5708977|NCT00141297|19673763|P3|Overall Study|Other|0
5708978|NCT00141297|19673764|P2|Overall Study|Other|0
5708979|NCT00141297|19673765|P1|Overall Study|Other|0
5708980|NCT00141297|19673756|P10|Overall Study|Withdrawal by Subject|0
5708981|NCT00141297|19673757|P9|Overall Study|Withdrawal by Subject|1
5708982|NCT00141297|19673758|P8|Overall Study|Withdrawal by Subject|0
5708983|NCT00141297|19673759|P7|Overall Study|Withdrawal by Subject|0
5708984|NCT00141297|19673760|P6|Overall Study|Withdrawal by Subject|0
5708985|NCT00141297|19673761|P5|Overall Study|Withdrawal by Subject|0
5708986|NCT00141297|19673762|P4|Overall Study|Withdrawal by Subject|0
5708987|NCT00141297|19673763|P3|Overall Study|Withdrawal by Subject|0
5708988|NCT00141297|19673764|P2|Overall Study|Withdrawal by Subject|0
5708989|NCT00141297|19673765|P1|Overall Study|Withdrawal by Subject|0
5708990|NCT00141297|19673756|P10|Overall Study|Death|0
5708991|NCT00141297|19673757|P9|Overall Study|Death|1
5708992|NCT00141297|19673758|P8|Overall Study|Death|0
5708993|NCT00141297|19673759|P7|Overall Study|Death|0
5708994|NCT00141297|19673760|P6|Overall Study|Death|0
5708995|NCT00141297|19673761|P5|Overall Study|Death|0
5708996|NCT00141297|19673762|P4|Overall Study|Death|0
5708997|NCT00141297|19673763|P3|Overall Study|Death|0
5708998|NCT00141297|19673764|P2|Overall Study|Death|0
5708999|NCT00141297|19673765|P1|Overall Study|Death|1
5709000|NCT00141297|19673756|P10|Overall Study|Adverse Event|0
5709001|NCT00141297|19673757|P9|Overall Study|Adverse Event|1
5709002|NCT00141297|19673758|P8|Overall Study|Adverse Event|1
5709003|NCT00141297|19673759|P7|Overall Study|Adverse Event|0
5709004|NCT00141297|19673760|P6|Overall Study|Adverse Event|1
5709005|NCT00141297|19673761|P5|Overall Study|Adverse Event|1
5709006|NCT00141297|19673762|P4|Overall Study|Adverse Event|0
5709007|NCT00141297|19673763|P3|Overall Study|Adverse Event|1
5709008|NCT00141297|19673764|P2|Overall Study|Adverse Event|0
5709009|NCT00141297|19673765|P1|Overall Study|Adverse Event|0
5709010|NCT00141271|19674043|P3|Overall Study|Other|5
5709011|NCT00141271|19674044|P2|Overall Study|Other|12
5709012|NCT00141271|19674045|P1|Overall Study|Other|11
5709013|NCT00141271|19674043|P3|Overall Study|Withdrawal by Subject|10
5709014|NCT00141271|19674044|P2|Overall Study|Withdrawal by Subject|9
5709015|NCT00141271|19674045|P1|Overall Study|Withdrawal by Subject|14
5709016|NCT00141271|19674043|P3|Overall Study|Lost to Follow-up|21
5709017|NCT00141271|19674044|P2|Overall Study|Lost to Follow-up|15
5709018|NCT00141271|19674045|P1|Overall Study|Lost to Follow-up|15
5709019|NCT00141271|19674043|P3|Overall Study|Lack of Efficacy|3
5709020|NCT00141271|19674044|P2|Overall Study|Lack of Efficacy|7
5709021|NCT00141271|19674045|P1|Overall Study|Lack of Efficacy|7
5709022|NCT00141271|19674043|P3|Overall Study|Laboratory Abnormality|1
5709023|NCT00141271|19674044|P2|Overall Study|Laboratory Abnormality|1
5709024|NCT00141271|19674045|P1|Overall Study|Laboratory Abnormality|2
5709025|NCT00141271|19674043|P3|Overall Study|Adverse Event|17
5709026|NCT00141271|19674044|P2|Overall Study|Adverse Event|19
5709027|NCT00141271|19674045|P1|Overall Study|Adverse Event|31
5709028|NCT00141219|19674166|P2|Overall Study|Withdrawal by Subject|2
5709029|NCT00141219|19674167|P1|Overall Study|Withdrawal by Subject|6
5709030|NCT00141219|19674166|P2|Overall Study|Lack of Efficacy|4
5709031|NCT00141219|19674167|P1|Overall Study|Lack of Efficacy|5
5709032|NCT00141219|19674166|P2|Overall Study|Adverse Event|6
5709033|NCT00141219|19674167|P1|Overall Study|Adverse Event|8
5709034|NCT00141219|19674166|P2|Overall Study|Protocol violations|4
5709035|NCT00141219|19674167|P1|Overall Study|Protocol violations|5
5709036|NCT00141102|19674224|P2|Overall Study|Death|2
5709037|NCT00141102|19674225|P1|Overall Study|Death|2
5709038|NCT00141102|19674224|P2|Overall Study|Randomized But Did Not Receive Treatment|9
5709039|NCT00141102|19674225|P1|Overall Study|Randomized But Did Not Receive Treatment|15
5709040|NCT00141102|19674224|P2|Overall Study|Withdrawal by Subject|142
5709041|NCT00141102|19674225|P1|Overall Study|Withdrawal by Subject|112
5709042|NCT00141102|19674224|P2|Overall Study|Other|76
5709043|NCT00141102|19674225|P1|Overall Study|Other|87
5709044|NCT00141102|19674224|P2|Overall Study|Lost to Follow-up|32
5709045|NCT00141102|19674225|P1|Overall Study|Lost to Follow-up|29
5709046|NCT00141102|19674224|P2|Overall Study|Lack of Efficacy|26
5709047|NCT00141102|19674225|P1|Overall Study|Lack of Efficacy|21
5709048|NCT00141102|19674224|P2|Overall Study|Laboratory Abnormality|33
5709049|NCT00141102|19674225|P1|Overall Study|Laboratory Abnormality|9
5709050|NCT00141102|19674224|P2|Overall Study|Adverse Event|305
5709051|NCT00141102|19674225|P1|Overall Study|Adverse Event|233
5709052|NCT00141037|19674265|P2|Overall Study|Graft Failure|4
5709053|NCT00141037|19674266|P1|Overall Study|Graft Failure|3
5709054|NCT00141037|19674265|P2|Overall Study|Moved from area|7
5709055|NCT00141037|19674266|P1|Overall Study|Moved from area|1
5709056|NCT00141037|19674265|P2|Overall Study|Other|1
5709057|NCT00141037|19674266|P1|Overall Study|Other|0
5709058|NCT00141037|19674265|P2|Overall Study|Withdrawal by Subject|1
5709059|NCT00141037|19674266|P1|Overall Study|Withdrawal by Subject|2
5709060|NCT00141037|19674265|P2|Overall Study|Protocol Violation|2
5709061|NCT00141037|19674266|P1|Overall Study|Protocol Violation|0
5709062|NCT00141037|19674265|P2|Overall Study|Lost to Follow-up|1
5709063|NCT00141037|19674266|P1|Overall Study|Lost to Follow-up|3
5709064|NCT00141037|19674265|P2|Overall Study|Physician Decision|2
5709065|NCT00141037|19674266|P1|Overall Study|Physician Decision|1
5709066|NCT00140426|19674301|P2|Overall Study|Withdrawal by Subject|3
5709067|NCT00140426|19674302|P1|Overall Study|Withdrawal by Subject|0
5709068|NCT00140413|19674335|P2|Overall Study|Withdrawal by Subject|0
5709069|NCT00140413|19674336|P1|Overall Study|Withdrawal by Subject|2
5709070|NCT00140413|19674335|P2|Overall Study|Lost to Follow-up|0
5709071|NCT00140413|19674336|P1|Overall Study|Lost to Follow-up|1
5709072|NCT00140140|19674467|P3|Overall Study|Physician Decision|0
5709073|NCT00140140|19674468|P2|Overall Study|Physician Decision|1
5709074|NCT00140140|19674469|P1|Overall Study|Physician Decision|1
5709075|NCT00140140|19674467|P3|Overall Study|Unacceptable toxicity|2
5709076|NCT00140140|19674468|P2|Overall Study|Unacceptable toxicity|1
5709077|NCT00140140|19674469|P1|Overall Study|Unacceptable toxicity|1
5709078|NCT00139776|19674519|P4|Period III|Withdrawal by Subject|21
5709079|NCT00139776|19674520|P3|Period III|Withdrawal by Subject|16
5709080|NCT00139776|19674521|P2|Period III|Withdrawal by Subject|0
5709081|NCT00139776|19674522|P1|Period III|Withdrawal by Subject|0
5709082|NCT00139776|19674519|P4|Period III|Lost to Follow-up|4
5709083|NCT00139776|19674520|P3|Period III|Lost to Follow-up|5
5709084|NCT00139776|19674521|P2|Period III|Lost to Follow-up|0
5709085|NCT00139776|19674522|P1|Period III|Lost to Follow-up|0
5709086|NCT00139776|19674519|P4|Period III|Lack of Efficacy|24
5709087|NCT00139776|19674520|P3|Period III|Lack of Efficacy|10
5709088|NCT00139776|19674521|P2|Period III|Lack of Efficacy|0
5709089|NCT00139776|19674522|P1|Period III|Lack of Efficacy|0
5709090|NCT00139776|19674519|P4|Period III|Other|34
5709091|NCT00139776|19674520|P3|Period III|Other|23
5709092|NCT00139776|19674521|P2|Period III|Other|0
5709093|NCT00139776|19674522|P1|Period III|Other|0
5709094|NCT00139776|19674519|P4|Period III|Adverse Event|23
5709095|NCT00139776|19674520|P3|Period III|Adverse Event|22
5709096|NCT00139776|19674521|P2|Period III|Adverse Event|0
5709097|NCT00139776|19674522|P1|Period III|Adverse Event|0
5709098|NCT00139776|19674519|P4|Period II|Not Randomized into Period III|0
5709099|NCT00139776|19674520|P3|Period II|Not Randomized into Period III|0
5709100|NCT00139776|19674521|P2|Period II|Not Randomized into Period III|322
5709101|NCT00139776|19674522|P1|Period II|Not Randomized into Period III|0
5709102|NCT00139776|19674519|P4|Period I|Did not enter Period II|0
5709103|NCT00139776|19674520|P3|Period I|Did not enter Period II|0
5709104|NCT00139776|19674521|P2|Period I|Did not enter Period II|0
5709105|NCT00139776|19674522|P1|Period I|Did not enter Period II|575
5709106|NCT00139737|19674557|P1|Overall Study|Screened, Not Treated|13
5709107|NCT00139737|19674557|P1|Overall Study|Did Not Meet Entrance Criteria|1
5709108|NCT00139737|19674557|P1|Overall Study|Withdrew During Screening Phase|8
5709109|NCT00139737|19674557|P1|Overall Study|Protocol Violation|18
5709110|NCT00139737|19674557|P1|Overall Study|Laboratory Abnormality|2
5709111|NCT00139737|19674557|P1|Overall Study|Death|3
5709112|NCT00139737|19674557|P1|Overall Study|Lost to Follow-up|8
5709113|NCT00139737|19674557|P1|Overall Study|Lack of Efficacy|40
5709114|NCT00139737|19674557|P1|Overall Study|Adverse Event|58
5709115|NCT00139737|19674557|P1|Overall Study|Withdrawal by Subject|190
5709116|NCT00139659|19674563|P2|Overall Study|Withdrawal by Subject|10
5709117|NCT00139659|19674564|P1|Overall Study|Withdrawal by Subject|14
5709118|NCT00139659|19674563|P2|Overall Study|Reason not Specified|3
5709119|NCT00139659|19674564|P1|Overall Study|Reason not Specified|6
5709120|NCT00139659|19674563|P2|Overall Study|Lost to Follow-up|3
5709121|NCT00139659|19674564|P1|Overall Study|Lost to Follow-up|7
5709122|NCT00139659|19674563|P2|Overall Study|Lack of Efficacy|1
5709123|NCT00139659|19674564|P1|Overall Study|Lack of Efficacy|1
5709124|NCT00139659|19674563|P2|Overall Study|Adverse Event|1
5709125|NCT00139659|19674564|P1|Overall Study|Adverse Event|12
5709126|NCT00139477|19674642|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
5709127|NCT00139477|19674643|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
5709128|NCT00139477|19674642|P2|Second Intervention -6Months to 12Months|Relocation|0
5709129|NCT00139477|19674643|P1|Second Intervention -6Months to 12Months|Relocation|1
5709130|NCT00139477|19674642|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
5709131|NCT00139477|19674643|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
5709132|NCT00139477|19674642|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
5709133|NCT00139477|19674643|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
5709134|NCT00139477|19674642|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
5709135|NCT00139477|19674643|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
5709136|NCT00139477|19674642|P2|First Intervention -Baseline to 6Months|Relocation|2
5709137|NCT00139477|19674643|P1|First Intervention -Baseline to 6Months|Relocation|1
5709138|NCT00139477|19674642|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
5709139|NCT00139477|19674643|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
5709140|NCT00138671|19674678|P2|Overall Study|Other|3
5709141|NCT00138671|19674679|P1|Overall Study|Other|3
5709142|NCT00138671|19674678|P2|Overall Study|Withdrawal by Subject|5
5709143|NCT00138671|19674679|P1|Overall Study|Withdrawal by Subject|3
5709144|NCT00138671|19674678|P2|Overall Study|Lost to Follow-up|2
5709145|NCT00138671|19674679|P1|Overall Study|Lost to Follow-up|1
5709146|NCT00138671|19674678|P2|Overall Study|Adverse Event|3
5709147|NCT00138671|19674679|P1|Overall Study|Adverse Event|6
5709148|NCT00138671|19674678|P2|Overall Study|Death|3
5709149|NCT00138671|19674679|P1|Overall Study|Death|0
5709150|NCT00138658|19674729|P1|Overall Study|Withdrawal by Subject|5
5709151|NCT00138658|19674729|P1|Overall Study|Physician Decision|11
5709152|NCT00138658|19674729|P1|Overall Study|Disease Progression|21
5709153|NCT00138658|19674729|P1|Overall Study|Death|1
5709154|NCT00138658|19674729|P1|Overall Study|Adverse Event|23
5709155|NCT00138424|19674752|P4|Overall Study|Physician Decision|0
5709156|NCT00138424|19674753|P3|Overall Study|Physician Decision|0
5709157|NCT00138424|19674754|P2|Overall Study|Physician Decision|1
5709158|NCT00138424|19674755|P1|Overall Study|Physician Decision|0
5709159|NCT00138151|19674838|P1|Overall Study|Physician Decision|1
5709160|NCT00138151|19674838|P1|Overall Study|Withdrawal by Subject|3
5709161|NCT00138073|19674853|P1|Overall Study|lack of resources|55
5709162|NCT00137839|19674892|P1|Overall Study|Prolonged Treatment Delay|1
5709163|NCT00137839|19674892|P1|Overall Study|Not Start Treatment|1
5709164|NCT00137839|19674892|P1|Overall Study|Disease Progression|60
5709165|NCT00137839|19674892|P1|Overall Study|Death|8
5709166|NCT00137839|19674892|P1|Overall Study|Physician Decision|7
5709167|NCT00137839|19674892|P1|Overall Study|Adverse Event|7
5709168|NCT00137631|19674905|P2|Overall Study|Lost to Follow-up|41
5709169|NCT00137631|19674906|P1|Overall Study|Lost to Follow-up|37
5709170|NCT00137449|19674922|P2|Overall Study|Withdrawal by Subject|1
5709171|NCT00137449|19674923|P1|Overall Study|Withdrawal by Subject|1
5709172|NCT00137449|19674922|P2|Overall Study|Adverse Event|1
5709173|NCT00137449|19674923|P1|Overall Study|Adverse Event|3
5709174|NCT00137449|19674922|P2|Overall Study|Death|3
5709175|NCT00137449|19674923|P1|Overall Study|Death|4
5709176|NCT00137449|19674922|P2|Overall Study|Disease Progression|13
5709177|NCT00137449|19674923|P1|Overall Study|Disease Progression|8
5709178|NCT00137436|19674960|P1|Overall Study|Other|5
5709179|NCT00137436|19674960|P1|Overall Study|Withdrawal by Subject|6
5709180|NCT00137436|19674960|P1|Overall Study|Lack of Efficacy|17
5709181|NCT00137436|19674960|P1|Overall Study|Death|2
5709182|NCT00137436|19674960|P1|Overall Study|Adverse Event|13
5709183|NCT00137423|19674979|P2|Overall Study|Death|1
5709184|NCT00137423|19674980|P1|Overall Study|Death|0
5709185|NCT00137423|19674979|P2|Overall Study|Lack of Efficacy|33
5709186|NCT00137423|19674980|P1|Overall Study|Lack of Efficacy|31
5709187|NCT00137423|19674979|P2|Overall Study|consent withdrawn|1
5709188|NCT00137423|19674980|P1|Overall Study|consent withdrawn|1
5709189|NCT00137423|19674979|P2|Overall Study|Adverse Event|9
5709190|NCT00137423|19674980|P1|Overall Study|Adverse Event|7
5709191|NCT00137267|19675017|P2|Overall Study|Lost to Follow-up|21
5709192|NCT00137267|19675018|P1|Overall Study|Lost to Follow-up|15
5709193|NCT00137111|19675030|P4|Total Therapy|Non Compliance|0
5709194|NCT00137111|19675031|P3|Total Therapy|Non Compliance|0
5709195|NCT00137111|19675032|P2|Total Therapy|Non Compliance|0
5709196|NCT00137111|19675033|P1|Total Therapy|Non Compliance|5
5709197|NCT00137111|19675030|P4|Total Therapy|Death|0
5709198|NCT00137111|19675031|P3|Total Therapy|Death|0
5709199|NCT00137111|19675032|P2|Total Therapy|Death|0
5709200|NCT00137111|19675033|P1|Total Therapy|Death|35
5709201|NCT00137046|19675047|P2|Overall Study|Withdrew prior to study treatment|1
5709202|NCT00137046|19675048|P1|Overall Study|Withdrew prior to study treatment|1
5709203|NCT00137046|19675047|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
5709204|NCT00137046|19675048|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
5709205|NCT00137046|19675047|P2|Overall Study|Withdrawal by Subject|42
5709206|NCT00137046|19675048|P1|Overall Study|Withdrawal by Subject|33
5709207|NCT00137046|19675047|P2|Overall Study|Other|19
5709208|NCT00137046|19675048|P1|Overall Study|Other|23
5709209|NCT00137046|19675047|P2|Overall Study|Lost to Follow-up|24
5709210|NCT00137046|19675048|P1|Overall Study|Lost to Follow-up|8
5709211|NCT00137046|19675047|P2|Overall Study|Lack of Efficacy|1
5709212|NCT00137046|19675048|P1|Overall Study|Lack of Efficacy|13
5709213|NCT00137046|19675047|P2|Overall Study|Laboratory Abnormality|0
5709214|NCT00137046|19675048|P1|Overall Study|Laboratory Abnormality|2
5709215|NCT00137046|19675047|P2|Overall Study|Adverse Event|5
5709216|NCT00137046|19675048|P1|Overall Study|Adverse Event|16
5709217|NCT00137046|19675047|P2|Overall Study|Death|1
5709218|NCT00137046|19675048|P1|Overall Study|Death|2
5709219|NCT00136955|19675096|P1|Overall Study|Incl. prog. disease, protocol violation|12
5709220|NCT00136955|19675096|P1|Overall Study|Withdrawal by Subject|2
5709221|NCT00136955|19675096|P1|Overall Study|Lost to Follow-up|1
5709222|NCT00136955|19675096|P1|Overall Study|Adverse Event|8
5709223|NCT00136916|19675105|P2|Overall Study|Discontinued in follow up period|0
5709224|NCT00136916|19675106|P1|Overall Study|Discontinued in follow up period|3
5709225|NCT00136916|19675105|P2|Overall Study|Other|24
5709226|NCT00136916|19675106|P1|Overall Study|Other|22
5709227|NCT00136916|19675105|P2|Overall Study|Withdrawal by Subject|46
5709228|NCT00136916|19675106|P1|Overall Study|Withdrawal by Subject|44
5709229|NCT00136916|19675105|P2|Overall Study|Lost to Follow-up|14
5709230|NCT00136916|19675106|P1|Overall Study|Lost to Follow-up|12
5709231|NCT00136916|19675105|P2|Overall Study|Lack of Efficacy|3
5709232|NCT00136916|19675106|P1|Overall Study|Lack of Efficacy|13
5709233|NCT00136916|19675105|P2|Overall Study|Laboratory abnormality|1
5709234|NCT00136916|19675106|P1|Overall Study|Laboratory abnormality|0
5709235|NCT00136916|19675105|P2|Overall Study|Adverse Event|8
5709236|NCT00136916|19675106|P1|Overall Study|Adverse Event|27
5709237|NCT00136916|19675105|P2|Overall Study|Death|3
5709238|NCT00136916|19675106|P1|Overall Study|Death|1
5709239|NCT00136916|19675105|P2|Overall Study|Never received study treatment|5
5709240|NCT00136916|19675106|P1|Overall Study|Never received study treatment|3
5709241|NCT00136604|19675213|P5|Overall Study|Migrated/moved from study area|0
5709242|NCT00136604|19675214|P4|Overall Study|Migrated/moved from study area|0
5709243|NCT00136604|19675215|P3|Overall Study|Migrated/moved from study area|0
5709244|NCT00136604|19675216|P2|Overall Study|Migrated/moved from study area|1
5709245|NCT00136604|19675217|P1|Overall Study|Migrated/moved from study area|0
5709246|NCT00136604|19675213|P5|Overall Study|Lost to Follow-up|1
5709247|NCT00136604|19675214|P4|Overall Study|Lost to Follow-up|0
5709248|NCT00136604|19675215|P3|Overall Study|Lost to Follow-up|0
5709249|NCT00136604|19675216|P2|Overall Study|Lost to Follow-up|0
5709250|NCT00136604|19675217|P1|Overall Study|Lost to Follow-up|1
5709251|NCT00136357|19675325|P2|Overall Study|Withdrawal by Subject|2
5709252|NCT00136357|19675326|P1|Overall Study|Withdrawal by Subject|3
5709253|NCT00136318|19675334|P2|Overall Study|Withdrawal by Subject|2
5709254|NCT00136318|19675335|P1|Overall Study|Withdrawal by Subject|2
5709255|NCT00136318|19675334|P2|Overall Study|Adverse Event|5
5709256|NCT00136318|19675335|P1|Overall Study|Adverse Event|5
5709257|NCT00136084|19675362|P2|Overall Study|Withdrawal by Subject|1
5709258|NCT00136084|19675363|P1|Overall Study|Withdrawal by Subject|5
5709259|NCT00136084|19675362|P2|Overall Study|No Response|2
5709260|NCT00136084|19675363|P1|Overall Study|No Response|1
5709261|NCT00136084|19675362|P2|Overall Study|Lost to Follow-up|0
5709262|NCT00136084|19675363|P1|Overall Study|Lost to Follow-up|2
5709263|NCT00136084|19675362|P2|Overall Study|Relapse|23
5709264|NCT00136084|19675363|P1|Overall Study|Relapse|20
5709265|NCT00136084|19675362|P2|Overall Study|Unacceptable toxicity|11
5709266|NCT00136084|19675363|P1|Overall Study|Unacceptable toxicity|8
5709267|NCT00136084|19675362|P2|Overall Study|Death|5
5709268|NCT00136084|19675363|P1|Overall Study|Death|12
5709269|NCT00135707|19675399|P2|Overall Study|Institutional review board request|0
5709270|NCT00135707|19675400|P1|Overall Study|Institutional review board request|1
5709271|NCT00135707|19675399|P2|Overall Study|Withdrawal by Subject|1
5709272|NCT00135707|19675400|P1|Overall Study|Withdrawal by Subject|0
5709273|NCT00135707|19675399|P2|Overall Study|Lost to Follow-up|89
5709274|NCT00135707|19675400|P1|Overall Study|Lost to Follow-up|94
5709275|NCT00135694|19675483|P3|Overall Study|Ineligible for Random assignment|0
5709276|NCT00135694|19675484|P2|Overall Study|Ineligible for Random assignment|0
5709277|NCT00135694|19675485|P1|Overall Study|Ineligible for Random assignment|42
5709278|NCT00135694|19675483|P3|Overall Study|Hepatitis C related reasons|0
5709279|NCT00135694|19675484|P2|Overall Study|Hepatitis C related reasons|1
5709280|NCT00135694|19675485|P1|Overall Study|Hepatitis C related reasons|39
5709281|NCT00135694|19675483|P3|Overall Study|Protocol Violation|0
5709282|NCT00135694|19675484|P2|Overall Study|Protocol Violation|1
5709283|NCT00135694|19675485|P1|Overall Study|Protocol Violation|19
5709284|NCT00135694|19675483|P3|Overall Study|Withdrawal by Subject|4
5709285|NCT00135694|19675484|P2|Overall Study|Withdrawal by Subject|7
5709286|NCT00135694|19675485|P1|Overall Study|Withdrawal by Subject|41
5709287|NCT00135694|19675483|P3|Overall Study|Lost to Follow-up|1
5709288|NCT00135694|19675484|P2|Overall Study|Lost to Follow-up|7
5709289|NCT00135694|19675485|P1|Overall Study|Lost to Follow-up|8
5709290|NCT00135694|19675483|P3|Overall Study|Death|2
5709291|NCT00135694|19675484|P2|Overall Study|Death|1
5709292|NCT00135694|19675485|P1|Overall Study|Death|14
5709293|NCT00135694|19675483|P3|Overall Study|Adverse Event|0
5709294|NCT00135694|19675484|P2|Overall Study|Adverse Event|4
5709295|NCT00135694|19675485|P1|Overall Study|Adverse Event|17
5709296|NCT00135512|19675503|P1|Overall Study|Other|42
5709297|NCT00135512|19675503|P1|Overall Study|Lack of Efficacy|25
5709298|NCT00135512|19675503|P1|Overall Study|Adverse Event|56
5709299|NCT00135356|19675515|P2|Overall Study|Withdrawal by Subject|4
5709300|NCT00135356|19675516|P1|Overall Study|Withdrawal by Subject|2
5709301|NCT00135356|19675515|P2|Overall Study|No longer meets study criteria|0
5709302|NCT00135356|19675516|P1|Overall Study|No longer meets study criteria|2
5709303|NCT00135356|19675515|P2|Overall Study|Poor/noncompliance|1
5709304|NCT00135356|19675516|P1|Overall Study|Poor/noncompliance|1
5709305|NCT00135356|19675515|P2|Overall Study|Change in antiviral regimen|1
5709306|NCT00135356|19675516|P1|Overall Study|Change in antiviral regimen|0
5709307|NCT00135356|19675515|P2|Overall Study|Surgery for abdominal fat|0
5709308|NCT00135356|19675516|P1|Overall Study|Surgery for abdominal fat|1
5709309|NCT00135356|19675515|P2|Overall Study|Lost to Follow-up|1
5709310|NCT00135356|19675516|P1|Overall Study|Lost to Follow-up|3
5709311|NCT00135356|19675515|P2|Overall Study|Lack of Efficacy|0
5709312|NCT00135356|19675516|P1|Overall Study|Lack of Efficacy|2
5709313|NCT00135356|19675515|P2|Overall Study|Adverse Event|2
5709314|NCT00135356|19675516|P1|Overall Study|Adverse Event|6
5709315|NCT00135330|19675559|P3|Overall Study|Sponsor Decision|0
5709316|NCT00135330|19675560|P2|Overall Study|Sponsor Decision|1
5709317|NCT00135330|19675561|P1|Overall Study|Sponsor Decision|0
5709318|NCT00135330|19675559|P3|Overall Study|Patient Decision|4
5709319|NCT00135330|19675560|P2|Overall Study|Patient Decision|1
5709320|NCT00135330|19675561|P1|Overall Study|Patient Decision|5
5709321|NCT00135330|19675559|P3|Overall Study|Protocol Violation|3
5709322|NCT00135330|19675560|P2|Overall Study|Protocol Violation|3
5709323|NCT00135330|19675561|P1|Overall Study|Protocol Violation|4
5709324|NCT00135330|19675559|P3|Overall Study|Physician Decision|0
5709325|NCT00135330|19675560|P2|Overall Study|Physician Decision|1
5709326|NCT00135330|19675561|P1|Overall Study|Physician Decision|1
5709327|NCT00135330|19675559|P3|Overall Study|Lost to Follow-up|3
5709328|NCT00135330|19675560|P2|Overall Study|Lost to Follow-up|2
5709329|NCT00135330|19675561|P1|Overall Study|Lost to Follow-up|0
5709330|NCT00135330|19675559|P3|Overall Study|Adverse Event|1
5709331|NCT00135330|19675560|P2|Overall Study|Adverse Event|5
5709332|NCT00135330|19675561|P1|Overall Study|Adverse Event|2
5709333|NCT00134901|19675759|P2|Overall Study|discontinued intervention|10
5709334|NCT00134901|19675760|P1|Overall Study|discontinued intervention|12
5709335|NCT00134901|19675759|P2|Overall Study|Lost to Follow-up|5
5709336|NCT00134901|19675760|P1|Overall Study|Lost to Follow-up|5
5709337|NCT00134784|19675772|P4|Overall Study|Withdrawal by Subject|1
5709338|NCT00134784|19675773|P3|Overall Study|Withdrawal by Subject|2
5709339|NCT00134784|19675774|P2|Overall Study|Withdrawal by Subject|2
5709340|NCT00134784|19675775|P1|Overall Study|Withdrawal by Subject|2
5709341|NCT00134719|19675785|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
5709342|NCT00134719|19675786|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
5709343|NCT00134719|19675787|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
5709344|NCT00134719|19675785|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
5709345|NCT00134719|19675786|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
5709346|NCT00134719|19675787|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
5709347|NCT00134719|19675785|P3|Primary Vaccination Phase|Lost to Follow-up|3
5709348|NCT00134719|19675786|P2|Primary Vaccination Phase|Lost to Follow-up|3
5709349|NCT00134719|19675787|P1|Primary Vaccination Phase|Lost to Follow-up|7
5709350|NCT00134719|19675785|P3|Primary Vaccination Phase|Withdrawal by Subject|2
5709351|NCT00134719|19675786|P2|Primary Vaccination Phase|Withdrawal by Subject|3
5709352|NCT00134719|19675787|P1|Primary Vaccination Phase|Withdrawal by Subject|2
5709353|NCT00134719|19675785|P3|Primary Vaccination Phase|Protocol Violation|0
5709354|NCT00134719|19675786|P2|Primary Vaccination Phase|Protocol Violation|0
5709355|NCT00134719|19675787|P1|Primary Vaccination Phase|Protocol Violation|1
5709356|NCT00134719|19675785|P3|Primary Vaccination Phase|Adverse Event|0
5709357|NCT00134719|19675786|P2|Primary Vaccination Phase|Adverse Event|0
5709358|NCT00134719|19675787|P1|Primary Vaccination Phase|Adverse Event|4
5709359|NCT00134563|19675918|P3|Overall Study|Reason other than above|5
5709360|NCT00134563|19675919|P2|Overall Study|Reason other than above|2
5709361|NCT00134563|19675920|P1|Overall Study|Reason other than above|0
5709362|NCT00134563|19675918|P3|Overall Study|did not wish to continue|26
5709363|NCT00134563|19675919|P2|Overall Study|did not wish to continue|32
5709364|NCT00134563|19675920|P1|Overall Study|did not wish to continue|33
5709365|NCT00134563|19675918|P3|Overall Study|progressive disease|2
5709366|NCT00134563|19675919|P2|Overall Study|progressive disease|4
5709367|NCT00134563|19675920|P1|Overall Study|progressive disease|11
5709368|NCT00134563|19675918|P3|Overall Study|Lost to Follow-up|2
5709369|NCT00134563|19675919|P2|Overall Study|Lost to Follow-up|0
5709370|NCT00134563|19675920|P1|Overall Study|Lost to Follow-up|4
5709371|NCT00134563|19675918|P3|Overall Study|Protocol Violation|5
5709372|NCT00134563|19675919|P2|Overall Study|Protocol Violation|2
5709373|NCT00134563|19675920|P1|Overall Study|Protocol Violation|3
5709374|NCT00134563|19675918|P3|Overall Study|Lack of Efficacy|17
5709375|NCT00134563|19675919|P2|Overall Study|Lack of Efficacy|14
5709376|NCT00134563|19675920|P1|Overall Study|Lack of Efficacy|24
5709377|NCT00134563|19675918|P3|Overall Study|Adverse Event|38
5709378|NCT00134563|19675919|P2|Overall Study|Adverse Event|37
5709379|NCT00134563|19675920|P1|Overall Study|Adverse Event|29
5709380|NCT00134563|19675918|P3|Overall Study|Not treated due to protocol violation|1
5709381|NCT00134563|19675919|P2|Overall Study|Not treated due to protocol violation|1
5709382|NCT00134563|19675920|P1|Overall Study|Not treated due to protocol violation|0
5709383|NCT00134082|19675981|P1|Overall Study|Death|1
5709384|NCT00134082|19675981|P1|Overall Study|Adverse Event|2
5709385|NCT00134056|19675990|P2|Eligible for Protocol Assigned Treatment|Other|56
5709386|NCT00134056|19675991|P1|Eligible for Protocol Assigned Treatment|Other|55
5709387|NCT00134056|19675990|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
5709388|NCT00134056|19675991|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
5709389|NCT00134056|19675990|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
5709390|NCT00134056|19675991|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
5709391|NCT00134056|19675990|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
5709392|NCT00134056|19675991|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
5709393|NCT00134056|19675990|P2|Randomization|Not eligible for assigned treatment|20
5709394|NCT00134056|19675991|P1|Randomization|Not eligible for assigned treatment|22
5709395|NCT00133991|19676035|P1|Overall Study|Death|4
5709396|NCT00133952|19676074|P2|Overall Study|Sponsor Decision|1
5709397|NCT00133952|19676075|P1|Overall Study|Sponsor Decision|0
5709398|NCT00133952|19676074|P2|Overall Study|Physician Decision|3
5709399|NCT00133952|19676075|P1|Overall Study|Physician Decision|4
5709400|NCT00133952|19676074|P2|Overall Study|Withdrawal by Subject|4
5709401|NCT00133952|19676075|P1|Overall Study|Withdrawal by Subject|20
5709402|NCT00133952|19676074|P2|Overall Study|Protocol Violation|1
5709403|NCT00133952|19676075|P1|Overall Study|Protocol Violation|1
5709404|NCT00133952|19676074|P2|Overall Study|Protocol Entry Criteria Exclusion|1
5709405|NCT00133952|19676075|P1|Overall Study|Protocol Entry Criteria Exclusion|4
5709406|NCT00133952|19676074|P2|Overall Study|Lost to Follow-up|14
5709407|NCT00133952|19676075|P1|Overall Study|Lost to Follow-up|9
5709408|NCT00133952|19676074|P2|Overall Study|Death|2
5709409|NCT00133952|19676075|P1|Overall Study|Death|3
5709410|NCT00133952|19676074|P2|Overall Study|Adverse Event|2
5709411|NCT00133952|19676075|P1|Overall Study|Adverse Event|1
5709412|NCT00133705|19676106|P2|Overall Study|Withdrawal by Subject|3
5709413|NCT00133705|19676107|P1|Overall Study|Withdrawal by Subject|2
5709414|NCT00132873|19676242|P1|Overall Study|Planned Pregnancy|1
5709415|NCT00132873|19676242|P1|Overall Study|Withdrawal by Subject|3
5709416|NCT00132873|19676242|P1|Overall Study|Lack of Efficacy|1
5709417|NCT00132873|19676242|P1|Overall Study|Lost to Follow-up|1
5709418|NCT00132873|19676242|P1|Overall Study|Adverse Event|3
5709419|NCT00132808|19676250|P3|Stratum II|Withdrawal by Subject|6
5709420|NCT00132808|19676251|P2|Stratum II|Withdrawal by Subject|9
5709421|NCT00132808|19676252|P1|Stratum II|Withdrawal by Subject|4
5709422|NCT00132808|19676250|P3|Stratum II|Protocol Violation|1
5709423|NCT00132808|19676251|P2|Stratum II|Protocol Violation|2
5709424|NCT00132808|19676252|P1|Stratum II|Protocol Violation|0
5709425|NCT00132808|19676250|P3|Stratum II|Lost to Follow-up|1
5709426|NCT00132808|19676251|P2|Stratum II|Lost to Follow-up|2
5709427|NCT00132808|19676252|P1|Stratum II|Lost to Follow-up|2
5709428|NCT00132808|19676250|P3|Stratum II|Death|0
5709429|NCT00132808|19676251|P2|Stratum II|Death|0
5709430|NCT00132808|19676252|P1|Stratum II|Death|1
5709431|NCT00132808|19676250|P3|Stratum II|Adverse Event|1
5709432|NCT00132808|19676251|P2|Stratum II|Adverse Event|2
5709433|NCT00132808|19676252|P1|Stratum II|Adverse Event|1
5709434|NCT00132808|19676250|P3|Stratum I|Abnormal test procedure result (s)|1
5709435|NCT00132808|19676251|P2|Stratum I|Abnormal test procedure result (s)|0
5709436|NCT00132808|19676252|P1|Stratum I|Abnormal test procedure result (s)|0
5709437|NCT00132808|19676250|P3|Stratum I|Withdrawal by Subject|3
5709438|NCT00132808|19676251|P2|Stratum I|Withdrawal by Subject|7
5709439|NCT00132808|19676252|P1|Stratum I|Withdrawal by Subject|4
5709440|NCT00132808|19676250|P3|Stratum I|Lost to Follow-up|1
5709441|NCT00132808|19676251|P2|Stratum I|Lost to Follow-up|4
5709442|NCT00132808|19676252|P1|Stratum I|Lost to Follow-up|3
5709443|NCT00132808|19676250|P3|Stratum I|Adverse Event|0
5709444|NCT00132808|19676251|P2|Stratum I|Adverse Event|1
5709445|NCT00132808|19676252|P1|Stratum I|Adverse Event|2
5709446|NCT00132769|19676277|P2|Overall Study|Protocol Violation|1
5709447|NCT00132769|19676278|P1|Overall Study|Protocol Violation|1
5709448|NCT00132769|19676277|P2|Overall Study|Adverse Event|1
5709449|NCT00132769|19676278|P1|Overall Study|Adverse Event|2
5709450|NCT00132769|19676277|P2|Overall Study|Lack of Efficacy|6
5709451|NCT00132769|19676278|P1|Overall Study|Lack of Efficacy|7
5709452|NCT00132769|19676277|P2|Overall Study|Withdrawal by Subject|3
5709453|NCT00132769|19676278|P1|Overall Study|Withdrawal by Subject|1
5709454|NCT00132730|19676304|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
5709455|NCT00132730|19676305|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
5709456|NCT00132730|19676306|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
5709457|NCT00132730|19676307|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
5709526|NCT00132691|19676353|P2|Overall Study|Death|0
5709458|NCT00132730|19676308|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
5709459|NCT00132730|19676309|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
5709460|NCT00132730|19676304|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
5709461|NCT00132730|19676305|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
5709462|NCT00132730|19676306|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
5709463|NCT00132730|19676307|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
5709464|NCT00132730|19676308|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
5709465|NCT00132730|19676309|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
5709466|NCT00132730|19676304|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5709467|NCT00132730|19676305|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
5709468|NCT00132730|19676306|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5709469|NCT00132730|19676307|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5709470|NCT00132730|19676308|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5709471|NCT00132730|19676309|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
5709472|NCT00132730|19676304|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5709473|NCT00132730|19676305|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
5709474|NCT00132730|19676306|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5709475|NCT00132730|19676307|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5709476|NCT00132730|19676308|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5709477|NCT00132730|19676309|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
5709478|NCT00132730|19676304|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
5709479|NCT00132730|19676305|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
5709480|NCT00132730|19676306|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
5709481|NCT00132730|19676307|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
5709482|NCT00132730|19676308|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
5709483|NCT00132730|19676309|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
5709484|NCT00132730|19676304|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
5709485|NCT00132730|19676305|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
5709486|NCT00132730|19676306|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
5709487|NCT00132730|19676307|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
5709488|NCT00132730|19676308|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
5709489|NCT00132730|19676309|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
5709490|NCT00132730|19676304|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5709491|NCT00132730|19676305|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5709492|NCT00132730|19676306|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
5709493|NCT00132730|19676307|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5709494|NCT00132730|19676308|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5709495|NCT00132730|19676309|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
5709496|NCT00132730|19676304|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
5709497|NCT00132730|19676305|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
5709498|NCT00132730|19676306|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
5709499|NCT00132730|19676307|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
5709500|NCT00132730|19676308|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
5709501|NCT00132730|19676309|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
5709502|NCT00132730|19676304|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
5709503|NCT00132730|19676305|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
5709504|NCT00132730|19676306|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
5709505|NCT00132730|19676307|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
5709506|NCT00132730|19676308|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
5709507|NCT00132730|19676309|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
5709508|NCT00132730|19676304|P6|Period II - 12-week Treatment (Base)|Other reasons|0
5709509|NCT00132730|19676305|P5|Period II - 12-week Treatment (Base)|Other reasons|0
5709510|NCT00132730|19676306|P4|Period II - 12-week Treatment (Base)|Other reasons|13
5709511|NCT00132730|19676307|P3|Period II - 12-week Treatment (Base)|Other reasons|9
5709512|NCT00132730|19676308|P2|Period II - 12-week Treatment (Base)|Other reasons|10
5709513|NCT00132730|19676309|P1|Period II - 12-week Treatment (Base)|Other reasons|11
5709514|NCT00132730|19676304|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
5709515|NCT00132730|19676305|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
5709516|NCT00132730|19676306|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
5709517|NCT00132730|19676307|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
5709518|NCT00132730|19676308|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
5709519|NCT00132730|19676309|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
5709520|NCT00132730|19676304|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
5709521|NCT00132730|19676305|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
5709522|NCT00132730|19676306|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
5709523|NCT00132730|19676307|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
5709524|NCT00132730|19676308|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
5709525|NCT00132730|19676309|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
5709527|NCT00132691|19676354|P1|Overall Study|Death|2
5709528|NCT00132691|19676353|P2|Overall Study|Missed 2-year visit|4
5709529|NCT00132691|19676354|P1|Overall Study|Missed 2-year visit|4
5709530|NCT00132691|19676353|P2|Overall Study|Lost to Follow-up|8
5709531|NCT00132691|19676354|P1|Overall Study|Lost to Follow-up|5
5709532|NCT00132678|19676394|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
5709533|NCT00132678|19676395|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
5709534|NCT00132678|19676396|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
5709535|NCT00132678|19676394|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
5709536|NCT00132678|19676395|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
5709537|NCT00132678|19676396|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
5709538|NCT00132678|19676394|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
5709539|NCT00132678|19676395|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
5709540|NCT00132678|19676396|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
5709541|NCT00132678|19676394|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
5709542|NCT00132678|19676395|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
5709543|NCT00132678|19676396|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
5709544|NCT00132678|19676394|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
5709545|NCT00132678|19676395|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
5709546|NCT00132678|19676396|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
5709547|NCT00132678|19676394|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
5709548|NCT00132678|19676395|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
5709549|NCT00132678|19676396|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
5709550|NCT00132678|19676394|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
5709551|NCT00132678|19676395|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
5709552|NCT00132678|19676396|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
5709553|NCT00132678|19676394|P3|Period III (Open-Label Stabilization)|Pregnancy|0
5709554|NCT00132678|19676395|P2|Period III (Open-Label Stabilization)|Pregnancy|0
5709555|NCT00132678|19676396|P1|Period III (Open-Label Stabilization)|Pregnancy|2
5709556|NCT00132678|19676394|P3|Period III (Open-Label Stabilization)|Physician Decision|0
5709557|NCT00132678|19676395|P2|Period III (Open-Label Stabilization)|Physician Decision|0
5709558|NCT00132678|19676396|P1|Period III (Open-Label Stabilization)|Physician Decision|1
5709559|NCT00132678|19676394|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
5709560|NCT00132678|19676395|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
5709561|NCT00132678|19676396|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
5709562|NCT00132678|19676394|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
5709563|NCT00132678|19676395|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
5709564|NCT00132678|19676396|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
5709565|NCT00132678|19676394|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
5709566|NCT00132678|19676395|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
5709567|NCT00132678|19676396|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
5709568|NCT00132678|19676394|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
5709569|NCT00132678|19676395|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
5709570|NCT00132678|19676396|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
5709571|NCT00132678|19676394|P3|Period III (Open-Label Stabilization)|Non responder|0
5709572|NCT00132678|19676395|P2|Period III (Open-Label Stabilization)|Non responder|0
5709573|NCT00132678|19676396|P1|Period III (Open-Label Stabilization)|Non responder|107
5709574|NCT00132678|19676394|P3|Period III (Open-Label Stabilization)|Adverse Event|0
5709575|NCT00132678|19676395|P2|Period III (Open-Label Stabilization)|Adverse Event|0
5709576|NCT00132678|19676396|P1|Period III (Open-Label Stabilization)|Adverse Event|12
5709577|NCT00132678|19676394|P3|Period III (Open-Label Stabilization)|Death|0
5709578|NCT00132678|19676395|P2|Period III (Open-Label Stabilization)|Death|0
5709579|NCT00132678|19676396|P1|Period III (Open-Label Stabilization)|Death|2
5709580|NCT00132678|19676394|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
5709581|NCT00132678|19676395|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
5709582|NCT00132678|19676396|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
5709583|NCT00132678|19676394|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
5709584|NCT00132678|19676395|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
5709585|NCT00132678|19676396|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
5709586|NCT00132678|19676394|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
5709587|NCT00132678|19676395|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
5709588|NCT00132678|19676396|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
5709589|NCT00132678|19676394|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
5709590|NCT00132678|19676395|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
5709591|NCT00132678|19676396|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
5709592|NCT00132678|19676394|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
5709593|NCT00132678|19676395|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
5709594|NCT00132678|19676396|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
5709595|NCT00132678|19676394|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
5709596|NCT00132678|19676395|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
5709597|NCT00132678|19676396|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
5709598|NCT00132678|19676394|P3|Period II (Open-Label Oral Risperidone)|Death|1
5709599|NCT00132678|19676395|P2|Period II (Open-Label Oral Risperidone)|Death|0
5709600|NCT00132678|19676396|P1|Period II (Open-Label Oral Risperidone)|Death|0
5709601|NCT00132496|19676410|P2|Overall Study|Physician Decision|0
5709602|NCT00132496|19676411|P1|Overall Study|Physician Decision|1
5709603|NCT00132496|19676410|P2|Overall Study|Withdrawal by Subject|2
5709604|NCT00132496|19676411|P1|Overall Study|Withdrawal by Subject|1
5709605|NCT00132314|19676419|P2|Overall Study|Refused intervention at baseline|7
5709606|NCT00132314|19676420|P1|Overall Study|Refused intervention at baseline|2
5709607|NCT00132314|19676419|P2|Overall Study|Lacked SSN|3
5709608|NCT00132314|19676420|P1|Overall Study|Lacked SSN|1
5709609|NCT00132314|19676419|P2|Overall Study|Lost to Follow-up|62
5709610|NCT00132314|19676420|P1|Overall Study|Lost to Follow-up|70
5709611|NCT00132301|19676430|P2|Overall Study|Excluded by Data Monitoring Committee|0
5709612|NCT00132301|19676431|P1|Overall Study|Excluded by Data Monitoring Committee|1
5709613|NCT00132301|19676430|P2|Overall Study|Other|1
5709614|NCT00132301|19676431|P1|Overall Study|Other|1
5709615|NCT00132301|19676430|P2|Overall Study|Lost to Follow-up|3
5709616|NCT00132301|19676431|P1|Overall Study|Lost to Follow-up|5
5709617|NCT00132301|19676430|P2|Overall Study|Physician Decision|1
5709618|NCT00132301|19676431|P1|Overall Study|Physician Decision|1
5709619|NCT00132301|19676430|P2|Overall Study|Withdrawal by Subject|2
5709620|NCT00132301|19676431|P1|Overall Study|Withdrawal by Subject|5
5709621|NCT00132301|19676430|P2|Overall Study|Death|6
5709622|NCT00132301|19676431|P1|Overall Study|Death|7
5709623|NCT00132132|19676439|P2|Overall Study|Lost to Follow-up|2
5709624|NCT00132132|19676440|P1|Overall Study|Lost to Follow-up|7
5709625|NCT00132041|19676448|P1|18 Months Post Ablation|ExtraHepatic tumor|1
5709626|NCT00132041|19676448|P1|18 Months Post Ablation|Non-Protocol Treatment|3
5709627|NCT00132041|19676448|P1|18 Months Post Ablation|Transplant|1
5709628|NCT00132041|19676448|P1|18 Months Post Ablation|Withdrawal by Subject|1
5709629|NCT00132041|19676448|P1|15 Months Post Ablation|Non-Protocol Treatment|1
5709630|NCT00132041|19676448|P1|15 Months Post Ablation|Transplant|5
5709631|NCT00132041|19676448|P1|15 Months Post Ablation|Death|1
5709632|NCT00132041|19676448|P1|15 Months Post Ablation|Withdrawal by Subject|1
5709633|NCT00132041|19676448|P1|12 Months Post Ablation|non-protocol Treatment|1
5709634|NCT00132041|19676448|P1|12 Months Post Ablation|Transplant|1
5709635|NCT00132041|19676448|P1|12 Months Post Ablation|Death|1
5709636|NCT00132041|19676448|P1|12 Months Post Ablation|Withdrawal by Subject|1
5709637|NCT00132041|19676448|P1|9 Months Post Ablation|Transplant|1
5709638|NCT00132041|19676448|P1|9 Months Post Ablation|Death|1
5709639|NCT00132041|19676448|P1|6 Months Post Ablation|Transplant|6
5709640|NCT00132041|19676448|P1|6 Months Post Ablation|Death|2
5709641|NCT00132041|19676448|P1|6 Months Post Ablation|Withdrawal by Subject|2
5709642|NCT00132041|19676448|P1|3 Months Post Ablation|Non-Protocol Treatment|2
5709643|NCT00132041|19676448|P1|3 Months Post Ablation|Transplant|1
5709644|NCT00132041|19676448|P1|Baseline|Ineligible|6
5709645|NCT00132028|19676463|P1|Overall Study|Physician Decision|3
5709646|NCT00132028|19676463|P1|Overall Study|not eligible|2
5709647|NCT00132028|19676463|P1|Overall Study|Withdrawal by Subject|2
5709648|NCT00132028|19676463|P1|Overall Study|Lack of Efficacy|11
5709649|NCT00132028|19676463|P1|Overall Study|Death|2
5709650|NCT00132028|19676463|P1|Overall Study|Adverse Event|7
5709651|NCT00131937|19676475|P1|Overall Study|Alternative therapy|1
5709652|NCT00131937|19676475|P1|Overall Study|Disease Progression|7
5709653|NCT00131937|19676475|P1|Overall Study|Physician Decision|1
5709654|NCT00131937|19676475|P1|Overall Study|Withdrawal by Subject|2
5709655|NCT00131937|19676475|P1|Overall Study|Adverse Event|3
5709656|NCT00131911|19676483|P2|Overall Study|Withdrawal by Subject|0
5709657|NCT00131911|19676484|P1|Overall Study|Withdrawal by Subject|1
5709658|NCT00131664|19676554|P6|Second Period (Additional Drug Added)|Administrative reasons|0
5709659|NCT00131664|19676555|P5|Second Period (Additional Drug Added)|Administrative reasons|1
5709660|NCT00131664|19676556|P4|Second Period (Additional Drug Added)|Administrative reasons|0
5709661|NCT00131664|19676557|P3|Second Period (Additional Drug Added)|Administrative reasons|0
5709662|NCT00131664|19676558|P2|Second Period (Additional Drug Added)|Administrative reasons|2
5709663|NCT00131664|19676559|P1|Second Period (Additional Drug Added)|Administrative reasons|4
5709664|NCT00131664|19676554|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5709665|NCT00131664|19676555|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5709666|NCT00131664|19676556|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
5709667|NCT00131664|19676557|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5709668|NCT00131664|19676558|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5709669|NCT00131664|19676559|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
5709670|NCT00131664|19676554|P6|Second Period (Additional Drug Added)|Adverse Event|1
5709671|NCT00131664|19676555|P5|Second Period (Additional Drug Added)|Adverse Event|0
5709672|NCT00131664|19676556|P4|Second Period (Additional Drug Added)|Adverse Event|0
5709673|NCT00131664|19676557|P3|Second Period (Additional Drug Added)|Adverse Event|0
5709674|NCT00131664|19676558|P2|Second Period (Additional Drug Added)|Adverse Event|1
5709675|NCT00131664|19676559|P1|Second Period (Additional Drug Added)|Adverse Event|0
5709676|NCT00131664|19676554|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5709677|NCT00131664|19676555|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5709678|NCT00131664|19676556|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5709679|NCT00131664|19676557|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5709680|NCT00131664|19676558|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
5709681|NCT00131664|19676559|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
5709682|NCT00131664|19676554|P6|Second Period (Additional Drug Added)|Protocol Violation|0
5709683|NCT00131664|19676555|P5|Second Period (Additional Drug Added)|Protocol Violation|0
5709684|NCT00131664|19676556|P4|Second Period (Additional Drug Added)|Protocol Violation|0
5709685|NCT00131664|19676557|P3|Second Period (Additional Drug Added)|Protocol Violation|1
5709686|NCT00131664|19676558|P2|Second Period (Additional Drug Added)|Protocol Violation|1
5709687|NCT00131664|19676559|P1|Second Period (Additional Drug Added)|Protocol Violation|0
5709688|NCT00131664|19676554|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
5709689|NCT00131664|19676555|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
5709690|NCT00131664|19676556|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
5709691|NCT00131664|19676557|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
5709692|NCT00131664|19676558|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
5709693|NCT00131664|19676559|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
5709694|NCT00131664|19676554|P6|First Period (First 6 Months)|Administrative reasons|0
5709695|NCT00131664|19676555|P5|First Period (First 6 Months)|Administrative reasons|0
5709696|NCT00131664|19676556|P4|First Period (First 6 Months)|Administrative reasons|0
5709697|NCT00131664|19676557|P3|First Period (First 6 Months)|Administrative reasons|5
5709698|NCT00131664|19676558|P2|First Period (First 6 Months)|Administrative reasons|0
5709699|NCT00131664|19676559|P1|First Period (First 6 Months)|Administrative reasons|2
5709700|NCT00131664|19676554|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
5709701|NCT00131664|19676555|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
5709702|NCT00131664|19676556|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
5709703|NCT00131664|19676557|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
5709704|NCT00131664|19676558|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
5709705|NCT00131664|19676559|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
5709706|NCT00131664|19676554|P6|First Period (First 6 Months)|Adverse Event|0
5709707|NCT00131664|19676555|P5|First Period (First 6 Months)|Adverse Event|0
5709708|NCT00131664|19676556|P4|First Period (First 6 Months)|Adverse Event|0
5709709|NCT00131664|19676557|P3|First Period (First 6 Months)|Adverse Event|5
5709710|NCT00131664|19676558|P2|First Period (First 6 Months)|Adverse Event|4
5709711|NCT00131664|19676559|P1|First Period (First 6 Months)|Adverse Event|9
5709712|NCT00131664|19676554|P6|First Period (First 6 Months)|Withdrawal by Subject|0
5709713|NCT00131664|19676555|P5|First Period (First 6 Months)|Withdrawal by Subject|0
5709714|NCT00131664|19676556|P4|First Period (First 6 Months)|Withdrawal by Subject|0
5709715|NCT00131664|19676557|P3|First Period (First 6 Months)|Withdrawal by Subject|2
5709716|NCT00131664|19676558|P2|First Period (First 6 Months)|Withdrawal by Subject|6
5709717|NCT00131664|19676559|P1|First Period (First 6 Months)|Withdrawal by Subject|4
5709718|NCT00131664|19676554|P6|First Period (First 6 Months)|Protocol Violation|0
5709719|NCT00131664|19676555|P5|First Period (First 6 Months)|Protocol Violation|0
5709720|NCT00131664|19676556|P4|First Period (First 6 Months)|Protocol Violation|0
5709721|NCT00131664|19676557|P3|First Period (First 6 Months)|Protocol Violation|1
5709722|NCT00131664|19676558|P2|First Period (First 6 Months)|Protocol Violation|2
5709723|NCT00131664|19676559|P1|First Period (First 6 Months)|Protocol Violation|2
5709724|NCT00131664|19676554|P6|First Period (First 6 Months)|Death|0
5709725|NCT00131664|19676555|P5|First Period (First 6 Months)|Death|0
5709726|NCT00131664|19676556|P4|First Period (First 6 Months)|Death|0
5709727|NCT00131664|19676557|P3|First Period (First 6 Months)|Death|0
5709728|NCT00131664|19676558|P2|First Period (First 6 Months)|Death|1
5709729|NCT00131664|19676559|P1|First Period (First 6 Months)|Death|0
5709730|NCT00131664|19676554|P6|First Period (First 6 Months)|Lost to Follow-up|0
5709731|NCT00131664|19676555|P5|First Period (First 6 Months)|Lost to Follow-up|0
5709732|NCT00131664|19676556|P4|First Period (First 6 Months)|Lost to Follow-up|0
5709733|NCT00131664|19676557|P3|First Period (First 6 Months)|Lost to Follow-up|3
5709734|NCT00131664|19676558|P2|First Period (First 6 Months)|Lost to Follow-up|3
5709735|NCT00131664|19676559|P1|First Period (First 6 Months)|Lost to Follow-up|7
5709736|NCT00131508|19676631|P2|Overall Study|Withdrawal by Subject|2
5709737|NCT00131508|19676632|P1|Overall Study|Withdrawal by Subject|1
5709738|NCT00131508|19676631|P2|Overall Study|Non-Compliance|4
5709739|NCT00131508|19676632|P1|Overall Study|Non-Compliance|2
5709740|NCT00131508|19676631|P2|Overall Study|Disease progression|2
5709741|NCT00131508|19676632|P1|Overall Study|Disease progression|0
5709742|NCT00131469|19676656|P2|Overall Study|scan not analyzable|6
5709743|NCT00131469|19676657|P1|Overall Study|scan not analyzable|3
5709744|NCT00131469|19676656|P2|Overall Study|Lost to Follow-up|1
5709745|NCT00131469|19676657|P1|Overall Study|Lost to Follow-up|0
5709746|NCT00131469|19676656|P2|Overall Study|Death|1
5709747|NCT00131469|19676657|P1|Overall Study|Death|0
5709748|NCT00131469|19676656|P2|Overall Study|Protocol Violation|1
5709749|NCT00131469|19676657|P1|Overall Study|Protocol Violation|3
5709750|NCT00131469|19676656|P2|Overall Study|Withdrawal by Subject|4
5709751|NCT00131469|19676657|P1|Overall Study|Withdrawal by Subject|3
5709752|NCT00131365|19676703|P1|Overall Study|Alternative treatment|3
5709753|NCT00131365|19676703|P1|Overall Study|Withdrawal by Subject|1
5709754|NCT00131352|19676710|P2|Repeat Treatment Period|Other|0
5709755|NCT00131352|19676711|P1|Repeat Treatment Period|Other|1
5709756|NCT00131352|19676710|P2|Repeat Treatment Period|Adverse Event|0
5709757|NCT00131352|19676711|P1|Repeat Treatment Period|Adverse Event|1
5709758|NCT00131352|19676710|P2|Initial Treatment Period|Other|2
5709759|NCT00131352|19676711|P1|Initial Treatment Period|Other|0
5709760|NCT00131352|19676710|P2|Initial Treatment Period|Lack of Efficacy|4
5709761|NCT00131352|19676711|P1|Initial Treatment Period|Lack of Efficacy|6
5709762|NCT00131352|19676710|P2|Initial Treatment Period|Withdrawal by Subject|1
5709763|NCT00131352|19676711|P1|Initial Treatment Period|Withdrawal by Subject|1
5709764|NCT00131352|19676710|P2|Initial Treatment Period|Non-compliant|2
5709765|NCT00131352|19676711|P1|Initial Treatment Period|Non-compliant|1
5709766|NCT00131352|19676710|P2|Initial Treatment Period|Adverse Event|3
5709767|NCT00131352|19676711|P1|Initial Treatment Period|Adverse Event|1
5709768|NCT00131248|19676733|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
5709769|NCT00131248|19676734|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
5709770|NCT00130832|19676761|P2|Overall Study|Other|3
5709771|NCT00130832|19676762|P1|Overall Study|Other|0
5709772|NCT00130832|19676761|P2|Overall Study|Moved|2
5709773|NCT00130832|19676762|P1|Overall Study|Moved|2
5709774|NCT00130832|19676761|P2|Overall Study|Withdrawal by Subject|1
5709775|NCT00130832|19676762|P1|Overall Study|Withdrawal by Subject|6
5709776|NCT00130832|19676761|P2|Overall Study|Protocol Violation|8
5709777|NCT00130832|19676762|P1|Overall Study|Protocol Violation|6
5709778|NCT00130832|19676761|P2|Overall Study|Lost to Follow-up|2
5709779|NCT00130832|19676762|P1|Overall Study|Lost to Follow-up|1
5709780|NCT00130832|19676761|P2|Overall Study|Adverse Event|1
5709781|NCT00130832|19676762|P1|Overall Study|Adverse Event|1
5709782|NCT00130793|19676774|P2|Overall Study|Withdrew consent|0
5709783|NCT00130793|19676775|P1|Overall Study|Withdrew consent|2
5709784|NCT00130793|19676774|P2|Overall Study|Lost to Follow-up|4
5709785|NCT00130793|19676775|P1|Overall Study|Lost to Follow-up|1
5709786|NCT00130728|19676796|P2|Overall Study|Withdrawal by Subject|2
5709787|NCT00130728|19676797|P1|Overall Study|Withdrawal by Subject|0
5709788|NCT00130728|19676796|P2|Overall Study|Lost to Follow-up|0
5709789|NCT00130728|19676797|P1|Overall Study|Lost to Follow-up|4
5709790|NCT00130728|19676796|P2|Overall Study|Death|211
5709791|NCT00130728|19676797|P1|Overall Study|Death|207
5709792|NCT00130689|19676809|P1|Overall Study|Ineligible|6
5709793|NCT00130689|19676809|P1|Overall Study|Withdrawal by Subject|3
5709794|NCT00130689|19676809|P1|Overall Study|Clinical Deterioration|4
5709795|NCT00130689|19676809|P1|Overall Study|Death|1
5709796|NCT00130689|19676809|P1|Overall Study|Progressive Disease|29
5709797|NCT00130637|19676813|P1|Overall Study|Withdrawal by Subject|1
5709798|NCT00130637|19676813|P1|Overall Study|Adverse Event|2
5709799|NCT00130533|19676820|P2|Overall Study|Other|5
5709800|NCT00130533|19676821|P1|Overall Study|Other|12
5709801|NCT00130533|19676820|P2|Overall Study|Second Primary Malignancy|1
5709802|NCT00130533|19676821|P1|Overall Study|Second Primary Malignancy|0
5709803|NCT00130533|19676820|P2|Overall Study|Sponsor´s decision|0
5709804|NCT00130533|19676821|P1|Overall Study|Sponsor´s decision|2
5709805|NCT00130533|19676820|P2|Overall Study|Lost to Follow-up|1
5709806|NCT00130533|19676821|P1|Overall Study|Lost to Follow-up|1
5709807|NCT00130533|19676820|P2|Overall Study|Protocol Violation|1
5709808|NCT00130533|19676821|P1|Overall Study|Protocol Violation|5
5709809|NCT00130533|19676820|P2|Overall Study|Death|2
5709810|NCT00130533|19676821|P1|Overall Study|Death|4
5709811|NCT00130533|19676820|P2|Overall Study|Interruption of treatment > 3 weeks|0
5709812|NCT00130533|19676821|P1|Overall Study|Interruption of treatment > 3 weeks|11
5709813|NCT00130533|19676820|P2|Overall Study|Disease relapse|13
5709814|NCT00130533|19676821|P1|Overall Study|Disease relapse|9
5709815|NCT00130533|19676820|P2|Overall Study|Adverse Event|1
5709816|NCT00130533|19676821|P1|Overall Study|Adverse Event|34
5709817|NCT00130533|19676820|P2|Overall Study|Withdrawal by Subject|6
5709818|NCT00130533|19676821|P1|Overall Study|Withdrawal by Subject|33
5709819|NCT00130520|19676833|P1|Overall Study|Did not meet re-treatment criteria|1
5709820|NCT00130520|19676833|P1|Overall Study|Protocol non-compliance|1
5709821|NCT00130520|19676833|P1|Overall Study|Disease Progression|23
5709822|NCT00130520|19676833|P1|Overall Study|Withdrawal by Subject|1
5709823|NCT00130520|19676833|P1|Overall Study|Physician Decision|1
5709824|NCT00130520|19676833|P1|Overall Study|Death|1
5709825|NCT00130520|19676833|P1|Overall Study|Adverse Event|11
5709826|NCT00130286|19676843|P4|Overall Study|Missing lab specimens|0
5709827|NCT00130286|19676844|P3|Overall Study|Missing lab specimens|0
5709828|NCT00130286|19676845|P2|Overall Study|Missing lab specimens|2
5709829|NCT00130286|19676846|P1|Overall Study|Missing lab specimens|0
5709830|NCT00130286|19676843|P4|Overall Study|Adverse Event|0
5709831|NCT00130286|19676844|P3|Overall Study|Adverse Event|2
5709832|NCT00130286|19676845|P2|Overall Study|Adverse Event|0
5709833|NCT00130286|19676846|P1|Overall Study|Adverse Event|0
5709834|NCT00130286|19676843|P4|Overall Study|Withdrawal by Subject|2
5709835|NCT00130286|19676844|P3|Overall Study|Withdrawal by Subject|2
5709836|NCT00130286|19676845|P2|Overall Study|Withdrawal by Subject|1
5709837|NCT00130286|19676846|P1|Overall Study|Withdrawal by Subject|0
5709838|NCT00130247|19676866|P2|Overall Study|Not compliant with DOT|2
5709839|NCT00130247|19676867|P1|Overall Study|Not compliant with DOT|0
5709840|NCT00130247|19676866|P2|Overall Study|Post-randomization exclusion|2
5709841|NCT00130247|19676867|P1|Overall Study|Post-randomization exclusion|1
5709842|NCT00130247|19676866|P2|Overall Study|Pregnancy|0
5709843|NCT00130247|19676867|P1|Overall Study|Pregnancy|1
5709844|NCT00130208|19676885|P2|Washout Period (8 Weeks)|Other|1
5709845|NCT00130208|19676886|P1|Washout Period (8 Weeks)|Other|1
5709846|NCT00130208|19676885|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
5709847|NCT00130208|19676886|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
5709848|NCT00130208|19676885|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
5709849|NCT00130208|19676886|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
5709850|NCT00130208|19676885|P2|Washout Period (8 Weeks)|Adverse Event|6
5709851|NCT00130208|19676886|P1|Washout Period (8 Weeks)|Adverse Event|3
5709852|NCT00130208|19676885|P2|Maintenance Period (26 Weeks)|Other|1
5709853|NCT00130208|19676886|P1|Maintenance Period (26 Weeks)|Other|1
5709854|NCT00130208|19676885|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
5709855|NCT00130208|19676886|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
5709856|NCT00130208|19676885|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
5709857|NCT00130208|19676886|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
5709858|NCT00130208|19676885|P2|Maintenance Period (26 Weeks)|Physician Decision|2
5709859|NCT00130208|19676886|P1|Maintenance Period (26 Weeks)|Physician Decision|0
5709860|NCT00130208|19676885|P2|Maintenance Period (26 Weeks)|Adverse Event|12
5709861|NCT00130208|19676886|P1|Maintenance Period (26 Weeks)|Adverse Event|10
5709862|NCT00130039|19676922|P2|Overall Study|clinical events without follow up MRI|4
5709863|NCT00130039|19676923|P1|Overall Study|clinical events without follow up MRI|5
5709864|NCT00130039|19676922|P2|Overall Study|Physician Decision|0
5709865|NCT00130039|19676923|P1|Overall Study|Physician Decision|3
5709866|NCT00130039|19676922|P2|Overall Study|Adverse Event|2
5709867|NCT00130039|19676923|P1|Overall Study|Adverse Event|4
5709868|NCT00130039|19676922|P2|Overall Study|Lost to Follow-up|1
5709869|NCT00130039|19676923|P1|Overall Study|Lost to Follow-up|3
5709870|NCT00130039|19676922|P2|Overall Study|Withdrawal by Subject|11
5709871|NCT00130039|19676923|P1|Overall Study|Withdrawal by Subject|15
5709872|NCT00129987|19676941|P2|1 Year|Withdrawal by Subject|21
5709873|NCT00129987|19676942|P1|1 Year|Withdrawal by Subject|32
5709874|NCT00129987|19676941|P2|1st Educational Session|Withdrawal by Subject|109
5709875|NCT00129987|19676942|P1|1st Educational Session|Withdrawal by Subject|141
5709876|NCT00129974|19676954|P1|Overall Study|Other|1
5709877|NCT00129961|19676961|P2|Overall Study|Missing Record|1
5709878|NCT00129961|19676962|P1|Overall Study|Missing Record|0
5709879|NCT00129961|19676961|P2|Overall Study|Withdrawal by Subject|1
5709880|NCT00129961|19676962|P1|Overall Study|Withdrawal by Subject|2
5709881|NCT00129961|19676961|P2|Overall Study|Physician Decision|0
5709882|NCT00129961|19676962|P1|Overall Study|Physician Decision|1
5709883|NCT00129961|19676961|P2|Overall Study|Withdrawal by Sponsor|20
5709884|NCT00129961|19676962|P1|Overall Study|Withdrawal by Sponsor|14
5709885|NCT00129961|19676961|P2|Overall Study|Death|1
5709886|NCT00129961|19676962|P1|Overall Study|Death|1
5709887|NCT00129961|19676961|P2|Overall Study|Adverse Event|0
5709888|NCT00129961|19676962|P1|Overall Study|Adverse Event|1
5709889|NCT00129935|19676998|P2|Overall Study|Incorrect study treatment|0
5709890|NCT00129935|19676999|P1|Overall Study|Incorrect study treatment|1
5709891|NCT00129935|19676998|P2|Overall Study|Crossed to the other arm|1
5709892|NCT00129935|19676999|P1|Overall Study|Crossed to the other arm|2
5709893|NCT00129935|19676998|P2|Overall Study|Other|2
5709894|NCT00129935|19676999|P1|Overall Study|Other|3
5709895|NCT00129935|19676998|P2|Overall Study|Second primary|1
5709896|NCT00129935|19676999|P1|Overall Study|Second primary|0
5709897|NCT00129935|19676998|P2|Overall Study|Recurrence|3
5709898|NCT00129935|19676999|P1|Overall Study|Recurrence|1
5709899|NCT00129935|19676998|P2|Overall Study|Physician Decision|4
5709900|NCT00129935|19676999|P1|Overall Study|Physician Decision|3
5709901|NCT00129935|19676998|P2|Overall Study|Protocol Violation|4
5709902|NCT00129935|19676999|P1|Overall Study|Protocol Violation|0
5709903|NCT00129935|19676998|P2|Overall Study|Withdrawal by Subject|20
5709904|NCT00129935|19676999|P1|Overall Study|Withdrawal by Subject|7
5709905|NCT00129935|19676998|P2|Overall Study|Death|1
5709906|NCT00129935|19676999|P1|Overall Study|Death|1
5709907|NCT00129935|19676998|P2|Overall Study|Adverse Event|56
5709908|NCT00129935|19676999|P1|Overall Study|Adverse Event|18
5709909|NCT00129766|19677017|P2|Overall Study|Lost to Follow-up|21
5709910|NCT00129766|19677018|P1|Overall Study|Lost to Follow-up|26
5709911|NCT00129766|19677017|P2|Overall Study|Withdrawal of consent|30
5709912|NCT00129766|19677018|P1|Overall Study|Withdrawal of consent|31
5709913|NCT00129766|19677017|P2|Overall Study|Death|8
5709914|NCT00129766|19677018|P1|Overall Study|Death|3
5709915|NCT00129701|19677067|P1|Overall Study|Withdrawal by Subject|33
5709916|NCT00129649|19677076|P2|Overall Study|Withdrawal by Subject|65
5709917|NCT00129649|19677077|P1|Overall Study|Withdrawal by Subject|76
5709918|NCT00129623|19677085|P2|Overall Study|Uncertainty to return|1
5709919|NCT00129623|19677086|P1|Overall Study|Uncertainty to return|0
5709920|NCT00129623|19677085|P2|Overall Study|Relocated job out of state|0
5709921|NCT00129623|19677086|P1|Overall Study|Relocated job out of state|1
5709922|NCT00129623|19677085|P2|Overall Study|Failure to Return|1
5709923|NCT00129623|19677086|P1|Overall Study|Failure to Return|1
5709924|NCT00129623|19677085|P2|Overall Study|Refused Treatment|3
5709925|NCT00129623|19677086|P1|Overall Study|Refused Treatment|5
5709926|NCT00129623|19677085|P2|Overall Study|Adverse Event|7
5709927|NCT00129623|19677086|P1|Overall Study|Adverse Event|3
5709928|NCT00129545|19677111|P3|Overall Study|Device not implanted|0
5709929|NCT00129545|19677112|P2|Overall Study|Device not implanted|61
5709930|NCT00129545|19677113|P1|Overall Study|Device not implanted|16
5709931|NCT00129545|19677111|P3|Overall Study|Physician Decision|10
5709932|NCT00129545|19677112|P2|Overall Study|Physician Decision|3
5709933|NCT00129545|19677113|P1|Overall Study|Physician Decision|0
5709934|NCT00129545|19677111|P3|Overall Study|Lost to Follow-up|13
5709935|NCT00129545|19677112|P2|Overall Study|Lost to Follow-up|22
5709936|NCT00129545|19677113|P1|Overall Study|Lost to Follow-up|2
5709937|NCT00129545|19677111|P3|Overall Study|Withdrawal by Subject|44
5709938|NCT00129545|19677112|P2|Overall Study|Withdrawal by Subject|18
5709939|NCT00129545|19677113|P1|Overall Study|Withdrawal by Subject|3
5709940|NCT00129545|19677111|P3|Overall Study|Death|44
5709941|NCT00129545|19677112|P2|Overall Study|Death|60
5709942|NCT00129545|19677113|P1|Overall Study|Death|5
5709943|NCT00129467|19677142|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
5709944|NCT00129467|19677143|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
5709945|NCT00129467|19677142|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
5709946|NCT00129467|19677143|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
5709947|NCT00129467|19677142|P2|Received Intervention|Dizzyness, fatigue|1
5709948|NCT00129467|19677143|P1|Received Intervention|Dizzyness, fatigue|0
5709949|NCT00129467|19677142|P2|Received Intervention|Intolerance to citalopram|1
5709950|NCT00129467|19677143|P1|Received Intervention|Intolerance to citalopram|0
5709951|NCT00129467|19677142|P2|Received Intervention|Nausea|0
5709952|NCT00129467|19677143|P1|Received Intervention|Nausea|1
5709953|NCT00129467|19677142|P2|Received Intervention|Withdrawal by Subject|0
5709954|NCT00129467|19677143|P1|Received Intervention|Withdrawal by Subject|1
5709955|NCT00129467|19677142|P2|Received Intervention|Delirium|0
5709956|NCT00129467|19677143|P1|Received Intervention|Delirium|2
5709957|NCT00129467|19677142|P2|Received Intervention|Cardiac SAE (hypertension)|1
5709958|NCT00129467|19677143|P1|Received Intervention|Cardiac SAE (hypertension)|1
5709959|NCT00129467|19677142|P2|Received Intervention|Death|1
5709960|NCT00129467|19677143|P1|Received Intervention|Death|1
5709961|NCT00129402|19677174|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
5709962|NCT00129402|19677175|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5709963|NCT00129402|19677176|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5709964|NCT00129402|19677177|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5709965|NCT00129402|19677178|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5709966|NCT00129402|19677179|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5709967|NCT00129402|19677180|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
5709968|NCT00129402|19677174|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
5709969|NCT00129402|19677175|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5709970|NCT00129402|19677176|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5709971|NCT00129402|19677177|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5709972|NCT00129402|19677178|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5709973|NCT00129402|19677179|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5709974|NCT00129402|19677180|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
5709975|NCT00129402|19677174|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
5709976|NCT00129402|19677175|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5709977|NCT00129402|19677176|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5709978|NCT00129402|19677177|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5709979|NCT00129402|19677178|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5709980|NCT00129402|19677179|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5709981|NCT00129402|19677180|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
5709982|NCT00129402|19677174|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
5709983|NCT00129402|19677175|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5709984|NCT00129402|19677176|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5709985|NCT00129402|19677177|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5709986|NCT00129402|19677178|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5709987|NCT00129402|19677179|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5709988|NCT00129402|19677180|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
5709989|NCT00129402|19677174|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5709990|NCT00129402|19677175|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
5709991|NCT00129402|19677176|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5709992|NCT00129402|19677177|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5709993|NCT00129402|19677178|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
5709994|NCT00129402|19677179|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5709995|NCT00129402|19677180|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
5709996|NCT00129402|19677174|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5709997|NCT00129402|19677175|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
5709998|NCT00129402|19677176|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5709999|NCT00129402|19677177|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5710000|NCT00129402|19677178|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
5710001|NCT00129402|19677179|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5710002|NCT00129402|19677180|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
5710003|NCT00129402|19677174|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5710004|NCT00129402|19677175|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5710005|NCT00129402|19677176|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5710006|NCT00129402|19677177|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5710007|NCT00129402|19677178|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
5710008|NCT00129402|19677179|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5710009|NCT00129402|19677180|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
5710010|NCT00129402|19677174|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5710011|NCT00129402|19677175|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
5710012|NCT00129402|19677176|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5710013|NCT00129402|19677177|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5710014|NCT00129402|19677178|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
5710015|NCT00129402|19677179|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5710016|NCT00129402|19677180|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
5710017|NCT00129402|19677174|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5710018|NCT00129402|19677175|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5710019|NCT00129402|19677176|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5710020|NCT00129402|19677177|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5710021|NCT00129402|19677178|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
5710022|NCT00129402|19677179|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5710023|NCT00129402|19677180|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
5710024|NCT00129402|19677174|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5710025|NCT00129402|19677175|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5710026|NCT00129402|19677176|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
5710027|NCT00129402|19677177|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5710028|NCT00129402|19677178|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
5710029|NCT00129402|19677179|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5710030|NCT00129402|19677180|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
5710031|NCT00129402|19677174|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5710032|NCT00129402|19677175|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5710033|NCT00129402|19677176|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5710034|NCT00129402|19677177|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
5710035|NCT00129402|19677178|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5710036|NCT00129402|19677179|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5710037|NCT00129402|19677180|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
5710038|NCT00129402|19677174|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5710039|NCT00129402|19677175|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
5710040|NCT00129402|19677176|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5710041|NCT00129402|19677177|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5710042|NCT00129402|19677178|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5710043|NCT00129402|19677179|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5710044|NCT00129402|19677180|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
5710045|NCT00129402|19677174|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
5710046|NCT00129402|19677175|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
5710047|NCT00129402|19677176|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
5710048|NCT00129402|19677177|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
5710049|NCT00129402|19677178|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
5710050|NCT00129402|19677179|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
5710051|NCT00129402|19677180|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
5710052|NCT00129389|19677199|P2|Overall Study|Crossed to the other arm|16
5710053|NCT00129389|19677200|P1|Overall Study|Crossed to the other arm|1
5710054|NCT00129389|19677199|P2|Overall Study|Not eligible|2
5710055|NCT00129389|19677200|P1|Overall Study|Not eligible|1
5710056|NCT00129389|19677199|P2|Overall Study|Relapse|0
5710057|NCT00129389|19677200|P1|Overall Study|Relapse|1
5710058|NCT00129389|19677199|P2|Overall Study|Withdrawal by Subject|23
5710059|NCT00129389|19677200|P1|Overall Study|Withdrawal by Subject|9
5710060|NCT00129389|19677199|P2|Overall Study|Protocol Violation|6
5710061|NCT00129389|19677200|P1|Overall Study|Protocol Violation|0
5710062|NCT00129389|19677199|P2|Overall Study|Physician Decision|4
5710063|NCT00129389|19677200|P1|Overall Study|Physician Decision|0
5710064|NCT00129389|19677199|P2|Overall Study|Lost to Follow-up|1
5710065|NCT00129389|19677200|P1|Overall Study|Lost to Follow-up|2
5710066|NCT00129389|19677199|P2|Overall Study|Death|1
5710067|NCT00129389|19677200|P1|Overall Study|Death|0
5710068|NCT00129389|19677199|P2|Overall Study|Adverse Event|87
5710069|NCT00129389|19677200|P1|Overall Study|Adverse Event|19
5710070|NCT00129376|19677208|P1|Overall Study|Lack of Efficacy|1
5710071|NCT00129376|19677208|P1|Overall Study|Adverse Event|1
5710072|NCT00129311|19677218|P2|Overall Study|Withdrawal by Subject|19
5710073|NCT00129311|19677219|P1|Overall Study|Withdrawal by Subject|12
5710074|NCT00129272|19677248|P2|Overall Study|Withdrawal by Subject|11
5710075|NCT00129272|19677249|P1|Overall Study|Withdrawal by Subject|5
5710076|NCT00129272|19677248|P2|Overall Study|Lost to Follow-up|11
5710077|NCT00129272|19677249|P1|Overall Study|Lost to Follow-up|12
5710078|NCT00129259|19677259|P2|Overall Study|Only available minimal phone assessments|1
5710079|NCT00129259|19677260|P1|Overall Study|Only available minimal phone assessments|0
5710080|NCT00129259|19677259|P2|Overall Study|Withdrawal by Subject|1
5710081|NCT00129259|19677260|P1|Overall Study|Withdrawal by Subject|2
5710082|NCT00129259|19677259|P2|Overall Study|Lost to Follow-up|1
5710083|NCT00129259|19677260|P1|Overall Study|Lost to Follow-up|1
5710084|NCT00129220|19677288|P3|Study Period III|Reason Not Specified|2
5710085|NCT00129220|19677289|P2|Study Period III|Reason Not Specified|0
5710086|NCT00129220|19677290|P1|Study Period III|Reason Not Specified|9
5710087|NCT00129220|19677288|P3|Study Period III|Sponsor Decision|0
5710088|NCT00129220|19677289|P2|Study Period III|Sponsor Decision|0
5710089|NCT00129220|19677290|P1|Study Period III|Sponsor Decision|1
5710090|NCT00129220|19677288|P3|Study Period III|Withdrawal by Subject|3
5710091|NCT00129220|19677289|P2|Study Period III|Withdrawal by Subject|0
5710092|NCT00129220|19677290|P1|Study Period III|Withdrawal by Subject|1
5710093|NCT00129220|19677288|P3|Study Period III|Protocol Violation|2
5710094|NCT00129220|19677289|P2|Study Period III|Protocol Violation|1
5710095|NCT00129220|19677290|P1|Study Period III|Protocol Violation|1
5710096|NCT00129220|19677288|P3|Study Period III|Adverse Event|3
5710097|NCT00129220|19677289|P2|Study Period III|Adverse Event|0
5710098|NCT00129220|19677290|P1|Study Period III|Adverse Event|1
5710099|NCT00129220|19677288|P3|Study Period II|Reason Not Specified|5
5710100|NCT00129220|19677289|P2|Study Period II|Reason Not Specified|0
5710101|NCT00129220|19677290|P1|Study Period II|Reason Not Specified|2
5710102|NCT00129220|19677288|P3|Study Period II|Withdrawal by Subject|4
5710103|NCT00129220|19677289|P2|Study Period II|Withdrawal by Subject|3
5710104|NCT00129220|19677290|P1|Study Period II|Withdrawal by Subject|1
5710105|NCT00129220|19677288|P3|Study Period II|Physician Decision|0
5710106|NCT00129220|19677289|P2|Study Period II|Physician Decision|1
5710107|NCT00129220|19677290|P1|Study Period II|Physician Decision|0
5710108|NCT00129220|19677288|P3|Study Period II|Protocol Violation|1
5710109|NCT00129220|19677289|P2|Study Period II|Protocol Violation|2
5710110|NCT00129220|19677290|P1|Study Period II|Protocol Violation|4
5710111|NCT00129220|19677288|P3|Study Period II|Entry Criteria Not Met|2
5710112|NCT00129220|19677289|P2|Study Period II|Entry Criteria Not Met|0
5710113|NCT00129220|19677290|P1|Study Period II|Entry Criteria Not Met|2
5710114|NCT00129220|19677288|P3|Study Period II|Lack of Efficacy|28
5710115|NCT00129220|19677289|P2|Study Period II|Lack of Efficacy|1
5710116|NCT00129220|19677290|P1|Study Period II|Lack of Efficacy|15
5710117|NCT00129220|19677288|P3|Study Period II|Adverse Event|7
5710118|NCT00129220|19677289|P2|Study Period II|Adverse Event|5
5710119|NCT00129220|19677290|P1|Study Period II|Adverse Event|9
5710120|NCT00129129|19677330|P5|Fourth Dose Phase|Protocol Violation|0
5710121|NCT00129129|19677331|P4|Fourth Dose Phase|Protocol Violation|1
5710122|NCT00129129|19677332|P3|Fourth Dose Phase|Protocol Violation|0
5710123|NCT00129129|19677333|P2|Fourth Dose Phase|Protocol Violation|0
5710124|NCT00129129|19677334|P1|Fourth Dose Phase|Protocol Violation|0
5710125|NCT00129129|19677330|P5|Fourth Dose Phase|Other|1
5710126|NCT00129129|19677331|P4|Fourth Dose Phase|Other|1
5710127|NCT00129129|19677332|P3|Fourth Dose Phase|Other|0
5710128|NCT00129129|19677333|P2|Fourth Dose Phase|Other|0
5710129|NCT00129129|19677334|P1|Fourth Dose Phase|Other|0
5710130|NCT00129129|19677330|P5|Fourth Dose Phase|Migration from study area|2
5710131|NCT00129129|19677331|P4|Fourth Dose Phase|Migration from study area|0
5710132|NCT00129129|19677332|P3|Fourth Dose Phase|Migration from study area|0
5710133|NCT00129129|19677333|P2|Fourth Dose Phase|Migration from study area|0
5710134|NCT00129129|19677334|P1|Fourth Dose Phase|Migration from study area|0
5710135|NCT00129129|19677330|P5|Fourth Dose Phase|Withdrawal by Subject|1
5710136|NCT00129129|19677331|P4|Fourth Dose Phase|Withdrawal by Subject|0
5710137|NCT00129129|19677332|P3|Fourth Dose Phase|Withdrawal by Subject|0
5710138|NCT00129129|19677333|P2|Fourth Dose Phase|Withdrawal by Subject|0
5710139|NCT00129129|19677334|P1|Fourth Dose Phase|Withdrawal by Subject|0
5710140|NCT00129129|19677330|P5|Fourth Dose Phase|Lost to Follow-up|2
5710141|NCT00129129|19677331|P4|Fourth Dose Phase|Lost to Follow-up|2
5710142|NCT00129129|19677332|P3|Fourth Dose Phase|Lost to Follow-up|0
5710143|NCT00129129|19677333|P2|Fourth Dose Phase|Lost to Follow-up|0
5710144|NCT00129129|19677334|P1|Fourth Dose Phase|Lost to Follow-up|4
5710145|NCT00129129|19677330|P5|Primary Phase|Other|0
5710146|NCT00129129|19677331|P4|Primary Phase|Other|0
5710147|NCT00129129|19677332|P3|Primary Phase|Other|0
5710148|NCT00129129|19677333|P2|Primary Phase|Other|5
5710149|NCT00129129|19677334|P1|Primary Phase|Other|2
5710150|NCT00129129|19677330|P5|Primary Phase|Lost to Follow-up|0
5710151|NCT00129129|19677331|P4|Primary Phase|Lost to Follow-up|0
5710152|NCT00129129|19677332|P3|Primary Phase|Lost to Follow-up|0
5710153|NCT00129129|19677333|P2|Primary Phase|Lost to Follow-up|6
5710154|NCT00129129|19677334|P1|Primary Phase|Lost to Follow-up|8
5710155|NCT00129129|19677330|P5|Primary Phase|Migration from study area|0
5710156|NCT00129129|19677331|P4|Primary Phase|Migration from study area|0
5710157|NCT00129129|19677332|P3|Primary Phase|Migration from study area|0
5710158|NCT00129129|19677333|P2|Primary Phase|Migration from study area|3
5710159|NCT00129129|19677334|P1|Primary Phase|Migration from study area|1
5710160|NCT00129129|19677330|P5|Primary Phase|Withdrawal by Subject|0
5710161|NCT00129129|19677331|P4|Primary Phase|Withdrawal by Subject|0
5710162|NCT00129129|19677332|P3|Primary Phase|Withdrawal by Subject|0
5710163|NCT00129129|19677333|P2|Primary Phase|Withdrawal by Subject|10
5710164|NCT00129129|19677334|P1|Primary Phase|Withdrawal by Subject|12
5710165|NCT00129129|19677330|P5|Primary Phase|Adverse Event|0
5710166|NCT00129129|19677331|P4|Primary Phase|Adverse Event|0
5710167|NCT00129129|19677332|P3|Primary Phase|Adverse Event|0
5710168|NCT00129129|19677333|P2|Primary Phase|Adverse Event|1
5710169|NCT00129129|19677334|P1|Primary Phase|Adverse Event|2
5710170|NCT00129116|19677541|P5|Booster Phase|Lost to Follow-up|1
5710171|NCT00129116|19677542|P4|Booster Phase|Lost to Follow-up|0
5710172|NCT00129116|19677543|P3|Booster Phase|Lost to Follow-up|0
5710173|NCT00129116|19677544|P2|Booster Phase|Lost to Follow-up|0
5710174|NCT00129116|19677545|P1|Booster Phase|Lost to Follow-up|2
5710175|NCT00129116|19677541|P5|Primary Phase|Other|0
5710176|NCT00129116|19677542|P4|Primary Phase|Other|0
5710177|NCT00129116|19677543|P3|Primary Phase|Other|1
5710178|NCT00129116|19677544|P2|Primary Phase|Other|0
5710179|NCT00129116|19677545|P1|Primary Phase|Other|0
5710180|NCT00129116|19677541|P5|Primary Phase|Withdrawal by Subject|0
5710181|NCT00129116|19677542|P4|Primary Phase|Withdrawal by Subject|0
5710182|NCT00129116|19677543|P3|Primary Phase|Withdrawal by Subject|0
5710183|NCT00129116|19677544|P2|Primary Phase|Withdrawal by Subject|1
5710184|NCT00129116|19677545|P1|Primary Phase|Withdrawal by Subject|0
5710185|NCT00129116|19677541|P5|Primary Phase|Adverse Event|0
5710186|NCT00129116|19677542|P4|Primary Phase|Adverse Event|0
5710187|NCT00129116|19677543|P3|Primary Phase|Adverse Event|0
5710188|NCT00129116|19677544|P2|Primary Phase|Adverse Event|1
5710189|NCT00129116|19677545|P1|Primary Phase|Adverse Event|1
5710190|NCT00129116|19677541|P5|Primary Phase|Protocol Violation|0
5710191|NCT00129116|19677542|P4|Primary Phase|Protocol Violation|0
5710192|NCT00129116|19677543|P3|Primary Phase|Protocol Violation|0
5710193|NCT00129116|19677544|P2|Primary Phase|Protocol Violation|1
5710194|NCT00129116|19677545|P1|Primary Phase|Protocol Violation|0
5710195|NCT00129116|19677541|P5|Primary Phase|Lost to Follow-up|1
5710196|NCT00129116|19677542|P4|Primary Phase|Lost to Follow-up|1
5710197|NCT00129116|19677543|P3|Primary Phase|Lost to Follow-up|0
5710198|NCT00129116|19677544|P2|Primary Phase|Lost to Follow-up|1
5710199|NCT00129116|19677545|P1|Primary Phase|Lost to Follow-up|1
5710200|NCT00128830|19677829|P1|Overall Study|Other|9
5710201|NCT00128830|19677829|P1|Overall Study|Discontinued or ineligible for study|2
5710202|NCT00128830|19677829|P1|Overall Study|Non-compliant|4
5710203|NCT00128830|19677829|P1|Overall Study|Reached a virologic endpoint|29
5710204|NCT00128830|19677829|P1|Overall Study|Lost to Follow-up|4
5710205|NCT00128830|19677829|P1|Overall Study|Withdrawal by Subject|14
5710206|NCT00128830|19677829|P1|Overall Study|Adverse Event|10
5710207|NCT00128661|19677871|P2|Overall Study|Other|8
5710208|NCT00128661|19677872|P1|Overall Study|Other|7
5710209|NCT00128661|19677871|P2|Overall Study|Withdrawal by Subject|232
5710210|NCT00128661|19677872|P1|Overall Study|Withdrawal by Subject|243
5710211|NCT00128661|19677871|P2|Overall Study|Lost to Follow-up|7
5710212|NCT00128661|19677872|P1|Overall Study|Lost to Follow-up|10
5710213|NCT00128661|19677871|P2|Overall Study|Adverse Event|11
5710214|NCT00128661|19677872|P1|Overall Study|Adverse Event|14
5710215|NCT00128492|19677918|P2|Overall Study|Pregnancy|1
5710216|NCT00128492|19677919|P1|Overall Study|Pregnancy|0
5710217|NCT00128492|19677918|P2|Overall Study|Withdrawal by Subject|5
5710218|NCT00128492|19677919|P1|Overall Study|Withdrawal by Subject|3
5710219|NCT00128492|19677918|P2|Overall Study|Personal or administrative|22
5710220|NCT00128492|19677919|P1|Overall Study|Personal or administrative|10
5710221|NCT00128492|19677918|P2|Overall Study|Noncompliance|5
5710222|NCT00128492|19677919|P1|Overall Study|Noncompliance|0
5710223|NCT00128492|19677918|P2|Overall Study|Lost to Follow-up|5
5710224|NCT00128492|19677919|P1|Overall Study|Lost to Follow-up|1
5710225|NCT00128492|19677918|P2|Overall Study|Death|0
5710226|NCT00128492|19677919|P1|Overall Study|Death|1
5710227|NCT00128492|19677918|P2|Overall Study|AE related to study|4
5710228|NCT00128492|19677919|P1|Overall Study|AE related to study|1
5710229|NCT00128492|19677918|P2|Overall Study|Study drug intolerance (AE)|8
5710230|NCT00128492|19677919|P1|Overall Study|Study drug intolerance (AE)|2
5710231|NCT00128492|19677918|P2|Overall Study|AE unrelated to study|9
5710232|NCT00128492|19677919|P1|Overall Study|AE unrelated to study|2
5710233|NCT00128206|19678076|P2|Overall Study|Adverse Event|2
5710234|NCT00128206|19678077|P1|Overall Study|Adverse Event|0
5710235|NCT00128206|19678076|P2|Overall Study|Lost to Follow-up|118
5710236|NCT00128206|19678077|P1|Overall Study|Lost to Follow-up|137
5710237|NCT00128102|19678373|P2|Overall Study|Protocol Violation|2
5710238|NCT00128102|19678374|P1|Overall Study|Protocol Violation|2
5710239|NCT00128102|19678373|P2|Overall Study|Withdrawal by Subject|11
5710240|NCT00128102|19678374|P1|Overall Study|Withdrawal by Subject|19
5710241|NCT00128102|19678373|P2|Overall Study|Physician Decision|3
5710242|NCT00128102|19678374|P1|Overall Study|Physician Decision|3
5710243|NCT00128102|19678373|P2|Overall Study|Death|13
5710244|NCT00128102|19678374|P1|Overall Study|Death|12
5710245|NCT00128102|19678373|P2|Overall Study|Adverse Event|11
5710246|NCT00128102|19678374|P1|Overall Study|Adverse Event|34
5710247|NCT00128102|19678373|P2|Overall Study|Progressive Disease|285
5710248|NCT00128102|19678374|P1|Overall Study|Progressive Disease|255
5710249|NCT00128102|19678373|P2|Overall Study|Other|1
5710250|NCT00128102|19678374|P1|Overall Study|Other|0
5710251|NCT00128102|19678373|P2|Overall Study|Site Discontinued|6
5710252|NCT00128102|19678374|P1|Overall Study|Site Discontinued|3
5710253|NCT00127933|19678400|P2|Overall Study|Randomized but not dosed|0
5710254|NCT00127933|19678401|P1|Overall Study|Randomized but not dosed|1
5710255|NCT00127855|19678422|P5|Primary Vaccination Course|Other|1
5710256|NCT00127855|19678423|P4|Primary Vaccination Course|Other|0
5710257|NCT00127855|19678424|P3|Primary Vaccination Course|Other|0
5710258|NCT00127855|19678425|P2|Primary Vaccination Course|Other|0
5710259|NCT00127855|19678426|P1|Primary Vaccination Course|Other|0
5710260|NCT00127855|19678422|P5|Primary Vaccination Course|Lost to Follow-up|2
5710261|NCT00127855|19678423|P4|Primary Vaccination Course|Lost to Follow-up|0
5710262|NCT00127855|19678424|P3|Primary Vaccination Course|Lost to Follow-up|1
5710263|NCT00127855|19678425|P2|Primary Vaccination Course|Lost to Follow-up|1
5710264|NCT00127855|19678426|P1|Primary Vaccination Course|Lost to Follow-up|1
5710265|NCT00127855|19678422|P5|Primary Vaccination Course|Withdrawal by Subject|1
5710266|NCT00127855|19678423|P4|Primary Vaccination Course|Withdrawal by Subject|0
5710267|NCT00127855|19678424|P3|Primary Vaccination Course|Withdrawal by Subject|0
5710268|NCT00127855|19678425|P2|Primary Vaccination Course|Withdrawal by Subject|0
5710269|NCT00127855|19678426|P1|Primary Vaccination Course|Withdrawal by Subject|1
5710270|NCT00127855|19678422|P5|Primary Vaccination Course|Adverse Event|0
5710271|NCT00127855|19678423|P4|Primary Vaccination Course|Adverse Event|0
5710272|NCT00127855|19678424|P3|Primary Vaccination Course|Adverse Event|1
5710273|NCT00127855|19678425|P2|Primary Vaccination Course|Adverse Event|0
5710274|NCT00127855|19678426|P1|Primary Vaccination Course|Adverse Event|0
5710275|NCT00127842|19678608|P1|Overall Study|Other|5
5710276|NCT00127842|19678608|P1|Overall Study|Protocol Violation|1
5710277|NCT00127842|19678608|P1|Overall Study|Noncompliance|2
5710278|NCT00127842|19678608|P1|Overall Study|Lack of Efficacy|12
5710279|NCT00127842|19678608|P1|Overall Study|Lost to Follow-up|1
5710280|NCT00127842|19678608|P1|Overall Study|Withdrawal by Subject|3
5710281|NCT00127842|19678608|P1|Overall Study|Adverse Event|15
5710282|NCT00127803|19678626|P4|Overall Study|Lost to Follow-up|1
5710283|NCT00127803|19678627|P3|Overall Study|Lost to Follow-up|0
5710284|NCT00127803|19678628|P2|Overall Study|Lost to Follow-up|0
5710285|NCT00127803|19678629|P1|Overall Study|Lost to Follow-up|0
5710286|NCT00127803|19678626|P4|Overall Study|Withdrawal by Subject|0
5710287|NCT00127803|19678627|P3|Overall Study|Withdrawal by Subject|0
5710288|NCT00127803|19678628|P2|Overall Study|Withdrawal by Subject|0
5710289|NCT00127803|19678629|P1|Overall Study|Withdrawal by Subject|1
5710290|NCT00127803|19678626|P4|Overall Study|Adverse Event|0
5710291|NCT00127803|19678627|P3|Overall Study|Adverse Event|0
5710292|NCT00127803|19678628|P2|Overall Study|Adverse Event|0
5710293|NCT00127803|19678629|P1|Overall Study|Adverse Event|2
5710294|NCT00127712|19678678|P2|Overall Study|Lack of GI access to continue|0
5710295|NCT00127712|19678679|P1|Overall Study|Lack of GI access to continue|2
5710296|NCT00127712|19678678|P2|Overall Study|Adverse Event|0
5710297|NCT00127712|19678679|P1|Overall Study|Adverse Event|3
5710298|NCT00127660|19678695|P4|Overall Study|Protocol Violation|0
5710299|NCT00127660|19678696|P3|Overall Study|Protocol Violation|5
5710300|NCT00127660|19678697|P2|Overall Study|Protocol Violation|3
5710301|NCT00127660|19678698|P1|Overall Study|Protocol Violation|3
5710302|NCT00127608|19678708|P1|Overall Study|VZV DNA negative|1
5710303|NCT00127413|19678752|P4|Overall Study|Lost to Follow-up|2
5710304|NCT00127413|19678753|P3|Overall Study|Lost to Follow-up|8
5710305|NCT00127413|19678754|P2|Overall Study|Lost to Follow-up|4
5710306|NCT00127413|19678755|P1|Overall Study|Lost to Follow-up|6
5710307|NCT00127205|19678796|P3|Overall Study|Progression|84
5710308|NCT00127205|19678797|P2|Overall Study|Progression|130
5710309|NCT00127205|19678798|P1|Overall Study|Progression|127
5710310|NCT00127205|19678796|P3|Overall Study|Under Review|6
5710311|NCT00127205|19678797|P2|Overall Study|Under Review|21
5710312|NCT00127205|19678798|P1|Overall Study|Under Review|13
5710313|NCT00127205|19678796|P3|Overall Study|Other-non protocol specified|77
5710314|NCT00127205|19678797|P2|Overall Study|Other-non protocol specified|129
5710315|NCT00127205|19678798|P1|Overall Study|Other-non protocol specified|141
5710316|NCT00127205|19678796|P3|Overall Study|Withdrawal by Subject|172
5710317|NCT00127205|19678797|P2|Overall Study|Withdrawal by Subject|308
5710318|NCT00127205|19678798|P1|Overall Study|Withdrawal by Subject|318
5710319|NCT00127205|19678796|P3|Overall Study|Death|6
5710320|NCT00127205|19678797|P2|Overall Study|Death|6
5710321|NCT00127205|19678798|P1|Overall Study|Death|8
5710322|NCT00127205|19678796|P3|Overall Study|Adverse Event|272
5710323|NCT00127205|19678797|P2|Overall Study|Adverse Event|386
5710324|NCT00127205|19678798|P1|Overall Study|Adverse Event|228
5710325|NCT00127192|19678820|P5|Overall Study|Adverse event in pre-treatment period|0
5710326|NCT00127192|19678821|P4|Overall Study|Adverse event in pre-treatment period|0
5710327|NCT00127192|19678822|P3|Overall Study|Adverse event in pre-treatment period|0
5710328|NCT00127192|19678823|P2|Overall Study|Adverse event in pre-treatment period|0
5710329|NCT00127192|19678824|P1|Overall Study|Adverse event in pre-treatment period|1
5710330|NCT00127192|19678820|P5|Overall Study|Withdrawal by Subject|3
5710331|NCT00127192|19678821|P4|Overall Study|Withdrawal by Subject|0
5710332|NCT00127192|19678822|P3|Overall Study|Withdrawal by Subject|1
5710333|NCT00127192|19678823|P2|Overall Study|Withdrawal by Subject|0
5710334|NCT00127192|19678824|P1|Overall Study|Withdrawal by Subject|0
5710335|NCT00127192|19678820|P5|Overall Study|Lack of Efficacy|2
5710336|NCT00127192|19678821|P4|Overall Study|Lack of Efficacy|0
5710337|NCT00127192|19678822|P3|Overall Study|Lack of Efficacy|0
5710338|NCT00127192|19678823|P2|Overall Study|Lack of Efficacy|0
5710339|NCT00127192|19678824|P1|Overall Study|Lack of Efficacy|2
5710340|NCT00127192|19678820|P5|Overall Study|Adverse Event|0
5710341|NCT00127192|19678821|P4|Overall Study|Adverse Event|1
5710342|NCT00127192|19678822|P3|Overall Study|Adverse Event|1
5710343|NCT00127192|19678823|P2|Overall Study|Adverse Event|1
5710344|NCT00127192|19678824|P1|Overall Study|Adverse Event|0
5710345|NCT00127166|19678848|P2|Period II|Patient did not perform Visit 6 exercise|0
5710346|NCT00127166|19678849|P1|Period II|Patient did not perform Visit 6 exercise|1
5710347|NCT00127166|19678848|P2|Period II|Withdrawal by Subject|0
5710348|NCT00127166|19678849|P1|Period II|Withdrawal by Subject|2
5710349|NCT00127166|19678848|P2|Washout Period|Patient did not meet inclusion criteria|1
5710350|NCT00127166|19678849|P1|Washout Period|Patient did not meet inclusion criteria|0
5710351|NCT00127166|19678848|P2|Period I|Patient did not meet inclusion criteria|0
5710352|NCT00127166|19678849|P1|Period I|Patient did not meet inclusion criteria|1
5710353|NCT00127166|19678848|P2|Period I|Withdrawal by Subject|0
5710354|NCT00127166|19678849|P1|Period I|Withdrawal by Subject|2
5710355|NCT00127166|19678848|P2|Period I|Protocol Violation|2
5710356|NCT00127166|19678849|P1|Period I|Protocol Violation|0
5710357|NCT00127101|19678869|P6|Continuation Phase|Withdrawal by Subject|1
5710358|NCT00127101|19678870|P5|Continuation Phase|Withdrawal by Subject|2
5710359|NCT00127101|19678871|P4|Continuation Phase|Withdrawal by Subject|0
5710360|NCT00127101|19678872|P3|Continuation Phase|Withdrawal by Subject|1
5710361|NCT00127101|19678873|P2|Continuation Phase|Withdrawal by Subject|0
5710362|NCT00127101|19678874|P1|Continuation Phase|Withdrawal by Subject|0
5710363|NCT00127101|19678869|P6|Continuation Phase|Lack of Efficacy|1
5710364|NCT00127101|19678870|P5|Continuation Phase|Lack of Efficacy|0
5710365|NCT00127101|19678871|P4|Continuation Phase|Lack of Efficacy|0
5710366|NCT00127101|19678872|P3|Continuation Phase|Lack of Efficacy|0
5710367|NCT00127101|19678873|P2|Continuation Phase|Lack of Efficacy|0
5710368|NCT00127101|19678874|P1|Continuation Phase|Lack of Efficacy|0
5710369|NCT00127101|19678869|P6|Continuation Phase|Adverse Event|1
5710370|NCT00127101|19678870|P5|Continuation Phase|Adverse Event|1
5710371|NCT00127101|19678871|P4|Continuation Phase|Adverse Event|0
5710372|NCT00127101|19678872|P3|Continuation Phase|Adverse Event|0
5710373|NCT00127101|19678873|P2|Continuation Phase|Adverse Event|0
5710374|NCT00127101|19678874|P1|Continuation Phase|Adverse Event|0
5710375|NCT00127101|19678869|P6|Base Protocol|Withdrawal by Subject|1
5710376|NCT00127101|19678870|P5|Base Protocol|Withdrawal by Subject|0
5710377|NCT00127101|19678871|P4|Base Protocol|Withdrawal by Subject|0
5710378|NCT00127101|19678872|P3|Base Protocol|Withdrawal by Subject|1
5710379|NCT00127101|19678873|P2|Base Protocol|Withdrawal by Subject|2
5710380|NCT00127101|19678874|P1|Base Protocol|Withdrawal by Subject|1
5710381|NCT00127101|19678869|P6|Base Protocol|Lack of Efficacy|0
5710382|NCT00127101|19678870|P5|Base Protocol|Lack of Efficacy|2
5710383|NCT00127101|19678871|P4|Base Protocol|Lack of Efficacy|0
5710384|NCT00127101|19678872|P3|Base Protocol|Lack of Efficacy|0
5710385|NCT00127101|19678873|P2|Base Protocol|Lack of Efficacy|0
5710386|NCT00127101|19678874|P1|Base Protocol|Lack of Efficacy|1
5710387|NCT00127101|19678869|P6|Base Protocol|Adverse Event|0
5710388|NCT00127101|19678870|P5|Base Protocol|Adverse Event|0
5710389|NCT00127101|19678871|P4|Base Protocol|Adverse Event|0
5710390|NCT00127101|19678872|P3|Base Protocol|Adverse Event|1
5710391|NCT00127101|19678873|P2|Base Protocol|Adverse Event|2
5710392|NCT00127101|19678874|P1|Base Protocol|Adverse Event|0
5710393|NCT00127036|19678909|P2|Overall Study|Screen Failure|0
5710394|NCT00127036|19678910|P1|Overall Study|Screen Failure|2
5710395|NCT00127036|19678909|P2|Overall Study|Insufficient Data for Analysis|11
5710396|NCT00127036|19678910|P1|Overall Study|Insufficient Data for Analysis|6
5710397|NCT00126776|19678922|P2|Overall Study|follow up complete on all patients|0
5710398|NCT00126776|19678923|P1|Overall Study|follow up complete on all patients|0
5710399|NCT00126659|19678972|P3|Overall Study|Adverse Event|2
5710400|NCT00126659|19678973|P2|Overall Study|Adverse Event|0
5710401|NCT00126659|19678974|P1|Overall Study|Adverse Event|0
5710402|NCT00126594|19678982|P2|Overall Study|Disease Progression|24
5710403|NCT00126594|19678983|P1|Overall Study|Disease Progression|29
5710404|NCT00126594|19678982|P2|Overall Study|Non-compliance|1
5710405|NCT00126594|19678983|P1|Overall Study|Non-compliance|0
5710406|NCT00126594|19678982|P2|Overall Study|Adverse Event|5
5710407|NCT00126594|19678983|P1|Overall Study|Adverse Event|7
5710408|NCT00126594|19678982|P2|Overall Study|Physician Decision|3
5710409|NCT00126594|19678983|P1|Overall Study|Physician Decision|1
5710410|NCT00126594|19678982|P2|Overall Study|Withdrawal by Subject|4
5710411|NCT00126594|19678983|P1|Overall Study|Withdrawal by Subject|0
5710412|NCT00126594|19678982|P2|Overall Study|Ineligible|0
5710413|NCT00126594|19678983|P1|Overall Study|Ineligible|2
5710414|NCT00126581|19679000|P2|Overall Study|Other illness/MD discretion|4
5710415|NCT00126581|19679001|P1|Overall Study|Other illness/MD discretion|3
5710416|NCT00126581|19679000|P2|Overall Study|Alternative therapy|3
5710417|NCT00126581|19679001|P1|Overall Study|Alternative therapy|3
5710418|NCT00126581|19679000|P2|Overall Study|Withdrawal by Subject|4
5710419|NCT00126581|19679001|P1|Overall Study|Withdrawal by Subject|1
5710420|NCT00126581|19679000|P2|Overall Study|Death|2
5710421|NCT00126581|19679001|P1|Overall Study|Death|3
5710422|NCT00126581|19679000|P2|Overall Study|Adverse Event|7
5710423|NCT00126581|19679001|P1|Overall Study|Adverse Event|3
5710424|NCT00126568|19679021|P1|Overall Study|Death|2
5710425|NCT00126555|19679028|P1|Overall Study|Progressive Disease|3
5710426|NCT00126555|19679028|P1|Overall Study|Adverse Event|2
5710427|NCT00126555|19679028|P1|Overall Study|Withdrawal by Subject|1
5710428|NCT00126503|19679050|P2|Overall Study|Physician Decision|1
5710429|NCT00126503|19679051|P1|Overall Study|Physician Decision|2
5710430|NCT00126503|19679050|P2|Overall Study|non-compliant|0
5710431|NCT00126503|19679051|P1|Overall Study|non-compliant|1
5710432|NCT00126503|19679050|P2|Overall Study|Adverse Event|3
5710433|NCT00126503|19679051|P1|Overall Study|Adverse Event|13
5710434|NCT00126503|19679050|P2|Overall Study|Death|0
5710435|NCT00126503|19679051|P1|Overall Study|Death|3
5710436|NCT00126503|19679050|P2|Overall Study|other complicating disease|1
5710437|NCT00126503|19679051|P1|Overall Study|other complicating disease|4
5710438|NCT00126503|19679050|P2|Overall Study|alternative therapy|1
5710439|NCT00126503|19679051|P1|Overall Study|alternative therapy|1
5710440|NCT00126503|19679050|P2|Overall Study|Withdrawal by Subject|1
5710441|NCT00126503|19679051|P1|Overall Study|Withdrawal by Subject|0
5710442|NCT00126503|19679050|P2|Overall Study|disease progression|14
5710443|NCT00126503|19679051|P1|Overall Study|disease progression|23
5710444|NCT00126490|19679063|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
5710445|NCT00126438|19679073|P2|Overall Study|Withdrawal by Subject|2
5710446|NCT00126438|19679074|P1|Overall Study|Withdrawal by Subject|3
5710447|NCT00126438|19679073|P2|Overall Study|Protocol Violation|8
5710448|NCT00126438|19679074|P1|Overall Study|Protocol Violation|8
5710449|NCT00126438|19679073|P2|Overall Study|Lost to Follow-up|0
5710450|NCT00126438|19679074|P1|Overall Study|Lost to Follow-up|22
5710451|NCT00126438|19679073|P2|Overall Study|Withdrawal due to adverse event|0
5710452|NCT00126438|19679074|P1|Overall Study|Withdrawal due to adverse event|1
5710453|NCT00126425|19679082|P2|Overall Study|Other|0
5710454|NCT00126425|19679083|P1|Overall Study|Other|5
5710455|NCT00126425|19679082|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
5710456|NCT00126425|19679083|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
5710457|NCT00126425|19679082|P2|Overall Study|Adverse Event|0
5710458|NCT00126425|19679083|P1|Overall Study|Adverse Event|1
5710459|NCT00126425|19679082|P2|Overall Study|Protocol Violation|6
5710460|NCT00126425|19679083|P1|Overall Study|Protocol Violation|9
5710461|NCT00126425|19679082|P2|Overall Study|Lost to Follow-up|4
5710462|NCT00126425|19679083|P1|Overall Study|Lost to Follow-up|8
5710463|NCT00126425|19679082|P2|Overall Study|Withdrawal by Subject|1
5710464|NCT00126425|19679083|P1|Overall Study|Withdrawal by Subject|17
5710465|NCT00126191|19679091|P2|Overall Study|Death|1
5710466|NCT00126191|19679092|P1|Overall Study|Death|0
5710467|NCT00126191|19679091|P2|Overall Study|Physician Decision|1
5710468|NCT00126191|19679092|P1|Overall Study|Physician Decision|0
5710469|NCT00126126|19679102|P2|Overall Study|Lost to Follow-up|2
5710470|NCT00126126|19679103|P1|Overall Study|Lost to Follow-up|0
5710471|NCT00125853|19679142|P2|Wash-out (4 Weeks)|Lost to Follow-up|7
5710472|NCT00125853|19679143|P1|Wash-out (4 Weeks)|Lost to Follow-up|3
5710473|NCT00125359|19679257|P1|Overall Study|Physician Decision|14
5710474|NCT00125359|19679257|P1|Overall Study|Adverse Event|5
5710475|NCT00125359|19679257|P1|Overall Study|Death|4
5710476|NCT00125268|19679266|P2|Overall Study|Withdrawal by Subject|1
5710477|NCT00125268|19679267|P1|Overall Study|Withdrawal by Subject|1
5710478|NCT00125242|19679279|P2|Overall Study|did not qualify|2
5710479|NCT00125242|19679280|P1|Overall Study|did not qualify|7
5710480|NCT00125190|19679285|P1|Overall Study|Lost to Follow-up|4
5710481|NCT00125190|19679285|P1|Overall Study|Other|1
5710482|NCT00125190|19679285|P1|Overall Study|Adverse Event|1
5710483|NCT00125190|19679285|P1|Overall Study|Non-compliance|2
5710484|NCT00125190|19679285|P1|Overall Study|Subject/Parent Decision|7
5710485|NCT00125164|19679301|P4|Overall Study|Withdrawal by Subject|1
5710486|NCT00125164|19679302|P3|Overall Study|Withdrawal by Subject|1
5710487|NCT00125164|19679303|P2|Overall Study|Withdrawal by Subject|0
5710488|NCT00125164|19679304|P1|Overall Study|Withdrawal by Subject|2
5710489|NCT00125164|19679301|P4|Overall Study|Lost to Follow-up|1
5710490|NCT00125164|19679302|P3|Overall Study|Lost to Follow-up|1
5710491|NCT00125164|19679303|P2|Overall Study|Lost to Follow-up|0
5710492|NCT00125164|19679304|P1|Overall Study|Lost to Follow-up|0
5710493|NCT00125164|19679301|P4|Overall Study|Adverse Event|4
5710494|NCT00125164|19679302|P3|Overall Study|Adverse Event|2
5710495|NCT00125164|19679303|P2|Overall Study|Adverse Event|0
5710496|NCT00125164|19679304|P1|Overall Study|Adverse Event|0
5710497|NCT00125138|19679358|P4|Overall Study|Sponsor decision-pt moved to assist care|1
5710498|NCT00125138|19679359|P3|Overall Study|Sponsor decision-pt moved to assist care|0
5710499|NCT00125138|19679360|P2|Overall Study|Sponsor decision-pt moved to assist care|0
5710500|NCT00125138|19679361|P1|Overall Study|Sponsor decision-pt moved to assist care|0
5710501|NCT00125138|19679358|P4|Overall Study|Lack of Efficacy|1
5710502|NCT00125138|19679359|P3|Overall Study|Lack of Efficacy|0
5710503|NCT00125138|19679360|P2|Overall Study|Lack of Efficacy|0
5710504|NCT00125138|19679361|P1|Overall Study|Lack of Efficacy|0
5710505|NCT00125138|19679358|P4|Overall Study|Withdrawal by Subject|1
5710506|NCT00125138|19679359|P3|Overall Study|Withdrawal by Subject|1
5710507|NCT00125138|19679360|P2|Overall Study|Withdrawal by Subject|3
5710508|NCT00125138|19679361|P1|Overall Study|Withdrawal by Subject|2
5710509|NCT00125138|19679358|P4|Overall Study|Adverse Event|2
5710510|NCT00125138|19679359|P3|Overall Study|Adverse Event|3
5710511|NCT00125138|19679360|P2|Overall Study|Adverse Event|0
5710512|NCT00125138|19679361|P1|Overall Study|Adverse Event|1
5710513|NCT00124982|19679410|P3|Long-term Period|Neurologist Recommendation|1
5710514|NCT00124982|19679411|P2|Long-term Period|Neurologist Recommendation|0
5710515|NCT00124982|19679412|P1|Long-term Period|Neurologist Recommendation|0
5710516|NCT00124982|19679410|P3|Long-term Period|Administrative Reason by Sponsor|1
5710517|NCT00124982|19679411|P2|Long-term Period|Administrative Reason by Sponsor|0
5710518|NCT00124982|19679412|P1|Long-term Period|Administrative Reason by Sponsor|0
5710519|NCT00124982|19679410|P3|Long-term Period|Poor/Non-compliance|2
5710520|NCT00124982|19679411|P2|Long-term Period|Poor/Non-compliance|0
5710521|NCT00124982|19679412|P1|Long-term Period|Poor/Non-compliance|0
5710522|NCT00124982|19679410|P3|Long-term Period|Pregnancy|1
5710523|NCT00124982|19679411|P2|Long-term Period|Pregnancy|0
5710524|NCT00124982|19679412|P1|Long-term Period|Pregnancy|0
5710525|NCT00124982|19679410|P3|Long-term Period|Withdrawal by Subject|16
5710526|NCT00124982|19679411|P2|Long-term Period|Withdrawal by Subject|0
5710527|NCT00124982|19679412|P1|Long-term Period|Withdrawal by Subject|0
5710528|NCT00124982|19679410|P3|Long-term Period|Lost to Follow-up|4
5710529|NCT00124982|19679411|P2|Long-term Period|Lost to Follow-up|0
5710530|NCT00124982|19679412|P1|Long-term Period|Lost to Follow-up|0
5710531|NCT00124982|19679410|P3|Long-term Period|Lack of Efficacy|46
5710532|NCT00124982|19679411|P2|Long-term Period|Lack of Efficacy|0
5710533|NCT00124982|19679412|P1|Long-term Period|Lack of Efficacy|0
5710534|NCT00124982|19679410|P3|Long-term Period|Adverse Event|17
5710535|NCT00124982|19679411|P2|Long-term Period|Adverse Event|0
5710536|NCT00124982|19679412|P1|Long-term Period|Adverse Event|0
5710537|NCT00124982|19679410|P3|Long-term Period|Death|1
5710538|NCT00124982|19679411|P2|Long-term Period|Death|0
5710539|NCT00124982|19679412|P1|Long-term Period|Death|0
5710540|NCT00124982|19679410|P3|Short-term Period|Participant Had Lymphopenia|0
5710541|NCT00124982|19679411|P2|Short-term Period|Participant Had Lymphopenia|0
5710542|NCT00124982|19679412|P1|Short-term Period|Participant Had Lymphopenia|1
5710543|NCT00124982|19679410|P3|Short-term Period|Investigator Decision-No Specific AE|0
5710544|NCT00124982|19679411|P2|Short-term Period|Investigator Decision-No Specific AE|0
5710545|NCT00124982|19679412|P1|Short-term Period|Investigator Decision-No Specific AE|1
5710546|NCT00124982|19679410|P3|Short-term Period|Participant Chose Own Doctor|0
5710547|NCT00124982|19679411|P2|Short-term Period|Participant Chose Own Doctor|1
5710548|NCT00124982|19679412|P1|Short-term Period|Participant Chose Own Doctor|0
5710549|NCT00124982|19679410|P3|Short-term Period|Participant Decision|0
5710550|NCT00124982|19679411|P2|Short-term Period|Participant Decision|0
5710551|NCT00124982|19679412|P1|Short-term Period|Participant Decision|1
5710552|NCT00124982|19679410|P3|Short-term Period|No Longer Meets Study Criteria|0
5710553|NCT00124982|19679411|P2|Short-term Period|No Longer Meets Study Criteria|2
5710554|NCT00124982|19679412|P1|Short-term Period|No Longer Meets Study Criteria|1
5710555|NCT00124982|19679410|P3|Short-term Period|Poor/Non-compliance|0
5710556|NCT00124982|19679411|P2|Short-term Period|Poor/Non-compliance|1
5710557|NCT00124982|19679412|P1|Short-term Period|Poor/Non-compliance|3
5710558|NCT00124982|19679410|P3|Short-term Period|Withdrawal of Consent|0
5710559|NCT00124982|19679411|P2|Short-term Period|Withdrawal of Consent|9
5710560|NCT00124982|19679412|P1|Short-term Period|Withdrawal of Consent|7
5710561|NCT00124982|19679410|P3|Short-term Period|Lost to Follow-up|0
5710562|NCT00124982|19679411|P2|Short-term Period|Lost to Follow-up|5
5710563|NCT00124982|19679412|P1|Short-term Period|Lost to Follow-up|8
5710564|NCT00124982|19679410|P3|Short-term Period|Lack of Efficacy|0
5710565|NCT00124982|19679411|P2|Short-term Period|Lack of Efficacy|73
5710566|NCT00124982|19679412|P1|Short-term Period|Lack of Efficacy|32
5710567|NCT00124982|19679410|P3|Short-term Period|Adverse Event|0
5710568|NCT00124982|19679411|P2|Short-term Period|Adverse Event|22
5710569|NCT00124982|19679412|P1|Short-term Period|Adverse Event|17
5710570|NCT00124982|19679410|P3|Short-term Period|Death|0
5710571|NCT00124982|19679411|P2|Short-term Period|Death|1
5710572|NCT00124982|19679412|P1|Short-term Period|Death|1
5710573|NCT00124943|19679494|P4|Phase II|Withdrawal by Subject|2
5710574|NCT00124943|19679495|P3|Phase II|Withdrawal by Subject|0
5710575|NCT00124943|19679496|P2|Phase II|Withdrawal by Subject|0
5710576|NCT00124943|19679497|P1|Phase II|Withdrawal by Subject|0
5710577|NCT00124943|19679494|P4|Phase II|Lost to Follow-up|1
5710578|NCT00124943|19679495|P3|Phase II|Lost to Follow-up|0
5710579|NCT00124943|19679496|P2|Phase II|Lost to Follow-up|0
5710580|NCT00124943|19679497|P1|Phase II|Lost to Follow-up|0
5710581|NCT00124943|19679494|P4|Phase II|Protocol Violation|1
5710582|NCT00124943|19679495|P3|Phase II|Protocol Violation|0
5710583|NCT00124943|19679496|P2|Phase II|Protocol Violation|0
5710584|NCT00124943|19679497|P1|Phase II|Protocol Violation|0
5710585|NCT00124943|19679494|P4|Phase II|Adverse Event|1
5710586|NCT00124943|19679495|P3|Phase II|Adverse Event|0
5710587|NCT00124943|19679496|P2|Phase II|Adverse Event|2
5710588|NCT00124943|19679497|P1|Phase II|Adverse Event|0
5710589|NCT00124917|19679535|P1|Overall Study|Physician Decision|3
5710590|NCT00124748|19679545|P2|Overall Study|Death|3
5710591|NCT00124748|19679546|P1|Overall Study|Death|1
5710592|NCT00124748|19679545|P2|Overall Study|Administrative Problem(Study Terminated)|174
5710593|NCT00124748|19679546|P1|Overall Study|Administrative Problem(Study Terminated)|101
5710594|NCT00124748|19679545|P2|Overall Study|Lost to Follow-up|7
5710595|NCT00124748|19679546|P1|Overall Study|Lost to Follow-up|2
5710596|NCT00124748|19679545|P2|Overall Study|Withdrawal by Subject|15
5710597|NCT00124748|19679546|P1|Overall Study|Withdrawal by Subject|5
5710598|NCT00124748|19679545|P2|Overall Study|Protocol Violation|1
5710599|NCT00124748|19679546|P1|Overall Study|Protocol Violation|3
5710600|NCT00124748|19679545|P2|Overall Study|No longer requires study drug|1
5710601|NCT00124748|19679546|P1|Overall Study|No longer requires study drug|1
5710602|NCT00124748|19679545|P2|Overall Study|Lack of Efficacy|41
5710603|NCT00124748|19679546|P1|Overall Study|Lack of Efficacy|20
5710604|NCT00124748|19679545|P2|Overall Study|Abnormal Procedure|1
5710605|NCT00124748|19679546|P1|Overall Study|Abnormal Procedure|0
5710606|NCT00124748|19679545|P2|Overall Study|Abnormal laboratory Value|2
5710607|NCT00124748|19679546|P1|Overall Study|Abnormal laboratory Value|2
5710608|NCT00124748|19679545|P2|Overall Study|Adverse Event|39
5710609|NCT00124748|19679546|P1|Overall Study|Adverse Event|8
5710610|NCT00124709|19679653|P2|Overall Study|Lost to Follow-up|120
5710611|NCT00124709|19679654|P1|Overall Study|Lost to Follow-up|114
5710612|NCT00124709|19679653|P2|Overall Study|Withdrawal by Subject|136
5710613|NCT00124709|19679654|P1|Overall Study|Withdrawal by Subject|127
5710614|NCT00124709|19679653|P2|Overall Study|Protocol Violation|5
5710615|NCT00124709|19679654|P1|Overall Study|Protocol Violation|3
5710616|NCT00124709|19679653|P2|Overall Study|Lack of Efficacy|10
5710617|NCT00124709|19679654|P1|Overall Study|Lack of Efficacy|5
5710618|NCT00124709|19679653|P2|Overall Study|Adverse Event|0
5710619|NCT00124709|19679654|P1|Overall Study|Adverse Event|3
5710620|NCT00124709|19679653|P2|Overall Study|Randomized but did not take medication|1
5710621|NCT00124709|19679654|P1|Overall Study|Randomized but did not take medication|3
5710622|NCT00124657|19679671|P3|Overall Study|Intercurrent illness|0
5710623|NCT00124657|19679672|P2|Overall Study|Intercurrent illness|0
5710624|NCT00124657|19679673|P1|Overall Study|Intercurrent illness|1
5710625|NCT00124657|19679671|P3|Overall Study|Progressive disease|27
5710626|NCT00124657|19679672|P2|Overall Study|Progressive disease|5
5710627|NCT00124657|19679673|P1|Overall Study|Progressive disease|14
5710628|NCT00124657|19679671|P3|Overall Study|Non-compliance|4
5710629|NCT00124657|19679672|P2|Overall Study|Non-compliance|0
5710630|NCT00124657|19679673|P1|Overall Study|Non-compliance|1
5710631|NCT00124657|19679671|P3|Overall Study|Toxicity|1
5710632|NCT00124657|19679672|P2|Overall Study|Toxicity|0
5710633|NCT00124657|19679673|P1|Overall Study|Toxicity|0
5710634|NCT00124618|19679708|P1|Overall Study|Ineligible|1
5710635|NCT00124462|19679723|P2|Overall Study|Device fitting, n=2, other hlth issues|1
5710636|NCT00124462|19679724|P1|Overall Study|Device fitting, n=2, other hlth issues|1
5710637|NCT00124462|19679723|P2|Overall Study|Withdrawal by Subject|5
5710638|NCT00124462|19679724|P1|Overall Study|Withdrawal by Subject|4
5710639|NCT00124462|19679723|P2|Overall Study|Physician Decision|4
5710640|NCT00124462|19679724|P1|Overall Study|Physician Decision|3
5710641|NCT00124462|19679723|P2|Overall Study|Lost to Follow-up|3
5710642|NCT00124462|19679724|P1|Overall Study|Lost to Follow-up|3
5710643|NCT00124449|19679734|P2|18-Month Untreated Observation Period|Relocated|0
5710644|NCT00124449|19679735|P1|18-Month Untreated Observation Period|Relocated|1
5710645|NCT00124449|19679734|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
5710646|NCT00124449|19679735|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
5710647|NCT00124449|19679734|P2|18-Month Untreated Observation Period|Pregnancy|0
5710648|NCT00124449|19679735|P1|18-Month Untreated Observation Period|Pregnancy|1
5710649|NCT00124449|19679734|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
5710650|NCT00124449|19679735|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
5710651|NCT00124449|19679734|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
5710652|NCT00124449|19679735|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
5710653|NCT00124449|19679734|P2|18-Month Untreated Observation Period|Adverse Event|1
5710654|NCT00124449|19679735|P1|18-Month Untreated Observation Period|Adverse Event|0
5710655|NCT00124449|19679734|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
5710656|NCT00124449|19679735|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
5710657|NCT00124449|19679734|P2|6-month Double-Blind Treatment Period|Sponsor request|1
5710658|NCT00124449|19679735|P1|6-month Double-Blind Treatment Period|Sponsor request|0
5710659|NCT00124449|19679734|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
5710660|NCT00124449|19679735|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
5710661|NCT00124449|19679734|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
5710662|NCT00124449|19679735|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
5710663|NCT00124449|19679734|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
5710664|NCT00124449|19679735|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
5710665|NCT00124449|19679734|P2|6-month Double-Blind Treatment Period|Adverse Event|0
5710666|NCT00124449|19679735|P1|6-month Double-Blind Treatment Period|Adverse Event|1
5710667|NCT00124072|19679789|P4|Overall Study|Death|480
5710668|NCT00124072|19679790|P3|Overall Study|Death|471
5710669|NCT00124072|19679791|P2|Overall Study|Death|484
5710670|NCT00124072|19679792|P1|Overall Study|Death|499
5710671|NCT00124072|19679789|P4|Overall Study|Lost to Follow-up for Morbidity|18
5710672|NCT00124072|19679790|P3|Overall Study|Lost to Follow-up for Morbidity|19
5710673|NCT00124072|19679791|P2|Overall Study|Lost to Follow-up for Morbidity|25
5710674|NCT00124072|19679792|P1|Overall Study|Lost to Follow-up for Morbidity|15
5710675|NCT00124072|19679789|P4|Overall Study|Lost to Follow-up for Mortality|2
5710676|NCT00124072|19679790|P3|Overall Study|Lost to Follow-up for Mortality|2
5710677|NCT00124072|19679791|P2|Overall Study|Lost to Follow-up for Mortality|3
5710678|NCT00124072|19679792|P1|Overall Study|Lost to Follow-up for Mortality|0
5710679|NCT00124020|19679804|P2|Overall Study|Transfer to another hospital|0
5710680|NCT00124020|19679805|P1|Overall Study|Transfer to another hospital|2
5710681|NCT00124020|19679804|P2|Overall Study|Other|1
5710682|NCT00124020|19679805|P1|Overall Study|Other|1
5710683|NCT00124020|19679804|P2|Overall Study|Lost to Follow-up|8
5710684|NCT00124020|19679805|P1|Overall Study|Lost to Follow-up|5
5710685|NCT00124020|19679804|P2|Overall Study|Withdrawal by Subject|11
5710686|NCT00124020|19679805|P1|Overall Study|Withdrawal by Subject|13
5710687|NCT00124020|19679804|P2|Overall Study|Death|71
5710688|NCT00124020|19679805|P1|Overall Study|Death|67
5710689|NCT00123955|19679813|P2|Overall Study|Death|1
5710690|NCT00123955|19679814|P1|Overall Study|Death|0
5710691|NCT00123955|19679813|P2|Overall Study|Withdrawal by Subject|3
5710692|NCT00123955|19679814|P1|Overall Study|Withdrawal by Subject|4
5710693|NCT00123955|19679813|P2|Overall Study|Adverse Event|0
5710694|NCT00123955|19679814|P1|Overall Study|Adverse Event|1
5710695|NCT00123734|19679826|P1|Overall Study|Withdrawal by Subject|1
5710696|NCT00123734|19679826|P1|Overall Study|Dropout|1
5710697|NCT00123734|19679826|P1|Overall Study|Lost to Follow-up|3
5710698|NCT00123734|19679826|P1|Overall Study|Death|3
5710699|NCT00123487|19679911|P2|Treated With Study Drug|Unknown (case report form lost)|1
5710700|NCT00123487|19679912|P1|Treated With Study Drug|Unknown (case report form lost)|0
5710701|NCT00123487|19679911|P2|Treated With Study Drug|Withdrawal by Subject|13
5710702|NCT00123487|19679912|P1|Treated With Study Drug|Withdrawal by Subject|11
5710703|NCT00123487|19679911|P2|Treated With Study Drug|Study Drug Toxicity|80
5710704|NCT00123487|19679912|P1|Treated With Study Drug|Study Drug Toxicity|62
5710705|NCT00123487|19679911|P2|Treated With Study Drug|Other|58
5710706|NCT00123487|19679912|P1|Treated With Study Drug|Other|59
5710707|NCT00123487|19679911|P2|Treated With Study Drug|Physician Decision|9
5710708|NCT00123487|19679912|P1|Treated With Study Drug|Physician Decision|8
5710709|NCT00123487|19679911|P2|Treated With Study Drug|Disease Progression|122
5710710|NCT00123487|19679912|P1|Treated With Study Drug|Disease Progression|141
5710711|NCT00123487|19679911|P2|Treated With Study Drug|Adverse Event|22
5710712|NCT00123487|19679912|P1|Treated With Study Drug|Adverse Event|23
5710713|NCT00123487|19679911|P2|Randomized|SAE prior to starting treatment|0
5710714|NCT00123487|19679912|P1|Randomized|SAE prior to starting treatment|1
5710715|NCT00123487|19679911|P2|Randomized|Death prior to starting treatment|1
5710716|NCT00123487|19679912|P1|Randomized|Death prior to starting treatment|0
5710717|NCT00123474|19679956|P4|As Treated at Study Closure|Withdrawal by Subject|16
5710718|NCT00123474|19679957|P3|As Treated at Study Closure|Withdrawal by Subject|18
5710719|NCT00123474|19679958|P2|As Treated at Study Closure|Withdrawal by Subject|19
5710720|NCT00123474|19679959|P1|As Treated at Study Closure|Withdrawal by Subject|14
5710721|NCT00123474|19679956|P4|As Treated at Study Closure|Study Drug Toxicity|51
5710722|NCT00123474|19679957|P3|As Treated at Study Closure|Study Drug Toxicity|45
5710723|NCT00123474|19679958|P2|As Treated at Study Closure|Study Drug Toxicity|45
5710724|NCT00123474|19679959|P1|As Treated at Study Closure|Study Drug Toxicity|39
5710725|NCT00123474|19679956|P4|As Treated at Study Closure|non-specified|60
5710726|NCT00123474|19679957|P3|As Treated at Study Closure|non-specified|57
5710727|NCT00123474|19679958|P2|As Treated at Study Closure|non-specified|47
5710728|NCT00123474|19679959|P1|As Treated at Study Closure|non-specified|54
5710729|NCT00123474|19679956|P4|As Treated at Study Closure|Investigator Request|5
5710730|NCT00123474|19679957|P3|As Treated at Study Closure|Investigator Request|7
5710731|NCT00123474|19679958|P2|As Treated at Study Closure|Investigator Request|6
5710732|NCT00123474|19679959|P1|As Treated at Study Closure|Investigator Request|12
5710733|NCT00123474|19679956|P4|As Treated at Study Closure|Disease Progression|27
5710734|NCT00123474|19679957|P3|As Treated at Study Closure|Disease Progression|29
5710735|NCT00123474|19679958|P2|As Treated at Study Closure|Disease Progression|42
5710736|NCT00123474|19679959|P1|As Treated at Study Closure|Disease Progression|35
5710737|NCT00123474|19679956|P4|As Treated at Study Closure|Adverse Event|8
5710738|NCT00123474|19679957|P3|As Treated at Study Closure|Adverse Event|10
5710739|NCT00123474|19679958|P2|As Treated at Study Closure|Adverse Event|4
5710740|NCT00123474|19679959|P1|As Treated at Study Closure|Adverse Event|10
5710741|NCT00123474|19679956|P4|As Treated at Study Closure|not reported when site closed|0
5710742|NCT00123474|19679957|P3|As Treated at Study Closure|not reported when site closed|1
5710743|NCT00123474|19679958|P2|As Treated at Study Closure|not reported when site closed|0
5710744|NCT00123474|19679959|P1|As Treated at Study Closure|not reported when site closed|1
5710745|NCT00123474|19679956|P4|Randomized to Treatment|Randomized, never treated|1
5710746|NCT00123474|19679957|P3|Randomized to Treatment|Randomized, never treated|2
5710747|NCT00123474|19679958|P2|Randomized to Treatment|Randomized, never treated|4
5710748|NCT00123474|19679959|P1|Randomized to Treatment|Randomized, never treated|1
5710749|NCT00123422|19680053|P3|Overall Study|Lost to Follow-up|2
5710750|NCT00123422|19680054|P2|Overall Study|Lost to Follow-up|2
5710751|NCT00123422|19680055|P1|Overall Study|Lost to Follow-up|1
5710752|NCT00123422|19680053|P3|Overall Study|Withdrawal by Subject|2
5710753|NCT00123422|19680054|P2|Overall Study|Withdrawal by Subject|2
5710754|NCT00123422|19680055|P1|Overall Study|Withdrawal by Subject|1
5710755|NCT00123422|19680053|P3|Overall Study|Physician Decision|6
5710756|NCT00123422|19680054|P2|Overall Study|Physician Decision|2
5710757|NCT00123422|19680055|P1|Overall Study|Physician Decision|2
5710758|NCT00122980|19680143|P2|Overall Study|Study termination|35
5710759|NCT00122980|19680144|P1|Overall Study|Study termination|27
5710760|NCT00122980|19680143|P2|Overall Study|Adjudicated stroke (study endpoint)|0
5710761|NCT00122980|19680144|P1|Overall Study|Adjudicated stroke (study endpoint)|7
5710762|NCT00122980|19680143|P2|Overall Study|Withdrawal by Subject|3
5710763|NCT00122980|19680144|P1|Overall Study|Withdrawal by Subject|2
5710764|NCT00122980|19680143|P2|Overall Study|Protocol Violation|1
5710765|NCT00122980|19680144|P1|Overall Study|Protocol Violation|5
5710766|NCT00122980|19680143|P2|Overall Study|Physician Decision|0
5710767|NCT00122980|19680144|P1|Overall Study|Physician Decision|2
5710768|NCT00122980|19680143|P2|Overall Study|Death|1
5710769|NCT00122980|19680144|P1|Overall Study|Death|0
5710770|NCT00122954|19680168|P2|Overall Study|Protocol Violation|1
5710771|NCT00122954|19680169|P1|Overall Study|Protocol Violation|0
5710772|NCT00122954|19680168|P2|Overall Study|Withdrawal by Subject|2
5710773|NCT00122954|19680169|P1|Overall Study|Withdrawal by Subject|2
5710774|NCT00122681|19680179|P2|Overall Study|Personal reasons|147
5710775|NCT00122681|19680180|P1|Overall Study|Personal reasons|150
5710776|NCT00122681|19680179|P2|Overall Study|Withdrawal by Subject|251
5710777|NCT00122681|19680180|P1|Overall Study|Withdrawal by Subject|257
5710778|NCT00122681|19680179|P2|Overall Study|Protocol Violation|10
5710779|NCT00122681|19680180|P1|Overall Study|Protocol Violation|7
5710780|NCT00122681|19680179|P2|Overall Study|Lost to Follow-up|1097
5710781|NCT00122681|19680180|P1|Overall Study|Lost to Follow-up|1080
5710782|NCT00122681|19680179|P2|Overall Study|Adverse Event|16
5710783|NCT00122681|19680180|P1|Overall Study|Adverse Event|20
5710784|NCT00122460|19680254|P2|Overall Study|investigational study phase ongoing|1
5710785|NCT00122460|19680255|P1|Overall Study|investigational study phase ongoing|7
5710786|NCT00122382|19680304|P3|Open-Label Study|Withdrawal of Consent|4
5710787|NCT00122382|19680305|P2|Open-Label Study|Withdrawal of Consent|0
5710788|NCT00122382|19680306|P1|Open-Label Study|Withdrawal of Consent|0
5710789|NCT00122382|19680304|P3|Open-Label Study|Poor/Non-Compliance|1
5710790|NCT00122382|19680305|P2|Open-Label Study|Poor/Non-Compliance|0
5710791|NCT00122382|19680306|P1|Open-Label Study|Poor/Non-Compliance|0
5710792|NCT00122382|19680304|P3|Open-Label Study|Pregnancy|2
5710793|NCT00122382|19680305|P2|Open-Label Study|Pregnancy|0
5710794|NCT00122382|19680306|P1|Open-Label Study|Pregnancy|0
5710795|NCT00122382|19680304|P3|Open-Label Study|Lost to Follow-up|3
5710796|NCT00122382|19680305|P2|Open-Label Study|Lost to Follow-up|0
5710797|NCT00122382|19680306|P1|Open-Label Study|Lost to Follow-up|0
5710798|NCT00122382|19680304|P3|Open-Label Study|Lack of Efficacy|3
5710799|NCT00122382|19680305|P2|Open-Label Study|Lack of Efficacy|0
5710800|NCT00122382|19680306|P1|Open-Label Study|Lack of Efficacy|0
5710801|NCT00122382|19680304|P3|Open-Label Study|Death|2
5710802|NCT00122382|19680305|P2|Open-Label Study|Death|0
5710803|NCT00122382|19680306|P1|Open-Label Study|Death|0
5710804|NCT00122382|19680304|P3|Open-Label Study|Adverse Event|11
5710805|NCT00122382|19680305|P2|Open-Label Study|Adverse Event|0
5710806|NCT00122382|19680306|P1|Open-Label Study|Adverse Event|0
5710807|NCT00122382|19680304|P3|Double-Blind Study|Randomized but not treated|0
5710808|NCT00122382|19680305|P2|Double-Blind Study|Randomized but not treated|2
5710809|NCT00122382|19680306|P1|Double-Blind Study|Randomized but not treated|0
5710810|NCT00122382|19680304|P3|Double-Blind Study|Methotrexate Discontinued|0
5710811|NCT00122382|19680305|P2|Double-Blind Study|Methotrexate Discontinued|1
5710812|NCT00122382|19680306|P1|Double-Blind Study|Methotrexate Discontinued|0
5710813|NCT00122382|19680304|P3|Double-Blind Study|Protocol Violation|0
5710814|NCT00122382|19680305|P2|Double-Blind Study|Protocol Violation|0
5710815|NCT00122382|19680306|P1|Double-Blind Study|Protocol Violation|1
5710816|NCT00122382|19680304|P3|Double-Blind Study|Withdrawal of Consent|0
5710817|NCT00122382|19680305|P2|Double-Blind Study|Withdrawal of Consent|3
5710818|NCT00122382|19680306|P1|Double-Blind Study|Withdrawal of Consent|7
5710819|NCT00122382|19680304|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
5710820|NCT00122382|19680305|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
5710821|NCT00122382|19680306|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
5710822|NCT00122382|19680304|P3|Double-Blind Study|Pregnancy|0
5710823|NCT00122382|19680305|P2|Double-Blind Study|Pregnancy|0
5710824|NCT00122382|19680306|P1|Double-Blind Study|Pregnancy|2
5710825|NCT00122382|19680304|P3|Double-Blind Study|Lost to Follow-up|0
5710826|NCT00122382|19680305|P2|Double-Blind Study|Lost to Follow-up|1
5710827|NCT00122382|19680306|P1|Double-Blind Study|Lost to Follow-up|2
5710828|NCT00122382|19680304|P3|Double-Blind Study|Lack of Efficacy|0
5710829|NCT00122382|19680305|P2|Double-Blind Study|Lack of Efficacy|8
5710830|NCT00122382|19680306|P1|Double-Blind Study|Lack of Efficacy|0
5710831|NCT00122382|19680304|P3|Double-Blind Study|Death|0
5710832|NCT00122382|19680305|P2|Double-Blind Study|Death|2
5710833|NCT00122382|19680306|P1|Double-Blind Study|Death|2
5710834|NCT00122382|19680304|P3|Double-Blind Study|Adverse Event|0
5710835|NCT00122382|19680305|P2|Double-Blind Study|Adverse Event|11
5710836|NCT00122382|19680306|P1|Double-Blind Study|Adverse Event|9
5710837|NCT00122317|19680450|P1|Overall Study|Withdrawal by Subject|1
5710838|NCT00122317|19680450|P1|Overall Study|patient non-compliance|1
5710839|NCT00122317|19680450|P1|Overall Study|Physician Decision|2
5710840|NCT00122317|19680450|P1|Overall Study|Adverse Event|4
5710841|NCT00122317|19680450|P1|Overall Study|Death|3
5710842|NCT00122278|19680459|P2|Overall Study|Lost to Follow-up|0
5710843|NCT00122278|19680460|P1|Overall Study|Lost to Follow-up|2
5710844|NCT00122187|19680470|P2|Overall Study|Withdrew because of resource limitations|2
5710845|NCT00122187|19680471|P1|Overall Study|Withdrew because of resource limitations|2
5710846|NCT00122135|19680485|P2|Overall Study|Withdrawal by Subject|0
5710847|NCT00122135|19680486|P1|Overall Study|Withdrawal by Subject|3
5710848|NCT00122109|19680494|P2|Overall Study|Did not meet criteria|7
5710849|NCT00122109|19680495|P1|Overall Study|Did not meet criteria|6
5710850|NCT00121992|19680521|P2|Overall Study|Treatment not received|11
5710851|NCT00121992|19680522|P1|Overall Study|Treatment not received|2
5710852|NCT00121667|19680784|P4|Short Term (ST) + Long Term (LT) Period|Death|2
5710853|NCT00121667|19680785|P3|Short Term (ST) + Long Term (LT) Period|Death|0
5710854|NCT00121667|19680786|P2|Short Term (ST) + Long Term (LT) Period|Death|0
5710855|NCT00121667|19680787|P1|Short Term (ST) + Long Term (LT) Period|Death|1
5710856|NCT00121667|19680784|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
5710857|NCT00121667|19680785|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
5710858|NCT00121667|19680786|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
5710859|NCT00121667|19680787|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
5710860|NCT00121667|19680784|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
5710861|NCT00121667|19680785|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
5710862|NCT00121667|19680786|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
5710863|NCT00121667|19680787|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
5710864|NCT00121667|19680784|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
5710865|NCT00121667|19680785|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
5710866|NCT00121667|19680786|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
5710867|NCT00121667|19680787|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
5710868|NCT00121667|19680784|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
5710869|NCT00121667|19680785|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
5710870|NCT00121667|19680786|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
5710871|NCT00121667|19680787|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
5710872|NCT00121667|19680784|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
5710873|NCT00121667|19680785|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
5710874|NCT00121667|19680786|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
5710875|NCT00121667|19680787|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
5710876|NCT00121667|19680784|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
5710877|NCT00121667|19680785|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
5710878|NCT00121667|19680786|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
5710879|NCT00121667|19680787|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
5710880|NCT00121667|19680784|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
5710881|NCT00121667|19680785|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
5710882|NCT00121667|19680786|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
5710883|NCT00121667|19680787|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
5710884|NCT00121667|19680784|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
5710885|NCT00121667|19680785|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
5710886|NCT00121667|19680786|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
5710887|NCT00121667|19680787|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
5710888|NCT00121667|19680784|P4|Short Term (ST) Period|Pregnancy|1
5710889|NCT00121667|19680785|P3|Short Term (ST) Period|Pregnancy|0
5710890|NCT00121667|19680786|P2|Short Term (ST) Period|Pregnancy|0
5710891|NCT00121667|19680787|P1|Short Term (ST) Period|Pregnancy|0
5710892|NCT00121667|19680784|P4|Short Term (ST) Period|Death|1
5710893|NCT00121667|19680785|P3|Short Term (ST) Period|Death|0
5710894|NCT00121667|19680786|P2|Short Term (ST) Period|Death|0
5710895|NCT00121667|19680787|P1|Short Term (ST) Period|Death|0
5710896|NCT00121667|19680784|P4|Short Term (ST) Period|Other Reason|0
5710897|NCT00121667|19680785|P3|Short Term (ST) Period|Other Reason|0
5710898|NCT00121667|19680786|P2|Short Term (ST) Period|Other Reason|0
5710899|NCT00121667|19680787|P1|Short Term (ST) Period|Other Reason|3
5710900|NCT00121667|19680784|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
5710901|NCT00121667|19680785|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
5710902|NCT00121667|19680786|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
5710903|NCT00121667|19680787|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
5710904|NCT00121667|19680784|P4|Short Term (ST) Period|Poor / Non-compliance|2
5710905|NCT00121667|19680785|P3|Short Term (ST) Period|Poor / Non-compliance|1
5710906|NCT00121667|19680786|P2|Short Term (ST) Period|Poor / Non-compliance|1
5710907|NCT00121667|19680787|P1|Short Term (ST) Period|Poor / Non-compliance|0
5710908|NCT00121667|19680784|P4|Short Term (ST) Period|Lost to Follow-up|3
5710909|NCT00121667|19680785|P3|Short Term (ST) Period|Lost to Follow-up|4
5710910|NCT00121667|19680786|P2|Short Term (ST) Period|Lost to Follow-up|4
5710911|NCT00121667|19680787|P1|Short Term (ST) Period|Lost to Follow-up|3
5710912|NCT00121667|19680784|P4|Short Term (ST) Period|Adverse Event|3
5710913|NCT00121667|19680785|P3|Short Term (ST) Period|Adverse Event|5
5710914|NCT00121667|19680786|P2|Short Term (ST) Period|Adverse Event|6
5710915|NCT00121667|19680787|P1|Short Term (ST) Period|Adverse Event|5
5710916|NCT00121667|19680784|P4|Short Term (ST) Period|Subject Withdrew Consent|11
5710917|NCT00121667|19680785|P3|Short Term (ST) Period|Subject Withdrew Consent|4
5710918|NCT00121667|19680786|P2|Short Term (ST) Period|Subject Withdrew Consent|13
5710919|NCT00121667|19680787|P1|Short Term (ST) Period|Subject Withdrew Consent|8
5710920|NCT00121667|19680784|P4|Short Term (ST) Period|Lack of Efficacy|44
5710921|NCT00121667|19680785|P3|Short Term (ST) Period|Lack of Efficacy|27
5710922|NCT00121667|19680786|P2|Short Term (ST) Period|Lack of Efficacy|22
5710923|NCT00121667|19680787|P1|Short Term (ST) Period|Lack of Efficacy|25
5710924|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Other Reason|1
5710925|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Other Reason|0
5710926|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Other Reason|2
5710927|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Other Reason|3
5710928|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Other Reason|5
5710929|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Missing|0
5710930|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Missing|0
5710931|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Missing|1
5710932|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Missing|0
5710933|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Missing|0
5710934|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Death|0
5710935|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Death|1
5710936|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Death|0
5710937|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Death|0
5710938|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Death|0
5710939|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
5710940|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
5710941|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
5710942|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
5710943|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
5710944|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Pregnancy|0
5710945|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Pregnancy|1
5710946|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Pregnancy|0
5710947|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Pregnancy|1
5710948|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Pregnancy|0
5710949|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
5710950|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
5710951|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
5710952|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
5710953|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
5710954|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
5710955|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
5710956|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
5710957|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
5710958|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
5710959|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
5710960|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
5710961|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
5710962|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
5710963|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
5710964|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Adverse Event|5
5710965|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Adverse Event|5
5710966|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Adverse Event|10
5710967|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Adverse Event|10
5710968|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Adverse Event|9
5710969|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
5710970|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
5710971|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
5710972|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
5710973|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
5710974|NCT00121641|19680885|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
5710975|NCT00121641|19680886|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
5710976|NCT00121641|19680887|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
5710977|NCT00121641|19680888|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
5710978|NCT00121641|19680889|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
5710979|NCT00121641|19680885|P5|24-week Short-term Treatment Period|Other Reason|0
5710980|NCT00121641|19680886|P4|24-week Short-term Treatment Period|Other Reason|0
5710981|NCT00121641|19680887|P3|24-week Short-term Treatment Period|Other Reason|0
5710982|NCT00121641|19680888|P2|24-week Short-term Treatment Period|Other Reason|0
5710983|NCT00121641|19680889|P1|24-week Short-term Treatment Period|Other Reason|1
5710984|NCT00121641|19680885|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
5710985|NCT00121641|19680886|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
5710986|NCT00121641|19680887|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
5710987|NCT00121641|19680888|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
5710988|NCT00121641|19680889|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
5710989|NCT00121641|19680885|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
5710990|NCT00121641|19680886|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
5710991|NCT00121641|19680887|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
5710992|NCT00121641|19680888|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
5710993|NCT00121641|19680889|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
5710994|NCT00121641|19680885|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
5710995|NCT00121641|19680886|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
5710996|NCT00121641|19680887|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
5710997|NCT00121641|19680888|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
5710998|NCT00121641|19680889|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
5710999|NCT00121641|19680885|P5|24-week Short-term Treatment Period|Adverse Event|2
5711000|NCT00121641|19680886|P4|24-week Short-term Treatment Period|Adverse Event|0
5711001|NCT00121641|19680887|P3|24-week Short-term Treatment Period|Adverse Event|4
5711002|NCT00121641|19680888|P2|24-week Short-term Treatment Period|Adverse Event|3
5711003|NCT00121641|19680889|P1|24-week Short-term Treatment Period|Adverse Event|3
5711004|NCT00121641|19680885|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
5711005|NCT00121641|19680886|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
5711006|NCT00121641|19680887|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
5711007|NCT00121641|19680888|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
5711008|NCT00121641|19680889|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
5711009|NCT00121641|19680885|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
5711010|NCT00121641|19680886|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
5711011|NCT00121641|19680887|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
5711012|NCT00121641|19680888|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
5711013|NCT00121641|19680889|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
5711014|NCT00121485|19681002|P2|Overall Study|Crossover|2
5711015|NCT00121485|19681003|P1|Overall Study|Crossover|0
5711016|NCT00121485|19681002|P2|Overall Study|Not implanted|5
5711017|NCT00121485|19681003|P1|Overall Study|Not implanted|1
5711018|NCT00121238|19681048|P1|Overall Study|Protocol Violation|2
5711019|NCT00121238|19681048|P1|Overall Study|disease progression before intervention|1
5711020|NCT00121199|19681064|P1|Overall Study|Ineligible|9
5711021|NCT00121199|19681064|P1|Overall Study|Other - Not Protocol Specified|3
5711022|NCT00121199|19681064|P1|Overall Study|Death|3
5711023|NCT00121199|19681064|P1|Overall Study|Progression/Relapse|1
5711024|NCT00121199|19681064|P1|Overall Study|Refusal Unrelated to Adverse Event|1
5711025|NCT00121199|19681064|P1|Overall Study|Adverse Event|11
5711026|NCT00121134|19681108|P4|Overall Study|Patient Personal Reasons|0
5711027|NCT00121134|19681109|P3|Overall Study|Patient Personal Reasons|0
5711028|NCT00121134|19681110|P2|Overall Study|Patient Personal Reasons|1
5711029|NCT00121134|19681111|P1|Overall Study|Patient Personal Reasons|0
5711030|NCT00121134|19681108|P4|Overall Study|Intercurrent Illness|1
5711031|NCT00121134|19681109|P3|Overall Study|Intercurrent Illness|0
5711032|NCT00121134|19681110|P2|Overall Study|Intercurrent Illness|0
5711033|NCT00121134|19681111|P1|Overall Study|Intercurrent Illness|0
5711034|NCT00121134|19681108|P4|Overall Study|Treatment Delay|0
5711035|NCT00121134|19681109|P3|Overall Study|Treatment Delay|0
5711036|NCT00121134|19681110|P2|Overall Study|Treatment Delay|0
5711037|NCT00121134|19681111|P1|Overall Study|Treatment Delay|1
5711038|NCT00121134|19681108|P4|Overall Study|Physician Decision|1
5711039|NCT00121134|19681109|P3|Overall Study|Physician Decision|4
5711040|NCT00121134|19681110|P2|Overall Study|Physician Decision|4
5711041|NCT00121134|19681111|P1|Overall Study|Physician Decision|6
5711042|NCT00121134|19681108|P4|Overall Study|Toxicity|5
5711043|NCT00121134|19681109|P3|Overall Study|Toxicity|13
5711044|NCT00121134|19681110|P2|Overall Study|Toxicity|7
5711045|NCT00121134|19681111|P1|Overall Study|Toxicity|4
5711046|NCT00121134|19681108|P4|Overall Study|Progression of Disease|2
5711047|NCT00121134|19681109|P3|Overall Study|Progression of Disease|4
5711048|NCT00121134|19681110|P2|Overall Study|Progression of Disease|3
5711049|NCT00121134|19681111|P1|Overall Study|Progression of Disease|5
5711050|NCT00120874|19681123|P2|Overall Study|Death|1
5711051|NCT00120874|19681124|P1|Overall Study|Death|0
5711052|NCT00120627|19681162|P2|Overall Study|Withdrawal by Subject|5
5711053|NCT00120627|19681163|P1|Overall Study|Withdrawal by Subject|5
5711054|NCT00120406|19681214|P2|Overall Study|patient moved but has not withdrawn|1
5711055|NCT00120406|19681215|P1|Overall Study|patient moved but has not withdrawn|0
5711056|NCT00120406|19681214|P2|Overall Study|received non-study stent|2
5711057|NCT00120406|19681215|P1|Overall Study|received non-study stent|0
5711058|NCT00120406|19681214|P2|Overall Study|Lost to Follow-up|2
5711059|NCT00120406|19681215|P1|Overall Study|Lost to Follow-up|5
5711060|NCT00120406|19681214|P2|Overall Study|Withdrawal by Subject|7
5711061|NCT00120406|19681215|P1|Overall Study|Withdrawal by Subject|5
5711062|NCT00120406|19681214|P2|Overall Study|Death|4
5711063|NCT00120406|19681215|P1|Overall Study|Death|9
5711064|NCT00120289|19681225|P2|Overall Study|Withdrawal by Subject|13
5711065|NCT00120289|19681226|P1|Overall Study|Withdrawal by Subject|14
5711066|NCT00120289|19681225|P2|Overall Study|Lost to Follow-up|14
5711067|NCT00120289|19681226|P1|Overall Study|Lost to Follow-up|11
5711068|NCT00120289|19681225|P2|Overall Study|Death|82
5711069|NCT00120289|19681226|P1|Overall Study|Death|96
5711070|NCT00120250|19681238|P2|Overall Study|Protocol Violation|1
5711071|NCT00120250|19681239|P1|Overall Study|Protocol Violation|0
5711072|NCT00120250|19681238|P2|Overall Study|Lost to Follow-up|1
5711073|NCT00120250|19681239|P1|Overall Study|Lost to Follow-up|1
5711074|NCT00120042|19681255|P3|Overall Study|all completed protocl|0
5711075|NCT00120042|19681256|P2|Overall Study|all completed protocl|0
5711076|NCT00120042|19681257|P1|Overall Study|all completed protocl|0
5711077|NCT00119678|19681280|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
5711078|NCT00119678|19681281|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
5711079|NCT00119678|19681280|P2|Open-label Treatment Period|Pregnancy|0
5711080|NCT00119678|19681281|P1|Open-label Treatment Period|Pregnancy|1
5711081|NCT00119678|19681280|P2|Open-label Treatment Period|Participants not meeting study criteria|0
5711082|NCT00119678|19681281|P1|Open-label Treatment Period|Participants not meeting study criteria|2
5711083|NCT00119678|19681280|P2|Open-label Treatment Period|Participant withdrew consent|0
5711084|NCT00119678|19681281|P1|Open-label Treatment Period|Participant withdrew consent|4
5711085|NCT00119678|19681280|P2|Open-label Treatment Period|Lost to Follow-up|0
5711086|NCT00119678|19681281|P1|Open-label Treatment Period|Lost to Follow-up|3
5711087|NCT00119678|19681280|P2|Open-label Treatment Period|Lack of Efficacy|0
5711088|NCT00119678|19681281|P1|Open-label Treatment Period|Lack of Efficacy|9
5711089|NCT00119678|19681280|P2|Open-label Treatment Period|Adverse Event|0
5711090|NCT00119678|19681281|P1|Open-label Treatment Period|Adverse Event|3
5711091|NCT00119678|19681280|P2|Open-label Treatment Period|Death|0
5711092|NCT00119678|19681281|P1|Open-label Treatment Period|Death|1
5711093|NCT00119678|19681280|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
5711094|NCT00119678|19681281|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
5711095|NCT00119678|19681280|P2|Double-blind Treatment Period|Not treated|2
5711096|NCT00119678|19681281|P1|Double-blind Treatment Period|Not treated|1
5711097|NCT00119678|19681280|P2|Double-blind Treatment Period|Pregnancy|2
5711098|NCT00119678|19681281|P1|Double-blind Treatment Period|Pregnancy|0
5711099|NCT00119678|19681280|P2|Double-blind Treatment Period|Poor/Non-compliance|0
5711100|NCT00119678|19681281|P1|Double-blind Treatment Period|Poor/Non-compliance|3
5711101|NCT00119678|19681280|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
5711102|NCT00119678|19681281|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
5711103|NCT00119678|19681280|P2|Double-blind Treatment Period|Participant withdrew consent|4
5711104|NCT00119678|19681281|P1|Double-blind Treatment Period|Participant withdrew consent|4
5711105|NCT00119678|19681280|P2|Double-blind Treatment Period|Lost to Follow-up|2
5711106|NCT00119678|19681281|P1|Double-blind Treatment Period|Lost to Follow-up|1
5711107|NCT00119678|19681280|P2|Double-blind Treatment Period|Lack of Efficacy|12
5711108|NCT00119678|19681281|P1|Double-blind Treatment Period|Lack of Efficacy|21
5711109|NCT00119678|19681280|P2|Double-blind Treatment Period|Adverse Event|1
5711110|NCT00119678|19681281|P1|Double-blind Treatment Period|Adverse Event|7
5711111|NCT00119678|19681280|P2|Double-blind Treatment Period|Death|0
5711112|NCT00119678|19681281|P1|Double-blind Treatment Period|Death|1
5711113|NCT00119405|19681327|P1|Overall Study|Withdrawal by Subject|1
5711114|NCT00119379|19681341|P2|Overall Study|Adverse Event|1
5711115|NCT00119379|19681342|P1|Overall Study|Adverse Event|4
5711116|NCT00119262|19681360|P2|Overall Study|others|5
5711117|NCT00119262|19681361|P1|Overall Study|others|0
5711118|NCT00119262|19681360|P2|Overall Study|ineligble|2
5711119|NCT00119262|19681361|P1|Overall Study|ineligble|1
5711120|NCT00119262|19681360|P2|Overall Study|other disease|2
5711121|NCT00119262|19681361|P1|Overall Study|other disease|0
5711122|NCT00119262|19681360|P2|Overall Study|Adverse Event|35
5711123|NCT00119262|19681361|P1|Overall Study|Adverse Event|33
5711124|NCT00119262|19681360|P2|Overall Study|Withdrawal by Subject|11
5711125|NCT00119262|19681361|P1|Overall Study|Withdrawal by Subject|12
5711126|NCT00119262|19681360|P2|Overall Study|Lack of Efficacy|3
5711127|NCT00119262|19681361|P1|Overall Study|Lack of Efficacy|0
5711128|NCT00119015|19681398|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
5711129|NCT00119015|19681399|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
5711130|NCT00119015|19681400|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
5711131|NCT00118911|19681416|P2|Overall Study|Withdrawal by Subject|5
5711132|NCT00118911|19681417|P1|Overall Study|Withdrawal by Subject|2
5711133|NCT00118898|19681429|P4|Overall Study|Not able to get to clinic|40
5711134|NCT00118898|19681430|P3|Overall Study|Not able to get to clinic|31
5711135|NCT00118898|19681431|P2|Overall Study|Not able to get to clinic|43
5711136|NCT00118898|19681432|P1|Overall Study|Not able to get to clinic|34
5711137|NCT00118898|19681429|P4|Overall Study|Not compliant with requirements|11
5711138|NCT00118898|19681430|P3|Overall Study|Not compliant with requirements|11
5711139|NCT00118898|19681431|P2|Overall Study|Not compliant with requirements|13
5711140|NCT00118898|19681432|P1|Overall Study|Not compliant with requirements|11
5711141|NCT00118898|19681429|P4|Overall Study|Severe debilitation|4
5711142|NCT00118898|19681430|P3|Overall Study|Severe debilitation|6
5711143|NCT00118898|19681431|P2|Overall Study|Severe debilitation|4
5711144|NCT00118898|19681432|P1|Overall Study|Severe debilitation|1
5711145|NCT00118898|19681429|P4|Overall Study|Site Closure|37
5711146|NCT00118898|19681430|P3|Overall Study|Site Closure|28
5711147|NCT00118898|19681431|P2|Overall Study|Site Closure|31
5711148|NCT00118898|19681432|P1|Overall Study|Site Closure|33
5711149|NCT00118898|19681429|P4|Overall Study|Withdrawal by Subject|8
5711150|NCT00118898|19681430|P3|Overall Study|Withdrawal by Subject|8
5711151|NCT00118898|19681431|P2|Overall Study|Withdrawal by Subject|5
5711152|NCT00118898|19681432|P1|Overall Study|Withdrawal by Subject|10
5711153|NCT00118898|19681429|P4|Overall Study|Lost to Follow-up|33
5711154|NCT00118898|19681430|P3|Overall Study|Lost to Follow-up|33
5711155|NCT00118898|19681431|P2|Overall Study|Lost to Follow-up|34
5711156|NCT00118898|19681432|P1|Overall Study|Lost to Follow-up|26
5711157|NCT00118898|19681429|P4|Overall Study|Death|8
5711158|NCT00118898|19681430|P3|Overall Study|Death|6
5711159|NCT00118898|19681431|P2|Overall Study|Death|11
5711160|NCT00118898|19681432|P1|Overall Study|Death|6
5711161|NCT00118716|19681558|P2|Overall Study|Investigator discretion|1
5711162|NCT00118716|19681559|P1|Overall Study|Investigator discretion|0
5711163|NCT00118716|19681558|P2|Overall Study|Expired drug use|2
5711164|NCT00118716|19681559|P1|Overall Study|Expired drug use|1
5711165|NCT00118716|19681558|P2|Overall Study|misrandomized|1
5711166|NCT00118716|19681559|P1|Overall Study|misrandomized|1
5711167|NCT00118716|19681558|P2|Overall Study|Non-compliance|3
5711168|NCT00118716|19681559|P1|Overall Study|Non-compliance|1
5711169|NCT00118716|19681558|P2|Overall Study|Discontinued by sponsor|1
5711170|NCT00118716|19681559|P1|Overall Study|Discontinued by sponsor|1
5711171|NCT00118716|19681558|P2|Overall Study|Exacerbation|2
5711172|NCT00118716|19681559|P1|Overall Study|Exacerbation|2
5711173|NCT00118716|19681558|P2|Overall Study|Withdrawal by Subject|1
5711174|NCT00118716|19681559|P1|Overall Study|Withdrawal by Subject|0
5711175|NCT00118716|19681558|P2|Overall Study|Protocol Violation|4
5711176|NCT00118716|19681559|P1|Overall Study|Protocol Violation|5
5711177|NCT00118716|19681558|P2|Overall Study|Adverse Event|7
5711178|NCT00118716|19681559|P1|Overall Study|Adverse Event|2
5711179|NCT00118703|19681579|P2|Overall Study|Lost to Follow-up|2
5711180|NCT00118703|19681580|P1|Overall Study|Lost to Follow-up|1
5711181|NCT00118703|19681579|P2|Overall Study|Withdrawal by Subject|5
5711182|NCT00118703|19681580|P1|Overall Study|Withdrawal by Subject|2
5711183|NCT00118703|19681579|P2|Overall Study|Participant took two different treatment|1
5711184|NCT00118703|19681580|P1|Overall Study|Participant took two different treatment|0
5711185|NCT00118703|19681579|P2|Overall Study|Adverse Event|1
5711186|NCT00118703|19681580|P1|Overall Study|Adverse Event|1
5711187|NCT00118703|19681579|P2|Overall Study|Protocol Violation|0
5711188|NCT00118703|19681580|P1|Overall Study|Protocol Violation|1
5711189|NCT00118482|19681677|P2|Overall Study|Withdrawal by Subject|22
5711190|NCT00118482|19681678|P1|Overall Study|Withdrawal by Subject|23
5711191|NCT00118482|19681677|P2|Overall Study|Lost to Follow-up|7
5711192|NCT00118482|19681678|P1|Overall Study|Lost to Follow-up|7
5711193|NCT00118430|19681693|P3|Overall Study|Lost to Follow-up|28
5711194|NCT00118430|19681694|P2|Overall Study|Lost to Follow-up|22
5711195|NCT00118430|19681695|P1|Overall Study|Lost to Follow-up|15
5711196|NCT00118430|19681693|P3|Overall Study|Withdrawal by Subject|0
5711197|NCT00118430|19681694|P2|Overall Study|Withdrawal by Subject|2
5711198|NCT00118430|19681695|P1|Overall Study|Withdrawal by Subject|6
5711199|NCT00118417|19681710|P2|Phase II (Weeks 6 to 12)|Remission|2
5711200|NCT00118417|19681711|P1|Phase II (Weeks 6 to 12)|Remission|1
5711201|NCT00118417|19681710|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
5711202|NCT00118417|19681711|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
5711203|NCT00118417|19681710|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
5711204|NCT00118417|19681711|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
5711205|NCT00118417|19681710|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
5711206|NCT00118417|19681711|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
5711207|NCT00118417|19681710|P2|Phase I (Weeks 0 to 6)|Remission|0
5711208|NCT00118417|19681711|P1|Phase I (Weeks 0 to 6)|Remission|8
5711209|NCT00118287|19681855|P1|Overall Study|Muscle pain|1
5711210|NCT00118287|19681855|P1|Overall Study|Intracranial haemorrhage|1
5711211|NCT00118157|19681888|P1|Overall Study|Withdrawal by Subject|2
5711212|NCT00118157|19681888|P1|Overall Study|Death|8
5711213|NCT00118157|19681888|P1|Overall Study|Adverse Event|2
5711214|NCT00118092|19681906|P1|Overall Study|Protocol Violation|1
5711215|NCT00118092|19681906|P1|Overall Study|Withdrawal by Subject|1
5711216|NCT00118040|19681924|P3|Overall Study|Other|1
5711217|NCT00118040|19681925|P2|Overall Study|Other|0
5711218|NCT00118040|19681926|P1|Overall Study|Other|0
5711219|NCT00118040|19681924|P3|Overall Study|Non-Compliant Participant|2
5711220|NCT00118040|19681925|P2|Overall Study|Non-Compliant Participant|1
5711221|NCT00118040|19681926|P1|Overall Study|Non-Compliant Participant|1
5711222|NCT00118040|19681924|P3|Overall Study|Medical Contraindication|1
5711223|NCT00118040|19681925|P2|Overall Study|Medical Contraindication|0
5711224|NCT00118040|19681926|P1|Overall Study|Medical Contraindication|0
5711225|NCT00118040|19681924|P3|Overall Study|Withdrawal by Subject|2
5711226|NCT00118040|19681925|P2|Overall Study|Withdrawal by Subject|0
5711227|NCT00118040|19681926|P1|Overall Study|Withdrawal by Subject|0
5711228|NCT00118040|19681924|P3|Overall Study|Adverse Event|0
5711229|NCT00118040|19681925|P2|Overall Study|Adverse Event|1
5711230|NCT00118040|19681926|P1|Overall Study|Adverse Event|0
5711231|NCT00117988|19681987|P1|Overall Study|Adverse Event|1
5711232|NCT00117988|19681987|P1|Overall Study|Death|3
5711233|NCT00117949|19682010|P4|Overall Study|Hepatic abnormalities|1
5711234|NCT00117949|19682011|P3|Overall Study|Hepatic abnormalities|0
5711235|NCT00117949|19682012|P2|Overall Study|Hepatic abnormalities|1
5711236|NCT00117949|19682013|P1|Overall Study|Hepatic abnormalities|0
5711237|NCT00117949|19682010|P4|Overall Study|PSA reduction <=50%|4
5711238|NCT00117949|19682011|P3|Overall Study|PSA reduction <=50%|2
5711239|NCT00117949|19682012|P2|Overall Study|PSA reduction <=50%|2
5711240|NCT00117949|19682013|P1|Overall Study|PSA reduction <=50%|0
5711241|NCT00117949|19682010|P4|Overall Study|PSA increase >=10ng/mL|0
5711242|NCT00117949|19682011|P3|Overall Study|PSA increase >=10ng/mL|1
5711243|NCT00117949|19682012|P2|Overall Study|PSA increase >=10ng/mL|1
5711244|NCT00117949|19682013|P1|Overall Study|PSA increase >=10ng/mL|0
5711245|NCT00117949|19682010|P4|Overall Study|Prostate-specific antigen increase >=25%|2
5711246|NCT00117949|19682011|P3|Overall Study|Prostate-specific antigen increase >=25%|1
5711247|NCT00117949|19682012|P2|Overall Study|Prostate-specific antigen increase >=25%|1
5711248|NCT00117949|19682013|P1|Overall Study|Prostate-specific antigen increase >=25%|0
5711249|NCT00117949|19682010|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
5711250|NCT00117949|19682011|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
5711251|NCT00117949|19682012|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
5711252|NCT00117949|19682013|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
5711253|NCT00117949|19682010|P4|Overall Study|Testosterone >1.0 ng/mL|15
5711254|NCT00117949|19682011|P3|Overall Study|Testosterone >1.0 ng/mL|17
5711255|NCT00117949|19682012|P2|Overall Study|Testosterone >1.0 ng/mL|18
5711256|NCT00117949|19682013|P1|Overall Study|Testosterone >1.0 ng/mL|10
5711257|NCT00117845|19682047|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
5711258|NCT00117793|19682065|P1|Overall Study|Withdrawal by Subject|12
5711259|NCT00117676|19682088|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
5711260|NCT00117676|19682089|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
5711261|NCT00117676|19682088|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
5711262|NCT00117676|19682089|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
5711263|NCT00117676|19682088|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
5711264|NCT00117676|19682089|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
5711265|NCT00117676|19682088|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
5711266|NCT00117676|19682089|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
5711267|NCT00117676|19682088|P2|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
5711268|NCT00117676|19682089|P1|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
5711269|NCT00117676|19682088|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
5711270|NCT00117676|19682089|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
5711271|NCT00117676|19682088|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
5711272|NCT00117676|19682089|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
5711273|NCT00117676|19682088|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
5711274|NCT00117676|19682089|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
5711275|NCT00117676|19682088|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
5711276|NCT00117676|19682089|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
5711277|NCT00117676|19682088|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
5711278|NCT00117676|19682089|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
5711279|NCT00117676|19682088|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
5711280|NCT00117676|19682089|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
5711281|NCT00117676|19682088|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
5711282|NCT00117676|19682089|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
5711283|NCT00117676|19682088|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
5711284|NCT00117676|19682089|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
5711285|NCT00117676|19682088|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
5711286|NCT00117676|19682089|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
5711287|NCT00117676|19682088|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
5711288|NCT00117676|19682089|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
5711289|NCT00117676|19682088|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
5711290|NCT00117676|19682089|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
5711291|NCT00117676|19682088|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
5711292|NCT00117676|19682089|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
5711293|NCT00117676|19682088|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
5711294|NCT00117676|19682089|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
5711295|NCT00117676|19682088|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
5711296|NCT00117676|19682089|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
5711297|NCT00117676|19682088|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
5711298|NCT00117676|19682089|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
5711299|NCT00117676|19682088|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
5711300|NCT00117676|19682089|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
5711301|NCT00117676|19682088|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
5711302|NCT00117676|19682089|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
5711303|NCT00117676|19682088|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
5711304|NCT00117676|19682089|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
5711305|NCT00117676|19682088|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
5711306|NCT00117676|19682089|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
5711307|NCT00117676|19682088|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
5711308|NCT00117676|19682089|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
5711309|NCT00117676|19682088|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
5711310|NCT00117676|19682089|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
5711311|NCT00117676|19682088|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
5711312|NCT00117676|19682089|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
5711313|NCT00117676|19682088|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
5711314|NCT00117676|19682089|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
5711315|NCT00117676|19682088|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
5711316|NCT00117676|19682089|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
5711317|NCT00117676|19682088|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
5711318|NCT00117676|19682089|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
5711319|NCT00117676|19682088|P2|Double-blind Period Through Week 48|Withdrew Consent|1
5711320|NCT00117676|19682089|P1|Double-blind Period Through Week 48|Withdrew Consent|0
5711321|NCT00117676|19682088|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
5711322|NCT00117676|19682089|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
5711323|NCT00117676|19682088|P2|Double-blind Period Through Week 48|Protocol Violation|1
5711324|NCT00117676|19682089|P1|Double-blind Period Through Week 48|Protocol Violation|0
5711325|NCT00117676|19682088|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
5711326|NCT00117676|19682089|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
5711327|NCT00117676|19682088|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
5711328|NCT00117676|19682089|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
5711329|NCT00117637|19682178|P2|Second Intervention (Period 2)|reason not reported|0
5711330|NCT00117637|19682179|P1|Second Intervention (Period 2)|reason not reported|1
5711331|NCT00117637|19682178|P2|Second Intervention (Period 2)|non compliant with study medication|1
5711332|NCT00117637|19682179|P1|Second Intervention (Period 2)|non compliant with study medication|1
5711333|NCT00117637|19682178|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
5711334|NCT00117637|19682179|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
5711335|NCT00117637|19682178|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
5711336|NCT00117637|19682179|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
5711337|NCT00117637|19682178|P2|Second Intervention (Period 2)|Protocol Violation|0
5711338|NCT00117637|19682179|P1|Second Intervention (Period 2)|Protocol Violation|1
5711339|NCT00117637|19682178|P2|Second Intervention (Period 2)|Lost to Follow-up|0
5711340|NCT00117637|19682179|P1|Second Intervention (Period 2)|Lost to Follow-up|1
5711341|NCT00117637|19682178|P2|Second Intervention (Period 2)|Adverse Event|9
5711342|NCT00117637|19682179|P1|Second Intervention (Period 2)|Adverse Event|0
5711343|NCT00117637|19682178|P2|First Intervention (Period 1)|reason not reported|1
5711344|NCT00117637|19682179|P1|First Intervention (Period 1)|reason not reported|0
5711345|NCT00117637|19682178|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
5711346|NCT00117637|19682179|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
5711347|NCT00117637|19682178|P2|First Intervention (Period 1)|protocol driven decision point|0
5711348|NCT00117637|19682179|P1|First Intervention (Period 1)|protocol driven decision point|1
5711349|NCT00117637|19682178|P2|First Intervention (Period 1)|study terminated by the sponsor|1
5711350|NCT00117637|19682179|P1|First Intervention (Period 1)|study terminated by the sponsor|3
5711351|NCT00117637|19682178|P2|First Intervention (Period 1)|Withdrawal by Subject|4
5711352|NCT00117637|19682179|P1|First Intervention (Period 1)|Withdrawal by Subject|2
5711353|NCT00117637|19682178|P2|First Intervention (Period 1)|Protocol Violation|0
5711354|NCT00117637|19682179|P1|First Intervention (Period 1)|Protocol Violation|1
5711355|NCT00117637|19682178|P2|First Intervention (Period 1)|Lost to Follow-up|2
5711356|NCT00117637|19682179|P1|First Intervention (Period 1)|Lost to Follow-up|0
5711357|NCT00117637|19682178|P2|First Intervention (Period 1)|Adverse Event|16
5711358|NCT00117637|19682179|P1|First Intervention (Period 1)|Adverse Event|11
5711359|NCT00117598|19682254|P5|After Treament Cross Over|Other|2
5711360|NCT00117598|19682255|P4|After Treament Cross Over|Other|1
5711361|NCT00117598|19682256|P3|After Treament Cross Over|Other|0
5711362|NCT00117598|19682257|P2|After Treament Cross Over|Other|0
5711363|NCT00117598|19682258|P1|After Treament Cross Over|Other|0
5711364|NCT00117598|19682254|P5|After Treament Cross Over|Withdrawal by Subject|0
5711365|NCT00117598|19682255|P4|After Treament Cross Over|Withdrawal by Subject|1
5711366|NCT00117598|19682256|P3|After Treament Cross Over|Withdrawal by Subject|0
5711367|NCT00117598|19682257|P2|After Treament Cross Over|Withdrawal by Subject|0
5711368|NCT00117598|19682258|P1|After Treament Cross Over|Withdrawal by Subject|0
5711369|NCT00117598|19682254|P5|After Treament Cross Over|Death|2
5711370|NCT00117598|19682255|P4|After Treament Cross Over|Death|1
5711371|NCT00117598|19682256|P3|After Treament Cross Over|Death|0
5711372|NCT00117598|19682257|P2|After Treament Cross Over|Death|0
5711373|NCT00117598|19682258|P1|After Treament Cross Over|Death|0
5711374|NCT00117598|19682254|P5|Prior to Treatment Cross Over|Other|0
5711375|NCT00117598|19682255|P4|Prior to Treatment Cross Over|Other|0
5711376|NCT00117598|19682256|P3|Prior to Treatment Cross Over|Other|9
5711377|NCT00117598|19682257|P2|Prior to Treatment Cross Over|Other|9
5711378|NCT00117598|19682258|P1|Prior to Treatment Cross Over|Other|15
5711379|NCT00117598|19682254|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
5711380|NCT00117598|19682255|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
5711381|NCT00117598|19682256|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
5711382|NCT00117598|19682257|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
5711383|NCT00117598|19682258|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
5711384|NCT00117598|19682254|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
5711385|NCT00117598|19682255|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
5711386|NCT00117598|19682256|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
5711387|NCT00117598|19682257|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
5711388|NCT00117598|19682258|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
5711389|NCT00117598|19682254|P5|Prior to Treatment Cross Over|Death|0
5711390|NCT00117598|19682255|P4|Prior to Treatment Cross Over|Death|0
5711391|NCT00117598|19682256|P3|Prior to Treatment Cross Over|Death|37
5711392|NCT00117598|19682257|P2|Prior to Treatment Cross Over|Death|41
5711393|NCT00117598|19682258|P1|Prior to Treatment Cross Over|Death|40
5711394|NCT00117572|19682292|P2|Overall Study|Protocol Violation|0
5711395|NCT00117572|19682293|P1|Overall Study|Protocol Violation|1
5711396|NCT00117572|19682292|P2|Overall Study|Withdrawal by Subject|3
5711397|NCT00117572|19682293|P1|Overall Study|Withdrawal by Subject|3
5711398|NCT00117572|19682292|P2|Overall Study|Site withdrew before starting treatment|3
5711399|NCT00117572|19682293|P1|Overall Study|Site withdrew before starting treatment|2
5711400|NCT00117338|19682334|P2|Overall Study|Lack of Efficacy|1
5711401|NCT00117338|19682335|P1|Overall Study|Lack of Efficacy|0
5711402|NCT00117338|19682334|P2|Overall Study|Did not meet Inclusion Criteria|0
5711403|NCT00117338|19682335|P1|Overall Study|Did not meet Inclusion Criteria|1
5711404|NCT00117338|19682334|P2|Overall Study|Withdrawal by Subject|0
5711405|NCT00117338|19682335|P1|Overall Study|Withdrawal by Subject|1
5711406|NCT00117338|19682334|P2|Overall Study|Protocol Violation|2
5711407|NCT00117338|19682335|P1|Overall Study|Protocol Violation|3
5711408|NCT00117338|19682334|P2|Overall Study|Adverse Event|1
5711409|NCT00117338|19682335|P1|Overall Study|Adverse Event|0
5711410|NCT00117325|19682355|P2|Overall Study|Admisnitrative|0
5711411|NCT00117325|19682356|P1|Overall Study|Admisnitrative|1
5711412|NCT00117325|19682355|P2|Overall Study|Early termination|1
5711413|NCT00117325|19682356|P1|Overall Study|Early termination|1
5711414|NCT00117325|19682355|P2|Overall Study|Use of prohibited medicine|2
5711415|NCT00117325|19682356|P1|Overall Study|Use of prohibited medicine|1
5711416|NCT00117325|19682355|P2|Overall Study|Lack of Efficacy|0
5711417|NCT00117325|19682356|P1|Overall Study|Lack of Efficacy|1
5711418|NCT00117325|19682355|P2|Overall Study|Withdrawal by Subject|2
5711419|NCT00117325|19682356|P1|Overall Study|Withdrawal by Subject|3
5711420|NCT00117325|19682355|P2|Overall Study|Protocol Violation|3
5711421|NCT00117325|19682356|P1|Overall Study|Protocol Violation|2
5711422|NCT00117325|19682355|P2|Overall Study|Lost to Follow-up|1
5711423|NCT00117325|19682356|P1|Overall Study|Lost to Follow-up|1
5711424|NCT00117325|19682355|P2|Overall Study|Adverse Event|3
5711425|NCT00117325|19682356|P1|Overall Study|Adverse Event|3
5711426|NCT00117312|19682388|P4|Overall Study|Withdrawal by Subject|0
5711427|NCT00117312|19682389|P3|Overall Study|Withdrawal by Subject|0
5711428|NCT00117312|19682390|P2|Overall Study|Withdrawal by Subject|2
5711429|NCT00117312|19682391|P1|Overall Study|Withdrawal by Subject|0
5711430|NCT00117312|19682388|P4|Overall Study|Hepatic abnormality|1
5711431|NCT00117312|19682389|P3|Overall Study|Hepatic abnormality|0
5711432|NCT00117312|19682390|P2|Overall Study|Hepatic abnormality|1
5711433|NCT00117312|19682391|P1|Overall Study|Hepatic abnormality|0
5711434|NCT00117312|19682388|P4|Overall Study|PSA increase >= 10ng/mL|0
5711435|NCT00117312|19682389|P3|Overall Study|PSA increase >= 10ng/mL|1
5711436|NCT00117312|19682390|P2|Overall Study|PSA increase >= 10ng/mL|1
5711437|NCT00117312|19682391|P1|Overall Study|PSA increase >= 10ng/mL|0
5711438|NCT00117312|19682388|P4|Overall Study|PSA decrease <=50%|4
5711439|NCT00117312|19682389|P3|Overall Study|PSA decrease <=50%|2
5711440|NCT00117312|19682390|P2|Overall Study|PSA decrease <=50%|2
5711441|NCT00117312|19682391|P1|Overall Study|PSA decrease <=50%|0
5711442|NCT00117312|19682388|P4|Overall Study|Protocol Violation|0
5711443|NCT00117312|19682389|P3|Overall Study|Protocol Violation|3
5711444|NCT00117312|19682390|P2|Overall Study|Protocol Violation|1
5711445|NCT00117312|19682391|P1|Overall Study|Protocol Violation|0
5711446|NCT00117312|19682388|P4|Overall Study|Adverse Event|0
5711447|NCT00117312|19682389|P3|Overall Study|Adverse Event|0
5711448|NCT00117312|19682390|P2|Overall Study|Adverse Event|2
5711449|NCT00117312|19682391|P1|Overall Study|Adverse Event|0
5711450|NCT00117312|19682388|P4|Overall Study|Patient choice|1
5711451|NCT00117312|19682389|P3|Overall Study|Patient choice|2
5711452|NCT00117312|19682390|P2|Overall Study|Patient choice|0
5711453|NCT00117312|19682391|P1|Overall Study|Patient choice|0
5711454|NCT00117312|19682388|P4|Overall Study|Other|1
5711455|NCT00117312|19682389|P3|Overall Study|Other|3
5711456|NCT00117312|19682390|P2|Overall Study|Other|1
5711457|NCT00117312|19682391|P1|Overall Study|Other|0
5711458|NCT00117312|19682388|P4|Overall Study|Prostate-specific antigen increase >=25%|3
5711459|NCT00117312|19682389|P3|Overall Study|Prostate-specific antigen increase >=25%|5
5711460|NCT00117312|19682390|P2|Overall Study|Prostate-specific antigen increase >=25%|1
5711461|NCT00117312|19682391|P1|Overall Study|Prostate-specific antigen increase >=25%|0
5711462|NCT00117312|19682388|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
5711463|NCT00117312|19682389|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
5711464|NCT00117312|19682390|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
5711465|NCT00117312|19682391|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
5711466|NCT00117312|19682388|P4|Overall Study|Testosterone >1.0 ng/mL|9
5711467|NCT00117312|19682389|P3|Overall Study|Testosterone >1.0 ng/mL|5
5711468|NCT00117312|19682390|P2|Overall Study|Testosterone >1.0 ng/mL|9
5711469|NCT00117312|19682391|P1|Overall Study|Testosterone >1.0 ng/mL|9
5711470|NCT00117286|19682407|P2|Overall Study|Research site closing|2
5711471|NCT00117286|19682408|P1|Overall Study|Research site closing|0
5711472|NCT00117286|19682407|P2|Overall Study|Lack of Efficacy|1
5711473|NCT00117286|19682408|P1|Overall Study|Lack of Efficacy|2
5711474|NCT00117286|19682407|P2|Overall Study|Physician Decision|7
5711475|NCT00117286|19682408|P1|Overall Study|Physician Decision|3
5711476|NCT00117286|19682407|P2|Overall Study|Withdrawal by Subject|2
5711477|NCT00117286|19682408|P1|Overall Study|Withdrawal by Subject|6
5711478|NCT00117286|19682407|P2|Overall Study|Protocol Violation|3
5711479|NCT00117286|19682408|P1|Overall Study|Protocol Violation|3
5711480|NCT00117286|19682407|P2|Overall Study|Lost to Follow-up|0
5711481|NCT00117286|19682408|P1|Overall Study|Lost to Follow-up|2
5711482|NCT00117286|19682407|P2|Overall Study|Adverse Event|6
5711483|NCT00117286|19682408|P1|Overall Study|Adverse Event|12
5711484|NCT00117156|19682416|P1|Overall Study|Trt for Pre-Exist Second Primary|1
5711485|NCT00117156|19682416|P1|Overall Study|Physician Decision|1
5711486|NCT00117156|19682416|P1|Overall Study|Adverse Event|9
5711487|NCT00116844|19682484|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
5711488|NCT00116844|19682485|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
5711489|NCT00116844|19682484|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
5711490|NCT00116844|19682485|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
5711491|NCT00116844|19682484|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
5711492|NCT00116844|19682485|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
5711493|NCT00116844|19682484|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
5711494|NCT00116844|19682485|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
5711495|NCT00116844|19682484|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
5711496|NCT00116844|19682485|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
5711497|NCT00116844|19682484|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
5711498|NCT00116844|19682485|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
5711499|NCT00116844|19682484|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
5711500|NCT00116844|19682485|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
5711501|NCT00116844|19682484|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
5711502|NCT00116844|19682485|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
5711503|NCT00116844|19682484|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
5711504|NCT00116844|19682485|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
5711505|NCT00116831|19682503|P2|Overall Study|Missing data for participant|0
5711506|NCT00116831|19682504|P1|Overall Study|Missing data for participant|1
5711507|NCT00116831|19682503|P2|Overall Study|Insufficient therapeutic effect|1
5711508|NCT00116831|19682504|P1|Overall Study|Insufficient therapeutic effect|0
5711509|NCT00116831|19682503|P2|Overall Study|Withdrawal by Subject|32
5711510|NCT00116831|19682504|P1|Overall Study|Withdrawal by Subject|32
5711511|NCT00116831|19682503|P2|Overall Study|Withdrawn investigational product|0
5711512|NCT00116831|19682504|P1|Overall Study|Withdrawn investigational product|1
5711513|NCT00116831|19682503|P2|Overall Study|Low haemoglobin on screening|0
5711514|NCT00116831|19682504|P1|Overall Study|Low haemoglobin on screening|1
5711515|NCT00116831|19682503|P2|Overall Study|Hypoglycaemic events|0
5711516|NCT00116831|19682504|P1|Overall Study|Hypoglycaemic events|1
5711517|NCT00116831|19682503|P2|Overall Study|Protocol Violation|6
5711518|NCT00116831|19682504|P1|Overall Study|Protocol Violation|3
5711519|NCT00116831|19682503|P2|Overall Study|Lost to Follow-up|6
5711520|NCT00116831|19682504|P1|Overall Study|Lost to Follow-up|8
5711521|NCT00116831|19682503|P2|Overall Study|Baseline IVUS determined unevaluable|11
5711522|NCT00116831|19682504|P1|Overall Study|Baseline IVUS determined unevaluable|12
5711523|NCT00116831|19682503|P2|Overall Study|Adverse Event|16
5711524|NCT00116831|19682504|P1|Overall Study|Adverse Event|14
5711525|NCT00116805|19682582|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
5711526|NCT00116805|19682583|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
5711527|NCT00116805|19682582|P2|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
5711528|NCT00116805|19682583|P1|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
5711529|NCT00116805|19682582|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
5711530|NCT00116805|19682583|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
5711531|NCT00116805|19682582|P2|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
5711532|NCT00116805|19682583|P1|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
5711533|NCT00116805|19682582|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
5711534|NCT00116805|19682583|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
5711535|NCT00116805|19682582|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
5711536|NCT00116805|19682583|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
5711537|NCT00116805|19682582|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
5711538|NCT00116805|19682583|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
5711539|NCT00116805|19682582|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
5711540|NCT00116805|19682583|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
5711541|NCT00116805|19682582|P2|Open-label Period Weeks 337 - 384|Completed Study|0
5711542|NCT00116805|19682583|P1|Open-label Period Weeks 337 - 384|Completed Study|1
5711543|NCT00116805|19682582|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
5711544|NCT00116805|19682583|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
5711545|NCT00116805|19682582|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
5711546|NCT00116805|19682583|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
5711547|NCT00116805|19682582|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
5711548|NCT00116805|19682583|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
5711549|NCT00116805|19682582|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
5711550|NCT00116805|19682583|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
5711551|NCT00116805|19682582|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
5711552|NCT00116805|19682583|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
5711553|NCT00116805|19682582|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
5711554|NCT00116805|19682583|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
5711555|NCT00116805|19682582|P2|Open-label Period Weeks 289 - 336|Completed Study|1
5711556|NCT00116805|19682583|P1|Open-label Period Weeks 289 - 336|Completed Study|0
5711557|NCT00116805|19682582|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
5711558|NCT00116805|19682583|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
5711559|NCT00116805|19682582|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
5711560|NCT00116805|19682583|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
5711561|NCT00116805|19682582|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
5711562|NCT00116805|19682583|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
5711563|NCT00116805|19682582|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
5711564|NCT00116805|19682583|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
5711565|NCT00116805|19682582|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
5711566|NCT00116805|19682583|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
5711567|NCT00116805|19682582|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
5711568|NCT00116805|19682583|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
5711569|NCT00116805|19682582|P2|Open-label Period Weeks 193 - 240|Completed Study|1
5711570|NCT00116805|19682583|P1|Open-label Period Weeks 193 - 240|Completed Study|0
5711571|NCT00116805|19682582|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
5711650|NCT00116753|19682712|P1|Overall Study|Withdrawal by Subject|11
5711572|NCT00116805|19682583|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
5711573|NCT00116805|19682582|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
5711574|NCT00116805|19682583|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
5711575|NCT00116805|19682582|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
5711576|NCT00116805|19682583|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
5711577|NCT00116805|19682582|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
5711578|NCT00116805|19682583|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
5711579|NCT00116805|19682582|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
5711580|NCT00116805|19682583|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
5711581|NCT00116805|19682582|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
5711582|NCT00116805|19682583|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
5711583|NCT00116805|19682582|P2|Open-label Period Weeks 145 - 192|Completed Study|1
5711584|NCT00116805|19682583|P1|Open-label Period Weeks 145 - 192|Completed Study|1
5711585|NCT00116805|19682582|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
5711586|NCT00116805|19682583|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
5711587|NCT00116805|19682582|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
5711588|NCT00116805|19682583|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
5711589|NCT00116805|19682582|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
5711590|NCT00116805|19682583|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
5711591|NCT00116805|19682582|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
5711592|NCT00116805|19682583|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
5711593|NCT00116805|19682582|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
5711594|NCT00116805|19682583|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
5711595|NCT00116805|19682582|P2|Open-label Period Weeks 97 - 144|Completed Study|0
5711596|NCT00116805|19682583|P1|Open-label Period Weeks 97 - 144|Completed Study|1
5711597|NCT00116805|19682582|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
5711598|NCT00116805|19682583|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
5711599|NCT00116805|19682582|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
5711600|NCT00116805|19682583|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
5711601|NCT00116805|19682582|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
5711602|NCT00116805|19682583|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
5711603|NCT00116805|19682582|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
5711604|NCT00116805|19682583|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
5711605|NCT00116805|19682582|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
5711606|NCT00116805|19682583|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
5711607|NCT00116805|19682582|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
5711608|NCT00116805|19682583|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
5711609|NCT00116805|19682582|P2|Double-blind Period Through Week 48|Withdrew Consent|2
5711610|NCT00116805|19682583|P1|Double-blind Period Through Week 48|Withdrew Consent|4
5711611|NCT00116805|19682582|P2|Double-blind Period Through Week 48|Protocol Violation|1
5711612|NCT00116805|19682583|P1|Double-blind Period Through Week 48|Protocol Violation|1
5711613|NCT00116805|19682582|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
5711614|NCT00116805|19682583|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
5711615|NCT00116779|19682676|P2|Overall Study|Elevated PSA levels|2
5711616|NCT00116779|19682677|P1|Overall Study|Elevated PSA levels|2
5711617|NCT00116779|19682676|P2|Overall Study|Physician Decision|1
5711618|NCT00116779|19682677|P1|Overall Study|Physician Decision|3
5711619|NCT00116779|19682676|P2|Overall Study|Inadequate testosterone suppression|9
5711620|NCT00116779|19682677|P1|Overall Study|Inadequate testosterone suppression|7
5711621|NCT00116779|19682676|P2|Overall Study|Withdrawal by Subject|1
5711622|NCT00116779|19682677|P1|Overall Study|Withdrawal by Subject|4
5711623|NCT00116779|19682676|P2|Overall Study|Protocol Violation|4
5711624|NCT00116779|19682677|P1|Overall Study|Protocol Violation|1
5711625|NCT00116779|19682676|P2|Overall Study|Adverse Event|2
5711626|NCT00116779|19682677|P1|Overall Study|Adverse Event|4
5711627|NCT00116753|19682710|P3|Overall Study|Dosing Error|0
5711628|NCT00116753|19682711|P2|Overall Study|Dosing Error|1
5711629|NCT00116753|19682712|P1|Overall Study|Dosing Error|0
5711630|NCT00116753|19682710|P3|Overall Study|Progressive Parkinson's Disease|0
5711631|NCT00116753|19682711|P2|Overall Study|Progressive Parkinson's Disease|0
5711632|NCT00116753|19682712|P1|Overall Study|Progressive Parkinson's Disease|1
5711633|NCT00116753|19682710|P3|Overall Study|Abnormal Echocardiogram|1
5711634|NCT00116753|19682711|P2|Overall Study|Abnormal Echocardiogram|0
5711635|NCT00116753|19682712|P1|Overall Study|Abnormal Echocardiogram|0
5711636|NCT00116753|19682710|P3|Overall Study|Disease Progression|3
5711637|NCT00116753|19682711|P2|Overall Study|Disease Progression|4
5711638|NCT00116753|19682712|P1|Overall Study|Disease Progression|3
5711639|NCT00116753|19682710|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
5711640|NCT00116753|19682711|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
5711641|NCT00116753|19682712|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
5711642|NCT00116753|19682710|P3|Overall Study|Protocol Violation|1
5711643|NCT00116753|19682711|P2|Overall Study|Protocol Violation|0
5711644|NCT00116753|19682712|P1|Overall Study|Protocol Violation|0
5711645|NCT00116753|19682710|P3|Overall Study|Lost to Follow-up|1
5711646|NCT00116753|19682711|P2|Overall Study|Lost to Follow-up|2
5711647|NCT00116753|19682712|P1|Overall Study|Lost to Follow-up|0
5711648|NCT00116753|19682710|P3|Overall Study|Withdrawal by Subject|8
5711649|NCT00116753|19682711|P2|Overall Study|Withdrawal by Subject|12
5711651|NCT00116753|19682710|P3|Overall Study|Adverse Event|7
5711652|NCT00116753|19682711|P2|Overall Study|Adverse Event|10
5711653|NCT00116753|19682712|P1|Overall Study|Adverse Event|16
5711654|NCT00116688|19682734|P2|Overall Study|Other|0
5711655|NCT00116688|19682735|P1|Overall Study|Other|11
5711656|NCT00116688|19682734|P2|Overall Study|Pregnancy|0
5711657|NCT00116688|19682735|P1|Overall Study|Pregnancy|1
5711658|NCT00116688|19682734|P2|Overall Study|Protocol-specified criteria|0
5711659|NCT00116688|19682735|P1|Overall Study|Protocol-specified criteria|3
5711660|NCT00116688|19682734|P2|Overall Study|Death|0
5711661|NCT00116688|19682735|P1|Overall Study|Death|15
5711662|NCT00116688|19682734|P2|Overall Study|Lost to Follow-up|0
5711663|NCT00116688|19682735|P1|Overall Study|Lost to Follow-up|3
5711664|NCT00116688|19682734|P2|Overall Study|Physician Decision|0
5711665|NCT00116688|19682735|P1|Overall Study|Physician Decision|7
5711666|NCT00116688|19682734|P2|Overall Study|Requirement for alternative therapy|1
5711667|NCT00116688|19682735|P1|Overall Study|Requirement for alternative therapy|11
5711668|NCT00116688|19682734|P2|Overall Study|Withdrawal by Subject|2
5711669|NCT00116688|19682735|P1|Overall Study|Withdrawal by Subject|26
5711670|NCT00116688|19682734|P2|Overall Study|Adverse Event|0
5711671|NCT00116688|19682735|P1|Overall Study|Adverse Event|11
5711672|NCT00116688|19682734|P2|Overall Study|Noncompliance|1
5711673|NCT00116688|19682735|P1|Overall Study|Noncompliance|3
5711674|NCT00116688|19682734|P2|Overall Study|Protocol deviation|0
5711675|NCT00116688|19682735|P1|Overall Study|Protocol deviation|1
5711676|NCT00116649|19682750|P1|Overall Study|Protocol Specified|7
5711677|NCT00116649|19682750|P1|Overall Study|Various Reasons|18
5711678|NCT00116649|19682750|P1|Overall Study|Local Skin Reaction|9
5711679|NCT00116649|19682750|P1|Overall Study|Withdrawal by Subject|68
5711680|NCT00116649|19682750|P1|Overall Study|Lost to Follow-up|32
5711681|NCT00116649|19682750|P1|Overall Study|Lack of Efficacy|1
5711682|NCT00116649|19682750|P1|Overall Study|Adverse Event|20
5711683|NCT00116584|19682757|P2|Overall Study|Protocol Violation|1
5711684|NCT00116584|19682758|P1|Overall Study|Protocol Violation|1
5711685|NCT00116584|19682757|P2|Overall Study|Withdrawal by Subject|0
5711686|NCT00116584|19682758|P1|Overall Study|Withdrawal by Subject|1
5711687|NCT00116558|19682771|P3|Overall Study|disease progression|18
5711688|NCT00116558|19682772|P2|Overall Study|disease progression|7
5711689|NCT00116558|19682773|P1|Overall Study|disease progression|3
5711690|NCT00116558|19682771|P3|Overall Study|Withdrawal by Subject|12
5711691|NCT00116558|19682772|P2|Overall Study|Withdrawal by Subject|3
5711692|NCT00116558|19682773|P1|Overall Study|Withdrawal by Subject|17
5711693|NCT00116558|19682771|P3|Overall Study|Death|3
5711694|NCT00116558|19682772|P2|Overall Study|Death|5
5711695|NCT00116558|19682773|P1|Overall Study|Death|11
5711696|NCT00116428|19682784|P2|Overall Study|Did not meet inclusion criteria|0
5711697|NCT00116428|19682785|P1|Overall Study|Did not meet inclusion criteria|1
5711698|NCT00116428|19682784|P2|Overall Study|Withdrawal by Subject|5
5711699|NCT00116428|19682785|P1|Overall Study|Withdrawal by Subject|2
5711700|NCT00116272|19682814|P2|Overall Study|Lost to Follow-up|6
5711701|NCT00116272|19682815|P1|Overall Study|Lost to Follow-up|11
5711702|NCT00116168|19682884|P4|Overall Study|Lost to Follow-up|0
5711703|NCT00116168|19682885|P3|Overall Study|Lost to Follow-up|0
5711704|NCT00116168|19682886|P2|Overall Study|Lost to Follow-up|5
5711705|NCT00116168|19682887|P1|Overall Study|Lost to Follow-up|6
5711706|NCT00115934|19682951|P2|Overall Study|Did not receive intervention|2
5711707|NCT00115934|19682952|P1|Overall Study|Did not receive intervention|3
5711708|NCT00115934|19682951|P2|Overall Study|Lost to Follow-up|0
5711709|NCT00115934|19682952|P1|Overall Study|Lost to Follow-up|1
5711710|NCT00115804|19683001|P1|Overall Study|Adverse Event|2
5711711|NCT00115778|19683012|P2|Overall Study|Withdrawal by Subject|1
5711712|NCT00115778|19683013|P1|Overall Study|Withdrawal by Subject|0
5711713|NCT00115765|19683033|P4|Overall Study|Other|2
5711714|NCT00115765|19683034|P3|Overall Study|Other|9
5711715|NCT00115765|19683035|P2|Overall Study|Other|12
5711716|NCT00115765|19683036|P1|Overall Study|Other|6
5711717|NCT00115765|19683033|P4|Overall Study|Lost to Follow-up|1
5711718|NCT00115765|19683034|P3|Overall Study|Lost to Follow-up|18
5711719|NCT00115765|19683035|P2|Overall Study|Lost to Follow-up|20
5711720|NCT00115765|19683036|P1|Overall Study|Lost to Follow-up|3
5711721|NCT00115765|19683033|P4|Overall Study|Physician Decision|13
5711722|NCT00115765|19683034|P3|Overall Study|Physician Decision|18
5711723|NCT00115765|19683035|P2|Overall Study|Physician Decision|15
5711724|NCT00115765|19683036|P1|Overall Study|Physician Decision|4
5711725|NCT00115765|19683033|P4|Overall Study|Withdrawal by Subject|15
5711726|NCT00115765|19683034|P3|Overall Study|Withdrawal by Subject|76
5711727|NCT00115765|19683035|P2|Overall Study|Withdrawal by Subject|53
5711728|NCT00115765|19683036|P1|Overall Study|Withdrawal by Subject|22
5711729|NCT00115739|19683074|P1|Overall Study|Lost to Follow-up|3
5711730|NCT00115349|19683083|P2|Overall Study|Study closed due to low enrollment.|9
5711731|NCT00115349|19683084|P1|Overall Study|Study closed due to low enrollment.|11
5711732|NCT00115336|19683092|P2|Overall Study|Hospital discharge before study drug|1
5711733|NCT00115336|19683093|P1|Overall Study|Hospital discharge before study drug|0
5711734|NCT00115063|19683130|P2|Overall Study|Death|0
5711735|NCT00115063|19683131|P1|Overall Study|Death|1
5711736|NCT00115063|19683130|P2|Overall Study|Lost to Follow-up|104
5711737|NCT00115063|19683131|P1|Overall Study|Lost to Follow-up|98
5711738|NCT00115037|19683149|P6|Phase2|Lost to Follow-up|10
5711739|NCT00115037|19683150|P5|Phase2|Lost to Follow-up|4
5711740|NCT00115037|19683151|P4|Phase2|Lost to Follow-up|14
5711741|NCT00115037|19683152|P3|Phase2|Lost to Follow-up|12
5711742|NCT00115037|19683153|P2|Phase2|Lost to Follow-up|0
5711743|NCT00115037|19683154|P1|Phase2|Lost to Follow-up|0
5711744|NCT00115037|19683149|P6|Phase2|Withdrawal by Subject|1
5711745|NCT00115037|19683150|P5|Phase2|Withdrawal by Subject|2
5711746|NCT00115037|19683151|P4|Phase2|Withdrawal by Subject|1
5711747|NCT00115037|19683152|P3|Phase2|Withdrawal by Subject|2
5711748|NCT00115037|19683153|P2|Phase2|Withdrawal by Subject|0
5711749|NCT00115037|19683154|P1|Phase2|Withdrawal by Subject|0
5711750|NCT00115037|19683149|P6|Phase2|Death|1
5711751|NCT00115037|19683150|P5|Phase2|Death|0
5711752|NCT00115037|19683151|P4|Phase2|Death|0
5711753|NCT00115037|19683152|P3|Phase2|Death|1
5711754|NCT00115037|19683153|P2|Phase2|Death|0
5711755|NCT00115037|19683154|P1|Phase2|Death|0
5711756|NCT00115037|19683149|P6|Phase1|Withdrawal by Subject|0
5711757|NCT00115037|19683150|P5|Phase1|Withdrawal by Subject|0
5711758|NCT00115037|19683151|P4|Phase1|Withdrawal by Subject|0
5711759|NCT00115037|19683152|P3|Phase1|Withdrawal by Subject|0
5711760|NCT00115037|19683153|P2|Phase1|Withdrawal by Subject|4
5711761|NCT00115037|19683154|P1|Phase1|Withdrawal by Subject|9
5711762|NCT00115037|19683149|P6|Phase1|Lost to Follow-up|0
5711763|NCT00115037|19683150|P5|Phase1|Lost to Follow-up|0
5711764|NCT00115037|19683151|P4|Phase1|Lost to Follow-up|0
5711765|NCT00115037|19683152|P3|Phase1|Lost to Follow-up|0
5711766|NCT00115037|19683153|P2|Phase1|Lost to Follow-up|23
5711767|NCT00115037|19683154|P1|Phase1|Lost to Follow-up|16
5711768|NCT00114972|19683170|P2|Overall Study|Lost to Follow-up|5
5711769|NCT00114972|19683171|P1|Overall Study|Lost to Follow-up|8
5711770|NCT00114972|19683170|P2|Overall Study|Withdrawal by Subject|7
5711771|NCT00114972|19683171|P1|Overall Study|Withdrawal by Subject|40
5711772|NCT00114959|19683191|P1|Overall Study|Death|1
5711773|NCT00114959|19683191|P1|Overall Study|Physician Decision|1
5711774|NCT00114959|19683191|P1|Overall Study|Lack of Efficacy|6
5711775|NCT00114777|19683201|P3|Long-Term Extension to Month 84|Other|2
5711776|NCT00114777|19683202|P2|Long-Term Extension to Month 84|Other|0
5711777|NCT00114777|19683203|P1|Long-Term Extension to Month 84|Other|2
5711778|NCT00114777|19683201|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
5711779|NCT00114777|19683202|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
5711780|NCT00114777|19683203|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
5711781|NCT00114777|19683201|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
5711782|NCT00114777|19683202|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
5711783|NCT00114777|19683203|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
5711784|NCT00114777|19683201|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
5711785|NCT00114777|19683202|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
5711786|NCT00114777|19683203|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
5711787|NCT00114777|19683201|P3|Long-Term Extension to Month 84|Adverse Event|7
5711788|NCT00114777|19683202|P2|Long-Term Extension to Month 84|Adverse Event|14
5711789|NCT00114777|19683203|P1|Long-Term Extension to Month 84|Adverse Event|15
5711790|NCT00114777|19683201|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
5711791|NCT00114777|19683202|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
5711792|NCT00114777|19683203|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
5711793|NCT00114777|19683201|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
5711794|NCT00114777|19683202|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
5711795|NCT00114777|19683203|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
5711796|NCT00114777|19683201|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
5711797|NCT00114777|19683202|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
5711798|NCT00114777|19683203|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
5711799|NCT00114777|19683201|P3|Long-Term Extension to Month 84|Death|7
5711800|NCT00114777|19683202|P2|Long-Term Extension to Month 84|Death|13
5711801|NCT00114777|19683203|P1|Long-Term Extension to Month 84|Death|8
5711802|NCT00114777|19683201|P3|Randomization to Month 36|Other|12
5711803|NCT00114777|19683202|P2|Randomization to Month 36|Other|3
5711804|NCT00114777|19683203|P1|Randomization to Month 36|Other|9
5711805|NCT00114777|19683201|P3|Randomization to Month 36|Withdrawal by Subject|5
5711806|NCT00114777|19683202|P2|Randomization to Month 36|Withdrawal by Subject|4
5711807|NCT00114777|19683203|P1|Randomization to Month 36|Withdrawal by Subject|3
5711808|NCT00114777|19683201|P3|Randomization to Month 36|Adverse Event|44
5711809|NCT00114777|19683202|P2|Randomization to Month 36|Adverse Event|35
5711810|NCT00114777|19683203|P1|Randomization to Month 36|Adverse Event|34
5711811|NCT00114777|19683201|P3|Randomization to Month 36|Poor or Non-Compliance|1
5711812|NCT00114777|19683202|P2|Randomization to Month 36|Poor or Non-Compliance|0
5711813|NCT00114777|19683203|P1|Randomization to Month 36|Poor or Non-Compliance|0
5711814|NCT00114777|19683201|P3|Randomization to Month 36|Lack of Efficacy|17
5711815|NCT00114777|19683202|P2|Randomization to Month 36|Lack of Efficacy|15
5711816|NCT00114777|19683203|P1|Randomization to Month 36|Lack of Efficacy|19
5711817|NCT00114777|19683201|P3|Randomization to Month 36|No Longer Met Study Criteria|2
5711818|NCT00114777|19683202|P2|Randomization to Month 36|No Longer Met Study Criteria|0
5711819|NCT00114777|19683203|P1|Randomization to Month 36|No Longer Met Study Criteria|0
5711820|NCT00114777|19683201|P3|Randomization to Month 36|Death|3
5711821|NCT00114777|19683202|P2|Randomization to Month 36|Death|4
5711822|NCT00114777|19683203|P1|Randomization to Month 36|Death|10
5711823|NCT00114738|19683277|P3|Screening for Randomization|Other|0
5711824|NCT00114738|19683278|P2|Screening for Randomization|Other|0
5711825|NCT00114738|19683279|P1|Screening for Randomization|Other|1
5711826|NCT00114738|19683277|P3|Screening for Randomization|CNS Hemorrhage|0
5711827|NCT00114738|19683278|P2|Screening for Randomization|CNS Hemorrhage|0
5711828|NCT00114738|19683279|P1|Screening for Randomization|CNS Hemorrhage|1
5711829|NCT00114738|19683277|P3|Screening for Randomization|Progressive disease|0
5711830|NCT00114738|19683278|P2|Screening for Randomization|Progressive disease|0
5711831|NCT00114738|19683279|P1|Screening for Randomization|Progressive disease|2
5711832|NCT00114738|19683277|P3|Screening for Randomization|Neuropathy|0
5711833|NCT00114738|19683278|P2|Screening for Randomization|Neuropathy|0
5711834|NCT00114738|19683279|P1|Screening for Randomization|Neuropathy|17
5711835|NCT00114738|19683277|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
5711836|NCT00114738|19683278|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
5711837|NCT00114738|19683279|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
5711838|NCT00114738|19683277|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
5711839|NCT00114738|19683278|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
5711840|NCT00114738|19683279|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
5711841|NCT00114634|19683292|P1|Overall Study|failure to return forms|3
5711842|NCT00114530|19683308|P2|Overall Study|Ineligible|0
5711843|NCT00114530|19683309|P1|Overall Study|Ineligible|1
5711844|NCT00114530|19683308|P2|Overall Study|Subject decision after endpoint failure|1
5711845|NCT00114530|19683309|P1|Overall Study|Subject decision after endpoint failure|0
5711846|NCT00114530|19683308|P2|Overall Study|Breast Cancer|0
5711847|NCT00114530|19683309|P1|Overall Study|Breast Cancer|1
5711848|NCT00114530|19683308|P2|Overall Study|Withdrawal by Subject|6
5711849|NCT00114530|19683309|P1|Overall Study|Withdrawal by Subject|2
5711850|NCT00114530|19683308|P2|Overall Study|Physician Decision|1
5711851|NCT00114530|19683309|P1|Overall Study|Physician Decision|1
5711852|NCT00114530|19683308|P2|Overall Study|Lost to Follow-up|1
5711853|NCT00114530|19683309|P1|Overall Study|Lost to Follow-up|1
5711854|NCT00114530|19683308|P2|Overall Study|Death|11
5711855|NCT00114530|19683309|P1|Overall Study|Death|3
5711856|NCT00114244|19683446|P2|Overall Study|Withdrawal by Subject|2
5711857|NCT00114244|19683447|P1|Overall Study|Withdrawal by Subject|0
5711858|NCT00114244|19683446|P2|Overall Study|Adverse Event|5
5711859|NCT00114244|19683447|P1|Overall Study|Adverse Event|2
5711860|NCT00114231|19683459|P2|Overall Study|Biopsy done after registration|0
5711861|NCT00114231|19683460|P1|Overall Study|Biopsy done after registration|1
5711862|NCT00114231|19683459|P2|Overall Study|No Absolute Neutrophil Count|0
5711863|NCT00114231|19683460|P1|Overall Study|No Absolute Neutrophil Count|2
5711864|NCT00114231|19683459|P2|Overall Study|Tumor fixed on digital exam|1
5711865|NCT00114231|19683460|P1|Overall Study|Tumor fixed on digital exam|0
5711866|NCT00114231|19683459|P2|Overall Study|Tumor size > 4cm|0
5711867|NCT00114231|19683460|P1|Overall Study|Tumor size > 4cm|1
5711868|NCT00114231|19683459|P2|Overall Study|Low creatinine clearance|1
5711869|NCT00114231|19683460|P1|Overall Study|Low creatinine clearance|0
5711870|NCT00114231|19683459|P2|Overall Study|No adenocarcinoma|0
5711871|NCT00114231|19683460|P1|Overall Study|No adenocarcinoma|1
5711872|NCT00114231|19683459|P2|Overall Study|Suspected metastatic disease|0
5711873|NCT00114231|19683460|P1|Overall Study|Suspected metastatic disease|1
5711874|NCT00114231|19683459|P2|Overall Study|QARC requirement not met|0
5711875|NCT00114231|19683460|P1|Overall Study|QARC requirement not met|1
5711876|NCT00114231|19683459|P2|Overall Study|No consent|0
5711877|NCT00114231|19683460|P1|Overall Study|No consent|2
5711878|NCT00114218|19683469|P1|Overall Study|Never Treated|1
5711879|NCT00114218|19683469|P1|Overall Study|Wrong Primary|1
5711880|NCT00114218|19683469|P1|Overall Study|Wrong Cell Type|2
5711881|NCT00114166|19683476|P2|Overall Study|Wrong primary|1
5711882|NCT00114166|19683477|P1|Overall Study|Wrong primary|0
5711883|NCT00114140|19683487|P1|Overall Study|Protocol Violation|7
5711884|NCT00114127|19683501|P2|Overall Study|Withdrawal by Subject|3
5711885|NCT00114127|19683502|P1|Overall Study|Withdrawal by Subject|1
5711886|NCT00114127|19683501|P2|Overall Study|Lost to Follow-up|0
5711887|NCT00114127|19683502|P1|Overall Study|Lost to Follow-up|1
5711888|NCT00114127|19683501|P2|Overall Study|Adverse Event|1
5711889|NCT00114127|19683502|P1|Overall Study|Adverse Event|2
5711890|NCT00113919|19683574|P1|Overall Study|Death|6
5711891|NCT00113919|19683574|P1|Overall Study|Physician Decision|8
5711892|NCT00113841|19683642|P2|Overall Study|Non-compliant|0
5711893|NCT00113841|19683643|P1|Overall Study|Non-compliant|1
5711894|NCT00113841|19683642|P2|Overall Study|Disease progression|2
5711895|NCT00113841|19683643|P1|Overall Study|Disease progression|0
5711896|NCT00113763|19683651|P2|Overall Study|Ongoing|0
5711897|NCT00113763|19683652|P1|Overall Study|Ongoing|1
5711898|NCT00113763|19683651|P2|Overall Study|Non-compliance|0
5711899|NCT00113763|19683652|P1|Overall Study|Non-compliance|1
5711900|NCT00113763|19683651|P2|Overall Study|Other|6
5711901|NCT00113763|19683652|P1|Overall Study|Other|27
5711902|NCT00113763|19683651|P2|Overall Study|Withdrawal by Subject|4
5711903|NCT00113763|19683652|P1|Overall Study|Withdrawal by Subject|1
5711904|NCT00113763|19683651|P2|Overall Study|Lost to Follow-up|0
5711905|NCT00113763|19683652|P1|Overall Study|Lost to Follow-up|10
5711906|NCT00113763|19683651|P2|Overall Study|Disease Progression|14
5711907|NCT00113763|19683652|P1|Overall Study|Disease Progression|28
5711908|NCT00113763|19683651|P2|Overall Study|Adverse Event|2
5711909|NCT00113763|19683652|P1|Overall Study|Adverse Event|5
5711910|NCT00113607|19683678|P2|Overall Study|Other|32
5711911|NCT00113607|19683679|P1|Overall Study|Other|43
5711912|NCT00113607|19683678|P2|Overall Study|Complete Response (Confirmed)|24
5711913|NCT00113607|19683679|P1|Overall Study|Complete Response (Confirmed)|14
5711914|NCT00113607|19683678|P2|Overall Study|Disease Progression|142
5711915|NCT00113607|19683679|P1|Overall Study|Disease Progression|180
5711916|NCT00113607|19683678|P2|Overall Study|Lost to Follow-up|2
5711917|NCT00113607|19683679|P1|Overall Study|Lost to Follow-up|0
5711918|NCT00113607|19683678|P2|Overall Study|Withdrawal by Subject|58
5711919|NCT00113607|19683679|P1|Overall Study|Withdrawal by Subject|50
5711920|NCT00113607|19683678|P2|Overall Study|Death|8
5711921|NCT00113607|19683679|P1|Overall Study|Death|8
5711922|NCT00113607|19683678|P2|Overall Study|Adverse Event|71
5711923|NCT00113607|19683679|P1|Overall Study|Adverse Event|40
5711924|NCT00113568|19683693|P1|Overall Study|Other|112
5711925|NCT00113568|19683693|P1|Overall Study|Withdrawal by Subject|117
5711926|NCT00113568|19683693|P1|Overall Study|Protocol Violation|32
5711927|NCT00113568|19683693|P1|Overall Study|Lost to Follow-up|156
5711928|NCT00113568|19683693|P1|Overall Study|Lack of Efficacy|30
5711929|NCT00113568|19683693|P1|Overall Study|Death|1
5711930|NCT00113568|19683693|P1|Overall Study|Adverse Event|97
5711931|NCT00113555|19683705|P1|Overall Study|Lost to Follow-up|8
5711932|NCT00113555|19683705|P1|Overall Study|Missed Followup|4
5711933|NCT00113555|19683705|P1|Overall Study|Death|1
5711934|NCT00113555|19683705|P1|Overall Study|Permanently Explanted|7
5711935|NCT00113555|19683705|P1|Overall Study|Baseline Failure|59
5711936|NCT00113529|19683715|P1|Overall Study|Withdrawal by Subject|4
5711937|NCT00113529|19683715|P1|Overall Study|Decision of sponsor|6
5711938|NCT00113529|19683715|P1|Overall Study|Lack of Efficacy|20
5711939|NCT00113529|19683715|P1|Overall Study|Adverse Event|4
5711940|NCT00113516|19683748|P2|Part 2|Ongoing|1
5711941|NCT00113516|19683749|P1|Part 2|Ongoing|0
5711942|NCT00113516|19683748|P2|Part 2|Laboratory Abnormality|1
5711943|NCT00113516|19683749|P1|Part 2|Laboratory Abnormality|0
5711944|NCT00113516|19683748|P2|Part 2|Other|3
5711945|NCT00113516|19683749|P1|Part 2|Other|0
5711946|NCT00113516|19683748|P2|Part 2|Withdrawal by Subject|3
5711947|NCT00113516|19683749|P1|Part 2|Withdrawal by Subject|0
5711948|NCT00113516|19683748|P2|Part 2|Lack of Efficacy|37
5711949|NCT00113516|19683749|P1|Part 2|Lack of Efficacy|0
5711950|NCT00113516|19683748|P2|Part 2|Death|5
5711951|NCT00113516|19683749|P1|Part 2|Death|0
5711952|NCT00113516|19683748|P2|Part 2|Adverse Event|16
5711953|NCT00113516|19683749|P1|Part 2|Adverse Event|0
5711954|NCT00113516|19683748|P2|Part 1|Missing|0
5711955|NCT00113516|19683749|P1|Part 1|Missing|65
5711956|NCT00113516|19683748|P2|Part 1|Ongoing|0
5711957|NCT00113516|19683749|P1|Part 1|Ongoing|1
5711958|NCT00113516|19683748|P2|Part 1|Laboratory Abnormality|0
5711959|NCT00113516|19683749|P1|Part 1|Laboratory Abnormality|1
5711960|NCT00113516|19683748|P2|Part 1|Did Not Meet Entrance Criteria|0
5711961|NCT00113516|19683749|P1|Part 1|Did Not Meet Entrance Criteria|1
5711962|NCT00113516|19683748|P2|Part 1|Lack of Efficacy|0
5711963|NCT00113516|19683749|P1|Part 1|Lack of Efficacy|2
5711964|NCT00113516|19683748|P2|Part 1|Withdrawal by Subject|0
5711965|NCT00113516|19683749|P1|Part 1|Withdrawal by Subject|2
5711966|NCT00113516|19683748|P2|Part 1|Other|0
5711967|NCT00113516|19683749|P1|Part 1|Other|3
5711968|NCT00113516|19683748|P2|Part 1|Death|0
5711969|NCT00113516|19683749|P1|Part 1|Death|3
5711970|NCT00113516|19683748|P2|Part 1|Adverse Event|0
5711971|NCT00113516|19683749|P1|Part 1|Adverse Event|6
5711972|NCT00113490|19683792|P2|Overall Study|Lost to Follow-up|0
5711973|NCT00113490|19683793|P1|Overall Study|Lost to Follow-up|1
5711974|NCT00113490|19683792|P2|Overall Study|Withdrawal by Subject|3
5711975|NCT00113490|19683793|P1|Overall Study|Withdrawal by Subject|1
5711976|NCT00113399|19683826|P2|Overall Study|Other|1
5711977|NCT00113399|19683827|P1|Overall Study|Other|0
5711978|NCT00113399|19683826|P2|Overall Study|Complete Response|1
5711979|NCT00113399|19683827|P1|Overall Study|Complete Response|0
5711980|NCT00113399|19683826|P2|Overall Study|Withdrawal by Subject|2
5711981|NCT00113399|19683827|P1|Overall Study|Withdrawal by Subject|1
5711982|NCT00113399|19683826|P2|Overall Study|Death|1
5711983|NCT00113399|19683827|P1|Overall Study|Death|1
5711984|NCT00113386|19683835|P2|Overall Study|Unknown - Lost to Follow-Up|1
5711985|NCT00113386|19683836|P1|Overall Study|Unknown - Lost to Follow-Up|2
5711986|NCT00113386|19683835|P2|Overall Study|Ineligible|2
5711987|NCT00113386|19683836|P1|Overall Study|Ineligible|1
5711988|NCT00113386|19683835|P2|Overall Study|Toxicity|0
5711989|NCT00113386|19683836|P1|Overall Study|Toxicity|3
5711990|NCT00113386|19683835|P2|Overall Study|Physician Decision|1
5711991|NCT00113386|19683836|P1|Overall Study|Physician Decision|0
5711992|NCT00113386|19683835|P2|Overall Study|Withdrawal by Subject|0
5711993|NCT00113386|19683836|P1|Overall Study|Withdrawal by Subject|1
5711994|NCT00113373|19683842|P1|Overall Study|Never Treated|1
5711995|NCT00113373|19683842|P1|Overall Study|Ineligible: second primary|1
5711996|NCT00113373|19683842|P1|Overall Study|Ineligible: wrong primary|1
5711997|NCT00113360|19683857|P1|Overall Study|Did not meet eligibility criteria|3
5711998|NCT00113360|19683857|P1|Overall Study|Subject required surgery|1
5711999|NCT00113360|19683857|P1|Overall Study|Adverse Event|3
5712000|NCT00113295|19683871|P2|Overall Study|Unrelated Medical Illness|0
5712001|NCT00113295|19683872|P1|Overall Study|Unrelated Medical Illness|1
5712002|NCT00113295|19683871|P2|Overall Study|Adverse Event|1
5712003|NCT00113295|19683872|P1|Overall Study|Adverse Event|4
5712004|NCT00113269|19683891|P4|Overall Study|Unable to return for follow up|0
5712005|NCT00113269|19683892|P3|Overall Study|Unable to return for follow up|0
5712006|NCT00113269|19683893|P2|Overall Study|Unable to return for follow up|1
5712007|NCT00113269|19683894|P1|Overall Study|Unable to return for follow up|2
5712008|NCT00113269|19683891|P4|Overall Study|Did not meet eligibility criteria|1
5712009|NCT00113269|19683892|P3|Overall Study|Did not meet eligibility criteria|0
5712010|NCT00113269|19683893|P2|Overall Study|Did not meet eligibility criteria|0
5712011|NCT00113269|19683894|P1|Overall Study|Did not meet eligibility criteria|1
5712012|NCT00113269|19683891|P4|Overall Study|Withdrew consent, Prednisone initiated|1
5712013|NCT00113269|19683892|P3|Overall Study|Withdrew consent, Prednisone initiated|0
5712014|NCT00113269|19683893|P2|Overall Study|Withdrew consent, Prednisone initiated|0
5712015|NCT00113269|19683894|P1|Overall Study|Withdrew consent, Prednisone initiated|0
5712016|NCT00113269|19683891|P4|Overall Study|Received pancreas transplant|2
5712017|NCT00113269|19683892|P3|Overall Study|Received pancreas transplant|0
5712018|NCT00113269|19683893|P2|Overall Study|Received pancreas transplant|0
5712019|NCT00113269|19683894|P1|Overall Study|Received pancreas transplant|0
5712020|NCT00113269|19683891|P4|Overall Study|Moved|3
5712021|NCT00113269|19683892|P3|Overall Study|Moved|0
5712022|NCT00113269|19683893|P2|Overall Study|Moved|1
5712023|NCT00113269|19683894|P1|Overall Study|Moved|0
5712024|NCT00113269|19683891|P4|Overall Study|Discontinued due to rejection|0
5712025|NCT00113269|19683892|P3|Overall Study|Discontinued due to rejection|1
5712026|NCT00113269|19683893|P2|Overall Study|Discontinued due to rejection|0
5712027|NCT00113269|19683894|P1|Overall Study|Discontinued due to rejection|0
5712028|NCT00113269|19683891|P4|Overall Study|Sponsor elected to discontinue patient|1
5712029|NCT00113269|19683892|P3|Overall Study|Sponsor elected to discontinue patient|0
5712030|NCT00113269|19683893|P2|Overall Study|Sponsor elected to discontinue patient|0
5712031|NCT00113269|19683894|P1|Overall Study|Sponsor elected to discontinue patient|1
5712032|NCT00113269|19683891|P4|Overall Study|Lost to Follow-up|3
5712033|NCT00113269|19683892|P3|Overall Study|Lost to Follow-up|6
5712034|NCT00113269|19683893|P2|Overall Study|Lost to Follow-up|3
5712035|NCT00113269|19683894|P1|Overall Study|Lost to Follow-up|2
5712036|NCT00113269|19683891|P4|Overall Study|Protocol Violation|2
5712037|NCT00113269|19683892|P3|Overall Study|Protocol Violation|4
5712038|NCT00113269|19683893|P2|Overall Study|Protocol Violation|0
5712039|NCT00113269|19683894|P1|Overall Study|Protocol Violation|1
5712040|NCT00113269|19683891|P4|Overall Study|Graft loss|9
5712041|NCT00113269|19683892|P3|Overall Study|Graft loss|4
5712042|NCT00113269|19683893|P2|Overall Study|Graft loss|6
5712043|NCT00113269|19683894|P1|Overall Study|Graft loss|6
5712044|NCT00113269|19683891|P4|Overall Study|Withdrawal by Subject|2
5712045|NCT00113269|19683892|P3|Overall Study|Withdrawal by Subject|4
5712046|NCT00113269|19683893|P2|Overall Study|Withdrawal by Subject|3
5712047|NCT00113269|19683894|P1|Overall Study|Withdrawal by Subject|4
5712048|NCT00113269|19683891|P4|Overall Study|Adverse Event|7
5712049|NCT00113269|19683892|P3|Overall Study|Adverse Event|11
5712050|NCT00113269|19683893|P2|Overall Study|Adverse Event|7
5712051|NCT00113269|19683894|P1|Overall Study|Adverse Event|2
5712052|NCT00113269|19683891|P4|Overall Study|Did not meet eligibility - pre-treatment|2
5712053|NCT00113269|19683892|P3|Overall Study|Did not meet eligibility - pre-treatment|0
5712054|NCT00113269|19683893|P2|Overall Study|Did not meet eligibility - pre-treatment|0
5712055|NCT00113269|19683894|P1|Overall Study|Did not meet eligibility - pre-treatment|0
5712056|NCT00113269|19683891|P4|Overall Study|Death in operating room|1
5712057|NCT00113269|19683892|P3|Overall Study|Death in operating room|0
5712058|NCT00113269|19683893|P2|Overall Study|Death in operating room|0
5712059|NCT00113269|19683894|P1|Overall Study|Death in operating room|0
5712060|NCT00113269|19683891|P4|Overall Study|Early graft loss, technical|0
5712061|NCT00113269|19683892|P3|Overall Study|Early graft loss, technical|2
5712062|NCT00113269|19683893|P2|Overall Study|Early graft loss, technical|0
5712063|NCT00113269|19683894|P1|Overall Study|Early graft loss, technical|0
5712064|NCT00113269|19683891|P4|Overall Study|Not transplanted, recipient issues|4
5712065|NCT00113269|19683892|P3|Overall Study|Not transplanted, recipient issues|7
5712066|NCT00113269|19683893|P2|Overall Study|Not transplanted, recipient issues|1
5712067|NCT00113269|19683894|P1|Overall Study|Not transplanted, recipient issues|2
5712068|NCT00113269|19683891|P4|Overall Study|Not transplanted, donor issues|2
5712069|NCT00113269|19683892|P3|Overall Study|Not transplanted, donor issues|2
5712070|NCT00113269|19683893|P2|Overall Study|Not transplanted, donor issues|0
5712071|NCT00113269|19683894|P1|Overall Study|Not transplanted, donor issues|4
5712072|NCT00113087|19683954|P2|Overall Study|Family or MD withdrew subject|5
5712073|NCT00113087|19683955|P1|Overall Study|Family or MD withdrew subject|10
5712074|NCT00113087|19683954|P2|Overall Study|Death or Transplant|16
5712075|NCT00113087|19683955|P1|Overall Study|Death or Transplant|14
5712076|NCT00112957|19684026|P1|Overall Study|Physician Decision|1
5712077|NCT00112957|19684026|P1|Overall Study|Progressive disease|18
5712078|NCT00112905|19684066|P1|Overall Study|performance status was deteiorating|1
5712079|NCT00112905|19684066|P1|Overall Study|Alternative treatment|1
5712080|NCT00112905|19684066|P1|Overall Study|Ineligibility|5
5712081|NCT00112905|19684066|P1|Overall Study|Death|1
5712082|NCT00112905|19684066|P1|Overall Study|Adverse Event|4
5712083|NCT00112866|19684075|P2|Overall Study|did not start treatment post-op|2
5712084|NCT00112866|19684076|P1|Overall Study|did not start treatment post-op|1
5712085|NCT00112866|19684075|P2|Overall Study|Protocol Violation|0
5712086|NCT00112866|19684076|P1|Overall Study|Protocol Violation|1
5712087|NCT00112840|19684098|P3|Overall Study|Protocol Violation|5
5712088|NCT00112840|19684099|P2|Overall Study|Protocol Violation|0
5712089|NCT00112840|19684100|P1|Overall Study|Protocol Violation|0
5712090|NCT00112840|19684098|P3|Overall Study|Withdrawal by Subject|1
5712091|NCT00112840|19684099|P2|Overall Study|Withdrawal by Subject|0
5712092|NCT00112840|19684100|P1|Overall Study|Withdrawal by Subject|1
5712093|NCT00112840|19684098|P3|Overall Study|Physician Decision|0
5712094|NCT00112840|19684099|P2|Overall Study|Physician Decision|0
5712095|NCT00112840|19684100|P1|Overall Study|Physician Decision|1
5712096|NCT00112736|19684119|P2|Overall Study|1 pt never had had RX due rapid decline|0
5712097|NCT00112736|19684120|P1|Overall Study|1 pt never had had RX due rapid decline|1
5712098|NCT00112489|19684177|P1|Overall Study|Ineligible|7
5712099|NCT00112489|19684177|P1|Overall Study|Patient never treated|2
5712100|NCT00112489|19684177|P1|Overall Study|Other, Not Specified|9
5712101|NCT00112489|19684177|P1|Overall Study|Death|2
5712102|NCT00112489|19684177|P1|Overall Study|Adverse Event|12
5712103|NCT00112489|19684177|P1|Overall Study|Refused further treatment|8
5712104|NCT00112463|19684187|P1|Overall Study|Never started treatment|2
5712105|NCT00112463|19684187|P1|Overall Study|Withdrawal by Subject|2
5712106|NCT00112463|19684187|P1|Overall Study|Toxicity|3
5712107|NCT00112463|19684187|P1|Overall Study|Second Primary|1
5712108|NCT00112463|19684187|P1|Overall Study|Progression|30
5712109|NCT00112463|19684187|P1|Overall Study|Physician Decision|1
5712110|NCT00112437|19684199|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
5712111|NCT00112437|19684200|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712112|NCT00112437|19684201|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
5712113|NCT00112437|19684202|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
5712114|NCT00112437|19684203|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712115|NCT00112437|19684204|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712116|NCT00112437|19684205|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712117|NCT00112437|19684206|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712118|NCT00112437|19684207|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712119|NCT00112437|19684208|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712120|NCT00112437|19684209|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712121|NCT00112437|19684210|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712122|NCT00112437|19684211|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712123|NCT00112437|19684212|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712124|NCT00112437|19684213|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712125|NCT00112437|19684214|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712126|NCT00112437|19684215|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712127|NCT00112437|19684216|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712128|NCT00112437|19684217|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712129|NCT00112437|19684218|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712130|NCT00112437|19684219|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712131|NCT00112437|19684220|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712132|NCT00112437|19684221|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712133|NCT00112437|19684222|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712134|NCT00112437|19684223|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712135|NCT00112437|19684224|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
5712136|NCT00112437|19684199|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
5712137|NCT00112437|19684200|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
5712138|NCT00112437|19684201|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
5712139|NCT00112437|19684202|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
5712140|NCT00112437|19684203|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
5712141|NCT00112437|19684204|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
5712142|NCT00112437|19684205|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
5712143|NCT00112437|19684206|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
5712144|NCT00112437|19684207|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
5712145|NCT00112437|19684208|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
5712146|NCT00112437|19684209|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
5712147|NCT00112437|19684210|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
5712148|NCT00112437|19684211|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
5712149|NCT00112437|19684212|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
5712150|NCT00112437|19684213|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
5712151|NCT00112437|19684214|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
5712152|NCT00112437|19684215|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
5712153|NCT00112437|19684216|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
5712154|NCT00112437|19684217|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
5712155|NCT00112437|19684218|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
5712156|NCT00112437|19684219|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
5712157|NCT00112437|19684220|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
5712158|NCT00112437|19684221|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
5712159|NCT00112437|19684222|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
5712160|NCT00112437|19684223|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
5712161|NCT00112437|19684224|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
5712162|NCT00112437|19684199|P26|Years 6-10 (60-Month Extension)|Other|0
5712163|NCT00112437|19684200|P25|Years 6-10 (60-Month Extension)|Other|1
5712164|NCT00112437|19684201|P24|Years 6-10 (60-Month Extension)|Other|0
5712165|NCT00112437|19684202|P23|Years 6-10 (60-Month Extension)|Other|0
5712166|NCT00112437|19684203|P22|Years 6-10 (60-Month Extension)|Other|0
5712167|NCT00112437|19684204|P21|Years 6-10 (60-Month Extension)|Other|0
5712168|NCT00112437|19684205|P20|Years 6-10 (60-Month Extension)|Other|0
5712169|NCT00112437|19684206|P19|Years 6-10 (60-Month Extension)|Other|0
5712170|NCT00112437|19684207|P18|Years 6-10 (60-Month Extension)|Other|0
5712171|NCT00112437|19684208|P17|Years 6-10 (60-Month Extension)|Other|0
5712172|NCT00112437|19684209|P16|Years 6-10 (60-Month Extension)|Other|0
5712173|NCT00112437|19684210|P15|Years 6-10 (60-Month Extension)|Other|0
5712174|NCT00112437|19684211|P14|Years 6-10 (60-Month Extension)|Other|0
5712175|NCT00112437|19684212|P13|Years 6-10 (60-Month Extension)|Other|0
5712176|NCT00112437|19684213|P12|Years 6-10 (60-Month Extension)|Other|0
5712177|NCT00112437|19684214|P11|Years 6-10 (60-Month Extension)|Other|0
5712178|NCT00112437|19684215|P10|Years 6-10 (60-Month Extension)|Other|0
5712179|NCT00112437|19684216|P9|Years 6-10 (60-Month Extension)|Other|0
5712180|NCT00112437|19684217|P8|Years 6-10 (60-Month Extension)|Other|0
5712181|NCT00112437|19684218|P7|Years 6-10 (60-Month Extension)|Other|0
5712182|NCT00112437|19684219|P6|Years 6-10 (60-Month Extension)|Other|0
5712183|NCT00112437|19684220|P5|Years 6-10 (60-Month Extension)|Other|0
5712184|NCT00112437|19684221|P4|Years 6-10 (60-Month Extension)|Other|0
5712185|NCT00112437|19684222|P3|Years 6-10 (60-Month Extension)|Other|0
5712186|NCT00112437|19684223|P2|Years 6-10 (60-Month Extension)|Other|0
5712187|NCT00112437|19684224|P1|Years 6-10 (60-Month Extension)|Other|0
5712188|NCT00112437|19684199|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
5712189|NCT00112437|19684200|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712190|NCT00112437|19684201|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712191|NCT00112437|19684202|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712192|NCT00112437|19684203|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712193|NCT00112437|19684204|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712194|NCT00112437|19684205|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712195|NCT00112437|19684206|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712196|NCT00112437|19684207|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712197|NCT00112437|19684208|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712198|NCT00112437|19684209|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712199|NCT00112437|19684210|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712200|NCT00112437|19684211|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712201|NCT00112437|19684212|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712202|NCT00112437|19684213|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712203|NCT00112437|19684214|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712204|NCT00112437|19684215|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712205|NCT00112437|19684216|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712206|NCT00112437|19684217|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712207|NCT00112437|19684218|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712208|NCT00112437|19684219|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712209|NCT00112437|19684220|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712210|NCT00112437|19684221|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712211|NCT00112437|19684222|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712212|NCT00112437|19684223|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712213|NCT00112437|19684224|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
5712214|NCT00112437|19684199|P26|Years 6-10 (60-Month Extension)|Death|0
5712215|NCT00112437|19684200|P25|Years 6-10 (60-Month Extension)|Death|0
5712216|NCT00112437|19684201|P24|Years 6-10 (60-Month Extension)|Death|2
5712217|NCT00112437|19684202|P23|Years 6-10 (60-Month Extension)|Death|0
5712218|NCT00112437|19684203|P22|Years 6-10 (60-Month Extension)|Death|0
5712219|NCT00112437|19684204|P21|Years 6-10 (60-Month Extension)|Death|0
5712220|NCT00112437|19684205|P20|Years 6-10 (60-Month Extension)|Death|0
5712221|NCT00112437|19684206|P19|Years 6-10 (60-Month Extension)|Death|0
5712222|NCT00112437|19684207|P18|Years 6-10 (60-Month Extension)|Death|0
5712223|NCT00112437|19684208|P17|Years 6-10 (60-Month Extension)|Death|0
5712224|NCT00112437|19684209|P16|Years 6-10 (60-Month Extension)|Death|0
5712225|NCT00112437|19684210|P15|Years 6-10 (60-Month Extension)|Death|0
5712226|NCT00112437|19684211|P14|Years 6-10 (60-Month Extension)|Death|0
5712227|NCT00112437|19684212|P13|Years 6-10 (60-Month Extension)|Death|0
5712228|NCT00112437|19684213|P12|Years 6-10 (60-Month Extension)|Death|0
5712229|NCT00112437|19684214|P11|Years 6-10 (60-Month Extension)|Death|0
5712230|NCT00112437|19684215|P10|Years 6-10 (60-Month Extension)|Death|0
5712231|NCT00112437|19684216|P9|Years 6-10 (60-Month Extension)|Death|0
5712232|NCT00112437|19684217|P8|Years 6-10 (60-Month Extension)|Death|0
5712233|NCT00112437|19684218|P7|Years 6-10 (60-Month Extension)|Death|0
5712234|NCT00112437|19684219|P6|Years 6-10 (60-Month Extension)|Death|0
5712235|NCT00112437|19684220|P5|Years 6-10 (60-Month Extension)|Death|0
5712236|NCT00112437|19684221|P4|Years 6-10 (60-Month Extension)|Death|0
5712237|NCT00112437|19684222|P3|Years 6-10 (60-Month Extension)|Death|0
5712238|NCT00112437|19684223|P2|Years 6-10 (60-Month Extension)|Death|0
5712239|NCT00112437|19684224|P1|Years 6-10 (60-Month Extension)|Death|0
5712240|NCT00112437|19684199|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
5712241|NCT00112437|19684200|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
5712242|NCT00112437|19684201|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
5712243|NCT00112437|19684202|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
5712244|NCT00112437|19684203|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
5712245|NCT00112437|19684204|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
5712246|NCT00112437|19684205|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
5712247|NCT00112437|19684206|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
5712248|NCT00112437|19684207|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
5712249|NCT00112437|19684208|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
5712250|NCT00112437|19684209|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
5712251|NCT00112437|19684210|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
5712252|NCT00112437|19684211|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
5712253|NCT00112437|19684212|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
5712254|NCT00112437|19684213|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
5712255|NCT00112437|19684214|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
5712256|NCT00112437|19684215|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
5712257|NCT00112437|19684216|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
5712258|NCT00112437|19684217|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
5712259|NCT00112437|19684218|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
5712260|NCT00112437|19684219|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
5712261|NCT00112437|19684220|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
5712262|NCT00112437|19684221|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
5712263|NCT00112437|19684222|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
5712264|NCT00112437|19684223|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
5712265|NCT00112437|19684224|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
5712266|NCT00112437|19684199|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712267|NCT00112437|19684200|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712268|NCT00112437|19684201|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712269|NCT00112437|19684202|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712270|NCT00112437|19684203|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
5712271|NCT00112437|19684204|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
5712272|NCT00112437|19684205|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712273|NCT00112437|19684206|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712274|NCT00112437|19684207|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712275|NCT00112437|19684208|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712276|NCT00112437|19684209|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712277|NCT00112437|19684210|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712278|NCT00112437|19684211|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712279|NCT00112437|19684212|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712280|NCT00112437|19684213|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712281|NCT00112437|19684214|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712282|NCT00112437|19684215|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712283|NCT00112437|19684216|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712284|NCT00112437|19684217|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712285|NCT00112437|19684218|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712286|NCT00112437|19684219|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712287|NCT00112437|19684220|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712288|NCT00112437|19684221|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712289|NCT00112437|19684222|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712290|NCT00112437|19684223|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712291|NCT00112437|19684224|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
5712292|NCT00112437|19684199|P26|Years 4-5 (24-Month Extension)|Participant moved|0
5712293|NCT00112437|19684200|P25|Years 4-5 (24-Month Extension)|Participant moved|0
5712294|NCT00112437|19684201|P24|Years 4-5 (24-Month Extension)|Participant moved|0
5712295|NCT00112437|19684202|P23|Years 4-5 (24-Month Extension)|Participant moved|0
5712296|NCT00112437|19684203|P22|Years 4-5 (24-Month Extension)|Participant moved|1
5712297|NCT00112437|19684204|P21|Years 4-5 (24-Month Extension)|Participant moved|0
5712298|NCT00112437|19684205|P20|Years 4-5 (24-Month Extension)|Participant moved|0
5712299|NCT00112437|19684206|P19|Years 4-5 (24-Month Extension)|Participant moved|0
5712300|NCT00112437|19684207|P18|Years 4-5 (24-Month Extension)|Participant moved|0
5712301|NCT00112437|19684208|P17|Years 4-5 (24-Month Extension)|Participant moved|0
5712302|NCT00112437|19684209|P16|Years 4-5 (24-Month Extension)|Participant moved|0
5712303|NCT00112437|19684210|P15|Years 4-5 (24-Month Extension)|Participant moved|0
5712304|NCT00112437|19684211|P14|Years 4-5 (24-Month Extension)|Participant moved|0
5712305|NCT00112437|19684212|P13|Years 4-5 (24-Month Extension)|Participant moved|0
5712306|NCT00112437|19684213|P12|Years 4-5 (24-Month Extension)|Participant moved|0
5712307|NCT00112437|19684214|P11|Years 4-5 (24-Month Extension)|Participant moved|0
5712308|NCT00112437|19684215|P10|Years 4-5 (24-Month Extension)|Participant moved|0
5712309|NCT00112437|19684216|P9|Years 4-5 (24-Month Extension)|Participant moved|0
5712310|NCT00112437|19684217|P8|Years 4-5 (24-Month Extension)|Participant moved|0
5712311|NCT00112437|19684218|P7|Years 4-5 (24-Month Extension)|Participant moved|0
5712312|NCT00112437|19684219|P6|Years 4-5 (24-Month Extension)|Participant moved|0
5712313|NCT00112437|19684220|P5|Years 4-5 (24-Month Extension)|Participant moved|0
5712314|NCT00112437|19684221|P4|Years 4-5 (24-Month Extension)|Participant moved|0
5712315|NCT00112437|19684222|P3|Years 4-5 (24-Month Extension)|Participant moved|0
5712316|NCT00112437|19684223|P2|Years 4-5 (24-Month Extension)|Participant moved|0
5712317|NCT00112437|19684224|P1|Years 4-5 (24-Month Extension)|Participant moved|0
5712318|NCT00112437|19684199|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
5712319|NCT00112437|19684200|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
5712320|NCT00112437|19684201|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
5712321|NCT00112437|19684202|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
5712322|NCT00112437|19684203|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
5712323|NCT00112437|19684204|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
5712324|NCT00112437|19684205|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
5712325|NCT00112437|19684206|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
5712326|NCT00112437|19684207|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
5712327|NCT00112437|19684208|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
5712328|NCT00112437|19684209|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
5712329|NCT00112437|19684210|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
5712330|NCT00112437|19684211|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
5712331|NCT00112437|19684212|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
5712332|NCT00112437|19684213|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
5712333|NCT00112437|19684214|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
5712334|NCT00112437|19684215|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
5712335|NCT00112437|19684216|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
5712336|NCT00112437|19684217|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
5712337|NCT00112437|19684218|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
5712338|NCT00112437|19684219|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
5712339|NCT00112437|19684220|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
5712340|NCT00112437|19684221|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
5712341|NCT00112437|19684222|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
5712342|NCT00112437|19684223|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
5712343|NCT00112437|19684224|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
5712344|NCT00112437|19684199|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712345|NCT00112437|19684200|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712346|NCT00112437|19684201|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712347|NCT00112437|19684202|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712348|NCT00112437|19684203|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712349|NCT00112437|19684204|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
5712350|NCT00112437|19684205|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712351|NCT00112437|19684206|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712352|NCT00112437|19684207|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712353|NCT00112437|19684208|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712354|NCT00112437|19684209|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712355|NCT00112437|19684210|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712356|NCT00112437|19684211|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712357|NCT00112437|19684212|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712358|NCT00112437|19684213|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712359|NCT00112437|19684214|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712360|NCT00112437|19684215|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712361|NCT00112437|19684216|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712362|NCT00112437|19684217|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712363|NCT00112437|19684218|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712364|NCT00112437|19684219|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712365|NCT00112437|19684220|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712366|NCT00112437|19684221|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712367|NCT00112437|19684222|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712368|NCT00112437|19684223|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712369|NCT00112437|19684224|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
5712370|NCT00112437|19684199|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712371|NCT00112437|19684200|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712372|NCT00112437|19684201|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712373|NCT00112437|19684202|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712374|NCT00112437|19684203|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
5712375|NCT00112437|19684204|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
5712376|NCT00112437|19684205|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712377|NCT00112437|19684206|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712378|NCT00112437|19684207|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712379|NCT00112437|19684208|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712380|NCT00112437|19684209|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712381|NCT00112437|19684210|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712382|NCT00112437|19684211|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712383|NCT00112437|19684212|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712384|NCT00112437|19684213|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712385|NCT00112437|19684214|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712386|NCT00112437|19684215|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712387|NCT00112437|19684216|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712388|NCT00112437|19684217|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712389|NCT00112437|19684218|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712390|NCT00112437|19684219|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712391|NCT00112437|19684220|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712392|NCT00112437|19684221|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712393|NCT00112437|19684222|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712394|NCT00112437|19684223|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712395|NCT00112437|19684224|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
5712396|NCT00112437|19684199|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712397|NCT00112437|19684200|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712398|NCT00112437|19684201|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712399|NCT00112437|19684202|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712400|NCT00112437|19684203|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712401|NCT00112437|19684204|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712402|NCT00112437|19684205|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712403|NCT00112437|19684206|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712404|NCT00112437|19684207|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712405|NCT00112437|19684208|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712406|NCT00112437|19684209|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712407|NCT00112437|19684210|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712408|NCT00112437|19684211|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712409|NCT00112437|19684212|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712410|NCT00112437|19684213|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
5712411|NCT00112437|19684214|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
5712412|NCT00112437|19684215|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712413|NCT00112437|19684216|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712414|NCT00112437|19684217|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712415|NCT00112437|19684218|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712416|NCT00112437|19684219|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712417|NCT00112437|19684220|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712418|NCT00112437|19684221|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712419|NCT00112437|19684222|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712420|NCT00112437|19684223|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712421|NCT00112437|19684224|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
5712422|NCT00112437|19684199|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712423|NCT00112437|19684200|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712424|NCT00112437|19684201|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712425|NCT00112437|19684202|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712426|NCT00112437|19684203|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712427|NCT00112437|19684204|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712428|NCT00112437|19684205|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712429|NCT00112437|19684206|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712430|NCT00112437|19684207|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712431|NCT00112437|19684208|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712432|NCT00112437|19684209|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712433|NCT00112437|19684210|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
5712434|NCT00112437|19684211|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712435|NCT00112437|19684212|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712436|NCT00112437|19684213|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
5712437|NCT00112437|19684214|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712438|NCT00112437|19684215|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712439|NCT00112437|19684216|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712440|NCT00112437|19684217|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712441|NCT00112437|19684218|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712442|NCT00112437|19684219|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712443|NCT00112437|19684220|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712444|NCT00112437|19684221|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712445|NCT00112437|19684222|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712446|NCT00112437|19684223|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712447|NCT00112437|19684224|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
5712448|NCT00112437|19684199|P26|Year 3 (12-Month Extension)|Protocol Violation|0
5712449|NCT00112437|19684200|P25|Year 3 (12-Month Extension)|Protocol Violation|0
5712450|NCT00112437|19684201|P24|Year 3 (12-Month Extension)|Protocol Violation|0
5712451|NCT00112437|19684202|P23|Year 3 (12-Month Extension)|Protocol Violation|0
5712452|NCT00112437|19684203|P22|Year 3 (12-Month Extension)|Protocol Violation|0
5712453|NCT00112437|19684204|P21|Year 3 (12-Month Extension)|Protocol Violation|0
5712454|NCT00112437|19684205|P20|Year 3 (12-Month Extension)|Protocol Violation|0
5712455|NCT00112437|19684206|P19|Year 3 (12-Month Extension)|Protocol Violation|0
5712456|NCT00112437|19684207|P18|Year 3 (12-Month Extension)|Protocol Violation|0
5712457|NCT00112437|19684208|P17|Year 3 (12-Month Extension)|Protocol Violation|0
5712458|NCT00112437|19684209|P16|Year 3 (12-Month Extension)|Protocol Violation|1
5712459|NCT00112437|19684210|P15|Year 3 (12-Month Extension)|Protocol Violation|0
5712460|NCT00112437|19684211|P14|Year 3 (12-Month Extension)|Protocol Violation|0
5712461|NCT00112437|19684212|P13|Year 3 (12-Month Extension)|Protocol Violation|0
5712462|NCT00112437|19684213|P12|Year 3 (12-Month Extension)|Protocol Violation|0
5712463|NCT00112437|19684214|P11|Year 3 (12-Month Extension)|Protocol Violation|0
5712464|NCT00112437|19684215|P10|Year 3 (12-Month Extension)|Protocol Violation|0
5712465|NCT00112437|19684216|P9|Year 3 (12-Month Extension)|Protocol Violation|0
5712466|NCT00112437|19684217|P8|Year 3 (12-Month Extension)|Protocol Violation|0
5712467|NCT00112437|19684218|P7|Year 3 (12-Month Extension)|Protocol Violation|0
5712468|NCT00112437|19684219|P6|Year 3 (12-Month Extension)|Protocol Violation|0
5712469|NCT00112437|19684220|P5|Year 3 (12-Month Extension)|Protocol Violation|0
5712470|NCT00112437|19684221|P4|Year 3 (12-Month Extension)|Protocol Violation|0
5712471|NCT00112437|19684222|P3|Year 3 (12-Month Extension)|Protocol Violation|0
5712472|NCT00112437|19684223|P2|Year 3 (12-Month Extension)|Protocol Violation|0
5712473|NCT00112437|19684224|P1|Year 3 (12-Month Extension)|Protocol Violation|0
5712474|NCT00112437|19684199|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712475|NCT00112437|19684200|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712476|NCT00112437|19684201|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712477|NCT00112437|19684202|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712478|NCT00112437|19684203|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712479|NCT00112437|19684204|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712480|NCT00112437|19684205|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712481|NCT00112437|19684206|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712482|NCT00112437|19684207|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712483|NCT00112437|19684208|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712484|NCT00112437|19684209|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
5712485|NCT00112437|19684210|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712486|NCT00112437|19684211|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712487|NCT00112437|19684212|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712488|NCT00112437|19684213|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712489|NCT00112437|19684214|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712490|NCT00112437|19684215|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712491|NCT00112437|19684216|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712492|NCT00112437|19684217|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712493|NCT00112437|19684218|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712494|NCT00112437|19684219|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712495|NCT00112437|19684220|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712496|NCT00112437|19684221|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712497|NCT00112437|19684222|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712498|NCT00112437|19684223|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712499|NCT00112437|19684224|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
5712500|NCT00112437|19684199|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712501|NCT00112437|19684200|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712502|NCT00112437|19684201|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712503|NCT00112437|19684202|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712504|NCT00112437|19684203|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712505|NCT00112437|19684204|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712506|NCT00112437|19684205|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712507|NCT00112437|19684206|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
5712508|NCT00112437|19684207|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712509|NCT00112437|19684208|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712510|NCT00112437|19684209|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
5712511|NCT00112437|19684210|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712512|NCT00112437|19684211|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
5712513|NCT00112437|19684212|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712514|NCT00112437|19684213|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
5712515|NCT00112437|19684214|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712516|NCT00112437|19684215|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712517|NCT00112437|19684216|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712518|NCT00112437|19684217|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712519|NCT00112437|19684218|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712520|NCT00112437|19684219|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712521|NCT00112437|19684220|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712522|NCT00112437|19684221|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712523|NCT00112437|19684222|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712524|NCT00112437|19684223|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712525|NCT00112437|19684224|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
5712526|NCT00112437|19684199|P26|Year 3 (12-Month Extension)|Adverse Event|0
5712527|NCT00112437|19684200|P25|Year 3 (12-Month Extension)|Adverse Event|0
5712528|NCT00112437|19684201|P24|Year 3 (12-Month Extension)|Adverse Event|0
5712529|NCT00112437|19684202|P23|Year 3 (12-Month Extension)|Adverse Event|0
5712530|NCT00112437|19684203|P22|Year 3 (12-Month Extension)|Adverse Event|0
5712531|NCT00112437|19684204|P21|Year 3 (12-Month Extension)|Adverse Event|0
5712532|NCT00112437|19684205|P20|Year 3 (12-Month Extension)|Adverse Event|1
5712533|NCT00112437|19684206|P19|Year 3 (12-Month Extension)|Adverse Event|0
5712534|NCT00112437|19684207|P18|Year 3 (12-Month Extension)|Adverse Event|1
5712535|NCT00112437|19684208|P17|Year 3 (12-Month Extension)|Adverse Event|3
5712536|NCT00112437|19684209|P16|Year 3 (12-Month Extension)|Adverse Event|1
5712537|NCT00112437|19684210|P15|Year 3 (12-Month Extension)|Adverse Event|0
5712538|NCT00112437|19684211|P14|Year 3 (12-Month Extension)|Adverse Event|0
5712539|NCT00112437|19684212|P13|Year 3 (12-Month Extension)|Adverse Event|0
5712540|NCT00112437|19684213|P12|Year 3 (12-Month Extension)|Adverse Event|0
5712541|NCT00112437|19684214|P11|Year 3 (12-Month Extension)|Adverse Event|1
5712542|NCT00112437|19684215|P10|Year 3 (12-Month Extension)|Adverse Event|0
5712543|NCT00112437|19684216|P9|Year 3 (12-Month Extension)|Adverse Event|0
5712544|NCT00112437|19684217|P8|Year 3 (12-Month Extension)|Adverse Event|0
5712545|NCT00112437|19684218|P7|Year 3 (12-Month Extension)|Adverse Event|0
5712546|NCT00112437|19684219|P6|Year 3 (12-Month Extension)|Adverse Event|0
5712547|NCT00112437|19684220|P5|Year 3 (12-Month Extension)|Adverse Event|0
5712548|NCT00112437|19684221|P4|Year 3 (12-Month Extension)|Adverse Event|0
5712549|NCT00112437|19684222|P3|Year 3 (12-Month Extension)|Adverse Event|0
5712550|NCT00112437|19684223|P2|Year 3 (12-Month Extension)|Adverse Event|0
5712551|NCT00112437|19684224|P1|Year 3 (12-Month Extension)|Adverse Event|0
5712552|NCT00112437|19684199|P26|Year 2 (12-Month Extension)|Moved|0
5712553|NCT00112437|19684200|P25|Year 2 (12-Month Extension)|Moved|0
5712554|NCT00112437|19684201|P24|Year 2 (12-Month Extension)|Moved|0
5712555|NCT00112437|19684202|P23|Year 2 (12-Month Extension)|Moved|0
5712556|NCT00112437|19684203|P22|Year 2 (12-Month Extension)|Moved|0
5712557|NCT00112437|19684204|P21|Year 2 (12-Month Extension)|Moved|0
5712558|NCT00112437|19684205|P20|Year 2 (12-Month Extension)|Moved|0
5712559|NCT00112437|19684206|P19|Year 2 (12-Month Extension)|Moved|0
5712560|NCT00112437|19684207|P18|Year 2 (12-Month Extension)|Moved|0
5712561|NCT00112437|19684208|P17|Year 2 (12-Month Extension)|Moved|0
5712562|NCT00112437|19684209|P16|Year 2 (12-Month Extension)|Moved|0
5712563|NCT00112437|19684210|P15|Year 2 (12-Month Extension)|Moved|0
5712564|NCT00112437|19684211|P14|Year 2 (12-Month Extension)|Moved|0
5712565|NCT00112437|19684212|P13|Year 2 (12-Month Extension)|Moved|0
5712566|NCT00112437|19684213|P12|Year 2 (12-Month Extension)|Moved|0
5712567|NCT00112437|19684214|P11|Year 2 (12-Month Extension)|Moved|0
5712568|NCT00112437|19684215|P10|Year 2 (12-Month Extension)|Moved|1
5712569|NCT00112437|19684216|P9|Year 2 (12-Month Extension)|Moved|0
5712570|NCT00112437|19684217|P8|Year 2 (12-Month Extension)|Moved|0
5712571|NCT00112437|19684218|P7|Year 2 (12-Month Extension)|Moved|0
5712572|NCT00112437|19684219|P6|Year 2 (12-Month Extension)|Moved|0
5712573|NCT00112437|19684220|P5|Year 2 (12-Month Extension)|Moved|0
5712574|NCT00112437|19684221|P4|Year 2 (12-Month Extension)|Moved|0
5712575|NCT00112437|19684222|P3|Year 2 (12-Month Extension)|Moved|0
5712576|NCT00112437|19684223|P2|Year 2 (12-Month Extension)|Moved|0
5712577|NCT00112437|19684224|P1|Year 2 (12-Month Extension)|Moved|0
5712578|NCT00112437|19684199|P26|Year 2 (12-Month Extension)|patient was out of windows|0
5712579|NCT00112437|19684200|P25|Year 2 (12-Month Extension)|patient was out of windows|0
5712580|NCT00112437|19684201|P24|Year 2 (12-Month Extension)|patient was out of windows|0
5712581|NCT00112437|19684202|P23|Year 2 (12-Month Extension)|patient was out of windows|0
5712582|NCT00112437|19684203|P22|Year 2 (12-Month Extension)|patient was out of windows|0
5712583|NCT00112437|19684204|P21|Year 2 (12-Month Extension)|patient was out of windows|0
5712584|NCT00112437|19684205|P20|Year 2 (12-Month Extension)|patient was out of windows|0
5712585|NCT00112437|19684206|P19|Year 2 (12-Month Extension)|patient was out of windows|0
5712586|NCT00112437|19684207|P18|Year 2 (12-Month Extension)|patient was out of windows|0
5712587|NCT00112437|19684208|P17|Year 2 (12-Month Extension)|patient was out of windows|0
5712588|NCT00112437|19684209|P16|Year 2 (12-Month Extension)|patient was out of windows|0
5712589|NCT00112437|19684210|P15|Year 2 (12-Month Extension)|patient was out of windows|0
5712590|NCT00112437|19684211|P14|Year 2 (12-Month Extension)|patient was out of windows|0
5712591|NCT00112437|19684212|P13|Year 2 (12-Month Extension)|patient was out of windows|0
5712592|NCT00112437|19684213|P12|Year 2 (12-Month Extension)|patient was out of windows|0
5712593|NCT00112437|19684214|P11|Year 2 (12-Month Extension)|patient was out of windows|0
5712594|NCT00112437|19684215|P10|Year 2 (12-Month Extension)|patient was out of windows|1
5712595|NCT00112437|19684216|P9|Year 2 (12-Month Extension)|patient was out of windows|0
5712596|NCT00112437|19684217|P8|Year 2 (12-Month Extension)|patient was out of windows|0
5712597|NCT00112437|19684218|P7|Year 2 (12-Month Extension)|patient was out of windows|0
5712598|NCT00112437|19684219|P6|Year 2 (12-Month Extension)|patient was out of windows|0
5712599|NCT00112437|19684220|P5|Year 2 (12-Month Extension)|patient was out of windows|0
5712600|NCT00112437|19684221|P4|Year 2 (12-Month Extension)|patient was out of windows|0
5712601|NCT00112437|19684222|P3|Year 2 (12-Month Extension)|patient was out of windows|0
5712602|NCT00112437|19684223|P2|Year 2 (12-Month Extension)|patient was out of windows|0
5712603|NCT00112437|19684224|P1|Year 2 (12-Month Extension)|patient was out of windows|0
5712604|NCT00112437|19684199|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712605|NCT00112437|19684200|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712606|NCT00112437|19684201|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712607|NCT00112437|19684202|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712608|NCT00112437|19684203|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712609|NCT00112437|19684204|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712610|NCT00112437|19684205|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712611|NCT00112437|19684206|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712612|NCT00112437|19684207|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712613|NCT00112437|19684208|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712614|NCT00112437|19684209|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712615|NCT00112437|19684210|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712616|NCT00112437|19684211|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712617|NCT00112437|19684212|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712618|NCT00112437|19684213|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712619|NCT00112437|19684214|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712620|NCT00112437|19684215|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
5712621|NCT00112437|19684216|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712622|NCT00112437|19684217|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712623|NCT00112437|19684218|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712624|NCT00112437|19684219|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712625|NCT00112437|19684220|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712626|NCT00112437|19684221|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712627|NCT00112437|19684222|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712628|NCT00112437|19684223|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712629|NCT00112437|19684224|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
5712630|NCT00112437|19684199|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712631|NCT00112437|19684200|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712632|NCT00112437|19684201|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712633|NCT00112437|19684202|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712634|NCT00112437|19684203|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712635|NCT00112437|19684204|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712636|NCT00112437|19684205|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712637|NCT00112437|19684206|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712638|NCT00112437|19684207|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712639|NCT00112437|19684208|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712640|NCT00112437|19684209|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712641|NCT00112437|19684210|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712642|NCT00112437|19684211|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712643|NCT00112437|19684212|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712644|NCT00112437|19684213|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712645|NCT00112437|19684214|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712646|NCT00112437|19684215|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
5712647|NCT00112437|19684216|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
5712648|NCT00112437|19684217|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
5712649|NCT00112437|19684218|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
5712650|NCT00112437|19684219|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
5712651|NCT00112437|19684220|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712652|NCT00112437|19684221|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712653|NCT00112437|19684222|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712654|NCT00112437|19684223|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712655|NCT00112437|19684224|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
5712656|NCT00112437|19684199|P26|Year 2 (12-Month Extension)|Protocol Violation|0
5712657|NCT00112437|19684200|P25|Year 2 (12-Month Extension)|Protocol Violation|0
5712658|NCT00112437|19684201|P24|Year 2 (12-Month Extension)|Protocol Violation|0
5712659|NCT00112437|19684202|P23|Year 2 (12-Month Extension)|Protocol Violation|0
5712660|NCT00112437|19684203|P22|Year 2 (12-Month Extension)|Protocol Violation|0
5712661|NCT00112437|19684204|P21|Year 2 (12-Month Extension)|Protocol Violation|0
5712662|NCT00112437|19684205|P20|Year 2 (12-Month Extension)|Protocol Violation|0
5712663|NCT00112437|19684206|P19|Year 2 (12-Month Extension)|Protocol Violation|0
5712664|NCT00112437|19684207|P18|Year 2 (12-Month Extension)|Protocol Violation|0
5712665|NCT00112437|19684208|P17|Year 2 (12-Month Extension)|Protocol Violation|0
5712666|NCT00112437|19684209|P16|Year 2 (12-Month Extension)|Protocol Violation|0
5712667|NCT00112437|19684210|P15|Year 2 (12-Month Extension)|Protocol Violation|0
5712668|NCT00112437|19684211|P14|Year 2 (12-Month Extension)|Protocol Violation|0
5712669|NCT00112437|19684212|P13|Year 2 (12-Month Extension)|Protocol Violation|0
5712670|NCT00112437|19684213|P12|Year 2 (12-Month Extension)|Protocol Violation|0
5712671|NCT00112437|19684214|P11|Year 2 (12-Month Extension)|Protocol Violation|0
5712672|NCT00112437|19684215|P10|Year 2 (12-Month Extension)|Protocol Violation|0
5712673|NCT00112437|19684216|P9|Year 2 (12-Month Extension)|Protocol Violation|1
5712674|NCT00112437|19684217|P8|Year 2 (12-Month Extension)|Protocol Violation|0
5712675|NCT00112437|19684218|P7|Year 2 (12-Month Extension)|Protocol Violation|0
5712676|NCT00112437|19684219|P6|Year 2 (12-Month Extension)|Protocol Violation|0
5712677|NCT00112437|19684220|P5|Year 2 (12-Month Extension)|Protocol Violation|0
5712678|NCT00112437|19684221|P4|Year 2 (12-Month Extension)|Protocol Violation|0
5712679|NCT00112437|19684222|P3|Year 2 (12-Month Extension)|Protocol Violation|0
5712680|NCT00112437|19684223|P2|Year 2 (12-Month Extension)|Protocol Violation|0
5712681|NCT00112437|19684224|P1|Year 2 (12-Month Extension)|Protocol Violation|0
5712682|NCT00112437|19684199|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712683|NCT00112437|19684200|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712684|NCT00112437|19684201|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712685|NCT00112437|19684202|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712686|NCT00112437|19684203|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712687|NCT00112437|19684204|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712688|NCT00112437|19684205|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712689|NCT00112437|19684206|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712690|NCT00112437|19684207|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712691|NCT00112437|19684208|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712692|NCT00112437|19684209|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712693|NCT00112437|19684210|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712694|NCT00112437|19684211|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712695|NCT00112437|19684212|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712696|NCT00112437|19684213|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712697|NCT00112437|19684214|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712698|NCT00112437|19684215|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712699|NCT00112437|19684216|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
5712700|NCT00112437|19684217|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712701|NCT00112437|19684218|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712702|NCT00112437|19684219|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712703|NCT00112437|19684220|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712704|NCT00112437|19684221|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712705|NCT00112437|19684222|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712706|NCT00112437|19684223|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712707|NCT00112437|19684224|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
5712708|NCT00112437|19684199|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712709|NCT00112437|19684200|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712710|NCT00112437|19684201|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712711|NCT00112437|19684202|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712712|NCT00112437|19684203|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712713|NCT00112437|19684204|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712714|NCT00112437|19684205|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712715|NCT00112437|19684206|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712716|NCT00112437|19684207|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712717|NCT00112437|19684208|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712718|NCT00112437|19684209|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712719|NCT00112437|19684210|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712720|NCT00112437|19684211|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712721|NCT00112437|19684212|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712722|NCT00112437|19684213|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712723|NCT00112437|19684214|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712724|NCT00112437|19684215|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
5712725|NCT00112437|19684216|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712726|NCT00112437|19684217|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712727|NCT00112437|19684218|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
5712728|NCT00112437|19684219|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
5712729|NCT00112437|19684220|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712730|NCT00112437|19684221|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712731|NCT00112437|19684222|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712732|NCT00112437|19684223|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712733|NCT00112437|19684224|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
5712734|NCT00112437|19684199|P26|Year 2 (12-Month Extension)|Adverse Event|0
5712735|NCT00112437|19684200|P25|Year 2 (12-Month Extension)|Adverse Event|0
5712736|NCT00112437|19684201|P24|Year 2 (12-Month Extension)|Adverse Event|0
5712737|NCT00112437|19684202|P23|Year 2 (12-Month Extension)|Adverse Event|0
5712738|NCT00112437|19684203|P22|Year 2 (12-Month Extension)|Adverse Event|0
5712739|NCT00112437|19684204|P21|Year 2 (12-Month Extension)|Adverse Event|0
5712740|NCT00112437|19684205|P20|Year 2 (12-Month Extension)|Adverse Event|0
5712741|NCT00112437|19684206|P19|Year 2 (12-Month Extension)|Adverse Event|0
5712742|NCT00112437|19684207|P18|Year 2 (12-Month Extension)|Adverse Event|0
5712743|NCT00112437|19684208|P17|Year 2 (12-Month Extension)|Adverse Event|0
5712744|NCT00112437|19684209|P16|Year 2 (12-Month Extension)|Adverse Event|0
5712745|NCT00112437|19684210|P15|Year 2 (12-Month Extension)|Adverse Event|0
5712746|NCT00112437|19684211|P14|Year 2 (12-Month Extension)|Adverse Event|0
5712747|NCT00112437|19684212|P13|Year 2 (12-Month Extension)|Adverse Event|0
5712748|NCT00112437|19684213|P12|Year 2 (12-Month Extension)|Adverse Event|0
5712749|NCT00112437|19684214|P11|Year 2 (12-Month Extension)|Adverse Event|0
5712750|NCT00112437|19684215|P10|Year 2 (12-Month Extension)|Adverse Event|7
5712751|NCT00112437|19684216|P9|Year 2 (12-Month Extension)|Adverse Event|1
5712752|NCT00112437|19684217|P8|Year 2 (12-Month Extension)|Adverse Event|6
5712753|NCT00112437|19684218|P7|Year 2 (12-Month Extension)|Adverse Event|2
5712754|NCT00112437|19684219|P6|Year 2 (12-Month Extension)|Adverse Event|1
5712755|NCT00112437|19684220|P5|Year 2 (12-Month Extension)|Adverse Event|0
5712756|NCT00112437|19684221|P4|Year 2 (12-Month Extension)|Adverse Event|0
5712757|NCT00112437|19684222|P3|Year 2 (12-Month Extension)|Adverse Event|0
5712758|NCT00112437|19684223|P2|Year 2 (12-Month Extension)|Adverse Event|0
5712759|NCT00112437|19684224|P1|Year 2 (12-Month Extension)|Adverse Event|0
5712760|NCT00112437|19684199|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712761|NCT00112437|19684200|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712762|NCT00112437|19684201|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712763|NCT00112437|19684202|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712764|NCT00112437|19684203|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712765|NCT00112437|19684204|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712766|NCT00112437|19684205|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712767|NCT00112437|19684206|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712768|NCT00112437|19684207|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712769|NCT00112437|19684208|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712770|NCT00112437|19684209|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712771|NCT00112437|19684210|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712772|NCT00112437|19684211|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712773|NCT00112437|19684212|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712774|NCT00112437|19684213|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712775|NCT00112437|19684214|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712776|NCT00112437|19684215|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712777|NCT00112437|19684216|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712778|NCT00112437|19684217|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712779|NCT00112437|19684218|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712780|NCT00112437|19684219|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712781|NCT00112437|19684220|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
5712782|NCT00112437|19684221|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712783|NCT00112437|19684222|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712784|NCT00112437|19684223|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712785|NCT00112437|19684224|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
5712786|NCT00112437|19684199|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712787|NCT00112437|19684200|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712788|NCT00112437|19684201|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712789|NCT00112437|19684202|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712790|NCT00112437|19684203|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712791|NCT00112437|19684204|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712792|NCT00112437|19684205|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712793|NCT00112437|19684206|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712794|NCT00112437|19684207|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712795|NCT00112437|19684208|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712796|NCT00112437|19684209|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712797|NCT00112437|19684210|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712798|NCT00112437|19684211|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712799|NCT00112437|19684212|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712800|NCT00112437|19684213|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712801|NCT00112437|19684214|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712802|NCT00112437|19684215|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712803|NCT00112437|19684216|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712804|NCT00112437|19684217|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712805|NCT00112437|19684218|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712806|NCT00112437|19684219|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712807|NCT00112437|19684220|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712808|NCT00112437|19684221|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
5712809|NCT00112437|19684222|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712810|NCT00112437|19684223|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712811|NCT00112437|19684224|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
5712812|NCT00112437|19684199|P26|Year 1 (12-Month Base Study)|moved|0
5712813|NCT00112437|19684200|P25|Year 1 (12-Month Base Study)|moved|0
5712814|NCT00112437|19684201|P24|Year 1 (12-Month Base Study)|moved|0
5712815|NCT00112437|19684202|P23|Year 1 (12-Month Base Study)|moved|0
5712816|NCT00112437|19684203|P22|Year 1 (12-Month Base Study)|moved|0
5712817|NCT00112437|19684204|P21|Year 1 (12-Month Base Study)|moved|0
5712818|NCT00112437|19684205|P20|Year 1 (12-Month Base Study)|moved|0
5712819|NCT00112437|19684206|P19|Year 1 (12-Month Base Study)|moved|0
5712820|NCT00112437|19684207|P18|Year 1 (12-Month Base Study)|moved|0
5712821|NCT00112437|19684208|P17|Year 1 (12-Month Base Study)|moved|0
5712822|NCT00112437|19684209|P16|Year 1 (12-Month Base Study)|moved|0
5712823|NCT00112437|19684210|P15|Year 1 (12-Month Base Study)|moved|0
5712824|NCT00112437|19684211|P14|Year 1 (12-Month Base Study)|moved|0
5712825|NCT00112437|19684212|P13|Year 1 (12-Month Base Study)|moved|0
5712826|NCT00112437|19684213|P12|Year 1 (12-Month Base Study)|moved|0
5712827|NCT00112437|19684214|P11|Year 1 (12-Month Base Study)|moved|0
5712828|NCT00112437|19684215|P10|Year 1 (12-Month Base Study)|moved|0
5712829|NCT00112437|19684216|P9|Year 1 (12-Month Base Study)|moved|0
5712830|NCT00112437|19684217|P8|Year 1 (12-Month Base Study)|moved|0
5712831|NCT00112437|19684218|P7|Year 1 (12-Month Base Study)|moved|0
5712832|NCT00112437|19684219|P6|Year 1 (12-Month Base Study)|moved|0
5712833|NCT00112437|19684220|P5|Year 1 (12-Month Base Study)|moved|0
5712834|NCT00112437|19684221|P4|Year 1 (12-Month Base Study)|moved|0
5712835|NCT00112437|19684222|P3|Year 1 (12-Month Base Study)|moved|1
5712836|NCT00112437|19684223|P2|Year 1 (12-Month Base Study)|moved|1
5712837|NCT00112437|19684224|P1|Year 1 (12-Month Base Study)|moved|0
5712838|NCT00112437|19684199|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712839|NCT00112437|19684200|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712840|NCT00112437|19684201|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712841|NCT00112437|19684202|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712842|NCT00112437|19684203|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712843|NCT00112437|19684204|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712844|NCT00112437|19684205|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712845|NCT00112437|19684206|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712846|NCT00112437|19684207|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712847|NCT00112437|19684208|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712848|NCT00112437|19684209|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712849|NCT00112437|19684210|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712850|NCT00112437|19684211|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712851|NCT00112437|19684212|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712852|NCT00112437|19684213|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712853|NCT00112437|19684214|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712854|NCT00112437|19684215|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712855|NCT00112437|19684216|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712856|NCT00112437|19684217|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712857|NCT00112437|19684218|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712858|NCT00112437|19684219|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
5712859|NCT00112437|19684220|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
5712860|NCT00112437|19684221|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
5712861|NCT00112437|19684222|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
5712862|NCT00112437|19684223|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
5712863|NCT00112437|19684224|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
5712864|NCT00112437|19684199|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
5712865|NCT00112437|19684200|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
5712866|NCT00112437|19684201|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
5712867|NCT00112437|19684202|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
5712868|NCT00112437|19684203|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
5712869|NCT00112437|19684204|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
5712870|NCT00112437|19684205|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
5712871|NCT00112437|19684206|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
5712872|NCT00112437|19684207|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
5712873|NCT00112437|19684208|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
5712874|NCT00112437|19684209|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
5712875|NCT00112437|19684210|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
5712876|NCT00112437|19684211|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
5712877|NCT00112437|19684212|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
5712878|NCT00112437|19684213|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
5712879|NCT00112437|19684214|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
5712880|NCT00112437|19684215|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
5712881|NCT00112437|19684216|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
5712882|NCT00112437|19684217|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
5712883|NCT00112437|19684218|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
5712884|NCT00112437|19684219|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
5712885|NCT00112437|19684220|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
5712886|NCT00112437|19684221|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
5712887|NCT00112437|19684222|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
5712888|NCT00112437|19684223|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
5712889|NCT00112437|19684224|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
5712890|NCT00112437|19684199|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712891|NCT00112437|19684200|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712892|NCT00112437|19684201|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712893|NCT00112437|19684202|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712894|NCT00112437|19684203|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712895|NCT00112437|19684204|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712896|NCT00112437|19684205|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712897|NCT00112437|19684206|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712898|NCT00112437|19684207|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712899|NCT00112437|19684208|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712900|NCT00112437|19684209|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712901|NCT00112437|19684210|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712902|NCT00112437|19684211|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712903|NCT00112437|19684212|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712904|NCT00112437|19684213|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712905|NCT00112437|19684214|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712906|NCT00112437|19684215|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712907|NCT00112437|19684216|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712908|NCT00112437|19684217|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712909|NCT00112437|19684218|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712910|NCT00112437|19684219|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712911|NCT00112437|19684220|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712912|NCT00112437|19684221|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712913|NCT00112437|19684222|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712914|NCT00112437|19684223|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
5712915|NCT00112437|19684224|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
5712916|NCT00112437|19684199|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712917|NCT00112437|19684200|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712918|NCT00112437|19684201|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712919|NCT00112437|19684202|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712920|NCT00112437|19684203|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712921|NCT00112437|19684204|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712922|NCT00112437|19684205|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712923|NCT00112437|19684206|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712924|NCT00112437|19684207|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712925|NCT00112437|19684208|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712926|NCT00112437|19684209|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712927|NCT00112437|19684210|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712928|NCT00112437|19684211|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712929|NCT00112437|19684212|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712930|NCT00112437|19684213|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712931|NCT00112437|19684214|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712932|NCT00112437|19684215|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712933|NCT00112437|19684216|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712934|NCT00112437|19684217|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712935|NCT00112437|19684218|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712936|NCT00112437|19684219|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712937|NCT00112437|19684220|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712938|NCT00112437|19684221|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712939|NCT00112437|19684222|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712940|NCT00112437|19684223|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
5712941|NCT00112437|19684224|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
5712942|NCT00112437|19684199|P26|Year 1 (12-Month Base Study)|Adverse Event|0
5712943|NCT00112437|19684200|P25|Year 1 (12-Month Base Study)|Adverse Event|0
5712944|NCT00112437|19684201|P24|Year 1 (12-Month Base Study)|Adverse Event|0
5712945|NCT00112437|19684202|P23|Year 1 (12-Month Base Study)|Adverse Event|0
5712946|NCT00112437|19684203|P22|Year 1 (12-Month Base Study)|Adverse Event|0
5712947|NCT00112437|19684204|P21|Year 1 (12-Month Base Study)|Adverse Event|0
5712948|NCT00112437|19684205|P20|Year 1 (12-Month Base Study)|Adverse Event|0
5712949|NCT00112437|19684206|P19|Year 1 (12-Month Base Study)|Adverse Event|0
5712950|NCT00112437|19684207|P18|Year 1 (12-Month Base Study)|Adverse Event|0
5712951|NCT00112437|19684208|P17|Year 1 (12-Month Base Study)|Adverse Event|0
5712952|NCT00112437|19684209|P16|Year 1 (12-Month Base Study)|Adverse Event|0
5712953|NCT00112437|19684210|P15|Year 1 (12-Month Base Study)|Adverse Event|0
5712954|NCT00112437|19684211|P14|Year 1 (12-Month Base Study)|Adverse Event|0
5712955|NCT00112437|19684212|P13|Year 1 (12-Month Base Study)|Adverse Event|0
5712956|NCT00112437|19684213|P12|Year 1 (12-Month Base Study)|Adverse Event|0
5712957|NCT00112437|19684214|P11|Year 1 (12-Month Base Study)|Adverse Event|0
5712958|NCT00112437|19684215|P10|Year 1 (12-Month Base Study)|Adverse Event|0
5712959|NCT00112437|19684216|P9|Year 1 (12-Month Base Study)|Adverse Event|0
5712960|NCT00112437|19684217|P8|Year 1 (12-Month Base Study)|Adverse Event|0
5712961|NCT00112437|19684218|P7|Year 1 (12-Month Base Study)|Adverse Event|0
5712962|NCT00112437|19684219|P6|Year 1 (12-Month Base Study)|Adverse Event|0
5712963|NCT00112437|19684220|P5|Year 1 (12-Month Base Study)|Adverse Event|3
5712964|NCT00112437|19684221|P4|Year 1 (12-Month Base Study)|Adverse Event|4
5712965|NCT00112437|19684222|P3|Year 1 (12-Month Base Study)|Adverse Event|6
5712966|NCT00112437|19684223|P2|Year 1 (12-Month Base Study)|Adverse Event|10
5712967|NCT00112437|19684224|P1|Year 1 (12-Month Base Study)|Adverse Event|9
5712968|NCT00112385|19684504|P2|Overall Study|Withdrawal by Subject|1
5712969|NCT00112385|19684505|P1|Overall Study|Withdrawal by Subject|0
5712970|NCT00112385|19684504|P2|Overall Study|Lost to Follow-up|0
5712971|NCT00112385|19684505|P1|Overall Study|Lost to Follow-up|1
5712972|NCT00112359|19684595|P2|Overall Study|Other|0
5712973|NCT00112359|19684596|P1|Overall Study|Other|3
5712974|NCT00112359|19684595|P2|Overall Study|Personal/administrative|1
5712975|NCT00112359|19684596|P1|Overall Study|Personal/administrative|1
5712976|NCT00112359|19684595|P2|Overall Study|Lost to Follow-up|1
5712977|NCT00112359|19684596|P1|Overall Study|Lost to Follow-up|0
5712978|NCT00112359|19684595|P2|Overall Study|Related adverse event|3
5712979|NCT00112359|19684596|P1|Overall Study|Related adverse event|5
5712980|NCT00112359|19684595|P2|Overall Study|Trial drug intolerance (adverse event)|0
5712981|NCT00112359|19684596|P1|Overall Study|Trial drug intolerance (adverse event)|2
5712982|NCT00112359|19684595|P2|Overall Study|Unrelated adverse event|8
5712983|NCT00112359|19684596|P1|Overall Study|Unrelated adverse event|16
5712984|NCT00112294|19684622|P2|Overall Study|Still on study|0
5712985|NCT00112294|19684623|P1|Overall Study|Still on study|5
5712986|NCT00112047|19684931|P2|Atripla Phase|Other|1
5712987|NCT00112047|19684932|P1|Atripla Phase|Other|3
5712988|NCT00112047|19684931|P2|Atripla Phase|Non-compliance|0
5712989|NCT00112047|19684932|P1|Atripla Phase|Non-compliance|1
5712990|NCT00112047|19684931|P2|Atripla Phase|Sub-optimal virological response|1
5712991|NCT00112047|19684932|P1|Atripla Phase|Sub-optimal virological response|0
5712992|NCT00112047|19684931|P2|Atripla Phase|Withdrew consent|7
5712993|NCT00112047|19684932|P1|Atripla Phase|Withdrew consent|7
5712994|NCT00112047|19684931|P2|Atripla Phase|Death|2
5712995|NCT00112047|19684932|P1|Atripla Phase|Death|0
5712996|NCT00112047|19684931|P2|Atripla Phase|Pregnancy|1
5712997|NCT00112047|19684932|P1|Atripla Phase|Pregnancy|0
5712998|NCT00112047|19684931|P2|Atripla Phase|Lost to Follow-up|7
5712999|NCT00112047|19684932|P1|Atripla Phase|Lost to Follow-up|5
5713000|NCT00112047|19684931|P2|Atripla Phase|Adverse Event|1
5713001|NCT00112047|19684932|P1|Atripla Phase|Adverse Event|2
5713002|NCT00112047|19684931|P2|Randomized Phase|High Hepatitis B DNA|1
5713003|NCT00112047|19684932|P1|Randomized Phase|High Hepatitis B DNA|0
5713004|NCT00112047|19684931|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
5713005|NCT00112047|19684932|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
5713006|NCT00112047|19684931|P2|Randomized Phase|Moved out of State|1
5713007|NCT00112047|19684932|P1|Randomized Phase|Moved out of State|0
5713008|NCT00112047|19684931|P2|Randomized Phase|Incarceration|2
5713009|NCT00112047|19684932|P1|Randomized Phase|Incarceration|3
5713010|NCT00112047|19684931|P2|Randomized Phase|Inability to swallow pills|1
5713011|NCT00112047|19684932|P1|Randomized Phase|Inability to swallow pills|0
5713012|NCT00112047|19684931|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
5713013|NCT00112047|19684932|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
5713014|NCT00112047|19684931|P2|Randomized Phase|Death|3
5713015|NCT00112047|19684932|P1|Randomized Phase|Death|1
5713016|NCT00112047|19684931|P2|Randomized Phase|Pregnancy|1
5713017|NCT00112047|19684932|P1|Randomized Phase|Pregnancy|3
5713018|NCT00112047|19684931|P2|Randomized Phase|Protocol Violation|0
5713019|NCT00112047|19684932|P1|Randomized Phase|Protocol Violation|2
5713020|NCT00112047|19684931|P2|Randomized Phase|Noncompliance|4
5713021|NCT00112047|19684932|P1|Randomized Phase|Noncompliance|8
5713022|NCT00112047|19684931|P2|Randomized Phase|Sub-optimal virological response|13
5713023|NCT00112047|19684932|P1|Randomized Phase|Sub-optimal virological response|3
5713024|NCT00112047|19684931|P2|Randomized Phase|Withrawal of consent|18
5713025|NCT00112047|19684932|P1|Randomized Phase|Withrawal of consent|10
5713026|NCT00112047|19684931|P2|Randomized Phase|Adverse Event|10
5713027|NCT00112047|19684932|P1|Randomized Phase|Adverse Event|10
5713028|NCT00112047|19684931|P2|Randomized Phase|Lost to Follow-up|33
5713029|NCT00112047|19684932|P1|Randomized Phase|Lost to Follow-up|26
5713030|NCT00111917|19685032|P2|Overall Study|Withdrawal by Subject|1
5713031|NCT00111917|19685033|P1|Overall Study|Withdrawal by Subject|1
5713032|NCT00111839|19685048|P3|Overall Study|Randomized but Not Treated|2
5713033|NCT00111839|19685049|P2|Overall Study|Randomized but Not Treated|0
5713034|NCT00111839|19685050|P1|Overall Study|Randomized but Not Treated|0
5713035|NCT00111839|19685048|P3|Overall Study|Other|3
5713036|NCT00111839|19685049|P2|Overall Study|Other|3
5713037|NCT00111839|19685050|P1|Overall Study|Other|6
5713038|NCT00111839|19685048|P3|Overall Study|Logistical Constraint|0
5713039|NCT00111839|19685049|P2|Overall Study|Logistical Constraint|0
5713040|NCT00111839|19685050|P1|Overall Study|Logistical Constraint|1
5713041|NCT00111839|19685048|P3|Overall Study|Lost to Follow-up|0
5713042|NCT00111839|19685049|P2|Overall Study|Lost to Follow-up|0
5713043|NCT00111839|19685050|P1|Overall Study|Lost to Follow-up|1
5713044|NCT00111839|19685048|P3|Overall Study|Withdrawal by Subject|2
5713045|NCT00111839|19685049|P2|Overall Study|Withdrawal by Subject|2
5713046|NCT00111839|19685050|P1|Overall Study|Withdrawal by Subject|2
5713047|NCT00111839|19685048|P3|Overall Study|Death|6
5713048|NCT00111839|19685049|P2|Overall Study|Death|1
5713049|NCT00111839|19685050|P1|Overall Study|Death|1
5713050|NCT00111839|19685048|P3|Overall Study|Protocol Violation|2
5713051|NCT00111839|19685049|P2|Overall Study|Protocol Violation|4
5713052|NCT00111839|19685050|P1|Overall Study|Protocol Violation|2
5713053|NCT00111839|19685048|P3|Overall Study|Adverse Event|1
5713054|NCT00111839|19685049|P2|Overall Study|Adverse Event|3
5713055|NCT00111839|19685050|P1|Overall Study|Adverse Event|5
5713056|NCT00111839|19685048|P3|Overall Study|Disease Progression|33
5713057|NCT00111839|19685049|P2|Overall Study|Disease Progression|33
5713058|NCT00111839|19685050|P1|Overall Study|Disease Progression|30
5713059|NCT00111813|19685070|P6|Overall Study|Other|0
5713060|NCT00111813|19685071|P5|Overall Study|Other|0
5713061|NCT00111813|19685072|P4|Overall Study|Other|0
5713062|NCT00111813|19685073|P3|Overall Study|Other|1
5713063|NCT00111813|19685074|P2|Overall Study|Other|0
5713064|NCT00111813|19685075|P1|Overall Study|Other|0
5713065|NCT00111813|19685070|P6|Overall Study|Lack of Efficacy|1
5713066|NCT00111813|19685071|P5|Overall Study|Lack of Efficacy|0
5713067|NCT00111813|19685072|P4|Overall Study|Lack of Efficacy|0
5713068|NCT00111813|19685073|P3|Overall Study|Lack of Efficacy|0
5713069|NCT00111813|19685074|P2|Overall Study|Lack of Efficacy|0
5713070|NCT00111813|19685075|P1|Overall Study|Lack of Efficacy|0
5713071|NCT00111813|19685070|P6|Overall Study|Progressive disease|3
5713072|NCT00111813|19685071|P5|Overall Study|Progressive disease|4
5713073|NCT00111813|19685072|P4|Overall Study|Progressive disease|3
5713074|NCT00111813|19685073|P3|Overall Study|Progressive disease|5
5713075|NCT00111813|19685074|P2|Overall Study|Progressive disease|1
5713076|NCT00111813|19685075|P1|Overall Study|Progressive disease|2
5713077|NCT00111813|19685070|P6|Overall Study|Adverse Event|2
5713078|NCT00111813|19685071|P5|Overall Study|Adverse Event|2
5713079|NCT00111813|19685072|P4|Overall Study|Adverse Event|2
5713080|NCT00111813|19685073|P3|Overall Study|Adverse Event|4
5713081|NCT00111813|19685074|P2|Overall Study|Adverse Event|2
5713082|NCT00111813|19685075|P1|Overall Study|Adverse Event|1
5713083|NCT00111800|19685114|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5713084|NCT00111800|19685115|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5713085|NCT00111800|19685116|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5713086|NCT00111800|19685117|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
5713087|NCT00111800|19685118|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5713088|NCT00111800|19685119|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
5713089|NCT00111800|19685114|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5713090|NCT00111800|19685115|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5713091|NCT00111800|19685116|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5713092|NCT00111800|19685117|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
5713093|NCT00111800|19685118|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5713094|NCT00111800|19685119|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
5713095|NCT00111800|19685114|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5713096|NCT00111800|19685115|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5713097|NCT00111800|19685116|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5713098|NCT00111800|19685117|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5713099|NCT00111800|19685118|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
5713100|NCT00111800|19685119|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
5713101|NCT00111800|19685114|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5713102|NCT00111800|19685115|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5713103|NCT00111800|19685116|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5713104|NCT00111800|19685117|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
5713105|NCT00111800|19685118|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5713106|NCT00111800|19685119|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
5713107|NCT00111800|19685114|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
5713108|NCT00111800|19685115|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
5713109|NCT00111800|19685116|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
5713110|NCT00111800|19685117|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
5713111|NCT00111800|19685118|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
5713112|NCT00111800|19685119|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
5713113|NCT00111800|19685114|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
5713114|NCT00111800|19685115|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
5713115|NCT00111800|19685116|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
5713116|NCT00111800|19685117|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
5713117|NCT00111800|19685118|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
5713118|NCT00111800|19685119|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
5713119|NCT00111800|19685114|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
5713120|NCT00111800|19685115|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
5713121|NCT00111800|19685116|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
5713122|NCT00111800|19685117|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
5713123|NCT00111800|19685118|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
5713124|NCT00111800|19685119|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
5713125|NCT00111800|19685114|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
5713126|NCT00111800|19685115|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
5713127|NCT00111800|19685116|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
5713128|NCT00111800|19685117|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
5713129|NCT00111800|19685118|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
5713130|NCT00111800|19685119|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
5713131|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
5713132|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5713133|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5713134|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5713135|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5713136|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
5713137|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5713138|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
5713139|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5713140|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5713141|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5713142|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
5713143|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5713144|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
5713145|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5713146|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5713147|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5713148|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
5713149|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5713384|NCT00110617|19685590|P2|Overall Study|Administrative problems|5
5713150|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5713151|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
5713152|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5713153|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5713154|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
5713155|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5713156|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5713157|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
5713158|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5713159|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5713160|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
5713161|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5713162|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5713163|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5713164|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5713165|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
5713166|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
5713167|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5713168|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5713169|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5713170|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5713171|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
5713172|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
5713173|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5713174|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5713175|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5713176|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5713177|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
5713178|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
5713179|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5713180|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5713181|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5713182|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5713183|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
5713184|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
5713185|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5713186|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5713187|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5713188|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5713189|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
5713190|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
5713191|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
5713192|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
5713193|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
5713194|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
5713195|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
5713196|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
5713197|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
5713198|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
5713199|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
5713200|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
5713201|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
5713202|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
5713203|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
5713204|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
5713205|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
5713206|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
5713207|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
5713208|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
5713209|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
5713210|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
5713211|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
5713212|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
5713213|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
5713214|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
5713385|NCT00110617|19685591|P1|Overall Study|Administrative problems|6
5713215|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
5713216|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
5713217|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
5713218|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
5713219|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
5713220|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
5713221|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
5713222|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
5713223|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
5713224|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
5713225|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
5713226|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
5713227|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
5713228|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
5713229|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
5713230|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
5713231|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
5713232|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
5713233|NCT00111800|19685114|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
5713234|NCT00111800|19685115|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
5713235|NCT00111800|19685116|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
5713236|NCT00111800|19685117|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
5713237|NCT00111800|19685118|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
5713238|NCT00111800|19685119|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
5713239|NCT00111761|19685289|P2|Part 2|Other|0
5713240|NCT00111761|19685290|P1|Part 2|Other|1
5713241|NCT00111761|19685289|P2|Part 2|Protocol-specified criteria|0
5713242|NCT00111761|19685290|P1|Part 2|Protocol-specified criteria|1
5713243|NCT00111761|19685289|P2|Part 2|Disease progression|0
5713244|NCT00111761|19685290|P1|Part 2|Disease progression|3
5713245|NCT00111761|19685289|P2|Part 2|Death|0
5713246|NCT00111761|19685290|P1|Part 2|Death|1
5713247|NCT00111761|19685289|P2|Part 2|Physician Decision|0
5713248|NCT00111761|19685290|P1|Part 2|Physician Decision|1
5713249|NCT00111761|19685289|P2|Part 2|Adverse Event|0
5713250|NCT00111761|19685290|P1|Part 2|Adverse Event|1
5713251|NCT00111761|19685289|P2|Part 1|Withdrawal by Subject|1
5713252|NCT00111761|19685290|P1|Part 1|Withdrawal by Subject|0
5713253|NCT00111761|19685289|P2|Part 1|Other|1
5713254|NCT00111761|19685290|P1|Part 1|Other|0
5713255|NCT00111761|19685289|P2|Part 1|Death|2
5713256|NCT00111761|19685290|P1|Part 1|Death|0
5713257|NCT00111761|19685289|P2|Part 1|Physician Decision|1
5713258|NCT00111761|19685290|P1|Part 1|Physician Decision|0
5713259|NCT00111475|19685327|P10|Overall Study|Lost to Follow-up|0
5713260|NCT00111475|19685328|P9|Overall Study|Lost to Follow-up|0
5713261|NCT00111475|19685329|P8|Overall Study|Lost to Follow-up|0
5713262|NCT00111475|19685330|P7|Overall Study|Lost to Follow-up|0
5713263|NCT00111475|19685331|P6|Overall Study|Lost to Follow-up|1
5713264|NCT00111475|19685332|P5|Overall Study|Lost to Follow-up|0
5713265|NCT00111475|19685333|P4|Overall Study|Lost to Follow-up|0
5713266|NCT00111475|19685334|P3|Overall Study|Lost to Follow-up|0
5713267|NCT00111475|19685335|P2|Overall Study|Lost to Follow-up|0
5713268|NCT00111475|19685336|P1|Overall Study|Lost to Follow-up|0
5713269|NCT00111241|19685454|P2|Overall Study|Adverse Event|0
5713270|NCT00111241|19685455|P1|Overall Study|Adverse Event|1
5713271|NCT00111241|19685454|P2|Overall Study|Protocol Violation|8
5713272|NCT00111241|19685455|P1|Overall Study|Protocol Violation|9
5713273|NCT00111241|19685454|P2|Overall Study|Withdrawal by Subject|0
5713274|NCT00111241|19685455|P1|Overall Study|Withdrawal by Subject|4
5713275|NCT00111241|19685454|P2|Overall Study|Lost to Follow-up|0
5713276|NCT00111241|19685455|P1|Overall Study|Lost to Follow-up|1
5713277|NCT00111228|19685466|P3|Overall Study|Withdrawal by Subject|0
5713278|NCT00111228|19685467|P2|Overall Study|Withdrawal by Subject|1
5713279|NCT00111228|19685468|P1|Overall Study|Withdrawal by Subject|5
5713280|NCT00111007|19685481|P2|Long Term Follow-up|Missing|3
5713281|NCT00111007|19685482|P1|Long Term Follow-up|Missing|10
5713282|NCT00111007|19685481|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
5713283|NCT00111007|19685482|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
5713284|NCT00111007|19685481|P2|Long Term Follow-up|Withdrawal by Subject|1
5713285|NCT00111007|19685482|P1|Long Term Follow-up|Withdrawal by Subject|0
5713286|NCT00111007|19685481|P2|Long Term Follow-up|Lost to Follow-up|1
5713287|NCT00111007|19685482|P1|Long Term Follow-up|Lost to Follow-up|1
5713288|NCT00111007|19685481|P2|Long Term Follow-up|Death|39
5713289|NCT00111007|19685482|P1|Long Term Follow-up|Death|34
5713290|NCT00111007|19685481|P2|Active Follow-up|Disease progression/recurrence/relapse|2
5713291|NCT00111007|19685482|P1|Active Follow-up|Disease progression/recurrence/relapse|3
5713292|NCT00111007|19685481|P2|Active Follow-up|Death|0
5713293|NCT00111007|19685482|P1|Active Follow-up|Death|2
5713294|NCT00111007|19685481|P2|Active Follow-up|Adverse Event|0
5713295|NCT00111007|19685482|P1|Active Follow-up|Adverse Event|1
5713296|NCT00111007|19685481|P2|Double-blind (DB) Treatment|Primary reason with other category|1
5713297|NCT00111007|19685482|P1|Double-blind (DB) Treatment|Primary reason with other category|0
5713298|NCT00111007|19685481|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
5713299|NCT00111007|19685482|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
5713300|NCT00111007|19685481|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
5713301|NCT00111007|19685482|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
5713302|NCT00111007|19685481|P2|Double-blind (DB) Treatment|Relapse|0
5713303|NCT00111007|19685482|P1|Double-blind (DB) Treatment|Relapse|1
5713304|NCT00111007|19685481|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
5713305|NCT00111007|19685482|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
5713306|NCT00111007|19685481|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
5713307|NCT00111007|19685482|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
5713308|NCT00111007|19685481|P2|Double-blind (DB) Treatment|Protocol Violation|1
5713309|NCT00111007|19685482|P1|Double-blind (DB) Treatment|Protocol Violation|0
5713310|NCT00111007|19685481|P2|Double-blind (DB) Treatment|Death|2
5713311|NCT00111007|19685482|P1|Double-blind (DB) Treatment|Death|5
5713312|NCT00111007|19685481|P2|Double-blind (DB) Treatment|Adverse Event|4
5713313|NCT00111007|19685482|P1|Double-blind (DB) Treatment|Adverse Event|12
5713314|NCT00110994|19685498|P2|Long Term Follow-up|Death|17
5713315|NCT00110994|19685499|P1|Long Term Follow-up|Death|19
5713316|NCT00110994|19685498|P2|Active Follow-up|Other reasons|2
5713317|NCT00110994|19685499|P1|Active Follow-up|Other reasons|0
5713318|NCT00110994|19685498|P2|Active Follow-up|Disease progression/recurrence/replace|0
5713319|NCT00110994|19685499|P1|Active Follow-up|Disease progression/recurrence/replace|1
5713320|NCT00110994|19685498|P2|Double-blind (DB) Treatment|other reasons|3
5713321|NCT00110994|19685499|P1|Double-blind (DB) Treatment|other reasons|2
5713322|NCT00110994|19685498|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
5713323|NCT00110994|19685499|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
5713324|NCT00110994|19685498|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
5713325|NCT00110994|19685499|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
5713326|NCT00110994|19685498|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
5713327|NCT00110994|19685499|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
5713328|NCT00110994|19685498|P2|Double-blind (DB) Treatment|Death|0
5713329|NCT00110994|19685499|P1|Double-blind (DB) Treatment|Death|1
5713330|NCT00110994|19685498|P2|Double-blind (DB) Treatment|Adverse Event|0
5713331|NCT00110994|19685499|P1|Double-blind (DB) Treatment|Adverse Event|3
5713332|NCT00110890|19685525|P2|Overall Study|Did not enter follow-up phase|4
5713333|NCT00110890|19685526|P1|Overall Study|Did not enter follow-up phase|10
5713334|NCT00110890|19685525|P2|Overall Study|Parathyroidectomy|1
5713335|NCT00110890|19685526|P1|Overall Study|Parathyroidectomy|0
5713336|NCT00110890|19685525|P2|Overall Study|Disease progression|1
5713337|NCT00110890|19685526|P1|Overall Study|Disease progression|0
5713338|NCT00110890|19685525|P2|Overall Study|Requirement for alternative therapy|1
5713339|NCT00110890|19685526|P1|Overall Study|Requirement for alternative therapy|0
5713340|NCT00110890|19685525|P2|Overall Study|Ineligibility determined|0
5713341|NCT00110890|19685526|P1|Overall Study|Ineligibility determined|3
5713342|NCT00110890|19685525|P2|Overall Study|Other|23
5713343|NCT00110890|19685526|P1|Overall Study|Other|34
5713344|NCT00110890|19685525|P2|Overall Study|Invest. Product Commercially Available|110
5713345|NCT00110890|19685526|P1|Overall Study|Invest. Product Commercially Available|217
5713346|NCT00110890|19685525|P2|Overall Study|Kidney Transplant|12
5713347|NCT00110890|19685526|P1|Overall Study|Kidney Transplant|16
5713348|NCT00110890|19685525|P2|Overall Study|Noncompliance|0
5713349|NCT00110890|19685526|P1|Overall Study|Noncompliance|10
5713350|NCT00110890|19685525|P2|Overall Study|Protocol Deviation|0
5713351|NCT00110890|19685526|P1|Overall Study|Protocol Deviation|1
5713352|NCT00110890|19685525|P2|Overall Study|Withdrawal by Subject|5
5713353|NCT00110890|19685526|P1|Overall Study|Withdrawal by Subject|17
5713354|NCT00110890|19685525|P2|Overall Study|Physician Decision|5
5713355|NCT00110890|19685526|P1|Overall Study|Physician Decision|4
5713356|NCT00110890|19685525|P2|Overall Study|Lost to Follow-up|1
5713357|NCT00110890|19685526|P1|Overall Study|Lost to Follow-up|3
5713358|NCT00110890|19685525|P2|Overall Study|Death|9
5713359|NCT00110890|19685526|P1|Overall Study|Death|16
5713360|NCT00110890|19685525|P2|Overall Study|Adverse Event|7
5713361|NCT00110890|19685526|P1|Overall Study|Adverse Event|30
5713362|NCT00110812|19685543|P3|Extended Follow-up|Lost to Follow-up|1
5713363|NCT00110812|19685544|P2|Extended Follow-up|Lost to Follow-up|3
5713364|NCT00110812|19685545|P1|Extended Follow-up|Lost to Follow-up|1
5713365|NCT00110812|19685543|P3|Extended Follow-up|Withdrawal by Subject|0
5713366|NCT00110812|19685544|P2|Extended Follow-up|Withdrawal by Subject|1
5713367|NCT00110812|19685545|P1|Extended Follow-up|Withdrawal by Subject|0
5713368|NCT00110812|19685543|P3|Extended Follow-up|Death|3
5713369|NCT00110812|19685544|P2|Extended Follow-up|Death|0
5713370|NCT00110812|19685545|P1|Extended Follow-up|Death|1
5713371|NCT00110812|19685543|P3|Main Study|Lost to Follow-up|10
5713372|NCT00110812|19685544|P2|Main Study|Lost to Follow-up|11
5713373|NCT00110812|19685545|P1|Main Study|Lost to Follow-up|8
5713374|NCT00110812|19685543|P3|Main Study|Withdrawal by Subject|1
5713375|NCT00110812|19685544|P2|Main Study|Withdrawal by Subject|0
5713376|NCT00110812|19685545|P1|Main Study|Withdrawal by Subject|0
5713377|NCT00110812|19685543|P3|Main Study|Death|2
5713378|NCT00110812|19685544|P2|Main Study|Death|0
5713379|NCT00110812|19685545|P1|Main Study|Death|0
5713380|NCT00110617|19685590|P2|Overall Study|Did not receive study drug|12
5713381|NCT00110617|19685591|P1|Overall Study|Did not receive study drug|0
5713382|NCT00110617|19685590|P2|Overall Study|Death|1
5713383|NCT00110617|19685591|P1|Overall Study|Death|1
5713386|NCT00110617|19685590|P2|Overall Study|Lost to Follow-up|1
5713387|NCT00110617|19685591|P1|Overall Study|Lost to Follow-up|9
5713388|NCT00110617|19685590|P2|Overall Study|Withdrawal by Subject|4
5713389|NCT00110617|19685591|P1|Overall Study|Withdrawal by Subject|10
5713390|NCT00110617|19685590|P2|Overall Study|Protocol Violation|0
5713391|NCT00110617|19685591|P1|Overall Study|Protocol Violation|5
5713392|NCT00110617|19685590|P2|Overall Study|Patient no longer requires study drug|0
5713393|NCT00110617|19685591|P1|Overall Study|Patient no longer requires study drug|1
5713394|NCT00110617|19685590|P2|Overall Study|Lack of Efficacy|0
5713395|NCT00110617|19685591|P1|Overall Study|Lack of Efficacy|1
5713396|NCT00110617|19685590|P2|Overall Study|Abnormal Laboratory Value|2
5713397|NCT00110617|19685591|P1|Overall Study|Abnormal Laboratory Value|4
5713398|NCT00110617|19685590|P2|Overall Study|Adverse Event|4
5713399|NCT00110617|19685591|P1|Overall Study|Adverse Event|2
5713400|NCT00110396|19685708|P1|Overall Study|Patient is to be administered copaxone|1
5713401|NCT00110396|19685708|P1|Overall Study|The patient has refused to visit site|1
5713402|NCT00110396|19685708|P1|Overall Study|The patient has refused|2
5713403|NCT00110396|19685708|P1|Overall Study|Patient refused to come back|1
5713404|NCT00110396|19685708|P1|Overall Study|Protocol Violation|2
5713405|NCT00110396|19685708|P1|Overall Study|Pregnancy (Protocol violation)|2
5713406|NCT00110396|19685708|P1|Overall Study|Pregnancy|1
5713407|NCT00110396|19685708|P1|Overall Study|Participation in MS vaccine study|1
5713408|NCT00110396|19685708|P1|Overall Study|Patient's decision|1
5713409|NCT00110396|19685708|P1|Overall Study|Patient will|1
5713410|NCT00110396|19685708|P1|Overall Study|Patient refused to participate|1
5713411|NCT00110396|19685708|P1|Overall Study|Patient refused to continue|1
5713412|NCT00110396|19685708|P1|Overall Study|Patient non-compliance|1
5713413|NCT00110396|19685708|P1|Overall Study|Decided not to continue treatment|1
5713414|NCT00110396|19685708|P1|Overall Study|Lack of Efficacy|1
5713415|NCT00110396|19685708|P1|Overall Study|Initiated mitoxantrone therapy|1
5713416|NCT00110396|19685708|P1|Overall Study|Administration of plasmapheresis|1
5713417|NCT00110396|19685708|P1|Overall Study|Lost to Follow-up|1
5713418|NCT00110396|19685708|P1|Overall Study|Adverse Event|15
5713419|NCT00110357|19685716|P2|Overall Study|Withdrawal by Subject|1
5713420|NCT00110357|19685717|P1|Overall Study|Withdrawal by Subject|3
5713421|NCT00110357|19685716|P2|Overall Study|Study Drug Toxicity|3
5713422|NCT00110357|19685717|P1|Overall Study|Study Drug Toxicity|1
5713423|NCT00110357|19685716|P2|Overall Study|Study Closure|0
5713424|NCT00110357|19685717|P1|Overall Study|Study Closure|1
5713425|NCT00110357|19685716|P2|Overall Study|Disease progression/relapse|15
5713426|NCT00110357|19685717|P1|Overall Study|Disease progression/relapse|20
5713427|NCT00110357|19685716|P2|Overall Study|Deterioration without progression|0
5713428|NCT00110357|19685717|P1|Overall Study|Deterioration without progression|2
5713429|NCT00110305|19685805|P2|Overall Study|Other|2
5713430|NCT00110305|19685806|P1|Overall Study|Other|8
5713431|NCT00110305|19685805|P2|Overall Study|Lost to Follow-up|3
5713432|NCT00110305|19685806|P1|Overall Study|Lost to Follow-up|20
5713433|NCT00110305|19685805|P2|Overall Study|Withdrawal by Subject|7
5713434|NCT00110305|19685806|P1|Overall Study|Withdrawal by Subject|7
5713435|NCT00110305|19685805|P2|Overall Study|Protocol Violation|1
5713436|NCT00110305|19685806|P1|Overall Study|Protocol Violation|0
5713437|NCT00110305|19685805|P2|Overall Study|Subject Reached A Virologic Endpoint|3
5713438|NCT00110305|19685806|P1|Overall Study|Subject Reached A Virologic Endpoint|21
5713439|NCT00110305|19685805|P2|Overall Study|Subject Ineligible To Continue The Trial|1
5713440|NCT00110305|19685806|P1|Overall Study|Subject Ineligible To Continue The Trial|2
5713441|NCT00110305|19685805|P2|Overall Study|Subject Non-Compliant|2
5713442|NCT00110305|19685806|P1|Overall Study|Subject Non-Compliant|9
5713443|NCT00110305|19685805|P2|Overall Study|Sponsors Decision|0
5713444|NCT00110305|19685806|P1|Overall Study|Sponsors Decision|1
5713445|NCT00110305|19685805|P2|Overall Study|Adverse Event|13
5713446|NCT00110305|19685806|P1|Overall Study|Adverse Event|46
5713447|NCT00110214|19685859|P2|Overall Study|Other (not specified)|75
5713448|NCT00110214|19685860|P1|Overall Study|Other (not specified)|61
5713449|NCT00110214|19685859|P2|Overall Study|Refused further treatment|65
5713450|NCT00110214|19685860|P1|Overall Study|Refused further treatment|52
5713451|NCT00110214|19685859|P2|Overall Study|Adverse Event|192
5713452|NCT00110214|19685860|P1|Overall Study|Adverse Event|115
5713453|NCT00110214|19685859|P2|Overall Study|Disease progression or death|151
5713454|NCT00110214|19685860|P1|Overall Study|Disease progression or death|260
5713455|NCT00110214|19685859|P2|Overall Study|Never started treatment|20
5713456|NCT00110214|19685860|P1|Overall Study|Never started treatment|21
5713457|NCT00110149|19685872|P1|Overall Study|Physician Decision|3
5713458|NCT00110084|19685886|P1|Overall Study|Other|2
5713459|NCT00110084|19685886|P1|Overall Study|Intercurrent Illness|1
5713460|NCT00110084|19685886|P1|Overall Study|Alternate Therapy|5
5713461|NCT00110084|19685886|P1|Overall Study|Patient Refusal|10
5713462|NCT00110084|19685886|P1|Overall Study|Death|1
5713463|NCT00110084|19685886|P1|Overall Study|Adverse Event|9
5713464|NCT00110019|19685895|P2|Overall Study|other reasons|30
5713465|NCT00110019|19685896|P1|Overall Study|other reasons|22
5713466|NCT00110019|19685895|P2|Overall Study|Not start protocol therapy|16
5713467|NCT00110019|19685896|P1|Overall Study|Not start protocol therapy|17
5713468|NCT00110019|19685895|P2|Overall Study|symptom deterioration|16
5713469|NCT00110019|19685896|P1|Overall Study|symptom deterioration|13
5713470|NCT00110019|19685895|P2|Overall Study|complicating disease|1
5713471|NCT00110019|19685896|P1|Overall Study|complicating disease|1
5713472|NCT00110019|19685895|P2|Overall Study|alternative therapy|1
5713473|NCT00110019|19685896|P1|Overall Study|alternative therapy|5
5713474|NCT00110019|19685895|P2|Overall Study|Withdrawal by Subject|9
5713475|NCT00110019|19685896|P1|Overall Study|Withdrawal by Subject|21
5713476|NCT00110019|19685895|P2|Overall Study|Death|15
5713477|NCT00110019|19685896|P1|Overall Study|Death|13
5713478|NCT00110019|19685895|P2|Overall Study|Adverse Event|40
5713479|NCT00110019|19685896|P1|Overall Study|Adverse Event|61
5713480|NCT00110019|19685895|P2|Overall Study|Lack of Efficacy|285
5713481|NCT00110019|19685896|P1|Overall Study|Lack of Efficacy|253
5713482|NCT00109967|19685908|P2|Overall Study|Death|2
5713483|NCT00109967|19685909|P1|Overall Study|Death|0
5713484|NCT00109967|19685908|P2|Overall Study|Physician Decision|3
5713485|NCT00109967|19685909|P1|Overall Study|Physician Decision|1
5713486|NCT00109967|19685908|P2|Overall Study|Withdrawal by Subject|0
5713487|NCT00109967|19685909|P1|Overall Study|Withdrawal by Subject|5
5713488|NCT00109967|19685908|P2|Overall Study|Adverse Event|1
5713489|NCT00109967|19685909|P1|Overall Study|Adverse Event|12
5713490|NCT00109967|19685908|P2|Overall Study|Cancel Prior to Treatment|0
5713491|NCT00109967|19685909|P1|Overall Study|Cancel Prior to Treatment|2
5713492|NCT00109928|19685923|P1|Overall Study|not eligible|1
5713493|NCT00109928|19685923|P1|Overall Study|not protocol specified|2
5713494|NCT00109928|19685923|P1|Overall Study|Death|2
5713495|NCT00109928|19685923|P1|Overall Study|Progression|6
5713496|NCT00109928|19685923|P1|Overall Study|Adverse Event|2
5713497|NCT00109850|19685940|P1|Overall Study|Ineligible|1
5713498|NCT00109850|19685940|P1|Overall Study|Death|2
5713499|NCT00109850|19685940|P1|Overall Study|Adverse Event|1
5713500|NCT00109837|19685947|P1|Overall Study|Ineligible|1
5713501|NCT00109837|19685947|P1|Overall Study|Not treated|1
5713502|NCT00109837|19685947|P1|Overall Study|BCR/ABL+ or Ph+|17
5713503|NCT00109837|19685947|P1|Overall Study|Death|1
5713504|NCT00109837|19685947|P1|Overall Study|Refusal unrelated to adverse effects|1
5713505|NCT00109837|19685947|P1|Overall Study|Adverse Event|2
5713506|NCT00109772|19685957|P2|Open-label Extension|Other|10
5713507|NCT00109772|19685958|P1|Open-label Extension|Other|4
5713508|NCT00109772|19685957|P2|Open-label Extension|Protocol Violation|2
5713509|NCT00109772|19685958|P1|Open-label Extension|Protocol Violation|2
5713510|NCT00109772|19685957|P2|Open-label Extension|Death|1
5713511|NCT00109772|19685958|P1|Open-label Extension|Death|0
5713512|NCT00109772|19685957|P2|Open-label Extension|Lost to Follow-up|0
5713513|NCT00109772|19685958|P1|Open-label Extension|Lost to Follow-up|1
5713514|NCT00109772|19685957|P2|Open-label Extension|Withdrawal by Subject|6
5713515|NCT00109772|19685958|P1|Open-label Extension|Withdrawal by Subject|9
5713516|NCT00109772|19685957|P2|Open-label Extension|Lack of Efficacy|11
5713517|NCT00109772|19685958|P1|Open-label Extension|Lack of Efficacy|19
5713518|NCT00109772|19685957|P2|Open-label Extension|Adverse Event|19
5713519|NCT00109772|19685958|P1|Open-label Extension|Adverse Event|10
5713520|NCT00109772|19685957|P2|Double-blind Treatment|Withdrew prior to treatment|1
5713521|NCT00109772|19685958|P1|Double-blind Treatment|Withdrew prior to treatment|3
5713522|NCT00109772|19685957|P2|Double-blind Treatment|Other|4
5713523|NCT00109772|19685958|P1|Double-blind Treatment|Other|0
5713524|NCT00109772|19685957|P2|Double-blind Treatment|Protocol Violation|1
5713525|NCT00109772|19685958|P1|Double-blind Treatment|Protocol Violation|0
5713526|NCT00109772|19685957|P2|Double-blind Treatment|Lost to Follow-up|3
5713527|NCT00109772|19685958|P1|Double-blind Treatment|Lost to Follow-up|2
5713528|NCT00109772|19685957|P2|Double-blind Treatment|Withdrawal by Subject|1
5713529|NCT00109772|19685958|P1|Double-blind Treatment|Withdrawal by Subject|2
5713530|NCT00109772|19685957|P2|Double-blind Treatment|Lack of Efficacy|0
5713531|NCT00109772|19685958|P1|Double-blind Treatment|Lack of Efficacy|1
5713532|NCT00109772|19685957|P2|Double-blind Treatment|Adverse Event|5
5713533|NCT00109772|19685958|P1|Double-blind Treatment|Adverse Event|14
5713534|NCT00109733|19685998|P2|Overall Study|Could not commit time for study|1
5713535|NCT00109733|19685999|P1|Overall Study|Could not commit time for study|1
5713536|NCT00109733|19685998|P2|Overall Study|Non-compliant|1
5713537|NCT00109733|19685999|P1|Overall Study|Non-compliant|0
5713538|NCT00109733|19685998|P2|Overall Study|Stopped taking study drug|1
5713539|NCT00109733|19685999|P1|Overall Study|Stopped taking study drug|1
5713540|NCT00109733|19685998|P2|Overall Study|Protocol Violation|1
5713541|NCT00109733|19685999|P1|Overall Study|Protocol Violation|0
5713542|NCT00109590|19686016|P3|Overall Study|Never Started Treatment|3
5713543|NCT00109590|19686017|P2|Overall Study|Never Started Treatment|2
5713544|NCT00109590|19686018|P1|Overall Study|Never Started Treatment|1
5713545|NCT00109590|19686016|P3|Overall Study|Lost to Follow-up|1
5713546|NCT00109590|19686017|P2|Overall Study|Lost to Follow-up|0
5713547|NCT00109590|19686018|P1|Overall Study|Lost to Follow-up|1
5713548|NCT00109577|19686060|P2|Overall Study|Withdrawal by Subject|3
5713549|NCT00109577|19686061|P1|Overall Study|Withdrawal by Subject|3
5713550|NCT00109343|19686094|P3|Overall Study|Other|1
5713551|NCT00109343|19686095|P2|Overall Study|Other|2
5713552|NCT00109343|19686096|P1|Overall Study|Other|5
5713553|NCT00109343|19686094|P3|Overall Study|Subject Moved|1
5713554|NCT00109343|19686095|P2|Overall Study|Subject Moved|2
5713555|NCT00109343|19686096|P1|Overall Study|Subject Moved|6
5713556|NCT00109343|19686094|P3|Overall Study|Withdrawal by Subject|10
5713557|NCT00109343|19686095|P2|Overall Study|Withdrawal by Subject|11
5713558|NCT00109343|19686096|P1|Overall Study|Withdrawal by Subject|15
5713559|NCT00109343|19686094|P3|Overall Study|Protocol Violation|2
5713560|NCT00109343|19686095|P2|Overall Study|Protocol Violation|2
5713561|NCT00109343|19686096|P1|Overall Study|Protocol Violation|1
5713562|NCT00109343|19686094|P3|Overall Study|Lost to Follow-up|14
5713563|NCT00109343|19686095|P2|Overall Study|Lost to Follow-up|20
5713564|NCT00109343|19686096|P1|Overall Study|Lost to Follow-up|35
5713565|NCT00109343|19686094|P3|Overall Study|Lack of Efficacy|0
5713566|NCT00109343|19686095|P2|Overall Study|Lack of Efficacy|0
5713567|NCT00109343|19686096|P1|Overall Study|Lack of Efficacy|1
5713568|NCT00109343|19686094|P3|Overall Study|Adverse Event|2
5713569|NCT00109343|19686095|P2|Overall Study|Adverse Event|0
5713570|NCT00109343|19686096|P1|Overall Study|Adverse Event|1
5713571|NCT00109031|19686141|P4|Overall Study|Protocol Violation|0
5713572|NCT00109031|19686142|P3|Overall Study|Protocol Violation|1
5713573|NCT00109031|19686143|P2|Overall Study|Protocol Violation|0
5713574|NCT00109031|19686144|P1|Overall Study|Protocol Violation|0
5713575|NCT00109031|19686141|P4|Overall Study|Physician Decision|0
5713576|NCT00109031|19686142|P3|Overall Study|Physician Decision|0
5713577|NCT00109031|19686143|P2|Overall Study|Physician Decision|1
5713578|NCT00109031|19686144|P1|Overall Study|Physician Decision|0
5713579|NCT00109031|19686141|P4|Overall Study|Withdrawal by Subject|0
5713580|NCT00109031|19686142|P3|Overall Study|Withdrawal by Subject|0
5713581|NCT00109031|19686143|P2|Overall Study|Withdrawal by Subject|1
5713582|NCT00109031|19686144|P1|Overall Study|Withdrawal by Subject|0
5713583|NCT00109031|19686141|P4|Overall Study|Adverse Event|0
5713584|NCT00109031|19686142|P3|Overall Study|Adverse Event|1
5713585|NCT00109031|19686143|P2|Overall Study|Adverse Event|0
5713586|NCT00109031|19686144|P1|Overall Study|Adverse Event|0
5713587|NCT00108953|19686195|P2|Follow-up|Study terminated by sponsor|6
5713588|NCT00108953|19686196|P1|Follow-up|Study terminated by sponsor|10
5713589|NCT00108953|19686195|P2|Follow-up|Lost to Follow-up|1
5713590|NCT00108953|19686196|P1|Follow-up|Lost to Follow-up|1
5713591|NCT00108953|19686195|P2|Follow-up|Death|26
5713592|NCT00108953|19686196|P1|Follow-up|Death|18
5713593|NCT00108862|19686218|P2|Overall Study|Lost to Follow-up|19
5713594|NCT00108862|19686219|P1|Overall Study|Lost to Follow-up|27
5713595|NCT00108862|19686218|P2|Overall Study|Withdrawal by Subject|6
5713596|NCT00108862|19686219|P1|Overall Study|Withdrawal by Subject|10
5713597|NCT00108862|19686218|P2|Overall Study|Death|37
5713598|NCT00108862|19686219|P1|Overall Study|Death|31
5713599|NCT00108732|19686247|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
5713600|NCT00108732|19686247|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
5713601|NCT00108732|19686247|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
5713602|NCT00108732|19686247|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
5713603|NCT00108732|19686247|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
5713604|NCT00108732|19686247|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
5713605|NCT00108732|19686247|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
5713606|NCT00108628|19686256|P2|Overall Study|Death|0
5713607|NCT00108628|19686257|P1|Overall Study|Death|1
5713608|NCT00108628|19686256|P2|Overall Study|Lack of Efficacy|1
5713609|NCT00108628|19686257|P1|Overall Study|Lack of Efficacy|2
5713610|NCT00108628|19686256|P2|Overall Study|Withdrawal by Subject|9
5713611|NCT00108628|19686257|P1|Overall Study|Withdrawal by Subject|17
5713612|NCT00108485|19686307|P2|Overall Study|Lost to Follow-up|2
5713613|NCT00108485|19686308|P1|Overall Study|Lost to Follow-up|0
5713614|NCT00108485|19686307|P2|Overall Study|Withdrawal by Subject|0
5713615|NCT00108485|19686308|P1|Overall Study|Withdrawal by Subject|3
5713616|NCT00108433|19686316|P2|Overall Study|Other|14
5713617|NCT00108433|19686317|P1|Overall Study|Other|14
5713618|NCT00108433|19686316|P2|Overall Study|Adverse Event|1
5713619|NCT00108433|19686317|P1|Overall Study|Adverse Event|3
5713620|NCT00108433|19686316|P2|Overall Study|Death|0
5713621|NCT00108433|19686317|P1|Overall Study|Death|3
5713622|NCT00108433|19686316|P2|Overall Study|Lack of Efficacy|2
5713623|NCT00108433|19686317|P1|Overall Study|Lack of Efficacy|1
5713624|NCT00108355|19686333|P2|Overall Study|Loculated ascites, limiting paracentesis|1
5713625|NCT00108355|19686334|P1|Overall Study|Loculated ascites, limiting paracentesis|1
5713626|NCT00108355|19686333|P2|Overall Study|Peritonitis at index paracentesis|1
5713627|NCT00108355|19686334|P1|Overall Study|Peritonitis at index paracentesis|1
5713628|NCT00108160|19686383|P2|Overall Study|Protocol Violation|5
5713629|NCT00108160|19686384|P1|Overall Study|Protocol Violation|9
5713630|NCT00108160|19686383|P2|Overall Study|Withdrawal by Subject|2
5713631|NCT00108160|19686384|P1|Overall Study|Withdrawal by Subject|4
5713632|NCT00108160|19686383|P2|Overall Study|Death|2
5713633|NCT00108160|19686384|P1|Overall Study|Death|1
5713634|NCT00108160|19686383|P2|Overall Study|Lost to Follow-up|12
5713635|NCT00108160|19686384|P1|Overall Study|Lost to Follow-up|25
5713636|NCT00108082|19686397|P3|Overall Study|Blood Pressure Not Controlled|0
5713637|NCT00108082|19686398|P2|Overall Study|Blood Pressure Not Controlled|0
5713638|NCT00108082|19686399|P1|Overall Study|Blood Pressure Not Controlled|1
5713639|NCT00108082|19686397|P3|Overall Study|Investigator Not at Site|0
5713640|NCT00108082|19686398|P2|Overall Study|Investigator Not at Site|0
5713641|NCT00108082|19686399|P1|Overall Study|Investigator Not at Site|1
5713642|NCT00108082|19686397|P3|Overall Study|Subject Left Site Location|0
5713643|NCT00108082|19686398|P2|Overall Study|Subject Left Site Location|0
5713644|NCT00108082|19686399|P1|Overall Study|Subject Left Site Location|1
5713645|NCT00108082|19686397|P3|Overall Study|Study Medication Not Tapered|0
5713646|NCT00108082|19686398|P2|Overall Study|Study Medication Not Tapered|1
5713647|NCT00108082|19686399|P1|Overall Study|Study Medication Not Tapered|0
5713648|NCT00108082|19686397|P3|Overall Study|Protocol Amendment|0
5713649|NCT00108082|19686398|P2|Overall Study|Protocol Amendment|1
5713650|NCT00108082|19686399|P1|Overall Study|Protocol Amendment|0
5713651|NCT00108082|19686397|P3|Overall Study|Site Closed Study|0
5713652|NCT00108082|19686398|P2|Overall Study|Site Closed Study|2
5713653|NCT00108082|19686399|P1|Overall Study|Site Closed Study|0
5713654|NCT00108082|19686397|P3|Overall Study|Stopped Study Medication|1
5713655|NCT00108082|19686398|P2|Overall Study|Stopped Study Medication|0
5713656|NCT00108082|19686399|P1|Overall Study|Stopped Study Medication|0
5713657|NCT00108082|19686397|P3|Overall Study|Non-compliance|2
5713658|NCT00108082|19686398|P2|Overall Study|Non-compliance|0
5713659|NCT00108082|19686399|P1|Overall Study|Non-compliance|1
5713660|NCT00108082|19686397|P3|Overall Study|Incorrectly Randomized|2
5713661|NCT00108082|19686398|P2|Overall Study|Incorrectly Randomized|0
5713662|NCT00108082|19686399|P1|Overall Study|Incorrectly Randomized|0
5713663|NCT00108082|19686397|P3|Overall Study|Woman of Child-bearing Potential|2
5713664|NCT00108082|19686398|P2|Overall Study|Woman of Child-bearing Potential|0
5713665|NCT00108082|19686399|P1|Overall Study|Woman of Child-bearing Potential|2
5713666|NCT00108082|19686397|P3|Overall Study|Amendment 4: > Month 12|5
5713667|NCT00108082|19686398|P2|Overall Study|Amendment 4: > Month 12|7
5713668|NCT00108082|19686399|P1|Overall Study|Amendment 4: > Month 12|5
5713669|NCT00108082|19686397|P3|Overall Study|Lack of Efficacy|2
5713670|NCT00108082|19686398|P2|Overall Study|Lack of Efficacy|1
5713671|NCT00108082|19686399|P1|Overall Study|Lack of Efficacy|3
5713672|NCT00108082|19686397|P3|Overall Study|Protocol Violation|0
5713673|NCT00108082|19686398|P2|Overall Study|Protocol Violation|2
5713674|NCT00108082|19686399|P1|Overall Study|Protocol Violation|1
5713675|NCT00108082|19686397|P3|Overall Study|Consent Withdrawn|5
5713676|NCT00108082|19686398|P2|Overall Study|Consent Withdrawn|3
5713677|NCT00108082|19686399|P1|Overall Study|Consent Withdrawn|3
5713678|NCT00108082|19686397|P3|Overall Study|Lost to Follow-up|7
5713679|NCT00108082|19686398|P2|Overall Study|Lost to Follow-up|3
5713680|NCT00108082|19686399|P1|Overall Study|Lost to Follow-up|6
5713681|NCT00108082|19686397|P3|Overall Study|Adverse Event|17
5713682|NCT00108082|19686398|P2|Overall Study|Adverse Event|12
5713683|NCT00108082|19686399|P1|Overall Study|Adverse Event|14
5713684|NCT00108069|19686448|P2|Overall Study|Progessive disease|11
5713685|NCT00108069|19686449|P1|Overall Study|Progessive disease|27
5713686|NCT00108069|19686448|P2|Overall Study|Death|0
5713687|NCT00108069|19686449|P1|Overall Study|Death|1
5713688|NCT00108069|19686448|P2|Overall Study|Withdrawal by Subject|0
5713689|NCT00108069|19686449|P1|Overall Study|Withdrawal by Subject|1
5713690|NCT00108069|19686448|P2|Overall Study|Adverse Event|1
5713691|NCT00108069|19686449|P1|Overall Study|Adverse Event|1
5713692|NCT00108069|19686448|P2|Overall Study|Never rec'd study drug|1
5713693|NCT00108069|19686449|P1|Overall Study|Never rec'd study drug|0
5713694|NCT00107991|19686463|P1|18-Week Post Treatment Assessment|Adverse Event|2
5713695|NCT00107991|19686463|P1|12 Week Treatment Period|Incarcerated|1
5713696|NCT00107991|19686463|P1|12 Week Treatment Period|Protocol Violation|1
5713697|NCT00107991|19686463|P1|12 Week Treatment Period|Adverse Event|1
5713698|NCT00107991|19686463|P1|12 Week Treatment Period|Lack of Efficacy|2
5713699|NCT00107991|19686463|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
5713700|NCT00107991|19686463|P1|Eligibility Assessment|chronic uncontrolled asthma|1
5713701|NCT00107991|19686463|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
5713702|NCT00107991|19686463|P1|Eligibility Assessment|Abnormal labs|2
5713703|NCT00107991|19686463|P1|Eligibility Assessment|Positive purified protein derivative|4
5713704|NCT00107991|19686463|P1|Eligibility Assessment|Unwilling to participate|7
5713705|NCT00107991|19686463|P1|Eligibility Assessment|Disease not severe enough|7
5713706|NCT00107978|19686473|P2|Overall Study|Other|4
5713707|NCT00107978|19686474|P1|Overall Study|Other|5
5713708|NCT00107978|19686473|P2|Overall Study|Protocol Violation|1
5713709|NCT00107978|19686474|P1|Overall Study|Protocol Violation|0
5713710|NCT00107978|19686473|P2|Overall Study|Withdrawal by Subject|9
5713711|NCT00107978|19686474|P1|Overall Study|Withdrawal by Subject|4
5713712|NCT00107978|19686473|P2|Overall Study|Lost to Follow-up|28
5713713|NCT00107978|19686474|P1|Overall Study|Lost to Follow-up|20
5713714|NCT00107978|19686473|P2|Overall Study|Death|3
5713715|NCT00107978|19686474|P1|Overall Study|Death|3
5713716|NCT00107978|19686473|P2|Overall Study|Adverse Event|5
5713717|NCT00107978|19686474|P1|Overall Study|Adverse Event|1
5713718|NCT00107952|19686482|P2|Overall Study|Never received study treatment|6
5713719|NCT00107952|19686483|P1|Overall Study|Never received study treatment|9
5713720|NCT00107952|19686482|P2|Overall Study|Other|5
5713721|NCT00107952|19686483|P1|Overall Study|Other|2
5713722|NCT00107952|19686482|P2|Overall Study|Withdrawal by Subject|6
5713723|NCT00107952|19686483|P1|Overall Study|Withdrawal by Subject|9
5713724|NCT00107952|19686482|P2|Overall Study|Lost to Follow-up|3
5713725|NCT00107952|19686483|P1|Overall Study|Lost to Follow-up|0
5713726|NCT00107952|19686482|P2|Overall Study|Death|61
5713727|NCT00107952|19686483|P1|Overall Study|Death|75
5713728|NCT00107900|19686495|P6|Overall Study|Administrative Reasons|0
5713729|NCT00107900|19686496|P5|Overall Study|Administrative Reasons|2
5713730|NCT00107900|19686497|P4|Overall Study|Administrative Reasons|2
5713731|NCT00107900|19686498|P3|Overall Study|Administrative Reasons|2
5713732|NCT00107900|19686499|P2|Overall Study|Administrative Reasons|0
5713733|NCT00107900|19686500|P1|Overall Study|Administrative Reasons|1
5713734|NCT00107900|19686495|P6|Overall Study|Withdrawal by Subject|1
5713735|NCT00107900|19686496|P5|Overall Study|Withdrawal by Subject|1
5713736|NCT00107900|19686497|P4|Overall Study|Withdrawal by Subject|0
5713737|NCT00107900|19686498|P3|Overall Study|Withdrawal by Subject|5
5713738|NCT00107900|19686499|P2|Overall Study|Withdrawal by Subject|0
5713739|NCT00107900|19686500|P1|Overall Study|Withdrawal by Subject|1
5713740|NCT00107900|19686495|P6|Overall Study|Protocol Violation|0
5713741|NCT00107900|19686496|P5|Overall Study|Protocol Violation|7
5713742|NCT00107900|19686497|P4|Overall Study|Protocol Violation|5
5713743|NCT00107900|19686498|P3|Overall Study|Protocol Violation|5
5713744|NCT00107900|19686499|P2|Overall Study|Protocol Violation|0
5713745|NCT00107900|19686500|P1|Overall Study|Protocol Violation|1
5713746|NCT00107900|19686495|P6|Overall Study|Lost to Follow-up|5
5713747|NCT00107900|19686496|P5|Overall Study|Lost to Follow-up|5
5713748|NCT00107900|19686497|P4|Overall Study|Lost to Follow-up|2
5713749|NCT00107900|19686498|P3|Overall Study|Lost to Follow-up|3
5713750|NCT00107900|19686499|P2|Overall Study|Lost to Follow-up|1
5713751|NCT00107900|19686500|P1|Overall Study|Lost to Follow-up|4
5713752|NCT00107900|19686495|P6|Overall Study|Death|0
5713753|NCT00107900|19686496|P5|Overall Study|Death|1
5713754|NCT00107900|19686497|P4|Overall Study|Death|0
5713755|NCT00107900|19686498|P3|Overall Study|Death|0
5713756|NCT00107900|19686499|P2|Overall Study|Death|0
5713757|NCT00107900|19686500|P1|Overall Study|Death|0
5713758|NCT00107900|19686495|P6|Overall Study|Adverse Event|3
5713759|NCT00107900|19686496|P5|Overall Study|Adverse Event|5
5713760|NCT00107900|19686497|P4|Overall Study|Adverse Event|3
5713761|NCT00107900|19686498|P3|Overall Study|Adverse Event|10
5713762|NCT00107900|19686499|P2|Overall Study|Adverse Event|2
5713763|NCT00107900|19686500|P1|Overall Study|Adverse Event|3
5713764|NCT00107783|19686534|P2|Overall Study|Second hip replacement|1
5713765|NCT00107783|19686535|P1|Overall Study|Second hip replacement|1
5713766|NCT00107783|19686534|P2|Overall Study|Withdrawal by Subject|0
5713767|NCT00107783|19686535|P1|Overall Study|Withdrawal by Subject|2
5713768|NCT00107783|19686534|P2|Overall Study|Death|1
5713769|NCT00107783|19686535|P1|Overall Study|Death|0
5713770|NCT00107783|19686534|P2|Overall Study|Adverse Event|2
5713771|NCT00107783|19686535|P1|Overall Study|Adverse Event|0
5713772|NCT00107653|19686570|P2|Overall Study|Administrative Reasons|3
5713773|NCT00107653|19686571|P1|Overall Study|Administrative Reasons|3
5713774|NCT00107653|19686570|P2|Overall Study|Lost to Follow-up|5
5713775|NCT00107653|19686571|P1|Overall Study|Lost to Follow-up|13
5713776|NCT00107653|19686570|P2|Overall Study|Withdrawal by Subject|13
5713777|NCT00107653|19686571|P1|Overall Study|Withdrawal by Subject|12
5713778|NCT00107653|19686570|P2|Overall Study|Protocol Violation|0
5713779|NCT00107653|19686571|P1|Overall Study|Protocol Violation|1
5713780|NCT00107653|19686570|P2|Overall Study|Violation of Selection Criteria at Entry|1
5713781|NCT00107653|19686571|P1|Overall Study|Violation of Selection Criteria at Entry|1
5713782|NCT00107653|19686570|P2|Overall Study|Insufficient Therapeutic Response|11
5713783|NCT00107653|19686571|P1|Overall Study|Insufficient Therapeutic Response|25
5713784|NCT00107653|19686570|P2|Overall Study|Adverse Event|43
5713785|NCT00107653|19686571|P1|Overall Study|Adverse Event|24
5713786|NCT00107614|19686617|P1|Overall Study|Death|2
5713787|NCT00107614|19686617|P1|Overall Study|Physician Decision|10
5713788|NCT00107380|19686648|P1|Overall Study|Ineligible|2
5713789|NCT00107380|19686648|P1|Overall Study|Other - not protocol specified|7
5713790|NCT00107380|19686648|P1|Overall Study|Death|3
5713791|NCT00107380|19686648|P1|Overall Study|Progression/relapse|4
5713792|NCT00107380|19686648|P1|Overall Study|Refusal Unrelated to Adverse Event|7
5713793|NCT00107380|19686648|P1|Overall Study|Adverse Event|7
5713794|NCT00107315|19686654|P1|Overall Study|Withdrawal by Subject|2
5713795|NCT00107315|19686654|P1|Overall Study|Adverse Event|4
5713796|NCT00107315|19686654|P1|Overall Study|Disease Progression|9
5713797|NCT00107276|19686661|P1|Overall Study|Ineligible|16
5713798|NCT00107276|19686661|P1|Overall Study|Death|1
5713799|NCT00107276|19686661|P1|Overall Study|Patient refusal|1
5713800|NCT00107276|19686661|P1|Overall Study|M.D. decision|2
5713801|NCT00107276|19686661|P1|Overall Study|Adverse Event|6
5713802|NCT00107276|19686661|P1|Overall Study|Progression|46
5713803|NCT00107198|19686667|P1|Overall Study|Ineligible|5
5713804|NCT00107198|19686667|P1|Overall Study|Withdrawal by Subject|6
5713805|NCT00107198|19686667|P1|Overall Study|Protocol Violation|1
5713806|NCT00107198|19686667|P1|Overall Study|Lost to Follow-up|12
5713807|NCT00107198|19686667|P1|Overall Study|Lack of Efficacy|28
5713808|NCT00107172|19686677|P2|Overall Study|Other Reason|3
5713809|NCT00107172|19686678|P1|Overall Study|Other Reason|4
5713810|NCT00107172|19686677|P2|Overall Study|Death|2
5713811|NCT00107172|19686678|P1|Overall Study|Death|0
5713812|NCT00107172|19686677|P2|Overall Study|Withdrawal by Subject|0
5713813|NCT00107172|19686678|P1|Overall Study|Withdrawal by Subject|1
5713814|NCT00107120|19686708|P2|Overall Study|death of parent|1
5713815|NCT00107120|19686709|P1|Overall Study|death of parent|0
5713816|NCT00107120|19686708|P2|Overall Study|moving away from site|1
5713817|NCT00107120|19686709|P1|Overall Study|moving away from site|1
5713818|NCT00107120|19686708|P2|Overall Study|Pregnancy|1
5713819|NCT00107120|19686709|P1|Overall Study|Pregnancy|0
5713820|NCT00107120|19686708|P2|Overall Study|Lost to Follow-up|6
5713821|NCT00107120|19686709|P1|Overall Study|Lost to Follow-up|8
5713822|NCT00107120|19686708|P2|Overall Study|Withdrawal by Subject|9
5713823|NCT00107120|19686709|P1|Overall Study|Withdrawal by Subject|8
5713824|NCT00107120|19686708|P2|Overall Study|Protocol Violation|0
5713825|NCT00107120|19686709|P1|Overall Study|Protocol Violation|3
5713826|NCT00107120|19686708|P2|Overall Study|Lack of Efficacy|5
5713827|NCT00107120|19686709|P1|Overall Study|Lack of Efficacy|5
5713828|NCT00107120|19686708|P2|Overall Study|Adverse Event|1
5713829|NCT00107120|19686709|P1|Overall Study|Adverse Event|4
5713830|NCT00107042|19686721|P2|Overall Study|Disallowed medications|2
5713831|NCT00107042|19686722|P1|Overall Study|Disallowed medications|0
5713832|NCT00107042|19686721|P2|Overall Study|vaccinated outside window|1
5713833|NCT00107042|19686722|P1|Overall Study|vaccinated outside window|1
5713834|NCT00107042|19686721|P2|Overall Study|Inadvertent enrollment|1
5713835|NCT00107042|19686722|P1|Overall Study|Inadvertent enrollment|0
5713836|NCT00107042|19686721|P2|Overall Study|Pregnancy|1
5713837|NCT00107042|19686722|P1|Overall Study|Pregnancy|1
5713838|NCT00107042|19686721|P2|Overall Study|Moved out of area|3
5713839|NCT00107042|19686722|P1|Overall Study|Moved out of area|5
5713840|NCT00107042|19686721|P2|Overall Study|Withdrawal by Subject|1
5713841|NCT00107042|19686722|P1|Overall Study|Withdrawal by Subject|6
5713842|NCT00107042|19686721|P2|Overall Study|Lost to Follow-up|7
5713843|NCT00107042|19686722|P1|Overall Study|Lost to Follow-up|9
5713844|NCT00106964|19686788|P3|Overall Study|Required disallowed medication|0
5713845|NCT00106964|19686789|P2|Overall Study|Required disallowed medication|1
5713846|NCT00106964|19686790|P1|Overall Study|Required disallowed medication|0
5713847|NCT00106964|19686788|P3|Overall Study|Did not meet eligibility criteria|2
5713848|NCT00106964|19686789|P2|Overall Study|Did not meet eligibility criteria|2
5713849|NCT00106964|19686790|P1|Overall Study|Did not meet eligibility criteria|0
5713850|NCT00106964|19686788|P3|Overall Study|Failure to adhere|0
5713851|NCT00106964|19686789|P2|Overall Study|Failure to adhere|0
5713852|NCT00106964|19686790|P1|Overall Study|Failure to adhere|2
5713853|NCT00106964|19686788|P3|Overall Study|Site Funding Terminated|1
5713854|NCT00106964|19686789|P2|Overall Study|Site Funding Terminated|1
5713855|NCT00106964|19686790|P1|Overall Study|Site Funding Terminated|0
5713856|NCT00106964|19686788|P3|Overall Study|Incarceration|0
5713857|NCT00106964|19686789|P2|Overall Study|Incarceration|1
5713858|NCT00106964|19686790|P1|Overall Study|Incarceration|0
5713859|NCT00106964|19686788|P3|Overall Study|Death|0
5713860|NCT00106964|19686789|P2|Overall Study|Death|1
5713861|NCT00106964|19686790|P1|Overall Study|Death|1
5713862|NCT00106964|19686788|P3|Overall Study|Pregnancy|2
5713863|NCT00106964|19686789|P2|Overall Study|Pregnancy|3
5713864|NCT00106964|19686790|P1|Overall Study|Pregnancy|2
5713865|NCT00106964|19686788|P3|Overall Study|Lost to Follow-up|2
5713866|NCT00106964|19686789|P2|Overall Study|Lost to Follow-up|6
5713867|NCT00106964|19686790|P1|Overall Study|Lost to Follow-up|8
5713868|NCT00106704|19686885|P2|Overall Study|Laboratory test|1
5713869|NCT00106704|19686886|P1|Overall Study|Laboratory test|1
5713870|NCT00106704|19686885|P2|Overall Study|Unable to re-enter US|0
5713871|NCT00106704|19686886|P1|Overall Study|Unable to re-enter US|1
5713872|NCT00106704|19686885|P2|Overall Study|Patient Received Glycemic Medication|41
5713873|NCT00106704|19686886|P1|Overall Study|Patient Received Glycemic Medication|22
5713874|NCT00106704|19686885|P2|Overall Study|Planned major surgery|0
5713875|NCT00106704|19686886|P1|Overall Study|Planned major surgery|1
5713876|NCT00106704|19686885|P2|Overall Study|Site terminated|1
5713877|NCT00106704|19686886|P1|Overall Study|Site terminated|0
5713878|NCT00106704|19686885|P2|Overall Study|Patient moved|0
5713879|NCT00106704|19686886|P1|Overall Study|Patient moved|1
5713880|NCT00106704|19686885|P2|Overall Study|Withdrawal by Subject|21
5713881|NCT00106704|19686886|P1|Overall Study|Withdrawal by Subject|14
5713882|NCT00106704|19686885|P2|Overall Study|Protocol Violation|7
5713883|NCT00106704|19686886|P1|Overall Study|Protocol Violation|4
5713884|NCT00106704|19686885|P2|Overall Study|Pregnancy|0
5713885|NCT00106704|19686886|P1|Overall Study|Pregnancy|1
5713886|NCT00106704|19686885|P2|Overall Study|Lost to Follow-up|3
5713887|NCT00106704|19686886|P1|Overall Study|Lost to Follow-up|7
5713888|NCT00106704|19686885|P2|Overall Study|Lack of Efficacy|69
5713889|NCT00106704|19686886|P1|Overall Study|Lack of Efficacy|67
5713890|NCT00106704|19686885|P2|Overall Study|Death|1
5713891|NCT00106704|19686886|P1|Overall Study|Death|2
5713892|NCT00106704|19686885|P2|Overall Study|Adverse Event|7
5713893|NCT00106704|19686886|P1|Overall Study|Adverse Event|10
5713894|NCT00106639|19686897|P3|Overall Study|Participant defaulted|1
5713895|NCT00106639|19686898|P2|Overall Study|Participant defaulted|1
5713896|NCT00106639|19686899|P1|Overall Study|Participant defaulted|0
5713897|NCT00106639|19686897|P3|Overall Study|Withdrawal by Subject|0
5713898|NCT00106639|19686898|P2|Overall Study|Withdrawal by Subject|1
5713899|NCT00106639|19686899|P1|Overall Study|Withdrawal by Subject|0
5713900|NCT00106639|19686897|P3|Overall Study|Protocol Violation|0
5713901|NCT00106639|19686898|P2|Overall Study|Protocol Violation|1
5713902|NCT00106639|19686899|P1|Overall Study|Protocol Violation|0
5713903|NCT00106639|19686897|P3|Overall Study|Adverse Event|1
5713904|NCT00106639|19686898|P2|Overall Study|Adverse Event|4
5713905|NCT00106639|19686899|P1|Overall Study|Adverse Event|3
5713906|NCT00106626|19687026|P4|Overall Study|> 14 day delay in therapy start|0
5713907|NCT00106626|19687027|P3|Overall Study|> 14 day delay in therapy start|0
5713908|NCT00106626|19687028|P2|Overall Study|> 14 day delay in therapy start|1
5713909|NCT00106626|19687029|P1|Overall Study|> 14 day delay in therapy start|0
5713910|NCT00106626|19687026|P4|Overall Study|Received radiation on new therapy|0
5713911|NCT00106626|19687027|P3|Overall Study|Received radiation on new therapy|0
5713912|NCT00106626|19687028|P2|Overall Study|Received radiation on new therapy|0
5713913|NCT00106626|19687029|P1|Overall Study|Received radiation on new therapy|1
5713914|NCT00106626|19687026|P4|Overall Study|Progressive Disease|10
5713915|NCT00106626|19687027|P3|Overall Study|Progressive Disease|9
5713916|NCT00106626|19687028|P2|Overall Study|Progressive Disease|1
5713917|NCT00106626|19687029|P1|Overall Study|Progressive Disease|4
5713918|NCT00106626|19687026|P4|Overall Study|Adverse Event|3
5713919|NCT00106626|19687027|P3|Overall Study|Adverse Event|3
5713920|NCT00106626|19687028|P2|Overall Study|Adverse Event|4
5713921|NCT00106626|19687029|P1|Overall Study|Adverse Event|5
5713922|NCT00106353|19687374|P7|Part 2|Physician Decision|0
5713923|NCT00106353|19687375|P6|Part 2|Physician Decision|1
5713924|NCT00106353|19687376|P5|Part 2|Physician Decision|0
5713925|NCT00106353|19687377|P4|Part 2|Physician Decision|0
5713926|NCT00106353|19687378|P3|Part 2|Physician Decision|0
5713927|NCT00106353|19687379|P2|Part 2|Physician Decision|0
5713928|NCT00106353|19687380|P1|Part 2|Physician Decision|0
5713929|NCT00106353|19687374|P7|Part 2|Withdrawal by Subject|0
5713930|NCT00106353|19687375|P6|Part 2|Withdrawal by Subject|0
5713931|NCT00106353|19687376|P5|Part 2|Withdrawal by Subject|1
5713932|NCT00106353|19687377|P4|Part 2|Withdrawal by Subject|0
5713933|NCT00106353|19687378|P3|Part 2|Withdrawal by Subject|0
5713934|NCT00106353|19687379|P2|Part 2|Withdrawal by Subject|0
5713935|NCT00106353|19687380|P1|Part 2|Withdrawal by Subject|0
5713936|NCT00106353|19687374|P7|Part 2|Other|1
5713937|NCT00106353|19687375|P6|Part 2|Other|1
5713938|NCT00106353|19687376|P5|Part 2|Other|1
5713939|NCT00106353|19687377|P4|Part 2|Other|0
5713940|NCT00106353|19687378|P3|Part 2|Other|0
5713941|NCT00106353|19687379|P2|Part 2|Other|0
5713942|NCT00106353|19687380|P1|Part 2|Other|0
5713943|NCT00106353|19687374|P7|Part 2|Adverse Event|1
5713944|NCT00106353|19687375|P6|Part 2|Adverse Event|2
5713945|NCT00106353|19687376|P5|Part 2|Adverse Event|0
5713946|NCT00106353|19687377|P4|Part 2|Adverse Event|0
5713947|NCT00106353|19687378|P3|Part 2|Adverse Event|0
5713948|NCT00106353|19687379|P2|Part 2|Adverse Event|0
5713949|NCT00106353|19687380|P1|Part 2|Adverse Event|0
5713950|NCT00106353|19687374|P7|Part 2|Symptomatic deterioration|0
5713951|NCT00106353|19687375|P6|Part 2|Symptomatic deterioration|0
5713952|NCT00106353|19687376|P5|Part 2|Symptomatic deterioration|3
5713953|NCT00106353|19687377|P4|Part 2|Symptomatic deterioration|0
5713954|NCT00106353|19687378|P3|Part 2|Symptomatic deterioration|0
5713955|NCT00106353|19687379|P2|Part 2|Symptomatic deterioration|0
5713956|NCT00106353|19687380|P1|Part 2|Symptomatic deterioration|0
5713957|NCT00106353|19687374|P7|Part 2|Death|1
5713958|NCT00106353|19687375|P6|Part 2|Death|0
5713959|NCT00106353|19687376|P5|Part 2|Death|3
5713960|NCT00106353|19687377|P4|Part 2|Death|0
5713961|NCT00106353|19687378|P3|Part 2|Death|0
5713962|NCT00106353|19687379|P2|Part 2|Death|0
5713963|NCT00106353|19687380|P1|Part 2|Death|0
5713964|NCT00106353|19687374|P7|Part 2|Disease progression|13
5713965|NCT00106353|19687375|P6|Part 2|Disease progression|14
5713966|NCT00106353|19687376|P5|Part 2|Disease progression|8
5713967|NCT00106353|19687377|P4|Part 2|Disease progression|0
5713968|NCT00106353|19687378|P3|Part 2|Disease progression|0
5713969|NCT00106353|19687379|P2|Part 2|Disease progression|0
5713970|NCT00106353|19687380|P1|Part 2|Disease progression|0
5713971|NCT00106353|19687374|P7|Part 1|Adverse Event|0
5713972|NCT00106353|19687375|P6|Part 1|Adverse Event|0
5713973|NCT00106353|19687376|P5|Part 1|Adverse Event|0
5713974|NCT00106353|19687377|P4|Part 1|Adverse Event|1
5713975|NCT00106353|19687378|P3|Part 1|Adverse Event|0
5713976|NCT00106353|19687379|P2|Part 1|Adverse Event|0
5713977|NCT00106353|19687380|P1|Part 1|Adverse Event|0
5713978|NCT00106353|19687374|P7|Part 1|Entered follow-up phase|0
5713979|NCT00106353|19687375|P6|Part 1|Entered follow-up phase|0
5713980|NCT00106353|19687376|P5|Part 1|Entered follow-up phase|0
5713981|NCT00106353|19687377|P4|Part 1|Entered follow-up phase|1
5713982|NCT00106353|19687378|P3|Part 1|Entered follow-up phase|0
5713983|NCT00106353|19687379|P2|Part 1|Entered follow-up phase|1
5713984|NCT00106353|19687380|P1|Part 1|Entered follow-up phase|1
5713985|NCT00106353|19687374|P7|Part 1|Symptomatic deterioration|0
5713986|NCT00106353|19687375|P6|Part 1|Symptomatic deterioration|0
5713987|NCT00106353|19687376|P5|Part 1|Symptomatic deterioration|0
5713988|NCT00106353|19687377|P4|Part 1|Symptomatic deterioration|0
5713989|NCT00106353|19687378|P3|Part 1|Symptomatic deterioration|1
5713990|NCT00106353|19687379|P2|Part 1|Symptomatic deterioration|0
5713991|NCT00106353|19687380|P1|Part 1|Symptomatic deterioration|0
5713992|NCT00106353|19687374|P7|Part 1|Withdrawal by Subject|0
5713993|NCT00106353|19687375|P6|Part 1|Withdrawal by Subject|0
5713994|NCT00106353|19687376|P5|Part 1|Withdrawal by Subject|0
5713995|NCT00106353|19687377|P4|Part 1|Withdrawal by Subject|2
5713996|NCT00106353|19687378|P3|Part 1|Withdrawal by Subject|1
5713997|NCT00106353|19687379|P2|Part 1|Withdrawal by Subject|0
5713998|NCT00106353|19687380|P1|Part 1|Withdrawal by Subject|0
5713999|NCT00106353|19687374|P7|Part 1|Disease progression|0
5714000|NCT00106353|19687375|P6|Part 1|Disease progression|0
5714001|NCT00106353|19687376|P5|Part 1|Disease progression|0
5714002|NCT00106353|19687377|P4|Part 1|Disease progression|3
5714003|NCT00106353|19687378|P3|Part 1|Disease progression|1
5714004|NCT00106353|19687379|P2|Part 1|Disease progression|4
5714005|NCT00106353|19687380|P1|Part 1|Disease progression|3
5714006|NCT00106249|19687507|P2|Overall Study|Lost to Follow-up|2
5714007|NCT00106249|19687508|P1|Overall Study|Lost to Follow-up|3
5714008|NCT00106184|19687520|P2|Overall Study|Withdrawal by Subject|2
5714009|NCT00106184|19687521|P1|Overall Study|Withdrawal by Subject|3
5714010|NCT00106080|19687563|P2|Overall Study|Withdrew/Loss to follow-up|27
5714011|NCT00106080|19687564|P1|Overall Study|Withdrew/Loss to follow-up|43
5714012|NCT00106028|19687574|P2|Overall Study|Lost to Follow-up|1
5714013|NCT00106028|19687575|P1|Overall Study|Lost to Follow-up|0
5714014|NCT00106028|19687574|P2|Overall Study|Withdrawal by Subject|8
5714015|NCT00106028|19687575|P1|Overall Study|Withdrawal by Subject|2
5714016|NCT00106028|19687574|P2|Overall Study|Protocol Violation|1
5714017|NCT00106028|19687575|P1|Overall Study|Protocol Violation|1
5714018|NCT00106028|19687574|P2|Overall Study|Adverse Event|2
5714019|NCT00106028|19687575|P1|Overall Study|Adverse Event|3
5714020|NCT00106002|19687669|P1|Overall Study|Ineligible after Registration|1
5714021|NCT00106002|19687669|P1|Overall Study|Did not take any study drug|1
5714022|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
5714023|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
5714024|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
5714025|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
5714026|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Death|0
5714027|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Death|0
5714028|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
5714029|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
5714030|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
5714031|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
5714032|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
5714033|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
5714034|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
5714035|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
5714036|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
5714037|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
5714038|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
5714039|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
5714040|NCT00105989|19687677|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
5714041|NCT00105989|19687678|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
5714042|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
5714043|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
5714044|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
5714045|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
5714046|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Death|0
5714047|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Death|0
5714048|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
5714049|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
5714050|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
5714051|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
5714052|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
5714053|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
5714054|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
5714055|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
5714056|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
5714057|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
5714058|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
5714059|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
5714060|NCT00105989|19687677|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
5714061|NCT00105989|19687678|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
5714062|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
5714063|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
5714064|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
5714065|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
5714066|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Death|0
5714067|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Death|1
5714068|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Physician Decision|0
5714069|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Physician Decision|0
5714070|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
5714071|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
5714072|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
5714073|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
5714074|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
5714075|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
5714076|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
5714077|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
5714078|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
5714079|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
5714080|NCT00105989|19687677|P2|Acute - Open Label: Week 0-10|Adverse Event|0
5714081|NCT00105989|19687678|P1|Acute - Open Label: Week 0-10|Adverse Event|33
5714082|NCT00105586|19687794|P2|Overall Study|Physician Decision|13
5714083|NCT00105586|19687795|P1|Overall Study|Physician Decision|13
5714084|NCT00105586|19687794|P2|Overall Study|Adverse Event|3
5714085|NCT00105586|19687795|P1|Overall Study|Adverse Event|4
5714086|NCT00105560|19687803|P1|Overall Study|Lost to Follow-up|1
5714087|NCT00105534|19687825|P2|Overall Study|Other Reason|2
5714088|NCT00105534|19687826|P1|Overall Study|Other Reason|0
5714089|NCT00105534|19687825|P2|Overall Study|Treatment unmasked|0
5714090|NCT00105534|19687826|P1|Overall Study|Treatment unmasked|1
5714091|NCT00105534|19687825|P2|Overall Study|Lack of Efficacy|15
5714092|NCT00105534|19687826|P1|Overall Study|Lack of Efficacy|7
5714093|NCT00105534|19687825|P2|Overall Study|Lost to Follow-up|1
5714094|NCT00105534|19687826|P1|Overall Study|Lost to Follow-up|5
5714095|NCT00105534|19687825|P2|Overall Study|Withdrawal by Subject|6
5714096|NCT00105534|19687826|P1|Overall Study|Withdrawal by Subject|6
5714097|NCT00105534|19687825|P2|Overall Study|Protocol Violation|4
5714098|NCT00105534|19687826|P1|Overall Study|Protocol Violation|1
5714099|NCT00105534|19687825|P2|Overall Study|Adverse Event|5
5714100|NCT00105534|19687826|P1|Overall Study|Adverse Event|2
5714101|NCT00105521|19687838|P4|Overall Study|Lost to Follow-up|0
5714102|NCT00105521|19687839|P3|Overall Study|Lost to Follow-up|0
5714103|NCT00105521|19687840|P2|Overall Study|Lost to Follow-up|1
5714104|NCT00105521|19687841|P1|Overall Study|Lost to Follow-up|0
5714105|NCT00105521|19687838|P4|Overall Study|Protocol Violation|4
5714106|NCT00105521|19687839|P3|Overall Study|Protocol Violation|4
5714107|NCT00105521|19687840|P2|Overall Study|Protocol Violation|5
5714108|NCT00105521|19687841|P1|Overall Study|Protocol Violation|3
5714109|NCT00105521|19687838|P4|Overall Study|Lack of Efficacy|1
5714110|NCT00105521|19687839|P3|Overall Study|Lack of Efficacy|0
5714111|NCT00105521|19687840|P2|Overall Study|Lack of Efficacy|0
5714112|NCT00105521|19687841|P1|Overall Study|Lack of Efficacy|0
5714113|NCT00105521|19687838|P4|Overall Study|Withdrawal by Subject|4
5714114|NCT00105521|19687839|P3|Overall Study|Withdrawal by Subject|1
5714115|NCT00105521|19687840|P2|Overall Study|Withdrawal by Subject|0
5714116|NCT00105521|19687841|P1|Overall Study|Withdrawal by Subject|1
5714117|NCT00105521|19687838|P4|Overall Study|Adverse Event|8
5714118|NCT00105521|19687839|P3|Overall Study|Adverse Event|10
5714119|NCT00105521|19687840|P2|Overall Study|Adverse Event|4
5714120|NCT00105521|19687841|P1|Overall Study|Adverse Event|10
5714121|NCT00105521|19687838|P4|Overall Study|Other|0
5714122|NCT00105521|19687839|P3|Overall Study|Other|2
5714123|NCT00105521|19687840|P2|Overall Study|Other|1
5714124|NCT00105521|19687841|P1|Overall Study|Other|1
5714125|NCT00105508|19687865|P2|Overall Study|Other|9
5714126|NCT00105508|19687866|P1|Overall Study|Other|8
5714127|NCT00105508|19687865|P2|Overall Study|Protocol Violation|2
5714128|NCT00105508|19687866|P1|Overall Study|Protocol Violation|1
5714129|NCT00105508|19687865|P2|Overall Study|Lost to Follow-up|0
5714130|NCT00105508|19687866|P1|Overall Study|Lost to Follow-up|3
5714131|NCT00105508|19687865|P2|Overall Study|Withdrawal by Subject|6
5714132|NCT00105508|19687866|P1|Overall Study|Withdrawal by Subject|10
5714133|NCT00105508|19687865|P2|Overall Study|Insufficient Efficacy|0
5714134|NCT00105508|19687866|P1|Overall Study|Insufficient Efficacy|1
5714135|NCT00105508|19687865|P2|Overall Study|Adverse Event|19
5714136|NCT00105508|19687866|P1|Overall Study|Adverse Event|16
5714137|NCT00105508|19687865|P2|Overall Study|Prephase Dropout|0
5714138|NCT00105508|19687866|P1|Overall Study|Prephase Dropout|1
5714139|NCT00105482|19687880|P2|Overall Study|Withdrawn by PI|1
5714140|NCT00105482|19687881|P1|Overall Study|Withdrawn by PI|1
5714141|NCT00105482|19687880|P2|Overall Study|Scheduling Conflict|3
5714142|NCT00105482|19687881|P1|Overall Study|Scheduling Conflict|2
5714143|NCT00105482|19687880|P2|Overall Study|Lost Interest|32
5714144|NCT00105482|19687881|P1|Overall Study|Lost Interest|29
5714145|NCT00105482|19687880|P2|Overall Study|Withdrawal by Subject|1
5714146|NCT00105482|19687881|P1|Overall Study|Withdrawal by Subject|0
5714147|NCT00105482|19687880|P2|Overall Study|Lost to Follow-up|17
5714148|NCT00105482|19687881|P1|Overall Study|Lost to Follow-up|26
5714149|NCT00105482|19687880|P2|Overall Study|Adverse Event|1
5714150|NCT00105482|19687881|P1|Overall Study|Adverse Event|1
5714151|NCT00105469|19687897|P2|Overall Study|Other Reason|0
5714152|NCT00105469|19687898|P1|Overall Study|Other Reason|4
5714153|NCT00105469|19687897|P2|Overall Study|Lack of Efficacy|0
5714154|NCT00105469|19687898|P1|Overall Study|Lack of Efficacy|2
5714155|NCT00105469|19687897|P2|Overall Study|Lost to Follow-up|0
5714156|NCT00105469|19687898|P1|Overall Study|Lost to Follow-up|1
5714157|NCT00105469|19687897|P2|Overall Study|Withdrawal by Subject|3
5714158|NCT00105469|19687898|P1|Overall Study|Withdrawal by Subject|2
5714159|NCT00105469|19687897|P2|Overall Study|Protocol Violation|0
5714160|NCT00105469|19687898|P1|Overall Study|Protocol Violation|4
5714161|NCT00105469|19687897|P2|Overall Study|Adverse Event|8
5714162|NCT00105469|19687898|P1|Overall Study|Adverse Event|9
5714163|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
5714164|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
5714165|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
5714166|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
5714167|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
5714168|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
5714169|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
5714170|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
5714171|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
5714172|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
5714173|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
5714174|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
5714175|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
5714176|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
5714177|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
5714178|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
5714179|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
5714180|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
5714181|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
5714182|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
5714183|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
5714184|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
5714185|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
5714186|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
5714187|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
5714188|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
5714189|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
5714190|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
5714191|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
5714192|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
5714193|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
5714194|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
5714195|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
5714196|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
5714197|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
5714198|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
5714199|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
5714200|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
5714201|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
5714202|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
5714203|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
5714204|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
5714205|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
5714206|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
5714207|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
5714208|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
5714209|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
5714210|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
5714211|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
5714212|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
5714213|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
5714214|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
5714215|NCT00105443|19687908|P4|Follow-up and/or Open Label Nexavar|Death|4
5714216|NCT00105443|19687909|P3|Follow-up and/or Open Label Nexavar|Death|219
5714217|NCT00105443|19687910|P2|Follow-up and/or Open Label Nexavar|Death|7
5714218|NCT00105443|19687911|P1|Follow-up and/or Open Label Nexavar|Death|180
5714219|NCT00105443|19687908|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
5714220|NCT00105443|19687909|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
5714221|NCT00105443|19687910|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
5714222|NCT00105443|19687911|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
5714223|NCT00105443|19687908|P4|Double-Blind Treatment|Physician Decision|0
5714224|NCT00105443|19687909|P3|Double-Blind Treatment|Physician Decision|2
5714225|NCT00105443|19687910|P2|Double-Blind Treatment|Physician Decision|0
5714226|NCT00105443|19687911|P1|Double-Blind Treatment|Physician Decision|1
5714227|NCT00105443|19687908|P4|Double-Blind Treatment|Withdrawal by Subject|0
5714228|NCT00105443|19687909|P3|Double-Blind Treatment|Withdrawal by Subject|7
5714229|NCT00105443|19687910|P2|Double-Blind Treatment|Withdrawal by Subject|0
5714230|NCT00105443|19687911|P1|Double-Blind Treatment|Withdrawal by Subject|8
5714231|NCT00105443|19687908|P4|Double-Blind Treatment|Lost to Follow-up|0
5714232|NCT00105443|19687909|P3|Double-Blind Treatment|Lost to Follow-up|1
5714233|NCT00105443|19687910|P2|Double-Blind Treatment|Lost to Follow-up|0
5714234|NCT00105443|19687911|P1|Double-Blind Treatment|Lost to Follow-up|0
5714235|NCT00105443|19687908|P4|Double-Blind Treatment|Adverse Event|0
5714236|NCT00105443|19687909|P3|Double-Blind Treatment|Adverse Event|0
5714237|NCT00105443|19687910|P2|Double-Blind Treatment|Adverse Event|0
5714238|NCT00105443|19687911|P1|Double-Blind Treatment|Adverse Event|1
5714239|NCT00105235|19687938|P1|Overall Study|Withdrawal by Subject|2
5714240|NCT00105235|19687938|P1|Overall Study|Physician Decision|1
5714241|NCT00105235|19687938|P1|Overall Study|Death|4
5714242|NCT00105196|19687951|P2|Overall Study|Subject became unblinded|1
5714243|NCT00105196|19687952|P1|Overall Study|Subject became unblinded|0
5714244|NCT00105196|19687951|P2|Overall Study|marijuana use|1
5714245|NCT00105196|19687952|P1|Overall Study|marijuana use|0
5714246|NCT00105196|19687951|P2|Overall Study|pending surgery|1
5714247|NCT00105196|19687952|P1|Overall Study|pending surgery|0
5714248|NCT00105196|19687951|P2|Overall Study|Protocol Violation|2
5714249|NCT00105196|19687952|P1|Overall Study|Protocol Violation|5
5714250|NCT00105196|19687951|P2|Overall Study|Poor/noncompliance|4
5714251|NCT00105196|19687952|P1|Overall Study|Poor/noncompliance|3
5714252|NCT00105196|19687951|P2|Overall Study|Lost to Follow-up|2
5714253|NCT00105196|19687952|P1|Overall Study|Lost to Follow-up|3
5714254|NCT00105196|19687951|P2|Overall Study|Withdrawal by Subject|6
5714255|NCT00105196|19687952|P1|Overall Study|Withdrawal by Subject|6
5714256|NCT00105196|19687951|P2|Overall Study|Adverse Event|3
5714257|NCT00105196|19687952|P1|Overall Study|Adverse Event|11
5714258|NCT00105196|19687951|P2|Overall Study|Lack of Efficacy|3
5714259|NCT00105196|19687952|P1|Overall Study|Lack of Efficacy|2
5714260|NCT00105183|19687975|P3|Overall Study|Other reason|0
5714261|NCT00105183|19687976|P2|Overall Study|Other reason|2
5714262|NCT00105183|19687977|P1|Overall Study|Other reason|1
5714263|NCT00105183|19687975|P3|Overall Study|Lost to Follow-up|1
5714264|NCT00105183|19687976|P2|Overall Study|Lost to Follow-up|1
5714265|NCT00105183|19687977|P1|Overall Study|Lost to Follow-up|0
5714266|NCT00105183|19687975|P3|Overall Study|Physician Decision|3
5714267|NCT00105183|19687976|P2|Overall Study|Physician Decision|2
5714268|NCT00105183|19687977|P1|Overall Study|Physician Decision|1
5714269|NCT00105183|19687975|P3|Overall Study|Withdrawal by Subject|4
5714270|NCT00105183|19687976|P2|Overall Study|Withdrawal by Subject|1
5714271|NCT00105183|19687977|P1|Overall Study|Withdrawal by Subject|1
5714272|NCT00105183|19687975|P3|Overall Study|Death|15
5714273|NCT00105183|19687976|P2|Overall Study|Death|13
5714274|NCT00105183|19687977|P1|Overall Study|Death|19
5714275|NCT00105157|19688013|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
5714276|NCT00105157|19688014|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
5714277|NCT00105157|19688015|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
5714278|NCT00105157|19688016|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
5714279|NCT00105157|19688013|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
5714280|NCT00105157|19688014|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
5714281|NCT00105157|19688015|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
5714282|NCT00105157|19688016|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
5714283|NCT00105157|19688013|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
5714284|NCT00105157|19688014|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
5714285|NCT00105157|19688015|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
5714286|NCT00105157|19688016|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
5714287|NCT00105157|19688013|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
5714288|NCT00105157|19688014|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
5714289|NCT00105157|19688015|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
5714290|NCT00105157|19688016|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
5714291|NCT00105157|19688013|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
5714292|NCT00105157|19688014|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
5714293|NCT00105157|19688015|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
5714294|NCT00105157|19688016|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
5714295|NCT00105157|19688013|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
5714296|NCT00105157|19688014|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
5714297|NCT00105157|19688015|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
5714298|NCT00105157|19688016|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
5714299|NCT00105157|19688013|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
5714300|NCT00105157|19688014|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
5714301|NCT00105157|19688015|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
5714302|NCT00105157|19688016|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
5714303|NCT00105157|19688013|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
5714304|NCT00105157|19688014|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
5714305|NCT00105157|19688015|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
5714306|NCT00105157|19688016|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
5714307|NCT00105157|19688013|P4|Open-Label Continuation of DB|Lost to Follow-up|0
5714308|NCT00105157|19688014|P3|Open-Label Continuation of DB|Lost to Follow-up|1
5714309|NCT00105157|19688015|P2|Open-Label Continuation of DB|Lost to Follow-up|1
5714310|NCT00105157|19688016|P1|Open-Label Continuation of DB|Lost to Follow-up|1
5714311|NCT00105157|19688013|P4|Open-Label Continuation of DB|Lack of Efficacy|1
5714312|NCT00105157|19688014|P3|Open-Label Continuation of DB|Lack of Efficacy|3
5714313|NCT00105157|19688015|P2|Open-Label Continuation of DB|Lack of Efficacy|4
5714314|NCT00105157|19688016|P1|Open-Label Continuation of DB|Lack of Efficacy|1
5714315|NCT00105157|19688013|P4|Open-Label Continuation of DB|Adverse Event|0
5714316|NCT00105157|19688014|P3|Open-Label Continuation of DB|Adverse Event|0
5714317|NCT00105157|19688015|P2|Open-Label Continuation of DB|Adverse Event|1
5714318|NCT00105157|19688016|P1|Open-Label Continuation of DB|Adverse Event|3
5714319|NCT00105157|19688013|P4|Double-Blind (DB)|Lack of Efficacy|38
5714320|NCT00105157|19688014|P3|Double-Blind (DB)|Lack of Efficacy|11
5714321|NCT00105157|19688015|P2|Double-Blind (DB)|Lack of Efficacy|14
5714322|NCT00105157|19688016|P1|Double-Blind (DB)|Lack of Efficacy|11
5714323|NCT00105157|19688013|P4|Double-Blind (DB)|Adverse Event|1
5714324|NCT00105157|19688014|P3|Double-Blind (DB)|Adverse Event|1
5714325|NCT00105157|19688015|P2|Double-Blind (DB)|Adverse Event|0
5714326|NCT00105157|19688016|P1|Double-Blind (DB)|Adverse Event|2
5714327|NCT00105157|19688013|P4|Double-Blind (DB)|Never Treated|0
5714328|NCT00105157|19688014|P3|Double-Blind (DB)|Never Treated|0
5714329|NCT00105157|19688015|P2|Double-Blind (DB)|Never Treated|0
5714330|NCT00105157|19688016|P1|Double-Blind (DB)|Never Treated|1
5714331|NCT00105079|19688210|P2|Overall Study|Other|1
5714332|NCT00105079|19688211|P1|Overall Study|Other|3
5714333|NCT00105079|19688210|P2|Overall Study|Protocol Violation|0
5714334|NCT00105079|19688211|P1|Overall Study|Protocol Violation|1
5714335|NCT00105079|19688210|P2|Overall Study|Violation of selection criteria at entry|2
5714336|NCT00105079|19688211|P1|Overall Study|Violation of selection criteria at entry|0
5714337|NCT00105079|19688210|P2|Overall Study|Refused treatment|4
5714338|NCT00105079|19688211|P1|Overall Study|Refused treatment|6
5714339|NCT00105079|19688210|P2|Overall Study|Lack of Efficacy|3
5714340|NCT00105079|19688211|P1|Overall Study|Lack of Efficacy|9
5714341|NCT00105079|19688210|P2|Overall Study|Lost to Follow-up|12
5714342|NCT00105079|19688211|P1|Overall Study|Lost to Follow-up|12
5714343|NCT00105079|19688210|P2|Overall Study|Death|1
5714344|NCT00105079|19688211|P1|Overall Study|Death|3
5714345|NCT00105079|19688210|P2|Overall Study|Adverse Event|12
5714346|NCT00105079|19688211|P1|Overall Study|Adverse Event|5
5714347|NCT00105066|19688229|P2|Overall Study|Adverse Event|5
5714348|NCT00105066|19688230|P1|Overall Study|Adverse Event|2
5714349|NCT00104884|19688308|P1|Overall Study|Disease progression|4
5714350|NCT00104871|19688312|P1|Overall Study|Not evaluable|1
5714351|NCT00104728|19688333|P1|Overall Study|screen failures|19
5714352|NCT00104650|19688341|P3|Follow-up Period|Other|0
5714353|NCT00104650|19688342|P2|Follow-up Period|Other|1
5714354|NCT00104650|19688343|P1|Follow-up Period|Other|0
5714355|NCT00104650|19688341|P3|Follow-up Period|Lost to Follow-up|2
5714356|NCT00104650|19688342|P2|Follow-up Period|Lost to Follow-up|1
5714357|NCT00104650|19688343|P1|Follow-up Period|Lost to Follow-up|0
5714358|NCT00104650|19688341|P3|Follow-up Period|Disease progression|0
5714359|NCT00104650|19688342|P2|Follow-up Period|Disease progression|1
5714360|NCT00104650|19688343|P1|Follow-up Period|Disease progression|3
5714361|NCT00104650|19688341|P3|Follow-up Period|Death|4
5714362|NCT00104650|19688342|P2|Follow-up Period|Death|6
5714363|NCT00104650|19688343|P1|Follow-up Period|Death|6
5714364|NCT00104650|19688341|P3|Follow-up Period|Withdrawal by Subject|3
5714365|NCT00104650|19688342|P2|Follow-up Period|Withdrawal by Subject|3
5714366|NCT00104650|19688343|P1|Follow-up Period|Withdrawal by Subject|0
5714367|NCT00104650|19688341|P3|Follow-up Period|Adverse Event|1
5714368|NCT00104650|19688342|P2|Follow-up Period|Adverse Event|0
5714369|NCT00104650|19688343|P1|Follow-up Period|Adverse Event|1
5714370|NCT00104650|19688341|P3|Follow-up Period|Physician Decision|0
5714371|NCT00104650|19688342|P2|Follow-up Period|Physician Decision|1
5714372|NCT00104650|19688343|P1|Follow-up Period|Physician Decision|1
5714373|NCT00104650|19688341|P3|Treatment Period (25 Weeks)|Protocol deviation|0
5714374|NCT00104650|19688342|P2|Treatment Period (25 Weeks)|Protocol deviation|1
5714375|NCT00104650|19688343|P1|Treatment Period (25 Weeks)|Protocol deviation|0
5714376|NCT00104650|19688341|P3|Treatment Period (25 Weeks)|Other|0
5714377|NCT00104650|19688342|P2|Treatment Period (25 Weeks)|Other|0
5714378|NCT00104650|19688343|P1|Treatment Period (25 Weeks)|Other|1
5714379|NCT00104650|19688341|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
5714380|NCT00104650|19688342|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
5714381|NCT00104650|19688343|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
5714382|NCT00104650|19688341|P3|Treatment Period (25 Weeks)|Disease progression|2
5714383|NCT00104650|19688342|P2|Treatment Period (25 Weeks)|Disease progression|3
5714384|NCT00104650|19688343|P1|Treatment Period (25 Weeks)|Disease progression|2
5714385|NCT00104650|19688341|P3|Treatment Period (25 Weeks)|Death|6
5714386|NCT00104650|19688342|P2|Treatment Period (25 Weeks)|Death|5
5714387|NCT00104650|19688343|P1|Treatment Period (25 Weeks)|Death|7
5714388|NCT00104650|19688341|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
5714389|NCT00104650|19688342|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
5714390|NCT00104650|19688343|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
5714391|NCT00104650|19688341|P3|Treatment Period (25 Weeks)|Physician Decision|1
5714392|NCT00104650|19688342|P2|Treatment Period (25 Weeks)|Physician Decision|0
5714393|NCT00104650|19688343|P1|Treatment Period (25 Weeks)|Physician Decision|0
5714394|NCT00104637|19688375|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
5714395|NCT00104637|19688376|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
5714396|NCT00104572|19688405|P3|Overall Study|Withdrawal by Subject|0
5714397|NCT00104572|19688406|P2|Overall Study|Withdrawal by Subject|3
5714398|NCT00104572|19688407|P1|Overall Study|Withdrawal by Subject|3
5714399|NCT00104520|19688426|P2|Overall Study|Other|5
5714400|NCT00104520|19688427|P1|Overall Study|Other|1
5714401|NCT00104520|19688426|P2|Overall Study|Personal/administrative|1
5714402|NCT00104520|19688427|P1|Overall Study|Personal/administrative|1
5714403|NCT00104520|19688426|P2|Overall Study|Noncompliance|2
5714404|NCT00104520|19688427|P1|Overall Study|Noncompliance|0
5714405|NCT00104520|19688426|P2|Overall Study|Lost to Follow-up|0
5714406|NCT00104520|19688427|P1|Overall Study|Lost to Follow-up|1
5714407|NCT00104520|19688426|P2|Overall Study|Related adverse event|15
5714408|NCT00104520|19688427|P1|Overall Study|Related adverse event|13
5714409|NCT00104520|19688426|P2|Overall Study|Study drug intolerance|1
5714410|NCT00104520|19688427|P1|Overall Study|Study drug intolerance|0
5714411|NCT00104520|19688426|P2|Overall Study|Unrelated adverse event|47
5714412|NCT00104520|19688427|P1|Overall Study|Unrelated adverse event|34
5714413|NCT00104416|19688447|P5|Continuation Phase|Non-compliance|1
5714414|NCT00104416|19688448|P4|Continuation Phase|Non-compliance|0
5714415|NCT00104416|19688449|P3|Continuation Phase|Non-compliance|0
5714416|NCT00104416|19688450|P2|Continuation Phase|Non-compliance|0
5714417|NCT00104416|19688451|P1|Continuation Phase|Non-compliance|0
5714418|NCT00104416|19688447|P5|Continuation Phase|Pregnancy|0
5714419|NCT00104416|19688448|P4|Continuation Phase|Pregnancy|1
5714420|NCT00104416|19688449|P3|Continuation Phase|Pregnancy|1
5714421|NCT00104416|19688450|P2|Continuation Phase|Pregnancy|0
5714422|NCT00104416|19688451|P1|Continuation Phase|Pregnancy|0
5714423|NCT00104416|19688447|P5|Continuation Phase|Withdrawal by Subject|1
5714424|NCT00104416|19688448|P4|Continuation Phase|Withdrawal by Subject|1
5714425|NCT00104416|19688449|P3|Continuation Phase|Withdrawal by Subject|2
5714426|NCT00104416|19688450|P2|Continuation Phase|Withdrawal by Subject|0
5714427|NCT00104416|19688451|P1|Continuation Phase|Withdrawal by Subject|0
5714428|NCT00104416|19688447|P5|Continuation Phase|Lost to Follow-up|1
5714429|NCT00104416|19688448|P4|Continuation Phase|Lost to Follow-up|0
5714430|NCT00104416|19688449|P3|Continuation Phase|Lost to Follow-up|1
5714431|NCT00104416|19688450|P2|Continuation Phase|Lost to Follow-up|0
5714432|NCT00104416|19688451|P1|Continuation Phase|Lost to Follow-up|0
5714433|NCT00104416|19688447|P5|Continuation Phase|Adverse Event|2
5714434|NCT00104416|19688448|P4|Continuation Phase|Adverse Event|0
5714435|NCT00104416|19688449|P3|Continuation Phase|Adverse Event|2
5714436|NCT00104416|19688450|P2|Continuation Phase|Adverse Event|0
5714437|NCT00104416|19688451|P1|Continuation Phase|Adverse Event|0
5714438|NCT00104416|19688447|P5|Double-Blind Phase|Participant Did Not Take Drug|0
5714439|NCT00104416|19688448|P4|Double-Blind Phase|Participant Did Not Take Drug|0
5714440|NCT00104416|19688449|P3|Double-Blind Phase|Participant Did Not Take Drug|0
5714441|NCT00104416|19688450|P2|Double-Blind Phase|Participant Did Not Take Drug|4
5714442|NCT00104416|19688451|P1|Double-Blind Phase|Participant Did Not Take Drug|3
5714443|NCT00104416|19688447|P5|Double-Blind Phase|Pregnancy|0
5714444|NCT00104416|19688448|P4|Double-Blind Phase|Pregnancy|0
5714445|NCT00104416|19688449|P3|Double-Blind Phase|Pregnancy|0
5714446|NCT00104416|19688450|P2|Double-Blind Phase|Pregnancy|0
5714447|NCT00104416|19688451|P1|Double-Blind Phase|Pregnancy|1
5714448|NCT00104416|19688447|P5|Double-Blind Phase|Withdrawal by Subject|0
5714449|NCT00104416|19688448|P4|Double-Blind Phase|Withdrawal by Subject|0
5714450|NCT00104416|19688449|P3|Double-Blind Phase|Withdrawal by Subject|0
5714451|NCT00104416|19688450|P2|Double-Blind Phase|Withdrawal by Subject|3
5714452|NCT00104416|19688451|P1|Double-Blind Phase|Withdrawal by Subject|2
5714453|NCT00104416|19688447|P5|Double-Blind Phase|Protocol Violation|0
5714454|NCT00104416|19688448|P4|Double-Blind Phase|Protocol Violation|0
5714455|NCT00104416|19688449|P3|Double-Blind Phase|Protocol Violation|0
5714456|NCT00104416|19688450|P2|Double-Blind Phase|Protocol Violation|1
5714457|NCT00104416|19688451|P1|Double-Blind Phase|Protocol Violation|0
5714458|NCT00104416|19688447|P5|Double-Blind Phase|Lost to Follow-up|0
5714459|NCT00104416|19688448|P4|Double-Blind Phase|Lost to Follow-up|0
5714460|NCT00104416|19688449|P3|Double-Blind Phase|Lost to Follow-up|0
5714461|NCT00104416|19688450|P2|Double-Blind Phase|Lost to Follow-up|1
5714462|NCT00104416|19688451|P1|Double-Blind Phase|Lost to Follow-up|0
5714463|NCT00104416|19688447|P5|Double-Blind Phase|Adverse Event|0
5714464|NCT00104416|19688448|P4|Double-Blind Phase|Adverse Event|0
5714465|NCT00104416|19688449|P3|Double-Blind Phase|Adverse Event|0
5714466|NCT00104416|19688450|P2|Double-Blind Phase|Adverse Event|1
5714467|NCT00104416|19688451|P1|Double-Blind Phase|Adverse Event|2
5714468|NCT00104299|19688496|P2|Overall Study|To have renal transplant|0
5714469|NCT00104299|19688497|P1|Overall Study|To have renal transplant|1
5714470|NCT00104299|19688496|P2|Overall Study|Physician Decision|1
5714471|NCT00104299|19688497|P1|Overall Study|Physician Decision|1
5714472|NCT00104299|19688496|P2|Overall Study|Withdrawal by Subject|6
5714473|NCT00104299|19688497|P1|Overall Study|Withdrawal by Subject|2
5714474|NCT00104299|19688496|P2|Overall Study|Death|2
5714475|NCT00104299|19688497|P1|Overall Study|Death|2
5714476|NCT00104299|19688496|P2|Overall Study|Adverse Event|1
5714477|NCT00104299|19688497|P1|Overall Study|Adverse Event|3
5714478|NCT00104247|19688519|P2|Overall Study|Noncompliant with dosing|1
5714479|NCT00104247|19688520|P1|Overall Study|Noncompliant with dosing|0
5714480|NCT00104247|19688519|P2|Overall Study|Withdrawal by Subject|0
5714481|NCT00104247|19688520|P1|Overall Study|Withdrawal by Subject|1
5714482|NCT00104104|19688539|P2|Overall Study|Death|6
5714483|NCT00104104|19688540|P1|Overall Study|Death|9
5714484|NCT00104104|19688539|P2|Overall Study|Administrative problems|13
5714485|NCT00104104|19688540|P1|Overall Study|Administrative problems|12
5714486|NCT00104104|19688539|P2|Overall Study|Lost to Follow-up|7
5714487|NCT00104104|19688540|P1|Overall Study|Lost to Follow-up|3
5714488|NCT00104104|19688539|P2|Overall Study|Withdrawal by Subject|15
5714489|NCT00104104|19688540|P1|Overall Study|Withdrawal by Subject|11
5714490|NCT00104104|19688539|P2|Overall Study|Protocol Violation|2
5714491|NCT00104104|19688540|P1|Overall Study|Protocol Violation|5
5714492|NCT00104104|19688539|P2|Overall Study|Condition no longer requires study drug|4
5714493|NCT00104104|19688540|P1|Overall Study|Condition no longer requires study drug|7
5714494|NCT00104104|19688539|P2|Overall Study|Lack of Efficacy|3
5714495|NCT00104104|19688540|P1|Overall Study|Lack of Efficacy|0
5714496|NCT00104104|19688539|P2|Overall Study|Abnormal laboratory value(s)|14
5714497|NCT00104104|19688540|P1|Overall Study|Abnormal laboratory value(s)|20
5714498|NCT00104104|19688539|P2|Overall Study|Adverse Event|8
5714499|NCT00104104|19688540|P1|Overall Study|Adverse Event|8
5714500|NCT00104052|19688554|P1|Overall Study|Discontinuation unrelated to treatment|2
5714501|NCT00104052|19688554|P1|Overall Study|Lack of Efficacy|26
5714502|NCT00104052|19688554|P1|Overall Study|Adverse Event|1
5714503|NCT00103857|19688565|P7|50-Week Extension Study|reason unspecified|0
5714504|NCT00103857|19688566|P6|50-Week Extension Study|reason unspecified|0
5714505|NCT00103857|19688567|P5|50-Week Extension Study|reason unspecified|1
5714506|NCT00103857|19688568|P4|50-Week Extension Study|reason unspecified|0
5714507|NCT00103857|19688569|P3|50-Week Extension Study|reason unspecified|0
5714508|NCT00103857|19688570|P2|50-Week Extension Study|reason unspecified|0
5714509|NCT00103857|19688571|P1|50-Week Extension Study|reason unspecified|0
5714510|NCT00103857|19688565|P7|50-Week Extension Study|patient scheduled for elective surgery|0
5714511|NCT00103857|19688566|P6|50-Week Extension Study|patient scheduled for elective surgery|0
5714512|NCT00103857|19688567|P5|50-Week Extension Study|patient scheduled for elective surgery|0
5714513|NCT00103857|19688568|P4|50-Week Extension Study|patient scheduled for elective surgery|0
5714514|NCT00103857|19688569|P3|50-Week Extension Study|patient scheduled for elective surgery|1
5714515|NCT00103857|19688570|P2|50-Week Extension Study|patient scheduled for elective surgery|0
5714516|NCT00103857|19688571|P1|50-Week Extension Study|patient scheduled for elective surgery|0
5714517|NCT00103857|19688565|P7|50-Week Extension Study|patient moved|0
5714518|NCT00103857|19688566|P6|50-Week Extension Study|patient moved|0
5714519|NCT00103857|19688567|P5|50-Week Extension Study|patient moved|0
5714520|NCT00103857|19688568|P4|50-Week Extension Study|patient moved|2
5714521|NCT00103857|19688569|P3|50-Week Extension Study|patient moved|1
5714522|NCT00103857|19688570|P2|50-Week Extension Study|patient moved|0
5714523|NCT00103857|19688571|P1|50-Week Extension Study|patient moved|0
5714524|NCT00103857|19688565|P7|50-Week Extension Study|non-compliance with study procedures|0
5714525|NCT00103857|19688566|P6|50-Week Extension Study|non-compliance with study procedures|0
5714526|NCT00103857|19688567|P5|50-Week Extension Study|non-compliance with study procedures|1
5714527|NCT00103857|19688568|P4|50-Week Extension Study|non-compliance with study procedures|1
5714528|NCT00103857|19688569|P3|50-Week Extension Study|non-compliance with study procedures|0
5714529|NCT00103857|19688570|P2|50-Week Extension Study|non-compliance with study procedures|0
5714530|NCT00103857|19688571|P1|50-Week Extension Study|non-compliance with study procedures|1
5714531|NCT00103857|19688565|P7|50-Week Extension Study|protocol discontinuation criteria|0
5714532|NCT00103857|19688566|P6|50-Week Extension Study|protocol discontinuation criteria|3
5714533|NCT00103857|19688567|P5|50-Week Extension Study|protocol discontinuation criteria|3
5714534|NCT00103857|19688568|P4|50-Week Extension Study|protocol discontinuation criteria|2
5714535|NCT00103857|19688569|P3|50-Week Extension Study|protocol discontinuation criteria|3
5714536|NCT00103857|19688570|P2|50-Week Extension Study|protocol discontinuation criteria|2
5714537|NCT00103857|19688571|P1|50-Week Extension Study|protocol discontinuation criteria|2
5714538|NCT00103857|19688565|P7|50-Week Extension Study|Withdrawal by Subject|0
5714539|NCT00103857|19688566|P6|50-Week Extension Study|Withdrawal by Subject|3
5714540|NCT00103857|19688567|P5|50-Week Extension Study|Withdrawal by Subject|3
5714541|NCT00103857|19688568|P4|50-Week Extension Study|Withdrawal by Subject|8
5714542|NCT00103857|19688569|P3|50-Week Extension Study|Withdrawal by Subject|2
5714543|NCT00103857|19688570|P2|50-Week Extension Study|Withdrawal by Subject|5
5714544|NCT00103857|19688571|P1|50-Week Extension Study|Withdrawal by Subject|2
5714545|NCT00103857|19688565|P7|50-Week Extension Study|Protocol Violation|0
5714546|NCT00103857|19688566|P6|50-Week Extension Study|Protocol Violation|1
5714547|NCT00103857|19688567|P5|50-Week Extension Study|Protocol Violation|0
5714548|NCT00103857|19688568|P4|50-Week Extension Study|Protocol Violation|2
5714549|NCT00103857|19688569|P3|50-Week Extension Study|Protocol Violation|1
5714550|NCT00103857|19688570|P2|50-Week Extension Study|Protocol Violation|1
5714551|NCT00103857|19688571|P1|50-Week Extension Study|Protocol Violation|1
5714552|NCT00103857|19688565|P7|50-Week Extension Study|Pregnancy|0
5714553|NCT00103857|19688566|P6|50-Week Extension Study|Pregnancy|0
5714554|NCT00103857|19688567|P5|50-Week Extension Study|Pregnancy|1
5714555|NCT00103857|19688568|P4|50-Week Extension Study|Pregnancy|0
5714556|NCT00103857|19688569|P3|50-Week Extension Study|Pregnancy|1
5714557|NCT00103857|19688570|P2|50-Week Extension Study|Pregnancy|0
5714558|NCT00103857|19688571|P1|50-Week Extension Study|Pregnancy|0
5714559|NCT00103857|19688565|P7|50-Week Extension Study|Physician Decision|0
5714560|NCT00103857|19688566|P6|50-Week Extension Study|Physician Decision|0
5714561|NCT00103857|19688567|P5|50-Week Extension Study|Physician Decision|0
5714562|NCT00103857|19688568|P4|50-Week Extension Study|Physician Decision|0
5714563|NCT00103857|19688569|P3|50-Week Extension Study|Physician Decision|1
5714564|NCT00103857|19688570|P2|50-Week Extension Study|Physician Decision|1
5714565|NCT00103857|19688571|P1|50-Week Extension Study|Physician Decision|0
5714566|NCT00103857|19688565|P7|50-Week Extension Study|Lost to Follow-up|0
5714567|NCT00103857|19688566|P6|50-Week Extension Study|Lost to Follow-up|3
5714568|NCT00103857|19688567|P5|50-Week Extension Study|Lost to Follow-up|3
5714569|NCT00103857|19688568|P4|50-Week Extension Study|Lost to Follow-up|4
5714570|NCT00103857|19688569|P3|50-Week Extension Study|Lost to Follow-up|1
5714571|NCT00103857|19688570|P2|50-Week Extension Study|Lost to Follow-up|0
5714572|NCT00103857|19688571|P1|50-Week Extension Study|Lost to Follow-up|4
5714573|NCT00103857|19688565|P7|50-Week Extension Study|Lack of Efficacy|0
5714574|NCT00103857|19688566|P6|50-Week Extension Study|Lack of Efficacy|8
5714575|NCT00103857|19688567|P5|50-Week Extension Study|Lack of Efficacy|8
5714576|NCT00103857|19688568|P4|50-Week Extension Study|Lack of Efficacy|16
5714577|NCT00103857|19688569|P3|50-Week Extension Study|Lack of Efficacy|13
5714578|NCT00103857|19688570|P2|50-Week Extension Study|Lack of Efficacy|15
5714579|NCT00103857|19688571|P1|50-Week Extension Study|Lack of Efficacy|26
5714580|NCT00103857|19688565|P7|50-Week Extension Study|Death|0
5714581|NCT00103857|19688566|P6|50-Week Extension Study|Death|1
5714582|NCT00103857|19688567|P5|50-Week Extension Study|Death|0
5714583|NCT00103857|19688568|P4|50-Week Extension Study|Death|1
5714584|NCT00103857|19688569|P3|50-Week Extension Study|Death|0
5714585|NCT00103857|19688570|P2|50-Week Extension Study|Death|0
5714586|NCT00103857|19688571|P1|50-Week Extension Study|Death|0
5714587|NCT00103857|19688565|P7|50-Week Extension Study|Adverse Event|0
5714588|NCT00103857|19688566|P6|50-Week Extension Study|Adverse Event|1
5714589|NCT00103857|19688567|P5|50-Week Extension Study|Adverse Event|1
5714590|NCT00103857|19688568|P4|50-Week Extension Study|Adverse Event|0
5714591|NCT00103857|19688569|P3|50-Week Extension Study|Adverse Event|2
5714592|NCT00103857|19688570|P2|50-Week Extension Study|Adverse Event|3
5714593|NCT00103857|19688571|P1|50-Week Extension Study|Adverse Event|2
5714594|NCT00103857|19688565|P7|54-Week Base Study|patient intolerance to rescue therapy|0
5714595|NCT00103857|19688566|P6|54-Week Base Study|patient intolerance to rescue therapy|0
5714596|NCT00103857|19688567|P5|54-Week Base Study|patient intolerance to rescue therapy|0
5714597|NCT00103857|19688568|P4|54-Week Base Study|patient intolerance to rescue therapy|0
5714598|NCT00103857|19688569|P3|54-Week Base Study|patient intolerance to rescue therapy|0
5714599|NCT00103857|19688570|P2|54-Week Base Study|patient intolerance to rescue therapy|0
5714600|NCT00103857|19688571|P1|54-Week Base Study|patient intolerance to rescue therapy|1
5714601|NCT00103857|19688565|P7|54-Week Base Study|site error|0
5714602|NCT00103857|19688566|P6|54-Week Base Study|site error|1
5714603|NCT00103857|19688567|P5|54-Week Base Study|site error|0
5714604|NCT00103857|19688568|P4|54-Week Base Study|site error|0
5714605|NCT00103857|19688569|P3|54-Week Base Study|site error|0
5714606|NCT00103857|19688570|P2|54-Week Base Study|site error|0
5714607|NCT00103857|19688571|P1|54-Week Base Study|site error|0
5714608|NCT00103857|19688565|P7|54-Week Base Study|laboratory reporting error|0
5714609|NCT00103857|19688566|P6|54-Week Base Study|laboratory reporting error|0
5714610|NCT00103857|19688567|P5|54-Week Base Study|laboratory reporting error|1
5714611|NCT00103857|19688568|P4|54-Week Base Study|laboratory reporting error|0
5714612|NCT00103857|19688569|P3|54-Week Base Study|laboratory reporting error|0
5714613|NCT00103857|19688570|P2|54-Week Base Study|laboratory reporting error|0
5714614|NCT00103857|19688571|P1|54-Week Base Study|laboratory reporting error|0
5714615|NCT00103857|19688565|P7|54-Week Base Study|patient incarcerated|0
5714616|NCT00103857|19688566|P6|54-Week Base Study|patient incarcerated|1
5714617|NCT00103857|19688567|P5|54-Week Base Study|patient incarcerated|1
5714618|NCT00103857|19688568|P4|54-Week Base Study|patient incarcerated|0
5714619|NCT00103857|19688569|P3|54-Week Base Study|patient incarcerated|0
5714620|NCT00103857|19688570|P2|54-Week Base Study|patient incarcerated|0
5714621|NCT00103857|19688571|P1|54-Week Base Study|patient incarcerated|0
5714622|NCT00103857|19688565|P7|54-Week Base Study|non-compliance with study procedures|0
5714623|NCT00103857|19688566|P6|54-Week Base Study|non-compliance with study procedures|2
5714624|NCT00103857|19688567|P5|54-Week Base Study|non-compliance with study procedures|0
5714625|NCT00103857|19688568|P4|54-Week Base Study|non-compliance with study procedures|0
5714626|NCT00103857|19688569|P3|54-Week Base Study|non-compliance with study procedures|0
5714627|NCT00103857|19688570|P2|54-Week Base Study|non-compliance with study procedures|2
5714628|NCT00103857|19688571|P1|54-Week Base Study|non-compliance with study procedures|1
5714629|NCT00103857|19688565|P7|54-Week Base Study|patient moved|0
5714630|NCT00103857|19688566|P6|54-Week Base Study|patient moved|1
5714631|NCT00103857|19688567|P5|54-Week Base Study|patient moved|3
5714632|NCT00103857|19688568|P4|54-Week Base Study|patient moved|2
5714633|NCT00103857|19688569|P3|54-Week Base Study|patient moved|1
5714634|NCT00103857|19688570|P2|54-Week Base Study|patient moved|1
5714635|NCT00103857|19688571|P1|54-Week Base Study|patient moved|0
5714636|NCT00103857|19688565|P7|54-Week Base Study|protocol discontinuation criteria|5
5714637|NCT00103857|19688566|P6|54-Week Base Study|protocol discontinuation criteria|3
5714638|NCT00103857|19688567|P5|54-Week Base Study|protocol discontinuation criteria|5
5714639|NCT00103857|19688568|P4|54-Week Base Study|protocol discontinuation criteria|6
5714640|NCT00103857|19688569|P3|54-Week Base Study|protocol discontinuation criteria|2
5714641|NCT00103857|19688570|P2|54-Week Base Study|protocol discontinuation criteria|5
5714642|NCT00103857|19688571|P1|54-Week Base Study|protocol discontinuation criteria|2
5714643|NCT00103857|19688565|P7|54-Week Base Study|Withdrawal by Subject|4
5714644|NCT00103857|19688566|P6|54-Week Base Study|Withdrawal by Subject|15
5714645|NCT00103857|19688567|P5|54-Week Base Study|Withdrawal by Subject|10
5714646|NCT00103857|19688568|P4|54-Week Base Study|Withdrawal by Subject|15
5714647|NCT00103857|19688569|P3|54-Week Base Study|Withdrawal by Subject|16
5714648|NCT00103857|19688570|P2|54-Week Base Study|Withdrawal by Subject|16
5714649|NCT00103857|19688571|P1|54-Week Base Study|Withdrawal by Subject|17
5714650|NCT00103857|19688565|P7|54-Week Base Study|Protocol Violation|3
5714651|NCT00103857|19688566|P6|54-Week Base Study|Protocol Violation|3
5714652|NCT00103857|19688567|P5|54-Week Base Study|Protocol Violation|0
5714653|NCT00103857|19688568|P4|54-Week Base Study|Protocol Violation|4
5714654|NCT00103857|19688569|P3|54-Week Base Study|Protocol Violation|2
5714655|NCT00103857|19688570|P2|54-Week Base Study|Protocol Violation|4
5714656|NCT00103857|19688571|P1|54-Week Base Study|Protocol Violation|6
5714657|NCT00103857|19688565|P7|54-Week Base Study|Pregnancy|1
5714658|NCT00103857|19688566|P6|54-Week Base Study|Pregnancy|0
5714659|NCT00103857|19688567|P5|54-Week Base Study|Pregnancy|1
5714660|NCT00103857|19688568|P4|54-Week Base Study|Pregnancy|0
5714661|NCT00103857|19688569|P3|54-Week Base Study|Pregnancy|0
5714662|NCT00103857|19688570|P2|54-Week Base Study|Pregnancy|0
5714663|NCT00103857|19688571|P1|54-Week Base Study|Pregnancy|1
5714664|NCT00103857|19688565|P7|54-Week Base Study|Physician Decision|0
5714665|NCT00103857|19688566|P6|54-Week Base Study|Physician Decision|0
5714666|NCT00103857|19688567|P5|54-Week Base Study|Physician Decision|1
5714667|NCT00103857|19688568|P4|54-Week Base Study|Physician Decision|0
5714668|NCT00103857|19688569|P3|54-Week Base Study|Physician Decision|0
5714669|NCT00103857|19688570|P2|54-Week Base Study|Physician Decision|1
5714670|NCT00103857|19688571|P1|54-Week Base Study|Physician Decision|1
5714671|NCT00103857|19688565|P7|54-Week Base Study|Lost to Follow-up|3
5714672|NCT00103857|19688566|P6|54-Week Base Study|Lost to Follow-up|9
5714673|NCT00103857|19688567|P5|54-Week Base Study|Lost to Follow-up|10
5714674|NCT00103857|19688568|P4|54-Week Base Study|Lost to Follow-up|5
5714675|NCT00103857|19688569|P3|54-Week Base Study|Lost to Follow-up|7
5714676|NCT00103857|19688570|P2|54-Week Base Study|Lost to Follow-up|4
5714677|NCT00103857|19688571|P1|54-Week Base Study|Lost to Follow-up|5
5714678|NCT00103857|19688565|P7|54-Week Base Study|Lack of Efficacy|19
5714679|NCT00103857|19688566|P6|54-Week Base Study|Lack of Efficacy|14
5714680|NCT00103857|19688567|P5|54-Week Base Study|Lack of Efficacy|3
5714681|NCT00103857|19688568|P4|54-Week Base Study|Lack of Efficacy|4
5714682|NCT00103857|19688569|P3|54-Week Base Study|Lack of Efficacy|8
5714683|NCT00103857|19688570|P2|54-Week Base Study|Lack of Efficacy|14
5714684|NCT00103857|19688571|P1|54-Week Base Study|Lack of Efficacy|11
5714685|NCT00103857|19688565|P7|54-Week Base Study|Death|0
5714686|NCT00103857|19688566|P6|54-Week Base Study|Death|1
5714687|NCT00103857|19688567|P5|54-Week Base Study|Death|1
5714688|NCT00103857|19688568|P4|54-Week Base Study|Death|0
5714689|NCT00103857|19688569|P3|54-Week Base Study|Death|0
5714690|NCT00103857|19688570|P2|54-Week Base Study|Death|0
5714691|NCT00103857|19688571|P1|54-Week Base Study|Death|0
5714692|NCT00103857|19688565|P7|54-Week Base Study|Adverse Event|3
5714693|NCT00103857|19688566|P6|54-Week Base Study|Adverse Event|11
5714694|NCT00103857|19688567|P5|54-Week Base Study|Adverse Event|5
5714695|NCT00103857|19688568|P4|54-Week Base Study|Adverse Event|6
5714696|NCT00103857|19688569|P3|54-Week Base Study|Adverse Event|11
5714697|NCT00103857|19688570|P2|54-Week Base Study|Adverse Event|9
5714698|NCT00103857|19688571|P1|54-Week Base Study|Adverse Event|12
5714699|NCT00103740|19688670|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
5714700|NCT00103740|19688671|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
5714701|NCT00103740|19688670|P2|Period 2 - Extended Observation Period|Death|2
5714702|NCT00103740|19688671|P1|Period 2 - Extended Observation Period|Death|6
5714703|NCT00103740|19688670|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
5714704|NCT00103740|19688671|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
5714705|NCT00103740|19688670|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
5714706|NCT00103740|19688671|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
5714707|NCT00103740|19688670|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
5714708|NCT00103740|19688671|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
5714709|NCT00103740|19688670|P2|Period 1 - Core|Patient withdrew consent|2
5714710|NCT00103740|19688671|P1|Period 1 - Core|Patient withdrew consent|3
5714711|NCT00103740|19688670|P2|Period 1 - Core|Protocol Violation|2
5714712|NCT00103740|19688671|P1|Period 1 - Core|Protocol Violation|3
5714713|NCT00103740|19688670|P2|Period 1 - Core|Adverse Event|0
5714714|NCT00103740|19688671|P1|Period 1 - Core|Adverse Event|1
5714715|NCT00103662|19688699|P2|Overall Study|Intercurrent illness|0
5714716|NCT00103662|19688700|P1|Overall Study|Intercurrent illness|1
5714717|NCT00103662|19688699|P2|Overall Study|Failed mobilization|4
5714718|NCT00103662|19688700|P1|Overall Study|Failed mobilization|0
5714719|NCT00103662|19688699|P2|Overall Study|Other|9
5714720|NCT00103662|19688700|P1|Overall Study|Other|6
5714721|NCT00103662|19688699|P2|Overall Study|Lost to Follow-up|1
5714722|NCT00103662|19688700|P1|Overall Study|Lost to Follow-up|0
5714723|NCT00103662|19688699|P2|Overall Study|Elective Withdrawal|5
5714724|NCT00103662|19688700|P1|Overall Study|Elective Withdrawal|5
5714725|NCT00103662|19688699|P2|Overall Study|Death|7
5714726|NCT00103662|19688700|P1|Overall Study|Death|7
5714727|NCT00103662|19688699|P2|Overall Study|Entered Rescue Procedure|7
5714728|NCT00103662|19688700|P1|Overall Study|Entered Rescue Procedure|0
5714729|NCT00103610|19688726|P2|Overall Study|Noncompliance|1
5714730|NCT00103610|19688727|P1|Overall Study|Noncompliance|0
5714731|NCT00103610|19688726|P2|Overall Study|Failed mobilization|5
5714732|NCT00103610|19688727|P1|Overall Study|Failed mobilization|1
5714733|NCT00103610|19688726|P2|Overall Study|Other|7
5714734|NCT00103610|19688727|P1|Overall Study|Other|2
5714735|NCT00103610|19688726|P2|Overall Study|Adverse Event|2
5714736|NCT00103610|19688727|P1|Overall Study|Adverse Event|2
5714737|NCT00103610|19688726|P2|Overall Study|Lost to Follow-up|1
5714738|NCT00103610|19688727|P1|Overall Study|Lost to Follow-up|3
5714739|NCT00103610|19688726|P2|Overall Study|Elective Withdrawal|0
5714740|NCT00103610|19688727|P1|Overall Study|Elective Withdrawal|4
5714741|NCT00103610|19688726|P2|Overall Study|Death|12
5714742|NCT00103610|19688727|P1|Overall Study|Death|16
5714743|NCT00103610|19688726|P2|Overall Study|Entered Rescue Procedure|52
5714744|NCT00103610|19688727|P1|Overall Study|Entered Rescue Procedure|10
5714745|NCT00103506|19688751|P2|Overall Study|Withdrawal by Subject|21
5714746|NCT00103506|19688752|P1|Overall Study|Withdrawal by Subject|18
5714747|NCT00103506|19688751|P2|Overall Study|Lost to Follow-up|13
5714748|NCT00103506|19688752|P1|Overall Study|Lost to Follow-up|13
5714749|NCT00103506|19688751|P2|Overall Study|Death|253
5714750|NCT00103506|19688752|P1|Overall Study|Death|257
5714751|NCT00103506|19688751|P2|Overall Study|Study closed by sponsor|37
5714752|NCT00103506|19688752|P1|Overall Study|Study closed by sponsor|34
5714753|NCT00103402|19688764|P2|Overall Study|Personal constraints/Other|0
5714754|NCT00103402|19688765|P1|Overall Study|Personal constraints/Other|5
5714755|NCT00103402|19688764|P2|Overall Study|Dissatisfied/No longer interested|6
5714756|NCT00103402|19688765|P1|Overall Study|Dissatisfied/No longer interested|6
5714757|NCT00103402|19688764|P2|Overall Study|Lost to Follow-up|7
5714758|NCT00103402|19688765|P1|Overall Study|Lost to Follow-up|8
5714759|NCT00103402|19688764|P2|Overall Study|Adverse Event|4
5714760|NCT00103402|19688765|P1|Overall Study|Adverse Event|3
5714761|NCT00103311|19688806|P2|Overall Study|Adverse Event|0
5714762|NCT00103311|19688807|P1|Overall Study|Adverse Event|1
5714763|NCT00103311|19688806|P2|Overall Study|Withdrawal by Subject|1
5714764|NCT00103311|19688807|P1|Overall Study|Withdrawal by Subject|2
5714765|NCT00103311|19688806|P2|Overall Study|Lost to Follow-up|0
5714766|NCT00103311|19688807|P1|Overall Study|Lost to Follow-up|1
5714767|NCT00103285|19688817|P8|Response Assignment|Other|53
5714768|NCT00103285|19688818|P7|Response Assignment|Other|11
5714769|NCT00103285|19688819|P6|Response Assignment|Other|17
5714770|NCT00103285|19688820|P5|Response Assignment|Other|37
5714771|NCT00103285|19688821|P4|Response Assignment|Other|38
5714772|NCT00103285|19688822|P3|Response Assignment|Other|48
5714773|NCT00103285|19688823|P2|Response Assignment|Other|30
5714774|NCT00103285|19688824|P1|Response Assignment|Other|0
5714775|NCT00103285|19688817|P8|Response Assignment|Refusal|10
5714776|NCT00103285|19688818|P7|Response Assignment|Refusal|30
5714777|NCT00103285|19688819|P6|Response Assignment|Refusal|15
5714778|NCT00103285|19688820|P5|Response Assignment|Refusal|25
5714779|NCT00103285|19688821|P4|Response Assignment|Refusal|3
5714780|NCT00103285|19688822|P3|Response Assignment|Refusal|5
5714781|NCT00103285|19688823|P2|Response Assignment|Refusal|53
5714782|NCT00103285|19688824|P1|Response Assignment|Refusal|0
5714783|NCT00103285|19688817|P8|Response Assignment|Ineligible|5
5714784|NCT00103285|19688818|P7|Response Assignment|Ineligible|1
5714785|NCT00103285|19688819|P6|Response Assignment|Ineligible|3
5714786|NCT00103285|19688820|P5|Response Assignment|Ineligible|0
5714787|NCT00103285|19688821|P4|Response Assignment|Ineligible|2
5714788|NCT00103285|19688822|P3|Response Assignment|Ineligible|6
5714789|NCT00103285|19688823|P2|Response Assignment|Ineligible|8
5714790|NCT00103285|19688824|P1|Response Assignment|Ineligible|0
5714791|NCT00103285|19688817|P8|Response Assignment|Withdrawal by Subject|2
5714792|NCT00103285|19688818|P7|Response Assignment|Withdrawal by Subject|0
5714793|NCT00103285|19688819|P6|Response Assignment|Withdrawal by Subject|2
5714794|NCT00103285|19688820|P5|Response Assignment|Withdrawal by Subject|2
5714795|NCT00103285|19688821|P4|Response Assignment|Withdrawal by Subject|1
5714796|NCT00103285|19688822|P3|Response Assignment|Withdrawal by Subject|1
5714797|NCT00103285|19688823|P2|Response Assignment|Withdrawal by Subject|4
5714798|NCT00103285|19688824|P1|Response Assignment|Withdrawal by Subject|0
5714799|NCT00103285|19688817|P8|Response Assignment|Protocol Violation|0
5714800|NCT00103285|19688818|P7|Response Assignment|Protocol Violation|0
5714801|NCT00103285|19688819|P6|Response Assignment|Protocol Violation|0
5714802|NCT00103285|19688820|P5|Response Assignment|Protocol Violation|0
5714803|NCT00103285|19688821|P4|Response Assignment|Protocol Violation|0
5714804|NCT00103285|19688822|P3|Response Assignment|Protocol Violation|0
5714805|NCT00103285|19688823|P2|Response Assignment|Protocol Violation|2
5714806|NCT00103285|19688824|P1|Response Assignment|Protocol Violation|0
5714807|NCT00103285|19688817|P8|Response Assignment|Physician Decision|35
5714808|NCT00103285|19688818|P7|Response Assignment|Physician Decision|4
5714809|NCT00103285|19688819|P6|Response Assignment|Physician Decision|7
5714810|NCT00103285|19688820|P5|Response Assignment|Physician Decision|13
5714811|NCT00103285|19688821|P4|Response Assignment|Physician Decision|9
5714812|NCT00103285|19688822|P3|Response Assignment|Physician Decision|14
5714813|NCT00103285|19688823|P2|Response Assignment|Physician Decision|13
5714814|NCT00103285|19688824|P1|Response Assignment|Physician Decision|0
5714815|NCT00103285|19688817|P8|Response Assignment|Lost to Follow-up|5
5714816|NCT00103285|19688818|P7|Response Assignment|Lost to Follow-up|2
5714817|NCT00103285|19688819|P6|Response Assignment|Lost to Follow-up|2
5714818|NCT00103285|19688820|P5|Response Assignment|Lost to Follow-up|1
5714819|NCT00103285|19688821|P4|Response Assignment|Lost to Follow-up|5
5714820|NCT00103285|19688822|P3|Response Assignment|Lost to Follow-up|5
5714821|NCT00103285|19688823|P2|Response Assignment|Lost to Follow-up|9
5714822|NCT00103285|19688824|P1|Response Assignment|Lost to Follow-up|0
5714823|NCT00103285|19688817|P8|Response Assignment|Death|8
5714824|NCT00103285|19688818|P7|Response Assignment|Death|0
5714825|NCT00103285|19688819|P6|Response Assignment|Death|1
5714826|NCT00103285|19688820|P5|Response Assignment|Death|3
5714827|NCT00103285|19688821|P4|Response Assignment|Death|2
5714828|NCT00103285|19688822|P3|Response Assignment|Death|2
5714829|NCT00103285|19688823|P2|Response Assignment|Death|5
5714830|NCT00103285|19688824|P1|Response Assignment|Death|0
5714831|NCT00103285|19688817|P8|Response Assignment|Adverse Event|2
5714832|NCT00103285|19688818|P7|Response Assignment|Adverse Event|1
5714833|NCT00103285|19688819|P6|Response Assignment|Adverse Event|1
5714834|NCT00103285|19688820|P5|Response Assignment|Adverse Event|3
5714835|NCT00103285|19688821|P4|Response Assignment|Adverse Event|2
5714836|NCT00103285|19688822|P3|Response Assignment|Adverse Event|3
5714837|NCT00103285|19688823|P2|Response Assignment|Adverse Event|8
5714838|NCT00103285|19688824|P1|Response Assignment|Adverse Event|0
5714839|NCT00103285|19688817|P8|Induction|Other|0
5714840|NCT00103285|19688818|P7|Induction|Other|0
5714841|NCT00103285|19688819|P6|Induction|Other|0
5714842|NCT00103285|19688820|P5|Induction|Other|0
5714843|NCT00103285|19688821|P4|Induction|Other|0
5714844|NCT00103285|19688822|P3|Induction|Other|0
5714845|NCT00103285|19688823|P2|Induction|Other|0
5714846|NCT00103285|19688824|P1|Induction|Other|258
5714847|NCT00103285|19688817|P8|Induction|Refusal|0
5714848|NCT00103285|19688818|P7|Induction|Refusal|0
5714849|NCT00103285|19688819|P6|Induction|Refusal|0
5714850|NCT00103285|19688820|P5|Induction|Refusal|0
5714851|NCT00103285|19688821|P4|Induction|Refusal|0
5714852|NCT00103285|19688822|P3|Induction|Refusal|0
5714853|NCT00103285|19688823|P2|Induction|Refusal|0
5714854|NCT00103285|19688824|P1|Induction|Refusal|906
5714855|NCT00103285|19688817|P8|Induction|Ineligible|0
5714856|NCT00103285|19688818|P7|Induction|Ineligible|0
5714857|NCT00103285|19688819|P6|Induction|Ineligible|0
5714858|NCT00103285|19688820|P5|Induction|Ineligible|0
5714859|NCT00103285|19688821|P4|Induction|Ineligible|0
5714860|NCT00103285|19688822|P3|Induction|Ineligible|0
5714861|NCT00103285|19688823|P2|Induction|Ineligible|0
5714862|NCT00103285|19688824|P1|Induction|Ineligible|43
5714863|NCT00103285|19688817|P8|Induction|Withdrawal by Subject|0
5714864|NCT00103285|19688818|P7|Induction|Withdrawal by Subject|0
5714865|NCT00103285|19688819|P6|Induction|Withdrawal by Subject|0
5714866|NCT00103285|19688820|P5|Induction|Withdrawal by Subject|0
5714867|NCT00103285|19688821|P4|Induction|Withdrawal by Subject|0
5714868|NCT00103285|19688822|P3|Induction|Withdrawal by Subject|0
5714869|NCT00103285|19688823|P2|Induction|Withdrawal by Subject|0
5714870|NCT00103285|19688824|P1|Induction|Withdrawal by Subject|1
5714871|NCT00103285|19688817|P8|Induction|Physician Decision|0
5714872|NCT00103285|19688818|P7|Induction|Physician Decision|0
5714873|NCT00103285|19688819|P6|Induction|Physician Decision|0
5714874|NCT00103285|19688820|P5|Induction|Physician Decision|0
5714875|NCT00103285|19688821|P4|Induction|Physician Decision|0
5714876|NCT00103285|19688822|P3|Induction|Physician Decision|0
5714877|NCT00103285|19688823|P2|Induction|Physician Decision|0
5714878|NCT00103285|19688824|P1|Induction|Physician Decision|103
5714879|NCT00103285|19688817|P8|Induction|Death|0
5714880|NCT00103285|19688818|P7|Induction|Death|0
5714881|NCT00103285|19688819|P6|Induction|Death|0
5714882|NCT00103285|19688820|P5|Induction|Death|0
5714883|NCT00103285|19688821|P4|Induction|Death|0
5714884|NCT00103285|19688822|P3|Induction|Death|0
5714885|NCT00103285|19688823|P2|Induction|Death|0
5714886|NCT00103285|19688824|P1|Induction|Death|24
5714887|NCT00103285|19688817|P8|Induction|Adverse Event|0
5714888|NCT00103285|19688818|P7|Induction|Adverse Event|0
5714889|NCT00103285|19688819|P6|Induction|Adverse Event|0
5714890|NCT00103285|19688820|P5|Induction|Adverse Event|0
5714891|NCT00103285|19688821|P4|Induction|Adverse Event|0
5714892|NCT00103285|19688822|P3|Induction|Adverse Event|0
5714893|NCT00103285|19688823|P2|Induction|Adverse Event|0
5714894|NCT00103285|19688824|P1|Induction|Adverse Event|14
5714895|NCT00103259|19688853|P2|Overall Study|ineligible/no protocol therapy|6
5714896|NCT00103259|19688854|P1|Overall Study|ineligible/no protocol therapy|4
5714897|NCT00103259|19688853|P2|Overall Study|other (reasons were not specified)|1
5714898|NCT00103259|19688854|P1|Overall Study|other (reasons were not specified)|2
5714899|NCT00103259|19688853|P2|Overall Study|alternative therapy|0
5714900|NCT00103259|19688854|P1|Overall Study|alternative therapy|1
5714901|NCT00103259|19688853|P2|Overall Study|Withdrawal by Subject|3
5714902|NCT00103259|19688854|P1|Overall Study|Withdrawal by Subject|2
5714903|NCT00103259|19688853|P2|Overall Study|Death|2
5714904|NCT00103259|19688854|P1|Overall Study|Death|3
5714905|NCT00103207|19688866|P1|Overall Study|Diagnosis of BAC not confirmed|27
5714906|NCT00103207|19688866|P1|Overall Study|Ineligible|4
5714907|NCT00103207|19688866|P1|Overall Study|Other complicating disease|1
5714908|NCT00103207|19688866|P1|Overall Study|Withdrawal by Subject|2
5714909|NCT00103207|19688866|P1|Overall Study|Death|1
5714910|NCT00103207|19688866|P1|Overall Study|Adverse Event|3
5714911|NCT00103142|19688885|P2|Overall Study|Progression of disease|1
5714912|NCT00103142|19688886|P1|Overall Study|Progression of disease|2
5714913|NCT00103142|19688885|P2|Overall Study|Adverse Event|0
5714914|NCT00103142|19688886|P1|Overall Study|Adverse Event|1
5714915|NCT00103012|19688902|P3|Overall Study|Subject non-compliant with medications|1
5714916|NCT00103012|19688903|P2|Overall Study|Subject non-compliant with medications|0
5714917|NCT00103012|19688904|P1|Overall Study|Subject non-compliant with medications|0
5714918|NCT00103012|19688902|P3|Overall Study|Adverse Event|1
5714919|NCT00103012|19688903|P2|Overall Study|Adverse Event|0
5714920|NCT00103012|19688904|P1|Overall Study|Adverse Event|0
5714921|NCT00103012|19688902|P3|Overall Study|Pregnancy|0
5714922|NCT00103012|19688903|P2|Overall Study|Pregnancy|0
5714923|NCT00103012|19688904|P1|Overall Study|Pregnancy|1
5714924|NCT00103012|19688902|P3|Overall Study|Withdrawal by Subject|2
5714925|NCT00103012|19688903|P2|Overall Study|Withdrawal by Subject|1
5714926|NCT00103012|19688904|P1|Overall Study|Withdrawal by Subject|2
5714927|NCT00102960|19688915|P3|Overall Study|Withdrawal by Subject|1
5714928|NCT00102960|19688916|P2|Overall Study|Withdrawal by Subject|0
5714929|NCT00102960|19688917|P1|Overall Study|Withdrawal by Subject|1
5714930|NCT00102960|19688915|P3|Overall Study|Lost to Follow-up|16
5714931|NCT00102960|19688916|P2|Overall Study|Lost to Follow-up|12
5714932|NCT00102960|19688917|P1|Overall Study|Lost to Follow-up|6
5714933|NCT00102960|19688915|P3|Overall Study|Death|11
5714934|NCT00102960|19688916|P2|Overall Study|Death|11
5714935|NCT00102960|19688917|P1|Overall Study|Death|23
5714936|NCT00102804|19688966|P2|Overall Study|Alive, Receiving Treatment|2
5714937|NCT00102804|19688967|P1|Overall Study|Alive, Receiving Treatment|7
5714938|NCT00102804|19688966|P2|Overall Study|Sponsor Decision|0
5714939|NCT00102804|19688967|P1|Overall Study|Sponsor Decision|1
5714940|NCT00102804|19688966|P2|Overall Study|Satisfactory Response|0
5714941|NCT00102804|19688967|P1|Overall Study|Satisfactory Response|2
5714942|NCT00102804|19688966|P2|Overall Study|Protocol Violation|1
5714943|NCT00102804|19688967|P1|Overall Study|Protocol Violation|2
5714944|NCT00102804|19688966|P2|Overall Study|Lost to Follow-up|1
5714945|NCT00102804|19688967|P1|Overall Study|Lost to Follow-up|4
5714946|NCT00102804|19688966|P2|Overall Study|Enrollment Criteria Not Met|0
5714947|NCT00102804|19688967|P1|Overall Study|Enrollment Criteria Not Met|6
5714948|NCT00102804|19688966|P2|Overall Study|Death|6
5714949|NCT00102804|19688967|P1|Overall Study|Death|5
5714950|NCT00102804|19688966|P2|Overall Study|Physician Decision|6
5714951|NCT00102804|19688967|P1|Overall Study|Physician Decision|24
5714952|NCT00102804|19688966|P2|Overall Study|Adverse Event|3
5714953|NCT00102804|19688967|P1|Overall Study|Adverse Event|37
5714954|NCT00102804|19688966|P2|Overall Study|Withdrawal by Subject|7
5714955|NCT00102804|19688967|P1|Overall Study|Withdrawal by Subject|46
5714956|NCT00102804|19688966|P2|Overall Study|Progressive Disease (PD)|196
5714957|NCT00102804|19688967|P1|Overall Study|Progressive Disease (PD)|307
5714958|NCT00102687|19688988|P5|Maintenance Period|Physician Decision|4
5714959|NCT00102687|19688989|P4|Maintenance Period|Physician Decision|0
5714960|NCT00102687|19688990|P3|Maintenance Period|Physician Decision|3
5714961|NCT00102687|19688991|P2|Maintenance Period|Physician Decision|2
5714962|NCT00102687|19688992|P1|Maintenance Period|Physician Decision|1
5714963|NCT00102687|19688988|P5|Maintenance Period|Death|1
5714964|NCT00102687|19688989|P4|Maintenance Period|Death|1
5714965|NCT00102687|19688990|P3|Maintenance Period|Death|0
5714966|NCT00102687|19688991|P2|Maintenance Period|Death|0
5714967|NCT00102687|19688992|P1|Maintenance Period|Death|0
5714968|NCT00102687|19688988|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
5714969|NCT00102687|19688989|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
5714970|NCT00102687|19688990|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
5714971|NCT00102687|19688991|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
5714972|NCT00102687|19688992|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
5714973|NCT00102687|19688988|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
5714974|NCT00102687|19688989|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
5714975|NCT00102687|19688990|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
5714976|NCT00102687|19688991|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
5714977|NCT00102687|19688992|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
5714978|NCT00102687|19688988|P5|Maintenance Period|Adverse Event|3
5714979|NCT00102687|19688989|P4|Maintenance Period|Adverse Event|1
5714980|NCT00102687|19688990|P3|Maintenance Period|Adverse Event|0
5714981|NCT00102687|19688991|P2|Maintenance Period|Adverse Event|0
5714982|NCT00102687|19688992|P1|Maintenance Period|Adverse Event|1
5714983|NCT00102687|19688988|P5|Maintenance Period|Withdrawal by Subject|1
5714984|NCT00102687|19688989|P4|Maintenance Period|Withdrawal by Subject|3
5714985|NCT00102687|19688990|P3|Maintenance Period|Withdrawal by Subject|2
5714986|NCT00102687|19688991|P2|Maintenance Period|Withdrawal by Subject|0
5714987|NCT00102687|19688992|P1|Maintenance Period|Withdrawal by Subject|4
5714988|NCT00102687|19688988|P5|Initial Period|Death|0
5714989|NCT00102687|19688989|P4|Initial Period|Death|0
5714990|NCT00102687|19688990|P3|Initial Period|Death|1
5714991|NCT00102687|19688991|P2|Initial Period|Death|1
5714992|NCT00102687|19688992|P1|Initial Period|Death|1
5714993|NCT00102687|19688988|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
5714994|NCT00102687|19688989|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
5714995|NCT00102687|19688990|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
5714996|NCT00102687|19688991|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
5714997|NCT00102687|19688992|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
5714998|NCT00102687|19688988|P5|Initial Period|Sponsor's decision|0
5714999|NCT00102687|19688989|P4|Initial Period|Sponsor's decision|0
5715000|NCT00102687|19688990|P3|Initial Period|Sponsor's decision|1
5715001|NCT00102687|19688991|P2|Initial Period|Sponsor's decision|1
5715002|NCT00102687|19688992|P1|Initial Period|Sponsor's decision|0
5715003|NCT00102687|19688988|P5|Initial Period|Physician Decision|0
5715004|NCT00102687|19688989|P4|Initial Period|Physician Decision|0
5715005|NCT00102687|19688990|P3|Initial Period|Physician Decision|6
5715006|NCT00102687|19688991|P2|Initial Period|Physician Decision|9
5715007|NCT00102687|19688992|P1|Initial Period|Physician Decision|2
5715008|NCT00102687|19688988|P5|Initial Period|Protocol Violation|0
5715009|NCT00102687|19688989|P4|Initial Period|Protocol Violation|0
5715010|NCT00102687|19688990|P3|Initial Period|Protocol Violation|2
5715011|NCT00102687|19688991|P2|Initial Period|Protocol Violation|0
5715012|NCT00102687|19688992|P1|Initial Period|Protocol Violation|0
5715013|NCT00102687|19688988|P5|Initial Period|Transformation to AML (blast > 30%)|0
5715014|NCT00102687|19688989|P4|Initial Period|Transformation to AML (blast > 30%)|0
5715015|NCT00102687|19688990|P3|Initial Period|Transformation to AML (blast > 30%)|0
5715016|NCT00102687|19688991|P2|Initial Period|Transformation to AML (blast > 30%)|3
5715017|NCT00102687|19688992|P1|Initial Period|Transformation to AML (blast > 30%)|1
5715018|NCT00102687|19688988|P5|Initial Period|Adverse Event|0
5715019|NCT00102687|19688989|P4|Initial Period|Adverse Event|0
5715020|NCT00102687|19688990|P3|Initial Period|Adverse Event|9
5715021|NCT00102687|19688991|P2|Initial Period|Adverse Event|7
5715022|NCT00102687|19688992|P1|Initial Period|Adverse Event|4
5715023|NCT00102687|19688988|P5|Initial Period|Withdrawal by Subject|0
5715024|NCT00102687|19688989|P4|Initial Period|Withdrawal by Subject|0
5715025|NCT00102687|19688990|P3|Initial Period|Withdrawal by Subject|5
5715026|NCT00102687|19688991|P2|Initial Period|Withdrawal by Subject|3
5715027|NCT00102687|19688992|P1|Initial Period|Withdrawal by Subject|6
5715028|NCT00102596|19689056|P2|Part A|Adverse Event|0
5715029|NCT00102596|19689057|P1|Part A|Adverse Event|1
5715030|NCT00102596|19689056|P2|Part A|Screen failures|0
5715031|NCT00102596|19689057|P1|Part A|Screen failures|6
5715032|NCT00102531|19689068|P2|Overall Study|Physician Decision|1
5715033|NCT00102531|19689069|P1|Overall Study|Physician Decision|0
5715034|NCT00102531|19689068|P2|Overall Study|Disease Progression|9
5715035|NCT00102531|19689069|P1|Overall Study|Disease Progression|5
5715036|NCT00102531|19689068|P2|Overall Study|Adverse Event|1
5715037|NCT00102531|19689069|P1|Overall Study|Adverse Event|0
5715038|NCT00102440|19689084|P3|Overall Study|Protocol Violation|1
5715039|NCT00102440|19689085|P2|Overall Study|Protocol Violation|2
5715040|NCT00102440|19689086|P1|Overall Study|Protocol Violation|7
5715041|NCT00102440|19689084|P3|Overall Study|Other|14
5715042|NCT00102440|19689085|P2|Overall Study|Other|14
5715043|NCT00102440|19689086|P1|Overall Study|Other|11
5715044|NCT00102440|19689084|P3|Overall Study|Personal Reason(s)|13
5715045|NCT00102440|19689085|P2|Overall Study|Personal Reason(s)|13
5715046|NCT00102440|19689086|P1|Overall Study|Personal Reason(s)|19
5715047|NCT00102440|19689084|P3|Overall Study|Gout Flare|9
5715048|NCT00102440|19689085|P2|Overall Study|Gout Flare|28
5715049|NCT00102440|19689086|P1|Overall Study|Gout Flare|10
5715050|NCT00102440|19689084|P3|Overall Study|Adverse Event|8
5715051|NCT00102440|19689085|P2|Overall Study|Adverse Event|23
5715052|NCT00102440|19689086|P1|Overall Study|Adverse Event|16
5715053|NCT00102440|19689084|P3|Overall Study|Lost to Follow-up|21
5715054|NCT00102440|19689085|P2|Overall Study|Lost to Follow-up|18
5715055|NCT00102440|19689086|P1|Overall Study|Lost to Follow-up|25
5715056|NCT00102063|19689136|P3|Overall Study|Protocol Violation|1
5715057|NCT00102063|19689137|P2|Overall Study|Protocol Violation|1
5715058|NCT00102063|19689138|P1|Overall Study|Protocol Violation|0
5715059|NCT00102063|19689136|P3|Overall Study|Lost to Follow-up|1
5715060|NCT00102063|19689137|P2|Overall Study|Lost to Follow-up|0
5715061|NCT00102063|19689138|P1|Overall Study|Lost to Follow-up|0
5715062|NCT00102063|19689136|P3|Overall Study|Withdrawal by Subject|5
5715063|NCT00102063|19689137|P2|Overall Study|Withdrawal by Subject|12
5715064|NCT00102063|19689138|P1|Overall Study|Withdrawal by Subject|4
5715065|NCT00102063|19689136|P3|Overall Study|Adverse Event|2
5715066|NCT00102063|19689137|P2|Overall Study|Adverse Event|4
5715067|NCT00102063|19689138|P1|Overall Study|Adverse Event|7
5715068|NCT00102063|19689136|P3|Overall Study|Lack of Efficacy|1
5715069|NCT00102063|19689137|P2|Overall Study|Lack of Efficacy|1
5715070|NCT00102063|19689138|P1|Overall Study|Lack of Efficacy|5
5715071|NCT00101907|19689196|P6|Overall Study|Withdrawal by Subject|0
5715072|NCT00101907|19689197|P5|Overall Study|Withdrawal by Subject|1
5715073|NCT00101907|19689198|P4|Overall Study|Withdrawal by Subject|0
5715074|NCT00101907|19689199|P3|Overall Study|Withdrawal by Subject|1
5715075|NCT00101907|19689200|P2|Overall Study|Withdrawal by Subject|0
5715076|NCT00101907|19689201|P1|Overall Study|Withdrawal by Subject|1
5715077|NCT00101907|19689196|P6|Overall Study|Physician Decision|0
5715078|NCT00101907|19689197|P5|Overall Study|Physician Decision|1
5715079|NCT00101907|19689198|P4|Overall Study|Physician Decision|1
5715080|NCT00101907|19689199|P3|Overall Study|Physician Decision|0
5715081|NCT00101907|19689200|P2|Overall Study|Physician Decision|0
5715082|NCT00101907|19689201|P1|Overall Study|Physician Decision|0
5715083|NCT00101907|19689196|P6|Overall Study|Death|0
5715084|NCT00101907|19689197|P5|Overall Study|Death|3
5715085|NCT00101907|19689198|P4|Overall Study|Death|0
5715086|NCT00101907|19689199|P3|Overall Study|Death|0
5715087|NCT00101907|19689200|P2|Overall Study|Death|1
5715088|NCT00101907|19689201|P1|Overall Study|Death|0
5715089|NCT00101907|19689196|P6|Overall Study|Adverse Event|0
5715090|NCT00101907|19689197|P5|Overall Study|Adverse Event|0
5715091|NCT00101907|19689198|P4|Overall Study|Adverse Event|0
5715092|NCT00101907|19689199|P3|Overall Study|Adverse Event|0
5715093|NCT00101907|19689200|P2|Overall Study|Adverse Event|0
5715094|NCT00101907|19689201|P1|Overall Study|Adverse Event|1
5715095|NCT00101868|19689243|P2|Overall Study|Lost to Follow-up|13
5715096|NCT00101868|19689244|P1|Overall Study|Lost to Follow-up|8
5715097|NCT00101868|19689243|P2|Overall Study|Protocol Violation|0
5715098|NCT00101868|19689244|P1|Overall Study|Protocol Violation|3
5715099|NCT00101868|19689243|P2|Overall Study|Withdrawal by Subject|9
5715100|NCT00101868|19689244|P1|Overall Study|Withdrawal by Subject|8
5715101|NCT00101868|19689243|P2|Overall Study|Death|10
5715102|NCT00101868|19689244|P1|Overall Study|Death|10
5715103|NCT00101686|19689314|P10|Overall Study|Withdrawal by Subject|9
5715104|NCT00101686|19689315|P9|Overall Study|Withdrawal by Subject|8
5715105|NCT00101686|19689316|P8|Overall Study|Withdrawal by Subject|7
5715106|NCT00101686|19689317|P7|Overall Study|Withdrawal by Subject|7
5715107|NCT00101686|19689318|P6|Overall Study|Withdrawal by Subject|7
5715108|NCT00101686|19689319|P5|Overall Study|Withdrawal by Subject|8
5715109|NCT00101686|19689320|P4|Overall Study|Withdrawal by Subject|8
5715110|NCT00101686|19689321|P3|Overall Study|Withdrawal by Subject|6
5715111|NCT00101686|19689322|P2|Overall Study|Withdrawal by Subject|8
5715112|NCT00101686|19689323|P1|Overall Study|Withdrawal by Subject|9
5715113|NCT00101686|19689314|P10|Overall Study|Other|3
5715114|NCT00101686|19689315|P9|Overall Study|Other|3
5715115|NCT00101686|19689316|P8|Overall Study|Other|5
5715116|NCT00101686|19689317|P7|Overall Study|Other|1
5715117|NCT00101686|19689318|P6|Overall Study|Other|12
5715118|NCT00101686|19689319|P5|Overall Study|Other|2
5715119|NCT00101686|19689320|P4|Overall Study|Other|6
5715120|NCT00101686|19689321|P3|Overall Study|Other|1
5715121|NCT00101686|19689322|P2|Overall Study|Other|4
5715122|NCT00101686|19689323|P1|Overall Study|Other|1
5715123|NCT00101686|19689314|P10|Overall Study|Physician Decision|1
5715124|NCT00101686|19689315|P9|Overall Study|Physician Decision|1
5715125|NCT00101686|19689316|P8|Overall Study|Physician Decision|5
5715126|NCT00101686|19689317|P7|Overall Study|Physician Decision|5
5715127|NCT00101686|19689318|P6|Overall Study|Physician Decision|9
5715128|NCT00101686|19689319|P5|Overall Study|Physician Decision|8
5715129|NCT00101686|19689320|P4|Overall Study|Physician Decision|7
5715130|NCT00101686|19689321|P3|Overall Study|Physician Decision|6
5715131|NCT00101686|19689322|P2|Overall Study|Physician Decision|13
5715132|NCT00101686|19689323|P1|Overall Study|Physician Decision|10
5715133|NCT00101686|19689314|P10|Overall Study|intercurrent non-cancer related illness|1
5715134|NCT00101686|19689315|P9|Overall Study|intercurrent non-cancer related illness|1
5715135|NCT00101686|19689316|P8|Overall Study|intercurrent non-cancer related illness|0
5715136|NCT00101686|19689317|P7|Overall Study|intercurrent non-cancer related illness|1
5715137|NCT00101686|19689318|P6|Overall Study|intercurrent non-cancer related illness|3
5715138|NCT00101686|19689319|P5|Overall Study|intercurrent non-cancer related illness|1
5715139|NCT00101686|19689320|P4|Overall Study|intercurrent non-cancer related illness|0
5715140|NCT00101686|19689321|P3|Overall Study|intercurrent non-cancer related illness|2
5715141|NCT00101686|19689322|P2|Overall Study|intercurrent non-cancer related illness|0
5715142|NCT00101686|19689323|P1|Overall Study|intercurrent non-cancer related illness|0
5715143|NCT00101686|19689314|P10|Overall Study|Randomized but did not receive treament|1
5715144|NCT00101686|19689315|P9|Overall Study|Randomized but did not receive treament|0
5715145|NCT00101686|19689316|P8|Overall Study|Randomized but did not receive treament|1
5715146|NCT00101686|19689317|P7|Overall Study|Randomized but did not receive treament|0
5715147|NCT00101686|19689318|P6|Overall Study|Randomized but did not receive treament|2
5715148|NCT00101686|19689319|P5|Overall Study|Randomized but did not receive treament|2
5715149|NCT00101686|19689320|P4|Overall Study|Randomized but did not receive treament|2
5715150|NCT00101686|19689321|P3|Overall Study|Randomized but did not receive treament|2
5715151|NCT00101686|19689322|P2|Overall Study|Randomized but did not receive treament|6
5715152|NCT00101686|19689323|P1|Overall Study|Randomized but did not receive treament|1
5715153|NCT00101686|19689314|P10|Overall Study|unacceptable toxicity|4
5715154|NCT00101686|19689315|P9|Overall Study|unacceptable toxicity|1
5715155|NCT00101686|19689316|P8|Overall Study|unacceptable toxicity|2
5715156|NCT00101686|19689317|P7|Overall Study|unacceptable toxicity|4
5715157|NCT00101686|19689318|P6|Overall Study|unacceptable toxicity|10
5715158|NCT00101686|19689319|P5|Overall Study|unacceptable toxicity|16
5715159|NCT00101686|19689320|P4|Overall Study|unacceptable toxicity|6
5715160|NCT00101686|19689321|P3|Overall Study|unacceptable toxicity|10
5715161|NCT00101686|19689322|P2|Overall Study|unacceptable toxicity|9
5715162|NCT00101686|19689323|P1|Overall Study|unacceptable toxicity|3
5715163|NCT00101686|19689314|P10|Overall Study|>3 week delay treatment due toxicity|0
5715164|NCT00101686|19689315|P9|Overall Study|>3 week delay treatment due toxicity|3
5715165|NCT00101686|19689316|P8|Overall Study|>3 week delay treatment due toxicity|1
5715166|NCT00101686|19689317|P7|Overall Study|>3 week delay treatment due toxicity|2
5715167|NCT00101686|19689318|P6|Overall Study|>3 week delay treatment due toxicity|3
5715168|NCT00101686|19689319|P5|Overall Study|>3 week delay treatment due toxicity|7
5715169|NCT00101686|19689320|P4|Overall Study|>3 week delay treatment due toxicity|2
5715170|NCT00101686|19689321|P3|Overall Study|>3 week delay treatment due toxicity|1
5715171|NCT00101686|19689322|P2|Overall Study|>3 week delay treatment due toxicity|2
5715172|NCT00101686|19689323|P1|Overall Study|>3 week delay treatment due toxicity|6
5715173|NCT00101686|19689314|P10|Overall Study|initiation other anti-cancer treatment|3
5715174|NCT00101686|19689315|P9|Overall Study|initiation other anti-cancer treatment|3
5715175|NCT00101686|19689316|P8|Overall Study|initiation other anti-cancer treatment|2
5715176|NCT00101686|19689317|P7|Overall Study|initiation other anti-cancer treatment|2
5715177|NCT00101686|19689318|P6|Overall Study|initiation other anti-cancer treatment|1
5715178|NCT00101686|19689319|P5|Overall Study|initiation other anti-cancer treatment|1
5715179|NCT00101686|19689320|P4|Overall Study|initiation other anti-cancer treatment|3
5715180|NCT00101686|19689321|P3|Overall Study|initiation other anti-cancer treatment|4
5715181|NCT00101686|19689322|P2|Overall Study|initiation other anti-cancer treatment|3
5715182|NCT00101686|19689323|P1|Overall Study|initiation other anti-cancer treatment|4
5715183|NCT00101686|19689314|P10|Overall Study|Progressive Disease|8
5715184|NCT00101686|19689315|P9|Overall Study|Progressive Disease|10
5715185|NCT00101686|19689316|P8|Overall Study|Progressive Disease|7
5715186|NCT00101686|19689317|P7|Overall Study|Progressive Disease|5
5715187|NCT00101686|19689318|P6|Overall Study|Progressive Disease|25
5715188|NCT00101686|19689319|P5|Overall Study|Progressive Disease|28
5715189|NCT00101686|19689320|P4|Overall Study|Progressive Disease|38
5715190|NCT00101686|19689321|P3|Overall Study|Progressive Disease|37
5715191|NCT00101686|19689322|P2|Overall Study|Progressive Disease|28
5715192|NCT00101686|19689323|P1|Overall Study|Progressive Disease|37
5715193|NCT00101582|19689440|P2|Overall Study|Other|1
5715194|NCT00101582|19689441|P1|Overall Study|Other|0
5715195|NCT00101582|19689440|P2|Overall Study|Death|5
5715196|NCT00101582|19689441|P1|Overall Study|Death|3
5715197|NCT00101582|19689440|P2|Overall Study|Physician Decision|0
5715198|NCT00101582|19689441|P1|Overall Study|Physician Decision|1
5715199|NCT00101582|19689440|P2|Overall Study|Withdrawal by Subject|4
5715200|NCT00101582|19689441|P1|Overall Study|Withdrawal by Subject|6
5715201|NCT00101582|19689440|P2|Overall Study|Adverse Event|4
5715202|NCT00101582|19689441|P1|Overall Study|Adverse Event|1
5715203|NCT00101582|19689440|P2|Overall Study|Ineligibility determined|1
5715204|NCT00101582|19689441|P1|Overall Study|Ineligibility determined|0
5715205|NCT00101452|19689464|P3|Overall Study|Other|12
5715206|NCT00101452|19689465|P2|Overall Study|Other|16
5715207|NCT00101452|19689466|P1|Overall Study|Other|15
5715208|NCT00101452|19689464|P3|Overall Study|Protocol Violation|3
5715209|NCT00101452|19689465|P2|Overall Study|Protocol Violation|1
5715210|NCT00101452|19689466|P1|Overall Study|Protocol Violation|2
5715211|NCT00101452|19689464|P3|Overall Study|Physician Decision|2
5715212|NCT00101452|19689465|P2|Overall Study|Physician Decision|3
5715213|NCT00101452|19689466|P1|Overall Study|Physician Decision|0
5715214|NCT00101452|19689464|P3|Overall Study|Baseline Fail|2
5715215|NCT00101452|19689465|P2|Overall Study|Baseline Fail|1
5715216|NCT00101452|19689466|P1|Overall Study|Baseline Fail|2
5715217|NCT00101452|19689464|P3|Overall Study|Withdrawal by Subject|9
5715218|NCT00101452|19689465|P2|Overall Study|Withdrawal by Subject|14
5715219|NCT00101452|19689466|P1|Overall Study|Withdrawal by Subject|10
5715220|NCT00101452|19689464|P3|Overall Study|Lost to Follow-up|14
5715221|NCT00101452|19689465|P2|Overall Study|Lost to Follow-up|8
5715222|NCT00101452|19689466|P1|Overall Study|Lost to Follow-up|13
5715223|NCT00101452|19689464|P3|Overall Study|Adverse Event|1
5715224|NCT00101452|19689465|P2|Overall Study|Adverse Event|0
5715225|NCT00101452|19689466|P1|Overall Study|Adverse Event|2
5715226|NCT00101439|19689480|P2|Period 2|Withdrawal by Subject|2
5715227|NCT00101439|19689481|P1|Period 2|Withdrawal by Subject|0
5715228|NCT00101400|19689497|P1|Survival Follow-Up|Alive|7
5715229|NCT00101283|19689517|P2|Overall Study|Prostate Cancer Recurrence|1
5715230|NCT00101283|19689518|P1|Overall Study|Prostate Cancer Recurrence|0
5715231|NCT00101283|19689517|P2|Overall Study|Insurance Refusal|1
5715232|NCT00101283|19689518|P1|Overall Study|Insurance Refusal|0
5715233|NCT00101283|19689517|P2|Overall Study|Withdrawal by Subject|1
5715234|NCT00101283|19689518|P1|Overall Study|Withdrawal by Subject|0
5715235|NCT00101192|19689528|P1|Overall Study|Inevaluable|1
5715236|NCT00101192|19689528|P1|Overall Study|Ineligible|6
5715237|NCT00101166|19689532|P1|Overall Study|progressive disease|10
5715238|NCT00101101|19689540|P1|Overall Study|never received vaccine|20
5715239|NCT00101010|19689561|P1|Overall Study|Physician Decision|1
5715240|NCT00100932|19689568|P2|Overall Study|Other|2
5715241|NCT00100932|19689569|P1|Overall Study|Other|5
5715242|NCT00100932|19689568|P2|Overall Study|Physician Decision|5
5715243|NCT00100932|19689569|P1|Overall Study|Physician Decision|7
5715244|NCT00100932|19689568|P2|Overall Study|Progressive Disease|18
5715245|NCT00100932|19689569|P1|Overall Study|Progressive Disease|44
5715246|NCT00100932|19689568|P2|Overall Study|Withdrawal by Subject|0
5715247|NCT00100932|19689569|P1|Overall Study|Withdrawal by Subject|6
5715248|NCT00100932|19689568|P2|Overall Study|Adverse Event|2
5715249|NCT00100932|19689569|P1|Overall Study|Adverse Event|11
5715250|NCT00100828|19689584|P1|Overall Study|Physician Decision|6
5715251|NCT00100815|19689588|P1|Overall Study|Other|3
5715252|NCT00100815|19689588|P1|Overall Study|Death|4
5715253|NCT00100815|19689588|P1|Overall Study|Adverse Event|18
5715254|NCT00100815|19689588|P1|Overall Study|Progression|24
5715255|NCT00100802|19689596|P1|Overall Study|Ineligible|12
5715256|NCT00100802|19689596|P1|Overall Study|Withdrawal by Subject|5
5715257|NCT00100802|19689596|P1|Overall Study|Protocol Violation|1
5715258|NCT00100802|19689596|P1|Overall Study|Physician Decision|5
5715259|NCT00100802|19689596|P1|Overall Study|Lack of Efficacy|47
5715260|NCT00100802|19689596|P1|Overall Study|Death|1
5715261|NCT00100802|19689596|P1|Overall Study|Adverse Event|9
5715262|NCT00100789|19689601|P1|Overall Study|Never received treatment|1
5715263|NCT00100789|19689601|P1|Overall Study|Ineligible|3
5715264|NCT00100789|19689601|P1|Overall Study|Not protocol specified|5
5715265|NCT00100789|19689601|P1|Overall Study|Death|2
5715266|NCT00100789|19689601|P1|Overall Study|Progression/relapse|42
5715267|NCT00100789|19689601|P1|Overall Study|Withdrawal by Subject|1
5715268|NCT00100789|19689601|P1|Overall Study|Adverse Event|10
5715269|NCT00100178|19689678|P3|Overall Study|Physician Decision|3
5715270|NCT00100178|19689679|P2|Overall Study|Physician Decision|1
5715271|NCT00100178|19689680|P1|Overall Study|Physician Decision|6
5715272|NCT00100178|19689678|P3|Overall Study|Withdrawal by Subject|1
5715273|NCT00100178|19689679|P2|Overall Study|Withdrawal by Subject|1
5715274|NCT00100178|19689680|P1|Overall Study|Withdrawal by Subject|1
5715275|NCT00100178|19689678|P3|Overall Study|Adverse Event|1
5715276|NCT00100178|19689679|P2|Overall Study|Adverse Event|2
5715277|NCT00100178|19689680|P1|Overall Study|Adverse Event|2
5715278|NCT00100178|19689678|P3|Overall Study|Lost to Follow-up|5
5715279|NCT00100178|19689679|P2|Overall Study|Lost to Follow-up|6
5715280|NCT00100178|19689680|P1|Overall Study|Lost to Follow-up|0
5715281|NCT00100048|19689709|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5715282|NCT00100048|19689710|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5715283|NCT00100048|19689711|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
5715284|NCT00100048|19689712|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5715285|NCT00100048|19689713|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5715286|NCT00100048|19689714|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
5715287|NCT00100048|19689709|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
5715288|NCT00100048|19689710|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
5715289|NCT00100048|19689711|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
5715290|NCT00100048|19689712|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
5715291|NCT00100048|19689713|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
5715292|NCT00100048|19689714|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
5715293|NCT00100048|19689709|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
5715294|NCT00100048|19689710|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
5715295|NCT00100048|19689711|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
5715296|NCT00100048|19689712|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
5715297|NCT00100048|19689713|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
5715298|NCT00100048|19689714|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
5715299|NCT00100048|19689709|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
5715300|NCT00100048|19689710|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
5715301|NCT00100048|19689711|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
5715302|NCT00100048|19689712|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
5715303|NCT00100048|19689713|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
5715304|NCT00100048|19689714|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
5715305|NCT00100048|19689709|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
5715306|NCT00100048|19689710|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
5715307|NCT00100048|19689711|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
5715308|NCT00100048|19689712|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
5715309|NCT00100048|19689713|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
5715310|NCT00100048|19689714|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
5715311|NCT00100048|19689709|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
5715312|NCT00100048|19689710|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
5715313|NCT00100048|19689711|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
5715314|NCT00100048|19689712|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
5715315|NCT00100048|19689713|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
5715316|NCT00100048|19689714|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
5715317|NCT00100048|19689709|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
5715318|NCT00100048|19689710|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
5715319|NCT00100048|19689711|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
5715320|NCT00100048|19689712|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
5715321|NCT00100048|19689713|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
5715322|NCT00100048|19689714|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
5715323|NCT00100048|19689709|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
5715324|NCT00100048|19689710|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
5715325|NCT00100048|19689711|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
5715326|NCT00100048|19689712|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
5715327|NCT00100048|19689713|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
5715328|NCT00100048|19689714|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
5715329|NCT00099983|19689823|P2|Overall Study|Other issue|0
5715330|NCT00099983|19689824|P1|Overall Study|Other issue|1
5715331|NCT00099983|19689823|P2|Overall Study|Intolerant of burden of visits|1
5715332|NCT00099983|19689824|P1|Overall Study|Intolerant of burden of visits|0
5715333|NCT00099983|19689823|P2|Overall Study|Incarcerated|1
5715334|NCT00099983|19689824|P1|Overall Study|Incarcerated|0
5715335|NCT00099983|19689823|P2|Overall Study|Other psychiatric problem|0
5715336|NCT00099983|19689824|P1|Overall Study|Other psychiatric problem|1
5715337|NCT00099983|19689823|P2|Overall Study|Moved|0
5715338|NCT00099983|19689824|P1|Overall Study|Moved|1
5715339|NCT00099983|19689823|P2|Overall Study|Unable to return for appointments|1
5715340|NCT00099983|19689824|P1|Overall Study|Unable to return for appointments|1
5715341|NCT00099983|19689823|P2|Overall Study|Lack of Efficacy|1
5715342|NCT00099983|19689824|P1|Overall Study|Lack of Efficacy|0
5715343|NCT00099983|19689823|P2|Overall Study|Adverse Event|1
5715344|NCT00099983|19689824|P1|Overall Study|Adverse Event|1
5715345|NCT00099983|19689823|P2|Overall Study|Withdrawal by Subject|2
5715346|NCT00099983|19689824|P1|Overall Study|Withdrawal by Subject|3
5715347|NCT00099983|19689823|P2|Overall Study|Missing Source Documents|15
5715348|NCT00099983|19689824|P1|Overall Study|Missing Source Documents|14
5715349|NCT00099983|19689823|P2|Overall Study|Lost to Follow-up|3
5715350|NCT00099983|19689824|P1|Overall Study|Lost to Follow-up|2
5715351|NCT00099632|19689836|P6|Overall Study|Protocol Violation|1
5715352|NCT00099632|19689837|P5|Overall Study|Protocol Violation|0
5715353|NCT00099632|19689838|P4|Overall Study|Protocol Violation|0
5715354|NCT00099632|19689839|P3|Overall Study|Protocol Violation|0
5715355|NCT00099632|19689840|P2|Overall Study|Protocol Violation|0
5715356|NCT00099632|19689841|P1|Overall Study|Protocol Violation|0
5715357|NCT00099632|19689836|P6|Overall Study|Withdrawal by Subject|1
5715358|NCT00099632|19689837|P5|Overall Study|Withdrawal by Subject|0
5715359|NCT00099632|19689838|P4|Overall Study|Withdrawal by Subject|0
5715360|NCT00099632|19689839|P3|Overall Study|Withdrawal by Subject|0
5715361|NCT00099632|19689840|P2|Overall Study|Withdrawal by Subject|1
5715362|NCT00099632|19689841|P1|Overall Study|Withdrawal by Subject|0
5715363|NCT00099632|19689836|P6|Overall Study|Lost to Follow-up|0
5715364|NCT00099632|19689837|P5|Overall Study|Lost to Follow-up|1
5715365|NCT00099632|19689838|P4|Overall Study|Lost to Follow-up|1
5715366|NCT00099632|19689839|P3|Overall Study|Lost to Follow-up|3
5715367|NCT00099632|19689840|P2|Overall Study|Lost to Follow-up|0
5715368|NCT00099632|19689841|P1|Overall Study|Lost to Follow-up|1
5715369|NCT00099437|19689881|P2|Overall Study|Ongoing in FU but not on treatment|45
5715370|NCT00099437|19689882|P1|Overall Study|Ongoing in FU but not on treatment|37
5715371|NCT00099437|19689881|P2|Overall Study|Withdrawal by Subject|10
5715372|NCT00099437|19689882|P1|Overall Study|Withdrawal by Subject|6
5715373|NCT00099437|19689881|P2|Overall Study|Death|261
5715374|NCT00099437|19689882|P1|Overall Study|Death|293
5715375|NCT00099437|19689881|P2|Overall Study|Lost to Follow-up|33
5715376|NCT00099437|19689882|P1|Overall Study|Lost to Follow-up|30
5715377|NCT00099359|19689905|P3|Overall Study|moved out of area|4
5715378|NCT00099359|19689906|P2|Overall Study|moved out of area|7
5715379|NCT00099359|19689907|P1|Overall Study|moved out of area|9
5715380|NCT00099359|19689905|P3|Overall Study|Lost to Follow-up|24
5715381|NCT00099359|19689906|P2|Overall Study|Lost to Follow-up|24
5715382|NCT00099359|19689907|P1|Overall Study|Lost to Follow-up|15
5715383|NCT00099359|19689905|P3|Overall Study|Withdrawal by Subject|23
5715384|NCT00099359|19689906|P2|Overall Study|Withdrawal by Subject|19
5715385|NCT00099359|19689907|P1|Overall Study|Withdrawal by Subject|19
5715386|NCT00099359|19689905|P3|Overall Study|Death|17
5715387|NCT00099359|19689906|P2|Overall Study|Death|15
5715388|NCT00099359|19689907|P1|Overall Study|Death|11
5715389|NCT00099268|19689930|P2|Overall Study|Death|1
5715390|NCT00099268|19689931|P1|Overall Study|Death|3
5715391|NCT00099268|19689930|P2|Overall Study|Administrative problems|4
5715392|NCT00099268|19689931|P1|Overall Study|Administrative problems|4
5715393|NCT00099268|19689930|P2|Overall Study|Lack of Efficacy|18
5715394|NCT00099268|19689931|P1|Overall Study|Lack of Efficacy|5
5715395|NCT00099268|19689930|P2|Overall Study|Lost to Follow-up|4
5715396|NCT00099268|19689931|P1|Overall Study|Lost to Follow-up|6
5715397|NCT00099268|19689930|P2|Overall Study|Protocol Violation|8
5715398|NCT00099268|19689931|P1|Overall Study|Protocol Violation|9
5715399|NCT00099268|19689930|P2|Overall Study|Adverse Event|19
5715400|NCT00099268|19689931|P1|Overall Study|Adverse Event|19
5715401|NCT00099268|19689930|P2|Overall Study|Withdrawal by Subject|28
5715402|NCT00099268|19689931|P1|Overall Study|Withdrawal by Subject|46
5715403|NCT00098865|19689971|P1|Overall Study|Alternative Therapy|1
5715404|NCT00098865|19689971|P1|Overall Study|Adverse Event|2
5715405|NCT00098865|19689971|P1|Overall Study|Progressive Disease|6
5715406|NCT00098839|19689979|P2|Overall Study|Ineligible|0
5715407|NCT00098839|19689980|P1|Overall Study|Ineligible|2
5715408|NCT00098839|19689979|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
5715409|NCT00098839|19689980|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
5715410|NCT00098839|19689979|P2|Overall Study|Relapse|3
5715411|NCT00098839|19689980|P1|Overall Study|Relapse|6
5715412|NCT00098839|19689979|P2|Overall Study|Refusal of further protocol therapy|1
5715413|NCT00098839|19689980|P1|Overall Study|Refusal of further protocol therapy|3
5715414|NCT00098839|19689979|P2|Overall Study|Withdrawal by Subject|0
5715415|NCT00098839|19689980|P1|Overall Study|Withdrawal by Subject|1
5715416|NCT00098839|19689979|P2|Overall Study|Physician Decision|14
5715417|NCT00098839|19689980|P1|Overall Study|Physician Decision|4
5715418|NCT00098839|19689979|P2|Overall Study|Death|2
5715419|NCT00098839|19689980|P1|Overall Study|Death|1
5715420|NCT00098839|19689979|P2|Overall Study|Adverse Event|2
5715421|NCT00098839|19689980|P1|Overall Study|Adverse Event|5
5715422|NCT00098813|19689991|P1|Overall Study|Reversal of RAI resistance|1
5715423|NCT00098813|19689991|P1|Overall Study|Other complicating disease|1
5715424|NCT00098813|19689991|P1|Overall Study|Progression of Disease|1
5715425|NCT00098813|19689991|P1|Overall Study|Withdrawal by Subject|7
5715426|NCT00098813|19689991|P1|Overall Study|Protocol Violation|1
5715427|NCT00098813|19689991|P1|Overall Study|Death|8
5715428|NCT00098787|19689998|P3|Overall Study|Other|9
5715429|NCT00098787|19689999|P2|Overall Study|Other|6
5715430|NCT00098787|19690000|P1|Overall Study|Other|7
5715431|NCT00098787|19689998|P3|Overall Study|Alternative therapy|13
5715432|NCT00098787|19689999|P2|Overall Study|Alternative therapy|13
5715433|NCT00098787|19690000|P1|Overall Study|Alternative therapy|8
5715434|NCT00098787|19689998|P3|Overall Study|Withdrawal by Subject|6
5715435|NCT00098787|19689999|P2|Overall Study|Withdrawal by Subject|12
5715436|NCT00098787|19690000|P1|Overall Study|Withdrawal by Subject|4
5715437|NCT00098787|19689998|P3|Overall Study|Death|0
5715438|NCT00098787|19689999|P2|Overall Study|Death|1
5715439|NCT00098787|19690000|P1|Overall Study|Death|6
5715440|NCT00098787|19689998|P3|Overall Study|Adverse Event|8
5715441|NCT00098787|19689999|P2|Overall Study|Adverse Event|17
5715442|NCT00098787|19690000|P1|Overall Study|Adverse Event|8
5715443|NCT00098787|19689998|P3|Overall Study|Disease progression|23
5715444|NCT00098787|19689999|P2|Overall Study|Disease progression|17
5715445|NCT00098787|19690000|P1|Overall Study|Disease progression|28
5715446|NCT00098787|19689998|P3|Overall Study|Ineligible|3
5715447|NCT00098787|19689999|P2|Overall Study|Ineligible|7
5715448|NCT00098787|19690000|P1|Overall Study|Ineligible|9
5715449|NCT00098787|19689998|P3|Overall Study|Never started treatment|1
5715450|NCT00098787|19689999|P2|Overall Study|Never started treatment|2
5715451|NCT00098787|19690000|P1|Overall Study|Never started treatment|3
5715452|NCT00098774|19690014|P1|Overall Study|Physician Decision|2
5715453|NCT00098774|19690014|P1|Overall Study|Failed (to respond) during induction|4
5715454|NCT00098774|19690014|P1|Overall Study|Withdrawal by Subject|1
5715455|NCT00098774|19690014|P1|Overall Study|Disease Progression|9
5715456|NCT00098774|19690014|P1|Overall Study|Adverse Event|2
5715457|NCT00098748|19690024|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
5715458|NCT00098748|19690025|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
5715459|NCT00098748|19690026|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
5715460|NCT00098748|19690024|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
5715461|NCT00098748|19690025|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
5715462|NCT00098748|19690026|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
5715463|NCT00098748|19690024|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
5715464|NCT00098748|19690025|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
5715465|NCT00098748|19690026|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
5715466|NCT00098748|19690024|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
5715467|NCT00098748|19690025|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
5715468|NCT00098748|19690026|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
5715469|NCT00098748|19690024|P3|Continued on Open-Label Treatment|Adverse Event|0
5715470|NCT00098748|19690025|P2|Continued on Open-Label Treatment|Adverse Event|1
5715471|NCT00098748|19690026|P1|Continued on Open-Label Treatment|Adverse Event|0
5715472|NCT00098748|19690024|P3|Received Study Treatment|Subject defaulted|4
5715473|NCT00098748|19690025|P2|Received Study Treatment|Subject defaulted|4
5715474|NCT00098748|19690026|P1|Received Study Treatment|Subject defaulted|3
5715475|NCT00098748|19690024|P3|Received Study Treatment|Other|6
5715476|NCT00098748|19690025|P2|Received Study Treatment|Other|2
5715477|NCT00098748|19690026|P1|Received Study Treatment|Other|2
5715478|NCT00098748|19690024|P3|Received Study Treatment|Lack of Efficacy|27
5715479|NCT00098748|19690025|P2|Received Study Treatment|Lack of Efficacy|27
5715480|NCT00098748|19690026|P1|Received Study Treatment|Lack of Efficacy|40
5715481|NCT00098748|19690024|P3|Received Study Treatment|Adverse Event|5
5715482|NCT00098748|19690025|P2|Received Study Treatment|Adverse Event|2
5715483|NCT00098748|19690026|P1|Received Study Treatment|Adverse Event|1
5715484|NCT00098748|19690024|P3|Received Study Treatment|Death|2
5715485|NCT00098748|19690025|P2|Received Study Treatment|Death|1
5715486|NCT00098748|19690026|P1|Received Study Treatment|Death|2
5715487|NCT00098748|19690024|P3|Assigned to Study Treatment|Randomized, but not treated|2
5715488|NCT00098748|19690025|P2|Assigned to Study Treatment|Randomized, but not treated|2
5715489|NCT00098748|19690026|P1|Assigned to Study Treatment|Randomized, but not treated|0
5715490|NCT00098722|19690082|P7|Observation Phase|Other|10
5715491|NCT00098722|19690083|P6|Observation Phase|Other|21
5715492|NCT00098722|19690084|P5|Observation Phase|Other|0
5715493|NCT00098722|19690085|P4|Observation Phase|Other|0
5715494|NCT00098722|19690086|P3|Observation Phase|Other|0
5715495|NCT00098722|19690087|P2|Observation Phase|Other|0
5715496|NCT00098722|19690088|P1|Observation Phase|Other|0
5715497|NCT00098722|19690082|P7|Observation Phase|Participant defaulted|4
5715498|NCT00098722|19690083|P6|Observation Phase|Participant defaulted|17
5715499|NCT00098722|19690084|P5|Observation Phase|Participant defaulted|0
5715500|NCT00098722|19690085|P4|Observation Phase|Participant defaulted|0
5715501|NCT00098722|19690086|P3|Observation Phase|Participant defaulted|0
5715502|NCT00098722|19690087|P2|Observation Phase|Participant defaulted|0
5715503|NCT00098722|19690088|P1|Observation Phase|Participant defaulted|0
5715504|NCT00098722|19690082|P7|Observation Phase|Lack of Efficacy|0
5715505|NCT00098722|19690083|P6|Observation Phase|Lack of Efficacy|2
5715506|NCT00098722|19690084|P5|Observation Phase|Lack of Efficacy|0
5715507|NCT00098722|19690085|P4|Observation Phase|Lack of Efficacy|0
5715508|NCT00098722|19690086|P3|Observation Phase|Lack of Efficacy|0
5715509|NCT00098722|19690087|P2|Observation Phase|Lack of Efficacy|0
5715510|NCT00098722|19690088|P1|Observation Phase|Lack of Efficacy|0
5715511|NCT00098722|19690082|P7|Observation Phase|Death|3
5715512|NCT00098722|19690083|P6|Observation Phase|Death|5
5715513|NCT00098722|19690084|P5|Observation Phase|Death|0
5715514|NCT00098722|19690085|P4|Observation Phase|Death|0
5715515|NCT00098722|19690086|P3|Observation Phase|Death|0
5715516|NCT00098722|19690087|P2|Observation Phase|Death|0
5715517|NCT00098722|19690088|P1|Observation Phase|Death|0
5715518|NCT00098722|19690082|P7|Open Label Phase|Other|0
5715519|NCT00098722|19690083|P6|Open Label Phase|Other|0
5715520|NCT00098722|19690084|P5|Open Label Phase|Other|0
5715521|NCT00098722|19690085|P4|Open Label Phase|Other|18
5715522|NCT00098722|19690086|P3|Open Label Phase|Other|0
5715523|NCT00098722|19690087|P2|Open Label Phase|Other|0
5715524|NCT00098722|19690088|P1|Open Label Phase|Other|0
5715525|NCT00098722|19690082|P7|Open Label Phase|Ongoing at cut-off date|0
5715526|NCT00098722|19690083|P6|Open Label Phase|Ongoing at cut-off date|0
5715527|NCT00098722|19690084|P5|Open Label Phase|Ongoing at cut-off date|50
5715528|NCT00098722|19690085|P4|Open Label Phase|Ongoing at cut-off date|220
5715529|NCT00098722|19690086|P3|Open Label Phase|Ongoing at cut-off date|0
5715530|NCT00098722|19690087|P2|Open Label Phase|Ongoing at cut-off date|0
5715531|NCT00098722|19690088|P1|Open Label Phase|Ongoing at cut-off date|0
5715532|NCT00098722|19690082|P7|Open Label Phase|Participant defaulted|0
5715533|NCT00098722|19690083|P6|Open Label Phase|Participant defaulted|0
5715534|NCT00098722|19690084|P5|Open Label Phase|Participant defaulted|0
5715535|NCT00098722|19690085|P4|Open Label Phase|Participant defaulted|18
5715536|NCT00098722|19690086|P3|Open Label Phase|Participant defaulted|0
5715537|NCT00098722|19690087|P2|Open Label Phase|Participant defaulted|0
5715538|NCT00098722|19690088|P1|Open Label Phase|Participant defaulted|0
5715539|NCT00098722|19690082|P7|Open Label Phase|Pregnancy|0
5715540|NCT00098722|19690083|P6|Open Label Phase|Pregnancy|0
5715541|NCT00098722|19690084|P5|Open Label Phase|Pregnancy|0
5715542|NCT00098722|19690085|P4|Open Label Phase|Pregnancy|1
5715543|NCT00098722|19690086|P3|Open Label Phase|Pregnancy|0
5715544|NCT00098722|19690087|P2|Open Label Phase|Pregnancy|0
5715545|NCT00098722|19690088|P1|Open Label Phase|Pregnancy|0
5715546|NCT00098722|19690082|P7|Open Label Phase|Lack of Efficacy|0
5715547|NCT00098722|19690083|P6|Open Label Phase|Lack of Efficacy|0
5715548|NCT00098722|19690084|P5|Open Label Phase|Lack of Efficacy|0
5715549|NCT00098722|19690085|P4|Open Label Phase|Lack of Efficacy|8
5715550|NCT00098722|19690086|P3|Open Label Phase|Lack of Efficacy|0
5715551|NCT00098722|19690087|P2|Open Label Phase|Lack of Efficacy|0
5715552|NCT00098722|19690088|P1|Open Label Phase|Lack of Efficacy|0
5715553|NCT00098722|19690082|P7|Open Label Phase|Death|0
5715554|NCT00098722|19690083|P6|Open Label Phase|Death|0
5715555|NCT00098722|19690084|P5|Open Label Phase|Death|0
5715556|NCT00098722|19690085|P4|Open Label Phase|Death|2
5715557|NCT00098722|19690086|P3|Open Label Phase|Death|0
5715558|NCT00098722|19690087|P2|Open Label Phase|Death|0
5715559|NCT00098722|19690088|P1|Open Label Phase|Death|0
5715560|NCT00098722|19690082|P7|Open Label Phase|Adverse Event|0
5715561|NCT00098722|19690083|P6|Open Label Phase|Adverse Event|0
5715562|NCT00098722|19690084|P5|Open Label Phase|Adverse Event|0
5715563|NCT00098722|19690085|P4|Open Label Phase|Adverse Event|5
5715564|NCT00098722|19690086|P3|Open Label Phase|Adverse Event|0
5715565|NCT00098722|19690087|P2|Open Label Phase|Adverse Event|0
5715566|NCT00098722|19690088|P1|Open Label Phase|Adverse Event|0
5715567|NCT00098722|19690082|P7|Double Blind Phase|Other|0
5715568|NCT00098722|19690083|P6|Double Blind Phase|Other|0
5715569|NCT00098722|19690084|P5|Double Blind Phase|Other|0
5715570|NCT00098722|19690085|P4|Double Blind Phase|Other|0
5715571|NCT00098722|19690086|P3|Double Blind Phase|Other|7
5715572|NCT00098722|19690087|P2|Double Blind Phase|Other|8
5715573|NCT00098722|19690088|P1|Double Blind Phase|Other|7
5715574|NCT00098722|19690082|P7|Double Blind Phase|Ongoing at cut-off date|0
5715575|NCT00098722|19690083|P6|Double Blind Phase|Ongoing at cut-off date|0
5715576|NCT00098722|19690084|P5|Double Blind Phase|Ongoing at cut-off date|0
5715577|NCT00098722|19690085|P4|Double Blind Phase|Ongoing at cut-off date|0
5715578|NCT00098722|19690086|P3|Double Blind Phase|Ongoing at cut-off date|57
5715579|NCT00098722|19690087|P2|Double Blind Phase|Ongoing at cut-off date|137
5715580|NCT00098722|19690088|P1|Double Blind Phase|Ongoing at cut-off date|128
5715581|NCT00098722|19690082|P7|Double Blind Phase|Randomized, not treated|0
5715582|NCT00098722|19690083|P6|Double Blind Phase|Randomized, not treated|0
5715583|NCT00098722|19690084|P5|Double Blind Phase|Randomized, not treated|0
5715584|NCT00098722|19690085|P4|Double Blind Phase|Randomized, not treated|0
5715585|NCT00098722|19690086|P3|Double Blind Phase|Randomized, not treated|3
5715586|NCT00098722|19690087|P2|Double Blind Phase|Randomized, not treated|3
5715587|NCT00098722|19690088|P1|Double Blind Phase|Randomized, not treated|4
5715588|NCT00098722|19690082|P7|Double Blind Phase|Pregnancy|0
5715589|NCT00098722|19690083|P6|Double Blind Phase|Pregnancy|0
5715590|NCT00098722|19690084|P5|Double Blind Phase|Pregnancy|0
5715591|NCT00098722|19690085|P4|Double Blind Phase|Pregnancy|0
5715592|NCT00098722|19690086|P3|Double Blind Phase|Pregnancy|0
5715593|NCT00098722|19690087|P2|Double Blind Phase|Pregnancy|0
5715594|NCT00098722|19690088|P1|Double Blind Phase|Pregnancy|1
5715595|NCT00098722|19690082|P7|Double Blind Phase|Participant defaulted|0
5715596|NCT00098722|19690083|P6|Double Blind Phase|Participant defaulted|0
5715597|NCT00098722|19690084|P5|Double Blind Phase|Participant defaulted|0
5715598|NCT00098722|19690085|P4|Double Blind Phase|Participant defaulted|0
5715599|NCT00098722|19690086|P3|Double Blind Phase|Participant defaulted|9
5715600|NCT00098722|19690087|P2|Double Blind Phase|Participant defaulted|11
5715601|NCT00098722|19690088|P1|Double Blind Phase|Participant defaulted|16
5715602|NCT00098722|19690082|P7|Double Blind Phase|Lack of Efficacy|0
5715603|NCT00098722|19690083|P6|Double Blind Phase|Lack of Efficacy|0
5715604|NCT00098722|19690084|P5|Double Blind Phase|Lack of Efficacy|0
5715605|NCT00098722|19690085|P4|Double Blind Phase|Lack of Efficacy|0
5715606|NCT00098722|19690086|P3|Double Blind Phase|Lack of Efficacy|15
5715607|NCT00098722|19690087|P2|Double Blind Phase|Lack of Efficacy|23
5715608|NCT00098722|19690088|P1|Double Blind Phase|Lack of Efficacy|21
5715609|NCT00098722|19690082|P7|Double Blind Phase|Death|0
5715610|NCT00098722|19690083|P6|Double Blind Phase|Death|0
5715611|NCT00098722|19690084|P5|Double Blind Phase|Death|0
5715612|NCT00098722|19690085|P4|Double Blind Phase|Death|0
5715613|NCT00098722|19690086|P3|Double Blind Phase|Death|0
5715614|NCT00098722|19690087|P2|Double Blind Phase|Death|5
5715615|NCT00098722|19690088|P1|Double Blind Phase|Death|2
5715616|NCT00098722|19690082|P7|Double Blind Phase|Adverse Event|0
5715617|NCT00098722|19690083|P6|Double Blind Phase|Adverse Event|0
5715618|NCT00098722|19690084|P5|Double Blind Phase|Adverse Event|0
5715619|NCT00098722|19690085|P4|Double Blind Phase|Adverse Event|0
5715620|NCT00098722|19690086|P3|Double Blind Phase|Adverse Event|3
5715621|NCT00098722|19690087|P2|Double Blind Phase|Adverse Event|7
5715622|NCT00098722|19690088|P1|Double Blind Phase|Adverse Event|7
5715623|NCT00098475|19690162|P4|Step 2|Never started treatment|0
5715624|NCT00098475|19690163|P3|Step 2|Never started treatment|0
5715625|NCT00098475|19690164|P2|Step 2|Never started treatment|1
5715626|NCT00098475|19690165|P1|Step 2|Never started treatment|1
5715627|NCT00098475|19690162|P4|Step 2|Alternative therapy|0
5715628|NCT00098475|19690163|P3|Step 2|Alternative therapy|0
5715629|NCT00098475|19690164|P2|Step 2|Alternative therapy|2
5715630|NCT00098475|19690165|P1|Step 2|Alternative therapy|1
5715631|NCT00098475|19690162|P4|Step 2|Physician Decision|0
5715632|NCT00098475|19690163|P3|Step 2|Physician Decision|0
5715633|NCT00098475|19690164|P2|Step 2|Physician Decision|1
5715634|NCT00098475|19690165|P1|Step 2|Physician Decision|0
5715635|NCT00098475|19690162|P4|Step 2|Withdrawal by Subject|0
5715636|NCT00098475|19690163|P3|Step 2|Withdrawal by Subject|0
5715637|NCT00098475|19690164|P2|Step 2|Withdrawal by Subject|2
5715638|NCT00098475|19690165|P1|Step 2|Withdrawal by Subject|0
5715639|NCT00098475|19690162|P4|Step 2|Adverse Event|0
5715640|NCT00098475|19690163|P3|Step 2|Adverse Event|0
5715641|NCT00098475|19690164|P2|Step 2|Adverse Event|0
5715642|NCT00098475|19690165|P1|Step 2|Adverse Event|2
5715643|NCT00098475|19690162|P4|Step 2|Disease progression|0
5715644|NCT00098475|19690163|P3|Step 2|Disease progression|0
5715645|NCT00098475|19690164|P2|Step 2|Disease progression|4
5715646|NCT00098475|19690165|P1|Step 2|Disease progression|1
5715647|NCT00098475|19690162|P4|Step 1|Not documented|0
5715648|NCT00098475|19690163|P3|Step 1|Not documented|0
5715649|NCT00098475|19690164|P2|Step 1|Not documented|1
5715650|NCT00098475|19690165|P1|Step 1|Not documented|0
5715651|NCT00098475|19690162|P4|Step 1|Patient fell with fracture|0
5715652|NCT00098475|19690163|P3|Step 1|Patient fell with fracture|0
5715653|NCT00098475|19690164|P2|Step 1|Patient fell with fracture|0
5715654|NCT00098475|19690165|P1|Step 1|Patient fell with fracture|1
5715655|NCT00098475|19690162|P4|Step 1|Misinterpretation of lab data|0
5715656|NCT00098475|19690163|P3|Step 1|Misinterpretation of lab data|0
5715657|NCT00098475|19690164|P2|Step 1|Misinterpretation of lab data|1
5715658|NCT00098475|19690165|P1|Step 1|Misinterpretation of lab data|0
5715659|NCT00098475|19690162|P4|Step 1|Criteria to continue treatment not met|0
5715660|NCT00098475|19690163|P3|Step 1|Criteria to continue treatment not met|0
5715661|NCT00098475|19690164|P2|Step 1|Criteria to continue treatment not met|1
5715662|NCT00098475|19690165|P1|Step 1|Criteria to continue treatment not met|0
5715663|NCT00098475|19690162|P4|Step 1|Referred to other physicians|0
5715664|NCT00098475|19690163|P3|Step 1|Referred to other physicians|0
5715665|NCT00098475|19690164|P2|Step 1|Referred to other physicians|1
5715666|NCT00098475|19690165|P1|Step 1|Referred to other physicians|0
5715667|NCT00098475|19690162|P4|Step 1|Rising paraprotein|0
5715668|NCT00098475|19690163|P3|Step 1|Rising paraprotein|0
5715669|NCT00098475|19690164|P2|Step 1|Rising paraprotein|1
5715670|NCT00098475|19690165|P1|Step 1|Rising paraprotein|0
5715671|NCT00098475|19690162|P4|Step 1|Insurance issue|0
5715672|NCT00098475|19690163|P3|Step 1|Insurance issue|0
5715673|NCT00098475|19690164|P2|Step 1|Insurance issue|1
5715674|NCT00098475|19690165|P1|Step 1|Insurance issue|0
5715675|NCT00098475|19690162|P4|Step 1|Declining performance status|0
5715676|NCT00098475|19690163|P3|Step 1|Declining performance status|0
5715677|NCT00098475|19690164|P2|Step 1|Declining performance status|1
5715678|NCT00098475|19690165|P1|Step 1|Declining performance status|0
5715679|NCT00098475|19690162|P4|Step 1|Off treatment for > specified timeframe|0
5715680|NCT00098475|19690163|P3|Step 1|Off treatment for > specified timeframe|0
5715681|NCT00098475|19690164|P2|Step 1|Off treatment for > specified timeframe|1
5715682|NCT00098475|19690165|P1|Step 1|Off treatment for > specified timeframe|1
5715683|NCT00098475|19690162|P4|Step 1|Incorrect disease assessment|0
5715684|NCT00098475|19690163|P3|Step 1|Incorrect disease assessment|0
5715685|NCT00098475|19690164|P2|Step 1|Incorrect disease assessment|0
5715686|NCT00098475|19690165|P1|Step 1|Incorrect disease assessment|2
5715687|NCT00098475|19690162|P4|Step 1|Both patient and physician's decision|0
5715688|NCT00098475|19690163|P3|Step 1|Both patient and physician's decision|0
5715689|NCT00098475|19690164|P2|Step 1|Both patient and physician's decision|1
5715690|NCT00098475|19690165|P1|Step 1|Both patient and physician's decision|2
5715691|NCT00098475|19690162|P4|Step 1|Cannot comply due to other tx|0
5715692|NCT00098475|19690163|P3|Step 1|Cannot comply due to other tx|0
5715693|NCT00098475|19690164|P2|Step 1|Cannot comply due to other tx|1
5715694|NCT00098475|19690165|P1|Step 1|Cannot comply due to other tx|0
5715695|NCT00098475|19690162|P4|Step 1|Complications|0
5715696|NCT00098475|19690163|P3|Step 1|Complications|0
5715697|NCT00098475|19690164|P2|Step 1|Complications|0
5715698|NCT00098475|19690165|P1|Step 1|Complications|1
5715699|NCT00098475|19690162|P4|Step 1|Knee surgery|0
5715700|NCT00098475|19690163|P3|Step 1|Knee surgery|0
5715701|NCT00098475|19690164|P2|Step 1|Knee surgery|0
5715702|NCT00098475|19690165|P1|Step 1|Knee surgery|1
5715703|NCT00098475|19690162|P4|Step 1|Still on treatment as of this analysis|0
5715704|NCT00098475|19690163|P3|Step 1|Still on treatment as of this analysis|0
5715705|NCT00098475|19690164|P2|Step 1|Still on treatment as of this analysis|27
5715706|NCT00098475|19690165|P1|Step 1|Still on treatment as of this analysis|14
5715707|NCT00098475|19690162|P4|Step 1|Never started treatment|0
5715708|NCT00098475|19690163|P3|Step 1|Never started treatment|0
5715709|NCT00098475|19690164|P2|Step 1|Never started treatment|2
5715710|NCT00098475|19690165|P1|Step 1|Never started treatment|0
5715711|NCT00098475|19690162|P4|Step 1|Other disease|0
5715712|NCT00098475|19690163|P3|Step 1|Other disease|1
5715713|NCT00098475|19690164|P2|Step 1|Other disease|1
5715714|NCT00098475|19690165|P1|Step 1|Other disease|2
5715715|NCT00098475|19690162|P4|Step 1|Alternative therapy|0
5715716|NCT00098475|19690163|P3|Step 1|Alternative therapy|1
5715717|NCT00098475|19690164|P2|Step 1|Alternative therapy|43
5715718|NCT00098475|19690165|P1|Step 1|Alternative therapy|31
5715719|NCT00098475|19690162|P4|Step 1|Physician Decision|0
5715720|NCT00098475|19690163|P3|Step 1|Physician Decision|0
5715721|NCT00098475|19690164|P2|Step 1|Physician Decision|2
5715722|NCT00098475|19690165|P1|Step 1|Physician Decision|5
5715723|NCT00098475|19690162|P4|Step 1|Withdrawal by Subject|0
5715724|NCT00098475|19690163|P3|Step 1|Withdrawal by Subject|0
5715725|NCT00098475|19690164|P2|Step 1|Withdrawal by Subject|11
5715726|NCT00098475|19690165|P1|Step 1|Withdrawal by Subject|14
5715727|NCT00098475|19690162|P4|Step 1|Death|1
5715728|NCT00098475|19690163|P3|Step 1|Death|0
5715729|NCT00098475|19690164|P2|Step 1|Death|5
5715730|NCT00098475|19690165|P1|Step 1|Death|8
5715731|NCT00098475|19690162|P4|Step 1|Adverse Event|1
5715732|NCT00098475|19690163|P3|Step 1|Adverse Event|0
5715733|NCT00098475|19690164|P2|Step 1|Adverse Event|37
5715734|NCT00098475|19690165|P1|Step 1|Adverse Event|56
5715735|NCT00098475|19690162|P4|Step 1|Progressive disease|1
5715736|NCT00098475|19690163|P3|Step 1|Progressive disease|2
5715737|NCT00098475|19690164|P2|Step 1|Progressive disease|35
5715738|NCT00098475|19690165|P1|Step 1|Progressive disease|33
5715739|NCT00098345|19690202|P1|Overall Study|progression|4
5715740|NCT00098345|19690202|P1|Overall Study|Withdrawal by Subject|2
5715741|NCT00098345|19690202|P1|Overall Study|Adverse Event|7
5715742|NCT00098306|19690215|P7|Observational Phase|Un-specified|4
5715743|NCT00098306|19690216|P6|Observational Phase|Un-specified|7
5715744|NCT00098306|19690217|P5|Observational Phase|Un-specified|0
5715745|NCT00098306|19690218|P4|Observational Phase|Un-specified|0
5715746|NCT00098306|19690219|P3|Observational Phase|Un-specified|0
5715747|NCT00098306|19690220|P2|Observational Phase|Un-specified|0
5715748|NCT00098306|19690221|P1|Observational Phase|Un-specified|0
5715749|NCT00098306|19690215|P7|Observational Phase|Participant defaulted|18
5715750|NCT00098306|19690216|P6|Observational Phase|Participant defaulted|34
5715751|NCT00098306|19690217|P5|Observational Phase|Participant defaulted|0
5715752|NCT00098306|19690218|P4|Observational Phase|Participant defaulted|0
5715753|NCT00098306|19690219|P3|Observational Phase|Participant defaulted|0
5715754|NCT00098306|19690220|P2|Observational Phase|Participant defaulted|0
5715755|NCT00098306|19690221|P1|Observational Phase|Participant defaulted|0
5715756|NCT00098306|19690215|P7|Observational Phase|Death|4
5715757|NCT00098306|19690216|P6|Observational Phase|Death|5
5715758|NCT00098306|19690217|P5|Observational Phase|Death|0
5715759|NCT00098306|19690218|P4|Observational Phase|Death|0
5715760|NCT00098306|19690219|P3|Observational Phase|Death|0
5715761|NCT00098306|19690220|P2|Observational Phase|Death|0
5715762|NCT00098306|19690221|P1|Observational Phase|Death|0
5715763|NCT00098306|19690215|P7|Open Label|Ongoing at cut-off date|0
5715764|NCT00098306|19690216|P6|Open Label|Ongoing at cut-off date|0
5715765|NCT00098306|19690217|P5|Open Label|Ongoing at cut-off date|62
5715766|NCT00098306|19690218|P4|Open Label|Ongoing at cut-off date|269
5715767|NCT00098306|19690219|P3|Open Label|Ongoing at cut-off date|0
5715768|NCT00098306|19690220|P2|Open Label|Ongoing at cut-off date|0
5715769|NCT00098306|19690221|P1|Open Label|Ongoing at cut-off date|0
5715770|NCT00098306|19690215|P7|Open Label|Un-specified|0
5715771|NCT00098306|19690216|P6|Open Label|Un-specified|0
5715772|NCT00098306|19690217|P5|Open Label|Un-specified|0
5715773|NCT00098306|19690218|P4|Open Label|Un-specified|15
5715774|NCT00098306|19690219|P3|Open Label|Un-specified|0
5715775|NCT00098306|19690220|P2|Open Label|Un-specified|0
5715776|NCT00098306|19690221|P1|Open Label|Un-specified|0
5715777|NCT00098306|19690215|P7|Open Label|Participant defaulted|0
5715778|NCT00098306|19690216|P6|Open Label|Participant defaulted|0
5715779|NCT00098306|19690217|P5|Open Label|Participant defaulted|0
5715780|NCT00098306|19690218|P4|Open Label|Participant defaulted|24
5715781|NCT00098306|19690219|P3|Open Label|Participant defaulted|0
5715782|NCT00098306|19690220|P2|Open Label|Participant defaulted|0
5715783|NCT00098306|19690221|P1|Open Label|Participant defaulted|0
5715784|NCT00098306|19690215|P7|Open Label|Death|0
5715785|NCT00098306|19690216|P6|Open Label|Death|0
5715786|NCT00098306|19690217|P5|Open Label|Death|0
5715787|NCT00098306|19690218|P4|Open Label|Death|4
5715788|NCT00098306|19690219|P3|Open Label|Death|0
5715789|NCT00098306|19690220|P2|Open Label|Death|0
5715790|NCT00098306|19690221|P1|Open Label|Death|0
5715791|NCT00098306|19690215|P7|Open Label|Adverse Event|0
5715792|NCT00098306|19690216|P6|Open Label|Adverse Event|0
5715793|NCT00098306|19690217|P5|Open Label|Adverse Event|0
5715794|NCT00098306|19690218|P4|Open Label|Adverse Event|2
5715795|NCT00098306|19690219|P3|Open Label|Adverse Event|0
5715796|NCT00098306|19690220|P2|Open Label|Adverse Event|0
5715797|NCT00098306|19690221|P1|Open Label|Adverse Event|0
5715798|NCT00098306|19690215|P7|Open Label|Lack of Efficacy|0
5715799|NCT00098306|19690216|P6|Open Label|Lack of Efficacy|0
5715800|NCT00098306|19690217|P5|Open Label|Lack of Efficacy|0
5715801|NCT00098306|19690218|P4|Open Label|Lack of Efficacy|13
5715802|NCT00098306|19690219|P3|Open Label|Lack of Efficacy|0
5715803|NCT00098306|19690220|P2|Open Label|Lack of Efficacy|0
5715804|NCT00098306|19690221|P1|Open Label|Lack of Efficacy|0
5715805|NCT00098306|19690215|P7|Double Blind|Un-specified|0
5715806|NCT00098306|19690216|P6|Double Blind|Un-specified|0
5715807|NCT00098306|19690217|P5|Double Blind|Un-specified|0
5715808|NCT00098306|19690218|P4|Double Blind|Un-specified|0
5715809|NCT00098306|19690219|P3|Double Blind|Un-specified|11
5715810|NCT00098306|19690220|P2|Double Blind|Un-specified|3
5715811|NCT00098306|19690221|P1|Double Blind|Un-specified|7
5715812|NCT00098306|19690215|P7|Double Blind|Participant defaulted|0
5715813|NCT00098306|19690216|P6|Double Blind|Participant defaulted|0
5715814|NCT00098306|19690217|P5|Double Blind|Participant defaulted|0
5715815|NCT00098306|19690218|P4|Double Blind|Participant defaulted|0
5715816|NCT00098306|19690219|P3|Double Blind|Participant defaulted|11
5715817|NCT00098306|19690220|P2|Double Blind|Participant defaulted|18
5715818|NCT00098306|19690221|P1|Double Blind|Participant defaulted|19
5715819|NCT00098306|19690215|P7|Double Blind|Death|0
5715820|NCT00098306|19690216|P6|Double Blind|Death|0
5715821|NCT00098306|19690217|P5|Double Blind|Death|0
5715822|NCT00098306|19690218|P4|Double Blind|Death|0
5715823|NCT00098306|19690219|P3|Double Blind|Death|1
5715824|NCT00098306|19690220|P2|Double Blind|Death|4
5715825|NCT00098306|19690221|P1|Double Blind|Death|1
5715826|NCT00098306|19690215|P7|Double Blind|Lack of Efficacy|0
5715827|NCT00098306|19690216|P6|Double Blind|Lack of Efficacy|0
5715828|NCT00098306|19690217|P5|Double Blind|Lack of Efficacy|0
5715829|NCT00098306|19690218|P4|Double Blind|Lack of Efficacy|0
5715830|NCT00098306|19690219|P3|Double Blind|Lack of Efficacy|17
5715831|NCT00098306|19690220|P2|Double Blind|Lack of Efficacy|34
5715832|NCT00098306|19690221|P1|Double Blind|Lack of Efficacy|43
5715833|NCT00098306|19690215|P7|Double Blind|Adverse Event|0
5715834|NCT00098306|19690216|P6|Double Blind|Adverse Event|0
5715835|NCT00098306|19690217|P5|Double Blind|Adverse Event|0
5715836|NCT00098306|19690218|P4|Double Blind|Adverse Event|0
5715837|NCT00098306|19690219|P3|Double Blind|Adverse Event|6
5715838|NCT00098306|19690220|P2|Double Blind|Adverse Event|10
5715839|NCT00098306|19690221|P1|Double Blind|Adverse Event|11
5715840|NCT00098306|19690215|P7|Double Blind|Ongoing at cut-off date|0
5715841|NCT00098306|19690216|P6|Double Blind|Ongoing at cut-off date|0
5715842|NCT00098306|19690217|P5|Double Blind|Ongoing at cut-off date|0
5715843|NCT00098306|19690218|P4|Double Blind|Ongoing at cut-off date|0
5715844|NCT00098306|19690219|P3|Double Blind|Ongoing at cut-off date|72
5715845|NCT00098306|19690220|P2|Double Blind|Ongoing at cut-off date|166
5715846|NCT00098306|19690221|P1|Double Blind|Ongoing at cut-off date|151
5715847|NCT00098306|19690215|P7|Double Blind|Randomized, not treated|0
5715848|NCT00098306|19690216|P6|Double Blind|Randomized, not treated|0
5715849|NCT00098306|19690217|P5|Double Blind|Randomized, not treated|0
5715850|NCT00098306|19690218|P4|Double Blind|Randomized, not treated|0
5715851|NCT00098306|19690219|P3|Double Blind|Randomized, not treated|2
5715852|NCT00098306|19690220|P2|Double Blind|Randomized, not treated|5
5715853|NCT00098306|19690221|P1|Double Blind|Randomized, not treated|9
5715854|NCT00098293|19690287|P5|Supplemental Phase (SP)|Other|22
5715855|NCT00098293|19690288|P4|Supplemental Phase (SP)|Other|0
5715856|NCT00098293|19690289|P3|Supplemental Phase (SP)|Other|0
5715857|NCT00098293|19690290|P2|Supplemental Phase (SP)|Other|0
5715858|NCT00098293|19690291|P1|Supplemental Phase (SP)|Other|0
5715859|NCT00098293|19690287|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
5715860|NCT00098293|19690288|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
5715861|NCT00098293|19690289|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
5715862|NCT00098293|19690290|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
5715863|NCT00098293|19690291|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
5715864|NCT00098293|19690287|P5|Supplemental Phase (SP)|Lost to Follow-up|2
5715865|NCT00098293|19690288|P4|Supplemental Phase (SP)|Lost to Follow-up|0
5715866|NCT00098293|19690289|P3|Supplemental Phase (SP)|Lost to Follow-up|0
5715867|NCT00098293|19690290|P2|Supplemental Phase (SP)|Lost to Follow-up|0
5715868|NCT00098293|19690291|P1|Supplemental Phase (SP)|Lost to Follow-up|0
5715869|NCT00098293|19690287|P5|Supplemental Phase (SP)|Death|1
5715870|NCT00098293|19690288|P4|Supplemental Phase (SP)|Death|0
5715871|NCT00098293|19690289|P3|Supplemental Phase (SP)|Death|0
5715872|NCT00098293|19690290|P2|Supplemental Phase (SP)|Death|0
5715873|NCT00098293|19690291|P1|Supplemental Phase (SP)|Death|0
5715874|NCT00098293|19690287|P5|Open-label (OL) Phase|Death|0
5715875|NCT00098293|19690288|P4|Open-label (OL) Phase|Death|0
5715876|NCT00098293|19690289|P3|Open-label (OL) Phase|Death|3
5715877|NCT00098293|19690290|P2|Open-label (OL) Phase|Death|2
5715878|NCT00098293|19690291|P1|Open-label (OL) Phase|Death|0
5715879|NCT00098293|19690287|P5|Open-label (OL) Phase|Participant Defaulted|0
5715880|NCT00098293|19690288|P4|Open-label (OL) Phase|Participant Defaulted|20
5715881|NCT00098293|19690289|P3|Open-label (OL) Phase|Participant Defaulted|16
5715882|NCT00098293|19690290|P2|Open-label (OL) Phase|Participant Defaulted|6
5715883|NCT00098293|19690291|P1|Open-label (OL) Phase|Participant Defaulted|0
5715884|NCT00098293|19690287|P5|Open-label (OL) Phase|Protocol Violation|0
5715885|NCT00098293|19690288|P4|Open-label (OL) Phase|Protocol Violation|16
5715886|NCT00098293|19690289|P3|Open-label (OL) Phase|Protocol Violation|13
5715887|NCT00098293|19690290|P2|Open-label (OL) Phase|Protocol Violation|6
5715888|NCT00098293|19690291|P1|Open-label (OL) Phase|Protocol Violation|0
5715889|NCT00098293|19690287|P5|Open-label (OL) Phase|Pregnancy|0
5715890|NCT00098293|19690288|P4|Open-label (OL) Phase|Pregnancy|3
5715891|NCT00098293|19690289|P3|Open-label (OL) Phase|Pregnancy|0
5715892|NCT00098293|19690290|P2|Open-label (OL) Phase|Pregnancy|1
5715893|NCT00098293|19690291|P1|Open-label (OL) Phase|Pregnancy|0
5715894|NCT00098293|19690287|P5|Open-label (OL) Phase|Lack of Efficacy|0
5715895|NCT00098293|19690288|P4|Open-label (OL) Phase|Lack of Efficacy|20
5715896|NCT00098293|19690289|P3|Open-label (OL) Phase|Lack of Efficacy|2
5715897|NCT00098293|19690290|P2|Open-label (OL) Phase|Lack of Efficacy|7
5715898|NCT00098293|19690291|P1|Open-label (OL) Phase|Lack of Efficacy|0
5715899|NCT00098293|19690287|P5|Open-label (OL) Phase|Adverse Event|0
5715900|NCT00098293|19690288|P4|Open-label (OL) Phase|Adverse Event|6
5715901|NCT00098293|19690289|P3|Open-label (OL) Phase|Adverse Event|7
5715902|NCT00098293|19690290|P2|Open-label (OL) Phase|Adverse Event|3
5715903|NCT00098293|19690291|P1|Open-label (OL) Phase|Adverse Event|0
5715904|NCT00098293|19690287|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
5715905|NCT00098293|19690288|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
5715906|NCT00098293|19690289|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
5715907|NCT00098293|19690290|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
5715908|NCT00098293|19690291|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
5715909|NCT00098293|19690287|P5|Double-blind (DB) Phase|Terminated by sponsor|0
5715910|NCT00098293|19690288|P4|Double-blind (DB) Phase|Terminated by sponsor|0
5715911|NCT00098293|19690289|P3|Double-blind (DB) Phase|Terminated by sponsor|0
5715912|NCT00098293|19690290|P2|Double-blind (DB) Phase|Terminated by sponsor|0
5715913|NCT00098293|19690291|P1|Double-blind (DB) Phase|Terminated by sponsor|135
5715914|NCT00098293|19690287|P5|Double-blind (DB) Phase|Protocol Violation|0
5715915|NCT00098293|19690288|P4|Double-blind (DB) Phase|Protocol Violation|0
5715916|NCT00098293|19690289|P3|Double-blind (DB) Phase|Protocol Violation|22
5715917|NCT00098293|19690290|P2|Double-blind (DB) Phase|Protocol Violation|18
5715918|NCT00098293|19690291|P1|Double-blind (DB) Phase|Protocol Violation|2
5715919|NCT00098293|19690287|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
5715920|NCT00098293|19690288|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
5715921|NCT00098293|19690289|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
5715922|NCT00098293|19690290|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
5715923|NCT00098293|19690291|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
5715924|NCT00098293|19690287|P5|Double-blind (DB) Phase|Death|0
5715925|NCT00098293|19690288|P4|Double-blind (DB) Phase|Death|0
5715926|NCT00098293|19690289|P3|Double-blind (DB) Phase|Death|2
5715927|NCT00098293|19690290|P2|Double-blind (DB) Phase|Death|2
5715928|NCT00098293|19690291|P1|Double-blind (DB) Phase|Death|1
5715929|NCT00098293|19690287|P5|Double-blind (DB) Phase|Lack of Efficacy|0
5715930|NCT00098293|19690288|P4|Double-blind (DB) Phase|Lack of Efficacy|0
5715931|NCT00098293|19690289|P3|Double-blind (DB) Phase|Lack of Efficacy|30
5715932|NCT00098293|19690290|P2|Double-blind (DB) Phase|Lack of Efficacy|64
5715933|NCT00098293|19690291|P1|Double-blind (DB) Phase|Lack of Efficacy|11
5715934|NCT00098293|19690287|P5|Double-blind (DB) Phase|Participant Defaulted|0
5715935|NCT00098293|19690288|P4|Double-blind (DB) Phase|Participant Defaulted|0
5715936|NCT00098293|19690289|P3|Double-blind (DB) Phase|Participant Defaulted|36
5715937|NCT00098293|19690290|P2|Double-blind (DB) Phase|Participant Defaulted|40
5715938|NCT00098293|19690291|P1|Double-blind (DB) Phase|Participant Defaulted|11
5715939|NCT00098293|19690287|P5|Double-blind (DB) Phase|Pregnancy|0
5715940|NCT00098293|19690288|P4|Double-blind (DB) Phase|Pregnancy|0
5715941|NCT00098293|19690289|P3|Double-blind (DB) Phase|Pregnancy|9
5715942|NCT00098293|19690290|P2|Double-blind (DB) Phase|Pregnancy|7
5715943|NCT00098293|19690291|P1|Double-blind (DB) Phase|Pregnancy|0
5715944|NCT00098293|19690287|P5|Double-blind (DB) Phase|Adverse Event|0
5715945|NCT00098293|19690288|P4|Double-blind (DB) Phase|Adverse Event|0
5715946|NCT00098293|19690289|P3|Double-blind (DB) Phase|Adverse Event|60
5715947|NCT00098293|19690290|P2|Double-blind (DB) Phase|Adverse Event|27
5715948|NCT00098293|19690291|P1|Double-blind (DB) Phase|Adverse Event|14
5715949|NCT00098254|19690344|P1|Overall Study|Death|1
5715950|NCT00098254|19690344|P1|Overall Study|Adverse Event|2
5715951|NCT00098020|19690410|P1|Overall Study|Low epidermal growth factor receptor|1
5715952|NCT00098020|19690410|P1|Overall Study|Low urine PCR|1
5715953|NCT00098020|19690410|P1|Overall Study|elevated liver enzymes|1
5715954|NCT00098020|19690410|P1|Overall Study|Lost to Follow-up|1
5715955|NCT00098020|19690410|P1|Overall Study|Adverse Event|2
5715956|NCT00097981|19690417|P2|Overall Study|Other|13
5715957|NCT00097981|19690418|P1|Overall Study|Other|19
5715958|NCT00097981|19690417|P2|Overall Study|Transplant planned|27
5715959|NCT00097981|19690418|P1|Overall Study|Transplant planned|28
5715960|NCT00097981|19690417|P2|Overall Study|Disease Progression|2
5715961|NCT00097981|19690418|P1|Overall Study|Disease Progression|8
5715962|NCT00097981|19690417|P2|Overall Study|Physician Decision|1
5715963|NCT00097981|19690418|P1|Overall Study|Physician Decision|7
5715964|NCT00097981|19690417|P2|Overall Study|Death|4
5715965|NCT00097981|19690418|P1|Overall Study|Death|2
5715966|NCT00097981|19690417|P2|Overall Study|Protocol Violation|1
5715967|NCT00097981|19690418|P1|Overall Study|Protocol Violation|1
5715968|NCT00097981|19690417|P2|Overall Study|Withdrawal by Subject|8
5715969|NCT00097981|19690418|P1|Overall Study|Withdrawal by Subject|10
5715970|NCT00097981|19690417|P2|Overall Study|Adverse Event|44
5715971|NCT00097981|19690418|P1|Overall Study|Adverse Event|31
5715972|NCT00097786|19690440|P4|Overall Study|lost to follow-up for all-cause death|310
5715973|NCT00097786|19690441|P3|Overall Study|lost to follow-up for all-cause death|313
5715974|NCT00097786|19690442|P2|Overall Study|lost to follow-up for all-cause death|292
5715975|NCT00097786|19690443|P1|Overall Study|lost to follow-up for all-cause death|296
5715976|NCT00097773|19690465|P4|Overall Study|Other|0
5715977|NCT00097773|19690466|P3|Overall Study|Other|2
5715978|NCT00097773|19690467|P2|Overall Study|Other|0
5715979|NCT00097773|19690468|P1|Overall Study|Other|1
5715980|NCT00097773|19690465|P4|Overall Study|Adverse Event|0
5715981|NCT00097773|19690466|P3|Overall Study|Adverse Event|0
5715982|NCT00097773|19690467|P2|Overall Study|Adverse Event|1
5715983|NCT00097773|19690468|P1|Overall Study|Adverse Event|0
5715984|NCT00097773|19690465|P4|Overall Study|Withdrawal by Subject|1
5715985|NCT00097773|19690466|P3|Overall Study|Withdrawal by Subject|3
5715986|NCT00097773|19690467|P2|Overall Study|Withdrawal by Subject|3
5715987|NCT00097773|19690468|P1|Overall Study|Withdrawal by Subject|3
5715988|NCT00097773|19690465|P4|Overall Study|Physician Decision|1
5715989|NCT00097773|19690466|P3|Overall Study|Physician Decision|3
5715990|NCT00097773|19690467|P2|Overall Study|Physician Decision|2
5715991|NCT00097773|19690468|P1|Overall Study|Physician Decision|2
5715992|NCT00097773|19690465|P4|Overall Study|Lost to Follow-up|1
5715993|NCT00097773|19690466|P3|Overall Study|Lost to Follow-up|0
5715994|NCT00097773|19690467|P2|Overall Study|Lost to Follow-up|2
5715995|NCT00097773|19690468|P1|Overall Study|Lost to Follow-up|2
5715996|NCT00097721|19690488|P2|Overall Study|Reason not given|1
5715997|NCT00097721|19690489|P1|Overall Study|Reason not given|1
5715998|NCT00097721|19690488|P2|Overall Study|Physician Decision|3
5715999|NCT00097721|19690489|P1|Overall Study|Physician Decision|1
5716000|NCT00097721|19690488|P2|Overall Study|Progressive Disease|27
5716001|NCT00097721|19690489|P1|Overall Study|Progressive Disease|55
5716002|NCT00097721|19690488|P2|Overall Study|Withdrawal by Subject|1
5716003|NCT00097721|19690489|P1|Overall Study|Withdrawal by Subject|6
5716004|NCT00097721|19690488|P2|Overall Study|Adverse Event|1
5716005|NCT00097721|19690489|P1|Overall Study|Adverse Event|8
5716006|NCT00097591|19690548|P2|Overall Study|Other|3
5716007|NCT00097591|19690549|P1|Overall Study|Other|0
5716008|NCT00097591|19690548|P2|Overall Study|Lost to follow up|10
5716009|NCT00097591|19690549|P1|Overall Study|Lost to follow up|6
5716010|NCT00097591|19690548|P2|Overall Study|Unable to attend termination visit|51
5716011|NCT00097591|19690549|P1|Overall Study|Unable to attend termination visit|53
5716012|NCT00097591|19690548|P2|Overall Study|Less than 6 months on study drug|7
5716013|NCT00097591|19690549|P1|Overall Study|Less than 6 months on study drug|9
5716014|NCT00097591|19690548|P2|Overall Study|Withdrawal of consent|323
5716015|NCT00097591|19690549|P1|Overall Study|Withdrawal of consent|342
5716016|NCT00097539|19690572|P7|Overall Study|Reason not Specified|2
5716017|NCT00097539|19690573|P6|Overall Study|Reason not Specified|40
5716018|NCT00097539|19690574|P5|Overall Study|Reason not Specified|11
5716019|NCT00097539|19690575|P4|Overall Study|Reason not Specified|21
5716020|NCT00097539|19690576|P3|Overall Study|Reason not Specified|53
5716021|NCT00097539|19690577|P2|Overall Study|Reason not Specified|49
5716022|NCT00097539|19690578|P1|Overall Study|Reason not Specified|111
5716023|NCT00097539|19690572|P7|Overall Study|Reasons Other Than Above|34
5716024|NCT00097539|19690573|P6|Overall Study|Reasons Other Than Above|1244
5716025|NCT00097539|19690574|P5|Overall Study|Reasons Other Than Above|361
5716026|NCT00097539|19690575|P4|Overall Study|Reasons Other Than Above|692
5716027|NCT00097539|19690576|P3|Overall Study|Reasons Other Than Above|1757
5716028|NCT00097539|19690577|P2|Overall Study|Reasons Other Than Above|1382
5716029|NCT00097539|19690578|P1|Overall Study|Reasons Other Than Above|3602
5716030|NCT00097539|19690572|P7|Overall Study|Death|0
5716031|NCT00097539|19690573|P6|Overall Study|Death|3
5716032|NCT00097539|19690574|P5|Overall Study|Death|1
5716033|NCT00097539|19690575|P4|Overall Study|Death|0
5716034|NCT00097539|19690576|P3|Overall Study|Death|0
5716035|NCT00097539|19690577|P2|Overall Study|Death|7
5716036|NCT00097539|19690578|P1|Overall Study|Death|2
5716037|NCT00097539|19690572|P7|Overall Study|Adverse Event|1
5716038|NCT00097539|19690573|P6|Overall Study|Adverse Event|59
5716039|NCT00097539|19690574|P5|Overall Study|Adverse Event|30
5716040|NCT00097539|19690575|P4|Overall Study|Adverse Event|27
5716041|NCT00097539|19690576|P3|Overall Study|Adverse Event|37
5716042|NCT00097539|19690577|P2|Overall Study|Adverse Event|133
5716043|NCT00097539|19690578|P1|Overall Study|Adverse Event|78
5716044|NCT00097539|19690572|P7|Overall Study|Lack of Efficacy|5
5716045|NCT00097539|19690573|P6|Overall Study|Lack of Efficacy|228
5716046|NCT00097539|19690574|P5|Overall Study|Lack of Efficacy|45
5716047|NCT00097539|19690575|P4|Overall Study|Lack of Efficacy|105
5716048|NCT00097539|19690576|P3|Overall Study|Lack of Efficacy|202
5716049|NCT00097539|19690577|P2|Overall Study|Lack of Efficacy|122
5716050|NCT00097539|19690578|P1|Overall Study|Lack of Efficacy|249
5716051|NCT00097539|19690572|P7|Overall Study|Participant Non-compliant|18
5716052|NCT00097539|19690573|P6|Overall Study|Participant Non-compliant|543
5716053|NCT00097539|19690574|P5|Overall Study|Participant Non-compliant|136
5716054|NCT00097539|19690575|P4|Overall Study|Participant Non-compliant|353
5716055|NCT00097539|19690576|P3|Overall Study|Participant Non-compliant|1067
5716056|NCT00097539|19690577|P2|Overall Study|Participant Non-compliant|567
5716057|NCT00097539|19690578|P1|Overall Study|Participant Non-compliant|2140
5716058|NCT00097539|19690572|P7|Overall Study|Withdrawal by Subject|3
5716059|NCT00097539|19690573|P6|Overall Study|Withdrawal by Subject|229
5716060|NCT00097539|19690574|P5|Overall Study|Withdrawal by Subject|68
5716061|NCT00097539|19690575|P4|Overall Study|Withdrawal by Subject|217
5716062|NCT00097539|19690576|P3|Overall Study|Withdrawal by Subject|346
5716063|NCT00097539|19690577|P2|Overall Study|Withdrawal by Subject|323
5716064|NCT00097539|19690578|P1|Overall Study|Withdrawal by Subject|925
5716065|NCT00097539|19690572|P7|Overall Study|Status Unknown (Or no final evaluation)|108
5716066|NCT00097539|19690573|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
5716067|NCT00097539|19690574|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
5716068|NCT00097539|19690575|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
5716069|NCT00097539|19690576|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
5716070|NCT00097539|19690577|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
5716071|NCT00097539|19690578|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
5716072|NCT00097500|19690624|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
5716073|NCT00097500|19690625|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
5716074|NCT00097500|19690624|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
5716075|NCT00097500|19690625|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
5716076|NCT00097500|19690624|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
5716077|NCT00097500|19690625|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
5716078|NCT00097500|19690624|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
5716079|NCT00097500|19690625|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
5716080|NCT00097500|19690624|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
5716081|NCT00097500|19690625|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
5716082|NCT00097500|19690624|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
5716083|NCT00097500|19690625|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
5716084|NCT00097500|19690624|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
5716085|NCT00097500|19690625|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
5716086|NCT00097370|19690656|P1|Stage 3|Lost to Follow-up|1
5716087|NCT00097370|19690656|P1|Stage 3|Sponsor Terminated Study|52
5716088|NCT00097370|19690656|P1|Stage 3|Lack of Efficacy|1
5716089|NCT00097370|19690656|P1|Stage 3|Withdrawal by Subject|3
5716090|NCT00097370|19690656|P1|Stage 3|Adverse Event|2
5716091|NCT00097370|19690656|P1|Stage 2|Lost to Follow-up|1
5716092|NCT00097370|19690656|P1|Stage 2|Sponsor Terminated Study|2
5716093|NCT00097370|19690656|P1|Stage 2|Pregnancy|1
5716094|NCT00097370|19690656|P1|Stage 2|Lack of Efficacy|3
5716095|NCT00097370|19690656|P1|Stage 2|Withdrawal by Subject|1
5716096|NCT00097370|19690656|P1|Stage 2|Adverse Event|5
5716097|NCT00097370|19690656|P1|Stage 1|Lack of Efficacy|2
5716098|NCT00097370|19690656|P1|Stage 1|Withdrawal by Subject|1
5716099|NCT00097370|19690656|P1|Stage 1|Adverse Event|3
5716100|NCT00096993|19690690|P2|Overall Study|Other unspecified|1
5716101|NCT00096993|19690691|P1|Overall Study|Other unspecified|1
5716102|NCT00096993|19690690|P2|Overall Study|Non-compliance|1
5716103|NCT00096993|19690691|P1|Overall Study|Non-compliance|0
5716104|NCT00096993|19690690|P2|Overall Study|Physician Decision|1
5716105|NCT00096993|19690691|P1|Overall Study|Physician Decision|2
5716106|NCT00096993|19690690|P2|Overall Study|Subject's decision|1
5716107|NCT00096993|19690691|P1|Overall Study|Subject's decision|3
5716108|NCT00096993|19690690|P2|Overall Study|Adverse Event|8
5716109|NCT00096993|19690691|P1|Overall Study|Adverse Event|2
5716110|NCT00096993|19690690|P2|Overall Study|Disease progression|53
5716111|NCT00096993|19690691|P1|Overall Study|Disease progression|56
5716112|NCT00096993|19690690|P2|Overall Study|Death|0
5716113|NCT00096993|19690691|P1|Overall Study|Death|1
5716114|NCT00096954|19690707|P2|Overall Study|Lost to Follow-up|5
5716115|NCT00096954|19690708|P1|Overall Study|Lost to Follow-up|8
5716116|NCT00096954|19690707|P2|Overall Study|Non-compliance|3
5716117|NCT00096954|19690708|P1|Overall Study|Non-compliance|0
5716118|NCT00096954|19690707|P2|Overall Study|Initiation of immunotherapy|0
5716119|NCT00096954|19690708|P1|Overall Study|Initiation of immunotherapy|1
5716120|NCT00096954|19690707|P2|Overall Study|Pregnancy|1
5716121|NCT00096954|19690708|P1|Overall Study|Pregnancy|1
5716122|NCT00096954|19690707|P2|Overall Study|Sponsors Decision|1
5716123|NCT00096954|19690708|P1|Overall Study|Sponsors Decision|1
5716124|NCT00096954|19690707|P2|Overall Study|Physician Decision|1
5716125|NCT00096954|19690708|P1|Overall Study|Physician Decision|1
5716126|NCT00096954|19690707|P2|Overall Study|Withdrawal by Subject|8
5716127|NCT00096954|19690708|P1|Overall Study|Withdrawal by Subject|9
5716128|NCT00096954|19690707|P2|Overall Study|Adverse Event|1
5716129|NCT00096954|19690708|P1|Overall Study|Adverse Event|3
5716130|NCT00096941|19690720|P1|Overall Study|disease progression|3
5716131|NCT00096785|19690727|P2|Overall Study|Relocated|0
5716132|NCT00096785|19690728|P1|Overall Study|Relocated|1
5716133|NCT00096785|19690727|P2|Overall Study|Withdrawal by Subject|1
5716134|NCT00096785|19690728|P1|Overall Study|Withdrawal by Subject|0
5716135|NCT00096785|19690727|P2|Overall Study|Lost to Follow-up|0
5716136|NCT00096785|19690728|P1|Overall Study|Lost to Follow-up|1
5716137|NCT00096538|19690757|P1|Overall Study|Withdrawal by Subject|1
5716138|NCT00096486|19690765|P4|Overall Study|Not Treated|1
5716139|NCT00096486|19690766|P3|Overall Study|Not Treated|1
5716140|NCT00096486|19690767|P2|Overall Study|Not Treated|0
5716141|NCT00096486|19690768|P1|Overall Study|Not Treated|0
5716142|NCT00096486|19690765|P4|Overall Study|Withdrawal by Subject|1
5716143|NCT00096486|19690766|P3|Overall Study|Withdrawal by Subject|1
5716144|NCT00096486|19690767|P2|Overall Study|Withdrawal by Subject|0
5716145|NCT00096486|19690768|P1|Overall Study|Withdrawal by Subject|0
5716146|NCT00096447|19690787|P1|Overall Study|Never treated|1
5716147|NCT00096382|19690803|P2|Overall Study|Death during treatment|0
5716148|NCT00096382|19690804|P1|Overall Study|Death during treatment|1
5716149|NCT00096382|19690803|P2|Overall Study|Not treated|0
5716150|NCT00096382|19690804|P1|Overall Study|Not treated|1
5716151|NCT00096356|19690814|P2|Overall Study|multiple reasons|18
5716152|NCT00096356|19690815|P1|Overall Study|multiple reasons|10
5716153|NCT00096356|19690814|P2|Overall Study|Lack of Efficacy|0
5716154|NCT00096356|19690815|P1|Overall Study|Lack of Efficacy|1
5716155|NCT00096356|19690814|P2|Overall Study|Withdrawal by Subject|23
5716156|NCT00096356|19690815|P1|Overall Study|Withdrawal by Subject|17
5716157|NCT00096356|19690814|P2|Overall Study|Physician Decision|3
5716158|NCT00096356|19690815|P1|Overall Study|Physician Decision|5
5716159|NCT00096356|19690814|P2|Overall Study|Adverse Event|9
5716160|NCT00096356|19690815|P1|Overall Study|Adverse Event|11
5716161|NCT00096278|19690827|P2|Overall Study|Patient not at risk for primary endpoint|2
5716162|NCT00096278|19690828|P1|Overall Study|Patient not at risk for primary endpoint|3
5716163|NCT00096278|19690827|P2|Overall Study|No follow-up data|18
5716164|NCT00096278|19690828|P1|Overall Study|No follow-up data|15
5716165|NCT00096265|19690847|P3|Overall Study|Ineligible|0
5716166|NCT00096265|19690848|P2|Overall Study|Ineligible|0
5716167|NCT00096265|19690849|P1|Overall Study|Ineligible|1
5716168|NCT00096226|19690875|P1|Overall Study|Protocol treatment not started|1
5716169|NCT00096226|19690875|P1|Overall Study|Ineligible|2
5716170|NCT00096200|19690889|P3|Overall Study|Ineligible pathology|0
5716171|NCT00096200|19690890|P2|Overall Study|Ineligible pathology|1
5716172|NCT00096200|19690891|P1|Overall Study|Ineligible pathology|0
5716173|NCT00096200|19690889|P3|Overall Study|Withdrawal by Subject|0
5716174|NCT00096200|19690890|P2|Overall Study|Withdrawal by Subject|2
5716175|NCT00096200|19690891|P1|Overall Study|Withdrawal by Subject|1
5716176|NCT00096200|19690889|P3|Overall Study|Adverse Event|0
5716177|NCT00096200|19690890|P2|Overall Study|Adverse Event|4
5716178|NCT00096200|19690891|P1|Overall Study|Adverse Event|0
5716179|NCT00096174|19690905|P1|Overall Study|other reason|8
5716180|NCT00096174|19690905|P1|Overall Study|Ineligible|6
5716181|NCT00096174|19690905|P1|Overall Study|Not started protocol therapy|3
5716182|NCT00096174|19690905|P1|Overall Study|Withdrawal by Subject|15
5716183|NCT00096174|19690905|P1|Overall Study|Death|6
5716184|NCT00096174|19690905|P1|Overall Study|Adverse Event|15
5716185|NCT00096174|19690905|P1|Overall Study|Lack of Efficacy|9
5716186|NCT00096135|19690950|P2|Overall Study|Ineligible|0
5716187|NCT00096135|19690951|P1|Overall Study|Ineligible|2
5716188|NCT00096135|19690950|P2|Overall Study|Other, specify|3
5716189|NCT00096135|19690951|P1|Overall Study|Other, specify|15
5716190|NCT00096135|19690950|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
5716191|NCT00096135|19690951|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
5716192|NCT00096135|19690950|P2|Overall Study|Refusal of further protocol therapy|1
5716193|NCT00096135|19690951|P1|Overall Study|Refusal of further protocol therapy|4
5716194|NCT00096135|19690950|P2|Overall Study|Physician Decision|4
5716195|NCT00096135|19690951|P1|Overall Study|Physician Decision|20
5716196|NCT00096044|19690967|P1|Overall Study|Disease Progression|4
5716197|NCT00096044|19690967|P1|Overall Study|Adverse Event|21
5716198|NCT00096044|19690967|P1|Overall Study|Withdrawal by Subject|9
5716199|NCT00096031|19690976|P1|Overall Study|Not protocol specified|5
5716200|NCT00096031|19690976|P1|Overall Study|Ineligible|8
5716201|NCT00096031|19690976|P1|Overall Study|Withdrawal by Subject|1
5716202|NCT00096031|19690976|P1|Overall Study|Death|4
5716203|NCT00096031|19690976|P1|Overall Study|Lack of Efficacy|42
5716204|NCT00096031|19690976|P1|Overall Study|Adverse Event|3
5716205|NCT00096018|19690984|P2|Overall Study|Miscellaneous|1
5716206|NCT00096018|19690985|P1|Overall Study|Miscellaneous|2
5716207|NCT00096018|19690984|P2|Overall Study|Withdrawal by Subject|2
5716208|NCT00096018|19690985|P1|Overall Study|Withdrawal by Subject|0
5716209|NCT00096018|19690984|P2|Overall Study|Death|1
5716210|NCT00096018|19690985|P1|Overall Study|Death|0
5716211|NCT00096018|19690984|P2|Overall Study|Adverse Event|5
5716212|NCT00096018|19690985|P1|Overall Study|Adverse Event|0
5716213|NCT00096018|19690984|P2|Overall Study|Miscellaneous (not treated)|2
5716214|NCT00096018|19690985|P1|Overall Study|Miscellaneous (not treated)|0
5716215|NCT00096018|19690984|P2|Overall Study|Became Ineligible (not treated)|3
5716216|NCT00096018|19690985|P1|Overall Study|Became Ineligible (not treated)|0
5716217|NCT00095979|19690993|P1|Overall Study|Ineligible: Second primary cancer site|2
5716218|NCT00095940|19691011|P9|Lapatinib Continuation/Phase II|Adverse Event|0
5716219|NCT00095940|19691012|P8|Lapatinib Continuation/Phase II|Adverse Event|1
5716220|NCT00095940|19691013|P7|Lapatinib Continuation/Phase II|Adverse Event|0
5716221|NCT00095940|19691014|P6|Lapatinib Continuation/Phase II|Adverse Event|0
5716222|NCT00095940|19691015|P5|Lapatinib Continuation/Phase II|Adverse Event|0
5716223|NCT00095940|19691016|P4|Lapatinib Continuation/Phase II|Adverse Event|0
5716224|NCT00095940|19691017|P3|Lapatinib Continuation/Phase II|Adverse Event|0
5716225|NCT00095940|19691018|P2|Lapatinib Continuation/Phase II|Adverse Event|0
5716226|NCT00095940|19691019|P1|Lapatinib Continuation/Phase II|Adverse Event|0
5716227|NCT00095940|19691011|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
5716228|NCT00095940|19691012|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5716229|NCT00095940|19691013|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5716230|NCT00095940|19691014|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5716231|NCT00095940|19691015|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5716232|NCT00095940|19691016|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
5716233|NCT00095940|19691017|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
5716234|NCT00095940|19691018|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
5716235|NCT00095940|19691019|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
5716236|NCT00095940|19691011|P9|Lapatinib Continuation/Phase II|Disease Progression|12
5716237|NCT00095940|19691012|P8|Lapatinib Continuation/Phase II|Disease Progression|1
5716238|NCT00095940|19691013|P7|Lapatinib Continuation/Phase II|Disease Progression|2
5716239|NCT00095940|19691014|P6|Lapatinib Continuation/Phase II|Disease Progression|13
5716240|NCT00095940|19691015|P5|Lapatinib Continuation/Phase II|Disease Progression|0
5716241|NCT00095940|19691016|P4|Lapatinib Continuation/Phase II|Disease Progression|0
5716242|NCT00095940|19691017|P3|Lapatinib Continuation/Phase II|Disease Progression|15
5716243|NCT00095940|19691018|P2|Lapatinib Continuation/Phase II|Disease Progression|1
5716244|NCT00095940|19691019|P1|Lapatinib Continuation/Phase II|Disease Progression|1
5716245|NCT00095836|19691052|P1|Overall Study|Death|2
5716246|NCT00095836|19691052|P1|Overall Study|Adverse Event|1
5716247|NCT00095836|19691052|P1|Overall Study|Lost to Follow-up|1
5716248|NCT00095628|19691082|P1|Overall Study|Disease progression prior to treatment|1
5716249|NCT00095576|19691093|P2|Overall Study|Subject moved|36
5716250|NCT00095576|19691094|P1|Overall Study|Subject moved|30
5716251|NCT00095576|19691093|P2|Overall Study|Site terminated|67
5716252|NCT00095576|19691094|P1|Overall Study|Site terminated|75
5716253|NCT00095576|19691093|P2|Overall Study|Option to switch to a rollover study|1099
5716254|NCT00095576|19691094|P1|Overall Study|Option to switch to a rollover study|1097
5716255|NCT00095576|19691093|P2|Overall Study|Withdrawal by Subject|47
5716256|NCT00095576|19691094|P1|Overall Study|Withdrawal by Subject|34
5716257|NCT00095576|19691093|P2|Overall Study|Protocol Violation|0
5716258|NCT00095576|19691094|P1|Overall Study|Protocol Violation|1
5716259|NCT00095576|19691093|P2|Overall Study|Lost to Follow-up|229
5716260|NCT00095576|19691094|P1|Overall Study|Lost to Follow-up|233
5716261|NCT00095576|19691093|P2|Overall Study|Adverse Event|3
5716262|NCT00095576|19691094|P1|Overall Study|Adverse Event|5
5716263|NCT00095498|19691118|P3|Overall Study|Requirement for alternative therapy|2
5716264|NCT00095498|19691119|P2|Overall Study|Requirement for alternative therapy|0
5716265|NCT00095498|19691120|P1|Overall Study|Requirement for alternative therapy|1
5716266|NCT00095498|19691118|P3|Overall Study|Protocol Violation|1
5716267|NCT00095498|19691119|P2|Overall Study|Protocol Violation|0
5716268|NCT00095498|19691120|P1|Overall Study|Protocol Violation|0
5716269|NCT00095498|19691118|P3|Overall Study|Other|6
5716270|NCT00095498|19691119|P2|Overall Study|Other|7
5716271|NCT00095498|19691120|P1|Overall Study|Other|6
5716272|NCT00095498|19691118|P3|Overall Study|Noncompliance|1
5716273|NCT00095498|19691119|P2|Overall Study|Noncompliance|0
5716274|NCT00095498|19691120|P1|Overall Study|Noncompliance|1
5716275|NCT00095498|19691118|P3|Overall Study|Lost to Follow-up|2
5716276|NCT00095498|19691119|P2|Overall Study|Lost to Follow-up|1
5716277|NCT00095498|19691120|P1|Overall Study|Lost to Follow-up|1
5716278|NCT00095498|19691118|P3|Overall Study|Ineligibility determined|2
5716279|NCT00095498|19691119|P2|Overall Study|Ineligibility determined|0
5716280|NCT00095498|19691120|P1|Overall Study|Ineligibility determined|3
5716281|NCT00095498|19691118|P3|Overall Study|Disease progression|1
5716282|NCT00095498|19691119|P2|Overall Study|Disease progression|1
5716283|NCT00095498|19691120|P1|Overall Study|Disease progression|0
5716284|NCT00095498|19691118|P3|Overall Study|Withdrawal by Subject|15
5716285|NCT00095498|19691119|P2|Overall Study|Withdrawal by Subject|16
5716286|NCT00095498|19691120|P1|Overall Study|Withdrawal by Subject|15
5716287|NCT00095498|19691118|P3|Overall Study|Adverse Event|1
5716288|NCT00095498|19691119|P2|Overall Study|Adverse Event|0
5716289|NCT00095498|19691120|P1|Overall Study|Adverse Event|1
5716290|NCT00095498|19691118|P3|Overall Study|Physician Decision|8
5716291|NCT00095498|19691119|P2|Overall Study|Physician Decision|10
5716292|NCT00095498|19691120|P1|Overall Study|Physician Decision|9
5716293|NCT00095303|19691547|P2|Follow Up Study|Lost to Follow-up|58
5716294|NCT00095303|19691548|P1|Follow Up Study|Lost to Follow-up|59
5716295|NCT00095303|19691547|P2|Main Study|Lost to Follow-up|87
5716296|NCT00095303|19691548|P1|Main Study|Lost to Follow-up|91
5716297|NCT00095238|19691616|P2|Overall Study|Other Reasons|88
5716298|NCT00095238|19691617|P1|Overall Study|Other Reasons|87
5716299|NCT00095238|19691616|P2|Overall Study|Missing|0
5716300|NCT00095238|19691617|P1|Overall Study|Missing|1
5716301|NCT00095238|19691616|P2|Overall Study|Study terminated by sponsor|1
5716302|NCT00095238|19691617|P1|Overall Study|Study terminated by sponsor|0
5716303|NCT00095238|19691616|P2|Overall Study|No longer met study criteria|5
5716304|NCT00095238|19691617|P1|Overall Study|No longer met study criteria|4
5716305|NCT00095238|19691616|P2|Overall Study|Noncompliance|45
5716306|NCT00095238|19691617|P1|Overall Study|Noncompliance|44
5716307|NCT00095238|19691616|P2|Overall Study|Lost to Follow-up|24
5716308|NCT00095238|19691617|P1|Overall Study|Lost to Follow-up|19
5716309|NCT00095238|19691616|P2|Overall Study|Death|170
5716310|NCT00095238|19691617|P1|Overall Study|Death|154
5716311|NCT00095238|19691616|P2|Overall Study|Subject Withdrew Consent|223
5716312|NCT00095238|19691617|P1|Overall Study|Subject Withdrew Consent|208
5716313|NCT00095238|19691616|P2|Overall Study|Adverse Event|287
5716314|NCT00095238|19691617|P1|Overall Study|Adverse Event|331
5716315|NCT00095238|19691616|P2|Overall Study|Lack of Efficacy|9
5716316|NCT00095238|19691617|P1|Overall Study|Lack of Efficacy|9
5716317|NCT00095212|19691679|P2|Overall Study|Withdrawal by Subject|3
5716318|NCT00095212|19691680|P1|Overall Study|Withdrawal by Subject|1
5716319|NCT00095199|19691710|P4|Overall Study|Data inadvertently lost by site|0
5716320|NCT00095199|19691711|P3|Overall Study|Data inadvertently lost by site|0
5716321|NCT00095199|19691712|P2|Overall Study|Data inadvertently lost by site|0
5716322|NCT00095199|19691713|P1|Overall Study|Data inadvertently lost by site|1
5716323|NCT00095199|19691710|P4|Overall Study|Primary tumor removed in other surgery|0
5716324|NCT00095199|19691711|P3|Overall Study|Primary tumor removed in other surgery|0
5716325|NCT00095199|19691712|P2|Overall Study|Primary tumor removed in other surgery|1
5716326|NCT00095199|19691713|P1|Overall Study|Primary tumor removed in other surgery|0
5716327|NCT00095199|19691710|P4|Overall Study|Started radiotherapy regimen|0
5716328|NCT00095199|19691711|P3|Overall Study|Started radiotherapy regimen|0
5716329|NCT00095199|19691712|P2|Overall Study|Started radiotherapy regimen|1
5716330|NCT00095199|19691713|P1|Overall Study|Started radiotherapy regimen|0
5716331|NCT00095199|19691710|P4|Overall Study|Started Palliative Radiotherapy|0
5716332|NCT00095199|19691711|P3|Overall Study|Started Palliative Radiotherapy|0
5716333|NCT00095199|19691712|P2|Overall Study|Started Palliative Radiotherapy|0
5716334|NCT00095199|19691713|P1|Overall Study|Started Palliative Radiotherapy|1
5716335|NCT00095199|19691710|P4|Overall Study|Not eligible|1
5716336|NCT00095199|19691711|P3|Overall Study|Not eligible|0
5716337|NCT00095199|19691712|P2|Overall Study|Not eligible|7
5716338|NCT00095199|19691713|P1|Overall Study|Not eligible|1
5716339|NCT00095199|19691710|P4|Overall Study|Physician Decision|1
5716340|NCT00095199|19691711|P3|Overall Study|Physician Decision|1
5716341|NCT00095199|19691712|P2|Overall Study|Physician Decision|6
5716342|NCT00095199|19691713|P1|Overall Study|Physician Decision|5
5716343|NCT00095199|19691710|P4|Overall Study|Surgery needed could not start in 7 days|0
5716344|NCT00095199|19691711|P3|Overall Study|Surgery needed could not start in 7 days|1
5716345|NCT00095199|19691712|P2|Overall Study|Surgery needed could not start in 7 days|0
5716346|NCT00095199|19691713|P1|Overall Study|Surgery needed could not start in 7 days|0
5716347|NCT00095199|19691710|P4|Overall Study|Liver function test results elevated|1
5716348|NCT00095199|19691711|P3|Overall Study|Liver function test results elevated|1
5716349|NCT00095199|19691712|P2|Overall Study|Liver function test results elevated|0
5716350|NCT00095199|19691713|P1|Overall Study|Liver function test results elevated|0
5716351|NCT00095199|19691710|P4|Overall Study|Protocol Violation|0
5716352|NCT00095199|19691711|P3|Overall Study|Protocol Violation|2
5716353|NCT00095199|19691712|P2|Overall Study|Protocol Violation|4
5716354|NCT00095199|19691713|P1|Overall Study|Protocol Violation|4
5716355|NCT00095199|19691710|P4|Overall Study|Withdrawal by Subject|22
5716356|NCT00095199|19691711|P3|Overall Study|Withdrawal by Subject|13
5716357|NCT00095199|19691712|P2|Overall Study|Withdrawal by Subject|16
5716358|NCT00095199|19691713|P1|Overall Study|Withdrawal by Subject|21
5716359|NCT00095199|19691710|P4|Overall Study|Death|9
5716360|NCT00095199|19691711|P3|Overall Study|Death|11
5716361|NCT00095199|19691712|P2|Overall Study|Death|6
5716362|NCT00095199|19691713|P1|Overall Study|Death|10
5716363|NCT00095199|19691710|P4|Overall Study|Progressive disease|98
5716364|NCT00095199|19691711|P3|Overall Study|Progressive disease|105
5716365|NCT00095199|19691712|P2|Overall Study|Progressive disease|179
5716366|NCT00095199|19691713|P1|Overall Study|Progressive disease|213
5716367|NCT00095199|19691710|P4|Overall Study|Adverse Event|11
5716368|NCT00095199|19691711|P3|Overall Study|Adverse Event|26
5716369|NCT00095199|19691712|P2|Overall Study|Adverse Event|22
5716370|NCT00095199|19691713|P1|Overall Study|Adverse Event|40
5716371|NCT00095173|19691751|P6|Open-Label Extension Phase (Period C)|Other|8
5716372|NCT00095173|19691752|P5|Open-Label Extension Phase (Period C)|Other|6
5716373|NCT00095173|19691753|P4|Open-Label Extension Phase (Period C)|Other|4
5716374|NCT00095173|19691754|P3|Open-Label Extension Phase (Period C)|Other|0
5716375|NCT00095173|19691755|P2|Open-Label Extension Phase (Period C)|Other|0
5716376|NCT00095173|19691756|P1|Open-Label Extension Phase (Period C)|Other|0
5716377|NCT00095173|19691751|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
5716378|NCT00095173|19691752|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
5716379|NCT00095173|19691753|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
5716380|NCT00095173|19691754|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
5716381|NCT00095173|19691755|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
5716382|NCT00095173|19691756|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
5716383|NCT00095173|19691751|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
5716384|NCT00095173|19691752|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
5716385|NCT00095173|19691753|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
5716386|NCT00095173|19691754|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
5716387|NCT00095173|19691755|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
5716388|NCT00095173|19691756|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
5716389|NCT00095173|19691751|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
5716390|NCT00095173|19691752|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
5716391|NCT00095173|19691753|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
5716392|NCT00095173|19691754|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
5716393|NCT00095173|19691755|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
5716394|NCT00095173|19691756|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
5716395|NCT00095173|19691751|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
5716396|NCT00095173|19691752|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
5716397|NCT00095173|19691753|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
5716398|NCT00095173|19691754|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
5716399|NCT00095173|19691755|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
5716400|NCT00095173|19691756|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
5716401|NCT00095173|19691751|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
5716402|NCT00095173|19691752|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
5716403|NCT00095173|19691753|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
5716404|NCT00095173|19691754|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
5716405|NCT00095173|19691755|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
5716406|NCT00095173|19691756|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
5716407|NCT00095173|19691751|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
5716408|NCT00095173|19691752|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
5716409|NCT00095173|19691753|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
5716410|NCT00095173|19691754|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
5716411|NCT00095173|19691755|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
5716412|NCT00095173|19691756|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
5716413|NCT00095173|19691751|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
5716414|NCT00095173|19691752|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
5716415|NCT00095173|19691753|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
5716416|NCT00095173|19691754|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
5716417|NCT00095173|19691755|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
5716418|NCT00095173|19691756|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
5716419|NCT00095173|19691751|P6|Open-Label Extension Phase (Period C)|Death|1
5716420|NCT00095173|19691752|P5|Open-Label Extension Phase (Period C)|Death|0
5716421|NCT00095173|19691753|P4|Open-Label Extension Phase (Period C)|Death|0
5716422|NCT00095173|19691754|P3|Open-Label Extension Phase (Period C)|Death|0
5716423|NCT00095173|19691755|P2|Open-Label Extension Phase (Period C)|Death|0
5716424|NCT00095173|19691756|P1|Open-Label Extension Phase (Period C)|Death|0
5716425|NCT00095173|19691751|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5716426|NCT00095173|19691752|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5716427|NCT00095173|19691753|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5716428|NCT00095173|19691754|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5716429|NCT00095173|19691755|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
5716430|NCT00095173|19691756|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
5716431|NCT00095173|19691751|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
5716432|NCT00095173|19691752|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
5716433|NCT00095173|19691753|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
5716434|NCT00095173|19691754|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
5716435|NCT00095173|19691755|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
5716436|NCT00095173|19691756|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
5716437|NCT00095173|19691751|P6|Open-Label Lead-In Phase (Period A)|Other|0
5716438|NCT00095173|19691752|P5|Open-Label Lead-In Phase (Period A)|Other|0
5716439|NCT00095173|19691753|P4|Open-Label Lead-In Phase (Period A)|Other|0
5716440|NCT00095173|19691754|P3|Open-Label Lead-In Phase (Period A)|Other|0
5716441|NCT00095173|19691755|P2|Open-Label Lead-In Phase (Period A)|Other|0
5716442|NCT00095173|19691756|P1|Open-Label Lead-In Phase (Period A)|Other|1
5716443|NCT00095173|19691751|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5716444|NCT00095173|19691752|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5716445|NCT00095173|19691753|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5716446|NCT00095173|19691754|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5716447|NCT00095173|19691755|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
5716448|NCT00095173|19691756|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
5716449|NCT00095173|19691751|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5716450|NCT00095173|19691752|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5716451|NCT00095173|19691753|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5716452|NCT00095173|19691754|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5716453|NCT00095173|19691755|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
5716454|NCT00095173|19691756|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
5716455|NCT00095173|19691751|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5716456|NCT00095173|19691752|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5716457|NCT00095173|19691753|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5716458|NCT00095173|19691754|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5716459|NCT00095173|19691755|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
5716460|NCT00095173|19691756|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
5716461|NCT00095147|19691794|P5|Long-term Extension Period|Leaving country|1
5716462|NCT00095147|19691795|P4|Long-term Extension Period|Leaving country|0
5716463|NCT00095147|19691796|P3|Long-term Extension Period|Leaving country|0
5716464|NCT00095147|19691797|P2|Long-term Extension Period|Leaving country|0
5716465|NCT00095147|19691798|P1|Long-term Extension Period|Leaving country|0
5716466|NCT00095147|19691794|P5|Long-term Extension Period|Participant chose to use Revellex|1
5716467|NCT00095147|19691795|P4|Long-term Extension Period|Participant chose to use Revellex|0
5716468|NCT00095147|19691796|P3|Long-term Extension Period|Participant chose to use Revellex|0
5716469|NCT00095147|19691797|P2|Long-term Extension Period|Participant chose to use Revellex|0
5716470|NCT00095147|19691798|P1|Long-term Extension Period|Participant chose to use Revellex|0
5716471|NCT00095147|19691794|P5|Long-term Extension Period|No longer meets study criteria|1
5716472|NCT00095147|19691795|P4|Long-term Extension Period|No longer meets study criteria|0
5716473|NCT00095147|19691796|P3|Long-term Extension Period|No longer meets study criteria|0
5716474|NCT00095147|19691797|P2|Long-term Extension Period|No longer meets study criteria|0
5716475|NCT00095147|19691798|P1|Long-term Extension Period|No longer meets study criteria|0
5716476|NCT00095147|19691794|P5|Long-term Extension Period|Pregnancy|1
5716477|NCT00095147|19691795|P4|Long-term Extension Period|Pregnancy|0
5716478|NCT00095147|19691796|P3|Long-term Extension Period|Pregnancy|0
5716479|NCT00095147|19691797|P2|Long-term Extension Period|Pregnancy|0
5716480|NCT00095147|19691798|P1|Long-term Extension Period|Pregnancy|0
5716481|NCT00095147|19691794|P5|Long-term Extension Period|Withdrawal of consent|12
5716482|NCT00095147|19691795|P4|Long-term Extension Period|Withdrawal of consent|0
5716483|NCT00095147|19691796|P3|Long-term Extension Period|Withdrawal of consent|0
5716484|NCT00095147|19691797|P2|Long-term Extension Period|Withdrawal of consent|0
5716485|NCT00095147|19691798|P1|Long-term Extension Period|Withdrawal of consent|0
5716486|NCT00095147|19691794|P5|Long-term Extension Period|Lost to Follow-up|6
5716487|NCT00095147|19691795|P4|Long-term Extension Period|Lost to Follow-up|0
5716488|NCT00095147|19691796|P3|Long-term Extension Period|Lost to Follow-up|0
5716489|NCT00095147|19691797|P2|Long-term Extension Period|Lost to Follow-up|0
5716490|NCT00095147|19691798|P1|Long-term Extension Period|Lost to Follow-up|0
5716491|NCT00095147|19691794|P5|Long-term Extension Period|Lack of Efficacy|9
5716492|NCT00095147|19691795|P4|Long-term Extension Period|Lack of Efficacy|0
5716493|NCT00095147|19691796|P3|Long-term Extension Period|Lack of Efficacy|0
5716494|NCT00095147|19691797|P2|Long-term Extension Period|Lack of Efficacy|0
5716495|NCT00095147|19691798|P1|Long-term Extension Period|Lack of Efficacy|0
5716496|NCT00095147|19691794|P5|Long-term Extension Period|Adverse Event|11
5716497|NCT00095147|19691795|P4|Long-term Extension Period|Adverse Event|0
5716498|NCT00095147|19691796|P3|Long-term Extension Period|Adverse Event|0
5716499|NCT00095147|19691797|P2|Long-term Extension Period|Adverse Event|0
5716500|NCT00095147|19691798|P1|Long-term Extension Period|Adverse Event|0
5716501|NCT00095147|19691794|P5|Long-term Extension Period|Death|3
5716502|NCT00095147|19691795|P4|Long-term Extension Period|Death|0
5716503|NCT00095147|19691796|P3|Long-term Extension Period|Death|0
5716504|NCT00095147|19691797|P2|Long-term Extension Period|Death|0
5716505|NCT00095147|19691798|P1|Long-term Extension Period|Death|0
5716506|NCT00095147|19691794|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
5716507|NCT00095147|19691795|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
5716508|NCT00095147|19691796|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
5716509|NCT00095147|19691797|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
5716510|NCT00095147|19691798|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
5716511|NCT00095147|19691794|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
5716512|NCT00095147|19691795|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
5716513|NCT00095147|19691796|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
5716514|NCT00095147|19691797|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
5716515|NCT00095147|19691798|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
5716516|NCT00095147|19691794|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
5716517|NCT00095147|19691795|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
5716518|NCT00095147|19691796|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
5716519|NCT00095147|19691797|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
5716520|NCT00095147|19691798|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
5716521|NCT00095147|19691794|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
5716522|NCT00095147|19691795|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
5716523|NCT00095147|19691796|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
5716524|NCT00095147|19691797|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
5716525|NCT00095147|19691798|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
5716526|NCT00095147|19691794|P5|Double-blind Period 2 (Days 198-365)|Death|0
5716527|NCT00095147|19691795|P4|Double-blind Period 2 (Days 198-365)|Death|1
5716528|NCT00095147|19691796|P3|Double-blind Period 2 (Days 198-365)|Death|0
5716529|NCT00095147|19691797|P2|Double-blind Period 2 (Days 198-365)|Death|1
5716530|NCT00095147|19691798|P1|Double-blind Period 2 (Days 198-365)|Death|0
5716531|NCT00095147|19691794|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
5716532|NCT00095147|19691795|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
5716533|NCT00095147|19691796|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
5716534|NCT00095147|19691797|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
5716535|NCT00095147|19691798|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
5716536|NCT00095147|19691794|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
5716537|NCT00095147|19691795|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
5716538|NCT00095147|19691796|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
5716539|NCT00095147|19691797|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
5716540|NCT00095147|19691798|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
5716541|NCT00095147|19691794|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
5716542|NCT00095147|19691795|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
5716543|NCT00095147|19691796|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
5716544|NCT00095147|19691797|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
5716545|NCT00095147|19691798|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
5716546|NCT00095147|19691794|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
5716547|NCT00095147|19691795|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
5716548|NCT00095147|19691796|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
5716549|NCT00095147|19691797|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
5716550|NCT00095147|19691798|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
5716551|NCT00095147|19691794|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
5716552|NCT00095147|19691795|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
5716553|NCT00095147|19691796|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
5716554|NCT00095147|19691797|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
5716555|NCT00095147|19691798|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
5716556|NCT00095147|19691794|P5|Double-blind Period 1 (Days 1-197)|Death|0
5716557|NCT00095147|19691795|P4|Double-blind Period 1 (Days 1-197)|Death|0
5716558|NCT00095147|19691796|P3|Double-blind Period 1 (Days 1-197)|Death|0
5716559|NCT00095147|19691797|P2|Double-blind Period 1 (Days 1-197)|Death|0
5716560|NCT00095147|19691798|P1|Double-blind Period 1 (Days 1-197)|Death|1
5716561|NCT00095121|19691993|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
5716562|NCT00095121|19691994|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
5716563|NCT00095121|19691993|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
5716564|NCT00095121|19691994|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
5716565|NCT00095056|19692040|P2|Phase B (Weeks 12-54)|Protocol Violation|1
5716566|NCT00095056|19692041|P1|Phase B (Weeks 12-54)|Protocol Violation|0
5716567|NCT00095056|19692040|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
5716568|NCT00095056|19692041|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
5716569|NCT00095056|19692040|P2|Phase B (Weeks 12-54)|Death|1
5716570|NCT00095056|19692041|P1|Phase B (Weeks 12-54)|Death|3
5716571|NCT00095056|19692040|P2|Phase B (Weeks 12-54)|Patient Moved|0
5716572|NCT00095056|19692041|P1|Phase B (Weeks 12-54)|Patient Moved|1
5716573|NCT00095056|19692040|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
5716574|NCT00095056|19692041|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
5716575|NCT00095056|19692040|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
5716576|NCT00095056|19692041|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
5716577|NCT00095056|19692040|P2|Phase B (Weeks 12-54)|Adverse Event|2
5716578|NCT00095056|19692041|P1|Phase B (Weeks 12-54)|Adverse Event|2
5716579|NCT00095056|19692040|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
5716580|NCT00095056|19692041|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
5716581|NCT00095056|19692040|P2|Phase A (Weeks 0-12)|Death|0
5716582|NCT00095056|19692041|P1|Phase A (Weeks 0-12)|Death|1
5716583|NCT00095056|19692040|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
5716584|NCT00095056|19692041|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
5716585|NCT00095056|19692040|P2|Phase A (Weeks 0-12)|Adverse Event|1
5716586|NCT00095056|19692041|P1|Phase A (Weeks 0-12)|Adverse Event|1
5716587|NCT00094861|19692170|P2|Overall Study|Other|0
5716588|NCT00094861|19692171|P1|Overall Study|Other|3
5716589|NCT00094861|19692170|P2|Overall Study|Death|2
5716590|NCT00094861|19692171|P1|Overall Study|Death|4
5716591|NCT00094861|19692170|P2|Overall Study|Lost to Follow-up|1
5716592|NCT00094861|19692171|P1|Overall Study|Lost to Follow-up|0
5716593|NCT00094861|19692170|P2|Overall Study|Physician Decision|1
5716594|NCT00094861|19692171|P1|Overall Study|Physician Decision|1
5716595|NCT00094861|19692170|P2|Overall Study|Withdrawal by Subject|3
5716596|NCT00094861|19692171|P1|Overall Study|Withdrawal by Subject|5
5716597|NCT00094861|19692170|P2|Overall Study|Adverse Event|2
5716598|NCT00094861|19692171|P1|Overall Study|Adverse Event|5
5716599|NCT00094835|19692198|P7|Overall Study|Other|0
5716600|NCT00094835|19692199|P6|Overall Study|Other|0
5716601|NCT00094835|19692200|P5|Overall Study|Other|0
5716602|NCT00094835|19692201|P4|Overall Study|Other|1
5716603|NCT00094835|19692202|P3|Overall Study|Other|1
5716604|NCT00094835|19692203|P2|Overall Study|Other|1
5716605|NCT00094835|19692204|P1|Overall Study|Other|1
5716606|NCT00094835|19692198|P7|Overall Study|Non-compliance|1
5716607|NCT00094835|19692199|P6|Overall Study|Non-compliance|2
5716608|NCT00094835|19692200|P5|Overall Study|Non-compliance|2
5716609|NCT00094835|19692201|P4|Overall Study|Non-compliance|0
5716610|NCT00094835|19692202|P3|Overall Study|Non-compliance|2
5716611|NCT00094835|19692203|P2|Overall Study|Non-compliance|2
5716612|NCT00094835|19692204|P1|Overall Study|Non-compliance|1
5716613|NCT00094835|19692198|P7|Overall Study|Death|0
5716614|NCT00094835|19692199|P6|Overall Study|Death|0
5716615|NCT00094835|19692200|P5|Overall Study|Death|1
5716616|NCT00094835|19692201|P4|Overall Study|Death|0
5716617|NCT00094835|19692202|P3|Overall Study|Death|0
5716618|NCT00094835|19692203|P2|Overall Study|Death|0
5716619|NCT00094835|19692204|P1|Overall Study|Death|1
5716620|NCT00094835|19692198|P7|Overall Study|Lost to Follow-up|0
5716621|NCT00094835|19692199|P6|Overall Study|Lost to Follow-up|0
5716622|NCT00094835|19692200|P5|Overall Study|Lost to Follow-up|1
5716623|NCT00094835|19692201|P4|Overall Study|Lost to Follow-up|0
5716624|NCT00094835|19692202|P3|Overall Study|Lost to Follow-up|0
5716625|NCT00094835|19692203|P2|Overall Study|Lost to Follow-up|0
5716626|NCT00094835|19692204|P1|Overall Study|Lost to Follow-up|0
5716627|NCT00094835|19692198|P7|Overall Study|Withdrawal by Subject|1
5716628|NCT00094835|19692199|P6|Overall Study|Withdrawal by Subject|0
5716629|NCT00094835|19692200|P5|Overall Study|Withdrawal by Subject|0
5716630|NCT00094835|19692201|P4|Overall Study|Withdrawal by Subject|0
5716631|NCT00094835|19692202|P3|Overall Study|Withdrawal by Subject|0
5716632|NCT00094835|19692203|P2|Overall Study|Withdrawal by Subject|0
5716633|NCT00094835|19692204|P1|Overall Study|Withdrawal by Subject|0
5716634|NCT00094835|19692198|P7|Overall Study|Physician Decision|0
5716635|NCT00094835|19692199|P6|Overall Study|Physician Decision|1
5716636|NCT00094835|19692200|P5|Overall Study|Physician Decision|0
5716637|NCT00094835|19692201|P4|Overall Study|Physician Decision|0
5716638|NCT00094835|19692202|P3|Overall Study|Physician Decision|0
5716639|NCT00094835|19692203|P2|Overall Study|Physician Decision|0
5716640|NCT00094835|19692204|P1|Overall Study|Physician Decision|1
5716641|NCT00094809|19692282|P2|Overall Study|Other|1
5716642|NCT00094809|19692283|P1|Overall Study|Other|1
5716643|NCT00094809|19692282|P2|Overall Study|Study drug not received|8
5716644|NCT00094809|19692283|P1|Overall Study|Study drug not received|2
5716645|NCT00094809|19692282|P2|Overall Study|Informed consent signed after treatment|0
5716646|NCT00094809|19692283|P1|Overall Study|Informed consent signed after treatment|1
5716647|NCT00094809|19692282|P2|Overall Study|Other|4
5716648|NCT00094809|19692283|P1|Overall Study|Other|2
5716649|NCT00094809|19692282|P2|Overall Study|Protocol-specified criteria|1
5716650|NCT00094809|19692283|P1|Overall Study|Protocol-specified criteria|1
5716651|NCT00094809|19692282|P2|Overall Study|Death|25
5716652|NCT00094809|19692283|P1|Overall Study|Death|19
5716653|NCT00094809|19692282|P2|Overall Study|Lost to Follow-up|6
5716654|NCT00094809|19692283|P1|Overall Study|Lost to Follow-up|6
5716655|NCT00094809|19692282|P2|Overall Study|Physician Decision|5
5716656|NCT00094809|19692283|P1|Overall Study|Physician Decision|3
5716657|NCT00094809|19692282|P2|Overall Study|Disease progression|3
5716658|NCT00094809|19692283|P1|Overall Study|Disease progression|3
5716659|NCT00094809|19692282|P2|Overall Study|Withdrawal by Subject|9
5716660|NCT00094809|19692283|P1|Overall Study|Withdrawal by Subject|8
5716661|NCT00094809|19692282|P2|Overall Study|Adverse Event|1
5716662|NCT00094809|19692283|P1|Overall Study|Adverse Event|3
5716663|NCT00094809|19692282|P2|Overall Study|Noncompliance|0
5716664|NCT00094809|19692283|P1|Overall Study|Noncompliance|1
5716665|NCT00094809|19692282|P2|Overall Study|Protocol deviation|2
5716666|NCT00094809|19692283|P1|Overall Study|Protocol deviation|2
5716667|NCT00094770|19692309|P2|Year 2 (Week 0 to Week 104)|Other|23
5716668|NCT00094770|19692310|P1|Year 2 (Week 0 to Week 104)|Other|15
5716669|NCT00094770|19692309|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
5716670|NCT00094770|19692310|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
5716671|NCT00094770|19692309|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
5716672|NCT00094770|19692310|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
5716673|NCT00094770|19692309|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
5716674|NCT00094770|19692310|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
5716675|NCT00094770|19692309|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
5716676|NCT00094770|19692310|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
5716677|NCT00094770|19692309|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
5716678|NCT00094770|19692310|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
5716679|NCT00094770|19692309|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
5716680|NCT00094770|19692310|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
5716681|NCT00094770|19692309|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
5716682|NCT00094770|19692310|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
5716683|NCT00094770|19692309|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
5716684|NCT00094770|19692310|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
5716685|NCT00094770|19692309|P2|Year 1 ( Week 0 to Week 52)|Other|11
5716686|NCT00094770|19692310|P1|Year 1 ( Week 0 to Week 52)|Other|10
5716687|NCT00094770|19692309|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
5716688|NCT00094770|19692310|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
5716689|NCT00094770|19692309|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
5716690|NCT00094770|19692310|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
5716691|NCT00094770|19692309|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
5716692|NCT00094770|19692310|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
5716693|NCT00094770|19692309|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
5716694|NCT00094770|19692310|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
5716695|NCT00094770|19692309|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
5716696|NCT00094770|19692310|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
5716697|NCT00094770|19692309|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
5716698|NCT00094770|19692310|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
5716699|NCT00094770|19692309|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
5716700|NCT00094770|19692310|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
5716701|NCT00094770|19692309|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
5716702|NCT00094770|19692310|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
5716703|NCT00094757|19692341|P3|Overall Study|Protocol specified discontinuation|0
5716704|NCT00094757|19692342|P2|Overall Study|Protocol specified discontinuation|3
5716705|NCT00094757|19692343|P1|Overall Study|Protocol specified discontinuation|1
5716706|NCT00094757|19692341|P3|Overall Study|Other|1
5716707|NCT00094757|19692342|P2|Overall Study|Other|3
5716708|NCT00094757|19692343|P1|Overall Study|Other|3
5716709|NCT00094757|19692341|P3|Overall Study|Withdrawal by Subject|5
5716710|NCT00094757|19692342|P2|Overall Study|Withdrawal by Subject|21
5716711|NCT00094757|19692343|P1|Overall Study|Withdrawal by Subject|14
5716712|NCT00094757|19692341|P3|Overall Study|Protocol Violation|3
5716713|NCT00094757|19692342|P2|Overall Study|Protocol Violation|5
5716714|NCT00094757|19692343|P1|Overall Study|Protocol Violation|8
5716715|NCT00094757|19692341|P3|Overall Study|Patient Moved|1
5716716|NCT00094757|19692342|P2|Overall Study|Patient Moved|1
5716717|NCT00094757|19692343|P1|Overall Study|Patient Moved|2
5716718|NCT00094757|19692341|P3|Overall Study|Lost to Follow-up|6
5716719|NCT00094757|19692342|P2|Overall Study|Lost to Follow-up|5
5716720|NCT00094757|19692343|P1|Overall Study|Lost to Follow-up|3
5716721|NCT00094757|19692341|P3|Overall Study|Lack of Efficacy|8
5716722|NCT00094757|19692342|P2|Overall Study|Lack of Efficacy|15
5716723|NCT00094757|19692343|P1|Overall Study|Lack of Efficacy|11
5716724|NCT00094757|19692341|P3|Overall Study|Adverse Event|6
5716725|NCT00094757|19692342|P2|Overall Study|Adverse Event|9
5716726|NCT00094757|19692343|P1|Overall Study|Adverse Event|11
5716727|NCT00094653|19692363|P3|Overall Study|Protocol Violation|1
5716728|NCT00094653|19692364|P2|Overall Study|Protocol Violation|0
5716729|NCT00094653|19692365|P1|Overall Study|Protocol Violation|0
5716730|NCT00094653|19692363|P3|Overall Study|Lost to Follow-up|1
5716731|NCT00094653|19692364|P2|Overall Study|Lost to Follow-up|2
5716732|NCT00094653|19692365|P1|Overall Study|Lost to Follow-up|3
5716733|NCT00094653|19692363|P3|Overall Study|Other|2
5716734|NCT00094653|19692364|P2|Overall Study|Other|2
5716735|NCT00094653|19692365|P1|Overall Study|Other|2
5716736|NCT00094653|19692363|P3|Overall Study|Subject Withdrew Consent|3
5716737|NCT00094653|19692364|P2|Overall Study|Subject Withdrew Consent|2
5716738|NCT00094653|19692365|P1|Overall Study|Subject Withdrew Consent|10
5716739|NCT00094653|19692363|P3|Overall Study|Death|119
5716740|NCT00094653|19692364|P2|Overall Study|Death|100
5716741|NCT00094653|19692365|P1|Overall Study|Death|306
5716742|NCT00094575|19692428|P2|Overall Study|Death|146
5716743|NCT00094575|19692429|P1|Overall Study|Death|146
5716744|NCT00094536|19692449|P1|Treatment and Follow-up|Unable to attend visits|1
5716745|NCT00094536|19692449|P1|Treatment and Follow-up|Subject non-compliance|9
5716746|NCT00094536|19692449|P1|Treatment and Follow-up|Withdrawal by Subject|1
5716747|NCT00094536|19692449|P1|Treatment and Follow-up|Lost to Follow-up|7
5716748|NCT00094536|19692449|P1|Treatment and Follow-up|Lack of Efficacy|9
5716749|NCT00094536|19692449|P1|Treatment and Follow-up|Adverse Event|4
5716750|NCT00094536|19692449|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
5716751|NCT00094458|19692473|P6|OLE: Open-Label Extension|Patient decision|0
5716752|NCT00094458|19692474|P5|OLE: Open-Label Extension|Patient decision|1
5716753|NCT00094458|19692475|P4|OLE: Open-Label Extension|Patient decision|0
5716754|NCT00094458|19692476|P3|OLE: Open-Label Extension|Patient decision|0
5716755|NCT00094458|19692477|P2|OLE: Open-Label Extension|Patient decision|0
5716756|NCT00094458|19692478|P1|OLE: Open-Label Extension|Patient decision|0
5716757|NCT00094458|19692473|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
5716758|NCT00094458|19692474|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
5716759|NCT00094458|19692475|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
5716760|NCT00094458|19692476|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
5716761|NCT00094458|19692477|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
5716762|NCT00094458|19692478|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
5716763|NCT00094458|19692473|P6|OLE: Open-Label Extension|Adverse Event|4
5716764|NCT00094458|19692474|P5|OLE: Open-Label Extension|Adverse Event|3
5716765|NCT00094458|19692475|P4|OLE: Open-Label Extension|Adverse Event|0
5716766|NCT00094458|19692476|P3|OLE: Open-Label Extension|Adverse Event|0
5716767|NCT00094458|19692477|P2|OLE: Open-Label Extension|Adverse Event|0
5716768|NCT00094458|19692478|P1|OLE: Open-Label Extension|Adverse Event|0
5716769|NCT00094458|19692473|P6|Study Extension: Week 30 Through Week 50|Other|0
5716770|NCT00094458|19692474|P5|Study Extension: Week 30 Through Week 50|Other|0
5716771|NCT00094458|19692475|P4|Study Extension: Week 30 Through Week 50|Other|0
5716772|NCT00094458|19692476|P3|Study Extension: Week 30 Through Week 50|Other|3
5716773|NCT00094458|19692477|P2|Study Extension: Week 30 Through Week 50|Other|2
5716774|NCT00094458|19692478|P1|Study Extension: Week 30 Through Week 50|Other|1
5716775|NCT00094458|19692473|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
5716776|NCT00094458|19692474|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
5716777|NCT00094458|19692475|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
5716778|NCT00094458|19692476|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
5716779|NCT00094458|19692477|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
5716780|NCT00094458|19692478|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
5716781|NCT00094458|19692473|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
5716782|NCT00094458|19692474|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
5716783|NCT00094458|19692475|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
5716784|NCT00094458|19692476|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
5716785|NCT00094458|19692477|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
5716786|NCT00094458|19692478|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
5716787|NCT00094458|19692473|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
5716788|NCT00094458|19692474|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
5716789|NCT00094458|19692475|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
5716790|NCT00094458|19692476|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
5716791|NCT00094458|19692477|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
5716792|NCT00094458|19692478|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
5716793|NCT00094458|19692473|P6|Main Study: Through Week 30|Other|0
5716794|NCT00094458|19692474|P5|Main Study: Through Week 30|Other|0
5716795|NCT00094458|19692475|P4|Main Study: Through Week 30|Other|0
5716796|NCT00094458|19692476|P3|Main Study: Through Week 30|Other|9
5716797|NCT00094458|19692477|P2|Main Study: Through Week 30|Other|16
5716798|NCT00094458|19692478|P1|Main Study: Through Week 30|Other|19
5716799|NCT00094458|19692473|P6|Main Study: Through Week 30|Death|0
5716800|NCT00094458|19692474|P5|Main Study: Through Week 30|Death|0
5716801|NCT00094458|19692475|P4|Main Study: Through Week 30|Death|0
5716802|NCT00094458|19692476|P3|Main Study: Through Week 30|Death|0
5716803|NCT00094458|19692477|P2|Main Study: Through Week 30|Death|0
5716804|NCT00094458|19692478|P1|Main Study: Through Week 30|Death|1
5716805|NCT00094458|19692473|P6|Main Study: Through Week 30|Adverse Event|0
5716806|NCT00094458|19692474|P5|Main Study: Through Week 30|Adverse Event|0
5716807|NCT00094458|19692475|P4|Main Study: Through Week 30|Adverse Event|0
5716808|NCT00094458|19692476|P3|Main Study: Through Week 30|Adverse Event|28
5716809|NCT00094458|19692477|P2|Main Study: Through Week 30|Adverse Event|20
5716810|NCT00094458|19692478|P1|Main Study: Through Week 30|Adverse Event|38
5716811|NCT00094458|19692473|P6|Main Study: Through Week 30|Withdrawal by Subject|0
5716812|NCT00094458|19692474|P5|Main Study: Through Week 30|Withdrawal by Subject|0
5716813|NCT00094458|19692475|P4|Main Study: Through Week 30|Withdrawal by Subject|0
5716814|NCT00094458|19692476|P3|Main Study: Through Week 30|Withdrawal by Subject|7
5716815|NCT00094458|19692477|P2|Main Study: Through Week 30|Withdrawal by Subject|9
5716816|NCT00094458|19692478|P1|Main Study: Through Week 30|Withdrawal by Subject|18
5716817|NCT00094458|19692473|P6|Main Study: Through Week 30|Lost to Follow-up|0
5716818|NCT00094458|19692474|P5|Main Study: Through Week 30|Lost to Follow-up|0
5716819|NCT00094458|19692475|P4|Main Study: Through Week 30|Lost to Follow-up|0
5716820|NCT00094458|19692476|P3|Main Study: Through Week 30|Lost to Follow-up|2
5716821|NCT00094458|19692477|P2|Main Study: Through Week 30|Lost to Follow-up|5
5716822|NCT00094458|19692478|P1|Main Study: Through Week 30|Lost to Follow-up|5
5716823|NCT00094458|19692473|P6|Main Study: Through Week 30|Eligibility criteria not met|0
5716824|NCT00094458|19692474|P5|Main Study: Through Week 30|Eligibility criteria not met|0
5716825|NCT00094458|19692475|P4|Main Study: Through Week 30|Eligibility criteria not met|0
5716826|NCT00094458|19692476|P3|Main Study: Through Week 30|Eligibility criteria not met|2
5716827|NCT00094458|19692477|P2|Main Study: Through Week 30|Eligibility criteria not met|8
5716828|NCT00094458|19692478|P1|Main Study: Through Week 30|Eligibility criteria not met|3
5716829|NCT00094445|19692516|P1|Overall Study|Progressive Disease|2
5716830|NCT00094445|19692516|P1|Overall Study|Lost to Follow-up|1
5716831|NCT00094445|19692516|P1|Overall Study|Withdrawal by Subject|3
5716832|NCT00094328|19692520|P1|Overall Study|Lost to Follow-up|1
5716833|NCT00094302|19692534|P2|Overall Study|Death|246
5716834|NCT00094302|19692535|P1|Overall Study|Death|266
5716835|NCT00094302|19692534|P2|Overall Study|Withdrawal by Subject|111
5716836|NCT00094302|19692535|P1|Overall Study|Withdrawal by Subject|103
5716837|NCT00094302|19692534|P2|Overall Study|Physician Decision|8
5716838|NCT00094302|19692535|P1|Overall Study|Physician Decision|5
5716839|NCT00094302|19692534|P2|Overall Study|Lost to Follow-up|41
5716840|NCT00094302|19692535|P1|Overall Study|Lost to Follow-up|43
5716841|NCT00094172|19692624|P2|Overall Study|Started other MS therapy due to disease|0
5716842|NCT00094172|19692625|P1|Overall Study|Started other MS therapy due to disease|1
5716843|NCT00094172|19692624|P2|Overall Study|Primary endpoint met.|0
5716844|NCT00094172|19692625|P1|Overall Study|Primary endpoint met.|1
5716845|NCT00094172|19692624|P2|Overall Study|Withdrawal by Subject|5
5716846|NCT00094172|19692625|P1|Overall Study|Withdrawal by Subject|10
5716847|NCT00094172|19692624|P2|Overall Study|Protocol Violation|1
5716848|NCT00094172|19692625|P1|Overall Study|Protocol Violation|0
5716849|NCT00094172|19692624|P2|Overall Study|Lost to Follow-up|0
5716850|NCT00094172|19692625|P1|Overall Study|Lost to Follow-up|2
5716851|NCT00094172|19692624|P2|Overall Study|Adverse Event|1
5716852|NCT00094172|19692625|P1|Overall Study|Adverse Event|0
5716853|NCT00094107|19692635|P1|Overall Study|Withdrawal due to Disease Progression|1
5716854|NCT00094107|19692635|P1|Overall Study|Adverse Event|3
5716855|NCT00094107|19692635|P1|Overall Study|Death|5
5716856|NCT00094107|19692635|P1|Overall Study|Lack of Efficacy|23
5716857|NCT00094094|19692644|P1|Overall Study|Adverse Event|7
5716858|NCT00094094|19692644|P1|Overall Study|Lack of Efficacy|23
5716859|NCT00094094|19692644|P1|Overall Study|Death|2
5716860|NCT00094055|19692653|P1|Overall Study|Withdrawal by Subject|9
5716861|NCT00094055|19692653|P1|Overall Study|roll-over to another study|14
5716862|NCT00094055|19692653|P1|Overall Study|clinical progression|1
5716863|NCT00094055|19692653|P1|Overall Study|progressive disease|2
5716864|NCT00094055|19692653|P1|Overall Study|Lost to Follow-up|2
5716865|NCT00094055|19692653|P1|Overall Study|Lack of Efficacy|17
5716866|NCT00094055|19692653|P1|Overall Study|Death|4
5716867|NCT00094055|19692653|P1|Overall Study|Adverse Event|11
5716868|NCT00093808|19692710|P1|Overall Study|Protocol Violation|1
5716869|NCT00093808|19692710|P1|Overall Study|Cancel participation before receiving tx|1
5716870|NCT00093795|19692720|P3|Overall Study|No follow up data|17
5716871|NCT00093795|19692721|P2|Overall Study|No follow up data|16
5716872|NCT00093795|19692722|P1|Overall Study|No follow up data|20
5716873|NCT00093496|19692767|P2|Overall Study|Protocol Violation|3
5716874|NCT00093496|19692768|P1|Overall Study|Protocol Violation|1
5716875|NCT00093470|19692781|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
5716876|NCT00093470|19692782|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
5716877|NCT00093470|19692781|P2|Overall Study|Never started treatment|0
5716878|NCT00093470|19692782|P1|Overall Study|Never started treatment|1
5716879|NCT00093470|19692781|P2|Overall Study|Physician Decision|0
5716880|NCT00093470|19692782|P1|Overall Study|Physician Decision|2
5716881|NCT00093470|19692781|P2|Overall Study|Other complicating disease|0
5716882|NCT00093470|19692782|P1|Overall Study|Other complicating disease|3
5716883|NCT00093470|19692781|P2|Overall Study|Alternative therapy|0
5716884|NCT00093470|19692782|P1|Overall Study|Alternative therapy|2
5716885|NCT00093470|19692781|P2|Overall Study|Withdrawal by Subject|0
5716886|NCT00093470|19692782|P1|Overall Study|Withdrawal by Subject|8
5716887|NCT00093470|19692781|P2|Overall Study|Death|0
5716888|NCT00093470|19692782|P1|Overall Study|Death|2
5716889|NCT00093470|19692781|P2|Overall Study|Adverse Event|0
5716890|NCT00093470|19692782|P1|Overall Study|Adverse Event|15
5716891|NCT00093470|19692781|P2|Overall Study|Disease progression|0
5716892|NCT00093470|19692782|P1|Overall Study|Disease progression|39
5716893|NCT00093145|19692796|P1|Overall Study|Other|1
5716894|NCT00093145|19692796|P1|Overall Study|Withdrawal by Subject|9
5716895|NCT00093145|19692796|P1|Overall Study|Physician Decision|5
5716896|NCT00093145|19692796|P1|Overall Study|Unacceptable Toxicity Only|2
5716897|NCT00093015|19692838|P2|Overall Study|Death|385
5716898|NCT00093015|19692839|P1|Overall Study|Death|375
5716899|NCT00093015|19692838|P2|Overall Study|Lost to Follow-up|108
5716900|NCT00093015|19692839|P1|Overall Study|Lost to Follow-up|96
5716901|NCT00093015|19692838|P2|Overall Study|Withdrawal by Subject|171
5716902|NCT00093015|19692839|P1|Overall Study|Withdrawal by Subject|194
5716903|NCT00092677|19692867|P2|Overall Study|Adminstrative|9
5716904|NCT00092677|19692868|P1|Overall Study|Adminstrative|5
5716905|NCT00092677|19692867|P2|Overall Study|Lost to Follow-up|2
5716906|NCT00092677|19692868|P1|Overall Study|Lost to Follow-up|0
5716907|NCT00092547|19692912|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
5716908|NCT00092547|19692913|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
5716909|NCT00092547|19692914|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
5716910|NCT00092547|19692912|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
5716911|NCT00092547|19692913|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
5716912|NCT00092547|19692914|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
5716913|NCT00092547|19692912|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
5716914|NCT00092547|19692913|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
5716915|NCT00092547|19692914|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
5716916|NCT00092547|19692912|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
5716917|NCT00092547|19692913|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
5716918|NCT00092547|19692914|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
5716919|NCT00092547|19692912|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
5716920|NCT00092547|19692913|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
5716921|NCT00092547|19692914|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
5716922|NCT00092547|19692912|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
5716923|NCT00092547|19692913|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
5716924|NCT00092547|19692914|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
5716925|NCT00092547|19692912|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
5716926|NCT00092547|19692913|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
5716927|NCT00092547|19692914|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
5716928|NCT00092547|19692912|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
5716929|NCT00092547|19692913|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
5716930|NCT00092547|19692914|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
5716931|NCT00092547|19692912|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
5716932|NCT00092547|19692913|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
5716933|NCT00092547|19692914|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
5716934|NCT00092547|19692912|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
5716935|NCT00092547|19692913|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
5716936|NCT00092547|19692914|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
5716937|NCT00092547|19692912|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
5716938|NCT00092547|19692913|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
5716939|NCT00092547|19692914|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
5716940|NCT00092547|19692912|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
5716941|NCT00092547|19692913|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
5716942|NCT00092547|19692914|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
5716943|NCT00092547|19692912|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
5716944|NCT00092547|19692913|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
5716945|NCT00092547|19692914|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
5716946|NCT00092547|19692912|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
5716947|NCT00092547|19692913|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
5716948|NCT00092547|19692914|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
5716949|NCT00092547|19692912|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
5716950|NCT00092547|19692913|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
5716951|NCT00092547|19692914|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
5716952|NCT00092547|19692912|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
5716953|NCT00092547|19692913|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
5716954|NCT00092547|19692914|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
5716955|NCT00092547|19692912|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
5716956|NCT00092547|19692913|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
5716957|NCT00092547|19692914|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
5716958|NCT00092547|19692912|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
5716959|NCT00092547|19692913|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
5716960|NCT00092547|19692914|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
5716961|NCT00092547|19692912|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
5716962|NCT00092547|19692913|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
5716963|NCT00092547|19692914|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
5716964|NCT00092547|19692912|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
5716965|NCT00092547|19692913|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
5716966|NCT00092547|19692914|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
5716967|NCT00092547|19692912|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
5716968|NCT00092547|19692913|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
5716969|NCT00092547|19692914|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
5716970|NCT00092534|19692958|P5|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
5716971|NCT00092534|19692959|P4|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
5716972|NCT00092534|19692960|P3|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
5716973|NCT00092534|19692961|P2|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
5716974|NCT00092534|19692962|P1|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
5716975|NCT00092534|19692958|P5|Base Study EXT|Protocol Violation|0
5716976|NCT00092534|19692959|P4|Base Study EXT|Protocol Violation|0
5716977|NCT00092534|19692960|P3|Base Study EXT|Protocol Violation|15
5716978|NCT00092534|19692961|P2|Base Study EXT|Protocol Violation|0
5716979|NCT00092534|19692962|P1|Base Study EXT|Protocol Violation|0
5716980|NCT00092534|19692958|P5|Base Study EXT|Study ended|0
5716981|NCT00092534|19692959|P4|Base Study EXT|Study ended|0
5716982|NCT00092534|19692960|P3|Base Study EXT|Study ended|29
5716983|NCT00092534|19692961|P2|Base Study EXT|Study ended|0
5716984|NCT00092534|19692962|P1|Base Study EXT|Study ended|0
5716985|NCT00092534|19692958|P5|Base Study EXT|Site closed|0
5716986|NCT00092534|19692959|P4|Base Study EXT|Site closed|0
5716987|NCT00092534|19692960|P3|Base Study EXT|Site closed|21
5716988|NCT00092534|19692961|P2|Base Study EXT|Site closed|0
5716989|NCT00092534|19692962|P1|Base Study EXT|Site closed|0
5716990|NCT00092534|19692958|P5|Base Study EXT|Travel|0
5716991|NCT00092534|19692959|P4|Base Study EXT|Travel|0
5716992|NCT00092534|19692960|P3|Base Study EXT|Travel|2
5716993|NCT00092534|19692961|P2|Base Study EXT|Travel|0
5716994|NCT00092534|19692962|P1|Base Study EXT|Travel|0
5716995|NCT00092534|19692958|P5|Base Study EXT|Participant moved|0
5716996|NCT00092534|19692959|P4|Base Study EXT|Participant moved|0
5716997|NCT00092534|19692960|P3|Base Study EXT|Participant moved|6
5716998|NCT00092534|19692961|P2|Base Study EXT|Participant moved|0
5716999|NCT00092534|19692962|P1|Base Study EXT|Participant moved|0
5717000|NCT00092534|19692958|P5|Base Study EXT|Withdrawal by Subject|0
5717001|NCT00092534|19692959|P4|Base Study EXT|Withdrawal by Subject|0
5717002|NCT00092534|19692960|P3|Base Study EXT|Withdrawal by Subject|18
5717003|NCT00092534|19692961|P2|Base Study EXT|Withdrawal by Subject|0
5717004|NCT00092534|19692962|P1|Base Study EXT|Withdrawal by Subject|0
5717005|NCT00092534|19692958|P5|Base Study EXT|Pregnancy|0
5717006|NCT00092534|19692959|P4|Base Study EXT|Pregnancy|0
5717007|NCT00092534|19692960|P3|Base Study EXT|Pregnancy|12
5717008|NCT00092534|19692961|P2|Base Study EXT|Pregnancy|0
5717009|NCT00092534|19692962|P1|Base Study EXT|Pregnancy|0
5717010|NCT00092534|19692958|P5|Base Study EXT|Physician Decision|0
5717011|NCT00092534|19692959|P4|Base Study EXT|Physician Decision|0
5717012|NCT00092534|19692960|P3|Base Study EXT|Physician Decision|1
5717013|NCT00092534|19692961|P2|Base Study EXT|Physician Decision|0
5717014|NCT00092534|19692962|P1|Base Study EXT|Physician Decision|0
5717015|NCT00092534|19692958|P5|Base Study EXT|Lost to Follow-up|0
5717016|NCT00092534|19692959|P4|Base Study EXT|Lost to Follow-up|0
5717017|NCT00092534|19692960|P3|Base Study EXT|Lost to Follow-up|41
5717018|NCT00092534|19692961|P2|Base Study EXT|Lost to Follow-up|0
5717019|NCT00092534|19692962|P1|Base Study EXT|Lost to Follow-up|0
5717020|NCT00092534|19692958|P5|Base Study Follow-Up Period|Subjects in extension|0
5717021|NCT00092534|19692959|P4|Base Study Follow-Up Period|Subjects in extension|0
5717022|NCT00092534|19692960|P3|Base Study Follow-Up Period|Subjects in extension|0
5717023|NCT00092534|19692961|P2|Base Study Follow-Up Period|Subjects in extension|371
5717024|NCT00092534|19692962|P1|Base Study Follow-Up Period|Subjects in extension|15
5717025|NCT00092534|19692958|P5|Base Study Follow-Up Period|Subjects continuing|0
5717026|NCT00092534|19692959|P4|Base Study Follow-Up Period|Subjects continuing|0
5717027|NCT00092534|19692960|P3|Base Study Follow-Up Period|Subjects continuing|0
5717028|NCT00092534|19692961|P2|Base Study Follow-Up Period|Subjects continuing|31
5717029|NCT00092534|19692962|P1|Base Study Follow-Up Period|Subjects continuing|27
5717030|NCT00092534|19692958|P5|Base Study Follow-Up Period|Site Closed|0
5717031|NCT00092534|19692959|P4|Base Study Follow-Up Period|Site Closed|0
5717032|NCT00092534|19692960|P3|Base Study Follow-Up Period|Site Closed|0
5717033|NCT00092534|19692961|P2|Base Study Follow-Up Period|Site Closed|2
5717034|NCT00092534|19692962|P1|Base Study Follow-Up Period|Site Closed|0
5717035|NCT00092534|19692958|P5|Base Study Follow-Up Period|Travel|0
5717036|NCT00092534|19692959|P4|Base Study Follow-Up Period|Travel|0
5717037|NCT00092534|19692960|P3|Base Study Follow-Up Period|Travel|0
5717038|NCT00092534|19692961|P2|Base Study Follow-Up Period|Travel|7
5717039|NCT00092534|19692962|P1|Base Study Follow-Up Period|Travel|10
5717040|NCT00092534|19692958|P5|Base Study Follow-Up Period|Moved|0
5717041|NCT00092534|19692959|P4|Base Study Follow-Up Period|Moved|0
5717042|NCT00092534|19692960|P3|Base Study Follow-Up Period|Moved|0
5717043|NCT00092534|19692961|P2|Base Study Follow-Up Period|Moved|58
5717044|NCT00092534|19692962|P1|Base Study Follow-Up Period|Moved|62
5717045|NCT00092534|19692958|P5|Base Study Follow-Up Period|Withdrawal by Subject|0
5717046|NCT00092534|19692959|P4|Base Study Follow-Up Period|Withdrawal by Subject|0
5717047|NCT00092534|19692960|P3|Base Study Follow-Up Period|Withdrawal by Subject|0
5717048|NCT00092534|19692961|P2|Base Study Follow-Up Period|Withdrawal by Subject|62
5717049|NCT00092534|19692962|P1|Base Study Follow-Up Period|Withdrawal by Subject|71
5717050|NCT00092534|19692958|P5|Base Study Follow-Up Period|Protocol Violation|0
5717051|NCT00092534|19692959|P4|Base Study Follow-Up Period|Protocol Violation|0
5717052|NCT00092534|19692960|P3|Base Study Follow-Up Period|Protocol Violation|0
5717053|NCT00092534|19692961|P2|Base Study Follow-Up Period|Protocol Violation|2
5717054|NCT00092534|19692962|P1|Base Study Follow-Up Period|Protocol Violation|1
5717055|NCT00092534|19692958|P5|Base Study Follow-Up Period|Pregnancy|0
5717056|NCT00092534|19692959|P4|Base Study Follow-Up Period|Pregnancy|0
5717057|NCT00092534|19692960|P3|Base Study Follow-Up Period|Pregnancy|0
5717058|NCT00092534|19692961|P2|Base Study Follow-Up Period|Pregnancy|10
5717059|NCT00092534|19692962|P1|Base Study Follow-Up Period|Pregnancy|6
5717060|NCT00092534|19692958|P5|Base Study Follow-Up Period|Lost to Follow-up|0
5717061|NCT00092534|19692959|P4|Base Study Follow-Up Period|Lost to Follow-up|0
5717062|NCT00092534|19692960|P3|Base Study Follow-Up Period|Lost to Follow-up|0
5717063|NCT00092534|19692961|P2|Base Study Follow-Up Period|Lost to Follow-up|146
5717064|NCT00092534|19692962|P1|Base Study Follow-Up Period|Lost to Follow-up|120
5717065|NCT00092534|19692958|P5|Base Study Follow-Up Period|Death|0
5717066|NCT00092534|19692959|P4|Base Study Follow-Up Period|Death|0
5717067|NCT00092534|19692960|P3|Base Study Follow-Up Period|Death|0
5717068|NCT00092534|19692961|P2|Base Study Follow-Up Period|Death|1
5717069|NCT00092534|19692962|P1|Base Study Follow-Up Period|Death|2
5717070|NCT00092534|19692958|P5|Base Study Follow-Up Period|Adverse Event|0
5717071|NCT00092534|19692959|P4|Base Study Follow-Up Period|Adverse Event|0
5717072|NCT00092534|19692960|P3|Base Study Follow-Up Period|Adverse Event|0
5717073|NCT00092534|19692961|P2|Base Study Follow-Up Period|Adverse Event|4
5717074|NCT00092534|19692962|P1|Base Study Follow-Up Period|Adverse Event|2
5717075|NCT00092534|19692958|P5|Base Study Vaccination Period|Site Closed|0
5717076|NCT00092534|19692959|P4|Base Study Vaccination Period|Site Closed|0
5717077|NCT00092534|19692960|P3|Base Study Vaccination Period|Site Closed|0
5717078|NCT00092534|19692961|P2|Base Study Vaccination Period|Site Closed|1
5717079|NCT00092534|19692962|P1|Base Study Vaccination Period|Site Closed|0
5717080|NCT00092534|19692958|P5|Base Study Vaccination Period|Travel|0
5717081|NCT00092534|19692959|P4|Base Study Vaccination Period|Travel|0
5717082|NCT00092534|19692960|P3|Base Study Vaccination Period|Travel|0
5717083|NCT00092534|19692961|P2|Base Study Vaccination Period|Travel|0
5717084|NCT00092534|19692962|P1|Base Study Vaccination Period|Travel|1
5717085|NCT00092534|19692958|P5|Base Study Vaccination Period|New Medical History (Not AEs)|0
5717086|NCT00092534|19692959|P4|Base Study Vaccination Period|New Medical History (Not AEs)|0
5717087|NCT00092534|19692960|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
5717088|NCT00092534|19692961|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
5717089|NCT00092534|19692962|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
5717090|NCT00092534|19692958|P5|Base Study Vaccination Period|Moved|0
5717091|NCT00092534|19692959|P4|Base Study Vaccination Period|Moved|0
5717092|NCT00092534|19692960|P3|Base Study Vaccination Period|Moved|0
5717093|NCT00092534|19692961|P2|Base Study Vaccination Period|Moved|12
5717094|NCT00092534|19692962|P1|Base Study Vaccination Period|Moved|14
5717095|NCT00092534|19692958|P5|Base Study Vaccination Period|Withdrawal by Subject|0
5717096|NCT00092534|19692959|P4|Base Study Vaccination Period|Withdrawal by Subject|0
5717097|NCT00092534|19692960|P3|Base Study Vaccination Period|Withdrawal by Subject|0
5717098|NCT00092534|19692961|P2|Base Study Vaccination Period|Withdrawal by Subject|58
5717099|NCT00092534|19692962|P1|Base Study Vaccination Period|Withdrawal by Subject|85
5717100|NCT00092534|19692958|P5|Base Study Vaccination Period|Protocol Violation|0
5717101|NCT00092534|19692959|P4|Base Study Vaccination Period|Protocol Violation|0
5717102|NCT00092534|19692960|P3|Base Study Vaccination Period|Protocol Violation|0
5717103|NCT00092534|19692961|P2|Base Study Vaccination Period|Protocol Violation|1
5717104|NCT00092534|19692962|P1|Base Study Vaccination Period|Protocol Violation|2
5717105|NCT00092534|19692958|P5|Base Study Vaccination Period|Pregnancy|0
5717106|NCT00092534|19692959|P4|Base Study Vaccination Period|Pregnancy|0
5717107|NCT00092534|19692960|P3|Base Study Vaccination Period|Pregnancy|0
5717108|NCT00092534|19692961|P2|Base Study Vaccination Period|Pregnancy|7
5717109|NCT00092534|19692962|P1|Base Study Vaccination Period|Pregnancy|9
5717110|NCT00092534|19692958|P5|Base Study Vaccination Period|Physician Decision|0
5717111|NCT00092534|19692959|P4|Base Study Vaccination Period|Physician Decision|0
5717112|NCT00092534|19692960|P3|Base Study Vaccination Period|Physician Decision|0
5717113|NCT00092534|19692961|P2|Base Study Vaccination Period|Physician Decision|0
5717114|NCT00092534|19692962|P1|Base Study Vaccination Period|Physician Decision|1
5717115|NCT00092534|19692958|P5|Base Study Vaccination Period|Lost to Follow-up|0
5717116|NCT00092534|19692959|P4|Base Study Vaccination Period|Lost to Follow-up|0
5717117|NCT00092534|19692960|P3|Base Study Vaccination Period|Lost to Follow-up|0
5717118|NCT00092534|19692961|P2|Base Study Vaccination Period|Lost to Follow-up|37
5717119|NCT00092534|19692962|P1|Base Study Vaccination Period|Lost to Follow-up|41
5717120|NCT00092534|19692958|P5|Base Study Vaccination Period|Death|0
5717121|NCT00092534|19692959|P4|Base Study Vaccination Period|Death|0
5717122|NCT00092534|19692960|P3|Base Study Vaccination Period|Death|0
5717123|NCT00092534|19692961|P2|Base Study Vaccination Period|Death|4
5717124|NCT00092534|19692962|P1|Base Study Vaccination Period|Death|5
5717125|NCT00092534|19692958|P5|Base Study Vaccination Period|Adverse Event|0
5717126|NCT00092534|19692959|P4|Base Study Vaccination Period|Adverse Event|0
5717127|NCT00092534|19692960|P3|Base Study Vaccination Period|Adverse Event|0
5717128|NCT00092534|19692961|P2|Base Study Vaccination Period|Adverse Event|1
5717129|NCT00092534|19692962|P1|Base Study Vaccination Period|Adverse Event|3
5717130|NCT00092534|19692958|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
5717131|NCT00092534|19692959|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
5717132|NCT00092534|19692960|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
5717133|NCT00092534|19692961|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
5717134|NCT00092534|19692962|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
5717135|NCT00092521|19692993|P4|Extension Study (Group 4)|Unable/unwilling to return|25
5717136|NCT00092521|19692994|P3|Extension Study (Group 4)|Unable/unwilling to return|0
5717137|NCT00092521|19692995|P2|Extension Study (Group 4)|Unable/unwilling to return|0
5717138|NCT00092521|19692996|P1|Extension Study (Group 4)|Unable/unwilling to return|0
5717139|NCT00092521|19692993|P4|Extension Study (Group 4)|Site Terminated|4
5717140|NCT00092521|19692994|P3|Extension Study (Group 4)|Site Terminated|0
5717141|NCT00092521|19692995|P2|Extension Study (Group 4)|Site Terminated|0
5717142|NCT00092521|19692996|P1|Extension Study (Group 4)|Site Terminated|0
5717143|NCT00092521|19692993|P4|Extension Study (Group 4)|Moved|16
5717144|NCT00092521|19692994|P3|Extension Study (Group 4)|Moved|0
5717145|NCT00092521|19692995|P2|Extension Study (Group 4)|Moved|0
5717146|NCT00092521|19692996|P1|Extension Study (Group 4)|Moved|0
5717147|NCT00092521|19692993|P4|Extension Study (Group 4)|Withdrawal by Subject|46
5717148|NCT00092521|19692994|P3|Extension Study (Group 4)|Withdrawal by Subject|0
5717149|NCT00092521|19692995|P2|Extension Study (Group 4)|Withdrawal by Subject|0
5717150|NCT00092521|19692996|P1|Extension Study (Group 4)|Withdrawal by Subject|0
5717151|NCT00092521|19692993|P4|Extension Study (Group 4)|Protocol Violation|2
5717152|NCT00092521|19692994|P3|Extension Study (Group 4)|Protocol Violation|0
5717153|NCT00092521|19692995|P2|Extension Study (Group 4)|Protocol Violation|0
5717154|NCT00092521|19692996|P1|Extension Study (Group 4)|Protocol Violation|0
5717155|NCT00092521|19692993|P4|Extension Study (Group 4)|Pregnancy|4
5717156|NCT00092521|19692994|P3|Extension Study (Group 4)|Pregnancy|0
5717157|NCT00092521|19692995|P2|Extension Study (Group 4)|Pregnancy|0
5717158|NCT00092521|19692996|P1|Extension Study (Group 4)|Pregnancy|0
5717159|NCT00092521|19692993|P4|Extension Study (Group 4)|Lost to Follow-up|87
5717160|NCT00092521|19692994|P3|Extension Study (Group 4)|Lost to Follow-up|0
5717161|NCT00092521|19692995|P2|Extension Study (Group 4)|Lost to Follow-up|0
5717162|NCT00092521|19692996|P1|Extension Study (Group 4)|Lost to Follow-up|0
5717163|NCT00092521|19692993|P4|Extension Study (Group 4)|Adverse Event|2
5717164|NCT00092521|19692994|P3|Extension Study (Group 4)|Adverse Event|0
5717165|NCT00092521|19692995|P2|Extension Study (Group 4)|Adverse Event|0
5717166|NCT00092521|19692996|P1|Extension Study (Group 4)|Adverse Event|0
5717167|NCT00092521|19692993|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
5717168|NCT00092521|19692994|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
5717169|NCT00092521|19692995|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
5717170|NCT00092521|19692996|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
5717171|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Visits Compressed|0
5717172|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Visits Compressed|5
5717173|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Visits Compressed|0
5717174|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Visits Compressed|5
5717175|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Travel|0
5717176|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Travel|0
5717177|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Travel|0
5717178|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Travel|2
5717179|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Site Terminated|0
5717180|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Site Terminated|3
5717181|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Site Terminated|0
5717182|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Site Terminated|3
5717183|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Moved|0
5717184|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Moved|28
5717185|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Moved|2
5717186|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Moved|32
5717187|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
5717188|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
5717189|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
5717190|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
5717191|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Protocol Violation|0
5717192|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Protocol Violation|5
5717193|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Protocol Violation|1
5717194|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Protocol Violation|1
5717195|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
5717196|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
5717197|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
5717198|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
5717199|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Death|0
5717200|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Death|1
5717201|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Death|0
5717202|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Death|2
5717203|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Adverse Event|0
5717204|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Adverse Event|0
5717205|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Adverse Event|0
5717206|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Adverse Event|1
5717207|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Subjects in Extension|0
5717208|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Subjects in Extension|412
5717209|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Subjects in Extension|109
5717210|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Subjects in Extension|13
5717211|NCT00092521|19692993|P4|Follow-Up (After Month 7)|Subjects Continuing|0
5717212|NCT00092521|19692994|P3|Follow-Up (After Month 7)|Subjects Continuing|35
5717213|NCT00092521|19692995|P2|Follow-Up (After Month 7)|Subjects Continuing|4
5717214|NCT00092521|19692996|P1|Follow-Up (After Month 7)|Subjects Continuing|34
5717215|NCT00092521|19692993|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
5717216|NCT00092521|19692994|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
5717217|NCT00092521|19692995|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
5717218|NCT00092521|19692996|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
5717219|NCT00092521|19692993|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
5717220|NCT00092521|19692994|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
5717221|NCT00092521|19692995|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
5717222|NCT00092521|19692996|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
5717223|NCT00092521|19692993|P4|Vaccination (Day 1 Through Month 7)|Moved|0
5717224|NCT00092521|19692994|P3|Vaccination (Day 1 Through Month 7)|Moved|18
5717225|NCT00092521|19692995|P2|Vaccination (Day 1 Through Month 7)|Moved|1
5717226|NCT00092521|19692996|P1|Vaccination (Day 1 Through Month 7)|Moved|14
5717227|NCT00092521|19692993|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
5717228|NCT00092521|19692994|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
5717229|NCT00092521|19692995|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
5717230|NCT00092521|19692996|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
5717231|NCT00092521|19692993|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
5717232|NCT00092521|19692994|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
5717233|NCT00092521|19692995|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
5717234|NCT00092521|19692996|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
5717235|NCT00092521|19692993|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
5717236|NCT00092521|19692994|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
5717237|NCT00092521|19692995|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
5717238|NCT00092521|19692996|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
5717239|NCT00092521|19692993|P4|Vaccination (Day 1 Through Month 7)|Death|0
5717240|NCT00092521|19692994|P3|Vaccination (Day 1 Through Month 7)|Death|1
5717241|NCT00092521|19692995|P2|Vaccination (Day 1 Through Month 7)|Death|0
5717242|NCT00092521|19692996|P1|Vaccination (Day 1 Through Month 7)|Death|0
5717243|NCT00092521|19692993|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
5717244|NCT00092521|19692994|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
5717245|NCT00092521|19692995|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
5717246|NCT00092521|19692996|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
5717247|NCT00092521|19692993|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
5717248|NCT00092521|19692994|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
5717249|NCT00092521|19692995|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
5717250|NCT00092521|19692996|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
5717251|NCT00092495|19693010|P5|Base Study Follow-up Period|Withdrawal by Subject|0
5717252|NCT00092495|19693011|P4|Base Study Follow-up Period|Withdrawal by Subject|0
5717253|NCT00092495|19693012|P3|Base Study Follow-up Period|Withdrawal by Subject|0
5717254|NCT00092495|19693013|P2|Base Study Follow-up Period|Withdrawal by Subject|0
5717255|NCT00092495|19693014|P1|Base Study Follow-up Period|Withdrawal by Subject|2
5717256|NCT00092495|19693010|P5|Base Study Follow-up Period|Lost to Follow-up|0
5717257|NCT00092495|19693011|P4|Base Study Follow-up Period|Lost to Follow-up|12
5717258|NCT00092495|19693012|P3|Base Study Follow-up Period|Lost to Follow-up|3
5717259|NCT00092495|19693013|P2|Base Study Follow-up Period|Lost to Follow-up|3
5717260|NCT00092495|19693014|P1|Base Study Follow-up Period|Lost to Follow-up|1
5717261|NCT00092495|19693010|P5|Base Study Follow-up Period|Extended|0
5717262|NCT00092495|19693011|P4|Base Study Follow-up Period|Extended|2
5717263|NCT00092495|19693012|P3|Base Study Follow-up Period|Extended|1
5717264|NCT00092495|19693013|P2|Base Study Follow-up Period|Extended|0
5717265|NCT00092495|19693014|P1|Base Study Follow-up Period|Extended|0
5717266|NCT00092495|19693010|P5|Base Study Vaccination Period|Withdrawal by Subject|0
5717267|NCT00092495|19693011|P4|Base Study Vaccination Period|Withdrawal by Subject|25
5717268|NCT00092495|19693012|P3|Base Study Vaccination Period|Withdrawal by Subject|14
5717269|NCT00092495|19693013|P2|Base Study Vaccination Period|Withdrawal by Subject|10
5717270|NCT00092495|19693014|P1|Base Study Vaccination Period|Withdrawal by Subject|9
5717271|NCT00092495|19693010|P5|Base Study Vaccination Period|Protocol Violation|0
5717272|NCT00092495|19693011|P4|Base Study Vaccination Period|Protocol Violation|0
5717273|NCT00092495|19693012|P3|Base Study Vaccination Period|Protocol Violation|0
5717274|NCT00092495|19693013|P2|Base Study Vaccination Period|Protocol Violation|0
5717275|NCT00092495|19693014|P1|Base Study Vaccination Period|Protocol Violation|1
5717276|NCT00092495|19693010|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
5717277|NCT00092495|19693011|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
5717278|NCT00092495|19693012|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
5717279|NCT00092495|19693013|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
5717366|NCT00092443|19693132|P1|Overall Study|Adverse Event|9
5717280|NCT00092495|19693014|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
5717281|NCT00092495|19693010|P5|Base Study Vaccination Period|Pregnancy|0
5717282|NCT00092495|19693011|P4|Base Study Vaccination Period|Pregnancy|0
5717283|NCT00092495|19693012|P3|Base Study Vaccination Period|Pregnancy|0
5717284|NCT00092495|19693013|P2|Base Study Vaccination Period|Pregnancy|0
5717285|NCT00092495|19693014|P1|Base Study Vaccination Period|Pregnancy|2
5717286|NCT00092495|19693010|P5|Base Study Vaccination Period|Other|0
5717287|NCT00092495|19693011|P4|Base Study Vaccination Period|Other|2
5717288|NCT00092495|19693012|P3|Base Study Vaccination Period|Other|0
5717289|NCT00092495|19693013|P2|Base Study Vaccination Period|Other|1
5717290|NCT00092495|19693014|P1|Base Study Vaccination Period|Other|1
5717291|NCT00092495|19693010|P5|Base Study Vaccination Period|Moved|0
5717292|NCT00092495|19693011|P4|Base Study Vaccination Period|Moved|2
5717293|NCT00092495|19693012|P3|Base Study Vaccination Period|Moved|2
5717294|NCT00092495|19693013|P2|Base Study Vaccination Period|Moved|1
5717295|NCT00092495|19693014|P1|Base Study Vaccination Period|Moved|3
5717296|NCT00092495|19693010|P5|Base Study Vaccination Period|Lost to Follow-up|0
5717297|NCT00092495|19693011|P4|Base Study Vaccination Period|Lost to Follow-up|36
5717298|NCT00092495|19693012|P3|Base Study Vaccination Period|Lost to Follow-up|11
5717299|NCT00092495|19693013|P2|Base Study Vaccination Period|Lost to Follow-up|6
5717300|NCT00092495|19693014|P1|Base Study Vaccination Period|Lost to Follow-up|16
5717301|NCT00092495|19693010|P5|Base Study Vaccination Period|Adverse Event|0
5717302|NCT00092495|19693011|P4|Base Study Vaccination Period|Adverse Event|3
5717303|NCT00092495|19693012|P3|Base Study Vaccination Period|Adverse Event|0
5717304|NCT00092495|19693013|P2|Base Study Vaccination Period|Adverse Event|0
5717305|NCT00092495|19693014|P1|Base Study Vaccination Period|Adverse Event|1
5717306|NCT00092495|19693010|P5|Base Study Vaccination Period|*Pregnancy|0
5717307|NCT00092495|19693011|P4|Base Study Vaccination Period|*Pregnancy|7
5717308|NCT00092495|19693012|P3|Base Study Vaccination Period|*Pregnancy|5
5717309|NCT00092495|19693013|P2|Base Study Vaccination Period|*Pregnancy|2
5717310|NCT00092495|19693014|P1|Base Study Vaccination Period|*Pregnancy|0
5717311|NCT00092495|19693010|P5|Base Study Vaccination Period|*Other reasons|0
5717312|NCT00092495|19693011|P4|Base Study Vaccination Period|*Other reasons|1
5717313|NCT00092495|19693012|P3|Base Study Vaccination Period|*Other reasons|0
5717314|NCT00092495|19693013|P2|Base Study Vaccination Period|*Other reasons|0
5717315|NCT00092495|19693014|P1|Base Study Vaccination Period|*Other reasons|1
5717316|NCT00092495|19693010|P5|Base Study Vaccination Period|*Clinical AE|0
5717317|NCT00092495|19693011|P4|Base Study Vaccination Period|*Clinical AE|2
5717318|NCT00092495|19693012|P3|Base Study Vaccination Period|*Clinical AE|1
5717319|NCT00092495|19693013|P2|Base Study Vaccination Period|*Clinical AE|0
5717320|NCT00092495|19693014|P1|Base Study Vaccination Period|*Clinical AE|1
5717321|NCT00092495|19693010|P5|Base Study Vaccination Period|Extended|0
5717322|NCT00092495|19693011|P4|Base Study Vaccination Period|Extended|1
5717323|NCT00092495|19693012|P3|Base Study Vaccination Period|Extended|0
5717324|NCT00092495|19693013|P2|Base Study Vaccination Period|Extended|0
5717325|NCT00092495|19693014|P1|Base Study Vaccination Period|Extended|0
5717326|NCT00092495|19693010|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
5717327|NCT00092495|19693011|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
5717328|NCT00092495|19693012|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
5717329|NCT00092495|19693013|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
5717330|NCT00092495|19693014|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
5717331|NCT00092456|19693080|P4|Overall Study|Other|0
5717332|NCT00092456|19693081|P3|Overall Study|Other|3
5717333|NCT00092456|19693082|P2|Overall Study|Other|2
5717334|NCT00092456|19693083|P1|Overall Study|Other|4
5717335|NCT00092456|19693080|P4|Overall Study|Moved|1
5717336|NCT00092456|19693081|P3|Overall Study|Moved|0
5717337|NCT00092456|19693082|P2|Overall Study|Moved|1
5717338|NCT00092456|19693083|P1|Overall Study|Moved|1
5717339|NCT00092456|19693080|P4|Overall Study|Withdrawal by Subject|6
5717340|NCT00092456|19693081|P3|Overall Study|Withdrawal by Subject|16
5717341|NCT00092456|19693082|P2|Overall Study|Withdrawal by Subject|5
5717342|NCT00092456|19693083|P1|Overall Study|Withdrawal by Subject|13
5717343|NCT00092456|19693080|P4|Overall Study|Protocol Violation|6
5717344|NCT00092456|19693081|P3|Overall Study|Protocol Violation|8
5717345|NCT00092456|19693082|P2|Overall Study|Protocol Violation|7
5717346|NCT00092456|19693083|P1|Overall Study|Protocol Violation|5
5717347|NCT00092456|19693080|P4|Overall Study|Lost to Follow-up|2
5717348|NCT00092456|19693081|P3|Overall Study|Lost to Follow-up|1
5717349|NCT00092456|19693082|P2|Overall Study|Lost to Follow-up|2
5717350|NCT00092456|19693083|P1|Overall Study|Lost to Follow-up|2
5717351|NCT00092456|19693080|P4|Overall Study|Adverse Event|1
5717352|NCT00092456|19693081|P3|Overall Study|Adverse Event|1
5717353|NCT00092456|19693082|P2|Overall Study|Adverse Event|0
5717354|NCT00092456|19693083|P1|Overall Study|Adverse Event|0
5717355|NCT00092443|19693131|P2|Overall Study|Other|13
5717356|NCT00092443|19693132|P1|Overall Study|Other|17
5717357|NCT00092443|19693131|P2|Overall Study|Moved|5
5717358|NCT00092443|19693132|P1|Overall Study|Moved|5
5717359|NCT00092443|19693131|P2|Overall Study|Withdrawal by Subject|11
5717360|NCT00092443|19693132|P1|Overall Study|Withdrawal by Subject|9
5717361|NCT00092443|19693131|P2|Overall Study|Protocol Violation|9
5717362|NCT00092443|19693132|P1|Overall Study|Protocol Violation|11
5717363|NCT00092443|19693131|P2|Overall Study|Lost to Follow-up|3
5717364|NCT00092443|19693132|P1|Overall Study|Lost to Follow-up|7
5717365|NCT00092443|19693131|P2|Overall Study|Adverse Event|13
5717367|NCT00092417|19693150|P2|Overall Study|Other|0
5717368|NCT00092417|19693151|P1|Overall Study|Other|1
5717369|NCT00092417|19693150|P2|Overall Study|Withdrawal by Subject|1
5717370|NCT00092417|19693151|P1|Overall Study|Withdrawal by Subject|2
5717371|NCT00092417|19693150|P2|Overall Study|Lost to Follow-up|0
5717372|NCT00092417|19693151|P1|Overall Study|Lost to Follow-up|2
5717373|NCT00092131|19693165|P2|Treatment Period II|Adverse Event|1
5717374|NCT00092131|19693166|P1|Treatment Period II|Adverse Event|0
5717375|NCT00092131|19693165|P2|Treatment Period I|Adverse Event|0
5717376|NCT00092131|19693166|P1|Treatment Period I|Adverse Event|1
5717377|NCT00092118|19693196|P2|Overall Study|Other|5
5717378|NCT00092118|19693197|P1|Overall Study|Other|6
5717379|NCT00092118|19693196|P2|Overall Study|Withdrawal by Subject|10
5717380|NCT00092118|19693197|P1|Overall Study|Withdrawal by Subject|4
5717381|NCT00092118|19693196|P2|Overall Study|Protocol Violation|25
5717382|NCT00092118|19693197|P1|Overall Study|Protocol Violation|23
5717383|NCT00092118|19693196|P2|Overall Study|Lost to Follow-up|3
5717384|NCT00092118|19693197|P1|Overall Study|Lost to Follow-up|4
5717385|NCT00092118|19693196|P2|Overall Study|Lack of Efficacy|14
5717386|NCT00092118|19693197|P1|Overall Study|Lack of Efficacy|12
5717387|NCT00092118|19693196|P2|Overall Study|Adverse Event|32
5717388|NCT00092118|19693197|P1|Overall Study|Adverse Event|35
5717389|NCT00091949|19693231|P2|Overall Study|Lost to Follow-up|41
5717390|NCT00091949|19693232|P1|Overall Study|Lost to Follow-up|58
5717391|NCT00091949|19693231|P2|Overall Study|Withdrawal by Subject|110
5717392|NCT00091949|19693232|P1|Overall Study|Withdrawal by Subject|117
5717393|NCT00091832|19693256|P6|Overall Study|Protocol Violation|1
5717394|NCT00091832|19693257|P5|Overall Study|Protocol Violation|0
5717395|NCT00091832|19693258|P4|Overall Study|Protocol Violation|0
5717396|NCT00091832|19693259|P3|Overall Study|Protocol Violation|1
5717397|NCT00091832|19693260|P2|Overall Study|Protocol Violation|0
5717398|NCT00091832|19693261|P1|Overall Study|Protocol Violation|0
5717399|NCT00091832|19693256|P6|Overall Study|Other|0
5717400|NCT00091832|19693257|P5|Overall Study|Other|0
5717401|NCT00091832|19693258|P4|Overall Study|Other|0
5717402|NCT00091832|19693259|P3|Overall Study|Other|2
5717403|NCT00091832|19693260|P2|Overall Study|Other|1
5717404|NCT00091832|19693261|P1|Overall Study|Other|0
5717405|NCT00091832|19693256|P6|Overall Study|Noncompliance|0
5717406|NCT00091832|19693257|P5|Overall Study|Noncompliance|0
5717407|NCT00091832|19693258|P4|Overall Study|Noncompliance|0
5717408|NCT00091832|19693259|P3|Overall Study|Noncompliance|0
5717409|NCT00091832|19693260|P2|Overall Study|Noncompliance|1
5717410|NCT00091832|19693261|P1|Overall Study|Noncompliance|0
5717411|NCT00091832|19693256|P6|Overall Study|Lost to Follow-up|1
5717412|NCT00091832|19693257|P5|Overall Study|Lost to Follow-up|2
5717413|NCT00091832|19693258|P4|Overall Study|Lost to Follow-up|3
5717414|NCT00091832|19693259|P3|Overall Study|Lost to Follow-up|3
5717415|NCT00091832|19693260|P2|Overall Study|Lost to Follow-up|0
5717416|NCT00091832|19693261|P1|Overall Study|Lost to Follow-up|1
5717417|NCT00091832|19693256|P6|Overall Study|Ineligibility Determined|0
5717418|NCT00091832|19693257|P5|Overall Study|Ineligibility Determined|1
5717419|NCT00091832|19693258|P4|Overall Study|Ineligibility Determined|0
5717420|NCT00091832|19693259|P3|Overall Study|Ineligibility Determined|1
5717421|NCT00091832|19693260|P2|Overall Study|Ineligibility Determined|0
5717422|NCT00091832|19693261|P1|Overall Study|Ineligibility Determined|0
5717423|NCT00091832|19693256|P6|Overall Study|Disease Progression|2
5717424|NCT00091832|19693257|P5|Overall Study|Disease Progression|1
5717425|NCT00091832|19693258|P4|Overall Study|Disease Progression|1
5717426|NCT00091832|19693259|P3|Overall Study|Disease Progression|0
5717427|NCT00091832|19693260|P2|Overall Study|Disease Progression|0
5717428|NCT00091832|19693261|P1|Overall Study|Disease Progression|2
5717429|NCT00091832|19693256|P6|Overall Study|Death|6
5717430|NCT00091832|19693257|P5|Overall Study|Death|5
5717431|NCT00091832|19693258|P4|Overall Study|Death|8
5717432|NCT00091832|19693259|P3|Overall Study|Death|5
5717433|NCT00091832|19693260|P2|Overall Study|Death|4
5717434|NCT00091832|19693261|P1|Overall Study|Death|6
5717435|NCT00091832|19693256|P6|Overall Study|Withdrawal by Subject|1
5717436|NCT00091832|19693257|P5|Overall Study|Withdrawal by Subject|3
5717437|NCT00091832|19693258|P4|Overall Study|Withdrawal by Subject|1
5717438|NCT00091832|19693259|P3|Overall Study|Withdrawal by Subject|0
5717439|NCT00091832|19693260|P2|Overall Study|Withdrawal by Subject|5
5717440|NCT00091832|19693261|P1|Overall Study|Withdrawal by Subject|4
5717441|NCT00091832|19693256|P6|Overall Study|Adverse Event|0
5717442|NCT00091832|19693257|P5|Overall Study|Adverse Event|3
5717443|NCT00091832|19693258|P4|Overall Study|Adverse Event|1
5717444|NCT00091832|19693259|P3|Overall Study|Adverse Event|0
5717445|NCT00091832|19693260|P2|Overall Study|Adverse Event|0
5717446|NCT00091832|19693261|P1|Overall Study|Adverse Event|0
5717447|NCT00091832|19693256|P6|Overall Study|Physician Decision|0
5717448|NCT00091832|19693257|P5|Overall Study|Physician Decision|0
5717449|NCT00091832|19693258|P4|Overall Study|Physician Decision|0
5717450|NCT00091832|19693259|P3|Overall Study|Physician Decision|0
5717451|NCT00091832|19693260|P2|Overall Study|Physician Decision|0
5717452|NCT00091832|19693261|P1|Overall Study|Physician Decision|1
5717453|NCT00091819|19693379|P2|Overall Study|Never received study treatment|4
5717454|NCT00091819|19693380|P1|Overall Study|Never received study treatment|3
5717455|NCT00091819|19693379|P2|Overall Study|Other|3
5717456|NCT00091819|19693380|P1|Overall Study|Other|2
5717457|NCT00091819|19693379|P2|Overall Study|Protocol Violation|2
5717458|NCT00091819|19693380|P1|Overall Study|Protocol Violation|1
5717459|NCT00091819|19693379|P2|Overall Study|Withdrawal by Subject|8
5717460|NCT00091819|19693380|P1|Overall Study|Withdrawal by Subject|5
5717461|NCT00091819|19693379|P2|Overall Study|Lost to Follow-up|23
5717462|NCT00091819|19693380|P1|Overall Study|Lost to Follow-up|26
5717463|NCT00091819|19693379|P2|Overall Study|Death|5
5717464|NCT00091819|19693380|P1|Overall Study|Death|4
5717465|NCT00091819|19693379|P2|Overall Study|Adverse Event|1
5717466|NCT00091819|19693380|P1|Overall Study|Adverse Event|1
5717467|NCT00091793|19693388|P2|Overall Study|Other|0
5717468|NCT00091793|19693389|P1|Overall Study|Other|2
5717469|NCT00091793|19693388|P2|Overall Study|Noncompliance|0
5717470|NCT00091793|19693389|P1|Overall Study|Noncompliance|2
5717471|NCT00091793|19693388|P2|Overall Study|Lost to Follow-up|5
5717472|NCT00091793|19693389|P1|Overall Study|Lost to Follow-up|7
5717473|NCT00091793|19693388|P2|Overall Study|Ineligibility determined|0
5717474|NCT00091793|19693389|P1|Overall Study|Ineligibility determined|2
5717475|NCT00091793|19693388|P2|Overall Study|Withdrawal by Subject|15
5717476|NCT00091793|19693389|P1|Overall Study|Withdrawal by Subject|10
5717477|NCT00091793|19693388|P2|Overall Study|Adverse Event|2
5717478|NCT00091793|19693389|P1|Overall Study|Adverse Event|1
5717479|NCT00091572|19693413|P2|Overall Study|Toxicity (Related AE)|9
5717480|NCT00091572|19693414|P1|Overall Study|Toxicity (Related AE)|53
5717481|NCT00091572|19693413|P2|Overall Study|Major Protocol Violation|0
5717482|NCT00091572|19693414|P1|Overall Study|Major Protocol Violation|2
5717483|NCT00091572|19693413|P2|Overall Study|Ongoing (still on treatment)|12
5717484|NCT00091572|19693414|P1|Overall Study|Ongoing (still on treatment)|8
5717485|NCT00091572|19693413|P2|Overall Study|Other Reason|13
5717486|NCT00091572|19693414|P1|Overall Study|Other Reason|6
5717487|NCT00091572|19693413|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
5717488|NCT00091572|19693414|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
5717489|NCT00091572|19693413|P2|Overall Study|Death not due to malignancy/toxicity|3
5717490|NCT00091572|19693414|P1|Overall Study|Death not due to malignancy/toxicity|1
5717491|NCT00091572|19693413|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
5717492|NCT00091572|19693414|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
5717493|NCT00091572|19693413|P2|Overall Study|Lost to Follow-up|1
5717494|NCT00091572|19693414|P1|Overall Study|Lost to Follow-up|1
5717495|NCT00091442|19693445|P2|Overall Study|Other|6
5717496|NCT00091442|19693446|P1|Overall Study|Other|2
5717497|NCT00091442|19693445|P2|Overall Study|Lost to Follow-up|3
5717498|NCT00091442|19693446|P1|Overall Study|Lost to Follow-up|1
5717499|NCT00091442|19693445|P2|Overall Study|Death|7
5717500|NCT00091442|19693446|P1|Overall Study|Death|9
5717501|NCT00091442|19693445|P2|Overall Study|2cycles therapy beyond Complete response|16
5717502|NCT00091442|19693446|P1|Overall Study|2cycles therapy beyond Complete response|9
5717503|NCT00091442|19693445|P2|Overall Study|Adverse Event|48
5717504|NCT00091442|19693446|P1|Overall Study|Adverse Event|29
5717505|NCT00091442|19693445|P2|Overall Study|Withdrawal by Subject|46
5717506|NCT00091442|19693446|P1|Overall Study|Withdrawal by Subject|38
5717507|NCT00091442|19693445|P2|Overall Study|Physician Decision|58
5717508|NCT00091442|19693446|P1|Overall Study|Physician Decision|61
5717509|NCT00091442|19693445|P2|Overall Study|Progressive Disease|189
5717510|NCT00091442|19693446|P1|Overall Study|Progressive Disease|220
5717511|NCT00091390|19693456|P1|Overall Study|No protocol treatment|3
5717512|NCT00091390|19693456|P1|Overall Study|Protocol Violation|1
5717513|NCT00091169|19693481|P2|Overall Study|Not start protocol therapy|17
5717514|NCT00091169|19693482|P1|Overall Study|Not start protocol therapy|26
5717515|NCT00091169|19693481|P2|Overall Study|Other|4
5717516|NCT00091169|19693482|P1|Overall Study|Other|3
5717517|NCT00091169|19693481|P2|Overall Study|Withdrawal by Subject|13
5717518|NCT00091169|19693482|P1|Overall Study|Withdrawal by Subject|10
5717519|NCT00091169|19693481|P2|Overall Study|Death|1
5717520|NCT00091169|19693482|P1|Overall Study|Death|4
5717521|NCT00091169|19693481|P2|Overall Study|Adverse Event|17
5717522|NCT00091169|19693482|P1|Overall Study|Adverse Event|11
5717523|NCT00091169|19693481|P2|Overall Study|Disease progression|1
5717524|NCT00091169|19693482|P1|Overall Study|Disease progression|3
5717525|NCT00091026|19693500|P2|Overall Study|Unknown-never received treatment|1
5717526|NCT00091026|19693501|P1|Overall Study|Unknown-never received treatment|0
5717527|NCT00091026|19693500|P2|Overall Study|Patient withdrew and never received trea|2
5717528|NCT00091026|19693501|P1|Overall Study|Patient withdrew and never received trea|0
5717529|NCT00091026|19693500|P2|Overall Study|Patient deemed non eligible-never receiv|0
5717530|NCT00091026|19693501|P1|Overall Study|Patient deemed non eligible-never receiv|1
5717531|NCT00090987|19693511|P1|Overall Study|Incarcerated|1
5717532|NCT00090987|19693511|P1|Overall Study|Non-compliance|4
5717533|NCT00090987|19693511|P1|Overall Study|alternative therapy|1
5717534|NCT00090987|19693511|P1|Overall Study|Withdrawal by Subject|3
5717535|NCT00090987|19693511|P1|Overall Study|Lack of Efficacy|7
5717536|NCT00090987|19693511|P1|Overall Study|Adverse Event|5
5717537|NCT00090857|19693524|P2|Overall Study|Adverse Event|2
5717538|NCT00090857|19693525|P1|Overall Study|Adverse Event|2
5717539|NCT00090857|19693524|P2|Overall Study|Withdrawal by Subject|0
5717540|NCT00090857|19693525|P1|Overall Study|Withdrawal by Subject|2
5717541|NCT00090857|19693524|P2|Overall Study|Lost to Follow-up|1
5717542|NCT00090857|19693525|P1|Overall Study|Lost to Follow-up|0
5717543|NCT00090779|19693564|P2|Step 3|Off extended study due to study closure|3
5717544|NCT00090779|19693565|P1|Step 3|Off extended study due to study closure|4
5717545|NCT00090779|19693564|P2|Step 3|Initiation of ART and off extended study|2
5717546|NCT00090779|19693565|P1|Step 3|Initiation of ART and off extended study|3
5717547|NCT00090779|19693564|P2|Step 2|Non-compliance to study requirements|1
5717548|NCT00090779|19693565|P1|Step 2|Non-compliance to study requirements|0
5717549|NCT00090779|19693564|P2|Step 2|Subject relocated|1
5717550|NCT00090779|19693565|P1|Step 2|Subject relocated|0
5717551|NCT00090779|19693564|P2|Step 2|Off study per study closure|16
5717552|NCT00090779|19693565|P1|Step 2|Off study per study closure|6
5717553|NCT00090779|19693564|P2|Step 1|Subject relocated|8
5717554|NCT00090779|19693565|P1|Step 1|Subject relocated|2
5717555|NCT00090779|19693564|P2|Step 1|Non-compliance to study requirements|1
5717556|NCT00090779|19693565|P1|Step 1|Non-compliance to study requirements|0
5717557|NCT00090779|19693564|P2|Step 1|Pregnancy|0
5717558|NCT00090779|19693565|P1|Step 1|Pregnancy|1
5717559|NCT00090779|19693564|P2|Step 1|Physician Decision|0
5717560|NCT00090779|19693565|P1|Step 1|Physician Decision|1
5717561|NCT00090779|19693564|P2|Step 1|Death|2
5717562|NCT00090779|19693565|P1|Step 1|Death|0
5717563|NCT00090779|19693564|P2|Step 1|Lost to Follow-up|2
5717564|NCT00090779|19693565|P1|Step 1|Lost to Follow-up|3
5717565|NCT00090779|19693564|P2|Step 1|Withdrawal by Subject|2
5717566|NCT00090779|19693565|P1|Step 1|Withdrawal by Subject|4
5717567|NCT00090766|19693589|P3|Overall Study|Lost to Follow-up|2
5717568|NCT00090766|19693590|P2|Overall Study|Lost to Follow-up|0
5717569|NCT00090766|19693591|P1|Overall Study|Lost to Follow-up|2
5717570|NCT00090766|19693589|P3|Overall Study|Admin|0
5717571|NCT00090766|19693590|P2|Overall Study|Admin|2
5717572|NCT00090766|19693591|P1|Overall Study|Admin|0
5717573|NCT00090766|19693589|P3|Overall Study|Death|0
5717574|NCT00090766|19693590|P2|Overall Study|Death|0
5717575|NCT00090766|19693591|P1|Overall Study|Death|1
5717576|NCT00090766|19693589|P3|Overall Study|Nephrectomy Planned|1
5717577|NCT00090766|19693590|P2|Overall Study|Nephrectomy Planned|0
5717578|NCT00090766|19693591|P1|Overall Study|Nephrectomy Planned|0
5717579|NCT00090753|19693633|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
5717580|NCT00090753|19693634|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
5717581|NCT00090753|19693633|P2|Extended Treatment Period|Mircera Commercialization|93
5717582|NCT00090753|19693634|P1|Extended Treatment Period|Mircera Commercialization|188
5717583|NCT00090753|19693633|P2|Extended Treatment Period|Renal Transplant|12
5717584|NCT00090753|19693634|P1|Extended Treatment Period|Renal Transplant|15
5717585|NCT00090753|19693633|P2|Extended Treatment Period|Lost to Follow-up|1
5717586|NCT00090753|19693634|P1|Extended Treatment Period|Lost to Follow-up|3
5717587|NCT00090753|19693633|P2|Extended Treatment Period|Refused Treatment|12
5717588|NCT00090753|19693634|P1|Extended Treatment Period|Refused Treatment|18
5717589|NCT00090753|19693633|P2|Extended Treatment Period|Lack of Efficacy|0
5717590|NCT00090753|19693634|P1|Extended Treatment Period|Lack of Efficacy|1
5717591|NCT00090753|19693633|P2|Extended Treatment Period|Death|30
5717592|NCT00090753|19693634|P1|Extended Treatment Period|Death|58
5717593|NCT00090753|19693633|P2|Extended Treatment Period|Adverse Event|0
5717594|NCT00090753|19693634|P1|Extended Treatment Period|Adverse Event|11
5717595|NCT00090753|19693633|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
5717596|NCT00090753|19693634|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
5717597|NCT00090753|19693633|P2|First Treatment Period|Mircera Commercialization|0
5717598|NCT00090753|19693634|P1|First Treatment Period|Mircera Commercialization|1
5717599|NCT00090753|19693633|P2|First Treatment Period|Renal Transplant|50
5717600|NCT00090753|19693634|P1|First Treatment Period|Renal Transplant|70
5717601|NCT00090753|19693633|P2|First Treatment Period|Lost to Follow-up|4
5717602|NCT00090753|19693634|P1|First Treatment Period|Lost to Follow-up|4
5717603|NCT00090753|19693633|P2|First Treatment Period|Refused Treatment|25
5717604|NCT00090753|19693634|P1|First Treatment Period|Refused Treatment|32
5717605|NCT00090753|19693633|P2|First Treatment Period|Lack of Efficacy|1
5717606|NCT00090753|19693634|P1|First Treatment Period|Lack of Efficacy|2
5717607|NCT00090753|19693633|P2|First Treatment Period|Death|62
5717608|NCT00090753|19693634|P1|First Treatment Period|Death|88
5717609|NCT00090753|19693633|P2|First Treatment Period|Adverse Event|8
5717610|NCT00090753|19693634|P1|First Treatment Period|Adverse Event|20
5717611|NCT00090610|19693644|P2|Overall Study|Withdrawal by Subject|1
5717612|NCT00090610|19693645|P1|Overall Study|Withdrawal by Subject|1
5717613|NCT00090584|19693661|P2|Baseline to 8 Months|Lost to Follow-up|41
5717614|NCT00090584|19693662|P1|Baseline to 8 Months|Lost to Follow-up|44
5717615|NCT00090584|19693661|P2|Baseline to 10 Weeks|Lost to Follow-up|12
5717616|NCT00090584|19693662|P1|Baseline to 10 Weeks|Lost to Follow-up|15
5717617|NCT00090519|19693694|P2|Overall Study|Sponsor Decision|1
5717618|NCT00090519|19693695|P1|Overall Study|Sponsor Decision|3
5717619|NCT00090519|19693694|P2|Overall Study|Physician Decision|3
5717620|NCT00090519|19693695|P1|Overall Study|Physician Decision|2
5717621|NCT00090519|19693694|P2|Overall Study|Withdrawal by Subject|29
5717622|NCT00090519|19693695|P1|Overall Study|Withdrawal by Subject|28
5717623|NCT00090519|19693694|P2|Overall Study|Lost to Follow-up|29
5717624|NCT00090519|19693695|P1|Overall Study|Lost to Follow-up|26
5717625|NCT00090519|19693694|P2|Overall Study|Death|9
5717626|NCT00090519|19693695|P1|Overall Study|Death|9
5717627|NCT00090519|19693694|P2|Overall Study|Adverse Event|4
5717628|NCT00090519|19693695|P1|Overall Study|Adverse Event|5
5717629|NCT00090493|19693719|P1|Overall Study|Physician Decision|2
5717630|NCT00090363|19693726|P3|Overall Study|Continuing on study off treatment|16
5717631|NCT00090363|19693727|P2|Overall Study|Continuing on study off treatment|13
5717632|NCT00090363|19693728|P1|Overall Study|Continuing on study off treatment|14
5717633|NCT00090363|19693726|P3|Overall Study|Reasons not specified|1
5717634|NCT00090363|19693727|P2|Overall Study|Reasons not specified|1
5717635|NCT00090363|19693728|P1|Overall Study|Reasons not specified|2
5717636|NCT00090363|19693726|P3|Overall Study|Consent expired|9
5717637|NCT00090363|19693727|P2|Overall Study|Consent expired|10
5717638|NCT00090363|19693728|P1|Overall Study|Consent expired|7
5717639|NCT00090363|19693726|P3|Overall Study|Eligibility criteria not fulfilled|1
5717640|NCT00090363|19693727|P2|Overall Study|Eligibility criteria not fulfilled|0
5717641|NCT00090363|19693728|P1|Overall Study|Eligibility criteria not fulfilled|0
5717642|NCT00090363|19693726|P3|Overall Study|Study-specific discontinuation criteria|62
5717643|NCT00090363|19693727|P2|Overall Study|Study-specific discontinuation criteria|74
5717644|NCT00090363|19693728|P1|Overall Study|Study-specific discontinuation criteria|75
5717645|NCT00090363|19693726|P3|Overall Study|Withdrawal by Subject|6
5717646|NCT00090363|19693727|P2|Overall Study|Withdrawal by Subject|7
5717647|NCT00090363|19693728|P1|Overall Study|Withdrawal by Subject|7
5717648|NCT00090363|19693726|P3|Overall Study|Lost to Follow-up|1
5717649|NCT00090363|19693727|P2|Overall Study|Lost to Follow-up|2
5717650|NCT00090363|19693728|P1|Overall Study|Lost to Follow-up|1
5717651|NCT00090545|19693750|P2|Overall Study|Adverse Event|2
5717652|NCT00090545|19693751|P1|Overall Study|Adverse Event|0
5717653|NCT00090545|19693750|P2|Overall Study|Death|1
5717654|NCT00090545|19693751|P1|Overall Study|Death|0
5717655|NCT00090545|19693750|P2|Overall Study|Refused further treatment|4
5717656|NCT00090545|19693751|P1|Overall Study|Refused further treatment|1
5717657|NCT00090545|19693750|P2|Overall Study|Disease progression on study|17
5717658|NCT00090545|19693751|P1|Overall Study|Disease progression on study|21
5717659|NCT00090285|19693771|P6|Long-term Follow-up (EXT2)|Physician Decision|5
5717660|NCT00090285|19693772|P5|Long-term Follow-up (EXT2)|Physician Decision|6
5717661|NCT00090285|19693773|P4|Long-term Follow-up (EXT2)|Physician Decision|0
5717662|NCT00090285|19693774|P3|Long-term Follow-up (EXT2)|Physician Decision|0
5717663|NCT00090285|19693775|P2|Long-term Follow-up (EXT2)|Physician Decision|0
5717664|NCT00090285|19693776|P1|Long-term Follow-up (EXT2)|Physician Decision|0
5717665|NCT00090285|19693771|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
5717666|NCT00090285|19693772|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
5717667|NCT00090285|19693773|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5717668|NCT00090285|19693774|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5717669|NCT00090285|19693775|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5717670|NCT00090285|19693776|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5717671|NCT00090285|19693771|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
5717672|NCT00090285|19693772|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
5717673|NCT00090285|19693773|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5717674|NCT00090285|19693774|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5717675|NCT00090285|19693775|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5717676|NCT00090285|19693776|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5717677|NCT00090285|19693771|P6|Long-term Follow-up (EXT2)|Adverse Event|2
5717678|NCT00090285|19693772|P5|Long-term Follow-up (EXT2)|Adverse Event|5
5717679|NCT00090285|19693773|P4|Long-term Follow-up (EXT2)|Adverse Event|0
5717680|NCT00090285|19693774|P3|Long-term Follow-up (EXT2)|Adverse Event|0
5717681|NCT00090285|19693775|P2|Long-term Follow-up (EXT2)|Adverse Event|0
5717682|NCT00090285|19693776|P1|Long-term Follow-up (EXT2)|Adverse Event|0
5717683|NCT00090285|19693771|P6|Extension 1|Moved|0
5717684|NCT00090285|19693772|P5|Extension 1|Moved|0
5717685|NCT00090285|19693773|P4|Extension 1|Moved|0
5717686|NCT00090285|19693774|P3|Extension 1|Moved|3
5717687|NCT00090285|19693775|P2|Extension 1|Moved|0
5717688|NCT00090285|19693776|P1|Extension 1|Moved|0
5717689|NCT00090285|19693771|P6|Extension 1|Other|0
5717690|NCT00090285|19693772|P5|Extension 1|Other|0
5717691|NCT00090285|19693773|P4|Extension 1|Other|0
5717692|NCT00090285|19693774|P3|Extension 1|Other|4
5717693|NCT00090285|19693775|P2|Extension 1|Other|0
5717694|NCT00090285|19693776|P1|Extension 1|Other|0
5717695|NCT00090285|19693771|P6|Extension 1|Withdrawal by Subject|0
5717696|NCT00090285|19693772|P5|Extension 1|Withdrawal by Subject|0
5717697|NCT00090285|19693773|P4|Extension 1|Withdrawal by Subject|1
5717698|NCT00090285|19693774|P3|Extension 1|Withdrawal by Subject|13
5717699|NCT00090285|19693775|P2|Extension 1|Withdrawal by Subject|0
5717700|NCT00090285|19693776|P1|Extension 1|Withdrawal by Subject|0
5717701|NCT00090285|19693771|P6|Extension 1|Lost to Follow-up|0
5717702|NCT00090285|19693772|P5|Extension 1|Lost to Follow-up|0
5717703|NCT00090285|19693773|P4|Extension 1|Lost to Follow-up|0
5717704|NCT00090285|19693774|P3|Extension 1|Lost to Follow-up|35
5717705|NCT00090285|19693775|P2|Extension 1|Lost to Follow-up|0
5717706|NCT00090285|19693776|P1|Extension 1|Lost to Follow-up|0
5717707|NCT00090285|19693771|P6|Extension 1|Adverse Event|0
5717708|NCT00090285|19693772|P5|Extension 1|Adverse Event|0
5717709|NCT00090285|19693773|P4|Extension 1|Adverse Event|0
5717710|NCT00090285|19693774|P3|Extension 1|Adverse Event|2
5717711|NCT00090285|19693775|P2|Extension 1|Adverse Event|0
5717712|NCT00090285|19693776|P1|Extension 1|Adverse Event|0
5717713|NCT00090285|19693771|P6|Base Study Follow-up Period|Subject Incarcerated|0
5717714|NCT00090285|19693772|P5|Base Study Follow-up Period|Subject Incarcerated|0
5717715|NCT00090285|19693773|P4|Base Study Follow-up Period|Subject Incarcerated|0
5717716|NCT00090285|19693774|P3|Base Study Follow-up Period|Subject Incarcerated|0
5717717|NCT00090285|19693775|P2|Base Study Follow-up Period|Subject Incarcerated|2
5717718|NCT00090285|19693776|P1|Base Study Follow-up Period|Subject Incarcerated|0
5717719|NCT00090285|19693771|P6|Base Study Follow-up Period|Uncooperative|0
5717720|NCT00090285|19693772|P5|Base Study Follow-up Period|Uncooperative|0
5717721|NCT00090285|19693773|P4|Base Study Follow-up Period|Uncooperative|0
5717722|NCT00090285|19693774|P3|Base Study Follow-up Period|Uncooperative|0
5717723|NCT00090285|19693775|P2|Base Study Follow-up Period|Uncooperative|4
5717724|NCT00090285|19693776|P1|Base Study Follow-up Period|Uncooperative|3
5717725|NCT00090285|19693771|P6|Base Study Follow-up Period|Protocol Violation|0
5717726|NCT00090285|19693772|P5|Base Study Follow-up Period|Protocol Violation|0
5717727|NCT00090285|19693773|P4|Base Study Follow-up Period|Protocol Violation|0
5717728|NCT00090285|19693774|P3|Base Study Follow-up Period|Protocol Violation|0
5717729|NCT00090285|19693775|P2|Base Study Follow-up Period|Protocol Violation|0
5717730|NCT00090285|19693776|P1|Base Study Follow-up Period|Protocol Violation|1
5717731|NCT00090285|19693771|P6|Base Study Follow-up Period|Other|0
5717732|NCT00090285|19693772|P5|Base Study Follow-up Period|Other|0
5717733|NCT00090285|19693773|P4|Base Study Follow-up Period|Other|0
5717734|NCT00090285|19693774|P3|Base Study Follow-up Period|Other|0
5717735|NCT00090285|19693775|P2|Base Study Follow-up Period|Other|0
5717736|NCT00090285|19693776|P1|Base Study Follow-up Period|Other|2
5717737|NCT00090285|19693771|P6|Base Study Follow-up Period|Moved|0
5717738|NCT00090285|19693772|P5|Base Study Follow-up Period|Moved|0
5717739|NCT00090285|19693773|P4|Base Study Follow-up Period|Moved|0
5717740|NCT00090285|19693774|P3|Base Study Follow-up Period|Moved|0
5717741|NCT00090285|19693775|P2|Base Study Follow-up Period|Moved|36
5717742|NCT00090285|19693776|P1|Base Study Follow-up Period|Moved|41
5717743|NCT00090285|19693771|P6|Base Study Follow-up Period|Withdrawal by Subject|0
5717744|NCT00090285|19693772|P5|Base Study Follow-up Period|Withdrawal by Subject|0
5717745|NCT00090285|19693773|P4|Base Study Follow-up Period|Withdrawal by Subject|0
5717746|NCT00090285|19693774|P3|Base Study Follow-up Period|Withdrawal by Subject|0
5717747|NCT00090285|19693775|P2|Base Study Follow-up Period|Withdrawal by Subject|64
5717748|NCT00090285|19693776|P1|Base Study Follow-up Period|Withdrawal by Subject|53
5717749|NCT00090285|19693771|P6|Base Study Follow-up Period|Lost to Follow-up|0
5717750|NCT00090285|19693772|P5|Base Study Follow-up Period|Lost to Follow-up|0
5717751|NCT00090285|19693773|P4|Base Study Follow-up Period|Lost to Follow-up|0
5717752|NCT00090285|19693774|P3|Base Study Follow-up Period|Lost to Follow-up|0
5717753|NCT00090285|19693775|P2|Base Study Follow-up Period|Lost to Follow-up|226
5717754|NCT00090285|19693776|P1|Base Study Follow-up Period|Lost to Follow-up|232
5717755|NCT00090285|19693771|P6|Base Study Follow-up Period|Adverse Event|0
5717756|NCT00090285|19693772|P5|Base Study Follow-up Period|Adverse Event|0
5717757|NCT00090285|19693773|P4|Base Study Follow-up Period|Adverse Event|0
5717758|NCT00090285|19693774|P3|Base Study Follow-up Period|Adverse Event|0
5717759|NCT00090285|19693775|P2|Base Study Follow-up Period|Adverse Event|10
5717760|NCT00090285|19693776|P1|Base Study Follow-up Period|Adverse Event|3
5717761|NCT00090285|19693771|P6|Base Study Vaccination Period|HIV positive|0
5717762|NCT00090285|19693772|P5|Base Study Vaccination Period|HIV positive|0
5717763|NCT00090285|19693773|P4|Base Study Vaccination Period|HIV positive|0
5717764|NCT00090285|19693774|P3|Base Study Vaccination Period|HIV positive|0
5717765|NCT00090285|19693775|P2|Base Study Vaccination Period|HIV positive|1
5717766|NCT00090285|19693776|P1|Base Study Vaccination Period|HIV positive|1
5717767|NCT00090285|19693771|P6|Base Study Vaccination Period|Subject Incarcerated|0
5717768|NCT00090285|19693772|P5|Base Study Vaccination Period|Subject Incarcerated|0
5717769|NCT00090285|19693773|P4|Base Study Vaccination Period|Subject Incarcerated|0
5717770|NCT00090285|19693774|P3|Base Study Vaccination Period|Subject Incarcerated|0
5717771|NCT00090285|19693775|P2|Base Study Vaccination Period|Subject Incarcerated|2
5717772|NCT00090285|19693776|P1|Base Study Vaccination Period|Subject Incarcerated|2
5717773|NCT00090285|19693771|P6|Base Study Vaccination Period|Other|0
5717774|NCT00090285|19693772|P5|Base Study Vaccination Period|Other|0
5717775|NCT00090285|19693773|P4|Base Study Vaccination Period|Other|0
5717776|NCT00090285|19693774|P3|Base Study Vaccination Period|Other|0
5717777|NCT00090285|19693775|P2|Base Study Vaccination Period|Other|2
5717778|NCT00090285|19693776|P1|Base Study Vaccination Period|Other|2
5717779|NCT00090285|19693771|P6|Base Study Vaccination Period|Site Terminated|0
5717780|NCT00090285|19693772|P5|Base Study Vaccination Period|Site Terminated|0
5717781|NCT00090285|19693773|P4|Base Study Vaccination Period|Site Terminated|0
5717782|NCT00090285|19693774|P3|Base Study Vaccination Period|Site Terminated|0
5717783|NCT00090285|19693775|P2|Base Study Vaccination Period|Site Terminated|0
5717784|NCT00090285|19693776|P1|Base Study Vaccination Period|Site Terminated|1
5717785|NCT00090285|19693771|P6|Base Study Vaccination Period|Moved|0
5717786|NCT00090285|19693772|P5|Base Study Vaccination Period|Moved|0
5717787|NCT00090285|19693773|P4|Base Study Vaccination Period|Moved|0
5717788|NCT00090285|19693774|P3|Base Study Vaccination Period|Moved|0
5717789|NCT00090285|19693775|P2|Base Study Vaccination Period|Moved|21
5717790|NCT00090285|19693776|P1|Base Study Vaccination Period|Moved|20
5717791|NCT00090285|19693771|P6|Base Study Vaccination Period|Uncooperative|0
5717792|NCT00090285|19693772|P5|Base Study Vaccination Period|Uncooperative|0
5717793|NCT00090285|19693773|P4|Base Study Vaccination Period|Uncooperative|0
5717794|NCT00090285|19693774|P3|Base Study Vaccination Period|Uncooperative|0
5717795|NCT00090285|19693775|P2|Base Study Vaccination Period|Uncooperative|2
5717796|NCT00090285|19693776|P1|Base Study Vaccination Period|Uncooperative|2
5717797|NCT00090285|19693771|P6|Base Study Vaccination Period|Withdrawal by Subject|0
5717798|NCT00090285|19693772|P5|Base Study Vaccination Period|Withdrawal by Subject|0
5717881|NCT00090220|19693857|P4|Extension 1 (EXT1)|Protocol Violation|1
5717799|NCT00090285|19693773|P4|Base Study Vaccination Period|Withdrawal by Subject|0
5717800|NCT00090285|19693774|P3|Base Study Vaccination Period|Withdrawal by Subject|0
5717801|NCT00090285|19693775|P2|Base Study Vaccination Period|Withdrawal by Subject|69
5717802|NCT00090285|19693776|P1|Base Study Vaccination Period|Withdrawal by Subject|64
5717803|NCT00090285|19693771|P6|Base Study Vaccination Period|Protocol Violation|0
5717804|NCT00090285|19693772|P5|Base Study Vaccination Period|Protocol Violation|0
5717805|NCT00090285|19693773|P4|Base Study Vaccination Period|Protocol Violation|0
5717806|NCT00090285|19693774|P3|Base Study Vaccination Period|Protocol Violation|0
5717807|NCT00090285|19693775|P2|Base Study Vaccination Period|Protocol Violation|3
5717808|NCT00090285|19693776|P1|Base Study Vaccination Period|Protocol Violation|2
5717809|NCT00090285|19693771|P6|Base Study Vaccination Period|Lost to Follow-up|0
5717810|NCT00090285|19693772|P5|Base Study Vaccination Period|Lost to Follow-up|0
5717811|NCT00090285|19693773|P4|Base Study Vaccination Period|Lost to Follow-up|0
5717812|NCT00090285|19693774|P3|Base Study Vaccination Period|Lost to Follow-up|0
5717813|NCT00090285|19693775|P2|Base Study Vaccination Period|Lost to Follow-up|112
5717814|NCT00090285|19693776|P1|Base Study Vaccination Period|Lost to Follow-up|111
5717815|NCT00090285|19693771|P6|Base Study Vaccination Period|Adverse Event|0
5717816|NCT00090285|19693772|P5|Base Study Vaccination Period|Adverse Event|0
5717817|NCT00090285|19693773|P4|Base Study Vaccination Period|Adverse Event|0
5717818|NCT00090285|19693774|P3|Base Study Vaccination Period|Adverse Event|0
5717819|NCT00090285|19693775|P2|Base Study Vaccination Period|Adverse Event|4
5717820|NCT00090285|19693776|P1|Base Study Vaccination Period|Adverse Event|2
5717821|NCT00090285|19693771|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
5717822|NCT00090285|19693772|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
5717823|NCT00090285|19693773|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
5717824|NCT00090285|19693774|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
5717825|NCT00090285|19693775|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
5717826|NCT00090285|19693776|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
5717827|NCT00090259|19693813|P2|Overall Study|Investigator site closed|7
5717828|NCT00090259|19693814|P1|Overall Study|Investigator site closed|11
5717829|NCT00090259|19693813|P2|Overall Study|Withdrawal by Subject|15
5717830|NCT00090259|19693814|P1|Overall Study|Withdrawal by Subject|21
5717831|NCT00090259|19693813|P2|Overall Study|Lost to Follow-up|26
5717832|NCT00090259|19693814|P1|Overall Study|Lost to Follow-up|30
5717833|NCT00090233|19693830|P2|Overall Study|Data not available at data cut-off point|1563
5717834|NCT00090233|19693831|P1|Overall Study|Data not available at data cut-off point|1552
5717835|NCT00090233|19693830|P2|Overall Study|Other|1160
5717836|NCT00090233|19693831|P1|Overall Study|Other|1211
5717837|NCT00090233|19693830|P2|Overall Study|Moved|189
5717838|NCT00090233|19693831|P1|Overall Study|Moved|203
5717839|NCT00090233|19693830|P2|Overall Study|Withdrawal by Subject|211
5717840|NCT00090233|19693831|P1|Overall Study|Withdrawal by Subject|182
5717841|NCT00090233|19693830|P2|Overall Study|Protocol Violation|1022
5717842|NCT00090233|19693831|P1|Overall Study|Protocol Violation|960
5717843|NCT00090233|19693830|P2|Overall Study|Lost to Follow-up|95
5717844|NCT00090233|19693831|P1|Overall Study|Lost to Follow-up|68
5717845|NCT00090233|19693830|P2|Overall Study|Adverse Event|198
5717846|NCT00090233|19693831|P1|Overall Study|Adverse Event|214
5717847|NCT00090233|19693830|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
5717848|NCT00090233|19693831|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
5717849|NCT00090220|19693855|P6|Long-term Follow-up (EXT2)|Other|0
5717850|NCT00090220|19693856|P5|Long-term Follow-up (EXT2)|Other|1
5717851|NCT00090220|19693857|P4|Long-term Follow-up (EXT2)|Other|0
5717852|NCT00090220|19693858|P3|Long-term Follow-up (EXT2)|Other|0
5717853|NCT00090220|19693859|P2|Long-term Follow-up (EXT2)|Other|0
5717854|NCT00090220|19693860|P1|Long-term Follow-up (EXT2)|Other|0
5717855|NCT00090220|19693855|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
5717856|NCT00090220|19693856|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
5717857|NCT00090220|19693857|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5717858|NCT00090220|19693858|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5717859|NCT00090220|19693859|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5717860|NCT00090220|19693860|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
5717861|NCT00090220|19693855|P6|Long-term Follow-up (EXT2)|Death|1
5717862|NCT00090220|19693856|P5|Long-term Follow-up (EXT2)|Death|1
5717863|NCT00090220|19693857|P4|Long-term Follow-up (EXT2)|Death|0
5717864|NCT00090220|19693858|P3|Long-term Follow-up (EXT2)|Death|0
5717865|NCT00090220|19693859|P2|Long-term Follow-up (EXT2)|Death|0
5717866|NCT00090220|19693860|P1|Long-term Follow-up (EXT2)|Death|0
5717867|NCT00090220|19693855|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
5717868|NCT00090220|19693856|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
5717869|NCT00090220|19693857|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5717870|NCT00090220|19693858|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5717871|NCT00090220|19693859|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5717872|NCT00090220|19693860|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
5717873|NCT00090220|19693855|P6|Extension 1 (EXT1)|Other reason|0
5717874|NCT00090220|19693856|P5|Extension 1 (EXT1)|Other reason|0
5717875|NCT00090220|19693857|P4|Extension 1 (EXT1)|Other reason|0
5717876|NCT00090220|19693858|P3|Extension 1 (EXT1)|Other reason|2
5717877|NCT00090220|19693859|P2|Extension 1 (EXT1)|Other reason|0
5717878|NCT00090220|19693860|P1|Extension 1 (EXT1)|Other reason|0
5717879|NCT00090220|19693855|P6|Extension 1 (EXT1)|Protocol Violation|0
5717880|NCT00090220|19693856|P5|Extension 1 (EXT1)|Protocol Violation|0
5717882|NCT00090220|19693858|P3|Extension 1 (EXT1)|Protocol Violation|0
5717883|NCT00090220|19693859|P2|Extension 1 (EXT1)|Protocol Violation|0
5717884|NCT00090220|19693860|P1|Extension 1 (EXT1)|Protocol Violation|0
5717885|NCT00090220|19693855|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
5717886|NCT00090220|19693856|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
5717887|NCT00090220|19693857|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
5717888|NCT00090220|19693858|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
5717889|NCT00090220|19693859|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
5717890|NCT00090220|19693860|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
5717891|NCT00090220|19693855|P6|Extension 1 (EXT1)|Moved|0
5717892|NCT00090220|19693856|P5|Extension 1 (EXT1)|Moved|0
5717893|NCT00090220|19693857|P4|Extension 1 (EXT1)|Moved|1
5717894|NCT00090220|19693858|P3|Extension 1 (EXT1)|Moved|2
5717895|NCT00090220|19693859|P2|Extension 1 (EXT1)|Moved|0
5717896|NCT00090220|19693860|P1|Extension 1 (EXT1)|Moved|0
5717897|NCT00090220|19693855|P6|Extension 1 (EXT1)|Lost to Follow-up|0
5717898|NCT00090220|19693856|P5|Extension 1 (EXT1)|Lost to Follow-up|0
5717899|NCT00090220|19693857|P4|Extension 1 (EXT1)|Lost to Follow-up|0
5717900|NCT00090220|19693858|P3|Extension 1 (EXT1)|Lost to Follow-up|22
5717901|NCT00090220|19693859|P2|Extension 1 (EXT1)|Lost to Follow-up|0
5717902|NCT00090220|19693860|P1|Extension 1 (EXT1)|Lost to Follow-up|0
5717903|NCT00090220|19693855|P6|Extension 1 (EXT1)|Adverse Event|0
5717904|NCT00090220|19693856|P5|Extension 1 (EXT1)|Adverse Event|0
5717905|NCT00090220|19693857|P4|Extension 1 (EXT1)|Adverse Event|0
5717906|NCT00090220|19693858|P3|Extension 1 (EXT1)|Adverse Event|4
5717907|NCT00090220|19693859|P2|Extension 1 (EXT1)|Adverse Event|0
5717908|NCT00090220|19693860|P1|Extension 1 (EXT1)|Adverse Event|0
5717909|NCT00090220|19693855|P6|Base Study Follow-up Period|Other|0
5717910|NCT00090220|19693856|P5|Base Study Follow-up Period|Other|0
5717911|NCT00090220|19693857|P4|Base Study Follow-up Period|Other|0
5717912|NCT00090220|19693858|P3|Base Study Follow-up Period|Other|0
5717913|NCT00090220|19693859|P2|Base Study Follow-up Period|Other|21
5717914|NCT00090220|19693860|P1|Base Study Follow-up Period|Other|19
5717915|NCT00090220|19693855|P6|Base Study Follow-up Period|Patient Moved|0
5717916|NCT00090220|19693856|P5|Base Study Follow-up Period|Patient Moved|0
5717917|NCT00090220|19693857|P4|Base Study Follow-up Period|Patient Moved|0
5717918|NCT00090220|19693858|P3|Base Study Follow-up Period|Patient Moved|0
5717919|NCT00090220|19693859|P2|Base Study Follow-up Period|Patient Moved|28
5717920|NCT00090220|19693860|P1|Base Study Follow-up Period|Patient Moved|20
5717921|NCT00090220|19693855|P6|Base Study Follow-up Period|Withdrawal by Subject|0
5717922|NCT00090220|19693856|P5|Base Study Follow-up Period|Withdrawal by Subject|0
5717923|NCT00090220|19693857|P4|Base Study Follow-up Period|Withdrawal by Subject|0
5717924|NCT00090220|19693858|P3|Base Study Follow-up Period|Withdrawal by Subject|0
5717925|NCT00090220|19693859|P2|Base Study Follow-up Period|Withdrawal by Subject|36
5717926|NCT00090220|19693860|P1|Base Study Follow-up Period|Withdrawal by Subject|27
5717927|NCT00090220|19693855|P6|Base Study Follow-up Period|Lost to Follow-up|0
5717928|NCT00090220|19693856|P5|Base Study Follow-up Period|Lost to Follow-up|0
5717929|NCT00090220|19693857|P4|Base Study Follow-up Period|Lost to Follow-up|0
5717930|NCT00090220|19693858|P3|Base Study Follow-up Period|Lost to Follow-up|0
5717931|NCT00090220|19693859|P2|Base Study Follow-up Period|Lost to Follow-up|78
5717932|NCT00090220|19693860|P1|Base Study Follow-up Period|Lost to Follow-up|88
5717933|NCT00090220|19693855|P6|Base Study Follow-up Period|Adverse Event|0
5717934|NCT00090220|19693856|P5|Base Study Follow-up Period|Adverse Event|0
5717935|NCT00090220|19693857|P4|Base Study Follow-up Period|Adverse Event|0
5717936|NCT00090220|19693858|P3|Base Study Follow-up Period|Adverse Event|0
5717937|NCT00090220|19693859|P2|Base Study Follow-up Period|Adverse Event|1
5717938|NCT00090220|19693860|P1|Base Study Follow-up Period|Adverse Event|6
5717939|NCT00090220|19693855|P6|Base Study Vaccination Period|Other|0
5717940|NCT00090220|19693856|P5|Base Study Vaccination Period|Other|0
5717941|NCT00090220|19693857|P4|Base Study Vaccination Period|Other|0
5717942|NCT00090220|19693858|P3|Base Study Vaccination Period|Other|0
5717943|NCT00090220|19693859|P2|Base Study Vaccination Period|Other|4
5717944|NCT00090220|19693860|P1|Base Study Vaccination Period|Other|4
5717945|NCT00090220|19693855|P6|Base Study Vaccination Period|Patient Moved|0
5717946|NCT00090220|19693856|P5|Base Study Vaccination Period|Patient Moved|0
5717947|NCT00090220|19693857|P4|Base Study Vaccination Period|Patient Moved|0
5717948|NCT00090220|19693858|P3|Base Study Vaccination Period|Patient Moved|0
5717949|NCT00090220|19693859|P2|Base Study Vaccination Period|Patient Moved|2
5717950|NCT00090220|19693860|P1|Base Study Vaccination Period|Patient Moved|6
5717951|NCT00090220|19693855|P6|Base Study Vaccination Period|Withdrawal by Subject|0
5717952|NCT00090220|19693856|P5|Base Study Vaccination Period|Withdrawal by Subject|0
5717953|NCT00090220|19693857|P4|Base Study Vaccination Period|Withdrawal by Subject|0
5717954|NCT00090220|19693858|P3|Base Study Vaccination Period|Withdrawal by Subject|0
5717955|NCT00090220|19693859|P2|Base Study Vaccination Period|Withdrawal by Subject|27
5717956|NCT00090220|19693860|P1|Base Study Vaccination Period|Withdrawal by Subject|23
5717957|NCT00090220|19693855|P6|Base Study Vaccination Period|Lost to Follow-up|0
5717958|NCT00090220|19693856|P5|Base Study Vaccination Period|Lost to Follow-up|0
5717959|NCT00090220|19693857|P4|Base Study Vaccination Period|Lost to Follow-up|0
5717960|NCT00090220|19693858|P3|Base Study Vaccination Period|Lost to Follow-up|0
5717961|NCT00090220|19693859|P2|Base Study Vaccination Period|Lost to Follow-up|28
5717962|NCT00090220|19693860|P1|Base Study Vaccination Period|Lost to Follow-up|24
5717963|NCT00090220|19693855|P6|Base Study Vaccination Period|Adverse Event|0
5717964|NCT00090220|19693856|P5|Base Study Vaccination Period|Adverse Event|0
5717965|NCT00090220|19693857|P4|Base Study Vaccination Period|Adverse Event|0
5717966|NCT00090220|19693858|P3|Base Study Vaccination Period|Adverse Event|0
5717967|NCT00090220|19693859|P2|Base Study Vaccination Period|Adverse Event|1
5717968|NCT00090220|19693860|P1|Base Study Vaccination Period|Adverse Event|6
5717969|NCT00090220|19693855|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
5717970|NCT00090220|19693856|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
5717971|NCT00090220|19693857|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
5717972|NCT00090220|19693858|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
5717973|NCT00090220|19693859|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
5717974|NCT00090220|19693860|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
5717975|NCT00090402|19693955|P3|Overall Study|stopped taking study medication|1
5717976|NCT00090402|19693956|P2|Overall Study|stopped taking study medication|0
5717977|NCT00090402|19693957|P1|Overall Study|stopped taking study medication|1
5717978|NCT00090402|19693955|P3|Overall Study|subject moved|0
5717979|NCT00090402|19693956|P2|Overall Study|subject moved|1
5717980|NCT00090402|19693957|P1|Overall Study|subject moved|0
5717981|NCT00090402|19693955|P3|Overall Study|Death|0
5717982|NCT00090402|19693956|P2|Overall Study|Death|1
5717983|NCT00090402|19693957|P1|Overall Study|Death|1
5717984|NCT00090142|19693971|P2|Treatment Period II|Other|0
5717985|NCT00090142|19693972|P1|Treatment Period II|Other|1
5717986|NCT00090142|19693971|P2|Treatment Period I|Other|1
5717987|NCT00090142|19693972|P1|Treatment Period I|Other|0
5717988|NCT00090142|19693971|P2|Treatment Period I|Withdrawal by Subject|0
5717989|NCT00090142|19693972|P1|Treatment Period I|Withdrawal by Subject|2
5717990|NCT00090142|19693971|P2|Treatment Period I|Protocol Violation|0
5717991|NCT00090142|19693972|P1|Treatment Period I|Protocol Violation|2
5717992|NCT00090142|19693971|P2|Treatment Period I|Lost to Follow-up|2
5717993|NCT00090142|19693972|P1|Treatment Period I|Lost to Follow-up|1
5717994|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Other|0
5717995|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Other|1
5717996|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Other|0
5717997|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Jailed|0
5717998|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Jailed|1
5717999|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Jailed|0
5718000|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
5718001|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
5718002|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
5718003|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Depression|0
5718004|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Depression|1
5718005|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Depression|0
5718006|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
5718007|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
5718008|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
5718009|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
5718010|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
5718011|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
5718012|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Back Pain|0
5718013|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Back Pain|1
5718014|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Back Pain|0
5718015|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
5718016|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
5718017|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
5718018|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
5718019|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
5718020|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
5718021|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
5718022|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
5718023|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
5718024|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Gyneomastia|0
5718025|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Gyneomastia|0
5718026|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Gyneomastia|1
5718027|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Death|1
5718028|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Death|0
5718029|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Death|1
5718030|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
5718031|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
5718032|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
5718033|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Enrollment Error|2
5718034|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Enrollment Error|0
5718035|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Enrollment Error|1
5718036|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Loss of Libido|0
5718037|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Loss of Libido|0
5718038|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Loss of Libido|1
5718039|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
5718040|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
5718041|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
5718042|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
5718043|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
5718044|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
5718045|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
5718046|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
5718047|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
5718048|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
5718049|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
5718050|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
5718051|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Participant relocated|1
5718052|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Participant relocated|3
5718053|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Participant relocated|2
5718054|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
5718055|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
5718056|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
5718057|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Loss of Contact|2
5718058|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Loss of Contact|0
5718059|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Loss of Contact|4
5718060|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
5718061|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
5718062|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
5718063|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
5718064|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
5718065|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
5718066|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Protocol Violation|17
5718067|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Protocol Violation|18
5718068|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Protocol Violation|18
5718069|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
5718070|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
5718071|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
5718072|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
5718073|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
5718074|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
5718075|NCT00090103|19694003|P3|16-Week Safety Follow-up Period|Adverse Event|44
5718076|NCT00090103|19694004|P2|16-Week Safety Follow-up Period|Adverse Event|39
5718077|NCT00090103|19694005|P1|16-Week Safety Follow-up Period|Adverse Event|34
5718078|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
5718079|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
5718080|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
5718081|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
5718082|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
5718083|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
5718084|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
5718085|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
5718086|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
5718087|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
5718088|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
5718089|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
5718090|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
5718091|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
5718092|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
5718093|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
5718094|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
5718095|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
5718096|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
5718097|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
5718098|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
5718099|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
5718100|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
5718101|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
5718102|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
5718103|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
5718104|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
5718105|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
5718106|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
5718107|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
5718108|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
5718109|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
5718110|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
5718111|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
5718112|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
5718113|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
5718114|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
5718115|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
5718116|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
5718117|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
5718118|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
5718119|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
5718120|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
5718121|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
5718122|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
5718123|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
5718124|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
5718125|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
5718126|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
5718127|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
5718128|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
5718129|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
5718130|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
5718131|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
5718132|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
5718133|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
5718134|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
5718135|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
5718136|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
5718137|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
5718138|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
5718139|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
5718140|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
5718141|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
5718142|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
5718143|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
5718144|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
5718145|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
5718146|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
5718147|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
5718148|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
5718149|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
5718150|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
5718151|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
5718152|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
5718153|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
5718154|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
5718155|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
5718156|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
5718157|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
5718158|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
5718159|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
5718160|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
5718161|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
5718162|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
5718163|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
5718164|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
5718165|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
5718166|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
5718167|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
5718168|NCT00090103|19694003|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
5718169|NCT00090103|19694004|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
5718170|NCT00090103|19694005|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
5718171|NCT00089999|19694171|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
5718172|NCT00089999|19694172|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
5718173|NCT00089999|19694171|P2|Overall Study|Patient Underwent Surgery|0
5718174|NCT00089999|19694172|P1|Overall Study|Patient Underwent Surgery|2
5718175|NCT00089999|19694171|P2|Overall Study|Physician Decision|2
5718176|NCT00089999|19694172|P1|Overall Study|Physician Decision|2
5718177|NCT00089999|19694171|P2|Overall Study|Clinical Progression|2
5718178|NCT00089999|19694172|P1|Overall Study|Clinical Progression|1
5718179|NCT00089999|19694171|P2|Overall Study|Poor General Condition|0
5718180|NCT00089999|19694172|P1|Overall Study|Poor General Condition|1
5718181|NCT00089999|19694171|P2|Overall Study|Death|3
5718182|NCT00089999|19694172|P1|Overall Study|Death|3
5718183|NCT00089999|19694171|P2|Overall Study|Symptomatic Progression of Cancer|5
5718184|NCT00089999|19694172|P1|Overall Study|Symptomatic Progression of Cancer|2
5718185|NCT00089999|19694171|P2|Overall Study|Radiological Progression of Cancer|44
5718186|NCT00089999|19694172|P1|Overall Study|Radiological Progression of Cancer|52
5718187|NCT00089999|19694171|P2|Overall Study|Lost to Follow-up|1
5718188|NCT00089999|19694172|P1|Overall Study|Lost to Follow-up|2
5718189|NCT00089999|19694171|P2|Overall Study|Withdrawal by Subject|4
5718190|NCT00089999|19694172|P1|Overall Study|Withdrawal by Subject|0
5718191|NCT00089999|19694171|P2|Overall Study|Adverse Event|7
5718192|NCT00089999|19694172|P1|Overall Study|Adverse Event|4
5718193|NCT00089986|19694195|P3|Overall Study|Withdrawal by Subject|2
5718194|NCT00089986|19694196|P2|Overall Study|Withdrawal by Subject|6
5718195|NCT00089986|19694197|P1|Overall Study|Withdrawal by Subject|3
5718196|NCT00089986|19694195|P3|Overall Study|Do not resuscitate (DNR)|1
5718197|NCT00089986|19694196|P2|Overall Study|Do not resuscitate (DNR)|0
5718198|NCT00089986|19694197|P1|Overall Study|Do not resuscitate (DNR)|0
5718199|NCT00089986|19694195|P3|Overall Study|Family decision|0
5718200|NCT00089986|19694196|P2|Overall Study|Family decision|1
5718201|NCT00089986|19694197|P1|Overall Study|Family decision|0
5718202|NCT00089986|19694195|P3|Overall Study|Enrollment in another study|0
5718203|NCT00089986|19694196|P2|Overall Study|Enrollment in another study|1
5718204|NCT00089986|19694197|P1|Overall Study|Enrollment in another study|0
5718205|NCT00089986|19694195|P3|Overall Study|Investigator decision to withdrew|0
5718206|NCT00089986|19694196|P2|Overall Study|Investigator decision to withdrew|1
5718207|NCT00089986|19694197|P1|Overall Study|Investigator decision to withdrew|0
5718208|NCT00089986|19694195|P3|Overall Study|Hemohlobin stopping rule|0
5718209|NCT00089986|19694196|P2|Overall Study|Hemohlobin stopping rule|1
5718210|NCT00089986|19694197|P1|Overall Study|Hemohlobin stopping rule|0
5718211|NCT00089986|19694195|P3|Overall Study|Subject withdrew but agreed follow up|0
5718212|NCT00089986|19694196|P2|Overall Study|Subject withdrew but agreed follow up|2
5718213|NCT00089986|19694197|P1|Overall Study|Subject withdrew but agreed follow up|1
5718214|NCT00089986|19694195|P3|Overall Study|Patient transferred to another hospital|0
5718215|NCT00089986|19694196|P2|Overall Study|Patient transferred to another hospital|1
5718216|NCT00089986|19694197|P1|Overall Study|Patient transferred to another hospital|2
5718217|NCT00089986|19694195|P3|Overall Study|Protocol Violation|0
5718218|NCT00089986|19694196|P2|Overall Study|Protocol Violation|1
5718219|NCT00089986|19694197|P1|Overall Study|Protocol Violation|0
5718220|NCT00089986|19694195|P3|Overall Study|Lost to Follow-up|1
5718221|NCT00089986|19694196|P2|Overall Study|Lost to Follow-up|1
5718222|NCT00089986|19694197|P1|Overall Study|Lost to Follow-up|3
5718223|NCT00089986|19694195|P3|Overall Study|Adverse Event|6
5718224|NCT00089986|19694196|P2|Overall Study|Adverse Event|9
5718225|NCT00089986|19694197|P1|Overall Study|Adverse Event|6
5718226|NCT00089973|19694214|P1|Overall Study|Death|1
5718227|NCT00089973|19694214|P1|Overall Study|Disease progression|45
5718228|NCT00089973|19694214|P1|Overall Study|Withdrawal by Subject|1
5718229|NCT00089973|19694214|P1|Overall Study|Adverse Event|3
5718230|NCT00089895|19694229|P2|Overall Study|Missing|2
5718231|NCT00089895|19694230|P1|Overall Study|Missing|4
5718232|NCT00089895|19694229|P2|Overall Study|Not otherwise specified|8
5718233|NCT00089895|19694230|P1|Overall Study|Not otherwise specified|4
5718234|NCT00089895|19694229|P2|Overall Study|Exclusion criteria met|6
5718235|NCT00089895|19694230|P1|Overall Study|Exclusion criteria met|6
5718236|NCT00089895|19694229|P2|Overall Study|Physician Decision|7
5718237|NCT00089895|19694230|P1|Overall Study|Physician Decision|3
5718238|NCT00089895|19694229|P2|Overall Study|Bleeding|2
5718239|NCT00089895|19694230|P1|Overall Study|Bleeding|0
5718240|NCT00089895|19694229|P2|Overall Study|Surgery|1
5718241|NCT00089895|19694230|P1|Overall Study|Surgery|0
5718242|NCT00089895|19694229|P2|Overall Study|Technical reason|2
5718243|NCT00089895|19694230|P1|Overall Study|Technical reason|7
5718244|NCT00089895|19694229|P2|Overall Study|Consent Withdrawn|14
5718245|NCT00089895|19694230|P1|Overall Study|Consent Withdrawn|11
5718246|NCT00089843|19694242|P4|Overall Study|Physician Decision|1
5718247|NCT00089843|19694243|P3|Overall Study|Physician Decision|0
5718248|NCT00089843|19694244|P2|Overall Study|Physician Decision|0
5718249|NCT00089843|19694245|P1|Overall Study|Physician Decision|1
5718250|NCT00089843|19694242|P4|Overall Study|Withdrawal by Subject|6
5718251|NCT00089843|19694243|P3|Overall Study|Withdrawal by Subject|5
5718252|NCT00089843|19694244|P2|Overall Study|Withdrawal by Subject|4
5718253|NCT00089843|19694245|P1|Overall Study|Withdrawal by Subject|1
5718254|NCT00089791|19694257|P2|Overall Study|Requirement for alternative therapy|4
5718255|NCT00089791|19694258|P1|Overall Study|Requirement for alternative therapy|7
5718256|NCT00089791|19694257|P2|Overall Study|Protocol deviation|10
5718257|NCT00089791|19694258|P1|Overall Study|Protocol deviation|12
5718258|NCT00089791|19694257|P2|Overall Study|Other|32
5718259|NCT00089791|19694258|P1|Overall Study|Other|20
5718260|NCT00089791|19694257|P2|Overall Study|Noncompliance|13
5718261|NCT00089791|19694258|P1|Overall Study|Noncompliance|17
5718262|NCT00089791|19694257|P2|Overall Study|Lost to Follow-up|57
5718263|NCT00089791|19694258|P1|Overall Study|Lost to Follow-up|57
5718264|NCT00089791|19694257|P2|Overall Study|Ineligibility determined|9
5718265|NCT00089791|19694258|P1|Overall Study|Ineligibility determined|12
5718266|NCT00089791|19694257|P2|Overall Study|Disease progression|3
5718267|NCT00089791|19694258|P1|Overall Study|Disease progression|7
5718268|NCT00089791|19694257|P2|Overall Study|Death|62
5718269|NCT00089791|19694258|P1|Overall Study|Death|78
5718270|NCT00089791|19694257|P2|Overall Study|Withdrawal by Subject|344
5718271|NCT00089791|19694258|P1|Overall Study|Withdrawal by Subject|403
5718272|NCT00089791|19694257|P2|Overall Study|Adverse Event|93
5718273|NCT00089791|19694258|P1|Overall Study|Adverse Event|81
5718274|NCT00089791|19694257|P2|Overall Study|Physician Decision|3
5718275|NCT00089791|19694258|P1|Overall Study|Physician Decision|6
5718276|NCT00089778|19694292|P3|Overall Study|Protocol Violation|1
5718277|NCT00089778|19694293|P2|Overall Study|Protocol Violation|0
5718278|NCT00089778|19694294|P1|Overall Study|Protocol Violation|0
5718279|NCT00089674|19694307|P2|Overall Study|Requirement for alternative therapy|4
5718280|NCT00089674|19694308|P1|Overall Study|Requirement for alternative therapy|14
5718281|NCT00089674|19694307|P2|Overall Study|Other|9
5718282|NCT00089674|19694308|P1|Overall Study|Other|5
5718283|NCT00089674|19694307|P2|Overall Study|Noncompliance|3
5718284|NCT00089674|19694308|P1|Overall Study|Noncompliance|7
5718285|NCT00089674|19694307|P2|Overall Study|Lost to Follow-up|17
5718286|NCT00089674|19694308|P1|Overall Study|Lost to Follow-up|21
5718287|NCT00089674|19694307|P2|Overall Study|Ineligibility determined|10
5718288|NCT00089674|19694308|P1|Overall Study|Ineligibility determined|8
5718289|NCT00089674|19694307|P2|Overall Study|Disease progression|23
5718290|NCT00089674|19694308|P1|Overall Study|Disease progression|21
5718291|NCT00089674|19694307|P2|Overall Study|Death|43
5718292|NCT00089674|19694308|P1|Overall Study|Death|43
5718293|NCT00089674|19694307|P2|Overall Study|Withdrawal by Subject|127
5718294|NCT00089674|19694308|P1|Overall Study|Withdrawal by Subject|143
5718295|NCT00089674|19694307|P2|Overall Study|Adverse Event|29
5718296|NCT00089674|19694308|P1|Overall Study|Adverse Event|23
5718297|NCT00089674|19694307|P2|Overall Study|Physician Decision|2
5718298|NCT00089674|19694308|P1|Overall Study|Physician Decision|4
5718299|NCT00089661|19694334|P2|Overall Study|Other|1
5718300|NCT00089661|19694335|P1|Overall Study|Other|2
5718301|NCT00089661|19694334|P2|Overall Study|Noncompliance|4
5718302|NCT00089661|19694335|P1|Overall Study|Noncompliance|2
5718303|NCT00089661|19694334|P2|Overall Study|Ineligibility determined|4
5718304|NCT00089661|19694335|P1|Overall Study|Ineligibility determined|4
5718305|NCT00089661|19694334|P2|Overall Study|Disease progression|3
5718306|NCT00089661|19694335|P1|Overall Study|Disease progression|1
5718307|NCT00089661|19694334|P2|Overall Study|Withdrawal by Subject|9
5718308|NCT00089661|19694335|P1|Overall Study|Withdrawal by Subject|11
5718309|NCT00089661|19694334|P2|Overall Study|Lost to Follow-up|3
5718310|NCT00089661|19694335|P1|Overall Study|Lost to Follow-up|0
5718311|NCT00089661|19694334|P2|Overall Study|Death|0
5718312|NCT00089661|19694335|P1|Overall Study|Death|1
5718313|NCT00089661|19694334|P2|Overall Study|Adverse Event|2
5718314|NCT00089661|19694335|P1|Overall Study|Adverse Event|0
5718315|NCT00089648|19694351|P1|Overall Study|Lack of Efficacy|33
5718316|NCT00089648|19694351|P1|Overall Study|Withdrawal by Subject|1
5718317|NCT00089648|19694351|P1|Overall Study|Adverse Event|7
5718318|NCT00089635|19694367|P1|Overall Study|Other|2
5718319|NCT00089635|19694367|P1|Overall Study|Ineligibility determined|1
5718320|NCT00089635|19694367|P1|Overall Study|Withdrawal by Subject|6
5718321|NCT00089635|19694367|P1|Overall Study|Lost to Follow-up|3
5718322|NCT00089635|19694367|P1|Overall Study|Disease Progression|12
5718323|NCT00089635|19694367|P1|Overall Study|Death|17
5718324|NCT00089635|19694367|P1|Overall Study|Adverse Event|2
5718325|NCT00089583|19694381|P2|Overall Study|Participant Incarcerated|1
5718326|NCT00089583|19694382|P1|Overall Study|Participant Incarcerated|0
5718327|NCT00089583|19694381|P2|Overall Study|Necessity to Use Prohibited Drug|0
5718328|NCT00089583|19694382|P1|Overall Study|Necessity to Use Prohibited Drug|1
5718329|NCT00089583|19694381|P2|Overall Study|Start of Disallowed Medication|1
5718330|NCT00089583|19694382|P1|Overall Study|Start of Disallowed Medication|0
5718331|NCT00089583|19694381|P2|Overall Study|Principal Investigator Decision|10
5718332|NCT00089583|19694382|P1|Overall Study|Principal Investigator Decision|0
5718333|NCT00089583|19694381|P2|Overall Study|Protocol Violation|3
5718334|NCT00089583|19694382|P1|Overall Study|Protocol Violation|0
5718335|NCT00089583|19694381|P2|Overall Study|Reason Not Provided|1
5718336|NCT00089583|19694382|P1|Overall Study|Reason Not Provided|0
5718337|NCT00089583|19694381|P2|Overall Study|Participant Management Criteria Met|1
5718338|NCT00089583|19694382|P1|Overall Study|Participant Management Criteria Met|0
5718339|NCT00089583|19694381|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
5718340|NCT00089583|19694382|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
5718341|NCT00089583|19694381|P2|Overall Study|Non-Compliance|4
5718342|NCT00089583|19694382|P1|Overall Study|Non-Compliance|0
5718343|NCT00089583|19694381|P2|Overall Study|Participant Refused Study Medication|2
5718344|NCT00089583|19694382|P1|Overall Study|Participant Refused Study Medication|0
5718345|NCT00089583|19694381|P2|Overall Study|Participant (Par) Didn't Take Medication|0
5718346|NCT00089583|19694382|P1|Overall Study|Participant (Par) Didn't Take Medication|1
5718347|NCT00089583|19694381|P2|Overall Study|Withdrawal by Subject|4
5718348|NCT00089583|19694382|P1|Overall Study|Withdrawal by Subject|0
5718349|NCT00089583|19694381|P2|Overall Study|Insufficient Viral Load Response|5
5718350|NCT00089583|19694382|P1|Overall Study|Insufficient Viral Load Response|5
5718351|NCT00089583|19694381|P2|Overall Study|Adverse Event|3
5718352|NCT00089583|19694382|P1|Overall Study|Adverse Event|0
5718353|NCT00089609|19694476|P2|Overall Study|Withdrawal by Subject|1
5718354|NCT00089609|19694477|P1|Overall Study|Withdrawal by Subject|3
5718355|NCT00089544|19694496|P2|Overall Study|Ineligible|0
5718356|NCT00089544|19694497|P1|Overall Study|Ineligible|1
5718357|NCT00089505|19694511|P4|Overall Study|Protocol Violation|0
5718358|NCT00089505|19694512|P3|Overall Study|Protocol Violation|1
5718359|NCT00089505|19694513|P2|Overall Study|Protocol Violation|0
5718360|NCT00089505|19694514|P1|Overall Study|Protocol Violation|0
5718361|NCT00089505|19694511|P4|Overall Study|Physician Decision|0
5718362|NCT00089505|19694512|P3|Overall Study|Physician Decision|0
5718363|NCT00089505|19694513|P2|Overall Study|Physician Decision|0
5718364|NCT00089505|19694514|P1|Overall Study|Physician Decision|1
5718365|NCT00089505|19694511|P4|Overall Study|Lost to Follow-up|7
5718366|NCT00089505|19694512|P3|Overall Study|Lost to Follow-up|9
5718367|NCT00089505|19694513|P2|Overall Study|Lost to Follow-up|1
5718368|NCT00089505|19694514|P1|Overall Study|Lost to Follow-up|1
5718369|NCT00089505|19694511|P4|Overall Study|Withdrawal by Subject|6
5718370|NCT00089505|19694512|P3|Overall Study|Withdrawal by Subject|6
5718371|NCT00089505|19694513|P2|Overall Study|Withdrawal by Subject|0
5718372|NCT00089505|19694514|P1|Overall Study|Withdrawal by Subject|3
5718373|NCT00089505|19694511|P4|Overall Study|Death|8
5718374|NCT00089505|19694512|P3|Overall Study|Death|5
5718375|NCT00089505|19694513|P2|Overall Study|Death|1
5718376|NCT00089505|19694514|P1|Overall Study|Death|4
5718377|NCT00089479|19694558|P2|Overall Study|Lost to Follow-up|107
5718378|NCT00089479|19694559|P1|Overall Study|Lost to Follow-up|137
5718379|NCT00089479|19694558|P2|Overall Study|Withdrawal by Subject|107
5718380|NCT00089479|19694559|P1|Overall Study|Withdrawal by Subject|86
5718381|NCT00089479|19694558|P2|Overall Study|Death|75
5718382|NCT00089479|19694559|P1|Overall Study|Death|108
5718383|NCT00089297|19694602|P1|Overall Study|Non-compliance|1
5718384|NCT00089297|19694602|P1|Overall Study|IRB approval not ready|1
5718385|NCT00089297|19694602|P1|Overall Study|Secondary malignancy|1
5718386|NCT00089297|19694602|P1|Overall Study|Ineligible|11
5718387|NCT00089297|19694602|P1|Overall Study|Disease progression|2
5718388|NCT00089297|19694602|P1|Overall Study|Withdrawal by Subject|12
5718389|NCT00089297|19694602|P1|Overall Study|Death|1
5718390|NCT00089297|19694602|P1|Overall Study|Adverse Event|9
5718391|NCT00089284|19694614|P7|Overall Study|Adverse event before starting treatment|1
5718392|NCT00089284|19694615|P6|Overall Study|Adverse event before starting treatment|0
5718393|NCT00089284|19694616|P5|Overall Study|Adverse event before starting treatment|0
5718394|NCT00089284|19694617|P4|Overall Study|Adverse event before starting treatment|0
5718395|NCT00089284|19694618|P3|Overall Study|Adverse event before starting treatment|0
5718396|NCT00089284|19694619|P2|Overall Study|Adverse event before starting treatment|0
5718397|NCT00089284|19694620|P1|Overall Study|Adverse event before starting treatment|0
5718398|NCT00089141|19694657|P2|Overall Study|Termination of trial|24
5718399|NCT00089141|19694658|P1|Overall Study|Termination of trial|18
5718400|NCT00089076|19694694|P1|Overall Study|Progression|7
5718401|NCT00089076|19694694|P1|Overall Study|Withdrawal by Subject|2
5718402|NCT00089076|19694694|P1|Overall Study|Alternate Therapy|1
5718403|NCT00088907|19694751|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
5718404|NCT00088907|19694752|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
5718405|NCT00088907|19694751|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
5718406|NCT00088907|19694752|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
5718407|NCT00088907|19694751|P2|Single Gefitinib Treatment (Step 2)|Death|0
5718408|NCT00088907|19694752|P1|Single Gefitinib Treatment (Step 2)|Death|1
5718409|NCT00088907|19694751|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
5718410|NCT00088907|19694752|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
5718411|NCT00088907|19694751|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
5718412|NCT00088907|19694752|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
5718413|NCT00088907|19694751|P2|Randomized Study (Step 1)|unknown/not specify|13
5718414|NCT00088907|19694752|P1|Randomized Study (Step 1)|unknown/not specify|24
5718415|NCT00088907|19694751|P2|Randomized Study (Step 1)|complicating disease|1
5718416|NCT00088907|19694752|P1|Randomized Study (Step 1)|complicating disease|3
5718417|NCT00088907|19694751|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
5718418|NCT00088907|19694752|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
5718419|NCT00088907|19694751|P2|Randomized Study (Step 1)|Death|12
5718420|NCT00088907|19694752|P1|Randomized Study (Step 1)|Death|11
5718421|NCT00088907|19694751|P2|Randomized Study (Step 1)|Adverse Event|19
5718422|NCT00088907|19694752|P1|Randomized Study (Step 1)|Adverse Event|14
5718423|NCT00088907|19694751|P2|Randomized Study (Step 1)|Lack of Efficacy|62
5718424|NCT00088907|19694752|P1|Randomized Study (Step 1)|Lack of Efficacy|55
5718425|NCT00088881|19694763|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
5718426|NCT00088881|19694763|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
5718427|NCT00088881|19694763|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
5718428|NCT00088881|19694763|P1|Step 1 - R-CHOP|Physician Decision|1
5718429|NCT00088881|19694763|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
5718430|NCT00088881|19694763|P1|Step 1 - R-CHOP|Adverse Event|1
5718431|NCT00088881|19694763|P1|Step 1 - R-CHOP|Patient ineligible|9
5718432|NCT00088829|19694772|P1|Overall Study|PI left institution and study was close|22
5718433|NCT00088595|19694814|P1|Overall Study|New Cancer Therapy|2
5718434|NCT00088595|19694814|P1|Overall Study|Ongoing (After Core)|7
5718435|NCT00088595|19694814|P1|Overall Study|Withdrawal by Subject|8
5718436|NCT00088595|19694814|P1|Overall Study|Adverse Event|11
5718437|NCT00088530|19694832|P2|Overall Study|Patient never treated|0
5718438|NCT00088530|19694833|P1|Overall Study|Patient never treated|1
5718439|NCT00088530|19694832|P2|Overall Study|Sponsor decision|1
5718440|NCT00088530|19694833|P1|Overall Study|Sponsor decision|0
5718441|NCT00088530|19694832|P2|Overall Study|Physician Decision|0
5718442|NCT00088530|19694833|P1|Overall Study|Physician Decision|2
5718443|NCT00088530|19694832|P2|Overall Study|Lost to Follow-up|0
5718444|NCT00088530|19694833|P1|Overall Study|Lost to Follow-up|2
5718445|NCT00088530|19694832|P2|Overall Study|Withdrawal by Subject|5
5718446|NCT00088530|19694833|P1|Overall Study|Withdrawal by Subject|2
5718447|NCT00088530|19694832|P2|Overall Study|Adverse Event|9
5718448|NCT00088530|19694833|P1|Overall Study|Adverse Event|15
5718449|NCT00088530|19694832|P2|Overall Study|Progressive/Relapsed Disease|39
5718450|NCT00088530|19694833|P1|Overall Study|Progressive/Relapsed Disease|28
5718451|NCT00088465|19694845|P1|Overall Study|Death|11
5718452|NCT00088465|19694845|P1|Overall Study|Protocol Violation|17
5718453|NCT00088465|19694845|P1|Overall Study|Lack of Efficacy|27
5718454|NCT00088465|19694845|P1|Overall Study|Sponsor Decision|37
5718455|NCT00088465|19694845|P1|Overall Study|Physician Decision|45
5718456|NCT00088465|19694845|P1|Overall Study|Lost to Follow-up|57
5718457|NCT00088465|19694845|P1|Overall Study|Adverse Event|77
5718458|NCT00088465|19694845|P1|Overall Study|Withdrawal by Subject|290
5718459|NCT00088452|19694871|P3|Overall Study|Did not receive intervention|1
5718460|NCT00088452|19694872|P2|Overall Study|Did not receive intervention|0
5718461|NCT00088452|19694873|P1|Overall Study|Did not receive intervention|1
5718462|NCT00088413|19694891|P4|Overall Study|Patient unevaluable due to adverse event|0
5718463|NCT00088413|19694892|P3|Overall Study|Patient unevaluable due to adverse event|1
5718464|NCT00088413|19694893|P2|Overall Study|Patient unevaluable due to adverse event|0
5718465|NCT00088413|19694894|P1|Overall Study|Patient unevaluable due to adverse event|0
5718466|NCT00088413|19694891|P4|Overall Study|Other|0
5718467|NCT00088413|19694892|P3|Overall Study|Other|0
5718468|NCT00088413|19694893|P2|Overall Study|Other|1
5718469|NCT00088413|19694894|P1|Overall Study|Other|0
5718470|NCT00088413|19694891|P4|Overall Study|Progressive disease|14
5718471|NCT00088413|19694892|P3|Overall Study|Progressive disease|8
5718472|NCT00088413|19694893|P2|Overall Study|Progressive disease|11
5718473|NCT00088413|19694894|P1|Overall Study|Progressive disease|9
5718474|NCT00088413|19694891|P4|Overall Study|Death|0
5718475|NCT00088413|19694892|P3|Overall Study|Death|0
5718476|NCT00088413|19694893|P2|Overall Study|Death|1
5718477|NCT00088413|19694894|P1|Overall Study|Death|0
5718478|NCT00088413|19694891|P4|Overall Study|Off study due to missing a vaccine dose|0
5718479|NCT00088413|19694892|P3|Overall Study|Off study due to missing a vaccine dose|0
5718480|NCT00088413|19694893|P2|Overall Study|Off study due to missing a vaccine dose|0
5718481|NCT00088413|19694894|P1|Overall Study|Off study due to missing a vaccine dose|1
5718482|NCT00088413|19694891|P4|Overall Study|Refused trmt Off-study per pt wishes|0
5718483|NCT00088413|19694892|P3|Overall Study|Refused trmt Off-study per pt wishes|1
5718484|NCT00088413|19694893|P2|Overall Study|Refused trmt Off-study per pt wishes|1
5718485|NCT00088413|19694894|P1|Overall Study|Refused trmt Off-study per pt wishes|0
5718486|NCT00088413|19694891|P4|Overall Study|Adverse Events/Side Effects|0
5718487|NCT00088413|19694892|P3|Overall Study|Adverse Events/Side Effects|1
5718488|NCT00088413|19694893|P2|Overall Study|Adverse Events/Side Effects|1
5718489|NCT00088413|19694894|P1|Overall Study|Adverse Events/Side Effects|0
5718490|NCT00088413|19694891|P4|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
5718491|NCT00088413|19694892|P3|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
5718492|NCT00088413|19694893|P2|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
5718493|NCT00088413|19694894|P1|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
5718494|NCT00088374|19694908|P1|Overall Study|patient received <1 cycle only of 17AAG|1
5718495|NCT00088374|19694908|P1|Overall Study|patient did not receive any 17AAG|1
5718496|NCT00088205|19694926|P1|Overall Study|Death Due to Study Disease|4
5718497|NCT00088205|19694926|P1|Overall Study|Physician Decision|1
5718498|NCT00088205|19694926|P1|Overall Study|Progressive Disease|51
5718499|NCT00088205|19694926|P1|Overall Study|Adverse Event|4
5718500|NCT00088166|19694943|P2|Overall Study|Withdrawal by Subject|5
5718501|NCT00088166|19694944|P1|Overall Study|Withdrawal by Subject|5
5718502|NCT00088166|19694943|P2|Overall Study|Patient deterioration|39
5718503|NCT00088166|19694944|P1|Overall Study|Patient deterioration|29
5718504|NCT00088166|19694943|P2|Overall Study|Protocol Violation|5
5718505|NCT00088166|19694944|P1|Overall Study|Protocol Violation|1
5718506|NCT00088166|19694943|P2|Overall Study|Physician Decision|1
5718507|NCT00088166|19694944|P1|Overall Study|Physician Decision|4
5718508|NCT00088166|19694943|P2|Overall Study|Lost to Follow-up|1
5718509|NCT00088166|19694944|P1|Overall Study|Lost to Follow-up|0
5718510|NCT00088166|19694943|P2|Overall Study|Death|1
5718511|NCT00088166|19694944|P1|Overall Study|Death|3
5718512|NCT00088166|19694943|P2|Overall Study|Adverse Event|9
5718513|NCT00088166|19694944|P1|Overall Study|Adverse Event|11
5718514|NCT00088153|19694968|P2|Overall Study|Lost to Follow-up|12
5718515|NCT00088153|19694969|P1|Overall Study|Lost to Follow-up|11
5718516|NCT00088153|19694968|P2|Overall Study|Withdrawal by Subject|10
5718517|NCT00088153|19694969|P1|Overall Study|Withdrawal by Subject|10
5718518|NCT00088153|19694968|P2|Overall Study|Physician Decision|3
5718519|NCT00088153|19694969|P1|Overall Study|Physician Decision|3
5718520|NCT00087698|19694979|P1|Overall Study|Protocol Violation|1
5718521|NCT00087698|19694979|P1|Overall Study|Death from Study Drug Toxicity|2
5718522|NCT00087698|19694979|P1|Overall Study|Death from Study Disease|2
5718523|NCT00087698|19694979|P1|Overall Study|Clinical Relapse|1
5718524|NCT00087698|19694979|P1|Overall Study|Protocol Entry Criteria Not Met|2
5718525|NCT00087698|19694979|P1|Overall Study|Lack of Efficacy, Physician Perception|3
5718526|NCT00087698|19694979|P1|Overall Study|Withdrawal by Subject|4
5718527|NCT00087698|19694979|P1|Overall Study|Adverse Event|4
5718528|NCT00087698|19694979|P1|Overall Study|Death from Other Causes|3
5718529|NCT00087698|19694979|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
5718530|NCT00087685|19694988|P1|Overall Study|Withdrawal by Subject|3
5718531|NCT00087685|19694988|P1|Overall Study|Progressive Disease|5
5718532|NCT00087685|19694988|P1|Overall Study|Non-Compliance|1
5718533|NCT00087685|19694988|P1|Overall Study|Adverse Event|5
5718534|NCT00087646|19695001|P4|Overall Study|Violation of Selection Criteria at Entry|1
5718535|NCT00087646|19695002|P3|Overall Study|Violation of Selection Criteria at Entry|0
5718536|NCT00087646|19695003|P2|Overall Study|Violation of Selection Criteria at Entry|0
5718537|NCT00087646|19695004|P1|Overall Study|Violation of Selection Criteria at Entry|1
5718538|NCT00087646|19695001|P4|Overall Study|Other Protocol Violation|0
5718539|NCT00087646|19695002|P3|Overall Study|Other Protocol Violation|0
5718540|NCT00087646|19695003|P2|Overall Study|Other Protocol Violation|1
5718541|NCT00087646|19695004|P1|Overall Study|Other Protocol Violation|3
5718542|NCT00087646|19695001|P4|Overall Study|Administrative/Other|2
5718543|NCT00087646|19695002|P3|Overall Study|Administrative/Other|1
5718544|NCT00087646|19695003|P2|Overall Study|Administrative/Other|1
5718545|NCT00087646|19695004|P1|Overall Study|Administrative/Other|6
5718546|NCT00087646|19695001|P4|Overall Study|Failure to Return|3
5718547|NCT00087646|19695002|P3|Overall Study|Failure to Return|2
5718548|NCT00087646|19695003|P2|Overall Study|Failure to Return|2
5718549|NCT00087646|19695004|P1|Overall Study|Failure to Return|5
5718550|NCT00087646|19695001|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
5718551|NCT00087646|19695002|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
5718552|NCT00087646|19695003|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
5718553|NCT00087646|19695004|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
5718554|NCT00087646|19695001|P4|Overall Study|Insufficient therapeutic response|51
5718555|NCT00087646|19695002|P3|Overall Study|Insufficient therapeutic response|38
5718556|NCT00087646|19695003|P2|Overall Study|Insufficient therapeutic response|24
5718557|NCT00087646|19695004|P1|Overall Study|Insufficient therapeutic response|64
5718558|NCT00087646|19695001|P4|Overall Study|Withdrawal by Subject|2
5718559|NCT00087646|19695002|P3|Overall Study|Withdrawal by Subject|2
5718560|NCT00087646|19695003|P2|Overall Study|Withdrawal by Subject|1
5718561|NCT00087646|19695004|P1|Overall Study|Withdrawal by Subject|6
5718562|NCT00087646|19695001|P4|Overall Study|Death|0
5718563|NCT00087646|19695002|P3|Overall Study|Death|0
5718564|NCT00087646|19695003|P2|Overall Study|Death|1
5718565|NCT00087646|19695004|P1|Overall Study|Death|0
5718566|NCT00087646|19695001|P4|Overall Study|Adverse Event|20
5718567|NCT00087646|19695002|P3|Overall Study|Adverse Event|18
5718568|NCT00087646|19695003|P2|Overall Study|Adverse Event|6
5718569|NCT00087646|19695004|P1|Overall Study|Adverse Event|37
5718570|NCT00087607|19695043|P2|Overall Study|Violation of Selection Criteria at Entry|1
5718571|NCT00087607|19695044|P1|Overall Study|Violation of Selection Criteria at Entry|0
5718572|NCT00087607|19695043|P2|Overall Study|Other Protocol Violation|2
5718573|NCT00087607|19695044|P1|Overall Study|Other Protocol Violation|5
5718574|NCT00087607|19695043|P2|Overall Study|Refused Treatment|7
5718575|NCT00087607|19695044|P1|Overall Study|Refused Treatment|5
5718576|NCT00087607|19695043|P2|Overall Study|Administrative|12
5718577|NCT00087607|19695044|P1|Overall Study|Administrative|12
5718578|NCT00087607|19695043|P2|Overall Study|Withdrew Consent|16
5718579|NCT00087607|19695044|P1|Overall Study|Withdrew Consent|12
5718580|NCT00087607|19695043|P2|Overall Study|Failure to return|17
5718581|NCT00087607|19695044|P1|Overall Study|Failure to return|21
5718582|NCT00087607|19695043|P2|Overall Study|Insufficient Therapeutic Response|42
5718583|NCT00087607|19695044|P1|Overall Study|Insufficient Therapeutic Response|53
5718584|NCT00087607|19695043|P2|Overall Study|Death|1
5718585|NCT00087607|19695044|P1|Overall Study|Death|0
5718586|NCT00087607|19695043|P2|Overall Study|Adverse Event|24
5718587|NCT00087607|19695044|P1|Overall Study|Adverse Event|14
5718588|NCT00087594|19695084|P2|Overall Study|Lack of Efficacy|5
5718589|NCT00087594|19695085|P1|Overall Study|Lack of Efficacy|2
5718590|NCT00087594|19695084|P2|Overall Study|Withdrawal by Subject|2
5718591|NCT00087594|19695085|P1|Overall Study|Withdrawal by Subject|4
5718592|NCT00087594|19695084|P2|Overall Study|Lost to Follow-up|2
5718593|NCT00087594|19695085|P1|Overall Study|Lost to Follow-up|0
5718594|NCT00087594|19695084|P2|Overall Study|Adverse Event|3
5718595|NCT00087594|19695085|P1|Overall Study|Adverse Event|2
5718596|NCT00087568|19695119|P2|Overall Study|Lack of Efficacy|1
5718597|NCT00087568|19695120|P1|Overall Study|Lack of Efficacy|24
5718598|NCT00087568|19695119|P2|Overall Study|Lost to Follow-up|0
5718599|NCT00087568|19695120|P1|Overall Study|Lost to Follow-up|1
5718600|NCT00087568|19695119|P2|Overall Study|Withdrawal by Subject|1
5718601|NCT00087568|19695120|P1|Overall Study|Withdrawal by Subject|1
5718602|NCT00087568|19695119|P2|Overall Study|Adverse Event|0
5718603|NCT00087568|19695120|P1|Overall Study|Adverse Event|4
5718604|NCT00087555|19695147|P3|Overall Study|Patient wanted to go back on Med|0
5718605|NCT00087555|19695148|P2|Overall Study|Patient wanted to go back on Med|0
5718606|NCT00087555|19695149|P1|Overall Study|Patient wanted to go back on Med|1
5718607|NCT00087555|19695147|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
5718608|NCT00087555|19695148|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
5718609|NCT00087555|19695149|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
5718610|NCT00087555|19695147|P3|Overall Study|Non Compliance|1
5718611|NCT00087555|19695148|P2|Overall Study|Non Compliance|0
5718612|NCT00087555|19695149|P1|Overall Study|Non Compliance|0
5718613|NCT00087555|19695147|P3|Overall Study|Lack of Efficacy|1
5718614|NCT00087555|19695148|P2|Overall Study|Lack of Efficacy|0
5718615|NCT00087555|19695149|P1|Overall Study|Lack of Efficacy|2
5718616|NCT00087555|19695147|P3|Overall Study|Withdrawal by Subject|1
5718617|NCT00087555|19695148|P2|Overall Study|Withdrawal by Subject|2
5718618|NCT00087555|19695149|P1|Overall Study|Withdrawal by Subject|3
5718619|NCT00087555|19695147|P3|Overall Study|Pregnancy|1
5718620|NCT00087555|19695148|P2|Overall Study|Pregnancy|1
5718621|NCT00087555|19695149|P1|Overall Study|Pregnancy|0
5718622|NCT00087555|19695147|P3|Overall Study|Screen Failure|0
5718623|NCT00087555|19695148|P2|Overall Study|Screen Failure|1
5718624|NCT00087555|19695149|P1|Overall Study|Screen Failure|1
5718625|NCT00087555|19695147|P3|Overall Study|Protocol Violation|2
5718626|NCT00087555|19695148|P2|Overall Study|Protocol Violation|0
5718627|NCT00087555|19695149|P1|Overall Study|Protocol Violation|0
5718628|NCT00087555|19695147|P3|Overall Study|Non - Compliance|0
5718629|NCT00087555|19695148|P2|Overall Study|Non - Compliance|0
5718630|NCT00087555|19695149|P1|Overall Study|Non - Compliance|1
5718631|NCT00087555|19695147|P3|Overall Study|Lost to Follow-up|1
5718632|NCT00087555|19695148|P2|Overall Study|Lost to Follow-up|1
5718633|NCT00087555|19695149|P1|Overall Study|Lost to Follow-up|0
5718634|NCT00087555|19695147|P3|Overall Study|Adverse Event|14
5718635|NCT00087555|19695148|P2|Overall Study|Adverse Event|6
5718636|NCT00087555|19695149|P1|Overall Study|Adverse Event|3
5718637|NCT00087529|19695159|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
5718638|NCT00087529|19695160|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
5718639|NCT00087529|19695159|P2|Overall Study|Disease Progression|4
5718640|NCT00087529|19695160|P1|Overall Study|Disease Progression|5
5718641|NCT00087529|19695159|P2|Overall Study|Participant Noncompliance|1
5718642|NCT00087529|19695160|P1|Overall Study|Participant Noncompliance|0
5718643|NCT00087529|19695159|P2|Overall Study|Initiation of Excluded Therapy|1
5718644|NCT00087529|19695160|P1|Overall Study|Initiation of Excluded Therapy|0
5718645|NCT00087529|19695159|P2|Overall Study|Physician Decision|8
5718646|NCT00087529|19695160|P1|Overall Study|Physician Decision|4
5718647|NCT00087529|19695159|P2|Overall Study|Participant Decision|37
5718648|NCT00087529|19695160|P1|Overall Study|Participant Decision|14
5718649|NCT00087529|19695159|P2|Overall Study|Lost to Follow-up|3
5718650|NCT00087529|19695160|P1|Overall Study|Lost to Follow-up|2
5718651|NCT00087529|19695159|P2|Overall Study|Pregnancy|1
5718652|NCT00087529|19695160|P1|Overall Study|Pregnancy|0
5718653|NCT00087529|19695159|P2|Overall Study|Adverse Event|8
5718654|NCT00087529|19695160|P1|Overall Study|Adverse Event|0
5718655|NCT00087529|19695159|P2|Overall Study|Death|0
5718656|NCT00087529|19695160|P1|Overall Study|Death|1
5718657|NCT00087516|19695175|P4|Overall Study|Other|0
5718658|NCT00087516|19695176|P3|Overall Study|Other|1
5718659|NCT00087516|19695177|P2|Overall Study|Other|0
5718660|NCT00087516|19695178|P1|Overall Study|Other|0
5718661|NCT00087516|19695175|P4|Overall Study|Recommendation of Primary Care Physician|1
5718662|NCT00087516|19695176|P3|Overall Study|Recommendation of Primary Care Physician|0
5718663|NCT00087516|19695177|P2|Overall Study|Recommendation of Primary Care Physician|0
5718664|NCT00087516|19695178|P1|Overall Study|Recommendation of Primary Care Physician|0
5718665|NCT00087516|19695175|P4|Overall Study|Patient was non-compliant|0
5718666|NCT00087516|19695176|P3|Overall Study|Patient was non-compliant|0
5718667|NCT00087516|19695177|P2|Overall Study|Patient was non-compliant|1
5718668|NCT00087516|19695178|P1|Overall Study|Patient was non-compliant|3
5718669|NCT00087516|19695175|P4|Overall Study|Patient moved|0
5718670|NCT00087516|19695176|P3|Overall Study|Patient moved|1
5718671|NCT00087516|19695177|P2|Overall Study|Patient moved|2
5718672|NCT00087516|19695178|P1|Overall Study|Patient moved|3
5718673|NCT00087516|19695175|P4|Overall Study|Protocol specified discontinuation|26
5718674|NCT00087516|19695176|P3|Overall Study|Protocol specified discontinuation|33
5718675|NCT00087516|19695177|P2|Overall Study|Protocol specified discontinuation|33
5718676|NCT00087516|19695178|P1|Overall Study|Protocol specified discontinuation|35
5718677|NCT00087516|19695175|P4|Overall Study|Site terminated|0
5718678|NCT00087516|19695176|P3|Overall Study|Site terminated|1
5718679|NCT00087516|19695177|P2|Overall Study|Site terminated|2
5718680|NCT00087516|19695178|P1|Overall Study|Site terminated|0
5718681|NCT00087516|19695175|P4|Overall Study|Withdrawal by Subject|12
5718682|NCT00087516|19695176|P3|Overall Study|Withdrawal by Subject|11
5718683|NCT00087516|19695177|P2|Overall Study|Withdrawal by Subject|27
5718684|NCT00087516|19695178|P1|Overall Study|Withdrawal by Subject|16
5718685|NCT00087516|19695175|P4|Overall Study|Protocol Violation|6
5718686|NCT00087516|19695176|P3|Overall Study|Protocol Violation|3
5718687|NCT00087516|19695177|P2|Overall Study|Protocol Violation|8
5718688|NCT00087516|19695178|P1|Overall Study|Protocol Violation|4
5718689|NCT00087516|19695175|P4|Overall Study|Lost to Follow-up|5
5718690|NCT00087516|19695176|P3|Overall Study|Lost to Follow-up|5
5718691|NCT00087516|19695177|P2|Overall Study|Lost to Follow-up|6
5718692|NCT00087516|19695178|P1|Overall Study|Lost to Follow-up|8
5718693|NCT00087516|19695175|P4|Overall Study|Lack of Efficacy|29
5718694|NCT00087516|19695176|P3|Overall Study|Lack of Efficacy|39
5718695|NCT00087516|19695177|P2|Overall Study|Lack of Efficacy|80
5718696|NCT00087516|19695178|P1|Overall Study|Lack of Efficacy|82
5718697|NCT00087516|19695175|P4|Overall Study|Adverse Event|6
5718698|NCT00087516|19695176|P3|Overall Study|Adverse Event|3
5718699|NCT00087516|19695177|P2|Overall Study|Adverse Event|10
5718700|NCT00087516|19695178|P1|Overall Study|Adverse Event|10
5718701|NCT00087490|19695207|P2|Overall Study|Randomized but not treated|18
5718702|NCT00087490|19695208|P1|Overall Study|Randomized but not treated|7
5718703|NCT00087490|19695207|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
5718704|NCT00087490|19695208|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
5718705|NCT00087490|19695207|P2|Overall Study|Protocol Violation or (/) Unspecified|201
5718706|NCT00087490|19695208|P1|Overall Study|Protocol Violation or (/) Unspecified|214
5718707|NCT00087490|19695207|P2|Overall Study|Lack of Efficacy|2
5718708|NCT00087490|19695208|P1|Overall Study|Lack of Efficacy|0
5718709|NCT00087490|19695207|P2|Overall Study|Adverse Event|8
5718710|NCT00087490|19695208|P1|Overall Study|Adverse Event|3
5718711|NCT00087490|19695207|P2|Overall Study|Death|4
5718712|NCT00087490|19695208|P1|Overall Study|Death|6
5718713|NCT00087438|19695242|P1|Overall Study|Ineligible / No protocol treatment|4
5718714|NCT00087152|19695252|P1|Overall Study|Ineligible|6
5718715|NCT00087139|19695261|P3|Overall Study|Extradural disease|1
5718716|NCT00087139|19695262|P2|Overall Study|Extradural disease|0
5718717|NCT00087139|19695263|P1|Overall Study|Extradural disease|0
5718718|NCT00087139|19695261|P3|Overall Study|Response achieved|0
5718719|NCT00087139|19695262|P2|Overall Study|Response achieved|1
5718720|NCT00087139|19695263|P1|Overall Study|Response achieved|0
5718721|NCT00087139|19695261|P3|Overall Study|Use of coumadin|0
5718722|NCT00087139|19695262|P2|Overall Study|Use of coumadin|0
5718723|NCT00087139|19695263|P1|Overall Study|Use of coumadin|1
5718724|NCT00087139|19695261|P3|Overall Study|Symptomatic deterioration|3
5718725|NCT00087139|19695262|P2|Overall Study|Symptomatic deterioration|1
5718726|NCT00087139|19695263|P1|Overall Study|Symptomatic deterioration|1
5718727|NCT00087139|19695261|P3|Overall Study|Ineligible|4
5718728|NCT00087139|19695262|P2|Overall Study|Ineligible|7
5718729|NCT00087139|19695263|P1|Overall Study|Ineligible|4
5718730|NCT00087139|19695261|P3|Overall Study|Disease progression|12
5718731|NCT00087139|19695262|P2|Overall Study|Disease progression|19
5718732|NCT00087139|19695263|P1|Overall Study|Disease progression|9
5718733|NCT00087139|19695261|P3|Overall Study|Physician Decision|1
5718734|NCT00087139|19695262|P2|Overall Study|Physician Decision|1
5718735|NCT00087139|19695263|P1|Overall Study|Physician Decision|1
5718736|NCT00087139|19695261|P3|Overall Study|Withdrawal by Subject|2
5718737|NCT00087139|19695262|P2|Overall Study|Withdrawal by Subject|2
5718738|NCT00087139|19695263|P1|Overall Study|Withdrawal by Subject|3
5718739|NCT00087139|19695261|P3|Overall Study|Death|0
5718740|NCT00087139|19695262|P2|Overall Study|Death|1
5718741|NCT00087139|19695263|P1|Overall Study|Death|2
5718742|NCT00087139|19695261|P3|Overall Study|Adverse Event|13
5718743|NCT00087139|19695262|P2|Overall Study|Adverse Event|17
5718744|NCT00087139|19695263|P1|Overall Study|Adverse Event|18
5718745|NCT00087126|19695278|P1|Overall Study|Never treated|1
5718746|NCT00087126|19695278|P1|Overall Study|Ineligible - second primary|1
5718747|NCT00086996|19695303|P1|Overall Study|not eligible|5
5718748|NCT00086996|19695303|P1|Overall Study|Other|6
5718749|NCT00086996|19695303|P1|Overall Study|Withdrawal by Subject|13
5718750|NCT00086996|19695303|P1|Overall Study|progression/relapse|7
5718751|NCT00086996|19695303|P1|Overall Study|Death|4
5718752|NCT00086996|19695303|P1|Overall Study|Adverse Event|29
5718753|NCT00086684|19695325|P3|Overall Study|Other|3
5718754|NCT00086684|19695326|P2|Overall Study|Other|2
5718755|NCT00086684|19695327|P1|Overall Study|Other|4
5718756|NCT00086684|19695325|P3|Overall Study|WITHDRAWAL OF CONSENT|5
5718757|NCT00086684|19695326|P2|Overall Study|WITHDRAWAL OF CONSENT|7
5718758|NCT00086684|19695327|P1|Overall Study|WITHDRAWAL OF CONSENT|5
5718759|NCT00086684|19695325|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
5718760|NCT00086684|19695326|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
5718761|NCT00086684|19695327|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
5718762|NCT00086684|19695325|P3|Overall Study|NONCOMPLIANCE|6
5718763|NCT00086684|19695326|P2|Overall Study|NONCOMPLIANCE|7
5718764|NCT00086684|19695327|P1|Overall Study|NONCOMPLIANCE|5
5718765|NCT00086684|19695325|P3|Overall Study|Withdrawal by Subject|10
5718766|NCT00086684|19695326|P2|Overall Study|Withdrawal by Subject|4
5718767|NCT00086684|19695327|P1|Overall Study|Withdrawal by Subject|0
5718768|NCT00086684|19695325|P3|Overall Study|Protocol Violation|0
5718769|NCT00086684|19695326|P2|Overall Study|Protocol Violation|3
5718770|NCT00086684|19695327|P1|Overall Study|Protocol Violation|8
5718771|NCT00086684|19695325|P3|Overall Study|Lost to Follow-up|10
5718772|NCT00086684|19695326|P2|Overall Study|Lost to Follow-up|8
5718773|NCT00086684|19695327|P1|Overall Study|Lost to Follow-up|15
5718774|NCT00086684|19695325|P3|Overall Study|Lack of Efficacy|5
5718775|NCT00086684|19695326|P2|Overall Study|Lack of Efficacy|6
5718776|NCT00086684|19695327|P1|Overall Study|Lack of Efficacy|6
5718777|NCT00086684|19695325|P3|Overall Study|Adverse Event|14
5718778|NCT00086684|19695326|P2|Overall Study|Adverse Event|17
5718779|NCT00086684|19695327|P1|Overall Study|Adverse Event|12
5718780|NCT00086619|19695340|P2|Overall Study|Protocol Violation|1
5718781|NCT00086619|19695341|P1|Overall Study|Protocol Violation|1
5718782|NCT00086619|19695340|P2|Overall Study|Adverse Event|10
5718783|NCT00086619|19695341|P1|Overall Study|Adverse Event|8
5718784|NCT00086619|19695340|P2|Overall Study|Withdrawal by Subject|6
5718785|NCT00086619|19695341|P1|Overall Study|Withdrawal by Subject|6
5718786|NCT00086580|19695351|P2|Observation Period|Other|7
5718787|NCT00086580|19695352|P1|Observation Period|Other|8
5718788|NCT00086580|19695351|P2|Observation Period|Death|55
5718789|NCT00086580|19695352|P1|Observation Period|Death|33
5718790|NCT00086580|19695351|P2|Observation Period|Withdrawal by Subject|2
5718791|NCT00086580|19695352|P1|Observation Period|Withdrawal by Subject|4
5718792|NCT00086580|19695351|P2|Observation Period|Unable to comply with protocol|1
5718793|NCT00086580|19695352|P1|Observation Period|Unable to comply with protocol|1
5718794|NCT00086580|19695351|P2|Follow-up Period|Other|6
5718795|NCT00086580|19695352|P1|Follow-up Period|Other|7
5718796|NCT00086580|19695351|P2|Follow-up Period|Death|7
5718797|NCT00086580|19695352|P1|Follow-up Period|Death|13
5718798|NCT00086580|19695351|P2|Follow-up Period|AE - not related|0
5718799|NCT00086580|19695352|P1|Follow-up Period|AE - not related|1
5718800|NCT00086580|19695351|P2|Follow-up Period|Physician Decision|1
5718801|NCT00086580|19695352|P1|Follow-up Period|Physician Decision|0
5718802|NCT00086580|19695351|P2|Follow-up Period|Withdrawal by Subject|6
5718803|NCT00086580|19695352|P1|Follow-up Period|Withdrawal by Subject|6
5718804|NCT00086580|19695351|P2|Follow-up Period|Unable to comply with protocol|0
5718805|NCT00086580|19695352|P1|Follow-up Period|Unable to comply with protocol|5
5718806|NCT00086580|19695351|P2|Follow-up Period|Disease progression|99
5718807|NCT00086580|19695352|P1|Follow-up Period|Disease progression|72
5718808|NCT00086580|19695351|P2|Treatment Period|Other|3
5718809|NCT00086580|19695352|P1|Treatment Period|Other|5
5718810|NCT00086580|19695351|P2|Treatment Period|Death|7
5718811|NCT00086580|19695352|P1|Treatment Period|Death|5
5718812|NCT00086580|19695351|P2|Treatment Period|Anemia or thrombocytopenia|4
5718813|NCT00086580|19695352|P1|Treatment Period|Anemia or thrombocytopenia|1
5718814|NCT00086580|19695351|P2|Treatment Period|Toxicity - treatment related|15
5718815|NCT00086580|19695352|P1|Treatment Period|Toxicity - treatment related|15
5718816|NCT00086580|19695351|P2|Treatment Period|AE - not treatment related|7
5718817|NCT00086580|19695352|P1|Treatment Period|AE - not treatment related|7
5718818|NCT00086580|19695351|P2|Treatment Period|Physician Decision|7
5718819|NCT00086580|19695352|P1|Treatment Period|Physician Decision|13
5718820|NCT00086580|19695351|P2|Treatment Period|Withdrawal by Subject|8
5718821|NCT00086580|19695352|P1|Treatment Period|Withdrawal by Subject|7
5718822|NCT00086580|19695351|P2|Treatment Period|Unable to comply with protocol|1
5718823|NCT00086580|19695352|P1|Treatment Period|Unable to comply with protocol|3
5718824|NCT00086580|19695351|P2|Treatment Period|Disease progression|8
5718825|NCT00086580|19695352|P1|Treatment Period|Disease progression|9
5718826|NCT00086411|19695400|P4|Overall Study|Lost to Follow-up|12
5718827|NCT00086411|19695401|P3|Overall Study|Lost to Follow-up|13
5718828|NCT00086411|19695402|P2|Overall Study|Lost to Follow-up|11
5718829|NCT00086411|19695403|P1|Overall Study|Lost to Follow-up|11
5718830|NCT00086385|19695421|P4|Overall Study|Death|1
5718831|NCT00086385|19695422|P3|Overall Study|Death|1
5718832|NCT00086385|19695423|P2|Overall Study|Death|2
5718833|NCT00086385|19695424|P1|Overall Study|Death|2
5718834|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Discontinued in error|0
5718835|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Discontinued in error|1
5718836|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
5718837|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
5718838|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
5718839|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
5718840|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Patient Died|1
5718841|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Patient Died|3
5718842|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
5718843|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
5718844|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
5718845|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
5718846|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Patient Moved|2
5718847|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Patient Moved|2
5718848|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
5718849|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
5718850|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Protocol Violation|0
5718851|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Protocol Violation|1
5718852|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Physician Decision|0
5718853|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Physician Decision|3
5718854|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
5718855|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
5718856|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
5718857|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
5718858|NCT00086515|19695436|P2|Phase B (Weeks 24-104)|Adverse Event|10
5718859|NCT00086515|19695437|P1|Phase B (Weeks 24-104)|Adverse Event|16
5718860|NCT00086515|19695436|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
5718861|NCT00086515|19695437|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
5718862|NCT00086515|19695436|P2|Phase A to Phase B Transition Period|Poor compliance|0
5718863|NCT00086515|19695437|P1|Phase A to Phase B Transition Period|Poor compliance|1
5718864|NCT00086515|19695436|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
5718865|NCT00086515|19695437|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
5718866|NCT00086515|19695436|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
5718867|NCT00086515|19695437|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
5718868|NCT00086515|19695436|P2|Phase A to Phase B Transition Period|Protocol Violation|1
5718869|NCT00086515|19695437|P1|Phase A to Phase B Transition Period|Protocol Violation|0
5718870|NCT00086515|19695436|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
5718871|NCT00086515|19695437|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
5718872|NCT00086515|19695436|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
5718873|NCT00086515|19695437|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
5718874|NCT00086515|19695436|P2|Phase A to Phase B Transition Period|Adverse Event|1
5718875|NCT00086515|19695437|P1|Phase A to Phase B Transition Period|Adverse Event|2
5718876|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
5718877|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
5718878|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
5718879|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
5718880|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Poor compliance|0
5718881|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Poor compliance|1
5718882|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
5718883|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
5718884|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Patient Moved|3
5718885|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Patient Moved|2
5718886|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
5718887|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
5718888|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Protocol Violation|1
5718889|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Protocol Violation|3
5718890|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
5718891|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
5718892|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
5718893|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
5718894|NCT00086515|19695436|P2|Phase A (Weeks 0-24)|Adverse Event|9
5718895|NCT00086515|19695437|P1|Phase A (Weeks 0-24)|Adverse Event|17
5718896|NCT00086502|19695449|P2|Overall Study|Patient Accidentally Unblinded|0
5718897|NCT00086502|19695450|P1|Overall Study|Patient Accidentally Unblinded|1
5718898|NCT00086502|19695449|P2|Overall Study|Protocol Discontinuation Criteria|3
5718899|NCT00086502|19695450|P1|Overall Study|Protocol Discontinuation Criteria|1
5718900|NCT00086502|19695449|P2|Overall Study|Patient Moved|1
5718901|NCT00086502|19695450|P1|Overall Study|Patient Moved|1
5718902|NCT00086502|19695449|P2|Overall Study|Withdrawal by Subject|6
5718903|NCT00086502|19695450|P1|Overall Study|Withdrawal by Subject|5
5718904|NCT00086502|19695449|P2|Overall Study|Protocol Violation|3
5718905|NCT00086502|19695450|P1|Overall Study|Protocol Violation|3
5718906|NCT00086502|19695449|P2|Overall Study|Pregnancy|1
5718907|NCT00086502|19695450|P1|Overall Study|Pregnancy|0
5718908|NCT00086502|19695449|P2|Overall Study|Physician Decision|1
5718909|NCT00086502|19695450|P1|Overall Study|Physician Decision|1
5718910|NCT00086502|19695449|P2|Overall Study|Lost to Follow-up|1
5718911|NCT00086502|19695450|P1|Overall Study|Lost to Follow-up|3
5718912|NCT00086502|19695449|P2|Overall Study|Lack of Efficacy|2
5718913|NCT00086502|19695450|P1|Overall Study|Lack of Efficacy|0
5718914|NCT00086502|19695449|P2|Overall Study|Adverse Event|2
5718915|NCT00086502|19695450|P1|Overall Study|Adverse Event|11
5718916|NCT00086346|19695475|P2|Patients Dosed With Test Article|Lack of Efficacy|0
5718917|NCT00086346|19695476|P1|Patients Dosed With Test Article|Lack of Efficacy|11
5718918|NCT00086346|19695475|P2|Patients Dosed With Test Article|Protocol Violation|3
5718919|NCT00086346|19695476|P1|Patients Dosed With Test Article|Protocol Violation|11
5718920|NCT00086346|19695475|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
5718921|NCT00086346|19695476|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
5718922|NCT00086346|19695475|P2|Patients Dosed With Test Article|Nonmedical event|3
5718923|NCT00086346|19695476|P1|Patients Dosed With Test Article|Nonmedical event|7
5718924|NCT00086346|19695475|P2|Patients Dosed With Test Article|Lost to Follow-up|3
5718925|NCT00086346|19695476|P1|Patients Dosed With Test Article|Lost to Follow-up|1
5718926|NCT00086346|19695475|P2|Patients Dosed With Test Article|Adverse Event|11
5718927|NCT00086346|19695476|P1|Patients Dosed With Test Article|Adverse Event|94
5718928|NCT00086346|19695475|P2|Randomization|Did not receive test article|4
5718929|NCT00086346|19695476|P1|Randomization|Did not receive test article|4
5718930|NCT00086281|19695503|P15|Phase 2|Adverse Event|0
5718931|NCT00086281|19695504|P14|Phase 2|Adverse Event|1
5718932|NCT00086281|19695505|P13|Phase 2|Adverse Event|1
5718933|NCT00086281|19695506|P12|Phase 2|Adverse Event|0
5718934|NCT00086281|19695507|P11|Phase 2|Adverse Event|0
5718935|NCT00086281|19695508|P10|Phase 2|Adverse Event|0
5718936|NCT00086281|19695509|P9|Phase 2|Adverse Event|0
5718937|NCT00086281|19695510|P8|Phase 2|Adverse Event|0
5718938|NCT00086281|19695511|P7|Phase 2|Adverse Event|0
5718939|NCT00086281|19695512|P6|Phase 2|Adverse Event|0
5718940|NCT00086281|19695513|P5|Phase 2|Adverse Event|0
5718941|NCT00086281|19695514|P4|Phase 2|Adverse Event|0
5718942|NCT00086281|19695515|P3|Phase 2|Adverse Event|0
5718943|NCT00086281|19695516|P2|Phase 2|Adverse Event|0
5718944|NCT00086281|19695517|P1|Phase 2|Adverse Event|0
5718945|NCT00086281|19695503|P15|Phase 1|Serious Adverse Event|1
5718946|NCT00086281|19695504|P14|Phase 1|Serious Adverse Event|0
5718947|NCT00086281|19695505|P13|Phase 1|Serious Adverse Event|0
5718948|NCT00086281|19695506|P12|Phase 1|Serious Adverse Event|0
5718949|NCT00086281|19695507|P11|Phase 1|Serious Adverse Event|0
5718950|NCT00086281|19695508|P10|Phase 1|Serious Adverse Event|0
5718951|NCT00086281|19695509|P9|Phase 1|Serious Adverse Event|0
5718952|NCT00086281|19695510|P8|Phase 1|Serious Adverse Event|0
5718953|NCT00086281|19695511|P7|Phase 1|Serious Adverse Event|0
5718954|NCT00086281|19695512|P6|Phase 1|Serious Adverse Event|0
5718955|NCT00086281|19695513|P5|Phase 1|Serious Adverse Event|0
5718956|NCT00086281|19695514|P4|Phase 1|Serious Adverse Event|0
5718957|NCT00086281|19695515|P3|Phase 1|Serious Adverse Event|0
5718958|NCT00086281|19695516|P2|Phase 1|Serious Adverse Event|0
5718959|NCT00086281|19695517|P1|Phase 1|Serious Adverse Event|0
5718960|NCT00086281|19695503|P15|Phase 1|Protocol Violation|0
5718961|NCT00086281|19695504|P14|Phase 1|Protocol Violation|0
5718962|NCT00086281|19695505|P13|Phase 1|Protocol Violation|0
5718963|NCT00086281|19695506|P12|Phase 1|Protocol Violation|0
5718964|NCT00086281|19695507|P11|Phase 1|Protocol Violation|1
5718965|NCT00086281|19695508|P10|Phase 1|Protocol Violation|0
5718966|NCT00086281|19695509|P9|Phase 1|Protocol Violation|0
5718967|NCT00086281|19695510|P8|Phase 1|Protocol Violation|0
5718968|NCT00086281|19695511|P7|Phase 1|Protocol Violation|0
5718969|NCT00086281|19695512|P6|Phase 1|Protocol Violation|0
5718970|NCT00086281|19695513|P5|Phase 1|Protocol Violation|0
5718971|NCT00086281|19695514|P4|Phase 1|Protocol Violation|0
5718972|NCT00086281|19695515|P3|Phase 1|Protocol Violation|0
5718973|NCT00086281|19695516|P2|Phase 1|Protocol Violation|0
5718974|NCT00086281|19695517|P1|Phase 1|Protocol Violation|0
5718975|NCT00086281|19695503|P15|Phase 1|Adverse Event|2
5718976|NCT00086281|19695504|P14|Phase 1|Adverse Event|1
5718977|NCT00086281|19695505|P13|Phase 1|Adverse Event|1
5718978|NCT00086281|19695506|P12|Phase 1|Adverse Event|1
5718979|NCT00086281|19695507|P11|Phase 1|Adverse Event|2
5718980|NCT00086281|19695508|P10|Phase 1|Adverse Event|1
5718981|NCT00086281|19695509|P9|Phase 1|Adverse Event|0
5718982|NCT00086281|19695510|P8|Phase 1|Adverse Event|0
5718983|NCT00086281|19695511|P7|Phase 1|Adverse Event|0
5718984|NCT00086281|19695512|P6|Phase 1|Adverse Event|0
5718985|NCT00086281|19695513|P5|Phase 1|Adverse Event|0
5718986|NCT00086281|19695514|P4|Phase 1|Adverse Event|0
5718987|NCT00086281|19695515|P3|Phase 1|Adverse Event|0
5718988|NCT00086281|19695516|P2|Phase 1|Adverse Event|0
5718989|NCT00086281|19695517|P1|Phase 1|Adverse Event|0
5718990|NCT00086307|19695530|P3|Overall Study|Withdrawal by Subject|2
5718991|NCT00086307|19695531|P2|Overall Study|Withdrawal by Subject|0
5718992|NCT00086307|19695532|P1|Overall Study|Withdrawal by Subject|0
5718993|NCT00086307|19695530|P3|Overall Study|Fatigue and difficulty falling asleep|1
5718994|NCT00086307|19695531|P2|Overall Study|Fatigue and difficulty falling asleep|0
5718995|NCT00086307|19695532|P1|Overall Study|Fatigue and difficulty falling asleep|0
5718996|NCT00086307|19695530|P3|Overall Study|Suicidal ideation|1
5718997|NCT00086307|19695531|P2|Overall Study|Suicidal ideation|0
5718998|NCT00086307|19695532|P1|Overall Study|Suicidal ideation|0
5718999|NCT00086307|19695530|P3|Overall Study|Constipation and sleepiness|1
5719000|NCT00086307|19695531|P2|Overall Study|Constipation and sleepiness|0
5719001|NCT00086307|19695532|P1|Overall Study|Constipation and sleepiness|0
5719002|NCT00086307|19695530|P3|Overall Study|Nausea and headaches|1
5719003|NCT00086307|19695531|P2|Overall Study|Nausea and headaches|0
5719004|NCT00086307|19695532|P1|Overall Study|Nausea and headaches|0
5719005|NCT00086307|19695530|P3|Overall Study|Shortness of breath and muscle spasms|0
5719006|NCT00086307|19695531|P2|Overall Study|Shortness of breath and muscle spasms|0
5719007|NCT00086307|19695532|P1|Overall Study|Shortness of breath and muscle spasms|1
5719008|NCT00086307|19695530|P3|Overall Study|Lack of Efficacy|2
5719009|NCT00086307|19695531|P2|Overall Study|Lack of Efficacy|1
5719010|NCT00086307|19695532|P1|Overall Study|Lack of Efficacy|1
5719011|NCT00086190|19695543|P3|Overall Study|Worsening depression|2
5719012|NCT00086190|19695544|P2|Overall Study|Worsening depression|0
5719013|NCT00086190|19695545|P1|Overall Study|Worsening depression|0
5719014|NCT00086190|19695543|P3|Overall Study|Moved|0
5719015|NCT00086190|19695544|P2|Overall Study|Moved|0
5719016|NCT00086190|19695545|P1|Overall Study|Moved|1
5719017|NCT00086190|19695543|P3|Overall Study|Protocol Violation|0
5719018|NCT00086190|19695544|P2|Overall Study|Protocol Violation|0
5719019|NCT00086190|19695545|P1|Overall Study|Protocol Violation|1
5719020|NCT00086190|19695543|P3|Overall Study|Withdrawal by Subject|2
5719021|NCT00086190|19695544|P2|Overall Study|Withdrawal by Subject|2
5719022|NCT00086190|19695545|P1|Overall Study|Withdrawal by Subject|0
5719023|NCT00086190|19695543|P3|Overall Study|Adverse Event|2
5719024|NCT00086190|19695544|P2|Overall Study|Adverse Event|2
5719025|NCT00086190|19695545|P1|Overall Study|Adverse Event|6
5719026|NCT00086047|19695614|P2|Overall Study|Physician Decision|1
5719027|NCT00086047|19695615|P1|Overall Study|Physician Decision|0
5719028|NCT00086047|19695614|P2|Overall Study|Lost to Follow-up|6
5719029|NCT00086047|19695615|P1|Overall Study|Lost to Follow-up|7
5719030|NCT00085917|19695623|P2|Overall Study|Adverse Event|3
5719031|NCT00085917|19695624|P1|Overall Study|Adverse Event|4
5719032|NCT00085735|19695653|P6|Overall Study|Pt transferred to inst w/out study open|0
5719033|NCT00085735|19695654|P5|Overall Study|Pt transferred to inst w/out study open|0
5719034|NCT00085735|19695655|P4|Overall Study|Pt transferred to inst w/out study open|0
5719035|NCT00085735|19695656|P3|Overall Study|Pt transferred to inst w/out study open|0
5719036|NCT00085735|19695657|P2|Overall Study|Pt transferred to inst w/out study open|0
5719037|NCT00085735|19695658|P1|Overall Study|Pt transferred to inst w/out study open|1
5719038|NCT00085735|19695653|P6|Overall Study|Reason not documented|0
5719039|NCT00085735|19695654|P5|Overall Study|Reason not documented|1
5719040|NCT00085735|19695655|P4|Overall Study|Reason not documented|0
5719041|NCT00085735|19695656|P3|Overall Study|Reason not documented|1
5719042|NCT00085735|19695657|P2|Overall Study|Reason not documented|0
5719043|NCT00085735|19695658|P1|Overall Study|Reason not documented|1
5719044|NCT00085735|19695653|P6|Overall Study|Excess residual disease|4
5719045|NCT00085735|19695654|P5|Overall Study|Excess residual disease|1
5719046|NCT00085735|19695655|P4|Overall Study|Excess residual disease|1
5719047|NCT00085735|19695656|P3|Overall Study|Excess residual disease|1
5719048|NCT00085735|19695657|P2|Overall Study|Excess residual disease|2
5719049|NCT00085735|19695658|P1|Overall Study|Excess residual disease|2
5719050|NCT00085735|19695653|P6|Overall Study|Patient ineligible|8
5719051|NCT00085735|19695654|P5|Overall Study|Patient ineligible|17
5719052|NCT00085735|19695655|P4|Overall Study|Patient ineligible|7
5719053|NCT00085735|19695656|P3|Overall Study|Patient ineligible|3
5719054|NCT00085735|19695657|P2|Overall Study|Patient ineligible|0
5719055|NCT00085735|19695658|P1|Overall Study|Patient ineligible|1
5719056|NCT00085735|19695653|P6|Overall Study|Withdrawal by Subject|8
5719057|NCT00085735|19695654|P5|Overall Study|Withdrawal by Subject|7
5719058|NCT00085735|19695655|P4|Overall Study|Withdrawal by Subject|5
5719059|NCT00085735|19695656|P3|Overall Study|Withdrawal by Subject|4
5719060|NCT00085735|19695657|P2|Overall Study|Withdrawal by Subject|0
5719061|NCT00085735|19695658|P1|Overall Study|Withdrawal by Subject|1
5719062|NCT00085735|19695653|P6|Overall Study|Protocol Violation|0
5719063|NCT00085735|19695654|P5|Overall Study|Protocol Violation|0
5719064|NCT00085735|19695655|P4|Overall Study|Protocol Violation|0
5719065|NCT00085735|19695656|P3|Overall Study|Protocol Violation|0
5719066|NCT00085735|19695657|P2|Overall Study|Protocol Violation|0
5719067|NCT00085735|19695658|P1|Overall Study|Protocol Violation|1
5719068|NCT00085735|19695653|P6|Overall Study|Physician Decision|8
5719069|NCT00085735|19695654|P5|Overall Study|Physician Decision|11
5719070|NCT00085735|19695655|P4|Overall Study|Physician Decision|3
5719071|NCT00085735|19695656|P3|Overall Study|Physician Decision|2
5719072|NCT00085735|19695657|P2|Overall Study|Physician Decision|3
5719073|NCT00085735|19695658|P1|Overall Study|Physician Decision|2
5719074|NCT00085735|19695653|P6|Overall Study|Lost to Follow-up|0
5719075|NCT00085735|19695654|P5|Overall Study|Lost to Follow-up|1
5719076|NCT00085735|19695655|P4|Overall Study|Lost to Follow-up|0
5719077|NCT00085735|19695656|P3|Overall Study|Lost to Follow-up|0
5719078|NCT00085735|19695657|P2|Overall Study|Lost to Follow-up|1
5719079|NCT00085735|19695658|P1|Overall Study|Lost to Follow-up|0
5719080|NCT00085735|19695653|P6|Overall Study|Lack of Efficacy|3
5719081|NCT00085735|19695654|P5|Overall Study|Lack of Efficacy|4
5719082|NCT00085735|19695655|P4|Overall Study|Lack of Efficacy|3
5719083|NCT00085735|19695656|P3|Overall Study|Lack of Efficacy|6
5719084|NCT00085735|19695657|P2|Overall Study|Lack of Efficacy|4
5719085|NCT00085735|19695658|P1|Overall Study|Lack of Efficacy|2
5719086|NCT00085735|19695653|P6|Overall Study|Adverse Event|0
5719087|NCT00085735|19695654|P5|Overall Study|Adverse Event|0
5719088|NCT00085735|19695655|P4|Overall Study|Adverse Event|0
5719089|NCT00085735|19695656|P3|Overall Study|Adverse Event|0
5719090|NCT00085735|19695657|P2|Overall Study|Adverse Event|0
5719091|NCT00085735|19695658|P1|Overall Study|Adverse Event|1
5719092|NCT00085709|19695713|P2|Overall Study|Withdrawal by Subject|1
5719093|NCT00085709|19695714|P1|Overall Study|Withdrawal by Subject|2
5719094|NCT00085709|19695713|P2|Overall Study|Not eligible|19
5719095|NCT00085709|19695714|P1|Overall Study|Not eligible|19
5719096|NCT00085709|19695713|P2|Overall Study|Not protocol specified|22
5719097|NCT00085709|19695714|P1|Overall Study|Not protocol specified|12
5719098|NCT00085709|19695713|P2|Overall Study|Progression|4
5719099|NCT00085709|19695714|P1|Overall Study|Progression|3
5719100|NCT00085709|19695713|P2|Overall Study|Refusal unrelated to adverse events|2
5719101|NCT00085709|19695714|P1|Overall Study|Refusal unrelated to adverse events|1
5719102|NCT00085709|19695713|P2|Overall Study|Death|2
5719103|NCT00085709|19695714|P1|Overall Study|Death|8
5719104|NCT00085709|19695713|P2|Overall Study|Adverse Event|0
5719105|NCT00085709|19695714|P1|Overall Study|Adverse Event|8
5719106|NCT00085644|19695730|P3|Open-Label Period|Personal reason|4
5719107|NCT00085644|19695731|P2|Open-Label Period|Personal reason|0
5719108|NCT00085644|19695732|P1|Open-Label Period|Personal reason|0
5719109|NCT00085644|19695730|P3|Open-Label Period|Protocol Violation|4
5719110|NCT00085644|19695731|P2|Open-Label Period|Protocol Violation|0
5719111|NCT00085644|19695732|P1|Open-Label Period|Protocol Violation|0
5719112|NCT00085644|19695730|P3|Open-Label Period|Contemplating pregnancy|3
5719113|NCT00085644|19695731|P2|Open-Label Period|Contemplating pregnancy|0
5719114|NCT00085644|19695732|P1|Open-Label Period|Contemplating pregnancy|0
5719115|NCT00085644|19695730|P3|Open-Label Period|Pregnancy|3
5719116|NCT00085644|19695731|P2|Open-Label Period|Pregnancy|0
5719117|NCT00085644|19695732|P1|Open-Label Period|Pregnancy|0
5719118|NCT00085644|19695730|P3|Open-Label Period|Lack of Efficacy|15
5719119|NCT00085644|19695731|P2|Open-Label Period|Lack of Efficacy|0
5719120|NCT00085644|19695732|P1|Open-Label Period|Lack of Efficacy|0
5719121|NCT00085644|19695730|P3|Open-Label Period|Lost to Follow-up|13
5719122|NCT00085644|19695731|P2|Open-Label Period|Lost to Follow-up|0
5719123|NCT00085644|19695732|P1|Open-Label Period|Lost to Follow-up|0
5719124|NCT00085644|19695730|P3|Open-Label Period|Withdrawal by Subject|29
5719125|NCT00085644|19695731|P2|Open-Label Period|Withdrawal by Subject|0
5719126|NCT00085644|19695732|P1|Open-Label Period|Withdrawal by Subject|0
5719127|NCT00085644|19695730|P3|Open-Label Period|Adverse Event|38
5719128|NCT00085644|19695731|P2|Open-Label Period|Adverse Event|0
5719129|NCT00085644|19695732|P1|Open-Label Period|Adverse Event|0
5719130|NCT00085644|19695730|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
5719131|NCT00085644|19695731|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
5719132|NCT00085644|19695732|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
5719133|NCT00085644|19695730|P3|Double-Blind Period|Contemplating pregnancy|0
5719134|NCT00085644|19695731|P2|Double-Blind Period|Contemplating pregnancy|0
5719135|NCT00085644|19695732|P1|Double-Blind Period|Contemplating pregnancy|1
5719136|NCT00085644|19695730|P3|Double-Blind Period|Lack/loss of efficacy|0
5719137|NCT00085644|19695731|P2|Double-Blind Period|Lack/loss of efficacy|2
5719138|NCT00085644|19695732|P1|Double-Blind Period|Lack/loss of efficacy|2
5719139|NCT00085644|19695730|P3|Double-Blind Period|Lost to Follow-up|0
5719140|NCT00085644|19695731|P2|Double-Blind Period|Lost to Follow-up|1
5719141|NCT00085644|19695732|P1|Double-Blind Period|Lost to Follow-up|2
5719142|NCT00085644|19695730|P3|Double-Blind Period|Withdrawal by Subject|0
5719143|NCT00085644|19695731|P2|Double-Blind Period|Withdrawal by Subject|0
5719144|NCT00085644|19695732|P1|Double-Blind Period|Withdrawal by Subject|3
5719145|NCT00085644|19695730|P3|Double-Blind Period|Adverse Event|0
5719146|NCT00085644|19695731|P2|Double-Blind Period|Adverse Event|2
5719147|NCT00085644|19695732|P1|Double-Blind Period|Adverse Event|5
5719148|NCT00085631|19695773|P3|Overall Study|Missing Data|7
5719149|NCT00085631|19695774|P2|Overall Study|Missing Data|11
5719150|NCT00085631|19695775|P1|Overall Study|Missing Data|4
5719151|NCT00085566|19695785|P3|Overall Study|Clinical progression|1
5719152|NCT00085566|19695786|P2|Overall Study|Clinical progression|0
5719153|NCT00085566|19695787|P1|Overall Study|Clinical progression|0
5719154|NCT00085566|19695785|P3|Overall Study|Patient Not treated|3
5719155|NCT00085566|19695786|P2|Overall Study|Patient Not treated|0
5719156|NCT00085566|19695787|P1|Overall Study|Patient Not treated|0
5719157|NCT00085566|19695785|P3|Overall Study|Adverse Event|10
5719158|NCT00085566|19695786|P2|Overall Study|Adverse Event|0
5719159|NCT00085566|19695787|P1|Overall Study|Adverse Event|0
5719160|NCT00085540|19695797|P2|Overall Study|Protocol Violation|1
5719161|NCT00085540|19695798|P1|Overall Study|Protocol Violation|0
5719162|NCT00085540|19695797|P2|Overall Study|Withdrawal by Subject|1
5719163|NCT00085540|19695798|P1|Overall Study|Withdrawal by Subject|0
5719164|NCT00085423|19695810|P1|Overall Study|screen failure|1
5719165|NCT00085423|19695810|P1|Overall Study|Withdrawal by Subject|1
5719166|NCT00085202|19695861|P2|Overall Study|Progressive disease|11
5719167|NCT00085202|19695862|P1|Overall Study|Progressive disease|1
5719168|NCT00085202|19695861|P2|Overall Study|Physician Decision|1
5719169|NCT00085202|19695862|P1|Overall Study|Physician Decision|4
5719170|NCT00085202|19695861|P2|Overall Study|Withdrawal by Subject|1
5719171|NCT00085202|19695862|P1|Overall Study|Withdrawal by Subject|2
5719172|NCT00085202|19695861|P2|Overall Study|Non-specified|5
5719173|NCT00085202|19695862|P1|Overall Study|Non-specified|3
5719174|NCT00085202|19695861|P2|Overall Study|Excessive toxicity|5
5719175|NCT00085202|19695862|P1|Overall Study|Excessive toxicity|6
5719176|NCT00085202|19695861|P2|Overall Study|Bone involvement confirmed by bone scan|1
5719177|NCT00085202|19695862|P1|Overall Study|Bone involvement confirmed by bone scan|0
5719178|NCT00085202|19695861|P2|Overall Study|Still on therapy|0
5719179|NCT00085202|19695862|P1|Overall Study|Still on therapy|2
5719180|NCT00085098|19695883|P2|Overall Study|Ineligible|1
5719181|NCT00085098|19695884|P1|Overall Study|Ineligible|1
5719182|NCT00085098|19695883|P2|Overall Study|Withdrawal by Subject|1
5719183|NCT00085098|19695884|P1|Overall Study|Withdrawal by Subject|0
5719184|NCT00084929|19695894|P1|Overall Study|Missing Reference Standard (Colonoscopy)|42
5719185|NCT00084929|19695894|P1|Overall Study|Missing/incomplete CTC exam|9
5719186|NCT00084929|19695894|P1|Overall Study|Withdrawal by Subject|10
5719187|NCT00084929|19695894|P1|Overall Study|Ineligible - Medical history|6
5719188|NCT00084929|19695894|P1|Overall Study|ineligible - Pre-scheduled procedure not|1
5719189|NCT00084929|19695894|P1|Overall Study|ineligible - medical contraindication|1
5719190|NCT00084864|19695916|P4|Overall Study|Adverse Event|0
5719191|NCT00084864|19695917|P3|Overall Study|Adverse Event|0
5719192|NCT00084864|19695918|P2|Overall Study|Adverse Event|0
5719193|NCT00084864|19695919|P1|Overall Study|Adverse Event|1
5719194|NCT00084838|19695945|P1|Overall Study|Ineligible|4
5719195|NCT00084838|19695945|P1|Overall Study|Pt Non-Compliance|1
5719196|NCT00084838|19695945|P1|Overall Study|Progressive Disease|4
5719197|NCT00084838|19695945|P1|Overall Study|Withdrawal by Subject|1
5719198|NCT00084838|19695945|P1|Overall Study|Adverse Event|2
5719199|NCT00084838|19695945|P1|Overall Study|Death|1
5719200|NCT00084747|19695967|P1|Overall Study|Withdrawal by Subject|2
5719201|NCT00084747|19695967|P1|Overall Study|Death|3
5719202|NCT00084747|19695967|P1|Overall Study|Relapsed|8
5719203|NCT00084682|19695972|P1|Overall Study|Withdrawal by Subject|1
5719204|NCT00084617|19695976|P1|Overall Study|Protocol Violation|1
5719205|NCT00084617|19695976|P1|Overall Study|Lack of Efficacy|1
5719206|NCT00084617|19695976|P1|Overall Study|Withdrawal by Subject|7
5719207|NCT00084487|19695982|P1|Overall Study|Death|1
5719208|NCT00084318|19696026|P2|Overall Study|No protocol treatment|0
5719209|NCT00084318|19696027|P1|Overall Study|No protocol treatment|2
5719210|NCT00084318|19696026|P2|Overall Study|Protocol Violation|11
5719211|NCT00084318|19696027|P1|Overall Study|Protocol Violation|15
5719212|NCT00084318|19696026|P2|Overall Study|Withdrawal by Subject|2
5719213|NCT00084318|19696027|P1|Overall Study|Withdrawal by Subject|5
5719214|NCT00084266|19696047|P2|Overall Study|Randomized not treated|20
5719215|NCT00084266|19696048|P1|Overall Study|Randomized not treated|21
5719216|NCT00084266|19696047|P2|Overall Study|Other|344
5719217|NCT00084266|19696048|P1|Overall Study|Other|360
5719218|NCT00084266|19696047|P2|Overall Study|Participant not willing to participate|8
5719219|NCT00084266|19696048|P1|Overall Study|Participant not willing to participate|3
5719220|NCT00084266|19696047|P2|Overall Study|Lost to Follow-up|3
5719221|NCT00084266|19696048|P1|Overall Study|Lost to Follow-up|5
5719222|NCT00084266|19696047|P2|Overall Study|Lack of Efficacy|4
5719223|NCT00084266|19696048|P1|Overall Study|Lack of Efficacy|2
5719224|NCT00084266|19696047|P2|Overall Study|Adverse Event|5
5719225|NCT00084266|19696048|P1|Overall Study|Adverse Event|8
5719226|NCT00084266|19696047|P2|Overall Study|Death|39
5719227|NCT00084266|19696048|P1|Overall Study|Death|42
5719228|NCT00084136|19696106|P3|NRTI Comparison|Not reason above|0
5719229|NCT00084136|19696107|P2|NRTI Comparison|Not reason above|0
5719230|NCT00084136|19696108|P1|NRTI Comparison|Not reason above|1
5719231|NCT00084136|19696106|P3|NRTI Comparison|Clinic site closed|14
5719232|NCT00084136|19696107|P2|NRTI Comparison|Clinic site closed|0
5719233|NCT00084136|19696108|P1|NRTI Comparison|Clinic site closed|12
5719234|NCT00084136|19696106|P3|NRTI Comparison|Withdrawal by Subject|38
5719235|NCT00084136|19696107|P2|NRTI Comparison|Withdrawal by Subject|0
5719236|NCT00084136|19696108|P1|NRTI Comparison|Withdrawal by Subject|54
5719237|NCT00084136|19696106|P3|NRTI Comparison|Lost to Follow-up|12
5719238|NCT00084136|19696107|P2|NRTI Comparison|Lost to Follow-up|0
5719239|NCT00084136|19696108|P1|NRTI Comparison|Lost to Follow-up|14
5719240|NCT00084136|19696106|P3|NRTI Comparison|Death|18
5719241|NCT00084136|19696107|P2|NRTI Comparison|Death|0
5719242|NCT00084136|19696108|P1|NRTI Comparison|Death|20
5719243|NCT00084136|19696106|P3|PI Comparison|Clinic site closed|0
5719244|NCT00084136|19696107|P2|PI Comparison|Clinic site closed|0
5719245|NCT00084136|19696108|P1|PI Comparison|Clinic site closed|1
5719246|NCT00084136|19696106|P3|PI Comparison|Withdrawal by Subject|0
5719247|NCT00084136|19696107|P2|PI Comparison|Withdrawal by Subject|30
5719248|NCT00084136|19696108|P1|PI Comparison|Withdrawal by Subject|33
5719249|NCT00084136|19696106|P3|PI Comparison|Lost to Follow-up|0
5719250|NCT00084136|19696107|P2|PI Comparison|Lost to Follow-up|8
5719251|NCT00084136|19696108|P1|PI Comparison|Lost to Follow-up|11
5719252|NCT00084136|19696106|P3|PI Comparison|Death|0
5719253|NCT00084136|19696107|P2|PI Comparison|Death|9
5719254|NCT00084136|19696108|P1|PI Comparison|Death|10
5719255|NCT00084084|19696167|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
5719256|NCT00084084|19696167|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
5719257|NCT00083915|19696177|P2|Overall Study|Insurance issues|1
5719258|NCT00083915|19696178|P1|Overall Study|Insurance issues|1
5719259|NCT00083915|19696177|P2|Overall Study|No response|1
5719260|NCT00083915|19696178|P1|Overall Study|No response|3
5719261|NCT00083915|19696177|P2|Overall Study|Failure to collect|0
5719262|NCT00083915|19696178|P1|Overall Study|Failure to collect|3
5719263|NCT00083915|19696177|P2|Overall Study|disease progression|23
5719264|NCT00083915|19696178|P1|Overall Study|disease progression|18
5719265|NCT00083915|19696177|P2|Overall Study|Withdrawal by Subject|3
5719266|NCT00083915|19696178|P1|Overall Study|Withdrawal by Subject|8
5719267|NCT00083915|19696177|P2|Overall Study|Physician Decision|6
5719268|NCT00083915|19696178|P1|Overall Study|Physician Decision|11
5719269|NCT00083915|19696177|P2|Overall Study|Death|3
5719270|NCT00083915|19696178|P1|Overall Study|Death|6
5719271|NCT00083889|19696186|P2|Overall Study|Crossover to SU011248|25
5719272|NCT00083889|19696187|P1|Overall Study|Crossover to SU011248|0
5719273|NCT00083889|19696186|P2|Overall Study|Completed on marketed sunitinub|0
5719274|NCT00083889|19696187|P1|Overall Study|Completed on marketed sunitinub|3
5719275|NCT00083889|19696186|P2|Overall Study|Randomized: did not take study drug|15
5719276|NCT00083889|19696187|P1|Overall Study|Randomized: did not take study drug|0
5719277|NCT00083889|19696186|P2|Overall Study|Decision of sponsor|4
5719278|NCT00083889|19696187|P1|Overall Study|Decision of sponsor|32
5719279|NCT00083889|19696186|P2|Overall Study|Lack of Efficacy|219
5719280|NCT00083889|19696187|P1|Overall Study|Lack of Efficacy|240
5719281|NCT00083889|19696186|P2|Overall Study|Withdrawal by Subject|24
5719282|NCT00083889|19696187|P1|Overall Study|Withdrawal by Subject|22
5719283|NCT00083889|19696186|P2|Overall Study|Protocol Violation|2
5719284|NCT00083889|19696187|P1|Overall Study|Protocol Violation|2
5719285|NCT00083889|19696186|P2|Overall Study|Adverse Event|86
5719286|NCT00083889|19696187|P1|Overall Study|Adverse Event|76
5719287|NCT00083759|19696245|P2|Overall Study|Other|13
5719288|NCT00083759|19696246|P1|Overall Study|Other|14
5719289|NCT00083759|19696245|P2|Overall Study|Sponsor's Discretion|29
5719290|NCT00083759|19696246|P1|Overall Study|Sponsor's Discretion|28
5719291|NCT00083759|19696245|P2|Overall Study|Non-Compliance|0
5719292|NCT00083759|19696246|P1|Overall Study|Non-Compliance|1
5719293|NCT00083759|19696245|P2|Overall Study|Subject Withdrew Consent|2
5719294|NCT00083759|19696246|P1|Overall Study|Subject Withdrew Consent|2
5719295|NCT00083759|19696245|P2|Overall Study|Inadequate Therapeutic Response|35
5719296|NCT00083759|19696246|P1|Overall Study|Inadequate Therapeutic Response|32
5719297|NCT00083759|19696245|P2|Overall Study|Death|1
5719298|NCT00083759|19696246|P1|Overall Study|Death|1
5719299|NCT00083759|19696245|P2|Overall Study|Lost to Follow-up|0
5719300|NCT00083759|19696246|P1|Overall Study|Lost to Follow-up|1
5719301|NCT00083759|19696245|P2|Overall Study|Adverse Event|3
5719302|NCT00083759|19696246|P1|Overall Study|Adverse Event|5
5719303|NCT00083616|19696264|P1|Overall Study|Other|6
5719304|NCT00083616|19696264|P1|Overall Study|Non-compliance|1
5719305|NCT00083616|19696264|P1|Overall Study|Ineligibility determined|2
5719306|NCT00083616|19696264|P1|Overall Study|Withdrawal by Subject|3
5719307|NCT00083616|19696264|P1|Overall Study|Physician Decision|2
5719308|NCT00083616|19696264|P1|Overall Study|Lost to Follow-up|1
5719309|NCT00083616|19696264|P1|Overall Study|Disease Progression|16
5719310|NCT00082888|19696292|P3|Overall Study|Ineligible|0
5719311|NCT00082888|19696293|P2|Overall Study|Ineligible|0
5719312|NCT00082888|19696294|P1|Overall Study|Ineligible|1
5719313|NCT00082810|19696314|P1|Overall Study|Withdrawal by Subject|4
5719314|NCT00082810|19696314|P1|Overall Study|Progressive disease|24
5719315|NCT00082810|19696314|P1|Overall Study|Adverse Event|3
5719316|NCT00082758|19696325|P3|Overall Study|Protocol Violation|0
5719317|NCT00082758|19696326|P2|Overall Study|Protocol Violation|1
5719318|NCT00082758|19696327|P1|Overall Study|Protocol Violation|0
5719319|NCT00082758|19696325|P3|Overall Study|Withdrawal by Subject|0
5719320|NCT00082758|19696326|P2|Overall Study|Withdrawal by Subject|0
5719321|NCT00082758|19696327|P1|Overall Study|Withdrawal by Subject|3
5719322|NCT00082758|19696325|P3|Overall Study|Physician Decision|0
5719323|NCT00082758|19696326|P2|Overall Study|Physician Decision|1
5719324|NCT00082758|19696327|P1|Overall Study|Physician Decision|0
5719325|NCT00082758|19696325|P3|Overall Study|Lack of Efficacy|0
5719326|NCT00082758|19696326|P2|Overall Study|Lack of Efficacy|13
5719327|NCT00082758|19696327|P1|Overall Study|Lack of Efficacy|12
5719328|NCT00082758|19696325|P3|Overall Study|Adverse Event|0
5719329|NCT00082758|19696326|P2|Overall Study|Adverse Event|2
5719330|NCT00082758|19696327|P1|Overall Study|Adverse Event|0
5719331|NCT00083226|19696347|P1|Overall Study|ineligible or not receiving treatment|4
5719332|NCT00083226|19696347|P1|Overall Study|Other|2
5719333|NCT00083226|19696347|P1|Overall Study|Withdrawal by Subject|4
5719334|NCT00083226|19696347|P1|Overall Study|Death|4
5719335|NCT00083226|19696347|P1|Overall Study|Adverse Event|9
5719336|NCT00083226|19696347|P1|Overall Study|Lack of Efficacy|19
5719337|NCT00082628|19696391|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
5719338|NCT00082628|19696392|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
5719339|NCT00082628|19696393|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
5719340|NCT00082628|19696394|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
5719341|NCT00082628|19696395|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
5719342|NCT00082628|19696391|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
5719343|NCT00082628|19696392|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
5719344|NCT00082628|19696393|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
5719345|NCT00082628|19696394|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
5719346|NCT00082628|19696395|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
5719347|NCT00082628|19696391|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
5719348|NCT00082628|19696392|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
5719349|NCT00082628|19696393|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
5719350|NCT00082628|19696394|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
5719351|NCT00082628|19696395|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
5719352|NCT00082628|19696391|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
5719353|NCT00082628|19696392|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
5719354|NCT00082628|19696393|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
5719355|NCT00082628|19696394|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
5719356|NCT00082628|19696395|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
5719357|NCT00082628|19696391|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
5719358|NCT00082628|19696392|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
5719359|NCT00082628|19696393|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
5719360|NCT00082628|19696394|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
5719361|NCT00082628|19696395|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
5719362|NCT00082628|19696391|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
5719363|NCT00082628|19696392|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
5719364|NCT00082628|19696393|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
5719365|NCT00082628|19696394|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
5719366|NCT00082628|19696395|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
5719367|NCT00082628|19696391|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
5719368|NCT00082628|19696392|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
5719369|NCT00082628|19696393|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
5719370|NCT00082628|19696394|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
5719371|NCT00082628|19696395|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
5719372|NCT00082433|19696415|P2|Overall Study|Impending surgery|1
5719373|NCT00082433|19696416|P1|Overall Study|Impending surgery|0
5719374|NCT00082433|19696415|P2|Overall Study|New primary cancer|0
5719375|NCT00082433|19696416|P1|Overall Study|New primary cancer|1
5719376|NCT00082433|19696415|P2|Overall Study|Noncompliance|1
5719377|NCT00082433|19696416|P1|Overall Study|Noncompliance|2
5719378|NCT00082433|19696415|P2|Overall Study|Ineligible|1
5719379|NCT00082433|19696416|P1|Overall Study|Ineligible|2
5719380|NCT00082433|19696415|P2|Overall Study|Not Treated|11
5719381|NCT00082433|19696416|P1|Overall Study|Not Treated|12
5719382|NCT00082433|19696415|P2|Overall Study|Still On Treatment|1
5719383|NCT00082433|19696416|P1|Overall Study|Still On Treatment|2
5719384|NCT00082433|19696415|P2|Overall Study|Withdrawal by Subject|30
5719385|NCT00082433|19696416|P1|Overall Study|Withdrawal by Subject|55
5719386|NCT00082433|19696415|P2|Overall Study|Study Drug Toxicity|66
5719387|NCT00082433|19696416|P1|Overall Study|Study Drug Toxicity|179
5719388|NCT00082433|19696415|P2|Overall Study|Lost to Follow-up|2
5719389|NCT00082433|19696416|P1|Overall Study|Lost to Follow-up|1
5719390|NCT00082433|19696415|P2|Overall Study|Physician Decision|61
5719391|NCT00082433|19696416|P1|Overall Study|Physician Decision|50
5719392|NCT00082433|19696415|P2|Overall Study|Disease Progression/Relapse|388
5719393|NCT00082433|19696416|P1|Overall Study|Disease Progression/Relapse|270
5719394|NCT00082433|19696415|P2|Overall Study|Death|18
5719395|NCT00082433|19696416|P1|Overall Study|Death|8
5719396|NCT00082433|19696415|P2|Overall Study|Adverse Event|17
5719397|NCT00082433|19696416|P1|Overall Study|Adverse Event|12
5719398|NCT00082381|19696436|P2|Overall Study|Loss of Glucose Control|0
5719399|NCT00082381|19696437|P1|Overall Study|Loss of Glucose Control|4
5719400|NCT00082381|19696436|P2|Overall Study|Protocol Violation|11
5719401|NCT00082381|19696437|P1|Overall Study|Protocol Violation|10
5719402|NCT00082381|19696436|P2|Overall Study|Physician Decision|2
5719403|NCT00082381|19696437|P1|Overall Study|Physician Decision|1
5719404|NCT00082381|19696436|P2|Overall Study|Patient Decision|4
5719405|NCT00082381|19696437|P1|Overall Study|Patient Decision|8
5719406|NCT00082381|19696436|P2|Overall Study|Lost to Follow-up|7
5719407|NCT00082381|19696437|P1|Overall Study|Lost to Follow-up|5
5719408|NCT00082381|19696436|P2|Overall Study|Adverse Event|2
5719409|NCT00082381|19696437|P1|Overall Study|Adverse Event|27
5719410|NCT00082407|19696457|P2|Overall Study|Lost to Follow-up|3
5719411|NCT00082407|19696458|P1|Overall Study|Lost to Follow-up|0
5719412|NCT00082407|19696457|P2|Overall Study|Death|1
5719413|NCT00082407|19696458|P1|Overall Study|Death|2
5719414|NCT00082407|19696457|P2|Overall Study|Loss of Glucose Control|2
5719415|NCT00082407|19696458|P1|Overall Study|Loss of Glucose Control|2
5719416|NCT00082407|19696457|P2|Overall Study|Physician Decision|3
5719417|NCT00082407|19696458|P1|Overall Study|Physician Decision|5
5719418|NCT00082407|19696457|P2|Overall Study|Patient Decision|6
5719419|NCT00082407|19696458|P1|Overall Study|Patient Decision|13
5719420|NCT00082407|19696457|P2|Overall Study|Protocol Violation|12
5719421|NCT00082407|19696458|P1|Overall Study|Protocol Violation|14
5719422|NCT00082407|19696457|P2|Overall Study|Adverse Event|0
5719423|NCT00082407|19696458|P1|Overall Study|Adverse Event|20
5719424|NCT00082368|19696476|P1|Overall Study|Not treated-pt had poor IV access|1
5719425|NCT00082355|19696481|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
5719426|NCT00082355|19696481|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
5719427|NCT00082355|19696481|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
5719428|NCT00082173|19696515|P2|Overall Study|Culture negative or resistant at baselin|6
5719429|NCT00082173|19696516|P1|Overall Study|Culture negative or resistant at baselin|5
5719430|NCT00082173|19696515|P2|Overall Study|Adverse Event|0
5719431|NCT00082173|19696516|P1|Overall Study|Adverse Event|1
5719432|NCT00082173|19696515|P2|Overall Study|Lost to Follow-up|0
5719433|NCT00082173|19696516|P1|Overall Study|Lost to Follow-up|1
5719434|NCT00082173|19696515|P2|Overall Study|Withdrawal by Subject|5
5719435|NCT00082173|19696516|P1|Overall Study|Withdrawal by Subject|3
5719436|NCT00081770|19696561|P3|Overall Study|Other|8
5719437|NCT00081770|19696562|P2|Overall Study|Other|7
5719438|NCT00081770|19696563|P1|Overall Study|Other|2
5719439|NCT00081770|19696561|P3|Overall Study|Administrative|1
5719440|NCT00081770|19696562|P2|Overall Study|Administrative|0
5719441|NCT00081770|19696563|P1|Overall Study|Administrative|1
5719442|NCT00081770|19696561|P3|Overall Study|Did not meet protocol eligibility|3
5719443|NCT00081770|19696562|P2|Overall Study|Did not meet protocol eligibility|0
5719444|NCT00081770|19696563|P1|Overall Study|Did not meet protocol eligibility|2
5719445|NCT00081770|19696561|P3|Overall Study|Withdrawal by Subject|42
5719446|NCT00081770|19696562|P2|Overall Study|Withdrawal by Subject|40
5719447|NCT00081770|19696563|P1|Overall Study|Withdrawal by Subject|45
5719448|NCT00081770|19696561|P3|Overall Study|Protocol Violation|10
5719449|NCT00081770|19696562|P2|Overall Study|Protocol Violation|10
5719450|NCT00081770|19696563|P1|Overall Study|Protocol Violation|15
5719451|NCT00081770|19696561|P3|Overall Study|Lost to Follow-up|45
5719452|NCT00081770|19696562|P2|Overall Study|Lost to Follow-up|34
5719453|NCT00081770|19696563|P1|Overall Study|Lost to Follow-up|45
5719454|NCT00081770|19696561|P3|Overall Study|Lack of Efficacy|211
5719455|NCT00081770|19696562|P2|Overall Study|Lack of Efficacy|357
5719456|NCT00081770|19696563|P1|Overall Study|Lack of Efficacy|262
5719457|NCT00081770|19696561|P3|Overall Study|Adverse Event|136
5719458|NCT00081770|19696562|P2|Overall Study|Adverse Event|98
5719459|NCT00081770|19696563|P1|Overall Study|Adverse Event|130
5719460|NCT00081731|19696582|P2|Overall Study|scientific integrity issue|8
5719461|NCT00081731|19696583|P1|Overall Study|scientific integrity issue|8
5719462|NCT00081653|19696603|P2|Overall Study|Loss of bone mass|2
5719463|NCT00081653|19696604|P1|Overall Study|Loss of bone mass|0
5719464|NCT00081653|19696603|P2|Overall Study|Participant leaving country|0
5719465|NCT00081653|19696604|P1|Overall Study|Participant leaving country|1
5719466|NCT00081653|19696603|P2|Overall Study|Bone loss|0
5719467|NCT00081653|19696604|P1|Overall Study|Bone loss|2
5719468|NCT00081653|19696603|P2|Overall Study|Low bone mineral density|0
5719469|NCT00081653|19696604|P1|Overall Study|Low bone mineral density|1
5719470|NCT00081653|19696603|P2|Overall Study|Refused Treatment|14
5719471|NCT00081653|19696604|P1|Overall Study|Refused Treatment|18
5719472|NCT00081653|19696603|P2|Overall Study|Lost to Follow-up|4
5719473|NCT00081653|19696604|P1|Overall Study|Lost to Follow-up|2
5719474|NCT00081653|19696603|P2|Overall Study|Adverse Event|17
5719475|NCT00081653|19696604|P1|Overall Study|Adverse Event|23
5719476|NCT00081497|19696622|P2|Overall Study|Non-compliance|1
5719477|NCT00081497|19696623|P1|Overall Study|Non-compliance|0
5719478|NCT00081497|19696622|P2|Overall Study|Withdrawal by Subject|0
5719479|NCT00081497|19696623|P1|Overall Study|Withdrawal by Subject|1
5719480|NCT00081497|19696622|P2|Overall Study|Death|1
5719481|NCT00081497|19696623|P1|Overall Study|Death|0
5719482|NCT00081497|19696622|P2|Overall Study|Adverse Event|0
5719483|NCT00081497|19696623|P1|Overall Study|Adverse Event|2
5719484|NCT00081458|19696641|P3|Overall Study|Randomized but not dosed|1
5719485|NCT00081458|19696642|P2|Overall Study|Randomized but not dosed|0
5719486|NCT00081458|19696643|P1|Overall Study|Randomized but not dosed|0
5719487|NCT00081458|19696641|P3|Overall Study|Withdrawal by Subject|1
5719488|NCT00081458|19696642|P2|Overall Study|Withdrawal by Subject|3
5719489|NCT00081458|19696643|P1|Overall Study|Withdrawal by Subject|0
5719490|NCT00081458|19696641|P3|Overall Study|Adverse Event|2
5719491|NCT00081458|19696642|P2|Overall Study|Adverse Event|5
5719492|NCT00081458|19696643|P1|Overall Study|Adverse Event|1
5719493|NCT00081289|19696699|P2|Overall Study|Ineligible / no protocol treatment|4
5719494|NCT00081289|19696700|P1|Overall Study|Ineligible / no protocol treatment|3
5719495|NCT00081289|19696699|P2|Overall Study|Accrued prior to chemotherapy amendment|17
5719496|NCT00081289|19696700|P1|Overall Study|Accrued prior to chemotherapy amendment|18
5719497|NCT00081263|19696744|P2|Overall Study|Inadequate data|10
5719498|NCT00081263|19696745|P1|Overall Study|Inadequate data|5
5719499|NCT00081263|19696744|P2|Overall Study|Never treated|5
5719500|NCT00081263|19696745|P1|Overall Study|Never treated|4
5719501|NCT00081263|19696744|P2|Overall Study|Inadequate pathology|1
5719502|NCT00081263|19696745|P1|Overall Study|Inadequate pathology|0
5719503|NCT00081263|19696744|P2|Overall Study|improper pre-protocol therapy|1
5719504|NCT00081263|19696745|P1|Overall Study|improper pre-protocol therapy|0
5719505|NCT00081263|19696744|P2|Overall Study|wrong cell type|5
5719506|NCT00081263|19696745|P1|Overall Study|wrong cell type|7
5719507|NCT00081263|19696744|P2|Overall Study|clerical error|0
5719508|NCT00081263|19696745|P1|Overall Study|clerical error|1
5719509|NCT00081159|19696755|P2|Overall Study|Lost to Follow-up|1
5719510|NCT00081159|19696756|P1|Overall Study|Lost to Follow-up|2
5719511|NCT00081159|19696755|P2|Overall Study|Myelosuppression prior to treatment|1
5719512|NCT00081159|19696756|P1|Overall Study|Myelosuppression prior to treatment|0
5719513|NCT00081159|19696755|P2|Overall Study|Withdrawal by Subject|3
5719514|NCT00081159|19696756|P1|Overall Study|Withdrawal by Subject|0
5719515|NCT00080938|19696766|P1|Overall Study|Ineligible|4
5719516|NCT00080938|19696766|P1|Overall Study|Not started protocol therapy|1
5719517|NCT00080938|19696766|P1|Overall Study|other disease|1
5719518|NCT00080938|19696766|P1|Overall Study|Lack of Efficacy|7
5719519|NCT00080938|19696766|P1|Overall Study|Death|2
5719520|NCT00080938|19696766|P1|Overall Study|Withdrawal by Subject|6
5719521|NCT00080938|19696766|P1|Overall Study|Adverse Event|3
5719522|NCT00080899|19696782|P1|Overall Study|Adverse Event|1
5719523|NCT00080483|19696794|P2|Overall Study|Physician Decision|1
5719524|NCT00080483|19696795|P1|Overall Study|Physician Decision|1
5719525|NCT00080483|19696794|P2|Overall Study|Lost to Follow-up|1
5719526|NCT00080483|19696795|P1|Overall Study|Lost to Follow-up|1
5719527|NCT00002525|19696803|P2|Overall Study|Never start protocol therapy|0
5719528|NCT00002525|19696804|P1|Overall Study|Never start protocol therapy|8
5719529|NCT00002525|19696803|P2|Overall Study|Other|0
5719530|NCT00002525|19696804|P1|Overall Study|Other|26
5719531|NCT00002525|19696803|P2|Overall Study|Error|0
5719532|NCT00002525|19696804|P1|Overall Study|Error|6
5719533|NCT00002525|19696803|P2|Overall Study|Duke's A, B1, D disease|0
5719534|NCT00002525|19696804|P1|Overall Study|Duke's A, B1, D disease|92
5719535|NCT00002525|19696803|P2|Overall Study|Other complicating disease|0
5719536|NCT00002525|19696804|P1|Overall Study|Other complicating disease|1
5719537|NCT00002525|19696803|P2|Overall Study|Start non-protocol therapy|0
5719538|NCT00002525|19696804|P1|Overall Study|Start non-protocol therapy|1
5719539|NCT00002525|19696803|P2|Overall Study|Withdrawal by Subject|0
5719540|NCT00002525|19696804|P1|Overall Study|Withdrawal by Subject|11
5719541|NCT00002525|19696803|P2|Overall Study|Death|0
5719542|NCT00002525|19696804|P1|Overall Study|Death|5
5719543|NCT00002525|19696803|P2|Overall Study|Adverse Event|0
5719544|NCT00002525|19696804|P1|Overall Study|Adverse Event|36
5719545|NCT00080301|19696831|P2|Overall Study|Still on Treatment as of CSR date|1
5719546|NCT00080301|19696832|P1|Overall Study|Still on Treatment as of CSR date|0
5719547|NCT00080301|19696831|P2|Overall Study|Randomized but Never Treated|10
5719548|NCT00080301|19696832|P1|Overall Study|Randomized but Never Treated|5
5719549|NCT00080288|19696852|P2|Overall Study|Miscellaneous|11
5719550|NCT00080288|19696853|P1|Overall Study|Miscellaneous|11
5719551|NCT00080288|19696852|P2|Overall Study|Withdrawal by Subject|16
5719552|NCT00080288|19696853|P1|Overall Study|Withdrawal by Subject|3
5719553|NCT00080288|19696852|P2|Overall Study|Physician Decision|2
5719554|NCT00080288|19696853|P1|Overall Study|Physician Decision|6
5719555|NCT00080288|19696852|P2|Overall Study|Lost to Follow-up|5
5719556|NCT00080288|19696853|P1|Overall Study|Lost to Follow-up|3
5719557|NCT00080288|19696852|P2|Overall Study|Adverse Event|4
5719558|NCT00080288|19696853|P1|Overall Study|Adverse Event|7
5719559|NCT00080223|19696861|P1|Overall Study|Physician Decision|1
5719560|NCT00080223|19696861|P1|Overall Study|Participant unwilling to continue|2
5719561|NCT00080223|19696861|P1|Overall Study|Non-compliance With Study Treatment|7
5719562|NCT00080223|19696861|P1|Overall Study|Lung Transplantation|9
5719563|NCT00080223|19696861|P1|Overall Study|Withdrawal by Subject|13
5719564|NCT00080223|19696861|P1|Overall Study|Death|21
5719565|NCT00080223|19696861|P1|Overall Study|Adverse Event|23
5719566|NCT00002540|19696871|P2|Overall Study|Refused Screen (Prostate Screening)|2433
5719567|NCT00002540|19696872|P1|Overall Study|Refused Screen (Prostate Screening)|0
5719568|NCT00002540|19696871|P2|Overall Study|Refused ASU (Control)|0
5719569|NCT00002540|19696872|P1|Overall Study|Refused ASU (Control)|597
5719570|NCT00002540|19696871|P2|Overall Study|Died Before ASU (Control)|0
5719571|NCT00002540|19696872|P1|Overall Study|Died Before ASU (Control)|202
5719572|NCT00002540|19696871|P2|Overall Study|Died Before Randomization|6
5719573|NCT00002540|19696872|P1|Overall Study|Died Before Randomization|2
5719574|NCT00002540|19696871|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
5719575|NCT00002540|19696872|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
5719576|NCT00080119|19696902|P4|Overall Study|Lost to Follow-up|14
5719577|NCT00080119|19696903|P3|Overall Study|Lost to Follow-up|19
5719578|NCT00080119|19696904|P2|Overall Study|Lost to Follow-up|19
5719579|NCT00080119|19696905|P1|Overall Study|Lost to Follow-up|16
5719580|NCT00080119|19696902|P4|Overall Study|Unwilling to adhere to study requirement|1
5719581|NCT00080119|19696903|P3|Overall Study|Unwilling to adhere to study requirement|5
5719582|NCT00080119|19696904|P2|Overall Study|Unwilling to adhere to study requirement|2
5719583|NCT00080119|19696905|P1|Overall Study|Unwilling to adhere to study requirement|3
5719584|NCT00080119|19696902|P4|Overall Study|Consent withdrawn|6
5719585|NCT00080119|19696903|P3|Overall Study|Consent withdrawn|4
5719586|NCT00080119|19696904|P2|Overall Study|Consent withdrawn|17
5719587|NCT00080119|19696905|P1|Overall Study|Consent withdrawn|13
5719588|NCT00080119|19696902|P4|Overall Study|Unable to get to clinic|1
5719589|NCT00080119|19696903|P3|Overall Study|Unable to get to clinic|7
5719590|NCT00080119|19696904|P2|Overall Study|Unable to get to clinic|24
5719591|NCT00080119|19696905|P1|Overall Study|Unable to get to clinic|24
5719592|NCT00080119|19696902|P4|Overall Study|Discontinued because of study closure|141
5719593|NCT00080119|19696903|P3|Overall Study|Discontinued because of study closure|130
5719594|NCT00080119|19696904|P2|Overall Study|Discontinued because of study closure|0
5719595|NCT00080119|19696905|P1|Overall Study|Discontinued because of study closure|0
5719596|NCT00079937|19696939|P2|Overall Study|Administrative problems|11
5719597|NCT00079937|19696940|P1|Overall Study|Administrative problems|22
5719598|NCT00079937|19696939|P2|Overall Study|Lost to Follow-up|5
5719599|NCT00079937|19696940|P1|Overall Study|Lost to Follow-up|12
5719600|NCT00079937|19696939|P2|Overall Study|Withdrawal by Subject|7
5719601|NCT00079937|19696940|P1|Overall Study|Withdrawal by Subject|21
5719602|NCT00079937|19696939|P2|Overall Study|Protocol Violation|6
5719603|NCT00079937|19696940|P1|Overall Study|Protocol Violation|8
5719604|NCT00079937|19696939|P2|Overall Study|Subject no longer requires study drug|0
5719605|NCT00079937|19696940|P1|Overall Study|Subject no longer requires study drug|3
5719606|NCT00079937|19696939|P2|Overall Study|Unsatisfactory therapeutic effect|2
5719607|NCT00079937|19696940|P1|Overall Study|Unsatisfactory therapeutic effect|1
5719608|NCT00079937|19696939|P2|Overall Study|Adverse Event|1
5719609|NCT00079937|19696940|P1|Overall Study|Adverse Event|2
5719610|NCT00009737|19696958|P2|Overall Study|Administrative/Other Reasons|1
5719611|NCT00009737|19696959|P1|Overall Study|Administrative/Other Reasons|7
5719612|NCT00009737|19696958|P2|Overall Study|Lost to Follow-up|1
5719613|NCT00009737|19696959|P1|Overall Study|Lost to Follow-up|1
5719614|NCT00009737|19696958|P2|Overall Study|Refused Treatment|16
5719615|NCT00009737|19696959|P1|Overall Study|Refused Treatment|15
5719616|NCT00009737|19696958|P2|Overall Study|Other Protocol Violation|0
5719617|NCT00009737|19696959|P1|Overall Study|Other Protocol Violation|1
5719618|NCT00009737|19696958|P2|Overall Study|Violation of Selection Criteria at Entry|9
5719619|NCT00009737|19696959|P1|Overall Study|Violation of Selection Criteria at Entry|13
5719620|NCT00009737|19696958|P2|Overall Study|Lack of Efficacy|15
5719621|NCT00009737|19696959|P1|Overall Study|Lack of Efficacy|17
5719622|NCT00009737|19696958|P2|Overall Study|Death|6
5719623|NCT00009737|19696959|P1|Overall Study|Death|4
5719624|NCT00009737|19696958|P2|Overall Study|Adverse Event|75
5719625|NCT00009737|19696959|P1|Overall Study|Adverse Event|112
5719626|NCT00079781|19696978|P3|Follow-up Period|Death|1
5719627|NCT00079781|19696979|P2|Follow-up Period|Death|0
5719628|NCT00079781|19696980|P1|Follow-up Period|Death|0
5719629|NCT00079781|19696978|P3|Follow-up Period|Lost to Follow-up|0
5719630|NCT00079781|19696979|P2|Follow-up Period|Lost to Follow-up|0
5719631|NCT00079781|19696980|P1|Follow-up Period|Lost to Follow-up|1
5719632|NCT00079781|19696978|P3|Follow-up Period|Withdrawal by Subject|1
5719633|NCT00079781|19696979|P2|Follow-up Period|Withdrawal by Subject|0
5719634|NCT00079781|19696980|P1|Follow-up Period|Withdrawal by Subject|3
5719635|NCT00079781|19696978|P3|Pre-implant Period|Did not meet I/E criteria|1
5719636|NCT00079781|19696979|P2|Pre-implant Period|Did not meet I/E criteria|1
5719637|NCT00079781|19696980|P1|Pre-implant Period|Did not meet I/E criteria|1
5719638|NCT00079781|19696978|P3|Pre-implant Period|Withdrawal by Subject|0
5719639|NCT00079781|19696979|P2|Pre-implant Period|Withdrawal by Subject|0
5719640|NCT00079781|19696980|P1|Pre-implant Period|Withdrawal by Subject|2
5719641|NCT00079677|19696989|P2|Overall Study|Miscellaneous|0
5719642|NCT00079677|19696990|P1|Overall Study|Miscellaneous|2
5719643|NCT00079677|19696989|P2|Overall Study|Withdrawal by Subject|3
5719644|NCT00079677|19696990|P1|Overall Study|Withdrawal by Subject|5
5719645|NCT00079677|19696989|P2|Overall Study|Protocol Violation|3
5719646|NCT00079677|19696990|P1|Overall Study|Protocol Violation|2
5719647|NCT00079677|19696989|P2|Overall Study|Physician Decision|0
5719648|NCT00079677|19696990|P1|Overall Study|Physician Decision|3
5719649|NCT00079677|19696989|P2|Overall Study|Lost to Follow-up|2
5719650|NCT00079677|19696990|P1|Overall Study|Lost to Follow-up|2
5719651|NCT00079677|19696989|P2|Overall Study|Lack of Efficacy|0
5719652|NCT00079677|19696990|P1|Overall Study|Lack of Efficacy|1
5719653|NCT00079677|19696989|P2|Overall Study|Adverse Event|6
5719654|NCT00079677|19696990|P1|Overall Study|Adverse Event|5
5719655|NCT00079417|19697006|P1|Overall Study|Ineligible|7
5719656|NCT00079417|19697006|P1|Overall Study|Physician Decision|2
5719657|NCT00079391|19697014|P1|Overall Study|Withdrawal by Subject|1
5719658|NCT00079339|19697026|P3|Overall Study|Disease progression|2
5719659|NCT00079339|19697027|P2|Overall Study|Disease progression|28
5719660|NCT00079339|19697028|P1|Overall Study|Disease progression|3
5719661|NCT00079339|19697026|P3|Overall Study|Withdrawal by Subject|1
5719662|NCT00079339|19697027|P2|Overall Study|Withdrawal by Subject|4
5719663|NCT00079339|19697028|P1|Overall Study|Withdrawal by Subject|0
5719664|NCT00079339|19697026|P3|Overall Study|Non-compliance|1
5719665|NCT00079339|19697027|P2|Overall Study|Non-compliance|0
5719666|NCT00079339|19697028|P1|Overall Study|Non-compliance|0
5719667|NCT00079339|19697026|P3|Overall Study|Death|0
5719668|NCT00079339|19697027|P2|Overall Study|Death|0
5719669|NCT00079339|19697028|P1|Overall Study|Death|1
5719670|NCT00079339|19697026|P3|Overall Study|Adverse Event|2
5719671|NCT00079339|19697027|P2|Overall Study|Adverse Event|7
5719672|NCT00079339|19697028|P1|Overall Study|Adverse Event|1
5719673|NCT00079274|19697059|P7|Overall Study|Other|0
5719674|NCT00079274|19697060|P6|Overall Study|Other|2
5719675|NCT00079274|19697061|P5|Overall Study|Other|1
5719676|NCT00079274|19697062|P4|Overall Study|Other|55
5719677|NCT00079274|19697063|P3|Overall Study|Other|5
5719678|NCT00079274|19697064|P2|Overall Study|Other|7
5719679|NCT00079274|19697065|P1|Overall Study|Other|43
5719680|NCT00079274|19697059|P7|Overall Study|Cytogenetic resistance|0
5719681|NCT00079274|19697060|P6|Overall Study|Cytogenetic resistance|0
5719682|NCT00079274|19697061|P5|Overall Study|Cytogenetic resistance|0
5719683|NCT00079274|19697062|P4|Overall Study|Cytogenetic resistance|2
5719684|NCT00079274|19697063|P3|Overall Study|Cytogenetic resistance|0
5719685|NCT00079274|19697064|P2|Overall Study|Cytogenetic resistance|0
5719686|NCT00079274|19697065|P1|Overall Study|Cytogenetic resistance|0
5719687|NCT00079274|19697059|P7|Overall Study|Death|0
5719688|NCT00079274|19697060|P6|Overall Study|Death|0
5719689|NCT00079274|19697061|P5|Overall Study|Death|0
5719690|NCT00079274|19697062|P4|Overall Study|Death|15
5719691|NCT00079274|19697063|P3|Overall Study|Death|1
5719692|NCT00079274|19697064|P2|Overall Study|Death|0
5719693|NCT00079274|19697065|P1|Overall Study|Death|4
5719694|NCT00079274|19697059|P7|Overall Study|Other Medical Problems|0
5719695|NCT00079274|19697060|P6|Overall Study|Other Medical Problems|0
5719696|NCT00079274|19697061|P5|Overall Study|Other Medical Problems|0
5719697|NCT00079274|19697062|P4|Overall Study|Other Medical Problems|7
5719698|NCT00079274|19697063|P3|Overall Study|Other Medical Problems|0
5719699|NCT00079274|19697064|P2|Overall Study|Other Medical Problems|1
5719700|NCT00079274|19697065|P1|Overall Study|Other Medical Problems|6
5719701|NCT00079274|19697059|P7|Overall Study|Alternate Treatment|0
5719702|NCT00079274|19697060|P6|Overall Study|Alternate Treatment|0
5719703|NCT00079274|19697061|P5|Overall Study|Alternate Treatment|0
5719704|NCT00079274|19697062|P4|Overall Study|Alternate Treatment|3
5719705|NCT00079274|19697063|P3|Overall Study|Alternate Treatment|0
5719706|NCT00079274|19697064|P2|Overall Study|Alternate Treatment|1
5719707|NCT00079274|19697065|P1|Overall Study|Alternate Treatment|6
5719708|NCT00079274|19697059|P7|Overall Study|Recurrence|0
5719709|NCT00079274|19697060|P6|Overall Study|Recurrence|2
5719710|NCT00079274|19697061|P5|Overall Study|Recurrence|0
5719711|NCT00079274|19697062|P4|Overall Study|Recurrence|15
5719712|NCT00079274|19697063|P3|Overall Study|Recurrence|1
5719713|NCT00079274|19697064|P2|Overall Study|Recurrence|0
5719714|NCT00079274|19697065|P1|Overall Study|Recurrence|21
5719715|NCT00079274|19697059|P7|Overall Study|Adverse Event|0
5719716|NCT00079274|19697060|P6|Overall Study|Adverse Event|8
5719717|NCT00079274|19697061|P5|Overall Study|Adverse Event|7
5719718|NCT00079274|19697062|P4|Overall Study|Adverse Event|184
5719719|NCT00079274|19697063|P3|Overall Study|Adverse Event|8
5719720|NCT00079274|19697064|P2|Overall Study|Adverse Event|8
5719721|NCT00079274|19697065|P1|Overall Study|Adverse Event|130
5719722|NCT00079274|19697059|P7|Overall Study|Withdrawal by Subject|0
5719723|NCT00079274|19697060|P6|Overall Study|Withdrawal by Subject|8
5719724|NCT00079274|19697061|P5|Overall Study|Withdrawal by Subject|7
5719725|NCT00079274|19697062|P4|Overall Study|Withdrawal by Subject|163
5719726|NCT00079274|19697063|P3|Overall Study|Withdrawal by Subject|12
5719727|NCT00079274|19697064|P2|Overall Study|Withdrawal by Subject|10
5719728|NCT00079274|19697065|P1|Overall Study|Withdrawal by Subject|111
5719729|NCT00079183|19697086|P1|Overall Study|Specimen collection non-compliance|1
5719730|NCT00079183|19697086|P1|Overall Study|Study medication non-compliance|2
5719731|NCT00079183|19697086|P1|Overall Study|Withdrawal by Subject|4
5719732|NCT00079040|19697101|P1|Overall Study|Ineligible|1
5719733|NCT00079040|19697101|P1|Overall Study|Withdrew before treatment|1
5719734|NCT00078949|19697124|P4|Overall Study|No treated|3
5719735|NCT00078949|19697125|P3|Overall Study|No treated|3
5719736|NCT00078949|19697126|P2|Overall Study|No treated|5
5719737|NCT00078949|19697127|P1|Overall Study|No treated|4
5719738|NCT00078819|19697156|P4|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
5719739|NCT00078819|19697157|P3|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
5719740|NCT00078819|19697158|P2|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
5719741|NCT00078819|19697159|P1|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
5719742|NCT00078819|19697156|P4|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
5719743|NCT00078819|19697157|P3|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
5719744|NCT00078819|19697158|P2|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
5719745|NCT00078819|19697159|P1|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
5719746|NCT00078819|19697156|P4|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
5719747|NCT00078819|19697157|P3|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
5719748|NCT00078819|19697158|P2|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
5719749|NCT00078819|19697159|P1|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
5719750|NCT00078819|19697156|P4|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
5719751|NCT00078819|19697157|P3|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
5719752|NCT00078819|19697158|P2|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
5719753|NCT00078819|19697159|P1|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
5719754|NCT00078819|19697156|P4|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
5719755|NCT00078819|19697157|P3|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
5719756|NCT00078819|19697158|P2|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
5719757|NCT00078819|19697159|P1|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
5719758|NCT00078819|19697156|P4|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
5719759|NCT00078819|19697157|P3|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
5719760|NCT00078819|19697158|P2|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
5719761|NCT00078819|19697159|P1|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
5719762|NCT00078819|19697156|P4|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
5719763|NCT00078819|19697157|P3|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
5719764|NCT00078819|19697158|P2|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
5719765|NCT00078819|19697159|P1|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
5719766|NCT00078819|19697156|P4|Double-blind Treatment Period: Week 1-12|Adverse Event|0
5719767|NCT00078819|19697157|P3|Double-blind Treatment Period: Week 1-12|Adverse Event|0
5719768|NCT00078819|19697158|P2|Double-blind Treatment Period: Week 1-12|Adverse Event|1
5719769|NCT00078819|19697159|P1|Double-blind Treatment Period: Week 1-12|Adverse Event|0
5719770|NCT00078806|19697184|P4|Part 2|Adverse Event|0
5719771|NCT00078806|19697185|P3|Part 2|Adverse Event|0
5719772|NCT00078806|19697186|P2|Part 2|Adverse Event|1
5719773|NCT00078806|19697187|P1|Part 2|Adverse Event|0
5719774|NCT00078806|19697184|P4|Part 1B|Lack of Efficacy|0
5719775|NCT00078806|19697185|P3|Part 1B|Lack of Efficacy|0
5719776|NCT00078806|19697186|P2|Part 1B|Lack of Efficacy|0
5719777|NCT00078806|19697187|P1|Part 1B|Lack of Efficacy|7
5719778|NCT00078806|19697184|P4|Part 1B|Adverse Event|0
5719779|NCT00078806|19697185|P3|Part 1B|Adverse Event|0
5719780|NCT00078806|19697186|P2|Part 1B|Adverse Event|0
5719781|NCT00078806|19697187|P1|Part 1B|Adverse Event|1
5719782|NCT00078806|19697184|P4|Part 1A|Other|0
5719783|NCT00078806|19697185|P3|Part 1A|Other|0
5719784|NCT00078806|19697186|P2|Part 1A|Other|0
5719785|NCT00078806|19697187|P1|Part 1A|Other|1
5719786|NCT00078806|19697184|P4|Part 1A|Lack of Efficacy|0
5719787|NCT00078806|19697185|P3|Part 1A|Lack of Efficacy|0
5719788|NCT00078806|19697186|P2|Part 1A|Lack of Efficacy|0
5719789|NCT00078806|19697187|P1|Part 1A|Lack of Efficacy|7
5719790|NCT00078806|19697184|P4|Part 1A|Adverse Event|0
5719791|NCT00078806|19697185|P3|Part 1A|Adverse Event|0
5719792|NCT00078806|19697186|P2|Part 1A|Adverse Event|0
5719793|NCT00078806|19697187|P1|Part 1A|Adverse Event|2
5719794|NCT00078767|19697223|P2|Overall Study|Withdrawal by Subject|1
5719795|NCT00078767|19697224|P1|Overall Study|Withdrawal by Subject|1
5719796|NCT00005947|19697271|P2|Overall Study|Site Closure|0
5719797|NCT00005947|19697272|P1|Overall Study|Site Closure|1
5719798|NCT00005947|19697271|P2|Overall Study|Patient Refused to Continue|1
5719799|NCT00005947|19697272|P1|Overall Study|Patient Refused to Continue|2
5719800|NCT00005947|19697271|P2|Overall Study|Death|40
5719801|NCT00005947|19697272|P1|Overall Study|Death|54
5719802|NCT00002597|19697308|P2|Overall Study|Withdrawal by Subject|6
5719803|NCT00002597|19697309|P1|Overall Study|Withdrawal by Subject|7
5719804|NCT00002597|19697308|P2|Overall Study|Protocol Violation|17
5719805|NCT00002597|19697309|P1|Overall Study|Protocol Violation|19
5719806|NCT00078377|19697334|P3|Overall Study|Miscellaneous|1
5719807|NCT00078377|19697335|P2|Overall Study|Miscellaneous|6
5719808|NCT00078377|19697336|P1|Overall Study|Miscellaneous|2
5719809|NCT00078377|19697334|P3|Overall Study|Withdrawal by Subject|4
5719810|NCT00078377|19697335|P2|Overall Study|Withdrawal by Subject|4
5719811|NCT00078377|19697336|P1|Overall Study|Withdrawal by Subject|3
5719812|NCT00078377|19697334|P3|Overall Study|Physician Decision|0
5719813|NCT00078377|19697335|P2|Overall Study|Physician Decision|0
5719814|NCT00078377|19697336|P1|Overall Study|Physician Decision|2
5719815|NCT00078377|19697334|P3|Overall Study|Lost to Follow-up|1
5719816|NCT00078377|19697335|P2|Overall Study|Lost to Follow-up|1
5719817|NCT00078377|19697336|P1|Overall Study|Lost to Follow-up|0
5719818|NCT00078377|19697334|P3|Overall Study|Lack of Efficacy|2
5719819|NCT00078377|19697335|P2|Overall Study|Lack of Efficacy|0
5719820|NCT00078377|19697336|P1|Overall Study|Lack of Efficacy|2
5719821|NCT00078377|19697334|P3|Overall Study|Adverse Event|1
5719822|NCT00078377|19697335|P2|Overall Study|Adverse Event|5
5719823|NCT00078377|19697336|P1|Overall Study|Adverse Event|2
5719824|NCT00078338|19697351|P2|Overall Study|Subjects randomized, but not treated|3
5719825|NCT00078338|19697352|P1|Overall Study|Subjects randomized, but not treated|3
5719826|NCT00078338|19697351|P2|Overall Study|Other|16
5719827|NCT00078338|19697352|P1|Overall Study|Other|28
5719828|NCT00078338|19697351|P2|Overall Study|Disease Progression|7
5719829|NCT00078338|19697352|P1|Overall Study|Disease Progression|4
5719830|NCT00078338|19697351|P2|Overall Study|Protocol Violation|2
5719831|NCT00078338|19697352|P1|Overall Study|Protocol Violation|2
5719832|NCT00078338|19697351|P2|Overall Study|Lost to Follow-up|2
5719833|NCT00078338|19697352|P1|Overall Study|Lost to Follow-up|17
5719834|NCT00078338|19697351|P2|Overall Study|Adverse Event|24
5719835|NCT00078338|19697352|P1|Overall Study|Adverse Event|31
5719836|NCT00078325|19697445|P3|Overall Study|Miscellaneous|1
5719837|NCT00078325|19697446|P2|Overall Study|Miscellaneous|1
5719838|NCT00078325|19697447|P1|Overall Study|Miscellaneous|1
5719839|NCT00078325|19697445|P3|Overall Study|Physician Decision|1
5719840|NCT00078325|19697446|P2|Overall Study|Physician Decision|0
5719841|NCT00078325|19697447|P1|Overall Study|Physician Decision|2
5719842|NCT00078325|19697445|P3|Overall Study|Lost to Follow-up|1
5719843|NCT00078325|19697446|P2|Overall Study|Lost to Follow-up|1
5719844|NCT00078325|19697447|P1|Overall Study|Lost to Follow-up|0
5719845|NCT00078325|19697445|P3|Overall Study|Withdrawal by Subject|3
5719846|NCT00078325|19697446|P2|Overall Study|Withdrawal by Subject|5
5719847|NCT00078325|19697447|P1|Overall Study|Withdrawal by Subject|1
5719848|NCT00078325|19697445|P3|Overall Study|Protocol Violation|0
5719849|NCT00078325|19697446|P2|Overall Study|Protocol Violation|2
5719850|NCT00078325|19697447|P1|Overall Study|Protocol Violation|2
5719851|NCT00078325|19697445|P3|Overall Study|Adverse Event|5
5719852|NCT00078325|19697446|P2|Overall Study|Adverse Event|10
5719853|NCT00078325|19697447|P1|Overall Study|Adverse Event|15
5719854|NCT00078312|19697458|P1|Overall Study|Miscellaneous|33
5719855|NCT00078312|19697458|P1|Overall Study|Withdrawal by Subject|33
5719856|NCT00078312|19697458|P1|Overall Study|Protocol Violation|3
5719857|NCT00078312|19697458|P1|Overall Study|Physician Decision|9
5719858|NCT00078312|19697458|P1|Overall Study|Lost to Follow-up|41
5719859|NCT00078312|19697458|P1|Overall Study|Lack of Efficacy|15
5719860|NCT00078312|19697458|P1|Overall Study|Adverse Event|43
5719861|NCT00077974|19697473|P1|Overall Study|Decision of Sponsor|2
5719862|NCT00077974|19697473|P1|Overall Study|Lack of Efficacy|76
5719863|NCT00077974|19697473|P1|Overall Study|Withdrawal by Subject|3
5719864|NCT00077974|19697473|P1|Overall Study|Protocol Violation|1
5719865|NCT00077974|19697473|P1|Overall Study|Adverse Event|22
5719866|NCT00077857|19697490|P2|Overall Study|Other|13
5719867|NCT00077857|19697491|P1|Overall Study|Other|15
5719868|NCT00077857|19697490|P2|Overall Study|Failure to return|5
5719869|NCT00077857|19697491|P1|Overall Study|Failure to return|5
5719870|NCT00077857|19697490|P2|Overall Study|Refused treatment|21
5719871|NCT00077857|19697491|P1|Overall Study|Refused treatment|29
5719872|NCT00077857|19697490|P2|Overall Study|Other protocol violation|1
5719873|NCT00077857|19697491|P1|Overall Study|Other protocol violation|0
5719874|NCT00077857|19697490|P2|Overall Study|Violation of selection criteria at entry|1
5719875|NCT00077857|19697491|P1|Overall Study|Violation of selection criteria at entry|3
5719876|NCT00077857|19697490|P2|Overall Study|Insufficient therapeutic response|128
5719877|NCT00077857|19697491|P1|Overall Study|Insufficient therapeutic response|112
5719878|NCT00077857|19697490|P2|Overall Study|Death|3
5719879|NCT00077857|19697491|P1|Overall Study|Death|7
5719880|NCT00077857|19697490|P2|Overall Study|Adverse Event|32
5719881|NCT00077857|19697491|P1|Overall Study|Adverse Event|30
5719882|NCT00077766|19697511|P2|Overall Study|Participants Vacation|1
5719883|NCT00077766|19697512|P1|Overall Study|Participants Vacation|2
5719884|NCT00077766|19697511|P2|Overall Study|Stop Dialysis|1
5719885|NCT00077766|19697512|P1|Overall Study|Stop Dialysis|0
5719886|NCT00077766|19697511|P2|Overall Study|Started Nocturnal Dialysis|1
5719887|NCT00077766|19697512|P1|Overall Study|Started Nocturnal Dialysis|0
5719888|NCT00077766|19697511|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
5719889|NCT00077766|19697512|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
5719890|NCT00077766|19697511|P2|Overall Study|Dialysis|1
5719891|NCT00077766|19697512|P1|Overall Study|Dialysis|0
5719892|NCT00077766|19697511|P2|Overall Study|Dialysis Discontinued|0
5719893|NCT00077766|19697512|P1|Overall Study|Dialysis Discontinued|1
5719894|NCT00077766|19697511|P2|Overall Study|Participant's decision|0
5719895|NCT00077766|19697512|P1|Overall Study|Participant's decision|1
5719896|NCT00077766|19697511|P2|Overall Study|Investigators Discretion|0
5719897|NCT00077766|19697512|P1|Overall Study|Investigators Discretion|1
5719898|NCT00077766|19697511|P2|Overall Study|Transplantation|1
5719899|NCT00077766|19697512|P1|Overall Study|Transplantation|5
5719900|NCT00077766|19697511|P2|Overall Study|Kidney Transplantation|5
5719901|NCT00077766|19697512|P1|Overall Study|Kidney Transplantation|9
5719902|NCT00077766|19697511|P2|Overall Study|Protocol Violation|0
5719903|NCT00077766|19697512|P1|Overall Study|Protocol Violation|1
5719904|NCT00077766|19697511|P2|Overall Study|Lost to Follow-up|0
5719905|NCT00077766|19697512|P1|Overall Study|Lost to Follow-up|2
5719906|NCT00077766|19697511|P2|Overall Study|Death|10
5719907|NCT00077766|19697512|P1|Overall Study|Death|12
5719908|NCT00077766|19697511|P2|Overall Study|Withdrawal by Subject|3
5719909|NCT00077766|19697512|P1|Overall Study|Withdrawal by Subject|4
5719910|NCT00077766|19697511|P2|Overall Study|Adverse Event|1
5719911|NCT00077766|19697512|P1|Overall Study|Adverse Event|1
5719912|NCT00077675|19697537|P2|Overall Study|Never received study treatment|3
5719913|NCT00077675|19697538|P1|Overall Study|Never received study treatment|3
5719914|NCT00077675|19697537|P2|Overall Study|Other|1
5719915|NCT00077675|19697538|P1|Overall Study|Other|0
5719916|NCT00077675|19697537|P2|Overall Study|Withdrawal by Subject|0
5719917|NCT00077675|19697538|P1|Overall Study|Withdrawal by Subject|1
5719918|NCT00077675|19697537|P2|Overall Study|Lost to Follow-up|3
5719919|NCT00077675|19697538|P1|Overall Study|Lost to Follow-up|6
5719920|NCT00077675|19697537|P2|Overall Study|Adverse Event|2
5719921|NCT00077675|19697538|P1|Overall Study|Adverse Event|1
5719922|NCT00077649|19697548|P4|Overall Study|Randomized but never dosed|0
5719923|NCT00077649|19697549|P3|Overall Study|Randomized but never dosed|0
5719924|NCT00077649|19697550|P2|Overall Study|Randomized but never dosed|0
5719925|NCT00077649|19697551|P1|Overall Study|Randomized but never dosed|1
5719926|NCT00077649|19697548|P4|Overall Study|Abnormality of Laboratory Test|2
5719927|NCT00077649|19697549|P3|Overall Study|Abnormality of Laboratory Test|1
5719928|NCT00077649|19697550|P2|Overall Study|Abnormality of Laboratory Test|2
5719929|NCT00077649|19697551|P1|Overall Study|Abnormality of Laboratory Test|1
5719930|NCT00077649|19697548|P4|Overall Study|Lost to Follow-up|2
5719931|NCT00077649|19697549|P3|Overall Study|Lost to Follow-up|3
5719932|NCT00077649|19697550|P2|Overall Study|Lost to Follow-up|2
5719933|NCT00077649|19697551|P1|Overall Study|Lost to Follow-up|2
5719934|NCT00077649|19697548|P4|Overall Study|Withdrawal by Subject|2
5719935|NCT00077649|19697549|P3|Overall Study|Withdrawal by Subject|1
5719936|NCT00077649|19697550|P2|Overall Study|Withdrawal by Subject|1
5719937|NCT00077649|19697551|P1|Overall Study|Withdrawal by Subject|0
5719938|NCT00077649|19697548|P4|Overall Study|Lack of Efficacy|2
5719939|NCT00077649|19697549|P3|Overall Study|Lack of Efficacy|3
5719940|NCT00077649|19697550|P2|Overall Study|Lack of Efficacy|3
5719941|NCT00077649|19697551|P1|Overall Study|Lack of Efficacy|5
5719942|NCT00077649|19697548|P4|Overall Study|Adverse Event|9
5719943|NCT00077649|19697549|P3|Overall Study|Adverse Event|7
5719944|NCT00077649|19697550|P2|Overall Study|Adverse Event|1
5719945|NCT00077649|19697551|P1|Overall Study|Adverse Event|5
5719946|NCT00077636|19697599|P2|Overall Study|Abnormality Of Laboratory Test|2
5719947|NCT00077636|19697600|P1|Overall Study|Abnormality Of Laboratory Test|3
5719948|NCT00077636|19697599|P2|Overall Study|Lost to Follow-up|18
5719949|NCT00077636|19697600|P1|Overall Study|Lost to Follow-up|10
5719950|NCT00077636|19697599|P2|Overall Study|Protocol Violation|2
5719951|NCT00077636|19697600|P1|Overall Study|Protocol Violation|0
5719952|NCT00077636|19697599|P2|Overall Study|Adverse Event|34
5719953|NCT00077636|19697600|P1|Overall Study|Adverse Event|17
5719954|NCT00077636|19697599|P2|Overall Study|Withdrawal by Subject|2
5719955|NCT00077636|19697600|P1|Overall Study|Withdrawal by Subject|2
5719956|NCT00077636|19697599|P2|Overall Study|Admin|3
5719957|NCT00077636|19697600|P1|Overall Study|Admin|3
5719958|NCT00077636|19697599|P2|Overall Study|Refused Treatment|31
5719959|NCT00077636|19697600|P1|Overall Study|Refused Treatment|9
5719960|NCT00077623|19697621|P3|Overall Study|Failure to return|0
5719961|NCT00077623|19697622|P2|Overall Study|Failure to return|0
5719962|NCT00077623|19697623|P1|Overall Study|Failure to return|1
5719963|NCT00077623|19697621|P3|Overall Study|Death|11
5719964|NCT00077623|19697622|P2|Overall Study|Death|18
5719965|NCT00077623|19697623|P1|Overall Study|Death|12
5719966|NCT00077623|19697621|P3|Overall Study|Insufficient therapeutic response|0
5719967|NCT00077623|19697622|P2|Overall Study|Insufficient therapeutic response|0
5719968|NCT00077623|19697623|P1|Overall Study|Insufficient therapeutic response|2
5719969|NCT00077623|19697621|P3|Overall Study|Other-Non safety reason|19
5719970|NCT00077623|19697622|P2|Overall Study|Other-Non safety reason|15
5719971|NCT00077623|19697623|P1|Overall Study|Other-Non safety reason|18
5719972|NCT00077623|19697621|P3|Overall Study|Withdrawal by Subject|1
5719973|NCT00077623|19697622|P2|Overall Study|Withdrawal by Subject|10
5719974|NCT00077623|19697623|P1|Overall Study|Withdrawal by Subject|2
5719975|NCT00077623|19697621|P3|Overall Study|Adverse Event|1
5719976|NCT00077623|19697622|P2|Overall Study|Adverse Event|0
5719977|NCT00077623|19697623|P1|Overall Study|Adverse Event|1
5719978|NCT00077610|19697658|P3|Overall Study|Sponsors decision to withdraw|1
5719979|NCT00077610|19697659|P2|Overall Study|Sponsors decision to withdraw|0
5719980|NCT00077610|19697660|P1|Overall Study|Sponsors decision to withdraw|0
5719981|NCT00077610|19697658|P3|Overall Study|Financial issues|0
5719982|NCT00077610|19697659|P2|Overall Study|Financial issues|1
5719983|NCT00077610|19697660|P1|Overall Study|Financial issues|0
5719984|NCT00077610|19697658|P3|Overall Study|Relocation|5
5719985|NCT00077610|19697659|P2|Overall Study|Relocation|8
5719986|NCT00077610|19697660|P1|Overall Study|Relocation|0
5719987|NCT00077610|19697658|P3|Overall Study|Change in dialysis modality|0
5719988|NCT00077610|19697659|P2|Overall Study|Change in dialysis modality|0
5719989|NCT00077610|19697660|P1|Overall Study|Change in dialysis modality|1
5719990|NCT00077610|19697658|P3|Overall Study|Transfer to other center for surgery|0
5719991|NCT00077610|19697659|P2|Overall Study|Transfer to other center for surgery|0
5719992|NCT00077610|19697660|P1|Overall Study|Transfer to other center for surgery|1
5719993|NCT00077610|19697658|P3|Overall Study|Transfer to satellite unit|0
5719994|NCT00077610|19697659|P2|Overall Study|Transfer to satellite unit|0
5719995|NCT00077610|19697660|P1|Overall Study|Transfer to satellite unit|1
5719996|NCT00077610|19697658|P3|Overall Study|Transferred to nursing home|1
5719997|NCT00077610|19697659|P2|Overall Study|Transferred to nursing home|0
5719998|NCT00077610|19697660|P1|Overall Study|Transferred to nursing home|0
5719999|NCT00077610|19697658|P3|Overall Study|Transferred to other unit|1
5720000|NCT00077610|19697659|P2|Overall Study|Transferred to other unit|0
5720001|NCT00077610|19697660|P1|Overall Study|Transferred to other unit|0
5720002|NCT00077610|19697658|P3|Overall Study|Given Epogen in hospital|0
5720003|NCT00077610|19697659|P2|Overall Study|Given Epogen in hospital|0
5720004|NCT00077610|19697660|P1|Overall Study|Given Epogen in hospital|1
5720005|NCT00077610|19697658|P3|Overall Study|Worsening of health condition|0
5720006|NCT00077610|19697659|P2|Overall Study|Worsening of health condition|1
5720007|NCT00077610|19697660|P1|Overall Study|Worsening of health condition|1
5720008|NCT00077610|19697658|P3|Overall Study|Principal Investigator's decision|1
5720009|NCT00077610|19697659|P2|Overall Study|Principal Investigator's decision|0
5720010|NCT00077610|19697660|P1|Overall Study|Principal Investigator's decision|1
5720011|NCT00077610|19697658|P3|Overall Study|Multiple blood transfusions|1
5720012|NCT00077610|19697659|P2|Overall Study|Multiple blood transfusions|0
5720013|NCT00077610|19697660|P1|Overall Study|Multiple blood transfusions|0
5720014|NCT00077610|19697658|P3|Overall Study|Insufficient Therapeutic Response|0
5720015|NCT00077610|19697659|P2|Overall Study|Insufficient Therapeutic Response|0
5720016|NCT00077610|19697660|P1|Overall Study|Insufficient Therapeutic Response|1
5720017|NCT00077610|19697658|P3|Overall Study|Withdrew from dialysis care|3
5720018|NCT00077610|19697659|P2|Overall Study|Withdrew from dialysis care|0
5720019|NCT00077610|19697660|P1|Overall Study|Withdrew from dialysis care|5
5720020|NCT00077610|19697658|P3|Overall Study|Renal transplant|11
5720021|NCT00077610|19697659|P2|Overall Study|Renal transplant|15
5720022|NCT00077610|19697660|P1|Overall Study|Renal transplant|12
5720023|NCT00077610|19697658|P3|Overall Study|Death|13
5720024|NCT00077610|19697659|P2|Overall Study|Death|13
5720025|NCT00077610|19697660|P1|Overall Study|Death|17
5720026|NCT00077610|19697658|P3|Overall Study|Withdrawal by Subject|6
5720027|NCT00077610|19697659|P2|Overall Study|Withdrawal by Subject|10
5720028|NCT00077610|19697660|P1|Overall Study|Withdrawal by Subject|4
5720029|NCT00077610|19697658|P3|Overall Study|Lost to Follow-up|2
5720030|NCT00077610|19697659|P2|Overall Study|Lost to Follow-up|1
5720031|NCT00077610|19697660|P1|Overall Study|Lost to Follow-up|0
5720032|NCT00077610|19697658|P3|Overall Study|Adverse Event|1
5720033|NCT00077610|19697659|P2|Overall Study|Adverse Event|7
5720034|NCT00077610|19697660|P1|Overall Study|Adverse Event|9
5720035|NCT00077376|19697689|P1|Overall Study|Insurance ran out|1
5720036|NCT00077376|19697689|P1|Overall Study|Surgery|1
5720037|NCT00077376|19697689|P1|Overall Study|Symptomatic deterioration|1
5720038|NCT00077376|19697689|P1|Overall Study|Still on treatment|1
5720039|NCT00077376|19697689|P1|Overall Study|Complicating disease|1
5720040|NCT00077376|19697689|P1|Overall Study|Alternative therapy|5
5720041|NCT00077376|19697689|P1|Overall Study|Physician Decision|1
5720042|NCT00077376|19697689|P1|Overall Study|Death|1
5720043|NCT00077376|19697689|P1|Overall Study|Withdrawal by Subject|2
5720044|NCT00077376|19697689|P1|Overall Study|Adverse Event|8
5720045|NCT00077207|19697700|P1|Overall Study|Ineligible|1
5720046|NCT00077207|19697700|P1|Overall Study|Withdrawal by Subject|6
5720047|NCT00077207|19697700|P1|Overall Study|Physician Decision|6
5720048|NCT00077207|19697700|P1|Overall Study|Lack of Efficacy|12
5720049|NCT00077207|19697700|P1|Overall Study|Adverse Event|5
5720050|NCT00077064|19697712|P2|Overall Study|Patient refusal|2
5720051|NCT00077064|19697713|P1|Overall Study|Patient refusal|0
5720052|NCT00077064|19697712|P2|Overall Study|Adverse Event|4
5720053|NCT00077064|19697713|P1|Overall Study|Adverse Event|0
5720054|NCT00076999|19697729|P5|Overall Study|Other reason (not specified)|13
5720055|NCT00076999|19697730|P4|Overall Study|Other reason (not specified)|1
5720056|NCT00076999|19697731|P3|Overall Study|Other reason (not specified)|4
5720057|NCT00076999|19697732|P2|Overall Study|Other reason (not specified)|8
5720058|NCT00076999|19697733|P1|Overall Study|Other reason (not specified)|8
5720059|NCT00076999|19697729|P5|Overall Study|Withdrawal by Subject|1
5720060|NCT00076999|19697730|P4|Overall Study|Withdrawal by Subject|0
5720061|NCT00076999|19697731|P3|Overall Study|Withdrawal by Subject|3
5720062|NCT00076999|19697732|P2|Overall Study|Withdrawal by Subject|4
5720063|NCT00076999|19697733|P1|Overall Study|Withdrawal by Subject|0
5720064|NCT00076999|19697729|P5|Overall Study|Lost to Follow-up|0
5720065|NCT00076999|19697730|P4|Overall Study|Lost to Follow-up|0
5720066|NCT00076999|19697731|P3|Overall Study|Lost to Follow-up|0
5720067|NCT00076999|19697732|P2|Overall Study|Lost to Follow-up|1
5720068|NCT00076999|19697733|P1|Overall Study|Lost to Follow-up|2
5720069|NCT00076999|19697729|P5|Overall Study|Protocol Violation|9
5720070|NCT00076999|19697730|P4|Overall Study|Protocol Violation|0
5720071|NCT00076999|19697731|P3|Overall Study|Protocol Violation|4
5720072|NCT00076999|19697732|P2|Overall Study|Protocol Violation|3
5720073|NCT00076999|19697733|P1|Overall Study|Protocol Violation|0
5720074|NCT00076999|19697729|P5|Overall Study|Adverse Event|2
5720075|NCT00076999|19697730|P4|Overall Study|Adverse Event|0
5720076|NCT00076999|19697731|P3|Overall Study|Adverse Event|6
5720077|NCT00076999|19697732|P2|Overall Study|Adverse Event|8
5720078|NCT00076999|19697733|P1|Overall Study|Adverse Event|2
5720079|NCT00003222|19697852|P2|Overall Study|Physician Decision|1
5720080|NCT00003222|19697853|P1|Overall Study|Physician Decision|0
5720081|NCT00076804|19697865|P2|Overall Study|Early study Closure|32
5720082|NCT00076804|19697866|P1|Overall Study|Early study Closure|32
5720083|NCT00076804|19697865|P2|Overall Study|Withdrawal by Subject|8
5720084|NCT00076804|19697866|P1|Overall Study|Withdrawal by Subject|10
5720085|NCT00076804|19697865|P2|Overall Study|Lost to Follow-up|9
5720086|NCT00076804|19697866|P1|Overall Study|Lost to Follow-up|9
5720087|NCT00076804|19697865|P2|Overall Study|Death|20
5720088|NCT00076804|19697866|P1|Overall Study|Death|9
5720089|NCT00076752|19697878|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
5720090|NCT00076752|19697878|P1|Overall Study|Death|2
5720091|NCT00076570|19697924|P2|Overall Study|Drug intolerance|8
5720092|NCT00076570|19697925|P1|Overall Study|Drug intolerance|8
5720093|NCT00003298|19697933|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
5720094|NCT00003298|19697933|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
5720095|NCT00003298|19697933|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
5720096|NCT00003298|19697933|P1|Step 2 (Adjuvant Therapy)|Death|1
5720097|NCT00003298|19697933|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
5720098|NCT00003298|19697933|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
5720099|NCT00003298|19697933|P1|Re-register to Step 2 After Surgery|Reason unknown|1
5720100|NCT00003298|19697933|P1|Re-register to Step 2 After Surgery|Other complications|2
5720101|NCT00003298|19697933|P1|Re-register to Step 2 After Surgery|Positive margins|5
5720102|NCT00003298|19697933|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
5720103|NCT00003298|19697933|P1|Surgery|Unevaluable and off study|2
5720104|NCT00003298|19697933|P1|Surgery|Progression before surgery|2
5720105|NCT00003298|19697933|P1|Surgery|Unresectable at surgery|3
5720106|NCT00003298|19697933|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
5720107|NCT00003298|19697933|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
5720108|NCT00076336|19697943|P2|Overall Study|Treatment failure|5
5720109|NCT00076336|19697944|P1|Overall Study|Treatment failure|4
5720110|NCT00076336|19697943|P2|Overall Study|Virologic Breakthrough|16
5720111|NCT00076336|19697944|P1|Overall Study|Virologic Breakthrough|14
5720112|NCT00076336|19697943|P2|Overall Study|Liver Transplantation|3
5720113|NCT00076336|19697944|P1|Overall Study|Liver Transplantation|3
5720114|NCT00076336|19697943|P2|Overall Study|Patient, Investigator, Sponsor request|6
5720115|NCT00076336|19697944|P1|Overall Study|Patient, Investigator, Sponsor request|8
5720116|NCT00076336|19697943|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
5720117|NCT00076336|19697944|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
5720118|NCT00076336|19697943|P2|Overall Study|Non-Compliance|0
5720119|NCT00076336|19697944|P1|Overall Study|Non-Compliance|2
5720120|NCT00076336|19697943|P2|Overall Study|Lost to Follow-up|4
5720121|NCT00076336|19697944|P1|Overall Study|Lost to Follow-up|4
5720122|NCT00076336|19697943|P2|Overall Study|Adverse Event|4
5720123|NCT00076336|19697944|P1|Overall Study|Adverse Event|4
5720124|NCT00076336|19697943|P2|Overall Study|Death|17
5720125|NCT00076336|19697944|P1|Overall Study|Death|13
5720126|NCT00076102|19697997|P1|Overall Study|refusal of further therapy|2
5720127|NCT00076102|19697997|P1|Overall Study|plexiform neurofibroma surgery|1
5720128|NCT00076102|19697997|P1|Overall Study|Progression in pre-existing brain tumor|1
5720129|NCT00076102|19697997|P1|Overall Study|Clinical progression|1
5720130|NCT00076024|19698025|P4|Phase 2, Open-label|Other|2
5720131|NCT00076024|19698026|P3|Phase 2, Open-label|Other|0
5720132|NCT00076024|19698027|P2|Phase 2, Open-label|Other|0
5720133|NCT00076024|19698028|P1|Phase 2, Open-label|Other|0
5720134|NCT00076024|19698025|P4|Phase 2, Open-label|Withdrawal by Subject|1
5720135|NCT00076024|19698026|P3|Phase 2, Open-label|Withdrawal by Subject|0
5720136|NCT00076024|19698027|P2|Phase 2, Open-label|Withdrawal by Subject|0
5720137|NCT00076024|19698028|P1|Phase 2, Open-label|Withdrawal by Subject|0
5720138|NCT00076024|19698025|P4|Phase 2, Open-label|Lack of Efficacy|11
5720139|NCT00076024|19698026|P3|Phase 2, Open-label|Lack of Efficacy|0
5720140|NCT00076024|19698027|P2|Phase 2, Open-label|Lack of Efficacy|0
5720141|NCT00076024|19698028|P1|Phase 2, Open-label|Lack of Efficacy|0
5720142|NCT00076024|19698025|P4|Phase 2, Open-label|Adverse Event|2
5720143|NCT00076024|19698026|P3|Phase 2, Open-label|Adverse Event|0
5720144|NCT00076024|19698027|P2|Phase 2, Open-label|Adverse Event|0
5720145|NCT00076024|19698028|P1|Phase 2, Open-label|Adverse Event|0
5720146|NCT00076024|19698025|P4|Phase 2, Double-blind|Randomized but not treated|0
5720147|NCT00076024|19698026|P3|Phase 2, Double-blind|Randomized but not treated|0
5720148|NCT00076024|19698027|P2|Phase 2, Double-blind|Randomized but not treated|1
5720149|NCT00076024|19698028|P1|Phase 2, Double-blind|Randomized but not treated|0
5720150|NCT00076024|19698025|P4|Phase 2, Double-blind|Un-specified|0
5720151|NCT00076024|19698026|P3|Phase 2, Double-blind|Un-specified|6
5720152|NCT00076024|19698027|P2|Phase 2, Double-blind|Un-specified|14
5720153|NCT00076024|19698028|P1|Phase 2, Double-blind|Un-specified|0
5720154|NCT00076024|19698025|P4|Phase 2, Double-blind|Adverse Event|0
5720155|NCT00076024|19698026|P3|Phase 2, Double-blind|Adverse Event|6
5720156|NCT00076024|19698027|P2|Phase 2, Double-blind|Adverse Event|25
5720157|NCT00076024|19698028|P1|Phase 2, Double-blind|Adverse Event|0
5720158|NCT00076024|19698025|P4|Phase 2, Double-blind|Withdrawal by Subject|0
5720159|NCT00076024|19698026|P3|Phase 2, Double-blind|Withdrawal by Subject|4
5720160|NCT00076024|19698027|P2|Phase 2, Double-blind|Withdrawal by Subject|13
5720161|NCT00076024|19698028|P1|Phase 2, Double-blind|Withdrawal by Subject|0
5720162|NCT00076024|19698025|P4|Phase 2, Double-blind|Lack of Efficacy|0
5720163|NCT00076024|19698026|P3|Phase 2, Double-blind|Lack of Efficacy|40
5720164|NCT00076024|19698027|P2|Phase 2, Double-blind|Lack of Efficacy|59
5720165|NCT00076024|19698028|P1|Phase 2, Double-blind|Lack of Efficacy|0
5720166|NCT00076024|19698025|P4|Phase 1, Lead-in|Clinical progression|0
5720167|NCT00076024|19698026|P3|Phase 1, Lead-in|Clinical progression|0
5720168|NCT00076024|19698027|P2|Phase 1, Lead-in|Clinical progression|0
5720169|NCT00076024|19698028|P1|Phase 1, Lead-in|Clinical progression|1
5720170|NCT00076024|19698025|P4|Phase 1, Lead-in|Adverse Event|0
5720171|NCT00076024|19698026|P3|Phase 1, Lead-in|Adverse Event|0
5720172|NCT00076024|19698027|P2|Phase 1, Lead-in|Adverse Event|0
5720173|NCT00076024|19698028|P1|Phase 1, Lead-in|Adverse Event|1
5720174|NCT00076024|19698025|P4|Phase 1, Lead-in|Lack of Efficacy|0
5720175|NCT00076024|19698026|P3|Phase 1, Lead-in|Lack of Efficacy|0
5720176|NCT00076024|19698027|P2|Phase 1, Lead-in|Lack of Efficacy|0
5720177|NCT00076024|19698028|P1|Phase 1, Lead-in|Lack of Efficacy|4
5720178|NCT00076011|19698042|P1|Overall Study|Ongoing|1
5720179|NCT00076011|19698042|P1|Overall Study|Other|11
5720180|NCT00076011|19698042|P1|Overall Study|Study terminated by sponsor|3
5720181|NCT00076011|19698042|P1|Overall Study|Withdrawal by Subject|1
5720182|NCT00076011|19698042|P1|Overall Study|Lack of Efficacy|25
5720183|NCT00076011|19698042|P1|Overall Study|Adverse Event|10
5720184|NCT00076011|19698042|P1|Overall Study|Death|1
5720185|NCT00075946|19698054|P5|Overall Study|Other|0
5720186|NCT00075946|19698055|P4|Overall Study|Other|2
5720187|NCT00075946|19698056|P3|Overall Study|Other|0
5720188|NCT00075946|19698057|P2|Overall Study|Other|13
5720189|NCT00075946|19698058|P1|Overall Study|Other|5
5720190|NCT00075946|19698054|P5|Overall Study|Time to progression less than 6 months|0
5720191|NCT00075946|19698055|P4|Overall Study|Time to progression less than 6 months|3
5720192|NCT00075946|19698056|P3|Overall Study|Time to progression less than 6 months|8
5720193|NCT00075946|19698057|P2|Overall Study|Time to progression less than 6 months|30
5720194|NCT00075946|19698058|P1|Overall Study|Time to progression less than 6 months|15
5720195|NCT00075946|19698054|P5|Overall Study|No response to retreatment|0
5720196|NCT00075946|19698055|P4|Overall Study|No response to retreatment|0
5720197|NCT00075946|19698056|P3|Overall Study|No response to retreatment|2
5720198|NCT00075946|19698057|P2|Overall Study|No response to retreatment|0
5720199|NCT00075946|19698058|P1|Overall Study|No response to retreatment|23
5720200|NCT00075946|19698054|P5|Overall Study|Other complicating disease|0
5720201|NCT00075946|19698055|P4|Overall Study|Other complicating disease|4
5720202|NCT00075946|19698056|P3|Overall Study|Other complicating disease|1
5720203|NCT00075946|19698057|P2|Overall Study|Other complicating disease|13
5720204|NCT00075946|19698058|P1|Overall Study|Other complicating disease|7
5720205|NCT00075946|19698054|P5|Overall Study|Alternative therapy|0
5720206|NCT00075946|19698055|P4|Overall Study|Alternative therapy|0
5720207|NCT00075946|19698056|P3|Overall Study|Alternative therapy|5
5720208|NCT00075946|19698057|P2|Overall Study|Alternative therapy|2
5720209|NCT00075946|19698058|P1|Overall Study|Alternative therapy|16
5720210|NCT00075946|19698054|P5|Overall Study|Withdrawal by Subject|0
5720211|NCT00075946|19698055|P4|Overall Study|Withdrawal by Subject|9
5720212|NCT00075946|19698056|P3|Overall Study|Withdrawal by Subject|4
5720213|NCT00075946|19698057|P2|Overall Study|Withdrawal by Subject|58
5720214|NCT00075946|19698058|P1|Overall Study|Withdrawal by Subject|23
5720215|NCT00075946|19698054|P5|Overall Study|Death|0
5720216|NCT00075946|19698055|P4|Overall Study|Death|0
5720217|NCT00075946|19698056|P3|Overall Study|Death|0
5720218|NCT00075946|19698057|P2|Overall Study|Death|1
5720219|NCT00075946|19698058|P1|Overall Study|Death|0
5720220|NCT00075946|19698054|P5|Overall Study|Adverse Event|0
5720221|NCT00075946|19698055|P4|Overall Study|Adverse Event|2
5720222|NCT00075946|19698056|P3|Overall Study|Adverse Event|0
5720223|NCT00075946|19698057|P2|Overall Study|Adverse Event|10
5720224|NCT00075946|19698058|P1|Overall Study|Adverse Event|2
5720225|NCT00075946|19698054|P5|Overall Study|Still on treatment at time of analysis|0
5720226|NCT00075946|19698055|P4|Overall Study|Still on treatment at time of analysis|9
5720227|NCT00075946|19698056|P3|Overall Study|Still on treatment at time of analysis|3
5720228|NCT00075946|19698057|P2|Overall Study|Still on treatment at time of analysis|19
5720229|NCT00075946|19698058|P1|Overall Study|Still on treatment at time of analysis|52
5720230|NCT00075946|19698054|P5|Overall Study|Incorrectly randomized (no response)|0
5720231|NCT00075946|19698055|P4|Overall Study|Incorrectly randomized (no response)|1
5720232|NCT00075946|19698056|P3|Overall Study|Incorrectly randomized (no response)|5
5720233|NCT00075946|19698057|P2|Overall Study|Incorrectly randomized (no response)|5
5720234|NCT00075946|19698058|P1|Overall Study|Incorrectly randomized (no response)|5
5720235|NCT00075946|19698054|P5|Overall Study|Did not achieve response after induction|182
5720236|NCT00075946|19698055|P4|Overall Study|Did not achieve response after induction|0
5720237|NCT00075946|19698056|P3|Overall Study|Did not achieve response after induction|0
5720238|NCT00075946|19698057|P2|Overall Study|Did not achieve response after induction|0
5720239|NCT00075946|19698058|P1|Overall Study|Did not achieve response after induction|0
5720240|NCT00075946|19698054|P5|Overall Study|Path ineligible: undetermined histology|6
5720241|NCT00075946|19698055|P4|Overall Study|Path ineligible: undetermined histology|0
5720242|NCT00075946|19698056|P3|Overall Study|Path ineligible: undetermined histology|0
5720243|NCT00075946|19698057|P2|Overall Study|Path ineligible: undetermined histology|0
5720244|NCT00075946|19698058|P1|Overall Study|Path ineligible: undetermined histology|0
5720245|NCT00075881|19698073|P1|Overall Study|never start protocol therapy|1
5720246|NCT00075881|19698073|P1|Overall Study|Ineligible|1
5720247|NCT00075881|19698073|P1|Overall Study|missing data|2
5720248|NCT00075881|19698073|P1|Overall Study|other|4
5720249|NCT00075881|19698073|P1|Overall Study|other complicating disease|3
5720250|NCT00075881|19698073|P1|Overall Study|Protocol Violation|4
5720251|NCT00075881|19698073|P1|Overall Study|Withdrawal by Subject|2
5720252|NCT00075881|19698073|P1|Overall Study|Death|1
5720253|NCT00075881|19698073|P1|Overall Study|Adverse Event|7
5720254|NCT00075881|19698073|P1|Overall Study|Lack of Efficacy|18
5720255|NCT00075816|19698117|P2|Overall Study|Did not undergo transplantation|11
5720256|NCT00075816|19698118|P1|Overall Study|Did not undergo transplantation|14
5720257|NCT00075764|19698187|P2|Overall Study|Under review|1
5720258|NCT00075764|19698188|P1|Overall Study|Under review|0
5720259|NCT00075764|19698187|P2|Overall Study|Not protocol specified|19
5720260|NCT00075764|19698188|P1|Overall Study|Not protocol specified|27
5720261|NCT00075764|19698187|P2|Overall Study|Delinquent|2
5720262|NCT00075764|19698188|P1|Overall Study|Delinquent|4
5720263|NCT00075764|19698187|P2|Overall Study|Still on treatment|15
5720264|NCT00075764|19698188|P1|Overall Study|Still on treatment|8
5720265|NCT00075764|19698187|P2|Overall Study|Progression|274
5720266|NCT00075764|19698188|P1|Overall Study|Progression|269
5720267|NCT00075764|19698187|P2|Overall Study|Withdrawal by Subject|18
5720268|NCT00075764|19698188|P1|Overall Study|Withdrawal by Subject|28
5720269|NCT00075764|19698187|P2|Overall Study|Death|8
5720270|NCT00075764|19698188|P1|Overall Study|Death|4
5720271|NCT00075764|19698187|P2|Overall Study|Adverse Event|12
5720272|NCT00075764|19698188|P1|Overall Study|Adverse Event|5
5720273|NCT00075725|19698212|P12|Overall Study|Pt incarcerated|0
5720274|NCT00075725|19698213|P11|Overall Study|Pt incarcerated|0
5720275|NCT00075725|19698214|P10|Overall Study|Pt incarcerated|0
5720276|NCT00075725|19698215|P9|Overall Study|Pt incarcerated|0
5720277|NCT00075725|19698216|P8|Overall Study|Pt incarcerated|1
5720278|NCT00075725|19698217|P7|Overall Study|Pt incarcerated|0
5720279|NCT00075725|19698218|P6|Overall Study|Pt incarcerated|0
5720280|NCT00075725|19698219|P5|Overall Study|Pt incarcerated|0
5720281|NCT00075725|19698220|P4|Overall Study|Pt incarcerated|0
5720282|NCT00075725|19698221|P3|Overall Study|Pt incarcerated|0
5720283|NCT00075725|19698222|P2|Overall Study|Pt incarcerated|0
5720284|NCT00075725|19698223|P1|Overall Study|Pt incarcerated|0
5720285|NCT00075725|19698212|P12|Overall Study|Pt care terminated due to pt behavior|0
5720286|NCT00075725|19698213|P11|Overall Study|Pt care terminated due to pt behavior|0
5720287|NCT00075725|19698214|P10|Overall Study|Pt care terminated due to pt behavior|0
5720288|NCT00075725|19698215|P9|Overall Study|Pt care terminated due to pt behavior|0
5720289|NCT00075725|19698216|P8|Overall Study|Pt care terminated due to pt behavior|1
5720290|NCT00075725|19698217|P7|Overall Study|Pt care terminated due to pt behavior|0
5720291|NCT00075725|19698218|P6|Overall Study|Pt care terminated due to pt behavior|0
5720292|NCT00075725|19698219|P5|Overall Study|Pt care terminated due to pt behavior|0
5720293|NCT00075725|19698220|P4|Overall Study|Pt care terminated due to pt behavior|0
5720294|NCT00075725|19698221|P3|Overall Study|Pt care terminated due to pt behavior|0
5720295|NCT00075725|19698222|P2|Overall Study|Pt care terminated due to pt behavior|0
5720296|NCT00075725|19698223|P1|Overall Study|Pt care terminated due to pt behavior|0
5720297|NCT00075725|19698212|P12|Overall Study|Other complications|0
5720298|NCT00075725|19698213|P11|Overall Study|Other complications|0
5720299|NCT00075725|19698214|P10|Overall Study|Other complications|0
5720300|NCT00075725|19698215|P9|Overall Study|Other complications|0
5720301|NCT00075725|19698216|P8|Overall Study|Other complications|0
5720302|NCT00075725|19698217|P7|Overall Study|Other complications|0
5720303|NCT00075725|19698218|P6|Overall Study|Other complications|1
5720304|NCT00075725|19698219|P5|Overall Study|Other complications|0
5720305|NCT00075725|19698220|P4|Overall Study|Other complications|0
5720306|NCT00075725|19698221|P3|Overall Study|Other complications|0
5720307|NCT00075725|19698222|P2|Overall Study|Other complications|0
5720308|NCT00075725|19698223|P1|Overall Study|Other complications|0
5720309|NCT00075725|19698212|P12|Overall Study|Study Closure|0
5720310|NCT00075725|19698213|P11|Overall Study|Study Closure|0
5720311|NCT00075725|19698214|P10|Overall Study|Study Closure|0
5720312|NCT00075725|19698215|P9|Overall Study|Study Closure|0
5720313|NCT00075725|19698216|P8|Overall Study|Study Closure|1
5720314|NCT00075725|19698217|P7|Overall Study|Study Closure|0
5720315|NCT00075725|19698218|P6|Overall Study|Study Closure|3
5720316|NCT00075725|19698219|P5|Overall Study|Study Closure|1
5720317|NCT00075725|19698220|P4|Overall Study|Study Closure|0
5720318|NCT00075725|19698221|P3|Overall Study|Study Closure|0
5720319|NCT00075725|19698222|P2|Overall Study|Study Closure|0
5720320|NCT00075725|19698223|P1|Overall Study|Study Closure|1
5720321|NCT00075725|19698212|P12|Overall Study|Institution Terminated|0
5720322|NCT00075725|19698213|P11|Overall Study|Institution Terminated|0
5720323|NCT00075725|19698214|P10|Overall Study|Institution Terminated|0
5720324|NCT00075725|19698215|P9|Overall Study|Institution Terminated|0
5720325|NCT00075725|19698216|P8|Overall Study|Institution Terminated|3
5720326|NCT00075725|19698217|P7|Overall Study|Institution Terminated|0
5720327|NCT00075725|19698218|P6|Overall Study|Institution Terminated|0
5720328|NCT00075725|19698219|P5|Overall Study|Institution Terminated|1
5720329|NCT00075725|19698220|P4|Overall Study|Institution Terminated|0
5720330|NCT00075725|19698221|P3|Overall Study|Institution Terminated|0
5720331|NCT00075725|19698222|P2|Overall Study|Institution Terminated|0
5720332|NCT00075725|19698223|P1|Overall Study|Institution Terminated|0
5720333|NCT00075725|19698212|P12|Overall Study|Pt relocated|0
5720334|NCT00075725|19698213|P11|Overall Study|Pt relocated|0
5720335|NCT00075725|19698214|P10|Overall Study|Pt relocated|0
5720336|NCT00075725|19698215|P9|Overall Study|Pt relocated|1
5720337|NCT00075725|19698216|P8|Overall Study|Pt relocated|2
5720338|NCT00075725|19698217|P7|Overall Study|Pt relocated|1
5720339|NCT00075725|19698218|P6|Overall Study|Pt relocated|1
5720340|NCT00075725|19698219|P5|Overall Study|Pt relocated|0
5720341|NCT00075725|19698220|P4|Overall Study|Pt relocated|2
5720342|NCT00075725|19698221|P3|Overall Study|Pt relocated|0
5720343|NCT00075725|19698222|P2|Overall Study|Pt relocated|0
5720344|NCT00075725|19698223|P1|Overall Study|Pt relocated|0
5720345|NCT00075725|19698212|P12|Overall Study|Pt received additional steroids|0
5720346|NCT00075725|19698213|P11|Overall Study|Pt received additional steroids|0
5720347|NCT00075725|19698214|P10|Overall Study|Pt received additional steroids|0
5720348|NCT00075725|19698215|P9|Overall Study|Pt received additional steroids|0
5720349|NCT00075725|19698216|P8|Overall Study|Pt received additional steroids|0
5720350|NCT00075725|19698217|P7|Overall Study|Pt received additional steroids|0
5720351|NCT00075725|19698218|P6|Overall Study|Pt received additional steroids|0
5720352|NCT00075725|19698219|P5|Overall Study|Pt received additional steroids|0
5720353|NCT00075725|19698220|P4|Overall Study|Pt received additional steroids|1
5720354|NCT00075725|19698221|P3|Overall Study|Pt received additional steroids|0
5720355|NCT00075725|19698222|P2|Overall Study|Pt received additional steroids|0
5720356|NCT00075725|19698223|P1|Overall Study|Pt received additional steroids|0
5720357|NCT00075725|19698212|P12|Overall Study|Pt went to transplant|0
5720358|NCT00075725|19698213|P11|Overall Study|Pt went to transplant|0
5720359|NCT00075725|19698214|P10|Overall Study|Pt went to transplant|0
5720360|NCT00075725|19698215|P9|Overall Study|Pt went to transplant|0
5720361|NCT00075725|19698216|P8|Overall Study|Pt went to transplant|0
5720362|NCT00075725|19698217|P7|Overall Study|Pt went to transplant|0
5720363|NCT00075725|19698218|P6|Overall Study|Pt went to transplant|1
5720364|NCT00075725|19698219|P5|Overall Study|Pt went to transplant|0
5720365|NCT00075725|19698220|P4|Overall Study|Pt went to transplant|1
5720366|NCT00075725|19698221|P3|Overall Study|Pt went to transplant|0
5720367|NCT00075725|19698222|P2|Overall Study|Pt went to transplant|0
5720368|NCT00075725|19698223|P1|Overall Study|Pt went to transplant|0
5720369|NCT00075725|19698212|P12|Overall Study|specimen(s) not submitted|0
5720370|NCT00075725|19698213|P11|Overall Study|specimen(s) not submitted|0
5720371|NCT00075725|19698214|P10|Overall Study|specimen(s) not submitted|0
5720372|NCT00075725|19698215|P9|Overall Study|specimen(s) not submitted|0
5720373|NCT00075725|19698216|P8|Overall Study|specimen(s) not submitted|0
5720374|NCT00075725|19698217|P7|Overall Study|specimen(s) not submitted|0
5720375|NCT00075725|19698218|P6|Overall Study|specimen(s) not submitted|0
5720376|NCT00075725|19698219|P5|Overall Study|specimen(s) not submitted|0
5720377|NCT00075725|19698220|P4|Overall Study|specimen(s) not submitted|0
5720378|NCT00075725|19698221|P3|Overall Study|specimen(s) not submitted|2
5720379|NCT00075725|19698222|P2|Overall Study|specimen(s) not submitted|0
5720380|NCT00075725|19698223|P1|Overall Study|specimen(s) not submitted|0
5720381|NCT00075725|19698212|P12|Overall Study|Unsuccessful institutional transfer|0
5720382|NCT00075725|19698213|P11|Overall Study|Unsuccessful institutional transfer|0
5720383|NCT00075725|19698214|P10|Overall Study|Unsuccessful institutional transfer|1
5720384|NCT00075725|19698215|P9|Overall Study|Unsuccessful institutional transfer|0
5720385|NCT00075725|19698216|P8|Overall Study|Unsuccessful institutional transfer|0
5720386|NCT00075725|19698217|P7|Overall Study|Unsuccessful institutional transfer|0
5720387|NCT00075725|19698218|P6|Overall Study|Unsuccessful institutional transfer|0
5720388|NCT00075725|19698219|P5|Overall Study|Unsuccessful institutional transfer|0
5720389|NCT00075725|19698220|P4|Overall Study|Unsuccessful institutional transfer|0
5720390|NCT00075725|19698221|P3|Overall Study|Unsuccessful institutional transfer|2
5720391|NCT00075725|19698222|P2|Overall Study|Unsuccessful institutional transfer|0
5720392|NCT00075725|19698223|P1|Overall Study|Unsuccessful institutional transfer|0
5720393|NCT00075725|19698212|P12|Overall Study|Clinic chart lost unable to recreate|0
5720394|NCT00075725|19698213|P11|Overall Study|Clinic chart lost unable to recreate|0
5720395|NCT00075725|19698214|P10|Overall Study|Clinic chart lost unable to recreate|0
5720396|NCT00075725|19698215|P9|Overall Study|Clinic chart lost unable to recreate|0
5720397|NCT00075725|19698216|P8|Overall Study|Clinic chart lost unable to recreate|0
5720398|NCT00075725|19698217|P7|Overall Study|Clinic chart lost unable to recreate|0
5720399|NCT00075725|19698218|P6|Overall Study|Clinic chart lost unable to recreate|0
5720400|NCT00075725|19698219|P5|Overall Study|Clinic chart lost unable to recreate|0
5720401|NCT00075725|19698220|P4|Overall Study|Clinic chart lost unable to recreate|0
5720402|NCT00075725|19698221|P3|Overall Study|Clinic chart lost unable to recreate|1
5720403|NCT00075725|19698222|P2|Overall Study|Clinic chart lost unable to recreate|0
5720404|NCT00075725|19698223|P1|Overall Study|Clinic chart lost unable to recreate|0
5720405|NCT00075725|19698212|P12|Overall Study|Pt trying to find a BM donor|0
5720406|NCT00075725|19698213|P11|Overall Study|Pt trying to find a BM donor|0
5720407|NCT00075725|19698214|P10|Overall Study|Pt trying to find a BM donor|0
5720408|NCT00075725|19698215|P9|Overall Study|Pt trying to find a BM donor|0
5720409|NCT00075725|19698216|P8|Overall Study|Pt trying to find a BM donor|0
5720410|NCT00075725|19698217|P7|Overall Study|Pt trying to find a BM donor|0
5720411|NCT00075725|19698218|P6|Overall Study|Pt trying to find a BM donor|0
5720412|NCT00075725|19698219|P5|Overall Study|Pt trying to find a BM donor|0
5720413|NCT00075725|19698220|P4|Overall Study|Pt trying to find a BM donor|0
5720414|NCT00075725|19698221|P3|Overall Study|Pt trying to find a BM donor|0
5720415|NCT00075725|19698222|P2|Overall Study|Pt trying to find a BM donor|1
5720416|NCT00075725|19698223|P1|Overall Study|Pt trying to find a BM donor|0
5720417|NCT00075725|19698212|P12|Overall Study|Other|3
5720418|NCT00075725|19698213|P11|Overall Study|Other|0
5720419|NCT00075725|19698214|P10|Overall Study|Other|1
5720420|NCT00075725|19698215|P9|Overall Study|Other|2
5720421|NCT00075725|19698216|P8|Overall Study|Other|9
5720422|NCT00075725|19698217|P7|Overall Study|Other|2
5720423|NCT00075725|19698218|P6|Overall Study|Other|4
5720424|NCT00075725|19698219|P5|Overall Study|Other|1
5720425|NCT00075725|19698220|P4|Overall Study|Other|1
5720426|NCT00075725|19698221|P3|Overall Study|Other|1
5720427|NCT00075725|19698222|P2|Overall Study|Other|2
5720428|NCT00075725|19698223|P1|Overall Study|Other|4
5720429|NCT00075725|19698212|P12|Overall Study|Inevaluable|0
5720430|NCT00075725|19698213|P11|Overall Study|Inevaluable|1
5720431|NCT00075725|19698214|P10|Overall Study|Inevaluable|0
5720432|NCT00075725|19698215|P9|Overall Study|Inevaluable|2
5720433|NCT00075725|19698216|P8|Overall Study|Inevaluable|11
5720434|NCT00075725|19698217|P7|Overall Study|Inevaluable|1
5720435|NCT00075725|19698218|P6|Overall Study|Inevaluable|9
5720436|NCT00075725|19698219|P5|Overall Study|Inevaluable|2
5720437|NCT00075725|19698220|P4|Overall Study|Inevaluable|2
5720438|NCT00075725|19698221|P3|Overall Study|Inevaluable|4
5720439|NCT00075725|19698222|P2|Overall Study|Inevaluable|1
5720440|NCT00075725|19698223|P1|Overall Study|Inevaluable|1
5720441|NCT00075725|19698212|P12|Overall Study|Pt has very high risk ALL characteristic|3
5720442|NCT00075725|19698213|P11|Overall Study|Pt has very high risk ALL characteristic|0
5720443|NCT00075725|19698214|P10|Overall Study|Pt has very high risk ALL characteristic|1
5720444|NCT00075725|19698215|P9|Overall Study|Pt has very high risk ALL characteristic|29
5720445|NCT00075725|19698216|P8|Overall Study|Pt has very high risk ALL characteristic|74
5720446|NCT00075725|19698217|P7|Overall Study|Pt has very high risk ALL characteristic|23
5720447|NCT00075725|19698218|P6|Overall Study|Pt has very high risk ALL characteristic|75
5720448|NCT00075725|19698219|P5|Overall Study|Pt has very high risk ALL characteristic|11
5720449|NCT00075725|19698220|P4|Overall Study|Pt has very high risk ALL characteristic|18
5720450|NCT00075725|19698221|P3|Overall Study|Pt has very high risk ALL characteristic|26
5720451|NCT00075725|19698222|P2|Overall Study|Pt has very high risk ALL characteristic|11
5720452|NCT00075725|19698223|P1|Overall Study|Pt has very high risk ALL characteristic|15
5720453|NCT00075725|19698212|P12|Overall Study|MRD positive after extended ind|0
5720454|NCT00075725|19698213|P11|Overall Study|MRD positive after extended ind|0
5720455|NCT00075725|19698214|P10|Overall Study|MRD positive after extended ind|0
5720456|NCT00075725|19698215|P9|Overall Study|MRD positive after extended ind|0
5720457|NCT00075725|19698216|P8|Overall Study|MRD positive after extended ind|1
5720458|NCT00075725|19698217|P7|Overall Study|MRD positive after extended ind|0
5720459|NCT00075725|19698218|P6|Overall Study|MRD positive after extended ind|2
5720460|NCT00075725|19698219|P5|Overall Study|MRD positive after extended ind|1
5720461|NCT00075725|19698220|P4|Overall Study|MRD positive after extended ind|0
5720462|NCT00075725|19698221|P3|Overall Study|MRD positive after extended ind|1
5720463|NCT00075725|19698222|P2|Overall Study|MRD positive after extended ind|1
5720464|NCT00075725|19698223|P1|Overall Study|MRD positive after extended ind|0
5720465|NCT00075725|19698212|P12|Overall Study|Insurance issues|0
5720466|NCT00075725|19698213|P11|Overall Study|Insurance issues|0
5720467|NCT00075725|19698214|P10|Overall Study|Insurance issues|0
5720468|NCT00075725|19698215|P9|Overall Study|Insurance issues|0
5720469|NCT00075725|19698216|P8|Overall Study|Insurance issues|1
5720470|NCT00075725|19698217|P7|Overall Study|Insurance issues|0
5720471|NCT00075725|19698218|P6|Overall Study|Insurance issues|1
5720472|NCT00075725|19698219|P5|Overall Study|Insurance issues|1
5720473|NCT00075725|19698220|P4|Overall Study|Insurance issues|1
5720474|NCT00075725|19698221|P3|Overall Study|Insurance issues|0
5720475|NCT00075725|19698222|P2|Overall Study|Insurance issues|1
5720476|NCT00075725|19698223|P1|Overall Study|Insurance issues|0
5720477|NCT00075725|19698212|P12|Overall Study|Pt age out of range for treatment|0
5720478|NCT00075725|19698213|P11|Overall Study|Pt age out of range for treatment|0
5720479|NCT00075725|19698214|P10|Overall Study|Pt age out of range for treatment|0
5720480|NCT00075725|19698215|P9|Overall Study|Pt age out of range for treatment|0
5720481|NCT00075725|19698216|P8|Overall Study|Pt age out of range for treatment|1
5720482|NCT00075725|19698217|P7|Overall Study|Pt age out of range for treatment|0
5720483|NCT00075725|19698218|P6|Overall Study|Pt age out of range for treatment|1
5720484|NCT00075725|19698219|P5|Overall Study|Pt age out of range for treatment|0
5720485|NCT00075725|19698220|P4|Overall Study|Pt age out of range for treatment|0
5720486|NCT00075725|19698221|P3|Overall Study|Pt age out of range for treatment|0
5720487|NCT00075725|19698222|P2|Overall Study|Pt age out of range for treatment|1
5720488|NCT00075725|19698223|P1|Overall Study|Pt age out of range for treatment|0
5720489|NCT00075725|19698212|P12|Overall Study|Pt non compliant with therapy|0
5720490|NCT00075725|19698213|P11|Overall Study|Pt non compliant with therapy|0
5720491|NCT00075725|19698214|P10|Overall Study|Pt non compliant with therapy|0
5720492|NCT00075725|19698215|P9|Overall Study|Pt non compliant with therapy|3
5720493|NCT00075725|19698216|P8|Overall Study|Pt non compliant with therapy|5
5720494|NCT00075725|19698217|P7|Overall Study|Pt non compliant with therapy|2
5720495|NCT00075725|19698218|P6|Overall Study|Pt non compliant with therapy|14
5720496|NCT00075725|19698219|P5|Overall Study|Pt non compliant with therapy|2
5720497|NCT00075725|19698220|P4|Overall Study|Pt non compliant with therapy|0
5720498|NCT00075725|19698221|P3|Overall Study|Pt non compliant with therapy|1
5720499|NCT00075725|19698222|P2|Overall Study|Pt non compliant with therapy|1
5720500|NCT00075725|19698223|P1|Overall Study|Pt non compliant with therapy|2
5720501|NCT00075725|19698212|P12|Overall Study|Pt/Guardian refused RT therapy|0
5720502|NCT00075725|19698213|P11|Overall Study|Pt/Guardian refused RT therapy|0
5720503|NCT00075725|19698214|P10|Overall Study|Pt/Guardian refused RT therapy|0
5720504|NCT00075725|19698215|P9|Overall Study|Pt/Guardian refused RT therapy|0
5720505|NCT00075725|19698216|P8|Overall Study|Pt/Guardian refused RT therapy|0
5720506|NCT00075725|19698217|P7|Overall Study|Pt/Guardian refused RT therapy|0
5720507|NCT00075725|19698218|P6|Overall Study|Pt/Guardian refused RT therapy|0
5720508|NCT00075725|19698219|P5|Overall Study|Pt/Guardian refused RT therapy|1
5720509|NCT00075725|19698220|P4|Overall Study|Pt/Guardian refused RT therapy|2
5720510|NCT00075725|19698221|P3|Overall Study|Pt/Guardian refused RT therapy|1
5720511|NCT00075725|19698222|P2|Overall Study|Pt/Guardian refused RT therapy|0
5720512|NCT00075725|19698223|P1|Overall Study|Pt/Guardian refused RT therapy|1
5720513|NCT00075725|19698212|P12|Overall Study|Ineligible or wrong diagnosis|4
5720514|NCT00075725|19698213|P11|Overall Study|Ineligible or wrong diagnosis|2
5720515|NCT00075725|19698214|P10|Overall Study|Ineligible or wrong diagnosis|1
5720516|NCT00075725|19698215|P9|Overall Study|Ineligible or wrong diagnosis|10
5720517|NCT00075725|19698216|P8|Overall Study|Ineligible or wrong diagnosis|9
5720518|NCT00075725|19698217|P7|Overall Study|Ineligible or wrong diagnosis|6
5720519|NCT00075725|19698218|P6|Overall Study|Ineligible or wrong diagnosis|17
5720520|NCT00075725|19698219|P5|Overall Study|Ineligible or wrong diagnosis|3
5720521|NCT00075725|19698220|P4|Overall Study|Ineligible or wrong diagnosis|10
5720522|NCT00075725|19698221|P3|Overall Study|Ineligible or wrong diagnosis|3
5720523|NCT00075725|19698222|P2|Overall Study|Ineligible or wrong diagnosis|3
5720524|NCT00075725|19698223|P1|Overall Study|Ineligible or wrong diagnosis|8
5720525|NCT00075725|19698212|P12|Overall Study|Patient off treatment|0
5720526|NCT00075725|19698213|P11|Overall Study|Patient off treatment|0
5720527|NCT00075725|19698214|P10|Overall Study|Patient off treatment|0
5720528|NCT00075725|19698215|P9|Overall Study|Patient off treatment|1
5720529|NCT00075725|19698216|P8|Overall Study|Patient off treatment|2
5720530|NCT00075725|19698217|P7|Overall Study|Patient off treatment|0
5720531|NCT00075725|19698218|P6|Overall Study|Patient off treatment|0
5720532|NCT00075725|19698219|P5|Overall Study|Patient off treatment|1
5720533|NCT00075725|19698220|P4|Overall Study|Patient off treatment|2
5720534|NCT00075725|19698221|P3|Overall Study|Patient off treatment|1
5720535|NCT00075725|19698222|P2|Overall Study|Patient off treatment|0
5720536|NCT00075725|19698223|P1|Overall Study|Patient off treatment|0
5720537|NCT00075725|19698212|P12|Overall Study|Disease Progression, all other reasons|5
5720538|NCT00075725|19698213|P11|Overall Study|Disease Progression, all other reasons|0
5720539|NCT00075725|19698214|P10|Overall Study|Disease Progression, all other reasons|4
5720540|NCT00075725|19698215|P9|Overall Study|Disease Progression, all other reasons|21
5720541|NCT00075725|19698216|P8|Overall Study|Disease Progression, all other reasons|46
5720542|NCT00075725|19698217|P7|Overall Study|Disease Progression, all other reasons|20
5720543|NCT00075725|19698218|P6|Overall Study|Disease Progression, all other reasons|59
5720544|NCT00075725|19698219|P5|Overall Study|Disease Progression, all other reasons|21
5720545|NCT00075725|19698220|P4|Overall Study|Disease Progression, all other reasons|6
5720546|NCT00075725|19698221|P3|Overall Study|Disease Progression, all other reasons|33
5720547|NCT00075725|19698222|P2|Overall Study|Disease Progression, all other reasons|5
5720548|NCT00075725|19698223|P1|Overall Study|Disease Progression, all other reasons|17
5720549|NCT00075725|19698212|P12|Overall Study|Withdrawal by Subject|0
5720550|NCT00075725|19698213|P11|Overall Study|Withdrawal by Subject|0
5720551|NCT00075725|19698214|P10|Overall Study|Withdrawal by Subject|2
5720552|NCT00075725|19698215|P9|Overall Study|Withdrawal by Subject|10
5720553|NCT00075725|19698216|P8|Overall Study|Withdrawal by Subject|31
5720554|NCT00075725|19698217|P7|Overall Study|Withdrawal by Subject|7
5720555|NCT00075725|19698218|P6|Overall Study|Withdrawal by Subject|27
5720556|NCT00075725|19698219|P5|Overall Study|Withdrawal by Subject|6
5720557|NCT00075725|19698220|P4|Overall Study|Withdrawal by Subject|10
5720558|NCT00075725|19698221|P3|Overall Study|Withdrawal by Subject|6
5720559|NCT00075725|19698222|P2|Overall Study|Withdrawal by Subject|3
5720560|NCT00075725|19698223|P1|Overall Study|Withdrawal by Subject|12
5720561|NCT00075725|19698212|P12|Overall Study|Protocol Violation|1
5720562|NCT00075725|19698213|P11|Overall Study|Protocol Violation|0
5720563|NCT00075725|19698214|P10|Overall Study|Protocol Violation|0
5720564|NCT00075725|19698215|P9|Overall Study|Protocol Violation|3
5720565|NCT00075725|19698216|P8|Overall Study|Protocol Violation|2
5720566|NCT00075725|19698217|P7|Overall Study|Protocol Violation|1
5720567|NCT00075725|19698218|P6|Overall Study|Protocol Violation|2
5720568|NCT00075725|19698219|P5|Overall Study|Protocol Violation|3
5720569|NCT00075725|19698220|P4|Overall Study|Protocol Violation|3
5720570|NCT00075725|19698221|P3|Overall Study|Protocol Violation|0
5720571|NCT00075725|19698222|P2|Overall Study|Protocol Violation|1
5720572|NCT00075725|19698223|P1|Overall Study|Protocol Violation|1
5720573|NCT00075725|19698212|P12|Overall Study|Pregnancy|0
5720574|NCT00075725|19698213|P11|Overall Study|Pregnancy|0
5720575|NCT00075725|19698214|P10|Overall Study|Pregnancy|0
5720576|NCT00075725|19698215|P9|Overall Study|Pregnancy|0
5720577|NCT00075725|19698216|P8|Overall Study|Pregnancy|1
5720578|NCT00075725|19698217|P7|Overall Study|Pregnancy|0
5720579|NCT00075725|19698218|P6|Overall Study|Pregnancy|1
5720580|NCT00075725|19698219|P5|Overall Study|Pregnancy|0
5720581|NCT00075725|19698220|P4|Overall Study|Pregnancy|0
5720582|NCT00075725|19698221|P3|Overall Study|Pregnancy|0
5720583|NCT00075725|19698222|P2|Overall Study|Pregnancy|0
5720584|NCT00075725|19698223|P1|Overall Study|Pregnancy|0
5720585|NCT00075725|19698212|P12|Overall Study|Physician Decision|0
5720586|NCT00075725|19698213|P11|Overall Study|Physician Decision|1
5720587|NCT00075725|19698214|P10|Overall Study|Physician Decision|0
5720588|NCT00075725|19698215|P9|Overall Study|Physician Decision|5
5720589|NCT00075725|19698216|P8|Overall Study|Physician Decision|17
5720590|NCT00075725|19698217|P7|Overall Study|Physician Decision|3
5720591|NCT00075725|19698218|P6|Overall Study|Physician Decision|19
5720592|NCT00075725|19698219|P5|Overall Study|Physician Decision|4
5720593|NCT00075725|19698220|P4|Overall Study|Physician Decision|8
5720594|NCT00075725|19698221|P3|Overall Study|Physician Decision|5
5720595|NCT00075725|19698222|P2|Overall Study|Physician Decision|6
5720596|NCT00075725|19698223|P1|Overall Study|Physician Decision|2
5720597|NCT00075725|19698212|P12|Overall Study|Lost to Follow-up|0
5720598|NCT00075725|19698213|P11|Overall Study|Lost to Follow-up|0
5720599|NCT00075725|19698214|P10|Overall Study|Lost to Follow-up|0
5720600|NCT00075725|19698215|P9|Overall Study|Lost to Follow-up|1
5720601|NCT00075725|19698216|P8|Overall Study|Lost to Follow-up|4
5720602|NCT00075725|19698217|P7|Overall Study|Lost to Follow-up|2
5720603|NCT00075725|19698218|P6|Overall Study|Lost to Follow-up|13
5720604|NCT00075725|19698219|P5|Overall Study|Lost to Follow-up|0
5720605|NCT00075725|19698220|P4|Overall Study|Lost to Follow-up|1
5720606|NCT00075725|19698221|P3|Overall Study|Lost to Follow-up|4
5720607|NCT00075725|19698222|P2|Overall Study|Lost to Follow-up|1
5720608|NCT00075725|19698223|P1|Overall Study|Lost to Follow-up|1
5720609|NCT00075725|19698212|P12|Overall Study|Death|0
5720610|NCT00075725|19698213|P11|Overall Study|Death|3
5720611|NCT00075725|19698214|P10|Overall Study|Death|4
5720612|NCT00075725|19698215|P9|Overall Study|Death|14
5720613|NCT00075725|19698216|P8|Overall Study|Death|22
5720614|NCT00075725|19698217|P7|Overall Study|Death|4
5720615|NCT00075725|19698218|P6|Overall Study|Death|25
5720616|NCT00075725|19698219|P5|Overall Study|Death|3
5720617|NCT00075725|19698220|P4|Overall Study|Death|2
5720618|NCT00075725|19698221|P3|Overall Study|Death|10
5720619|NCT00075725|19698222|P2|Overall Study|Death|5
5720620|NCT00075725|19698223|P1|Overall Study|Death|3
5720621|NCT00075725|19698212|P12|Overall Study|Adverse Event|2
5720622|NCT00075725|19698213|P11|Overall Study|Adverse Event|2
5720623|NCT00075725|19698214|P10|Overall Study|Adverse Event|4
5720624|NCT00075725|19698215|P9|Overall Study|Adverse Event|15
5720625|NCT00075725|19698216|P8|Overall Study|Adverse Event|51
5720626|NCT00075725|19698217|P7|Overall Study|Adverse Event|3
5720627|NCT00075725|19698218|P6|Overall Study|Adverse Event|38
5720628|NCT00075725|19698219|P5|Overall Study|Adverse Event|4
5720629|NCT00075725|19698220|P4|Overall Study|Adverse Event|8
5720630|NCT00075725|19698221|P3|Overall Study|Adverse Event|20
5720631|NCT00075725|19698222|P2|Overall Study|Adverse Event|6
5720632|NCT00075725|19698223|P1|Overall Study|Adverse Event|6
5720633|NCT00075582|19698320|P2|Overall Study|Ineligible for study|16
5720634|NCT00075582|19698321|P1|Overall Study|Ineligible for study|36
5720635|NCT00075582|19698320|P2|Overall Study|Withdrawal by Subject|2
5720636|NCT00075582|19698321|P1|Overall Study|Withdrawal by Subject|2
5720637|NCT00075582|19698320|P2|Overall Study|Physician Decision|8
5720638|NCT00075582|19698321|P1|Overall Study|Physician Decision|5
5720639|NCT00075582|19698320|P2|Overall Study|Lack of Efficacy|8
5720640|NCT00075582|19698321|P1|Overall Study|Lack of Efficacy|4
5720641|NCT00075582|19698320|P2|Overall Study|Adverse Event|1
5720642|NCT00075582|19698321|P1|Overall Study|Adverse Event|3
5720643|NCT00075504|19698335|P2|Overall Study|Withdrawal by Subject|7
5720644|NCT00075504|19698336|P1|Overall Study|Withdrawal by Subject|9
5720645|NCT00075478|19698348|P2|Overall Study|Physician Decision|1
5720646|NCT00075478|19698349|P1|Overall Study|Physician Decision|0
5720647|NCT00075478|19698348|P2|Overall Study|not eligible|0
5720648|NCT00075478|19698349|P1|Overall Study|not eligible|1
5720649|NCT00075400|19698369|P1|Overall Study|Never treated|2
5720650|NCT00075400|19698369|P1|Overall Study|Ineligible: wrong primary|1
5720651|NCT00075270|19698390|P2|Overall Study|Missing|13
5720652|NCT00075270|19698391|P1|Overall Study|Missing|26
5720653|NCT00075270|19698390|P2|Overall Study|Other/Unknown|5
5720654|NCT00075270|19698391|P1|Overall Study|Other/Unknown|9
5720655|NCT00075270|19698390|P2|Overall Study|Death|215
5720656|NCT00075270|19698391|P1|Overall Study|Death|198
5720657|NCT00075270|19698390|P2|Overall Study|Protocol Violation|2
5720658|NCT00075270|19698391|P1|Overall Study|Protocol Violation|0
5720659|NCT00075270|19698390|P2|Overall Study|Lost to Follow-up|28
5720660|NCT00075270|19698391|P1|Overall Study|Lost to Follow-up|25
5720661|NCT00075270|19698390|P2|Overall Study|Withdrawal by Subject|21
5720662|NCT00075270|19698391|P1|Overall Study|Withdrawal by Subject|28
5720663|NCT00075218|19698437|P3|Open-Label Treatment|enrolled in a separate continuation|9
5720664|NCT00075218|19698438|P2|Open-Label Treatment|enrolled in a separate continuation|0
5720665|NCT00075218|19698439|P1|Open-Label Treatment|enrolled in a separate continuation|0
5720666|NCT00075218|19698437|P3|Open-Label Treatment|Protocol Violation|1
5720667|NCT00075218|19698438|P2|Open-Label Treatment|Protocol Violation|0
5720668|NCT00075218|19698439|P1|Open-Label Treatment|Protocol Violation|0
5720669|NCT00075218|19698437|P3|Open-Label Treatment|Decision of Sponsor|8
5720670|NCT00075218|19698438|P2|Open-Label Treatment|Decision of Sponsor|0
5720671|NCT00075218|19698439|P1|Open-Label Treatment|Decision of Sponsor|0
5720672|NCT00075218|19698437|P3|Open-Label Treatment|Withdrawal by Subject|12
5720673|NCT00075218|19698438|P2|Open-Label Treatment|Withdrawal by Subject|0
5720674|NCT00075218|19698439|P1|Open-Label Treatment|Withdrawal by Subject|0
5720675|NCT00075218|19698437|P3|Open-Label Treatment|Adverse Event|51
5720676|NCT00075218|19698438|P2|Open-Label Treatment|Adverse Event|0
5720677|NCT00075218|19698439|P1|Open-Label Treatment|Adverse Event|0
5720678|NCT00075218|19698437|P3|Open-Label Treatment|Lack of Efficacy|174
5720679|NCT00075218|19698438|P2|Open-Label Treatment|Lack of Efficacy|0
5720680|NCT00075218|19698439|P1|Open-Label Treatment|Lack of Efficacy|0
5720681|NCT00075218|19698437|P3|Double-Blind Treatment|No study medication taken|0
5720682|NCT00075218|19698438|P2|Double-Blind Treatment|No study medication taken|0
5720683|NCT00075218|19698439|P1|Double-Blind Treatment|No study medication taken|2
5720684|NCT00075218|19698437|P3|Double-Blind Treatment|Decision of Sponsor|0
5720685|NCT00075218|19698438|P2|Double-Blind Treatment|Decision of Sponsor|1
5720686|NCT00075218|19698439|P1|Double-Blind Treatment|Decision of Sponsor|0
5720687|NCT00075218|19698437|P3|Double-Blind Treatment|Lack of Efficacy|0
5720688|NCT00075218|19698438|P2|Double-Blind Treatment|Lack of Efficacy|6
5720689|NCT00075218|19698439|P1|Double-Blind Treatment|Lack of Efficacy|58
5720690|NCT00075218|19698437|P3|Double-Blind Treatment|Lost to Follow-up|0
5720691|NCT00075218|19698438|P2|Double-Blind Treatment|Lost to Follow-up|0
5720692|NCT00075218|19698439|P1|Double-Blind Treatment|Lost to Follow-up|1
5720693|NCT00075218|19698437|P3|Double-Blind Treatment|Withdrawal by Subject|0
5720694|NCT00075218|19698438|P2|Double-Blind Treatment|Withdrawal by Subject|4
5720695|NCT00075218|19698439|P1|Double-Blind Treatment|Withdrawal by Subject|7
5720696|NCT00075218|19698437|P3|Double-Blind Treatment|Adverse Event|0
5720697|NCT00075218|19698438|P2|Double-Blind Treatment|Adverse Event|4
5720698|NCT00075218|19698439|P1|Double-Blind Treatment|Adverse Event|23
5720699|NCT00075023|19698488|P2|Pilot Study|Withdrawal by Subject|0
5720700|NCT00075023|19698489|P1|Pilot Study|Withdrawal by Subject|1
5720701|NCT00075023|19698488|P2|Pilot Study|Physician Decision|2
5720702|NCT00075023|19698489|P1|Pilot Study|Physician Decision|1
5720703|NCT00074984|19698498|P2|Overall Study|Patient Withdrawn Per Protocol|3
5720704|NCT00074984|19698499|P1|Overall Study|Patient Withdrawn Per Protocol|0
5720705|NCT00074984|19698498|P2|Overall Study|Withdrawal by Subject|3
5720706|NCT00074984|19698499|P1|Overall Study|Withdrawal by Subject|2
5720707|NCT00074984|19698498|P2|Overall Study|Death|2
5720708|NCT00074984|19698499|P1|Overall Study|Death|1
5720709|NCT00074958|19698514|P1|Overall Study|Adverse Event|1
5720710|NCT00074711|19698555|P2|Overall Study|Participant stopped study drug|6
5720711|NCT00074711|19698556|P1|Overall Study|Participant stopped study drug|4
5720712|NCT00074711|19698555|P2|Overall Study|Lost to Follow-up|8
5720713|NCT00074711|19698556|P1|Overall Study|Lost to Follow-up|10
5720714|NCT00074711|19698555|P2|Overall Study|Withdrawal by Subject|1
5720715|NCT00074711|19698556|P1|Overall Study|Withdrawal by Subject|1
5720716|NCT00074581|19698574|P2|Overall Study|Other|19
5720717|NCT00074581|19698575|P1|Overall Study|Other|14
5720718|NCT00074581|19698574|P2|Overall Study|Ended relationship w. index participant|106
5720719|NCT00074581|19698575|P1|Overall Study|Ended relationship w. index participant|117
5720720|NCT00074581|19698574|P2|Overall Study|Lost to Follow-up|11
5720721|NCT00074581|19698575|P1|Overall Study|Lost to Follow-up|16
5720722|NCT00074581|19698574|P2|Overall Study|Were withdrawn by investigator|2
5720723|NCT00074581|19698575|P1|Overall Study|Were withdrawn by investigator|5
5720724|NCT00074581|19698574|P2|Overall Study|Relocated|9
5720725|NCT00074581|19698575|P1|Overall Study|Relocated|14
5720726|NCT00074581|19698574|P2|Overall Study|Unable to adhere to visit schedule|14
5720727|NCT00074581|19698575|P1|Overall Study|Unable to adhere to visit schedule|13
5720728|NCT00074581|19698574|P2|Overall Study|Withdrawal by Subject|49
5720729|NCT00074581|19698575|P1|Overall Study|Withdrawal by Subject|50
5720730|NCT00074581|19698574|P2|Overall Study|Death|16
5720731|NCT00074581|19698575|P1|Overall Study|Death|15
5720732|NCT00074490|19698588|P6|Overall Study|Progressive malignancy|0
5720733|NCT00074490|19698589|P5|Overall Study|Progressive malignancy|3
5720734|NCT00074490|19698590|P4|Overall Study|Progressive malignancy|0
5720735|NCT00074490|19698591|P3|Overall Study|Progressive malignancy|0
5720736|NCT00074490|19698592|P2|Overall Study|Progressive malignancy|7
5720737|NCT00074490|19698593|P1|Overall Study|Progressive malignancy|0
5720738|NCT00074412|19698627|P2|Overall Study|Lost to Follow-up|58
5720739|NCT00074412|19698628|P1|Overall Study|Lost to Follow-up|52
5720740|NCT00074412|19698627|P2|Overall Study|Death|26
5720741|NCT00074412|19698628|P1|Overall Study|Death|30
5720742|NCT00074282|19698659|P3|Step 2|Ineligible|1
5720743|NCT00074282|19698660|P2|Step 2|Ineligible|0
5720744|NCT00074282|19698661|P1|Step 2|Ineligible|0
5720745|NCT00074282|19698659|P3|Step 2|Physician Decision|1
5720746|NCT00074282|19698660|P2|Step 2|Physician Decision|0
5720747|NCT00074282|19698661|P1|Step 2|Physician Decision|0
5720748|NCT00074282|19698659|P3|Step 2|Withdrawal by Subject|2
5720749|NCT00074282|19698660|P2|Step 2|Withdrawal by Subject|0
5720750|NCT00074282|19698661|P1|Step 2|Withdrawal by Subject|0
5720751|NCT00074282|19698659|P3|Step 2|Death|3
5720752|NCT00074282|19698660|P2|Step 2|Death|0
5720753|NCT00074282|19698661|P1|Step 2|Death|0
5720754|NCT00074282|19698659|P3|Step 2|Disease progression|5
5720755|NCT00074282|19698660|P2|Step 2|Disease progression|0
5720756|NCT00074282|19698661|P1|Step 2|Disease progression|0
5720757|NCT00074282|19698659|P3|Step 2|Adverse Event|12
5720758|NCT00074282|19698660|P2|Step 2|Adverse Event|2
5720759|NCT00074282|19698661|P1|Step 2|Adverse Event|0
5720760|NCT00074282|19698659|P3|Step 1|Never started treatment|0
5720761|NCT00074282|19698660|P2|Step 1|Never started treatment|0
5720762|NCT00074282|19698661|P1|Step 1|Never started treatment|2
5720763|NCT00074282|19698659|P3|Step 1|Ineligible|0
5720764|NCT00074282|19698660|P2|Step 1|Ineligible|0
5720765|NCT00074282|19698661|P1|Step 1|Ineligible|4
5720766|NCT00074282|19698659|P3|Step 1|Physician Decision|0
5720767|NCT00074282|19698660|P2|Step 1|Physician Decision|0
5720768|NCT00074282|19698661|P1|Step 1|Physician Decision|1
5720769|NCT00074282|19698659|P3|Step 1|Other complicating disease|0
5720770|NCT00074282|19698660|P2|Step 1|Other complicating disease|0
5720771|NCT00074282|19698661|P1|Step 1|Other complicating disease|2
5720772|NCT00074282|19698659|P3|Step 1|Alternative therapy|0
5720773|NCT00074282|19698660|P2|Step 1|Alternative therapy|0
5720774|NCT00074282|19698661|P1|Step 1|Alternative therapy|2
5720775|NCT00074282|19698659|P3|Step 1|Disease progression|0
5720776|NCT00074282|19698660|P2|Step 1|Disease progression|0
5720777|NCT00074282|19698661|P1|Step 1|Disease progression|2
5720778|NCT00074282|19698659|P3|Step 1|Withdrawal by Subject|0
5720779|NCT00074282|19698660|P2|Step 1|Withdrawal by Subject|0
5720780|NCT00074282|19698661|P1|Step 1|Withdrawal by Subject|7
5720781|NCT00074282|19698659|P3|Step 1|Death|0
5720782|NCT00074282|19698660|P2|Step 1|Death|0
5720783|NCT00074282|19698661|P1|Step 1|Death|6
5720784|NCT00074282|19698659|P3|Step 1|Adverse Event|0
5720785|NCT00074282|19698660|P2|Step 1|Adverse Event|0
5720786|NCT00074282|19698661|P1|Step 1|Adverse Event|32
5720787|NCT00074152|19698688|P2|Overall Study|Lack of Efficacy|24
5720788|NCT00074152|19698689|P1|Overall Study|Lack of Efficacy|34
5720789|NCT00074152|19698688|P2|Overall Study|Death|9
5720790|NCT00074152|19698689|P1|Overall Study|Death|21
5720791|NCT00073983|19698706|P1|Overall Study|not evaluable|1
5720792|NCT00073918|19698727|P1|Overall Study|Eligibility requirement not met-low CD20|1
5720793|NCT00073918|19698727|P1|Overall Study|Rapid disease progression|2
5720794|NCT00073918|19698727|P1|Overall Study|Eligibility requirement not met - HAMA+|1
5720795|NCT00073749|19698741|P7|Overall Study|Other|0
5720796|NCT00073749|19698742|P6|Overall Study|Other|2
5720797|NCT00073749|19698743|P5|Overall Study|Other|0
5720798|NCT00073749|19698744|P4|Overall Study|Other|0
5720799|NCT00073749|19698745|P3|Overall Study|Other|0
5720800|NCT00073749|19698746|P2|Overall Study|Other|0
5720801|NCT00073749|19698747|P1|Overall Study|Other|0
5720802|NCT00073749|19698741|P7|Overall Study|Lost to Follow-up|2
5720803|NCT00073749|19698742|P6|Overall Study|Lost to Follow-up|0
5720804|NCT00073749|19698743|P5|Overall Study|Lost to Follow-up|0
5720805|NCT00073749|19698744|P4|Overall Study|Lost to Follow-up|0
5720806|NCT00073749|19698745|P3|Overall Study|Lost to Follow-up|0
5720807|NCT00073749|19698746|P2|Overall Study|Lost to Follow-up|0
5720808|NCT00073749|19698747|P1|Overall Study|Lost to Follow-up|0
5720809|NCT00073749|19698741|P7|Overall Study|Discontinuation of Study by Sponsor|4
5720810|NCT00073749|19698742|P6|Overall Study|Discontinuation of Study by Sponsor|0
5720811|NCT00073749|19698743|P5|Overall Study|Discontinuation of Study by Sponsor|0
5720812|NCT00073749|19698744|P4|Overall Study|Discontinuation of Study by Sponsor|0
5720813|NCT00073749|19698745|P3|Overall Study|Discontinuation of Study by Sponsor|0
5720814|NCT00073749|19698746|P2|Overall Study|Discontinuation of Study by Sponsor|0
5720815|NCT00073749|19698747|P1|Overall Study|Discontinuation of Study by Sponsor|0
5720816|NCT00073749|19698741|P7|Overall Study|Withdrawal by Subject|2
5720817|NCT00073749|19698742|P6|Overall Study|Withdrawal by Subject|0
5720818|NCT00073749|19698743|P5|Overall Study|Withdrawal by Subject|1
5720819|NCT00073749|19698744|P4|Overall Study|Withdrawal by Subject|0
5720820|NCT00073749|19698745|P3|Overall Study|Withdrawal by Subject|0
5720821|NCT00073749|19698746|P2|Overall Study|Withdrawal by Subject|1
5720822|NCT00073749|19698747|P1|Overall Study|Withdrawal by Subject|0
5720823|NCT00073749|19698741|P7|Overall Study|Physician Decision|0
5720824|NCT00073749|19698742|P6|Overall Study|Physician Decision|2
5720825|NCT00073749|19698743|P5|Overall Study|Physician Decision|0
5720826|NCT00073749|19698744|P4|Overall Study|Physician Decision|0
5720827|NCT00073749|19698745|P3|Overall Study|Physician Decision|1
5720828|NCT00073749|19698746|P2|Overall Study|Physician Decision|0
5720829|NCT00073749|19698747|P1|Overall Study|Physician Decision|0
5720830|NCT00073749|19698741|P7|Overall Study|Adverse Event|0
5720831|NCT00073749|19698742|P6|Overall Study|Adverse Event|1
5720832|NCT00073749|19698743|P5|Overall Study|Adverse Event|2
5720833|NCT00073749|19698744|P4|Overall Study|Adverse Event|4
5720834|NCT00073749|19698745|P3|Overall Study|Adverse Event|6
5720835|NCT00073749|19698746|P2|Overall Study|Adverse Event|3
5720836|NCT00073749|19698747|P1|Overall Study|Adverse Event|0
5720837|NCT00073749|19698741|P7|Overall Study|Death|29
5720838|NCT00073749|19698742|P6|Overall Study|Death|0
5720839|NCT00073749|19698743|P5|Overall Study|Death|0
5720840|NCT00073749|19698744|P4|Overall Study|Death|0
5720841|NCT00073749|19698745|P3|Overall Study|Death|1
5720842|NCT00073749|19698746|P2|Overall Study|Death|1
5720843|NCT00073749|19698747|P1|Overall Study|Death|0
5720844|NCT00073749|19698741|P7|Overall Study|Disease Progression|3
5720845|NCT00073749|19698742|P6|Overall Study|Disease Progression|1
5720846|NCT00073749|19698743|P5|Overall Study|Disease Progression|3
5720847|NCT00073749|19698744|P4|Overall Study|Disease Progression|2
5720848|NCT00073749|19698745|P3|Overall Study|Disease Progression|3
5720849|NCT00073749|19698746|P2|Overall Study|Disease Progression|0
5720850|NCT00073749|19698747|P1|Overall Study|Disease Progression|2
5720851|NCT00073528|19698778|P2|Overall Study|Ongoing|344
5720852|NCT00073528|19698779|P1|Overall Study|Ongoing|349
5720853|NCT00073528|19698778|P2|Overall Study|Non-compliance|1
5720854|NCT00073528|19698779|P1|Overall Study|Non-compliance|0
5720855|NCT00073528|19698778|P2|Overall Study|Enrolled in Error|1
5720856|NCT00073528|19698779|P1|Overall Study|Enrolled in Error|0
5720857|NCT00073528|19698778|P2|Overall Study|Participant Was Unblinded|1
5720858|NCT00073528|19698779|P1|Overall Study|Participant Was Unblinded|0
5720859|NCT00073528|19698778|P2|Overall Study|Progressive Disease|1
5720860|NCT00073528|19698779|P1|Overall Study|Progressive Disease|0
5720861|NCT00073528|19698778|P2|Overall Study|Randomized in Error; Not Treated|0
5720862|NCT00073528|19698779|P1|Overall Study|Randomized in Error; Not Treated|2
5720863|NCT00073528|19698778|P2|Overall Study|Mastectomy Intervention|0
5720864|NCT00073528|19698779|P1|Overall Study|Mastectomy Intervention|1
5720865|NCT00073528|19698778|P2|Overall Study|Death|238
5720866|NCT00073528|19698779|P1|Overall Study|Death|229
5720867|NCT00073528|19698778|P2|Overall Study|Protocol Violation|5
5720868|NCT00073528|19698779|P1|Overall Study|Protocol Violation|3
5720869|NCT00073528|19698778|P2|Overall Study|Lost to Follow-up|22
5720870|NCT00073528|19698779|P1|Overall Study|Lost to Follow-up|26
5720871|NCT00073528|19698778|P2|Overall Study|Withdrawal by Subject|29
5720872|NCT00073528|19698779|P1|Overall Study|Withdrawal by Subject|34
5720873|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
5720874|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
5720875|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
5720876|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
5720877|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
5720878|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
5720879|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
5720880|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
5720881|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
5720882|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
5720883|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
5720884|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
5720885|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
5720886|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
5720887|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
5720888|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
5720889|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
5720890|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
5720891|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
5720892|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
5720893|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
5720894|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
5720895|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
5720896|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
5720897|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
5720898|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
5720899|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
5720900|NCT00073307|19698868|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
5720901|NCT00073307|19698869|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
5720902|NCT00073307|19698870|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
5720903|NCT00073307|19698868|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
5720904|NCT00073307|19698869|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
5720905|NCT00073307|19698870|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
5720906|NCT00073307|19698868|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
5720907|NCT00073307|19698869|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
5720908|NCT00073307|19698870|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
5720909|NCT00073307|19698868|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
5720910|NCT00073307|19698869|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
5720911|NCT00073307|19698870|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
5720912|NCT00073307|19698868|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
5720913|NCT00073307|19698869|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
5720914|NCT00073307|19698870|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
5720915|NCT00073307|19698868|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
5720916|NCT00073307|19698869|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
5720917|NCT00073307|19698870|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
5720918|NCT00073307|19698868|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
5720919|NCT00073307|19698869|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
5720920|NCT00073307|19698870|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
5720921|NCT00073307|19698868|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
5720922|NCT00073307|19698869|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
5720923|NCT00073307|19698870|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
5720924|NCT00073307|19698868|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
5720925|NCT00073307|19698869|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
5720926|NCT00073307|19698870|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
5720927|NCT00073307|19698868|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
5720928|NCT00073307|19698869|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
5720929|NCT00073307|19698870|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
5720930|NCT00073021|19698901|P2|Overall Study|Lack of Efficacy|5
5720931|NCT00073021|19698902|P1|Overall Study|Lack of Efficacy|11
5720932|NCT00073021|19698901|P2|Overall Study|Physician Decision|1
5720933|NCT00073021|19698902|P1|Overall Study|Physician Decision|3
5720934|NCT00073021|19698901|P2|Overall Study|Withdrawal by Subject|5
5720935|NCT00073021|19698902|P1|Overall Study|Withdrawal by Subject|6
5720936|NCT00073021|19698901|P2|Overall Study|Adverse Event|4
5720937|NCT00073021|19698902|P1|Overall Study|Adverse Event|4
5720938|NCT00073021|19698901|P2|Overall Study|Protocol Violation|1
5720939|NCT00073021|19698902|P1|Overall Study|Protocol Violation|2
5720940|NCT00073008|19698932|P2|Overall Study|"Other selected on Case Report Form"|5
5720941|NCT00073008|19698933|P1|Overall Study|"Other selected on Case Report Form"|7
5720942|NCT00073008|19698932|P2|Overall Study|Death|47
5720943|NCT00073008|19698933|P1|Overall Study|Death|46
5720944|NCT00073008|19698932|P2|Overall Study|Lost to Follow-up|3
5720945|NCT00073008|19698933|P1|Overall Study|Lost to Follow-up|1
5720946|NCT00073008|19698932|P2|Overall Study|Withdrawal by Subject|2
5720947|NCT00073008|19698933|P1|Overall Study|Withdrawal by Subject|2
5720948|NCT00073008|19698932|P2|Overall Study|Missing|6
5720949|NCT00073008|19698933|P1|Overall Study|Missing|6
5720950|NCT00072475|19698972|P1|Overall Study|Patient/Investigator Decision|4
5720951|NCT00072475|19698972|P1|Overall Study|Withdrawal by Subject|46
5720952|NCT00072475|19698972|P1|Overall Study|Death|3
5720953|NCT00072475|19698972|P1|Overall Study|Adverse Event|44
5720954|NCT00072384|19698987|P1|Overall Study|Ineligible|8
5720955|NCT00072384|19698987|P1|Overall Study|Physician Decision|1
5720956|NCT00072293|19699000|P2|Overall Study|Withdrawal by Subject|1
5720957|NCT00072293|19699001|P1|Overall Study|Withdrawal by Subject|0
5720958|NCT00072293|19699000|P2|Overall Study|Lost to Follow-up|1
5720959|NCT00072293|19699001|P1|Overall Study|Lost to Follow-up|1
5720960|NCT00072280|19699013|P2|Follow-up|Early termination of study|2
5720961|NCT00072280|19699014|P1|Follow-up|Early termination of study|2
5720962|NCT00072280|19699013|P2|Treatment|Found ineligible|2
5720963|NCT00072280|19699014|P1|Treatment|Found ineligible|1
5720964|NCT00072189|19699019|P1|Overall Study|Withdrawal by Subject|1
5720965|NCT00072176|19699027|P2|Overall Study|Protocol Violation|1
5720966|NCT00072176|19699028|P1|Overall Study|Protocol Violation|0
5720967|NCT00072176|19699027|P2|Overall Study|Withdrawal by Subject|0
5720968|NCT00072176|19699028|P1|Overall Study|Withdrawal by Subject|1
5720969|NCT00071981|19699040|P4|Overall Study|others (not specified in the study)|0
5720970|NCT00071981|19699041|P3|Overall Study|others (not specified in the study)|2
5720971|NCT00071981|19699042|P2|Overall Study|others (not specified in the study)|2
5720972|NCT00071981|19699043|P1|Overall Study|others (not specified in the study)|0
5720973|NCT00071981|19699040|P4|Overall Study|No protocol therapy|0
5720974|NCT00071981|19699041|P3|Overall Study|No protocol therapy|1
5720975|NCT00071981|19699042|P2|Overall Study|No protocol therapy|5
5720976|NCT00071981|19699043|P1|Overall Study|No protocol therapy|2
5720977|NCT00071981|19699040|P4|Overall Study|Withdrawal by Subject|0
5720978|NCT00071981|19699041|P3|Overall Study|Withdrawal by Subject|0
5720979|NCT00071981|19699042|P2|Overall Study|Withdrawal by Subject|1
5720980|NCT00071981|19699043|P1|Overall Study|Withdrawal by Subject|3
5720981|NCT00071981|19699040|P4|Overall Study|Death|1
5720982|NCT00071981|19699041|P3|Overall Study|Death|1
5720983|NCT00071981|19699042|P2|Overall Study|Death|0
5720984|NCT00071981|19699043|P1|Overall Study|Death|0
5720985|NCT00071981|19699040|P4|Overall Study|Adverse Event|1
5720986|NCT00071981|19699041|P3|Overall Study|Adverse Event|3
5720987|NCT00071981|19699042|P2|Overall Study|Adverse Event|4
5720988|NCT00071981|19699043|P1|Overall Study|Adverse Event|4
5720989|NCT00071981|19699040|P4|Overall Study|Lack of Efficacy|43
5720990|NCT00071981|19699041|P3|Overall Study|Lack of Efficacy|30
5720991|NCT00071981|19699042|P2|Overall Study|Lack of Efficacy|29
5720992|NCT00071981|19699043|P1|Overall Study|Lack of Efficacy|37
5720993|NCT00071812|19699086|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
5720994|NCT00071812|19699087|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
5720995|NCT00071812|19699088|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
5720996|NCT00071812|19699089|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
5720997|NCT00071812|19699086|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
5720998|NCT00071812|19699087|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5720999|NCT00071812|19699088|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5721000|NCT00071812|19699089|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5721001|NCT00071812|19699086|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
5721002|NCT00071812|19699087|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
5721003|NCT00071812|19699088|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
5721004|NCT00071812|19699089|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
5721005|NCT00071812|19699086|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
5721006|NCT00071812|19699087|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
5721007|NCT00071812|19699088|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
5721008|NCT00071812|19699089|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
5721009|NCT00071812|19699086|P4|24-Week Open-Label Extension Period|Adverse Event|7
5721010|NCT00071812|19699087|P3|24-Week Open-Label Extension Period|Adverse Event|0
5721011|NCT00071812|19699088|P2|24-Week Open-Label Extension Period|Adverse Event|0
5721012|NCT00071812|19699089|P1|24-Week Open-Label Extension Period|Adverse Event|0
5721013|NCT00071812|19699086|P4|24-Week Double-Blind Period|Protocol Violation|1
5721014|NCT00071812|19699087|P3|24-Week Double-Blind Period|Protocol Violation|0
5721015|NCT00071812|19699088|P2|24-Week Double-Blind Period|Protocol Violation|0
5721016|NCT00071812|19699089|P1|24-Week Double-Blind Period|Protocol Violation|0
5721017|NCT00071812|19699086|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
5721018|NCT00071812|19699087|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
5721019|NCT00071812|19699088|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
5721020|NCT00071812|19699089|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
5721021|NCT00071812|19699086|P4|24-Week Double-Blind Period|Lost to Follow-up|0
5721022|NCT00071812|19699087|P3|24-Week Double-Blind Period|Lost to Follow-up|1
5721023|NCT00071812|19699088|P2|24-Week Double-Blind Period|Lost to Follow-up|1
5721024|NCT00071812|19699089|P1|24-Week Double-Blind Period|Lost to Follow-up|0
5721025|NCT00071812|19699086|P4|24-Week Double-Blind Period|Lack of Efficacy|1
5721026|NCT00071812|19699087|P3|24-Week Double-Blind Period|Lack of Efficacy|2
5721027|NCT00071812|19699088|P2|24-Week Double-Blind Period|Lack of Efficacy|1
5721028|NCT00071812|19699089|P1|24-Week Double-Blind Period|Lack of Efficacy|3
5721029|NCT00071812|19699086|P4|24-Week Double-Blind Period|Adverse Event|4
5721030|NCT00071812|19699087|P3|24-Week Double-Blind Period|Adverse Event|4
5721031|NCT00071812|19699088|P2|24-Week Double-Blind Period|Adverse Event|3
5721032|NCT00071812|19699089|P1|24-Week Double-Blind Period|Adverse Event|2
5721033|NCT00071799|19699131|P2|Overall Study|Not Documented|2
5721034|NCT00071799|19699132|P1|Overall Study|Not Documented|0
5721035|NCT00071799|19699131|P2|Overall Study|Different Central+Local Pathology Review|1
5721036|NCT00071799|19699132|P1|Overall Study|Different Central+Local Pathology Review|0
5721037|NCT00071799|19699131|P2|Overall Study|Disease Progression|20
5721038|NCT00071799|19699132|P1|Overall Study|Disease Progression|23
5721039|NCT00071799|19699131|P2|Overall Study|Lack of Efficacy|18
5721040|NCT00071799|19699132|P1|Overall Study|Lack of Efficacy|11
5721041|NCT00071799|19699131|P2|Overall Study|Physician Decision|2
5721042|NCT00071799|19699132|P1|Overall Study|Physician Decision|0
5721043|NCT00071799|19699131|P2|Overall Study|Withdrawal by Subject|37
5721044|NCT00071799|19699132|P1|Overall Study|Withdrawal by Subject|15
5721045|NCT00071799|19699131|P2|Overall Study|Lost to Follow-up|1
5721046|NCT00071799|19699132|P1|Overall Study|Lost to Follow-up|1
5721047|NCT00071799|19699131|P2|Overall Study|Protocol Violation|7
5721048|NCT00071799|19699132|P1|Overall Study|Protocol Violation|1
5721049|NCT00071799|19699131|P2|Overall Study|Adverse Event|10
5721050|NCT00071799|19699132|P1|Overall Study|Adverse Event|19
5721051|NCT00071760|19699185|P1|Overall Study|Ongoing|25
5721052|NCT00071760|19699185|P1|Overall Study|Study Team Rec./Resistance|1
5721053|NCT00071760|19699185|P1|Overall Study|Investigator's Recommendation (Rec.)|4
5721054|NCT00071760|19699185|P1|Overall Study|Relocation|1
5721055|NCT00071760|19699185|P1|Overall Study|Unavailability of RTV|8
5721056|NCT00071760|19699185|P1|Overall Study|Pulmonary Tuberculosis|1
5721057|NCT00071760|19699185|P1|Overall Study|Insufficient Viral Load Response|3
5721058|NCT00071760|19699185|P1|Overall Study|Withdrawal by Subject|3
5721059|NCT00071760|19699185|P1|Overall Study|Protocol Violation|1
5721060|NCT00071760|19699185|P1|Overall Study|Lost to Follow-up|4
5721061|NCT00071760|19699185|P1|Overall Study|Adverse Event|3
5721062|NCT00071513|19699265|P2|Follow-up Assessment|Withdrawal by Subject|6
5721063|NCT00071513|19699266|P1|Follow-up Assessment|Withdrawal by Subject|6
5721064|NCT00071513|19699265|P2|Intervention Component|Withdrawal by Subject|3
5721065|NCT00071513|19699266|P1|Intervention Component|Withdrawal by Subject|2
5721066|NCT00071487|19699278|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
5721067|NCT00071487|19699279|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
5721068|NCT00071487|19699280|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
5721069|NCT00071487|19699281|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
5721070|NCT00071487|19699278|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
5721071|NCT00071487|19699279|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
5721072|NCT00071487|19699280|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
5721073|NCT00071487|19699281|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
5721074|NCT00071487|19699278|P4|24-Week Open-Label Extension Period|Pregnancy|1
5721075|NCT00071487|19699279|P3|24-Week Open-Label Extension Period|Pregnancy|0
5721076|NCT00071487|19699280|P2|24-Week Open-Label Extension Period|Pregnancy|0
5721077|NCT00071487|19699281|P1|24-Week Open-Label Extension Period|Pregnancy|0
5721078|NCT00071487|19699278|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
5721079|NCT00071487|19699279|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5721080|NCT00071487|19699280|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5721081|NCT00071487|19699281|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
5721082|NCT00071487|19699278|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
5721083|NCT00071487|19699279|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
5721084|NCT00071487|19699280|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
5721085|NCT00071487|19699281|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
5721086|NCT00071487|19699278|P4|24-Week Open-Label Extension Period|Adverse Event|6
5721087|NCT00071487|19699279|P3|24-Week Open-Label Extension Period|Adverse Event|1
5721088|NCT00071487|19699280|P2|24-Week Open-Label Extension Period|Adverse Event|0
5721089|NCT00071487|19699281|P1|24-Week Open-Label Extension Period|Adverse Event|0
5721090|NCT00071487|19699278|P4|52-Week Double-Blind Period|Lack of Compliance|3
5721091|NCT00071487|19699279|P3|52-Week Double-Blind Period|Lack of Compliance|3
5721092|NCT00071487|19699280|P2|52-Week Double-Blind Period|Lack of Compliance|3
5721093|NCT00071487|19699281|P1|52-Week Double-Blind Period|Lack of Compliance|6
5721094|NCT00071487|19699278|P4|52-Week Double-Blind Period|Death|0
5721095|NCT00071487|19699279|P3|52-Week Double-Blind Period|Death|0
5721096|NCT00071487|19699280|P2|52-Week Double-Blind Period|Death|1
5721097|NCT00071487|19699281|P1|52-Week Double-Blind Period|Death|0
5721098|NCT00071487|19699278|P4|52-Week Double-Blind Period|Protocol Violation|0
5721099|NCT00071487|19699279|P3|52-Week Double-Blind Period|Protocol Violation|1
5721100|NCT00071487|19699280|P2|52-Week Double-Blind Period|Protocol Violation|1
5721101|NCT00071487|19699281|P1|52-Week Double-Blind Period|Protocol Violation|0
5721102|NCT00071487|19699278|P4|52-Week Double-Blind Period|Pregnancy|0
5721103|NCT00071487|19699279|P3|52-Week Double-Blind Period|Pregnancy|0
5721104|NCT00071487|19699280|P2|52-Week Double-Blind Period|Pregnancy|1
5721105|NCT00071487|19699281|P1|52-Week Double-Blind Period|Pregnancy|0
5721106|NCT00071487|19699278|P4|52-Week Double-Blind Period|Lost to Follow-up|2
5721107|NCT00071487|19699279|P3|52-Week Double-Blind Period|Lost to Follow-up|2
5721108|NCT00071487|19699280|P2|52-Week Double-Blind Period|Lost to Follow-up|0
5721109|NCT00071487|19699281|P1|52-Week Double-Blind Period|Lost to Follow-up|0
5721110|NCT00071487|19699278|P4|52-Week Double-Blind Period|Physician Decision|0
5721111|NCT00071487|19699279|P3|52-Week Double-Blind Period|Physician Decision|0
5721112|NCT00071487|19699280|P2|52-Week Double-Blind Period|Physician Decision|0
5721113|NCT00071487|19699281|P1|52-Week Double-Blind Period|Physician Decision|1
5721114|NCT00071487|19699278|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
5721115|NCT00071487|19699279|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
5721116|NCT00071487|19699280|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
5721117|NCT00071487|19699281|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
5721118|NCT00071487|19699278|P4|52-Week Double-Blind Period|Lack of Efficacy|1
5721119|NCT00071487|19699279|P3|52-Week Double-Blind Period|Lack of Efficacy|0
5721120|NCT00071487|19699280|P2|52-Week Double-Blind Period|Lack of Efficacy|2
5721121|NCT00071487|19699281|P1|52-Week Double-Blind Period|Lack of Efficacy|1
5721122|NCT00071487|19699278|P4|52-Week Double-Blind Period|Adverse Event|8
5721123|NCT00071487|19699279|P3|52-Week Double-Blind Period|Adverse Event|4
5721124|NCT00071487|19699280|P2|52-Week Double-Blind Period|Adverse Event|8
5721125|NCT00071487|19699281|P1|52-Week Double-Blind Period|Adverse Event|5
5721126|NCT00071396|19699325|P1|Overall Study|Physician Decision|2
5721127|NCT00071396|19699325|P1|Overall Study|Withdrawal by Subject|1
5721128|NCT00071110|19699331|P2|Overall Study|Protocol Violation|4
5721129|NCT00071110|19699332|P1|Overall Study|Protocol Violation|0
5721130|NCT00071032|19699346|P2|Overall Study|Missing Primary Outcome|1
5721131|NCT00071032|19699347|P1|Overall Study|Missing Primary Outcome|0
5721132|NCT00071032|19699346|P2|Overall Study|Withdrawal by Subject|6
5721133|NCT00071032|19699347|P1|Overall Study|Withdrawal by Subject|8
5721134|NCT00071032|19699346|P2|Overall Study|Lost to Follow-up|1
5721135|NCT00071032|19699347|P1|Overall Study|Lost to Follow-up|1
5721136|NCT00071006|19699383|P1|Overall Study|Other|3
5721137|NCT00071006|19699383|P1|Overall Study|Withdrawal by Subject|1
5721138|NCT00071006|19699383|P1|Overall Study|Adverse Event|1
5721139|NCT00071006|19699383|P1|Overall Study|Lack of Efficacy|7
5721140|NCT00070941|19699396|P3|Overall Study|Adverse Event|4
5721141|NCT00070941|19699397|P2|Overall Study|Adverse Event|8
5721142|NCT00070941|19699398|P1|Overall Study|Adverse Event|10
5721143|NCT00071058|19699406|P1|Overall Study|brain tumor-removed from study|1
5721144|NCT00070707|19699413|P2|Overall Study|Unrelated to Study Medication|0
5721145|NCT00070707|19699414|P1|Overall Study|Unrelated to Study Medication|1
5721146|NCT00070707|19699413|P2|Overall Study|Protocol Violation|4
5721147|NCT00070707|19699414|P1|Overall Study|Protocol Violation|8
5721148|NCT00070707|19699413|P2|Overall Study|Lack of Efficacy|1
5721149|NCT00070707|19699414|P1|Overall Study|Lack of Efficacy|4
5721150|NCT00070707|19699413|P2|Overall Study|Adverse Event|2
5721151|NCT00070707|19699414|P1|Overall Study|Adverse Event|1
5721152|NCT00003907|19699462|P2|Overall Study|ineligible or not treated|2
5721153|NCT00003907|19699463|P1|Overall Study|ineligible or not treated|2
5721154|NCT00003907|19699462|P2|Overall Study|Other|3
5721155|NCT00003907|19699463|P1|Overall Study|Other|1
5721156|NCT00003907|19699462|P2|Overall Study|Complicating disease|0
5721157|NCT00003907|19699463|P1|Overall Study|Complicating disease|1
5721158|NCT00003907|19699462|P2|Overall Study|Progressive disease|4
5721159|NCT00003907|19699463|P1|Overall Study|Progressive disease|4
5721160|NCT00003907|19699462|P2|Overall Study|Withdrawal by Subject|3
5721161|NCT00003907|19699463|P1|Overall Study|Withdrawal by Subject|1
5721162|NCT00003907|19699462|P2|Overall Study|Death|0
5721163|NCT00003907|19699463|P1|Overall Study|Death|2
5721164|NCT00003907|19699462|P2|Overall Study|Adverse Event|11
5721165|NCT00003907|19699463|P1|Overall Study|Adverse Event|2
5721166|NCT00070564|19699479|P6|Overall Study|Not reported|0
5721167|NCT00070564|19699480|P5|Overall Study|Not reported|1
5721168|NCT00070564|19699481|P4|Overall Study|Not reported|0
5721169|NCT00070564|19699482|P3|Overall Study|Not reported|0
5721170|NCT00070564|19699483|P2|Overall Study|Not reported|0
5721171|NCT00070564|19699484|P1|Overall Study|Not reported|0
5721172|NCT00070564|19699479|P6|Overall Study|Withdrawal by Subject|8
5721173|NCT00070564|19699480|P5|Overall Study|Withdrawal by Subject|8
5721174|NCT00070564|19699481|P4|Overall Study|Withdrawal by Subject|30
5721175|NCT00070564|19699482|P3|Overall Study|Withdrawal by Subject|23
5721176|NCT00070564|19699483|P2|Overall Study|Withdrawal by Subject|37
5721177|NCT00070564|19699484|P1|Overall Study|Withdrawal by Subject|26
5721178|NCT00070564|19699479|P6|Overall Study|Other, not protocol specified|7
5721179|NCT00070564|19699480|P5|Overall Study|Other, not protocol specified|6
5721180|NCT00070564|19699481|P4|Overall Study|Other, not protocol specified|19
5721181|NCT00070564|19699482|P3|Overall Study|Other, not protocol specified|14
5721182|NCT00070564|19699483|P2|Overall Study|Other, not protocol specified|15
5721183|NCT00070564|19699484|P1|Overall Study|Other, not protocol specified|17
5721184|NCT00070564|19699479|P6|Overall Study|Death|1
5721185|NCT00070564|19699480|P5|Overall Study|Death|0
5721186|NCT00070564|19699481|P4|Overall Study|Death|3
5721187|NCT00070564|19699482|P3|Overall Study|Death|5
5721188|NCT00070564|19699483|P2|Overall Study|Death|1
5721189|NCT00070564|19699484|P1|Overall Study|Death|4
5721190|NCT00070564|19699479|P6|Overall Study|Adverse Event|36
5721191|NCT00070564|19699480|P5|Overall Study|Adverse Event|63
5721192|NCT00070564|19699481|P4|Overall Study|Adverse Event|108
5721193|NCT00070564|19699482|P3|Overall Study|Adverse Event|120
5721194|NCT00070564|19699483|P2|Overall Study|Adverse Event|142
5721195|NCT00070564|19699484|P1|Overall Study|Adverse Event|150
5721196|NCT00070564|19699479|P6|Overall Study|Delinquent|0
5721197|NCT00070564|19699480|P5|Overall Study|Delinquent|0
5721198|NCT00070564|19699481|P4|Overall Study|Delinquent|0
5721199|NCT00070564|19699482|P3|Overall Study|Delinquent|2
5721200|NCT00070564|19699483|P2|Overall Study|Delinquent|4
5721201|NCT00070564|19699484|P1|Overall Study|Delinquent|1
5721202|NCT00070564|19699479|P6|Overall Study|Progression|0
5721203|NCT00070564|19699480|P5|Overall Study|Progression|1
5721204|NCT00070564|19699481|P4|Overall Study|Progression|7
5721205|NCT00070564|19699482|P3|Overall Study|Progression|7
5721206|NCT00070564|19699483|P2|Overall Study|Progression|4
5721207|NCT00070564|19699484|P1|Overall Study|Progression|2
5721208|NCT00070499|19699538|P4|Overall Study|Not eligible|2
5721209|NCT00070499|19699539|P3|Overall Study|Not eligible|3
5721210|NCT00070499|19699540|P2|Overall Study|Not eligible|5
5721211|NCT00070499|19699541|P1|Overall Study|Not eligible|2
5721212|NCT00070499|19699538|P4|Overall Study|Did not start treatment|2
5721213|NCT00070499|19699539|P3|Overall Study|Did not start treatment|0
5721214|NCT00070499|19699540|P2|Overall Study|Did not start treatment|0
5721215|NCT00070499|19699541|P1|Overall Study|Did not start treatment|1
5721216|NCT00070499|19699538|P4|Overall Study|Still on protocol treatment|57
5721217|NCT00070499|19699539|P3|Overall Study|Still on protocol treatment|79
5721218|NCT00070499|19699540|P2|Overall Study|Still on protocol treatment|4
5721219|NCT00070499|19699541|P1|Overall Study|Still on protocol treatment|10
5721220|NCT00070499|19699538|P4|Overall Study|Other - not protocol specified|20
5721221|NCT00070499|19699539|P3|Overall Study|Other - not protocol specified|12
5721222|NCT00070499|19699540|P2|Overall Study|Other - not protocol specified|3
5721223|NCT00070499|19699541|P1|Overall Study|Other - not protocol specified|7
5721224|NCT00070499|19699538|P4|Overall Study|Death|2
5721225|NCT00070499|19699539|P3|Overall Study|Death|1
5721226|NCT00070499|19699540|P2|Overall Study|Death|1
5721227|NCT00070499|19699541|P1|Overall Study|Death|1
5721228|NCT00070499|19699538|P4|Overall Study|Progression/relapse|4
5721229|NCT00070499|19699539|P3|Overall Study|Progression/relapse|1
5721230|NCT00070499|19699540|P2|Overall Study|Progression/relapse|2
5721231|NCT00070499|19699541|P1|Overall Study|Progression/relapse|4
5721232|NCT00070499|19699538|P4|Overall Study|Refusal unrelated to adverse effects|8
5721233|NCT00070499|19699539|P3|Overall Study|Refusal unrelated to adverse effects|5
5721234|NCT00070499|19699540|P2|Overall Study|Refusal unrelated to adverse effects|5
5721235|NCT00070499|19699541|P1|Overall Study|Refusal unrelated to adverse effects|7
5721236|NCT00070499|19699538|P4|Overall Study|Adverse Event|15
5721237|NCT00070499|19699539|P3|Overall Study|Adverse Event|19
5721238|NCT00070499|19699540|P2|Overall Study|Adverse Event|6
5721239|NCT00070499|19699541|P1|Overall Study|Adverse Event|6
5721240|NCT00070317|19699567|P1|Overall Study|Ineligible-Inadequate pathology|6
5721241|NCT00070317|19699567|P1|Overall Study|Ineligible-Improper prior treatment|2
5721242|NCT00070317|19699567|P1|Overall Study|Ineligible required test not done|1
5721243|NCT00070317|19699567|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
5721244|NCT00070317|19699567|P1|Overall Study|Inevaluable (Never Treated)|1
5721245|NCT00070291|19699572|P1|Step 2|Adverse Event|1
5721246|NCT00070291|19699572|P1|Step 1|Adverse Event|1
5721247|NCT00070291|19699572|P1|Step 1|Withdrawal by Subject|1
5721248|NCT00070109|19699588|P5|Overall Study|removed from prot thpy prior to chemo|0
5721249|NCT00070109|19699589|P4|Overall Study|removed from prot thpy prior to chemo|1
5721250|NCT00070109|19699590|P3|Overall Study|removed from prot thpy prior to chemo|0
5721251|NCT00070109|19699591|P2|Overall Study|removed from prot thpy prior to chemo|0
5721252|NCT00070109|19699592|P1|Overall Study|removed from prot thpy prior to chemo|0
5721253|NCT00070109|19699588|P5|Overall Study|Adverse Event|2
5721254|NCT00070109|19699589|P4|Overall Study|Adverse Event|4
5721255|NCT00070109|19699590|P3|Overall Study|Adverse Event|2
5721256|NCT00070109|19699591|P2|Overall Study|Adverse Event|0
5721257|NCT00070109|19699592|P1|Overall Study|Adverse Event|0
5721258|NCT00070109|19699588|P5|Overall Study|Withdrawal by Subject|0
5721259|NCT00070109|19699589|P4|Overall Study|Withdrawal by Subject|0
5721260|NCT00070109|19699590|P3|Overall Study|Withdrawal by Subject|1
5721261|NCT00070109|19699591|P2|Overall Study|Withdrawal by Subject|1
5721262|NCT00070109|19699592|P1|Overall Study|Withdrawal by Subject|0
5721263|NCT00070109|19699588|P5|Overall Study|Physician Decision|0
5721264|NCT00070109|19699589|P4|Overall Study|Physician Decision|0
5721265|NCT00070109|19699590|P3|Overall Study|Physician Decision|0
5721266|NCT00070109|19699591|P2|Overall Study|Physician Decision|0
5721267|NCT00070109|19699592|P1|Overall Study|Physician Decision|1
5721268|NCT00070109|19699588|P5|Overall Study|Lack of Efficacy|5
5721269|NCT00070109|19699589|P4|Overall Study|Lack of Efficacy|15
5721270|NCT00070109|19699590|P3|Overall Study|Lack of Efficacy|5
5721271|NCT00070109|19699591|P2|Overall Study|Lack of Efficacy|4
5721272|NCT00070109|19699592|P1|Overall Study|Lack of Efficacy|6
5721273|NCT00070109|19699588|P5|Overall Study|Death|1
5721274|NCT00070109|19699589|P4|Overall Study|Death|0
5721275|NCT00070109|19699590|P3|Overall Study|Death|0
5721276|NCT00070109|19699591|P2|Overall Study|Death|1
5721277|NCT00070109|19699592|P1|Overall Study|Death|1
5721278|NCT00070018|19699620|P1|Overall Study|Withdrawal by Subject|1
5721279|NCT00070018|19699620|P1|Overall Study|Lack of Efficacy|1
5721280|NCT00070018|19699620|P1|Overall Study|Adverse Event|2
5721281|NCT00069953|19699624|P1|Overall Study|Protocol Violation|2
5721282|NCT00069784|19699630|P2|Overall Study|Other|0
5721283|NCT00069784|19699631|P1|Overall Study|Other|17
5721284|NCT00069784|19699630|P2|Overall Study|Withdrawal by Subject|0
5721285|NCT00069784|19699631|P1|Overall Study|Withdrawal by Subject|1090
5721286|NCT00069784|19699630|P2|Overall Study|Adverse Event|0
5721287|NCT00069784|19699631|P1|Overall Study|Adverse Event|105
5721288|NCT00069823|19699651|P2|Overall Study|Did not have follow-up diary cards|3
5721289|NCT00069823|19699652|P1|Overall Study|Did not have follow-up diary cards|6
5721290|NCT00069641|19699695|P3|Overall Study|Death|1
5721291|NCT00069641|19699696|P2|Overall Study|Death|0
5721292|NCT00069641|19699697|P1|Overall Study|Death|1
5721293|NCT00069576|19699724|P2|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
5721294|NCT00069576|19699725|P1|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
5721295|NCT00069576|19699724|P2|Original Trial|Lost to Follow-up|33
5721296|NCT00069576|19699725|P1|Original Trial|Lost to Follow-up|25
5721297|NCT00069277|19699775|P1|Overall Study|Physician Decision|2
5721298|NCT00069277|19699775|P1|Overall Study|Progressive Disease|15
5721299|NCT00069277|19699775|P1|Overall Study|Withdrawal by Subject|1
5721300|NCT00069277|19699775|P1|Overall Study|Adverse Event|3
5721301|NCT00069264|19699779|P1|Overall Study|Discon Therapy|3
5721302|NCT00069264|19699779|P1|Overall Study|Withdrawal by Subject|3
5721303|NCT00069264|19699779|P1|Overall Study|Progressive Disease|23
5721304|NCT00069264|19699779|P1|Overall Study|Adverse Event|3
5721305|NCT00069238|19699807|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
5721306|NCT00069238|19699808|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
5721307|NCT00069238|19699809|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
5721308|NCT00069238|19699807|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
5721309|NCT00069238|19699808|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
5721310|NCT00069238|19699809|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
5721311|NCT00069238|19699807|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
5721312|NCT00069238|19699808|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
5721313|NCT00069238|19699809|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
5721314|NCT00069121|19699817|P2|Overall Study|Lost to Follow-up|63
5721315|NCT00069121|19699818|P1|Overall Study|Lost to Follow-up|63
5721316|NCT00069121|19699817|P2|Overall Study|Withdrawal by Subject|20
5721317|NCT00069121|19699818|P1|Overall Study|Withdrawal by Subject|18
5721318|NCT00069121|19699817|P2|Overall Study|Death|242
5721319|NCT00069121|19699818|P1|Overall Study|Death|286
5721320|NCT00069108|19699840|P2|Overall Study|Refused treatment|10
5721321|NCT00069108|19699841|P1|Overall Study|Refused treatment|5
5721322|NCT00069108|19699840|P2|Overall Study|Violation criteria|4
5721323|NCT00069108|19699841|P1|Overall Study|Violation criteria|1
5721324|NCT00069108|19699840|P2|Overall Study|Insufficient therapy|144
5721325|NCT00069108|19699841|P1|Overall Study|Insufficient therapy|117
5721326|NCT00069108|19699840|P2|Overall Study|Administration|4
5721327|NCT00069108|19699841|P1|Overall Study|Administration|15
5721328|NCT00069108|19699840|P2|Overall Study|Death|6
5721329|NCT00069108|19699841|P1|Overall Study|Death|6
5721330|NCT00069108|19699840|P2|Overall Study|Adverse Event|42
5721331|NCT00069108|19699841|P1|Overall Study|Adverse Event|64
5721332|NCT00069108|19699840|P2|Overall Study|Withdrawal by Subject|9
5721333|NCT00069108|19699841|P1|Overall Study|Withdrawal by Subject|5
5721334|NCT00069095|19699873|P6|Follow-up Phase|Death|101
5721335|NCT00069095|19699874|P5|Follow-up Phase|Death|92
5721336|NCT00069095|19699875|P4|Follow-up Phase|Death|112
5721337|NCT00069095|19699876|P3|Follow-up Phase|Death|120
5721338|NCT00069095|19699877|P2|Follow-up Phase|Death|206
5721339|NCT00069095|19699878|P1|Follow-up Phase|Death|174
5721340|NCT00069095|19699873|P6|Post-study Treatment Phase|Investigator decision|1
5721341|NCT00069095|19699874|P5|Post-study Treatment Phase|Investigator decision|0
5721342|NCT00069095|19699875|P4|Post-study Treatment Phase|Investigator decision|0
5721343|NCT00069095|19699876|P3|Post-study Treatment Phase|Investigator decision|0
5721344|NCT00069095|19699877|P2|Post-study Treatment Phase|Investigator decision|0
5721345|NCT00069095|19699878|P1|Post-study Treatment Phase|Investigator decision|0
5721346|NCT00069095|19699873|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5721347|NCT00069095|19699874|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
5721348|NCT00069095|19699875|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5721349|NCT00069095|19699876|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5721350|NCT00069095|19699877|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5721351|NCT00069095|19699878|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
5721352|NCT00069095|19699873|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
5721353|NCT00069095|19699874|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
5721354|NCT00069095|19699875|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
5721355|NCT00069095|19699876|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
5721356|NCT00069095|19699877|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
5721357|NCT00069095|19699878|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
5721358|NCT00069095|19699873|P6|Post-study Treatment Phase|Participant had progressive disease|0
5721359|NCT00069095|19699874|P5|Post-study Treatment Phase|Participant had progressive disease|1
5721360|NCT00069095|19699875|P4|Post-study Treatment Phase|Participant had progressive disease|0
5721361|NCT00069095|19699876|P3|Post-study Treatment Phase|Participant had progressive disease|0
5721362|NCT00069095|19699877|P2|Post-study Treatment Phase|Participant had progressive disease|0
5721363|NCT00069095|19699878|P1|Post-study Treatment Phase|Participant had progressive disease|0
5721364|NCT00069095|19699873|P6|Post-study Treatment Phase|Death|0
5721365|NCT00069095|19699874|P5|Post-study Treatment Phase|Death|1
5721366|NCT00069095|19699875|P4|Post-study Treatment Phase|Death|0
5721367|NCT00069095|19699876|P3|Post-study Treatment Phase|Death|0
5721368|NCT00069095|19699877|P2|Post-study Treatment Phase|Death|0
5721369|NCT00069095|19699878|P1|Post-study Treatment Phase|Death|0
5721370|NCT00069095|19699873|P6|Post-study Treatment Phase|Surgery|0
5721371|NCT00069095|19699874|P5|Post-study Treatment Phase|Surgery|1
5721372|NCT00069095|19699875|P4|Post-study Treatment Phase|Surgery|1
5721373|NCT00069095|19699876|P3|Post-study Treatment Phase|Surgery|0
5721374|NCT00069095|19699877|P2|Post-study Treatment Phase|Surgery|0
5721375|NCT00069095|19699878|P1|Post-study Treatment Phase|Surgery|0
5721376|NCT00069095|19699873|P6|Post-study Treatment Phase|Participant completed treatment|0
5721377|NCT00069095|19699874|P5|Post-study Treatment Phase|Participant completed treatment|0
5721378|NCT00069095|19699875|P4|Post-study Treatment Phase|Participant completed treatment|1
5721379|NCT00069095|19699876|P3|Post-study Treatment Phase|Participant completed treatment|0
5721380|NCT00069095|19699877|P2|Post-study Treatment Phase|Participant completed treatment|0
5721381|NCT00069095|19699878|P1|Post-study Treatment Phase|Participant completed treatment|0
5721382|NCT00069095|19699873|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
5721383|NCT00069095|19699874|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
5721384|NCT00069095|19699875|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
5721385|NCT00069095|19699876|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
5721386|NCT00069095|19699877|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
5721387|NCT00069095|19699878|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
5721388|NCT00069095|19699873|P6|Post-study Treatment Phase|Participant will start new treatment|0
5721389|NCT00069095|19699874|P5|Post-study Treatment Phase|Participant will start new treatment|0
5721390|NCT00069095|19699875|P4|Post-study Treatment Phase|Participant will start new treatment|0
5721391|NCT00069095|19699876|P3|Post-study Treatment Phase|Participant will start new treatment|1
5721392|NCT00069095|19699877|P2|Post-study Treatment Phase|Participant will start new treatment|0
5721393|NCT00069095|19699878|P1|Post-study Treatment Phase|Participant will start new treatment|0
5721394|NCT00069095|19699873|P6|Post-study Treatment Phase|Participant withdrew consent|0
5721395|NCT00069095|19699874|P5|Post-study Treatment Phase|Participant withdrew consent|0
5721396|NCT00069095|19699875|P4|Post-study Treatment Phase|Participant withdrew consent|0
5721397|NCT00069095|19699876|P3|Post-study Treatment Phase|Participant withdrew consent|1
5721398|NCT00069095|19699877|P2|Post-study Treatment Phase|Participant withdrew consent|0
5721399|NCT00069095|19699878|P1|Post-study Treatment Phase|Participant withdrew consent|0
5721400|NCT00069095|19699873|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
5721401|NCT00069095|19699874|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
5721402|NCT00069095|19699875|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
5721403|NCT00069095|19699876|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
5721404|NCT00069095|19699877|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
5721405|NCT00069095|19699878|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
5721406|NCT00069095|19699873|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
5721407|NCT00069095|19699874|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
5721408|NCT00069095|19699875|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
5721409|NCT00069095|19699876|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
5721410|NCT00069095|19699877|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
5721411|NCT00069095|19699878|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
5721412|NCT00069095|19699873|P6|Post-study Treatment Phase|Participant had complete response|0
5721413|NCT00069095|19699874|P5|Post-study Treatment Phase|Participant had complete response|0
5721414|NCT00069095|19699875|P4|Post-study Treatment Phase|Participant had complete response|0
5721415|NCT00069095|19699876|P3|Post-study Treatment Phase|Participant had complete response|0
5721416|NCT00069095|19699877|P2|Post-study Treatment Phase|Participant had complete response|1
5721417|NCT00069095|19699878|P1|Post-study Treatment Phase|Participant had complete response|1
5721418|NCT00069095|19699873|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
5721419|NCT00069095|19699874|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
5721420|NCT00069095|19699875|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
5721421|NCT00069095|19699876|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
5721422|NCT00069095|19699877|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
5721423|NCT00069095|19699878|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
5721424|NCT00069095|19699873|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
5721425|NCT00069095|19699874|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
5721426|NCT00069095|19699875|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
5721427|NCT00069095|19699876|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
5721428|NCT00069095|19699877|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
5721429|NCT00069095|19699878|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
5721430|NCT00069095|19699873|P6|Post-study Treatment Phase|Eligible for surgery|0
5721431|NCT00069095|19699874|P5|Post-study Treatment Phase|Eligible for surgery|0
5721432|NCT00069095|19699875|P4|Post-study Treatment Phase|Eligible for surgery|0
5721433|NCT00069095|19699876|P3|Post-study Treatment Phase|Eligible for surgery|0
5721434|NCT00069095|19699877|P2|Post-study Treatment Phase|Eligible for surgery|0
5721435|NCT00069095|19699878|P1|Post-study Treatment Phase|Eligible for surgery|2
5721436|NCT00069095|19699873|P6|Post-study Treatment Phase|Adverse Event|1
5721437|NCT00069095|19699874|P5|Post-study Treatment Phase|Adverse Event|5
5721438|NCT00069095|19699875|P4|Post-study Treatment Phase|Adverse Event|0
5721439|NCT00069095|19699876|P3|Post-study Treatment Phase|Adverse Event|1
5721440|NCT00069095|19699877|P2|Post-study Treatment Phase|Adverse Event|3
5721441|NCT00069095|19699878|P1|Post-study Treatment Phase|Adverse Event|2
5721442|NCT00069095|19699873|P6|Post-study Treatment Phase|Missing reason|17
5721443|NCT00069095|19699874|P5|Post-study Treatment Phase|Missing reason|18
5721444|NCT00069095|19699875|P4|Post-study Treatment Phase|Missing reason|8
5721445|NCT00069095|19699876|P3|Post-study Treatment Phase|Missing reason|12
5721446|NCT00069095|19699877|P2|Post-study Treatment Phase|Missing reason|3
5721447|NCT00069095|19699878|P1|Post-study Treatment Phase|Missing reason|1
5721448|NCT00069095|19699873|P6|Primary Treatment Phase|Violation criteria|5
5721449|NCT00069095|19699874|P5|Primary Treatment Phase|Violation criteria|1
5721450|NCT00069095|19699875|P4|Primary Treatment Phase|Violation criteria|3
5721451|NCT00069095|19699876|P3|Primary Treatment Phase|Violation criteria|4
5721452|NCT00069095|19699877|P2|Primary Treatment Phase|Violation criteria|2
5721453|NCT00069095|19699878|P1|Primary Treatment Phase|Violation criteria|0
5721454|NCT00069095|19699873|P6|Primary Treatment Phase|Other Violation|1
5721455|NCT00069095|19699874|P5|Primary Treatment Phase|Other Violation|0
5721456|NCT00069095|19699875|P4|Primary Treatment Phase|Other Violation|1
5721457|NCT00069095|19699876|P3|Primary Treatment Phase|Other Violation|1
5721458|NCT00069095|19699877|P2|Primary Treatment Phase|Other Violation|1
5721459|NCT00069095|19699878|P1|Primary Treatment Phase|Other Violation|0
5721460|NCT00069095|19699873|P6|Primary Treatment Phase|Withdrew|9
5721461|NCT00069095|19699874|P5|Primary Treatment Phase|Withdrew|4
5721462|NCT00069095|19699875|P4|Primary Treatment Phase|Withdrew|2
5721463|NCT00069095|19699876|P3|Primary Treatment Phase|Withdrew|8
5721464|NCT00069095|19699877|P2|Primary Treatment Phase|Withdrew|3
5721465|NCT00069095|19699878|P1|Primary Treatment Phase|Withdrew|2
5721466|NCT00069095|19699873|P6|Primary Treatment Phase|Refused treatment|27
5721467|NCT00069095|19699874|P5|Primary Treatment Phase|Refused treatment|24
5721468|NCT00069095|19699875|P4|Primary Treatment Phase|Refused treatment|31
5721469|NCT00069095|19699876|P3|Primary Treatment Phase|Refused treatment|17
5721470|NCT00069095|19699877|P2|Primary Treatment Phase|Refused treatment|26
5721471|NCT00069095|19699878|P1|Primary Treatment Phase|Refused treatment|15
5721472|NCT00069095|19699873|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
5721473|NCT00069095|19699874|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
5721474|NCT00069095|19699875|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
5721475|NCT00069095|19699876|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
5721476|NCT00069095|19699877|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
5721477|NCT00069095|19699878|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
5721478|NCT00069095|19699873|P6|Primary Treatment Phase|Failure to return|2
5721479|NCT00069095|19699874|P5|Primary Treatment Phase|Failure to return|0
5721480|NCT00069095|19699875|P4|Primary Treatment Phase|Failure to return|0
5721481|NCT00069095|19699876|P3|Primary Treatment Phase|Failure to return|0
5721482|NCT00069095|19699877|P2|Primary Treatment Phase|Failure to return|5
5721483|NCT00069095|19699878|P1|Primary Treatment Phase|Failure to return|5
5721484|NCT00069095|19699873|P6|Primary Treatment Phase|Death|8
5721485|NCT00069095|19699874|P5|Primary Treatment Phase|Death|8
5721486|NCT00069095|19699875|P4|Primary Treatment Phase|Death|5
5721487|NCT00069095|19699876|P3|Primary Treatment Phase|Death|2
5721488|NCT00069095|19699877|P2|Primary Treatment Phase|Death|8
5721489|NCT00069095|19699878|P1|Primary Treatment Phase|Death|14
5721490|NCT00069095|19699873|P6|Primary Treatment Phase|Adverse Event|101
5721491|NCT00069095|19699874|P5|Primary Treatment Phase|Adverse Event|109
5721492|NCT00069095|19699875|P4|Primary Treatment Phase|Adverse Event|72
5721493|NCT00069095|19699876|P3|Primary Treatment Phase|Adverse Event|71
5721494|NCT00069095|19699877|P2|Primary Treatment Phase|Adverse Event|92
5721495|NCT00069095|19699878|P1|Primary Treatment Phase|Adverse Event|99
5721496|NCT00069095|19699873|P6|Primary Treatment Phase|Admin/Other|42
5721497|NCT00069095|19699874|P5|Primary Treatment Phase|Admin/Other|48
5721498|NCT00069095|19699875|P4|Primary Treatment Phase|Admin/Other|45
5721499|NCT00069095|19699876|P3|Primary Treatment Phase|Admin/Other|31
5721500|NCT00069095|19699877|P2|Primary Treatment Phase|Admin/Other|38
5721501|NCT00069095|19699878|P1|Primary Treatment Phase|Admin/Other|29
5721502|NCT00069095|19699873|P6|Primary Treatment Phase|Ongoing|4
5721503|NCT00069095|19699874|P5|Primary Treatment Phase|Ongoing|7
5721504|NCT00069095|19699875|P4|Primary Treatment Phase|Ongoing|7
5721505|NCT00069095|19699876|P3|Primary Treatment Phase|Ongoing|5
5721506|NCT00069095|19699877|P2|Primary Treatment Phase|Ongoing|0
5721507|NCT00069095|19699878|P1|Primary Treatment Phase|Ongoing|0
5721508|NCT00068822|19699948|P2|First Randomized Intervention|Lost to Follow-up|2
5721509|NCT00068822|19699949|P1|First Randomized Intervention|Lost to Follow-up|1
5721510|NCT00068692|19699983|P8|Step 2: Randomization|never start protocol therapy|0
5721511|NCT00068692|19699984|P7|Step 2: Randomization|never start protocol therapy|0
5721512|NCT00068692|19699985|P6|Step 2: Randomization|never start protocol therapy|0
5721513|NCT00068692|19699986|P5|Step 2: Randomization|never start protocol therapy|1
5721514|NCT00068692|19699987|P4|Step 2: Randomization|never start protocol therapy|0
5721515|NCT00068692|19699988|P3|Step 2: Randomization|never start protocol therapy|1
5721516|NCT00068692|19699989|P2|Step 2: Randomization|never start protocol therapy|0
5721517|NCT00068692|19699990|P1|Step 2: Randomization|never start protocol therapy|0
5721518|NCT00068692|19699983|P8|Step 2: Randomization|Other|0
5721519|NCT00068692|19699984|P7|Step 2: Randomization|Other|0
5721520|NCT00068692|19699985|P6|Step 2: Randomization|Other|1
5721521|NCT00068692|19699986|P5|Step 2: Randomization|Other|0
5721522|NCT00068692|19699987|P4|Step 2: Randomization|Other|1
5721523|NCT00068692|19699988|P3|Step 2: Randomization|Other|0
5721524|NCT00068692|19699989|P2|Step 2: Randomization|Other|0
5721525|NCT00068692|19699990|P1|Step 2: Randomization|Other|0
5721526|NCT00068692|19699983|P8|Step 2: Randomization|Physician Decision|0
5721527|NCT00068692|19699984|P7|Step 2: Randomization|Physician Decision|0
5721528|NCT00068692|19699985|P6|Step 2: Randomization|Physician Decision|0
5721529|NCT00068692|19699986|P5|Step 2: Randomization|Physician Decision|1
5721530|NCT00068692|19699987|P4|Step 2: Randomization|Physician Decision|1
5721531|NCT00068692|19699988|P3|Step 2: Randomization|Physician Decision|0
5721532|NCT00068692|19699989|P2|Step 2: Randomization|Physician Decision|0
5721533|NCT00068692|19699990|P1|Step 2: Randomization|Physician Decision|0
5721534|NCT00068692|19699983|P8|Step 2: Randomization|alternative therapy|0
5721535|NCT00068692|19699984|P7|Step 2: Randomization|alternative therapy|0
5721536|NCT00068692|19699985|P6|Step 2: Randomization|alternative therapy|0
5721537|NCT00068692|19699986|P5|Step 2: Randomization|alternative therapy|1
5721538|NCT00068692|19699987|P4|Step 2: Randomization|alternative therapy|1
5721539|NCT00068692|19699988|P3|Step 2: Randomization|alternative therapy|0
5721540|NCT00068692|19699989|P2|Step 2: Randomization|alternative therapy|0
5721541|NCT00068692|19699990|P1|Step 2: Randomization|alternative therapy|0
5721542|NCT00068692|19699983|P8|Step 2: Randomization|Withdrawal by Subject|3
5721543|NCT00068692|19699984|P7|Step 2: Randomization|Withdrawal by Subject|0
5721544|NCT00068692|19699985|P6|Step 2: Randomization|Withdrawal by Subject|2
5721545|NCT00068692|19699986|P5|Step 2: Randomization|Withdrawal by Subject|3
5721546|NCT00068692|19699987|P4|Step 2: Randomization|Withdrawal by Subject|6
5721547|NCT00068692|19699988|P3|Step 2: Randomization|Withdrawal by Subject|4
5721548|NCT00068692|19699989|P2|Step 2: Randomization|Withdrawal by Subject|0
5721549|NCT00068692|19699990|P1|Step 2: Randomization|Withdrawal by Subject|0
5721550|NCT00068692|19699983|P8|Step 2: Randomization|Death|1
5721551|NCT00068692|19699984|P7|Step 2: Randomization|Death|0
5721552|NCT00068692|19699985|P6|Step 2: Randomization|Death|0
5721553|NCT00068692|19699986|P5|Step 2: Randomization|Death|1
5721554|NCT00068692|19699987|P4|Step 2: Randomization|Death|0
5721555|NCT00068692|19699988|P3|Step 2: Randomization|Death|0
5721556|NCT00068692|19699989|P2|Step 2: Randomization|Death|0
5721557|NCT00068692|19699990|P1|Step 2: Randomization|Death|0
5721558|NCT00068692|19699983|P8|Step 2: Randomization|Adverse Event|4
5721559|NCT00068692|19699984|P7|Step 2: Randomization|Adverse Event|4
5721560|NCT00068692|19699985|P6|Step 2: Randomization|Adverse Event|3
5721561|NCT00068692|19699986|P5|Step 2: Randomization|Adverse Event|2
5721562|NCT00068692|19699987|P4|Step 2: Randomization|Adverse Event|2
5721563|NCT00068692|19699988|P3|Step 2: Randomization|Adverse Event|4
5721564|NCT00068692|19699989|P2|Step 2: Randomization|Adverse Event|0
5721565|NCT00068692|19699990|P1|Step 2: Randomization|Adverse Event|0
5721566|NCT00068692|19699983|P8|Step 2: Randomization|Disesae progression/replase|0
5721567|NCT00068692|19699984|P7|Step 2: Randomization|Disesae progression/replase|0
5721568|NCT00068692|19699985|P6|Step 2: Randomization|Disesae progression/replase|0
5721569|NCT00068692|19699986|P5|Step 2: Randomization|Disesae progression/replase|0
5721570|NCT00068692|19699987|P4|Step 2: Randomization|Disesae progression/replase|1
5721571|NCT00068692|19699988|P3|Step 2: Randomization|Disesae progression/replase|1
5721572|NCT00068692|19699989|P2|Step 2: Randomization|Disesae progression/replase|0
5721573|NCT00068692|19699990|P1|Step 2: Randomization|Disesae progression/replase|0
5721574|NCT00068692|19699983|P8|Step 1: Registration|Registered but not randomized|0
5721575|NCT00068692|19699984|P7|Step 1: Registration|Registered but not randomized|0
5721576|NCT00068692|19699985|P6|Step 1: Registration|Registered but not randomized|0
5721577|NCT00068692|19699986|P5|Step 1: Registration|Registered but not randomized|0
5721578|NCT00068692|19699987|P4|Step 1: Registration|Registered but not randomized|0
5721579|NCT00068692|19699988|P3|Step 1: Registration|Registered but not randomized|0
5721580|NCT00068692|19699989|P2|Step 1: Registration|Registered but not randomized|1
5721581|NCT00068692|19699990|P1|Step 1: Registration|Registered but not randomized|0
5721582|NCT00068692|19699983|P8|Step 1: Registration|Not start protocol therapy|0
5721583|NCT00068692|19699984|P7|Step 1: Registration|Not start protocol therapy|0
5721584|NCT00068692|19699985|P6|Step 1: Registration|Not start protocol therapy|0
5721585|NCT00068692|19699986|P5|Step 1: Registration|Not start protocol therapy|0
5721586|NCT00068692|19699987|P4|Step 1: Registration|Not start protocol therapy|0
5721587|NCT00068692|19699988|P3|Step 1: Registration|Not start protocol therapy|0
5721588|NCT00068692|19699989|P2|Step 1: Registration|Not start protocol therapy|0
5721589|NCT00068692|19699990|P1|Step 1: Registration|Not start protocol therapy|3
5721590|NCT00068692|19699983|P8|Step 1: Registration|Other|0
5721591|NCT00068692|19699984|P7|Step 1: Registration|Other|0
5721592|NCT00068692|19699985|P6|Step 1: Registration|Other|0
5721593|NCT00068692|19699986|P5|Step 1: Registration|Other|0
5721594|NCT00068692|19699987|P4|Step 1: Registration|Other|0
5721595|NCT00068692|19699988|P3|Step 1: Registration|Other|0
5721596|NCT00068692|19699989|P2|Step 1: Registration|Other|0
5721597|NCT00068692|19699990|P1|Step 1: Registration|Other|2
5721598|NCT00068692|19699983|P8|Step 1: Registration|Not eligible|0
5721599|NCT00068692|19699984|P7|Step 1: Registration|Not eligible|0
5721600|NCT00068692|19699985|P6|Step 1: Registration|Not eligible|0
5721601|NCT00068692|19699986|P5|Step 1: Registration|Not eligible|0
5721602|NCT00068692|19699987|P4|Step 1: Registration|Not eligible|0
5721603|NCT00068692|19699988|P3|Step 1: Registration|Not eligible|0
5721604|NCT00068692|19699989|P2|Step 1: Registration|Not eligible|0
5721605|NCT00068692|19699990|P1|Step 1: Registration|Not eligible|6
5721606|NCT00068692|19699983|P8|Step 1: Registration|Protocol Violation|0
5721607|NCT00068692|19699984|P7|Step 1: Registration|Protocol Violation|0
5721608|NCT00068692|19699985|P6|Step 1: Registration|Protocol Violation|0
5721609|NCT00068692|19699986|P5|Step 1: Registration|Protocol Violation|0
5721610|NCT00068692|19699987|P4|Step 1: Registration|Protocol Violation|0
5721611|NCT00068692|19699988|P3|Step 1: Registration|Protocol Violation|0
5721612|NCT00068692|19699989|P2|Step 1: Registration|Protocol Violation|0
5721613|NCT00068692|19699990|P1|Step 1: Registration|Protocol Violation|1
5721614|NCT00068692|19699983|P8|Step 1: Registration|Complicating disease|0
5721615|NCT00068692|19699984|P7|Step 1: Registration|Complicating disease|0
5721616|NCT00068692|19699985|P6|Step 1: Registration|Complicating disease|0
5721617|NCT00068692|19699986|P5|Step 1: Registration|Complicating disease|0
5721618|NCT00068692|19699987|P4|Step 1: Registration|Complicating disease|0
5721619|NCT00068692|19699988|P3|Step 1: Registration|Complicating disease|0
5721620|NCT00068692|19699989|P2|Step 1: Registration|Complicating disease|0
5721621|NCT00068692|19699990|P1|Step 1: Registration|Complicating disease|2
5721622|NCT00068692|19699983|P8|Step 1: Registration|Alternative therapy|0
5721623|NCT00068692|19699984|P7|Step 1: Registration|Alternative therapy|0
5721624|NCT00068692|19699985|P6|Step 1: Registration|Alternative therapy|0
5721625|NCT00068692|19699986|P5|Step 1: Registration|Alternative therapy|0
5721626|NCT00068692|19699987|P4|Step 1: Registration|Alternative therapy|0
5721627|NCT00068692|19699988|P3|Step 1: Registration|Alternative therapy|0
5721628|NCT00068692|19699989|P2|Step 1: Registration|Alternative therapy|0
5721629|NCT00068692|19699990|P1|Step 1: Registration|Alternative therapy|2
5721630|NCT00068692|19699983|P8|Step 1: Registration|Withdrawal by Subject|0
5721631|NCT00068692|19699984|P7|Step 1: Registration|Withdrawal by Subject|0
5721632|NCT00068692|19699985|P6|Step 1: Registration|Withdrawal by Subject|0
5721633|NCT00068692|19699986|P5|Step 1: Registration|Withdrawal by Subject|0
5721634|NCT00068692|19699987|P4|Step 1: Registration|Withdrawal by Subject|0
5721635|NCT00068692|19699988|P3|Step 1: Registration|Withdrawal by Subject|0
5721636|NCT00068692|19699989|P2|Step 1: Registration|Withdrawal by Subject|0
5721637|NCT00068692|19699990|P1|Step 1: Registration|Withdrawal by Subject|11
5721638|NCT00068692|19699983|P8|Step 1: Registration|Death|0
5721639|NCT00068692|19699984|P7|Step 1: Registration|Death|0
5721640|NCT00068692|19699985|P6|Step 1: Registration|Death|0
5721641|NCT00068692|19699986|P5|Step 1: Registration|Death|0
5721642|NCT00068692|19699987|P4|Step 1: Registration|Death|0
5721643|NCT00068692|19699988|P3|Step 1: Registration|Death|0
5721644|NCT00068692|19699989|P2|Step 1: Registration|Death|0
5721645|NCT00068692|19699990|P1|Step 1: Registration|Death|1
5721646|NCT00068692|19699983|P8|Step 1: Registration|Adverse Event|0
5721647|NCT00068692|19699984|P7|Step 1: Registration|Adverse Event|0
5721648|NCT00068692|19699985|P6|Step 1: Registration|Adverse Event|0
5721649|NCT00068692|19699986|P5|Step 1: Registration|Adverse Event|0
5721650|NCT00068692|19699987|P4|Step 1: Registration|Adverse Event|0
5721651|NCT00068692|19699988|P3|Step 1: Registration|Adverse Event|0
5721652|NCT00068692|19699989|P2|Step 1: Registration|Adverse Event|0
5721653|NCT00068692|19699990|P1|Step 1: Registration|Adverse Event|7
5721654|NCT00068692|19699983|P8|Step 1: Registration|Disese progression/relapse|0
5721655|NCT00068692|19699984|P7|Step 1: Registration|Disese progression/relapse|0
5721656|NCT00068692|19699985|P6|Step 1: Registration|Disese progression/relapse|0
5721657|NCT00068692|19699986|P5|Step 1: Registration|Disese progression/relapse|0
5721658|NCT00068692|19699987|P4|Step 1: Registration|Disese progression/relapse|0
5721659|NCT00068692|19699988|P3|Step 1: Registration|Disese progression/relapse|0
5721660|NCT00068692|19699989|P2|Step 1: Registration|Disese progression/relapse|0
5721661|NCT00068692|19699990|P1|Step 1: Registration|Disese progression/relapse|5
5721662|NCT00068601|19700013|P2|Overall Study|Missing primary outcome data|34
5721663|NCT00068601|19700014|P1|Overall Study|Missing primary outcome data|30
5721664|NCT00068601|19700013|P2|Overall Study|Lost to Follow-up|2
5721665|NCT00068601|19700014|P1|Overall Study|Lost to Follow-up|3
5721666|NCT00068601|19700013|P2|Overall Study|Death|3
5721667|NCT00068601|19700014|P1|Overall Study|Death|11
5721668|NCT00068601|19700013|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
5721669|NCT00068601|19700014|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
5721670|NCT00068601|19700013|P2|Overall Study|Not evaluable: withdrew consent|4
5721671|NCT00068601|19700014|P1|Overall Study|Not evaluable: withdrew consent|5
5721672|NCT00068601|19700013|P2|Overall Study|Ineligible|13
5721673|NCT00068601|19700014|P1|Overall Study|Ineligible|11
5721674|NCT00068588|19700027|P3|Overall Study|Poor KPS|1
5721675|NCT00068588|19700028|P2|Overall Study|Poor KPS|0
5721676|NCT00068588|19700029|P1|Overall Study|Poor KPS|0
5721677|NCT00068588|19700027|P3|Overall Study|Withdrawal by Subject|1
5721678|NCT00068588|19700028|P2|Overall Study|Withdrawal by Subject|0
5721679|NCT00068588|19700029|P1|Overall Study|Withdrawal by Subject|0
5721680|NCT00068588|19700027|P3|Overall Study|Adverse Event|2
5721681|NCT00068588|19700028|P2|Overall Study|Adverse Event|0
5721682|NCT00068588|19700029|P1|Overall Study|Adverse Event|0
5721683|NCT00068445|19700045|P2|Treatment|Other (Specifics not available)|5
5721684|NCT00068445|19700046|P1|Treatment|Other (Specifics not available)|9
5721685|NCT00068445|19700045|P2|Treatment|Adverse Event|1
5721686|NCT00068445|19700046|P1|Treatment|Adverse Event|7
5721687|NCT00068445|19700045|P2|Treatment|Refused Further Treatment|10
5721688|NCT00068445|19700046|P1|Treatment|Refused Further Treatment|13
5721689|NCT00068445|19700045|P2|Randomization|Ineligible|1
5721690|NCT00068445|19700046|P1|Randomization|Ineligible|1
5721691|NCT00068445|19700045|P2|Randomization|Cancel|3
5721692|NCT00068445|19700046|P1|Randomization|Cancel|1
5721693|NCT00068419|19700070|P1|Overall Study|Ineligible|11
5721694|NCT00068419|19700070|P1|Overall Study|Withdrawal by Subject|14
5721695|NCT00068419|19700070|P1|Overall Study|Physician Decision|7
5721696|NCT00068419|19700070|P1|Overall Study|Lost to Follow-up|1
5721697|NCT00068419|19700070|P1|Overall Study|Lack of Efficacy|24
5721698|NCT00068419|19700070|P1|Overall Study|Adverse Event|3
5721699|NCT00068406|19700079|P1|Overall Study|Ineligible-Inadequate Pathology|2
5721700|NCT00068406|19700079|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
5721701|NCT00068393|19700084|P1|Overall Study|Quality of life worsening|1
5721702|NCT00068393|19700084|P1|Overall Study|Alternative treatment|1
5721703|NCT00068393|19700084|P1|Overall Study|Withdrawal by Subject|3
5721704|NCT00068393|19700084|P1|Overall Study|Death|3
5721705|NCT00068393|19700084|P1|Overall Study|Adverse Event|2
5721706|NCT00068380|19700090|P1|Overall Study|Adverse Event|2
5721707|NCT00068380|19700090|P1|Overall Study|Withdrawal by Subject|3
5721708|NCT00068250|19700134|P4|Phase I: Dose Level 2|Protocol Violation|0
5721709|NCT00068250|19700135|P3|Phase I: Dose Level 2|Protocol Violation|0
5721710|NCT00068250|19700136|P2|Phase I: Dose Level 2|Protocol Violation|1
5721711|NCT00068250|19700137|P1|Phase I: Dose Level 2|Protocol Violation|0
5721712|NCT00068237|19700147|P1|Overall Study|No protocol treatment received|2
5721713|NCT00068237|19700147|P1|Overall Study|Ineligible|3
5721714|NCT00068107|19700159|P1|Overall Study|Withdrawal by Subject|1
5721715|NCT00068107|19700159|P1|Overall Study|Death|2
5721716|NCT00068107|19700159|P1|Overall Study|end-stage renal disease|6
5721717|NCT00067990|19700172|P2|Overall Study|Withdrawal by Subject|12
5721718|NCT00067990|19700173|P1|Overall Study|Withdrawal by Subject|4
5721719|NCT00067990|19700172|P2|Overall Study|ESRD, Non IF/TA|3
5721720|NCT00067990|19700173|P1|Overall Study|ESRD, Non IF/TA|1
5721721|NCT00067990|19700172|P2|Overall Study|Death|7
5721722|NCT00067990|19700173|P1|Overall Study|Death|5
5721723|NCT00067470|19700196|P2|Overall Study|Withdrawal by Subject|1
5721724|NCT00067470|19700197|P1|Overall Study|Withdrawal by Subject|0
5721725|NCT00067002|19700234|P2|Overall Study|Graft Failure|6
5721726|NCT00067002|19700235|P1|Overall Study|Graft Failure|5
5721727|NCT00067002|19700234|P2|Overall Study|Delayed|1
5721728|NCT00067002|19700235|P1|Overall Study|Delayed|1
5721729|NCT00067002|19700234|P2|Overall Study|Early Death|2
5721730|NCT00067002|19700235|P1|Overall Study|Early Death|1
5721731|NCT00066807|19700293|P2|Overall Study|Study was terminated early|15
5721732|NCT00066807|19700294|P1|Overall Study|Study was terminated early|14
5721733|NCT00066742|19700319|P1|Consolidation Chemotherapy|Ineligible|2
5721734|NCT00066742|19700319|P1|Consolidation Chemotherapy|not protocol specified|1
5721735|NCT00066742|19700319|P1|Induction Chemoradiotherapy|Ineligible|3
5721736|NCT00066742|19700319|P1|Induction Chemoradiotherapy|not protocol specified|2
5721737|NCT00066742|19700319|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
5721738|NCT00066742|19700319|P1|Induction Chemoradiotherapy|Adverse Event|21
5721739|NCT00066742|19700319|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
5721740|NCT00066703|19700328|P2|Overall Study|Treatment ongoing|311
5721741|NCT00066703|19700329|P1|Overall Study|Treatment ongoing|346
5721742|NCT00066703|19700328|P2|Overall Study|Withdrawal by Subject|63
5721743|NCT00066703|19700329|P1|Overall Study|Withdrawal by Subject|38
5721744|NCT00066703|19700328|P2|Overall Study|Lost to Follow-up|28
5721745|NCT00066703|19700329|P1|Overall Study|Lost to Follow-up|31
5721746|NCT00066703|19700328|P2|Overall Study|Lack of Efficacy|69
5721747|NCT00066703|19700329|P1|Overall Study|Lack of Efficacy|114
5721748|NCT00066703|19700328|P2|Overall Study|Death|0
5721749|NCT00066703|19700329|P1|Overall Study|Death|3
5721750|NCT00066703|19700328|P2|Overall Study|Adverse Event|111
5721751|NCT00066703|19700329|P1|Overall Study|Adverse Event|80
5721752|NCT00066690|19700344|P3|Overall Study|Treatment Ongoing|282
5721753|NCT00066690|19700345|P2|Overall Study|Treatment Ongoing|278
5721754|NCT00066690|19700346|P1|Overall Study|Treatment Ongoing|246
5721755|NCT00066690|19700344|P3|Overall Study|Withdrawal by Subject|49
5721756|NCT00066690|19700345|P2|Overall Study|Withdrawal by Subject|55
5721757|NCT00066690|19700346|P1|Overall Study|Withdrawal by Subject|50
5721758|NCT00066690|19700344|P3|Overall Study|Lost to Follow-up|29
5721759|NCT00066690|19700345|P2|Overall Study|Lost to Follow-up|21
5721760|NCT00066690|19700346|P1|Overall Study|Lost to Follow-up|40
5721761|NCT00066690|19700344|P3|Overall Study|Lack of Efficacy|76
5721762|NCT00066690|19700345|P2|Overall Study|Lack of Efficacy|110
5721763|NCT00066690|19700346|P1|Overall Study|Lack of Efficacy|114
5721764|NCT00066690|19700344|P3|Overall Study|Death|2
5721765|NCT00066690|19700345|P2|Overall Study|Death|0
5721766|NCT00066690|19700346|P1|Overall Study|Death|3
5721767|NCT00066690|19700344|P3|Overall Study|Adverse Event|126
5721768|NCT00066690|19700345|P2|Overall Study|Adverse Event|58
5721769|NCT00066690|19700346|P1|Overall Study|Adverse Event|145
5721770|NCT00066573|19700365|P2|Overall Study|Did not received protocol treatment|28
5721771|NCT00066573|19700366|P1|Overall Study|Did not received protocol treatment|28
5721772|NCT00066469|19700378|P1|Overall Study|ineligible|1
5721773|NCT00066469|19700378|P1|Overall Study|Withdrawal by Subject|1
5721774|NCT00066469|19700378|P1|Overall Study|Physician Decision|1
5721775|NCT00066469|19700378|P1|Overall Study|Lost to Follow-up|1
5721776|NCT00066469|19700378|P1|Overall Study|Lack of Efficacy|9
5721777|NCT00066469|19700378|P1|Overall Study|Death|3
5721778|NCT00066365|19700384|P2|Overall Study|Ineligible|2
5721779|NCT00066365|19700385|P1|Overall Study|Ineligible|4
5721780|NCT00066365|19700384|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
5721781|NCT00066365|19700385|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
5721782|NCT00066365|19700384|P2|Overall Study|Physician Decision|0
5721783|NCT00066365|19700385|P1|Overall Study|Physician Decision|1
5721784|NCT00066365|19700384|P2|Overall Study|Lack of Efficacy|12
5721785|NCT00066365|19700385|P1|Overall Study|Lack of Efficacy|15
5721786|NCT00066365|19700384|P2|Overall Study|Adverse Event|0
5721787|NCT00066365|19700385|P1|Overall Study|Adverse Event|1
5721788|NCT00066222|19700413|P1|Overall Study|No protocol treatment received|1
5721789|NCT00066170|19700426|P4|Overall Study|Other|0
5721790|NCT00066170|19700427|P3|Overall Study|Other|2
5721791|NCT00066170|19700428|P2|Overall Study|Other|5
5721792|NCT00066170|19700429|P1|Overall Study|Other|1
5721793|NCT00066170|19700426|P4|Overall Study|Protocol Violation|0
5721794|NCT00066170|19700427|P3|Overall Study|Protocol Violation|0
5721795|NCT00066170|19700428|P2|Overall Study|Protocol Violation|0
5721796|NCT00066170|19700429|P1|Overall Study|Protocol Violation|3
5721797|NCT00066170|19700426|P4|Overall Study|Non-Compliance with Trial Medicine|1
5721798|NCT00066170|19700427|P3|Overall Study|Non-Compliance with Trial Medicine|0
5721799|NCT00066170|19700428|P2|Overall Study|Non-Compliance with Trial Medicine|0
5721800|NCT00066170|19700429|P1|Overall Study|Non-Compliance with Trial Medicine|1
5721801|NCT00066170|19700426|P4|Overall Study|Lost to Follow-up|0
5721802|NCT00066170|19700427|P3|Overall Study|Lost to Follow-up|0
5721803|NCT00066170|19700428|P2|Overall Study|Lost to Follow-up|1
5721804|NCT00066170|19700429|P1|Overall Study|Lost to Follow-up|0
5721805|NCT00066170|19700426|P4|Overall Study|Serious Adverse Event|1
5721806|NCT00066170|19700427|P3|Overall Study|Serious Adverse Event|1
5721807|NCT00066170|19700428|P2|Overall Study|Serious Adverse Event|0
5721808|NCT00066170|19700429|P1|Overall Study|Serious Adverse Event|0
5721809|NCT00066170|19700426|P4|Overall Study|Adverse Event|7
5721810|NCT00066170|19700427|P3|Overall Study|Adverse Event|1
5721811|NCT00066170|19700428|P2|Overall Study|Adverse Event|4
5721812|NCT00066170|19700429|P1|Overall Study|Adverse Event|2
5721813|NCT00066066|19700442|P6|Overall Study|Lost to Follow-up|5
5721814|NCT00066066|19700443|P5|Overall Study|Lost to Follow-up|3
5721815|NCT00066066|19700444|P4|Overall Study|Lost to Follow-up|4
5721816|NCT00066066|19700445|P3|Overall Study|Lost to Follow-up|7
5721817|NCT00066066|19700446|P2|Overall Study|Lost to Follow-up|4
5721818|NCT00066066|19700447|P1|Overall Study|Lost to Follow-up|6
5721819|NCT00065507|19700525|P2|Overall Study|Subject No Longer Meets Study Criteria|0
5721820|NCT00065507|19700526|P1|Overall Study|Subject No Longer Meets Study Criteria|1
5721821|NCT00065507|19700525|P2|Overall Study|Subject Withdrew Consent|1
5721822|NCT00065507|19700526|P1|Overall Study|Subject Withdrew Consent|2
5721823|NCT00065507|19700525|P2|Overall Study|Lost to Follow-up|0
5721824|NCT00065507|19700526|P1|Overall Study|Lost to Follow-up|3
5721825|NCT00065507|19700525|P2|Overall Study|Poor/Non-compliance|2
5721826|NCT00065507|19700526|P1|Overall Study|Poor/Non-compliance|3
5721827|NCT00065507|19700525|P2|Overall Study|Lack of Efficacy|6
5721828|NCT00065507|19700526|P1|Overall Study|Lack of Efficacy|0
5721829|NCT00065507|19700525|P2|Overall Study|Adverse Event|3
5721830|NCT00065507|19700526|P1|Overall Study|Adverse Event|4
5721831|NCT00065507|19700525|P2|Overall Study|Death|17
5721832|NCT00065507|19700526|P1|Overall Study|Death|16
5721833|NCT00065468|19700591|P3|Overall Study|Other|18
5721834|NCT00065468|19700592|P2|Overall Study|Other|24
5721835|NCT00065468|19700593|P1|Overall Study|Other|14
5721836|NCT00065468|19700591|P3|Overall Study|Disease progression|1
5721837|NCT00065468|19700592|P2|Overall Study|Disease progression|0
5721838|NCT00065468|19700593|P1|Overall Study|Disease progression|0
5721839|NCT00065468|19700591|P3|Overall Study|Discontinuation of study by Sponsor|13
5721840|NCT00065468|19700592|P2|Overall Study|Discontinuation of study by Sponsor|9
5721841|NCT00065468|19700593|P1|Overall Study|Discontinuation of study by Sponsor|13
5721842|NCT00065468|19700591|P3|Overall Study|Lost to Follow-up|2
5721843|NCT00065468|19700592|P2|Overall Study|Lost to Follow-up|3
5721844|NCT00065468|19700593|P1|Overall Study|Lost to Follow-up|5
5721845|NCT00065468|19700591|P3|Overall Study|Withdrawal by Subject|5
5721846|NCT00065468|19700592|P2|Overall Study|Withdrawal by Subject|4
5721847|NCT00065468|19700593|P1|Overall Study|Withdrawal by Subject|3
5721848|NCT00065468|19700591|P3|Overall Study|Death|171
5721849|NCT00065468|19700592|P2|Overall Study|Death|169
5721850|NCT00065468|19700593|P1|Overall Study|Death|172
5721851|NCT00065442|19700624|P2|Overall Study|Withdrawal by Subject|9
5721852|NCT00065442|19700625|P1|Overall Study|Withdrawal by Subject|3
5721853|NCT00065442|19700624|P2|Overall Study|Death|210
5721854|NCT00065442|19700625|P1|Overall Study|Death|121
5721855|NCT00065442|19700624|P2|Overall Study|Lost to Follow-up|1
5721856|NCT00065442|19700625|P1|Overall Study|Lost to Follow-up|1
5721857|NCT00065429|19700640|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5721858|NCT00065429|19700641|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5721859|NCT00065429|19700642|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
5721860|NCT00065429|19700643|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5721861|NCT00065429|19700644|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5721862|NCT00065429|19700645|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5721863|NCT00065429|19700646|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
5721864|NCT00065429|19700640|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5721865|NCT00065429|19700641|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5721866|NCT00065429|19700642|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
5721867|NCT00065429|19700643|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5721868|NCT00065429|19700644|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5721869|NCT00065429|19700645|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5721870|NCT00065429|19700646|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
5721871|NCT00065429|19700640|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
5721872|NCT00065429|19700641|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
5721873|NCT00065429|19700642|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
5721874|NCT00065429|19700643|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
5721875|NCT00065429|19700644|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
5721876|NCT00065429|19700645|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
5721877|NCT00065429|19700646|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
5721878|NCT00065429|19700640|P7|Phase I - May 2001 - Oct 2002|Death|0
5721879|NCT00065429|19700641|P6|Phase I - May 2001 - Oct 2002|Death|0
5721880|NCT00065429|19700642|P5|Phase I - May 2001 - Oct 2002|Death|1
5721881|NCT00065429|19700643|P4|Phase I - May 2001 - Oct 2002|Death|0
5721882|NCT00065429|19700644|P3|Phase I - May 2001 - Oct 2002|Death|0
5721883|NCT00065429|19700645|P2|Phase I - May 2001 - Oct 2002|Death|0
5721884|NCT00065429|19700646|P1|Phase I - May 2001 - Oct 2002|Death|0
5721885|NCT00065429|19700640|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
5721886|NCT00065429|19700641|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
5721887|NCT00065429|19700642|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
5721888|NCT00065429|19700643|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
5721889|NCT00065429|19700644|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
5721890|NCT00065429|19700645|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
5721891|NCT00065429|19700646|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
5721892|NCT00065429|19700640|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5721893|NCT00065429|19700641|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5721894|NCT00065429|19700642|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5721895|NCT00065429|19700643|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5721896|NCT00065429|19700644|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
5721897|NCT00065429|19700645|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5721898|NCT00065429|19700646|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
5721899|NCT00065429|19700640|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5721900|NCT00065429|19700641|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
5721901|NCT00065429|19700642|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5721902|NCT00065429|19700643|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5721903|NCT00065429|19700644|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5721904|NCT00065429|19700645|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5721905|NCT00065429|19700646|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
5721906|NCT00065260|19700660|P2|Overall Study|Death|1
5721907|NCT00065260|19700661|P1|Overall Study|Death|0
5721908|NCT00065182|19700669|P2|Overall Study|Decline in Status|1
5721909|NCT00065182|19700670|P1|Overall Study|Decline in Status|0
5721910|NCT00065182|19700669|P2|Overall Study|Death|1
5721911|NCT00065182|19700670|P1|Overall Study|Death|0
5721912|NCT00065182|19700669|P2|Overall Study|No clinical benefit|0
5721913|NCT00065182|19700670|P1|Overall Study|No clinical benefit|1
5721914|NCT00065182|19700669|P2|Overall Study|Withdrawal by Subject|3
5721915|NCT00065182|19700670|P1|Overall Study|Withdrawal by Subject|8
5721916|NCT00065182|19700669|P2|Overall Study|Sponsor Decision|7
5721917|NCT00065182|19700670|P1|Overall Study|Sponsor Decision|11
5721918|NCT00065182|19700669|P2|Overall Study|Serious adverse events (SAE)|0
5721919|NCT00065182|19700670|P1|Overall Study|Serious adverse events (SAE)|1
5721920|NCT00065182|19700669|P2|Overall Study|Protocol Violation|4
5721921|NCT00065182|19700670|P1|Overall Study|Protocol Violation|3
5721922|NCT00065182|19700669|P2|Overall Study|Lost to Follow-up|4
5721923|NCT00065182|19700670|P1|Overall Study|Lost to Follow-up|0
5721924|NCT00065182|19700669|P2|Overall Study|Adverse Event|17
5721925|NCT00065182|19700670|P1|Overall Study|Adverse Event|24
5721926|NCT00065156|19700696|P1|Overall Study|Secondary Malign Disease|1
5721927|NCT00065156|19700696|P1|Overall Study|Loss of Response|1
5721928|NCT00065156|19700696|P1|Overall Study|Non-Compliance|2
5721929|NCT00065156|19700696|P1|Overall Study|Investigator Decision|2
5721930|NCT00065156|19700696|P1|Overall Study|Disease Progression|7
5721931|NCT00065156|19700696|P1|Overall Study|Study Closed by Sponsor|2
5721932|NCT00065156|19700696|P1|Overall Study|Death|11
5721933|NCT00065156|19700696|P1|Overall Study|Lost to Follow-up|1
5721934|NCT00065156|19700696|P1|Overall Study|Withdrawal by Subject|8
5721935|NCT00065156|19700696|P1|Overall Study|Lack of Efficacy|52
5721936|NCT00065156|19700696|P1|Overall Study|Adverse Event|37
5721937|NCT00065065|19700713|P2|Overall Study|Other|2
5721938|NCT00065065|19700714|P1|Overall Study|Other|2
5721939|NCT00065065|19700713|P2|Overall Study|Lack of Efficacy|11
5721940|NCT00065065|19700714|P1|Overall Study|Lack of Efficacy|4
5721941|NCT00065065|19700713|P2|Overall Study|Withdrawal by Subject|5
5721942|NCT00065065|19700714|P1|Overall Study|Withdrawal by Subject|1
5721943|NCT00065065|19700713|P2|Overall Study|Adverse Event|2
5721944|NCT00065065|19700714|P1|Overall Study|Adverse Event|3
5721945|NCT00003895|19700726|P2|Overall Study|Withdrawal by Subject|3
5721946|NCT00003895|19700727|P1|Overall Study|Withdrawal by Subject|0
5721947|NCT00003895|19700726|P2|Overall Study|Patient Vacation|0
5721948|NCT00003895|19700727|P1|Overall Study|Patient Vacation|2
5721949|NCT00003895|19700726|P2|Overall Study|Lack of Efficacy|1
5721950|NCT00003895|19700727|P1|Overall Study|Lack of Efficacy|1
5721951|NCT00003895|19700726|P2|Overall Study|Adverse Event|0
5721952|NCT00003895|19700727|P1|Overall Study|Adverse Event|4
5721953|NCT00064987|19700735|P2|Overall Study|Physician Decision|0
5721954|NCT00064987|19700736|P1|Overall Study|Physician Decision|3
5721955|NCT00064753|19700767|P2|Overall Study|Lost to Follow-up|235
5721956|NCT00064753|19700768|P1|Overall Study|Lost to Follow-up|225
5721957|NCT00064753|19700767|P2|Overall Study|Withdrawal by Subject|171
5721958|NCT00064753|19700768|P1|Overall Study|Withdrawal by Subject|198
5721959|NCT00064753|19700767|P2|Overall Study|Death|242
5721960|NCT00064753|19700768|P1|Overall Study|Death|251
5721961|NCT00003645|19700798|P2|Overall Study|Withdrawal by Subject|3
5721962|NCT00003645|19700799|P1|Overall Study|Withdrawal by Subject|1
5721963|NCT00003645|19700798|P2|Overall Study|Lost to Follow-up|8
5721964|NCT00003645|19700799|P1|Overall Study|Lost to Follow-up|7
5721965|NCT00003645|19700798|P2|Overall Study|Death|1
5721966|NCT00003645|19700799|P1|Overall Study|Death|4
5721967|NCT00064792|19700813|P2|Overall Study|Adverse Event|0
5721968|NCT00064792|19700814|P1|Overall Study|Adverse Event|3
5721969|NCT00064792|19700813|P2|Overall Study|Withdrawal by Subject|0
5721970|NCT00064792|19700814|P1|Overall Study|Withdrawal by Subject|2
5721971|NCT00064701|19700825|P3|Clinical Continuation Phase|Patient opted out|1
5721972|NCT00064701|19700826|P2|Clinical Continuation Phase|Patient opted out|0
5721973|NCT00064701|19700827|P1|Clinical Continuation Phase|Patient opted out|0
5721974|NCT00064701|19700825|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
5721975|NCT00064701|19700826|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
5721976|NCT00064701|19700827|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
5721977|NCT00064701|19700825|P3|Clinical Continuation Phase|Discharged to nursing home|0
5721978|NCT00064701|19700826|P2|Clinical Continuation Phase|Discharged to nursing home|1
5721979|NCT00064701|19700827|P1|Clinical Continuation Phase|Discharged to nursing home|0
5721980|NCT00064701|19700825|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
5721981|NCT00064701|19700826|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
5721982|NCT00064701|19700827|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
5721983|NCT00064701|19700825|P3|Clinical Continuation Phase|Pancreas transplant|0
5721984|NCT00064701|19700826|P2|Clinical Continuation Phase|Pancreas transplant|0
5721985|NCT00064701|19700827|P1|Clinical Continuation Phase|Pancreas transplant|1
5721986|NCT00064701|19700825|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
5721987|NCT00064701|19700826|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
5721988|NCT00064701|19700827|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
5721989|NCT00064701|19700825|P3|Clinical Continuation Phase|Physician Decision|0
5721990|NCT00064701|19700826|P2|Clinical Continuation Phase|Physician Decision|3
5721991|NCT00064701|19700827|P1|Clinical Continuation Phase|Physician Decision|1
5721992|NCT00064701|19700825|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
5721993|NCT00064701|19700826|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
5721994|NCT00064701|19700827|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
5721995|NCT00064701|19700825|P3|Clinical Continuation Phase|Sponsor discontinued study|79
5721996|NCT00064701|19700826|P2|Clinical Continuation Phase|Sponsor discontinued study|129
5721997|NCT00064701|19700827|P1|Clinical Continuation Phase|Sponsor discontinued study|113
5721998|NCT00064701|19700825|P3|Clinical Continuation Phase|Rejection|2
5721999|NCT00064701|19700826|P2|Clinical Continuation Phase|Rejection|2
5722000|NCT00064701|19700827|P1|Clinical Continuation Phase|Rejection|1
5722001|NCT00064701|19700825|P3|Clinical Continuation Phase|Graft Failure|2
5722002|NCT00064701|19700826|P2|Clinical Continuation Phase|Graft Failure|5
5722003|NCT00064701|19700827|P1|Clinical Continuation Phase|Graft Failure|5
5722004|NCT00064701|19700825|P3|Clinical Continuation Phase|Lost to Follow-up|6
5722005|NCT00064701|19700826|P2|Clinical Continuation Phase|Lost to Follow-up|3
5722006|NCT00064701|19700827|P1|Clinical Continuation Phase|Lost to Follow-up|6
5722007|NCT00064701|19700825|P3|Clinical Continuation Phase|Withdrawal by Subject|22
5722008|NCT00064701|19700826|P2|Clinical Continuation Phase|Withdrawal by Subject|3
5722009|NCT00064701|19700827|P1|Clinical Continuation Phase|Withdrawal by Subject|22
5722010|NCT00064701|19700825|P3|Clinical Continuation Phase|Non-compliance|7
5722011|NCT00064701|19700826|P2|Clinical Continuation Phase|Non-compliance|6
5722012|NCT00064701|19700827|P1|Clinical Continuation Phase|Non-compliance|8
5722013|NCT00064701|19700825|P3|Clinical Continuation Phase|Adverse Event|14
5722014|NCT00064701|19700826|P2|Clinical Continuation Phase|Adverse Event|21
5722015|NCT00064701|19700827|P1|Clinical Continuation Phase|Adverse Event|12
5722016|NCT00064701|19700825|P3|One Year Post-transplant|Pancreas transplant|1
5722017|NCT00064701|19700826|P2|One Year Post-transplant|Pancreas transplant|0
5722018|NCT00064701|19700827|P1|One Year Post-transplant|Pancreas transplant|0
5722019|NCT00064701|19700825|P3|One Year Post-transplant|Poor absorption|0
5722020|NCT00064701|19700826|P2|One Year Post-transplant|Poor absorption|1
5722021|NCT00064701|19700827|P1|One Year Post-transplant|Poor absorption|0
5722022|NCT00064701|19700825|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
5722023|NCT00064701|19700826|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
5722024|NCT00064701|19700827|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
5722025|NCT00064701|19700825|P3|One Year Post-transplant|Incorrect study drug dispensed|0
5722026|NCT00064701|19700826|P2|One Year Post-transplant|Incorrect study drug dispensed|1
5722027|NCT00064701|19700827|P1|One Year Post-transplant|Incorrect study drug dispensed|0
5722028|NCT00064701|19700825|P3|One Year Post-transplant|Acute tubular necrosis|0
5722029|NCT00064701|19700826|P2|One Year Post-transplant|Acute tubular necrosis|0
5722030|NCT00064701|19700827|P1|One Year Post-transplant|Acute tubular necrosis|1
5722031|NCT00064701|19700825|P3|One Year Post-transplant|Converted to rapamycin|0
5722032|NCT00064701|19700826|P2|One Year Post-transplant|Converted to rapamycin|0
5722033|NCT00064701|19700827|P1|One Year Post-transplant|Converted to rapamycin|1
5722034|NCT00064701|19700825|P3|One Year Post-transplant|Lost to Follow-up|0
5722035|NCT00064701|19700826|P2|One Year Post-transplant|Lost to Follow-up|0
5722036|NCT00064701|19700827|P1|One Year Post-transplant|Lost to Follow-up|1
5722037|NCT00064701|19700825|P3|One Year Post-transplant|Withdrawal by Subject|1
5722038|NCT00064701|19700826|P2|One Year Post-transplant|Withdrawal by Subject|4
5722039|NCT00064701|19700827|P1|One Year Post-transplant|Withdrawal by Subject|0
5722040|NCT00064701|19700825|P3|One Year Post-transplant|Graft Failure|1
5722041|NCT00064701|19700826|P2|One Year Post-transplant|Graft Failure|2
5722042|NCT00064701|19700827|P1|One Year Post-transplant|Graft Failure|3
5722043|NCT00064701|19700825|P3|One Year Post-transplant|Non-compliance|5
5722044|NCT00064701|19700826|P2|One Year Post-transplant|Non-compliance|2
5722045|NCT00064701|19700827|P1|One Year Post-transplant|Non-compliance|4
5722046|NCT00064701|19700825|P3|One Year Post-transplant|Rejection|16
5722047|NCT00064701|19700826|P2|One Year Post-transplant|Rejection|1
5722048|NCT00064701|19700827|P1|One Year Post-transplant|Rejection|0
5722049|NCT00064701|19700825|P3|One Year Post-transplant|Adverse Event|37
5722050|NCT00064701|19700826|P2|One Year Post-transplant|Adverse Event|19
5722051|NCT00064701|19700827|P1|One Year Post-transplant|Adverse Event|23
5722052|NCT00064701|19700825|P3|One Year Post-transplant|Did not receive study drug|11
5722053|NCT00064701|19700826|P2|One Year Post-transplant|Did not receive study drug|12
5722054|NCT00064701|19700827|P1|One Year Post-transplant|Did not receive study drug|7
5722055|NCT00064662|19700879|P2|Overall Study|Administratively withdrawn|2
5722056|NCT00064662|19700880|P1|Overall Study|Administratively withdrawn|2
5722057|NCT00064662|19700879|P2|Overall Study|Withdrawal by Subject|14
5722058|NCT00064662|19700880|P1|Overall Study|Withdrawal by Subject|14
5722059|NCT00064662|19700879|P2|Overall Study|Lost to Follow-up|44
5722060|NCT00064662|19700880|P1|Overall Study|Lost to Follow-up|57
5722061|NCT00064662|19700879|P2|Overall Study|Death|1
5722062|NCT00064662|19700880|P1|Overall Study|Death|1
5722063|NCT00064350|19700891|P3|Cross-Over|Other|0
5722064|NCT00064350|19700892|P2|Cross-Over|Other|2
5722065|NCT00064350|19700893|P1|Cross-Over|Other|0
5722066|NCT00064350|19700891|P3|Cross-Over|Ineligible or never started treatment|0
5722067|NCT00064350|19700892|P2|Cross-Over|Ineligible or never started treatment|6
5722068|NCT00064350|19700893|P1|Cross-Over|Ineligible or never started treatment|3
5722069|NCT00064350|19700891|P3|Cross-Over|Withdrawal by Subject|0
5722070|NCT00064350|19700892|P2|Cross-Over|Withdrawal by Subject|2
5722071|NCT00064350|19700893|P1|Cross-Over|Withdrawal by Subject|2
5722072|NCT00064350|19700891|P3|Cross-Over|Death|0
5722073|NCT00064350|19700892|P2|Cross-Over|Death|3
5722074|NCT00064350|19700893|P1|Cross-Over|Death|1
5722075|NCT00064350|19700891|P3|Cross-Over|Adverse Event|0
5722076|NCT00064350|19700892|P2|Cross-Over|Adverse Event|1
5722077|NCT00064350|19700893|P1|Cross-Over|Adverse Event|0
5722078|NCT00064350|19700891|P3|Randomization|Other|0
5722079|NCT00064350|19700892|P2|Randomization|Other|0
5722080|NCT00064350|19700893|P1|Randomization|Other|5
5722081|NCT00064350|19700891|P3|Randomization|Ineligible or never started treatment|0
5722082|NCT00064350|19700892|P2|Randomization|Ineligible or never started treatment|15
5722083|NCT00064350|19700893|P1|Randomization|Ineligible or never started treatment|9
5722084|NCT00064350|19700891|P3|Randomization|Withdrawal by Subject|0
5722085|NCT00064350|19700892|P2|Randomization|Withdrawal by Subject|0
5722086|NCT00064350|19700893|P1|Randomization|Withdrawal by Subject|1
5722087|NCT00064350|19700891|P3|Randomization|Death|0
5722088|NCT00064350|19700892|P2|Randomization|Death|0
5722089|NCT00064350|19700893|P1|Randomization|Death|3
5722090|NCT00064350|19700891|P3|Randomization|Adverse Event|0
5722091|NCT00064350|19700892|P2|Randomization|Adverse Event|3
5722092|NCT00064350|19700893|P1|Randomization|Adverse Event|8
5722093|NCT00064350|19700891|P3|Induction Treatment|Other|13
5722094|NCT00064350|19700892|P2|Induction Treatment|Other|0
5722095|NCT00064350|19700893|P1|Induction Treatment|Other|0
5722096|NCT00064350|19700891|P3|Induction Treatment|Ineligible or never started treatment|34
5722097|NCT00064350|19700892|P2|Induction Treatment|Ineligible or never started treatment|6
5722098|NCT00064350|19700893|P1|Induction Treatment|Ineligible or never started treatment|3
5722099|NCT00064350|19700891|P3|Induction Treatment|Withdrawal by Subject|21
5722100|NCT00064350|19700892|P2|Induction Treatment|Withdrawal by Subject|0
5722101|NCT00064350|19700893|P1|Induction Treatment|Withdrawal by Subject|0
5722102|NCT00064350|19700891|P3|Induction Treatment|Death|9
5722103|NCT00064350|19700892|P2|Induction Treatment|Death|0
5722104|NCT00064350|19700893|P1|Induction Treatment|Death|0
5722105|NCT00064350|19700891|P3|Induction Treatment|Adverse Event|49
5722106|NCT00064350|19700892|P2|Induction Treatment|Adverse Event|2
5722107|NCT00064350|19700893|P1|Induction Treatment|Adverse Event|0
5722108|NCT00064350|19700891|P3|Induction Treatment|Disease Progression|110
5722109|NCT00064350|19700892|P2|Induction Treatment|Disease Progression|1
5722110|NCT00064350|19700893|P1|Induction Treatment|Disease Progression|5
5722111|NCT00064337|19700908|P1|Maintenance|Death|1
5722112|NCT00064337|19700908|P1|Maintenance|Not protocol-specified|2
5722113|NCT00064337|19700908|P1|Maintenance|On treatment at time of analysis|2
5722114|NCT00064337|19700908|P1|Maintenance|Progression|2
5722115|NCT00064337|19700908|P1|Maintenance|Adverse Event|3
5722116|NCT00064337|19700908|P1|Transplant|Progression|2
5722117|NCT00064337|19700908|P1|Transplant|Patient Refusal|2
5722118|NCT00064337|19700908|P1|Transplant|Death|3
5722119|NCT00064337|19700908|P1|Transplant|Not protocol-specified|5
5722120|NCT00064337|19700908|P1|Transplant|Adverse Event|9
5722121|NCT00064337|19700908|P1|PBSCC or Induction/PBSCC|Death|2
5722122|NCT00064337|19700908|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
5722123|NCT00064337|19700908|P1|PBSCC or Induction/PBSCC|Progression|3
5722124|NCT00064337|19700908|P1|PBSCC or Induction/PBSCC|Adverse Event|6
5722125|NCT00064337|19700908|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
5722126|NCT00064298|19700917|P2|Overall Study|Disease Progression|1
5722127|NCT00064298|19700918|P1|Overall Study|Disease Progression|2
5722128|NCT00064298|19700917|P2|Overall Study|Death|1
5722129|NCT00064298|19700918|P1|Overall Study|Death|0
5722130|NCT00064298|19700917|P2|Overall Study|Lost to Follow-up|2
5722131|NCT00064298|19700918|P1|Overall Study|Lost to Follow-up|2
5722132|NCT00064298|19700917|P2|Overall Study|Withdrawal by Subject|1
5722133|NCT00064298|19700918|P1|Overall Study|Withdrawal by Subject|2
5722134|NCT00064259|19700926|P4|Overall Study|Adverse Event|1
5722135|NCT00064259|19700927|P3|Overall Study|Adverse Event|0
5722136|NCT00064259|19700928|P2|Overall Study|Adverse Event|0
5722137|NCT00064259|19700929|P1|Overall Study|Adverse Event|1
5722138|NCT00064077|19700937|P4|Overall Study|Other reasons|2
5722139|NCT00064077|19700938|P3|Overall Study|Other reasons|1
5722140|NCT00064077|19700939|P2|Overall Study|Other reasons|2
5722141|NCT00064077|19700940|P1|Overall Study|Other reasons|2
5722142|NCT00064077|19700937|P4|Overall Study|No tumor|0
5722143|NCT00064077|19700938|P3|Overall Study|No tumor|1
5722144|NCT00064077|19700939|P2|Overall Study|No tumor|0
5722145|NCT00064077|19700940|P1|Overall Study|No tumor|0
5722146|NCT00064077|19700937|P4|Overall Study|No surgery|0
5722147|NCT00064077|19700938|P3|Overall Study|No surgery|1
5722148|NCT00064077|19700939|P2|Overall Study|No surgery|0
5722149|NCT00064077|19700940|P1|Overall Study|No surgery|0
5722150|NCT00064077|19700937|P4|Overall Study|Pathology|4
5722151|NCT00064077|19700938|P3|Overall Study|Pathology|3
5722152|NCT00064077|19700939|P2|Overall Study|Pathology|7
5722153|NCT00064077|19700940|P1|Overall Study|Pathology|10
5722154|NCT00064077|19700937|P4|Overall Study|Poor risk|1
5722155|NCT00064077|19700938|P3|Overall Study|Poor risk|1
5722156|NCT00064077|19700939|P2|Overall Study|Poor risk|0
5722157|NCT00064077|19700940|P1|Overall Study|Poor risk|2
5722158|NCT00064077|19700937|P4|Overall Study|Improper prior treatment|0
5722159|NCT00064077|19700938|P3|Overall Study|Improper prior treatment|0
5722160|NCT00064077|19700939|P2|Overall Study|Improper prior treatment|0
5722161|NCT00064077|19700940|P1|Overall Study|Improper prior treatment|1
5722162|NCT00064025|19700984|P1|Overall Study|Inevaluable|3
5722163|NCT00064025|19700984|P1|Overall Study|Ineligible|4
5722164|NCT00063999|19700993|P2|Overall Study|Ineligible|24
5722165|NCT00063999|19700994|P1|Overall Study|Ineligible|44
5722166|NCT00063999|19700993|P2|Overall Study|Withdrawal by Subject|0
5722167|NCT00063999|19700994|P1|Overall Study|Withdrawal by Subject|1
5722168|NCT00063986|19701010|P1|Overall Study|Intra-operatively ineligible|4
5722169|NCT00063986|19701010|P1|Overall Study|Ineligible|1
5722170|NCT00063986|19701010|P1|Overall Study|Withdrawal by Subject|1
5722171|NCT00063934|19701022|P1|Overall Study|Ineligible|1
5722172|NCT00063882|19701031|P2|Overall Study|Withdrawal by Subject|1
5722173|NCT00063882|19701032|P1|Overall Study|Withdrawal by Subject|2
5722174|NCT00063882|19701031|P2|Overall Study|Protocol Violation|3
5722175|NCT00063882|19701032|P1|Overall Study|Protocol Violation|3
5722176|NCT00063258|19701159|P2|Overall Study|Lack of Efficacy|0
5722177|NCT00063258|19701160|P1|Overall Study|Lack of Efficacy|2
5722178|NCT00063258|19701159|P2|Overall Study|Physician Decision|0
5722179|NCT00063258|19701160|P1|Overall Study|Physician Decision|2
5722180|NCT00063154|19701166|P1|Overall Study|Did not receive treatment|8
5722181|NCT00063154|19701166|P1|Overall Study|Reason unspecified|1
5722182|NCT00063154|19701166|P1|Overall Study|Death|3
5722183|NCT00063154|19701166|P1|Overall Study|Physician Decision|10
5722184|NCT00063154|19701166|P1|Overall Study|Adverse Event|2
5722185|NCT00063154|19701166|P1|Overall Study|Disease progression|27
5722186|NCT00062868|19701200|P21|Dose Level 3|Withdrew|0
5722187|NCT00062868|19701201|P20|Dose Level 3|Withdrew|0
5722188|NCT00062868|19701202|P19|Dose Level 3|Withdrew|0
5722189|NCT00062868|19701203|P18|Dose Level 3|Withdrew|0
5722190|NCT00062868|19701204|P17|Dose Level 3|Withdrew|0
5722191|NCT00062868|19701205|P16|Dose Level 3|Withdrew|0
5722192|NCT00062868|19701206|P15|Dose Level 3|Withdrew|0
5722193|NCT00062868|19701207|P14|Dose Level 3|Withdrew|0
5722194|NCT00062868|19701208|P13|Dose Level 3|Withdrew|0
5722195|NCT00062868|19701209|P12|Dose Level 3|Withdrew|0
5722196|NCT00062868|19701210|P11|Dose Level 3|Withdrew|0
5722197|NCT00062868|19701211|P10|Dose Level 3|Withdrew|0
5722198|NCT00062868|19701212|P9|Dose Level 3|Withdrew|0
5722199|NCT00062868|19701213|P8|Dose Level 3|Withdrew|0
5722200|NCT00062868|19701214|P7|Dose Level 3|Withdrew|0
5722201|NCT00062868|19701215|P6|Dose Level 3|Withdrew|0
5722202|NCT00062868|19701216|P5|Dose Level 3|Withdrew|0
5722203|NCT00062868|19701217|P4|Dose Level 3|Withdrew|0
5722204|NCT00062868|19701218|P3|Dose Level 3|Withdrew|2
5722205|NCT00062868|19701219|P2|Dose Level 3|Withdrew|0
5722206|NCT00062868|19701220|P1|Dose Level 3|Withdrew|0
5722207|NCT00062868|19701200|P21|Dose Level 3|Lost to Follow-up|0
5722208|NCT00062868|19701201|P20|Dose Level 3|Lost to Follow-up|0
5722209|NCT00062868|19701202|P19|Dose Level 3|Lost to Follow-up|0
5722210|NCT00062868|19701203|P18|Dose Level 3|Lost to Follow-up|0
5722211|NCT00062868|19701204|P17|Dose Level 3|Lost to Follow-up|0
5722212|NCT00062868|19701205|P16|Dose Level 3|Lost to Follow-up|0
5722213|NCT00062868|19701206|P15|Dose Level 3|Lost to Follow-up|1
5722214|NCT00062868|19701207|P14|Dose Level 3|Lost to Follow-up|0
5722215|NCT00062868|19701208|P13|Dose Level 3|Lost to Follow-up|0
5722216|NCT00062868|19701209|P12|Dose Level 3|Lost to Follow-up|0
5722217|NCT00062868|19701210|P11|Dose Level 3|Lost to Follow-up|0
5722218|NCT00062868|19701211|P10|Dose Level 3|Lost to Follow-up|0
5722219|NCT00062868|19701212|P9|Dose Level 3|Lost to Follow-up|0
5722220|NCT00062868|19701213|P8|Dose Level 3|Lost to Follow-up|0
5722221|NCT00062868|19701214|P7|Dose Level 3|Lost to Follow-up|0
5722222|NCT00062868|19701215|P6|Dose Level 3|Lost to Follow-up|0
5722223|NCT00062868|19701216|P5|Dose Level 3|Lost to Follow-up|0
5722224|NCT00062868|19701217|P4|Dose Level 3|Lost to Follow-up|0
5722225|NCT00062868|19701218|P3|Dose Level 3|Lost to Follow-up|0
5722226|NCT00062868|19701219|P2|Dose Level 3|Lost to Follow-up|0
5722227|NCT00062868|19701220|P1|Dose Level 3|Lost to Follow-up|0
5722228|NCT00062868|19701200|P21|Dose Level 3|Death|0
5722229|NCT00062868|19701201|P20|Dose Level 3|Death|0
5722230|NCT00062868|19701202|P19|Dose Level 3|Death|0
5722231|NCT00062868|19701203|P18|Dose Level 3|Death|1
5722232|NCT00062868|19701204|P17|Dose Level 3|Death|0
5722233|NCT00062868|19701205|P16|Dose Level 3|Death|0
5722234|NCT00062868|19701206|P15|Dose Level 3|Death|0
5722235|NCT00062868|19701207|P14|Dose Level 3|Death|0
5722236|NCT00062868|19701208|P13|Dose Level 3|Death|0
5722237|NCT00062868|19701209|P12|Dose Level 3|Death|1
5722238|NCT00062868|19701210|P11|Dose Level 3|Death|0
5722239|NCT00062868|19701211|P10|Dose Level 3|Death|0
5722240|NCT00062868|19701212|P9|Dose Level 3|Death|0
5722241|NCT00062868|19701213|P8|Dose Level 3|Death|0
5722242|NCT00062868|19701214|P7|Dose Level 3|Death|0
5722243|NCT00062868|19701215|P6|Dose Level 3|Death|0
5722244|NCT00062868|19701216|P5|Dose Level 3|Death|0
5722245|NCT00062868|19701217|P4|Dose Level 3|Death|0
5722246|NCT00062868|19701218|P3|Dose Level 3|Death|0
5722247|NCT00062868|19701219|P2|Dose Level 3|Death|0
5722248|NCT00062868|19701220|P1|Dose Level 3|Death|0
5722249|NCT00062868|19701200|P21|Dose Level 2|Lost to Follow-up|0
5722250|NCT00062868|19701201|P20|Dose Level 2|Lost to Follow-up|0
5722251|NCT00062868|19701202|P19|Dose Level 2|Lost to Follow-up|0
5722252|NCT00062868|19701203|P18|Dose Level 2|Lost to Follow-up|0
5722253|NCT00062868|19701204|P17|Dose Level 2|Lost to Follow-up|1
5722254|NCT00062868|19701205|P16|Dose Level 2|Lost to Follow-up|0
5722255|NCT00062868|19701206|P15|Dose Level 2|Lost to Follow-up|0
5722256|NCT00062868|19701207|P14|Dose Level 2|Lost to Follow-up|1
5722257|NCT00062868|19701208|P13|Dose Level 2|Lost to Follow-up|0
5722258|NCT00062868|19701209|P12|Dose Level 2|Lost to Follow-up|0
5722259|NCT00062868|19701210|P11|Dose Level 2|Lost to Follow-up|0
5722260|NCT00062868|19701211|P10|Dose Level 2|Lost to Follow-up|0
5722261|NCT00062868|19701212|P9|Dose Level 2|Lost to Follow-up|0
5722262|NCT00062868|19701213|P8|Dose Level 2|Lost to Follow-up|0
5722263|NCT00062868|19701214|P7|Dose Level 2|Lost to Follow-up|0
5722264|NCT00062868|19701215|P6|Dose Level 2|Lost to Follow-up|0
5722265|NCT00062868|19701216|P5|Dose Level 2|Lost to Follow-up|0
5722266|NCT00062868|19701217|P4|Dose Level 2|Lost to Follow-up|0
5722267|NCT00062868|19701218|P3|Dose Level 2|Lost to Follow-up|0
5722268|NCT00062868|19701219|P2|Dose Level 2|Lost to Follow-up|0
5722269|NCT00062868|19701220|P1|Dose Level 2|Lost to Follow-up|0
5722270|NCT00062868|19701200|P21|Dose Level 2|Death|0
5722271|NCT00062868|19701201|P20|Dose Level 2|Death|0
5722272|NCT00062868|19701202|P19|Dose Level 2|Death|0
5722273|NCT00062868|19701203|P18|Dose Level 2|Death|0
5722274|NCT00062868|19701204|P17|Dose Level 2|Death|2
5722275|NCT00062868|19701205|P16|Dose Level 2|Death|0
5722276|NCT00062868|19701206|P15|Dose Level 2|Death|0
5722277|NCT00062868|19701207|P14|Dose Level 2|Death|0
5722278|NCT00062868|19701208|P13|Dose Level 2|Death|0
5722279|NCT00062868|19701209|P12|Dose Level 2|Death|0
5722280|NCT00062868|19701210|P11|Dose Level 2|Death|1
5722281|NCT00062868|19701211|P10|Dose Level 2|Death|0
5722282|NCT00062868|19701212|P9|Dose Level 2|Death|0
5722283|NCT00062868|19701213|P8|Dose Level 2|Death|0
5722284|NCT00062868|19701214|P7|Dose Level 2|Death|0
5722285|NCT00062868|19701215|P6|Dose Level 2|Death|0
5722286|NCT00062868|19701216|P5|Dose Level 2|Death|2
5722287|NCT00062868|19701217|P4|Dose Level 2|Death|0
5722288|NCT00062868|19701218|P3|Dose Level 2|Death|0
5722289|NCT00062868|19701219|P2|Dose Level 2|Death|3
5722290|NCT00062868|19701220|P1|Dose Level 2|Death|0
5722291|NCT00062868|19701200|P21|Dose Level 1|Lost to Follow-up|1
5722292|NCT00062868|19701201|P20|Dose Level 1|Lost to Follow-up|0
5722293|NCT00062868|19701202|P19|Dose Level 1|Lost to Follow-up|2
5722294|NCT00062868|19701203|P18|Dose Level 1|Lost to Follow-up|0
5722295|NCT00062868|19701204|P17|Dose Level 1|Lost to Follow-up|0
5722296|NCT00062868|19701205|P16|Dose Level 1|Lost to Follow-up|0
5722297|NCT00062868|19701206|P15|Dose Level 1|Lost to Follow-up|0
5722298|NCT00062868|19701207|P14|Dose Level 1|Lost to Follow-up|0
5722299|NCT00062868|19701208|P13|Dose Level 1|Lost to Follow-up|1
5722300|NCT00062868|19701209|P12|Dose Level 1|Lost to Follow-up|0
5722301|NCT00062868|19701210|P11|Dose Level 1|Lost to Follow-up|0
5722302|NCT00062868|19701211|P10|Dose Level 1|Lost to Follow-up|0
5722303|NCT00062868|19701212|P9|Dose Level 1|Lost to Follow-up|0
5722304|NCT00062868|19701213|P8|Dose Level 1|Lost to Follow-up|0
5722305|NCT00062868|19701214|P7|Dose Level 1|Lost to Follow-up|0
5722306|NCT00062868|19701215|P6|Dose Level 1|Lost to Follow-up|0
5722307|NCT00062868|19701216|P5|Dose Level 1|Lost to Follow-up|0
5722308|NCT00062868|19701217|P4|Dose Level 1|Lost to Follow-up|0
5722309|NCT00062868|19701218|P3|Dose Level 1|Lost to Follow-up|0
5722310|NCT00062868|19701219|P2|Dose Level 1|Lost to Follow-up|0
5722311|NCT00062868|19701220|P1|Dose Level 1|Lost to Follow-up|0
5722312|NCT00062868|19701200|P21|Dose Level 1|Death|1
5722313|NCT00062868|19701201|P20|Dose Level 1|Death|0
5722314|NCT00062868|19701202|P19|Dose Level 1|Death|7
5722315|NCT00062868|19701203|P18|Dose Level 1|Death|0
5722316|NCT00062868|19701204|P17|Dose Level 1|Death|0
5722317|NCT00062868|19701205|P16|Dose Level 1|Death|0
5722318|NCT00062868|19701206|P15|Dose Level 1|Death|0
5722319|NCT00062868|19701207|P14|Dose Level 1|Death|0
5722320|NCT00062868|19701208|P13|Dose Level 1|Death|0
5722321|NCT00062868|19701209|P12|Dose Level 1|Death|0
5722322|NCT00062868|19701210|P11|Dose Level 1|Death|0
5722323|NCT00062868|19701211|P10|Dose Level 1|Death|0
5722324|NCT00062868|19701212|P9|Dose Level 1|Death|0
5722325|NCT00062868|19701213|P8|Dose Level 1|Death|0
5722326|NCT00062868|19701214|P7|Dose Level 1|Death|3
5722327|NCT00062868|19701215|P6|Dose Level 1|Death|0
5722328|NCT00062868|19701216|P5|Dose Level 1|Death|0
5722329|NCT00062868|19701217|P4|Dose Level 1|Death|2
5722330|NCT00062868|19701218|P3|Dose Level 1|Death|0
5722331|NCT00062868|19701219|P2|Dose Level 1|Death|0
5722332|NCT00062868|19701220|P1|Dose Level 1|Death|2
5722333|NCT00062751|19701319|P5|Overall Study|Death|0
5722334|NCT00062751|19701320|P4|Overall Study|Death|0
5722335|NCT00062751|19701321|P3|Overall Study|Death|1
5722336|NCT00062751|19701322|P2|Overall Study|Death|0
5722337|NCT00062751|19701323|P1|Overall Study|Death|1
5722338|NCT00062751|19701319|P5|Overall Study|Symptomatic deterioration|1
5722339|NCT00062751|19701320|P4|Overall Study|Symptomatic deterioration|0
5722340|NCT00062751|19701321|P3|Overall Study|Symptomatic deterioration|0
5722341|NCT00062751|19701322|P2|Overall Study|Symptomatic deterioration|1
5722342|NCT00062751|19701323|P1|Overall Study|Symptomatic deterioration|1
5722343|NCT00062751|19701319|P5|Overall Study|Withdrawal by Subject|0
5722344|NCT00062751|19701320|P4|Overall Study|Withdrawal by Subject|1
5722345|NCT00062751|19701321|P3|Overall Study|Withdrawal by Subject|2
5722346|NCT00062751|19701322|P2|Overall Study|Withdrawal by Subject|2
5722347|NCT00062751|19701323|P1|Overall Study|Withdrawal by Subject|1
5722348|NCT00062751|19701319|P5|Overall Study|Other|1
5722349|NCT00062751|19701320|P4|Overall Study|Other|0
5722350|NCT00062751|19701321|P3|Overall Study|Other|1
5722351|NCT00062751|19701322|P2|Overall Study|Other|3
5722352|NCT00062751|19701323|P1|Overall Study|Other|2
5722353|NCT00062751|19701319|P5|Overall Study|Adverse Event|2
5722354|NCT00062751|19701320|P4|Overall Study|Adverse Event|2
5722355|NCT00062751|19701321|P3|Overall Study|Adverse Event|2
5722356|NCT00062751|19701322|P2|Overall Study|Adverse Event|7
5722357|NCT00062751|19701323|P1|Overall Study|Adverse Event|4
5722358|NCT00062751|19701319|P5|Overall Study|Disease progression|2
5722359|NCT00062751|19701320|P4|Overall Study|Disease progression|2
5722360|NCT00062751|19701321|P3|Overall Study|Disease progression|24
5722361|NCT00062751|19701322|P2|Overall Study|Disease progression|17
5722362|NCT00062751|19701323|P1|Overall Study|Disease progression|24
5722363|NCT00062647|19701409|P2|Overall Study|Never received study treatment|1
5722364|NCT00062647|19701410|P1|Overall Study|Never received study treatment|1
5722365|NCT00062647|19701409|P2|Overall Study|Other|4
5722366|NCT00062647|19701410|P1|Overall Study|Other|4
5722367|NCT00062647|19701409|P2|Overall Study|Failed continuation criteria|2
5722368|NCT00062647|19701410|P1|Overall Study|Failed continuation criteria|4
5722369|NCT00062647|19701409|P2|Overall Study|Lost to Follow-up|2
5722370|NCT00062647|19701410|P1|Overall Study|Lost to Follow-up|1
5722371|NCT00062647|19701409|P2|Overall Study|Protocol Violation|0
5722372|NCT00062647|19701410|P1|Overall Study|Protocol Violation|1
5722373|NCT00062647|19701409|P2|Overall Study|Withdrawal by Subject|1
5722374|NCT00062647|19701410|P1|Overall Study|Withdrawal by Subject|2
5722375|NCT00062647|19701409|P2|Overall Study|Adverse Event|1
5722376|NCT00062647|19701410|P1|Overall Study|Adverse Event|1
5722377|NCT00062647|19701409|P2|Overall Study|Death|2
5722378|NCT00062647|19701410|P1|Overall Study|Death|2
5722379|NCT00062439|19701416|P1|Consolidation Chemotherapy|Adverse Event|2
5722380|NCT00062439|19701416|P1|Surgery|Adverse Event|2
5722381|NCT00062439|19701416|P1|Surgery|Death|1
5722382|NCT00062439|19701416|P1|Surgery|Physician Decision|4
5722470|NCT00059215|19701682|P1|Overall Study|Physician Decision|1
5722383|NCT00062439|19701416|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
5722384|NCT00062439|19701416|P1|Post Chemoradiation Assessment|Physician Decision|1
5722385|NCT00062439|19701416|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
5722386|NCT00062439|19701416|P1|Post Chemoradiation Assessment|Disease progression|2
5722387|NCT00062439|19701416|P1|Post Chemoradiation Assessment|Death|1
5722388|NCT00062439|19701416|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
5722389|NCT00062439|19701416|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
5722390|NCT00062439|19701416|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
5722391|NCT00062439|19701416|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
5722392|NCT00062374|19701428|P1|Overall Study|Not treated|12
5722393|NCT00062166|19701433|P1|Overall Study|Withdrawal by Subject|6
5722394|NCT00062010|19701441|P1|Overall Study|Ineligible|3
5722395|NCT00061945|19701449|P2|Course IV: Alemtuzumab|Early exits|15
5722396|NCT00061945|19701450|P1|Course IV: Alemtuzumab|Early exits|6
5722397|NCT00061945|19701449|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
5722398|NCT00061945|19701450|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
5722399|NCT00061945|19701449|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
5722400|NCT00061945|19701450|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
5722401|NCT00061945|19701449|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
5722402|NCT00061945|19701450|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
5722403|NCT00061932|19701460|P2|Overall Study|Withdrawal by Subject|4
5722404|NCT00061932|19701461|P1|Overall Study|Withdrawal by Subject|13
5722405|NCT00061633|19701474|P2|Overall Study|Never received study treatment|2
5722406|NCT00061633|19701475|P1|Overall Study|Never received study treatment|0
5722407|NCT00061633|19701474|P2|Overall Study|Other|1
5722408|NCT00061633|19701475|P1|Overall Study|Other|1
5722409|NCT00061633|19701474|P2|Overall Study|Lost to Follow-up|4
5722410|NCT00061633|19701475|P1|Overall Study|Lost to Follow-up|1
5722411|NCT00061633|19701474|P2|Overall Study|Withdrawal by Subject|2
5722412|NCT00061633|19701475|P1|Overall Study|Withdrawal by Subject|2
5722413|NCT00061633|19701474|P2|Overall Study|Adverse Event|2
5722414|NCT00061633|19701475|P1|Overall Study|Adverse Event|1
5722415|NCT00061048|19701500|P1|Overall Study|disease progression|20
5722416|NCT00061048|19701500|P1|Overall Study|Adverse Event|2
5722417|NCT00060944|19701510|P2|Overall Study|randomized but not treated|4
5722418|NCT00060944|19701511|P1|Overall Study|randomized but not treated|6
5722419|NCT00060944|19701510|P2|Overall Study|Other|4
5722420|NCT00060944|19701511|P1|Overall Study|Other|2
5722421|NCT00060944|19701510|P2|Overall Study|Treatment Switch|13
5722422|NCT00060944|19701511|P1|Overall Study|Treatment Switch|0
5722423|NCT00060944|19701510|P2|Overall Study|Subject Ineligible To Continue|1
5722424|NCT00060944|19701511|P1|Overall Study|Subject Ineligible To Continue|2
5722425|NCT00060944|19701510|P2|Overall Study|Lost to Follow-up|0
5722426|NCT00060944|19701511|P1|Overall Study|Lost to Follow-up|1
5722427|NCT00060944|19701510|P2|Overall Study|Disease Progression|94
5722428|NCT00060944|19701511|P1|Overall Study|Disease Progression|93
5722429|NCT00060944|19701510|P2|Overall Study|Withdrawal by Subject|5
5722430|NCT00060944|19701511|P1|Overall Study|Withdrawal by Subject|18
5722431|NCT00060944|19701510|P2|Overall Study|Death|3
5722432|NCT00060944|19701511|P1|Overall Study|Death|2
5722433|NCT00060944|19701510|P2|Overall Study|Adverse Event|10
5722434|NCT00060944|19701511|P1|Overall Study|Adverse Event|12
5722435|NCT00060840|19701527|P2|Overall Study|Other|0
5722436|NCT00060840|19701528|P1|Overall Study|Other|1
5722437|NCT00060840|19701527|P2|Overall Study|Physician Decision|0
5722438|NCT00060840|19701528|P1|Overall Study|Physician Decision|1
5722439|NCT00060840|19701527|P2|Overall Study|Subinvestigator unavailable|1
5722440|NCT00060840|19701528|P1|Overall Study|Subinvestigator unavailable|0
5722441|NCT00060840|19701527|P2|Overall Study|Withdrawal by Subject|1
5722442|NCT00060840|19701528|P1|Overall Study|Withdrawal by Subject|0
5722443|NCT00060840|19701527|P2|Overall Study|Death|1
5722444|NCT00060840|19701528|P1|Overall Study|Death|0
5722445|NCT00060840|19701527|P2|Overall Study|Change in surgical plan|6
5722446|NCT00060840|19701528|P1|Overall Study|Change in surgical plan|2
5722447|NCT00059839|19701594|P2|Overall Study|Ineligible|3
5722448|NCT00059839|19701595|P1|Overall Study|Ineligible|1
5722449|NCT00059839|19701594|P2|Overall Study|Withdrawal by Subject|6
5722450|NCT00059839|19701595|P1|Overall Study|Withdrawal by Subject|1
5722451|NCT00059839|19701594|P2|Overall Study|Physician Decision|2
5722452|NCT00059839|19701595|P1|Overall Study|Physician Decision|1
5722453|NCT00059839|19701594|P2|Overall Study|Lost to Follow-up|0
5722454|NCT00059839|19701595|P1|Overall Study|Lost to Follow-up|2
5722455|NCT00059839|19701594|P2|Overall Study|Lack of Efficacy|5
5722456|NCT00059839|19701595|P1|Overall Study|Lack of Efficacy|6
5722457|NCT00059839|19701594|P2|Overall Study|Death|1
5722458|NCT00059839|19701595|P1|Overall Study|Death|1
5722459|NCT00059787|19701601|P1|Overall Study|Other|4
5722460|NCT00059787|19701601|P1|Overall Study|ineligible|1
5722461|NCT00059787|19701601|P1|Overall Study|disease progression|2
5722462|NCT00059787|19701601|P1|Overall Study|Adverse Event|13
5722463|NCT00059332|19701652|P2|Overall Study|Lost to Follow-up|1
5722464|NCT00059332|19701653|P1|Overall Study|Lost to Follow-up|1
5722465|NCT00059332|19701652|P2|Overall Study|Withdrawal by Subject|1
5722466|NCT00059332|19701653|P1|Overall Study|Withdrawal by Subject|2
5722467|NCT00059215|19701679|P4|Overall Study|Physician Decision|1
5722468|NCT00059215|19701680|P3|Overall Study|Physician Decision|1
5722469|NCT00059215|19701681|P2|Overall Study|Physician Decision|2
5722471|NCT00059215|19701679|P4|Overall Study|Protocol entry criteria not met|2
5722472|NCT00059215|19701680|P3|Overall Study|Protocol entry criteria not met|0
5722473|NCT00059215|19701681|P2|Overall Study|Protocol entry criteria not met|1
5722474|NCT00059215|19701682|P1|Overall Study|Protocol entry criteria not met|1
5722475|NCT00059215|19701679|P4|Overall Study|Protocol Violation|0
5722476|NCT00059215|19701680|P3|Overall Study|Protocol Violation|1
5722477|NCT00059215|19701681|P2|Overall Study|Protocol Violation|0
5722478|NCT00059215|19701682|P1|Overall Study|Protocol Violation|1
5722479|NCT00059215|19701679|P4|Overall Study|Withdrawal by Subject|3
5722480|NCT00059215|19701680|P3|Overall Study|Withdrawal by Subject|1
5722481|NCT00059215|19701681|P2|Overall Study|Withdrawal by Subject|4
5722482|NCT00059215|19701682|P1|Overall Study|Withdrawal by Subject|4
5722483|NCT00059215|19701679|P4|Overall Study|Lost to Follow-up|0
5722484|NCT00059215|19701680|P3|Overall Study|Lost to Follow-up|0
5722485|NCT00059215|19701681|P2|Overall Study|Lost to Follow-up|2
5722486|NCT00059215|19701682|P1|Overall Study|Lost to Follow-up|1
5722487|NCT00059215|19701679|P4|Overall Study|Death|0
5722488|NCT00059215|19701680|P3|Overall Study|Death|3
5722489|NCT00059215|19701681|P2|Overall Study|Death|0
5722490|NCT00059215|19701682|P1|Overall Study|Death|0
5722491|NCT00059215|19701679|P4|Overall Study|Adverse Event|9
5722492|NCT00059215|19701680|P3|Overall Study|Adverse Event|9
5722493|NCT00059215|19701681|P2|Overall Study|Adverse Event|5
5722494|NCT00059215|19701682|P1|Overall Study|Adverse Event|5
5722495|NCT00058825|19701719|P1|Overall Study|Death|3
5722496|NCT00058825|19701719|P1|Overall Study|Graft Failure|5
5722497|NCT00058825|19701719|P1|Overall Study|Progressive Disease|5
5722498|NCT00058825|19701719|P1|Overall Study|Relapse|9
5722499|NCT00058552|19701735|P2|Overall Study|Clinical disease progression|4
5722500|NCT00058552|19701736|P1|Overall Study|Clinical disease progression|0
5722501|NCT00058552|19701735|P2|Overall Study|Physician Decision|5
5722502|NCT00058552|19701736|P1|Overall Study|Physician Decision|2
5722503|NCT00058552|19701735|P2|Overall Study|Withdrawal by Subject|5
5722504|NCT00058552|19701736|P1|Overall Study|Withdrawal by Subject|3
5722505|NCT00058552|19701735|P2|Overall Study|Adverse Event|2
5722506|NCT00058552|19701736|P1|Overall Study|Adverse Event|4
5722507|NCT00058552|19701735|P2|Overall Study|Disease progression|44
5722508|NCT00058552|19701736|P1|Overall Study|Disease progression|52
5722509|NCT00058552|19701735|P2|Overall Study|Died prior to receiving treatment|2
5722510|NCT00058552|19701736|P1|Overall Study|Died prior to receiving treatment|4
5722511|NCT00058539|19701754|P1|Overall Study|Death|1
5722512|NCT00058539|19701754|P1|Overall Study|Physician Decision|9
5722513|NCT00058539|19701754|P1|Overall Study|Withdrawal by Subject|5
5722514|NCT00058539|19701754|P1|Overall Study|Adverse Event|3
5722515|NCT00058539|19701754|P1|Overall Study|Disease progression|24
5722516|NCT00058422|19701764|P1|Overall Study|Not treated|2
5722517|NCT00058214|19701795|P1|Overall Study|Adverse Event|1
5722518|NCT00058123|19701817|P1|Overall Study|Received >3 prior treatments|1
5722519|NCT00058123|19701817|P1|Overall Study|Wrong histology|9
5722520|NCT00058058|19701824|P1|Overall Study|Poor positioning, illness,pain|3
5722521|NCT00058058|19701824|P1|Overall Study|technical issues|6
5722522|NCT00058058|19701824|P1|Overall Study|Claustrophobic|5
5722523|NCT00058058|19701824|P1|Overall Study|Ineligible|20
5722524|NCT00058058|19701824|P1|Overall Study|Withdrawal by Subject|4
5722525|NCT00057954|19701849|P1|Overall Study|Disease progression|1
5722526|NCT00057954|19701849|P1|Overall Study|Death|1
5722527|NCT00057941|19701857|P2|Overall Study|Ineligible|5
5722528|NCT00057941|19701858|P1|Overall Study|Ineligible|2
5722529|NCT00057941|19701857|P2|Overall Study|insurance, symptomatic deterioration|3
5722530|NCT00057941|19701858|P1|Overall Study|insurance, symptomatic deterioration|1
5722531|NCT00057941|19701857|P2|Overall Study|still on treatment|1
5722532|NCT00057941|19701858|P1|Overall Study|still on treatment|3
5722533|NCT00057941|19701857|P2|Overall Study|Withdrawal by Subject|1
5722534|NCT00057941|19701858|P1|Overall Study|Withdrawal by Subject|6
5722535|NCT00057941|19701857|P2|Overall Study|Lack of Efficacy|53
5722536|NCT00057941|19701858|P1|Overall Study|Lack of Efficacy|54
5722537|NCT00057941|19701857|P2|Overall Study|Adverse Event|9
5722538|NCT00057941|19701858|P1|Overall Study|Adverse Event|7
5722539|NCT00057941|19701857|P2|Overall Study|Death|2
5722540|NCT00057941|19701858|P1|Overall Study|Death|1
5722541|NCT00057876|19701866|P2|Overall Study|other complicating disease|0
5722542|NCT00057876|19701867|P1|Overall Study|other complicating disease|1
5722543|NCT00057876|19701866|P2|Overall Study|other reason|2
5722544|NCT00057876|19701867|P1|Overall Study|other reason|2
5722545|NCT00057876|19701866|P2|Overall Study|Ineligible|2
5722546|NCT00057876|19701867|P1|Overall Study|Ineligible|1
5722547|NCT00057876|19701866|P2|Overall Study|Lack of Efficacy|8
5722548|NCT00057876|19701867|P1|Overall Study|Lack of Efficacy|10
5722549|NCT00057876|19701866|P2|Overall Study|Withdrawal by Subject|6
5722550|NCT00057876|19701867|P1|Overall Study|Withdrawal by Subject|5
5722551|NCT00057876|19701866|P2|Overall Study|Death|1
5722552|NCT00057876|19701867|P1|Overall Study|Death|2
5722553|NCT00057876|19701866|P2|Overall Study|Adverse Event|8
5722554|NCT00057876|19701867|P1|Overall Study|Adverse Event|8
5722555|NCT00057863|19701877|P1|Overall Study|Withdrawal by Subject|2
5722556|NCT00057863|19701877|P1|Overall Study|Death|1
5722557|NCT00057837|19701886|P2|Overall Study|Never started treatment|1
5722558|NCT00057837|19701887|P1|Overall Study|Never started treatment|1
5722559|NCT00057837|19701886|P2|Overall Study|Ineligible|3
5722560|NCT00057837|19701887|P1|Overall Study|Ineligible|3
5722561|NCT00057837|19701886|P2|Overall Study|Physician Decision|0
5722562|NCT00057837|19701887|P1|Overall Study|Physician Decision|1
5722563|NCT00057837|19701886|P2|Overall Study|Other complicating disease|1
5722564|NCT00057837|19701887|P1|Overall Study|Other complicating disease|2
5722565|NCT00057837|19701886|P2|Overall Study|Alternative therapy|1
5722566|NCT00057837|19701887|P1|Overall Study|Alternative therapy|0
5722567|NCT00057837|19701886|P2|Overall Study|Withdrawal by Subject|3
5722568|NCT00057837|19701887|P1|Overall Study|Withdrawal by Subject|5
5722569|NCT00057837|19701886|P2|Overall Study|Death|4
5722570|NCT00057837|19701887|P1|Overall Study|Death|5
5722571|NCT00057837|19701886|P2|Overall Study|Adverse Event|12
5722572|NCT00057837|19701887|P1|Overall Study|Adverse Event|2
5722573|NCT00057837|19701886|P2|Overall Study|Progression/relapse|14
5722574|NCT00057837|19701887|P1|Overall Study|Progression/relapse|12
5722575|NCT00057811|19701899|P2|Overall Study|Inevaluable|2
5722576|NCT00057811|19701900|P1|Overall Study|Inevaluable|1
5722577|NCT00057811|19701899|P2|Overall Study|Ineligible|2
5722578|NCT00057811|19701900|P1|Overall Study|Ineligible|4
5722579|NCT00057811|19701899|P2|Overall Study|Withdrawal by Subject|4
5722580|NCT00057811|19701900|P1|Overall Study|Withdrawal by Subject|3
5722581|NCT00057811|19701899|P2|Overall Study|Physician Decision|0
5722582|NCT00057811|19701900|P1|Overall Study|Physician Decision|1
5722583|NCT00057811|19701899|P2|Overall Study|Lack of Efficacy|4
5722584|NCT00057811|19701900|P1|Overall Study|Lack of Efficacy|1
5722585|NCT00057746|19701919|P3|Overall Study|Withdrawal by Subject|1
5722586|NCT00057746|19701920|P2|Overall Study|Withdrawal by Subject|0
5722587|NCT00057746|19701921|P1|Overall Study|Withdrawal by Subject|0
5722588|NCT00023673|19701932|P4|Overall Study|Patient withdrew consent|1
5722589|NCT00023673|19701933|P3|Overall Study|Patient withdrew consent|0
5722590|NCT00023673|19701934|P2|Overall Study|Patient withdrew consent|0
5722591|NCT00023673|19701935|P1|Overall Study|Patient withdrew consent|0
5722592|NCT00023673|19701932|P4|Overall Study|Ineligible / no protocol treatment|1
5722593|NCT00023673|19701933|P3|Overall Study|Ineligible / no protocol treatment|0
5722594|NCT00023673|19701934|P2|Overall Study|Ineligible / no protocol treatment|0
5722595|NCT00023673|19701935|P1|Overall Study|Ineligible / no protocol treatment|0
5722596|NCT00057330|19701999|P2|Overall Study|Other|206
5722597|NCT00057330|19702000|P1|Overall Study|Other|260
5722598|NCT00057330|19701999|P2|Overall Study|Physician Decision|0
5722599|NCT00057330|19702000|P1|Overall Study|Physician Decision|1
5722600|NCT00057330|19701999|P2|Overall Study|Lost to Follow-up|617
5722601|NCT00057330|19702000|P1|Overall Study|Lost to Follow-up|745
5722602|NCT00057330|19701999|P2|Overall Study|Withdrawal by Subject|84
5722603|NCT00057330|19702000|P1|Overall Study|Withdrawal by Subject|115
5722604|NCT00057330|19701999|P2|Overall Study|Protocol Violation|1
5722605|NCT00057330|19702000|P1|Overall Study|Protocol Violation|1
5722606|NCT00057330|19701999|P2|Overall Study|Death|0
5722607|NCT00057330|19702000|P1|Overall Study|Death|1
5722608|NCT00057330|19701999|P2|Overall Study|Adverse Event|12
5722609|NCT00057330|19702000|P1|Overall Study|Adverse Event|9
5722610|NCT00056862|19702030|P2|Overall Study|Protocol Violation|0
5722611|NCT00056862|19702031|P1|Overall Study|Protocol Violation|1
5722612|NCT00056407|19702089|P2|Overall Study|Missing|34
5722613|NCT00056407|19702090|P1|Overall Study|Missing|25
5722614|NCT00056407|19702089|P2|Overall Study|"Listed as Other on Case Report Form"|60
5722615|NCT00056407|19702090|P1|Overall Study|"Listed as Other on Case Report Form"|98
5722616|NCT00056407|19702089|P2|Overall Study|Diagnosed with Prostate Cancer|166
5722617|NCT00056407|19702090|P1|Overall Study|Diagnosed with Prostate Cancer|202
5722618|NCT00056407|19702089|P2|Overall Study|Protocol Violation|95
5722619|NCT00056407|19702090|P1|Overall Study|Protocol Violation|104
5722620|NCT00056407|19702089|P2|Overall Study|Lost to Follow-up|113
5722621|NCT00056407|19702090|P1|Overall Study|Lost to Follow-up|123
5722622|NCT00056407|19702089|P2|Overall Study|Withdrawal by Subject|361
5722623|NCT00056407|19702090|P1|Overall Study|Withdrawal by Subject|377
5722624|NCT00056407|19702089|P2|Overall Study|Adverse Event|364
5722625|NCT00056407|19702090|P1|Overall Study|Adverse Event|282
5722626|NCT00056316|19702148|P2|Overall Study|Death/NH placement of pt|1
5722627|NCT00056316|19702149|P1|Overall Study|Death/NH placement of pt|1
5722628|NCT00056316|19702148|P2|Overall Study|Withdrawal by Subject|2
5722629|NCT00056316|19702149|P1|Overall Study|Withdrawal by Subject|2
5722630|NCT00056160|19702163|P2|Final Follow-up|Adverse Event|0
5722631|NCT00056160|19702164|P1|Final Follow-up|Adverse Event|1
5722632|NCT00056160|19702163|P2|Final Follow-up|Transferred into RevAssist Program|0
5722633|NCT00056160|19702164|P1|Final Follow-up|Transferred into RevAssist Program|2
5722634|NCT00056160|19702163|P2|Final Follow-up|Transferred into expanded access study.|0
5722635|NCT00056160|19702164|P1|Final Follow-up|Transferred into expanded access study.|3
5722636|NCT00056160|19702163|P2|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
5722637|NCT00056160|19702164|P1|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
5722638|NCT00056160|19702163|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
5722639|NCT00056160|19702164|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
5722640|NCT00056160|19702163|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
5722641|NCT00056160|19702164|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
5722642|NCT00056160|19702163|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
5722643|NCT00056160|19702164|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
5722644|NCT00056160|19702163|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
5722645|NCT00056160|19702164|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
5722646|NCT00056160|19702163|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
5722647|NCT00056160|19702164|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
5722648|NCT00056160|19702163|P2|Up to Unblinding (07 Jun 2005)|Other|7
5722649|NCT00056160|19702164|P1|Up to Unblinding (07 Jun 2005)|Other|8
5722650|NCT00056160|19702163|P2|Up to Unblinding (07 Jun 2005)|Death|1
5722651|NCT00056160|19702164|P1|Up to Unblinding (07 Jun 2005)|Death|2
5722652|NCT00056160|19702163|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
5722653|NCT00056160|19702164|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
5722654|NCT00056160|19702163|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
5722655|NCT00056160|19702164|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
5722656|NCT00056160|19702163|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
5722657|NCT00056160|19702164|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
5722658|NCT00056160|19702163|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
5722659|NCT00056160|19702164|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
5722660|NCT00055601|19702187|P2|Overall Study|No protocol treatment received|1
5722661|NCT00055601|19702188|P1|Overall Study|No protocol treatment received|1
5722662|NCT00055601|19702187|P2|Overall Study|Protocol Violation|1
5722663|NCT00055601|19702188|P1|Overall Study|Protocol Violation|1
5722664|NCT00055497|19702202|P4|Overall Study|Other|11
5722665|NCT00055497|19702203|P3|Overall Study|Other|0
5722666|NCT00055497|19702204|P2|Overall Study|Other|0
5722667|NCT00055497|19702205|P1|Overall Study|Other|0
5722668|NCT00055497|19702202|P4|Overall Study|Administrative Reasons|1
5722669|NCT00055497|19702203|P3|Overall Study|Administrative Reasons|0
5722670|NCT00055497|19702204|P2|Overall Study|Administrative Reasons|0
5722671|NCT00055497|19702205|P1|Overall Study|Administrative Reasons|0
5722672|NCT00055497|19702202|P4|Overall Study|Lack of Efficacy|27
5722673|NCT00055497|19702203|P3|Overall Study|Lack of Efficacy|0
5722674|NCT00055497|19702204|P2|Overall Study|Lack of Efficacy|0
5722675|NCT00055497|19702205|P1|Overall Study|Lack of Efficacy|1
5722676|NCT00055497|19702202|P4|Overall Study|Protocol Violation|3
5722677|NCT00055497|19702203|P3|Overall Study|Protocol Violation|0
5722678|NCT00055497|19702204|P2|Overall Study|Protocol Violation|0
5722679|NCT00055497|19702205|P1|Overall Study|Protocol Violation|0
5722680|NCT00055497|19702202|P4|Overall Study|Lost to Follow-up|5
5722681|NCT00055497|19702203|P3|Overall Study|Lost to Follow-up|0
5722682|NCT00055497|19702204|P2|Overall Study|Lost to Follow-up|1
5722683|NCT00055497|19702205|P1|Overall Study|Lost to Follow-up|0
5722684|NCT00055497|19702202|P4|Overall Study|Withdrawal by Subject|15
5722685|NCT00055497|19702203|P3|Overall Study|Withdrawal by Subject|1
5722686|NCT00055497|19702204|P2|Overall Study|Withdrawal by Subject|1
5722687|NCT00055497|19702205|P1|Overall Study|Withdrawal by Subject|3
5722688|NCT00055497|19702202|P4|Overall Study|Adverse Event|28
5722689|NCT00055497|19702203|P3|Overall Study|Adverse Event|1
5722690|NCT00055497|19702204|P2|Overall Study|Adverse Event|1
5722691|NCT00055497|19702205|P1|Overall Study|Adverse Event|1
5722692|NCT00055471|19702250|P3|Period 1: Dose Escalation Period|Disease progression|0
5722693|NCT00055471|19702251|P2|Period 1: Dose Escalation Period|Disease progression|1
5722694|NCT00055471|19702252|P1|Period 1: Dose Escalation Period|Disease progression|0
5722695|NCT00055471|19702250|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
5722696|NCT00055471|19702251|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
5722697|NCT00055471|19702252|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
5722698|NCT00055471|19702250|P3|Period 1: Dose Escalation Period|Adverse Event|2
5722699|NCT00055471|19702251|P2|Period 1: Dose Escalation Period|Adverse Event|1
5722700|NCT00055471|19702252|P1|Period 1: Dose Escalation Period|Adverse Event|0
5722701|NCT00054717|19702307|P2|Overall Study|Other reason not defined above|217
5722702|NCT00054717|19702308|P1|Overall Study|Other reason not defined above|117
5722703|NCT00054717|19702307|P2|Overall Study|Withdrawal by Subject|20
5722704|NCT00054717|19702308|P1|Overall Study|Withdrawal by Subject|32
5722705|NCT00054717|19702307|P2|Overall Study|Lost to Follow-up|13
5722706|NCT00054717|19702308|P1|Overall Study|Lost to Follow-up|23
5722707|NCT00054717|19702307|P2|Overall Study|Protocol Violation|19
5722708|NCT00054717|19702308|P1|Overall Study|Protocol Violation|18
5722709|NCT00054717|19702307|P2|Overall Study|Adverse Event|22
5722710|NCT00054717|19702308|P1|Overall Study|Adverse Event|70
5722711|NCT00054717|19702307|P2|Overall Study|Randomized but not treated|8
5722712|NCT00054717|19702308|P1|Overall Study|Randomized but not treated|2
5722713|NCT00054704|19702496|P2|Overall Study|Lost to Follow-up|1
5722714|NCT00054704|19702497|P1|Overall Study|Lost to Follow-up|0
5722715|NCT00054704|19702496|P2|Overall Study|Adverse Event|1
5722716|NCT00054704|19702497|P1|Overall Study|Adverse Event|3
5722717|NCT00054704|19702496|P2|Overall Study|Lack of Efficacy|3
5722718|NCT00054704|19702497|P1|Overall Study|Lack of Efficacy|2
5722719|NCT00054691|19702503|P1|Overall Study|Noncompliant|1
5722720|NCT00054691|19702503|P1|Overall Study|Unmeasurable Disease|2
5722721|NCT00054639|19702517|P1|Overall Study|Physician Decision|1
5722722|NCT00054639|19702517|P1|Overall Study|Lack of Efficacy|1
5722723|NCT00054327|19702550|P6|Overall Study|Engraftment failure|0
5722724|NCT00054327|19702551|P5|Overall Study|Engraftment failure|0
5722725|NCT00054327|19702552|P4|Overall Study|Engraftment failure|0
5722726|NCT00054327|19702553|P3|Overall Study|Engraftment failure|0
5722727|NCT00054327|19702554|P2|Overall Study|Engraftment failure|0
5722728|NCT00054327|19702555|P1|Overall Study|Engraftment failure|1
5722729|NCT00054275|19702593|P1|Overall Study|Physician Decision|1
5722730|NCT00054275|19702593|P1|Overall Study|Progressive disease in cycle 1|1
5722731|NCT00054275|19702593|P1|Overall Study|Adverse Event|5
5722732|NCT00054275|19702593|P1|Overall Study|Withdrawal by Subject|4
5722733|NCT00054132|19702599|P1|Overall Study|Not Treated|1
5722734|NCT00053898|19702626|P2|Overall Study|Follow-up from telephone contact only|1
5722735|NCT00053898|19702627|P1|Overall Study|Follow-up from telephone contact only|5
5722736|NCT00053898|19702626|P2|Overall Study|No follow-up data from any source|12
5722737|NCT00053898|19702627|P1|Overall Study|No follow-up data from any source|9
5722738|NCT00053846|19702653|P2|Overall Study|Pills too large|1
5722739|NCT00053846|19702654|P1|Overall Study|Pills too large|0
5722740|NCT00053846|19702653|P2|Overall Study|Quit due to side effects|3
5722741|NCT00053846|19702654|P1|Overall Study|Quit due to side effects|1
5722742|NCT00053846|19702653|P2|Overall Study|Did not return data|2
5722743|NCT00053846|19702654|P1|Overall Study|Did not return data|1
5722744|NCT00053846|19702653|P2|Overall Study|Became ineligible|1
5722745|NCT00053846|19702654|P1|Overall Study|Became ineligible|3
5722746|NCT00053846|19702653|P2|Overall Study|Expired|0
5722747|NCT00053846|19702654|P1|Overall Study|Expired|5
5722748|NCT00053846|19702653|P2|Overall Study|Became too ill|7
5722749|NCT00053846|19702654|P1|Overall Study|Became too ill|8
5722750|NCT00053846|19702653|P2|Overall Study|Changed mind|13
5722751|NCT00053846|19702654|P1|Overall Study|Changed mind|8
5722752|NCT00053417|19702813|P4|Overall Study|Lost to Follow-up|0
5722753|NCT00053417|19702814|P3|Overall Study|Lost to Follow-up|0
5722754|NCT00053417|19702815|P2|Overall Study|Lost to Follow-up|1
5722755|NCT00053417|19702816|P1|Overall Study|Lost to Follow-up|1
5722756|NCT00053417|19702813|P4|Overall Study|Withdrawal by Subject|0
5722757|NCT00053417|19702814|P3|Overall Study|Withdrawal by Subject|0
5722758|NCT00053417|19702815|P2|Overall Study|Withdrawal by Subject|1
5722759|NCT00053417|19702816|P1|Overall Study|Withdrawal by Subject|0
5722760|NCT00053417|19702813|P4|Overall Study|Non-Compliance|1
5722761|NCT00053417|19702814|P3|Overall Study|Non-Compliance|0
5722762|NCT00053417|19702815|P2|Overall Study|Non-Compliance|0
5722763|NCT00053417|19702816|P1|Overall Study|Non-Compliance|0
5722764|NCT00053417|19702813|P4|Overall Study|Adverse Event|5
5722765|NCT00053417|19702814|P3|Overall Study|Adverse Event|1
5722766|NCT00053417|19702815|P2|Overall Study|Adverse Event|0
5722767|NCT00053417|19702816|P1|Overall Study|Adverse Event|1
5722768|NCT00053365|19702826|P1|Overall Study|Never treated|4
5722769|NCT00053365|19702826|P1|Overall Study|Platinum-sensitive interval >12 months|1
5722770|NCT00053365|19702826|P1|Overall Study|Incorrect cell type|1
5722771|NCT00053352|19702835|P2|Overall Study|Disease at new site|0
5722772|NCT00053352|19702836|P1|Overall Study|Disease at new site|1
5722773|NCT00053352|19702835|P2|Overall Study|Ineligible|8
5722774|NCT00053352|19702836|P1|Overall Study|Ineligible|8
5722775|NCT00053352|19702835|P2|Overall Study|Withdrawal by Subject|0
5722776|NCT00053352|19702836|P1|Overall Study|Withdrawal by Subject|1
5722777|NCT00053352|19702835|P2|Overall Study|Physician Decision|1
5722778|NCT00053352|19702836|P1|Overall Study|Physician Decision|11
5722779|NCT00053352|19702835|P2|Overall Study|Lost to Follow-up|1
5722780|NCT00053352|19702836|P1|Overall Study|Lost to Follow-up|0
5722781|NCT00003830|19702852|P2|Overall Study|Sentinel node positive patients|793
5722782|NCT00003830|19702853|P1|Overall Study|Sentinel node positive patients|829
5722783|NCT00003830|19702852|P2|Overall Study|No follow up data|0
5722784|NCT00003830|19702853|P1|Overall Study|No follow up data|3
5722785|NCT00052962|19702879|P2|Overall Study|Not randomized/not evaluable|0
5722786|NCT00052962|19702880|P1|Overall Study|Not randomized/not evaluable|1
5722787|NCT00052962|19702879|P2|Overall Study|Not evaluable|2
5722788|NCT00052962|19702880|P1|Overall Study|Not evaluable|0
5722789|NCT00052715|19702899|P1|Overall Study|wrong histology|1
5722790|NCT00049673|19702915|P2|Overall Study|No receive treatment/lost to follow-up|3
5722791|NCT00049673|19702916|P1|Overall Study|No receive treatment/lost to follow-up|1
5722792|NCT00049543|19702926|P2|Overall Study|still on treatment|9
5722793|NCT00049543|19702927|P1|Overall Study|still on treatment|2
5722794|NCT00049530|19702937|P1|Overall Study|ineligible|3
5722795|NCT00049530|19702937|P1|Overall Study|symptomatic deterioration|1
5722796|NCT00049530|19702937|P1|Overall Study|Death|1
5722797|NCT00049530|19702937|P1|Overall Study|Adverse Event|2
5722798|NCT00049530|19702937|P1|Overall Study|Lack of Efficacy|25
5722799|NCT00049517|19702946|P6|Conditioning/Transplant|Reasons not reported|5
5722800|NCT00049517|19702947|P5|Conditioning/Transplant|Reasons not reported|5
5722801|NCT00049517|19702948|P4|Conditioning/Transplant|Reasons not reported|15
5722802|NCT00049517|19702949|P3|Conditioning/Transplant|Reasons not reported|18
5722803|NCT00049517|19702950|P2|Conditioning/Transplant|Reasons not reported|31
5722804|NCT00049517|19702951|P1|Conditioning/Transplant|Reasons not reported|25
5722805|NCT00049517|19702946|P6|Conditioning/Transplant|Other complicating disease|1
5722806|NCT00049517|19702947|P5|Conditioning/Transplant|Other complicating disease|0
5722807|NCT00049517|19702948|P4|Conditioning/Transplant|Other complicating disease|4
5722808|NCT00049517|19702949|P3|Conditioning/Transplant|Other complicating disease|0
5722809|NCT00049517|19702950|P2|Conditioning/Transplant|Other complicating disease|0
5722810|NCT00049517|19702951|P1|Conditioning/Transplant|Other complicating disease|2
5722811|NCT00049517|19702946|P6|Conditioning/Transplant|Alternative therapy|0
5722812|NCT00049517|19702947|P5|Conditioning/Transplant|Alternative therapy|1
5722813|NCT00049517|19702948|P4|Conditioning/Transplant|Alternative therapy|1
5722814|NCT00049517|19702949|P3|Conditioning/Transplant|Alternative therapy|2
5722815|NCT00049517|19702950|P2|Conditioning/Transplant|Alternative therapy|4
5722816|NCT00049517|19702951|P1|Conditioning/Transplant|Alternative therapy|4
5722817|NCT00049517|19702946|P6|Conditioning/Transplant|Withdrawal by Subject|0
5722818|NCT00049517|19702947|P5|Conditioning/Transplant|Withdrawal by Subject|0
5722819|NCT00049517|19702948|P4|Conditioning/Transplant|Withdrawal by Subject|7
5722820|NCT00049517|19702949|P3|Conditioning/Transplant|Withdrawal by Subject|4
5722821|NCT00049517|19702950|P2|Conditioning/Transplant|Withdrawal by Subject|8
5722822|NCT00049517|19702951|P1|Conditioning/Transplant|Withdrawal by Subject|4
5722823|NCT00049517|19702946|P6|Conditioning/Transplant|Death|0
5722824|NCT00049517|19702947|P5|Conditioning/Transplant|Death|0
5722825|NCT00049517|19702948|P4|Conditioning/Transplant|Death|2
5722826|NCT00049517|19702949|P3|Conditioning/Transplant|Death|0
5722827|NCT00049517|19702950|P2|Conditioning/Transplant|Death|0
5722828|NCT00049517|19702951|P1|Conditioning/Transplant|Death|1
5722829|NCT00049517|19702946|P6|Conditioning/Transplant|Adverse Event|0
5722830|NCT00049517|19702947|P5|Conditioning/Transplant|Adverse Event|0
5722831|NCT00049517|19702948|P4|Conditioning/Transplant|Adverse Event|8
5722832|NCT00049517|19702949|P3|Conditioning/Transplant|Adverse Event|4
5722833|NCT00049517|19702950|P2|Conditioning/Transplant|Adverse Event|1
5722834|NCT00049517|19702951|P1|Conditioning/Transplant|Adverse Event|2
5722835|NCT00049517|19702946|P6|Conditioning/Transplant|Disease progression|0
5722836|NCT00049517|19702947|P5|Conditioning/Transplant|Disease progression|0
5722837|NCT00049517|19702948|P4|Conditioning/Transplant|Disease progression|6
5722838|NCT00049517|19702949|P3|Conditioning/Transplant|Disease progression|10
5722839|NCT00049517|19702950|P2|Conditioning/Transplant|Disease progression|6
5722840|NCT00049517|19702951|P1|Conditioning/Transplant|Disease progression|14
5722841|NCT00049517|19702946|P6|Induction|Reasons not reported|25
5722842|NCT00049517|19702947|P5|Induction|Reasons not reported|22
5722843|NCT00049517|19702948|P4|Induction|Reasons not reported|0
5722844|NCT00049517|19702949|P3|Induction|Reasons not reported|0
5722845|NCT00049517|19702950|P2|Induction|Reasons not reported|0
5722846|NCT00049517|19702951|P1|Induction|Reasons not reported|0
5722847|NCT00049517|19702946|P6|Induction|Other complicating disease|0
5722848|NCT00049517|19702947|P5|Induction|Other complicating disease|3
5722849|NCT00049517|19702948|P4|Induction|Other complicating disease|0
5722850|NCT00049517|19702949|P3|Induction|Other complicating disease|0
5722851|NCT00049517|19702950|P2|Induction|Other complicating disease|0
5722852|NCT00049517|19702951|P1|Induction|Other complicating disease|0
5722853|NCT00049517|19702946|P6|Induction|Alternative therapy|2
5722854|NCT00049517|19702947|P5|Induction|Alternative therapy|2
5722855|NCT00049517|19702948|P4|Induction|Alternative therapy|0
5722856|NCT00049517|19702949|P3|Induction|Alternative therapy|0
5722857|NCT00049517|19702950|P2|Induction|Alternative therapy|0
5722858|NCT00049517|19702951|P1|Induction|Alternative therapy|0
5722859|NCT00049517|19702946|P6|Induction|Withdrawal by Subject|3
5722860|NCT00049517|19702947|P5|Induction|Withdrawal by Subject|1
5722861|NCT00049517|19702948|P4|Induction|Withdrawal by Subject|0
5722862|NCT00049517|19702949|P3|Induction|Withdrawal by Subject|0
5722863|NCT00049517|19702950|P2|Induction|Withdrawal by Subject|0
5722864|NCT00049517|19702951|P1|Induction|Withdrawal by Subject|0
5722865|NCT00049517|19702946|P6|Induction|Death|6
5722866|NCT00049517|19702947|P5|Induction|Death|9
5722867|NCT00049517|19702948|P4|Induction|Death|0
5722868|NCT00049517|19702949|P3|Induction|Death|0
5722869|NCT00049517|19702950|P2|Induction|Death|0
5722870|NCT00049517|19702951|P1|Induction|Death|0
5722871|NCT00049517|19702946|P6|Induction|Adverse Event|7
5722872|NCT00049517|19702947|P5|Induction|Adverse Event|5
5722873|NCT00049517|19702948|P4|Induction|Adverse Event|0
5722874|NCT00049517|19702949|P3|Induction|Adverse Event|0
5722875|NCT00049517|19702950|P2|Induction|Adverse Event|0
5722876|NCT00049517|19702951|P1|Induction|Adverse Event|0
5722877|NCT00049517|19702946|P6|Induction|Disease progression|11
5722878|NCT00049517|19702947|P5|Induction|Disease progression|18
5722879|NCT00049517|19702948|P4|Induction|Disease progression|0
5722880|NCT00049517|19702949|P3|Induction|Disease progression|0
5722881|NCT00049517|19702950|P2|Induction|Disease progression|0
5722882|NCT00049517|19702951|P1|Induction|Disease progression|0
5722883|NCT00049322|19702969|P2|Overall Study|refused angio|3
5722884|NCT00049322|19702970|P1|Overall Study|refused angio|0
5722885|NCT00049322|19702969|P2|Overall Study|Adverse Event|0
5722886|NCT00049322|19702970|P1|Overall Study|Adverse Event|1
5722887|NCT00049322|19702969|P2|Overall Study|disease burden|3
5722888|NCT00049322|19702970|P1|Overall Study|disease burden|0
5722889|NCT00049257|19702982|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
5722890|NCT00049257|19702982|P1|Carboplatin, Paclitaxel|Death|2
5722891|NCT00049257|19702982|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
5722892|NCT00049257|19702982|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
5722893|NCT00049127|19702994|P5|Overall Study|Withdrawal by Subject|0
5722894|NCT00049127|19702995|P4|Overall Study|Withdrawal by Subject|0
5722895|NCT00049127|19702996|P3|Overall Study|Withdrawal by Subject|1
5722896|NCT00049127|19702997|P2|Overall Study|Withdrawal by Subject|0
5722897|NCT00049127|19702998|P1|Overall Study|Withdrawal by Subject|0
5722898|NCT00048997|19703036|P2|Overall Study|Withdrawal by Subject|1
5722899|NCT00048997|19703037|P1|Overall Study|Withdrawal by Subject|6
5722900|NCT00048997|19703036|P2|Overall Study|Protocol Violation|2
5722901|NCT00048997|19703037|P1|Overall Study|Protocol Violation|7
5722902|NCT00047385|19703060|P2|Overall Study|Eligible for screening but had no screen|492
5722903|NCT00047385|19703061|P1|Overall Study|Eligible for screening but had no screen|260
5722904|NCT00047385|19703060|P2|Overall Study|Lung Cancer diagnosed before screening|3
5722905|NCT00047385|19703061|P1|Overall Study|Lung Cancer diagnosed before screening|5
5722906|NCT00047385|19703060|P2|Overall Study|Death before any screening|5
5722907|NCT00047385|19703061|P1|Overall Study|Death before any screening|2
5722908|NCT00047320|19703079|P1|Overall Study|Ineligible|2
5722909|NCT00047320|19703079|P1|Overall Study|Withdrawal by Subject|9
5722910|NCT00047320|19703079|P1|Overall Study|Physician Decision|8
5722911|NCT00047320|19703079|P1|Overall Study|Lost to Follow-up|1
5722912|NCT00047320|19703079|P1|Overall Study|Lack of Efficacy|8
5722913|NCT00047008|19703094|P2|Overall Study|Ineligible|8
5722914|NCT00047008|19703095|P1|Overall Study|Ineligible|9
5722915|NCT00047008|19703094|P2|Overall Study|Withdrawn consent|3
5722916|NCT00047008|19703095|P1|Overall Study|Withdrawn consent|2
5722917|NCT00046930|19703103|P2|Overall Study|Ineligible|4
5722918|NCT00046930|19703104|P1|Overall Study|Ineligible|12
5722919|NCT00046891|19703119|P2|Overall Study|Adverse Event|5
5722920|NCT00046891|19703120|P1|Overall Study|Adverse Event|5
5722921|NCT00046891|19703119|P2|Overall Study|Withdrawal by Subject|15
5722922|NCT00046891|19703120|P1|Overall Study|Withdrawal by Subject|18
5722923|NCT00046891|19703119|P2|Overall Study|Ineligible|1
5722924|NCT00046891|19703120|P1|Overall Study|Ineligible|1
5722925|NCT00046891|19703119|P2|Overall Study|Cancels|9
5722926|NCT00046891|19703120|P1|Overall Study|Cancels|5
5722927|NCT00046839|19703140|P2|Overall Study|Withdrawal of consent|0
5722928|NCT00046839|19703141|P1|Overall Study|Withdrawal of consent|1
5722929|NCT00046839|19703140|P2|Overall Study|Ineligible / No protocol treatment|2
5722930|NCT00046839|19703141|P1|Overall Study|Ineligible / No protocol treatment|0
5722931|NCT00045734|19703148|P1|Overall Study|Protocol Violation|1
5722932|NCT00045708|19703163|P3|Phase 1|early progressive disease|0
5722933|NCT00045708|19703164|P2|Phase 1|early progressive disease|1
5722934|NCT00045708|19703165|P1|Phase 1|early progressive disease|0
5722935|NCT00045630|19703190|P1|Overall Study|Ineligible|2
5722936|NCT00045630|19703190|P1|Overall Study|Death|1
5722937|NCT00045630|19703190|P1|Overall Study|Progression/relapse|1
5722938|NCT00045630|19703190|P1|Overall Study|Refusal unrelated to adverse event|1
5722939|NCT00045630|19703190|P1|Overall Study|Adverse Event|1
5722940|NCT00045305|19703209|P1|Overall Study|site error|2
5722941|NCT00045305|19703209|P1|Overall Study|Death|3
5722942|NCT00045305|19703209|P1|Overall Study|Adverse Event|3
5722943|NCT00045305|19703209|P1|Overall Study|Lack of Efficacy|6
5722944|NCT00045162|19703220|P2|Overall Study|Other|16
5722945|NCT00045162|19703221|P1|Overall Study|Other|21
5722946|NCT00045162|19703220|P2|Overall Study|Withdrawal by Subject|3
5722947|NCT00045162|19703221|P1|Overall Study|Withdrawal by Subject|5
5722948|NCT00045162|19703220|P2|Overall Study|Death|10
5722949|NCT00045162|19703221|P1|Overall Study|Death|10
5722950|NCT00045162|19703220|P2|Overall Study|Lack of Efficacy|29
5722951|NCT00045162|19703221|P1|Overall Study|Lack of Efficacy|32
5722952|NCT00045162|19703220|P2|Overall Study|Adverse Event|50
5722953|NCT00045162|19703221|P1|Overall Study|Adverse Event|55
5722954|NCT00045162|19703220|P2|Overall Study|Not treated|2
5722955|NCT00045162|19703221|P1|Overall Study|Not treated|7
5722956|NCT00045162|19703220|P2|Overall Study|Ineligible|8
5722957|NCT00045162|19703221|P1|Overall Study|Ineligible|12
5722958|NCT00045110|19703236|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
5722959|NCT00045110|19703237|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
5722960|NCT00045110|19703238|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
5722961|NCT00045110|19703236|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
5722962|NCT00045110|19703237|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
5722963|NCT00045110|19703238|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
5722964|NCT00045110|19703236|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
5722965|NCT00045110|19703237|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
5722966|NCT00045110|19703238|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
5722967|NCT00045032|19703287|P3|Overall Study|Other|105
5722968|NCT00045032|19703288|P2|Overall Study|Other|84
5722969|NCT00045032|19703289|P1|Overall Study|Other|93
5722970|NCT00045032|19703287|P3|Overall Study|Failure to Return|61
5722971|NCT00045032|19703288|P2|Overall Study|Failure to Return|62
5722972|NCT00045032|19703289|P1|Overall Study|Failure to Return|57
5722973|NCT00045032|19703287|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
5722974|NCT00045032|19703288|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
5722975|NCT00045032|19703289|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
5722976|NCT00045032|19703287|P3|Overall Study|Other Protocol Violation|1
5722977|NCT00045032|19703288|P2|Overall Study|Other Protocol Violation|0
5722978|NCT00045032|19703289|P1|Overall Study|Other Protocol Violation|2
5722979|NCT00045032|19703287|P3|Overall Study|Violation of Selection Criteria at Entry|6
5722980|NCT00045032|19703288|P2|Overall Study|Violation of Selection Criteria at Entry|6
5722981|NCT00045032|19703289|P1|Overall Study|Violation of Selection Criteria at Entry|3
5722982|NCT00045032|19703287|P3|Overall Study|Insufficient Therapeutic Response|445
5722983|NCT00045032|19703288|P2|Overall Study|Insufficient Therapeutic Response|437
5722984|NCT00045032|19703289|P1|Overall Study|Insufficient Therapeutic Response|542
5722985|NCT00045032|19703287|P3|Overall Study|Death|17
5722986|NCT00045032|19703288|P2|Overall Study|Death|24
5722987|NCT00045032|19703289|P1|Overall Study|Death|22
5722988|NCT00045032|19703287|P3|Overall Study|Adverse Event/Intercurrent Illness|7
5722989|NCT00045032|19703288|P2|Overall Study|Adverse Event/Intercurrent Illness|2
5723081|NCT00040742|19703598|P2|Overall Study|Adverse Event|16
5722990|NCT00045032|19703289|P1|Overall Study|Adverse Event/Intercurrent Illness|2
5722991|NCT00042991|19703423|P7|Overall Study|Alternative Therapy|0
5722992|NCT00042991|19703424|P6|Overall Study|Alternative Therapy|0
5722993|NCT00042991|19703425|P5|Overall Study|Alternative Therapy|1
5722994|NCT00042991|19703426|P4|Overall Study|Alternative Therapy|0
5722995|NCT00042991|19703427|P3|Overall Study|Alternative Therapy|0
5722996|NCT00042991|19703428|P2|Overall Study|Alternative Therapy|0
5722997|NCT00042991|19703429|P1|Overall Study|Alternative Therapy|0
5722998|NCT00042991|19703423|P7|Overall Study|Disease Progression|2
5722999|NCT00042991|19703424|P6|Overall Study|Disease Progression|4
5723000|NCT00042991|19703425|P5|Overall Study|Disease Progression|1
5723001|NCT00042991|19703426|P4|Overall Study|Disease Progression|2
5723002|NCT00042991|19703427|P3|Overall Study|Disease Progression|2
5723003|NCT00042991|19703428|P2|Overall Study|Disease Progression|29
5723004|NCT00042991|19703429|P1|Overall Study|Disease Progression|5
5723005|NCT00042991|19703423|P7|Overall Study|Withdrawal by Subject|0
5723006|NCT00042991|19703424|P6|Overall Study|Withdrawal by Subject|0
5723007|NCT00042991|19703425|P5|Overall Study|Withdrawal by Subject|1
5723008|NCT00042991|19703426|P4|Overall Study|Withdrawal by Subject|0
5723009|NCT00042991|19703427|P3|Overall Study|Withdrawal by Subject|2
5723010|NCT00042991|19703428|P2|Overall Study|Withdrawal by Subject|7
5723011|NCT00042991|19703429|P1|Overall Study|Withdrawal by Subject|0
5723012|NCT00042991|19703423|P7|Overall Study|Adverse Event|0
5723013|NCT00042991|19703424|P6|Overall Study|Adverse Event|1
5723014|NCT00042991|19703425|P5|Overall Study|Adverse Event|0
5723015|NCT00042991|19703426|P4|Overall Study|Adverse Event|0
5723016|NCT00042991|19703427|P3|Overall Study|Adverse Event|2
5723017|NCT00042991|19703428|P2|Overall Study|Adverse Event|4
5723018|NCT00042991|19703429|P1|Overall Study|Adverse Event|1
5723019|NCT00042939|19703472|P2|Overall Study|Did not start treatment|1
5723020|NCT00042939|19703473|P1|Overall Study|Did not start treatment|2
5723021|NCT00042939|19703472|P2|Overall Study|Treatment break > 4 weeks|1
5723022|NCT00042939|19703473|P1|Overall Study|Treatment break > 4 weeks|0
5723023|NCT00042939|19703472|P2|Overall Study|Still on treatment|0
5723024|NCT00042939|19703473|P1|Overall Study|Still on treatment|1
5723025|NCT00042939|19703472|P2|Overall Study|Patient non-compliance|0
5723026|NCT00042939|19703473|P1|Overall Study|Patient non-compliance|1
5723027|NCT00042939|19703472|P2|Overall Study|Rising ca 19-9|0
5723028|NCT00042939|19703473|P1|Overall Study|Rising ca 19-9|1
5723029|NCT00042939|19703472|P2|Overall Study|QOL diminished|0
5723030|NCT00042939|19703473|P1|Overall Study|QOL diminished|1
5723031|NCT00042939|19703472|P2|Overall Study|Deterioration of health|4
5723032|NCT00042939|19703473|P1|Overall Study|Deterioration of health|3
5723033|NCT00042939|19703472|P2|Overall Study|Ineligible|2
5723034|NCT00042939|19703473|P1|Overall Study|Ineligible|2
5723035|NCT00042939|19703472|P2|Overall Study|Other disease|0
5723036|NCT00042939|19703473|P1|Overall Study|Other disease|1
5723037|NCT00042939|19703472|P2|Overall Study|Withdrawal by Subject|4
5723038|NCT00042939|19703473|P1|Overall Study|Withdrawal by Subject|3
5723039|NCT00042939|19703472|P2|Overall Study|Death|2
5723040|NCT00042939|19703473|P1|Overall Study|Death|3
5723041|NCT00042939|19703472|P2|Overall Study|Adverse Event|7
5723042|NCT00042939|19703473|P1|Overall Study|Adverse Event|6
5723043|NCT00041132|19703487|P1|Overall Study|Physician Decision|2
5723044|NCT00041132|19703487|P1|Overall Study|Withdrawal by Subject|1
5723045|NCT00041132|19703487|P1|Overall Study|Not Eligible|7
5723046|NCT00041132|19703487|P1|Overall Study|Death|1
5723047|NCT00041132|19703487|P1|Overall Study|Adverse Event|19
5723048|NCT00041080|19703522|P2|Overall Study|Ineligible|0
5723049|NCT00041080|19703523|P1|Overall Study|Ineligible|1
5723050|NCT00041080|19703522|P2|Overall Study|Did not start therapy|1
5723051|NCT00041080|19703523|P1|Overall Study|Did not start therapy|1
5723052|NCT00041080|19703522|P2|Overall Study|Concommitant Illness/Other|2
5723053|NCT00041080|19703523|P1|Overall Study|Concommitant Illness/Other|1
5723054|NCT00041080|19703522|P2|Overall Study|Withdrawal by Subject|6
5723055|NCT00041080|19703523|P1|Overall Study|Withdrawal by Subject|6
5723056|NCT00041080|19703522|P2|Overall Study|Adverse Event|1
5723057|NCT00041080|19703523|P1|Overall Study|Adverse Event|21
5723058|NCT00041067|19703529|P1|Overall Study|Ineligible|2
5723059|NCT00041067|19703529|P1|Overall Study|Other reasons|23
5723060|NCT00041067|19703529|P1|Overall Study|Patient refusal|12
5723061|NCT00041067|19703529|P1|Overall Study|Progression|19
5723062|NCT00041067|19703529|P1|Overall Study|Adverse Event|20
5723063|NCT00040742|19703596|P4|Overall Study|Other medical|5
5723064|NCT00040742|19703597|P3|Overall Study|Other medical|5
5723065|NCT00040742|19703598|P2|Overall Study|Other medical|5
5723066|NCT00040742|19703599|P1|Overall Study|Other medical|7
5723067|NCT00040742|19703596|P4|Overall Study|Incomplete Forms|5
5723068|NCT00040742|19703597|P3|Overall Study|Incomplete Forms|4
5723069|NCT00040742|19703598|P2|Overall Study|Incomplete Forms|10
5723070|NCT00040742|19703599|P1|Overall Study|Incomplete Forms|6
5723071|NCT00040742|19703596|P4|Overall Study|Chemotoxicity|2
5723072|NCT00040742|19703597|P3|Overall Study|Chemotoxicity|5
5723073|NCT00040742|19703598|P2|Overall Study|Chemotoxicity|3
5723074|NCT00040742|19703599|P1|Overall Study|Chemotoxicity|4
5723075|NCT00040742|19703596|P4|Overall Study|Withdrawal by Subject|13
5723076|NCT00040742|19703597|P3|Overall Study|Withdrawal by Subject|10
5723077|NCT00040742|19703598|P2|Overall Study|Withdrawal by Subject|15
5723078|NCT00040742|19703599|P1|Overall Study|Withdrawal by Subject|7
5723079|NCT00040742|19703596|P4|Overall Study|Adverse Event|9
5723080|NCT00040742|19703597|P3|Overall Study|Adverse Event|21
5723082|NCT00040742|19703599|P1|Overall Study|Adverse Event|15
5723083|NCT00040742|19703596|P4|Overall Study|Death|0
5723084|NCT00040742|19703597|P3|Overall Study|Death|1
5723085|NCT00040742|19703598|P2|Overall Study|Death|0
5723086|NCT00040742|19703599|P1|Overall Study|Death|0
5723087|NCT00039377|19703613|P4|Initial Registration|Withdrawal by Subject|0
5723088|NCT00039377|19703614|P3|Initial Registration|Withdrawal by Subject|0
5723089|NCT00039377|19703615|P2|Initial Registration|Withdrawal by Subject|0
5723090|NCT00039377|19703616|P1|Initial Registration|Withdrawal by Subject|3
5723091|NCT00039377|19703613|P4|Initial Registration|Received non-protocol therapy|0
5723092|NCT00039377|19703614|P3|Initial Registration|Received non-protocol therapy|0
5723093|NCT00039377|19703615|P2|Initial Registration|Received non-protocol therapy|0
5723094|NCT00039377|19703616|P1|Initial Registration|Received non-protocol therapy|11
5723095|NCT00039377|19703613|P4|Initial Registration|Relapsed|0
5723096|NCT00039377|19703614|P3|Initial Registration|Relapsed|0
5723097|NCT00039377|19703615|P2|Initial Registration|Relapsed|0
5723098|NCT00039377|19703616|P1|Initial Registration|Relapsed|6
5723099|NCT00039377|19703613|P4|Initial Registration|Adverse Event|0
5723100|NCT00039377|19703614|P3|Initial Registration|Adverse Event|0
5723101|NCT00039377|19703615|P2|Initial Registration|Adverse Event|0
5723102|NCT00039377|19703616|P1|Initial Registration|Adverse Event|2
5723103|NCT00039130|19703632|P1|Overall Study|Physician Decision|3
5723104|NCT00039130|19703632|P1|Overall Study|Subsequent treatment|2
5723105|NCT00039130|19703632|P1|Overall Study|Progression|2
5723106|NCT00039130|19703632|P1|Overall Study|Withdrawal by Subject|3
5723107|NCT00039130|19703632|P1|Overall Study|Death|9
5723108|NCT00039130|19703632|P1|Overall Study|Adverse Event|11
5723109|NCT00033657|19703648|P2|Adjuvant Chemotherapy|Other|2
5723110|NCT00033657|19703649|P1|Adjuvant Chemotherapy|Other|0
5723111|NCT00033657|19703648|P2|Adjuvant Chemotherapy|alternative therapy|0
5723112|NCT00033657|19703649|P1|Adjuvant Chemotherapy|alternative therapy|1
5723113|NCT00033657|19703648|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
5723114|NCT00033657|19703649|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
5723115|NCT00033657|19703648|P2|Adjuvant Chemotherapy|Death|1
5723116|NCT00033657|19703649|P1|Adjuvant Chemotherapy|Death|2
5723117|NCT00033657|19703648|P2|Adjuvant Chemotherapy|Adverse Event|10
5723118|NCT00033657|19703649|P1|Adjuvant Chemotherapy|Adverse Event|7
5723119|NCT00033657|19703648|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
5723120|NCT00033657|19703649|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
5723121|NCT00033657|19703648|P2|Surgical Resection|not complete resection|3
5723122|NCT00033657|19703649|P1|Surgical Resection|not complete resection|0
5723123|NCT00033657|19703648|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
5723124|NCT00033657|19703649|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
5723125|NCT00033657|19703648|P2|Neoadjuvant Chemotherapy|Ineligible|4
5723126|NCT00033657|19703649|P1|Neoadjuvant Chemotherapy|Ineligible|8
5723127|NCT00033657|19703648|P2|Neoadjuvant Chemotherapy|other complicating disease|1
5723128|NCT00033657|19703649|P1|Neoadjuvant Chemotherapy|other complicating disease|0
5723129|NCT00033657|19703648|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
5723130|NCT00033657|19703649|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
5723131|NCT00033657|19703648|P2|Neoadjuvant Chemotherapy|Death|1
5723132|NCT00033657|19703649|P1|Neoadjuvant Chemotherapy|Death|1
5723133|NCT00033657|19703648|P2|Neoadjuvant Chemotherapy|Adverse Event|2
5723134|NCT00033657|19703649|P1|Neoadjuvant Chemotherapy|Adverse Event|0
5723135|NCT00033657|19703648|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
5723136|NCT00033657|19703649|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
5723137|NCT00033631|19703663|P2|Overall Study|Withdrawal by Subject|4
5723138|NCT00033631|19703664|P1|Overall Study|Withdrawal by Subject|4
5723139|NCT00033631|19703663|P2|Overall Study|Protocol Violation|11
5723140|NCT00033631|19703664|P1|Overall Study|Protocol Violation|14
5723141|NCT00033540|19703682|P1|Overall Study|Never received treatment|2
5723142|NCT00033540|19703682|P1|Overall Study|Ineligible|3
5723143|NCT00033540|19703682|P1|Overall Study|Other|5
5723144|NCT00033540|19703682|P1|Overall Study|Withdrawal by Subject|6
5723145|NCT00033540|19703682|P1|Overall Study|Progression|26
5723146|NCT00033540|19703682|P1|Overall Study|Death|1
5723147|NCT00033540|19703682|P1|Overall Study|Adverse Event|14
5723148|NCT00033514|19703692|P2|Overall Study|Withdrawal by Subject|3
5723149|NCT00033514|19703693|P1|Overall Study|Withdrawal by Subject|0
5723150|NCT00033514|19703692|P2|Overall Study|Lost to Follow-up|1
5723151|NCT00033514|19703693|P1|Overall Study|Lost to Follow-up|1
5723152|NCT00033371|19703703|P2|Overall Study|Disease Progression|1
5723153|NCT00033371|19703704|P1|Overall Study|Disease Progression|0
5723154|NCT00033371|19703703|P2|Overall Study|Withdrawal by Subject|3
5723155|NCT00033371|19703704|P1|Overall Study|Withdrawal by Subject|3
5723156|NCT00033371|19703703|P2|Overall Study|Lost to Follow-up|1
5723157|NCT00033371|19703704|P1|Overall Study|Lost to Follow-up|2
5723158|NCT00033371|19703703|P2|Overall Study|Adverse Event|5
5723159|NCT00033371|19703704|P1|Overall Study|Adverse Event|1
5723160|NCT00033293|19703722|P2|Overall Study|Treatment refused|6
5723161|NCT00033293|19703723|P1|Overall Study|Treatment refused|0
5723162|NCT00033293|19703722|P2|Overall Study|Could not be weaned from steroid therapy|1
5723163|NCT00033293|19703723|P1|Overall Study|Could not be weaned from steroid therapy|1
5723164|NCT00033293|19703722|P2|Overall Study|Withdrawal by Subject|0
5723165|NCT00033293|19703723|P1|Overall Study|Withdrawal by Subject|1
5723166|NCT00033293|19703722|P2|Overall Study|Physician Decision|1
5723167|NCT00033293|19703723|P1|Overall Study|Physician Decision|3
5723168|NCT00033293|19703722|P2|Overall Study|Lost to Follow-up|1
5723169|NCT00033293|19703723|P1|Overall Study|Lost to Follow-up|0
5723170|NCT00033293|19703722|P2|Overall Study|Lack of Efficacy|8
5723171|NCT00033293|19703723|P1|Overall Study|Lack of Efficacy|5
5723172|NCT00033293|19703722|P2|Overall Study|Death|1
5723173|NCT00033293|19703723|P1|Overall Study|Death|0
5723174|NCT00031694|19703741|P1|Overall Study|Withdrawal by Subject|5
5723175|NCT00031694|19703741|P1|Overall Study|Death|2
5723176|NCT00031694|19703741|P1|Overall Study|Adverse Event|12
5723177|NCT00031590|19703745|P1|Overall Study|Withdrawal by parents|2
5723178|NCT00031590|19703745|P1|Overall Study|Adverse Event|1
5723179|NCT00030901|19703752|P3|Randomization|Ineligible|14
5723180|NCT00030901|19703753|P2|Randomization|Ineligible|15
5723181|NCT00030901|19703754|P1|Randomization|Ineligible|0
5723182|NCT00030901|19703752|P3|Randomization|Other|33
5723183|NCT00030901|19703753|P2|Randomization|Other|36
5723184|NCT00030901|19703754|P1|Randomization|Other|0
5723185|NCT00030901|19703752|P3|Randomization|Death|3
5723186|NCT00030901|19703753|P2|Randomization|Death|1
5723187|NCT00030901|19703754|P1|Randomization|Death|0
5723188|NCT00030901|19703752|P3|Randomization|Progression/Relapse|21
5723189|NCT00030901|19703753|P2|Randomization|Progression/Relapse|22
5723190|NCT00030901|19703754|P1|Randomization|Progression/Relapse|0
5723191|NCT00030901|19703752|P3|Randomization|Refusal Unrelated to Adverse Event|10
5723192|NCT00030901|19703753|P2|Randomization|Refusal Unrelated to Adverse Event|16
5723193|NCT00030901|19703754|P1|Randomization|Refusal Unrelated to Adverse Event|0
5723194|NCT00030901|19703752|P3|Randomization|Adverse Event|7
5723195|NCT00030901|19703753|P2|Randomization|Adverse Event|11
5723196|NCT00030901|19703754|P1|Randomization|Adverse Event|0
5723197|NCT00030901|19703752|P3|Initial Registration|Ineligible|0
5723198|NCT00030901|19703753|P2|Initial Registration|Ineligible|0
5723199|NCT00030901|19703754|P1|Initial Registration|Ineligible|167
5723200|NCT00030823|19703762|P1|Overall Study|Withdrawal by Subject|1
5723201|NCT00028769|19703770|P1|Overall Study|Not Analyzable|1
5723202|NCT00028769|19703770|P1|Overall Study|Ineligible|5
5723203|NCT00028769|19703770|P1|Overall Study|Other - Not Protocol Specified|1
5723204|NCT00028769|19703770|P1|Overall Study|Progression or Death|31
5723205|NCT00028769|19703770|P1|Overall Study|Refusal Unrelated to Adverse Events|1
5723206|NCT00028769|19703770|P1|Overall Study|Adverse Event|2
5723207|NCT00028002|19703776|P1|Overall Study|Ineligible|8
5723208|NCT00028002|19703776|P1|Overall Study|Withdrawal by Subject|3
5723209|NCT00027846|19703786|P3|Overall Study|Neuraxis dissemination during/after ther|5
5723210|NCT00027846|19703787|P2|Overall Study|Neuraxis dissemination during/after ther|2
5723211|NCT00027846|19703788|P1|Overall Study|Neuraxis dissemination during/after ther|0
5723212|NCT00027846|19703786|P3|Overall Study|Entry into another COG therapeutic study|2
5723213|NCT00027846|19703787|P2|Overall Study|Entry into another COG therapeutic study|5
5723214|NCT00027846|19703788|P1|Overall Study|Entry into another COG therapeutic study|0
5723215|NCT00027846|19703786|P3|Overall Study|Ineligible for study|14
5723216|NCT00027846|19703787|P2|Overall Study|Ineligible for study|6
5723217|NCT00027846|19703788|P1|Overall Study|Ineligible for study|2
5723218|NCT00027846|19703786|P3|Overall Study|Withdrawal by Subject|7
5723219|NCT00027846|19703787|P2|Overall Study|Withdrawal by Subject|14
5723220|NCT00027846|19703788|P1|Overall Study|Withdrawal by Subject|0
5723221|NCT00027846|19703786|P3|Overall Study|Lost to Follow-up|9
5723222|NCT00027846|19703787|P2|Overall Study|Lost to Follow-up|41
5723223|NCT00027846|19703788|P1|Overall Study|Lost to Follow-up|0
5723224|NCT00027560|19703806|P1|Overall Study|Withdrawal by Subject|1
5723225|NCT00026494|19703819|P4|Overall Study|Clinical progression|0
5723226|NCT00026494|19703820|P3|Overall Study|Clinical progression|3
5723227|NCT00026494|19703821|P2|Overall Study|Clinical progression|0
5723228|NCT00026494|19703822|P1|Overall Study|Clinical progression|0
5723229|NCT00026494|19703819|P4|Overall Study|Patient not treated|0
5723230|NCT00026494|19703820|P3|Overall Study|Patient not treated|2
5723231|NCT00026494|19703821|P2|Overall Study|Patient not treated|0
5723232|NCT00026494|19703822|P1|Overall Study|Patient not treated|0
5723233|NCT00026494|19703819|P4|Overall Study|Patient non-compliance|0
5723234|NCT00026494|19703820|P3|Overall Study|Patient non-compliance|0
5723235|NCT00026494|19703821|P2|Overall Study|Patient non-compliance|0
5723236|NCT00026494|19703822|P1|Overall Study|Patient non-compliance|1
5723237|NCT00026494|19703819|P4|Overall Study|Withdrawal by Subject|0
5723238|NCT00026494|19703820|P3|Overall Study|Withdrawal by Subject|1
5723239|NCT00026494|19703821|P2|Overall Study|Withdrawal by Subject|0
5723240|NCT00026494|19703822|P1|Overall Study|Withdrawal by Subject|1
5723241|NCT00026312|19703834|P2|Overall Study|Refusal by patient/parent/guardian|59
5723242|NCT00026312|19703835|P1|Overall Study|Refusal by patient/parent/guardian|8
5723243|NCT00026312|19703834|P2|Overall Study|Entry onto another COG study|1
5723244|NCT00026312|19703835|P1|Overall Study|Entry onto another COG study|0
5723245|NCT00026312|19703834|P2|Overall Study|Ineligible|5
5723246|NCT00026312|19703835|P1|Overall Study|Ineligible|4
5723247|NCT00026312|19703834|P2|Overall Study|Withdrawal by Subject|6
5723248|NCT00026312|19703835|P1|Overall Study|Withdrawal by Subject|1
5723249|NCT00026312|19703834|P2|Overall Study|Protocol Violation|3
5723250|NCT00026312|19703835|P1|Overall Study|Protocol Violation|0
5723251|NCT00026312|19703834|P2|Overall Study|Physician Decision|37
5723252|NCT00026312|19703835|P1|Overall Study|Physician Decision|1
5723253|NCT00026312|19703834|P2|Overall Study|Lost to Follow-up|5
5723254|NCT00026312|19703835|P1|Overall Study|Lost to Follow-up|0
5723255|NCT00026312|19703834|P2|Overall Study|Lack of Efficacy|114
5723256|NCT00026312|19703835|P1|Overall Study|Lack of Efficacy|19
5723257|NCT00026312|19703834|P2|Overall Study|Death|7
5723258|NCT00026312|19703835|P1|Overall Study|Death|1
5723259|NCT00026312|19703834|P2|Overall Study|Adverse Event|32
5723260|NCT00026312|19703835|P1|Overall Study|Adverse Event|0
5723261|NCT00026208|19703874|P2|Overall Study|Complications of auto accident|0
5723262|NCT00026208|19703875|P1|Overall Study|Complications of auto accident|1
5723263|NCT00025662|19703893|P1|Overall Study|Technical failure of manipulation|1
5723264|NCT00025662|19703893|P1|Overall Study|Withdrawal by Subject|2
5723265|NCT00025506|19703901|P1|Overall Study|Never Treated|2
5723266|NCT00025506|19703901|P1|Overall Study|Ineligible: inadequate pathology|2
5723267|NCT00025506|19703901|P1|Overall Study|Ineligible: wrong cell type|5
5723268|NCT00025506|19703901|P1|Overall Study|Ineligible: clerical error|1
5723269|NCT00025259|19703922|P7|Overall Study|Adverse Event|0
5723270|NCT00025259|19703923|P6|Overall Study|Adverse Event|0
5723271|NCT00025259|19703924|P5|Overall Study|Adverse Event|0
5723272|NCT00025259|19703925|P4|Overall Study|Adverse Event|0
5723273|NCT00025259|19703926|P3|Overall Study|Adverse Event|0
5723274|NCT00025259|19703927|P2|Overall Study|Adverse Event|0
5723275|NCT00025259|19703928|P1|Overall Study|Adverse Event|1
5723276|NCT00025259|19703922|P7|Overall Study|Randomization error|2
5723277|NCT00025259|19703923|P6|Overall Study|Randomization error|7
5723278|NCT00025259|19703924|P5|Overall Study|Randomization error|1
5723279|NCT00025259|19703925|P4|Overall Study|Randomization error|0
5723280|NCT00025259|19703926|P3|Overall Study|Randomization error|0
5723281|NCT00025259|19703927|P2|Overall Study|Randomization error|0
5723282|NCT00025259|19703928|P1|Overall Study|Randomization error|1
5723283|NCT00025259|19703922|P7|Overall Study|Ineligible|1
5723284|NCT00025259|19703923|P6|Overall Study|Ineligible|0
5723285|NCT00025259|19703924|P5|Overall Study|Ineligible|6
5723286|NCT00025259|19703925|P4|Overall Study|Ineligible|0
5723287|NCT00025259|19703926|P3|Overall Study|Ineligible|0
5723288|NCT00025259|19703927|P2|Overall Study|Ineligible|1
5723289|NCT00025259|19703928|P1|Overall Study|Ineligible|14
5723290|NCT00025259|19703922|P7|Overall Study|Withdrawal by Subject|3
5723291|NCT00025259|19703923|P6|Overall Study|Withdrawal by Subject|8
5723292|NCT00025259|19703924|P5|Overall Study|Withdrawal by Subject|11
5723293|NCT00025259|19703925|P4|Overall Study|Withdrawal by Subject|14
5723294|NCT00025259|19703926|P3|Overall Study|Withdrawal by Subject|6
5723295|NCT00025259|19703927|P2|Overall Study|Withdrawal by Subject|27
5723296|NCT00025259|19703928|P1|Overall Study|Withdrawal by Subject|9
5723297|NCT00025259|19703922|P7|Overall Study|Protocol Violation|3
5723298|NCT00025259|19703923|P6|Overall Study|Protocol Violation|1
5723299|NCT00025259|19703924|P5|Overall Study|Protocol Violation|2
5723300|NCT00025259|19703925|P4|Overall Study|Protocol Violation|1
5723301|NCT00025259|19703926|P3|Overall Study|Protocol Violation|2
5723302|NCT00025259|19703927|P2|Overall Study|Protocol Violation|2
5723303|NCT00025259|19703928|P1|Overall Study|Protocol Violation|3
5723304|NCT00025259|19703922|P7|Overall Study|Physician Decision|1
5723305|NCT00025259|19703923|P6|Overall Study|Physician Decision|2
5723306|NCT00025259|19703924|P5|Overall Study|Physician Decision|4
5723307|NCT00025259|19703925|P4|Overall Study|Physician Decision|5
5723308|NCT00025259|19703926|P3|Overall Study|Physician Decision|0
5723309|NCT00025259|19703927|P2|Overall Study|Physician Decision|1
5723310|NCT00025259|19703928|P1|Overall Study|Physician Decision|12
5723311|NCT00025259|19703922|P7|Overall Study|Lost to Follow-up|1
5723312|NCT00025259|19703923|P6|Overall Study|Lost to Follow-up|3
5723313|NCT00025259|19703924|P5|Overall Study|Lost to Follow-up|1
5723314|NCT00025259|19703925|P4|Overall Study|Lost to Follow-up|13
5723315|NCT00025259|19703926|P3|Overall Study|Lost to Follow-up|13
5723316|NCT00025259|19703927|P2|Overall Study|Lost to Follow-up|9
5723317|NCT00025259|19703928|P1|Overall Study|Lost to Follow-up|2
5723318|NCT00025259|19703922|P7|Overall Study|Lack of Efficacy|38
5723319|NCT00025259|19703923|P6|Overall Study|Lack of Efficacy|30
5723320|NCT00025259|19703924|P5|Overall Study|Lack of Efficacy|11
5723321|NCT00025259|19703925|P4|Overall Study|Lack of Efficacy|78
5723322|NCT00025259|19703926|P3|Overall Study|Lack of Efficacy|60
5723323|NCT00025259|19703927|P2|Overall Study|Lack of Efficacy|46
5723324|NCT00025259|19703928|P1|Overall Study|Lack of Efficacy|2
5723325|NCT00025259|19703922|P7|Overall Study|Death|2
5723326|NCT00025259|19703923|P6|Overall Study|Death|1
5723327|NCT00025259|19703924|P5|Overall Study|Death|0
5723328|NCT00025259|19703925|P4|Overall Study|Death|3
5723329|NCT00025259|19703926|P3|Overall Study|Death|0
5723330|NCT00025259|19703927|P2|Overall Study|Death|3
5723331|NCT00025259|19703928|P1|Overall Study|Death|1
5723332|NCT00025233|19703964|P1|Overall Study|Never treated|1
5723333|NCT00025233|19703964|P1|Overall Study|Ineligible: improper prior treatment|1
5723334|NCT00025233|19703964|P1|Overall Study|Ineligible: wrong primary|1
5723335|NCT00025233|19703964|P1|Overall Study|Ineligible: wrong cell type|1
5723336|NCT00025155|19703979|P1|Overall Study|Ineligible: Second primary cancer site|1
5723337|NCT00025155|19703979|P1|Overall Study|Ineligible: Wrong primary cancer site|1
5723338|NCT00024258|19703990|P1|Overall Study|Disease Progression|8
5723339|NCT00024258|19703990|P1|Overall Study|Withdrawal by Subject|1
5723340|NCT00024167|19703997|P2|Overall Study|Death|47
5723341|NCT00024167|19703998|P1|Overall Study|Death|53
5723342|NCT00023764|19704022|P1|Overall Study|delay in obtaining staging images|1
5723343|NCT00023764|19704022|P1|Overall Study|patient received other treatment|1
5723344|NCT00023764|19704022|P1|Overall Study|Progression of disease|6
5723345|NCT00023764|19704022|P1|Overall Study|Withdrawal by Subject|1
5723346|NCT00023764|19704022|P1|Overall Study|Adverse Event|4
5723347|NCT00023764|19704022|P1|Overall Study|Other|1
5723348|NCT00023712|19704029|P2|Overall Study|Never treated|1
5723349|NCT00023712|19704030|P1|Overall Study|Never treated|1
5723350|NCT00023712|19704029|P2|Overall Study|Not platinum sensitive|0
5723351|NCT00023712|19704030|P1|Overall Study|Not platinum sensitive|1
5723352|NCT00022698|19704054|P2|Overall Study|Administrative /other|7
5723353|NCT00022698|19704055|P1|Overall Study|Administrative /other|1
5723354|NCT00022698|19704054|P2|Overall Study|Insufficient therapeutic response|14
5723355|NCT00022698|19704055|P1|Overall Study|Insufficient therapeutic response|2
5723356|NCT00022698|19704054|P2|Overall Study|Refused treatment|2
5723357|NCT00022698|19704055|P1|Overall Study|Refused treatment|0
5723358|NCT00022698|19704054|P2|Overall Study|Failure to return|1
5723359|NCT00022698|19704055|P1|Overall Study|Failure to return|0
5723360|NCT00022698|19704054|P2|Overall Study|Death|2
5723361|NCT00022698|19704055|P1|Overall Study|Death|0
5723362|NCT00022698|19704054|P2|Overall Study|Adverse Event|9
5723363|NCT00022698|19704055|P1|Overall Study|Adverse Event|5
5723364|NCT00022672|19704080|P2|Extension Phase|Other|1
5723365|NCT00022672|19704081|P1|Extension Phase|Other|1
5723366|NCT00022672|19704080|P2|Extension Phase|Refused Treatment|2
5723367|NCT00022672|19704081|P1|Extension Phase|Refused Treatment|0
5723368|NCT00022672|19704080|P2|Extension Phase|Insufficient Therapeutic Response|44
5723369|NCT00022672|19704081|P1|Extension Phase|Insufficient Therapeutic Response|1
5723370|NCT00022672|19704080|P2|Extension Phase|Death|1
5723371|NCT00022672|19704081|P1|Extension Phase|Death|0
5723372|NCT00022672|19704080|P2|Extension Phase|Adverse Event|3
5723373|NCT00022672|19704081|P1|Extension Phase|Adverse Event|1
5723374|NCT00022672|19704080|P2|Main Phase: 24 Months|Other|0
5723375|NCT00022672|19704081|P1|Main Phase: 24 Months|Other|1
5723376|NCT00022672|19704080|P2|Main Phase: 24 Months|Failure to Return|1
5723377|NCT00022672|19704081|P1|Main Phase: 24 Months|Failure to Return|1
5723378|NCT00022672|19704080|P2|Main Phase: 24 Months|Refused Treatment|4
5723379|NCT00022672|19704081|P1|Main Phase: 24 Months|Refused Treatment|3
5723380|NCT00022672|19704080|P2|Main Phase: 24 Months|Other Protocol Violation|0
5723381|NCT00022672|19704081|P1|Main Phase: 24 Months|Other Protocol Violation|1
5723382|NCT00022672|19704080|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
5723383|NCT00022672|19704081|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
5723384|NCT00022672|19704080|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
5723385|NCT00022672|19704081|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
5723386|NCT00022672|19704080|P2|Main Phase: 24 Months|Death|3
5723387|NCT00022672|19704081|P1|Main Phase: 24 Months|Death|0
5723388|NCT00022672|19704080|P2|Main Phase: 24 Months|Adverse Event|0
5723389|NCT00022672|19704081|P1|Main Phase: 24 Months|Adverse Event|6
5723390|NCT00022659|19704114|P1|Overall Study|Never treated|1
5723391|NCT00022659|19704114|P1|Overall Study|Ineligible: wrong primary|1
5723392|NCT00022633|19704127|P2|Overall Study|Ineligible|0
5723393|NCT00022633|19704128|P1|Overall Study|Ineligible|4
5723394|NCT00022633|19704127|P2|Overall Study|Other - not protocol specified|2
5723395|NCT00022633|19704128|P1|Overall Study|Other - not protocol specified|3
5723396|NCT00022633|19704127|P2|Overall Study|Death|0
5723397|NCT00022633|19704128|P1|Overall Study|Death|4
5723398|NCT00022633|19704127|P2|Overall Study|Progression/relapse|2
5723399|NCT00022633|19704128|P1|Overall Study|Progression/relapse|9
5723400|NCT00022633|19704127|P2|Overall Study|Refusal unrelated to adverse event|0
5723401|NCT00022633|19704128|P1|Overall Study|Refusal unrelated to adverse event|1
5723402|NCT00022633|19704127|P2|Overall Study|Adverse Event|1
5723403|NCT00022633|19704128|P1|Overall Study|Adverse Event|11
5723404|NCT00022516|19704141|P2|Overall Study|Incomplete documentation|27
5723405|NCT00022516|19704142|P1|Overall Study|Incomplete documentation|0
5723406|NCT00022516|19704141|P2|Overall Study|Withdrawal by Subject|113
5723407|NCT00022516|19704142|P1|Overall Study|Withdrawal by Subject|2
5723408|NCT00022516|19704141|P2|Overall Study|Protocol Violation|3
5723409|NCT00022516|19704142|P1|Overall Study|Protocol Violation|1
5723410|NCT00022516|19704141|P2|Overall Study|Physician Decision|1
5723411|NCT00022516|19704142|P1|Overall Study|Physician Decision|0
5723412|NCT00022516|19704141|P2|Overall Study|Lack of Efficacy|27
5723413|NCT00022516|19704142|P1|Overall Study|Lack of Efficacy|0
5723414|NCT00022516|19704141|P2|Overall Study|Adverse Event|59
5723415|NCT00022516|19704142|P1|Overall Study|Adverse Event|0
5723416|NCT00021255|19704161|P3|Overall Study|Randomized but not treated|18
5723417|NCT00021255|19704162|P2|Overall Study|Randomized but not treated|2
5723418|NCT00021255|19704163|P1|Overall Study|Randomized but not treated|28
5723419|NCT00021255|19704161|P3|Overall Study|Missing|13
5723420|NCT00021255|19704162|P2|Overall Study|Missing|27
5723421|NCT00021255|19704163|P1|Overall Study|Missing|0
5723422|NCT00021255|19704161|P3|Overall Study|Other than specified above|19
5723423|NCT00021255|19704162|P2|Overall Study|Other than specified above|38
5723424|NCT00021255|19704163|P1|Overall Study|Other than specified above|0
5723425|NCT00021255|19704161|P3|Overall Study|Protocol Violation|0
5723426|NCT00021255|19704162|P2|Overall Study|Protocol Violation|2
5723427|NCT00021255|19704163|P1|Overall Study|Protocol Violation|0
5723428|NCT00021255|19704161|P3|Overall Study|Adverse Event|18
5723429|NCT00021255|19704162|P2|Overall Study|Adverse Event|30
5723430|NCT00021255|19704163|P1|Overall Study|Adverse Event|46
5723431|NCT00021255|19704161|P3|Overall Study|Herceptin toxicity|6
5723432|NCT00021255|19704162|P2|Overall Study|Herceptin toxicity|22
5723433|NCT00021255|19704163|P1|Overall Study|Herceptin toxicity|0
5723434|NCT00021255|19704161|P3|Overall Study|Cardiac toxicity|32
5723435|NCT00021255|19704162|P2|Overall Study|Cardiac toxicity|61
5723436|NCT00021255|19704163|P1|Overall Study|Cardiac toxicity|0
5723437|NCT00021255|19704161|P3|Overall Study|Lost to Follow-up|3
5723438|NCT00021255|19704162|P2|Overall Study|Lost to Follow-up|2
5723439|NCT00021255|19704163|P1|Overall Study|Lost to Follow-up|0
5723440|NCT00021255|19704161|P3|Overall Study|Withdrawal by Subject|26
5723441|NCT00021255|19704162|P2|Overall Study|Withdrawal by Subject|64
5723442|NCT00021255|19704163|P1|Overall Study|Withdrawal by Subject|41
5723443|NCT00021255|19704161|P3|Overall Study|Second primary malignancy|1
5723444|NCT00021255|19704162|P2|Overall Study|Second primary malignancy|4
5723445|NCT00021255|19704163|P1|Overall Study|Second primary malignancy|0
5723446|NCT00021255|19704161|P3|Overall Study|Breast cancer relapse|11
5723447|NCT00021255|19704162|P2|Overall Study|Breast cancer relapse|18
5723448|NCT00021255|19704163|P1|Overall Study|Breast cancer relapse|5
5723449|NCT00021255|19704161|P3|Overall Study|Death|2
5723450|NCT00021255|19704162|P2|Overall Study|Death|0
5723451|NCT00021255|19704163|P1|Overall Study|Death|1
5723452|NCT00021229|19704180|P3|Overall Study|Punctate hemmorrhage post RT|0
5723453|NCT00021229|19704181|P2|Overall Study|Punctate hemmorrhage post RT|0
5723454|NCT00021229|19704182|P1|Overall Study|Punctate hemmorrhage post RT|2
5723455|NCT00021229|19704180|P3|Overall Study|Physician Decision|1
5723456|NCT00021229|19704181|P2|Overall Study|Physician Decision|0
5723457|NCT00021229|19704182|P1|Overall Study|Physician Decision|0
5723458|NCT00021229|19704180|P3|Overall Study|Protocol Violation|0
5723459|NCT00021229|19704181|P2|Overall Study|Protocol Violation|1
5723460|NCT00021229|19704182|P1|Overall Study|Protocol Violation|1
5723461|NCT00021229|19704180|P3|Overall Study|Progressive Disease|12
5723462|NCT00021229|19704181|P2|Overall Study|Progressive Disease|19
5723463|NCT00021229|19704182|P1|Overall Study|Progressive Disease|15
5723464|NCT00021229|19704180|P3|Overall Study|Withdrawal by Subject|1
5723465|NCT00021229|19704181|P2|Overall Study|Withdrawal by Subject|7
5723466|NCT00021229|19704182|P1|Overall Study|Withdrawal by Subject|7
5723467|NCT00021229|19704180|P3|Overall Study|Death|0
5723468|NCT00021229|19704181|P2|Overall Study|Death|1
5723469|NCT00021229|19704182|P1|Overall Study|Death|0
5723470|NCT00021229|19704180|P3|Overall Study|Adverse Event|2
5723471|NCT00021229|19704181|P2|Overall Study|Adverse Event|5
5723472|NCT00021229|19704182|P1|Overall Study|Adverse Event|10
5723473|NCT00019604|19704237|P1|Overall Study|Details for other not available|4
5723474|NCT00019604|19704237|P1|Overall Study|Unable to evaluate|1
5723475|NCT00019604|19704237|P1|Overall Study|Too much disease|1
5723476|NCT00019604|19704237|P1|Overall Study|Pt going to immunotherapy study|1
5723477|NCT00019604|19704237|P1|Overall Study|Started new chemo regimen|1
5723478|NCT00019604|19704237|P1|Overall Study|Resectable disease|1
5723479|NCT00019604|19704237|P1|Overall Study|Non compliant|1
5723480|NCT00019604|19704237|P1|Overall Study|Non compliant on systemic CH|1
5723481|NCT00019604|19704237|P1|Overall Study|Move to a different study|1
5723482|NCT00019604|19704237|P1|Overall Study|Going to have liver transplant|1
5723483|NCT00019604|19704237|P1|Overall Study|Carcinoid tumor, not treatable|1
5723484|NCT00019604|19704237|P1|Overall Study|Refused treatment|1
5723485|NCT00019604|19704237|P1|Overall Study|Progressive disease|23
5723486|NCT00019604|19704237|P1|Overall Study|Death|1
5723487|NCT00016354|19704260|P8|Overall Study|Lack of Efficacy|1
5723488|NCT00016354|19704261|P7|Overall Study|Lack of Efficacy|0
5723489|NCT00016354|19704262|P6|Overall Study|Lack of Efficacy|0
5723490|NCT00016354|19704263|P5|Overall Study|Lack of Efficacy|0
5723491|NCT00016354|19704264|P4|Overall Study|Lack of Efficacy|0
5723492|NCT00016354|19704265|P3|Overall Study|Lack of Efficacy|0
5723493|NCT00016354|19704266|P2|Overall Study|Lack of Efficacy|0
5723494|NCT00016354|19704267|P1|Overall Study|Lack of Efficacy|0
5723495|NCT00014495|19704281|P4|Overall Study|Clinical deterioration|1
5723496|NCT00014495|19704282|P3|Overall Study|Clinical deterioration|0
5723497|NCT00014495|19704283|P2|Overall Study|Clinical deterioration|0
5723498|NCT00014495|19704284|P1|Overall Study|Clinical deterioration|0
5723499|NCT00014495|19704281|P4|Overall Study|Death|0
5723500|NCT00014495|19704282|P3|Overall Study|Death|1
5723501|NCT00014495|19704283|P2|Overall Study|Death|0
5723502|NCT00014495|19704284|P1|Overall Study|Death|0
5723503|NCT00012012|19704350|P2|Overall Study|Withdrawal by Subject|2
5723504|NCT00012012|19704351|P1|Overall Study|Withdrawal by Subject|0
5723505|NCT00012012|19704350|P2|Overall Study|Protocol Violation|1
5723506|NCT00012012|19704351|P1|Overall Study|Protocol Violation|1
5723507|NCT00010257|19704390|P2|Overall Study|Withdrawal by Subject|0
5723508|NCT00010257|19704391|P1|Overall Study|Withdrawal by Subject|1
5723509|NCT00009945|19704401|P2|Overall Study|no follow up data|5
5723510|NCT00009945|19704402|P1|Overall Study|no follow up data|7
5723511|NCT00008385|19704418|P2|Overall Study|Not start protocol therapy|175
5723512|NCT00008385|19704419|P1|Overall Study|Not start protocol therapy|44
5723513|NCT00008385|19704418|P2|Overall Study|Other|212
5723514|NCT00008385|19704419|P1|Overall Study|Other|105
5723515|NCT00008385|19704418|P2|Overall Study|Maximum dose reached|2
5723516|NCT00008385|19704419|P1|Overall Study|Maximum dose reached|0
5723517|NCT00008385|19704418|P2|Overall Study|Other complicating disease|30
5723518|NCT00008385|19704419|P1|Overall Study|Other complicating disease|17
5723519|NCT00008385|19704418|P2|Overall Study|Start non-protocol therapy|1
5723520|NCT00008385|19704419|P1|Overall Study|Start non-protocol therapy|3
5723521|NCT00008385|19704418|P2|Overall Study|Withdrawal by Subject|157
5723522|NCT00008385|19704419|P1|Overall Study|Withdrawal by Subject|67
5723523|NCT00008385|19704418|P2|Overall Study|Death|18
5723524|NCT00008385|19704419|P1|Overall Study|Death|12
5723525|NCT00008385|19704418|P2|Overall Study|Adverse Event|20
5723526|NCT00008385|19704419|P1|Overall Study|Adverse Event|8
5723527|NCT00008385|19704418|P2|Overall Study|Progressive disease|117
5723528|NCT00008385|19704419|P1|Overall Study|Progressive disease|52
5723529|NCT00008385|19704418|P2|Overall Study|Off treatment reasons not reported|70
5723530|NCT00008385|19704419|P1|Overall Study|Off treatment reasons not reported|79
5723531|NCT00008138|19704429|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
5723532|NCT00008138|19704429|P1|Post-Cytoreduction Chemotherapy|Progression|1
5723533|NCT00008138|19704429|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
5723534|NCT00008138|19704429|P1|Interval Debulking|Withdrawal by Subject|2
5723535|NCT00008138|19704429|P1|Neoadjuvant Chemotherapy|not protocol specified|8
5723536|NCT00008138|19704429|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
5723537|NCT00008138|19704429|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
5723538|NCT00008138|19704429|P1|Neoadjuvant Chemotherapy|Adverse Event|3
5723539|NCT00006916|19704435|P1|Overall Study|Complication of device insertion|1
5723540|NCT00006916|19704435|P1|Overall Study|Device not inserted|4
5723541|NCT00006903|19704441|P3|Overall Study|Ineligible|2
5723542|NCT00006903|19704442|P2|Overall Study|Ineligible|1
5723543|NCT00006903|19704443|P1|Overall Study|Ineligible|10
5723544|NCT00006903|19704441|P3|Overall Study|Patient never treated|1
5723545|NCT00006903|19704442|P2|Overall Study|Patient never treated|0
5723546|NCT00006903|19704443|P1|Overall Study|Patient never treated|0
5723547|NCT00006903|19704441|P3|Overall Study|Death|0
5723548|NCT00006903|19704442|P2|Overall Study|Death|1
5723549|NCT00006903|19704443|P1|Overall Study|Death|0
5723550|NCT00006903|19704441|P3|Overall Study|Adverse Event|1
5723551|NCT00006903|19704442|P2|Overall Study|Adverse Event|0
5723552|NCT00006903|19704443|P1|Overall Study|Adverse Event|0
5723553|NCT00006903|19704441|P3|Overall Study|Refused further treatment|1
5723554|NCT00006903|19704442|P2|Overall Study|Refused further treatment|2
5723555|NCT00006903|19704443|P1|Overall Study|Refused further treatment|0
5723556|NCT00006903|19704441|P3|Overall Study|Still receiving treatment|1
5723557|NCT00006903|19704442|P2|Overall Study|Still receiving treatment|0
5723558|NCT00006903|19704443|P1|Overall Study|Still receiving treatment|0
5723559|NCT00006721|19704456|P3|Overall Study|Eligible but no Treatment Received|0
5723560|NCT00006721|19704457|P2|Overall Study|Eligible but no Treatment Received|0
5723561|NCT00006721|19704458|P1|Overall Study|Eligible but no Treatment Received|1
5723562|NCT00006721|19704456|P3|Overall Study|Ineligible|10
5723563|NCT00006721|19704457|P2|Overall Study|Ineligible|12
5723564|NCT00006721|19704458|P1|Overall Study|Ineligible|2
5723565|NCT00006721|19704456|P3|Overall Study|Other - Not Protocol Specified|7
5723566|NCT00006721|19704457|P2|Overall Study|Other - Not Protocol Specified|7
5723567|NCT00006721|19704458|P1|Overall Study|Other - Not Protocol Specified|0
5723568|NCT00006721|19704456|P3|Overall Study|Death|2
5723569|NCT00006721|19704457|P2|Overall Study|Death|1
5723570|NCT00006721|19704458|P1|Overall Study|Death|0
5723571|NCT00006721|19704456|P3|Overall Study|Progression/Relapse|2
5723572|NCT00006721|19704457|P2|Overall Study|Progression/Relapse|1
5723573|NCT00006721|19704458|P1|Overall Study|Progression/Relapse|0
5723574|NCT00006721|19704456|P3|Overall Study|Refusal Unrelated to Adverse Event|8
5723575|NCT00006721|19704457|P2|Overall Study|Refusal Unrelated to Adverse Event|0
5723576|NCT00006721|19704458|P1|Overall Study|Refusal Unrelated to Adverse Event|1
5723577|NCT00006721|19704456|P3|Overall Study|Adverse Event|4
5723578|NCT00006721|19704457|P2|Overall Study|Adverse Event|4
5723579|NCT00006721|19704458|P1|Overall Study|Adverse Event|0
5723580|NCT00006478|19704476|P1|Overall Study|Physician Decision|6
5723581|NCT00006478|19704476|P1|Overall Study|Vaccine could not be produced|1
5723582|NCT00006392|19704487|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
5723583|NCT00006392|19704488|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
5723584|NCT00006392|19704489|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
5723585|NCT00006392|19704490|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
5723586|NCT00006392|19704487|P4|Overall Study|Ineligible|5
5723587|NCT00006392|19704488|P3|Overall Study|Ineligible|5
5723588|NCT00006392|19704489|P2|Overall Study|Ineligible|3
5723589|NCT00006392|19704490|P1|Overall Study|Ineligible|11
5723590|NCT00006389|19704520|P1|Overall Study|Adverse Event|1
5723591|NCT00006237|19704537|P2|Overall Study|Not protocol specified|5
5723592|NCT00006237|19704538|P1|Overall Study|Not protocol specified|14
5723593|NCT00006237|19704537|P2|Overall Study|Withdrawal by Subject|1
5723594|NCT00006237|19704538|P1|Overall Study|Withdrawal by Subject|0
5723595|NCT00006237|19704537|P2|Overall Study|Not eligible|20
5723596|NCT00006237|19704538|P1|Overall Study|Not eligible|9
5723597|NCT00006237|19704537|P2|Overall Study|Progression/relapse|2
5723598|NCT00006237|19704538|P1|Overall Study|Progression/relapse|54
5723599|NCT00006237|19704537|P2|Overall Study|Refusal unrelated to adverse effects|4
5723600|NCT00006237|19704538|P1|Overall Study|Refusal unrelated to adverse effects|8
5723601|NCT00006237|19704537|P2|Overall Study|Death|0
5723602|NCT00006237|19704538|P1|Overall Study|Death|1
5723603|NCT00006237|19704537|P2|Overall Study|Adverse Event|29
5723604|NCT00006237|19704538|P1|Overall Study|Adverse Event|39
5723605|NCT00006011|19704581|P3|Overall Study|Ineligible|9
5723606|NCT00006011|19704582|P2|Overall Study|Ineligible|16
5723607|NCT00006011|19704583|P1|Overall Study|Ineligible|18
5723608|NCT00006011|19704581|P3|Overall Study|Other|5
5723609|NCT00006011|19704582|P2|Overall Study|Other|2
5723610|NCT00006011|19704583|P1|Overall Study|Other|4
5723611|NCT00006011|19704581|P3|Overall Study|Death|2
5723612|NCT00006011|19704582|P2|Overall Study|Death|1
5723613|NCT00006011|19704583|P1|Overall Study|Death|0
5723614|NCT00006011|19704581|P3|Overall Study|Adverse Event|5
5723615|NCT00006011|19704582|P2|Overall Study|Adverse Event|39
5723616|NCT00006011|19704583|P1|Overall Study|Adverse Event|15
5723617|NCT00006011|19704581|P3|Overall Study|Refused further treatment|26
5723618|NCT00006011|19704582|P2|Overall Study|Refused further treatment|13
5723619|NCT00006011|19704583|P1|Overall Study|Refused further treatment|15
5723620|NCT00006011|19704581|P3|Overall Study|Disease progression|26
5723621|NCT00006011|19704582|P2|Overall Study|Disease progression|6
5723622|NCT00006011|19704583|P1|Overall Study|Disease progression|13
5723623|NCT00005957|19704591|P2|Overall Study|Crossover to the other arm|19
5723624|NCT00005957|19704592|P1|Overall Study|Crossover to the other arm|5
5723625|NCT00005957|19704591|P2|Overall Study|No treated|9
5723626|NCT00005957|19704592|P1|Overall Study|No treated|3
5723627|NCT00005879|19704602|P2|Overall Study|Withdrawal by Subject|10
5723628|NCT00005879|19704603|P1|Overall Study|Withdrawal by Subject|8
5723629|NCT00005047|19704626|P4|Overall Study|Lack of Efficacy|0
5723630|NCT00005047|19704627|P3|Overall Study|Lack of Efficacy|0
5723631|NCT00005047|19704628|P2|Overall Study|Lack of Efficacy|0
5723632|NCT00005047|19704629|P1|Overall Study|Lack of Efficacy|1
5723633|NCT00005047|19704626|P4|Overall Study|Lost to Follow-up|0
5723634|NCT00005047|19704627|P3|Overall Study|Lost to Follow-up|0
5723635|NCT00005047|19704628|P2|Overall Study|Lost to Follow-up|0
5723636|NCT00005047|19704629|P1|Overall Study|Lost to Follow-up|1
5723637|NCT00005047|19704626|P4|Overall Study|Adverse Event|0
5723638|NCT00005047|19704627|P3|Overall Study|Adverse Event|0
5723639|NCT00005047|19704628|P2|Overall Study|Adverse Event|0
5723640|NCT00005047|19704629|P1|Overall Study|Adverse Event|5
5723641|NCT00005047|19704626|P4|Overall Study|Withdrawal by Subject|0
5723642|NCT00005047|19704627|P3|Overall Study|Withdrawal by Subject|0
5723643|NCT00005047|19704628|P2|Overall Study|Withdrawal by Subject|0
5723644|NCT00005047|19704629|P1|Overall Study|Withdrawal by Subject|12
5723645|NCT00005044|19704645|P2|Overall Study|No protocol treatment|1
5723646|NCT00005044|19704646|P1|Overall Study|No protocol treatment|0
5723647|NCT00005044|19704645|P2|Overall Study|Withdrawal by Subject|5
5723648|NCT00005044|19704646|P1|Overall Study|Withdrawal by Subject|1
5723649|NCT00005044|19704645|P2|Overall Study|Protocol Violation|46
5723650|NCT00005044|19704646|P1|Overall Study|Protocol Violation|37
5723651|NCT00004888|19704666|P2|Overall Study|Toxic death|0
5723652|NCT00004888|19704667|P1|Overall Study|Toxic death|1
5723653|NCT00004888|19704666|P2|Overall Study|Death without progressive disease|1
5723654|NCT00004888|19704667|P1|Overall Study|Death without progressive disease|0
5723655|NCT00004888|19704666|P2|Overall Study|Progressive Disease|9
5723656|NCT00004888|19704667|P1|Overall Study|Progressive Disease|4
5723657|NCT00004888|19704666|P2|Overall Study|Physician Decision|1
5723658|NCT00004888|19704667|P1|Overall Study|Physician Decision|1
5723659|NCT00004888|19704666|P2|Overall Study|Withdrawal by Subject|3
5723660|NCT00004888|19704667|P1|Overall Study|Withdrawal by Subject|0
5723661|NCT00004888|19704666|P2|Overall Study|Adverse Event|10
5723662|NCT00004888|19704667|P1|Overall Study|Adverse Event|5
5723663|NCT00004859|19704685|P2|Overall Study|Other|21
5723664|NCT00004859|19704686|P1|Overall Study|Other|13
5723665|NCT00004859|19704685|P2|Overall Study|missing data|11
5723666|NCT00004859|19704686|P1|Overall Study|missing data|14
5723667|NCT00004859|19704685|P2|Overall Study|error|1
5723668|NCT00004859|19704686|P1|Overall Study|error|3
5723669|NCT00004859|19704685|P2|Overall Study|other disease|3
5723670|NCT00004859|19704686|P1|Overall Study|other disease|0
5723671|NCT00004859|19704685|P2|Overall Study|Protocol Violation|2
5723672|NCT00004859|19704686|P1|Overall Study|Protocol Violation|2
5723673|NCT00004859|19704685|P2|Overall Study|Withdrawal by Subject|33
5723674|NCT00004859|19704686|P1|Overall Study|Withdrawal by Subject|7
5723675|NCT00004859|19704685|P2|Overall Study|Death|5
5723676|NCT00004859|19704686|P1|Overall Study|Death|5
5723677|NCT00004859|19704685|P2|Overall Study|Adverse Event|93
5723678|NCT00004859|19704686|P1|Overall Study|Adverse Event|31
5723679|NCT00004859|19704685|P2|Overall Study|Lack of Efficacy|113
5723680|NCT00004859|19704686|P1|Overall Study|Lack of Efficacy|43
5723681|NCT00004259|19704700|P4|Overall Study|Withdrawal by Subject|0
5723682|NCT00004259|19704701|P3|Overall Study|Withdrawal by Subject|0
5723683|NCT00004259|19704702|P2|Overall Study|Withdrawal by Subject|2
5723684|NCT00004259|19704703|P1|Overall Study|Withdrawal by Subject|0
5723685|NCT00004259|19704700|P4|Overall Study|Protocol Violation|0
5723686|NCT00004259|19704701|P3|Overall Study|Protocol Violation|0
5723687|NCT00004259|19704702|P2|Overall Study|Protocol Violation|2
5723688|NCT00004259|19704703|P1|Overall Study|Protocol Violation|1
5723689|NCT00004228|19704728|P7|Overall Study|ineligible|5
5723690|NCT00004228|19704729|P6|Overall Study|ineligible|2
5723691|NCT00004228|19704730|P5|Overall Study|ineligible|1
5723692|NCT00004228|19704731|P4|Overall Study|ineligible|1
5723693|NCT00004228|19704732|P3|Overall Study|ineligible|4
5723694|NCT00004228|19704733|P2|Overall Study|ineligible|2
5723695|NCT00004228|19704734|P1|Overall Study|ineligible|4
5723696|NCT00004228|19704728|P7|Overall Study|Other|0
5723697|NCT00004228|19704729|P6|Overall Study|Other|0
5723698|NCT00004228|19704730|P5|Overall Study|Other|0
5723699|NCT00004228|19704731|P4|Overall Study|Other|0
5723700|NCT00004228|19704732|P3|Overall Study|Other|1
5723701|NCT00004228|19704733|P2|Overall Study|Other|0
5723702|NCT00004228|19704734|P1|Overall Study|Other|0
5723703|NCT00004228|19704728|P7|Overall Study|Withdrawal by Subject|2
5723704|NCT00004228|19704729|P6|Overall Study|Withdrawal by Subject|1
5723705|NCT00004228|19704730|P5|Overall Study|Withdrawal by Subject|2
5723706|NCT00004228|19704731|P4|Overall Study|Withdrawal by Subject|0
5723707|NCT00004228|19704732|P3|Overall Study|Withdrawal by Subject|1
5723708|NCT00004228|19704733|P2|Overall Study|Withdrawal by Subject|0
5723709|NCT00004228|19704734|P1|Overall Study|Withdrawal by Subject|3
5723710|NCT00004228|19704728|P7|Overall Study|Protocol Violation|0
5723711|NCT00004228|19704729|P6|Overall Study|Protocol Violation|2
5723712|NCT00004228|19704730|P5|Overall Study|Protocol Violation|1
5723713|NCT00004228|19704731|P4|Overall Study|Protocol Violation|1
5723714|NCT00004228|19704732|P3|Overall Study|Protocol Violation|2
5723715|NCT00004228|19704733|P2|Overall Study|Protocol Violation|5
5723716|NCT00004228|19704734|P1|Overall Study|Protocol Violation|0
5723717|NCT00004228|19704728|P7|Overall Study|Physician Decision|1
5723718|NCT00004228|19704729|P6|Overall Study|Physician Decision|1
5723719|NCT00004228|19704730|P5|Overall Study|Physician Decision|1
5723720|NCT00004228|19704731|P4|Overall Study|Physician Decision|2
5723721|NCT00004228|19704732|P3|Overall Study|Physician Decision|3
5723722|NCT00004228|19704733|P2|Overall Study|Physician Decision|0
5723723|NCT00004228|19704734|P1|Overall Study|Physician Decision|1
5723724|NCT00004228|19704728|P7|Overall Study|Lost to Follow-up|0
5723725|NCT00004228|19704729|P6|Overall Study|Lost to Follow-up|0
5723726|NCT00004228|19704730|P5|Overall Study|Lost to Follow-up|0
5723727|NCT00004228|19704731|P4|Overall Study|Lost to Follow-up|0
5723728|NCT00004228|19704732|P3|Overall Study|Lost to Follow-up|1
5723729|NCT00004228|19704733|P2|Overall Study|Lost to Follow-up|0
5723730|NCT00004228|19704734|P1|Overall Study|Lost to Follow-up|0
5723731|NCT00004228|19704728|P7|Overall Study|Lack of Efficacy|4
5723732|NCT00004228|19704729|P6|Overall Study|Lack of Efficacy|8
5723733|NCT00004228|19704730|P5|Overall Study|Lack of Efficacy|9
5723734|NCT00004228|19704731|P4|Overall Study|Lack of Efficacy|3
5723735|NCT00004228|19704732|P3|Overall Study|Lack of Efficacy|5
5723736|NCT00004228|19704733|P2|Overall Study|Lack of Efficacy|6
5723737|NCT00004228|19704734|P1|Overall Study|Lack of Efficacy|1
5723738|NCT00004228|19704728|P7|Overall Study|Death|0
5723739|NCT00004228|19704729|P6|Overall Study|Death|0
5723740|NCT00004228|19704730|P5|Overall Study|Death|1
5723741|NCT00004228|19704731|P4|Overall Study|Death|0
5723742|NCT00004228|19704732|P3|Overall Study|Death|2
5723743|NCT00004228|19704733|P2|Overall Study|Death|1
5723744|NCT00004228|19704734|P1|Overall Study|Death|0
5723745|NCT00004228|19704728|P7|Overall Study|Adverse Event|0
5723746|NCT00004228|19704729|P6|Overall Study|Adverse Event|0
5723747|NCT00004228|19704730|P5|Overall Study|Adverse Event|1
5723748|NCT00004228|19704731|P4|Overall Study|Adverse Event|0
5723749|NCT00004228|19704732|P3|Overall Study|Adverse Event|0
5723750|NCT00004228|19704733|P2|Overall Study|Adverse Event|1
5723751|NCT00004228|19704734|P1|Overall Study|Adverse Event|0
5723752|NCT00004124|19704768|P2|Overall Study|Received no protocol therapy|20
5723753|NCT00004124|19704769|P1|Overall Study|Received no protocol therapy|12
5723754|NCT00004088|19704794|P1|Overall Study|Physician Decision|1
5723755|NCT00004088|19704794|P1|Overall Study|Protocol Violation|3
5723756|NCT00004088|19704794|P1|Overall Study|Withdrawal by Subject|1
5723757|NCT00004088|19704794|P1|Overall Study|No C2 given due to study on hold by IRB|4
5723758|NCT00003901|19704827|P1|Overall Study|Medical problems|6
5723759|NCT00003901|19704827|P1|Overall Study|Chest X-Ray not done prior registration|1
5723760|NCT00003901|19704827|P1|Overall Study|CT Scan not within protocol requirement|2
5723761|NCT00003901|19704827|P1|Overall Study|Ineligible|6
5723762|NCT00003901|19704827|P1|Overall Study|Withdrawal by Subject|1
5723763|NCT00003901|19704827|P1|Overall Study|Adverse Event|1
5723764|NCT00003896|19704838|P1|Overall Study|ineligible|5
5723765|NCT00003896|19704838|P1|Overall Study|not protocol specified|3
5723766|NCT00003896|19704838|P1|Overall Study|Death|3
5723767|NCT00003896|19704838|P1|Overall Study|Lack of Efficacy|1
5723768|NCT00003896|19704838|P1|Overall Study|Withdrawal by Subject|1
5723769|NCT00003896|19704838|P1|Overall Study|Adverse Event|16
5723770|NCT00003875|19704844|P1|Overall Study|Screen Failed|1
5723771|NCT00003869|19704853|P2|Overall Study|Alternative treatmnt, medical problems|4
5723772|NCT00003869|19704854|P1|Overall Study|Alternative treatmnt, medical problems|5
5723773|NCT00003869|19704853|P2|Overall Study|Death|2
5723774|NCT00003869|19704854|P1|Overall Study|Death|1
5723775|NCT00003869|19704853|P2|Overall Study|Withdrawal by Subject|3
5723776|NCT00003869|19704854|P1|Overall Study|Withdrawal by Subject|21
5723777|NCT00003869|19704853|P2|Overall Study|Adverse Event|3
5723778|NCT00003869|19704854|P1|Overall Study|Adverse Event|14
5723779|NCT00003782|19704880|P3|Overall Study|No follow up data|26
5723780|NCT00003782|19704881|P2|Overall Study|No follow up data|31
5723781|NCT00003782|19704882|P1|Overall Study|No follow up data|30
5723782|NCT00003702|19704892|P2|Overall Study|Inadequate documentation of disease|3
5723783|NCT00003702|19704893|P1|Overall Study|Inadequate documentation of disease|1
5723784|NCT00003702|19704892|P2|Overall Study|WHO score > 6|1
5723785|NCT00003702|19704893|P1|Overall Study|WHO score > 6|2
5723786|NCT00003702|19704892|P2|Overall Study|Did not meet criteria for persistence|5
5723787|NCT00003702|19704893|P1|Overall Study|Did not meet criteria for persistence|8
5723788|NCT00003702|19704892|P2|Overall Study|Ineligible cell types|2
5723789|NCT00003702|19704893|P1|Overall Study|Ineligible cell types|2
5723790|NCT00003659|19704902|P1|Overall Study|Withdrawal by Subject|3
5723791|NCT00003641|19704923|P2|Overall Study|Never started interferon|12
5723792|NCT00003641|19704924|P1|Overall Study|Never started interferon|567
5723793|NCT00003641|19704923|P2|Overall Study|Should not receive interferon therapy|0
5723794|NCT00003641|19704924|P1|Overall Study|Should not receive interferon therapy|2
5723795|NCT00003641|19704923|P2|Overall Study|Unknown/missing|22
5723796|NCT00003641|19704924|P1|Overall Study|Unknown/missing|0
5723797|NCT00003641|19704923|P2|Overall Study|Disease progression|2
5723798|NCT00003641|19704924|P1|Overall Study|Disease progression|0
5723799|NCT00003641|19704923|P2|Overall Study|Adverse Event|38
5723800|NCT00003641|19704924|P1|Overall Study|Adverse Event|0
5723801|NCT00003641|19704923|P2|Overall Study|Withdrawal by Subject|100
5723802|NCT00003641|19704924|P1|Overall Study|Withdrawal by Subject|0
5723803|NCT00003631|19704935|P3|Overall Study|Evaluable for toxicity only|2
5723804|NCT00003631|19704936|P2|Overall Study|Evaluable for toxicity only|0
5723805|NCT00003631|19704937|P1|Overall Study|Evaluable for toxicity only|0
5723806|NCT00003631|19704935|P3|Overall Study|Death|1
5723807|NCT00003631|19704936|P2|Overall Study|Death|0
5723808|NCT00003631|19704937|P1|Overall Study|Death|0
5723809|NCT00003631|19704935|P3|Overall Study|Adverse Event|5
5723810|NCT00003631|19704936|P2|Overall Study|Adverse Event|1
5723811|NCT00003631|19704937|P1|Overall Study|Adverse Event|1
5723812|NCT00003631|19704935|P3|Overall Study|Protocol Violation|0
5723813|NCT00003631|19704936|P2|Overall Study|Protocol Violation|0
5723814|NCT00003631|19704937|P1|Overall Study|Protocol Violation|1
5723815|NCT00003631|19704935|P3|Overall Study|Patient not treated|1
5723816|NCT00003631|19704936|P2|Overall Study|Patient not treated|0
5723817|NCT00003631|19704937|P1|Overall Study|Patient not treated|1
5723818|NCT00003590|19704945|P1|Overall Study|Physician Decision|1
5723819|NCT00003590|19704945|P1|Overall Study|Death|1
5723820|NCT00003590|19704945|P1|Overall Study|Lack of Efficacy|11
5723821|NCT00003590|19704945|P1|Overall Study|Withdrawal by Subject|1
5723822|NCT00003590|19704945|P1|Overall Study|Adverse Event|7
5723823|NCT00003590|19704945|P1|Overall Study|Ineligible Patient|1
5723824|NCT00003537|19704950|P1|Overall Study|Not evalauable|1
5723825|NCT00003535|19704955|P1|Overall Study|Not evaluable|5
5723826|NCT00003531|19704960|P1|Overall Study|Not evaluable|10
5723827|NCT00003526|19704964|P1|Overall Study|Not evaluable|6
5723828|NCT00003509|19704968|P1|Overall Study|Not evaluable|5
5723829|NCT00003499|19704972|P1|Overall Study|Not evaluable|8
5723830|NCT00003498|19704977|P1|Overall Study|Not evaluable.|4
5723831|NCT00003492|19704981|P1|Overall Study|Not evaluable|6
5723832|NCT00003483|19704985|P1|Overall Study|Not evaluable|1
5723833|NCT00003479|19704990|P1|Overall Study|Not evaluable|3
5723834|NCT00003477|19704995|P1|Overall Study|Not evalauable|4
5723835|NCT00003476|19705000|P1|Overall Study|Not evaluable|1
5723836|NCT00003475|19705005|P1|Overall Study|Not evaluable|13
5723837|NCT00003474|19705010|P1|Overall Study|Not Evaluable|14
5723838|NCT00003473|19705015|P1|Overall Study|Three patients were not evaluable.|3
5723839|NCT00003472|19705020|P1|Overall Study|Not evaluable|3
5723840|NCT00003471|19705025|P1|Overall Study|Not evaluable|4
5723841|NCT00003470|19705030|P1|Overall Study|Not evaluable|6
5723842|NCT00003458|19705055|P1|Overall Study|Not evaluable|4
5723843|NCT00003457|19705060|P1|Overall Study|Not evaluable|9
5723844|NCT00003456|19705065|P1|Overall Study|Not evaluable|8
5723845|NCT00003389|19705082|P2|Overall Study|Ineligible|27
5723846|NCT00003389|19705083|P1|Overall Study|Ineligible|33
5723847|NCT00003389|19705082|P2|Overall Study|Off-treatment reason missing|21
5723848|NCT00003389|19705083|P1|Overall Study|Off-treatment reason missing|31
5723849|NCT00003389|19705082|P2|Overall Study|Complicating disease|0
5723850|NCT00003389|19705083|P1|Overall Study|Complicating disease|1
5723851|NCT00003389|19705082|P2|Overall Study|Alternative therapy|1
5723852|NCT00003389|19705083|P1|Overall Study|Alternative therapy|2
5723853|NCT00003389|19705082|P2|Overall Study|Withdrawal by Subject|5
5723854|NCT00003389|19705083|P1|Overall Study|Withdrawal by Subject|12
5723855|NCT00003389|19705082|P2|Overall Study|Death|3
5723856|NCT00003389|19705083|P1|Overall Study|Death|0
5723857|NCT00003389|19705082|P2|Overall Study|Adverse Event|2
5723858|NCT00003389|19705083|P1|Overall Study|Adverse Event|13
5723859|NCT00003389|19705082|P2|Overall Study|Disease progression|1
5723860|NCT00003389|19705083|P1|Overall Study|Disease progression|6
5723861|NCT00003377|19705098|P5|Period II|Ureteral stent complications|1
5723862|NCT00003377|19705099|P4|Period II|Ureteral stent complications|0
5723863|NCT00003377|19705100|P3|Period II|Ureteral stent complications|0
5723864|NCT00003377|19705101|P2|Period II|Ureteral stent complications|0
5723865|NCT00003377|19705102|P1|Period II|Ureteral stent complications|0
5723866|NCT00003377|19705098|P5|Period I|Dose Limiting Toxicity(DLT)|0
5723867|NCT00003377|19705099|P4|Period I|Dose Limiting Toxicity(DLT)|1
5723868|NCT00003377|19705100|P3|Period I|Dose Limiting Toxicity(DLT)|1
5723869|NCT00003377|19705101|P2|Period I|Dose Limiting Toxicity(DLT)|0
5723870|NCT00003377|19705102|P1|Period I|Dose Limiting Toxicity(DLT)|0
5723871|NCT00003199|19705116|P1|Overall Study|Screen fail|15
5723872|NCT00003199|19705116|P1|Overall Study|Lack of insurance clearance|2
5723873|NCT00003199|19705116|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
5723874|NCT00003138|19705124|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
5723875|NCT00003138|19705125|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
5723876|NCT00003138|19705124|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
5723877|NCT00003138|19705125|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
5723878|NCT00003138|19705124|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
5723879|NCT00003138|19705125|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
5723880|NCT00003138|19705124|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
5723881|NCT00003138|19705125|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
5723882|NCT00003138|19705124|P2|Step 1|Never started treatment|0
5723883|NCT00003138|19705125|P1|Step 1|Never started treatment|1
5723884|NCT00003138|19705124|P2|Step 1|Reasons off treatment not documented|57
5723885|NCT00003138|19705125|P1|Step 1|Reasons off treatment not documented|60
5723886|NCT00002931|19705142|P1|Overall Study|rapidly progressing disease during|2
5723887|NCT00002874|19705150|P2|Overall Study|Protocol Violation|34
5723888|NCT00002874|19705151|P1|Overall Study|Protocol Violation|44
5723889|NCT00002874|19705150|P2|Overall Study|Withdrawal by Subject|1
5723890|NCT00002874|19705151|P1|Overall Study|Withdrawal by Subject|1
5723891|NCT00002850|19705176|P3|Overall Study|Withdrawal by Subject|0
5723892|NCT00002850|19705177|P2|Overall Study|Withdrawal by Subject|1
5723893|NCT00002850|19705178|P1|Overall Study|Withdrawal by Subject|0
5723894|NCT00002850|19705176|P3|Overall Study|Protocol Violation|1
5723895|NCT00002850|19705177|P2|Overall Study|Protocol Violation|0
5723896|NCT00002850|19705178|P1|Overall Study|Protocol Violation|1
5723897|NCT00002850|19705176|P3|Overall Study|Death|3
5723898|NCT00002850|19705177|P2|Overall Study|Death|1
5723899|NCT00002850|19705178|P1|Overall Study|Death|4
5723900|NCT00002842|19705186|P1|Overall Study|ineligible for surgical resection|27
5723901|NCT00002766|19705192|P2|Overall Study|Protocol Violation|0
5723902|NCT00002766|19705193|P1|Overall Study|Protocol Violation|1
5723903|NCT00002766|19705192|P2|Overall Study|Adverse Event|1
5723904|NCT00002766|19705193|P1|Overall Study|Adverse Event|1
5723905|NCT00002766|19705192|P2|Overall Study|Patient Not Treated|2
5723906|NCT00002766|19705193|P1|Overall Study|Patient Not Treated|1
5723907|NCT00002766|19705192|P2|Overall Study|Withdrawal by Subject|1
5723908|NCT00002766|19705193|P1|Overall Study|Withdrawal by Subject|0
5723909|NCT00002651|19705201|P3|Consolidation and Randomization|not eligible|112
5723910|NCT00002651|19705202|P2|Consolidation and Randomization|not eligible|102
5723911|NCT00002651|19705203|P1|Consolidation and Randomization|not eligible|0
5723912|NCT00002651|19705201|P3|Consolidation and Randomization|Other|313
5723913|NCT00002651|19705202|P2|Consolidation and Randomization|Other|314
5723914|NCT00002651|19705203|P1|Consolidation and Randomization|Other|0
5723915|NCT00002651|19705201|P3|Consolidation and Randomization|Death|48
5723916|NCT00002651|19705202|P2|Consolidation and Randomization|Death|38
5723917|NCT00002651|19705203|P1|Consolidation and Randomization|Death|0
5723918|NCT00002651|19705201|P3|Consolidation and Randomization|Progression/relapse|298
5723919|NCT00002651|19705202|P2|Consolidation and Randomization|Progression/relapse|295
5723920|NCT00002651|19705203|P1|Consolidation and Randomization|Progression/relapse|0
5723921|NCT00002651|19705201|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
5723922|NCT00002651|19705202|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
5723923|NCT00002651|19705203|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
5723924|NCT00002651|19705201|P3|Consolidation and Randomization|Adverse Event|14
5723925|NCT00002651|19705202|P2|Consolidation and Randomization|Adverse Event|36
5723926|NCT00002651|19705203|P1|Consolidation and Randomization|Adverse Event|0
5723927|NCT00002651|19705201|P3|Induction|not eligible|0
5723928|NCT00002651|19705202|P2|Induction|not eligible|0
5723929|NCT00002651|19705203|P1|Induction|not eligible|90
5723930|NCT00002651|19705201|P3|Induction|Other|0
5723931|NCT00002651|19705202|P2|Induction|Other|0
5723932|NCT00002651|19705203|P1|Induction|Other|823
5723933|NCT00002651|19705201|P3|Induction|Death|0
5723934|NCT00002651|19705202|P2|Induction|Death|0
5723935|NCT00002651|19705203|P1|Induction|Death|62
5723936|NCT00002651|19705201|P3|Induction|Progression/relapse|0
5723937|NCT00002651|19705202|P2|Induction|Progression/relapse|0
5723938|NCT00002651|19705203|P1|Induction|Progression/relapse|274
5723939|NCT00002651|19705201|P3|Induction|Refusal unrelated to adverse event|0
5723940|NCT00002651|19705202|P2|Induction|Refusal unrelated to adverse event|0
5723941|NCT00002651|19705203|P1|Induction|Refusal unrelated to adverse event|50
5723942|NCT00002651|19705201|P3|Induction|Adverse Event|0
5723943|NCT00002651|19705202|P2|Induction|Adverse Event|0
5723944|NCT00002651|19705203|P1|Induction|Adverse Event|44
5723945|NCT00002558|19705221|P2|Overall Study|Withdrawal by Subject|1
5723946|NCT00002558|19705222|P1|Overall Study|Withdrawal by Subject|0
5723947|NCT00051636|19705247|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
5723948|NCT00051636|19705248|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
5723949|NCT00051636|19705247|P2|Period 2- Extended Observation Period|Death|5
5723950|NCT00051636|19705248|P1|Period 2- Extended Observation Period|Death|4
5723951|NCT00051636|19705247|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
5723952|NCT00051636|19705248|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
5723953|NCT00051636|19705247|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
5723954|NCT00051636|19705248|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
5723955|NCT00051636|19705247|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
5723956|NCT00051636|19705248|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
5723957|NCT00051636|19705247|P2|Period 1 - Core|Lost to Follow-up|2
5723958|NCT00051636|19705248|P1|Period 1 - Core|Lost to Follow-up|0
5723959|NCT00051636|19705247|P2|Period 1 - Core|Withdrawal by Subject|2
5723960|NCT00051636|19705248|P1|Period 1 - Core|Withdrawal by Subject|1
5723961|NCT00051636|19705247|P2|Period 1 - Core|Protocol Violation|0
5723962|NCT00051636|19705248|P1|Period 1 - Core|Protocol Violation|1
5723963|NCT00051636|19705247|P2|Period 1 - Core|Adverse Event|2
5723964|NCT00051636|19705248|P1|Period 1 - Core|Adverse Event|2
5723965|NCT00051558|19705276|P2|Overall Study|Physician Decision|0
5723966|NCT00051558|19705277|P1|Overall Study|Physician Decision|5
5723967|NCT00051558|19705276|P2|Overall Study|Significant Lab Value|0
5723968|NCT00051558|19705277|P1|Overall Study|Significant Lab Value|2
5723969|NCT00051558|19705276|P2|Overall Study|Other|1
5723970|NCT00051558|19705277|P1|Overall Study|Other|2
5723971|NCT00051558|19705276|P2|Overall Study|Sponsor Decision|1
5723972|NCT00051558|19705277|P1|Overall Study|Sponsor Decision|6
5723973|NCT00051558|19705276|P2|Overall Study|Protocol Entry Criteria Unmet|2
5723974|NCT00051558|19705277|P1|Overall Study|Protocol Entry Criteria Unmet|1
5723975|NCT00051558|19705276|P2|Overall Study|Protocol Violation|4
5723976|NCT00051558|19705277|P1|Overall Study|Protocol Violation|3
5723977|NCT00051558|19705276|P2|Overall Study|Lost to Follow-up|13
5723978|NCT00051558|19705277|P1|Overall Study|Lost to Follow-up|4
5723979|NCT00051558|19705276|P2|Overall Study|Death|15
5723980|NCT00051558|19705277|P1|Overall Study|Death|9
5723981|NCT00051558|19705276|P2|Overall Study|Withdrawal by Subject|42
5723982|NCT00051558|19705277|P1|Overall Study|Withdrawal by Subject|29
5723983|NCT00051558|19705276|P2|Overall Study|Adverse Event|18
5723984|NCT00051558|19705277|P1|Overall Study|Adverse Event|30
5723985|NCT00051363|19705313|P2|Overall Study|Excluded Pre-Randomization|5
5723986|NCT00051363|19705314|P1|Overall Study|Excluded Pre-Randomization|2
5723987|NCT00051363|19705313|P2|Overall Study|Death|2
5723988|NCT00051363|19705314|P1|Overall Study|Death|2
5723989|NCT00051363|19705313|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
5723990|NCT00051363|19705314|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
5723991|NCT00051363|19705313|P2|Overall Study|Dropped Post-Rand for Any Reason|126
5723992|NCT00051363|19705314|P1|Overall Study|Dropped Post-Rand for Any Reason|102
5723993|NCT00051025|19705354|P2|Overall Study|Death|1
5723994|NCT00051025|19705355|P1|Overall Study|Death|0
5723995|NCT00051025|19705354|P2|Overall Study|Withdrawal by Subject|1
5723996|NCT00051025|19705355|P1|Overall Study|Withdrawal by Subject|0
5723997|NCT00051025|19705354|P2|Overall Study|Adverse Event|1
5723998|NCT00051025|19705355|P1|Overall Study|Adverse Event|1
5723999|NCT00051025|19705354|P2|Overall Study|Progressive Disease|1
5724000|NCT00051025|19705355|P1|Overall Study|Progressive Disease|1
5724001|NCT00050960|19705369|P2|Overall Study|Death|15
5724002|NCT00050960|19705370|P1|Overall Study|Death|13
5724003|NCT00050960|19705369|P2|Overall Study|Non-compliance|1
5724004|NCT00050960|19705370|P1|Overall Study|Non-compliance|3
5724005|NCT00050960|19705369|P2|Overall Study|Administrative|46
5724006|NCT00050960|19705370|P1|Overall Study|Administrative|31
5724007|NCT00050960|19705369|P2|Overall Study|Withdrawal by Subject|18
5724008|NCT00050960|19705370|P1|Overall Study|Withdrawal by Subject|23
5724009|NCT00050960|19705369|P2|Overall Study|Lost to Follow-up|1
5724010|NCT00050960|19705370|P1|Overall Study|Lost to Follow-up|0
5724011|NCT00050960|19705369|P2|Overall Study|Adverse Event|61
5724012|NCT00050960|19705370|P1|Overall Study|Adverse Event|62
5724013|NCT00050960|19705369|P2|Overall Study|Complete Response|2
5724014|NCT00050960|19705370|P1|Overall Study|Complete Response|0
5724015|NCT00050960|19705369|P2|Overall Study|Partial Response|19
5724016|NCT00050960|19705370|P1|Overall Study|Partial Response|14
5724017|NCT00050960|19705369|P2|Overall Study|Stable Disease|48
5724018|NCT00050960|19705370|P1|Overall Study|Stable Disease|19
5724019|NCT00050960|19705369|P2|Overall Study|Progressive Disease|93
5724020|NCT00050960|19705370|P1|Overall Study|Progressive Disease|137
5724021|NCT00050778|19705379|P3|Overall Study|Familial and personal reasons|0
5724022|NCT00050778|19705380|P2|Overall Study|Familial and personal reasons|0
5724023|NCT00050778|19705381|P1|Overall Study|Familial and personal reasons|1
5724024|NCT00050778|19705379|P3|Overall Study|Randomized but not treated|2
5724025|NCT00050778|19705380|P2|Overall Study|Randomized but not treated|5
5724026|NCT00050778|19705381|P1|Overall Study|Randomized but not treated|4
5724027|NCT00050778|19705379|P3|Overall Study|Withdrawal by Subject|4
5724028|NCT00050778|19705380|P2|Overall Study|Withdrawal by Subject|8
5724029|NCT00050778|19705381|P1|Overall Study|Withdrawal by Subject|6
5724030|NCT00050778|19705379|P3|Overall Study|Protocol Violation|1
5724031|NCT00050778|19705380|P2|Overall Study|Protocol Violation|0
5724032|NCT00050778|19705381|P1|Overall Study|Protocol Violation|2
5724033|NCT00050778|19705379|P3|Overall Study|Physician Decision|2
5724034|NCT00050778|19705380|P2|Overall Study|Physician Decision|0
5724035|NCT00050778|19705381|P1|Overall Study|Physician Decision|3
5724036|NCT00050778|19705379|P3|Overall Study|Lost to Follow-up|4
5724037|NCT00050778|19705380|P2|Overall Study|Lost to Follow-up|2
5724038|NCT00050778|19705381|P1|Overall Study|Lost to Follow-up|0
5724039|NCT00050778|19705379|P3|Overall Study|Lack of Efficacy|2
5724040|NCT00050778|19705380|P2|Overall Study|Lack of Efficacy|2
5724041|NCT00050778|19705381|P1|Overall Study|Lack of Efficacy|16
5724042|NCT00050778|19705379|P3|Overall Study|Death|1
5724043|NCT00050778|19705380|P2|Overall Study|Death|1
5724044|NCT00050778|19705381|P1|Overall Study|Death|0
5724045|NCT00050778|19705379|P3|Overall Study|Adverse Event|2
5724046|NCT00050778|19705380|P2|Overall Study|Adverse Event|3
5724047|NCT00050778|19705381|P1|Overall Study|Adverse Event|13
5724048|NCT00050622|19705407|P1|Overall Study|Adverse Event|1
5724049|NCT00050167|19705445|P2|Overall Study|not eligible not invasive|1
5724050|NCT00050167|19705446|P1|Overall Study|not eligible not invasive|1
5724051|NCT00050011|19705479|P2|Overall Study|Unknown - Reason is missing|2
5724052|NCT00050011|19705480|P1|Overall Study|Unknown - Reason is missing|0
5724053|NCT00050011|19705479|P2|Overall Study|Death|4
5724054|NCT00050011|19705480|P1|Overall Study|Death|7
5724055|NCT00050011|19705479|P2|Overall Study|Administrative problems|6
5724056|NCT00050011|19705480|P1|Overall Study|Administrative problems|10
5724057|NCT00050011|19705479|P2|Overall Study|Lost to Follow-up|9
5724058|NCT00050011|19705480|P1|Overall Study|Lost to Follow-up|7
5724059|NCT00050011|19705479|P2|Overall Study|Withdrawal by Subject|26
5724060|NCT00050011|19705480|P1|Overall Study|Withdrawal by Subject|34
5724061|NCT00050011|19705479|P2|Overall Study|Protocol Violation|10
5724062|NCT00050011|19705480|P1|Overall Study|Protocol Violation|4
5724063|NCT00050011|19705479|P2|Overall Study|Participant condition no longer required|0
5724064|NCT00050011|19705480|P1|Overall Study|Participant condition no longer required|1
5724065|NCT00050011|19705479|P2|Overall Study|Lack of Efficacy|21
5724066|NCT00050011|19705480|P1|Overall Study|Lack of Efficacy|16
5724067|NCT00050011|19705479|P2|Overall Study|Abnormal test procedure results|1
5724068|NCT00050011|19705480|P1|Overall Study|Abnormal test procedure results|0
5724069|NCT00050011|19705479|P2|Overall Study|Abnormal laboratory value(s)|1
5724070|NCT00050011|19705480|P1|Overall Study|Abnormal laboratory value(s)|1
5724071|NCT00050011|19705479|P2|Overall Study|Adverse Event|46
5724072|NCT00050011|19705480|P1|Overall Study|Adverse Event|41
5724073|NCT00049842|19705502|P2|Follow-up Phase|Other|4
5724074|NCT00049842|19705503|P1|Follow-up Phase|Other|1
5724075|NCT00049842|19705502|P2|Follow-up Phase|Adverse Event|1
5724076|NCT00049842|19705503|P1|Follow-up Phase|Adverse Event|6
5724077|NCT00049842|19705502|P2|Treatment Phase|Did not meet protocol eligibility|1
5724078|NCT00049842|19705503|P1|Treatment Phase|Did not meet protocol eligibility|0
5724079|NCT00049842|19705502|P2|Treatment Phase|Administrative|3
5724080|NCT00049842|19705503|P1|Treatment Phase|Administrative|0
5724081|NCT00049842|19705502|P2|Treatment Phase|Lost to Follow-up|8
5724082|NCT00049842|19705503|P1|Treatment Phase|Lost to Follow-up|4
5724083|NCT00049842|19705502|P2|Treatment Phase|Non-compliance with protocol|8
5724084|NCT00049842|19705503|P1|Treatment Phase|Non-compliance with protocol|7
5724085|NCT00049842|19705502|P2|Treatment Phase|Withdrawal by Subject|46
5724086|NCT00049842|19705503|P1|Treatment Phase|Withdrawal by Subject|35
5724087|NCT00049842|19705502|P2|Treatment Phase|Adverse Event|12
5724088|NCT00049842|19705503|P1|Treatment Phase|Adverse Event|47
5724089|NCT00048932|19705521|P3|Open Label Period (OL)|Participant Surgery|1
5724090|NCT00048932|19705522|P2|Open Label Period (OL)|Participant Surgery|0
5724091|NCT00048932|19705523|P1|Open Label Period (OL)|Participant Surgery|0
5724092|NCT00048932|19705521|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
5724093|NCT00048932|19705522|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
5724094|NCT00048932|19705523|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
5724095|NCT00048932|19705521|P3|Open Label Period (OL)|Site Staff Issues|2
5724096|NCT00048932|19705522|P2|Open Label Period (OL)|Site Staff Issues|0
5724097|NCT00048932|19705523|P1|Open Label Period (OL)|Site Staff Issues|0
5724098|NCT00048932|19705521|P3|Open Label Period (OL)|Investigator Decision|4
5724099|NCT00048932|19705522|P2|Open Label Period (OL)|Investigator Decision|0
5724100|NCT00048932|19705523|P1|Open Label Period (OL)|Investigator Decision|0
5724101|NCT00048932|19705521|P3|Open Label Period (OL)|Medication Lost Efficacy|1
5724102|NCT00048932|19705522|P2|Open Label Period (OL)|Medication Lost Efficacy|0
5724103|NCT00048932|19705523|P1|Open Label Period (OL)|Medication Lost Efficacy|0
5724104|NCT00048932|19705521|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
5724105|NCT00048932|19705522|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
5724106|NCT00048932|19705523|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
5724107|NCT00048932|19705521|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
5724108|NCT00048932|19705522|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
5724109|NCT00048932|19705523|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
5724110|NCT00048932|19705521|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
5724111|NCT00048932|19705522|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
5724112|NCT00048932|19705523|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
5724113|NCT00048932|19705521|P3|Open Label Period (OL)|Patient Decision|4
5724114|NCT00048932|19705522|P2|Open Label Period (OL)|Patient Decision|0
5724115|NCT00048932|19705523|P1|Open Label Period (OL)|Patient Decision|0
5724116|NCT00048932|19705521|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
5724117|NCT00048932|19705522|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
5724118|NCT00048932|19705523|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
5724119|NCT00048932|19705521|P3|Open Label Period (OL)|Trial Terminated|1
5724120|NCT00048932|19705522|P2|Open Label Period (OL)|Trial Terminated|0
5724121|NCT00048932|19705523|P1|Open Label Period (OL)|Trial Terminated|0
5724122|NCT00048932|19705521|P3|Open Label Period (OL)|Site Closure|3
5724123|NCT00048932|19705522|P2|Open Label Period (OL)|Site Closure|0
5724124|NCT00048932|19705523|P1|Open Label Period (OL)|Site Closure|0
5724125|NCT00048932|19705521|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
5724126|NCT00048932|19705522|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
5724127|NCT00048932|19705523|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
5724128|NCT00048932|19705521|P3|Open Label Period (OL)|Participant Relocated|6
5724129|NCT00048932|19705522|P2|Open Label Period (OL)|Participant Relocated|0
5724130|NCT00048932|19705523|P1|Open Label Period (OL)|Participant Relocated|0
5724131|NCT00048932|19705521|P3|Open Label Period (OL)|Participant Transportation Issues|1
5724132|NCT00048932|19705522|P2|Open Label Period (OL)|Participant Transportation Issues|0
5724133|NCT00048932|19705523|P1|Open Label Period (OL)|Participant Transportation Issues|0
5724134|NCT00048932|19705521|P3|Open Label Period (OL)|Investigator Retiring|2
5724135|NCT00048932|19705522|P2|Open Label Period (OL)|Investigator Retiring|0
5724136|NCT00048932|19705523|P1|Open Label Period (OL)|Investigator Retiring|0
5724137|NCT00048932|19705521|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
5724138|NCT00048932|19705522|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
5724139|NCT00048932|19705523|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
5724140|NCT00048932|19705521|P3|Open Label Period (OL)|Pregnancy|6
5724141|NCT00048932|19705522|P2|Open Label Period (OL)|Pregnancy|0
5724142|NCT00048932|19705523|P1|Open Label Period (OL)|Pregnancy|0
5724143|NCT00048932|19705521|P3|Open Label Period (OL)|Poor/Non-Compliance|13
5724144|NCT00048932|19705522|P2|Open Label Period (OL)|Poor/Non-Compliance|0
5724145|NCT00048932|19705523|P1|Open Label Period (OL)|Poor/Non-Compliance|0
5724146|NCT00048932|19705521|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
5724147|NCT00048932|19705522|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
5724148|NCT00048932|19705523|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
5724149|NCT00048932|19705521|P3|Open Label Period (OL)|Withdrawal by Subject|117
5724150|NCT00048932|19705522|P2|Open Label Period (OL)|Withdrawal by Subject|0
5724151|NCT00048932|19705523|P1|Open Label Period (OL)|Withdrawal by Subject|0
5724152|NCT00048932|19705521|P3|Open Label Period (OL)|Lost to Follow-up|27
5724153|NCT00048932|19705522|P2|Open Label Period (OL)|Lost to Follow-up|0
5724154|NCT00048932|19705523|P1|Open Label Period (OL)|Lost to Follow-up|0
5724155|NCT00048932|19705521|P3|Open Label Period (OL)|Lack of Efficacy|81
5724156|NCT00048932|19705522|P2|Open Label Period (OL)|Lack of Efficacy|0
5724157|NCT00048932|19705523|P1|Open Label Period (OL)|Lack of Efficacy|0
5724158|NCT00048932|19705521|P3|Open Label Period (OL)|Adverse Event|103
5724159|NCT00048932|19705522|P2|Open Label Period (OL)|Adverse Event|0
5724160|NCT00048932|19705523|P1|Open Label Period (OL)|Adverse Event|0
5724161|NCT00048932|19705521|P3|Open Label Period (OL)|Death|25
5724162|NCT00048932|19705522|P2|Open Label Period (OL)|Death|0
5724163|NCT00048932|19705523|P1|Open Label Period (OL)|Death|0
5724164|NCT00048932|19705521|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
5724165|NCT00048932|19705522|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
5724166|NCT00048932|19705523|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
5724167|NCT00048932|19705521|P3|Double Blind Period (DB)|Withdrawal by Subject|0
5724168|NCT00048932|19705522|P2|Double Blind Period (DB)|Withdrawal by Subject|10
5724169|NCT00048932|19705523|P1|Double Blind Period (DB)|Withdrawal by Subject|24
5724170|NCT00048932|19705521|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
5724171|NCT00048932|19705522|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
5724172|NCT00048932|19705523|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
5724173|NCT00048932|19705521|P3|Double Blind Period (DB)|Pregnancy|0
5724174|NCT00048932|19705522|P2|Double Blind Period (DB)|Pregnancy|0
5724175|NCT00048932|19705523|P1|Double Blind Period (DB)|Pregnancy|1
5724176|NCT00048932|19705521|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
5724177|NCT00048932|19705522|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
5724178|NCT00048932|19705523|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
5724179|NCT00048932|19705521|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
5724180|NCT00048932|19705522|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
5724181|NCT00048932|19705523|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
5724182|NCT00048932|19705521|P3|Double Blind Period (DB)|Relocation|0
5724183|NCT00048932|19705522|P2|Double Blind Period (DB)|Relocation|0
5724184|NCT00048932|19705523|P1|Double Blind Period (DB)|Relocation|1
5724185|NCT00048932|19705521|P3|Double Blind Period (DB)|Lost to Follow-up|0
5724186|NCT00048932|19705522|P2|Double Blind Period (DB)|Lost to Follow-up|4
5724187|NCT00048932|19705523|P1|Double Blind Period (DB)|Lost to Follow-up|3
5724188|NCT00048932|19705521|P3|Double Blind Period (DB)|Lack of Efficacy|0
5724189|NCT00048932|19705522|P2|Double Blind Period (DB)|Lack of Efficacy|44
5724190|NCT00048932|19705523|P1|Double Blind Period (DB)|Lack of Efficacy|26
5724191|NCT00048932|19705521|P3|Double Blind Period (DB)|Death|0
5724192|NCT00048932|19705522|P2|Double Blind Period (DB)|Death|3
5724193|NCT00048932|19705523|P1|Double Blind Period (DB)|Death|5
5724194|NCT00048932|19705521|P3|Double Blind Period (DB)|Adverse Event|0
5724195|NCT00048932|19705522|P2|Double Blind Period (DB)|Adverse Event|19
5724196|NCT00048932|19705523|P1|Double Blind Period (DB)|Adverse Event|51
5724197|NCT00048932|19705521|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
5724198|NCT00048932|19705522|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
5724199|NCT00048932|19705523|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
5724200|NCT00048581|19705565|P3|Open-Label Period|Study Ended By Sponsor|1
5724201|NCT00048581|19705566|P2|Open-Label Period|Study Ended By Sponsor|0
5724202|NCT00048581|19705567|P1|Open-Label Period|Study Ended By Sponsor|0
5724203|NCT00048581|19705565|P3|Open-Label Period|Primary Investigator Retired|2
5724204|NCT00048581|19705566|P2|Open-Label Period|Primary Investigator Retired|0
5724205|NCT00048581|19705567|P1|Open-Label Period|Primary Investigator Retired|0
5724206|NCT00048581|19705565|P3|Open-Label Period|Problem With Transportation To Site|1
5724207|NCT00048581|19705566|P2|Open-Label Period|Problem With Transportation To Site|0
5724208|NCT00048581|19705567|P1|Open-Label Period|Problem With Transportation To Site|0
5724209|NCT00048581|19705565|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
5724210|NCT00048581|19705566|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
5724211|NCT00048581|19705567|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
5724212|NCT00048581|19705565|P3|Open-Label Period|Study Site Closure|2
5724213|NCT00048581|19705566|P2|Open-Label Period|Study Site Closure|0
5724214|NCT00048581|19705567|P1|Open-Label Period|Study Site Closure|0
5724215|NCT00048581|19705565|P3|Open-Label Period|Pregnancy|7
5724216|NCT00048581|19705566|P2|Open-Label Period|Pregnancy|0
5724217|NCT00048581|19705567|P1|Open-Label Period|Pregnancy|0
5724218|NCT00048581|19705565|P3|Open-Label Period|Poor/Non-compliance|5
5724219|NCT00048581|19705566|P2|Open-Label Period|Poor/Non-compliance|0
5724220|NCT00048581|19705567|P1|Open-Label Period|Poor/Non-compliance|0
5724221|NCT00048581|19705565|P3|Open-Label Period|No Longer Meets Study Criteria|2
5724222|NCT00048581|19705566|P2|Open-Label Period|No Longer Meets Study Criteria|0
5724223|NCT00048581|19705567|P1|Open-Label Period|No Longer Meets Study Criteria|0
5724224|NCT00048581|19705565|P3|Open-Label Period|Withdrawal by Subject|20
5724225|NCT00048581|19705566|P2|Open-Label Period|Withdrawal by Subject|0
5724226|NCT00048581|19705567|P1|Open-Label Period|Withdrawal by Subject|0
5724227|NCT00048581|19705565|P3|Open-Label Period|Lost to Follow-up|14
5724228|NCT00048581|19705566|P2|Open-Label Period|Lost to Follow-up|0
5724229|NCT00048581|19705567|P1|Open-Label Period|Lost to Follow-up|0
5724230|NCT00048581|19705565|P3|Open-Label Period|Lack of Efficacy|69
5724231|NCT00048581|19705566|P2|Open-Label Period|Lack of Efficacy|0
5724232|NCT00048581|19705567|P1|Open-Label Period|Lack of Efficacy|0
5724233|NCT00048581|19705565|P3|Open-Label Period|Adverse Event|37
5724234|NCT00048581|19705566|P2|Open-Label Period|Adverse Event|0
5724235|NCT00048581|19705567|P1|Open-Label Period|Adverse Event|0
5724236|NCT00048581|19705565|P3|Open-Label Period|Death|4
5724237|NCT00048581|19705566|P2|Open-Label Period|Death|0
5724238|NCT00048581|19705567|P1|Open-Label Period|Death|0
5724239|NCT00048581|19705565|P3|Double-Blind Period|Investigator Decision|0
5724240|NCT00048581|19705566|P2|Double-Blind Period|Investigator Decision|0
5724241|NCT00048581|19705567|P1|Double-Blind Period|Investigator Decision|1
5724242|NCT00048581|19705565|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
5724243|NCT00048581|19705566|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
5724244|NCT00048581|19705567|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
5724245|NCT00048581|19705565|P3|Double-Blind Period|Withdrawal by Subject|0
5724246|NCT00048581|19705566|P2|Double-Blind Period|Withdrawal by Subject|2
5724247|NCT00048581|19705567|P1|Double-Blind Period|Withdrawal by Subject|5
5724248|NCT00048581|19705565|P3|Double-Blind Period|Lost to Follow-up|0
5724249|NCT00048581|19705566|P2|Double-Blind Period|Lost to Follow-up|0
5724250|NCT00048581|19705567|P1|Double-Blind Period|Lost to Follow-up|5
5724251|NCT00048581|19705565|P3|Double-Blind Period|Lack of Efficacy|0
5724252|NCT00048581|19705566|P2|Double-Blind Period|Lack of Efficacy|27
5724253|NCT00048581|19705567|P1|Double-Blind Period|Lack of Efficacy|14
5724254|NCT00048581|19705565|P3|Double-Blind Period|Adverse Event|0
5724255|NCT00048581|19705566|P2|Double-Blind Period|Adverse Event|5
5724256|NCT00048581|19705567|P1|Double-Blind Period|Adverse Event|9
5724257|NCT00048568|19705734|P3|Open-Label Period|Lost to Follow-up|7
5724258|NCT00048568|19705735|P2|Open-Label Period|Lost to Follow-up|0
5724259|NCT00048568|19705736|P1|Open-Label Period|Lost to Follow-up|0
5724260|NCT00048568|19705734|P3|Open-Label Period|Unknown Reasons|25
5724261|NCT00048568|19705735|P2|Open-Label Period|Unknown Reasons|0
5724262|NCT00048568|19705736|P1|Open-Label Period|Unknown Reasons|0
5724263|NCT00048568|19705734|P3|Open-Label Period|Administrative Decision By Sponsor|1
5724264|NCT00048568|19705735|P2|Open-Label Period|Administrative Decision By Sponsor|0
5724265|NCT00048568|19705736|P1|Open-Label Period|Administrative Decision By Sponsor|0
5724266|NCT00048568|19705734|P3|Open-Label Period|No Longer Met Study Criteria|2
5724267|NCT00048568|19705735|P2|Open-Label Period|No Longer Met Study Criteria|0
5724268|NCT00048568|19705736|P1|Open-Label Period|No Longer Met Study Criteria|0
5724269|NCT00048568|19705734|P3|Open-Label Period|Pregnancy|5
5724270|NCT00048568|19705735|P2|Open-Label Period|Pregnancy|0
5724271|NCT00048568|19705736|P1|Open-Label Period|Pregnancy|0
5724272|NCT00048568|19705734|P3|Open-Label Period|Withdrawal by Subject|26
5724273|NCT00048568|19705735|P2|Open-Label Period|Withdrawal by Subject|0
5724274|NCT00048568|19705736|P1|Open-Label Period|Withdrawal by Subject|0
5724275|NCT00048568|19705734|P3|Open-Label Period|Lack of Efficacy|32
5724276|NCT00048568|19705735|P2|Open-Label Period|Lack of Efficacy|0
5724277|NCT00048568|19705736|P1|Open-Label Period|Lack of Efficacy|0
5724278|NCT00048568|19705734|P3|Open-Label Period|Adverse Event|49
5724279|NCT00048568|19705735|P2|Open-Label Period|Adverse Event|0
5724280|NCT00048568|19705736|P1|Open-Label Period|Adverse Event|0
5724281|NCT00048568|19705734|P3|Open-Label Period|Death|13
5724282|NCT00048568|19705735|P2|Open-Label Period|Death|0
5724283|NCT00048568|19705736|P1|Open-Label Period|Death|0
5724284|NCT00048568|19705734|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
5724285|NCT00048568|19705735|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
5724286|NCT00048568|19705736|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
5724287|NCT00048568|19705734|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
5724288|NCT00048568|19705735|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
5724289|NCT00048568|19705736|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
5724290|NCT00048568|19705734|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
5724291|NCT00048568|19705735|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
5724292|NCT00048568|19705736|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
5724293|NCT00048568|19705734|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
5724294|NCT00048568|19705735|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
5724295|NCT00048568|19705736|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
5724296|NCT00048568|19705734|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
5724297|NCT00048568|19705735|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
5724298|NCT00048568|19705736|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
5724299|NCT00048568|19705734|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
5724300|NCT00048568|19705735|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
5724301|NCT00048568|19705736|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
5724302|NCT00048568|19705734|P3|Double-Blind Period Days 170 to 365|Death|0
5724303|NCT00048568|19705735|P2|Double-Blind Period Days 170 to 365|Death|1
5724304|NCT00048568|19705736|P1|Double-Blind Period Days 170 to 365|Death|1
5724305|NCT00048568|19705734|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
5724306|NCT00048568|19705735|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
5724307|NCT00048568|19705736|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
5724308|NCT00048568|19705734|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
5724309|NCT00048568|19705735|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
5724310|NCT00048568|19705736|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
5724311|NCT00048568|19705734|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
5724312|NCT00048568|19705735|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
5724313|NCT00048568|19705736|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
5724314|NCT00048568|19705734|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
5724315|NCT00048568|19705735|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
5724316|NCT00048568|19705736|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
5724317|NCT00048568|19705734|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
5724318|NCT00048568|19705735|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
5724319|NCT00048568|19705736|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
5724320|NCT00048724|19706041|P2|Overall Study|Administrative|1
5724321|NCT00048724|19706042|P1|Overall Study|Administrative|1
5724322|NCT00048724|19706041|P2|Overall Study|Did Not Meet Protocol Eligibility|2
5724323|NCT00048724|19706042|P1|Overall Study|Did Not Meet Protocol Eligibility|2
5724324|NCT00048724|19706041|P2|Overall Study|Noncompliance With Protocol|12
5724325|NCT00048724|19706042|P1|Overall Study|Noncompliance With Protocol|4
5724326|NCT00048724|19706041|P2|Overall Study|Protocol-defined Clinical Event|32
5724327|NCT00048724|19706042|P1|Overall Study|Protocol-defined Clinical Event|17
5724328|NCT00048724|19706041|P2|Overall Study|Lost to Follow-up|5
5724329|NCT00048724|19706042|P1|Overall Study|Lost to Follow-up|5
5724330|NCT00048724|19706041|P2|Overall Study|Withdrawal by Subject|54
5724331|NCT00048724|19706042|P1|Overall Study|Withdrawal by Subject|34
5724332|NCT00048724|19706041|P2|Overall Study|Adverse Event|12
5724333|NCT00048724|19706042|P1|Overall Study|Adverse Event|53
5724334|NCT00048542|19706054|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
5724335|NCT00048542|19706055|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
5724336|NCT00048542|19706056|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5724337|NCT00048542|19706057|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5724338|NCT00048542|19706058|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5724339|NCT00048542|19706059|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5724340|NCT00048542|19706060|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5724341|NCT00048542|19706061|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
5724342|NCT00048542|19706054|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
5724343|NCT00048542|19706055|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
5724344|NCT00048542|19706056|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5724345|NCT00048542|19706057|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5724346|NCT00048542|19706058|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5724347|NCT00048542|19706059|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5724348|NCT00048542|19706060|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5724349|NCT00048542|19706061|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
5724350|NCT00048542|19706054|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
5724351|NCT00048542|19706055|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
5724352|NCT00048542|19706056|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5724353|NCT00048542|19706057|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5724354|NCT00048542|19706058|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5724355|NCT00048542|19706059|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5724356|NCT00048542|19706060|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5724357|NCT00048542|19706061|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
5724358|NCT00048542|19706054|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
5724359|NCT00048542|19706055|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
5724360|NCT00048542|19706056|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5724361|NCT00048542|19706057|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5724362|NCT00048542|19706058|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5724363|NCT00048542|19706059|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5724364|NCT00048542|19706060|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5724365|NCT00048542|19706061|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
5724366|NCT00048542|19706054|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
5724367|NCT00048542|19706055|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
5724368|NCT00048542|19706056|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5724369|NCT00048542|19706057|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5724370|NCT00048542|19706058|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5724371|NCT00048542|19706059|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5724372|NCT00048542|19706060|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5724373|NCT00048542|19706061|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
5724374|NCT00048542|19706054|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
5724375|NCT00048542|19706055|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
5724376|NCT00048542|19706056|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5724377|NCT00048542|19706057|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5724378|NCT00048542|19706058|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5724379|NCT00048542|19706059|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5724380|NCT00048542|19706060|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5724381|NCT00048542|19706061|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
5724382|NCT00048542|19706054|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
5724383|NCT00048542|19706055|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
5724384|NCT00048542|19706056|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
5724385|NCT00048542|19706057|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
5724386|NCT00048542|19706058|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
5724387|NCT00048542|19706059|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
5724388|NCT00048542|19706060|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
5724389|NCT00048542|19706061|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
5724390|NCT00048542|19706054|P8|Open-Label Extension BSA Phase|Adverse Event|0
5724391|NCT00048542|19706055|P7|Open-Label Extension BSA Phase|Adverse Event|0
5724392|NCT00048542|19706056|P6|Open-Label Extension BSA Phase|Adverse Event|1
5724393|NCT00048542|19706057|P5|Open-Label Extension BSA Phase|Adverse Event|1
5724394|NCT00048542|19706058|P4|Open-Label Extension BSA Phase|Adverse Event|0
5724395|NCT00048542|19706059|P3|Open-Label Extension BSA Phase|Adverse Event|0
5724396|NCT00048542|19706060|P2|Open-Label Extension BSA Phase|Adverse Event|0
5724397|NCT00048542|19706061|P1|Open-Label Extension BSA Phase|Adverse Event|0
5724398|NCT00048542|19706054|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
5724399|NCT00048542|19706055|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
5724400|NCT00048542|19706056|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
5724401|NCT00048542|19706057|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
5724402|NCT00048542|19706058|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
5724403|NCT00048542|19706059|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
5724404|NCT00048542|19706060|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
5724405|NCT00048542|19706061|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
5724406|NCT00048542|19706054|P8|Open-Label Extension BSA Phase|Protocol Violation|0
5724407|NCT00048542|19706055|P7|Open-Label Extension BSA Phase|Protocol Violation|0
5724408|NCT00048542|19706056|P6|Open-Label Extension BSA Phase|Protocol Violation|1
5724409|NCT00048542|19706057|P5|Open-Label Extension BSA Phase|Protocol Violation|0
5724410|NCT00048542|19706058|P4|Open-Label Extension BSA Phase|Protocol Violation|0
5724411|NCT00048542|19706059|P3|Open-Label Extension BSA Phase|Protocol Violation|0
5724412|NCT00048542|19706060|P2|Open-Label Extension BSA Phase|Protocol Violation|0
5724413|NCT00048542|19706061|P1|Open-Label Extension BSA Phase|Protocol Violation|0
5724414|NCT00048542|19706054|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5724415|NCT00048542|19706055|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5724416|NCT00048542|19706056|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
5724417|NCT00048542|19706057|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
5724418|NCT00048542|19706058|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5724419|NCT00048542|19706059|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5724420|NCT00048542|19706060|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5724421|NCT00048542|19706061|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
5724422|NCT00048542|19706054|P8|Double-Blind Phase|Randomized in error|0
5724423|NCT00048542|19706055|P7|Double-Blind Phase|Randomized in error|0
5724424|NCT00048542|19706056|P6|Double-Blind Phase|Randomized in error|0
5724425|NCT00048542|19706057|P5|Double-Blind Phase|Randomized in error|0
5724426|NCT00048542|19706058|P4|Double-Blind Phase|Randomized in error|0
5724427|NCT00048542|19706059|P3|Double-Blind Phase|Randomized in error|0
5724428|NCT00048542|19706060|P2|Double-Blind Phase|Randomized in error|0
5724429|NCT00048542|19706061|P1|Double-Blind Phase|Randomized in error|1
5724430|NCT00048542|19706054|P8|Double-Blind Phase|Sponsor request or decision|0
5724431|NCT00048542|19706055|P7|Double-Blind Phase|Sponsor request or decision|0
5724432|NCT00048542|19706056|P6|Double-Blind Phase|Sponsor request or decision|0
5724433|NCT00048542|19706057|P5|Double-Blind Phase|Sponsor request or decision|0
5724434|NCT00048542|19706058|P4|Double-Blind Phase|Sponsor request or decision|0
5724435|NCT00048542|19706059|P3|Double-Blind Phase|Sponsor request or decision|0
5724436|NCT00048542|19706060|P2|Double-Blind Phase|Sponsor request or decision|0
5724437|NCT00048542|19706061|P1|Double-Blind Phase|Sponsor request or decision|2
5724438|NCT00048542|19706054|P8|Double-Blind Phase|Protocol Violation|0
5724439|NCT00048542|19706055|P7|Double-Blind Phase|Protocol Violation|0
5724440|NCT00048542|19706056|P6|Double-Blind Phase|Protocol Violation|0
5724441|NCT00048542|19706057|P5|Double-Blind Phase|Protocol Violation|0
5724442|NCT00048542|19706058|P4|Double-Blind Phase|Protocol Violation|0
5724443|NCT00048542|19706059|P3|Double-Blind Phase|Protocol Violation|1
5724444|NCT00048542|19706060|P2|Double-Blind Phase|Protocol Violation|0
5724445|NCT00048542|19706061|P1|Double-Blind Phase|Protocol Violation|0
5724446|NCT00048542|19706054|P8|Double-Blind Phase|Withdrawal by Subject|0
5724447|NCT00048542|19706055|P7|Double-Blind Phase|Withdrawal by Subject|0
5724448|NCT00048542|19706056|P6|Double-Blind Phase|Withdrawal by Subject|0
5724449|NCT00048542|19706057|P5|Double-Blind Phase|Withdrawal by Subject|0
5724450|NCT00048542|19706058|P4|Double-Blind Phase|Withdrawal by Subject|0
5724451|NCT00048542|19706059|P3|Double-Blind Phase|Withdrawal by Subject|0
5724452|NCT00048542|19706060|P2|Double-Blind Phase|Withdrawal by Subject|1
5724453|NCT00048542|19706061|P1|Double-Blind Phase|Withdrawal by Subject|0
5724454|NCT00048347|19706127|P1|Overall Study|Screen failure|2
5724455|NCT00048165|19706133|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
5724456|NCT00048165|19706134|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
5724457|NCT00048165|19706133|P2|Completed 12 Months Study|Death|1
5724458|NCT00048165|19706134|P1|Completed 12 Months Study|Death|2
5724459|NCT00048165|19706133|P2|Completed 12 Months Study|Administration/Other|2
5724460|NCT00048165|19706134|P1|Completed 12 Months Study|Administration/Other|0
5724461|NCT00048165|19706133|P2|Completed 6 Months Study|Did not receive study drug|6
5724462|NCT00048165|19706134|P1|Completed 6 Months Study|Did not receive study drug|6
5724463|NCT00048165|19706133|P2|Completed 6 Months Study|Violation criteria|2
5724464|NCT00048165|19706134|P1|Completed 6 Months Study|Violation criteria|0
5724465|NCT00048165|19706133|P2|Completed 6 Months Study|Refused treatment|5
5724466|NCT00048165|19706134|P1|Completed 6 Months Study|Refused treatment|5
5724467|NCT00048165|19706133|P2|Completed 6 Months Study|Other violation|6
5724468|NCT00048165|19706134|P1|Completed 6 Months Study|Other violation|4
5724469|NCT00048165|19706133|P2|Completed 6 Months Study|Insufficient therapy|4
5724470|NCT00048165|19706134|P1|Completed 6 Months Study|Insufficient therapy|1
5724471|NCT00048165|19706133|P2|Completed 6 Months Study|Death|6
5724472|NCT00048165|19706134|P1|Completed 6 Months Study|Death|12
5724473|NCT00048165|19706133|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
5724474|NCT00048165|19706134|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
5724475|NCT00048165|19706133|P2|Completed 6 Months Study|Abnormality of laboratory test|0
5724476|NCT00048165|19706134|P1|Completed 6 Months Study|Abnormality of laboratory test|1
5724477|NCT00048165|19706133|P2|Completed 6 Months Study|Administration/Other|8
5724478|NCT00048165|19706134|P1|Completed 6 Months Study|Administration/Other|8
5724479|NCT00048074|19706169|P3|Overall Study|Social reasons|0
5724480|NCT00048074|19706170|P2|Overall Study|Social reasons|0
5724481|NCT00048074|19706171|P1|Overall Study|Social reasons|1
5724482|NCT00048074|19706169|P3|Overall Study|Out of station|1
5724483|NCT00048074|19706170|P2|Overall Study|Out of station|1
5724484|NCT00048074|19706171|P1|Overall Study|Out of station|0
5724485|NCT00048074|19706169|P3|Overall Study|Poor compliance|0
5724486|NCT00048074|19706170|P2|Overall Study|Poor compliance|1
5724487|NCT00048074|19706171|P1|Overall Study|Poor compliance|0
5724488|NCT00048074|19706169|P3|Overall Study|Husband ill|0
5724489|NCT00048074|19706170|P2|Overall Study|Husband ill|1
5724490|NCT00048074|19706171|P1|Overall Study|Husband ill|0
5724491|NCT00048074|19706169|P3|Overall Study|Study participation was terminated|0
5724492|NCT00048074|19706170|P2|Overall Study|Study participation was terminated|1
5724493|NCT00048074|19706171|P1|Overall Study|Study participation was terminated|0
5724494|NCT00048074|19706169|P3|Overall Study|Protocol Violation|0
5724495|NCT00048074|19706170|P2|Overall Study|Protocol Violation|3
5724496|NCT00048074|19706171|P1|Overall Study|Protocol Violation|1
5724497|NCT00048074|19706169|P3|Overall Study|Withdrawal by Subject|35
5724498|NCT00048074|19706170|P2|Overall Study|Withdrawal by Subject|30
5724499|NCT00048074|19706171|P1|Overall Study|Withdrawal by Subject|28
5724500|NCT00048074|19706169|P3|Overall Study|Lost to Follow-up|6
5724501|NCT00048074|19706170|P2|Overall Study|Lost to Follow-up|6
5724502|NCT00048074|19706171|P1|Overall Study|Lost to Follow-up|2
5724503|NCT00048074|19706169|P3|Overall Study|Death|2
5724504|NCT00048074|19706170|P2|Overall Study|Death|3
5724505|NCT00048074|19706171|P1|Overall Study|Death|3
5724506|NCT00048074|19706169|P3|Overall Study|Adverse Event|53
5724507|NCT00048074|19706170|P2|Overall Study|Adverse Event|41
5724508|NCT00048074|19706171|P1|Overall Study|Adverse Event|46
5724509|NCT00048061|19706228|P4|Overall Study|Early improvement|0
5724510|NCT00048061|19706229|P3|Overall Study|Early improvement|3
5724511|NCT00048061|19706230|P2|Overall Study|Early improvement|5
5724512|NCT00048061|19706231|P1|Overall Study|Early improvement|6
5724513|NCT00048061|19706228|P4|Overall Study|Did not follow-up|5
5724514|NCT00048061|19706229|P3|Overall Study|Did not follow-up|4
5724515|NCT00048061|19706230|P2|Overall Study|Did not follow-up|5
5724516|NCT00048061|19706231|P1|Overall Study|Did not follow-up|5
5724517|NCT00048061|19706228|P4|Overall Study|Withdrawal by Subject|32
5724518|NCT00048061|19706229|P3|Overall Study|Withdrawal by Subject|29
5724519|NCT00048061|19706230|P2|Overall Study|Withdrawal by Subject|29
5724520|NCT00048061|19706231|P1|Overall Study|Withdrawal by Subject|20
5724521|NCT00048061|19706228|P4|Overall Study|Lost to Follow-up|5
5724522|NCT00048061|19706229|P3|Overall Study|Lost to Follow-up|4
5724523|NCT00048061|19706230|P2|Overall Study|Lost to Follow-up|2
5724524|NCT00048061|19706231|P1|Overall Study|Lost to Follow-up|3
5724525|NCT00048061|19706228|P4|Overall Study|Adverse Event|37
5724526|NCT00048061|19706229|P3|Overall Study|Adverse Event|44
5724527|NCT00048061|19706230|P2|Overall Study|Adverse Event|32
5724528|NCT00048061|19706231|P1|Overall Study|Adverse Event|41
5724529|NCT00048048|19706310|P12|Extension Year 2|Early withdrawals|2
5724530|NCT00048048|19706311|P11|Extension Year 2|Early withdrawals|4
5724531|NCT00048048|19706312|P10|Extension Year 2|Early withdrawals|0
5724532|NCT00048048|19706313|P9|Extension Year 2|Early withdrawals|0
5724533|NCT00048048|19706314|P8|Extension Year 2|Early withdrawals|0
5724534|NCT00048048|19706315|P7|Extension Year 2|Early withdrawals|0
5724535|NCT00048048|19706316|P6|Extension Year 2|Early withdrawals|0
5724536|NCT00048048|19706317|P5|Extension Year 2|Early withdrawals|0
5724537|NCT00048048|19706318|P4|Extension Year 2|Early withdrawals|0
5724538|NCT00048048|19706319|P3|Extension Year 2|Early withdrawals|0
5724539|NCT00048048|19706320|P2|Extension Year 2|Early withdrawals|0
5724540|NCT00048048|19706321|P1|Extension Year 2|Early withdrawals|0
5724541|NCT00048048|19706310|P12|Extension Year 1|Early withdrawals|4
5724542|NCT00048048|19706311|P11|Extension Year 1|Early withdrawals|2
5724543|NCT00048048|19706312|P10|Extension Year 1|Early withdrawals|2
5724544|NCT00048048|19706313|P9|Extension Year 1|Early withdrawals|0
5724545|NCT00048048|19706314|P8|Extension Year 1|Early withdrawals|0
5724546|NCT00048048|19706315|P7|Extension Year 1|Early withdrawals|0
5724547|NCT00048048|19706316|P6|Extension Year 1|Early withdrawals|0
5724548|NCT00048048|19706317|P5|Extension Year 1|Early withdrawals|0
5724549|NCT00048048|19706318|P4|Extension Year 1|Early withdrawals|0
5724550|NCT00048048|19706319|P3|Extension Year 1|Early withdrawals|0
5724551|NCT00048048|19706320|P2|Extension Year 1|Early withdrawals|0
5724552|NCT00048048|19706321|P1|Extension Year 1|Early withdrawals|0
5724553|NCT00048048|19706310|P12|Core Treatment|Adverse Event|0
5724554|NCT00048048|19706311|P11|Core Treatment|Adverse Event|0
5724555|NCT00048048|19706312|P10|Core Treatment|Adverse Event|0
5724556|NCT00048048|19706313|P9|Core Treatment|Adverse Event|0
5724557|NCT00048048|19706314|P8|Core Treatment|Adverse Event|1
5724558|NCT00048048|19706315|P7|Core Treatment|Adverse Event|0
5724559|NCT00048048|19706316|P6|Core Treatment|Adverse Event|0
5724560|NCT00048048|19706317|P5|Core Treatment|Adverse Event|0
5724561|NCT00048048|19706318|P4|Core Treatment|Adverse Event|0
5724562|NCT00048048|19706319|P3|Core Treatment|Adverse Event|0
5724563|NCT00048048|19706320|P2|Core Treatment|Adverse Event|0
5724564|NCT00048048|19706321|P1|Core Treatment|Adverse Event|0
5724565|NCT00048048|19706310|P12|Core Treatment|Withdrawal by Subject|0
5724566|NCT00048048|19706311|P11|Core Treatment|Withdrawal by Subject|0
5724567|NCT00048048|19706312|P10|Core Treatment|Withdrawal by Subject|0
5724568|NCT00048048|19706313|P9|Core Treatment|Withdrawal by Subject|0
5724569|NCT00048048|19706314|P8|Core Treatment|Withdrawal by Subject|0
5724570|NCT00048048|19706315|P7|Core Treatment|Withdrawal by Subject|0
5724571|NCT00048048|19706316|P6|Core Treatment|Withdrawal by Subject|0
5724572|NCT00048048|19706317|P5|Core Treatment|Withdrawal by Subject|0
5724573|NCT00048048|19706318|P4|Core Treatment|Withdrawal by Subject|0
5724574|NCT00048048|19706319|P3|Core Treatment|Withdrawal by Subject|1
5724575|NCT00048048|19706320|P2|Core Treatment|Withdrawal by Subject|0
5724576|NCT00048048|19706321|P1|Core Treatment|Withdrawal by Subject|0
5724577|NCT00048035|19706377|P8|Extension Year 2|Early Withdrawals|3
5724578|NCT00048035|19706378|P7|Extension Year 2|Early Withdrawals|3
5724579|NCT00048035|19706379|P6|Extension Year 2|Early Withdrawals|0
5724580|NCT00048035|19706380|P5|Extension Year 2|Early Withdrawals|0
5724581|NCT00048035|19706381|P4|Extension Year 2|Early Withdrawals|0
5724582|NCT00048035|19706382|P3|Extension Year 2|Early Withdrawals|0
5724583|NCT00048035|19706383|P2|Extension Year 2|Early Withdrawals|0
5724584|NCT00048035|19706384|P1|Extension Year 2|Early Withdrawals|0
5724585|NCT00048035|19706377|P8|Extension Year 1|Early Withdrawals|11
5724586|NCT00048035|19706378|P7|Extension Year 1|Early Withdrawals|11
5724587|NCT00048035|19706379|P6|Extension Year 1|Early Withdrawals|0
5724588|NCT00048035|19706380|P5|Extension Year 1|Early Withdrawals|0
5724589|NCT00048035|19706381|P4|Extension Year 1|Early Withdrawals|0
5724590|NCT00048035|19706382|P3|Extension Year 1|Early Withdrawals|0
5724591|NCT00048035|19706383|P2|Extension Year 1|Early Withdrawals|0
5724592|NCT00048035|19706384|P1|Extension Year 1|Early Withdrawals|0
5724593|NCT00048035|19706377|P8|Core Period|Early Withdrawals|0
5724594|NCT00048035|19706378|P7|Core Period|Early Withdrawals|0
5724595|NCT00048035|19706379|P6|Core Period|Early Withdrawals|1
5724596|NCT00048035|19706380|P5|Core Period|Early Withdrawals|1
5724597|NCT00048035|19706381|P4|Core Period|Early Withdrawals|1
5724598|NCT00048035|19706382|P3|Core Period|Early Withdrawals|1
5724599|NCT00048035|19706383|P2|Core Period|Early Withdrawals|2
5724600|NCT00048035|19706384|P1|Core Period|Early Withdrawals|4
5724601|NCT00047879|19706422|P2|Overall Study|Progressive disease|3
5724602|NCT00047879|19706423|P1|Overall Study|Progressive disease|4
5724603|NCT00047463|19706459|P2|Overall Study|Withdrawal by Subject|3
5724604|NCT00047463|19706460|P1|Overall Study|Withdrawal by Subject|0
5724605|NCT00045942|19706577|P9|PKC412A2104E2|Death|0
5724606|NCT00045942|19706578|P8|PKC412A2104E2|Death|0
5724607|NCT00045942|19706579|P7|PKC412A2104E2|Death|2
5724608|NCT00045942|19706580|P6|PKC412A2104E2|Death|1
5724609|NCT00045942|19706581|P5|PKC412A2104E2|Death|0
5724610|NCT00045942|19706582|P4|PKC412A2104E2|Death|0
5724611|NCT00045942|19706583|P3|PKC412A2104E2|Death|0
5724612|NCT00045942|19706584|P2|PKC412A2104E2|Death|0
5724613|NCT00045942|19706585|P1|PKC412A2104E2|Death|0
5724614|NCT00045942|19706577|P9|PKC412A2104E2|Adverse Event|0
5724615|NCT00045942|19706578|P8|PKC412A2104E2|Adverse Event|1
5724616|NCT00045942|19706579|P7|PKC412A2104E2|Adverse Event|3
5724617|NCT00045942|19706580|P6|PKC412A2104E2|Adverse Event|4
5724618|NCT00045942|19706581|P5|PKC412A2104E2|Adverse Event|0
5724619|NCT00045942|19706582|P4|PKC412A2104E2|Adverse Event|0
5724620|NCT00045942|19706583|P3|PKC412A2104E2|Adverse Event|0
5724621|NCT00045942|19706584|P2|PKC412A2104E2|Adverse Event|0
5724622|NCT00045942|19706585|P1|PKC412A2104E2|Adverse Event|0
5724623|NCT00045942|19706577|P9|PKC412A2104E2|Lack of Efficacy|6
5724624|NCT00045942|19706578|P8|PKC412A2104E2|Lack of Efficacy|2
5724625|NCT00045942|19706579|P7|PKC412A2104E2|Lack of Efficacy|2
5724626|NCT00045942|19706580|P6|PKC412A2104E2|Lack of Efficacy|3
5724627|NCT00045942|19706581|P5|PKC412A2104E2|Lack of Efficacy|0
5724628|NCT00045942|19706582|P4|PKC412A2104E2|Lack of Efficacy|0
5724629|NCT00045942|19706583|P3|PKC412A2104E2|Lack of Efficacy|0
5724630|NCT00045942|19706584|P2|PKC412A2104E2|Lack of Efficacy|0
5724631|NCT00045942|19706585|P1|PKC412A2104E2|Lack of Efficacy|0
5724632|NCT00045942|19706577|P9|PKC412A2104E2|Withdrawal by Subject|0
5724633|NCT00045942|19706578|P8|PKC412A2104E2|Withdrawal by Subject|1
5724634|NCT00045942|19706579|P7|PKC412A2104E2|Withdrawal by Subject|0
5724635|NCT00045942|19706580|P6|PKC412A2104E2|Withdrawal by Subject|1
5724636|NCT00045942|19706581|P5|PKC412A2104E2|Withdrawal by Subject|0
5724637|NCT00045942|19706582|P4|PKC412A2104E2|Withdrawal by Subject|0
5724638|NCT00045942|19706583|P3|PKC412A2104E2|Withdrawal by Subject|0
5724639|NCT00045942|19706584|P2|PKC412A2104E2|Withdrawal by Subject|0
5724640|NCT00045942|19706585|P1|PKC412A2104E2|Withdrawal by Subject|0
5724641|NCT00045942|19706577|P9|PKC412A2104E2|Lost to Follow-up|0
5724642|NCT00045942|19706578|P8|PKC412A2104E2|Lost to Follow-up|3
5724643|NCT00045942|19706579|P7|PKC412A2104E2|Lost to Follow-up|0
5724644|NCT00045942|19706580|P6|PKC412A2104E2|Lost to Follow-up|0
5724645|NCT00045942|19706581|P5|PKC412A2104E2|Lost to Follow-up|0
5724646|NCT00045942|19706582|P4|PKC412A2104E2|Lost to Follow-up|0
5724647|NCT00045942|19706583|P3|PKC412A2104E2|Lost to Follow-up|0
5724648|NCT00045942|19706584|P2|PKC412A2104E2|Lost to Follow-up|0
5724649|NCT00045942|19706585|P1|PKC412A2104E2|Lost to Follow-up|0
5724650|NCT00045942|19706577|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5724651|NCT00045942|19706578|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5724652|NCT00045942|19706579|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5724653|NCT00045942|19706580|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5724654|NCT00045942|19706581|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5724655|NCT00045942|19706582|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
5724656|NCT00045942|19706583|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
5724657|NCT00045942|19706584|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5724658|NCT00045942|19706585|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
5724659|NCT00045942|19706577|P9|PKC412A2104E1|Death|0
5724660|NCT00045942|19706578|P8|PKC412A2104E1|Death|0
5724661|NCT00045942|19706579|P7|PKC412A2104E1|Death|0
5724662|NCT00045942|19706580|P6|PKC412A2104E1|Death|0
5724663|NCT00045942|19706581|P5|PKC412A2104E1|Death|1
5724664|NCT00045942|19706582|P4|PKC412A2104E1|Death|1
5724665|NCT00045942|19706583|P3|PKC412A2104E1|Death|1
5724666|NCT00045942|19706584|P2|PKC412A2104E1|Death|4
5724667|NCT00045942|19706585|P1|PKC412A2104E1|Death|0
5724668|NCT00045942|19706577|P9|PKC412A2104E1|Adverse Event|0
5724669|NCT00045942|19706578|P8|PKC412A2104E1|Adverse Event|0
5724670|NCT00045942|19706579|P7|PKC412A2104E1|Adverse Event|0
5724671|NCT00045942|19706580|P6|PKC412A2104E1|Adverse Event|0
5724672|NCT00045942|19706581|P5|PKC412A2104E1|Adverse Event|6
5724673|NCT00045942|19706582|P4|PKC412A2104E1|Adverse Event|3
5724674|NCT00045942|19706583|P3|PKC412A2104E1|Adverse Event|1
5724675|NCT00045942|19706584|P2|PKC412A2104E1|Adverse Event|1
5724676|NCT00045942|19706585|P1|PKC412A2104E1|Adverse Event|0
5724677|NCT00045942|19706577|P9|PKC412A2104E1|Abnormal laboratory value|0
5724678|NCT00045942|19706578|P8|PKC412A2104E1|Abnormal laboratory value|0
5724679|NCT00045942|19706579|P7|PKC412A2104E1|Abnormal laboratory value|0
5724680|NCT00045942|19706580|P6|PKC412A2104E1|Abnormal laboratory value|0
5724681|NCT00045942|19706581|P5|PKC412A2104E1|Abnormal laboratory value|0
5724682|NCT00045942|19706582|P4|PKC412A2104E1|Abnormal laboratory value|0
5724683|NCT00045942|19706583|P3|PKC412A2104E1|Abnormal laboratory value|0
5724684|NCT00045942|19706584|P2|PKC412A2104E1|Abnormal laboratory value|1
5724685|NCT00045942|19706585|P1|PKC412A2104E1|Abnormal laboratory value|0
5724686|NCT00045942|19706577|P9|PKC412A2104E1|Lack of Efficacy|0
5724687|NCT00045942|19706578|P8|PKC412A2104E1|Lack of Efficacy|0
5724688|NCT00045942|19706579|P7|PKC412A2104E1|Lack of Efficacy|0
5724689|NCT00045942|19706580|P6|PKC412A2104E1|Lack of Efficacy|0
5724690|NCT00045942|19706581|P5|PKC412A2104E1|Lack of Efficacy|17
5724691|NCT00045942|19706582|P4|PKC412A2104E1|Lack of Efficacy|23
5724692|NCT00045942|19706583|P3|PKC412A2104E1|Lack of Efficacy|11
5724693|NCT00045942|19706584|P2|PKC412A2104E1|Lack of Efficacy|11
5724694|NCT00045942|19706585|P1|PKC412A2104E1|Lack of Efficacy|0
5724695|NCT00045942|19706577|P9|PKC412A2104E1|Condition no longer requires study drug|0
5724696|NCT00045942|19706578|P8|PKC412A2104E1|Condition no longer requires study drug|0
5724697|NCT00045942|19706579|P7|PKC412A2104E1|Condition no longer requires study drug|0
5724698|NCT00045942|19706580|P6|PKC412A2104E1|Condition no longer requires study drug|0
5724699|NCT00045942|19706581|P5|PKC412A2104E1|Condition no longer requires study drug|1
5724700|NCT00045942|19706582|P4|PKC412A2104E1|Condition no longer requires study drug|0
5724701|NCT00045942|19706583|P3|PKC412A2104E1|Condition no longer requires study drug|1
5724702|NCT00045942|19706584|P2|PKC412A2104E1|Condition no longer requires study drug|1
5724703|NCT00045942|19706585|P1|PKC412A2104E1|Condition no longer requires study drug|0
5724704|NCT00045942|19706577|P9|PKC412A2104E1|Withdrawal by Subject|0
5724705|NCT00045942|19706578|P8|PKC412A2104E1|Withdrawal by Subject|0
5724706|NCT00045942|19706579|P7|PKC412A2104E1|Withdrawal by Subject|0
5724707|NCT00045942|19706580|P6|PKC412A2104E1|Withdrawal by Subject|0
5724708|NCT00045942|19706581|P5|PKC412A2104E1|Withdrawal by Subject|2
5724709|NCT00045942|19706582|P4|PKC412A2104E1|Withdrawal by Subject|5
5724710|NCT00045942|19706583|P3|PKC412A2104E1|Withdrawal by Subject|2
5724711|NCT00045942|19706584|P2|PKC412A2104E1|Withdrawal by Subject|0
5724712|NCT00045942|19706585|P1|PKC412A2104E1|Withdrawal by Subject|0
5724713|NCT00045942|19706577|P9|PKC412A2104 (Core)|Death|0
5724714|NCT00045942|19706578|P8|PKC412A2104 (Core)|Death|0
5724715|NCT00045942|19706579|P7|PKC412A2104 (Core)|Death|0
5724716|NCT00045942|19706580|P6|PKC412A2104 (Core)|Death|0
5724717|NCT00045942|19706581|P5|PKC412A2104 (Core)|Death|0
5724718|NCT00045942|19706582|P4|PKC412A2104 (Core)|Death|0
5724719|NCT00045942|19706583|P3|PKC412A2104 (Core)|Death|0
5724720|NCT00045942|19706584|P2|PKC412A2104 (Core)|Death|0
5724721|NCT00045942|19706585|P1|PKC412A2104 (Core)|Death|1
5724722|NCT00045942|19706577|P9|PKC412A2104 (Core)|Lack of Efficacy|0
5724723|NCT00045942|19706578|P8|PKC412A2104 (Core)|Lack of Efficacy|0
5724724|NCT00045942|19706579|P7|PKC412A2104 (Core)|Lack of Efficacy|0
5724725|NCT00045942|19706580|P6|PKC412A2104 (Core)|Lack of Efficacy|0
5724726|NCT00045942|19706581|P5|PKC412A2104 (Core)|Lack of Efficacy|0
5724727|NCT00045942|19706582|P4|PKC412A2104 (Core)|Lack of Efficacy|0
5724728|NCT00045942|19706583|P3|PKC412A2104 (Core)|Lack of Efficacy|0
5724729|NCT00045942|19706584|P2|PKC412A2104 (Core)|Lack of Efficacy|0
5724730|NCT00045942|19706585|P1|PKC412A2104 (Core)|Lack of Efficacy|13
5724731|NCT00045942|19706577|P9|PKC412A2104 (Core)|Adverse Event|0
5724732|NCT00045942|19706578|P8|PKC412A2104 (Core)|Adverse Event|0
5724733|NCT00045942|19706579|P7|PKC412A2104 (Core)|Adverse Event|0
5724734|NCT00045942|19706580|P6|PKC412A2104 (Core)|Adverse Event|0
5724735|NCT00045942|19706581|P5|PKC412A2104 (Core)|Adverse Event|0
5724736|NCT00045942|19706582|P4|PKC412A2104 (Core)|Adverse Event|0
5724737|NCT00045942|19706583|P3|PKC412A2104 (Core)|Adverse Event|0
5724738|NCT00045942|19706584|P2|PKC412A2104 (Core)|Adverse Event|0
5724739|NCT00045942|19706585|P1|PKC412A2104 (Core)|Adverse Event|5
5724740|NCT00045942|19706577|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
5724741|NCT00045942|19706578|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
5724742|NCT00045942|19706579|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
5724743|NCT00045942|19706580|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
5724744|NCT00045942|19706581|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
5724745|NCT00045942|19706582|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
5724746|NCT00045942|19706583|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
5724747|NCT00045942|19706584|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
5724748|NCT00045942|19706585|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
5724749|NCT00044512|19706674|P1|Follow Up|Lost to Follow-up|2
5724750|NCT00044213|19706689|P4|Overall Study|Lost to Follow-up|4
5724751|NCT00044213|19706690|P3|Overall Study|Lost to Follow-up|5
5724752|NCT00044213|19706691|P2|Overall Study|Lost to Follow-up|5
5724753|NCT00044213|19706692|P1|Overall Study|Lost to Follow-up|8
5724754|NCT00044213|19706689|P4|Overall Study|Death|49
5724755|NCT00044213|19706690|P3|Overall Study|Death|42
5724756|NCT00044213|19706691|P2|Overall Study|Death|42
5724757|NCT00044213|19706692|P1|Overall Study|Death|42
5724758|NCT00044213|19706689|P4|Overall Study|Withdrawal by Subject|83
5724759|NCT00044213|19706690|P3|Overall Study|Withdrawal by Subject|91
5724760|NCT00044213|19706691|P2|Overall Study|Withdrawal by Subject|65
5724761|NCT00044213|19706692|P1|Overall Study|Withdrawal by Subject|50
5724762|NCT00044083|19706757|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
5724763|NCT00044083|19706758|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
5724764|NCT00044083|19706757|P2|First Intervention (One Week) Patients|Used illegal drug|0
5724765|NCT00044083|19706758|P1|First Intervention (One Week) Patients|Used illegal drug|1
5724766|NCT00044083|19706757|P2|First Intervention (One Week) Patients|Not follow directions|2
5724767|NCT00044083|19706758|P1|First Intervention (One Week) Patients|Not follow directions|0
5724768|NCT00044083|19706757|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
5724769|NCT00044083|19706758|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
5724770|NCT00044083|19706757|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
5724771|NCT00044083|19706758|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
5724772|NCT00044083|19706757|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
5724773|NCT00044083|19706758|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
5724774|NCT00044083|19706757|P2|First Intervention (One Week)- HV's|Pregnancy|0
5724775|NCT00044083|19706758|P1|First Intervention (One Week)- HV's|Pregnancy|1
5724776|NCT00044083|19706757|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
5724777|NCT00044083|19706758|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
5724778|NCT00044083|19706757|P2|First Intervention (One Week)- HV's|Not follow directions|2
5724779|NCT00044083|19706758|P1|First Intervention (One Week)- HV's|Not follow directions|2
5724780|NCT00044083|19706757|P2|First Intervention (One Week)- HV's|Adverse Event|0
5724781|NCT00044083|19706758|P1|First Intervention (One Week)- HV's|Adverse Event|1
5724782|NCT00043979|19706796|P3|Period 1|recipient with progressive disease|3
5724783|NCT00043979|19706797|P2|Period 1|recipient with progressive disease|4
5724784|NCT00043979|19706798|P1|Period 1|recipient with progressive disease|7
5724785|NCT00043550|19706819|P3|Overall Study|Withdrawal by Subject|20
5724786|NCT00043550|19706820|P2|Overall Study|Withdrawal by Subject|12
5724787|NCT00043550|19706821|P1|Overall Study|Withdrawal by Subject|22
5724788|NCT00043186|19706838|P9|Overall Study|Other|0
5724789|NCT00043186|19706839|P8|Overall Study|Other|0
5724790|NCT00043186|19706840|P7|Overall Study|Other|0
5724791|NCT00043186|19706841|P6|Overall Study|Other|0
5724792|NCT00043186|19706842|P5|Overall Study|Other|0
5724793|NCT00043186|19706843|P4|Overall Study|Other|1
5724794|NCT00043186|19706844|P3|Overall Study|Other|1
5724795|NCT00043186|19706845|P2|Overall Study|Other|0
5724796|NCT00043186|19706846|P1|Overall Study|Other|0
5724797|NCT00043186|19706838|P9|Overall Study|Noncompliance|0
5724798|NCT00043186|19706839|P8|Overall Study|Noncompliance|0
5724799|NCT00043186|19706840|P7|Overall Study|Noncompliance|0
5724800|NCT00043186|19706841|P6|Overall Study|Noncompliance|0
5724801|NCT00043186|19706842|P5|Overall Study|Noncompliance|0
5724802|NCT00043186|19706843|P4|Overall Study|Noncompliance|1
5724803|NCT00043186|19706844|P3|Overall Study|Noncompliance|1
5724804|NCT00043186|19706845|P2|Overall Study|Noncompliance|0
5724805|NCT00043186|19706846|P1|Overall Study|Noncompliance|0
5724806|NCT00043186|19706838|P9|Overall Study|Lost to Follow-up|2
5724807|NCT00043186|19706839|P8|Overall Study|Lost to Follow-up|1
5724808|NCT00043186|19706840|P7|Overall Study|Lost to Follow-up|1
5724809|NCT00043186|19706841|P6|Overall Study|Lost to Follow-up|1
5724810|NCT00043186|19706842|P5|Overall Study|Lost to Follow-up|1
5724811|NCT00043186|19706843|P4|Overall Study|Lost to Follow-up|1
5724812|NCT00043186|19706844|P3|Overall Study|Lost to Follow-up|1
5724813|NCT00043186|19706845|P2|Overall Study|Lost to Follow-up|5
5724814|NCT00043186|19706846|P1|Overall Study|Lost to Follow-up|3
5724815|NCT00043186|19706838|P9|Overall Study|Ineligibility determined|1
5724816|NCT00043186|19706839|P8|Overall Study|Ineligibility determined|0
5724817|NCT00043186|19706840|P7|Overall Study|Ineligibility determined|0
5724818|NCT00043186|19706841|P6|Overall Study|Ineligibility determined|0
5724819|NCT00043186|19706842|P5|Overall Study|Ineligibility determined|0
5724820|NCT00043186|19706843|P4|Overall Study|Ineligibility determined|0
5724821|NCT00043186|19706844|P3|Overall Study|Ineligibility determined|0
5724822|NCT00043186|19706845|P2|Overall Study|Ineligibility determined|0
5724823|NCT00043186|19706846|P1|Overall Study|Ineligibility determined|0
5724824|NCT00043186|19706838|P9|Overall Study|Disease progression|0
5724825|NCT00043186|19706839|P8|Overall Study|Disease progression|4
5724826|NCT00043186|19706840|P7|Overall Study|Disease progression|0
5724827|NCT00043186|19706841|P6|Overall Study|Disease progression|0
5724828|NCT00043186|19706842|P5|Overall Study|Disease progression|0
5724829|NCT00043186|19706843|P4|Overall Study|Disease progression|3
5724830|NCT00043186|19706844|P3|Overall Study|Disease progression|0
5724831|NCT00043186|19706845|P2|Overall Study|Disease progression|0
5724832|NCT00043186|19706846|P1|Overall Study|Disease progression|1
5724833|NCT00043186|19706838|P9|Overall Study|Death|0
5724834|NCT00043186|19706839|P8|Overall Study|Death|0
5724835|NCT00043186|19706840|P7|Overall Study|Death|2
5724836|NCT00043186|19706841|P6|Overall Study|Death|0
5724837|NCT00043186|19706842|P5|Overall Study|Death|0
5724838|NCT00043186|19706843|P4|Overall Study|Death|0
5724839|NCT00043186|19706844|P3|Overall Study|Death|1
5724840|NCT00043186|19706845|P2|Overall Study|Death|0
5724841|NCT00043186|19706846|P1|Overall Study|Death|0
5724842|NCT00043186|19706838|P9|Overall Study|Withdrawal by Subject|10
5724843|NCT00043186|19706839|P8|Overall Study|Withdrawal by Subject|9
5724844|NCT00043186|19706840|P7|Overall Study|Withdrawal by Subject|12
5724845|NCT00043186|19706841|P6|Overall Study|Withdrawal by Subject|6
5724846|NCT00043186|19706842|P5|Overall Study|Withdrawal by Subject|14
5724847|NCT00043186|19706843|P4|Overall Study|Withdrawal by Subject|13
5724848|NCT00043186|19706844|P3|Overall Study|Withdrawal by Subject|11
5724849|NCT00043186|19706845|P2|Overall Study|Withdrawal by Subject|8
5724850|NCT00043186|19706846|P1|Overall Study|Withdrawal by Subject|11
5724851|NCT00043186|19706838|P9|Overall Study|Adverse Event|3
5724852|NCT00043186|19706839|P8|Overall Study|Adverse Event|1
5724853|NCT00043186|19706840|P7|Overall Study|Adverse Event|2
5724854|NCT00043186|19706841|P6|Overall Study|Adverse Event|1
5724855|NCT00043186|19706842|P5|Overall Study|Adverse Event|2
5724856|NCT00043186|19706843|P4|Overall Study|Adverse Event|3
5724857|NCT00043186|19706844|P3|Overall Study|Adverse Event|2
5724858|NCT00043186|19706845|P2|Overall Study|Adverse Event|2
5724859|NCT00043186|19706846|P1|Overall Study|Adverse Event|2
5724860|NCT00043186|19706838|P9|Overall Study|Physician Decision|1
5724861|NCT00043186|19706839|P8|Overall Study|Physician Decision|1
5724862|NCT00043186|19706840|P7|Overall Study|Physician Decision|0
5724863|NCT00043186|19706841|P6|Overall Study|Physician Decision|0
5724864|NCT00043186|19706842|P5|Overall Study|Physician Decision|1
5724865|NCT00043186|19706843|P4|Overall Study|Physician Decision|0
5724866|NCT00043186|19706844|P3|Overall Study|Physician Decision|3
5724867|NCT00043186|19706845|P2|Overall Study|Physician Decision|0
5724868|NCT00043186|19706846|P1|Overall Study|Physician Decision|0
5724869|NCT00042666|19707172|P1|Overall Study|Other|4
5724870|NCT00042666|19707172|P1|Overall Study|Other|1
5724871|NCT00042666|19707172|P1|Overall Study|Progressive Disease|41
5724872|NCT00042666|19707172|P1|Overall Study|Participant/Physician Perception|1
5724873|NCT00042666|19707172|P1|Overall Study|Protocol Violation|1
5724874|NCT00042666|19707172|P1|Overall Study|Death|4
5724875|NCT00042666|19707172|P1|Overall Study|Adverse Event|2
5724876|NCT00042432|19707184|P2|Overall Study|Other|0
5724877|NCT00042432|19707185|P1|Overall Study|Other|2
5724878|NCT00042432|19707184|P2|Overall Study|Initiation of maintenance dialysis|1
5724879|NCT00042432|19707185|P1|Overall Study|Initiation of maintenance dialysis|1
5724880|NCT00042432|19707184|P2|Overall Study|Ineligibility determined|0
5724881|NCT00042432|19707185|P1|Overall Study|Ineligibility determined|1
5724882|NCT00042432|19707184|P2|Overall Study|Death|2
5724883|NCT00042432|19707185|P1|Overall Study|Death|0
5724884|NCT00042432|19707184|P2|Overall Study|Withdrawal by Subject|3
5724885|NCT00042432|19707185|P1|Overall Study|Withdrawal by Subject|1
5724886|NCT00042432|19707184|P2|Overall Study|Adverse Event|1
5724887|NCT00042432|19707185|P1|Overall Study|Adverse Event|4
5724888|NCT00041756|19707238|P5|Overall Study|Data Monitoring Committee Recommendation|21
5724889|NCT00041756|19707239|P4|Overall Study|Data Monitoring Committee Recommendation|0
5724890|NCT00041756|19707240|P3|Overall Study|Data Monitoring Committee Recommendation|0
5724891|NCT00041756|19707241|P2|Overall Study|Data Monitoring Committee Recommendation|0
5724892|NCT00041756|19707242|P1|Overall Study|Data Monitoring Committee Recommendation|0
5724893|NCT00041756|19707238|P5|Overall Study|Unable to meet protocol criteria|1
5724894|NCT00041756|19707239|P4|Overall Study|Unable to meet protocol criteria|0
5724895|NCT00041756|19707240|P3|Overall Study|Unable to meet protocol criteria|1
5724896|NCT00041756|19707241|P2|Overall Study|Unable to meet protocol criteria|0
5724897|NCT00041756|19707242|P1|Overall Study|Unable to meet protocol criteria|0
5724898|NCT00041756|19707238|P5|Overall Study|Lost to Follow-up|0
5724899|NCT00041756|19707239|P4|Overall Study|Lost to Follow-up|1
5724900|NCT00041756|19707240|P3|Overall Study|Lost to Follow-up|0
5724901|NCT00041756|19707241|P2|Overall Study|Lost to Follow-up|1
5724902|NCT00041756|19707242|P1|Overall Study|Lost to Follow-up|0
5724903|NCT00041756|19707238|P5|Overall Study|Withdrawal by Subject|3
5724904|NCT00041756|19707239|P4|Overall Study|Withdrawal by Subject|2
5724905|NCT00041756|19707240|P3|Overall Study|Withdrawal by Subject|4
5724906|NCT00041756|19707241|P2|Overall Study|Withdrawal by Subject|3
5724907|NCT00041756|19707242|P1|Overall Study|Withdrawal by Subject|3
5724908|NCT00041756|19707238|P5|Overall Study|Protocol Violation|1
5724909|NCT00041756|19707239|P4|Overall Study|Protocol Violation|2
5724910|NCT00041756|19707240|P3|Overall Study|Protocol Violation|2
5724911|NCT00041756|19707241|P2|Overall Study|Protocol Violation|1
5724912|NCT00041756|19707242|P1|Overall Study|Protocol Violation|1
5724913|NCT00041756|19707238|P5|Overall Study|Adverse Event|34
5724914|NCT00041756|19707239|P4|Overall Study|Adverse Event|11
5724915|NCT00041756|19707240|P3|Overall Study|Adverse Event|6
5724916|NCT00041756|19707241|P2|Overall Study|Adverse Event|10
5724917|NCT00041756|19707242|P1|Overall Study|Adverse Event|4
5724918|NCT00041470|19707270|P1|Overall Study|Loss of Funding|38
5724919|NCT00040664|19707275|P4|Overall Study|Non-viability of oral suspension|0
5724920|NCT00040664|19707276|P3|Overall Study|Non-viability of oral suspension|1
5724921|NCT00040664|19707277|P2|Overall Study|Non-viability of oral suspension|0
5724922|NCT00040664|19707278|P1|Overall Study|Non-viability of oral suspension|1
5724923|NCT00040664|19707275|P4|Overall Study|Change of formulation|0
5724924|NCT00040664|19707276|P3|Overall Study|Change of formulation|0
5724925|NCT00040664|19707277|P2|Overall Study|Change of formulation|2
5724926|NCT00040664|19707278|P1|Overall Study|Change of formulation|2
5724927|NCT00040664|19707275|P4|Overall Study|Pharmacokinetic target not achieved|1
5724928|NCT00040664|19707276|P3|Overall Study|Pharmacokinetic target not achieved|0
5724929|NCT00040664|19707277|P2|Overall Study|Pharmacokinetic target not achieved|1
5724930|NCT00040664|19707278|P1|Overall Study|Pharmacokinetic target not achieved|2
5724931|NCT00040664|19707275|P4|Overall Study|Poor taste|0
5724932|NCT00040664|19707276|P3|Overall Study|Poor taste|2
5724933|NCT00040664|19707277|P2|Overall Study|Poor taste|0
5724934|NCT00040664|19707278|P1|Overall Study|Poor taste|2
5724935|NCT00040664|19707275|P4|Overall Study|Medication adherence/compliance problems|5
5724936|NCT00040664|19707276|P3|Overall Study|Medication adherence/compliance problems|1
5724937|NCT00040664|19707277|P2|Overall Study|Medication adherence/compliance problems|2
5724938|NCT00040664|19707278|P1|Overall Study|Medication adherence/compliance problems|8
5724939|NCT00040664|19707275|P4|Overall Study|Pregnancy|3
5724940|NCT00040664|19707276|P3|Overall Study|Pregnancy|0
5724941|NCT00040664|19707277|P2|Overall Study|Pregnancy|0
5724942|NCT00040664|19707278|P1|Overall Study|Pregnancy|3
5724943|NCT00040664|19707275|P4|Overall Study|Withdrawal by Subject|4
5724944|NCT00040664|19707276|P3|Overall Study|Withdrawal by Subject|3
5724945|NCT00040664|19707277|P2|Overall Study|Withdrawal by Subject|0
5724946|NCT00040664|19707278|P1|Overall Study|Withdrawal by Subject|7
5724947|NCT00040664|19707275|P4|Overall Study|Protocol Violation|1
5724948|NCT00040664|19707276|P3|Overall Study|Protocol Violation|0
5724949|NCT00040664|19707277|P2|Overall Study|Protocol Violation|1
5724950|NCT00040664|19707278|P1|Overall Study|Protocol Violation|2
5724951|NCT00040664|19707275|P4|Overall Study|Lost to Follow-up|2
5724952|NCT00040664|19707276|P3|Overall Study|Lost to Follow-up|0
5724953|NCT00040664|19707277|P2|Overall Study|Lost to Follow-up|2
5724954|NCT00040664|19707278|P1|Overall Study|Lost to Follow-up|4
5724955|NCT00040664|19707275|P4|Overall Study|Insufficient CD4 response|0
5724956|NCT00040664|19707276|P3|Overall Study|Insufficient CD4 response|1
5724957|NCT00040664|19707277|P2|Overall Study|Insufficient CD4 response|0
5724958|NCT00040664|19707278|P1|Overall Study|Insufficient CD4 response|1
5724959|NCT00040664|19707275|P4|Overall Study|Lack of Efficacy|4
5724960|NCT00040664|19707276|P3|Overall Study|Lack of Efficacy|3
5724961|NCT00040664|19707277|P2|Overall Study|Lack of Efficacy|2
5724962|NCT00040664|19707278|P1|Overall Study|Lack of Efficacy|9
5724963|NCT00040664|19707275|P4|Overall Study|Adverse Event|7
5724964|NCT00040664|19707276|P3|Overall Study|Adverse Event|2
5724965|NCT00040664|19707277|P2|Overall Study|Adverse Event|3
5724966|NCT00040664|19707278|P1|Overall Study|Adverse Event|12
5724967|NCT00040365|19707344|P1|Overall Study|Lost to Follow-up|3
5724968|NCT00040365|19707344|P1|Overall Study|Progressive disease|7
5724969|NCT00040365|19707344|P1|Overall Study|Death|1
5724970|NCT00039871|19707353|P1|Overall Study|Never entered follow-up|7
5724971|NCT00039871|19707353|P1|Overall Study|Discontinued at Week 12 per protocol|1061
5724972|NCT00039871|19707353|P1|Overall Study|Administrative|1
5724973|NCT00039871|19707353|P1|Overall Study|Did not meet eligibility criteria|11
5724974|NCT00039871|19707353|P1|Overall Study|Withdrawal by Subject|97
5724975|NCT00039871|19707353|P1|Overall Study|Protocol Violation|24
5724976|NCT00039871|19707353|P1|Overall Study|Lost to Follow-up|18
5724977|NCT00039871|19707353|P1|Overall Study|Adverse Event|165
5724978|NCT00039741|19707363|P4|Overall Study|Missed final visit|2
5724979|NCT00039741|19707364|P3|Overall Study|Missed final visit|2
5724980|NCT00039741|19707365|P2|Overall Study|Missed final visit|1
5724981|NCT00039741|19707366|P1|Overall Study|Missed final visit|2
5724982|NCT00039741|19707363|P4|Overall Study|Withdrew consent|1
5724983|NCT00039741|19707364|P3|Overall Study|Withdrew consent|0
5724984|NCT00039741|19707365|P2|Overall Study|Withdrew consent|5
5724985|NCT00039741|19707366|P1|Overall Study|Withdrew consent|0
5724986|NCT00039741|19707363|P4|Overall Study|Non-compliance with protocol|0
5724987|NCT00039741|19707364|P3|Overall Study|Non-compliance with protocol|1
5724988|NCT00039741|19707365|P2|Overall Study|Non-compliance with protocol|0
5724989|NCT00039741|19707366|P1|Overall Study|Non-compliance with protocol|1
5724990|NCT00039741|19707363|P4|Overall Study|Moved|6
5724991|NCT00039741|19707364|P3|Overall Study|Moved|3
5724992|NCT00039741|19707365|P2|Overall Study|Moved|2
5724993|NCT00039741|19707366|P1|Overall Study|Moved|3
5724994|NCT00039741|19707363|P4|Overall Study|Not able to get to clinic|3
5724995|NCT00039741|19707364|P3|Overall Study|Not able to get to clinic|0
5724996|NCT00039741|19707365|P2|Overall Study|Not able to get to clinic|2
5724997|NCT00039741|19707366|P1|Overall Study|Not able to get to clinic|5
5724998|NCT00039741|19707363|P4|Overall Study|Confounding medical condition|0
5724999|NCT00039741|19707364|P3|Overall Study|Confounding medical condition|0
5725000|NCT00039741|19707365|P2|Overall Study|Confounding medical condition|0
5725001|NCT00039741|19707366|P1|Overall Study|Confounding medical condition|1
5725002|NCT00039741|19707363|P4|Overall Study|Lost to Follow-up|2
5725003|NCT00039741|19707364|P3|Overall Study|Lost to Follow-up|5
5725004|NCT00039741|19707365|P2|Overall Study|Lost to Follow-up|1
5725005|NCT00039741|19707366|P1|Overall Study|Lost to Follow-up|3
5725006|NCT00039741|19707363|P4|Overall Study|Death|0
5725007|NCT00039741|19707364|P3|Overall Study|Death|0
5725008|NCT00039741|19707365|P2|Overall Study|Death|1
5725009|NCT00039741|19707366|P1|Overall Study|Death|0
5725010|NCT00038948|19707410|P2|Overall Study|Lack of Efficacy|6
5725011|NCT00038948|19707411|P1|Overall Study|Lack of Efficacy|3
5725012|NCT00038948|19707410|P2|Overall Study|Protocol Violation|7
5725013|NCT00038948|19707411|P1|Overall Study|Protocol Violation|3
5725014|NCT00038948|19707410|P2|Overall Study|Withdrawal by Subject|10
5725015|NCT00038948|19707411|P1|Overall Study|Withdrawal by Subject|23
5725016|NCT00038948|19707410|P2|Overall Study|Nonmedical event|7
5725017|NCT00038948|19707411|P1|Overall Study|Nonmedical event|5
5725018|NCT00038948|19707410|P2|Overall Study|Lost to Follow-up|4
5725019|NCT00038948|19707411|P1|Overall Study|Lost to Follow-up|4
5725020|NCT00038948|19707410|P2|Overall Study|Adverse Event|43
5725021|NCT00038948|19707411|P1|Overall Study|Adverse Event|131
5725022|NCT00038649|19707446|P1|Overall Study|Adverse Event|9
5725023|NCT00038467|19707459|P2|Overall Study|Other|28
5725024|NCT00038467|19707460|P1|Overall Study|Other|26
5725025|NCT00038467|19707459|P2|Overall Study|Randomized, but not treated|35
5725026|NCT00038467|19707460|P1|Overall Study|Randomized, but not treated|31
5725027|NCT00038467|19707459|P2|Overall Study|Recurrence|179
5725028|NCT00038467|19707460|P1|Overall Study|Recurrence|109
5725029|NCT00038467|19707459|P2|Overall Study|Lost to Follow-up|10
5725030|NCT00038467|19707460|P1|Overall Study|Lost to Follow-up|15
5725031|NCT00038467|19707459|P2|Overall Study|Death|16
5725032|NCT00038467|19707460|P1|Overall Study|Death|22
5725033|NCT00038467|19707459|P2|Overall Study|Protocol Violation|22
5725034|NCT00038467|19707460|P1|Overall Study|Protocol Violation|19
5725035|NCT00038467|19707459|P2|Overall Study|Withdrawal by Subject|107
5725036|NCT00038467|19707460|P1|Overall Study|Withdrawal by Subject|150
5725037|NCT00038467|19707459|P2|Overall Study|Adverse Event|145
5725038|NCT00038467|19707460|P1|Overall Study|Adverse Event|170
5725039|NCT00038142|19707522|P2|Overall Study|Unknown Reason|0
5725040|NCT00038142|19707523|P1|Overall Study|Unknown Reason|8
5725041|NCT00038142|19707522|P2|Overall Study|Adverse Event|0
5725042|NCT00038142|19707523|P1|Overall Study|Adverse Event|1
5725043|NCT00038142|19707522|P2|Overall Study|Death|0
5725044|NCT00038142|19707523|P1|Overall Study|Death|1
5725045|NCT00038142|19707522|P2|Overall Study|Progressive Disease|7
5725046|NCT00038142|19707523|P1|Overall Study|Progressive Disease|11
5725047|NCT00038142|19707522|P2|Overall Study|Ineligible|0
5725048|NCT00038142|19707523|P1|Overall Study|Ineligible|1
5725049|NCT00038103|19707531|P2|Overall Study|Randomized/never treated|0
5725050|NCT00038103|19707532|P1|Overall Study|Randomized/never treated|2
5725051|NCT00038103|19707531|P2|Overall Study|Sponsor Decision|1
5725052|NCT00038103|19707532|P1|Overall Study|Sponsor Decision|0
5725053|NCT00038103|19707531|P2|Overall Study|Protocol Violation|2
5725054|NCT00038103|19707532|P1|Overall Study|Protocol Violation|0
5725055|NCT00038103|19707531|P2|Overall Study|Lost to Follow-up|3
5725056|NCT00038103|19707532|P1|Overall Study|Lost to Follow-up|0
5725057|NCT00038103|19707531|P2|Overall Study|Withdrawal by Subject|3
5725058|NCT00038103|19707532|P1|Overall Study|Withdrawal by Subject|0
5725059|NCT00038103|19707531|P2|Overall Study|Lack of Efficacy|41
5725060|NCT00038103|19707532|P1|Overall Study|Lack of Efficacy|48
5725061|NCT00038103|19707531|P2|Overall Study|Adverse Event|6
5725062|NCT00038103|19707532|P1|Overall Study|Adverse Event|5
5725063|NCT00037830|19707555|P3|Overall Study|Unrelated Medical Problem|0
5725064|NCT00037830|19707556|P2|Overall Study|Unrelated Medical Problem|0
5725065|NCT00037830|19707557|P1|Overall Study|Unrelated Medical Problem|2
5725066|NCT00037830|19707555|P3|Overall Study|Protocol Violation|0
5725067|NCT00037830|19707556|P2|Overall Study|Protocol Violation|2
5725068|NCT00037830|19707557|P1|Overall Study|Protocol Violation|2
5725069|NCT00037830|19707555|P3|Overall Study|Withdrawal by Subject|1
5725070|NCT00037830|19707556|P2|Overall Study|Withdrawal by Subject|5
5725071|NCT00037830|19707557|P1|Overall Study|Withdrawal by Subject|4
5725072|NCT00037830|19707555|P3|Overall Study|Adverse Event|0
5725073|NCT00037830|19707556|P2|Overall Study|Adverse Event|0
5725074|NCT00037830|19707557|P1|Overall Study|Adverse Event|2
5725075|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
5725076|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
5725077|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|Too early switch|103
5725078|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|Too early switch|0
5725079|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
5725080|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
5725081|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|Protocol Violation|91
5725082|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|Protocol Violation|23
5725083|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
5725084|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
5725085|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|Treatment refusal|208
5725086|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|Treatment refusal|113
5725087|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|Other|288
5725088|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|Other|277
5725089|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|Adverse Event|782
5725090|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|Adverse Event|501
5725091|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
5725092|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
5725093|NCT00036270|19707589|P2|Study Treatment to 5 Year Report|Ongoing|736
5725094|NCT00036270|19707590|P1|Study Treatment to 5 Year Report|Ongoing|1081
5725095|NCT00036270|19707589|P2|Randomized to Study Treatment|Withdrawal by Subject|7
5725096|NCT00036270|19707590|P1|Randomized to Study Treatment|Withdrawal by Subject|6
5725097|NCT00035932|19707609|P3|Overall Study|Lack of Efficacy|28
5725098|NCT00035932|19707610|P2|Overall Study|Lack of Efficacy|33
5725099|NCT00035932|19707611|P1|Overall Study|Lack of Efficacy|33
5725100|NCT00035932|19707609|P3|Overall Study|Study Termination by Sponsor|0
5725101|NCT00035932|19707610|P2|Overall Study|Study Termination by Sponsor|0
5725102|NCT00035932|19707611|P1|Overall Study|Study Termination by Sponsor|1
5725103|NCT00035932|19707609|P3|Overall Study|Withdrawal by Subject|0
5725104|NCT00035932|19707610|P2|Overall Study|Withdrawal by Subject|5
5725105|NCT00035932|19707611|P1|Overall Study|Withdrawal by Subject|1
5725106|NCT00035932|19707609|P3|Overall Study|Protocol Violation While on Study|2
5725107|NCT00035932|19707610|P2|Overall Study|Protocol Violation While on Study|1
5725108|NCT00035932|19707611|P1|Overall Study|Protocol Violation While on Study|0
5725109|NCT00035932|19707609|P3|Overall Study|Noncompliance|6
5725110|NCT00035932|19707610|P2|Overall Study|Noncompliance|7
5725111|NCT00035932|19707611|P1|Overall Study|Noncompliance|6
5725112|NCT00035932|19707609|P3|Overall Study|Lost to Follow-up|3
5725113|NCT00035932|19707610|P2|Overall Study|Lost to Follow-up|4
5725114|NCT00035932|19707611|P1|Overall Study|Lost to Follow-up|4
5725115|NCT00035932|19707609|P3|Overall Study|Disease Progression / Relapse|0
5725116|NCT00035932|19707610|P2|Overall Study|Disease Progression / Relapse|1
5725117|NCT00035932|19707611|P1|Overall Study|Disease Progression / Relapse|1
5725118|NCT00035932|19707609|P3|Overall Study|Death|1
5725119|NCT00035932|19707610|P2|Overall Study|Death|0
5725120|NCT00035932|19707611|P1|Overall Study|Death|0
5725121|NCT00035932|19707609|P3|Overall Study|Adverse Event|9
5725122|NCT00035932|19707610|P2|Overall Study|Adverse Event|9
5725123|NCT00035932|19707611|P1|Overall Study|Adverse Event|10
5725124|NCT00035815|19707737|P2|Overall Study|Withdrawal by Subject|11
5725125|NCT00035815|19707738|P1|Overall Study|Withdrawal by Subject|17
5725126|NCT00035555|19707751|P3|Overall Study|Received cyclosporin in error|1
5725127|NCT00035555|19707752|P2|Overall Study|Received cyclosporin in error|0
5725128|NCT00035555|19707753|P1|Overall Study|Received cyclosporin in error|0
5725129|NCT00035555|19707751|P3|Overall Study|Investigator deemed not a good candidate|1
5725130|NCT00035555|19707752|P2|Overall Study|Investigator deemed not a good candidate|0
5725131|NCT00035555|19707753|P1|Overall Study|Investigator deemed not a good candidate|0
5725132|NCT00035555|19707751|P3|Overall Study|Withdrawal by Subject|2
5725133|NCT00035555|19707752|P2|Overall Study|Withdrawal by Subject|0
5725134|NCT00035555|19707753|P1|Overall Study|Withdrawal by Subject|2
5725135|NCT00035555|19707751|P3|Overall Study|Treatment failure/lack of efficacy|3
5725136|NCT00035555|19707752|P2|Overall Study|Treatment failure/lack of efficacy|5
5725137|NCT00035555|19707753|P1|Overall Study|Treatment failure/lack of efficacy|7
5725138|NCT00035555|19707751|P3|Overall Study|Prohibited medication|0
5725139|NCT00035555|19707752|P2|Overall Study|Prohibited medication|1
5725140|NCT00035555|19707753|P1|Overall Study|Prohibited medication|1
5725141|NCT00035555|19707751|P3|Overall Study|Noncompliance|1
5725142|NCT00035555|19707752|P2|Overall Study|Noncompliance|1
5725143|NCT00035555|19707753|P1|Overall Study|Noncompliance|0
5725144|NCT00035555|19707751|P3|Overall Study|Lost to Follow-up|1
5725145|NCT00035555|19707752|P2|Overall Study|Lost to Follow-up|0
5725146|NCT00035555|19707753|P1|Overall Study|Lost to Follow-up|0
5725147|NCT00035555|19707751|P3|Overall Study|Death|2
5725148|NCT00035555|19707752|P2|Overall Study|Death|0
5725149|NCT00035555|19707753|P1|Overall Study|Death|0
5725150|NCT00035555|19707751|P3|Overall Study|Allograft loss|2
5725151|NCT00035555|19707752|P2|Overall Study|Allograft loss|1
5725152|NCT00035555|19707753|P1|Overall Study|Allograft loss|1
5725153|NCT00035555|19707751|P3|Overall Study|Adverse Event|9
5725154|NCT00035555|19707752|P2|Overall Study|Adverse Event|8
5725155|NCT00035555|19707753|P1|Overall Study|Adverse Event|5
5725156|NCT00032487|19707837|P2|Overall Study|Had other reason|12
5725157|NCT00032487|19707838|P1|Overall Study|Had other reason|12
5725158|NCT00032487|19707837|P2|Overall Study|Lost to Follow-up|58
5725159|NCT00032487|19707838|P1|Overall Study|Lost to Follow-up|57
5725160|NCT00032487|19707837|P2|Overall Study|Adverse Event|7
5725161|NCT00032487|19707838|P1|Overall Study|Adverse Event|3
5725162|NCT00032487|19707837|P2|Overall Study|Withdrawal by Subject|43
5725163|NCT00032487|19707838|P1|Overall Study|Withdrawal by Subject|67
5725164|NCT00031551|19707848|P2|Overall Study|Withdrew due to chemotherapy effects|0
5725165|NCT00031551|19707849|P1|Overall Study|Withdrew due to chemotherapy effects|2
5725166|NCT00031486|19707861|P2|Overall Study|Other|1
5725167|NCT00031486|19707862|P1|Overall Study|Other|1
5725168|NCT00031486|19707861|P2|Overall Study|Did not meet eligibility requirement|1
5725169|NCT00031486|19707862|P1|Overall Study|Did not meet eligibility requirement|2
5725170|NCT00031486|19707861|P2|Overall Study|Non-compliant|4
5725171|NCT00031486|19707862|P1|Overall Study|Non-compliant|0
5725172|NCT00031486|19707861|P2|Overall Study|Death|3
5725173|NCT00031486|19707862|P1|Overall Study|Death|0
5725174|NCT00031486|19707861|P2|Overall Study|Withdrawal by Subject|2
5725175|NCT00031486|19707862|P1|Overall Study|Withdrawal by Subject|3
5725176|NCT00031486|19707861|P2|Overall Study|Lost to Follow-up|1
5725177|NCT00031486|19707862|P1|Overall Study|Lost to Follow-up|0
5725178|NCT00031486|19707861|P2|Overall Study|Adverse Event|0
5725179|NCT00031486|19707862|P1|Overall Study|Adverse Event|1
5725180|NCT00031460|19707888|P2|Overall Study|Confirmed unevaluable|1
5725181|NCT00031460|19707889|P1|Overall Study|Confirmed unevaluable|0
5725182|NCT00031460|19707888|P2|Overall Study|Disruption of blinded drug supply|0
5725183|NCT00031460|19707889|P1|Overall Study|Disruption of blinded drug supply|2
5725184|NCT00031460|19707888|P2|Overall Study|Reactivation of Disease|9
5725185|NCT00031460|19707889|P1|Overall Study|Reactivation of Disease|5
5725186|NCT00031460|19707888|P2|Overall Study|Death|1
5725187|NCT00031460|19707889|P1|Overall Study|Death|0
5725188|NCT00031460|19707888|P2|Overall Study|Non-Compliant|1
5725189|NCT00031460|19707889|P1|Overall Study|Non-Compliant|1
5725190|NCT00031460|19707888|P2|Overall Study|Withdrawal by Subject|1
5725191|NCT00031460|19707889|P1|Overall Study|Withdrawal by Subject|1
5725192|NCT00031460|19707888|P2|Overall Study|Lost to Follow-up|1
5725193|NCT00031460|19707889|P1|Overall Study|Lost to Follow-up|0
5725194|NCT00031447|19707903|P2|Overall Study|Disruption of blinded study drug supply|4
5725195|NCT00031447|19707904|P1|Overall Study|Disruption of blinded study drug supply|7
5725196|NCT00031447|19707903|P2|Overall Study|Re-activation of Disease|1
5725197|NCT00031447|19707904|P1|Overall Study|Re-activation of Disease|2
5725198|NCT00031447|19707903|P2|Overall Study|Non-compliant|1
5725199|NCT00031447|19707904|P1|Overall Study|Non-compliant|1
5725200|NCT00031447|19707903|P2|Overall Study|Lost to Follow-up|1
5725201|NCT00031447|19707904|P1|Overall Study|Lost to Follow-up|0
5725202|NCT00029146|19707979|P2|Overall Study|Lost to Follow-up|1
5725203|NCT00029146|19707980|P1|Overall Study|Lost to Follow-up|2
5725204|NCT00027378|19708031|P2|Overall Study|Physician Decision|3
5725205|NCT00027378|19708032|P1|Overall Study|Physician Decision|0
5725206|NCT00027027|19708045|P5|Overall Study|Withdrawal by Subject|1
5725207|NCT00027027|19708046|P4|Overall Study|Withdrawal by Subject|0
5725208|NCT00027027|19708047|P3|Overall Study|Withdrawal by Subject|0
5725209|NCT00027027|19708048|P2|Overall Study|Withdrawal by Subject|0
5725210|NCT00027027|19708049|P1|Overall Study|Withdrawal by Subject|0
5725211|NCT00027027|19708045|P5|Overall Study|Physician Decision Due To PD|5
5725212|NCT00027027|19708046|P4|Overall Study|Physician Decision Due To PD|3
5725213|NCT00027027|19708047|P3|Overall Study|Physician Decision Due To PD|2
5725214|NCT00027027|19708048|P2|Overall Study|Physician Decision Due To PD|3
5725215|NCT00027027|19708049|P1|Overall Study|Physician Decision Due To PD|2
5725216|NCT00027027|19708045|P5|Overall Study|PD Requiring Surgery|0
5725217|NCT00027027|19708046|P4|Overall Study|PD Requiring Surgery|0
5725218|NCT00027027|19708047|P3|Overall Study|PD Requiring Surgery|1
5725219|NCT00027027|19708048|P2|Overall Study|PD Requiring Surgery|0
5725220|NCT00027027|19708049|P1|Overall Study|PD Requiring Surgery|0
5725221|NCT00027027|19708045|P5|Overall Study|Clinical Symptoms Progression not PD|0
5725222|NCT00027027|19708046|P4|Overall Study|Clinical Symptoms Progression not PD|0
5725223|NCT00027027|19708047|P3|Overall Study|Clinical Symptoms Progression not PD|0
5725224|NCT00027027|19708048|P2|Overall Study|Clinical Symptoms Progression not PD|0
5725225|NCT00027027|19708049|P1|Overall Study|Clinical Symptoms Progression not PD|1
5725226|NCT00027027|19708045|P5|Overall Study|Admitted for Signs of PD|1
5725227|NCT00027027|19708046|P4|Overall Study|Admitted for Signs of PD|0
5725228|NCT00027027|19708047|P3|Overall Study|Admitted for Signs of PD|0
5725229|NCT00027027|19708048|P2|Overall Study|Admitted for Signs of PD|0
5725230|NCT00027027|19708049|P1|Overall Study|Admitted for Signs of PD|0
5725231|NCT00027027|19708045|P5|Overall Study|Adverse Event|1
5725232|NCT00027027|19708046|P4|Overall Study|Adverse Event|0
5725233|NCT00027027|19708047|P3|Overall Study|Adverse Event|1
5725234|NCT00027027|19708048|P2|Overall Study|Adverse Event|0
5725235|NCT00027027|19708049|P1|Overall Study|Adverse Event|0
5725236|NCT00026793|19708094|P1|Overall Study|Off study|2
5725237|NCT00026793|19708094|P1|Overall Study|Physician Decision|2
5725238|NCT00026793|19708094|P1|Overall Study|Death on study due to underlying disease|4
5725239|NCT00025883|19708104|P1|Overall Study|didn't reach 6 months of Metreleptin|10
5725240|NCT00025883|19708104|P1|Overall Study|Adverse Event|1
5725241|NCT00025883|19708104|P1|Overall Study|Death|1
5725242|NCT00025883|19708104|P1|Overall Study|no baseline data|1
5725243|NCT00025883|19708104|P1|Overall Study|had atypical progeriod lipodystrophy|4
5725244|NCT00023595|19708116|P5|10 Year Follow up|Lost to Follow-up|0
5725245|NCT00023595|19708117|P4|10 Year Follow up|Lost to Follow-up|0
5725246|NCT00023595|19708118|P3|10 Year Follow up|Lost to Follow-up|3
5725247|NCT00023595|19708119|P2|10 Year Follow up|Lost to Follow-up|10
5725248|NCT00023595|19708120|P1|10 Year Follow up|Lost to Follow-up|12
5725249|NCT00023595|19708116|P5|5 Year Follow up|Lost to Follow-up|3
5725250|NCT00023595|19708117|P4|5 Year Follow up|Lost to Follow-up|7
5725251|NCT00023595|19708118|P3|5 Year Follow up|Lost to Follow-up|1
5725252|NCT00023595|19708119|P2|5 Year Follow up|Lost to Follow-up|2
5725253|NCT00023595|19708120|P1|5 Year Follow up|Lost to Follow-up|2
5725254|NCT00023452|19708331|P2|Overall Study|Other|69
5725255|NCT00023452|19708332|P1|Overall Study|Other|204
5725256|NCT00023452|19708331|P2|Overall Study|Pregnant|20
5725257|NCT00023452|19708332|P1|Overall Study|Pregnant|53
5725258|NCT00023452|19708331|P2|Overall Study|Refused Treatment (continued follow-up)|224
5725259|NCT00023452|19708332|P1|Overall Study|Refused Treatment (continued follow-up)|225
5725260|NCT00023452|19708331|P2|Overall Study|Physician Decision|21
5725261|NCT00023452|19708332|P1|Overall Study|Physician Decision|49
5725262|NCT00023452|19708331|P2|Overall Study|Lost to Follow-up|60
5725263|NCT00023452|19708332|P1|Overall Study|Lost to Follow-up|293
5725264|NCT00023452|19708331|P2|Overall Study|Adverse Event|196
5725265|NCT00023452|19708332|P1|Overall Study|Adverse Event|139
5725266|NCT00023452|19708331|P2|Overall Study|Withdrawal by Subject|54
5725267|NCT00023452|19708332|P1|Overall Study|Withdrawal by Subject|66
5725268|NCT00023452|19708331|P2|Overall Study|Death|0
5725269|NCT00023452|19708332|P1|Overall Study|Death|2
5725270|NCT00023452|19708331|P2|Overall Study|Out of Window|69
5725271|NCT00023452|19708332|P1|Overall Study|Out of Window|129
5725272|NCT00023452|19708331|P2|Overall Study|Ineligible for Study|159
5725273|NCT00023452|19708332|P1|Overall Study|Ineligible for Study|163
5725274|NCT00023322|19708356|P1|Overall Study|Lost to Follow-up|1
5725275|NCT00022763|19708380|P2|Overall Study|Admin|2
5725276|NCT00022763|19708381|P1|Overall Study|Admin|3
5725277|NCT00022763|19708380|P2|Overall Study|Insufficient Therapy|0
5725278|NCT00022763|19708381|P1|Overall Study|Insufficient Therapy|1
5725279|NCT00022763|19708380|P2|Overall Study|Withdrawal by Subject|7
5725280|NCT00022763|19708381|P1|Overall Study|Withdrawal by Subject|4
5725281|NCT00022763|19708380|P2|Overall Study|Lost to Follow-up|3
5725282|NCT00022763|19708381|P1|Overall Study|Lost to Follow-up|0
5725283|NCT00022763|19708380|P2|Overall Study|Death|1
5725284|NCT00022763|19708381|P1|Overall Study|Death|0
5725285|NCT00022763|19708380|P2|Overall Study|Injection Site Reactions|2
5725286|NCT00022763|19708381|P1|Overall Study|Injection Site Reactions|0
5725287|NCT00022763|19708380|P2|Overall Study|Adverse Event|2
5725288|NCT00022763|19708381|P1|Overall Study|Adverse Event|1
5725289|NCT00014911|19708423|P1|Overall Study|Immunosuppression-related Side Effects|1
5725290|NCT00014911|19708423|P1|Overall Study|Unknown Reasons|2
5725291|NCT00014911|19708423|P1|Overall Study|Withdrawal by Subject|6
5725292|NCT00014911|19708423|P1|Overall Study|Lost to Follow-up|1
5725293|NCT00014911|19708423|P1|Overall Study|Adverse Event|1
5725294|NCT00006604|19708439|P17|Overall Study|Other Reason|0
5725295|NCT00006604|19708440|P16|Overall Study|Other Reason|0
5725296|NCT00006604|19708441|P15|Overall Study|Other Reason|0
5725297|NCT00006604|19708442|P14|Overall Study|Other Reason|0
5725298|NCT00006604|19708443|P13|Overall Study|Other Reason|0
5725299|NCT00006604|19708444|P12|Overall Study|Other Reason|0
5725300|NCT00006604|19708445|P11|Overall Study|Other Reason|0
5725301|NCT00006604|19708446|P10|Overall Study|Other Reason|1
5725302|NCT00006604|19708447|P9|Overall Study|Other Reason|0
5725303|NCT00006604|19708448|P8|Overall Study|Other Reason|0
5725304|NCT00006604|19708449|P7|Overall Study|Other Reason|0
5725305|NCT00006604|19708450|P6|Overall Study|Other Reason|1
5725306|NCT00006604|19708451|P5|Overall Study|Other Reason|0
5725307|NCT00006604|19708452|P4|Overall Study|Other Reason|0
5725308|NCT00006604|19708453|P3|Overall Study|Other Reason|0
5725309|NCT00006604|19708454|P2|Overall Study|Other Reason|0
5725310|NCT00006604|19708455|P1|Overall Study|Other Reason|0
5725311|NCT00006604|19708439|P17|Overall Study|Lost to Follow-up|3
5725312|NCT00006604|19708440|P16|Overall Study|Lost to Follow-up|1
5725313|NCT00006604|19708441|P15|Overall Study|Lost to Follow-up|0
5725314|NCT00006604|19708442|P14|Overall Study|Lost to Follow-up|0
5725315|NCT00006604|19708443|P13|Overall Study|Lost to Follow-up|0
5725316|NCT00006604|19708444|P12|Overall Study|Lost to Follow-up|0
5725317|NCT00006604|19708445|P11|Overall Study|Lost to Follow-up|0
5725318|NCT00006604|19708446|P10|Overall Study|Lost to Follow-up|2
5725319|NCT00006604|19708447|P9|Overall Study|Lost to Follow-up|0
5725320|NCT00006604|19708448|P8|Overall Study|Lost to Follow-up|1
5725321|NCT00006604|19708449|P7|Overall Study|Lost to Follow-up|0
5725322|NCT00006604|19708450|P6|Overall Study|Lost to Follow-up|0
5725323|NCT00006604|19708451|P5|Overall Study|Lost to Follow-up|0
5725324|NCT00006604|19708452|P4|Overall Study|Lost to Follow-up|0
5725325|NCT00006604|19708453|P3|Overall Study|Lost to Follow-up|0
5725326|NCT00006604|19708454|P2|Overall Study|Lost to Follow-up|0
5725327|NCT00006604|19708455|P1|Overall Study|Lost to Follow-up|0
5725328|NCT00006604|19708439|P17|Overall Study|Subj/parent not willing to adhere to req|4
5725329|NCT00006604|19708440|P16|Overall Study|Subj/parent not willing to adhere to req|3
5725330|NCT00006604|19708441|P15|Overall Study|Subj/parent not willing to adhere to req|3
5725331|NCT00006604|19708442|P14|Overall Study|Subj/parent not willing to adhere to req|2
5725332|NCT00006604|19708443|P13|Overall Study|Subj/parent not willing to adhere to req|0
5725333|NCT00006604|19708444|P12|Overall Study|Subj/parent not willing to adhere to req|0
5725334|NCT00006604|19708445|P11|Overall Study|Subj/parent not willing to adhere to req|3
5725335|NCT00006604|19708446|P10|Overall Study|Subj/parent not willing to adhere to req|6
5725336|NCT00006604|19708447|P9|Overall Study|Subj/parent not willing to adhere to req|0
5725337|NCT00006604|19708448|P8|Overall Study|Subj/parent not willing to adhere to req|1
5725338|NCT00006604|19708449|P7|Overall Study|Subj/parent not willing to adhere to req|3
5725339|NCT00006604|19708450|P6|Overall Study|Subj/parent not willing to adhere to req|0
5725340|NCT00006604|19708451|P5|Overall Study|Subj/parent not willing to adhere to req|0
5725341|NCT00006604|19708452|P4|Overall Study|Subj/parent not willing to adhere to req|3
5725342|NCT00006604|19708453|P3|Overall Study|Subj/parent not willing to adhere to req|1
5725343|NCT00006604|19708454|P2|Overall Study|Subj/parent not willing to adhere to req|0
5725344|NCT00006604|19708455|P1|Overall Study|Subj/parent not willing to adhere to req|0
5725345|NCT00006604|19708439|P17|Overall Study|Withdrawal by Subject|1
5725346|NCT00006604|19708440|P16|Overall Study|Withdrawal by Subject|0
5725347|NCT00006604|19708441|P15|Overall Study|Withdrawal by Subject|1
5725348|NCT00006604|19708442|P14|Overall Study|Withdrawal by Subject|2
5725349|NCT00006604|19708443|P13|Overall Study|Withdrawal by Subject|1
5725350|NCT00006604|19708444|P12|Overall Study|Withdrawal by Subject|0
5725351|NCT00006604|19708445|P11|Overall Study|Withdrawal by Subject|2
5725352|NCT00006604|19708446|P10|Overall Study|Withdrawal by Subject|3
5725353|NCT00006604|19708447|P9|Overall Study|Withdrawal by Subject|1
5725354|NCT00006604|19708448|P8|Overall Study|Withdrawal by Subject|0
5725355|NCT00006604|19708449|P7|Overall Study|Withdrawal by Subject|2
5725356|NCT00006604|19708450|P6|Overall Study|Withdrawal by Subject|2
5725357|NCT00006604|19708451|P5|Overall Study|Withdrawal by Subject|1
5725358|NCT00006604|19708452|P4|Overall Study|Withdrawal by Subject|0
5725359|NCT00006604|19708453|P3|Overall Study|Withdrawal by Subject|2
5725360|NCT00006604|19708454|P2|Overall Study|Withdrawal by Subject|0
5725361|NCT00006604|19708455|P1|Overall Study|Withdrawal by Subject|1
5725362|NCT00006604|19708439|P17|Overall Study|Site closing|1
5725363|NCT00006604|19708440|P16|Overall Study|Site closing|0
5725364|NCT00006604|19708441|P15|Overall Study|Site closing|0
5725365|NCT00006604|19708442|P14|Overall Study|Site closing|1
5725366|NCT00006604|19708443|P13|Overall Study|Site closing|1
5725367|NCT00006604|19708444|P12|Overall Study|Site closing|1
5725368|NCT00006604|19708445|P11|Overall Study|Site closing|0
5725369|NCT00006604|19708446|P10|Overall Study|Site closing|0
5725370|NCT00006604|19708447|P9|Overall Study|Site closing|0
5725371|NCT00006604|19708448|P8|Overall Study|Site closing|1
5725372|NCT00006604|19708449|P7|Overall Study|Site closing|0
5725373|NCT00006604|19708450|P6|Overall Study|Site closing|0
5725374|NCT00006604|19708451|P5|Overall Study|Site closing|0
5725375|NCT00006604|19708452|P4|Overall Study|Site closing|1
5725376|NCT00006604|19708453|P3|Overall Study|Site closing|1
5725377|NCT00006604|19708454|P2|Overall Study|Site closing|0
5725378|NCT00006604|19708455|P1|Overall Study|Site closing|0
5725379|NCT00006604|19708439|P17|Overall Study|Subj/Parent not able to get to clinic|0
5725380|NCT00006604|19708440|P16|Overall Study|Subj/Parent not able to get to clinic|0
5725381|NCT00006604|19708441|P15|Overall Study|Subj/Parent not able to get to clinic|3
5725382|NCT00006604|19708442|P14|Overall Study|Subj/Parent not able to get to clinic|1
5725383|NCT00006604|19708443|P13|Overall Study|Subj/Parent not able to get to clinic|1
5725384|NCT00006604|19708444|P12|Overall Study|Subj/Parent not able to get to clinic|1
5725385|NCT00006604|19708445|P11|Overall Study|Subj/Parent not able to get to clinic|2
5725386|NCT00006604|19708446|P10|Overall Study|Subj/Parent not able to get to clinic|1
5725387|NCT00006604|19708447|P9|Overall Study|Subj/Parent not able to get to clinic|0
5725388|NCT00006604|19708448|P8|Overall Study|Subj/Parent not able to get to clinic|0
5725389|NCT00006604|19708449|P7|Overall Study|Subj/Parent not able to get to clinic|1
5725390|NCT00006604|19708450|P6|Overall Study|Subj/Parent not able to get to clinic|0
5725391|NCT00006604|19708451|P5|Overall Study|Subj/Parent not able to get to clinic|1
5725392|NCT00006604|19708452|P4|Overall Study|Subj/Parent not able to get to clinic|1
5725393|NCT00006604|19708453|P3|Overall Study|Subj/Parent not able to get to clinic|0
5725394|NCT00006604|19708454|P2|Overall Study|Subj/Parent not able to get to clinic|0
5725395|NCT00006604|19708455|P1|Overall Study|Subj/Parent not able to get to clinic|0
5725396|NCT00006604|19708439|P17|Overall Study|Severe debilitation, unable to continue|0
5725397|NCT00006604|19708440|P16|Overall Study|Severe debilitation, unable to continue|0
5725398|NCT00006604|19708441|P15|Overall Study|Severe debilitation, unable to continue|2
5725399|NCT00006604|19708442|P14|Overall Study|Severe debilitation, unable to continue|0
5725400|NCT00006604|19708443|P13|Overall Study|Severe debilitation, unable to continue|1
5725401|NCT00006604|19708444|P12|Overall Study|Severe debilitation, unable to continue|2
5725402|NCT00006604|19708445|P11|Overall Study|Severe debilitation, unable to continue|0
5725403|NCT00006604|19708446|P10|Overall Study|Severe debilitation, unable to continue|5
5725404|NCT00006604|19708447|P9|Overall Study|Severe debilitation, unable to continue|0
5725405|NCT00006604|19708448|P8|Overall Study|Severe debilitation, unable to continue|0
5725406|NCT00006604|19708449|P7|Overall Study|Severe debilitation, unable to continue|3
5725407|NCT00006604|19708450|P6|Overall Study|Severe debilitation, unable to continue|0
5725408|NCT00006604|19708451|P5|Overall Study|Severe debilitation, unable to continue|0
5725409|NCT00006604|19708452|P4|Overall Study|Severe debilitation, unable to continue|0
5725410|NCT00006604|19708453|P3|Overall Study|Severe debilitation, unable to continue|0
5725411|NCT00006604|19708454|P2|Overall Study|Severe debilitation, unable to continue|0
5725412|NCT00006604|19708455|P1|Overall Study|Severe debilitation, unable to continue|0
5725413|NCT00006604|19708439|P17|Overall Study|Death|0
5725414|NCT00006604|19708440|P16|Overall Study|Death|0
5725415|NCT00006604|19708441|P15|Overall Study|Death|0
5725416|NCT00006604|19708442|P14|Overall Study|Death|0
5725417|NCT00006604|19708443|P13|Overall Study|Death|0
5725418|NCT00006604|19708444|P12|Overall Study|Death|1
5725419|NCT00006604|19708445|P11|Overall Study|Death|1
5725420|NCT00006604|19708446|P10|Overall Study|Death|1
5725421|NCT00006604|19708447|P9|Overall Study|Death|0
5725422|NCT00006604|19708448|P8|Overall Study|Death|0
5725423|NCT00006604|19708449|P7|Overall Study|Death|0
5725424|NCT00006604|19708450|P6|Overall Study|Death|0
5725425|NCT00006604|19708451|P5|Overall Study|Death|0
5725426|NCT00006604|19708452|P4|Overall Study|Death|0
5725427|NCT00006604|19708453|P3|Overall Study|Death|0
5725428|NCT00006604|19708454|P2|Overall Study|Death|0
5725429|NCT00006604|19708455|P1|Overall Study|Death|0
5725430|NCT00006604|19708439|P17|Overall Study|Randomization entry error-no RX, no FU|0
5725431|NCT00006604|19708440|P16|Overall Study|Randomization entry error-no RX, no FU|0
5725432|NCT00006604|19708441|P15|Overall Study|Randomization entry error-no RX, no FU|0
5725433|NCT00006604|19708442|P14|Overall Study|Randomization entry error-no RX, no FU|0
5725434|NCT00006604|19708443|P13|Overall Study|Randomization entry error-no RX, no FU|0
5725435|NCT00006604|19708444|P12|Overall Study|Randomization entry error-no RX, no FU|1
5725436|NCT00006604|19708445|P11|Overall Study|Randomization entry error-no RX, no FU|0
5725437|NCT00006604|19708446|P10|Overall Study|Randomization entry error-no RX, no FU|0
5725438|NCT00006604|19708447|P9|Overall Study|Randomization entry error-no RX, no FU|0
5725439|NCT00006604|19708448|P8|Overall Study|Randomization entry error-no RX, no FU|0
5725440|NCT00006604|19708449|P7|Overall Study|Randomization entry error-no RX, no FU|0
5725441|NCT00006604|19708450|P6|Overall Study|Randomization entry error-no RX, no FU|0
5725442|NCT00006604|19708451|P5|Overall Study|Randomization entry error-no RX, no FU|0
5725443|NCT00006604|19708452|P4|Overall Study|Randomization entry error-no RX, no FU|0
5725444|NCT00006604|19708453|P3|Overall Study|Randomization entry error-no RX, no FU|0
5725445|NCT00006604|19708454|P2|Overall Study|Randomization entry error-no RX, no FU|0
5725446|NCT00006604|19708455|P1|Overall Study|Randomization entry error-no RX, no FU|0
5725447|NCT00006604|19708439|P17|Overall Study|Met study objective - no further FU|0
5725448|NCT00006604|19708440|P16|Overall Study|Met study objective - no further FU|1
5725449|NCT00006604|19708441|P15|Overall Study|Met study objective - no further FU|1
5725450|NCT00006604|19708442|P14|Overall Study|Met study objective - no further FU|0
5725451|NCT00006604|19708443|P13|Overall Study|Met study objective - no further FU|0
5725452|NCT00006604|19708444|P12|Overall Study|Met study objective - no further FU|0
5725453|NCT00006604|19708445|P11|Overall Study|Met study objective - no further FU|0
5725454|NCT00006604|19708446|P10|Overall Study|Met study objective - no further FU|0
5725455|NCT00006604|19708447|P9|Overall Study|Met study objective - no further FU|0
5725456|NCT00006604|19708448|P8|Overall Study|Met study objective - no further FU|0
5725457|NCT00006604|19708449|P7|Overall Study|Met study objective - no further FU|0
5725458|NCT00006604|19708450|P6|Overall Study|Met study objective - no further FU|0
5725459|NCT00006604|19708451|P5|Overall Study|Met study objective - no further FU|0
5725460|NCT00006604|19708452|P4|Overall Study|Met study objective - no further FU|0
5725461|NCT00006604|19708453|P3|Overall Study|Met study objective - no further FU|0
5725462|NCT00006604|19708454|P2|Overall Study|Met study objective - no further FU|0
5725463|NCT00006604|19708455|P1|Overall Study|Met study objective - no further FU|1
5725464|NCT00004978|19708571|P2|Overall Study|site closure - not in analysis cohort|20
5725465|NCT00004978|19708572|P1|Overall Study|site closure - not in analysis cohort|19
5725466|NCT00004978|19708571|P2|Overall Study|Withdrawal by Subject|26
5725467|NCT00004978|19708572|P1|Overall Study|Withdrawal by Subject|17
5725468|NCT00004978|19708571|P2|Overall Study|Lost to Follow-up|108
5725469|NCT00004978|19708572|P1|Overall Study|Lost to Follow-up|101
5725470|NCT00004978|19708571|P2|Overall Study|Death|116
5725471|NCT00004978|19708572|P1|Overall Study|Death|107
5725472|NCT00021541|19708598|P2|Period 2-crossover|Pts that did not progress|3
5725473|NCT00021541|19708599|P1|Period 2-crossover|Pts that did not progress|2
5725474|NCT00021541|19708598|P2|Period 2-crossover|non-adherence|0
5725475|NCT00021541|19708599|P1|Period 2-crossover|non-adherence|1
5725476|NCT00021541|19708598|P2|Period 2-crossover|Adverse Event|2
5725477|NCT00021541|19708599|P1|Period 2-crossover|Adverse Event|2
5725478|NCT00021541|19708598|P2|Period 2-crossover|Withdrawal by Subject|4
5725479|NCT00021541|19708599|P1|Period 2-crossover|Withdrawal by Subject|3
5725480|NCT00021541|19708598|P2|Period 2-crossover|refused phase B|2
5725481|NCT00021541|19708599|P1|Period 2-crossover|refused phase B|2
5725482|NCT00021541|19708598|P2|Period 1-First Treatment|Ineligible|2
5725483|NCT00021541|19708599|P1|Period 1-First Treatment|Ineligible|0
5725484|NCT00021541|19708598|P2|Period 1-First Treatment|Pts that did not progress|2
5725485|NCT00021541|19708599|P1|Period 1-First Treatment|Pts that did not progress|2
5725486|NCT00021541|19708598|P2|Period 1-First Treatment|Death|0
5725487|NCT00021541|19708599|P1|Period 1-First Treatment|Death|1
5725488|NCT00021541|19708598|P2|Period 1-First Treatment|non-adherence|0
5725489|NCT00021541|19708599|P1|Period 1-First Treatment|non-adherence|3
5725490|NCT00021541|19708598|P2|Period 1-First Treatment|Adverse Event|1
5725491|NCT00021541|19708599|P1|Period 1-First Treatment|Adverse Event|2
5725492|NCT00021541|19708598|P2|Period 1-First Treatment|Withdrawal by Subject|3
5725493|NCT00021541|19708599|P1|Period 1-First Treatment|Withdrawal by Subject|3
5725494|NCT00015457|19708613|P2|Second Intervention|Withdrawal by Subject|0
5725495|NCT00015457|19708614|P1|Second Intervention|Withdrawal by Subject|1
5725496|NCT00015457|19708613|P2|First Intervention|Lack of Efficacy|1
5725497|NCT00015457|19708614|P1|First Intervention|Lack of Efficacy|0
5725498|NCT00015457|19708613|P2|First Intervention|Adverse Event|2
5725499|NCT00015457|19708614|P1|First Intervention|Adverse Event|0
5725500|NCT00013611|19708624|P2|Overall Study|Lost to Follow-up|100
5725501|NCT00013611|19708625|P1|Overall Study|Lost to Follow-up|91
5725502|NCT00010803|19708643|P2|Overall Study|Withdrawal by Subject|98
5725503|NCT00010803|19708644|P1|Overall Study|Withdrawal by Subject|97
5725504|NCT00010374|19708659|P1|Overall Study|False positive phrenic nerve test|1
5725505|NCT00007475|19708677|P4|Overall Study|Adverse Event|0
5725506|NCT00007475|19708678|P3|Overall Study|Adverse Event|0
5725507|NCT00007475|19708679|P2|Overall Study|Adverse Event|0
5725508|NCT00007475|19708680|P1|Overall Study|Adverse Event|3
5725509|NCT00007475|19708677|P4|Overall Study|Withdrawal by Subject|0
5725510|NCT00007475|19708678|P3|Overall Study|Withdrawal by Subject|0
5725511|NCT00007475|19708679|P2|Overall Study|Withdrawal by Subject|0
5725512|NCT00007475|19708680|P1|Overall Study|Withdrawal by Subject|1
5725513|NCT00007345|19708702|P2|Overall Study|Death on study|1
5725514|NCT00007345|19708703|P1|Overall Study|Death on study|1
5725515|NCT00007345|19708702|P2|Overall Study|Intercurrent illness|0
5725516|NCT00007345|19708703|P1|Overall Study|Intercurrent illness|1
5725517|NCT00007345|19708702|P2|Overall Study|Switched to alternative treatment|3
5725518|NCT00007345|19708703|P1|Overall Study|Switched to alternative treatment|0
5725519|NCT00007345|19708702|P2|Overall Study|Refused further treatment|7
5725520|NCT00007345|19708703|P1|Overall Study|Refused further treatment|0
5725521|NCT00007020|19708721|P1|Overall Study|No evidence of treatment|6
5725522|NCT00007020|19708721|P1|Overall Study|Pt cared for by outside physician|4
5725523|NCT00007020|19708721|P1|Overall Study|Pt withdrawn (liver transplant)|4
5725524|NCT00007020|19708721|P1|Overall Study|Pt withdrawn (worsening cholestasis)|1
5725525|NCT00007020|19708721|P1|Overall Study|Lost to Follow-up|13
5725526|NCT00007020|19708721|P1|Overall Study|Death|16
5725527|NCT00006489|19708734|P4|Overall Study|Death|1
5725528|NCT00006489|19708735|P3|Overall Study|Death|0
5725529|NCT00006489|19708736|P2|Overall Study|Death|0
5725530|NCT00006489|19708737|P1|Overall Study|Death|0
5725531|NCT00006489|19708734|P4|Overall Study|Scheduling Conflict|1
5725532|NCT00006489|19708735|P3|Overall Study|Scheduling Conflict|2
5725533|NCT00006489|19708736|P2|Overall Study|Scheduling Conflict|3
5725534|NCT00006489|19708737|P1|Overall Study|Scheduling Conflict|0
5725535|NCT00006489|19708734|P4|Overall Study|Withdrawal by Subject|6
5725536|NCT00006489|19708735|P3|Overall Study|Withdrawal by Subject|9
5725537|NCT00006489|19708736|P2|Overall Study|Withdrawal by Subject|9
5725538|NCT00006489|19708737|P1|Overall Study|Withdrawal by Subject|10
5725539|NCT00006489|19708734|P4|Overall Study|Adverse Event|3
5725540|NCT00006489|19708735|P3|Overall Study|Adverse Event|4
5725541|NCT00006489|19708736|P2|Overall Study|Adverse Event|2
5725542|NCT00006489|19708737|P1|Overall Study|Adverse Event|3
5725543|NCT00006409|19708772|P6|Post-3 Year Intervention|Protocol Violation|62
5725544|NCT00006409|19708773|P5|Post-3 Year Intervention|Protocol Violation|62
5725545|NCT00006409|19708774|P4|Post-3 Year Intervention|Protocol Violation|0
5725546|NCT00006409|19708775|P3|Post-3 Year Intervention|Protocol Violation|0
5725547|NCT00006409|19708776|P2|Post-3 Year Intervention|Protocol Violation|0
5725548|NCT00006409|19708777|P1|Post-3 Year Intervention|Protocol Violation|0
5725549|NCT00006409|19708772|P6|Post-2 Year Intervention|Protocol Violation|0
5725550|NCT00006409|19708773|P5|Post-2 Year Intervention|Protocol Violation|0
5725551|NCT00006409|19708774|P4|Post-2 Year Intervention|Protocol Violation|168
5725552|NCT00006409|19708775|P3|Post-2 Year Intervention|Protocol Violation|251
5725553|NCT00006409|19708776|P2|Post-2 Year Intervention|Protocol Violation|0
5725554|NCT00006409|19708777|P1|Post-2 Year Intervention|Protocol Violation|0
5725555|NCT00006409|19708772|P6|Baseline|Protocol Violation|0
5725556|NCT00006409|19708773|P5|Baseline|Protocol Violation|0
5725557|NCT00006409|19708774|P4|Baseline|Protocol Violation|0
5725558|NCT00006409|19708775|P3|Baseline|Protocol Violation|0
5725559|NCT00006409|19708776|P2|Baseline|Protocol Violation|70
5725560|NCT00006409|19708777|P1|Baseline|Protocol Violation|48
5725561|NCT00006305|19708816|P4|Overall Study|Withdrawal by Subject|14
5725562|NCT00006305|19708817|P3|Overall Study|Withdrawal by Subject|15
5725563|NCT00006305|19708818|P2|Overall Study|Withdrawal by Subject|10
5725564|NCT00006305|19708819|P1|Overall Study|Withdrawal by Subject|17
5725565|NCT00006289|19708835|P2|Second Intervention (5 Weeks)|Protocol Violation|1
5725566|NCT00006289|19708836|P1|Second Intervention (5 Weeks)|Protocol Violation|1
5725567|NCT00006289|19708835|P2|First Intervention (5 Weeks)|Adverse Event|0
5725568|NCT00006289|19708836|P1|First Intervention (5 Weeks)|Adverse Event|1
5725569|NCT00006184|19708854|P2|Overall Study|Death|0
5725570|NCT00006184|19708855|P1|Overall Study|Death|1
5725571|NCT00006164|19708906|P2|Overall Study|Withdrew or lost to follow-up|81
5725572|NCT00006164|19708907|P1|Overall Study|Withdrew or lost to follow-up|70
5725573|NCT00005937|19708950|P1|Overall Study|Lack of Efficacy|5
5725574|NCT00005908|19708954|P2|Overall Study|Withdrawal by Subject|0
5725575|NCT00005908|19708955|P1|Overall Study|Withdrawal by Subject|1
5725576|NCT00005906|19708964|P1|Overall Study|Lack of Efficacy|3
5725577|NCT00004980|19709008|P2|Overall Study|Physician Decision|1
5725578|NCT00004980|19709009|P1|Overall Study|Physician Decision|0
5725579|NCT00004980|19709008|P2|Overall Study|memory difficulties|1
5725580|NCT00004980|19709009|P1|Overall Study|memory difficulties|1
5725581|NCT00004980|19709008|P2|Overall Study|Withdrawal by Subject|0
5725582|NCT00004980|19709009|P1|Overall Study|Withdrawal by Subject|1
5725583|NCT00004732|19709023|P2|Overall Study|Lost to Follow-up|47
5725584|NCT00004732|19709024|P1|Overall Study|Lost to Follow-up|33
5725585|NCT00004732|19709023|P2|Overall Study|Withdrawal by Subject|64
5725586|NCT00004732|19709024|P1|Overall Study|Withdrawal by Subject|36
5725587|NCT00004635|19709034|P2|Period Two|discrepancy in data entry|1
5725588|NCT00004635|19709035|P1|Period Two|discrepancy in data entry|0
5725589|NCT00004635|19709034|P2|Period Two|Lost to Follow-up|0
5725590|NCT00004635|19709035|P1|Period Two|Lost to Follow-up|1
5725591|NCT00004635|19709034|P2|Period Two|secondary malignancy|1
5725592|NCT00004635|19709035|P1|Period Two|secondary malignancy|1
5725593|NCT00004635|19709034|P2|Period Two|travel issues|1
5725594|NCT00004635|19709035|P1|Period Two|travel issues|0
5725595|NCT00004635|19709034|P2|Period Two|health problem|1
5725596|NCT00004635|19709035|P1|Period Two|health problem|1
5725597|NCT00004635|19709034|P2|Period Two|refused|2
5725598|NCT00004635|19709035|P1|Period Two|refused|0
5725599|NCT00004635|19709034|P2|Period Two|Adverse Event|0
5725600|NCT00004635|19709035|P1|Period Two|Adverse Event|1
5725601|NCT00004635|19709034|P2|Period Two|progression|3
5725602|NCT00004635|19709035|P1|Period Two|progression|2
5725603|NCT00004635|19709034|P2|Period One|discrepancy in data entry|1
5725604|NCT00004635|19709035|P1|Period One|discrepancy in data entry|0
5725605|NCT00004635|19709034|P2|Period One|health problem|1
5725606|NCT00004635|19709035|P1|Period One|health problem|0
5725607|NCT00004635|19709034|P2|Period One|progressed|2
5725608|NCT00004635|19709035|P1|Period One|progressed|0
5725609|NCT00004635|19709034|P2|Period One|second malignancy|0
5725610|NCT00004635|19709035|P1|Period One|second malignancy|1
5725611|NCT00004635|19709034|P2|Period One|PSA did not go <5 ng/mL|0
5725612|NCT00004635|19709035|P1|Period One|PSA did not go <5 ng/mL|1
5725613|NCT00004635|19709034|P2|Period One|Protocol Violation|0
5725614|NCT00004635|19709035|P1|Period One|Protocol Violation|1
5725615|NCT00004635|19709034|P2|Period One|Withdrawal by Subject|1
5725616|NCT00004635|19709035|P1|Period One|Withdrawal by Subject|1
5725617|NCT00004635|19709034|P2|Period One|refused|1
5725618|NCT00004635|19709035|P1|Period One|refused|2
5725619|NCT00004563|19709047|P2|Overall Study|Death|3
5725620|NCT00004563|19709048|P1|Overall Study|Death|2
5725621|NCT00004563|19709047|P2|Overall Study|Lack of Efficacy|5
5725622|NCT00004563|19709048|P1|Overall Study|Lack of Efficacy|3
5725623|NCT00004563|19709047|P2|Overall Study|Withdrawal by Subject|16
5725624|NCT00004563|19709048|P1|Overall Study|Withdrawal by Subject|20
5725625|NCT00004562|19709060|P2|Overall Study|Lost to Follow-up|91
5725626|NCT00004562|19709061|P1|Overall Study|Lost to Follow-up|102
5725627|NCT00001962|19709102|P1|Overall Study|Adverse Event|1
5725628|NCT00001962|19709102|P1|Overall Study|Lost to Follow-up|2
5725629|NCT00001962|19709102|P1|Overall Study|Death|1
5725630|NCT00001962|19709102|P1|Overall Study|Lack of Accrual|6
5725631|NCT00001962|19709102|P1|Overall Study|Lack of Efficacy|18
5725632|NCT00001959|19709106|P1|Overall Study|non-compliance|1
5725633|NCT00001959|19709106|P1|Overall Study|disabling sedation|1
5725634|NCT00001959|19709106|P1|Overall Study|newly diagnosed colon cancer|1
5725635|NCT00001941|19709112|P5|Overall Study|not treated- rapidly progressing disease|1
5725636|NCT00001941|19709113|P4|Overall Study|not treated- rapidly progressing disease|0
5725637|NCT00001941|19709114|P3|Overall Study|not treated- rapidly progressing disease|0
5725638|NCT00001941|19709115|P2|Overall Study|not treated- rapidly progressing disease|0
5725639|NCT00001941|19709116|P1|Overall Study|not treated- rapidly progressing disease|0
5725640|NCT00001832|19709148|P15|Treatment Period|Not treated|0
5725641|NCT00001832|19709149|P14|Treatment Period|Not treated|0
5725642|NCT00001832|19709150|P13|Treatment Period|Not treated|0
5725643|NCT00001832|19709151|P12|Treatment Period|Not treated|0
5725644|NCT00001832|19709152|P11|Treatment Period|Not treated|0
5725645|NCT00001832|19709153|P10|Treatment Period|Not treated|0
5725646|NCT00001832|19709154|P9|Treatment Period|Not treated|0
5725647|NCT00001832|19709155|P8|Treatment Period|Not treated|1
5725648|NCT00001832|19709156|P7|Treatment Period|Not treated|0
5725649|NCT00001832|19709157|P6|Treatment Period|Not treated|0
5725650|NCT00001832|19709158|P5|Treatment Period|Not treated|0
5725651|NCT00001832|19709159|P4|Treatment Period|Not treated|0
5725652|NCT00001832|19709160|P3|Treatment Period|Not treated|0
5725653|NCT00001832|19709161|P2|Treatment Period|Not treated|0
5725654|NCT00001832|19709162|P1|Treatment Period|Not treated|0
5725655|NCT00001832|19709148|P15|Treatment Period|Death during treatment|0
5725656|NCT00001832|19709149|P14|Treatment Period|Death during treatment|0
5725657|NCT00001832|19709150|P13|Treatment Period|Death during treatment|0
5725658|NCT00001832|19709151|P12|Treatment Period|Death during treatment|0
5725659|NCT00001832|19709152|P11|Treatment Period|Death during treatment|0
5725660|NCT00001832|19709153|P10|Treatment Period|Death during treatment|0
5725661|NCT00001832|19709154|P9|Treatment Period|Death during treatment|0
5725662|NCT00001832|19709155|P8|Treatment Period|Death during treatment|0
5725663|NCT00001832|19709156|P7|Treatment Period|Death during treatment|0
5725664|NCT00001832|19709157|P6|Treatment Period|Death during treatment|1
5725665|NCT00001832|19709158|P5|Treatment Period|Death during treatment|0
5725666|NCT00001832|19709159|P4|Treatment Period|Death during treatment|0
5725667|NCT00001832|19709160|P3|Treatment Period|Death during treatment|0
5725668|NCT00001832|19709161|P2|Treatment Period|Death during treatment|0
5725669|NCT00001832|19709162|P1|Treatment Period|Death during treatment|0
5725670|NCT00001832|19709148|P15|Apheresis Period|not able to manufacture treatment cells|0
5725671|NCT00001832|19709149|P14|Apheresis Period|not able to manufacture treatment cells|0
5725672|NCT00001832|19709150|P13|Apheresis Period|not able to manufacture treatment cells|0
5725673|NCT00001832|19709151|P12|Apheresis Period|not able to manufacture treatment cells|0
5725674|NCT00001832|19709152|P11|Apheresis Period|not able to manufacture treatment cells|0
5725675|NCT00001832|19709153|P10|Apheresis Period|not able to manufacture treatment cells|0
5725676|NCT00001832|19709154|P9|Apheresis Period|not able to manufacture treatment cells|0
5725677|NCT00001832|19709155|P8|Apheresis Period|not able to manufacture treatment cells|0
5725678|NCT00001832|19709156|P7|Apheresis Period|not able to manufacture treatment cells|0
5725679|NCT00001832|19709157|P6|Apheresis Period|not able to manufacture treatment cells|0
5725680|NCT00001832|19709158|P5|Apheresis Period|not able to manufacture treatment cells|0
5725681|NCT00001832|19709159|P4|Apheresis Period|not able to manufacture treatment cells|0
5725682|NCT00001832|19709160|P3|Apheresis Period|not able to manufacture treatment cells|0
5725683|NCT00001832|19709161|P2|Apheresis Period|not able to manufacture treatment cells|0
5725684|NCT00001832|19709162|P1|Apheresis Period|not able to manufacture treatment cells|60
5725685|NCT00001723|19709208|P2|Overall Study|medication intolerance|2
5725686|NCT00001723|19709209|P1|Overall Study|medication intolerance|1
5725687|NCT00001723|19709208|P2|Overall Study|Lost to Follow-up|2
5725688|NCT00001723|19709209|P1|Overall Study|Lost to Follow-up|2
5725689|NCT00001723|19709208|P2|Overall Study|Lack of family interest|5
5725690|NCT00001723|19709209|P1|Overall Study|Lack of family interest|4
5725691|NCT00001723|19709208|P2|Overall Study|Lack of Efficacy|7
5725692|NCT00001723|19709209|P1|Overall Study|Lack of Efficacy|6
5725693|NCT00001703|19709225|P1|Overall Study|recurrent disease|2
5725694|NCT00001703|19709225|P1|Overall Study|No evidence of disease|1
5725695|NCT00001703|19709225|P1|Overall Study|progressed disease|2
5725696|NCT00001596|19709263|P2|Overall Study|Adverse Event|0
5725697|NCT00001596|19709264|P1|Overall Study|Adverse Event|1
5725698|NCT00001596|19709263|P2|Overall Study|Study Termination|9
5725699|NCT00001596|19709264|P1|Overall Study|Study Termination|12
5725700|NCT00001596|19709263|P2|Overall Study|Withdrawal by Subject|1
5725701|NCT00001596|19709264|P1|Overall Study|Withdrawal by Subject|3
5725702|NCT00001596|19709263|P2|Overall Study|Death|0
5725703|NCT00001596|19709264|P1|Overall Study|Death|1
5725704|NCT00001575|19709295|P1|Overall Study|Withdrawn/deaths|23
5725705|NCT00001575|19709295|P1|Overall Study|Screening failures-Ph I portion|22
5725706|NCT00001566|19709301|P1|Overall Study|unable to complete initial apheresis|1
5725707|NCT00001566|19709301|P1|Overall Study|Lost to Follow-up|1
5725708|NCT00001566|19709301|P1|Overall Study|Death|13
5725709|NCT00001566|19709301|P1|Overall Study|stopped after C3 due to symptomatic PD|1
5725710|NCT00001566|19709301|P1|Overall Study|patients' choice to discontinue protocol|3
5725711|NCT00001262|19709341|P3|Overall Study|Withdrawal by Subject|0
5725712|NCT00001262|19709342|P2|Overall Study|Withdrawal by Subject|3
5725713|NCT00001262|19709343|P1|Overall Study|Withdrawal by Subject|0
5725714|NCT00001262|19709341|P3|Overall Study|Death|0
5725715|NCT00001262|19709342|P2|Overall Study|Death|11
5725716|NCT00001262|19709343|P1|Overall Study|Death|10
5725717|NCT00001213|19709369|P1|Overall Study|Death|18
5725718|NCT00000378|19709380|P2|Overall Study|Lack of Efficacy|14
5725719|NCT00000378|19709381|P1|Overall Study|Lack of Efficacy|16
5725720|NCT00000620|19709398|P8|Overall Study|missed closeout visit|16
5725721|NCT00000620|19709399|P7|Overall Study|missed closeout visit|13
5725722|NCT00000620|19709400|P6|Overall Study|missed closeout visit|28
5725723|NCT00000620|19709401|P5|Overall Study|missed closeout visit|26
5725724|NCT00000620|19709402|P4|Overall Study|missed closeout visit|11
5725725|NCT00000620|19709403|P3|Overall Study|missed closeout visit|16
5725726|NCT00000620|19709404|P2|Overall Study|missed closeout visit|28
5725727|NCT00000620|19709405|P1|Overall Study|missed closeout visit|22
5725728|NCT00000620|19709398|P8|Overall Study|Withdrawal by Subject|21
5725729|NCT00000620|19709399|P7|Overall Study|Withdrawal by Subject|32
5725730|NCT00000620|19709400|P6|Overall Study|Withdrawal by Subject|32
5725731|NCT00000620|19709401|P5|Overall Study|Withdrawal by Subject|30
5725732|NCT00000620|19709402|P4|Overall Study|Withdrawal by Subject|27
5725733|NCT00000620|19709403|P3|Overall Study|Withdrawal by Subject|28
5725734|NCT00000620|19709404|P2|Overall Study|Withdrawal by Subject|27
5725735|NCT00000620|19709405|P1|Overall Study|Withdrawal by Subject|40
5725736|NCT00000620|19709398|P8|Overall Study|Lost to Follow-up|14
5725737|NCT00000620|19709399|P7|Overall Study|Lost to Follow-up|13
5725738|NCT00000620|19709400|P6|Overall Study|Lost to Follow-up|15
5725739|NCT00000620|19709401|P5|Overall Study|Lost to Follow-up|15
5725740|NCT00000620|19709402|P4|Overall Study|Lost to Follow-up|14
5725741|NCT00000620|19709403|P3|Overall Study|Lost to Follow-up|14
5725742|NCT00000620|19709404|P2|Overall Study|Lost to Follow-up|14
5725743|NCT00000620|19709405|P1|Overall Study|Lost to Follow-up|14
5725744|NCT00000620|19709398|P8|Overall Study|Death|95
5725745|NCT00000620|19709399|P7|Overall Study|Death|91
5725746|NCT00000620|19709400|P6|Overall Study|Death|77
5725747|NCT00000620|19709401|P5|Overall Study|Death|64
5725748|NCT00000620|19709402|P4|Overall Study|Death|126
5725749|NCT00000620|19709403|P3|Overall Study|Death|112
5725750|NCT00000620|19709404|P2|Overall Study|Death|67
5725751|NCT00000620|19709405|P1|Overall Study|Death|86
5725752|NCT00004445|19709486|P1|Overall Study|Withdrawal by Subject|1
5725753|NCT00004445|19709486|P1|Overall Study|Physician Decision|2
5725754|NCT00004412|19709499|P3|Randomized Period|Moved to Crossover Period|0
5725755|NCT00004412|19709500|P2|Randomized Period|Moved to Crossover Period|0
5725756|NCT00004412|19709501|P1|Randomized Period|Moved to Crossover Period|3
5725757|NCT00000135|19709542|P2|Overall Study|Death|14
5725758|NCT00000135|19709543|P1|Overall Study|Death|27
